data_2kul_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kul _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.349999999999994 110.358 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.75 1.29 56.34 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.778 -0.725 . . . . 64.230000000000004 113.24 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.503 ' O ' HG11 ' A' ' 39' ' ' VAL . 31.8 mt-10 -70.05 110.08 4.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.275 0.537 . . . . 75.409999999999997 109.642 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.862 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -89.74 133.47 31.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.157 0.503 . . . . 75.219999999999999 110.499 178.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.59 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.79 -0.641 . . . . 74.400000000000006 110.888 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 24.0 m -84.65 125.67 32.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.736 0.303 . . . . 73.349999999999994 110.534 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -170.5 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 63.32 110.462 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 75.1 mtm -71.67 -20.55 61.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.778 0.288 . . . . 72.209999999999994 111.778 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.71 1.95 32.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.999 0.428 . . . . 71.329999999999998 110.343 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 71.22 24.37 3.83 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.141 -0.936 . . . . 71.230000000000004 112.595 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 30' ' ' THR . 90.1 mttt -103.05 136.72 42.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 74.140000000000001 109.532 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.862 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 19.2 tt0 -96.66 97.38 9.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.259 -0.645 . . . . 74.099999999999994 109.259 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.551 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 63.3 m95 -80.85 128.09 33.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.341 -0.845 . . . . 73.510000000000005 111.217 -172.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 56' ' ' MET . 68.1 tttt -92.01 108.02 19.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 110.294 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 27' ' ' GLU . 10.0 p -68.74 136.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.124 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -109.15 -86.13 1.75 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.694 -0.765 . . . . 45.5 112.588 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 95.2 mt -106.78 136.45 19.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.859 0.361 . . . . 72.349999999999994 111.527 -174.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.2 Cg_exo -78.07 106.69 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.163 2.575 . . . . 73.120000000000005 111.431 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.0 mt -73.9 -49.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 75.019999999999996 110.063 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.59 -23.56 12.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.907 -0.663 . . . . 52.240000000000002 112.371 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -110.35 164.79 12.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.115 -0.328 . . . . 64.450000000000003 110.115 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.83 -166.57 28.33 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.644 -0.983 . . . . 74.0 110.644 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.822 ' HA3' HG11 ' A' ' 196' ' ' VAL . . . -82.54 46.65 3.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.402 -0.904 . . . . 74.430000000000007 112.463 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.424 ' HB3' HD11 ' A' ' 51' ' ' ILE . 65.8 t80 177.93 -59.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.999 0.428 . . . . 74.120000000000005 110.013 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.32 154.78 8.97 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.532 -0.758 . . . . 73.040000000000006 111.215 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.4 m 59.27 38.4 23.3 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.23 0.538 . . . . 71.5 111.322 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.424 HD11 ' HB3' ' A' ' 48' ' ' PHE . 16.6 mm -88.43 138.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.94 -0.573 . . . . 72.109999999999999 110.062 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.449 ' HB3' HG21 ' A' ' 39' ' ' VAL . 87.4 m-85 -108.13 152.59 24.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 72.129999999999995 110.999 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.71 143.62 30.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.257 -0.646 . . . . 75.310000000000002 109.257 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.57 114.67 27.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.19 0.519 . . . . 72.120000000000005 111.137 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.486 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 28.3 t70 -84.98 -40.81 16.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.802 -0.635 . . . . 64.310000000000002 109.649 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.702 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 96.7 mmm 63.21 173.99 0.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.079 -0.964 . . . . 74.430000000000007 112.345 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -89.57 108.71 19.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.796 -0.638 . . . . 73.140000000000001 109.913 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -83.31 83.43 7.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.117 0.484 . . . . 70.349999999999994 110.363 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.778 -0.647 . . . . 70.129999999999995 110.731 179.449 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HB1' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 112.915 0.709 . . . . 73.420000000000002 112.915 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.468 ' HD3' ' HB1' ' A' ' 66' ' ' ALA . 7.8 Cg_exo -74.16 51.44 2.46 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.575 2.184 . . . . 71.420000000000002 113.912 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 31.2 p -138.93 162.44 34.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.075 0.464 . . . . 72.319999999999993 111.286 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.48 166.37 27.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 73.040000000000006 109.369 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 130' ' ' ILE . 2.6 p -136.33 128.99 45.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.536 -0.466 . . . . 72.010000000000005 112.138 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.637 ' HE2' ' SD ' ' A' ' 129' ' ' MET . 32.6 ttpt -85.35 142.55 29.24 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.826 -0.624 . . . . 75.219999999999999 109.582 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.83 132.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.952 -0.388 . . . . 74.530000000000001 109.952 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.957 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 5.1 tp10 -140.1 135.64 16.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.299 -0.409 . . . . 74.329999999999998 109.99 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.13 143.55 94.78 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.499 2.133 . . . . 74.209999999999994 112.151 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t -71.61 -2.64 17.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.388 -0.369 . . . . 74.299999999999997 111.66 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.2 -22.23 64.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.292 -0.633 . . . . 72.409999999999997 109.292 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.63 105.49 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.843 -1.071 . . . . 72.109999999999999 113.128 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -108.38 -89.63 2.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.298 -0.865 . . . . 74.209999999999994 111.13 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -84.83 -20.75 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.386 2.724 . . . . 74.230000000000004 111.831 176.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.957 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 55.2 tp -52.26 -49.53 63.87 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.405 0.891 . . . . 74.430000000000007 113.405 -169.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.2 -45.2 95.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.395 -0.522 . . . . 74.120000000000005 111.008 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.0 m -64.95 -46.51 81.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.022 0.439 . . . . 73.209999999999994 110.68 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 36.1 tt0 -65.29 -52.45 54.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.403 -0.817 . . . . 73.239999999999995 111.276 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.728 HD23 ' HE2' ' A' ' 129' ' ' MET . 3.3 tm? -65.93 -39.36 90.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.918 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.05 -49.72 76.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.805 -0.443 . . . . 75.120000000000005 109.805 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.459 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 76.2 t80 -65.93 -44.42 85.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.714 -0.676 . . . . 74.219999999999999 110.316 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.948 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 68.2 t80 -54.96 -53.9 49.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.804 -0.634 . . . . 74.530000000000001 111.005 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.54 -31.76 72.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.921 -0.581 . . . . 72.019999999999996 110.705 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -78.83 -29.52 44.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.420000000000002 111.877 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.66 -35.35 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.912 0.338 . . . . 75.530000000000001 111.912 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -83.64 71.52 10.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.748 0.785 . . . . 64.120000000000005 110.567 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 96' ' ' ILE . 4.6 tmtt? -125.02 103.79 30.17 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.839 -1.073 . . . . 75.219999999999999 109.428 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -42.98 -47.94 7.99 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.083 3.189 . . . . 72.540000000000006 113.368 -174.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 11.1 tp10 -57.99 -60.19 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 74.120000000000005 110.721 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -61.7 -41.46 97.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.566 -0.743 . . . . 72.310000000000002 111.504 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.595 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 69.6 mt -58.03 -52.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 O-C-N 123.073 0.233 . . . . 74.409999999999997 110.82 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -58.45 -42.61 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.532 -0.304 . . . . 73.030000000000001 110.959 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.7 mmtp -61.86 -62.67 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.907 -0.588 . . . . 74.049999999999997 111.943 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.639 ' CH2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.9 -35.23 72.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.584 -0.447 . . . . 71.019999999999996 111.643 -171.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.938 -0.305 . . . . 71.420000000000002 110.393 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -69.17 -41.33 77.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.439999999999998 111.129 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 p -76.4 -31.79 58.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.843 0.682 . . . . 73.329999999999998 112.843 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 36.1 ttm180 -89.7 5.54 45.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.065 0.459 . . . . 72.019999999999996 110.557 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 61.71 30.39 18.43 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.631 -0.713 . . . . 72.299999999999997 110.648 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.628 ' HG ' ' OD1' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -78.95 161.3 26.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.571 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.567 ' HB2' HH22 ' A' ' 321' ' ' ARG . 5.5 tmtm? -85.61 -66.29 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 75.420000000000002 109.982 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -163.07 135.51 5.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 74.209999999999994 110.817 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.639 HD23 ' CH2' ' A' ' 99' ' ' TRP . 26.7 tp -79.6 121.12 24.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 72.5 110.32 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.96 56.36 4.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.876 -0.678 . . . . 60.219999999999999 112.717 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 93.1 t -128.15 125.56 23.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.922 -0.399 . . . . 72.010000000000005 109.922 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.948 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -56.1 143.78 82.58 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.897 2.398 . . . . 75.109999999999999 112.593 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 113' ' ' TYR . 20.8 tptm -67.79 131.56 45.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 73.549999999999997 111.003 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.439 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 77.7 t80 -80.69 124.47 29.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.341 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 130' ' ' ILE . 14.2 m95 -106.11 -58.67 1.88 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.476 -0.564 . . . . 74.129999999999995 109.476 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.39 174.51 35.56 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.599 -0.728 . . . . 63.409999999999997 112.048 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.9 p -171.27 147.82 2.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.554 -0.535 . . . . 74.219999999999999 109.554 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.32 -167.9 33.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.116 -1.04 . . . . 74.519999999999996 112.611 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.5 tt -126.95 133.46 50.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.723 -0.473 . . . . 75.040000000000006 109.723 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -134.84 109.48 8.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.473 -0.331 . . . . 73.030000000000001 110.29 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.815 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 18.0 t70 -73.68 122.88 23.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.115 -0.493 . . . . 75.129999999999995 109.69 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -129.46 121.56 27.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 75.439999999999998 110.071 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.1 m120 63.74 16.5 9.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.915 -0.584 . . . . 73.209999999999994 111.658 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.57 -0.25 56.76 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.685 -0.769 . . . . 74.450000000000003 112.405 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -117.22 115.35 25.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.095 -0.705 . . . . 72.420000000000002 109.095 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.815 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.7 p -76.31 119.61 20.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 74.239999999999995 111.157 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 129.81 55.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 75.310000000000002 109.656 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.42 134.37 40.77 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.796 -0.816 . . . . 75.329999999999998 108.796 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.524 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 44.6 p90 -122.48 142.88 50.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 111.021 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.728 ' HE2' HD23 ' A' ' 84' ' ' LEU . 15.4 ptm -129.87 131.22 46.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 73.099999999999994 109.993 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 114' ' ' TRP . 3.3 mm -97.5 123.04 49.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 74.019999999999996 110.624 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 87' ' ' TYR . 38.4 mtm -126.5 178.38 5.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 71.129999999999995 110.415 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -65.58 151.39 46.56 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.625 -0.509 . . . . 73.099999999999994 109.625 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -72.23 116.12 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.254 0.549 . . . . 74.519999999999996 111.113 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 17.0 m-85 -104.97 143.35 33.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 75.140000000000001 110.214 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA3' ' CD1' ' A' ' 187' ' ' TYR . . . -140.16 -15.36 0.52 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.475 -0.869 . . . . 62.420000000000002 112.721 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.873 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 13.6 m -122.2 132.29 54.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.682 -0.305 . . . . 73.109999999999999 110.503 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 139' ' ' GLN . 3.6 p30 -125.74 148.88 48.93 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.843 -0.428 . . . . 74.329999999999998 109.843 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 157' ' ' LEU . 9.8 mp -74.71 -8.1 55.34 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.989 0.366 . . . . 74.019999999999996 111.989 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.406 ' HB3' ' OD1' ' A' ' 137' ' ' ASP . 7.5 tp-100 -76.91 -48.6 17.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 75.230000000000004 110.647 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.58 -37.22 62.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.949 0.404 . . . . 61.210000000000001 110.049 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.44 -33.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 73.340000000000003 110.503 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.486 ' CE1' ' HD2' ' A' ' 147' ' ' LYS . 13.9 t80 -53.23 -46.59 69.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.009 -0.541 . . . . 75.200000000000003 109.581 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -71.22 -52.91 16.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.476 -0.784 . . . . 72.230000000000004 110.796 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.07 73.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.912 0.708 . . . . 74.239999999999995 112.912 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -104.23 10.03 35.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.92 0.39 . . . . 75.120000000000005 110.368 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.408 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 53.28 40.27 31.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.742 -0.663 . . . . 71.129999999999995 111.628 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER 42.73 30.78 0.26 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.583 1.153 . . . . 73.299999999999997 113.669 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -86.27 95.01 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.515 -0.474 . . . . 74.519999999999996 110.042 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 66.5 m-85 -109.15 119.8 40.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.078 -0.51 . . . . 74.239999999999995 109.828 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.7 m -74.7 168.18 20.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.266 -0.424 . . . . 72.519999999999996 110.72 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 53.2 mtm-85 -51.67 -47.0 64.0 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.315 -0.402 . . . . 74.010000000000005 111.648 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.566 ' HD3' ' N ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -63.99 -30.05 71.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.853 0.358 . . . . 73.530000000000001 111.29 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.566 ' N ' ' HD3' ' A' ' 152' ' ' LYS . 1.3 m -72.49 -52.12 17.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.895 0.378 . . . . 72.340000000000003 110.383 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -41.06 91.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.71 -0.677 . . . . 75.5 110.913 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.04 -50.11 75.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 74.340000000000003 110.764 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.605 ' NE2' ' HA ' ' A' ' 335' ' ' ASP . 1.5 mp0 -64.06 -38.31 90.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.557 -0.292 . . . . 72.109999999999999 111.264 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 161' ' ' ILE . 4.8 mp -60.94 -52.83 63.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 74.430000000000007 110.558 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.484 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.6 p -68.03 -31.85 71.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 74.129999999999995 111.095 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.0 tp -57.03 -53.11 61.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 72.040000000000006 111.043 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 156' ' ' GLN . 2.1 mpt_? -67.91 -29.41 68.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.938 0.399 . . . . 75.439999999999998 110.638 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 157' ' ' LEU . 40.3 mm -65.73 -36.96 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 71.540000000000006 110.241 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 158' ' ' SER . 94.2 mt -62.16 -43.53 98.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 75.230000000000004 110.441 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.628 ' OD1' ' HG ' ' A' ' 105' ' ' LEU . 51.3 m-20 -55.71 -54.37 45.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.352 0.596 . . . . 73.200000000000003 110.484 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 161' ' ' ILE . 14.0 tt -71.98 -37.77 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 75.239999999999995 111.948 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.63 -38.58 90.79 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.829 -0.349 . . . . 73.129999999999995 111.169 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.39 -47.82 75.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.229 -0.588 . . . . 72.109999999999999 110.075 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.516 ' HA ' ' OE2' ' A' ' 170' ' ' GLU . 63.5 t80 -58.49 -41.67 85.83 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.437 0.532 . . . . 75.25 112.437 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.459 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 pt -88.29 -33.3 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.601 -0.439 . . . . 60.450000000000003 112.069 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.749 ' HD2' ' HD3' ' A' ' 240' ' ' ARG . 37.0 t60 -91.57 -5.92 53.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.665 0.269 . . . . 73.230000000000004 111.064 -172.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 167' ' ' TYR . 13.2 pt-20 -78.81 -19.79 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.482 . . . . 75.200000000000003 109.734 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -97.49 -65.07 0.99 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.91 -0.587 . . . . 73.319999999999993 111.447 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.601 ' HG2' ' HB2' ' A' ' 203' ' ' ARG . 35.7 tt0 -162.05 -44.31 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.24 0.829 . . . . 61.420000000000002 113.24 -168.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -80.49 158.06 25.97 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.246 0.832 . . . . 73.409999999999997 113.246 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 169' ' ' HIS . 3.6 m -129.7 172.26 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.58 -1.191 . . . . 74.219999999999999 108.48 171.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 19.7 t-80 -144.64 92.49 2.3 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.115 -0.698 . . . . 75.239999999999995 109.115 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 246' ' ' ILE . . . -63.71 -47.33 87.54 Favored Glycine 0 C--O 1.226 -0.4 0 O-C-N 123.522 0.514 . . . . 73.25 113.67 -170.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.527 ' HB3' HD11 ' A' ' 200' ' ' LEU . 26.1 t0 -99.02 105.44 17.57 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.387 -0.478 . . . . 72.140000000000001 110.525 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 29.0 mm -89.97 91.3 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 74.019999999999996 109.575 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -93.98 149.82 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.372 -0.831 . . . . 72.310000000000002 109.798 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 138' ' ' LEU . . . -54.85 -26.83 37.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 71.540000000000006 111.733 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.5 p -77.39 -5.58 50.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.945 0.35 . . . . 74.239999999999995 111.945 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 197' ' ' ASP . 12.2 m120 -83.18 -22.96 33.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 71.129999999999995 110.809 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.75 115.97 31.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 110.426 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.6 mm? -113.83 131.8 56.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 74.099999999999994 109.817 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.873 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.8 mt -89.45 140.92 29.04 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 110.178 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 189' ' ' ASN . 43.7 t-20 -59.71 125.61 24.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.97 -0.752 . . . . 71.310000000000002 108.97 175.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.519 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 36.2 t80 -52.6 -31.27 35.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.507 0.558 . . . . 74.420000000000002 112.507 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -126.91 24.55 6.44 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.381 -0.527 . . . . 75.400000000000006 111.914 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 6.1 t30 -159.57 80.78 2.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.456 -0.572 . . . . 74.319999999999993 109.456 174.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.67 -24.26 55.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 123.33 2.686 . . . . 74.409999999999997 113.993 -170.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -71.0 -14.38 62.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.926 -0.309 . . . . 75.230000000000004 111.592 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -114.04 114.75 26.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 74.140000000000001 110.294 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.68 142.86 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.831 . . . . 72.099999999999994 110.787 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.777 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 59.1 m-85 -115.92 157.97 23.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 65.439999999999998 109.945 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 8.9 tt -115.97 141.21 48.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 72.219999999999999 109.792 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.822 HG11 ' HA3' ' A' ' 47' ' ' GLY . 1.4 p -141.27 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.568 -0.901 . . . . 72.209999999999994 108.568 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 196' ' ' VAL . 17.8 t70 68.74 65.49 0.31 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 72.120000000000005 108.449 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.432 ' CD2' ' HG3' ' A' ' 83' ' ' GLU . 85.6 m-85 -88.49 16.52 6.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.099 -1.409 . . . . 75.340000000000003 110.656 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -70.33 -26.52 74.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.702 -0.761 . . . . 72.430000000000007 111.296 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 177' ' ' ASP . 35.7 mt -88.78 36.38 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 110.494 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -106.07 98.88 8.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.161 0.505 . . . . 73.439999999999998 110.354 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -100.27 145.84 27.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.964 -0.754 . . . . 73.120000000000005 108.964 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.601 ' HB2' ' HG2' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -88.86 130.54 35.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.164 0.506 . . . . 75.340000000000003 111.028 -177.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -103.23 -54.0 2.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 74.219999999999999 110.088 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.18 94.43 30.57 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.792 -0.64 . . . . 73.010000000000005 110.427 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 207' ' ' GLU . 18.5 Cg_endo -60.0 123.17 12.65 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.486 2.124 . . . . 63.219999999999999 111.523 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 206' ' ' PRO . 32.4 tt0 70.31 -63.96 0.38 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.865 0.728 . . . . 75.209999999999994 111.076 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.68 28.51 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.413 -0.675 . . . . 73.319999999999993 111.413 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.94 110.7 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.211 -0.292 . . . . 75.109999999999999 110.211 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -75.94 104.41 6.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.914 . . . . 64.310000000000002 108.531 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -88.44 0.08 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.906 -0.588 . . . . 75.040000000000006 111.631 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 173.05 139.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.442 -0.947 . . . . 74.400000000000006 108.442 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -84.3 87.92 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.075 0.941 . . . . 71.019999999999996 110.241 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 214' ' ' LYS . 3.0 mmtt -155.24 33.15 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.031 -0.986 . . . . 64.319999999999993 109.947 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.3 -5.55 54.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.316 -0.856 . . . . 71.049999999999997 109.645 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.683 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.1 p-10 -79.33 113.8 39.63 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.144 -0.935 . . . . 72.150000000000006 111.499 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.515 2.144 . . . . 72.109999999999999 111.876 175.644 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.521 0.677 . . . . 74.310000000000002 109.613 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 102.23 -166.28 17.42 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.691 -0.766 . . . . 74.400000000000006 112.293 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 70.4 p -80.29 151.35 29.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.961 0.41 . . . . 63.439999999999998 110.994 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.425 ' HA ' HG23 ' A' ' 228' ' ' THR . 17.9 tt -63.02 -9.02 3.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.67 0.747 . . . . 72.430000000000007 110.885 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.05 -68.13 0.32 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.783 -1.098 . . . . 75.409999999999997 111.521 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -103.24 -11.19 18.16 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.243 0.46 . . . . 74.120000000000005 112.243 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 225' ' ' ILE . 5.6 t -62.34 -8.94 6.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.01 0.374 . . . . 75.140000000000001 112.01 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.9 t 62.49 -174.04 0.15 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.771 0.429 . . . . 70.310000000000002 110.9 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.421 HD13 ' N ' ' A' ' 230' ' ' ILE . 3.7 mp -73.33 -40.19 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.382 -0.599 . . . . 72.200000000000003 109.382 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' HG12 ' A' ' 236' ' ' VAL . 2.1 m-20 -49.69 -72.65 0.05 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.603 -1.18 . . . . 73.400000000000006 111.934 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.42 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 72.439999999999998 111.53 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -62.46 -39.8 94.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.537 0.208 . . . . 74.409999999999997 110.579 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.24 -26.19 61.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.659 . . . . 74.230000000000004 109.219 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 110.75 7.25 25.87 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.775 -0.648 . . . . 73.450000000000003 112.817 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.683 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 9.5 p -89.94 136.98 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.973 0.416 . . . . 74.010000000000005 110.413 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.92 115.07 43.08 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 74.129999999999995 109.891 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.639 ' HB2' ' HA3' ' A' ' 242' ' ' GLY . 81.7 Cg_endo -79.28 148.97 21.59 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.647 2.231 . . . . 73.340000000000003 112.857 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.5 t -85.47 -159.95 0.48 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.797 -0.816 . . . . 71.200000000000003 108.797 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.749 ' HD3' ' HD2' ' A' ' 169' ' ' HIS . 14.9 mmt-85 -54.18 -35.55 62.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.75 0.309 . . . . 74.310000000000002 111.237 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.973 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 8.2 mmm180 -56.65 -32.89 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 72.409999999999997 112.125 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 238' ' ' PRO . . . -67.37 -54.73 18.51 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.593 -0.813 . . . . 75.340000000000003 111.72 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.88 -41.75 83.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.043 0.449 . . . . 74.140000000000001 110.538 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 91.8 mt -64.36 -38.46 91.12 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.863 -0.608 . . . . 74.239999999999995 110.891 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.81 -50.27 69.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.491 0.662 . . . . 75.239999999999995 110.189 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 242' ' ' GLY . 35.6 mt -59.04 -47.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.018 -0.992 . . . . 74.040000000000006 110.89 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.483 HD12 HG21 ' A' ' 161' ' ' ILE . 56.7 tp -57.9 -42.63 85.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 64.439999999999998 110.608 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.64 94.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.965 -0.636 . . . . 64.230000000000004 112.051 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.434 ' HH ' ' HD3' ' A' ' 279' ' ' ARG . 22.1 m-30 -64.26 -42.0 96.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 64.420000000000002 110.906 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 27.0 m -69.65 -36.87 76.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.582 -0.281 . . . . 71.299999999999997 110.691 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.8 mtp -62.11 -49.8 74.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 74.349999999999994 111.015 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.08 -32.01 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 74.209999999999994 110.708 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -56.48 -53.93 51.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.011 0.434 . . . . 74.530000000000001 110.503 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.0 m0 -69.27 -28.44 66.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 71.430000000000007 111.252 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.24 -32.77 38.36 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.188 0.44 . . . . 72.329999999999998 112.188 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 290' ' ' PHE . 61.7 p -103.8 -28.58 11.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.421 -0.512 . . . . 74.140000000000001 111.75 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 114.8 -36.74 3.8 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.338 -0.934 . . . . 74.129999999999995 113.062 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.53 147.48 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.265 0.533 . . . . 74.219999999999999 111.102 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.444 HD12 ' CZ2' ' A' ' 261' ' ' TRP . 96.1 mt -94.17 139.22 22.45 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.44 -0.345 . . . . 71.209999999999994 110.449 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 -36.95 98.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.981 2.454 . . . . 74.409999999999997 112.53 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.538 ' HB2' HG11 ' A' ' 271' ' ' VAL . 41.7 p90 -87.55 -2.35 58.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 75.329999999999998 110.852 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 64.2 tt0 -86.92 -37.79 17.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.141 -0.689 . . . . 73.400000000000006 109.141 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.99 -20.37 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.133 -0.691 . . . . 75.549999999999997 109.133 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -107.9 26.18 10.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.924 . . . . 74.25 110.795 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -74.36 64.41 1.12 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.685 0.755 . . . . 74.420000000000002 109.873 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -157.22 14.07 0.25 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.149 -0.932 . . . . 74.019999999999996 109.442 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 13.9 t70 -157.31 120.31 2.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.917 -0.583 . . . . 74.510000000000005 110.556 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 15.6 Cg_exo -68.85 -27.23 31.26 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.0 2.467 . . . . 72.409999999999997 112.602 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -73.32 -48.37 34.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.556 -0.535 . . . . 72.120000000000005 109.556 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.563 . . . . 72.409999999999997 112.184 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.538 HG11 ' HB2' ' A' ' 261' ' ' TRP . 35.3 m -65.49 -41.86 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.55 -0.46 . . . . 74.099999999999994 110.906 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -66.7 -48.79 68.13 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.19 -0.3 . . . . 74.510000000000005 110.19 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.91 -53.36 56.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.225 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.405 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 27.2 m -59.06 -41.77 88.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.353 0.408 . . . . 74.340000000000003 111.463 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 279' ' ' ARG . 97.6 mttt -63.86 -48.25 77.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.009 -0.276 . . . . 63.310000000000002 110.942 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.63 HG12 HH21 ' A' ' 279' ' ' ARG . 66.0 mt -63.12 -43.37 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.304 0.573 . . . . 55.0 110.281 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.71 -46.62 77.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.801 -1.091 . . . . 75.5 111.538 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.724 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 32.4 m-85 -74.26 -32.2 62.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 73.200000000000003 111.814 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.63 HH21 HG12 ' A' ' 276' ' ' ILE . 88.0 mtm180 -74.71 -16.23 60.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.256 0.465 . . . . 74.219999999999999 112.256 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 41.3 mt-10 -60.9 -48.99 79.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.77 0.319 . . . . 74.099999999999994 110.742 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.482 ' HB2' HD22 ' A' ' 285' ' ' LEU . 15.1 m120 -127.93 70.93 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 73.200000000000003 109.725 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.459 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -54.02 -44.28 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.764 -0.653 . . . . 72.120000000000005 112.615 -173.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.459 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.6 -47.51 78.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 73.209999999999994 110.847 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 27.8 t -67.22 -49.25 65.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.715 -0.675 . . . . 74.310000000000002 110.605 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.724 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.0 mm? -64.16 -50.37 68.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 111.561 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 282' ' ' ILE . 0.1 OUTLIER -58.38 -44.66 89.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.543 0.211 . . . . 75.299999999999997 111.56 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.681 ' HA ' ' HG2' ' A' ' 296' ' ' PRO . 18.8 t70 -68.16 -27.46 66.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 110.812 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -96.58 6.46 48.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.941 -0.572 . . . . 75.239999999999995 111.533 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.6 -38.41 59.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.027 0.441 . . . . 74.319999999999993 110.795 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.666 ' HB2' HG21 ' A' ' 256' ' ' THR . 29.3 t80 -137.56 75.29 44.8 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 73.409999999999997 109.575 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -93.93 110.94 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.382 2.721 . . . . 74.519999999999996 112.54 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -159.59 -82.66 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.257 -0.646 . . . . 71.109999999999999 109.257 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -144.13 29.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.535 -0.913 . . . . 73.540000000000006 108.535 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -94.8 162.46 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.632 -1.167 . . . . 75.140000000000001 109.855 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -122.68 90.81 49.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.576 -0.527 . . . . 71.519999999999996 109.576 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.681 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 89.1 Cg_endo -98.85 37.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.055 2.503 . . . . 73.409999999999997 112.207 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.87 -39.91 12.8 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.629 -0.796 . . . . 65.430000000000007 111.654 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.504 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -55.03 -44.21 74.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.269 -0.466 . . . . 71.230000000000004 110.123 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.6 mp -69.74 -42.58 80.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 65.299999999999997 110.528 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.74 -48.6 81.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 75.109999999999999 111.18 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.752 ' HE2' ' HA ' ' A' ' 301' ' ' LYS . 8.5 mmpt? -66.08 -41.94 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 73.420000000000002 110.836 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -55.59 -48.56 74.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.108 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.484 ' HA ' HG21 ' A' ' 306' ' ' VAL . 93.8 mmm -68.67 -37.84 79.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.2 -0.454 . . . . 74.140000000000001 111.366 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.5 -39.86 94.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.28 0.562 . . . . 75.120000000000005 109.619 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.8 m -65.19 -44.51 88.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.191 -0.913 . . . . 74.310000000000002 111.388 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.535 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 29.4 m -69.01 -31.61 51.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 120.622 -0.431 . . . . 73.230000000000004 111.349 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -74.03 -28.28 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.249 0.547 . . . . 74.409999999999997 109.907 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.04 -16.89 61.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 71.340000000000003 111.782 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 306' ' ' VAL . 4.2 pp -95.64 16.45 17.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.673 0.273 . . . . 74.530000000000001 111.601 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 16.1 t70 68.48 -96.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.786 -0.643 . . . . 71.040000000000006 111.478 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.973 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.2 OUTLIER -136.89 -38.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.943 0.402 . . . . 74.299999999999997 110.035 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.7 t -158.38 29.17 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 75.329999999999998 110.045 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -71.46 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.235 -0.654 . . . . 74.430000000000007 109.235 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 58.8 mmtt -130.25 79.59 72.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 70.409999999999997 111.227 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.522 ' HA ' HD22 ' A' ' 309' ' ' LEU . 18.3 Cg_endo -91.78 118.05 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.598 2.199 . . . . 72.319999999999993 111.531 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 319' ' ' ASN . 30.3 tp -133.7 103.99 6.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.057 -0.519 . . . . 74.209999999999994 109.721 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.66 -33.72 76.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.641 -0.709 . . . . 74.200000000000003 111.472 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.28 -27.39 66.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.632 -0.427 . . . . 72.530000000000001 110.709 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.497 ' HB2' HD23 ' A' ' 316' ' ' LEU . 5.9 t30 -72.25 -38.51 68.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.328 0.585 . . . . 61.409999999999997 109.457 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.405 ' HA ' HG23 ' A' ' 323' ' ' ILE . 68.7 mt -69.96 -37.08 75.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.45 -0.796 . . . . 75.310000000000002 109.381 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.567 HH22 ' HB2' ' A' ' 106' ' ' LYS . 23.8 ttt180 -59.65 -41.06 89.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.785 -1.098 . . . . 74.450000000000003 109.973 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.73 -52.39 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 74.319999999999993 111.985 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.437 0.161 . . . . 74.239999999999995 110.956 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 155' ' ' LEU . 94.1 mt -64.38 -46.92 81.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.713 0.292 . . . . 75.120000000000005 110.992 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.49 -34.92 78.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 73.340000000000003 111.03 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -42.77 95.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 72.340000000000003 110.402 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.504 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.47 -46.34 85.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 64.510000000000005 111.711 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.488 HD21 ' HG ' ' A' ' 155' ' ' LEU . 35.1 tp -59.78 -42.66 93.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.172 0.51 . . . . 72.150000000000006 110.698 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -70.88 -25.83 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.674 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.9 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 64.310000000000002 111.01 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.5 tt -89.17 2.9 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.384 0.612 . . . . 75.439999999999998 110.611 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.39 15.31 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.952 -0.642 . . . . 71.329999999999998 113.847 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.616 ' HG ' ' HB2' ' A' ' 336' ' ' ASP . 17.1 t -121.97 138.57 54.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.407 0.604 . . . . 63.149999999999999 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -154.67 99.5 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.067 -0.515 . . . . 75.239999999999995 109.806 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.605 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 13.8 t70 55.26 54.12 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.047 0.927 . . . . 72.129999999999995 108.675 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.616 ' HB2' ' HG ' ' A' ' 333' ' ' SER . 29.4 t70 -66.49 103.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.346 -1.297 . . . . 75.230000000000004 112.486 -167.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.01 71.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.56 -0.745 . . . . 52.340000000000003 113.565 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 96.2 mttt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.967 0.413 . . . . 71.200000000000003 110.884 -179.278 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.626 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 23.5 mtmm . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.966 0.412 . . . . 75.420000000000002 111.363 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.01 159.22 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 73.510000000000005 111.911 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -74.87 141.22 16.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.155 0.502 . . . . 73.209999999999994 111.254 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.9 t -86.18 73.66 10.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.539 0.685 . . . . 72.540000000000006 110.092 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.786 -0.643 . . . . 75.140000000000001 111.443 -176.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.522 ' HA ' HG21 ' A' ' 39' ' ' VAL . 99.3 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.031 -0.359 . . . . 74.340000000000003 110.031 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.579 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . 99.6 -3.59 57.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 74.519999999999996 112.655 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -96.67 159.43 14.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.944 0.402 . . . . 72.510000000000005 110.714 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -79.1 146.06 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 72.340000000000003 112.159 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tp -133.79 122.51 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.236 -0.893 . . . . 72.340000000000003 109.568 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.572 ' HG1' ' HG3' ' A' ' 36' ' ' GLU . 3.6 m -96.77 134.21 40.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.712 -0.222 . . . . 64.109999999999999 111.505 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.57 -176.32 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.565 -0.532 . . . . 73.340000000000003 109.565 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.4 tpp -72.59 -22.54 60.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.552 0.215 . . . . 74.409999999999997 111.162 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.7 21.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.108 0.48 . . . . 73.150000000000006 110.226 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 71.07 36.12 1.48 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.991 -1.004 . . . . 70.439999999999998 111.409 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.05 121.96 45.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 62.030000000000001 110.199 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.572 ' HG3' ' HG1' ' A' ' 30' ' ' THR . 4.1 mp0 -87.03 97.2 10.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.226 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 44.1 m95 -84.93 -171.74 3.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.63 -0.878 . . . . 65.319999999999993 108.63 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 66.0 mttt -134.68 137.05 43.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.426 . . . . 72.540000000000006 110.402 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 52' ' ' TYR . 2.4 m -69.23 118.64 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 73.040000000000006 110.693 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.42 ' CA ' ' HB3' ' A' ' 56' ' ' MET . . . -107.28 -116.43 4.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.834 -0.698 . . . . 74.519999999999996 112.214 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 mm? -91.08 122.69 66.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.81 0.338 . . . . 74.439999999999998 110.977 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_exo -78.51 104.77 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.914 2.409 . . . . 73.25 111.052 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.14 -46.86 23.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 75.530000000000001 110.227 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.37 -27.67 8.3 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.433 -0.667 . . . . 73.129999999999995 111.433 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -107.79 165.27 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.29 -0.455 . . . . 74.519999999999996 109.878 -177.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 184' ' ' LEU . . . 156.69 -88.37 0.12 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.498 -0.641 . . . . 52.25 111.498 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . -158.22 50.13 0.42 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.609 -0.805 . . . . 63.299999999999997 112.353 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 63.7 t80 171.71 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.119 0.568 . . . . 74.019999999999996 109.684 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.18 134.77 1.7 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.99 -0.844 . . . . 75.409999999999997 110.99 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.5 t 65.52 76.48 0.33 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.622 0.725 . . . . 72.409999999999997 110.176 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -121.65 135.47 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 73.519999999999996 109.73 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 39' ' ' VAL . 51.9 p90 -131.15 154.78 47.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.181 -0.608 . . . . 73.109999999999999 111.311 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HA ' HG13 ' A' ' 69' ' ' VAL . 2.0 tt -71.52 133.18 45.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 73.540000000000006 109.418 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 37' ' ' TRP . . . -93.39 36.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.224 0.453 . . . . 73.230000000000004 112.224 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.43 ' O ' HD21 ' A' ' 53' ' ' LEU . 17.0 t0 -178.73 152.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.112 -0.699 . . . . 72.329999999999998 109.112 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.579 ' SD ' ' HA2' ' A' ' 26' ' ' GLY . 4.6 ppp? -144.58 6.66 1.26 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 73.510000000000005 110.38 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -139.33 -179.34 5.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 75.019999999999996 109.792 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -90.21 72.69 7.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.764 -0.458 . . . . 74.430000000000007 109.764 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 121.493 0.663 . . . . 43.549999999999997 109.789 176.226 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.562 0.696 . . . . 72.019999999999996 110.12 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.72 23.34 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.891 2.394 . . . . 74.329999999999998 113.084 -172.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.2 p -124.18 139.02 54.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.367 0.603 . . . . 74.409999999999997 111.944 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 53' ' ' LEU . 20.5 m -130.85 170.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.393 -0.821 . . . . 73.129999999999995 109.544 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 1.5 p -132.48 127.2 56.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.059 0.457 . . . . 63.350000000000001 111.431 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 17.9 ptpt -85.34 130.1 34.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.241 -0.891 . . . . 73.019999999999996 109.101 174.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.6 127.74 66.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.983 0.42 . . . . 74.109999999999999 111.397 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 25.9 tt0 -115.25 141.01 26.47 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.393 -0.965 . . . . 74.400000000000006 108.393 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.38 -171.45 0.12 Allowed 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.218 1.945 . . . . 74.239999999999995 111.639 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 t -76.79 78.97 3.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.256 0.551 . . . . 73.109999999999999 109.559 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -122.08 -52.49 1.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 73.430000000000007 110.541 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.38 46.34 1.98 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.884 0.849 . . . . 74.040000000000006 109.651 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.98 -80.81 0.86 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.127 -0.942 . . . . 44.310000000000002 111.658 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.8 Cg_exo -59.77 -43.96 34.35 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.712 2.275 . . . . 61.32 112.033 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.28 -33.27 75.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.298 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.57 -50.53 69.11 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.909 0.385 . . . . 54.530000000000001 111.033 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.0 m -65.15 -43.74 90.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 74.109999999999999 110.674 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.525 ' CD ' ' HZ1' ' A' ' 71' ' ' LYS . 25.8 tt0 -66.83 -35.48 80.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 70.129999999999995 110.388 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.07 -49.28 78.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 109.944 178.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -60.23 -39.69 87.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.007 0.432 . . . . 75.310000000000002 110.708 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.01 -52.62 65.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.204 -0.453 . . . . 72.540000000000006 110.413 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.84 -33.19 73.71 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.25 111.382 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -63.61 -28.46 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.642 0.238 . . . . 74.439999999999998 111.642 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.631 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 2.9 mmp_? -93.65 -16.09 24.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.054 0.39 . . . . 74.510000000000005 112.054 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.81 17.71 22.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.597 0.713 . . . . 61.350000000000001 110.511 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.21 136.27 38.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.067 -0.97 . . . . 75.120000000000005 112.807 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 34.4 ttmt 73.45 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.83 -1.077 . . . . 74.430000000000007 111.948 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HA ' HD13 ' A' ' 96' ' ' ILE . 62.0 Cg_exo -53.03 -28.71 41.46 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.711 2.94 . . . . 74.409999999999997 113.373 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.83 -50.87 62.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 74.510000000000005 111.163 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 35.1 mt-30 -73.19 -34.72 66.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.132 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 100' ' ' ILE . 65.8 mt -58.9 -53.96 40.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 75.430000000000007 110.488 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -62.48 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 75.519999999999996 110.574 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 22.2 ttmm -55.04 -65.3 0.61 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.94 -0.573 . . . . 75.040000000000006 111.37 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.581 ' HZ2' HD12 ' A' ' 108' ' ' LEU . 3.7 p90 -69.5 -32.9 72.05 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.496 -0.482 . . . . 73.310000000000002 110.884 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 107' ' ' TYR . 48.7 mt -59.05 -39.5 78.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 120.67 0.271 . . . . 73.409999999999997 110.594 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -76.51 -27.62 56.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.87 0.366 . . . . 73.430000000000007 110.312 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -70.43 -44.21 68.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 110.748 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 103' ' ' ARG . 42.2 mtt-85 -83.2 -13.81 54.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.474 -0.33 . . . . 73.230000000000004 110.759 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 57.51 69.57 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.745 0.783 . . . . 75.099999999999994 109.733 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 10.2 tp -108.81 -167.91 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.76 -1.109 . . . . 72.120000000000005 109.04 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.594 ' HG3' ' CD1' ' A' ' 107' ' ' TYR . 20.7 tptm -100.16 -68.15 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.571 -0.452 . . . . 73.120000000000005 110.033 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.594 ' CD1' ' HG3' ' A' ' 106' ' ' LYS . 55.2 p90 -179.96 152.06 0.45 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.985 0.422 . . . . 74.150000000000006 110.587 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.581 HD12 ' HZ2' ' A' ' 99' ' ' TRP . 83.5 mt -78.41 136.55 37.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 74.099999999999994 111.007 -176.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.84 51.5 4.45 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.126 -0.789 . . . . 74.409999999999997 111.126 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.416 HG22 ' HB3' ' A' ' 108' ' ' LEU . 60.5 t -119.73 129.75 25.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.876 -0.416 . . . . 74.5 109.876 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 35.1 Cg_exo -61.07 148.86 91.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.763 2.308 . . . . 74.150000000000006 112.454 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HD2' ' CE2' ' A' ' 114' ' ' TRP . 4.1 ttmp? -62.91 128.57 36.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.779 -0.646 . . . . 74.209999999999994 110.804 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -90.9 85.14 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.929 -0.578 . . . . 74.049999999999997 110.656 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.557 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 10.4 m95 -67.33 -55.5 13.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 74.040000000000006 109.858 173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.09 -171.32 36.94 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.414 -0.812 . . . . 70.519999999999996 111.622 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 43.1 p 176.94 175.14 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.475 -0.565 . . . . 61.439999999999998 109.475 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.15 -159.32 28.74 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.069 -1.062 . . . . 72.420000000000002 112.884 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.8 tt -131.52 138.64 49.02 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.495 -0.557 . . . . 73.319999999999993 109.495 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -143.24 134.86 26.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.683 -0.488 . . . . 74.439999999999998 109.683 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.882 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.9 t70 -74.89 140.07 43.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.801 -0.444 . . . . 73.530000000000001 109.801 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -103.46 40.68 1.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.714 -0.476 . . . . 73.040000000000006 109.714 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.42 67.53 0.83 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.651 -0.704 . . . . 73.420000000000002 110.412 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.03 -58.24 0.56 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.261 -0.881 . . . . 73.530000000000001 111.492 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 42.4 tptt -134.29 142.74 47.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.431 -0.581 . . . . 75.5 109.431 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.9 m -88.29 148.73 24.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.325 -0.398 . . . . 73.340000000000003 111.437 -176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.8 151.64 37.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 73.450000000000003 110.81 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -113.39 120.0 39.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.925 -0.769 . . . . 75.140000000000001 108.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.57 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -134.95 162.4 32.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 73.439999999999998 112.081 -171.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 45.7 ttm -140.2 139.81 35.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.672 -0.695 . . . . 74.219999999999999 110.613 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.56 HD12 ' HB ' ' A' ' 70' ' ' VAL . 7.7 mm -98.17 126.0 51.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.322 -0.399 . . . . 63.299999999999997 110.421 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 8.2 ptp -138.54 -179.22 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 71.349999999999994 110.38 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -73.21 156.15 38.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.66 -0.866 . . . . 74.140000000000001 108.66 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.536 ' HG3' ' HB3' ' A' ' 187' ' ' TYR . 25.1 ptt180 -85.41 135.2 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.027 0.441 . . . . 74.420000000000002 111.781 -174.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.469 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 43.3 m-85 -124.02 153.44 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.340000000000003 109.841 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.502 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -159.13 8.67 0.17 Allowed Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.946 -1.121 . . . . 72.519999999999996 113.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.055 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.0 m -122.98 125.5 45.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.021 -0.694 . . . . 72.439999999999998 110.791 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 181' ' ' SER . 3.3 t70 -116.48 140.14 49.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 74.310000000000002 111.422 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 10.2 mp -67.94 -33.06 73.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.71 -0.677 . . . . 73.209999999999994 111.797 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 55.2 tp60 -72.63 -35.83 67.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.46 . . . . 74.109999999999999 110.088 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 46.4 tptt -70.83 -48.13 55.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.026 -0.534 . . . . 74.129999999999995 110.528 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.43 -30.04 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.97 -0.559 . . . . 74.310000000000002 110.176 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 1.1 t80 -51.27 -46.08 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.534 -0.757 . . . . 72.409999999999997 110.593 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.54 -36.01 33.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.138 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.349 0.5 . . . . 72.540000000000006 112.349 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -101.95 3.66 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 110.475 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 59.02 55.8 4.28 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.318 -0.856 . . . . 64.030000000000001 111.935 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 257' ' ' GLY . 21.9 pttm 45.53 38.78 4.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.067 0.947 . . . . 75.219999999999999 113.113 172.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -115.79 88.75 2.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 75.209999999999994 109.933 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -101.75 123.8 46.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.397 -0.365 . . . . 72.120000000000005 111.009 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.9 m -72.37 147.32 46.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.906 -0.588 . . . . 75.140000000000001 110.861 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.627 ' NH2' ' HB3' ' A' ' 295' ' ' LYS . 42.0 ttm105 -56.11 -36.5 68.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.126 -0.488 . . . . 74.349999999999994 111.912 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -51.78 -44.3 63.35 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.354 0.597 . . . . 74.430000000000007 110.75 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.456 ' O ' HD11 ' A' ' 157' ' ' LEU . 74.9 m -71.93 -49.98 32.96 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.678 -0.692 . . . . 72.530000000000001 110.791 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.12 -35.24 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 62.340000000000003 110.646 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.703 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -65.78 -52.74 48.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 74.519999999999996 110.851 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 25.5 tt0 -60.6 -46.77 88.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.33 -0.548 . . . . 71.120000000000005 109.883 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 153' ' ' THR . 6.4 mp -54.92 -51.72 65.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.905 -0.589 . . . . 75.209999999999994 111.226 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -57.68 -44.71 85.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.445 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.75 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 111.116 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.63 -38.04 86.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.115 0.483 . . . . 75.409999999999997 110.734 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 59.1 mt -71.04 -37.27 66.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.756 . . . . 74.409999999999997 110.061 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.82 -50.7 71.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.252 -0.431 . . . . 73.140000000000001 110.382 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.595 ' OD2' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-20 -52.34 -57.55 9.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.771 -0.65 . . . . 71.420000000000002 111.323 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.14 -35.9 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.793 -0.639 . . . . 72.340000000000003 111.012 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 16.7 tp -60.59 -38.7 85.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.779 0.323 . . . . 73.430000000000007 110.85 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.66 -48.09 64.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.595 -0.52 . . . . 74.530000000000001 109.595 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.64 -48.6 77.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.901 -0.59 . . . . 71.239999999999995 111.834 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.487 HD13 HD12 ' A' ' 165' ' ' LEU . 32.2 pt -67.04 -36.97 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.88 -0.328 . . . . 74.409999999999997 111.716 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.448 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 49.2 m80 -69.99 -26.89 64.3 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.586 -0.445 . . . . 73.349999999999994 110.863 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.9 -27.55 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.182 0.515 . . . . 73.129999999999995 109.928 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.99 66.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 73.219999999999999 111.466 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 77.8 -51.39 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.814 1.042 . . . . 73.400000000000006 113.814 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -85.91 142.06 29.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.497 1.295 . . . . 71.200000000000003 114.497 -161.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 169' ' ' HIS . 25.6 m -115.88 164.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.404 -1.271 . . . . 75.030000000000001 107.949 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -126.16 92.47 3.59 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 71.439999999999998 110.358 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.447 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -65.29 -42.08 96.37 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.715 -0.675 . . . . 63.219999999999999 113.249 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.606 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 32.7 t70 -89.18 107.72 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 111.577 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.521 ' HB ' HG22 ' A' ' 246' ' ' ILE . 38.0 mm -110.89 112.27 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.918 -0.771 . . . . 75.299999999999997 108.918 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -138.49 159.03 43.12 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.923 -0.769 . . . . 74.409999999999997 108.923 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 138' ' ' LEU . . . -55.9 -36.44 67.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 111.204 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.564 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 4.6 m -68.98 -5.34 21.0 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 70.420000000000002 112.44 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -93.2 -13.37 28.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.009 0.433 . . . . 75.420000000000002 110.72 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.52 HD21 HD11 ' A' ' 161' ' ' ILE . 7.3 mp -105.89 111.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.723 -0.671 . . . . 73.519999999999996 109.755 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 196' ' ' VAL . 3.7 mm? -114.48 130.94 56.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.798 -0.637 . . . . 73.439999999999998 110.326 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 1.055 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 41.4 mt -84.62 142.88 29.62 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.638 -0.71 . . . . 73.200000000000003 109.674 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.469 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 40.5 t-20 -59.93 135.43 57.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.533 -0.543 . . . . 73.530000000000001 109.533 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.536 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 82.7 t80 -61.82 -30.38 70.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.981 0.419 . . . . 73.349999999999994 111.221 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -93.95 -36.02 12.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.303 -0.408 . . . . 72.040000000000006 110.074 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 4.6 m-20 -114.96 87.97 16.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 61.140000000000001 110.215 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.2 -11.21 24.93 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.349 2.033 . . . . 64.109999999999999 112.157 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -96.16 15.21 21.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 74.209999999999994 109.924 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.18 107.65 8.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.196 -0.911 . . . . 74.439999999999998 109.063 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.405 HG13 HD12 ' A' ' 157' ' ' LEU . 10.7 p -102.21 142.21 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.37 0.605 . . . . 72.329999999999998 112.035 -172.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.442 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 95.7 m-85 -125.75 144.42 50.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.462 -0.79 . . . . 75.129999999999995 110.181 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.45 99.94 11.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.902 -1.147 . . . . 74.120000000000005 107.902 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.596 HG23 HD22 ' A' ' 184' ' ' LEU . 29.2 m -101.34 0.77 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.203 0.446 . . . . 74.340000000000003 112.203 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.48 95.88 5.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 109.812 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.47 6.5 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.809 -0.632 . . . . 74.420000000000002 109.715 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.55 -33.73 67.53 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.516 -0.765 . . . . 74.439999999999998 111.457 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.47 30.33 2.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.437 . . . . 72.439999999999998 110.743 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -92.83 99.69 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.163 0.506 . . . . 71.420000000000002 109.661 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -107.5 138.77 43.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.952 -0.567 . . . . 75.299999999999997 110.349 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.33 133.46 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 74.049999999999997 110.871 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 206' ' ' PRO . 5.9 t80 -137.31 -54.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 63.520000000000003 111.295 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.2 p -108.37 103.15 49.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 112.07 0.396 . . . . 63.439999999999998 112.07 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 24.6 Cg_exo -63.28 118.31 5.22 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.697 2.265 . . . . 72.450000000000003 110.8 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 64.77 10.11 5.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.943 -0.571 . . . . 75.219999999999999 111.059 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 169' ' ' HIS . . . 96.07 0.88 61.53 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.741 -0.742 . . . . 64.409999999999997 113.063 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.82 110.79 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 117.128 0.464 . . . . 74.329999999999998 112.189 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -177.63 144.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.963 -0.754 . . . . 64.099999999999994 108.963 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.68 115.22 8.1 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.611 -0.515 . . . . 72.299999999999997 109.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -159.14 102.81 1.62 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.029 -0.268 . . . . 74.120000000000005 110.915 -175.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.445 ' HA ' HG22 ' A' ' 236' ' ' VAL . 44.8 p90 -124.89 130.99 53.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 73.239999999999995 111.334 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 71.9 mmtt -129.18 -86.74 0.54 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.078 -0.964 . . . . 74.510000000000005 108.933 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 29.6 tt0 177.39 -63.81 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.946 -0.57 . . . . 54.310000000000002 110.161 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -148.76 104.74 3.43 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.039 -0.528 . . . . 75.200000000000003 111.307 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.44 ' CD ' ' HA3' ' A' ' 235' ' ' GLY . 1.4 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 C-N-CA 122.965 2.443 . . . . 62.329999999999998 112.003 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.003 -0.369 . . . . 71.299999999999997 110.003 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.606 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -90.43 171.2 36.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.891 -0.671 . . . . 61.25 112.534 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.433 ' O ' ' HB ' ' A' ' 228' ' ' THR . 25.0 p -69.6 130.82 43.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 73.140000000000001 110.716 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.541 HG12 HG11 ' A' ' 271' ' ' VAL . 16.6 tt -63.46 -18.05 21.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.443 0.639 . . . . 73.329999999999998 110.324 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.576 ' HG2' HD13 ' A' ' 265' ' ' LEU . 24.8 mt-10 -55.59 -63.03 1.3 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.974 -1.012 . . . . 72.230000000000004 111.06 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.85 -40.56 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.893 -0.594 . . . . 74.310000000000002 111.15 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.446 ' CG2' ' HB1' ' A' ' 232' ' ' ALA . 93.2 m -56.63 -29.16 61.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.098 -0.501 . . . . 71.329999999999998 110.908 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 35.8 m 64.11 -147.48 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.72 -0.673 . . . . 75.540000000000006 111.372 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 60.0 mt -72.65 -34.72 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.846 0.355 . . . . 73.25 110.962 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.468 ' HA ' HG13 ' A' ' 236' ' ' VAL . 1.5 m-20 -51.76 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.03 -0.987 . . . . 64.120000000000005 113.599 -169.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.91 -29.43 67.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 61.25 111.404 -173.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.77 -33.6 75.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.943 -0.571 . . . . 73.239999999999995 111.492 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 5.9 m-20 -92.89 -27.77 16.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 72.519999999999996 111.029 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.44 ' HA3' ' CD ' ' A' ' 217' ' ' PRO . . . 127.01 -4.99 7.37 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.717 -1.23 . . . . 71.030000000000001 114.182 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 231' ' ' ASP . 3.2 p -75.24 127.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.743 0.771 . . . . 73.409999999999997 109.626 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 212' ' ' GLU . . . -59.08 121.36 54.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 60.310000000000002 112.075 -172.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.465 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 16.5 Cg_exo -66.95 101.18 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.949 2.433 . . . . 73.430000000000007 111.841 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 51.0 m -84.89 -168.42 2.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.171 -0.677 . . . . 74.040000000000006 109.171 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.524 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 20.1 mmt180 -52.24 -46.62 65.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.873 0.324 . . . . 74.209999999999994 111.873 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 307' ' ' LYS . 20.2 ttt180 -68.97 -30.08 68.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.969 -0.292 . . . . 74.409999999999997 110.789 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.5 23.97 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.786 -0.721 . . . . 73.310000000000002 111.99 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -60.1 -42.0 93.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.926 0.393 . . . . 62.329999999999998 110.42 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 89.8 mt -62.42 -38.74 90.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.18 -0.464 . . . . 75.040000000000006 111.592 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.43 -48.92 75.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.311 0.577 . . . . 75.150000000000006 109.877 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.521 HG22 ' HB ' ' A' ' 178' ' ' ILE . 68.6 mt -57.03 -44.48 82.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.13 -0.941 . . . . 74.5 110.718 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.5 -41.47 94.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 73.109999999999999 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.68 -46.2 93.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.301 -0.476 . . . . 60.240000000000002 112.62 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -61.96 -38.25 87.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 75.150000000000006 110.878 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.5 m -66.89 -47.16 72.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.416 . . . . 75.409999999999997 110.631 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 86.7 mtp -60.89 -43.32 98.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 73.519999999999996 111.301 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.523 HD13 ' HG3' ' A' ' 286' ' ' MET . 12.7 tt -67.35 -34.95 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.458 -0.497 . . . . 74.510000000000005 110.917 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -62.96 -43.65 98.2 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.83 -0.348 . . . . 73.129999999999995 110.452 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -66.01 -35.29 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 74.530000000000001 110.631 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.0 -32.84 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 74.109999999999999 111.818 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.5 p -102.71 -27.98 12.39 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.623 -0.431 . . . . 73.430000000000007 111.825 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 147' ' ' LYS . . . 119.75 -45.87 1.19 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 70.200000000000003 113.719 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.01 159.33 39.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.596 0.698 . . . . 73.230000000000004 111.098 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 90.7 mt -95.19 137.64 22.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 70.209999999999994 110.582 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.8 Cg_exo -67.33 -28.79 39.24 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.004 2.469 . . . . 72.010000000000005 112.907 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -101.66 9.91 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 110.757 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 16.5 tt0 -59.44 -45.78 90.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.595 . . . . 63.210000000000001 112.315 -170.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.77 -16.3 61.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 74.409999999999997 111.049 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -107.54 16.87 23.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.39 . . . . 73.329999999999998 111.096 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 226' ' ' GLU . 37.4 mt -70.07 -14.03 62.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.551 0.691 . . . . 75.150000000000006 110.007 172.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.23 -19.42 58.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.119 -0.946 . . . . 61.109999999999999 110.018 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 271' ' ' VAL . 9.6 m-20 -94.83 113.29 60.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.455 -0.793 . . . . 73.120000000000005 110.071 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.72 -38.47 93.0 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.706 2.271 . . . . 73.239999999999995 112.89 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.672 ' HZ2' ' HB3' ' A' ' 269' ' ' LYS . 7.7 mtpm? -69.47 -42.98 74.14 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.894 -0.323 . . . . 74.409999999999997 111.467 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.71 -38.46 91.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.003 -0.279 . . . . 74.319999999999993 111.19 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.541 HG11 HG12 ' A' ' 225' ' ' ILE . 38.2 t -65.75 -39.88 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.948 0.404 . . . . 73.430000000000007 110.224 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -64.07 -56.31 15.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 74.409999999999997 110.335 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.41 -44.68 96.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.781 -0.645 . . . . 65.200000000000003 112.023 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 55.3 p -63.57 -50.49 69.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 121.083 -0.247 . . . . 74.140000000000001 111.321 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 33.3 mmtp -64.08 -34.04 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.18 -0.208 . . . . 74.519999999999996 111.31 -175.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.43 -53.76 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.925 0.393 . . . . 74.209999999999994 111.014 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -71.1 -30.82 67.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 73.219999999999999 111.475 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -73.47 -35.44 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.725 -0.216 . . . . 73.439999999999998 110.91 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.87 -31.22 72.21 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.253 0.549 . . . . 73.109999999999999 110.238 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.36 -59.37 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.256 -0.883 . . . . 73.409999999999997 110.483 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.451 ' HB3' HD21 ' A' ' 285' ' ' LEU . 0.6 OUTLIER -108.57 59.42 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.312 -0.404 . . . . 71.129999999999995 111.195 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.457 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -62.81 -43.95 99.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.549999999999997 112.196 -177.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.457 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.47 -47.8 77.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.795 0.295 . . . . 61.130000000000003 111.795 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.6 t -66.44 -46.71 75.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.76 0.314 . . . . 75.349999999999994 110.927 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 281' ' ' ASN . 4.4 mm? -68.16 -49.86 58.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 73.439999999999998 111.821 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.523 ' HG3' HD13 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -62.09 -39.99 94.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.627 0.251 . . . . 72.439999999999998 111.55 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.64 -31.33 66.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 72.319999999999993 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -69.91 -33.2 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 74.120000000000005 109.975 178.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.23 -19.66 62.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 75.450000000000003 111.264 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.903 ' HB3' ' HB3' ' A' ' 296' ' ' PRO . 6.7 t80 -128.52 87.81 54.03 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 121.101 0.476 . . . . 72.109999999999999 110.323 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.5 2.98 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.365 2.71 . . . . 73.5 111.939 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.9 149.69 24.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.684 -0.858 . . . . 75.200000000000003 108.684 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 56.3 mmtt -91.98 29.67 1.56 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.037 0.384 . . . . 75.319999999999993 112.037 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.58 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 42.3 t-20 -64.11 -69.88 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.943 -1.502 . . . . 72.209999999999994 106.943 167.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.627 ' HB3' ' NH2' ' A' ' 151' ' ' ARG . 49.9 tptt 169.15 114.76 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.257 0.973 . . . . 74.329999999999998 109.59 160.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.903 ' HB3' ' HB3' ' A' ' 290' ' ' PHE . 89.3 Cg_endo -96.22 46.26 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.673 2.249 . . . . 75.430000000000007 111.544 169.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.25 -43.02 1.02 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.384 -0.912 . . . . 73.5 113.048 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.461 ' HB2' HD13 ' A' ' 299' ' ' ILE . 0.9 OUTLIER -57.53 -64.11 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 74.109999999999999 110.408 -175.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.461 HD13 ' HB2' ' A' ' 298' ' ' GLU . 2.8 mp -60.25 -39.69 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 73.420000000000002 111.049 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.63 68.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 73.319999999999993 111.374 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 301' ' ' LYS . 12.8 tptt -79.93 -23.27 41.87 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.354 . . . . 75.030000000000001 110.926 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.447 ' CD1' HD22 ' A' ' 320' ' ' LEU . 65.7 t80 -59.99 -48.22 82.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 75.010000000000005 109.911 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.525 ' HA ' HG21 ' A' ' 306' ' ' VAL . 82.6 mtp -72.5 -32.9 66.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.983 -0.553 . . . . 73.319999999999993 110.548 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 4.4 tp10 -54.96 -45.74 74.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.788 0.804 . . . . 74.540000000000006 109.109 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 63.2 m -63.57 -47.33 81.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.315 -1.311 . . . . 64.319999999999993 111.965 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 303' ' ' MET . 21.6 m -66.2 -34.26 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.862 -0.335 . . . . 71.329999999999998 111.741 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -76.45 -27.67 56.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.406 -0.518 . . . . 75.510000000000005 109.755 177.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 24.6 tp -77.4 -26.96 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.784 -0.643 . . . . 74.040000000000006 110.925 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.4 pp -86.3 18.46 3.18 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.765 0.317 . . . . 74.129999999999995 110.745 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 24.0 t70 73.47 -79.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.497 -0.774 . . . . 73.219999999999999 111.938 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -162.11 -31.43 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.537 0.684 . . . . 74.219999999999999 109.755 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.6 t -170.57 29.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.486 -0.779 . . . . 74.010000000000005 108.978 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 3.3 tm-20 -70.85 -71.11 0.27 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.177 -0.92 . . . . 72.450000000000003 110.274 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -132.31 87.36 43.17 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.386 -0.37 . . . . 74.109999999999999 110.275 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.51 118.0 3.15 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.414 2.076 . . . . 64.519999999999996 111.689 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.2 mt -112.31 94.58 5.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.226 0.536 . . . . 74.230000000000004 110.183 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -68.41 -33.33 74.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.513 -0.767 . . . . 74.219999999999999 110.807 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.93 -38.94 90.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 73.109999999999999 110.567 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.85 -44.84 88.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 64.439999999999998 110.437 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 86.8 mt -60.19 -47.88 84.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 73.299999999999997 110.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 325' ' ' LEU . 8.1 ppt_? -73.78 -19.09 60.87 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.741 -0.384 . . . . 72.099999999999994 111.214 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.17 -32.57 29.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 64.099999999999994 111.449 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -75.81 -32.57 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 120.005 -0.678 . . . . 64.230000000000004 110.042 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 298' ' ' GLU . 95.2 mt -66.08 -41.92 90.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.944 -0.761 . . . . 73.409999999999997 108.944 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -65.12 -32.02 73.51 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.512 -0.767 . . . . 70.239999999999995 110.121 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -49.19 78.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.263 -0.643 . . . . 75.409999999999997 109.263 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.1 -40.31 95.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.753 -0.737 . . . . 64.219999999999999 112.689 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.703 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 28.8 tp -69.12 -43.36 74.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.377 0.608 . . . . 75.409999999999997 110.848 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.94 -38.11 82.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.242 -0.89 . . . . 74.450000000000003 110.892 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.07 75.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 62.409999999999997 111.291 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -89.8 -7.28 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.974 0.416 . . . . 74.129999999999995 110.759 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 83.77 26.34 42.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 45.539999999999999 113.563 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 9.4 t -117.87 171.35 8.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.257 0.528 . . . . 63.409999999999997 110.925 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.533 ' HA ' HD23 ' A' ' 328' ' ' LEU . 0.0 OUTLIER -153.44 161.14 42.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 62.509999999999998 110.425 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 156' ' ' GLN . 7.2 p-10 -89.81 -12.09 40.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.73 0.3 . . . . 74.140000000000001 111.499 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 106' ' ' LYS . 27.0 m-20 -92.3 102.01 14.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 75.439999999999998 111.077 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 147.08 -68.79 0.38 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.155 -1.021 . . . . 73.019999999999996 113.014 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 110.214 -0.291 . . . . 72.450000000000003 110.214 -173.56 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.985 0.422 . . . . 72.129999999999995 110.237 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.5 t -100.97 -171.03 1.93 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 73.239999999999995 110.085 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 144.3 14.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.128 0.489 . . . . 75.439999999999998 111.084 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 15.2 t -73.04 166.97 22.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.628 . . . . 74.109999999999999 110.874 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.096 -0.502 . . . . 72.230000000000004 110.293 -176.15 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.743 0.306 . . . . 75.030000000000001 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.83 0.01 56.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.056 -0.592 . . . . 74.349999999999994 112.198 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.44 160.43 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 75.420000000000002 110.932 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.44 115.59 45.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.961 -0.563 . . . . 72.099999999999994 109.673 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 37' ' ' TRP . 19.2 pt -96.68 122.73 48.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.859 -0.609 . . . . 75.209999999999994 109.965 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 17.6 m -101.11 119.17 38.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.099 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.6 p-10 -90.03 -170.3 2.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.355 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.68 -21.1 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 74.040000000000006 111.222 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.81 2.41 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 73.109999999999999 109.96 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 60.13 34.64 21.2 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.164 -0.925 . . . . 75.540000000000006 111.353 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' THR . 30.3 mmmt -92.83 150.43 20.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.019 -0.537 . . . . 73.140000000000001 109.932 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.87 96.2 7.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.875 -0.602 . . . . 74.439999999999998 110.66 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.513 ' HB2' HG13 ' A' ' 29' ' ' ILE . 25.6 m95 -98.92 138.72 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 72.519999999999996 109.637 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 56' ' ' MET . 31.6 ttmt -106.46 119.28 38.85 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.831 -0.347 . . . . 72.319999999999993 110.629 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.29 127.61 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 61.210000000000001 110.727 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.429 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . -113.96 -115.19 3.17 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.515 -0.85 . . . . 71.140000000000001 113.01 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 49.5 tp -77.93 125.47 85.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.572 0.225 . . . . 74.120000000000005 111.504 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 10.0 Cg_exo -72.47 120.03 6.48 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.854 2.37 . . . . 74.530000000000001 111.254 172.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 45' ' ' GLN . 63.1 mt -97.04 -53.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.117 0.484 . . . . 74.040000000000006 110.749 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.494 ' O ' ' HA2' ' A' ' 49' ' ' GLY . . . 94.73 -25.19 24.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.822 -0.704 . . . . 74.209999999999994 112.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.405 ' H ' HG22 ' A' ' 43' ' ' ILE . 49.5 tp60 -117.0 162.94 16.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.651 -0.5 . . . . 70.109999999999999 109.651 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.23 -3.34 16.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.623 -1.391 . . . . 74.140000000000001 109.623 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -176.49 -142.66 4.42 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 114.296 -0.952 . . . . 72.109999999999999 110.976 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.835 ' HZ ' ' HA3' ' A' ' 199' ' ' GLY . 92.4 m-85 -60.86 -46.95 88.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.62 0.247 . . . . 74.519999999999996 111.066 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . 156.36 164.72 13.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.765 -0.731 . . . . 55.539999999999999 111.691 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.0 m 61.83 39.17 14.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.014 0.435 . . . . 73.349999999999994 111.042 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 6.2 mm -88.68 132.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 74.25 109.809 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -109.63 164.52 12.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 75.340000000000003 111.06 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.604 HD12 HH21 ' A' ' 133' ' ' ARG . 7.0 tt -83.09 128.89 34.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.957 -0.757 . . . . 61.119999999999997 108.957 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -106.3 37.1 2.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.716 1.006 . . . . 74.140000000000001 113.716 -166.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 50.6 t0 172.39 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.977 0.511 . . . . 63.450000000000003 109.965 169.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.429 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 21.5 ptm -107.39 19.94 19.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.146 -0.479 . . . . 74.340000000000003 110.107 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 58' ' ' SER . 8.2 t-20 -124.63 -165.16 1.34 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 64.329999999999998 109.72 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.452 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 22.8 t -107.99 89.99 3.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.985 0.422 . . . . 74.510000000000005 110.146 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.402 0.62 . . . . 72.439999999999998 110.151 174.771 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 109.39 -0.596 . . . . 73.310000000000002 109.39 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.67 29.74 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.187 2.591 . . . . 75.549999999999997 113.003 -171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 p -130.82 137.06 49.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.301 0.572 . . . . 74.219999999999999 111.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 143.85 37.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.626 -0.879 . . . . 72.450000000000003 108.626 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 6.2 p -118.64 121.06 66.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.482 0.658 . . . . 71.299999999999997 111.947 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HD3' ' HD2' ' A' ' 48' ' ' PHE . 39.0 ttmt -89.36 126.11 35.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.216 -0.902 . . . . 72.5 109.09 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.24 133.04 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.159 0.504 . . . . 73.430000000000007 111.97 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 15.8 mt-10 -140.1 170.53 9.53 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.862 -0.792 . . . . 75.319999999999993 108.862 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 14.3 Cg_endo -57.13 156.43 24.78 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.402 2.068 . . . . 73.409999999999997 112.799 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.561 ' HA ' ' HG3' ' A' ' 127' ' ' ARG . 15.5 t -84.37 34.04 0.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 55.009999999999998 110.834 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.82 -83.67 0.55 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.179 -0.464 . . . . 72.239999999999995 111.165 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.22 -89.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.89 -0.324 . . . . 73.409999999999997 111.19 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.51 -176.63 1.46 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.101 -0.5 . . . . 74.450000000000003 113.552 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.508 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 6.4 Cg_exo -74.82 -22.04 15.65 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.059 2.506 . . . . 73.239999999999995 111.249 169.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.516 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.7 tm? -51.94 -40.54 60.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.513 -0.767 . . . . 71.310000000000002 110.823 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.95 -38.87 83.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.120000000000005 111.021 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.9 m -67.04 -41.62 86.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.07 0.462 . . . . 65.409999999999997 110.25 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 198' ' ' TYR . 31.3 mt-10 -67.08 -38.07 85.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.832 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.85 -41.7 71.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.008 0.432 . . . . 75.420000000000002 109.913 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -57.04 -54.08 50.78 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 74.120000000000005 110.897 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -64.49 -48.69 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.729 0.64 . . . . 73.209999999999994 112.729 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.491 ' HE1' ' HD2' ' A' ' 198' ' ' TYR . 3.8 m-85 -65.97 -34.26 77.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.611 0.244 . . . . 71.219999999999999 111.403 -175.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.55 -33.74 58.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.813 -0.355 . . . . 73.239999999999995 111.901 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 13.6 tpt180 -97.44 -45.81 6.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.911 0.708 . . . . 75.299999999999997 112.911 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -0.97 56.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.855 0.687 . . . . 63.140000000000001 112.855 -169.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -104.36 -151.59 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.084 -0.246 . . . . 73.219999999999999 111.156 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.562 ' HG2' ' OE2' ' A' ' 94' ' ' GLU . 56.9 tttm 74.56 102.94 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 123.689 0.796 . . . . 73.549999999999997 110.05 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.26 -52.77 8.29 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.387 3.392 . . . . 60.43 115.567 -165.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -72.01 -32.55 67.28 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 74.409999999999997 112.901 -169.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -74.55 -30.11 61.62 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.029 -0.669 . . . . 71.230000000000004 110.333 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 92' ' ' LYS . 72.6 mt -61.15 -53.03 54.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.344 -0.613 . . . . 74.010000000000005 109.344 172.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.1 -34.73 60.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 74.400000000000006 110.497 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -56.54 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 75.140000000000001 110.783 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.414 ' HE1' HD12 ' A' ' 108' ' ' LEU . 1.8 p90 -70.11 -34.17 72.77 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.949 -0.701 . . . . 74.319999999999993 111.249 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 108' ' ' LEU . 60.7 mt -64.45 -33.34 62.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.201 0.524 . . . . 75.200000000000003 109.694 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -71.03 -40.84 71.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.551 -0.75 . . . . 74.239999999999995 110.275 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 m -67.85 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 52.399999999999999 111.532 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -75.91 -23.5 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 111.173 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 68.92 64.52 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.941 0.776 . . . . 75.129999999999995 110.039 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' ' OD2' ' A' ' 163' ' ' ASP . 3.4 mm? -106.97 -163.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.163 -0.926 . . . . 75.030000000000001 109.625 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HG2' HD23 ' A' ' 159' ' ' LEU . 50.8 tptt -121.74 -59.62 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.472 0.545 . . . . 73.510000000000005 112.472 -174.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -159.07 98.38 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.514 -0.475 . . . . 74.409999999999997 111.447 -168.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.501 HD23 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tt -78.9 115.19 18.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.739 -0.837 . . . . 75.549999999999997 108.739 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.54 64.79 3.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.956 -0.64 . . . . 71.219999999999999 112.722 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.501 ' HB ' HD23 ' A' ' 108' ' ' LEU . 7.7 p -111.24 135.9 20.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.087 -0.338 . . . . 74.109999999999999 110.087 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HD3' HG12 ' A' ' 196' ' ' VAL . 19.1 Cg_endo -60.12 140.07 90.58 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.854 2.369 . . . . 71.150000000000006 112.802 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.848 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 84.2 tttt -65.62 128.73 37.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.129999999999995 110.08 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -109.52 117.71 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.57 -0.741 . . . . 70.0 110.698 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.476 ' CD1' HG21 ' A' ' 130' ' ' ILE . 38.5 m95 -89.86 -49.45 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.425 0.631 . . . . 75.439999999999998 109.554 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 178.32 -174.49 46.76 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.901 -1.045 . . . . 71.409999999999997 111.881 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.459 ' C ' ' HB2' ' A' ' 31' ' ' ASP . 93.1 p -168.37 150.51 5.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.847 -0.798 . . . . 75.439999999999998 108.847 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -166.41 -162.41 17.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.086 -1.054 . . . . 72.430000000000007 113.067 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 125' ' ' SER . 7.3 tt -128.48 129.3 45.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.862 -0.422 . . . . 74.349999999999994 109.862 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -129.59 123.86 32.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.153 -0.684 . . . . 64.239999999999995 109.153 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 7.3 t70 -89.11 138.07 31.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.27 -0.423 . . . . 73.010000000000005 110.177 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 121' ' ' LYS . 13.2 tmtt? -90.94 28.9 1.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.7 0.762 . . . . 73.329999999999998 109.581 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.0 t30 62.27 70.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.944 -1.025 . . . . 72.010000000000005 110.058 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.66 10.68 12.45 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.245 -0.889 . . . . 75.200000000000003 111.78 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -164.49 104.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.813 -0.44 . . . . 75.519999999999996 109.813 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.477 ' HB3' HD23 ' A' ' 118' ' ' LEU . 12.4 m -76.14 130.59 38.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.176 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.89 149.02 41.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 75.129999999999995 110.478 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 75' ' ' SER . 94.1 mtt180 -113.11 133.17 55.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.475 -0.565 . . . . 61.32 109.475 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.587 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 54.4 p90 -126.7 143.39 51.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.272 -0.422 . . . . 71.519999999999996 110.895 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.1 ptp -128.84 137.2 51.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.406 -0.361 . . . . 75.439999999999998 110.259 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 114' ' ' TRP . 49.8 mt -103.97 121.4 55.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 73.349999999999994 111.794 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ptm -122.72 178.25 5.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.502 -0.772 . . . . 74.409999999999997 109.89 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.848 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.2 t70 -80.95 -178.15 6.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.72 0.295 . . . . 74.420000000000002 111.126 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.604 HH21 HD12 ' A' ' 53' ' ' LEU . 5.8 mmt85 -83.79 83.83 7.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.412 0.625 . . . . 75.439999999999998 112.352 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -103.69 170.56 7.86 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.907 -0.775 . . . . 74.540000000000006 108.907 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.63 -41.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.347 -1.406 . . . . 72.209999999999994 113.544 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.781 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 18.4 m -71.23 122.85 20.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.011 0.406 . . . . 75.319999999999993 111.21 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.54 118.13 24.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.433 -0.803 . . . . 75.109999999999999 110.106 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.24 -22.67 67.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.642 -0.873 . . . . 75.219999999999999 108.642 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.42 ' HA ' ' HB2' ' A' ' 180' ' ' ALA . 5.8 tp-100 -56.07 -48.6 75.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.752 -1.113 . . . . 74.439999999999998 110.977 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -75.46 -27.97 59.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 75.430000000000007 111.531 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -46.69 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.023 -0.271 . . . . 74.540000000000006 110.279 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.615 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -74.02 -32.99 63.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.385 -0.526 . . . . 74.200000000000003 110.301 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.92 -33.67 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.833 0.349 . . . . 73.340000000000003 110.924 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -83.94 -31.37 25.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.142 0.423 . . . . 74.219999999999999 112.142 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -104.24 13.82 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 71.120000000000005 111.018 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.409 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 55.2 46.61 23.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.95 -0.568 . . . . 75.0 111.373 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.615 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER 42.09 38.79 1.17 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.0 113.17 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -94.71 96.85 9.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 110.133 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 85.0 m-85 -113.5 147.74 37.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.44 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 154' ' ' VAL . 7.3 p -83.55 167.82 16.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.017 -0.538 . . . . 62.509999999999998 110.898 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.637 ' NH1' ' HB ' ' A' ' 331' ' ' ILE . 35.4 ttt180 -55.18 -46.18 75.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 73.120000000000005 111.23 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 333' ' ' SER . 86.2 mttt -58.2 -51.79 68.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.223 -0.444 . . . . 70.109999999999999 111.478 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -56.28 -43.67 79.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.938 -0.574 . . . . 75.540000000000006 112.025 -178.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 150' ' ' SER . 53.0 t -64.11 -48.43 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 74.510000000000005 110.735 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 2.7 mm? -58.43 -45.15 89.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 111.394 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 57.4 mm-40 -61.27 -44.84 96.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 74.510000000000005 111.494 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 153' ' ' THR . 88.4 mt -61.1 -49.11 78.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 75.120000000000005 110.622 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.1 p -62.52 -31.99 72.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 74.400000000000006 111.297 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.472 HD23 ' HG2' ' A' ' 106' ' ' LYS . 59.4 tp -63.12 -46.77 85.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 75.420000000000002 110.629 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 12.4 mmt85 -63.03 -44.73 95.12 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.893 0.854 . . . . 74.150000000000006 110.02 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.96 -33.88 66.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.578 -1.192 . . . . 72.329999999999998 110.815 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.7 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.871 -0.418 . . . . 73.049999999999997 109.871 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -55.32 -56.94 14.33 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.516 0.674 . . . . 72.310000000000002 110.459 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.3 tt -67.88 -37.13 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.566 -0.743 . . . . 75.439999999999998 111.572 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.49 ' HG ' ' NE2' ' A' ' 175' ' ' HIS . 8.8 tt -61.03 -39.4 89.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.293 -0.262 . . . . 71.510000000000005 110.293 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -67.33 -54.02 24.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 71.150000000000006 109.363 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -56.05 -46.68 78.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.574 -0.739 . . . . 75.439999999999998 112.293 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 164' ' ' ILE . 29.1 pt -80.77 -32.41 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.208 0.447 . . . . 74.319999999999993 112.208 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.437 ' CE1' ' HA ' ' A' ' 240' ' ' ARG . 3.7 t60 -69.48 -34.76 74.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.373 -0.603 . . . . 64.230000000000004 109.373 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -27.04 67.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.453 -0.794 . . . . 75.150000000000006 110.503 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.81 19.46 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 72.349999999999994 112.098 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.484 ' HA ' ' HD2' ' A' ' 204' ' ' TYR . 44.5 mt-10 72.1 16.65 5.26 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.711 0.634 . . . . 75.409999999999997 112.711 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -121.4 144.65 48.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.253 0.549 . . . . 72.430000000000007 110.856 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 202' ' ' TYR . 23.6 t -104.31 163.44 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.51 -0.768 . . . . 74.120000000000005 109.352 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.49 ' NE2' ' HG ' ' A' ' 165' ' ' LEU . 5.7 p80 -132.33 105.3 7.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.076 -0.713 . . . . 74.120000000000005 109.076 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.424 ' HA3' ' OD2' ' A' ' 222' ' ' ASP . . . -63.76 -54.88 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.638 -0.71 . . . . 65.329999999999998 114.148 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.6 90.13 5.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.605 0.717 . . . . 64.400000000000006 111.626 -174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.528 HG23 ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -94.3 102.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.916 -1.512 . . . . 74.230000000000004 106.916 159.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.681 ' HG3' ' HE2' ' A' ' 227' ' ' PHE . 29.4 tttp -173.99 -137.04 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.171 -1.418 . . . . 75.349999999999994 107.171 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 179' ' ' LYS . . . -120.9 1.24 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.479 -0.328 . . . . 71.319999999999993 110.636 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -28.02 50.93 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 111.959 0.355 . . . . 73.400000000000006 111.959 -171.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 182' ' ' ASN . 5.6 m120 -108.55 11.06 26.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.722 0.296 . . . . 75.109999999999999 111.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 179' ' ' LYS . 8.3 mp -102.61 109.46 21.08 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.369 -0.532 . . . . 73.409999999999997 109.986 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.43 HD22 HG21 ' A' ' 196' ' ' VAL . 3.8 mm? -117.79 128.57 54.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.839 . . . . 75.140000000000001 109.821 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.781 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 80.6 mt -81.43 146.85 30.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.771 -0.649 . . . . 74.230000000000004 110.269 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.27 121.01 13.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.476 -1.676 . . . . 73.400000000000006 106.476 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -14.34 54.6 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.761 -0.376 . . . . 73.530000000000001 111.728 -167.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -87.22 -53.71 4.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.842 0.353 . . . . 74.409999999999997 110.814 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.1 m-20 -108.48 114.45 59.09 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 75.239999999999995 110.918 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 6.8 Cg_exo -73.11 -12.45 25.72 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 123.241 2.627 . . . . 75.299999999999997 112.398 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.55 4.56 39.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 73.349999999999994 110.837 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -123.45 96.77 5.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.925 -0.58 . . . . 74.140000000000001 110.995 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.2 130.69 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.666 -0.697 . . . . 72.420000000000002 109.676 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -120.17 142.23 49.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 110.709 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.405 HD21 HD11 ' A' ' 164' ' ' ILE . 34.2 tp -88.15 99.27 12.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.245 -1.02 . . . . 74.230000000000004 108.245 175.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.453 HG12 ' HD3' ' A' ' 111' ' ' PRO . 15.3 m -120.61 -178.2 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.345 -0.389 . . . . 74.019999999999996 110.212 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.439 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . 2.6 t70 60.16 71.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.787 0.804 . . . . 75.120000000000005 108.979 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.534 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 70.5 m-85 -81.47 34.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.083 -0.962 . . . . 74.430000000000007 111.556 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.835 ' HA3' ' HZ ' ' A' ' 48' ' ' PHE . . . -77.25 -3.4 81.91 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.556 -0.831 . . . . 72.439999999999998 112.348 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.878 HD13 ' HA ' ' A' ' 352' ' ' LYS . 5.4 mp -114.75 34.37 4.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.701 0.286 . . . . 75.319999999999993 111.376 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.08 125.86 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.866 0.365 . . . . 51.130000000000003 110.438 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.68 ' HD1' HD12 ' A' ' 354' ' ' ILE . 36.2 t80 -108.35 174.77 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.077 -0.51 . . . . 73.140000000000001 109.913 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -89.07 135.61 33.47 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.59 0.356 . . . . 72.340000000000003 111.173 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.484 ' HD2' ' HA ' ' A' ' 172' ' ' GLU . 8.5 t80 -96.98 -60.34 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 72.150000000000006 110.416 173.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 8.4 p -138.04 142.56 36.24 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 110.881 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 3.1 Cg_exo -75.53 74.83 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.197 2.598 . . . . 64.109999999999999 112.203 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.94 86.66 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.573 -0.739 . . . . 75.019999999999996 111.921 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.07 -53.89 4.91 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 73.140000000000001 113.775 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.524 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 14.5 m -73.02 111.07 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.304 0.573 . . . . 71.109999999999999 110.936 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 205' ' ' CYS . 20.0 m80 -74.59 110.23 8.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.84 -0.618 . . . . 71.109999999999999 109.964 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 212' ' ' GLU . 8.1 tmtm? -97.92 130.89 44.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 75.109999999999999 108.872 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.471 ' N ' ' HD3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -84.19 -98.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.387 -0.37 . . . . 71.430000000000007 111.57 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.508 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 20.4 p90 -91.97 91.61 7.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.808 0.813 . . . . 75.239999999999995 112.121 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -39.74 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.239 -0.892 . . . . 75.329999999999998 108.938 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.07 179.34 0.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.975 -1.012 . . . . 74.319999999999993 111.905 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.438 ' HB3' ' HA3' ' A' ' 235' ' ' GLY . 12.0 t70 -147.94 127.86 6.62 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.134 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 21.9 Cg_exo . . . . . 0 CA--C 1.532 0.378 0 C-N-CA 123.172 2.581 . . . . 75.150000000000006 113.384 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.424 ' OD2' ' HA3' ' A' ' 176' ' ' GLY . 5.1 p-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.81 0.338 . . . . 73.099999999999994 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.51 170.32 40.4 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.782 -0.723 . . . . 74.030000000000001 111.725 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 228' ' ' THR . 53.1 p -70.49 141.96 51.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.093 0.446 . . . . 74.340000000000003 111.5 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 265' ' ' LEU . 73.3 mt -55.49 -34.11 33.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 115.769 -0.65 . . . . 63.25 112.406 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.795 ' HG3' ' HG ' ' A' ' 265' ' ' LEU . 3.0 mp0 -52.69 -39.43 61.97 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.002 0.43 . . . . 72.450000000000003 110.366 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.798 ' HB3' HG22 ' A' ' 246' ' ' ILE . 70.9 m-85 -105.06 -93.0 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.206 -0.452 . . . . 64.450000000000003 110.404 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.528 ' HG1' ' C ' ' A' ' 227' ' ' PHE . 7.5 p 58.03 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.049 1.5 . . . . 63.439999999999998 115.049 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 227' ' ' PHE . 47.6 t 64.44 -175.84 0.17 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.851 -0.796 . . . . 64.329999999999998 108.851 -172.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 230' ' ' ILE . 2.9 mp -71.2 -37.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.2 -0.667 . . . . 71.129999999999995 109.2 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.75 -73.2 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.691 -1.141 . . . . 63.340000000000003 112.104 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.61 -29.65 70.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.372 -0.376 . . . . 75.239999999999995 111.783 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.448 ' HE1' HG22 ' A' ' 225' ' ' ILE . 8.1 t60 -66.21 -37.46 85.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 75.549999999999997 110.297 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -77.92 -38.33 45.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 74.450000000000003 110.513 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 216' ' ' ASP . . . 114.55 9.26 14.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.761 -0.733 . . . . 74.109999999999999 112.109 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 6.2 p -89.35 137.71 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.737 -0.468 . . . . 72.319999999999993 109.737 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -57.64 117.92 22.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 74.409999999999997 111.203 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.592 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 23.5 Cg_exo -65.24 101.91 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.681 2.254 . . . . 62.530000000000001 111.42 176.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.1 p -77.68 -20.58 53.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 72.319999999999993 110.657 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.793 ' HD2' ' HG3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER 178.3 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.18 -0.918 . . . . 74.400000000000006 108.823 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.968 ' HD3' ' HD1' ' A' ' 311' ' ' TYR . 5.7 mtp85 -59.5 -60.96 3.01 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.183 -0.917 . . . . 72.519999999999996 111.404 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 238' ' ' PRO . . . -43.36 -65.97 1.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 O-C-N 124.065 0.853 . . . . 74.5 114.203 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.11 -30.54 65.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.339 0.57 . . . . 74.340000000000003 111.624 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.466 ' HB3' HH21 ' A' ' 240' ' ' ARG . 17.6 tp -75.29 -35.78 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.887 0.375 . . . . 70.209999999999994 110.921 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.09 -37.55 46.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.492 -0.322 . . . . 64.439999999999998 110.401 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.798 HG22 ' HB3' ' A' ' 227' ' ' PHE . 87.4 mt -60.93 -38.29 78.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.743 -0.465 . . . . 73.549999999999997 109.743 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 178' ' ' ILE . 51.8 tp -59.4 -47.35 85.8 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 110.365 175.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.39 -44.94 93.39 Favored Glycine 0 C--O 1.237 0.283 0 C-N-CA 120.978 -0.629 . . . . 61.340000000000003 112.233 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.519 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 12.7 m-85 -57.09 -44.08 82.83 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 120.572 0.225 . . . . 74.040000000000006 111.142 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.528 ' SG ' HG23 ' A' ' 178' ' ' ILE . 78.6 m -67.19 -38.1 84.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.622 -0.263 . . . . 75.530000000000001 111.36 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.484 ' HE2' HD22 ' A' ' 324' ' ' LEU . 84.3 mtp -60.4 -49.64 76.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.57 -0.286 . . . . 72.409999999999997 110.924 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 299' ' ' ILE . 12.3 tt -70.32 -31.43 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.305 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.548 ' OE1' ' HG3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -61.02 -46.16 91.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.576 . . . . 74.040000000000006 110.181 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.3 m0 -71.7 -35.3 70.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.129999999999995 111.369 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.4 tp -76.42 -30.87 57.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.984 0.364 . . . . 74.329999999999998 111.984 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 289' ' ' CYS . 73.6 p -103.36 -27.59 12.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 73.549999999999997 111.378 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.404 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 83.66 0.25 89.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.769 -0.729 . . . . 70.010000000000005 113.238 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -157.07 144.04 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.369 0.584 . . . . 74.140000000000001 111.425 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 92.2 mt -129.74 139.55 35.99 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 75.239999999999995 109.567 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 38.8 Cg_exo -58.22 -24.27 66.3 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.115 2.543 . . . . 70.209999999999994 113.752 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 25.1 p90 -98.91 -17.73 18.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.406 0.521 . . . . 75.409999999999997 112.406 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 1.5 pp20? -86.16 -14.66 43.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.336 -0.546 . . . . 71.530000000000001 110.68 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.86 -45.85 90.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 61.340000000000003 109.571 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.39 29.05 7.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.367 -0.833 . . . . 75.5 109.737 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.795 ' HG ' ' HG3' ' A' ' 226' ' ' GLU . 2.5 tm? -47.7 -34.24 7.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.855 0.862 . . . . 73.319999999999993 112.525 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -66.44 -12.25 56.22 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.013 0.375 . . . . 74.310000000000002 112.013 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.6 110.5 49.82 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 73.140000000000001 109.665 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.515 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 32.0 Cg_endo -63.04 -24.44 73.7 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.194 2.596 . . . . 72.25 113.999 -171.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -63.13 -49.98 72.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.791 0.329 . . . . 75.510000000000005 110.792 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -63.18 -36.82 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 110.285 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.747 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 69.7 t -62.35 -45.21 99.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 75.420000000000002 111.136 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 79.9 mtp180 -64.78 -54.87 24.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.394 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.31 -41.44 97.01 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.709 0.29 . . . . 75.140000000000001 111.692 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 27.7 m -62.91 -40.28 97.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.477 -0.329 . . . . 75.25 110.796 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.539 ' HZ3' HG12 ' A' ' 271' ' ' VAL . 46.2 mttp -65.17 -42.78 93.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 74.340000000000003 111.129 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.7 mt -61.43 -46.21 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 71.230000000000004 110.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -64.12 -34.82 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.379 -0.373 . . . . 75.230000000000004 111.514 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.45 ' O ' HG21 ' A' ' 282' ' ' ILE . 5.1 m-85 -72.16 -32.31 66.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.707 -0.224 . . . . 74.510000000000005 111.597 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -77.92 -34.07 51.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 74.030000000000001 110.538 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.51 -42.63 12.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.969 -0.56 . . . . 74.310000000000002 112.032 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.451 ' O ' HD22 ' A' ' 285' ' ' LEU . 10.9 t-20 -124.86 81.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.589 . . . . 74.129999999999995 110.481 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -74.38 -34.09 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 75.310000000000002 112.54 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.85 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.391 0.515 . . . . 75.420000000000002 112.391 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.2 m -70.27 -48.84 54.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 64.109999999999999 110.972 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 281' ' ' ASN . 4.1 mm? -63.12 -50.59 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.078 -0.51 . . . . 74.340000000000003 111.364 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.615 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.3 OUTLIER -60.79 -40.76 93.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.897 0.332 . . . . 73.420000000000002 111.897 -177.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.73 -42.39 95.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 111.115 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 288' ' ' LYS . 43.3 mmtm -81.21 4.31 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.354 0.502 . . . . 74.239999999999995 112.354 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.503 ' HB3' HG21 ' A' ' 256' ' ' THR . 80.2 m -83.32 -17.43 42.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 64.439999999999998 109.904 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.7 89.41 51.4 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 74.409999999999997 109.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.88 3.03 7.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.323 2.682 . . . . 73.200000000000003 112.481 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -99.71 174.21 6.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.893 -0.78 . . . . 65.530000000000001 108.893 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -86.86 79.59 8.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.434 0.635 . . . . 74.530000000000001 111.304 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.92 157.02 28.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.004 -0.998 . . . . 73.540000000000006 108.601 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -105.07 117.49 58.45 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 112.227 0.455 . . . . 73.25 112.227 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -95.51 38.57 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.297 2.664 . . . . 74.239999999999995 110.957 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -69.91 -36.92 74.3 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.547 -0.751 . . . . 75.25 113.209 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.48 ' HB3' HD21 ' A' ' 324' ' ' LEU . 1.5 mp0 -50.99 -52.72 39.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.965 0.412 . . . . 74.129999999999995 110.69 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 252' ' ' ILE . 4.0 mp -70.76 -36.64 65.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.616 . . . . 75.519999999999996 110.415 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.73 68.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.454 -0.339 . . . . 75.219999999999999 110.784 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.011 -0.541 . . . . 74.519999999999996 110.156 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.557 ' CD1' HD21 ' A' ' 320' ' ' LEU . 68.0 t80 -56.66 -42.79 79.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 75.310000000000002 110.2 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.615 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 95.7 mmm -70.44 -40.86 73.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.57 -0.741 . . . . 65.420000000000002 110.603 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 46.6 mt-10 -53.06 -50.42 64.38 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.204 -0.665 . . . . 64.439999999999998 109.204 172.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 79.3 m -56.83 -50.49 72.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.659 -1.155 . . . . 73.200000000000003 112.087 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 303' ' ' MET . 28.8 m -69.41 -26.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.391 0.515 . . . . 72.430000000000007 112.391 -174.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.795 ' HZ1' ' HB2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -90.92 -16.15 28.6 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.786 -0.366 . . . . 75.120000000000005 111.692 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 53.0 mt -68.37 -37.59 80.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 74.340000000000003 110.592 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.3 pp -87.13 12.92 10.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.381 0.61 . . . . 74.400000000000006 110.19 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.85 -93.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.643 -1.162 . . . . 73.430000000000007 112.961 171.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.968 ' HD1' ' HD3' ' A' ' 241' ' ' ARG . 40.2 t80 -115.72 -58.56 2.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.86 0.319 . . . . 73.230000000000004 111.86 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.1 p -133.73 10.07 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.1 0.407 . . . . 74.140000000000001 112.1 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.0 60.9 6.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.387 0.514 . . . . 73.319999999999993 112.387 -169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? 64.97 103.86 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.389 -0.823 . . . . 74.420000000000002 113.189 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.793 ' HG3' ' HD2' ' A' ' 240' ' ' ARG . 4.4 Cg_exo -78.92 119.5 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.734 2.289 . . . . 72.120000000000005 111.303 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 94.1 mt -84.32 81.38 8.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.758 0.313 . . . . 74.430000000000007 110.987 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.49 -36.42 75.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 72.510000000000005 111.366 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -61.45 -45.99 91.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.415 . . . . 73.209999999999994 110.498 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.05 -40.32 90.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 110.277 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 87.8 mt -58.19 -52.55 65.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 74.129999999999995 110.1 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -40.33 77.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.805 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.65 -50.31 69.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 64.409999999999997 111.635 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.69 -31.97 27.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 111.679 0.252 . . . . 74.530000000000001 111.679 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.484 HD22 ' HE2' ' A' ' 251' ' ' MET . 93.0 mt -66.35 -48.63 69.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 72.239999999999995 110.621 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.6 -27.11 63.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 72.319999999999993 110.919 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.38 -49.06 78.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.437 -0.579 . . . . 73.430000000000007 109.437 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.72 -40.18 93.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.656 -0.783 . . . . 75.420000000000002 112.108 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.601 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 tm? -59.08 -43.96 91.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 73.209999999999994 110.517 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 333' ' ' SER . 30.1 ttpt -72.82 -30.01 63.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.855 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.03 69.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 73.450000000000003 112.071 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.637 ' HB ' ' NH1' ' A' ' 151' ' ' ARG . 13.7 tt -83.34 -7.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 75.510000000000005 111.013 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.19 -6.15 26.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.588 -0.815 . . . . 64.349999999999994 113.188 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 20.1 p -100.19 158.48 15.83 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.659 -0.318 . . . . 71.420000000000002 110.704 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -148.87 -68.36 0.22 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.294 -0.632 . . . . 72.310000000000002 109.294 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 336' ' ' ASP . 9.2 t70 56.43 -155.9 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.722 -0.672 . . . . 65.400000000000006 111.402 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 335' ' ' ASP . 27.2 t70 -153.03 -36.7 0.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.22 -0.446 . . . . 65.329999999999998 110.855 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . 0.487 ' HA2' ' OE1' ' A' ' 156' ' ' GLN . . . 177.97 49.73 0.07 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.969 -1.11 . . . . 74.510000000000005 114.082 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 117.278 0.539 . . . . 74.129999999999995 111.556 177.803 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.878 ' HA ' HD13 ' A' ' 200' ' ' LEU . 33.1 pttt . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.829 0.347 . . . . 75.25 111.919 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 10.8 t 166.85 135.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.291 -0.868 . . . . 73.329999999999998 109.602 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.858 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -94.4 142.08 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.546 -0.538 . . . . 73.439999999999998 109.546 175.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 354' ' ' ILE . 24.5 m -64.48 97.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.045 -0.525 . . . . 72.430000000000007 111.97 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.45 ' HE3' ' CG2' ' A' ' 354' ' ' ILE . 94.9 mttt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.638 . . . . 75.420000000000002 109.992 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.242 -0.281 . . . . 73.230000000000004 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.24 -21.91 43.32 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.798 -0.715 . . . . 73.329999999999998 113.533 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.67 160.76 29.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.704 0.752 . . . . 73.010000000000005 110.306 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 6.4 pt -116.76 129.67 72.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.468 0.651 . . . . 74.450000000000003 110.949 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.539 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 33.1 pt -91.8 154.48 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 111.091 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' HB2' ' A' ' 35' ' ' LYS . 4.8 m -112.5 114.13 26.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 72.209999999999994 111.273 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.66 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.7 p-10 -112.05 -166.54 1.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 74.150000000000006 109.834 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 116' ' ' SER . 20.9 mmt -63.65 -22.55 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.337 -0.392 . . . . 74.519999999999996 111.46 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.52 4.8 19.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.776 0.322 . . . . 74.430000000000007 111.013 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 71.26 44.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.771 -0.649 . . . . 75.219999999999999 111.61 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HB2' HG22 ' A' ' 30' ' ' THR . 37.7 ttmt 72.97 113.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.324 -0.853 . . . . 74.219999999999999 113.262 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.76 37.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 75.409999999999997 110.61 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 11.3 m95 -134.01 126.12 29.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 70.409999999999997 110.117 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.58 124.9 50.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.682 0.277 . . . . 74.219999999999999 110.304 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.97 126.14 25.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 74.409999999999997 110.928 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.02 -107.88 3.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.766 -0.73 . . . . 61.439999999999998 112.306 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.1 tp -86.67 123.94 70.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.71 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.614 ' HD2' HD12 ' A' ' 41' ' ' LEU . 58.2 Cg_endo -74.81 109.04 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.45 2.1 . . . . 72.530000000000001 111.837 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.9 mt -74.0 -53.46 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.34 0.59 . . . . 74.200000000000003 110.048 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.92 -29.51 5.88 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.65 -0.705 . . . . 73.319999999999993 112.575 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -119.01 165.1 14.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.163 -0.31 . . . . 73.439999999999998 110.163 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.13 51.82 1.43 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.548 -0.834 . . . . 73.310000000000002 111.749 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.67 -126.71 2.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.503 -0.856 . . . . 75.310000000000002 112.008 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -92.77 -33.69 14.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.9 0.381 . . . . 71.319999999999993 110.919 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.13 160.68 8.39 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.369 -0.692 . . . . 71.140000000000001 111.369 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.8 t 53.53 53.81 11.01 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.273 0.558 . . . . 63.149999999999999 110.652 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.429 HD11 ' CB ' ' A' ' 71' ' ' LYS . 5.3 mm -89.07 137.81 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 71.099999999999994 110.273 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HB2' HG11 ' A' ' 70' ' ' VAL . 84.5 m-85 -121.22 148.54 44.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 72.010000000000005 111.193 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.831 HD11 ' HB3' ' A' ' 41' ' ' LEU . 75.3 mt -87.4 140.72 29.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.049 -0.523 . . . . 75.340000000000003 109.837 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.29 37.84 4.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.374 0.607 . . . . 65.150000000000006 109.914 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 66' ' ' ALA . 8.7 p-10 -98.22 9.12 43.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.489 -0.778 . . . . 73.450000000000003 111.249 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.62 2.61 50.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 74.319999999999993 111.736 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.38 87.78 7.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.158 -0.617 . . . . 73.310000000000002 110.029 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 t -104.1 79.77 1.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.727 -0.842 . . . . 73.549999999999997 108.727 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 75.239999999999995 110.756 -176.604 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.413 ' HB3' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.31 0.576 . . . . 74.040000000000006 110.557 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 187' ' ' TYR . 93.3 Cg_endo -80.81 36.95 0.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.089 2.526 . . . . 72.129999999999995 113.14 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.6 m -117.86 136.15 53.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.62 0.724 . . . . 53.329999999999998 111.849 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 53' ' ' LEU . 35.4 m -136.2 148.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.996 -1.002 . . . . 75.120000000000005 108.746 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -123.73 120.66 60.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.291 0.567 . . . . 75.310000000000002 111.028 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' CB ' HD11 ' A' ' 51' ' ' ILE . 25.3 pttm -105.58 134.44 48.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.234 -0.654 . . . . 74.420000000000002 109.234 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 126' ' ' TYR . 15.9 t -120.51 148.94 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 72.430000000000007 112.054 -165.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.8 141.16 31.88 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 70.430000000000007 109.422 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.65 134.64 58.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.456 2.104 . . . . 72.340000000000003 111.633 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -73.41 88.46 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.185 0.517 . . . . 63.030000000000001 111.1 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -139.15 -68.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.585 -0.894 . . . . 72.150000000000006 108.585 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 5.3 p30 -128.5 -75.42 0.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.558 -0.746 . . . . 72.209999999999994 109.032 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . 72.35 110.5 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 114.058 0.383 . . . . 73.030000000000001 114.058 170.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HD2' ' HA2' ' A' ' 78' ' ' GLY . 12.0 Cg_endo -55.77 -22.35 36.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.858 2.372 . . . . 74.310000000000002 111.398 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -59.85 -30.1 68.74 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.454 -0.793 . . . . 64.430000000000007 110.559 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.35 -38.93 71.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.933 -0.395 . . . . 73.140000000000001 109.933 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.6 m -60.95 -46.96 88.6 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.426 0.632 . . . . 64.319999999999993 109.522 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.789 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 34.6 tt0 -63.14 -37.98 89.35 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.348 -0.842 . . . . 72.019999999999996 110.64 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.511 HD22 ' HE2' ' A' ' 129' ' ' MET . 3.2 tm? -58.4 -45.3 88.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.486 -0.324 . . . . 75.219999999999999 110.681 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.82 -50.97 71.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 75.430000000000007 110.852 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 168' ' ' ILE . 92.7 t80 -62.63 -40.1 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 71.129999999999995 110.95 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 2.8 t80 -62.3 -45.14 94.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.309 -0.859 . . . . 72.329999999999998 111.052 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.02 -29.68 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.678 0.275 . . . . 73.439999999999998 111.323 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -69.2 -27.84 65.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 73.200000000000003 110.813 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.75 10.83 36.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 71.120000000000005 110.912 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.89 173.78 11.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.384 . . . . 71.010000000000005 111.74 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.749 ' HB3' HE21 ' A' ' 95' ' ' GLN . 36.7 ttmt 70.83 98.22 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.129 -0.941 . . . . 71.219999999999999 110.321 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.92 -31.51 81.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.693 2.928 . . . . 72.319999999999993 113.741 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.732 ' HG2' ' HE3' ' A' ' 98' ' ' LYS . 43.6 tt0 -60.86 -46.8 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.219 -0.193 . . . . 74.340000000000003 110.787 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.749 HE21 ' HB3' ' A' ' 92' ' ' LYS . 45.2 mt-30 -58.77 -44.1 90.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.884 0.373 . . . . 74.329999999999998 110.055 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.1 mt -56.32 -52.72 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.484 -0.78 . . . . 72.209999999999994 110.224 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.16 -36.83 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.099 -0.501 . . . . 75.099999999999994 110.96 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.732 ' HE3' ' HG2' ' A' ' 94' ' ' GLU . 97.4 mttt -60.44 -58.44 8.48 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.044 -0.525 . . . . 74.439999999999998 111.177 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.2 p90 -72.44 -34.23 67.65 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.155 -0.618 . . . . 72.120000000000005 110.788 -174.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 96' ' ' ILE . 22.4 mm -55.28 -49.12 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.548 0.213 . . . . 63.109999999999999 110.731 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.83 -44.89 84.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.301 . . . . 73.439999999999998 111.135 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.5 m -71.13 -23.97 62.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 72.129999999999995 111.575 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.597 HH22 ' HB2' ' A' ' 170' ' ' GLU . 20.6 ttt180 -96.24 -1.84 47.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.457 -176.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.95 35.68 8.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.76 -0.654 . . . . 75.120000000000005 111.325 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.487 HD11 ' HD3' ' A' ' 103' ' ' ARG . 81.2 mt -94.97 -165.51 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.524 . . . . 73.019999999999996 109.956 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.779 ' HB3' ' HZ3' ' A' ' 106' ' ' LYS . 3.2 mmmp? -108.87 -61.79 1.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.751 -0.463 . . . . 72.540000000000006 109.751 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 32.4 p90 178.62 144.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 73.329999999999998 109.618 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.673 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 22.5 tp -79.34 125.49 29.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.673 -0.694 . . . . 74.349999999999994 110.805 -172.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 59.71 4.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.105 -0.569 . . . . 40.420000000000002 112.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.48 134.41 21.97 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.716 -0.475 . . . . 75.219999999999999 109.716 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.704 ' HB3' ' HZ ' ' A' ' 134' ' ' PHE . 17.1 Cg_endo -59.8 142.55 98.85 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.302 2.001 . . . . 72.409999999999997 112.057 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.72 147.83 50.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 74.549999999999997 111.303 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.05 128.98 55.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.913 -0.585 . . . . 72.239999999999995 110.742 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.488 ' HB2' HG21 ' A' ' 130' ' ' ILE . 70.3 m95 -103.33 -59.7 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.304 0.573 . . . . 73.340000000000003 109.665 174.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.17 175.52 42.3 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.507 -0.77 . . . . 74.319999999999993 112.564 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.625 ' O ' ' HG2' ' A' ' 32' ' ' MET . 18.7 p -150.49 155.93 40.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.442 -0.947 . . . . 75.310000000000002 108.442 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.66 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -172.56 -160.01 20.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.201 -1.476 . . . . 72.530000000000001 113.799 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 tp -136.92 136.21 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.058 -0.571 . . . . 74.310000000000002 110.02 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.556 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 3.7 t-160 -139.77 121.91 15.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.212 -0.662 . . . . 72.540000000000006 109.212 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 22.3 t70 -88.49 130.83 35.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 74.510000000000005 109.905 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -87.34 -72.02 0.54 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.919 0.39 . . . . 73.030000000000001 110.667 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -135.75 33.4 2.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 74.409999999999997 110.184 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.1 -23.1 21.89 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.477 -1.049 . . . . 75.329999999999998 110.477 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.7 mptt -87.45 104.44 16.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.77 -0.826 . . . . 71.099999999999994 108.77 172.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.1 m -77.52 129.07 35.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.829 -0.623 . . . . 62.109999999999999 110.468 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.508 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . 47.8 m-85 -107.89 124.1 49.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.084 -0.507 . . . . 74.25 111.106 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -100.29 131.28 46.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.037 -0.727 . . . . 74.420000000000002 109.037 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.556 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 17.5 p90 -144.52 164.7 30.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.39 -0.368 . . . . 72.299999999999997 111.467 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.511 ' HE2' HD22 ' A' ' 84' ' ' LEU . 16.7 ptp -135.63 143.43 45.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.958 -0.565 . . . . 65.510000000000005 110.972 174.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.558 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 6.0 mm -97.48 121.34 47.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.279 -0.873 . . . . 75.040000000000006 110.027 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.9 ptm -133.56 176.46 8.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.461 -0.791 . . . . 73.450000000000003 109.871 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -72.47 145.83 47.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.264 0.554 . . . . 74.299999999999997 111.757 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HD3' HG11 ' A' ' 69' ' ' VAL . 16.6 tpt180 -71.37 129.35 38.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.221 -0.9 . . . . 73.450000000000003 111.385 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.704 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 50.0 m-85 -103.76 142.53 34.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.246 -0.65 . . . . 75.420000000000002 109.246 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.37 -16.14 4.36 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.432 -0.89 . . . . 64.310000000000002 111.754 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.824 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 61.4 m -121.71 125.88 47.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.609 0.243 . . . . 73.25 110.421 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.01 138.11 44.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 71.439999999999998 109.454 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.724 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.4 tp -71.85 -17.38 62.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.232 -0.284 . . . . 75.310000000000002 110.232 -176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.888 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 52.4 tt0 -68.85 -51.15 43.54 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.152 0.427 . . . . 64.140000000000001 112.152 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.5 tptt -79.56 -35.31 40.02 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.255 -0.578 . . . . 74.209999999999994 110.436 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -43.2 92.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 111.265 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -65.38 -31.52 72.67 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.315 -0.554 . . . . 75.409999999999997 110.232 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -67.01 -38.17 85.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.825 0.345 . . . . 72.219999999999999 110.424 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.04 -32.21 68.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 74.109999999999999 111.529 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -99.06 4.6 47.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 75.519999999999996 111.136 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.3 33.98 21.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.055 -0.521 . . . . 70.349999999999994 110.967 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 16.9 pttp 43.32 33.09 0.55 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.485 1.114 . . . . 75.040000000000006 113.15 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -110.58 95.92 5.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.53 -0.915 . . . . 73.510000000000005 108.53 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 147' ' ' LYS . 24.7 m-85 -112.32 157.12 21.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.612 -0.722 . . . . 74.200000000000003 110.949 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 m -62.69 156.31 23.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.009 -0.541 . . . . 73.219999999999999 109.751 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -55.72 -26.04 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.822 0.305 . . . . 75.219999999999999 111.822 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HG2' ' OD2' ' A' ' 335' ' ' ASP . 57.1 mttm -52.65 -54.32 35.01 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.231 0.539 . . . . 72.340000000000003 111.004 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 m -65.16 -36.17 83.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.638 -0.71 . . . . 73.450000000000003 111.222 -174.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 -49.38 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.107 -0.497 . . . . 72.310000000000002 110.788 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 328' ' ' LEU . 0.5 OUTLIER -68.5 -50.39 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 74.200000000000003 110.53 -176.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 337' ' ' GLY . 2.3 mp0 -61.61 -40.43 94.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.128 0.418 . . . . 73.120000000000005 112.128 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.481 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.9 mp -63.96 -46.83 82.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.03 -0.268 . . . . 72.239999999999995 110.36 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.431 ' HA ' HD13 ' A' ' 247' ' ' LEU . 37.6 t -60.27 -46.65 89.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.239999999999995 110.865 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 106' ' ' LYS . 58.7 tp -55.62 -46.36 77.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 71.25 111.277 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.558 HH11 HG13 ' A' ' 193' ' ' VAL . 89.9 mtt180 -66.68 -34.03 76.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 74.310000000000002 111.294 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 157' ' ' LEU . 48.1 mm -68.89 -34.71 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 74.519999999999996 110.291 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.454 HD11 HD13 ' A' ' 324' ' ' LEU . 95.7 mt -61.11 -47.41 86.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.486 -0.324 . . . . 61.32 110.6 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.74 -48.02 78.73 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.124 -0.489 . . . . 72.519999999999996 111.155 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 161' ' ' ILE . 14.7 tt -71.83 -36.47 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.774 -0.37 . . . . 74.439999999999998 111.677 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 168' ' ' ILE . 42.5 tp -65.41 -32.62 74.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.439999999999998 110.985 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.12 -45.96 72.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.826 -0.435 . . . . 53.130000000000003 109.826 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -59.04 -44.05 91.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 72.049999999999997 111.893 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 165' ' ' LEU . 40.6 pt -76.57 -34.28 23.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.715 -0.394 . . . . 70.040000000000006 111.683 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -75.79 -19.1 59.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.67 -0.412 . . . . 75.200000000000003 110.443 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.597 ' HB2' HH22 ' A' ' 103' ' ' ARG . 13.6 tt0 -53.34 -31.8 46.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.016 -0.735 . . . . 75.450000000000003 109.016 170.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.537 ' C ' ' HG3' ' A' ' 172' ' ' GLU . 48.1 m80 -98.45 -101.94 0.21 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.981 -1.008 . . . . 74.420000000000002 110.596 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.537 ' HG3' ' C ' ' A' ' 171' ' ' HIS . 12.1 mt-10 -153.87 14.0 0.47 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.645 0.239 . . . . 75.540000000000006 111.645 -171.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -122.46 148.04 45.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 72.409999999999997 112.601 -164.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.01 173.21 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.034 -0.984 . . . . 73.030000000000001 109.401 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.14 -65.11 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 63.420000000000002 110.897 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.28 50.97 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.435 -0.888 . . . . 50.539999999999999 113.056 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.604 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 34.0 t70 -141.37 108.37 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.983 0.392 . . . . 54.030000000000001 111.169 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 178' ' ' ILE . 25.2 mm -111.27 35.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.81 0.814 . . . . 73.129999999999995 109.4 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.495 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 56.4 tptt -59.71 134.87 57.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 72.409999999999997 110.169 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.724 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -48.06 -33.64 8.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.83 0.678 . . . . 75.319999999999993 112.83 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.888 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 28.6 p -59.41 -25.58 64.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.848 0.356 . . . . 64.439999999999998 111.671 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -88.51 1.02 55.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 74.409999999999997 111.87 -171.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.21 127.01 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 75.319999999999993 110.579 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.42 134.9 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 72.040000000000006 111.007 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.824 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 8.6 mp -95.64 145.86 24.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.149 -0.478 . . . . 63.140000000000001 109.815 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.433 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 26.2 t-20 -62.73 144.39 56.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.378 -0.373 . . . . 63.149999999999999 110.417 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.643 ' CE2' ' HE2' ' A' ' 188' ' ' LYS . 1.3 p90 -60.56 -32.37 71.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.219 0.451 . . . . 74.010000000000005 112.219 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.643 ' HE2' ' CE2' ' A' ' 187' ' ' TYR . 75.8 mmtt -93.71 -43.91 8.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 72.530000000000001 110.237 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -101.94 105.3 41.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 74.150000000000006 111.961 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 4.3 Cg_exo -77.15 -7.04 17.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.957 2.438 . . . . 75.019999999999996 111.466 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.96 -16.86 32.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.839 -0.619 . . . . 72.340000000000003 110.7 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -111.08 110.98 21.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.405 0.621 . . . . 74.140000000000001 111.11 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.558 HG13 HH11 ' A' ' 160' ' ' ARG . 13.0 p -108.09 138.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.882 -1.053 . . . . 75.129999999999995 109.913 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.56 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 47.0 m-85 -125.33 153.74 42.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.442 -0.577 . . . . 73.010000000000005 109.442 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 32.5 tp -96.48 142.3 28.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.059 -0.349 . . . . 74.340000000000003 110.059 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.467 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.0 p -124.04 -173.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.293 -0.632 . . . . 74.409999999999997 109.293 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.593 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 52.5 t0 60.63 62.32 1.53 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.894 0.854 . . . . 75.329999999999998 109.116 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.789 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 21.7 m-85 -81.11 7.59 10.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.147 -0.933 . . . . 71.239999999999995 109.788 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.45 76.5 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.579 -0.737 . . . . 74.299999999999997 111.622 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.867 ' HA ' ' HB ' ' A' ' 354' ' ' ILE . 2.4 pp -89.91 4.07 51.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.753 0.311 . . . . 74.430000000000007 111.355 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -68.89 102.1 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.194 0.521 . . . . 75.319999999999993 109.974 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.596 ' HB2' HG13 ' A' ' 354' ' ' ILE . 84.8 t80 -98.39 125.54 43.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 71.519999999999996 110.117 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -74.4 97.16 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 62.520000000000003 109.147 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.646 ' HB2' ' HB3' ' A' ' 237' ' ' ALA . 2.7 p90 -87.07 -14.93 40.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 73.519999999999996 111.625 -170.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 24.8 p -137.4 104.47 8.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 110.871 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.16 119.97 7.06 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.413 2.075 . . . . 74.319999999999993 111.708 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 64.98 -80.79 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.769 -0.65 . . . . 73.239999999999995 111.046 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.84 0.64 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 74.25 112.098 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 51.0 t -105.63 111.74 36.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.077 -0.342 . . . . 71.120000000000005 110.077 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -83.94 146.07 28.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.859 0.361 . . . . 74.340000000000003 110.295 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.435 ' HD3' ' OE2' ' A' ' 212' ' ' GLU . 10.1 mmtt -84.02 156.37 22.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.449 . . . . 75.329999999999998 109.989 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -102.25 153.62 19.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.315 -0.624 . . . . 73.450000000000003 109.315 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -74.13 55.82 0.59 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.563 0.579 . . . . 72.010000000000005 112.563 -174.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -117.28 -15.49 10.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.11 -0.496 . . . . 74.129999999999995 110.498 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 236' ' ' VAL . 3.0 tp10 -80.94 141.14 34.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 74.129999999999995 111.669 -170.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -148.98 83.15 6.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.534 -0.913 . . . . 70.430000000000007 108.534 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 C--O 1.233 0.243 0 C-N-CA 122.414 2.076 . . . . 72.150000000000006 112.205 -176.077 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 121.044 0.449 . . . . 64.200000000000003 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -76.44 159.36 49.97 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.707 -0.758 . . . . 74.420000000000002 111.674 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 228' ' ' THR . 6.6 p -68.58 150.3 48.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.472 0.177 . . . . 74.040000000000006 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.466 ' HB ' HD12 ' A' ' 265' ' ' LEU . 43.8 mm -52.97 -34.36 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.903 0.383 . . . . 75.25 111.479 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.18 -47.06 84.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.964 -0.562 . . . . 74.409999999999997 111.293 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.978 ' HB3' HG22 ' A' ' 246' ' ' ILE . 41.0 m-85 -112.1 15.75 20.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 75.310000000000002 111.968 -170.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 224' ' ' THR . 1.3 p -57.87 -36.83 72.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.441 0.534 . . . . 65.0 112.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.6 t 57.23 -173.97 0.08 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.378 -0.601 . . . . 74.340000000000003 109.378 -170.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 230' ' ' ILE . 2.1 mp -73.5 -39.15 54.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.262 0.553 . . . . 72.319999999999993 109.849 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.82 -66.45 0.4 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.888 -1.051 . . . . 70.310000000000002 111.967 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.57 69.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 75.120000000000005 111.914 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -63.02 -43.67 98.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.629 -0.26 . . . . 65.109999999999999 111.099 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.39 -32.88 58.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.212 0.53 . . . . 75.420000000000002 110.819 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.25 1.45 55.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.625 -0.798 . . . . 72.540000000000006 111.49 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.606 HG23 ' HA ' ' A' ' 213' ' ' TYR . 8.8 p -72.42 141.88 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 110.0 -0.37 . . . . 73.519999999999996 110.0 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 204' ' ' TYR . . . -47.76 109.89 1.23 Allowed Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 74.439999999999998 111.728 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.57 121.21 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 73.209999999999994 111.864 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 m -79.8 170.59 16.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.82 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -62.7 -29.98 71.06 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.415 -0.514 . . . . 75.040000000000006 110.434 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 0.2 OUTLIER -55.12 -38.8 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 109.858 174.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -67.26 -50.95 41.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.536 -0.756 . . . . 65.310000000000002 111.971 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -39.67 94.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.992 0.425 . . . . 74.439999999999998 110.174 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.35 -44.28 97.44 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.086 -0.506 . . . . 73.25 110.775 174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.62 -36.99 81.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.76 -0.655 . . . . 74.109999999999999 110.181 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.978 HG22 ' HB3' ' A' ' 227' ' ' PHE . 96.5 mt -62.77 -43.01 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.648 -0.706 . . . . 72.420000000000002 110.151 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.497 ' O ' ' HG3' ' A' ' 251' ' ' MET . 61.7 tp -60.34 -39.6 87.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 110.321 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.797 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.62 -42.06 99.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.035 -0.602 . . . . 73.129999999999995 112.254 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 246' ' ' ILE . 22.2 m-85 -56.93 -41.35 78.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.248 0.547 . . . . 75.120000000000005 110.046 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 46.4 m -65.57 -45.44 83.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.553 -0.749 . . . . 74.519999999999996 110.656 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.2 mtp -58.39 -48.53 80.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.228 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.495 HD12 ' HE2' ' A' ' 286' ' ' MET . 8.9 tt -66.53 -34.29 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.713 -0.395 . . . . 75.409999999999997 110.742 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.503 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 41.6 tt0 -66.75 -46.4 75.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.141 -0.224 . . . . 74.430000000000007 110.772 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.0 m0 -68.37 -28.21 66.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 71.010000000000005 111.363 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.5 tp -81.49 -31.05 33.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 75.239999999999995 111.706 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.7 p -101.8 -28.2 12.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.801 -0.359 . . . . 74.040000000000006 111.683 -173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 87.01 -13.79 58.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.858 -0.687 . . . . 73.349999999999994 112.745 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -156.26 141.04 17.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.919 -0.4 . . . . 75.540000000000006 109.919 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 93.9 mt -101.79 148.93 36.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 73.129999999999995 110.758 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.441 ' HG2' ' CE3' ' A' ' 261' ' ' TRP . 18.2 Cg_endo -60.07 -29.11 88.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.708 2.272 . . . . 74.420000000000002 112.766 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.501 ' HB3' ' CB ' ' A' ' 274' ' ' SER . 33.5 p90 -105.13 7.58 33.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.72 0.295 . . . . 75.540000000000006 111.222 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 39.8 tt0 -67.22 -37.48 83.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.026 0.441 . . . . 64.030000000000001 111.332 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.56 -22.14 62.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.348 0.594 . . . . 73.409999999999997 110.091 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -109.56 21.73 16.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.526 -0.761 . . . . 75.109999999999999 110.731 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.469 ' O ' HD13 ' A' ' 265' ' ' LEU . 1.6 tm? -63.33 -24.0 67.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 74.239999999999995 111.03 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.416 ' HZ1' ' HB2' ' A' ' 266' ' ' LYS . 9.9 mtmp? -88.56 12.69 13.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 72.540000000000006 111.698 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.54 118.46 17.98 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-O 120.766 0.317 . . . . 73.519999999999996 110.636 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.17 -30.62 74.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 74.310000000000002 113.267 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -73.23 -41.67 63.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.751 0.31 . . . . 74.319999999999993 110.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -68.89 -46.54 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 74.219999999999999 111.204 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 34.1 m -62.88 -31.21 51.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.928 -0.309 . . . . 75.430000000000007 111.143 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 276' ' ' ILE . 10.7 ttt85 -61.16 -62.72 1.64 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 110.139 -0.319 . . . . 74.450000000000003 110.139 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.39 -44.65 84.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.77 -0.65 . . . . 74.519999999999996 111.563 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.501 ' CB ' ' HB3' ' A' ' 261' ' ' TRP . 19.7 m -65.15 -40.94 95.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.962 -0.563 . . . . 75.430000000000007 111.668 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -78.52 -23.01 46.5 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.537 -0.465 . . . . 72.299999999999997 110.921 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 272' ' ' ARG . 62.4 mt -71.32 -46.5 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.838 -0.431 . . . . 73.439999999999998 109.838 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -62.64 -40.01 95.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.346 -0.388 . . . . 75.299999999999997 110.545 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -60.14 -46.86 88.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 74.109999999999999 110.842 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -76.98 -13.91 59.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.624 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.83 -36.19 79.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.099 -0.501 . . . . 63.43 110.052 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -161.9 96.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.416 -0.587 . . . . 74.409999999999997 109.416 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' A' ' 303' ' ' MET . 3.7 mp -80.16 -51.48 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.186 0.439 . . . . 75.519999999999996 112.186 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 300' ' ' ALA . . . -58.12 -46.94 84.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.597 0.221 . . . . 73.329999999999998 111.597 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -64.99 -37.14 86.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 74.519999999999996 110.559 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.27 -34.44 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 75.540000000000006 110.69 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.695 ' HE3' HG21 ' A' ' 299' ' ' ILE . 49.5 mtt -74.38 -34.22 63.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.687 -0.233 . . . . 75.209999999999994 111.44 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -59.92 -36.52 77.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.288 -0.634 . . . . 71.530000000000001 109.288 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -75.35 -24.48 57.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.976 -1.011 . . . . 74.019999999999996 110.965 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.0 m -72.85 -23.46 60.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.619 -0.264 . . . . 72.140000000000001 111.229 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.82 81.24 11.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.85 0.315 . . . . 62.210000000000001 111.85 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.37 -18.34 49.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.533 2.156 . . . . 75.409999999999997 111.228 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -76.78 -5.91 50.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.75 -0.659 . . . . 64.540000000000006 109.85 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 64.95 90.14 0.09 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.057 -0.974 . . . . 72.239999999999995 112.315 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.44 -177.14 3.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.816 -1.549 . . . . 75.409999999999997 106.816 170.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 295' ' ' LYS . 15.3 tptp -122.29 87.26 48.21 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 118.808 0.731 . . . . 73.420000000000002 110.332 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.46 39.65 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.323 2.682 . . . . 75.099999999999994 111.348 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -65.61 -37.32 93.47 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.837 -0.619 . . . . 72.140000000000001 112.861 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.547 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -60.35 -46.61 89.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.31 0.576 . . . . 72.439999999999998 109.899 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.695 HG21 ' HE3' ' A' ' 286' ' ' MET . 4.2 mp -76.29 -38.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.473 -0.785 . . . . 72.239999999999995 110.442 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 283' ' ' ALA . . . -60.39 -53.24 59.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 75.430000000000007 111.488 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.52 ' HB3' HD12 ' A' ' 323' ' ' ILE . 27.8 tptp -69.4 -36.32 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.397 -0.365 . . . . 72.019999999999996 110.412 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 320' ' ' LEU . 62.9 t80 -55.76 -50.92 69.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.908 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.797 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 82.9 mmm -70.61 -40.86 72.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.918 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.15 -34.15 77.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.547 -0.538 . . . . 74.409999999999997 109.547 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -73.25 -45.23 57.14 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.508 0.558 . . . . 74.200000000000003 112.508 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 303' ' ' MET . 34.1 m -63.54 -25.3 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.348 0.594 . . . . 74.409999999999997 110.342 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -74.6 -44.18 51.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 75.510000000000005 111.455 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 85.1 mt -84.38 71.23 10.7 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.139 0.792 . . . . 64.230000000000004 113.139 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.987 ' HG ' ' H ' ' A' ' 310' ' ' ASP . 1.3 pt? -159.61 -71.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.369 -0.974 . . . . 64.420000000000002 108.369 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.987 ' H ' ' HG ' ' A' ' 309' ' ' LEU . 2.8 t70 174.52 -73.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 124.002 0.814 . . . . 71.120000000000005 109.093 168.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.539 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 0.4 OUTLIER -162.35 -51.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.245 0.832 . . . . 71.120000000000005 113.245 173.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 7.0 m -139.36 32.0 2.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.598 0.713 . . . . 73.420000000000002 110.943 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.557 ' OE1' ' HB3' ' A' ' 310' ' ' ASP . 7.8 mp0 -62.5 -76.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 64.129999999999995 109.962 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.5 ' HB2' ' HZ3' ' A' ' 314' ' ' LYS . 4.6 ttmp? -156.75 93.51 2.36 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 73.430000000000007 109.459 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 117.39 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.949 1.766 . . . . 72.439999999999998 110.747 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.07 85.43 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 75.299999999999997 109.923 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 321' ' ' ARG . 60.5 t80 -57.2 -36.91 71.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.43 -0.805 . . . . 73.310000000000002 110.987 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.52 -39.26 90.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 72.129999999999995 110.417 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -68.06 -42.97 79.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 72.409999999999997 111.274 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 302' ' ' TYR . 2.0 mm? -63.07 -43.38 98.73 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.939 -0.304 . . . . 75.5 110.749 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.539 ' NH2' ' HG2' ' A' ' 106' ' ' LYS . 65.0 mtp85 -67.7 -38.5 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.911 -0.316 . . . . 73.420000000000002 110.351 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -48.4 76.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 64.319999999999993 111.203 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -64.67 -41.42 92.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.815 -0.175 . . . . 64.030000000000001 111.232 -176.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 162' ' ' LEU . 80.5 mt -63.24 -46.06 88.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.822 0.344 . . . . 74.439999999999998 110.869 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -35.26 75.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.381 -0.372 . . . . 74.420000000000002 110.449 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -55.68 -47.84 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.862 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -68.07 -45.89 69.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.901 -0.666 . . . . 71.150000000000006 112.166 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 155' ' ' LEU . 40.6 tp -59.17 -45.7 90.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.127 0.489 . . . . 74.319999999999993 110.812 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -73.96 -24.63 59.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 74.030000000000001 111.164 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.43 -43.14 77.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.682 0.277 . . . . 72.200000000000003 110.991 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.29 -6.73 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.364 0.602 . . . . 75.150000000000006 110.651 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.99 24.31 38.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.893 -0.67 . . . . 71.510000000000005 112.943 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.0 t -108.21 153.53 23.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.903 -0.406 . . . . 61.43 109.903 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.0 132.86 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.152 -0.476 . . . . 74.019999999999996 109.831 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 16.7 m-20 -138.6 -58.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.382 -0.372 . . . . 63.219999999999999 110.482 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 106' ' ' LYS . 48.9 t0 59.29 90.15 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.169 0.918 . . . . 64.019999999999996 111.064 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' A' ' 156' ' ' GLN . . . 96.85 -31.85 7.18 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.825 -0.703 . . . . 70.340000000000003 112.398 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 335' ' ' ASP . 53.4 mttp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 74.150000000000006 110.984 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.583 ' O ' ' HB ' ' A' ' 353' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 112.087 0.402 . . . . 74.310000000000002 112.087 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 93.8 m 74.83 139.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.871 0.732 . . . . 71.329999999999998 110.666 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.867 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.4 OUTLIER -90.8 140.57 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 72.430000000000007 110.844 -177.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' THR . . . . . 0.485 ' N ' HD11 ' A' ' 354' ' ' ILE . 88.0 m -68.64 102.48 1.5 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.009 -0.541 . . . . 73.510000000000005 110.833 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.281 -0.637 . . . . 72.510000000000005 109.281 178.035 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.806 0.336 . . . . 73.140000000000001 110.473 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.65 1.22 83.33 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.883 -0.675 . . . . 71.409999999999997 112.537 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 154.02 20.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.088 -0.338 . . . . 74.519999999999996 110.088 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 14.6 mt -106.42 136.94 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 74.310000000000002 111.639 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.419 HG21 ' CG ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER -121.41 136.1 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.44 -0.8 . . . . 75.109999999999999 109.466 175.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -106.12 121.86 45.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.268 -0.271 . . . . 73.430000000000007 110.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.25 179.6 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.772 -0.371 . . . . 74.519999999999996 110.01 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.798 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 18.6 mmt -63.41 -22.1 66.68 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.387 0.514 . . . . 73.329999999999998 112.387 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.74 6.08 16.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.739 0.305 . . . . 60.130000000000003 111.218 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 74.71 11.37 3.85 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.613 -0.721 . . . . 75.530000000000001 111.337 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 133.48 33.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.788 -0.449 . . . . 75.439999999999998 109.788 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 42.6 mt-10 -104.61 92.47 4.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.379 0.609 . . . . 73.219999999999999 110.501 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE3' ' HB2' ' A' ' 56' ' ' MET . 10.9 m95 -83.64 159.02 21.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 74.099999999999994 109.089 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.06 146.68 44.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.098 -0.641 . . . . 75.209999999999994 110.618 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.53 HG23 ' CE1' ' A' ' 52' ' ' TYR . 58.5 t -72.65 116.88 15.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.393 -0.821 . . . . 73.329999999999998 110.409 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 -94.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.518 -0.848 . . . . 62.439999999999998 112.095 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.9 mm? -111.74 129.95 23.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.759 0.314 . . . . 73.540000000000006 110.869 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.8 Cg_exo -75.07 103.77 1.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.193 2.595 . . . . 74.439999999999998 111.544 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.3 mt -86.82 -47.89 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 111.016 -175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.65 -30.8 8.99 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.137 -0.554 . . . . 73.340000000000003 112.05 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -118.07 163.25 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.181 -0.303 . . . . 74.409999999999997 110.181 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.69 -33.27 1.3 Allowed Glycine 0 C--O 1.227 -0.325 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.54 -71.55 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.38 -0.688 . . . . 54.130000000000003 111.38 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -122.58 -71.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.82 0.343 . . . . 74.400000000000006 110.382 176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.34 157.68 30.09 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.451 -0.66 . . . . 62.109999999999999 111.451 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.9 t 60.46 50.48 5.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.278 0.561 . . . . 74.400000000000006 110.843 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -105.85 137.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 109.877 177.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.53 ' CE1' HG23 ' A' ' 39' ' ' VAL . 52.6 p90 -128.78 158.78 37.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 72.209999999999994 111.228 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.85 132.15 39.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.553 -0.749 . . . . 74.129999999999995 109.943 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.89 105.56 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.588 -0.278 . . . . 71.510000000000005 110.279 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 1.1 p-10 -95.51 -27.53 15.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.474 -0.33 . . . . 61.329999999999998 111.009 -176.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.617 ' HB2' ' CE3' ' A' ' 37' ' ' TRP . 1.8 tmt? 66.5 -84.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.709 0.63 . . . . 64.129999999999995 110.466 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 178.61 133.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.691 -0.855 . . . . 61.439999999999998 108.691 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -79.49 54.49 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.024 0.44 . . . . 73.340000000000003 110.725 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.035 -0.529 . . . . 75.430000000000007 111.635 -178.458 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.888 0.375 . . . . 74.140000000000001 111.692 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.52 36.36 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.535 2.157 . . . . 73.310000000000002 111.571 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -133.75 137.92 45.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.697 0.76 . . . . 74.219999999999999 112.385 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.465 HG12 ' HG3' ' A' ' 133' ' ' ARG . 31.5 m -132.42 152.25 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.881 -1.054 . . . . 75.230000000000004 108.67 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.613 ' HB ' HG12 ' A' ' 130' ' ' ILE . 1.2 p -131.97 131.19 61.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.058 0.456 . . . . 74.109999999999999 112.139 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.787 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -92.15 139.52 30.54 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.401 -0.818 . . . . 70.319999999999993 109.841 176.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.57 134.74 49.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.502 -0.479 . . . . 73.230000000000004 112.123 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.773 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 3.0 mt-10 -144.57 177.89 1.64 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.612 -0.722 . . . . 55.310000000000002 109.069 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.773 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 37.3 Cg_endo -66.96 164.4 29.98 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.673 1.582 . . . . 64.400000000000006 112.14 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -59.04 -40.29 84.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 71.430000000000007 110.75 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -85.42 88.04 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.232 0.539 . . . . 73.299999999999997 109.595 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.458 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 12.4 t-20 -121.09 -166.07 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.35 -0.841 . . . . 72.549999999999997 109.329 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . -125.9 -75.82 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.75 -0.54 . . . . 43.049999999999997 111.75 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.409 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 17.8 Cg_endo -58.43 -24.59 69.62 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.098 2.532 . . . . 72.349999999999994 113.036 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' HE ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -57.21 -30.46 64.58 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.767 0.317 . . . . 74.230000000000004 111.379 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -72.79 -45.55 57.93 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.094 0.473 . . . . 73.420000000000002 110.116 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -48.43 77.18 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.218 -0.901 . . . . 73.049999999999997 110.814 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 10.9 pt-20 -65.81 -36.65 84.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 110.883 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.75 -50.57 73.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.881 0.372 . . . . 65.239999999999995 110.163 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -45.75 84.09 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.021 -0.536 . . . . 74.430000000000007 110.595 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -67.67 -50.48 57.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 74.25 111.128 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 1.7 t80 -59.93 -42.37 93.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 74.420000000000002 110.837 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 6.7 tp60 -72.65 -34.26 67.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.198 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -75.7 -21.27 57.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.702 0.287 . . . . 74.319999999999993 111.361 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.01 15.72 24.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.084 0.469 . . . . 51.539999999999999 111.165 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -91.62 -175.75 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.621 . . . . 70.019999999999996 111.897 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.93 92.13 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.021 -0.99 . . . . 74.439999999999998 110.755 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.19 -29.14 55.13 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.844 2.363 . . . . 71.239999999999995 111.884 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -62.33 -54.75 35.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.706 -0.679 . . . . 73.299999999999997 110.285 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.26 -43.83 95.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.627 -0.715 . . . . 64.319999999999993 110.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 HD23 ' A' ' 108' ' ' LEU . 81.4 mt -56.96 -54.34 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.691 -0.686 . . . . 73.519999999999996 110.66 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -58.23 -38.64 77.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 74.5 110.504 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -60.08 -58.92 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 72.310000000000002 111.503 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -34.9 67.54 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.077 -0.649 . . . . 72.530000000000001 111.005 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.408 HD11 HD22 ' A' ' 108' ' ' LEU . 33.5 mm -59.63 -43.64 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 74.109999999999999 110.783 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -78.11 -41.06 36.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.503 -0.317 . . . . 75.420000000000002 111.51 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 m -75.83 -35.78 59.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.106 0.41 . . . . 71.400000000000006 112.106 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -94.92 -5.79 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.763 -0.199 . . . . 74.120000000000005 111.04 -174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 73.06 84.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.905 0.753 . . . . 74.329999999999998 111.853 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 163' ' ' ASP . 5.6 mp -137.18 -176.58 4.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.436 -0.802 . . . . 73.310000000000002 109.173 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HD2' ' HD1' ' A' ' 107' ' ' TYR . 1.3 tmtm? -96.57 -72.03 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.189 -0.671 . . . . 71.140000000000001 109.189 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.621 ' HD1' ' HD2' ' A' ' 106' ' ' LYS . 35.1 p90 175.53 123.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.389 -0.597 . . . . 73.140000000000001 109.389 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.63 ' H ' HD21 ' A' ' 108' ' ' LEU . 2.6 pt? -78.22 135.96 37.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.69 -0.404 . . . . 73.340000000000003 110.128 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.52 67.94 2.78 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.989 -0.55 . . . . 74.510000000000005 113.098 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.37 128.83 25.81 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.766 0.317 . . . . 73.150000000000006 110.163 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.559 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.2 Cg_endo -55.71 144.89 74.08 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.906 2.404 . . . . 65.129999999999995 113.229 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.879 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 23.5 tptm -62.52 132.33 52.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.388 -0.824 . . . . 73.519999999999996 111.39 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.609 . . . . 74.420000000000002 110.646 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.406 ' CD1' HG21 ' A' ' 130' ' ' ILE . 71.4 m95 -116.63 -71.95 0.71 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 65.209999999999994 109.581 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.63 -178.07 25.15 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.252 -0.885 . . . . 74.129999999999995 111.733 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' MET . 48.5 p -166.64 167.91 14.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.213 -0.662 . . . . 74.409999999999997 109.213 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.51 -147.44 16.29 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.847 -1.168 . . . . 74.120000000000005 112.88 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.403 ' C ' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.09 147.87 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.042 0.449 . . . . 72.400000000000006 110.759 -176.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 29' ' ' ILE . 44.0 t-80 -123.7 115.76 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 62.340000000000003 109.112 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.819 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 9.3 t70 -83.98 136.81 33.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.189 -0.46 . . . . 74.549999999999997 109.931 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 6.1 ptmm? -87.96 20.0 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.598 0.237 . . . . 74.310000000000002 110.376 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 66.99 75.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.881 -0.785 . . . . 72.150000000000006 108.881 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.42 -24.21 3.08 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.157 -0.929 . . . . 54.329999999999998 112.079 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.415 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 18.6 ttpp -168.17 136.99 2.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.928 -0.397 . . . . 72.25 109.928 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.819 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 9.2 m -84.09 155.44 22.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.257 0.551 . . . . 73.329999999999998 112.002 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.54 155.34 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.339 -0.846 . . . . 75.340000000000003 108.745 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.67 ' HE ' HD13 ' A' ' 80' ' ' LEU . 32.7 ttt180 -114.83 128.0 56.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.426 0.155 . . . . 73.409999999999997 110.803 -171.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -137.9 163.12 32.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.231 0.539 . . . . 74.409999999999997 112.005 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.787 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 37.0 ttm -145.11 141.29 28.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.501 -0.772 . . . . 71.549999999999997 110.03 176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.613 HG12 ' HB ' ' A' ' 70' ' ' VAL . 47.4 mt -100.79 134.62 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 72.030000000000001 111.42 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 12.3 ptm -129.68 175.65 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 71.239999999999995 109.535 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.879 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 5.0 t70 -72.44 174.54 7.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.807 -0.442 . . . . 75.140000000000001 109.807 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.578 ' HE ' ' HE1' ' A' ' 187' ' ' TYR . 9.7 ttp180 -86.77 93.11 9.18 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.17 0.986 . . . . 74.420000000000002 110.99 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.596 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 47.0 m-85 -103.06 170.55 7.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.822 -1.081 . . . . 72.530000000000001 109.322 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.11 -46.1 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.5 -0.857 . . . . 75.519999999999996 111.946 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 19.6 m -95.33 125.72 40.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.927 -0.397 . . . . 73.310000000000002 109.927 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 p30 -116.8 174.41 6.1 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.031 -0.359 . . . . 72.219999999999999 110.031 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.5 -20.14 60.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 73.219999999999999 111.397 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -74.35 -37.27 63.57 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.908 -0.404 . . . . 72.049999999999997 109.908 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 55.7 mttp -57.7 -51.44 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.816 -0.629 . . . . 71.230000000000004 110.654 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.14 -34.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.327 -0.397 . . . . 73.430000000000007 110.263 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.577 ' HE2' HE22 ' A' ' 253' ' ' GLN . 48.1 t80 -52.7 -52.94 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 74.510000000000005 110.841 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -80.64 -41.57 23.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.903 -0.59 . . . . 75.099999999999994 111.83 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.32 70.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.272 0.471 . . . . 73.329999999999998 112.272 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.56 ' OD1' ' HB2' ' A' ' 148' ' ' ARG . 2.1 t-20 -105.51 0.08 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 71.030000000000001 110.536 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.74 46.46 25.82 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.322 -0.854 . . . . 63.240000000000002 112.018 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.536 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 33.2 mttt 71.56 100.07 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.604 -0.726 . . . . 75.409999999999997 112.577 175.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.56 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . 7.2 mmt180 -150.33 72.78 1.12 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 73.540000000000006 109.882 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.89 118.88 37.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.874 -0.603 . . . . 74.140000000000001 109.862 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -70.85 149.93 46.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.374 -0.375 . . . . 72.329999999999998 110.08 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.593 ' HD3' HD22 ' A' ' 294' ' ' ASN . 11.3 ttp180 -61.16 -31.44 71.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.329 -0.396 . . . . 74.5 111.348 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -59.86 -48.37 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.184 0.516 . . . . 74.230000000000004 109.922 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 90.2 m -61.93 -48.67 79.39 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.336 -0.847 . . . . 74.409999999999997 110.521 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.2 t -55.87 -47.71 79.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.085 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 324' ' ' LEU . 0.3 OUTLIER -62.69 -48.63 78.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 73.409999999999997 110.581 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 22.6 mm-40 -62.46 -41.32 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.119 -0.232 . . . . 74.5 111.212 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.6 mp -59.98 -47.48 85.63 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.101 0.25 . . . . 72.230000000000004 110.619 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.5 t -59.65 -43.97 93.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 62.409999999999997 110.561 176.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 162' ' ' LEU . 24.5 tp -63.98 -35.63 81.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.05 -0.523 . . . . 73.299999999999997 110.879 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.667 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -61.14 -45.03 96.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.332 0.586 . . . . 73.310000000000002 109.761 175.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.48 ' HA ' HG22 ' A' ' 164' ' ' ILE . 49.5 mm -66.22 -35.11 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.225 -0.898 . . . . 75.230000000000004 110.126 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 159' ' ' LEU . 50.5 mt -56.92 -54.78 42.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.219 0.451 . . . . 74.030000000000001 112.219 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.452 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.9 p30 -76.25 -35.05 59.15 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.522 -0.871 . . . . 63.450000000000003 112.201 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 161' ' ' ILE . 13.4 tt -67.02 -37.02 78.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.034 -0.666 . . . . 65.109999999999999 110.32 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.59 -36.86 76.63 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 116.317 -0.401 . . . . 73.439999999999998 110.356 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -57.06 -52.52 64.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.602 -0.518 . . . . 74.239999999999995 109.602 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -58.47 -40.41 82.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.361 -0.836 . . . . 75.120000000000005 112.43 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 29.3 pt -92.47 -32.64 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.006 0.743 . . . . 75.150000000000006 113.006 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -73.87 -29.71 62.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.04 -0.356 . . . . 75.519999999999996 110.04 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -27.46 69.24 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.945 -0.571 . . . . 73.239999999999995 110.084 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.24 -67.61 0.86 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.49 -0.777 . . . . 73.409999999999997 112.649 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -148.35 -68.39 0.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.291 0.849 . . . . 75.340000000000003 113.291 -166.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.11 146.64 25.32 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.321 0.86 . . . . 73.530000000000001 113.321 -166.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 202' ' ' TYR . 15.0 m -120.86 149.65 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.716 -1.216 . . . . 72.519999999999996 107.716 164.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.503 ' CE1' HD13 ' A' ' 178' ' ' ILE . 23.6 p80 -74.67 -29.42 61.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.618 -0.433 . . . . 72.329999999999998 111.669 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.562 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 75.45 -59.77 2.84 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.932 -0.652 . . . . 75.5 113.168 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.782 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 9.8 t70 -104.9 131.61 52.17 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 72.109999999999999 109.911 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.558 ' HB ' HG22 ' A' ' 246' ' ' ILE . 7.8 tp -114.69 14.43 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.942 0.349 . . . . 73.409999999999997 111.942 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.509 ' HD2' ' HE2' ' A' ' 227' ' ' PHE . 50.5 tptt -57.34 152.27 14.54 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.23 -0.294 . . . . 74.439999999999998 110.586 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.19 -14.8 11.87 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.081 0.4 . . . . 75.109999999999999 112.081 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 p -76.99 -15.11 59.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.942 0.401 . . . . 64.0 110.705 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.54 HD22 HD23 ' A' ' 200' ' ' LEU . 3.0 m-20 -90.35 -12.08 38.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.048 -0.524 . . . . 75.340000000000003 111.104 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.74 131.5 56.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.099 0.476 . . . . 72.530000000000001 110.235 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -127.53 157.16 40.88 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.571 -0.74 . . . . 73.120000000000005 110.378 179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 48.9 mt -106.16 149.07 27.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.864 -0.607 . . . . 75.519999999999996 109.72 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.596 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 24.0 t-20 -64.07 121.4 14.07 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.131 -1.433 . . . . 72.540000000000006 107.131 168.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.578 ' HE1' ' HE ' ' A' ' 133' ' ' ARG . 1.7 p90 -70.27 -15.78 62.94 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.3 -0.96 . . . . 73.510000000000005 110.582 -167.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -88.16 -28.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.962 -0.563 . . . . 74.349999999999994 110.448 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.547 ' HB3' ' OD1' ' A' ' 191' ' ' ASP . 45.2 m-80 -136.2 109.59 9.76 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-O 120.809 0.337 . . . . 72.129999999999995 111.211 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 13.6 Cg_exo -69.63 -7.73 21.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.263 2.642 . . . . 75.439999999999998 112.95 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 338' ' ' LYS . 9.9 p-10 -85.95 -7.65 58.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 73.340000000000003 110.268 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.647 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 80.6 mt-30 -101.23 91.95 4.74 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.586 -0.734 . . . . 74.519999999999996 110.029 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.96 122.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.832 -0.622 . . . . 63.130000000000003 110.024 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 64.8 m-85 -128.39 151.77 48.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.935 -0.575 . . . . 70.109999999999999 110.292 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 196' ' ' VAL . 3.3 tt -84.87 150.51 24.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.218 -1.401 . . . . 73.140000000000001 107.218 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.526 ' N ' HD22 ' A' ' 195' ' ' LEU . 31.6 m -56.78 178.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.772 0.32 . . . . 73.129999999999995 111.618 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.7 11.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.121 0.786 . . . . 75.140000000000001 113.121 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 196' ' ' VAL . 6.1 m-85 61.5 43.7 10.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.774 0.797 . . . . 75.030000000000001 110.981 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 354' ' ' ILE . . . -68.96 -10.73 62.12 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.685 -1.366 . . . . 64.129999999999995 109.685 166.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 352' ' ' LYS . 5.7 mp -113.56 104.89 12.71 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.072 -1.084 . . . . 74.230000000000004 108.072 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.803 ' H ' HG23 ' A' ' 354' ' ' ILE . . . -163.24 107.55 1.06 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.795 -0.638 . . . . 42.329999999999998 110.745 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.523 ' O ' HG22 ' A' ' 174' ' ' VAL . 55.1 t80 -99.4 126.0 45.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.841 -0.8 . . . . 75.510000000000005 108.841 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.543 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 14.8 ptm180 -81.97 123.84 29.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 70.400000000000006 110.79 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.492 ' HD1' ' HB1' ' A' ' 237' ' ' ALA . 18.4 t80 -84.36 -18.4 36.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.671 . . . . 72.010000000000005 109.952 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 55.5 m -118.24 85.77 25.57 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.934 -0.575 . . . . 71.530000000000001 110.91 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 209' ' ' VAL . 13.1 Cg_exo -70.5 103.69 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.607 2.204 . . . . 74.200000000000003 111.124 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.543 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 28.8 tt0 70.11 -1.28 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.991 -0.549 . . . . 74.239999999999995 111.031 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.32 -12.25 10.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.238 -0.506 . . . . 71.230000000000004 111.864 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.464 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 49.6 t -69.46 132.63 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 75.409999999999997 111.241 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -105.97 110.13 22.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.173 -0.677 . . . . 74.329999999999998 109.173 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 211' ' ' LYS . 17.2 mmmt -103.76 152.75 21.48 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 -170.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.33 -166.36 1.57 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.496 -1.229 . . . . 74.340000000000003 109.514 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.597 ' HA ' HG22 ' A' ' 236' ' ' VAL . 21.6 p90 -76.48 152.15 36.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 74.329999999999998 111.603 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 215' ' ' GLU . 21.6 ttmm -140.92 -53.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 75.239999999999995 110.994 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 214' ' ' LYS . 41.9 tt0 72.54 111.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.861 0.726 . . . . 72.319999999999993 110.491 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -91.12 134.65 29.61 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 73.439999999999998 110.505 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 123.149 2.566 . . . . 62.039999999999999 113.173 -178.717 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.117 0.484 . . . . 71.230000000000004 110.068 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.782 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -103.61 -158.2 24.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.68 -0.772 . . . . 73.439999999999998 112.431 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 38.7 p -79.07 144.21 34.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.775 -0.25 . . . . 75.25 110.486 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.436 HD12 HG23 ' A' ' 271' ' ' VAL . 15.7 tt -55.1 -24.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.324 0.583 . . . . 74.409999999999997 111.177 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 39.1 tt0 -55.42 -61.96 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.17 -0.923 . . . . 65.209999999999994 111.489 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.774 ' HZ ' ' HG3' ' A' ' 253' ' ' GLN . 10.7 m-85 -103.95 -22.37 13.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.902 0.705 . . . . 74.25 112.902 -173.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.0 OUTLIER -70.05 -7.34 40.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.997 0.427 . . . . 74.340000000000003 110.462 -178.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 25.7 t 68.58 175.91 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.347 -0.842 . . . . 74.340000000000003 111.082 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.484 HD11 ' NH1' ' A' ' 279' ' ' ARG . 4.9 pt -71.42 -32.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 72.239999999999995 110.229 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 238' ' ' PRO . 2.2 m-20 -46.43 -69.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.269 -0.878 . . . . 73.219999999999999 111.188 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.04 67.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 73.409999999999997 111.2 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 26.6 t-80 -55.17 -41.91 72.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.831 0.348 . . . . 75.510000000000005 110.915 178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -79.56 0.94 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 75.109999999999999 111.486 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 72.33 32.8 62.14 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 120.965 -0.636 . . . . 71.409999999999997 112.687 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 213' ' ' TYR . 3.4 p -120.95 140.94 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.281 -0.266 . . . . 74.019999999999996 110.281 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.492 ' HB1' ' HD1' ' A' ' 204' ' ' TYR . . . -54.76 110.64 2.28 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 109.008 -0.738 . . . . 62.109999999999999 109.008 170.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . 23.6 Cg_exo -62.82 -91.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.862 2.375 . . . . 53.229999999999997 113.866 -167.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 238' ' ' PRO . 55.7 p 173.11 -158.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.645 -0.502 . . . . 74.209999999999994 109.645 -172.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.426 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 4.0 mpt_? -85.52 -45.76 11.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.878 -1.156 . . . . 73.150000000000006 107.878 168.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 19.1 ttt-85 -62.33 -39.55 93.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.032 -1.44 . . . . 74.409999999999997 111.686 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.542 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.9 -57.32 12.97 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.976 -0.556 . . . . 64.420000000000002 112.765 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 246' ' ' ILE . 11.6 t70 -67.05 -32.52 73.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 65.5 110.482 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 315' ' ' PRO . 77.9 mt -63.57 -39.71 95.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.48 -0.327 . . . . 74.430000000000007 111.27 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.09 -34.98 78.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.256 0.55 . . . . 73.200000000000003 109.805 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 243' ' ' ASP . 70.0 mt -60.64 -42.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 74.310000000000002 110.447 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.538 HD11 ' SG ' ' A' ' 250' ' ' CYS . 39.0 tp -66.58 -38.06 86.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.045 -0.525 . . . . 71.530000000000001 109.966 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.41 96.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 72.519999999999996 111.38 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 246' ' ' ILE . 14.1 m-30 -51.19 -58.84 5.09 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 122.603 0.361 . . . . 74.510000000000005 111.403 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 247' ' ' LEU . 30.1 p -61.45 -37.35 83.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.821 -0.351 . . . . 72.120000000000005 111.662 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 64.9 mtm -60.86 -50.93 71.46 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.779 -0.368 . . . . 62.409999999999997 111.416 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.437 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.5 tt -70.06 -31.58 48.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.682 -0.407 . . . . 73.519999999999996 110.424 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.774 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 24.0 tm0? -64.98 -51.79 59.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.56 -0.291 . . . . 64.319999999999993 110.573 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -63.3 -40.45 97.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.318 . . . . 74.549999999999997 111.565 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.491 ' HG ' ' HE2' ' A' ' 290' ' ' PHE . 33.9 tp -77.86 -30.95 51.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.629 0.603 . . . . 75.340000000000003 112.629 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 60.6 p -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.412 -0.515 . . . . 64.310000000000002 110.867 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.536 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 83.96 7.41 85.58 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.843 -0.694 . . . . 64.510000000000005 113.109 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.07 143.82 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.973 0.887 . . . . 74.319999999999993 112.49 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 89.5 mt -129.48 139.39 35.54 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.332 -0.849 . . . . 61.119999999999997 108.798 168.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.54 -37.23 97.84 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.339 2.026 . . . . 73.129999999999995 112.162 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.539 ' HB2' HG12 ' A' ' 271' ' ' VAL . 34.4 p90 -92.5 11.32 26.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.957 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 36.8 tt0 -86.46 -39.41 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 73.439999999999998 110.504 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -84.15 -24.52 30.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.459 0.647 . . . . 73.420000000000002 109.339 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.68 22.63 15.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.111 -0.95 . . . . 71.239999999999995 111.189 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.682 ' HA ' ' CG1' ' A' ' 271' ' ' VAL . 3.4 pp -70.78 -13.99 62.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.541 0.686 . . . . 72.450000000000003 110.302 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.474 ' N ' HD11 ' A' ' 265' ' ' LEU . 19.9 ptmt -79.01 2.97 18.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.786 -1.097 . . . . 75.25 110.796 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 15.0 t70 -135.01 127.6 18.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.441 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 22.4 Cg_exo -65.71 -29.58 51.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.025 2.483 . . . . 73.400000000000006 113.558 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -79.07 -38.08 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.667 -0.413 . . . . 74.0 110.609 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.417 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 28.8 m-85 -69.29 -49.74 53.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.438 -0.346 . . . . 71.430000000000007 111.209 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.682 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 22.3 m -54.7 -40.4 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 120.491 -0.484 . . . . 73.450000000000003 111.12 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 276' ' ' ILE . 42.0 ttt85 -62.07 -55.79 25.44 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.58 0.229 . . . . 74.430000000000007 111.12 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 24.2 t70 -61.23 -46.33 90.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 111.353 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.433 ' HB3' ' HE3' ' A' ' 261' ' ' TRP . 69.3 m -60.64 -39.4 88.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 73.010000000000005 111.175 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 67.6 mttm -64.71 -40.2 94.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 74.519999999999996 110.362 176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 272' ' ' ARG . 81.5 mt -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.049999999999997 110.027 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 277' ' ' ARG . 14.7 mmp_? -56.83 -48.53 77.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 73.450000000000003 110.985 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -67.21 -44.47 79.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 70.129999999999995 111.845 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.484 ' NH1' HD11 ' A' ' 230' ' ' ILE . 89.2 mtt180 -65.11 -42.1 94.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.906 0.384 . . . . 75.219999999999999 110.922 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.23 -57.72 8.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 72.540000000000006 111.19 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.62 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 61.6 t30 -115.36 59.03 0.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 73.109999999999999 110.904 -171.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.567 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -51.7 -51.45 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.671 0.619 . . . . 74.439999999999998 112.671 -176.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.567 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.93 -47.88 83.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.106 0.41 . . . . 72.310000000000002 112.106 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.62 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 5.1 m -77.69 -28.46 51.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.38 -0.373 . . . . 70.019999999999996 111.02 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 281' ' ' ASN . 2.7 mm? -68.76 -54.74 14.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.998 -0.281 . . . . 73.540000000000006 110.529 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -41.26 92.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 74.0 110.976 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.28 -51.61 68.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.841 -0.618 . . . . 71.409999999999997 111.423 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -91.19 3.54 54.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.244 0.461 . . . . 75.019999999999996 112.244 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.56 -23.64 42.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.604 -0.517 . . . . 73.219999999999999 109.604 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.491 ' HE2' ' HG ' ' A' ' 255' ' ' LEU . 0.4 OUTLIER -133.64 73.85 71.58 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.295 -0.412 . . . . 72.310000000000002 110.98 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.48 32.49 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.724 2.283 . . . . 75.430000000000007 111.106 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 171.2 8.14 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.214 -0.903 . . . . 70.439999999999998 109.259 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -73.24 86.27 1.43 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 111.82 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.593 HD22 ' HD3' ' A' ' 151' ' ' ARG . 12.6 t30 -152.48 -89.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.537 -0.756 . . . . 75.219999999999999 110.047 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 0.9 OUTLIER 169.73 102.77 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 109.578 -0.527 . . . . 74.510000000000005 109.578 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -99.02 50.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.241 2.627 . . . . 73.319999999999993 112.228 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -117.14 -46.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.208 -0.996 . . . . 43.25 113.529 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.558 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 2.6 mp0 -58.2 -56.56 20.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 74.420000000000002 111.03 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 252' ' ' ILE . 3.7 mp -63.1 -33.94 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.866 -0.607 . . . . 73.219999999999999 110.407 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.42 -53.93 50.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 72.150000000000006 110.922 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.5 -27.83 63.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.096 -0.502 . . . . 72.409999999999997 111.158 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.495 ' HH ' HD23 ' A' ' 247' ' ' LEU . 33.6 t80 -62.1 -53.11 60.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.942 0.401 . . . . 71.540000000000006 110.282 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.549 ' HA ' HG22 ' A' ' 306' ' ' VAL . 70.1 mtp -72.61 -31.89 65.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 72.400000000000006 110.914 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.493 ' HA ' HG13 ' A' ' 282' ' ' ILE . 36.9 tt0 -60.85 -46.84 88.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.57 . . . . 75.299999999999997 109.572 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.64 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 29.0 m -57.09 -52.97 63.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.118 -0.946 . . . . 74.409999999999997 111.212 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 303' ' ' MET . 24.9 m -63.34 -32.33 56.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 121.068 -0.253 . . . . 75.040000000000006 111.336 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.473 ' HA ' ' HE ' ' A' ' 241' ' ' ARG . 86.7 tttt -60.49 -48.09 83.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 73.219999999999999 110.187 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 47.4 tp -70.78 -19.69 62.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.684 . . . . 73.099999999999994 111.297 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.752 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 53.1 mt -72.81 -19.26 61.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.265 0.469 . . . . 72.510000000000005 112.265 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 21.6 t70 62.09 -179.86 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.918 0.389 . . . . 75.450000000000003 110.304 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -84.39 -23.39 30.11 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.782 -0.574 . . . . 63.439999999999998 110.065 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.5 m -95.88 -24.43 16.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.043 0.757 . . . . 73.239999999999995 113.043 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.752 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 5.2 mm-40 -87.28 -172.99 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.136 -0.626 . . . . 74.120000000000005 112.03 -169.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.611 ' HD2' ' H ' ' A' ' 314' ' ' LYS . 7.4 mptt -85.44 132.2 45.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 74.219999999999999 110.782 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.538 ' HA ' HD13 ' A' ' 309' ' ' LEU . 57.7 Cg_endo -74.08 118.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.097 1.864 . . . . 74.400000000000006 111.226 174.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.3 mt -87.54 77.32 8.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.319 -0.4 . . . . 73.239999999999995 111.36 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.21 -34.02 76.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.539 . . . . 74.129999999999995 110.423 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.21 -51.09 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.911 -0.586 . . . . 73.319999999999993 110.323 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -65.28 -42.29 93.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.497 -0.774 . . . . 73.099999999999994 110.664 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 90.5 mt -63.45 -43.14 98.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 72.209999999999994 110.67 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -56.44 -52.56 64.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 74.310000000000002 110.703 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.05 -44.72 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 74.400000000000006 111.769 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.0 -32.95 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.762 -0.375 . . . . 64.230000000000004 111.777 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.539 ' HB3' HD23 ' A' ' 155' ' ' LEU . 88.8 mt -69.47 -49.59 53.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.242 0.544 . . . . 74.299999999999997 110.406 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 325' ' ' LEU . 4.3 mm? -67.88 -26.83 66.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 73.129999999999995 110.697 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.22 -47.57 79.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.908 0.385 . . . . 73.400000000000006 110.264 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.7 96.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 63.409999999999997 112.0 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 333' ' ' SER . 3.9 mm? -73.4 -32.46 64.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 74.019999999999996 111.135 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.26 -24.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.916 0.388 . . . . 73.150000000000006 110.508 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.8 -24.46 65.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.019 -0.537 . . . . 74.120000000000005 111.267 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 49.1 pt -111.95 13.19 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.421 . . . . 73.409999999999997 110.588 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.22 25.08 75.35 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.867 -0.606 . . . . 71.409999999999997 113.033 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 37.5 m -120.51 145.49 47.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.313 0.578 . . . . 75.140000000000001 111.761 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 334' ' ' LYS . 10.3 mtpm? -140.27 -72.71 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.383 -0.826 . . . . 75.120000000000005 109.168 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.2 115.49 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.796 -1.093 . . . . 74.120000000000005 109.557 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -164.06 -69.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.399 -0.819 . . . . 74.519999999999996 109.146 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.16 87.34 1.19 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.918 -0.873 . . . . 53.549999999999997 110.918 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HD3' ' HB2' ' A' ' 191' ' ' ASP . 89.2 mttt . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 113.569 0.951 . . . . 73.409999999999997 113.569 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.555 ' HB2' HD21 ' A' ' 200' ' ' LEU . 40.8 mtmt . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.661 -0.496 . . . . 74.25 109.661 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.0 t -144.79 162.43 36.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.525 0.202 . . . . 74.349999999999994 111.092 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.803 HG23 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -66.39 143.64 15.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.966 -0.561 . . . . 64.329999999999998 111.638 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 13.2 t -79.75 132.79 36.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.509 -0.768 . . . . 73.430000000000007 109.267 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.1 tttp . . . . . 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 72.519999999999996 111.374 -176.625 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.802 -0.444 . . . . 74.140000000000001 109.802 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.72 1.72 56.34 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 113.482 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.96 153.46 30.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.585 0.692 . . . . 74.540000000000006 109.464 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.424 ' HA ' HD11 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.9 131.57 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.355 0.597 . . . . 73.400000000000006 111.01 -175.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.53 137.45 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.132 -0.94 . . . . 74.040000000000006 109.536 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.6 m -117.49 120.4 37.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.569 -0.287 . . . . 75.310000000000002 110.405 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.9 p-10 -91.04 -169.53 2.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.336 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.79 ' HA ' ' HE3' ' A' ' 32' ' ' MET . 11.2 mmt -72.2 -17.81 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.797 0.295 . . . . 72.319999999999993 111.797 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.95 9.49 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 72.109999999999999 110.979 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 69.4 17.73 8.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.71 -0.677 . . . . 74.329999999999998 111.497 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.766 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 10.3 mmpt? -83.7 127.17 33.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.62 -0.511 . . . . 75.540000000000006 109.62 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.01 92.38 4.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 73.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -116.05 172.18 7.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.389 -0.823 . . . . 72.129999999999995 111.164 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -98.47 145.93 26.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 73.040000000000006 110.322 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -95.41 103.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.617 -0.882 . . . . 74.439999999999998 108.617 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.94 -129.97 6.73 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.652 -0.785 . . . . 64.209999999999994 113.687 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.84 131.11 89.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.94 0.4 . . . . 73.099999999999994 111.827 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.76 124.0 11.4 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.883 2.388 . . . . 72.349999999999994 111.425 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 53' ' ' LEU . 59.3 mt -104.86 -66.33 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.047 0.451 . . . . 75.200000000000003 110.699 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 94.97 102.47 1.82 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.785 -0.721 . . . . 75.420000000000002 111.732 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -86.55 165.71 16.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.344 -0.243 . . . . 75.019999999999996 110.344 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.11 -29.46 68.76 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.12 -0.562 . . . . 64.219999999999999 113.776 -170.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.16 -63.3 3.17 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 73.510000000000005 112.85 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.401 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 52.0 m-85 -116.95 -34.71 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.647 0.261 . . . . 74.340000000000003 111.583 -175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 -179.79 45.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.796 -0.716 . . . . 61.399999999999999 112.695 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 91.0 m 63.32 30.37 15.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.5 0.667 . . . . 75.420000000000002 111.136 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 71' ' ' LYS . 34.6 mm -89.33 136.79 22.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.55 -0.75 . . . . 73.519999999999996 109.675 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -107.48 145.92 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.197 0.523 . . . . 74.030000000000001 111.113 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 43' ' ' ILE . 64.1 tp -79.29 145.66 33.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.326 -0.852 . . . . 72.040000000000006 109.711 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.91 116.61 26.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.397 -0.594 . . . . 73.319999999999993 109.397 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -76.76 -50.88 12.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.183 -0.673 . . . . 71.519999999999996 109.183 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt 48.37 43.72 19.63 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.25 -0.886 . . . . 75.530000000000001 109.931 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -72.23 77.11 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.821 . . . . 74.219999999999999 110.447 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.4 m -126.78 -162.61 1.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.136 -0.938 . . . . 64.099999999999994 110.275 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.6 m . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.623 0.249 . . . . 64.140000000000001 111.617 -177.742 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 120.879 0.371 . . . . 62.32 110.339 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -95.94 11.07 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.855 2.37 . . . . 75.439999999999998 110.994 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.424 ' HB2' HG21 ' A' ' 130' ' ' ILE . 7.0 p -145.91 153.92 41.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.602 0.715 . . . . 72.439999999999998 112.905 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.448 HG11 ' HD2' ' A' ' 133' ' ' ARG . 15.3 m -136.89 153.82 30.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.035 -0.984 . . . . 75.129999999999995 109.098 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.9 p -122.42 122.64 66.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 111.646 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 22.6 ttpt -87.24 126.63 34.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.71 -0.677 . . . . 71.409999999999997 109.781 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.63 123.15 70.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 123.745 0.653 . . . . 74.439999999999998 110.009 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.471 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 41.7 mt-10 -140.69 152.51 66.13 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.356 -0.383 . . . . 75.319999999999993 110.344 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.51 126.0 20.05 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.591 2.194 . . . . 73.25 111.964 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -85.74 -15.97 40.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.128 0.49 . . . . 61.409999999999997 110.36 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.63 -20.08 43.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.863 -0.608 . . . . 73.109999999999999 110.78 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -172.07 96.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.216 -0.661 . . . . 73.409999999999997 109.216 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.78 145.62 10.65 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.032 -1.08 . . . . 63.210000000000001 113.224 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.0 Cg_exo -60.88 -19.59 62.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.98 3.12 . . . . 62.409999999999997 112.285 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.2 tm? -50.72 -30.05 12.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.855 -0.611 . . . . 74.019999999999996 110.741 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.72 -48.38 75.29 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.76 0.314 . . . . 71.530000000000001 110.828 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.6 m -67.63 -41.99 83.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 73.530000000000001 110.481 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -58.45 -42.52 87.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.744 . . . . 75.109999999999999 110.513 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.68 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 73.0 110.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 66.7 mmtt -63.55 -46.85 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.922 -0.311 . . . . 75.400000000000006 110.451 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.06 -39.95 95.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.040000000000006 110.048 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.556 ' O ' ' HB1' ' A' ' 91' ' ' ALA . 48.0 t80 -63.29 -34.4 77.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.407 -0.815 . . . . 73.430000000000007 110.662 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -77.51 -32.67 54.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.82 0.343 . . . . 74.310000000000002 111.345 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HG3' ' HE2' ' A' ' 173' ' ' TYR . 39.5 mmt180 -78.73 -49.21 13.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.091 0.404 . . . . 74.319999999999993 112.091 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.83 -31.47 10.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.859 0.688 . . . . 73.420000000000002 112.859 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 87' ' ' TYR . . . -84.42 89.0 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.42 0.628 . . . . 72.340000000000003 111.324 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 95' ' ' GLN . 8.9 tmtt? -154.04 91.98 3.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.525 -0.917 . . . . 73.319999999999993 108.525 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 113' ' ' TYR . 95.6 Cg_exo -44.25 -52.56 5.62 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.952 3.101 . . . . 73.549999999999997 114.53 -170.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.7 -45.16 92.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 74.239999999999995 110.625 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 6.9 tp60 -66.27 -44.39 83.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.707 -0.678 . . . . 73.430000000000007 110.565 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 92' ' ' LYS . 68.4 mt -58.94 -53.75 43.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.977 -0.556 . . . . 72.200000000000003 110.574 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.54 -38.88 69.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.236 -0.438 . . . . 70.329999999999998 110.593 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -61.07 -62.3 1.95 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.773 -0.648 . . . . 74.349999999999994 111.371 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.801 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -71.3 -34.36 70.56 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.253 -0.579 . . . . 72.109999999999999 111.105 -173.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.75 -50.68 78.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.312 0.101 . . . . 72.040000000000006 111.027 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -69.4 -36.85 77.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.657 -0.417 . . . . 64.329999999999998 110.806 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 72.099999999999994 110.782 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 7.8 ttt180 -83.38 0.97 43.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 72.040000000000006 110.374 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 26.0 mtpp 66.54 29.62 8.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.358 -0.837 . . . . 72.329999999999998 111.532 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 89.1 mt -92.34 176.7 6.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.72 -0.673 . . . . 71.140000000000001 109.942 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 10.8 mmpt? -103.37 -55.01 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.595 -0.275 . . . . 74.450000000000003 111.051 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -157.51 171.18 20.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 72.230000000000004 110.109 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.801 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 39.3 tp -129.32 137.57 51.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.995 -0.372 . . . . 73.209999999999994 109.995 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.86 64.21 3.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.155 -0.545 . . . . 73.540000000000006 113.253 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 135.8 27.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 110.065 -0.346 . . . . 70.25 110.065 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.07 135.07 30.11 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.039 2.492 . . . . 65.209999999999994 112.509 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 24.2 tptm -66.75 124.06 21.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 74.409999999999997 111.001 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 14.0 t80 -81.27 112.56 18.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.67 -0.695 . . . . 75.129999999999995 111.022 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.5 ' HB2' HG22 ' A' ' 130' ' ' ILE . 68.9 m95 -105.42 -52.51 2.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.624 -0.88 . . . . 73.129999999999995 108.624 169.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.44 46.91 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.008 -0.996 . . . . 74.099999999999994 111.759 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 p -168.74 162.84 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.625 -0.509 . . . . 73.019999999999996 109.625 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.67 -179.44 46.18 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.754 -1.212 . . . . 70.310000000000002 113.207 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.496 HD21 ' N ' ' A' ' 119' ' ' HIS . 5.9 tt -123.88 137.74 54.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.688 -0.856 . . . . 75.349999999999994 108.688 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.496 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -134.84 147.7 49.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 73.439999999999998 110.822 178.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.97 140.96 37.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.389 -0.823 . . . . 74.120000000000005 110.175 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 126' ' ' TYR . 43.4 tttm -108.66 17.64 21.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.638 -0.255 . . . . 74.299999999999997 110.501 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 56.8 m-80 71.27 97.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.309 0.644 . . . . 71.530000000000001 110.207 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.05 -44.81 1.4 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.807 -0.711 . . . . 65.340000000000003 112.012 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -129.69 138.25 51.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.831 -0.433 . . . . 74.299999999999997 109.831 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.0 m -101.53 140.57 35.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 75.409999999999997 110.349 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 121' ' ' LYS . 35.5 p90 -128.3 149.94 50.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.182 0.515 . . . . 75.319999999999993 110.155 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -117.57 142.42 47.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.027 -0.731 . . . . 74.099999999999994 109.027 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.6 p90 -137.93 153.07 49.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.989 0.423 . . . . 72.040000000000006 111.291 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 20.0 ptp -139.75 139.42 36.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.982 -0.554 . . . . 74.450000000000003 110.576 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.551 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 5.0 mm -98.17 118.69 45.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.859 -0.61 . . . . 73.310000000000002 110.065 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.419 ' SD ' HG21 ' A' ' 196' ' ' VAL . 25.1 ptt? -123.2 171.1 9.6 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.13 -0.693 . . . . 73.519999999999996 109.13 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.835 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t70 -65.2 162.15 17.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 74.510000000000005 110.442 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.448 ' HD2' HG11 ' A' ' 69' ' ' VAL . 1.7 tpt180 -76.57 112.79 13.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.44 0.638 . . . . 72.109999999999999 110.862 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.11 143.08 33.06 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.942 -0.762 . . . . 75.120000000000005 108.942 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -136.92 -2.15 2.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.291 -0.957 . . . . 65.400000000000006 112.233 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 1.07 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.8 m -121.83 125.27 46.1 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.845 -0.209 . . . . 72.450000000000003 110.512 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.444 ' HA ' HD13 ' A' ' 184' ' ' LEU . 6.4 p-10 -116.35 139.67 50.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.434 -0.58 . . . . 72.019999999999996 109.434 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.841 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 5.6 tp -68.95 -15.34 63.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.718 -0.219 . . . . 72.109999999999999 110.928 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -62.3 -50.19 72.66 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.012 0.434 . . . . 62.210000000000001 110.963 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -80.6 -23.24 39.96 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.497 -0.481 . . . . 75.129999999999995 109.841 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.841 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 27.6 mt -60.19 -51.26 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 111.794 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.665 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 5.5 p90 -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.386 -0.525 . . . . 75.319999999999993 110.228 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -80.99 -25.98 36.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.527 . . . . 73.510000000000005 110.705 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.0 0.428 . . . . 72.329999999999998 110.592 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -101.38 2.38 39.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 71.219999999999999 110.157 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 44.16 72.74 0.18 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.046 -0.979 . . . . 73.329999999999998 112.672 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.7 pttp 45.23 34.11 1.35 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.058 0.943 . . . . 74.530000000000001 112.951 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -138.87 92.68 2.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.061 0.458 . . . . 74.409999999999997 109.82 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.665 ' CZ ' ' HA ' ' A' ' 142' ' ' TYR . 55.6 m-85 -104.14 150.95 23.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.968 -0.56 . . . . 73.239999999999995 111.666 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -86.7 147.98 25.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.689 -0.687 . . . . 71.510000000000005 109.162 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -57.55 -29.08 64.09 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 112.736 0.643 . . . . 74.310000000000002 112.736 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.23 -53.64 55.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.861 0.362 . . . . 75.549999999999997 111.402 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.41 ' O ' HD12 ' A' ' 157' ' ' LEU . 3.9 m -64.32 -44.95 89.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 74.239999999999995 111.038 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.96 -40.05 85.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 110.94 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.706 ' HG ' HD21 ' A' ' 328' ' ' LEU . 1.7 mm? -63.29 -50.94 68.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 72.109999999999999 111.623 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.8 tt0 -61.88 -38.36 88.01 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.009 -0.676 . . . . 71.329999999999998 110.267 -178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 153' ' ' THR . 7.7 mp -59.96 -48.6 81.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 72.200000000000003 110.447 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -56.26 -47.52 78.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 72.409999999999997 110.491 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.785 ' HG ' ' HD2' ' A' ' 321' ' ' ARG . 9.1 mp -57.3 -52.42 65.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 111.266 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.438 ' O ' HG22 ' A' ' 164' ' ' ILE . 2.1 mpt_? -67.75 -33.68 75.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 74.310000000000002 111.379 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -63.62 -43.53 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.7 -0.481 . . . . 72.230000000000004 109.7 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 321' ' ' ARG . 83.0 mt -63.01 -42.45 99.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.73 -0.214 . . . . 75.319999999999993 110.805 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.24 -60.53 3.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.362 0.601 . . . . 73.450000000000003 110.775 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.537 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 tt -71.83 -39.74 68.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 72.430000000000007 111.968 -174.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.8 mp -65.71 -36.89 84.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 117.759 0.254 . . . . 65.109999999999999 111.302 -177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.26 -48.72 74.68 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.182 -0.673 . . . . 74.430000000000007 109.182 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 79.5 t80 -57.48 -46.26 83.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.157 -0.929 . . . . 75.0 111.816 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 164' ' ' ILE . 34.1 pt -82.41 -32.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.466 0.543 . . . . 75.25 112.466 -174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -64.54 -43.62 93.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 110.011 -0.366 . . . . 73.340000000000003 110.011 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -82.95 14.66 3.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.714 0.769 . . . . 74.219999999999999 109.472 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 1.4 t-80 -136.69 40.95 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.467 -0.788 . . . . 64.400000000000006 109.842 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 205' ' ' CYS . 41.7 mt-10 85.4 -61.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.395 1.059 . . . . 72.120000000000005 113.557 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.624 ' HE2' ' HG3' ' A' ' 89' ' ' ARG . 13.0 m-85 -84.27 116.13 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.406 0.521 . . . . 73.439999999999998 112.406 -164.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 238' ' ' PRO . 16.4 t -109.63 151.21 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.357 -0.609 . . . . 70.319999999999993 109.357 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -115.46 106.95 14.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 73.099999999999994 109.739 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.42 -25.86 55.95 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.551 -0.833 . . . . 71.140000000000001 111.828 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.519 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 7.1 t70 -98.38 101.73 13.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 75.329999999999998 110.24 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.71 31.95 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.961 0.886 . . . . 74.109999999999999 110.078 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 179' ' ' LYS . 3.4 ttmp? -62.96 149.62 44.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.166 -0.925 . . . . 73.010000000000005 110.699 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.62 -14.61 8.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.786 0.662 . . . . 63.509999999999998 112.786 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 m -73.48 -20.81 60.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.48 . . . . 75.510000000000005 110.847 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.628 ' ND2' HD21 ' A' ' 195' ' ' LEU . 2.1 t30 -82.32 -21.49 36.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.488 -0.778 . . . . 74.140000000000001 111.592 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.433 HD22 HG23 ' A' ' 193' ' ' VAL . 5.9 mp -101.85 119.67 39.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.985 0.422 . . . . 64.140000000000001 111.533 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 137' ' ' ASP . 3.9 mm? -121.47 145.68 47.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 72.5 110.159 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 1.07 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 52.6 mt -109.67 152.2 25.91 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 110.054 -0.35 . . . . 71.219999999999999 110.054 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.606 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 21.1 t-20 -72.64 147.91 45.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 72.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 -20.91 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 73.200000000000003 111.527 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -113.85 -9.84 13.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.972 0.415 . . . . 72.340000000000003 110.25 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -135.35 96.72 13.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.512 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.68 -18.75 15.01 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.968 2.445 . . . . 72.030000000000001 112.897 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 338' ' ' LYS . 5.5 p-10 -86.88 5.33 37.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.08 0.466 . . . . 74.030000000000001 111.583 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -118.65 109.53 16.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.728 -0.471 . . . . 72.540000000000006 109.728 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.433 HG23 HD22 ' A' ' 183' ' ' LEU . 6.5 p -103.57 126.47 58.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.101 -0.499 . . . . 75.349999999999994 110.528 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.606 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 9.7 m-85 -114.03 156.34 24.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.711 -0.677 . . . . 74.219999999999999 109.462 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.628 HD21 ' ND2' ' A' ' 182' ' ' ASN . 21.3 mt -107.8 116.89 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.838 -0.431 . . . . 75.349999999999994 109.838 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.419 HG21 ' SD ' ' A' ' 131' ' ' MET . 9.2 p -159.96 159.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.79 -0.186 . . . . 74.319999999999993 111.027 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.4 t70 64.98 29.75 12.13 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.533 0.682 . . . . 74.430000000000007 110.74 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 18.9 p90 -100.06 -41.62 7.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 75.549999999999997 111.108 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.8 32.9 75.83 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.619 -0.801 . . . . 74.040000000000006 111.993 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.816 HD22 ' HB3' ' A' ' 352' ' ' LYS . 30.5 mt -131.2 90.31 2.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.249 0.547 . . . . 73.5 110.589 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.28 121.85 9.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 73.530000000000001 110.981 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.59 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 61.4 t80 -114.34 131.18 56.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.143 -0.688 . . . . 74.540000000000006 109.143 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.858 0.361 . . . . 74.319999999999993 111.524 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 237' ' ' ALA . 31.8 t80 -80.81 -40.09 25.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 109.96 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 10.7 p -125.81 87.8 55.33 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 43.310000000000002 110.79 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 18.7 Cg_endo -59.42 113.84 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.624 2.216 . . . . 71.040000000000006 111.733 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 63.9 26.63 14.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.828 -0.624 . . . . 75.439999999999998 111.373 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.35 -19.8 52.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.749 -0.739 . . . . 64.120000000000005 113.123 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.52 114.15 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.091 -0.337 . . . . 74.409999999999997 110.091 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -100.38 157.07 16.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.825 -0.35 . . . . 72.450000000000003 110.272 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -115.44 -172.91 2.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.516 -0.55 . . . . 74.239999999999995 109.516 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -97.83 -164.27 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.198 0.311 . . . . 72.439999999999998 110.42 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -60.29 97.88 0.05 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.575 0.702 . . . . 75.430000000000007 111.088 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.427 ' N ' HG22 ' A' ' 236' ' ' VAL . 55.2 mtpt -67.42 -53.73 26.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.36 -0.836 . . . . 72.530000000000001 112.256 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 37.8 77.94 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.126 0.965 . . . . 72.430000000000007 110.359 -164.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.8 135.77 59.25 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.194 -1.366 . . . . 71.340000000000003 111.492 -168.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 CA--C 1.53 0.301 0 C-N-CA 123.268 2.646 . . . . 63.530000000000001 113.656 -177.501 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 202' ' ' TYR . 16.2 p-10 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.087 -0.338 . . . . 71.409999999999997 110.087 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.519 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . -108.24 -169.41 21.32 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.822 -0.704 . . . . 64.519999999999996 113.743 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.562 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 0.7 OUTLIER -90.53 148.77 22.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.963 0.411 . . . . 70.310000000000002 110.902 -176.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.452 HG12 HG11 ' A' ' 271' ' ' VAL . 13.3 tt -63.64 -24.28 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 113.761 1.022 . . . . 72.349999999999994 113.761 -168.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.562 ' OE1' ' HB ' ' A' ' 224' ' ' THR . 0.0 OUTLIER -70.1 -41.43 74.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.288 -0.565 . . . . 73.150000000000006 110.878 -172.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 246' ' ' ILE . 29.4 m-85 -101.02 -39.94 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.268 -0.173 . . . . 72.010000000000005 111.454 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.582 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 94.0 m -60.29 -14.87 20.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.358 0.503 . . . . 74.530000000000001 112.358 -175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 14.1 m 72.28 -167.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 65.420000000000002 111.053 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.5 mp -71.54 -34.42 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.764 -0.458 . . . . 71.540000000000006 109.764 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.625 ' O ' HG11 ' A' ' 236' ' ' VAL . 25.2 t70 -44.64 -91.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.479 -1.237 . . . . 70.319999999999993 113.279 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.582 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.75 -27.79 69.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.122 -0.361 . . . . 73.239999999999995 111.686 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.407 ' CE1' HD11 ' A' ' 225' ' ' ILE . 81.1 t60 -56.84 -37.27 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 73.510000000000005 111.246 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.68 0.5 52.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 71.299999999999997 111.49 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.77 8.16 62.3 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.462 -0.875 . . . . 52.039999999999999 113.352 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 231' ' ' ASP . 11.9 p -86.96 140.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.979 -0.749 . . . . 65.510000000000005 108.979 175.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 204' ' ' TYR . . . -68.0 117.19 46.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.471 -0.331 . . . . 72.140000000000001 110.131 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.555 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 6.6 Cg_endo -49.25 124.12 11.25 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.635 2.89 . . . . 74.450000000000003 112.983 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 t -143.09 93.38 2.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.25 -0.432 . . . . 73.129999999999995 111.297 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.536 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 59.6 mtt180 75.96 -57.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.604 -0.726 . . . . 73.230000000000004 112.052 170.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.724 ' HG3' ' HD1' ' A' ' 311' ' ' TYR . 11.4 mmm-85 -57.38 -54.69 43.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.422 0.153 . . . . 72.530000000000001 110.592 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.02 -58.55 9.32 Favored Glycine 0 N--CA 1.448 -0.56 0 O-C-N 123.794 0.684 . . . . 63.219999999999999 112.426 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.42 -47.99 47.57 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.11 0.481 . . . . 73.430000000000007 111.412 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 64.3 mt -71.78 -45.29 62.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.803 -0.635 . . . . 71.140000000000001 111.529 -175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.96 -39.11 79.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.559 0.219 . . . . 73.299999999999997 111.061 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 242' ' ' GLY . 99.0 mt -59.63 -45.85 93.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.066 0.46 . . . . 74.329999999999998 110.288 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.523 HD12 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -65.06 -43.08 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 64.430000000000007 110.591 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.36 -42.84 95.85 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.923 -0.656 . . . . 73.200000000000003 112.504 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.522 ' CZ ' ' HD2' ' A' ' 275' ' ' LYS . 22.9 m-30 -66.33 -48.43 70.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.491 0.182 . . . . 75.340000000000003 111.491 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.4 p -66.8 -40.91 88.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.574 -0.451 . . . . 72.109999999999999 111.088 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.47 -45.6 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 72.219999999999999 110.896 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 70.299999999999997 110.346 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.466 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 48.9 tt0 -71.51 -41.61 69.04 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 121.097 -0.241 . . . . 75.430000000000007 110.458 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -66.73 -26.32 66.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 74.239999999999995 110.672 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.1 tp -81.18 -41.19 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.854 -0.612 . . . . 74.349999999999994 111.776 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.5 p -103.62 -27.26 12.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.391 0.515 . . . . 72.430000000000007 112.391 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.7 -59.52 0.36 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.724 -0.75 . . . . 75.219999999999999 113.048 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -121.76 144.02 49.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.848 0.356 . . . . 72.230000000000004 110.963 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 94.8 mt -105.7 145.12 30.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 75.519999999999996 110.715 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.62 -31.92 92.73 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.803 2.335 . . . . 61.340000000000003 112.291 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 48.0 p90 -96.84 11.09 36.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.535 . . . . 74.420000000000002 110.41 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 30.5 tt0 -83.18 -42.06 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.162 0.506 . . . . 72.150000000000006 110.201 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -88.54 -12.11 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.051 -0.522 . . . . 63.530000000000001 109.829 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.17 10.1 25.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.748 -0.66 . . . . 75.439999999999998 111.907 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 3.7 pp -70.86 -7.31 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.178 0.513 . . . . 74.310000000000002 110.916 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.45 -13.07 60.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.429 -0.805 . . . . 75.329999999999998 110.794 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.486 ' CG ' ' HZ2' ' A' ' 269' ' ' LYS . 12.9 t70 -124.61 122.03 25.78 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 62.200000000000003 109.841 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 32.7 Cg_exo -62.69 -30.59 78.74 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.987 2.458 . . . . 74.519999999999996 113.375 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.684 ' HZ1' ' HB2' ' A' ' 269' ' ' LYS . 0.0 OUTLIER -76.45 -38.06 56.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.061 -0.348 . . . . 73.549999999999997 110.061 -176.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.51 -49.13 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.899 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.712 ' O ' ' HG2' ' A' ' 275' ' ' LYS . 38.0 t -55.88 -50.99 65.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.599 0.238 . . . . 73.129999999999995 110.997 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -61.14 -50.41 73.31 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 111.182 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 32.1 t70 -61.37 -45.6 93.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 74.329999999999998 111.082 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.9 m -61.31 -32.76 72.62 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.719 -0.219 . . . . 54.130000000000003 111.49 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 35.2 mmtp -60.27 -49.46 77.53 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.189 -0.671 . . . . 65.310000000000002 109.189 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.64 -33.1 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.213 -0.903 . . . . 73.430000000000007 110.968 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 16.5 mmm180 -62.66 -40.27 96.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.672 -0.24 . . . . 75.0 111.041 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.428 ' HD1' ' HA ' ' A' ' 278' ' ' TYR . 2.9 m-85 -74.06 -33.99 63.87 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.513 -0.475 . . . . 72.409999999999997 110.942 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -66.74 -20.96 66.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.467 -0.333 . . . . 74.0 110.957 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -49.64 -56.9 8.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.866 -0.607 . . . . 74.120000000000005 110.759 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -150.31 75.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.82 -0.807 . . . . 72.329999999999998 108.82 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 304' ' ' GLU . 0.2 OUTLIER -53.47 -37.19 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.793 -1.094 . . . . 71.340000000000003 113.232 -171.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 300' ' ' ALA . . . -61.41 -49.0 78.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.013 -0.275 . . . . 74.349999999999994 111.676 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 m -78.07 -39.09 42.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.733 0.302 . . . . 74.109999999999999 111.114 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.76 -46.26 90.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.192 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.51 ' HE2' ' SD ' ' A' ' 303' ' ' MET . 23.6 mmt -74.26 -29.03 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 72.239999999999995 110.805 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 17.1 t70 -62.32 -31.38 72.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 71.430000000000007 110.169 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.646 ' HB3' ' HZ2' ' A' ' 288' ' ' LYS . 9.2 mtpm? -83.61 -21.63 32.5 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.891 -0.595 . . . . 64.209999999999994 111.735 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.01 -38.63 86.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.657 0.265 . . . . 71.040000000000006 111.264 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 5.4 t80 -135.81 79.49 45.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.765 -0.374 . . . . 75.530000000000001 110.486 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.59 19.71 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.113 2.542 . . . . 73.530000000000001 111.918 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 33.8 mt-10 -87.48 35.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.877 -0.601 . . . . 74.549999999999997 111.42 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 68.82 10.06 7.7 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.548 0.944 . . . . 72.329999999999998 113.548 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 11.6 t30 -82.09 -81.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.875 -0.417 . . . . 74.349999999999994 109.875 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 2.0 tpmt? 168.22 107.72 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.141 0 O-C-N 123.59 0.557 . . . . 74.319999999999993 109.757 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -102.34 39.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.667 2.911 . . . . 74.230000000000004 111.881 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.16 -38.27 2.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.527 -0.844 . . . . 72.129999999999995 113.334 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.419 ' HB3' HD21 ' A' ' 324' ' ' LEU . 2.8 mp0 -59.14 -53.64 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.43 . . . . 55.420000000000002 110.51 -176.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.67 -37.77 80.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.604 -0.725 . . . . 75.439999999999998 110.323 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 283' ' ' ALA . . . -61.36 -52.5 64.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 71.310000000000002 111.31 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 301' ' ' LYS . 21.8 ttmt -70.69 -31.98 69.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.916 0.389 . . . . 74.519999999999996 110.538 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 306' ' ' VAL . 64.6 t80 -57.95 -48.97 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 74.219999999999999 110.217 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.51 ' SD ' ' HE2' ' A' ' 286' ' ' MET . 87.4 mtp -72.48 -32.61 66.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 111.274 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.522 ' HA ' HD11 ' A' ' 282' ' ' ILE . 7.8 tp10 -59.47 -37.67 78.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.841 0.829 . . . . 75.430000000000007 108.878 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.444 HG22 HD21 ' A' ' 320' ' ' LEU . 60.7 m -69.06 -42.59 76.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.632 -1.167 . . . . 62.119999999999997 111.455 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 303' ' ' MET . 5.5 m -70.55 -26.94 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.882 0.372 . . . . 75.040000000000006 110.578 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.44 -48.72 76.59 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.53 . . . . 74.310000000000002 110.215 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 308' ' ' LEU . 3.3 tt -68.5 -25.54 65.01 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.471 -0.786 . . . . 74.329999999999998 110.046 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -62.52 -18.84 62.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.519 -0.764 . . . . 75.420000000000002 111.878 -176.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.6 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.391 0.432 . . . . 74.219999999999999 110.294 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.724 ' HD1' ' HG3' ' A' ' 241' ' ' ARG . 3.9 m-30 -136.75 -43.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 75.200000000000003 110.402 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.4 t -136.92 20.61 3.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 112.205 -168.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -88.83 50.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.638 -0.664 . . . . 74.430000000000007 112.277 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER 58.97 94.22 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.196 -0.911 . . . . 75.450000000000003 113.456 170.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.441 ' HA ' HD23 ' A' ' 309' ' ' LEU . 64.3 Cg_endo -90.4 121.4 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.786 2.324 . . . . 71.340000000000003 111.802 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.2 mt -84.96 99.08 10.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.824 0.345 . . . . 73.519999999999996 110.366 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -61.64 -45.03 95.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.942 -0.572 . . . . 74.519999999999996 111.765 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.0 -0.37 . . . . 74.439999999999998 110.0 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.29 -36.5 84.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 73.319999999999993 110.336 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.681 ' O ' HG13 ' A' ' 323' ' ' ILE . 77.2 mt -60.68 -48.7 80.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 65.200000000000003 110.982 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.785 ' HD2' ' HG ' ' A' ' 159' ' ' LEU . 32.8 ptt180 -74.2 -20.88 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.841 -0.744 . . . . 74.430000000000007 110.772 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.94 -39.88 79.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.716 -0.22 . . . . 73.299999999999997 110.818 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.681 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.2 pp -72.18 -30.23 35.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.791 -0.448 . . . . 72.409999999999997 109.791 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.63 -49.31 63.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 73.319999999999993 110.279 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.752 HD12 HD23 ' A' ' 159' ' ' LEU . 88.8 mt -64.86 -29.24 70.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.055 -0.521 . . . . 74.329999999999998 110.66 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -63.96 -47.48 80.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.607 . . . . 74.510000000000005 110.497 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.65 -30.65 76.68 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 72.430000000000007 111.942 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' A' ' 155' ' ' LEU . 56.4 tp -72.8 -50.59 23.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 72.420000000000002 110.835 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.432 ' HB3' ' HZ3' ' A' ' 329' ' ' LYS . 7.5 ttpm? -73.83 -14.02 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.311 -0.404 . . . . 74.340000000000003 110.696 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.98 -23.61 67.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 111.499 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.2 tt -97.17 -6.8 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 73.109999999999999 110.113 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.71 24.02 34.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.856 -0.688 . . . . 75.430000000000007 113.208 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.8 m -123.36 158.62 30.67 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.455 -0.438 . . . . 63.350000000000001 110.595 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -156.45 176.73 12.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.439 -0.346 . . . . 75.310000000000002 110.135 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.23 -36.07 18.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.721 -0.474 . . . . 72.140000000000001 109.721 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.8 t70 75.14 16.92 2.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.091 -0.959 . . . . 65.129999999999995 110.88 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.51 39.08 50.97 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.934 -0.866 . . . . 73.049999999999997 110.934 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 191' ' ' ASP . 39.0 ttmt . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.397 -0.402 . . . . 75.439999999999998 110.343 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.816 ' HB3' HD22 ' A' ' 200' ' ' LEU . 35.2 tptt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 109.218 -0.66 . . . . 64.530000000000001 109.218 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.609 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 10.3 t -155.87 169.73 23.72 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.513 0.197 . . . . 72.420000000000002 110.71 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 144.06 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.698 0.629 . . . . 71.030000000000001 112.698 -172.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 11.4 t -92.07 132.83 36.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.188 -0.914 . . . . 71.209999999999994 110.001 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 61.6 tttp . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.492 0.187 . . . . 73.430000000000007 110.613 174.728 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.426 HG21 ' O ' ' A' ' 40' ' ' GLY . 46.6 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.689 0.28 . . . . 74.310000000000002 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.79 57.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.765 -0.731 . . . . 73.200000000000003 114.125 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.82 -177.08 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.173 0.987 . . . . 73.439999999999998 112.312 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.427 HG23 ' HB2' ' A' ' 36' ' ' GLU . 3.2 mp -107.49 138.53 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.376 0.88 . . . . 74.109999999999999 113.376 -162.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.06 126.64 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.148 -0.933 . . . . 72.450000000000003 109.593 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -103.7 136.53 43.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.1 0.778 . . . . 74.400000000000006 113.1 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.816 ' HB3' ' CZ2' ' A' ' 37' ' ' TRP . 10.9 p30 -88.39 -179.44 6.1 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 71.230000000000004 110.758 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.897 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -71.16 -9.72 58.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 71.450000000000003 111.774 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.18 6.82 46.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 74.450000000000003 110.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 52.5 mmtt 68.82 23.79 6.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.347 -0.842 . . . . 73.040000000000006 111.684 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.643 ' HZ3' ' HB3' ' A' ' 114' ' ' TRP . 40.4 ttpt -90.67 114.49 26.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.453 -0.943 . . . . 73.510000000000005 108.453 171.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.427 ' HB2' HG23 ' A' ' 28' ' ' ILE . 6.0 pt-20 -92.51 102.0 14.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.734 -0.666 . . . . 70.349999999999994 110.791 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.817 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 0.4 OUTLIER -80.27 147.08 31.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 65.25 109.689 -177.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.473 ' HE3' ' O ' ' A' ' 56' ' ' MET . 28.1 ttpp -106.06 119.45 39.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.753 -0.462 . . . . 74.219999999999999 109.753 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.99 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.665 . . . . 65.400000000000006 111.27 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.426 ' O ' HG21 ' A' ' 25' ' ' VAL . . . -109.2 -129.43 5.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.49 -0.644 . . . . 74.439999999999998 111.49 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 mm? -76.08 141.85 71.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.686 0.279 . . . . 74.340000000000003 111.134 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_endo -86.97 120.43 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.245 2.63 . . . . 72.310000000000002 111.775 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 53' ' ' LEU . 3.8 mp -96.57 -54.82 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.407 . . . . 62.109999999999999 110.622 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 97.74 162.99 31.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.828 -0.701 . . . . 72.019999999999996 111.491 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.741 ' HB2' HG12 ' A' ' 51' ' ' ILE . 27.6 tp60 -133.56 128.59 35.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.987 0.394 . . . . 73.310000000000002 110.175 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.58 108.6 2.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.617 -0.802 . . . . 43.450000000000003 112.418 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -16.14 46.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.906 -0.664 . . . . 74.340000000000003 112.291 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.669 ' CE2' ' HA ' ' A' ' 198' ' ' TYR . 21.2 m-85 -113.38 -59.39 2.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.736 0.303 . . . . 75.140000000000001 110.318 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.72 -105.59 0.22 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.8 -0.714 . . . . 72.099999999999994 112.562 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.644 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 49.8 t -142.05 142.0 32.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.596 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.741 HG12 ' HB2' ' A' ' 45' ' ' GLN . 27.4 mm -121.74 136.88 57.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.5 -0.556 . . . . 74.239999999999995 109.5 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.25 144.66 35.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.755 0.312 . . . . 71.120000000000005 110.643 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HA ' HG11 ' A' ' 69' ' ' VAL . 57.9 tp -84.37 152.04 24.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.364 -0.606 . . . . 64.109999999999999 109.364 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.38 104.4 12.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.827 0.346 . . . . 74.409999999999997 111.056 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.1 -35.18 42.73 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.11 -0.7 . . . . 71.25 109.11 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 37' ' ' TRP . 13.8 tpt 69.54 -70.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.482 -1.235 . . . . 73.200000000000003 113.194 171.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -139.32 104.9 5.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.176 0.512 . . . . 64.150000000000006 111.159 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -83.61 40.01 0.71 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 64.510000000000005 111.52 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 110.799 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.475 ' HB1' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.131 0 N-CA-C 109.243 -0.651 . . . . 74.230000000000004 109.243 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HD3' ' HB1' ' A' ' 66' ' ' ALA . 68.0 Cg_endo -78.37 55.84 5.58 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 121.594 1.529 . . . . 72.439999999999998 110.95 169.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 8.6 p -145.51 157.93 43.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.999 -0.546 . . . . 75.209999999999994 110.699 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 53' ' ' LEU . 7.2 m -135.34 161.43 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 74.209999999999994 110.369 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.572 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 4.9 p -119.75 119.98 61.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.651 0.739 . . . . 72.319999999999993 111.934 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 4.8 tptp -79.98 115.97 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.776 -1.102 . . . . 74.430000000000007 108.768 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 128' ' ' PHE . 6.9 p -125.7 128.32 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.065 0.46 . . . . 65.400000000000006 111.577 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.4 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 77.3 mt-10 -138.06 152.24 71.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 75.129999999999995 109.833 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.92 165.8 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.346 2.03 . . . . 70.239999999999995 112.302 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.1 m -78.08 69.94 4.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.332 0.587 . . . . 72.150000000000006 110.453 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -122.66 7.12 9.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 73.209999999999994 110.453 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 67.62 93.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.267 -0.878 . . . . 72.340000000000003 110.762 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.63 -154.11 6.14 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.576 -0.738 . . . . 73.239999999999995 111.646 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 31.4 Cg_exo -59.15 -35.52 97.62 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.21 2.607 . . . . 73.120000000000005 112.553 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.54 -36.37 44.72 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.926 0.766 . . . . 74.549999999999997 111.433 -176.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -66.57 -49.28 66.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.805 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 m -62.71 -48.35 79.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 74.409999999999997 111.107 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 8.3 pt-20 -69.35 -33.54 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.968 -0.56 . . . . 74.439999999999998 111.166 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.595 HD21 ' HD3' ' A' ' 127' ' ' ARG . 43.7 tp -58.48 -47.48 83.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.003 0.43 . . . . 75.530000000000001 110.575 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.39 -36.8 82.03 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.117 -0.492 . . . . 75.409999999999997 110.511 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.45 -52.59 64.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.941 -0.572 . . . . 73.129999999999995 110.237 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 4.9 m-85 -57.27 -46.89 82.65 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.139 -0.482 . . . . 74.200000000000003 110.697 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.95 64.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 74.420000000000002 111.337 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -90.52 -26.81 19.57 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.848 0.314 . . . . 73.019999999999996 111.848 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.76 17.99 22.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.768 0.318 . . . . 73.400000000000006 111.649 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -85.54 164.74 17.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.555 0.576 . . . . 61.32 112.555 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 96' ' ' ILE . 2.8 tppt? 77.88 99.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.847 -1.07 . . . . 75.310000000000002 111.09 170.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 11.6 Cg_endo -55.12 -29.16 64.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.441 2.761 . . . . 72.430000000000007 113.443 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 4.3 tp10 -55.42 -59.43 4.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 73.299999999999997 110.596 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 6.4 tp60 -68.11 -35.6 78.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.966 -0.561 . . . . 74.329999999999998 110.449 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' LYS . 73.5 mt -55.45 -49.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 72.299999999999997 110.277 177.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -59.52 -42.78 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.456 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.7 mmtt -55.65 -59.59 4.64 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.723 -0.671 . . . . 75.230000000000004 112.113 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.91 -34.97 69.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.024 -0.67 . . . . 73.219999999999999 111.228 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.653 HD13 ' HG ' ' A' ' 108' ' ' LEU . 28.5 mt -59.15 -49.14 84.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 121.095 -0.242 . . . . 74.439999999999998 111.199 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -74.63 -35.74 62.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 74.140000000000001 111.267 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.7 m -72.63 -39.78 66.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.799 0.333 . . . . 73.219999999999999 111.226 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -87.89 7.08 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.462 -0.335 . . . . 72.319999999999993 111.848 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 71.07 29.49 2.91 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.423 0.452 . . . . 73.329999999999998 112.138 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.05 -169.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.799 -0.445 . . . . 73.230000000000004 109.799 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 26.5 mmtm -115.36 -62.76 1.55 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.845 -0.428 . . . . 75.25 109.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.418 ' HA ' HD11 ' A' ' 100' ' ' ILE . 37.6 p90 -174.85 138.56 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.442 0.464 . . . . 62.100000000000001 110.503 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.653 ' HG ' HD13 ' A' ' 100' ' ' ILE . 72.8 mt -79.24 118.57 21.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.178 -0.464 . . . . 72.030000000000001 109.844 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' CZ ' ' A' ' 160' ' ' ARG . . . -79.03 54.87 4.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.383 -0.913 . . . . 75.099999999999994 111.817 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.59 149.96 39.02 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.905 -0.406 . . . . 73.319999999999993 109.905 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.75 ' HB3' ' HE2' ' A' ' 134' ' ' PHE . 21.0 Cg_exo -66.08 144.72 76.78 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.26 1.973 . . . . 75.140000000000001 111.923 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.82 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 16.0 tttp -70.74 118.26 13.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 72.420000000000002 110.56 -176.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.498 ' CD1' ' HD2' ' A' ' 87' ' ' TYR . 66.4 t80 -95.23 120.68 35.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 75.450000000000003 110.926 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.643 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 80.0 m95 -98.92 -51.31 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 75.129999999999995 110.769 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -169.0 172.61 43.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.864 -0.607 . . . . 73.109999999999999 112.134 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.607 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 34.2 p -160.3 157.37 27.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.196 -0.298 . . . . 74.019999999999996 110.196 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.25 -177.92 46.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.572 -0.823 . . . . 74.430000000000007 112.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.449 HD23 ' HB3' ' A' ' 125' ' ' SER . 9.5 tt -126.15 134.37 51.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.858 0.361 . . . . 75.010000000000005 110.206 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.553 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . 56.3 t60 -140.88 118.23 11.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.465 -0.568 . . . . 74.329999999999998 109.465 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.3 t70 -67.45 129.77 40.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.89 -0.595 . . . . 63.509999999999998 110.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 84.7 tttt -134.85 122.67 22.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.234 -0.439 . . . . 75.450000000000003 110.022 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.48 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 22.1 m120 66.73 15.95 10.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.063 -0.517 . . . . 72.439999999999998 111.522 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 -2.01 61.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.559 -0.829 . . . . 65.299999999999997 112.052 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 74.239999999999995 109.667 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.9 m -76.37 104.88 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 72.439999999999998 110.658 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -93.95 136.54 34.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.565 -0.743 . . . . 73.209999999999994 110.492 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.595 ' HD3' HD21 ' A' ' 84' ' ' LEU . 36.2 ttm180 -112.28 124.29 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.075 -0.713 . . . . 75.540000000000006 109.075 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.572 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.7 p90 -126.9 160.23 31.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 72.549999999999997 111.943 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.607 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 30.3 ttp -145.19 135.87 24.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.373 -0.83 . . . . 75.219999999999999 110.28 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.562 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 3.6 mm -96.99 128.34 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 62.340000000000003 111.539 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.6 ptp -122.59 167.78 12.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.996 -1.002 . . . . 74.099999999999994 108.976 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.82 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 11.0 t70 -72.53 152.03 42.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.96 -0.756 . . . . 71.030000000000001 108.96 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.408 ' HG3' ' HB3' ' A' ' 187' ' ' TYR . 27.7 tpt180 -76.59 102.07 5.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.817 0.818 . . . . 75.099999999999994 112.05 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 111' ' ' PRO . 8.9 m-85 -102.69 141.85 34.81 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.253 -1.388 . . . . 74.420000000000002 107.253 168.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.66 10.5 0.81 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.4 -1.381 . . . . 74.010000000000005 113.41 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.923 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 16.2 m -113.73 123.39 49.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.803 -0.814 . . . . 73.109999999999999 108.803 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.899 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 2.3 m-20 -105.03 129.51 53.45 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 121.151 -0.22 . . . . 62.229999999999997 110.412 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.35 -24.02 67.5 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.431 -0.508 . . . . 74.200000000000003 109.677 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.899 ' HG2' ' HB3' ' A' ' 137' ' ' ASP . 28.0 pt20 -70.68 -37.12 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 51.450000000000003 110.413 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.564 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 63.1 mttp -70.94 -35.05 72.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.9 0.381 . . . . 75.109999999999999 110.202 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.52 -31.03 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.278 -0.419 . . . . 63.439999999999998 110.512 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.472 ' CZ ' ' HD3' ' A' ' 147' ' ' LYS . 40.0 t80 -52.74 -53.72 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.686 -0.688 . . . . 74.219999999999999 111.886 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -99.57 -1.75 37.45 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 63.049999999999997 111.245 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.94 -32.87 15.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.37 . . . . 71.430000000000007 110.542 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -0.65 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.45 -0.574 . . . . 74.420000000000002 109.45 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 147' ' ' LYS . . . 55.29 36.69 27.59 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.659 -0.701 . . . . 65.319999999999993 111.226 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.472 ' HD3' ' CZ ' ' A' ' 142' ' ' TYR . 29.8 mtmt 72.57 93.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.551 -0.749 . . . . 74.109999999999999 112.46 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.3 tpp85 -143.69 97.64 3.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.865 -1.061 . . . . 74.340000000000003 109.244 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -119.64 153.81 34.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 75.420000000000002 110.234 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 m -101.28 175.44 5.58 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.634 -0.506 . . . . 63.310000000000002 109.634 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 328' ' ' LEU . 21.8 ttm180 -67.32 -37.13 82.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.347 -0.141 . . . . 74.340000000000003 111.084 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.828 ' HG2' ' HA ' ' A' ' 335' ' ' ASP . 2.1 tmtp? -55.98 -46.99 78.5 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.319 -0.252 . . . . 74.109999999999999 110.319 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.488 ' O ' HD11 ' A' ' 157' ' ' LEU . 0.0 OUTLIER -58.26 -48.1 81.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.846 0.355 . . . . 71.530000000000001 111.195 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.25 -42.07 90.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.312 -0.404 . . . . 62.130000000000003 110.771 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.32 -52.64 21.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 73.019999999999996 111.182 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -63.72 -44.04 94.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.539 0.209 . . . . 74.140000000000001 110.838 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 161' ' ' ILE . 10.9 mp -64.64 -41.87 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 73.140000000000001 110.755 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -59.35 -49.54 77.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.6 0.238 . . . . 75.109999999999999 110.531 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.684 HD23 HD21 ' A' ' 325' ' ' LEU . 8.8 mp -58.47 -50.72 72.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.403 -0.362 . . . . 63.219999999999999 111.752 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -66.08 -21.9 66.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 72.400000000000006 111.222 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 157' ' ' LEU . 23.6 mm -69.66 -40.91 79.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 109.72 -0.474 . . . . 75.219999999999999 109.72 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.76 -47.5 86.03 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.984 0.178 . . . . 72.450000000000003 110.784 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.41 -56.37 13.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.9 0.381 . . . . 75.510000000000005 111.419 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.448 HG21 HH21 ' A' ' 160' ' ' ARG . 11.3 tt -68.72 -35.86 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.418 -0.355 . . . . 74.519999999999996 111.05 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.568 HD11 ' CD2' ' A' ' 175' ' ' HIS . 68.5 tp -67.28 -38.5 85.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.547 -0.297 . . . . 73.409999999999997 111.488 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 27.8 mm-40 -76.63 -28.83 56.22 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.592 -0.443 . . . . 64.310000000000002 110.204 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -60.32 -48.71 80.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.357 . . . . 73.209999999999994 110.391 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 173' ' ' TYR . 18.5 pt -72.49 -31.97 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 73.109999999999999 110.957 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 23.6 m170 -64.84 -38.05 89.67 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.982 0.176 . . . . 73.400000000000006 111.06 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.1 -6.17 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.012 0.434 . . . . 71.129999999999995 111.137 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -100.65 -85.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.217 -0.66 . . . . 75.109999999999999 109.217 170.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 15.0 pt-20 -169.44 1.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 71.349999999999994 111.746 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.584 ' HB2' ' HB ' ' A' ' 168' ' ' ILE . 39.2 m-85 -106.19 158.09 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.178 0.513 . . . . 72.519999999999996 111.719 -165.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.72 168.55 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.876 -1.056 . . . . 75.329999999999998 108.561 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.568 ' CD2' HD11 ' A' ' 165' ' ' LEU . 8.4 p80 -102.94 121.37 42.38 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.447 -0.501 . . . . 72.120000000000005 110.645 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 -39.14 95.24 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.768 -0.73 . . . . 74.129999999999995 112.731 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.453 ' HB3' HD11 ' A' ' 200' ' ' LEU . 29.4 t70 -135.06 127.85 31.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 71.310000000000002 111.976 -175.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.575 ' HB ' HG23 ' A' ' 246' ' ' ILE . 32.2 mm -111.88 124.72 68.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.311 -0.996 . . . . 73.140000000000001 108.311 167.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -166.08 167.64 16.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.645 -0.502 . . . . 73.400000000000006 109.645 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.54 -19.16 63.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.946 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.706 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 3.1 p -75.1 -21.07 59.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 61.240000000000002 111.963 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' HG12 ' A' ' 196' ' ' VAL . 2.0 p30 -110.79 12.51 22.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 72.439999999999998 111.733 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.2 mt -113.47 114.4 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.293 -0.412 . . . . 70.420000000000002 110.586 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.31 138.74 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 110.86 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 39.3 mt -95.18 154.02 17.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.105 -0.702 . . . . 74.129999999999995 109.105 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.433 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 27.5 t-20 -59.44 147.56 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.477 -0.564 . . . . 73.200000000000003 109.477 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.408 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 10.7 p90 -60.91 -25.59 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.008 0.373 . . . . 73.310000000000002 112.008 -172.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -120.41 -26.3 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.007 0.373 . . . . 73.450000000000003 112.007 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.504 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 4.9 t30 -112.1 115.01 50.79 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.573 -0.451 . . . . 62.200000000000003 111.106 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 7.6 Cg_exo -72.99 -29.83 11.56 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.299 2.666 . . . . 64.239999999999995 114.413 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.27 13.7 10.99 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.514 -0.474 . . . . 75.209999999999994 111.53 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.503 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 18.9 mm-40 -112.92 94.98 5.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 71.420000000000002 109.992 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.467 HG13 ' HG ' ' A' ' 157' ' ' LEU . 6.4 p -104.99 126.54 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 111.2 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 45.1 m-85 -128.75 158.98 37.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.631 . . . . 75.200000000000003 110.238 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.452 HD11 ' NH2' ' A' ' 160' ' ' ARG . 8.3 mp -83.34 147.21 28.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.244 -0.28 . . . . 75.010000000000005 110.244 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 182' ' ' ASN . 14.7 p -83.79 148.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.309 -0.405 . . . . 72.109999999999999 110.618 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.0 88.0 0.15 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.721 0.772 . . . . 74.109999999999999 110.422 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.669 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -105.72 -9.38 17.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.803 -1.09 . . . . 75.340000000000003 111.303 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 57.55 16.96 24.57 Favored Glycine 0 C--O 1.223 -0.555 0 CA-C-N 115.904 -0.589 . . . . 52.140000000000001 112.726 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.653 ' HG ' ' HA ' ' A' ' 353' ' ' THR . 0.5 OUTLIER -91.9 49.1 1.5 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.674 0.749 . . . . 73.450000000000003 110.238 -174.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -119.87 110.4 16.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.41 -0.814 . . . . 64.109999999999999 110.169 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -98.27 -174.54 2.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.833 -1.173 . . . . 72.5 107.833 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.454 ' HD2' ' OE1' ' A' ' 172' ' ' GLU . 36.8 ptt180 -131.29 133.52 45.47 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.683 -0.636 . . . . 74.140000000000001 111.675 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -93.59 -17.51 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.309 -0.86 . . . . 71.430000000000007 110.169 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 40.4 m -128.6 76.0 79.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.254 -0.43 . . . . 74.040000000000006 110.884 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 203' ' ' ARG . 91.5 Cg_exo -45.35 103.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.182 2.588 . . . . 74.439999999999998 113.263 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 61.81 28.73 17.64 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.325 -0.852 . . . . 63.210000000000001 111.301 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.42 -15.68 45.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 72.329999999999998 113.078 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.28 110.53 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 O-C-N 122.409 -0.465 . . . . 75.200000000000003 109.938 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 14.9 p-80 -63.8 127.45 31.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 75.109999999999999 110.399 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 214' ' ' LYS . 37.6 tptt -103.14 142.99 33.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.114 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -81.68 -169.3 2.26 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.166 -0.309 . . . . 62.329999999999998 110.166 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.733 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 69.1 t80 -64.1 91.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.431 -0.581 . . . . 73.209999999999994 109.431 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.52 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 22.2 tptm -156.0 16.09 0.35 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.163 -0.472 . . . . 71.439999999999998 110.517 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 237' ' ' ALA . 35.0 tt0 -72.51 -66.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.924 0.392 . . . . 75.239999999999995 110.486 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -140.52 140.35 22.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.787 -0.449 . . . . 73.140000000000001 109.787 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 123.206 2.604 . . . . 74.430000000000007 113.451 179.521 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.53 0.205 . . . . 70.450000000000003 110.985 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -99.8 -166.85 29.45 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.862 -0.685 . . . . 63.009999999999998 112.087 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.9 p -70.38 143.9 51.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 75.510000000000005 111.062 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 271' ' ' VAL . 0.3 OUTLIER -64.8 -20.66 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.644 0.735 . . . . 65.420000000000002 109.546 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -61.58 -48.43 80.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.02 -0.991 . . . . 71.299999999999997 111.475 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 246' ' ' ILE . 94.1 m-85 -111.77 -15.83 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.344 0.868 . . . . 75.409999999999997 113.344 -169.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.526 ' HB ' ' HB1' ' A' ' 232' ' ' ALA . 1.1 p -54.39 -27.07 34.1 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.652 0.982 . . . . 70.400000000000006 113.652 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.56 ' HB2' ' HE2' ' A' ' 249' ' ' TYR . 15.3 t 64.43 -159.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.337 0.398 . . . . 75.140000000000001 110.418 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 3.3 mp -67.33 -45.65 85.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.613 -0.267 . . . . 73.129999999999995 110.981 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -74.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.722 0.638 . . . . 74.549999999999997 112.722 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.526 ' HB1' ' HB ' ' A' ' 228' ' ' THR . . . -67.88 -27.59 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.010000000000005 112.163 -172.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.624 -0.262 . . . . 75.540000000000006 110.976 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 2.7 t30 -82.56 -36.64 26.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.641 -0.254 . . . . 70.239999999999995 110.882 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 144.5 9.3 0.37 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 119.794 -1.194 . . . . 64.519999999999996 114.121 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.733 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 12.1 p -122.41 139.58 48.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 117.374 0.587 . . . . 63.329999999999998 110.547 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.469 ' HB2' ' OE1' ' A' ' 215' ' ' GLU . . . -55.14 148.93 27.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 71.329999999999998 110.575 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.33 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.833 2.356 . . . . 64.030000000000001 111.489 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.6 p -79.16 -72.36 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.768 0.794 . . . . 70.340000000000003 110.767 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 240' ' ' ARG . 0.3 OUTLIER -154.57 -42.51 0.09 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.832 -1.544 . . . . 74.329999999999998 106.832 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 48.8 ttt-85 -58.23 -70.2 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.51 -1.677 . . . . 75.420000000000002 111.174 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.705 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -62.99 -36.38 93.38 Favored Glycine 0 C--O 1.223 -0.543 0 CA-C-N 115.821 -0.627 . . . . 72.299999999999997 112.886 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.0 -50.54 66.38 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.261 0.553 . . . . 71.430000000000007 110.475 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.62 -30.7 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.531 -0.758 . . . . 75.439999999999998 111.02 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.419 ' OE2' ' HD3' ' A' ' 279' ' ' ARG . 39.2 mt-10 -66.1 -39.22 89.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.049 -0.26 . . . . 73.109999999999999 110.716 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.705 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.6 mt -58.2 -47.33 87.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.124 0.488 . . . . 74.140000000000001 109.814 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.13 -43.62 98.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.729 -0.669 . . . . 73.109999999999999 110.26 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.18 96.44 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.979 -0.555 . . . . 54.109999999999999 112.769 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.56 ' HE2' ' HB2' ' A' ' 229' ' ' SER . 19.3 m-85 -59.04 -41.33 87.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 73.450000000000003 110.518 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.401 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.5 m -62.73 -45.09 94.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.206 -0.452 . . . . 74.530000000000001 110.573 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.445 ' HE3' HG13 ' A' ' 299' ' ' ILE . 90.4 mtp -59.66 -50.26 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 63.210000000000001 111.47 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -66.07 -36.62 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 121.01 -0.276 . . . . 74.239999999999995 110.392 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -62.57 -42.88 99.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 74.329999999999998 110.983 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -64.04 -38.9 92.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 75.140000000000001 111.145 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.5 tp -81.11 -30.33 34.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.446 0.536 . . . . 74.349999999999994 112.446 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 290' ' ' PHE . 76.6 p -103.45 -28.82 11.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.388 -0.525 . . . . 71.049999999999997 111.828 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.3 14.27 82.51 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.101 -0.571 . . . . 61.140000000000001 113.019 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -150.68 149.93 30.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.349 0.575 . . . . 74.540000000000006 112.05 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.596 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 95.6 mt -129.82 139.44 35.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 74.140000000000001 108.87 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.631 ' HG2' ' HE1' ' A' ' 278' ' ' TYR . 25.0 Cg_exo -65.25 -9.92 23.88 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.678 2.252 . . . . 73.140000000000001 113.044 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.566 ' HB2' HG11 ' A' ' 271' ' ' VAL . 38.6 p90 -118.98 28.16 8.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.122 0.416 . . . . 71.219999999999999 112.122 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 55.0 mt-10 -66.78 -51.22 58.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.191 0.52 . . . . 75.030000000000001 110.825 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.74 -27.69 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.701 -0.681 . . . . 73.140000000000001 110.687 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 270' ' ' TYR . 13.6 m120 -98.58 12.99 33.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.739 -0.664 . . . . 74.219999999999999 111.01 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.94 -39.18 80.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.016 0.436 . . . . 74.030000000000001 111.183 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -78.84 11.34 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 111.737 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -125.99 106.01 25.64 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.282 -0.636 . . . . 53.420000000000002 109.282 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.54 -23.09 74.49 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.027 2.485 . . . . 70.319999999999993 113.385 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -74.03 -46.89 40.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.946 -0.39 . . . . 75.400000000000006 109.946 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.407 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 16.2 m-30 -67.21 -41.78 85.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.836 -0.62 . . . . 74.329999999999998 110.822 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 261' ' ' TRP . 17.1 m -64.69 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.765 0.317 . . . . 71.150000000000006 110.216 177.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 276' ' ' ILE . 53.0 ttt-85 -66.55 -48.5 69.48 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.241 -0.436 . . . . 72.549999999999997 110.495 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.0 -40.77 90.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.354 -0.385 . . . . 72.319999999999993 110.694 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 35.2 m -61.82 -41.85 98.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.951 -0.568 . . . . 70.0 110.97 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 229' ' ' SER . 68.2 mttm -63.92 -37.63 88.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 75.420000000000002 110.288 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.1 mt -65.54 -38.76 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 73.010000000000005 110.581 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.478 ' HA ' ' OE2' ' A' ' 280' ' ' GLU . 0.3 OUTLIER -62.27 -40.49 96.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.904 0.383 . . . . 74.239999999999995 110.453 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.631 ' HE1' ' HG2' ' A' ' 260' ' ' PRO . 28.0 m-85 -66.76 -29.89 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 73.340000000000003 110.751 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.445 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -81.54 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 72.030000000000001 111.211 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 277' ' ' ARG . 49.4 mt-10 -79.88 -71.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.1 0.476 . . . . 74.120000000000005 110.222 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.91 94.45 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 109.626 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 304' ' ' GLU . 3.9 mp -67.07 -51.99 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.432 -0.349 . . . . 74.129999999999995 110.468 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.94 84.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 74.209999999999994 111.399 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.2 m -61.65 -45.94 91.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.339 -0.391 . . . . 73.519999999999996 111.183 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 289' ' ' CYS . 3.9 mm? -65.88 -44.47 85.25 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.307 -0.406 . . . . 65.049999999999997 111.184 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.5 mmt -67.13 -43.46 82.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 71.530000000000001 111.243 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.66 -45.37 77.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 73.439999999999998 110.939 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.65 5.2 51.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.013 -0.54 . . . . 73.530000000000001 111.603 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 48.8 t -85.19 -43.79 13.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.014 -0.736 . . . . 74.519999999999996 109.014 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.664 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 53.4 t80 -129.44 78.94 74.87 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.672 -0.695 . . . . 62.229999999999997 109.895 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -94.48 36.74 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.354 2.703 . . . . 64.200000000000003 111.903 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.44 -166.81 1.69 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 109.543 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.96 66.93 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.581 0.705 . . . . 75.349999999999994 111.079 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.664 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 46.6 t30 -167.7 151.5 6.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.56 -1.2 . . . . 71.120000000000005 107.761 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -107.26 112.29 62.88 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.288 -0.565 . . . . 74.030000000000001 110.718 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.08 109.21 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.473 2.115 . . . . 75.299999999999997 110.978 172.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -136.96 -40.72 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.512 -0.852 . . . . 64.340000000000003 111.631 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.539 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 0.7 OUTLIER -63.87 -61.3 2.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 72.329999999999998 109.952 -178.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.486 HG22 ' HB ' ' A' ' 252' ' ' ILE . 3.5 mp -62.21 -40.12 86.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.486 -0.779 . . . . 75.049999999999997 110.56 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.11 -54.21 49.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.635 . . . . 75.120000000000005 111.479 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -69.1 -39.88 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.127 -0.229 . . . . 74.519999999999996 111.16 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -56.33 -53.39 57.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 74.140000000000001 110.546 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 306' ' ' VAL . 62.0 mtp -72.77 -30.58 64.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.88 -0.6 . . . . 65.129999999999995 111.635 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.473 ' HA ' HG12 ' A' ' 282' ' ' ILE . 40.9 tt0 -66.63 -45.29 79.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.316 0.579 . . . . 75.129999999999995 109.657 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 19.1 m -59.68 -47.32 86.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.225 -0.898 . . . . 73.340000000000003 111.67 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 303' ' ' MET . 20.0 m -68.74 -27.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 74.120000000000005 111.128 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 7.7 tmtm? -67.29 -33.97 76.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.168 0.509 . . . . 75.329999999999998 110.056 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.498 ' O ' HD21 ' A' ' 308' ' ' LEU . 6.0 tt -75.14 -31.26 61.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.598 -0.728 . . . . 73.319999999999993 109.976 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 92.9 mt -63.89 -33.86 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 64.519999999999996 111.897 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 8.3 t70 60.51 -165.75 0.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.818 -0.438 . . . . 71.420000000000002 109.818 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.434 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 13.7 m-85 -63.6 -37.61 87.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.579 0.585 . . . . 73.400000000000006 112.579 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 m -149.3 74.95 1.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.201 -0.6 . . . . 64.25 112.519 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.735 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -118.67 -175.47 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.704 -0.48 . . . . 70.5 109.704 165.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 39.5 mttp -86.19 109.38 22.62 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.12 -0.491 . . . . 74.510000000000005 110.448 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 4.0 Cg_endo -85.64 119.14 1.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.932 2.421 . . . . 74.230000000000004 112.526 -176.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.25 85.98 6.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 75.439999999999998 110.128 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -65.51 -34.1 77.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.886 -0.597 . . . . 74.0 111.686 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.71 -29.44 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.892 -0.323 . . . . 73.299999999999997 110.688 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.73 -45.08 60.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.605 -0.517 . . . . 75.209999999999994 109.605 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.586 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 93.7 mt -56.53 -46.02 80.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.783 -0.644 . . . . 71.099999999999994 110.02 174.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -54.34 -50.14 68.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.682 -0.69 . . . . 75.540000000000006 110.998 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -37.83 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 55.119999999999997 111.847 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.8 pp -72.3 -28.72 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 120.571 -0.452 . . . . 74.129999999999995 111.035 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.87 -49.35 62.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.272 0.558 . . . . 72.219999999999999 109.629 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.684 HD21 HD23 ' A' ' 159' ' ' LEU . 4.3 mm? -64.65 -31.15 72.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.584 -0.735 . . . . 74.540000000000006 110.618 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -47.04 87.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 74.530000000000001 109.939 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.539 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -61.31 -46.14 95.02 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.756 -0.735 . . . . 73.099999999999994 112.072 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 26.8 tp -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.433 0.635 . . . . 71.099999999999994 110.558 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 329' ' ' LYS . 34.8 ttpt -65.75 -46.48 78.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.011 -0.995 . . . . 74.209999999999994 112.123 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.67 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.623 0.601 . . . . 74.099999999999994 112.623 -172.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.69 -7.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.021 0.438 . . . . 75.209999999999994 111.363 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 90.18 24.65 28.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.226 -0.988 . . . . 75.150000000000006 113.082 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 12.4 p -100.78 138.98 37.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.881 0.372 . . . . 64.219999999999999 110.436 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -151.67 80.61 1.28 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.983 -0.553 . . . . 74.5 109.761 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.828 ' HA ' ' HG2' ' A' ' 152' ' ' LYS . 26.2 t0 68.46 111.29 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.053 -0.976 . . . . 61.100000000000001 109.782 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -76.8 -7.04 54.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 61.240000000000002 111.058 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.93 58.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.268 -0.968 . . . . 61.119999999999997 113.152 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 111.841 0.312 . . . . 75.549999999999997 111.841 173.466 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 353' ' ' THR . 9.8 tmtt? . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.635 -0.135 . . . . 74.420000000000002 110.635 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.653 ' HA ' ' HG ' ' A' ' 200' ' ' LEU . 0.6 OUTLIER 69.23 179.19 0.24 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.402 1.081 . . . . 72.329999999999998 111.655 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -65.45 144.13 15.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.728 0.775 . . . . 75.099999999999994 112.847 -172.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.9 t -71.96 154.7 41.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.642 -1.163 . . . . 64.049999999999997 111.06 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 109.727 178.014 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 109.46 -0.571 . . . . 75.099999999999994 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.1 2.1 56.98 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.598 -0.811 . . . . 75.409999999999997 111.821 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 13.5 pt-20 -74.63 155.43 37.82 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.116 0.484 . . . . 74.030000000000001 110.756 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' A' ' 38' ' ' LYS . 33.3 mm -87.11 118.74 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 72.329999999999998 110.191 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.1 137.9 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.889 0.376 . . . . 75.420000000000002 110.212 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 m -86.42 111.54 20.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 71.129999999999995 109.954 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.512 ' H ' ' HA ' ' A' ' 35' ' ' LYS . 12.0 t70 -111.38 159.57 17.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 74.5 110.272 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.827 ' HA ' ' HE3' ' A' ' 32' ' ' MET . 8.9 mmt -62.03 -22.56 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.047 0.451 . . . . 72.219999999999999 110.134 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.57 23.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 71.010000000000005 111.151 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 2.8 tmmt? 74.0 44.88 0.24 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 72.439999999999998 110.466 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 60.0 pttt 45.28 -149.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.858 0.863 . . . . 74.409999999999997 112.681 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.587 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 53.9 mt-10 69.59 39.37 1.56 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.299 0.64 . . . . 73.420000000000002 111.095 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -126.77 121.38 31.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.79 -0.818 . . . . 72.239999999999995 108.79 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.591 ' HG2' ' SD ' ' A' ' 56' ' ' MET . 23.1 pttp -105.22 131.65 52.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.791 -0.764 . . . . 72.239999999999995 110.96 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.75 129.68 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.488 -0.778 . . . . 72.439999999999998 110.499 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.745 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -116.69 -106.28 2.45 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.624 -0.798 . . . . 63.100000000000001 113.185 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.0 tm? -62.89 118.3 40.87 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-O 121.15 0.5 . . . . 75.349999999999994 110.899 -174.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.925 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.7 Cg_exo -73.78 93.38 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.755 2.303 . . . . 75.540000000000006 111.733 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.07 -53.15 27.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.292 0.568 . . . . 73.420000000000002 109.618 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.17 -56.38 0.51 Allowed Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.456 -0.793 . . . . 63.0 112.035 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.594 ' HG2' ' HA2' ' A' ' 49' ' ' GLY . 56.4 mt-30 -151.77 130.05 12.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.837 0.351 . . . . 74.430000000000007 110.527 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.419 ' H ' HD12 ' A' ' 51' ' ' ILE . . . -99.55 26.71 23.33 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.331 -1.108 . . . . 75.230000000000004 110.331 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.62 -50.65 0.76 Allowed Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.608 -0.597 . . . . 72.109999999999999 111.608 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.7 ' HZ ' ' HB2' ' A' ' 79' ' ' PRO . 49.4 t80 -77.22 -76.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.588 0.232 . . . . 73.430000000000007 110.405 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 45' ' ' GLN . . . 172.86 150.43 7.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.131 -1.033 . . . . 70.019999999999996 113.084 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.9 t 45.66 67.01 0.8 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.989 0.915 . . . . 70.420000000000002 112.398 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 46' ' ' GLY . 17.0 mt -123.46 136.46 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 74.109999999999999 111.705 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.925 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 73.4 m-85 -129.42 165.9 20.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.393 . . . . 74.299999999999997 111.059 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 54' ' ' ALA . 1.3 tm? -90.81 143.12 27.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.067 -0.716 . . . . 74.349999999999994 109.067 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.578 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -92.55 75.27 5.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.236 0.541 . . . . 65.530000000000001 110.738 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.745 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 8.9 m-20 -79.29 67.47 5.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.652 . . . . 72.010000000000005 110.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.591 ' SD ' ' HG2' ' A' ' 38' ' ' LYS . 16.0 tpt -82.0 -52.25 7.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 75.140000000000001 110.645 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.39 115.37 7.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.484 . . . . 73.040000000000006 110.009 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.8 m -126.2 38.88 4.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 71.150000000000006 110.504 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 112.49 0.552 . . . . 75.150000000000006 112.49 -174.099 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 113.839 1.052 . . . . 74.109999999999999 113.839 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 58.0 Cg_endo -71.03 33.12 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.136 1.89 . . . . 74.409999999999997 113.757 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 66' ' ' ALA . 83.8 m -121.5 138.32 54.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.972 0.415 . . . . 74.450000000000003 110.22 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.482 ' CG1' ' HD3' ' A' ' 133' ' ' ARG . 15.9 m -114.92 143.22 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.09 -0.505 . . . . 74.219999999999999 109.862 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.0 p -117.13 116.09 50.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.88 0.847 . . . . 64.230000000000004 110.137 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.473 ' HD3' ' SD ' ' A' ' 129' ' ' MET . 16.3 ptmt -92.7 128.43 38.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.591 -1.186 . . . . 74.200000000000003 109.208 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 6.9 p -135.47 124.26 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 119.542 -0.863 . . . . 72.409999999999997 112.816 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 5.6 mm-40 -124.71 171.43 7.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.111 -0.95 . . . . 72.530000000000001 108.809 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.61 152.99 51.83 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.905 1.737 . . . . 72.340000000000003 111.43 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.9 t -53.71 -35.99 61.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.082 0.468 . . . . 73.150000000000006 110.408 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.39 116.02 30.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.771 . . . . 75.049999999999997 109.612 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -151.7 -68.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 61.5 110.745 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 -86.9 0.38 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.719 -0.753 . . . . 71.319999999999993 112.111 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.7 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . 51.1 Cg_exo -53.71 -43.73 55.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.123 2.549 . . . . 73.530000000000001 113.05 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 3.4 tm? -55.77 -45.84 78.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.962 0.41 . . . . 74.409999999999997 110.418 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.93 -35.96 77.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.15 0.5 . . . . 74.430000000000007 110.635 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -67.72 -48.48 66.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.93 -0.577 . . . . 75.519999999999996 110.921 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.778 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . 8.1 pt-20 -69.63 -27.89 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.141 -0.318 . . . . 73.120000000000005 110.141 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HA ' ' HE1' ' A' ' 129' ' ' MET . 59.7 tp -62.99 -44.2 96.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.414 -0.357 . . . . 72.420000000000002 110.63 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 42.0 tptt -64.1 -46.14 85.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.261 -0.427 . . . . 73.299999999999997 109.876 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.406 ' HZ ' HG23 ' A' ' 168' ' ' ILE . 60.8 t80 -59.57 -47.93 83.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 73.439999999999998 110.128 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.43 -46.83 80.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.221 -0.9 . . . . 72.329999999999998 110.474 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -61.47 -35.39 77.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.218 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 79.0 mtp180 -81.44 -18.74 44.27 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.084 0.401 . . . . 75.510000000000005 112.084 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.97 -34.9 6.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.66 0.615 . . . . 74.420000000000002 112.66 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . -95.51 11.29 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.262 0.553 . . . . 75.150000000000006 111.998 -172.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 30.0 tttm -76.86 139.79 66.49 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 115.384 -0.825 . . . . 62.310000000000002 110.269 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 80.8 Cg_exo -47.37 -53.48 6.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.343 2.696 . . . . 64.439999999999998 113.697 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -40.72 93.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 63.140000000000001 110.683 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.483 ' HB3' ' OH ' ' A' ' 167' ' ' TYR . 13.2 mm100 -61.59 -48.9 78.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.609 -0.723 . . . . 71.519999999999996 111.148 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.641 HD13 ' HZ3' ' A' ' 112' ' ' LYS . 62.3 mt -66.0 -48.62 81.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.892 -0.594 . . . . 74.140000000000001 111.283 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -61.66 -37.91 85.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 73.510000000000005 111.026 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -61.24 -48.58 80.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 73.209999999999994 110.262 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -66.79 -46.0 76.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 73.209999999999994 111.096 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -54.95 -50.66 60.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 73.319999999999993 111.273 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -69.25 -32.43 71.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.457 . . . . 74.409999999999997 111.194 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 m -76.24 -40.36 52.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.593 -0.276 . . . . 74.099999999999994 111.743 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.548 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 10.8 ttt180 -93.64 9.05 38.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.973 -0.291 . . . . 74.329999999999998 111.167 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.854 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.1 mmpt? 64.81 28.9 12.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 111.542 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 88.5 mt -90.86 -173.61 3.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.041 -0.527 . . . . 75.239999999999995 111.022 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -26.54 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.329999999999998 109.833 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -154.13 165.2 36.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 75.109999999999999 110.213 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.4 tp -124.98 137.17 54.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 70.510000000000005 109.461 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.7 52.96 2.83 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.299 -0.477 . . . . 72.340000000000003 113.253 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.64 133.22 23.22 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.071 -0.714 . . . . 73.140000000000001 109.071 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HG3' ' HZ ' ' A' ' 134' ' ' PHE . 24.2 Cg_exo -60.77 136.78 68.61 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.406 2.071 . . . . 71.310000000000002 111.401 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.721 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -65.29 125.77 26.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.09 0.472 . . . . 73.420000000000002 110.815 -178.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.36 113.96 19.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 73.120000000000005 110.114 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.444 ' CD1' HG23 ' A' ' 130' ' ' ILE . 24.5 m95 -92.48 -49.94 5.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.287 -0.635 . . . . 72.519999999999996 109.287 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.4 ' HA3' ' OD1' ' A' ' 31' ' ' ASP . . . -176.63 -168.76 37.12 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.591 -0.814 . . . . 74.5 112.684 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 82.4 p -179.96 177.21 0.68 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.934 -1.136 . . . . 73.340000000000003 107.934 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.82 -175.83 43.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.09 -1.529 . . . . 71.299999999999997 113.929 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 125' ' ' SER . 2.0 tm? -120.33 127.3 52.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.03 -1.1 . . . . 73.239999999999995 108.03 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.421 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 51.7 t60 -130.89 117.14 18.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.02 0.438 . . . . 74.219999999999999 111.083 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -67.1 149.89 49.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 74.439999999999998 109.994 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -128.12 -89.33 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.865 0.364 . . . . 75.030000000000001 110.177 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -142.3 87.4 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.989 -0.745 . . . . 62.329999999999998 108.989 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -36.42 3.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.040000000000006 112.066 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -109.34 163.71 13.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.904 -0.406 . . . . 73.420000000000002 109.904 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.451 ' HB3' HD13 ' A' ' 118' ' ' LEU . 50.0 m -123.98 138.54 54.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.174 -0.466 . . . . 60.049999999999997 109.815 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.417 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 66.1 m-85 -103.65 145.63 29.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.515 . . . . 73.450000000000003 110.998 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -118.31 116.84 27.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.96 -0.756 . . . . 75.049999999999997 108.96 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 44.7 p90 -123.48 163.14 21.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.176 0.512 . . . . 73.150000000000006 112.244 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.483 ' HE1' ' HA ' ' A' ' 84' ' ' LEU . 14.2 ttm -143.46 133.12 23.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.937 -1.029 . . . . 71.150000000000006 109.785 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.444 HG23 ' CD1' ' A' ' 114' ' ' TRP . 37.5 mt -97.77 127.03 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.686 0.279 . . . . 72.409999999999997 110.25 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.509 ' HE3' HG23 ' A' ' 196' ' ' VAL . 18.7 ptm -138.78 177.97 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 73.319999999999993 111.273 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.63 142.03 58.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.731 -0.668 . . . . 63.539999999999999 111.351 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.482 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 9.0 tpt180 -79.33 112.89 17.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.267 0.556 . . . . 73.400000000000006 111.152 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.582 ' HZ ' ' HG3' ' A' ' 111' ' ' PRO . 16.0 m-85 -102.02 149.29 24.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.915 -0.584 . . . . 62.329999999999998 109.597 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.54 -6.54 2.96 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.651 -0.785 . . . . 71.129999999999995 111.883 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.936 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 44.9 m -120.8 124.21 44.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.952 0.406 . . . . 72.239999999999995 111.551 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.503 ' HA ' HD13 ' A' ' 184' ' ' LEU . 13.3 m-20 -98.07 125.73 43.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 74.040000000000006 109.56 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 17.2 tp -67.38 -18.67 65.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 109.615 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 46.3 tp60 -60.09 -50.4 73.86 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.541 -0.754 . . . . 75.099999999999994 111.192 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -31.05 67.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.73 0.3 . . . . 73.209999999999994 110.283 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.52 HD11 ' HA ' ' A' ' 138' ' ' LEU . 71.7 mt -64.25 -51.95 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 62.030000000000001 110.733 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.929 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -68.91 -31.83 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.889 -0.412 . . . . 70.349999999999994 109.889 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.34 -53.45 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 73.430000000000007 111.178 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.15 -22.09 53.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.5 111.809 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.38 -1.48 47.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.936 0.398 . . . . 72.030000000000001 111.359 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 58.57 33.68 23.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.166 -0.47 . . . . 63.509999999999998 111.034 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.929 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 56.4 pttt 43.15 42.86 3.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.763 1.225 . . . . 75.010000000000005 113.226 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -115.68 90.09 3.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.077 -0.712 . . . . 75.400000000000006 109.077 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.44 157.36 17.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.542 . . . . 75.239999999999995 111.364 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -71.21 158.37 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.683 -0.689 . . . . 70.349999999999994 111.452 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.46 HH21 ' CD ' ' A' ' 298' ' ' GLU . 6.1 tpt180 -53.73 -39.03 64.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.162 -0.926 . . . . 71.230000000000004 111.084 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 336' ' ' ASP . 25.8 mtpp -61.71 -61.96 2.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.527 -0.761 . . . . 72.409999999999997 111.564 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t -64.86 -36.37 84.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 112.088 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.25 -43.04 98.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.727 0.299 . . . . 75.510000000000005 110.913 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.691 ' HG ' ' HG ' ' A' ' 328' ' ' LEU . 0.4 OUTLIER -64.87 -47.4 78.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.457 -0.338 . . . . 74.230000000000004 110.168 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 335' ' ' ASP . 5.8 tp-100 -59.15 -45.24 91.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.723 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.487 ' O ' HD11 ' A' ' 161' ' ' ILE . 35.2 tp -59.98 -46.81 88.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 71.510000000000005 110.367 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.2 t -61.3 -39.27 89.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.459 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.51 -49.72 74.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.509 . . . . 74.019999999999996 110.202 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.687 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -60.62 -40.55 92.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.892 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 157' ' ' LEU . 1.7 mp -61.79 -40.64 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 109.864 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.98 -37.87 86.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 75.140000000000001 110.781 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.6 m-20 -56.12 -58.19 8.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.363 0.601 . . . . 73.420000000000002 110.593 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 195' ' ' LEU . 18.7 tt -71.14 -35.89 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.573 -0.739 . . . . 74.409999999999997 111.231 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.8 -38.54 91.34 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.825 -0.171 . . . . 65.530000000000001 110.91 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.342 -0.614 . . . . 74.219999999999999 109.342 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 95' ' ' GLN . 61.4 t80 -56.18 -45.19 79.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.142 -0.936 . . . . 71.299999999999997 111.962 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.406 HG23 ' HZ ' ' A' ' 86' ' ' PHE . 35.1 pt -84.89 -32.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.856 -0.337 . . . . 63.409999999999997 111.874 -176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.621 ' HE1' ' HA ' ' A' ' 240' ' ' ARG . 5.1 t60 -66.2 -41.13 90.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.301 -0.259 . . . . 65.010000000000005 110.301 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.905 0.383 . . . . 74.299999999999997 110.452 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -88.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 75.439999999999998 110.467 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 11.2 pt-20 -166.11 11.69 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.856 0.687 . . . . 74.230000000000004 112.856 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.78 141.81 51.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.778 -0.369 . . . . 73.129999999999995 110.895 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 238' ' ' PRO . 12.9 m -123.65 126.06 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 75.540000000000006 110.392 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.624 ' HD1' HD12 ' A' ' 178' ' ' ILE . 41.7 t-80 -89.09 69.84 8.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.983 -0.747 . . . . 61.109999999999999 108.983 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.89 46.68 3.39 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.689 -0.687 . . . . 71.200000000000003 113.806 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 224' ' ' THR . 11.1 t70 -175.7 96.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 75.109999999999999 109.255 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.702 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -90.01 70.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.392 0.615 . . . . 60.340000000000003 110.393 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.664 ' HD2' ' OG1' ' A' ' 224' ' ' THR . 56.6 tttm -83.76 134.87 34.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.143 -0.688 . . . . 73.120000000000005 109.143 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -54.87 -26.34 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 73.109999999999999 112.051 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 0.9 OUTLIER -66.5 -25.56 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.409 -0.359 . . . . 70.230000000000004 111.261 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HB2' HD11 ' A' ' 200' ' ' LEU . 6.9 t-20 -84.11 -7.42 59.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 109.882 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.444 HD22 HD13 ' A' ' 161' ' ' ILE . 21.1 mt -105.75 115.57 30.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.071 -0.968 . . . . 73.150000000000006 110.503 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.503 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.1 mm? -118.08 140.35 49.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 74.209999999999994 110.535 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.936 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 9.0 mp -100.72 145.27 28.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.655 -0.498 . . . . 73.409999999999997 109.655 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.656 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 25.5 t-20 -59.99 147.64 38.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.17 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -57.69 -26.83 62.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.395 0.517 . . . . 72.450000000000003 112.395 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -115.48 -15.83 11.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 70.310000000000002 111.878 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.26 107.11 30.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 112.018 0.377 . . . . 73.430000000000007 112.018 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.529 ' HA ' HD23 ' A' ' 185' ' ' LEU . 17.9 Cg_exo -67.62 -21.84 45.06 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.069 2.513 . . . . 73.0 111.586 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.668 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 7.3 p-10 -91.39 6.51 45.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.556 . . . . 71.450000000000003 111.047 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -119.35 99.78 6.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 71.420000000000002 109.646 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.24 133.67 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.885 -0.598 . . . . 75.25 110.496 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.656 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 18.0 m-85 -128.17 158.05 39.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 75.540000000000006 110.018 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 164' ' ' ILE . 82.9 mt -95.63 150.2 20.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.671 0.272 . . . . 73.430000000000007 110.608 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.509 HG23 ' HE3' ' A' ' 131' ' ' MET . 4.2 p -138.23 175.87 7.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.736 -0.839 . . . . 74.209999999999994 108.736 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER 75.64 -58.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.461 0.476 . . . . 64.530000000000001 110.769 174.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.778 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 25.8 m-85 63.77 12.21 6.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.428 -0.805 . . . . 74.430000000000007 112.343 173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.35 -15.64 81.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.601 -1.0 . . . . 62.130000000000003 110.601 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.817 HD22 ' HE3' ' A' ' 352' ' ' LYS . 89.9 mt -92.92 17.09 11.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.01 -0.595 . . . . 64.140000000000001 110.283 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 175' ' ' HIS . . . -127.76 99.42 5.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.104 -0.702 . . . . 74.400000000000006 109.104 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -99.54 149.64 23.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.302 0.572 . . . . 73.099999999999994 111.106 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 203' ' ' ARG . 32.7 ptt180 -60.1 115.52 3.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.852 -1.067 . . . . 74.340000000000003 111.131 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -101.83 -29.76 11.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.384 0.611 . . . . 71.120000000000005 109.745 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 45.7 m -133.88 64.42 66.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 74.340000000000003 109.643 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.25 113.86 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.93 2.42 . . . . 75.120000000000005 113.167 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 70.21 14.3 7.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.723 -0.671 . . . . 74.299999999999997 110.457 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.04 -7.25 52.24 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.874 -0.679 . . . . 74.420000000000002 112.307 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.84 111.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 74.150000000000006 110.535 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -102.69 128.58 49.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.285 -0.416 . . . . 74.010000000000005 110.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -115.46 162.22 17.48 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.371 -0.603 . . . . 74.049999999999997 109.371 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -83.75 -172.16 4.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.484 0.659 . . . . 74.200000000000003 111.915 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -76.41 151.86 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 75.329999999999998 111.861 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -134.33 0.65 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 74.450000000000003 110.473 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 69.49 -63.13 0.39 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.501 -0.772 . . . . 72.420000000000002 112.522 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.2 105.5 1.88 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.76 0.314 . . . . 72.120000000000005 111.778 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.452 -0.916 0 C-N-CA 123.49 2.793 . . . . 65.239999999999995 113.3 172.713 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 120.917 0.389 . . . . 71.310000000000002 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.57 -170.4 46.32 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.959 -0.564 . . . . 73.0 112.833 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.664 ' OG1' ' HD2' ' A' ' 179' ' ' LYS . 1.1 m -91.1 114.25 26.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.689 -0.486 . . . . 74.310000000000002 109.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.616 HG12 HG13 ' A' ' 271' ' ' VAL . 18.3 tt -52.77 -17.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 113.377 0.88 . . . . 74.239999999999995 113.377 -167.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -65.42 -43.88 89.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 73.409999999999997 109.846 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.605 ' HD2' ' HB ' ' A' ' 224' ' ' THR . 36.6 m-85 -96.07 -41.41 8.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.58 -0.736 . . . . 75.450000000000003 111.381 -174.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.47 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 0.2 OUTLIER -57.45 -5.56 0.35 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.499 1.296 . . . . 65.430000000000007 114.499 -166.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.6 t 62.99 -158.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.932 0.396 . . . . 62.409999999999997 110.162 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.5 mt -71.87 -47.53 55.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.417 -0.356 . . . . 72.25 110.795 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -35.99 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.276 1.213 . . . . 60.420000000000002 114.276 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.63 ' HB1' ' HG3' ' A' ' 238' ' ' PRO . . . -70.0 -30.14 67.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.477 0.547 . . . . 74.329999999999998 112.477 -167.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -21.76 61.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 74.299999999999997 110.119 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.24 -34.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.785 -0.45 . . . . 74.129999999999995 109.785 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 142.17 -33.93 1.88 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.242 -0.98 . . . . 74.340000000000003 113.231 177.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.52 140.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.827 0.314 . . . . 74.439999999999998 110.637 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -56.86 135.34 79.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 73.049999999999997 110.348 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.63 ' HG3' ' HB1' ' A' ' 232' ' ' ALA . 75.8 Cg_exo -49.89 115.72 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 2.458 . . . . 74.540000000000006 112.279 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 84.6 p -83.59 -178.06 6.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.04 -0.527 . . . . 73.519999999999996 110.534 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.621 ' HA ' ' HE1' ' A' ' 169' ' ' HIS . 9.3 ptp85 -64.55 -31.29 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.612 0.72 . . . . 75.030000000000001 109.537 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -64.26 -40.26 95.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.226 -0.897 . . . . 75.109999999999999 109.538 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -58.93 -69.29 1.32 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.068 -0.969 . . . . 55.210000000000001 112.391 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -61.45 -33.82 74.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.128 0.464 . . . . 61.420000000000002 112.078 -170.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.59 -46.92 57.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.566 -0.454 . . . . 74.510000000000005 111.734 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.18 -27.71 60.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.003 0.43 . . . . 74.109999999999999 110.305 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.5 mt -63.92 -45.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 74.010000000000005 110.507 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.529 HD23 ' HH ' ' A' ' 302' ' ' TYR . 37.6 tp -60.38 -36.51 78.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.834 -0.432 . . . . 74.329999999999998 109.834 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.19 -47.61 88.3 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.754 -0.736 . . . . 71.439999999999998 112.142 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -59.65 -43.75 93.79 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.777 0.322 . . . . 73.540000000000006 110.79 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 35.4 m -65.49 -37.44 86.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.451 . . . . 75.109999999999999 110.908 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.38 -50.71 70.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 110.866 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.8 tt -69.79 -28.62 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.649 -0.42 . . . . 65.209999999999994 110.443 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.79 -50.84 71.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.934 0.397 . . . . 63.329999999999998 110.322 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.9 m0 -70.3 -24.97 63.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.531 -0.759 . . . . 72.219999999999999 111.012 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.732 HD13 HD22 ' A' ' 294' ' ' ASN . 30.1 tp -76.39 -32.6 58.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 111.719 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -103.37 -27.24 12.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.531 0.567 . . . . 70.519999999999996 112.531 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 86.83 -20.49 24.09 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.447 -0.882 . . . . 44.350000000000001 112.588 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -147.36 144.35 28.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.616 -0.512 . . . . 75.340000000000003 109.616 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.74 149.03 36.39 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 110.29 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.17 -34.94 98.57 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.323 2.015 . . . . 73.439999999999998 112.18 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -96.57 13.64 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 75.510000000000005 110.862 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.18 -31.15 69.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 75.129999999999995 110.669 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -84.13 -6.86 59.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.794 0.807 . . . . 70.040000000000006 109.556 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.86 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 2.9 m-20 -106.86 5.12 28.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.927 -1.033 . . . . 74.409999999999997 109.51 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 265' ' ' LEU . 1.9 tm? -65.16 -33.7 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.553 -0.749 . . . . 75.420000000000002 111.537 -170.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.42 -23.22 65.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.207 0.447 . . . . 72.319999999999993 112.207 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.593 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 14.7 t70 -109.7 127.5 27.04 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.929 0.395 . . . . 65.030000000000001 111.69 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.94 -39.85 67.47 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.391 2.728 . . . . 75.510000000000005 113.649 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 9.8 ptmm? -79.11 -37.88 37.56 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.359 -0.536 . . . . 75.420000000000002 110.008 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.86 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 9.1 m-85 -58.11 -42.84 86.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.56 0.219 . . . . 75.319999999999993 110.818 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.616 HG13 HG12 ' A' ' 225' ' ' ILE . 65.3 t -63.16 -50.6 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.563 -0.29 . . . . 71.010000000000005 110.519 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 276' ' ' ILE . 31.0 ttp180 -60.13 -48.86 79.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.602 -0.272 . . . . 73.409999999999997 111.273 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.68 -45.72 85.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.466 0.479 . . . . 73.540000000000006 111.514 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 21.4 m -66.79 -43.26 84.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.102 -0.499 . . . . 52.340000000000003 111.174 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 7.8 mmmm -61.6 -32.64 72.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.758 0.313 . . . . 74.530000000000001 110.636 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 272' ' ' ARG . 75.7 mt -72.91 -44.44 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.385 -0.37 . . . . 75.040000000000006 111.013 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.45 -32.61 74.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.973 0.416 . . . . 71.140000000000001 110.563 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -74.24 -32.25 62.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.38 -0.373 . . . . 72.209999999999994 110.817 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -59.11 -33.42 70.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.39 -0.368 . . . . 74.510000000000005 110.854 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.45 -39.9 70.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.569 -0.742 . . . . 74.209999999999994 111.417 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 284' ' ' SER . 36.5 t30 -153.99 84.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 110.438 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -78.72 -35.96 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 111.968 -176.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.73 80.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.797 0.332 . . . . 75.349999999999994 111.241 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' SER . . . . . 0.494 ' HB3' ' ND2' ' A' ' 281' ' ' ASN . 22.7 t -75.3 -45.71 38.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 72.349999999999994 110.454 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -61.67 -42.41 98.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.925 0.343 . . . . 72.420000000000002 111.925 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.0 mmt -74.99 -43.58 53.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.93 -0.308 . . . . 73.409999999999997 111.301 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.69 -38.98 84.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.102 0.477 . . . . 74.450000000000003 111.023 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -84.54 -2.0 56.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.84 -0.618 . . . . 75.329999999999998 110.575 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.46 -21.4 38.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 74.310000000000002 109.393 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -137.48 76.92 41.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 75.340000000000003 109.029 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.49 44.7 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.557 2.838 . . . . 72.420000000000002 112.691 -173.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.11 -179.44 3.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.975 -0.38 . . . . 71.209999999999994 109.975 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -81.05 20.54 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.372 0.508 . . . . 74.010000000000005 112.372 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.732 HD22 HD13 ' A' ' 255' ' ' LEU . 41.5 t30 -77.47 -48.14 17.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.47 -0.567 . . . . 62.109999999999999 109.47 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 23.9 tptm 77.85 95.09 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 115.222 -0.899 . . . . 65.349999999999994 111.147 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.84 48.04 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.889 2.392 . . . . 55.509999999999998 112.196 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.14 54.93 Favored Glycine 0 C--O 1.238 0.356 0 CA-C-N 115.942 -0.572 . . . . 72.239999999999995 112.76 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 323' ' ' ILE . 1.7 mp0 -55.37 -45.14 76.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 74.439999999999998 110.497 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.7 mp -63.0 -45.3 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 73.340000000000003 110.827 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.13 50.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 75.510000000000005 111.428 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 301' ' ' LYS . 22.3 mtpp -77.17 -27.94 53.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 75.209999999999994 111.897 -176.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.529 ' HH ' HD23 ' A' ' 247' ' ' LEU . 45.1 t80 -55.99 -52.78 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.518 . . . . 71.420000000000002 109.97 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG23 ' A' ' 306' ' ' VAL . 55.6 mtp -72.68 -36.28 67.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.464 -0.789 . . . . 72.540000000000006 110.869 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.39 -46.42 83.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.362 0.601 . . . . 74.420000000000002 109.795 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 47.9 m -63.17 -52.5 62.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.037 -0.983 . . . . 73.439999999999998 112.078 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 303' ' ' MET . 34.6 m -64.24 -27.35 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.712 0.291 . . . . 74.230000000000004 111.551 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -80.65 -30.48 36.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.711 0.291 . . . . 73.319999999999993 111.042 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.86 -17.73 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.326 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 67.8 mt -71.16 -13.84 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 72.040000000000006 110.889 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 35.7 t70 59.23 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 73.340000000000003 111.736 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.536 ' O ' ' HD2' ' A' ' 240' ' ' ARG . 49.5 t80 -152.4 -48.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.442 0.163 . . . . 71.209999999999994 110.685 174.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 5.4 m -125.67 36.14 4.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.243 0.544 . . . . 53.439999999999998 111.668 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 14.8 tp10 -90.49 23.06 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.937 -0.477 . . . . 75.420000000000002 110.04 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 72.36 130.64 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 115.466 -0.788 . . . . 71.430000000000007 111.811 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.548 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 1.4 Cg_endo -82.37 118.31 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.415 2.076 . . . . 75.310000000000002 110.881 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.461 ' O ' HD11 ' A' ' 320' ' ' LEU . 16.9 tp -104.09 92.6 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 75.510000000000005 110.138 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.72 -40.44 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 75.519999999999996 111.556 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.6 pm0 -67.22 -29.3 68.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 111.617 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.432 ' HB2' HD22 ' A' ' 316' ' ' LEU . 23.3 t-20 -66.06 -48.87 69.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.791 -0.448 . . . . 71.329999999999998 109.791 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 9.4 mp -60.47 -43.15 97.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.602 -0.726 . . . . 73.219999999999999 110.619 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.435 ' O ' HD22 ' A' ' 325' ' ' LEU . 1.2 tmt_? -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.140000000000001 110.63 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.21 -40.5 71.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 72.310000000000002 111.274 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -63.72 -37.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.618 0.247 . . . . 75.439999999999998 110.373 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 298' ' ' GLU . 87.1 mt -67.86 -46.73 70.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.954 0.407 . . . . 73.349999999999994 110.667 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 321' ' ' ARG . 4.3 mm? -66.93 -29.26 69.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.310000000000002 111.171 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 326' ' ' GLN . 1.0 OUTLIER -66.34 -42.38 88.23 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.406 -0.59 . . . . 72.129999999999995 109.406 178.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.99 98.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.802 -0.713 . . . . 73.099999999999994 111.925 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.691 ' HG ' ' HG ' ' A' ' 155' ' ' LEU . 14.1 mt -69.18 -36.37 77.26 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.854 -0.204 . . . . 75.010000000000005 111.488 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -60.3 -34.03 73.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.747 0.308 . . . . 73.219999999999999 110.426 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.82 -29.79 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 54.530000000000001 111.816 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.7 pt -107.68 1.01 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 74.040000000000006 111.094 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 77.07 24.99 65.1 Favored Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.949 -0.643 . . . . 73.109999999999999 113.052 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.58 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 62.6 m -107.45 156.7 18.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.077 0.465 . . . . 75.439999999999998 111.254 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -152.96 16.8 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.394 -0.965 . . . . 74.510000000000005 108.394 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 338' ' ' LYS . 24.7 t70 67.27 125.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.529 -1.214 . . . . 73.340000000000003 109.298 -162.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -132.49 -49.26 0.91 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.282 -0.872 . . . . 73.109999999999999 110.763 -169.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -70.56 -10.16 66.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.842 -0.694 . . . . 50.210000000000001 111.824 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.668 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 12.3 mmmm . . . . . 0 CA--C 1.519 -0.221 0 C-N-CA 123.622 0.769 . . . . 75.409999999999997 111.431 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.817 ' HE3' HD22 ' A' ' 200' ' ' LEU . 4.5 mptp? . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.246 0.546 . . . . 71.25 110.556 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.8 t -161.45 157.67 25.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 71.400000000000006 108.691 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 354' ' ' ILE . 0.1 OUTLIER -99.63 126.83 52.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.323 0.582 . . . . 73.420000000000002 111.785 -173.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 18.5 m -75.95 74.12 2.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.608 -0.724 . . . . 75.329999999999998 109.908 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.68 . . . . 75.329999999999998 110.432 -179.453 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG11 ' HA2' ' A' ' 40' ' ' GLY . 90.1 t . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 108.389 -0.967 . . . . 73.109999999999999 108.389 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.81 -5.66 59.97 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.492 -0.861 . . . . 62.43 112.271 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.52 140.82 31.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.697 -0.483 . . . . 71.019999999999996 109.697 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -98.53 131.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.247 0.546 . . . . 74.049999999999997 110.779 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.3 137.0 47.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.745 -0.661 . . . . 64.540000000000006 110.039 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 23.6 m -106.76 121.01 43.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.29 -0.414 . . . . 73.549999999999997 110.627 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.595 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 3.2 p-10 -83.35 -175.44 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 71.109999999999999 110.812 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.452 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 25.3 mmt -65.95 -28.09 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.372 0.508 . . . . 73.239999999999995 112.372 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.748 ' HB1' ' HE2' ' A' ' 35' ' ' LYS . . . -90.71 9.69 28.89 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.99 0.424 . . . . 75.239999999999995 110.822 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 63.4 69.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.412 -0.813 . . . . 74.450000000000003 112.862 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.748 ' HE2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -127.33 141.91 51.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.162 -0.681 . . . . 74.120000000000005 109.162 168.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.59 101.55 14.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.983 0.42 . . . . 71.450000000000003 110.233 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.635 ' HZ2' ' HZ3' ' A' ' 35' ' ' LYS . 70.5 m95 -98.97 108.61 21.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 75.010000000000005 110.515 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.73 123.41 27.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.212 -0.662 . . . . 73.230000000000004 109.212 175.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.86 132.32 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.136 -0.484 . . . . 72.340000000000003 110.531 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 25' ' ' VAL . . . -116.12 -131.75 4.88 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 121.09 -0.576 . . . . 73.310000000000002 112.992 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.8 tt -63.75 128.31 92.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.053 0.454 . . . . 73.230000000000004 111.381 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.9 Cg_exo -74.95 100.65 1.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.15 2.567 . . . . 73.409999999999997 111.991 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.639 HD12 HD13 ' A' ' 53' ' ' LEU . 69.3 mt -62.33 -55.93 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.162 0.506 . . . . 73.439999999999998 110.925 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.94 148.05 18.49 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.649 -0.786 . . . . 62.539999999999999 111.899 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' HG12 ' A' ' 51' ' ' ILE . 25.3 tm0? -112.73 165.88 11.87 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.262 -1.014 . . . . 73.549999999999997 108.262 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' NZ ' ' A' ' 140' ' ' LYS . . . -40.57 -51.45 3.85 Favored Glycine 0 C--N 1.335 0.475 0 O-C-N 123.47 0.482 . . . . 64.040000000000006 113.884 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 26.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.959 -1.115 . . . . 72.209999999999994 113.47 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 75.5 t80 -129.84 -77.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.094 0.447 . . . . 75.040000000000006 111.287 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.66 -40.63 76.79 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.179 -0.534 . . . . 54.43 113.954 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 45' ' ' GLN . 59.3 m 64.2 96.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.31 0.576 . . . . 74.140000000000001 110.81 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 45' ' ' GLN . 4.1 mm -101.31 139.71 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 73.140000000000001 111.618 -172.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.81 158.73 16.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 73.230000000000004 109.728 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.639 HD13 HD12 ' A' ' 43' ' ' ILE . 9.5 tt -97.1 144.57 26.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.582 -0.525 . . . . 73.430000000000007 109.582 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 53' ' ' LEU . . . -118.5 114.78 23.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.759 0.314 . . . . 74.140000000000001 110.283 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.43 8.42 33.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.395 -0.366 . . . . 73.109999999999999 111.049 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 1.4 tmt? 69.49 -60.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.376 0.67 . . . . 72.510000000000005 109.805 -174.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' MET . 62.9 t30 174.16 149.05 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.931 0.769 . . . . 74.219999999999999 109.273 171.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p -82.39 73.22 9.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.344 0.592 . . . . 73.209999999999994 110.348 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.337 -0.847 . . . . 75.510000000000005 109.728 -179.237 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.699 0.761 . . . . 74.200000000000003 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.438 ' HG2' ' CH2' ' A' ' 114' ' ' TRP . 82.5 Cg_endo -90.92 37.96 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.427 2.751 . . . . 75.230000000000004 113.76 -169.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.89 139.05 53.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.153 0.501 . . . . 70.129999999999995 111.606 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 53' ' ' LEU . 34.2 m -130.29 162.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.235 -0.654 . . . . 74.420000000000002 109.235 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 130' ' ' ILE . 7.4 p -132.73 130.13 58.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.611 0.72 . . . . 72.329999999999998 111.688 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 51' ' ' ILE . 76.2 tttt -94.79 137.47 33.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.023 -0.989 . . . . 74.409999999999997 109.42 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.83 140.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 75.319999999999993 111.743 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 16.2 mt-10 -157.35 161.1 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 75.150000000000006 109.576 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.01 148.54 92.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.321 2.014 . . . . 71.409999999999997 111.353 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.0 t -47.47 -50.02 24.1 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.553 0.533 . . . . 74.409999999999997 112.208 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.48 45.28 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.749 0.309 . . . . 74.439999999999998 111.456 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -69.34 -37.5 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.353 0.597 . . . . 73.409999999999997 110.264 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.03 -80.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.584 -0.817 . . . . 74.329999999999998 112.422 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.4 Cg_exo -60.91 -40.99 48.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.075 2.517 . . . . 74.030000000000001 112.768 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 1.6 tm? -52.63 -48.6 66.27 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 123.518 0.511 . . . . 74.430000000000007 111.172 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.29 -45.9 89.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.706 0.289 . . . . 74.530000000000001 111.185 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 201' ' ' ALA . 3.2 m -63.61 -42.5 98.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.336 0.589 . . . . 72.25 110.424 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.21 -30.27 64.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 75.150000000000006 110.484 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.63 -41.97 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 63.420000000000002 110.729 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.565 ' HD2' ' HE2' ' A' ' 173' ' ' TYR . 41.6 ttmt -63.71 -40.11 95.95 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.714 -0.395 . . . . 75.030000000000001 109.961 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.24 -45.44 93.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.317 0.58 . . . . 73.450000000000003 109.648 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.491 ' OH ' ' HA ' ' A' ' 113' ' ' TYR . 81.1 t80 -58.28 -37.24 74.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 75.329999999999998 110.926 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.52 -32.77 72.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 72.239999999999995 111.057 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 12.4 mmt180 -72.08 -37.9 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.519999999999996 111.075 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.457 ' O ' HD13 ' A' ' 96' ' ' ILE . . . -96.27 17.16 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 73.340000000000003 111.118 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.63 146.9 25.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.909 -0.587 . . . . 73.319999999999993 111.594 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt 77.92 117.25 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.256 -0.884 . . . . 72.340000000000003 111.533 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.52 -29.33 78.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.337 2.691 . . . . 63.039999999999999 113.087 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.43 -53.26 60.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.684 0.278 . . . . 73.530000000000001 111.395 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.89 -47.75 81.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 75.549999999999997 110.152 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 90' ' ' ALA . 59.0 mt -56.21 -51.25 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.674 . . . . 74.439999999999998 111.022 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -53.83 -42.17 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 74.010000000000005 110.621 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -60.32 -60.23 4.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.576 -0.738 . . . . 72.099999999999994 111.449 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -73.26 -34.44 65.83 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 119.964 -0.694 . . . . 72.209999999999994 111.353 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.64 HD13 ' HG ' ' A' ' 108' ' ' LEU . 28.3 mm -59.72 -38.04 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.668 -0.413 . . . . 74.040000000000006 110.475 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -78.77 -48.13 15.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.307 -0.406 . . . . 75.400000000000006 111.24 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.0 m -73.66 -43.92 58.17 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.891 0.33 . . . . 74.340000000000003 111.891 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HD3' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -73.92 -27.33 60.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.782 -0.822 . . . . 75.329999999999998 108.782 178.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 9.9 mtmp? 71.66 83.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.663 -1.153 . . . . 74.420000000000002 111.474 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.1 mt -121.69 173.74 7.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.986 -1.006 . . . . 62.329999999999998 109.318 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -89.35 -62.57 1.45 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.906 -0.318 . . . . 73.299999999999997 110.469 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 160' ' ' ARG . 27.4 p90 -164.78 146.26 7.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.916 0.389 . . . . 74.219999999999999 110.546 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD13 ' A' ' 100' ' ' ILE . 42.3 mt -91.85 118.08 30.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 63.229999999999997 111.019 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.52 59.69 4.94 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 109.977 -1.249 . . . . 75.420000000000002 109.977 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.795 HG23 ' HD2' ' A' ' 111' ' ' PRO . 2.2 p -121.12 151.56 55.64 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.261 -0.47 . . . . 74.040000000000006 110.285 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.795 ' HD2' HG23 ' A' ' 110' ' ' VAL . 89.2 Cg_exo -42.84 134.77 5.3 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.96 2.44 . . . . 72.310000000000002 113.618 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 131' ' ' MET . 23.5 tptm -91.46 130.5 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 74.530000000000001 110.142 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.491 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 46.1 t80 -91.09 128.62 36.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.131 0.491 . . . . 73.310000000000002 112.135 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.55 ' CD1' HG21 ' A' ' 130' ' ' ILE . 47.6 m95 -129.71 -43.66 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.369 -0.832 . . . . 74.239999999999995 108.794 170.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.89 162.93 32.24 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.7 -1.136 . . . . 72.530000000000001 111.448 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 p -164.16 145.5 8.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.746 -0.464 . . . . 60.520000000000003 109.746 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA2' ' HG2' ' A' ' 32' ' ' MET . . . -170.17 -171.55 35.75 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.141 -1.028 . . . . 62.219999999999999 112.817 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.84 130.84 44.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.035 -0.728 . . . . 74.400000000000006 109.035 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 30.7 t-80 -125.5 133.32 52.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.487 -0.324 . . . . 70.510000000000005 110.137 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 125' ' ' SER . 25.7 m-20 69.54 145.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.919 0.762 . . . . 73.519999999999996 112.0 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -151.52 -24.49 0.2 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 73.310000000000002 111.243 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -67.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.336 -0.393 . . . . 73.549999999999997 111.827 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.92 -28.27 3.46 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.12 -0.792 . . . . 74.010000000000005 111.12 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.0 130.68 46.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.19 -0.671 . . . . 74.439999999999998 109.19 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 4.0 p -113.92 117.43 31.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 110.46 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -110.82 132.62 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.226 0.536 . . . . 73.549999999999997 111.672 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -111.95 127.46 55.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.581 -0.736 . . . . 71.129999999999995 109.099 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.445 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 49.0 p90 -123.3 142.1 51.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.222 0.534 . . . . 73.439999999999998 110.86 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.8 ptm -136.13 130.18 32.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.379 -0.828 . . . . 75.230000000000004 109.879 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.55 HG21 ' CD1' ' A' ' 114' ' ' TRP . 15.9 mt -97.51 135.31 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.986 -0.552 . . . . 74.439999999999998 111.543 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 53.8 mtm -130.73 -179.88 5.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.038 -0.528 . . . . 73.540000000000006 109.788 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.05 165.44 24.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.697 -0.483 . . . . 63.25 109.697 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.534 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -69.39 133.19 47.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.397 0.618 . . . . 75.409999999999997 111.519 -172.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.484 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 20.5 m-85 -122.3 172.21 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.669 . . . . 74.340000000000003 110.202 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.772 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -173.72 -51.54 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 43.219999999999999 111.916 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.1 m -100.86 144.15 30.16 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.753 -0.462 . . . . 75.109999999999999 109.753 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 p30 -139.01 163.04 33.44 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.018 -0.364 . . . . 64.409999999999997 110.018 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 10.0 mp -73.14 -24.4 60.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.189 0.44 . . . . 73.209999999999994 112.189 -173.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 10.0 pt20 -71.24 -31.8 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.623 -0.431 . . . . 74.319999999999993 110.424 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.488 ' NZ ' ' HA2' ' A' ' 46' ' ' GLY . 55.9 mttp -71.75 -37.24 70.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.99 0.424 . . . . 74.200000000000003 110.757 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 137' ' ' ASP . 62.0 mt -74.66 -51.54 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.915 -0.584 . . . . 71.519999999999996 112.281 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.666 ' HD1' ' HB2' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -65.96 -32.61 74.19 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.337 0.495 . . . . 71.150000000000006 112.337 -166.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.83 -6.82 59.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.181 -0.607 . . . . 72.439999999999998 110.823 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -104.05 -30.28 10.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.36 0.6 . . . . 64.200000000000003 110.45 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -97.92 -0.61 44.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.546 -0.752 . . . . 75.420000000000002 110.876 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.11 16.23 9.44 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.462 -0.79 . . . . 62.399999999999999 111.926 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.691 ' HE3' ' HB3' ' A' ' 253' ' ' GLN . 2.6 ttpt 64.19 53.67 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.732 -0.667 . . . . 73.329999999999998 110.939 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -133.43 95.15 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.366 -0.975 . . . . 75.329999999999998 108.366 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.48 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 44.6 m-85 -103.68 157.23 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.871 -0.604 . . . . 74.540000000000006 111.368 -172.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.2 p -60.9 147.88 41.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.773 -0.648 . . . . 71.310000000000002 110.778 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.422 ' HD3' ' OE2' ' A' ' 298' ' ' GLU . 26.7 ttm-85 -61.88 -33.19 73.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 71.430000000000007 110.608 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.32 -46.17 90.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.669 -0.696 . . . . 73.230000000000004 110.268 177.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.415 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 32.6 m -72.03 -45.74 59.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.772 -0.649 . . . . 71.439999999999998 111.155 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.2 -40.92 76.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.401 -0.363 . . . . 73.349999999999994 110.681 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 324' ' ' LEU . 19.2 tp -63.48 -47.89 79.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 74.150000000000006 110.668 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.7 -45.48 81.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.691 0.281 . . . . 70.310000000000002 111.051 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 161' ' ' ILE . 93.2 mt -58.52 -51.62 69.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 75.120000000000005 110.146 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 247' ' ' LEU . 15.5 m -57.9 -43.2 86.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.776 -0.647 . . . . 73.200000000000003 110.921 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 92.8 mt -61.19 -56.12 24.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 75.519999999999996 111.206 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.584 HH21 HG23 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -65.59 -23.5 66.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.614 0.245 . . . . 72.230000000000004 111.3 -176.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 157' ' ' LEU . 27.1 mm -65.62 -46.46 89.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.649 -0.501 . . . . 75.329999999999998 109.649 174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.09 -38.72 92.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.618 0.229 . . . . 73.420000000000002 111.618 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.82 -55.51 33.92 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.161 0.505 . . . . 75.230000000000004 110.656 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.584 HG23 HH21 ' A' ' 160' ' ' ARG . 16.9 tt -70.44 -36.22 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.001 -0.545 . . . . 71.319999999999993 110.59 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 58.8 tp -62.65 -37.32 85.89 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.456 -0.202 . . . . 75.299999999999997 110.456 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -50.83 66.28 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.194 0.521 . . . . 75.140000000000001 109.874 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.621 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 44.1 t80 -51.68 -44.64 63.18 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 114.825 -1.08 . . . . 73.430000000000007 111.805 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.74 -31.36 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.768 0.318 . . . . 73.140000000000001 111.189 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.649 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 30.3 t-80 -50.77 -54.96 19.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.511 -0.768 . . . . 75.230000000000004 111.098 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.47 40.2 1.59 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.403 0.62 . . . . 63.420000000000002 110.66 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.621 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 3.0 t-80 -110.21 -72.72 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 73.450000000000003 109.083 174.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.447 ' CD ' ' HD1' ' A' ' 171' ' ' HIS . 0.1 OUTLIER -170.68 -38.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.461 -0.336 . . . . 73.450000000000003 111.293 173.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.565 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 46.8 m-85 -107.33 138.79 42.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 72.519999999999996 111.639 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.26 172.51 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.122 -0.49 . . . . 73.420000000000002 110.396 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 44.2 t60 -141.16 111.76 6.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.356 -0.384 . . . . 72.439999999999998 110.111 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.78 -44.26 6.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 72.530000000000001 113.568 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.756 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 35.7 t70 -81.37 87.09 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.267 -0.549 . . . . 74.219999999999999 112.269 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.412 HD13 ' HD2' ' A' ' 175' ' ' HIS . 26.6 mm -86.69 63.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.703 . . . . 75.310000000000002 109.534 170.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -97.31 156.99 16.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.328 -0.619 . . . . 72.409999999999997 109.328 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 138' ' ' LEU . . . -64.01 -10.84 24.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.943 0.349 . . . . 73.549999999999997 111.943 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.526 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 46.6 t -71.56 -22.55 61.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.457 -0.338 . . . . 71.310000000000002 111.134 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -95.42 -2.25 49.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 70.120000000000005 110.794 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.46 126.62 55.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 74.310000000000002 111.512 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 1.0 OUTLIER -137.71 158.74 43.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 75.319999999999993 110.996 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.428 HD22 ' HB ' ' A' ' 193' ' ' VAL . 43.6 mt -102.67 152.17 21.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.936 -0.575 . . . . 72.450000000000003 111.25 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.746 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 42.1 t-20 -69.38 128.1 35.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.507 -0.923 . . . . 75.099999999999994 108.507 169.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.772 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 39.7 t80 -60.21 -35.36 75.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 72.310000000000002 111.905 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.487 ' HD3' ' NH1' ' A' ' 133' ' ' ARG . 76.0 tttt -97.78 -25.49 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.386 -0.37 . . . . 72.150000000000006 111.218 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 82.7 m-20 -115.99 98.17 50.66 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.42 -0.355 . . . . 72.209999999999994 110.14 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 189' ' ' ASN . 33.7 Cg_endo -63.98 -21.67 68.44 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 123.089 2.526 . . . . 75.510000000000005 113.241 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 31.2 p-10 -95.77 6.91 47.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 74.230000000000004 111.296 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -106.16 91.86 3.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.026 -0.534 . . . . 75.209999999999994 109.834 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.428 ' HB ' HD22 ' A' ' 185' ' ' LEU . 4.1 p -102.42 122.95 55.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.695 -0.684 . . . . 74.420000000000002 110.109 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.746 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 79.3 m-85 -106.91 157.76 17.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.647 -0.706 . . . . 74.209999999999994 110.897 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.41 ' HB2' HH22 ' A' ' 160' ' ' ARG . 43.1 tp -109.16 101.66 10.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 72.0 109.444 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.694 HG13 ' HG3' ' A' ' 111' ' ' PRO . 24.2 m -146.13 171.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.6 0.238 . . . . 73.510000000000005 110.831 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.54 51.6 4.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.497 -0.774 . . . . 73.519999999999996 110.775 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.621 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 22.5 p90 -126.67 -44.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.423 -0.808 . . . . 73.230000000000004 111.124 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 79' ' ' PRO . . . 67.02 5.67 34.28 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.899 -0.667 . . . . 73.230000000000004 112.873 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.898 HD12 ' HD2' ' A' ' 352' ' ' LYS . 30.3 mt -92.33 97.31 10.79 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.768 0.318 . . . . 65.219999999999999 110.873 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.469 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -149.47 100.14 2.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 75.200000000000003 109.663 173.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -105.18 143.01 33.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.389 -0.368 . . . . 75.319999999999993 110.463 -176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 203' ' ' ARG . 8.8 ptm180 -71.3 115.98 11.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.118 -0.492 . . . . 75.099999999999994 111.55 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 239' ' ' SER . 68.9 t80 -83.76 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.72 -0.673 . . . . 73.530000000000001 109.746 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 8.1 p -99.33 119.51 60.23 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 63.549999999999997 109.42 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.615 ' HG2' HG22 ' A' ' 209' ' ' VAL . 11.7 Cg_endo -56.64 88.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.233 2.622 . . . . 73.510000000000005 113.559 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 62.62 24.58 14.64 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.448 -0.796 . . . . 73.230000000000004 112.626 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.11 -42.6 1.37 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.364 -0.922 . . . . 72.230000000000004 113.232 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 206' ' ' PRO . 24.4 m -79.19 132.42 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 74.319999999999993 111.068 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -70.0 153.61 43.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 65.129999999999995 110.727 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.748 ' HA ' ' HE2' ' A' ' 211' ' ' LYS . 0.1 OUTLIER -130.86 134.6 46.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 74.420000000000002 109.444 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.86 145.91 55.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.458 -0.571 . . . . 75.430000000000007 109.458 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.58 136.81 56.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.477 0.656 . . . . 73.530000000000001 111.187 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.43 -148.88 0.36 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.118 -0.946 . . . . 74.25 108.962 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -139.75 -49.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.767 -0.373 . . . . 64.439999999999998 110.086 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -138.84 104.26 7.49 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.088 0.403 . . . . 72.420000000000002 112.088 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 122.029 1.819 . . . . 74.510000000000005 109.989 162.746 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.081 0.467 . . . . 73.439999999999998 110.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.756 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 88.4 -153.38 24.19 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.455 -0.793 . . . . 42.350000000000001 112.303 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.73 145.42 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 73.040000000000006 110.181 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 228' ' ' THR . 15.3 tt -61.39 -23.44 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.709 0.633 . . . . 74.140000000000001 112.709 -171.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.46 -34.47 76.0 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.32 -0.237 . . . . 74.329999999999998 111.222 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.499 ' O ' HG12 ' A' ' 246' ' ' ILE . 13.3 m-85 -104.07 -17.65 14.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.418 0.525 . . . . 75.310000000000002 112.418 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.551 ' O ' ' HB1' ' A' ' 232' ' ' ALA . 1.8 t -72.94 7.97 1.78 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.091 0.472 . . . . 74.019999999999996 111.451 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 26.2 t 63.34 -179.77 0.15 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.264 0.554 . . . . 74.120000000000005 110.932 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.5 -41.13 64.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 72.319999999999993 109.559 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.09 -62.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.847 -1.069 . . . . 64.420000000000002 111.589 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 228' ' ' THR . . . -66.4 -29.41 69.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.254 . . . . 74.319999999999993 111.228 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.433 ' HB3' ' O ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -64.7 -29.69 70.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.232 -0.187 . . . . 62.310000000000002 110.543 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -76.13 -27.17 56.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 74.040000000000006 110.002 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 133.59 -20.81 4.09 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.027 -0.606 . . . . 62.130000000000003 113.251 178.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.1 130.75 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 74.209999999999994 112.309 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -62.71 123.7 80.41 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 75.319999999999993 108.652 170.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.511 ' HB2' ' H ' ' A' ' 239' ' ' SER . 73.2 Cg_exo -46.14 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.682 2.922 . . . . 72.310000000000002 114.887 -168.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.516 ' HA ' ' OH ' ' A' ' 204' ' ' TYR . 3.6 m 161.37 -83.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.751 1.221 . . . . 71.230000000000004 108.173 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.605 ' HG2' ' HG3' ' A' ' 315' ' ' PRO . 9.5 mpt_? -136.09 -31.87 0.89 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.36 -0.978 . . . . 72.420000000000002 108.36 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.769 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.32 -67.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.188 -1.369 . . . . 74.409999999999997 112.216 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.655 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.71 -40.51 96.65 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-N 116.03 -0.532 . . . . 72.329999999999998 112.864 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.31 -53.85 39.1 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.802 0.81 . . . . 73.310000000000002 110.284 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 306' ' ' VAL . 10.5 mp -64.96 -33.11 75.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.055 -0.975 . . . . 74.299999999999997 110.952 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.57 -40.45 97.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.524 0.202 . . . . 74.420000000000002 110.532 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 242' ' ' GLY . 73.0 mt -56.63 -46.17 82.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.117 -0.492 . . . . 72.420000000000002 110.737 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.7 tp -61.91 -40.25 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.223 -0.591 . . . . 74.530000000000001 110.532 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.34 91.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.554 -0.831 . . . . 73.239999999999995 112.044 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.458 ' CZ ' ' HE3' ' A' ' 275' ' ' LYS . 20.7 m-85 -64.67 -45.02 88.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.505 0.193 . . . . 70.349999999999994 111.464 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 5.0 p -72.58 -35.96 68.07 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.408 -0.517 . . . . 73.540000000000006 111.219 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 85.5 mtp -58.21 -52.12 66.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.341 . . . . 64.420000000000002 110.651 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.5 tt -67.62 -32.11 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 74.150000000000006 110.775 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.691 ' HB3' ' HE3' ' A' ' 147' ' ' LYS . 19.0 mt-30 -62.34 -50.95 69.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.676 0.274 . . . . 73.319999999999993 111.211 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 147' ' ' LYS . 29.7 m0 -68.18 -24.42 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 111.496 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -84.99 -31.47 23.49 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.34 0.496 . . . . 71.129999999999995 112.34 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.523 HG23 ' HD1' ' A' ' 290' ' ' PHE . 51.7 p -103.92 -28.67 11.44 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.999 0.74 . . . . 75.430000000000007 112.999 -171.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 112.55 -49.49 0.84 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.184 -1.007 . . . . 71.530000000000001 112.956 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -151.62 145.41 25.08 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.609 -0.347 . . . . 74.120000000000005 110.348 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.485 ' CD1' ' HG3' ' A' ' 253' ' ' GLN . 31.2 mt -104.97 147.48 34.55 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.642 -0.254 . . . . 75.120000000000005 110.4 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.5 -35.93 86.93 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.875 2.383 . . . . 73.109999999999999 112.907 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.561 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 18.6 p90 -95.35 8.34 43.48 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 120.686 -0.405 . . . . 73.340000000000003 111.117 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' ' 265' ' ' LEU . 66.2 tt0 -85.14 -24.8 27.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.343 0.592 . . . . 71.109999999999999 109.689 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -96.92 -23.4 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.653 -0.703 . . . . 72.430000000000007 109.671 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 261' ' ' TRP . 94.7 m-20 -102.51 14.34 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.731 -0.668 . . . . 72.010000000000005 111.354 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.561 ' HB3' ' O ' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -70.08 -12.73 61.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.02 0.438 . . . . 75.120000000000005 110.783 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -64.64 -16.65 63.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 74.439999999999998 111.356 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.531 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 5.9 t70 -129.72 117.96 18.63 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-O 120.933 0.397 . . . . 63.039999999999999 110.626 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.405 ' HB3' ' CE1' ' A' ' 233' ' ' HIS . 77.4 Cg_exo -51.69 -27.84 27.64 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.722 2.948 . . . . 72.239999999999995 113.946 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.9 mttp -60.26 -52.45 65.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.902 0.382 . . . . 73.420000000000002 110.279 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.531 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 95.4 m-85 -72.37 -34.67 68.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 75.530000000000001 110.994 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 265' ' ' LEU . 92.5 t -55.57 -50.5 66.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.35 -0.386 . . . . 70.209999999999994 110.602 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -70.33 -44.07 68.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 75.310000000000002 110.368 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.29 -55.42 31.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.784 -0.644 . . . . 71.340000000000003 111.174 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.5 p -61.11 -44.37 97.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.158 -0.474 . . . . 74.519999999999996 111.027 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.458 ' HE3' ' CZ ' ' A' ' 249' ' ' TYR . 50.4 mttp -55.95 -48.11 76.36 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 116.651 -0.249 . . . . 74.510000000000005 111.174 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.6 -41.91 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.732 -0.213 . . . . 72.239999999999995 111.066 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -63.03 -40.23 97.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.545 -0.298 . . . . 75.319999999999993 111.384 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.92 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 23.0 m-85 -73.88 -33.36 64.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.684 0.278 . . . . 72.340000000000003 111.219 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 279' ' ' ARG . 13.8 mtp180 -71.43 -23.76 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 73.409999999999997 111.173 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -57.49 -59.07 5.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 75.120000000000005 110.378 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.5 88.52 2.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 61.310000000000002 110.023 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.2 mm -55.44 -51.37 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 72.129999999999995 111.33 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.27 83.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 74.109999999999999 111.28 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 31.4 m -68.09 -44.06 77.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 75.239999999999995 111.697 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.92 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.1 mm? -64.39 -46.67 82.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.598 -0.274 . . . . 70.340000000000003 111.336 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -32.69 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.255 . . . . 61.530000000000001 111.013 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.432 ' CG ' ' HZ1' ' A' ' 293' ' ' LYS . 11.7 t70 -59.48 -37.91 79.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 111.014 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.608 ' HB3' ' HZ3' ' A' ' 288' ' ' LYS . 2.7 mmmp? -94.54 -13.26 26.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.97 -0.559 . . . . 63.350000000000001 111.462 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 46.3 t -78.18 -25.28 47.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.842 0.353 . . . . 75.329999999999998 111.157 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.523 ' HD1' HG23 ' A' ' 256' ' ' THR . 19.9 t80 -109.82 93.07 13.7 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.150000000000006 109.594 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 88.8 Cg_exo -47.45 -48.35 15.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.678 2.918 . . . . 75.0 114.329 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.92 -25.08 67.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 74.329999999999998 110.773 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.432 ' HZ1' ' CG ' ' A' ' 287' ' ' ASP . 21.2 ttmm 58.97 41.91 20.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 72.140000000000001 110.17 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -63.75 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.794 . . . . 75.120000000000005 110.021 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 331' ' ' ILE . 50.9 mttp -152.88 99.07 2.77 Favored Pre-proline 0 C--O 1.227 -0.127 0 CA-C-O 120.489 0.185 . . . . 74.030000000000001 110.513 172.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -99.4 38.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.887 2.391 . . . . 72.150000000000006 111.419 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.24 -50.9 5.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.068 -0.587 . . . . 63.140000000000001 113.268 -170.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.907 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.6 mp0 -54.88 -52.91 61.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.965 0.412 . . . . 75.409999999999997 110.213 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.1 mp -60.65 -47.32 93.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.425 -0.807 . . . . 72.420000000000002 111.12 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.29 86.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.774 0.321 . . . . 55.109999999999999 111.543 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -66.48 -38.57 87.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.157 0.503 . . . . 75.030000000000001 110.046 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.607 ' CD1' HD12 ' A' ' 320' ' ' LEU . 76.2 t80 -60.0 -52.51 65.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.468 -0.787 . . . . 75.239999999999995 110.76 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.497 ' HA ' HG22 ' A' ' 306' ' ' VAL . 79.9 mtp -71.93 -32.19 67.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.339 -0.391 . . . . 63.130000000000003 111.616 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.51 -42.24 91.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.715 0.769 . . . . 71.439999999999998 109.333 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 m -65.39 -44.03 88.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.756 -1.111 . . . . 74.230000000000004 111.548 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 302' ' ' TYR . 4.2 m -70.04 -27.24 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 72.129999999999995 110.654 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.5 -44.09 92.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 110.009 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.8 tp -76.93 1.71 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 75.439999999999998 110.943 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -9.03 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 75.439999999999998 110.328 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 21.0 t70 64.36 -81.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.258 0.623 . . . . 74.409999999999997 111.083 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.769 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -149.6 -44.77 0.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.604 -0.517 . . . . 71.140000000000001 109.604 174.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.5 t -154.98 37.86 0.41 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.691 -0.686 . . . . 72.420000000000002 110.622 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -51.75 -69.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.051 0.453 . . . . 54.520000000000003 111.143 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -175.63 110.34 0.26 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 109.545 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.605 ' HG3' ' HG2' ' A' ' 240' ' ' ARG . 51.8 Cg_endo -69.81 117.64 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.841 1.694 . . . . 64.319999999999993 111.121 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 319' ' ' ASN . 16.5 tp -108.56 82.15 1.57 Allowed 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.355 -0.609 . . . . 62.329999999999998 109.355 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -58.3 -36.43 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.333 -0.849 . . . . 71.209999999999994 110.977 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.15 -52.34 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 74.25 110.527 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.456 ' HB2' HD22 ' A' ' 316' ' ' LEU . 8.2 t30 -59.22 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 71.150000000000006 111.325 -176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 3.3 mm? -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.498 -0.319 . . . . 73.230000000000004 111.426 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -69.53 -34.03 73.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.65 0.262 . . . . 73.209999999999994 110.869 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.5 -42.94 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 72.420000000000002 111.254 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -67.92 -27.33 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 120.887 -0.325 . . . . 73.129999999999995 111.039 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 73.1 mt -65.13 -47.46 77.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.077 -0.342 . . . . 72.400000000000006 110.077 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.12 -33.13 75.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.444 . . . . 73.430000000000007 110.246 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -39.42 89.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 75.209999999999994 110.261 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.907 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.11 -45.02 94.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.004 -0.617 . . . . 61.130000000000003 112.088 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 331' ' ' ILE . 31.1 tp -65.2 -35.25 80.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.336 0.588 . . . . 75.019999999999996 110.041 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.29 -34.3 77.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.792 -0.64 . . . . 74.319999999999993 110.12 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.43 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 71.040000000000006 111.547 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.573 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . 13.1 tt -86.79 -2.76 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 109.901 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 78.19 24.38 63.85 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.722 -0.672 . . . . 71.230000000000004 112.867 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.441 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 11.1 t -120.65 159.55 25.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.952 -0.388 . . . . 75.400000000000006 109.952 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -174.0 4.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.576 -0.527 . . . . 75.200000000000003 109.576 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 28.1 t70 -65.39 120.04 12.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.145 0.497 . . . . 71.049999999999997 111.076 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.26 100.79 7.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.68 . . . . 65.230000000000004 109.371 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . 0.532 ' C ' ' HD2' ' A' ' 338' ' ' LYS . . . 82.34 -81.05 1.73 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.821 -0.704 . . . . 75.209999999999994 111.493 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 111.875 0.324 . . . . 74.439999999999998 111.875 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.898 ' HD2' HD12 ' A' ' 200' ' ' LEU . 11.1 tppt? . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.811 0.339 . . . . 74.140000000000001 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 52.4 m -156.83 150.9 24.97 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.42 -0.355 . . . . 73.140000000000001 110.114 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.719 HG23 ' HA ' ' A' ' 200' ' ' LEU . 12.9 pt -74.93 143.22 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.917 0.389 . . . . 75.340000000000003 111.984 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 97.9 3.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.593 -0.73 . . . . 72.230000000000004 110.428 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 58.9 pttt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 75.400000000000006 111.661 179.764 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 HG12 ' HA2' ' A' ' 40' ' ' GLY . 40.2 t . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.999 -0.371 . . . . 71.200000000000003 109.999 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.8 -0.14 57.74 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.961 -0.563 . . . . 52.219999999999999 113.192 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.17 129.86 40.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.316 0.558 . . . . 74.340000000000003 110.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -77.44 130.46 36.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.435 0.636 . . . . 74.25 110.766 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -134.12 128.45 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.072 -0.967 . . . . 75.409999999999997 109.584 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 49.6 m -108.39 119.08 38.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.922 0.392 . . . . 72.129999999999995 110.35 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 116' ' ' SER . 5.7 p-10 -92.93 169.15 10.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 54.5 109.953 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.654 ' HG2' ' O ' ' A' ' 116' ' ' SER . 24.7 ptt? -71.96 -10.22 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.278 0.473 . . . . 71.329999999999998 112.278 -170.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.96 8.85 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.673 0.273 . . . . 70.439999999999998 110.601 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? 69.45 81.45 0.17 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.541 -0.754 . . . . 74.319999999999993 111.534 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 30' ' ' THR . 35.6 mtmm -152.99 135.95 15.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.009 -0.541 . . . . 72.299999999999997 109.966 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -105.55 89.23 3.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.985 -0.376 . . . . 71.530000000000001 109.985 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 57' ' ' ASN . 27.4 p-90 -116.19 160.15 20.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.872 0.368 . . . . 74.340000000000003 110.918 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 28' ' ' ILE . 1.1 ptpm? -110.64 127.22 55.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 75.129999999999995 110.277 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.89 144.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.375 -0.602 . . . . 74.230000000000004 109.375 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -111.73 -121.12 4.0 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.481 -0.866 . . . . 61.509999999999998 113.198 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 92.2 mt -81.39 138.01 48.39 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 75.439999999999998 111.425 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.4 Cg_exo -74.39 108.07 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.056 2.504 . . . . 75.439999999999998 112.057 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 53' ' ' LEU . 45.2 mt -76.75 -47.57 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 74.230000000000004 109.842 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.53 -32.53 6.42 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.754 -0.657 . . . . 64.239999999999995 112.953 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.56 141.74 28.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.873 0.368 . . . . 75.219999999999999 110.516 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.08 62.33 0.14 Allowed Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.148 -0.781 . . . . 70.349999999999994 111.148 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.98 8.1 87.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.014 -0.612 . . . . 74.519999999999996 112.642 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.595 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 53.2 t80 -164.87 -73.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.919 -0.4 . . . . 70.340000000000003 109.919 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.58 157.7 7.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.952 -0.642 . . . . 71.439999999999998 112.064 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.4 m 63.19 38.13 10.78 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.04 0.448 . . . . 74.450000000000003 111.057 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 71' ' ' LYS . 2.1 mm -98.2 137.79 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 75.409999999999997 110.722 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -117.06 147.88 41.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.241 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HB2' HD12 ' A' ' 43' ' ' ILE . 60.3 tp -85.95 152.94 22.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.086 -0.709 . . . . 75.409999999999997 109.086 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.56 31.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.735 -0.468 . . . . 72.219999999999999 109.735 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 23.2 t70 -83.81 -49.43 9.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.21 0.528 . . . . 75.040000000000006 110.233 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.593 ' HE2' ' HA ' ' A' ' 59' ' ' SER . 54.6 ttp -162.13 135.3 6.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 73.409999999999997 109.914 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -97.63 -44.44 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.36 . . . . 72.519999999999996 110.11 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.5 t -100.89 120.11 39.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.365 -0.606 . . . . 74.299999999999997 109.365 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.593 ' HA ' ' HE2' ' A' ' 56' ' ' MET . 12.5 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 113.397 0.888 . . . . 74.140000000000001 113.397 -169.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.963 0.411 . . . . 73.400000000000006 109.961 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.78 44.79 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.154 2.569 . . . . 72.349999999999994 112.34 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 p -148.4 148.96 30.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.134 0.492 . . . . 71.430000000000007 111.697 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 132' ' ' ASP . 21.6 m -125.85 157.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.034 -0.728 . . . . 63.100000000000001 109.034 172.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.7 p -128.71 124.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.18 0.514 . . . . 75.120000000000005 111.169 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.543 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -87.44 132.82 33.87 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 74.5 108.968 173.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.7 129.29 74.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.425 -0.51 . . . . 74.209999999999994 112.023 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.497 ' OE2' ' HB2' ' A' ' 80' ' ' LEU . 43.8 mt-10 -125.87 159.01 63.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 73.430000000000007 109.363 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.96 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.392 2.061 . . . . 65.099999999999994 112.608 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -66.68 -36.48 82.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.443 0.64 . . . . 74.019999999999996 109.525 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -88.87 73.92 8.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.103 -0.953 . . . . 75.010000000000005 109.227 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -81.25 177.38 9.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.729 -0.669 . . . . 73.239999999999995 110.399 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -130.05 -100.59 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.522 -0.847 . . . . 73.420000000000002 112.553 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.9 Cg_exo -61.91 -21.73 72.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.556 2.837 . . . . 74.120000000000005 113.307 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 46.0 tp -51.17 -34.94 33.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.678 0.621 . . . . 61.409999999999997 112.678 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 86.1 t80 -66.76 -44.65 80.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.531 -0.468 . . . . 74.510000000000005 110.553 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -68.24 -50.03 56.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.842 -0.617 . . . . 74.319999999999993 110.708 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 198' ' ' TYR . 9.1 pt-20 -64.58 -52.98 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.247 -0.888 . . . . 75.140000000000001 110.875 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.504 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 63.4 tp -59.93 -40.93 90.59 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 111.572 0.212 . . . . 73.140000000000001 111.572 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 3.3 tmtm? -60.95 -51.12 70.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.783 0.325 . . . . 74.530000000000001 110.612 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.8 -32.26 67.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.222 -0.591 . . . . 73.109999999999999 109.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.501 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 31.2 t80 -57.67 -45.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 74.030000000000001 109.795 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 28.3 mt-30 -61.33 -38.54 87.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.927 -0.579 . . . . 65.409999999999997 110.697 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.496 ' HA ' ' HZ3' ' A' ' 92' ' ' LYS . 17.4 mtm180 -68.9 -28.08 66.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.832 -0.347 . . . . 73.150000000000006 111.902 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.89 -35.58 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.856 0.687 . . . . 44.420000000000002 112.856 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.2 80.13 7.67 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.415 0.894 . . . . 63.32 113.415 -169.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.496 ' HZ3' ' HA ' ' A' ' 89' ' ' ARG . 5.4 mptt -139.61 129.57 14.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 108.983 -0.747 . . . . 70.219999999999999 108.983 168.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.99 -38.36 69.31 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.618 2.212 . . . . 72.239999999999995 111.849 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.495 ' HG2' ' HD3' ' A' ' 98' ' ' LYS . 16.5 tt0 -64.69 -61.03 2.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 71.319999999999993 110.847 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.64 -34.22 77.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 73.439999999999998 111.511 -172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 100' ' ' ILE . 66.9 mt -64.71 -52.61 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.673 -0.24 . . . . 73.420000000000002 110.445 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.543 ' HA ' HD11 ' A' ' 100' ' ' ILE . 6.6 tp-100 -58.13 -36.69 73.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.323 0.582 . . . . 73.219999999999999 110.27 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 48.2 mtpt -67.98 -28.86 67.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 73.030000000000001 111.126 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.757 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 57.4 t90 -66.3 -56.26 12.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.611 -0.268 . . . . 74.420000000000002 110.792 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.577 HG21 ' HB2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.07 -26.02 37.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 C-N-CA 120.685 -0.406 . . . . 74.340000000000003 111.422 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -66.22 -39.32 89.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.95 -0.3 . . . . 73.409999999999997 110.437 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.3 m -76.02 -48.98 18.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.353 -0.385 . . . . 62.299999999999997 111.738 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.31 57.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 72.439999999999998 109.651 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 1.002 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER 58.35 77.28 0.3 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.103 -0.953 . . . . 75.530000000000001 111.087 -174.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.577 ' HB2' HG21 ' A' ' 100' ' ' ILE . 95.7 mt -136.7 -176.69 4.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.888 -1.051 . . . . 73.120000000000005 108.892 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -79.57 -70.22 0.53 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.643 0.258 . . . . 73.510000000000005 110.805 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.94 163.17 34.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 73.010000000000005 109.94 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.527 ' HG ' ' CE3' ' A' ' 99' ' ' TRP . 0.9 OUTLIER -79.42 137.19 37.17 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.566 0.541 . . . . 72.400000000000006 111.356 -176.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.33 17.82 16.98 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 121.256 -0.497 . . . . 64.450000000000003 112.655 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG22 HD23 ' A' ' 108' ' ' LEU . 76.0 t -101.71 135.25 19.8 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.743 0.417 . . . . 75.040000000000006 110.372 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.501 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 28.3 Cg_endo -63.78 159.62 40.75 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.366 2.71 . . . . 72.230000000000004 114.269 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -81.38 154.67 26.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.619 -1.173 . . . . 75.319999999999993 111.101 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -99.97 116.51 32.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.515 -0.311 . . . . 75.409999999999997 110.355 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.577 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 41.1 m95 -100.88 -29.14 12.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.953 0.406 . . . . 75.519999999999996 110.546 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 158.32 -179.53 33.94 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.577 -0.821 . . . . 71.519999999999996 112.645 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.654 ' O ' ' HG2' ' A' ' 32' ' ' MET . 36.9 p -169.99 175.33 5.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.529 -0.915 . . . . 61.420000000000002 108.529 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.14 -150.93 19.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.477 -1.344 . . . . 63.119999999999997 113.293 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.1 tt -133.27 134.13 43.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.883 0.373 . . . . 73.239999999999995 110.522 -174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -126.54 108.63 11.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 29.4 t70 -79.09 150.58 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.299 0.571 . . . . 54.210000000000001 111.718 -172.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -133.05 52.44 2.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.725 -0.843 . . . . 71.340000000000003 108.725 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 67.17 75.84 0.3 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.168 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.25 -42.88 3.18 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.9 -0.591 . . . . 65.209999999999994 112.008 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.95 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -89.06 82.74 6.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.879 -0.786 . . . . 74.299999999999997 108.879 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.8 m -78.46 135.95 37.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.224 -0.898 . . . . 74.129999999999995 110.776 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -94.69 137.98 33.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.035 0.445 . . . . 73.129999999999995 110.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -112.77 120.36 41.23 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.64 -0.874 . . . . 73.120000000000005 108.64 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.418 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 42.1 p90 -133.94 162.71 31.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.421 0.526 . . . . 72.430000000000007 112.421 -170.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.3 ttm -129.87 131.49 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.325 -0.852 . . . . 74.340000000000003 109.719 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.577 ' CG2' ' HB2' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -102.68 122.93 55.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.273 0.558 . . . . 74.129999999999995 109.746 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.408 ' HE1' ' CE2' ' A' ' 134' ' ' PHE . 19.6 ptm -133.83 -169.97 2.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.531 -0.759 . . . . 72.109999999999999 110.445 -172.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.615 ' O ' HG21 ' A' ' 69' ' ' VAL . 71.9 m-20 -64.24 169.71 4.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 111.962 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.637 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -82.5 106.0 14.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.51 0.671 . . . . 74.400000000000006 111.978 -174.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.408 ' CE2' ' HE1' ' A' ' 131' ' ' MET . 43.9 m-85 -124.39 172.25 9.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 74.310000000000002 110.26 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.23 -38.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.841 . . . . 53.340000000000003 112.344 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 m -95.87 128.19 42.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.368 -0.234 . . . . 73.140000000000001 110.368 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -122.66 160.9 24.85 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.646 -0.501 . . . . 74.230000000000004 109.646 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 10.6 mp -75.8 -8.43 56.86 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.227 0.454 . . . . 75.019999999999996 112.227 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -73.67 -49.75 24.32 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.148 -0.686 . . . . 75.150000000000006 109.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -76.86 -21.64 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.606 -0.438 . . . . 73.310000000000002 110.914 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 54.6 mt -74.12 -51.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.562 -0.29 . . . . 73.420000000000002 110.947 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.428 ' HE1' ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.76 -32.47 73.78 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.126 -0.23 . . . . 74.420000000000002 110.944 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.18 -43.31 82.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 63.219999999999999 110.137 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.71 -31.53 61.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 74.120000000000005 110.986 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.25 -2.59 58.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 75.519999999999996 110.912 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.97 38.04 22.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.472 -0.785 . . . . 72.140000000000001 112.511 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.64 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 74.1 mttt 62.17 73.12 0.48 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.433 0.531 . . . . 75.219999999999999 112.433 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -156.29 82.2 0.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.307 0.575 . . . . 74.310000000000002 109.729 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.49 141.34 29.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.604 -0.726 . . . . 73.25 111.141 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 144.09 57.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.77 -0.65 . . . . 75.120000000000005 109.852 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.477 ' HD2' HD11 ' A' ' 331' ' ' ILE . 13.1 ttm180 -63.24 -29.55 70.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.347 0.129 . . . . 72.129999999999995 111.347 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -57.6 -44.59 85.53 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.21 0.528 . . . . 74.010000000000005 110.071 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.496 ' O ' HD12 ' A' ' 157' ' ' LEU . 6.8 m -66.98 -41.32 87.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.38 -0.827 . . . . 74.150000000000006 110.577 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.52 -45.51 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 75.519999999999996 111.403 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 328' ' ' LEU . 3.9 mm? -68.55 -37.69 80.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.506 -0.316 . . . . 74.239999999999995 111.356 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -65.84 -39.62 90.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.181 0.515 . . . . 62.310000000000002 109.98 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.508 HD13 HG11 ' A' ' 193' ' ' VAL . 5.2 mp -63.19 -51.98 64.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.53 -0.759 . . . . 63.420000000000002 111.295 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.2 p -63.19 -34.98 78.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 73.329999999999998 111.178 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.25 -40.54 97.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 74.209999999999994 110.801 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.787 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -68.94 -43.22 75.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 74.439999999999998 111.204 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 183' ' ' LEU . 42.5 mt -64.59 -29.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.149 -0.478 . . . . 74.510000000000005 109.845 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.512 HD11 ' HD2' ' A' ' 317' ' ' TYR . 29.0 tp -63.1 -55.68 23.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.523 -0.762 . . . . 75.299999999999997 111.148 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.757 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 4.8 p-10 -67.93 -31.51 71.32 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.573 -0.451 . . . . 73.439999999999998 110.703 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 168' ' ' ILE . 70.5 mt -66.82 -46.82 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.41 -0.359 . . . . 72.200000000000003 111.041 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.3 pp -68.71 -33.81 74.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 64.310000000000002 110.086 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.58 -56.31 21.82 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.323 -0.399 . . . . 61.229999999999997 110.362 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.39 -49.09 79.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 72.310000000000002 112.192 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.8 pt -75.01 -38.26 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.107 0.41 . . . . 62.450000000000003 112.107 -173.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.78 -21.0 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.11 0.481 . . . . 71.430000000000007 109.831 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 207' ' ' GLU . 31.8 tt0 -75.27 -6.0 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.478 -0.783 . . . . 74.349999999999994 110.302 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -124.44 -69.69 0.79 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.663 -0.415 . . . . 72.519999999999996 111.645 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.771 ' HB3' ' HB2' ' A' ' 203' ' ' ARG . 35.6 mt-10 -155.48 -59.02 0.1 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.469 0.544 . . . . 74.420000000000002 112.469 -170.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.834 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 48.1 m-85 -83.71 147.78 27.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.12 0.785 . . . . 70.340000000000003 113.12 -166.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.48 HG23 ' HD2' ' A' ' 204' ' ' TYR . 16.9 m -132.26 164.03 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.981 -1.008 . . . . 70.409999999999997 108.924 171.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -105.35 131.2 53.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.738 -0.467 . . . . 73.129999999999995 109.738 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.31 -10.41 64.0 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.05 -1.22 . . . . 64.530000000000001 110.05 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 1.045 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 15.6 t70 -123.88 110.73 15.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.675 -0.763 . . . . 75.099999999999994 110.638 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.2 mm -111.86 66.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.416 -0.957 . . . . 74.239999999999995 108.416 166.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.431 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 79.9 tttt -90.54 161.77 15.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.886 -0.597 . . . . 75.439999999999998 109.882 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -57.6 -19.31 25.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 111.786 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 p -75.91 -12.07 60.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.522 -0.308 . . . . 62.439999999999998 111.488 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.503 ' HB3' ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -82.5 -30.05 30.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.713 0.292 . . . . 63.149999999999999 110.646 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 161' ' ' ILE . 6.4 mp -94.05 131.54 39.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 74.150000000000006 110.581 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.578 ' CD1' ' HB2' ' A' ' 194' ' ' TYR . 1.1 pp -138.42 157.43 46.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 73.310000000000002 111.048 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.59 156.69 20.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 109.5 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.679 HD22 ' HE1' ' A' ' 194' ' ' TYR . 51.1 m-80 -63.51 152.15 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.709 -0.478 . . . . 74.510000000000005 109.709 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -56.5 -32.7 65.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.101 -0.499 . . . . 70.209999999999994 111.133 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.47 3.43 5.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.209 0.448 . . . . 75.310000000000002 112.209 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 186' ' ' ASN . 12.7 m120 -128.53 92.89 39.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.823 -0.351 . . . . 73.409999999999997 111.242 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -9.26 16.46 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.829 2.353 . . . . 72.400000000000006 111.258 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.13 -6.89 50.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 74.129999999999995 111.193 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.68 122.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.094 0.474 . . . . 71.0 110.573 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 157' ' ' LEU . 7.1 p -103.62 137.45 32.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.451 -0.795 . . . . 75.310000000000002 109.712 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.679 ' HE1' HD22 ' A' ' 186' ' ' ASN . 4.7 m-85 -114.09 158.17 21.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.932 -0.766 . . . . 73.319999999999993 108.932 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 182' ' ' ASN . 10.1 tt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.42 -0.956 . . . . 73.040000000000006 108.42 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.412 ' O ' HD22 ' A' ' 195' ' ' LEU . 7.2 p -50.79 130.49 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.285 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.635 ' HB2' ' CD2' ' A' ' 198' ' ' TYR . 1.2 p-10 -58.25 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.627 -1.17 . . . . 75.409999999999997 112.684 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' A' ' 197' ' ' ASP . 24.1 m-85 -135.21 26.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.953 -0.467 . . . . 73.319999999999993 111.796 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -64.13 -39.38 97.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.504 -0.855 . . . . 73.040000000000006 111.167 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.38 89.35 2.77 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.533 ' H ' HG21 ' A' ' 354' ' ' ILE . . . -166.23 149.66 7.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 61.299999999999997 110.842 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -142.45 144.65 33.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.63 -0.507 . . . . 74.340000000000003 109.63 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.834 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 23.1 ptt180 -84.44 141.08 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 75.450000000000003 110.327 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.48 ' HD2' HG23 ' A' ' 174' ' ' VAL . 6.9 m-85 -139.23 -59.35 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 75.310000000000002 112.257 -171.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.95 121.75 41.0 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.475 . . . . 75.150000000000006 111.548 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 103.38 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 73.040000000000006 111.791 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 170' ' ' GLU . 29.1 tt0 71.65 -11.38 0.74 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.754 0.821 . . . . 75.510000000000005 111.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.63 -30.79 1.94 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.359 -0.924 . . . . 70.219999999999999 113.165 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.72 122.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.24 0.543 . . . . 65.310000000000002 110.903 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -89.6 154.76 19.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.06 -0.518 . . . . 72.109999999999999 110.472 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.505 ' HZ2' ' HB3' ' A' ' 211' ' ' LYS . 8.8 mtpm? -93.72 -175.11 3.65 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.021 -0.536 . . . . 73.040000000000006 110.159 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.4 mp0 -52.68 130.09 31.43 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.53 0.519 . . . . 73.310000000000002 110.664 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -65.37 129.13 38.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 74.319999999999993 110.609 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 216' ' ' ASP . 42.0 mmtm -98.08 -45.18 6.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.627 -0.715 . . . . 72.099999999999994 110.575 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.836 ' HA ' ' HB3' ' A' ' 234' ' ' ASN . 50.4 mt-10 67.2 -5.13 0.75 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.134 0.79 . . . . 73.540000000000006 113.134 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 215' ' ' GLU . 6.0 t70 169.2 86.25 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 O-C-N 123.515 0.51 . . . . 73.439999999999998 110.033 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 61.3 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 122.22 1.947 . . . . 74.439999999999998 111.973 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.554 ' HB3' HG21 ' A' ' 355' ' ' THR . 20.5 p-10 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.508 0.194 . . . . 64.019999999999996 111.393 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 1.045 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -93.79 -149.49 25.38 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 75.430000000000007 113.775 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.495 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 69.3 p -81.26 150.14 28.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.661 0.267 . . . . 75.0 110.988 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.23 -31.33 47.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.708 -175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.529 ' HA ' HD21 ' A' ' 265' ' ' LEU . 2.4 mp0 -49.14 -50.93 35.2 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.456 -0.793 . . . . 63.310000000000002 111.184 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 179' ' ' LYS . 97.3 m-85 -101.92 -13.58 17.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 73.340000000000003 112.031 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 232' ' ' ALA . 35.9 m -46.95 -49.58 20.42 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.385 0.428 . . . . 63.409999999999997 111.086 176.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.3 m 59.33 -156.02 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.853 -0.612 . . . . 74.319999999999993 110.888 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.4 mp -71.75 -53.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.367 -0.378 . . . . 74.409999999999997 110.282 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 238' ' ' PRO . 1.6 m-20 -49.46 -60.56 2.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.514 -0.766 . . . . 71.129999999999995 112.991 -173.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 228' ' ' THR . . . -69.94 -30.2 67.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.928 0.394 . . . . 50.329999999999998 111.795 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -67.82 -42.82 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 109.863 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.836 ' HB3' ' HA ' ' A' ' 215' ' ' GLU . 6.4 m-20 -77.25 -4.53 45.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.17 . . . . 70.340000000000003 111.195 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.11 53.74 Favored Glycine 0 C--N 1.335 0.515 0 O-C-N 123.497 0.498 . . . . 53.420000000000002 112.56 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.25 140.98 42.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.584 0.23 . . . . 75.129999999999995 110.839 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.07 106.94 2.12 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.871 -0.789 . . . . 72.120000000000005 108.871 169.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HB3' ' OD2' ' A' ' 231' ' ' ASP . 19.9 Cg_endo -61.07 -87.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.503 2.136 . . . . 71.239999999999995 112.826 -171.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.7 m 171.13 -49.37 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.798 1.239 . . . . 74.340000000000003 107.736 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.38 -16.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.818 -1.537 . . . . 75.120000000000005 107.76 -173.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.577 ' NH2' ' HD2' ' A' ' 279' ' ' ARG . 9.5 mmm180 -52.4 -68.0 0.21 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.334 -1.303 . . . . 74.120000000000005 110.984 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -45.55 -42.02 9.8 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 123.706 0.629 . . . . 75.200000000000003 113.711 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.02 -64.99 0.64 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.769 0.795 . . . . 74.140000000000001 110.207 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.437 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 36.2 mt -74.06 -30.46 62.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.78 -1.1 . . . . 74.109999999999999 111.198 -174.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 7.8 tp10 -62.21 -57.91 9.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.420000000000002 110.274 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.74 -41.29 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 75.239999999999995 110.341 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.427 HD21 ' HH ' ' A' ' 302' ' ' TYR . 55.4 tp -57.89 -41.63 82.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.051 0.453 . . . . 72.329999999999998 110.816 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -43.76 98.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.07 -0.586 . . . . 71.129999999999995 112.203 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -63.07 -34.53 77.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.668 0.27 . . . . 74.239999999999995 110.896 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 57.9 m -62.0 -51.79 66.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.014 0.435 . . . . 74.209999999999994 110.525 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 76.3 mtm -61.45 -42.02 98.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.862 -0.608 . . . . 64.010000000000005 111.866 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.49 HD13 ' HE1' ' A' ' 286' ' ' MET . 11.1 tt -68.59 -34.33 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.392 -0.523 . . . . 74.319999999999993 110.974 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.27 -40.33 71.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 110.231 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.07 -28.46 67.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.246 -0.434 . . . . 75.219999999999999 111.247 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.8 tp -92.34 -40.04 11.14 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.174 0.435 . . . . 73.230000000000004 112.174 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 m -100.14 -17.63 17.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.509 . . . . 71.129999999999995 111.25 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.64 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 85.69 -59.74 4.74 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.759 -0.734 . . . . 62.32 112.545 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -113.8 141.76 46.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.336 -0.508 . . . . 71.209999999999994 109.924 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.915 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 85.6 mt -103.16 142.08 23.83 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.69 . . . . 73.040000000000006 110.098 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 278' ' ' TYR . 15.2 Cg_exo -68.84 -2.3 9.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.807 2.338 . . . . 74.219999999999999 112.967 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.485 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 36.4 p90 -124.3 5.6 8.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 73.010000000000005 110.21 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.915 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 34.1 tt0 -72.31 -21.63 61.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 71.549999999999997 111.048 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.92 -20.18 33.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.451 . . . . 75.230000000000004 109.976 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 89.2 m-20 -96.15 7.12 47.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.78 -0.646 . . . . 73.310000000000002 110.465 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.9 tm? -64.39 -20.84 66.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.472 -0.785 . . . . 74.549999999999997 110.519 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -73.35 -1.6 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 75.230000000000004 112.337 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 271' ' ' VAL . 20.8 t70 -137.28 120.87 11.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 121.073 -0.251 . . . . 73.340000000000003 110.958 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.12 -29.73 88.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.307 2.671 . . . . 64.319999999999993 113.505 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.42 -41.71 38.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.805 0.336 . . . . 75.219999999999999 110.245 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.672 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 24.3 m-85 -64.63 -40.92 96.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 74.319999999999993 110.715 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 267' ' ' ASP . 89.8 t -54.16 -49.33 62.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 123.125 0.265 . . . . 75.010000000000005 110.975 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 276' ' ' ILE . 45.3 mtm180 -62.4 -59.05 5.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.631 -0.259 . . . . 73.030000000000001 111.115 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.0 -47.96 79.59 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.486 0.491 . . . . 74.340000000000003 111.629 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.8 m -58.53 -50.54 73.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.479 -0.328 . . . . 75.239999999999995 110.53 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.39 -32.92 73.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.654 -0.248 . . . . 73.25 111.229 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 272' ' ' ARG . 82.8 mt -64.15 -42.41 95.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 60.109999999999999 110.216 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 280' ' ' GLU . 11.0 mmp_? -62.0 -41.64 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 74.209999999999994 111.053 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 260' ' ' PRO . 73.3 m-85 -74.08 -43.27 58.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 73.019999999999996 110.904 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.577 ' HD2' ' NH2' ' A' ' 241' ' ' ARG . 34.3 ttp180 -65.38 -20.02 66.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.355 0.597 . . . . 74.530000000000001 110.708 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 277' ' ' ARG . 36.6 tt0 -60.53 -47.91 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.164 -0.925 . . . . 75.129999999999995 110.761 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -159.2 94.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.299 0.571 . . . . 74.319999999999993 110.41 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.727 HG13 ' HB2' ' A' ' 303' ' ' MET . 0.2 OUTLIER -80.67 -29.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.598 -0.728 . . . . 73.409999999999997 111.921 -177.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 300' ' ' ALA . . . -52.53 -48.36 66.11 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.522 0.564 . . . . 74.439999999999998 112.522 -168.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.9 m -69.53 -38.11 77.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.96 0.409 . . . . 75.239999999999995 111.666 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.7 -48.2 40.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.067 -0.515 . . . . 74.400000000000006 111.321 -172.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.49 ' HE1' HD13 ' A' ' 252' ' ' ILE . 1.3 mpt? -61.24 -40.56 94.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.348 . . . . 73.150000000000006 110.765 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.21 -28.16 69.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.896 -0.593 . . . . 74.099999999999994 111.224 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -75.36 -43.64 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.774 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.11 -41.89 99.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.89 -0.595 . . . . 74.329999999999998 111.472 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.42 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 47.2 m-85 -123.15 82.2 51.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.56 -0.291 . . . . 74.109999999999999 110.953 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.62 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.288 1.992 . . . . 71.109999999999999 112.045 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.05 -9.0 28.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.338 0.59 . . . . 71.019999999999996 109.993 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -74.82 -36.13 62.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.167 -0.924 . . . . 74.230000000000004 111.006 -174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -173.66 -165.98 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 75.329999999999998 108.632 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -120.88 114.27 32.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 65.540000000000006 111.51 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.42 ' HG3' ' HB2' ' A' ' 290' ' ' PHE . 42.2 Cg_endo -105.23 37.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.675 2.917 . . . . 75.540000000000006 112.163 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -79.5 -50.87 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.847 -0.692 . . . . 73.109999999999999 113.068 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.452 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.1 pm0 -64.17 -36.94 85.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.911 0.386 . . . . 74.409999999999997 110.864 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.64 -48.37 72.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 74.150000000000006 110.773 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 283' ' ' ALA . . . -61.9 -35.73 79.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 75.439999999999998 110.375 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -70.95 -42.11 70.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 74.239999999999995 110.076 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 306' ' ' VAL . 82.7 t80 -56.19 -49.22 74.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.528 -0.76 . . . . 74.340000000000003 110.536 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.727 ' HB2' HG13 ' A' ' 282' ' ' ILE . 79.1 mtp -72.69 -31.38 64.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 74.329999999999998 111.235 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 37.1 tt0 -62.06 -42.23 98.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.774 0.797 . . . . 64.400000000000006 109.056 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 86.8 m -60.56 -45.98 91.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.634 -1.166 . . . . 72.209999999999994 111.211 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 302' ' ' TYR . 9.8 m -73.03 -33.79 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 121.028 -0.269 . . . . 75.239999999999995 111.712 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -72.75 -24.63 60.99 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.816 -0.439 . . . . 74.129999999999995 109.816 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.16 -12.04 60.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.882 -0.599 . . . . 74.400000000000006 110.816 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 96.6 mt -81.12 8.25 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 73.349999999999994 111.401 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.47 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.357 0.663 . . . . 74.319999999999993 112.209 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.89 -50.72 0.71 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.514 -0.921 . . . . 71.109999999999999 108.514 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 17.3 m -136.64 67.66 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.514 -0.766 . . . . 72.409999999999997 110.349 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 13.0 tp10 -104.46 161.28 14.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 62.420000000000002 109.608 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.25 110.14 5.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 74.420000000000002 111.205 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.29 121.6 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.863 2.375 . . . . 70.420000000000002 113.034 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.3 mt -93.79 92.86 7.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 75.010000000000005 110.523 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.522 ' HA ' HD11 ' A' ' 320' ' ' LEU . 12.7 m-85 -63.76 -32.14 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 74.129999999999995 111.013 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 321' ' ' ARG . 21.7 mp0 -57.11 -46.45 82.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 74.340000000000003 110.14 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -68.13 -37.01 80.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 70.310000000000002 110.472 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 317' ' ' TYR . 96.2 mt -60.27 -52.29 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 73.349999999999994 110.919 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 318' ' ' GLU . 6.6 ptp180 -66.85 -28.39 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 75.010000000000005 109.739 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.39 -51.78 58.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 73.040000000000006 111.122 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.431 HD11 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -69.46 -30.04 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 121.063 -0.255 . . . . 74.540000000000006 111.24 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.453 ' HB3' HD13 ' A' ' 155' ' ' LEU . 79.1 mt -67.83 -48.54 65.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 74.510000000000005 110.344 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.61 -29.73 69.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 74.319999999999993 110.755 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -48.02 82.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.188 -0.671 . . . . 62.530000000000001 109.188 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.452 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.85 -38.51 94.38 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.893 -0.67 . . . . 62.240000000000002 112.749 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 333' ' ' SER . 41.7 tp -66.5 -41.96 88.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.172 0.511 . . . . 73.129999999999995 110.561 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.54 -25.88 60.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.98 -0.554 . . . . 72.109999999999999 110.544 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.07 83.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 75.420000000000002 110.587 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.477 HD11 ' HD2' ' A' ' 151' ' ' ARG . 47.0 pt -89.35 7.29 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 74.549999999999997 110.647 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 73.34 25.33 73.19 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.005 -0.543 . . . . 70.439999999999998 113.424 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.574 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 59.4 m -112.29 139.36 47.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.875 0.369 . . . . 74.430000000000007 111.494 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -136.61 -66.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 74.420000000000002 110.084 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.22 147.36 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.943 0.402 . . . . 75.420000000000002 110.299 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.46 -39.89 5.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.932 -0.576 . . . . 74.140000000000001 109.789 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.61 -31.16 1.67 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.008 -0.615 . . . . 63.119999999999997 112.626 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.733 ' HZ2' ' HB3' ' A' ' 338' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.573 0.582 . . . . 72.010000000000005 112.573 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.881 -0.415 . . . . 74.030000000000001 109.881 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.7 t -157.03 172.52 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.666 -0.494 . . . . 75.200000000000003 109.666 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.533 HG21 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -67.24 142.88 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.791 0.329 . . . . 74.420000000000002 110.404 177.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 222' ' ' ASP . 14.5 t -98.02 135.03 40.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.671 -0.863 . . . . 74.209999999999994 108.671 176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 75.549999999999997 109.986 -174.676 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.463 HG13 ' HA2' ' A' ' 40' ' ' GLY . 92.0 t . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.775 0.321 . . . . 71.349999999999994 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.47 -15.61 57.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.203 -0.522 . . . . 63.109999999999999 114.363 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' HG11 ' A' ' 39' ' ' VAL . 48.1 mm-40 -63.47 129.06 38.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.799 0.799 . . . . 70.430000000000007 109.737 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.689 HG22 ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -95.2 131.43 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.626 . . . . 73.409999999999997 111.993 -174.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.464 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 38.9 pt -96.91 150.13 4.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.437 -0.801 . . . . 73.25 109.213 171.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HZ ' ' A' ' 128' ' ' PHE . 6.8 m -105.63 113.24 26.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.534 -0.303 . . . . 73.0 111.225 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.6 t70 -65.13 152.1 44.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 71.450000000000003 109.658 175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 tpt -67.35 -18.85 65.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.476 . . . . 73.310000000000002 111.454 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.31 17.45 20.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.099 -0.5 . . . . 74.230000000000004 110.639 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 68.81 84.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.406 0.682 . . . . 75.109999999999999 111.373 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 41.1 mtmt -152.57 131.94 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 72.150000000000006 109.371 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 56' ' ' MET . 3.4 mp0 -89.06 127.74 35.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.737 0.303 . . . . 74.430000000000007 110.738 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.833 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 74.5 m95 -125.25 117.73 24.45 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.555 -0.535 . . . . 73.049999999999997 109.555 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.689 ' HG2' HG22 ' A' ' 28' ' ' ILE . 22.0 mtmm -78.75 130.75 36.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.572 -0.451 . . . . 75.420000000000002 109.88 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.611 HG21 ' CD2' ' A' ' 52' ' ' TYR . 3.2 p -67.38 117.5 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.166 -0.47 . . . . 63.020000000000003 110.431 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -90.51 -128.93 3.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.845 -0.693 . . . . 51.299999999999997 111.841 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.4 mt -86.81 137.62 33.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.721 -0.282 . . . . 72.439999999999998 111.049 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.71 102.69 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.824 2.349 . . . . 73.439999999999998 110.331 171.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mt -86.98 -70.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.903 -0.589 . . . . 74.109999999999999 110.697 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.25 165.7 17.3 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.667 -0.778 . . . . 72.540000000000006 111.78 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.869 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 2.2 tt0 -131.91 166.17 22.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.41 -0.589 . . . . 70.340000000000003 109.41 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA3' ' OD2' ' A' ' 137' ' ' ASP . . . -82.82 42.61 2.98 Favored Glycine 0 C--O 1.232 -0.026 0 C-N-CA 121.511 -0.376 . . . . 71.319999999999993 112.959 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.11 -75.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 109.999 -1.241 . . . . 61.420000000000002 109.999 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HZ ' ' HA ' ' A' ' 353' ' ' THR . 24.1 m-85 -96.64 83.45 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 64.209999999999994 109.586 168.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.869 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -68.95 -158.38 1.5 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.608 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 72.2 m 70.77 30.99 2.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.296 0.569 . . . . 70.400000000000006 110.806 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 ' HB2' ' A' ' 45' ' ' GLN . 4.2 mm -93.88 122.0 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.307 -0.627 . . . . 74.530000000000001 109.307 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.762 ' HE1' ' HB ' ' A' ' 72' ' ' VAL . 28.3 p90 -108.2 150.43 27.26 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.154 -0.618 . . . . 74.239999999999995 110.879 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HA ' HG11 ' A' ' 69' ' ' VAL . 7.9 tt -68.97 134.17 49.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.363 -0.835 . . . . 75.230000000000004 110.512 -176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.68 102.92 14.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.083 -0.508 . . . . 74.310000000000002 109.959 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.37 -35.9 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 72.25 111.251 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.833 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 13.9 tmm? 66.17 -73.92 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.236 -0.654 . . . . 62.119999999999997 109.236 -172.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.14 140.71 13.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.931 -0.766 . . . . 65.299999999999997 108.931 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -81.72 49.6 1.37 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.359 0.6 . . . . 64.129999999999995 110.624 -173.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 75.430000000000007 109.951 -179.87 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.263 -0.643 . . . . 72.519999999999996 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.29 32.18 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.293 2.662 . . . . 74.329999999999998 113.593 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.2 p -127.52 136.69 52.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.529 0.681 . . . . 70.310000000000002 111.226 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 53' ' ' LEU . 12.8 m -141.99 162.38 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.343 -0.844 . . . . 71.310000000000002 109.282 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -132.78 126.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.676 0.75 . . . . 63.299999999999997 111.421 -179.057 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 60.8 tttm -87.5 127.22 35.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.702 -1.136 . . . . 75.430000000000007 109.171 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.762 ' HB ' ' HE1' ' A' ' 52' ' ' TYR . 11.9 p -116.42 135.6 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.014 0.435 . . . . 73.209999999999994 111.573 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 49.2 mm-40 -142.36 143.4 26.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.524 -0.762 . . . . 74.310000000000002 109.072 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 77' ' ' ASN . 37.6 Cg_exo -60.49 133.01 46.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.52 1.48 . . . . 75.319999999999993 109.978 170.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -60.09 -30.39 69.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.788 0.328 . . . . 75.319999999999993 110.896 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.74 24.22 10.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 71.150000000000006 111.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 74' ' ' PRO . 63.3 t30 -85.98 -50.19 7.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.913 0.387 . . . . 73.0 110.223 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.85 -77.67 0.24 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.378 -0.915 . . . . 62.450000000000003 113.65 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.95 -43.31 59.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.268 2.645 . . . . 63.140000000000001 114.295 -169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.01 -29.93 67.62 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 111.957 0.354 . . . . 74.219999999999999 111.957 -171.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -66.02 -50.76 63.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.429 -0.508 . . . . 73.409999999999997 110.504 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 m -69.06 -40.18 78.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.489 0.662 . . . . 71.450000000000003 110.005 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' A' ' 71' ' ' LYS . 33.3 tt0 -59.73 -53.71 54.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.803 -1.089 . . . . 74.310000000000002 111.074 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.453 ' HB2' HD11 ' A' ' 80' ' ' LEU . 51.7 tp -66.24 -33.03 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 73.5 111.074 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE3' ' OH ' ' A' ' 173' ' ' TYR . 64.8 tttp -60.01 -47.34 86.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.011 0.434 . . . . 75.140000000000001 110.096 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 173' ' ' TYR . 59.0 t80 -71.19 -41.62 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 73.049999999999997 110.361 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -57.32 -50.23 73.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 64.540000000000006 110.838 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -24.41 63.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.109 0.48 . . . . 74.519999999999996 110.533 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -69.7 -39.16 77.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 75.140000000000001 111.597 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HA ' ' HE2' ' A' ' 167' ' ' TYR . . . -107.44 -34.09 7.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.228 0.825 . . . . 75.219999999999999 113.228 -171.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 113' ' ' TYR . . . -85.77 100.39 12.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.548 0.689 . . . . 73.329999999999998 111.819 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -166.75 100.41 0.66 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.388 -0.968 . . . . 75.019999999999996 108.388 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -43.07 -45.33 9.43 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.78 2.987 . . . . 74.349999999999994 114.042 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.74 -49.68 74.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.36 -0.382 . . . . 74.319999999999993 110.959 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.47 -38.74 87.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.621 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 100' ' ' ILE . 81.0 mt -58.13 -53.29 47.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.727 -0.669 . . . . 74.340000000000003 110.879 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -62.1 -40.78 97.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.515 -0.311 . . . . 74.519999999999996 111.248 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -57.06 -48.98 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.341 -0.39 . . . . 73.439999999999998 110.877 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.554 ' CE2' ' HG3' ' A' ' 103' ' ' ARG . 66.0 t-105 -65.24 -49.01 71.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 74.329999999999998 110.711 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 96' ' ' ILE . 94.4 mt -53.52 -51.29 43.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.137 0.494 . . . . 75.400000000000006 111.519 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -73.72 -31.21 63.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.51 -0.768 . . . . 73.420000000000002 111.226 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.3 m -76.17 -40.09 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.02 0.438 . . . . 54.140000000000001 111.238 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 11.1 mmm180 -91.8 10.0 30.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 72.549999999999997 111.915 -173.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.7 mmpt? 63.58 27.25 14.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 74.299999999999997 111.617 173.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.474 ' HB3' ' OD1' ' A' ' 163' ' ' ASP . 97.7 mt -89.11 178.36 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.977 0.418 . . . . 75.120000000000005 111.438 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -83.32 -66.95 0.83 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.964 -0.754 . . . . 73.310000000000002 108.964 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.7 p90 179.87 133.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.728 -1.124 . . . . 75.420000000000002 109.541 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -78.74 116.14 18.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.54 -0.541 . . . . 74.299999999999997 109.54 177.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.93 72.19 1.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.749 -0.659 . . . . 74.420000000000002 112.904 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.456 HG12 ' HD2' ' A' ' 111' ' ' PRO . 67.4 t -101.99 140.33 21.09 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.755 -0.831 . . . . 64.540000000000006 108.755 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.456 ' HD2' HG12 ' A' ' 110' ' ' VAL . 1.3 Cg_endo -44.88 134.33 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.199 2.599 . . . . 74.510000000000005 112.443 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.864 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 21.4 tptm -65.4 106.23 1.34 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 73.109999999999999 110.693 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.447 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 35.1 t80 -79.85 113.8 18.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.726 -1.125 . . . . 74.400000000000006 111.184 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.461 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 15.0 m95 -97.94 -36.23 10.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.467 -0.938 . . . . 75.450000000000003 108.467 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.49 178.25 48.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.724 -1.125 . . . . 64.430000000000007 111.115 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.9 p -172.68 165.42 5.42 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.481 -0.563 . . . . 73.239999999999995 109.481 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.09 -173.81 46.09 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.92 -1.134 . . . . 54.119999999999997 113.103 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 125' ' ' SER . 8.8 tt -134.93 128.68 32.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.44 -0.948 . . . . 75.310000000000002 108.44 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -140.89 125.62 18.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 73.549999999999997 110.566 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.24 123.92 26.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 64.340000000000003 110.098 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -87.93 -56.97 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.277 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.05 79.93 0.77 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.288 -0.634 . . . . 73.349999999999994 109.288 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.19 33.52 85.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.169 -0.773 . . . . 73.400000000000006 111.169 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 13.6 tppt? -158.91 105.0 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.498 -0.556 . . . . 74.530000000000001 109.498 -174.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.48 ' HB3' HD23 ' A' ' 118' ' ' LEU . 25.3 m -78.85 108.73 12.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.038 0.447 . . . . 74.409999999999997 111.07 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -92.05 131.75 37.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.053 -0.521 . . . . 73.430000000000007 110.555 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.425 ' HE ' HD22 ' A' ' 84' ' ' LEU . 10.0 ttt180 -113.24 117.15 31.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.507 -0.923 . . . . 74.430000000000007 108.507 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HZ ' ' O ' ' A' ' 30' ' ' THR . 49.0 p90 -133.44 161.62 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 112.057 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.4 ptp -139.46 141.65 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 74.310000000000002 110.55 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.548 HD13 ' HB ' ' A' ' 70' ' ' VAL . 11.2 mm -98.31 118.56 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.142 0.496 . . . . 73.040000000000006 110.312 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 21.6 ptm -127.72 163.68 23.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.674 -0.694 . . . . 71.25 110.509 -175.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.864 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.9 t70 -70.35 156.85 38.75 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.718 -0.475 . . . . 71.519999999999996 109.718 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 133' ' ' ARG . 22.3 tpt180 -82.81 108.52 16.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.388 0.614 . . . . 74.439999999999998 111.31 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.64 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 17.0 m-85 -103.26 142.27 34.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.062 -1.088 . . . . 75.409999999999997 108.062 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.29 -4.38 3.23 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 119.583 -1.294 . . . . 65.540000000000006 113.453 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.917 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.4 m -120.59 124.49 45.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.844 0.354 . . . . 75.340000000000003 110.295 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.79 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 3.9 m-20 -90.53 134.99 33.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.157 -0.474 . . . . 62.530000000000001 110.022 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 36.9 tp -61.83 -36.61 81.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.951 -0.759 . . . . 72.349999999999994 108.951 172.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.79 ' HG3' ' HB3' ' A' ' 137' ' ' ASP . 1.4 pp0? -64.64 -28.15 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 75.129999999999995 111.547 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.621 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 58.2 mttp -72.52 -39.82 67.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.837 -0.345 . . . . 71.040000000000006 110.629 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.28 -36.9 44.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.515 0.674 . . . . 74.540000000000006 109.337 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.594 ' HB3' ' HA ' ' A' ' 139' ' ' GLN . 28.6 t80 -55.19 -54.27 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.738 -1.119 . . . . 74.400000000000006 111.202 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.97 -33.87 61.94 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.755 -0.378 . . . . 61.310000000000002 111.235 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.79 -32.76 72.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.945 0.35 . . . . 75.099999999999994 111.945 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -105.1 8.68 34.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 75.420000000000002 110.614 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.11 48.52 17.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.319 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.687 ' HG3' HE22 ' A' ' 253' ' ' GLN . 0.0 OUTLIER 43.67 77.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.818 1.247 . . . . 72.0 113.749 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.63 102.97 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.751 -0.659 . . . . 74.230000000000004 109.269 168.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.696 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 65.9 m-85 -108.76 156.1 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.996 -0.547 . . . . 70.129999999999995 109.884 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -70.59 156.88 38.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.319 -0.4 . . . . 74.010000000000005 110.585 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.577 ' HG2' HD13 ' A' ' 331' ' ' ILE . 25.0 tpt180 -45.99 -57.28 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.547 -0.752 . . . . 75.120000000000005 112.144 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -67.27 -28.1 67.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 111.514 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 m -70.94 -45.19 64.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.442 -0.345 . . . . 63.539999999999999 110.571 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.84 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 74.439999999999998 110.585 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 324' ' ' LEU . 0.2 OUTLIER -65.02 -42.87 93.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 75.140000000000001 110.325 -178.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -55.21 -52.57 62.93 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.773 -0.454 . . . . 74.340000000000003 109.773 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.24 -50.65 73.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 111.125 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.43 ' HA ' HD12 ' A' ' 161' ' ' ILE . 32.1 t -57.93 -38.05 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 65.230000000000004 111.241 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.81 -40.86 75.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.856 -0.424 . . . . 75.0 109.856 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.586 ' HA ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -67.42 -31.4 71.58 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.787 0.803 . . . . 75.340000000000003 110.307 -178.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 158' ' ' SER . 58.4 mt -67.92 -35.14 71.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.591 -0.731 . . . . 75.439999999999998 109.695 174.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.445 HD12 ' HD1' ' A' ' 317' ' ' TYR . 43.4 tp -63.84 -40.48 96.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.088 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.4 m-20 -53.34 -59.52 4.47 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.491 0.663 . . . . 65.129999999999995 110.895 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -67.11 -37.35 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.856 -0.611 . . . . 74.230000000000004 111.101 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.66 -37.94 89.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.72 0.295 . . . . 74.200000000000003 110.296 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -56.09 -58.81 6.34 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.87 -0.605 . . . . 74.120000000000005 109.46 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.421 ' HE2' ' HA ' ' A' ' 90' ' ' ALA . 39.9 t80 -55.5 -48.98 73.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.859 -1.064 . . . . 74.219999999999999 112.572 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 164' ' ' ILE . 39.7 pt -84.19 -36.52 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.605 0.594 . . . . 73.439999999999998 112.605 -170.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -82.34 -26.17 33.21 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 73.209999999999994 112.144 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.37 -18.46 64.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.75 -0.78 . . . . 72.299999999999997 110.048 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.9 -74.75 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 70.329999999999998 112.346 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -135.86 -68.71 0.5 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.145 0.794 . . . . 74.519999999999996 113.145 -167.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 79.6 m-85 -84.99 167.26 16.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.488 0.922 . . . . 74.310000000000002 113.488 -161.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.486 HG22 ' HG2' ' A' ' 238' ' ' PRO . 27.4 m -142.21 172.18 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.065 -1.425 . . . . 75.439999999999998 109.48 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 177' ' ' ASP . 11.5 t-160 -158.64 96.21 1.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.612 -0.514 . . . . 73.109999999999999 109.612 173.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.48 ' O ' HD12 ' A' ' 246' ' ' ILE . . . -67.49 -33.61 82.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.116 -0.564 . . . . 74.519999999999996 112.389 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.53 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 20.6 t70 -74.57 91.56 2.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.141 0.496 . . . . 74.340000000000003 111.315 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.04 67.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.038 0.923 . . . . 75.340000000000003 108.955 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.413 ' HB2' ' HZ2' ' A' ' 179' ' ' LYS . 3.7 ttmp? -88.27 139.14 30.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.99 -1.005 . . . . 71.439999999999998 109.222 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -56.17 -16.68 5.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.314 0.487 . . . . 75.129999999999995 112.314 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.62 ' HA ' ' HG2' ' A' ' 139' ' ' GLN . 29.8 t -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.331 -0.395 . . . . 72.109999999999999 111.431 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.43 ' O ' HD12 ' A' ' 195' ' ' LEU . 84.5 m-20 -92.21 -11.74 34.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.724 0.297 . . . . 75.420000000000002 111.584 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.49 119.47 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 75.540000000000006 110.493 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.4 mm? -119.03 140.59 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.682 -0.69 . . . . 75.310000000000002 110.61 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.917 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 69.2 mt -97.87 142.82 29.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.989 -0.55 . . . . 74.109999999999999 110.339 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.64 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -61.48 136.75 58.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 110.042 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -56.17 -31.27 63.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.832 0.348 . . . . 71.239999999999995 111.627 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.707 ' HA ' ' HE3' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -90.97 -22.58 20.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.959 0.355 . . . . 73.349999999999994 111.959 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -138.42 110.21 8.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 111.888 0.329 . . . . 75.510000000000005 111.888 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.57 -12.94 32.14 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.73 2.286 . . . . 73.319999999999993 111.252 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -90.49 7.39 39.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.369 -0.832 . . . . 72.209999999999994 111.153 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 16.7 mm-40 -121.84 106.78 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.431 . . . . 62.130000000000003 110.76 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.2 122.11 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 75.329999999999998 110.813 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -114.75 157.44 23.2 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.866 -0.606 . . . . 75.239999999999995 109.922 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 182' ' ' ASN . 34.1 tp -107.53 103.3 12.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.222 -0.658 . . . . 74.340000000000003 109.222 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.7 m -120.77 -167.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.497 -0.319 . . . . 74.140000000000001 110.487 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.2 m-20 70.66 -62.13 0.45 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.816 0.698 . . . . 63.530000000000001 110.674 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 60.98 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 74.019999999999996 111.654 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 68.46 -68.34 0.39 Allowed Glycine 0 N--CA 1.447 -0.63 0 O-C-N 123.415 0.447 . . . . 74.540000000000006 112.088 -174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 353' ' ' THR . 2.4 mp -88.26 81.07 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.856 0.36 . . . . 73.420000000000002 110.145 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.73 98.02 5.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.01 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -164.11 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.365 -0.976 . . . . 74.409999999999997 108.365 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 9.3 ptp180 -137.75 150.62 47.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.559 -0.456 . . . . 74.129999999999995 111.426 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -83.1 -36.74 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.583 -0.735 . . . . 75.409999999999997 110.412 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 6.6 p -134.82 129.64 19.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 111.198 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 9.9 Cg_exo -71.49 100.71 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.943 2.429 . . . . 75.120000000000005 111.094 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 71.06 -62.57 0.45 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.456 0.702 . . . . 73.209999999999994 112.053 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.7 -36.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.791 . . . . 74.219999999999999 112.963 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 26.6 m -60.87 132.4 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.443 . . . . 71.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.32 138.16 37.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.136 -0.483 . . . . 74.140000000000001 109.857 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 211' ' ' LYS . 12.6 tptm -108.33 172.63 6.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.131 0.491 . . . . 75.150000000000006 112.311 -167.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 211' ' ' LYS . 19.0 tt0 -90.96 174.19 7.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.505 -0.771 . . . . 72.120000000000005 111.019 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.408 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -73.19 6.27 2.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -168.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -166.5 96.78 0.57 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.71 -0.619 . . . . 74.329999999999998 110.633 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.447 ' OE1' ' HG2' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -136.24 -4.14 2.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.377 -0.829 . . . . 71.329999999999998 110.859 178.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.474 ' OD1' ' HD2' ' A' ' 217' ' ' PRO . 10.6 t70 -79.05 148.01 70.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.823 -0.626 . . . . 65.129999999999995 110.774 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.474 ' HD2' ' OD1' ' A' ' 216' ' ' ASP . 69.6 Cg_exo . . . . . 0 N--CA 1.481 0.758 0 C-N-CA 124.32 3.347 . . . . 64.129999999999995 114.928 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 121.595 0.712 . . . . 72.549999999999997 111.785 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.53 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . 110.52 174.82 20.49 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.723 -0.751 . . . . 61.340000000000003 112.459 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.39 141.63 43.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.669 0.271 . . . . 74.340000000000003 110.622 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 271' ' ' VAL . 15.4 tt -58.36 -17.06 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.355 0.598 . . . . 73.349999999999994 111.323 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -50.49 -55.52 15.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.921 -1.036 . . . . 75.109999999999999 111.603 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.569 ' O ' HG12 ' A' ' 246' ' ' ILE . 38.9 m-85 -111.24 -28.11 8.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.071 0.767 . . . . 74.530000000000001 113.071 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 225' ' ' ILE . 5.8 t -64.98 -6.4 8.44 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.758 0.651 . . . . 71.540000000000006 112.758 -169.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.748 ' HA ' ' HE2' ' A' ' 275' ' ' LYS . 23.0 t 65.0 -169.85 0.2 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.393 176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 234' ' ' ASN . 15.3 pt -73.34 -34.35 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 111.684 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 236' ' ' VAL . 11.7 t70 -53.82 -74.88 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.827 -170.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.78 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 70.439999999999998 111.616 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -62.7 -27.53 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.603 -0.271 . . . . 70.150000000000006 111.62 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 0.0 OUTLIER -78.41 -28.81 46.93 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.859 0.318 . . . . 73.519999999999996 111.859 -175.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 112.37 45.65 0.78 Allowed Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.346 -0.931 . . . . 63.549999999999997 112.848 -177.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 231' ' ' ASP . 15.0 p -123.44 143.27 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.0 -0.741 . . . . 72.319999999999993 109.0 171.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -53.25 110.72 2.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.676 -0.861 . . . . 73.340000000000003 108.676 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 174' ' ' VAL . 69.6 Cg_exo -41.97 115.18 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.772 2.981 . . . . 75.540000000000006 113.561 -169.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 93.9 p -90.83 -175.54 4.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.248 -0.887 . . . . 71.349999999999994 111.163 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.877 ' HG2' ' HB3' ' A' ' 315' ' ' PRO . 9.8 mtm-85 -53.94 -36.69 63.06 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.534 -0.757 . . . . 71.25 111.248 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.439 HH22 ' HD2' ' A' ' 279' ' ' ARG . 12.3 mtp180 -66.27 -33.56 76.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.797 -0.638 . . . . 75.400000000000006 110.498 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -57.43 -65.1 3.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.881 -0.676 . . . . 70.299999999999997 111.84 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.16 -48.1 71.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.34 0.59 . . . . 70.310000000000002 110.758 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.695 ' HG ' HD23 ' A' ' 320' ' ' LEU . 9.2 mp -67.95 -46.02 72.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.169 -0.923 . . . . 75.219999999999999 112.045 -173.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -64.43 -47.08 80.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.611 -0.435 . . . . 71.129999999999995 110.789 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 227' ' ' PHE . 76.0 mt -61.45 -40.11 85.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.347 -0.388 . . . . 74.030000000000001 111.425 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.657 HD22 ' HH ' ' A' ' 302' ' ' TYR . 37.9 tp -64.23 -45.12 89.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 75.530000000000001 110.217 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.64 95.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.906 -0.664 . . . . 74.230000000000004 112.081 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 14.8 m-30 -56.26 -45.84 79.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.782 0.325 . . . . 73.040000000000006 110.812 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.82 -35.22 78.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 73.140000000000001 110.892 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 83.8 mtp -59.47 -54.54 45.47 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.737 0.303 . . . . 75.25 110.988 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.6 tt -67.8 -32.06 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 74.530000000000001 110.45 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.687 HE22 ' HG3' ' A' ' 147' ' ' LYS . 9.5 tm0? -61.58 -53.59 54.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 74.219999999999999 110.364 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.696 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.8 m0 -69.45 -26.42 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 75.299999999999997 111.662 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.506 HD11 HD22 ' A' ' 294' ' ' ASN . 33.4 tp -83.87 -36.22 23.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.203 0.446 . . . . 75.319999999999993 112.203 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.5 p -103.49 -27.4 12.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.688 -0.405 . . . . 62.399999999999999 112.058 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 98.79 -1.35 58.09 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.429 -0.891 . . . . 74.340000000000003 113.272 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -148.12 163.16 37.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.178 0.513 . . . . 74.310000000000002 111.691 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.645 ' HG ' ' HG2' ' A' ' 253' ' ' GLN . 60.2 mt -111.87 142.48 26.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.202 -0.908 . . . . 74.439999999999998 109.649 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.47 -25.68 59.38 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.615 2.21 . . . . 64.519999999999996 112.601 177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.436 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 48.0 p90 -111.65 18.94 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.353 -0.385 . . . . 73.430000000000007 110.771 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 35.3 tt0 -66.03 -44.5 84.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.551 . . . . 72.209999999999994 110.467 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.96 -6.72 55.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.97 0.891 . . . . 70.230000000000004 109.552 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -104.62 0.8 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.097 -0.956 . . . . 74.219999999999999 111.227 -177.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 261' ' ' TRP . 80.5 mt -71.33 -6.9 43.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.12 0.486 . . . . 62.109999999999999 110.885 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -60.91 -33.4 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.483 -0.781 . . . . 75.450000000000003 111.332 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.718 ' HB2' ' CD1' ' A' ' 270' ' ' TYR . 7.8 m-20 -145.33 145.82 27.89 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-O 120.541 0.21 . . . . 41.43 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.649 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 25.3 Cg_endo -62.92 -28.09 75.09 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.61 2.207 . . . . 72.319999999999993 112.002 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -42.49 96.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.202 0.525 . . . . 74.109999999999999 109.719 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.718 ' CD1' ' HB2' ' A' ' 267' ' ' ASP . 9.5 m-85 -66.67 -45.33 79.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 111.31 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 225' ' ' ILE . 20.3 m -65.03 -29.16 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.535 -0.302 . . . . 71.349999999999994 111.225 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.649 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 33.7 mtm180 -60.62 -58.61 7.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.096 -0.705 . . . . 75.319999999999993 109.096 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -52.26 -50.55 61.87 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 111.018 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 50.3 m -59.6 -50.33 74.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 74.319999999999993 111.463 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.748 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 59.7 mttp -66.36 -44.49 83.06 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.879 -0.329 . . . . 75.329999999999998 111.376 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.5 -48.34 85.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 120.812 0.339 . . . . 74.530000000000001 110.935 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -54.71 -50.09 69.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 75.420000000000002 110.776 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -74.21 -39.07 63.38 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 111.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.439 ' HD2' HH22 ' A' ' 241' ' ' ARG . 52.2 ttp180 -50.44 -40.34 50.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.542 0.337 . . . . 72.239999999999995 111.792 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -70.28 -36.15 74.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.297 0.48 . . . . 75.510000000000005 112.297 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -129.19 38.57 3.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.795 0.331 . . . . 74.120000000000005 111.663 -170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.503 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -49.91 -50.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 113.115 0.783 . . . . 73.200000000000003 113.115 -176.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 300' ' ' ALA . . . -58.07 -47.77 82.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 74.019999999999996 112.149 -172.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -68.25 -44.4 75.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.011 0.434 . . . . 74.409999999999997 111.204 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 285' ' ' LEU . 4.3 mm? -67.25 -50.98 58.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 75.450000000000003 111.431 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -60.87 -40.54 93.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 72.109999999999999 111.193 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.64 -42.31 98.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 74.140000000000001 111.23 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -81.8 -15.72 53.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.614 -0.266 . . . . 75.120000000000005 111.674 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.6 m -72.89 -28.08 62.27 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.29 -0.256 . . . . 64.510000000000005 111.217 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 294' ' ' ASN . 3.9 t80 -128.69 86.63 57.06 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 74.420000000000002 110.518 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -94.91 24.93 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.389 2.726 . . . . 73.010000000000005 113.011 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -100.38 -166.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.376 -0.602 . . . . 71.510000000000005 109.376 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 31.0 mmtp -81.29 62.44 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.457 0.646 . . . . 75.540000000000006 111.583 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.506 HD22 HD11 ' A' ' 255' ' ' LEU . 38.7 t-20 -157.11 128.91 7.1 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.368 -1.345 . . . . 73.510000000000005 107.368 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -100.87 106.08 41.94 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.176 -0.209 . . . . 75.010000000000005 111.305 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 93.6 Cg_endo -93.6 38.17 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.899 2.399 . . . . 74.549999999999997 111.967 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -73.39 -42.34 42.06 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.077 -0.582 . . . . 72.510000000000005 111.972 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.458 ' OE2' HG13 ' A' ' 299' ' ' ILE . 1.3 pm0 -66.44 -35.84 81.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.19 . . . . 64.540000000000006 110.527 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.458 HG13 ' OE2' ' A' ' 298' ' ' GLU . 44.3 mt -67.79 -46.96 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 73.150000000000006 110.509 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 283' ' ' ALA . . . -60.67 -39.91 90.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 70.540000000000006 110.537 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 323' ' ' ILE . 85.3 tttt -80.58 -28.79 37.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 74.5 110.785 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.657 ' HH ' HD22 ' A' ' 247' ' ' LEU . 33.2 t80 -55.71 -50.2 70.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.207 0.527 . . . . 73.549999999999997 109.897 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.445 ' HA ' HG21 ' A' ' 306' ' ' VAL . 95.2 mmm -70.54 -34.57 72.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.598 -0.728 . . . . 73.219999999999999 110.711 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 282' ' ' ILE . 0.3 OUTLIER -61.67 -42.2 98.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.808 0.813 . . . . 73.0 109.384 175.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 59.9 m -61.81 -51.38 68.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.927 -1.033 . . . . 71.510000000000005 111.488 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.509 HG13 HD23 ' A' ' 244' ' ' LEU . 16.3 m -67.75 -27.85 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.494 -0.321 . . . . 73.450000000000003 111.582 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -25.54 33.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.871 0.367 . . . . 65.430000000000007 110.212 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 27.5 tp -86.96 -16.01 37.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 75.230000000000004 111.036 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 80.0 mt -68.97 -101.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.499 -0.319 . . . . 75.319999999999993 111.06 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 313' ' ' GLU . 24.3 t70 166.82 164.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.994 -0.743 . . . . 73.540000000000006 108.994 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.5 -37.04 85.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.976 0.417 . . . . 75.310000000000002 110.576 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.455 ' HA ' ' NH2' ' A' ' 240' ' ' ARG . 0.2 OUTLIER -105.99 -26.27 11.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.015 -0.539 . . . . 60.340000000000003 112.336 -171.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 310' ' ' ASP . 5.3 tp10 -92.83 112.51 24.5 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.277 0.843 . . . . 73.099999999999994 113.277 -168.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.517 ' HG2' ' OE1' ' A' ' 313' ' ' GLU . 39.8 mmtm 68.42 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 115.529 1.677 . . . . 73.349999999999994 115.529 162.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.877 ' HB3' ' HG2' ' A' ' 240' ' ' ARG . 94.7 Cg_endo -93.6 116.78 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.101 1.867 . . . . 73.109999999999999 109.02 156.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 320' ' ' LEU . 22.1 tp -126.04 98.48 5.52 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.125 -0.63 . . . . 73.450000000000003 111.111 -171.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.445 ' HD1' HD12 ' A' ' 162' ' ' LEU . 74.6 m-85 -64.63 -35.45 81.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.75 . . . . 74.430000000000007 110.735 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.36 -42.96 82.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.684 0.624 . . . . 75.230000000000004 112.684 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.524 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 26.5 t-20 -60.64 -43.72 97.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.109 0.48 . . . . 73.049999999999997 109.795 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.695 HD23 ' HG ' ' A' ' 244' ' ' LEU . 6.7 mp -69.11 -42.2 76.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.393 -0.821 . . . . 73.329999999999998 110.189 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -58.62 -49.48 77.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 74.549999999999997 110.347 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.25 -29.19 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 70.299999999999997 110.285 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.509 HD12 ' HD3' ' A' ' 301' ' ' LYS . 0.3 OUTLIER -63.91 -43.16 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 74.010000000000005 110.186 176.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 87.9 mt -70.11 -45.93 65.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 65.310000000000002 111.095 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 328' ' ' LEU . 4.5 mm? -64.28 -32.75 74.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 75.120000000000005 110.666 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.82 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.129999999999995 110.241 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -63.38 -33.26 86.75 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.888 -0.597 . . . . 75.010000000000005 112.217 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 334' ' ' LYS . 96.6 mt -69.82 -44.15 70.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.087 0.47 . . . . 73.239999999999995 110.263 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.56 -27.3 69.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 74.540000000000006 111.187 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.0 73.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.109999999999999 111.615 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.577 HD13 ' HG2' ' A' ' 151' ' ' ARG . 48.4 pt -97.04 -2.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 70.219999999999999 111.181 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.613 -0.803 . . . . 55.100000000000001 113.587 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.8 m -138.37 170.53 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.151 0.476 . . . . 64.010000000000005 110.553 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.478 ' O ' HD11 ' A' ' 328' ' ' LEU . 96.2 mttt -124.99 -85.64 0.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.024 -0.362 . . . . 71.349999999999994 110.024 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -127.12 150.73 49.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.59 -0.522 . . . . 73.519999999999996 109.59 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.01 -20.56 28.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.932 0.396 . . . . 63.439999999999998 110.672 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 92.4 -6.33 77.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.93 -0.652 . . . . 73.129999999999995 112.235 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 109.81 -0.441 . . . . 74.150000000000006 109.81 -178.322 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 109.979 -0.378 . . . . 64.230000000000004 109.979 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 13.5 t -176.01 164.18 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.056 -0.35 . . . . 53.5 110.056 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -67.14 142.02 17.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.885 0.374 . . . . 75.200000000000003 111.069 -176.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 6.2 t -94.78 76.0 3.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.85 0.833 . . . . 74.140000000000001 110.587 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 15.5 ptmt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 74.040000000000006 110.248 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.621 0.248 . . . . 72.430000000000007 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.6 1.56 57.65 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.983 -0.627 . . . . 73.150000000000006 112.47 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HG2' HG13 ' A' ' 39' ' ' VAL . 14.6 pt-20 -71.79 139.02 48.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.974 0.416 . . . . 74.310000000000002 109.982 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 38' ' ' LYS . 46.8 mm -88.34 116.18 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.434 -0.803 . . . . 74.420000000000002 110.342 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.416 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 33.5 pt -106.39 147.21 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.923 -0.581 . . . . 61.140000000000001 110.851 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.5 m -109.53 127.04 54.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.4 -0.818 . . . . 73.5 109.129 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 1.8 p-10 -131.26 -163.18 1.29 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.777 -0.369 . . . . 72.040000000000006 111.396 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.77 ' HA ' ' HE3' ' A' ' 32' ' ' MET . 18.8 mmt -63.23 -24.05 67.7 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 111.392 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . . . -81.02 21.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 53.439999999999998 109.947 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 38.9 mmtm 89.81 -38.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.763 1.225 . . . . 75.239999999999995 113.427 166.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.675 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 52.9 pttt 160.36 166.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.974 0.731 . . . . 75.209999999999994 112.974 -172.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.675 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 40.2 mt-10 73.85 50.57 0.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.967 1.469 . . . . 75.049999999999997 114.967 159.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.539 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 75.7 m95 -106.18 141.31 37.75 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.334 -0.988 . . . . 74.510000000000005 108.334 163.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 23.1 pttp -114.27 120.06 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.913 -0.773 . . . . 75.219999999999999 108.913 172.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' HG2' ' A' ' 27' ' ' GLU . 15.0 p -75.53 145.54 10.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.26 -0.427 . . . . 74.040000000000006 111.293 -172.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.48 -148.63 23.81 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.948 -0.569 . . . . 64.540000000000006 112.444 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.4 153.3 81.67 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.578 0.227 . . . . 73.439999999999998 111.176 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.61 135.6 24.29 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.11 2.54 . . . . 75.129999999999995 111.748 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -108.48 -58.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.016 0.436 . . . . 74.150000000000006 110.33 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 161.58 37.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.868 -0.682 . . . . 73.310000000000002 112.38 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.635 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 33.2 tt0 -139.51 159.95 40.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.587 -0.524 . . . . 71.140000000000001 109.587 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 45' ' ' GLN . . . -76.05 -34.06 48.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.001 -0.618 . . . . 73.340000000000003 112.033 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.28 -85.04 0.79 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.983 -0.847 . . . . 73.209999999999994 110.983 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 197' ' ' ASP . 31.6 m-85 -98.55 94.17 6.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.329 -0.619 . . . . 64.239999999999995 109.329 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.635 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -73.26 -162.04 6.95 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.05 -0.523 . . . . 72.549999999999997 113.56 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.92 31.82 13.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.15 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.82 134.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.818 -0.628 . . . . 75.450000000000003 109.829 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -107.8 159.16 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.774 0.321 . . . . 75.329999999999998 110.625 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 69' ' ' VAL . 37.3 tp -81.65 133.38 35.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.463 -0.569 . . . . 73.439999999999998 109.463 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 103.13 15.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.984 0.421 . . . . 74.400000000000006 110.503 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.56 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 6.8 t70 -96.32 -175.57 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.541 -0.911 . . . . 74.439999999999998 108.541 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 37' ' ' TRP . 71.7 mtm -136.74 152.55 50.47 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.175 -0.328 . . . . 63.130000000000003 110.875 -171.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -125.69 -60.5 1.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.556 -0.293 . . . . 74.120000000000005 110.42 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -120.16 38.67 3.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.115 0.483 . . . . 73.420000000000002 110.498 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.305 -0.628 . . . . 74.530000000000001 109.305 176.288 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 133' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.366 -0.975 . . . . 51.130000000000003 108.366 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.61 9.54 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.259 1.973 . . . . 71.219999999999999 112.462 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.1 p -162.01 151.38 15.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.554 0.692 . . . . 72.340000000000003 112.668 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 53' ' ' LEU . 35.8 m -127.09 165.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.207 -1.034 . . . . 54.43 108.207 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.27 120.45 51.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.409 0.623 . . . . 73.310000000000002 111.574 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -79.71 119.0 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 72.209999999999994 108.877 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.37 120.14 61.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.763 0.316 . . . . 75.340000000000003 110.515 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -136.52 156.9 76.13 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.336 -0.616 . . . . 73.510000000000005 109.336 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.12 147.01 92.47 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.921 1.748 . . . . 75.209999999999994 110.978 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 66.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.095 0.474 . . . . 74.519999999999996 110.097 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -151.99 -40.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 63.409999999999997 110.708 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.533 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 65.7 t30 -63.91 123.49 19.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.008 -0.542 . . . . 74.409999999999997 111.878 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.26 -54.07 36.61 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.643 -0.708 . . . . 63.420000000000002 113.829 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 91.3 Cg_exo -46.95 -37.93 22.88 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.082 2.521 . . . . 75.510000000000005 113.344 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.35 -50.97 71.93 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.928 -0.397 . . . . 74.400000000000006 109.928 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -60.31 -40.26 89.92 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.571 0.701 . . . . 71.109999999999999 110.701 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.1 m -71.34 -47.09 58.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 74.209999999999994 111.579 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.53 -36.18 78.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.797 -0.446 . . . . 72.319999999999993 109.797 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.407 HD13 ' HE3' ' A' ' 129' ' ' MET . 62.8 tp -60.86 -38.43 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 72.349999999999994 110.58 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HA ' ' HG3' ' A' ' 88' ' ' GLN . 6.1 ttpp -70.54 -31.54 68.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.864 0.364 . . . . 64.409999999999997 110.425 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.43 -32.55 71.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.869 -0.332 . . . . 73.530000000000001 110.584 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -65.88 -50.1 65.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 110.403 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -68.31 -16.05 63.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.677 0.275 . . . . 72.140000000000001 111.098 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.54 -68.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.947 0.351 . . . . 72.319999999999993 111.947 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.47 -34.41 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.011 0.745 . . . . 73.409999999999997 113.011 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.92 88.66 4.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.667 0.746 . . . . 62.420000000000002 110.583 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.643 ' HB2' ' HZ2' ' A' ' 92' ' ' LYS . 4.7 ttmp? -168.96 129.82 1.05 Allowed Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.04 -0.982 . . . . 74.140000000000001 109.452 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.44 -51.47 7.9 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.331 2.687 . . . . 73.230000000000004 113.397 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 34.4 mt-10 -63.74 -45.06 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 111.901 0.334 . . . . 74.109999999999999 111.901 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -62.94 -47.91 81.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.682 0.277 . . . . 72.319999999999993 110.908 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 100' ' ' ILE . 69.8 mt -59.27 -47.47 90.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 73.430000000000007 110.0 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -54.81 -47.7 73.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.194 -0.912 . . . . 72.530000000000001 111.115 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 58.3 mtpt -61.81 -46.2 90.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 73.239999999999995 111.56 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.622 ' CZ3' HD13 ' A' ' 108' ' ' LEU . 44.7 t90 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.822 -0.351 . . . . 73.450000000000003 110.82 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 96' ' ' ILE . 30.5 mm -60.5 -37.94 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 64.129999999999995 111.357 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -75.96 -34.3 59.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.42 -0.355 . . . . 72.340000000000003 111.459 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.9 m -76.85 -48.68 17.71 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.898 0.38 . . . . 75.540000000000006 111.516 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 103' ' ' ARG . 5.6 tpm_? -76.64 -18.87 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.286 -0.416 . . . . 75.329999999999998 110.609 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? 64.74 78.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.822 0.82 . . . . 74.099999999999994 109.971 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.0 mt -138.64 -167.96 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.117 -0.947 . . . . 73.239999999999995 109.845 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -106.38 -50.86 3.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.777 -0.369 . . . . 75.409999999999997 110.964 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -153.4 146.76 24.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.681 0.277 . . . . 65.239999999999995 110.416 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.622 HD13 ' CZ3' ' A' ' 99' ' ' TRP . 46.4 tp -97.95 133.59 42.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 75.349999999999994 110.428 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.7 58.54 4.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 51.020000000000003 112.492 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -111.33 137.55 21.09 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.251 -0.648 . . . . 75.329999999999998 109.251 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.458 ' HA ' ' CD2' ' A' ' 194' ' ' TYR . 7.9 Cg_endo -50.5 134.5 39.42 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.564 2.176 . . . . 72.230000000000004 112.782 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.999 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.8 tptm -73.66 126.97 31.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 73.209999999999994 110.331 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.46 134.18 55.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.697 -0.683 . . . . 73.420000000000002 110.245 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.494 ' CD1' HG21 ' A' ' 130' ' ' ILE . 40.0 m95 -107.27 -75.16 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.418 0.627 . . . . 73.129999999999995 110.055 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.48 -168.18 12.02 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.281 -0.872 . . . . 42.210000000000001 111.458 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 32' ' ' MET . 66.6 p -175.32 173.01 2.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.184 -0.302 . . . . 73.430000000000007 110.184 -175.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.07 -170.54 42.55 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.81 -0.71 . . . . 72.0 112.226 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -122.0 132.17 54.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.181 -0.674 . . . . 63.140000000000001 109.181 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -148.65 123.19 9.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.636 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.82 145.36 52.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.708 -0.849 . . . . 73.409999999999997 108.708 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -143.82 18.42 1.81 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.126 -0.629 . . . . 74.540000000000006 112.151 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -179.67 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.179 0.514 . . . . 72.030000000000001 111.616 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.44 14.91 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.91 -1.676 . . . . 62.350000000000001 108.91 -166.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 1.4 tpmt? -146.09 124.97 12.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.807 -1.197 . . . . 74.319999999999993 108.279 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.448 ' HB3' HD23 ' A' ' 118' ' ' LEU . 18.4 m -75.63 105.1 6.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.91 0.386 . . . . 75.409999999999997 110.372 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.38 144.75 25.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.075 -0.511 . . . . 73.420000000000002 109.671 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -113.34 125.7 54.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.106 -1.072 . . . . 75.540000000000006 108.106 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -121.12 148.41 44.24 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.159 0.504 . . . . 72.349999999999994 111.064 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.407 ' HE3' HD13 ' A' ' 84' ' ' LEU . 23.5 ptp -135.26 134.83 40.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.226 -0.897 . . . . 72.430000000000007 109.304 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.494 HG21 ' CD1' ' A' ' 114' ' ' TRP . 19.1 mt -96.73 123.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.32 0.581 . . . . 74.409999999999997 110.137 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 11.8 ptm -128.67 -179.16 4.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.84 -1.073 . . . . 72.340000000000003 110.417 -172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.999 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 31.6 t70 -68.92 156.19 38.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.36 . . . . 63.109999999999999 111.346 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.594 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 2.4 tmt_? -89.32 106.94 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 72.340000000000003 110.732 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 132' ' ' ASP . 19.2 m-85 -102.21 172.24 7.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.689 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.45 -37.5 0.02 OUTLIER Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.693 -0.765 . . . . 74.140000000000001 112.706 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.7 m -121.55 142.07 50.44 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.809 -0.23 . . . . 74.430000000000007 111.036 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -124.65 176.69 6.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.642 0.258 . . . . 74.200000000000003 110.807 176.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 183' ' ' LEU . 5.3 mp -77.63 -27.9 51.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.346 0.499 . . . . 75.530000000000001 112.346 -177.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.4 ' OE1' ' HB3' ' A' ' 181' ' ' SER . 23.5 tt0 -75.39 -34.41 61.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.57 -0.452 . . . . 75.129999999999995 111.274 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 45.6 tptt -68.7 -38.43 80.29 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 73.5 110.117 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.466 HD13 ' O ' ' A' ' 137' ' ' ASP . 1.8 mp -68.18 -38.84 80.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 75.209999999999994 109.763 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.512 ' HH ' ' NE2' ' A' ' 253' ' ' GLN . 39.9 t80 -55.18 -43.09 74.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.493 -0.776 . . . . 74.329999999999998 110.425 174.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.46 -50.37 18.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.804 -0.634 . . . . 73.519999999999996 110.904 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.77 73.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.383 0.512 . . . . 71.409999999999997 112.383 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.61 0.79 39.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 75.230000000000004 110.647 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.511 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 56.53 75.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.896 -0.593 . . . . 54.350000000000001 111.923 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER 29.71 77.13 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.043 1.337 . . . . 74.239999999999995 114.132 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -160.28 105.7 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.64 -0.709 . . . . 71.129999999999995 109.092 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 49.9 m-85 -110.1 155.73 21.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 75.129999999999995 111.101 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -78.49 155.52 29.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.92 -0.582 . . . . 73.239999999999995 110.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -57.8 -38.85 76.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 74.239999999999995 110.642 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.56 -45.87 88.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 72.540000000000006 110.494 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.8 m -66.54 -52.37 46.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.827 -0.624 . . . . 72.329999999999998 110.948 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.7 t -60.24 -47.26 92.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.138 -0.483 . . . . 71.530000000000001 111.648 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.55 -37.87 80.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 75.140000000000001 110.762 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.835 HE21 ' HB2' ' A' ' 335' ' ' ASP . 30.2 mm-40 -60.22 -47.53 85.57 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.695 0.283 . . . . 75.019999999999996 110.61 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 153' ' ' THR . 81.9 mt -58.11 -50.51 73.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 70.439999999999998 110.131 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.558 ' HA ' HD12 ' A' ' 247' ' ' LEU . 25.2 t -58.18 -47.44 83.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.891 -0.595 . . . . 65.0 110.94 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 325' ' ' LEU . 0.7 OUTLIER -64.74 -52.64 55.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 73.329999999999998 111.083 -176.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.434 ' NH1' HD23 ' A' ' 159' ' ' LEU . 13.6 mmt180 -72.51 -30.11 64.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 70.319999999999993 111.348 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.592 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -71.09 -30.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.818 -0.438 . . . . 74.530000000000001 109.818 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.45 -43.84 76.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.943 -0.391 . . . . 75.310000000000002 109.943 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.549 ' HB3' ' HH2' ' A' ' 99' ' ' TRP . 72.7 m-20 -58.53 -55.22 37.89 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.683 0.754 . . . . 72.140000000000001 110.432 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.586 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -63.19 -34.79 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 70.129999999999995 110.378 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.719 ' O ' ' HB3' ' A' ' 169' ' ' HIS . 6.3 tt -56.44 -37.93 70.92 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.577 -0.283 . . . . 73.340000000000003 110.318 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -57.29 -59.56 4.94 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.112 -0.699 . . . . 73.530000000000001 109.112 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.46 -28.19 66.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.967 -1.469 . . . . 74.540000000000006 113.501 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.0 pt -108.9 -48.18 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.908 0.707 . . . . 75.230000000000004 112.908 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.719 ' HB3' ' O ' ' A' ' 165' ' ' LEU . 7.0 t60 -59.87 -47.66 84.84 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.998 0.186 . . . . 75.109999999999999 110.85 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.689 ' HG3' ' HD2' ' A' ' 169' ' ' HIS . 21.1 mt-10 -106.47 80.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.978 0.894 . . . . 75.310000000000002 109.404 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -175.35 -44.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.481 -1.69 . . . . 74.319999999999993 109.128 -170.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 45.2 tt0 -162.61 -72.62 0.05 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.938 -0.573 . . . . 74.530000000000001 111.403 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.631 ' CD1' ' HA ' ' A' ' 203' ' ' ARG . 21.9 m-85 -122.79 155.21 37.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.187 0.518 . . . . 64.310000000000002 111.388 -174.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 204' ' ' TYR . 31.0 m -97.37 167.29 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 73.209999999999994 109.431 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.554 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . 2.9 m-70 -114.3 -85.77 0.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.862 -0.335 . . . . 73.310000000000002 111.558 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.96 6.45 85.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.683 -0.77 . . . . 52.0 111.38 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.771 ' HB3' ' HB2' ' A' ' 200' ' ' LEU . 17.8 p-10 -89.66 28.39 1.32 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 73.340000000000003 111.077 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.447 ' HB ' HG22 ' A' ' 246' ' ' ILE . 46.2 mm -75.6 97.45 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.314 0.578 . . . . 73.530000000000001 110.527 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.871 ' HZ2' ' HB3' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -157.3 165.04 36.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.461 -0.791 . . . . 75.430000000000007 109.502 172.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.44 -23.56 64.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.967 0.729 . . . . 74.409999999999997 112.967 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 139' ' ' GLN . 67.7 p -75.51 -18.59 59.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.837 0.31 . . . . 71.549999999999997 111.837 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 177' ' ' ASP . 2.6 m-20 -97.44 -26.94 14.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 111.891 0.33 . . . . 73.349999999999994 111.891 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 138' ' ' LEU . 6.3 mp -95.69 118.38 32.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.11 0.481 . . . . 72.140000000000001 110.407 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -133.81 158.67 42.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.565 -0.743 . . . . 75.409999999999997 110.88 177.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 11.7 mt -103.55 157.59 16.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.906 -0.588 . . . . 72.150000000000006 109.601 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.866 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 23.8 t-20 -65.62 142.31 58.1 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.618 -0.882 . . . . 73.209999999999994 108.618 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.594 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 2.5 p90 -60.58 -22.24 63.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.964 0.357 . . . . 72.219999999999999 111.964 -173.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -124.25 6.23 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.293 0.568 . . . . 74.120000000000005 110.261 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.866 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 47.6 t-20 -139.87 101.92 7.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.892 -0.595 . . . . 72.349999999999994 109.835 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.48 -20.47 5.8 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.832 2.355 . . . . 75.019999999999996 113.716 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.47 1.62 57.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.953 0.406 . . . . 62.329999999999998 111.257 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.54 107.55 15.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.994 0.426 . . . . 74.349999999999994 110.437 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.33 142.12 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 73.120000000000005 109.937 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.458 ' CD2' ' HA ' ' A' ' 111' ' ' PRO . 44.1 m-85 -127.04 157.49 39.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.302 . . . . 74.049999999999997 110.732 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.7 mt -96.49 129.91 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.258 -0.428 . . . . 75.329999999999998 110.479 174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 184' ' ' LEU . 34.2 m -135.79 177.49 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 65.439999999999998 110.225 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.488 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 53.5 t0 59.8 66.73 0.95 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.6 0.714 . . . . 75.230000000000004 109.287 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -75.38 67.52 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.16 -0.927 . . . . 74.420000000000002 111.078 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 352' ' ' LYS . . . -93.52 1.87 69.74 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.464 -0.789 . . . . 71.540000000000006 111.651 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.771 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 77.8 mt -138.19 94.35 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.56 0.695 . . . . 72.450000000000003 110.587 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -155.0 115.8 3.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.725 -1.125 . . . . 74.299999999999997 108.921 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -132.38 160.61 35.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.635 -0.257 . . . . 75.049999999999997 110.699 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.631 ' HA ' ' CD1' ' A' ' 173' ' ' TYR . 5.4 ptp180 -62.52 149.36 43.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 111.144 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.469 ' HD2' ' HG ' ' A' ' 205' ' ' CYS . 42.1 t80 -149.86 -56.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 73.129999999999995 110.534 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HG ' ' HD2' ' A' ' 204' ' ' TYR . 5.8 p -148.34 72.08 10.93 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 73.430000000000007 111.534 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.76 142.67 4.89 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.989 2.459 . . . . 73.030000000000001 111.853 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 66.25 9.48 6.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 73.5 111.726 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.86 67.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.04 -0.6 . . . . 52.32 112.299 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 61.9 t -96.42 117.44 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.537 0.208 . . . . 70.239999999999995 110.49 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -100.23 145.86 27.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.853 -0.425 . . . . 71.0 109.853 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -114.97 152.58 32.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.303 -0.408 . . . . 75.150000000000006 110.413 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.39 173.98 11.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.483 -0.562 . . . . 75.239999999999995 109.483 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.46 ' HB2' HG22 ' A' ' 236' ' ' VAL . 19.4 p90 -79.19 74.03 5.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.665 1.222 . . . . 75.219999999999999 110.223 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -154.91 92.97 1.5 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.055 -1.43 . . . . 72.439999999999998 108.49 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 2.7 mm-40 -122.61 -98.5 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.251 0.834 . . . . 71.25 113.251 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.49 119.26 61.92 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.411 -0.359 . . . . 73.25 111.664 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 N--CA 1.462 -0.358 0 C-N-CA 122.769 2.313 . . . . 73.140000000000001 112.379 177.793 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.408 ' OD2' ' HB ' ' A' ' 355' ' ' THR . 19.0 p-10 . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 110.849 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -77.04 177.34 52.45 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.687 -0.768 . . . . 72.519999999999996 111.361 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -73.26 129.69 38.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.248 0.547 . . . . 75.430000000000007 111.667 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 271' ' ' VAL . 47.7 mm -54.17 -31.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.342 -0.845 . . . . 72.340000000000003 112.336 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.476 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -56.92 -69.46 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.277 -0.42 . . . . 72.25 111.566 -179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.449 ' HB3' HG21 ' A' ' 246' ' ' ILE . 94.6 m-85 -112.48 49.34 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.107 0.41 . . . . 72.420000000000002 112.107 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -18.18 35.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.629 0.252 . . . . 73.200000000000003 111.519 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.4 m 52.48 -162.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.891 -0.595 . . . . 73.120000000000005 111.159 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.2 mp -72.83 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.711 0.291 . . . . 74.109999999999999 110.507 177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 238' ' ' PRO . 1.3 m-20 -51.44 -70.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.159 -0.928 . . . . 74.340000000000003 112.468 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.22 70.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 71.400000000000006 111.383 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.32 -28.79 68.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.034 -0.53 . . . . 73.219999999999999 110.767 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.15 -30.62 16.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 110.859 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.57 6.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.668 -0.777 . . . . 70.540000000000006 111.625 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.589 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 9.1 p -120.49 141.55 40.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.236 -0.283 . . . . 75.219999999999999 110.236 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.71 124.69 58.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 71.230000000000004 110.778 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.572 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 91.0 Cg_exo -46.63 106.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 72.140000000000001 112.418 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.574 ' HB3' HG23 ' A' ' 312' ' ' THR . 36.4 m -92.04 42.26 1.1 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.148 -0.933 . . . . 71.010000000000005 110.928 -172.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 239' ' ' SER . 66.0 mtt180 85.29 -28.69 0.08 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.075 0.95 . . . . 70.150000000000006 111.159 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 311' ' ' TYR . 9.4 mmm180 -59.13 -61.39 2.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.542 0.21 . . . . 72.310000000000002 110.921 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -49.18 -55.36 12.45 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 115.724 -0.671 . . . . 73.209999999999994 113.219 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.463 ' HB3' HD12 ' A' ' 165' ' ' LEU . 3.3 m-20 -52.72 -54.56 32.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.98 0.419 . . . . 72.340000000000003 111.176 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 240' ' ' ARG . 11.2 mp -64.92 -45.93 83.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 74.040000000000006 111.391 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.46 -38.57 84.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.075 -0.25 . . . . 72.239999999999995 111.593 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 227' ' ' PHE . 84.2 mt -59.13 -44.0 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 74.129999999999995 110.482 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 158' ' ' SER . 33.2 tp -61.57 -42.63 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.010000000000005 110.293 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.63 95.86 Favored Glycine 0 C--O 1.236 0.271 0 C-N-CA 120.907 -0.663 . . . . 73.140000000000001 112.227 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -58.79 -49.16 78.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.649 0.261 . . . . 72.140000000000001 111.279 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 28.5 p -66.43 -36.79 83.68 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 73.310000000000002 111.453 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 72.5 mtm -60.65 -51.75 68.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 111.023 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 299' ' ' ILE . 15.4 tt -67.38 -30.23 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.582 -0.447 . . . . 75.409999999999997 110.694 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.523 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 35.0 tt0 -67.91 -44.95 75.74 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.532 0.206 . . . . 72.530000000000001 110.584 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 22.7 m0 -65.4 -29.15 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 75.230000000000004 110.902 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -81.04 -35.71 31.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 112.003 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 62.5 p -103.37 -27.93 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.858 -0.337 . . . . 75.430000000000007 111.74 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.36 17.09 65.18 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.865 -0.683 . . . . 52.340000000000003 112.982 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -155.6 144.17 20.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.128 0.464 . . . . 73.430000000000007 111.145 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 29.3 mt -108.95 138.84 20.46 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 75.5 109.825 171.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 48.3 Cg_exo -58.03 -28.33 82.88 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.867 2.378 . . . . 74.030000000000001 112.57 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -108.22 11.72 27.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 74.150000000000006 111.375 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 38.4 tt0 -75.56 -39.37 58.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 71.510000000000005 110.36 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.45 -29.15 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.69 0.757 . . . . 71.519999999999996 109.864 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -108.04 19.75 19.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.138 -0.937 . . . . 73.519999999999996 110.689 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 262' ' ' GLU . 1.8 tt -75.93 73.29 2.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.825 0.821 . . . . 73.239999999999995 110.362 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -147.52 -63.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.544 -1.207 . . . . 72.019999999999996 109.817 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.738 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 12.1 t70 -91.33 135.27 28.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.245 -0.888 . . . . 73.25 111.431 -173.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -58.23 -27.11 79.43 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.498 2.799 . . . . 75.549999999999997 114.331 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 269' ' ' LYS . 1.8 mppt? -82.72 -40.07 21.09 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.605 -0.438 . . . . 73.040000000000006 110.542 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.738 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 37.0 m-85 -60.93 -49.19 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 73.319999999999993 110.704 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 225' ' ' ILE . 33.8 m -66.6 -31.71 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.816 -0.354 . . . . 65.530000000000001 110.663 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -58.58 -56.67 19.17 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.087 0.47 . . . . 75.030000000000001 110.352 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.85 -43.47 79.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.474 -0.785 . . . . 74.409999999999997 111.038 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 41.7 m -60.34 -41.2 93.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 74.019999999999996 111.501 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.36 -48.29 70.66 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.114 -0.235 . . . . 73.409999999999997 110.615 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.46 -40.68 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 72.349999999999994 111.03 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -56.13 -51.02 69.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.647 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 33.4 m-85 -74.45 -36.05 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 74.5 111.12 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.517 ' HD2' HH22 ' A' ' 241' ' ' ARG . 26.2 ttp180 -57.23 -31.95 66.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.538 . . . . 64.340000000000003 111.28 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.5 -23.22 50.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.108 -0.496 . . . . 62.229999999999997 111.063 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -127.98 30.43 5.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.581 -0.281 . . . . 74.150000000000006 110.779 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 279' ' ' ARG . 0.2 OUTLIER -47.95 -42.28 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.04 1.126 . . . . 74.040000000000006 114.04 -171.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.414 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.16 -50.51 73.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.423 0.527 . . . . 71.430000000000007 112.423 -169.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 t -78.08 -36.21 48.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.834 0.35 . . . . 74.219999999999999 110.313 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 278' ' ' TYR . 89.9 mt -71.95 -44.8 62.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 70.25 111.372 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.45 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -72.02 -40.6 68.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.639 -0.255 . . . . 71.349999999999994 110.946 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.79 -35.41 80.51 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.145 0.497 . . . . 63.530000000000001 111.046 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 288' ' ' LYS . 28.5 ttmt -99.76 7.63 44.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.774 -0.648 . . . . 73.530000000000001 110.658 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 47.0 t -75.95 -22.95 55.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.203 0.525 . . . . 75.530000000000001 110.048 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 33.6 t80 -127.35 77.39 75.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.546 -0.909 . . . . 74.219999999999999 108.546 173.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.85 12.07 2.76 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.895 2.397 . . . . 75.519999999999996 113.364 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 4.0 mp0 -71.11 -99.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.661 -0.496 . . . . 71.420000000000002 109.661 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -161.52 79.13 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.334 0.588 . . . . 75.329999999999998 110.771 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.5 t-20 -150.3 162.92 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.035 -1.098 . . . . 75.010000000000005 108.035 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.85 103.87 43.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 111.905 0.335 . . . . 75.409999999999997 111.905 -175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 85.1 Cg_endo -98.26 37.81 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.011 2.474 . . . . 60.310000000000002 111.207 173.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -74.02 -43.71 32.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.628 -0.714 . . . . 75.200000000000003 111.942 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.4 mp0 -53.39 -51.15 63.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.212 0.53 . . . . 72.019999999999996 109.849 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 252' ' ' ILE . 20.7 mt -62.09 -50.93 78.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.281 -0.872 . . . . 75.319999999999993 111.4 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 70.549999999999997 111.149 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.77 -28.54 40.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 110.489 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.405 ' HE1' ' O ' ' A' ' 244' ' ' LEU . 52.1 t80 -60.74 -42.64 97.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.287 -0.634 . . . . 75.140000000000001 109.287 172.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 306' ' ' VAL . 66.3 mtp -72.71 -36.16 67.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.541 -0.754 . . . . 74.450000000000003 110.809 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -55.93 -46.42 78.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 109.342 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 91.3 m -57.33 -52.28 65.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.713 -1.131 . . . . 70.25 111.611 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 303' ' ' MET . 22.9 m -67.45 -31.63 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 111.78 0.289 . . . . 65.420000000000002 111.78 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -70.32 -48.81 54.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.095 0.474 . . . . 73.430000000000007 110.808 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 17.5 tp -82.73 -3.03 55.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 63.32 110.481 -175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 6.9 tt -67.65 -76.7 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.314 -0.857 . . . . 75.230000000000004 110.315 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.56 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 8.1 t70 162.19 -152.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.134 -1.432 . . . . 71.209999999999994 107.134 -176.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.575 ' O ' ' HG2' ' A' ' 241' ' ' ARG . 20.4 t80 -105.03 -39.97 6.06 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.938 -0.393 . . . . 74.439999999999998 109.938 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.574 HG23 ' HB3' ' A' ' 239' ' ' SER . 1.6 m -138.4 5.51 2.48 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.683 0.623 . . . . 60.310000000000002 112.683 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.22 -89.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.556 1.317 . . . . 73.439999999999998 114.556 -167.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 314' ' ' LYS . 13.2 tppt? -109.09 107.42 59.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 113.165 0.802 . . . . 74.129999999999995 113.165 -161.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.487 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 68.7 Cg_endo -88.73 119.82 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.618 2.212 . . . . 64.209999999999994 112.034 169.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.2 mt -118.84 85.55 2.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.268 0.556 . . . . 65.230000000000004 109.786 176.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 315' ' ' PRO . 80.7 m-85 -67.98 -34.97 77.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.704 -0.68 . . . . 72.319999999999993 111.964 -172.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -29.53 46.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.902 -0.319 . . . . 72.25 110.904 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.62 -48.71 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.889 -0.411 . . . . 75.010000000000005 109.889 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 85.9 mt -58.4 -43.61 88.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.617 -0.72 . . . . 74.239999999999995 110.485 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.425 ' O ' HD22 ' A' ' 325' ' ' LEU . 7.4 mtp180 -64.21 -33.36 75.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 73.439999999999998 111.12 177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.44 -46.16 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.275 0.472 . . . . 75.109999999999999 112.275 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 320' ' ' LEU . 0.3 OUTLIER -72.45 -27.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 119.474 -0.89 . . . . 63.119999999999997 110.414 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.13 -49.04 75.96 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.492 -0.559 . . . . 73.019999999999996 109.492 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.522 ' O ' ' HG2' ' A' ' 329' ' ' LYS . 4.0 mm? -67.59 -26.91 66.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 73.450000000000003 111.002 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . 0.647 ' HA ' ' HE2' ' A' ' 329' ' ' LYS . 20.2 tp60 -59.52 -49.01 79.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 73.019999999999996 110.427 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.91 -38.55 94.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.248 -0.977 . . . . 70.420000000000002 111.298 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.941 HD11 ' HA ' ' A' ' 334' ' ' LYS . 3.0 tm? -57.21 -50.35 73.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.181 -0.51 . . . . 72.120000000000005 111.043 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 326' ' ' GLN . 54.8 pttt -81.15 -17.48 49.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.759 0.281 . . . . 75.400000000000006 111.759 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.76 63.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 73.230000000000004 110.894 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -77.46 -6.95 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.206 0.527 . . . . 71.140000000000001 110.626 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 89.67 12.27 62.76 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.856 -0.688 . . . . 74.140000000000001 112.887 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 170.37 8.69 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.043 -0.354 . . . . 70.430000000000007 110.043 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.941 ' HA ' HD11 ' A' ' 328' ' ' LEU . 77.6 tttt -146.28 156.56 43.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.541 . . . . 75.25 109.538 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.835 ' HB2' HE21 ' A' ' 156' ' ' GLN . 6.9 p-10 -87.65 126.64 35.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.166 0.508 . . . . 64.519999999999996 110.142 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -104.3 -24.18 13.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 62.509999999999998 110.862 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 85.39 -1.96 88.25 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.172 -0.537 . . . . 64.219999999999999 112.42 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.613 0.207 . . . . 75.230000000000004 110.803 -175.294 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.697 ' HB2' ' HA3' ' A' ' 199' ' ' GLY . 3.9 mppt? . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.756 0.312 . . . . 74.349999999999994 110.549 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.7 t -134.3 132.47 39.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.29 -0.413 . . . . 73.439999999999998 110.562 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.707 HG13 ' HD3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -84.69 142.7 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 72.299999999999997 110.782 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' THR . . . . . 0.408 ' HB ' ' OD2' ' A' ' 222' ' ' ASP . 4.9 t -79.54 81.77 5.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.038 0.923 . . . . 72.200000000000003 110.045 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.707 ' HD3' HG13 ' A' ' 354' ' ' ILE . 10.5 mtpm? . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.439 -0.8 . . . . 71.219999999999999 110.509 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.232 0.164 0 N-CA-C 110.298 -0.26 . . . . 74.549999999999997 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.87 57.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.88 -0.676 . . . . 74.299999999999997 112.73 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.03 167.56 12.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.315 0.578 . . . . 73.450000000000003 111.527 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.92 131.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.144 -0.935 . . . . 64.329999999999998 111.249 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -105.77 136.81 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 72.549999999999997 109.427 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.5 m -93.83 113.95 26.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.134 0.42 . . . . 74.140000000000001 112.134 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 14.4 t70 -72.65 154.77 40.58 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.636 -0.711 . . . . 64.219999999999999 110.06 174.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.646 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 52.3 tpp -70.63 -30.36 66.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.879 0.371 . . . . 75.239999999999995 110.971 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.82 18.48 3.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.203 -0.453 . . . . 71.519999999999996 110.052 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 61.29 77.71 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.062 -0.972 . . . . 74.439999999999998 110.032 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 45.4 mmtm -140.52 115.48 9.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.972 -1.013 . . . . 73.439999999999998 109.139 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.74 111.55 17.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.245 -0.434 . . . . 51.229999999999997 110.228 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.89 163.15 13.54 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.95 -0.759 . . . . 75.319999999999993 108.95 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 56' ' ' MET . 21.7 ttpt -114.6 129.49 56.68 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.654 -0.418 . . . . 75.430000000000007 110.25 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -75.89 104.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.071 0.462 . . . . 73.209999999999994 109.9 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.22 -104.54 2.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.442 -0.885 . . . . 73.310000000000002 113.246 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 mm? -86.29 127.71 60.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.043 0.449 . . . . 70.120000000000005 111.471 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.3 Cg_exo -78.74 106.25 2.08 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.106 2.537 . . . . 70.519999999999996 111.77 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -81.28 -37.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 110.17 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 87.53 -45.44 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.829 -0.7 . . . . 65.010000000000005 112.696 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLY . 26.2 tp60 -103.23 165.63 10.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.596 -0.52 . . . . 72.120000000000005 109.596 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.614 ' O ' ' HE2' ' A' ' 71' ' ' LYS . . . 98.77 13.36 40.73 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.445 -1.462 . . . . 74.150000000000006 109.445 -168.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.845 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -168.24 -164.4 23.87 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 114.325 -0.938 . . . . 73.019999999999996 111.169 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -102.92 8.72 39.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.764 0.316 . . . . 74.420000000000002 111.625 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.03 -76.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.329 -0.939 . . . . 63.240000000000002 113.182 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . 0.613 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 84.6 m -150.18 110.43 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 73.099999999999994 109.964 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.845 HD12 ' HA3' ' A' ' 47' ' ' GLY . 30.3 mm -100.31 137.83 26.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.073 -0.512 . . . . 74.349999999999994 110.62 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -110.07 145.15 37.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 74.299999999999997 110.616 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.424 ' HA ' HG11 ' A' ' 69' ' ' VAL . 9.7 tt -91.16 138.27 31.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.421 -0.585 . . . . 75.219999999999999 109.421 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.18 96.23 5.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 73.340000000000003 110.945 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.13 -32.4 19.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 71.209999999999994 110.444 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.59 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 9.2 tpt 62.27 34.85 15.65 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.658 -0.701 . . . . 74.010000000000005 111.465 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.5 t30 74.07 121.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.573 0.701 . . . . 72.430000000000007 111.831 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 m -71.11 108.95 4.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.592 -0.731 . . . . 72.420000000000002 110.572 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.848 -0.615 . . . . 62.43 111.051 -177.871 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.196 0.522 . . . . 61.119999999999997 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 4.0 Cg_exo -79.87 40.72 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.294 2.663 . . . . 74.450000000000003 112.341 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 131' ' ' MET . 2.2 p -140.71 137.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.398 0.618 . . . . 70.209999999999994 111.931 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 53' ' ' LEU . 30.9 m -137.87 161.85 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.312 -0.858 . . . . 73.319999999999993 108.971 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -123.59 122.29 64.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.482 0.658 . . . . 73.239999999999995 112.371 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.824 ' HA ' HD11 ' A' ' 51' ' ' ILE . 36.9 ttmt -89.6 122.19 32.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.741 -1.118 . . . . 75.239999999999995 109.297 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 128' ' ' PHE . 35.7 m -115.91 139.16 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.03 0.382 . . . . 72.409999999999997 112.03 -175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 6.6 mm-40 -148.91 139.44 13.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 74.439999999999998 109.823 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 25.2 Cg_exo -63.1 150.94 87.18 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.942 2.428 . . . . 72.200000000000003 112.324 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 m -73.06 66.83 0.85 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.301 0.572 . . . . 54.420000000000002 112.068 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -113.61 -6.44 13.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.52 -1.289 . . . . 72.409999999999997 107.52 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 90.69 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 113.987 -1.46 . . . . 63.420000000000002 111.391 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.43 -139.66 5.72 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.441 -0.8 . . . . 61.210000000000001 111.5 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HG3' HG22 ' A' ' 353' ' ' THR . 28.0 Cg_exo -61.59 -22.93 75.66 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.057 2.505 . . . . 74.420000000000002 112.175 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -56.81 -34.74 67.99 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.743 -0.662 . . . . 74.140000000000001 110.294 178.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.19 -41.43 85.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 73.319999999999993 110.43 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.2 m -65.59 -41.76 92.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.235 -0.439 . . . . 73.040000000000006 110.348 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -58.31 -45.99 86.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.694 . . . . 73.430000000000007 110.425 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -67.48 -33.69 75.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 74.340000000000003 111.128 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.434 ' HE3' ' HE1' ' A' ' 173' ' ' TYR . 6.2 tmtm? -64.19 -45.18 89.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.351 -0.611 . . . . 74.340000000000003 109.351 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -65.26 -41.5 94.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 73.409999999999997 110.275 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.533 ' CE2' ' HD1' ' A' ' 113' ' ' TYR . 42.8 t80 -59.28 -49.03 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.076 -0.965 . . . . 75.519999999999996 110.512 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -64.04 -34.17 77.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 74.319999999999993 111.226 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.545 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -75.52 -53.56 8.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.493 0.553 . . . . 73.299999999999997 112.493 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.75 -33.7 7.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.832 0.679 . . . . 75.019999999999996 112.832 -169.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.06 84.84 7.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.322 0.582 . . . . 64.230000000000004 110.738 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -157.48 128.43 3.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.772 -0.649 . . . . 74.439999999999998 109.466 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.0 -52.38 8.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.354 2.703 . . . . 74.019999999999996 113.23 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.75 -45.37 92.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 74.409999999999997 110.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -69.22 -45.58 69.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.004 -0.543 . . . . 75.409999999999997 110.716 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.11 -50.42 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 73.519999999999996 110.998 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -61.46 -37.3 83.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.809 0.338 . . . . 75.430000000000007 110.391 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -59.63 -51.5 69.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 74.340000000000003 110.832 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.811 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 23.6 t90 -68.59 -51.1 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 75.549999999999997 110.684 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.93 -40.05 81.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.510000000000005 111.713 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -63.77 -56.54 14.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 75.310000000000002 110.856 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.3 m -65.04 -40.84 95.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.754 -0.657 . . . . 61.149999999999999 111.239 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -75.53 -13.83 60.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.988 -0.551 . . . . 74.099999999999994 110.929 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 6.0 ttpm? 62.58 57.74 1.77 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.336 0.588 . . . . 74.150000000000006 110.392 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -117.62 -174.52 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 75.040000000000006 110.806 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.47 -59.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.878 -0.601 . . . . 64.329999999999998 111.284 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -144.81 157.26 44.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 72.310000000000002 110.764 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HB3' HG13 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -105.8 137.35 43.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 72.409999999999997 109.199 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.27 33.05 1.78 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.941 -0.647 . . . . 72.319999999999993 113.287 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 108' ' ' LEU . 11.0 p -109.25 137.16 20.14 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.405 -0.591 . . . . 74.540000000000006 109.405 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.434 ' HD2' HG21 ' A' ' 110' ' ' VAL . 5.9 Cg_endo -47.28 135.21 19.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.51 2.807 . . . . 74.510000000000005 113.343 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 44.3 tptt -65.01 121.15 14.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 72.439999999999998 110.839 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HD1' ' CE2' ' A' ' 87' ' ' TYR . 27.2 t80 -80.44 132.27 35.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.272 -0.876 . . . . 74.340000000000003 111.357 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.487 ' HB2' HG21 ' A' ' 130' ' ' ILE . 69.9 m95 -122.42 -54.03 1.89 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.875 -0.787 . . . . 74.310000000000002 108.875 170.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.38 176.71 46.72 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.393 -0.822 . . . . 71.25 111.96 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -157.29 153.62 27.75 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.996 -0.742 . . . . 72.329999999999998 108.996 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 32' ' ' MET . . . -161.43 176.07 37.98 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.357 -1.401 . . . . 74.109999999999999 114.147 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 tp -137.08 129.08 29.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.010000000000005 108.785 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -144.49 131.79 20.75 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.701 -0.4 . . . . 73.200000000000003 110.648 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.954 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 8.2 t70 -69.74 136.75 51.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 74.439999999999998 110.824 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -90.72 -60.01 2.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 73.519999999999996 109.258 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -170.18 85.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.633 -0.712 . . . . 73.200000000000003 109.603 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.38 -34.86 5.43 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.604 -0.598 . . . . 75.310000000000002 111.604 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -132.02 140.8 49.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 75.0 109.919 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.954 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 11.5 p -89.65 156.14 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 64.299999999999997 110.897 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -111.5 130.69 55.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.737 -0.665 . . . . 72.409999999999997 110.391 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -96.44 118.03 32.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.709 -0.849 . . . . 74.409999999999997 108.709 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.6 p90 -129.16 156.57 43.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.967 0.413 . . . . 75.430000000000007 111.5 -173.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 18.5 ptp -137.27 139.59 41.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.671 -0.695 . . . . 74.420000000000002 110.335 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.531 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.7 mm -97.86 117.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.1 -0.5 . . . . 60.520000000000003 109.711 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER -121.84 -175.96 3.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 75.340000000000003 111.088 -175.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.697 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 20.8 t70 -64.5 157.01 27.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 72.530000000000001 110.633 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 1.2 tmt_? -93.71 109.36 21.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.268 0.556 . . . . 72.5 110.045 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 63.7 m-85 -101.84 171.39 7.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.589 . . . . 73.219999999999999 109.9 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.7 -36.78 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.472 -0.871 . . . . 64.530000000000001 112.42 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.5 m -103.06 124.94 49.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.962 0.411 . . . . 74.400000000000006 111.141 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.561 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 1.3 m-20 -87.42 132.9 33.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.06 -0.518 . . . . 71.439999999999998 109.905 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.685 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 14.8 tp -68.94 -38.29 79.37 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.065 -1.087 . . . . 70.120000000000005 108.065 171.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.983 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 4.9 pt20 -59.51 -49.0 79.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.339 -0.846 . . . . 75.140000000000001 112.418 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 25.2 mtmm -71.57 -36.91 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.768 -0.373 . . . . 55.539999999999999 111.371 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.03 -48.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 74.310000000000002 110.568 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.685 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.05 -44.95 95.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 71.140000000000001 111.922 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.3 -34.39 59.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.876 0.369 . . . . 63.25 110.727 -172.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.4 -28.85 62.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 73.120000000000005 110.557 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.64 0.11 56.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.37 0.605 . . . . 63.219999999999999 110.185 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 58.81 45.12 15.93 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.296 -0.865 . . . . 75.420000000000002 112.27 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 254' ' ' TRP . 0.0 OUTLIER 39.89 79.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.932 0.872 . . . . 74.510000000000005 112.998 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 148' ' ' ARG . 14.4 ttt180 -146.5 88.48 1.78 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.68 -1.145 . . . . 74.430000000000007 108.367 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.716 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 52.4 m-85 -120.09 156.16 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.084 -0.507 . . . . 74.340000000000003 112.025 -172.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.4 m -67.61 155.66 38.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.854 . . . . 72.420000000000002 110.257 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.599 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 7.7 tpp85 -59.71 -39.7 85.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.824 0.345 . . . . 74.209999999999994 110.797 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.736 ' HD2' ' HB2' ' A' ' 335' ' ' ASP . 26.2 pttm -66.3 -30.36 70.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.337 -0.392 . . . . 73.450000000000003 111.201 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.418 ' O ' HD12 ' A' ' 157' ' ' LEU . 6.9 m -70.2 -41.52 73.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 73.310000000000002 110.175 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.72 -43.62 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.617 -0.72 . . . . 73.239999999999995 110.945 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.638 HD22 HD22 ' A' ' 328' ' ' LEU . 3.3 mp -69.06 -40.16 78.69 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.483 0.549 . . . . 75.209999999999994 112.483 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -56.29 -45.06 80.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 75.420000000000002 110.301 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 153' ' ' THR . 8.6 mp -64.18 -52.03 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 73.219999999999999 111.313 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.3 p -65.27 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.286 . . . . 64.430000000000007 111.671 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.665 HD22 HD22 ' A' ' 325' ' ' LEU . 7.0 mp -56.3 -48.99 75.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.539 0.2 . . . . 64.540000000000006 111.539 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.76 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 2.3 mmp_? -61.15 -42.68 98.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 75.310000000000002 110.907 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 183' ' ' LEU . 31.4 mm -63.62 -38.19 81.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 72.040000000000006 110.581 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 317' ' ' TYR . 67.3 mt -58.01 -53.04 62.73 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.891 0.33 . . . . 75.340000000000003 111.891 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.811 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -70.08 -39.44 75.59 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.454 -0.498 . . . . 74.409999999999997 112.119 -175.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.54 -36.57 75.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.871 -0.731 . . . . 74.099999999999994 110.953 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.91 -38.86 83.47 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.797 -0.183 . . . . 74.5 111.212 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.476 ' HG3' ' N ' ' A' ' 167' ' ' TYR . 4.1 pt-20 -68.93 -40.96 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.233 -0.587 . . . . 55.530000000000001 110.009 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.476 ' N ' ' HG3' ' A' ' 166' ' ' GLU . 66.3 t80 -55.84 -45.81 78.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.693 -0.685 . . . . 75.409999999999997 111.735 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.55 -31.46 9.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.486 -0.324 . . . . 72.329999999999998 111.797 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -66.8 -27.06 67.27 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.436 -0.347 . . . . 75.340000000000003 110.689 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 37.0 tt0 -77.65 28.56 0.16 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.107 0.479 . . . . 71.409999999999997 111.491 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -151.18 -65.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.525 -0.734 . . . . 74.420000000000002 111.597 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 35.3 mt-10 -147.25 -31.44 0.32 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.696 0.628 . . . . 71.030000000000001 112.696 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.434 ' HE1' ' HE3' ' A' ' 85' ' ' LYS . 5.4 m-85 -99.18 128.85 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.784 1.031 . . . . 75.409999999999997 113.784 -155.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 204' ' ' TYR . 15.4 m -123.01 139.5 49.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.707 -1.133 . . . . 64.340000000000003 108.015 163.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.491 ' HD1' HD21 ' A' ' 195' ' ' LEU . 15.3 t-160 -93.77 -32.88 13.81 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.827 -0.349 . . . . 73.030000000000001 110.203 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.65 -76.87 0.28 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.078 -0.582 . . . . 71.219999999999999 111.852 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.484 ' CG ' ' HZ2' ' A' ' 352' ' ' LYS . 22.5 t70 -66.9 101.93 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.037 0.446 . . . . 64.349999999999994 110.343 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 178' ' ' ILE . 9.4 tp -99.73 20.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.876 0.846 . . . . 71.150000000000006 110.051 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 181' ' ' SER . 2.8 tmtm? -57.56 144.3 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.93 . . . . 71.25 110.256 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.523 ' HA ' HD13 ' A' ' 183' ' ' LEU . . . -62.3 -0.36 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.906 -0.588 . . . . 72.439999999999998 112.553 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.983 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 14.2 p -70.48 -17.28 62.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 54.310000000000002 111.514 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 198' ' ' TYR . 14.6 m120 -112.53 6.67 18.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 63.439999999999998 111.3 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 180' ' ' ALA . 7.1 mp -105.06 115.66 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.706 -0.479 . . . . 74.129999999999995 109.706 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.63 140.3 49.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.433 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 53.3 mt -94.71 138.41 32.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.707 -0.679 . . . . 75.219999999999999 109.874 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.61 140.47 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.096 -0.705 . . . . 63.299999999999997 109.096 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 5.6 p90 -62.42 -22.4 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.128 0.418 . . . . 73.540000000000006 112.128 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -104.3 -51.18 3.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.761 0.315 . . . . 74.209999999999994 111.039 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -112.11 106.82 56.12 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 74.140000000000001 110.979 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.13 -11.71 25.32 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.096 2.531 . . . . 62.240000000000002 112.49 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 26.8 t70 -70.87 -19.99 62.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.57 . . . . 74.129999999999995 110.703 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -111.09 103.05 11.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.45 0.643 . . . . 72.530000000000001 110.18 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.94 137.99 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 74.420000000000002 109.74 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.518 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 96.3 m-85 -120.3 141.98 49.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.044 0.449 . . . . 73.25 111.054 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.491 HD21 ' HD1' ' A' ' 175' ' ' HIS . 37.6 tp -90.76 99.97 12.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.728 -0.669 . . . . 73.150000000000006 109.392 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.5 m -139.99 160.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.457 -0.338 . . . . 74.450000000000003 111.636 -174.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.442 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 16.6 t70 60.67 78.16 0.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.968 -1.015 . . . . 70.420000000000002 111.575 174.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.557 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 19.4 p90 -151.41 -40.76 0.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.548 -0.751 . . . . 74.450000000000003 112.015 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 354' ' ' ILE . . . 66.72 2.16 15.03 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.751 -0.737 . . . . 74.099999999999994 112.661 -175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.557 ' H ' ' HD2' ' A' ' 198' ' ' TYR . 6.2 mp -91.94 35.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 73.239999999999995 111.474 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -84.49 97.78 9.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.363 -0.977 . . . . 72.519999999999996 108.363 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -99.97 127.48 46.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.265 0.555 . . . . 72.049999999999997 110.697 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 2.0 ttp180 -72.86 112.45 8.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.483 -0.78 . . . . 64.209999999999994 110.229 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 237' ' ' ALA . 13.7 p90 -92.57 -26.22 17.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.84 -0.43 . . . . 75.420000000000002 109.84 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.0 p -133.31 127.42 19.84 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 75.209999999999994 111.145 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.65 131.39 13.51 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.505 2.137 . . . . 70.439999999999998 111.752 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 65.96 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.79 0.681 . . . . 74.319999999999993 111.291 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.27 15.75 0.14 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.155 -0.545 . . . . 74.010000000000005 111.927 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -94.95 110.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.931 -0.396 . . . . 74.510000000000005 109.931 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.98 145.82 55.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 73.450000000000003 110.998 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 215' ' ' GLU . 74.8 tttt -111.02 145.09 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.828 -0.624 . . . . 75.200000000000003 110.755 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.2 -163.39 1.02 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.872 -0.604 . . . . 71.519999999999996 110.172 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.507 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 0.9 OUTLIER -76.27 67.79 2.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.809 0.67 . . . . 71.400000000000006 112.809 -175.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 75.6 tttt -158.43 83.28 0.83 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.855 -0.611 . . . . 73.340000000000003 109.725 169.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 235' ' ' GLY . 9.8 tp10 -105.9 -72.93 0.7 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.939 -0.573 . . . . 75.439999999999998 110.464 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -138.34 109.39 8.14 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.61 -0.268 . . . . 61.030000000000001 110.418 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 123.23 2.62 . . . . 73.230000000000004 112.481 -178.372 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.323 . . . . 75.430000000000007 111.491 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -96.88 -170.46 33.95 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 71.209999999999994 112.789 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.3 m -69.58 142.24 53.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.443 0.164 . . . . 71.340000000000003 110.77 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.529 HD11 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -56.96 -23.83 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.471 0.653 . . . . 73.409999999999997 110.542 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.23 -53.47 54.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.465 -0.788 . . . . 65.420000000000002 111.937 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.27 7.0 19.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.085 0.772 . . . . 75.209999999999994 113.085 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 232' ' ' ALA . 0.6 OUTLIER -64.42 -21.1 66.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 73.150000000000006 111.288 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.664 ' HA ' ' CD ' ' A' ' 275' ' ' LYS . 50.8 m 59.77 -162.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.709 -0.678 . . . . 72.109999999999999 110.247 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 230' ' ' ILE . 0.2 OUTLIER -71.0 -34.16 54.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.421 -0.512 . . . . 75.140000000000001 110.281 176.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.419 ' HA ' HG13 ' A' ' 236' ' ' VAL . 5.2 m-20 -59.76 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.631 -0.713 . . . . 63.340000000000003 112.316 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 228' ' ' THR . . . -63.65 -31.59 72.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 71.120000000000005 111.714 -172.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -68.97 -31.35 70.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.496 -0.32 . . . . 73.239999999999995 111.164 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.69 0.52 55.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 64.230000000000004 110.711 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 215' ' ' GLU . . . 87.12 33.89 11.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.459 -0.877 . . . . 71.439999999999998 113.829 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 1.4 p -120.79 129.22 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.226 0.513 . . . . 75.409999999999997 110.803 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 204' ' ' TYR . . . -77.29 111.6 18.03 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 64.329999999999998 109.578 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 123.82 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.577 2.185 . . . . 74.230000000000004 113.295 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.1 m -95.37 104.59 16.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.886 -0.597 . . . . 61.329999999999998 110.041 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.632 HH11 HD11 ' A' ' 309' ' ' LEU . 0.0 OUTLIER 79.8 -56.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.64 0.776 . . . . 74.140000000000001 110.866 175.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.645 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.61 -54.89 38.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.32 -0.4 . . . . 74.109999999999999 111.457 -173.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.13 -44.95 97.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 55.229999999999997 112.592 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.43 -53.74 33.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.113 0.482 . . . . 75.129999999999995 111.12 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.621 ' HB2' HH21 ' A' ' 240' ' ' ARG . 3.7 mm? -72.22 -40.34 67.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.662 . . . . 73.299999999999997 111.537 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -46.43 89.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.69 0.281 . . . . 62.310000000000002 111.049 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.441 HG12 ' HG ' ' A' ' 229' ' ' SER . 75.1 mt -66.6 -33.92 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 65.299999999999997 110.714 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.1 86.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.517 -0.549 . . . . 74.109999999999999 109.517 174.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -58.76 -39.1 93.25 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.737 -0.744 . . . . 75.019999999999996 112.18 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.07 -42.18 94.4 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.965 0.358 . . . . 75.420000000000002 111.965 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 31.2 p -69.64 -35.8 75.53 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.243 -0.583 . . . . 74.150000000000006 110.955 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 70.6 mtm -65.69 -46.81 77.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.056 -0.258 . . . . 73.209999999999994 111.073 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.8 -28.78 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.738 -0.385 . . . . 72.019999999999996 110.586 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -46.55 87.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.97 -0.382 . . . . 73.230000000000004 109.97 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.716 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 16.8 m0 -67.32 -28.64 68.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.915 -0.584 . . . . 75.25 110.906 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -83.9 -35.78 23.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 74.329999999999998 112.628 -173.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 42.9 p -102.64 -14.69 16.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.416 0.524 . . . . 73.340000000000003 112.416 -171.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.28 -33.54 4.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.235 -0.983 . . . . 61.149999999999999 113.006 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 143.93 18.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.371 -0.488 . . . . 73.140000000000001 110.868 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.49 HD11 ' CZ2' ' A' ' 261' ' ' TRP . 96.3 mt -103.9 149.5 37.25 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 74.129999999999995 110.315 176.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.01 -40.25 86.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.751 2.301 . . . . 73.299999999999997 112.681 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.49 ' CZ2' HD11 ' A' ' 259' ' ' LEU . 25.0 p90 -87.13 -0.38 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.531 -0.304 . . . . 71.319999999999993 111.35 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.511 ' HA ' HD22 ' A' ' 265' ' ' LEU . 84.7 tt0 -79.63 -28.27 40.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.093 0.473 . . . . 73.340000000000003 109.945 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.19 -27.95 32.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 64.5 110.26 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -108.4 17.42 22.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.529 -0.76 . . . . 74.109999999999999 112.098 -173.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 262' ' ' GLU . 4.2 pp -73.56 -7.85 53.55 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.091 0.472 . . . . 73.219999999999999 111.085 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -64.21 -14.12 53.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 75.200000000000003 111.058 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.69 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 10.9 t70 -134.69 127.89 18.71 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 110.223 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.0 Cg_exo -61.59 -33.06 87.71 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.351 2.701 . . . . 72.150000000000006 114.794 -171.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.69 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 22.9 pttm -74.29 -24.04 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.515 -0.474 . . . . 75.129999999999995 111.471 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 267' ' ' ASP . 74.6 m-85 -71.22 -49.55 42.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 75.239999999999995 110.157 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.636 HG11 ' HZ3' ' A' ' 275' ' ' LYS . 96.1 t -58.5 -37.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.784 -0.644 . . . . 74.030000000000001 110.954 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.434 ' O ' HG13 ' A' ' 276' ' ' ILE . 48.5 ttt-85 -59.85 -61.9 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 74.129999999999995 110.876 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -45.58 91.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.974 -0.557 . . . . 73.540000000000006 111.82 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 15.1 p -61.46 -49.92 74.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.883 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.664 ' CD ' ' HA ' ' A' ' 229' ' ' SER . 56.2 mttp -66.69 -37.35 84.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 64.310000000000002 111.75 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' A' ' 280' ' ' GLU . 83.0 mt -60.85 -49.58 84.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.42 . . . . 73.400000000000006 110.557 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -69.01 -33.63 73.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 74.420000000000002 111.003 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.81 -36.4 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 110.644 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.407 ' O ' HG21 ' A' ' 282' ' ' ILE . 58.2 ttp180 -71.06 -38.22 72.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 74.310000000000002 110.805 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 72.7 mt-10 -67.58 -42.32 82.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 74.239999999999995 110.986 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.452 ' HB2' HD22 ' A' ' 285' ' ' LEU . 30.0 m-80 -117.78 46.97 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 73.549999999999997 110.649 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 304' ' ' GLU . 0.2 OUTLIER -49.63 -51.35 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.865 0.691 . . . . 73.329999999999998 112.865 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.508 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.11 -43.54 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.913 0.387 . . . . 61.25 111.339 -175.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.4 m -65.96 -45.39 81.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.839 -0.619 . . . . 75.430000000000007 110.853 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 281' ' ' ASN . 4.0 mm? -69.39 -43.12 74.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 74.299999999999997 111.603 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.529 ' HE2' ' HA ' ' A' ' 286' ' ' MET . 30.5 mmt -64.57 -40.34 95.38 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.965 -0.294 . . . . 74.319999999999993 111.051 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 16.1 t70 -66.26 -48.64 69.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 74.310000000000002 111.2 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -98.94 14.54 28.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 111.875 -169.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 47.4 t -85.44 -27.25 25.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 73.040000000000006 109.777 173.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 290' ' ' PHE . 0.1 OUTLIER -138.1 68.5 48.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 71.310000000000002 111.298 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.19 31.89 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.035 2.49 . . . . 71.340000000000003 111.919 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.76 -85.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.666 -0.697 . . . . 70.200000000000003 111.808 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -145.4 16.27 1.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.964 0.887 . . . . 71.420000000000002 109.492 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -104.73 -142.92 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.338 -0.847 . . . . 74.519999999999996 109.958 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 47.9 tptt -156.06 114.98 2.16 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.657 -0.247 . . . . 75.0 110.613 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.469 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 47.3 Cg_endo -95.42 77.99 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.342 2.695 . . . . 72.349999999999994 111.697 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -119.95 -59.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.201 -0.999 . . . . 72.109999999999999 112.535 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.599 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 1.1 mp0 -60.02 -61.43 2.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.675 0.274 . . . . 74.109999999999999 110.399 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.7 mp -60.6 -37.17 74.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.62 . . . . 74.109999999999999 110.63 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.61 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 70.329999999999998 111.335 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -72.03 -33.58 68.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.120000000000005 110.34 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -55.41 -49.39 72.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.669 -0.696 . . . . 74.099999999999994 110.708 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.456 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 94.3 mmm -72.02 -39.67 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 74.049999999999997 111.057 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.518 ' HA ' HG13 ' A' ' 282' ' ' ILE . 23.1 tt0 -57.46 -45.68 84.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.634 0.73 . . . . 63.229999999999997 109.71 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.6 m -60.07 -51.08 71.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.54 -1.209 . . . . 72.540000000000006 112.0 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 303' ' ' MET . 31.0 m -73.37 -27.91 24.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.331 0.493 . . . . 71.310000000000002 112.331 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -75.62 -43.82 45.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.889 0.376 . . . . 74.340000000000003 110.703 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.95 76.74 10.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.344 0.498 . . . . 75.0 112.344 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.632 HD11 HH11 ' A' ' 240' ' ' ARG . 0.5 OUTLIER -163.28 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.864 171.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.959 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 32.4 t70 -178.35 164.22 1.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.993 -0.373 . . . . 65.209999999999994 109.993 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.645 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 2.2 t80 -58.58 -64.6 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.861 0.465 . . . . 75.25 111.069 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 t -114.77 36.42 3.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.409 0.623 . . . . 74.420000000000002 110.731 -173.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.959 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 9.9 tp10 -67.57 -86.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 65.409999999999997 111.481 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 179.98 137.53 0.29 Allowed Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 109.502 -0.555 . . . . 74.239999999999995 109.502 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -91.96 128.64 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.622 2.215 . . . . 73.120000000000005 112.995 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.476 ' O ' HD11 ' A' ' 320' ' ' LEU . 90.4 mt -79.96 75.78 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.518 -0.549 . . . . 74.030000000000001 109.518 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 162' ' ' LEU . 67.1 t80 -57.67 -39.29 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.778 -0.646 . . . . 74.310000000000002 111.401 -174.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.08 -43.7 98.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.294 -0.412 . . . . 64.439999999999998 110.517 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -76.7 -29.87 56.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.52 -0.309 . . . . 72.5 111.225 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.534 ' O ' HG21 ' A' ' 323' ' ' ILE . 7.1 mp -69.34 -48.13 62.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 74.319999999999993 110.9 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.422 HH22 ' NH2' ' A' ' 160' ' ' ARG . 20.9 ttt180 -70.57 -28.13 64.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 75.340000000000003 109.758 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.41 -41.03 66.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.882 -0.599 . . . . 72.319999999999993 111.464 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -67.72 -36.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.956 -0.387 . . . . 75.140000000000001 109.956 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 155' ' ' LEU . 92.1 mt -60.46 -49.43 77.59 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 110.079 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.665 HD22 HD22 ' A' ' 159' ' ' LEU . 3.8 mm? -62.61 -37.92 88.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.554 . . . . 74.409999999999997 111.408 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -55.56 -47.36 76.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.586 -0.279 . . . . 75.329999999999998 110.827 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.83 -42.64 96.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 75.150000000000006 112.184 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 333' ' ' SER . 27.4 tp -65.86 -42.97 89.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 75.340000000000003 111.114 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.541 ' HB3' ' HZ1' ' A' ' 329' ' ' LYS . 9.0 mtpm? -66.69 -32.59 73.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 73.430000000000007 110.363 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.19 64.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 74.319999999999993 111.089 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 328' ' ' LEU . 12.7 tt -85.68 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 120.948 0.404 . . . . 74.109999999999999 110.495 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.83 36.45 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.562 -0.827 . . . . 43.25 113.508 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.676 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 52.3 m -129.42 162.57 27.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.034 0.417 . . . . 73.120000000000005 111.16 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.761 ' HD2' ' HB2' ' A' ' 336' ' ' ASP . 5.6 tmtt? -179.5 -51.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.931 -0.766 . . . . 75.25 108.931 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.736 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 8.1 t70 70.04 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.154 -0.93 . . . . 74.129999999999995 110.473 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . 0.761 ' HB2' ' HD2' ' A' ' 334' ' ' LYS . 10.9 t70 58.56 94.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.669 0.606 . . . . 72.109999999999999 111.21 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 150.14 -36.07 0.97 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.958 -0.857 . . . . 72.219999999999999 110.958 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 N-CA-C 109.547 -0.538 . . . . 71.409999999999997 109.547 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.484 ' HZ2' ' CG ' ' A' ' 177' ' ' ASP . 41.1 mttt . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.153 0.501 . . . . 74.319999999999993 112.133 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.608 HG22 ' HG3' ' A' ' 79' ' ' PRO . 95.8 m -150.44 137.35 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.641 -0.708 . . . . 73.219999999999999 109.946 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -66.91 134.03 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.271 0.558 . . . . 71.319999999999993 110.27 -176.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' THR . . . . . 0.446 ' N ' HD13 ' A' ' 354' ' ' ILE . 50.9 m -64.96 94.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 72.430000000000007 112.054 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 115.761 -0.654 . . . . 75.299999999999997 111.305 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.517 ' HA ' HG11 ' A' ' 39' ' ' VAL . 61.3 t . . . . . 0 C--O 1.235 0.295 0 CA-C-O 120.896 0.379 . . . . 75.420000000000002 110.928 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.37 0.03 56.96 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.694 -0.765 . . . . 53.049999999999997 113.425 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 9.4 pt-20 -82.48 150.74 26.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.029 -0.73 . . . . 73.129999999999995 109.029 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 28' ' ' ILE . 1.2 tp -91.42 131.54 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 71.340000000000003 110.057 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.34 132.14 71.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.498 -0.773 . . . . 72.230000000000004 109.222 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 m -118.08 114.08 22.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.935 -0.395 . . . . 75.209999999999994 109.935 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.528 ' OD2' ' HA3' ' A' ' 115' ' ' GLY . 4.7 p-10 -95.23 -172.02 2.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 70.209999999999994 110.41 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.1 mmt -70.58 -11.27 60.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.475 0.546 . . . . 74.230000000000004 112.475 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.06 2.45 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.226 -0.296 . . . . 74.329999999999998 110.372 174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.28 24.93 8.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.517 -0.765 . . . . 75.519999999999996 110.687 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 30' ' ' THR . 29.1 mtpp -93.63 124.75 37.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.85 -0.614 . . . . 74.299999999999997 110.163 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.79 92.21 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.354 -0.61 . . . . 71.120000000000005 109.354 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.974 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 25.1 p-90 -116.83 140.02 49.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.792 -0.64 . . . . 74.329999999999998 111.141 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 56' ' ' MET . 23.6 pttm -85.6 139.26 31.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.101 -0.703 . . . . 62.43 109.101 174.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 25' ' ' VAL . 3.6 p -66.95 117.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 75.109999999999999 109.061 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.98 -121.59 4.89 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.418 -0.896 . . . . 62.310000000000002 112.731 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.664 HD23 ' HD2' ' A' ' 42' ' ' PRO . 2.4 tm? -73.31 118.02 65.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.916 0.388 . . . . 75.409999999999997 110.397 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HD2' HD23 ' A' ' 41' ' ' LEU . 65.1 Cg_endo -75.91 96.7 1.07 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.492 2.128 . . . . 72.430000000000007 111.797 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 53' ' ' LEU . 56.7 mt -62.77 -45.56 98.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.242 0.544 . . . . 72.329999999999998 110.337 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.25 83.67 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.399 -0.819 . . . . 74.219999999999999 112.226 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -139.04 159.85 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.902 -0.407 . . . . 74.340000000000003 109.902 -174.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.73 49.88 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.634 -0.793 . . . . 74.319999999999993 111.497 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.03 112.06 2.71 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.686 -0.768 . . . . 63.210000000000001 112.218 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.567 ' HD2' ' HE2' ' A' ' 71' ' ' LYS . 21.5 m-85 68.25 -72.38 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.465 0.706 . . . . 74.109999999999999 111.447 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.8 174.91 13.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.034 -0.603 . . . . 72.510000000000005 111.625 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.39 31.1 17.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.379 . . . . 62.119999999999997 111.483 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 71' ' ' LYS . 18.1 mm -88.82 136.59 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.92 -0.4 . . . . 74.420000000000002 109.92 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -108.19 153.65 22.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.52 0.2 . . . . 73.319999999999993 110.975 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.534 HD12 HD12 ' A' ' 43' ' ' ILE . 8.1 tt -100.91 137.39 39.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.372 -0.603 . . . . 64.439999999999998 109.372 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.401 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . . . -94.98 93.73 7.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 55.32 110.494 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.13 -15.87 57.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 110.837 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.974 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 47.8 mtp 59.94 -163.47 0.24 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.75 -0.659 . . . . 73.430000000000007 110.39 -176.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.38 141.22 48.45 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.545 -0.909 . . . . 62.229999999999997 108.545 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -77.35 38.12 0.22 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.337 0.495 . . . . 73.430000000000007 112.337 -171.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.324 -0.501 0 N-CA-C 109.592 -0.521 . . . . 74.219999999999999 109.592 173.744 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.221 0.452 . . . . 73.239999999999995 112.221 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.625 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 56.1 Cg_endo -71.21 62.39 2.62 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.697 1.598 . . . . 74.299999999999997 112.611 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 54' ' ' ALA . 9.3 p -120.79 152.47 38.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.7 -0.482 . . . . 74.340000000000003 109.7 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -122.94 155.8 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.656 0.265 . . . . 64.200000000000003 110.784 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -121.48 120.71 62.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.314 0.578 . . . . 61.439999999999998 111.415 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.604 ' HG3' HD12 ' A' ' 51' ' ' ILE . 77.6 tttt -95.64 131.84 41.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 75.219999999999999 109.116 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 128' ' ' PHE . 34.7 m -118.68 151.76 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.207 0.447 . . . . 71.540000000000006 112.207 -173.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 4.1 pt-20 -132.9 155.93 80.62 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.322 -0.399 . . . . 72.299999999999997 110.211 172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.29 114.87 2.53 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.632 2.221 . . . . 74.25 112.24 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t 81.47 -96.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.032 0.933 . . . . 61.109999999999999 112.467 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -171.02 12.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.299 1.222 . . . . 62.0 114.299 -167.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.37 103.95 3.74 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.779 -0.768 . . . . 74.420000000000002 112.394 -171.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.96 -161.24 32.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.921 -0.657 . . . . 62.329999999999998 111.781 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.875 ' HB3' ' HA2' ' A' ' 199' ' ' GLY . 31.2 Cg_exo -60.02 -26.64 82.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.017 2.478 . . . . 72.329999999999998 112.465 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.8 tm? -64.52 -37.07 86.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.457 -0.572 . . . . 72.340000000000003 109.457 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.88 -38.28 86.02 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.214 0.53 . . . . 74.430000000000007 109.808 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.3 m -62.87 -45.05 94.37 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.68 -0.691 . . . . 74.519999999999996 110.162 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.68 -29.72 69.06 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.934 -0.576 . . . . 74.510000000000005 110.752 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -59.08 -50.24 74.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.418 -0.215 . . . . 74.420000000000002 110.418 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -58.57 -47.27 84.83 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.769 0.319 . . . . 72.200000000000003 110.627 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.405 ' HD2' ' CD1' ' A' ' 87' ' ' TYR . 83.8 t80 -57.58 -52.19 66.41 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.895 -0.593 . . . . 75.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CD1' ' HD2' ' A' ' 86' ' ' PHE . 6.1 m-30 -62.35 -43.73 98.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.594 -0.275 . . . . 75.439999999999998 111.232 -175.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.18 -33.46 76.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.81 0.3 . . . . 72.219999999999999 111.81 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -95.48 -23.04 17.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.663 0.616 . . . . 72.010000000000005 112.663 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -104.11 -34.54 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.78 0.659 . . . . 73.400000000000006 112.78 -174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.81 78.36 9.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.31 0.576 . . . . 74.219999999999999 111.594 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 96' ' ' ILE . 19.2 tptp -155.51 101.79 2.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.894 -0.78 . . . . 73.530000000000001 108.894 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -43.72 -46.46 10.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.878 3.052 . . . . 75.299999999999997 114.138 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.26 -51.73 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 75.200000000000003 111.156 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -64.95 -40.89 95.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 74.430000000000007 110.488 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.5 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 72.8 mt -57.94 -53.6 43.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 61.399999999999999 110.857 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -62.04 -31.05 71.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.829 -0.623 . . . . 72.230000000000004 110.637 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -70.54 -50.9 32.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 111.525 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.531 ' CZ2' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -73.53 -35.66 65.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 119.749 -0.78 . . . . 74.510000000000005 110.57 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.84 -34.95 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.439 0.638 . . . . 71.420000000000002 110.089 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -65.46 -49.34 69.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.243 -0.89 . . . . 74.409999999999997 111.229 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -75.75 -41.8 52.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.287 0.477 . . . . 75.140000000000001 112.287 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 105' ' ' LEU . 18.4 mmt180 -78.1 -17.38 57.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.477 -0.329 . . . . 74.140000000000001 111.189 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 64.95 59.97 0.84 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.949 0.88 . . . . 74.310000000000002 110.177 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 103' ' ' ARG . 7.3 mp -97.09 -166.3 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.557 -1.201 . . . . 75.120000000000005 108.542 173.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -128.64 -54.42 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.9 -0.72 . . . . 72.049999999999997 112.388 -174.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -164.73 107.88 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.713 -0.395 . . . . 71.549999999999997 110.981 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.531 HD21 ' CZ2' ' A' ' 99' ' ' TRP . 18.2 tp -80.21 132.0 35.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 75.450000000000003 111.01 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.72 70.91 2.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.997 -0.62 . . . . 71.439999999999998 111.904 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.89 142.44 29.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.515 -0.18 . . . . 72.430000000000007 110.515 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.8 Cg_exo -72.82 140.4 32.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.468 2.112 . . . . 72.430000000000007 112.084 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -72.57 106.49 4.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.696 -0.483 . . . . 74.319999999999993 109.696 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -81.7 119.91 24.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.985 -0.552 . . . . 74.150000000000006 110.743 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -95.73 -65.63 0.96 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.205 0.526 . . . . 72.109999999999999 109.802 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.528 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -151.07 -170.76 18.43 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.622 -0.717 . . . . 75.519999999999996 112.317 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 129' ' ' MET . 51.2 p -167.8 -177.36 3.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.864 -0.421 . . . . 72.409999999999997 109.864 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.43 -175.08 38.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.22 -0.99 . . . . 52.210000000000001 112.629 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -133.39 127.88 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.915 -0.772 . . . . 72.120000000000005 108.915 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -138.62 120.87 15.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 73.140000000000001 110.772 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 11.7 t70 -81.36 131.26 35.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 63.420000000000002 110.612 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -96.26 -53.21 3.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 72.219999999999999 110.588 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -169.22 91.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 70.049999999999997 109.869 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.27 11.5 67.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.194 -0.527 . . . . 64.150000000000006 112.162 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -144.16 108.35 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.078 -0.342 . . . . 63.119999999999997 110.078 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.484 ' HB3' HD22 ' A' ' 118' ' ' LEU . 24.3 m -85.09 111.33 19.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.04 -0.527 . . . . 75.109999999999999 109.901 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -91.53 128.33 37.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 75.200000000000003 110.987 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 32.3 ttm180 -91.21 128.27 36.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.333 -0.988 . . . . 74.450000000000003 108.333 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.575 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.8 p90 -134.1 152.68 51.94 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.955 -0.298 . . . . 75.129999999999995 111.147 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 70.9 mtm -136.97 140.46 42.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.078 -0.51 . . . . 74.120000000000005 110.285 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.543 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.1 mm -99.05 119.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.212 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.598 ' HE1' ' HB2' ' A' ' 71' ' ' LYS . 3.1 mpp? -126.35 -174.14 3.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 63.140000000000001 110.315 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.92 158.04 26.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 74.430000000000007 110.625 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.625 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -67.15 115.46 6.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 74.409999999999997 112.186 -174.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 29.7 m-85 -119.52 171.68 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.512 -0.767 . . . . 75.049999999999997 109.283 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 -54.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.385 -0.912 . . . . 61.109999999999999 112.105 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -81.1 124.31 29.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 74.420000000000002 110.702 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.545 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -92.95 145.35 24.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.094 -1.076 . . . . 64.200000000000003 108.094 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.548 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 33.1 tp -60.92 -38.08 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.668 -0.413 . . . . 73.430000000000007 110.065 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.87 ' HA ' ' HD2' ' A' ' 142' ' ' TYR . 50.7 tt0 -59.97 -37.24 79.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.200000000000003 111.531 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -55.24 -59.59 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 75.549999999999997 110.43 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.23 -39.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.264 -0.88 . . . . 73.219999999999999 111.12 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.87 ' HD2' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.48 -38.74 91.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.353 -0.385 . . . . 75.329999999999998 111.234 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.585 ' HG3' ' CE2' ' A' ' 142' ' ' TYR . 32.6 mt-10 -83.48 -18.49 38.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.722 -0.391 . . . . 72.409999999999997 111.439 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -79.03 -23.98 43.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.323 0.582 . . . . 71.420000000000002 110.06 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -97.72 1.09 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.544 -0.753 . . . . 71.439999999999998 109.27 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.76 39.92 30.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.105 -0.952 . . . . 62.25 111.98 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.668 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 41.5 pttt 42.52 38.29 1.21 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.074 0.95 . . . . 74.140000000000001 113.22 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -98.76 81.33 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.075 -0.713 . . . . 73.150000000000006 109.075 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.93 156.97 26.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.965 0.412 . . . . 73.209999999999994 111.291 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.8 t -99.34 -172.55 2.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 54.43 110.224 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.438 ' HD3' ' CD ' ' A' ' 298' ' ' GLU . 3.9 ttm180 -65.39 -24.03 67.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 75.010000000000005 111.294 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -58.09 -68.73 0.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.927 -0.579 . . . . 74.230000000000004 111.897 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.7 p -59.11 -47.34 85.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 63.329999999999998 111.905 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.33 -41.67 71.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.689 -0.687 . . . . 71.219999999999999 111.332 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -71.41 -50.03 35.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.363 -0.38 . . . . 73.439999999999998 110.412 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.92 -44.95 87.16 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.863 0.363 . . . . 75.120000000000005 111.204 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 161' ' ' ILE . 8.3 mp -61.29 -52.73 63.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.125 -0.489 . . . . 73.349999999999994 111.137 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.0 p -63.74 -34.13 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.24 . . . . 74.129999999999995 111.526 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.33 -53.44 57.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.412 -0.358 . . . . 74.400000000000006 110.356 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -70.16 -29.27 66.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.07 0.462 . . . . 74.430000000000007 110.78 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 157' ' ' LEU . 30.1 mm -67.5 -37.99 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.523 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.55 -39.92 95.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.971 -0.381 . . . . 75.219999999999999 109.971 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.17 -63.23 1.22 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.685 0.755 . . . . 71.430000000000007 110.462 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 195' ' ' LEU . 18.4 tt -64.45 -34.85 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.375 -0.829 . . . . 73.120000000000005 111.264 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.497 HD11 ' CE1' ' A' ' 175' ' ' HIS . 50.3 tp -60.95 -40.05 91.82 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.825 -0.17 . . . . 72.530000000000001 111.274 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -65.74 -39.11 90.77 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.535 -0.466 . . . . 64.109999999999999 110.904 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -59.06 -49.44 77.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.371 -0.532 . . . . 73.409999999999997 111.594 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.0 pt -74.03 -32.2 32.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.813 -0.355 . . . . 75.150000000000006 110.969 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.95 -45.75 92.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 73.030000000000001 110.915 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.33 8.08 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.94 0.4 . . . . 74.25 110.928 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -104.86 -67.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.083 -0.247 . . . . 75.010000000000005 111.016 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -152.46 -58.94 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.518 0.562 . . . . 54.219999999999999 112.518 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.587 ' HB3' ' HA ' ' A' ' 203' ' ' ARG . 10.5 p90 -121.36 164.75 16.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.331 0.863 . . . . 73.430000000000007 113.331 -164.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.9 173.27 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.756 -1.111 . . . . 73.129999999999995 108.931 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.497 ' CE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -129.44 103.7 7.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.585 0.707 . . . . 74.519999999999996 112.038 -175.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.01 -39.4 89.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.362 -0.836 . . . . 53.100000000000001 111.524 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 1.006 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 28.5 t70 -89.84 91.07 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.256 0.55 . . . . 75.5 110.041 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.53 HG23 ' SG ' ' A' ' 250' ' ' CYS . 8.4 tt -110.01 25.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.087 0.946 . . . . 75.230000000000004 109.242 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.449 ' HZ1' ' CD ' ' A' ' 226' ' ' GLU . 20.4 tptm -60.6 162.16 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.138 -0.937 . . . . 74.140000000000001 109.96 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.14 -5.37 1.04 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.033 0.753 . . . . 75.239999999999995 113.033 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.62 ' HB2' ' HZ2' ' A' ' 352' ' ' LYS . 1.0 OUTLIER -76.87 -20.65 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 75.120000000000005 110.413 176.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -88.37 -15.12 36.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 71.25 110.292 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.52 120.57 38.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 73.230000000000004 110.297 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 137' ' ' ASP . 4.5 mm? -116.22 141.82 47.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.957 -0.565 . . . . 74.540000000000006 110.449 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 190' ' ' PRO . 9.8 mp -99.29 160.36 14.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.559 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.42 151.22 47.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.179 -0.675 . . . . 52.25 109.179 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.06 -26.23 62.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.303 0.483 . . . . 75.230000000000004 112.303 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 188' ' ' LYS . 32.5 tptt -112.36 -58.09 2.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.8 0.667 . . . . 74.049999999999997 112.8 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -104.57 131.13 22.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.414 0.626 . . . . 73.439999999999998 112.201 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.474 ' HA ' HD22 ' A' ' 185' ' ' LEU . 96.5 Cg_endo -77.21 -7.5 17.15 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.326 2.684 . . . . 74.239999999999995 113.544 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.88 -6.9 57.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.313 0.578 . . . . 74.310000000000002 110.182 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 88.1 mm-40 -105.29 92.75 4.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 74.150000000000006 110.342 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.16 120.45 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.441 0.639 . . . . 75.0 109.849 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 61.9 m-85 -113.08 154.86 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.351 -0.84 . . . . 74.420000000000002 109.515 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.543 ' HB3' HD13 ' A' ' 164' ' ' ILE . 14.0 tp -110.12 107.48 17.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.882 -0.414 . . . . 74.299999999999997 109.882 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.444 HG13 ' HG3' ' A' ' 111' ' ' PRO . 19.8 m -138.41 -166.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 63.439999999999998 109.972 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.05 56.17 1.06 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.854 0.835 . . . . 74.140000000000001 109.922 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -82.85 67.12 8.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.086 -0.961 . . . . 73.430000000000007 110.61 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.875 ' HA2' ' HB3' ' A' ' 79' ' ' PRO . . . -64.34 -57.84 12.11 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.436 -0.802 . . . . 51.539999999999999 111.498 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' A' ' 222' ' ' ASP . 3.7 mp -106.47 88.06 2.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.341 0.591 . . . . 72.049999999999997 110.289 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -114.8 110.65 20.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.542 -0.754 . . . . 73.129999999999995 109.761 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.47 115.58 29.63 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.066 -0.516 . . . . 74.120000000000005 109.63 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.587 ' HA ' ' HB3' ' A' ' 173' ' ' TYR . 35.8 ptt180 -69.76 137.36 51.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 111.543 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' A' ' 239' ' ' SER . 56.0 t80 -93.68 -55.64 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.561 -0.745 . . . . 75.209999999999994 110.546 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.5 p -110.81 96.73 30.3 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 72.430000000000007 110.651 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 28.8 Cg_exo -60.94 114.44 2.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.671 2.248 . . . . 73.329999999999998 112.077 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 64.45 20.19 12.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.609 -0.723 . . . . 74.530000000000001 111.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.05 60.23 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.872 -0.68 . . . . 74.140000000000001 113.121 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 55.6 t -88.88 118.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.806 0.336 . . . . 73.099999999999994 110.624 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.489 ' HB2' ' OE2' ' A' ' 212' ' ' GLU . 17.9 p80 -71.09 128.11 34.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 70.230000000000004 111.001 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -114.13 -31.02 6.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 75.409999999999997 111.164 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.489 ' OE2' ' HB2' ' A' ' 210' ' ' HIS . 2.8 mp0 59.1 -100.04 0.1 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.992 -0.549 . . . . 72.310000000000002 110.273 -174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.503 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 18.1 p90 -80.71 103.41 10.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.593 0.711 . . . . 75.430000000000007 110.953 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -98.14 -51.38 4.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.033 -0.729 . . . . 65.420000000000002 109.033 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 62.65 90.48 0.08 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.197 -0.91 . . . . 75.109999999999999 112.525 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.47 82.55 62.88 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.531 -0.759 . . . . 75.349999999999994 109.872 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.528 0.202 0 C-N-CA 123.068 2.512 . . . . 70.319999999999993 112.619 -178.033 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.716 ' HB3' ' HB3' ' A' ' 200' ' ' LEU . 2.6 m-20 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.467 0.651 . . . . 71.530000000000001 112.337 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 1.006 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . 147.24 164.16 11.0 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.919 -1.037 . . . . 63.539999999999999 111.017 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.403 HG21 ' H ' ' A' ' 226' ' ' GLU . 22.8 m -69.02 139.62 54.95 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.785 -0.45 . . . . 73.239999999999995 109.785 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.542 ' HA ' ' OG1' ' A' ' 228' ' ' THR . 49.4 mt -56.31 -22.33 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.569 0.699 . . . . 74.230000000000004 110.997 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 34.9 tt0 -51.68 -42.51 62.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 74.310000000000002 110.311 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 246' ' ' ILE . 59.1 m-85 -104.32 -90.72 0.38 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.766 -0.652 . . . . 74.430000000000007 109.635 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 225' ' ' ILE . 28.0 m 67.02 -63.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.822 0.701 . . . . 71.409999999999997 112.566 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.452 ' HA ' ' HG3' ' A' ' 275' ' ' LYS . 49.7 m 67.75 172.09 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.284 0.634 . . . . 73.530000000000001 111.094 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.7 mp -71.75 -40.53 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.159 0.504 . . . . 71.540000000000006 109.866 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . 1.6 m-20 -54.3 -61.13 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.682 -1.145 . . . . 74.519999999999996 111.758 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.02 82.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 71.319999999999993 111.538 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -67.9 -26.54 66.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.499 -0.319 . . . . 74.120000000000005 111.503 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.469 ' HB3' HG12 ' A' ' 236' ' ' VAL . 65.6 t30 -80.36 -4.7 54.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.539 0.685 . . . . 74.109999999999999 109.66 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.66 76.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.55 -0.75 . . . . 63.32 112.326 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 7.2 p -111.81 127.7 68.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.954 0.407 . . . . 73.010000000000005 110.441 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.94 112.24 39.05 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.004 -0.543 . . . . 74.319999999999993 109.704 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.674 ' HG2' ' HA3' ' A' ' 242' ' ' GLY . 24.6 Cg_exo -63.15 152.78 77.89 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.325 2.017 . . . . 74.430000000000007 111.398 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.627 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 16.0 p -77.09 -18.37 58.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.444 . . . . 72.450000000000003 111.08 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.781 ' HD3' ' HG3' ' A' ' 315' ' ' PRO . 7.1 ptp180 178.11 -40.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 72.049999999999997 110.449 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -55.17 -53.91 49.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 74.439999999999998 111.771 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.674 ' HA3' ' HG2' ' A' ' 238' ' ' PRO . . . -59.78 -44.98 96.52 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 116.005 -0.543 . . . . 73.239999999999995 114.232 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.51 -42.07 92.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 71.140000000000001 109.452 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.87 -36.12 82.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.734 -0.667 . . . . 74.400000000000006 110.828 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -51.03 71.26 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.997 -0.547 . . . . 71.030000000000001 110.339 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 227' ' ' PHE . 66.9 mt -63.23 -39.73 86.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.425 -0.807 . . . . 73.150000000000006 110.831 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.485 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.3 tp -57.82 -43.45 85.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.344 -0.389 . . . . 74.5 110.392 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.68 97.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.037 -0.602 . . . . 63.420000000000002 112.555 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.49 ' HA ' HG21 ' A' ' 252' ' ' ILE . 35.5 m-85 -67.11 -31.22 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 74.310000000000002 111.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.53 ' SG ' HG23 ' A' ' 178' ' ' ILE . 59.6 m -65.93 -44.13 86.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 72.439999999999998 109.655 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.485 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.1 mtp -61.62 -49.9 74.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.131 -0.94 . . . . 70.099999999999994 111.199 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.659 HD13 ' SD ' ' A' ' 286' ' ' MET . 4.6 tt -61.85 -36.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.993 -0.283 . . . . 73.340000000000003 110.875 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 259' ' ' LEU . 8.7 tt0 -59.77 -50.48 73.68 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.101 -0.24 . . . . 72.310000000000002 111.323 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.13 -31.04 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.744 0.307 . . . . 71.230000000000004 111.186 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.0 tp -84.56 -19.13 33.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.336 0.495 . . . . 72.400000000000006 112.336 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.3 p -106.48 -27.83 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.109 -0.369 . . . . 64.5 111.979 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 113.35 -35.8 4.37 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.575 -0.821 . . . . 40.520000000000003 112.708 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -156.98 165.5 35.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.941 0.371 . . . . 70.209999999999994 110.081 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 253' ' ' GLN . 72.0 mt -94.27 139.61 22.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.201 -0.296 . . . . 75.340000000000003 110.201 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 32.8 Cg_exo -60.59 -27.31 84.62 Favored 'Trans proline' 0 CA--C 1.526 0.122 0 C-N-CA 122.726 2.284 . . . . 73.230000000000004 112.36 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -100.07 10.95 40.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.126 -0.488 . . . . 72.150000000000006 111.057 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.533 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 50.6 tt0 -69.28 -29.59 67.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.237 0.541 . . . . 72.310000000000002 110.906 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.3 -21.56 49.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.025 0.441 . . . . 74.519999999999996 110.733 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.84 5.25 24.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 72.430000000000007 112.012 -173.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 2.7 pp -79.88 8.25 7.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.915 0.388 . . . . 72.530000000000001 111.369 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -67.54 -17.85 64.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 74.109999999999999 110.093 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 16.0 t70 -141.64 134.21 13.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.63 -0.714 . . . . 71.439999999999998 109.522 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 46.9 Cg_exo -56.91 -19.16 30.72 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 123.308 2.672 . . . . 63.509999999999998 114.151 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.59 -53.92 51.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.032 0.444 . . . . 71.340000000000003 111.134 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -67.44 -33.88 76.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.051 -0.522 . . . . 70.400000000000006 110.439 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 225' ' ' ILE . 61.7 t -61.09 -43.08 95.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 71.439999999999998 110.372 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -55.13 -57.1 13.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 73.349999999999994 110.421 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -64.76 -40.87 96.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.94 -0.573 . . . . 73.510000000000005 111.472 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -59.76 -40.47 88.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.496 -0.32 . . . . 73.439999999999998 111.106 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 229' ' ' SER . 44.4 mmtm -66.96 -39.82 87.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.012 -0.275 . . . . 73.519999999999996 110.918 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 58.8 mt -63.95 -49.13 83.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.777 0.322 . . . . 72.420000000000002 110.824 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -57.78 -47.24 83.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 110.974 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.15 -36.26 64.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.312 0.486 . . . . 74.409999999999997 112.312 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -68.48 -29.02 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 75.409999999999997 110.252 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -65.24 0.75 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.975 -0.557 . . . . 75.549999999999997 110.021 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.438 ' O ' HD21 ' A' ' 285' ' ' LEU . 47.2 t30 -107.58 77.54 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 64.450000000000003 110.387 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -48.83 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.283 -0.871 . . . . 74.239999999999995 111.193 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 65.409999999999997 112.205 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 39.3 t -66.23 -48.08 71.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.56 -0.291 . . . . 72.230000000000004 111.041 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -67.13 -34.17 77.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.652 0.241 . . . . 75.019999999999996 111.652 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 252' ' ' ILE . 26.2 mmt -71.06 -37.94 72.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.961 0.41 . . . . 75.239999999999995 111.092 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.4 -38.91 12.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.145 0.424 . . . . 75.209999999999994 112.145 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -78.03 -15.09 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.135 0.421 . . . . 75.010000000000005 112.135 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 88.9 m -76.94 -21.58 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 75.209999999999994 110.516 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.615 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 6.4 m-85 -133.98 86.7 36.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 75.409999999999997 110.64 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.38 -69.03 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.73 2.287 . . . . 62.210000000000001 111.955 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.06 95.51 3.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.104 0.478 . . . . 72.230000000000004 110.271 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 178.61 -52.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.272 -1.01 . . . . 74.409999999999997 108.272 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 290' ' ' PHE . 15.1 t30 -148.58 163.18 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.547 -1.206 . . . . 74.319999999999993 107.946 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.581 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 1.7 tpmt? -136.94 106.22 8.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.504 -0.478 . . . . 71.010000000000005 111.016 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.01 45.14 1.92 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.375 2.716 . . . . 65.540000000000006 111.537 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.58 99.76 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.784 -0.644 . . . . 73.219999999999999 112.319 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.438 ' CD ' ' HD3' ' A' ' 151' ' ' ARG . 28.8 mp0 -62.78 -41.32 99.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.694 -0.484 . . . . 73.239999999999995 109.694 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.429 HG23 ' HB ' ' A' ' 252' ' ' ILE . 15.0 mm -63.93 -46.86 92.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.644 -0.707 . . . . 72.099999999999994 110.28 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.1 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.685 -0.689 . . . . 73.329999999999998 110.971 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.75 -44.52 95.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.776 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -56.62 -50.86 70.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 73.200000000000003 111.586 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.534 ' HA ' HG23 ' A' ' 306' ' ' VAL . 12.3 mtp -70.89 -38.62 73.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.633 -0.258 . . . . 71.409999999999997 111.612 -175.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.3 -35.74 81.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.504 0.668 . . . . 73.5 109.407 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 54.7 m -65.57 -52.85 49.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 71.030000000000001 111.22 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.54 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 35.3 m -67.26 -30.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.05 0.452 . . . . 72.25 110.802 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -57.44 -43.45 83.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 74.329999999999998 110.461 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.91 11.23 21.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 72.030000000000001 111.886 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 305' ' ' THR . 42.9 mt -90.7 -23.29 20.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.874 -0.417 . . . . 74.010000000000005 109.874 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.602 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 28.6 t70 56.48 -156.72 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.447 -0.797 . . . . 64.349999999999994 110.748 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.602 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.1 m-85 -86.16 -33.01 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.916 0.389 . . . . 75.140000000000001 110.112 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.9 t -144.99 26.5 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.209999999999994 111.42 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 7.8 tt0 -92.88 23.19 4.33 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.512 0.672 . . . . 74.439999999999998 109.627 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.14 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 114.34 -1.3 . . . . 73.310000000000002 112.222 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.781 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 93.5 Cg_endo -78.88 119.6 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.823 2.348 . . . . 75.420000000000002 111.799 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.7 tp -93.41 84.36 4.72 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.0 0.429 . . . . 75.310000000000002 110.12 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.466 ' HA ' HD11 ' A' ' 320' ' ' LEU . 74.2 m-85 -60.47 -32.77 71.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.623 -0.717 . . . . 75.510000000000005 110.086 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.78 -46.15 74.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.512 -0.767 . . . . 71.219999999999999 110.541 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.497 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 28.9 t-20 -72.33 -35.28 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.581 -0.282 . . . . 74.209999999999994 110.703 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 97.0 mt -58.39 -52.85 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 70.409999999999997 110.34 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.53 -21.54 61.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 75.450000000000003 110.323 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.04 -50.92 44.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 110.933 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -70.91 -29.59 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.795 -0.362 . . . . 71.219999999999999 110.996 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 85.5 mt -64.8 -49.4 70.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.082 0.468 . . . . 74.019999999999996 110.096 175.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.94 -26.76 64.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 75.319999999999993 110.945 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -58.48 -47.81 82.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 109.853 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.409 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -74.97 -39.88 36.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.819 -0.705 . . . . 61.539999999999999 112.368 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.462 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 2.6 tm? -57.67 -49.44 76.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.19 0.519 . . . . 72.400000000000006 110.204 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -24.61 58.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.431 -0.349 . . . . 73.439999999999998 111.477 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.63 91.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 75.040000000000006 111.184 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -88.21 -9.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.246 0.546 . . . . 63.310000000000002 110.602 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 69.49 20.86 75.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.928 -0.653 . . . . 72.109999999999999 112.952 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -131.73 138.64 48.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.803 0.302 . . . . 63.32 110.993 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 334' ' ' LYS . 26.6 mtmt -113.35 -73.07 0.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.859 0.838 . . . . 73.010000000000005 109.047 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -167.53 -39.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.069 -1.423 . . . . 71.329999999999998 107.718 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.6 t0 69.72 32.7 3.17 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 114.461 -1.245 . . . . 65.209999999999994 110.973 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.64 14.22 41.4 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.965 -0.636 . . . . 71.310000000000002 112.696 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 110.272 -0.27 . . . . 73.430000000000007 110.272 -176.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.62 ' HZ2' ' HB2' ' A' ' 181' ' ' SER . 65.8 mttm . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.097 -0.705 . . . . 74.120000000000005 109.097 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.649 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 12.0 t -169.63 140.14 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.109 -0.33 . . . . 73.319999999999993 110.109 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 138.37 22.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.799 -0.445 . . . . 73.209999999999994 109.799 178.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 32.8 m -68.55 80.92 0.27 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.352 0.596 . . . . 54.409999999999997 112.174 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 74.219999999999999 110.243 171.587 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.487 HG11 ' HA2' ' A' ' 40' ' ' GLY . 84.7 t . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.642 . . . . 71.109999999999999 109.265 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.99 2.13 56.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.147 -1.025 . . . . 43.340000000000003 113.422 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 31.3 mt-10 -78.72 140.79 38.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.282 0.541 . . . . 73.319999999999993 110.414 174.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -82.18 131.75 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 72.109999999999999 111.153 -175.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.59 135.04 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.08 -0.964 . . . . 72.340000000000003 108.943 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -115.64 133.73 55.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 63.439999999999998 110.28 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -97.58 -172.5 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.844 -0.428 . . . . 72.219999999999999 109.844 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.784 ' HA ' ' HE1' ' A' ' 32' ' ' MET . 18.5 mmt -72.49 -20.02 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 71.319999999999993 110.99 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 12.93 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.538 -0.301 . . . . 71.519999999999996 110.983 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 11.6 mptt 65.86 33.14 8.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.911 -0.586 . . . . 70.239999999999995 112.404 172.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmpp? -83.58 115.16 21.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.891 -0.781 . . . . 75.109999999999999 108.891 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.34 84.28 3.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.347 0.594 . . . . 72.439999999999998 109.953 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 46.0 p-90 -114.84 149.73 36.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.724 -0.671 . . . . 72.310000000000002 110.933 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.845 ' HG2' ' HB2' ' A' ' 57' ' ' ASN . 18.2 pttp -98.57 134.46 41.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 74.409999999999997 109.377 173.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.06 132.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.694 -0.484 . . . . 64.219999999999999 109.694 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.487 ' HA2' HG11 ' A' ' 25' ' ' VAL . . . -107.56 -133.41 7.15 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.722 -0.751 . . . . 65.230000000000004 112.564 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.8 tp -66.55 125.23 90.17 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.97 0.414 . . . . 74.239999999999995 111.667 -177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 108.99 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.394 2.063 . . . . 63.439999999999998 110.946 171.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.493 HG22 ' HG2' ' A' ' 45' ' ' GLN . 47.5 mt -76.35 -52.32 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 63.130000000000003 109.709 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.88 -18.17 17.56 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.867 -0.682 . . . . 73.310000000000002 112.641 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.523 ' HB2' ' OD2' ' A' ' 137' ' ' ASP . 20.0 pt20 -124.45 165.14 18.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.676 -0.49 . . . . 72.230000000000004 109.676 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.97 66.26 0.15 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.794 -0.717 . . . . 62.210000000000001 111.916 -172.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 181' ' ' SER . . . 80.5 -88.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.998 -0.62 . . . . 65.400000000000006 112.83 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -89.59 -13.66 36.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 111.253 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.32 167.46 42.79 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.838 -0.696 . . . . 34.329999999999998 113.143 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.2 m 62.77 35.11 14.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.172 0.511 . . . . 62.009999999999998 111.56 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 71' ' ' LYS . 5.3 mm -89.27 138.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 75.239999999999995 109.668 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.13 138.67 49.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.95 0.405 . . . . 73.239999999999995 111.088 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.441 HD21 HG12 ' A' ' 69' ' ' VAL . 3.5 tm? -73.02 127.21 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.706 -0.85 . . . . 75.230000000000004 108.706 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.02 91.37 7.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.279 0.562 . . . . 72.439999999999998 109.698 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.74 61.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.82 . . . . 72.030000000000001 109.03 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -35.8 127.96 0.66 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.65 -1.159 . . . . 75.340000000000003 112.302 -175.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.845 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 65.5 t30 -93.63 79.67 4.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.614 -0.721 . . . . 75.430000000000007 110.718 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 p -126.31 145.87 50.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.89 0.376 . . . . 72.140000000000001 110.964 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.81 -0.632 . . . . 75.310000000000002 109.785 173.264 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.273 0.559 . . . . 71.340000000000003 109.585 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.531 ' HA ' ' CZ ' ' A' ' 133' ' ' ARG . 4.5 Cg_endo -84.08 25.57 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.457 2.771 . . . . 75.439999999999998 112.424 -170.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' HG23 ' A' ' 130' ' ' ILE . 9.6 p -162.05 142.26 10.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.483 0.658 . . . . 61.43 112.566 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' A' ' 133' ' ' ARG . 35.8 m -127.98 149.1 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.163 -0.926 . . . . 72.319999999999993 108.684 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.564 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -121.12 126.06 74.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.066 0.46 . . . . 74.430000000000007 109.954 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.784 ' HB3' HG23 ' A' ' 51' ' ' ILE . 25.1 pttm -111.13 139.87 46.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.291 -0.964 . . . . 63.0 109.944 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' A' ' 128' ' ' PHE . 32.7 m -110.53 151.28 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.98 -1.009 . . . . 74.209999999999994 111.881 -168.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.716 ' OE1' ' HA ' ' A' ' 77' ' ' ASN . 43.1 tt0 -127.31 130.23 23.76 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.854 -1.066 . . . . 64.519999999999996 108.246 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -174.27 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.301 2.001 . . . . 73.439999999999998 112.272 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -66.34 71.86 0.07 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.28 0.562 . . . . 52.229999999999997 110.723 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -141.06 -59.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.772 -0.649 . . . . 62.439999999999998 109.309 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 69.97 87.91 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.305 1.003 . . . . 63.039999999999999 111.213 175.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.79 -80.07 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 64.439999999999998 112.547 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.57 -45.04 19.17 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.554 2.169 . . . . 74.230000000000004 112.668 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.444 HD11 ' HE2' ' A' ' 71' ' ' LYS . 62.4 tp -73.18 -38.61 66.09 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.52 -0.548 . . . . 72.540000000000006 109.52 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.425 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 90.8 t80 -55.96 -44.0 78.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.036 -0.529 . . . . 75.450000000000003 110.579 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . 0.412 HG22 ' HA2' ' A' ' 199' ' ' GLY . 36.8 m -67.17 -49.64 64.0 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 115.879 -0.6 . . . . 74.329999999999998 111.4 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 197' ' ' ASP . 5.6 pt-20 -73.16 -24.14 60.53 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.057 -0.657 . . . . 71.510000000000005 110.923 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -64.13 -43.19 96.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.441 -0.577 . . . . 74.450000000000003 109.441 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 81' ' ' PHE . 32.4 mmmt -59.76 -48.33 82.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.051 -0.522 . . . . 74.349999999999994 110.483 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.69 -45.38 83.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.091 -0.504 . . . . 74.540000000000006 110.797 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 113' ' ' TYR . 47.5 t80 -61.58 -46.29 90.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.795 . . . . 73.129999999999995 110.975 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.0 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.284 . . . . 63.140000000000001 110.941 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.35 -39.82 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 75.519999999999996 110.685 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.61 15.64 27.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.056 0.455 . . . . 75.299999999999997 111.586 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 113' ' ' TYR . . . -80.45 40.22 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.114 -0.494 . . . . 75.209999999999994 112.195 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.75 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -138.59 114.98 8.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.523 -0.308 . . . . 73.5 110.617 -177.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.81 -31.08 91.45 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.545 2.163 . . . . 72.25 111.488 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.75 ' HG2' ' HB3' ' A' ' 92' ' ' LYS . 10.6 pt-20 -54.86 -53.0 61.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.601 -0.727 . . . . 74.109999999999999 111.132 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HG3' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt-30 -72.17 -43.89 63.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.968 -0.56 . . . . 74.120000000000005 110.177 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.495 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.6 mt -53.87 -54.49 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 111.006 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.4 -32.72 71.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 71.109999999999999 110.718 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -58.39 -59.19 5.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.156 -0.475 . . . . 75.430000000000007 110.957 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.606 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.1 -31.81 70.79 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 120.162 -0.615 . . . . 75.140000000000001 110.774 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 96' ' ' ILE . 20.4 mt -54.49 -47.28 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 121.191 -0.203 . . . . 75.439999999999998 111.252 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -72.61 -35.24 67.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.041 -0.664 . . . . 71.430000000000007 110.954 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.6 m -70.52 -40.47 73.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.128 0.489 . . . . 71.310000000000002 111.979 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.635 ' HG2' HD11 ' A' ' 105' ' ' LEU . 5.3 tpt180 -87.12 -9.57 54.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.359 . . . . 74.299999999999997 110.982 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 67.93 37.99 2.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.966 0.889 . . . . 75.150000000000006 109.541 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.7 ' HG ' ' HB2' ' A' ' 163' ' ' ASP . 1.5 tp -79.81 170.69 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.974 -1.012 . . . . 74.299999999999997 109.301 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HB3' HH22 ' A' ' 160' ' ' ARG . 9.3 tmtm? -113.33 -56.98 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.277 -0.569 . . . . 75.239999999999995 110.711 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -151.86 120.72 6.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.737 0.303 . . . . 74.340000000000003 110.235 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.606 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 33.5 tp -79.26 130.87 35.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.041 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.61 49.0 2.68 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.906 -0.664 . . . . 72.25 113.068 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.58 118.79 15.9 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 110.118 -0.327 . . . . 73.209999999999994 110.118 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 134' ' ' PHE . 92.5 Cg_endo -80.08 161.17 23.6 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.265 2.643 . . . . 75.340000000000003 113.468 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.36 137.25 58.24 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.742 -0.663 . . . . 74.0 111.436 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 91' ' ' ALA . 40.5 t80 -94.33 133.49 37.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.351 -0.84 . . . . 75.329999999999998 110.33 177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.454 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 39.2 m95 -112.66 -36.39 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.047 -0.261 . . . . 74.140000000000001 111.699 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.87 48.3 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.484 -0.865 . . . . 63.229999999999997 112.601 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 80.3 p -169.71 166.71 9.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 65.310000000000002 109.939 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.53 174.12 33.02 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.205 -0.998 . . . . 74.219999999999999 112.644 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 125' ' ' SER . 10.1 tt -118.53 127.24 53.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.085 -0.709 . . . . 75.140000000000001 109.085 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -131.29 119.72 22.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.989 0.423 . . . . 73.230000000000004 110.192 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 37.9 t70 -74.29 120.8 20.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 72.150000000000006 109.572 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.68 -60.47 2.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.199 0.523 . . . . 64.209999999999994 110.312 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -178.41 96.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.883 -1.053 . . . . 74.299999999999997 108.3 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 -37.18 2.33 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.71 -0.757 . . . . 70.310000000000002 111.787 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -110.44 131.69 54.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.185 -0.302 . . . . 73.400000000000006 110.185 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 19.4 m -103.04 118.46 36.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.125 -0.489 . . . . 74.430000000000007 109.809 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.38 124.75 43.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.114 0.483 . . . . 72.310000000000002 111.017 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -98.41 120.29 38.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.183 -1.043 . . . . 72.400000000000006 108.183 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.525 ' HB3' HG11 ' A' ' 72' ' ' VAL . 35.0 p90 -139.1 163.99 30.97 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.741 -0.384 . . . . 75.030000000000001 111.554 -171.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 26.0 ptt? -146.58 146.42 30.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.309 0.576 . . . . 72.310000000000002 111.635 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.564 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -96.68 124.37 49.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.439 -1.255 . . . . 75.329999999999998 110.631 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 16.6 ptm -130.66 176.46 8.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.147 -0.933 . . . . 74.519999999999996 109.014 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' O ' HG21 ' A' ' 69' ' ' VAL . 12.6 t70 -65.81 170.37 5.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.645 -0.422 . . . . 62.219999999999999 110.079 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.974 ' HD2' ' HB2' ' A' ' 188' ' ' LYS . 4.1 ptp180 -67.93 113.59 5.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.873 0.844 . . . . 74.219999999999999 112.639 -167.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -115.26 171.3 7.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.107 -0.951 . . . . 75.340000000000003 109.433 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.65 -43.4 0.18 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.624 -1.274 . . . . 72.519999999999996 113.389 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.74 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.3 m -80.63 122.41 27.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.945 0.402 . . . . 72.030000000000001 111.479 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 45' ' ' GLN . 5.1 m-20 -88.55 129.11 35.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.613 -0.721 . . . . 62.009999999999998 110.065 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 141' ' ' ILE . 14.8 tp -66.82 -29.96 70.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.389 0.614 . . . . 74.439999999999998 109.379 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.499 ' CG ' ' HB3' ' A' ' 137' ' ' ASP . 20.3 pt20 -62.56 -44.28 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.291 -0.868 . . . . 71.0 111.403 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.421 ' HG3' ' HG3' ' A' ' 139' ' ' GLN . 63.2 mttp -78.8 -11.43 59.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.942 0.401 . . . . 74.530000000000001 110.715 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.467 HD13 ' HA ' ' A' ' 138' ' ' LEU . 94.3 mt -74.9 -51.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.481 . . . . 73.530000000000001 110.145 172.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.823 ' HB2' ' HA ' ' A' ' 147' ' ' LYS . 1.1 p90 -72.08 -32.32 66.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.533 -0.467 . . . . 75.329999999999998 110.155 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.06 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.323 . . . . 75.510000000000005 110.845 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.88 -32.35 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.385 . . . . 64.219999999999999 111.378 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 50.0 t30 -104.41 19.78 19.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.75 -0.38 . . . . 75.310000000000002 111.773 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 54.57 32.42 16.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.869 0.468 . . . . 62.310000000000002 112.19 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.823 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 31.1 ttmt 65.43 22.32 11.91 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.586 -0.734 . . . . 74.349999999999994 112.0 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 145' ' ' ASN . 30.0 mmt180 -83.35 107.56 15.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.462 -0.57 . . . . 71.010000000000005 109.462 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -112.75 152.19 29.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 110.772 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 p -89.22 172.78 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 64.209999999999994 110.614 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 37.5 mmm-85 -68.23 -35.92 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 73.310000000000002 111.275 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -73.26 -39.74 65.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.799 -175.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.0 p -64.86 -56.17 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 111.237 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.438 ' CG1' ' HG3' ' A' ' 251' ' ' MET . 40.5 t -59.8 -37.43 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.085 -0.507 . . . . 75.430000000000007 110.919 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.812 HD23 ' HG ' ' A' ' 328' ' ' LEU . 15.0 tp -56.62 -51.22 69.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.646 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -68.0 -33.57 74.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.032 -0.531 . . . . 62.450000000000003 110.719 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 153' ' ' THR . 95.4 mt -61.7 -50.8 70.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 75.430000000000007 110.202 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -55.0 -37.9 67.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 72.219999999999999 110.942 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.92 -45.96 91.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.662 -0.244 . . . . 72.109999999999999 111.472 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.644 ' HA ' ' NE ' ' A' ' 160' ' ' ARG . 9.7 mmp_? -63.31 -38.61 91.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.134 0.493 . . . . 73.129999999999995 111.51 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.505 ' HA ' HG23 ' A' ' 164' ' ' ILE . 1.8 mp -71.81 -32.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.585 -0.446 . . . . 71.109999999999999 109.987 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -59.22 -56.0 27.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.497 -0.319 . . . . 74.129999999999995 111.321 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.7 ' HB2' ' HG ' ' A' ' 105' ' ' LEU . 43.4 p-10 -78.1 -24.64 47.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.049 -0.66 . . . . 75.0 112.018 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 161' ' ' ILE . 12.1 tt -72.89 -36.49 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.268 -0.573 . . . . 72.150000000000006 110.41 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 168' ' ' ILE . 42.6 mt -65.26 -38.1 89.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.288 . . . . 73.340000000000003 110.456 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -56.5 -51.69 67.54 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.4 0.619 . . . . 74.219999999999999 110.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -61.21 -49.98 74.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.132 -0.94 . . . . 74.129999999999995 112.29 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.484 HD13 HD22 ' A' ' 165' ' ' LEU . 35.1 pt -71.35 -37.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.277 -0.569 . . . . 74.310000000000002 111.518 -175.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.626 ' HA ' HG12 ' A' ' 174' ' ' VAL . 62.9 t-80 -68.54 -40.86 80.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.372 -0.531 . . . . 75.340000000000003 111.554 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.54 13.86 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.379 -0.529 . . . . 63.039999999999999 111.294 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.2 78.76 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.503 0.668 . . . . 74.140000000000001 111.352 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 2.7 mp0 72.78 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.266 -1.334 . . . . 64.409999999999997 113.289 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.4 ' HB3' ' CB ' ' A' ' 201' ' ' ALA . 91.7 m-85 -80.79 118.13 22.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.023 0.749 . . . . 75.340000000000003 113.023 -162.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' ' 169' ' ' HIS . 3.2 m -125.72 138.92 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.831 -0.622 . . . . 70.200000000000003 110.283 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 1.057 ' HB2' ' HA ' ' A' ' 201' ' ' ALA . 4.6 t-80 -175.68 -50.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.0 0.428 . . . . 70.540000000000006 110.94 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.35 -75.93 0.29 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.077 -0.809 . . . . 70.450000000000003 111.077 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.92 34.54 13.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.051 0.453 . . . . 74.230000000000004 111.764 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 161' ' ' ILE . 21.4 mm -79.39 65.26 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.026 0.917 . . . . 72.140000000000001 110.018 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.878 ' HE3' HG21 ' A' ' 224' ' ' THR . 12.8 mmtt -103.4 141.65 35.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 75.439999999999998 109.157 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.53 47.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.197 0.522 . . . . 72.340000000000003 110.807 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.626 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 11.7 p -77.09 -19.28 57.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 74.549999999999997 111.552 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.485 ' OD1' ' HE3' ' A' ' 352' ' ' LYS . 17.2 m120 -114.4 2.58 14.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.668 0.27 . . . . 73.150000000000006 111.231 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.493 HD21 HD11 ' A' ' 161' ' ' ILE . 10.7 mp -104.13 111.21 23.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.095 -0.705 . . . . 74.420000000000002 109.095 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 47' ' ' GLY . 3.7 mm? -113.57 130.81 56.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.056 0.455 . . . . 73.540000000000006 111.688 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.74 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 94.1 mt -75.06 145.62 42.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.385 -0.825 . . . . 75.140000000000001 110.432 173.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 24.2 t-20 -73.7 137.48 44.08 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.523 -0.917 . . . . 74.519999999999996 108.523 172.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.739 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 33.2 t80 -62.77 -31.14 72.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.095 0.474 . . . . 74.019999999999996 111.11 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.974 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 6.2 tmtm? -91.57 -45.55 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.973 -0.558 . . . . 75.349999999999994 110.151 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 48.6 m-80 -104.88 100.05 22.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.431 -0.349 . . . . 73.420000000000002 110.852 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.06 -6.15 13.04 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.975 2.45 . . . . 75.340000000000003 113.237 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.428 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 8.9 p-10 -92.86 -1.01 57.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.719 0.266 . . . . 74.209999999999994 111.719 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.476 ' OE1' ' HD2' ' A' ' 160' ' ' ARG . 84.4 mm-40 -129.09 129.73 45.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.383 . . . . 73.439999999999998 111.06 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.03 143.31 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 74.430000000000007 110.269 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.803 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 36.8 m-85 -118.56 155.11 31.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 109.824 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.444 HD13 HD13 ' A' ' 164' ' ' ILE . 11.3 mt -95.93 146.41 24.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.686 0.279 . . . . 73.030000000000001 110.964 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -120.84 -171.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.399 -0.593 . . . . 63.200000000000003 109.399 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.584 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 8.2 t70 76.25 -71.77 0.11 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.634 0.584 . . . . 74.420000000000002 110.638 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.445 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 23.1 m-85 58.03 9.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.545 0.943 . . . . 72.040000000000006 113.545 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.658 ' HA3' ' CG2' ' A' ' 354' ' ' ILE . . . -100.1 -33.98 5.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.937 -1.125 . . . . 61.439999999999998 114.444 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.523 ' CD1' ' HZ1' ' A' ' 352' ' ' LYS . 8.5 mp -68.41 -23.03 64.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.369 0.584 . . . . 74.409999999999997 110.018 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 1.057 ' HA ' ' HB2' ' A' ' 175' ' ' HIS . . . -58.48 112.35 1.55 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.518 -0.764 . . . . 73.530000000000001 110.054 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' A' ' 356' ' ' LYS . 6.4 t80 -98.47 132.37 43.97 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.56 -0.904 . . . . 75.329999999999998 108.56 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 7.1 ppt_? -86.54 141.56 28.96 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.405 0.521 . . . . 74.200000000000003 112.405 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.78 ' HB2' HG12 ' A' ' 209' ' ' VAL . 32.1 m-85 -69.67 -92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.309 -0.859 . . . . 72.140000000000001 109.947 170.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 40.1 m -142.48 141.23 20.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.889 -1.051 . . . . 72.25 108.793 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.71 104.65 0.11 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.945 2.43 . . . . 73.099999999999994 112.454 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 62.1 22.15 12.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.448 -0.797 . . . . 73.140000000000001 111.564 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.58 42.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.04 -0.824 . . . . 73.219999999999999 111.04 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.78 HG12 ' HB2' ' A' ' 204' ' ' TYR . 15.8 m -59.29 109.89 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.483 0.659 . . . . 75.230000000000004 112.611 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 t60 179.85 124.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.266 -0.879 . . . . 73.239999999999995 109.156 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -152.67 163.38 39.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.554 -0.906 . . . . 70.140000000000001 108.554 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -112.25 174.95 5.64 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.516 -0.55 . . . . 64.319999999999993 109.516 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -61.82 101.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 112.245 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -105.0 -3.41 23.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 74.120000000000005 110.057 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.422 ' HG3' HD22 ' A' ' 234' ' ' ASN . 43.0 tt0 66.03 -76.27 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 114.851 -1.068 . . . . 72.420000000000002 111.689 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -118.43 100.64 51.43 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.953 0.406 . . . . 75.349999999999994 111.917 -171.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 C-N-CA 122.71 2.273 . . . . 74.450000000000003 112.066 171.999 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.44 ' O ' HD22 ' A' ' 200' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.109 0.481 . . . . 71.239999999999995 110.316 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 162.74 177.9 36.13 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.177 -0.919 . . . . 70.439999999999998 110.924 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.878 HG21 ' HE3' ' A' ' 179' ' ' LYS . 23.6 p -78.63 117.12 19.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 74.540000000000006 110.574 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.576 ' HA ' ' HB ' ' A' ' 228' ' ' THR . 57.9 mt -63.0 -21.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 72.519999999999996 112.124 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.463 ' HG3' HD13 ' A' ' 265' ' ' LEU . 1.6 mp0 -58.26 -42.89 87.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.013 0.435 . . . . 75.409999999999997 110.273 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.587 ' HE1' ' HA ' ' A' ' 250' ' ' CYS . 97.8 m-85 -102.25 -18.44 15.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.604 -0.726 . . . . 74.319999999999993 110.69 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.576 ' HB ' ' HA ' ' A' ' 225' ' ' ILE . 90.7 m -66.78 108.6 2.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.525 . . . . 75.209999999999994 110.982 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.9 p -73.29 -173.52 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.315 -0.857 . . . . 73.209999999999994 110.791 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.16 -38.05 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 72.420000000000002 110.317 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.62 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.447 -0.797 . . . . 71.549999999999997 111.353 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 228' ' ' THR . . . -58.06 -44.83 87.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 64.209999999999994 111.718 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -61.35 -37.33 82.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.86 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.422 HD22 ' HG3' ' A' ' 215' ' ' GLU . 29.0 t-20 -74.25 -36.88 63.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 63.340000000000003 110.535 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.87 -19.77 12.04 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.748 -0.739 . . . . 71.510000000000005 112.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.63 134.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 73.439999999999998 110.699 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.47 114.33 55.85 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.093 -0.503 . . . . 70.299999999999997 110.444 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.558 ' HB2' ' H ' ' A' ' 242' ' ' GLY . 87.1 Cg_endo -80.83 147.74 17.19 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.819 2.346 . . . . 74.409999999999997 112.428 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.411 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 49.0 m -88.55 69.77 8.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.934 0.397 . . . . 72.299999999999997 110.543 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.534 ' O ' HD22 ' A' ' 244' ' ' LEU . 20.2 mtp180 73.29 -4.76 2.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.39 -0.823 . . . . 75.450000000000003 111.461 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -56.74 7.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.457 . . . . 72.430000000000007 109.838 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.558 ' H ' ' HB2' ' A' ' 238' ' ' PRO . . . -71.22 -36.31 63.74 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.837 -0.697 . . . . 45.030000000000001 112.034 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 240' ' ' ARG . 5.0 m-20 -54.41 -49.53 69.73 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.375 0.607 . . . . 75.310000000000002 110.003 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 240' ' ' ARG . 4.4 mm? -72.04 -32.68 67.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 74.140000000000001 111.656 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.65 -38.03 80.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.384 -0.526 . . . . 74.439999999999998 110.553 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 242' ' ' GLY . 60.4 mt -59.81 -44.22 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.318 -0.253 . . . . 72.540000000000006 110.318 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 161' ' ' ILE . 53.6 tp -60.57 -36.35 78.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.879 0.371 . . . . 75.299999999999997 110.429 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.64 95.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.907 -0.663 . . . . 73.430000000000007 111.684 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -62.14 -44.59 96.29 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.053 -0.351 . . . . 75.019999999999996 110.053 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.587 ' HA ' ' HE1' ' A' ' 227' ' ' PHE . 39.3 m -59.31 -50.19 74.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 75.329999999999998 110.709 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.438 ' HG3' ' CG1' ' A' ' 154' ' ' VAL . 26.7 ttt -60.15 -48.53 81.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.536 -0.756 . . . . 73.219999999999999 111.583 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.407 HG23 HD22 ' A' ' 259' ' ' LEU . 12.9 tt -68.1 -33.35 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.752 -0.379 . . . . 75.450000000000003 110.872 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.677 ' HG2' ' HD3' ' A' ' 147' ' ' LYS . 8.5 tt0 -66.82 -46.95 73.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.633 -0.258 . . . . 73.200000000000003 110.738 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -66.85 -27.98 67.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.048 0.452 . . . . 72.430000000000007 110.747 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . 0.428 HD13 ' ND2' ' A' ' 294' ' ' ASN . 24.0 tp -77.65 -28.64 51.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.52 . . . . 72.439999999999998 111.457 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 290' ' ' PHE . 27.8 p -101.47 -27.31 13.2 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.232 0.456 . . . . 72.510000000000005 112.232 -173.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.47 ' HA3' ' NH1' ' A' ' 148' ' ' ARG . . . 96.79 -37.27 3.5 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.573 -0.822 . . . . 74.450000000000003 111.579 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.14 142.21 19.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.75 -0.463 . . . . 75.120000000000005 109.75 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.557 HD12 ' CZ2' ' A' ' 261' ' ' TRP . 89.4 mt -97.5 145.05 29.03 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.137 -0.483 . . . . 74.439999999999998 110.406 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.07 -20.53 61.43 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.702 2.268 . . . . 74.329999999999998 112.875 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.578 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 12.6 p90 -106.58 -2.79 21.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.424 -0.511 . . . . 75.420000000000002 111.969 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.583 ' O ' HD23 ' A' ' 265' ' ' LEU . 8.2 pt-20 -86.36 -25.92 25.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.901 -0.719 . . . . 74.120000000000005 109.662 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.94 -37.34 55.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.607 0.718 . . . . 72.010000000000005 109.668 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -108.86 27.58 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.02 . . . . 74.209999999999994 111.588 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 262' ' ' GLU . 1.4 pt? -86.05 -2.0 57.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.951 0.405 . . . . 72.319999999999993 111.062 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.6 -8.64 43.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.917 -0.583 . . . . 74.239999999999995 111.44 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.469 ' OD1' ' HG3' ' A' ' 269' ' ' LYS . 10.4 t0 -128.25 122.99 22.27 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.874 -0.417 . . . . 61.020000000000003 109.874 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.05 -26.34 25.27 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.57 2.847 . . . . 74.120000000000005 114.041 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.7 mttp -55.03 -50.09 69.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.865 0.364 . . . . 73.099999999999994 110.882 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -73.97 -36.35 64.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 74.409999999999997 111.844 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.489 HG11 ' HZ3' ' A' ' 275' ' ' LYS . 60.2 t -56.92 -50.53 75.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.891 0.377 . . . . 73.349999999999994 110.39 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -67.32 -42.85 82.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.872 -0.603 . . . . 71.340000000000003 110.59 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 277' ' ' ARG . 18.4 t70 -55.26 -61.74 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.631 -0.713 . . . . 75.140000000000001 110.65 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.2 p -57.01 -47.86 79.86 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.647 0.592 . . . . 73.549999999999997 112.253 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.489 ' HZ3' HG11 ' A' ' 271' ' ' VAL . 53.5 mttp -58.73 -49.78 76.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.209 0.448 . . . . 73.140000000000001 112.209 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.94 -37.95 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.369 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 273' ' ' ASP . 27.6 ttt180 -58.16 -44.02 87.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.474 -0.784 . . . . 73.310000000000002 110.761 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -73.22 -31.25 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.976 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.577 ' HA ' ' HD3' ' A' ' 307' ' ' LYS . 2.0 ttp180 -67.18 -23.46 65.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.628 -0.26 . . . . 74.230000000000004 111.207 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.03 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.986 0.422 . . . . 75.25 110.829 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.437 ' O ' HD21 ' A' ' 285' ' ' LEU . 2.8 t-20 -110.18 94.36 4.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.251 -0.648 . . . . 73.109999999999999 109.251 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.609 ' HB ' ' HG2' ' A' ' 304' ' ' GLU . 12.9 mt -80.4 -47.74 20.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.319 -0.855 . . . . 71.450000000000003 111.599 -170.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' HB1' ' OE2' ' A' ' 304' ' ' GLU . . . -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 71.420000000000002 112.341 -171.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.5 t -61.1 -41.37 96.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.651 0.241 . . . . 75.310000000000002 111.651 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 281' ' ' ASN . 4.4 mm? -72.16 -42.99 65.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.705 0.288 . . . . 74.340000000000003 110.998 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -74.33 -34.46 63.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.847 0.356 . . . . 70.319999999999993 110.987 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.745 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 14.2 t70 -70.43 -33.65 71.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 75.040000000000006 110.174 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -76.87 -11.48 59.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 74.040000000000006 111.369 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.3 m -63.74 -55.29 24.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.752 0.311 . . . . 75.420000000000002 110.975 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.448 ' CE1' ' HD2' ' A' ' 293' ' ' LYS . 50.5 m-85 -136.76 73.0 54.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 74.349999999999994 111.299 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.23 -53.62 3.39 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.394 2.063 . . . . 74.420000000000002 112.28 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -120.58 -25.13 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.45 0.537 . . . . 72.310000000000002 112.45 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 293' ' ' LYS . 9.7 tmtm? -71.56 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.5 110.683 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.428 ' ND2' HD13 ' A' ' 255' ' ' LEU . 25.2 t-20 -158.89 -90.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.984 -0.286 . . . . 75.319999999999993 110.791 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.563 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 28.8 tptp 172.75 115.64 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-O 120.825 0.345 . . . . 75.219999999999999 110.348 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.745 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 95.8 Cg_endo -89.88 59.94 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.99 2.46 . . . . 75.510000000000005 111.612 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.94 -83.02 1.56 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.391 -0.909 . . . . 64.219999999999999 113.06 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.502 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -53.63 -54.98 29.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.795 0.438 . . . . 60.140000000000001 111.14 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.417 ' H ' HD11 ' A' ' 299' ' ' ILE . 4.0 mp -58.26 -42.56 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 73.129999999999995 111.278 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.24 -54.1 48.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 73.349999999999994 111.019 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -65.48 -37.83 87.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.137 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 17.7 t80 -58.53 -42.81 88.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.224 0.535 . . . . 73.420000000000002 110.278 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.576 ' HE2' ' HA ' ' A' ' 303' ' ' MET . 1.0 OUTLIER -65.34 -47.05 77.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.449 -0.796 . . . . 72.519999999999996 111.051 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.609 ' HG2' ' HB ' ' A' ' 282' ' ' ILE . 46.8 mt-10 -59.12 -47.04 86.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 109.837 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 88.1 m -57.67 -52.19 66.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.259 -0.882 . . . . 73.439999999999998 112.154 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.551 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 33.4 m -67.92 -27.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 73.530000000000001 111.485 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 279' ' ' ARG . 44.0 mttp -80.81 -16.26 54.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 74.209999999999994 110.891 176.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 82.6 mt -89.62 0.74 56.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.540000000000006 110.664 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 314' ' ' LYS . 27.6 mt -79.81 0.19 31.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.3 0.571 . . . . 73.25 109.718 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.3 t70 64.55 -88.44 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.611 -1.177 . . . . 64.230000000000004 111.939 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -153.73 -48.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.204 0.526 . . . . 74.510000000000005 110.415 -173.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.9 m -140.06 33.53 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.553 . . . . 73.150000000000006 110.841 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -82.99 -88.65 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.102 -0.374 . . . . 73.530000000000001 111.482 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.646 ' O ' HD23 ' A' ' 309' ' ' LEU . 10.3 ptpp? -175.98 154.25 1.42 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.12 -0.696 . . . . 74.409999999999997 109.12 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 240' ' ' ARG . 96.3 Cg_endo -90.66 125.75 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.213 1.942 . . . . 73.340000000000003 110.807 167.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 316' ' ' LEU . 7.5 tp -79.48 79.66 5.92 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.23 -0.656 . . . . 74.140000000000001 109.23 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.433 ' CE1' HD13 ' A' ' 162' ' ' LEU . 73.7 t80 -55.51 -49.37 72.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.973 -1.012 . . . . 75.430000000000007 112.524 -171.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -34.36 70.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.611 -0.268 . . . . 64.340000000000003 111.179 -175.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.25 -45.71 69.08 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.336 -0.246 . . . . 74.439999999999998 110.336 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.86 -45.22 86.64 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.318 -0.401 . . . . 75.219999999999999 110.795 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.25 -42.26 93.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 72.230000000000004 110.275 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.97 -55.51 32.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 73.349999999999994 111.202 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.49 -28.14 42.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.677 0.275 . . . . 74.540000000000006 111.401 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 155' ' ' LEU . 27.0 tp -66.71 -50.92 61.25 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.474 0.654 . . . . 74.319999999999993 110.125 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 325' ' ' LEU . 4.4 mm? -73.35 -32.81 64.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 73.140000000000001 110.441 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.85 -47.54 80.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 74.099999999999994 110.773 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.2 -40.77 96.97 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 52.329999999999998 112.061 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.812 ' HG ' HD23 ' A' ' 155' ' ' LEU . 2.3 tm? -68.96 -41.6 77.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.098 0.475 . . . . 73.530000000000001 110.153 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.98 -25.3 67.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 72.439999999999998 110.681 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.57 -22.57 63.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 72.430000000000007 112.34 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 328' ' ' LEU . 13.5 tt -92.25 -1.07 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.338 0.589 . . . . 74.200000000000003 110.694 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.82 24.11 33.66 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.451 -0.88 . . . . 74.310000000000002 112.622 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.2 m -128.86 169.37 14.67 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 122.748 -0.266 . . . . 72.010000000000005 110.407 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -159.22 -154.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.296 -0.631 . . . . 73.230000000000004 109.296 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.97 116.96 4.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.609 0.242 . . . . 65.150000000000006 111.014 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.71 89.66 3.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.094 -0.503 . . . . 73.450000000000003 111.493 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 68.4 13.36 65.12 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.004 -0.544 . . . . 64.400000000000006 114.165 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 338' ' ' LYS . 29.8 mmtm . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.684 0.624 . . . . 75.010000000000005 112.684 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.523 ' HZ1' ' CD1' ' A' ' 200' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 110.301 -0.259 . . . . 75.25 110.301 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 41.7 m -107.65 139.72 41.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.507 -0.315 . . . . 64.409999999999997 110.848 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.658 ' CG2' ' HA3' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -68.83 134.18 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.833 0.349 . . . . 75.129999999999995 110.73 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 12.3 t -93.41 142.55 27.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 71.219999999999999 111.885 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.636 ' HA ' ' HE2' ' A' ' 202' ' ' TYR . 23.5 pttm . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 115.096 -0.956 . . . . 74.319999999999993 108.978 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG13 ' HA2' ' A' ' 40' ' ' GLY . 66.4 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.114 -0.328 . . . . 72.519999999999996 110.114 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 38' ' ' LYS . . . 100.38 2.86 55.61 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.96 -0.638 . . . . 72.510000000000005 112.856 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.04 130.95 44.8 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.81 -0.811 . . . . 75.310000000000002 108.81 173.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -86.53 128.86 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 75.439999999999998 111.505 -172.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -125.87 129.81 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.915 . . . . 74.150000000000006 109.939 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.7 m -104.29 123.13 46.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.075 -0.511 . . . . 71.510000000000005 110.035 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.683 ' HA ' ' HZ ' ' A' ' 128' ' ' PHE . 4.8 p-10 -82.26 175.65 10.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.544 -0.539 . . . . 73.5 109.544 175.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.5 ptm -71.86 -11.2 60.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.233 0.457 . . . . 75.140000000000001 112.233 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.75 2.59 53.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 71.040000000000006 110.25 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 65.91 77.91 0.28 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.091 -0.959 . . . . 73.200000000000003 112.586 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.88 138.67 9.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.26 -0.882 . . . . 72.329999999999998 109.079 167.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -89.1 130.48 35.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 111.77 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.528 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 20.8 p-90 -136.07 147.21 47.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.503 -0.772 . . . . 75.0 109.27 172.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.871 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 17.0 pttp -94.59 136.78 34.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.416 -0.514 . . . . 71.129999999999995 111.003 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.2 144.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.684 -0.689 . . . . 63.329999999999998 109.794 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.545 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -108.39 -110.61 3.41 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.58 -0.819 . . . . 71.019999999999996 112.763 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.5 mp -95.35 137.1 22.13 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 71.140000000000001 111.235 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.0 Cg_exo -75.14 120.08 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.967 2.444 . . . . 74.140000000000001 111.449 174.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 53' ' ' LEU . 42.3 mt -90.88 -33.6 5.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.34 0.591 . . . . 75.299999999999997 110.097 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.8 -47.17 2.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.803 -0.713 . . . . 72.319999999999993 111.775 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -122.95 165.35 16.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.013 -0.366 . . . . 74.319999999999993 110.013 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.53 55.07 0.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.026 -1.229 . . . . 72.299999999999997 110.026 -170.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 154.0 -93.39 0.14 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 111.141 -0.784 . . . . 73.230000000000004 111.141 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.604 ' H ' HD11 ' A' ' 51' ' ' ILE . 90.1 m-85 -146.41 -55.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.239 -0.652 . . . . 75.25 109.239 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.03 157.55 29.86 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.695 -0.562 . . . . 65.230000000000004 111.695 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.0 t 57.34 46.27 18.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 110.762 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 71' ' ' LYS . 42.5 mm -88.45 138.48 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.817 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.3 152.4 37.86 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.067 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.5 tt -101.32 143.92 30.78 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.196 -0.668 . . . . 73.439999999999998 109.196 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.93 108.43 17.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.071 0.462 . . . . 74.439999999999998 110.912 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.33 42.37 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 71.200000000000003 109.592 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.871 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 13.0 tpt -49.5 -30.88 9.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.275 -0.875 . . . . 65.430000000000007 112.553 -176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' MET . 8.9 m-80 68.99 -166.36 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.311 0.382 . . . . 63.420000000000002 110.332 -177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 m -124.93 148.46 48.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.255 -0.276 . . . . 61.130000000000003 110.255 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 71.230000000000004 111.119 -179.039 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.424 0.63 . . . . 63.439999999999998 110.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.826 ' HA ' ' HG2' ' A' ' 133' ' ' ARG . 4.8 Cg_exo -76.62 85.54 1.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.98 2.454 . . . . 74.230000000000004 112.303 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 131' ' ' MET . 6.1 p -153.66 138.68 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 111.441 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.16 160.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.48 -0.782 . . . . 73.349999999999994 109.115 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 4.1 p -128.1 119.41 50.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.653 0.739 . . . . 72.219999999999999 111.958 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.663 ' HA ' HD13 ' A' ' 51' ' ' ILE . 17.9 ptmt -99.96 123.3 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.083 -0.962 . . . . 72.409999999999997 109.677 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 128' ' ' PHE . 13.9 m -114.29 151.85 16.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 75.299999999999997 111.054 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 72' ' ' VAL . 18.1 mm-40 -165.34 145.27 5.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 O-C-N 123.821 0.701 . . . . 73.239999999999995 110.025 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' TYR . 27.4 Cg_endo -63.47 141.25 79.97 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.291 1.994 . . . . 74.140000000000001 111.532 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -64.84 -21.38 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.103 0.478 . . . . 74.140000000000001 110.448 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.26 11.12 15.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.919 -0.582 . . . . 70.340000000000003 111.931 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -95.26 -53.91 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.392 -0.523 . . . . 74.310000000000002 110.312 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.66 -76.04 0.41 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.901 -1.142 . . . . 75.530000000000001 114.248 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.45 -35.36 21.49 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.195 3.263 . . . . 73.109999999999999 114.684 -170.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -56.84 -45.42 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 71.150000000000006 110.395 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.46 -31.47 70.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 75.5 110.697 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.8 m -65.64 -49.02 70.2 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.205 -0.452 . . . . 75.150000000000006 110.64 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.65 -31.83 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.140000000000001 109.862 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.34 -41.33 96.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.929 -0.578 . . . . 74.109999999999999 110.739 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.731 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -62.23 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.56 -0.291 . . . . 74.420000000000002 110.608 177.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.91 -51.91 68.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 74.510000000000005 110.211 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 131' ' ' MET . 73.0 t80 -60.43 -34.55 74.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.493 -0.776 . . . . 72.140000000000001 111.826 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.93 -42.41 69.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.311 . . . . 72.420000000000002 111.442 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -80.51 -28.27 37.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.421 -0.354 . . . . 64.109999999999999 110.776 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.572 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -93.64 16.23 14.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.857 0.36 . . . . 65.430000000000007 111.325 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -95.2 164.88 12.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.377 -0.374 . . . . 61.130000000000003 111.619 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt 72.29 110.5 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 74.230000000000004 111.389 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.01 -36.98 78.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.404 2.736 . . . . 74.129999999999995 113.34 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.25 -42.1 98.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.925 0.393 . . . . 74.200000000000003 110.941 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -66.65 -48.64 68.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 71.219999999999999 109.889 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.57 -51.31 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.303 -0.862 . . . . 70.329999999999998 110.598 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.4 -36.74 69.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 72.230000000000004 110.683 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -61.95 -56.52 18.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 75.230000000000004 111.236 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.572 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 2.1 p90 -72.55 -35.04 67.91 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 119.683 -0.807 . . . . 74.549999999999997 111.154 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 33.4 mm -58.3 -42.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.47 0.653 . . . . 71.420000000000002 109.984 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.83 -57.77 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.021 -0.991 . . . . 74.25 111.222 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -71.6 -29.88 65.19 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.181 0.437 . . . . 72.310000000000002 112.181 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -83.55 -6.25 59.4 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.453 0.538 . . . . 72.430000000000007 112.453 -177.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.6 mptt 63.34 31.0 15.51 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.511 0.507 . . . . 74.319999999999993 111.237 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 94.4 mt -83.59 169.08 15.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.661 . . . . 74.420000000000002 109.558 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -101.94 -72.74 0.68 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.16 0.43 . . . . 74.129999999999995 112.16 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -150.8 110.46 4.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.509 . . . . 75.219999999999999 111.614 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -79.77 127.92 32.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 75.400000000000006 110.692 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.95 67.87 3.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.025 -0.607 . . . . 74.140000000000001 112.398 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.65 135.3 20.73 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 122.284 0.234 . . . . 73.450000000000003 110.694 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HA ' ' CE2' ' A' ' 194' ' ' TYR . 34.8 Cg_exo -61.0 152.87 68.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.996 2.464 . . . . 74.310000000000002 113.136 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -70.34 136.54 49.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.761 -0.654 . . . . 73.439999999999998 111.124 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.449 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 48.7 t80 -84.53 129.79 34.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.679 -0.691 . . . . 63.439999999999998 111.461 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.529 ' HB2' HG23 ' A' ' 130' ' ' ILE . 81.7 m95 -120.78 -50.78 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.327 0.584 . . . . 75.420000000000002 109.974 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.17 178.3 43.05 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.747 -0.661 . . . . 74.439999999999998 112.321 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' MET . 22.8 t -164.69 -178.87 5.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.429 -0.582 . . . . 75.420000000000002 109.429 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.91 -151.52 23.23 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.969 -0.634 . . . . 71.129999999999995 111.921 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -137.13 145.67 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.904 -0.406 . . . . 71.439999999999998 109.904 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -149.19 108.1 3.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.452 -0.34 . . . . 73.109999999999999 110.199 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -174.34 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.504 0.503 . . . . 75.120000000000005 110.286 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 54.1 29.68 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.406 0.622 . . . . 71.25 111.419 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.03 -30.95 6.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.582 -0.895 . . . . 74.319999999999993 108.582 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.75 -42.08 0.35 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.919 -1.037 . . . . 73.540000000000006 111.316 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.458 ' HG3' ' H ' ' A' ' 125' ' ' SER . 14.9 tptm -173.58 -177.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.525 -0.546 . . . . 64.5 109.525 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.458 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 1.2 p -76.32 104.99 7.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.501 0.667 . . . . 73.439999999999998 111.212 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 7.3 m-85 -98.36 120.48 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.505 -0.77 . . . . 72.400000000000006 110.002 176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -92.03 142.49 27.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.978 -0.379 . . . . 74.420000000000002 109.978 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.683 ' HZ ' ' HA ' ' A' ' 31' ' ' ASP . 52.9 p90 -127.82 143.68 51.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.512 -0.313 . . . . 75.150000000000006 110.737 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 77.2 mtp -123.1 122.14 37.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 74.519999999999996 110.496 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.574 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 4.7 mm -98.42 117.04 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 72.209999999999994 110.173 175.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 67.2 mtm -127.84 179.89 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.187 -0.671 . . . . 63.210000000000001 109.187 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.1 t70 -63.54 154.3 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.315 -0.624 . . . . 75.209999999999994 109.315 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.826 ' HG2' ' HA ' ' A' ' 67' ' ' PRO . 11.6 ptp180 -82.31 125.37 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.494 0.664 . . . . 74.409999999999997 110.992 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -104.34 171.7 7.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.529 -0.76 . . . . 65.519999999999996 109.781 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.75 -38.7 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.855 -1.164 . . . . 61.43 113.264 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 69.8 m -94.37 124.71 38.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 71.329999999999998 111.485 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.537 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 1.1 m-20 -90.21 134.54 34.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.868 -0.606 . . . . 72.519999999999996 110.038 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.8 tp -69.66 -29.22 66.62 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.807 -0.812 . . . . 74.540000000000006 108.807 174.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 29.0 pt20 -69.86 -33.12 71.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.745 -0.661 . . . . 75.340000000000003 110.987 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -69.56 -39.8 77.17 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.376 -0.601 . . . . 74.329999999999998 109.376 178.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.57 -40.97 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 110.115 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.746 ' CE1' ' HD3' ' A' ' 147' ' ' LYS . 22.5 t80 -52.75 -48.83 66.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.58 . . . . 74.540000000000006 110.655 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.8 -44.92 79.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 74.120000000000005 111.371 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.57 51.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.039 0.385 . . . . 70.230000000000004 112.039 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -96.74 2.59 52.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.935 0.397 . . . . 64.310000000000002 110.887 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.16 38.55 29.97 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 111.644 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.746 ' HD3' ' CE1' ' A' ' 142' ' ' TYR . 37.3 pttt 46.33 29.46 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 75.150000000000006 113.726 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -99.92 84.08 2.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.366 -0.605 . . . . 75.049999999999997 109.366 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 5.0 m-30 -94.52 156.38 16.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.782 -0.644 . . . . 74.349999999999994 110.68 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 p -73.51 138.06 44.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.239 -0.652 . . . . 75.209999999999994 109.239 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.79 71.53 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.326 0.491 . . . . 74.219999999999999 112.326 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -60.15 -39.25 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 72.420000000000002 110.929 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.448 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 30.4 m -71.57 -40.43 69.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.102 -0.499 . . . . 74.230000000000004 110.057 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.14 -47.18 84.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.778 -0.646 . . . . 71.549999999999997 111.28 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.727 ' HB3' HD21 ' A' ' 328' ' ' LEU . 0.2 OUTLIER -70.71 -44.11 67.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.215 -0.448 . . . . 73.299999999999997 110.687 -176.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -55.73 -46.2 77.81 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.03 0.443 . . . . 74.219999999999999 110.736 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 161' ' ' ILE . 87.7 mt -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.903 -0.59 . . . . 72.040000000000006 110.931 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 p -64.24 -32.25 73.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 72.349999999999994 111.808 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.531 HD11 HD22 ' A' ' 325' ' ' LEU . 76.3 mt -61.25 -53.41 57.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.658 0.266 . . . . 73.420000000000002 110.851 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -66.81 -29.47 69.42 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.106 0.479 . . . . 72.239999999999995 110.538 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.483 ' HA ' HG23 ' A' ' 164' ' ' ILE . 28.2 mm -68.97 -35.04 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.359 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.44 -46.62 89.31 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.729 -0.471 . . . . 71.519999999999996 109.729 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -57.2 -48.38 78.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 111.479 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 161' ' ' ILE . 15.9 tt -72.32 -36.85 56.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.443 -0.344 . . . . 73.140000000000001 111.607 -175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.411 HD22 HD13 ' A' ' 178' ' ' ILE . 37.1 mt -64.63 -38.7 91.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.99 -0.284 . . . . 75.430000000000007 110.84 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -71.32 -37.9 71.75 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.942 -0.303 . . . . 71.439999999999998 110.532 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -50.91 -42.21 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 71.340000000000003 110.979 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.8 pt -91.91 -43.82 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.411 0.523 . . . . 75.150000000000006 112.411 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -72.86 -30.94 64.38 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.623 0.249 . . . . 63.020000000000003 111.567 -171.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.463 ' HG2' HH22 ' A' ' 240' ' ' ARG . 3.5 tm-20 -59.18 -28.77 66.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 70.409999999999997 110.084 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -101.41 -66.47 0.91 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.745 0.646 . . . . 71.310000000000002 112.745 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HG3' ' HD1' ' A' ' 173' ' ' TYR . 11.3 pt-20 -145.97 -60.56 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.219 1.192 . . . . 73.340000000000003 114.219 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 203' ' ' ARG . 55.2 p90 -104.42 160.36 14.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.343 0.592 . . . . 74.340000000000003 112.47 -168.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 14.2 m -129.54 172.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.096 -0.956 . . . . 74.349999999999994 109.741 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 13.4 t-80 -98.98 -41.32 7.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.834 -0.432 . . . . 72.150000000000006 109.834 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 228' ' ' THR . . . 62.66 38.45 96.46 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.766 -0.73 . . . . 72.430000000000007 112.754 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.553 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 19.3 t70 179.71 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.765 0.426 . . . . 65.340000000000003 109.889 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.411 HD13 HD22 ' A' ' 165' ' ' LEU . 49.5 mm -111.16 79.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.508 0.67 . . . . 73.439999999999998 110.1 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.611 ' HZ3' ' HD2' ' A' ' 227' ' ' PHE . 46.4 mttp -103.79 153.05 21.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.46 -0.791 . . . . 72.109999999999999 110.647 174.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -63.36 -16.27 59.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 72.310000000000002 110.918 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.616 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 12.7 m -71.84 -14.16 61.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.961 -0.563 . . . . 70.349999999999994 111.472 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -97.43 -12.4 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 74.140000000000001 110.913 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 161' ' ' ILE . 8.0 mp -105.67 120.26 41.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.363 0.601 . . . . 74.340000000000003 110.622 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 196' ' ' VAL . 3.6 mm? -118.03 131.35 56.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.298 -0.865 . . . . 61.340000000000003 110.131 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.771 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 86.2 mt -86.84 154.9 20.52 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.485 -0.561 . . . . 75.219999999999999 109.485 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.13 153.46 18.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.344 -0.984 . . . . 73.209999999999994 108.344 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -47.56 -33.29 6.3 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.419 0.525 . . . . 73.030000000000001 112.419 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -154.84 51.75 0.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.519 . . . . 75.340000000000003 110.441 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.484 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 2.7 t-20 -135.43 107.4 10.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.379 -0.601 . . . . 73.129999999999995 109.379 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 23.2 Cg_exo -66.49 -29.49 44.7 Favored 'Trans proline' 0 N--CA 1.474 0.36 0 C-N-CA 123.437 2.758 . . . . 54.130000000000003 115.305 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 338' ' ' LYS . 0.7 OUTLIER -94.29 -21.91 18.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.079 -0.649 . . . . 64.120000000000005 111.483 -173.334 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 194' ' ' TYR . 19.4 tp60 -91.38 93.62 9.12 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.569 0.7 . . . . 73.319999999999993 110.373 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.49 142.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.838 -1.074 . . . . 73.519999999999996 110.247 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 192' ' ' GLN . 37.1 m-85 -124.04 157.34 34.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.189 -0.459 . . . . 72.299999999999997 110.045 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.9 tp -94.49 99.36 11.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.613 -0.884 . . . . 75.299999999999997 108.613 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.528 ' HB ' HD21 ' A' ' 184' ' ' LEU . 46.7 t -130.26 157.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 64.310000000000002 110.465 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 51.16 64.96 1.63 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.818 0.818 . . . . 60.329999999999998 111.297 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 200' ' ' LEU . 12.9 p90 -123.17 -64.85 1.14 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.078 -0.965 . . . . 73.349999999999994 110.65 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . 77.02 -13.7 8.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.552 . . . . 43.200000000000003 112.059 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -84.63 89.75 7.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 110.073 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -141.92 99.25 3.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 74.019999999999996 109.912 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.67 138.52 42.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 75.120000000000005 109.675 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.598 ' HD2' ' HB3' ' A' ' 173' ' ' TYR . 4.8 mpt_? -71.36 129.06 37.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.944 0.402 . . . . 72.200000000000003 111.496 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.588 ' HA ' ' HB2' ' A' ' 237' ' ' ALA . 11.6 t80 -95.49 -54.41 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.763 -0.653 . . . . 73.519999999999996 110.064 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 172' ' ' GLU . 6.7 p -134.1 105.39 11.39 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.697 -0.683 . . . . 74.209999999999994 110.105 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 210' ' ' HIS . 52.2 Cg_exo -54.16 107.37 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.586 2.19 . . . . 65.129999999999995 111.568 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 65.9 11.68 7.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.103 -0.953 . . . . 74.120000000000005 111.418 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.54 -5.51 40.84 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.024 -0.607 . . . . 52.5 113.223 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.26 111.54 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.03 0.415 . . . . 74.329999999999998 111.536 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 206' ' ' PRO . 12.6 t-160 -178.19 -101.13 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.96 -0.563 . . . . 74.310000000000002 110.888 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.464 ' HE3' HG21 ' A' ' 312' ' ' THR . 60.3 tttm 51.49 89.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 75.310000000000002 111.947 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -166.22 136.71 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 74.209999999999994 111.139 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.754 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 20.3 t80 -94.75 80.45 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 75.030000000000001 111.495 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -178.9 70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.547 -0.751 . . . . 74.25 109.517 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -106.49 -71.29 0.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.082 -0.508 . . . . 64.129999999999995 110.777 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -119.12 118.2 32.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.915 0.388 . . . . 75.129999999999995 110.395 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.233 0.266 0 C-N-CA 123.295 2.663 . . . . 74.200000000000003 112.899 -177.006 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.963 0.411 . . . . 73.120000000000005 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -88.04 -155.36 28.96 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.898 -0.667 . . . . 75.200000000000003 112.36 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.9 p -88.7 151.59 22.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.941 0.4 . . . . 63.329999999999998 111.062 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -53.27 -33.08 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 113.739 1.014 . . . . 71.420000000000002 113.739 -167.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.415 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -81.93 -60.15 2.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.272 0.842 . . . . 73.200000000000003 113.272 -170.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.611 ' HD2' ' HZ3' ' A' ' 179' ' ' LYS . 28.9 m-85 -87.89 -0.23 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.28 0.474 . . . . 64.420000000000002 112.28 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 39.4 m -85.61 -10.3 56.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.346 0.593 . . . . 74.430000000000007 109.815 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.0 t 67.44 -175.7 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.1 -0.955 . . . . 72.230000000000004 111.259 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 82.6 mt -70.5 -34.59 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.393 -0.822 . . . . 64.120000000000005 109.731 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.656 ' HB3' ' HA ' ' A' ' 238' ' ' PRO . 1.8 m-20 -47.38 -84.23 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.801 -1.091 . . . . 74.519999999999996 112.547 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.638 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . . . -66.31 -28.32 68.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.154 -0.476 . . . . 65.5 111.993 -172.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.05 -26.6 62.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.662 -0.415 . . . . 75.209999999999994 110.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.401 ' ND2' ' HH ' ' A' ' 213' ' ' TYR . 1.8 t30 -95.75 -4.85 43.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.369 . . . . 70.129999999999995 110.981 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.59 21.07 17.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.352 -0.927 . . . . 73.099999999999994 113.391 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.754 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 7.1 p -117.63 141.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 71.129999999999995 109.67 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 204' ' ' TYR . . . -56.71 125.06 66.77 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.084 -0.507 . . . . 74.209999999999994 110.966 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.656 ' HA ' ' HB3' ' A' ' 231' ' ' ASP . 33.3 Cg_exo -60.27 115.18 2.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.156 2.571 . . . . 71.239999999999995 112.701 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 69.9 m -83.79 169.31 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 75.099999999999994 110.774 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.463 HH22 ' HG2' ' A' ' 170' ' ' GLU . 20.4 mtt180 -59.51 -20.53 56.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.528 0.68 . . . . 73.409999999999997 110.251 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.558 HH11 ' HG ' ' A' ' 309' ' ' LEU . 10.7 mmt180 -64.99 -41.82 95.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 109.645 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.503 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -69.59 -41.41 75.87 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 74.140000000000001 112.275 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.07 -45.18 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.581 0.229 . . . . 73.530000000000001 111.083 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 306' ' ' VAL . 9.5 mp -60.9 -41.99 97.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.403 -0.362 . . . . 73.519999999999996 110.916 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.92 -51.09 71.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.788 -0.642 . . . . 74.099999999999994 110.771 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.4 mt -62.35 -42.1 94.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.009 -0.541 . . . . 75.209999999999994 111.09 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.481 ' O ' ' HG3' ' A' ' 251' ' ' MET . 46.8 tp -61.96 -39.52 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 110.169 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.53 -39.65 98.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.339 -0.934 . . . . 74.030000000000001 111.645 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -66.55 -39.47 88.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.907 0.336 . . . . 73.340000000000003 111.907 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 20.0 p -68.12 -34.17 75.88 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.294 -0.563 . . . . 72.430000000000007 110.133 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.52 ' HE3' HD23 ' A' ' 324' ' ' LEU . 81.6 mtp -62.9 -53.59 51.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.443 -0.344 . . . . 75.129999999999995 110.983 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.533 HD12 ' SD ' ' A' ' 286' ' ' MET . 5.5 tt -65.98 -31.7 54.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.679 0.276 . . . . 74.120000000000005 110.303 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.26 -53.95 51.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 74.200000000000003 110.898 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 19.1 m0 -76.39 -25.16 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 73.200000000000003 111.222 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.5 tp -76.35 -46.3 28.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 60.240000000000002 111.617 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 76.5 p -103.71 -17.73 14.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.914 -0.315 . . . . 72.230000000000004 111.674 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 72.14 18.48 77.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 70.230000000000004 111.914 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -144.48 147.35 33.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.675 0.274 . . . . 75.25 110.957 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.846 ' HB2' ' HG3' ' A' ' 262' ' ' GLU . 96.1 mt -118.28 138.93 26.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.652 -0.87 . . . . 74.400000000000006 108.652 168.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.0 Cg_exo -65.45 -17.35 57.36 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.978 2.452 . . . . 74.510000000000005 114.243 -171.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.51 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 16.3 p90 -132.93 34.64 3.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.414 0.524 . . . . 74.420000000000002 112.414 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.846 ' HG3' ' HB2' ' A' ' 259' ' ' LEU . 43.4 mt-10 -68.03 -42.72 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.41 0.624 . . . . 63.409999999999997 109.692 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.13 -21.21 64.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 73.200000000000003 109.939 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.607 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 3.2 m-20 -89.81 -2.55 58.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.252 -0.886 . . . . 74.030000000000001 111.157 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.499 HD22 HG12 ' A' ' 271' ' ' VAL . 89.7 mt -66.63 -2.83 5.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.796 0.331 . . . . 64.420000000000002 111.521 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -62.59 -40.02 95.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.919 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.563 ' OD1' ' HE3' ' A' ' 269' ' ' LYS . 10.7 t70 -135.13 135.41 22.78 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 42.310000000000002 110.982 -171.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.6 Cg_exo -60.72 -28.86 87.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.242 2.628 . . . . 74.439999999999998 113.476 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.563 ' HE3' ' OD1' ' A' ' 267' ' ' ASP . 0.0 OUTLIER -78.11 -34.93 49.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.729 -0.471 . . . . 73.109999999999999 109.729 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.607 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 6.4 m-85 -56.63 -50.54 71.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.811 -0.631 . . . . 74.409999999999997 111.058 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.499 HG12 HD22 ' A' ' 265' ' ' LEU . 7.8 m -70.47 -35.3 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 71.340000000000003 111.479 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 276' ' ' ILE . 82.3 mtt180 -56.96 -56.34 22.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.512 0.196 . . . . 74.140000000000001 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 0.1 OUTLIER -66.39 -42.67 87.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 72.140000000000001 111.439 -176.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 16.2 m -61.01 -41.97 97.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.217 0.532 . . . . 73.420000000000002 110.256 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.21 -43.91 92.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.277 -0.874 . . . . 75.510000000000005 110.471 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 272' ' ' ARG . 79.7 mt -66.14 -44.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 75.109999999999999 111.274 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 26.4 mmt180 -68.96 -36.15 77.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.589 0.233 . . . . 73.530000000000001 111.606 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 21.2 m-85 -73.12 -33.92 65.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.061 -0.255 . . . . 74.109999999999999 110.868 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -72.13 -22.93 61.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.267 0.556 . . . . 74.120000000000005 109.971 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -74.82 -53.44 9.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.537 -0.756 . . . . 65.540000000000006 110.51 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.499 ' HB2' HD22 ' A' ' 285' ' ' LEU . 30.4 m-80 -111.72 55.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.635 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.528 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -52.13 -51.04 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 73.010000000000005 112.077 -178.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.528 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.23 -46.94 84.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 63.229999999999997 111.42 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.4 m -61.19 -49.14 78.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.811 -0.631 . . . . 74.5 111.143 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 281' ' ' ASN . 4.3 mm? -71.58 -44.23 64.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.349999999999994 111.874 -175.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.627 ' HE1' ' SD ' ' A' ' 303' ' ' MET . 21.8 mmt -64.69 -38.66 91.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.0 -0.28 . . . . 71.319999999999993 111.726 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.17 -39.01 65.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 74.120000000000005 110.413 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.05 -39.1 63.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 72.209999999999994 111.731 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.8 m -77.37 -11.36 59.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.607 0.225 . . . . 62.509999999999998 111.607 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.699 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 10.5 t80 -129.7 69.53 81.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.181 0.515 . . . . 75.129999999999995 110.449 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -90.67 12.35 2.43 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.041 2.494 . . . . 72.439999999999998 112.534 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -75.03 -9.38 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 74.219999999999999 110.375 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 71.27 84.56 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.893 -1.049 . . . . 71.340000000000003 112.221 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.699 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 27.3 t-20 -128.3 -80.27 0.58 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.802 -1.184 . . . . 62.409999999999997 107.802 169.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 60.0 tttp 175.13 96.85 0.08 OUTLIER Pre-proline 0 N--CA 1.461 0.092 0 O-C-N 123.743 0.652 . . . . 74.150000000000006 110.526 169.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -99.84 38.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.986 2.457 . . . . 75.209999999999994 111.47 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.3 -51.46 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 71.150000000000006 112.924 -172.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 0.9 OUTLIER -72.61 -30.85 64.7 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.235 -0.283 . . . . 74.319999999999993 110.235 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.3 mp -63.08 -44.3 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 74.230000000000004 109.57 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.33 88.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.933 -0.576 . . . . 63.130000000000003 111.138 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.71 -41.07 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.635 -0.257 . . . . 75.540000000000006 110.648 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.441 ' O ' ' HB ' ' A' ' 305' ' ' THR . 56.9 t80 -55.14 -45.35 75.64 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.502 -0.317 . . . . 61.25 110.986 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.627 ' SD ' ' HE1' ' A' ' 286' ' ' MET . 74.8 mtp -72.72 -31.35 64.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.598 -0.274 . . . . 65.310000000000002 111.62 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.29 -30.37 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.475 0.655 . . . . 72.239999999999995 109.236 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 86.7 m -66.32 -40.3 89.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.346 -0.843 . . . . 71.420000000000002 110.869 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.695 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 5.7 m -73.49 -27.03 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.819 -0.352 . . . . 74.129999999999995 110.492 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -62.3 -42.85 99.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 73.430000000000007 110.498 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.1 tp -97.11 16.22 20.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 74.349999999999994 110.05 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 27.4 tp -71.92 -32.53 67.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 74.120000000000005 110.666 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 27.1 t70 67.5 161.7 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.322 -0.854 . . . . 60.530000000000001 110.848 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -77.75 -22.72 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.699 0.285 . . . . 75.439999999999998 111.187 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.464 HG21 ' HE3' ' A' ' 211' ' ' LYS . 24.3 m -124.01 -20.28 5.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.592 0.59 . . . . 71.230000000000004 112.592 -173.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 14.5 tp10 -57.02 -101.16 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.344 0.868 . . . . 73.109999999999999 113.344 -166.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -147.04 120.17 4.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 121.641 -0.662 . . . . 75.230000000000004 111.508 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.425 ' HA ' HD11 ' A' ' 309' ' ' LEU . 57.3 Cg_endo -91.03 118.57 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.542 2.162 . . . . 73.230000000000004 111.121 170.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 96.1 mt -116.04 82.43 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.79 0.328 . . . . 74.540000000000006 111.318 -176.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.481 ' HA ' HD12 ' A' ' 320' ' ' LEU . 35.9 m-85 -62.28 -33.46 74.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.022 -0.535 . . . . 72.540000000000006 111.428 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.28 -40.45 90.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 75.430000000000007 110.95 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -73.21 -37.51 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.687 -0.486 . . . . 74.209999999999994 109.687 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 50.6 mt -59.32 -47.71 84.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.113 -0.494 . . . . 74.209999999999994 110.154 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -57.96 -41.59 83.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 70.450000000000003 110.408 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.49 -52.28 61.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.706 -0.679 . . . . 73.510000000000005 111.686 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.5 tt -63.58 -47.52 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 111.91 0.337 . . . . 73.430000000000007 111.91 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.52 HD23 ' HE3' ' A' ' 251' ' ' MET . 71.5 mt -66.19 -39.14 89.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.247 0.546 . . . . 73.109999999999999 110.435 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 159' ' ' LEU . 2.8 tm? -69.28 -35.28 75.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.152 -0.684 . . . . 74.409999999999997 109.152 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -62.91 -37.71 88.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 73.120000000000005 109.962 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.17 -41.0 95.13 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.903 -0.665 . . . . 61.140000000000001 112.215 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 155' ' ' LEU . 41.6 tp -71.65 -37.94 70.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.19 0.519 . . . . 72.25 110.746 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -72.08 -22.98 61.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.511 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.496 . . . . 73.340000000000003 110.957 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.427 HD12 HD11 ' A' ' 328' ' ' LEU . 33.5 pt -95.44 1.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.982 0.42 . . . . 73.230000000000004 110.583 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.08 75.38 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.774 -0.648 . . . . 54.549999999999997 113.224 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 5.4 t -117.32 170.13 8.94 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.474 -0.427 . . . . 53.409999999999997 110.751 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.446 ' HA ' HD22 ' A' ' 328' ' ' LEU . 27.3 ttpp -160.11 -56.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 74.430000000000007 108.889 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 178.6 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.914 -1.039 . . . . 75.239999999999995 108.452 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.8 t70 72.45 -71.55 0.13 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.681 -1.145 . . . . 74.219999999999999 111.786 172.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -117.94 57.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.805 -0.712 . . . . 70.549999999999997 112.303 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.491 ' HG3' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.046 0.451 . . . . 71.340000000000003 110.91 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.656 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 28.4 ttpt . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 109.173 -0.677 . . . . 75.420000000000002 109.173 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.649 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 10.4 t -106.67 162.39 13.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.168 -0.308 . . . . 73.129999999999995 110.168 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 143.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.398 0.618 . . . . 75.530000000000001 111.738 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.5 m -101.4 97.35 7.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.329 -0.851 . . . . 75.099999999999994 111.125 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 74.109999999999999 110.749 179.69 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.802 -0.444 . . . . 72.040000000000006 109.802 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.99 -7.87 60.82 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.725 -0.75 . . . . 73.349999999999994 112.404 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.56 128.64 36.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.824 0.345 . . . . 74.120000000000005 110.914 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.8 mt -86.62 129.0 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 74.310000000000002 110.174 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.476 HG13 ' HB2' ' A' ' 37' ' ' TRP . 29.4 pt -116.26 147.12 19.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 73.219999999999999 110.81 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 35' ' ' LYS . 55.0 m -118.15 125.77 50.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.512 -0.767 . . . . 75.349999999999994 109.6 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 2.2 p-10 -121.27 -164.53 1.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.881 0.372 . . . . 72.439999999999998 111.057 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.884 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 13.8 mmt -68.63 -14.43 63.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.336 -0.393 . . . . 71.239999999999995 111.697 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.453 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -81.7 11.37 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 70.209999999999994 109.78 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 24.4 tptp 92.36 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.034 1.334 . . . . 70.409999999999997 113.285 167.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.986 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 21.2 ptmt 159.59 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.563 0.54 . . . . 74.439999999999998 111.608 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.986 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 38.8 mt-10 82.62 59.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.186 1.18 . . . . 73.400000000000006 114.186 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.476 ' HB2' HG13 ' A' ' 29' ' ' ILE . 40.4 m95 -138.95 151.13 46.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.189 -1.411 . . . . 75.450000000000003 107.189 165.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.681 ' HE3' ' HB3' ' A' ' 56' ' ' MET . 61.0 pttt -154.47 144.47 21.83 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.857 -0.737 . . . . 74.349999999999994 111.24 172.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.81 126.44 25.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.293 -0.867 . . . . 74.439999999999998 110.619 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.68 -60.66 0.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.449 -0.882 . . . . 71.340000000000003 112.355 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 6.6 tt -103.82 120.62 50.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.998 -0.371 . . . . 65.299999999999997 109.998 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 4.8 Cg_exo -79.0 112.74 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.351 2.701 . . . . 75.129999999999995 111.776 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.755 HG23 ' HG2' ' A' ' 45' ' ' GLN . 49.2 mt -95.48 -57.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.333 -0.394 . . . . 73.25 110.37 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -20.1 22.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.205 -0.522 . . . . 62.340000000000003 113.254 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.755 ' HG2' HG23 ' A' ' 43' ' ' ILE . 12.0 pt20 -111.44 165.01 12.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.006 -0.368 . . . . 75.409999999999997 110.006 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.85 -170.15 26.45 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.693 -0.963 . . . . 72.239999999999995 110.693 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.594 ' HA3' ' CG2' ' A' ' 196' ' ' VAL . . . -81.85 50.38 4.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.752 -0.737 . . . . 61.439999999999998 113.098 -175.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 4.2 t80 166.5 -37.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.395 0.678 . . . . 74.219999999999999 109.299 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.24 157.2 17.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.031 -0.604 . . . . 65.420000000000002 112.25 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.9 m 65.16 41.37 4.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.131 0.491 . . . . 72.099999999999994 111.349 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.626 HD12 ' HB3' ' A' ' 71' ' ' LYS . 5.2 mm -97.33 138.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.494 -0.558 . . . . 70.099999999999994 109.494 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.679 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 97.7 m-85 -122.32 167.36 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 61.43 111.752 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 55' ' ' ASP . 3.8 tt -115.16 139.53 49.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.069 -0.514 . . . . 73.430000000000007 109.999 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.499 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -93.1 68.22 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 73.109999999999999 109.763 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.572 ' HB2' HD21 ' A' ' 53' ' ' LEU . 31.7 t70 -89.47 -14.93 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.162 -0.926 . . . . 72.109999999999999 112.041 -169.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.948 ' HE2' ' HA ' ' A' ' 56' ' ' MET . 5.2 mmt -95.05 -0.71 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.446 0.536 . . . . 75.340000000000003 112.446 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.35 80.2 1.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.481 0.658 . . . . 75.420000000000002 110.503 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -124.9 104.23 8.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.706 -0.679 . . . . 71.349999999999994 110.707 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.261 -0.427 . . . . 71.439999999999998 110.067 177.535 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.628 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 111.839 0.311 . . . . 75.310000000000002 111.839 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 66' ' ' ALA . 10.7 Cg_exo -73.58 43.94 0.84 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.573 2.182 . . . . 74.209999999999994 112.814 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.0 m -117.31 142.35 47.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.754 0.311 . . . . 71.140000000000001 110.326 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 53' ' ' LEU . 31.7 m -117.15 158.74 17.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 75.25 109.831 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.1 p -137.72 126.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.326 0.584 . . . . 75.299999999999997 111.664 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.626 ' HB3' HD12 ' A' ' 51' ' ' ILE . 46.7 pttt -98.81 136.26 39.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.398 -0.819 . . . . 73.439999999999998 109.132 174.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 8.4 p -137.21 138.2 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.568 0.581 . . . . 72.049999999999997 112.568 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.506 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 27.0 mt-10 -123.1 163.76 31.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.598 -0.728 . . . . 73.400000000000006 109.05 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.75 -177.07 1.11 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.328 2.019 . . . . 73.129999999999995 111.918 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.1 t -76.83 11.72 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.772 0.32 . . . . 71.349999999999994 111.696 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.81 -40.51 92.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 73.409999999999997 109.739 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 81' ' ' PHE . 64.0 t30 60.7 83.02 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.06 -0.973 . . . . 63.350000000000001 111.468 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.51 -83.05 0.18 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.647 -0.787 . . . . 73.129999999999995 111.719 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.86 -44.38 16.63 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.683 2.255 . . . . 74.439999999999998 111.624 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.506 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.93 -34.9 73.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.454 -0.339 . . . . 71.120000000000005 110.405 177.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.5 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 74.7 t80 -63.57 -47.76 80.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.043 0.449 . . . . 73.420000000000002 110.257 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.0 m -65.54 -42.63 91.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.66 -0.7 . . . . 73.209999999999994 110.074 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.85 -43.7 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.23 -0.895 . . . . 74.340000000000003 110.54 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 46.4 tp -55.83 -47.35 77.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.736 -0.666 . . . . 71.409999999999997 110.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.721 ' HE2' ' HA ' ' A' ' 85' ' ' LYS . 11.1 mmpt? -60.47 -41.76 94.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 110.46 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.98 -44.44 94.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.799 -0.637 . . . . 75.019999999999996 110.814 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.612 ' HD2' ' HB2' ' A' ' 113' ' ' TYR . 18.9 m-85 -70.55 -39.61 73.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.824 0.305 . . . . 73.400000000000006 111.824 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 81.5 mm-40 -68.02 -18.31 64.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.038 0.447 . . . . 61.549999999999997 110.5 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -96.72 -70.49 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 74.439999999999998 111.634 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.651 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -83.89 -34.48 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.274 0.842 . . . . 70.129999999999995 113.274 -170.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.34 79.36 3.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.377 0.608 . . . . 74.049999999999997 112.16 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.687 ' HZ1' ' HB2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -154.24 116.33 2.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.845 -0.798 . . . . 75.129999999999995 108.845 176.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.05 -54.02 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.333 2.688 . . . . 75.140000000000001 114.067 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 1.2 pp20? -72.95 -28.34 62.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.845 0.355 . . . . 72.25 110.624 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.452 ' CB ' ' HB3' ' A' ' 92' ' ' LYS . 3.6 tp-100 -67.81 -48.99 64.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.458 -0.571 . . . . 72.530000000000001 109.458 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 108' ' ' LEU . 81.5 mt -57.19 -53.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.603 -0.726 . . . . 75.430000000000007 110.434 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.02 -40.05 66.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.429 -0.805 . . . . 75.329999999999998 110.611 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 18.5 ttpt -67.24 -59.47 3.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.25 -0.886 . . . . 72.109999999999999 111.482 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.651 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 1.3 p90 -68.44 -34.03 75.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 120.474 -0.49 . . . . 74.510000000000005 110.833 -176.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 105' ' ' LEU . 2.9 tp -72.1 -29.09 31.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.885 0.374 . . . . 74.439999999999998 110.032 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -65.52 -47.34 76.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.736 -0.665 . . . . 65.0 109.778 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -74.66 -19.01 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 73.420000000000002 111.447 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 17.9 tpt180 -79.44 -18.45 52.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.152 -0.476 . . . . 75.549999999999997 110.538 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 103' ' ' ARG . 63.5 mttm 71.44 28.32 2.92 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.777 0.673 . . . . 75.030000000000001 111.197 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.634 ' HB2' HG13 ' A' ' 100' ' ' ILE . 46.7 mt -100.0 -170.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 75.329999999999998 110.432 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 107' ' ' TYR . 24.7 pttm -119.58 -34.91 3.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.514 0.561 . . . . 75.310000000000002 112.514 -172.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.408 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -150.03 179.27 8.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.926 0.393 . . . . 75.140000000000001 110.758 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -162.16 127.96 3.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.799 -0.815 . . . . 73.109999999999999 108.799 170.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.53 59.67 4.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.822 -0.704 . . . . 63.399999999999999 112.625 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.487 HG22 HD21 ' A' ' 108' ' ' LEU . 88.5 t -116.83 122.51 31.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.977 -0.379 . . . . 72.230000000000004 109.977 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.583 ' HG2' ' HH ' ' A' ' 87' ' ' TYR . 18.0 Cg_exo -66.19 149.32 85.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.884 2.389 . . . . 74.219999999999999 113.07 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.6 tptm -65.07 117.59 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 74.420000000000002 110.561 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.612 ' HB2' ' HD2' ' A' ' 87' ' ' TYR . 61.2 t80 -89.03 123.03 32.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.342 -0.845 . . . . 75.329999999999998 110.121 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -96.4 -67.01 0.87 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.286 -0.635 . . . . 74.439999999999998 109.286 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . 0.412 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -155.36 -178.13 29.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.423 -0.808 . . . . 75.340000000000003 112.144 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 p -164.73 163.7 21.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 55.240000000000002 109.046 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.26 -168.74 36.84 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.738 -1.22 . . . . 74.219999999999999 113.118 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.17 127.28 31.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.534 -0.543 . . . . 73.400000000000006 109.534 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -123.46 109.94 14.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.945 -0.571 . . . . 75.230000000000004 110.637 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.876 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 13.8 t70 -75.7 118.79 18.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.426 -0.583 . . . . 71.230000000000004 109.426 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.689 ' HG2' HD21 ' A' ' 122' ' ' ASN . 87.2 tttt -105.66 94.67 5.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.391 -0.368 . . . . 75.230000000000004 111.03 -174.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.689 HD21 ' HG2' ' A' ' 121' ' ' LYS . 44.6 m-80 71.51 -41.78 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.548 0.739 . . . . 72.409999999999997 112.846 173.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.89 -38.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.637 -0.792 . . . . 75.040000000000006 112.708 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.31 143.54 45.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.896 0.379 . . . . 72.209999999999994 110.114 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.876 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.0 p -94.62 149.16 21.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.150000000000006 112.134 -174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.447 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 67.4 m-85 -115.57 145.28 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 73.510000000000005 109.968 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -112.45 120.46 41.72 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.01 -0.737 . . . . 74.329999999999998 109.01 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.51 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -124.87 162.93 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 74.530000000000001 112.042 -170.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.8 ttm -144.88 136.95 25.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 71.109999999999999 110.695 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 70' ' ' VAL . 7.2 mm -97.45 127.78 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 74.329999999999998 111.021 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 71.1 mtp -121.28 164.2 17.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.526 -0.761 . . . . 74.450000000000003 110.426 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.628 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 25.5 t70 -81.26 98.35 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 111.306 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.441 ' HG2' ' C ' ' A' ' 132' ' ' ASP . 3.7 ptt180 29.71 95.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.411 1.634 . . . . 74.340000000000003 115.411 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.32 151.88 26.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 73.340000000000003 109.444 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.767 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -165.73 -15.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.38 -1.391 . . . . 74.230000000000004 114.967 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.707 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.7 m -120.65 124.7 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.274 1.037 . . . . 71.439999999999998 111.682 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 140' ' ' LYS . 1.3 m-20 -101.29 131.05 47.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.855 -0.794 . . . . 73.319999999999993 108.855 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 180' ' ' ALA . 4.9 mp -61.48 -36.91 81.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 74.319999999999993 110.856 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 27.2 pt20 -58.79 -47.92 83.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.455 0.539 . . . . 74.0 112.455 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 137' ' ' ASP . 20.3 ptmt -70.29 -34.85 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 75.430000000000007 110.783 -175.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.468 HG13 ' O ' ' A' ' 137' ' ' ASP . 17.1 mt -75.05 -39.77 44.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.515 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -62.44 -43.44 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 73.120000000000005 111.957 -175.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.86 -40.6 83.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.185 -0.606 . . . . 72.040000000000006 110.601 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.89 -31.75 70.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 74.510000000000005 111.136 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -88.78 5.66 42.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 73.109999999999999 110.392 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 61.4 41.28 13.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.466 -0.788 . . . . 72.400000000000006 112.216 176.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.684 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER 41.75 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.935 0.894 . . . . 74.230000000000004 112.668 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 11.6 ttp180 -153.78 93.5 1.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.038 -0.983 . . . . 75.109999999999999 109.975 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HD2' HG21 ' A' ' 153' ' ' THR . 85.0 m-85 -112.6 137.74 50.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 74.040000000000006 110.001 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.6 p -73.31 168.85 18.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.375 -0.375 . . . . 52.340000000000003 110.978 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.523 ' HB3' HD12 ' A' ' 328' ' ' LEU . 81.8 mtt180 -55.03 -37.06 66.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.913 -0.585 . . . . 75.519999999999996 110.725 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -60.65 -42.94 97.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.352 -0.84 . . . . 73.319999999999993 110.572 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.67 HG21 ' HD2' ' A' ' 149' ' ' PHE . 10.2 m -71.76 -52.23 18.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.5 -0.773 . . . . 61.420000000000002 111.303 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.82 -42.82 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.409999999999997 110.966 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.546 HD22 ' HG ' ' A' ' 328' ' ' LEU . 16.9 tp -65.61 -49.47 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 73.019999999999996 110.575 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 20.8 mm-40 -58.97 -47.74 84.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.923 0.342 . . . . 72.310000000000002 111.923 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.87 -43.92 97.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.472 -0.331 . . . . 73.239999999999995 110.892 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t -62.33 -43.04 99.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.150000000000006 110.355 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 82.3 mt -61.45 -39.9 92.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.242 -0.436 . . . . 74.400000000000006 111.262 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 81.6 mmt-85 -62.73 -49.15 76.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.017 0.437 . . . . 73.310000000000002 110.378 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.56 -30.31 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 110.681 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -47.42 86.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 70.109999999999999 110.569 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.46 -42.23 99.32 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.59 0.71 . . . . 65.120000000000005 110.097 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 168' ' ' ILE . 61.3 mt -61.44 -46.44 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.225 -0.898 . . . . 65.439999999999998 110.74 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.43 ' HG ' ' HE1' ' A' ' 317' ' ' TYR . 64.4 tp -57.69 -39.03 76.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 74.540000000000006 110.803 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 103' ' ' ARG . 2.0 mm-40 -56.13 -65.81 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.767 -0.652 . . . . 75.219999999999999 110.476 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 82.2 t80 -63.27 -49.47 73.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.626 -0.715 . . . . 75.430000000000007 112.861 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 164' ' ' ILE . 30.7 pt -79.46 -32.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.293 -0.563 . . . . 75.120000000000005 112.249 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.768 ' HE1' HG13 ' A' ' 174' ' ' VAL . 2.8 t60 -88.21 -18.19 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.038 -0.665 . . . . 74.310000000000002 111.117 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -86.88 21.96 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.907 0.861 . . . . 70.310000000000002 109.018 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -131.03 -79.37 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.475 -0.784 . . . . 74.540000000000006 111.137 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.713 ' HG2' ' H ' ' A' ' 207' ' ' GLU . 32.3 mt-10 -147.46 -46.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 74.200000000000003 111.977 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.96 137.63 35.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.709 . . . . 74.450000000000003 112.821 -161.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.768 HG13 ' HE1' ' A' ' 169' ' ' HIS . 33.2 m -106.69 170.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.942 -1.026 . . . . 74.420000000000002 109.729 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.727 ' HB3' ' HD2' ' A' ' 198' ' ' TYR . 1.8 p-80 -147.62 103.23 3.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.205 0.526 . . . . 70.030000000000001 111.188 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 -28.36 15.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.628 -0.796 . . . . 51.299999999999997 111.989 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.521 ' HB3' ' HA3' ' A' ' 199' ' ' GLY . 5.7 t0 -112.94 93.78 4.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.913 0.387 . . . . 74.010000000000005 110.059 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 64.8 mt -92.28 -73.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.22 -0.659 . . . . 73.109999999999999 109.22 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.513 ' HG3' ' H ' ' A' ' 180' ' ' ALA . 6.3 tptm 50.76 -139.25 0.94 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.572 -0.529 . . . . 74.219999999999999 109.572 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 138' ' ' LEU . . . -120.84 -3.58 9.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.408 0.623 . . . . 74.420000000000002 109.408 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.684 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 39.7 m -77.88 -27.68 49.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.419 -0.81 . . . . 73.0 112.044 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 76.7 m-20 -104.51 6.31 34.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.444 -0.503 . . . . 74.209999999999994 111.558 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.72 120.17 40.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.651 . . . . 73.340000000000003 109.721 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 47' ' ' GLY . 66.0 mt -120.59 143.67 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.004 -0.544 . . . . 74.310000000000002 110.834 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.707 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.8 mt -92.5 141.4 28.55 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.334 -0.617 . . . . 63.219999999999999 109.334 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.5 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 25.4 t-20 -60.55 139.19 57.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.446 -0.946 . . . . 73.099999999999994 108.446 171.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.767 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 71.7 t80 -57.36 -30.52 64.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.718 0.266 . . . . 75.140000000000001 111.718 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 83.1 tttt -116.15 -30.52 5.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.48 -0.488 . . . . 74.420000000000002 111.799 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.487 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 85.2 m-20 -99.46 101.87 14.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.793 0.33 . . . . 73.540000000000006 110.888 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 10.2 Cg_exo -71.78 -25.81 19.88 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.995 2.463 . . . . 64.019999999999996 113.387 -174.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -4.94 59.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.024 0.44 . . . . 72.430000000000007 111.18 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -108.62 97.1 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.386 0.612 . . . . 73.450000000000003 110.449 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.411 HG11 ' HG3' ' A' ' 160' ' ' ARG . 7.9 p -103.38 130.87 53.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.255 -0.884 . . . . 73.200000000000003 109.23 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.5 ' HE2' ' HB2' ' A' ' 186' ' ' ASN . 41.9 m-85 -115.72 155.45 27.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.004 -0.544 . . . . 72.510000000000005 110.189 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 2.9 tt -120.52 122.7 41.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.407 -0.59 . . . . 74.420000000000002 109.407 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.594 ' CG2' ' HA3' ' A' ' 47' ' ' GLY . 16.5 m -129.17 166.95 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 74.430000000000007 110.58 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.0 t70 68.97 -57.9 0.51 Allowed 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.984 0.803 . . . . 74.200000000000003 111.842 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.799 ' HB2' ' HB2' ' A' ' 201' ' ' ALA . 93.7 m-85 75.79 5.37 3.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.606 0.762 . . . . 73.230000000000004 112.052 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 177' ' ' ASP . . . 82.48 -38.77 2.63 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.37 -0.443 . . . . 65.219999999999999 112.946 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.768 ' HA ' ' HA ' ' A' ' 354' ' ' ILE . 1.1 pp -164.38 40.05 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.3 0.24 . . . . 72.439999999999998 110.882 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.799 ' HB2' ' HB2' ' A' ' 198' ' ' TYR . . . -53.21 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.549 0.69 . . . . 74.400000000000006 111.761 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -123.4 133.58 54.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 74.230000000000004 108.649 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 172' ' ' GLU . 10.9 ptp180 -77.71 109.74 11.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.324 0.583 . . . . 74.209999999999994 109.918 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 2.9 t80 -66.83 -46.18 75.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.774 . . . . 74.439999999999998 110.305 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.995 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 54.6 m -142.42 140.06 18.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.843 -0.799 . . . . 73.349999999999994 108.843 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 14.4 Cg_exo -68.1 98.04 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.381 2.054 . . . . 73.239999999999995 112.151 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.713 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 33.6 tt0 73.91 -54.7 0.68 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.961 -1.018 . . . . 61.219999999999999 111.761 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.11 65.8 2.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.948 -0.644 . . . . 42.439999999999998 112.534 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.995 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 7.6 p -58.54 112.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.639 0.733 . . . . 75.319999999999993 112.411 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -169.45 72.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.374 -0.83 . . . . 74.099999999999994 110.575 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -126.15 150.59 48.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 73.319999999999993 110.095 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.39 171.64 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.5 -0.318 . . . . 74.540000000000006 110.82 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.894 ' HB2' HG23 ' A' ' 236' ' ' VAL . 16.2 p90 -74.54 92.1 2.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.372 0.606 . . . . 74.409999999999997 112.517 -168.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 67.5 mmtt -152.64 104.96 2.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.939 -0.573 . . . . 74.140000000000001 110.315 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 68.6 mm-40 -136.42 -155.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 109.855 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 10.7 t70 -85.58 115.31 61.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.913 -0.403 . . . . 72.510000000000005 109.913 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . 0.779 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 28.0 Cg_exo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 123.688 2.926 . . . . 62.149999999999999 114.272 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 N-CA-C 113.065 0.765 . . . . 75.150000000000006 113.065 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -97.68 164.31 21.86 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.986 -1.246 . . . . 52.340000000000003 109.986 169.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 226' ' ' GLU . 14.9 t -68.74 113.15 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.1 0.95 . . . . 74.109999999999999 110.069 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.57 HG12 HG13 ' A' ' 271' ' ' VAL . 15.5 tt -57.24 -21.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.043 -0.981 . . . . 61.240000000000002 111.831 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.513 ' HG2' ' OG1' ' A' ' 224' ' ' THR . 17.1 pt-20 -60.12 -44.69 94.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 75.209999999999994 110.489 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.603 ' HB3' HG22 ' A' ' 246' ' ' ILE . 9.3 m-30 -109.53 -34.67 6.44 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.635 0.606 . . . . 74.299999999999997 112.635 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 7.4 t -70.9 14.15 0.16 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.543 0.572 . . . . 74.040000000000006 112.543 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 227' ' ' PHE . 33.3 t 66.52 -177.23 0.2 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.659 0.743 . . . . 73.409999999999997 111.863 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.43 ' HA ' ' CD2' ' A' ' 233' ' ' HIS . 42.3 mt -72.35 -35.15 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.067 -0.97 . . . . 72.129999999999995 110.081 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.486 ' HB3' HG13 ' A' ' 236' ' ' VAL . 4.1 m-20 -49.9 -56.35 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.64 -1.164 . . . . 72.400000000000006 112.334 -174.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.69 76.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 230' ' ' ILE . 12.0 p80 -70.82 -16.39 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.546 -0.461 . . . . 75.120000000000005 110.61 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.51 -21.22 45.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 73.409999999999997 109.909 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' ' 217' ' ' PRO . . . 111.17 20.07 7.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.776 -0.726 . . . . 64.310000000000002 113.617 175.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.894 HG23 ' HB2' ' A' ' 213' ' ' TYR . 7.3 p -122.17 136.41 59.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.333 -0.51 . . . . 73.230000000000004 110.966 175.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 204' ' ' TYR . . . -64.46 125.83 89.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 73.349999999999994 110.977 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.6 130.57 34.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.922 2.415 . . . . 73.109999999999999 112.065 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.484 ' HB2' ' HD2' ' A' ' 240' ' ' ARG . 21.9 p -153.21 154.22 34.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.165 -0.47 . . . . 62.32 110.837 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.484 ' HD2' ' HB2' ' A' ' 239' ' ' SER . 4.1 mpt_? 57.09 -100.5 0.11 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.508 0.723 . . . . 75.319999999999993 111.23 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -64.19 -32.09 73.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.030000000000001 110.282 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.5 -57.17 21.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.927 -0.654 . . . . 73.310000000000002 112.026 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 239' ' ' SER . 4.5 m-20 -57.15 -42.48 81.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 72.239999999999995 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.507 HD21 HG12 ' A' ' 306' ' ' VAL . 9.7 mp -61.28 -42.78 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.947 -0.57 . . . . 75.230000000000004 111.106 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -69.22 -37.68 78.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 55.219999999999999 110.795 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.9 mt -62.47 -41.93 93.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.919 0.39 . . . . 71.420000000000002 110.473 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.508 HD13 ' SG ' ' A' ' 250' ' ' CYS . 52.8 tp -60.06 -40.41 89.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.97 -0.559 . . . . 73.5 110.436 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.03 -40.68 97.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.5 -0.857 . . . . 64.120000000000005 111.903 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.472 ' HD2' ' HA ' ' A' ' 227' ' ' PHE . 22.1 m-30 -65.6 -41.14 93.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.89 0.329 . . . . 72.030000000000001 111.89 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.508 ' SG ' HD13 ' A' ' 247' ' ' LEU . 26.4 p -69.06 -34.37 75.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.007 -0.677 . . . . 73.5 110.543 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -66.89 -39.82 87.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.59 -0.277 . . . . 75.010000000000005 111.401 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.547 HD11 ' HE3' ' A' ' 286' ' ' MET . 3.8 tt -69.62 -34.32 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.459 -0.497 . . . . 72.310000000000002 110.67 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.923 HE21 ' HG ' ' A' ' 259' ' ' LEU . 16.1 mm-40 -68.1 -32.6 73.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.637 0.256 . . . . 64.439999999999998 111.402 176.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -75.98 -38.1 57.8 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 74.439999999999998 111.184 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.3 tp -80.54 -48.04 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.17 0.433 . . . . 72.129999999999995 112.17 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 58.9 p -109.66 -27.67 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.16 0.505 . . . . 72.239999999999995 111.143 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.46 ' HA3' ' HG3' ' A' ' 147' ' ' LYS . . . 68.32 34.95 81.34 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.450000000000003 112.906 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.09 142.84 34.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 72.239999999999995 110.903 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.923 ' HG ' HE21 ' A' ' 253' ' ' GLN . 88.6 mt -117.71 142.62 30.93 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.841 -0.618 . . . . 63.119999999999997 109.694 170.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 25.4 Cg_exo -63.94 -49.43 3.98 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 122.379 2.053 . . . . 73.329999999999998 111.138 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.417 ' HD1' HD23 ' A' ' 265' ' ' LEU . 30.7 p90 -82.94 25.58 0.67 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 72.430000000000007 111.142 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 259' ' ' LEU . 23.0 tt0 -68.37 -48.47 64.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 73.540000000000006 111.413 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.7 -32.74 71.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.19 0.519 . . . . 72.299999999999997 110.884 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -107.23 22.25 16.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.868 -0.605 . . . . 73.530000000000001 111.06 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.468 ' O ' HD13 ' A' ' 265' ' ' LEU . 3.0 tm? -61.33 -24.02 66.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.764 0.792 . . . . 75.5 109.706 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -68.13 -15.82 63.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.7 -1.137 . . . . 74.239999999999995 112.064 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.709 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 9.0 t0 -125.78 122.66 24.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.887 0.375 . . . . 64.049999999999997 110.638 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.71 -24.04 77.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.295 2.663 . . . . 74.310000000000002 113.82 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.5 -48.32 72.97 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.165 0.507 . . . . 74.510000000000005 109.952 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.709 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 97.4 m-85 -67.33 -38.69 85.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.361 -0.836 . . . . 72.219999999999999 110.595 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 225' ' ' ILE . 59.1 t -57.28 -49.77 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 73.010000000000005 110.204 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 276' ' ' ILE . 16.7 ttp180 -57.66 -54.42 47.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 74.349999999999994 110.428 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.95 -48.59 78.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.037 -0.983 . . . . 74.530000000000001 111.935 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.7 t -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.398 -0.365 . . . . 73.439999999999998 111.237 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 96.4 mttt -70.35 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.746 -0.381 . . . . 75.239999999999995 110.629 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.6 mt -64.76 -38.5 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.037 0.446 . . . . 72.129999999999995 110.007 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.07 -45.71 79.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.623 -0.717 . . . . 74.299999999999997 110.963 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -76.09 -32.42 59.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.957 -0.297 . . . . 73.439999999999998 111.706 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 275' ' ' LYS . 99.6 mtt180 -60.18 -23.41 63.95 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.581 0.229 . . . . 72.340000000000003 110.771 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -50.32 -53.58 27.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.793 -0.64 . . . . 72.510000000000005 110.412 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -170.11 99.41 0.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 65.400000000000006 109.615 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.21 -34.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 75.200000000000003 110.743 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 300' ' ' ALA . . . -60.08 -46.75 88.54 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.6 0.593 . . . . 73.010000000000005 112.6 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 15.8 m -60.26 -48.75 80.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.228 0.537 . . . . 73.230000000000004 110.993 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.21 -50.21 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 73.019999999999996 111.204 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.547 ' HE3' HD11 ' A' ' 252' ' ' ILE . 23.6 mmt -60.22 -45.08 94.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 75.099999999999994 111.486 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.17 -31.94 73.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 75.010000000000005 111.425 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -82.62 -13.21 56.89 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.717 0.294 . . . . 75.549999999999997 111.444 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 92.0 m -78.64 -69.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.796 0.295 . . . . 72.549999999999997 111.796 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 294' ' ' ASN . 39.2 m-85 -125.29 90.78 50.24 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 112.112 0.412 . . . . 74.010000000000005 112.112 -173.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -92.49 1.1 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.665 2.243 . . . . 75.030000000000001 112.105 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.89 -69.46 0.45 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.944 -0.571 . . . . 74.409999999999997 111.307 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.71 ' HB3' ' HZ3' ' A' ' 293' ' ' LYS . 3.1 mmmp? -49.56 -61.97 1.81 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.040000000000006 111.655 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.414 ' H ' ' HB3' ' A' ' 290' ' ' PHE . 15.8 m120 -113.54 -155.72 0.58 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.997 -0.742 . . . . 70.219999999999999 108.997 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.68 ' HE3' HG22 ' A' ' 331' ' ' ILE . 26.7 tptp -164.97 87.24 1.04 Allowed Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.774 0.321 . . . . 74.400000000000006 110.154 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -100.64 37.29 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.11 2.54 . . . . 73.530000000000001 112.171 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.02 -37.74 7.1 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.495 -0.859 . . . . 74.239999999999995 111.072 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.646 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 20.9 mp0 -66.95 -47.12 72.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.762 -0.829 . . . . 75.310000000000002 108.762 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.09 -38.96 77.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 114.863 -1.062 . . . . 74.109999999999999 110.363 173.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 283' ' ' ALA . . . -59.57 -50.25 74.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.532 -0.304 . . . . 71.340000000000003 111.208 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.1 -43.18 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 110.107 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.439 ' CE1' HD23 ' A' ' 320' ' ' LEU . 87.7 t80 -56.92 -47.08 81.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.412 -0.813 . . . . 74.5 111.203 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.511 ' HA ' HG23 ' A' ' 306' ' ' VAL . 93.8 mmm -68.2 -41.85 80.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 72.430000000000007 111.568 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -60.21 -40.55 90.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 64.140000000000001 109.77 175.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 98.4 m -60.28 -50.15 74.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.322 -0.854 . . . . 74.150000000000006 111.296 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 303' ' ' MET . 19.8 m -70.67 -33.99 55.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.842 0.312 . . . . 73.549999999999997 111.842 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -21.12 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.454 -0.498 . . . . 73.239999999999995 110.312 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.9 tp -81.49 -5.3 57.82 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.158 -0.474 . . . . 74.030000000000001 110.968 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 305' ' ' THR . 90.1 mt -91.17 6.61 44.39 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.776 0.287 . . . . 71.310000000000002 111.776 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 24.3 t70 61.45 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.705 0.628 . . . . 71.409999999999997 111.961 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 -52.12 0.31 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.121 -0.491 . . . . 74.5 110.179 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.2 t -149.12 29.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.761 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 42.6 mm-40 -51.89 -62.87 1.36 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.45 -0.341 . . . . 75.409999999999997 111.028 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -171.12 102.27 0.4 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.502 -0.317 . . . . 73.340000000000003 110.398 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.4 118.85 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.538 2.159 . . . . 71.540000000000006 111.576 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.3 mt -114.33 92.83 4.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.453 -0.34 . . . . 74.049999999999997 111.354 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.43 ' HE1' ' HG ' ' A' ' 165' ' ' LEU . 97.5 m-85 -57.66 -34.07 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.164 0.507 . . . . 75.299999999999997 110.084 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.37 -55.33 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.055 -0.975 . . . . 61.43 111.027 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.97 -41.55 95.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 74.109999999999999 110.969 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 67.3 mt -56.96 -53.3 59.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.208 -0.451 . . . . 72.099999999999994 111.32 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 322' ' ' ASP . 11.0 ptt180 -65.26 -36.53 84.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 110.207 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . 0.501 ' N ' ' HG3' ' A' ' 321' ' ' ARG . 30.0 t70 -68.23 -51.21 47.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.819 -0.628 . . . . 74.430000000000007 111.63 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.88 -31.23 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.924 -0.311 . . . . 73.510000000000005 111.14 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.41 -48.87 59.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.372 -0.376 . . . . 74.219999999999999 110.571 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -39.88 83.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 110.046 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.23 -48.43 81.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 74.310000000000002 111.197 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.646 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.36 -46.15 91.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 72.519999999999996 112.085 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -60.96 -45.21 95.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 74.409999999999997 110.841 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -70.25 -26.91 64.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.016 0.436 . . . . 73.310000000000002 110.583 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.24 -29.28 63.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 111.537 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.68 HG22 ' HE3' ' A' ' 295' ' ' LYS . 32.6 pt -90.19 -5.51 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 73.510000000000005 111.063 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 91.58 23.91 27.34 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.782 -0.723 . . . . 73.420000000000002 113.405 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -127.22 138.53 53.13 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.438 -0.448 . . . . 73.319999999999993 110.373 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . 0.534 ' HB3' ' HZ3' ' A' ' 334' ' ' LYS . 9.9 mtpm? -138.66 -113.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.647 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -159.73 113.93 2.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.507 0.67 . . . . 74.099999999999994 111.578 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.6 156.04 4.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.851 -1.068 . . . . 65.030000000000001 109.263 172.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.33 50.74 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.288 -0.725 . . . . 63.240000000000002 111.288 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 61.8 mttp . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.173 -0.514 . . . . 72.239999999999995 110.701 -178.959 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 353' ' ' THR . 12.8 tptp . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.821 -0.437 . . . . 71.519999999999996 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 14.8 t -173.48 156.27 2.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.376 -0.602 . . . . 75.040000000000006 109.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.768 ' HA ' ' HA ' ' A' ' 200' ' ' LEU . 0.2 OUTLIER -67.43 131.81 32.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.097 0.475 . . . . 71.319999999999993 111.204 -176.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 355' ' ' THR . 7.6 t -78.61 85.29 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.182 0.992 . . . . 63.43 110.752 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . 0.442 ' HB2' ' HZ3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.534 -0.757 . . . . 74.530000000000001 110.499 178.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HD3' ' A' ' 42' ' ' PRO . 61.5 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.001 -0.74 . . . . 74.319999999999993 109.001 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.599 -0.81 . . . . 74.030000000000001 112.687 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.1 147.07 43.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 117.202 0.501 . . . . 74.230000000000004 110.097 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -106.72 115.88 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.933 -0.576 . . . . 74.140000000000001 109.629 176.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 37' ' ' TRP . 14.9 pt -97.49 141.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.923 -0.581 . . . . 71.140000000000001 110.538 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 112.08 23.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.012 -0.54 . . . . 73.329999999999998 111.117 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.679 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 11.7 t70 -93.62 -179.2 4.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.64 -0.874 . . . . 62.310000000000002 108.64 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' MET . . . . . 0.913 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 17.1 mmt -73.35 -13.76 61.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.416 0.524 . . . . 72.219999999999999 112.416 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.558 ' HB2' ' HH2' ' A' ' 37' ' ' TRP . . . -84.73 2.58 41.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.869 0.366 . . . . 75.310000000000002 110.727 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.598 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 32.2 ttmt 48.26 73.44 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.907 0.883 . . . . 75.239999999999995 112.561 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.81 ' H ' ' HZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -143.61 -154.96 0.56 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.321 -1.363 . . . . 74.540000000000006 107.321 173.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 3.1 mp0 -123.27 102.12 7.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.16 0.505 . . . . 72.239999999999995 111.029 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.81 ' HZ3' ' H ' ' A' ' 35' ' ' LYS . 3.8 m-90 -85.04 104.85 15.33 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.925 -0.769 . . . . 75.25 108.925 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -79.5 122.26 26.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.505 . . . . 73.430000000000007 110.832 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 52' ' ' TYR . 60.6 t -74.79 107.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.733 -0.469 . . . . 73.140000000000001 109.733 174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -61.13 4.56 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.779 -0.724 . . . . 65.239999999999995 112.116 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 pt? -159.64 152.06 17.55 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.066 -0.346 . . . . 74.349999999999994 110.066 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.584 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.4 Cg_exo -73.91 101.83 1.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.742 2.295 . . . . 74.010000000000005 111.562 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 53' ' ' LEU . 65.0 mt -66.74 -42.78 89.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 73.030000000000001 109.72 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.96 -31.38 8.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.64 -0.79 . . . . 75.140000000000001 111.873 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -140.81 129.86 23.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.581 0.705 . . . . 74.230000000000004 110.925 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 39.43 0.12 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 108.239 -1.944 . . . . 70.340000000000003 108.239 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.34 122.76 4.96 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.456 -1.058 . . . . 72.200000000000003 110.456 -166.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . 0.656 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 6.3 t80 66.91 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.129 0.572 . . . . 75.109999999999999 111.262 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.5 165.22 16.89 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.208 -0.52 . . . . 72.129999999999995 111.938 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.88 35.13 21.8 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.231 0.538 . . . . 71.200000000000003 110.892 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 71' ' ' LYS . 43.0 mm -88.44 138.53 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 72.439999999999998 111.051 -175.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.584 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 30.0 m-85 -108.28 157.23 18.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.255 -0.429 . . . . 74.430000000000007 110.813 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.594 ' HB2' HD13 ' A' ' 43' ' ' ILE . 59.6 tp -94.35 136.61 34.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 109.776 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.1 103.31 15.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.602 0.239 . . . . 70.430000000000007 110.443 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 56' ' ' MET . 27.8 t70 -79.37 -25.6 42.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 63.340000000000003 110.327 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.473 ' HE1' ' HA ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER 67.26 163.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.375 -0.83 . . . . 71.140000000000001 110.804 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -87.44 65.92 8.85 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.048 -0.723 . . . . 72.120000000000005 109.048 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.9 m -77.36 70.12 3.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 63.219999999999999 110.709 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.592 -0.731 . . . . 75.439999999999998 111.06 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.294 0.569 . . . . 75.430000000000007 111.1 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.468 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 4.1 Cg_exo -80.14 38.86 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.014 2.476 . . . . 73.439999999999998 111.504 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . 0.423 ' HB2' HG21 ' A' ' 130' ' ' ILE . 6.9 p -145.3 138.18 26.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.549 0.69 . . . . 74.25 112.771 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.75 165.76 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.061 -0.972 . . . . 70.219999999999999 108.409 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.591 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -119.83 120.15 62.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.841 0.829 . . . . 71.439999999999998 112.68 -178.106 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.774 ' HA ' HD13 ' A' ' 51' ' ' ILE . 22.1 tptm -84.21 125.8 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 113.198 -1.819 . . . . 74.409999999999997 108.662 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.01 150.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.566 0.58 . . . . 63.25 112.566 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -152.2 135.25 9.25 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.388 -0.824 . . . . 73.510000000000005 109.11 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 -166.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.322 2.015 . . . . 74.120000000000005 111.715 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.4 m -74.68 60.29 0.91 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.215 0.531 . . . . 70.010000000000005 110.869 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -105.56 -38.99 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.347 -0.612 . . . . 71.340000000000003 109.347 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.65 76.01 0.33 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.135 -0.938 . . . . 64.439999999999998 110.523 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -152.24 -99.09 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.246 -0.978 . . . . 54.009999999999998 112.733 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 49.0 Cg_exo -56.9 -45.59 35.23 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.127 2.552 . . . . 74.519999999999996 113.614 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -68.98 -41.02 78.44 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.999 -0.28 . . . . 75.040000000000006 110.815 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 85.1 t80 -61.37 -47.55 85.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.928 0.394 . . . . 74.109999999999999 110.289 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 m -66.1 -42.59 89.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.596 . . . . 74.109999999999999 110.587 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG2' ' HE2' ' A' ' 87' ' ' TYR . 36.4 tt0 -64.88 -40.62 95.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.655 -0.702 . . . . 63.140000000000001 110.419 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.95 -39.28 85.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 72.299999999999997 110.535 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.755 ' HE2' ' HA ' ' A' ' 85' ' ' LYS . 10.9 mmpt? -59.02 -44.66 91.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.304 -0.407 . . . . 74.450000000000003 110.202 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.69 -49.55 77.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.764 -0.653 . . . . 75.310000000000002 110.836 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.537 ' HE2' ' HG2' ' A' ' 83' ' ' GLU . 56.3 m-85 -64.01 -38.32 90.65 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.651 -0.249 . . . . 73.310000000000002 111.426 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -61.42 -37.41 83.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.813 0.34 . . . . 73.319999999999993 110.78 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -88.26 -27.19 21.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.928 0.344 . . . . 74.510000000000005 111.928 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.58 16.05 25.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 71.340000000000003 111.893 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -76.05 163.87 26.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.039 0.385 . . . . 63.119999999999997 112.039 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.469 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.1 mmtt 75.89 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.161 -0.927 . . . . 75.310000000000002 112.425 175.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 -35.69 98.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.492 2.795 . . . . 75.510000000000005 113.184 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.44 -41.89 90.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 74.340000000000003 110.863 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.57 -42.32 78.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 71.349999999999994 109.797 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 92' ' ' LYS . 59.2 mt -57.8 -53.48 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 65.230000000000004 110.572 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.664 HE21 ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -60.29 -31.83 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 74.329999999999998 111.332 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -58.76 -56.36 23.25 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.238 0.336 . . . . 72.319999999999993 110.686 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.75 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.81 -34.19 73.35 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.303 -0.559 . . . . 72.510000000000005 110.735 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 107' ' ' TYR . 56.7 mt -58.13 -50.5 78.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.786 -0.188 . . . . 74.329999999999998 111.055 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -66.51 -38.44 87.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 74.219999999999999 110.621 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -67.57 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.402 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -78.03 -15.34 59.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.464 . . . . 74.219999999999999 110.965 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 68.77 33.21 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.64 -0.709 . . . . 74.25 110.697 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.513 ' HG ' ' H ' ' A' ' 106' ' ' LYS . 21.1 tp -81.95 177.13 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.985 -1.117 . . . . 74.409999999999997 107.985 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.513 ' H ' ' HG ' ' A' ' 105' ' ' LEU . 20.2 mmtm -103.15 -49.89 3.63 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.949 -0.7 . . . . 75.019999999999996 111.816 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . 0.681 ' HE2' ' HD3' ' A' ' 160' ' ' ARG . 34.4 p90 -162.0 -176.98 5.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 73.430000000000007 111.428 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.75 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 52.8 tp -133.22 131.76 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.569 -0.53 . . . . 64.310000000000002 109.569 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.4 57.64 4.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.868 -0.682 . . . . 72.349999999999994 112.66 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.19 131.47 22.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.303 . . . . 65.420000000000002 110.47 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.48 145.76 72.0 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 74.310000000000002 111.923 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -58.83 129.11 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.016 -0.538 . . . . 75.040000000000006 110.805 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -100.48 128.94 46.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 109.919 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -100.69 -62.96 1.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.492 . . . . 74.209999999999994 109.945 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.83 -157.79 15.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.637 -0.71 . . . . 42.119999999999997 112.223 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 32' ' ' MET . 14.0 p -169.07 152.4 5.11 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.551 -0.537 . . . . 74.530000000000001 109.551 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -158.7 -164.92 14.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.028 -1.082 . . . . 74.230000000000004 113.315 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.3 137.06 42.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.741 0.305 . . . . 74.319999999999993 110.477 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . 0.448 ' CG ' HG23 ' A' ' 29' ' ' ILE . 72.8 t60 -140.75 113.18 8.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.841 0.353 . . . . 74.549999999999997 110.241 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.836 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 32.8 t70 -72.43 126.39 29.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.059 -0.519 . . . . 64.099999999999994 110.422 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 122' ' ' ASN . 46.1 tptt -89.42 25.13 2.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.247 0.546 . . . . 74.430000000000007 109.539 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.8 OUTLIER 74.25 63.99 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.305 -0.861 . . . . 73.140000000000001 110.158 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.4 -54.04 0.72 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.794 -1.094 . . . . 62.539999999999999 111.33 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -112.91 121.98 46.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.972 -0.381 . . . . 73.310000000000002 109.972 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.836 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 47.3 m -86.68 117.57 25.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.596 -0.52 . . . . 74.519999999999996 109.596 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -91.18 140.45 29.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 64.209999999999994 110.066 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -99.22 133.99 42.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.589 -0.523 . . . . 74.030000000000001 109.589 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.591 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 43.9 p90 -128.78 161.12 30.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.142 -0.481 . . . . 75.109999999999999 110.557 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 48.2 ttp -139.52 133.26 30.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.977 -0.556 . . . . 74.430000000000007 110.099 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.54 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 13.1 mm -96.43 123.99 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.183 0.515 . . . . 75.340000000000003 110.296 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.4 ptm -137.13 -178.09 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 75.219999999999999 110.671 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.49 154.8 34.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.085 0.469 . . . . 75.530000000000001 110.833 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 67' ' ' PRO . 28.9 ptt180 -89.88 124.17 34.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.723 -0.671 . . . . 72.299999999999997 112.199 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 26.0 m-85 -103.05 160.31 14.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 74.340000000000003 109.832 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . 0.715 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -145.44 -25.81 0.1 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.089 -1.053 . . . . 74.329999999999998 113.252 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.719 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 58.8 m -121.48 126.42 49.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.876 0.338 . . . . 73.340000000000003 111.694 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.545 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -98.04 134.94 40.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 72.530000000000001 109.929 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 71.209999999999994 111.211 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 22.9 tp60 -58.33 -49.31 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 112.104 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.545 ' HG2' ' OD1' ' A' ' 137' ' ' ASP . 20.5 pttm -85.61 -20.92 28.78 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.981 -0.687 . . . . 75.329999999999998 111.009 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.96 -46.35 79.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.277 0.56 . . . . 72.319999999999993 109.647 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.751 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -67.32 -32.76 73.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.792 . . . . 70.25 110.514 176.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.69 -54.92 8.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.948 -0.569 . . . . 75.129999999999995 111.405 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.51 72.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 74.129999999999995 111.76 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -87.4 0.53 55.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 73.430000000000007 110.167 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 53.86 52.35 13.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.454 -0.794 . . . . 75.409999999999997 112.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.1 OUTLIER 40.08 75.96 0.07 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.53 0.732 . . . . 73.239999999999995 112.257 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.4 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 18.2 ttp180 -149.79 79.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.582 -0.736 . . . . 73.340000000000003 109.235 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.751 ' HZ ' ' HA ' ' A' ' 142' ' ' TYR . 38.3 m-85 -111.02 156.47 21.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.121 0.486 . . . . 73.319999999999993 111.702 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 154' ' ' VAL . 42.0 p -68.02 152.1 46.03 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.373 -0.83 . . . . 62.219999999999999 110.197 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.561 ' HG2' HD23 ' A' ' 328' ' ' LEU . 41.0 ttm105 -66.56 -26.38 67.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.963 0.411 . . . . 73.420000000000002 110.186 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.22 -43.89 69.73 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.016 -0.538 . . . . 74.310000000000002 111.171 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 21.2 p -68.27 -44.64 75.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 72.200000000000003 110.943 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 150' ' ' SER . 92.6 t -57.61 -42.84 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 74.129999999999995 111.152 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.51 HD13 ' HB3' ' A' ' 324' ' ' LEU . 2.5 mm? -64.9 -42.37 94.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.52 -0.309 . . . . 75.430000000000007 111.001 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.681 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 17.8 mm-40 -59.97 -46.01 90.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.49 0.186 . . . . 61.43 110.858 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 153' ' ' THR . 98.7 mt -59.62 -41.15 89.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 73.040000000000006 110.888 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.7 t -59.57 -47.11 86.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 63.350000000000001 111.006 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 325' ' ' LEU . 10.1 mp -63.8 -37.92 89.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 54.140000000000001 111.388 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.681 ' HD3' ' HE2' ' A' ' 107' ' ' TYR . 15.3 mmt180 -57.88 -52.59 64.84 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.465 -0.568 . . . . 72.510000000000005 109.465 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.0 -49.75 82.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.093 -0.958 . . . . 75.129999999999995 110.784 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.63 -54.54 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.948 0.351 . . . . 75.230000000000004 111.948 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.55 -48.6 76.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.579 0.228 . . . . 64.109999999999999 111.362 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 167' ' ' TYR . 16.7 tt -72.34 -36.63 55.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 120.428 -0.509 . . . . 70.319999999999993 111.21 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.4 -38.27 81.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 75.030000000000001 110.924 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.744 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 34.1 mm-40 -76.78 -23.95 52.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.842 -0.343 . . . . 71.319999999999993 110.517 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 164' ' ' ILE . 69.6 t80 -58.39 -48.65 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.349999999999994 110.076 172.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.6 pt -80.27 -32.29 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.54 -0.3 . . . . 75.310000000000002 111.372 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.744 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 4.9 m170 -56.55 -44.18 80.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.935 0.346 . . . . 75.219999999999999 111.935 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.15 12.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 75.420000000000002 111.41 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -120.97 -72.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.268 -0.424 . . . . 71.209999999999994 109.905 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.512 ' OE2' ' HD3' ' A' ' 203' ' ' ARG . 9.2 pt-20 -177.3 -35.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.541 0.571 . . . . 73.040000000000006 112.541 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.56 135.85 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 74.310000000000002 111.005 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 28.7 m -129.8 142.9 42.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.593 -0.731 . . . . 54.030000000000001 109.536 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.549 ' CE1' ' HB3' ' A' ' 200' ' ' LEU . 3.6 t60 -100.96 -47.07 4.9 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.788 -0.365 . . . . 74.319999999999993 110.1 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.955 ' HA2' ' HB3' ' A' ' 243' ' ' ASP . . . 73.23 -62.14 1.79 Allowed Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.918 -0.658 . . . . 74.140000000000001 111.979 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 4.9 t70 -55.08 111.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.199 0.6 . . . . 61.009999999999998 112.457 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.62 43.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.45 0.643 . . . . 64.129999999999995 109.585 170.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -81.6 145.44 30.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.608 -0.516 . . . . 75.209999999999994 109.608 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.08 -2.14 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.835 0.68 . . . . 75.299999999999997 112.835 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 4.7 p -76.91 -26.44 54.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.709 0.263 . . . . 74.340000000000003 111.709 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.61 -0.61 31.7 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 111.787 0.291 . . . . 75.409999999999997 111.787 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.77 111.19 23.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 109.973 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 137' ' ' ASP . 4.3 mm? -114.26 136.07 53.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.087 -0.506 . . . . 73.120000000000005 110.598 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.5 mt -93.58 141.71 28.16 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.82 -0.627 . . . . 74.329999999999998 110.141 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.98 138.74 58.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.528 -0.545 . . . . 74.209999999999994 109.528 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . 0.715 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 64.0 t80 -57.99 -30.91 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.37 0.508 . . . . 74.239999999999995 112.37 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 26.5 tptp -101.58 -44.25 5.64 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.808 -0.357 . . . . 74.430000000000007 111.125 -176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.585 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 4.4 m120 -102.01 104.85 38.78 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 72.5 111.505 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 17.4 Cg_exo -68.42 -14.21 39.44 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.208 2.605 . . . . 55.240000000000002 112.247 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.48 -3.8 58.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.889 -0.596 . . . . 75.319999999999993 110.799 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.585 ' HG3' ' HB3' ' A' ' 189' ' ' ASN . 72.3 mt-30 -109.64 96.99 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 73.420000000000002 110.524 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.1 p -103.55 134.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 70.439999999999998 109.969 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 64.2 m-85 -125.2 157.28 36.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.016 -0.538 . . . . 75.239999999999995 110.202 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 72.7 mt -103.1 127.5 50.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.199 -0.455 . . . . 71.019999999999996 110.066 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.491 HG11 HD22 ' A' ' 184' ' ' LEU . 7.6 p -139.37 170.78 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.624 -0.51 . . . . 71.409999999999997 109.624 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 65.12 56.81 0.99 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.002 0.906 . . . . 75.030000000000001 109.617 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.459 ' HD2' ' HB1' ' A' ' 201' ' ' ALA . 4.5 m-85 -73.91 39.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.365 -1.289 . . . . 74.530000000000001 112.809 -176.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -81.15 47.39 3.57 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.262 -0.735 . . . . 53.149999999999999 111.262 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.549 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 tt -170.98 44.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 74.109999999999999 108.096 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 198' ' ' TYR . . . -133.04 106.07 7.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 72.340000000000003 110.268 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -115.72 -177.45 3.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.096 -0.502 . . . . 74.129999999999995 110.44 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.512 ' HD3' ' OE2' ' A' ' 172' ' ' GLU . 58.8 mtt-85 -104.54 117.81 35.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.274 -0.421 . . . . 75.209999999999994 111.388 -170.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -87.99 -45.3 10.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.181 0.515 . . . . 74.329999999999998 110.239 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 172' ' ' GLU . 11.0 p -128.81 66.33 75.15 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.889 -0.596 . . . . 74.109999999999999 110.838 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.55 143.9 76.55 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.645 2.23 . . . . 64.409999999999997 112.349 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 74.07 6.74 4.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.436 -0.802 . . . . 75.420000000000002 111.144 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.03 10.92 74.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.097 -0.573 . . . . 62.340000000000003 112.471 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 40.4 t -116.71 128.14 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.646 -0.501 . . . . 75.109999999999999 109.646 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -64.66 141.63 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.855 -0.424 . . . . 73.299999999999997 109.855 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -114.34 166.47 11.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 74.519999999999996 111.332 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -72.89 144.67 47.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 75.25 110.152 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . 0.437 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 53.6 p90 -68.2 147.46 52.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.42 -0.585 . . . . 72.0 109.42 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 2.3 mptp? -90.58 -69.26 0.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.346 0.869 . . . . 74.450000000000003 113.346 -167.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 9.3 mm-40 63.35 71.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.627 -0.879 . . . . 73.310000000000002 108.627 -165.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.6 146.22 68.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.901 -1.045 . . . . 74.129999999999995 111.004 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 C--N 1.347 0.471 0 C-N-CA 122.78 2.32 . . . . 74.310000000000002 113.379 177.672 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.287 0.477 . . . . 75.010000000000005 112.287 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 200' ' ' LEU . . . -77.27 153.14 40.87 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.671 -0.776 . . . . 72.420000000000002 112.866 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -70.2 122.39 19.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.09 0.471 . . . . 65.230000000000004 110.551 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.87 -12.91 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.959 -0.564 . . . . 63.549999999999997 111.709 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' HD23 ' A' ' 265' ' ' LEU . 38.5 tt0 -55.34 -59.54 4.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.6 -0.727 . . . . 72.239999999999995 110.555 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.82 -33.05 7.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.11 -0.496 . . . . 72.109999999999999 110.103 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 98.5 m -58.0 121.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.701 0.763 . . . . 74.150000000000006 110.84 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.591 ' H ' HD11 ' A' ' 246' ' ' ILE . 47.7 t -56.61 166.38 0.94 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.105 -1.407 . . . . 73.200000000000003 111.758 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 37.5 mt -55.15 -51.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.436 -0.802 . . . . 72.349999999999994 110.608 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -56.16 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 65.129999999999995 111.504 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.45 97.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 73.439999999999998 111.817 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.24 -17.53 59.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 70.530000000000001 110.467 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.66 -8.41 59.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.597 -0.729 . . . . 73.109999999999999 111.683 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 86.7 24.14 39.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.055 -1.069 . . . . 72.310000000000002 112.843 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 213' ' ' TYR . 10.0 p -120.51 140.98 42.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.303 -0.629 . . . . 71.530000000000001 109.303 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.46 113.56 7.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.662 0.268 . . . . 62.329999999999998 110.771 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.48 134.93 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.587 2.191 . . . . 65.230000000000004 112.117 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 34.9 p -79.36 -164.52 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.969 -0.56 . . . . 71.319999999999993 109.66 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -62.93 -19.28 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.453 -0.499 . . . . 74.439999999999998 109.965 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 241' ' ' ARG . 1.8 mtp-105 -63.32 -30.55 71.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.909 -0.587 . . . . 72.420000000000002 111.116 177.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.578 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.25 -66.65 2.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.05 -0.595 . . . . 73.540000000000006 112.502 -175.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.955 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -76.8 -29.77 56.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.252 0.464 . . . . 74.5 112.252 -174.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.99 -34.2 77.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 72.129999999999995 110.981 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . 0.529 ' HG3' ' HE1' ' A' ' 303' ' ' MET . 34.9 tt0 -74.99 -34.31 61.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.503 -0.554 . . . . 60.43 109.503 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.591 HD11 ' H ' ' A' ' 229' ' ' SER . 93.7 mt -64.41 -37.77 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 72.450000000000003 110.393 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.503 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 47.9 tp -61.5 -40.2 93.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.588 -0.523 . . . . 74.329999999999998 109.588 174.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.15 99.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.601 -0.809 . . . . 62.310000000000002 111.743 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -54.37 -57.14 12.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.844 0.354 . . . . 73.239999999999995 111.218 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.2 p -67.21 -40.94 86.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 73.099999999999994 111.993 -174.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.12 -47.57 85.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.672 0.272 . . . . 72.299999999999997 111.42 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.34 -29.24 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.414 -0.514 . . . . 73.310000000000002 110.253 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -67.55 -46.8 71.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.595 -0.275 . . . . 73.299999999999997 110.543 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -61.96 -31.28 71.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.352 -0.385 . . . . 62.549999999999997 110.588 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.59 -41.2 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.015 -0.539 . . . . 74.099999999999994 112.089 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 67.1 p -101.92 -27.89 12.71 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.186 0.439 . . . . 73.010000000000005 112.186 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 96.96 -5.07 63.39 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.488 -0.863 . . . . 74.530000000000001 113.694 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -150.83 144.07 24.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.799 0.8 . . . . 74.450000000000003 112.458 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.44 HD11 ' CZ2' ' A' ' 261' ' ' TRP . 60.3 mt -122.5 138.9 29.94 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.198 -0.91 . . . . 72.340000000000003 108.871 166.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.19 -34.79 98.91 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.728 2.285 . . . . 74.530000000000001 113.309 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.514 ' HB2' HG13 ' A' ' 271' ' ' VAL . 36.7 p90 -95.3 2.92 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.646 -0.252 . . . . 72.5 111.438 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.86 -33.84 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.889 0.376 . . . . 74.310000000000002 110.492 -177.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.42 -28.64 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.723 0.773 . . . . 74.549999999999997 109.309 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 270' ' ' TYR . 9.9 m120 -86.23 7.14 26.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.069 -0.968 . . . . 72.340000000000003 110.497 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 226' ' ' GLU . 1.7 tm? -54.94 -35.32 64.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 71.450000000000003 111.243 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.57 14.88 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.817 0.673 . . . . 74.299999999999997 112.817 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.7 t70 -139.89 113.98 7.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.733 0.301 . . . . 73.109999999999999 110.325 174.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.87 -30.81 92.72 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.41 2.74 . . . . 74.209999999999994 113.777 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -69.2 -44.54 71.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.694 0.283 . . . . 75.230000000000004 110.647 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 264' ' ' ASN . 43.8 m-85 -66.71 -49.97 64.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.669 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 261' ' ' TRP . 19.4 m -62.5 -35.81 71.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.131 -0.227 . . . . 74.230000000000004 111.585 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.426 ' O ' HG13 ' A' ' 276' ' ' ILE . 30.1 ttm180 -63.06 -53.27 56.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.6 -0.273 . . . . 74.519999999999996 110.334 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.66 -40.0 88.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 111.14 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.7 m -61.66 -44.69 96.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.451 -0.341 . . . . 51.030000000000001 111.34 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.71 -33.6 71.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.709 0.29 . . . . 75.120000000000005 110.868 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 272' ' ' ARG . 77.4 mt -67.21 -43.88 88.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.948 0.404 . . . . 71.319999999999993 109.981 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -63.0 -36.15 82.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.851 -0.613 . . . . 73.150000000000006 110.293 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.29 -46.3 89.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 74.120000000000005 111.026 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -64.5 -26.35 68.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.924 0.392 . . . . 74.450000000000003 110.866 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.13 -32.17 50.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 64.25 111.32 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.536 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -136.05 53.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.947 0.403 . . . . 74.25 110.389 -172.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -57.0 -44.45 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 113.577 0.954 . . . . 75.319999999999993 113.577 -171.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.452 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -69.8 -47.32 63.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.866 0.321 . . . . 74.439999999999998 111.866 -170.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.4 t -68.36 -45.15 73.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.511 -0.313 . . . . 73.409999999999997 110.74 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.0 mm? -61.21 -53.44 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 75.140000000000001 111.575 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.683 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.1 OUTLIER -59.7 -42.79 93.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.743 0.275 . . . . 75.510000000000005 111.743 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.07 -37.33 85.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.131 0.491 . . . . 74.530000000000001 111.088 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -89.85 1.72 55.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 75.319999999999993 111.624 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 90.4 m -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 74.040000000000006 110.707 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 14.8 t80 -132.81 86.97 42.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 71.430000000000007 109.223 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.9 34.35 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.431 2.754 . . . . 75.519999999999996 112.847 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 51.5 mt-10 -120.59 -165.67 1.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.293 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -92.04 85.55 5.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.084 0.469 . . . . 74.230000000000004 110.661 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.27 -165.64 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.99 -0.744 . . . . 73.120000000000005 108.99 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.769 ' HD3' HD12 ' A' ' 331' ' ' ILE . 21.7 mtpp -120.48 90.14 45.14 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.483 0.183 . . . . 75.510000000000005 111.489 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -99.53 36.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.94 2.427 . . . . 73.209999999999994 111.395 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.56 -42.9 3.53 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.795 -0.717 . . . . 70.439999999999998 112.031 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -56.84 -46.08 81.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.968 0.413 . . . . 75.209999999999994 110.128 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.16 -41.24 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.895 -0.593 . . . . 71.209999999999994 110.586 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.91 -50.14 74.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 73.420000000000002 111.171 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.329999999999998 110.469 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.56 ' CD1' HD21 ' A' ' 320' ' ' LEU . 73.1 t80 -56.19 -46.54 79.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 73.510000000000005 110.843 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.683 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 94.8 mmm -71.46 -39.37 70.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.814 -0.63 . . . . 72.530000000000001 111.209 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 25.2 tt0 -58.66 -50.03 75.37 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.771 0.796 . . . . 75.310000000000002 109.369 174.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 88.9 m -57.65 -50.97 71.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.702 -1.136 . . . . 73.349999999999994 111.733 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.515 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 33.7 m -67.21 -27.22 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 112.21 0.448 . . . . 50.399999999999999 112.21 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -80.33 -19.86 45.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.363 -0.535 . . . . 75.519999999999996 110.339 -179.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 30.4 tp -94.41 17.84 12.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.116 -0.493 . . . . 71.319999999999993 111.143 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 315' ' ' PRO . 92.2 mt -93.77 -12.78 28.38 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.282 0.475 . . . . 73.150000000000006 112.282 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 13.2 t70 58.48 -164.37 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.591 0.356 . . . . 74.230000000000004 110.123 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.502 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.3 m-85 -64.93 -52.07 58.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 73.109999999999999 110.416 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 311' ' ' TYR . 19.8 m -155.16 69.05 0.7 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.222 0.534 . . . . 75.140000000000001 111.023 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 310' ' ' ASP . 25.2 mt-10 -104.99 33.43 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.495 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 25.4 mttt 64.53 103.53 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.219 0 CA-C-N 114.512 -1.222 . . . . 75.099999999999994 112.239 -176.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 309' ' ' LEU . 19.6 Cg_endo -63.22 136.49 56.04 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.284 1.989 . . . . 63.219999999999999 110.49 170.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 92.9 mt -79.19 79.82 5.59 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.857 -0.337 . . . . 75.329999999999998 110.699 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 315' ' ' PRO . 17.2 m-85 -53.41 -48.5 68.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.495 -0.775 . . . . 73.430000000000007 109.948 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -63.04 -53.24 56.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.848 -1.069 . . . . 61.299999999999997 111.785 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 27.0 t-20 -59.77 -51.37 70.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.747 -0.206 . . . . 63.340000000000003 111.333 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 302' ' ' TYR . 95.5 mt -59.16 -48.75 80.46 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.948 0.404 . . . . 75.409999999999997 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -62.3 -40.56 96.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 73.019999999999996 110.203 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.72 -49.38 47.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 63.409999999999997 111.51 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.79 -33.61 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.872 -0.331 . . . . 75.510000000000005 111.323 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.51 ' HB3' HD13 ' A' ' 155' ' ' LEU . 88.7 mt -69.9 -49.37 52.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 74.430000000000007 110.591 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.532 HD12 HD21 ' A' ' 159' ' ' LEU . 82.5 mt -67.04 -34.07 76.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 72.519999999999996 111.031 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.12 -47.67 79.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 65.430000000000007 110.48 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.77 79.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.69 -0.767 . . . . 73.219999999999999 111.975 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.561 HD23 ' HG2' ' A' ' 151' ' ' ARG . 3.1 tm? -68.23 -49.54 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.094 0.473 . . . . 73.519999999999996 110.336 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 333' ' ' SER . 85.6 tttt -71.87 -34.34 69.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 73.150000000000006 111.065 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -27.32 67.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.173 0.434 . . . . 71.409999999999997 112.173 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.769 HD12 ' HD3' ' A' ' 295' ' ' LYS . 15.6 tt -86.25 -6.3 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.416 -0.514 . . . . 73.200000000000003 110.87 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 110.64 24.45 5.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.278 -0.963 . . . . 54.409999999999997 113.875 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 13.3 t -119.47 149.57 41.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.332 0.566 . . . . 55.149999999999999 110.082 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -162.7 27.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.551 -0.907 . . . . 72.430000000000007 108.551 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.49 105.87 17.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.311 -1.313 . . . . 73.040000000000006 110.804 -170.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.2 -21.16 5.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 74.310000000000002 111.641 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.76 -23.47 64.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.632 -0.794 . . . . 61.039999999999999 113.126 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.674 0.274 . . . . 74.299999999999997 110.772 -178.474 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.414 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.72 -0.474 . . . . 73.430000000000007 109.72 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.9 t -104.38 153.87 20.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.609 0.243 . . . . 73.409999999999997 110.366 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.22 128.44 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.282 0.563 . . . . 62.509999999999998 110.981 -173.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 33.3 m -77.82 97.96 5.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 63.240000000000002 111.822 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 109.519 -0.549 . . . . 74.340000000000003 109.519 170.689 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.545 HG12 ' HA2' ' A' ' 40' ' ' GLY . 61.9 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 108.712 -0.847 . . . . 74.310000000000002 108.712 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.37 2.95 56.63 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.307 -0.949 . . . . 64.209999999999994 112.911 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 133.0 51.2 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.197 -0.668 . . . . 75.540000000000006 109.197 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -81.04 131.11 34.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.678 0.751 . . . . 63.530000000000001 111.338 -173.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.63 129.85 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.726 -1.124 . . . . 65.140000000000001 109.641 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 21.1 m -118.45 123.83 46.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.559 -0.291 . . . . 74.310000000000002 110.594 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.2 -173.09 2.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.398 -0.365 . . . . 74.239999999999995 110.71 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.06 -14.31 61.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.29 8.54 8.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.836 0.35 . . . . 41.439999999999998 110.434 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.6 tptt 55.81 63.21 2.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.334 -0.848 . . . . 74.450000000000003 110.686 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 30' ' ' THR . 48.6 mmtm -134.92 120.84 19.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.059 -0.973 . . . . 75.450000000000003 109.723 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.93 77.29 4.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 73.200000000000003 109.428 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.577 ' HB2' ' O ' ' A' ' 56' ' ' MET . 37.4 p-90 -96.81 -176.55 3.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.686 -0.688 . . . . 71.230000000000004 110.375 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' HG2' ' HB3' ' A' ' 56' ' ' MET . 18.8 pttp -133.69 137.14 45.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.299999999999997 111.562 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.01 151.68 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.952 -1.022 . . . . 74.299999999999997 110.797 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -96.6 -124.44 4.67 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.452 -0.659 . . . . 62.520000000000003 111.452 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.13 128.88 43.55 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.838 0.351 . . . . 72.340000000000003 110.48 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HB3' ' CE2' ' A' ' 52' ' ' TYR . 15.5 Cg_exo -68.91 119.1 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.91 2.406 . . . . 75.129999999999995 111.463 176.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.83 -59.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.147 0.499 . . . . 75.120000000000005 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.67 -8.3 76.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.899 -0.667 . . . . 61.329999999999998 112.316 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -127.4 161.38 28.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.487 0.184 . . . . 75.209999999999994 110.561 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.67 -130.92 2.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.402 -1.079 . . . . 64.340000000000003 110.402 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.57 -2.69 86.94 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.473 -0.87 . . . . 70.340000000000003 111.527 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.78 -68.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.728 -0.471 . . . . 74.319999999999993 109.728 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.93 174.23 24.63 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.865 -0.683 . . . . 64.530000000000001 111.888 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.7 m 62.68 32.72 16.07 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.108 0.48 . . . . 75.530000000000001 111.583 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.13 137.37 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 74.430000000000007 110.603 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 11.0 m-85 -111.89 148.97 32.53 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.849 -0.426 . . . . 74.400000000000006 109.849 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 54' ' ' ALA . 4.5 tt -90.63 139.87 30.3 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.828 -0.804 . . . . 75.439999999999998 108.828 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.495 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.796 -0.362 . . . . 65.340000000000003 110.751 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.77 -53.37 6.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 74.540000000000006 110.495 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.577 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 22.7 ttt -118.75 122.8 43.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.463 -0.789 . . . . 74.219999999999999 110.038 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -144.3 142.64 30.55 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.392 -0.966 . . . . 73.319999999999993 108.392 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.2 m -72.37 76.17 1.02 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.428 0.633 . . . . 71.200000000000003 110.457 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.443 -0.821 0 CA-C-N 115.623 -0.717 . . . . 73.530000000000001 110.035 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.122 0.487 . . . . 71.230000000000004 110.018 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.447 ' C ' ' HB2' ' A' ' 133' ' ' ARG . 3.6 Cg_exo -79.67 40.36 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.149 2.566 . . . . 75.439999999999998 111.273 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 p -144.26 146.95 32.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 112.826 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 132' ' ' ASP . 34.6 m -128.08 167.05 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.021 -0.99 . . . . 75.420000000000002 109.389 172.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 3.1 p -130.42 123.83 56.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.256 0.551 . . . . 73.109999999999999 111.488 -176.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 62.4 tttm -82.43 122.3 27.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.443 -0.577 . . . . 72.409999999999997 109.443 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.9 122.48 65.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.4 -0.364 . . . . 64.340000000000003 110.577 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.434 ' HB3' HD22 ' A' ' 80' ' ' LEU . 6.0 tp10 -136.07 137.54 25.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 74.209999999999994 109.053 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.62 133.25 50.34 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.17 1.913 . . . . 74.219999999999999 112.061 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 t -81.18 15.01 2.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.099 0.476 . . . . 74.25 110.655 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 124' ' ' LYS . 10.0 t70 -67.65 -69.1 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 63.439999999999998 110.105 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -170.32 118.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.705 -0.68 . . . . 71.209999999999994 109.477 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.71 -161.95 28.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.465 -0.874 . . . . 72.310000000000002 112.478 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.01 -21.54 49.37 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.18 2.587 . . . . 72.430000000000007 112.913 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 80' ' ' LEU . 1.2 tm? -52.31 -37.64 56.31 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.602 0.564 . . . . 74.109999999999999 111.16 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.15 -41.81 85.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 73.010000000000005 110.574 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -69.15 -46.3 67.96 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.708 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 80' ' ' LEU . 11.4 pt-20 -67.99 -31.1 70.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.189 -0.46 . . . . 72.400000000000006 110.838 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.51 -39.71 88.82 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.366 -0.235 . . . . 74.219999999999999 110.366 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -57.26 -49.01 77.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 74.420000000000002 110.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.11 -49.51 69.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 74.439999999999998 111.131 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CZ ' ' HD1' ' A' ' 113' ' ' TYR . 55.8 t80 -59.91 -38.13 81.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.731 -0.668 . . . . 75.439999999999998 111.563 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.14 -39.63 63.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 73.329999999999998 110.867 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -27.83 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 71.329999999999998 110.955 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . 0.59 ' HA ' ' CH2' ' A' ' 99' ' ' TRP . . . -106.74 16.52 24.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.963 0.411 . . . . 64.209999999999994 111.352 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' LYS . . . -82.58 158.19 23.17 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.109 -0.496 . . . . 73.420000000000002 111.478 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' ILE . 49.9 mtmt 75.17 107.01 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.293 -0.867 . . . . 74.430000000000007 111.394 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 49.7 Cg_exo -55.69 -35.33 92.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.362 2.708 . . . . 75.519999999999996 113.197 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.713 ' HG2' ' HE2' ' A' ' 98' ' ' LYS . 38.6 tt0 -66.46 -45.8 78.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 72.340000000000003 110.946 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.69 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 48.8 tt0 -62.64 -36.87 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.405 -0.591 . . . . 74.129999999999995 109.405 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 93' ' ' PRO . 67.4 mt -55.96 -45.88 80.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.537 -0.756 . . . . 72.030000000000001 110.284 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 96.3 mt-30 -53.78 -47.06 71.11 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.856 -0.611 . . . . 73.230000000000004 110.586 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.713 ' HE2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -63.85 -57.75 8.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.48 0.548 . . . . 74.120000000000005 112.48 -177.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.59 ' CH2' ' HA ' ' A' ' 90' ' ' ALA . 1.1 p90 -69.52 -34.71 74.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 119.968 -0.693 . . . . 74.430000000000007 111.501 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . 0.461 HD11 HD23 ' A' ' 108' ' ' LEU . 26.1 mm -63.45 -47.07 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.41 . . . . 74.450000000000003 110.122 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.94 -35.67 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 74.310000000000002 110.886 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.1 m -76.25 -34.63 59.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.555 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -84.61 1.91 43.93 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 122.299 -0.251 . . . . 63.200000000000003 111.546 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 65.94 25.9 11.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.582 0.551 . . . . 74.150000000000006 111.104 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.58 -178.32 5.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 74.299999999999997 109.362 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.9 -45.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.73 0.641 . . . . 74.200000000000003 112.73 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -154.08 117.48 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.522 -0.871 . . . . 75.430000000000007 112.342 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.605 ' H ' HD22 ' A' ' 108' ' ' LEU . 2.6 pt? -103.96 136.24 43.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 74.439999999999998 109.294 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.85 66.65 3.53 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.852 -0.689 . . . . 73.239999999999995 112.926 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 11.7 p -104.11 136.76 19.15 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 110.262 -0.273 . . . . 72.430000000000007 110.262 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 38.8 Cg_exo -61.73 146.23 96.81 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.685 2.256 . . . . 74.200000000000003 112.719 176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -67.77 122.91 19.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.623 -0.717 . . . . 75.200000000000003 111.157 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.437 ' HD1' ' CZ ' ' A' ' 87' ' ' TYR . 40.4 t80 -84.33 116.08 22.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.976 -0.557 . . . . 75.420000000000002 110.866 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.483 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 73.3 m95 -104.71 -63.01 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 74.209999999999994 109.065 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.08 172.13 31.39 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.148 -0.933 . . . . 71.549999999999997 111.305 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 p -169.83 159.82 8.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.577 0.227 . . . . 73.299999999999997 110.628 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.41 -165.03 37.62 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.855 -0.688 . . . . 61.149999999999999 111.662 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.748 ' HB3' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -137.47 147.22 45.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.914 0.387 . . . . 74.319999999999993 110.452 178.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -124.55 112.08 16.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.561 -0.533 . . . . 74.310000000000002 109.561 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 15.1 t0 -71.74 148.08 46.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.005 -0.543 . . . . 72.150000000000006 111.031 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 26.5 tptp -117.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.545 -0.752 . . . . 72.519999999999996 110.179 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 121' ' ' LYS . 15.8 m120 -135.26 30.72 3.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 110.287 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.26 -31.64 6.35 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.008 -0.837 . . . . 63.020000000000003 111.008 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 76' ' ' ASP . 44.3 mttp -100.18 96.4 7.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.19 -0.67 . . . . 74.430000000000007 109.19 173.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 4.9 p -76.26 142.56 41.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.436 -0.802 . . . . 71.150000000000006 111.254 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -96.18 121.57 38.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.86 -0.609 . . . . 74.099999999999994 109.716 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . 0.748 ' HG3' ' HB3' ' A' ' 118' ' ' LEU . 16.0 ttt180 -102.57 132.77 48.43 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.269 -0.641 . . . . 74.519999999999996 109.269 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 39.9 p90 -133.41 160.06 38.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.038 0.447 . . . . 75.030000000000001 111.797 -170.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.2 ptp -142.31 141.04 32.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.613 -0.721 . . . . 74.450000000000003 109.888 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.527 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -97.3 122.76 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.036 0.446 . . . . 74.230000000000004 110.384 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.5 mtm -127.15 -175.98 3.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 74.25 110.282 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.528 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 5.7 m-20 -58.3 152.52 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 65.109999999999999 110.502 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HB2' ' C ' ' A' ' 67' ' ' PRO . 35.3 ttt180 -72.79 105.62 4.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.711 -0.478 . . . . 71.310000000000002 109.711 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 132' ' ' ASP . 28.3 m-85 -101.76 171.02 7.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.274 -0.421 . . . . 75.239999999999995 110.533 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.29 -43.97 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.674 -0.774 . . . . 74.329999999999998 111.844 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 5.6 t -120.87 159.8 24.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.069 0.462 . . . . 70.549999999999997 110.531 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.592 ' HB3' HD11 ' A' ' 184' ' ' LEU . 1.1 p30 -143.57 -172.54 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 72.329999999999998 109.78 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 180' ' ' ALA . 6.8 mp -77.08 -24.51 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 112.075 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.769 ' HA ' ' HD1' ' A' ' 142' ' ' TYR . 3.2 pt20 -75.46 -36.29 60.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.695 -0.802 . . . . 72.25 109.968 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.473 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 43.1 mttp -57.83 -34.25 69.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 73.409999999999997 110.182 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.0 -51.29 20.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.489 -0.778 . . . . 65.129999999999995 111.227 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.769 ' HD1' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -72.18 -33.85 67.99 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.752 0.649 . . . . 74.140000000000001 112.752 -170.264 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 31.2 mt-10 -72.07 -31.25 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.349 . . . . 75.540000000000006 110.913 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.54 -32.1 15.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.979 0.362 . . . . 74.530000000000001 111.979 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -98.95 0.31 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 74.349999999999994 110.742 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.81 64.85 1.44 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.51 -0.768 . . . . 71.0 111.984 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 142' ' ' TYR . 17.5 ptpt 34.09 74.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.199 1.185 . . . . 73.209999999999994 114.199 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.42 103.84 5.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 72.099999999999994 110.415 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 89.6 m-85 -121.03 155.8 33.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.975 -0.557 . . . . 75.010000000000005 110.474 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 154' ' ' VAL . 67.0 p -80.62 148.35 30.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.46 -0.336 . . . . 64.230000000000004 110.208 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -26.63 66.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.002 0.43 . . . . 75.200000000000003 110.549 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 335' ' ' ASP . 63.0 tttm -62.08 -51.79 66.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.654 -0.703 . . . . 74.349999999999994 109.655 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.568 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 33.3 m -64.26 -46.84 81.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.274 -0.876 . . . . 61.119999999999997 110.497 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 150' ' ' SER . 69.6 t -54.64 -46.01 72.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 75.129999999999995 111.462 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.621 HD22 HD21 ' A' ' 328' ' ' LEU . 1.7 tp -63.82 -49.15 73.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.615 -0.266 . . . . 73.400000000000006 110.734 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -60.44 -39.91 89.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 74.140000000000001 110.801 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 153' ' ' THR . 94.0 mt -62.41 -49.69 74.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.416 -0.356 . . . . 72.010000000000005 110.425 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 m -58.1 -40.56 81.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 72.140000000000001 111.179 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 321' ' ' ARG . 3.5 mm? -61.98 -54.31 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 73.120000000000005 111.471 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.406 ' O ' HG21 ' A' ' 164' ' ' ILE . 86.6 mtt180 -64.16 -39.27 93.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 73.450000000000003 110.957 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.401 HG13 HD13 ' A' ' 195' ' ' LEU . 1.6 mp -65.89 -40.39 87.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 110.606 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.92 -44.13 96.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.616 0.246 . . . . 72.129999999999995 110.898 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.42 -55.37 35.95 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.026 -0.534 . . . . 71.239999999999995 110.846 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 160' ' ' ARG . 13.8 tt -69.16 -35.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.087 -0.506 . . . . 75.230000000000004 111.519 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.661 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 45.2 tp -63.81 -39.4 94.16 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.276 -0.17 . . . . 72.030000000000001 111.331 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.453 ' HA ' ' CB ' ' A' ' 169' ' ' HIS . 22.8 tp10 -80.85 -25.61 37.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.968 0.413 . . . . 65.230000000000004 110.365 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.42 -45.81 92.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.442 . . . . 71.340000000000003 110.487 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.85 -29.67 11.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 75.030000000000001 110.521 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.661 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 3.5 t-160 -61.95 -21.85 65.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.663 -0.699 . . . . 74.340000000000003 110.468 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -96.42 10.21 38.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.773 -0.648 . . . . 75.099999999999994 109.918 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 172' ' ' GLU . 73.9 t60 -116.68 -77.3 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.435 -0.348 . . . . 75.200000000000003 111.767 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 206' ' ' PRO . 8.3 pt-20 -161.22 -10.11 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.339 1.237 . . . . 73.349999999999994 114.339 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.573 ' CD2' ' HB1' ' A' ' 201' ' ' ALA . 16.7 p90 -155.97 161.85 40.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.714 0.688 . . . . 74.140000000000001 111.229 -170.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.706 HG11 ' HE2' ' A' ' 204' ' ' TYR . 35.6 m -131.6 160.44 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.637 -0.71 . . . . 70.409999999999997 110.209 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.64 96.55 10.75 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.005 -1.109 . . . . 75.310000000000002 108.005 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.47 73.57 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.948 -0.644 . . . . 72.329999999999998 112.389 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 179' ' ' LYS . 25.1 t70 -121.26 98.49 6.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.039 0.447 . . . . 54.140000000000001 110.305 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 178' ' ' ILE . 30.5 mm -87.8 38.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.388 1.09 . . . . 73.340000000000003 109.274 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . 0.449 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 7.9 ttpm? -75.95 164.83 25.79 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.586 -0.894 . . . . 74.310000000000002 108.586 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 138' ' ' LEU . . . -56.58 -15.87 5.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.562 0.579 . . . . 63.219999999999999 112.562 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' SER . . . . . 0.416 ' OG ' ' HE2' ' A' ' 179' ' ' LYS . 11.9 p -76.82 -15.43 59.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.731 0.301 . . . . 63.310000000000002 111.595 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.406 ' HB3' HD12 ' A' ' 183' ' ' LEU . 5.6 t-20 -83.2 -30.75 27.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.626 0.727 . . . . 74.329999999999998 110.346 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . 0.546 ' HG ' HD23 ' A' ' 195' ' ' LEU . 6.0 mp -96.11 110.9 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.999 -1.0 . . . . 75.329999999999998 110.695 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 137' ' ' ASP . 2.2 mm? -98.33 156.6 16.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.704 -0.68 . . . . 73.040000000000006 110.228 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 79.5 mt -119.27 159.13 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.512 -0.551 . . . . 74.230000000000004 109.512 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 11.9 t30 -60.86 151.06 31.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.825 -1.176 . . . . 72.310000000000002 107.825 170.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -48.72 -27.83 3.18 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.085 0.772 . . . . 73.349999999999994 113.085 -166.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -156.58 34.93 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.244 0.545 . . . . 74.010000000000005 110.557 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 5.0 t30 -126.08 103.5 26.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.558 -0.534 . . . . 73.420000000000002 109.558 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.61 -28.67 13.97 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.087 2.525 . . . . 62.420000000000002 114.337 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.75 -6.84 55.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.759 -0.376 . . . . 75.349999999999994 111.156 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.551 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 11.4 mm-40 -111.81 97.04 6.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 71.019999999999996 110.837 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.76 130.07 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.989 -1.005 . . . . 71.299999999999997 110.322 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.485 ' CD2' ' HE1' ' A' ' 134' ' ' PHE . 35.0 m-85 -124.43 147.38 48.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.063 -0.717 . . . . 70.420000000000002 109.063 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.546 HD23 ' HG ' ' A' ' 183' ' ' LEU . 49.4 mt -96.56 116.3 28.86 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.593 -0.443 . . . . 72.310000000000002 110.814 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 198' ' ' TYR . 2.7 p -148.43 87.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.817 0.818 . . . . 64.439999999999998 110.963 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.75 -50.91 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 60.43 109.493 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 196' ' ' VAL . 18.5 m-85 51.51 35.02 13.39 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.494 -0.775 . . . . 72.510000000000005 110.705 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -154.27 -31.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.853 -1.067 . . . . 65.230000000000004 112.117 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 25.7 mt -97.01 9.77 41.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.78 0.8 . . . . 74.450000000000003 108.855 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.573 ' HB1' ' CD2' ' A' ' 173' ' ' TYR . . . -97.46 111.67 23.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.831 -1.077 . . . . 73.230000000000004 110.528 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -98.49 115.26 28.17 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 109.907 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.421 ' NH2' ' HB3' ' A' ' 206' ' ' PRO . 0.6 OUTLIER -87.74 114.54 24.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.54 0.686 . . . . 73.439999999999998 110.101 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.706 ' HE2' HG11 ' A' ' 174' ' ' VAL . 9.5 p90 -89.65 -41.57 11.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.142 -0.935 . . . . 73.129999999999995 111.527 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 78.0 m -153.04 108.18 2.65 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.599 -0.519 . . . . 73.549999999999997 109.599 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.669 ' HA ' ' HB2' ' A' ' 172' ' ' GLU . 28.0 Cg_endo -63.32 84.05 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.899 2.399 . . . . 72.400000000000006 113.628 -174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 76.48 -11.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.263 1.025 . . . . 74.439999999999998 110.574 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 206' ' ' PRO . . . -105.92 51.65 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.418 -1.073 . . . . 70.319999999999993 110.418 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . 0.656 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 3.4 p -48.88 111.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.742 0.782 . . . . 74.549999999999997 113.075 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -164.13 70.9 0.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 74.510000000000005 109.003 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 205' ' ' CYS . 47.2 tptt -139.54 111.06 7.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.473 -0.785 . . . . 73.140000000000001 109.402 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -101.53 176.42 5.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 75.400000000000006 111.278 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -74.17 84.04 1.84 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.634 -0.712 . . . . 73.439999999999998 110.527 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -166.17 28.07 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.456 0.646 . . . . 75.219999999999999 109.771 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.64 144.5 51.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 75.129999999999995 111.594 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -173.82 91.76 0.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.048 -0.978 . . . . 73.430000000000007 108.567 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.462 -0.356 0 C-N-CA 122.14 1.894 . . . . 74.25 110.948 176.838 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . 0.602 ' OD1' HG21 ' A' ' 228' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 114.149 1.166 . . . . 62.43 114.149 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.408 ' O ' ' HE1' ' A' ' 233' ' ' HIS . . . -127.0 -116.35 2.01 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.449 -0.881 . . . . 61.240000000000002 114.229 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.9 m -92.1 110.67 22.05 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.369 0.267 . . . . 63.219999999999999 111.438 -173.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.1 tt -58.36 -19.09 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 111.88 0.326 . . . . 73.129999999999995 111.88 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.94 -61.83 2.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.44 -0.345 . . . . 74.329999999999998 110.642 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.445 ' HD2' ' SG ' ' A' ' 250' ' ' CYS . 84.4 m-85 -86.15 -42.95 13.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.634 -0.257 . . . . 74.219999999999999 110.817 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.602 HG21 ' OD1' ' A' ' 222' ' ' ASP . 26.0 m -57.91 -27.67 63.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.158 -0.474 . . . . 74.420000000000002 111.364 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 71.5 m 65.99 -170.01 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.592 -0.731 . . . . 73.349999999999994 111.463 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 230' ' ' ILE . 0.1 OUTLIER -72.65 -33.89 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 74.019999999999996 112.218 -175.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.09 -75.25 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.999 0.74 . . . . 63.539999999999999 112.999 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.46 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.04 -30.47 71.0 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.185 0.517 . . . . 62.140000000000001 111.346 -176.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 229' ' ' SER . 1.5 t60 -71.74 -23.92 61.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.855 -0.612 . . . . 73.310000000000002 111.043 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -97.54 -15.19 20.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.035 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.2 -9.95 59.72 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.294 -0.955 . . . . 61.219999999999999 112.689 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.64 129.72 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 74.140000000000001 109.639 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -61.51 116.95 22.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.009 -0.541 . . . . 72.430000000000007 112.112 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.77 106.11 0.31 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.779 2.319 . . . . 74.019999999999996 110.835 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.0 p -130.51 109.49 10.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.954 -0.566 . . . . 73.409999999999997 111.505 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.716 ' HG2' HG23 ' A' ' 312' ' ' THR . 2.2 mpt_? 76.66 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.005 -0.998 . . . . 71.409999999999997 110.994 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 310' ' ' ASP . 21.6 ttp180 -69.58 -30.94 68.83 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.297 -0.561 . . . . 73.209999999999994 110.172 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -52.94 46.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 74.140000000000001 111.782 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.437 ' HB3' HD23 ' A' ' 165' ' ' LEU . 4.5 m-20 -53.84 -46.04 71.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.463 0.649 . . . . 74.329999999999998 110.327 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 320' ' ' LEU . 75.0 mt -71.75 -35.99 70.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.478 -0.783 . . . . 75.540000000000006 111.699 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.64 -39.95 95.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 72.329999999999998 110.329 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 227' ' ' PHE . 80.3 mt -64.85 -49.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 110.307 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.571 HD23 ' HH ' ' A' ' 302' ' ' TYR . 51.1 tp -58.81 -47.13 85.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.286 -0.415 . . . . 72.299999999999997 111.251 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -34.7 90.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.958 -0.639 . . . . 75.219999999999999 112.243 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.415 ' CD2' ' HE3' ' A' ' 275' ' ' LYS . 24.0 t80 -62.72 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.231 0.539 . . . . 74.030000000000001 109.811 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 227' ' ' PHE . 60.5 m -61.67 -45.36 94.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.625 -0.716 . . . . 72.519999999999996 110.433 176.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -55.23 -52.97 61.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.943 -0.571 . . . . 65.109999999999999 111.612 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.9 tt -65.49 -37.16 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 70.049999999999997 111.124 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.14 -42.21 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 74.120000000000005 111.771 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 41.0 m0 -62.34 -31.84 72.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 75.310000000000002 110.674 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.16 -41.26 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.189 -0.459 . . . . 75.239999999999995 112.208 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 65.2 p -104.06 -29.11 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.767 0.654 . . . . 73.519999999999996 112.767 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.0 24.09 64.51 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 121.056 -0.592 . . . . 75.140000000000001 112.985 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -155.67 142.86 19.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.114 0.457 . . . . 75.349999999999994 109.937 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.4 mt -130.57 149.75 74.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.272 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.2 6.45 3.47 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.97 2.447 . . . . 74.340000000000003 112.926 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -143.45 24.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 73.420000000000002 110.914 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.534 ' HA ' HD22 ' A' ' 265' ' ' LEU . 12.9 pt-20 -63.83 -30.38 71.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.362 0.504 . . . . 64.109999999999999 112.362 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' A' ' 266' ' ' LYS . 34.5 t70 -83.02 -25.61 32.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.379 -0.529 . . . . 75.409999999999997 109.796 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . 0.81 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 95.2 m-20 -77.34 -3.78 41.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.782 -0.644 . . . . 73.549999999999997 110.469 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 262' ' ' GLU . 2.1 mm? -61.57 -18.56 59.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.802 -0.636 . . . . 71.120000000000005 110.592 172.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 263' ' ' ASP . 6.0 ptmt -70.57 -19.27 62.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 75.040000000000006 111.604 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.593 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 16.1 t70 -135.5 132.56 19.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.955 0.407 . . . . 64.219999999999999 111.38 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.24 -30.68 81.85 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.247 2.631 . . . . 75.319999999999993 114.494 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 7.3 ptpp? -73.57 -29.56 62.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.879 -0.728 . . . . 75.420000000000002 109.832 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.81 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 54.3 m-85 -76.97 -44.35 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.729 -0.669 . . . . 74.420000000000002 111.451 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 29.9 m -63.89 -35.8 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.839 -0.345 . . . . 75.019999999999996 110.796 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -61.83 -57.49 11.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 74.129999999999995 110.287 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.76 -49.74 73.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.335 -0.848 . . . . 75.129999999999995 111.127 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 20.1 m -63.11 -44.58 95.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.099999999999994 111.595 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE3' ' CD2' ' A' ' 249' ' ' TYR . 68.5 tttt -66.04 -37.33 85.59 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.684 -0.406 . . . . 74.120000000000005 110.457 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 78.5 mt -69.01 -47.9 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.606 -0.27 . . . . 73.25 111.146 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -60.96 -40.71 94.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.332 . . . . 73.040000000000006 110.908 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -73.4 -31.45 63.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 70.239999999999995 110.985 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.45 -20.2 65.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 74.430000000000007 111.133 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -80.39 -35.59 35.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.457 -0.338 . . . . 75.140000000000001 110.79 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -123.23 47.51 1.98 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.814 0.34 . . . . 73.030000000000001 110.651 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.0 mt -51.84 -52.84 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.33 0.863 . . . . 75.120000000000005 113.33 -171.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -62.83 -48.66 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.244 0.461 . . . . 70.219999999999999 112.244 -169.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.0 m -64.88 -48.41 74.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.219 0.533 . . . . 72.099999999999994 110.558 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.64 -54.4 16.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.523 -0.762 . . . . 74.420000000000002 111.674 -174.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -65.04 -43.34 92.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.57 0.211 . . . . 75.109999999999999 111.57 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.42 -39.94 81.4 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.804 -0.359 . . . . 74.129999999999995 111.278 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -76.42 -20.73 56.8 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.99 -0.284 . . . . 74.049999999999997 111.377 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 97.9 m -76.86 -16.35 59.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 74.510000000000005 110.476 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.48 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 59.4 t80 -115.24 81.06 7.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.576 -0.527 . . . . 74.030000000000001 109.576 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 91.1 Cg_endo -95.26 34.92 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.458 2.772 . . . . 65.340000000000003 112.13 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -82.18 -174.9 5.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.594 -0.73 . . . . 74.329999999999998 110.258 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.7 mmtt -89.28 13.17 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 110.848 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.48 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 3.1 t-20 -105.88 -163.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.292 -1.003 . . . . 74.510000000000005 108.292 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.434 ' HE3' ' HB ' ' A' ' 331' ' ' ILE . 19.6 pttp -149.66 124.9 4.87 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.79 0.328 . . . . 75.430000000000007 111.208 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.43 37.22 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 61.43 111.88 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.67 86.64 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.95 -0.643 . . . . 65.129999999999995 111.838 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.705 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.4 mp0 -52.43 -46.49 66.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.029 0.442 . . . . 72.450000000000003 110.7 176.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . 0.416 HG13 ' HE2' ' A' ' 251' ' ' MET . 3.8 mp -71.97 -42.69 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.78 -0.645 . . . . 64.209999999999994 110.789 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.83 68.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.809 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 301' ' ' LYS . 23.3 mtpp -75.07 -30.16 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 74.349999999999994 111.506 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . 0.571 ' HH ' HD23 ' A' ' 247' ' ' LEU . 66.0 t80 -55.45 -45.96 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.083 0.468 . . . . 73.5 110.134 171.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG22 ' A' ' 306' ' ' VAL . 72.1 mtp -72.28 -35.42 68.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 75.200000000000003 110.64 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -57.42 -44.33 84.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.577 0.703 . . . . 64.329999999999998 109.583 173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.8 m -61.13 -49.98 75.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.891 -1.05 . . . . 71.510000000000005 111.893 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 303' ' ' MET . 16.8 m -66.77 -27.53 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.911 0.386 . . . . 75.120000000000005 110.758 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -65.25 -42.26 93.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 75.200000000000003 110.042 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 50.0 tp -71.37 -21.61 62.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.428 -0.805 . . . . 64.299999999999997 110.906 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 309' ' ' LEU . 6.3 tt -71.1 -14.75 62.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 110.291 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.634 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 34.8 t70 67.56 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.628 -0.715 . . . . 50.409999999999997 111.852 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -136.43 -51.93 0.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.24 -0.652 . . . . 74.209999999999994 109.24 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' THR . . . . . 0.716 HG23 ' HG2' ' A' ' 240' ' ' ARG . 55.3 m -148.37 75.88 1.34 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.786 -0.643 . . . . 74.109999999999999 111.358 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -83.3 -165.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.106 -1.072 . . . . 75.209999999999994 108.106 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.443 ' HD3' ' C ' ' A' ' 314' ' ' LYS . 11.0 tmtt? -76.13 113.53 28.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.516 -0.92 . . . . 70.219999999999999 108.516 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.539 ' HG3' ' HG3' ' A' ' 240' ' ' ARG . 12.3 Cg_exo -68.43 117.46 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.038 1.826 . . . . 73.349999999999994 110.966 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 320' ' ' LEU . 95.6 mt -94.11 68.68 3.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.072 -0.513 . . . . 72.510000000000005 110.521 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -57.92 -32.86 68.18 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.211 -0.663 . . . . 64.349999999999994 109.211 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.4 mp0 -58.01 -56.7 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.756 -1.111 . . . . 73.530000000000001 110.302 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 26.2 t-20 -71.96 -33.17 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 75.439999999999998 111.734 -175.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 7.9 mp -61.28 -48.19 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.367 . . . . 72.239999999999995 111.058 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.511 ' HB2' HD13 ' A' ' 159' ' ' LEU . 15.4 ptp180 -72.01 -24.67 61.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.325 -0.55 . . . . 73.349999999999994 109.951 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.08 -49.02 55.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 73.049999999999997 110.989 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -62.68 -39.0 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 110.066 -0.346 . . . . 75.040000000000006 110.066 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.53 ' HB3' HD13 ' A' ' 155' ' ' LEU . 79.5 mt -62.33 -49.74 74.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 70.019999999999996 110.527 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . 0.644 ' O ' ' HG3' ' A' ' 329' ' ' LYS . 4.1 mm? -70.15 -26.9 64.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 64.329999999999998 111.366 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.01 -43.54 64.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.918 0.389 . . . . 71.519999999999996 110.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.705 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.03 -36.04 92.57 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 61.340000000000003 111.798 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.621 HD21 HD22 ' A' ' 155' ' ' LEU . 17.4 tp -69.21 -29.93 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 74.129999999999995 110.057 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . 0.644 ' HG3' ' O ' ' A' ' 325' ' ' LEU . 62.3 mttp -65.28 -38.78 91.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 61.539999999999999 110.55 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.28 73.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.755 -0.657 . . . . 74.049999999999997 111.655 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.434 ' HB ' ' HE3' ' A' ' 295' ' ' LYS . 15.2 tt -92.64 2.49 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 63.509999999999998 110.375 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.09 25.77 73.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.897 -0.668 . . . . 61.109999999999999 113.576 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 25.6 m -121.83 158.93 27.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.435 0.617 . . . . 74.340000000000003 111.272 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -150.74 172.76 15.07 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.042 -0.725 . . . . 73.400000000000006 109.042 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 30.6 t70 -120.63 127.74 52.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.763 -0.458 . . . . 74.439999999999998 109.763 172.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.74 21.11 3.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 64.299999999999997 110.832 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.23 45.37 15.24 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.491 -1.043 . . . . 64.439999999999998 110.491 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.559 -0.32 . . . . 74.299999999999997 111.716 -172.598 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.641 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 57.7 tptt . . . . . 0 C--O 1.224 -0.265 0 N-CA-C 108.51 -0.922 . . . . 75.299999999999997 108.51 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.4 t -73.18 164.62 26.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.522 0.146 . . . . 74.430000000000007 110.656 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -66.3 142.36 16.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 71.540000000000006 111.683 -174.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.0 t -75.36 134.84 40.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.766 -0.457 . . . . 71.099999999999994 109.766 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.646 0.736 . . . . 73.400000000000006 109.105 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.202 0.525 . . . . 73.099999999999994 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.52 -9.1 62.44 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.776 -0.647 . . . . 71.420000000000002 112.547 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.61 138.37 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 73.120000000000005 111.091 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -95.4 129.17 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.654 -0.703 . . . . 73.439999999999998 111.909 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.78 137.63 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.665 -0.698 . . . . 71.420000000000002 109.195 167.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 18.6 m -118.36 124.26 47.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.107 -0.237 . . . . 75.209999999999994 111.238 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.52 -177.93 4.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.459 -0.337 . . . . 71.109999999999999 110.482 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -16.78 62.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 71.519999999999996 112.744 -173.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.65 30.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.776 0.322 . . . . 72.5 110.525 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt 58.44 77.94 0.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.286 -0.87 . . . . 75.420000000000002 111.354 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' THR . 47.0 mmtm -136.09 125.18 24.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 71.109999999999999 108.73 173.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.18 85.45 6.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.008 0.432 . . . . 75.319999999999993 110.236 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 45.1 m95 -79.34 117.04 19.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.887 -0.597 . . . . 72.109999999999999 109.479 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 23.0 pttm -97.38 131.18 44.3 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.882 -0.727 . . . . 72.329999999999998 109.181 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 52' ' ' TYR . 59.0 t -67.8 130.32 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.931 -0.577 . . . . 71.450000000000003 110.947 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.15 -101.49 1.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.752 -0.737 . . . . 63.350000000000001 111.78 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.41 121.96 75.18 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.049 0.452 . . . . 72.129999999999995 110.11 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 7.4 Cg_exo -73.72 99.72 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.034 2.49 . . . . 73.230000000000004 111.376 175.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.94 -56.34 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 72.439999999999998 110.585 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.84 -24.76 28.27 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.82 -0.705 . . . . 72.129999999999995 112.246 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -134.9 165.72 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.951 0.405 . . . . 74.540000000000006 111.266 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.62 52.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.596 -0.729 . . . . 61.009999999999998 111.743 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.4 16.79 77.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.923 -0.656 . . . . 72.0 112.892 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -168.22 -84.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.117 -0.327 . . . . 74.209999999999994 110.117 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.28 144.92 4.2 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.283 -0.96 . . . . 63.100000000000001 112.67 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.8 m 62.67 61.15 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.323 0.582 . . . . 75.120000000000005 111.016 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 71' ' ' LYS . 1.1 mm -118.31 138.29 49.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.805 -0.634 . . . . 74.239999999999995 109.836 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' HB3' HG11 ' A' ' 39' ' ' VAL . 97.7 m-85 -122.28 154.13 37.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.53 0.205 . . . . 71.519999999999996 110.623 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.95 132.37 34.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.914 -0.773 . . . . 75.420000000000002 108.914 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.29 98.9 8.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 74.019999999999996 112.126 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.69 59.87 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.913 -0.585 . . . . 74.530000000000001 109.876 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' MET . . . . . 0.501 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.3 ttm -36.52 -72.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.162 0.914 . . . . 75.340000000000003 112.825 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -178.57 -176.27 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.322 -0.992 . . . . 75.430000000000007 108.322 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.3 m -70.76 123.67 22.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.574 -0.528 . . . . 70.040000000000006 109.574 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.238 -179.052 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 108.821 -0.807 . . . . 64.400000000000006 108.821 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.595 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 84.9 Cg_endo -82.59 39.05 0.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.3 . . . . 72.510000000000005 112.836 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 70.9 m -136.81 137.57 39.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.577 0.704 . . . . 55.539999999999999 112.15 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.66 154.0 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.203 -0.908 . . . . 75.019999999999996 109.323 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.8 p -125.22 123.99 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.455 0.645 . . . . 75.450000000000003 111.746 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HB3' HD11 ' A' ' 51' ' ' ILE . 10.5 ptmm? -103.23 133.81 47.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.228 -0.896 . . . . 73.109999999999999 109.487 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.57 148.72 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.082 0.401 . . . . 74.299999999999997 112.082 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 31.9 tt0 -142.43 139.49 17.63 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 108.43 -0.952 . . . . 73.420000000000002 108.43 171.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.39 176.19 2.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.312 2.008 . . . . 74.530000000000001 111.697 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.2 m -79.53 41.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.112 0.482 . . . . 71.219999999999999 111.537 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -84.06 -24.66 30.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.33 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 70.01 75.76 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.429 0.633 . . . . 72.099999999999994 110.371 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -124.52 -128.21 3.25 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.48 -0.782 . . . . 73.219999999999999 112.271 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 19.3 Cg_endo -59.95 -35.0 94.85 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.874 2.383 . . . . 74.450000000000003 112.759 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.2 tm? -56.03 -50.01 72.12 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.122 0.264 . . . . 74.349999999999994 111.12 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -67.21 -38.14 84.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.745 0.307 . . . . 73.439999999999998 111.063 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.5 m -64.96 -46.84 79.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 75.299999999999997 109.811 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.69 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 39.7 tt0 -60.77 -43.34 98.16 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.694 -1.139 . . . . 71.209999999999994 110.209 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.22 -48.64 73.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 75.400000000000006 110.796 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -56.79 -58.5 7.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 74.540000000000006 110.276 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.416 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 79.6 t80 -59.67 -51.32 70.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.27 -0.877 . . . . 75.420000000000002 111.388 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.401 ' HE2' ' HD1' ' A' ' 113' ' ' TYR . 91.8 t80 -58.58 -47.16 85.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.343 -0.844 . . . . 71.239999999999995 111.648 -176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -68.32 -30.08 68.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 74.450000000000003 111.103 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.33 -30.36 62.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 73.409999999999997 111.521 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -34.37 11.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.468 0.544 . . . . 70.400000000000006 112.468 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.47 88.98 7.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.389 0.515 . . . . 50.219999999999999 112.389 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 95' ' ' GLN . 1.3 ttpp -146.12 105.86 4.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 171.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 -54.11 5.46 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.899 3.066 . . . . 72.349999999999994 115.041 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -33.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.381 . . . . 73.540000000000006 110.497 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLN . . . . . 0.487 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 26.0 tp60 -65.03 -47.94 75.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 73.129999999999995 110.016 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 92' ' ' LYS . 74.2 mt -58.98 -53.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 115.676 -0.693 . . . . 73.120000000000005 110.685 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.0 -41.67 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 72.530000000000001 110.961 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -65.24 -53.18 48.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.145 -0.48 . . . . 73.409999999999997 111.502 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TRP . . . . . 0.415 ' CZ2' HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -72.91 -34.65 66.76 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.931 -0.708 . . . . 72.409999999999997 110.965 -175.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.4 mm -63.16 -45.17 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.666 0.27 . . . . 73.230000000000004 111.031 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -73.03 -27.9 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.807 0.337 . . . . 70.049999999999997 110.544 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.8 m -75.75 -40.87 54.68 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.12 0.486 . . . . 75.329999999999998 110.574 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.701 ' HG3' HD11 ' A' ' 105' ' ' LEU . 31.1 tpt180 -72.55 -18.41 61.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.25 110.365 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 39.8 tptt 67.57 54.05 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.963 -1.017 . . . . 72.340000000000003 110.217 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . 0.701 HD11 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mp -108.56 -167.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.824 -1.08 . . . . 75.340000000000003 109.449 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HB3' ' HZ1' ' A' ' 106' ' ' LYS . 5.2 mtpm? -100.11 -61.91 1.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.098 -0.334 . . . . 73.019999999999996 110.098 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -173.78 144.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 73.549999999999997 110.339 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 110' ' ' VAL . 44.3 tp -79.43 115.0 18.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.968 -0.753 . . . . 71.329999999999998 108.968 175.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.469 ' HA3' ' NH2' ' A' ' 160' ' ' ARG . . . -77.42 60.24 3.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.019 -0.61 . . . . 71.040000000000006 113.098 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.582 HG23 ' HG ' ' A' ' 108' ' ' LEU . 92.1 t -123.47 132.87 24.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.384 -0.598 . . . . 75.510000000000005 109.384 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.69 152.83 12.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.103 2.535 . . . . 74.140000000000001 112.996 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -76.94 122.33 24.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 74.319999999999993 110.674 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.401 ' HD1' ' HE2' ' A' ' 87' ' ' TYR . 56.2 t80 -80.74 111.77 17.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.257 -0.883 . . . . 72.140000000000001 110.276 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.467 ' HB2' HG22 ' A' ' 130' ' ' ILE . 40.4 m95 -90.2 -59.28 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.49 -0.559 . . . . 74.349999999999994 109.49 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.32 37.9 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.321 -0.854 . . . . 73.200000000000003 111.35 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.2 p -163.34 172.97 13.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.805 -0.443 . . . . 72.329999999999998 109.805 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.94 -173.01 40.78 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.124 -1.036 . . . . 75.239999999999995 112.271 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 125' ' ' SER . 8.6 tt -121.44 132.93 55.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.395 -0.595 . . . . 71.540000000000006 109.395 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -139.22 126.65 21.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.863 0.363 . . . . 75.420000000000002 110.422 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 21.6 t70 -75.68 126.75 31.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.803 -0.635 . . . . 71.400000000000006 110.487 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -83.45 -54.7 4.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.982 -0.377 . . . . 74.450000000000003 109.982 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.09 71.47 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.591 -0.522 . . . . 72.430000000000007 109.591 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.35 -19.08 49.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.831 -0.699 . . . . 73.310000000000002 111.632 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -113.76 120.0 39.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.124 -0.695 . . . . 71.439999999999998 109.124 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.6 p -92.87 134.52 35.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 71.439999999999998 110.813 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.09 140.24 50.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.974 -0.557 . . . . 74.040000000000006 110.312 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -105.61 124.56 49.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.083 -0.71 . . . . 74.120000000000005 109.083 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.587 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 48.7 p90 -122.29 154.42 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 110.869 -173.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 80.3 mtp -129.61 124.77 34.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 65.400000000000006 110.777 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ILE . . . . . 0.554 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 mm -98.13 121.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 71.129999999999995 110.461 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -133.25 178.09 7.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 74.010000000000005 109.321 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.3 p-10 -68.13 154.96 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 61.039999999999999 110.202 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -83.26 122.99 29.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.385 0.612 . . . . 71.109999999999999 112.118 -171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 90.2 m-85 -102.8 171.55 7.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.195 -0.911 . . . . 74.239999999999995 109.121 173.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.25 -30.43 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.886 -1.15 . . . . 65.010000000000005 113.24 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 49.9 m -105.27 125.67 51.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.048 0.424 . . . . 73.409999999999997 112.057 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.432 ' HA ' HD13 ' A' ' 184' ' ' LEU . 3.9 m-20 -88.91 124.14 33.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 109.543 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 13.4 tp -64.35 -26.26 68.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.221 0.534 . . . . 73.400000000000006 109.768 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.546 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 28.2 tt0 -62.9 -48.7 77.84 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 110.977 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 9.0 mmpt? -70.07 -29.79 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.233 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -65.09 -48.98 81.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.653 -0.703 . . . . 73.409999999999997 110.993 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.77 -32.12 73.21 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 119.866 -0.734 . . . . 74.340000000000003 109.68 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.05 -38.9 89.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 73.319999999999993 110.69 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.6 67.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 111.917 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -104.55 6.09 34.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.432 . . . . 64.140000000000001 110.906 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.57 54.9 6.02 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.706 -0.679 . . . . 73.400000000000006 112.257 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 257' ' ' GLY . 46.3 mtmt 55.59 53.44 9.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 75.239999999999995 112.569 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -123.46 96.41 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 74.420000000000002 109.87 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 21.7 m-85 -102.14 132.21 48.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.202 -0.454 . . . . 75.540000000000006 111.016 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 m -58.2 144.96 38.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.504 -0.771 . . . . 75.349999999999994 109.628 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.497 ' NH1' ' HB3' ' A' ' 294' ' ' ASN . 45.9 ttt85 -59.92 -37.9 80.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.686 -0.234 . . . . 73.340000000000003 111.51 -172.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 153' ' ' THR . 11.9 ptpt -61.67 -38.19 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 64.519999999999996 110.253 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 152' ' ' LYS . 9.0 m -68.0 -45.37 74.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.106 -0.497 . . . . 73.420000000000002 110.436 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.6 t -61.89 -47.34 93.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.385 -0.37 . . . . 72.319999999999993 110.585 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -62.84 -52.4 63.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 74.439999999999998 110.545 -176.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -63.48 -33.52 75.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.587 0.232 . . . . 74.200000000000003 110.812 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . 0.57 ' O ' HG12 ' A' ' 161' ' ' ILE . 2.7 mp -65.94 -51.21 60.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 73.439999999999998 110.681 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.45 ' HB2' HD23 ' A' ' 247' ' ' LEU . 36.3 p -58.18 -37.16 74.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.075 -0.25 . . . . 72.109999999999999 110.902 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 74.5 mt -60.33 -54.39 46.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 75.209999999999994 111.219 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.478 HH11 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -66.57 -15.76 63.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 111.0 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 157' ' ' LEU . 37.4 mm -72.35 -42.41 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.452 -0.573 . . . . 63.109999999999999 109.452 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.521 ' HB3' ' HE1' ' A' ' 317' ' ' TYR . 2.2 mm? -62.04 -42.21 98.93 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.62 -0.263 . . . . 73.420000000000002 110.459 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -63.03 1.22 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.6 0.714 . . . . 64.219999999999999 110.703 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 168' ' ' ILE . 18.1 tt -68.16 -41.4 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.234 -0.894 . . . . 75.409999999999997 111.565 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 243' ' ' ASP . 30.9 mt -63.66 -39.02 93.29 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.516 -0.474 . . . . 72.0 110.885 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 7.5 tp10 -57.28 -56.68 18.63 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.819 -0.438 . . . . 75.230000000000004 109.819 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.8 -42.94 80.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.473 -0.785 . . . . 74.239999999999995 112.078 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 174' ' ' VAL . 28.1 pt -80.7 -40.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.943 0.719 . . . . 73.010000000000005 112.943 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' HIS . . . . . 0.462 ' NE2' ' HA ' ' A' ' 166' ' ' GLU . 1.3 p-80 -75.89 -17.83 59.64 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.696 -0.802 . . . . 73.219999999999999 111.253 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.3 16.33 17.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 71.299999999999997 109.966 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -136.95 -89.01 0.28 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.106 -0.497 . . . . 73.340000000000003 110.88 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -147.56 114.96 6.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.615 0.245 . . . . 74.340000000000003 110.711 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' TYR . . . . . 0.52 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 64.8 m-85 76.26 157.43 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.237 0.961 . . . . 74.430000000000007 112.35 169.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 22.2 m -142.33 172.41 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.394 -0.821 . . . . 72.200000000000003 109.594 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' HIS . . . . . 0.674 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 14.2 t60 -119.9 103.12 9.06 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.984 -0.286 . . . . 75.329999999999998 110.414 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.486 ' HA2' HD11 ' A' ' 246' ' ' ILE . . . -73.71 -46.93 22.33 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.847 -0.692 . . . . 61.119999999999997 112.114 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . 0.931 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 24.9 t70 -65.58 94.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.146 0.498 . . . . 72.329999999999998 110.281 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 161' ' ' ILE . 8.3 tp -97.45 14.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.759 -0.655 . . . . 72.430000000000007 110.605 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -53.6 146.28 13.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.072 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.98 -10.65 6.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.807 0.669 . . . . 75.010000000000005 112.807 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.9 p -73.79 -15.93 61.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.983 0.42 . . . . 75.319999999999993 110.826 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASN . . . . . 0.464 ' O ' HD11 ' A' ' 195' ' ' LEU . 41.3 m-80 -85.77 -16.67 38.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 75.409999999999997 110.751 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.73 115.0 29.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.972 -0.558 . . . . 62.450000000000003 110.253 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.0 mm? -110.69 135.21 51.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 74.430000000000007 110.229 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.775 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.9 mt -85.54 137.59 32.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 109.853 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -62.58 135.13 57.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.941 -0.572 . . . . 70.209999999999994 109.893 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -56.0 -33.54 64.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.847 -0.615 . . . . 73.109999999999999 112.126 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -81.86 -54.21 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 74.549999999999997 110.812 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.1 112.83 49.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.446 -0.343 . . . . 62.399999999999999 111.531 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.36 -10.56 28.35 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.845 2.363 . . . . 73.439999999999998 111.138 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ASP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 5.0 p-10 -88.67 0.67 56.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.433 -0.803 . . . . 65.430000000000007 110.592 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLN . . . . . 0.53 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 77.4 mt-30 -114.07 102.64 10.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.526 . . . . 62.219999999999999 110.081 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.3 p -106.79 120.59 58.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.319 0.58 . . . . 75.150000000000006 110.703 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 93.3 m-85 -117.12 157.81 25.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 110.312 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 182' ' ' ASN . 31.6 tp -96.91 150.55 20.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.272 -0.422 . . . . 72.430000000000007 110.454 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 197' ' ' ASP . 3.0 p -136.39 -155.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.04 -0.726 . . . . 65.030000000000001 109.04 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.542 ' N ' HG13 ' A' ' 196' ' ' VAL . 9.2 t70 72.24 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.318 0.647 . . . . 74.219999999999999 109.706 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . 0.69 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 36.1 m-85 55.92 -7.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.246 1.202 . . . . 74.340000000000003 114.246 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 197' ' ' ASP . . . -72.72 -31.43 62.59 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.949 -0.861 . . . . 53.329999999999998 110.949 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . 0.674 ' HB2' ' CE1' ' A' ' 175' ' ' HIS . 92.0 mt -89.06 53.53 2.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.069 0.462 . . . . 74.140000000000001 110.307 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -98.75 99.0 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 62.420000000000002 110.163 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -122.35 104.57 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 75.510000000000005 111.888 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ARG . . . . . 0.562 ' NH1' HG12 ' A' ' 174' ' ' VAL . 31.9 ttm180 -178.73 -73.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.077 -0.51 . . . . 72.120000000000005 110.44 172.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' TYR . . . . . 0.45 ' H ' ' HA ' ' A' ' 173' ' ' TYR . 81.9 t80 70.61 112.4 0.05 Allowed 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 124.036 0.835 . . . . 72.230000000000004 111.044 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 56.6 m -116.07 100.89 53.89 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.056 -0.72 . . . . 73.340000000000003 109.056 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 11.5 Cg_endo -55.41 107.4 0.24 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.471 2.114 . . . . 73.439999999999998 111.818 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 206' ' ' PRO . 11.2 mm-40 72.29 16.05 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.84 -0.618 . . . . 72.400000000000006 110.746 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.55 74.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.891 -0.671 . . . . 72.049999999999997 111.878 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.3 111.61 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.015 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 238' ' ' PRO . 24.7 p80 -87.55 147.16 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.448 . . . . 73.219999999999999 110.947 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' A' ' 215' ' ' GLU . 53.6 mtpt -71.35 166.63 21.24 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 75.530000000000001 110.168 173.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.7 174.34 11.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.852 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -74.96 88.54 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.953 0.882 . . . . 74.430000000000007 110.66 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -138.85 12.69 2.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.266 -0.879 . . . . 74.239999999999995 110.494 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' GLU . . . . . 1.094 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 4.1 mm-40 -102.52 118.04 36.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 111.472 -171.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -150.41 82.75 6.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.84 -0.8 . . . . 75.409999999999997 108.84 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 C-N-CA 122.297 1.998 . . . . 74.310000000000002 111.474 179.147 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 111.768 0.284 . . . . 71.420000000000002 111.768 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLY . . . . . 0.931 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -109.51 -104.17 2.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.75 -0.738 . . . . 74.340000000000003 112.81 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' A' ' 228' ' ' THR . 2.2 p -89.82 146.99 24.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.671 0.272 . . . . 63.100000000000001 110.525 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -68.22 -27.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 74.219999999999999 110.548 -175.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -55.74 5.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.487 -0.324 . . . . 54.200000000000003 110.14 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' PHE . . . . . 0.408 ' HB3' HG21 ' A' ' 178' ' ' ILE . 90.8 m-85 -86.15 3.16 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.017 0.377 . . . . 74.329999999999998 112.017 -169.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' THR . . . . . 0.591 ' O ' ' HB1' ' A' ' 232' ' ' ALA . 6.8 t -77.71 -6.02 52.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 72.239999999999995 110.517 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.585 ' HA ' ' HE2' ' A' ' 249' ' ' TYR . 41.9 t 65.96 173.36 0.23 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.147 0.499 . . . . 75.150000000000006 111.168 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.7 -34.84 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.222 0.534 . . . . 75.109999999999999 109.57 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.79 -62.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.281 -0.872 . . . . 73.319999999999993 112.294 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 228' ' ' THR . . . -65.43 -28.38 69.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 63.119999999999997 110.939 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' HIS . . . . . 0.494 ' HB2' HG23 ' A' ' 228' ' ' THR . 14.3 t-80 -74.82 -17.82 60.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.381 -0.372 . . . . 74.019999999999996 110.719 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.94 -30.06 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.693 -0.855 . . . . 63.100000000000001 108.693 170.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 109.75 -9.1 32.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.237 -0.892 . . . . 71.140000000000001 112.392 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' VAL . . . . . 1.094 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 5.3 p -62.04 109.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.619 0.723 . . . . 75.430000000000007 110.172 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' ALA . . . . . 0.711 ' HB1' ' HD3' ' A' ' 238' ' ' PRO . . . -67.46 -61.43 4.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 74.420000000000002 112.433 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.711 ' HD3' ' HB1' ' A' ' 237' ' ' ALA . 31.5 Cg_endo -93.79 73.08 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.673 2.248 . . . . 63.229999999999997 113.573 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.9 t -132.46 110.42 10.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.795 0.331 . . . . 74.430000000000007 110.701 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' ARG . . . . . 0.444 ' HA ' ' OD1' ' A' ' 243' ' ' ASP . 29.8 ttt180 -66.73 -16.91 64.57 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.552 0.692 . . . . 71.450000000000003 110.492 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . 0.946 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.53 -43.36 75.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.904 -1.043 . . . . 75.329999999999998 109.61 175.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -63.74 -46.32 92.22 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.128 -0.942 . . . . 65.209999999999994 112.423 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ASP . . . . . 0.516 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -47.28 -51.57 18.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.645 0.736 . . . . 71.349999999999994 110.358 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.4 -31.95 64.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.858 -1.065 . . . . 72.340000000000003 111.956 -173.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.96 -38.66 64.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.7 -0.4 . . . . 75.439999999999998 110.547 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 242' ' ' GLY . 90.9 mt -58.69 -48.38 86.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.375 0.607 . . . . 73.219999999999999 110.59 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.52 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -59.73 -41.03 89.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.645 -0.707 . . . . 74.319999999999993 110.06 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 252' ' ' ILE . . . -54.84 -41.98 77.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.01 -0.614 . . . . 75.400000000000006 112.111 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' TYR . . . . . 0.585 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 19.4 m-30 -55.94 -59.49 4.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.808 0.337 . . . . 72.319999999999993 111.026 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' A' ' 247' ' ' LEU . 25.6 p -62.35 -36.15 81.32 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.552 -0.459 . . . . 51.439999999999998 111.32 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.2 mtp -60.99 -54.39 45.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.667 0.27 . . . . 55.240000000000002 111.278 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 248' ' ' GLY . 8.9 tt -68.36 -36.49 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 75.209999999999994 110.677 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.573 0.225 . . . . 71.319999999999993 111.348 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' TRP . . . . . 0.643 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 39.0 m0 -75.77 -27.39 58.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 74.120000000000005 110.991 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 tp -84.24 -31.52 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.347 -0.388 . . . . 74.409999999999997 111.72 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.3 p -101.73 -20.95 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.06 -0.4 . . . . 73.129999999999995 111.52 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.483 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 85.11 -19.58 21.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.9 -0.667 . . . . 75.439999999999998 112.851 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.9 143.65 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.785 -0.45 . . . . 64.150000000000006 109.785 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' LEU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 262' ' ' GLU . 86.6 mt -119.58 141.76 31.55 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.132 -0.321 . . . . 70.420000000000002 110.132 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 48.1 Cg_exo -57.08 -45.68 34.08 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.031 2.487 . . . . 63.020000000000003 112.504 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' TRP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 36.8 p90 -80.29 -17.87 50.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.904 -0.589 . . . . 72.129999999999995 110.755 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 259' ' ' LEU . 1.8 tm-20 -77.7 -35.31 52.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.294 0.569 . . . . 74.109999999999999 109.763 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.52 -34.53 76.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.317 0.58 . . . . 73.530000000000001 110.041 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -108.45 24.76 12.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 73.519999999999996 111.992 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 3.4 pp -71.81 -1.33 13.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.756 0.312 . . . . 74.340000000000003 111.666 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.54 -6.25 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.469 -0.332 . . . . 74.519999999999996 110.747 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASP . . . . . 0.606 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 33.0 t70 -139.06 125.56 12.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.108 -0.33 . . . . 64.0 110.108 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 36.4 Cg_exo -60.4 -21.71 68.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.306 2.671 . . . . 72.430000000000007 113.981 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.87 -39.39 79.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.726 -0.39 . . . . 73.540000000000006 110.17 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' TYR . . . . . 0.606 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 44.8 m-85 -65.88 -50.45 64.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 73.120000000000005 111.456 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 30.0 m -63.3 -35.18 71.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.992 -0.283 . . . . 74.010000000000005 111.201 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 276' ' ' ILE . 38.8 ttp180 -63.17 -62.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.987 0.422 . . . . 71.109999999999999 110.408 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 11.2 t70 -62.99 -44.41 96.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.515 -0.766 . . . . 71.430000000000007 111.352 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' SER . . . . . 0.478 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 25.1 m -61.18 -47.41 86.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.406 . . . . 60.32 111.225 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.8 -36.63 84.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.79 -0.364 . . . . 72.230000000000004 111.132 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.5 mt -60.38 -42.65 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.601 0.238 . . . . 74.409999999999997 110.585 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 273' ' ' ASP . 57.2 mtt180 -61.14 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.404 -0.362 . . . . 72.129999999999995 110.755 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' TYR . . . . . 0.478 ' HD1' ' O ' ' A' ' 274' ' ' SER . 35.7 m-85 -69.86 -43.67 71.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 112.057 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' ARG . . . . . 0.477 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 2.3 ptm180 -67.99 -25.21 65.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.908 -0.317 . . . . 74.329999999999998 111.347 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -85.5 -42.79 14.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.872 0.368 . . . . 74.340000000000003 110.803 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' ASN . . . . . 0.744 HD21 HD22 ' A' ' 285' ' ' LEU . 9.5 t30 -130.51 87.45 2.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.138 0.494 . . . . 73.310000000000002 110.351 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ILE . . . . . 0.43 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -81.64 -40.67 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.428 0.899 . . . . 71.400000000000006 113.428 -172.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ALA . . . . . 0.43 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -65.89 -51.35 59.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.345 0.868 . . . . 74.299999999999997 113.345 -163.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.7 p -77.04 -28.89 55.0 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.574 -0.45 . . . . 74.109999999999999 110.944 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.744 HD22 HD21 ' A' ' 281' ' ' ASN . 1.9 mm? -64.95 -54.97 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 73.439999999999998 110.458 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' MET . . . . . 0.405 ' HE2' ' SD ' ' A' ' 303' ' ' MET . 24.6 mmt -63.47 -39.67 95.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.602 -0.272 . . . . 75.329999999999998 111.316 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.84 -38.29 90.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 74.200000000000003 111.486 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -91.75 -20.31 21.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.728 0.64 . . . . 74.239999999999995 112.728 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.25 -44.9 86.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.748 0.309 . . . . 75.019999999999996 111.199 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 296' ' ' PRO . 17.5 p90 -136.82 89.74 17.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 122.002 0.906 . . . . 73.420000000000002 110.77 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.11 49.43 3.03 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.856 2.371 . . . . 71.109999999999999 111.986 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -100.39 -145.59 0.34 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.332 -0.395 . . . . 74.219999999999999 110.807 -178.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 70.1 mmtt -120.03 17.29 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.646 0.98 . . . . 65.129999999999995 113.646 -166.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.497 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 14.6 m-80 -93.13 -15.99 25.41 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.184 -0.323 . . . . 71.409999999999997 110.345 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 11.4 mptt 75.1 112.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 123.847 0.717 . . . . 72.439999999999998 111.05 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' PRO . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 290' ' ' PHE . 96.7 Cg_endo -83.04 37.71 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.551 2.167 . . . . 75.019999999999996 112.255 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -81.72 -68.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.9 -0.667 . . . . 72.430000000000007 112.5 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 151' ' ' ARG . 1.9 mp0 -55.98 -36.63 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 122.045 0.138 . . . . 60.0 111.266 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 2.9 mp -61.71 -49.53 83.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.827 0.346 . . . . 74.349999999999994 110.609 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.36 85.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.807 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 301' ' ' LYS . 69.1 mmtt -68.3 -31.59 71.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.275 -0.42 . . . . 73.450000000000003 111.808 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -62.24 -47.68 83.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.079 0.466 . . . . 75.400000000000006 110.257 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' MET . . . . . 0.489 ' HA ' HG22 ' A' ' 306' ' ' VAL . 68.6 mtp -73.25 -31.13 63.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.323 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 33.2 tt0 -59.76 -44.16 93.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.745 -0.835 . . . . 74.519999999999996 108.745 171.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 58.6 m -58.47 -46.44 86.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.91 -1.041 . . . . 71.409999999999997 111.695 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 303' ' ' MET . 14.1 m -68.17 -26.21 33.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.97 -0.292 . . . . 73.299999999999997 111.25 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 18.5 ttmt -74.68 -34.08 62.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 72.420000000000002 110.14 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 91.7 mt -81.99 5.16 20.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 72.439999999999998 112.126 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 315' ' ' PRO . 4.2 pp -107.19 9.28 30.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.417 0.627 . . . . 73.340000000000003 109.452 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 12.2 t70 67.41 -81.82 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.335 -1.302 . . . . 72.209999999999994 111.887 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' TYR . . . . . 0.946 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.8 OUTLIER -161.91 -48.81 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.954 0.883 . . . . 65.430000000000007 109.364 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 m -145.4 35.94 1.08 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.052 -1.092 . . . . 75.510000000000005 108.052 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' GLU . . . . . 0.559 ' O ' ' HD3' ' A' ' 314' ' ' LYS . 3.4 tm-20 -77.54 -82.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.898 -1.047 . . . . 73.519999999999996 108.793 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LYS . . . . . 0.559 ' HD3' ' O ' ' A' ' 313' ' ' GLU . 0.6 OUTLIER -150.96 99.73 3.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.051 -0.722 . . . . 75.439999999999998 109.051 171.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.542 ' HA ' HD21 ' A' ' 309' ' ' LEU . 24.4 Cg_exo -63.28 118.28 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.017 1.812 . . . . 72.340000000000003 111.124 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.9 84.02 4.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.384 0.612 . . . . 63.409999999999997 110.55 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' TYR . . . . . 0.521 ' HE1' ' HB3' ' A' ' 162' ' ' LEU . 61.5 t80 -64.41 -38.89 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.333 -0.848 . . . . 72.340000000000003 110.807 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 39.8 tt0 -56.73 -55.09 38.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.342 -0.845 . . . . 75.310000000000002 111.327 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -57.05 -50.3 73.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.127 -0.488 . . . . 60.130000000000003 111.776 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 4.2 pp -65.05 -40.26 94.51 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.903 -0.319 . . . . 74.319999999999993 111.641 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' ARG . . . . . 0.43 ' N ' HD13 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.47 -25.51 59.44 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.332 -0.547 . . . . 74.510000000000005 109.886 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 318' ' ' GLU . 0.4 OUTLIER -73.5 -45.39 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 74.420000000000002 110.413 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.13 -31.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.931 -0.307 . . . . 74.329999999999998 111.14 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.7 mt -63.79 -48.62 76.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.911 0.386 . . . . 73.120000000000005 110.175 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.9 -38.67 89.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.161 -0.472 . . . . 63.310000000000002 110.688 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -60.74 -44.79 96.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 74.140000000000001 110.891 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.4 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.76 -46.37 83.49 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.772 . . . . 70.120000000000005 112.556 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' LEU . . . . . 0.769 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 1.8 tm? -63.49 -38.87 92.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 71.310000000000002 110.038 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 75.409999999999997 110.652 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.31 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 65.209999999999994 111.812 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 328' ' ' LEU . 40.5 pt -76.8 -6.34 8.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.844 0.354 . . . . 72.109999999999999 111.362 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.06 25.44 14.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.483 -0.865 . . . . 73.230000000000004 113.149 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 41.1 m -129.02 147.71 50.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.921 0.36 . . . . 73.140000000000001 110.985 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -172.1 75.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.648 0.737 . . . . 74.129999999999995 110.324 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -94.41 -8.32 39.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 55.5 110.613 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.0 t70 82.03 -19.73 0.4 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.669 0.788 . . . . 73.109999999999999 112.352 171.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . 155.5 50.34 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.554 -1.308 . . . . 73.450000000000003 113.842 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' LYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 21.2 ttmm . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 108.997 -0.742 . . . . 74.409999999999997 108.997 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' LYS . . . . . 0.51 ' HB3' HD21 ' A' ' 200' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.13 0.491 . . . . 72.420000000000002 110.894 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.0 t -129.39 168.89 15.62 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.069 -1.086 . . . . 73.019999999999996 108.069 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 200' ' ' LEU . 3.4 pt -66.01 142.67 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.417 0.627 . . . . 74.120000000000005 111.836 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 m -73.07 72.46 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.857 -1.065 . . . . 73.310000000000002 110.583 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.726 -0.67 . . . . 75.099999999999994 111.282 -177.419 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.019 -0.363 . . . . 70.400000000000006 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.3 143.34 24.99 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.785 2.323 . . . . 73.140000000000001 113.085 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -135.02 148.19 49.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 73.430000000000007 109.56 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.68 134.33 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 74.219999999999999 111.104 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -152.7 135.5 15.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.979 -0.555 . . . . 73.430000000000007 110.3 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 179.67 108.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.48 0.487 . . . . 74.040000000000006 110.703 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.12 90.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.717 0.294 . . . . 62.109999999999999 111.045 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -178.71 109.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.782 -0.644 . . . . 72.150000000000006 110.019 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.59 151.34 11.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.6 -0.273 . . . . 71.030000000000001 111.06 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 105.48 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.193 -0.527 . . . . 72.310000000000002 113.411 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -157.64 79.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 75.219999999999999 110.723 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -146.09 126.94 14.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 75.409999999999997 110.129 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.8 m -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.131 -0.486 . . . . 71.010000000000005 110.488 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -133.3 119.35 19.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.822 -0.436 . . . . 71.329999999999998 109.822 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.98 80.09 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 74.219999999999999 111.932 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.72 145.15 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.294 -0.412 . . . . 72.219999999999999 110.012 171.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -149.82 149.53 30.64 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.03 -0.73 . . . . 73.349999999999994 109.03 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.62 75.56 1.49 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 75.430000000000007 112.404 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 19' ' ' LEU . 1.4 pp -124.86 120.46 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 74.200000000000003 109.489 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.02 -51.3 4.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.006 -0.543 . . . . 75.340000000000003 110.658 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 69.16 -63.0 0.39 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.227 0.954 . . . . 64.430000000000007 112.686 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.21 -71.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.896 0.332 . . . . 74.140000000000001 111.896 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.76 113.09 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.453 0.168 . . . . 73.239999999999995 111.453 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.38 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.01 0.819 . . . . 73.129999999999995 109.461 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.3 121.64 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.458 -0.792 . . . . 71.349999999999994 110.358 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.75 1.29 56.34 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.778 -0.725 . . . . 64.230000000000004 113.24 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.503 ' O ' HG11 ' A' ' 39' ' ' VAL . 31.8 mt-10 -70.05 110.08 4.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.275 0.537 . . . . 75.409999999999997 109.642 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.862 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -89.74 133.47 31.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.157 0.503 . . . . 75.219999999999999 110.499 178.713 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.59 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.79 -0.641 . . . . 74.400000000000006 110.888 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.555 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 24.0 m -84.65 125.67 32.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.736 0.303 . . . . 73.349999999999994 110.534 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -170.5 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 63.32 110.462 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 75.1 mtm -71.67 -20.55 61.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.778 0.288 . . . . 72.209999999999994 111.778 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.71 1.95 32.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.999 0.428 . . . . 71.329999999999998 110.343 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 71.22 24.37 3.83 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.141 -0.936 . . . . 71.230000000000004 112.595 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 30' ' ' THR . 90.1 mttt -103.05 136.72 42.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 74.140000000000001 109.532 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.862 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 19.2 tt0 -96.66 97.38 9.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.259 -0.645 . . . . 74.099999999999994 109.259 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.551 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 63.3 m95 -80.85 128.09 33.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.341 -0.845 . . . . 73.510000000000005 111.217 -172.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 56' ' ' MET . 68.1 tttt -92.01 108.02 19.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.164 -0.471 . . . . 71.510000000000005 110.294 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.503 HG11 ' O ' ' A' ' 27' ' ' GLU . 10.0 p -68.74 136.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.949 0.404 . . . . 71.200000000000003 110.124 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.486 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -109.15 -86.13 1.75 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.694 -0.765 . . . . 45.5 112.588 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.497 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 95.2 mt -106.78 136.45 19.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.859 0.361 . . . . 72.349999999999994 111.527 -174.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.2 Cg_exo -78.07 106.69 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.163 2.575 . . . . 73.120000000000005 111.431 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.0 mt -73.9 -49.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 75.019999999999996 110.063 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.59 -23.56 12.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.907 -0.663 . . . . 52.240000000000002 112.371 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -110.35 164.79 12.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.115 -0.328 . . . . 64.450000000000003 110.115 -177.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.83 -166.57 28.33 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.644 -0.983 . . . . 74.0 110.644 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.822 ' HA3' HG11 ' A' ' 196' ' ' VAL . . . -82.54 46.65 3.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.402 -0.904 . . . . 74.430000000000007 112.463 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.753 ' HD1' ' HB3' ' A' ' 351' ' ' ALA . 65.8 t80 177.93 -59.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.999 0.428 . . . . 74.120000000000005 110.013 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.32 154.78 8.97 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.532 -0.758 . . . . 73.040000000000006 111.215 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.4 m 59.27 38.4 23.3 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.23 0.538 . . . . 71.5 111.322 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.424 HD11 ' HB3' ' A' ' 48' ' ' PHE . 16.6 mm -88.43 138.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.94 -0.573 . . . . 72.109999999999999 110.062 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.449 ' HB3' HG21 ' A' ' 39' ' ' VAL . 87.4 m-85 -108.13 152.59 24.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 72.129999999999995 110.999 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.71 143.62 30.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.257 -0.646 . . . . 75.310000000000002 109.257 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.57 114.67 27.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.19 0.519 . . . . 72.120000000000005 111.137 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.486 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 28.3 t70 -84.98 -40.81 16.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.802 -0.635 . . . . 64.310000000000002 109.649 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.702 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 96.7 mmm 63.21 173.99 0.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.079 -0.964 . . . . 74.430000000000007 112.345 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -89.57 108.71 19.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.796 -0.638 . . . . 73.140000000000001 109.913 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -83.31 83.43 7.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.117 0.484 . . . . 70.349999999999994 110.363 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -70.76 -66.07 0.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.778 -0.647 . . . . 70.129999999999995 110.731 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -144.82 -55.56 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.974 -0.557 . . . . 75.329999999999998 109.722 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 p -142.81 93.31 2.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.929 -0.578 . . . . 72.340000000000003 110.631 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.61 143.17 16.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.538 . . . . 75.019999999999996 110.147 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.81 -100.43 0.13 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.793 -0.717 . . . . 71.340000000000003 112.449 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -120.22 14.49 12.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.258 0.552 . . . . 71.349999999999994 109.817 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.39 -27.13 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.411 -0.813 . . . . 72.510000000000005 111.668 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.468 ' HB1' ' HD3' ' A' ' 67' ' ' PRO . . . -76.12 -50.41 3.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.915 0.709 . . . . 73.420000000000002 112.915 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.468 ' HD3' ' HB1' ' A' ' 66' ' ' ALA . 7.8 Cg_exo -74.16 51.44 2.46 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.575 2.184 . . . . 71.420000000000002 113.912 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 31.2 p -138.93 162.44 34.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.075 0.464 . . . . 72.319999999999993 111.286 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.48 166.37 27.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 73.040000000000006 109.369 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' HB ' HD11 ' A' ' 130' ' ' ILE . 2.6 p -136.33 128.99 45.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.536 -0.466 . . . . 72.010000000000005 112.138 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.637 ' HE2' ' SD ' ' A' ' 129' ' ' MET . 32.6 ttpt -85.35 142.55 29.24 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.826 -0.624 . . . . 75.219999999999999 109.582 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.83 132.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.952 -0.388 . . . . 74.530000000000001 109.952 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.957 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 5.1 tp10 -140.1 135.64 16.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.299 -0.409 . . . . 74.329999999999998 109.99 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.13 143.55 94.78 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.499 2.133 . . . . 74.209999999999994 112.151 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t -71.61 -2.64 17.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.388 -0.369 . . . . 74.299999999999997 111.66 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.2 -22.23 64.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.292 -0.633 . . . . 72.409999999999997 109.292 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.63 105.49 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.843 -1.071 . . . . 72.109999999999999 113.128 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -108.38 -89.63 2.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.298 -0.865 . . . . 74.209999999999994 111.13 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -84.83 -20.75 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.386 2.724 . . . . 74.230000000000004 111.831 176.143 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.957 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 55.2 tp -52.26 -49.53 63.87 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.405 0.891 . . . . 74.430000000000007 113.405 -169.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.2 -45.2 95.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.395 -0.522 . . . . 74.120000000000005 111.008 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.0 m -64.95 -46.51 81.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.022 0.439 . . . . 73.209999999999994 110.68 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.432 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 36.1 tt0 -65.29 -52.45 54.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.403 -0.817 . . . . 73.239999999999995 111.276 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.728 HD23 ' HE2' ' A' ' 129' ' ' MET . 3.3 tm? -65.93 -39.36 90.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.918 -176.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.05 -49.72 76.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.805 -0.443 . . . . 75.120000000000005 109.805 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.459 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 76.2 t80 -65.93 -44.42 85.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.714 -0.676 . . . . 74.219999999999999 110.316 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.948 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 68.2 t80 -54.96 -53.9 49.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.804 -0.634 . . . . 74.530000000000001 111.005 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.54 -31.76 72.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.921 -0.581 . . . . 72.019999999999996 110.705 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -78.83 -29.52 44.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 72.420000000000002 111.877 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.66 -35.35 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.912 0.338 . . . . 75.530000000000001 111.912 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.488 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -83.64 71.52 10.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.748 0.785 . . . . 64.120000000000005 110.567 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.465 ' O ' HG13 ' A' ' 96' ' ' ILE . 4.6 tmtt? -125.02 103.79 30.17 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.839 -1.073 . . . . 75.219999999999999 109.428 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.423 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -42.98 -47.94 7.99 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.083 3.189 . . . . 72.540000000000006 113.368 -174.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.414 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 11.1 tp10 -57.99 -60.19 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 74.120000000000005 110.721 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -61.7 -41.46 97.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.566 -0.743 . . . . 72.310000000000002 111.504 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.595 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 69.6 mt -58.03 -52.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 O-C-N 123.073 0.233 . . . . 74.409999999999997 110.82 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -58.45 -42.61 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.532 -0.304 . . . . 73.030000000000001 110.959 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.7 mmtp -61.86 -62.67 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.907 -0.588 . . . . 74.049999999999997 111.943 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.639 ' CH2' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.9 -35.23 72.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.584 -0.447 . . . . 71.019999999999996 111.643 -171.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.938 -0.305 . . . . 71.420000000000002 110.393 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -69.17 -41.33 77.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 74.439999999999998 111.129 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 p -76.4 -31.79 58.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.843 0.682 . . . . 73.329999999999998 112.843 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 103' ' ' ARG . 36.1 ttm180 -89.7 5.54 45.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.065 0.459 . . . . 72.019999999999996 110.557 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 61.71 30.39 18.43 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.631 -0.713 . . . . 72.299999999999997 110.648 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.628 ' HG ' ' OD1' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -78.95 161.3 26.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 110.571 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.567 ' HB2' HH22 ' A' ' 321' ' ' ARG . 5.5 tmtm? -85.61 -66.29 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 75.420000000000002 109.982 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -163.07 135.51 5.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 74.209999999999994 110.817 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.639 HD23 ' CH2' ' A' ' 99' ' ' TRP . 26.7 tp -79.6 121.12 24.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 72.5 110.32 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.96 56.36 4.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.876 -0.678 . . . . 60.219999999999999 112.717 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 93.1 t -128.15 125.56 23.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.922 -0.399 . . . . 72.010000000000005 109.922 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.948 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -56.1 143.78 82.58 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.897 2.398 . . . . 75.109999999999999 112.593 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.439 ' HE2' ' O ' ' A' ' 113' ' ' TYR . 20.8 tptm -67.79 131.56 45.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 73.549999999999997 111.003 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.439 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 77.7 t80 -80.69 124.47 29.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 74.340000000000003 110.341 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.606 ' CD1' HG22 ' A' ' 130' ' ' ILE . 14.2 m95 -106.11 -58.67 1.88 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.476 -0.564 . . . . 74.129999999999995 109.476 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.39 174.51 35.56 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.599 -0.728 . . . . 63.409999999999997 112.048 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.9 p -171.27 147.82 2.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.554 -0.535 . . . . 74.219999999999999 109.554 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.32 -167.9 33.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.116 -1.04 . . . . 74.519999999999996 112.611 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.5 tt -126.95 133.46 50.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.723 -0.473 . . . . 75.040000000000006 109.723 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -134.84 109.48 8.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.473 -0.331 . . . . 73.030000000000001 110.29 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.815 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 18.0 t70 -73.68 122.88 23.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.115 -0.493 . . . . 75.129999999999995 109.69 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.0 tttp -129.46 121.56 27.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 75.439999999999998 110.071 -177.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 20.1 m120 63.74 16.5 9.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.915 -0.584 . . . . 73.209999999999994 111.658 179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.57 -0.25 56.76 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.685 -0.769 . . . . 74.450000000000003 112.405 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -117.22 115.35 25.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.095 -0.705 . . . . 72.420000000000002 109.095 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.815 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.7 p -76.31 119.61 20.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 74.239999999999995 111.157 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 129.81 55.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 75.310000000000002 109.656 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.42 134.37 40.77 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.796 -0.816 . . . . 75.329999999999998 108.796 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.524 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 44.6 p90 -122.48 142.88 50.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.233 -0.44 . . . . 75.409999999999997 111.021 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.728 ' HE2' HD23 ' A' ' 84' ' ' LEU . 15.4 ptm -129.87 131.22 46.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 73.099999999999994 109.993 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.606 HG22 ' CD1' ' A' ' 114' ' ' TRP . 3.3 mm -97.5 123.04 49.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 74.019999999999996 110.624 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.4 ' HG2' ' CZ ' ' A' ' 87' ' ' TYR . 38.4 mtm -126.5 178.38 5.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 71.129999999999995 110.415 -177.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -65.58 151.39 46.56 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.625 -0.509 . . . . 73.099999999999994 109.625 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -72.23 116.12 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.254 0.549 . . . . 74.519999999999996 111.113 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.551 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 17.0 m-85 -104.97 143.35 33.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 75.140000000000001 110.214 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.519 ' HA3' ' CD1' ' A' ' 187' ' ' TYR . . . -140.16 -15.36 0.52 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.475 -0.869 . . . . 62.420000000000002 112.721 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.873 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 13.6 m -122.2 132.29 54.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.682 -0.305 . . . . 73.109999999999999 110.503 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.406 ' OD1' ' HB3' ' A' ' 139' ' ' GLN . 3.6 p30 -125.74 148.88 48.93 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.843 -0.428 . . . . 74.329999999999998 109.843 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.437 HD23 HD21 ' A' ' 157' ' ' LEU . 9.8 mp -74.71 -8.1 55.34 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.989 0.366 . . . . 74.019999999999996 111.989 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.666 ' HG2' ' HG ' ' A' ' 349' ' ' LEU . 7.5 tp-100 -76.91 -48.6 17.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 75.230000000000004 110.647 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.58 -37.22 62.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.949 0.404 . . . . 61.210000000000001 110.049 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.448 HG22 HD12 ' A' ' 341' ' ' LEU . 69.5 mt -62.44 -33.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 73.340000000000003 110.503 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.486 ' CE1' ' HD2' ' A' ' 147' ' ' LYS . 13.9 t80 -53.23 -46.59 69.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.009 -0.541 . . . . 75.200000000000003 109.581 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -71.22 -52.91 16.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.476 -0.784 . . . . 72.230000000000004 110.796 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.07 73.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.912 0.708 . . . . 74.239999999999995 112.912 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -104.23 10.03 35.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.92 0.39 . . . . 75.120000000000005 110.368 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.408 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 53.28 40.27 31.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.742 -0.663 . . . . 71.129999999999995 111.628 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER 42.73 30.78 0.26 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.583 1.153 . . . . 73.299999999999997 113.669 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -86.27 95.01 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.515 -0.474 . . . . 74.519999999999996 110.042 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.438 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 66.5 m-85 -109.15 119.8 40.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.078 -0.51 . . . . 74.239999999999995 109.828 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.7 m -74.7 168.18 20.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.266 -0.424 . . . . 72.519999999999996 110.72 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 53.2 mtm-85 -51.67 -47.0 64.0 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.315 -0.402 . . . . 74.010000000000005 111.648 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.792 ' HE2' ' HB2' ' A' ' 340' ' ' ASP . 0.0 OUTLIER -63.99 -30.05 71.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.853 0.358 . . . . 73.530000000000001 111.29 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.566 ' N ' ' HD3' ' A' ' 152' ' ' LYS . 1.3 m -72.49 -52.12 17.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.895 0.378 . . . . 72.340000000000003 110.383 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -41.06 91.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.71 -0.677 . . . . 75.5 110.913 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.04 -50.11 75.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 74.340000000000003 110.764 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.605 ' NE2' ' HA ' ' A' ' 335' ' ' ASP . 1.5 mp0 -64.06 -38.31 90.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.557 -0.292 . . . . 72.109999999999999 111.264 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.554 ' O ' HG12 ' A' ' 161' ' ' ILE . 4.8 mp -60.94 -52.83 63.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 74.430000000000007 110.558 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.484 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.6 p -68.03 -31.85 71.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 74.129999999999995 111.095 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.0 tp -57.03 -53.11 61.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 72.040000000000006 111.043 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.472 ' HD3' ' O ' ' A' ' 156' ' ' GLN . 2.1 mpt_? -67.91 -29.41 68.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.938 0.399 . . . . 75.439999999999998 110.638 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.554 HG12 ' O ' ' A' ' 157' ' ' LEU . 40.3 mm -65.73 -36.96 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 71.540000000000006 110.241 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 158' ' ' SER . 94.2 mt -62.16 -43.53 98.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 75.230000000000004 110.441 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.628 ' OD1' ' HG ' ' A' ' 105' ' ' LEU . 51.3 m-20 -55.71 -54.37 45.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.352 0.596 . . . . 73.200000000000003 110.484 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.406 HG22 ' HA ' ' A' ' 161' ' ' ILE . 14.0 tt -71.98 -37.77 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 75.239999999999995 111.948 -174.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.63 -38.58 90.79 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.829 -0.349 . . . . 73.129999999999995 111.169 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.39 -47.82 75.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.229 -0.588 . . . . 72.109999999999999 110.075 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.516 ' HA ' ' OE2' ' A' ' 170' ' ' GLU . 63.5 t80 -58.49 -41.67 85.83 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.437 0.532 . . . . 75.25 112.437 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.459 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 pt -88.29 -33.3 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.601 -0.439 . . . . 60.450000000000003 112.069 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.749 ' HD2' ' HD3' ' A' ' 240' ' ' ARG . 37.0 t60 -91.57 -5.92 53.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.665 0.269 . . . . 73.230000000000004 111.064 -172.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.516 ' OE2' ' HA ' ' A' ' 167' ' ' TYR . 13.2 pt-20 -78.81 -19.79 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.482 . . . . 75.200000000000003 109.734 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -97.49 -65.07 0.99 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.91 -0.587 . . . . 73.319999999999993 111.447 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.601 ' HG2' ' HB2' ' A' ' 203' ' ' ARG . 35.7 tt0 -162.05 -44.31 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.24 0.829 . . . . 61.420000000000002 113.24 -168.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -80.49 158.06 25.97 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.246 0.832 . . . . 73.409999999999997 113.246 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.717 HG11 ' CE1' ' A' ' 169' ' ' HIS . 3.6 m -129.7 172.26 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.58 -1.191 . . . . 74.219999999999999 108.48 171.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.492 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 19.7 t-80 -144.64 92.49 2.3 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.115 -0.698 . . . . 75.239999999999995 109.115 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.402 ' O ' HD11 ' A' ' 246' ' ' ILE . . . -63.71 -47.33 87.54 Favored Glycine 0 C--O 1.226 -0.4 0 O-C-N 123.522 0.514 . . . . 73.25 113.67 -170.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.527 ' HB3' HD11 ' A' ' 200' ' ' LEU . 26.1 t0 -99.02 105.44 17.57 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.387 -0.478 . . . . 72.140000000000001 110.525 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.405 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 29.0 mm -89.97 91.3 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 74.019999999999996 109.575 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -93.98 149.82 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.372 -0.831 . . . . 72.310000000000002 109.798 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 138' ' ' LEU . . . -54.85 -26.83 37.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 71.540000000000006 111.733 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.5 p -77.39 -5.58 50.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.945 0.35 . . . . 74.239999999999995 111.945 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.469 ' ND2' ' HB3' ' A' ' 197' ' ' ASP . 12.2 m120 -83.18 -22.96 33.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 71.129999999999995 110.809 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.75 115.97 31.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.142 -0.481 . . . . 74.420000000000002 110.426 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.477 HD23 ' N ' ' A' ' 184' ' ' LEU . 2.6 mm? -113.83 131.8 56.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 74.099999999999994 109.817 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.873 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.8 mt -89.45 140.92 29.04 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.198 -0.456 . . . . 74.349999999999994 110.178 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 189' ' ' ASN . 43.7 t-20 -59.71 125.61 24.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.97 -0.752 . . . . 71.310000000000002 108.97 175.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.519 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 36.2 t80 -52.6 -31.27 35.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.507 0.558 . . . . 74.420000000000002 112.507 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -126.91 24.55 6.44 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.381 -0.527 . . . . 75.400000000000006 111.914 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.501 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 6.1 t30 -159.57 80.78 2.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.456 -0.572 . . . . 74.319999999999993 109.456 174.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.67 -24.26 55.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 123.33 2.686 . . . . 74.409999999999997 113.993 -170.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -71.0 -14.38 62.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.926 -0.309 . . . . 75.230000000000004 111.592 -175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -114.04 114.75 26.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 74.140000000000001 110.294 179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.68 142.86 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.831 . . . . 72.099999999999994 110.787 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.777 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 59.1 m-85 -115.92 157.97 23.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 65.439999999999998 109.945 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.418 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 8.9 tt -115.97 141.21 48.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 72.219999999999999 109.792 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.822 HG11 ' HA3' ' A' ' 47' ' ' GLY . 1.4 p -141.27 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.568 -0.901 . . . . 72.209999999999994 108.568 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.476 ' H ' HG21 ' A' ' 196' ' ' VAL . 17.8 t70 68.74 65.49 0.31 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 72.120000000000005 108.449 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.432 ' CD2' ' HG3' ' A' ' 83' ' ' GLU . 85.6 m-85 -88.49 16.52 6.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.099 -1.409 . . . . 75.340000000000003 110.656 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -70.33 -26.52 74.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.702 -0.761 . . . . 72.430000000000007 111.296 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.527 HD11 ' HB3' ' A' ' 177' ' ' ASP . 35.7 mt -88.78 36.38 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 75.530000000000001 110.494 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -106.07 98.88 8.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.161 0.505 . . . . 73.439999999999998 110.354 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -100.27 145.84 27.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.964 -0.754 . . . . 73.120000000000005 108.964 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.601 ' HB2' ' HG2' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -88.86 130.54 35.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.164 0.506 . . . . 75.340000000000003 111.028 -177.537 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -103.23 -54.0 2.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 74.219999999999999 110.088 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.18 94.43 30.57 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.792 -0.64 . . . . 73.010000000000005 110.427 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.431 ' O ' ' HB3' ' A' ' 207' ' ' GLU . 18.5 Cg_endo -60.0 123.17 12.65 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.486 2.124 . . . . 63.219999999999999 111.523 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 206' ' ' PRO . 32.4 tt0 70.31 -63.96 0.38 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.865 0.728 . . . . 75.209999999999994 111.076 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.68 28.51 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.413 -0.675 . . . . 73.319999999999993 111.413 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.94 110.7 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.211 -0.292 . . . . 75.109999999999999 110.211 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -75.94 104.41 6.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.914 . . . . 64.310000000000002 108.531 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -88.44 0.08 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.906 -0.588 . . . . 75.040000000000006 111.631 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 173.05 139.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.442 -0.947 . . . . 74.400000000000006 108.442 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -84.3 87.92 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.075 0.941 . . . . 71.019999999999996 110.241 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 214' ' ' LYS . 3.0 mmtt -155.24 33.15 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.031 -0.986 . . . . 64.319999999999993 109.947 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.3 -5.55 54.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.316 -0.856 . . . . 71.049999999999997 109.645 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.683 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.1 p-10 -79.33 113.8 39.63 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.144 -0.935 . . . . 72.150000000000006 111.499 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.95 -52.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.515 2.144 . . . . 72.109999999999999 111.876 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -156.03 -56.21 0.09 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 75.549999999999997 109.327 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -163.66 138.82 6.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 73.420000000000002 110.087 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.629 ' HB2' ' HA2' ' A' ' 235' ' ' GLY . 84.3 m -134.32 -60.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.013 -0.365 . . . . 71.310000000000002 110.013 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 41.1 p-80 52.98 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.49 1.116 . . . . 72.150000000000006 113.733 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -86.2 105.88 16.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.521 0.677 . . . . 74.310000000000002 109.613 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.439 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 102.23 -166.28 17.42 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.691 -0.766 . . . . 74.400000000000006 112.293 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 70.4 p -80.29 151.35 29.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.961 0.41 . . . . 63.439999999999998 110.994 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.425 ' HA ' HG23 ' A' ' 228' ' ' THR . 17.9 tt -63.02 -9.02 3.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.67 0.747 . . . . 72.430000000000007 110.885 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.05 -68.13 0.32 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.783 -1.098 . . . . 75.409999999999997 111.521 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -103.24 -11.19 18.16 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.243 0.46 . . . . 74.120000000000005 112.243 -174.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.425 HG23 ' HA ' ' A' ' 225' ' ' ILE . 5.6 t -62.34 -8.94 6.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.01 0.374 . . . . 75.140000000000001 112.01 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.9 t 62.49 -174.04 0.15 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.771 0.429 . . . . 70.310000000000002 110.9 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.421 HD13 ' N ' ' A' ' 230' ' ' ILE . 3.7 mp -73.33 -40.19 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.382 -0.599 . . . . 72.200000000000003 109.382 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.443 ' O ' HG12 ' A' ' 236' ' ' VAL . 2.1 m-20 -49.69 -72.65 0.05 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.603 -1.18 . . . . 73.400000000000006 111.934 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.42 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 72.439999999999998 111.53 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.589 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 67.6 t60 -62.46 -39.8 94.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.537 0.208 . . . . 74.409999999999997 110.579 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.24 -26.19 61.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.659 . . . . 74.230000000000004 109.219 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.629 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 110.75 7.25 25.87 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.775 -0.648 . . . . 73.450000000000003 112.817 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.683 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 9.5 p -89.94 136.98 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.973 0.416 . . . . 74.010000000000005 110.413 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.92 115.07 43.08 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 74.129999999999995 109.891 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.639 ' HB2' ' HA3' ' A' ' 242' ' ' GLY . 81.7 Cg_endo -79.28 148.97 21.59 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.647 2.231 . . . . 73.340000000000003 112.857 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.5 t -85.47 -159.95 0.48 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.797 -0.816 . . . . 71.200000000000003 108.797 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.749 ' HD3' ' HD2' ' A' ' 169' ' ' HIS . 14.9 mmt-85 -54.18 -35.55 62.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.75 0.309 . . . . 74.310000000000002 111.237 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.973 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 8.2 mmm180 -56.65 -32.89 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 72.409999999999997 112.125 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.639 ' HA3' ' HB2' ' A' ' 238' ' ' PRO . . . -67.37 -54.73 18.51 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.593 -0.813 . . . . 75.340000000000003 111.72 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.88 -41.75 83.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.043 0.449 . . . . 74.140000000000001 110.538 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 91.8 mt -64.36 -38.46 91.12 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.863 -0.608 . . . . 74.239999999999995 110.891 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.81 -50.27 69.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.491 0.662 . . . . 75.239999999999995 110.189 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.45 HG13 ' O ' ' A' ' 242' ' ' GLY . 35.6 mt -59.04 -47.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.018 -0.992 . . . . 74.040000000000006 110.89 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.483 HD12 HG21 ' A' ' 161' ' ' ILE . 56.7 tp -57.9 -42.63 85.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 64.439999999999998 110.608 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.64 94.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.965 -0.636 . . . . 64.230000000000004 112.051 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.434 ' HH ' ' HD3' ' A' ' 279' ' ' ARG . 22.1 m-30 -64.26 -42.0 96.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 64.420000000000002 110.906 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.405 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 27.0 m -69.65 -36.87 76.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.582 -0.281 . . . . 71.299999999999997 110.691 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.466 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.8 mtp -62.11 -49.8 74.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 74.349999999999994 111.015 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.08 -32.01 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 74.209999999999994 110.708 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -56.48 -53.93 51.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.011 0.434 . . . . 74.530000000000001 110.503 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.438 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.0 m0 -69.27 -28.44 66.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 71.430000000000007 111.252 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.24 -32.77 38.36 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.188 0.44 . . . . 72.329999999999998 112.188 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 290' ' ' PHE . 61.7 p -103.8 -28.58 11.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.421 -0.512 . . . . 74.140000000000001 111.75 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.519 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 114.8 -36.74 3.8 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.338 -0.934 . . . . 74.129999999999995 113.062 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.53 147.48 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.265 0.533 . . . . 74.219999999999999 111.102 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.444 HD12 ' CZ2' ' A' ' 261' ' ' TRP . 96.1 mt -94.17 139.22 22.45 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.44 -0.345 . . . . 71.209999999999994 110.449 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 -36.95 98.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.981 2.454 . . . . 74.409999999999997 112.53 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.538 ' HB2' HG11 ' A' ' 271' ' ' VAL . 41.7 p90 -87.55 -2.35 58.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 75.329999999999998 110.852 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 64.2 tt0 -86.92 -37.79 17.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.141 -0.689 . . . . 73.400000000000006 109.141 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.99 -20.37 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.133 -0.691 . . . . 75.549999999999997 109.133 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -107.9 26.18 10.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.924 . . . . 74.25 110.795 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -74.36 64.41 1.12 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.685 0.755 . . . . 74.420000000000002 109.873 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -157.22 14.07 0.25 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.149 -0.932 . . . . 74.019999999999996 109.442 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 13.9 t70 -157.31 120.31 2.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.917 -0.583 . . . . 74.510000000000005 110.556 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 15.6 Cg_exo -68.85 -27.23 31.26 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.0 2.467 . . . . 72.409999999999997 112.602 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -73.32 -48.37 34.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.556 -0.535 . . . . 72.120000000000005 109.556 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.563 . . . . 72.409999999999997 112.184 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.538 HG11 ' HB2' ' A' ' 261' ' ' TRP . 35.3 m -65.49 -41.86 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.55 -0.46 . . . . 74.099999999999994 110.906 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -66.7 -48.79 68.13 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.19 -0.3 . . . . 74.510000000000005 110.19 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.91 -53.36 56.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.225 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.405 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 27.2 m -59.06 -41.77 88.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.353 0.408 . . . . 74.340000000000003 111.463 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 279' ' ' ARG . 97.6 mttt -63.86 -48.25 77.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.009 -0.276 . . . . 63.310000000000002 110.942 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.63 HG12 HH21 ' A' ' 279' ' ' ARG . 66.0 mt -63.12 -43.37 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.304 0.573 . . . . 55.0 110.281 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.71 -46.62 77.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.801 -1.091 . . . . 75.5 111.538 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.724 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 32.4 m-85 -74.26 -32.2 62.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 73.200000000000003 111.814 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.63 HH21 HG12 ' A' ' 276' ' ' ILE . 88.0 mtm180 -74.71 -16.23 60.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.256 0.465 . . . . 74.219999999999999 112.256 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 41.3 mt-10 -60.9 -48.99 79.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.77 0.319 . . . . 74.099999999999994 110.742 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.482 ' HB2' HD22 ' A' ' 285' ' ' LEU . 15.1 m120 -127.93 70.93 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 73.200000000000003 109.725 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.459 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -54.02 -44.28 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.764 -0.653 . . . . 72.120000000000005 112.615 -173.657 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.459 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.6 -47.51 78.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 73.209999999999994 110.847 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 27.8 t -67.22 -49.25 65.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.715 -0.675 . . . . 74.310000000000002 110.605 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.724 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.0 mm? -64.16 -50.37 68.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 74.129999999999995 111.561 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 282' ' ' ILE . 0.1 OUTLIER -58.38 -44.66 89.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.543 0.211 . . . . 75.299999999999997 111.56 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.681 ' HA ' ' HG2' ' A' ' 296' ' ' PRO . 18.8 t70 -68.16 -27.46 66.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 74.340000000000003 110.812 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -96.58 6.46 48.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.941 -0.572 . . . . 75.239999999999995 111.533 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.6 -38.41 59.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.027 0.441 . . . . 74.319999999999993 110.795 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.666 ' HB2' HG21 ' A' ' 256' ' ' THR . 29.3 t80 -137.56 75.29 44.8 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 73.409999999999997 109.575 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -93.93 110.94 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.382 2.721 . . . . 74.519999999999996 112.54 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -159.59 -82.66 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.257 -0.646 . . . . 71.109999999999999 109.257 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -144.13 29.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.535 -0.913 . . . . 73.540000000000006 108.535 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -94.8 162.46 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.632 -1.167 . . . . 75.140000000000001 109.855 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -122.68 90.81 49.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.576 -0.527 . . . . 71.519999999999996 109.576 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.681 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 89.1 Cg_endo -98.85 37.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.055 2.503 . . . . 73.409999999999997 112.207 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.87 -39.91 12.8 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.629 -0.796 . . . . 65.430000000000007 111.654 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.504 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -55.03 -44.21 74.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.269 -0.466 . . . . 71.230000000000004 110.123 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.6 mp -69.74 -42.58 80.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 65.299999999999997 110.528 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.74 -48.6 81.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 75.109999999999999 111.18 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.752 ' HE2' ' HA ' ' A' ' 301' ' ' LYS . 8.5 mmpt? -66.08 -41.94 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 73.420000000000002 110.836 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -55.59 -48.56 74.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.108 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.484 ' HA ' HG21 ' A' ' 306' ' ' VAL . 93.8 mmm -68.67 -37.84 79.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.2 -0.454 . . . . 74.140000000000001 111.366 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.5 -39.86 94.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.28 0.562 . . . . 75.120000000000005 109.619 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.8 m -65.19 -44.51 88.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.191 -0.913 . . . . 74.310000000000002 111.388 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.535 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 29.4 m -69.01 -31.61 51.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 120.622 -0.431 . . . . 73.230000000000004 111.349 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -74.03 -28.28 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.249 0.547 . . . . 74.409999999999997 109.907 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.04 -16.89 61.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 71.340000000000003 111.782 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 306' ' ' VAL . 4.2 pp -95.64 16.45 17.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.673 0.273 . . . . 74.530000000000001 111.601 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 16.1 t70 68.48 -96.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.786 -0.643 . . . . 71.040000000000006 111.478 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.973 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.2 OUTLIER -136.89 -38.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.943 0.402 . . . . 74.299999999999997 110.035 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.7 t -158.38 29.17 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 75.329999999999998 110.045 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -71.46 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.235 -0.654 . . . . 74.430000000000007 109.235 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 58.8 mmtt -130.25 79.59 72.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 70.409999999999997 111.227 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.522 ' HA ' HD22 ' A' ' 309' ' ' LEU . 18.3 Cg_endo -91.78 118.05 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.598 2.199 . . . . 72.319999999999993 111.531 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.497 HD23 ' HB2' ' A' ' 319' ' ' ASN . 30.3 tp -133.7 103.99 6.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.057 -0.519 . . . . 74.209999999999994 109.721 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -64.66 -33.72 76.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.641 -0.709 . . . . 74.200000000000003 111.472 -176.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.28 -27.39 66.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.632 -0.427 . . . . 72.530000000000001 110.709 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.497 ' HB2' HD23 ' A' ' 316' ' ' LEU . 5.9 t30 -72.25 -38.51 68.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.328 0.585 . . . . 61.409999999999997 109.457 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.405 ' HA ' HG23 ' A' ' 323' ' ' ILE . 68.7 mt -69.96 -37.08 75.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.45 -0.796 . . . . 75.310000000000002 109.381 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.567 HH22 ' HB2' ' A' ' 106' ' ' LYS . 23.8 ttt180 -59.65 -41.06 89.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.785 -1.098 . . . . 74.450000000000003 109.973 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.73 -52.39 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 74.319999999999993 111.985 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.424 HD13 ' HB2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.437 0.161 . . . . 74.239999999999995 110.956 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.483 ' HB3' HD13 ' A' ' 155' ' ' LEU . 94.1 mt -64.38 -46.92 81.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.713 0.292 . . . . 75.120000000000005 110.992 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.49 -34.92 78.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 73.340000000000003 111.03 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -42.77 95.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 72.340000000000003 110.402 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.504 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.47 -46.34 85.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 64.510000000000005 111.711 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.488 HD21 ' HG ' ' A' ' 155' ' ' LEU . 35.1 tp -59.78 -42.66 93.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.172 0.51 . . . . 72.150000000000006 110.698 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -70.88 -25.83 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.519999999999996 110.674 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.9 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 64.310000000000002 111.01 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.5 tt -89.17 2.9 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.384 0.612 . . . . 75.439999999999998 110.611 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.39 15.31 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.952 -0.642 . . . . 71.329999999999998 113.847 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.616 ' HG ' ' HB2' ' A' ' 336' ' ' ASP . 17.1 t -121.97 138.57 54.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.407 0.604 . . . . 63.149999999999999 110.856 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -154.67 99.5 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.067 -0.515 . . . . 75.239999999999995 109.806 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.605 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 13.8 t70 55.26 54.12 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.047 0.927 . . . . 72.129999999999995 108.675 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.616 ' HB2' ' HG ' ' A' ' 333' ' ' SER . 29.4 t70 -66.49 103.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.346 -1.297 . . . . 75.230000000000004 112.486 -167.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.01 71.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.56 -0.745 . . . . 52.340000000000003 113.565 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 96.2 mttt 58.3 78.1 0.26 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.967 0.413 . . . . 71.200000000000003 110.884 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.803 ' HG ' ' H ' ' A' ' 340' ' ' ASP . 13.1 tp 65.36 -169.66 0.2 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.566 -0.743 . . . . 75.340000000000003 110.571 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . 0.803 ' H ' ' HG ' ' A' ' 339' ' ' LEU . 14.7 t70 -144.04 2.72 1.18 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.323 0.582 . . . . 71.209999999999994 110.5 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.536 HD23 HD11 ' A' ' 185' ' ' LEU . 8.3 tp -104.38 82.98 2.0 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.008 0.433 . . . . 71.019999999999996 110.727 -171.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 16.2 m -111.23 22.53 15.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.045 -0.525 . . . . 73.340000000000003 110.121 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.9 t -63.83 -25.02 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.527 -0.76 . . . . 74.540000000000006 111.593 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.659 ' HA ' ' OG ' ' A' ' 136' ' ' SER . 31.5 m 41.63 54.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 75.230000000000004 113.222 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.437 ' O ' ' HA ' ' A' ' 136' ' ' SER . 2.4 mm-40 -102.42 144.78 30.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.566 -0.743 . . . . 71.329999999999998 110.791 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -126.37 116.32 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 73.510000000000005 110.02 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 162.65 58.52 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.649 -0.58 . . . . 74.030000000000001 111.649 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 139' ' ' GLN . . . -93.1 -143.9 13.87 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.024 -0.608 . . . . 75.040000000000006 113.604 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.666 ' HG ' ' HG2' ' A' ' 139' ' ' GLN . 97.5 mt -114.1 -162.73 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.446 -0.377 . . . . 63.399999999999999 110.657 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -116.96 162.41 17.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 74.25 110.454 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.753 ' HB3' ' HD1' ' A' ' 48' ' ' PHE . . . -82.04 164.94 21.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.433 -0.349 . . . . 74.519999999999996 110.108 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.626 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 23.5 mtmm -129.56 159.33 36.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.966 0.412 . . . . 75.420000000000002 111.363 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.01 159.22 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 73.510000000000005 111.911 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -74.87 141.22 16.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.155 0.502 . . . . 73.209999999999994 111.254 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.9 t -86.18 73.66 10.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.539 0.685 . . . . 72.540000000000006 110.092 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -72.96 -38.05 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.786 -0.643 . . . . 75.140000000000001 111.443 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.534 ' HG3' ' N ' ' A' ' 358' ' ' ARG . 16.5 ptpt -168.0 -50.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 75.049999999999997 111.231 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.534 ' N ' ' HG3' ' A' ' 357' ' ' LYS . 7.1 tpt180 -151.37 134.16 15.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 72.209999999999994 110.325 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -119.39 109.87 16.28 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.403 -0.591 . . . . 74.329999999999998 109.403 172.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.615 ' NZ ' ' HB2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.078 -0.963 . . . . 72.340000000000003 110.493 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.634 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 64.4 mtt . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 119.756 -0.164 . . . . 64.530000000000001 111.041 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 95.5 Cg_endo -83.27 139.19 9.17 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.814 1.676 . . . . 72.319999999999993 111.706 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -130.29 118.51 21.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.118 -0.492 . . . . 73.010000000000005 110.743 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.37 106.47 9.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.64 -0.709 . . . . 75.439999999999998 110.157 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -114.9 123.76 49.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.924 -0.58 . . . . 73.200000000000003 110.193 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.72 124.9 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 70.439999999999998 110.16 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.03 88.99 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 71.140000000000001 110.49 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.42 99.57 8.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 72.099999999999994 110.222 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.38 95.57 6.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.41 -0.359 . . . . 74.439999999999998 110.416 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 104.66 3.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.62 -0.8 . . . . 72.140000000000001 111.948 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -130.54 135.69 48.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.695 -0.483 . . . . 75.109999999999999 109.695 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -131.56 109.38 10.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.587 -0.523 . . . . 71.530000000000001 109.587 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 p -118.64 121.55 40.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.74 -0.664 . . . . 72.329999999999998 109.958 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -154.74 29.99 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.295 -0.411 . . . . 72.409999999999997 110.5 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.88 109.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 75.510000000000005 110.132 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -120.66 116.23 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.522 . . . . 73.450000000000003 111.441 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -108.43 166.19 10.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.966 -0.753 . . . . 75.120000000000005 108.966 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -73.68 86.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.918 0.39 . . . . 74.450000000000003 110.982 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp -170.1 161.91 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 73.040000000000006 111.042 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.04 -82.75 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.077 -1.083 . . . . 72.430000000000007 108.077 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -145.98 -179.34 6.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.267 -1.012 . . . . 65.549999999999997 108.267 169.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -76.11 75.36 2.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.573 0.701 . . . . 74.420000000000002 111.11 179.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -169.37 84.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.135 -0.938 . . . . 73.340000000000003 109.402 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.22 -162.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.684 -0.689 . . . . 74.439999999999998 109.918 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.522 ' HA ' HG21 ' A' ' 39' ' ' VAL . 99.3 t -60.48 134.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.309 -0.405 . . . . 74.340000000000003 110.031 173.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.579 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . 99.6 -3.59 57.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 74.519999999999996 112.655 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -96.67 159.43 14.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.944 0.402 . . . . 72.510000000000005 110.714 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -79.1 146.06 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 72.340000000000003 112.159 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tp -133.79 122.51 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.236 -0.893 . . . . 72.340000000000003 109.568 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.572 ' HG1' ' HG3' ' A' ' 36' ' ' GLU . 3.6 m -96.77 134.21 40.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.712 -0.222 . . . . 64.109999999999999 111.505 -175.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.57 -176.32 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.565 -0.532 . . . . 73.340000000000003 109.565 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 50.4 tpp -72.59 -22.54 60.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.552 0.215 . . . . 74.409999999999997 111.162 -176.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.7 21.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.108 0.48 . . . . 73.150000000000006 110.226 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 71.07 36.12 1.48 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.991 -1.004 . . . . 70.439999999999998 111.409 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.05 121.96 45.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 62.030000000000001 110.199 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.572 ' HG3' ' HG1' ' A' ' 30' ' ' THR . 4.1 mp0 -87.03 97.2 10.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.187 -0.46 . . . . 74.530000000000001 110.226 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 44.1 m95 -84.93 -171.74 3.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.63 -0.878 . . . . 65.319999999999993 108.63 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 26' ' ' GLY . 66.0 mttt -134.68 137.05 43.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.426 . . . . 72.540000000000006 110.402 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.533 HG11 ' CE1' ' A' ' 52' ' ' TYR . 2.4 m -69.23 118.64 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 73.040000000000006 110.693 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.42 ' CA ' ' HB3' ' A' ' 56' ' ' MET . . . -107.28 -116.43 4.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.834 -0.698 . . . . 74.519999999999996 112.214 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 mm? -91.08 122.69 66.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.81 0.338 . . . . 74.439999999999998 110.977 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_exo -78.51 104.77 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.914 2.409 . . . . 73.25 111.052 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 58.9 mt -79.14 -46.86 23.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 75.530000000000001 110.227 -177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.37 -27.67 8.3 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.433 -0.667 . . . . 73.129999999999995 111.433 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.734 ' HG3' HD11 ' A' ' 349' ' ' LEU . 2.0 mp0 -107.79 165.27 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.29 -0.455 . . . . 74.519999999999996 109.878 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.475 ' O ' ' HG ' ' A' ' 184' ' ' LEU . . . 156.69 -88.37 0.12 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.498 -0.641 . . . . 52.25 111.498 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.462 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . -158.22 50.13 0.42 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.609 -0.805 . . . . 63.299999999999997 112.353 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 63.7 t80 171.71 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.119 0.568 . . . . 74.019999999999996 109.684 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 161.18 134.77 1.7 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.99 -0.844 . . . . 75.409999999999997 110.99 -178.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.5 t 65.52 76.48 0.33 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.622 0.725 . . . . 72.409999999999997 110.176 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.1 mm -121.65 135.47 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 73.519999999999996 109.73 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CE1' HG11 ' A' ' 39' ' ' VAL . 51.9 p90 -131.15 154.78 47.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.181 -0.608 . . . . 73.109999999999999 111.311 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HA ' HG13 ' A' ' 69' ' ' VAL . 2.0 tt -71.52 133.18 45.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 73.540000000000006 109.418 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 37' ' ' TRP . . . -93.39 36.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.224 0.453 . . . . 73.230000000000004 112.224 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.43 ' O ' HD21 ' A' ' 53' ' ' LEU . 17.0 t0 -178.73 152.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.112 -0.699 . . . . 72.329999999999998 109.112 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.579 ' SD ' ' HA2' ' A' ' 26' ' ' GLY . 4.6 ppp? -144.58 6.66 1.26 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 73.510000000000005 110.38 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -139.33 -179.34 5.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 75.019999999999996 109.792 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -90.21 72.69 7.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.764 -0.458 . . . . 74.430000000000007 109.764 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 m -59.23 -37.1 76.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.493 0.663 . . . . 43.549999999999997 109.789 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' HG2' ' H ' ' A' ' 61' ' ' SER . 17.5 tt0 -144.96 -163.33 1.68 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.572 -1.64 . . . . 74.430000000000007 106.572 170.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.484 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 50.6 m -66.77 86.85 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.682 0.673 . . . . 75.310000000000002 111.489 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.51 124.42 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 74.439999999999998 111.312 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.4 -1.01 5.3 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.295 -0.866 . . . . 70.129999999999995 111.206 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 m -120.31 23.58 10.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 111.562 0.208 . . . . 52.140000000000001 111.562 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.557 ' HB2' HH12 ' A' ' 133' ' ' ARG . 22.2 m-20 60.66 25.46 15.22 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.38 0.425 . . . . 72.200000000000003 111.231 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.76 91.8 0.07 OUTLIER Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 121.562 0.696 . . . . 72.019999999999996 110.12 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.72 23.34 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.891 2.394 . . . . 74.329999999999998 113.084 -172.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.2 p -124.18 139.02 54.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.367 0.603 . . . . 74.409999999999997 111.944 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.532 HG13 ' HA ' ' A' ' 53' ' ' LEU . 20.5 m -130.85 170.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.393 -0.821 . . . . 73.129999999999995 109.544 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 1.5 p -132.48 127.2 56.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.059 0.457 . . . . 63.350000000000001 111.431 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HZ1' ' CD ' ' A' ' 83' ' ' GLU . 17.9 ptpt -85.34 130.1 34.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.241 -0.891 . . . . 73.019999999999996 109.101 174.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.6 127.74 66.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.983 0.42 . . . . 74.109999999999999 111.397 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.444 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 25.9 tt0 -115.25 141.01 26.47 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.393 -0.965 . . . . 74.400000000000006 108.393 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.38 -171.45 0.12 Allowed 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.218 1.945 . . . . 74.239999999999995 111.639 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 t -76.79 78.97 3.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.256 0.551 . . . . 73.109999999999999 109.559 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -122.08 -52.49 1.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 73.430000000000007 110.541 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.38 46.34 1.98 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.884 0.849 . . . . 74.040000000000006 109.651 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.98 -80.81 0.86 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.127 -0.942 . . . . 44.310000000000002 111.658 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.444 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.8 Cg_exo -59.77 -43.96 34.35 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.712 2.275 . . . . 61.32 112.033 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.28 -33.27 75.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.319999999999993 110.298 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.57 -50.53 69.11 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.909 0.385 . . . . 54.530000000000001 111.033 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.0 m -65.15 -43.74 90.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 74.109999999999999 110.674 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.525 ' CD ' ' HZ1' ' A' ' 71' ' ' LYS . 25.8 tt0 -66.83 -35.48 80.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 70.129999999999995 110.388 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.07 -49.28 78.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 109.944 178.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -60.23 -39.69 87.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.007 0.432 . . . . 75.310000000000002 110.708 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.01 -52.62 65.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.204 -0.453 . . . . 72.540000000000006 110.413 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.84 -33.19 73.71 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.25 111.382 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -63.61 -28.46 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.642 0.238 . . . . 74.439999999999998 111.642 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.631 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 2.9 mmp_? -93.65 -16.09 24.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.054 0.39 . . . . 74.510000000000005 112.054 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.81 17.71 22.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.597 0.713 . . . . 61.350000000000001 110.511 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.21 136.27 38.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.067 -0.97 . . . . 75.120000000000005 112.807 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.424 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 34.4 ttmt 73.45 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.83 -1.077 . . . . 74.430000000000007 111.948 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.403 ' HA ' HD13 ' A' ' 96' ' ' ILE . 62.0 Cg_exo -53.03 -28.71 41.46 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.711 2.94 . . . . 74.409999999999997 113.373 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.83 -50.87 62.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 74.510000000000005 111.163 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.516 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 35.1 mt-30 -73.19 -34.72 66.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.117 -0.492 . . . . 73.109999999999999 110.132 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.429 HG22 HD11 ' A' ' 100' ' ' ILE . 65.8 mt -58.9 -53.96 40.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 75.430000000000007 110.488 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -62.48 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 75.519999999999996 110.574 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 22.2 ttmm -55.04 -65.3 0.61 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.94 -0.573 . . . . 75.040000000000006 111.37 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.581 ' HZ2' HD12 ' A' ' 108' ' ' LEU . 3.7 p90 -69.5 -32.9 72.05 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.496 -0.482 . . . . 73.310000000000002 110.884 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.542 HD13 ' HA ' ' A' ' 107' ' ' TYR . 48.7 mt -59.05 -39.5 78.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 120.67 0.271 . . . . 73.409999999999997 110.594 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -76.51 -27.62 56.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.87 0.366 . . . . 73.430000000000007 110.312 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -70.43 -44.21 68.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.409999999999997 110.748 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.413 HH11 ' HD3' ' A' ' 103' ' ' ARG . 42.2 mtt-85 -83.2 -13.81 54.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.474 -0.33 . . . . 73.230000000000004 110.759 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 57.51 69.57 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.745 0.783 . . . . 75.099999999999994 109.733 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.595 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 10.2 tp -108.81 -167.91 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.76 -1.109 . . . . 72.120000000000005 109.04 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.594 ' HG3' ' CD1' ' A' ' 107' ' ' TYR . 20.7 tptm -100.16 -68.15 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.571 -0.452 . . . . 73.120000000000005 110.033 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.594 ' CD1' ' HG3' ' A' ' 106' ' ' LYS . 55.2 p90 -179.96 152.06 0.45 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.985 0.422 . . . . 74.150000000000006 110.587 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.581 HD12 ' HZ2' ' A' ' 99' ' ' TRP . 83.5 mt -78.41 136.55 37.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 74.099999999999994 111.007 -176.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.84 51.5 4.45 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.126 -0.789 . . . . 74.409999999999997 111.126 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.416 HG22 ' HB3' ' A' ' 108' ' ' LEU . 60.5 t -119.73 129.75 25.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.876 -0.416 . . . . 74.5 109.876 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 35.1 Cg_exo -61.07 148.86 91.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.763 2.308 . . . . 74.150000000000006 112.454 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.557 ' HD2' ' CE2' ' A' ' 114' ' ' TRP . 4.1 ttmp? -62.91 128.57 36.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.779 -0.646 . . . . 74.209999999999994 110.804 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -90.9 85.14 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.929 -0.578 . . . . 74.049999999999997 110.656 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.557 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 10.4 m95 -67.33 -55.5 13.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 74.040000000000006 109.858 173.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.09 -171.32 36.94 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.414 -0.812 . . . . 70.519999999999996 111.622 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.473 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 43.1 p 176.94 175.14 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.475 -0.565 . . . . 61.439999999999998 109.475 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 154.15 -159.32 28.74 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.069 -1.062 . . . . 72.420000000000002 112.884 175.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.468 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.8 tt -131.52 138.64 49.02 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.495 -0.557 . . . . 73.319999999999993 109.495 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -143.24 134.86 26.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.683 -0.488 . . . . 74.439999999999998 109.683 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.882 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.9 t70 -74.89 140.07 43.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.801 -0.444 . . . . 73.530000000000001 109.801 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -103.46 40.68 1.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.714 -0.476 . . . . 73.040000000000006 109.714 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.42 67.53 0.83 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.651 -0.704 . . . . 73.420000000000002 110.412 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.03 -58.24 0.56 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.261 -0.881 . . . . 73.530000000000001 111.492 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 42.4 tptt -134.29 142.74 47.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.431 -0.581 . . . . 75.5 109.431 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.882 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.9 m -88.29 148.73 24.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.325 -0.398 . . . . 73.340000000000003 111.437 -176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.8 151.64 37.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 73.450000000000003 110.81 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -113.39 120.0 39.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.925 -0.769 . . . . 75.140000000000001 108.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.57 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -134.95 162.4 32.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 73.439999999999998 112.081 -171.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.473 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 45.7 ttm -140.2 139.81 35.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.672 -0.695 . . . . 74.219999999999999 110.613 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.56 HD12 ' HB ' ' A' ' 70' ' ' VAL . 7.7 mm -98.17 126.0 51.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.322 -0.399 . . . . 63.299999999999997 110.421 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 8.2 ptp -138.54 -179.22 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 71.349999999999994 110.38 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -73.21 156.15 38.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.66 -0.866 . . . . 74.140000000000001 108.66 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.557 HH12 ' HB2' ' A' ' 65' ' ' ASP . 25.1 ptt180 -85.41 135.2 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.027 0.441 . . . . 74.420000000000002 111.781 -174.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.469 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 43.3 m-85 -124.02 153.44 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 71.340000000000003 109.841 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.502 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -159.13 8.67 0.17 Allowed Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.946 -1.121 . . . . 72.519999999999996 113.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.055 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.0 m -122.98 125.5 45.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.021 -0.694 . . . . 72.439999999999998 110.791 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.564 ' OD1' ' HA ' ' A' ' 181' ' ' SER . 3.3 t70 -116.48 140.14 49.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 74.310000000000002 111.422 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 10.2 mp -67.94 -33.06 73.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.71 -0.677 . . . . 73.209999999999994 111.797 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.467 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 55.2 tp60 -72.63 -35.83 67.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.46 . . . . 74.109999999999999 110.088 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 46.4 tptt -70.83 -48.13 55.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.026 -0.534 . . . . 74.129999999999995 110.528 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 HG21 ' HB2' ' A' ' 341' ' ' LEU . 80.7 mt -62.43 -30.04 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.97 -0.559 . . . . 74.310000000000002 110.176 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 1.1 t80 -51.27 -46.08 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.534 -0.757 . . . . 72.409999999999997 110.593 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.54 -36.01 33.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.205 -0.452 . . . . 73.299999999999997 110.138 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.349 0.5 . . . . 72.540000000000006 112.349 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -101.95 3.66 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 110.475 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 59.02 55.8 4.28 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.318 -0.856 . . . . 64.030000000000001 111.935 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.403 ' HD2' ' O ' ' A' ' 257' ' ' GLY . 21.9 pttm 45.53 38.78 4.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.067 0.947 . . . . 75.219999999999999 113.113 172.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -115.79 88.75 2.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 75.209999999999994 109.933 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -101.75 123.8 46.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.397 -0.365 . . . . 72.120000000000005 111.009 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.9 m -72.37 147.32 46.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.906 -0.588 . . . . 75.140000000000001 110.861 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.627 ' NH2' ' HB3' ' A' ' 295' ' ' LYS . 42.0 ttm105 -56.11 -36.5 68.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.126 -0.488 . . . . 74.349999999999994 111.912 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.745 ' HD2' ' HB2' ' A' ' 340' ' ' ASP . 12.7 ptpt -51.78 -44.3 63.35 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.354 0.597 . . . . 74.430000000000007 110.75 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.529 ' HA ' HD23 ' A' ' 339' ' ' LEU . 74.9 m -71.93 -49.98 32.96 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.678 -0.692 . . . . 72.530000000000001 110.791 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.12 -35.24 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 62.340000000000003 110.646 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.703 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -65.78 -52.74 48.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 74.519999999999996 110.851 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.604 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 25.5 tt0 -60.6 -46.77 88.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.33 -0.548 . . . . 71.120000000000005 109.883 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.456 HD11 ' O ' ' A' ' 153' ' ' THR . 6.4 mp -54.92 -51.72 65.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.905 -0.589 . . . . 75.209999999999994 111.226 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -57.68 -44.71 85.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 64.340000000000003 110.445 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 89.6 mt -63.75 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 73.129999999999995 111.116 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.604 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.63 -38.04 86.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.115 0.483 . . . . 75.409999999999997 110.734 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.522 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 59.1 mt -71.04 -37.27 66.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.756 . . . . 74.409999999999997 110.061 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.82 -50.7 71.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.252 -0.431 . . . . 73.140000000000001 110.382 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.595 ' OD2' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-20 -52.34 -57.55 9.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.771 -0.65 . . . . 71.420000000000002 111.323 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.14 -35.9 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.793 -0.639 . . . . 72.340000000000003 111.012 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 16.7 tp -60.59 -38.7 85.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.779 0.323 . . . . 73.430000000000007 110.85 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.66 -48.09 64.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.595 -0.52 . . . . 74.530000000000001 109.595 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.64 -48.6 77.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.901 -0.59 . . . . 71.239999999999995 111.834 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.487 HD13 HD12 ' A' ' 165' ' ' LEU . 32.2 pt -67.04 -36.97 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.88 -0.328 . . . . 74.409999999999997 111.716 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.448 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 49.2 m80 -69.99 -26.89 64.3 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.586 -0.445 . . . . 73.349999999999994 110.863 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.9 -27.55 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.182 0.515 . . . . 73.129999999999995 109.928 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.99 66.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 73.219999999999999 111.466 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 77.8 -51.39 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.814 1.042 . . . . 73.400000000000006 113.814 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -85.91 142.06 29.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.497 1.295 . . . . 71.200000000000003 114.497 -161.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 169' ' ' HIS . 25.6 m -115.88 164.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.404 -1.271 . . . . 75.030000000000001 107.949 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -126.16 92.47 3.59 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 71.439999999999998 110.358 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.447 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -65.29 -42.08 96.37 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.715 -0.675 . . . . 63.219999999999999 113.249 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.606 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 32.7 t70 -89.18 107.72 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 73.409999999999997 111.577 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.521 ' HB ' HG22 ' A' ' 246' ' ' ILE . 38.0 mm -110.89 112.27 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.918 -0.771 . . . . 75.299999999999997 108.918 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -138.49 159.03 43.12 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.923 -0.769 . . . . 74.409999999999997 108.923 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.496 ' HB2' ' HB3' ' A' ' 138' ' ' LEU . . . -55.9 -36.44 67.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 111.204 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.564 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 4.6 m -68.98 -5.34 21.0 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 70.420000000000002 112.44 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -93.2 -13.37 28.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.009 0.433 . . . . 75.420000000000002 110.72 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.52 HD21 HD11 ' A' ' 161' ' ' ILE . 7.3 mp -105.89 111.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.723 -0.671 . . . . 73.519999999999996 109.755 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 196' ' ' VAL . 3.7 mm? -114.48 130.94 56.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.798 -0.637 . . . . 73.439999999999998 110.326 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 1.055 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 41.4 mt -84.62 142.88 29.62 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.638 -0.71 . . . . 73.200000000000003 109.674 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.469 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 40.5 t-20 -59.93 135.43 57.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.533 -0.543 . . . . 73.530000000000001 109.533 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.536 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 82.7 t80 -61.82 -30.38 70.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.981 0.419 . . . . 73.349999999999994 111.221 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -93.95 -36.02 12.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.303 -0.408 . . . . 72.040000000000006 110.074 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 4.6 m-20 -114.96 87.97 16.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 61.140000000000001 110.215 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.43 ' HB2' ' HB3' ' A' ' 342' ' ' SER . 57.1 Cg_endo -73.2 -11.21 24.93 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.349 2.033 . . . . 64.109999999999999 112.157 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -96.16 15.21 21.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 74.209999999999994 109.924 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.18 107.65 8.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.196 -0.911 . . . . 74.439999999999998 109.063 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.405 HG13 HD12 ' A' ' 157' ' ' LEU . 10.7 p -102.21 142.21 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.37 0.605 . . . . 72.329999999999998 112.035 -172.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.442 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 95.7 m-85 -125.75 144.42 50.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.462 -0.79 . . . . 75.129999999999995 110.181 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.45 99.94 11.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.902 -1.147 . . . . 74.120000000000005 107.902 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.596 HG23 HD22 ' A' ' 184' ' ' LEU . 29.2 m -101.34 0.77 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.203 0.446 . . . . 74.340000000000003 112.203 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.48 95.88 5.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.043 0.449 . . . . 73.239999999999995 109.812 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.47 6.5 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.809 -0.632 . . . . 74.420000000000002 109.715 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.55 -33.73 67.53 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.516 -0.765 . . . . 74.439999999999998 111.457 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.47 30.33 2.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.437 . . . . 72.439999999999998 110.743 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -92.83 99.69 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.163 0.506 . . . . 71.420000000000002 109.661 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -107.5 138.77 43.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.952 -0.567 . . . . 75.299999999999997 110.349 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.33 133.46 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 74.049999999999997 110.871 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 206' ' ' PRO . 5.9 t80 -137.31 -54.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 63.520000000000003 111.295 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.2 p -108.37 103.15 49.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 112.07 0.396 . . . . 63.439999999999998 112.07 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 24.6 Cg_exo -63.28 118.31 5.22 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.697 2.265 . . . . 72.450000000000003 110.8 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 64.77 10.11 5.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.943 -0.571 . . . . 75.219999999999999 111.059 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.448 ' HA2' ' O ' ' A' ' 169' ' ' HIS . . . 96.07 0.88 61.53 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.741 -0.742 . . . . 64.409999999999997 113.063 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.82 110.79 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 117.128 0.464 . . . . 74.329999999999998 112.189 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -177.63 144.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.963 -0.754 . . . . 64.099999999999994 108.963 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.68 115.22 8.1 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.611 -0.515 . . . . 72.299999999999997 109.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.42 ' O ' ' HB2' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -159.14 102.81 1.62 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.029 -0.268 . . . . 74.120000000000005 110.915 -175.014 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.445 ' HA ' HG22 ' A' ' 236' ' ' VAL . 44.8 p90 -124.89 130.99 53.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 73.239999999999995 111.334 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 71.9 mmtt -129.18 -86.74 0.54 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.078 -0.964 . . . . 74.510000000000005 108.933 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 29.6 tt0 177.39 -63.81 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.946 -0.57 . . . . 54.310000000000002 110.161 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -148.76 104.74 3.43 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.039 -0.528 . . . . 75.200000000000003 111.307 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.44 ' CD ' ' HA3' ' A' ' 235' ' ' GLY . 1.4 Cg_endo -83.8 -50.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.965 2.443 . . . . 62.329999999999998 112.003 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -151.87 21.34 0.69 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.399 -0.364 . . . . 73.450000000000003 111.228 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 219' ' ' ARG . 1.4 mpt_? 51.63 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.103 0.561 . . . . 72.340000000000003 111.288 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.65 ' SG ' ' HA2' ' A' ' 235' ' ' GLY . 97.7 m -56.84 -41.17 77.41 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.813 0.301 . . . . 75.109999999999999 111.813 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 45.28 43.39 8.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.917 0.887 . . . . 74.230000000000004 112.269 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -80.66 -53.91 6.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.005 -0.543 . . . . 71.299999999999997 110.003 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.606 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -90.43 171.2 36.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.891 -0.671 . . . . 61.25 112.534 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.433 ' O ' ' HB ' ' A' ' 228' ' ' THR . 25.0 p -69.6 130.82 43.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 73.140000000000001 110.716 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.541 HG12 HG11 ' A' ' 271' ' ' VAL . 16.6 tt -63.46 -18.05 21.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.443 0.639 . . . . 73.329999999999998 110.324 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.576 ' HG2' HD13 ' A' ' 265' ' ' LEU . 24.8 mt-10 -55.59 -63.03 1.3 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.974 -1.012 . . . . 72.230000000000004 111.06 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.85 -40.56 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.893 -0.594 . . . . 74.310000000000002 111.15 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.446 ' CG2' ' HB1' ' A' ' 232' ' ' ALA . 93.2 m -56.63 -29.16 61.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.098 -0.501 . . . . 71.329999999999998 110.908 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 35.8 m 64.11 -147.48 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.72 -0.673 . . . . 75.540000000000006 111.372 171.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.447 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 60.0 mt -72.65 -34.72 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.846 0.355 . . . . 73.25 110.962 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.468 ' HA ' HG13 ' A' ' 236' ' ' VAL . 1.5 m-20 -51.76 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.03 -0.987 . . . . 64.120000000000005 113.599 -169.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.465 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.91 -29.43 67.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 61.25 111.404 -173.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -66.77 -33.6 75.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.943 -0.571 . . . . 73.239999999999995 111.492 -175.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 5.9 m-20 -92.89 -27.77 16.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 72.519999999999996 111.029 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.65 ' HA2' ' SG ' ' A' ' 220' ' ' CYS . . . 127.01 -4.99 7.37 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.717 -1.23 . . . . 71.030000000000001 114.182 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.468 HG13 ' HA ' ' A' ' 231' ' ' ASP . 3.2 p -75.24 127.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.743 0.771 . . . . 73.409999999999997 109.626 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.42 ' HB2' ' O ' ' A' ' 212' ' ' GLU . . . -59.08 121.36 54.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 60.310000000000002 112.075 -172.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.465 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 16.5 Cg_exo -66.95 101.18 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.949 2.433 . . . . 73.430000000000007 111.841 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 51.0 m -84.89 -168.42 2.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.171 -0.677 . . . . 74.040000000000006 109.171 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.524 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 20.1 mmt180 -52.24 -46.62 65.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.873 0.324 . . . . 74.209999999999994 111.873 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.455 ' CZ ' ' HA ' ' A' ' 307' ' ' LYS . 20.2 ttt180 -68.97 -30.08 68.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.969 -0.292 . . . . 74.409999999999997 110.789 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.5 23.97 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.786 -0.721 . . . . 73.310000000000002 111.99 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -60.1 -42.0 93.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.926 0.393 . . . . 62.329999999999998 110.42 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 89.8 mt -62.42 -38.74 90.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.18 -0.464 . . . . 75.040000000000006 111.592 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.43 -48.92 75.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.311 0.577 . . . . 75.150000000000006 109.877 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.521 HG22 ' HB ' ' A' ' 178' ' ' ILE . 68.6 mt -57.03 -44.48 82.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.13 -0.941 . . . . 74.5 110.718 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.5 -41.47 94.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 73.109999999999999 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.68 -46.2 93.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.301 -0.476 . . . . 60.240000000000002 112.62 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -61.96 -38.25 87.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 75.150000000000006 110.878 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.5 m -66.89 -47.16 72.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.416 . . . . 75.409999999999997 110.631 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 86.7 mtp -60.89 -43.32 98.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 73.519999999999996 111.301 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.523 HD13 ' HG3' ' A' ' 286' ' ' MET . 12.7 tt -67.35 -34.95 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.458 -0.497 . . . . 74.510000000000005 110.917 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -62.96 -43.65 98.2 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.83 -0.348 . . . . 73.129999999999995 110.452 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -66.01 -35.29 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 74.530000000000001 110.631 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.0 -32.84 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 74.109999999999999 111.818 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.5 p -102.71 -27.98 12.39 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.623 -0.431 . . . . 73.430000000000007 111.825 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.403 ' O ' ' HD2' ' A' ' 147' ' ' LYS . . . 119.75 -45.87 1.19 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 70.200000000000003 113.719 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.01 159.33 39.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.596 0.698 . . . . 73.230000000000004 111.098 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 90.7 mt -95.19 137.64 22.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 70.209999999999994 110.582 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.8 Cg_exo -67.33 -28.79 39.24 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.004 2.469 . . . . 72.010000000000005 112.907 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -101.66 9.91 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.212 -0.449 . . . . 75.109999999999999 110.757 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 16.5 tt0 -59.44 -45.78 90.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.595 . . . . 63.210000000000001 112.315 -170.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.77 -16.3 61.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 74.409999999999997 111.049 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -107.54 16.87 23.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.39 . . . . 73.329999999999998 111.096 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.576 HD13 ' HG2' ' A' ' 226' ' ' GLU . 37.4 mt -70.07 -14.03 62.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.551 0.691 . . . . 75.150000000000006 110.007 172.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.23 -19.42 58.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.119 -0.946 . . . . 61.109999999999999 110.018 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 271' ' ' VAL . 9.6 m-20 -94.83 113.29 60.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.455 -0.793 . . . . 73.120000000000005 110.071 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.72 -38.47 93.0 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.706 2.271 . . . . 73.239999999999995 112.89 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.672 ' HZ2' ' HB3' ' A' ' 269' ' ' LYS . 7.7 mtpm? -69.47 -42.98 74.14 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.894 -0.323 . . . . 74.409999999999997 111.467 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.71 -38.46 91.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.003 -0.279 . . . . 74.319999999999993 111.19 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.541 HG11 HG12 ' A' ' 225' ' ' ILE . 38.2 t -65.75 -39.88 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.948 0.404 . . . . 73.430000000000007 110.224 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -64.07 -56.31 15.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 74.409999999999997 110.335 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.41 -44.68 96.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.781 -0.645 . . . . 65.200000000000003 112.023 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 55.3 p -63.57 -50.49 69.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 121.083 -0.247 . . . . 74.140000000000001 111.321 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.41 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 33.3 mmtp -64.08 -34.04 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.18 -0.208 . . . . 74.519999999999996 111.31 -175.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.43 -53.76 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.925 0.393 . . . . 74.209999999999994 111.014 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -71.1 -30.82 67.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 73.219999999999999 111.475 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -73.47 -35.44 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.725 -0.216 . . . . 73.439999999999998 110.91 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.87 -31.22 72.21 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.253 0.549 . . . . 73.109999999999999 110.238 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.36 -59.37 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.256 -0.883 . . . . 73.409999999999997 110.483 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.451 ' HB3' HD21 ' A' ' 285' ' ' LEU . 0.6 OUTLIER -108.57 59.42 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.312 -0.404 . . . . 71.129999999999995 111.195 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.457 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -62.81 -43.95 99.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.549999999999997 112.196 -177.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.457 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.47 -47.8 77.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.795 0.295 . . . . 61.130000000000003 111.795 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.6 t -66.44 -46.71 75.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.76 0.314 . . . . 75.349999999999994 110.927 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.451 HD21 ' HB3' ' A' ' 281' ' ' ASN . 4.4 mm? -68.16 -49.86 58.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 73.439999999999998 111.821 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.523 ' HG3' HD13 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -62.09 -39.99 94.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.627 0.251 . . . . 72.439999999999998 111.55 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.64 -31.33 66.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 72.319999999999993 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -69.91 -33.2 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 74.120000000000005 109.975 178.682 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.23 -19.66 62.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 75.450000000000003 111.264 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.903 ' HB3' ' HB3' ' A' ' 296' ' ' PRO . 6.7 t80 -128.52 87.81 54.03 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 121.101 0.476 . . . . 72.109999999999999 110.323 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.5 2.98 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.365 2.71 . . . . 73.5 111.939 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.9 149.69 24.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.684 -0.858 . . . . 75.200000000000003 108.684 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.459 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 56.3 mmtt -91.98 29.67 1.56 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.037 0.384 . . . . 75.319999999999993 112.037 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.58 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 42.3 t-20 -64.11 -69.88 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.943 -1.502 . . . . 72.209999999999994 106.943 167.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.627 ' HB3' ' NH2' ' A' ' 151' ' ' ARG . 49.9 tptt 169.15 114.76 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.257 0.973 . . . . 74.329999999999998 109.59 160.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.903 ' HB3' ' HB3' ' A' ' 290' ' ' PHE . 89.3 Cg_endo -96.22 46.26 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.673 2.249 . . . . 75.430000000000007 111.544 169.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.25 -43.02 1.02 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.384 -0.912 . . . . 73.5 113.048 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.461 ' HB2' HD13 ' A' ' 299' ' ' ILE . 0.9 OUTLIER -57.53 -64.11 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 74.109999999999999 110.408 -175.612 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.461 HD13 ' HB2' ' A' ' 298' ' ' GLU . 2.8 mp -60.25 -39.69 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 73.420000000000002 111.049 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.63 68.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 73.319999999999993 111.374 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 301' ' ' LYS . 12.8 tptt -79.93 -23.27 41.87 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.354 . . . . 75.030000000000001 110.926 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.447 ' CD1' HD22 ' A' ' 320' ' ' LEU . 65.7 t80 -59.99 -48.22 82.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 75.010000000000005 109.911 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.525 ' HA ' HG21 ' A' ' 306' ' ' VAL . 82.6 mtp -72.5 -32.9 66.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.983 -0.553 . . . . 73.319999999999993 110.548 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.447 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 4.4 tp10 -54.96 -45.74 74.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.788 0.804 . . . . 74.540000000000006 109.109 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 63.2 m -63.57 -47.33 81.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.315 -1.311 . . . . 64.319999999999993 111.965 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 303' ' ' MET . 21.6 m -66.2 -34.26 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.862 -0.335 . . . . 71.329999999999998 111.741 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.455 ' HA ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -76.45 -27.67 56.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.406 -0.518 . . . . 75.510000000000005 109.755 177.841 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 24.6 tp -77.4 -26.96 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.784 -0.643 . . . . 74.040000000000006 110.925 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 4.4 pp -86.3 18.46 3.18 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.765 0.317 . . . . 74.129999999999995 110.745 177.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 24.0 t70 73.47 -79.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.497 -0.774 . . . . 73.219999999999999 111.938 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -162.11 -31.43 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.537 0.684 . . . . 74.219999999999999 109.755 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.6 t -170.57 29.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.486 -0.779 . . . . 74.010000000000005 108.978 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.488 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 3.3 tm-20 -70.85 -71.11 0.27 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.177 -0.92 . . . . 72.450000000000003 110.274 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -132.31 87.36 43.17 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.386 -0.37 . . . . 74.109999999999999 110.275 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.51 118.0 3.15 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.414 2.076 . . . . 64.519999999999996 111.689 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.468 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.2 mt -112.31 94.58 5.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.226 0.536 . . . . 74.230000000000004 110.183 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -68.41 -33.33 74.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.513 -0.767 . . . . 74.219999999999999 110.807 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.93 -38.94 90.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 73.109999999999999 110.567 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.85 -44.84 88.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 64.439999999999998 110.437 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 86.8 mt -60.19 -47.88 84.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 73.299999999999997 110.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.558 ' O ' ' HB2' ' A' ' 325' ' ' LEU . 8.1 ppt_? -73.78 -19.09 60.87 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.741 -0.384 . . . . 72.099999999999994 111.214 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.17 -32.57 29.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 64.099999999999994 111.449 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -75.81 -32.57 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 120.005 -0.678 . . . . 64.230000000000004 110.042 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.444 HD22 ' HB3' ' A' ' 298' ' ' GLU . 95.2 mt -66.08 -41.92 90.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.944 -0.761 . . . . 73.409999999999997 108.944 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.558 ' HB2' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -65.12 -32.02 73.51 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.512 -0.767 . . . . 70.239999999999995 110.121 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -49.19 78.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.263 -0.643 . . . . 75.409999999999997 109.263 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.1 -40.31 95.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.753 -0.737 . . . . 64.219999999999999 112.689 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.703 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 28.8 tp -69.12 -43.36 74.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.377 0.608 . . . . 75.409999999999997 110.848 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.94 -38.11 82.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.242 -0.89 . . . . 74.450000000000003 110.892 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.07 75.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 62.409999999999997 111.291 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -89.8 -7.28 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.974 0.416 . . . . 74.129999999999995 110.759 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 83.77 26.34 42.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 45.539999999999999 113.563 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.479 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 9.4 t -117.87 171.35 8.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.257 0.528 . . . . 63.409999999999997 110.925 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.533 ' HA ' HD23 ' A' ' 328' ' ' LEU . 0.0 OUTLIER -153.44 161.14 42.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 62.509999999999998 110.425 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.515 ' HB2' ' HG3' ' A' ' 156' ' ' GLN . 7.2 p-10 -89.81 -12.09 40.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.73 0.3 . . . . 74.140000000000001 111.499 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.45 ' CG ' ' HZ1' ' A' ' 106' ' ' LYS . 27.0 m-20 -92.3 102.01 14.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 75.439999999999998 111.077 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 147.08 -68.79 0.38 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.155 -1.021 . . . . 73.019999999999996 113.014 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 156.98 30.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.214 -0.291 . . . . 72.450000000000003 110.214 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.529 HD23 ' HA ' ' A' ' 153' ' ' THR . 49.6 mt -100.24 -115.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.8 -0.182 . . . . 73.140000000000001 110.989 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . 0.745 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 9.6 t70 -174.07 -33.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.041 0.448 . . . . 64.319999999999993 111.067 -174.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.429 ' HB2' HG21 ' A' ' 141' ' ' ILE . 1.5 pt? -93.25 17.25 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.547 . . . . 73.120000000000005 110.302 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.43 ' HB3' ' HB2' ' A' ' 190' ' ' PRO . 4.6 m -73.58 81.04 1.49 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.582 -0.735 . . . . 73.099999999999994 110.97 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.1 t -127.57 0.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.807 -0.633 . . . . 74.519999999999996 110.471 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.605 ' HA ' ' OG ' ' A' ' 136' ' ' SER . 13.0 p 47.02 103.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.572 1.149 . . . . 72.129999999999995 113.745 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -129.05 99.35 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.478 -0.783 . . . . 75.0 112.044 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 53.09 -94.75 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.204 1.001 . . . . 74.299999999999997 113.518 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 155.94 169.38 20.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.0 -0.619 . . . . 64.409999999999997 111.843 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -101.44 130.5 10.25 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.824 -0.703 . . . . 70.099999999999994 112.428 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.734 HD11 ' HG3' ' A' ' 45' ' ' GLN . 6.3 mp -120.19 126.66 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.617 0.246 . . . . 71.519999999999996 110.492 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -148.92 141.89 24.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.842 -0.429 . . . . 71.450000000000003 109.842 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -123.09 80.29 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.118 0.485 . . . . 74.0 110.833 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -141.85 116.17 9.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.117 -0.492 . . . . 72.129999999999995 110.237 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.5 t -100.97 -171.03 1.93 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 73.239999999999995 110.085 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 144.3 14.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.128 0.489 . . . . 75.439999999999998 111.084 -176.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.428 HG21 ' HB3' ' A' ' 220' ' ' CYS . 15.2 t -73.04 166.97 22.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.628 . . . . 74.109999999999999 110.874 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.17 131.54 22.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.096 -0.502 . . . . 72.230000000000004 110.293 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -70.03 106.88 3.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.809 -0.441 . . . . 74.439999999999998 109.809 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -78.14 113.1 15.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.704 -0.48 . . . . 75.0 109.704 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -86.6 175.03 8.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 73.519999999999996 110.071 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.436 -0.792 . . . . 73.340000000000003 109.484 177.351 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.493 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.895 0.378 . . . . 71.209999999999994 110.048 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.4 Cg_endo -83.17 138.47 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.855 2.37 . . . . 73.409999999999997 112.456 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -143.22 97.63 3.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.615 -0.721 . . . . 75.409999999999997 109.571 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 p -123.54 134.19 67.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.317 -0.856 . . . . 74.430000000000007 109.753 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 137.14 47.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.459 -0.337 . . . . 73.540000000000006 110.64 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.98 104.53 3.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.897 -0.592 . . . . 73.409999999999997 110.279 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.39 -58.41 2.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.736 -0.665 . . . . 74.140000000000001 109.871 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 65.84 147.01 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.255 0.972 . . . . 75.349999999999994 112.201 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.46 134.88 37.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 72.349999999999994 109.948 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.87 -179.53 40.55 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.777 -0.725 . . . . 74.219999999999999 111.967 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 63.0 82.46 0.18 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.398 0.618 . . . . 74.319999999999993 111.232 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.18 176.23 5.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 74.140000000000001 109.996 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.9 p -120.67 124.75 45.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.828 0.347 . . . . 62.310000000000002 111.264 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 t -79.06 102.4 8.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.214 -0.448 . . . . 74.010000000000005 109.989 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.23 104.97 9.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.967 -0.56 . . . . 63.539999999999999 110.135 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -139.09 152.35 47.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.332 -0.618 . . . . 75.420000000000002 109.332 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -146.29 153.47 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 64.140000000000001 110.604 174.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -148.51 172.3 14.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.694 -0.685 . . . . 72.439999999999998 109.965 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -80.51 95.81 6.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.302 -0.629 . . . . 74.129999999999995 109.302 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.64 -71.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 73.530000000000001 111.189 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -138.38 143.85 39.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.932 -1.136 . . . . 74.450000000000003 107.932 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.506 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 53.1 tt0 -168.26 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.699 -0.482 . . . . 72.340000000000003 109.699 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 31.2 t80 168.7 115.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 64.219999999999999 110.737 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -173.03 127.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 64.549999999999997 110.795 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.8 129.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.743 0.306 . . . . 75.030000000000001 110.548 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.83 0.01 56.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.056 -0.592 . . . . 74.349999999999994 112.198 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.44 160.43 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 75.420000000000002 110.932 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.44 115.59 45.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.961 -0.563 . . . . 72.099999999999994 109.673 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.513 HG13 ' HB2' ' A' ' 37' ' ' TRP . 19.2 pt -96.68 122.73 48.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.859 -0.609 . . . . 75.209999999999994 109.965 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 17.6 m -101.11 119.17 38.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.205 -0.452 . . . . 74.439999999999998 110.099 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.492 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.6 p-10 -90.03 -170.3 2.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.427 -0.351 . . . . 72.310000000000002 110.355 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.68 -21.1 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 74.040000000000006 111.222 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.81 2.41 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 73.109999999999999 109.96 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 60.13 34.64 21.2 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.164 -0.925 . . . . 75.540000000000006 111.353 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 30' ' ' THR . 30.3 mmmt -92.83 150.43 20.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.019 -0.537 . . . . 73.140000000000001 109.932 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.87 96.2 7.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.875 -0.602 . . . . 74.439999999999998 110.66 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.513 ' HB2' HG13 ' A' ' 29' ' ' ILE . 25.6 m95 -98.92 138.72 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 72.519999999999996 109.637 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 56' ' ' MET . 31.6 ttmt -106.46 119.28 38.85 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.831 -0.347 . . . . 72.319999999999993 110.629 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.29 127.61 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 61.210000000000001 110.727 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.429 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . -113.96 -115.19 3.17 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.515 -0.85 . . . . 71.140000000000001 113.01 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 49.5 tp -77.93 125.47 85.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.572 0.225 . . . . 74.120000000000005 111.504 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 10.0 Cg_exo -72.47 120.03 6.48 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.854 2.37 . . . . 74.530000000000001 111.254 172.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.405 HG22 ' H ' ' A' ' 45' ' ' GLN . 63.1 mt -97.04 -53.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.117 0.484 . . . . 74.040000000000006 110.749 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.494 ' O ' ' HA2' ' A' ' 49' ' ' GLY . . . 94.73 -25.19 24.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.822 -0.704 . . . . 74.209999999999994 112.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.572 HE22 ' HG ' ' A' ' 349' ' ' LEU . 49.5 tp60 -117.0 162.94 16.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.651 -0.5 . . . . 70.109999999999999 109.651 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.23 -3.34 16.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.623 -1.391 . . . . 74.140000000000001 109.623 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.523 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -176.49 -142.66 4.42 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 114.296 -0.952 . . . . 72.109999999999999 110.976 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.835 ' HZ ' ' HA3' ' A' ' 199' ' ' GLY . 92.4 m-85 -60.86 -46.95 88.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.62 0.247 . . . . 74.519999999999996 111.066 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.494 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . 156.36 164.72 13.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.765 -0.731 . . . . 55.539999999999999 111.691 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.0 m 61.83 39.17 14.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.014 0.435 . . . . 73.349999999999994 111.042 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.435 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 6.2 mm -88.68 132.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 74.25 109.809 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -109.63 164.52 12.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 75.340000000000003 111.06 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.604 HD12 HH21 ' A' ' 133' ' ' ARG . 7.0 tt -83.09 128.89 34.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.957 -0.757 . . . . 61.119999999999997 108.957 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -106.3 37.1 2.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.716 1.006 . . . . 74.140000000000001 113.716 -166.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.444 ' HB2' ' O ' ' A' ' 54' ' ' ALA . 50.6 t0 172.39 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.977 0.511 . . . . 63.450000000000003 109.965 169.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.429 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 21.5 ptm -107.39 19.94 19.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.146 -0.479 . . . . 74.340000000000003 110.107 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' CG ' ' H ' ' A' ' 58' ' ' SER . 8.2 t-20 -124.63 -165.16 1.34 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 64.329999999999998 109.72 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.452 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 22.8 t -107.99 89.99 3.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.985 0.422 . . . . 74.510000000000005 110.146 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 p -62.6 -29.21 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.402 0.62 . . . . 72.439999999999998 110.151 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -169.04 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.839 -1.073 . . . . 73.310000000000002 108.387 171.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -137.9 108.16 6.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.021 -0.99 . . . . 74.400000000000006 109.206 172.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.97 133.8 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.75 -0.463 . . . . 72.109999999999999 109.75 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.76 32.7 2.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 72.439999999999998 112.648 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.3 m 55.48 35.55 25.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.017 0.437 . . . . 75.439999999999998 110.846 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -153.45 -47.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.188 -0.46 . . . . 71.420000000000002 112.03 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 53' ' ' LEU . . . 67.31 83.17 0.19 Allowed Pre-proline 0 N--CA 1.463 0.182 0 O-C-N 124.158 0.911 . . . . 73.310000000000002 109.39 -170.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -80.67 29.74 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.187 2.591 . . . . 75.549999999999997 113.003 -171.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 p -130.82 137.06 49.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.301 0.572 . . . . 74.219999999999999 111.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 143.85 37.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.626 -0.879 . . . . 72.450000000000003 108.626 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 6.2 p -118.64 121.06 66.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.482 0.658 . . . . 71.299999999999997 111.947 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.566 ' HD3' ' HD2' ' A' ' 48' ' ' PHE . 39.0 ttmt -89.36 126.11 35.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.216 -0.902 . . . . 72.5 109.09 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.24 133.04 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.159 0.504 . . . . 73.430000000000007 111.97 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.753 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 15.8 mt-10 -140.1 170.53 9.53 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.862 -0.792 . . . . 75.319999999999993 108.862 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 14.3 Cg_endo -57.13 156.43 24.78 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.402 2.068 . . . . 73.409999999999997 112.799 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.561 ' HA ' ' HG3' ' A' ' 127' ' ' ARG . 15.5 t -84.37 34.04 0.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 55.009999999999998 110.834 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.82 -83.67 0.55 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.179 -0.464 . . . . 72.239999999999995 111.165 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.22 -89.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.89 -0.324 . . . . 73.409999999999997 111.19 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.51 -176.63 1.46 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.101 -0.5 . . . . 74.450000000000003 113.552 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.508 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 6.4 Cg_exo -74.82 -22.04 15.65 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.059 2.506 . . . . 73.239999999999995 111.249 169.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.516 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.7 tm? -51.94 -40.54 60.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.513 -0.767 . . . . 71.310000000000002 110.823 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.95 -38.87 83.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 73.120000000000005 111.021 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.9 m -67.04 -41.62 86.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.07 0.462 . . . . 65.409999999999997 110.25 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.534 ' HG2' ' HB2' ' A' ' 198' ' ' TYR . 31.3 mt-10 -67.08 -38.07 85.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 74.239999999999995 110.832 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.85 -41.7 71.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.008 0.432 . . . . 75.420000000000002 109.913 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -57.04 -54.08 50.78 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 74.120000000000005 110.897 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -64.49 -48.69 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.729 0.64 . . . . 73.209999999999994 112.729 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.491 ' HE1' ' HD2' ' A' ' 198' ' ' TYR . 3.8 m-85 -65.97 -34.26 77.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.611 0.244 . . . . 71.219999999999999 111.403 -175.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.55 -33.74 58.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.813 -0.355 . . . . 73.239999999999995 111.901 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.47 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 13.6 tpt180 -97.44 -45.81 6.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.911 0.708 . . . . 75.299999999999997 112.911 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -0.97 56.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.855 0.687 . . . . 63.140000000000001 112.855 -169.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.519 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -104.36 -151.59 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.084 -0.246 . . . . 73.219999999999999 111.156 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.562 ' HG2' ' OE2' ' A' ' 94' ' ' GLU . 56.9 tttm 74.56 102.94 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 123.689 0.796 . . . . 73.549999999999997 110.05 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -50.26 -52.77 8.29 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.387 3.392 . . . . 60.43 115.567 -165.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.562 ' OE2' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -72.01 -32.55 67.28 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 74.409999999999997 112.901 -169.16 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -74.55 -30.11 61.62 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.029 -0.669 . . . . 71.230000000000004 110.333 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.549 HG13 ' O ' ' A' ' 92' ' ' LYS . 72.6 mt -61.15 -53.03 54.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.344 -0.613 . . . . 74.010000000000005 109.344 172.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.1 -34.73 60.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 74.400000000000006 110.497 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -56.54 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 75.140000000000001 110.783 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.414 ' HE1' HD12 ' A' ' 108' ' ' LEU . 1.8 p90 -70.11 -34.17 72.77 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.949 -0.701 . . . . 74.319999999999993 111.249 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.402 HD13 ' HB2' ' A' ' 108' ' ' LEU . 60.7 mt -64.45 -33.34 62.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.201 0.524 . . . . 75.200000000000003 109.694 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -71.03 -40.84 71.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.551 -0.75 . . . . 74.239999999999995 110.275 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 m -67.85 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 52.399999999999999 111.532 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -75.91 -23.5 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 111.173 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 68.92 64.52 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.941 0.776 . . . . 75.129999999999995 110.039 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.406 ' HB3' ' OD2' ' A' ' 163' ' ' ASP . 3.4 mm? -106.97 -163.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.163 -0.926 . . . . 75.030000000000001 109.625 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.472 ' HG2' HD23 ' A' ' 159' ' ' LEU . 50.8 tptt -121.74 -59.62 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.472 0.545 . . . . 73.510000000000005 112.472 -174.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -159.07 98.38 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.514 -0.475 . . . . 74.409999999999997 111.447 -168.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.501 HD23 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tt -78.9 115.19 18.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.739 -0.837 . . . . 75.549999999999997 108.739 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.54 64.79 3.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.956 -0.64 . . . . 71.219999999999999 112.722 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.501 ' HB ' HD23 ' A' ' 108' ' ' LEU . 7.7 p -111.24 135.9 20.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.087 -0.338 . . . . 74.109999999999999 110.087 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HD3' HG12 ' A' ' 196' ' ' VAL . 19.1 Cg_endo -60.12 140.07 90.58 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.854 2.369 . . . . 71.150000000000006 112.802 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.848 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 84.2 tttt -65.62 128.73 37.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.129999999999995 110.08 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -109.52 117.71 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.57 -0.741 . . . . 70.0 110.698 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.476 ' CD1' HG21 ' A' ' 130' ' ' ILE . 38.5 m95 -89.86 -49.45 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.425 0.631 . . . . 75.439999999999998 109.554 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 178.32 -174.49 46.76 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.901 -1.045 . . . . 71.409999999999997 111.881 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.459 ' C ' ' HB2' ' A' ' 31' ' ' ASP . 93.1 p -168.37 150.51 5.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.847 -0.798 . . . . 75.439999999999998 108.847 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.492 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -166.41 -162.41 17.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.086 -1.054 . . . . 72.430000000000007 113.067 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 125' ' ' SER . 7.3 tt -128.48 129.3 45.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.862 -0.422 . . . . 74.349999999999994 109.862 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -129.59 123.86 32.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.153 -0.684 . . . . 64.239999999999995 109.153 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 7.3 t70 -89.11 138.07 31.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.27 -0.423 . . . . 73.010000000000005 110.177 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.554 ' HD3' ' O ' ' A' ' 121' ' ' LYS . 13.2 tmtt? -90.94 28.9 1.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.7 0.762 . . . . 73.329999999999998 109.581 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.0 t30 62.27 70.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.944 -1.025 . . . . 72.010000000000005 110.058 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.66 10.68 12.45 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.245 -0.889 . . . . 75.200000000000003 111.78 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.782 ' HE2' ' HA ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -164.49 104.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.813 -0.44 . . . . 75.519999999999996 109.813 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.477 ' HB3' HD23 ' A' ' 118' ' ' LEU . 12.4 m -76.14 130.59 38.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.278 -0.419 . . . . 74.340000000000003 111.176 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.89 149.02 41.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 75.129999999999995 110.478 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.561 ' HG3' ' HA ' ' A' ' 75' ' ' SER . 94.1 mtt180 -113.11 133.17 55.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.475 -0.565 . . . . 61.32 109.475 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.587 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 54.4 p90 -126.7 143.39 51.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.272 -0.422 . . . . 71.519999999999996 110.895 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 17.1 ptp -128.84 137.2 51.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.406 -0.361 . . . . 75.439999999999998 110.259 177.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.476 HG21 ' CD1' ' A' ' 114' ' ' TRP . 49.8 mt -103.97 121.4 55.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 73.349999999999994 111.794 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ptm -122.72 178.25 5.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.502 -0.772 . . . . 74.409999999999997 109.89 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.848 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.2 t70 -80.95 -178.15 6.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.72 0.295 . . . . 74.420000000000002 111.126 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.604 HH21 HD12 ' A' ' 53' ' ' LEU . 5.8 mmt85 -83.79 83.83 7.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.412 0.625 . . . . 75.439999999999998 112.352 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -103.69 170.56 7.86 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.907 -0.775 . . . . 74.540000000000006 108.907 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.63 -41.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.347 -1.406 . . . . 72.209999999999994 113.544 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.781 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 18.4 m -71.23 122.85 20.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.011 0.406 . . . . 75.319999999999993 111.21 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HB2' ' HA2' ' A' ' 347' ' ' GLY . 0.3 OUTLIER -84.54 118.13 24.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.433 -0.803 . . . . 75.109999999999999 110.106 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.24 -22.67 67.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.642 -0.873 . . . . 75.219999999999999 108.642 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.509 ' CG ' ' HD3' ' A' ' 350' ' ' LYS . 5.8 tp-100 -56.07 -48.6 75.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.752 -1.113 . . . . 74.439999999999998 110.977 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.577 ' CB ' ' HB2' ' A' ' 346' ' ' ASN . 59.6 mmtt -75.46 -27.97 59.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 75.430000000000007 111.531 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.815 HD11 ' HA ' ' A' ' 345' ' ' GLU . 1.7 mp -61.5 -46.69 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.023 -0.271 . . . . 74.540000000000006 110.279 176.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.615 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -74.02 -32.99 63.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.385 -0.526 . . . . 74.200000000000003 110.301 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.92 -33.67 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.833 0.349 . . . . 73.340000000000003 110.924 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -83.94 -31.37 25.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.142 0.423 . . . . 74.219999999999999 112.142 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -104.24 13.82 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 71.120000000000005 111.018 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.409 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 55.2 46.61 23.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.95 -0.568 . . . . 75.0 111.373 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.615 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER 42.09 38.79 1.17 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.0 113.17 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -94.71 96.85 9.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.964 0.411 . . . . 73.239999999999995 110.133 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.441 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 85.0 m-85 -113.5 147.74 37.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.147 -0.479 . . . . 74.209999999999994 110.44 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.457 ' O ' HG22 ' A' ' 154' ' ' VAL . 7.3 p -83.55 167.82 16.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.017 -0.538 . . . . 62.509999999999998 110.898 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.637 ' NH1' ' HB ' ' A' ' 331' ' ' ILE . 35.4 ttt180 -55.18 -46.18 75.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 73.120000000000005 111.23 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 333' ' ' SER . 86.2 mttt -58.2 -51.79 68.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.223 -0.444 . . . . 70.109999999999999 111.478 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -56.28 -43.67 79.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.938 -0.574 . . . . 75.540000000000006 112.025 -178.52 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 150' ' ' SER . 53.0 t -64.11 -48.43 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 74.510000000000005 110.735 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.601 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 2.7 mm? -58.43 -45.15 89.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 75.010000000000005 111.394 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.549 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 57.4 mm-40 -61.27 -44.84 96.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 74.510000000000005 111.494 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 153' ' ' THR . 88.4 mt -61.1 -49.11 78.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 75.120000000000005 110.622 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.1 p -62.52 -31.99 72.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 74.400000000000006 111.297 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.472 HD23 ' HG2' ' A' ' 106' ' ' LYS . 59.4 tp -63.12 -46.77 85.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 75.420000000000002 110.629 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 12.4 mmt85 -63.03 -44.73 95.12 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.893 0.854 . . . . 74.150000000000006 110.02 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.96 -33.88 66.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.578 -1.192 . . . . 72.329999999999998 110.815 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.7 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.871 -0.418 . . . . 73.049999999999997 109.871 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.406 ' OD2' ' HB3' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -55.32 -56.94 14.33 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.516 0.674 . . . . 72.310000000000002 110.459 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.3 tt -67.88 -37.13 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.566 -0.743 . . . . 75.439999999999998 111.572 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.49 ' HG ' ' NE2' ' A' ' 175' ' ' HIS . 8.8 tt -61.03 -39.4 89.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.293 -0.262 . . . . 71.510000000000005 110.293 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -67.33 -54.02 24.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 71.150000000000006 109.363 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -56.05 -46.68 78.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.574 -0.739 . . . . 75.439999999999998 112.293 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 164' ' ' ILE . 29.1 pt -80.77 -32.41 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.208 0.447 . . . . 74.319999999999993 112.208 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.437 ' CE1' ' HA ' ' A' ' 240' ' ' ARG . 3.7 t60 -69.48 -34.76 74.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.373 -0.603 . . . . 64.230000000000004 109.373 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -27.04 67.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.453 -0.794 . . . . 75.150000000000006 110.503 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.81 19.46 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 72.349999999999994 112.098 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.484 ' HA ' ' HD2' ' A' ' 204' ' ' TYR . 44.5 mt-10 72.1 16.65 5.26 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.711 0.634 . . . . 75.409999999999997 112.711 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -121.4 144.65 48.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.253 0.549 . . . . 72.430000000000007 110.856 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 202' ' ' TYR . 23.6 t -104.31 163.44 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.51 -0.768 . . . . 74.120000000000005 109.352 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.49 ' NE2' ' HG ' ' A' ' 165' ' ' LEU . 5.7 p80 -132.33 105.3 7.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.076 -0.713 . . . . 74.120000000000005 109.076 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.424 ' HA3' ' OD2' ' A' ' 222' ' ' ASP . . . -63.76 -54.88 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.638 -0.71 . . . . 65.329999999999998 114.148 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -80.6 90.13 5.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.605 0.717 . . . . 64.400000000000006 111.626 -174.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.528 HG23 ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -94.3 102.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.916 -1.512 . . . . 74.230000000000004 106.916 159.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.681 ' HG3' ' HE2' ' A' ' 227' ' ' PHE . 29.4 tttp -173.99 -137.04 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.171 -1.418 . . . . 75.349999999999994 107.171 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.45 ' H ' ' CG ' ' A' ' 179' ' ' LYS . . . -120.9 1.24 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.479 -0.328 . . . . 71.319999999999993 110.636 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.454 ' O ' HD21 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -77.69 -28.02 50.93 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 111.959 0.355 . . . . 73.400000000000006 111.959 -171.543 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.429 HD21 ' HA ' ' A' ' 182' ' ' ASN . 5.6 m120 -108.55 11.06 26.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.722 0.296 . . . . 75.109999999999999 111.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.437 HD12 ' O ' ' A' ' 179' ' ' LYS . 8.3 mp -102.61 109.46 21.08 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.369 -0.532 . . . . 73.409999999999997 109.986 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.612 HD21 HD22 ' A' ' 349' ' ' LEU . 3.8 mm? -117.79 128.57 54.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.839 . . . . 75.140000000000001 109.821 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.781 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 80.6 mt -81.43 146.85 30.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.771 -0.649 . . . . 74.230000000000004 110.269 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.27 121.01 13.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.476 -1.676 . . . . 73.400000000000006 106.476 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -14.34 54.6 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.761 -0.376 . . . . 73.530000000000001 111.728 -167.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -87.22 -53.71 4.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.842 0.353 . . . . 74.409999999999997 110.814 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.468 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.1 m-20 -108.48 114.45 59.09 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 75.239999999999995 110.918 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 6.8 Cg_exo -73.11 -12.45 25.72 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 123.241 2.627 . . . . 75.299999999999997 112.398 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.948 ' HA ' ' HB2' ' A' ' 339' ' ' LEU . 8.2 p-10 -86.55 4.56 39.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 73.349999999999994 110.837 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 80.0 mt-30 -123.45 96.77 5.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.925 -0.58 . . . . 74.140000000000001 110.995 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.2 130.69 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.666 -0.697 . . . . 72.420000000000002 109.676 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -120.17 142.23 49.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 110.709 -177.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.405 HD21 HD11 ' A' ' 164' ' ' ILE . 34.2 tp -88.15 99.27 12.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.245 -1.02 . . . . 74.230000000000004 108.245 175.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.453 HG12 ' HD3' ' A' ' 111' ' ' PRO . 15.3 m -120.61 -178.2 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.345 -0.389 . . . . 74.019999999999996 110.212 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.439 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . 2.6 t70 60.16 71.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.787 0.804 . . . . 75.120000000000005 108.979 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.534 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 70.5 m-85 -81.47 34.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.083 -0.962 . . . . 74.430000000000007 111.556 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.835 ' HA3' ' HZ ' ' A' ' 48' ' ' PHE . . . -77.25 -3.4 81.91 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.556 -0.831 . . . . 72.439999999999998 112.348 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.878 HD13 ' HA ' ' A' ' 352' ' ' LYS . 5.4 mp -114.75 34.37 4.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.701 0.286 . . . . 75.319999999999993 111.376 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.08 125.86 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.866 0.365 . . . . 51.130000000000003 110.438 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.68 ' HD1' HD12 ' A' ' 354' ' ' ILE . 36.2 t80 -108.35 174.77 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.077 -0.51 . . . . 73.140000000000001 109.913 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -89.07 135.61 33.47 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.59 0.356 . . . . 72.340000000000003 111.173 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.484 ' HD2' ' HA ' ' A' ' 172' ' ' GLU . 8.5 t80 -96.98 -60.34 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 72.150000000000006 110.416 173.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.524 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 8.4 p -138.04 142.56 36.24 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.647 -0.251 . . . . 74.349999999999994 110.881 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 3.1 Cg_exo -75.53 74.83 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.197 2.598 . . . . 64.109999999999999 112.203 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.94 86.66 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.573 -0.739 . . . . 75.019999999999996 111.921 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.07 -53.89 4.91 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 73.140000000000001 113.775 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.524 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 14.5 m -73.02 111.07 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.304 0.573 . . . . 71.109999999999999 110.936 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.487 ' HA ' ' HB3' ' A' ' 205' ' ' CYS . 20.0 m80 -74.59 110.23 8.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.84 -0.618 . . . . 71.109999999999999 109.964 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.471 ' HD3' ' N ' ' A' ' 212' ' ' GLU . 8.1 tmtm? -97.92 130.89 44.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 75.109999999999999 108.872 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.471 ' N ' ' HD3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -84.19 -98.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.387 -0.37 . . . . 71.430000000000007 111.57 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.508 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 20.4 p90 -91.97 91.61 7.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.808 0.813 . . . . 75.239999999999995 112.121 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -39.74 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.239 -0.892 . . . . 75.329999999999998 108.938 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.07 179.34 0.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.975 -1.012 . . . . 74.319999999999993 111.905 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.438 ' HB3' ' HA3' ' A' ' 235' ' ' GLY . 12.0 t70 -147.94 127.86 6.62 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 72.439999999999998 110.134 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 21.9 Cg_exo -66.3 -22.7 52.7 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.172 2.581 . . . . 75.150000000000006 113.384 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' C ' ' HD2' ' A' ' 219' ' ' ARG . 22.1 pttm -124.98 17.83 8.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.877 0.325 . . . . 75.129999999999995 111.877 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.42 ' HD2' ' C ' ' A' ' 218' ' ' LYS . 1.0 OUTLIER 66.5 124.33 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.769 0.828 . . . . 74.129999999999995 111.847 177.076 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.526 ' CB ' ' HA2' ' A' ' 235' ' ' GLY . 36.6 t -72.5 -58.7 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.4 . . . . 74.219999999999999 110.255 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 27.2 p80 44.66 40.98 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.053 0.941 . . . . 75.140000000000001 112.592 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.424 ' OD2' ' HA3' ' A' ' 176' ' ' GLY . 5.1 p-10 -67.27 -31.17 71.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.966 -0.561 . . . . 73.099999999999994 111.083 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.51 170.32 40.4 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.782 -0.723 . . . . 74.030000000000001 111.725 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.477 ' O ' HG23 ' A' ' 228' ' ' THR . 53.1 p -70.49 141.96 51.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.093 0.446 . . . . 74.340000000000003 111.5 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.513 ' HB ' HD12 ' A' ' 265' ' ' LEU . 73.3 mt -55.49 -34.11 33.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 115.769 -0.65 . . . . 63.25 112.406 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.795 ' HG3' ' HG ' ' A' ' 265' ' ' LEU . 3.0 mp0 -52.69 -39.43 61.97 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.002 0.43 . . . . 72.450000000000003 110.366 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.798 ' HB3' HG22 ' A' ' 246' ' ' ILE . 70.9 m-85 -105.06 -93.0 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.206 -0.452 . . . . 64.450000000000003 110.404 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.528 ' HG1' ' C ' ' A' ' 227' ' ' PHE . 7.5 p 58.03 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.049 1.5 . . . . 63.439999999999998 115.049 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.464 ' H ' ' C ' ' A' ' 227' ' ' PHE . 47.6 t 64.44 -175.84 0.17 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.851 -0.796 . . . . 64.329999999999998 108.851 -172.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.437 HD11 ' N ' ' A' ' 230' ' ' ILE . 2.9 mp -71.2 -37.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.2 -0.667 . . . . 71.129999999999995 109.2 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.75 -73.2 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.691 -1.141 . . . . 63.340000000000003 112.104 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.61 -29.65 70.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.372 -0.376 . . . . 75.239999999999995 111.783 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.448 ' HE1' HG22 ' A' ' 225' ' ' ILE . 8.1 t60 -66.21 -37.46 85.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 75.549999999999997 110.297 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -77.92 -38.33 45.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 74.450000000000003 110.513 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.526 ' HA2' ' CB ' ' A' ' 220' ' ' CYS . . . 114.55 9.26 14.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.761 -0.733 . . . . 74.109999999999999 112.109 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.508 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 6.2 p -89.35 137.71 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.737 -0.468 . . . . 72.319999999999993 109.737 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -57.64 117.92 22.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 74.409999999999997 111.203 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.592 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 23.5 Cg_exo -65.24 101.91 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.681 2.254 . . . . 62.530000000000001 111.42 176.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 3.1 p -77.68 -20.58 53.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 72.319999999999993 110.657 -176.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.793 ' HD2' ' HG3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER 178.3 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.18 -0.918 . . . . 74.400000000000006 108.823 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.968 ' HD3' ' HD1' ' A' ' 311' ' ' TYR . 5.7 mtp85 -59.5 -60.96 3.01 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.183 -0.917 . . . . 72.519999999999996 111.404 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.592 ' HA3' ' HB3' ' A' ' 238' ' ' PRO . . . -43.36 -65.97 1.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 O-C-N 124.065 0.853 . . . . 74.5 114.203 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.11 -30.54 65.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.339 0.57 . . . . 74.340000000000003 111.624 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.466 ' HB3' HH21 ' A' ' 240' ' ' ARG . 17.6 tp -75.29 -35.78 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.887 0.375 . . . . 70.209999999999994 110.921 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.09 -37.55 46.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.492 -0.322 . . . . 64.439999999999998 110.401 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.798 HG22 ' HB3' ' A' ' 227' ' ' PHE . 87.4 mt -60.93 -38.29 78.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.743 -0.465 . . . . 73.549999999999997 109.743 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.515 ' HA ' HG21 ' A' ' 178' ' ' ILE . 51.8 tp -59.4 -47.35 85.8 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.201 -0.454 . . . . 74.319999999999993 110.365 175.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.39 -44.94 93.39 Favored Glycine 0 C--O 1.237 0.283 0 C-N-CA 120.978 -0.629 . . . . 61.340000000000003 112.233 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.519 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 12.7 m-85 -57.09 -44.08 82.83 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 120.572 0.225 . . . . 74.040000000000006 111.142 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.528 ' SG ' HG23 ' A' ' 178' ' ' ILE . 78.6 m -67.19 -38.1 84.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.622 -0.263 . . . . 75.530000000000001 111.36 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.484 ' HE2' HD22 ' A' ' 324' ' ' LEU . 84.3 mtp -60.4 -49.64 76.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.57 -0.286 . . . . 72.409999999999997 110.924 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 299' ' ' ILE . 12.3 tt -70.32 -31.43 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 74.239999999999995 110.305 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.548 ' OE1' ' HG3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -61.02 -46.16 91.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.576 . . . . 74.040000000000006 110.181 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.3 m0 -71.7 -35.3 70.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 75.129999999999995 111.369 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.4 tp -76.42 -30.87 57.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.984 0.364 . . . . 74.329999999999998 111.984 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.503 HG21 ' HB3' ' A' ' 289' ' ' CYS . 73.6 p -103.36 -27.59 12.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 73.549999999999997 111.378 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.404 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 83.66 0.25 89.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.769 -0.729 . . . . 70.010000000000005 113.238 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -157.07 144.04 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.369 0.584 . . . . 74.140000000000001 111.425 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.557 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 92.2 mt -129.74 139.55 35.99 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 75.239999999999995 109.567 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 38.8 Cg_exo -58.22 -24.27 66.3 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.115 2.543 . . . . 70.209999999999994 113.752 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.747 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 25.1 p90 -98.91 -17.73 18.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.406 0.521 . . . . 75.409999999999997 112.406 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.557 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 1.5 pp20? -86.16 -14.66 43.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.336 -0.546 . . . . 71.530000000000001 110.68 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.86 -45.85 90.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 61.340000000000003 109.571 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.39 29.05 7.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.367 -0.833 . . . . 75.5 109.737 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.795 ' HG ' ' HG3' ' A' ' 226' ' ' GLU . 2.5 tm? -47.7 -34.24 7.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.855 0.862 . . . . 73.319999999999993 112.525 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -66.44 -12.25 56.22 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.013 0.375 . . . . 74.310000000000002 112.013 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.6 110.5 49.82 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 73.140000000000001 109.665 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.515 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 32.0 Cg_endo -63.04 -24.44 73.7 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.194 2.596 . . . . 72.25 113.999 -171.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -63.13 -49.98 72.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.791 0.329 . . . . 75.510000000000005 110.792 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -63.18 -36.82 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 73.329999999999998 110.285 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.747 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 69.7 t -62.35 -45.21 99.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 75.420000000000002 111.136 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.515 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 79.9 mtp180 -64.78 -54.87 24.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 73.120000000000005 111.394 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.31 -41.44 97.01 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.709 0.29 . . . . 75.140000000000001 111.692 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.519 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 27.7 m -62.91 -40.28 97.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.477 -0.329 . . . . 75.25 110.796 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.539 ' HZ3' HG12 ' A' ' 271' ' ' VAL . 46.2 mttp -65.17 -42.78 93.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 74.340000000000003 111.129 178.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.7 mt -61.43 -46.21 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 71.230000000000004 110.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -64.12 -34.82 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.379 -0.373 . . . . 75.230000000000004 111.514 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.45 ' O ' HG21 ' A' ' 282' ' ' ILE . 5.1 m-85 -72.16 -32.31 66.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.707 -0.224 . . . . 74.510000000000005 111.597 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -77.92 -34.07 51.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 74.030000000000001 110.538 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.51 -42.63 12.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.969 -0.56 . . . . 74.310000000000002 112.032 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.451 ' O ' HD22 ' A' ' 285' ' ' LEU . 10.9 t-20 -124.86 81.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.589 . . . . 74.129999999999995 110.481 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.45 HG21 ' O ' ' A' ' 278' ' ' TYR . 0.2 OUTLIER -74.38 -34.09 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 75.310000000000002 112.54 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.85 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.391 0.515 . . . . 75.420000000000002 112.391 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.2 m -70.27 -48.84 54.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 64.109999999999999 110.972 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.451 HD22 ' O ' ' A' ' 281' ' ' ASN . 4.1 mm? -63.12 -50.59 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.078 -0.51 . . . . 74.340000000000003 111.364 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.615 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.3 OUTLIER -60.79 -40.76 93.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.897 0.332 . . . . 73.420000000000002 111.897 -177.547 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.73 -42.39 95.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 111.115 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 288' ' ' LYS . 43.3 mmtm -81.21 4.31 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.354 0.502 . . . . 74.239999999999995 112.354 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.503 ' HB3' HG21 ' A' ' 256' ' ' THR . 80.2 m -83.32 -17.43 42.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 64.439999999999998 109.904 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -123.7 89.41 51.4 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 74.409999999999997 109.81 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.88 3.03 7.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.323 2.682 . . . . 73.200000000000003 112.481 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -99.71 174.21 6.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.893 -0.78 . . . . 65.530000000000001 108.893 -179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -86.86 79.59 8.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.434 0.635 . . . . 74.530000000000001 111.304 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.92 157.02 28.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.004 -0.998 . . . . 73.540000000000006 108.601 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -105.07 117.49 58.45 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 112.227 0.455 . . . . 73.25 112.227 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -95.51 38.57 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.297 2.664 . . . . 74.239999999999995 110.957 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -69.91 -36.92 74.3 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.547 -0.751 . . . . 75.25 113.209 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.48 ' HB3' HD21 ' A' ' 324' ' ' LEU . 1.5 mp0 -50.99 -52.72 39.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.965 0.412 . . . . 74.129999999999995 110.69 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 252' ' ' ILE . 4.0 mp -70.76 -36.64 65.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.616 . . . . 75.519999999999996 110.415 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.73 68.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.454 -0.339 . . . . 75.219999999999999 110.784 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.011 -0.541 . . . . 74.519999999999996 110.156 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.557 ' CD1' HD21 ' A' ' 320' ' ' LEU . 68.0 t80 -56.66 -42.79 79.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 75.310000000000002 110.2 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.615 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 95.7 mmm -70.44 -40.86 73.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.57 -0.741 . . . . 65.420000000000002 110.603 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.658 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 46.6 mt-10 -53.06 -50.42 64.38 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.204 -0.665 . . . . 64.439999999999998 109.204 172.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 79.3 m -56.83 -50.49 72.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.659 -1.155 . . . . 73.200000000000003 112.087 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.507 HG22 ' HA ' ' A' ' 303' ' ' MET . 28.8 m -69.41 -26.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.391 0.515 . . . . 72.430000000000007 112.391 -174.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.795 ' HZ1' ' HB2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -90.92 -16.15 28.6 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.786 -0.366 . . . . 75.120000000000005 111.692 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.658 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 53.0 mt -68.37 -37.59 80.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 74.340000000000003 110.592 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.3 pp -87.13 12.92 10.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.381 0.61 . . . . 74.400000000000006 110.19 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.85 -93.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.643 -1.162 . . . . 73.430000000000007 112.961 171.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.968 ' HD1' ' HD3' ' A' ' 241' ' ' ARG . 40.2 t80 -115.72 -58.56 2.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.86 0.319 . . . . 73.230000000000004 111.86 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.1 p -133.73 10.07 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.1 0.407 . . . . 74.140000000000001 112.1 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.0 60.9 6.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.387 0.514 . . . . 73.319999999999993 112.387 -169.026 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? 64.97 103.86 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.389 -0.823 . . . . 74.420000000000002 113.189 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.793 ' HG3' ' HD2' ' A' ' 240' ' ' ARG . 4.4 Cg_exo -78.92 119.5 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.734 2.289 . . . . 72.120000000000005 111.303 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.58 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 94.1 mt -84.32 81.38 8.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.758 0.313 . . . . 74.430000000000007 110.987 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.49 -36.42 75.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 72.510000000000005 111.366 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -61.45 -45.99 91.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.415 . . . . 73.209999999999994 110.498 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.05 -40.32 90.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 71.430000000000007 110.277 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 87.8 mt -58.19 -52.55 65.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 74.129999999999995 110.1 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -40.33 77.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 75.209999999999994 110.805 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.65 -50.31 69.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 64.409999999999997 111.635 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.69 -31.97 27.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 111.679 0.252 . . . . 74.530000000000001 111.679 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.484 HD22 ' HE2' ' A' ' 251' ' ' MET . 93.0 mt -66.35 -48.63 69.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 72.239999999999995 110.621 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.6 -27.11 63.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 72.319999999999993 110.919 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.38 -49.06 78.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.437 -0.579 . . . . 73.430000000000007 109.437 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.72 -40.18 93.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.656 -0.783 . . . . 75.420000000000002 112.108 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.601 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 tm? -59.08 -43.96 91.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 73.209999999999994 110.517 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.698 ' HA ' ' O ' ' A' ' 333' ' ' SER . 30.1 ttpt -72.82 -30.01 63.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 74.319999999999993 110.855 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.03 69.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 73.450000000000003 112.071 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.637 ' HB ' ' NH1' ' A' ' 151' ' ' ARG . 13.7 tt -83.34 -7.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 75.510000000000005 111.013 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.19 -6.15 26.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.588 -0.815 . . . . 64.349999999999994 113.188 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.698 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 20.1 p -100.19 158.48 15.83 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.659 -0.318 . . . . 71.420000000000002 110.704 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -148.87 -68.36 0.22 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.294 -0.632 . . . . 72.310000000000002 109.294 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.527 ' CG ' ' H ' ' A' ' 336' ' ' ASP . 9.2 t70 56.43 -155.9 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.722 -0.672 . . . . 65.400000000000006 111.402 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.527 ' H ' ' CG ' ' A' ' 335' ' ' ASP . 27.2 t70 -153.03 -36.7 0.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.22 -0.446 . . . . 65.329999999999998 110.855 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.487 ' HA2' ' OE1' ' A' ' 156' ' ' GLN . . . 177.97 49.73 0.07 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.969 -1.11 . . . . 74.510000000000005 114.082 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.59 130.33 51.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.278 0.539 . . . . 74.129999999999995 111.556 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.948 ' HB2' ' HA ' ' A' ' 191' ' ' ASP . 3.9 mm? -121.34 147.15 46.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 73.409999999999997 110.185 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.29 -75.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.176 -0.675 . . . . 74.420000000000002 109.176 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.519 HD12 HD11 ' A' ' 185' ' ' LEU . 3.7 mm? 44.5 28.23 0.3 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.918 -1.037 . . . . 74.319999999999993 113.613 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.1 p -104.22 15.84 27.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.508 0.67 . . . . 72.540000000000006 109.892 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 344' ' ' VAL . 7.5 p -61.74 -42.21 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.137 -0.938 . . . . 72.340000000000003 111.7 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.505 HG11 HG11 ' A' ' 343' ' ' VAL . 7.5 p -162.72 -54.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.874 0.694 . . . . 71.019999999999996 112.874 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.815 ' HA ' HD11 ' A' ' 141' ' ' ILE . 45.8 mt-10 65.8 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.568 0.581 . . . . 72.530000000000001 112.568 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.577 ' HB2' ' CB ' ' A' ' 140' ' ' LYS . 20.5 m120 -131.75 -165.05 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.38 -0.97 . . . . 74.430000000000007 108.38 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.608 ' HA2' ' HB2' ' A' ' 137' ' ' ASP . . . -156.07 164.22 32.23 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.28 -0.962 . . . . 73.519999999999996 112.47 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 164.83 -40.28 0.3 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.652 -0.785 . . . . 61.219999999999999 113.565 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.612 HD22 HD21 ' A' ' 184' ' ' LEU . 52.2 mt 63.12 95.56 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.294 0.568 . . . . 71.549999999999997 111.08 -172.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.509 ' HD3' ' CG ' ' A' ' 139' ' ' GLN . 50.7 mtpt -83.0 -0.28 48.09 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.908 -0.587 . . . . 74.530000000000001 111.905 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -158.27 121.45 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.902 -0.407 . . . . 70.239999999999995 109.902 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.878 ' HA ' HD13 ' A' ' 200' ' ' LEU . 33.1 pttt -161.85 87.9 0.68 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.829 0.347 . . . . 75.25 111.919 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.482 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 10.8 t 166.85 135.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.291 -0.868 . . . . 73.329999999999998 109.602 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.858 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -94.4 142.08 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.546 -0.538 . . . . 73.439999999999998 109.546 175.548 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.508 ' N ' HD13 ' A' ' 354' ' ' ILE . 24.5 m -64.48 97.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.045 -0.525 . . . . 72.430000000000007 111.97 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.45 ' HE3' ' CG2' ' A' ' 354' ' ' ILE . 94.9 mttt -114.37 -85.15 0.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.638 . . . . 75.420000000000002 109.992 174.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 64.1 tttm 175.77 122.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.316 -1.365 . . . . 74.329999999999998 107.316 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 358' ' ' ARG . 19.8 ptt-85 -66.49 146.87 54.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.194 0.521 . . . . 73.200000000000003 111.869 -171.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.556 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -160.15 -90.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.27 -1.011 . . . . 74.340000000000003 108.27 178.43 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.556 ' N ' ' HD2' ' A' ' 359' ' ' LYS . 34.1 ttmt . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.195 -1.409 . . . . 75.219999999999999 107.195 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.604 -0.147 . . . . 73.109999999999999 110.604 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.47 154.43 59.28 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.795 2.33 . . . . 73.140000000000001 111.766 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -153.25 125.61 8.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.01 -0.367 . . . . 73.349999999999994 110.01 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 p -159.11 135.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.876 0.369 . . . . 72.5 111.052 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.421 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 58.0 pttt -137.33 94.3 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.622 0.725 . . . . 75.099999999999994 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.95 85.23 2.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.962 -0.563 . . . . 71.420000000000002 109.958 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.631 -0.713 . . . . 72.349999999999994 110.125 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.54 149.81 29.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.98 0.419 . . . . 73.129999999999995 110.105 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.89 33.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.837 -0.62 . . . . 61.43 109.853 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.23 105.49 2.72 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.665 -0.779 . . . . 73.230000000000004 112.42 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -117.73 86.99 2.62 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.847 -0.797 . . . . 73.540000000000006 108.847 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -96.2 94.11 7.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 73.299999999999997 110.67 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -108.94 122.94 48.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.491 -0.559 . . . . 74.450000000000003 109.491 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 p -88.12 124.48 33.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.431 -0.35 . . . . 73.129999999999995 111.178 -177.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.3 108.32 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.407 -0.59 . . . . 72.010000000000005 109.407 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -125.71 20.83 7.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.056 -0.52 . . . . 74.25 111.517 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -68.98 88.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.323 0.582 . . . . 63.229999999999997 110.73 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -124.79 -1.44 7.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.555 -0.748 . . . . 75.230000000000004 109.288 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.754 ' H ' HD22 ' A' ' 19' ' ' LEU . 2.1 pt? -87.5 113.93 23.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.132 -0.94 . . . . 74.209999999999994 111.198 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . -161.56 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.131 -0.94 . . . . 64.319999999999993 109.608 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 42.8 tt0 173.04 -74.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.657 0.598 . . . . 71.040000000000006 109.657 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -123.02 56.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.578 0.704 . . . . 74.239999999999995 109.519 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -79.63 -23.65 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.484 -0.78 . . . . 73.140000000000001 110.553 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.04 -53.11 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 72.239999999999995 109.687 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.36 142.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.358 -0.837 . . . . 73.230000000000004 110.242 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.24 -21.91 43.32 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.798 -0.715 . . . . 73.329999999999998 113.533 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.67 160.76 29.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.704 0.752 . . . . 73.010000000000005 110.306 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 6.4 pt -116.76 129.67 72.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.468 0.651 . . . . 74.450000000000003 110.949 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.539 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 33.1 pt -91.8 154.48 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.511 -0.768 . . . . 75.219999999999999 111.091 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.61 HG22 ' HB2' ' A' ' 35' ' ' LYS . 4.8 m -112.5 114.13 26.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 72.209999999999994 111.273 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.66 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.7 p-10 -112.05 -166.54 1.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 74.150000000000006 109.834 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.625 ' HG2' ' O ' ' A' ' 116' ' ' SER . 20.9 mmt -63.65 -22.55 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.337 -0.392 . . . . 74.519999999999996 111.46 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.52 4.8 19.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.776 0.322 . . . . 74.430000000000007 111.013 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 71.26 44.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.771 -0.649 . . . . 75.219999999999999 111.61 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.61 ' HB2' HG22 ' A' ' 30' ' ' THR . 37.7 ttmt 72.97 113.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.324 -0.853 . . . . 74.219999999999999 113.262 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.76 37.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 75.409999999999997 110.61 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 11.3 m95 -134.01 126.12 29.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 70.409999999999997 110.117 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.58 124.9 50.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.682 0.277 . . . . 74.219999999999999 110.304 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.97 126.14 25.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 74.409999999999997 110.928 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.02 -107.88 3.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.766 -0.73 . . . . 61.439999999999998 112.306 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.831 ' HB3' HD11 ' A' ' 53' ' ' LEU . 49.1 tp -86.67 123.94 70.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.71 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.614 ' HD2' HD12 ' A' ' 41' ' ' LEU . 58.2 Cg_endo -74.81 109.04 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.45 2.1 . . . . 72.530000000000001 111.837 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 36.9 mt -74.0 -53.46 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.34 0.59 . . . . 74.200000000000003 110.048 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.92 -29.51 5.88 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.65 -0.705 . . . . 73.319999999999993 112.575 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -119.01 165.1 14.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.163 -0.31 . . . . 73.439999999999998 110.163 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.13 51.82 1.43 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.548 -0.834 . . . . 73.310000000000002 111.749 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 350' ' ' LYS . . . 145.67 -126.71 2.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.503 -0.856 . . . . 75.310000000000002 112.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -92.77 -33.69 14.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.9 0.381 . . . . 71.319999999999993 110.919 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 141.13 160.68 8.39 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.369 -0.692 . . . . 71.140000000000001 111.369 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.8 t 53.53 53.81 11.01 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.273 0.558 . . . . 63.149999999999999 110.652 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.429 HD11 ' CB ' ' A' ' 71' ' ' LYS . 5.3 mm -89.07 137.81 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 71.099999999999994 110.273 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HB2' HG11 ' A' ' 70' ' ' VAL . 84.5 m-85 -121.22 148.54 44.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 72.010000000000005 111.193 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.831 HD11 ' HB3' ' A' ' 41' ' ' LEU . 75.3 mt -87.4 140.72 29.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.049 -0.523 . . . . 75.340000000000003 109.837 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.29 37.84 4.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.374 0.607 . . . . 65.150000000000006 109.914 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.413 ' HA ' ' HB3' ' A' ' 66' ' ' ALA . 8.7 p-10 -98.22 9.12 43.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.489 -0.778 . . . . 73.450000000000003 111.249 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.62 2.61 50.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 74.319999999999993 111.736 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.38 87.78 7.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.158 -0.617 . . . . 73.310000000000002 110.029 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 t -104.1 79.77 1.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.727 -0.842 . . . . 73.549999999999997 108.727 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.9 m -66.02 -56.28 12.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 75.239999999999995 110.756 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -142.86 -64.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.892 -0.41 . . . . 73.109999999999999 109.892 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.1 p -140.81 90.95 2.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 74.219999999999999 111.263 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.503 HG22 ' HB1' ' A' ' 66' ' ' ALA . 8.1 p -81.7 144.46 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.156 -0.475 . . . . 73.409999999999997 109.804 176.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.84 -104.27 0.12 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.981 -0.628 . . . . 73.310000000000002 113.378 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 p -81.17 62.69 5.22 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.815 0.672 . . . . 75.299999999999997 112.815 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 66.13 16.71 10.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.531 -0.304 . . . . 70.030000000000001 111.729 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.503 ' HB1' HG22 ' A' ' 62' ' ' VAL . . . 63.58 88.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.234 0 O-C-N 123.697 0.623 . . . . 74.040000000000006 110.557 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 187' ' ' TYR . 93.3 Cg_endo -80.81 36.95 0.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.089 2.526 . . . . 72.129999999999995 113.14 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.6 m -117.86 136.15 53.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.62 0.724 . . . . 53.329999999999998 111.849 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.642 HG13 HD21 ' A' ' 53' ' ' LEU . 35.4 m -136.2 148.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.996 -1.002 . . . . 75.120000000000005 108.746 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -123.73 120.66 60.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.291 0.567 . . . . 75.310000000000002 111.028 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' CB ' HD11 ' A' ' 51' ' ' ILE . 25.3 pttm -105.58 134.44 48.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.234 -0.654 . . . . 74.420000000000002 109.234 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.508 ' CG1' ' HB3' ' A' ' 126' ' ' TYR . 15.9 t -120.51 148.94 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 72.430000000000007 112.054 -165.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -137.8 141.16 31.88 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 70.430000000000007 109.422 173.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.65 134.64 58.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.456 2.104 . . . . 72.340000000000003 111.633 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -73.41 88.46 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.185 0.517 . . . . 63.030000000000001 111.1 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -139.15 -68.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.585 -0.894 . . . . 72.150000000000006 108.585 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.498 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 5.3 p30 -128.5 -75.42 0.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.558 -0.746 . . . . 72.209999999999994 109.032 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . 72.35 110.5 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 114.058 0.383 . . . . 73.030000000000001 114.058 170.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.42 ' HD2' ' HA2' ' A' ' 78' ' ' GLY . 12.0 Cg_endo -55.77 -22.35 36.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.858 2.372 . . . . 74.310000000000002 111.398 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.9 tp -59.85 -30.1 68.74 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.454 -0.793 . . . . 64.430000000000007 110.559 175.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.35 -38.93 71.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.933 -0.395 . . . . 73.140000000000001 109.933 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.6 m -60.95 -46.96 88.6 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.426 0.632 . . . . 64.319999999999993 109.522 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.789 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 34.6 tt0 -63.14 -37.98 89.35 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.348 -0.842 . . . . 72.019999999999996 110.64 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.511 HD22 ' HE2' ' A' ' 129' ' ' MET . 3.2 tm? -58.4 -45.3 88.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.486 -0.324 . . . . 75.219999999999999 110.681 -179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.82 -50.97 71.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 75.430000000000007 110.852 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.449 ' CE1' HG21 ' A' ' 168' ' ' ILE . 92.7 t80 -62.63 -40.1 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 71.129999999999995 110.95 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.504 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 2.8 t80 -62.3 -45.14 94.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.309 -0.859 . . . . 72.329999999999998 111.052 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.02 -29.68 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.678 0.275 . . . . 73.439999999999998 111.323 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.6 tpm_? -69.2 -27.84 65.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 73.200000000000003 110.813 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.75 10.83 36.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 71.120000000000005 110.912 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.89 173.78 11.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.384 . . . . 71.010000000000005 111.74 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.749 ' HB3' HE21 ' A' ' 95' ' ' GLN . 36.7 ttmt 70.83 98.22 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.129 -0.941 . . . . 71.219999999999999 110.321 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.92 -31.51 81.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.693 2.928 . . . . 72.319999999999993 113.741 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.732 ' HG2' ' HE3' ' A' ' 98' ' ' LYS . 43.6 tt0 -60.86 -46.8 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.219 -0.193 . . . . 74.340000000000003 110.787 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.749 HE21 ' HB3' ' A' ' 92' ' ' LYS . 45.2 mt-30 -58.77 -44.1 90.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.884 0.373 . . . . 74.329999999999998 110.055 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.46 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.1 mt -56.32 -52.72 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.484 -0.78 . . . . 72.209999999999994 110.224 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.16 -36.83 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.099 -0.501 . . . . 75.099999999999994 110.96 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.732 ' HE3' ' HG2' ' A' ' 94' ' ' GLU . 97.4 mttt -60.44 -58.44 8.48 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.044 -0.525 . . . . 74.439999999999998 111.177 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.2 p90 -72.44 -34.23 67.65 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.155 -0.618 . . . . 72.120000000000005 110.788 -174.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 96' ' ' ILE . 22.4 mm -55.28 -49.12 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.548 0.213 . . . . 63.109999999999999 110.731 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.83 -44.89 84.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.301 . . . . 73.439999999999998 111.135 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.5 m -71.13 -23.97 62.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 72.129999999999995 111.575 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.597 HH22 ' HB2' ' A' ' 170' ' ' GLU . 20.6 ttt180 -96.24 -1.84 47.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.456 . . . . 73.409999999999997 110.457 -176.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.95 35.68 8.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.76 -0.654 . . . . 75.120000000000005 111.325 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.487 HD11 ' HD3' ' A' ' 103' ' ' ARG . 81.2 mt -94.97 -165.51 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.524 . . . . 73.019999999999996 109.956 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.779 ' HB3' ' HZ3' ' A' ' 106' ' ' LYS . 3.2 mmmp? -108.87 -61.79 1.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.751 -0.463 . . . . 72.540000000000006 109.751 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 32.4 p90 178.62 144.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 73.329999999999998 109.618 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.673 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 22.5 tp -79.34 125.49 29.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.673 -0.694 . . . . 74.349999999999994 110.805 -172.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 59.71 4.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.105 -0.569 . . . . 40.420000000000002 112.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.48 134.41 21.97 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.716 -0.475 . . . . 75.219999999999999 109.716 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.704 ' HB3' ' HZ ' ' A' ' 134' ' ' PHE . 17.1 Cg_endo -59.8 142.55 98.85 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.302 2.001 . . . . 72.409999999999997 112.057 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.72 147.83 50.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 74.549999999999997 111.303 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.05 128.98 55.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.913 -0.585 . . . . 72.239999999999995 110.742 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.488 ' HB2' HG21 ' A' ' 130' ' ' ILE . 70.3 m95 -103.33 -59.7 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.304 0.573 . . . . 73.340000000000003 109.665 174.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.17 175.52 42.3 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.507 -0.77 . . . . 74.319999999999993 112.564 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.625 ' O ' ' HG2' ' A' ' 32' ' ' MET . 18.7 p -150.49 155.93 40.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.442 -0.947 . . . . 75.310000000000002 108.442 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.66 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -172.56 -160.01 20.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.201 -1.476 . . . . 72.530000000000001 113.799 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 tp -136.92 136.21 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.058 -0.571 . . . . 74.310000000000002 110.02 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.556 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 3.7 t-160 -139.77 121.91 15.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.212 -0.662 . . . . 72.540000000000006 109.212 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 22.3 t70 -88.49 130.83 35.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 74.510000000000005 109.905 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -87.34 -72.02 0.54 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.919 0.39 . . . . 73.030000000000001 110.667 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -135.75 33.4 2.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 74.409999999999997 110.184 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.1 -23.1 21.89 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.477 -1.049 . . . . 75.329999999999998 110.477 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.4 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.7 mptt -87.45 104.44 16.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.77 -0.826 . . . . 71.099999999999994 108.77 172.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.478 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.1 m -77.52 129.07 35.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.829 -0.623 . . . . 62.109999999999999 110.468 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.508 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . 47.8 m-85 -107.89 124.1 49.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.084 -0.507 . . . . 74.25 111.106 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -100.29 131.28 46.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.037 -0.727 . . . . 74.420000000000002 109.037 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.556 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 17.5 p90 -144.52 164.7 30.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.39 -0.368 . . . . 72.299999999999997 111.467 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.511 ' HE2' HD22 ' A' ' 84' ' ' LEU . 16.7 ptp -135.63 143.43 45.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.958 -0.565 . . . . 65.510000000000005 110.972 174.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.558 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 6.0 mm -97.48 121.34 47.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.279 -0.873 . . . . 75.040000000000006 110.027 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.9 ptm -133.56 176.46 8.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.461 -0.791 . . . . 73.450000000000003 109.871 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.522 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -72.47 145.83 47.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.264 0.554 . . . . 74.299999999999997 111.757 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HD3' HG11 ' A' ' 69' ' ' VAL . 16.6 tpt180 -71.37 129.35 38.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.221 -0.9 . . . . 73.450000000000003 111.385 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.704 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 50.0 m-85 -103.76 142.53 34.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.246 -0.65 . . . . 75.420000000000002 109.246 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.37 -16.14 4.36 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.432 -0.89 . . . . 64.310000000000002 111.754 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.824 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 61.4 m -121.71 125.88 47.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.609 0.243 . . . . 73.25 110.421 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.01 138.11 44.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 71.439999999999998 109.454 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.724 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.4 tp -71.85 -17.38 62.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.232 -0.284 . . . . 75.310000000000002 110.232 -176.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.888 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 52.4 tt0 -68.85 -51.15 43.54 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.152 0.427 . . . . 64.140000000000001 112.152 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.408 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.5 tptt -79.56 -35.31 40.02 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.255 -0.578 . . . . 74.209999999999994 110.436 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -43.2 92.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.167 -0.47 . . . . 73.209999999999994 111.265 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -65.38 -31.52 72.67 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.315 -0.554 . . . . 75.409999999999997 110.232 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -67.01 -38.17 85.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.825 0.345 . . . . 72.219999999999999 110.424 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.04 -32.21 68.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 74.109999999999999 111.529 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -99.06 4.6 47.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 75.519999999999996 111.136 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.3 33.98 21.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.055 -0.521 . . . . 70.349999999999994 110.967 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 16.9 pttp 43.32 33.09 0.55 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.485 1.114 . . . . 75.040000000000006 113.15 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -110.58 95.92 5.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.53 -0.915 . . . . 73.510000000000005 108.53 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.501 ' CZ ' ' HA ' ' A' ' 147' ' ' LYS . 24.7 m-85 -112.32 157.12 21.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.612 -0.722 . . . . 74.200000000000003 110.949 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 m -62.69 156.31 23.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.009 -0.541 . . . . 73.219999999999999 109.751 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -55.72 -26.04 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.822 0.305 . . . . 75.219999999999999 111.822 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.466 ' HG2' ' OD2' ' A' ' 335' ' ' ASP . 57.1 mttm -52.65 -54.32 35.01 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.231 0.539 . . . . 72.340000000000003 111.004 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.527 ' HA ' HD22 ' A' ' 339' ' ' LEU . 1.9 m -65.16 -36.17 83.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.638 -0.71 . . . . 73.450000000000003 111.222 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 -49.38 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.107 -0.497 . . . . 72.310000000000002 110.788 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.621 ' HG ' HD23 ' A' ' 328' ' ' LEU . 0.5 OUTLIER -68.5 -50.39 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 74.200000000000003 110.53 -176.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 337' ' ' GLY . 2.3 mp0 -61.61 -40.43 94.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.128 0.418 . . . . 73.120000000000005 112.128 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.481 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.9 mp -63.96 -46.83 82.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.03 -0.268 . . . . 72.239999999999995 110.36 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.431 ' HA ' HD13 ' A' ' 247' ' ' LEU . 37.6 t -60.27 -46.65 89.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.239999999999995 110.865 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.58 HD21 ' HG3' ' A' ' 106' ' ' LYS . 58.7 tp -55.62 -46.36 77.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 71.25 111.277 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.558 HH11 HG13 ' A' ' 193' ' ' VAL . 89.9 mtt180 -66.68 -34.03 76.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 74.310000000000002 111.294 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 157' ' ' LEU . 48.1 mm -68.89 -34.71 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 74.519999999999996 110.291 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.454 HD11 HD13 ' A' ' 324' ' ' LEU . 95.7 mt -61.11 -47.41 86.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.486 -0.324 . . . . 61.32 110.6 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.74 -48.02 78.73 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.124 -0.489 . . . . 72.519999999999996 111.155 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 161' ' ' ILE . 14.7 tt -71.83 -36.47 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.774 -0.37 . . . . 74.439999999999998 111.677 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 168' ' ' ILE . 42.5 tp -65.41 -32.62 74.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.439999999999998 110.985 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 28.6 tp10 -68.12 -45.96 72.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.826 -0.435 . . . . 53.130000000000003 109.826 174.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -59.04 -44.05 91.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 72.049999999999997 111.893 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 165' ' ' LEU . 40.6 pt -76.57 -34.28 23.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.715 -0.394 . . . . 70.040000000000006 111.683 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -75.79 -19.1 59.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.67 -0.412 . . . . 75.200000000000003 110.443 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.597 ' HB2' HH22 ' A' ' 103' ' ' ARG . 13.6 tt0 -53.34 -31.8 46.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.016 -0.735 . . . . 75.450000000000003 109.016 170.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.537 ' C ' ' HG3' ' A' ' 172' ' ' GLU . 48.1 m80 -98.45 -101.94 0.21 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.981 -1.008 . . . . 74.420000000000002 110.596 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.537 ' HG3' ' C ' ' A' ' 171' ' ' HIS . 12.1 mt-10 -153.87 14.0 0.47 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.645 0.239 . . . . 75.540000000000006 111.645 -171.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -122.46 148.04 45.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 72.409999999999997 112.601 -164.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.01 173.21 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.034 -0.984 . . . . 73.030000000000001 109.401 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.14 -65.11 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 63.420000000000002 110.897 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.28 50.97 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.435 -0.888 . . . . 50.539999999999999 113.056 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.604 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 34.0 t70 -141.37 108.37 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.983 0.392 . . . . 54.030000000000001 111.169 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.463 HG23 ' O ' ' A' ' 178' ' ' ILE . 25.2 mm -111.27 35.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.81 0.814 . . . . 73.129999999999995 109.4 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.495 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 56.4 tptt -59.71 134.87 57.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 72.409999999999997 110.169 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.724 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -48.06 -33.64 8.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.83 0.678 . . . . 75.319999999999993 112.83 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.888 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 28.6 p -59.41 -25.58 64.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.848 0.356 . . . . 64.439999999999998 111.671 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -88.51 1.02 55.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 74.409999999999997 111.87 -171.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.21 127.01 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 75.319999999999993 110.579 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.42 134.9 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 72.040000000000006 111.007 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.824 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 8.6 mp -95.64 145.86 24.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.149 -0.478 . . . . 63.140000000000001 109.815 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.433 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 26.2 t-20 -62.73 144.39 56.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.378 -0.373 . . . . 63.149999999999999 110.417 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.643 ' CE2' ' HE2' ' A' ' 188' ' ' LYS . 1.3 p90 -60.56 -32.37 71.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.219 0.451 . . . . 74.010000000000005 112.219 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.643 ' HE2' ' CE2' ' A' ' 187' ' ' TYR . 75.8 mmtt -93.71 -43.91 8.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 72.530000000000001 110.237 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -101.94 105.3 41.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 74.150000000000006 111.961 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 4.3 Cg_exo -77.15 -7.04 17.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.957 2.438 . . . . 75.019999999999996 111.466 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -87.96 -16.86 32.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.839 -0.619 . . . . 72.340000000000003 110.7 -178.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -111.08 110.98 21.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.405 0.621 . . . . 74.140000000000001 111.11 -175.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.558 HG13 HH11 ' A' ' 160' ' ' ARG . 13.0 p -108.09 138.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.882 -1.053 . . . . 75.129999999999995 109.913 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.56 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 47.0 m-85 -125.33 153.74 42.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.442 -0.577 . . . . 73.010000000000005 109.442 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 32.5 tp -96.48 142.3 28.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.059 -0.349 . . . . 74.340000000000003 110.059 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.467 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.0 p -124.04 -173.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.293 -0.632 . . . . 74.409999999999997 109.293 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.593 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 52.5 t0 60.63 62.32 1.53 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.894 0.854 . . . . 75.329999999999998 109.116 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.789 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 21.7 m-85 -81.11 7.59 10.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.147 -0.933 . . . . 71.239999999999995 109.788 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.45 76.5 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.579 -0.737 . . . . 74.299999999999997 111.622 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.867 ' HA ' ' HB ' ' A' ' 354' ' ' ILE . 2.4 pp -89.91 4.07 51.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.753 0.311 . . . . 74.430000000000007 111.355 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -68.89 102.1 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.194 0.521 . . . . 75.319999999999993 109.974 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.596 ' HB2' HG13 ' A' ' 354' ' ' ILE . 84.8 t80 -98.39 125.54 43.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 71.519999999999996 110.117 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.8 ttt180 -74.4 97.16 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 62.520000000000003 109.147 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.646 ' HB2' ' HB3' ' A' ' 237' ' ' ALA . 2.7 p90 -87.07 -14.93 40.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 73.519999999999996 111.625 -170.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 24.8 p -137.4 104.47 8.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.82 0.343 . . . . 72.549999999999997 110.871 177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -66.16 119.97 7.06 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.413 2.075 . . . . 74.319999999999993 111.708 176.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 64.98 -80.79 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.769 -0.65 . . . . 73.239999999999995 111.046 -178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.84 0.64 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 74.25 112.098 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 51.0 t -105.63 111.74 36.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.077 -0.342 . . . . 71.120000000000005 110.077 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -83.94 146.07 28.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.859 0.361 . . . . 74.340000000000003 110.295 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.435 ' HD3' ' OE2' ' A' ' 212' ' ' GLU . 10.1 mmtt -84.02 156.37 22.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.449 . . . . 75.329999999999998 109.989 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.435 ' OE2' ' HD3' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -102.25 153.62 19.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.315 -0.624 . . . . 73.450000000000003 109.315 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.606 ' HA ' HG23 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -74.13 55.82 0.59 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.563 0.579 . . . . 72.010000000000005 112.563 -174.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -117.28 -15.49 10.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.11 -0.496 . . . . 74.129999999999995 110.498 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.45 ' O ' ' HB ' ' A' ' 236' ' ' VAL . 3.0 tp10 -80.94 141.14 34.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 74.129999999999995 111.669 -170.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -148.98 83.15 6.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.534 -0.913 . . . . 70.430000000000007 108.534 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.75 -51.17 2.55 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.414 2.076 . . . . 72.150000000000006 112.205 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -175.79 29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 75.0 110.012 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 62.84 95.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.759 0.662 . . . . 74.439999999999998 111.349 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.467 ' HB3' ' OD2' ' A' ' 222' ' ' ASP . 99.3 m -67.06 -48.45 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 75.239999999999995 111.665 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 21.4 p80 47.21 35.08 3.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.677 0.791 . . . . 72.209999999999994 112.815 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.467 ' OD2' ' HB3' ' A' ' 220' ' ' CYS . 28.6 m-20 -66.46 -36.83 83.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.449 . . . . 64.200000000000003 110.906 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.604 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -76.44 159.36 49.97 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.707 -0.758 . . . . 74.420000000000002 111.674 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 228' ' ' THR . 6.6 p -68.58 150.3 48.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.472 0.177 . . . . 74.040000000000006 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.466 ' HB ' HD12 ' A' ' 265' ' ' LEU . 43.8 mm -52.97 -34.36 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.903 0.383 . . . . 75.25 111.479 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.18 -47.06 84.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.964 -0.562 . . . . 74.409999999999997 111.293 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.978 ' HB3' HG22 ' A' ' 246' ' ' ILE . 41.0 m-85 -112.1 15.75 20.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 75.310000000000002 111.968 -170.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 224' ' ' THR . 1.3 p -57.87 -36.83 72.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.441 0.534 . . . . 65.0 112.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.6 t 57.23 -173.97 0.08 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.378 -0.601 . . . . 74.340000000000003 109.378 -170.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.425 HD11 ' N ' ' A' ' 230' ' ' ILE . 2.1 mp -73.5 -39.15 54.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.262 0.553 . . . . 72.319999999999993 109.849 174.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.82 -66.45 0.4 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.888 -1.051 . . . . 70.310000000000002 111.967 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.57 69.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 75.120000000000005 111.914 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -63.02 -43.67 98.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.629 -0.26 . . . . 65.109999999999999 111.099 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.39 -32.88 58.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.212 0.53 . . . . 75.420000000000002 110.819 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.25 1.45 55.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.625 -0.798 . . . . 72.540000000000006 111.49 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.606 HG23 ' HA ' ' A' ' 213' ' ' TYR . 8.8 p -72.42 141.88 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 110.0 -0.37 . . . . 73.519999999999996 110.0 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 204' ' ' TYR . . . -47.76 109.89 1.23 Allowed Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 74.439999999999998 111.728 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.57 121.21 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 73.209999999999994 111.864 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 m -79.8 170.59 16.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.033 -0.53 . . . . 75.420000000000002 109.82 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -62.7 -29.98 71.06 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.415 -0.514 . . . . 75.040000000000006 110.434 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 0.2 OUTLIER -55.12 -38.8 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 75.219999999999999 109.858 174.348 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.484 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -67.26 -50.95 41.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.536 -0.756 . . . . 65.310000000000002 111.971 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -39.67 94.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.992 0.425 . . . . 74.439999999999998 110.174 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.35 -44.28 97.44 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.086 -0.506 . . . . 73.25 110.775 174.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.62 -36.99 81.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.76 -0.655 . . . . 74.109999999999999 110.181 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.978 HG22 ' HB3' ' A' ' 227' ' ' PHE . 96.5 mt -62.77 -43.01 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.648 -0.706 . . . . 72.420000000000002 110.151 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.497 ' O ' ' HG3' ' A' ' 251' ' ' MET . 61.7 tp -60.34 -39.6 87.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 110.321 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.797 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.62 -42.06 99.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.035 -0.602 . . . . 73.129999999999995 112.254 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.459 ' CD2' ' HA ' ' A' ' 246' ' ' ILE . 22.2 m-85 -56.93 -41.35 78.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.248 0.547 . . . . 75.120000000000005 110.046 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 46.4 m -65.57 -45.44 83.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.553 -0.749 . . . . 74.519999999999996 110.656 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.497 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.2 mtp -58.39 -48.53 80.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 74.129999999999995 111.228 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.495 HD12 ' HE2' ' A' ' 286' ' ' MET . 8.9 tt -66.53 -34.29 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.713 -0.395 . . . . 75.409999999999997 110.742 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.503 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 41.6 tt0 -66.75 -46.4 75.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.141 -0.224 . . . . 74.430000000000007 110.772 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.465 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.0 m0 -68.37 -28.21 66.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 71.010000000000005 111.363 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.5 tp -81.49 -31.05 33.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 75.239999999999995 111.706 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.7 p -101.8 -28.2 12.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.801 -0.359 . . . . 74.040000000000006 111.683 -173.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.424 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 87.01 -13.79 58.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.858 -0.687 . . . . 73.349999999999994 112.745 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -156.26 141.04 17.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.919 -0.4 . . . . 75.540000000000006 109.919 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 93.9 mt -101.79 148.93 36.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 73.129999999999995 110.758 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.441 ' HG2' ' CE3' ' A' ' 261' ' ' TRP . 18.2 Cg_endo -60.07 -29.11 88.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.708 2.272 . . . . 74.420000000000002 112.766 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.501 ' HB3' ' CB ' ' A' ' 274' ' ' SER . 33.5 p90 -105.13 7.58 33.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.72 0.295 . . . . 75.540000000000006 111.222 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.734 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 39.8 tt0 -67.22 -37.48 83.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.026 0.441 . . . . 64.030000000000001 111.332 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.56 -22.14 62.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.348 0.594 . . . . 73.409999999999997 110.091 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -109.56 21.73 16.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.526 -0.761 . . . . 75.109999999999999 110.731 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.469 ' O ' HD13 ' A' ' 265' ' ' LEU . 1.6 tm? -63.33 -24.0 67.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 74.239999999999995 111.03 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.416 ' HZ1' ' HB2' ' A' ' 266' ' ' LYS . 9.9 mtmp? -88.56 12.69 13.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 72.540000000000006 111.698 -177.211 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.54 118.46 17.98 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-O 120.766 0.317 . . . . 73.519999999999996 110.636 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.17 -30.62 74.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 74.310000000000002 113.267 -177.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -73.23 -41.67 63.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.751 0.31 . . . . 74.319999999999993 110.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -68.89 -46.54 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 74.219999999999999 111.204 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 34.1 m -62.88 -31.21 51.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.928 -0.309 . . . . 75.430000000000007 111.143 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.461 ' O ' HG13 ' A' ' 276' ' ' ILE . 10.7 ttt85 -61.16 -62.72 1.64 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 110.139 -0.319 . . . . 74.450000000000003 110.139 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.39 -44.65 84.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.77 -0.65 . . . . 74.519999999999996 111.563 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.501 ' CB ' ' HB3' ' A' ' 261' ' ' TRP . 19.7 m -65.15 -40.94 95.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.962 -0.563 . . . . 75.430000000000007 111.668 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -78.52 -23.01 46.5 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.537 -0.465 . . . . 72.299999999999997 110.921 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 272' ' ' ARG . 62.4 mt -71.32 -46.5 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.838 -0.431 . . . . 73.439999999999998 109.838 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -62.64 -40.01 95.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.346 -0.388 . . . . 75.299999999999997 110.545 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -60.14 -46.86 88.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 74.109999999999999 110.842 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -76.98 -13.91 59.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 74.209999999999994 110.624 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.83 -36.19 79.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.099 -0.501 . . . . 63.43 110.052 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -161.9 96.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.416 -0.587 . . . . 74.409999999999997 109.416 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.497 HG21 ' HB2' ' A' ' 303' ' ' MET . 3.7 mp -80.16 -51.48 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.186 0.439 . . . . 75.519999999999996 112.186 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.419 ' HA ' ' HB3' ' A' ' 300' ' ' ALA . . . -58.12 -46.94 84.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.597 0.221 . . . . 73.329999999999998 111.597 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -64.99 -37.14 86.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 74.519999999999996 110.559 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.27 -34.44 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 75.540000000000006 110.69 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.695 ' HE3' HG21 ' A' ' 299' ' ' ILE . 49.5 mtt -74.38 -34.22 63.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.687 -0.233 . . . . 75.209999999999994 111.44 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -59.92 -36.52 77.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.288 -0.634 . . . . 71.530000000000001 109.288 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -75.35 -24.48 57.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.976 -1.011 . . . . 74.019999999999996 110.965 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.0 m -72.85 -23.46 60.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.619 -0.264 . . . . 72.140000000000001 111.229 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.82 81.24 11.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.85 0.315 . . . . 62.210000000000001 111.85 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.37 -18.34 49.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.533 2.156 . . . . 75.409999999999997 111.228 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -76.78 -5.91 50.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.75 -0.659 . . . . 64.540000000000006 109.85 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 64.95 90.14 0.09 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.057 -0.974 . . . . 72.239999999999995 112.315 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.44 -177.14 3.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.816 -1.549 . . . . 75.409999999999997 106.816 170.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.405 ' HA ' ' HD2' ' A' ' 295' ' ' LYS . 15.3 tptp -122.29 87.26 48.21 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 118.808 0.731 . . . . 73.420000000000002 110.332 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.46 39.65 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.323 2.682 . . . . 75.099999999999994 111.348 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -65.61 -37.32 93.47 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.837 -0.619 . . . . 72.140000000000001 112.861 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.547 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -60.35 -46.61 89.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.31 0.576 . . . . 72.439999999999998 109.899 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.695 HG21 ' HE3' ' A' ' 286' ' ' MET . 4.2 mp -76.29 -38.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.473 -0.785 . . . . 72.239999999999995 110.442 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.419 ' HB3' ' HA ' ' A' ' 283' ' ' ALA . . . -60.39 -53.24 59.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 75.430000000000007 111.488 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.52 ' HB3' HD12 ' A' ' 323' ' ' ILE . 27.8 tptp -69.4 -36.32 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.397 -0.365 . . . . 72.019999999999996 110.412 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.523 ' CD1' HD11 ' A' ' 320' ' ' LEU . 62.9 t80 -55.76 -50.92 69.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 73.109999999999999 110.908 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.797 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 82.9 mmm -70.61 -40.86 72.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.105 -0.498 . . . . 74.25 111.918 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.15 -34.15 77.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.547 -0.538 . . . . 74.409999999999997 109.547 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -73.25 -45.23 57.14 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.508 0.558 . . . . 74.200000000000003 112.508 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.478 HG23 ' HA ' ' A' ' 303' ' ' MET . 34.1 m -63.54 -25.3 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.348 0.594 . . . . 74.409999999999997 110.342 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -74.6 -44.18 51.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 75.510000000000005 111.455 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 85.1 mt -84.38 71.23 10.7 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.139 0.792 . . . . 64.230000000000004 113.139 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.987 ' HG ' ' H ' ' A' ' 310' ' ' ASP . 1.3 pt? -159.61 -71.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.369 -0.974 . . . . 64.420000000000002 108.369 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.987 ' H ' ' HG ' ' A' ' 309' ' ' LEU . 2.8 t70 174.52 -73.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 124.002 0.814 . . . . 71.120000000000005 109.093 168.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.539 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 0.4 OUTLIER -162.35 -51.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.245 0.832 . . . . 71.120000000000005 113.245 173.085 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 7.0 m -139.36 32.0 2.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.598 0.713 . . . . 73.420000000000002 110.943 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.557 ' OE1' ' HB3' ' A' ' 310' ' ' ASP . 7.8 mp0 -62.5 -76.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 64.129999999999995 109.962 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.5 ' HB2' ' HZ3' ' A' ' 314' ' ' LYS . 4.6 ttmp? -156.75 93.51 2.36 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 73.430000000000007 109.459 173.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 117.39 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.949 1.766 . . . . 72.439999999999998 110.747 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.07 85.43 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 75.299999999999997 109.923 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.458 ' CZ ' ' HD2' ' A' ' 321' ' ' ARG . 60.5 t80 -57.2 -36.91 71.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.43 -0.805 . . . . 73.310000000000002 110.987 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.52 -39.26 90.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 72.129999999999995 110.417 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -68.06 -42.97 79.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 72.409999999999997 111.274 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.523 HD11 ' CD1' ' A' ' 302' ' ' TYR . 2.0 mm? -63.07 -43.38 98.73 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.939 -0.304 . . . . 75.5 110.749 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.539 ' NH2' ' HG2' ' A' ' 106' ' ' LYS . 65.0 mtp85 -67.7 -38.5 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.911 -0.316 . . . . 73.420000000000002 110.351 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -48.4 76.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 64.319999999999993 111.203 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.52 HD12 ' HB3' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -64.67 -41.42 92.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.815 -0.175 . . . . 64.030000000000001 111.232 -176.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.454 HD13 HD11 ' A' ' 162' ' ' LEU . 80.5 mt -63.24 -46.06 88.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.822 0.344 . . . . 74.439999999999998 110.869 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -35.26 75.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.381 -0.372 . . . . 74.420000000000002 110.449 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -55.68 -47.84 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 71.030000000000001 110.862 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.547 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -68.07 -45.89 69.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.901 -0.666 . . . . 71.150000000000006 112.166 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.621 HD23 ' HG ' ' A' ' 155' ' ' LEU . 40.6 tp -59.17 -45.7 90.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.127 0.489 . . . . 74.319999999999993 110.812 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -73.96 -24.63 59.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 74.030000000000001 111.164 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.43 -43.14 77.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.682 0.277 . . . . 72.200000000000003 110.991 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.29 -6.73 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.364 0.602 . . . . 75.150000000000006 110.651 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.99 24.31 38.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.893 -0.67 . . . . 71.510000000000005 112.943 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.0 t -108.21 153.53 23.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.903 -0.406 . . . . 61.43 109.903 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.0 132.86 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.152 -0.476 . . . . 74.019999999999996 109.831 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.769 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 16.7 m-20 -138.6 -58.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.382 -0.372 . . . . 63.219999999999999 110.482 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.427 ' CG ' ' HZ1' ' A' ' 106' ' ' LYS . 48.9 t0 59.29 90.15 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.169 0.918 . . . . 64.019999999999996 111.064 178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.475 ' H ' ' HG3' ' A' ' 156' ' ' GLN . . . 96.85 -31.85 7.18 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.825 -0.703 . . . . 70.340000000000003 112.398 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 335' ' ' ASP . 53.4 mttp -71.78 131.33 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 74.150000000000006 110.984 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.527 HD22 ' HA ' ' A' ' 153' ' ' THR . 27.5 mt -114.76 -172.15 2.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.138 -0.483 . . . . 75.209999999999994 110.527 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -148.39 37.63 0.84 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.291 1.043 . . . . 74.400000000000006 108.388 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 17.4 tp -132.64 39.31 3.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.002 -0.999 . . . . 75.109999999999999 111.05 -171.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.9 m -80.58 34.85 0.34 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.265 -0.425 . . . . 72.549999999999997 110.835 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 59.6 t -71.24 -52.13 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 74.329999999999998 110.683 -177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.8 t 64.49 95.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.71 -0.677 . . . . 72.010000000000005 111.794 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -100.75 -52.47 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 64.140000000000001 110.424 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 49.7 t30 74.13 93.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.96 0.788 . . . . 75.140000000000001 112.07 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -137.71 -57.75 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.38 -1.088 . . . . 53.240000000000002 110.38 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 102.69 171.03 26.61 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.835 -0.698 . . . . 52.149999999999999 112.812 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -131.17 178.24 6.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.126 0.489 . . . . 72.530000000000001 111.132 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.449 ' HZ2' ' HB2' ' A' ' 350' ' ' LYS . 9.7 mtmp? -120.96 141.22 50.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.434 -0.803 . . . . 73.109999999999999 109.418 169.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.26 154.94 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.53 . . . . 75.239999999999995 112.389 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.583 ' O ' ' HB ' ' A' ' 353' ' ' THR . 0.1 OUTLIER -93.95 -45.71 7.49 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.781 -0.645 . . . . 74.310000000000002 112.087 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.583 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 93.8 m 74.83 139.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.871 0.732 . . . . 71.329999999999998 110.666 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.867 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.4 OUTLIER -90.8 140.57 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 72.430000000000007 110.844 -177.614 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.485 ' N ' HD11 ' A' ' 354' ' ' ILE . 88.0 m -68.64 102.48 1.5 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.009 -0.541 . . . . 73.510000000000005 110.833 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 360' ' ' LYS . 4.9 tmtt? -141.06 112.5 7.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.281 -0.637 . . . . 72.510000000000005 109.281 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -156.34 131.53 9.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 73.310000000000002 111.101 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -175.95 -67.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.883 -1.154 . . . . 73.200000000000003 107.883 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.696 ' HA ' ' HE3' ' A' ' 359' ' ' LYS . 1.6 tpmt? -146.96 -47.04 0.18 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.426 -1.694 . . . . 72.530000000000001 106.426 170.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 356' ' ' LYS . 53.4 mttp . . . . . 0 C--O 1.241 0.613 0 CA-C-N 114.017 -1.447 . . . . 73.140000000000001 107.948 161.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 66.0 mtt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.135 -0.32 . . . . 75.109999999999999 110.135 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 87.2 Cg_exo -45.88 149.55 2.11 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.659 2.906 . . . . 70.219999999999999 114.02 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -142.31 137.8 30.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 74.129999999999995 110.785 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.38 109.62 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.391 -0.596 . . . . 75.209999999999994 109.391 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.48 ' HB2' ' HE1' ' A' ' 171' ' ' HIS . 18.6 ptmt -125.24 122.07 35.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.967 0.413 . . . . 75.439999999999998 111.11 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 171.99 15.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 75.430000000000007 110.066 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.82 163.9 31.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.464 -0.335 . . . . 74.230000000000004 110.586 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -119.47 152.92 36.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 74.129999999999995 110.266 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.18 151.8 33.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.093 -0.503 . . . . 70.120000000000005 110.808 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.69 136.22 12.76 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.857 -0.687 . . . . 75.5 112.037 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.452 HH11 ' HD2' ' A' ' 11' ' ' ARG . 18.8 ttt85 -113.32 115.98 29.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.163 -0.68 . . . . 73.219999999999999 109.163 176.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.61 148.01 24.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.918 -0.583 . . . . 74.349999999999994 111.075 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.471 ' HB3' ' HB3' ' A' ' 75' ' ' SER . 16.5 m -126.6 141.07 51.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.51 -0.768 . . . . 72.109999999999999 109.536 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -143.81 104.32 4.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 74.329999999999998 110.132 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.45 ' H ' ' HB2' ' A' ' 76' ' ' ASP . . . -164.46 83.73 0.42 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 73.540000000000006 110.199 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.578 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -92.81 172.15 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 73.349999999999994 110.18 -179.031 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.705 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -172.13 116.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.77 -0.826 . . . . 74.409999999999997 108.77 -176.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -79.72 27.73 0.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.321 0.489 . . . . 74.430000000000007 112.321 -171.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.428 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 55.2 tp -137.43 160.08 40.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.298 -0.63 . . . . 75.239999999999995 109.298 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.74 125.53 8.39 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.701 0.286 . . . . 70.340000000000003 110.426 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.406 ' C ' ' H ' ' A' ' 23' ' ' PHE . 1.1 pm0 -76.88 -30.14 56.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.568 -0.53 . . . . 63.140000000000001 109.568 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 70.77 -12.08 0.58 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.203 -0.908 . . . . 74.430000000000007 112.359 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' H ' ' C ' ' A' ' 21' ' ' GLU . 81.3 t80 -81.65 93.34 6.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.076 0.465 . . . . 73.400000000000006 110.088 178.026 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -126.27 -2.3 6.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.824 -0.625 . . . . 73.329999999999998 110.864 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.43 121.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 73.140000000000001 110.473 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.65 1.22 83.33 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.883 -0.675 . . . . 71.409999999999997 112.537 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 154.02 20.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.088 -0.338 . . . . 74.519999999999996 110.088 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 14.6 mt -106.42 136.94 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 74.310000000000002 111.639 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.419 HG21 ' CG ' ' A' ' 119' ' ' HIS . 0.2 OUTLIER -121.41 136.1 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.44 -0.8 . . . . 75.109999999999999 109.466 175.619 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -106.12 121.86 45.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.268 -0.271 . . . . 73.430000000000007 110.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.25 179.6 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.772 -0.371 . . . . 74.519999999999996 110.01 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.798 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 18.6 mmt -63.41 -22.1 66.68 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.387 0.514 . . . . 73.329999999999998 112.387 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.74 6.08 16.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.739 0.305 . . . . 60.130000000000003 111.218 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 74.71 11.37 3.85 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.613 -0.721 . . . . 75.530000000000001 111.337 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 133.48 33.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.788 -0.449 . . . . 75.439999999999998 109.788 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 42.6 mt-10 -104.61 92.47 4.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.379 0.609 . . . . 73.219999999999999 110.501 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.617 ' CE3' ' HB2' ' A' ' 56' ' ' MET . 10.9 m95 -83.64 159.02 21.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 74.099999999999994 109.089 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.06 146.68 44.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.098 -0.641 . . . . 75.209999999999994 110.618 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.53 HG23 ' CE1' ' A' ' 52' ' ' TYR . 58.5 t -72.65 116.88 15.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.393 -0.821 . . . . 73.329999999999998 110.409 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 -94.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.518 -0.848 . . . . 62.439999999999998 112.095 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.9 mm? -111.74 129.95 23.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.759 0.314 . . . . 73.540000000000006 110.869 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.8 Cg_exo -75.07 103.77 1.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.193 2.595 . . . . 74.439999999999998 111.544 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.3 mt -86.82 -47.89 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.229 -0.441 . . . . 74.340000000000003 111.016 -175.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.65 -30.8 8.99 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.137 -0.554 . . . . 73.340000000000003 112.05 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -118.07 163.25 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.181 -0.303 . . . . 74.409999999999997 110.181 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.69 -33.27 1.3 Allowed Glycine 0 C--O 1.227 -0.325 0 N-CA-C 111.146 -0.782 . . . . 72.219999999999999 111.146 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.54 -71.55 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.38 -0.688 . . . . 54.130000000000003 111.38 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' HD1' ' HB2' ' A' ' 351' ' ' ALA . 80.8 m-85 -122.58 -71.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.82 0.343 . . . . 74.400000000000006 110.382 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.34 157.68 30.09 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.451 -0.66 . . . . 62.109999999999999 111.451 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.9 t 60.46 50.48 5.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.278 0.561 . . . . 74.400000000000006 110.843 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.53 ' CD1' ' HB3' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -105.85 137.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 73.010000000000005 109.877 177.294 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.53 ' CE1' HG23 ' A' ' 39' ' ' VAL . 52.6 p90 -128.78 158.78 37.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 72.209999999999994 111.228 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.85 132.15 39.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.553 -0.749 . . . . 74.129999999999995 109.943 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.89 105.56 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.588 -0.278 . . . . 71.510000000000005 110.279 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.439 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 1.1 p-10 -95.51 -27.53 15.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.474 -0.33 . . . . 61.329999999999998 111.009 -176.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.617 ' HB2' ' CE3' ' A' ' 37' ' ' TRP . 1.8 tmt? 66.5 -84.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.709 0.63 . . . . 64.129999999999995 110.466 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 178.61 133.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.691 -0.855 . . . . 61.439999999999998 108.691 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -79.49 54.49 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.024 0.44 . . . . 73.340000000000003 110.725 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m -92.79 -60.51 1.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.035 -0.529 . . . . 75.430000000000007 111.635 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -144.88 -58.51 0.35 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.607 0.241 . . . . 75.140000000000001 111.611 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 t -58.1 -75.67 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.885 -0.598 . . . . 53.219999999999999 111.108 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.596 HG22 ' HA ' ' A' ' 66' ' ' ALA . 5.9 p -83.75 143.66 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.657 0.265 . . . . 72.319999999999993 110.441 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.2 178.1 47.54 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.591 -1.004 . . . . 74.530000000000001 110.591 171.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 t -77.73 61.67 2.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.429 0.633 . . . . 63.100000000000001 110.521 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.43 -43.93 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.685 -0.689 . . . . 72.140000000000001 110.227 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.596 ' HA ' HG22 ' A' ' 62' ' ' VAL . . . 61.36 73.48 0.58 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.045 -0.98 . . . . 74.140000000000001 111.692 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.52 36.36 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.535 2.157 . . . . 73.310000000000002 111.571 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -133.75 137.92 45.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.697 0.76 . . . . 74.219999999999999 112.385 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.465 HG12 ' HG3' ' A' ' 133' ' ' ARG . 31.5 m -132.42 152.25 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.881 -1.054 . . . . 75.230000000000004 108.67 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.613 ' HB ' HG12 ' A' ' 130' ' ' ILE . 1.2 p -131.97 131.19 61.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.058 0.456 . . . . 74.109999999999999 112.139 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.787 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -92.15 139.52 30.54 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.401 -0.818 . . . . 70.319999999999993 109.841 176.347 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.57 134.74 49.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.502 -0.479 . . . . 73.230000000000004 112.123 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.773 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 3.0 mt-10 -144.57 177.89 1.64 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.612 -0.722 . . . . 55.310000000000002 109.069 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.773 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 37.3 Cg_endo -66.96 164.4 29.98 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.673 1.582 . . . . 64.400000000000006 112.14 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.471 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 7.4 m -59.04 -40.29 84.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 71.430000000000007 110.75 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.45 ' HB2' ' H ' ' A' ' 15' ' ' ALA . 11.4 t70 -85.42 88.04 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.232 0.539 . . . . 73.299999999999997 109.595 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.458 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 12.4 t-20 -121.09 -166.07 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.35 -0.841 . . . . 72.549999999999997 109.329 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.458 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . -125.9 -75.82 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.75 -0.54 . . . . 43.049999999999997 111.75 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.409 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 17.8 Cg_endo -58.43 -24.59 69.62 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.098 2.532 . . . . 72.349999999999994 113.036 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.67 HD13 ' HE ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -57.21 -30.46 64.58 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.767 0.317 . . . . 74.230000000000004 111.379 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -72.79 -45.55 57.93 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.094 0.473 . . . . 73.420000000000002 110.116 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -48.43 77.18 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.218 -0.901 . . . . 73.049999999999997 110.814 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.56 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 10.9 pt-20 -65.81 -36.65 84.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.233 -0.439 . . . . 75.310000000000002 110.883 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.75 -50.57 73.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.881 0.372 . . . . 65.239999999999995 110.163 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -45.75 84.09 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.021 -0.536 . . . . 74.430000000000007 110.595 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -67.67 -50.48 57.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 74.25 111.128 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.56 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 1.7 t80 -59.93 -42.37 93.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 74.420000000000002 110.837 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 6.7 tp60 -72.65 -34.26 67.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 74.519999999999996 111.198 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.454 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -75.7 -21.27 57.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.702 0.287 . . . . 74.319999999999993 111.361 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.01 15.72 24.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.084 0.469 . . . . 51.539999999999999 111.165 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -91.62 -175.75 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.621 . . . . 70.019999999999996 111.897 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.93 92.13 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.021 -0.99 . . . . 74.439999999999998 110.755 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.19 -29.14 55.13 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.844 2.363 . . . . 71.239999999999995 111.884 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -62.33 -54.75 35.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.706 -0.679 . . . . 73.299999999999997 110.285 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.26 -43.83 95.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.627 -0.715 . . . . 64.319999999999993 110.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG23 HD23 ' A' ' 108' ' ' LEU . 81.4 mt -56.96 -54.34 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.691 -0.686 . . . . 73.519999999999996 110.66 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -58.23 -38.64 77.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 74.5 110.504 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -60.08 -58.92 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 72.310000000000002 111.503 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -34.9 67.54 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.077 -0.649 . . . . 72.530000000000001 111.005 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.408 HD11 HD22 ' A' ' 108' ' ' LEU . 33.5 mm -59.63 -43.64 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 74.109999999999999 110.783 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -78.11 -41.06 36.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.503 -0.317 . . . . 75.420000000000002 111.51 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 m -75.83 -35.78 59.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.106 0.41 . . . . 71.400000000000006 112.106 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -94.92 -5.79 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.763 -0.199 . . . . 74.120000000000005 111.04 -174.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 73.06 84.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.905 0.753 . . . . 74.329999999999998 111.853 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.452 HD23 ' HB2' ' A' ' 163' ' ' ASP . 5.6 mp -137.18 -176.58 4.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.436 -0.802 . . . . 73.310000000000002 109.173 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.621 ' HD2' ' HD1' ' A' ' 107' ' ' TYR . 1.3 tmtm? -96.57 -72.03 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.189 -0.671 . . . . 71.140000000000001 109.189 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.621 ' HD1' ' HD2' ' A' ' 106' ' ' LYS . 35.1 p90 175.53 123.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.389 -0.597 . . . . 73.140000000000001 109.389 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.63 ' H ' HD21 ' A' ' 108' ' ' LEU . 2.6 pt? -78.22 135.96 37.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.69 -0.404 . . . . 73.340000000000003 110.128 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.52 67.94 2.78 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.989 -0.55 . . . . 74.510000000000005 113.098 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.37 128.83 25.81 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.766 0.317 . . . . 73.150000000000006 110.163 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.559 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.2 Cg_endo -55.71 144.89 74.08 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.906 2.404 . . . . 65.129999999999995 113.229 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.879 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 23.5 tptm -62.52 132.33 52.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.388 -0.824 . . . . 73.519999999999996 111.39 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.609 . . . . 74.420000000000002 110.646 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.406 ' CD1' HG21 ' A' ' 130' ' ' ILE . 71.4 m95 -116.63 -71.95 0.71 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 65.209999999999994 109.581 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.63 -178.07 25.15 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.252 -0.885 . . . . 74.129999999999995 111.733 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 32' ' ' MET . 48.5 p -166.64 167.91 14.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.213 -0.662 . . . . 74.409999999999997 109.213 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.51 -147.44 16.29 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.847 -1.168 . . . . 74.120000000000005 112.88 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.403 ' C ' HD21 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.09 147.87 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.042 0.449 . . . . 72.400000000000006 110.759 -176.306 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.419 ' CG ' HG21 ' A' ' 29' ' ' ILE . 44.0 t-80 -123.7 115.76 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 62.340000000000003 109.112 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.819 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 9.3 t70 -83.98 136.81 33.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.189 -0.46 . . . . 74.549999999999997 109.931 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.415 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 6.1 ptmm? -87.96 20.0 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.598 0.237 . . . . 74.310000000000002 110.376 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 66.99 75.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.881 -0.785 . . . . 72.150000000000006 108.881 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.42 -24.21 3.08 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.157 -0.929 . . . . 54.329999999999998 112.079 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.705 ' HE2' ' HB2' ' A' ' 17' ' ' ARG . 18.6 ttpp -168.17 136.99 2.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.928 -0.397 . . . . 72.25 109.928 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.819 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 9.2 m -84.09 155.44 22.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.257 0.551 . . . . 73.329999999999998 112.002 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.54 155.34 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.339 -0.846 . . . . 75.340000000000003 108.745 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.67 ' HE ' HD13 ' A' ' 80' ' ' LEU . 32.7 ttt180 -114.83 128.0 56.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.426 0.155 . . . . 73.409999999999997 110.803 -171.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -137.9 163.12 32.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.231 0.539 . . . . 74.409999999999997 112.005 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.787 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 37.0 ttm -145.11 141.29 28.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.501 -0.772 . . . . 71.549999999999997 110.03 176.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.613 HG12 ' HB ' ' A' ' 70' ' ' VAL . 47.4 mt -100.79 134.62 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 72.030000000000001 111.42 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 12.3 ptm -129.68 175.65 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 71.239999999999995 109.535 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.879 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 5.0 t70 -72.44 174.54 7.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.807 -0.442 . . . . 75.140000000000001 109.807 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.578 ' HE ' ' HE1' ' A' ' 187' ' ' TYR . 9.7 ttp180 -86.77 93.11 9.18 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.17 0.986 . . . . 74.420000000000002 110.99 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.596 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 47.0 m-85 -103.06 170.55 7.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.822 -1.081 . . . . 72.530000000000001 109.322 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.11 -46.1 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.5 -0.857 . . . . 75.519999999999996 111.946 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.412 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 19.6 m -95.33 125.72 40.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.927 -0.397 . . . . 73.310000000000002 109.927 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 p30 -116.8 174.41 6.1 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.031 -0.359 . . . . 72.219999999999999 110.031 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 11.2 mp -74.5 -20.14 60.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 73.219999999999999 111.397 -176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -74.35 -37.27 63.57 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.908 -0.404 . . . . 72.049999999999997 109.908 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.412 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 55.7 mttp -57.7 -51.44 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.816 -0.629 . . . . 71.230000000000004 110.654 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.506 HG22 HD12 ' A' ' 341' ' ' LEU . 2.0 mp -68.14 -34.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.327 -0.397 . . . . 73.430000000000007 110.263 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.577 ' HE2' HE22 ' A' ' 253' ' ' GLN . 48.1 t80 -52.7 -52.94 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 74.510000000000005 110.841 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -80.64 -41.57 23.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.903 -0.59 . . . . 75.099999999999994 111.83 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.32 70.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.272 0.471 . . . . 73.329999999999998 112.272 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.843 ' HB2' HG11 ' A' ' 344' ' ' VAL . 2.1 t-20 -105.51 0.08 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 71.030000000000001 110.536 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.74 46.46 25.82 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.322 -0.854 . . . . 63.240000000000002 112.018 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.536 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 33.2 mttt 71.56 100.07 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.604 -0.726 . . . . 75.409999999999997 112.577 175.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.56 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . 7.2 mmt180 -150.33 72.78 1.12 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 73.540000000000006 109.882 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.89 118.88 37.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.874 -0.603 . . . . 74.140000000000001 109.862 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -70.85 149.93 46.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.374 -0.375 . . . . 72.329999999999998 110.08 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.593 ' HD3' HD22 ' A' ' 294' ' ' ASN . 11.3 ttp180 -61.16 -31.44 71.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.329 -0.396 . . . . 74.5 111.348 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -59.86 -48.37 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.184 0.516 . . . . 74.230000000000004 109.922 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.498 HG23 HD22 ' A' ' 339' ' ' LEU . 90.2 m -61.93 -48.67 79.39 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.336 -0.847 . . . . 74.409999999999997 110.521 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.2 t -55.87 -47.71 79.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.085 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.539 HD23 ' HB3' ' A' ' 324' ' ' LEU . 0.3 OUTLIER -62.69 -48.63 78.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 73.409999999999997 110.581 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.576 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 22.6 mm-40 -62.46 -41.32 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.119 -0.232 . . . . 74.5 111.212 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.411 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.6 mp -59.98 -47.48 85.63 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.101 0.25 . . . . 72.230000000000004 110.619 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.5 t -59.65 -43.97 93.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 62.409999999999997 110.561 176.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.463 ' HA ' HD13 ' A' ' 162' ' ' LEU . 24.5 tp -63.98 -35.63 81.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.05 -0.523 . . . . 73.299999999999997 110.879 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.667 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -61.14 -45.03 96.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.332 0.586 . . . . 73.310000000000002 109.761 175.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.48 ' HA ' HG22 ' A' ' 164' ' ' ILE . 49.5 mm -66.22 -35.11 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.225 -0.898 . . . . 75.230000000000004 110.126 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 159' ' ' LEU . 50.5 mt -56.92 -54.78 42.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.219 0.451 . . . . 74.030000000000001 112.219 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.452 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.9 p30 -76.25 -35.05 59.15 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.522 -0.871 . . . . 63.450000000000003 112.201 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.48 HG22 ' HA ' ' A' ' 161' ' ' ILE . 13.4 tt -67.02 -37.02 78.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.034 -0.666 . . . . 65.109999999999999 110.32 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 47.5 tp -69.59 -36.86 76.63 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 116.317 -0.401 . . . . 73.439999999999998 110.356 -179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -57.06 -52.52 64.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.602 -0.518 . . . . 74.239999999999995 109.602 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -58.47 -40.41 82.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.361 -0.836 . . . . 75.120000000000005 112.43 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 29.3 pt -92.47 -32.64 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.006 0.743 . . . . 75.150000000000006 113.006 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -73.87 -29.71 62.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.04 -0.356 . . . . 75.519999999999996 110.04 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.402 ' CD ' ' HZ1' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -62.65 -27.46 69.24 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.945 -0.571 . . . . 73.239999999999995 110.084 174.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.48 ' HE1' ' HB2' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -102.24 -67.61 0.86 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.49 -0.777 . . . . 73.409999999999997 112.649 -169.632 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -148.35 -68.39 0.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.291 0.849 . . . . 75.340000000000003 113.291 -166.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.11 146.64 25.32 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.321 0.86 . . . . 73.530000000000001 113.321 -166.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 202' ' ' TYR . 15.0 m -120.86 149.65 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.716 -1.216 . . . . 72.519999999999996 107.716 164.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.503 ' CE1' HD13 ' A' ' 178' ' ' ILE . 23.6 p80 -74.67 -29.42 61.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.618 -0.433 . . . . 72.329999999999998 111.669 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.562 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 75.45 -59.77 2.84 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.932 -0.652 . . . . 75.5 113.168 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.782 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 9.8 t70 -104.9 131.61 52.17 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 72.109999999999999 109.911 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.558 ' HB ' HG22 ' A' ' 246' ' ' ILE . 7.8 tp -114.69 14.43 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.942 0.349 . . . . 73.409999999999997 111.942 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.509 ' HD2' ' HE2' ' A' ' 227' ' ' PHE . 50.5 tptt -57.34 152.27 14.54 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.23 -0.294 . . . . 74.439999999999998 110.586 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.19 -14.8 11.87 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.081 0.4 . . . . 75.109999999999999 112.081 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 p -76.99 -15.11 59.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.942 0.401 . . . . 64.0 110.705 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.54 HD22 HD23 ' A' ' 200' ' ' LEU . 3.0 m-20 -90.35 -12.08 38.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.048 -0.524 . . . . 75.340000000000003 111.104 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.74 131.5 56.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.099 0.476 . . . . 72.530000000000001 110.235 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -127.53 157.16 40.88 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.571 -0.74 . . . . 73.120000000000005 110.378 179.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.539 HD12 HD23 ' A' ' 341' ' ' LEU . 48.9 mt -106.16 149.07 27.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.864 -0.607 . . . . 75.519999999999996 109.72 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.596 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 24.0 t-20 -64.07 121.4 14.07 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.131 -1.433 . . . . 72.540000000000006 107.131 168.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.578 ' HE1' ' HE ' ' A' ' 133' ' ' ARG . 1.7 p90 -70.27 -15.78 62.94 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.3 -0.96 . . . . 73.510000000000005 110.582 -167.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -88.16 -28.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.962 -0.563 . . . . 74.349999999999994 110.448 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.547 ' HB3' ' OD1' ' A' ' 191' ' ' ASP . 45.2 m-80 -136.2 109.59 9.76 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-O 120.809 0.337 . . . . 72.129999999999995 111.211 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 13.6 Cg_exo -69.63 -7.73 21.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.263 2.642 . . . . 75.439999999999998 112.95 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 338' ' ' LYS . 9.9 p-10 -85.95 -7.65 58.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 73.340000000000003 110.268 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.647 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 80.6 mt-30 -101.23 91.95 4.74 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.586 -0.734 . . . . 74.519999999999996 110.029 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.96 122.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.832 -0.622 . . . . 63.130000000000003 110.024 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 64.8 m-85 -128.39 151.77 48.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.935 -0.575 . . . . 70.109999999999999 110.292 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.526 HD22 ' N ' ' A' ' 196' ' ' VAL . 3.3 tt -84.87 150.51 24.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.218 -1.401 . . . . 73.140000000000001 107.218 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.526 ' N ' HD22 ' A' ' 195' ' ' LEU . 31.6 m -56.78 178.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.772 0.32 . . . . 73.129999999999995 111.618 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.7 11.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.121 0.786 . . . . 75.140000000000001 113.121 -174.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.522 ' H ' ' C ' ' A' ' 196' ' ' VAL . 6.1 m-85 61.5 43.7 10.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.774 0.797 . . . . 75.030000000000001 110.981 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.507 ' O ' HG22 ' A' ' 354' ' ' ILE . . . -68.96 -10.73 62.12 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.685 -1.366 . . . . 64.129999999999995 109.685 166.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.555 HD21 ' HB2' ' A' ' 352' ' ' LYS . 5.7 mp -113.56 104.89 12.71 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.072 -1.084 . . . . 74.230000000000004 108.072 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.803 ' H ' HG23 ' A' ' 354' ' ' ILE . . . -163.24 107.55 1.06 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.795 -0.638 . . . . 42.329999999999998 110.745 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.523 ' O ' HG22 ' A' ' 174' ' ' VAL . 55.1 t80 -99.4 126.0 45.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.841 -0.8 . . . . 75.510000000000005 108.841 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.543 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 14.8 ptm180 -81.97 123.84 29.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 70.400000000000006 110.79 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.492 ' HD1' ' HB1' ' A' ' 237' ' ' ALA . 18.4 t80 -84.36 -18.4 36.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.671 . . . . 72.010000000000005 109.952 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 55.5 m -118.24 85.77 25.57 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.934 -0.575 . . . . 71.530000000000001 110.91 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.464 ' HD2' ' O ' ' A' ' 209' ' ' VAL . 13.1 Cg_exo -70.5 103.69 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.607 2.204 . . . . 74.200000000000003 111.124 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.543 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 28.8 tt0 70.11 -1.28 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.991 -0.549 . . . . 74.239999999999995 111.031 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.32 -12.25 10.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.238 -0.506 . . . . 71.230000000000004 111.864 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.464 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 49.6 t -69.46 132.63 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 75.409999999999997 111.241 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -105.97 110.13 22.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.173 -0.677 . . . . 74.329999999999998 109.173 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.436 ' HA ' ' HD2' ' A' ' 211' ' ' LYS . 17.2 mmmt -103.76 152.75 21.48 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.155 0.798 . . . . 73.25 113.155 -170.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.33 -166.36 1.57 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.496 -1.229 . . . . 74.340000000000003 109.514 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.597 ' HA ' HG22 ' A' ' 236' ' ' VAL . 21.6 p90 -76.48 152.15 36.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 74.329999999999998 111.603 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' A' ' 215' ' ' GLU . 21.6 ttmm -140.92 -53.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 75.239999999999995 110.994 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 214' ' ' LYS . 41.9 tt0 72.54 111.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.861 0.726 . . . . 72.319999999999993 110.491 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -91.12 134.65 29.61 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 73.439999999999998 110.505 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.28 -23.43 74.26 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.149 2.566 . . . . 62.039999999999999 113.173 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -101.32 3.05 40.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.68 0.276 . . . . 75.400000000000006 110.862 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 53.23 81.63 0.09 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.53 -0.759 . . . . 74.319999999999993 111.998 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.418 ' O ' HG22 ' A' ' 355' ' ' THR . 80.1 m -80.24 67.51 6.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.406 0.622 . . . . 70.120000000000005 111.292 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.64 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 17.8 p80 -79.33 140.89 37.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.409 -0.814 . . . . 75.200000000000003 109.744 171.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.94 -53.04 5.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.117 0.484 . . . . 71.230000000000004 110.068 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.782 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -103.61 -158.2 24.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.68 -0.772 . . . . 73.439999999999998 112.431 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 38.7 p -79.07 144.21 34.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.775 -0.25 . . . . 75.25 110.486 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.436 HD12 HG23 ' A' ' 271' ' ' VAL . 15.7 tt -55.1 -24.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.324 0.583 . . . . 74.409999999999997 111.177 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.477 ' CD ' ' HZ2' ' A' ' 179' ' ' LYS . 39.1 tt0 -55.42 -61.96 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.17 -0.923 . . . . 65.209999999999994 111.489 175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.774 ' HZ ' ' HG3' ' A' ' 253' ' ' GLN . 10.7 m-85 -103.95 -22.37 13.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.902 0.705 . . . . 74.25 112.902 -173.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.0 OUTLIER -70.05 -7.34 40.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.997 0.427 . . . . 74.340000000000003 110.462 -178.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 25.7 t 68.58 175.91 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.347 -0.842 . . . . 74.340000000000003 111.082 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.484 HD11 ' NH1' ' A' ' 279' ' ' ARG . 4.9 pt -71.42 -32.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 72.239999999999995 110.229 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.595 ' HB3' ' HB3' ' A' ' 238' ' ' PRO . 2.2 m-20 -46.43 -69.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.269 -0.878 . . . . 73.219999999999999 111.188 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 221' ' ' HIS . . . -68.83 -29.04 67.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 73.409999999999997 111.2 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.64 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 26.6 t-80 -55.17 -41.91 72.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.831 0.348 . . . . 75.510000000000005 110.915 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -79.56 0.94 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 75.109999999999999 111.486 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 72.33 32.8 62.14 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 120.965 -0.636 . . . . 71.409999999999997 112.687 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.597 HG22 ' HA ' ' A' ' 213' ' ' TYR . 3.4 p -120.95 140.94 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.281 -0.266 . . . . 74.019999999999996 110.281 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.492 ' HB1' ' HD1' ' A' ' 204' ' ' TYR . . . -54.76 110.64 2.28 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 109.008 -0.738 . . . . 62.109999999999999 109.008 170.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.595 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . 23.6 Cg_exo -62.82 -91.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.862 2.375 . . . . 53.229999999999997 113.866 -167.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.452 ' H ' ' HB2' ' A' ' 238' ' ' PRO . 55.7 p 173.11 -158.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.645 -0.502 . . . . 74.209999999999994 109.645 -172.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.426 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 4.0 mpt_? -85.52 -45.76 11.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.878 -1.156 . . . . 73.150000000000006 107.878 168.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.58 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 19.1 ttt-85 -62.33 -39.55 93.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.032 -1.44 . . . . 74.409999999999997 111.686 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.542 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.9 -57.32 12.97 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.976 -0.556 . . . . 64.420000000000002 112.765 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.564 ' HA ' HD11 ' A' ' 246' ' ' ILE . 11.6 t70 -67.05 -32.52 73.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 65.5 110.482 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.463 HD12 ' HB3' ' A' ' 315' ' ' PRO . 77.9 mt -63.57 -39.71 95.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.48 -0.327 . . . . 74.430000000000007 111.27 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.09 -34.98 78.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.256 0.55 . . . . 73.200000000000003 109.805 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.564 HD11 ' HA ' ' A' ' 243' ' ' ASP . 70.0 mt -60.64 -42.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 74.310000000000002 110.447 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.538 HD11 ' SG ' ' A' ' 250' ' ' CYS . 39.0 tp -66.58 -38.06 86.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.045 -0.525 . . . . 71.530000000000001 109.966 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.41 96.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 72.519999999999996 111.38 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.541 ' HB2' ' O ' ' A' ' 246' ' ' ILE . 14.1 m-30 -51.19 -58.84 5.09 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 122.603 0.361 . . . . 74.510000000000005 111.403 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.538 ' SG ' HD11 ' A' ' 247' ' ' LEU . 30.1 p -61.45 -37.35 83.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.821 -0.351 . . . . 72.120000000000005 111.662 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 64.9 mtm -60.86 -50.93 71.46 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.779 -0.368 . . . . 62.409999999999997 111.416 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.437 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.5 tt -70.06 -31.58 48.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.682 -0.407 . . . . 73.519999999999996 110.424 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.774 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 24.0 tm0? -64.98 -51.79 59.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.56 -0.291 . . . . 64.319999999999993 110.573 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -63.3 -40.45 97.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.318 . . . . 74.549999999999997 111.565 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.491 ' HG ' ' HE2' ' A' ' 290' ' ' PHE . 33.9 tp -77.86 -30.95 51.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.629 0.603 . . . . 75.340000000000003 112.629 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 60.6 p -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.412 -0.515 . . . . 64.310000000000002 110.867 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.536 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 83.96 7.41 85.58 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.843 -0.694 . . . . 64.510000000000005 113.109 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.07 143.82 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.973 0.887 . . . . 74.319999999999993 112.49 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 89.5 mt -129.48 139.39 35.54 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.332 -0.849 . . . . 61.119999999999997 108.798 168.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.54 -37.23 97.84 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.339 2.026 . . . . 73.129999999999995 112.162 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.539 ' HB2' HG12 ' A' ' 271' ' ' VAL . 34.4 p90 -92.5 11.32 26.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.957 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.586 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 36.8 tt0 -86.46 -39.41 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 73.439999999999998 110.504 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -84.15 -24.52 30.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.459 0.647 . . . . 73.420000000000002 109.339 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.68 22.63 15.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.111 -0.95 . . . . 71.239999999999995 111.189 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.682 ' HA ' ' CG1' ' A' ' 271' ' ' VAL . 3.4 pp -70.78 -13.99 62.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.541 0.686 . . . . 72.450000000000003 110.302 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.474 ' N ' HD11 ' A' ' 265' ' ' LEU . 19.9 ptmt -79.01 2.97 18.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.786 -1.097 . . . . 75.25 110.796 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 15.0 t70 -135.01 127.6 18.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 74.409999999999997 110.441 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 22.4 Cg_exo -65.71 -29.58 51.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.025 2.483 . . . . 73.400000000000006 113.558 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -79.07 -38.08 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.667 -0.413 . . . . 74.0 110.609 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.417 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 28.8 m-85 -69.29 -49.74 53.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.438 -0.346 . . . . 71.430000000000007 111.209 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.682 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 22.3 m -54.7 -40.4 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 120.491 -0.484 . . . . 73.450000000000003 111.12 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 276' ' ' ILE . 42.0 ttt85 -62.07 -55.79 25.44 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.58 0.229 . . . . 74.430000000000007 111.12 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.436 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 24.2 t70 -61.23 -46.33 90.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.310000000000002 111.353 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.433 ' HB3' ' HE3' ' A' ' 261' ' ' TRP . 69.3 m -60.64 -39.4 88.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 73.010000000000005 111.175 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 67.6 mttm -64.71 -40.2 94.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 74.519999999999996 110.362 176.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 272' ' ' ARG . 81.5 mt -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.049999999999997 110.027 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 277' ' ' ARG . 14.7 mmp_? -56.83 -48.53 77.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 73.450000000000003 110.985 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -67.21 -44.47 79.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 70.129999999999995 111.845 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.484 ' NH1' HD11 ' A' ' 230' ' ' ILE . 89.2 mtt180 -65.11 -42.1 94.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.906 0.384 . . . . 75.219999999999999 110.922 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.23 -57.72 8.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 72.540000000000006 111.19 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.62 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 61.6 t30 -115.36 59.03 0.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 73.109999999999999 110.904 -171.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.567 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -51.7 -51.45 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.671 0.619 . . . . 74.439999999999998 112.671 -176.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.567 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.93 -47.88 83.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.106 0.41 . . . . 72.310000000000002 112.106 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.62 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 5.1 m -77.69 -28.46 51.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.38 -0.373 . . . . 70.019999999999996 111.02 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.421 HD21 ' HB3' ' A' ' 281' ' ' ASN . 2.7 mm? -68.76 -54.74 14.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.998 -0.281 . . . . 73.540000000000006 110.529 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.07 -41.26 92.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 74.0 110.976 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.28 -51.61 68.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.841 -0.618 . . . . 71.409999999999997 111.423 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -91.19 3.54 54.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.244 0.461 . . . . 75.019999999999996 112.244 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.56 -23.64 42.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.604 -0.517 . . . . 73.219999999999999 109.604 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.491 ' HE2' ' HG ' ' A' ' 255' ' ' LEU . 0.4 OUTLIER -133.64 73.85 71.58 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.295 -0.412 . . . . 72.310000000000002 110.98 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.48 32.49 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.724 2.283 . . . . 75.430000000000007 111.106 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 171.2 8.14 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.214 -0.903 . . . . 70.439999999999998 109.259 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -73.24 86.27 1.43 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.561 0.696 . . . . 74.420000000000002 111.82 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.593 HD22 ' HD3' ' A' ' 151' ' ' ARG . 12.6 t30 -152.48 -89.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.537 -0.756 . . . . 75.219999999999999 110.047 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.69 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 0.9 OUTLIER 169.73 102.77 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 109.578 -0.527 . . . . 74.510000000000005 109.578 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -99.02 50.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.241 2.627 . . . . 73.319999999999993 112.228 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -117.14 -46.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.208 -0.996 . . . . 43.25 113.529 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.558 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 2.6 mp0 -58.2 -56.56 20.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 74.420000000000002 111.03 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 252' ' ' ILE . 3.7 mp -63.1 -33.94 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.866 -0.607 . . . . 73.219999999999999 110.407 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.42 -53.93 50.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 72.150000000000006 110.922 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.5 -27.83 63.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.096 -0.502 . . . . 72.409999999999997 111.158 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.495 ' HH ' HD23 ' A' ' 247' ' ' LEU . 33.6 t80 -62.1 -53.11 60.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.942 0.401 . . . . 71.540000000000006 110.282 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.549 ' HA ' HG22 ' A' ' 306' ' ' VAL . 70.1 mtp -72.61 -31.89 65.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 72.400000000000006 110.914 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.493 ' HA ' HG13 ' A' ' 282' ' ' ILE . 36.9 tt0 -60.85 -46.84 88.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.57 . . . . 75.299999999999997 109.572 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.64 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 29.0 m -57.09 -52.97 63.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.118 -0.946 . . . . 74.409999999999997 111.212 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 303' ' ' MET . 24.9 m -63.34 -32.33 56.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 121.068 -0.253 . . . . 75.040000000000006 111.336 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.473 ' HA ' ' HE ' ' A' ' 241' ' ' ARG . 86.7 tttt -60.49 -48.09 83.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 73.219999999999999 110.187 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 47.4 tp -70.78 -19.69 62.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.684 . . . . 73.099999999999994 111.297 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.752 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 53.1 mt -72.81 -19.26 61.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.265 0.469 . . . . 72.510000000000005 112.265 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.58 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 21.6 t70 62.09 -179.86 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.918 0.389 . . . . 75.450000000000003 110.304 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -84.39 -23.39 30.11 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.782 -0.574 . . . . 63.439999999999998 110.065 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.5 m -95.88 -24.43 16.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.043 0.757 . . . . 73.239999999999995 113.043 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.752 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 5.2 mm-40 -87.28 -172.99 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.136 -0.626 . . . . 74.120000000000005 112.03 -169.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.611 ' HD2' ' H ' ' A' ' 314' ' ' LYS . 7.4 mptt -85.44 132.2 45.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 74.219999999999999 110.782 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.538 ' HA ' HD13 ' A' ' 309' ' ' LEU . 57.7 Cg_endo -74.08 118.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.097 1.864 . . . . 74.400000000000006 111.226 174.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.574 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.3 mt -87.54 77.32 8.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.319 -0.4 . . . . 73.239999999999995 111.36 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.21 -34.02 76.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.539 . . . . 74.129999999999995 110.423 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.21 -51.09 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.911 -0.586 . . . . 73.319999999999993 110.323 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -65.28 -42.29 93.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.497 -0.774 . . . . 73.099999999999994 110.664 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 90.5 mt -63.45 -43.14 98.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 72.209999999999994 110.67 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -56.44 -52.56 64.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 74.310000000000002 110.703 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.05 -44.72 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 74.400000000000006 111.769 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.0 -32.95 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.762 -0.375 . . . . 64.230000000000004 111.777 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.539 ' HB3' HD23 ' A' ' 155' ' ' LEU . 88.8 mt -69.47 -49.59 53.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.242 0.544 . . . . 74.299999999999997 110.406 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 325' ' ' LEU . 4.3 mm? -67.88 -26.83 66.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 73.129999999999995 110.697 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.22 -47.57 79.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.908 0.385 . . . . 73.400000000000006 110.264 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.7 96.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 63.409999999999997 112.0 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 333' ' ' SER . 3.9 mm? -73.4 -32.46 64.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 74.019999999999996 111.135 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.26 -24.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.916 0.388 . . . . 73.150000000000006 110.508 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.8 -24.46 65.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.019 -0.537 . . . . 74.120000000000005 111.267 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 49.1 pt -111.95 13.19 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.421 . . . . 73.409999999999997 110.588 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.22 25.08 75.35 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.867 -0.606 . . . . 71.409999999999997 113.033 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.462 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 37.5 m -120.51 145.49 47.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.313 0.578 . . . . 75.140000000000001 111.761 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.618 ' HZ2' ' HB3' ' A' ' 334' ' ' LYS . 10.3 mtpm? -140.27 -72.71 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.383 -0.826 . . . . 75.120000000000005 109.168 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.2 115.49 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.796 -1.093 . . . . 74.120000000000005 109.557 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -164.06 -69.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.399 -0.819 . . . . 74.519999999999996 109.146 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.16 87.34 1.19 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.918 -0.873 . . . . 53.549999999999997 110.918 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HD3' ' HB2' ' A' ' 191' ' ' ASP . 89.2 mttt -43.25 102.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.569 0.951 . . . . 73.409999999999997 113.569 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.498 HD22 HG23 ' A' ' 153' ' ' THR . 35.6 mt 62.44 -174.32 0.15 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.181 -0.918 . . . . 72.230000000000004 112.837 171.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.31 7.51 1.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.433 -0.803 . . . . 70.25 110.324 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.539 HD23 HD12 ' A' ' 185' ' ' LEU . 9.5 tp -78.44 -52.82 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 74.200000000000003 110.989 -170.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 50.1 m 58.86 23.7 11.63 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 74.549999999999997 112.725 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.5 m 38.77 83.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.874 0.87 . . . . 75.439999999999998 112.789 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.843 HG11 ' HB2' ' A' ' 145' ' ' ASN . 7.3 p -63.5 -55.86 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.63 -0.714 . . . . 73.030000000000001 111.465 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -149.56 -176.23 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.235 -0.283 . . . . 73.25 110.235 178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.96 176.46 5.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.221 -0.445 . . . . 73.340000000000003 110.564 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -168.21 -169.51 31.78 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.827 -0.909 . . . . 74.409999999999997 110.827 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -119.53 112.79 2.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.638 -0.792 . . . . 65.219999999999999 112.338 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -93.77 168.07 11.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.885 0.374 . . . . 75.219999999999999 110.801 -179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -125.36 130.97 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 73.549999999999997 109.867 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.488 ' HB2' ' HD1' ' A' ' 48' ' ' PHE . . . -88.71 163.02 15.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 74.310000000000002 111.022 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.555 ' HB2' HD21 ' A' ' 200' ' ' LEU . 40.8 mtmt -138.95 176.56 8.59 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.661 -0.496 . . . . 74.25 109.661 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.0 t -144.79 162.43 36.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.525 0.202 . . . . 74.349999999999994 111.092 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.803 HG23 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -66.39 143.64 15.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.966 -0.561 . . . . 64.329999999999998 111.638 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.418 HG22 ' O ' ' A' ' 220' ' ' CYS . 13.2 t -79.75 132.79 36.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.509 -0.768 . . . . 73.430000000000007 109.267 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -150.75 7.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 72.519999999999996 111.374 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 64.09 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.073 -0.512 . . . . 74.040000000000006 109.909 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -147.7 170.11 18.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.984 -0.376 . . . . 74.430000000000007 109.984 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -90.63 -177.15 4.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 111.315 -175.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.474 ' HB2' ' HE2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.064 -0.969 . . . . 75.450000000000003 110.766 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.871 -0.418 . . . . 74.420000000000002 109.871 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.97 136.67 23.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.302 2.002 . . . . 73.349999999999994 112.474 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.557 ' O ' ' HD2' ' A' ' 3' ' ' ARG . 6.2 ppt_? -177.51 104.65 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 74.299999999999997 109.586 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.6 t -120.35 120.22 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 64.120000000000005 110.547 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -126.15 100.32 6.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.164 0.507 . . . . 73.219999999999999 110.997 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 90.03 0.32 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.414 -0.812 . . . . 71.329999999999998 109.637 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.57 90.39 3.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 73.120000000000005 111.122 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -88.78 135.92 33.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 74.310000000000002 110.092 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.37 118.58 37.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.347 -0.388 . . . . 74.049999999999997 110.442 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.87 132.62 11.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.807 -0.711 . . . . 52.240000000000002 111.981 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.0 ttt180 -156.19 105.93 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.043 -0.355 . . . . 73.430000000000007 110.043 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -130.79 128.93 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.089 0.471 . . . . 74.25 110.444 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -106.41 121.58 44.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 75.109999999999999 110.55 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -157.38 133.85 9.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 72.140000000000001 110.174 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.34 146.75 18.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 73.439999999999998 110.998 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -129.92 156.38 44.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 73.450000000000003 109.979 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -134.88 115.29 13.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.343 -0.614 . . . . 71.019999999999996 109.343 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -119.06 118.06 30.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.023 0.44 . . . . 74.530000000000001 111.283 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.5 tp -175.19 112.84 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 73.200000000000003 109.906 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.75 98.8 1.81 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.231 -0.44 . . . . 74.109999999999999 110.053 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -111.48 131.87 54.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.052 0.453 . . . . 73.340000000000003 110.64 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -84.42 49.03 1.6 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 73.310000000000002 112.064 -173.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.31 -49.83 6.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.144 -0.687 . . . . 73.200000000000003 109.144 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.89 -72.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.799 -1.091 . . . . 70.209999999999994 108.446 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.85 126.32 26.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 74.140000000000001 109.802 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.72 1.72 56.34 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.601 -0.809 . . . . 73.409999999999997 113.482 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.96 153.46 30.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.585 0.692 . . . . 74.540000000000006 109.464 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.424 ' HA ' HD11 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.9 131.57 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.355 0.597 . . . . 73.400000000000006 111.01 -175.447 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.53 137.45 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.132 -0.94 . . . . 74.040000000000006 109.536 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.525 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.6 m -117.49 120.4 37.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.569 -0.287 . . . . 75.310000000000002 110.405 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.401 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.9 p-10 -91.04 -169.53 2.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.267 -0.424 . . . . 74.209999999999994 110.336 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.79 ' HA ' ' HE3' ' A' ' 32' ' ' MET . 11.2 mmt -72.2 -17.81 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.797 0.295 . . . . 72.319999999999993 111.797 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.95 9.49 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 72.109999999999999 110.979 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 69.4 17.73 8.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.71 -0.677 . . . . 74.329999999999998 111.497 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.766 ' HA ' ' HE2' ' A' ' 35' ' ' LYS . 10.3 mmpt? -83.7 127.17 33.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.62 -0.511 . . . . 75.540000000000006 109.62 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.01 92.38 4.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 73.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -116.05 172.18 7.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.389 -0.823 . . . . 72.129999999999995 111.164 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -98.47 145.93 26.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 73.040000000000006 110.322 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -95.41 103.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.617 -0.882 . . . . 74.439999999999998 108.617 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.94 -129.97 6.73 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.652 -0.785 . . . . 64.209999999999994 113.687 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.9 mp -69.84 131.11 89.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.94 0.4 . . . . 73.099999999999994 111.827 -172.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.76 124.0 11.4 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.883 2.388 . . . . 72.349999999999994 111.425 174.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 53' ' ' LEU . 59.3 mt -104.86 -66.33 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.047 0.451 . . . . 75.200000000000003 110.699 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 94.97 102.47 1.82 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.785 -0.721 . . . . 75.420000000000002 111.732 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 45.7 tp60 -86.55 165.71 16.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.344 -0.243 . . . . 75.019999999999996 110.344 -178.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.11 -29.46 68.76 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.12 -0.562 . . . . 64.219999999999999 113.776 -170.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 351' ' ' ALA . . . -71.16 -63.3 3.17 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 73.510000000000005 112.85 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.401 ' CE1' ' HG2' ' A' ' 79' ' ' PRO . 52.0 m-85 -116.95 -34.71 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.647 0.261 . . . . 74.340000000000003 111.583 -175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 -179.79 45.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.796 -0.716 . . . . 61.399999999999999 112.695 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 91.0 m 63.32 30.37 15.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.5 0.667 . . . . 75.420000000000002 111.136 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.481 HD11 ' HA ' ' A' ' 71' ' ' LYS . 34.6 mm -89.33 136.79 22.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.55 -0.75 . . . . 73.519999999999996 109.675 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -107.48 145.92 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.197 0.523 . . . . 74.030000000000001 111.113 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' HB2' HD11 ' A' ' 43' ' ' ILE . 64.1 tp -79.29 145.66 33.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.326 -0.852 . . . . 72.040000000000006 109.711 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.91 116.61 26.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.397 -0.594 . . . . 73.319999999999993 109.397 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -76.76 -50.88 12.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.183 -0.673 . . . . 71.519999999999996 109.183 -178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt 48.37 43.72 19.63 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.25 -0.886 . . . . 75.530000000000001 109.931 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -72.23 77.11 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.821 . . . . 74.219999999999999 110.447 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.4 m -126.78 -162.61 1.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.136 -0.938 . . . . 64.099999999999994 110.275 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.6 m -98.01 7.8 45.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.623 0.249 . . . . 64.140000000000001 111.617 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.02 49.3 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 74.340000000000003 110.899 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m 62.12 86.21 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.619 -0.719 . . . . 74.239999999999995 111.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.48 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.739 -0.664 . . . . 75.25 110.366 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.12 -123.91 3.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.53 -1.028 . . . . 75.019999999999996 110.53 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 16.9 m -84.28 61.94 6.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.744 -0.835 . . . . 70.150000000000006 108.744 170.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.652 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 5.5 m-20 72.65 -83.32 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.783 -1.098 . . . . 71.230000000000004 110.946 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.54 102.44 11.39 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.366 -0.834 . . . . 62.32 110.339 -178.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.652 ' HD3' ' O ' ' A' ' 65' ' ' ASP . 86.2 Cg_endo -95.94 11.07 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.855 2.37 . . . . 75.439999999999998 110.994 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.424 ' HB2' HG21 ' A' ' 130' ' ' ILE . 7.0 p -145.91 153.92 41.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.602 0.715 . . . . 72.439999999999998 112.905 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.448 HG11 ' HD2' ' A' ' 133' ' ' ARG . 15.3 m -136.89 153.82 30.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.035 -0.984 . . . . 75.129999999999995 109.098 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.551 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.9 p -122.42 122.64 66.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 111.646 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.493 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 22.6 ttpt -87.24 126.63 34.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.71 -0.677 . . . . 71.409999999999997 109.781 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.63 123.15 70.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 123.745 0.653 . . . . 74.439999999999998 110.009 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.471 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 41.7 mt-10 -140.69 152.51 66.13 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.356 -0.383 . . . . 75.319999999999993 110.344 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.51 126.0 20.05 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.591 2.194 . . . . 73.25 111.964 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -85.74 -15.97 40.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.128 0.49 . . . . 61.409999999999997 110.36 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.63 -20.08 43.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.863 -0.608 . . . . 73.109999999999999 110.78 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -172.07 96.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.216 -0.661 . . . . 73.409999999999997 109.216 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -163.78 145.62 10.65 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.032 -1.08 . . . . 63.210000000000001 113.224 -177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.471 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.0 Cg_exo -60.88 -19.59 62.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.98 3.12 . . . . 62.409999999999997 112.285 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.515 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.2 tm? -50.72 -30.05 12.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.855 -0.611 . . . . 74.019999999999996 110.741 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.72 -48.38 75.29 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.76 0.314 . . . . 71.530000000000001 110.828 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.6 m -67.63 -41.99 83.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 73.530000000000001 110.481 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -58.45 -42.52 87.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.744 . . . . 75.109999999999999 110.513 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.68 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 73.0 110.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.535 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 66.7 mmtt -63.55 -46.85 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.922 -0.311 . . . . 75.400000000000006 110.451 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.06 -39.95 95.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.040000000000006 110.048 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.556 ' O ' ' HB1' ' A' ' 91' ' ' ALA . 48.0 t80 -63.29 -34.4 77.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.407 -0.815 . . . . 73.430000000000007 110.662 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -77.51 -32.67 54.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.82 0.343 . . . . 74.310000000000002 111.345 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' HG3' ' HE2' ' A' ' 173' ' ' TYR . 39.5 mmt180 -78.73 -49.21 13.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.091 0.404 . . . . 74.319999999999993 112.091 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.83 -31.47 10.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.859 0.688 . . . . 73.420000000000002 112.859 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.556 ' HB1' ' O ' ' A' ' 87' ' ' TYR . . . -84.42 89.0 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.42 0.628 . . . . 72.340000000000003 111.324 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.522 ' HB3' ' HB3' ' A' ' 95' ' ' GLN . 8.9 tmtt? -154.04 91.98 3.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.525 -0.917 . . . . 73.319999999999993 108.525 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.588 ' HD3' ' HB3' ' A' ' 113' ' ' TYR . 95.6 Cg_exo -44.25 -52.56 5.62 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.952 3.101 . . . . 73.549999999999997 114.53 -170.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.7 -45.16 92.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 74.239999999999995 110.625 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.522 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 6.9 tp60 -66.27 -44.39 83.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.707 -0.678 . . . . 73.430000000000007 110.565 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 92' ' ' LYS . 68.4 mt -58.94 -53.75 43.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.977 -0.556 . . . . 72.200000000000003 110.574 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.54 -38.88 69.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.236 -0.438 . . . . 70.329999999999998 110.593 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -61.07 -62.3 1.95 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.773 -0.648 . . . . 74.349999999999994 111.371 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.801 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -71.3 -34.36 70.56 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.253 -0.579 . . . . 72.109999999999999 111.105 -173.476 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 17.0 mm -58.75 -50.68 78.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.312 0.101 . . . . 72.040000000000006 111.027 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -69.4 -36.85 77.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.657 -0.417 . . . . 64.329999999999998 110.806 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 72.099999999999994 110.782 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 7.8 ttt180 -83.38 0.97 43.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 72.040000000000006 110.374 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 26.0 mtpp 66.54 29.62 8.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.358 -0.837 . . . . 72.329999999999998 111.532 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.477 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 89.1 mt -92.34 176.7 6.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.72 -0.673 . . . . 71.140000000000001 109.942 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.77 ' HA ' ' HE2' ' A' ' 106' ' ' LYS . 10.8 mmpt? -103.37 -55.01 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.595 -0.275 . . . . 74.450000000000003 111.051 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -157.51 171.18 20.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 72.230000000000004 110.109 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.801 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 39.3 tp -129.32 137.57 51.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.995 -0.372 . . . . 73.209999999999994 109.995 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.86 64.21 3.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.155 -0.545 . . . . 73.540000000000006 113.253 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 135.8 27.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 110.065 -0.346 . . . . 70.25 110.065 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.07 135.07 30.11 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.039 2.492 . . . . 65.209999999999994 112.509 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.835 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 24.2 tptm -66.75 124.06 21.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 74.409999999999997 111.001 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.588 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 14.0 t80 -81.27 112.56 18.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.67 -0.695 . . . . 75.129999999999995 111.022 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.5 ' HB2' HG22 ' A' ' 130' ' ' ILE . 68.9 m95 -105.42 -52.51 2.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.624 -0.88 . . . . 73.129999999999995 108.624 169.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.44 46.91 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.008 -0.996 . . . . 74.099999999999994 111.759 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 p -168.74 162.84 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.625 -0.509 . . . . 73.019999999999996 109.625 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.67 -179.44 46.18 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.754 -1.212 . . . . 70.310000000000002 113.207 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.496 HD21 ' N ' ' A' ' 119' ' ' HIS . 5.9 tt -123.88 137.74 54.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.688 -0.856 . . . . 75.349999999999994 108.688 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.496 ' N ' HD21 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -134.84 147.7 49.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 73.439999999999998 110.822 178.76 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.97 140.96 37.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.389 -0.823 . . . . 74.120000000000005 110.175 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.455 ' HB2' ' CE1' ' A' ' 126' ' ' TYR . 43.4 tttm -108.66 17.64 21.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.638 -0.255 . . . . 74.299999999999997 110.501 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.421 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 56.8 m-80 71.27 97.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.309 0.644 . . . . 71.530000000000001 110.207 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.05 -44.81 1.4 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.807 -0.711 . . . . 65.340000000000003 112.012 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -129.69 138.25 51.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.831 -0.433 . . . . 74.299999999999997 109.831 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.0 m -101.53 140.57 35.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 75.409999999999997 110.349 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.455 ' CE1' ' HB2' ' A' ' 121' ' ' LYS . 35.5 p90 -128.3 149.94 50.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.182 0.515 . . . . 75.319999999999993 110.155 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -117.57 142.42 47.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.027 -0.731 . . . . 74.099999999999994 109.027 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.6 p90 -137.93 153.07 49.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.989 0.423 . . . . 72.040000000000006 111.291 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.47 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 20.0 ptp -139.75 139.42 36.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.982 -0.554 . . . . 74.450000000000003 110.576 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.551 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 5.0 mm -98.17 118.69 45.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.859 -0.61 . . . . 73.310000000000002 110.065 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.419 ' SD ' HG21 ' A' ' 196' ' ' VAL . 25.1 ptt? -123.2 171.1 9.6 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.13 -0.693 . . . . 73.519999999999996 109.13 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.835 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t70 -65.2 162.15 17.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 74.510000000000005 110.442 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.448 ' HD2' HG11 ' A' ' 69' ' ' VAL . 1.7 tpt180 -76.57 112.79 13.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.44 0.638 . . . . 72.109999999999999 110.862 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.11 143.08 33.06 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.942 -0.762 . . . . 75.120000000000005 108.942 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -136.92 -2.15 2.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.291 -0.957 . . . . 65.400000000000006 112.233 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 1.07 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.8 m -121.83 125.27 46.1 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.845 -0.209 . . . . 72.450000000000003 110.512 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.444 ' HA ' HD13 ' A' ' 184' ' ' LEU . 6.4 p-10 -116.35 139.67 50.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.434 -0.58 . . . . 72.019999999999996 109.434 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.841 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 5.6 tp -68.95 -15.34 63.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.718 -0.219 . . . . 72.109999999999999 110.928 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.623 ' HB3' HD11 ' A' ' 349' ' ' LEU . 41.6 mm-40 -62.3 -50.19 72.66 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.012 0.434 . . . . 62.210000000000001 110.963 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.833 ' HB2' ' HA3' ' A' ' 347' ' ' GLY . 4.4 tppp? -80.6 -23.24 39.96 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.497 -0.481 . . . . 75.129999999999995 109.841 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.841 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 27.6 mt -60.19 -51.26 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 111.794 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.665 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 5.5 p90 -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.386 -0.525 . . . . 75.319999999999993 110.228 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -80.99 -25.98 36.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.527 . . . . 73.510000000000005 110.705 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.0 0.428 . . . . 72.329999999999998 110.592 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -101.38 2.38 39.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 71.219999999999999 110.157 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 44.16 72.74 0.18 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.046 -0.979 . . . . 73.329999999999998 112.672 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.7 pttp 45.23 34.11 1.35 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.058 0.943 . . . . 74.530000000000001 112.951 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -138.87 92.68 2.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.061 0.458 . . . . 74.409999999999997 109.82 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.665 ' CZ ' ' HA ' ' A' ' 142' ' ' TYR . 55.6 m-85 -104.14 150.95 23.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.968 -0.56 . . . . 73.239999999999995 111.666 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -86.7 147.98 25.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.689 -0.687 . . . . 71.510000000000005 109.162 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -57.55 -29.08 64.09 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 112.736 0.643 . . . . 74.310000000000002 112.736 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.23 -53.64 55.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.861 0.362 . . . . 75.549999999999997 111.402 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.41 ' O ' HD12 ' A' ' 157' ' ' LEU . 3.9 m -64.32 -44.95 89.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 74.239999999999995 111.038 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.96 -40.05 85.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 74.209999999999994 110.94 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.706 ' HG ' HD21 ' A' ' 328' ' ' LEU . 1.7 mm? -63.29 -50.94 68.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 72.109999999999999 111.623 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.464 ' HB3' HD21 ' A' ' 339' ' ' LEU . 16.8 tt0 -61.88 -38.36 88.01 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.009 -0.676 . . . . 71.329999999999998 110.267 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 153' ' ' THR . 7.7 mp -59.96 -48.6 81.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 72.200000000000003 110.447 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -56.26 -47.52 78.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 72.409999999999997 110.491 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.785 ' HG ' ' HD2' ' A' ' 321' ' ' ARG . 9.1 mp -57.3 -52.42 65.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.882 -0.599 . . . . 73.219999999999999 111.266 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.438 ' O ' HG22 ' A' ' 164' ' ' ILE . 2.1 mpt_? -67.75 -33.68 75.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 74.310000000000002 111.379 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.575 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -63.62 -43.53 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.7 -0.481 . . . . 72.230000000000004 109.7 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.46 HD13 ' HB3' ' A' ' 321' ' ' ARG . 83.0 mt -63.01 -42.45 99.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.73 -0.214 . . . . 75.319999999999993 110.805 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.24 -60.53 3.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.362 0.601 . . . . 73.450000000000003 110.775 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.537 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 tt -71.83 -39.74 68.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 72.430000000000007 111.968 -174.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.8 mp -65.71 -36.89 84.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 117.759 0.254 . . . . 65.109999999999999 111.302 -177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.26 -48.72 74.68 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.182 -0.673 . . . . 74.430000000000007 109.182 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 79.5 t80 -57.48 -46.26 83.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.157 -0.929 . . . . 75.0 111.816 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 164' ' ' ILE . 34.1 pt -82.41 -32.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.466 0.543 . . . . 75.25 112.466 -174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -64.54 -43.62 93.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 110.011 -0.366 . . . . 73.340000000000003 110.011 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -82.95 14.66 3.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.714 0.769 . . . . 74.219999999999999 109.472 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.477 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 1.4 t-80 -136.69 40.95 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.467 -0.788 . . . . 64.400000000000006 109.842 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.501 ' HG2' ' O ' ' A' ' 205' ' ' CYS . 41.7 mt-10 85.4 -61.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.395 1.059 . . . . 72.120000000000005 113.557 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.624 ' HE2' ' HG3' ' A' ' 89' ' ' ARG . 13.0 m-85 -84.27 116.13 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.406 0.521 . . . . 73.439999999999998 112.406 -164.636 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.431 HG12 ' HB2' ' A' ' 238' ' ' PRO . 16.4 t -109.63 151.21 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.357 -0.609 . . . . 70.319999999999993 109.357 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -115.46 106.95 14.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 73.099999999999994 109.739 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.42 -25.86 55.95 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.551 -0.833 . . . . 71.140000000000001 111.828 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.519 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 7.1 t70 -98.38 101.73 13.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 75.329999999999998 110.24 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.71 31.95 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.961 0.886 . . . . 74.109999999999999 110.078 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 179' ' ' LYS . 3.4 ttmp? -62.96 149.62 44.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.166 -0.925 . . . . 73.010000000000005 110.699 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.62 -14.61 8.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.786 0.662 . . . . 63.509999999999998 112.786 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 m -73.48 -20.81 60.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.48 . . . . 75.510000000000005 110.847 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.628 ' ND2' HD21 ' A' ' 195' ' ' LEU . 2.1 t30 -82.32 -21.49 36.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.488 -0.778 . . . . 74.140000000000001 111.592 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.433 HD22 HG23 ' A' ' 193' ' ' VAL . 5.9 mp -101.85 119.67 39.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.985 0.422 . . . . 64.140000000000001 111.533 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 137' ' ' ASP . 3.9 mm? -121.47 145.68 47.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 72.5 110.159 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 1.07 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 52.6 mt -109.67 152.2 25.91 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 110.054 -0.35 . . . . 71.219999999999999 110.054 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.606 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 21.1 t-20 -72.64 147.91 45.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 72.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 -20.91 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 73.200000000000003 111.527 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -113.85 -9.84 13.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.972 0.415 . . . . 72.340000000000003 110.25 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -135.35 96.72 13.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 74.310000000000002 110.512 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.68 -18.75 15.01 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.968 2.445 . . . . 72.030000000000001 112.897 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.465 ' HB3' ' HA ' ' A' ' 338' ' ' LYS . 5.5 p-10 -86.88 5.33 37.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.08 0.466 . . . . 74.030000000000001 111.583 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -118.65 109.53 16.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.728 -0.471 . . . . 72.540000000000006 109.728 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.433 HG23 HD22 ' A' ' 183' ' ' LEU . 6.5 p -103.57 126.47 58.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.101 -0.499 . . . . 75.349999999999994 110.528 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.606 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 9.7 m-85 -114.03 156.34 24.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.711 -0.677 . . . . 74.219999999999999 109.462 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.628 HD21 ' ND2' ' A' ' 182' ' ' ASN . 21.3 mt -107.8 116.89 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.838 -0.431 . . . . 75.349999999999994 109.838 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.419 HG21 ' SD ' ' A' ' 131' ' ' MET . 9.2 p -159.96 159.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.79 -0.186 . . . . 74.319999999999993 111.027 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.4 t70 64.98 29.75 12.13 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.533 0.682 . . . . 74.430000000000007 110.74 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.651 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 18.9 p90 -100.06 -41.62 7.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 75.549999999999997 111.108 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.8 32.9 75.83 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.619 -0.801 . . . . 74.040000000000006 111.993 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.816 HD22 ' HB3' ' A' ' 352' ' ' LYS . 30.5 mt -131.2 90.31 2.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.249 0.547 . . . . 73.5 110.589 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.28 121.85 9.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 73.530000000000001 110.981 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.59 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 61.4 t80 -114.34 131.18 56.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.143 -0.688 . . . . 74.540000000000006 109.143 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.858 0.361 . . . . 74.319999999999993 111.524 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.499 ' HA ' ' HB3' ' A' ' 237' ' ' ALA . 31.8 t80 -80.81 -40.09 25.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 73.230000000000004 109.96 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.501 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 10.7 p -125.81 87.8 55.33 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 43.310000000000002 110.79 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 18.7 Cg_endo -59.42 113.84 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.624 2.216 . . . . 71.040000000000006 111.733 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 63.9 26.63 14.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.828 -0.624 . . . . 75.439999999999998 111.373 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.35 -19.8 52.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.749 -0.739 . . . . 64.120000000000005 113.123 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.52 114.15 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.091 -0.337 . . . . 74.409999999999997 110.091 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -100.38 157.07 16.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.825 -0.35 . . . . 72.450000000000003 110.272 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -115.44 -172.91 2.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.516 -0.55 . . . . 74.239999999999995 109.516 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.403 ' H ' ' CD ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -97.83 -164.27 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.198 0.311 . . . . 72.439999999999998 110.42 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -60.29 97.88 0.05 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.575 0.702 . . . . 75.430000000000007 111.088 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.427 ' N ' HG22 ' A' ' 236' ' ' VAL . 55.2 mtpt -67.42 -53.73 26.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.36 -0.836 . . . . 72.530000000000001 112.256 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 37.8 77.94 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.126 0.965 . . . . 72.430000000000007 110.359 -164.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.8 135.77 59.25 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.194 -1.366 . . . . 71.340000000000003 111.492 -168.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.36 -18.85 66.57 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 123.268 2.646 . . . . 63.530000000000001 113.656 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.682 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 1.1 tpmt? -86.16 -8.84 57.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.234 -0.654 . . . . 74.530000000000001 109.234 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? 57.46 62.02 2.29 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.442 -0.799 . . . . 74.150000000000006 110.22 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.01 55.22 0.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.465 -0.788 . . . . 71.340000000000003 112.39 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.545 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 51.9 p-80 -67.27 134.37 51.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.481 -0.781 . . . . 71.040000000000006 110.047 171.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 202' ' ' TYR . 16.2 p-10 -89.84 -39.63 12.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.087 -0.338 . . . . 71.409999999999997 110.087 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.519 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . -108.24 -169.41 21.32 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.822 -0.704 . . . . 64.519999999999996 113.743 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.562 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 0.7 OUTLIER -90.53 148.77 22.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.963 0.411 . . . . 70.310000000000002 110.902 -176.054 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.452 HG12 HG11 ' A' ' 271' ' ' VAL . 13.3 tt -63.64 -24.28 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 113.761 1.022 . . . . 72.349999999999994 113.761 -168.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.562 ' OE1' ' HB ' ' A' ' 224' ' ' THR . 0.0 OUTLIER -70.1 -41.43 74.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.288 -0.565 . . . . 73.150000000000006 110.878 -172.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.478 ' O ' HG12 ' A' ' 246' ' ' ILE . 29.4 m-85 -101.02 -39.94 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.268 -0.173 . . . . 72.010000000000005 111.454 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.582 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 94.0 m -60.29 -14.87 20.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.358 0.503 . . . . 74.530000000000001 112.358 -175.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 14.1 m 72.28 -167.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 65.420000000000002 111.053 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.5 mp -71.54 -34.42 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.764 -0.458 . . . . 71.540000000000006 109.764 178.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.625 ' O ' HG11 ' A' ' 236' ' ' VAL . 25.2 t70 -44.64 -91.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.479 -1.237 . . . . 70.319999999999993 113.279 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.582 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.75 -27.79 69.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.122 -0.361 . . . . 73.239999999999995 111.686 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.545 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 81.1 t60 -56.84 -37.27 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 73.510000000000005 111.246 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.68 0.5 52.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 71.299999999999997 111.49 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.77 8.16 62.3 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.462 -0.875 . . . . 52.039999999999999 113.352 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.625 HG11 ' O ' ' A' ' 231' ' ' ASP . 11.9 p -86.96 140.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.979 -0.749 . . . . 65.510000000000005 108.979 175.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 204' ' ' TYR . . . -68.0 117.19 46.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.471 -0.331 . . . . 72.140000000000001 110.131 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.555 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 6.6 Cg_endo -49.25 124.12 11.25 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.635 2.89 . . . . 74.450000000000003 112.983 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 t -143.09 93.38 2.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.25 -0.432 . . . . 73.129999999999995 111.297 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.536 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 59.6 mtt180 75.96 -57.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.604 -0.726 . . . . 73.230000000000004 112.052 170.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.724 ' HG3' ' HD1' ' A' ' 311' ' ' TYR . 11.4 mmm-85 -57.38 -54.69 43.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.422 0.153 . . . . 72.530000000000001 110.592 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.49 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.02 -58.55 9.32 Favored Glycine 0 N--CA 1.448 -0.56 0 O-C-N 123.794 0.684 . . . . 63.219999999999999 112.426 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.42 -47.99 47.57 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.11 0.481 . . . . 73.430000000000007 111.412 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 64.3 mt -71.78 -45.29 62.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.803 -0.635 . . . . 71.140000000000001 111.529 -175.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.96 -39.11 79.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.559 0.219 . . . . 73.299999999999997 111.061 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 242' ' ' GLY . 99.0 mt -59.63 -45.85 93.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.066 0.46 . . . . 74.329999999999998 110.288 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.523 HD12 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -65.06 -43.08 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 64.430000000000007 110.591 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.36 -42.84 95.85 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.923 -0.656 . . . . 73.200000000000003 112.504 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.522 ' CZ ' ' HD2' ' A' ' 275' ' ' LYS . 22.9 m-30 -66.33 -48.43 70.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.491 0.182 . . . . 75.340000000000003 111.491 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.454 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.4 p -66.8 -40.91 88.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.574 -0.451 . . . . 72.109999999999999 111.088 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.47 -45.6 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 72.219999999999999 110.896 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 70.299999999999997 110.346 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.466 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 48.9 tt0 -71.51 -41.61 69.04 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 121.097 -0.241 . . . . 75.430000000000007 110.458 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -66.73 -26.32 66.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 74.239999999999995 110.672 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.1 tp -81.18 -41.19 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.854 -0.612 . . . . 74.349999999999994 111.776 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.5 p -103.62 -27.26 12.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.391 0.515 . . . . 72.430000000000007 112.391 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.7 -59.52 0.36 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.724 -0.75 . . . . 75.219999999999999 113.048 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -121.76 144.02 49.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.848 0.356 . . . . 72.230000000000004 110.963 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 94.8 mt -105.7 145.12 30.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 75.519999999999996 110.715 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.62 -31.92 92.73 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.803 2.335 . . . . 61.340000000000003 112.291 178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.461 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 48.0 p90 -96.84 11.09 36.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.535 . . . . 74.420000000000002 110.41 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.726 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 30.5 tt0 -83.18 -42.06 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.162 0.506 . . . . 72.150000000000006 110.201 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -88.54 -12.11 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.051 -0.522 . . . . 63.530000000000001 109.829 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.17 10.1 25.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.748 -0.66 . . . . 75.439999999999998 111.907 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 3.7 pp -70.86 -7.31 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.178 0.513 . . . . 74.310000000000002 110.916 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.45 -13.07 60.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.429 -0.805 . . . . 75.329999999999998 110.794 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.486 ' CG ' ' HZ2' ' A' ' 269' ' ' LYS . 12.9 t70 -124.61 122.03 25.78 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 62.200000000000003 109.841 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 32.7 Cg_exo -62.69 -30.59 78.74 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.987 2.458 . . . . 74.519999999999996 113.375 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.684 ' HZ1' ' HB2' ' A' ' 269' ' ' LYS . 0.0 OUTLIER -76.45 -38.06 56.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.061 -0.348 . . . . 73.549999999999997 110.061 -176.848 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.51 -49.13 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 72.230000000000004 110.899 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.712 ' O ' ' HG2' ' A' ' 275' ' ' LYS . 38.0 t -55.88 -50.99 65.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.599 0.238 . . . . 73.129999999999995 110.997 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -61.14 -50.41 73.31 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.262 -0.426 . . . . 74.109999999999999 111.182 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.585 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 32.1 t70 -61.37 -45.6 93.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 74.329999999999998 111.082 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.9 m -61.31 -32.76 72.62 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.719 -0.219 . . . . 54.130000000000003 111.49 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.712 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 35.2 mmtp -60.27 -49.46 77.53 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.189 -0.671 . . . . 65.310000000000002 109.189 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.64 -33.1 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.213 -0.903 . . . . 73.430000000000007 110.968 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 16.5 mmm180 -62.66 -40.27 96.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.672 -0.24 . . . . 75.0 111.041 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.428 ' HD1' ' HA ' ' A' ' 278' ' ' TYR . 2.9 m-85 -74.06 -33.99 63.87 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.513 -0.475 . . . . 72.409999999999997 110.942 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -66.74 -20.96 66.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.467 -0.333 . . . . 74.0 110.957 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -49.64 -56.9 8.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.866 -0.607 . . . . 74.120000000000005 110.759 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -150.31 75.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.82 -0.807 . . . . 72.329999999999998 108.82 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.522 HD11 ' HA ' ' A' ' 304' ' ' GLU . 0.2 OUTLIER -53.47 -37.19 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.793 -1.094 . . . . 71.340000000000003 113.232 -171.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 300' ' ' ALA . . . -61.41 -49.0 78.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.013 -0.275 . . . . 74.349999999999994 111.676 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 m -78.07 -39.09 42.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.733 0.302 . . . . 74.109999999999999 111.114 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.76 -46.26 90.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 74.310000000000002 111.192 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.51 ' HE2' ' SD ' ' A' ' 303' ' ' MET . 23.6 mmt -74.26 -29.03 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 72.239999999999995 110.805 179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 17.1 t70 -62.32 -31.38 72.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 71.430000000000007 110.169 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.646 ' HB3' ' HZ2' ' A' ' 288' ' ' LYS . 9.2 mtpm? -83.61 -21.63 32.5 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.891 -0.595 . . . . 64.209999999999994 111.735 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.01 -38.63 86.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.657 0.265 . . . . 71.040000000000006 111.264 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.452 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 5.4 t80 -135.81 79.49 45.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.765 -0.374 . . . . 75.530000000000001 110.486 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.59 19.71 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.113 2.542 . . . . 73.530000000000001 111.918 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.452 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 33.8 mt-10 -87.48 35.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.877 -0.601 . . . . 74.549999999999997 111.42 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 68.82 10.06 7.7 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.548 0.944 . . . . 72.329999999999998 113.548 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.515 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 11.6 t30 -82.09 -81.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.875 -0.417 . . . . 74.349999999999994 109.875 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 2.0 tpmt? 168.22 107.72 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.141 0 O-C-N 123.59 0.557 . . . . 74.319999999999993 109.757 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -102.34 39.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.667 2.911 . . . . 74.230000000000004 111.881 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.16 -38.27 2.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.527 -0.844 . . . . 72.129999999999995 113.334 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.419 ' HB3' HD21 ' A' ' 324' ' ' LEU . 2.8 mp0 -59.14 -53.64 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.43 . . . . 55.420000000000002 110.51 -176.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.67 -37.77 80.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.604 -0.725 . . . . 75.439999999999998 110.323 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.551 ' HB2' ' HA ' ' A' ' 283' ' ' ALA . . . -61.36 -52.5 64.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 71.310000000000002 111.31 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 301' ' ' LYS . 21.8 ttmt -70.69 -31.98 69.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.916 0.389 . . . . 74.519999999999996 110.538 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 306' ' ' VAL . 64.6 t80 -57.95 -48.97 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 74.219999999999999 110.217 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.51 ' SD ' ' HE2' ' A' ' 286' ' ' MET . 87.4 mtp -72.48 -32.61 66.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 74.230000000000004 111.274 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.522 ' HA ' HD11 ' A' ' 282' ' ' ILE . 7.8 tp10 -59.47 -37.67 78.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.841 0.829 . . . . 75.430000000000007 108.878 173.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.444 HG22 HD21 ' A' ' 320' ' ' LEU . 60.7 m -69.06 -42.59 76.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.632 -1.167 . . . . 62.119999999999997 111.455 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.506 HG23 ' HA ' ' A' ' 303' ' ' MET . 5.5 m -70.55 -26.94 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.882 0.372 . . . . 75.040000000000006 110.578 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.44 -48.72 76.59 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.53 . . . . 74.310000000000002 110.215 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.487 ' O ' HD23 ' A' ' 308' ' ' LEU . 3.3 tt -68.5 -25.54 65.01 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.471 -0.786 . . . . 74.329999999999998 110.046 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 315' ' ' PRO . 0.2 OUTLIER -62.52 -18.84 62.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.519 -0.764 . . . . 75.420000000000002 111.878 -176.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.6 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.391 0.432 . . . . 74.219999999999999 110.294 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.724 ' HD1' ' HG3' ' A' ' 241' ' ' ARG . 3.9 m-30 -136.75 -43.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 75.200000000000003 110.402 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.4 t -136.92 20.61 3.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 74.230000000000004 112.205 -168.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -88.83 50.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.638 -0.664 . . . . 74.430000000000007 112.277 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.473 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER 58.97 94.22 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.196 -0.911 . . . . 75.450000000000003 113.456 170.205 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.441 ' HA ' HD23 ' A' ' 309' ' ' LEU . 64.3 Cg_endo -90.4 121.4 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.786 2.324 . . . . 71.340000000000003 111.802 173.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.531 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.2 mt -84.96 99.08 10.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.824 0.345 . . . . 73.519999999999996 110.366 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -61.64 -45.03 95.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.942 -0.572 . . . . 74.519999999999996 111.765 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.0 -0.37 . . . . 74.439999999999998 110.0 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.29 -36.5 84.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 73.319999999999993 110.336 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.681 ' O ' HG13 ' A' ' 323' ' ' ILE . 77.2 mt -60.68 -48.7 80.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 65.200000000000003 110.982 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.785 ' HD2' ' HG ' ' A' ' 159' ' ' LEU . 32.8 ptt180 -74.2 -20.88 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.841 -0.744 . . . . 74.430000000000007 110.772 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.94 -39.88 79.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.716 -0.22 . . . . 73.299999999999997 110.818 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.681 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.2 pp -72.18 -30.23 35.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.791 -0.448 . . . . 72.409999999999997 109.791 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.63 -49.31 63.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 73.319999999999993 110.279 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.752 HD12 HD23 ' A' ' 159' ' ' LEU . 88.8 mt -64.86 -29.24 70.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.055 -0.521 . . . . 74.329999999999998 110.66 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -63.96 -47.48 80.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.607 . . . . 74.510000000000005 110.497 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.65 -30.65 76.68 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 72.430000000000007 111.942 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.706 HD21 ' HG ' ' A' ' 155' ' ' LEU . 56.4 tp -72.8 -50.59 23.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 72.420000000000002 110.835 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.432 ' HB3' ' HZ3' ' A' ' 329' ' ' LYS . 7.5 ttpm? -73.83 -14.02 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.311 -0.404 . . . . 74.340000000000003 110.696 -176.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.98 -23.61 67.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 111.499 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.598 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.2 tt -97.17 -6.8 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 73.109999999999999 110.113 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.71 24.02 34.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.856 -0.688 . . . . 75.430000000000007 113.208 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.8 m -123.36 158.62 30.67 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.455 -0.438 . . . . 63.350000000000001 110.595 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -156.45 176.73 12.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.439 -0.346 . . . . 75.310000000000002 110.135 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.23 -36.07 18.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.721 -0.474 . . . . 72.140000000000001 109.721 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.8 t70 75.14 16.92 2.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.091 -0.959 . . . . 65.129999999999995 110.88 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.51 39.08 50.97 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.934 -0.866 . . . . 73.049999999999997 110.934 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.465 ' HA ' ' HB3' ' A' ' 191' ' ' ASP . 39.0 ttmt -156.5 109.17 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.397 -0.402 . . . . 75.439999999999998 110.343 -175.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 156' ' ' GLN . 45.3 mt -78.97 92.93 5.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.689 0.757 . . . . 73.120000000000005 110.11 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.88 63.93 6.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.637 -1.246 . . . . 74.040000000000006 107.637 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.468 HD22 HG22 ' A' ' 141' ' ' ILE . 8.9 tp -72.5 -80.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.912 -1.494 . . . . 74.340000000000003 111.066 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.6 m 170.26 -162.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.373 -1.285 . . . . 75.420000000000002 108.268 -168.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.89 115.12 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.08 0.467 . . . . 73.510000000000005 110.163 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.675 HG23 ' HB3' ' A' ' 140' ' ' LYS . 2.6 p -80.14 -49.58 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.819 -0.628 . . . . 73.530000000000001 110.827 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 345' ' ' GLU . 3.8 tp10 50.52 45.82 26.15 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.61 -0.723 . . . . 74.409999999999997 112.068 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 73.31 130.63 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.803 0.811 . . . . 64.430000000000007 113.015 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.833 ' HA3' ' HB2' ' A' ' 140' ' ' LYS . . . -137.47 -70.03 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.311 -0.859 . . . . 62.119999999999997 111.325 170.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 84.34 -71.48 2.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.521 -0.371 . . . . 75.239999999999995 112.894 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 139' ' ' GLN . 8.8 mp 63.72 -92.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.23 0.612 . . . . 75.540000000000006 111.834 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -165.82 164.26 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 74.420000000000002 111.227 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . 0.529 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . . . -137.43 -156.64 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 73.420000000000002 110.365 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.816 ' HB3' HD22 ' A' ' 200' ' ' LEU . 35.2 tptt -138.13 -158.91 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.218 -0.66 . . . . 64.530000000000001 109.218 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.609 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 10.3 t -155.87 169.73 23.72 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.513 0.197 . . . . 72.420000000000002 110.71 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -69.22 144.06 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.698 0.629 . . . . 71.030000000000001 112.698 -172.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 11.4 t -92.07 132.83 36.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.188 -0.914 . . . . 71.209999999999994 110.001 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -170.41 -88.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.492 0.187 . . . . 73.430000000000007 110.613 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 57.5 tttp 177.71 95.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.442 -0.577 . . . . 72.340000000000003 109.442 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 40.0 mtt180 -84.78 87.9 7.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.306 0.574 . . . . 73.140000000000001 109.974 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 360' ' ' LYS . 1.0 OUTLIER -112.68 -20.44 11.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.372 -0.831 . . . . 74.099999999999994 110.768 -173.998 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 359' ' ' LYS . 39.2 mttm . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.604 -0.712 . . . . 74.420000000000002 109.654 -168.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.6 mpp? . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.0 -0.37 . . . . 64.310000000000002 110.0 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 20.2 Cg_exo -65.26 139.05 58.46 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.682 2.255 . . . . 73.5 112.484 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -102.42 116.69 33.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.0 -0.741 . . . . 75.219999999999999 109.0 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.58 130.45 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.54 0.57 . . . . 74.420000000000002 112.54 -170.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -123.71 90.36 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.702 -0.681 . . . . 65.409999999999997 109.681 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.01 105.37 2.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.588 0.233 . . . . 65.519999999999996 110.924 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.5 113.59 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 75.450000000000003 110.571 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -132.05 140.76 48.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.819 0.342 . . . . 73.140000000000001 110.276 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.83 36.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.155 -0.475 . . . . 73.129999999999995 110.977 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.01 64.25 0.27 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.025 -0.607 . . . . 74.540000000000006 112.841 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -134.44 149.87 50.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 73.340000000000003 110.363 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.14 137.3 39.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 74.409999999999997 110.337 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -83.54 136.81 34.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.925 -0.579 . . . . 54.329999999999998 110.368 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 m -153.12 148.15 26.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.648 -0.251 . . . . 73.030000000000001 110.439 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.627 ' H ' ' HG3' ' A' ' 36' ' ' GLU . . . -72.99 140.23 47.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 71.239999999999995 110.926 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.23 -49.3 7.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 75.349999999999994 111.472 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -152.81 178.53 9.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.011 0.434 . . . . 74.430000000000007 111.343 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.615 ' CD2' ' HB3' ' A' ' 27' ' ' GLU . 19.7 t-80 -90.4 123.37 34.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.578 -0.737 . . . . 73.030000000000001 109.909 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.703 HD11 ' HD2' ' A' ' 38' ' ' LYS . 11.3 mp -85.43 164.48 17.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 75.540000000000006 109.942 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.11 129.26 39.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.84 0.352 . . . . 73.299999999999997 111.057 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.691 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 9.8 tp10 -150.09 -88.77 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 74.340000000000003 109.707 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.566 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 49.2 tt0 163.63 -39.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.814 0.696 . . . . 74.420000000000002 110.506 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -95.93 -50.8 4.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.956 0.725 . . . . 74.439999999999998 112.956 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.543 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . 173.35 -17.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.076 0.465 . . . . 74.519999999999996 110.434 -167.274 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.691 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 46.6 t -60.78 127.22 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.15 -0.477 . . . . 74.310000000000002 110.259 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . 99.04 -1.79 57.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.765 -0.731 . . . . 73.200000000000003 114.125 175.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.615 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -110.82 -177.08 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.173 0.987 . . . . 73.439999999999998 112.312 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.427 HG23 ' HB2' ' A' ' 36' ' ' GLU . 3.2 mp -107.49 138.53 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.376 0.88 . . . . 74.109999999999999 113.376 -162.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.06 126.64 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.148 -0.933 . . . . 72.450000000000003 109.593 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -103.7 136.53 43.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.1 0.778 . . . . 74.400000000000006 113.1 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.816 ' HB3' ' CZ2' ' A' ' 37' ' ' TRP . 10.9 p30 -88.39 -179.44 6.1 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 71.230000000000004 110.758 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.897 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -71.16 -9.72 58.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 71.450000000000003 111.774 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.18 6.82 46.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 74.450000000000003 110.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.425 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 52.5 mmtt 68.82 23.79 6.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.347 -0.842 . . . . 73.040000000000006 111.684 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.643 ' HZ3' ' HB3' ' A' ' 114' ' ' TRP . 40.4 ttpt -90.67 114.49 26.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.453 -0.943 . . . . 73.510000000000005 108.453 171.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 15' ' ' ALA . 6.0 pt-20 -92.51 102.0 14.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.734 -0.666 . . . . 70.349999999999994 110.791 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.817 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 0.4 OUTLIER -80.27 147.08 31.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 65.25 109.689 -177.173 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.703 ' HD2' HD11 ' A' ' 19' ' ' LEU . 28.1 ttpp -106.06 119.45 39.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.753 -0.462 . . . . 74.219999999999999 109.753 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.99 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.665 . . . . 65.400000000000006 111.27 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.426 ' O ' HG21 ' A' ' 25' ' ' VAL . . . -109.2 -129.43 5.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.49 -0.644 . . . . 74.439999999999998 111.49 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.485 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 mm? -76.08 141.85 71.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.686 0.279 . . . . 74.340000000000003 111.134 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_endo -86.97 120.43 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.245 2.63 . . . . 72.310000000000002 111.775 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.42 HD12 ' HB2' ' A' ' 53' ' ' LEU . 3.8 mp -96.57 -54.82 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.407 . . . . 62.109999999999999 110.622 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 97.74 162.99 31.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.828 -0.701 . . . . 72.019999999999996 111.491 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.741 ' HB2' HG12 ' A' ' 51' ' ' ILE . 27.6 tp60 -133.56 128.59 35.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.987 0.394 . . . . 73.310000000000002 110.175 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.58 108.6 2.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.617 -0.802 . . . . 43.450000000000003 112.418 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -16.14 46.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.906 -0.664 . . . . 74.340000000000003 112.291 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.669 ' CE2' ' HA ' ' A' ' 198' ' ' TYR . 21.2 m-85 -113.38 -59.39 2.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.736 0.303 . . . . 75.140000000000001 110.318 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.72 -105.59 0.22 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.8 -0.714 . . . . 72.099999999999994 112.562 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.644 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 49.8 t -142.05 142.0 32.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 75.109999999999999 110.596 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.741 HG12 ' HB2' ' A' ' 45' ' ' GLN . 27.4 mm -121.74 136.88 57.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.5 -0.556 . . . . 74.239999999999995 109.5 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.25 144.66 35.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.755 0.312 . . . . 71.120000000000005 110.643 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.538 ' HA ' HG11 ' A' ' 69' ' ' VAL . 57.9 tp -84.37 152.04 24.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.364 -0.606 . . . . 64.109999999999999 109.364 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.38 104.4 12.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.827 0.346 . . . . 74.409999999999997 111.056 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.1 -35.18 42.73 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.11 -0.7 . . . . 71.25 109.11 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.817 ' SD ' ' HA ' ' A' ' 37' ' ' TRP . 13.8 tpt 69.54 -70.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.482 -1.235 . . . . 73.200000000000003 113.194 171.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -139.32 104.9 5.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.176 0.512 . . . . 64.150000000000006 111.159 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -83.61 40.01 0.71 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 64.510000000000005 111.52 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 m -104.45 -75.73 0.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 75.430000000000007 110.799 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.36 -1.88 22.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 65.329999999999998 110.049 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 t 62.85 77.87 0.31 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.547 -0.751 . . . . 65.299999999999997 109.198 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.4 p -60.4 129.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.058 -0.973 . . . . 72.409999999999997 111.365 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.03 23.49 5.19 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 116.057 -0.52 . . . . 65.340000000000003 113.276 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.2 m -121.02 -77.76 0.59 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.935 -0.394 . . . . 73.5 109.935 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -90.08 92.07 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.43 -0.35 . . . . 72.450000000000003 110.064 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.475 ' HB1' ' HD3' ' A' ' 67' ' ' PRO . . . -172.39 -50.36 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.421 -0.809 . . . . 74.230000000000004 109.243 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.475 ' HD3' ' HB1' ' A' ' 66' ' ' ALA . 68.0 Cg_endo -78.37 55.84 5.58 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 121.594 1.529 . . . . 72.439999999999998 110.95 169.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 8.6 p -145.51 157.93 43.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.999 -0.546 . . . . 75.209999999999994 110.699 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 53' ' ' LEU . 7.2 m -135.34 161.43 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 74.209999999999994 110.369 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.572 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 4.9 p -119.75 119.98 61.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.651 0.739 . . . . 72.319999999999993 111.934 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.489 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 4.8 tptp -79.98 115.97 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.776 -1.102 . . . . 74.430000000000007 108.768 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.435 ' HB ' ' HB3' ' A' ' 128' ' ' PHE . 6.9 p -125.7 128.32 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.065 0.46 . . . . 65.400000000000006 111.577 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.4 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 77.3 mt-10 -138.06 152.24 71.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 75.129999999999995 109.833 177.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.92 165.8 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.346 2.03 . . . . 70.239999999999995 112.302 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.1 m -78.08 69.94 4.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.332 0.587 . . . . 72.150000000000006 110.453 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -122.66 7.12 9.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 73.209999999999994 110.453 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 67.62 93.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.267 -0.878 . . . . 72.340000000000003 110.762 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.63 -154.11 6.14 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.576 -0.738 . . . . 73.239999999999995 111.646 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 31.4 Cg_exo -59.15 -35.52 97.62 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.21 2.607 . . . . 73.120000000000005 112.553 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.4 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.54 -36.37 44.72 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.926 0.766 . . . . 74.549999999999997 111.433 -176.598 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -66.57 -49.28 66.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.788 0.328 . . . . 75.420000000000002 110.805 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 m -62.71 -48.35 79.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 74.409999999999997 111.107 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 8.3 pt-20 -69.35 -33.54 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.968 -0.56 . . . . 74.439999999999998 111.166 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.595 HD21 ' HD3' ' A' ' 127' ' ' ARG . 43.7 tp -58.48 -47.48 83.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.003 0.43 . . . . 75.530000000000001 110.575 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.39 -36.8 82.03 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.117 -0.492 . . . . 75.409999999999997 110.511 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.45 -52.59 64.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.941 -0.572 . . . . 73.129999999999995 110.237 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 4.9 m-85 -57.27 -46.89 82.65 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.139 -0.482 . . . . 74.200000000000003 110.697 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.95 64.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 74.420000000000002 111.337 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -90.52 -26.81 19.57 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.848 0.314 . . . . 73.019999999999996 111.848 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.76 17.99 22.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.768 0.318 . . . . 73.400000000000006 111.649 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -85.54 164.74 17.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.555 0.576 . . . . 61.32 112.555 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 96' ' ' ILE . 2.8 tppt? 77.88 99.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.847 -1.07 . . . . 75.310000000000002 111.09 170.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 11.6 Cg_endo -55.12 -29.16 64.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.441 2.761 . . . . 72.430000000000007 113.443 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.602 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 4.3 tp10 -55.42 -59.43 4.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 73.299999999999997 110.596 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.465 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 6.4 tp60 -68.11 -35.6 78.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.966 -0.561 . . . . 74.329999999999998 110.449 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' LYS . 73.5 mt -55.45 -49.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 72.299999999999997 110.277 177.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -59.52 -42.78 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.409999999999997 110.456 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.7 mmtt -55.65 -59.59 4.64 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.723 -0.671 . . . . 75.230000000000004 112.113 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.91 -34.97 69.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.024 -0.67 . . . . 73.219999999999999 111.228 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.653 HD13 ' HG ' ' A' ' 108' ' ' LEU . 28.5 mt -59.15 -49.14 84.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 121.095 -0.242 . . . . 74.439999999999998 111.199 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -74.63 -35.74 62.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 74.140000000000001 111.267 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.7 m -72.63 -39.78 66.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.799 0.333 . . . . 73.219999999999999 111.226 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -87.89 7.08 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.462 -0.335 . . . . 72.319999999999993 111.848 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 71.07 29.49 2.91 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.423 0.452 . . . . 73.329999999999998 112.138 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.05 -169.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.799 -0.445 . . . . 73.230000000000004 109.799 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 26.5 mmtm -115.36 -62.76 1.55 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.845 -0.428 . . . . 75.25 109.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.418 ' HA ' HD11 ' A' ' 100' ' ' ILE . 37.6 p90 -174.85 138.56 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.442 0.464 . . . . 62.100000000000001 110.503 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.653 ' HG ' HD13 ' A' ' 100' ' ' ILE . 72.8 mt -79.24 118.57 21.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.178 -0.464 . . . . 72.030000000000001 109.844 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.498 ' HA3' ' CZ ' ' A' ' 160' ' ' ARG . . . -79.03 54.87 4.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.383 -0.913 . . . . 75.099999999999994 111.817 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.59 149.96 39.02 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.905 -0.406 . . . . 73.319999999999993 109.905 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.75 ' HB3' ' HE2' ' A' ' 134' ' ' PHE . 21.0 Cg_exo -66.08 144.72 76.78 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.26 1.973 . . . . 75.140000000000001 111.923 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.82 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 16.0 tttp -70.74 118.26 13.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 72.420000000000002 110.56 -176.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.498 ' CD1' ' HD2' ' A' ' 87' ' ' TYR . 66.4 t80 -95.23 120.68 35.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 75.450000000000003 110.926 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.643 ' HB3' ' HZ3' ' A' ' 35' ' ' LYS . 80.0 m95 -98.92 -51.31 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 75.129999999999995 110.769 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -169.0 172.61 43.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.864 -0.607 . . . . 73.109999999999999 112.134 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.607 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 34.2 p -160.3 157.37 27.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.196 -0.298 . . . . 74.019999999999996 110.196 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.25 -177.92 46.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.572 -0.823 . . . . 74.430000000000007 112.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.449 HD23 ' HB3' ' A' ' 125' ' ' SER . 9.5 tt -126.15 134.37 51.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.858 0.361 . . . . 75.010000000000005 110.206 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.553 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . 56.3 t60 -140.88 118.23 11.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.465 -0.568 . . . . 74.329999999999998 109.465 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.3 t70 -67.45 129.77 40.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.89 -0.595 . . . . 63.509999999999998 110.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.48 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 84.7 tttt -134.85 122.67 22.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.234 -0.439 . . . . 75.450000000000003 110.022 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.48 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 22.1 m120 66.73 15.95 10.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.063 -0.517 . . . . 72.439999999999998 111.522 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 -2.01 61.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.559 -0.829 . . . . 65.299999999999997 112.052 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 74.239999999999995 109.667 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.677 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.9 m -76.37 104.88 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 72.439999999999998 110.658 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -93.95 136.54 34.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.565 -0.743 . . . . 73.209999999999994 110.492 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.595 ' HD3' HD21 ' A' ' 84' ' ' LEU . 36.2 ttm180 -112.28 124.29 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.075 -0.713 . . . . 75.540000000000006 109.075 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.572 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.7 p90 -126.9 160.23 31.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 72.549999999999997 111.943 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.607 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 30.3 ttp -145.19 135.87 24.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.373 -0.83 . . . . 75.219999999999999 110.28 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.562 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 3.6 mm -96.99 128.34 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 62.340000000000003 111.539 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.6 ptp -122.59 167.78 12.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.996 -1.002 . . . . 74.099999999999994 108.976 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.82 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 11.0 t70 -72.53 152.03 42.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.96 -0.756 . . . . 71.030000000000001 108.96 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.408 ' HG3' ' HB3' ' A' ' 187' ' ' TYR . 27.7 tpt180 -76.59 102.07 5.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.817 0.818 . . . . 75.099999999999994 112.05 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.75 ' HE2' ' HB3' ' A' ' 111' ' ' PRO . 8.9 m-85 -102.69 141.85 34.81 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.253 -1.388 . . . . 74.420000000000002 107.253 168.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.66 10.5 0.81 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.4 -1.381 . . . . 74.010000000000005 113.41 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.923 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 16.2 m -113.73 123.39 49.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.803 -0.814 . . . . 73.109999999999999 108.803 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.899 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 2.3 m-20 -105.03 129.51 53.45 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 121.151 -0.22 . . . . 62.229999999999997 110.412 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.35 -24.02 67.5 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.431 -0.508 . . . . 74.200000000000003 109.677 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.899 ' HG2' ' HB3' ' A' ' 137' ' ' ASP . 28.0 pt20 -70.68 -37.12 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 51.450000000000003 110.413 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.564 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 63.1 mttp -70.94 -35.05 72.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.9 0.381 . . . . 75.109999999999999 110.202 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.437 HG21 HD13 ' A' ' 341' ' ' LEU . 1.8 mp -74.52 -31.03 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.278 -0.419 . . . . 63.439999999999998 110.512 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.472 ' CZ ' ' HD3' ' A' ' 147' ' ' LYS . 40.0 t80 -52.74 -53.72 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.686 -0.688 . . . . 74.219999999999999 111.886 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -99.57 -1.75 37.45 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 63.049999999999997 111.245 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.94 -32.87 15.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.37 . . . . 71.430000000000007 110.542 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -0.65 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.45 -0.574 . . . . 74.420000000000002 109.45 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 147' ' ' LYS . . . 55.29 36.69 27.59 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.659 -0.701 . . . . 65.319999999999993 111.226 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.472 ' HD3' ' CZ ' ' A' ' 142' ' ' TYR . 29.8 mtmt 72.57 93.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.551 -0.749 . . . . 74.109999999999999 112.46 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 2.3 tpp85 -143.69 97.64 3.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.865 -1.061 . . . . 74.340000000000003 109.244 173.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -119.64 153.81 34.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 75.420000000000002 110.234 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 m -101.28 175.44 5.58 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.634 -0.506 . . . . 63.310000000000002 109.634 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 328' ' ' LEU . 21.8 ttm180 -67.32 -37.13 82.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.347 -0.141 . . . . 74.340000000000003 111.084 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.828 ' HG2' ' HA ' ' A' ' 335' ' ' ASP . 2.1 tmtp? -55.98 -46.99 78.5 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.319 -0.252 . . . . 74.109999999999999 110.319 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.5 ' HA ' HD22 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -58.26 -48.1 81.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.846 0.355 . . . . 71.530000000000001 111.195 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.25 -42.07 90.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.312 -0.404 . . . . 62.130000000000003 110.771 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.32 -52.64 21.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 73.019999999999996 111.182 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -63.72 -44.04 94.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.539 0.209 . . . . 74.140000000000001 110.838 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 161' ' ' ILE . 10.9 mp -64.64 -41.87 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 73.140000000000001 110.755 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -59.35 -49.54 77.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.6 0.238 . . . . 75.109999999999999 110.531 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.684 HD23 HD21 ' A' ' 325' ' ' LEU . 8.8 mp -58.47 -50.72 72.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.403 -0.362 . . . . 63.219999999999999 111.752 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.544 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -66.08 -21.9 66.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 72.400000000000006 111.222 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 157' ' ' LEU . 23.6 mm -69.66 -40.91 79.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 109.72 -0.474 . . . . 75.219999999999999 109.72 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.76 -47.5 86.03 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.984 0.178 . . . . 72.450000000000003 110.784 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.41 -56.37 13.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.9 0.381 . . . . 75.510000000000005 111.419 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.448 HG21 HH21 ' A' ' 160' ' ' ARG . 11.3 tt -68.72 -35.86 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.418 -0.355 . . . . 74.519999999999996 111.05 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.568 HD11 ' CD2' ' A' ' 175' ' ' HIS . 68.5 tp -67.28 -38.5 85.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.547 -0.297 . . . . 73.409999999999997 111.488 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.448 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 27.8 mm-40 -76.63 -28.83 56.22 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.592 -0.443 . . . . 64.310000000000002 110.204 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -60.32 -48.71 80.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.357 . . . . 73.209999999999994 110.391 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 173' ' ' TYR . 18.5 pt -72.49 -31.97 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 73.109999999999999 110.957 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.448 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 23.6 m170 -64.84 -38.05 89.67 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.982 0.176 . . . . 73.400000000000006 111.06 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.1 -6.17 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.012 0.434 . . . . 71.129999999999995 111.137 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -100.65 -85.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.217 -0.66 . . . . 75.109999999999999 109.217 170.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.609 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 15.0 pt-20 -169.44 1.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 71.349999999999994 111.746 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.584 ' HB2' ' HB ' ' A' ' 168' ' ' ILE . 39.2 m-85 -106.19 158.09 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.178 0.513 . . . . 72.519999999999996 111.719 -165.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.72 168.55 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.876 -1.056 . . . . 75.329999999999998 108.561 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.568 ' CD2' HD11 ' A' ' 165' ' ' LEU . 8.4 p80 -102.94 121.37 42.38 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.447 -0.501 . . . . 72.120000000000005 110.645 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 -39.14 95.24 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.768 -0.73 . . . . 74.129999999999995 112.731 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.453 ' HB3' HD11 ' A' ' 200' ' ' LEU . 29.4 t70 -135.06 127.85 31.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 71.310000000000002 111.976 -175.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.575 ' HB ' HG23 ' A' ' 246' ' ' ILE . 32.2 mm -111.88 124.72 68.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.311 -0.996 . . . . 73.140000000000001 108.311 167.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -166.08 167.64 16.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.645 -0.502 . . . . 73.400000000000006 109.645 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.54 -19.16 63.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.946 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.706 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 3.1 p -75.1 -21.07 59.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 61.240000000000002 111.963 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.476 ' HA ' HG12 ' A' ' 196' ' ' VAL . 2.0 p30 -110.79 12.51 22.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 72.439999999999998 111.733 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.2 mt -113.47 114.4 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.293 -0.412 . . . . 70.420000000000002 110.586 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.31 138.74 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 72.239999999999995 110.86 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.923 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 39.3 mt -95.18 154.02 17.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.105 -0.702 . . . . 74.129999999999995 109.105 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.433 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 27.5 t-20 -59.44 147.56 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.477 -0.564 . . . . 73.200000000000003 109.477 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.408 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 10.7 p90 -60.91 -25.59 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.008 0.373 . . . . 73.310000000000002 112.008 -172.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -120.41 -26.3 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.007 0.373 . . . . 73.450000000000003 112.007 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.504 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 4.9 t30 -112.1 115.01 50.79 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.573 -0.451 . . . . 62.200000000000003 111.106 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 7.6 Cg_exo -72.99 -29.83 11.56 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.299 2.666 . . . . 64.239999999999995 114.413 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.549 ' HA ' HD13 ' A' ' 339' ' ' LEU . 8.3 p-10 -88.27 13.7 10.99 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.514 -0.474 . . . . 75.209999999999994 111.53 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.503 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 18.9 mm-40 -112.92 94.98 5.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 71.420000000000002 109.992 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.467 HG13 ' HG ' ' A' ' 157' ' ' LEU . 6.4 p -104.99 126.54 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 75.109999999999999 111.2 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 45.1 m-85 -128.75 158.98 37.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.631 . . . . 75.200000000000003 110.238 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.452 HD11 ' NH2' ' A' ' 160' ' ' ARG . 8.3 mp -83.34 147.21 28.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.244 -0.28 . . . . 75.010000000000005 110.244 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.476 HG12 ' HA ' ' A' ' 182' ' ' ASN . 14.7 p -83.79 148.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.309 -0.405 . . . . 72.109999999999999 110.618 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.0 88.0 0.15 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.721 0.772 . . . . 74.109999999999999 110.422 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.669 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -105.72 -9.38 17.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.803 -1.09 . . . . 75.340000000000003 111.303 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.533 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 57.55 16.96 24.57 Favored Glycine 0 C--O 1.223 -0.555 0 CA-C-N 115.904 -0.589 . . . . 52.140000000000001 112.726 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.653 ' HG ' ' HA ' ' A' ' 353' ' ' THR . 0.5 OUTLIER -91.9 49.1 1.5 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.674 0.749 . . . . 73.450000000000003 110.238 -174.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -119.87 110.4 16.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.41 -0.814 . . . . 64.109999999999999 110.169 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -98.27 -174.54 2.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.833 -1.173 . . . . 72.5 107.833 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.454 ' HD2' ' OE1' ' A' ' 172' ' ' GLU . 36.8 ptt180 -131.29 133.52 45.47 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.683 -0.636 . . . . 74.140000000000001 111.675 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -93.59 -17.51 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.309 -0.86 . . . . 71.430000000000007 110.169 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.609 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 40.4 m -128.6 76.0 79.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.254 -0.43 . . . . 74.040000000000006 110.884 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.417 ' HA ' ' HD2' ' A' ' 203' ' ' ARG . 91.5 Cg_exo -45.35 103.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.182 2.588 . . . . 74.439999999999998 113.263 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 61.81 28.73 17.64 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.325 -0.852 . . . . 63.210000000000001 111.301 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.42 -15.68 45.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 72.329999999999998 113.078 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.28 110.53 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 O-C-N 122.409 -0.465 . . . . 75.200000000000003 109.938 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.515 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 14.9 p-80 -63.8 127.45 31.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 75.109999999999999 110.399 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.52 ' HE3' ' HB3' ' A' ' 214' ' ' LYS . 37.6 tptt -103.14 142.99 33.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.798 -0.637 . . . . 73.150000000000006 110.114 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -81.68 -169.3 2.26 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.166 -0.309 . . . . 62.329999999999998 110.166 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.733 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 69.1 t80 -64.1 91.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.431 -0.581 . . . . 73.209999999999994 109.431 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.52 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 22.2 tptm -156.0 16.09 0.35 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.163 -0.472 . . . . 71.439999999999998 110.517 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.469 ' OE1' ' HB2' ' A' ' 237' ' ' ALA . 35.0 tt0 -72.51 -66.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.924 0.392 . . . . 75.239999999999995 110.486 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -140.52 140.35 22.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.787 -0.449 . . . . 73.140000000000001 109.787 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.465 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 3.3 Cg_endo -47.35 -51.06 10.14 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.206 2.604 . . . . 74.430000000000007 113.451 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 217' ' ' PRO . 32.1 mmtm -160.12 5.67 0.08 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.291 0.478 . . . . 75.099999999999994 112.291 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.44 ' NH2' ' HB2' ' A' ' 357' ' ' LYS . 7.3 ttp85 -113.36 37.56 3.16 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.508 0.671 . . . . 72.319999999999993 110.567 -171.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.466 ' HB2' ' HA2' ' A' ' 235' ' ' GLY . 41.0 t -71.13 -86.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.855 -0.528 . . . . 71.030000000000001 110.117 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 21.3 m-70 53.82 40.79 31.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 75.430000000000007 110.881 176.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.24 -48.47 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.204 0.315 . . . . 70.450000000000003 110.985 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -99.8 -166.85 29.45 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.862 -0.685 . . . . 63.009999999999998 112.087 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.9 p -70.38 143.9 51.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 75.510000000000005 111.062 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.427 HD11 HG23 ' A' ' 271' ' ' VAL . 0.3 OUTLIER -64.8 -20.66 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.644 0.735 . . . . 65.420000000000002 109.546 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -61.58 -48.43 80.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.02 -0.991 . . . . 71.299999999999997 111.475 179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.521 ' HB3' HG22 ' A' ' 246' ' ' ILE . 94.1 m-85 -111.77 -15.83 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.344 0.868 . . . . 75.409999999999997 113.344 -169.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.526 ' HB ' ' HB1' ' A' ' 232' ' ' ALA . 1.1 p -54.39 -27.07 34.1 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.652 0.982 . . . . 70.400000000000006 113.652 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.56 ' HB2' ' HE2' ' A' ' 249' ' ' TYR . 15.3 t 64.43 -159.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.337 0.398 . . . . 75.140000000000001 110.418 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.448 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 3.3 mp -67.33 -45.65 85.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.613 -0.267 . . . . 73.129999999999995 110.981 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -74.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.722 0.638 . . . . 74.549999999999997 112.722 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.526 ' HB1' ' HB ' ' A' ' 228' ' ' THR . . . -67.88 -27.59 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.010000000000005 112.163 -172.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.624 -0.262 . . . . 75.540000000000006 110.976 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.449 ' O ' ' HD3' ' A' ' 218' ' ' LYS . 2.7 t30 -82.56 -36.64 26.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.641 -0.254 . . . . 70.239999999999995 110.882 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 144.5 9.3 0.37 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 119.794 -1.194 . . . . 64.519999999999996 114.121 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.733 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 12.1 p -122.41 139.58 48.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 117.374 0.587 . . . . 63.329999999999998 110.547 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.469 ' HB2' ' OE1' ' A' ' 215' ' ' GLU . . . -55.14 148.93 27.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 71.329999999999998 110.575 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.33 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.833 2.356 . . . . 64.030000000000001 111.489 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.6 p -79.16 -72.36 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.768 0.794 . . . . 70.340000000000003 110.767 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 240' ' ' ARG . 0.3 OUTLIER -154.57 -42.51 0.09 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.832 -1.544 . . . . 74.329999999999998 106.832 176.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 48.8 ttt-85 -58.23 -70.2 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.51 -1.677 . . . . 75.420000000000002 111.174 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.705 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -62.99 -36.38 93.38 Favored Glycine 0 C--O 1.223 -0.543 0 CA-C-N 115.821 -0.627 . . . . 72.299999999999997 112.886 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.0 -50.54 66.38 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.261 0.553 . . . . 71.430000000000007 110.475 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.62 -30.7 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.531 -0.758 . . . . 75.439999999999998 111.02 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.419 ' OE2' ' HD3' ' A' ' 279' ' ' ARG . 39.2 mt-10 -66.1 -39.22 89.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.049 -0.26 . . . . 73.109999999999999 110.716 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.705 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.6 mt -58.2 -47.33 87.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.124 0.488 . . . . 74.140000000000001 109.814 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.13 -43.62 98.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.729 -0.669 . . . . 73.109999999999999 110.26 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.18 96.44 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.979 -0.555 . . . . 54.109999999999999 112.769 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.56 ' HE2' ' HB2' ' A' ' 229' ' ' SER . 19.3 m-85 -59.04 -41.33 87.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 73.450000000000003 110.518 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.401 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.5 m -62.73 -45.09 94.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.206 -0.452 . . . . 74.530000000000001 110.573 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.445 ' HE3' HG13 ' A' ' 299' ' ' ILE . 90.4 mtp -59.66 -50.26 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 63.210000000000001 111.47 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.486 ' HB ' HG22 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -66.07 -36.62 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 121.01 -0.276 . . . . 74.239999999999995 110.392 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -62.57 -42.88 99.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 74.329999999999998 110.983 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -64.04 -38.9 92.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 75.140000000000001 111.145 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.5 tp -81.11 -30.33 34.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.446 0.536 . . . . 74.349999999999994 112.446 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.554 HG21 ' HB2' ' A' ' 290' ' ' PHE . 76.6 p -103.45 -28.82 11.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.388 -0.525 . . . . 71.049999999999997 111.828 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 76.3 14.27 82.51 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.101 -0.571 . . . . 61.140000000000001 113.019 -179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -150.68 149.93 30.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.349 0.575 . . . . 74.540000000000006 112.05 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.596 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 95.6 mt -129.82 139.44 35.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 74.140000000000001 108.87 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.631 ' HG2' ' HE1' ' A' ' 278' ' ' TYR . 25.0 Cg_exo -65.25 -9.92 23.88 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.678 2.252 . . . . 73.140000000000001 113.044 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.566 ' HB2' HG11 ' A' ' 271' ' ' VAL . 38.6 p90 -118.98 28.16 8.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.122 0.416 . . . . 71.219999999999999 112.122 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.596 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 55.0 mt-10 -66.78 -51.22 58.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.191 0.52 . . . . 75.030000000000001 110.825 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.74 -27.69 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.701 -0.681 . . . . 73.140000000000001 110.687 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.407 ' HB3' ' HB2' ' A' ' 270' ' ' TYR . 13.6 m120 -98.58 12.99 33.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.739 -0.664 . . . . 74.219999999999999 111.01 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -58.94 -39.18 80.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.016 0.436 . . . . 74.030000000000001 111.183 -175.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -78.84 11.34 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.048 -0.524 . . . . 73.409999999999997 111.737 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -125.99 106.01 25.64 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.282 -0.636 . . . . 53.420000000000002 109.282 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.54 -23.09 74.49 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.027 2.485 . . . . 70.319999999999993 113.385 -173.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -74.03 -46.89 40.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.946 -0.39 . . . . 75.400000000000006 109.946 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.407 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 16.2 m-30 -67.21 -41.78 85.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.836 -0.62 . . . . 74.329999999999998 110.822 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.566 HG11 ' HB2' ' A' ' 261' ' ' TRP . 17.1 m -64.69 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.765 0.317 . . . . 71.150000000000006 110.216 177.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 276' ' ' ILE . 53.0 ttt-85 -66.55 -48.5 69.48 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.241 -0.436 . . . . 72.549999999999997 110.495 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.0 -40.77 90.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.354 -0.385 . . . . 72.319999999999993 110.694 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 35.2 m -61.82 -41.85 98.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.951 -0.568 . . . . 70.0 110.97 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.482 ' HD3' ' HA ' ' A' ' 229' ' ' SER . 68.2 mttm -63.92 -37.63 88.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 75.420000000000002 110.288 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.1 mt -65.54 -38.76 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 73.010000000000005 110.581 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.478 ' HA ' ' OE2' ' A' ' 280' ' ' GLU . 0.3 OUTLIER -62.27 -40.49 96.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.904 0.383 . . . . 74.239999999999995 110.453 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.631 ' HE1' ' HG2' ' A' ' 260' ' ' PRO . 28.0 m-85 -66.76 -29.89 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 73.340000000000003 110.751 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.445 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -81.54 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 72.030000000000001 111.211 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.478 ' OE2' ' HA ' ' A' ' 277' ' ' ARG . 49.4 mt-10 -79.88 -71.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.1 0.476 . . . . 74.120000000000005 110.222 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.91 94.45 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.913 -0.585 . . . . 72.209999999999994 109.626 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.473 HG12 ' HA ' ' A' ' 304' ' ' GLU . 3.9 mp -67.07 -51.99 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.432 -0.349 . . . . 74.129999999999995 110.468 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.94 84.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 74.209999999999994 111.399 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.2 m -61.65 -45.94 91.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.339 -0.391 . . . . 73.519999999999996 111.183 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 289' ' ' CYS . 3.9 mm? -65.88 -44.47 85.25 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.307 -0.406 . . . . 65.049999999999997 111.184 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.5 mmt -67.13 -43.46 82.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 71.530000000000001 111.243 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.66 -45.37 77.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 73.439999999999998 110.939 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.65 5.2 51.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.013 -0.54 . . . . 73.530000000000001 111.603 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 48.8 t -85.19 -43.79 13.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.014 -0.736 . . . . 74.519999999999996 109.014 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.664 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 53.4 t80 -129.44 78.94 74.87 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.672 -0.695 . . . . 62.229999999999997 109.895 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -94.48 36.74 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.354 2.703 . . . . 64.200000000000003 111.903 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.44 -166.81 1.69 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.943 -0.571 . . . . 72.030000000000001 109.543 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.96 66.93 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.581 0.705 . . . . 75.349999999999994 111.079 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.664 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 46.6 t30 -167.7 151.5 6.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.56 -1.2 . . . . 71.120000000000005 107.761 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -107.26 112.29 62.88 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.288 -0.565 . . . . 74.030000000000001 110.718 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.08 109.21 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.473 2.115 . . . . 75.299999999999997 110.978 172.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -136.96 -40.72 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.512 -0.852 . . . . 64.340000000000003 111.631 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.539 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 0.7 OUTLIER -63.87 -61.3 2.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 72.329999999999998 109.952 -178.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.486 HG22 ' HB ' ' A' ' 252' ' ' ILE . 3.5 mp -62.21 -40.12 86.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.486 -0.779 . . . . 75.049999999999997 110.56 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.11 -54.21 49.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.635 . . . . 75.120000000000005 111.479 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -69.1 -39.88 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.127 -0.229 . . . . 74.519999999999996 111.16 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -56.33 -53.39 57.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 74.140000000000001 110.546 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 306' ' ' VAL . 62.0 mtp -72.77 -30.58 64.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.88 -0.6 . . . . 65.129999999999995 111.635 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.473 ' HA ' HG12 ' A' ' 282' ' ' ILE . 40.9 tt0 -66.63 -45.29 79.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.316 0.579 . . . . 75.129999999999995 109.657 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.534 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 19.1 m -59.68 -47.32 86.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.225 -0.898 . . . . 73.340000000000003 111.67 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 303' ' ' MET . 20.0 m -68.74 -27.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 74.120000000000005 111.128 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 7.7 tmtm? -67.29 -33.97 76.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.168 0.509 . . . . 75.329999999999998 110.056 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.498 ' O ' HD21 ' A' ' 308' ' ' LEU . 6.0 tt -75.14 -31.26 61.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.598 -0.728 . . . . 73.319999999999993 109.976 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.735 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 92.9 mt -63.89 -33.86 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 64.519999999999996 111.897 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.542 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 8.3 t70 60.51 -165.75 0.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.818 -0.438 . . . . 71.420000000000002 109.818 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.434 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 13.7 m-85 -63.6 -37.61 87.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.579 0.585 . . . . 73.400000000000006 112.579 -173.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 m -149.3 74.95 1.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.201 -0.6 . . . . 64.25 112.519 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.735 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -118.67 -175.47 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.704 -0.48 . . . . 70.5 109.704 165.851 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 39.5 mttp -86.19 109.38 22.62 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.12 -0.491 . . . . 74.510000000000005 110.448 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 4.0 Cg_endo -85.64 119.14 1.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.932 2.421 . . . . 74.230000000000004 112.526 -176.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.25 85.98 6.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 75.439999999999998 110.128 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -65.51 -34.1 77.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.886 -0.597 . . . . 74.0 111.686 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.71 -29.44 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.892 -0.323 . . . . 73.299999999999997 110.688 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.73 -45.08 60.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.605 -0.517 . . . . 75.209999999999994 109.605 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.586 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 93.7 mt -56.53 -46.02 80.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.783 -0.644 . . . . 71.099999999999994 110.02 174.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -54.34 -50.14 68.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.682 -0.69 . . . . 75.540000000000006 110.998 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -37.83 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 55.119999999999997 111.847 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.8 pp -72.3 -28.72 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 120.571 -0.452 . . . . 74.129999999999995 111.035 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.87 -49.35 62.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.272 0.558 . . . . 72.219999999999999 109.629 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.684 HD21 HD23 ' A' ' 159' ' ' LEU . 4.3 mm? -64.65 -31.15 72.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.584 -0.735 . . . . 74.540000000000006 110.618 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -47.04 87.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 74.530000000000001 109.939 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.539 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -61.31 -46.14 95.02 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.756 -0.735 . . . . 73.099999999999994 112.072 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.418 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 26.8 tp -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.433 0.635 . . . . 71.099999999999994 110.558 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 329' ' ' LYS . 34.8 ttpt -65.75 -46.48 78.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.011 -0.995 . . . . 74.209999999999994 112.123 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.67 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.623 0.601 . . . . 74.099999999999994 112.623 -172.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.69 -7.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.021 0.438 . . . . 75.209999999999994 111.363 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 90.18 24.65 28.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.226 -0.988 . . . . 75.150000000000006 113.082 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.416 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 12.4 p -100.78 138.98 37.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.881 0.372 . . . . 64.219999999999999 110.436 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -151.67 80.61 1.28 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.983 -0.553 . . . . 74.5 109.761 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.828 ' HA ' ' HG2' ' A' ' 152' ' ' LYS . 26.2 t0 68.46 111.29 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.053 -0.976 . . . . 61.100000000000001 109.782 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -76.8 -7.04 54.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 61.240000000000002 111.058 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.93 58.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.268 -0.968 . . . . 61.119999999999997 113.152 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt 60.77 36.14 19.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.841 0.312 . . . . 75.549999999999997 111.841 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.549 HD13 ' HA ' ' A' ' 191' ' ' ASP . 29.1 mt 72.33 110.12 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.467 -0.788 . . . . 74.329999999999998 111.464 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.75 96.86 10.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 74.319999999999993 109.508 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.437 HD13 HG21 ' A' ' 141' ' ' ILE . 12.7 tp -160.78 24.96 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.029 -0.532 . . . . 73.430000000000007 110.529 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 41.3 m -82.15 87.02 6.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.357 0.598 . . . . 73.209999999999994 110.864 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.14 -46.58 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.282 -0.872 . . . . 75.340000000000003 108.692 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 23.4 t 31.09 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.936 -1.484 . . . . 72.340000000000003 114.016 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -127.86 -96.21 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.597 -0.441 . . . . 73.040000000000006 110.995 175.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.492 ' HA ' ' HG2' ' A' ' 140' ' ' LYS . 65.6 t30 -166.19 161.9 17.2 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.808 0.277 . . . . 75.409999999999997 110.725 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 120.59 174.13 15.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.216 -0.516 . . . . 50.119999999999997 112.302 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 139' ' ' GLN . . . 84.02 -1.03 89.25 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.287 -0.482 . . . . 74.430000000000007 113.97 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 349' ' ' LEU . 4.3 mm? -64.8 120.39 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.212 0.506 . . . . 74.25 112.007 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -163.1 118.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 74.150000000000006 109.814 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.51 174.74 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.551 -0.295 . . . . 64.230000000000004 110.79 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.585 ' O ' HG23 ' A' ' 353' ' ' THR . 9.8 tmtt? -164.08 -57.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.736 -0.211 . . . . 74.420000000000002 110.635 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.653 ' HA ' ' HG ' ' A' ' 200' ' ' LEU . 0.6 OUTLIER 69.23 179.19 0.24 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.402 1.081 . . . . 72.329999999999998 111.655 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.533 HG23 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -65.45 144.13 15.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.728 0.775 . . . . 75.099999999999994 112.847 -172.131 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.9 t -71.96 154.7 41.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.642 -1.163 . . . . 64.049999999999997 111.06 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -149.97 146.77 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 74.530000000000001 109.727 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.44 ' HB2' ' NH2' ' A' ' 219' ' ' ARG . 29.6 ttpt -138.93 69.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.69 0.281 . . . . 74.420000000000002 110.44 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.57 155.64 1.8 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.984 -0.553 . . . . 62.530000000000001 110.058 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.671 ' HZ1' ' HB2' ' A' ' 359' ' ' LYS . 0.0 OUTLIER -78.46 142.31 37.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.092 0.473 . . . . 75.340000000000003 111.489 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 360' ' ' LYS . 29.9 ttpt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.321 -0.847 . . . . 73.010000000000005 109.044 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.658 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 87.9 mtp . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 119.475 -0.298 . . . . 62.219999999999999 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.658 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 87.7 Cg_endo -80.77 142.24 14.04 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.512 1.474 . . . . 72.400000000000006 111.622 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -119.59 120.42 36.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.353 -0.385 . . . . 75.209999999999994 110.801 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -86.04 147.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.02 -0.537 . . . . 74.319999999999993 110.088 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.41 ' HD3' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -159.69 134.9 8.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.319 -0.4 . . . . 74.310000000000002 110.582 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -173.35 112.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.526 -0.761 . . . . 73.129999999999995 109.827 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 76.62 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.199 0.523 . . . . 72.299999999999997 110.921 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.38 86.99 2.39 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.315 -0.624 . . . . 73.420000000000002 109.315 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.37 119.33 2.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 72.140000000000001 110.564 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.21 127.13 1.74 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.421 -0.895 . . . . 75.329999999999998 112.596 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 11' ' ' ARG . 3.9 mpt_? -124.22 151.47 44.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.789 0.328 . . . . 75.319999999999993 110.597 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -94.98 133.71 38.45 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.629 -0.508 . . . . 74.109999999999999 109.629 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -79.79 128.22 33.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.16 -0.473 . . . . 63.030000000000001 111.119 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -65.79 113.18 4.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.363 -0.606 . . . . 73.219999999999999 109.363 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.71 172.94 11.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.025 0.441 . . . . 74.120000000000005 111.536 -173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -68.91 162.17 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 74.239999999999995 111.105 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -134.18 139.76 46.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.54 . . . . 71.150000000000006 109.982 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.424 ' CE1' ' HB2' ' A' ' 21' ' ' GLU . 3.6 p80 -153.73 133.29 12.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.458 -0.337 . . . . 73.340000000000003 110.484 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD12 ' N ' ' A' ' 20' ' ' ALA . 3.0 pp -77.05 -17.38 58.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 75.150000000000006 111.027 -177.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.406 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -82.11 63.51 6.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.473 . . . . 74.310000000000002 109.901 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.424 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 27.5 tt0 -145.11 89.96 2.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.583 -0.735 . . . . 72.400000000000006 109.469 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.94 3.78 54.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.559 -0.746 . . . . 75.319999999999993 111.439 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 7.46 32.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.353 -0.385 . . . . 74.140000000000001 110.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.91 -163.21 1.01 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.233 -0.439 . . . . 73.409999999999997 110.121 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.31 143.74 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.46 -0.571 . . . . 75.099999999999994 109.46 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.1 2.1 56.98 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.598 -0.811 . . . . 75.409999999999997 111.821 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.444 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 13.5 pt-20 -74.63 155.43 37.82 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.116 0.484 . . . . 74.030000000000001 110.756 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.525 HD11 ' HB3' ' A' ' 38' ' ' LYS . 33.3 mm -87.11 118.74 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 72.329999999999998 110.191 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.1 137.9 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.889 0.376 . . . . 75.420000000000002 110.212 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 m -86.42 111.54 20.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 71.129999999999995 109.954 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.512 ' H ' ' HA ' ' A' ' 35' ' ' LYS . 12.0 t70 -111.38 159.57 17.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 74.5 110.272 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.827 ' HA ' ' HE3' ' A' ' 32' ' ' MET . 8.9 mmt -62.03 -22.56 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.047 0.451 . . . . 72.219999999999999 110.134 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.57 23.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 71.010000000000005 111.151 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.469 ' HD2' ' O ' ' A' ' 34' ' ' LYS . 2.8 tmmt? 74.0 44.88 0.24 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 72.439999999999998 110.466 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 60.0 pttt 45.28 -149.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.858 0.863 . . . . 74.409999999999997 112.681 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.587 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 53.9 mt-10 69.59 39.37 1.56 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.299 0.64 . . . . 73.420000000000002 111.095 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -126.77 121.38 31.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.79 -0.818 . . . . 72.239999999999995 108.79 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.591 ' HG2' ' SD ' ' A' ' 56' ' ' MET . 23.1 pttp -105.22 131.65 52.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.791 -0.764 . . . . 72.239999999999995 110.96 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.7 p -70.75 129.68 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.488 -0.778 . . . . 72.439999999999998 110.499 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.745 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -116.69 -106.28 2.45 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.624 -0.798 . . . . 63.100000000000001 113.185 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.0 tm? -62.89 118.3 40.87 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-O 121.15 0.5 . . . . 75.349999999999994 110.899 -174.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.925 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.7 Cg_exo -73.78 93.38 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.755 2.303 . . . . 75.540000000000006 111.733 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.07 -53.15 27.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.292 0.568 . . . . 73.420000000000002 109.618 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.17 -56.38 0.51 Allowed Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.456 -0.793 . . . . 63.0 112.035 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.594 ' HG2' ' HA2' ' A' ' 49' ' ' GLY . 56.4 mt-30 -151.77 130.05 12.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.837 0.351 . . . . 74.430000000000007 110.527 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.419 ' H ' HD12 ' A' ' 51' ' ' ILE . . . -99.55 26.71 23.33 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.331 -1.108 . . . . 75.230000000000004 110.331 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 348' ' ' GLY . . . 113.62 -50.65 0.76 Allowed Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.608 -0.597 . . . . 72.109999999999999 111.608 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.7 ' HZ ' ' HB2' ' A' ' 79' ' ' PRO . 49.4 t80 -77.22 -76.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.588 0.232 . . . . 73.430000000000007 110.405 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.594 ' HA2' ' HG2' ' A' ' 45' ' ' GLN . . . 172.86 150.43 7.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.131 -1.033 . . . . 70.019999999999996 113.084 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.9 t 45.66 67.01 0.8 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.989 0.915 . . . . 70.420000000000002 112.398 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 46' ' ' GLY . 17.0 mt -123.46 136.46 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 74.109999999999999 111.705 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.925 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 73.4 m-85 -129.42 165.9 20.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.393 . . . . 74.299999999999997 111.059 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.578 HD13 ' N ' ' A' ' 54' ' ' ALA . 1.3 tm? -90.81 143.12 27.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.067 -0.716 . . . . 74.349999999999994 109.067 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.578 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -92.55 75.27 5.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.236 0.541 . . . . 65.530000000000001 110.738 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.745 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 8.9 m-20 -79.29 67.47 5.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.652 . . . . 72.010000000000005 110.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.591 ' SD ' ' HG2' ' A' ' 38' ' ' LYS . 16.0 tpt -82.0 -52.25 7.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 75.140000000000001 110.645 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.39 115.37 7.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.484 . . . . 73.040000000000006 110.009 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.8 m -126.2 38.88 4.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 71.150000000000006 110.504 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m -71.03 -53.27 15.35 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.49 0.552 . . . . 75.150000000000006 112.49 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.26 24.31 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 72.040000000000006 112.085 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m 57.96 64.9 1.41 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.767 0.794 . . . . 71.450000000000003 108.998 -170.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 65' ' ' ASP . 7.9 m -63.0 141.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.598 -1.183 . . . . 72.510000000000005 112.678 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.79 0.9 52.18 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.444 -0.798 . . . . 64.049999999999997 112.258 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.5 m -120.49 -49.11 2.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.186 0.439 . . . . 70.340000000000003 112.186 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.514 ' HB2' HG22 ' A' ' 62' ' ' VAL . 6.1 m-20 -67.13 -63.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.736 0.643 . . . . 72.409999999999997 112.736 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.492 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -63.24 -43.18 79.62 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 113.839 1.052 . . . . 74.109999999999999 113.839 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 58.0 Cg_endo -71.03 33.12 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.136 1.89 . . . . 74.409999999999997 113.757 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.42 ' H ' ' C ' ' A' ' 66' ' ' ALA . 83.8 m -121.5 138.32 54.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.972 0.415 . . . . 74.450000000000003 110.22 175.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.482 ' CG1' ' HD3' ' A' ' 133' ' ' ARG . 15.9 m -114.92 143.22 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.09 -0.505 . . . . 74.219999999999999 109.862 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.0 p -117.13 116.09 50.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.88 0.847 . . . . 64.230000000000004 110.137 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.473 ' HD3' ' SD ' ' A' ' 129' ' ' MET . 16.3 ptmt -92.7 128.43 38.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.591 -1.186 . . . . 74.200000000000003 109.208 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.417 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 6.9 p -135.47 124.26 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 119.542 -0.863 . . . . 72.409999999999997 112.816 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.534 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 5.6 mm-40 -124.71 171.43 7.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.111 -0.95 . . . . 72.530000000000001 108.809 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.61 152.99 51.83 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.905 1.737 . . . . 72.340000000000003 111.43 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.9 t -53.71 -35.99 61.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.082 0.468 . . . . 73.150000000000006 110.408 177.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.39 116.02 30.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.771 . . . . 75.049999999999997 109.612 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -151.7 -68.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 61.5 110.745 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 -86.9 0.38 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.719 -0.753 . . . . 71.319999999999993 112.111 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.7 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . 51.1 Cg_exo -53.71 -43.73 55.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.123 2.549 . . . . 73.530000000000001 113.05 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.534 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 3.4 tm? -55.77 -45.84 78.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.962 0.41 . . . . 74.409999999999997 110.418 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.93 -35.96 77.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.15 0.5 . . . . 74.430000000000007 110.635 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -67.72 -48.48 66.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.93 -0.577 . . . . 75.519999999999996 110.921 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.778 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . 8.1 pt-20 -69.63 -27.89 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.141 -0.318 . . . . 73.120000000000005 110.141 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.483 ' HA ' ' HE1' ' A' ' 129' ' ' MET . 59.7 tp -62.99 -44.2 96.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.414 -0.357 . . . . 72.420000000000002 110.63 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.505 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 42.0 tptt -64.1 -46.14 85.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.261 -0.427 . . . . 73.299999999999997 109.876 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.406 ' HZ ' HG23 ' A' ' 168' ' ' ILE . 60.8 t80 -59.57 -47.93 83.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 73.439999999999998 110.128 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.43 -46.83 80.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.221 -0.9 . . . . 72.329999999999998 110.474 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.429 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -61.47 -35.39 77.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.194 -0.457 . . . . 74.129999999999995 111.218 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.505 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 79.0 mtp180 -81.44 -18.74 44.27 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.084 0.401 . . . . 75.510000000000005 112.084 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.97 -34.9 6.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.66 0.615 . . . . 74.420000000000002 112.66 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.436 ' HB3' ' O ' ' A' ' 111' ' ' PRO . . . -95.51 11.29 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.262 0.553 . . . . 75.150000000000006 111.998 -172.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 30.0 tttm -76.86 139.79 66.49 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 115.384 -0.825 . . . . 62.310000000000002 110.269 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 80.8 Cg_exo -47.37 -53.48 6.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.343 2.696 . . . . 64.439999999999998 113.697 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -40.72 93.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 63.140000000000001 110.683 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.483 ' HB3' ' OH ' ' A' ' 167' ' ' TYR . 13.2 mm100 -61.59 -48.9 78.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.609 -0.723 . . . . 71.519999999999996 111.148 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.641 HD13 ' HZ3' ' A' ' 112' ' ' LYS . 62.3 mt -66.0 -48.62 81.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.892 -0.594 . . . . 74.140000000000001 111.283 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -61.66 -37.91 85.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 73.510000000000005 111.026 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -61.24 -48.58 80.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 73.209999999999994 110.262 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -66.79 -46.0 76.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 73.209999999999994 111.096 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -54.95 -50.66 60.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 73.319999999999993 111.273 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -69.25 -32.43 71.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.457 . . . . 74.409999999999997 111.194 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 m -76.24 -40.36 52.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.593 -0.276 . . . . 74.099999999999994 111.743 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.548 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 10.8 ttt180 -93.64 9.05 38.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.973 -0.291 . . . . 74.329999999999998 111.167 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.854 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.1 mmpt? 64.81 28.9 12.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.234 -0.439 . . . . 75.430000000000007 111.542 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.548 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 88.5 mt -90.86 -173.61 3.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.041 -0.527 . . . . 75.239999999999995 111.022 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -26.54 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.329999999999998 109.833 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -154.13 165.2 36.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 75.109999999999999 110.213 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.4 tp -124.98 137.17 54.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 70.510000000000005 109.461 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.7 52.96 2.83 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.299 -0.477 . . . . 72.340000000000003 113.253 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.64 133.22 23.22 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.071 -0.714 . . . . 73.140000000000001 109.071 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.582 ' HG3' ' HZ ' ' A' ' 134' ' ' PHE . 24.2 Cg_exo -60.77 136.78 68.61 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.406 2.071 . . . . 71.310000000000002 111.401 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.721 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -65.29 125.77 26.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.09 0.472 . . . . 73.420000000000002 110.815 -178.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.36 113.96 19.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 73.120000000000005 110.114 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.444 ' CD1' HG23 ' A' ' 130' ' ' ILE . 24.5 m95 -92.48 -49.94 5.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.287 -0.635 . . . . 72.519999999999996 109.287 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.4 ' HA3' ' OD1' ' A' ' 31' ' ' ASP . . . -176.63 -168.76 37.12 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.591 -0.814 . . . . 74.5 112.684 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 82.4 p -179.96 177.21 0.68 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.934 -1.136 . . . . 73.340000000000003 107.934 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.82 -175.83 43.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.09 -1.529 . . . . 71.299999999999997 113.929 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.451 HD13 ' HB3' ' A' ' 125' ' ' SER . 2.0 tm? -120.33 127.3 52.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.03 -1.1 . . . . 73.239999999999995 108.03 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.421 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 51.7 t60 -130.89 117.14 18.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.02 0.438 . . . . 74.219999999999999 111.083 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -67.1 149.89 49.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 74.439999999999998 109.994 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -128.12 -89.33 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.865 0.364 . . . . 75.030000000000001 110.177 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -142.3 87.4 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.989 -0.745 . . . . 62.329999999999998 108.989 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -36.42 3.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.040000000000006 112.066 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -109.34 163.71 13.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.904 -0.406 . . . . 73.420000000000002 109.904 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.451 ' HB3' HD13 ' A' ' 118' ' ' LEU . 50.0 m -123.98 138.54 54.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.174 -0.466 . . . . 60.049999999999997 109.815 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.417 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 66.1 m-85 -103.65 145.63 29.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.515 . . . . 73.450000000000003 110.998 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -118.31 116.84 27.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.96 -0.756 . . . . 75.049999999999997 108.96 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.421 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 44.7 p90 -123.48 163.14 21.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.176 0.512 . . . . 73.150000000000006 112.244 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.483 ' HE1' ' HA ' ' A' ' 84' ' ' LEU . 14.2 ttm -143.46 133.12 23.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.937 -1.029 . . . . 71.150000000000006 109.785 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.444 HG23 ' CD1' ' A' ' 114' ' ' TRP . 37.5 mt -97.77 127.03 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.686 0.279 . . . . 72.409999999999997 110.25 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.509 ' HE3' HG23 ' A' ' 196' ' ' VAL . 18.7 ptm -138.78 177.97 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 73.319999999999993 111.273 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.63 142.03 58.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.731 -0.668 . . . . 63.539999999999999 111.351 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.482 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 9.0 tpt180 -79.33 112.89 17.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.267 0.556 . . . . 73.400000000000006 111.152 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.582 ' HZ ' ' HG3' ' A' ' 111' ' ' PRO . 16.0 m-85 -102.02 149.29 24.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.915 -0.584 . . . . 62.329999999999998 109.597 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.54 -6.54 2.96 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.651 -0.785 . . . . 71.129999999999995 111.883 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.936 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 44.9 m -120.8 124.21 44.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.952 0.406 . . . . 72.239999999999995 111.551 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.503 ' HA ' HD13 ' A' ' 184' ' ' LEU . 13.3 m-20 -98.07 125.73 43.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 74.040000000000006 109.56 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.627 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 17.2 tp -67.38 -18.67 65.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.184 0.516 . . . . 73.140000000000001 109.615 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.409 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 46.3 tp60 -60.09 -50.4 73.86 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.541 -0.754 . . . . 75.099999999999994 111.192 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -31.05 67.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.73 0.3 . . . . 73.209999999999994 110.283 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.547 HG21 ' HG ' ' A' ' 341' ' ' LEU . 71.7 mt -64.25 -51.95 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 62.030000000000001 110.733 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.929 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -68.91 -31.83 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.889 -0.412 . . . . 70.349999999999994 109.889 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.34 -53.45 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 73.430000000000007 111.178 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.15 -22.09 53.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.5 111.809 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -96.38 -1.48 47.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.936 0.398 . . . . 72.030000000000001 111.359 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 58.57 33.68 23.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.166 -0.47 . . . . 63.509999999999998 111.034 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.929 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 56.4 pttt 43.15 42.86 3.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.763 1.225 . . . . 75.010000000000005 113.226 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -115.68 90.09 3.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.077 -0.712 . . . . 75.400000000000006 109.077 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.44 157.36 17.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.542 . . . . 75.239999999999995 111.364 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -71.21 158.37 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.683 -0.689 . . . . 70.349999999999994 111.452 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.46 HH21 ' CD ' ' A' ' 298' ' ' GLU . 6.1 tpt180 -53.73 -39.03 64.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.162 -0.926 . . . . 71.230000000000004 111.084 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.428 ' HZ1' ' CG ' ' A' ' 336' ' ' ASP . 25.8 mtpp -61.71 -61.96 2.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.527 -0.761 . . . . 72.409999999999997 111.564 -175.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t -64.86 -36.37 84.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.310000000000002 112.088 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.25 -43.04 98.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.727 0.299 . . . . 75.510000000000005 110.913 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.691 ' HG ' ' HG ' ' A' ' 328' ' ' LEU . 0.4 OUTLIER -64.87 -47.4 78.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.457 -0.338 . . . . 74.230000000000004 110.168 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.403 ' HB2' ' HB2' ' A' ' 335' ' ' ASP . 5.8 tp-100 -59.15 -45.24 91.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.835 0.35 . . . . 74.420000000000002 110.723 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.487 ' O ' HD11 ' A' ' 161' ' ' ILE . 35.2 tp -59.98 -46.81 88.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 71.510000000000005 110.367 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.2 t -61.3 -39.27 89.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 64.439999999999998 110.459 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.51 -49.72 74.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.509 . . . . 74.019999999999996 110.202 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.687 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -60.62 -40.55 92.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.892 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 157' ' ' LEU . 1.7 mp -61.79 -40.64 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 71.409999999999997 109.864 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.98 -37.87 86.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 75.140000000000001 110.781 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.434 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.6 m-20 -56.12 -58.19 8.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.363 0.601 . . . . 73.420000000000002 110.593 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.507 HD12 HD12 ' A' ' 195' ' ' LEU . 18.7 tt -71.14 -35.89 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.573 -0.739 . . . . 74.409999999999997 111.231 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.8 -38.54 91.34 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.825 -0.171 . . . . 65.530000000000001 110.91 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.342 -0.614 . . . . 74.219999999999999 109.342 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.483 ' OH ' ' HB3' ' A' ' 95' ' ' GLN . 61.4 t80 -56.18 -45.19 79.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.142 -0.936 . . . . 71.299999999999997 111.962 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.406 HG23 ' HZ ' ' A' ' 86' ' ' PHE . 35.1 pt -84.89 -32.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.856 -0.337 . . . . 63.409999999999997 111.874 -176.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.621 ' HE1' ' HA ' ' A' ' 240' ' ' ARG . 5.1 t60 -66.2 -41.13 90.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.301 -0.259 . . . . 65.010000000000005 110.301 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.905 0.383 . . . . 74.299999999999997 110.452 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -88.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 75.439999999999998 110.467 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 11.2 pt-20 -166.11 11.69 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.856 0.687 . . . . 74.230000000000004 112.856 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.78 141.81 51.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.778 -0.369 . . . . 73.129999999999995 110.895 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 238' ' ' PRO . 12.9 m -123.65 126.06 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 75.540000000000006 110.392 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.624 ' HD1' HD12 ' A' ' 178' ' ' ILE . 41.7 t-80 -89.09 69.84 8.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.983 -0.747 . . . . 61.109999999999999 108.983 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.89 46.68 3.39 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.689 -0.687 . . . . 71.200000000000003 113.806 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.485 ' CG ' ' H ' ' A' ' 224' ' ' THR . 11.1 t70 -175.7 96.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 75.109999999999999 109.255 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.702 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -90.01 70.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.392 0.615 . . . . 60.340000000000003 110.393 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.664 ' HD2' ' OG1' ' A' ' 224' ' ' THR . 56.6 tttm -83.76 134.87 34.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.143 -0.688 . . . . 73.120000000000005 109.143 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.627 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -54.87 -26.34 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 73.109999999999999 112.051 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.409 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 0.9 OUTLIER -66.5 -25.56 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.409 -0.359 . . . . 70.230000000000004 111.261 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.423 ' HB2' HD11 ' A' ' 200' ' ' LEU . 6.9 t-20 -84.11 -7.42 59.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 73.030000000000001 109.882 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.444 HD22 HD13 ' A' ' 161' ' ' ILE . 21.1 mt -105.75 115.57 30.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.071 -0.968 . . . . 73.150000000000006 110.503 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.843 HD21 ' HE3' ' A' ' 350' ' ' LYS . 4.1 mm? -118.08 140.35 49.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 74.209999999999994 110.535 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.936 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 9.0 mp -100.72 145.27 28.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.655 -0.498 . . . . 73.409999999999997 109.655 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.656 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 25.5 t-20 -59.99 147.64 38.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.17 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -57.69 -26.83 62.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.395 0.517 . . . . 72.450000000000003 112.395 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -115.48 -15.83 11.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 70.310000000000002 111.878 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.26 107.11 30.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 112.018 0.377 . . . . 73.430000000000007 112.018 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.529 ' HA ' HD23 ' A' ' 185' ' ' LEU . 17.9 Cg_exo -67.62 -21.84 45.06 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.069 2.513 . . . . 73.0 111.586 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.668 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 7.3 p-10 -91.39 6.51 45.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.556 . . . . 71.450000000000003 111.047 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -119.35 99.78 6.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 71.420000000000002 109.646 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.24 133.67 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.885 -0.598 . . . . 75.25 110.496 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.656 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 18.0 m-85 -128.17 158.05 39.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 75.540000000000006 110.018 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.507 HD12 HD12 ' A' ' 164' ' ' ILE . 82.9 mt -95.63 150.2 20.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.671 0.272 . . . . 73.430000000000007 110.608 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.509 HG23 ' HE3' ' A' ' 131' ' ' MET . 4.2 p -138.23 175.87 7.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.736 -0.839 . . . . 74.209999999999994 108.736 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.486 ' HB3' ' O ' ' A' ' 196' ' ' VAL . 0.6 OUTLIER 75.64 -58.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.461 0.476 . . . . 64.530000000000001 110.769 174.902 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.778 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 25.8 m-85 63.77 12.21 6.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.428 -0.805 . . . . 74.430000000000007 112.343 173.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.35 -15.64 81.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.601 -1.0 . . . . 62.130000000000003 110.601 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.817 HD22 ' HE3' ' A' ' 352' ' ' LYS . 89.9 mt -92.92 17.09 11.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.01 -0.595 . . . . 64.140000000000001 110.283 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 175' ' ' HIS . . . -127.76 99.42 5.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.104 -0.702 . . . . 74.400000000000006 109.104 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -99.54 149.64 23.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.302 0.572 . . . . 73.099999999999994 111.106 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.431 ' O ' ' HG3' ' A' ' 203' ' ' ARG . 32.7 ptt180 -60.1 115.52 3.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.852 -1.067 . . . . 74.340000000000003 111.131 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -101.83 -29.76 11.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.384 0.611 . . . . 71.120000000000005 109.745 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 45.7 m -133.88 64.42 66.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 74.340000000000003 109.643 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.25 113.86 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.93 2.42 . . . . 75.120000000000005 113.167 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 70.21 14.3 7.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.723 -0.671 . . . . 74.299999999999997 110.457 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.04 -7.25 52.24 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.874 -0.679 . . . . 74.420000000000002 112.307 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.84 111.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 74.150000000000006 110.535 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -102.69 128.58 49.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.285 -0.416 . . . . 74.010000000000005 110.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -115.46 162.22 17.48 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.371 -0.603 . . . . 74.049999999999997 109.371 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -83.75 -172.16 4.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.484 0.659 . . . . 74.200000000000003 111.915 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -76.41 151.86 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 75.329999999999998 111.861 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -134.33 0.65 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 74.450000000000003 110.473 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 69.49 -63.13 0.39 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.501 -0.772 . . . . 72.420000000000002 112.522 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -157.2 105.5 1.88 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.76 0.314 . . . . 72.120000000000005 111.778 -178.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -101.2 0.75 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.49 2.793 . . . . 65.239999999999995 113.3 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.43 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 4.7 tmtt? 176.23 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.243 0.09 . . . . 75.239999999999995 111.243 -170.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 218' ' ' LYS . 99.3 mtt180 71.09 103.25 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.334 -0.617 . . . . 65.230000000000004 109.334 -168.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.443 ' H ' ' HA2' ' A' ' 235' ' ' GLY . 49.5 t -79.5 -54.69 5.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.557 -0.747 . . . . 74.310000000000002 111.134 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.4 p80 44.19 41.31 4.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.765 . . . . 73.120000000000005 111.888 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -67.72 -38.36 83.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.707 -0.678 . . . . 71.310000000000002 110.776 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.57 -170.4 46.32 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.959 -0.564 . . . . 73.0 112.833 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.664 ' OG1' ' HD2' ' A' ' 179' ' ' LYS . 1.1 m -91.1 114.25 26.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.689 -0.486 . . . . 74.310000000000002 109.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.616 HG12 HG13 ' A' ' 271' ' ' VAL . 18.3 tt -52.77 -17.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 113.377 0.88 . . . . 74.239999999999995 113.377 -167.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -65.42 -43.88 89.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 73.409999999999997 109.846 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.605 ' HD2' ' HB ' ' A' ' 224' ' ' THR . 36.6 m-85 -96.07 -41.41 8.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.58 -0.736 . . . . 75.450000000000003 111.381 -174.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.47 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 0.2 OUTLIER -57.45 -5.56 0.35 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.499 1.296 . . . . 65.430000000000007 114.499 -166.821 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.6 t 62.99 -158.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.932 0.396 . . . . 62.409999999999997 110.162 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.5 mt -71.87 -47.53 55.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.417 -0.356 . . . . 72.25 110.795 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -35.99 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.276 1.213 . . . . 60.420000000000002 114.276 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.63 ' HB1' ' HG3' ' A' ' 238' ' ' PRO . . . -70.0 -30.14 67.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.477 0.547 . . . . 74.329999999999998 112.477 -167.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -21.76 61.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 74.299999999999997 110.119 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.24 -34.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.785 -0.45 . . . . 74.129999999999995 109.785 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.443 ' HA2' ' H ' ' A' ' 220' ' ' CYS . . . 142.17 -33.93 1.88 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.242 -0.98 . . . . 74.340000000000003 113.231 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.52 140.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.827 0.314 . . . . 74.439999999999998 110.637 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -56.86 135.34 79.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 73.049999999999997 110.348 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.63 ' HG3' ' HB1' ' A' ' 232' ' ' ALA . 75.8 Cg_exo -49.89 115.72 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 2.458 . . . . 74.540000000000006 112.279 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 84.6 p -83.59 -178.06 6.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.04 -0.527 . . . . 73.519999999999996 110.534 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.621 ' HA ' ' HE1' ' A' ' 169' ' ' HIS . 9.3 ptp85 -64.55 -31.29 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.612 0.72 . . . . 75.030000000000001 109.537 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -64.26 -40.26 95.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.226 -0.897 . . . . 75.109999999999999 109.538 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.454 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -58.93 -69.29 1.32 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.068 -0.969 . . . . 55.210000000000001 112.391 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -61.45 -33.82 74.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.128 0.464 . . . . 61.420000000000002 112.078 -170.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.59 -46.92 57.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.566 -0.454 . . . . 74.510000000000005 111.734 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.18 -27.71 60.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.003 0.43 . . . . 74.109999999999999 110.305 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.454 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.5 mt -63.92 -45.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 74.010000000000005 110.507 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.529 HD23 ' HH ' ' A' ' 302' ' ' TYR . 37.6 tp -60.38 -36.51 78.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.834 -0.432 . . . . 74.329999999999998 109.834 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.19 -47.61 88.3 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.754 -0.736 . . . . 71.439999999999998 112.142 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -59.65 -43.75 93.79 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.777 0.322 . . . . 73.540000000000006 110.79 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 35.4 m -65.49 -37.44 86.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.451 . . . . 75.109999999999999 110.908 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.38 -50.71 70.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 74.400000000000006 110.866 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.8 tt -69.79 -28.62 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.649 -0.42 . . . . 65.209999999999994 110.443 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.79 -50.84 71.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.934 0.397 . . . . 63.329999999999998 110.322 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.9 m0 -70.3 -24.97 63.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.531 -0.759 . . . . 72.219999999999999 111.012 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.732 HD13 HD22 ' A' ' 294' ' ' ASN . 30.1 tp -76.39 -32.6 58.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.239999999999995 111.719 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -103.37 -27.24 12.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.531 0.567 . . . . 70.519999999999996 112.531 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 86.83 -20.49 24.09 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.447 -0.882 . . . . 44.350000000000001 112.588 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -147.36 144.35 28.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.616 -0.512 . . . . 75.340000000000003 109.616 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.74 149.03 36.39 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 75.109999999999999 110.29 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.17 -34.94 98.57 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.323 2.015 . . . . 73.439999999999998 112.18 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -96.57 13.64 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 75.510000000000005 110.862 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.18 -31.15 69.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 75.129999999999995 110.669 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -84.13 -6.86 59.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.794 0.807 . . . . 70.040000000000006 109.556 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.86 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 2.9 m-20 -106.86 5.12 28.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.927 -1.033 . . . . 74.409999999999997 109.51 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.431 ' O ' HD12 ' A' ' 265' ' ' LEU . 1.9 tm? -65.16 -33.7 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.553 -0.749 . . . . 75.420000000000002 111.537 -170.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.42 -23.22 65.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.207 0.447 . . . . 72.319999999999993 112.207 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.593 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 14.7 t70 -109.7 127.5 27.04 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.929 0.395 . . . . 65.030000000000001 111.69 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.94 -39.85 67.47 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.391 2.728 . . . . 75.510000000000005 113.649 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 9.8 ptmm? -79.11 -37.88 37.56 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.359 -0.536 . . . . 75.420000000000002 110.008 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.86 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 9.1 m-85 -58.11 -42.84 86.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.56 0.219 . . . . 75.319999999999993 110.818 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.616 HG13 HG12 ' A' ' 225' ' ' ILE . 65.3 t -63.16 -50.6 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.563 -0.29 . . . . 71.010000000000005 110.519 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.446 ' O ' HG13 ' A' ' 276' ' ' ILE . 31.0 ttp180 -60.13 -48.86 79.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.602 -0.272 . . . . 73.409999999999997 111.273 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.68 -45.72 85.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.466 0.479 . . . . 73.540000000000006 111.514 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 21.4 m -66.79 -43.26 84.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.102 -0.499 . . . . 52.340000000000003 111.174 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 7.8 mmmm -61.6 -32.64 72.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.758 0.313 . . . . 74.530000000000001 110.636 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 272' ' ' ARG . 75.7 mt -72.91 -44.44 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.385 -0.37 . . . . 75.040000000000006 111.013 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.45 -32.61 74.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.973 0.416 . . . . 71.140000000000001 110.563 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -74.24 -32.25 62.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.38 -0.373 . . . . 72.209999999999994 110.817 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 23.7 mtp180 -59.11 -33.42 70.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.39 -0.368 . . . . 74.510000000000005 110.854 174.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.45 -39.9 70.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.569 -0.742 . . . . 74.209999999999994 111.417 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 284' ' ' SER . 36.5 t30 -153.99 84.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.193 0.52 . . . . 74.340000000000003 110.438 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.402 HD12 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -78.72 -35.96 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 73.519999999999996 111.968 -176.161 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.73 80.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.797 0.332 . . . . 75.349999999999994 111.241 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' SER . . . . . 0.494 ' HB3' ' ND2' ' A' ' 281' ' ' ASN . 22.7 t -75.3 -45.71 38.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 72.349999999999994 110.454 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.446 HD22 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -61.67 -42.41 98.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.925 0.343 . . . . 72.420000000000002 111.925 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.0 mmt -74.99 -43.58 53.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.93 -0.308 . . . . 73.409999999999997 111.301 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.69 -38.98 84.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.102 0.477 . . . . 74.450000000000003 111.023 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -84.54 -2.0 56.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.84 -0.618 . . . . 75.329999999999998 110.575 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.46 -21.4 38.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 74.310000000000002 109.393 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -137.48 76.92 41.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 75.340000000000003 109.029 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.49 44.7 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.557 2.838 . . . . 72.420000000000002 112.691 -173.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.11 -179.44 3.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.975 -0.38 . . . . 71.209999999999994 109.975 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -81.05 20.54 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.372 0.508 . . . . 74.010000000000005 112.372 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.732 HD22 HD13 ' A' ' 255' ' ' LEU . 41.5 t30 -77.47 -48.14 17.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.47 -0.567 . . . . 62.109999999999999 109.47 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.478 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 23.9 tptm 77.85 95.09 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 115.222 -0.899 . . . . 65.349999999999994 111.147 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.84 48.04 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.889 2.392 . . . . 55.509999999999998 112.196 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.14 54.93 Favored Glycine 0 C--O 1.238 0.356 0 CA-C-N 115.942 -0.572 . . . . 72.239999999999995 112.76 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.547 ' HA ' ' CD1' ' A' ' 323' ' ' ILE . 1.7 mp0 -55.37 -45.14 76.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 74.439999999999998 110.497 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.7 mp -63.0 -45.3 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 73.340000000000003 110.827 -176.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.13 50.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 75.510000000000005 111.428 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 301' ' ' LYS . 22.3 mtpp -77.17 -27.94 53.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 75.209999999999994 111.897 -176.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.529 ' HH ' HD23 ' A' ' 247' ' ' LEU . 45.1 t80 -55.99 -52.78 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.518 . . . . 71.420000000000002 109.97 173.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG23 ' A' ' 306' ' ' VAL . 55.6 mtp -72.68 -36.28 67.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.464 -0.789 . . . . 72.540000000000006 110.869 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -57.39 -46.42 83.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.362 0.601 . . . . 74.420000000000002 109.795 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 47.9 m -63.17 -52.5 62.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.037 -0.983 . . . . 73.439999999999998 112.078 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.517 HG23 ' HA ' ' A' ' 303' ' ' MET . 34.6 m -64.24 -27.35 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.712 0.291 . . . . 74.230000000000004 111.551 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -80.65 -30.48 36.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.711 0.291 . . . . 73.319999999999993 111.042 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.86 -17.73 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 74.439999999999998 110.326 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.609 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 67.8 mt -71.16 -13.84 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 72.040000000000006 110.889 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 35.7 t70 59.23 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 73.340000000000003 111.736 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.536 ' O ' ' HD2' ' A' ' 240' ' ' ARG . 49.5 t80 -152.4 -48.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.442 0.163 . . . . 71.209999999999994 110.685 174.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 5.4 m -125.67 36.14 4.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.243 0.544 . . . . 53.439999999999998 111.668 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.609 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 14.8 tp10 -90.49 23.06 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.937 -0.477 . . . . 75.420000000000002 110.04 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 72.36 130.64 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 115.466 -0.788 . . . . 71.430000000000007 111.811 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.548 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 1.4 Cg_endo -82.37 118.31 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.415 2.076 . . . . 75.310000000000002 110.881 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.461 ' O ' HD11 ' A' ' 320' ' ' LEU . 16.9 tp -104.09 92.6 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 75.510000000000005 110.138 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.72 -40.44 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 75.519999999999996 111.556 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.405 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.6 pm0 -67.22 -29.3 68.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 72.230000000000004 111.617 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.432 ' HB2' HD22 ' A' ' 316' ' ' LEU . 23.3 t-20 -66.06 -48.87 69.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.791 -0.448 . . . . 71.329999999999998 109.791 175.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.496 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 9.4 mp -60.47 -43.15 97.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.602 -0.726 . . . . 73.219999999999999 110.619 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.435 ' O ' HD22 ' A' ' 325' ' ' LEU . 1.2 tmt_? -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.140000000000001 110.63 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.21 -40.5 71.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 72.310000000000002 111.274 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.547 ' CD1' ' HA ' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -63.72 -37.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.618 0.247 . . . . 75.439999999999998 110.373 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 298' ' ' GLU . 87.1 mt -67.86 -46.73 70.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.954 0.407 . . . . 73.349999999999994 110.667 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 321' ' ' ARG . 4.3 mm? -66.93 -29.26 69.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 74.310000000000002 111.171 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 326' ' ' GLN . 1.0 OUTLIER -66.34 -42.38 88.23 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.406 -0.59 . . . . 72.129999999999995 109.406 178.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.99 98.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.802 -0.713 . . . . 73.099999999999994 111.925 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.691 ' HG ' ' HG ' ' A' ' 155' ' ' LEU . 14.1 mt -69.18 -36.37 77.26 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.854 -0.204 . . . . 75.010000000000005 111.488 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -60.3 -34.03 73.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.747 0.308 . . . . 73.219999999999999 110.426 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.82 -29.79 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 54.530000000000001 111.816 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.7 pt -107.68 1.01 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 74.040000000000006 111.094 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 77.07 24.99 65.1 Favored Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.949 -0.643 . . . . 73.109999999999999 113.052 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.58 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 62.6 m -107.45 156.7 18.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.077 0.465 . . . . 75.439999999999998 111.254 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -152.96 16.8 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.394 -0.965 . . . . 74.510000000000005 108.394 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 338' ' ' LYS . 24.7 t70 67.27 125.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.529 -1.214 . . . . 73.340000000000003 109.298 -162.016 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.428 ' CG ' ' HZ1' ' A' ' 152' ' ' LYS . 0.2 OUTLIER -132.49 -49.26 0.91 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.282 -0.872 . . . . 73.109999999999999 110.763 -169.434 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -70.56 -10.16 66.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.842 -0.694 . . . . 50.210000000000001 111.824 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.668 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 12.3 mmmm 67.41 82.9 0.17 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.622 0.769 . . . . 75.409999999999997 111.431 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.489 HD12 ' HA ' ' A' ' 191' ' ' ASP . 50.9 mt 59.8 71.63 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.902 -1.044 . . . . 74.299999999999997 112.793 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.56 95.97 0.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.911 -1.144 . . . . 75.310000000000002 107.911 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.547 ' HG ' HG21 ' A' ' 141' ' ' ILE . 2.5 tp -149.26 -44.37 0.14 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.734 0.642 . . . . 73.239999999999995 112.734 -166.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.6 m -50.9 120.19 4.61 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.787 0.662 . . . . 74.329999999999998 112.787 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.518 ' O ' ' HB ' ' A' ' 344' ' ' VAL . 18.3 m -131.06 20.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 75.319999999999993 110.144 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.518 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 69.0 t 90.77 109.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 124.317 1.011 . . . . 72.140000000000001 109.735 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.594 ' HG2' ' HB3' ' A' ' 136' ' ' SER . 6.1 mp0 -110.65 135.63 50.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.51 -0.768 . . . . 74.420000000000002 111.638 -169.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -178.07 106.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 71.099999999999994 110.019 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 175.81 66.71 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.554 -0.831 . . . . 73.519999999999996 111.905 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.463 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . -78.79 58.51 4.23 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.137 -0.554 . . . . 71.230000000000004 113.197 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.69 83.44 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 74.219999999999999 110.315 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.843 ' HE3' HD21 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -156.8 106.73 2.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.503 0.668 . . . . 70.349999999999994 110.663 177.052 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -148.83 106.66 3.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 73.510000000000005 109.845 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.817 ' HE3' HD22 ' A' ' 200' ' ' LEU . 4.5 mptp? -99.81 -167.7 1.5 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.246 0.546 . . . . 71.25 110.556 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.8 t -161.45 157.67 25.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 71.400000000000006 108.691 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.454 ' H ' HD12 ' A' ' 354' ' ' ILE . 0.1 OUTLIER -99.63 126.83 52.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.323 0.582 . . . . 73.420000000000002 111.785 -173.395 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 18.5 m -75.95 74.12 2.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.608 -0.724 . . . . 75.329999999999998 109.908 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -94.94 -32.05 13.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.68 . . . . 75.329999999999998 110.432 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 179.65 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.14 -0.689 . . . . 74.519999999999996 109.14 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -179.55 149.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.914 -0.773 . . . . 74.120000000000005 108.914 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.442 ' HZ2' ' C ' ' A' ' 360' ' ' LYS . 8.2 tmtm? -106.35 119.18 38.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.749 0.309 . . . . 74.230000000000004 110.568 -177.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.442 ' C ' ' HZ2' ' A' ' 359' ' ' LYS . 45.2 tttm . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.491 -0.766 . . . . 75.329999999999998 109.332 174.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtp . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.646 0.26 . . . . 71.219999999999999 110.599 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -93.02 137.06 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.413 2.075 . . . . 63.109999999999999 111.398 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -161.84 78.37 0.53 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.96 -0.755 . . . . 72.019999999999996 108.96 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.87 161.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.363 0.601 . . . . 73.329999999999998 111.567 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -117.89 95.47 4.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.627 -1.249 . . . . 73.519999999999996 107.627 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.47 -77.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.531 0.567 . . . . 74.129999999999995 112.531 -167.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.29 176.68 3.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.381 -0.372 . . . . 64.140000000000001 110.936 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -142.63 129.58 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.111 -0.495 . . . . 73.209999999999994 109.742 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.92 97.58 6.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.015 0.436 . . . . 74.129999999999995 110.469 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.75 94.6 1.47 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.784 -0.722 . . . . 71.239999999999995 112.917 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -146.08 149.22 33.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.201 -0.666 . . . . 74.310000000000002 109.201 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.03 144.76 50.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.487 . . . . 74.319999999999993 110.942 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -130.91 128.63 40.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.983 -0.553 . . . . 73.319999999999993 111.328 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -151.15 120.17 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.446 -0.343 . . . . 54.130000000000003 110.285 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.48 109.09 3.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 74.319999999999993 110.578 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -137.13 119.34 15.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 73.129999999999995 110.251 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 17' ' ' ARG . 20.2 ttt180 -160.03 97.35 1.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.53 -0.759 . . . . 74.109999999999999 110.353 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -111.83 123.16 49.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 73.409999999999997 109.655 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.402 ' N ' HD21 ' A' ' 19' ' ' LEU . 2.5 pt? -147.93 8.12 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.103 -0.499 . . . . 74.299999999999997 111.238 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.476 ' HB2' HG21 ' A' ' 25' ' ' VAL . . . -120.6 73.29 1.0 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.5 . . . . 74.010000000000005 111.52 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -132.09 108.21 9.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.219 -0.659 . . . . 75.340000000000003 109.219 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -171.24 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.873 -0.331 . . . . 70.519999999999996 111.856 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -158.07 74.15 0.7 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.459 0.647 . . . . 75.329999999999998 110.068 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 175.5 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.266 -1.383 . . . . 74.040000000000006 107.266 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.476 HG21 ' HB2' ' A' ' 20' ' ' ALA . 90.1 t -67.05 140.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.944 -1.026 . . . . 73.109999999999999 108.389 164.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.455 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.81 -5.66 59.97 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.492 -0.861 . . . . 62.43 112.271 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.52 140.82 31.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.697 -0.483 . . . . 71.019999999999996 109.697 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.412 ' H ' HD12 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -98.53 131.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.247 0.546 . . . . 74.049999999999997 110.779 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.3 137.0 47.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.745 -0.661 . . . . 64.540000000000006 110.039 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.599 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 23.6 m -106.76 121.01 43.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.29 -0.414 . . . . 73.549999999999997 110.627 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.595 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 3.2 p-10 -83.35 -175.44 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 71.109999999999999 110.812 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.452 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 25.3 mmt -65.95 -28.09 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.372 0.508 . . . . 73.239999999999995 112.372 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.748 ' HB1' ' HE2' ' A' ' 35' ' ' LYS . . . -90.71 9.69 28.89 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.99 0.424 . . . . 75.239999999999995 110.822 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 63.4 69.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.412 -0.813 . . . . 74.450000000000003 112.862 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.748 ' HE2' ' HB1' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -127.33 141.91 51.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.162 -0.681 . . . . 74.120000000000005 109.162 168.325 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.59 101.55 14.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.983 0.42 . . . . 71.450000000000003 110.233 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.635 ' HZ2' ' HZ3' ' A' ' 35' ' ' LYS . 70.5 m95 -98.97 108.61 21.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 75.010000000000005 110.515 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.73 123.41 27.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.212 -0.662 . . . . 73.230000000000004 109.212 175.875 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.86 132.32 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.136 -0.484 . . . . 72.340000000000003 110.531 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' HG11 ' A' ' 25' ' ' VAL . . . -116.12 -131.75 4.88 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 121.09 -0.576 . . . . 73.310000000000002 112.992 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.8 tt -63.75 128.31 92.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.053 0.454 . . . . 73.230000000000004 111.381 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.9 Cg_exo -74.95 100.65 1.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.15 2.567 . . . . 73.409999999999997 111.991 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.639 HD12 HD13 ' A' ' 53' ' ' LEU . 69.3 mt -62.33 -55.93 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.162 0.506 . . . . 73.439999999999998 110.925 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.94 148.05 18.49 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.649 -0.786 . . . . 62.539999999999999 111.899 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' HG12 ' A' ' 51' ' ' ILE . 25.3 tm0? -112.73 165.88 11.87 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.262 -1.014 . . . . 73.549999999999997 108.262 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.488 ' HA2' ' NZ ' ' A' ' 140' ' ' LYS . . . -40.57 -51.45 3.85 Favored Glycine 0 C--N 1.335 0.475 0 O-C-N 123.47 0.482 . . . . 64.040000000000006 113.884 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 26.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.959 -1.115 . . . . 72.209999999999994 113.47 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.548 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 75.5 t80 -129.84 -77.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.094 0.447 . . . . 75.040000000000006 111.287 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.66 -40.63 76.79 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.179 -0.534 . . . . 54.43 113.954 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.44 ' H ' ' HB3' ' A' ' 45' ' ' GLN . 59.3 m 64.2 96.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.31 0.576 . . . . 74.140000000000001 110.81 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 45' ' ' GLN . 4.1 mm -101.31 139.71 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 73.140000000000001 111.618 -172.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.81 158.73 16.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 73.230000000000004 109.728 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.639 HD13 HD12 ' A' ' 43' ' ' ILE . 9.5 tt -97.1 144.57 26.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.582 -0.525 . . . . 73.430000000000007 109.582 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' N ' HD22 ' A' ' 53' ' ' LEU . . . -118.5 114.78 23.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.759 0.314 . . . . 74.140000000000001 110.283 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.43 8.42 33.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.395 -0.366 . . . . 73.109999999999999 111.049 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.444 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 1.4 tmt? 69.49 -60.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.376 0.67 . . . . 72.510000000000005 109.805 -174.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 56' ' ' MET . 62.9 t30 174.16 149.05 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.931 0.769 . . . . 74.219999999999999 109.273 171.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p -82.39 73.22 9.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.344 0.592 . . . . 73.209999999999994 110.348 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.8 m -139.57 -173.92 3.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.337 -0.847 . . . . 75.510000000000005 109.728 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.93 56.79 2.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.668 . . . . 73.420000000000002 109.635 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 p -120.22 -52.93 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.743 . . . . 74.519999999999996 109.986 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.21 136.87 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 73.099999999999994 110.045 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.3 -10.92 4.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.472 -0.871 . . . . 73.129999999999995 112.529 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.4 m -116.88 -77.76 0.57 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.701 -0.293 . . . . 62.439999999999998 111.236 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.9 p30 -146.34 -35.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.725 0.639 . . . . 74.310000000000002 112.725 -173.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 75.41 80.61 0.14 Allowed Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 124.098 0.874 . . . . 74.200000000000003 109.25 -171.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.438 ' HG2' ' CH2' ' A' ' 114' ' ' TRP . 82.5 Cg_endo -90.92 37.96 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.427 2.751 . . . . 75.230000000000004 113.76 -169.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.89 139.05 53.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.153 0.501 . . . . 70.129999999999995 111.606 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 53' ' ' LEU . 34.2 m -130.29 162.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.235 -0.654 . . . . 74.420000000000002 109.235 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 130' ' ' ILE . 7.4 p -132.73 130.13 58.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.611 0.72 . . . . 72.329999999999998 111.688 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.499 ' HB2' HD13 ' A' ' 51' ' ' ILE . 76.2 tttt -94.79 137.47 33.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.023 -0.989 . . . . 74.409999999999997 109.42 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.83 140.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 75.319999999999993 111.743 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.54 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 16.2 mt-10 -157.35 161.1 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 75.150000000000006 109.576 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.01 148.54 92.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.321 2.014 . . . . 71.409999999999997 111.353 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.0 t -47.47 -50.02 24.1 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.553 0.533 . . . . 74.409999999999997 112.208 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.48 45.28 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.749 0.309 . . . . 74.439999999999998 111.456 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -69.34 -37.5 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.353 0.597 . . . . 73.409999999999997 110.264 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.03 -80.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.584 -0.817 . . . . 74.329999999999998 112.422 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.548 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.4 Cg_exo -60.91 -40.99 48.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.075 2.517 . . . . 74.030000000000001 112.768 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.54 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 1.6 tm? -52.63 -48.6 66.27 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 123.518 0.511 . . . . 74.430000000000007 111.172 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.29 -45.9 89.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.706 0.289 . . . . 74.530000000000001 111.185 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.469 HG23 ' HB2' ' A' ' 201' ' ' ALA . 3.2 m -63.61 -42.5 98.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.336 0.589 . . . . 72.25 110.424 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.21 -30.27 64.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 75.150000000000006 110.484 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.63 -41.97 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 63.420000000000002 110.729 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.565 ' HD2' ' HE2' ' A' ' 173' ' ' TYR . 41.6 ttmt -63.71 -40.11 95.95 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.714 -0.395 . . . . 75.030000000000001 109.961 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.24 -45.44 93.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.317 0.58 . . . . 73.450000000000003 109.648 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.491 ' OH ' ' HA ' ' A' ' 113' ' ' TYR . 81.1 t80 -58.28 -37.24 74.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 75.329999999999998 110.926 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.52 -32.77 72.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 72.239999999999995 111.057 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 12.4 mmt180 -72.08 -37.9 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.519999999999996 111.075 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.457 ' O ' HD13 ' A' ' 96' ' ' ILE . . . -96.27 17.16 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 73.340000000000003 111.118 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -87.63 146.9 25.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.909 -0.587 . . . . 73.319999999999993 111.594 -175.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 41.2 ttmt 77.92 117.25 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.256 -0.884 . . . . 72.340000000000003 111.533 174.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -56.52 -29.33 78.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.337 2.691 . . . . 63.039999999999999 113.087 -179.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.43 -53.26 60.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.684 0.278 . . . . 73.530000000000001 111.395 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.89 -47.75 81.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 75.549999999999997 110.152 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.457 HD13 ' O ' ' A' ' 90' ' ' ALA . 59.0 mt -56.21 -51.25 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.674 . . . . 74.439999999999998 111.022 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -53.83 -42.17 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 74.010000000000005 110.621 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -60.32 -60.23 4.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.576 -0.738 . . . . 72.099999999999994 111.449 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -73.26 -34.44 65.83 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 119.964 -0.694 . . . . 72.209999999999994 111.353 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.64 HD13 ' HG ' ' A' ' 108' ' ' LEU . 28.3 mm -59.72 -38.04 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.668 -0.413 . . . . 74.040000000000006 110.475 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -78.77 -48.13 15.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.307 -0.406 . . . . 75.400000000000006 111.24 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.0 m -73.66 -43.92 58.17 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.891 0.33 . . . . 74.340000000000003 111.891 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HD3' ' O ' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -73.92 -27.33 60.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.782 -0.822 . . . . 75.329999999999998 108.782 178.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.82 ' HZ1' ' HB2' ' A' ' 104' ' ' LYS . 9.9 mtmp? 71.66 83.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.663 -1.153 . . . . 74.420000000000002 111.474 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.1 mt -121.69 173.74 7.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.986 -1.006 . . . . 62.329999999999998 109.318 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -89.35 -62.57 1.45 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.906 -0.318 . . . . 73.299999999999997 110.469 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 160' ' ' ARG . 27.4 p90 -164.78 146.26 7.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.916 0.389 . . . . 74.219999999999999 110.546 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD13 ' A' ' 100' ' ' ILE . 42.3 mt -91.85 118.08 30.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 63.229999999999997 111.019 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.52 59.69 4.94 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 109.977 -1.249 . . . . 75.420000000000002 109.977 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.795 HG23 ' HD2' ' A' ' 111' ' ' PRO . 2.2 p -121.12 151.56 55.64 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.261 -0.47 . . . . 74.040000000000006 110.285 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.795 ' HD2' HG23 ' A' ' 110' ' ' VAL . 89.2 Cg_exo -42.84 134.77 5.3 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.96 2.44 . . . . 72.310000000000002 113.618 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 131' ' ' MET . 23.5 tptm -91.46 130.5 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 74.530000000000001 110.142 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.491 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 46.1 t80 -91.09 128.62 36.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.131 0.491 . . . . 73.310000000000002 112.135 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.55 ' CD1' HG21 ' A' ' 130' ' ' ILE . 47.6 m95 -129.71 -43.66 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.369 -0.832 . . . . 74.239999999999995 108.794 170.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.89 162.93 32.24 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.7 -1.136 . . . . 72.530000000000001 111.448 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 p -164.16 145.5 8.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.746 -0.464 . . . . 60.520000000000003 109.746 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.452 ' HA2' ' HG2' ' A' ' 32' ' ' MET . . . -170.17 -171.55 35.75 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.141 -1.028 . . . . 62.219999999999999 112.817 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.84 130.84 44.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.035 -0.728 . . . . 74.400000000000006 109.035 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.445 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 30.7 t-80 -125.5 133.32 52.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.487 -0.324 . . . . 70.510000000000005 110.137 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.431 ' O ' ' HA ' ' A' ' 125' ' ' SER . 25.7 m-20 69.54 145.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.919 0.762 . . . . 73.519999999999996 112.0 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -151.52 -24.49 0.2 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 73.310000000000002 111.243 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -67.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.336 -0.393 . . . . 73.549999999999997 111.827 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.92 -28.27 3.46 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.12 -0.792 . . . . 74.010000000000005 111.12 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.0 130.68 46.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.19 -0.671 . . . . 74.439999999999998 109.19 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 4.0 p -113.92 117.43 31.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.827 0.346 . . . . 74.420000000000002 110.46 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -110.82 132.62 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.226 0.536 . . . . 73.549999999999997 111.672 -175.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -111.95 127.46 55.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.581 -0.736 . . . . 71.129999999999995 109.099 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.445 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 49.0 p90 -123.3 142.1 51.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.222 0.534 . . . . 73.439999999999998 110.86 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.8 ptm -136.13 130.18 32.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.379 -0.828 . . . . 75.230000000000004 109.879 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.55 HG21 ' CD1' ' A' ' 114' ' ' TRP . 15.9 mt -97.51 135.31 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.986 -0.552 . . . . 74.439999999999998 111.543 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 53.8 mtm -130.73 -179.88 5.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.038 -0.528 . . . . 73.540000000000006 109.788 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.05 165.44 24.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.697 -0.483 . . . . 63.25 109.697 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.534 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -69.39 133.19 47.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.397 0.618 . . . . 75.409999999999997 111.519 -172.966 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.484 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 20.5 m-85 -122.3 172.21 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.669 . . . . 74.340000000000003 110.202 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.772 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -173.72 -51.54 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 43.219999999999999 111.916 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.498 ' HB3' HG23 ' A' ' 344' ' ' VAL . 21.1 m -100.86 144.15 30.16 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.753 -0.462 . . . . 75.109999999999999 109.753 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 p30 -139.01 163.04 33.44 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.018 -0.364 . . . . 64.409999999999997 110.018 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.513 ' HB3' ' HB2' ' A' ' 180' ' ' ALA . 10.0 mp -73.14 -24.4 60.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.189 0.44 . . . . 73.209999999999994 112.189 -173.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.526 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 10.0 pt20 -71.24 -31.8 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.623 -0.431 . . . . 74.319999999999993 110.424 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.65 ' HG2' ' H ' ' A' ' 347' ' ' GLY . 55.9 mttp -71.75 -37.24 70.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.99 0.424 . . . . 74.200000000000003 110.757 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.831 HG12 HG22 ' A' ' 344' ' ' VAL . 62.0 mt -74.66 -51.54 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.915 -0.584 . . . . 71.519999999999996 112.281 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.666 ' HD1' ' HB2' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -65.96 -32.61 74.19 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.337 0.495 . . . . 71.150000000000006 112.337 -166.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.83 -6.82 59.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.181 -0.607 . . . . 72.439999999999998 110.823 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -104.05 -30.28 10.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.36 0.6 . . . . 64.200000000000003 110.45 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -97.92 -0.61 44.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.546 -0.752 . . . . 75.420000000000002 110.876 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.11 16.23 9.44 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.462 -0.79 . . . . 62.399999999999999 111.926 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.691 ' HE3' ' HB3' ' A' ' 253' ' ' GLN . 2.6 ttpt 64.19 53.67 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.732 -0.667 . . . . 73.329999999999998 110.939 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -133.43 95.15 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.366 -0.975 . . . . 75.329999999999998 108.366 175.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.48 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 44.6 m-85 -103.68 157.23 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.871 -0.604 . . . . 74.540000000000006 111.368 -172.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.2 p -60.9 147.88 41.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.773 -0.648 . . . . 71.310000000000002 110.778 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.422 ' HD3' ' OE2' ' A' ' 298' ' ' GLU . 26.7 ttm-85 -61.88 -33.19 73.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 71.430000000000007 110.608 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.531 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.32 -46.17 90.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.669 -0.696 . . . . 73.230000000000004 110.268 177.288 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.516 HG22 HD21 ' A' ' 339' ' ' LEU . 32.6 m -72.03 -45.74 59.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.772 -0.649 . . . . 71.439999999999998 111.155 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.2 -40.92 76.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.401 -0.363 . . . . 73.349999999999994 110.681 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.482 HD11 ' HB3' ' A' ' 324' ' ' LEU . 19.2 tp -63.48 -47.89 79.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 74.150000000000006 110.668 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.7 -45.48 81.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.691 0.281 . . . . 70.310000000000002 111.051 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.576 ' O ' HG12 ' A' ' 161' ' ' ILE . 93.2 mt -58.52 -51.62 69.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 75.120000000000005 110.146 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.484 ' HA ' HD12 ' A' ' 247' ' ' LEU . 15.5 m -57.9 -43.2 86.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.776 -0.647 . . . . 73.200000000000003 110.921 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 92.8 mt -61.19 -56.12 24.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 75.519999999999996 111.206 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.584 HH21 HG23 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -65.59 -23.5 66.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.614 0.245 . . . . 72.230000000000004 111.3 -176.05 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.576 HG12 ' O ' ' A' ' 157' ' ' LEU . 27.1 mm -65.62 -46.46 89.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.649 -0.501 . . . . 75.329999999999998 109.649 174.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.09 -38.72 92.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.618 0.229 . . . . 73.420000000000002 111.618 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.82 -55.51 33.92 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.161 0.505 . . . . 75.230000000000004 110.656 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.584 HG23 HH21 ' A' ' 160' ' ' ARG . 16.9 tt -70.44 -36.22 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.001 -0.545 . . . . 71.319999999999993 110.59 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.649 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 58.8 tp -62.65 -37.32 85.89 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.456 -0.202 . . . . 75.299999999999997 110.456 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -50.83 66.28 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.194 0.521 . . . . 75.140000000000001 109.874 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.621 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 44.1 t80 -51.68 -44.64 63.18 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 114.825 -1.08 . . . . 73.430000000000007 111.805 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.74 -31.36 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.768 0.318 . . . . 73.140000000000001 111.189 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.649 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 30.3 t-80 -50.77 -54.96 19.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.511 -0.768 . . . . 75.230000000000004 111.098 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.47 40.2 1.59 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.403 0.62 . . . . 63.420000000000002 110.66 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.621 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 3.0 t-80 -110.21 -72.72 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 73.450000000000003 109.083 174.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.447 ' CD ' ' HD1' ' A' ' 171' ' ' HIS . 0.1 OUTLIER -170.68 -38.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.461 -0.336 . . . . 73.450000000000003 111.293 173.803 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.565 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 46.8 m-85 -107.33 138.79 42.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 72.519999999999996 111.639 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.26 172.51 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.122 -0.49 . . . . 73.420000000000002 110.396 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.529 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 44.2 t60 -141.16 111.76 6.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.356 -0.384 . . . . 72.439999999999998 110.111 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.78 -44.26 6.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 72.530000000000001 113.568 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.756 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 35.7 t70 -81.37 87.09 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.267 -0.549 . . . . 74.219999999999999 112.269 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.412 HD13 ' HD2' ' A' ' 175' ' ' HIS . 26.6 mm -86.69 63.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.703 . . . . 75.310000000000002 109.534 170.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -97.31 156.99 16.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.328 -0.619 . . . . 72.409999999999997 109.328 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.513 ' HB2' ' HB3' ' A' ' 138' ' ' LEU . . . -64.01 -10.84 24.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.943 0.349 . . . . 73.549999999999997 111.943 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.526 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 46.6 t -71.56 -22.55 61.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.457 -0.338 . . . . 71.310000000000002 111.134 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -95.42 -2.25 49.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 70.120000000000005 110.794 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.46 126.62 55.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 74.310000000000002 111.512 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.587 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 1.0 OUTLIER -137.71 158.74 43.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 75.319999999999993 110.996 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.428 HD22 ' HB ' ' A' ' 193' ' ' VAL . 43.6 mt -102.67 152.17 21.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.936 -0.575 . . . . 72.450000000000003 111.25 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.746 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 42.1 t-20 -69.38 128.1 35.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.507 -0.923 . . . . 75.099999999999994 108.507 169.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.772 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 39.7 t80 -60.21 -35.36 75.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 72.310000000000002 111.905 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.487 ' HD3' ' NH1' ' A' ' 133' ' ' ARG . 76.0 tttt -97.78 -25.49 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.386 -0.37 . . . . 72.150000000000006 111.218 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.512 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 82.7 m-20 -115.99 98.17 50.66 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.42 -0.355 . . . . 72.209999999999994 110.14 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 189' ' ' ASN . 33.7 Cg_endo -63.98 -21.67 68.44 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 123.089 2.526 . . . . 75.510000000000005 113.241 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 31.2 p-10 -95.77 6.91 47.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 74.230000000000004 111.296 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -106.16 91.86 3.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.026 -0.534 . . . . 75.209999999999994 109.834 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.428 ' HB ' HD22 ' A' ' 185' ' ' LEU . 4.1 p -102.42 122.95 55.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.695 -0.684 . . . . 74.420000000000002 110.109 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.746 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 79.3 m-85 -106.91 157.76 17.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.647 -0.706 . . . . 74.209999999999994 110.897 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.41 ' HB2' HH22 ' A' ' 160' ' ' ARG . 43.1 tp -109.16 101.66 10.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 72.0 109.444 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.694 HG13 ' HG3' ' A' ' 111' ' ' PRO . 24.2 m -146.13 171.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.6 0.238 . . . . 73.510000000000005 110.831 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.54 51.6 4.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.497 -0.774 . . . . 73.519999999999996 110.775 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.621 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 22.5 p90 -126.67 -44.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.423 -0.808 . . . . 73.230000000000004 111.124 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.508 ' HA3' ' HB3' ' A' ' 79' ' ' PRO . . . 67.02 5.67 34.28 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.899 -0.667 . . . . 73.230000000000004 112.873 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.898 HD12 ' HD2' ' A' ' 352' ' ' LYS . 30.3 mt -92.33 97.31 10.79 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.768 0.318 . . . . 65.219999999999999 110.873 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.469 ' HB2' HG23 ' A' ' 82' ' ' THR . . . -149.47 100.14 2.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 75.200000000000003 109.663 173.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -105.18 143.01 33.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.389 -0.368 . . . . 75.319999999999993 110.463 -176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 203' ' ' ARG . 8.8 ptm180 -71.3 115.98 11.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.118 -0.492 . . . . 75.099999999999994 111.55 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 239' ' ' SER . 68.9 t80 -83.76 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.72 -0.673 . . . . 73.530000000000001 109.746 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 8.1 p -99.33 119.51 60.23 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 63.549999999999997 109.42 176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.615 ' HG2' HG22 ' A' ' 209' ' ' VAL . 11.7 Cg_endo -56.64 88.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.233 2.622 . . . . 73.510000000000005 113.559 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 62.62 24.58 14.64 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.448 -0.796 . . . . 73.230000000000004 112.626 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.11 -42.6 1.37 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.364 -0.922 . . . . 72.230000000000004 113.232 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 206' ' ' PRO . 24.4 m -79.19 132.42 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 74.319999999999993 111.068 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -70.0 153.61 43.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 65.129999999999995 110.727 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.748 ' HA ' ' HE2' ' A' ' 211' ' ' LYS . 0.1 OUTLIER -130.86 134.6 46.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 74.420000000000002 109.444 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.86 145.91 55.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.458 -0.571 . . . . 75.430000000000007 109.458 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.58 136.81 56.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.477 0.656 . . . . 73.530000000000001 111.187 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.43 -148.88 0.36 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.118 -0.946 . . . . 74.25 108.962 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -139.75 -49.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.767 -0.373 . . . . 64.439999999999998 110.086 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -138.84 104.26 7.49 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.088 0.403 . . . . 72.420000000000002 112.088 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.477 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 54.9 Cg_endo -76.72 -42.63 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.029 1.819 . . . . 74.510000000000005 109.989 162.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.56 ' HA ' ' CE ' ' A' ' 218' ' ' LYS . 0.1 OUTLIER 175.81 58.34 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.578 -0.737 . . . . 75.230000000000004 110.467 173.3 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 50.95 38.87 21.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.607 0.763 . . . . 73.430000000000007 112.197 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.484 ' N ' ' HA2' ' A' ' 235' ' ' GLY . 48.8 t -83.9 91.97 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 75.349999999999994 111.731 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.627 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 20.1 p-80 -101.14 131.96 46.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.542 -0.753 . . . . 72.239999999999995 110.3 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -92.9 124.25 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.081 0.467 . . . . 73.439999999999998 110.554 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.756 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 88.4 -153.38 24.19 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.455 -0.793 . . . . 42.350000000000001 112.303 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.73 145.42 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 73.040000000000006 110.181 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.447 ' HA ' HG23 ' A' ' 228' ' ' THR . 15.3 tt -61.39 -23.44 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.709 0.633 . . . . 74.140000000000001 112.709 -171.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.46 -34.47 76.0 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.32 -0.237 . . . . 74.329999999999998 111.222 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.499 ' O ' HG12 ' A' ' 246' ' ' ILE . 13.3 m-85 -104.07 -17.65 14.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.418 0.525 . . . . 75.310000000000002 112.418 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.551 ' O ' ' HB1' ' A' ' 232' ' ' ALA . 1.8 t -72.94 7.97 1.78 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.091 0.472 . . . . 74.019999999999996 111.451 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.433 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 26.2 t 63.34 -179.77 0.15 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.264 0.554 . . . . 74.120000000000005 110.932 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.5 -41.13 64.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 72.319999999999993 109.559 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.09 -62.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.847 -1.069 . . . . 64.420000000000002 111.589 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.551 ' HB1' ' O ' ' A' ' 228' ' ' THR . . . -66.4 -29.41 69.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.254 . . . . 74.319999999999993 111.228 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.627 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -64.7 -29.69 70.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.232 -0.187 . . . . 62.310000000000002 110.543 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -76.13 -27.17 56.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 74.040000000000006 110.002 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.484 ' HA2' ' N ' ' A' ' 220' ' ' CYS . . . 133.59 -20.81 4.09 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.027 -0.606 . . . . 62.130000000000003 113.251 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.1 130.75 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 74.209999999999994 112.309 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -62.71 123.7 80.41 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 75.319999999999993 108.652 170.113 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.511 ' HB2' ' H ' ' A' ' 239' ' ' SER . 73.2 Cg_exo -46.14 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.682 2.922 . . . . 72.310000000000002 114.887 -168.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.516 ' HA ' ' OH ' ' A' ' 204' ' ' TYR . 3.6 m 161.37 -83.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.751 1.221 . . . . 71.230000000000004 108.173 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.605 ' HG2' ' HG3' ' A' ' 315' ' ' PRO . 9.5 mpt_? -136.09 -31.87 0.89 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.36 -0.978 . . . . 72.420000000000002 108.36 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.769 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.32 -67.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.188 -1.369 . . . . 74.409999999999997 112.216 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.655 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.71 -40.51 96.65 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-N 116.03 -0.532 . . . . 72.329999999999998 112.864 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.31 -53.85 39.1 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.802 0.81 . . . . 73.310000000000002 110.284 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.468 ' HB3' ' CG1' ' A' ' 306' ' ' VAL . 10.5 mp -64.96 -33.11 75.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.055 -0.975 . . . . 74.299999999999997 110.952 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.57 -40.45 97.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.524 0.202 . . . . 74.420000000000002 110.532 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.655 HG13 ' O ' ' A' ' 242' ' ' GLY . 73.0 mt -56.63 -46.17 82.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.117 -0.492 . . . . 72.420000000000002 110.737 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.538 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.7 tp -61.91 -40.25 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.223 -0.591 . . . . 74.530000000000001 110.532 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.34 91.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.554 -0.831 . . . . 73.239999999999995 112.044 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.458 ' CZ ' ' HE3' ' A' ' 275' ' ' LYS . 20.7 m-85 -64.67 -45.02 88.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.505 0.193 . . . . 70.349999999999994 111.464 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.507 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 5.0 p -72.58 -35.96 68.07 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.408 -0.517 . . . . 73.540000000000006 111.219 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.538 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 85.5 mtp -58.21 -52.12 66.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.341 . . . . 64.420000000000002 110.651 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.5 tt -67.62 -32.11 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 74.150000000000006 110.775 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.691 ' HB3' ' HE3' ' A' ' 147' ' ' LYS . 19.0 mt-30 -62.34 -50.95 69.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.676 0.274 . . . . 73.319999999999993 111.211 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.495 ' HA ' ' HG2' ' A' ' 147' ' ' LYS . 29.7 m0 -68.18 -24.42 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.131 -0.486 . . . . 75.319999999999993 111.496 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -84.99 -31.47 23.49 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.34 0.496 . . . . 71.129999999999995 112.34 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.523 HG23 ' HD1' ' A' ' 290' ' ' PHE . 51.7 p -103.92 -28.67 11.44 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.999 0.74 . . . . 75.430000000000007 112.999 -171.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 112.55 -49.49 0.84 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.184 -1.007 . . . . 71.530000000000001 112.956 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -151.62 145.41 25.08 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.609 -0.347 . . . . 74.120000000000005 110.348 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.485 ' CD1' ' HG3' ' A' ' 253' ' ' GLN . 31.2 mt -104.97 147.48 34.55 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.642 -0.254 . . . . 75.120000000000005 110.4 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.5 -35.93 86.93 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.875 2.383 . . . . 73.109999999999999 112.907 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.561 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 18.6 p90 -95.35 8.34 43.48 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 120.686 -0.405 . . . . 73.340000000000003 111.117 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.435 ' O ' HD13 ' A' ' 265' ' ' LEU . 66.2 tt0 -85.14 -24.8 27.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.343 0.592 . . . . 71.109999999999999 109.689 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -96.92 -23.4 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.653 -0.703 . . . . 72.430000000000007 109.671 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 261' ' ' TRP . 94.7 m-20 -102.51 14.34 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.731 -0.668 . . . . 72.010000000000005 111.354 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.561 ' HB3' ' O ' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -70.08 -12.73 61.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.02 0.438 . . . . 75.120000000000005 110.783 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -64.64 -16.65 63.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 74.439999999999998 111.356 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.531 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 5.9 t70 -129.72 117.96 18.63 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-O 120.933 0.397 . . . . 63.039999999999999 110.626 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.405 ' HB3' ' CE1' ' A' ' 233' ' ' HIS . 77.4 Cg_exo -51.69 -27.84 27.64 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.722 2.948 . . . . 72.239999999999995 113.946 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.444 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.9 mttp -60.26 -52.45 65.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.902 0.382 . . . . 73.420000000000002 110.279 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.531 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 95.4 m-85 -72.37 -34.67 68.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 75.530000000000001 110.994 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.488 HG23 ' HA ' ' A' ' 265' ' ' LEU . 92.5 t -55.57 -50.5 66.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.35 -0.386 . . . . 70.209999999999994 110.602 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -70.33 -44.07 68.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 75.310000000000002 110.368 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.29 -55.42 31.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.784 -0.644 . . . . 71.340000000000003 111.174 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.5 p -61.11 -44.37 97.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.158 -0.474 . . . . 74.519999999999996 111.027 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.458 ' HE3' ' CZ ' ' A' ' 249' ' ' TYR . 50.4 mttp -55.95 -48.11 76.36 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 116.651 -0.249 . . . . 74.510000000000005 111.174 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.6 -41.91 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.732 -0.213 . . . . 72.239999999999995 111.066 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -63.03 -40.23 97.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.545 -0.298 . . . . 75.319999999999993 111.384 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.92 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 23.0 m-85 -73.88 -33.36 64.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.684 0.278 . . . . 72.340000000000003 111.219 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 279' ' ' ARG . 13.8 mtp180 -71.43 -23.76 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 73.409999999999997 111.173 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -57.49 -59.07 5.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 75.120000000000005 110.378 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.5 88.52 2.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 61.310000000000002 110.023 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.2 mm -55.44 -51.37 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 72.129999999999995 111.33 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.27 83.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 74.109999999999999 111.28 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 31.4 m -68.09 -44.06 77.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 75.239999999999995 111.697 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.92 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.1 mm? -64.39 -46.67 82.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.598 -0.274 . . . . 70.340000000000003 111.336 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -32.69 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.255 . . . . 61.530000000000001 111.013 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.432 ' CG ' ' HZ1' ' A' ' 293' ' ' LYS . 11.7 t70 -59.48 -37.91 79.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.144 -0.48 . . . . 74.209999999999994 111.014 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.608 ' HB3' ' HZ3' ' A' ' 288' ' ' LYS . 2.7 mmmp? -94.54 -13.26 26.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.97 -0.559 . . . . 63.350000000000001 111.462 -179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.407 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 46.3 t -78.18 -25.28 47.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.842 0.353 . . . . 75.329999999999998 111.157 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.523 ' HD1' HG23 ' A' ' 256' ' ' THR . 19.9 t80 -109.82 93.07 13.7 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.150000000000006 109.594 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 88.8 Cg_exo -47.45 -48.35 15.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.678 2.918 . . . . 75.0 114.329 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.92 -25.08 67.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 74.329999999999998 110.773 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.432 ' HZ1' ' CG ' ' A' ' 287' ' ' ASP . 21.2 ttmm 58.97 41.91 20.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 72.140000000000001 110.17 -179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -63.75 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.794 . . . . 75.120000000000005 110.021 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 331' ' ' ILE . 50.9 mttp -152.88 99.07 2.77 Favored Pre-proline 0 C--O 1.227 -0.127 0 CA-C-O 120.489 0.185 . . . . 74.030000000000001 110.513 172.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -99.4 38.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.887 2.391 . . . . 72.150000000000006 111.419 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.24 -50.9 5.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.068 -0.587 . . . . 63.140000000000001 113.268 -170.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.907 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.6 mp0 -54.88 -52.91 61.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.965 0.412 . . . . 75.409999999999997 110.213 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.1 mp -60.65 -47.32 93.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.425 -0.807 . . . . 72.420000000000002 111.12 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.29 86.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.774 0.321 . . . . 55.109999999999999 111.543 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -66.48 -38.57 87.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.157 0.503 . . . . 75.030000000000001 110.046 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.607 ' CD1' HD12 ' A' ' 320' ' ' LEU . 76.2 t80 -60.0 -52.51 65.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.468 -0.787 . . . . 75.239999999999995 110.76 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.497 ' HA ' HG22 ' A' ' 306' ' ' VAL . 79.9 mtp -71.93 -32.19 67.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.339 -0.391 . . . . 63.130000000000003 111.616 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.51 -42.24 91.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.715 0.769 . . . . 71.439999999999998 109.333 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 m -65.39 -44.03 88.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.756 -1.111 . . . . 74.230000000000004 111.548 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.526 HG11 ' O ' ' A' ' 302' ' ' TYR . 4.2 m -70.04 -27.24 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 72.129999999999995 110.654 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.5 -44.09 92.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.199 0.523 . . . . 74.329999999999998 110.009 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.8 tp -76.93 1.71 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 75.439999999999998 110.943 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -9.03 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 75.439999999999998 110.328 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 21.0 t70 64.36 -81.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.258 0.623 . . . . 74.409999999999997 111.083 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.769 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -149.6 -44.77 0.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.604 -0.517 . . . . 71.140000000000001 109.604 174.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.5 t -154.98 37.86 0.41 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.691 -0.686 . . . . 72.420000000000002 110.622 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -51.75 -69.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.051 0.453 . . . . 54.520000000000003 111.143 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -175.63 110.34 0.26 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.596 -0.729 . . . . 74.109999999999999 109.545 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.605 ' HG3' ' HG2' ' A' ' 240' ' ' ARG . 51.8 Cg_endo -69.81 117.64 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.841 1.694 . . . . 64.319999999999993 111.121 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.456 HD22 ' HB2' ' A' ' 319' ' ' ASN . 16.5 tp -108.56 82.15 1.57 Allowed 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.355 -0.609 . . . . 62.329999999999998 109.355 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -58.3 -36.43 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.333 -0.849 . . . . 71.209999999999994 110.977 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.15 -52.34 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 74.25 110.527 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.456 ' HB2' HD22 ' A' ' 316' ' ' LEU . 8.2 t30 -59.22 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 71.150000000000006 111.325 -176.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.624 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 3.3 mm? -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.498 -0.319 . . . . 73.230000000000004 111.426 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -69.53 -34.03 73.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.65 0.262 . . . . 73.209999999999994 110.869 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.5 -42.94 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 72.420000000000002 111.254 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -67.92 -27.33 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 120.887 -0.325 . . . . 73.129999999999995 111.039 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.624 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 73.1 mt -65.13 -47.46 77.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.077 -0.342 . . . . 72.400000000000006 110.077 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.12 -33.13 75.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.444 . . . . 73.430000000000007 110.246 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -39.42 89.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 75.209999999999994 110.261 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.907 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.11 -45.02 94.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.004 -0.617 . . . . 61.130000000000003 112.088 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 331' ' ' ILE . 31.1 tp -65.2 -35.25 80.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.336 0.588 . . . . 75.019999999999996 110.041 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.29 -34.3 77.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.792 -0.64 . . . . 74.319999999999993 110.12 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.43 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 71.040000000000006 111.547 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.573 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . 13.1 tt -86.79 -2.76 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.413 0.625 . . . . 75.040000000000006 109.901 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 78.19 24.38 63.85 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.722 -0.672 . . . . 71.230000000000004 112.867 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.441 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 11.1 t -120.65 159.55 25.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.952 -0.388 . . . . 75.400000000000006 109.952 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -174.0 4.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.576 -0.527 . . . . 75.200000000000003 109.576 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 28.1 t70 -65.39 120.04 12.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.145 0.497 . . . . 71.049999999999997 111.076 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.26 100.79 7.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.68 . . . . 65.230000000000004 109.371 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.532 ' C ' ' HD2' ' A' ' 338' ' ' LYS . . . 82.34 -81.05 1.73 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.821 -0.704 . . . . 75.209999999999994 111.493 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -170.25 -66.16 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.875 0.324 . . . . 74.439999999999998 111.875 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.516 HD21 HG22 ' A' ' 153' ' ' THR . 94.1 mt -144.91 -179.26 6.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.518 0.199 . . . . 75.310000000000002 110.678 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -173.3 98.3 0.12 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.71 -0.848 . . . . 75.299999999999997 108.71 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.486 HD11 HD12 ' A' ' 141' ' ' ILE . 20.7 mt -96.79 -79.75 0.45 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.234 -0.439 . . . . 74.150000000000006 111.706 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 20.2 p -175.06 -86.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.399 0.518 . . . . 75.430000000000007 112.399 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 7.2 p -163.03 -30.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.372 0.508 . . . . 64.420000000000002 112.372 -172.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.831 HG22 HG12 ' A' ' 141' ' ' ILE . 39.2 t 69.73 100.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.99 0.424 . . . . 72.030000000000001 110.624 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 346' ' ' ASN . 53.0 mm-40 -109.33 21.58 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 72.400000000000006 111.968 -176.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 345' ' ' GLU . 55.1 m-80 74.33 151.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.963 0.887 . . . . 74.239999999999995 113.139 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.65 ' H ' ' HG2' ' A' ' 140' ' ' LYS . . . -176.43 164.95 35.01 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 109.408 -1.477 . . . . 71.420000000000002 109.408 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -142.86 105.09 0.38 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.955 -1.117 . . . . 75.510000000000005 113.172 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.528 HD13 ' HE2' ' A' ' 142' ' ' TYR . 79.7 mt -111.48 150.47 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.315 . . . . 75.140000000000001 110.151 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -152.7 -165.64 2.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 75.329999999999998 110.713 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 66.85 90.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.916 0.76 . . . . 74.430000000000007 110.828 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.898 ' HD2' HD12 ' A' ' 200' ' ' LEU . 11.1 tppt? -158.66 104.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 74.140000000000001 110.696 -174.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 52.4 m -156.83 150.9 24.97 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.42 -0.355 . . . . 73.140000000000001 110.114 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.719 HG23 ' HA ' ' A' ' 200' ' ' LEU . 12.9 pt -74.93 143.22 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.917 0.389 . . . . 75.340000000000003 111.984 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 97.9 3.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.593 -0.73 . . . . 72.230000000000004 110.428 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -135.44 -19.2 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 75.400000000000006 111.661 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.668 ' HE2' ' HA ' ' A' ' 357' ' ' LYS . 6.7 mmpt? -70.7 106.7 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 74.019999999999996 111.284 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.6 105.49 1.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 75.099999999999994 109.468 176.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.471 ' HD3' ' C ' ' A' ' 359' ' ' LYS . 14.1 tmtt? -64.4 127.86 33.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.94 -0.392 . . . . 72.200000000000003 109.94 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.544 ' HZ3' ' HB3' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.616 -0.707 . . . . 75.150000000000006 109.097 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.18 -0.304 . . . . 71.540000000000006 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.98 136.34 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.01 1.807 . . . . 62.520000000000003 112.339 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -143.82 27.42 1.49 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.842 -0.617 . . . . 74.540000000000006 109.857 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -93.89 144.86 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.611 -0.722 . . . . 73.349999999999994 111.759 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -130.39 102.42 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.713 -0.676 . . . . 70.219999999999999 109.238 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.85 108.61 9.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.895 0.379 . . . . 72.129999999999995 111.384 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.52 134.98 24.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 72.209999999999994 109.999 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.88 122.59 27.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.957 0.408 . . . . 74.329999999999998 111.141 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.92 142.75 30.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.988 -0.551 . . . . 74.430000000000007 109.901 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.03 -132.01 16.28 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.107 -0.797 . . . . 63.539999999999999 111.107 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.463 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -160.52 105.21 1.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.717 0.77 . . . . 75.129999999999995 110.243 173.804 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -98.3 75.77 2.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.456 -0.793 . . . . 74.209999999999994 108.934 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 p -86.44 122.93 31.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.259 -0.882 . . . . 72.140000000000001 111.519 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.8 m -131.2 99.72 4.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 65.420000000000002 109.497 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.46 43.59 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.429 -0.351 . . . . 63.109999999999999 111.193 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.01 49.64 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.437 0.637 . . . . 75.129999999999995 110.856 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -72.29 109.31 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 72.0 111.349 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -140.54 38.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.734 0.778 . . . . 72.120000000000005 108.935 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.2 tp -92.07 124.95 36.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.848 -1.069 . . . . 73.540000000000006 111.14 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.49 -78.35 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 72.219999999999999 109.51 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 68.08 -16.4 0.19 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.205 1.187 . . . . 75.549999999999997 114.205 168.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -83.39 -90.27 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.207 0.458 . . . . 70.109999999999999 111.182 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -134.06 93.49 3.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.501 0.667 . . . . 74.099999999999994 111.191 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 178.4 -59.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.196 -1.366 . . . . 70.420000000000002 107.978 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 HG12 ' HA2' ' A' ' 40' ' ' GLY . 40.2 t -66.19 123.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.851 -1.068 . . . . 71.200000000000003 109.999 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.8 -0.14 57.74 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.961 -0.563 . . . . 52.219999999999999 113.192 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -71.17 129.86 40.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.316 0.558 . . . . 74.340000000000003 110.097 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.483 HD13 ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -77.44 130.46 36.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.435 0.636 . . . . 74.25 110.766 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -134.12 128.45 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.072 -0.967 . . . . 75.409999999999997 109.584 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 49.6 m -108.39 119.08 38.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.922 0.392 . . . . 72.129999999999995 110.35 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.533 ' HB2' ' O ' ' A' ' 116' ' ' SER . 5.7 p-10 -92.93 169.15 10.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 54.5 109.953 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.654 ' HG2' ' O ' ' A' ' 116' ' ' SER . 24.7 ptt? -71.96 -10.22 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.278 0.473 . . . . 71.329999999999998 112.278 -170.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.96 8.85 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.673 0.273 . . . . 70.439999999999998 110.601 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? 69.45 81.45 0.17 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.541 -0.754 . . . . 74.319999999999993 111.534 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 30' ' ' THR . 35.6 mtmm -152.99 135.95 15.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.009 -0.541 . . . . 72.299999999999997 109.966 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -105.55 89.23 3.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.985 -0.376 . . . . 71.530000000000001 109.985 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' HB3' ' HA ' ' A' ' 57' ' ' ASN . 27.4 p-90 -116.19 160.15 20.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.872 0.368 . . . . 74.340000000000003 110.918 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HB3' HD13 ' A' ' 28' ' ' ILE . 1.1 ptpm? -110.64 127.22 55.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 75.129999999999995 110.277 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.89 144.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.375 -0.602 . . . . 74.230000000000004 109.375 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.462 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -111.73 -121.12 4.0 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.481 -0.866 . . . . 61.509999999999998 113.198 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 92.2 mt -81.39 138.01 48.39 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 75.439999999999998 111.425 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.4 Cg_exo -74.39 108.07 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.056 2.504 . . . . 75.439999999999998 112.057 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 HD12 ' HB2' ' A' ' 53' ' ' LEU . 45.2 mt -76.75 -47.57 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 74.230000000000004 109.842 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.53 -32.53 6.42 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.754 -0.657 . . . . 64.239999999999995 112.953 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.56 141.74 28.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.873 0.368 . . . . 75.219999999999999 110.516 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.08 62.33 0.14 Allowed Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.148 -0.781 . . . . 70.349999999999994 111.148 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.98 8.1 87.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.014 -0.612 . . . . 74.519999999999996 112.642 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.595 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 53.2 t80 -164.87 -73.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.919 -0.4 . . . . 70.340000000000003 109.919 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.58 157.7 7.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.952 -0.642 . . . . 71.439999999999998 112.064 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.4 m 63.19 38.13 10.78 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.04 0.448 . . . . 74.450000000000003 111.057 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.44 HD11 ' HB3' ' A' ' 71' ' ' LYS . 2.1 mm -98.2 137.79 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 75.409999999999997 110.722 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -117.06 147.88 41.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.144 -0.48 . . . . 74.120000000000005 110.241 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.513 ' HB2' HD12 ' A' ' 43' ' ' ILE . 60.3 tp -85.95 152.94 22.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.086 -0.709 . . . . 75.409999999999997 109.086 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.56 31.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.735 -0.468 . . . . 72.219999999999999 109.735 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.453 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 23.2 t70 -83.81 -49.43 9.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.21 0.528 . . . . 75.040000000000006 110.233 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.593 ' HE2' ' HA ' ' A' ' 59' ' ' SER . 54.6 ttp -162.13 135.3 6.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 73.409999999999997 109.914 -176.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' HA ' ' HB3' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -97.63 -44.44 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.36 . . . . 72.519999999999996 110.11 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.5 t -100.89 120.11 39.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.365 -0.606 . . . . 74.299999999999997 109.365 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.593 ' HA ' ' HE2' ' A' ' 56' ' ' MET . 12.5 p -61.21 -57.66 11.53 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.397 0.888 . . . . 74.140000000000001 113.397 -169.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.04 -58.54 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.56 -0.456 . . . . 73.239999999999995 111.045 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -85.15 77.38 10.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.06 0.457 . . . . 74.019999999999996 110.509 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.88 143.26 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.916 -0.583 . . . . 71.299999999999997 110.345 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.57 -89.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.688 -0.767 . . . . 71.299999999999997 111.949 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 m -111.35 50.31 0.83 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.916 -0.402 . . . . 74.439999999999998 109.916 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 65.13 -88.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.326 -0.852 . . . . 62.530000000000001 109.91 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -166.29 94.79 0.76 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.117 -0.492 . . . . 73.400000000000006 109.961 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.78 44.79 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.154 2.569 . . . . 72.349999999999994 112.34 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 p -148.4 148.96 30.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.134 0.492 . . . . 71.430000000000007 111.697 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.615 HG21 ' O ' ' A' ' 132' ' ' ASP . 21.6 m -125.85 157.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.034 -0.728 . . . . 63.100000000000001 109.034 172.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.556 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.7 p -128.71 124.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.18 0.514 . . . . 75.120000000000005 111.169 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.543 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 0.3 OUTLIER -87.44 132.82 33.87 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 74.5 108.968 173.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.7 129.29 74.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.425 -0.51 . . . . 74.209999999999994 112.023 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.497 ' OE2' ' HB2' ' A' ' 80' ' ' LEU . 43.8 mt-10 -125.87 159.01 63.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 73.430000000000007 109.363 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.96 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.392 2.061 . . . . 65.099999999999994 112.608 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -66.68 -36.48 82.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.443 0.64 . . . . 74.019999999999996 109.525 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' CG ' ' HZ1' ' A' ' 359' ' ' LYS . 24.2 t70 -88.87 73.92 8.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.103 -0.953 . . . . 75.010000000000005 109.227 174.231 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -81.25 177.38 9.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.729 -0.669 . . . . 73.239999999999995 110.399 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.424 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -130.05 -100.59 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.522 -0.847 . . . . 73.420000000000002 112.553 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.9 Cg_exo -61.91 -21.73 72.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.556 2.837 . . . . 74.120000000000005 113.307 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.497 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 46.0 tp -51.17 -34.94 33.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.678 0.621 . . . . 61.409999999999997 112.678 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.438 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 86.1 t80 -66.76 -44.65 80.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.531 -0.468 . . . . 74.510000000000005 110.553 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -68.24 -50.03 56.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.842 -0.617 . . . . 74.319999999999993 110.708 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 198' ' ' TYR . 9.1 pt-20 -64.58 -52.98 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.247 -0.888 . . . . 75.140000000000001 110.875 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.504 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 63.4 tp -59.93 -40.93 90.59 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 111.572 0.212 . . . . 73.140000000000001 111.572 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 3.3 tmtm? -60.95 -51.12 70.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.783 0.325 . . . . 74.530000000000001 110.612 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.8 -32.26 67.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.222 -0.591 . . . . 73.109999999999999 109.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.501 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 31.2 t80 -57.67 -45.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 74.030000000000001 109.795 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.504 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 28.3 mt-30 -61.33 -38.54 87.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.927 -0.579 . . . . 65.409999999999997 110.697 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.496 ' HA ' ' HZ3' ' A' ' 92' ' ' LYS . 17.4 mtm180 -68.9 -28.08 66.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.832 -0.347 . . . . 73.150000000000006 111.902 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.89 -35.58 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.856 0.687 . . . . 44.420000000000002 112.856 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.2 80.13 7.67 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.415 0.894 . . . . 63.32 113.415 -169.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.496 ' HZ3' ' HA ' ' A' ' 89' ' ' ARG . 5.4 mptt -139.61 129.57 14.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 108.983 -0.747 . . . . 70.219999999999999 108.983 168.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.99 -38.36 69.31 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.618 2.212 . . . . 72.239999999999995 111.849 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.495 ' HG2' ' HD3' ' A' ' 98' ' ' LYS . 16.5 tt0 -64.69 -61.03 2.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 71.319999999999993 110.847 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.64 -34.22 77.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 73.439999999999998 111.511 -172.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.569 ' O ' HD12 ' A' ' 100' ' ' ILE . 66.9 mt -64.71 -52.61 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.673 -0.24 . . . . 73.420000000000002 110.445 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.543 ' HA ' HD11 ' A' ' 100' ' ' ILE . 6.6 tp-100 -58.13 -36.69 73.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.323 0.582 . . . . 73.219999999999999 110.27 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.495 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 48.2 mtpt -67.98 -28.86 67.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 73.030000000000001 111.126 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.757 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 57.4 t90 -66.3 -56.26 12.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.611 -0.268 . . . . 74.420000000000002 110.792 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.577 HG21 ' HB2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.07 -26.02 37.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 C-N-CA 120.685 -0.406 . . . . 74.340000000000003 111.422 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -66.22 -39.32 89.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.95 -0.3 . . . . 73.409999999999997 110.437 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.3 m -76.02 -48.98 18.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.353 -0.385 . . . . 62.299999999999997 111.738 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.31 57.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 72.439999999999998 109.651 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 1.002 ' HA ' ' HE3' ' A' ' 104' ' ' LYS . 0.2 OUTLIER 58.35 77.28 0.3 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.103 -0.953 . . . . 75.530000000000001 111.087 -174.841 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.577 ' HB2' HG21 ' A' ' 100' ' ' ILE . 95.7 mt -136.7 -176.69 4.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.888 -1.051 . . . . 73.120000000000005 108.892 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -79.57 -70.22 0.53 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.643 0.258 . . . . 73.510000000000005 110.805 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 30.8 p90 -159.94 163.17 34.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 73.010000000000005 109.94 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.527 ' HG ' ' CE3' ' A' ' 99' ' ' TRP . 0.9 OUTLIER -79.42 137.19 37.17 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.566 0.541 . . . . 72.400000000000006 111.356 -176.021 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.33 17.82 16.98 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 121.256 -0.497 . . . . 64.450000000000003 112.655 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG22 HD23 ' A' ' 108' ' ' LEU . 76.0 t -101.71 135.25 19.8 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.743 0.417 . . . . 75.040000000000006 110.372 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.501 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 28.3 Cg_endo -63.78 159.62 40.75 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.366 2.71 . . . . 72.230000000000004 114.269 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -81.38 154.67 26.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.619 -1.173 . . . . 75.319999999999993 111.101 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -99.97 116.51 32.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.515 -0.311 . . . . 75.409999999999997 110.355 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.577 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 41.1 m95 -100.88 -29.14 12.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.953 0.406 . . . . 75.519999999999996 110.546 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 158.32 -179.53 33.94 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.577 -0.821 . . . . 71.519999999999996 112.645 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.654 ' O ' ' HG2' ' A' ' 32' ' ' MET . 36.9 p -169.99 175.33 5.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.529 -0.915 . . . . 61.420000000000002 108.529 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.14 -150.93 19.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.477 -1.344 . . . . 63.119999999999997 113.293 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.1 tt -133.27 134.13 43.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.883 0.373 . . . . 73.239999999999995 110.522 -174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -126.54 108.63 11.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 29.4 t70 -79.09 150.58 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.299 0.571 . . . . 54.210000000000001 111.718 -172.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -133.05 52.44 2.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.725 -0.843 . . . . 71.340000000000003 108.725 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 67.17 75.84 0.3 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.895 -1.048 . . . . 71.0 111.168 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.25 -42.88 3.18 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.9 -0.591 . . . . 65.209999999999994 112.008 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.95 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -89.06 82.74 6.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.879 -0.786 . . . . 74.299999999999997 108.879 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.735 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.8 m -78.46 135.95 37.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.224 -0.898 . . . . 74.129999999999995 110.776 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -94.69 137.98 33.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.035 0.445 . . . . 73.129999999999995 110.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -112.77 120.36 41.23 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.64 -0.874 . . . . 73.120000000000005 108.64 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.418 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 42.1 p90 -133.94 162.71 31.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.421 0.526 . . . . 72.430000000000007 112.421 -170.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.3 ttm -129.87 131.49 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.325 -0.852 . . . . 74.340000000000003 109.719 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.577 ' CG2' ' HB2' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -102.68 122.93 55.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.273 0.558 . . . . 74.129999999999995 109.746 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.408 ' HE1' ' CE2' ' A' ' 134' ' ' PHE . 19.6 ptm -133.83 -169.97 2.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.531 -0.759 . . . . 72.109999999999999 110.445 -172.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.615 ' O ' HG21 ' A' ' 69' ' ' VAL . 71.9 m-20 -64.24 169.71 4.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 111.962 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.637 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -82.5 106.0 14.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.51 0.671 . . . . 74.400000000000006 111.978 -174.962 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.408 ' CE2' ' HE1' ' A' ' 131' ' ' MET . 43.9 m-85 -124.39 172.25 9.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 74.310000000000002 110.26 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.23 -38.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.841 . . . . 53.340000000000003 112.344 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 m -95.87 128.19 42.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.368 -0.234 . . . . 73.140000000000001 110.368 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -122.66 160.9 24.85 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.646 -0.501 . . . . 74.230000000000004 109.646 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.54 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 10.6 mp -75.8 -8.43 56.86 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.227 0.454 . . . . 75.019999999999996 112.227 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.434 ' HB3' ' HA2' ' A' ' 348' ' ' GLY . 10.3 tm0? -73.67 -49.75 24.32 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.148 -0.686 . . . . 75.150000000000006 109.148 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.503 ' HD2' ' O ' ' A' ' 345' ' ' GLU . 13.5 pttm -76.86 -21.64 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.606 -0.438 . . . . 73.310000000000002 110.914 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.54 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 54.6 mt -74.12 -51.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.562 -0.29 . . . . 73.420000000000002 110.947 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.428 ' HE1' ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.76 -32.47 73.78 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.126 -0.23 . . . . 74.420000000000002 110.944 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.18 -43.31 82.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 63.219999999999999 110.137 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.71 -31.53 61.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 74.120000000000005 110.986 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.25 -2.59 58.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 75.519999999999996 110.912 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.97 38.04 22.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.472 -0.785 . . . . 72.140000000000001 112.511 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.64 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 74.1 mttt 62.17 73.12 0.48 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.433 0.531 . . . . 75.219999999999999 112.433 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -156.29 82.2 0.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.307 0.575 . . . . 74.310000000000002 109.729 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.49 141.34 29.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.604 -0.726 . . . . 73.25 111.141 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 144.09 57.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.77 -0.65 . . . . 75.120000000000005 109.852 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.477 ' HD2' HD11 ' A' ' 331' ' ' ILE . 13.1 ttm180 -63.24 -29.55 70.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.347 0.129 . . . . 72.129999999999995 111.347 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mttp -57.6 -44.59 85.53 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.21 0.528 . . . . 74.010000000000005 110.071 173.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.524 ' HA ' HD23 ' A' ' 339' ' ' LEU . 6.8 m -66.98 -41.32 87.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.38 -0.827 . . . . 74.150000000000006 110.577 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.52 -45.51 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 75.519999999999996 111.403 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.523 ' HG ' HD21 ' A' ' 328' ' ' LEU . 3.9 mm? -68.55 -37.69 80.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.506 -0.316 . . . . 74.239999999999995 111.356 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.413 ' HG2' HD21 ' A' ' 339' ' ' LEU . 52.3 tp60 -65.84 -39.62 90.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.181 0.515 . . . . 62.310000000000002 109.98 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.508 HD13 HG11 ' A' ' 193' ' ' VAL . 5.2 mp -63.19 -51.98 64.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.53 -0.759 . . . . 63.420000000000002 111.295 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.2 p -63.19 -34.98 78.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 73.329999999999998 111.178 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.25 -40.54 97.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 74.209999999999994 110.801 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.787 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -68.94 -43.22 75.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 74.439999999999998 111.204 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.5 HD13 HD23 ' A' ' 183' ' ' LEU . 42.5 mt -64.59 -29.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.149 -0.478 . . . . 74.510000000000005 109.845 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.512 HD11 ' HD2' ' A' ' 317' ' ' TYR . 29.0 tp -63.1 -55.68 23.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.523 -0.762 . . . . 75.299999999999997 111.148 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.757 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 4.8 p-10 -67.93 -31.51 71.32 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.573 -0.451 . . . . 73.439999999999998 110.703 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.45 ' O ' HG12 ' A' ' 168' ' ' ILE . 70.5 mt -66.82 -46.82 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.41 -0.359 . . . . 72.200000000000003 111.041 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.3 pp -68.71 -33.81 74.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 64.310000000000002 110.086 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -55.58 -56.31 21.82 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.323 -0.399 . . . . 61.229999999999997 110.362 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.39 -49.09 79.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 72.310000000000002 112.192 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.8 pt -75.01 -38.26 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.107 0.41 . . . . 62.450000000000003 112.107 -173.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.78 -21.0 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.11 0.481 . . . . 71.430000000000007 109.831 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.525 ' O ' ' HA ' ' A' ' 207' ' ' GLU . 31.8 tt0 -75.27 -6.0 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.478 -0.783 . . . . 74.349999999999994 110.302 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -124.44 -69.69 0.79 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.663 -0.415 . . . . 72.519999999999996 111.645 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.771 ' HB3' ' HB2' ' A' ' 203' ' ' ARG . 35.6 mt-10 -155.48 -59.02 0.1 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.469 0.544 . . . . 74.420000000000002 112.469 -170.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.834 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 48.1 m-85 -83.71 147.78 27.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.12 0.785 . . . . 70.340000000000003 113.12 -166.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.48 HG23 ' HD2' ' A' ' 204' ' ' TYR . 16.9 m -132.26 164.03 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.981 -1.008 . . . . 70.409999999999997 108.924 171.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -105.35 131.2 53.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.738 -0.467 . . . . 73.129999999999995 109.738 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.31 -10.41 64.0 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.05 -1.22 . . . . 64.530000000000001 110.05 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 1.045 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 15.6 t70 -123.88 110.73 15.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.675 -0.763 . . . . 75.099999999999994 110.638 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.2 mm -111.86 66.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.416 -0.957 . . . . 74.239999999999995 108.416 166.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.431 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 79.9 tttt -90.54 161.77 15.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.886 -0.597 . . . . 75.439999999999998 109.882 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -57.6 -19.31 25.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 71.329999999999998 111.786 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 p -75.91 -12.07 60.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.522 -0.308 . . . . 62.439999999999998 111.488 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.503 ' HB3' ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -82.5 -30.05 30.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.713 0.292 . . . . 63.149999999999999 110.646 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.5 HD23 HD13 ' A' ' 161' ' ' ILE . 6.4 mp -94.05 131.54 39.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 74.150000000000006 110.581 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.578 ' CD1' ' HB2' ' A' ' 194' ' ' TYR . 1.1 pp -138.42 157.43 46.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 73.310000000000002 111.048 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.59 156.69 20.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 72.409999999999997 109.5 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.679 HD22 ' HE1' ' A' ' 194' ' ' TYR . 51.1 m-80 -63.51 152.15 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.709 -0.478 . . . . 74.510000000000005 109.709 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -56.5 -32.7 65.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.101 -0.499 . . . . 70.209999999999994 111.133 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.47 3.43 5.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.209 0.448 . . . . 75.310000000000002 112.209 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.441 ' HB2' ' HB2' ' A' ' 186' ' ' ASN . 12.7 m120 -128.53 92.89 39.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.823 -0.351 . . . . 73.409999999999997 111.242 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -9.26 16.46 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.829 2.353 . . . . 72.400000000000006 111.258 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.13 -6.89 50.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 74.129999999999995 111.193 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.68 122.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.094 0.474 . . . . 71.0 110.573 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.508 HG11 HD13 ' A' ' 157' ' ' LEU . 7.1 p -103.62 137.45 32.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.451 -0.795 . . . . 75.310000000000002 109.712 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.679 ' HE1' HD22 ' A' ' 186' ' ' ASN . 4.7 m-85 -114.09 158.17 21.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.932 -0.766 . . . . 73.319999999999993 108.932 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.503 ' HG ' ' HB3' ' A' ' 182' ' ' ASN . 10.1 tt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.42 -0.956 . . . . 73.040000000000006 108.42 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.412 ' O ' HD22 ' A' ' 195' ' ' LEU . 7.2 p -50.79 130.49 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.285 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.635 ' HB2' ' CD2' ' A' ' 198' ' ' TYR . 1.2 p-10 -58.25 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.627 -1.17 . . . . 75.409999999999997 112.684 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.635 ' CD2' ' HB2' ' A' ' 197' ' ' ASP . 24.1 m-85 -135.21 26.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.953 -0.467 . . . . 73.319999999999993 111.796 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -64.13 -39.38 97.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.504 -0.855 . . . . 73.040000000000006 111.167 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.38 89.35 2.77 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.188 -0.671 . . . . 74.510000000000005 109.188 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.533 ' H ' HG21 ' A' ' 354' ' ' ILE . . . -166.23 149.66 7.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 61.299999999999997 110.842 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -142.45 144.65 33.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.63 -0.507 . . . . 74.340000000000003 109.63 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.834 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 23.1 ptt180 -84.44 141.08 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 75.450000000000003 110.327 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.48 ' HD2' HG23 ' A' ' 174' ' ' VAL . 6.9 m-85 -139.23 -59.35 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 75.310000000000002 112.257 -171.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.95 121.75 41.0 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.475 . . . . 75.150000000000006 111.548 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 103.38 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 73.040000000000006 111.791 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 170' ' ' GLU . 29.1 tt0 71.65 -11.38 0.74 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.754 0.821 . . . . 75.510000000000005 111.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.63 -30.79 1.94 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.359 -0.924 . . . . 70.219999999999999 113.165 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.72 122.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.24 0.543 . . . . 65.310000000000002 110.903 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -89.6 154.76 19.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.06 -0.518 . . . . 72.109999999999999 110.472 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.505 ' HZ2' ' HB3' ' A' ' 211' ' ' LYS . 8.8 mtpm? -93.72 -175.11 3.65 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.021 -0.536 . . . . 73.040000000000006 110.159 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.543 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.4 mp0 -52.68 130.09 31.43 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.53 0.519 . . . . 73.310000000000002 110.664 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 49.2 p90 -65.37 129.13 38.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 74.319999999999993 110.609 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.404 ' C ' ' H ' ' A' ' 216' ' ' ASP . 42.0 mmtm -98.08 -45.18 6.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.627 -0.715 . . . . 72.099999999999994 110.575 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.836 ' HA ' ' HB3' ' A' ' 234' ' ' ASN . 50.4 mt-10 67.2 -5.13 0.75 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.134 0.79 . . . . 73.540000000000006 113.134 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.571 ' HB2' ' O ' ' A' ' 215' ' ' GLU . 6.0 t70 169.2 86.25 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 O-C-N 123.515 0.51 . . . . 73.439999999999998 110.033 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 61.3 Cg_endo -87.72 -40.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.22 1.947 . . . . 74.439999999999998 111.973 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 218' ' ' LYS . 28.6 ttpt -168.47 11.92 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.713 -0.676 . . . . 73.540000000000006 110.241 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.52 98.72 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.061 0.458 . . . . 72.150000000000006 111.216 -167.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.412 ' HB3' HG22 ' A' ' 355' ' ' THR . 74.7 m -71.23 -68.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.315 -0.402 . . . . 72.5 110.371 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.425 ' HD2' HG21 ' A' ' 228' ' ' THR . 57.6 t-80 55.57 92.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.711 0.632 . . . . 75.430000000000007 112.024 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.554 ' HB3' HG21 ' A' ' 355' ' ' THR . 20.5 p-10 -91.23 -59.53 2.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.61 -0.268 . . . . 64.019999999999996 111.393 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 1.045 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -93.79 -149.49 25.38 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 75.430000000000007 113.775 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.495 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 69.3 p -81.26 150.14 28.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.661 0.267 . . . . 75.0 110.988 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.23 -31.33 47.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.196 -0.456 . . . . 75.010000000000005 110.708 -175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.529 ' HA ' HD21 ' A' ' 265' ' ' LEU . 2.4 mp0 -49.14 -50.93 35.2 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.456 -0.793 . . . . 63.310000000000002 111.184 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.431 ' CE2' ' HA ' ' A' ' 179' ' ' LYS . 97.3 m-85 -101.92 -13.58 17.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 73.340000000000003 112.031 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.49 HG22 ' HB3' ' A' ' 232' ' ' ALA . 35.9 m -46.95 -49.58 20.42 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.385 0.428 . . . . 63.409999999999997 111.086 176.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.3 m 59.33 -156.02 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.853 -0.612 . . . . 74.319999999999993 110.888 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 3.4 mp -71.75 -53.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.367 -0.378 . . . . 74.409999999999997 110.282 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 238' ' ' PRO . 1.6 m-20 -49.46 -60.56 2.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.514 -0.766 . . . . 71.129999999999995 112.991 -173.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.49 ' HB3' HG22 ' A' ' 228' ' ' THR . . . -69.94 -30.2 67.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.928 0.394 . . . . 50.329999999999998 111.795 -175.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -67.82 -42.82 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 109.863 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.836 ' HB3' ' HA ' ' A' ' 215' ' ' GLU . 6.4 m-20 -77.25 -4.53 45.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.17 . . . . 70.340000000000003 111.195 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.11 53.74 Favored Glycine 0 C--N 1.335 0.515 0 O-C-N 123.497 0.498 . . . . 53.420000000000002 112.56 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 7.4 p -120.25 140.98 42.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.584 0.23 . . . . 75.129999999999995 110.839 -177.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.07 106.94 2.12 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.871 -0.789 . . . . 72.120000000000005 108.871 169.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HB3' ' OD2' ' A' ' 231' ' ' ASP . 19.9 Cg_endo -61.07 -87.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.503 2.136 . . . . 71.239999999999995 112.826 -171.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 20.7 m 171.13 -49.37 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.798 1.239 . . . . 74.340000000000003 107.736 -178.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 176.38 -16.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.818 -1.537 . . . . 75.120000000000005 107.76 -173.031 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.577 ' NH2' ' HD2' ' A' ' 279' ' ' ARG . 9.5 mmm180 -52.4 -68.0 0.21 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.334 -1.303 . . . . 74.120000000000005 110.984 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -45.55 -42.02 9.8 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 123.706 0.629 . . . . 75.200000000000003 113.711 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.02 -64.99 0.64 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.769 0.795 . . . . 74.140000000000001 110.207 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.437 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 36.2 mt -74.06 -30.46 62.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.78 -1.1 . . . . 74.109999999999999 111.198 -174.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.404 ' HB2' ' O ' ' A' ' 241' ' ' ARG . 7.8 tp10 -62.21 -57.91 9.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.420000000000002 110.274 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.74 -41.29 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 75.239999999999995 110.341 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.427 HD21 ' HH ' ' A' ' 302' ' ' TYR . 55.4 tp -57.89 -41.63 82.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.051 0.453 . . . . 72.329999999999998 110.816 178.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -43.76 98.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.07 -0.586 . . . . 71.129999999999995 112.203 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -63.07 -34.53 77.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.668 0.27 . . . . 74.239999999999995 110.896 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 57.9 m -62.0 -51.79 66.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.014 0.435 . . . . 74.209999999999994 110.525 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 76.3 mtm -61.45 -42.02 98.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.862 -0.608 . . . . 64.010000000000005 111.866 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.49 HD13 ' HE1' ' A' ' 286' ' ' MET . 11.1 tt -68.59 -34.33 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.392 -0.523 . . . . 74.319999999999993 110.974 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.27 -40.33 71.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 73.239999999999995 110.231 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.07 -28.46 67.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.246 -0.434 . . . . 75.219999999999999 111.247 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.8 tp -92.34 -40.04 11.14 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.174 0.435 . . . . 73.230000000000004 112.174 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 m -100.14 -17.63 17.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.509 . . . . 71.129999999999995 111.25 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.64 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 85.69 -59.74 4.74 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.759 -0.734 . . . . 62.32 112.545 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -113.8 141.76 46.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.336 -0.508 . . . . 71.209999999999994 109.924 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.915 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 85.6 mt -103.16 142.08 23.83 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.69 . . . . 73.040000000000006 110.098 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 278' ' ' TYR . 15.2 Cg_exo -68.84 -2.3 9.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.807 2.338 . . . . 74.219999999999999 112.967 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.485 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 36.4 p90 -124.3 5.6 8.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 73.010000000000005 110.21 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.915 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 34.1 tt0 -72.31 -21.63 61.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 71.549999999999997 111.048 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.92 -20.18 33.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.451 . . . . 75.230000000000004 109.976 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 89.2 m-20 -96.15 7.12 47.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.78 -0.646 . . . . 73.310000000000002 110.465 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.529 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.9 tm? -64.39 -20.84 66.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.472 -0.785 . . . . 74.549999999999997 110.519 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -73.35 -1.6 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 75.230000000000004 112.337 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.592 ' O ' HG23 ' A' ' 271' ' ' VAL . 20.8 t70 -137.28 120.87 11.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 121.073 -0.251 . . . . 73.340000000000003 110.958 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -58.12 -29.73 88.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.307 2.671 . . . . 64.319999999999993 113.505 -176.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.42 -41.71 38.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.805 0.336 . . . . 75.219999999999999 110.245 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.672 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 24.3 m-85 -64.63 -40.92 96.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 74.319999999999993 110.715 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 267' ' ' ASP . 89.8 t -54.16 -49.33 62.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 123.125 0.265 . . . . 75.010000000000005 110.975 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.443 ' O ' HG13 ' A' ' 276' ' ' ILE . 45.3 mtm180 -62.4 -59.05 5.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.631 -0.259 . . . . 73.030000000000001 111.115 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.0 -47.96 79.59 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.486 0.491 . . . . 74.340000000000003 111.629 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.8 m -58.53 -50.54 73.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.479 -0.328 . . . . 75.239999999999995 110.53 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.39 -32.92 73.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.654 -0.248 . . . . 73.25 111.229 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 272' ' ' ARG . 82.8 mt -64.15 -42.41 95.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 60.109999999999999 110.216 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.431 ' O ' ' HB3' ' A' ' 280' ' ' GLU . 11.0 mmp_? -62.0 -41.64 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 74.209999999999994 111.053 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.468 ' CZ ' ' HB2' ' A' ' 260' ' ' PRO . 73.3 m-85 -74.08 -43.27 58.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 73.019999999999996 110.904 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.577 ' HD2' ' NH2' ' A' ' 241' ' ' ARG . 34.3 ttp180 -65.38 -20.02 66.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.355 0.597 . . . . 74.530000000000001 110.708 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.431 ' HB3' ' O ' ' A' ' 277' ' ' ARG . 36.6 tt0 -60.53 -47.91 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.164 -0.925 . . . . 75.129999999999995 110.761 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -159.2 94.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.299 0.571 . . . . 74.319999999999993 110.41 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.727 HG13 ' HB2' ' A' ' 303' ' ' MET . 0.2 OUTLIER -80.67 -29.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.598 -0.728 . . . . 73.409999999999997 111.921 -177.038 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.412 ' HA ' ' HB3' ' A' ' 300' ' ' ALA . . . -52.53 -48.36 66.11 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.522 0.564 . . . . 74.439999999999998 112.522 -168.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.9 m -69.53 -38.11 77.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.96 0.409 . . . . 75.239999999999995 111.666 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.5 mt -72.7 -48.2 40.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.067 -0.515 . . . . 74.400000000000006 111.321 -172.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.49 ' HE1' HD13 ' A' ' 252' ' ' ILE . 1.3 mpt? -61.24 -40.56 94.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.348 . . . . 73.150000000000006 110.765 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.21 -28.16 69.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.896 -0.593 . . . . 74.099999999999994 111.224 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -75.36 -43.64 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 72.219999999999999 110.774 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.11 -41.89 99.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.89 -0.595 . . . . 74.329999999999998 111.472 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.42 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 47.2 m-85 -123.15 82.2 51.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.56 -0.291 . . . . 74.109999999999999 110.953 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.62 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.288 1.992 . . . . 71.109999999999999 112.045 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.05 -9.0 28.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.338 0.59 . . . . 71.019999999999996 109.993 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -74.82 -36.13 62.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.167 -0.924 . . . . 74.230000000000004 111.006 -174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -173.66 -165.98 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 75.329999999999998 108.632 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 14.4 ptmm? -120.88 114.27 32.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 65.540000000000006 111.51 -177.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.42 ' HG3' ' HB2' ' A' ' 290' ' ' PHE . 42.2 Cg_endo -105.23 37.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.675 2.917 . . . . 75.540000000000006 112.163 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -79.5 -50.87 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.847 -0.692 . . . . 73.109999999999999 113.068 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.452 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.1 pm0 -64.17 -36.94 85.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.911 0.386 . . . . 74.409999999999997 110.864 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.64 -48.37 72.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 74.150000000000006 110.773 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 283' ' ' ALA . . . -61.9 -35.73 79.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 75.439999999999998 110.375 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 49.7 tptt -70.95 -42.11 70.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 74.239999999999995 110.076 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 306' ' ' VAL . 82.7 t80 -56.19 -49.22 74.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.528 -0.76 . . . . 74.340000000000003 110.536 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.727 ' HB2' HG13 ' A' ' 282' ' ' ILE . 79.1 mtp -72.69 -31.38 64.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 74.329999999999998 111.235 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.442 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 37.1 tt0 -62.06 -42.23 98.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.774 0.797 . . . . 64.400000000000006 109.056 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 86.8 m -60.56 -45.98 91.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.634 -1.166 . . . . 72.209999999999994 111.211 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.502 HG12 ' O ' ' A' ' 302' ' ' TYR . 9.8 m -73.03 -33.79 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 121.028 -0.269 . . . . 75.239999999999995 111.712 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -72.75 -24.63 60.99 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.816 -0.439 . . . . 74.129999999999995 109.816 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.16 -12.04 60.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.882 -0.599 . . . . 74.400000000000006 110.816 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 96.6 mt -81.12 8.25 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 73.349999999999994 111.401 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.47 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.357 0.663 . . . . 74.319999999999993 112.209 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.89 -50.72 0.71 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.514 -0.921 . . . . 71.109999999999999 108.514 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 17.3 m -136.64 67.66 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.514 -0.766 . . . . 72.409999999999997 110.349 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.467 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 13.0 tp10 -104.46 161.28 14.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 62.420000000000002 109.608 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.25 110.14 5.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 74.420000000000002 111.205 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.29 121.6 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.863 2.375 . . . . 70.420000000000002 113.034 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.44 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.3 mt -93.79 92.86 7.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 75.010000000000005 110.523 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.522 ' HA ' HD11 ' A' ' 320' ' ' LEU . 12.7 m-85 -63.76 -32.14 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 74.129999999999995 111.013 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 321' ' ' ARG . 21.7 mp0 -57.11 -46.45 82.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 74.340000000000003 110.14 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -68.13 -37.01 80.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 70.310000000000002 110.472 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.522 HD11 ' HA ' ' A' ' 317' ' ' TYR . 96.2 mt -60.27 -52.29 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 73.349999999999994 110.919 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 318' ' ' GLU . 6.6 ptp180 -66.85 -28.39 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 75.010000000000005 109.739 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.39 -51.78 58.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 73.040000000000006 111.122 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.431 HD11 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -69.46 -30.04 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 121.063 -0.255 . . . . 74.540000000000006 111.24 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.453 ' HB3' HD13 ' A' ' 155' ' ' LEU . 79.1 mt -67.83 -48.54 65.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 74.510000000000005 110.344 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.61 -29.73 69.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 74.319999999999993 110.755 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -48.02 82.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.188 -0.671 . . . . 62.530000000000001 109.188 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.452 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.85 -38.51 94.38 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.893 -0.67 . . . . 62.240000000000002 112.749 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 333' ' ' SER . 41.7 tp -66.5 -41.96 88.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.172 0.511 . . . . 73.129999999999995 110.561 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.54 -25.88 60.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.98 -0.554 . . . . 72.109999999999999 110.544 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.07 83.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 75.420000000000002 110.587 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.477 HD11 ' HD2' ' A' ' 151' ' ' ARG . 47.0 pt -89.35 7.29 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 74.549999999999997 110.647 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 73.34 25.33 73.19 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.005 -0.543 . . . . 70.439999999999998 113.424 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.574 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 59.4 m -112.29 139.36 47.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.875 0.369 . . . . 74.430000000000007 111.494 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -136.61 -66.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 74.420000000000002 110.084 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.22 147.36 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.943 0.402 . . . . 75.420000000000002 110.299 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.46 -39.89 5.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.932 -0.576 . . . . 74.140000000000001 109.789 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.61 -31.16 1.67 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.008 -0.615 . . . . 63.119999999999997 112.626 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.733 ' HZ2' ' HB3' ' A' ' 338' ' ' LYS . 0.1 OUTLIER -172.88 29.8 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.573 0.582 . . . . 72.010000000000005 112.573 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.524 HD23 ' HA ' ' A' ' 153' ' ' THR . 49.3 mt 71.57 150.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.09 0.947 . . . . 71.540000000000006 112.756 173.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 341' ' ' LEU . 34.0 t70 -122.01 104.85 9.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.024 -0.989 . . . . 71.329999999999998 110.081 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.428 ' HB3' ' O ' ' A' ' 340' ' ' ASP . 1.7 pt? 174.2 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.278 -0.874 . . . . 74.140000000000001 110.049 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.0 m -66.96 81.12 0.11 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.941 -0.572 . . . . 75.239999999999995 112.242 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.12 -30.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.245 -0.434 . . . . 74.319999999999993 110.113 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 46.6 t 59.62 95.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.494 -0.776 . . . . 74.120000000000005 112.429 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 35.3 mt-10 -134.79 -165.41 1.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.6 . . . . 70.530000000000001 109.625 173.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.18 153.63 20.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.602 0.239 . . . . 72.200000000000003 111.058 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 146.74 -147.67 18.73 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.304 -0.718 . . . . 75.109999999999999 111.304 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.434 ' HA2' ' HB3' ' A' ' 139' ' ' GLN . . . 82.83 49.36 5.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.704 -0.76 . . . . 44.340000000000003 112.241 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.3 mt -125.74 169.72 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.811 0.339 . . . . 75.340000000000003 111.412 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 63.61 87.44 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.355 -0.839 . . . . 74.549999999999997 112.395 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -127.38 -169.14 1.99 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 65.140000000000001 109.396 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 37.4 mmtm -144.13 -145.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.881 -0.415 . . . . 74.030000000000001 109.881 178.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.7 t -157.03 172.52 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.666 -0.494 . . . . 75.200000000000003 109.666 -172.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.533 HG21 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -67.24 142.88 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.791 0.329 . . . . 74.420000000000002 110.404 177.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.554 HG21 ' HB3' ' A' ' 222' ' ' ASP . 14.5 t -98.02 135.03 40.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.671 -0.863 . . . . 74.209999999999994 108.671 176.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -173.21 -52.15 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 75.549999999999997 109.986 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.403 ' HG3' ' O ' ' A' ' 358' ' ' ARG . 19.1 pttp -163.71 -175.33 4.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.815 -0.809 . . . . 73.140000000000001 108.815 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.403 ' O ' ' HG3' ' A' ' 357' ' ' LYS . 57.4 mtm180 -78.79 164.07 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.694 -0.484 . . . . 65.230000000000004 109.694 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.466 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 48.3 tttm -72.13 -40.41 68.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.864 0.364 . . . . 74.439999999999998 110.201 -178.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.697 -0.668 . . . . 74.25 109.88 177.003 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.014 0.435 . . . . 75.430000000000007 110.708 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.7 152.52 22.62 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.433 2.089 . . . . 75.439999999999998 111.413 175.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 19.9 mmm180 -110.03 61.32 0.6 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.777 -0.453 . . . . 74.510000000000005 109.777 178.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 61.0 t -97.2 108.8 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.877 -0.601 . . . . 75.099999999999994 110.752 -177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -109.49 141.94 41.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.067 -0.515 . . . . 74.099999999999994 109.829 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.89 108.9 3.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.375 . . . . 71.230000000000004 110.926 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.29 107.18 3.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 72.5 109.712 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -96.82 116.3 28.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.293 0.568 . . . . 71.219999999999999 111.163 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.58 129.79 16.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.559 -0.746 . . . . 71.109999999999999 109.443 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.93 89.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.481 -0.866 . . . . 62.329999999999998 112.613 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -116.52 110.83 19.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.161 0.505 . . . . 74.25 110.026 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -99.02 119.89 38.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.099 0.476 . . . . 71.209999999999994 111.417 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -130.57 120.39 23.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.23 -0.656 . . . . 74.239999999999995 109.23 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -169.05 101.99 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 75.420000000000002 110.799 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.91 113.97 14.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 74.200000000000003 109.616 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -135.43 159.89 40.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.214 0.531 . . . . 74.319999999999993 111.342 -176.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -130.29 103.33 6.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 74.25 109.323 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -97.76 44.05 1.05 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.099 0.476 . . . . 75.099999999999994 109.944 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.0 111.1 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 73.409999999999997 111.33 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 132.39 16.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.495 -0.775 . . . . 74.209999999999994 110.064 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.692 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 12.0 tp10 -156.06 150.81 26.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.792 -0.818 . . . . 74.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.54 -21.02 3.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.102 0.408 . . . . 74.430000000000007 112.102 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -119.35 29.3 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.338 0.59 . . . . 64.340000000000003 110.833 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.411 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . . . -158.97 -65.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 72.099999999999994 110.131 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.692 ' HB ' ' HB3' ' A' ' 21' ' ' GLU . 92.0 t -67.18 147.55 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.462 -0.79 . . . . 71.349999999999994 110.7 175.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.47 -15.61 57.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.203 -0.522 . . . . 63.109999999999999 114.363 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.474 ' O ' HG11 ' A' ' 39' ' ' VAL . 48.1 mm-40 -63.47 129.06 38.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.799 0.799 . . . . 70.430000000000007 109.737 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.689 HG22 ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -95.2 131.43 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.626 . . . . 73.409999999999997 111.993 -174.235 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.464 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 38.9 pt -96.91 150.13 4.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.437 -0.801 . . . . 73.25 109.213 171.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HZ ' ' A' ' 128' ' ' PHE . 6.8 m -105.63 113.24 26.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.534 -0.303 . . . . 73.0 111.225 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.6 t70 -65.13 152.1 44.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 71.450000000000003 109.658 175.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 2.4 tpt -67.35 -18.85 65.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.476 . . . . 73.310000000000002 111.454 -174.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.31 17.45 20.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.099 -0.5 . . . . 74.230000000000004 110.639 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 68.81 84.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.406 0.682 . . . . 75.109999999999999 111.373 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 41.1 mtmt -152.57 131.94 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 72.150000000000006 109.371 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.506 ' O ' ' HG2' ' A' ' 56' ' ' MET . 3.4 mp0 -89.06 127.74 35.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.737 0.303 . . . . 74.430000000000007 110.738 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.833 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 74.5 m95 -125.25 117.73 24.45 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.555 -0.535 . . . . 73.049999999999997 109.555 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.689 ' HG2' HG22 ' A' ' 28' ' ' ILE . 22.0 mtmm -78.75 130.75 36.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.572 -0.451 . . . . 75.420000000000002 109.88 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.611 HG21 ' CD2' ' A' ' 52' ' ' TYR . 3.2 p -67.38 117.5 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.166 -0.47 . . . . 63.020000000000003 110.431 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.463 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -90.51 -128.93 3.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.845 -0.693 . . . . 51.299999999999997 111.841 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.4 mt -86.81 137.62 33.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.721 -0.282 . . . . 72.439999999999998 111.049 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.71 102.69 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.824 2.349 . . . . 73.439999999999998 110.331 171.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mt -86.98 -70.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.903 -0.589 . . . . 74.109999999999999 110.697 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.25 165.7 17.3 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.667 -0.778 . . . . 72.540000000000006 111.78 -176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.869 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 2.2 tt0 -131.91 166.17 22.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.41 -0.589 . . . . 70.340000000000003 109.41 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.507 ' HA3' ' OD2' ' A' ' 137' ' ' ASP . . . -82.82 42.61 2.98 Favored Glycine 0 C--O 1.232 -0.026 0 C-N-CA 121.511 -0.376 . . . . 71.319999999999993 112.959 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 179.11 -75.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 109.999 -1.241 . . . . 61.420000000000002 109.999 179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.503 ' HZ ' ' HA ' ' A' ' 353' ' ' THR . 24.1 m-85 -96.64 83.45 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 64.209999999999994 109.586 168.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.869 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -68.95 -158.38 1.5 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.901 -0.59 . . . . 74.439999999999998 113.608 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 72.2 m 70.77 30.99 2.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.296 0.569 . . . . 70.400000000000006 110.806 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 ' HB2' ' A' ' 45' ' ' GLN . 4.2 mm -93.88 122.0 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.307 -0.627 . . . . 74.530000000000001 109.307 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.762 ' HE1' ' HB ' ' A' ' 72' ' ' VAL . 28.3 p90 -108.2 150.43 27.26 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.154 -0.618 . . . . 74.239999999999995 110.879 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HA ' HG11 ' A' ' 69' ' ' VAL . 7.9 tt -68.97 134.17 49.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.363 -0.835 . . . . 75.230000000000004 110.512 -176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.68 102.92 14.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.083 -0.508 . . . . 74.310000000000002 109.959 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.37 -35.9 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 72.25 111.251 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.833 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 13.9 tmm? 66.17 -73.92 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.236 -0.654 . . . . 62.119999999999997 109.236 -172.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.14 140.71 13.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.931 -0.766 . . . . 65.299999999999997 108.931 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -81.72 49.6 1.37 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.359 0.6 . . . . 64.129999999999995 110.624 -173.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -152.82 26.83 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 75.430000000000007 109.951 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 61' ' ' SER . 0.6 OUTLIER -81.87 170.34 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 73.340000000000003 109.275 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.537 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 21.3 t -67.93 -29.1 68.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.382 -0.372 . . . . 73.310000000000002 110.064 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG23 ' HD3' ' A' ' 67' ' ' PRO . 5.1 p -82.42 143.65 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.708 -0.479 . . . . 74.540000000000006 109.708 173.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.96 -46.07 0.11 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.13 -1.033 . . . . 72.140000000000001 113.137 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -78.16 -56.9 4.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.083 0.401 . . . . 64.420000000000002 112.083 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.46 -63.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.477 0.547 . . . . 74.549999999999997 112.477 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.34 77.33 0.36 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 109.263 -0.643 . . . . 72.519999999999996 109.263 -167.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HD3' HG23 ' A' ' 62' ' ' VAL . 85.7 Cg_endo -80.29 32.18 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.293 2.662 . . . . 74.329999999999998 113.593 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.2 p -127.52 136.69 52.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.529 0.681 . . . . 70.310000000000002 111.226 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.568 HG11 ' HA ' ' A' ' 53' ' ' LEU . 12.8 m -141.99 162.38 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.343 -0.844 . . . . 71.310000000000002 109.282 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.548 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -132.78 126.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.676 0.75 . . . . 63.299999999999997 111.421 -179.057 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.522 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 60.8 tttm -87.5 127.22 35.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.702 -1.136 . . . . 75.430000000000007 109.171 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.762 ' HB ' ' HE1' ' A' ' 52' ' ' TYR . 11.9 p -116.42 135.6 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.014 0.435 . . . . 73.209999999999994 111.573 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 49.2 mm-40 -142.36 143.4 26.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.524 -0.762 . . . . 74.310000000000002 109.072 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.52 ' HB2' ' HB2' ' A' ' 77' ' ' ASN . 37.6 Cg_exo -60.49 133.01 46.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.52 1.48 . . . . 75.319999999999993 109.978 170.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -60.09 -30.39 69.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.788 0.328 . . . . 75.319999999999993 110.896 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.74 24.22 10.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 71.150000000000006 111.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.52 ' HB2' ' HB2' ' A' ' 74' ' ' PRO . 63.3 t30 -85.98 -50.19 7.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.913 0.387 . . . . 73.0 110.223 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.85 -77.67 0.24 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.378 -0.915 . . . . 62.450000000000003 113.65 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.95 -43.31 59.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.268 2.645 . . . . 63.140000000000001 114.295 -169.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.5 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.01 -29.93 67.62 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 111.957 0.354 . . . . 74.219999999999999 111.957 -171.882 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -66.02 -50.76 63.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.429 -0.508 . . . . 73.409999999999997 110.504 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 m -69.06 -40.18 78.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.489 0.662 . . . . 71.450000000000003 110.005 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.522 ' CD ' ' HZ3' ' A' ' 71' ' ' LYS . 33.3 tt0 -59.73 -53.71 54.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.803 -1.089 . . . . 74.310000000000002 111.074 -179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.453 ' HB2' HD11 ' A' ' 80' ' ' LEU . 51.7 tp -66.24 -33.03 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 73.5 111.074 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.477 ' HE3' ' OH ' ' A' ' 173' ' ' TYR . 64.8 tttp -60.01 -47.34 86.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.011 0.434 . . . . 75.140000000000001 110.096 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' HE1' ' HB2' ' A' ' 173' ' ' TYR . 59.0 t80 -71.19 -41.62 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 73.049999999999997 110.361 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -57.32 -50.23 73.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 64.540000000000006 110.838 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -24.41 63.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.109 0.48 . . . . 74.519999999999996 110.533 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HE ' ' HA ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -69.7 -39.16 77.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 75.140000000000001 111.597 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.421 ' HA ' ' HE2' ' A' ' 167' ' ' TYR . . . -107.44 -34.09 7.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.228 0.825 . . . . 75.219999999999999 113.228 -171.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.447 ' HB1' ' HB2' ' A' ' 113' ' ' TYR . . . -85.77 100.39 12.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.548 0.689 . . . . 73.329999999999998 111.819 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -166.75 100.41 0.66 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.388 -0.968 . . . . 75.019999999999996 108.388 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -43.07 -45.33 9.43 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.78 2.987 . . . . 74.349999999999994 114.042 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.74 -49.68 74.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.36 -0.382 . . . . 74.319999999999993 110.959 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.47 -38.74 87.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.510000000000005 110.621 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.519 ' O ' HG13 ' A' ' 100' ' ' ILE . 81.0 mt -58.13 -53.29 47.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.727 -0.669 . . . . 74.340000000000003 110.879 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -62.1 -40.78 97.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.515 -0.311 . . . . 74.519999999999996 111.248 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -57.06 -48.98 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.341 -0.39 . . . . 73.439999999999998 110.877 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.554 ' CE2' ' HG3' ' A' ' 103' ' ' ARG . 66.0 t-105 -65.24 -49.01 71.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 74.329999999999998 110.711 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 96' ' ' ILE . 94.4 mt -53.52 -51.29 43.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.137 0.494 . . . . 75.400000000000006 111.519 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -73.72 -31.21 63.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.51 -0.768 . . . . 73.420000000000002 111.226 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.3 m -76.17 -40.09 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.02 0.438 . . . . 54.140000000000001 111.238 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 11.1 mmm180 -91.8 10.0 30.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 72.549999999999997 111.915 -173.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.444 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.7 mmpt? 63.58 27.25 14.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 74.299999999999997 111.617 173.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.474 ' HB3' ' OD1' ' A' ' 163' ' ' ASP . 97.7 mt -89.11 178.36 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.977 0.418 . . . . 75.120000000000005 111.438 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -83.32 -66.95 0.83 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.964 -0.754 . . . . 73.310000000000002 108.964 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.7 p90 179.87 133.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.728 -1.124 . . . . 75.420000000000002 109.541 176.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -78.74 116.14 18.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.54 -0.541 . . . . 74.299999999999997 109.54 177.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.93 72.19 1.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.749 -0.659 . . . . 74.420000000000002 112.904 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.456 HG12 ' HD2' ' A' ' 111' ' ' PRO . 67.4 t -101.99 140.33 21.09 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.755 -0.831 . . . . 64.540000000000006 108.755 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.456 ' HD2' HG12 ' A' ' 110' ' ' VAL . 1.3 Cg_endo -44.88 134.33 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.199 2.599 . . . . 74.510000000000005 112.443 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.864 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 21.4 tptm -65.4 106.23 1.34 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 73.109999999999999 110.693 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.447 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 35.1 t80 -79.85 113.8 18.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.726 -1.125 . . . . 74.400000000000006 111.184 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.461 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 15.0 m95 -97.94 -36.23 10.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.467 -0.938 . . . . 75.450000000000003 108.467 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.49 178.25 48.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.724 -1.125 . . . . 64.430000000000007 111.115 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 14.9 p -172.68 165.42 5.42 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.481 -0.563 . . . . 73.239999999999995 109.481 -179.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.09 -173.81 46.09 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.92 -1.134 . . . . 54.119999999999997 113.103 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.48 HD23 ' HB3' ' A' ' 125' ' ' SER . 8.8 tt -134.93 128.68 32.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.44 -0.948 . . . . 75.310000000000002 108.44 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -140.89 125.62 18.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 73.549999999999997 110.566 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.24 123.92 26.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 64.340000000000003 110.098 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -87.93 -56.97 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.277 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.05 79.93 0.77 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.288 -0.634 . . . . 73.349999999999994 109.288 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.19 33.52 85.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.169 -0.773 . . . . 73.400000000000006 111.169 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.406 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 13.6 tppt? -158.91 105.0 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.498 -0.556 . . . . 74.530000000000001 109.498 -174.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.48 ' HB3' HD23 ' A' ' 118' ' ' LEU . 25.3 m -78.85 108.73 12.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.038 0.447 . . . . 74.409999999999997 111.07 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -92.05 131.75 37.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.053 -0.521 . . . . 73.430000000000007 110.555 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.425 ' HE ' HD22 ' A' ' 84' ' ' LEU . 10.0 ttt180 -113.24 117.15 31.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.507 -0.923 . . . . 74.430000000000007 108.507 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HZ ' ' O ' ' A' ' 30' ' ' THR . 49.0 p90 -133.44 161.62 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.068 0.461 . . . . 73.219999999999999 112.057 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.4 ptp -139.46 141.65 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 74.310000000000002 110.55 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.548 HD13 ' HB ' ' A' ' 70' ' ' VAL . 11.2 mm -98.31 118.56 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.142 0.496 . . . . 73.040000000000006 110.312 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.466 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 21.6 ptm -127.72 163.68 23.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.674 -0.694 . . . . 71.25 110.509 -175.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.864 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.9 t70 -70.35 156.85 38.75 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.718 -0.475 . . . . 71.519999999999996 109.718 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.435 ' HA ' ' HD2' ' A' ' 133' ' ' ARG . 22.3 tpt180 -82.81 108.52 16.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.388 0.614 . . . . 74.439999999999998 111.31 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.64 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 17.0 m-85 -103.26 142.27 34.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.062 -1.088 . . . . 75.409999999999997 108.062 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.29 -4.38 3.23 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 119.583 -1.294 . . . . 65.540000000000006 113.453 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.917 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.4 m -120.59 124.49 45.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.844 0.354 . . . . 75.340000000000003 110.295 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.79 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 3.9 m-20 -90.53 134.99 33.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.157 -0.474 . . . . 62.530000000000001 110.022 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.423 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 36.9 tp -61.83 -36.61 81.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.951 -0.759 . . . . 72.349999999999994 108.951 172.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.79 ' HG3' ' HB3' ' A' ' 137' ' ' ASP . 1.4 pp0? -64.64 -28.15 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 75.129999999999995 111.547 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.621 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 58.2 mttp -72.52 -39.82 67.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.837 -0.345 . . . . 71.040000000000006 110.629 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.28 -36.9 44.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.515 0.674 . . . . 74.540000000000006 109.337 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.594 ' HB3' ' HA ' ' A' ' 139' ' ' GLN . 28.6 t80 -55.19 -54.27 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.738 -1.119 . . . . 74.400000000000006 111.202 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.97 -33.87 61.94 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.755 -0.378 . . . . 61.310000000000002 111.235 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.79 -32.76 72.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.945 0.35 . . . . 75.099999999999994 111.945 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -105.1 8.68 34.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 75.420000000000002 110.614 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.11 48.52 17.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 111.319 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.687 ' HG3' HE22 ' A' ' 253' ' ' GLN . 0.0 OUTLIER 43.67 77.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.818 1.247 . . . . 72.0 113.749 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.63 102.97 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.751 -0.659 . . . . 74.230000000000004 109.269 168.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.696 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 65.9 m-85 -108.76 156.1 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.996 -0.547 . . . . 70.129999999999995 109.884 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -70.59 156.88 38.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.319 -0.4 . . . . 74.010000000000005 110.585 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.577 ' HG2' HD13 ' A' ' 331' ' ' ILE . 25.0 tpt180 -45.99 -57.28 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.547 -0.752 . . . . 75.120000000000005 112.144 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -67.27 -28.1 67.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 111.514 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 m -70.94 -45.19 64.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.442 -0.345 . . . . 63.539999999999999 110.571 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.84 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 74.439999999999998 110.585 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.505 HD13 ' HB3' ' A' ' 324' ' ' LEU . 0.2 OUTLIER -65.02 -42.87 93.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 75.140000000000001 110.325 -178.986 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -55.21 -52.57 62.93 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.773 -0.454 . . . . 74.340000000000003 109.773 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.24 -50.65 73.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.936 -0.575 . . . . 74.310000000000002 111.125 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.43 ' HA ' HD12 ' A' ' 161' ' ' ILE . 32.1 t -57.93 -38.05 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 65.230000000000004 111.241 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.81 -40.86 75.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.856 -0.424 . . . . 75.0 109.856 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.586 ' HA ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -67.42 -31.4 71.58 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.787 0.803 . . . . 75.340000000000003 110.307 -178.916 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.43 HD12 ' HA ' ' A' ' 158' ' ' SER . 58.4 mt -67.92 -35.14 71.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.591 -0.731 . . . . 75.439999999999998 109.695 174.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.445 HD12 ' HD1' ' A' ' 317' ' ' TYR . 43.4 tp -63.84 -40.48 96.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 64.409999999999997 110.088 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.586 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.4 m-20 -53.34 -59.52 4.47 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.491 0.663 . . . . 65.129999999999995 110.895 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.486 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -67.11 -37.35 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.856 -0.611 . . . . 74.230000000000004 111.101 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.66 -37.94 89.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.72 0.295 . . . . 74.200000000000003 110.296 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -56.09 -58.81 6.34 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.87 -0.605 . . . . 74.120000000000005 109.46 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.421 ' HE2' ' HA ' ' A' ' 90' ' ' ALA . 39.9 t80 -55.5 -48.98 73.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.859 -1.064 . . . . 74.219999999999999 112.572 -176.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.486 HG12 ' O ' ' A' ' 164' ' ' ILE . 39.7 pt -84.19 -36.52 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.605 0.594 . . . . 73.439999999999998 112.605 -170.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -82.34 -26.17 33.21 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 73.209999999999994 112.144 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.37 -18.46 64.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.75 -0.78 . . . . 72.299999999999997 110.048 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.9 -74.75 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 70.329999999999998 112.346 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -135.86 -68.71 0.5 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.145 0.794 . . . . 74.519999999999996 113.145 -167.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.478 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 79.6 m-85 -84.99 167.26 16.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.488 0.922 . . . . 74.310000000000002 113.488 -161.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.486 HG22 ' HG2' ' A' ' 238' ' ' PRO . 27.4 m -142.21 172.18 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.065 -1.425 . . . . 75.439999999999998 109.48 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 177' ' ' ASP . 11.5 t-160 -158.64 96.21 1.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.612 -0.514 . . . . 73.109999999999999 109.612 173.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.48 ' O ' HD12 ' A' ' 246' ' ' ILE . . . -67.49 -33.61 82.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.116 -0.564 . . . . 74.519999999999996 112.389 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.53 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 20.6 t70 -74.57 91.56 2.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.141 0.496 . . . . 74.340000000000003 111.315 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.04 67.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.038 0.923 . . . . 75.340000000000003 108.955 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.413 ' HB2' ' HZ2' ' A' ' 179' ' ' LYS . 3.7 ttmp? -88.27 139.14 30.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.99 -1.005 . . . . 71.439999999999998 109.222 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.423 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -56.17 -16.68 5.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.314 0.487 . . . . 75.129999999999995 112.314 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.62 ' HA ' ' HG2' ' A' ' 139' ' ' GLN . 29.8 t -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.331 -0.395 . . . . 72.109999999999999 111.431 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.43 ' O ' HD12 ' A' ' 195' ' ' LEU . 84.5 m-20 -92.21 -11.74 34.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.724 0.297 . . . . 75.420000000000002 111.584 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.4 mp -100.49 119.47 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 75.540000000000006 110.493 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.4 mm? -119.03 140.59 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.682 -0.69 . . . . 75.310000000000002 110.61 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.917 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 69.2 mt -97.87 142.82 29.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.989 -0.55 . . . . 74.109999999999999 110.339 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.64 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -61.48 136.75 58.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.981 -0.554 . . . . 75.530000000000001 110.042 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -56.17 -31.27 63.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.832 0.348 . . . . 71.239999999999995 111.627 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.707 ' HA ' ' HE3' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -90.97 -22.58 20.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.959 0.355 . . . . 73.349999999999994 111.959 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -138.42 110.21 8.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 111.888 0.329 . . . . 75.510000000000005 111.888 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.57 -12.94 32.14 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.73 2.286 . . . . 73.319999999999993 111.252 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.966 ' HA ' ' HB2' ' A' ' 339' ' ' LEU . 7.4 p-10 -90.49 7.39 39.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.369 -0.832 . . . . 72.209999999999994 111.153 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.432 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 16.7 mm-40 -121.84 106.78 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.431 . . . . 62.130000000000003 110.76 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.2 122.11 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 75.329999999999998 110.813 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -114.75 157.44 23.2 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.866 -0.606 . . . . 75.239999999999995 109.922 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 182' ' ' ASN . 34.1 tp -107.53 103.3 12.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.222 -0.658 . . . . 74.340000000000003 109.222 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.45 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.7 m -120.77 -167.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.497 -0.319 . . . . 74.140000000000001 110.487 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.2 m-20 70.66 -62.13 0.45 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.816 0.698 . . . . 63.530000000000001 110.674 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 60.98 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 74.019999999999996 111.654 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.502 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 68.46 -68.34 0.39 Allowed Glycine 0 N--CA 1.447 -0.63 0 O-C-N 123.415 0.447 . . . . 74.540000000000006 112.088 -174.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 353' ' ' THR . 2.4 mp -88.26 81.07 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.856 0.36 . . . . 73.420000000000002 110.145 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.73 98.02 5.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.144 0.497 . . . . 73.340000000000003 110.01 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -164.11 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.365 -0.976 . . . . 74.409999999999997 108.365 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.478 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 9.3 ptp180 -137.75 150.62 47.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.559 -0.456 . . . . 74.129999999999995 111.426 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -83.1 -36.74 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.583 -0.735 . . . . 75.409999999999997 110.412 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.453 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 6.6 p -134.82 129.64 19.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.203 -0.453 . . . . 74.310000000000002 111.198 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 9.9 Cg_exo -71.49 100.71 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.943 2.429 . . . . 75.120000000000005 111.094 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 71.06 -62.57 0.45 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.456 0.702 . . . . 73.209999999999994 112.053 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.7 -36.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.791 . . . . 74.219999999999999 112.963 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 26.6 m -60.87 132.4 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.443 . . . . 71.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.32 138.16 37.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.136 -0.483 . . . . 74.140000000000001 109.857 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.487 ' HA ' ' HD2' ' A' ' 211' ' ' LYS . 12.6 tptm -108.33 172.63 6.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.131 0.491 . . . . 75.150000000000006 112.311 -167.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' A' ' 211' ' ' LYS . 19.0 tt0 -90.96 174.19 7.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.505 -0.771 . . . . 72.120000000000005 111.019 -175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.408 ' HA ' HG22 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -73.19 6.27 2.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.972 0.731 . . . . 74.299999999999997 112.972 -168.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -166.5 96.78 0.57 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.71 -0.619 . . . . 74.329999999999998 110.633 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.447 ' OE1' ' HG2' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -136.24 -4.14 2.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.377 -0.829 . . . . 71.329999999999998 110.859 178.238 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.474 ' OD1' ' HD2' ' A' ' 217' ' ' PRO . 10.6 t70 -79.05 148.01 70.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.823 -0.626 . . . . 65.129999999999995 110.774 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.759 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 69.6 Cg_exo -54.79 1.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.32 3.347 . . . . 64.129999999999995 114.928 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.759 ' HB2' ' O ' ' A' ' 217' ' ' PRO . 0.0 OUTLIER 112.83 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.748 1.619 . . . . 75.019999999999996 110.941 172.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.467 ' CZ ' ' HB3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 69.71 92.21 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.227 -0.897 . . . . 74.109999999999999 111.505 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.44 ' H ' ' HA2' ' A' ' 235' ' ' GLY . 7.7 p -86.85 -30.45 21.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.946 -0.39 . . . . 74.209999999999994 109.946 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 29.1 m80 73.89 -58.08 0.6 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.086 0.954 . . . . 74.319999999999993 111.704 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 30.4 t70 37.57 74.58 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.912 0.885 . . . . 72.549999999999997 111.785 -171.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.53 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . 110.52 174.82 20.49 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.723 -0.751 . . . . 61.340000000000003 112.459 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.39 141.63 43.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.669 0.271 . . . . 74.340000000000003 110.622 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.515 HD13 HG21 ' A' ' 271' ' ' VAL . 15.4 tt -58.36 -17.06 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.355 0.598 . . . . 73.349999999999994 111.323 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -50.49 -55.52 15.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.921 -1.036 . . . . 75.109999999999999 111.603 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.569 ' O ' HG12 ' A' ' 246' ' ' ILE . 38.9 m-85 -111.24 -28.11 8.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.071 0.767 . . . . 74.530000000000001 113.071 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.496 HG23 ' HA ' ' A' ' 225' ' ' ILE . 5.8 t -64.98 -6.4 8.44 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.758 0.651 . . . . 71.540000000000006 112.758 -169.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.748 ' HA ' ' HE2' ' A' ' 275' ' ' LYS . 23.0 t 65.0 -169.85 0.2 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.138 0.494 . . . . 73.349999999999994 111.393 176.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.455 ' O ' ' HB3' ' A' ' 234' ' ' ASN . 15.3 pt -73.34 -34.35 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.795 -0.639 . . . . 73.310000000000002 111.684 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.493 ' O ' HG13 ' A' ' 236' ' ' VAL . 11.7 t70 -53.82 -74.88 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.827 -170.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.78 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 70.439999999999998 111.616 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.842 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 57.6 t-80 -62.7 -27.53 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.603 -0.271 . . . . 70.150000000000006 111.62 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.455 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 0.0 OUTLIER -78.41 -28.81 46.93 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.859 0.318 . . . . 73.519999999999996 111.859 -175.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.44 ' HA2' ' H ' ' A' ' 220' ' ' CYS . . . 112.37 45.65 0.78 Allowed Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.346 -0.931 . . . . 63.549999999999997 112.848 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.493 HG13 ' O ' ' A' ' 231' ' ' ASP . 15.0 p -123.44 143.27 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.0 -0.741 . . . . 72.319999999999993 109.0 171.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -53.25 110.72 2.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.676 -0.861 . . . . 73.340000000000003 108.676 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.486 ' HG2' HG22 ' A' ' 174' ' ' VAL . 69.6 Cg_exo -41.97 115.18 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.772 2.981 . . . . 75.540000000000006 113.561 -169.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 93.9 p -90.83 -175.54 4.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.248 -0.887 . . . . 71.349999999999994 111.163 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.877 ' HG2' ' HB3' ' A' ' 315' ' ' PRO . 9.8 mtm-85 -53.94 -36.69 63.06 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.534 -0.757 . . . . 71.25 111.248 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.439 HH22 ' HD2' ' A' ' 279' ' ' ARG . 12.3 mtp180 -66.27 -33.56 76.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.797 -0.638 . . . . 75.400000000000006 110.498 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.423 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -57.43 -65.1 3.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.881 -0.676 . . . . 70.299999999999997 111.84 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.16 -48.1 71.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.34 0.59 . . . . 70.310000000000002 110.758 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.695 ' HG ' HD23 ' A' ' 320' ' ' LEU . 9.2 mp -67.95 -46.02 72.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.169 -0.923 . . . . 75.219999999999999 112.045 -173.496 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -64.43 -47.08 80.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.611 -0.435 . . . . 71.129999999999995 110.789 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.569 HG12 ' O ' ' A' ' 227' ' ' PHE . 76.0 mt -61.45 -40.11 85.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.347 -0.388 . . . . 74.030000000000001 111.425 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.657 HD22 ' HH ' ' A' ' 302' ' ' TYR . 37.9 tp -64.23 -45.12 89.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 75.530000000000001 110.217 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.64 95.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.906 -0.664 . . . . 74.230000000000004 112.081 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.445 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 14.8 m-30 -56.26 -45.84 79.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.782 0.325 . . . . 73.040000000000006 110.812 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.82 -35.22 78.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 73.140000000000001 110.892 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.406 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 83.8 mtp -59.47 -54.54 45.47 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.737 0.303 . . . . 75.25 110.988 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.6 tt -67.8 -32.06 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 74.530000000000001 110.45 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.687 HE22 ' HG3' ' A' ' 147' ' ' LYS . 9.5 tm0? -61.58 -53.59 54.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 74.219999999999999 110.364 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.696 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.8 m0 -69.45 -26.42 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 75.299999999999997 111.662 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.506 HD11 HD22 ' A' ' 294' ' ' ASN . 33.4 tp -83.87 -36.22 23.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.203 0.446 . . . . 75.319999999999993 112.203 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.5 p -103.49 -27.4 12.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.688 -0.405 . . . . 62.399999999999999 112.058 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.6 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 98.79 -1.35 58.09 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.429 -0.891 . . . . 74.340000000000003 113.272 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -148.12 163.16 37.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.178 0.513 . . . . 74.310000000000002 111.691 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.645 ' HG ' ' HG2' ' A' ' 253' ' ' GLN . 60.2 mt -111.87 142.48 26.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.202 -0.908 . . . . 74.439999999999998 109.649 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.47 -25.68 59.38 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.615 2.21 . . . . 64.519999999999996 112.601 177.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.436 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 48.0 p90 -111.65 18.94 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.353 -0.385 . . . . 73.430000000000007 110.771 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 35.3 tt0 -66.03 -44.5 84.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.551 . . . . 72.209999999999994 110.467 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.96 -6.72 55.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.97 0.891 . . . . 70.230000000000004 109.552 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.636 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -104.62 0.8 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.097 -0.956 . . . . 74.219999999999999 111.227 -177.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 261' ' ' TRP . 80.5 mt -71.33 -6.9 43.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.12 0.486 . . . . 62.109999999999999 110.885 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -60.91 -33.4 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.483 -0.781 . . . . 75.450000000000003 111.332 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.718 ' HB2' ' CD1' ' A' ' 270' ' ' TYR . 7.8 m-20 -145.33 145.82 27.89 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-O 120.541 0.21 . . . . 41.43 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.649 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 25.3 Cg_endo -62.92 -28.09 75.09 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.61 2.207 . . . . 72.319999999999993 112.002 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -42.49 96.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.202 0.525 . . . . 74.109999999999999 109.719 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.718 ' CD1' ' HB2' ' A' ' 267' ' ' ASP . 9.5 m-85 -66.67 -45.33 79.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.554 -0.748 . . . . 74.329999999999998 111.31 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.515 HG21 HD13 ' A' ' 225' ' ' ILE . 20.3 m -65.03 -29.16 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.535 -0.302 . . . . 71.349999999999994 111.225 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.649 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 33.7 mtm180 -60.62 -58.61 7.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.096 -0.705 . . . . 75.319999999999993 109.096 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -52.26 -50.55 61.87 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.859 -1.064 . . . . 71.219999999999999 111.018 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 50.3 m -59.6 -50.33 74.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 74.319999999999993 111.463 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.748 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 59.7 mttp -66.36 -44.49 83.06 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.879 -0.329 . . . . 75.329999999999998 111.376 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.5 -48.34 85.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 120.812 0.339 . . . . 74.530000000000001 110.935 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -54.71 -50.09 69.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 75.420000000000002 110.776 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -74.21 -39.07 63.38 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.184 -0.462 . . . . 74.530000000000001 111.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.439 ' HD2' HH22 ' A' ' 241' ' ' ARG . 52.2 ttp180 -50.44 -40.34 50.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.542 0.337 . . . . 72.239999999999995 111.792 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -70.28 -36.15 74.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.297 0.48 . . . . 75.510000000000005 112.297 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -129.19 38.57 3.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.795 0.331 . . . . 74.120000000000005 111.663 -170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.503 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -49.91 -50.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 113.115 0.783 . . . . 73.200000000000003 113.115 -176.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.536 ' HA ' ' HB2' ' A' ' 300' ' ' ALA . . . -58.07 -47.77 82.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 74.019999999999996 112.149 -172.387 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -68.25 -44.4 75.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.011 0.434 . . . . 74.409999999999997 111.204 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 285' ' ' LEU . 4.3 mm? -67.25 -50.98 58.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 75.450000000000003 111.431 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -60.87 -40.54 93.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 72.109999999999999 111.193 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.64 -42.31 98.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 74.140000000000001 111.23 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -81.8 -15.72 53.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.614 -0.266 . . . . 75.120000000000005 111.674 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.6 m -72.89 -28.08 62.27 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.29 -0.256 . . . . 64.510000000000005 111.217 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.439 ' CE1' ' HB3' ' A' ' 294' ' ' ASN . 3.9 t80 -128.69 86.63 57.06 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 74.420000000000002 110.518 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -94.91 24.93 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.389 2.726 . . . . 73.010000000000005 113.011 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -100.38 -166.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.376 -0.602 . . . . 71.510000000000005 109.376 -177.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.421 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 31.0 mmtp -81.29 62.44 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.457 0.646 . . . . 75.540000000000006 111.583 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.506 HD22 HD11 ' A' ' 255' ' ' LEU . 38.7 t-20 -157.11 128.91 7.1 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.368 -1.345 . . . . 73.510000000000005 107.368 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -100.87 106.08 41.94 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.176 -0.209 . . . . 75.010000000000005 111.305 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 93.6 Cg_endo -93.6 38.17 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.899 2.399 . . . . 74.549999999999997 111.967 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -73.39 -42.34 42.06 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.077 -0.582 . . . . 72.510000000000005 111.972 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.458 ' OE2' HG13 ' A' ' 299' ' ' ILE . 1.3 pm0 -66.44 -35.84 81.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.19 . . . . 64.540000000000006 110.527 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.458 HG13 ' OE2' ' A' ' 298' ' ' GLU . 44.3 mt -67.79 -46.96 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 73.150000000000006 110.509 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.536 ' HB2' ' HA ' ' A' ' 283' ' ' ALA . . . -60.67 -39.91 90.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 70.540000000000006 110.537 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.509 ' HD3' HD12 ' A' ' 323' ' ' ILE . 85.3 tttt -80.58 -28.79 37.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 74.5 110.785 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.657 ' HH ' HD22 ' A' ' 247' ' ' LEU . 33.2 t80 -55.71 -50.2 70.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.207 0.527 . . . . 73.549999999999997 109.897 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.445 ' HA ' HG21 ' A' ' 306' ' ' VAL . 95.2 mmm -70.54 -34.57 72.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.598 -0.728 . . . . 73.219999999999999 110.711 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.49 ' HA ' HD12 ' A' ' 282' ' ' ILE . 0.3 OUTLIER -61.67 -42.2 98.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.808 0.813 . . . . 73.0 109.384 175.477 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.522 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 59.9 m -61.81 -51.38 68.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.927 -1.033 . . . . 71.510000000000005 111.488 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.509 HG13 HD23 ' A' ' 244' ' ' LEU . 16.3 m -67.75 -27.85 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.494 -0.321 . . . . 73.450000000000003 111.582 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -25.54 33.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.871 0.367 . . . . 65.430000000000007 110.212 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 27.5 tp -86.96 -16.01 37.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 75.230000000000004 111.036 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 80.0 mt -68.97 -101.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.499 -0.319 . . . . 75.319999999999993 111.06 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.576 ' HB3' ' HB3' ' A' ' 313' ' ' GLU . 24.3 t70 166.82 164.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.994 -0.743 . . . . 73.540000000000006 108.994 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.5 -37.04 85.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.976 0.417 . . . . 75.310000000000002 110.576 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.455 ' HA ' ' NH2' ' A' ' 240' ' ' ARG . 0.2 OUTLIER -105.99 -26.27 11.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.015 -0.539 . . . . 60.340000000000003 112.336 -171.765 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.576 ' HB3' ' HB3' ' A' ' 310' ' ' ASP . 5.3 tp10 -92.83 112.51 24.5 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.277 0.843 . . . . 73.099999999999994 113.277 -168.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.517 ' HG2' ' OE1' ' A' ' 313' ' ' GLU . 39.8 mmtm 68.42 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 115.529 1.677 . . . . 73.349999999999994 115.529 162.013 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.877 ' HB3' ' HG2' ' A' ' 240' ' ' ARG . 94.7 Cg_endo -93.6 116.78 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.101 1.867 . . . . 73.109999999999999 109.02 156.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.535 ' O ' HD13 ' A' ' 320' ' ' LEU . 22.1 tp -126.04 98.48 5.52 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.125 -0.63 . . . . 73.450000000000003 111.111 -171.431 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.445 ' HD1' HD12 ' A' ' 162' ' ' LEU . 74.6 m-85 -64.63 -35.45 81.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.75 . . . . 74.430000000000007 110.735 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.36 -42.96 82.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.684 0.624 . . . . 75.230000000000004 112.684 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.524 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 26.5 t-20 -60.64 -43.72 97.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.109 0.48 . . . . 73.049999999999997 109.795 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.695 HD23 ' HG ' ' A' ' 244' ' ' LEU . 6.7 mp -69.11 -42.2 76.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.393 -0.821 . . . . 73.329999999999998 110.189 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -58.62 -49.48 77.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 74.549999999999997 110.347 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.25 -29.19 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 70.299999999999997 110.285 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.509 HD12 ' HD3' ' A' ' 301' ' ' LYS . 0.3 OUTLIER -63.91 -43.16 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 74.010000000000005 110.186 176.364 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 87.9 mt -70.11 -45.93 65.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 65.310000000000002 111.095 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.473 HD11 HD12 ' A' ' 328' ' ' LEU . 4.5 mm? -64.28 -32.75 74.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 75.120000000000005 110.666 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.82 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.129999999999995 110.241 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -63.38 -33.26 86.75 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.888 -0.597 . . . . 75.010000000000005 112.217 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 334' ' ' LYS . 96.6 mt -69.82 -44.15 70.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.087 0.47 . . . . 73.239999999999995 110.263 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.56 -27.3 69.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 74.540000000000006 111.187 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.0 73.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.109999999999999 111.615 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.577 HD13 ' HG2' ' A' ' 151' ' ' ARG . 48.4 pt -97.04 -2.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 70.219999999999999 111.181 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.613 -0.803 . . . . 55.100000000000001 113.587 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.8 m -138.37 170.53 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.151 0.476 . . . . 64.010000000000005 110.553 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.478 ' O ' HD11 ' A' ' 328' ' ' LEU . 96.2 mttt -124.99 -85.64 0.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.024 -0.362 . . . . 71.349999999999994 110.024 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -127.12 150.73 49.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.59 -0.522 . . . . 73.519999999999996 109.59 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.01 -20.56 28.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.932 0.396 . . . . 63.439999999999998 110.672 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 92.4 -6.33 77.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.93 -0.652 . . . . 73.129999999999995 112.235 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -155.04 175.0 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.81 -0.441 . . . . 74.150000000000006 109.81 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.966 ' HB2' ' HA ' ' A' ' 191' ' ' ASP . 43.7 mt -88.4 135.13 33.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.222 -0.658 . . . . 74.319999999999993 109.222 166.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.93 19.08 12.04 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.74 0.781 . . . . 73.519999999999996 109.534 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.1 97.96 4.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.999 -1.0 . . . . 75.109999999999999 111.086 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.9 m -86.69 109.46 19.22 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.67 -0.863 . . . . 64.409999999999997 108.67 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.76 84.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.562 0.696 . . . . 75.120000000000005 111.738 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.612 HG11 ' HG3' ' A' ' 345' ' ' GLU . 96.4 t -66.11 -53.7 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.275 -0.875 . . . . 74.349999999999994 110.244 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.612 ' HG3' HG11 ' A' ' 344' ' ' VAL . 42.8 mt-10 -150.64 -170.11 3.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.363 -0.835 . . . . 65.120000000000005 110.298 -176.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 3.2 p-10 -129.25 158.52 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 74.430000000000007 111.078 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.482 ' O ' ' HG2' ' A' ' 140' ' ' LYS . . . -139.5 -165.36 10.24 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.009 -0.837 . . . . 73.340000000000003 111.009 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -149.14 72.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.031 -1.081 . . . . 72.230000000000004 113.605 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.2 tt -114.87 107.19 15.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.237 -0.653 . . . . 54.539999999999999 109.237 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -128.9 -127.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.3 -0.409 . . . . 75.420000000000002 111.378 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 74.95 104.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.683 0.793 . . . . 73.329999999999998 111.754 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -164.86 147.36 8.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.477 -0.783 . . . . 64.230000000000004 109.979 -179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.585 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 13.5 t -176.01 164.18 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.056 -0.35 . . . . 53.5 110.056 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -67.14 142.02 17.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.885 0.374 . . . . 75.200000000000003 111.069 -176.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 6.2 t -94.78 76.0 3.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.85 0.833 . . . . 74.140000000000001 110.587 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 15.5 ptmt -98.9 129.07 45.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 74.040000000000006 110.248 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -143.31 -38.03 0.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.265 -0.425 . . . . 74.019999999999996 111.637 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.458 ' HD2' ' O ' ' A' ' 358' ' ' ARG . 0.4 OUTLIER -96.56 51.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 74.420000000000002 110.546 -177.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -175.68 120.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.545 -0.752 . . . . 73.319999999999993 109.949 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.481 ' HB3' ' NZ ' ' A' ' 360' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.661 -0.685 . . . . 75.420000000000002 109.731 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.659 ' HE2' ' HD2' ' A' ' 2' ' ' PRO . 97.7 mmm . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.957 -0.386 . . . . 75.319999999999993 109.957 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.659 ' HD2' ' HE2' ' A' ' 1' ' ' MET . 16.6 Cg_endo -57.9 146.13 87.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.719 2.279 . . . . 74.230000000000004 112.388 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -137.56 108.98 6.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.881 -0.6 . . . . 74.439999999999998 110.984 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.11 120.8 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 74.209999999999994 109.772 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -122.41 105.7 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 73.230000000000004 111.304 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -157.16 93.88 1.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.252 -0.885 . . . . 60.329999999999998 109.81 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.47 7.63 33.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.544 . . . . 71.420000000000002 111.595 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.71 121.28 27.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.46 -0.337 . . . . 75.120000000000005 110.483 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.12 109.29 1.97 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.076 -0.511 . . . . 75.549999999999997 110.673 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.92 125.36 1.83 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.968 -0.634 . . . . 75.010000000000005 111.818 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 mmm180 -122.67 112.94 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.056 0.455 . . . . 73.319999999999993 111.471 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.43 116.65 28.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.441 -0.578 . . . . 75.25 109.441 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -115.33 122.94 47.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.94 0.4 . . . . 71.439999999999998 110.215 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -93.02 114.56 27.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.125 0.488 . . . . 73.209999999999994 110.513 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.11 139.91 43.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.723 -0.671 . . . . 62.509999999999998 111.169 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -109.57 115.99 30.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.194 0.521 . . . . 75.109999999999999 111.335 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.447 ' HA ' ' HE ' ' A' ' 17' ' ' ARG . 1.8 mmp_? -104.1 103.78 13.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.962 -0.755 . . . . 73.109999999999999 108.962 172.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -65.99 150.59 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 74.319999999999993 110.661 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 mp -79.48 33.52 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 73.430000000000007 111.998 -173.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.68 -4.77 40.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.405 -0.961 . . . . 65.040000000000006 108.405 169.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.52 -41.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.297 -1.32 . . . . 75.510000000000005 109.275 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 48.97 -128.09 2.03 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.458 -0.792 . . . . 74.329999999999998 109.212 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 158.72 68.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.432 1.493 . . . . 75.409999999999997 109.219 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.1 -179.25 5.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.019 0.438 . . . . 74.030000000000001 112.071 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.67 136.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 72.430000000000007 110.99 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.6 1.56 57.65 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.983 -0.627 . . . . 73.150000000000006 112.47 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.412 ' HG2' HG13 ' A' ' 39' ' ' VAL . 14.6 pt-20 -71.79 139.02 48.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.974 0.416 . . . . 74.310000000000002 109.982 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.48 HD12 ' HB3' ' A' ' 38' ' ' LYS . 46.8 mm -88.34 116.18 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.434 -0.803 . . . . 74.420000000000002 110.342 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.416 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 33.5 pt -106.39 147.21 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.923 -0.581 . . . . 61.140000000000001 110.851 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.5 m -109.53 127.04 54.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.4 -0.818 . . . . 73.5 109.129 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.489 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 1.8 p-10 -131.26 -163.18 1.29 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.777 -0.369 . . . . 72.040000000000006 111.396 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.77 ' HA ' ' HE3' ' A' ' 32' ' ' MET . 18.8 mmt -63.23 -24.05 67.7 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.238 -0.437 . . . . 74.430000000000007 111.392 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.539 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . . . -81.02 21.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 53.439999999999998 109.947 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.553 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 38.9 mmtm 89.81 -38.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.763 1.225 . . . . 75.239999999999995 113.427 166.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.675 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 52.9 pttt 160.36 166.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.974 0.731 . . . . 75.209999999999994 112.974 -172.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.675 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 40.2 mt-10 73.85 50.57 0.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.967 1.469 . . . . 75.049999999999997 114.967 159.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.539 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 75.7 m95 -106.18 141.31 37.75 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.334 -0.988 . . . . 74.510000000000005 108.334 163.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 23.1 pttp -114.27 120.06 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.913 -0.773 . . . . 75.219999999999999 108.913 172.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.412 HG13 ' HG2' ' A' ' 27' ' ' GLU . 15.0 p -75.53 145.54 10.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.26 -0.427 . . . . 74.040000000000006 111.293 -172.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.48 -148.63 23.81 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.948 -0.569 . . . . 64.540000000000006 112.444 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.4 153.3 81.67 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.578 0.227 . . . . 73.439999999999998 111.176 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.61 135.6 24.29 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.11 2.54 . . . . 75.129999999999995 111.748 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 60.3 mt -108.48 -58.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.016 0.436 . . . . 74.150000000000006 110.33 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 161.58 37.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.868 -0.682 . . . . 73.310000000000002 112.38 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.635 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 33.2 tt0 -139.51 159.95 40.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.587 -0.524 . . . . 71.140000000000001 109.587 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 45' ' ' GLN . . . -76.05 -34.06 48.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.001 -0.618 . . . . 73.340000000000003 112.033 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.28 -85.04 0.79 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.983 -0.847 . . . . 73.209999999999994 110.983 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.488 ' CE2' ' HA ' ' A' ' 197' ' ' ASP . 31.6 m-85 -98.55 94.17 6.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.329 -0.619 . . . . 64.239999999999995 109.329 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.635 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -73.26 -162.04 6.95 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.05 -0.523 . . . . 72.549999999999997 113.56 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.92 31.82 13.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.371 0.605 . . . . 72.120000000000005 111.15 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 37.9 mm -88.82 134.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.818 -0.628 . . . . 75.450000000000003 109.829 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -107.8 159.16 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.774 0.321 . . . . 75.329999999999998 110.625 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.467 HD13 HG12 ' A' ' 69' ' ' VAL . 37.3 tp -81.65 133.38 35.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.463 -0.569 . . . . 73.439999999999998 109.463 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -98.01 103.13 15.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.984 0.421 . . . . 74.400000000000006 110.503 -177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.56 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 6.8 t70 -96.32 -175.57 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.541 -0.911 . . . . 74.439999999999998 108.541 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.512 ' HG2' ' CZ3' ' A' ' 37' ' ' TRP . 71.7 mtm -136.74 152.55 50.47 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.175 -0.328 . . . . 63.130000000000003 110.875 -171.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -125.69 -60.5 1.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.556 -0.293 . . . . 74.120000000000005 110.42 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -120.16 38.67 3.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.115 0.483 . . . . 73.420000000000002 110.498 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -107.06 -76.55 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.305 -0.628 . . . . 74.530000000000001 109.305 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -142.27 173.8 11.19 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.082 -0.71 . . . . 74.409999999999997 109.082 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.2 m -73.13 148.2 44.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.775 -0.454 . . . . 73.439999999999998 109.775 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 122.06 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.39 0.614 . . . . 70.439999999999998 111.006 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.428 ' C ' ' H ' ' A' ' 65' ' ' ASP . . . -80.86 69.72 3.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.905 -0.664 . . . . 43.439999999999998 112.493 -177.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 m 71.24 -34.87 0.31 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.631 0.773 . . . . 61.420000000000002 112.864 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.804 ' HB3' ' HH ' ' A' ' 187' ' ' TYR . 21.2 t70 -145.66 -73.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.479 -0.563 . . . . 62.009999999999998 109.479 -176.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' A' ' 133' ' ' ARG . . . 179.62 125.56 0.22 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.569 -1.196 . . . . 51.130000000000003 108.366 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.61 9.54 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.259 1.973 . . . . 71.219999999999999 112.462 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.1 p -162.01 151.38 15.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.554 0.692 . . . . 72.340000000000003 112.668 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.467 HG12 HD13 ' A' ' 53' ' ' LEU . 35.8 m -127.09 165.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.207 -1.034 . . . . 54.43 108.207 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.27 120.45 51.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.409 0.623 . . . . 73.310000000000002 111.574 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 1.9 ttmp? -79.71 119.0 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 72.209999999999994 108.877 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.37 120.14 61.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.763 0.316 . . . . 75.340000000000003 110.515 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -136.52 156.9 76.13 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.336 -0.616 . . . . 73.510000000000005 109.336 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.12 147.01 92.47 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.921 1.748 . . . . 75.209999999999994 110.978 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 66.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.095 0.474 . . . . 74.519999999999996 110.097 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -151.99 -40.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 63.409999999999997 110.708 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.533 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 65.7 t30 -63.91 123.49 19.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.008 -0.542 . . . . 74.409999999999997 111.878 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.26 -54.07 36.61 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.643 -0.708 . . . . 63.420000000000002 113.829 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.533 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 91.3 Cg_exo -46.95 -37.93 22.88 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.082 2.521 . . . . 75.510000000000005 113.344 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.35 -50.97 71.93 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.928 -0.397 . . . . 74.400000000000006 109.928 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -60.31 -40.26 89.92 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.571 0.701 . . . . 71.109999999999999 110.701 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.1 m -71.34 -47.09 58.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 74.209999999999994 111.579 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.53 -36.18 78.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.797 -0.446 . . . . 72.319999999999993 109.797 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.407 HD13 ' HE3' ' A' ' 129' ' ' MET . 62.8 tp -60.86 -38.43 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 72.349999999999994 110.58 177.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HA ' ' HG3' ' A' ' 88' ' ' GLN . 6.1 ttpp -70.54 -31.54 68.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.864 0.364 . . . . 64.409999999999997 110.425 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.43 -32.55 71.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.869 -0.332 . . . . 73.530000000000001 110.584 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -65.88 -50.1 65.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 71.430000000000007 110.403 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.454 ' HG3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -68.31 -16.05 63.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.677 0.275 . . . . 72.140000000000001 111.098 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.54 -68.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.947 0.351 . . . . 72.319999999999993 111.947 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.47 -34.41 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.011 0.745 . . . . 73.409999999999997 113.011 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.92 88.66 4.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.667 0.746 . . . . 62.420000000000002 110.583 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.643 ' HB2' ' HZ2' ' A' ' 92' ' ' LYS . 4.7 ttmp? -168.96 129.82 1.05 Allowed Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.04 -0.982 . . . . 74.140000000000001 109.452 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.44 -51.47 7.9 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.331 2.687 . . . . 73.230000000000004 113.397 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 34.4 mt-10 -63.74 -45.06 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 111.901 0.334 . . . . 74.109999999999999 111.901 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 33.1 mm-40 -62.94 -47.91 81.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.682 0.277 . . . . 72.319999999999993 110.908 -176.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.415 ' O ' HG12 ' A' ' 100' ' ' ILE . 69.8 mt -59.27 -47.47 90.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 73.430000000000007 110.0 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -54.81 -47.7 73.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.194 -0.912 . . . . 72.530000000000001 111.115 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.482 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 58.3 mtpt -61.81 -46.2 90.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 73.239999999999995 111.56 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.622 ' CZ3' HD13 ' A' ' 108' ' ' LEU . 44.7 t90 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.822 -0.351 . . . . 73.450000000000003 110.82 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.415 HG12 ' O ' ' A' ' 96' ' ' ILE . 30.5 mm -60.5 -37.94 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 64.129999999999995 111.357 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -75.96 -34.3 59.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.42 -0.355 . . . . 72.340000000000003 111.459 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.9 m -76.85 -48.68 17.71 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.898 0.38 . . . . 75.540000000000006 111.516 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 103' ' ' ARG . 5.6 tpm_? -76.64 -18.87 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.286 -0.416 . . . . 75.329999999999998 110.609 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? 64.74 78.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.822 0.82 . . . . 74.099999999999994 109.971 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.0 mt -138.64 -167.96 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.117 -0.947 . . . . 73.239999999999995 109.845 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -106.38 -50.86 3.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.777 -0.369 . . . . 75.409999999999997 110.964 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -153.4 146.76 24.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.681 0.277 . . . . 65.239999999999995 110.416 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.622 HD13 ' CZ3' ' A' ' 99' ' ' TRP . 46.4 tp -97.95 133.59 42.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 75.349999999999994 110.428 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.7 58.54 4.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 51.020000000000003 112.492 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -111.33 137.55 21.09 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.251 -0.648 . . . . 75.329999999999998 109.251 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.458 ' HA ' ' CD2' ' A' ' 194' ' ' TYR . 7.9 Cg_endo -50.5 134.5 39.42 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.564 2.176 . . . . 72.230000000000004 112.782 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.999 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.8 tptm -73.66 126.97 31.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 73.209999999999994 110.331 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.46 134.18 55.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.697 -0.683 . . . . 73.420000000000002 110.245 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.494 ' CD1' HG21 ' A' ' 130' ' ' ILE . 40.0 m95 -107.27 -75.16 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.418 0.627 . . . . 73.129999999999995 110.055 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.48 -168.18 12.02 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.281 -0.872 . . . . 42.210000000000001 111.458 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' A' ' 32' ' ' MET . 66.6 p -175.32 173.01 2.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.184 -0.302 . . . . 73.430000000000007 110.184 -175.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.07 -170.54 42.55 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.81 -0.71 . . . . 72.0 112.226 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -122.0 132.17 54.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.181 -0.674 . . . . 63.140000000000001 109.181 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -148.65 123.19 9.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.461 . . . . 73.209999999999994 110.636 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.82 145.36 52.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.708 -0.849 . . . . 73.409999999999997 108.708 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -143.82 18.42 1.81 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.126 -0.629 . . . . 74.540000000000006 112.151 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -179.67 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.179 0.514 . . . . 72.030000000000001 111.616 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.44 14.91 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.91 -1.676 . . . . 62.350000000000001 108.91 -166.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 1.4 tpmt? -146.09 124.97 12.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.807 -1.197 . . . . 74.319999999999993 108.279 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.448 ' HB3' HD23 ' A' ' 118' ' ' LEU . 18.4 m -75.63 105.1 6.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.91 0.386 . . . . 75.409999999999997 110.372 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.38 144.75 25.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.075 -0.511 . . . . 73.420000000000002 109.671 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -113.34 125.7 54.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.106 -1.072 . . . . 75.540000000000006 108.106 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -121.12 148.41 44.24 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.159 0.504 . . . . 72.349999999999994 111.064 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.407 ' HE3' HD13 ' A' ' 84' ' ' LEU . 23.5 ptp -135.26 134.83 40.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.226 -0.897 . . . . 72.430000000000007 109.304 178.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.494 HG21 ' CD1' ' A' ' 114' ' ' TRP . 19.1 mt -96.73 123.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.32 0.581 . . . . 74.409999999999997 110.137 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 11.8 ptm -128.67 -179.16 4.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.84 -1.073 . . . . 72.340000000000003 110.417 -172.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.999 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 31.6 t70 -68.92 156.19 38.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.36 . . . . 63.109999999999999 111.346 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.594 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 2.4 tmt_? -89.32 106.94 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 72.340000000000003 110.732 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 132' ' ' ASP . 19.2 m-85 -102.21 172.24 7.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 74.519999999999996 110.689 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.45 -37.5 0.02 OUTLIER Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.693 -0.765 . . . . 74.140000000000001 112.706 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.7 m -121.55 142.07 50.44 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.809 -0.23 . . . . 74.430000000000007 111.036 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.516 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -124.65 176.69 6.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.642 0.258 . . . . 74.200000000000003 110.807 176.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.483 HD21 ' HB2' ' A' ' 183' ' ' LEU . 5.3 mp -77.63 -27.9 51.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.346 0.499 . . . . 75.530000000000001 112.346 -177.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.4 ' OE1' ' HB3' ' A' ' 181' ' ' SER . 23.5 tt0 -75.39 -34.41 61.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.57 -0.452 . . . . 75.129999999999995 111.274 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.422 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 45.6 tptt -68.7 -38.43 80.29 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 73.5 110.117 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.572 HG12 ' HG ' ' A' ' 341' ' ' LEU . 1.8 mp -68.18 -38.84 80.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 75.209999999999994 109.763 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.512 ' HH ' ' NE2' ' A' ' 253' ' ' GLN . 39.9 t80 -55.18 -43.09 74.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.493 -0.776 . . . . 74.329999999999998 110.425 174.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.46 -50.37 18.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.804 -0.634 . . . . 73.519999999999996 110.904 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.77 73.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.383 0.512 . . . . 71.409999999999997 112.383 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.61 0.79 39.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 75.230000000000004 110.647 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.511 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 56.53 75.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.896 -0.593 . . . . 54.350000000000001 111.923 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 147' ' ' LYS . 0.0 OUTLIER 29.71 77.13 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.043 1.337 . . . . 74.239999999999995 114.132 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -160.28 105.7 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.64 -0.709 . . . . 71.129999999999995 109.092 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.408 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 49.9 m-85 -110.1 155.73 21.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 75.129999999999995 111.101 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -78.49 155.52 29.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.92 -0.582 . . . . 73.239999999999995 110.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -57.8 -38.85 76.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 74.239999999999995 110.642 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.56 -45.87 88.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 72.540000000000006 110.494 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.675 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.8 m -66.54 -52.37 46.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.827 -0.624 . . . . 72.329999999999998 110.948 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.7 t -60.24 -47.26 92.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.138 -0.483 . . . . 71.530000000000001 111.648 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.55 -37.87 80.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 75.140000000000001 110.762 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.835 HE21 ' HB2' ' A' ' 335' ' ' ASP . 30.2 mm-40 -60.22 -47.53 85.57 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.695 0.283 . . . . 75.019999999999996 110.61 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.675 ' HG ' ' O ' ' A' ' 153' ' ' THR . 81.9 mt -58.11 -50.51 73.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 70.439999999999998 110.131 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.558 ' HA ' HD12 ' A' ' 247' ' ' LEU . 25.2 t -58.18 -47.44 83.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.891 -0.595 . . . . 65.0 110.94 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.513 HD12 HD21 ' A' ' 325' ' ' LEU . 0.7 OUTLIER -64.74 -52.64 55.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 73.329999999999998 111.083 -176.315 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.434 ' NH1' HD23 ' A' ' 159' ' ' LEU . 13.6 mmt180 -72.51 -30.11 64.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 70.319999999999993 111.348 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.592 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -71.09 -30.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.818 -0.438 . . . . 74.530000000000001 109.818 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.45 -43.84 76.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.943 -0.391 . . . . 75.310000000000002 109.943 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.549 ' HB3' ' HH2' ' A' ' 99' ' ' TRP . 72.7 m-20 -58.53 -55.22 37.89 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.683 0.754 . . . . 72.140000000000001 110.432 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.586 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -63.19 -34.79 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 70.129999999999995 110.378 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.719 ' O ' ' HB3' ' A' ' 169' ' ' HIS . 6.3 tt -56.44 -37.93 70.92 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.577 -0.283 . . . . 73.340000000000003 110.318 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -57.29 -59.56 4.94 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.112 -0.699 . . . . 73.530000000000001 109.112 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.46 -28.19 66.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.967 -1.469 . . . . 74.540000000000006 113.501 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.0 pt -108.9 -48.18 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.908 0.707 . . . . 75.230000000000004 112.908 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.719 ' HB3' ' O ' ' A' ' 165' ' ' LEU . 7.0 t60 -59.87 -47.66 84.84 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.998 0.186 . . . . 75.109999999999999 110.85 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.689 ' HG3' ' HD2' ' A' ' 169' ' ' HIS . 21.1 mt-10 -106.47 80.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.978 0.894 . . . . 75.310000000000002 109.404 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -175.35 -44.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.481 -1.69 . . . . 74.319999999999993 109.128 -170.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.446 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 45.2 tt0 -162.61 -72.62 0.05 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.938 -0.573 . . . . 74.530000000000001 111.403 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.631 ' CD1' ' HA ' ' A' ' 203' ' ' ARG . 21.9 m-85 -122.79 155.21 37.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.187 0.518 . . . . 64.310000000000002 111.388 -174.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.451 HG11 ' HB2' ' A' ' 204' ' ' TYR . 31.0 m -97.37 167.29 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 73.209999999999994 109.431 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.554 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . 2.9 m-70 -114.3 -85.77 0.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.862 -0.335 . . . . 73.310000000000002 111.558 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.96 6.45 85.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.683 -0.77 . . . . 52.0 111.38 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.771 ' HB3' ' HB2' ' A' ' 200' ' ' LEU . 17.8 p-10 -89.66 28.39 1.32 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 73.340000000000003 111.077 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.447 ' HB ' HG22 ' A' ' 246' ' ' ILE . 46.2 mm -75.6 97.45 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.314 0.578 . . . . 73.530000000000001 110.527 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.871 ' HZ2' ' HB3' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -157.3 165.04 36.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.461 -0.791 . . . . 75.430000000000007 109.502 172.651 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.44 -23.56 64.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.967 0.729 . . . . 74.409999999999997 112.967 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.4 ' HB3' ' OE1' ' A' ' 139' ' ' GLN . 67.7 p -75.51 -18.59 59.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.837 0.31 . . . . 71.549999999999997 111.837 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 177' ' ' ASP . 2.6 m-20 -97.44 -26.94 14.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 111.891 0.33 . . . . 73.349999999999994 111.891 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.483 ' HB2' HD21 ' A' ' 138' ' ' LEU . 6.3 mp -95.69 118.38 32.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.11 0.481 . . . . 72.140000000000001 110.407 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -133.81 158.67 42.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.565 -0.743 . . . . 75.409999999999997 110.88 177.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.445 HD12 HD23 ' A' ' 341' ' ' LEU . 11.7 mt -103.55 157.59 16.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.906 -0.588 . . . . 72.150000000000006 109.601 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.866 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 23.8 t-20 -65.62 142.31 58.1 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.618 -0.882 . . . . 73.209999999999994 108.618 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.804 ' HH ' ' HB3' ' A' ' 65' ' ' ASP . 2.5 p90 -60.58 -22.24 63.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.964 0.357 . . . . 72.219999999999999 111.964 -173.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -124.25 6.23 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.293 0.568 . . . . 74.120000000000005 110.261 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.866 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 47.6 t-20 -139.87 101.92 7.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.892 -0.595 . . . . 72.349999999999994 109.835 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.48 -20.47 5.8 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.832 2.355 . . . . 75.019999999999996 113.716 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.47 1.62 57.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.953 0.406 . . . . 62.329999999999998 111.257 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.54 107.55 15.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.994 0.426 . . . . 74.349999999999994 110.437 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.33 142.12 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 73.120000000000005 109.937 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.458 ' CD2' ' HA ' ' A' ' 111' ' ' PRO . 44.1 m-85 -127.04 157.49 39.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.302 . . . . 74.049999999999997 110.732 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.7 mt -96.49 129.91 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.258 -0.428 . . . . 75.329999999999998 110.479 174.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.425 HG21 HD22 ' A' ' 184' ' ' LEU . 34.2 m -135.79 177.49 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 65.439999999999998 110.225 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.488 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 53.5 t0 59.8 66.73 0.95 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.6 0.714 . . . . 75.230000000000004 109.287 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -75.38 67.52 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.16 -0.927 . . . . 74.420000000000002 111.078 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 352' ' ' LYS . . . -93.52 1.87 69.74 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.464 -0.789 . . . . 71.540000000000006 111.651 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.771 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 77.8 mt -138.19 94.35 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.56 0.695 . . . . 72.450000000000003 110.587 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.439 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -155.0 115.8 3.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.725 -1.125 . . . . 74.299999999999997 108.921 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -132.38 160.61 35.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.635 -0.257 . . . . 75.049999999999997 110.699 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.631 ' HA ' ' CD1' ' A' ' 173' ' ' TYR . 5.4 ptp180 -62.52 149.36 43.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 74.519999999999996 111.144 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.469 ' HD2' ' HG ' ' A' ' 205' ' ' CYS . 42.1 t80 -149.86 -56.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 73.129999999999995 110.534 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.469 ' HG ' ' HD2' ' A' ' 204' ' ' TYR . 5.8 p -148.34 72.08 10.93 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 73.430000000000007 111.534 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.76 142.67 4.89 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.989 2.459 . . . . 73.030000000000001 111.853 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 66.25 9.48 6.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 73.5 111.726 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.86 67.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.04 -0.6 . . . . 52.32 112.299 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 61.9 t -96.42 117.44 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.537 0.208 . . . . 70.239999999999995 110.49 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -100.23 145.86 27.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.853 -0.425 . . . . 71.0 109.853 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -114.97 152.58 32.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.303 -0.408 . . . . 75.150000000000006 110.413 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.39 173.98 11.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.483 -0.562 . . . . 75.239999999999995 109.483 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.46 ' HB2' HG22 ' A' ' 236' ' ' VAL . 19.4 p90 -79.19 74.03 5.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.665 1.222 . . . . 75.219999999999999 110.223 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -154.91 92.97 1.5 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.055 -1.43 . . . . 72.439999999999998 108.49 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.589 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 2.7 mm-40 -122.61 -98.5 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.251 0.834 . . . . 71.25 113.251 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.49 119.26 61.92 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.411 -0.359 . . . . 73.25 111.664 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.29 -15.2 18.12 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.769 2.313 . . . . 73.140000000000001 112.379 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.34 -20.68 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.922 -0.399 . . . . 74.219999999999999 109.922 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 72.98 102.0 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.184 -0.916 . . . . 73.430000000000007 110.245 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.57 -73.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.555 -0.748 . . . . 73.540000000000006 111.633 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 46.15 26.84 0.47 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.838 0.855 . . . . 75.140000000000001 112.423 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.408 ' OD2' ' HB ' ' A' ' 355' ' ' THR . 19.0 p-10 -94.51 -4.53 47.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 110.849 -176.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -77.04 177.34 52.45 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.687 -0.768 . . . . 72.519999999999996 111.361 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -73.26 129.69 38.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.248 0.547 . . . . 75.430000000000007 111.667 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.436 HG23 HG23 ' A' ' 271' ' ' VAL . 47.7 mm -54.17 -31.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.342 -0.845 . . . . 72.340000000000003 112.336 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.476 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -56.92 -69.46 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.277 -0.42 . . . . 72.25 111.566 -179.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.449 ' HB3' HG21 ' A' ' 246' ' ' ILE . 94.6 m-85 -112.48 49.34 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.107 0.41 . . . . 72.420000000000002 112.107 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -18.18 35.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.629 0.252 . . . . 73.200000000000003 111.519 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.4 m 52.48 -162.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.891 -0.595 . . . . 73.120000000000005 111.159 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.4 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.2 mp -72.83 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.711 0.291 . . . . 74.109999999999999 110.507 177.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.572 ' OD2' ' HA ' ' A' ' 238' ' ' PRO . 1.3 m-20 -51.44 -70.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.159 -0.928 . . . . 74.340000000000003 112.468 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.22 70.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 71.400000000000006 111.383 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.32 -28.79 68.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.034 -0.53 . . . . 73.219999999999999 110.767 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.15 -30.62 16.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.239999999999995 110.859 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.57 6.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.668 -0.777 . . . . 70.540000000000006 111.625 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.589 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 9.1 p -120.49 141.55 40.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.236 -0.283 . . . . 75.219999999999999 110.236 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.71 124.69 58.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 71.230000000000004 110.778 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.572 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 91.0 Cg_exo -46.63 106.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 72.140000000000001 112.418 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.574 ' HB3' HG23 ' A' ' 312' ' ' THR . 36.4 m -92.04 42.26 1.1 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.148 -0.933 . . . . 71.010000000000005 110.928 -172.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.56 ' HB2' ' O ' ' A' ' 239' ' ' SER . 66.0 mtt180 85.29 -28.69 0.08 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.075 0.95 . . . . 70.150000000000006 111.159 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.575 ' HG2' ' O ' ' A' ' 311' ' ' TYR . 9.4 mmm180 -59.13 -61.39 2.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.542 0.21 . . . . 72.310000000000002 110.921 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -49.18 -55.36 12.45 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 115.724 -0.671 . . . . 73.209999999999994 113.219 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.463 ' HB3' HD12 ' A' ' 165' ' ' LEU . 3.3 m-20 -52.72 -54.56 32.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.98 0.419 . . . . 72.340000000000003 111.176 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 240' ' ' ARG . 11.2 mp -64.92 -45.93 83.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 74.040000000000006 111.391 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.46 -38.57 84.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.075 -0.25 . . . . 72.239999999999995 111.593 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.449 HG21 ' HB3' ' A' ' 227' ' ' PHE . 84.2 mt -59.13 -44.0 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 74.129999999999995 110.482 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.558 HD12 ' HA ' ' A' ' 158' ' ' SER . 33.2 tp -61.57 -42.63 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 73.010000000000005 110.293 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.63 95.86 Favored Glycine 0 C--O 1.236 0.271 0 C-N-CA 120.907 -0.663 . . . . 73.140000000000001 112.227 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -58.79 -49.16 78.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.649 0.261 . . . . 72.140000000000001 111.279 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 28.5 p -66.43 -36.79 83.68 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 73.310000000000002 111.453 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.425 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 72.5 mtm -60.65 -51.75 68.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 111.023 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.513 ' HB ' HG22 ' A' ' 299' ' ' ILE . 15.4 tt -67.38 -30.23 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.582 -0.447 . . . . 75.409999999999997 110.694 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.523 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 35.0 tt0 -67.91 -44.95 75.74 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.532 0.206 . . . . 72.530000000000001 110.584 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 22.7 m0 -65.4 -29.15 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 75.230000000000004 110.902 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -81.04 -35.71 31.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 73.329999999999998 112.003 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 62.5 p -103.37 -27.93 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.858 -0.337 . . . . 75.430000000000007 111.74 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.36 17.09 65.18 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.865 -0.683 . . . . 52.340000000000003 112.982 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -155.6 144.17 20.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.128 0.464 . . . . 73.430000000000007 111.145 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 29.3 mt -108.95 138.84 20.46 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 75.5 109.825 171.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 48.3 Cg_exo -58.03 -28.33 82.88 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.867 2.378 . . . . 74.030000000000001 112.57 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 46.7 p90 -108.22 11.72 27.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 74.150000000000006 111.375 -178.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.888 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 38.4 tt0 -75.56 -39.37 58.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 71.510000000000005 110.36 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.45 -29.15 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.69 0.757 . . . . 71.519999999999996 109.864 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -108.04 19.75 19.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.138 -0.937 . . . . 73.519999999999996 110.689 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 262' ' ' GLU . 1.8 tt -75.93 73.29 2.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.825 0.821 . . . . 73.239999999999995 110.362 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -147.52 -63.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.544 -1.207 . . . . 72.019999999999996 109.817 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.738 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 12.1 t70 -91.33 135.27 28.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.245 -0.888 . . . . 73.25 111.431 -173.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -58.23 -27.11 79.43 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.498 2.799 . . . . 75.549999999999997 114.331 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.441 ' HB2' ' HE2' ' A' ' 269' ' ' LYS . 1.8 mppt? -82.72 -40.07 21.09 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.605 -0.438 . . . . 73.040000000000006 110.542 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.738 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 37.0 m-85 -60.93 -49.19 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 73.319999999999993 110.704 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.436 HG23 HG23 ' A' ' 225' ' ' ILE . 33.8 m -66.6 -31.71 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.816 -0.354 . . . . 65.530000000000001 110.663 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -58.58 -56.67 19.17 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.087 0.47 . . . . 75.030000000000001 110.352 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.85 -43.47 79.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.474 -0.785 . . . . 74.409999999999997 111.038 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.404 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 41.7 m -60.34 -41.2 93.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 74.019999999999996 111.501 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.36 -48.29 70.66 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.114 -0.235 . . . . 73.409999999999997 110.615 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.46 -40.68 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 72.349999999999994 111.03 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -56.13 -51.02 69.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.647 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 33.4 m-85 -74.45 -36.05 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 74.5 111.12 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.517 ' HD2' HH22 ' A' ' 241' ' ' ARG . 26.2 ttp180 -57.23 -31.95 66.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.538 . . . . 64.340000000000003 111.28 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.5 -23.22 50.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.108 -0.496 . . . . 62.229999999999997 111.063 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -127.98 30.43 5.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.581 -0.281 . . . . 74.150000000000006 110.779 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.424 HG22 ' O ' ' A' ' 279' ' ' ARG . 0.2 OUTLIER -47.95 -42.28 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.04 1.126 . . . . 74.040000000000006 114.04 -171.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.414 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.16 -50.51 73.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.423 0.527 . . . . 71.430000000000007 112.423 -169.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 t -78.08 -36.21 48.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.834 0.35 . . . . 74.219999999999999 110.313 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.429 HD11 ' CD2' ' A' ' 278' ' ' TYR . 89.9 mt -71.95 -44.8 62.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 70.25 111.372 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.45 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -72.02 -40.6 68.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.639 -0.255 . . . . 71.349999999999994 110.946 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.79 -35.41 80.51 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.145 0.497 . . . . 63.530000000000001 111.046 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . 0.42 ' HB2' ' HE3' ' A' ' 288' ' ' LYS . 28.5 ttmt -99.76 7.63 44.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.774 -0.648 . . . . 73.530000000000001 110.658 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 47.0 t -75.95 -22.95 55.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.203 0.525 . . . . 75.530000000000001 110.048 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.424 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 33.6 t80 -127.35 77.39 75.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.546 -0.909 . . . . 74.219999999999999 108.546 173.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.85 12.07 2.76 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.895 2.397 . . . . 75.519999999999996 113.364 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 4.0 mp0 -71.11 -99.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.661 -0.496 . . . . 71.420000000000002 109.661 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -161.52 79.13 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.334 0.588 . . . . 75.329999999999998 110.771 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.5 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.5 t-20 -150.3 162.92 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.035 -1.098 . . . . 75.010000000000005 108.035 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.85 103.87 43.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 111.905 0.335 . . . . 75.409999999999997 111.905 -175.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.5 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 85.1 Cg_endo -98.26 37.81 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.011 2.474 . . . . 60.310000000000002 111.207 173.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -74.02 -43.71 32.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.628 -0.714 . . . . 75.200000000000003 111.942 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.473 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.4 mp0 -53.39 -51.15 63.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.212 0.53 . . . . 72.019999999999996 109.849 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.513 HG22 ' HB ' ' A' ' 252' ' ' ILE . 20.7 mt -62.09 -50.93 78.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.281 -0.872 . . . . 75.319999999999993 111.4 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 70.549999999999997 111.149 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.77 -28.54 40.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.24 -0.436 . . . . 74.420000000000002 110.489 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.405 ' HE1' ' O ' ' A' ' 244' ' ' LEU . 52.1 t80 -60.74 -42.64 97.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.287 -0.634 . . . . 75.140000000000001 109.287 172.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.53 ' HA ' HG21 ' A' ' 306' ' ' VAL . 66.3 mtp -72.71 -36.16 67.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.541 -0.754 . . . . 74.450000000000003 110.809 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -55.93 -46.42 78.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 72.420000000000002 109.342 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.51 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 91.3 m -57.33 -52.28 65.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.713 -1.131 . . . . 70.25 111.611 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 303' ' ' MET . 22.9 m -67.45 -31.63 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 111.78 0.289 . . . . 65.420000000000002 111.78 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -70.32 -48.81 54.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.095 0.474 . . . . 73.430000000000007 110.808 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 17.5 tp -82.73 -3.03 55.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 63.32 110.481 -175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 6.9 tt -67.65 -76.7 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.314 -0.857 . . . . 75.230000000000004 110.315 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.56 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 8.1 t70 162.19 -152.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.134 -1.432 . . . . 71.209999999999994 107.134 -176.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.575 ' O ' ' HG2' ' A' ' 241' ' ' ARG . 20.4 t80 -105.03 -39.97 6.06 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.938 -0.393 . . . . 74.439999999999998 109.938 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.574 HG23 ' HB3' ' A' ' 239' ' ' SER . 1.6 m -138.4 5.51 2.48 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.683 0.623 . . . . 60.310000000000002 112.683 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.22 -89.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.556 1.317 . . . . 73.439999999999998 114.556 -167.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.42 ' HB2' ' HE2' ' A' ' 314' ' ' LYS . 13.2 tppt? -109.09 107.42 59.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 113.165 0.802 . . . . 74.129999999999995 113.165 -161.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.487 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 68.7 Cg_endo -88.73 119.82 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.618 2.212 . . . . 64.209999999999994 112.034 169.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.63 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.2 mt -118.84 85.55 2.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.268 0.556 . . . . 65.230000000000004 109.786 176.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 315' ' ' PRO . 80.7 m-85 -67.98 -34.97 77.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.704 -0.68 . . . . 72.319999999999993 111.964 -172.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -29.53 46.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.902 -0.319 . . . . 72.25 110.904 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.62 -48.71 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.889 -0.411 . . . . 75.010000000000005 109.889 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.63 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 85.9 mt -58.4 -43.61 88.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.617 -0.72 . . . . 74.239999999999995 110.485 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.425 ' O ' HD22 ' A' ' 325' ' ' LEU . 7.4 mtp180 -64.21 -33.36 75.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 73.439999999999998 111.12 177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.44 -46.16 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.275 0.472 . . . . 75.109999999999999 112.275 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.46 ' CD1' ' HA ' ' A' ' 320' ' ' LEU . 0.3 OUTLIER -72.45 -27.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 119.474 -0.89 . . . . 63.119999999999997 110.414 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.13 -49.04 75.96 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.492 -0.559 . . . . 73.019999999999996 109.492 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.522 ' O ' ' HG2' ' A' ' 329' ' ' LYS . 4.0 mm? -67.59 -26.91 66.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 73.450000000000003 111.002 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . 0.647 ' HA ' ' HE2' ' A' ' 329' ' ' LYS . 20.2 tp60 -59.52 -49.01 79.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 73.019999999999996 110.427 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.91 -38.55 94.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.248 -0.977 . . . . 70.420000000000002 111.298 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.941 HD11 ' HA ' ' A' ' 334' ' ' LYS . 3.0 tm? -57.21 -50.35 73.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.181 -0.51 . . . . 72.120000000000005 111.043 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.647 ' HE2' ' HA ' ' A' ' 326' ' ' GLN . 54.8 pttt -81.15 -17.48 49.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.759 0.281 . . . . 75.400000000000006 111.759 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.76 63.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 73.230000000000004 110.894 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -77.46 -6.95 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.206 0.527 . . . . 71.140000000000001 110.626 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 89.67 12.27 62.76 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.856 -0.688 . . . . 74.140000000000001 112.887 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 170.37 8.69 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.043 -0.354 . . . . 70.430000000000007 110.043 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.941 ' HA ' HD11 ' A' ' 328' ' ' LEU . 77.6 tttt -146.28 156.56 43.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.541 . . . . 75.25 109.538 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.835 ' HB2' HE21 ' A' ' 156' ' ' GLN . 6.9 p-10 -87.65 126.64 35.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.166 0.508 . . . . 64.519999999999996 110.142 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -104.3 -24.18 13.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 62.509999999999998 110.862 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 85.39 -1.96 88.25 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.172 -0.537 . . . . 64.219999999999999 112.42 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.57 -27.82 62.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.613 0.207 . . . . 75.230000000000004 110.803 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 94.7 mt 60.76 88.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 123.823 0.702 . . . . 75.109999999999999 112.318 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.65 91.86 1.13 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 73.319999999999993 109.432 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.572 ' HG ' HG12 ' A' ' 141' ' ' ILE . 14.2 tp -127.64 9.27 6.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.312 -0.404 . . . . 75.200000000000003 110.717 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 44.7 m 73.03 -41.84 0.51 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.633 0.773 . . . . 74.439999999999998 112.276 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 34.1 t 63.33 71.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.618 0.723 . . . . 72.439999999999998 109.215 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.6 t -88.69 -67.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.887 . . . . 61.219999999999999 111.311 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 346' ' ' ASN . 29.3 tt0 -168.27 173.94 7.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.812 -0.81 . . . . 73.430000000000007 108.812 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.402 ' H ' ' HG2' ' A' ' 345' ' ' GLU . 22.5 p-10 -98.72 158.31 15.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.077 0.465 . . . . 72.25 110.309 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -173.96 21.6 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.775 -0.648 . . . . 70.010000000000005 111.515 179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -75.31 68.64 2.05 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.731 -0.271 . . . . 74.200000000000003 113.298 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 349' ' ' LEU . 2.7 pp -83.99 128.24 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.412 -0.588 . . . . 74.439999999999998 109.412 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -165.85 -65.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.92 -0.4 . . . . 74.420000000000002 109.92 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 62.49 103.74 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.824 0.702 . . . . 71.109999999999999 111.828 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.697 ' HB2' ' HA3' ' A' ' 199' ' ' GLY . 3.9 mppt? -110.42 169.77 8.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 74.349999999999994 110.549 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.7 t -134.3 132.47 39.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.29 -0.413 . . . . 73.439999999999998 110.562 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.707 HG13 ' HD3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -84.69 142.7 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 72.299999999999997 110.782 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.408 ' HB ' ' OD2' ' A' ' 222' ' ' ASP . 4.9 t -79.54 81.77 5.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.038 0.923 . . . . 72.200000000000003 110.045 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.707 ' HD3' HG13 ' A' ' 354' ' ' ILE . 10.5 mtpm? -140.46 168.53 19.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.439 -0.8 . . . . 71.219999999999999 110.509 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -110.82 150.22 29.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.097 -0.502 . . . . 74.340000000000003 110.649 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -96.7 146.36 24.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.662 -0.496 . . . . 72.530000000000001 109.662 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -109.65 -62.21 1.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.754 0.312 . . . . 72.019999999999996 110.401 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 42.7 mttp . . . . . 0 C--O 1.245 0.849 0 CA-C-O 118.585 -0.722 . . . . 74.340000000000003 110.231 175.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.038 -0.356 . . . . 73.049999999999997 110.038 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -62.82 138.66 70.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.586 2.191 . . . . 52.409999999999997 111.797 179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.468 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 2.1 mpt_? -94.92 137.65 33.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 72.310000000000002 110.338 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.08 145.79 12.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 73.120000000000005 111.235 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.08 139.97 47.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.983 -0.553 . . . . 75.430000000000007 110.319 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 153.35 28.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.419 . . . . 54.340000000000003 111.471 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.74 15.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 75.010000000000005 110.037 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -103.88 112.04 24.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.03 0.443 . . . . 74.109999999999999 111.442 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.77 112.27 12.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.936 -0.575 . . . . 71.010000000000005 109.62 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 118.75 4.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.651 -0.785 . . . . 74.230000000000004 113.171 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -87.07 127.09 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.82 0.343 . . . . 74.409999999999997 110.086 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -121.19 112.58 18.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.025 -0.534 . . . . 73.450000000000003 110.21 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.1 m -85.38 125.7 33.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.204 -0.453 . . . . 74.120000000000005 110.206 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -134.8 116.16 14.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 73.450000000000003 110.252 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.21 108.95 1.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 63.539999999999999 110.687 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -143.18 98.99 3.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.093 0.473 . . . . 72.209999999999994 110.299 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -150.85 88.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.453 -0.34 . . . . 75.200000000000003 111.06 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -173.34 149.67 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.836 -0.431 . . . . 75.400000000000006 109.836 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.2 tp -161.76 121.22 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.805 -0.443 . . . . 75.510000000000005 109.805 176.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.54 5.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 43.210000000000001 111.827 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -123.58 172.43 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.551 0.215 . . . . 55.009999999999998 110.84 177.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.58 93.37 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.022 0.439 . . . . 74.430000000000007 111.307 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -134.07 67.21 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.279 -0.637 . . . . 71.299999999999997 109.279 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.33 -56.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.875 -1.057 . . . . 75.129999999999995 109.557 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.03 127.43 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.597 -0.729 . . . . 74.549999999999997 110.298 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.87 57.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.88 -0.676 . . . . 74.299999999999997 112.73 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.03 167.56 12.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.315 0.578 . . . . 73.450000000000003 111.527 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.92 131.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.144 -0.935 . . . . 64.329999999999998 111.249 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.7 tt -105.77 136.81 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 72.549999999999997 109.427 175.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.5 m -93.83 113.95 26.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.134 0.42 . . . . 74.140000000000001 112.134 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.49 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 14.4 t70 -72.65 154.77 40.58 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.636 -0.711 . . . . 64.219999999999999 110.06 174.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.646 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 52.3 tpp -70.63 -30.36 66.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.879 0.371 . . . . 75.239999999999995 110.971 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.82 18.48 3.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.203 -0.453 . . . . 71.519999999999996 110.052 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.496 ' HD3' ' O ' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 61.29 77.71 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.062 -0.972 . . . . 74.439999999999998 110.032 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.49 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 45.4 mmtm -140.52 115.48 9.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.972 -1.013 . . . . 73.439999999999998 109.139 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.74 111.55 17.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.245 -0.434 . . . . 51.229999999999997 110.228 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 83.9 m95 -108.89 163.15 13.54 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.95 -0.759 . . . . 75.319999999999993 108.95 174.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HB2' ' HA ' ' A' ' 56' ' ' MET . 21.7 ttpt -114.6 129.49 56.68 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.654 -0.418 . . . . 75.430000000000007 110.25 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -75.89 104.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.071 0.462 . . . . 73.209999999999994 109.9 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.22 -104.54 2.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.442 -0.885 . . . . 73.310000000000002 113.246 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.445 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 mm? -86.29 127.71 60.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.043 0.449 . . . . 70.120000000000005 111.471 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.445 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.3 Cg_exo -78.74 106.25 2.08 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.106 2.537 . . . . 70.519999999999996 111.77 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -81.28 -37.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 75.319999999999993 110.17 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 87.53 -45.44 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.829 -0.7 . . . . 65.010000000000005 112.696 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.409 ' HG3' ' H ' ' A' ' 46' ' ' GLY . 26.2 tp60 -103.23 165.63 10.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.596 -0.52 . . . . 72.120000000000005 109.596 -175.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.614 ' O ' ' HE2' ' A' ' 71' ' ' LYS . . . 98.77 13.36 40.73 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.445 -1.462 . . . . 74.150000000000006 109.445 -168.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.845 ' HA3' HD12 ' A' ' 51' ' ' ILE . . . -168.24 -164.4 23.87 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 114.325 -0.938 . . . . 73.019999999999996 111.169 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -102.92 8.72 39.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.764 0.316 . . . . 74.420000000000002 111.625 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.03 -76.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.329 -0.939 . . . . 63.240000000000002 113.182 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . 0.613 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 84.6 m -150.18 110.43 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 73.099999999999994 109.964 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.845 HD12 ' HA3' ' A' ' 47' ' ' GLY . 30.3 mm -100.31 137.83 26.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.073 -0.512 . . . . 74.349999999999994 110.62 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -110.07 145.15 37.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 74.299999999999997 110.616 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.424 ' HA ' HG11 ' A' ' 69' ' ' VAL . 9.7 tt -91.16 138.27 31.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.421 -0.585 . . . . 75.219999999999999 109.421 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.18 96.23 5.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 73.340000000000003 110.945 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.13 -32.4 19.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 71.209999999999994 110.444 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.59 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 9.2 tpt 62.27 34.85 15.65 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.658 -0.701 . . . . 74.010000000000005 111.465 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.5 t30 74.07 121.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.573 0.701 . . . . 72.430000000000007 111.831 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.603 ' HA ' HG12 ' A' ' 62' ' ' VAL . 13.5 m -71.11 108.95 4.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.592 -0.731 . . . . 72.420000000000002 110.572 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 m -131.28 -67.31 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.848 -0.615 . . . . 62.43 111.051 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -157.97 -60.76 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 74.010000000000005 110.612 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 m -64.21 -21.36 66.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 74.030000000000001 112.465 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.603 HG12 ' HA ' ' A' ' 58' ' ' SER . 8.8 p -80.82 145.13 9.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.904 0.383 . . . . 72.530000000000001 110.776 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.79 -170.75 13.59 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.5 -0.857 . . . . 73.409999999999997 111.262 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.4 m -79.98 27.1 0.32 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.571 -0.37 . . . . 71.230000000000004 111.479 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.6 t70 175.56 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.567 -0.288 . . . . 75.120000000000005 110.63 -174.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . 76.9 116.79 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 124.362 1.039 . . . . 61.119999999999997 110.878 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 4.0 Cg_exo -79.87 40.72 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.294 2.663 . . . . 74.450000000000003 112.341 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.52 ' HA ' ' O ' ' A' ' 131' ' ' MET . 2.2 p -140.71 137.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.398 0.618 . . . . 70.209999999999994 111.931 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 53' ' ' LEU . 30.9 m -137.87 161.85 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.312 -0.858 . . . . 73.319999999999993 108.971 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -123.59 122.29 64.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.482 0.658 . . . . 73.239999999999995 112.371 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.824 ' HA ' HD11 ' A' ' 51' ' ' ILE . 36.9 ttmt -89.6 122.19 32.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.741 -1.118 . . . . 75.239999999999995 109.297 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.444 HG11 ' HB3' ' A' ' 128' ' ' PHE . 35.7 m -115.91 139.16 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.03 0.382 . . . . 72.409999999999997 112.03 -175.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.509 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 6.6 mm-40 -148.91 139.44 13.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 74.439999999999998 109.823 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 25.2 Cg_exo -63.1 150.94 87.18 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.942 2.428 . . . . 72.200000000000003 112.324 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 m -73.06 66.83 0.85 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.301 0.572 . . . . 54.420000000000002 112.068 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -113.61 -6.44 13.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.52 -1.289 . . . . 72.409999999999997 107.52 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 90.69 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 113.987 -1.46 . . . . 63.420000000000002 111.391 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.43 -139.66 5.72 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.441 -0.8 . . . . 61.210000000000001 111.5 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.608 ' HG3' HG22 ' A' ' 353' ' ' THR . 28.0 Cg_exo -61.59 -22.93 75.66 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.057 2.505 . . . . 74.420000000000002 112.175 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.509 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -56.81 -34.74 67.99 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.743 -0.662 . . . . 74.140000000000001 110.294 178.55 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.19 -41.43 85.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 73.319999999999993 110.43 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.2 m -65.59 -41.76 92.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.235 -0.439 . . . . 73.040000000000006 110.348 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -58.31 -45.99 86.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.694 . . . . 73.430000000000007 110.425 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -67.48 -33.69 75.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 74.340000000000003 111.128 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.434 ' HE3' ' HE1' ' A' ' 173' ' ' TYR . 6.2 tmtm? -64.19 -45.18 89.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.351 -0.611 . . . . 74.340000000000003 109.351 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -65.26 -41.5 94.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 73.409999999999997 110.275 176.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.533 ' CE2' ' HD1' ' A' ' 113' ' ' TYR . 42.8 t80 -59.28 -49.03 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.076 -0.965 . . . . 75.519999999999996 110.512 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -64.04 -34.17 77.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 74.319999999999993 111.226 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.545 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -75.52 -53.56 8.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.493 0.553 . . . . 73.299999999999997 112.493 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.75 -33.7 7.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.832 0.679 . . . . 75.019999999999996 112.832 -169.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.06 84.84 7.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.322 0.582 . . . . 64.230000000000004 110.738 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -157.48 128.43 3.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.772 -0.649 . . . . 74.439999999999998 109.466 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.0 -52.38 8.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.354 2.703 . . . . 74.019999999999996 113.23 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.75 -45.37 92.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 74.409999999999997 110.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -69.22 -45.58 69.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.004 -0.543 . . . . 75.409999999999997 110.716 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.11 -50.42 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 73.519999999999996 110.998 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -61.46 -37.3 83.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.809 0.338 . . . . 75.430000000000007 110.391 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 34.0 ttmt -59.63 -51.5 69.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 74.340000000000003 110.832 179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.811 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 23.6 t90 -68.59 -51.1 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 75.549999999999997 110.684 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.93 -40.05 81.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.510000000000005 111.713 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 45.7 ttt-85 -63.77 -56.54 14.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 75.310000000000002 110.856 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.3 m -65.04 -40.84 95.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.754 -0.657 . . . . 61.149999999999999 111.239 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -75.53 -13.83 60.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.988 -0.551 . . . . 74.099999999999994 110.929 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.48 ' HZ2' ' HB3' ' A' ' 104' ' ' LYS . 6.0 ttpm? 62.58 57.74 1.77 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.336 0.588 . . . . 74.150000000000006 110.392 -179.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -117.62 -174.52 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 75.040000000000006 110.806 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.47 -59.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.878 -0.601 . . . . 64.329999999999998 111.284 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -144.81 157.26 44.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 72.310000000000002 110.764 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HB3' HG13 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -105.8 137.35 43.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 72.409999999999997 109.199 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.27 33.05 1.78 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.941 -0.647 . . . . 72.319999999999993 113.287 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.532 HG13 ' HB3' ' A' ' 108' ' ' LEU . 11.0 p -109.25 137.16 20.14 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.405 -0.591 . . . . 74.540000000000006 109.405 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.434 ' HD2' HG21 ' A' ' 110' ' ' VAL . 5.9 Cg_endo -47.28 135.21 19.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.51 2.807 . . . . 74.510000000000005 113.343 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.697 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 44.3 tptt -65.01 121.15 14.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 72.439999999999998 110.839 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HD1' ' CE2' ' A' ' 87' ' ' TYR . 27.2 t80 -80.44 132.27 35.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.272 -0.876 . . . . 74.340000000000003 111.357 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.487 ' HB2' HG21 ' A' ' 130' ' ' ILE . 69.9 m95 -122.42 -54.03 1.89 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.875 -0.787 . . . . 74.310000000000002 108.875 170.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.38 176.71 46.72 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.393 -0.822 . . . . 71.25 111.96 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -157.29 153.62 27.75 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.996 -0.742 . . . . 72.329999999999998 108.996 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.646 ' HA2' ' HB2' ' A' ' 32' ' ' MET . . . -161.43 176.07 37.98 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.357 -1.401 . . . . 74.109999999999999 114.147 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 19.1 tp -137.08 129.08 29.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.010000000000005 108.785 176.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -144.49 131.79 20.75 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.701 -0.4 . . . . 73.200000000000003 110.648 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.954 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 8.2 t70 -69.74 136.75 51.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 74.439999999999998 110.824 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -90.72 -60.01 2.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 73.519999999999996 109.258 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -170.18 85.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.633 -0.712 . . . . 73.200000000000003 109.603 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.38 -34.86 5.43 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.604 -0.598 . . . . 75.310000000000002 111.604 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -132.02 140.8 49.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 75.0 109.919 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.954 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 11.5 p -89.65 156.14 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 64.299999999999997 110.897 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -111.5 130.69 55.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.737 -0.665 . . . . 72.409999999999997 110.391 175.29 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -96.44 118.03 32.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.709 -0.849 . . . . 74.409999999999997 108.709 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.6 p90 -129.16 156.57 43.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.967 0.413 . . . . 75.430000000000007 111.5 -173.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.516 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 18.5 ptp -137.27 139.59 41.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.671 -0.695 . . . . 74.420000000000002 110.335 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.531 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.7 mm -97.86 117.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.1 -0.5 . . . . 60.520000000000003 109.711 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.52 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER -121.84 -175.96 3.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 75.340000000000003 111.088 -175.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.697 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 20.8 t70 -64.5 157.01 27.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 72.530000000000001 110.633 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.428 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 1.2 tmt_? -93.71 109.36 21.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.268 0.556 . . . . 72.5 110.045 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.518 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 63.7 m-85 -101.84 171.39 7.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.589 . . . . 73.219999999999999 109.9 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.7 -36.78 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.472 -0.871 . . . . 64.530000000000001 112.42 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.664 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.5 m -103.06 124.94 49.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.962 0.411 . . . . 74.400000000000006 111.141 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.561 ' HB2' ' HB2' ' A' ' 140' ' ' LYS . 1.3 m-20 -87.42 132.9 33.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.06 -0.518 . . . . 71.439999999999998 109.905 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.685 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 14.8 tp -68.94 -38.29 79.37 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.065 -1.087 . . . . 70.120000000000005 108.065 171.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.983 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 4.9 pt20 -59.51 -49.0 79.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.339 -0.846 . . . . 75.140000000000001 112.418 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.561 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 25.2 mtmm -71.57 -36.91 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.768 -0.373 . . . . 55.539999999999999 111.371 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.03 -48.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 74.310000000000002 110.568 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.685 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.05 -44.95 95.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 71.140000000000001 111.922 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.3 -34.39 59.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.876 0.369 . . . . 63.25 110.727 -172.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.4 -28.85 62.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 73.120000000000005 110.557 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.64 0.11 56.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.37 0.605 . . . . 63.219999999999999 110.185 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 58.81 45.12 15.93 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.296 -0.865 . . . . 75.420000000000002 112.27 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.52 ' HB2' ' HA ' ' A' ' 254' ' ' TRP . 0.0 OUTLIER 39.89 79.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.932 0.872 . . . . 74.510000000000005 112.998 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.404 HH11 ' HD2' ' A' ' 148' ' ' ARG . 14.4 ttt180 -146.5 88.48 1.78 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.68 -1.145 . . . . 74.430000000000007 108.367 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.716 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 52.4 m-85 -120.09 156.16 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.084 -0.507 . . . . 74.340000000000003 112.025 -172.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.4 m -67.61 155.66 38.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.854 . . . . 72.420000000000002 110.257 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.599 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 7.7 tpp85 -59.71 -39.7 85.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.824 0.345 . . . . 74.209999999999994 110.797 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.736 ' HD2' ' HB2' ' A' ' 335' ' ' ASP . 26.2 pttm -66.3 -30.36 70.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.337 -0.392 . . . . 73.450000000000003 111.201 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.424 ' OG1' ' HB3' ' A' ' 340' ' ' ASP . 6.9 m -70.2 -41.52 73.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 73.310000000000002 110.175 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.72 -43.62 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.617 -0.72 . . . . 73.239999999999995 110.945 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.638 HD22 HD22 ' A' ' 328' ' ' LEU . 3.3 mp -69.06 -40.16 78.69 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.483 0.549 . . . . 75.209999999999994 112.483 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -56.29 -45.06 80.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 75.420000000000002 110.301 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 153' ' ' THR . 8.6 mp -64.18 -52.03 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 73.219999999999999 111.313 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.576 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.3 p -65.27 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.286 . . . . 64.430000000000007 111.671 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.665 HD22 HD22 ' A' ' 325' ' ' LEU . 7.0 mp -56.3 -48.99 75.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.539 0.2 . . . . 64.540000000000006 111.539 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.76 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 2.3 mmp_? -61.15 -42.68 98.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 75.310000000000002 110.907 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.435 HD12 HD23 ' A' ' 183' ' ' LEU . 31.4 mm -63.62 -38.19 81.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 72.040000000000006 110.581 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 317' ' ' TYR . 67.3 mt -58.01 -53.04 62.73 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.891 0.33 . . . . 75.340000000000003 111.891 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.811 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -70.08 -39.44 75.59 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.454 -0.498 . . . . 74.409999999999997 112.119 -175.611 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.54 -36.57 75.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.871 -0.731 . . . . 74.099999999999994 110.953 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.91 -38.86 83.47 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.797 -0.183 . . . . 74.5 111.212 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.476 ' HG3' ' N ' ' A' ' 167' ' ' TYR . 4.1 pt-20 -68.93 -40.96 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.233 -0.587 . . . . 55.530000000000001 110.009 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.476 ' N ' ' HG3' ' A' ' 166' ' ' GLU . 66.3 t80 -55.84 -45.81 78.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.693 -0.685 . . . . 75.409999999999997 111.735 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 26.9 pt -82.55 -31.46 9.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.486 -0.324 . . . . 72.329999999999998 111.797 -177.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -66.8 -27.06 67.27 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.436 -0.347 . . . . 75.340000000000003 110.689 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 170' ' ' GLU . 37.0 tt0 -77.65 28.56 0.16 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.107 0.479 . . . . 71.409999999999997 111.491 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -151.18 -65.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.525 -0.734 . . . . 74.420000000000002 111.597 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 35.3 mt-10 -147.25 -31.44 0.32 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.696 0.628 . . . . 71.030000000000001 112.696 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.434 ' HE1' ' HE3' ' A' ' 85' ' ' LYS . 5.4 m-85 -99.18 128.85 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.784 1.031 . . . . 75.409999999999997 113.784 -155.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 204' ' ' TYR . 15.4 m -123.01 139.5 49.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.707 -1.133 . . . . 64.340000000000003 108.015 163.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.491 ' HD1' HD21 ' A' ' 195' ' ' LEU . 15.3 t-160 -93.77 -32.88 13.81 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.827 -0.349 . . . . 73.030000000000001 110.203 -177.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.65 -76.87 0.28 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.078 -0.582 . . . . 71.219999999999999 111.852 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.484 ' CG ' ' HZ2' ' A' ' 352' ' ' LYS . 22.5 t70 -66.9 101.93 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.037 0.446 . . . . 64.349999999999994 110.343 176.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.416 HD11 ' HA ' ' A' ' 178' ' ' ILE . 9.4 tp -99.73 20.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.876 0.846 . . . . 71.150000000000006 110.051 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.414 ' C ' ' H ' ' A' ' 181' ' ' SER . 2.8 tmtm? -57.56 144.3 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.93 . . . . 71.25 110.256 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.523 ' HA ' HD13 ' A' ' 183' ' ' LEU . . . -62.3 -0.36 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.906 -0.588 . . . . 72.439999999999998 112.553 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.983 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 14.2 p -70.48 -17.28 62.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 54.310000000000002 111.514 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.52 ' CG ' ' HB3' ' A' ' 198' ' ' TYR . 14.6 m120 -112.53 6.67 18.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 63.439999999999998 111.3 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 180' ' ' ALA . 7.1 mp -105.06 115.66 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.706 -0.479 . . . . 74.129999999999995 109.706 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.63 140.3 49.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 75.409999999999997 110.433 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.664 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 53.3 mt -94.71 138.41 32.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.707 -0.679 . . . . 75.219999999999999 109.874 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.61 140.47 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.096 -0.705 . . . . 63.299999999999997 109.096 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.428 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 5.6 p90 -62.42 -22.4 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.128 0.418 . . . . 73.540000000000006 112.128 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -104.3 -51.18 3.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.761 0.315 . . . . 74.209999999999994 111.039 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -112.11 106.82 56.12 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 74.140000000000001 110.979 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.13 -11.71 25.32 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.096 2.531 . . . . 62.240000000000002 112.49 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 26.8 t70 -70.87 -19.99 62.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.57 . . . . 74.129999999999995 110.703 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -111.09 103.05 11.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.45 0.643 . . . . 72.530000000000001 110.18 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.94 137.99 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 74.420000000000002 109.74 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.518 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 96.3 m-85 -120.3 141.98 49.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.044 0.449 . . . . 73.25 111.054 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.491 HD21 ' HD1' ' A' ' 175' ' ' HIS . 37.6 tp -90.76 99.97 12.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.728 -0.669 . . . . 73.150000000000006 109.392 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.409 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.5 m -139.99 160.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.457 -0.338 . . . . 74.450000000000003 111.636 -174.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.442 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 16.6 t70 60.67 78.16 0.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.968 -1.015 . . . . 70.420000000000002 111.575 174.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.557 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 19.4 p90 -151.41 -40.76 0.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.548 -0.751 . . . . 74.450000000000003 112.015 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.647 ' O ' ' HB ' ' A' ' 354' ' ' ILE . . . 66.72 2.16 15.03 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.751 -0.737 . . . . 74.099999999999994 112.661 -175.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.557 ' H ' ' HD2' ' A' ' 198' ' ' TYR . 6.2 mp -91.94 35.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 73.239999999999995 111.474 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -84.49 97.78 9.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.363 -0.977 . . . . 72.519999999999996 108.363 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -99.97 127.48 46.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.265 0.555 . . . . 72.049999999999997 110.697 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.435 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 2.0 ttp180 -72.86 112.45 8.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.483 -0.78 . . . . 64.209999999999994 110.229 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.543 ' HB2' ' HB3' ' A' ' 237' ' ' ALA . 13.7 p90 -92.57 -26.22 17.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.84 -0.43 . . . . 75.420000000000002 109.84 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 18.0 p -133.31 127.42 19.84 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 75.209999999999994 111.145 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.65 131.39 13.51 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.505 2.137 . . . . 70.439999999999998 111.752 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 65.96 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.79 0.681 . . . . 74.319999999999993 111.291 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.27 15.75 0.14 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.155 -0.545 . . . . 74.010000000000005 111.927 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -94.95 110.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.931 -0.396 . . . . 74.510000000000005 109.931 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.98 145.82 55.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 73.450000000000003 110.998 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.446 ' HZ1' ' CD ' ' A' ' 215' ' ' GLU . 74.8 tttt -111.02 145.09 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.828 -0.624 . . . . 75.200000000000003 110.755 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.2 -163.39 1.02 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.872 -0.604 . . . . 71.519999999999996 110.172 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.507 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 0.9 OUTLIER -76.27 67.79 2.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.809 0.67 . . . . 71.400000000000006 112.809 -175.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.406 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 75.6 tttt -158.43 83.28 0.83 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.855 -0.611 . . . . 73.340000000000003 109.725 169.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.486 ' HB3' ' O ' ' A' ' 235' ' ' GLY . 9.8 tp10 -105.9 -72.93 0.7 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.939 -0.573 . . . . 75.439999999999998 110.464 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -138.34 109.39 8.14 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.61 -0.268 . . . . 61.030000000000001 110.418 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.2 -14.07 43.16 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.23 2.62 . . . . 73.230000000000004 112.481 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -85.99 3.88 40.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.237 0.541 . . . . 74.230000000000004 110.05 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.449 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 69.7 mtt85 67.27 85.6 0.14 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.44 -0.8 . . . . 63.219999999999999 110.653 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.02 -42.81 77.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.43 -1.259 . . . . 72.030000000000001 112.915 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 44.64 75.64 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.869 0.842 . . . . 72.239999999999995 111.453 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.32 -43.06 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 75.430000000000007 111.491 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -96.88 -170.46 33.95 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 71.209999999999994 112.789 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.3 m -69.58 142.24 53.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.443 0.164 . . . . 71.340000000000003 110.77 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.529 HD11 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -56.96 -23.83 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.471 0.653 . . . . 73.409999999999997 110.542 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.23 -53.47 54.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.465 -0.788 . . . . 65.420000000000002 111.937 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.27 7.0 19.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.085 0.772 . . . . 75.209999999999994 113.085 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.425 HG22 ' HB3' ' A' ' 232' ' ' ALA . 0.6 OUTLIER -64.42 -21.1 66.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 73.150000000000006 111.288 178.85 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.664 ' HA ' ' CD ' ' A' ' 275' ' ' LYS . 50.8 m 59.77 -162.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.709 -0.678 . . . . 72.109999999999999 110.247 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.414 ' H ' HD12 ' A' ' 230' ' ' ILE . 0.2 OUTLIER -71.0 -34.16 54.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.421 -0.512 . . . . 75.140000000000001 110.281 176.436 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.419 ' HA ' HG13 ' A' ' 236' ' ' VAL . 5.2 m-20 -59.76 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.631 -0.713 . . . . 63.340000000000003 112.316 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.425 ' HB3' HG22 ' A' ' 228' ' ' THR . . . -63.65 -31.59 72.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 71.120000000000005 111.714 -172.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -68.97 -31.35 70.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.496 -0.32 . . . . 73.239999999999995 111.164 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.69 0.52 55.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 64.230000000000004 110.711 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 215' ' ' GLU . . . 87.12 33.89 11.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.459 -0.877 . . . . 71.439999999999998 113.829 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.507 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 1.4 p -120.79 129.22 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.226 0.513 . . . . 75.409999999999997 110.803 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.543 ' HB3' ' HB2' ' A' ' 204' ' ' TYR . . . -77.29 111.6 18.03 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 64.329999999999998 109.578 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 123.82 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.577 2.185 . . . . 74.230000000000004 113.295 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.1 m -95.37 104.59 16.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.886 -0.597 . . . . 61.329999999999998 110.041 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.632 HH11 HD11 ' A' ' 309' ' ' LEU . 0.0 OUTLIER 79.8 -56.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.64 0.776 . . . . 74.140000000000001 110.866 175.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.645 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.61 -54.89 38.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.32 -0.4 . . . . 74.109999999999999 111.457 -173.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.436 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.13 -44.95 97.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 55.229999999999997 112.592 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.43 -53.74 33.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.113 0.482 . . . . 75.129999999999995 111.12 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.621 ' HB2' HH21 ' A' ' 240' ' ' ARG . 3.7 mm? -72.22 -40.34 67.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.662 . . . . 73.299999999999997 111.537 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -46.43 89.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.69 0.281 . . . . 62.310000000000002 111.049 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.441 HG12 ' HG ' ' A' ' 229' ' ' SER . 75.1 mt -66.6 -33.92 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 65.299999999999997 110.714 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.1 86.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.517 -0.549 . . . . 74.109999999999999 109.517 174.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.456 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -58.76 -39.1 93.25 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.737 -0.744 . . . . 75.019999999999996 112.18 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.07 -42.18 94.4 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.965 0.358 . . . . 75.420000000000002 111.965 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 31.2 p -69.64 -35.8 75.53 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.243 -0.583 . . . . 74.150000000000006 110.955 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 70.6 mtm -65.69 -46.81 77.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.056 -0.258 . . . . 73.209999999999994 111.073 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.8 -28.78 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.738 -0.385 . . . . 72.019999999999996 110.586 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -46.55 87.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.97 -0.382 . . . . 73.230000000000004 109.97 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.716 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 16.8 m0 -67.32 -28.64 68.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.915 -0.584 . . . . 75.25 110.906 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -83.9 -35.78 23.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 74.329999999999998 112.628 -173.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 42.9 p -102.64 -14.69 16.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.416 0.524 . . . . 73.340000000000003 112.416 -171.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.28 -33.54 4.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.235 -0.983 . . . . 61.149999999999999 113.006 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 143.93 18.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.371 -0.488 . . . . 73.140000000000001 110.868 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.49 HD11 ' CZ2' ' A' ' 261' ' ' TRP . 96.3 mt -103.9 149.5 37.25 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 74.129999999999995 110.315 176.455 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.01 -40.25 86.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.751 2.301 . . . . 73.299999999999997 112.681 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.49 ' CZ2' HD11 ' A' ' 259' ' ' LEU . 25.0 p90 -87.13 -0.38 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.531 -0.304 . . . . 71.319999999999993 111.35 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.511 ' HA ' HD22 ' A' ' 265' ' ' LEU . 84.7 tt0 -79.63 -28.27 40.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.093 0.473 . . . . 73.340000000000003 109.945 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.19 -27.95 32.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 64.5 110.26 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -108.4 17.42 22.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.529 -0.76 . . . . 74.109999999999999 112.098 -173.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.511 HD22 ' HA ' ' A' ' 262' ' ' GLU . 4.2 pp -73.56 -7.85 53.55 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.091 0.472 . . . . 73.219999999999999 111.085 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -64.21 -14.12 53.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 75.200000000000003 111.058 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.69 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 10.9 t70 -134.69 127.89 18.71 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 74.310000000000002 110.223 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.0 Cg_exo -61.59 -33.06 87.71 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.351 2.701 . . . . 72.150000000000006 114.794 -171.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.69 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 22.9 pttm -74.29 -24.04 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.515 -0.474 . . . . 75.129999999999995 111.471 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.502 ' CD1' ' HB3' ' A' ' 267' ' ' ASP . 74.6 m-85 -71.22 -49.55 42.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 75.239999999999995 110.157 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.636 HG11 ' HZ3' ' A' ' 275' ' ' LYS . 96.1 t -58.5 -37.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.784 -0.644 . . . . 74.030000000000001 110.954 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.434 ' O ' HG13 ' A' ' 276' ' ' ILE . 48.5 ttt-85 -59.85 -61.9 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 74.129999999999995 110.876 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -45.58 91.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.974 -0.557 . . . . 73.540000000000006 111.82 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 15.1 p -61.46 -49.92 74.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 72.329999999999998 111.883 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.664 ' CD ' ' HA ' ' A' ' 229' ' ' SER . 56.2 mttp -66.69 -37.35 84.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 64.310000000000002 111.75 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.529 ' O ' ' HG3' ' A' ' 280' ' ' GLU . 83.0 mt -60.85 -49.58 84.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.42 . . . . 73.400000000000006 110.557 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -69.01 -33.63 73.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 74.420000000000002 111.003 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.81 -36.4 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 72.200000000000003 110.644 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.407 ' O ' HG21 ' A' ' 282' ' ' ILE . 58.2 ttp180 -71.06 -38.22 72.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 74.310000000000002 110.805 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . 0.529 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 72.7 mt-10 -67.58 -42.32 82.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 74.239999999999995 110.986 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.452 ' HB2' HD22 ' A' ' 285' ' ' LEU . 30.0 m-80 -117.78 46.97 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 73.549999999999997 110.649 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.518 HG13 ' HA ' ' A' ' 304' ' ' GLU . 0.2 OUTLIER -49.63 -51.35 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.865 0.691 . . . . 73.329999999999998 112.865 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.508 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.11 -43.54 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.913 0.387 . . . . 61.25 111.339 -175.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.4 m -65.96 -45.39 81.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.839 -0.619 . . . . 75.430000000000007 110.853 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.452 HD22 ' HB2' ' A' ' 281' ' ' ASN . 4.0 mm? -69.39 -43.12 74.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 74.299999999999997 111.603 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.529 ' HE2' ' HA ' ' A' ' 286' ' ' MET . 30.5 mmt -64.57 -40.34 95.38 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.965 -0.294 . . . . 74.319999999999993 111.051 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 16.1 t70 -66.26 -48.64 69.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 74.310000000000002 111.2 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -98.94 14.54 28.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.847 -0.615 . . . . 73.340000000000003 111.875 -169.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.432 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 47.4 t -85.44 -27.25 25.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 73.040000000000006 109.777 173.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.42 ' HD1' ' HA ' ' A' ' 290' ' ' PHE . 0.1 OUTLIER -138.1 68.5 48.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 71.310000000000002 111.298 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.19 31.89 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.035 2.49 . . . . 71.340000000000003 111.919 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.76 -85.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.666 -0.697 . . . . 70.200000000000003 111.808 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -145.4 16.27 1.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.964 0.887 . . . . 71.420000000000002 109.492 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -104.73 -142.92 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.338 -0.847 . . . . 74.519999999999996 109.958 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.402 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 47.9 tptt -156.06 114.98 2.16 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.657 -0.247 . . . . 75.0 110.613 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.469 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 47.3 Cg_endo -95.42 77.99 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.342 2.695 . . . . 72.349999999999994 111.697 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -119.95 -59.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.201 -0.999 . . . . 72.109999999999999 112.535 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.599 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 1.1 mp0 -60.02 -61.43 2.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.675 0.274 . . . . 74.109999999999999 110.399 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.7 mp -60.6 -37.17 74.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.62 . . . . 74.109999999999999 110.63 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.61 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 70.329999999999998 111.335 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -72.03 -33.58 68.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.120000000000005 110.34 -177.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -55.41 -49.39 72.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.669 -0.696 . . . . 74.099999999999994 110.708 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.456 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 94.3 mmm -72.02 -39.67 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 74.049999999999997 111.057 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.518 ' HA ' HG13 ' A' ' 282' ' ' ILE . 23.1 tt0 -57.46 -45.68 84.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.634 0.73 . . . . 63.229999999999997 109.71 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.6 m -60.07 -51.08 71.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.54 -1.209 . . . . 72.540000000000006 112.0 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.445 HG21 ' HA ' ' A' ' 303' ' ' MET . 31.0 m -73.37 -27.91 24.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.331 0.493 . . . . 71.310000000000002 112.331 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -75.62 -43.82 45.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.889 0.376 . . . . 74.340000000000003 110.703 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.95 76.74 10.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.344 0.498 . . . . 75.0 112.344 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.632 HD11 HH11 ' A' ' 240' ' ' ARG . 0.5 OUTLIER -163.28 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.329999999999998 110.864 171.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.959 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 32.4 t70 -178.35 164.22 1.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.993 -0.373 . . . . 65.209999999999994 109.993 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.645 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 2.2 t80 -58.58 -64.6 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.861 0.465 . . . . 75.25 111.069 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 t -114.77 36.42 3.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.409 0.623 . . . . 74.420000000000002 110.731 -173.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.959 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 9.9 tp10 -67.57 -86.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 65.409999999999997 111.481 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 179.98 137.53 0.29 Allowed Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 109.502 -0.555 . . . . 74.239999999999995 109.502 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -91.96 128.64 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.622 2.215 . . . . 73.120000000000005 112.995 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.476 ' O ' HD11 ' A' ' 320' ' ' LEU . 90.4 mt -79.96 75.78 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.518 -0.549 . . . . 74.030000000000001 109.518 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.589 ' CE1' ' HB3' ' A' ' 162' ' ' LEU . 67.1 t80 -57.67 -39.29 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.778 -0.646 . . . . 74.310000000000002 111.401 -174.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.08 -43.7 98.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.294 -0.412 . . . . 64.439999999999998 110.517 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -76.7 -29.87 56.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.52 -0.309 . . . . 72.5 111.225 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.534 ' O ' HG21 ' A' ' 323' ' ' ILE . 7.1 mp -69.34 -48.13 62.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 74.319999999999993 110.9 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.422 HH22 ' NH2' ' A' ' 160' ' ' ARG . 20.9 ttt180 -70.57 -28.13 64.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 75.340000000000003 109.758 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.41 -41.03 66.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.882 -0.599 . . . . 72.319999999999993 111.464 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.534 HG21 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -67.72 -36.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.956 -0.387 . . . . 75.140000000000001 109.956 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 155' ' ' LEU . 92.1 mt -60.46 -49.43 77.59 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.936 0.398 . . . . 74.409999999999997 110.079 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.665 HD22 HD22 ' A' ' 159' ' ' LEU . 3.8 mm? -62.61 -37.92 88.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.554 . . . . 74.409999999999997 111.408 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -55.56 -47.36 76.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.586 -0.279 . . . . 75.329999999999998 110.827 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.549 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.83 -42.64 96.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 75.150000000000006 112.184 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.676 ' HG ' ' O ' ' A' ' 333' ' ' SER . 27.4 tp -65.86 -42.97 89.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 75.340000000000003 111.114 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.541 ' HB3' ' HZ1' ' A' ' 329' ' ' LYS . 9.0 mtpm? -66.69 -32.59 73.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 73.430000000000007 110.363 178.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.19 64.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 74.319999999999993 111.089 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.442 HG23 ' O ' ' A' ' 328' ' ' LEU . 12.7 tt -85.68 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 120.948 0.404 . . . . 74.109999999999999 110.495 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.83 36.45 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.562 -0.827 . . . . 43.25 113.508 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.676 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 52.3 m -129.42 162.57 27.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.034 0.417 . . . . 73.120000000000005 111.16 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.761 ' HD2' ' HB2' ' A' ' 336' ' ' ASP . 5.6 tmtt? -179.5 -51.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.931 -0.766 . . . . 75.25 108.931 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.736 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 8.1 t70 70.04 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.154 -0.93 . . . . 74.129999999999995 110.473 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . 0.761 ' HB2' ' HD2' ' A' ' 334' ' ' LYS . 10.9 t70 58.56 94.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.669 0.606 . . . . 72.109999999999999 111.21 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 150.14 -36.07 0.97 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.958 -0.857 . . . . 72.219999999999999 110.958 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.579 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -150.82 157.49 43.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.547 -0.538 . . . . 71.409999999999997 109.547 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 28.1 tp -90.38 130.85 36.42 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.999 -0.371 . . . . 70.299999999999997 109.999 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . 0.672 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 27.9 t0 -78.97 85.16 4.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.926 -0.579 . . . . 72.140000000000001 111.004 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 342' ' ' SER . 61.9 mt -138.93 -41.03 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.082 -0.963 . . . . 75.25 109.91 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.525 ' O ' ' HB ' ' A' ' 343' ' ' VAL . 44.4 t 74.18 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.978 -1.01 . . . . 75.230000000000004 108.734 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.525 ' HB ' ' O ' ' A' ' 342' ' ' SER . 10.2 p 167.32 81.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 122.137 0.97 . . . . 74.420000000000002 109.196 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.84 -77.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.437 -0.801 . . . . 71.329999999999998 111.274 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -138.67 165.78 26.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 75.030000000000001 111.12 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.97 146.84 50.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.862 -0.608 . . . . 75.25 109.856 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -120.27 -141.86 6.43 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.97 -0.634 . . . . 52.240000000000002 112.101 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -137.36 106.2 0.53 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.47 -0.872 . . . . 75.239999999999995 112.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.46 156.25 42.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.762 -0.459 . . . . 63.240000000000002 109.762 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -115.34 163.5 15.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.929 0.395 . . . . 74.540000000000006 111.245 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.14 -168.41 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.743 . . . . 72.140000000000001 109.675 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.484 ' HZ2' ' CG ' ' A' ' 177' ' ' ASP . 41.1 mttt -140.37 -179.69 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.153 0.501 . . . . 74.319999999999993 112.133 -175.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.608 HG22 ' HG3' ' A' ' 79' ' ' PRO . 95.8 m -150.44 137.35 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.641 -0.708 . . . . 73.219999999999999 109.946 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -66.91 134.03 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.271 0.558 . . . . 71.319999999999993 110.27 -176.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.446 ' N ' HD13 ' A' ' 354' ' ' ILE . 50.9 m -64.96 94.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 72.430000000000007 112.054 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.517 ' HD3' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.37 -25.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.761 -0.654 . . . . 75.299999999999997 111.305 174.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.517 ' HB2' ' HD3' ' A' ' 356' ' ' LYS . 77.3 tttt -122.51 145.85 47.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.131 -0.228 . . . . 73.540000000000006 110.412 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -73.96 -54.05 8.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 70.319999999999993 110.408 -179.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -176.18 -177.3 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.963 -1.125 . . . . 74.040000000000006 107.963 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.655 -0.688 . . . . 72.310000000000002 109.869 176.71 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.954 -0.387 . . . . 71.129999999999995 109.954 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.35 138.78 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.879 2.386 . . . . 71.299999999999997 112.328 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.413 ' HD2' ' N ' ' A' ' 3' ' ' ARG . 0.0 OUTLIER -133.72 118.35 18.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.273 0.558 . . . . 75.430000000000007 109.856 177.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.81 102.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.234 0.54 . . . . 73.540000000000006 110.509 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.717 ' HD3' ' H ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -104.81 123.45 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.986 -0.552 . . . . 75.140000000000001 109.784 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.75 122.62 4.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 72.239999999999995 110.505 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.85 -5.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 75.230000000000004 111.308 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 93.21 7.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.265 0.555 . . . . 74.349999999999994 111.292 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.99 78.69 1.3 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.632 -0.713 . . . . 74.25 110.144 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.91 -132.64 52.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.771 -0.649 . . . . 73.450000000000003 112.55 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.748 ' HE ' ' HA ' ' A' ' 11' ' ' ARG . 1.2 mmp_? 57.39 78.47 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.3 0.64 . . . . 73.439999999999998 112.355 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.21 -176.75 3.62 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.855 -0.424 . . . . 74.340000000000003 109.855 173.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -79.62 122.61 26.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.984 0.421 . . . . 73.099999999999994 111.736 -171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.0 m -92.45 142.43 27.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.571 -0.74 . . . . 74.549999999999997 109.336 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.62 176.85 8.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.111 0.482 . . . . 75.420000000000002 112.042 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -145.31 -165.46 2.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.08 -0.963 . . . . 73.540000000000006 109.289 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.457 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 7.7 tpm_? -57.72 -26.99 62.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.482 0.489 . . . . 75.340000000000003 111.46 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 17' ' ' ARG . 35.2 m170 77.19 61.04 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.485 0.714 . . . . 73.409999999999997 112.36 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 19' ' ' LEU . 2.3 pt? -145.0 88.03 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.668 0.747 . . . . 73.25 109.747 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.33 113.7 14.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.961 -0.563 . . . . 74.230000000000004 110.672 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -24.06 12.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 71.409999999999997 109.937 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 55.62 -101.58 0.13 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.58 -0.736 . . . . 72.120000000000005 109.575 -175.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 16.3 t80 178.37 77.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.319 0.58 . . . . 65.439999999999998 109.478 173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB3' ' OE2' ' A' ' 27' ' ' GLU . . . -130.13 2.09 4.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.478 -0.783 . . . . 71.439999999999998 109.879 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.517 ' HA ' HG11 ' A' ' 39' ' ' VAL . 61.3 t -56.24 128.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.22 -0.9 . . . . 75.420000000000002 110.928 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.37 0.03 56.96 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.694 -0.765 . . . . 53.049999999999997 113.425 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.561 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 9.4 pt-20 -82.48 150.74 26.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.029 -0.73 . . . . 73.129999999999995 109.029 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.429 HD12 ' HA ' ' A' ' 28' ' ' ILE . 1.2 tp -91.42 131.54 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 71.340000000000003 110.057 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.34 132.14 71.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.498 -0.773 . . . . 72.230000000000004 109.222 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.535 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 m -118.08 114.08 22.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.935 -0.395 . . . . 75.209999999999994 109.935 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.528 ' OD2' ' HA3' ' A' ' 115' ' ' GLY . 4.7 p-10 -95.23 -172.02 2.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 70.209999999999994 110.41 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.1 mmt -70.58 -11.27 60.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.475 0.546 . . . . 74.230000000000004 112.475 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.06 2.45 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.226 -0.296 . . . . 74.329999999999998 110.372 174.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.28 24.93 8.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.517 -0.765 . . . . 75.519999999999996 110.687 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.535 ' O ' ' HA ' ' A' ' 30' ' ' THR . 29.1 mtpp -93.63 124.75 37.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.85 -0.614 . . . . 74.299999999999997 110.163 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.79 92.21 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.354 -0.61 . . . . 71.120000000000005 109.354 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.974 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 25.1 p-90 -116.83 140.02 49.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.792 -0.64 . . . . 74.329999999999998 111.141 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 56' ' ' MET . 23.6 pttm -85.6 139.26 31.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.101 -0.703 . . . . 62.43 109.101 174.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 25' ' ' VAL . 3.6 p -66.95 117.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 75.109999999999999 109.061 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.98 -121.59 4.89 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.418 -0.896 . . . . 62.310000000000002 112.731 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.664 HD23 ' HD2' ' A' ' 42' ' ' PRO . 2.4 tm? -73.31 118.02 65.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.916 0.388 . . . . 75.409999999999997 110.397 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.664 ' HD2' HD23 ' A' ' 41' ' ' LEU . 65.1 Cg_endo -75.91 96.7 1.07 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.492 2.128 . . . . 72.430000000000007 111.797 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.534 HD12 HD12 ' A' ' 53' ' ' LEU . 56.7 mt -62.77 -45.56 98.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.242 0.544 . . . . 72.329999999999998 110.337 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.25 83.67 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.399 -0.819 . . . . 74.219999999999999 112.226 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.762 ' HG2' HD13 ' A' ' 349' ' ' LEU . 61.1 mt-30 -139.04 159.85 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.902 -0.407 . . . . 74.340000000000003 109.902 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.73 49.88 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.634 -0.793 . . . . 74.319999999999993 111.497 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.03 112.06 2.71 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.686 -0.768 . . . . 63.210000000000001 112.218 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.567 ' HD2' ' HE2' ' A' ' 71' ' ' LYS . 21.5 m-85 68.25 -72.38 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.465 0.706 . . . . 74.109999999999999 111.447 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.428 ' HA3' ' HB3' ' A' ' 18' ' ' HIS . . . 138.8 174.91 13.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.034 -0.603 . . . . 72.510000000000005 111.625 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.39 31.1 17.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.379 . . . . 62.119999999999997 111.483 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.604 HD12 ' HG3' ' A' ' 71' ' ' LYS . 18.1 mm -88.82 136.59 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.92 -0.4 . . . . 74.420000000000002 109.92 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -108.19 153.65 22.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.52 0.2 . . . . 73.319999999999993 110.975 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 HD12 HD12 ' A' ' 43' ' ' ILE . 8.1 tt -100.91 137.39 39.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.372 -0.603 . . . . 64.439999999999998 109.372 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.401 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . . . -94.98 93.73 7.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 55.32 110.494 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.13 -15.87 57.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 74.150000000000006 110.837 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.974 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 47.8 mtp 59.94 -163.47 0.24 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.75 -0.659 . . . . 73.430000000000007 110.39 -176.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.38 141.22 48.45 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.545 -0.909 . . . . 62.229999999999997 108.545 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -77.35 38.12 0.22 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.337 0.495 . . . . 73.430000000000007 112.337 -171.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 -38.42 10.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.592 -0.521 . . . . 74.219999999999999 109.592 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.46 102.3 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 74.010000000000005 109.964 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -169.05 124.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.187 -0.46 . . . . 74.040000000000006 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.513 HG12 ' OD1' ' A' ' 65' ' ' ASP . 8.5 p -82.6 144.06 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.486 -0.561 . . . . 70.099999999999994 109.486 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.51 4.05 1.11 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.152 -0.547 . . . . 71.109999999999999 113.723 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 62' ' ' VAL . 17.9 m -104.44 -18.21 14.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.868 0.334 . . . . 71.450000000000003 111.378 178.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.513 ' OD1' HG12 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -108.61 -22.45 12.26 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.638 -0.425 . . . . 72.109999999999999 110.928 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -60.36 -42.56 89.65 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.221 0.452 . . . . 73.239999999999995 112.221 174.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.625 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 56.1 Cg_endo -71.21 62.39 2.62 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.697 1.598 . . . . 74.299999999999997 112.611 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.401 ' SG ' ' HB3' ' A' ' 54' ' ' ALA . 9.3 p -120.79 152.47 38.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.7 -0.482 . . . . 74.340000000000003 109.7 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -122.94 155.8 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.656 0.265 . . . . 64.200000000000003 110.784 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.575 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -121.48 120.71 62.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.314 0.578 . . . . 61.439999999999998 111.415 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.604 ' HG3' HD12 ' A' ' 51' ' ' ILE . 77.6 tttt -95.64 131.84 41.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 75.219999999999999 109.116 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.479 HG13 ' HB3' ' A' ' 128' ' ' PHE . 34.7 m -118.68 151.76 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.207 0.447 . . . . 71.540000000000006 112.207 -173.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.474 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 4.1 pt-20 -132.9 155.93 80.62 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.322 -0.399 . . . . 72.299999999999997 110.211 172.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.483 ' HB2' HH12 ' A' ' 358' ' ' ARG . 2.0 Cg_endo -82.29 114.87 2.53 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.632 2.221 . . . . 74.25 112.24 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t 81.47 -96.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.032 0.933 . . . . 61.109999999999999 112.467 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -171.02 12.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.299 1.222 . . . . 62.0 114.299 -167.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.561 ' CB ' ' HB3' ' A' ' 359' ' ' LYS . 0.5 OUTLIER -146.37 103.95 3.74 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.779 -0.768 . . . . 74.420000000000002 112.394 -171.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.96 -161.24 32.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.921 -0.657 . . . . 62.329999999999998 111.781 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.875 ' HB3' ' HA2' ' A' ' 199' ' ' GLY . 31.2 Cg_exo -60.02 -26.64 82.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.017 2.478 . . . . 72.329999999999998 112.465 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.474 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.8 tm? -64.52 -37.07 86.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.457 -0.572 . . . . 72.340000000000003 109.457 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.88 -38.28 86.02 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.214 0.53 . . . . 74.430000000000007 109.808 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.3 m -62.87 -45.05 94.37 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.68 -0.691 . . . . 74.519999999999996 110.162 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.68 -29.72 69.06 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.934 -0.576 . . . . 74.510000000000005 110.752 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -59.08 -50.24 74.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.418 -0.215 . . . . 74.420000000000002 110.418 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -58.57 -47.27 84.83 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.769 0.319 . . . . 72.200000000000003 110.627 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.405 ' HD2' ' CD1' ' A' ' 87' ' ' TYR . 83.8 t80 -57.58 -52.19 66.41 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.895 -0.593 . . . . 75.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CD1' ' HD2' ' A' ' 86' ' ' PHE . 6.1 m-30 -62.35 -43.73 98.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.594 -0.275 . . . . 75.439999999999998 111.232 -175.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.18 -33.46 76.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.81 0.3 . . . . 72.219999999999999 111.81 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -95.48 -23.04 17.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.663 0.616 . . . . 72.010000000000005 112.663 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -104.11 -34.54 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.78 0.659 . . . . 73.400000000000006 112.78 -174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.81 78.36 9.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.31 0.576 . . . . 74.219999999999999 111.594 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.477 ' O ' HG13 ' A' ' 96' ' ' ILE . 19.2 tptp -155.51 101.79 2.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.894 -0.78 . . . . 73.530000000000001 108.894 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -43.72 -46.46 10.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.878 3.052 . . . . 75.299999999999997 114.138 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.26 -51.73 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 75.200000000000003 111.156 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -64.95 -40.89 95.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 74.430000000000007 110.488 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.5 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 72.8 mt -57.94 -53.6 43.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 61.399999999999999 110.857 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -62.04 -31.05 71.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.829 -0.623 . . . . 72.230000000000004 110.637 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 10.5 tppt? -70.54 -50.9 32.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.099 -0.501 . . . . 75.209999999999994 111.525 -175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.531 ' CZ2' HD21 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -73.53 -35.66 65.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 119.749 -0.78 . . . . 74.510000000000005 110.57 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.84 -34.95 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.439 0.638 . . . . 71.420000000000002 110.089 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -65.46 -49.34 69.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.243 -0.89 . . . . 74.409999999999997 111.229 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -75.75 -41.8 52.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.287 0.477 . . . . 75.140000000000001 112.287 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.505 ' HB2' HD13 ' A' ' 105' ' ' LEU . 18.4 mmt180 -78.1 -17.38 57.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.477 -0.329 . . . . 74.140000000000001 111.189 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 64.95 59.97 0.84 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.949 0.88 . . . . 74.310000000000002 110.177 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.505 HD13 ' HB2' ' A' ' 103' ' ' ARG . 7.3 mp -97.09 -166.3 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.557 -1.201 . . . . 75.120000000000005 108.542 173.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -128.64 -54.42 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.9 -0.72 . . . . 72.049999999999997 112.388 -174.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -164.73 107.88 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.713 -0.395 . . . . 71.549999999999997 110.981 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.531 HD21 ' CZ2' ' A' ' 99' ' ' TRP . 18.2 tp -80.21 132.0 35.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 75.450000000000003 111.01 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.72 70.91 2.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.997 -0.62 . . . . 71.439999999999998 111.904 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.3 p -115.89 142.44 29.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.515 -0.18 . . . . 72.430000000000007 110.515 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 134' ' ' PHE . 6.8 Cg_exo -72.82 140.4 32.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.468 2.112 . . . . 72.430000000000007 112.084 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -72.57 106.49 4.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.696 -0.483 . . . . 74.319999999999993 109.696 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -81.7 119.91 24.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.985 -0.552 . . . . 74.150000000000006 110.743 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -95.73 -65.63 0.96 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.205 0.526 . . . . 72.109999999999999 109.802 178.468 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.528 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -151.07 -170.76 18.43 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.622 -0.717 . . . . 75.519999999999996 112.317 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.416 ' HB3' ' HG2' ' A' ' 129' ' ' MET . 51.2 p -167.8 -177.36 3.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.864 -0.421 . . . . 72.409999999999997 109.864 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.43 -175.08 38.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.22 -0.99 . . . . 52.210000000000001 112.629 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -133.39 127.88 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.915 -0.772 . . . . 72.120000000000005 108.915 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -138.62 120.87 15.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 73.140000000000001 110.772 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.475 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 11.7 t70 -81.36 131.26 35.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 63.420000000000002 110.612 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -96.26 -53.21 3.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 72.219999999999999 110.588 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -169.22 91.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 70.049999999999997 109.869 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.27 11.5 67.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.194 -0.527 . . . . 64.150000000000006 112.162 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -144.16 108.35 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.078 -0.342 . . . . 63.119999999999997 110.078 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.484 ' HB3' HD22 ' A' ' 118' ' ' LEU . 24.3 m -85.09 111.33 19.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.04 -0.527 . . . . 75.109999999999999 109.901 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -91.53 128.33 37.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 75.200000000000003 110.987 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.472 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 32.3 ttm180 -91.21 128.27 36.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.333 -0.988 . . . . 74.450000000000003 108.333 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.575 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.8 p90 -134.1 152.68 51.94 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.955 -0.298 . . . . 75.129999999999995 111.147 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.564 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 70.9 mtm -136.97 140.46 42.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.078 -0.51 . . . . 74.120000000000005 110.285 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.543 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.1 mm -99.05 119.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 75.219999999999999 110.212 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.598 ' HE1' ' HB2' ' A' ' 71' ' ' LYS . 3.1 mpp? -126.35 -174.14 3.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 63.140000000000001 110.315 178.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.92 158.04 26.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 74.430000000000007 110.625 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.625 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -67.15 115.46 6.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 74.409999999999997 112.186 -174.673 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 29.7 m-85 -119.52 171.68 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.512 -0.767 . . . . 75.049999999999997 109.283 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 -54.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.385 -0.912 . . . . 61.109999999999999 112.105 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -81.1 124.31 29.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 74.420000000000002 110.702 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.545 ' HA ' HD12 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -92.95 145.35 24.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.094 -1.076 . . . . 64.200000000000003 108.094 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.548 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 33.1 tp -60.92 -38.08 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.668 -0.413 . . . . 73.430000000000007 110.065 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.87 ' HA ' ' HD2' ' A' ' 142' ' ' TYR . 50.7 tt0 -59.97 -37.24 79.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.200000000000003 111.531 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.866 ' HB3' ' HB2' ' A' ' 345' ' ' GLU . 8.8 mttp -55.24 -59.59 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 75.549999999999997 110.43 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.23 -39.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.264 -0.88 . . . . 73.219999999999999 111.12 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.87 ' HD2' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.48 -38.74 91.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.353 -0.385 . . . . 75.329999999999998 111.234 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.585 ' HG3' ' CE2' ' A' ' 142' ' ' TYR . 32.6 mt-10 -83.48 -18.49 38.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.722 -0.391 . . . . 72.409999999999997 111.439 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -79.03 -23.98 43.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.323 0.582 . . . . 71.420000000000002 110.06 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -97.72 1.09 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.544 -0.753 . . . . 71.439999999999998 109.27 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.76 39.92 30.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.105 -0.952 . . . . 62.25 111.98 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.668 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 41.5 pttt 42.52 38.29 1.21 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.074 0.95 . . . . 74.140000000000001 113.22 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -98.76 81.33 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.075 -0.713 . . . . 73.150000000000006 109.075 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.93 156.97 26.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.965 0.412 . . . . 73.209999999999994 111.291 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.8 t -99.34 -172.55 2.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 54.43 110.224 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.438 ' HD3' ' CD ' ' A' ' 298' ' ' GLU . 3.9 ttm180 -65.39 -24.03 67.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 75.010000000000005 111.294 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -58.09 -68.73 0.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.927 -0.579 . . . . 74.230000000000004 111.897 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.7 p -59.11 -47.34 85.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 63.329999999999998 111.905 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.33 -41.67 71.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.689 -0.687 . . . . 71.219999999999999 111.332 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.462 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -71.41 -50.03 35.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.363 -0.38 . . . . 73.439999999999998 110.412 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.92 -44.95 87.16 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.863 0.363 . . . . 75.120000000000005 111.204 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.583 ' O ' HG12 ' A' ' 161' ' ' ILE . 8.3 mp -61.29 -52.73 63.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.125 -0.489 . . . . 73.349999999999994 111.137 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.0 p -63.74 -34.13 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.24 . . . . 74.129999999999995 111.526 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.33 -53.44 57.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.412 -0.358 . . . . 74.400000000000006 110.356 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -70.16 -29.27 66.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.07 0.462 . . . . 74.430000000000007 110.78 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.583 HG12 ' O ' ' A' ' 157' ' ' LEU . 30.1 mm -67.5 -37.99 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 74.239999999999995 110.523 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.55 -39.92 95.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.971 -0.381 . . . . 75.219999999999999 109.971 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.17 -63.23 1.22 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.685 0.755 . . . . 71.430000000000007 110.462 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.543 HD13 ' HB3' ' A' ' 195' ' ' LEU . 18.4 tt -64.45 -34.85 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.375 -0.829 . . . . 73.120000000000005 111.264 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.497 HD11 ' CE1' ' A' ' 175' ' ' HIS . 50.3 tp -60.95 -40.05 91.82 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.825 -0.17 . . . . 72.530000000000001 111.274 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -65.74 -39.11 90.77 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.535 -0.466 . . . . 64.109999999999999 110.904 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -59.06 -49.44 77.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.371 -0.532 . . . . 73.409999999999997 111.594 177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.0 pt -74.03 -32.2 32.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.813 -0.355 . . . . 75.150000000000006 110.969 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.95 -45.75 92.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 73.030000000000001 110.915 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.33 8.08 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.94 0.4 . . . . 74.25 110.928 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -104.86 -67.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.083 -0.247 . . . . 75.010000000000005 111.016 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -152.46 -58.94 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.518 0.562 . . . . 54.219999999999999 112.518 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.587 ' HB3' ' HA ' ' A' ' 203' ' ' ARG . 10.5 p90 -121.36 164.75 16.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.331 0.863 . . . . 73.430000000000007 113.331 -164.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.9 173.27 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.756 -1.111 . . . . 73.129999999999995 108.931 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.497 ' CE1' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -129.44 103.7 7.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.585 0.707 . . . . 74.519999999999996 112.038 -175.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.01 -39.4 89.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.362 -0.836 . . . . 53.100000000000001 111.524 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 1.006 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 28.5 t70 -89.84 91.07 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.256 0.55 . . . . 75.5 110.041 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.53 HG23 ' SG ' ' A' ' 250' ' ' CYS . 8.4 tt -110.01 25.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.087 0.946 . . . . 75.230000000000004 109.242 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.449 ' HZ1' ' CD ' ' A' ' 226' ' ' GLU . 20.4 tptm -60.6 162.16 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.138 -0.937 . . . . 74.140000000000001 109.96 178.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.14 -5.37 1.04 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.033 0.753 . . . . 75.239999999999995 113.033 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.62 ' HB2' ' HZ2' ' A' ' 352' ' ' LYS . 1.0 OUTLIER -76.87 -20.65 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 75.120000000000005 110.413 176.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -88.37 -15.12 36.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 71.25 110.292 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.52 120.57 38.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 73.230000000000004 110.297 176.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 137' ' ' ASP . 4.5 mm? -116.22 141.82 47.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.957 -0.565 . . . . 74.540000000000006 110.449 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.474 HD22 ' HA ' ' A' ' 190' ' ' PRO . 9.8 mp -99.29 160.36 14.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.772 0.32 . . . . 74.230000000000004 110.559 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.42 151.22 47.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.179 -0.675 . . . . 52.25 109.179 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.06 -26.23 62.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.303 0.483 . . . . 75.230000000000004 112.303 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 188' ' ' LYS . 32.5 tptt -112.36 -58.09 2.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.8 0.667 . . . . 74.049999999999997 112.8 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -104.57 131.13 22.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.414 0.626 . . . . 73.439999999999998 112.201 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.474 ' HA ' HD22 ' A' ' 185' ' ' LEU . 96.5 Cg_endo -77.21 -7.5 17.15 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.326 2.684 . . . . 74.239999999999995 113.544 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.88 -6.9 57.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.313 0.578 . . . . 74.310000000000002 110.182 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 88.1 mm-40 -105.29 92.75 4.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 74.150000000000006 110.342 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.16 120.45 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.441 0.639 . . . . 75.0 109.849 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.437 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 61.9 m-85 -113.08 154.86 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.351 -0.84 . . . . 74.420000000000002 109.515 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.543 ' HB3' HD13 ' A' ' 164' ' ' ILE . 14.0 tp -110.12 107.48 17.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.882 -0.414 . . . . 74.299999999999997 109.882 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.444 HG13 ' HG3' ' A' ' 111' ' ' PRO . 19.8 m -138.41 -166.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 63.439999999999998 109.972 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.05 56.17 1.06 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.854 0.835 . . . . 74.140000000000001 109.922 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -82.85 67.12 8.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.086 -0.961 . . . . 73.430000000000007 110.61 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.875 ' HA2' ' HB3' ' A' ' 79' ' ' PRO . . . -64.34 -57.84 12.11 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.436 -0.802 . . . . 51.539999999999999 111.498 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.716 ' HB3' ' HB3' ' A' ' 222' ' ' ASP . 3.7 mp -106.47 88.06 2.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.341 0.591 . . . . 72.049999999999997 110.289 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -114.8 110.65 20.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.542 -0.754 . . . . 73.129999999999995 109.761 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.47 115.58 29.63 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.066 -0.516 . . . . 74.120000000000005 109.63 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.587 ' HA ' ' HB3' ' A' ' 173' ' ' TYR . 35.8 ptt180 -69.76 137.36 51.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 111.543 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.627 ' CE1' ' HA ' ' A' ' 239' ' ' SER . 56.0 t80 -93.68 -55.64 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.561 -0.745 . . . . 75.209999999999994 110.546 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.5 p -110.81 96.73 30.3 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 72.430000000000007 110.651 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 28.8 Cg_exo -60.94 114.44 2.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.671 2.248 . . . . 73.329999999999998 112.077 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 64.45 20.19 12.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.609 -0.723 . . . . 74.530000000000001 111.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.05 60.23 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.872 -0.68 . . . . 74.140000000000001 113.121 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 55.6 t -88.88 118.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.806 0.336 . . . . 73.099999999999994 110.624 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.489 ' HB2' ' OE2' ' A' ' 212' ' ' GLU . 17.9 p80 -71.09 128.11 34.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 70.230000000000004 111.001 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -114.13 -31.02 6.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 75.409999999999997 111.164 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.489 ' OE2' ' HB2' ' A' ' 210' ' ' HIS . 2.8 mp0 59.1 -100.04 0.1 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.992 -0.549 . . . . 72.310000000000002 110.273 -174.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.503 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 18.1 p90 -80.71 103.41 10.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.593 0.711 . . . . 75.430000000000007 110.953 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -98.14 -51.38 4.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.033 -0.729 . . . . 65.420000000000002 109.033 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 62.65 90.48 0.08 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.197 -0.91 . . . . 75.109999999999999 112.525 171.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.47 82.55 62.88 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.531 -0.759 . . . . 75.349999999999994 109.872 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.85 1.97 5.25 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.068 2.512 . . . . 70.319999999999993 112.619 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -48.88 -58.42 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.765 -0.652 . . . . 75.099999999999994 111.068 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -163.25 36.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 74.450000000000003 110.852 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 99.3 m -98.27 136.17 38.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.31 -0.405 . . . . 75.329999999999998 110.666 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.6 p80 178.87 32.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.104 -0.953 . . . . 73.420000000000002 108.586 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.716 ' HB3' ' HB3' ' A' ' 200' ' ' LEU . 2.6 m-20 -45.91 105.29 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.784 -1.098 . . . . 71.530000000000001 112.337 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 1.006 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . 147.24 164.16 11.0 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.919 -1.037 . . . . 63.539999999999999 111.017 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.403 HG21 ' H ' ' A' ' 226' ' ' GLU . 22.8 m -69.02 139.62 54.95 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.785 -0.45 . . . . 73.239999999999995 109.785 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.542 ' HA ' ' OG1' ' A' ' 228' ' ' THR . 49.4 mt -56.31 -22.33 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.569 0.699 . . . . 74.230000000000004 110.997 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.449 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 34.9 tt0 -51.68 -42.51 62.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 74.310000000000002 110.311 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 246' ' ' ILE . 59.1 m-85 -104.32 -90.72 0.38 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.766 -0.652 . . . . 74.430000000000007 109.635 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.542 ' OG1' ' HA ' ' A' ' 225' ' ' ILE . 28.0 m 67.02 -63.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.822 0.701 . . . . 71.409999999999997 112.566 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.452 ' HA ' ' HG3' ' A' ' 275' ' ' LYS . 49.7 m 67.75 172.09 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.284 0.634 . . . . 73.530000000000001 111.094 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 4.7 mp -71.75 -40.53 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.159 0.504 . . . . 71.540000000000006 109.866 -177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.53 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . 1.6 m-20 -54.3 -61.13 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.682 -1.145 . . . . 74.519999999999996 111.758 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.02 82.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 71.319999999999993 111.538 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -67.9 -26.54 66.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.499 -0.319 . . . . 74.120000000000005 111.503 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.469 ' HB3' HG12 ' A' ' 236' ' ' VAL . 65.6 t30 -80.36 -4.7 54.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.539 0.685 . . . . 74.109999999999999 109.66 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.66 76.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.55 -0.75 . . . . 63.32 112.326 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.503 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 7.2 p -111.81 127.7 68.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.954 0.407 . . . . 73.010000000000005 110.441 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.94 112.24 39.05 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.004 -0.543 . . . . 74.319999999999993 109.704 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.674 ' HG2' ' HA3' ' A' ' 242' ' ' GLY . 24.6 Cg_exo -63.15 152.78 77.89 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.325 2.017 . . . . 74.430000000000007 111.398 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.627 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 16.0 p -77.09 -18.37 58.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.444 . . . . 72.450000000000003 111.08 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.781 ' HD3' ' HG3' ' A' ' 315' ' ' PRO . 7.1 ptp180 178.11 -40.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 72.049999999999997 110.449 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 9.9 ttt180 -55.17 -53.91 49.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 74.439999999999998 111.771 -175.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.674 ' HA3' ' HG2' ' A' ' 238' ' ' PRO . . . -59.78 -44.98 96.52 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 116.005 -0.543 . . . . 73.239999999999995 114.232 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.51 -42.07 92.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 71.140000000000001 109.452 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.87 -36.12 82.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.734 -0.667 . . . . 74.400000000000006 110.828 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -51.03 71.26 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.997 -0.547 . . . . 71.030000000000001 110.339 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.513 HG22 ' HB3' ' A' ' 227' ' ' PHE . 66.9 mt -63.23 -39.73 86.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.425 -0.807 . . . . 73.150000000000006 110.831 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.485 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.3 tp -57.82 -43.45 85.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.344 -0.389 . . . . 74.5 110.392 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.68 97.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.037 -0.602 . . . . 63.420000000000002 112.555 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.49 ' HA ' HG21 ' A' ' 252' ' ' ILE . 35.5 m-85 -67.11 -31.22 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 74.310000000000002 111.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.53 ' SG ' HG23 ' A' ' 178' ' ' ILE . 59.6 m -65.93 -44.13 86.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 72.439999999999998 109.655 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.485 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.1 mtp -61.62 -49.9 74.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.131 -0.94 . . . . 70.099999999999994 111.199 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.659 HD13 ' SD ' ' A' ' 286' ' ' MET . 4.6 tt -61.85 -36.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.993 -0.283 . . . . 73.340000000000003 110.875 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.431 ' HB2' HD21 ' A' ' 259' ' ' LEU . 8.7 tt0 -59.77 -50.48 73.68 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.101 -0.24 . . . . 72.310000000000002 111.323 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.13 -31.04 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.744 0.307 . . . . 71.230000000000004 111.186 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.0 tp -84.56 -19.13 33.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.336 0.495 . . . . 72.400000000000006 112.336 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.3 p -106.48 -27.83 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.109 -0.369 . . . . 64.5 111.979 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 113.35 -35.8 4.37 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.575 -0.821 . . . . 40.520000000000003 112.708 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -156.98 165.5 35.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.941 0.371 . . . . 70.209999999999994 110.081 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.431 HD21 ' HB2' ' A' ' 253' ' ' GLN . 72.0 mt -94.27 139.61 22.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.201 -0.296 . . . . 75.340000000000003 110.201 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 32.8 Cg_exo -60.59 -27.31 84.62 Favored 'Trans proline' 0 CA--C 1.526 0.122 0 C-N-CA 122.726 2.284 . . . . 73.230000000000004 112.36 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -100.07 10.95 40.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.126 -0.488 . . . . 72.150000000000006 111.057 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.533 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 50.6 tt0 -69.28 -29.59 67.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.237 0.541 . . . . 72.310000000000002 110.906 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.3 -21.56 49.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.025 0.441 . . . . 74.519999999999996 110.733 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.84 5.25 24.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 72.430000000000007 112.012 -173.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 2.7 pp -79.88 8.25 7.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.915 0.388 . . . . 72.530000000000001 111.369 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -67.54 -17.85 64.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 74.109999999999999 110.093 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.414 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 16.0 t70 -141.64 134.21 13.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.63 -0.714 . . . . 71.439999999999998 109.522 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 46.9 Cg_exo -56.91 -19.16 30.72 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 123.308 2.672 . . . . 63.509999999999998 114.151 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.59 -53.92 51.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.032 0.444 . . . . 71.340000000000003 111.134 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -67.44 -33.88 76.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.051 -0.522 . . . . 70.400000000000006 110.439 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.495 HG23 HG23 ' A' ' 225' ' ' ILE . 61.7 t -61.09 -43.08 95.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 71.439999999999998 110.372 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -55.13 -57.1 13.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 73.349999999999994 110.421 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -64.76 -40.87 96.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.94 -0.573 . . . . 73.510000000000005 111.472 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -59.76 -40.47 88.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.496 -0.32 . . . . 73.439999999999998 111.106 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.452 ' HG3' ' HA ' ' A' ' 229' ' ' SER . 44.4 mmtm -66.96 -39.82 87.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.012 -0.275 . . . . 73.519999999999996 110.918 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 58.8 mt -63.95 -49.13 83.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.777 0.322 . . . . 72.420000000000002 110.824 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -57.78 -47.24 83.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 74.340000000000003 110.974 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.15 -36.26 64.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.312 0.486 . . . . 74.409999999999997 112.312 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -68.48 -29.02 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 75.409999999999997 110.252 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -65.24 0.75 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.975 -0.557 . . . . 75.549999999999997 110.021 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.438 ' O ' HD21 ' A' ' 285' ' ' LEU . 47.2 t30 -107.58 77.54 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 64.450000000000003 110.387 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.11 -48.83 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.283 -0.871 . . . . 74.239999999999995 111.193 -179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 65.409999999999997 112.205 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 39.3 t -66.23 -48.08 71.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.56 -0.291 . . . . 72.230000000000004 111.041 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -67.13 -34.17 77.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.652 0.241 . . . . 75.019999999999996 111.652 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.659 ' SD ' HD13 ' A' ' 252' ' ' ILE . 26.2 mmt -71.06 -37.94 72.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.961 0.41 . . . . 75.239999999999995 111.092 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.4 -38.91 12.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.145 0.424 . . . . 75.209999999999994 112.145 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -78.03 -15.09 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.135 0.421 . . . . 75.010000000000005 112.135 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 88.9 m -76.94 -21.58 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 75.209999999999994 110.516 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.615 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 6.4 m-85 -133.98 86.7 36.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 75.409999999999997 110.64 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.38 -69.03 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.73 2.287 . . . . 62.210000000000001 111.955 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.06 95.51 3.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.104 0.478 . . . . 72.230000000000004 110.271 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 178.61 -52.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.272 -1.01 . . . . 74.409999999999997 108.272 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 290' ' ' PHE . 15.1 t30 -148.58 163.18 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.547 -1.206 . . . . 74.319999999999993 107.946 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.581 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 1.7 tpmt? -136.94 106.22 8.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.504 -0.478 . . . . 71.010000000000005 111.016 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.01 45.14 1.92 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.375 2.716 . . . . 65.540000000000006 111.537 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.58 99.76 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.784 -0.644 . . . . 73.219999999999999 112.319 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.438 ' CD ' ' HD3' ' A' ' 151' ' ' ARG . 28.8 mp0 -62.78 -41.32 99.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.694 -0.484 . . . . 73.239999999999995 109.694 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.429 HG23 ' HB ' ' A' ' 252' ' ' ILE . 15.0 mm -63.93 -46.86 92.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.644 -0.707 . . . . 72.099999999999994 110.28 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.1 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.685 -0.689 . . . . 73.329999999999998 110.971 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.75 -44.52 95.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.776 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -56.62 -50.86 70.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 73.200000000000003 111.586 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.534 ' HA ' HG23 ' A' ' 306' ' ' VAL . 12.3 mtp -70.89 -38.62 73.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.633 -0.258 . . . . 71.409999999999997 111.612 -175.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.3 -35.74 81.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.504 0.668 . . . . 73.5 109.407 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.609 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 54.7 m -65.57 -52.85 49.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 71.030000000000001 111.22 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.54 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 35.3 m -67.26 -30.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.05 0.452 . . . . 72.25 110.802 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -57.44 -43.45 83.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 74.329999999999998 110.461 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.91 11.23 21.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 72.030000000000001 111.886 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 305' ' ' THR . 42.9 mt -90.7 -23.29 20.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.874 -0.417 . . . . 74.010000000000005 109.874 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.602 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 28.6 t70 56.48 -156.72 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.447 -0.797 . . . . 64.349999999999994 110.748 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.602 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.1 m-85 -86.16 -33.01 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.916 0.389 . . . . 75.140000000000001 110.112 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.9 t -144.99 26.5 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.209999999999994 111.42 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 7.8 tt0 -92.88 23.19 4.33 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.512 0.672 . . . . 74.439999999999998 109.627 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.14 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 114.34 -1.3 . . . . 73.310000000000002 112.222 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.781 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 93.5 Cg_endo -78.88 119.6 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.823 2.348 . . . . 75.420000000000002 111.799 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.497 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.7 tp -93.41 84.36 4.72 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.0 0.429 . . . . 75.310000000000002 110.12 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.466 ' HA ' HD11 ' A' ' 320' ' ' LEU . 74.2 m-85 -60.47 -32.77 71.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.623 -0.717 . . . . 75.510000000000005 110.086 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.78 -46.15 74.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.512 -0.767 . . . . 71.219999999999999 110.541 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.497 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 28.9 t-20 -72.33 -35.28 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.581 -0.282 . . . . 74.209999999999994 110.703 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.564 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 97.0 mt -58.39 -52.85 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 70.409999999999997 110.34 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.53 -21.54 61.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 75.450000000000003 110.323 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.04 -50.92 44.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.198 -0.455 . . . . 71.439999999999998 110.933 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.421 HD11 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -70.91 -29.59 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.795 -0.362 . . . . 71.219999999999999 110.996 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 85.5 mt -64.8 -49.4 70.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.082 0.468 . . . . 74.019999999999996 110.096 175.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.94 -26.76 64.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 75.319999999999993 110.945 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -58.48 -47.81 82.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 74.409999999999997 109.853 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.409 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -74.97 -39.88 36.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.819 -0.705 . . . . 61.539999999999999 112.368 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.462 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 2.6 tm? -57.67 -49.44 76.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.19 0.519 . . . . 72.400000000000006 110.204 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -24.61 58.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.431 -0.349 . . . . 73.439999999999998 111.477 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.63 91.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 75.040000000000006 111.184 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -88.21 -9.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.246 0.546 . . . . 63.310000000000002 110.602 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 69.49 20.86 75.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.928 -0.653 . . . . 72.109999999999999 112.952 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -131.73 138.64 48.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.803 0.302 . . . . 63.32 110.993 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.472 ' HE3' ' HB2' ' A' ' 334' ' ' LYS . 26.6 mtmt -113.35 -73.07 0.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.859 0.838 . . . . 73.010000000000005 109.047 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -167.53 -39.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.069 -1.423 . . . . 71.329999999999998 107.718 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.6 t0 69.72 32.7 3.17 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 114.461 -1.245 . . . . 65.209999999999994 110.973 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.64 14.22 41.4 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.965 -0.636 . . . . 71.310000000000002 112.696 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.496 ' HD2' ' O ' ' A' ' 339' ' ' LEU . 5.8 tmmm? -179.71 110.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.272 -0.27 . . . . 73.430000000000007 110.272 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.496 ' O ' ' HD2' ' A' ' 338' ' ' LYS . 8.6 mp -69.16 178.27 2.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.788 0.328 . . . . 74.409999999999997 110.613 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.31 12.8 2.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.39 0.614 . . . . 71.530000000000001 110.597 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 343' ' ' VAL . 81.0 mt -80.44 96.12 6.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.471 -0.786 . . . . 74.400000000000006 108.992 176.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.442 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.8 m -69.58 15.63 0.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.888 -1.051 . . . . 74.420000000000002 113.405 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 342' ' ' SER . 0.4 OUTLIER 69.12 -7.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.818 0.847 . . . . 74.120000000000005 112.331 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.414 ' H ' ' C ' ' A' ' 342' ' ' SER . 60.7 t -76.37 98.79 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.211 -0.663 . . . . 73.329999999999998 109.211 175.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.866 ' HB2' ' HB3' ' A' ' 140' ' ' LYS . 14.6 pt-20 -108.92 -55.93 2.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 74.329999999999998 111.853 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 18.8 m120 66.02 -77.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.37 0.668 . . . . 73.420000000000002 112.747 178.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -144.01 166.71 27.01 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.531 -0.843 . . . . 75.219999999999999 112.561 -174.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 152.49 -7.53 0.52 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.876 -0.678 . . . . 51.0 113.038 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.762 HD13 ' HG2' ' A' ' 45' ' ' GLN . 85.3 mt -54.47 128.36 31.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.65 0.38 . . . . 74.319999999999993 111.853 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -141.75 -177.51 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.034 -0.358 . . . . 73.230000000000004 110.034 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -126.88 159.01 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 74.140000000000001 111.517 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.62 ' HZ2' ' HB2' ' A' ' 181' ' ' SER . 65.8 mttm -141.12 169.8 16.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.374 -0.83 . . . . 74.120000000000005 109.097 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.649 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 12.0 t -169.63 140.14 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.109 -0.33 . . . . 73.319999999999993 110.109 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 138.37 22.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.799 -0.445 . . . . 73.209999999999994 109.799 178.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 32.8 m -68.55 80.92 0.27 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.352 0.596 . . . . 54.409999999999997 112.174 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -153.09 -82.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 74.219999999999999 110.243 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.545 ' HG2' ' N ' ' A' ' 358' ' ' ARG . 75.7 tttt -160.77 156.61 25.53 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.197 0.522 . . . . 74.329999999999998 111.586 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.545 ' N ' ' HG2' ' A' ' 357' ' ' LYS . 3.3 tpm_? -97.64 110.14 22.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.306 -0.861 . . . . 73.310000000000002 109.15 171.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.561 ' HB3' ' CB ' ' A' ' 77' ' ' ASN . 42.5 tttm -103.7 132.97 49.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.009 0.433 . . . . 75.349999999999994 111.5 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.417 ' HE2' ' HB2' ' A' ' 360' ' ' LYS . 5.5 ptmm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.892 -0.781 . . . . 75.209999999999994 108.892 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 110.25 -0.278 . . . . 70.019999999999996 110.25 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.94 138.39 44.12 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.307 2.672 . . . . 74.420000000000002 113.374 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.625 ' O ' ' HA ' ' A' ' 292' ' ' GLU . 5.9 mmm180 -138.1 99.03 3.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.386 -0.824 . . . . 74.329999999999998 109.045 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.6 m -73.08 94.17 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.952 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -136.3 -56.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 75.420000000000002 111.496 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 293' ' ' LYS . . . -107.64 -178.95 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.804 0.335 . . . . 73.340000000000003 111.531 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . . . -158.16 -173.26 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 71.010000000000005 110.127 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.408 ' HA ' ' OE1' ' A' ' 8' ' ' GLN . 13.1 mm-40 -95.64 150.65 20.11 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.224 -0.287 . . . . 75.340000000000003 110.224 175.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.07 153.16 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 65.140000000000001 111.234 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.56 176.65 16.19 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.426 -0.67 . . . . 75.239999999999995 111.426 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -143.13 120.68 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 72.010000000000005 110.864 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.81 94.8 8.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 74.109999999999999 110.825 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 t -80.59 167.22 20.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 61.420000000000002 108.967 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.471 ' HA ' HG12 ' A' ' 343' ' ' VAL . 56.7 m -135.55 120.94 19.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 73.310000000000002 112.014 -176.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.593 ' H ' HG12 ' A' ' 343' ' ' VAL . . . -140.87 148.49 40.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.098 -0.955 . . . . 71.439999999999998 109.009 175.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -153.4 139.45 18.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.262 -0.175 . . . . 73.099999999999994 110.676 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HG3' HD21 ' A' ' 41' ' ' LEU . 6.8 ptt180 -166.09 132.15 2.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.212 0.53 . . . . 74.310000000000002 111.112 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.669 ' HA ' HD23 ' A' ' 41' ' ' LEU . 19.5 t60 -149.74 14.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.374 -0.972 . . . . 71.219999999999999 108.374 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.55 148.25 23.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 75.219999999999999 111.199 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.41 -82.03 0.15 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.708 -0.678 . . . . 71.310000000000002 109.492 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 74.86 9.29 4.08 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.794 0.807 . . . . 74.319999999999993 109.746 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -93.69 141.6 28.3 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.622 -1.172 . . . . 74.109999999999999 108.226 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.23 94.61 3.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.783 0.801 . . . . 74.530000000000001 110.697 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -179.68 -45.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.657 -1.608 . . . . 74.430000000000007 106.657 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.487 HG11 ' HA2' ' A' ' 40' ' ' GLY . 84.7 t -66.86 140.35 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 113.829 -1.532 . . . . 71.109999999999999 109.265 166.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.99 2.13 56.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.147 -1.025 . . . . 43.340000000000003 113.422 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.416 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 31.3 mt-10 -78.72 140.79 38.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.282 0.541 . . . . 73.319999999999993 110.414 174.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.493 HD11 ' HB3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -82.18 131.75 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 72.109999999999999 111.153 -175.353 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.59 135.04 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.08 -0.964 . . . . 72.340000000000003 108.943 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -115.64 133.73 55.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 63.439999999999998 110.28 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -97.58 -172.5 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.844 -0.428 . . . . 72.219999999999999 109.844 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.784 ' HA ' ' HE1' ' A' ' 32' ' ' MET . 18.5 mmt -72.49 -20.02 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 71.319999999999993 110.99 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 12.93 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.538 -0.301 . . . . 71.519999999999996 110.983 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 11.6 mptt 65.86 33.14 8.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.911 -0.586 . . . . 70.239999999999995 112.404 172.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmpp? -83.58 115.16 21.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.891 -0.781 . . . . 75.109999999999999 108.891 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.34 84.28 3.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.347 0.594 . . . . 72.439999999999998 109.953 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.577 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 46.0 p-90 -114.84 149.73 36.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.724 -0.671 . . . . 72.310000000000002 110.933 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.845 ' HG2' ' HB2' ' A' ' 57' ' ' ASN . 18.2 pttp -98.57 134.46 41.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 74.409999999999997 109.377 173.365 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.06 132.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.694 -0.484 . . . . 64.219999999999999 109.694 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.487 ' HA2' HG11 ' A' ' 25' ' ' VAL . . . -107.56 -133.41 7.15 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.722 -0.751 . . . . 65.230000000000004 112.564 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.669 HD23 ' HA ' ' A' ' 18' ' ' HIS . 38.8 tp -66.55 125.23 90.17 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.97 0.414 . . . . 74.239999999999995 111.667 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -65.67 108.99 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.394 2.063 . . . . 63.439999999999998 110.946 171.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.493 HG22 ' HG2' ' A' ' 45' ' ' GLN . 47.5 mt -76.35 -52.32 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 63.130000000000003 109.709 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.88 -18.17 17.56 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.867 -0.682 . . . . 73.310000000000002 112.641 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.523 ' HB2' ' OD2' ' A' ' 137' ' ' ASP . 20.0 pt20 -124.45 165.14 18.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.676 -0.49 . . . . 72.230000000000004 109.676 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.97 66.26 0.15 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.794 -0.717 . . . . 62.210000000000001 111.916 -172.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 181' ' ' SER . . . 80.5 -88.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.998 -0.62 . . . . 65.400000000000006 112.83 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -89.59 -13.66 36.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 74.230000000000004 111.253 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.32 167.46 42.79 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.838 -0.696 . . . . 34.329999999999998 113.143 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.2 m 62.77 35.11 14.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.172 0.511 . . . . 62.009999999999998 111.56 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.784 HG23 ' HB3' ' A' ' 71' ' ' LYS . 5.3 mm -89.27 138.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 75.239999999999995 109.668 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.13 138.67 49.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.95 0.405 . . . . 73.239999999999995 111.088 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.441 HD21 HG12 ' A' ' 69' ' ' VAL . 3.5 tm? -73.02 127.21 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.706 -0.85 . . . . 75.230000000000004 108.706 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.02 91.37 7.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.279 0.562 . . . . 72.439999999999998 109.698 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -79.74 61.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.82 . . . . 72.030000000000001 109.03 -178.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.577 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -35.8 127.96 0.66 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.65 -1.159 . . . . 75.340000000000003 112.302 -175.127 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.845 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 65.5 t30 -93.63 79.67 4.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.614 -0.721 . . . . 75.430000000000007 110.718 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 p -126.31 145.87 50.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.89 0.376 . . . . 72.140000000000001 110.964 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -83.1 -32.18 26.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.81 -0.632 . . . . 75.310000000000002 109.785 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -138.8 86.78 2.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.777 -0.647 . . . . 74.400000000000006 110.654 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -178.47 -48.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.907 -0.588 . . . . 72.439999999999998 109.464 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.875 HG22 ' HD3' ' A' ' 67' ' ' PRO . 8.8 p -81.94 143.33 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.548 -0.538 . . . . 65.530000000000001 109.548 173.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.71 34.87 5.43 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.405 -1.078 . . . . 65.420000000000002 110.405 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.9 t 64.58 18.42 11.38 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.934 -0.633 . . . . 55.140000000000001 109.645 -173.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -99.9 -23.19 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 63.25 112.001 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.2 81.17 0.25 Allowed Pre-proline 0 C--N 1.331 -0.205 0 O-C-N 123.693 0.621 . . . . 71.340000000000003 109.585 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.875 ' HD3' HG22 ' A' ' 62' ' ' VAL . 4.5 Cg_endo -84.08 25.57 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.457 2.771 . . . . 75.439999999999998 112.424 -170.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.481 ' HB2' HG23 ' A' ' 130' ' ' ILE . 9.6 p -162.05 142.26 10.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.483 0.658 . . . . 61.43 112.566 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.529 HG11 ' HA ' ' A' ' 133' ' ' ARG . 35.8 m -127.98 149.1 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.163 -0.926 . . . . 72.319999999999993 108.684 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.564 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -121.12 126.06 74.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.066 0.46 . . . . 74.430000000000007 109.954 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.784 ' HB3' HG23 ' A' ' 51' ' ' ILE . 25.1 pttm -111.13 139.87 46.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.291 -0.964 . . . . 63.0 109.944 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.525 HG11 ' HB3' ' A' ' 128' ' ' PHE . 32.7 m -110.53 151.28 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.98 -1.009 . . . . 74.209999999999994 111.881 -168.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.716 ' OE1' ' HA ' ' A' ' 77' ' ' ASN . 43.1 tt0 -127.31 130.23 23.76 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.854 -1.066 . . . . 64.519999999999996 108.246 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -174.27 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.301 2.001 . . . . 73.439999999999998 112.272 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -66.34 71.86 0.07 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.28 0.562 . . . . 52.229999999999997 110.723 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -141.06 -59.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.772 -0.649 . . . . 62.439999999999998 109.309 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.716 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 69.97 87.91 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.305 1.003 . . . . 63.039999999999999 111.213 175.484 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.79 -80.07 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 64.439999999999998 112.547 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.57 -45.04 19.17 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.554 2.169 . . . . 74.230000000000004 112.668 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.444 HD11 ' HE2' ' A' ' 71' ' ' LYS . 62.4 tp -73.18 -38.61 66.09 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.52 -0.548 . . . . 72.540000000000006 109.52 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.425 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 90.8 t80 -55.96 -44.0 78.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.036 -0.529 . . . . 75.450000000000003 110.579 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . 0.412 HG22 ' HA2' ' A' ' 199' ' ' GLY . 36.8 m -67.17 -49.64 64.0 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 115.879 -0.6 . . . . 74.329999999999998 111.4 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.584 ' HB3' ' O ' ' A' ' 197' ' ' ASP . 5.6 pt-20 -73.16 -24.14 60.53 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.057 -0.657 . . . . 71.510000000000005 110.923 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -64.13 -43.19 96.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.441 -0.577 . . . . 74.450000000000003 109.441 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 81' ' ' PHE . 32.4 mmmt -59.76 -48.33 82.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.051 -0.522 . . . . 74.349999999999994 110.483 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.69 -45.38 83.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.091 -0.504 . . . . 74.540000000000006 110.797 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 113' ' ' TYR . 47.5 t80 -61.58 -46.29 90.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.795 . . . . 73.129999999999995 110.975 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.0 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.284 . . . . 63.140000000000001 110.941 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.35 -39.82 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 75.519999999999996 110.685 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.61 15.64 27.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.056 0.455 . . . . 75.299999999999997 111.586 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.495 ' HB2' ' HB3' ' A' ' 113' ' ' TYR . . . -80.45 40.22 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.114 -0.494 . . . . 75.209999999999994 112.195 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.75 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -138.59 114.98 8.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.523 -0.308 . . . . 73.5 110.617 -177.345 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.81 -31.08 91.45 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.545 2.163 . . . . 72.25 111.488 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.75 ' HG2' ' HB3' ' A' ' 92' ' ' LYS . 10.6 pt-20 -54.86 -53.0 61.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.601 -0.727 . . . . 74.109999999999999 111.132 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HG3' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt-30 -72.17 -43.89 63.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.968 -0.56 . . . . 74.120000000000005 110.177 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.495 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.6 mt -53.87 -54.49 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.711 -0.677 . . . . 73.439999999999998 111.006 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.4 -32.72 71.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 71.109999999999999 110.718 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -58.39 -59.19 5.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.156 -0.475 . . . . 75.430000000000007 110.957 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.606 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.1 -31.81 70.79 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 120.162 -0.615 . . . . 75.140000000000001 110.774 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 96' ' ' ILE . 20.4 mt -54.49 -47.28 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 121.191 -0.203 . . . . 75.439999999999998 111.252 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -72.61 -35.24 67.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.041 -0.664 . . . . 71.430000000000007 110.954 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.6 m -70.52 -40.47 73.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.128 0.489 . . . . 71.310000000000002 111.979 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.635 ' HG2' HD11 ' A' ' 105' ' ' LEU . 5.3 tpt180 -87.12 -9.57 54.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.359 . . . . 74.299999999999997 110.982 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 67.93 37.99 2.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.966 0.889 . . . . 75.150000000000006 109.541 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.7 ' HG ' ' HB2' ' A' ' 163' ' ' ASP . 1.5 tp -79.81 170.69 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.974 -1.012 . . . . 74.299999999999997 109.301 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.474 ' HB3' HH22 ' A' ' 160' ' ' ARG . 9.3 tmtm? -113.33 -56.98 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.277 -0.569 . . . . 75.239999999999995 110.711 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -151.86 120.72 6.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.737 0.303 . . . . 74.340000000000003 110.235 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.606 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 33.5 tp -79.26 130.87 35.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.21 -0.45 . . . . 72.319999999999993 110.041 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.61 49.0 2.68 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.906 -0.664 . . . . 72.25 113.068 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.58 118.79 15.9 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 110.118 -0.327 . . . . 73.209999999999994 110.118 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 134' ' ' PHE . 92.5 Cg_endo -80.08 161.17 23.6 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.265 2.643 . . . . 75.340000000000003 113.468 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.36 137.25 58.24 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.742 -0.663 . . . . 74.0 111.436 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.495 ' HB3' ' HB2' ' A' ' 91' ' ' ALA . 40.5 t80 -94.33 133.49 37.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.351 -0.84 . . . . 75.329999999999998 110.33 177.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.454 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 39.2 m95 -112.66 -36.39 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.047 -0.261 . . . . 74.140000000000001 111.699 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.87 48.3 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.484 -0.865 . . . . 63.229999999999997 112.601 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 80.3 p -169.71 166.71 9.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 65.310000000000002 109.939 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.53 174.12 33.02 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.205 -0.998 . . . . 74.219999999999999 112.644 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.501 HD23 ' HB3' ' A' ' 125' ' ' SER . 10.1 tt -118.53 127.24 53.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.085 -0.709 . . . . 75.140000000000001 109.085 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -131.29 119.72 22.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.989 0.423 . . . . 73.230000000000004 110.192 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 37.9 t70 -74.29 120.8 20.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 72.150000000000006 109.572 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.68 -60.47 2.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.199 0.523 . . . . 64.209999999999994 110.312 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -178.41 96.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.883 -1.053 . . . . 74.299999999999997 108.3 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 -37.18 2.33 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.71 -0.757 . . . . 70.310000000000002 111.787 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -110.44 131.69 54.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.185 -0.302 . . . . 73.400000000000006 110.185 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.693 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 19.4 m -103.04 118.46 36.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.125 -0.489 . . . . 74.430000000000007 109.809 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.38 124.75 43.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.114 0.483 . . . . 72.310000000000002 111.017 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -98.41 120.29 38.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.183 -1.043 . . . . 72.400000000000006 108.183 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.525 ' HB3' HG11 ' A' ' 72' ' ' VAL . 35.0 p90 -139.1 163.99 30.97 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.741 -0.384 . . . . 75.030000000000001 111.554 -171.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.493 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 26.0 ptt? -146.58 146.42 30.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.309 0.576 . . . . 72.310000000000002 111.635 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.564 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -96.68 124.37 49.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.439 -1.255 . . . . 75.329999999999998 110.631 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 16.6 ptm -130.66 176.46 8.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.147 -0.933 . . . . 74.519999999999996 109.014 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' O ' HG21 ' A' ' 69' ' ' VAL . 12.6 t70 -65.81 170.37 5.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.645 -0.422 . . . . 62.219999999999999 110.079 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.974 ' HD2' ' HB2' ' A' ' 188' ' ' LYS . 4.1 ptp180 -67.93 113.59 5.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.873 0.844 . . . . 74.219999999999999 112.639 -167.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -115.26 171.3 7.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.107 -0.951 . . . . 75.340000000000003 109.433 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.65 -43.4 0.18 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.624 -1.274 . . . . 72.519999999999996 113.389 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.74 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.3 m -80.63 122.41 27.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.945 0.402 . . . . 72.030000000000001 111.479 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.523 ' OD2' ' HB2' ' A' ' 45' ' ' GLN . 5.1 m-20 -88.55 129.11 35.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.613 -0.721 . . . . 62.009999999999998 110.065 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.467 ' HA ' HD13 ' A' ' 141' ' ' ILE . 14.8 tp -66.82 -29.96 70.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.389 0.614 . . . . 74.439999999999998 109.379 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.499 ' CG ' ' HB3' ' A' ' 137' ' ' ASP . 20.3 pt20 -62.56 -44.28 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.291 -0.868 . . . . 71.0 111.403 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.685 ' HD3' ' HA ' ' A' ' 346' ' ' ASN . 63.2 mttp -78.8 -11.43 59.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.942 0.401 . . . . 74.530000000000001 110.715 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.798 HD12 ' HG ' ' A' ' 341' ' ' LEU . 94.3 mt -74.9 -51.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.481 . . . . 73.530000000000001 110.145 172.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.823 ' HB2' ' HA ' ' A' ' 147' ' ' LYS . 1.1 p90 -72.08 -32.32 66.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.533 -0.467 . . . . 75.329999999999998 110.155 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.06 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.323 . . . . 75.510000000000005 110.845 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.88 -32.35 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.385 . . . . 64.219999999999999 111.378 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.5 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 50.0 t30 -104.41 19.78 19.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.75 -0.38 . . . . 75.310000000000002 111.773 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 54.57 32.42 16.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.869 0.468 . . . . 62.310000000000002 112.19 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.823 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 31.1 ttmt 65.43 22.32 11.91 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.586 -0.734 . . . . 74.349999999999994 112.0 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.5 ' HG2' ' O ' ' A' ' 145' ' ' ASN . 30.0 mmt180 -83.35 107.56 15.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.462 -0.57 . . . . 71.010000000000005 109.462 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -112.75 152.19 29.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 73.439999999999998 110.772 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 p -89.22 172.78 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 64.209999999999994 110.614 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.465 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 37.5 mmm-85 -68.23 -35.92 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 73.310000000000002 111.275 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.519 ' N ' ' HD2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -73.26 -39.74 65.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.799 -175.031 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.507 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.0 p -64.86 -56.17 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 72.409999999999997 111.237 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.438 ' CG1' ' HG3' ' A' ' 251' ' ' MET . 40.5 t -59.8 -37.43 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.085 -0.507 . . . . 75.430000000000007 110.919 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.812 HD23 ' HG ' ' A' ' 328' ' ' LEU . 15.0 tp -56.62 -51.22 69.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 72.409999999999997 110.646 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -68.0 -33.57 74.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.032 -0.531 . . . . 62.450000000000003 110.719 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 153' ' ' THR . 95.4 mt -61.7 -50.8 70.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 75.430000000000007 110.202 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -55.0 -37.9 67.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 72.219999999999999 110.942 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.92 -45.96 91.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.662 -0.244 . . . . 72.109999999999999 111.472 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.644 ' HA ' ' NE ' ' A' ' 160' ' ' ARG . 9.7 mmp_? -63.31 -38.61 91.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.134 0.493 . . . . 73.129999999999995 111.51 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.505 ' HA ' HG23 ' A' ' 164' ' ' ILE . 1.8 mp -71.81 -32.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.585 -0.446 . . . . 71.109999999999999 109.987 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.433 HD13 ' CE1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -59.22 -56.0 27.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.497 -0.319 . . . . 74.129999999999995 111.321 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.7 ' HB2' ' HG ' ' A' ' 105' ' ' LEU . 43.4 p-10 -78.1 -24.64 47.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.049 -0.66 . . . . 75.0 112.018 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.505 HG23 ' HA ' ' A' ' 161' ' ' ILE . 12.1 tt -72.89 -36.49 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.268 -0.573 . . . . 72.150000000000006 110.41 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.484 HD22 HD13 ' A' ' 168' ' ' ILE . 42.6 mt -65.26 -38.1 89.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.288 . . . . 73.340000000000003 110.456 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -56.5 -51.69 67.54 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.4 0.619 . . . . 74.219999999999999 110.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -61.21 -49.98 74.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.132 -0.94 . . . . 74.129999999999995 112.29 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.484 HD13 HD22 ' A' ' 165' ' ' LEU . 35.1 pt -71.35 -37.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.277 -0.569 . . . . 74.310000000000002 111.518 -175.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.626 ' HA ' HG12 ' A' ' 174' ' ' VAL . 62.9 t-80 -68.54 -40.86 80.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.372 -0.531 . . . . 75.340000000000003 111.554 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -85.54 13.86 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.379 -0.529 . . . . 63.039999999999999 111.294 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.2 78.76 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.503 0.668 . . . . 74.140000000000001 111.352 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 2.7 mp0 72.78 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.266 -1.334 . . . . 64.409999999999997 113.289 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.4 ' HB3' ' CB ' ' A' ' 201' ' ' ALA . 91.7 m-85 -80.79 118.13 22.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.023 0.749 . . . . 75.340000000000003 113.023 -162.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.626 HG12 ' HA ' ' A' ' 169' ' ' HIS . 3.2 m -125.72 138.92 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.831 -0.622 . . . . 70.200000000000003 110.283 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 1.057 ' HB2' ' HA ' ' A' ' 201' ' ' ALA . 4.6 t-80 -175.68 -50.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.0 0.428 . . . . 70.540000000000006 110.94 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.35 -75.93 0.29 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.077 -0.809 . . . . 70.450000000000003 111.077 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.92 34.54 13.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.051 0.453 . . . . 74.230000000000004 111.764 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.438 HD11 HG13 ' A' ' 161' ' ' ILE . 21.4 mm -79.39 65.26 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.026 0.917 . . . . 72.140000000000001 110.018 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.878 ' HE3' HG21 ' A' ' 224' ' ' THR . 12.8 mmtt -103.4 141.65 35.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 75.439999999999998 109.157 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.53 47.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.197 0.522 . . . . 72.340000000000003 110.807 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.626 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 11.7 p -77.09 -19.28 57.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 74.549999999999997 111.552 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.485 ' OD1' ' HE3' ' A' ' 352' ' ' LYS . 17.2 m120 -114.4 2.58 14.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.668 0.27 . . . . 73.150000000000006 111.231 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.493 HD21 HD11 ' A' ' 161' ' ' ILE . 10.7 mp -104.13 111.21 23.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.095 -0.705 . . . . 74.420000000000002 109.095 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 47' ' ' GLY . 3.7 mm? -113.57 130.81 56.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.056 0.455 . . . . 73.540000000000006 111.688 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.74 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 94.1 mt -75.06 145.62 42.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.385 -0.825 . . . . 75.140000000000001 110.432 173.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.803 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 24.2 t-20 -73.7 137.48 44.08 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.523 -0.917 . . . . 74.519999999999996 108.523 172.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.739 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 33.2 t80 -62.77 -31.14 72.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.095 0.474 . . . . 74.019999999999996 111.11 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.974 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 6.2 tmtm? -91.57 -45.55 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.973 -0.558 . . . . 75.349999999999994 110.151 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.413 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 48.6 m-80 -104.88 100.05 22.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.431 -0.349 . . . . 73.420000000000002 110.852 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.06 -6.15 13.04 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.975 2.45 . . . . 75.340000000000003 113.237 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.534 ' HA ' HD13 ' A' ' 339' ' ' LEU . 8.9 p-10 -92.86 -1.01 57.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.719 0.266 . . . . 74.209999999999994 111.719 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.476 ' OE1' ' HD2' ' A' ' 160' ' ' ARG . 84.4 mm-40 -129.09 129.73 45.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.383 . . . . 73.439999999999998 111.06 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 28.6 m -106.03 143.31 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 74.430000000000007 110.269 177.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.803 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 36.8 m-85 -118.56 155.11 31.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.177 -0.465 . . . . 74.340000000000003 109.824 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.444 HD13 HD13 ' A' ' 164' ' ' ILE . 11.3 mt -95.93 146.41 24.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.686 0.279 . . . . 73.030000000000001 110.964 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.468 ' O ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -120.84 -171.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.399 -0.593 . . . . 63.200000000000003 109.399 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.584 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 8.2 t70 76.25 -71.77 0.11 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.634 0.584 . . . . 74.420000000000002 110.638 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.445 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 23.1 m-85 58.03 9.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.545 0.943 . . . . 72.040000000000006 113.545 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.658 ' HA3' ' CG2' ' A' ' 354' ' ' ILE . . . -100.1 -33.98 5.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.937 -1.125 . . . . 61.439999999999998 114.444 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.523 ' CD1' ' HZ1' ' A' ' 352' ' ' LYS . 8.5 mp -68.41 -23.03 64.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.369 0.584 . . . . 74.409999999999997 110.018 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 1.057 ' HA ' ' HB2' ' A' ' 175' ' ' HIS . . . -58.48 112.35 1.55 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.518 -0.764 . . . . 73.530000000000001 110.054 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . 0.636 ' HE2' ' HA ' ' A' ' 356' ' ' LYS . 6.4 t80 -98.47 132.37 43.97 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.56 -0.904 . . . . 75.329999999999998 108.56 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.61 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 7.1 ppt_? -86.54 141.56 28.96 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.405 0.521 . . . . 74.200000000000003 112.405 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.78 ' HB2' HG12 ' A' ' 209' ' ' VAL . 32.1 m-85 -69.67 -92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.309 -0.859 . . . . 72.140000000000001 109.947 170.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 40.1 m -142.48 141.23 20.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.889 -1.051 . . . . 72.25 108.793 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.71 104.65 0.11 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.945 2.43 . . . . 73.099999999999994 112.454 -178.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 62.1 22.15 12.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.448 -0.797 . . . . 73.140000000000001 111.564 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.58 42.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.04 -0.824 . . . . 73.219999999999999 111.04 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.78 HG12 ' HB2' ' A' ' 204' ' ' TYR . 15.8 m -59.29 109.89 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.483 0.659 . . . . 75.230000000000004 112.611 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 t60 179.85 124.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.266 -0.879 . . . . 73.239999999999995 109.156 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -152.67 163.38 39.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.554 -0.906 . . . . 70.140000000000001 108.554 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -112.25 174.95 5.64 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.516 -0.55 . . . . 64.319999999999993 109.516 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -61.82 101.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.348 0.594 . . . . 75.450000000000003 112.245 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -105.0 -3.41 23.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 74.120000000000005 110.057 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.422 ' HG3' HD22 ' A' ' 234' ' ' ASN . 43.0 tt0 66.03 -76.27 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 114.851 -1.068 . . . . 72.420000000000002 111.689 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -118.43 100.64 51.43 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.953 0.406 . . . . 75.349999999999994 111.917 -171.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -86.36 -47.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.71 2.273 . . . . 74.450000000000003 112.066 171.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -150.18 21.47 0.86 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.137 0.575 . . . . 74.409999999999997 110.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 56.39 82.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.896 -0.593 . . . . 74.439999999999998 110.865 -171.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.751 ' HB3' ' HA2' ' A' ' 235' ' ' GLY . 25.4 t -85.23 16.24 3.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 72.010000000000005 111.218 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 9.8 p-80 -67.22 9.61 0.21 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.619 0.6 . . . . 72.129999999999995 112.619 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.446 ' H ' ' C ' ' A' ' 220' ' ' CYS . 0.2 OUTLIER -82.85 110.95 18.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.109 0.481 . . . . 71.239999999999995 110.316 -174.287 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 162.74 177.9 36.13 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.177 -0.919 . . . . 70.439999999999998 110.924 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.878 HG21 ' HE3' ' A' ' 179' ' ' LYS . 23.6 p -78.63 117.12 19.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 74.540000000000006 110.574 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.576 ' HA ' ' HB ' ' A' ' 228' ' ' THR . 57.9 mt -63.0 -21.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 72.519999999999996 112.124 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.463 ' HG3' HD13 ' A' ' 265' ' ' LEU . 1.6 mp0 -58.26 -42.89 87.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.013 0.435 . . . . 75.409999999999997 110.273 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.587 ' HE1' ' HA ' ' A' ' 250' ' ' CYS . 97.8 m-85 -102.25 -18.44 15.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.604 -0.726 . . . . 74.319999999999993 110.69 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.576 ' HB ' ' HA ' ' A' ' 225' ' ' ILE . 90.7 m -66.78 108.6 2.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.525 . . . . 75.209999999999994 110.982 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.9 p -73.29 -173.52 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.315 -0.857 . . . . 73.209999999999994 110.791 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.16 -38.05 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 72.420000000000002 110.317 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.62 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.447 -0.797 . . . . 71.549999999999997 111.353 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.504 ' HB3' HG21 ' A' ' 228' ' ' THR . . . -58.06 -44.83 87.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 64.209999999999994 111.718 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 68.4 t60 -61.35 -37.33 82.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.834 0.349 . . . . 73.129999999999995 110.86 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.422 HD22 ' HG3' ' A' ' 215' ' ' GLU . 29.0 t-20 -74.25 -36.88 63.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 63.340000000000003 110.535 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.751 ' HA2' ' HB3' ' A' ' 220' ' ' CYS . . . 116.87 -19.77 12.04 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.748 -0.739 . . . . 71.510000000000005 112.411 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.63 134.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 73.439999999999998 110.699 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.47 114.33 55.85 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.093 -0.503 . . . . 70.299999999999997 110.444 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.558 ' HB2' ' H ' ' A' ' 242' ' ' GLY . 87.1 Cg_endo -80.83 147.74 17.19 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.819 2.346 . . . . 74.409999999999997 112.428 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.411 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 49.0 m -88.55 69.77 8.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.934 0.397 . . . . 72.299999999999997 110.543 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.534 ' O ' HD22 ' A' ' 244' ' ' LEU . 20.2 mtp180 73.29 -4.76 2.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.39 -0.823 . . . . 75.450000000000003 111.461 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -56.74 7.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.457 . . . . 72.430000000000007 109.838 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.558 ' H ' ' HB2' ' A' ' 238' ' ' PRO . . . -71.22 -36.31 63.74 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.837 -0.697 . . . . 45.030000000000001 112.034 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.409 ' OD1' ' HA ' ' A' ' 240' ' ' ARG . 5.0 m-20 -54.41 -49.53 69.73 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.375 0.607 . . . . 75.310000000000002 110.003 179.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.534 HD22 ' O ' ' A' ' 240' ' ' ARG . 4.4 mm? -72.04 -32.68 67.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 74.140000000000001 111.656 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.65 -38.03 80.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.384 -0.526 . . . . 74.439999999999998 110.553 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 242' ' ' GLY . 60.4 mt -59.81 -44.22 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.318 -0.253 . . . . 72.540000000000006 110.318 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.5 HD13 HG21 ' A' ' 161' ' ' ILE . 53.6 tp -60.57 -36.35 78.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.879 0.371 . . . . 75.299999999999997 110.429 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.64 95.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.907 -0.663 . . . . 73.430000000000007 111.684 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -62.14 -44.59 96.29 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.053 -0.351 . . . . 75.019999999999996 110.053 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.587 ' HA ' ' HE1' ' A' ' 227' ' ' PHE . 39.3 m -59.31 -50.19 74.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 75.329999999999998 110.709 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.438 ' HG3' ' CG1' ' A' ' 154' ' ' VAL . 26.7 ttt -60.15 -48.53 81.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.536 -0.756 . . . . 73.219999999999999 111.583 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.407 HG23 HD22 ' A' ' 259' ' ' LEU . 12.9 tt -68.1 -33.35 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.752 -0.379 . . . . 75.450000000000003 110.872 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.677 ' HG2' ' HD3' ' A' ' 147' ' ' LYS . 8.5 tt0 -66.82 -46.95 73.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.633 -0.258 . . . . 73.200000000000003 110.738 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -66.85 -27.98 67.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.048 0.452 . . . . 72.430000000000007 110.747 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . 0.428 HD13 ' ND2' ' A' ' 294' ' ' ASN . 24.0 tp -77.65 -28.64 51.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.52 . . . . 72.439999999999998 111.457 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 290' ' ' PHE . 27.8 p -101.47 -27.31 13.2 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.232 0.456 . . . . 72.510000000000005 112.232 -173.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.47 ' HA3' ' NH1' ' A' ' 148' ' ' ARG . . . 96.79 -37.27 3.5 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.573 -0.822 . . . . 74.450000000000003 111.579 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.14 142.21 19.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.75 -0.463 . . . . 75.120000000000005 109.75 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.557 HD12 ' CZ2' ' A' ' 261' ' ' TRP . 89.4 mt -97.5 145.05 29.03 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.137 -0.483 . . . . 74.439999999999998 110.406 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.07 -20.53 61.43 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.702 2.268 . . . . 74.329999999999998 112.875 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.578 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 12.6 p90 -106.58 -2.79 21.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.424 -0.511 . . . . 75.420000000000002 111.969 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.583 ' O ' HD23 ' A' ' 265' ' ' LEU . 8.2 pt-20 -86.36 -25.92 25.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.901 -0.719 . . . . 74.120000000000005 109.662 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.94 -37.34 55.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.607 0.718 . . . . 72.010000000000005 109.668 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -108.86 27.58 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.02 . . . . 74.209999999999994 111.588 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.583 HD23 ' O ' ' A' ' 262' ' ' GLU . 1.4 pt? -86.05 -2.0 57.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.951 0.405 . . . . 72.319999999999993 111.062 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.6 -8.64 43.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.917 -0.583 . . . . 74.239999999999995 111.44 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.469 ' OD1' ' HG3' ' A' ' 269' ' ' LYS . 10.4 t0 -128.25 122.99 22.27 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.874 -0.417 . . . . 61.020000000000003 109.874 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.05 -26.34 25.27 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.57 2.847 . . . . 74.120000000000005 114.041 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.469 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.7 mttp -55.03 -50.09 69.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.865 0.364 . . . . 73.099999999999994 110.882 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -73.97 -36.35 64.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 74.409999999999997 111.844 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.489 HG11 ' HZ3' ' A' ' 275' ' ' LYS . 60.2 t -56.92 -50.53 75.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.891 0.377 . . . . 73.349999999999994 110.39 176.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -67.32 -42.85 82.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.872 -0.603 . . . . 71.340000000000003 110.59 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.589 ' O ' ' HB2' ' A' ' 277' ' ' ARG . 18.4 t70 -55.26 -61.74 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.631 -0.713 . . . . 75.140000000000001 110.65 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.2 p -57.01 -47.86 79.86 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.647 0.592 . . . . 73.549999999999997 112.253 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.489 ' HZ3' HG11 ' A' ' 271' ' ' VAL . 53.5 mttp -58.73 -49.78 76.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.209 0.448 . . . . 73.140000000000001 112.209 -176.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.94 -37.95 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.369 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.589 ' HB2' ' O ' ' A' ' 273' ' ' ASP . 27.6 ttt180 -58.16 -44.02 87.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.474 -0.784 . . . . 73.310000000000002 110.761 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -73.22 -31.25 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 74.340000000000003 110.976 178.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.577 ' HA ' ' HD3' ' A' ' 307' ' ' LYS . 2.0 ttp180 -67.18 -23.46 65.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.628 -0.26 . . . . 74.230000000000004 111.207 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.03 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.986 0.422 . . . . 75.25 110.829 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.437 ' O ' HD21 ' A' ' 285' ' ' LEU . 2.8 t-20 -110.18 94.36 4.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.251 -0.648 . . . . 73.109999999999999 109.251 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.609 ' HB ' ' HG2' ' A' ' 304' ' ' GLU . 12.9 mt -80.4 -47.74 20.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.319 -0.855 . . . . 71.450000000000003 111.599 -170.498 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' HB1' ' OE2' ' A' ' 304' ' ' GLU . . . -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 71.420000000000002 112.341 -171.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.5 t -61.1 -41.37 96.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.651 0.241 . . . . 75.310000000000002 111.651 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.437 HD21 ' O ' ' A' ' 281' ' ' ASN . 4.4 mm? -72.16 -42.99 65.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.705 0.288 . . . . 74.340000000000003 110.998 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -74.33 -34.46 63.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.847 0.356 . . . . 70.319999999999993 110.987 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.745 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 14.2 t70 -70.43 -33.65 71.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 75.040000000000006 110.174 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -76.87 -11.48 59.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 74.040000000000006 111.369 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.3 m -63.74 -55.29 24.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.752 0.311 . . . . 75.420000000000002 110.975 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.448 ' CE1' ' HD2' ' A' ' 293' ' ' LYS . 50.5 m-85 -136.76 73.0 54.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 74.349999999999994 111.299 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.23 -53.62 3.39 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.394 2.063 . . . . 74.420000000000002 112.28 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.625 ' HA ' ' O ' ' A' ' 3' ' ' ARG . 41.8 tt0 -120.58 -25.13 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.45 0.537 . . . . 72.310000000000002 112.45 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.513 ' HA ' ' HB2' ' A' ' 6' ' ' ALA . 9.7 tmtm? -71.56 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.5 110.683 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.499 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 25.2 t-20 -158.89 -90.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.984 -0.286 . . . . 75.319999999999993 110.791 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.563 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 28.8 tptp 172.75 115.64 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-O 120.825 0.345 . . . . 75.219999999999999 110.348 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.745 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 95.8 Cg_endo -89.88 59.94 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.99 2.46 . . . . 75.510000000000005 111.612 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.94 -83.02 1.56 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.391 -0.909 . . . . 64.219999999999999 113.06 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.502 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -53.63 -54.98 29.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.795 0.438 . . . . 60.140000000000001 111.14 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.417 ' H ' HD11 ' A' ' 299' ' ' ILE . 4.0 mp -58.26 -42.56 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 73.129999999999995 111.278 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.24 -54.1 48.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 73.349999999999994 111.019 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -65.48 -37.83 87.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 74.439999999999998 111.137 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.416 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 17.7 t80 -58.53 -42.81 88.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.224 0.535 . . . . 73.420000000000002 110.278 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.576 ' HE2' ' HA ' ' A' ' 303' ' ' MET . 1.0 OUTLIER -65.34 -47.05 77.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.449 -0.796 . . . . 72.519999999999996 111.051 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.609 ' HG2' ' HB ' ' A' ' 282' ' ' ILE . 46.8 mt-10 -59.12 -47.04 86.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 74.230000000000004 109.837 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 88.1 m -57.67 -52.19 66.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.259 -0.882 . . . . 73.439999999999998 112.154 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.551 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 33.4 m -67.92 -27.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 73.530000000000001 111.485 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 279' ' ' ARG . 44.0 mttp -80.81 -16.26 54.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 74.209999999999994 110.891 176.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 82.6 mt -89.62 0.74 56.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 74.540000000000006 110.664 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.646 HD23 ' O ' ' A' ' 314' ' ' LYS . 27.6 mt -79.81 0.19 31.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.3 0.571 . . . . 73.25 109.718 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 31.3 t70 64.55 -88.44 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.611 -1.177 . . . . 64.230000000000004 111.939 174.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -153.73 -48.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.204 0.526 . . . . 74.510000000000005 110.415 -173.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.9 m -140.06 33.53 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.553 . . . . 73.150000000000006 110.841 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 49.7 mm-40 -82.99 -88.65 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.102 -0.374 . . . . 73.530000000000001 111.482 -178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.646 ' O ' HD23 ' A' ' 309' ' ' LEU . 10.3 ptpp? -175.98 154.25 1.42 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.12 -0.696 . . . . 74.409999999999997 109.12 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.456 ' HG3' ' HB3' ' A' ' 240' ' ' ARG . 96.3 Cg_endo -90.66 125.75 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.213 1.942 . . . . 73.340000000000003 110.807 167.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.423 HD11 ' HA ' ' A' ' 316' ' ' LEU . 7.5 tp -79.48 79.66 5.92 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.23 -0.656 . . . . 74.140000000000001 109.23 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.433 ' CE1' HD13 ' A' ' 162' ' ' LEU . 73.7 t80 -55.51 -49.37 72.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.973 -1.012 . . . . 75.430000000000007 112.524 -171.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -34.36 70.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.611 -0.268 . . . . 64.340000000000003 111.179 -175.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.25 -45.71 69.08 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.336 -0.246 . . . . 74.439999999999998 110.336 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.86 -45.22 86.64 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.318 -0.401 . . . . 75.219999999999999 110.795 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.25 -42.26 93.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 72.230000000000004 110.275 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.97 -55.51 32.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 73.349999999999994 111.202 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.49 -28.14 42.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.677 0.275 . . . . 74.540000000000006 111.401 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.441 ' HG ' ' CD1' ' A' ' 155' ' ' LEU . 27.0 tp -66.71 -50.92 61.25 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.474 0.654 . . . . 74.319999999999993 110.125 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.403 HD11 ' HA ' ' A' ' 325' ' ' LEU . 4.4 mm? -73.35 -32.81 64.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 73.140000000000001 110.441 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.85 -47.54 80.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 74.099999999999994 110.773 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.502 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.2 -40.77 96.97 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 52.329999999999998 112.061 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.812 ' HG ' HD23 ' A' ' 155' ' ' LEU . 2.3 tm? -68.96 -41.6 77.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.098 0.475 . . . . 73.530000000000001 110.153 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.98 -25.3 67.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 72.439999999999998 110.681 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.57 -22.57 63.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 72.430000000000007 112.34 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.573 HG21 ' O ' ' A' ' 328' ' ' LEU . 13.5 tt -92.25 -1.07 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.338 0.589 . . . . 74.200000000000003 110.694 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.82 24.11 33.66 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.451 -0.88 . . . . 74.310000000000002 112.622 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 50.2 m -128.86 169.37 14.67 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 122.748 -0.266 . . . . 72.010000000000005 110.407 179.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -159.22 -154.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.296 -0.631 . . . . 73.230000000000004 109.296 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.97 116.96 4.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.609 0.242 . . . . 65.150000000000006 111.014 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.71 89.66 3.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.094 -0.503 . . . . 73.450000000000003 111.493 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 68.4 13.36 65.12 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.004 -0.544 . . . . 64.400000000000006 114.165 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' A' ' 338' ' ' LYS . 29.8 mmtm 59.13 88.38 0.07 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.684 0.624 . . . . 75.010000000000005 112.684 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.534 HD13 ' HA ' ' A' ' 191' ' ' ASP . 59.2 mt 68.32 174.97 0.27 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.149 -0.932 . . . . 72.549999999999997 112.501 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -178.14 102.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.785 -1.098 . . . . 65.120000000000005 109.201 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.798 ' HG ' HD12 ' A' ' 141' ' ' ILE . 2.7 mm? -116.02 -80.25 0.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.151 0.501 . . . . 72.209999999999994 110.307 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 25.5 p 168.93 -100.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.511 -1.222 . . . . 72.219999999999999 109.312 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.593 HG12 ' H ' ' A' ' 15' ' ' ALA . 4.1 m -159.09 1.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.804 -0.635 . . . . 73.409999999999997 112.012 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.539 HG12 ' HB2' ' A' ' 140' ' ' LYS . 66.2 t 63.81 101.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.955 0.407 . . . . 74.439999999999998 111.484 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -107.99 30.32 6.47 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.255 -0.278 . . . . 72.230000000000004 111.137 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.685 ' HA ' ' HD3' ' A' ' 140' ' ' LYS . 16.9 m120 62.39 -169.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.023 -0.535 . . . . 73.200000000000003 111.08 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.49 0.97 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.603 -0.808 . . . . 74.219999999999999 111.977 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -171.16 168.52 41.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.542 -0.837 . . . . 72.329999999999998 112.263 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.404 HD12 ' HZ2' ' A' ' 140' ' ' LYS . 4.7 tt -161.36 122.75 2.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.868 -0.79 . . . . 75.340000000000003 108.868 177.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -143.99 116.05 8.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.808 0.337 . . . . 74.439999999999998 110.342 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -100.76 179.07 4.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.74 -0.664 . . . . 70.530000000000001 110.582 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.523 ' HZ1' ' CD1' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -148.59 178.32 8.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 75.25 110.301 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.497 HG21 ' HB3' ' A' ' 359' ' ' LYS . 41.7 m -107.65 139.72 41.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.507 -0.315 . . . . 64.409999999999997 110.848 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.658 ' CG2' ' HA3' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -68.83 134.18 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.833 0.349 . . . . 75.129999999999995 110.73 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 12.3 t -93.41 142.55 27.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 71.219999999999999 111.885 -175.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.636 ' HA ' ' HE2' ' A' ' 202' ' ' TYR . 23.5 pttm 177.84 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.096 -0.956 . . . . 74.319999999999993 108.978 174.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 356' ' ' LYS . 87.8 tttt 169.95 -49.8 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 114.732 -1.122 . . . . 75.409999999999997 108.338 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -149.0 164.11 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.658 -1.155 . . . . 74.319999999999993 108.63 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.583 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -68.84 -29.99 68.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.848 0.314 . . . . 74.310000000000002 111.848 -177.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.583 ' N ' ' HD2' ' A' ' 359' ' ' LYS . 8.4 tmtt? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.391 -0.814 . . . . 74.219999999999999 108.878 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' HE2' ' HB2' ' A' ' 1' ' ' MET . 2.9 mpp? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.653 -0.499 . . . . 71.430000000000007 109.653 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.87 137.9 39.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.275 1.983 . . . . 72.010000000000005 111.303 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -146.48 24.3 1.25 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.339 0.59 . . . . 74.329999999999998 110.113 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -86.28 119.59 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.625 -0.716 . . . . 74.329999999999998 110.593 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -162.95 101.41 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.584 0.706 . . . . 54.25 111.402 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.01 100.1 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 70.140000000000001 109.435 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.72 93.7 4.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.453 . . . . 71.219999999999999 111.744 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -125.07 135.7 52.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.042 -0.526 . . . . 74.109999999999999 109.824 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.9 95.09 1.6 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.317 -0.401 . . . . 65.209999999999994 110.244 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.13 0.41 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.503 -0.855 . . . . 75.450000000000003 112.461 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 6.3 ptt180 -174.21 147.02 1.17 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.416 -0.216 . . . . 73.409999999999997 110.416 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 9.9 tt0 169.97 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.011 0.924 . . . . 64.420000000000002 109.068 168.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.8 m -82.06 123.0 28.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.108 -0.497 . . . . 74.219999999999999 110.703 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -144.02 96.76 2.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.921 -0.581 . . . . 74.329999999999998 109.852 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.88 -4.27 56.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.887 -0.597 . . . . 75.230000000000004 111.317 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -112.59 119.08 36.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.174 -0.467 . . . . 74.519999999999996 110.168 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -76.66 166.26 23.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.828 -0.623 . . . . 75.109999999999999 111.625 -174.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -175.26 168.41 3.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.268 -1.012 . . . . 75.230000000000004 108.268 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 19' ' ' LEU . 2.3 pt? -106.54 136.1 46.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.857 -0.337 . . . . 72.099999999999994 110.424 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.47 13.26 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 64.420000000000002 111.546 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.89 138.41 30.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.416 -0.356 . . . . 73.230000000000004 110.111 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -125.32 -30.77 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.471 -0.332 . . . . 75.140000000000001 111.226 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -89.99 56.04 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.522 0.677 . . . . 71.129999999999995 110.473 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -178.65 -54.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.756 -1.111 . . . . 72.310000000000002 108.325 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG13 ' HA2' ' A' ' 40' ' ' GLY . 66.4 t -65.35 128.53 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.628 -1.169 . . . . 72.519999999999996 110.114 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.559 ' HA2' ' HD2' ' A' ' 38' ' ' LYS . . . 100.38 2.86 55.61 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.96 -0.638 . . . . 72.510000000000005 112.856 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.04 130.95 44.8 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.81 -0.811 . . . . 75.310000000000002 108.81 173.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.446 HD13 ' HA ' ' A' ' 28' ' ' ILE . 0.8 OUTLIER -86.53 128.86 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 75.439999999999998 111.505 -172.842 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -125.87 129.81 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.915 . . . . 74.150000000000006 109.939 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.7 m -104.29 123.13 46.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.075 -0.511 . . . . 71.510000000000005 110.035 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.683 ' HA ' ' HZ ' ' A' ' 128' ' ' PHE . 4.8 p-10 -82.26 175.65 10.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.544 -0.539 . . . . 73.5 109.544 175.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.432 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.5 ptm -71.86 -11.2 60.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.233 0.457 . . . . 75.140000000000001 112.233 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.75 2.59 53.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 71.040000000000006 110.25 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 65.91 77.91 0.28 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.091 -0.959 . . . . 73.200000000000003 112.586 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.88 138.67 9.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.26 -0.882 . . . . 72.329999999999998 109.079 167.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -89.1 130.48 35.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 73.430000000000007 111.77 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.528 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 20.8 p-90 -136.07 147.21 47.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.503 -0.772 . . . . 75.0 109.27 172.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.871 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 17.0 pttp -94.59 136.78 34.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.416 -0.514 . . . . 71.129999999999995 111.003 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.2 144.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.684 -0.689 . . . . 63.329999999999998 109.794 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.545 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -108.39 -110.61 3.41 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.58 -0.819 . . . . 71.019999999999996 112.763 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.5 mp -95.35 137.1 22.13 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 71.140000000000001 111.235 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.0 Cg_exo -75.14 120.08 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.967 2.444 . . . . 74.140000000000001 111.449 174.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 53' ' ' LEU . 42.3 mt -90.88 -33.6 5.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.34 0.591 . . . . 75.299999999999997 110.097 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.8 -47.17 2.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.803 -0.713 . . . . 72.319999999999993 111.775 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -122.95 165.35 16.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.013 -0.366 . . . . 74.319999999999993 110.013 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' HA2' HD23 ' A' ' 349' ' ' LEU . . . 115.53 55.07 0.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.026 -1.229 . . . . 72.299999999999997 110.026 -170.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 154.0 -93.39 0.14 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 111.141 -0.784 . . . . 73.230000000000004 111.141 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.604 ' H ' HD11 ' A' ' 51' ' ' ILE . 90.1 m-85 -146.41 -55.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.239 -0.652 . . . . 75.25 109.239 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.03 157.55 29.86 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.695 -0.562 . . . . 65.230000000000004 111.695 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.0 t 57.34 46.27 18.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.185 0.517 . . . . 63.119999999999997 110.762 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.663 HD13 ' HA ' ' A' ' 71' ' ' LYS . 42.5 mm -88.45 138.48 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 74.409999999999997 111.817 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.3 152.4 37.86 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.12 -0.491 . . . . 73.439999999999998 111.067 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.617 ' HB2' HD12 ' A' ' 43' ' ' ILE . 9.5 tt -101.32 143.92 30.78 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.196 -0.668 . . . . 73.439999999999998 109.196 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.93 108.43 17.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.071 0.462 . . . . 74.439999999999998 110.912 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.33 42.37 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 71.200000000000003 109.592 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.871 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 13.0 tpt -49.5 -30.88 9.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.275 -0.875 . . . . 65.430000000000007 112.553 -176.417 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' HB2' ' O ' ' A' ' 56' ' ' MET . 8.9 m-80 68.99 -166.36 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.311 0.382 . . . . 63.420000000000002 110.332 -177.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.585 ' HB2' ' O ' ' A' ' 61' ' ' SER . 13.5 m -124.93 148.46 48.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.255 -0.276 . . . . 61.130000000000003 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 p -76.39 -42.22 45.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 71.230000000000004 111.119 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -106.33 97.45 7.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.25 110.34 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.4 t 68.13 158.2 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.395 -0.82 . . . . 72.25 110.588 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.17 131.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.114 0.483 . . . . 73.040000000000006 110.523 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.12 -148.39 8.9 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.474 -0.87 . . . . 63.509999999999998 111.109 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -88.75 57.89 4.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.991 0.424 . . . . 54.119999999999997 109.915 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 67.68 7.96 6.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.211 -0.904 . . . . 64.319999999999993 110.36 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.88 90.98 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 115.701 -0.681 . . . . 63.439999999999998 110.454 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.826 ' HA ' ' HG2' ' A' ' 133' ' ' ARG . 4.8 Cg_exo -76.62 85.54 1.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.98 2.454 . . . . 74.230000000000004 112.303 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 131' ' ' MET . 6.1 p -153.66 138.68 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.222 0.534 . . . . 73.239999999999995 111.441 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.16 160.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.48 -0.782 . . . . 73.349999999999994 109.115 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.574 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 4.1 p -128.1 119.41 50.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.653 0.739 . . . . 72.219999999999999 111.958 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.663 ' HA ' HD13 ' A' ' 51' ' ' ILE . 17.9 ptmt -99.96 123.3 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.083 -0.962 . . . . 72.409999999999997 109.677 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 128' ' ' PHE . 13.9 m -114.29 151.85 16.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 75.299999999999997 111.054 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 72' ' ' VAL . 18.1 mm-40 -165.34 145.27 5.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 O-C-N 123.821 0.701 . . . . 73.239999999999995 110.025 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 126' ' ' TYR . 27.4 Cg_endo -63.47 141.25 79.97 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.291 1.994 . . . . 74.140000000000001 111.532 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -64.84 -21.38 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.103 0.478 . . . . 74.140000000000001 110.448 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.26 11.12 15.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.919 -0.582 . . . . 70.340000000000003 111.931 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -95.26 -53.91 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.392 -0.523 . . . . 74.310000000000002 110.312 174.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.66 -76.04 0.41 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.901 -1.142 . . . . 75.530000000000001 114.248 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.45 -35.36 21.49 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.195 3.263 . . . . 73.109999999999999 114.684 -170.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -56.84 -45.42 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 71.150000000000006 110.395 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.46 -31.47 70.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 75.5 110.697 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.8 m -65.64 -49.02 70.2 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.205 -0.452 . . . . 75.150000000000006 110.64 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.65 -31.83 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.140000000000001 109.862 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 59.8 tp -61.34 -41.33 96.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.929 -0.578 . . . . 74.109999999999999 110.739 176.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.731 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -62.23 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.56 -0.291 . . . . 74.420000000000002 110.608 177.078 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.91 -51.91 68.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 74.510000000000005 110.211 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.455 ' CE1' ' HG2' ' A' ' 131' ' ' MET . 73.0 t80 -60.43 -34.55 74.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.493 -0.776 . . . . 72.140000000000001 111.826 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.93 -42.41 69.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.311 . . . . 72.420000000000002 111.442 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -80.51 -28.27 37.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.421 -0.354 . . . . 64.109999999999999 110.776 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.572 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -93.64 16.23 14.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.857 0.36 . . . . 65.430000000000007 111.325 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -95.2 164.88 12.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.377 -0.374 . . . . 61.130000000000003 111.619 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 37.9 ttmt 72.29 110.5 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 74.230000000000004 111.389 176.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.01 -36.98 78.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.404 2.736 . . . . 74.129999999999995 113.34 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.25 -42.1 98.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.925 0.393 . . . . 74.200000000000003 110.941 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -66.65 -48.64 68.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 71.219999999999999 109.889 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.5 mt -56.57 -51.31 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.303 -0.862 . . . . 70.329999999999998 110.598 178.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.4 -36.74 69.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 72.230000000000004 110.683 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -61.95 -56.52 18.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 75.230000000000004 111.236 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.572 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 2.1 p90 -72.55 -35.04 67.91 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 119.683 -0.807 . . . . 74.549999999999997 111.154 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 33.4 mm -58.3 -42.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.47 0.653 . . . . 71.420000000000002 109.984 176.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.83 -57.77 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.021 -0.991 . . . . 74.25 111.222 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -71.6 -29.88 65.19 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.181 0.437 . . . . 72.310000000000002 112.181 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -83.55 -6.25 59.4 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.453 0.538 . . . . 72.430000000000007 112.453 -177.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.492 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.6 mptt 63.34 31.0 15.51 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.511 0.507 . . . . 74.319999999999993 111.237 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.442 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 94.4 mt -83.59 169.08 15.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.661 . . . . 74.420000000000002 109.558 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -101.94 -72.74 0.68 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.16 0.43 . . . . 74.129999999999995 112.16 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -150.8 110.46 4.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.509 . . . . 75.219999999999999 111.614 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -79.77 127.92 32.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 75.400000000000006 110.692 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.95 67.87 3.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.025 -0.607 . . . . 74.140000000000001 112.398 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.2 p -110.65 135.3 20.73 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 122.284 0.234 . . . . 73.450000000000003 110.694 -179.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.46 ' HA ' ' CE2' ' A' ' 194' ' ' TYR . 34.8 Cg_exo -61.0 152.87 68.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.996 2.464 . . . . 74.310000000000002 113.136 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -70.34 136.54 49.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.761 -0.654 . . . . 73.439999999999998 111.124 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.449 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 48.7 t80 -84.53 129.79 34.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.679 -0.691 . . . . 63.439999999999998 111.461 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.529 ' HB2' HG23 ' A' ' 130' ' ' ILE . 81.7 m95 -120.78 -50.78 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.327 0.584 . . . . 75.420000000000002 109.974 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.17 178.3 43.05 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.747 -0.661 . . . . 74.439999999999998 112.321 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' A' ' 32' ' ' MET . 22.8 t -164.69 -178.87 5.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.429 -0.582 . . . . 75.420000000000002 109.429 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.91 -151.52 23.23 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.969 -0.634 . . . . 71.129999999999995 111.921 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -137.13 145.67 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.904 -0.406 . . . . 71.439999999999998 109.904 175.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -149.19 108.1 3.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.452 -0.34 . . . . 73.109999999999999 110.199 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -174.34 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.504 0.503 . . . . 75.120000000000005 110.286 176.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 54.1 29.68 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.406 0.622 . . . . 71.25 111.419 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.03 -30.95 6.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.582 -0.895 . . . . 74.319999999999993 108.582 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.75 -42.08 0.35 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.919 -1.037 . . . . 73.540000000000006 111.316 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.458 ' HG3' ' H ' ' A' ' 125' ' ' SER . 14.9 tptm -173.58 -177.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.525 -0.546 . . . . 64.5 109.525 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.458 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 1.2 p -76.32 104.99 7.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.501 0.667 . . . . 73.439999999999998 111.212 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 7.3 m-85 -98.36 120.48 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.505 -0.77 . . . . 72.400000000000006 110.002 176.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -92.03 142.49 27.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.978 -0.379 . . . . 74.420000000000002 109.978 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.683 ' HZ ' ' HA ' ' A' ' 31' ' ' ASP . 52.9 p90 -127.82 143.68 51.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.512 -0.313 . . . . 75.150000000000006 110.737 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.548 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 77.2 mtp -123.1 122.14 37.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 74.519999999999996 110.496 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.574 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 4.7 mm -98.42 117.04 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 72.209999999999994 110.173 175.872 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . 0.514 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 67.2 mtm -127.84 179.89 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.187 -0.671 . . . . 63.210000000000001 109.187 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.405 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.1 t70 -63.54 154.3 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.315 -0.624 . . . . 75.209999999999994 109.315 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.826 ' HG2' ' HA ' ' A' ' 67' ' ' PRO . 11.6 ptp180 -82.31 125.37 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.494 0.664 . . . . 74.409999999999997 110.992 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -104.34 171.7 7.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.529 -0.76 . . . . 65.519999999999996 109.781 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.75 -38.7 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.855 -1.164 . . . . 61.43 113.264 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.771 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 69.8 m -94.37 124.71 38.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 71.329999999999998 111.485 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.537 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 1.1 m-20 -90.21 134.54 34.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.868 -0.606 . . . . 72.519999999999996 110.038 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.416 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.8 tp -69.66 -29.22 66.62 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.807 -0.812 . . . . 74.540000000000006 108.807 174.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.616 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 29.0 pt20 -69.86 -33.12 71.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.745 -0.661 . . . . 75.340000000000003 110.987 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -69.56 -39.8 77.17 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.376 -0.601 . . . . 74.329999999999998 109.376 178.121 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.764 HG23 ' HG ' ' A' ' 341' ' ' LEU . 66.8 mt -68.57 -40.97 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.7 -0.682 . . . . 74.310000000000002 110.115 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.746 ' CE1' ' HD3' ' A' ' 147' ' ' LYS . 22.5 t80 -52.75 -48.83 66.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.58 . . . . 74.540000000000006 110.655 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.8 -44.92 79.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 74.120000000000005 111.371 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.57 51.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.039 0.385 . . . . 70.230000000000004 112.039 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -96.74 2.59 52.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.935 0.397 . . . . 64.310000000000002 110.887 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.16 38.55 29.97 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.074 -0.512 . . . . 75.340000000000003 111.644 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.746 ' HD3' ' CE1' ' A' ' 142' ' ' TYR . 37.3 pttt 46.33 29.46 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 75.150000000000006 113.726 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -99.92 84.08 2.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.366 -0.605 . . . . 75.049999999999997 109.366 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.491 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 5.0 m-30 -94.52 156.38 16.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.782 -0.644 . . . . 74.349999999999994 110.68 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 p -73.51 138.06 44.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.239 -0.652 . . . . 75.209999999999994 109.239 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.79 71.53 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.326 0.491 . . . . 74.219999999999999 112.326 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.494 ' HZ3' ' CB ' ' A' ' 340' ' ' ASP . 11.0 pttp -60.15 -39.25 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 72.420000000000002 110.929 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.478 HG22 HD22 ' A' ' 339' ' ' LEU . 30.4 m -71.57 -40.43 69.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.102 -0.499 . . . . 74.230000000000004 110.057 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.14 -47.18 84.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.778 -0.646 . . . . 71.549999999999997 111.28 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.727 ' HB3' HD21 ' A' ' 328' ' ' LEU . 0.2 OUTLIER -70.71 -44.11 67.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.215 -0.448 . . . . 73.299999999999997 110.687 -176.99 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.492 ' HG2' HD12 ' A' ' 339' ' ' LEU . 6.8 tp-100 -55.73 -46.2 77.81 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.03 0.443 . . . . 74.219999999999999 110.736 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.468 ' O ' HG12 ' A' ' 161' ' ' ILE . 87.7 mt -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.903 -0.59 . . . . 72.040000000000006 110.931 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 p -64.24 -32.25 73.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 72.349999999999994 111.808 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.531 HD11 HD22 ' A' ' 325' ' ' LEU . 76.3 mt -61.25 -53.41 57.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.658 0.266 . . . . 73.420000000000002 110.851 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -66.81 -29.47 69.42 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.106 0.479 . . . . 72.239999999999995 110.538 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.483 ' HA ' HG23 ' A' ' 164' ' ' ILE . 28.2 mm -68.97 -35.04 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.359 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.44 -46.62 89.31 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.729 -0.471 . . . . 71.519999999999996 109.729 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -57.2 -48.38 78.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.226 -0.443 . . . . 71.209999999999994 111.479 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.483 HG23 ' HA ' ' A' ' 161' ' ' ILE . 15.9 tt -72.32 -36.85 56.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.443 -0.344 . . . . 73.140000000000001 111.607 -175.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.411 HD22 HD13 ' A' ' 178' ' ' ILE . 37.1 mt -64.63 -38.7 91.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.99 -0.284 . . . . 75.430000000000007 110.84 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -71.32 -37.9 71.75 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.942 -0.303 . . . . 71.439999999999998 110.532 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -50.91 -42.21 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 71.340000000000003 110.979 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 38.8 pt -91.91 -43.82 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.411 0.523 . . . . 75.150000000000006 112.411 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 3.0 t-160 -72.86 -30.94 64.38 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.623 0.249 . . . . 63.020000000000003 111.567 -171.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.463 ' HG2' HH22 ' A' ' 240' ' ' ARG . 3.5 tm-20 -59.18 -28.77 66.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 70.409999999999997 110.084 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -101.41 -66.47 0.91 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.745 0.646 . . . . 71.310000000000002 112.745 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.53 ' HG3' ' HD1' ' A' ' 173' ' ' TYR . 11.3 pt-20 -145.97 -60.56 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.219 1.192 . . . . 73.340000000000003 114.219 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.598 ' HB3' ' HD2' ' A' ' 203' ' ' ARG . 55.2 p90 -104.42 160.36 14.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.343 0.592 . . . . 74.340000000000003 112.47 -168.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 14.2 m -129.54 172.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.096 -0.956 . . . . 74.349999999999994 109.741 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 13.4 t-80 -98.98 -41.32 7.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.834 -0.432 . . . . 72.150000000000006 109.834 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 228' ' ' THR . . . 62.66 38.45 96.46 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.766 -0.73 . . . . 72.430000000000007 112.754 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.553 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 19.3 t70 179.71 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.765 0.426 . . . . 65.340000000000003 109.889 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.411 HD13 HD22 ' A' ' 165' ' ' LEU . 49.5 mm -111.16 79.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.508 0.67 . . . . 73.439999999999998 110.1 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.611 ' HZ3' ' HD2' ' A' ' 227' ' ' PHE . 46.4 mttp -103.79 153.05 21.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.46 -0.791 . . . . 72.109999999999999 110.647 174.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.416 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -63.36 -16.27 59.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 72.310000000000002 110.918 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.616 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 12.7 m -71.84 -14.16 61.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.961 -0.563 . . . . 70.349999999999994 111.472 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -97.43 -12.4 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 74.140000000000001 110.913 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.483 HD21 HD11 ' A' ' 161' ' ' ILE . 8.0 mp -105.67 120.26 41.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.363 0.601 . . . . 74.340000000000003 110.622 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.528 HD21 ' HB ' ' A' ' 196' ' ' VAL . 3.6 mm? -118.03 131.35 56.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.298 -0.865 . . . . 61.340000000000003 110.131 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.771 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 86.2 mt -86.84 154.9 20.52 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.485 -0.561 . . . . 75.219999999999999 109.485 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.13 153.46 18.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.344 -0.984 . . . . 73.209999999999994 108.344 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -47.56 -33.29 6.3 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.419 0.525 . . . . 73.030000000000001 112.419 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -154.84 51.75 0.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.519 . . . . 75.340000000000003 110.441 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.484 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 2.7 t-20 -135.43 107.4 10.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.379 -0.601 . . . . 73.129999999999995 109.379 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 23.2 Cg_exo -66.49 -29.49 44.7 Favored 'Trans proline' 0 N--CA 1.474 0.36 0 C-N-CA 123.437 2.758 . . . . 54.130000000000003 115.305 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 338' ' ' LYS . 0.7 OUTLIER -94.29 -21.91 18.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.079 -0.649 . . . . 64.120000000000005 111.483 -173.334 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.467 ' HG3' ' CZ ' ' A' ' 194' ' ' TYR . 19.4 tp60 -91.38 93.62 9.12 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.569 0.7 . . . . 73.319999999999993 110.373 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.49 142.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.838 -1.074 . . . . 73.519999999999996 110.247 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.467 ' CZ ' ' HG3' ' A' ' 192' ' ' GLN . 37.1 m-85 -124.04 157.34 34.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.189 -0.459 . . . . 72.299999999999997 110.045 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.9 tp -94.49 99.36 11.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.613 -0.884 . . . . 75.299999999999997 108.613 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.528 ' HB ' HD21 ' A' ' 184' ' ' LEU . 46.7 t -130.26 157.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 64.310000000000002 110.465 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 51.16 64.96 1.63 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.818 0.818 . . . . 60.329999999999998 111.297 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.414 ' C ' ' H ' ' A' ' 200' ' ' LEU . 12.9 p90 -123.17 -64.85 1.14 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.078 -0.965 . . . . 73.349999999999994 110.65 -178.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.656 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . 77.02 -13.7 8.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.552 . . . . 43.200000000000003 112.059 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -84.63 89.75 7.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.127 0.489 . . . . 74.040000000000006 110.073 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -141.92 99.25 3.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 74.019999999999996 109.912 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.67 138.52 42.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 75.120000000000005 109.675 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.598 ' HD2' ' HB3' ' A' ' 173' ' ' TYR . 4.8 mpt_? -71.36 129.06 37.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.944 0.402 . . . . 72.200000000000003 111.496 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.588 ' HA ' ' HB2' ' A' ' 237' ' ' ALA . 11.6 t80 -95.49 -54.41 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.763 -0.653 . . . . 73.519999999999996 110.064 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.439 ' O ' ' HA ' ' A' ' 172' ' ' GLU . 6.7 p -134.1 105.39 11.39 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.697 -0.683 . . . . 74.209999999999994 110.105 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 210' ' ' HIS . 52.2 Cg_exo -54.16 107.37 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.586 2.19 . . . . 65.129999999999995 111.568 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 65.9 11.68 7.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.103 -0.953 . . . . 74.120000000000005 111.418 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.54 -5.51 40.84 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.024 -0.607 . . . . 52.5 113.223 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.26 111.54 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.03 0.415 . . . . 74.329999999999998 111.536 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.532 ' HB2' ' HD2' ' A' ' 206' ' ' PRO . 12.6 t-160 -178.19 -101.13 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.96 -0.563 . . . . 74.310000000000002 110.888 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.464 ' HE3' HG21 ' A' ' 312' ' ' THR . 60.3 tttm 51.49 89.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 75.310000000000002 111.947 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -166.22 136.71 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 74.209999999999994 111.139 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.754 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 20.3 t80 -94.75 80.45 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 75.030000000000001 111.495 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -178.9 70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.547 -0.751 . . . . 74.25 109.517 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -106.49 -71.29 0.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.082 -0.508 . . . . 64.129999999999995 110.777 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -119.12 118.2 32.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.915 0.388 . . . . 75.129999999999995 110.395 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.63 0.46 10.0 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.295 2.663 . . . . 74.200000000000003 112.899 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 16.6 ttmm -100.04 -8.6 23.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.546 -0.539 . . . . 73.420000000000002 109.546 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 218' ' ' LYS . 29.1 mtm105 73.19 114.36 0.06 Allowed 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.163 -0.926 . . . . 73.25 110.697 -177.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 37.1 m -61.01 -53.06 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.963 -0.562 . . . . 74.030000000000001 111.847 -175.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 26.0 p80 44.51 43.62 6.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.515 0.726 . . . . 70.209999999999994 111.911 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.71 -59.48 4.43 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.486 . . . . 73.120000000000005 111.207 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -88.04 -155.36 28.96 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.898 -0.667 . . . . 75.200000000000003 112.36 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.9 p -88.7 151.59 22.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.941 0.4 . . . . 63.329999999999998 111.062 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.477 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -53.27 -33.08 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 113.739 1.014 . . . . 71.420000000000002 113.739 -167.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.415 ' CD ' ' HZ1' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -81.93 -60.15 2.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.272 0.842 . . . . 73.200000000000003 113.272 -170.739 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.611 ' HD2' ' HZ3' ' A' ' 179' ' ' LYS . 28.9 m-85 -87.89 -0.23 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.28 0.474 . . . . 64.420000000000002 112.28 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.521 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 39.4 m -85.61 -10.3 56.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.346 0.593 . . . . 74.430000000000007 109.815 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.0 t 67.44 -175.7 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.1 -0.955 . . . . 72.230000000000004 111.259 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 82.6 mt -70.5 -34.59 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.393 -0.822 . . . . 64.120000000000005 109.731 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.656 ' HB3' ' HA ' ' A' ' 238' ' ' PRO . 1.8 m-20 -47.38 -84.23 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.801 -1.091 . . . . 74.519999999999996 112.547 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.638 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . . . -66.31 -28.32 68.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.154 -0.476 . . . . 65.5 111.993 -172.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.05 -26.6 62.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.662 -0.415 . . . . 75.209999999999994 110.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.401 ' ND2' ' HH ' ' A' ' 213' ' ' TYR . 1.8 t30 -95.75 -4.85 43.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.369 . . . . 70.129999999999995 110.981 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.59 21.07 17.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.352 -0.927 . . . . 73.099999999999994 113.391 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.754 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 7.1 p -117.63 141.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 71.129999999999995 109.67 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.588 ' HB2' ' HA ' ' A' ' 204' ' ' TYR . . . -56.71 125.06 66.77 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.084 -0.507 . . . . 74.209999999999994 110.966 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.656 ' HA ' ' HB3' ' A' ' 231' ' ' ASP . 33.3 Cg_exo -60.27 115.18 2.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.156 2.571 . . . . 71.239999999999995 112.701 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 69.9 m -83.79 169.31 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 75.099999999999994 110.774 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.463 HH22 ' HG2' ' A' ' 170' ' ' GLU . 20.4 mtt180 -59.51 -20.53 56.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.528 0.68 . . . . 73.409999999999997 110.251 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.558 HH11 ' HG ' ' A' ' 309' ' ' LEU . 10.7 mmt180 -64.99 -41.82 95.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 109.645 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.503 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -69.59 -41.41 75.87 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 74.140000000000001 112.275 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.07 -45.18 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.581 0.229 . . . . 73.530000000000001 111.083 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.519 HD23 HG12 ' A' ' 306' ' ' VAL . 9.5 mp -60.9 -41.99 97.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.403 -0.362 . . . . 73.519999999999996 110.916 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.92 -51.09 71.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.788 -0.642 . . . . 74.099999999999994 110.771 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.4 mt -62.35 -42.1 94.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.009 -0.541 . . . . 75.209999999999994 111.09 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.481 ' O ' ' HG3' ' A' ' 251' ' ' MET . 46.8 tp -61.96 -39.52 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 110.169 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.53 -39.65 98.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.339 -0.934 . . . . 74.030000000000001 111.645 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -66.55 -39.47 88.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.907 0.336 . . . . 73.340000000000003 111.907 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 20.0 p -68.12 -34.17 75.88 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.294 -0.563 . . . . 72.430000000000007 110.133 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.52 ' HE3' HD23 ' A' ' 324' ' ' LEU . 81.6 mtp -62.9 -53.59 51.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.443 -0.344 . . . . 75.129999999999995 110.983 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.533 HD12 ' SD ' ' A' ' 286' ' ' MET . 5.5 tt -65.98 -31.7 54.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.679 0.276 . . . . 74.120000000000005 110.303 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.26 -53.95 51.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 74.200000000000003 110.898 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.491 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 19.1 m0 -76.39 -25.16 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 73.200000000000003 111.222 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.5 tp -76.35 -46.3 28.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 60.240000000000002 111.617 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 76.5 p -103.71 -17.73 14.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.914 -0.315 . . . . 72.230000000000004 111.674 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.72 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 72.14 18.48 77.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 70.230000000000004 111.914 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -144.48 147.35 33.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.675 0.274 . . . . 75.25 110.957 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.846 ' HB2' ' HG3' ' A' ' 262' ' ' GLU . 96.1 mt -118.28 138.93 26.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.652 -0.87 . . . . 74.400000000000006 108.652 168.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.0 Cg_exo -65.45 -17.35 57.36 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.978 2.452 . . . . 74.510000000000005 114.243 -171.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.51 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 16.3 p90 -132.93 34.64 3.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.414 0.524 . . . . 74.420000000000002 112.414 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.846 ' HG3' ' HB2' ' A' ' 259' ' ' LEU . 43.4 mt-10 -68.03 -42.72 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.41 0.624 . . . . 63.409999999999997 109.692 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.13 -21.21 64.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 73.200000000000003 109.939 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.607 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 3.2 m-20 -89.81 -2.55 58.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.252 -0.886 . . . . 74.030000000000001 111.157 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.499 HD22 HG12 ' A' ' 271' ' ' VAL . 89.7 mt -66.63 -2.83 5.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.796 0.331 . . . . 64.420000000000002 111.521 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -62.59 -40.02 95.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 72.329999999999998 110.919 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.563 ' OD1' ' HE3' ' A' ' 269' ' ' LYS . 10.7 t70 -135.13 135.41 22.78 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 42.310000000000002 110.982 -171.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.6 Cg_exo -60.72 -28.86 87.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.242 2.628 . . . . 74.439999999999998 113.476 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.563 ' HE3' ' OD1' ' A' ' 267' ' ' ASP . 0.0 OUTLIER -78.11 -34.93 49.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.729 -0.471 . . . . 73.109999999999999 109.729 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.607 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 6.4 m-85 -56.63 -50.54 71.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.811 -0.631 . . . . 74.409999999999997 111.058 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.499 HG12 HD22 ' A' ' 265' ' ' LEU . 7.8 m -70.47 -35.3 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 71.340000000000003 111.479 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 276' ' ' ILE . 82.3 mtt180 -56.96 -56.34 22.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.512 0.196 . . . . 74.140000000000001 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.466 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 0.1 OUTLIER -66.39 -42.67 87.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 72.140000000000001 111.439 -176.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 16.2 m -61.01 -41.97 97.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.217 0.532 . . . . 73.420000000000002 110.256 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.21 -43.91 92.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.277 -0.874 . . . . 75.510000000000005 110.471 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 272' ' ' ARG . 79.7 mt -66.14 -44.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 75.109999999999999 111.274 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 26.4 mmt180 -68.96 -36.15 77.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.589 0.233 . . . . 73.530000000000001 111.606 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.424 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 21.2 m-85 -73.12 -33.92 65.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.061 -0.255 . . . . 74.109999999999999 110.868 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -72.13 -22.93 61.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.267 0.556 . . . . 74.120000000000005 109.971 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -74.82 -53.44 9.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.537 -0.756 . . . . 65.540000000000006 110.51 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.499 ' HB2' HD22 ' A' ' 285' ' ' LEU . 30.4 m-80 -111.72 55.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 72.409999999999997 110.635 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.528 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -52.13 -51.04 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 73.010000000000005 112.077 -178.701 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.528 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.23 -46.94 84.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 63.229999999999997 111.42 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.4 m -61.19 -49.14 78.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.811 -0.631 . . . . 74.5 111.143 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.499 HD22 ' HB2' ' A' ' 281' ' ' ASN . 4.3 mm? -71.58 -44.23 64.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.349999999999994 111.874 -175.173 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.627 ' HE1' ' SD ' ' A' ' 303' ' ' MET . 21.8 mmt -64.69 -38.66 91.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.0 -0.28 . . . . 71.319999999999993 111.726 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.17 -39.01 65.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 74.120000000000005 110.413 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.05 -39.1 63.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 72.209999999999994 111.731 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.8 m -77.37 -11.36 59.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.607 0.225 . . . . 62.509999999999998 111.607 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.699 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 10.5 t80 -129.7 69.53 81.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.181 0.515 . . . . 75.129999999999995 110.449 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -90.67 12.35 2.43 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.041 2.494 . . . . 72.439999999999998 112.534 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -75.03 -9.38 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 74.219999999999999 110.375 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 71.27 84.56 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.893 -1.049 . . . . 71.340000000000003 112.221 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.699 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 27.3 t-20 -128.3 -80.27 0.58 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.802 -1.184 . . . . 62.409999999999997 107.802 169.399 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 60.0 tttp 175.13 96.85 0.08 OUTLIER Pre-proline 0 N--CA 1.461 0.092 0 O-C-N 123.743 0.652 . . . . 74.150000000000006 110.526 169.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -99.84 38.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.986 2.457 . . . . 75.209999999999994 111.47 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.3 -51.46 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 71.150000000000006 112.924 -172.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.453 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 0.9 OUTLIER -72.61 -30.85 64.7 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.235 -0.283 . . . . 74.319999999999993 110.235 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.3 mp -63.08 -44.3 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 74.230000000000004 109.57 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.33 88.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.933 -0.576 . . . . 63.130000000000003 111.138 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.71 -41.07 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.635 -0.257 . . . . 75.540000000000006 110.648 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.441 ' O ' ' HB ' ' A' ' 305' ' ' THR . 56.9 t80 -55.14 -45.35 75.64 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.502 -0.317 . . . . 61.25 110.986 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.627 ' SD ' ' HE1' ' A' ' 286' ' ' MET . 74.8 mtp -72.72 -31.35 64.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.598 -0.274 . . . . 65.310000000000002 111.62 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.29 -30.37 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.475 0.655 . . . . 72.239999999999995 109.236 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.441 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 86.7 m -66.32 -40.3 89.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.346 -0.843 . . . . 71.420000000000002 110.869 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.695 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 5.7 m -73.49 -27.03 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.819 -0.352 . . . . 74.129999999999995 110.492 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -62.3 -42.85 99.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 73.430000000000007 110.498 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.1 tp -97.11 16.22 20.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 74.349999999999994 110.05 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.695 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 27.4 tp -71.92 -32.53 67.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 74.120000000000005 110.666 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 27.1 t70 67.5 161.7 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.322 -0.854 . . . . 60.530000000000001 110.848 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -77.75 -22.72 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.699 0.285 . . . . 75.439999999999998 111.187 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.464 HG21 ' HE3' ' A' ' 211' ' ' LYS . 24.3 m -124.01 -20.28 5.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.592 0.59 . . . . 71.230000000000004 112.592 -173.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 14.5 tp10 -57.02 -101.16 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.344 0.868 . . . . 73.109999999999999 113.344 -166.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -147.04 120.17 4.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 121.641 -0.662 . . . . 75.230000000000004 111.508 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.425 ' HA ' HD11 ' A' ' 309' ' ' LEU . 57.3 Cg_endo -91.03 118.57 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.542 2.162 . . . . 73.230000000000004 111.121 170.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.625 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 96.1 mt -116.04 82.43 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.79 0.328 . . . . 74.540000000000006 111.318 -176.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.481 ' HA ' HD12 ' A' ' 320' ' ' LEU . 35.9 m-85 -62.28 -33.46 74.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.022 -0.535 . . . . 72.540000000000006 111.428 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.28 -40.45 90.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 75.430000000000007 110.95 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -73.21 -37.51 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.687 -0.486 . . . . 74.209999999999994 109.687 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 50.6 mt -59.32 -47.71 84.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.113 -0.494 . . . . 74.209999999999994 110.154 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -57.96 -41.59 83.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 70.450000000000003 110.408 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.49 -52.28 61.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.706 -0.679 . . . . 73.510000000000005 111.686 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.5 tt -63.58 -47.52 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 111.91 0.337 . . . . 73.430000000000007 111.91 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.52 HD23 ' HE3' ' A' ' 251' ' ' MET . 71.5 mt -66.19 -39.14 89.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.247 0.546 . . . . 73.109999999999999 110.435 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.531 HD22 HD11 ' A' ' 159' ' ' LEU . 2.8 tm? -69.28 -35.28 75.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.152 -0.684 . . . . 74.409999999999997 109.152 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -62.91 -37.71 88.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 73.120000000000005 109.962 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.17 -41.0 95.13 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.903 -0.665 . . . . 61.140000000000001 112.215 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 155' ' ' LEU . 41.6 tp -71.65 -37.94 70.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.19 0.519 . . . . 72.25 110.746 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -72.08 -22.98 61.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 110.511 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.496 . . . . 73.340000000000003 110.957 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.427 HD12 HD11 ' A' ' 328' ' ' LEU . 33.5 pt -95.44 1.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.982 0.42 . . . . 73.230000000000004 110.583 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.08 75.38 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.774 -0.648 . . . . 54.549999999999997 113.224 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.417 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 5.4 t -117.32 170.13 8.94 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.474 -0.427 . . . . 53.409999999999997 110.751 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.446 ' HA ' HD22 ' A' ' 328' ' ' LEU . 27.3 ttpp -160.11 -56.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 74.430000000000007 108.889 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.541 ' HB2' ' H ' ' A' ' 339' ' ' LEU . 7.1 p-10 178.6 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.914 -1.039 . . . . 75.239999999999995 108.452 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.8 t70 72.45 -71.55 0.13 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.681 -1.145 . . . . 74.219999999999999 111.786 172.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -117.94 57.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.805 -0.712 . . . . 70.549999999999997 112.303 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.491 ' HG3' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER 62.76 64.93 0.85 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.046 0.451 . . . . 71.340000000000003 110.91 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.541 ' H ' ' HB2' ' A' ' 335' ' ' ASP . 10.9 mp 63.04 -171.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.075 -0.966 . . . . 72.329999999999998 111.487 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . 0.494 ' CB ' ' HZ3' ' A' ' 152' ' ' LYS . 32.4 t70 -159.43 82.37 0.76 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.264 -0.88 . . . . 73.5 108.732 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.764 ' HG ' HG23 ' A' ' 141' ' ' ILE . 28.8 tp -125.76 -74.97 0.59 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.316 -0.856 . . . . 64.540000000000006 110.727 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 58.1 m -173.78 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.269 -0.423 . . . . 74.120000000000005 111.237 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 84.5 t 67.81 96.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.65 -0.704 . . . . 75.310000000000002 110.124 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.429 ' C ' ' H ' ' A' ' 346' ' ' ASN . 19.4 t -88.95 -15.73 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.528 -0.76 . . . . 74.120000000000005 110.811 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 73.59 -37.3 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.185 0.594 . . . . 72.349999999999994 111.643 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.429 ' H ' ' C ' ' A' ' 344' ' ' VAL . 3.4 t-20 -125.46 130.39 51.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.698 -0.482 . . . . 73.120000000000005 109.698 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -136.87 -121.7 2.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.621 -0.8 . . . . 54.32 112.829 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -179.88 73.4 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.35 -0.452 . . . . 53.020000000000003 112.266 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.522 HD23 ' HA2' ' A' ' 46' ' ' GLY . 6.8 mp -59.07 145.14 43.22 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.392 0.277 . . . . 75.129999999999995 111.09 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -164.99 116.87 1.18 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.199 -0.455 . . . . 73.530000000000001 110.752 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.74 -178.34 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.301 -0.408 . . . . 72.430000000000007 112.1 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.656 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 28.4 ttpt -142.72 170.61 15.38 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.173 -0.677 . . . . 75.420000000000002 109.173 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.649 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 10.4 t -106.67 162.39 13.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.168 -0.308 . . . . 73.129999999999995 110.168 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.44 143.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.398 0.618 . . . . 75.530000000000001 111.738 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.5 m -101.4 97.35 7.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.329 -0.851 . . . . 75.099999999999994 111.125 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -145.98 -48.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 74.109999999999999 110.749 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.05 131.45 44.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.249 -0.432 . . . . 75.420000000000002 110.441 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -65.94 113.74 4.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 74.129999999999995 109.574 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -123.51 148.39 46.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 72.010000000000005 111.5 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.517 -0.754 . . . . 73.510000000000005 109.18 173.448 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.914 -0.402 . . . . 73.219999999999999 109.914 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.48 146.9 40.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.534 2.156 . . . . 64.349999999999994 111.993 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.438 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -98.09 113.91 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.14 -0.482 . . . . 71.319999999999993 109.824 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -81.06 131.41 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.417 -0.356 . . . . 74.420000000000002 110.47 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 122.24 13.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 75.310000000000002 110.656 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.85 -6.37 0.45 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.596 -0.729 . . . . 73.319999999999993 110.936 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.53 40.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 72.329999999999998 110.997 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -110.76 142.43 42.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.205 -0.452 . . . . 73.140000000000001 110.795 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.508 ' HA ' ' O ' ' A' ' 260' ' ' PRO . . . -84.56 145.74 27.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 75.439999999999998 110.372 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.33 -165.31 14.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.564 -0.826 . . . . 73.040000000000006 112.728 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -129.16 130.26 46.16 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.46 0.304 . . . . 73.340000000000003 110.7 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -171.3 37.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 63.149999999999999 110.851 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -82.36 120.0 24.87 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.181 -0.608 . . . . 74.230000000000004 110.605 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.6 m -162.49 124.61 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 75.049999999999997 109.733 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.64 149.75 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.9 0.381 . . . . 70.040000000000006 110.388 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.19 -175.22 4.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.409 . . . . 72.530000000000001 110.401 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -147.95 110.76 4.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.182 0.515 . . . . 73.219999999999999 111.83 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -145.35 124.58 12.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.948 -0.569 . . . . 74.430000000000007 110.21 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.405 HD21 HD23 ' A' ' 349' ' ' LEU . 4.4 pp -152.11 147.14 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.153 -0.476 . . . . 73.510000000000005 110.064 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.44 152.51 46.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.405 -0.361 . . . . 73.230000000000004 110.306 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -145.25 -166.87 2.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 74.310000000000002 111.434 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 76.11 52.64 0.06 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.981 -1.008 . . . . 74.209999999999994 113.051 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -81.19 174.1 11.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.752 -1.203 . . . . 74.400000000000006 107.752 164.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.67 95.59 5.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.253 0.549 . . . . 73.030000000000001 111.31 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 132.56 31.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.664 -0.698 . . . . 72.040000000000006 109.802 174.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.99 -7.87 60.82 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.725 -0.75 . . . . 73.349999999999994 112.404 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.56 128.64 36.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.824 0.345 . . . . 74.120000000000005 110.914 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.8 mt -86.62 129.0 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 74.310000000000002 110.174 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.476 HG13 ' HB2' ' A' ' 37' ' ' TRP . 29.4 pt -116.26 147.12 19.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 73.219999999999999 110.81 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 35' ' ' LYS . 55.0 m -118.15 125.77 50.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.512 -0.767 . . . . 75.349999999999994 109.6 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 2.2 p-10 -121.27 -164.53 1.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.881 0.372 . . . . 72.439999999999998 111.057 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.884 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 13.8 mmt -68.63 -14.43 63.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.336 -0.393 . . . . 71.239999999999995 111.697 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.453 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -81.7 11.37 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 70.209999999999994 109.78 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 24.4 tptp 92.36 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.034 1.334 . . . . 70.409999999999997 113.285 167.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.986 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 21.2 ptmt 159.59 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.563 0.54 . . . . 74.439999999999998 111.608 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.986 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 38.8 mt-10 82.62 59.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.186 1.18 . . . . 73.400000000000006 114.186 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.476 ' HB2' HG13 ' A' ' 29' ' ' ILE . 40.4 m95 -138.95 151.13 46.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.189 -1.411 . . . . 75.450000000000003 107.189 165.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.681 ' HE3' ' HB3' ' A' ' 56' ' ' MET . 61.0 pttt -154.47 144.47 21.83 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.857 -0.737 . . . . 74.349999999999994 111.24 172.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.81 126.44 25.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.293 -0.867 . . . . 74.439999999999998 110.619 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.68 -60.66 0.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.449 -0.882 . . . . 71.340000000000003 112.355 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 6.6 tt -103.82 120.62 50.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.998 -0.371 . . . . 65.299999999999997 109.998 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.679 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 4.8 Cg_exo -79.0 112.74 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.351 2.701 . . . . 75.129999999999995 111.776 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.755 HG23 ' HG2' ' A' ' 45' ' ' GLN . 49.2 mt -95.48 -57.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.333 -0.394 . . . . 73.25 110.37 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -20.1 22.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.205 -0.522 . . . . 62.340000000000003 113.254 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.755 ' HG2' HG23 ' A' ' 43' ' ' ILE . 12.0 pt20 -111.44 165.01 12.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.006 -0.368 . . . . 75.409999999999997 110.006 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.85 -170.15 26.45 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.693 -0.963 . . . . 72.239999999999995 110.693 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.594 ' HA3' ' CG2' ' A' ' 196' ' ' VAL . . . -81.85 50.38 4.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.752 -0.737 . . . . 61.439999999999998 113.098 -175.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.59 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 4.2 t80 166.5 -37.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.395 0.678 . . . . 74.219999999999999 109.299 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.24 157.2 17.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.031 -0.604 . . . . 65.420000000000002 112.25 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.9 m 65.16 41.37 4.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.131 0.491 . . . . 72.099999999999994 111.349 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.626 HD12 ' HB3' ' A' ' 71' ' ' LYS . 5.2 mm -97.33 138.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.494 -0.558 . . . . 70.099999999999994 109.494 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.679 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 97.7 m-85 -122.32 167.36 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 61.43 111.752 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.572 HD21 ' HB2' ' A' ' 55' ' ' ASP . 3.8 tt -115.16 139.53 49.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.069 -0.514 . . . . 73.430000000000007 109.999 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.499 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -93.1 68.22 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 73.109999999999999 109.763 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.572 ' HB2' HD21 ' A' ' 53' ' ' LEU . 31.7 t70 -89.47 -14.93 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.162 -0.926 . . . . 72.109999999999999 112.041 -169.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.948 ' HE2' ' HA ' ' A' ' 56' ' ' MET . 5.2 mmt -95.05 -0.71 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.446 0.536 . . . . 75.340000000000003 112.446 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.35 80.2 1.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.481 0.658 . . . . 75.420000000000002 110.503 177.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -124.9 104.23 8.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.706 -0.679 . . . . 71.349999999999994 110.707 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.8 m -107.31 125.34 51.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.261 -0.427 . . . . 71.439999999999998 110.067 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 62.83 35.22 13.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.264 0.554 . . . . 75.019999999999996 110.476 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.3 m 59.15 27.89 17.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.643 -0.708 . . . . 75.030000000000001 111.267 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.73 129.19 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.191 0.52 . . . . 75.150000000000006 111.412 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.94 24.67 30.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.066 -0.588 . . . . 55.130000000000003 113.012 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 p -117.46 -54.43 2.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.796 0.298 . . . . 74.420000000000002 111.212 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.7 -28.0 63.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 72.439999999999998 112.148 -173.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.628 ' HB2' ' HD3' ' A' ' 67' ' ' PRO . . . -72.95 -50.12 7.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 111.839 0.311 . . . . 75.310000000000002 111.839 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.628 ' HD3' ' HB2' ' A' ' 66' ' ' ALA . 10.7 Cg_exo -73.58 43.94 0.84 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.573 2.182 . . . . 74.209999999999994 112.814 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.0 m -117.31 142.35 47.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.754 0.311 . . . . 71.140000000000001 110.326 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.418 HG11 ' HG ' ' A' ' 53' ' ' LEU . 31.7 m -117.15 158.74 17.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 75.25 109.831 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.51 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.1 p -137.72 126.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.326 0.584 . . . . 75.299999999999997 111.664 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.626 ' HB3' HD12 ' A' ' 51' ' ' ILE . 46.7 pttt -98.81 136.26 39.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.398 -0.819 . . . . 73.439999999999998 109.132 174.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.447 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 8.4 p -137.21 138.2 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.568 0.581 . . . . 72.049999999999997 112.568 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.506 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 27.0 mt-10 -123.1 163.76 31.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.598 -0.728 . . . . 73.400000000000006 109.05 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.75 -177.07 1.11 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.328 2.019 . . . . 73.129999999999995 111.918 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.1 t -76.83 11.72 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.772 0.32 . . . . 71.349999999999994 111.696 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.81 -40.51 92.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 73.409999999999997 109.739 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . 0.5 ' OD1' ' HB2' ' A' ' 81' ' ' PHE . 64.0 t30 60.7 83.02 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.06 -0.973 . . . . 63.350000000000001 111.468 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.51 -83.05 0.18 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.647 -0.787 . . . . 73.129999999999995 111.719 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.86 -44.38 16.63 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.683 2.255 . . . . 74.439999999999998 111.624 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.506 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.93 -34.9 73.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.454 -0.339 . . . . 71.120000000000005 110.405 177.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.5 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 74.7 t80 -63.57 -47.76 80.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.043 0.449 . . . . 73.420000000000002 110.257 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.0 m -65.54 -42.63 91.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.66 -0.7 . . . . 73.209999999999994 110.074 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.85 -43.7 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.23 -0.895 . . . . 74.340000000000003 110.54 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 46.4 tp -55.83 -47.35 77.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.736 -0.666 . . . . 71.409999999999997 110.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.721 ' HE2' ' HA ' ' A' ' 85' ' ' LYS . 11.1 mmpt? -60.47 -41.76 94.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.340000000000003 110.46 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.98 -44.44 94.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.799 -0.637 . . . . 75.019999999999996 110.814 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.612 ' HD2' ' HB2' ' A' ' 113' ' ' TYR . 18.9 m-85 -70.55 -39.61 73.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.824 0.305 . . . . 73.400000000000006 111.824 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.534 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 81.5 mm-40 -68.02 -18.31 64.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.038 0.447 . . . . 61.549999999999997 110.5 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.561 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -96.72 -70.49 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 74.439999999999998 111.634 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.651 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -83.89 -34.48 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.274 0.842 . . . . 70.129999999999995 113.274 -170.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.34 79.36 3.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.377 0.608 . . . . 74.049999999999997 112.16 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.687 ' HZ1' ' HB2' ' A' ' 92' ' ' LYS . 0.1 OUTLIER -154.24 116.33 2.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.845 -0.798 . . . . 75.129999999999995 108.845 176.361 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -52.05 -54.02 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.333 2.688 . . . . 75.140000000000001 114.067 -170.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 1.2 pp20? -72.95 -28.34 62.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.845 0.355 . . . . 72.25 110.624 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.452 ' CB ' ' HB3' ' A' ' 92' ' ' LYS . 3.6 tp-100 -67.81 -48.99 64.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.458 -0.571 . . . . 72.530000000000001 109.458 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.461 HG21 HD12 ' A' ' 108' ' ' LEU . 81.5 mt -57.19 -53.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.603 -0.726 . . . . 75.430000000000007 110.434 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.02 -40.05 66.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.429 -0.805 . . . . 75.329999999999998 110.611 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 18.5 ttpt -67.24 -59.47 3.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.25 -0.886 . . . . 72.109999999999999 111.482 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.651 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 1.3 p90 -68.44 -34.03 75.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 120.474 -0.49 . . . . 74.510000000000005 110.833 -176.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.634 HG13 ' HB2' ' A' ' 105' ' ' LEU . 2.9 tp -72.1 -29.09 31.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.885 0.374 . . . . 74.439999999999998 110.032 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -65.52 -47.34 76.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.736 -0.665 . . . . 65.0 109.778 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -74.66 -19.01 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 73.420000000000002 111.447 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 104' ' ' LYS . 17.9 tpt180 -79.44 -18.45 52.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.152 -0.476 . . . . 75.549999999999997 110.538 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 103' ' ' ARG . 63.5 mttm 71.44 28.32 2.92 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.777 0.673 . . . . 75.030000000000001 111.197 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.634 ' HB2' HG13 ' A' ' 100' ' ' ILE . 46.7 mt -100.0 -170.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 75.329999999999998 110.432 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.408 ' HG3' ' HB2' ' A' ' 107' ' ' TYR . 24.7 pttm -119.58 -34.91 3.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.514 0.561 . . . . 75.310000000000002 112.514 -172.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.408 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -150.03 179.27 8.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.926 0.393 . . . . 75.140000000000001 110.758 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.487 HD21 HG22 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -162.16 127.96 3.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.799 -0.815 . . . . 73.109999999999999 108.799 170.3 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.535 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.53 59.67 4.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.822 -0.704 . . . . 63.399999999999999 112.625 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.487 HG22 HD21 ' A' ' 108' ' ' LEU . 88.5 t -116.83 122.51 31.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.977 -0.379 . . . . 72.230000000000004 109.977 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.583 ' HG2' ' HH ' ' A' ' 87' ' ' TYR . 18.0 Cg_exo -66.19 149.32 85.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.884 2.389 . . . . 74.219999999999999 113.07 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.628 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.6 tptm -65.07 117.59 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 74.420000000000002 110.561 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.612 ' HB2' ' HD2' ' A' ' 87' ' ' TYR . 61.2 t80 -89.03 123.03 32.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.342 -0.845 . . . . 75.329999999999998 110.121 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -96.4 -67.01 0.87 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.286 -0.635 . . . . 74.439999999999998 109.286 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . 0.412 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -155.36 -178.13 29.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.423 -0.808 . . . . 75.340000000000003 112.144 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.6 p -164.73 163.7 21.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 55.240000000000002 109.046 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.26 -168.74 36.84 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.738 -1.22 . . . . 74.219999999999999 113.118 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.17 127.28 31.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.534 -0.543 . . . . 73.400000000000006 109.534 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -123.46 109.94 14.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.945 -0.571 . . . . 75.230000000000004 110.637 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.876 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 13.8 t70 -75.7 118.79 18.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.426 -0.583 . . . . 71.230000000000004 109.426 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.689 ' HG2' HD21 ' A' ' 122' ' ' ASN . 87.2 tttt -105.66 94.67 5.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.391 -0.368 . . . . 75.230000000000004 111.03 -174.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.689 HD21 ' HG2' ' A' ' 121' ' ' LYS . 44.6 m-80 71.51 -41.78 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.548 0.739 . . . . 72.409999999999997 112.846 173.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.89 -38.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.637 -0.792 . . . . 75.040000000000006 112.708 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.31 143.54 45.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.896 0.379 . . . . 72.209999999999994 110.114 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.876 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.0 p -94.62 149.16 21.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.150000000000006 112.134 -174.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.447 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 67.4 m-85 -115.57 145.28 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 73.510000000000005 109.968 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -112.45 120.46 41.72 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.01 -0.737 . . . . 74.329999999999998 109.01 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.51 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -124.87 162.93 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 74.530000000000001 112.042 -170.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.8 ttm -144.88 136.95 25.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 71.109999999999999 110.695 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.503 HD12 ' HB ' ' A' ' 70' ' ' VAL . 7.2 mm -97.45 127.78 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 74.329999999999998 111.021 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 71.1 mtp -121.28 164.2 17.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.526 -0.761 . . . . 74.450000000000003 110.426 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.628 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 25.5 t70 -81.26 98.35 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.219 -0.446 . . . . 73.010000000000005 111.306 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.441 ' HG2' ' C ' ' A' ' 132' ' ' ASP . 3.7 ptt180 29.71 95.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.411 1.634 . . . . 74.340000000000003 115.411 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.32 151.88 26.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 73.340000000000003 109.444 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.767 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -165.73 -15.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.38 -1.391 . . . . 74.230000000000004 114.967 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.707 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.7 m -120.65 124.7 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.274 1.037 . . . . 71.439999999999998 111.682 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 140' ' ' LYS . 1.3 m-20 -101.29 131.05 47.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.855 -0.794 . . . . 73.319999999999993 108.855 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.558 ' HB3' ' HB3' ' A' ' 180' ' ' ALA . 4.9 mp -61.48 -36.91 81.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 74.319999999999993 110.856 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.684 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 27.2 pt20 -58.79 -47.92 83.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.455 0.539 . . . . 74.0 112.455 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.504 ' HG2' ' HB2' ' A' ' 137' ' ' ASP . 20.3 ptmt -70.29 -34.85 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 75.430000000000007 110.783 -175.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.501 HD13 HD21 ' A' ' 341' ' ' LEU . 17.1 mt -75.05 -39.77 44.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 75.340000000000003 110.515 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.684 ' CE1' ' HB3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -62.44 -43.44 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 73.120000000000005 111.957 -175.286 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.86 -40.6 83.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.185 -0.606 . . . . 72.040000000000006 110.601 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.89 -31.75 70.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 74.510000000000005 111.136 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -88.78 5.66 42.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 73.109999999999999 110.392 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 61.4 41.28 13.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.466 -0.788 . . . . 72.400000000000006 112.216 176.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.684 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER 41.75 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.935 0.894 . . . . 74.230000000000004 112.668 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 11.6 ttp180 -153.78 93.5 1.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.038 -0.983 . . . . 75.109999999999999 109.975 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HD2' HG21 ' A' ' 153' ' ' THR . 85.0 m-85 -112.6 137.74 50.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 74.040000000000006 110.001 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.6 p -73.31 168.85 18.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.375 -0.375 . . . . 52.340000000000003 110.978 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.523 ' HB3' HD12 ' A' ' 328' ' ' LEU . 81.8 mtt180 -55.03 -37.06 66.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.913 -0.585 . . . . 75.519999999999996 110.725 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -60.65 -42.94 97.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.352 -0.84 . . . . 73.319999999999993 110.572 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.67 HG21 ' HD2' ' A' ' 149' ' ' PHE . 10.2 m -71.76 -52.23 18.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.5 -0.773 . . . . 61.420000000000002 111.303 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.82 -42.82 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.409999999999997 110.966 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.546 HD22 ' HG ' ' A' ' 328' ' ' LEU . 16.9 tp -65.61 -49.47 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 73.019999999999996 110.575 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.482 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 20.8 mm-40 -58.97 -47.74 84.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.923 0.342 . . . . 72.310000000000002 111.923 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.87 -43.92 97.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.472 -0.331 . . . . 73.239999999999995 110.892 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t -62.33 -43.04 99.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.150000000000006 110.355 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 82.3 mt -61.45 -39.9 92.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.242 -0.436 . . . . 74.400000000000006 111.262 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 81.6 mmt-85 -62.73 -49.15 76.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.017 0.437 . . . . 73.310000000000002 110.378 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.56 -30.31 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 74.329999999999998 110.681 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -47.42 86.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 70.109999999999999 110.569 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.46 -42.23 99.32 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.59 0.71 . . . . 65.120000000000005 110.097 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 168' ' ' ILE . 61.3 mt -61.44 -46.44 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.225 -0.898 . . . . 65.439999999999998 110.74 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.43 ' HG ' ' HE1' ' A' ' 317' ' ' TYR . 64.4 tp -57.69 -39.03 76.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 74.540000000000006 110.803 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.457 ' CD ' HH21 ' A' ' 103' ' ' ARG . 2.0 mm-40 -56.13 -65.81 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.767 -0.652 . . . . 75.219999999999999 110.476 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.414 ' HE2' ' HB1' ' A' ' 90' ' ' ALA . 82.2 t80 -63.27 -49.47 73.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.626 -0.715 . . . . 75.430000000000007 112.861 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 164' ' ' ILE . 30.7 pt -79.46 -32.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.293 -0.563 . . . . 75.120000000000005 112.249 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.768 ' HE1' HG13 ' A' ' 174' ' ' VAL . 2.8 t60 -88.21 -18.19 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.038 -0.665 . . . . 74.310000000000002 111.117 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -86.88 21.96 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.907 0.861 . . . . 70.310000000000002 109.018 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -131.03 -79.37 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.475 -0.784 . . . . 74.540000000000006 111.137 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.713 ' HG2' ' H ' ' A' ' 207' ' ' GLU . 32.3 mt-10 -147.46 -46.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 74.200000000000003 111.977 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.96 137.63 35.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.709 . . . . 74.450000000000003 112.821 -161.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.768 HG13 ' HE1' ' A' ' 169' ' ' HIS . 33.2 m -106.69 170.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.942 -1.026 . . . . 74.420000000000002 109.729 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.727 ' HB3' ' HD2' ' A' ' 198' ' ' TYR . 1.8 p-80 -147.62 103.23 3.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.205 0.526 . . . . 70.030000000000001 111.188 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 -28.36 15.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.628 -0.796 . . . . 51.299999999999997 111.989 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.521 ' HB3' ' HA3' ' A' ' 199' ' ' GLY . 5.7 t0 -112.94 93.78 4.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.913 0.387 . . . . 74.010000000000005 110.059 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 64.8 mt -92.28 -73.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.22 -0.659 . . . . 73.109999999999999 109.22 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.513 ' HG3' ' H ' ' A' ' 180' ' ' ALA . 6.3 tptm 50.76 -139.25 0.94 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.572 -0.529 . . . . 74.219999999999999 109.572 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.558 ' HB3' ' HB3' ' A' ' 138' ' ' LEU . . . -120.84 -3.58 9.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.408 0.623 . . . . 74.420000000000002 109.408 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.684 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 39.7 m -77.88 -27.68 49.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.419 -0.81 . . . . 73.0 112.044 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 76.7 m-20 -104.51 6.31 34.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.444 -0.503 . . . . 74.209999999999994 111.558 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.72 120.17 40.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.651 . . . . 73.340000000000003 109.721 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 47' ' ' GLY . 66.0 mt -120.59 143.67 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.004 -0.544 . . . . 74.310000000000002 110.834 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.707 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.8 mt -92.5 141.4 28.55 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.334 -0.617 . . . . 63.219999999999999 109.334 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.5 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 25.4 t-20 -60.55 139.19 57.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.446 -0.946 . . . . 73.099999999999994 108.446 171.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.767 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 71.7 t80 -57.36 -30.52 64.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.718 0.266 . . . . 75.140000000000001 111.718 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.444 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 83.1 tttt -116.15 -30.52 5.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.48 -0.488 . . . . 74.420000000000002 111.799 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.487 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 85.2 m-20 -99.46 101.87 14.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.793 0.33 . . . . 73.540000000000006 110.888 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 10.2 Cg_exo -71.78 -25.81 19.88 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.995 2.463 . . . . 64.019999999999996 113.387 -174.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.495 ' HA ' HD22 ' A' ' 339' ' ' LEU . 1.0 OUTLIER -83.69 -4.94 59.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.024 0.44 . . . . 72.430000000000007 111.18 -174.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -108.62 97.1 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.386 0.612 . . . . 73.450000000000003 110.449 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.411 HG11 ' HG3' ' A' ' 160' ' ' ARG . 7.9 p -103.38 130.87 53.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.255 -0.884 . . . . 73.200000000000003 109.23 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.5 ' HE2' ' HB2' ' A' ' 186' ' ' ASN . 41.9 m-85 -115.72 155.45 27.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.004 -0.544 . . . . 72.510000000000005 110.189 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 2.9 tt -120.52 122.7 41.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.407 -0.59 . . . . 74.420000000000002 109.407 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.594 ' CG2' ' HA3' ' A' ' 47' ' ' GLY . 16.5 m -129.17 166.95 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 74.430000000000007 110.58 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.0 t70 68.97 -57.9 0.51 Allowed 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.984 0.803 . . . . 74.200000000000003 111.842 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.799 ' HB2' ' HB2' ' A' ' 201' ' ' ALA . 93.7 m-85 75.79 5.37 3.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.606 0.762 . . . . 73.230000000000004 112.052 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.521 ' HA3' ' HB3' ' A' ' 177' ' ' ASP . . . 82.48 -38.77 2.63 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.37 -0.443 . . . . 65.219999999999999 112.946 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.768 ' HA ' ' HA ' ' A' ' 354' ' ' ILE . 1.1 pp -164.38 40.05 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.3 0.24 . . . . 72.439999999999998 110.882 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.799 ' HB2' ' HB2' ' A' ' 198' ' ' TYR . . . -53.21 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.549 0.69 . . . . 74.400000000000006 111.761 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -123.4 133.58 54.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 74.230000000000004 108.649 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.489 ' HB2' ' HB3' ' A' ' 172' ' ' GLU . 10.9 ptp180 -77.71 109.74 11.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.324 0.583 . . . . 74.209999999999994 109.918 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.57 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 2.9 t80 -66.83 -46.18 75.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.774 . . . . 74.439999999999998 110.305 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.995 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 54.6 m -142.42 140.06 18.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.843 -0.799 . . . . 73.349999999999994 108.843 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 14.4 Cg_exo -68.1 98.04 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.381 2.054 . . . . 73.239999999999995 112.151 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.713 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 33.6 tt0 73.91 -54.7 0.68 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.961 -1.018 . . . . 61.219999999999999 111.761 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.11 65.8 2.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.948 -0.644 . . . . 42.439999999999998 112.534 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.995 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 7.6 p -58.54 112.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.639 0.733 . . . . 75.319999999999993 112.411 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -169.45 72.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.374 -0.83 . . . . 74.099999999999994 110.575 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -126.15 150.59 48.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 73.319999999999993 110.095 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.39 171.64 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.5 -0.318 . . . . 74.540000000000006 110.82 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.894 ' HB2' HG23 ' A' ' 236' ' ' VAL . 16.2 p90 -74.54 92.1 2.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.372 0.606 . . . . 74.409999999999997 112.517 -168.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 67.5 mmtt -152.64 104.96 2.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.939 -0.573 . . . . 74.140000000000001 110.315 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 68.6 mm-40 -136.42 -155.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 74.010000000000005 109.855 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 10.7 t70 -85.58 115.31 61.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.913 -0.403 . . . . 72.510000000000005 109.913 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . 0.779 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 28.0 Cg_exo -62.84 0.28 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.688 2.926 . . . . 62.149999999999999 114.272 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.472 ' HB2' ' HZ2' ' A' ' 218' ' ' LYS . 0.9 OUTLIER -134.22 -48.3 0.78 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.058 -0.401 . . . . 74.340000000000003 110.98 177.944 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -84.28 43.41 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 73.030000000000001 111.732 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.553 ' HB3' ' HA2' ' A' ' 235' ' ' GLY . 41.8 t -131.63 3.08 4.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 70.420000000000002 108.864 170.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.7 8.35 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 72.540000000000006 110.739 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.14 9.34 17.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 75.150000000000006 113.065 -167.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -97.68 164.31 21.86 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.986 -1.246 . . . . 52.340000000000003 109.986 169.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.513 ' OG1' ' HG2' ' A' ' 226' ' ' GLU . 14.9 t -68.74 113.15 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.1 0.95 . . . . 74.109999999999999 110.069 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.57 HG12 HG13 ' A' ' 271' ' ' VAL . 15.5 tt -57.24 -21.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.043 -0.981 . . . . 61.240000000000002 111.831 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.513 ' HG2' ' OG1' ' A' ' 224' ' ' THR . 17.1 pt-20 -60.12 -44.69 94.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 75.209999999999994 110.489 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.603 ' HB3' HG22 ' A' ' 246' ' ' ILE . 9.3 m-30 -109.53 -34.67 6.44 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.635 0.606 . . . . 74.299999999999997 112.635 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 7.4 t -70.9 14.15 0.16 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.543 0.572 . . . . 74.040000000000006 112.543 -171.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.444 ' H ' ' C ' ' A' ' 227' ' ' PHE . 33.3 t 66.52 -177.23 0.2 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.659 0.743 . . . . 73.409999999999997 111.863 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.43 ' HA ' ' CD2' ' A' ' 233' ' ' HIS . 42.3 mt -72.35 -35.15 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.067 -0.97 . . . . 72.129999999999995 110.081 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.486 ' HB3' HG13 ' A' ' 236' ' ' VAL . 4.1 m-20 -49.9 -56.35 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.64 -1.164 . . . . 72.400000000000006 112.334 -174.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -58.26 -49.69 76.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.473 0.546 . . . . 74.409999999999997 112.473 -174.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 230' ' ' ILE . 12.0 p80 -70.82 -16.39 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.546 -0.461 . . . . 75.120000000000005 110.61 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.51 -21.22 45.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 73.409999999999997 109.909 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.779 ' HA3' ' HA ' ' A' ' 217' ' ' PRO . . . 111.17 20.07 7.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.776 -0.726 . . . . 64.310000000000002 113.617 175.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.894 HG23 ' HB2' ' A' ' 213' ' ' TYR . 7.3 p -122.17 136.41 59.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.333 -0.51 . . . . 73.230000000000004 110.966 175.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.57 ' HB3' ' CE1' ' A' ' 204' ' ' TYR . . . -64.46 125.83 89.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 73.349999999999994 110.977 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_exo -60.6 130.57 34.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.922 2.415 . . . . 73.109999999999999 112.065 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.484 ' HB2' ' HD2' ' A' ' 240' ' ' ARG . 21.9 p -153.21 154.22 34.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.165 -0.47 . . . . 62.32 110.837 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.484 ' HD2' ' HB2' ' A' ' 239' ' ' SER . 4.1 mpt_? 57.09 -100.5 0.11 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.508 0.723 . . . . 75.319999999999993 111.23 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 6.7 ttp-105 -64.19 -32.09 73.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.031 -0.531 . . . . 73.030000000000001 110.282 -177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.605 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.5 -57.17 21.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.927 -0.654 . . . . 73.310000000000002 112.026 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.401 ' OD1' ' HA ' ' A' ' 239' ' ' SER . 4.5 m-20 -57.15 -42.48 81.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 72.239999999999995 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.507 HD21 HG12 ' A' ' 306' ' ' VAL . 9.7 mp -61.28 -42.78 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.947 -0.57 . . . . 75.230000000000004 111.106 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -69.22 -37.68 78.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 55.219999999999999 110.795 -179.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.605 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.9 mt -62.47 -41.93 93.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.919 0.39 . . . . 71.420000000000002 110.473 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.508 HD13 ' SG ' ' A' ' 250' ' ' CYS . 52.8 tp -60.06 -40.41 89.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.97 -0.559 . . . . 73.5 110.436 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.45 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.03 -40.68 97.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.5 -0.857 . . . . 64.120000000000005 111.903 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.472 ' HD2' ' HA ' ' A' ' 227' ' ' PHE . 22.1 m-30 -65.6 -41.14 93.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.89 0.329 . . . . 72.030000000000001 111.89 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.508 ' SG ' HD13 ' A' ' 247' ' ' LEU . 26.4 p -69.06 -34.37 75.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.007 -0.677 . . . . 73.5 110.543 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -66.89 -39.82 87.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.59 -0.277 . . . . 75.010000000000005 111.401 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.547 HD11 ' HE3' ' A' ' 286' ' ' MET . 3.8 tt -69.62 -34.32 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.459 -0.497 . . . . 72.310000000000002 110.67 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.923 HE21 ' HG ' ' A' ' 259' ' ' LEU . 16.1 mm-40 -68.1 -32.6 73.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.637 0.256 . . . . 64.439999999999998 111.402 176.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -75.98 -38.1 57.8 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 74.439999999999998 111.184 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.3 tp -80.54 -48.04 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.17 0.433 . . . . 72.129999999999995 112.17 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 58.9 p -109.66 -27.67 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.16 0.505 . . . . 72.239999999999995 111.143 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.46 ' HA3' ' HG3' ' A' ' 147' ' ' LYS . . . 68.32 34.95 81.34 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.450000000000003 112.906 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.09 142.84 34.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 72.239999999999995 110.903 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.923 ' HG ' HE21 ' A' ' 253' ' ' GLN . 88.6 mt -117.71 142.62 30.93 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.841 -0.618 . . . . 63.119999999999997 109.694 170.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.508 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 25.4 Cg_exo -63.94 -49.43 3.98 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 122.379 2.053 . . . . 73.329999999999998 111.138 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.417 ' HD1' HD23 ' A' ' 265' ' ' LEU . 30.7 p90 -82.94 25.58 0.67 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 72.430000000000007 111.142 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 259' ' ' LEU . 23.0 tt0 -68.37 -48.47 64.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 73.540000000000006 111.413 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.7 -32.74 71.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.19 0.519 . . . . 72.299999999999997 110.884 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -107.23 22.25 16.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.868 -0.605 . . . . 73.530000000000001 111.06 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.468 ' O ' HD13 ' A' ' 265' ' ' LEU . 3.0 tm? -61.33 -24.02 66.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.764 0.792 . . . . 75.5 109.706 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -68.13 -15.82 63.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.7 -1.137 . . . . 74.239999999999995 112.064 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.709 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 9.0 t0 -125.78 122.66 24.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.887 0.375 . . . . 64.049999999999997 110.638 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.71 -24.04 77.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.295 2.663 . . . . 74.310000000000002 113.82 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.5 -48.32 72.97 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.165 0.507 . . . . 74.510000000000005 109.952 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.709 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 97.4 m-85 -67.33 -38.69 85.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.361 -0.836 . . . . 72.219999999999999 110.595 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.57 HG13 HG12 ' A' ' 225' ' ' ILE . 59.1 t -57.28 -49.77 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 73.010000000000005 110.204 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.433 ' O ' HG13 ' A' ' 276' ' ' ILE . 16.7 ttp180 -57.66 -54.42 47.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 74.349999999999994 110.428 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.95 -48.59 78.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.037 -0.983 . . . . 74.530000000000001 111.935 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.7 t -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.398 -0.365 . . . . 73.439999999999998 111.237 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 96.4 mttt -70.35 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.746 -0.381 . . . . 75.239999999999995 110.629 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.433 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.6 mt -64.76 -38.5 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.037 0.446 . . . . 72.129999999999995 110.007 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.07 -45.71 79.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.623 -0.717 . . . . 74.299999999999997 110.963 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -76.09 -32.42 59.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.957 -0.297 . . . . 73.439999999999998 111.706 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' A' ' 275' ' ' LYS . 99.6 mtt180 -60.18 -23.41 63.95 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.581 0.229 . . . . 72.340000000000003 110.771 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -50.32 -53.58 27.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.793 -0.64 . . . . 72.510000000000005 110.412 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -170.11 99.41 0.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 65.400000000000006 109.615 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.21 -34.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 75.200000000000003 110.743 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.595 ' HA ' ' HB2' ' A' ' 300' ' ' ALA . . . -60.08 -46.75 88.54 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.6 0.593 . . . . 73.010000000000005 112.6 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 15.8 m -60.26 -48.75 80.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.228 0.537 . . . . 73.230000000000004 110.993 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.21 -50.21 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 73.019999999999996 111.204 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.547 ' HE3' HD11 ' A' ' 252' ' ' ILE . 23.6 mmt -60.22 -45.08 94.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 75.099999999999994 111.486 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.17 -31.94 73.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 75.010000000000005 111.425 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -82.62 -13.21 56.89 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.717 0.294 . . . . 75.549999999999997 111.444 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 92.0 m -78.64 -69.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.796 0.295 . . . . 72.549999999999997 111.796 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.414 ' HB3' ' H ' ' A' ' 294' ' ' ASN . 39.2 m-85 -125.29 90.78 50.24 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 112.112 0.412 . . . . 74.010000000000005 112.112 -173.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -92.49 1.1 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.665 2.243 . . . . 75.030000000000001 112.105 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.89 -69.46 0.45 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.944 -0.571 . . . . 74.409999999999997 111.307 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.71 ' HB3' ' HZ3' ' A' ' 293' ' ' LYS . 3.1 mmmp? -49.56 -61.97 1.81 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.773 -0.649 . . . . 75.040000000000006 111.655 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.414 ' H ' ' HB3' ' A' ' 290' ' ' PHE . 15.8 m120 -113.54 -155.72 0.58 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.997 -0.742 . . . . 70.219999999999999 108.997 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.68 ' HE3' HG22 ' A' ' 331' ' ' ILE . 26.7 tptp -164.97 87.24 1.04 Allowed Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.774 0.321 . . . . 74.400000000000006 110.154 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -100.64 37.29 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.11 2.54 . . . . 73.530000000000001 112.171 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.02 -37.74 7.1 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.495 -0.859 . . . . 74.239999999999995 111.072 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.646 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 20.9 mp0 -66.95 -47.12 72.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.762 -0.829 . . . . 75.310000000000002 108.762 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.8 mp -59.09 -38.96 77.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 114.863 -1.062 . . . . 74.109999999999999 110.363 173.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . 0.595 ' HB2' ' HA ' ' A' ' 283' ' ' ALA . . . -59.57 -50.25 74.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.532 -0.304 . . . . 71.340000000000003 111.208 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.1 -43.18 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.150000000000006 110.107 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.439 ' CE1' HD23 ' A' ' 320' ' ' LEU . 87.7 t80 -56.92 -47.08 81.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.412 -0.813 . . . . 74.5 111.203 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.511 ' HA ' HG23 ' A' ' 306' ' ' VAL . 93.8 mmm -68.2 -41.85 80.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 72.430000000000007 111.568 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -60.21 -40.55 90.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 64.140000000000001 109.77 175.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.471 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 98.4 m -60.28 -50.15 74.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.322 -0.854 . . . . 74.150000000000006 111.296 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.511 HG23 ' HA ' ' A' ' 303' ' ' MET . 19.8 m -70.67 -33.99 55.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.842 0.312 . . . . 73.549999999999997 111.842 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -21.12 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.454 -0.498 . . . . 73.239999999999995 110.312 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.9 tp -81.49 -5.3 57.82 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.158 -0.474 . . . . 74.030000000000001 110.968 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.471 ' HG ' ' O ' ' A' ' 305' ' ' THR . 90.1 mt -91.17 6.61 44.39 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.776 0.287 . . . . 71.310000000000002 111.776 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.555 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 24.3 t70 61.45 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.705 0.628 . . . . 71.409999999999997 111.961 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 -52.12 0.31 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.121 -0.491 . . . . 74.5 110.179 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.2 t -149.12 29.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.765 -0.652 . . . . 73.409999999999997 110.761 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.555 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 42.6 mm-40 -51.89 -62.87 1.36 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.45 -0.341 . . . . 75.409999999999997 111.028 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -171.12 102.27 0.4 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.502 -0.317 . . . . 73.340000000000003 110.398 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.4 118.85 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.538 2.159 . . . . 71.540000000000006 111.576 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.606 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.3 mt -114.33 92.83 4.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.453 -0.34 . . . . 74.049999999999997 111.354 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.43 ' HE1' ' HG ' ' A' ' 165' ' ' LEU . 97.5 m-85 -57.66 -34.07 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.164 0.507 . . . . 75.299999999999997 110.084 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.37 -55.33 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.055 -0.975 . . . . 61.43 111.027 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.97 -41.55 95.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 74.109999999999999 110.969 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 67.3 mt -56.96 -53.3 59.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.208 -0.451 . . . . 72.099999999999994 111.32 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.501 ' HG3' ' N ' ' A' ' 322' ' ' ASP . 11.0 ptt180 -65.26 -36.53 84.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.928 0.394 . . . . 72.439999999999998 110.207 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . 0.501 ' N ' ' HG3' ' A' ' 321' ' ' ARG . 30.0 t70 -68.23 -51.21 47.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.819 -0.628 . . . . 74.430000000000007 111.63 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.88 -31.23 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.924 -0.311 . . . . 73.510000000000005 111.14 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.41 -48.87 59.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.372 -0.376 . . . . 74.219999999999999 110.571 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -39.88 83.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 72.519999999999996 110.046 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.23 -48.43 81.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 74.310000000000002 111.197 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.646 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.36 -46.15 91.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 72.519999999999996 112.085 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.546 ' HG ' HD22 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -60.96 -45.21 95.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 74.409999999999997 110.841 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -70.25 -26.91 64.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.016 0.436 . . . . 73.310000000000002 110.583 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.24 -29.28 63.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 73.319999999999993 111.537 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.68 HG22 ' HE3' ' A' ' 295' ' ' LYS . 32.6 pt -90.19 -5.51 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 73.510000000000005 111.063 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 91.58 23.91 27.34 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.782 -0.723 . . . . 73.420000000000002 113.405 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -127.22 138.53 53.13 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.438 -0.448 . . . . 73.319999999999993 110.373 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . 0.534 ' HB3' ' HZ3' ' A' ' 334' ' ' LYS . 9.9 mtpm? -138.66 -113.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.329 . . . . 73.340000000000003 111.647 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -159.73 113.93 2.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.507 0.67 . . . . 74.099999999999994 111.578 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.6 156.04 4.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.851 -1.068 . . . . 65.030000000000001 109.263 172.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.33 50.74 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.288 -0.725 . . . . 63.240000000000002 111.288 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 59.09 66.31 1.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.173 -0.514 . . . . 72.239999999999995 110.701 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.528 HD13 HG22 ' A' ' 153' ' ' THR . 4.2 mm? 68.1 -171.54 0.19 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.059 -0.973 . . . . 75.519999999999996 111.352 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -122.78 17.7 10.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.736 0.779 . . . . 70.310000000000002 108.904 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.501 HD21 HD13 ' A' ' 141' ' ' ILE . 6.1 tt -125.68 108.37 11.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.384 -0.825 . . . . 73.519999999999996 110.839 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.1 m -143.45 16.74 1.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.812 -0.631 . . . . 74.439999999999998 109.775 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.08 -34.93 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 75.430000000000007 112.323 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.5 t 54.89 91.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.122 0.487 . . . . 73.450000000000003 111.411 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.32 168.85 12.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.456 -0.338 . . . . 60.200000000000003 110.969 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -136.98 143.49 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 74.219999999999999 110.531 -176.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -161.26 -77.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.101 -0.571 . . . . 54.009999999999998 111.717 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -130.83 166.31 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.034 -0.603 . . . . 74.219999999999999 111.63 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.405 HD23 HD21 ' A' ' 19' ' ' LEU . 2.6 pt? -165.25 141.59 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.912 0.387 . . . . 75.120000000000005 110.486 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -125.06 165.42 18.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 74.209999999999994 110.258 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.75 46.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.124 -0.695 . . . . 75.510000000000005 109.124 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.454 ' HG3' ' H ' ' A' ' 353' ' ' THR . 12.8 tptp -143.44 -157.14 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.821 -0.437 . . . . 71.519999999999996 109.821 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' THR . . . . . 0.454 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 14.8 t -173.48 156.27 2.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.376 -0.602 . . . . 75.040000000000006 109.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.768 ' HA ' ' HA ' ' A' ' 200' ' ' LEU . 0.2 OUTLIER -67.43 131.81 32.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.097 0.475 . . . . 71.319999999999993 111.204 -176.322 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 355' ' ' THR . 7.6 t -78.61 85.29 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.182 0.992 . . . . 63.43 110.752 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . 0.442 ' HB2' ' HZ3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -109.25 -29.4 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.534 -0.757 . . . . 74.530000000000001 110.499 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.41 ' HZ1' ' C ' ' A' ' 360' ' ' LYS . 61.3 tttm 172.23 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 108.529 -0.915 . . . . 74.140000000000001 108.529 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 54.8 ttm-85 173.1 -64.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.477 -1.238 . . . . 74.109999999999999 108.413 176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 360' ' ' LYS . 49.1 pttt -178.09 -38.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.578 -1.192 . . . . 74.310000000000002 108.084 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.535 ' HG2' ' HG3' ' A' ' 359' ' ' LYS . 29.9 mmmt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.746 -1.121 . . . . 73.310000000000002 108.489 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.252 -0.277 . . . . 72.209999999999994 110.252 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.93 138.55 44.66 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.393 2.062 . . . . 64.0 111.981 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -134.5 140.35 46.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 74.120000000000005 110.259 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.5 t -85.6 98.69 6.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.24 0.543 . . . . 73.120000000000005 110.496 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -114.66 130.18 56.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.504 -0.771 . . . . 71.099999999999994 109.753 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.7 149.03 31.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 74.549999999999997 110.949 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.4 84.56 2.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.908 -0.587 . . . . 65.120000000000005 110.29 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -77.41 133.58 38.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.105 -0.498 . . . . 73.310000000000002 109.911 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.15 136.31 47.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.332 -0.395 . . . . 74.340000000000003 110.855 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.69 119.49 4.94 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.115 -0.794 . . . . 54.030000000000001 111.115 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -97.56 -171.38 2.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 64.540000000000006 110.933 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -124.22 145.22 49.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.0 -0.546 . . . . 71.109999999999999 110.028 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -97.59 122.74 41.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.41 -0.359 . . . . 74.140000000000001 110.616 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -123.28 31.37 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.084 0.468 . . . . 72.219999999999999 111.097 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.56 89.36 3.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.162 0.506 . . . . 72.510000000000005 110.275 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.439 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 35.7 ttpt -97.41 94.3 6.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.89 -0.596 . . . . 74.519999999999996 110.741 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -177.24 140.89 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 74.129999999999995 110.82 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -121.09 28.32 7.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.851 -0.796 . . . . 74.329999999999998 108.851 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.0 143.33 25.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.666 -0.697 . . . . 75.349999999999994 110.092 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.48 -75.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.798 0.686 . . . . 74.420000000000002 109.776 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -137.85 74.95 1.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.607 -0.724 . . . . 71.519999999999996 110.328 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 60.65 87.48 0.09 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.931 -1.032 . . . . 74.439999999999998 111.665 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -81.64 81.49 7.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.605 0.716 . . . . 75.430000000000007 109.789 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.24 -55.03 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.192 -1.367 . . . . 75.420000000000002 107.834 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.433 HG21 ' HD3' ' A' ' 42' ' ' PRO . 61.5 t -66.37 108.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.933 -1.031 . . . . 74.319999999999993 109.001 169.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.599 -0.81 . . . . 74.030000000000001 112.687 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.1 147.07 43.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 117.202 0.501 . . . . 74.230000000000004 110.097 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.492 ' HB ' ' HB3' ' A' ' 36' ' ' GLU . 0.1 OUTLIER -106.72 115.88 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.933 -0.576 . . . . 74.140000000000001 109.629 176.124 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.532 HG13 ' HB2' ' A' ' 37' ' ' TRP . 14.9 pt -97.49 141.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.923 -0.581 . . . . 71.140000000000001 110.538 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 112.08 23.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.012 -0.54 . . . . 73.329999999999998 111.117 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.679 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 11.7 t70 -93.62 -179.2 4.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.64 -0.874 . . . . 62.310000000000002 108.64 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' MET . . . . . 0.913 ' HE2' ' HA ' ' A' ' 32' ' ' MET . 17.1 mmt -73.35 -13.76 61.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.416 0.524 . . . . 72.219999999999999 112.416 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.558 ' HB2' ' HH2' ' A' ' 37' ' ' TRP . . . -84.73 2.58 41.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.869 0.366 . . . . 75.310000000000002 110.727 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.598 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 32.2 ttmt 48.26 73.44 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.907 0.883 . . . . 75.239999999999995 112.561 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.81 ' H ' ' HZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -143.61 -154.96 0.56 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.321 -1.363 . . . . 74.540000000000006 107.321 173.648 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.492 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 3.1 mp0 -123.27 102.12 7.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.16 0.505 . . . . 72.239999999999995 111.029 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.81 ' HZ3' ' H ' ' A' ' 35' ' ' LYS . 3.8 m-90 -85.04 104.85 15.33 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.925 -0.769 . . . . 75.25 108.925 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -79.5 122.26 26.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.505 . . . . 73.430000000000007 110.832 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 52' ' ' TYR . 60.6 t -74.79 107.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.733 -0.469 . . . . 73.140000000000001 109.733 174.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -61.13 4.56 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.779 -0.724 . . . . 65.239999999999995 112.116 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 pt? -159.64 152.06 17.55 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.066 -0.346 . . . . 74.349999999999994 110.066 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.584 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.4 Cg_exo -73.91 101.83 1.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.742 2.295 . . . . 74.010000000000005 111.562 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 53' ' ' LEU . 65.0 mt -66.74 -42.78 89.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 73.030000000000001 109.72 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.96 -31.38 8.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.64 -0.79 . . . . 75.140000000000001 111.873 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.403 HE21 ' HA ' ' A' ' 349' ' ' LEU . 2.0 tm0? -140.81 129.86 23.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.581 0.705 . . . . 74.230000000000004 110.925 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 39.43 0.12 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 108.239 -1.944 . . . . 70.340000000000003 108.239 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.34 122.76 4.96 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.456 -1.058 . . . . 72.200000000000003 110.456 -166.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . 0.656 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 6.3 t80 66.91 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.129 0.572 . . . . 75.109999999999999 111.262 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.5 165.22 16.89 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.208 -0.52 . . . . 72.129999999999995 111.938 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.88 35.13 21.8 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.231 0.538 . . . . 71.200000000000003 110.892 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.774 HD13 ' HA ' ' A' ' 71' ' ' LYS . 43.0 mm -88.44 138.53 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 72.439999999999998 111.051 -175.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.584 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 30.0 m-85 -108.28 157.23 18.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.255 -0.429 . . . . 74.430000000000007 110.813 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.594 ' HB2' HD13 ' A' ' 43' ' ' ILE . 59.6 tp -94.35 136.61 34.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 74.519999999999996 109.776 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.1 103.31 15.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.602 0.239 . . . . 70.430000000000007 110.443 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 56' ' ' MET . 27.8 t70 -79.37 -25.6 42.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 63.340000000000003 110.327 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.473 ' HE1' ' HA ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER 67.26 163.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.375 -0.83 . . . . 71.140000000000001 110.804 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -87.44 65.92 8.85 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.048 -0.723 . . . . 72.120000000000005 109.048 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.9 m -77.36 70.12 3.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 63.219999999999999 110.709 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 p -66.89 -56.73 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.592 -0.731 . . . . 75.439999999999998 111.06 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -137.33 7.62 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 71.120000000000005 110.45 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -137.25 82.24 1.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.918 -0.583 . . . . 75.319999999999993 110.476 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.9 p -82.28 142.52 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 72.120000000000005 110.885 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.18 -165.87 36.92 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 53.43 111.594 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.1 t -75.16 62.63 1.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.937 0.399 . . . . 73.219999999999999 110.79 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 67.44 26.83 8.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.492 -0.776 . . . . 71.540000000000006 111.346 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.73 83.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 123.851 0.719 . . . . 75.430000000000007 111.1 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.468 ' HA ' ' NE ' ' A' ' 133' ' ' ARG . 4.1 Cg_exo -80.14 38.86 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.014 2.476 . . . . 73.439999999999998 111.504 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . 0.423 ' HB2' HG21 ' A' ' 130' ' ' ILE . 6.9 p -145.3 138.18 26.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.549 0.69 . . . . 74.25 112.771 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.75 165.76 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.061 -0.972 . . . . 70.219999999999999 108.409 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.591 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 0.8 OUTLIER -119.83 120.15 62.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.841 0.829 . . . . 71.439999999999998 112.68 -178.106 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.774 ' HA ' HD13 ' A' ' 51' ' ' ILE . 22.1 tptm -84.21 125.8 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 113.198 -1.819 . . . . 74.409999999999997 108.662 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.01 150.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.566 0.58 . . . . 63.25 112.566 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -152.2 135.25 9.25 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.388 -0.824 . . . . 73.510000000000005 109.11 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 -166.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.322 2.015 . . . . 74.120000000000005 111.715 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.4 m -74.68 60.29 0.91 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.215 0.531 . . . . 70.010000000000005 110.869 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -105.56 -38.99 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.347 -0.612 . . . . 71.340000000000003 109.347 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.65 76.01 0.33 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.135 -0.938 . . . . 64.439999999999998 110.523 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.434 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -152.24 -99.09 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.246 -0.978 . . . . 54.009999999999998 112.733 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.434 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 49.0 Cg_exo -56.9 -45.59 35.23 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.127 2.552 . . . . 74.519999999999996 113.614 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -68.98 -41.02 78.44 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.999 -0.28 . . . . 75.040000000000006 110.815 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.481 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 85.1 t80 -61.37 -47.55 85.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.928 0.394 . . . . 74.109999999999999 110.289 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 m -66.1 -42.59 89.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.596 . . . . 74.109999999999999 110.587 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.537 ' HG2' ' HE2' ' A' ' 87' ' ' TYR . 36.4 tt0 -64.88 -40.62 95.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.655 -0.702 . . . . 63.140000000000001 110.419 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.95 -39.28 85.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 72.299999999999997 110.535 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.755 ' HE2' ' HA ' ' A' ' 85' ' ' LYS . 10.9 mmpt? -59.02 -44.66 91.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.304 -0.407 . . . . 74.450000000000003 110.202 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.69 -49.55 77.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.764 -0.653 . . . . 75.310000000000002 110.836 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.537 ' HE2' ' HG2' ' A' ' 83' ' ' GLU . 56.3 m-85 -64.01 -38.32 90.65 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.651 -0.249 . . . . 73.310000000000002 111.426 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -61.42 -37.41 83.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.813 0.34 . . . . 73.319999999999993 110.78 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -88.26 -27.19 21.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.928 0.344 . . . . 74.510000000000005 111.928 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.58 16.05 25.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 71.340000000000003 111.893 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -76.05 163.87 26.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.039 0.385 . . . . 63.119999999999997 112.039 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.469 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.1 mmtt 75.89 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.161 -0.927 . . . . 75.310000000000002 112.425 175.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 -35.69 98.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.492 2.795 . . . . 75.510000000000005 113.184 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.44 -41.89 90.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 74.340000000000003 110.863 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.57 -42.32 78.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 71.349999999999994 109.797 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.469 HG13 ' O ' ' A' ' 92' ' ' LYS . 59.2 mt -57.8 -53.48 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 65.230000000000004 110.572 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.664 HE21 ' HA ' ' A' ' 97' ' ' GLN . 0.0 OUTLIER -60.29 -31.83 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 74.329999999999998 111.332 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -58.76 -56.36 23.25 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.238 0.336 . . . . 72.319999999999993 110.686 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.75 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.81 -34.19 73.35 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.303 -0.559 . . . . 72.510000000000005 110.735 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.511 HD12 ' HA ' ' A' ' 107' ' ' TYR . 56.7 mt -58.13 -50.5 78.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.786 -0.188 . . . . 74.329999999999998 111.055 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -66.51 -38.44 87.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 74.219999999999999 110.621 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -67.57 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 71.310000000000002 111.402 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -78.03 -15.34 59.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.464 . . . . 74.219999999999999 110.965 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 68.77 33.21 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.64 -0.709 . . . . 74.25 110.697 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.513 ' HG ' ' H ' ' A' ' 106' ' ' LYS . 21.1 tp -81.95 177.13 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.985 -1.117 . . . . 74.409999999999997 107.985 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.513 ' H ' ' HG ' ' A' ' 105' ' ' LEU . 20.2 mmtm -103.15 -49.89 3.63 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.949 -0.7 . . . . 75.019999999999996 111.816 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . 0.681 ' HE2' ' HD3' ' A' ' 160' ' ' ARG . 34.4 p90 -162.0 -176.98 5.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 73.430000000000007 111.428 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.75 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 52.8 tp -133.22 131.76 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.569 -0.53 . . . . 64.310000000000002 109.569 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.4 57.64 4.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.868 -0.682 . . . . 72.349999999999994 112.66 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.19 131.47 22.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.303 . . . . 65.420000000000002 110.47 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.48 145.76 72.0 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 74.310000000000002 111.923 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -58.83 129.11 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.016 -0.538 . . . . 75.040000000000006 110.805 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -100.48 128.94 46.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 75.129999999999995 109.919 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -100.69 -62.96 1.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.492 . . . . 74.209999999999994 109.945 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.83 -157.79 15.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.637 -0.71 . . . . 42.119999999999997 112.223 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . 0.527 ' O ' ' HG2' ' A' ' 32' ' ' MET . 14.0 p -169.07 152.4 5.11 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.551 -0.537 . . . . 74.530000000000001 109.551 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.679 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -158.7 -164.92 14.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.028 -1.082 . . . . 74.230000000000004 113.315 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.3 137.06 42.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.741 0.305 . . . . 74.319999999999993 110.477 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . 0.448 ' CG ' HG23 ' A' ' 29' ' ' ILE . 72.8 t60 -140.75 113.18 8.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.841 0.353 . . . . 74.549999999999997 110.241 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.836 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 32.8 t70 -72.43 126.39 29.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.059 -0.519 . . . . 64.099999999999994 110.422 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 122' ' ' ASN . 46.1 tptt -89.42 25.13 2.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.247 0.546 . . . . 74.430000000000007 109.539 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.51 HD21 ' N ' ' A' ' 122' ' ' ASN . 0.8 OUTLIER 74.25 63.99 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.305 -0.861 . . . . 73.140000000000001 110.158 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.4 -54.04 0.72 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.794 -1.094 . . . . 62.539999999999999 111.33 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -112.91 121.98 46.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.972 -0.381 . . . . 73.310000000000002 109.972 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.836 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 47.3 m -86.68 117.57 25.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.596 -0.52 . . . . 74.519999999999996 109.596 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -91.18 140.45 29.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 64.209999999999994 110.066 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -99.22 133.99 42.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.589 -0.523 . . . . 74.030000000000001 109.589 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.591 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 43.9 p90 -128.78 161.12 30.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.142 -0.481 . . . . 75.109999999999999 110.557 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.413 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 48.2 ttp -139.52 133.26 30.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.977 -0.556 . . . . 74.430000000000007 110.099 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.54 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 13.1 mm -96.43 123.99 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.183 0.515 . . . . 75.340000000000003 110.296 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.4 ptm -137.13 -178.09 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 75.219999999999999 110.671 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.49 154.8 34.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.085 0.469 . . . . 75.530000000000001 110.833 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.468 ' NE ' ' HA ' ' A' ' 67' ' ' PRO . 28.9 ptt180 -89.88 124.17 34.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.723 -0.671 . . . . 72.299999999999997 112.199 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 26.0 m-85 -103.05 160.31 14.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 74.340000000000003 109.832 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.715 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -145.44 -25.81 0.1 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.089 -1.053 . . . . 74.329999999999998 113.252 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.719 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 58.8 m -121.48 126.42 49.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.876 0.338 . . . . 73.340000000000003 111.694 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.545 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -98.04 134.94 40.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 72.530000000000001 109.929 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 71.209999999999994 111.211 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 22.9 tp60 -58.33 -49.31 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.452 . . . . 74.510000000000005 112.104 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.545 ' HG2' ' OD1' ' A' ' 137' ' ' ASP . 20.5 pttm -85.61 -20.92 28.78 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.981 -0.687 . . . . 75.329999999999998 111.009 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.96 -46.35 79.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.277 0.56 . . . . 72.319999999999993 109.647 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.751 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -67.32 -32.76 73.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.792 . . . . 70.25 110.514 176.904 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.69 -54.92 8.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.948 -0.569 . . . . 75.129999999999995 111.405 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.51 72.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 74.129999999999995 111.76 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -87.4 0.53 55.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 73.430000000000007 110.167 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.412 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 53.86 52.35 13.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.454 -0.794 . . . . 75.409999999999997 112.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.474 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.1 OUTLIER 40.08 75.96 0.07 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.53 0.732 . . . . 73.239999999999995 112.257 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.4 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 18.2 ttp180 -149.79 79.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.582 -0.736 . . . . 73.340000000000003 109.235 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.751 ' HZ ' ' HA ' ' A' ' 142' ' ' TYR . 38.3 m-85 -111.02 156.47 21.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.121 0.486 . . . . 73.319999999999993 111.702 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.456 ' O ' HG22 ' A' ' 154' ' ' VAL . 42.0 p -68.02 152.1 46.03 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.373 -0.83 . . . . 62.219999999999999 110.197 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.561 ' HG2' HD23 ' A' ' 328' ' ' LEU . 41.0 ttm105 -66.56 -26.38 67.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.963 0.411 . . . . 73.420000000000002 110.186 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.22 -43.89 69.73 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.016 -0.538 . . . . 74.310000000000002 111.171 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.453 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 21.2 p -68.27 -44.64 75.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 72.200000000000003 110.943 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 150' ' ' SER . 92.6 t -57.61 -42.84 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 74.129999999999995 111.152 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.51 HD13 ' HB3' ' A' ' 324' ' ' LEU . 2.5 mm? -64.9 -42.37 94.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.52 -0.309 . . . . 75.430000000000007 111.001 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.681 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 17.8 mm-40 -59.97 -46.01 90.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.49 0.186 . . . . 61.43 110.858 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 153' ' ' THR . 98.7 mt -59.62 -41.15 89.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 73.040000000000006 110.888 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.7 t -59.57 -47.11 86.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 63.350000000000001 111.006 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.532 HD21 HD12 ' A' ' 325' ' ' LEU . 10.1 mp -63.8 -37.92 89.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 54.140000000000001 111.388 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.681 ' HD3' ' HE2' ' A' ' 107' ' ' TYR . 15.3 mmt180 -57.88 -52.59 64.84 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.465 -0.568 . . . . 72.510000000000005 109.465 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.0 -49.75 82.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.093 -0.958 . . . . 75.129999999999995 110.784 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.63 -54.54 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.948 0.351 . . . . 75.230000000000004 111.948 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.55 -48.6 76.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.579 0.228 . . . . 64.109999999999999 111.362 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.451 ' O ' ' HB3' ' A' ' 167' ' ' TYR . 16.7 tt -72.34 -36.63 55.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 120.428 -0.509 . . . . 70.319999999999993 111.21 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.4 -38.27 81.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 75.030000000000001 110.924 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.744 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 34.1 mm-40 -76.78 -23.95 52.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.842 -0.343 . . . . 71.319999999999993 110.517 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 164' ' ' ILE . 69.6 t80 -58.39 -48.65 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.349999999999994 110.076 172.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.6 pt -80.27 -32.29 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.54 -0.3 . . . . 75.310000000000002 111.372 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.744 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 4.9 m170 -56.55 -44.18 80.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.935 0.346 . . . . 75.219999999999999 111.935 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.15 12.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 75.420000000000002 111.41 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -120.97 -72.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.268 -0.424 . . . . 71.209999999999994 109.905 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.512 ' OE2' ' HD3' ' A' ' 203' ' ' ARG . 9.2 pt-20 -177.3 -35.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.541 0.571 . . . . 73.040000000000006 112.541 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.56 135.85 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 74.310000000000002 111.005 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 28.7 m -129.8 142.9 42.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.593 -0.731 . . . . 54.030000000000001 109.536 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.549 ' CE1' ' HB3' ' A' ' 200' ' ' LEU . 3.6 t60 -100.96 -47.07 4.9 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.788 -0.365 . . . . 74.319999999999993 110.1 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.955 ' HA2' ' HB3' ' A' ' 243' ' ' ASP . . . 73.23 -62.14 1.79 Allowed Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.918 -0.658 . . . . 74.140000000000001 111.979 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.419 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 4.9 t70 -55.08 111.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.199 0.6 . . . . 61.009999999999998 112.457 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.62 43.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.45 0.643 . . . . 64.129999999999995 109.585 170.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -81.6 145.44 30.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.608 -0.516 . . . . 75.209999999999994 109.608 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.08 -2.14 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.835 0.68 . . . . 75.299999999999997 112.835 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.446 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 4.7 p -76.91 -26.44 54.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.709 0.263 . . . . 74.340000000000003 111.709 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.61 -0.61 31.7 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 111.787 0.291 . . . . 75.409999999999997 111.787 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.77 111.19 23.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 75.040000000000006 109.973 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 137' ' ' ASP . 4.3 mm? -114.26 136.07 53.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.087 -0.506 . . . . 73.120000000000005 110.598 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.719 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.5 mt -93.58 141.71 28.16 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.82 -0.627 . . . . 74.329999999999998 110.141 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.98 138.74 58.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.528 -0.545 . . . . 74.209999999999994 109.528 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . 0.715 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 64.0 t80 -57.99 -30.91 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.37 0.508 . . . . 74.239999999999995 112.37 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 26.5 tptp -101.58 -44.25 5.64 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.808 -0.357 . . . . 74.430000000000007 111.125 -176.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.585 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 4.4 m120 -102.01 104.85 38.78 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 72.5 111.505 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.644 ' HB3' HG22 ' A' ' 343' ' ' VAL . 17.4 Cg_exo -68.42 -14.21 39.44 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.208 2.605 . . . . 55.240000000000002 112.247 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.538 ' HA ' ' HG ' ' A' ' 339' ' ' LEU . 6.7 p-10 -88.48 -3.8 58.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.889 -0.596 . . . . 75.319999999999993 110.799 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.585 ' HG3' ' HB3' ' A' ' 189' ' ' ASN . 72.3 mt-30 -109.64 96.99 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 73.420000000000002 110.524 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.1 p -103.55 134.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 70.439999999999998 109.969 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 64.2 m-85 -125.2 157.28 36.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.016 -0.538 . . . . 75.239999999999995 110.202 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 72.7 mt -103.1 127.5 50.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.199 -0.455 . . . . 71.019999999999996 110.066 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.491 HG11 HD22 ' A' ' 184' ' ' LEU . 7.6 p -139.37 170.78 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.624 -0.51 . . . . 71.409999999999997 109.624 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 65.12 56.81 0.99 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.002 0.906 . . . . 75.030000000000001 109.617 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.459 ' HD2' ' HB1' ' A' ' 201' ' ' ALA . 4.5 m-85 -73.91 39.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.365 -1.289 . . . . 74.530000000000001 112.809 -176.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -81.15 47.39 3.57 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.262 -0.735 . . . . 53.149999999999999 111.262 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.549 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 tt -170.98 44.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 74.109999999999999 108.096 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.459 ' HB1' ' HD2' ' A' ' 198' ' ' TYR . . . -133.04 106.07 7.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 72.340000000000003 110.268 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -115.72 -177.45 3.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.096 -0.502 . . . . 74.129999999999995 110.44 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.512 ' HD3' ' OE2' ' A' ' 172' ' ' GLU . 58.8 mtt-85 -104.54 117.81 35.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.274 -0.421 . . . . 75.209999999999994 111.388 -170.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -87.99 -45.3 10.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.181 0.515 . . . . 74.329999999999998 110.239 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.413 ' SG ' ' HA ' ' A' ' 172' ' ' GLU . 11.0 p -128.81 66.33 75.15 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.889 -0.596 . . . . 74.109999999999999 110.838 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.55 143.9 76.55 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.645 2.23 . . . . 64.409999999999997 112.349 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 74.07 6.74 4.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.436 -0.802 . . . . 75.420000000000002 111.144 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.03 10.92 74.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.097 -0.573 . . . . 62.340000000000003 112.471 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 40.4 t -116.71 128.14 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.646 -0.501 . . . . 75.109999999999999 109.646 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -64.66 141.63 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.855 -0.424 . . . . 73.299999999999997 109.855 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -114.34 166.47 11.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 74.519999999999996 111.332 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -72.89 144.67 47.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 75.25 110.152 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . 0.437 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 53.6 p90 -68.2 147.46 52.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.42 -0.585 . . . . 72.0 109.42 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . 0.452 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 2.3 mptp? -90.58 -69.26 0.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.346 0.869 . . . . 74.450000000000003 113.346 -167.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 9.3 mm-40 63.35 71.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.627 -0.879 . . . . 73.310000000000002 108.627 -165.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.6 146.22 68.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.901 -1.045 . . . . 74.129999999999995 111.004 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.41 -24.59 71.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.78 2.32 . . . . 74.310000000000002 113.379 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -103.0 -39.58 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.962 -0.384 . . . . 74.150000000000006 109.962 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.419 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 93.0 mtt-85 74.03 117.62 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.317 -0.856 . . . . 74.409999999999997 110.974 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.634 ' SG ' ' HA2' ' A' ' 235' ' ' GLY . 9.1 p -57.57 -48.97 77.89 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 113.448 0.907 . . . . 70.439999999999998 113.448 -170.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 12.8 p-80 46.81 32.69 1.86 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.271 0.629 . . . . 73.219999999999999 111.998 -177.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.18 -41.61 76.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.287 0.477 . . . . 75.010000000000005 112.287 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.461 ' HA2' HD12 ' A' ' 200' ' ' LEU . . . -77.27 153.14 40.87 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.671 -0.776 . . . . 72.420000000000002 112.866 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -70.2 122.39 19.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.09 0.471 . . . . 65.230000000000004 110.551 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.87 -12.91 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.959 -0.564 . . . . 63.549999999999997 111.709 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . 0.489 ' HA ' HD23 ' A' ' 265' ' ' LEU . 38.5 tt0 -55.34 -59.54 4.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.6 -0.727 . . . . 72.239999999999995 110.555 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.82 -33.05 7.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.11 -0.496 . . . . 72.109999999999999 110.103 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 98.5 m -58.0 121.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.701 0.763 . . . . 74.150000000000006 110.84 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.591 ' H ' HD11 ' A' ' 246' ' ' ILE . 47.7 t -56.61 166.38 0.94 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.105 -1.407 . . . . 73.200000000000003 111.758 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 37.5 mt -55.15 -51.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.436 -0.802 . . . . 72.349999999999994 110.608 -178.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -56.16 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 65.129999999999995 111.504 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.45 97.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 73.439999999999998 111.817 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.24 -17.53 59.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 70.530000000000001 110.467 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.419 ' O ' ' HD3' ' A' ' 219' ' ' ARG . 6.0 t30 -80.66 -8.41 59.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.597 -0.729 . . . . 73.109999999999999 111.683 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.634 ' HA2' ' SG ' ' A' ' 220' ' ' CYS . . . 86.7 24.14 39.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.055 -1.069 . . . . 72.310000000000002 112.843 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 0.437 ' CG2' ' HB2' ' A' ' 213' ' ' TYR . 10.0 p -120.51 140.98 42.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.303 -0.629 . . . . 71.530000000000001 109.303 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.46 113.56 7.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.662 0.268 . . . . 62.329999999999998 110.771 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.48 134.93 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.587 2.191 . . . . 65.230000000000004 112.117 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 34.9 p -79.36 -164.52 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.969 -0.56 . . . . 71.319999999999993 109.66 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -62.93 -19.28 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.453 -0.499 . . . . 74.439999999999998 109.965 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.401 ' CZ ' ' HB3' ' A' ' 241' ' ' ARG . 1.8 mtp-105 -63.32 -30.55 71.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.909 -0.587 . . . . 72.420000000000002 111.116 177.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.578 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.25 -66.65 2.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.05 -0.595 . . . . 73.540000000000006 112.502 -175.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.955 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -76.8 -29.77 56.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.252 0.464 . . . . 74.5 112.252 -174.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.99 -34.2 77.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 72.129999999999995 110.981 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . 0.529 ' HG3' ' HE1' ' A' ' 303' ' ' MET . 34.9 tt0 -74.99 -34.31 61.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.503 -0.554 . . . . 60.43 109.503 176.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.591 HD11 ' H ' ' A' ' 229' ' ' SER . 93.7 mt -64.41 -37.77 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 72.450000000000003 110.393 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.503 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 47.9 tp -61.5 -40.2 93.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.588 -0.523 . . . . 74.329999999999998 109.588 174.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.15 99.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.601 -0.809 . . . . 62.310000000000002 111.743 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -54.37 -57.14 12.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.844 0.354 . . . . 73.239999999999995 111.218 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.2 p -67.21 -40.94 86.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 73.099999999999994 111.993 -174.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.12 -47.57 85.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.672 0.272 . . . . 72.299999999999997 111.42 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.34 -29.24 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.414 -0.514 . . . . 73.310000000000002 110.253 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -67.55 -46.8 71.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.595 -0.275 . . . . 73.299999999999997 110.543 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -61.96 -31.28 71.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.352 -0.385 . . . . 62.549999999999997 110.588 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.59 -41.2 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.015 -0.539 . . . . 74.099999999999994 112.089 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 67.1 p -101.92 -27.89 12.71 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.186 0.439 . . . . 73.010000000000005 112.186 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.456 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 96.96 -5.07 63.39 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.488 -0.863 . . . . 74.530000000000001 113.694 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -150.83 144.07 24.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.799 0.8 . . . . 74.450000000000003 112.458 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.44 HD11 ' CZ2' ' A' ' 261' ' ' TRP . 60.3 mt -122.5 138.9 29.94 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.198 -0.91 . . . . 72.340000000000003 108.871 166.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -58.19 -34.79 98.91 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.728 2.285 . . . . 74.530000000000001 113.309 -175.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.514 ' HB2' HG13 ' A' ' 271' ' ' VAL . 36.7 p90 -95.3 2.92 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.646 -0.252 . . . . 72.5 111.438 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.86 -33.84 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.889 0.376 . . . . 74.310000000000002 110.492 -177.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.42 -28.64 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.723 0.773 . . . . 74.549999999999997 109.309 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.457 ' HB3' ' CB ' ' A' ' 270' ' ' TYR . 9.9 m120 -86.23 7.14 26.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.069 -0.968 . . . . 72.340000000000003 110.497 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.489 HD23 ' HA ' ' A' ' 226' ' ' GLU . 1.7 tm? -54.94 -35.32 64.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 71.450000000000003 111.243 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.57 14.88 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.817 0.673 . . . . 74.299999999999997 112.817 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.403 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.7 t70 -139.89 113.98 7.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.733 0.301 . . . . 73.109999999999999 110.325 174.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.87 -30.81 92.72 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.41 2.74 . . . . 74.209999999999994 113.777 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -69.2 -44.54 71.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.694 0.283 . . . . 75.230000000000004 110.647 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 264' ' ' ASN . 43.8 m-85 -66.71 -49.97 64.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 73.420000000000002 111.669 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.514 HG13 ' HB2' ' A' ' 261' ' ' TRP . 19.4 m -62.5 -35.81 71.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.131 -0.227 . . . . 74.230000000000004 111.585 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.426 ' O ' HG13 ' A' ' 276' ' ' ILE . 30.1 ttm180 -63.06 -53.27 56.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.6 -0.273 . . . . 74.519999999999996 110.334 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.66 -40.0 88.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 72.420000000000002 111.14 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.7 m -61.66 -44.69 96.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.451 -0.341 . . . . 51.030000000000001 111.34 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.71 -33.6 71.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.709 0.29 . . . . 75.120000000000005 110.868 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.426 HG13 ' O ' ' A' ' 272' ' ' ARG . 77.4 mt -67.21 -43.88 88.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.948 0.404 . . . . 71.319999999999993 109.981 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -63.0 -36.15 82.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.851 -0.613 . . . . 73.150000000000006 110.293 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.29 -46.3 89.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 74.120000000000005 111.026 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -64.5 -26.35 68.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.924 0.392 . . . . 74.450000000000003 110.866 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.13 -32.17 50.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 64.25 111.32 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.536 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -136.05 53.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.947 0.403 . . . . 74.25 110.389 -172.323 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.452 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -57.0 -44.45 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 113.577 0.954 . . . . 75.319999999999993 113.577 -171.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.452 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -69.8 -47.32 63.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.866 0.321 . . . . 74.439999999999998 111.866 -170.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.4 t -68.36 -45.15 73.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.511 -0.313 . . . . 73.409999999999997 110.74 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.536 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.0 mm? -61.21 -53.44 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 75.140000000000001 111.575 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.683 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.1 OUTLIER -59.7 -42.79 93.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.743 0.275 . . . . 75.510000000000005 111.743 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.07 -37.33 85.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.131 0.491 . . . . 74.530000000000001 111.088 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -89.85 1.72 55.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 75.319999999999993 111.624 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 90.4 m -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 74.040000000000006 110.707 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 14.8 t80 -132.81 86.97 42.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 71.430000000000007 109.223 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.9 34.35 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.431 2.754 . . . . 75.519999999999996 112.847 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.58 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 51.5 mt-10 -120.59 -165.67 1.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 73.310000000000002 110.293 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -92.04 85.55 5.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.084 0.469 . . . . 74.230000000000004 110.661 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.27 -165.64 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.99 -0.744 . . . . 73.120000000000005 108.99 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.769 ' HD3' HD12 ' A' ' 331' ' ' ILE . 21.7 mtpp -120.48 90.14 45.14 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.483 0.183 . . . . 75.510000000000005 111.489 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -99.53 36.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.94 2.427 . . . . 73.209999999999994 111.395 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.56 -42.9 3.53 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.795 -0.717 . . . . 70.439999999999998 112.031 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -56.84 -46.08 81.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.968 0.413 . . . . 75.209999999999994 110.128 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.16 -41.24 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.895 -0.593 . . . . 71.209999999999994 110.586 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.91 -50.14 74.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 73.420000000000002 111.171 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.329999999999998 110.469 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.56 ' CD1' HD21 ' A' ' 320' ' ' LEU . 73.1 t80 -56.19 -46.54 79.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 73.510000000000005 110.843 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.683 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 94.8 mmm -71.46 -39.37 70.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.814 -0.63 . . . . 72.530000000000001 111.209 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 25.2 tt0 -58.66 -50.03 75.37 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.771 0.796 . . . . 75.310000000000002 109.369 174.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.418 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 88.9 m -57.65 -50.97 71.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.702 -1.136 . . . . 73.349999999999994 111.733 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.515 ' HA ' ' CD1' ' A' ' 309' ' ' LEU . 33.7 m -67.21 -27.22 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 112.21 0.448 . . . . 50.399999999999999 112.21 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -80.33 -19.86 45.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.363 -0.535 . . . . 75.519999999999996 110.339 -179.539 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.402 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 30.4 tp -94.41 17.84 12.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.116 -0.493 . . . . 71.319999999999993 111.143 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.518 HD23 ' HA ' ' A' ' 315' ' ' PRO . 92.2 mt -93.77 -12.78 28.38 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.282 0.475 . . . . 73.150000000000006 112.282 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.502 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 13.2 t70 58.48 -164.37 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.591 0.356 . . . . 74.230000000000004 110.123 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.502 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.3 m-85 -64.93 -52.07 58.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 73.109999999999999 110.416 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.466 ' HG1' ' C ' ' A' ' 311' ' ' TYR . 19.8 m -155.16 69.05 0.7 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.222 0.534 . . . . 75.140000000000001 111.023 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.487 ' HG3' ' HB3' ' A' ' 310' ' ' ASP . 25.2 mt-10 -104.99 33.43 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 73.409999999999997 109.493 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.495 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 25.4 mttt 64.53 103.53 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.219 0 CA-C-N 114.512 -1.222 . . . . 75.099999999999994 112.239 -176.436 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.518 ' HA ' HD23 ' A' ' 309' ' ' LEU . 19.6 Cg_endo -63.22 136.49 56.04 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.284 1.989 . . . . 63.219999999999999 110.49 170.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 92.9 mt -79.19 79.82 5.59 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.857 -0.337 . . . . 75.329999999999998 110.699 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.413 ' CE1' ' HG2' ' A' ' 315' ' ' PRO . 17.2 m-85 -53.41 -48.5 68.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.495 -0.775 . . . . 73.430000000000007 109.948 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -63.04 -53.24 56.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.848 -1.069 . . . . 61.299999999999997 111.785 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.426 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 27.0 t-20 -59.77 -51.37 70.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.747 -0.206 . . . . 63.340000000000003 111.333 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.56 HD21 ' CD1' ' A' ' 302' ' ' TYR . 95.5 mt -59.16 -48.75 80.46 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.948 0.404 . . . . 75.409999999999997 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -62.3 -40.56 96.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 73.019999999999996 110.203 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.72 -49.38 47.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 63.409999999999997 111.51 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.79 -33.61 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.872 -0.331 . . . . 75.510000000000005 111.323 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.51 ' HB3' HD13 ' A' ' 155' ' ' LEU . 88.7 mt -69.9 -49.37 52.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 74.430000000000007 110.591 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.532 HD12 HD21 ' A' ' 159' ' ' LEU . 82.5 mt -67.04 -34.07 76.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 72.519999999999996 111.031 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.12 -47.67 79.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 65.430000000000007 110.48 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.77 79.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.69 -0.767 . . . . 73.219999999999999 111.975 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.561 HD23 ' HG2' ' A' ' 151' ' ' ARG . 3.1 tm? -68.23 -49.54 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.094 0.473 . . . . 73.519999999999996 110.336 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.546 ' HA ' ' O ' ' A' ' 333' ' ' SER . 85.6 tttt -71.87 -34.34 69.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 73.150000000000006 111.065 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -27.32 67.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.173 0.434 . . . . 71.409999999999997 112.173 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.769 HD12 ' HD3' ' A' ' 295' ' ' LYS . 15.6 tt -86.25 -6.3 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.416 -0.514 . . . . 73.200000000000003 110.87 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 110.64 24.45 5.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.278 -0.963 . . . . 54.409999999999997 113.875 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 13.3 t -119.47 149.57 41.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.332 0.566 . . . . 55.149999999999999 110.082 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -162.7 27.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.551 -0.907 . . . . 72.430000000000007 108.551 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.49 105.87 17.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.311 -1.313 . . . . 73.040000000000006 110.804 -170.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.2 -21.16 5.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 74.310000000000002 111.641 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.76 -23.47 64.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.632 -0.794 . . . . 61.039999999999999 113.126 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -139.69 119.27 13.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.674 0.274 . . . . 74.299999999999997 110.772 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 191' ' ' ASP . 58.0 mt -87.47 117.83 26.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.756 -0.461 . . . . 73.530000000000001 109.756 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -83.49 25.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.342 -0.39 . . . . 74.349999999999994 110.847 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 342' ' ' SER . 25.6 tp -51.65 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.758 . . . . 73.209999999999994 111.372 -176.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 341' ' ' LEU . 7.6 t 176.62 -65.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.128 -0.487 . . . . 71.019999999999996 110.154 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.644 HG22 ' HB3' ' A' ' 190' ' ' PRO . 61.8 t 66.09 97.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 O-C-N 123.811 0.695 . . . . 75.409999999999997 110.824 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 345' ' ' GLU . 2.2 p -111.56 -74.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.79 -0.641 . . . . 62.229999999999997 111.65 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.43 ' H ' HG12 ' A' ' 344' ' ' VAL . 42.1 mt-10 -157.4 -175.69 5.54 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.829 0.347 . . . . 75.129999999999995 110.219 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 17.3 p30 -112.32 160.35 17.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.07 -0.514 . . . . 75.25 110.104 176.445 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 132.62 15.3 1.42 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.114 -1.041 . . . . 64.400000000000006 113.539 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.29 80.12 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.348 -0.93 . . . . 63.240000000000002 111.453 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.403 ' HA ' HE21 ' A' ' 45' ' ' GLN . 2.7 tt 54.52 89.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.717 0.807 . . . . 72.420000000000002 112.302 171.552 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 350' ' ' LYS . 37.9 mmtm -138.52 131.43 29.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.656 -0.702 . . . . 75.230000000000004 109.283 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -132.8 138.53 47.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.277 -0.42 . . . . 72.030000000000001 110.992 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.414 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -145.15 134.26 22.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.72 -0.474 . . . . 73.430000000000007 109.72 -178.174 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.9 t -104.38 153.87 20.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.609 0.243 . . . . 73.409999999999997 110.366 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.22 128.44 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.282 0.563 . . . . 62.509999999999998 110.981 -173.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' THR . . . . . 0.694 HG21 ' HB2' ' A' ' 358' ' ' ARG . 33.3 m -77.82 97.96 5.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 63.240000000000002 111.822 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -82.84 -48.34 10.87 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.519 -0.549 . . . . 74.340000000000003 109.519 170.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -151.53 86.33 1.33 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.675 . . . . 74.519999999999996 110.255 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.694 ' HB2' HG21 ' A' ' 355' ' ' THR . 15.2 mmt180 -134.58 113.11 11.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.525 -0.761 . . . . 65.510000000000005 109.037 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.36 -51.54 3.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.726 -0.472 . . . . 73.510000000000005 109.726 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.536 ' HE2' ' HA ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.911 -1.144 . . . . 75.540000000000006 107.911 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.576 0.227 . . . . 73.409999999999997 111.014 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.08 138.09 15.99 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.495 2.13 . . . . 61.25 110.685 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -121.44 -75.92 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 74.450000000000003 111.544 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.73 113.05 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.556 0.694 . . . . 75.310000000000002 111.274 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.455 ' HB2' ' H ' ' A' ' 6' ' ' ALA . 81.3 mttt -126.68 -93.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.401 -0.818 . . . . 74.209999999999994 109.391 175.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' H ' ' HB2' ' A' ' 5' ' ' LYS . . . -169.47 138.63 1.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.798 -0.637 . . . . 72.400000000000006 109.909 178.133 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.67 90.79 1.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.141 0.496 . . . . 73.409999999999997 110.445 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -88.73 60.26 5.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.324 0.583 . . . . 73.030000000000001 110.88 -177.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.4 102.62 6.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.647 -0.706 . . . . 74.349999999999994 110.861 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.85 111.52 4.26 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.904 -0.665 . . . . 72.239999999999995 111.496 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -144.98 114.72 7.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.598 0.237 . . . . 74.019999999999996 111.375 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.529 ' HA ' ' OE1' ' A' ' 143' ' ' GLU . 11.6 pt20 -150.19 131.48 14.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.119 -0.697 . . . . 65.010000000000005 109.119 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -130.74 122.68 27.68 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.055 -0.258 . . . . 62.25 111.19 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -174.49 131.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 73.430000000000007 110.765 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.45 35.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 71.209999999999994 109.902 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -116.35 99.79 7.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.74 0.274 . . . . 75.239999999999995 111.74 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -169.48 106.65 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 73.319999999999993 111.244 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.573 ' HE1' ' HB2' ' A' ' 42' ' ' PRO . 55.0 t-80 -169.16 89.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.093 -0.958 . . . . 74.040000000000006 108.946 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.2 pp -98.28 157.46 16.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.34 -0.391 . . . . 73.450000000000003 111.295 -175.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.78 140.3 20.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 75.0 109.617 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.37 172.56 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.034 -0.358 . . . . 75.430000000000007 110.034 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 66.82 -88.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.343 0.657 . . . . 74.409999999999997 111.659 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -124.26 91.08 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.417 0.627 . . . . 65.109999999999999 110.894 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -172.58 -58.7 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.62 -1.252 . . . . 65.299999999999997 107.62 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.545 HG12 ' HA2' ' A' ' 40' ' ' GLY . 61.9 t -65.59 130.96 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.515 -1.22 . . . . 74.310000000000002 108.712 167.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.37 2.95 56.63 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.307 -0.949 . . . . 64.209999999999994 112.911 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 133.0 51.2 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.197 -0.668 . . . . 75.540000000000006 109.197 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.474 HD12 ' HB3' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -81.04 131.11 34.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.678 0.751 . . . . 63.530000000000001 111.338 -173.159 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.63 129.85 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.726 -1.124 . . . . 65.140000000000001 109.641 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 21.1 m -118.45 123.83 46.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.559 -0.291 . . . . 74.310000000000002 110.594 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -111.2 -173.09 2.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.398 -0.365 . . . . 74.239999999999995 110.71 -179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.06 -14.31 61.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.356 0.502 . . . . 74.140000000000001 112.356 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.29 8.54 8.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.836 0.35 . . . . 41.439999999999998 110.434 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.6 tptt 55.81 63.21 2.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.334 -0.848 . . . . 74.450000000000003 110.686 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 30' ' ' THR . 48.6 mmtm -134.92 120.84 19.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.059 -0.973 . . . . 75.450000000000003 109.723 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.93 77.29 4.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 73.200000000000003 109.428 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.577 ' HB2' ' O ' ' A' ' 56' ' ' MET . 37.4 p-90 -96.81 -176.55 3.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.686 -0.688 . . . . 71.230000000000004 110.375 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.512 ' HG2' ' HB3' ' A' ' 56' ' ' MET . 18.8 pttp -133.69 137.14 45.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.299999999999997 111.562 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.01 151.68 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.952 -1.022 . . . . 74.299999999999997 110.797 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.545 ' HA2' HG12 ' A' ' 25' ' ' VAL . . . -96.6 -124.44 4.67 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.452 -0.659 . . . . 62.520000000000003 111.452 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.2 mp -92.13 128.88 43.55 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.838 0.351 . . . . 72.340000000000003 110.48 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.573 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 15.5 Cg_exo -68.91 119.1 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.91 2.406 . . . . 75.129999999999995 111.463 176.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.83 -59.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.147 0.499 . . . . 75.120000000000005 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.67 -8.3 76.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.899 -0.667 . . . . 61.329999999999998 112.316 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -127.4 161.38 28.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.487 0.184 . . . . 75.209999999999994 110.561 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.67 -130.92 2.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.402 -1.079 . . . . 64.340000000000003 110.402 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.57 -2.69 86.94 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.473 -0.87 . . . . 70.340000000000003 111.527 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.78 -68.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.728 -0.471 . . . . 74.319999999999993 109.728 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.93 174.23 24.63 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.865 -0.683 . . . . 64.530000000000001 111.888 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.7 m 62.68 32.72 16.07 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.108 0.48 . . . . 75.530000000000001 111.583 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.13 137.37 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 74.430000000000007 110.603 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.402 ' CE2' ' HB3' ' A' ' 42' ' ' PRO . 11.0 m-85 -111.89 148.97 32.53 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.849 -0.426 . . . . 74.400000000000006 109.849 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.495 HD23 ' N ' ' A' ' 54' ' ' ALA . 4.5 tt -90.63 139.87 30.3 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.828 -0.804 . . . . 75.439999999999998 108.828 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.495 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.796 -0.362 . . . . 65.340000000000003 110.751 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.77 -53.37 6.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 74.540000000000006 110.495 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.577 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 22.7 ttt -118.75 122.8 43.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.463 -0.789 . . . . 74.219999999999999 110.038 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -144.3 142.64 30.55 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.392 -0.966 . . . . 73.319999999999993 108.392 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.2 m -72.37 76.17 1.02 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.428 0.633 . . . . 71.200000000000003 110.457 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.668 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.5 m -81.37 141.84 33.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.623 -0.717 . . . . 73.530000000000001 110.035 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.93 -33.61 70.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 72.319999999999993 110.474 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -147.02 82.71 1.56 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.963 -0.562 . . . . 64.409999999999997 109.917 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.668 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 11.1 p -82.42 125.58 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 73.439999999999998 110.337 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 53.04 1.14 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.796 . . . . 55.439999999999998 111.702 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m 68.69 3.27 3.81 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.355 0.598 . . . . 74.430000000000007 110.499 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.05 122.12 13.75 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.31 -0.859 . . . . 62.130000000000003 109.232 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -73.73 110.68 9.59 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-O 121.122 0.487 . . . . 71.230000000000004 110.018 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.447 ' C ' ' HB2' ' A' ' 133' ' ' ARG . 3.6 Cg_exo -79.67 40.36 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.149 2.566 . . . . 75.439999999999998 111.273 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 p -144.26 146.95 32.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.623 0.725 . . . . 73.140000000000001 112.826 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 132' ' ' ASP . 34.6 m -128.08 167.05 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.021 -0.99 . . . . 75.420000000000002 109.389 172.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.558 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 3.1 p -130.42 123.83 56.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.256 0.551 . . . . 73.109999999999999 111.488 -176.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.45 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 62.4 tttm -82.43 122.3 27.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.443 -0.577 . . . . 72.409999999999997 109.443 175.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.9 122.48 65.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.4 -0.364 . . . . 64.340000000000003 110.577 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.434 ' HB3' HD22 ' A' ' 80' ' ' LEU . 6.0 tp10 -136.07 137.54 25.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 74.209999999999994 109.053 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.62 133.25 50.34 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.17 1.913 . . . . 74.219999999999999 112.061 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 t -81.18 15.01 2.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.099 0.476 . . . . 74.25 110.655 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.457 ' OD2' ' HE3' ' A' ' 124' ' ' LYS . 10.0 t70 -67.65 -69.1 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 63.439999999999998 110.105 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -170.32 118.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.705 -0.68 . . . . 71.209999999999994 109.477 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.71 -161.95 28.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.465 -0.874 . . . . 72.310000000000002 112.478 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.01 -21.54 49.37 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.18 2.587 . . . . 72.430000000000007 112.913 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.49 HD13 ' O ' ' A' ' 80' ' ' LEU . 1.2 tm? -52.31 -37.64 56.31 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.602 0.564 . . . . 74.109999999999999 111.16 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.15 -41.81 85.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 73.010000000000005 110.574 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -69.15 -46.3 67.96 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.201 -0.454 . . . . 75.140000000000001 110.708 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.458 ' HG2' ' HA ' ' A' ' 80' ' ' LEU . 11.4 pt-20 -67.99 -31.1 70.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.189 -0.46 . . . . 72.400000000000006 110.838 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.51 -39.71 88.82 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.366 -0.235 . . . . 74.219999999999999 110.366 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -57.26 -49.01 77.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 74.420000000000002 110.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.11 -49.51 69.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 74.439999999999998 111.131 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CZ ' ' HD1' ' A' ' 113' ' ' TYR . 55.8 t80 -59.91 -38.13 81.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.731 -0.668 . . . . 75.439999999999998 111.563 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.14 -39.63 63.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 73.329999999999998 110.867 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -27.83 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 71.329999999999998 110.955 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . 0.59 ' HA ' ' CH2' ' A' ' 99' ' ' TRP . . . -106.74 16.52 24.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.963 0.411 . . . . 64.209999999999994 111.352 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 92' ' ' LYS . . . -82.58 158.19 23.17 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.109 -0.496 . . . . 73.420000000000002 111.478 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' ILE . 49.9 mtmt 75.17 107.01 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.293 -0.867 . . . . 74.430000000000007 111.394 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.528 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 49.7 Cg_exo -55.69 -35.33 92.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.362 2.708 . . . . 75.519999999999996 113.197 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.713 ' HG2' ' HE2' ' A' ' 98' ' ' LYS . 38.6 tt0 -66.46 -45.8 78.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 72.340000000000003 110.946 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.69 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 48.8 tt0 -62.64 -36.87 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.405 -0.591 . . . . 74.129999999999995 109.405 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.486 HD12 ' HA ' ' A' ' 93' ' ' PRO . 67.4 mt -55.96 -45.88 80.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.537 -0.756 . . . . 72.030000000000001 110.284 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . 0.528 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 96.3 mt-30 -53.78 -47.06 71.11 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.856 -0.611 . . . . 73.230000000000004 110.586 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.713 ' HE2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -63.85 -57.75 8.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.48 0.548 . . . . 74.120000000000005 112.48 -177.532 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.59 ' CH2' ' HA ' ' A' ' 90' ' ' ALA . 1.1 p90 -69.52 -34.71 74.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 119.968 -0.693 . . . . 74.430000000000007 111.501 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . 0.461 HD11 HD23 ' A' ' 108' ' ' LEU . 26.1 mm -63.45 -47.07 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.41 . . . . 74.450000000000003 110.122 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.94 -35.67 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 74.310000000000002 110.886 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.1 m -76.25 -34.63 59.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.207 -0.451 . . . . 73.310000000000002 111.555 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -84.61 1.91 43.93 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 122.299 -0.251 . . . . 63.200000000000003 111.546 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 65.94 25.9 11.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.582 0.551 . . . . 74.150000000000006 111.104 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.58 -178.32 5.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 74.299999999999997 109.362 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.9 -45.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.73 0.641 . . . . 74.200000000000003 112.73 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -154.08 117.48 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.522 -0.871 . . . . 75.430000000000007 112.342 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.605 ' H ' HD22 ' A' ' 108' ' ' LEU . 2.6 pt? -103.96 136.24 43.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 74.439999999999998 109.294 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.85 66.65 3.53 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.852 -0.689 . . . . 73.239999999999995 112.926 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.412 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 11.7 p -104.11 136.76 19.15 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 110.262 -0.273 . . . . 72.430000000000007 110.262 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 38.8 Cg_exo -61.73 146.23 96.81 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.685 2.256 . . . . 74.200000000000003 112.719 176.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -67.77 122.91 19.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.623 -0.717 . . . . 75.200000000000003 111.157 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.437 ' HD1' ' CZ ' ' A' ' 87' ' ' TYR . 40.4 t80 -84.33 116.08 22.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.976 -0.557 . . . . 75.420000000000002 110.866 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.483 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 73.3 m95 -104.71 -63.01 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 74.209999999999994 109.065 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.08 172.13 31.39 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.148 -0.933 . . . . 71.549999999999997 111.305 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 p -169.83 159.82 8.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.577 0.227 . . . . 73.299999999999997 110.628 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.41 -165.03 37.62 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.855 -0.688 . . . . 61.149999999999999 111.662 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.748 ' HB3' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -137.47 147.22 45.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.914 0.387 . . . . 74.319999999999993 110.452 178.275 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -124.55 112.08 16.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.561 -0.533 . . . . 74.310000000000002 109.561 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.57 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 15.1 t0 -71.74 148.08 46.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.005 -0.543 . . . . 72.150000000000006 111.031 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 26.5 tptp -117.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.545 -0.752 . . . . 72.519999999999996 110.179 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.461 ' OD1' ' HG3' ' A' ' 121' ' ' LYS . 15.8 m120 -135.26 30.72 3.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.187 -0.46 . . . . 71.319999999999993 110.287 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.26 -31.64 6.35 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.008 -0.837 . . . . 63.020000000000003 111.008 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.457 ' HE3' ' OD2' ' A' ' 76' ' ' ASP . 44.3 mttp -100.18 96.4 7.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.19 -0.67 . . . . 74.430000000000007 109.19 173.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 4.9 p -76.26 142.56 41.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.436 -0.802 . . . . 71.150000000000006 111.254 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -96.18 121.57 38.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.86 -0.609 . . . . 74.099999999999994 109.716 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.748 ' HG3' ' HB3' ' A' ' 118' ' ' LEU . 16.0 ttt180 -102.57 132.77 48.43 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.269 -0.641 . . . . 74.519999999999996 109.269 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.558 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 39.9 p90 -133.41 160.06 38.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.038 0.447 . . . . 75.030000000000001 111.797 -170.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.2 ptp -142.31 141.04 32.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.613 -0.721 . . . . 74.450000000000003 109.888 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.527 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -97.3 122.76 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.036 0.446 . . . . 74.230000000000004 110.384 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.5 mtm -127.15 -175.98 3.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 74.25 110.282 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.528 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 5.7 m-20 -58.3 152.52 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 65.109999999999999 110.502 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.447 ' HB2' ' C ' ' A' ' 67' ' ' PRO . 35.3 ttt180 -72.79 105.62 4.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.711 -0.478 . . . . 71.310000000000002 109.711 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.528 ' CE1' ' HB2' ' A' ' 132' ' ' ASP . 28.3 m-85 -101.76 171.02 7.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.274 -0.421 . . . . 75.239999999999995 110.533 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.29 -43.97 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.674 -0.774 . . . . 74.329999999999998 111.844 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.473 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 5.6 t -120.87 159.8 24.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.069 0.462 . . . . 70.549999999999997 110.531 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.592 ' HB3' HD11 ' A' ' 184' ' ' LEU . 1.1 p30 -143.57 -172.54 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 72.329999999999998 109.78 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.519 ' HB3' ' HB3' ' A' ' 180' ' ' ALA . 6.8 mp -77.08 -24.51 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.164 -0.471 . . . . 75.150000000000006 112.075 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.769 ' HA ' ' HD1' ' A' ' 142' ' ' TYR . 3.2 pt20 -75.46 -36.29 60.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.695 -0.802 . . . . 72.25 109.968 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.856 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 43.1 mttp -57.83 -34.25 69.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 73.409999999999997 110.182 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.479 HG22 ' HG2' ' A' ' 345' ' ' GLU . 72.7 mt -76.0 -51.29 20.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.489 -0.778 . . . . 65.129999999999995 111.227 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.769 ' HD1' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -72.18 -33.85 67.99 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.752 0.649 . . . . 74.140000000000001 112.752 -170.264 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 31.2 mt-10 -72.07 -31.25 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.349 . . . . 75.540000000000006 110.913 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.54 -32.1 15.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.979 0.362 . . . . 74.530000000000001 111.979 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . 0.601 ' HB2' ' HG3' ' A' ' 345' ' ' GLU . 6.7 t-20 -98.95 0.31 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 74.349999999999994 110.742 -176.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.81 64.85 1.44 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.51 -0.768 . . . . 71.0 111.984 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.553 ' HB3' ' HD2' ' A' ' 142' ' ' TYR . 17.5 ptpt 34.09 74.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.199 1.185 . . . . 73.209999999999994 114.199 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.42 103.84 5.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 72.099999999999994 110.415 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.499 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 89.6 m-85 -121.03 155.8 33.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.975 -0.557 . . . . 75.010000000000005 110.474 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.462 ' O ' HG22 ' A' ' 154' ' ' VAL . 67.0 p -80.62 148.35 30.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.46 -0.336 . . . . 64.230000000000004 110.208 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -26.63 66.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.002 0.43 . . . . 75.200000000000003 110.549 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.437 ' HE2' ' HA ' ' A' ' 335' ' ' ASP . 63.0 tttm -62.08 -51.79 66.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.654 -0.703 . . . . 74.349999999999994 109.655 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.568 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 33.3 m -64.26 -46.84 81.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.274 -0.876 . . . . 61.119999999999997 110.497 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . 0.462 HG22 ' O ' ' A' ' 150' ' ' SER . 69.6 t -54.64 -46.01 72.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 75.129999999999995 111.462 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.621 HD22 HD21 ' A' ' 328' ' ' LEU . 1.7 tp -63.82 -49.15 73.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.615 -0.266 . . . . 73.400000000000006 110.734 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -60.44 -39.91 89.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 74.140000000000001 110.801 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.568 ' HG ' ' O ' ' A' ' 153' ' ' THR . 94.0 mt -62.41 -49.69 74.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.416 -0.356 . . . . 72.010000000000005 110.425 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 m -58.1 -40.56 81.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 72.140000000000001 111.179 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.511 HD13 ' HB2' ' A' ' 321' ' ' ARG . 3.5 mm? -61.98 -54.31 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 73.120000000000005 111.471 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.406 ' O ' HG21 ' A' ' 164' ' ' ILE . 86.6 mtt180 -64.16 -39.27 93.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 73.450000000000003 110.957 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.401 HG13 HD13 ' A' ' 195' ' ' LEU . 1.6 mp -65.89 -40.39 87.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 74.420000000000002 110.606 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.92 -44.13 96.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.616 0.246 . . . . 72.129999999999995 110.898 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.42 -55.37 35.95 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.026 -0.534 . . . . 71.239999999999995 110.846 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.406 HG21 ' O ' ' A' ' 160' ' ' ARG . 13.8 tt -69.16 -35.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.087 -0.506 . . . . 75.230000000000004 111.519 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.661 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 45.2 tp -63.81 -39.4 94.16 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.276 -0.17 . . . . 72.030000000000001 111.331 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.453 ' HA ' ' CB ' ' A' ' 169' ' ' HIS . 22.8 tp10 -80.85 -25.61 37.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.968 0.413 . . . . 65.230000000000004 110.365 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.42 -45.81 92.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.442 . . . . 71.340000000000003 110.487 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.85 -29.67 11.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 75.030000000000001 110.521 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.661 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 3.5 t-160 -61.95 -21.85 65.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.663 -0.699 . . . . 74.340000000000003 110.468 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -96.42 10.21 38.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.773 -0.648 . . . . 75.099999999999994 109.918 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . 0.529 ' CD2' ' HG2' ' A' ' 172' ' ' GLU . 73.9 t60 -116.68 -77.3 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.435 -0.348 . . . . 75.200000000000003 111.767 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.669 ' HB2' ' HA ' ' A' ' 206' ' ' PRO . 8.3 pt-20 -161.22 -10.11 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.339 1.237 . . . . 73.349999999999994 114.339 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.573 ' CD2' ' HB1' ' A' ' 201' ' ' ALA . 16.7 p90 -155.97 161.85 40.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.714 0.688 . . . . 74.140000000000001 111.229 -170.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.706 HG11 ' HE2' ' A' ' 204' ' ' TYR . 35.6 m -131.6 160.44 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.637 -0.71 . . . . 70.409999999999997 110.209 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.64 96.55 10.75 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.005 -1.109 . . . . 75.310000000000002 108.005 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.47 73.57 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.948 -0.644 . . . . 72.329999999999998 112.389 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.449 ' OD2' ' HB3' ' A' ' 179' ' ' LYS . 25.1 t70 -121.26 98.49 6.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.039 0.447 . . . . 54.140000000000001 110.305 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.495 HG22 ' O ' ' A' ' 178' ' ' ILE . 30.5 mm -87.8 38.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.388 1.09 . . . . 73.340000000000003 109.274 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . 0.449 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 7.9 ttpm? -75.95 164.83 25.79 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.586 -0.894 . . . . 74.310000000000002 108.586 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.519 ' HB3' ' HB3' ' A' ' 138' ' ' LEU . . . -56.58 -15.87 5.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.562 0.579 . . . . 63.219999999999999 112.562 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' SER . . . . . 0.416 ' OG ' ' HE2' ' A' ' 179' ' ' LYS . 11.9 p -76.82 -15.43 59.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.731 0.301 . . . . 63.310000000000002 111.595 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.406 ' HB3' HD12 ' A' ' 183' ' ' LEU . 5.6 t-20 -83.2 -30.75 27.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.626 0.727 . . . . 74.329999999999998 110.346 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.546 ' HG ' HD23 ' A' ' 195' ' ' LEU . 6.0 mp -96.11 110.9 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.999 -1.0 . . . . 75.329999999999998 110.695 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.592 HD11 ' HB3' ' A' ' 137' ' ' ASP . 2.2 mm? -98.33 156.6 16.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.704 -0.68 . . . . 73.040000000000006 110.228 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 79.5 mt -119.27 159.13 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.512 -0.551 . . . . 74.230000000000004 109.512 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 11.9 t30 -60.86 151.06 31.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.825 -1.176 . . . . 72.310000000000002 107.825 170.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -48.72 -27.83 3.18 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.085 0.772 . . . . 73.349999999999994 113.085 -166.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -156.58 34.93 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.244 0.545 . . . . 74.010000000000005 110.557 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . 0.672 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 5.0 t30 -126.08 103.5 26.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.558 -0.534 . . . . 73.420000000000002 109.558 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.61 -28.67 13.97 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.087 2.525 . . . . 62.420000000000002 114.337 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.75 -6.84 55.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.759 -0.376 . . . . 75.349999999999994 111.156 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.551 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 11.4 mm-40 -111.81 97.04 6.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 71.019999999999996 110.837 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.76 130.07 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.989 -1.005 . . . . 71.299999999999997 110.322 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.485 ' CD2' ' HE1' ' A' ' 134' ' ' PHE . 35.0 m-85 -124.43 147.38 48.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.063 -0.717 . . . . 70.420000000000002 109.063 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.546 HD23 ' HG ' ' A' ' 183' ' ' LEU . 49.4 mt -96.56 116.3 28.86 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.593 -0.443 . . . . 72.310000000000002 110.814 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' A' ' 198' ' ' TYR . 2.7 p -148.43 87.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.817 0.818 . . . . 64.439999999999998 110.963 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.75 -50.91 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 60.43 109.493 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.549 ' CE2' HG22 ' A' ' 196' ' ' VAL . 18.5 m-85 51.51 35.02 13.39 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.494 -0.775 . . . . 72.510000000000005 110.705 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.641 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -154.27 -31.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.853 -1.067 . . . . 65.230000000000004 112.117 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.44 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 25.7 mt -97.01 9.77 41.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.78 0.8 . . . . 74.450000000000003 108.855 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.573 ' HB1' ' CD2' ' A' ' 173' ' ' TYR . . . -97.46 111.67 23.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.831 -1.077 . . . . 73.230000000000004 110.528 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -98.49 115.26 28.17 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.204 -0.453 . . . . 74.140000000000001 109.907 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.421 ' NH2' ' HB3' ' A' ' 206' ' ' PRO . 0.6 OUTLIER -87.74 114.54 24.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.54 0.686 . . . . 73.439999999999998 110.101 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.706 ' HE2' HG11 ' A' ' 174' ' ' VAL . 9.5 p90 -89.65 -41.57 11.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.142 -0.935 . . . . 73.129999999999995 111.527 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.656 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 78.0 m -153.04 108.18 2.65 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.599 -0.519 . . . . 73.549999999999997 109.599 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.669 ' HA ' ' HB2' ' A' ' 172' ' ' GLU . 28.0 Cg_endo -63.32 84.05 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.899 2.399 . . . . 72.400000000000006 113.628 -174.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 76.48 -11.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.263 1.025 . . . . 74.439999999999998 110.574 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 206' ' ' PRO . . . -105.92 51.65 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.418 -1.073 . . . . 70.319999999999993 110.418 175.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . 0.656 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 3.4 p -48.88 111.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.742 0.782 . . . . 74.549999999999997 113.075 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -164.13 70.9 0.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 74.510000000000005 109.003 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.565 ' HB2' ' SG ' ' A' ' 205' ' ' CYS . 47.2 tptt -139.54 111.06 7.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.473 -0.785 . . . . 73.140000000000001 109.402 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -101.53 176.42 5.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 75.400000000000006 111.278 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 9.6 p90 -74.17 84.04 1.84 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.634 -0.712 . . . . 73.439999999999998 110.527 177.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -166.17 28.07 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.456 0.646 . . . . 75.219999999999999 109.771 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.64 144.5 51.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 75.129999999999995 111.594 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -173.82 91.76 0.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.048 -0.978 . . . . 73.430000000000007 108.567 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.29 -51.69 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.14 1.894 . . . . 74.25 110.948 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.765 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.1 OUTLIER -168.57 26.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.772 -0.825 . . . . 73.540000000000006 108.772 176.979 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.617 ' HA ' ' O ' ' A' ' 234' ' ' ASN . 99.0 mtt180 61.56 101.99 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.971 -1.013 . . . . 73.019999999999996 111.652 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.86 -36.12 64.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.821 -1.081 . . . . 72.439999999999998 112.416 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 48.84 44.07 21.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.521 0.728 . . . . 74.5 111.945 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . 0.602 ' OD1' HG21 ' A' ' 228' ' ' THR . 1.0 OUTLIER -40.65 -77.33 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.149 1.166 . . . . 62.43 114.149 176.675 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.408 ' O ' ' HE1' ' A' ' 233' ' ' HIS . . . -127.0 -116.35 2.01 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.449 -0.881 . . . . 61.240000000000002 114.229 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.9 m -92.1 110.67 22.05 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.369 0.267 . . . . 63.219999999999999 111.438 -173.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.1 tt -58.36 -19.09 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 111.88 0.326 . . . . 73.129999999999995 111.88 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.94 -61.83 2.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.44 -0.345 . . . . 74.329999999999998 110.642 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.445 ' HD2' ' SG ' ' A' ' 250' ' ' CYS . 84.4 m-85 -86.15 -42.95 13.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.634 -0.257 . . . . 74.219999999999999 110.817 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.602 HG21 ' OD1' ' A' ' 222' ' ' ASP . 26.0 m -57.91 -27.67 63.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.158 -0.474 . . . . 74.420000000000002 111.364 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 71.5 m 65.99 -170.01 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.592 -0.731 . . . . 73.349999999999994 111.463 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . 0.457 HD11 ' H ' ' A' ' 230' ' ' ILE . 0.1 OUTLIER -72.65 -33.89 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 74.019999999999996 112.218 -175.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -58.09 -75.25 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.999 0.74 . . . . 63.539999999999999 112.999 -172.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.46 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.04 -30.47 71.0 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.185 0.517 . . . . 62.140000000000001 111.346 -176.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 229' ' ' SER . 1.5 t60 -71.74 -23.92 61.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.855 -0.612 . . . . 73.310000000000002 111.043 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.617 ' O ' ' HA ' ' A' ' 219' ' ' ARG . 6.3 m-20 -97.54 -15.19 20.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 73.230000000000004 111.035 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.2 -9.95 59.72 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.294 -0.955 . . . . 61.219999999999999 112.689 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 8.1 p -71.64 129.72 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 74.140000000000001 109.639 176.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -61.51 116.95 22.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.009 -0.541 . . . . 72.430000000000007 112.112 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.77 106.11 0.31 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.779 2.319 . . . . 74.019999999999996 110.835 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.0 p -130.51 109.49 10.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.954 -0.566 . . . . 73.409999999999997 111.505 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.716 ' HG2' HG23 ' A' ' 312' ' ' THR . 2.2 mpt_? 76.66 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.005 -0.998 . . . . 71.409999999999997 110.994 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.634 ' HD3' ' O ' ' A' ' 310' ' ' ASP . 21.6 ttp180 -69.58 -30.94 68.83 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.297 -0.561 . . . . 73.209999999999994 110.172 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -52.94 46.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 74.140000000000001 111.782 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.437 ' HB3' HD23 ' A' ' 165' ' ' LEU . 4.5 m-20 -53.84 -46.04 71.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.463 0.649 . . . . 74.329999999999998 110.327 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . 0.47 HD12 HD21 ' A' ' 320' ' ' LEU . 75.0 mt -71.75 -35.99 70.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.478 -0.783 . . . . 75.540000000000006 111.699 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.64 -39.95 95.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 72.329999999999998 110.329 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 227' ' ' PHE . 80.3 mt -64.85 -49.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.62 . . . . 75.519999999999996 110.307 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.571 HD23 ' HH ' ' A' ' 302' ' ' TYR . 51.1 tp -58.81 -47.13 85.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.286 -0.415 . . . . 72.299999999999997 111.251 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -34.7 90.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.958 -0.639 . . . . 75.219999999999999 112.243 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.415 ' CD2' ' HE3' ' A' ' 275' ' ' LYS . 24.0 t80 -62.72 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.231 0.539 . . . . 74.030000000000001 109.811 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.445 ' SG ' ' HD2' ' A' ' 227' ' ' PHE . 60.5 m -61.67 -45.36 94.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.625 -0.716 . . . . 72.519999999999996 110.433 176.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.496 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -55.23 -52.97 61.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.943 -0.571 . . . . 65.109999999999999 111.612 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.9 tt -65.49 -37.16 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 70.049999999999997 111.124 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -69.14 -42.21 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 74.120000000000005 111.771 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 41.0 m0 -62.34 -31.84 72.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 75.310000000000002 110.674 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.16 -41.26 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.189 -0.459 . . . . 75.239999999999995 112.208 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 65.2 p -104.06 -29.11 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.767 0.654 . . . . 73.519999999999996 112.767 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.0 24.09 64.51 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 121.056 -0.592 . . . . 75.140000000000001 112.985 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -155.67 142.86 19.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.114 0.457 . . . . 75.349999999999994 109.937 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 20.4 mt -130.57 149.75 74.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 75.219999999999999 111.272 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.2 6.45 3.47 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.97 2.447 . . . . 74.340000000000003 112.926 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -143.45 24.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 73.420000000000002 110.914 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.534 ' HA ' HD22 ' A' ' 265' ' ' LEU . 12.9 pt-20 -63.83 -30.38 71.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.362 0.504 . . . . 64.109999999999999 112.362 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . 0.569 ' O ' ' HD2' ' A' ' 266' ' ' LYS . 34.5 t70 -83.02 -25.61 32.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.379 -0.529 . . . . 75.409999999999997 109.796 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.81 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 95.2 m-20 -77.34 -3.78 41.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.782 -0.644 . . . . 73.549999999999997 110.469 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 262' ' ' GLU . 2.1 mm? -61.57 -18.56 59.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.802 -0.636 . . . . 71.120000000000005 110.592 172.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . 0.569 ' HD2' ' O ' ' A' ' 263' ' ' ASP . 6.0 ptmt -70.57 -19.27 62.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 75.040000000000006 111.604 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.593 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 16.1 t70 -135.5 132.56 19.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.955 0.407 . . . . 64.219999999999999 111.38 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -62.24 -30.68 81.85 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.247 2.631 . . . . 75.319999999999993 114.494 -175.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . 0.593 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 7.3 ptpp? -73.57 -29.56 62.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.879 -0.728 . . . . 75.420000000000002 109.832 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.81 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 54.3 m-85 -76.97 -44.35 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.729 -0.669 . . . . 74.420000000000002 111.451 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.481 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 29.9 m -63.89 -35.8 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.839 -0.345 . . . . 75.019999999999996 110.796 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -61.83 -57.49 11.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 74.129999999999995 110.287 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.76 -49.74 73.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.335 -0.848 . . . . 75.129999999999995 111.127 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 20.1 m -63.11 -44.58 95.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.099999999999994 111.595 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE3' ' CD2' ' A' ' 249' ' ' TYR . 68.5 tttt -66.04 -37.33 85.59 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.684 -0.406 . . . . 74.120000000000005 110.457 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 78.5 mt -69.01 -47.9 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.606 -0.27 . . . . 73.25 111.146 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -60.96 -40.71 94.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.332 . . . . 73.040000000000006 110.908 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -73.4 -31.45 63.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 70.239999999999995 110.985 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.45 -20.2 65.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 74.430000000000007 111.133 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -80.39 -35.59 35.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.457 -0.338 . . . . 75.140000000000001 110.79 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -123.23 47.51 1.98 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.814 0.34 . . . . 73.030000000000001 110.651 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.0 mt -51.84 -52.84 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.33 0.863 . . . . 75.120000000000005 113.33 -171.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -62.83 -48.66 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.244 0.461 . . . . 70.219999999999999 112.244 -169.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.0 m -64.88 -48.41 74.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.219 0.533 . . . . 72.099999999999994 110.558 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.64 -54.4 16.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.523 -0.762 . . . . 74.420000000000002 111.674 -174.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -65.04 -43.34 92.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.57 0.211 . . . . 75.109999999999999 111.57 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.42 -39.94 81.4 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.804 -0.359 . . . . 74.129999999999995 111.278 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -76.42 -20.73 56.8 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.99 -0.284 . . . . 74.049999999999997 111.377 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . 0.451 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 97.9 m -76.86 -16.35 59.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 74.510000000000005 110.476 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.48 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 59.4 t80 -115.24 81.06 7.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.576 -0.527 . . . . 74.030000000000001 109.576 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 91.1 Cg_endo -95.26 34.92 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.458 2.772 . . . . 65.340000000000003 112.13 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -82.18 -174.9 5.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.594 -0.73 . . . . 74.329999999999998 110.258 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.464 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.7 mmtt -89.28 13.17 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.106 0.479 . . . . 73.120000000000005 110.848 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.48 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 3.1 t-20 -105.88 -163.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.292 -1.003 . . . . 74.510000000000005 108.292 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.434 ' HE3' ' HB ' ' A' ' 331' ' ' ILE . 19.6 pttp -149.66 124.9 4.87 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.79 0.328 . . . . 75.430000000000007 111.208 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -95.43 37.22 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 61.43 111.88 174.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.67 86.64 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.95 -0.643 . . . . 65.129999999999995 111.838 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.705 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.4 mp0 -52.43 -46.49 66.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.029 0.442 . . . . 72.450000000000003 110.7 176.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . 0.416 HG13 ' HE2' ' A' ' 251' ' ' MET . 3.8 mp -71.97 -42.69 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.78 -0.645 . . . . 64.209999999999994 110.789 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.83 68.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.809 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 301' ' ' LYS . 23.3 mtpp -75.07 -30.16 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 74.349999999999994 111.506 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . 0.571 ' HH ' HD23 ' A' ' 247' ' ' LEU . 66.0 t80 -55.45 -45.96 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.083 0.468 . . . . 73.5 110.134 171.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG22 ' A' ' 306' ' ' VAL . 72.1 mtp -72.28 -35.42 68.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 75.200000000000003 110.64 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -57.42 -44.33 84.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.577 0.703 . . . . 64.329999999999998 109.583 173.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.8 m -61.13 -49.98 75.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.891 -1.05 . . . . 71.510000000000005 111.893 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 303' ' ' MET . 16.8 m -66.77 -27.53 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.911 0.386 . . . . 75.120000000000005 110.758 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -65.25 -42.26 93.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 75.200000000000003 110.042 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 50.0 tp -71.37 -21.61 62.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.428 -0.805 . . . . 64.299999999999997 110.906 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.421 HD21 ' O ' ' A' ' 309' ' ' LEU . 6.3 tt -71.1 -14.75 62.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.043 -0.526 . . . . 72.319999999999993 110.291 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.634 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 34.8 t70 67.56 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.628 -0.715 . . . . 50.409999999999997 111.852 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -136.43 -51.93 0.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.24 -0.652 . . . . 74.209999999999994 109.24 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.716 HG23 ' HG2' ' A' ' 240' ' ' ARG . 55.3 m -148.37 75.88 1.34 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.786 -0.643 . . . . 74.109999999999999 111.358 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -83.3 -165.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.106 -1.072 . . . . 75.209999999999994 108.106 162.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.443 ' HD3' ' C ' ' A' ' 314' ' ' LYS . 11.0 tmtt? -76.13 113.53 28.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.516 -0.92 . . . . 70.219999999999999 108.516 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.539 ' HG3' ' HG3' ' A' ' 240' ' ' ARG . 12.3 Cg_exo -68.43 117.46 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.038 1.826 . . . . 73.349999999999994 110.966 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . 0.479 ' O ' HD13 ' A' ' 320' ' ' LEU . 95.6 mt -94.11 68.68 3.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.072 -0.513 . . . . 72.510000000000005 110.521 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -57.92 -32.86 68.18 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.211 -0.663 . . . . 64.349999999999994 109.211 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.4 mp0 -58.01 -56.7 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.756 -1.111 . . . . 73.530000000000001 110.302 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . 0.474 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 26.2 t-20 -71.96 -33.17 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 75.439999999999998 111.734 -175.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.528 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 7.9 mp -61.28 -48.19 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.367 . . . . 72.239999999999995 111.058 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.511 ' HB2' HD13 ' A' ' 159' ' ' LEU . 15.4 ptp180 -72.01 -24.67 61.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.325 -0.55 . . . . 73.349999999999994 109.951 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.08 -49.02 55.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 73.049999999999997 110.989 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . 0.403 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -62.68 -39.0 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 110.066 -0.346 . . . . 75.040000000000006 110.066 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.53 ' HB3' HD13 ' A' ' 155' ' ' LEU . 79.5 mt -62.33 -49.74 74.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 70.019999999999996 110.527 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . 0.644 ' O ' ' HG3' ' A' ' 329' ' ' LYS . 4.1 mm? -70.15 -26.9 64.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 64.329999999999998 111.366 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.01 -43.54 64.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.918 0.389 . . . . 71.519999999999996 110.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.705 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.03 -36.04 92.57 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 61.340000000000003 111.798 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.621 HD21 HD22 ' A' ' 155' ' ' LEU . 17.4 tp -69.21 -29.93 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 74.129999999999995 110.057 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . 0.644 ' HG3' ' O ' ' A' ' 325' ' ' LEU . 62.3 mttp -65.28 -38.78 91.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 61.539999999999999 110.55 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.28 73.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.755 -0.657 . . . . 74.049999999999997 111.655 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.434 ' HB ' ' HE3' ' A' ' 295' ' ' LYS . 15.2 tt -92.64 2.49 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 63.509999999999998 110.375 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.09 25.77 73.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.897 -0.668 . . . . 61.109999999999999 113.576 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' SER . . . . . 0.5 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 25.6 m -121.83 158.93 27.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.435 0.617 . . . . 74.340000000000003 111.272 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -150.74 172.76 15.07 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.042 -0.725 . . . . 73.400000000000006 109.042 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . 0.437 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 30.6 t70 -120.63 127.74 52.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.763 -0.458 . . . . 74.439999999999998 109.763 172.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.74 21.11 3.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 64.299999999999997 110.832 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.23 45.37 15.24 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.491 -1.043 . . . . 64.439999999999998 110.491 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -131.94 -32.96 1.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.559 -0.32 . . . . 74.299999999999997 111.716 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 153' ' ' THR . 78.2 mt 65.65 179.56 0.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.496 0.497 . . . . 73.209999999999994 110.313 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -179.48 82.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.154 0.502 . . . . 74.430000000000007 109.83 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.468 HD12 ' N ' ' A' ' 342' ' ' SER . 1.4 pp -106.98 -36.61 6.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.99 -0.55 . . . . 75.209999999999994 110.857 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' SER . . . . . 0.468 ' N ' HD12 ' A' ' 341' ' ' LEU . 77.3 p 178.33 -119.93 0.0 OUTLIER 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.819 -0.628 . . . . 74.049999999999997 109.584 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.427 ' O ' ' HB ' ' A' ' 344' ' ' VAL . 7.4 p -131.29 9.82 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.526 0.679 . . . . 74.140000000000001 109.287 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.427 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 57.9 t 74.63 105.95 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 114.927 -1.033 . . . . 73.510000000000005 109.747 -175.14 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 145' ' ' ASN . 8.6 mm-40 -72.56 -54.5 9.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.64 -0.709 . . . . 75.230000000000004 112.724 -168.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . 0.856 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 4.8 m-20 74.06 115.26 0.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.71 0.631 . . . . 74.310000000000002 110.699 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 151.78 64.9 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.136 -0.786 . . . . 75.230000000000004 111.136 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . 170.99 132.1 1.43 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.057 -0.592 . . . . 62.409999999999997 112.008 -176.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.6 tt -175.56 103.92 0.08 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.904 -0.406 . . . . 74.420000000000002 109.904 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.801 ' HA ' ' HE2' ' A' ' 350' ' ' LYS . 7.4 mmpt? -146.42 115.03 6.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.304 -0.628 . . . . 74.040000000000006 109.304 176.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -130.87 171.63 12.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 73.340000000000003 111.779 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.641 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 57.7 tptt -163.67 152.9 14.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.51 -0.922 . . . . 75.299999999999997 108.51 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.4 t -73.18 164.62 26.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.522 0.146 . . . . 74.430000000000007 110.656 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.548 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -66.3 142.36 16.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 71.540000000000006 111.683 -174.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.0 t -75.36 134.84 40.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.766 -0.457 . . . . 71.099999999999994 109.766 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.06 -61.07 1.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.646 0.736 . . . . 73.400000000000006 109.105 178.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -131.1 -166.32 1.68 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.799 -1.091 . . . . 74.239999999999995 108.222 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -77.49 86.18 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 72.409999999999997 109.539 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 48.6 tttm 76.44 -55.49 0.58 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.065 -0.971 . . . . 75.420000000000002 111.03 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.562 -0.733 . . . . 72.129999999999995 110.301 176.788 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.436 -0.209 . . . . 74.040000000000006 110.436 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.58 138.99 39.33 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.685 2.257 . . . . 70.319999999999993 111.607 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -86.08 -46.49 10.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.157 -0.474 . . . . 74.5 111.396 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.31 133.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.741 0.305 . . . . 71.400000000000006 111.418 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -103.2 118.75 37.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.636 -0.875 . . . . 73.209999999999994 108.636 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.18 122.33 40.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.108 0.48 . . . . 73.329999999999998 112.123 -171.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.72 128.73 9.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.378 -0.828 . . . . 53.329999999999998 108.979 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -134.17 131.63 38.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 73.510000000000005 111.466 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.68 37.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.509 -0.769 . . . . 74.129999999999995 109.264 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.23 152.9 19.89 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.578 -0.82 . . . . 61.310000000000002 111.987 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -83.58 134.08 34.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.98 0.419 . . . . 72.319999999999993 110.721 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -139.48 114.72 9.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 71.519999999999996 109.425 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -90.1 122.81 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.083 0.468 . . . . 63.32 111.218 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 m -81.73 80.28 8.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.182 -0.673 . . . . 73.030000000000001 109.182 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.83 133.1 47.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 71.340000000000003 112.199 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.562 -0.745 . . . . 73.150000000000006 109.774 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.99 122.45 47.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.092 -0.706 . . . . 74.040000000000006 109.092 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -89.61 85.72 6.55 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.407 -0.517 . . . . 75.310000000000002 110.533 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 tt -109.43 92.6 4.12 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.338 -0.986 . . . . 65.120000000000005 108.338 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -71.66 0.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.965 -0.562 . . . . 75.109999999999999 111.295 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -120.81 152.05 38.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.125 0.488 . . . . 72.439999999999998 111.14 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -80.05 72.12 6.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 74.409999999999997 109.948 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -131.59 18.7 4.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.945 0.879 . . . . 75.310000000000002 109.32 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.7 -48.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.768 -1.105 . . . . 63.140000000000001 109.252 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.06 116.72 5.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.39 -0.823 . . . . 73.099999999999994 110.374 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.52 -9.1 62.44 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.776 -0.647 . . . . 71.420000000000002 112.547 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.61 138.37 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 73.120000000000005 111.091 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -95.4 129.17 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.654 -0.703 . . . . 73.439999999999998 111.909 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 31.3 pt -121.78 137.63 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.665 -0.698 . . . . 71.420000000000002 109.195 167.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 18.6 m -118.36 124.26 47.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.107 -0.237 . . . . 75.209999999999994 111.238 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.52 -177.93 4.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.459 -0.337 . . . . 71.109999999999999 110.482 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -16.78 62.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 71.519999999999996 112.744 -173.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.65 30.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.776 0.322 . . . . 72.5 110.525 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt 58.44 77.94 0.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.286 -0.87 . . . . 75.420000000000002 111.354 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 30' ' ' THR . 47.0 mmtm -136.09 125.18 24.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 71.109999999999999 108.73 173.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.18 85.45 6.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.008 0.432 . . . . 75.319999999999993 110.236 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.501 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 45.1 m95 -79.34 117.04 19.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.887 -0.597 . . . . 72.109999999999999 109.479 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.59 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 23.0 pttm -97.38 131.18 44.3 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.882 -0.727 . . . . 72.329999999999998 109.181 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.481 HG11 ' HB3' ' A' ' 52' ' ' TYR . 59.0 t -67.8 130.32 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.931 -0.577 . . . . 71.450000000000003 110.947 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.15 -101.49 1.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.752 -0.737 . . . . 63.350000000000001 111.78 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -84.41 121.96 75.18 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.049 0.452 . . . . 72.129999999999995 110.11 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.436 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 7.4 Cg_exo -73.72 99.72 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.034 2.49 . . . . 73.230000000000004 111.376 175.06 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.94 -56.34 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 72.439999999999998 110.585 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.84 -24.76 28.27 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.82 -0.705 . . . . 72.129999999999995 112.246 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -134.9 165.72 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.951 0.405 . . . . 74.540000000000006 111.266 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.62 52.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.596 -0.729 . . . . 61.009999999999998 111.743 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.4 16.79 77.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.923 -0.656 . . . . 72.0 112.892 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -168.22 -84.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.117 -0.327 . . . . 74.209999999999994 110.117 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.28 144.92 4.2 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.283 -0.96 . . . . 63.100000000000001 112.67 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.8 m 62.67 61.15 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.323 0.582 . . . . 75.120000000000005 111.016 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.629 HD11 ' HB3' ' A' ' 71' ' ' LYS . 1.1 mm -118.31 138.29 49.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.805 -0.634 . . . . 74.239999999999995 109.836 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' HB3' HG11 ' A' ' 39' ' ' VAL . 97.7 m-85 -122.28 154.13 37.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.53 0.205 . . . . 71.519999999999996 110.623 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.95 132.37 34.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.914 -0.773 . . . . 75.420000000000002 108.914 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.29 98.9 8.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 74.019999999999996 112.126 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.69 59.87 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.913 -0.585 . . . . 74.530000000000001 109.876 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' MET . . . . . 0.501 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.3 ttm -36.52 -72.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.162 0.914 . . . . 75.340000000000003 112.825 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -178.57 -176.27 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.322 -0.992 . . . . 75.430000000000007 108.322 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.3 m -70.76 123.67 22.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.574 -0.528 . . . . 70.040000000000006 109.574 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.551 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 16.0 t -105.63 176.95 5.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.238 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.32 -73.23 0.17 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 75.439999999999998 110.581 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -112.25 66.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.411 0.624 . . . . 72.439999999999998 109.703 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.551 ' HB ' ' HB3' ' A' ' 59' ' ' SER . 12.6 p -81.62 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.675 -0.693 . . . . 72.140000000000001 110.16 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.61 165.48 40.6 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 109.728 -1.349 . . . . 54.240000000000002 109.728 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -79.95 60.42 3.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.424 0.63 . . . . 74.340000000000003 110.045 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -178.27 -120.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.636 -1.166 . . . . 72.420000000000002 108.664 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -179.2 93.45 0.21 Allowed Pre-proline 0 C--N 1.32 -0.679 0 C-N-CA 123.811 0.844 . . . . 64.400000000000006 108.821 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.595 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 84.9 Cg_endo -82.59 39.05 0.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.3 . . . . 72.510000000000005 112.836 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 70.9 m -136.81 137.57 39.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.577 0.704 . . . . 55.539999999999999 112.15 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.66 154.0 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.203 -0.908 . . . . 75.019999999999996 109.323 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.8 p -125.22 123.99 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.455 0.645 . . . . 75.450000000000003 111.746 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.629 ' HB3' HD11 ' A' ' 51' ' ' ILE . 10.5 ptmm? -103.23 133.81 47.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.228 -0.896 . . . . 73.109999999999999 109.487 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.57 148.72 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.082 0.401 . . . . 74.299999999999997 112.082 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . 0.412 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 31.9 tt0 -142.43 139.49 17.63 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 108.43 -0.952 . . . . 73.420000000000002 108.43 171.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.39 176.19 2.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.312 2.008 . . . . 74.530000000000001 111.697 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.2 m -79.53 41.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.112 0.482 . . . . 71.219999999999999 111.537 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -84.06 -24.66 30.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.255 -0.43 . . . . 74.420000000000002 110.33 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 70.01 75.76 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.429 0.633 . . . . 72.099999999999994 110.371 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -124.52 -128.21 3.25 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.48 -0.782 . . . . 73.219999999999999 112.271 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.408 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 19.3 Cg_endo -59.95 -35.0 94.85 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.874 2.383 . . . . 74.450000000000003 112.759 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.412 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.2 tm? -56.03 -50.01 72.12 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.122 0.264 . . . . 74.349999999999994 111.12 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -67.21 -38.14 84.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.745 0.307 . . . . 73.439999999999998 111.063 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.5 m -64.96 -46.84 79.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 75.299999999999997 109.811 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.69 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 39.7 tt0 -60.77 -43.34 98.16 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.694 -1.139 . . . . 71.209999999999994 110.209 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.22 -48.64 73.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 75.400000000000006 110.796 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -56.79 -58.5 7.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 74.540000000000006 110.276 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.416 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 79.6 t80 -59.67 -51.32 70.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.27 -0.877 . . . . 75.420000000000002 111.388 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.401 ' HE2' ' HD1' ' A' ' 113' ' ' TYR . 91.8 t80 -58.58 -47.16 85.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.343 -0.844 . . . . 71.239999999999995 111.648 -176.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -68.32 -30.08 68.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 74.450000000000003 111.103 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.33 -30.36 62.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 73.409999999999997 111.521 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -34.37 11.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.468 0.544 . . . . 70.400000000000006 112.468 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.47 88.98 7.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.389 0.515 . . . . 50.219999999999999 112.389 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LYS . . . . . 0.487 ' HE3' ' HB2' ' A' ' 95' ' ' GLN . 1.3 ttpp -146.12 105.86 4.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.989 -0.745 . . . . 73.120000000000005 108.989 171.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 -54.11 5.46 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.899 3.066 . . . . 72.349999999999994 115.041 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -33.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.381 . . . . 73.540000000000006 110.497 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.487 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 26.0 tp60 -65.03 -47.94 75.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 73.129999999999995 110.016 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG13 ' O ' ' A' ' 92' ' ' LYS . 74.2 mt -58.98 -53.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 115.676 -0.693 . . . . 73.120000000000005 110.685 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.0 -41.67 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 72.530000000000001 110.961 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -65.24 -53.18 48.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.145 -0.48 . . . . 73.409999999999997 111.502 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TRP . . . . . 0.415 ' CZ2' HD21 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -72.91 -34.65 66.76 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.931 -0.708 . . . . 72.409999999999997 110.965 -175.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.4 mm -63.16 -45.17 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.666 0.27 . . . . 73.230000000000004 111.031 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -73.03 -27.9 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.807 0.337 . . . . 70.049999999999997 110.544 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.8 m -75.75 -40.87 54.68 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.12 0.486 . . . . 75.329999999999998 110.574 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.701 ' HG3' HD11 ' A' ' 105' ' ' LEU . 31.1 tpt180 -72.55 -18.41 61.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 74.25 110.365 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 104' ' ' LYS . 39.8 tptt 67.57 54.05 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.963 -1.017 . . . . 72.340000000000003 110.217 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . 0.701 HD11 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mp -108.56 -167.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.824 -1.08 . . . . 75.340000000000003 109.449 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.584 ' HB3' ' HZ1' ' A' ' 106' ' ' LYS . 5.2 mtpm? -100.11 -61.91 1.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.098 -0.334 . . . . 73.019999999999996 110.098 -177.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -173.78 144.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 73.549999999999997 110.339 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 110' ' ' VAL . 44.3 tp -79.43 115.0 18.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.968 -0.753 . . . . 71.329999999999998 108.968 175.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.469 ' HA3' ' NH2' ' A' ' 160' ' ' ARG . . . -77.42 60.24 3.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.019 -0.61 . . . . 71.040000000000006 113.098 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.582 HG23 ' HG ' ' A' ' 108' ' ' LEU . 92.1 t -123.47 132.87 24.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.384 -0.598 . . . . 75.510000000000005 109.384 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.69 152.83 12.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.103 2.535 . . . . 74.140000000000001 112.996 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -76.94 122.33 24.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 74.319999999999993 110.674 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.401 ' HD1' ' HE2' ' A' ' 87' ' ' TYR . 56.2 t80 -80.74 111.77 17.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.257 -0.883 . . . . 72.140000000000001 110.276 178.285 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.467 ' HB2' HG22 ' A' ' 130' ' ' ILE . 40.4 m95 -90.2 -59.28 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.49 -0.559 . . . . 74.349999999999994 109.49 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.32 37.9 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.321 -0.854 . . . . 73.200000000000003 111.35 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.2 p -163.34 172.97 13.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.805 -0.443 . . . . 72.329999999999998 109.805 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.94 -173.01 40.78 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.124 -1.036 . . . . 75.239999999999995 112.271 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.461 HD22 ' HB2' ' A' ' 125' ' ' SER . 8.6 tt -121.44 132.93 55.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.395 -0.595 . . . . 71.540000000000006 109.395 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -139.22 126.65 21.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.863 0.363 . . . . 75.420000000000002 110.422 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 21.6 t70 -75.68 126.75 31.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.803 -0.635 . . . . 71.400000000000006 110.487 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.853 ' HE2' ' HA ' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -83.45 -54.7 4.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.982 -0.377 . . . . 74.450000000000003 109.982 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.09 71.47 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.591 -0.522 . . . . 72.430000000000007 109.591 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.35 -19.08 49.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.831 -0.699 . . . . 73.310000000000002 111.632 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -113.76 120.0 39.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.124 -0.695 . . . . 71.439999999999998 109.124 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . 0.639 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.6 p -92.87 134.52 35.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 71.439999999999998 110.813 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.09 140.24 50.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.974 -0.557 . . . . 74.040000000000006 110.312 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -105.61 124.56 49.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.083 -0.71 . . . . 74.120000000000005 109.083 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.587 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 48.7 p90 -122.29 154.42 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.075 -0.511 . . . . 73.329999999999998 110.869 -173.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 80.3 mtp -129.61 124.77 34.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 65.400000000000006 110.777 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ILE . . . . . 0.554 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 mm -98.13 121.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 71.129999999999995 110.461 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -133.25 178.09 7.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 74.010000000000005 109.321 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.595 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.3 p-10 -68.13 154.96 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 61.039999999999999 110.202 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -83.26 122.99 29.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.385 0.612 . . . . 71.109999999999999 112.118 -171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PHE . . . . . 0.442 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 90.2 m-85 -102.8 171.55 7.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.195 -0.911 . . . . 74.239999999999995 109.121 173.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.25 -30.43 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.886 -1.15 . . . . 65.010000000000005 113.24 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' SER . . . . . 0.775 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 49.9 m -105.27 125.67 51.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.048 0.424 . . . . 73.409999999999997 112.057 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.432 ' HA ' HD13 ' A' ' 184' ' ' LEU . 3.9 m-20 -88.91 124.14 33.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.805 -0.634 . . . . 75.099999999999994 109.543 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.458 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 13.4 tp -64.35 -26.26 68.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.221 0.534 . . . . 73.400000000000006 109.768 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.546 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 28.2 tt0 -62.9 -48.7 77.84 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.787 -0.642 . . . . 71.209999999999994 110.977 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.716 ' HE2' ' HA ' ' A' ' 140' ' ' LYS . 9.0 mmpt? -70.07 -29.79 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.233 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.518 HG21 HD12 ' A' ' 341' ' ' LEU . 82.3 mt -65.09 -48.98 81.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.653 -0.703 . . . . 73.409999999999997 110.993 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . 0.546 ' CD2' ' HA ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.77 -32.12 73.21 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 119.866 -0.734 . . . . 74.340000000000003 109.68 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.05 -38.9 89.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 73.319999999999993 110.69 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.6 67.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 71.200000000000003 111.917 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -104.55 6.09 34.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.432 . . . . 64.140000000000001 110.906 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.57 54.9 6.02 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.706 -0.679 . . . . 73.400000000000006 112.257 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.483 ' HE3' ' O ' ' A' ' 257' ' ' GLY . 46.3 mtmt 55.59 53.44 9.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 75.239999999999995 112.569 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -123.46 96.41 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 74.420000000000002 109.87 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.643 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 21.7 m-85 -102.14 132.21 48.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.202 -0.454 . . . . 75.540000000000006 111.016 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 m -58.2 144.96 38.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.504 -0.771 . . . . 75.349999999999994 109.628 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.497 ' NH1' ' HB3' ' A' ' 294' ' ' ASN . 45.9 ttt85 -59.92 -37.9 80.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.686 -0.234 . . . . 73.340000000000003 111.51 -172.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . 0.544 ' HG3' ' N ' ' A' ' 153' ' ' THR . 11.9 ptpt -61.67 -38.19 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 64.519999999999996 110.253 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . 0.544 ' N ' ' HG3' ' A' ' 152' ' ' LYS . 9.0 m -68.0 -45.37 74.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.106 -0.497 . . . . 73.420000000000002 110.436 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.6 t -61.89 -47.34 93.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.385 -0.37 . . . . 72.319999999999993 110.585 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -62.84 -52.4 63.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 74.439999999999998 110.545 -176.333 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -63.48 -33.52 75.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.587 0.232 . . . . 74.200000000000003 110.812 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . 0.57 ' O ' HG12 ' A' ' 161' ' ' ILE . 2.7 mp -65.94 -51.21 60.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 73.439999999999998 110.681 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.45 ' HB2' HD23 ' A' ' 247' ' ' LEU . 36.3 p -58.18 -37.16 74.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.075 -0.25 . . . . 72.109999999999999 110.902 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.53 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 74.5 mt -60.33 -54.39 46.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 75.209999999999994 111.219 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.478 HH11 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -66.57 -15.76 63.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.118 0.485 . . . . 73.510000000000005 111.0 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.57 HG12 ' O ' ' A' ' 157' ' ' LEU . 37.4 mm -72.35 -42.41 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.452 -0.573 . . . . 63.109999999999999 109.452 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.521 ' HB3' ' HE1' ' A' ' 317' ' ' TYR . 2.2 mm? -62.04 -42.21 98.93 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.62 -0.263 . . . . 73.420000000000002 110.459 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -63.03 1.22 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.6 0.714 . . . . 64.219999999999999 110.703 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . 0.423 ' O ' HG22 ' A' ' 168' ' ' ILE . 18.1 tt -68.16 -41.4 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.234 -0.894 . . . . 75.409999999999997 111.565 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.516 HD13 ' HB3' ' A' ' 243' ' ' ASP . 30.9 mt -63.66 -39.02 93.29 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.516 -0.474 . . . . 72.0 110.885 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 7.5 tp10 -57.28 -56.68 18.63 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.819 -0.438 . . . . 75.230000000000004 109.819 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.8 -42.94 80.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.473 -0.785 . . . . 74.239999999999995 112.078 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 174' ' ' VAL . 28.1 pt -80.7 -40.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.943 0.719 . . . . 73.010000000000005 112.943 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' HIS . . . . . 0.462 ' NE2' ' HA ' ' A' ' 166' ' ' GLU . 1.3 p-80 -75.89 -17.83 59.64 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.696 -0.802 . . . . 73.219999999999999 111.253 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.3 16.33 17.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 71.299999999999997 109.966 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -136.95 -89.01 0.28 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.106 -0.497 . . . . 73.340000000000003 110.88 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -147.56 114.96 6.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.615 0.245 . . . . 74.340000000000003 110.711 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' TYR . . . . . 0.52 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 64.8 m-85 76.26 157.43 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.237 0.961 . . . . 74.430000000000007 112.35 169.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 22.2 m -142.33 172.41 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.394 -0.821 . . . . 72.200000000000003 109.594 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' HIS . . . . . 0.674 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 14.2 t60 -119.9 103.12 9.06 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.984 -0.286 . . . . 75.329999999999998 110.414 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.486 ' HA2' HD11 ' A' ' 246' ' ' ILE . . . -73.71 -46.93 22.33 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.847 -0.692 . . . . 61.119999999999997 112.114 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . 0.931 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 24.9 t70 -65.58 94.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.146 0.498 . . . . 72.329999999999998 110.281 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.431 HD13 HD11 ' A' ' 161' ' ' ILE . 8.3 tp -97.45 14.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.759 -0.655 . . . . 72.430000000000007 110.605 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -53.6 146.28 13.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.072 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.98 -10.65 6.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.807 0.669 . . . . 75.010000000000005 112.807 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.9 p -73.79 -15.93 61.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.983 0.42 . . . . 75.319999999999993 110.826 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . 0.464 ' O ' HD11 ' A' ' 195' ' ' LEU . 41.3 m-80 -85.77 -16.67 38.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 75.409999999999997 110.751 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.73 115.0 29.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.972 -0.558 . . . . 62.450000000000003 110.253 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.432 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.0 mm? -110.69 135.21 51.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 74.430000000000007 110.229 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.775 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.9 mt -85.54 137.59 32.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.954 -0.567 . . . . 75.439999999999998 109.853 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -62.58 135.13 57.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.941 -0.572 . . . . 70.209999999999994 109.893 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -56.0 -33.54 64.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.847 -0.615 . . . . 73.109999999999999 112.126 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -81.86 -54.21 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 74.549999999999997 110.812 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.1 112.83 49.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.446 -0.343 . . . . 62.399999999999999 111.531 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.36 -10.56 28.35 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.845 2.363 . . . . 73.439999999999998 111.138 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . 0.564 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 5.0 p-10 -88.67 0.67 56.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.433 -0.803 . . . . 65.430000000000007 110.592 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLN . . . . . 0.53 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 77.4 mt-30 -114.07 102.64 10.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.526 . . . . 62.219999999999999 110.081 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.3 p -106.79 120.59 58.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.319 0.58 . . . . 75.150000000000006 110.703 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' TYR . . . . . 0.53 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 93.3 m-85 -117.12 157.81 25.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.114 -0.494 . . . . 74.409999999999997 110.312 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.464 HD11 ' O ' ' A' ' 182' ' ' ASN . 31.6 tp -96.91 150.55 20.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.272 -0.422 . . . . 72.430000000000007 110.454 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.542 HG13 ' N ' ' A' ' 197' ' ' ASP . 3.0 p -136.39 -155.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.04 -0.726 . . . . 65.030000000000001 109.04 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.542 ' N ' HG13 ' A' ' 196' ' ' VAL . 9.2 t70 72.24 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.318 0.647 . . . . 74.219999999999999 109.706 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . 0.69 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 36.1 m-85 55.92 -7.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.246 1.202 . . . . 74.340000000000003 114.246 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.533 ' H ' ' C ' ' A' ' 197' ' ' ASP . . . -72.72 -31.43 62.59 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.949 -0.861 . . . . 53.329999999999998 110.949 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . 0.674 ' HB2' ' CE1' ' A' ' 175' ' ' HIS . 92.0 mt -89.06 53.53 2.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.069 0.462 . . . . 74.140000000000001 110.307 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -98.75 99.0 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 62.420000000000002 110.163 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -122.35 104.57 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 75.510000000000005 111.888 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ARG . . . . . 0.562 ' NH1' HG12 ' A' ' 174' ' ' VAL . 31.9 ttm180 -178.73 -73.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.077 -0.51 . . . . 72.120000000000005 110.44 172.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' TYR . . . . . 0.45 ' H ' ' HA ' ' A' ' 173' ' ' TYR . 81.9 t80 70.61 112.4 0.05 Allowed 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 124.036 0.835 . . . . 72.230000000000004 111.044 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 56.6 m -116.07 100.89 53.89 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.056 -0.72 . . . . 73.340000000000003 109.056 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 11.5 Cg_endo -55.41 107.4 0.24 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.471 2.114 . . . . 73.439999999999998 111.818 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 206' ' ' PRO . 11.2 mm-40 72.29 16.05 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.84 -0.618 . . . . 72.400000000000006 110.746 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.55 74.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.891 -0.671 . . . . 72.049999999999997 111.878 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.3 111.61 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 75.120000000000005 110.015 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' HIS . . . . . 0.579 ' HB2' ' HB2' ' A' ' 238' ' ' PRO . 24.7 p80 -87.55 147.16 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.448 . . . . 73.219999999999999 110.947 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' LYS . . . . . 0.409 ' HZ3' ' CD ' ' A' ' 215' ' ' GLU . 53.6 mtpt -71.35 166.63 21.24 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 75.530000000000001 110.168 173.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.7 174.34 11.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.852 174.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -74.96 88.54 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.953 0.882 . . . . 74.430000000000007 110.66 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -138.85 12.69 2.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.266 -0.879 . . . . 74.239999999999995 110.494 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' GLU . . . . . 1.094 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 4.1 mm-40 -102.52 118.04 36.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 72.439999999999998 111.472 -171.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -150.41 82.75 6.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.84 -0.8 . . . . 75.409999999999997 108.84 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.14 -51.82 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.297 1.998 . . . . 74.310000000000002 111.474 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 75.0 mmtt -146.78 6.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 75.430000000000007 110.161 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 234' ' ' ASN . 8.3 mtm-85 63.75 94.42 0.05 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.976 0.893 . . . . 72.230000000000004 108.64 -162.098 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' CYS . . . . . 0.509 ' O ' ' HA ' ' A' ' 233' ' ' HIS . 66.0 m -79.19 -168.53 1.52 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.076 -1.42 . . . . 72.219999999999999 113.069 -165.327 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -178.48 93.81 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.712 -1.586 . . . . 72.519999999999996 108.246 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -76.69 -64.74 1.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 71.420000000000002 111.768 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLY . . . . . 0.931 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -109.51 -104.17 2.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.75 -0.738 . . . . 74.340000000000003 112.81 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' THR . . . . . 0.516 ' O ' ' HB ' ' A' ' 228' ' ' THR . 2.2 p -89.82 146.99 24.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.671 0.272 . . . . 63.100000000000001 110.525 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ILE . . . . . 0.506 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -68.22 -27.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 74.219999999999999 110.548 -175.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -55.74 5.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.487 -0.324 . . . . 54.200000000000003 110.14 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' PHE . . . . . 0.408 ' HB3' HG21 ' A' ' 178' ' ' ILE . 90.8 m-85 -86.15 3.16 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.017 0.377 . . . . 74.329999999999998 112.017 -169.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . 0.591 ' O ' ' HB1' ' A' ' 232' ' ' ALA . 6.8 t -77.71 -6.02 52.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 72.239999999999995 110.517 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.585 ' HA ' ' HE2' ' A' ' 249' ' ' TYR . 41.9 t 65.96 173.36 0.23 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.147 0.499 . . . . 75.150000000000006 111.168 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.7 -34.84 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.222 0.534 . . . . 75.109999999999999 109.57 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.79 -62.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.281 -0.872 . . . . 73.319999999999993 112.294 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' ALA . . . . . 0.591 ' HB1' ' O ' ' A' ' 228' ' ' THR . . . -65.43 -28.38 69.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 63.119999999999997 110.939 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' HIS . . . . . 0.509 ' HA ' ' O ' ' A' ' 220' ' ' CYS . 14.3 t-80 -74.82 -17.82 60.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.381 -0.372 . . . . 74.019999999999996 110.719 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.613 ' O ' ' HA ' ' A' ' 219' ' ' ARG . 2.7 t-20 -82.94 -30.06 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.693 -0.855 . . . . 63.100000000000001 108.693 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 109.75 -9.1 32.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.237 -0.892 . . . . 71.140000000000001 112.392 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' VAL . . . . . 1.094 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 5.3 p -62.04 109.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.619 0.723 . . . . 75.430000000000007 110.172 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' ALA . . . . . 0.711 ' HB1' ' HD3' ' A' ' 238' ' ' PRO . . . -67.46 -61.43 4.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 74.420000000000002 112.433 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.711 ' HD3' ' HB1' ' A' ' 237' ' ' ALA . 31.5 Cg_endo -93.79 73.08 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.673 2.248 . . . . 63.229999999999997 113.573 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.9 t -132.46 110.42 10.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.795 0.331 . . . . 74.430000000000007 110.701 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' ARG . . . . . 0.444 ' HA ' ' OD1' ' A' ' 243' ' ' ASP . 29.8 ttt180 -66.73 -16.91 64.57 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.552 0.692 . . . . 71.450000000000003 110.492 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . 0.946 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.53 -43.36 75.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.904 -1.043 . . . . 75.329999999999998 109.61 175.334 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' GLY . . . . . 0.492 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -63.74 -46.32 92.22 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.128 -0.942 . . . . 65.209999999999994 112.423 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ASP . . . . . 0.516 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -47.28 -51.57 18.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.645 0.736 . . . . 71.349999999999994 110.358 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.4 -31.95 64.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.858 -1.065 . . . . 72.340000000000003 111.956 -173.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.96 -38.66 64.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.7 -0.4 . . . . 75.439999999999998 110.547 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ILE . . . . . 0.492 HG13 ' O ' ' A' ' 242' ' ' GLY . 90.9 mt -58.69 -48.38 86.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.375 0.607 . . . . 73.219999999999999 110.59 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.52 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -59.73 -41.03 89.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.645 -0.707 . . . . 74.319999999999993 110.06 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.407 ' O ' HG22 ' A' ' 252' ' ' ILE . . . -54.84 -41.98 77.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.01 -0.614 . . . . 75.400000000000006 112.111 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' TYR . . . . . 0.585 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 19.4 m-30 -55.94 -59.49 4.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.808 0.337 . . . . 72.319999999999993 111.026 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' CYS . . . . . 0.515 ' SG ' HD11 ' A' ' 247' ' ' LEU . 25.6 p -62.35 -36.15 81.32 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.552 -0.459 . . . . 51.439999999999998 111.32 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' MET . . . . . 0.404 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.2 mtp -60.99 -54.39 45.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.667 0.27 . . . . 55.240000000000002 111.278 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.407 HG22 ' O ' ' A' ' 248' ' ' GLY . 8.9 tt -68.36 -36.49 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 75.209999999999994 110.677 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.573 0.225 . . . . 71.319999999999993 111.348 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' TRP . . . . . 0.643 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 39.0 m0 -75.77 -27.39 58.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 74.120000000000005 110.991 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 tp -84.24 -31.52 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.347 -0.388 . . . . 74.409999999999997 111.72 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.3 p -101.73 -20.95 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.06 -0.4 . . . . 73.129999999999995 111.52 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.483 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 85.11 -19.58 21.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.9 -0.667 . . . . 75.439999999999998 112.851 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.9 143.65 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.785 -0.45 . . . . 64.150000000000006 109.785 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' LEU . . . . . 0.663 ' HB2' ' HB3' ' A' ' 262' ' ' GLU . 86.6 mt -119.58 141.76 31.55 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.132 -0.321 . . . . 70.420000000000002 110.132 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 48.1 Cg_exo -57.08 -45.68 34.08 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.031 2.487 . . . . 63.020000000000003 112.504 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' TRP . . . . . 0.579 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 36.8 p90 -80.29 -17.87 50.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.904 -0.589 . . . . 72.129999999999995 110.755 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' GLU . . . . . 0.663 ' HB3' ' HB2' ' A' ' 259' ' ' LEU . 1.8 tm-20 -77.7 -35.31 52.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.294 0.569 . . . . 74.109999999999999 109.763 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.52 -34.53 76.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.317 0.58 . . . . 73.530000000000001 110.041 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -108.45 24.76 12.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 73.519999999999996 111.992 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.444 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 3.4 pp -71.81 -1.33 13.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.756 0.312 . . . . 74.340000000000003 111.666 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.54 -6.25 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.469 -0.332 . . . . 74.519999999999996 110.747 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASP . . . . . 0.606 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 33.0 t70 -139.06 125.56 12.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.108 -0.33 . . . . 64.0 110.108 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 36.4 Cg_exo -60.4 -21.71 68.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.306 2.671 . . . . 72.430000000000007 113.981 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.87 -39.39 79.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.726 -0.39 . . . . 73.540000000000006 110.17 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' TYR . . . . . 0.606 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 44.8 m-85 -65.88 -50.45 64.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 73.120000000000005 111.456 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' VAL . . . . . 0.579 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 30.0 m -63.3 -35.18 71.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.992 -0.283 . . . . 74.010000000000005 111.201 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ARG . . . . . 0.463 ' O ' HG13 ' A' ' 276' ' ' ILE . 38.8 ttp180 -63.17 -62.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.987 0.422 . . . . 71.109999999999999 110.408 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ASP . . . . . 0.484 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 11.2 t70 -62.99 -44.41 96.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.515 -0.766 . . . . 71.430000000000007 111.352 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' SER . . . . . 0.478 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 25.1 m -61.18 -47.41 86.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.406 . . . . 60.32 111.225 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.8 -36.63 84.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.79 -0.364 . . . . 72.230000000000004 111.132 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.5 mt -60.38 -42.65 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.601 0.238 . . . . 74.409999999999997 110.585 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 273' ' ' ASP . 57.2 mtt180 -61.14 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.404 -0.362 . . . . 72.129999999999995 110.755 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' TYR . . . . . 0.478 ' HD1' ' O ' ' A' ' 274' ' ' SER . 35.7 m-85 -69.86 -43.67 71.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.133 -0.485 . . . . 74.140000000000001 112.057 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' ARG . . . . . 0.477 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 2.3 ptm180 -67.99 -25.21 65.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.908 -0.317 . . . . 74.329999999999998 111.347 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -85.5 -42.79 14.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.872 0.368 . . . . 74.340000000000003 110.803 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' ASN . . . . . 0.744 HD21 HD22 ' A' ' 285' ' ' LEU . 9.5 t30 -130.51 87.45 2.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.138 0.494 . . . . 73.310000000000002 110.351 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ILE . . . . . 0.43 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -81.64 -40.67 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.428 0.899 . . . . 71.400000000000006 113.428 -172.0 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ALA . . . . . 0.43 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -65.89 -51.35 59.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.345 0.868 . . . . 74.299999999999997 113.345 -163.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.7 p -77.04 -28.89 55.0 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.574 -0.45 . . . . 74.109999999999999 110.944 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.744 HD22 HD21 ' A' ' 281' ' ' ASN . 1.9 mm? -64.95 -54.97 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 73.439999999999998 110.458 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' MET . . . . . 0.405 ' HE2' ' SD ' ' A' ' 303' ' ' MET . 24.6 mmt -63.47 -39.67 95.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.602 -0.272 . . . . 75.329999999999998 111.316 -177.286 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.84 -38.29 90.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 74.200000000000003 111.486 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -91.75 -20.31 21.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.728 0.64 . . . . 74.239999999999995 112.728 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.25 -44.9 86.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.748 0.309 . . . . 75.019999999999996 111.199 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 296' ' ' PRO . 17.5 p90 -136.82 89.74 17.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 122.002 0.906 . . . . 73.420000000000002 110.77 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.11 49.43 3.03 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.856 2.371 . . . . 71.109999999999999 111.986 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -100.39 -145.59 0.34 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.332 -0.395 . . . . 74.219999999999999 110.807 -178.332 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' LYS . . . . . 0.464 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 70.1 mmtt -120.03 17.29 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.646 0.98 . . . . 65.129999999999995 113.646 -166.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.497 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 14.6 m-80 -93.13 -15.99 25.41 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.184 -0.323 . . . . 71.409999999999997 110.345 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 11.4 mptt 75.1 112.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 123.847 0.717 . . . . 72.439999999999998 111.05 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' PRO . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 290' ' ' PHE . 96.7 Cg_endo -83.04 37.71 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.551 2.167 . . . . 75.019999999999996 112.255 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -81.72 -68.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.9 -0.667 . . . . 72.430000000000007 112.5 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLU . . . . . 0.4 ' CD ' HH21 ' A' ' 151' ' ' ARG . 1.9 mp0 -55.98 -36.63 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 122.045 0.138 . . . . 60.0 111.266 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 2.9 mp -61.71 -49.53 83.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.827 0.346 . . . . 74.349999999999994 110.609 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.36 85.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 74.200000000000003 110.807 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LYS . . . . . 0.472 ' HD3' ' HA ' ' A' ' 301' ' ' LYS . 69.1 mmtt -68.3 -31.59 71.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.275 -0.42 . . . . 73.450000000000003 111.808 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 82.5 t80 -62.24 -47.68 83.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.079 0.466 . . . . 75.400000000000006 110.257 175.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' MET . . . . . 0.489 ' HA ' HG22 ' A' ' 306' ' ' VAL . 68.6 mtp -73.25 -31.13 63.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 74.439999999999998 111.323 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' GLU . . . . . 0.5 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 33.2 tt0 -59.76 -44.16 93.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.745 -0.835 . . . . 74.519999999999996 108.745 171.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 58.6 m -58.47 -46.44 86.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.91 -1.041 . . . . 71.409999999999997 111.695 178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.489 HG22 ' HA ' ' A' ' 303' ' ' MET . 14.1 m -68.17 -26.21 33.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.97 -0.292 . . . . 73.299999999999997 111.25 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LYS . . . . . 0.477 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 18.5 ttmt -74.68 -34.08 62.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 72.420000000000002 110.14 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 91.7 mt -81.99 5.16 20.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 72.439999999999998 112.126 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' LEU . . . . . 0.542 HD21 ' HA ' ' A' ' 315' ' ' PRO . 4.2 pp -107.19 9.28 30.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.417 0.627 . . . . 73.340000000000003 109.452 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ASP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 12.2 t70 67.41 -81.82 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.335 -1.302 . . . . 72.209999999999994 111.887 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' TYR . . . . . 0.946 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.8 OUTLIER -161.91 -48.81 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.954 0.883 . . . . 65.430000000000007 109.364 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 m -145.4 35.94 1.08 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.052 -1.092 . . . . 75.510000000000005 108.052 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' GLU . . . . . 0.559 ' O ' ' HD3' ' A' ' 314' ' ' LYS . 3.4 tm-20 -77.54 -82.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.898 -1.047 . . . . 73.519999999999996 108.793 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LYS . . . . . 0.559 ' HD3' ' O ' ' A' ' 313' ' ' GLU . 0.6 OUTLIER -150.96 99.73 3.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.051 -0.722 . . . . 75.439999999999998 109.051 171.348 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.542 ' HA ' HD21 ' A' ' 309' ' ' LEU . 24.4 Cg_exo -63.28 118.28 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.017 1.812 . . . . 72.340000000000003 111.124 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.9 84.02 4.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.384 0.612 . . . . 63.409999999999997 110.55 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' TYR . . . . . 0.521 ' HE1' ' HB3' ' A' ' 162' ' ' LEU . 61.5 t80 -64.41 -38.89 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.333 -0.848 . . . . 72.340000000000003 110.807 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 39.8 tt0 -56.73 -55.09 38.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.342 -0.845 . . . . 75.310000000000002 111.327 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -57.05 -50.3 73.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.127 -0.488 . . . . 60.130000000000003 111.776 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' LEU . . . . . 0.505 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 4.2 pp -65.05 -40.26 94.51 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.903 -0.319 . . . . 74.319999999999993 111.641 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' ARG . . . . . 0.43 ' N ' HD13 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.47 -25.51 59.44 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.332 -0.547 . . . . 74.510000000000005 109.886 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' A' ' 318' ' ' GLU . 0.4 OUTLIER -73.5 -45.39 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 74.420000000000002 110.413 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.13 -31.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.931 -0.307 . . . . 74.329999999999998 111.14 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' LEU . . . . . 0.505 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.7 mt -63.79 -48.62 76.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.911 0.386 . . . . 73.120000000000005 110.175 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.9 -38.67 89.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.161 -0.472 . . . . 63.310000000000002 110.688 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -60.74 -44.79 96.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 74.140000000000001 110.891 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.4 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.76 -46.37 83.49 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.772 . . . . 70.120000000000005 112.556 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' LEU . . . . . 0.769 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 1.8 tm? -63.49 -38.87 92.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 71.310000000000002 110.038 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 75.409999999999997 110.652 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.31 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 65.209999999999994 111.812 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 328' ' ' LEU . 40.5 pt -76.8 -6.34 8.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.844 0.354 . . . . 72.109999999999999 111.362 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.06 25.44 14.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.483 -0.865 . . . . 73.230000000000004 113.149 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 41.1 m -129.02 147.71 50.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.921 0.36 . . . . 73.140000000000001 110.985 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -172.1 75.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.648 0.737 . . . . 74.129999999999995 110.324 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -94.41 -8.32 39.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 55.5 110.613 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.0 t70 82.03 -19.73 0.4 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.669 0.788 . . . . 73.109999999999999 112.352 171.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . 155.5 50.34 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.554 -1.308 . . . . 73.450000000000003 113.842 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' LYS . . . . . 0.564 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 21.2 ttmm -119.55 99.82 6.9 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.997 -0.742 . . . . 74.409999999999997 108.997 170.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' LEU . . . . . 0.523 HD21 ' HA ' ' A' ' 153' ' ' THR . 37.8 mt -86.8 151.67 23.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.157 -0.929 . . . . 74.200000000000003 112.036 -169.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -114.72 91.1 3.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.594 -0.73 . . . . 74.310000000000002 110.221 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' LEU . . . . . 0.518 HD12 HG21 ' A' ' 141' ' ' ILE . 3.2 mm? -99.04 -46.95 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.129 -0.487 . . . . 75.450000000000003 109.746 175.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 45.3 m 70.55 -44.77 0.58 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 73.120000000000005 113.324 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.79 -34.39 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.109 0.411 . . . . 74.129999999999995 112.109 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' VAL . . . . . 0.48 ' HB ' ' OG ' ' A' ' 136' ' ' SER . 34.6 m 40.97 43.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.007 0.923 . . . . 75.420000000000002 113.366 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -68.2 147.36 52.35 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.81 -0.632 . . . . 71.129999999999995 111.511 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -115.42 148.04 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 64.400000000000006 110.778 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' GLY . . . . . 0.538 ' HA3' ' HD2' ' A' ' 140' ' ' LYS . . . -152.41 -56.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 63.229999999999997 113.135 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 73.99 91.37 0.15 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.147 -0.549 . . . . 72.400000000000006 113.034 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' LEU . . . . . 0.435 ' O ' ' HG2' ' A' ' 350' ' ' LYS . 4.7 tt -152.39 92.38 1.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.642 -0.328 . . . . 73.120000000000005 110.423 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 349' ' ' LEU . 0.6 OUTLIER -159.56 104.51 1.61 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.133 -0.485 . . . . 73.400000000000006 110.67 178.45 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -142.66 91.35 2.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.796 0.332 . . . . 72.049999999999997 111.347 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' LYS . . . . . 0.51 ' HB3' HD21 ' A' ' 200' ' ' LEU . 0.4 OUTLIER -159.5 155.3 26.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.13 0.491 . . . . 72.420000000000002 110.894 176.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.0 t -129.39 168.89 15.62 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.069 -1.086 . . . . 73.019999999999996 108.069 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 200' ' ' LEU . 3.4 pt -66.01 142.67 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.417 0.627 . . . . 74.120000000000005 111.836 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 m -73.07 72.46 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.857 -1.065 . . . . 73.310000000000002 110.583 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -115.35 -48.26 2.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.726 -0.67 . . . . 75.099999999999994 111.282 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' LYS . . . . . 0.69 ' HG2' ' H ' ' A' ' 358' ' ' ARG . 31.7 ttmt -171.63 -166.35 0.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.947 -1.131 . . . . 63.32 107.947 -173.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ARG . . . . . 0.69 ' H ' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -86.72 -62.24 1.55 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 72.209999999999994 109.865 172.141 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 66.1 mttp -138.4 149.24 45.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.454 -0.339 . . . . 75.209999999999994 110.509 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' LYS . . . . . 0.441 ' HD3' ' C ' ' A' ' 360' ' ' LYS . 1.8 tmtp? . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.116 -0.945 . . . . 74.120000000000005 110.373 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.35 110.358 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.75 1.29 56.34 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.778 -0.725 . . . . 64.2 113.24 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.8 mt-10 -70.05 110.08 4.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.275 0.537 . . . . 75.41 109.642 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.905 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -89.74 133.47 31.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.157 0.503 . . . . 75.22 110.499 178.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.59 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.79 -0.641 . . . . 74.4 110.888 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 24.0 m -84.65 125.67 32.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.736 0.303 . . . . 64.41 110.534 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -170.5 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 63.32 110.462 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 75.1 mtm -71.67 -20.55 61.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.778 0.288 . . . . 71.42 111.778 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.71 1.95 32.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.999 0.428 . . . . 54.11 110.343 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 71.22 24.37 3.83 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.141 -0.936 . . . . 71.23 112.595 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 30' ' ' THR . 90.1 mttt -103.05 136.72 42.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 52.14 109.532 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.905 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 19.2 tt0 -96.66 97.38 9.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.564 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 63.3 m95 -80.85 128.09 33.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.341 -0.845 . . . . 73.31 111.217 -172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.727 ' HB3' ' HA ' ' A' ' 56' ' ' MET . 68.1 tttt -92.01 108.02 19.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.294 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' GLU . 10.0 p -68.74 136.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.949 0.404 . . . . 62.22 110.124 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -109.15 -86.13 1.75 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.694 -0.765 . . . . 40.22 112.588 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 95.2 mt -106.78 136.45 19.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.859 0.361 . . . . 72.35 111.527 -174.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.2 Cg_exo -78.07 106.69 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.163 2.575 . . . . 73.12 111.431 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 45' ' ' GLN . 60.0 mt -73.9 -49.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 75.02 110.063 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.59 -23.56 12.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.907 -0.663 . . . . 52.24 112.371 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.3 mp0 -110.35 164.79 12.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.115 -0.328 . . . . 64.45 110.115 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.83 -166.57 28.33 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.644 -0.983 . . . . 74.0 110.644 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.835 ' HA3' HG11 ' A' ' 196' ' ' VAL . . . -82.54 46.65 3.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.402 -0.904 . . . . 74.43 112.463 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 51' ' ' ILE . 65.8 t80 177.93 -59.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.999 0.428 . . . . 74.12 110.013 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.32 154.78 8.97 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.532 -0.758 . . . . 73.04 111.215 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.4 m 59.27 38.4 23.3 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.23 0.538 . . . . 71.5 111.322 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 48' ' ' PHE . 16.6 mm -88.43 138.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.94 -0.573 . . . . 71.12 110.062 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' A' ' 39' ' ' VAL . 87.4 m-85 -108.13 152.59 24.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 72.13 110.999 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.71 143.62 30.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.257 -0.646 . . . . 75.31 109.257 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.57 114.67 27.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.19 0.519 . . . . 72.12 111.137 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 28.3 t70 -84.98 -40.81 16.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.802 -0.635 . . . . 54.14 109.649 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.727 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 96.7 mmm 63.21 173.99 0.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.079 -0.964 . . . . 74.43 112.345 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -89.57 108.71 19.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.796 -0.638 . . . . 73.14 109.913 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -83.31 83.43 7.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.117 0.484 . . . . 53.24 110.363 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.778 -0.647 . . . . 70.13 110.731 179.449 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 112.915 0.709 . . . . 51.23 112.915 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 7.8 Cg_exo -74.16 51.44 2.46 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.575 2.184 . . . . 71.42 113.912 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 31.2 p -138.93 162.44 34.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.075 0.464 . . . . 72.32 111.286 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.48 166.37 27.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 64.01 109.369 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.6 p -136.33 128.99 45.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.536 -0.466 . . . . 64.23 112.138 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' SD ' ' A' ' 129' ' ' MET . 32.6 ttpt -85.35 142.55 29.24 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.826 -0.624 . . . . 63.35 109.582 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.83 132.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.952 -0.388 . . . . 71.05 109.952 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 5.1 tp10 -140.1 135.64 16.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.299 -0.409 . . . . 62.42 109.99 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.13 143.55 94.78 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.499 2.133 . . . . 73.23 112.151 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t -71.61 -2.64 17.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.388 -0.369 . . . . 71.12 111.66 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.2 -22.23 64.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.292 -0.633 . . . . 72.41 109.292 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.63 105.49 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.843 -1.071 . . . . 72.11 113.128 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -108.38 -89.63 2.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.298 -0.865 . . . . 72.13 111.13 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -84.83 -20.75 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.386 2.724 . . . . 74.23 111.831 176.143 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 55.2 tp -52.26 -49.53 63.87 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.405 0.891 . . . . 72.42 113.405 -169.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.2 -45.2 95.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.395 -0.522 . . . . 74.12 111.008 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.0 m -64.95 -46.51 81.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.022 0.439 . . . . 54.42 110.68 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 36.1 tt0 -65.29 -52.45 54.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.403 -0.817 . . . . 73.24 111.276 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.93 -39.36 90.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.41 110.918 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.05 -49.72 76.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.805 -0.443 . . . . 63.22 109.805 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.466 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 76.2 t80 -65.93 -44.42 85.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.714 -0.676 . . . . 74.22 110.316 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.95 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 68.2 t80 -54.96 -53.9 49.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.804 -0.634 . . . . 54.32 111.005 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.54 -31.76 72.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.921 -0.581 . . . . 72.02 110.705 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -78.83 -29.52 44.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 71.12 111.877 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.66 -35.35 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.912 0.338 . . . . 75.53 111.912 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -83.64 71.52 10.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.748 0.785 . . . . 64.12 110.567 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 96' ' ' ILE . 4.6 tmtt? -125.02 103.79 30.17 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.839 -1.073 . . . . 64.24 109.428 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -42.98 -47.94 7.99 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.083 3.189 . . . . 53.42 113.368 -174.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 11.1 tp10 -57.99 -60.19 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 74.12 110.721 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -61.7 -41.46 97.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.566 -0.743 . . . . 72.31 111.504 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 69.6 mt -58.03 -52.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 O-C-N 123.073 0.233 . . . . 65.13 110.82 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -58.45 -42.61 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.532 -0.304 . . . . 64.34 110.959 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.7 mmtp -61.86 -62.67 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.907 -0.588 . . . . 62.53 111.943 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.643 ' CH2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.9 -35.23 72.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.584 -0.447 . . . . 71.02 111.643 -171.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.938 -0.305 . . . . 70.51 110.393 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -69.17 -41.33 77.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 53.12 111.129 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 p -76.4 -31.79 58.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.843 0.682 . . . . 73.3 112.843 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 36.1 ttm180 -89.7 5.54 45.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.065 0.459 . . . . 61.03 110.557 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 61.71 30.39 18.43 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.631 -0.713 . . . . 64.34 110.648 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HG ' ' OD1' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -78.95 161.3 26.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.571 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HB2' HH22 ' A' ' 321' ' ' ARG . 5.5 tmtm? -85.61 -66.29 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -163.07 135.51 5.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 72.42 110.817 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.643 HD22 ' CH2' ' A' ' 99' ' ' TRP . 26.7 tp -79.6 121.12 24.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 72.5 110.32 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.96 56.36 4.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.876 -0.678 . . . . 60.22 112.717 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 93.1 t -128.15 125.56 23.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.922 -0.399 . . . . 70.44 109.922 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.95 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -56.1 143.78 82.58 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.897 2.398 . . . . 75.11 112.593 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 113' ' ' TYR . 20.8 tptm -67.79 131.56 45.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 73.55 111.003 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.453 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 77.7 t80 -80.69 124.47 29.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 61.5 110.341 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.624 ' CD1' HG22 ' A' ' 130' ' ' ILE . 14.2 m95 -106.11 -58.67 1.88 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.476 -0.564 . . . . 72.15 109.476 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.39 174.51 35.56 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.048 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.9 p -171.27 147.82 2.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.554 -0.535 . . . . 74.22 109.554 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.32 -167.9 33.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.116 -1.04 . . . . 50.02 112.611 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.5 tt -126.95 133.46 50.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.723 -0.473 . . . . 75.04 109.723 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -134.84 109.48 8.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.473 -0.331 . . . . 70.34 110.29 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.834 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 18.0 t70 -73.68 122.88 23.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.115 -0.493 . . . . 71.3 109.69 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 66.0 tttp -129.46 121.56 27.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.071 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 20.1 m120 63.74 16.5 9.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.915 -0.584 . . . . 62.04 111.658 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.57 -0.25 56.76 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.685 -0.769 . . . . 74.45 112.405 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -117.22 115.35 25.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.095 -0.705 . . . . 70.13 109.095 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.834 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.7 p -76.31 119.61 20.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 72.44 111.157 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 129.81 55.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 75.31 109.656 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.42 134.37 40.77 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.796 -0.816 . . . . 71.52 108.796 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.54 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 44.6 p90 -122.48 142.88 50.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.233 -0.44 . . . . 63.12 111.021 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.642 ' SD ' ' HE2' ' A' ' 71' ' ' LYS . 15.4 ptm -129.87 131.22 46.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 73.1 109.993 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 70' ' ' VAL . 3.3 mm -97.5 123.04 49.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 72.21 110.624 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 38.4 mtm -126.5 178.38 5.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 71.13 110.415 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -65.58 151.39 46.56 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.625 -0.509 . . . . 73.1 109.625 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -72.23 116.12 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.254 0.549 . . . . 72.23 111.113 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 17.0 m-85 -104.97 143.35 33.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.214 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.527 ' HA3' ' CD1' ' A' ' 187' ' ' TYR . . . -140.16 -15.36 0.52 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.475 -0.869 . . . . 61.14 112.721 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.887 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 13.6 m -122.2 132.29 54.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.682 -0.305 . . . . 73.11 110.503 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 139' ' ' GLN . 3.6 p30 -125.74 148.88 48.93 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.843 -0.428 . . . . 74.33 109.843 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.44 HD21 HD21 ' A' ' 157' ' ' LEU . 9.8 mp -74.71 -8.1 55.34 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.989 0.366 . . . . 53.15 111.989 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.413 ' HB3' ' OD1' ' A' ' 137' ' ' ASP . 55.7 tp60 -76.91 -48.6 17.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 64.44 110.647 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.58 -37.22 62.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.949 0.404 . . . . 61.21 110.049 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.44 -33.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.503 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.5 ' CE1' ' HD2' ' A' ' 147' ' ' LYS . 13.9 t80 -53.23 -46.59 69.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.009 -0.541 . . . . 75.2 109.581 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -71.22 -52.91 16.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.476 -0.784 . . . . 72.23 110.796 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.07 73.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.912 0.708 . . . . 74.24 112.912 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -104.23 10.03 35.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.92 0.39 . . . . 71.35 110.368 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.404 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 53.28 40.27 31.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.742 -0.663 . . . . 50.31 111.628 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER 42.73 30.78 0.26 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.583 1.153 . . . . 61.2 113.669 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -86.27 95.01 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.515 -0.474 . . . . 74.52 110.042 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 66.5 m-85 -109.15 119.8 40.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.078 -0.51 . . . . 74.24 109.828 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.7 m -74.7 168.18 20.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.266 -0.424 . . . . 72.52 110.72 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 53.2 mtm-85 -51.67 -47.0 64.0 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.315 -0.402 . . . . 63.51 111.648 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -63.99 -30.05 71.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.853 0.358 . . . . 64.1 111.29 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.567 ' N ' ' HD3' ' A' ' 152' ' ' LYS . 1.3 m -72.49 -52.12 17.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.895 0.378 . . . . 72.21 110.383 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -41.06 91.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.71 -0.677 . . . . 75.5 110.913 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.04 -50.11 75.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 74.34 110.764 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.619 ' NE2' ' HA ' ' A' ' 335' ' ' ASP . 1.5 mp0 -64.06 -38.31 90.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.557 -0.292 . . . . 62.52 111.264 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 161' ' ' ILE . 4.8 mp -60.94 -52.83 63.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 62.21 110.558 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.6 p -68.03 -31.85 71.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 64.33 111.095 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.0 tp -57.03 -53.11 61.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 71.42 111.043 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 156' ' ' GLN . 2.1 mpt_? -67.91 -29.41 68.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.938 0.399 . . . . 73.31 110.638 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 157' ' ' LEU . 40.3 mm -65.73 -36.96 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 51.22 110.241 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 158' ' ' SER . 94.2 mt -62.16 -43.53 98.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 60.22 110.441 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.644 ' OD1' ' HG ' ' A' ' 105' ' ' LEU . 51.3 m-20 -55.71 -54.37 45.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.352 0.596 . . . . 73.2 110.484 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.98 -37.77 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 75.24 111.948 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.63 -38.58 90.79 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.829 -0.349 . . . . 72.22 111.169 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.39 -47.82 75.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.229 -0.588 . . . . 72.11 110.075 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.538 ' HA ' ' OE2' ' A' ' 170' ' ' GLU . 63.5 t80 -58.49 -41.67 85.83 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.437 0.532 . . . . 75.25 112.437 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.466 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 pt -88.29 -33.3 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.601 -0.439 . . . . 60.45 112.069 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.769 ' HD2' ' HD3' ' A' ' 240' ' ' ARG . 37.0 t60 -91.57 -5.92 53.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.665 0.269 . . . . 71.33 111.064 -172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 167' ' ' TYR . 13.2 pt-20 -78.81 -19.79 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.482 . . . . 72.11 109.734 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -97.49 -65.07 0.99 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.91 -0.587 . . . . 73.32 111.447 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 203' ' ' ARG . 35.7 tt0 -162.05 -44.31 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.24 0.829 . . . . 61.42 113.24 -168.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -80.49 158.06 25.97 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.246 0.832 . . . . 73.41 113.246 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.727 HG12 ' CE1' ' A' ' 169' ' ' HIS . 3.6 m -129.7 172.26 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.58 -1.191 . . . . 74.22 108.48 171.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 19.7 t-80 -144.64 92.49 2.3 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.115 -0.698 . . . . 75.24 109.115 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -63.71 -47.33 87.54 Favored Glycine 0 C--O 1.226 -0.4 0 O-C-N 123.522 0.514 . . . . 73.25 113.67 -170.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.568 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.1 t0 -99.02 105.44 17.57 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.387 -0.478 . . . . 72.14 110.525 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.407 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 29.0 mm -89.97 91.3 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 74.02 109.575 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -93.98 149.82 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.372 -0.831 . . . . 72.31 109.798 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 138' ' ' LEU . . . -54.85 -26.83 37.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 45.11 111.733 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.5 p -77.39 -5.58 50.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.945 0.35 . . . . 72.23 111.945 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 197' ' ' ASP . 12.2 m120 -83.18 -22.96 33.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 71.13 110.809 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.75 115.97 31.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.426 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.5 HD21 HG12 ' A' ' 196' ' ' VAL . 2.6 mm? -113.83 131.8 56.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.817 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.887 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.8 mt -89.45 140.92 29.04 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.178 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 189' ' ' ASN . 43.7 t-20 -59.71 125.61 24.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.97 -0.752 . . . . 71.31 108.97 175.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.527 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 36.2 t80 -52.6 -31.27 35.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.507 0.558 . . . . 74.42 112.507 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -126.91 24.55 6.44 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.381 -0.527 . . . . 71.41 111.914 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 14.7 t-20 -159.57 80.78 2.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.456 -0.572 . . . . 72.14 109.456 174.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.67 -24.26 55.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 123.33 2.686 . . . . 63.05 113.993 -170.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 338' ' ' LYS . 4.4 p30 -71.0 -14.38 62.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.926 -0.309 . . . . 73.05 111.592 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.404 ' HG3' ' OD1' ' A' ' 191' ' ' ASP . 77.1 mt-30 -114.04 114.75 26.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 50.11 110.294 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.68 142.86 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.831 . . . . 72.1 110.787 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.785 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 59.1 m-85 -115.92 157.97 23.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 65.44 109.945 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 8.9 tt -115.97 141.21 48.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 70.25 109.792 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.835 HG11 ' HA3' ' A' ' 47' ' ' GLY . 1.4 p -141.27 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.568 -0.901 . . . . 72.21 108.568 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 196' ' ' VAL . 17.8 t70 68.74 65.49 0.31 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 53.23 108.449 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 83' ' ' GLU . 85.6 m-85 -88.49 16.52 6.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.099 -1.409 . . . . 71.14 110.656 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -70.33 -26.52 74.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.702 -0.761 . . . . 72.43 111.296 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 177' ' ' ASP . 35.7 mt -88.78 36.38 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 72.4 110.494 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -106.07 98.88 8.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.161 0.505 . . . . 73.44 110.354 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -100.27 145.84 27.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.964 -0.754 . . . . 71.21 108.964 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.608 ' HB2' ' HG2' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -88.86 130.54 35.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.164 0.506 . . . . 70.43 111.028 -177.537 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -103.23 -54.0 2.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 74.22 110.088 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.18 94.43 30.57 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.792 -0.64 . . . . 72.54 110.427 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 207' ' ' GLU . 18.5 Cg_endo -60.0 123.17 12.65 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.486 2.124 . . . . 61.02 111.523 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 206' ' ' PRO . 32.4 tt0 70.31 -63.96 0.38 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.865 0.728 . . . . 75.21 111.076 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.68 28.51 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.413 -0.675 . . . . 73.32 111.413 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.94 110.7 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.211 -0.292 . . . . 75.11 110.211 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -75.94 104.41 6.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.914 . . . . 64.31 108.531 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -88.44 0.08 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.906 -0.588 . . . . 71.03 111.631 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 173.05 139.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.442 -0.947 . . . . 74.4 108.442 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -84.3 87.92 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.075 0.941 . . . . 71.02 110.241 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 3.0 mmtt -155.24 33.15 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.031 -0.986 . . . . 64.21 109.947 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.3 -5.55 54.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.316 -0.856 . . . . 71.05 109.645 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.7 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.1 p-10 -79.33 113.8 39.63 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.144 -0.935 . . . . 72.15 111.499 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.515 2.144 . . . . 72.11 111.876 175.644 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.521 0.677 . . . . 74.31 109.613 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 102.23 -166.28 17.42 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.691 -0.766 . . . . 74.4 112.293 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 70.4 p -80.29 151.35 29.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.961 0.41 . . . . 62.2 110.994 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 228' ' ' THR . 17.9 tt -63.02 -9.02 3.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.67 0.747 . . . . 63.34 110.885 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.05 -68.13 0.32 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.783 -1.098 . . . . 75.41 111.521 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.422 ' HB3' HG23 ' A' ' 246' ' ' ILE . 77.7 m-85 -103.24 -11.19 18.16 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.243 0.46 . . . . 61.1 112.243 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.6 t -62.34 -8.94 6.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.01 0.374 . . . . 74.53 112.01 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.9 t 62.49 -174.04 0.15 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.771 0.429 . . . . 60.23 110.9 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.7 mp -73.33 -40.19 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.382 -0.599 . . . . 72.2 109.382 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 236' ' ' VAL . 2.1 m-20 -49.69 -72.65 0.05 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.603 -1.18 . . . . 73.4 111.934 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.42 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 72.44 111.53 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -62.46 -39.8 94.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.537 0.208 . . . . 74.41 110.579 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -73.24 -26.19 61.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.659 . . . . 74.23 109.219 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 110.75 7.25 25.87 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.775 -0.648 . . . . 73.45 112.817 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 9.5 p -89.94 136.98 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.973 0.416 . . . . 60.51 110.413 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.92 115.07 43.08 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 74.13 109.891 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.677 ' HB2' ' HA3' ' A' ' 242' ' ' GLY . 81.7 Cg_endo -79.28 148.97 21.59 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.647 2.231 . . . . 73.34 112.857 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.5 t -85.47 -159.95 0.48 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.797 -0.816 . . . . 55.52 108.797 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.769 ' HD3' ' HD2' ' A' ' 169' ' ' HIS . 14.9 mmt-85 -54.18 -35.55 62.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.75 0.309 . . . . 71.53 111.237 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 8.2 mmm180 -56.65 -32.89 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 72.41 112.125 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 238' ' ' PRO . . . -67.37 -54.73 18.51 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.593 -0.813 . . . . 75.34 111.72 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.88 -41.75 83.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.043 0.449 . . . . 74.14 110.538 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 91.8 mt -64.36 -38.46 91.12 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.863 -0.608 . . . . 74.12 110.891 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.81 -50.27 69.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.491 0.662 . . . . 74.32 110.189 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 35.6 mt -59.04 -47.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.018 -0.992 . . . . 74.04 110.89 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 161' ' ' ILE . 56.7 tp -57.9 -42.63 85.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 64.1 110.608 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.64 94.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.965 -0.636 . . . . 64.23 112.051 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -64.26 -42.0 96.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 64.42 110.906 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 27.0 m -69.65 -36.87 76.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.582 -0.281 . . . . 71.3 110.691 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.8 mtp -62.11 -49.8 74.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 73.4 111.015 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.08 -32.01 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 70.15 110.708 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -56.48 -53.93 51.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.011 0.434 . . . . 71.51 110.503 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.0 m0 -69.27 -28.44 66.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 71.43 111.252 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.24 -32.77 38.36 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.188 0.44 . . . . 72.33 112.188 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 290' ' ' PHE . 61.7 p -103.8 -28.58 11.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.421 -0.512 . . . . 74.14 111.75 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 114.8 -36.74 3.8 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.338 -0.934 . . . . 74.13 113.062 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.53 147.48 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.265 0.533 . . . . 74.22 111.102 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.1 mt -94.17 139.22 22.45 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.44 -0.345 . . . . 71.21 110.449 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 -36.95 98.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.981 2.454 . . . . 73.32 112.53 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.541 ' HB2' HG12 ' A' ' 271' ' ' VAL . 41.7 p90 -87.55 -2.35 58.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 75.33 110.852 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 64.2 tt0 -86.92 -37.79 17.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.141 -0.689 . . . . 73.4 109.141 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.99 -20.37 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.133 -0.691 . . . . 71.31 109.133 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -107.9 26.18 10.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.924 . . . . 74.25 110.795 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -74.36 64.41 1.12 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.685 0.755 . . . . 72.43 109.873 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -157.22 14.07 0.25 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.149 -0.932 . . . . 61.21 109.442 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 13.9 t70 -157.31 120.31 2.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.917 -0.583 . . . . 74.51 110.556 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 15.6 Cg_exo -68.85 -27.23 31.26 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.0 2.467 . . . . 62.42 112.602 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -73.32 -48.37 34.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.556 -0.535 . . . . 71.42 109.556 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.563 . . . . 53.31 112.184 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 261' ' ' TRP . 35.3 m -65.49 -41.86 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.55 -0.46 . . . . 72.44 110.906 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -66.7 -48.79 68.13 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.19 -0.3 . . . . 74.51 110.19 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.91 -53.36 56.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.225 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 27.2 m -59.06 -41.77 88.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.353 0.408 . . . . 74.34 111.463 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 279' ' ' ARG . 97.6 mttt -63.86 -48.25 77.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.009 -0.276 . . . . 63.31 110.942 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.668 HG12 HH21 ' A' ' 279' ' ' ARG . 66.0 mt -63.12 -43.37 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.304 0.573 . . . . 45.34 110.281 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.71 -46.62 77.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.801 -1.091 . . . . 74.3 111.538 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.743 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 32.4 m-85 -74.26 -32.2 62.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 73.2 111.814 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.668 HH21 HG12 ' A' ' 276' ' ' ILE . 88.0 mtm180 -74.71 -16.23 60.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.256 0.465 . . . . 74.22 112.256 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 41.3 mt-10 -60.9 -48.99 79.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.77 0.319 . . . . 74.1 110.742 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.504 ' HB2' HD23 ' A' ' 285' ' ' LEU . 15.1 m120 -127.93 70.93 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 71.4 109.725 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -54.02 -44.28 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.764 -0.653 . . . . 54.04 112.615 -173.657 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.457 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.6 -47.51 78.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 73.21 110.847 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 27.8 t -67.22 -49.25 65.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.715 -0.675 . . . . 74.31 110.605 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.743 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.0 mm? -64.16 -50.37 68.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 74.13 111.561 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 282' ' ' ILE . 0.1 OUTLIER -58.38 -44.66 89.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.543 0.211 . . . . 73.13 111.56 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.713 ' HA ' ' HG2' ' A' ' 296' ' ' PRO . 18.8 t70 -68.16 -27.46 66.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 74.34 110.812 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -96.58 6.46 48.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.941 -0.572 . . . . 70.12 111.533 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.6 -38.41 59.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.027 0.441 . . . . 71.21 110.795 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 256' ' ' THR . 29.3 t80 -137.56 75.29 44.8 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 73.41 109.575 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -93.93 110.94 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.382 2.721 . . . . 74.52 112.54 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -159.59 -82.66 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.257 -0.646 . . . . 71.11 109.257 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -144.13 29.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -94.8 162.46 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.632 -1.167 . . . . 64.11 109.855 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -122.68 90.81 49.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.576 -0.527 . . . . 52.13 109.576 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.713 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 89.1 Cg_endo -98.85 37.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.055 2.503 . . . . 51.44 112.207 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.87 -39.91 12.8 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.629 -0.796 . . . . 65.43 111.654 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.5 mp0 -55.03 -44.21 74.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.269 -0.466 . . . . 64.13 110.123 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.6 mp -69.74 -42.58 80.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 62.24 110.528 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.74 -48.6 81.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 75.11 111.18 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 301' ' ' LYS . 8.5 mmpt? -66.08 -41.94 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 73.21 110.836 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -55.59 -48.56 74.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.108 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.515 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.67 -37.84 79.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.2 -0.454 . . . . 64.42 111.366 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.5 -39.86 94.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.28 0.562 . . . . 75.12 109.619 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.8 m -65.19 -44.51 88.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.191 -0.913 . . . . 74.31 111.388 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 29.4 m -69.01 -31.61 51.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 120.622 -0.431 . . . . 73.23 111.349 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -74.03 -28.28 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.249 0.547 . . . . 64.23 109.907 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.04 -16.89 61.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 71.34 111.782 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 306' ' ' VAL . 4.2 pp -95.64 16.45 17.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.673 0.273 . . . . 60.14 111.601 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 16.1 t70 68.48 -96.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.786 -0.643 . . . . 71.04 111.478 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.2 OUTLIER -136.89 -38.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.943 0.402 . . . . 74.3 110.035 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.7 t -158.38 29.17 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 72.33 110.045 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -71.46 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.235 -0.654 . . . . 74.43 109.235 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 58.8 mmtt -130.25 79.59 72.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 70.41 111.227 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' HD22 ' A' ' 309' ' ' LEU . 18.3 Cg_endo -91.78 118.05 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.598 2.199 . . . . 72.32 111.531 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 319' ' ' ASN . 30.3 tp -133.7 103.99 6.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.057 -0.519 . . . . 71.13 109.721 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.406 ' OH ' ' HD2' ' A' ' 240' ' ' ARG . 4.5 m-85 -64.66 -33.72 76.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.641 -0.709 . . . . 74.2 111.472 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.28 -27.39 66.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.632 -0.427 . . . . 72.53 110.709 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.519 ' HB2' HD23 ' A' ' 316' ' ' LEU . 5.9 t30 -72.25 -38.51 68.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.328 0.585 . . . . 61.41 109.457 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' A' ' 323' ' ' ILE . 68.7 mt -69.96 -37.08 75.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.45 -0.796 . . . . 75.31 109.381 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.585 HH22 ' HB2' ' A' ' 106' ' ' LYS . 23.8 ttt180 -59.65 -41.06 89.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.785 -1.098 . . . . 74.45 109.973 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.73 -52.39 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 74.32 111.985 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.437 0.161 . . . . 54.13 110.956 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 155' ' ' LEU . 94.1 mt -64.38 -46.92 81.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.713 0.292 . . . . 64.5 110.992 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.49 -34.92 78.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 73.34 111.03 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -42.77 95.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 72.34 110.402 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.47 -46.34 85.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 40.02 111.711 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.508 HD22 ' HG ' ' A' ' 155' ' ' LEU . 35.1 tp -59.78 -42.66 93.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.172 0.51 . . . . 65.42 110.698 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -70.88 -25.83 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.674 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.9 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 41.2 111.01 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.5 tt -89.17 2.9 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.384 0.612 . . . . 73.31 110.611 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.39 15.31 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.952 -0.642 . . . . 71.33 113.847 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.1 t -121.97 138.57 54.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.407 0.604 . . . . 63.15 110.856 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -154.67 99.5 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.067 -0.515 . . . . 73.14 109.806 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.619 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 13.8 t70 55.26 54.12 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.047 0.927 . . . . 72.13 108.675 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.449 ' HB3' ' HE3' ' A' ' 152' ' ' LYS . 29.4 t70 -66.49 103.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.346 -1.297 . . . . 75.23 112.486 -167.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.01 71.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.56 -0.745 . . . . 52.34 113.565 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 191' ' ' ASP . 96.2 mttt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.967 0.413 . . . . 71.2 110.884 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.638 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 23.5 mtmm . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.966 0.412 . . . . 63.43 111.363 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.01 159.22 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 73.51 111.911 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -74.87 141.22 16.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.155 0.502 . . . . 73.21 111.254 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.9 t -86.18 73.66 10.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.539 0.685 . . . . 61.22 110.092 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.786 -0.643 . . . . 63.0 111.443 -176.886 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.57 ' HA ' HG23 ' A' ' 39' ' ' VAL . 99.3 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.031 -0.359 . . . . 74.34 110.031 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . 99.6 -3.59 57.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 72.41 112.655 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -96.67 159.43 14.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.944 0.402 . . . . 72.51 110.714 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -79.1 146.06 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 72.34 112.159 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tp -133.79 122.51 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.236 -0.893 . . . . 72.34 109.568 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -96.77 134.21 40.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.712 -0.222 . . . . 64.11 111.505 -175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.57 -176.32 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.565 -0.532 . . . . 73.34 109.565 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.406 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 50.4 tpp -72.59 -22.54 60.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.552 0.215 . . . . 65.22 111.162 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.7 21.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.108 0.48 . . . . 73.15 110.226 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 71.07 36.12 1.48 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.991 -1.004 . . . . 70.02 111.409 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.05 121.96 45.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 51.13 110.199 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mp0 -87.03 97.2 10.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.187 -0.46 . . . . 70.03 110.226 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 44.1 m95 -84.93 -171.74 3.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.63 -0.878 . . . . 65.14 108.63 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -134.68 137.05 43.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.426 . . . . 72.54 110.402 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 25' ' ' VAL . 2.4 m -69.23 118.64 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 73.04 110.693 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 56' ' ' MET . . . -107.28 -116.43 4.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.834 -0.698 . . . . 74.45 112.214 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 mm? -91.08 122.69 66.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.81 0.338 . . . . 74.03 110.977 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_exo -78.51 104.77 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.914 2.409 . . . . 71.15 111.052 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 45' ' ' GLN . 58.9 mt -79.14 -46.86 23.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 75.53 110.227 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.37 -27.67 8.3 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.433 -0.667 . . . . 73.13 111.433 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.0 mp0 -107.79 165.27 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.29 -0.455 . . . . 72.12 109.878 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 184' ' ' LEU . . . 156.69 -88.37 0.12 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.498 -0.641 . . . . 52.25 111.498 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . -158.22 50.13 0.42 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.609 -0.805 . . . . 63.3 112.353 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 63.7 t80 171.71 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.119 0.568 . . . . 74.02 109.684 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 161.18 134.77 1.7 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.99 -0.844 . . . . 75.41 110.99 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.5 t 65.52 76.48 0.33 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.622 0.725 . . . . 54.45 110.176 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.413 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.1 mm -121.65 135.47 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 73.52 109.73 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.548 ' CE1' HG12 ' A' ' 39' ' ' VAL . 51.9 p90 -131.15 154.78 47.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.181 -0.608 . . . . 64.11 111.311 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.0 tt -71.52 133.18 45.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 65.32 109.418 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 37' ' ' TRP . . . -93.39 36.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.224 0.453 . . . . 73.23 112.224 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' O ' HD22 ' A' ' 53' ' ' LEU . 17.0 t0 -178.73 152.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.112 -0.699 . . . . 72.33 109.112 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 26' ' ' GLY . 4.6 ppp? -144.58 6.66 1.26 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 73.51 110.38 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -139.33 -179.34 5.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 75.02 109.792 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -90.21 72.69 7.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.764 -0.458 . . . . 72.33 109.764 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 121.493 0.663 . . . . 43.14 109.789 176.226 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.562 0.696 . . . . 64.33 110.12 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.72 23.34 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.891 2.394 . . . . 73.22 113.084 -172.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.2 p -124.18 139.02 54.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.367 0.603 . . . . 74.41 111.944 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 53' ' ' LEU . 20.5 m -130.85 170.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.393 -0.821 . . . . 63.21 109.544 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.847 ' HB ' HD13 ' A' ' 130' ' ' ILE . 1.5 p -132.48 127.2 56.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.059 0.457 . . . . 62.03 111.431 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -85.34 130.1 34.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.241 -0.891 . . . . 73.02 109.101 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.6 127.74 66.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.983 0.42 . . . . 74.11 111.397 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 25.9 tt0 -115.25 141.01 26.47 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.393 -0.965 . . . . 64.23 108.393 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.38 -171.45 0.12 Allowed 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.218 1.945 . . . . 65.41 111.639 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 t -76.79 78.97 3.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.256 0.551 . . . . 64.52 109.559 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -122.08 -52.49 1.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 73.43 110.541 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.38 46.34 1.98 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.884 0.849 . . . . 44.24 109.651 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.98 -80.81 0.86 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.127 -0.942 . . . . 44.31 111.658 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.8 Cg_exo -59.77 -43.96 34.35 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.712 2.275 . . . . 35.0 112.033 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.28 -33.27 75.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.298 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.57 -50.53 69.11 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.909 0.385 . . . . 53.34 111.033 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.0 m -65.15 -43.74 90.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 74.11 110.674 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -66.83 -35.48 80.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 70.13 110.388 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.07 -49.28 78.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 74.22 109.944 178.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -60.23 -39.69 87.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.007 0.432 . . . . 75.31 110.708 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.01 -52.62 65.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.413 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.84 -33.19 73.71 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.25 111.382 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -63.61 -28.46 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.642 0.238 . . . . 74.32 111.642 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmp_? -93.65 -16.09 24.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.054 0.39 . . . . 73.32 112.054 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.81 17.71 22.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.597 0.713 . . . . 22.21 110.511 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.21 136.27 38.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.067 -0.97 . . . . 75.12 112.807 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 34.4 ttmt 73.45 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.83 -1.077 . . . . 74.43 111.948 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 62.0 Cg_exo -53.03 -28.71 41.46 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.711 2.94 . . . . 73.35 113.373 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.83 -50.87 62.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 72.11 111.163 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 35.1 mt-30 -73.19 -34.72 66.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.117 -0.492 . . . . 62.22 110.132 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' PRO . 65.8 mt -58.9 -53.96 40.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.488 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -62.48 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 75.52 110.574 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 22.2 ttmm -55.04 -65.3 0.61 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.94 -0.573 . . . . 74.31 111.37 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.59 ' HZ2' HD11 ' A' ' 108' ' ' LEU . 3.7 p90 -69.5 -32.9 72.05 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.496 -0.482 . . . . 73.31 110.884 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 107' ' ' TYR . 48.7 mt -59.05 -39.5 78.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 120.67 0.271 . . . . 73.41 110.594 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -76.51 -27.62 56.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.87 0.366 . . . . 73.43 110.312 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -70.43 -44.21 68.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.748 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 103' ' ' ARG . 42.2 mtt-85 -83.2 -13.81 54.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.474 -0.33 . . . . 71.13 110.759 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 57.51 69.57 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.745 0.783 . . . . 75.1 109.733 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.599 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 10.2 tp -108.81 -167.91 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.76 -1.109 . . . . 71.22 109.04 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 107' ' ' TYR . 20.7 tptm -100.16 -68.15 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.571 -0.452 . . . . 73.12 110.033 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.609 ' CD1' ' HG3' ' A' ' 106' ' ' LYS . 55.2 p90 -179.96 152.06 0.45 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.985 0.422 . . . . 61.12 110.587 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 HD11 ' HZ2' ' A' ' 99' ' ' TRP . 83.5 mt -78.41 136.55 37.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 74.1 111.007 -176.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.84 51.5 4.45 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.126 -0.789 . . . . 74.41 111.126 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 108' ' ' LEU . 60.5 t -119.73 129.75 25.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.876 -0.416 . . . . 62.11 109.876 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 35.1 Cg_exo -61.07 148.86 91.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.763 2.308 . . . . 53.44 112.454 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.575 ' HD2' ' CE2' ' A' ' 114' ' ' TRP . 4.1 ttmp? -62.91 128.57 36.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.779 -0.646 . . . . 74.21 110.804 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -90.9 85.14 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.929 -0.578 . . . . 72.34 110.656 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.575 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 10.4 m95 -67.33 -55.5 13.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 72.41 109.858 173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.09 -171.32 36.94 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.414 -0.812 . . . . 70.52 111.622 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.502 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 43.1 p 176.94 175.14 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.475 -0.565 . . . . 61.44 109.475 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 32' ' ' MET . . . 154.15 -159.32 28.74 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.069 -1.062 . . . . 72.42 112.884 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.8 tt -131.52 138.64 49.02 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.495 -0.557 . . . . 73.32 109.495 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -143.24 134.86 26.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.683 -0.488 . . . . 74.44 109.683 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.881 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.9 t70 -74.89 140.07 43.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.801 -0.444 . . . . 73.53 109.801 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -103.46 40.68 1.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.714 -0.476 . . . . 44.23 109.714 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.42 67.53 0.83 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.651 -0.704 . . . . 73.42 110.412 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.03 -58.24 0.56 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.261 -0.881 . . . . 52.11 111.492 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 42.4 tptt -134.29 142.74 47.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.431 -0.581 . . . . 62.23 109.431 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.881 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.9 m -88.29 148.73 24.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.325 -0.398 . . . . 72.31 111.437 -176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.8 151.64 37.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.81 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -113.39 120.0 39.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.925 -0.769 . . . . 75.14 108.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -134.95 162.4 32.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 73.44 112.081 -171.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 45.7 ttm -140.2 139.81 35.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.672 -0.695 . . . . 74.22 110.613 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.847 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.7 mm -98.17 126.0 51.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.322 -0.399 . . . . 60.41 110.421 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 8.2 ptp -138.54 -179.22 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 71.35 110.38 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -73.21 156.15 38.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.66 -0.866 . . . . 74.14 108.66 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.554 ' HB3' HG13 ' A' ' 69' ' ' VAL . 25.1 ptt180 -85.41 135.2 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.027 0.441 . . . . 65.15 111.781 -174.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 43.3 m-85 -124.02 153.44 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.3 109.841 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.504 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -159.13 8.67 0.17 Allowed Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.946 -1.121 . . . . 72.52 113.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.069 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.0 m -122.98 125.5 45.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.021 -0.694 . . . . 72.33 110.791 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 181' ' ' SER . 3.3 t70 -116.48 140.14 49.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 74.31 111.422 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.2 mp -67.94 -33.06 73.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.71 -0.677 . . . . 73.21 111.797 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 55.2 tp60 -72.63 -35.83 67.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.46 . . . . 61.23 110.088 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 46.4 tptt -70.83 -48.13 55.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.026 -0.534 . . . . 73.24 110.528 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.43 -30.04 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.97 -0.559 . . . . 74.31 110.176 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 1.1 t80 -51.27 -46.08 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.534 -0.757 . . . . 72.41 110.593 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.54 -36.01 33.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.205 -0.452 . . . . 70.23 110.138 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.349 0.5 . . . . 72.54 112.349 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -101.95 3.66 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 65.55 110.475 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' C ' ' HG2' ' A' ' 147' ' ' LYS . . . 59.02 55.8 4.28 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.318 -0.856 . . . . 55.02 111.935 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 257' ' ' GLY . 21.9 pttm 45.53 38.78 4.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.067 0.947 . . . . 75.22 113.113 172.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -115.79 88.75 2.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 71.31 109.933 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -101.75 123.8 46.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.397 -0.365 . . . . 72.12 111.009 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.9 m -72.37 147.32 46.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.906 -0.588 . . . . 72.14 110.861 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.638 ' NH2' ' HB3' ' A' ' 295' ' ' LYS . 42.0 ttm105 -56.11 -36.5 68.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.126 -0.488 . . . . 73.21 111.912 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -51.78 -44.3 63.35 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.354 0.597 . . . . 74.43 110.75 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 157' ' ' LEU . 74.9 m -71.93 -49.98 32.96 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.678 -0.692 . . . . 42.03 110.791 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.12 -35.24 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 42.24 110.646 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.715 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -65.78 -52.74 48.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 74.52 110.851 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.608 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 25.5 tt0 -60.6 -46.77 88.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.33 -0.548 . . . . 65.35 109.883 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 153' ' ' THR . 6.4 mp -54.92 -51.72 65.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.905 -0.589 . . . . 75.21 111.226 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -57.68 -44.71 85.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 54.22 110.445 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 89.6 mt -63.75 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 71.4 111.116 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.63 -38.04 86.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.115 0.483 . . . . 75.41 110.734 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.596 HD11 HD21 ' A' ' 183' ' ' LEU . 59.1 mt -71.04 -37.27 66.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.061 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.82 -50.7 71.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.252 -0.431 . . . . 61.43 110.382 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.599 ' OD2' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-20 -52.34 -57.55 9.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.771 -0.65 . . . . 71.42 111.323 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.14 -35.9 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.793 -0.639 . . . . 70.43 111.012 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 16.7 tp -60.59 -38.7 85.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.779 0.323 . . . . 73.42 110.85 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.66 -48.09 64.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.595 -0.52 . . . . 74.53 109.595 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.64 -48.6 77.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.901 -0.59 . . . . 71.24 111.834 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 165' ' ' LEU . 32.2 pt -67.04 -36.97 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.88 -0.328 . . . . 64.41 111.716 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 49.2 m80 -69.99 -26.89 64.3 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.586 -0.445 . . . . 54.03 110.863 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.9 -27.55 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.182 0.515 . . . . 61.12 109.928 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.99 66.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 73.22 111.466 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 77.8 -51.39 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.814 1.042 . . . . 71.31 113.814 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -85.91 142.06 29.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.497 1.295 . . . . 71.2 114.497 -161.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 169' ' ' HIS . 25.6 m -115.88 164.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.404 -1.271 . . . . 75.03 107.949 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -126.16 92.47 3.59 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 64.43 110.358 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -65.29 -42.08 96.37 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.715 -0.675 . . . . 51.32 113.249 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 32.7 t70 -89.18 107.72 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 73.41 111.577 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.581 ' HB ' HG22 ' A' ' 246' ' ' ILE . 38.0 mm -110.89 112.27 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.918 -0.771 . . . . 75.04 108.918 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -138.49 159.03 43.12 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.923 -0.769 . . . . 74.41 108.923 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -55.9 -36.44 67.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 72.21 111.204 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.579 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 4.6 m -68.98 -5.34 21.0 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 70.42 112.44 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -93.2 -13.37 28.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.009 0.433 . . . . 62.23 110.72 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 161' ' ' ILE . 7.3 mp -105.89 111.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.723 -0.671 . . . . 73.42 109.755 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 196' ' ' VAL . 3.7 mm? -114.48 130.94 56.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.798 -0.637 . . . . 73.44 110.326 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 1.069 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 41.4 mt -84.62 142.88 29.62 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.638 -0.71 . . . . 73.2 109.674 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.443 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 40.5 t-20 -59.93 135.43 57.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.533 -0.543 . . . . 73.53 109.533 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 82.7 t80 -61.82 -30.38 70.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.981 0.419 . . . . 73.35 111.221 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -93.95 -36.02 12.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.303 -0.408 . . . . 72.04 110.074 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 4.6 m-20 -114.96 87.97 16.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 61.14 110.215 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.2 -11.21 24.93 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.349 2.033 . . . . 61.21 112.157 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -96.16 15.21 21.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 74.21 109.924 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.18 107.65 8.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.196 -0.911 . . . . 74.44 109.063 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 157' ' ' LEU . 10.7 p -102.21 142.21 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.37 0.605 . . . . 72.33 112.035 -172.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.44 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 95.7 m-85 -125.75 144.42 50.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.462 -0.79 . . . . 71.13 110.181 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.45 99.94 11.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.902 -1.147 . . . . 74.12 107.902 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.65 HG22 HD23 ' A' ' 184' ' ' LEU . 29.2 m -101.34 0.77 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.203 0.446 . . . . 62.24 112.203 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.48 95.88 5.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.043 0.449 . . . . 73.24 109.812 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.47 6.5 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.809 -0.632 . . . . 74.42 109.715 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.55 -33.73 67.53 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.516 -0.765 . . . . 74.12 111.457 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.47 30.33 2.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.437 . . . . 72.44 110.743 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -92.83 99.69 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.163 0.506 . . . . 71.42 109.661 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -107.5 138.77 43.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.952 -0.567 . . . . 75.3 110.349 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.33 133.46 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 62.04 110.871 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 206' ' ' PRO . 5.9 t80 -137.31 -54.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 63.13 111.295 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.2 p -108.37 103.15 49.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 112.07 0.396 . . . . 63.44 112.07 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 24.6 Cg_exo -63.28 118.31 5.22 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.697 2.265 . . . . 72.45 110.8 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 64.77 10.11 5.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.943 -0.571 . . . . 75.22 111.059 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 169' ' ' HIS . . . 96.07 0.88 61.53 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.741 -0.742 . . . . 64.41 113.063 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.82 110.79 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 117.128 0.464 . . . . 72.52 112.189 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -177.63 144.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.963 -0.754 . . . . 64.1 108.963 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.68 115.22 8.1 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.611 -0.515 . . . . 72.3 109.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -159.14 102.81 1.62 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.029 -0.268 . . . . 64.41 110.915 -175.014 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.463 ' HA ' HG23 ' A' ' 236' ' ' VAL . 44.8 p90 -124.89 130.99 53.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 64.11 111.334 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 71.9 mmtt -129.18 -86.74 0.54 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.078 -0.964 . . . . 72.44 108.933 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 29.6 tt0 177.39 -63.81 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.946 -0.57 . . . . 54.31 110.161 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -148.76 104.74 3.43 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.039 -0.528 . . . . 75.2 111.307 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.461 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 1.4 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 C-N-CA 122.965 2.443 . . . . 62.33 112.003 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.003 -0.369 . . . . 71.3 110.003 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -90.43 171.2 36.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.891 -0.671 . . . . 61.25 112.534 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 228' ' ' THR . 25.0 p -69.6 130.82 43.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 73.14 110.716 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.549 HG12 HG11 ' A' ' 271' ' ' VAL . 16.6 tt -63.46 -18.05 21.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.443 0.639 . . . . 73.33 110.324 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.596 ' HG2' HD13 ' A' ' 265' ' ' LEU . 24.8 mt-10 -55.59 -63.03 1.3 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.974 -1.012 . . . . 63.03 111.06 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.85 -40.56 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.893 -0.594 . . . . 74.31 111.15 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 93.2 m -56.63 -29.16 61.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.098 -0.501 . . . . 63.21 110.908 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 35.8 m 64.11 -147.48 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.72 -0.673 . . . . 52.44 111.372 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 60.0 mt -72.65 -34.72 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.846 0.355 . . . . 73.25 110.962 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' A' ' 236' ' ' VAL . 1.5 m-20 -51.76 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.03 -0.987 . . . . 64.12 113.599 -169.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.91 -29.43 67.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 42.33 111.404 -173.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 229' ' ' SER . 58.3 t-80 -66.77 -33.6 75.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.943 -0.571 . . . . 72.24 111.492 -175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 5.9 m-20 -92.89 -27.77 16.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 72.52 111.029 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 127.01 -4.99 7.37 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.717 -1.23 . . . . 71.03 114.182 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 231' ' ' ASP . 3.2 p -75.24 127.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.743 0.771 . . . . 64.14 109.626 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 212' ' ' GLU . . . -59.08 121.36 54.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 60.31 112.075 -172.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 16.5 Cg_exo -66.95 101.18 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.949 2.433 . . . . 73.43 111.841 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 51.0 m -84.89 -168.42 2.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.171 -0.677 . . . . 74.04 109.171 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 20.1 mmt180 -52.24 -46.62 65.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.873 0.324 . . . . 74.21 111.873 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 307' ' ' LYS . 20.2 ttt180 -68.97 -30.08 68.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.969 -0.292 . . . . 54.14 110.789 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.5 23.97 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.786 -0.721 . . . . 62.21 111.99 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -60.1 -42.0 93.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.926 0.393 . . . . 62.33 110.42 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 89.8 mt -62.42 -38.74 90.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.18 -0.464 . . . . 74.44 111.592 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.43 -48.92 75.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.311 0.577 . . . . 75.15 109.877 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.581 HG22 ' HB ' ' A' ' 178' ' ' ILE . 68.6 mt -57.03 -44.48 82.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.13 -0.941 . . . . 74.5 110.718 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.5 -41.47 94.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.68 -46.2 93.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.301 -0.476 . . . . 53.53 112.62 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -61.96 -38.25 87.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 73.33 110.878 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.5 m -66.89 -47.16 72.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.416 . . . . 60.25 110.631 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 86.7 mtp -60.89 -43.32 98.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 63.42 111.301 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 286' ' ' MET . 12.7 tt -67.35 -34.95 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.458 -0.497 . . . . 74.51 110.917 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -62.96 -43.65 98.2 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.83 -0.348 . . . . 65.25 110.452 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -66.01 -35.29 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 73.44 110.631 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.0 -32.84 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 74.11 111.818 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.5 p -102.71 -27.98 12.39 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.623 -0.431 . . . . 73.43 111.825 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 147' ' ' LYS . . . 119.75 -45.87 1.19 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 65.13 113.719 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.01 159.33 39.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.596 0.698 . . . . 73.23 111.098 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 90.7 mt -95.19 137.64 22.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 61.42 110.582 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.8 Cg_exo -67.33 -28.79 39.24 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.004 2.469 . . . . 51.51 112.907 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -101.66 9.91 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.757 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 16.5 tt0 -59.44 -45.78 90.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.595 . . . . 63.21 112.315 -170.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.77 -16.3 61.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 74.41 111.049 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -107.54 16.87 23.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.39 . . . . 73.33 111.096 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' A' ' 226' ' ' GLU . 37.4 mt -70.07 -14.03 62.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.551 0.691 . . . . 75.15 110.007 172.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.23 -19.42 58.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.119 -0.946 . . . . 60.43 110.018 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 271' ' ' VAL . 9.6 m-20 -94.83 113.29 60.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.455 -0.793 . . . . 73.12 110.071 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.72 -38.47 93.0 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.706 2.271 . . . . 73.24 112.89 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 269' ' ' LYS . 7.7 mtpm? -69.47 -42.98 74.14 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.894 -0.323 . . . . 64.45 111.467 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.71 -38.46 91.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.003 -0.279 . . . . 73.21 111.19 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.549 HG11 HG12 ' A' ' 225' ' ' ILE . 38.2 t -65.75 -39.88 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.948 0.404 . . . . 53.15 110.224 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -64.07 -56.31 15.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 72.13 110.335 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.41 -44.68 96.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.781 -0.645 . . . . 65.2 112.023 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 55.3 p -63.57 -50.49 69.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 121.083 -0.247 . . . . 74.14 111.321 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 33.3 mmtp -64.08 -34.04 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.18 -0.208 . . . . 74.13 111.31 -175.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.43 -53.76 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.925 0.393 . . . . 72.44 111.014 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -71.1 -30.82 67.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 65.14 111.475 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -73.47 -35.44 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.725 -0.216 . . . . 73.44 110.91 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.87 -31.22 72.21 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.253 0.549 . . . . 71.01 110.238 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.36 -59.37 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.256 -0.883 . . . . 73.41 110.483 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.472 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.6 OUTLIER -108.57 59.42 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.312 -0.404 . . . . 65.12 111.195 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -62.81 -43.95 99.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.55 112.196 -177.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.47 -47.8 77.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.795 0.295 . . . . 61.13 111.795 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.6 t -66.44 -46.71 75.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.76 0.314 . . . . 75.35 110.927 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.4 mm? -68.16 -49.86 58.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 73.44 111.821 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.559 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -62.09 -39.99 94.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.627 0.251 . . . . 64.4 111.55 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.64 -31.33 66.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 72.32 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -69.91 -33.2 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 64.22 109.975 178.682 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.23 -19.66 62.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 75.45 111.264 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.933 ' HB3' ' HB3' ' A' ' 296' ' ' PRO . 6.7 t80 -128.52 87.81 54.03 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 121.101 0.476 . . . . 71.33 110.323 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.5 2.98 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.365 2.71 . . . . 73.5 111.939 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.9 149.69 24.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.684 -0.858 . . . . 73.24 108.684 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.3 mmtt -91.98 29.67 1.56 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.037 0.384 . . . . 55.44 112.037 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.601 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 42.3 t-20 -64.11 -69.88 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.943 -1.502 . . . . 72.21 106.943 167.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.638 ' HB3' ' NH2' ' A' ' 151' ' ' ARG . 49.9 tptt 169.15 114.76 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.257 0.973 . . . . 74.33 109.59 160.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.933 ' HB3' ' HB3' ' A' ' 290' ' ' PHE . 89.3 Cg_endo -96.22 46.26 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.673 2.249 . . . . 75.43 111.544 169.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.25 -43.02 1.02 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.384 -0.912 . . . . 33.33 113.048 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.485 ' HB2' HD12 ' A' ' 299' ' ' ILE . 0.9 OUTLIER -57.53 -64.11 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 74.11 110.408 -175.612 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 298' ' ' GLU . 2.8 mp -60.25 -39.69 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 72.52 111.049 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.63 68.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.374 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 12.8 tptt -79.93 -23.27 41.87 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.354 . . . . 75.03 110.926 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 320' ' ' LEU . 65.7 t80 -59.99 -48.22 82.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 75.01 109.911 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.623 ' HA ' HG22 ' A' ' 306' ' ' VAL . 82.6 mtp -72.5 -32.9 66.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.983 -0.553 . . . . 73.32 110.548 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 4.4 tp10 -54.96 -45.74 74.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.788 0.804 . . . . 74.54 109.109 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 63.2 m -63.57 -47.33 81.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.315 -1.311 . . . . 64.32 111.965 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 303' ' ' MET . 21.6 m -66.2 -34.26 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.862 -0.335 . . . . 71.33 111.741 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -76.45 -27.67 56.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.406 -0.518 . . . . 74.13 109.755 177.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 24.6 tp -77.4 -26.96 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.784 -0.643 . . . . 74.04 110.925 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 310' ' ' ASP . 4.4 pp -86.3 18.46 3.18 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.765 0.317 . . . . 65.34 110.745 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 24.0 t70 73.47 -79.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.497 -0.774 . . . . 73.22 111.938 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -162.11 -31.43 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.537 0.684 . . . . 74.22 109.755 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.6 t -170.57 29.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.486 -0.779 . . . . 74.01 108.978 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 3.3 tm-20 -70.85 -71.11 0.27 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.177 -0.92 . . . . 64.23 110.274 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -132.31 87.36 43.17 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.386 -0.37 . . . . 74.05 110.275 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.51 118.0 3.15 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.414 2.076 . . . . 63.54 111.689 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.2 mt -112.31 94.58 5.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.226 0.536 . . . . 74.23 110.183 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -68.41 -33.33 74.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.513 -0.767 . . . . 73.43 110.807 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.93 -38.94 90.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 61.13 110.567 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.85 -44.84 88.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 64.44 110.437 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 86.8 mt -60.19 -47.88 84.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 73.3 110.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 325' ' ' LEU . 8.1 ppt_? -73.78 -19.09 60.87 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.741 -0.384 . . . . 62.33 111.214 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.17 -32.57 29.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 60.12 111.449 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -75.81 -32.57 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 120.005 -0.678 . . . . 52.23 110.042 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 298' ' ' GLU . 95.2 mt -66.08 -41.92 90.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.944 -0.761 . . . . 52.04 108.944 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -65.12 -32.02 73.51 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.512 -0.767 . . . . 70.24 110.121 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -49.19 78.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.263 -0.643 . . . . 75.41 109.263 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.1 -40.31 95.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.753 -0.737 . . . . 64.22 112.689 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.715 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 28.8 tp -69.12 -43.36 74.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.377 0.608 . . . . 63.04 110.848 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.94 -38.11 82.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.242 -0.89 . . . . 72.14 110.892 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.07 75.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 60.14 111.291 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -89.8 -7.28 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.974 0.416 . . . . 53.51 110.759 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 83.77 26.34 42.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 45.54 113.563 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 9.4 t -117.87 171.35 8.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.257 0.528 . . . . 63.41 110.925 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' A' ' 328' ' ' LEU . 0.0 OUTLIER -153.44 161.14 42.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 62.51 110.425 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 156' ' ' GLN . 7.2 p-10 -89.81 -12.09 40.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.73 0.3 . . . . 74.14 111.499 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.3 102.01 14.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 72.33 111.077 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 147.08 -68.79 0.38 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.155 -1.021 . . . . 64.22 113.014 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 110.214 -0.291 . . . . 72.45 110.214 -173.56 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.985 0.422 . . . . 72.13 110.237 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.5 t -100.97 -171.03 1.93 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 73.24 110.085 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.69 144.3 14.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.128 0.489 . . . . 75.25 111.084 -176.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 15.2 t -73.04 166.97 22.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.628 . . . . 74.11 110.874 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.293 -176.15 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.743 0.306 . . . . 61.53 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.83 0.01 56.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.056 -0.592 . . . . 74.35 112.198 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.44 160.43 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 71.01 110.932 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.44 115.59 45.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.961 -0.563 . . . . 72.03 109.673 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 37' ' ' TRP . 19.2 pt -96.68 122.73 48.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.859 -0.609 . . . . 63.23 109.965 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 17.6 m -101.11 119.17 38.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.099 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.6 p-10 -90.03 -170.3 2.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.427 -0.351 . . . . 72.24 110.355 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.68 -21.1 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 73.11 111.222 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.81 2.41 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 44.23 109.96 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 60.13 34.64 21.2 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.164 -0.925 . . . . 75.44 111.353 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' THR . 30.3 mmmt -92.83 150.43 20.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.019 -0.537 . . . . 71.21 109.932 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.87 96.2 7.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.875 -0.602 . . . . 74.44 110.66 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HB2' HG13 ' A' ' 29' ' ' ILE . 25.6 m95 -98.92 138.72 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 63.31 109.637 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 56' ' ' MET . 31.6 ttmt -106.46 119.28 38.85 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.831 -0.347 . . . . 64.22 110.629 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.29 127.61 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 61.21 110.727 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . -113.96 -115.19 3.17 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.515 -0.85 . . . . 60.1 113.01 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 49.5 tp -77.93 125.47 85.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.572 0.225 . . . . 71.3 111.504 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 10.0 Cg_exo -72.47 120.03 6.48 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.854 2.37 . . . . 73.22 111.254 172.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 45' ' ' GLN . 63.1 mt -97.04 -53.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.117 0.484 . . . . 74.04 110.749 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' HA2' ' A' ' 49' ' ' GLY . . . 94.73 -25.19 24.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.822 -0.704 . . . . 74.21 112.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.468 ' H ' HG22 ' A' ' 43' ' ' ILE . 49.5 tp60 -117.0 162.94 16.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.651 -0.5 . . . . 70.11 109.651 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.23 -3.34 16.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.623 -1.391 . . . . 74.14 109.623 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -176.49 -142.66 4.42 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 114.296 -0.952 . . . . 72.11 110.976 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.84 ' HZ ' ' HA3' ' A' ' 199' ' ' GLY . 92.4 m-85 -60.86 -46.95 88.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.62 0.247 . . . . 74.23 111.066 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . 156.36 164.72 13.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.765 -0.731 . . . . 55.54 111.691 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.0 m 61.83 39.17 14.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.014 0.435 . . . . 41.31 111.042 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 6.2 mm -88.68 132.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 72.23 109.809 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -109.63 164.52 12.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 75.34 111.06 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 HH21 ' A' ' 133' ' ' ARG . 7.0 tt -83.09 128.89 34.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.957 -0.757 . . . . 51.22 108.957 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -106.3 37.1 2.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.716 1.006 . . . . 73.23 113.716 -166.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.6 t0 172.39 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.977 0.511 . . . . 63.45 109.965 169.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.447 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 21.5 ptm -107.39 19.94 19.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.107 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 58' ' ' SER . 8.2 t-20 -124.63 -165.16 1.34 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 63.13 109.72 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 22.8 t -107.99 89.99 3.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.985 0.422 . . . . 74.22 110.146 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.402 0.62 . . . . 72.44 110.151 174.771 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 109.39 -0.596 . . . . 43.11 109.39 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 133' ' ' ARG . 89.7 Cg_endo -80.67 29.74 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.187 2.591 . . . . 53.14 113.003 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 p -130.82 137.06 49.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.301 0.572 . . . . 74.22 111.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 143.85 37.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.626 -0.879 . . . . 71.43 108.626 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 6.2 p -118.64 121.06 66.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.482 0.658 . . . . 71.3 111.947 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HD3' ' HD2' ' A' ' 48' ' ' PHE . 39.0 ttmt -89.36 126.11 35.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.216 -0.902 . . . . 72.5 109.09 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.24 133.04 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.159 0.504 . . . . 73.02 111.97 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 15.8 mt-10 -140.1 170.53 9.53 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.862 -0.792 . . . . 72.32 108.862 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 14.3 Cg_endo -57.13 156.43 24.78 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.402 2.068 . . . . 72.13 112.799 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.552 ' HA ' ' HG3' ' A' ' 127' ' ' ARG . 15.5 t -84.37 34.04 0.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 44.54 110.834 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.82 -83.67 0.55 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.179 -0.464 . . . . 62.45 111.165 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.22 -89.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.89 -0.324 . . . . 73.41 111.19 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.51 -176.63 1.46 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.101 -0.5 . . . . 74.22 113.552 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.518 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 6.4 Cg_exo -74.82 -22.04 15.65 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.059 2.506 . . . . 73.24 111.249 169.015 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.523 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.7 tm? -51.94 -40.54 60.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.513 -0.767 . . . . 70.31 110.823 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.95 -38.87 83.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 53.5 111.021 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.9 m -67.04 -41.62 86.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.07 0.462 . . . . 65.41 110.25 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 198' ' ' TYR . 31.3 mt-10 -67.08 -38.07 85.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.832 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.85 -41.7 71.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.008 0.432 . . . . 64.55 109.913 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -57.04 -54.08 50.78 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 55.12 110.897 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -64.49 -48.69 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.729 0.64 . . . . 62.53 112.729 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.506 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 3.8 m-85 -65.97 -34.26 77.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.611 0.244 . . . . 71.22 111.403 -175.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.55 -33.74 58.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.813 -0.355 . . . . 73.24 111.901 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 13.6 tpt180 -97.44 -45.81 6.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.911 0.708 . . . . 75.3 112.911 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -0.97 56.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.855 0.687 . . . . 63.14 112.855 -169.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -104.36 -151.59 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.084 -0.246 . . . . 73.22 111.156 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG2' ' OE2' ' A' ' 94' ' ' GLU . 56.9 tttm 74.56 102.94 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 123.689 0.796 . . . . 72.01 110.05 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 Cg_endo -50.26 -52.77 8.29 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.387 3.392 . . . . 60.43 115.567 -165.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.568 ' OE2' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -72.01 -32.55 67.28 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 74.41 112.901 -169.16 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -74.55 -30.11 61.62 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.029 -0.669 . . . . 71.23 110.333 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 91' ' ' ALA . 72.6 mt -61.15 -53.03 54.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.344 -0.613 . . . . 64.12 109.344 172.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.1 -34.73 60.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 72.14 110.497 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -56.54 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.783 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.473 ' HE1' HD12 ' A' ' 108' ' ' LEU . 1.8 p90 -70.11 -34.17 72.77 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.949 -0.701 . . . . 74.32 111.249 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 108' ' ' LEU . 60.7 mt -64.45 -33.34 62.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.201 0.524 . . . . 41.22 109.694 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -71.03 -40.84 71.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.551 -0.75 . . . . 74.24 110.275 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 m -67.85 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 43.21 111.532 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -75.91 -23.5 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 75.14 111.173 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 68.92 64.52 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.941 0.776 . . . . 65.11 110.039 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' OD2' ' A' ' 163' ' ' ASP . 3.4 mm? -106.97 -163.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.163 -0.926 . . . . 64.2 109.625 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG2' HD21 ' A' ' 159' ' ' LEU . 50.8 tptt -121.74 -59.62 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.472 0.545 . . . . 72.21 112.472 -174.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -159.07 98.38 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.514 -0.475 . . . . 74.41 111.447 -168.52 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.511 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tt -78.9 115.19 18.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.739 -0.837 . . . . 73.14 108.739 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.54 64.79 3.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.956 -0.64 . . . . 34.11 112.722 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.511 ' HB ' HD22 ' A' ' 108' ' ' LEU . 7.7 p -111.24 135.9 20.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.087 -0.338 . . . . 70.33 110.087 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG12 ' A' ' 196' ' ' VAL . 19.1 Cg_endo -60.12 140.07 90.58 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.854 2.369 . . . . 65.41 112.802 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.872 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 84.2 tttt -65.62 128.73 37.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.08 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -109.52 117.71 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.57 -0.741 . . . . 64.35 110.698 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 130' ' ' ILE . 38.5 m95 -89.86 -49.45 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.425 0.631 . . . . 75.44 109.554 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 178.32 -174.49 46.76 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.901 -1.045 . . . . 71.41 111.881 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.472 ' C ' ' HB2' ' A' ' 31' ' ' ASP . 93.1 p -168.37 150.51 5.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.847 -0.798 . . . . 54.14 108.847 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -166.41 -162.41 17.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.086 -1.054 . . . . 72.43 113.067 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.3 tt -128.48 129.3 45.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.862 -0.422 . . . . 74.35 109.862 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -129.59 123.86 32.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.153 -0.684 . . . . 64.24 109.153 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 7.3 t70 -89.11 138.07 31.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.27 -0.423 . . . . 73.01 110.177 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 121' ' ' LYS . 13.2 tmtt? -90.94 28.9 1.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.7 0.762 . . . . 62.32 109.581 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.0 t30 62.27 70.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.944 -1.025 . . . . 72.01 110.058 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.66 10.68 12.45 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.245 -0.889 . . . . 75.2 111.78 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.79 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -164.49 104.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.813 -0.44 . . . . 73.54 109.813 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB3' HD21 ' A' ' 118' ' ' LEU . 12.4 m -76.14 130.59 38.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.278 -0.419 . . . . 44.24 111.176 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.89 149.02 41.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 75.13 110.478 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 75' ' ' SER . 94.1 mtt180 -113.11 133.17 55.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.475 -0.565 . . . . 51.2 109.475 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 54.4 p90 -126.7 143.39 51.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.272 -0.422 . . . . 64.23 110.895 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 17.1 ptp -128.84 137.2 51.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.406 -0.361 . . . . 75.44 110.259 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CD1' ' A' ' 114' ' ' TRP . 49.8 mt -103.97 121.4 55.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 73.2 111.794 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ptm -122.72 178.25 5.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.502 -0.772 . . . . 74.41 109.89 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.872 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.2 t70 -80.95 -178.15 6.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.72 0.295 . . . . 72.52 111.126 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.628 HH21 HD12 ' A' ' 53' ' ' LEU . 5.8 mmt85 -83.79 83.83 7.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.412 0.625 . . . . 73.51 112.352 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -103.69 170.56 7.86 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.907 -0.775 . . . . 71.54 108.907 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.63 -41.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.347 -1.406 . . . . 65.22 113.544 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.796 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 18.4 m -71.23 122.85 20.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.011 0.406 . . . . 75.32 111.21 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.54 118.13 24.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.433 -0.803 . . . . 75.11 110.106 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.24 -22.67 67.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.642 -0.873 . . . . 63.43 108.642 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 48.1 tp60 -56.07 -48.6 75.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.752 -1.113 . . . . 74.44 110.977 175.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -75.46 -27.97 59.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 73.33 111.531 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -46.69 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.023 -0.271 . . . . 74.54 110.279 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -74.02 -32.99 63.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.385 -0.526 . . . . 74.2 110.301 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.92 -33.67 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.833 0.349 . . . . 44.1 110.924 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -83.94 -31.37 25.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.142 0.423 . . . . 53.02 112.142 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -104.24 13.82 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 71.03 111.018 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 55.2 46.61 23.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.95 -0.568 . . . . 74.22 111.373 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.617 ' HB3' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER 42.09 38.79 1.17 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.0 113.17 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -94.71 96.85 9.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.964 0.411 . . . . 73.21 110.133 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 85.0 m-85 -113.5 147.74 37.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.44 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 154' ' ' VAL . 7.3 p -83.55 167.82 16.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.017 -0.538 . . . . 34.43 110.898 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.649 ' NH1' ' HB ' ' A' ' 331' ' ' ILE . 35.4 ttt180 -55.18 -46.18 75.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 73.12 111.23 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 333' ' ' SER . 86.2 mttt -58.2 -51.79 68.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.223 -0.444 . . . . 63.44 111.478 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -56.28 -43.67 79.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.938 -0.574 . . . . 75.14 112.025 -178.52 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 150' ' ' SER . 53.0 t -64.11 -48.43 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 71.2 110.735 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.606 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 2.7 mm? -58.43 -45.15 89.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.394 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 57.4 mm-40 -61.27 -44.84 96.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 61.33 111.494 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 88.4 mt -61.1 -49.11 78.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 72.52 110.622 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.1 p -62.52 -31.99 72.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 74.23 111.297 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 106' ' ' LYS . 59.4 tp -63.12 -46.77 85.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 74.43 110.629 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 12.4 mmt85 -63.03 -44.73 95.12 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.893 0.854 . . . . 60.3 110.02 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.96 -33.88 66.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.578 -1.192 . . . . 62.52 110.815 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.7 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.871 -0.418 . . . . 73.05 109.871 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -55.32 -56.94 14.33 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.516 0.674 . . . . 72.31 110.459 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.3 tt -67.88 -37.13 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.566 -0.743 . . . . 75.44 111.572 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.543 ' HG ' ' HE2' ' A' ' 175' ' ' HIS . 8.8 tt -61.03 -39.4 89.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.293 -0.262 . . . . 71.51 110.293 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -67.33 -54.02 24.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 71.15 109.363 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -56.05 -46.68 78.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.574 -0.739 . . . . 75.23 112.293 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 164' ' ' ILE . 29.1 pt -80.77 -32.41 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.208 0.447 . . . . 74.32 112.208 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 240' ' ' ARG . 3.7 t60 -69.48 -34.76 74.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.373 -0.603 . . . . 64.23 109.373 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -27.04 67.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.453 -0.794 . . . . 65.35 110.503 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.81 19.46 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 72.35 112.098 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 204' ' ' TYR . 44.5 mt-10 72.1 16.65 5.26 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.711 0.634 . . . . 75.41 112.711 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -121.4 144.65 48.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.253 0.549 . . . . 72.43 110.856 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 202' ' ' TYR . 23.6 t -104.31 163.44 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.51 -0.768 . . . . 74.12 109.352 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HE2' ' HG ' ' A' ' 165' ' ' LEU . 5.7 p80 -132.33 105.3 7.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.076 -0.713 . . . . 73.32 109.076 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.438 ' HA3' ' OD2' ' A' ' 222' ' ' ASP . . . -63.76 -54.88 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.638 -0.71 . . . . 65.33 114.148 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 200' ' ' LEU . 24.4 t70 -80.6 90.13 5.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.605 0.717 . . . . 64.4 111.626 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.54 HG22 ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -94.3 102.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.916 -1.512 . . . . 55.14 106.916 159.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.697 ' HG3' ' HE2' ' A' ' 227' ' ' PHE . 29.4 tttp -173.99 -137.04 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.171 -1.418 . . . . 74.51 107.171 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 179' ' ' LYS . . . -120.9 1.24 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.479 -0.328 . . . . 23.21 110.636 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -28.02 50.93 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 111.959 0.355 . . . . 73.4 111.959 -171.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 182' ' ' ASN . 5.6 m120 -108.55 11.06 26.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.722 0.296 . . . . 64.14 111.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 179' ' ' LYS . 8.3 mp -102.61 109.46 21.08 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.369 -0.532 . . . . 72.23 109.986 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.467 HD23 HG22 ' A' ' 196' ' ' VAL . 3.8 mm? -117.79 128.57 54.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.839 . . . . 71.02 109.821 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 80.6 mt -81.43 146.85 30.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.771 -0.649 . . . . 74.23 110.269 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.27 121.01 13.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.476 -1.676 . . . . 73.4 106.476 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -14.34 54.6 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.761 -0.376 . . . . 53.24 111.728 -167.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -87.22 -53.71 4.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.842 0.353 . . . . 74.41 110.814 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.1 m-20 -108.48 114.45 59.09 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.918 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 6.8 Cg_exo -73.11 -12.45 25.72 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 123.241 2.627 . . . . 74.3 112.398 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.55 4.56 39.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 63.31 110.837 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 194' ' ' TYR . 80.0 mt-30 -123.45 96.77 5.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.925 -0.58 . . . . 73.51 110.995 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.2 130.69 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.666 -0.697 . . . . 71.52 109.676 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 192' ' ' GLN . 89.0 m-85 -120.17 142.23 49.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.084 -0.507 . . . . 61.12 110.709 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 164' ' ' ILE . 34.2 tp -88.15 99.27 12.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.245 -1.02 . . . . 74.23 108.245 175.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.467 HG22 HD23 ' A' ' 184' ' ' LEU . 15.3 m -120.61 -178.2 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.345 -0.389 . . . . 73.02 110.212 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . 2.6 t70 60.16 71.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.787 0.804 . . . . 75.12 108.979 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.548 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 70.5 m-85 -81.47 34.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.083 -0.962 . . . . 73.33 111.556 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.84 ' HA3' ' HZ ' ' A' ' 48' ' ' PHE . . . -77.25 -3.4 81.91 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.556 -0.831 . . . . 72.44 112.348 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 352' ' ' LYS . 5.4 mp -114.75 34.37 4.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.701 0.286 . . . . 73.15 111.376 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.08 125.86 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.866 0.365 . . . . 51.13 110.438 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.708 ' HD1' HD11 ' A' ' 354' ' ' ILE . 36.2 t80 -108.35 174.77 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.077 -0.51 . . . . 73.14 109.913 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -89.07 135.61 33.47 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.59 0.356 . . . . 72.34 111.173 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 172' ' ' GLU . 8.5 t80 -96.98 -60.34 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 72.15 110.416 173.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 8.4 p -138.04 142.56 36.24 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.647 -0.251 . . . . 74.35 110.881 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 3.1 Cg_exo -75.53 74.83 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.197 2.598 . . . . 54.44 112.203 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.94 86.66 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.573 -0.739 . . . . 53.44 111.921 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.07 -53.89 4.91 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 72.41 113.775 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 14.5 m -73.02 111.07 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.304 0.573 . . . . 64.13 110.936 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 205' ' ' CYS . 20.0 m80 -74.59 110.23 8.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.84 -0.618 . . . . 71.11 109.964 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 212' ' ' GLU . 8.1 tmtm? -97.92 130.89 44.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 75.11 108.872 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -84.19 -98.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.387 -0.37 . . . . 71.43 111.57 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 20.4 p90 -91.97 91.61 7.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.808 0.813 . . . . 75.24 112.121 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -39.74 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.239 -0.892 . . . . 72.43 108.938 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.07 179.34 0.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.975 -1.012 . . . . 72.12 111.905 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 12.0 t70 -147.94 127.86 6.62 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 64.14 110.134 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 21.9 Cg_exo . . . . . 0 CA--C 1.532 0.378 0 C-N-CA 123.172 2.581 . . . . 75.15 113.384 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.438 ' OD2' ' HA3' ' A' ' 176' ' ' GLY . 5.1 p-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.81 0.338 . . . . 73.1 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.51 170.32 40.4 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.782 -0.723 . . . . 52.23 111.725 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 228' ' ' THR . 53.1 p -70.49 141.96 51.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.093 0.446 . . . . 71.33 111.5 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 265' ' ' LEU . 73.3 mt -55.49 -34.11 33.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 115.769 -0.65 . . . . 63.25 112.406 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.798 ' HG3' ' HG ' ' A' ' 265' ' ' LEU . 3.0 mp0 -52.69 -39.43 61.97 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.002 0.43 . . . . 72.45 110.366 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.828 ' HB3' HG23 ' A' ' 246' ' ' ILE . 70.9 m-85 -105.06 -93.0 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.404 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' THR . 7.5 p 58.03 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.049 1.5 . . . . 63.44 115.049 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 47.6 t 64.44 -175.84 0.17 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.851 -0.796 . . . . 44.12 108.851 -172.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 230' ' ' ILE . 2.9 mp -71.2 -37.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.2 -0.667 . . . . 71.13 109.2 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.75 -73.2 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.691 -1.141 . . . . 63.34 112.104 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.61 -29.65 70.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.372 -0.376 . . . . 75.24 111.783 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.458 ' HE1' HG23 ' A' ' 225' ' ' ILE . 8.1 t60 -66.21 -37.46 85.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 75.55 110.297 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -77.92 -38.33 45.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 74.45 110.513 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 216' ' ' ASP . . . 114.55 9.26 14.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.761 -0.733 . . . . 71.43 112.109 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 6.2 p -89.35 137.71 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.737 -0.468 . . . . 61.54 109.737 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -57.64 117.92 22.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 74.41 111.203 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 23.5 Cg_exo -65.24 101.91 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.681 2.254 . . . . 62.53 111.42 176.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 204' ' ' TYR . 3.1 p -77.68 -20.58 53.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 72.32 110.657 -176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.781 ' HD2' ' HG3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER 178.3 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.18 -0.918 . . . . 51.54 108.823 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HD3' ' HD1' ' A' ' 311' ' ' TYR . 5.7 mtp85 -59.5 -60.96 3.01 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.183 -0.917 . . . . 72.42 111.404 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 238' ' ' PRO . . . -43.36 -65.97 1.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 O-C-N 124.065 0.853 . . . . 54.33 114.203 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.11 -30.54 65.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.339 0.57 . . . . 63.32 111.624 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.49 ' HB3' HH21 ' A' ' 240' ' ' ARG . 17.6 tp -75.29 -35.78 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.887 0.375 . . . . 61.41 110.921 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.09 -37.55 46.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.492 -0.322 . . . . 62.1 110.401 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 227' ' ' PHE . 87.4 mt -60.93 -38.29 78.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.743 -0.465 . . . . 73.55 109.743 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 178' ' ' ILE . 51.8 tp -59.4 -47.35 85.8 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.365 175.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.39 -44.94 93.39 Favored Glycine 0 C--O 1.237 0.283 0 C-N-CA 120.978 -0.629 . . . . 44.01 112.233 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 12.7 m-85 -57.09 -44.08 82.83 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 120.572 0.225 . . . . 72.13 111.142 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.54 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.6 m -67.19 -38.1 84.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.622 -0.263 . . . . 73.23 111.36 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 84.3 mtp -60.4 -49.64 76.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.57 -0.286 . . . . 63.54 110.924 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.636 ' HB ' HG21 ' A' ' 299' ' ' ILE . 12.3 tt -70.32 -31.43 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 74.24 110.305 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.543 ' OE1' ' HG3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -61.02 -46.16 91.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.576 . . . . 63.03 110.181 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.3 m0 -71.7 -35.3 70.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.14 111.369 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.4 tp -76.42 -30.87 57.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.984 0.364 . . . . 74.33 111.984 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.534 HG21 ' HB3' ' A' ' 289' ' ' CYS . 73.6 p -103.36 -27.59 12.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 71.01 111.378 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 83.66 0.25 89.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.769 -0.729 . . . . 70.01 113.238 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -157.07 144.04 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.369 0.584 . . . . 71.23 111.425 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 92.2 mt -129.74 139.55 35.99 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 75.24 109.567 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 38.8 Cg_exo -58.22 -24.27 66.3 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.115 2.543 . . . . 70.21 113.752 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.771 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 25.1 p90 -98.91 -17.73 18.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.406 0.521 . . . . 75.41 112.406 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 1.5 pp20? -86.16 -14.66 43.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.336 -0.546 . . . . 71.53 110.68 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.86 -45.85 90.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 61.34 109.571 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.39 29.05 7.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.367 -0.833 . . . . 75.5 109.737 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.798 ' HG ' ' HG3' ' A' ' 226' ' ' GLU . 2.5 tm? -47.7 -34.24 7.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.855 0.862 . . . . 53.31 112.525 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -66.44 -12.25 56.22 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.013 0.375 . . . . 50.52 112.013 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.6 110.5 49.82 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 73.14 109.665 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.509 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 32.0 Cg_endo -63.04 -24.44 73.7 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.194 2.596 . . . . 72.25 113.999 -171.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -63.13 -49.98 72.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.791 0.329 . . . . 75.51 110.792 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -63.18 -36.82 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 73.33 110.285 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 69.7 t -62.35 -45.21 99.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 73.44 111.136 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 79.9 mtp180 -64.78 -54.87 24.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 73.12 111.394 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.31 -41.44 97.01 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.709 0.29 . . . . 71.21 111.692 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 27.7 m -62.91 -40.28 97.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.477 -0.329 . . . . 72.02 110.796 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -65.17 -42.78 93.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 74.34 111.129 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.7 mt -61.43 -46.21 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 71.23 110.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -64.12 -34.82 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.379 -0.373 . . . . 75.23 111.514 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 282' ' ' ILE . 5.1 m-85 -72.16 -32.31 66.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.707 -0.224 . . . . 74.51 111.597 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -77.92 -34.07 51.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 74.03 110.538 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.51 -42.63 12.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.969 -0.56 . . . . 74.31 112.032 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.447 ' O ' HD23 ' A' ' 285' ' ' LEU . 10.9 t-20 -124.86 81.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.589 . . . . 74.13 110.481 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -74.38 -34.09 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 75.31 112.54 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.85 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.2 m -70.27 -48.84 54.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 53.44 110.972 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.1 mm? -63.12 -50.59 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.078 -0.51 . . . . 74.12 111.364 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.635 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.3 OUTLIER -60.79 -40.76 93.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.897 0.332 . . . . 73.42 111.897 -177.547 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.73 -42.39 95.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.908 0.385 . . . . 74.54 111.115 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 288' ' ' LYS . 43.3 mmtm -81.21 4.31 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.354 0.502 . . . . 74.24 112.354 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 256' ' ' THR . 80.2 m -83.32 -17.43 42.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 51.31 109.904 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 0.9 OUTLIER -123.7 89.41 51.4 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 73.43 109.81 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.88 3.03 7.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.323 2.682 . . . . 73.2 112.481 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 6.1 mm-40 -99.71 174.21 6.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.893 -0.78 . . . . 65.53 108.893 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -86.86 79.59 8.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.434 0.635 . . . . 71.03 111.304 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -159.92 157.02 28.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.004 -0.998 . . . . 73.54 108.601 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -105.07 117.49 58.45 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 112.227 0.455 . . . . 71.43 112.227 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -95.51 38.57 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.297 2.664 . . . . 60.33 110.957 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -69.91 -36.92 74.3 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.547 -0.751 . . . . 61.23 113.209 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.535 ' HB3' HD23 ' A' ' 324' ' ' LEU . 1.5 mp0 -50.99 -52.72 39.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.965 0.412 . . . . 74.13 110.69 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.636 HG21 ' HB ' ' A' ' 252' ' ' ILE . 4.0 mp -70.76 -36.64 65.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.616 . . . . 73.25 110.415 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.73 68.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.454 -0.339 . . . . 72.21 110.784 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.011 -0.541 . . . . 64.5 110.156 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.568 ' CD1' HD22 ' A' ' 320' ' ' LEU . 68.0 t80 -56.66 -42.79 79.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 110.2 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.635 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 95.7 mmm -70.44 -40.86 73.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.57 -0.741 . . . . 63.33 110.603 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.671 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 46.6 mt-10 -53.06 -50.42 64.38 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.204 -0.665 . . . . 64.01 109.204 172.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 79.3 m -56.83 -50.49 72.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.659 -1.155 . . . . 73.2 112.087 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 303' ' ' MET . 28.8 m -69.41 -26.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.391 0.515 . . . . 54.51 112.391 -174.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -90.92 -16.15 28.6 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.786 -0.366 . . . . 75.12 111.692 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 53.0 mt -68.37 -37.59 80.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 74.34 110.592 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.3 pp -87.13 12.92 10.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.381 0.61 . . . . 42.12 110.19 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.85 -93.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.643 -1.162 . . . . 73.43 112.961 171.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HD1' ' HD3' ' A' ' 241' ' ' ARG . 40.2 t80 -115.72 -58.56 2.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.86 0.319 . . . . 73.23 111.86 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.1 p -133.73 10.07 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.1 0.407 . . . . 74.13 112.1 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.0 60.9 6.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.387 0.514 . . . . 73.32 112.387 -169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? 64.97 103.86 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.389 -0.823 . . . . 74.42 113.189 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.781 ' HG3' ' HD2' ' A' ' 240' ' ' ARG . 4.4 Cg_exo -78.92 119.5 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.734 2.289 . . . . 63.21 111.303 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 94.1 mt -84.32 81.38 8.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.758 0.313 . . . . 65.13 110.987 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.49 -36.42 75.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 64.3 111.366 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -61.45 -45.99 91.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.415 . . . . 63.35 110.498 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.05 -40.32 90.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.277 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 87.8 mt -58.19 -52.55 65.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 74.13 110.1 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -40.33 77.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 73.15 110.805 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.65 -50.31 69.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 63.14 111.635 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.69 -31.97 27.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 111.679 0.252 . . . . 74.53 111.679 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 298' ' ' GLU . 93.0 mt -66.35 -48.63 69.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 72.24 110.621 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.6 -27.11 63.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 72.32 110.919 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.38 -49.06 78.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.437 -0.579 . . . . 71.42 109.437 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.72 -40.18 93.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.656 -0.783 . . . . 62.4 112.108 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.606 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 tm? -59.08 -43.96 91.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 62.43 110.517 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 333' ' ' SER . 30.1 ttpt -72.82 -30.01 63.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 70.01 110.855 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.03 69.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 73.45 112.071 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.649 ' HB ' ' NH1' ' A' ' 151' ' ' ARG . 13.7 tt -83.34 -7.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 62.32 111.013 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.19 -6.15 26.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.588 -0.815 . . . . 60.13 113.188 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.707 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 20.1 p -100.19 158.48 15.83 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.659 -0.318 . . . . 64.31 110.704 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -148.87 -68.36 0.22 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.294 -0.632 . . . . 72.31 109.294 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 336' ' ' ASP . 9.2 t70 56.43 -155.9 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.722 -0.672 . . . . 65.4 111.402 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 335' ' ' ASP . 27.2 t70 -153.03 -36.7 0.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.22 -0.446 . . . . 65.33 110.855 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' GLY . . . . . 0.499 ' HA2' ' OE1' ' A' ' 156' ' ' GLN . . . 177.97 49.73 0.07 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.969 -1.11 . . . . 45.3 114.082 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 117.278 0.539 . . . . 74.13 111.556 177.803 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.905 ' HA ' HD11 ' A' ' 200' ' ' LEU . 33.1 pttt . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.829 0.347 . . . . 75.25 111.919 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 10.8 t 166.85 135.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.291 -0.868 . . . . 73.33 109.602 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.882 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -94.4 142.08 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.546 -0.538 . . . . 73.44 109.546 175.548 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.514 ' N ' HD13 ' A' ' 354' ' ' ILE . 24.5 m -64.48 97.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.045 -0.525 . . . . 63.34 111.97 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.467 ' HE3' ' CG2' ' A' ' 354' ' ' ILE . 94.9 mttt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.638 . . . . 73.43 109.992 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.242 -0.281 . . . . 71.4 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.24 -21.91 43.32 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.798 -0.715 . . . . 73.33 113.533 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.67 160.76 29.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.704 0.752 . . . . 73.01 110.306 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 6.4 pt -116.76 129.67 72.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.468 0.651 . . . . 65.44 110.949 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 33.1 pt -91.8 154.48 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.511 -0.768 . . . . 75.22 111.091 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 35' ' ' LYS . 4.8 m -112.5 114.13 26.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 72.21 111.273 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.678 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.7 p-10 -112.05 -166.54 1.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 55.3 109.834 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.624 ' HG2' ' O ' ' A' ' 116' ' ' SER . 20.9 mmt -63.65 -22.55 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.337 -0.392 . . . . 74.52 111.46 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.52 4.8 19.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.776 0.322 . . . . 53.23 111.013 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 71.26 44.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.771 -0.649 . . . . 75.22 111.61 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HB2' HG23 ' A' ' 30' ' ' THR . 37.7 ttmt 72.97 113.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.324 -0.853 . . . . 74.22 113.262 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.76 37.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 75.41 110.61 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 11.3 m95 -134.01 126.12 29.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 70.41 110.117 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.58 124.9 50.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.682 0.277 . . . . 74.22 110.304 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.97 126.14 25.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 44.22 110.928 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.02 -107.88 3.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.766 -0.73 . . . . 55.15 112.306 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.852 ' HB3' HD12 ' A' ' 53' ' ' LEU . 49.1 tp -86.67 123.94 70.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.727 0.299 . . . . 72.24 110.71 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 41' ' ' LEU . 58.2 Cg_endo -74.81 109.04 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.45 2.1 . . . . 71.13 111.837 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 36.9 mt -74.0 -53.46 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.34 0.59 . . . . 72.31 110.048 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.92 -29.51 5.88 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.65 -0.705 . . . . 73.32 112.575 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -119.01 165.1 14.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.163 -0.31 . . . . 73.44 110.163 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.13 51.82 1.43 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.548 -0.834 . . . . 73.31 111.749 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.67 -126.71 2.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.503 -0.856 . . . . 60.52 112.008 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -92.77 -33.69 14.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.9 0.381 . . . . 61.42 110.919 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.443 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 141.13 160.68 8.39 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.369 -0.692 . . . . 71.14 111.369 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.8 t 53.53 53.81 11.01 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.273 0.558 . . . . 52.0 110.652 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.3 mm -89.07 137.81 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 64.33 110.273 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' HG13 ' A' ' 70' ' ' VAL . 84.5 m-85 -121.22 148.54 44.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 64.32 111.193 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.852 HD12 ' HB3' ' A' ' 41' ' ' LEU . 75.3 mt -87.4 140.72 29.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.049 -0.523 . . . . 75.34 109.837 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.29 37.84 4.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.374 0.607 . . . . 65.15 109.914 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 8.7 p-10 -98.22 9.12 43.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.489 -0.778 . . . . 73.45 111.249 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.62 2.61 50.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 74.32 111.736 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.38 87.78 7.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.158 -0.617 . . . . 73.31 110.029 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 t -104.1 79.77 1.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.727 -0.842 . . . . 72.01 108.727 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 62.15 110.756 -176.604 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.31 0.576 . . . . 71.14 110.557 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 187' ' ' TYR . 93.3 Cg_endo -80.81 36.95 0.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.089 2.526 . . . . 72.13 113.14 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.6 m -117.86 136.15 53.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.62 0.724 . . . . 53.33 111.849 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 53' ' ' LEU . 35.4 m -136.2 148.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.996 -1.002 . . . . 75.12 108.746 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -123.73 120.66 60.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.291 0.567 . . . . 54.34 111.028 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CB ' HD12 ' A' ' 51' ' ' ILE . 25.3 pttm -105.58 134.44 48.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 126' ' ' TYR . 15.9 t -120.51 148.94 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 63.14 112.054 -165.643 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 80' ' ' LEU . 18.1 mm-40 -137.8 141.16 31.88 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 70.43 109.422 173.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.65 134.64 58.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.456 2.104 . . . . 72.34 111.633 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -73.41 88.46 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.185 0.517 . . . . 63.03 111.1 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -139.15 -68.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.585 -0.894 . . . . 72.15 108.585 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 5.3 p30 -128.5 -75.42 0.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.558 -0.746 . . . . 72.21 109.032 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . 72.35 110.5 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 114.058 0.383 . . . . 73.03 114.058 170.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA2' ' A' ' 78' ' ' GLY . 12.0 Cg_endo -55.77 -22.35 36.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.858 2.372 . . . . 60.52 111.398 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 57.9 tp -59.85 -30.1 68.74 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.454 -0.793 . . . . 64.43 110.559 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.35 -38.93 71.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.933 -0.395 . . . . 73.14 109.933 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.6 m -60.95 -46.96 88.6 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.426 0.632 . . . . 64.32 109.522 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 34.6 tt0 -63.14 -37.98 89.35 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.348 -0.842 . . . . 52.55 110.64 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.4 -45.3 88.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.486 -0.324 . . . . 60.34 110.681 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.82 -50.97 71.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.852 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 168' ' ' ILE . 92.7 t80 -62.63 -40.1 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 64.41 110.95 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 2.8 t80 -62.3 -45.14 94.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.309 -0.859 . . . . 72.33 111.052 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.02 -29.68 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.678 0.275 . . . . 72.11 111.323 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 7.6 tpm_? -69.2 -27.84 65.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 73.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.75 10.83 36.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 71.12 110.912 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.89 173.78 11.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.384 . . . . 71.01 111.74 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt 70.83 98.22 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.129 -0.941 . . . . 71.22 110.321 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.92 -31.51 81.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.693 2.928 . . . . 72.32 113.741 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.747 ' HG2' ' HE3' ' A' ' 98' ' ' LYS . 43.6 tt0 -60.86 -46.8 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.219 -0.193 . . . . 74.34 110.787 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -58.77 -44.1 90.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.884 0.373 . . . . 72.04 110.055 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.1 mt -56.32 -52.72 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.484 -0.78 . . . . 72.21 110.224 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.16 -36.83 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.099 -0.501 . . . . 75.1 110.96 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.747 ' HE3' ' HG2' ' A' ' 94' ' ' GLU . 97.4 mttt -60.44 -58.44 8.48 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.044 -0.525 . . . . 72.23 111.177 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.683 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.2 p90 -72.44 -34.23 67.65 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.155 -0.618 . . . . 72.12 110.788 -174.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 96' ' ' ILE . 22.4 mm -55.28 -49.12 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.548 0.213 . . . . 61.3 110.731 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.83 -44.89 84.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.301 . . . . 73.44 111.135 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.5 m -71.13 -23.97 62.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 72.13 111.575 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.607 HH22 ' HB2' ' A' ' 170' ' ' GLU . 20.6 ttt180 -96.24 -1.84 47.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.457 -176.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.95 35.68 8.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.76 -0.654 . . . . 71.15 111.325 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.532 HD11 ' HD3' ' A' ' 103' ' ' ARG . 81.2 mt -94.97 -165.51 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.524 . . . . 73.02 109.956 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HG3' HD21 ' A' ' 159' ' ' LEU . 3.2 mmmp? -108.87 -61.79 1.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.751 -0.463 . . . . 71.21 109.751 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 32.4 p90 178.62 144.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 73.33 109.618 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 22.5 tp -79.34 125.49 29.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.673 -0.694 . . . . 63.32 110.805 -172.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 59.71 4.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.105 -0.569 . . . . 40.42 112.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.48 134.41 21.97 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.716 -0.475 . . . . 64.01 109.716 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.729 ' HB3' ' HZ ' ' A' ' 134' ' ' PHE . 17.1 Cg_endo -59.8 142.55 98.85 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.302 2.001 . . . . 72.41 112.057 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.72 147.83 50.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 74.21 111.303 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.05 128.98 55.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.913 -0.585 . . . . 72.24 110.742 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.59 ' HB2' HG22 ' A' ' 130' ' ' ILE . 70.3 m95 -103.33 -59.7 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.304 0.573 . . . . 73.34 109.665 174.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.17 175.52 42.3 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.507 -0.77 . . . . 74.32 112.564 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' MET . 18.7 p -150.49 155.93 40.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.442 -0.947 . . . . 75.31 108.442 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.678 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -172.56 -160.01 20.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.201 -1.476 . . . . 72.53 113.799 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 tp -136.92 136.21 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.058 -0.571 . . . . 74.15 110.02 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 3.7 t-160 -139.77 121.91 15.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.212 -0.662 . . . . 65.2 109.212 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 22.3 t70 -88.49 130.83 35.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 71.42 109.905 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -87.34 -72.02 0.54 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.919 0.39 . . . . 71.4 110.667 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -135.75 33.4 2.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 74.41 110.184 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.1 -23.1 21.89 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.477 -1.049 . . . . 52.11 110.477 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.7 mptt -87.45 104.44 16.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.77 -0.826 . . . . 64.15 108.77 172.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.1 m -77.52 129.07 35.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.468 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . 47.8 m-85 -107.89 124.1 49.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.084 -0.507 . . . . 65.22 111.106 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -100.29 131.28 46.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.037 -0.727 . . . . 74.42 109.037 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 17.5 p90 -144.52 164.7 30.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.39 -0.368 . . . . 72.3 111.467 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 16.7 ptp -135.63 143.43 45.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.958 -0.565 . . . . 64.31 110.972 174.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.59 HG22 ' HB2' ' A' ' 114' ' ' TRP . 6.0 mm -97.48 121.34 47.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.279 -0.873 . . . . 75.04 110.027 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.9 ptm -133.56 176.46 8.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.461 -0.791 . . . . 71.34 109.871 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -72.47 145.83 47.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.264 0.554 . . . . 74.3 111.757 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HD3' HG11 ' A' ' 69' ' ' VAL . 16.6 tpt180 -71.37 129.35 38.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.221 -0.9 . . . . 73.12 111.385 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 50.0 m-85 -103.76 142.53 34.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.246 -0.65 . . . . 75.42 109.246 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.37 -16.14 4.36 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.432 -0.89 . . . . 64.31 111.754 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.861 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 61.4 m -121.71 125.88 47.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.609 0.243 . . . . 73.25 110.421 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.01 138.11 44.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 71.44 109.454 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.736 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.4 tp -71.85 -17.38 62.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.232 -0.284 . . . . 75.31 110.232 -176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.886 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 52.4 tt0 -68.85 -51.15 43.54 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.152 0.427 . . . . 64.14 112.152 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.5 tptt -79.56 -35.31 40.02 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.255 -0.578 . . . . 74.21 110.436 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -43.2 92.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.167 -0.47 . . . . 73.21 111.265 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -65.38 -31.52 72.67 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.315 -0.554 . . . . 75.41 110.232 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -67.01 -38.17 85.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.825 0.345 . . . . 62.15 110.424 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.04 -32.21 68.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 74.11 111.529 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -99.06 4.6 47.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 75.52 111.136 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.3 33.98 21.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.055 -0.521 . . . . 70.35 110.967 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 16.9 pttp 43.32 33.09 0.55 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.485 1.114 . . . . 71.21 113.15 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -110.58 95.92 5.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.53 -0.915 . . . . 73.22 108.53 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 147' ' ' LYS . 24.7 m-85 -112.32 157.12 21.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.612 -0.722 . . . . 74.2 110.949 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 m -62.69 156.31 23.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.009 -0.541 . . . . 73.22 109.751 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -55.72 -26.04 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.822 0.305 . . . . 72.45 111.822 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG2' ' OD2' ' A' ' 335' ' ' ASP . 57.1 mttm -52.65 -54.32 35.01 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.231 0.539 . . . . 70.33 111.004 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 m -65.16 -36.17 83.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.638 -0.71 . . . . 73.45 111.222 -174.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 -49.38 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.107 -0.497 . . . . 63.13 110.788 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.615 ' HG ' HD22 ' A' ' 328' ' ' LEU . 0.5 OUTLIER -68.5 -50.39 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 52.13 110.53 -176.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.564 ' HG3' ' H ' ' A' ' 337' ' ' GLY . 2.3 mp0 -61.61 -40.43 94.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.128 0.418 . . . . 73.12 112.128 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.9 mp -63.96 -46.83 82.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.03 -0.268 . . . . 65.11 110.36 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.454 ' HA ' HD11 ' A' ' 247' ' ' LEU . 37.6 t -60.27 -46.65 89.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.865 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 106' ' ' LYS . 58.7 tp -55.62 -46.36 77.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 64.42 111.277 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.584 HH11 HG12 ' A' ' 193' ' ' VAL . 89.9 mtt180 -66.68 -34.03 76.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 74.31 111.294 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 157' ' ' LEU . 48.1 mm -68.89 -34.71 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 63.3 110.291 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.477 HD11 HD12 ' A' ' 324' ' ' LEU . 95.7 mt -61.11 -47.41 86.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.486 -0.324 . . . . 61.32 110.6 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.74 -48.02 78.73 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.124 -0.489 . . . . 72.04 111.155 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' ILE . 14.7 tt -71.83 -36.47 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.774 -0.37 . . . . 50.25 111.677 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 168' ' ' ILE . 42.5 tp -65.41 -32.62 74.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.44 110.985 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 317' ' ' TYR . 28.6 tp10 -68.12 -45.96 72.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.826 -0.435 . . . . 53.13 109.826 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -59.04 -44.05 91.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 72.05 111.893 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 165' ' ' LEU . 40.6 pt -76.57 -34.28 23.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.715 -0.394 . . . . 65.12 111.683 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -75.79 -19.1 59.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.67 -0.412 . . . . 75.2 110.443 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.607 ' HB2' HH22 ' A' ' 103' ' ' ARG . 13.6 tt0 -53.34 -31.8 46.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.016 -0.735 . . . . 75.45 109.016 170.557 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.545 ' C ' ' HG3' ' A' ' 172' ' ' GLU . 48.1 m80 -98.45 -101.94 0.21 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.981 -1.008 . . . . 63.44 110.596 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' HG3' ' C ' ' A' ' 171' ' ' HIS . 12.1 mt-10 -153.87 14.0 0.47 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.645 0.239 . . . . 75.54 111.645 -171.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -122.46 148.04 45.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 72.41 112.601 -164.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.01 173.21 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.034 -0.984 . . . . 70.21 109.401 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.14 -65.11 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 63.42 110.897 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.28 50.97 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.435 -0.888 . . . . 33.21 113.056 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 34.0 t70 -141.37 108.37 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.983 0.392 . . . . 54.03 111.169 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 178' ' ' ILE . 25.2 mm -111.27 35.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.81 0.814 . . . . 73.13 109.4 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 56.4 tptt -59.71 134.87 57.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 72.41 110.169 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -48.06 -33.64 8.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.83 0.678 . . . . 75.32 112.83 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.886 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 28.6 p -59.41 -25.58 64.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.848 0.356 . . . . 64.44 111.671 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -88.51 1.02 55.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 74.41 111.87 -171.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.21 127.01 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 63.45 110.579 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.42 134.9 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 62.02 111.007 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.861 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 8.6 mp -95.64 145.86 24.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.149 -0.478 . . . . 54.52 109.815 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.438 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 26.2 t-20 -62.73 144.39 56.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.378 -0.373 . . . . 63.15 110.417 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.654 ' CE2' ' HE2' ' A' ' 188' ' ' LYS . 1.3 p90 -60.56 -32.37 71.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.219 0.451 . . . . 72.34 112.219 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.654 ' HE2' ' CE2' ' A' ' 187' ' ' TYR . 75.8 mmtt -93.71 -43.91 8.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 72.53 110.237 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -101.94 105.3 41.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 71.22 111.961 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 4.3 Cg_exo -77.15 -7.04 17.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.957 2.438 . . . . 75.02 111.466 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 192' ' ' GLN . 5.0 p-10 -87.96 -16.86 32.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.839 -0.619 . . . . 71.13 110.7 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HG3' ' OD2' ' A' ' 191' ' ' ASP . 42.8 mt-30 -111.08 110.98 21.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.405 0.621 . . . . 71.1 111.11 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.584 HG12 HH11 ' A' ' 160' ' ' ARG . 13.0 p -108.09 138.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.882 -1.053 . . . . 75.13 109.913 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 47.0 m-85 -125.33 153.74 42.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.442 -0.577 . . . . 63.51 109.442 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 32.5 tp -96.48 142.3 28.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.059 -0.349 . . . . 62.35 110.059 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.701 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.0 p -124.04 -173.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.293 -0.632 . . . . 73.32 109.293 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 196' ' ' VAL . 52.5 t0 60.63 62.32 1.53 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.894 0.854 . . . . 75.33 109.116 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.773 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 21.7 m-85 -81.11 7.59 10.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.147 -0.933 . . . . 71.24 109.788 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.45 76.5 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.579 -0.737 . . . . 63.33 111.622 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.885 ' HA ' ' HB ' ' A' ' 354' ' ' ILE . 2.4 pp -89.91 4.07 51.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.753 0.311 . . . . 74.43 111.355 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -68.89 102.1 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.194 0.521 . . . . 64.25 109.974 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.605 ' HB2' HG13 ' A' ' 354' ' ' ILE . 84.8 t80 -98.39 125.54 43.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 71.52 110.117 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 34.8 ttt180 -74.4 97.16 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 54.25 109.147 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.66 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 2.7 p90 -87.07 -14.93 40.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 73.52 111.625 -170.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 24.8 p -137.4 104.47 8.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.82 0.343 . . . . 72.55 110.871 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 34.1 Cg_endo -66.16 119.97 7.06 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.413 2.075 . . . . 74.32 111.708 176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.411 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 3.4 mp0 64.98 -80.79 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.769 -0.65 . . . . 73.24 111.046 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.84 0.64 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 74.25 112.098 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 51.0 t -105.63 111.74 36.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.077 -0.342 . . . . 71.12 110.077 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -83.94 146.07 28.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.859 0.361 . . . . 74.34 110.295 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 212' ' ' GLU . 10.1 mmtt -84.02 156.37 22.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.449 . . . . 73.3 109.989 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -102.25 153.62 19.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.315 -0.624 . . . . 73.45 109.315 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.874 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -74.13 55.82 0.59 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.563 0.579 . . . . 72.01 112.563 -174.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -117.28 -15.49 10.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.11 -0.496 . . . . 74.13 110.498 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 236' ' ' VAL . 3.0 tp10 -80.94 141.14 34.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.669 -170.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -148.98 83.15 6.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.534 -0.913 . . . . 70.43 108.534 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 C--O 1.233 0.243 0 C-N-CA 122.414 2.076 . . . . 72.15 112.205 -176.077 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 121.044 0.449 . . . . 64.2 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -76.44 159.36 49.97 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.707 -0.758 . . . . 74.42 111.674 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 228' ' ' THR . 6.6 p -68.58 150.3 48.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.472 0.177 . . . . 61.44 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 265' ' ' LEU . 43.8 mm -52.97 -34.36 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.903 0.383 . . . . 71.52 111.479 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.18 -47.06 84.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.964 -0.562 . . . . 74.41 111.293 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.984 ' HB3' HG23 ' A' ' 246' ' ' ILE . 41.0 m-85 -112.1 15.75 20.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 75.31 111.968 -170.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 224' ' ' THR . 1.3 p -57.87 -36.83 72.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.441 0.534 . . . . 63.1 112.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.6 t 57.23 -173.97 0.08 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.378 -0.601 . . . . 73.31 109.378 -170.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.5 -39.15 54.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.262 0.553 . . . . 65.51 109.849 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.82 -66.45 0.4 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.888 -1.051 . . . . 65.02 111.967 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.57 69.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 75.12 111.914 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -63.02 -43.67 98.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.629 -0.26 . . . . 65.11 111.099 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.39 -32.88 58.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.212 0.53 . . . . 75.42 110.819 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.25 1.45 55.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.625 -0.798 . . . . 62.54 111.49 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 213' ' ' TYR . 8.8 p -72.42 141.88 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 110.0 -0.37 . . . . 64.01 110.0 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -47.76 109.89 1.23 Allowed Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 61.41 111.728 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.57 121.21 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 73.21 111.864 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 m -79.8 170.59 16.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.033 -0.53 . . . . 75.42 109.82 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -62.7 -29.98 71.06 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.415 -0.514 . . . . 74.24 110.434 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 0.2 OUTLIER -55.12 -38.8 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.42 109.858 174.348 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -67.26 -50.95 41.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.536 -0.756 . . . . 65.31 111.971 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -39.67 94.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.992 0.425 . . . . 74.44 110.174 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.35 -44.28 97.44 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.086 -0.506 . . . . 54.12 110.775 174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.62 -36.99 81.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.76 -0.655 . . . . 74.11 110.181 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.984 HG23 ' HB3' ' A' ' 227' ' ' PHE . 96.5 mt -62.77 -43.01 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.648 -0.706 . . . . 72.42 110.151 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 251' ' ' MET . 61.7 tp -60.34 -39.6 87.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.321 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.805 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.62 -42.06 99.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.035 -0.602 . . . . 73.13 112.254 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 246' ' ' ILE . 22.2 m-85 -56.93 -41.35 78.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.248 0.547 . . . . 60.42 110.046 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 46.4 m -65.57 -45.44 83.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.553 -0.749 . . . . 74.52 110.656 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.2 mtp -58.39 -48.53 80.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 74.13 111.228 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.473 ' HB ' ' HE1' ' A' ' 286' ' ' MET . 8.9 tt -66.53 -34.29 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.713 -0.395 . . . . 75.41 110.742 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.505 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 41.6 tt0 -66.75 -46.4 75.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.141 -0.224 . . . . 71.24 110.772 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.0 m0 -68.37 -28.21 66.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 71.01 111.363 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.5 tp -81.49 -31.05 33.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 74.3 111.706 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.7 p -101.8 -28.2 12.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.801 -0.359 . . . . 74.04 111.683 -173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 87.01 -13.79 58.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.858 -0.687 . . . . 73.3 112.745 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -156.26 141.04 17.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.919 -0.4 . . . . 75.54 109.919 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 93.9 mt -101.79 148.93 36.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 52.14 110.758 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.448 ' HG2' ' CE3' ' A' ' 261' ' ' TRP . 18.2 Cg_endo -60.07 -29.11 88.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.708 2.272 . . . . 63.53 112.766 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.515 ' HB3' ' CB ' ' A' ' 274' ' ' SER . 33.5 p90 -105.13 7.58 33.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.72 0.295 . . . . 70.34 111.222 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 39.8 tt0 -67.22 -37.48 83.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.026 0.441 . . . . 44.2 111.332 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.56 -22.14 62.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.348 0.594 . . . . 73.41 110.091 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -109.56 21.73 16.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.526 -0.761 . . . . 75.11 110.731 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 225' ' ' ILE . 1.6 tm? -63.33 -24.0 67.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 73.03 111.03 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -88.56 12.69 13.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 62.54 111.698 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.54 118.46 17.98 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-O 120.766 0.317 . . . . 73.52 110.636 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 271' ' ' VAL . 24.4 Cg_exo -63.17 -30.62 74.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 73.03 113.267 -177.021 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -73.23 -41.67 63.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.751 0.31 . . . . 74.32 110.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -68.89 -46.54 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 74.22 111.204 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 268' ' ' PRO . 34.1 m -62.88 -31.21 51.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.928 -0.309 . . . . 70.03 111.143 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 276' ' ' ILE . 10.7 ttt85 -61.16 -62.72 1.64 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 110.139 -0.319 . . . . 74.45 110.139 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.39 -44.65 84.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.77 -0.65 . . . . 74.52 111.563 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 261' ' ' TRP . 19.7 m -65.15 -40.94 95.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.962 -0.563 . . . . 52.2 111.668 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -78.52 -23.01 46.5 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.537 -0.465 . . . . 53.5 110.921 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 272' ' ' ARG . 62.4 mt -71.32 -46.5 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.838 -0.431 . . . . 73.13 109.838 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -62.64 -40.01 95.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.346 -0.388 . . . . 75.01 110.545 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -60.14 -46.86 88.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 74.11 110.842 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -76.98 -13.91 59.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 73.43 110.624 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.83 -36.19 79.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.099 -0.501 . . . . 54.11 110.052 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 281' ' ' ASN . 2.6 t-20 -161.9 96.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.416 -0.587 . . . . 64.02 109.416 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 303' ' ' MET . 3.7 mp -80.16 -51.48 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.186 0.439 . . . . 54.42 112.186 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.409 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.12 -46.94 84.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.597 0.221 . . . . 71.21 111.597 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -64.99 -37.14 86.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 62.54 110.559 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.27 -34.44 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 65.01 110.69 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.473 ' HE1' ' HB ' ' A' ' 252' ' ' ILE . 49.5 mtt -74.38 -34.22 63.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.687 -0.233 . . . . 75.21 111.44 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -59.92 -36.52 77.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.288 -0.634 . . . . 71.53 109.288 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -75.35 -24.48 57.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.976 -1.011 . . . . 74.02 110.965 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.0 m -72.85 -23.46 60.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.619 -0.264 . . . . 72.14 111.229 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.82 81.24 11.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.85 0.315 . . . . 53.42 111.85 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.37 -18.34 49.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.533 2.156 . . . . 74.42 111.228 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -76.78 -5.91 50.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.75 -0.659 . . . . 54.32 109.85 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 64.95 90.14 0.09 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.057 -0.974 . . . . 72.24 112.315 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.44 -177.14 3.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.816 -1.549 . . . . 75.41 106.816 170.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -122.29 87.26 48.21 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 118.808 0.731 . . . . 73.03 110.332 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.46 39.65 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.323 2.682 . . . . 75.1 111.348 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -65.61 -37.32 93.47 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.837 -0.619 . . . . 72.14 112.861 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.567 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -60.35 -46.61 89.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.31 0.576 . . . . 72.31 109.899 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -76.29 -38.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.473 -0.785 . . . . 72.24 110.442 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.39 -53.24 59.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 75.43 111.488 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.593 ' HB3' HD11 ' A' ' 323' ' ' ILE . 27.8 tptp -69.4 -36.32 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.397 -0.365 . . . . 72.02 110.412 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.536 ' CD1' HD12 ' A' ' 320' ' ' LEU . 62.9 t80 -55.76 -50.92 69.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.908 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.805 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 82.9 mmm -70.61 -40.86 72.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.918 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.15 -34.15 77.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.547 -0.538 . . . . 74.41 109.547 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -73.25 -45.23 57.14 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.508 0.558 . . . . 74.2 112.508 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.1 m -63.54 -25.3 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.348 0.594 . . . . 74.41 110.342 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -74.6 -44.18 51.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 71.33 111.455 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 85.1 mt -84.38 71.23 10.7 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.139 0.792 . . . . 64.23 113.139 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 310' ' ' ASP . 1.3 pt? -159.61 -71.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.369 -0.974 . . . . 53.14 108.369 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.948 ' H ' ' HG ' ' A' ' 309' ' ' LEU . 2.8 t70 174.52 -73.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 124.002 0.814 . . . . 71.12 109.093 168.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 0.4 OUTLIER -162.35 -51.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.245 0.832 . . . . 71.12 113.245 173.085 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 7.0 m -139.36 32.0 2.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.598 0.713 . . . . 72.22 110.943 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 310' ' ' ASP . 7.8 mp0 -62.5 -76.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 64.13 109.962 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -156.75 93.51 2.36 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 73.43 109.459 173.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 117.39 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.949 1.766 . . . . 62.31 110.747 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.07 85.43 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 75.3 109.923 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.471 ' CZ ' ' HD2' ' A' ' 321' ' ' ARG . 60.5 t80 -57.2 -36.91 71.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.43 -0.805 . . . . 73.31 110.987 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.52 -39.26 90.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 72.13 110.417 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -68.06 -42.97 79.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 64.14 111.274 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.536 HD12 ' CD1' ' A' ' 302' ' ' TYR . 2.0 mm? -63.07 -43.38 98.73 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.939 -0.304 . . . . 75.5 110.749 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.558 ' NH2' ' HG2' ' A' ' 106' ' ' LYS . 65.0 mtp85 -67.7 -38.5 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.911 -0.316 . . . . 73.42 110.351 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -48.4 76.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 64.32 111.203 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -64.67 -41.42 92.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.815 -0.175 . . . . 64.03 111.232 -176.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 162' ' ' LEU . 80.5 mt -63.24 -46.06 88.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.822 0.344 . . . . 71.45 110.869 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -35.26 75.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.449 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -55.68 -47.84 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.862 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.567 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -68.07 -45.89 69.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.901 -0.666 . . . . 71.15 112.166 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.615 HD22 ' HG ' ' A' ' 155' ' ' LEU . 40.6 tp -59.17 -45.7 90.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.127 0.489 . . . . 74.21 110.812 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -73.96 -24.63 59.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 61.42 111.164 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.43 -43.14 77.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.682 0.277 . . . . 65.44 110.991 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.29 -6.73 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.364 0.602 . . . . 74.43 110.651 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.99 24.31 38.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.893 -0.67 . . . . 71.51 112.943 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.0 t -108.21 153.53 23.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.903 -0.406 . . . . 61.43 109.903 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.0 132.86 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.152 -0.476 . . . . 65.21 109.831 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 16.7 m-20 -138.6 -58.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.382 -0.372 . . . . 63.22 110.482 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 48.9 t0 59.29 90.15 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.169 0.918 . . . . 55.44 111.064 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' GLY . . . . . 0.564 ' H ' ' HG3' ' A' ' 156' ' ' GLN . . . 96.85 -31.85 7.18 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.825 -0.703 . . . . 70.34 112.398 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 335' ' ' ASP . 53.4 mttp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 54.11 110.984 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.58 ' O ' ' HB ' ' A' ' 353' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 112.087 0.402 . . . . 64.12 112.087 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 93.8 m 74.83 139.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.871 0.732 . . . . 71.33 110.666 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.885 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.4 OUTLIER -90.8 140.57 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 72.43 110.844 -177.614 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.505 ' N ' HD13 ' A' ' 354' ' ' ILE . 88.0 m -68.64 102.48 1.5 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.009 -0.541 . . . . 73.51 110.833 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.281 -0.637 . . . . 65.43 109.281 178.035 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.806 0.336 . . . . 52.23 110.473 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.65 1.22 83.33 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.883 -0.675 . . . . 71.41 112.537 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 154.02 20.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.088 -0.338 . . . . 74.52 110.088 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 14.6 mt -106.42 136.94 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 71.44 111.639 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.41 136.1 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.44 -0.8 . . . . 75.11 109.466 175.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -106.12 121.86 45.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.268 -0.271 . . . . 73.43 110.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.25 179.6 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.772 -0.371 . . . . 74.52 110.01 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.6 mmt -63.41 -22.1 66.68 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.387 0.514 . . . . 73.33 112.387 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.74 6.08 16.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.739 0.305 . . . . 60.13 111.218 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 74.71 11.37 3.85 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.613 -0.721 . . . . 75.53 111.337 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 133.48 33.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.788 -0.449 . . . . 51.24 109.788 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 42.6 mt-10 -104.61 92.47 4.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.379 0.609 . . . . 73.22 110.501 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 56' ' ' MET . 10.9 m95 -83.64 159.02 21.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 71.52 109.089 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.06 146.68 44.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.098 -0.641 . . . . 75.21 110.618 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 ' CE1' ' A' ' 52' ' ' TYR . 58.5 t -72.65 116.88 15.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.393 -0.821 . . . . 41.04 110.409 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 -94.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.518 -0.848 . . . . 62.44 112.095 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.9 mm? -111.74 129.95 23.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.759 0.314 . . . . 62.41 110.869 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.8 Cg_exo -75.07 103.77 1.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.193 2.595 . . . . 73.12 111.544 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.3 mt -86.82 -47.89 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.016 -175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.65 -30.8 8.99 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.137 -0.554 . . . . 73.34 112.05 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -118.07 163.25 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.181 -0.303 . . . . 73.14 110.181 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.69 -33.27 1.3 Allowed Glycine 0 C--O 1.227 -0.325 0 N-CA-C 111.146 -0.782 . . . . 40.12 111.146 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.54 -71.55 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.38 -0.688 . . . . 42.42 111.38 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' HZ ' ' H ' ' A' ' 199' ' ' GLY . 80.8 m-85 -122.58 -71.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.82 0.343 . . . . 74.4 110.382 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.34 157.68 30.09 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.451 -0.66 . . . . 44.14 111.451 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.9 t 60.46 50.48 5.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.278 0.561 . . . . 74.4 110.843 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -105.85 137.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 72.15 109.877 177.294 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.537 ' CE1' HG22 ' A' ' 39' ' ' VAL . 52.6 p90 -128.78 158.78 37.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 72.21 111.228 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.85 132.15 39.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.553 -0.749 . . . . 70.24 109.943 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.89 105.56 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.588 -0.278 . . . . 65.43 110.279 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 1.1 p-10 -95.51 -27.53 15.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.474 -0.33 . . . . 53.44 111.009 -176.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.632 ' HB2' ' CE3' ' A' ' 37' ' ' TRP . 1.8 tmt? 66.5 -84.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.709 0.63 . . . . 64.03 110.466 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 178.61 133.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.691 -0.855 . . . . 55.12 108.691 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -79.49 54.49 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.024 0.44 . . . . 73.34 110.725 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.035 -0.529 . . . . 64.52 111.635 -178.458 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.888 0.375 . . . . 74.14 111.692 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.52 36.36 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.535 2.157 . . . . 61.14 111.571 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -133.75 137.92 45.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.697 0.76 . . . . 53.11 112.385 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG13 ' HG3' ' A' ' 133' ' ' ARG . 31.5 m -132.42 152.25 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.881 -1.054 . . . . 75.23 108.67 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.63 ' HB ' HG12 ' A' ' 130' ' ' ILE . 1.2 p -131.97 131.19 61.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.058 0.456 . . . . 43.34 112.139 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -92.15 139.52 30.54 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.401 -0.818 . . . . 63.44 109.841 176.347 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.57 134.74 49.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.502 -0.479 . . . . 70.42 112.123 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.751 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 3.0 mt-10 -144.57 177.89 1.64 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.612 -0.722 . . . . 55.31 109.069 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.751 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 37.3 Cg_endo -66.96 164.4 29.98 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.673 1.582 . . . . 64.4 112.14 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -59.04 -40.29 84.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.75 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -85.42 88.04 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.232 0.539 . . . . 73.3 109.595 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 12.4 t-20 -121.09 -166.07 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.35 -0.841 . . . . 72.55 109.329 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . -125.9 -75.82 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.75 -0.54 . . . . 33.32 111.75 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 17.8 Cg_endo -58.43 -24.59 69.62 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.098 2.532 . . . . 72.35 113.036 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.697 HD12 ' HE ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -57.21 -30.46 64.58 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.767 0.317 . . . . 73.21 111.379 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -72.79 -45.55 57.93 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.094 0.473 . . . . 73.42 110.116 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -48.43 77.18 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.218 -0.901 . . . . 73.05 110.814 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 10.9 pt-20 -65.81 -36.65 84.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.233 -0.439 . . . . 75.31 110.883 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.75 -50.57 73.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.881 0.372 . . . . 62.41 110.163 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -45.75 84.09 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.021 -0.536 . . . . 72.41 110.595 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -67.67 -50.48 57.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 60.51 111.128 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 1.7 t80 -59.93 -42.37 93.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 74.42 110.837 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 6.7 tp60 -72.65 -34.26 67.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.198 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -75.7 -21.27 57.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.702 0.287 . . . . 74.15 111.361 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.01 15.72 24.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.084 0.469 . . . . 51.54 111.165 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.62 -175.75 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.621 . . . . 70.02 111.897 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.93 92.13 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.021 -0.99 . . . . 74.44 110.755 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.19 -29.14 55.13 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.844 2.363 . . . . 23.33 111.884 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -62.33 -54.75 35.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.706 -0.679 . . . . 71.22 110.285 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.26 -43.83 95.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.627 -0.715 . . . . 64.32 110.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG23 HD21 ' A' ' 108' ' ' LEU . 81.4 mt -56.96 -54.34 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.691 -0.686 . . . . 73.52 110.66 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -58.23 -38.64 77.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 74.5 110.504 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -60.08 -58.92 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.503 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -34.9 67.54 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.077 -0.649 . . . . 72.53 111.005 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 108' ' ' LEU . 33.5 mm -59.63 -43.64 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 71.22 110.783 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -78.11 -41.06 36.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.503 -0.317 . . . . 73.31 111.51 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 m -75.83 -35.78 59.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.106 0.41 . . . . 71.4 112.106 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -94.92 -5.79 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.763 -0.199 . . . . 74.12 111.04 -174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 73.06 84.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.905 0.753 . . . . 74.33 111.853 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 163' ' ' ASP . 5.6 mp -137.18 -176.58 4.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.436 -0.802 . . . . 61.34 109.173 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.649 ' HD2' ' HD1' ' A' ' 107' ' ' TYR . 1.3 tmtm? -96.57 -72.03 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.189 -0.671 . . . . 53.14 109.189 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.649 ' HD1' ' HD2' ' A' ' 106' ' ' LYS . 35.1 p90 175.53 123.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.389 -0.597 . . . . 72.41 109.389 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.6 pt? -78.22 135.96 37.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.69 -0.404 . . . . 70.21 110.128 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.52 67.94 2.78 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.989 -0.55 . . . . 74.51 113.098 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.37 128.83 25.81 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.766 0.317 . . . . 72.22 110.163 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.2 Cg_endo -55.71 144.89 74.08 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.906 2.404 . . . . 65.13 113.229 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.882 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 23.5 tptm -62.52 132.33 52.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.388 -0.824 . . . . 55.0 111.39 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.609 . . . . 74.42 110.646 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 132' ' ' ASP . 71.4 m95 -116.63 -71.95 0.71 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 62.42 109.581 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.63 -178.07 25.15 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.252 -0.885 . . . . 72.02 111.733 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 32' ' ' MET . 48.5 p -166.64 167.91 14.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.213 -0.662 . . . . 74.41 109.213 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.51 -147.44 16.29 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.847 -1.168 . . . . 64.32 112.88 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.455 ' H ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.09 147.87 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.042 0.449 . . . . 72.4 110.759 -176.306 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 29' ' ' ILE . 44.0 t-80 -123.7 115.76 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 60.25 109.112 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.826 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 9.3 t70 -83.98 136.81 33.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.189 -0.46 . . . . 74.55 109.931 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 6.1 ptmm? -87.96 20.0 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.598 0.237 . . . . 74.31 110.376 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 66.99 75.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.881 -0.785 . . . . 72.15 108.881 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.42 -24.21 3.08 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.157 -0.929 . . . . 54.32 112.079 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 18.6 ttpp -168.17 136.99 2.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.928 -0.397 . . . . 72.22 109.928 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 9.2 m -84.09 155.44 22.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.257 0.551 . . . . 73.33 112.002 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.54 155.34 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.339 -0.846 . . . . 75.34 108.745 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.697 ' HE ' HD12 ' A' ' 80' ' ' LEU . 32.7 ttt180 -114.83 128.0 56.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.426 0.155 . . . . 72.32 110.803 -171.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -137.9 163.12 32.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.231 0.539 . . . . 45.45 112.005 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.779 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 37.0 ttm -145.11 141.29 28.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.501 -0.772 . . . . 65.44 110.03 176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.63 HG12 ' HB ' ' A' ' 70' ' ' VAL . 47.4 mt -100.79 134.62 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 54.15 111.42 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 12.3 ptm -129.68 175.65 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 62.14 109.535 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.882 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 5.0 t70 -72.44 174.54 7.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.807 -0.442 . . . . 75.14 109.807 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.592 ' HE ' ' HE1' ' A' ' 187' ' ' TYR . 9.7 ttp180 -86.77 93.11 9.18 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.17 0.986 . . . . 54.24 110.99 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.599 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 47.0 m-85 -103.06 170.55 7.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.822 -1.081 . . . . 72.53 109.322 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.11 -46.1 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.5 -0.857 . . . . 42.24 111.946 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 19.6 m -95.33 125.72 40.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.927 -0.397 . . . . 73.31 109.927 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 p30 -116.8 174.41 6.1 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.031 -0.359 . . . . 72.22 110.031 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.421 HD21 HD21 ' A' ' 157' ' ' LEU . 11.2 mp -74.5 -20.14 60.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 73.22 111.397 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.35 -37.27 63.57 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.908 -0.404 . . . . 72.05 109.908 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 55.7 mttp -57.7 -51.44 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.816 -0.629 . . . . 71.23 110.654 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.14 -34.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.327 -0.397 . . . . 52.52 110.263 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.639 ' HE2' HE22 ' A' ' 253' ' ' GLN . 48.1 t80 -52.7 -52.94 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 74.51 110.841 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -80.64 -41.57 23.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.903 -0.59 . . . . 73.02 111.83 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.32 70.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.272 0.471 . . . . 73.33 112.272 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 148' ' ' ARG . 2.1 t-20 -105.51 0.08 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 71.03 110.536 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.74 46.46 25.82 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.322 -0.854 . . . . 63.24 112.018 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 33.2 mttt 71.56 100.07 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.604 -0.726 . . . . 63.44 112.577 175.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.573 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . 7.2 mmt180 -150.33 72.78 1.12 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 63.41 109.882 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.89 118.88 37.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.874 -0.603 . . . . 73.33 109.862 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -70.85 149.93 46.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.374 -0.375 . . . . 72.33 110.08 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.576 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 11.3 ttp180 -61.16 -31.44 71.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.329 -0.396 . . . . 74.5 111.348 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -59.86 -48.37 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.184 0.516 . . . . 74.23 109.922 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 90.2 m -61.93 -48.67 79.39 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.336 -0.847 . . . . 74.41 110.521 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.2 t -55.87 -47.71 79.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.085 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 324' ' ' LEU . 0.3 OUTLIER -62.69 -48.63 78.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.581 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 22.6 mm-40 -62.46 -41.32 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.119 -0.232 . . . . 74.5 111.212 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.6 mp -59.98 -47.48 85.63 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.101 0.25 . . . . 72.23 110.619 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.5 t -59.65 -43.97 93.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 54.34 110.561 176.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 162' ' ' LEU . 24.5 tp -63.98 -35.63 81.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.05 -0.523 . . . . 73.3 110.879 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.686 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -61.14 -45.03 96.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.332 0.586 . . . . 73.31 109.761 175.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 164' ' ' ILE . 49.5 mm -66.22 -35.11 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.225 -0.898 . . . . 73.41 110.126 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 159' ' ' LEU . 50.5 mt -56.92 -54.78 42.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.219 0.451 . . . . 72.05 112.219 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.462 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.9 p30 -76.25 -35.05 59.15 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.522 -0.871 . . . . 63.12 112.201 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 161' ' ' ILE . 13.4 tt -67.02 -37.02 78.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.034 -0.666 . . . . 64.31 110.32 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 47.5 tp -69.59 -36.86 76.63 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 116.317 -0.401 . . . . 73.44 110.356 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -57.06 -52.52 64.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.602 -0.518 . . . . 74.24 109.602 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -58.47 -40.41 82.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.361 -0.836 . . . . 75.12 112.43 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 29.3 pt -92.47 -32.64 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.006 0.743 . . . . 73.0 113.006 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 2.4 t-160 -73.87 -29.71 62.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.04 -0.356 . . . . 75.52 110.04 -175.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -27.46 69.24 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.945 -0.571 . . . . 72.14 110.084 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.24 -67.61 0.86 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.49 -0.777 . . . . 73.41 112.649 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -148.35 -68.39 0.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.291 0.849 . . . . 75.34 113.291 -166.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.11 146.64 25.32 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.321 0.86 . . . . 73.53 113.321 -166.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 202' ' ' TYR . 15.0 m -120.86 149.65 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.716 -1.216 . . . . 52.53 107.716 164.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 178' ' ' ILE . 23.6 p80 -74.67 -29.42 61.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.618 -0.433 . . . . 72.33 111.669 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.575 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 75.45 -59.77 2.84 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.932 -0.652 . . . . 63.25 113.168 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.799 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 9.8 t70 -104.9 131.61 52.17 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 72.11 109.911 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 246' ' ' ILE . 7.8 tp -114.69 14.43 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.942 0.349 . . . . 71.2 111.942 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.53 ' HD2' ' HE2' ' A' ' 227' ' ' PHE . 50.5 tptt -57.34 152.27 14.54 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.23 -0.294 . . . . 62.15 110.586 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.19 -14.8 11.87 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.081 0.4 . . . . 44.24 112.081 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 p -76.99 -15.11 59.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.942 0.401 . . . . 25.14 110.705 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.599 HD21 HD22 ' A' ' 200' ' ' LEU . 3.0 m-20 -90.35 -12.08 38.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.048 -0.524 . . . . 52.42 111.104 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.74 131.5 56.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.099 0.476 . . . . 72.53 110.235 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -127.53 157.16 40.88 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.571 -0.74 . . . . 73.12 110.378 179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 48.9 mt -106.16 149.07 27.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.864 -0.607 . . . . 62.11 109.72 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.599 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 24.0 t-20 -64.07 121.4 14.07 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.131 -1.433 . . . . 72.54 107.131 168.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.592 ' HE1' ' HE ' ' A' ' 133' ' ' ARG . 1.7 p90 -70.27 -15.78 62.94 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.3 -0.96 . . . . 72.14 110.582 -167.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -88.16 -28.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.962 -0.563 . . . . 74.35 110.448 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.546 ' HB3' ' OD1' ' A' ' 191' ' ' ASP . 45.2 m-80 -136.2 109.59 9.76 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-O 120.809 0.337 . . . . 72.13 111.211 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 13.6 Cg_exo -69.63 -7.73 21.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.263 2.642 . . . . 75.44 112.95 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 338' ' ' LYS . 9.9 p-10 -85.95 -7.65 58.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 73.34 110.268 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.657 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 80.6 mt-30 -101.23 91.95 4.74 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.586 -0.734 . . . . 74.52 110.029 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.96 122.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.832 -0.622 . . . . 61.45 110.024 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 64.8 m-85 -128.39 151.77 48.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.935 -0.575 . . . . 64.42 110.292 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 196' ' ' VAL . 3.3 tt -84.87 150.51 24.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.218 -1.401 . . . . 73.14 107.218 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.541 ' N ' HD23 ' A' ' 195' ' ' LEU . 31.6 m -56.78 178.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.772 0.32 . . . . 61.11 111.618 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 3.4 m-20 -63.7 11.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.121 0.786 . . . . 75.14 113.121 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 196' ' ' VAL . 6.1 m-85 61.5 43.7 10.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.774 0.797 . . . . 72.21 110.981 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' ILE . . . -68.96 -10.73 62.12 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.685 -1.366 . . . . 61.12 109.685 166.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.599 HD22 HD21 ' A' ' 182' ' ' ASN . 5.7 mp -113.56 104.89 12.71 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.072 -1.084 . . . . 73.24 108.072 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.871 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -163.24 107.55 1.06 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.795 -0.638 . . . . 42.33 110.745 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.518 ' O ' HG22 ' A' ' 174' ' ' VAL . 55.1 t80 -99.4 126.0 45.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.841 -0.8 . . . . 75.51 108.841 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.585 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 14.8 ptm180 -81.97 123.84 29.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 65.54 110.79 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' ' HB1' ' A' ' 237' ' ' ALA . 18.4 t80 -84.36 -18.4 36.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.671 . . . . 72.01 109.952 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 55.5 m -118.24 85.77 25.57 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.934 -0.575 . . . . 71.13 110.91 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 209' ' ' VAL . 13.1 Cg_exo -70.5 103.69 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.607 2.204 . . . . 74.15 111.124 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.585 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 28.8 tt0 70.11 -1.28 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.991 -0.549 . . . . 74.24 111.031 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.32 -12.25 10.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.238 -0.506 . . . . 41.44 111.864 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 49.6 t -69.46 132.63 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 75.41 111.241 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -105.97 110.13 22.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.173 -0.677 . . . . 71.43 109.173 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 17.2 mmmt -103.76 152.75 21.48 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.155 0.798 . . . . 70.14 113.155 -170.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.33 -166.36 1.57 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.496 -1.229 . . . . 72.21 109.514 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.6 p90 -76.48 152.15 36.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 74.33 111.603 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 215' ' ' GLU . 21.6 ttmm -140.92 -53.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 75.24 110.994 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 214' ' ' LYS . 41.9 tt0 72.54 111.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.861 0.726 . . . . 72.32 110.491 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -91.12 134.65 29.61 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 51.15 110.505 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 123.149 2.566 . . . . 50.23 113.173 -178.717 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.117 0.484 . . . . 71.23 110.068 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.799 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -103.61 -158.2 24.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.68 -0.772 . . . . 73.44 112.431 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 38.7 p -79.07 144.21 34.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.775 -0.25 . . . . 54.21 110.486 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 271' ' ' VAL . 15.7 tt -55.1 -24.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.324 0.583 . . . . 74.41 111.177 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.42 -61.96 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.17 -0.923 . . . . 64.41 111.489 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.768 ' HZ ' ' HG3' ' A' ' 253' ' ' GLN . 10.7 m-85 -103.95 -22.37 13.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.902 0.705 . . . . 73.22 112.902 -173.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.0 OUTLIER -70.05 -7.34 40.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.997 0.427 . . . . 74.34 110.462 -178.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 25.7 t 68.58 175.91 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.347 -0.842 . . . . 74.34 111.082 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.493 HD11 ' NH1' ' A' ' 279' ' ' ARG . 4.9 pt -71.42 -32.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 72.24 110.229 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 238' ' ' PRO . 2.2 m-20 -46.43 -69.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.269 -0.878 . . . . 72.44 111.188 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.04 67.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 73.22 111.2 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 230' ' ' ILE . 26.6 t-80 -55.17 -41.91 72.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.831 0.348 . . . . 75.51 110.915 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -79.56 0.94 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 75.11 111.486 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 72.33 32.8 62.14 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 120.965 -0.636 . . . . 71.41 112.687 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 213' ' ' TYR . 3.4 p -120.95 140.94 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.281 -0.266 . . . . 74.02 110.281 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB1' ' HD1' ' A' ' 204' ' ' TYR . . . -54.76 110.64 2.28 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 109.008 -0.738 . . . . 51.32 109.008 170.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.591 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . 23.6 Cg_exo -62.82 -91.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.862 2.375 . . . . 40.43 113.866 -167.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 238' ' ' PRO . 55.7 p 173.11 -158.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.645 -0.502 . . . . 72.51 109.645 -172.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.436 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 4.0 mpt_? -85.52 -45.76 11.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.878 -1.156 . . . . 70.51 107.878 168.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 19.1 ttt-85 -62.33 -39.55 93.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.032 -1.44 . . . . 74.41 111.686 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.9 -57.32 12.97 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.976 -0.556 . . . . 64.42 112.765 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HA ' HD12 ' A' ' 246' ' ' ILE . 11.6 t70 -67.05 -32.52 73.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 65.5 110.482 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 315' ' ' PRO . 77.9 mt -63.57 -39.71 95.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.48 -0.327 . . . . 71.14 111.27 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.09 -34.98 78.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.256 0.55 . . . . 73.2 109.805 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.587 HG22 ' HB ' ' A' ' 178' ' ' ILE . 70.0 mt -60.64 -42.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 74.23 110.447 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.548 HD12 ' SG ' ' A' ' 250' ' ' CYS . 39.0 tp -66.58 -38.06 86.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.045 -0.525 . . . . 71.53 109.966 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.41 96.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 72.52 111.38 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 246' ' ' ILE . 14.1 m-30 -51.19 -58.84 5.09 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 122.603 0.361 . . . . 74.51 111.403 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.548 ' SG ' HD12 ' A' ' 247' ' ' LEU . 30.1 p -61.45 -37.35 83.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.821 -0.351 . . . . 71.44 111.662 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 64.9 mtm -60.86 -50.93 71.46 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.779 -0.368 . . . . 62.41 111.416 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.472 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.5 tt -70.06 -31.58 48.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.682 -0.407 . . . . 73.21 110.424 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 24.0 tm0? -64.98 -51.79 59.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.56 -0.291 . . . . 64.32 110.573 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -63.3 -40.45 97.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.318 . . . . 74.55 111.565 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 290' ' ' PHE . 33.9 tp -77.86 -30.95 51.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.629 0.603 . . . . 74.35 112.629 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 60.6 p -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.412 -0.515 . . . . 60.54 110.867 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.541 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 83.96 7.41 85.58 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.843 -0.694 . . . . 64.51 113.109 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.07 143.82 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.973 0.887 . . . . 74.32 112.49 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 89.5 mt -129.48 139.39 35.54 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.332 -0.849 . . . . 32.24 108.798 168.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.54 -37.23 97.84 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.339 2.026 . . . . 72.12 112.162 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.6 ' HB2' HG12 ' A' ' 271' ' ' VAL . 34.4 p90 -92.5 11.32 26.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.957 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 36.8 tt0 -86.46 -39.41 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 44.23 110.504 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -84.15 -24.52 30.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.459 0.647 . . . . 73.42 109.339 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.68 22.63 15.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.111 -0.95 . . . . 71.24 111.189 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.694 ' HA ' ' CG1' ' A' ' 271' ' ' VAL . 3.4 pp -70.78 -13.99 62.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.541 0.686 . . . . 54.2 110.302 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 265' ' ' LEU . 19.9 ptmt -79.01 2.97 18.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.786 -1.097 . . . . 75.25 110.796 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 15.0 t70 -135.01 127.6 18.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 55.1 110.441 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 22.4 Cg_exo -65.71 -29.58 51.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.025 2.483 . . . . 73.4 113.558 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -79.07 -38.08 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.667 -0.413 . . . . 73.44 110.609 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.425 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 28.8 m-85 -69.29 -49.74 53.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.438 -0.346 . . . . 71.2 111.209 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.694 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 22.3 m -54.7 -40.4 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 120.491 -0.484 . . . . 53.52 111.12 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 276' ' ' ILE . 42.0 ttt85 -62.07 -55.79 25.44 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.58 0.229 . . . . 72.1 111.12 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 24.2 t70 -61.23 -46.33 90.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.31 111.353 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 261' ' ' TRP . 69.3 m -60.64 -39.4 88.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 53.34 111.175 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 67.6 mttm -64.71 -40.2 94.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 74.11 110.362 176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 272' ' ' ARG . 81.5 mt -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.05 110.027 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 14.7 mmp_? -56.83 -48.53 77.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 73.45 110.985 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -67.21 -44.47 79.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 70.13 111.845 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.493 ' NH1' HD11 ' A' ' 230' ' ' ILE . 89.2 mtt180 -65.11 -42.1 94.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.906 0.384 . . . . 75.22 110.922 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.23 -57.72 8.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 72.54 111.19 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 61.6 t30 -115.36 59.03 0.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 73.11 110.904 -171.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.563 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -51.7 -51.45 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.671 0.619 . . . . 74.44 112.671 -176.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.563 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.93 -47.88 83.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.106 0.41 . . . . 72.31 112.106 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' SER . . . . . 0.621 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 5.1 m -77.69 -28.46 51.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.38 -0.373 . . . . 70.02 111.02 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 281' ' ' ASN . 2.7 mm? -68.76 -54.74 14.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.998 -0.281 . . . . 65.01 110.529 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.412 ' HG2' HG22 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -60.07 -41.26 92.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 73.32 110.976 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.28 -51.61 68.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.841 -0.618 . . . . 62.03 111.423 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -91.19 3.54 54.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.244 0.461 . . . . 75.02 112.244 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.56 -23.64 42.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.604 -0.517 . . . . 73.22 109.604 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.498 ' HE2' ' HG ' ' A' ' 255' ' ' LEU . 0.4 OUTLIER -133.64 73.85 71.58 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.295 -0.412 . . . . 72.31 110.98 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.48 32.49 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.724 2.283 . . . . 75.43 111.106 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 171.2 8.14 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.214 -0.903 . . . . 70.44 109.259 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -73.24 86.27 1.43 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.561 0.696 . . . . 74.24 111.82 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 26.9 t-20 -152.48 -89.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.537 -0.756 . . . . 75.22 110.047 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.723 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 0.9 OUTLIER 169.73 102.77 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 109.578 -0.527 . . . . 74.51 109.578 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -99.02 50.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.241 2.627 . . . . 63.11 112.228 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -117.14 -46.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.208 -0.996 . . . . 43.25 113.529 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 2.6 mp0 -58.2 -56.56 20.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 73.32 111.03 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.7 mp -63.1 -33.94 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.866 -0.607 . . . . 70.32 110.407 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.42 -53.93 50.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 72.15 110.922 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.5 -27.83 63.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.096 -0.502 . . . . 65.13 111.158 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.478 ' CD2' HD22 ' A' ' 320' ' ' LEU . 33.6 t80 -62.1 -53.11 60.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.942 0.401 . . . . 71.54 110.282 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.593 ' HA ' HG22 ' A' ' 306' ' ' VAL . 70.1 mtp -72.61 -31.89 65.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 60.33 110.914 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.506 ' HA ' HG13 ' A' ' 282' ' ' ILE . 36.9 tt0 -60.85 -46.84 88.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.57 . . . . 63.01 109.572 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.652 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 29.0 m -57.09 -52.97 63.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.118 -0.946 . . . . 74.41 111.212 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 24.9 m -63.34 -32.33 56.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 121.068 -0.253 . . . . 45.14 111.336 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.515 ' HA ' ' HE ' ' A' ' 241' ' ' ARG . 86.7 tttt -60.49 -48.09 83.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 64.41 110.187 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 47.4 tp -70.78 -19.69 62.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.684 . . . . 63.51 111.297 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 53.1 mt -72.81 -19.26 61.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.265 0.469 . . . . 71.04 112.265 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 21.6 t70 62.09 -179.86 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.918 0.389 . . . . 75.45 110.304 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -84.39 -23.39 30.11 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.782 -0.574 . . . . 63.44 110.065 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.5 m -95.88 -24.43 16.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.043 0.757 . . . . 54.15 113.043 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.759 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 5.2 mm-40 -87.28 -172.99 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.136 -0.626 . . . . 74.12 112.03 -169.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.654 ' HD2' ' H ' ' A' ' 314' ' ' LYS . 7.4 mptt -85.44 132.2 45.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 71.42 110.782 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.593 ' HA ' HD13 ' A' ' 309' ' ' LEU . 57.7 Cg_endo -74.08 118.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.097 1.864 . . . . 64.55 111.226 174.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.3 mt -87.54 77.32 8.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.319 -0.4 . . . . 62.21 111.36 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.21 -34.02 76.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.539 . . . . 74.13 110.423 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.21 -51.09 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.911 -0.586 . . . . 72.25 110.323 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -65.28 -42.29 93.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.497 -0.774 . . . . 73.1 110.664 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 90.5 mt -63.45 -43.14 98.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 72.21 110.67 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -56.44 -52.56 64.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 74.31 110.703 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.05 -44.72 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 73.44 111.769 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.0 -32.95 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.762 -0.375 . . . . 64.23 111.777 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 155' ' ' LEU . 88.8 mt -69.47 -49.59 53.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.242 0.544 . . . . 74.3 110.406 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.3 mm? -67.88 -26.83 66.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 64.05 110.697 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.22 -47.57 79.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.908 0.385 . . . . 51.24 110.264 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.7 96.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 63.41 112.0 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 333' ' ' SER . 3.9 mm? -73.4 -32.46 64.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 72.03 111.135 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.26 -24.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.916 0.388 . . . . 73.15 110.508 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.8 -24.46 65.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.019 -0.537 . . . . 72.43 111.267 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 49.1 pt -111.95 13.19 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.421 . . . . 61.31 110.588 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.22 25.08 75.35 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.867 -0.606 . . . . 71.41 113.033 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 37.5 m -120.51 145.49 47.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.313 0.578 . . . . 75.14 111.761 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -140.27 -72.71 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.383 -0.826 . . . . 75.12 109.168 174.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.2 115.49 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.796 -1.093 . . . . 74.12 109.557 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -164.06 -69.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.399 -0.819 . . . . 74.52 109.146 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.16 87.34 1.19 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.918 -0.873 . . . . 53.55 110.918 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HD3' ' HB2' ' A' ' 191' ' ' ASP . 89.2 mttt . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 113.569 0.951 . . . . 73.41 113.569 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.587 ' HB2' HD21 ' A' ' 200' ' ' LEU . 40.8 mtmt . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.661 -0.496 . . . . 74.25 109.661 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.0 t -144.79 162.43 36.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.525 0.202 . . . . 64.31 111.092 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -66.39 143.64 15.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.966 -0.561 . . . . 64.01 111.638 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 13.2 t -79.75 132.79 36.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.509 -0.768 . . . . 73.43 109.267 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.1 tttp . . . . . 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 72.52 111.374 -176.625 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.802 -0.444 . . . . 74.14 109.802 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.72 1.72 56.34 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.601 -0.809 . . . . 70.03 113.482 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.96 153.46 30.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.585 0.692 . . . . 74.54 109.464 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.9 131.57 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.355 0.597 . . . . 65.45 111.01 -175.447 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.53 137.45 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.132 -0.94 . . . . 74.04 109.536 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.6 m -117.49 120.4 37.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.569 -0.287 . . . . 74.42 110.405 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.9 p-10 -91.04 -169.53 2.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.267 -0.424 . . . . 74.21 110.336 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 11.2 mmt -72.2 -17.81 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.797 0.295 . . . . 72.32 111.797 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.95 9.49 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 72.11 110.979 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 69.4 17.73 8.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.71 -0.677 . . . . 74.13 111.497 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 10.3 mmpt? -83.7 127.17 33.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.62 -0.511 . . . . 75.04 109.62 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.01 92.38 4.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 73.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -116.05 172.18 7.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.389 -0.823 . . . . 72.13 111.164 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -98.47 145.93 26.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 73.04 110.322 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -95.41 103.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.94 -129.97 6.73 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.652 -0.785 . . . . 64.21 113.687 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.9 mp -69.84 131.11 89.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.94 0.4 . . . . 61.33 111.827 -172.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 17.0 Cg_exo -67.76 124.0 11.4 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.883 2.388 . . . . 43.34 111.425 174.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 53' ' ' LEU . 59.3 mt -104.86 -66.33 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.047 0.451 . . . . 71.24 110.699 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 94.97 102.47 1.82 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.785 -0.721 . . . . 53.54 111.732 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' H ' HG12 ' A' ' 51' ' ' ILE . 45.7 tp60 -86.55 165.71 16.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.344 -0.243 . . . . 75.02 110.344 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.11 -29.46 68.76 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.12 -0.562 . . . . 63.05 113.776 -170.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.16 -63.3 3.17 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 73.51 112.85 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.95 -34.71 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.647 0.261 . . . . 64.31 111.583 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 -179.79 45.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.796 -0.716 . . . . 50.4 112.695 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 91.0 m 63.32 30.37 15.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.5 0.667 . . . . 75.42 111.136 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 71' ' ' LYS . 34.6 mm -89.33 136.79 22.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.55 -0.75 . . . . 73.52 109.675 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -107.48 145.92 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.197 0.523 . . . . 74.03 111.113 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.519 ' HB2' HD11 ' A' ' 43' ' ' ILE . 64.1 tp -79.29 145.66 33.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.326 -0.852 . . . . 72.04 109.711 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.91 116.61 26.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.397 -0.594 . . . . 73.32 109.397 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 25.6 m-20 -76.76 -50.88 12.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.183 -0.673 . . . . 64.22 109.183 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt 48.37 43.72 19.63 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.25 -0.886 . . . . 71.41 109.931 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -72.23 77.11 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.821 . . . . 74.22 110.447 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.4 m -126.78 -162.61 1.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.136 -0.938 . . . . 62.0 110.275 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.6 m . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.623 0.249 . . . . 63.41 111.617 -177.742 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 120.879 0.371 . . . . 52.13 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -95.94 11.07 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.855 2.37 . . . . 75.44 110.994 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.441 ' HB2' HG23 ' A' ' 130' ' ' ILE . 7.0 p -145.91 153.92 41.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.602 0.715 . . . . 72.44 112.905 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 133' ' ' ARG . 15.3 m -136.89 153.82 30.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.035 -0.984 . . . . 64.01 109.098 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.9 p -122.42 122.64 66.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.3 0.571 . . . . 62.2 111.646 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 22.6 ttpt -87.24 126.63 34.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.71 -0.677 . . . . 64.41 109.781 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.63 123.15 70.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 123.745 0.653 . . . . 74.44 110.009 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 41.7 mt-10 -140.69 152.51 66.13 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.356 -0.383 . . . . 75.32 110.344 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.51 126.0 20.05 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.591 2.194 . . . . 64.41 111.964 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -85.74 -15.97 40.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.128 0.49 . . . . 61.41 110.36 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.63 -20.08 43.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.863 -0.608 . . . . 73.11 110.78 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -172.07 96.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.216 -0.661 . . . . 73.41 109.216 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 79' ' ' PRO . . . -163.78 145.62 10.65 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.032 -1.08 . . . . 53.31 113.224 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.0 Cg_exo -60.88 -19.59 62.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.98 3.12 . . . . 50.1 112.285 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.2 tm? -50.72 -30.05 12.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.855 -0.611 . . . . 54.32 110.741 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.72 -48.38 75.29 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.76 0.314 . . . . 71.53 110.828 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.6 m -67.63 -41.99 83.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 73.53 110.481 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -58.45 -42.52 87.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.744 . . . . 65.01 110.513 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.68 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 54.42 110.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 66.7 mmtt -63.55 -46.85 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.922 -0.311 . . . . 64.32 110.451 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.06 -39.95 95.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.04 110.048 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t80 -63.29 -34.4 77.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.407 -0.815 . . . . 73.43 110.662 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -77.51 -32.67 54.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.82 0.343 . . . . 74.31 111.345 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' A' ' 173' ' ' TYR . 39.5 mmt180 -78.73 -49.21 13.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.091 0.404 . . . . 74.11 112.091 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.83 -31.47 10.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.859 0.688 . . . . 73.42 112.859 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -84.42 89.0 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.42 0.628 . . . . 72.34 111.324 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 95' ' ' GLN . 8.9 tmtt? -154.04 91.98 3.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.525 -0.917 . . . . 71.12 108.525 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 113' ' ' TYR . 95.6 Cg_exo -44.25 -52.56 5.62 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.952 3.101 . . . . 73.21 114.53 -170.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.7 -45.16 92.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 74.24 110.625 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 6.9 tp60 -66.27 -44.39 83.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.707 -0.678 . . . . 73.43 110.565 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 92' ' ' LYS . 68.4 mt -58.94 -53.75 43.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.977 -0.556 . . . . 64.44 110.574 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.54 -38.88 69.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.236 -0.438 . . . . 54.2 110.593 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -61.07 -62.3 1.95 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.773 -0.648 . . . . 74.35 111.371 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.802 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -71.3 -34.36 70.56 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.253 -0.579 . . . . 71.41 111.105 -173.476 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 100' ' ' ILE . 17.0 mm -58.75 -50.68 78.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.312 0.101 . . . . 72.04 111.027 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -69.4 -36.85 77.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.657 -0.417 . . . . 62.33 110.806 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 54.21 110.782 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 7.8 ttt180 -83.38 0.97 43.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 72.04 110.374 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 26.0 mtpp 66.54 29.62 8.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.358 -0.837 . . . . 72.33 111.532 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 89.1 mt -92.34 176.7 6.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.72 -0.673 . . . . 53.45 109.942 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 10.8 mmpt? -103.37 -55.01 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.595 -0.275 . . . . 74.45 111.051 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -157.51 171.18 20.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 72.23 110.109 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 39.3 tp -129.32 137.57 51.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.995 -0.372 . . . . 73.21 109.995 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.86 64.21 3.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.155 -0.545 . . . . 25.41 113.253 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 135.8 27.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 110.065 -0.346 . . . . 70.25 110.065 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.07 135.07 30.11 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.039 2.492 . . . . 42.41 112.509 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.861 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 24.2 tptm -66.75 124.06 21.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 73.43 111.001 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.613 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 14.0 t80 -81.27 112.56 18.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.67 -0.695 . . . . 71.32 111.022 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' ILE . 68.9 m95 -105.42 -52.51 2.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.624 -0.88 . . . . 73.13 108.624 169.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.44 46.91 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.008 -0.996 . . . . 45.04 111.759 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 p -168.74 162.84 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.625 -0.509 . . . . 73.02 109.625 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.67 -179.44 46.18 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.754 -1.212 . . . . 70.31 113.207 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 119' ' ' HIS . 5.9 tt -123.88 137.74 54.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.688 -0.856 . . . . 75.35 108.688 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -134.84 147.7 49.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 73.44 110.822 178.76 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.97 140.96 37.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.389 -0.823 . . . . 71.01 110.175 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 126' ' ' TYR . 43.4 tttm -108.66 17.64 21.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.638 -0.255 . . . . 65.11 110.501 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 56.8 m-80 71.27 97.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.309 0.644 . . . . 71.53 110.207 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.05 -44.81 1.4 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.807 -0.711 . . . . 65.34 112.012 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -129.69 138.25 51.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.831 -0.433 . . . . 74.3 109.831 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.0 m -101.53 140.57 35.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 75.41 110.349 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 121' ' ' LYS . 35.5 p90 -128.3 149.94 50.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.182 0.515 . . . . 60.35 110.155 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -117.57 142.42 47.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.027 -0.731 . . . . 74.1 109.027 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.6 p90 -137.93 153.07 49.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.989 0.423 . . . . 53.12 111.291 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 20.0 ptp -139.75 139.42 36.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.982 -0.554 . . . . 74.45 110.576 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 114' ' ' TRP . 5.0 mm -98.17 118.69 45.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.859 -0.61 . . . . 62.5 110.065 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 196' ' ' VAL . 25.1 ptt? -123.2 171.1 9.6 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.13 -0.693 . . . . 71.24 109.13 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t70 -65.2 162.15 17.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 72.23 110.442 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.7 tpt180 -76.57 112.79 13.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.44 0.638 . . . . 61.31 110.862 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.11 143.08 33.06 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.942 -0.762 . . . . 75.12 108.942 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -136.92 -2.15 2.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.291 -0.957 . . . . 55.42 112.233 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' SER . . . . . 1.093 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.8 m -121.83 125.27 46.1 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.845 -0.209 . . . . 70.53 110.512 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.482 ' HA ' HD13 ' A' ' 184' ' ' LEU . 6.4 p-10 -116.35 139.67 50.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.434 -0.58 . . . . 72.02 109.434 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 5.6 tp -68.95 -15.34 63.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.718 -0.219 . . . . 60.13 110.928 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -62.3 -50.19 72.66 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.012 0.434 . . . . 51.41 110.963 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -80.6 -23.24 39.96 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.497 -0.481 . . . . 75.13 109.841 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.863 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 27.6 mt -60.19 -51.26 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 75.31 111.794 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.686 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 5.5 p90 -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.386 -0.525 . . . . 72.33 110.228 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -80.99 -25.98 36.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.527 . . . . 73.51 110.705 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.0 0.428 . . . . 60.02 110.592 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -101.38 2.38 39.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 63.31 110.157 174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 44.16 72.74 0.18 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.046 -0.979 . . . . 73.33 112.672 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.7 pttp 45.23 34.11 1.35 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.058 0.943 . . . . 74.53 112.951 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -138.87 92.68 2.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.061 0.458 . . . . 74.41 109.82 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.686 ' CZ ' ' HA ' ' A' ' 142' ' ' TYR . 55.6 m-85 -104.14 150.95 23.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.968 -0.56 . . . . 72.51 111.666 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -86.7 147.98 25.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.689 -0.687 . . . . 41.54 109.162 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -57.55 -29.08 64.09 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 112.736 0.643 . . . . 74.31 112.736 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.23 -53.64 55.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.861 0.362 . . . . 73.34 111.402 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 157' ' ' LEU . 3.9 m -64.32 -44.95 89.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 60.1 111.038 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.96 -40.05 85.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.94 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.734 ' HG ' HD22 ' A' ' 328' ' ' LEU . 1.7 mm? -63.29 -50.94 68.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 72.11 111.623 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.8 tt0 -61.88 -38.36 88.01 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.009 -0.676 . . . . 71.33 110.267 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 153' ' ' THR . 7.7 mp -59.96 -48.6 81.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 71.42 110.447 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -56.26 -47.52 78.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 54.22 110.491 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.805 ' HG ' ' HD2' ' A' ' 321' ' ' ARG . 9.1 mp -57.3 -52.42 65.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.882 -0.599 . . . . 65.42 111.266 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 164' ' ' ILE . 2.1 mpt_? -67.75 -33.68 75.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 70.52 111.379 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -63.62 -43.53 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.7 -0.481 . . . . 72.23 109.7 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 321' ' ' ARG . 83.0 mt -63.01 -42.45 99.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.73 -0.214 . . . . 61.0 110.805 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.24 -60.53 3.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.362 0.601 . . . . 73.45 110.775 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 tt -71.83 -39.74 68.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 72.43 111.968 -174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.8 mp -65.71 -36.89 84.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 117.759 0.254 . . . . 65.11 111.302 -177.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.26 -48.72 74.68 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.182 -0.673 . . . . 70.4 109.182 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 79.5 t80 -57.48 -46.26 83.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.157 -0.929 . . . . 75.0 111.816 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 164' ' ' ILE . 34.1 pt -82.41 -32.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.466 0.543 . . . . 75.25 112.466 -174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -64.54 -43.62 93.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 110.011 -0.366 . . . . 73.34 110.011 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -82.95 14.66 3.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.714 0.769 . . . . 72.35 109.472 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 1.4 t-80 -136.69 40.95 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.467 -0.788 . . . . 64.4 109.842 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 205' ' ' CYS . 41.7 mt-10 85.4 -61.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.395 1.059 . . . . 53.31 113.557 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 89' ' ' ARG . 13.0 m-85 -84.27 116.13 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.406 0.521 . . . . 73.44 112.406 -164.636 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 238' ' ' PRO . 16.4 t -109.63 151.21 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.357 -0.609 . . . . 70.32 109.357 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -115.46 106.95 14.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 72.05 109.739 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.42 -25.86 55.95 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.551 -0.833 . . . . 71.14 111.828 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.552 ' HB3' HD13 ' A' ' 200' ' ' LEU . 7.1 t70 -98.38 101.73 13.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 75.33 110.24 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.71 31.95 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.961 0.886 . . . . 72.13 110.078 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 179' ' ' LYS . 3.4 ttmp? -62.96 149.62 44.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.166 -0.925 . . . . 63.33 110.699 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.62 -14.61 8.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.786 0.662 . . . . 63.51 112.786 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 m -73.48 -20.81 60.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.48 . . . . 75.51 110.847 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 3.5 t-20 -82.32 -21.49 36.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.488 -0.778 . . . . 42.14 111.592 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.467 HD23 HG21 ' A' ' 193' ' ' VAL . 5.9 mp -101.85 119.67 39.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.985 0.422 . . . . 63.02 111.533 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 137' ' ' ASP . 3.9 mm? -121.47 145.68 47.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 60.1 110.159 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 1.093 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 52.6 mt -109.67 152.2 25.91 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 110.054 -0.35 . . . . 71.22 110.054 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.61 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 21.1 t-20 -72.64 147.91 45.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 72.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 -20.91 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 72.22 111.527 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -113.85 -9.84 13.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.972 0.415 . . . . 72.34 110.25 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -135.35 96.72 13.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 62.51 110.512 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.68 -18.75 15.01 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.968 2.445 . . . . 72.03 112.897 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 338' ' ' LYS . 5.5 p-10 -86.88 5.33 37.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.08 0.466 . . . . 74.02 111.583 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -118.65 109.53 16.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.728 -0.471 . . . . 72.54 109.728 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.467 HG21 HD23 ' A' ' 183' ' ' LEU . 6.5 p -103.57 126.47 58.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.101 -0.499 . . . . 75.35 110.528 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.61 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 9.7 m-85 -114.03 156.34 24.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.711 -0.677 . . . . 74.12 109.462 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 21.3 mt -107.8 116.89 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.838 -0.431 . . . . 75.35 109.838 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 131' ' ' MET . 9.2 p -159.96 159.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.79 -0.186 . . . . 74.32 111.027 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.4 t70 64.98 29.75 12.13 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.533 0.682 . . . . 70.02 110.74 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.735 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 18.9 p90 -100.06 -41.62 7.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 75.55 111.108 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.8 32.9 75.83 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.619 -0.801 . . . . 53.4 111.993 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 352' ' ' LYS . 30.5 mt -131.2 90.31 2.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.249 0.547 . . . . 63.24 110.589 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.28 121.85 9.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 65.11 110.981 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 61.4 t80 -114.34 131.18 56.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.143 -0.688 . . . . 74.54 109.143 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.858 0.361 . . . . 74.32 111.524 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 31.8 t80 -80.81 -40.09 25.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 54.43 109.96 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 10.7 p -125.81 87.8 55.33 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 43.31 110.79 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 18.7 Cg_endo -59.42 113.84 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.624 2.216 . . . . 70.12 111.733 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 63.9 26.63 14.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.828 -0.624 . . . . 75.44 111.373 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.35 -19.8 52.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.749 -0.739 . . . . 64.12 113.123 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.52 114.15 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.091 -0.337 . . . . 62.51 110.091 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -100.38 157.07 16.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.825 -0.35 . . . . 72.14 110.272 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -115.44 -172.91 2.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.516 -0.55 . . . . 74.24 109.516 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -97.83 -164.27 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.198 0.311 . . . . 61.45 110.42 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -60.29 97.88 0.05 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.575 0.702 . . . . 73.14 111.088 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 236' ' ' VAL . 55.2 mtpt -67.42 -53.73 26.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.36 -0.836 . . . . 72.53 112.256 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 37.8 77.94 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.126 0.965 . . . . 72.43 110.359 -164.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.8 135.77 59.25 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.194 -1.366 . . . . 64.55 111.492 -168.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 CA--C 1.53 0.301 0 C-N-CA 123.268 2.646 . . . . 61.43 113.656 -177.501 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 202' ' ' TYR . 16.2 p-10 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.087 -0.338 . . . . 71.41 110.087 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . -108.24 -169.41 21.32 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.822 -0.704 . . . . 61.41 113.743 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.574 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 0.7 OUTLIER -90.53 148.77 22.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.963 0.411 . . . . 54.31 110.902 -176.054 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.47 HG12 HG11 ' A' ' 271' ' ' VAL . 13.3 tt -63.64 -24.28 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 113.761 1.022 . . . . 62.45 113.761 -168.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.574 ' OE1' ' HB ' ' A' ' 224' ' ' THR . 0.0 OUTLIER -70.1 -41.43 74.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.288 -0.565 . . . . 65.03 110.878 -172.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.496 ' O ' HG12 ' A' ' 246' ' ' ILE . 29.4 m-85 -101.02 -39.94 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.268 -0.173 . . . . 72.01 111.454 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.6 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 94.0 m -60.29 -14.87 20.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.358 0.503 . . . . 65.54 112.358 -175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 14.1 m 72.28 -167.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 52.32 111.053 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.5 mp -71.54 -34.42 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.764 -0.458 . . . . 71.54 109.764 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.633 ' O ' HG12 ' A' ' 236' ' ' VAL . 25.2 t70 -44.64 -91.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.479 -1.237 . . . . 70.32 113.279 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.6 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.75 -27.79 69.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.122 -0.361 . . . . 73.24 111.686 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -56.84 -37.27 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 72.3 111.246 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.68 0.5 52.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 71.3 111.49 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.77 8.16 62.3 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.462 -0.875 . . . . 52.04 113.352 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 231' ' ' ASP . 11.9 p -86.96 140.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.979 -0.749 . . . . 44.22 108.979 175.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -68.0 117.19 46.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.471 -0.331 . . . . 72.14 110.131 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.497 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 6.6 Cg_endo -49.25 124.12 11.25 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.635 2.89 . . . . 74.45 112.983 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 t -143.09 93.38 2.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.25 -0.432 . . . . 53.21 111.297 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 59.6 mtt180 75.96 -57.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.604 -0.726 . . . . 73.22 112.052 170.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.752 ' HG3' ' HD1' ' A' ' 311' ' ' TYR . 11.4 mmm-85 -57.38 -54.69 43.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.422 0.153 . . . . 70.43 110.592 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.02 -58.55 9.32 Favored Glycine 0 N--CA 1.448 -0.56 0 O-C-N 123.794 0.684 . . . . 61.41 112.426 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.42 -47.99 47.57 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.11 0.481 . . . . 73.43 111.412 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 64.3 mt -71.78 -45.29 62.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.803 -0.635 . . . . 65.42 111.529 -175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.96 -39.11 79.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.559 0.219 . . . . 71.34 111.061 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 227' ' ' PHE . 99.0 mt -59.63 -45.85 93.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.066 0.46 . . . . 73.24 110.288 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -65.06 -43.08 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 61.42 110.591 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.36 -42.84 95.85 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.923 -0.656 . . . . 73.2 112.504 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.53 ' CZ ' ' HD2' ' A' ' 275' ' ' LYS . 22.9 m-30 -66.33 -48.43 70.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.491 0.182 . . . . 75.34 111.491 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.4 p -66.8 -40.91 88.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.574 -0.451 . . . . 72.11 111.088 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.47 -45.6 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 63.34 110.896 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.346 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.465 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 48.9 tt0 -71.51 -41.61 69.04 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 121.097 -0.241 . . . . 75.43 110.458 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -66.73 -26.32 66.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 74.24 110.672 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.1 tp -81.18 -41.19 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.776 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.5 p -103.62 -27.26 12.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.391 0.515 . . . . 54.32 112.391 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.7 -59.52 0.36 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.724 -0.75 . . . . 75.22 113.048 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -121.76 144.02 49.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.848 0.356 . . . . 72.23 110.963 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 94.8 mt -105.7 145.12 30.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 75.52 110.715 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 31.2 Cg_exo -60.62 -31.92 92.73 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.803 2.335 . . . . 40.05 112.291 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 48.0 p90 -96.84 11.09 36.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.41 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 30.5 tt0 -83.18 -42.06 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.162 0.506 . . . . 44.24 110.201 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -88.54 -12.11 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.051 -0.522 . . . . 63.53 109.829 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.17 10.1 25.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.748 -0.66 . . . . 75.44 111.907 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 3.7 pp -70.86 -7.31 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.178 0.513 . . . . 74.11 110.916 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.45 -13.07 60.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.794 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.9 t70 -124.61 122.03 25.78 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 62.2 109.841 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 32.7 Cg_exo -62.69 -30.59 78.74 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.987 2.458 . . . . 74.52 113.375 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.571 ' HZ2' ' HB2' ' A' ' 269' ' ' LYS . 0.0 OUTLIER -76.45 -38.06 56.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.061 -0.348 . . . . 73.44 110.061 -176.848 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.51 -49.13 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.899 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.724 ' O ' ' HG2' ' A' ' 275' ' ' LYS . 38.0 t -55.88 -50.99 65.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.599 0.238 . . . . 73.13 110.997 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -61.14 -50.41 73.31 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.262 -0.426 . . . . 64.51 111.182 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 32.1 t70 -61.37 -45.6 93.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 74.33 111.082 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.9 m -61.31 -32.76 72.62 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.719 -0.219 . . . . 50.53 111.49 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 35.2 mmtp -60.27 -49.46 77.53 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.189 -0.671 . . . . 65.31 109.189 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.64 -33.1 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.213 -0.903 . . . . 72.4 110.968 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 16.5 mmm180 -62.66 -40.27 96.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.672 -0.24 . . . . 43.04 111.041 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 278' ' ' TYR . 2.9 m-85 -74.06 -33.99 63.87 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.513 -0.475 . . . . 72.41 110.942 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -66.74 -20.96 66.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.467 -0.333 . . . . 73.2 110.957 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -49.64 -56.9 8.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.866 -0.607 . . . . 74.12 110.759 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -150.31 75.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.82 -0.807 . . . . 63.01 108.82 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -53.47 -37.19 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.793 -1.094 . . . . 65.55 113.232 -171.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.585 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -61.41 -49.0 78.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.013 -0.275 . . . . 64.41 111.676 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 m -78.07 -39.09 42.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.733 0.302 . . . . 74.11 111.114 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.76 -46.26 90.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 74.31 111.192 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.26 -29.03 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 60.41 110.805 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 17.1 t70 -62.32 -31.38 72.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 71.43 110.169 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 288' ' ' LYS . 9.2 mtpm? -83.61 -21.63 32.5 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.891 -0.595 . . . . 62.13 111.735 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.01 -38.63 86.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.657 0.265 . . . . 62.5 111.264 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 5.4 t80 -135.81 79.49 45.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.765 -0.374 . . . . 64.35 110.486 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.59 19.71 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.113 2.542 . . . . 73.53 111.918 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 33.8 mt-10 -87.48 35.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.877 -0.601 . . . . 74.55 111.42 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 68.82 10.06 7.7 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.548 0.944 . . . . 72.33 113.548 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 27.0 t-20 -82.09 -81.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.875 -0.417 . . . . 73.21 109.875 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 2.0 tpmt? 168.22 107.72 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.141 0 O-C-N 123.59 0.557 . . . . 74.32 109.757 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -102.34 39.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.667 2.911 . . . . 74.23 111.881 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.16 -38.27 2.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.527 -0.844 . . . . 54.21 113.334 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.463 ' HB3' HD23 ' A' ' 324' ' ' LEU . 2.8 mp0 -59.14 -53.64 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.43 . . . . 51.13 110.51 -176.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.67 -37.77 80.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.604 -0.725 . . . . 75.44 110.323 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.36 -52.5 64.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 71.31 111.31 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 301' ' ' LYS . 21.8 ttmt -70.69 -31.98 69.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.916 0.389 . . . . 74.52 110.538 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.416 ' O ' HG13 ' A' ' 306' ' ' VAL . 64.6 t80 -57.95 -48.97 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 73.4 110.217 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.551 ' HA ' HG22 ' A' ' 306' ' ' VAL . 87.4 mtp -72.48 -32.61 66.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 62.03 111.274 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.47 -37.67 78.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.841 0.829 . . . . 74.34 108.878 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.489 HG21 HD21 ' A' ' 320' ' ' LEU . 60.7 m -69.06 -42.59 76.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.632 -1.167 . . . . 54.45 111.455 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 303' ' ' MET . 5.5 m -70.55 -26.94 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.882 0.372 . . . . 75.04 110.578 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.44 -48.72 76.59 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.53 . . . . 74.31 110.215 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 308' ' ' LEU . 3.3 tt -68.5 -25.54 65.01 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.471 -0.786 . . . . 74.33 110.046 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -62.52 -18.84 62.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.519 -0.764 . . . . 73.34 111.878 -176.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.6 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.391 0.432 . . . . 74.22 110.294 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.752 ' HD1' ' HG3' ' A' ' 241' ' ' ARG . 3.9 m-30 -136.75 -43.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 71.02 110.402 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.4 t -136.92 20.61 3.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 73.12 112.205 -168.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -88.83 50.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.638 -0.664 . . . . 74.43 112.277 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER 58.97 94.22 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.196 -0.911 . . . . 70.24 113.456 170.205 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.4 121.4 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.786 2.324 . . . . 64.44 111.802 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.2 mt -84.96 99.08 10.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.824 0.345 . . . . 73.52 110.366 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -61.64 -45.03 95.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.942 -0.572 . . . . 73.23 111.765 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.0 -0.37 . . . . 54.15 110.0 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.29 -36.5 84.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 73.32 110.336 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 323' ' ' ILE . 77.2 mt -60.68 -48.7 80.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 65.2 110.982 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.805 ' HD2' ' HG ' ' A' ' 159' ' ' LEU . 32.8 ptt180 -74.2 -20.88 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.841 -0.744 . . . . 73.2 110.772 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.94 -39.88 79.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.716 -0.22 . . . . 54.35 110.818 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.2 pp -72.18 -30.23 35.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.791 -0.448 . . . . 54.12 109.791 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.63 -49.31 63.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 64.32 110.279 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.763 HD11 HD21 ' A' ' 159' ' ' LEU . 88.8 mt -64.86 -29.24 70.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.055 -0.521 . . . . 51.33 110.66 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -63.96 -47.48 80.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.607 . . . . 74.51 110.497 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.65 -30.65 76.68 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 72.43 111.942 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.734 HD22 ' HG ' ' A' ' 155' ' ' LEU . 56.4 tp -72.8 -50.59 23.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 72.3 110.835 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -73.83 -14.02 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.311 -0.404 . . . . 74.34 110.696 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.98 -23.61 67.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.499 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.2 tt -97.17 -6.8 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 60.44 110.113 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.71 24.02 34.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.856 -0.688 . . . . 72.21 113.208 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.8 m -123.36 158.62 30.67 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.455 -0.438 . . . . 42.51 110.595 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -156.45 176.73 12.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.439 -0.346 . . . . 75.31 110.135 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.23 -36.07 18.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.721 -0.474 . . . . 71.55 109.721 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.8 t70 75.14 16.92 2.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.091 -0.959 . . . . 62.22 110.88 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.51 39.08 50.97 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.934 -0.866 . . . . 41.11 110.934 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 191' ' ' ASP . 39.0 ttmt . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.397 -0.402 . . . . 75.44 110.343 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.822 ' HB3' HD21 ' A' ' 200' ' ' LEU . 35.2 tptt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 10.3 t -155.87 169.73 23.72 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.513 0.197 . . . . 72.42 110.71 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.517 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -69.22 144.06 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.698 0.629 . . . . 65.13 112.698 -172.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 11.4 t -92.07 132.83 36.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.188 -0.914 . . . . 62.55 110.001 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 61.6 tttp . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.492 0.187 . . . . 73.43 110.613 174.728 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 40' ' ' GLY . 46.6 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.689 0.28 . . . . 71.34 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.79 57.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.765 -0.731 . . . . 62.24 114.125 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.82 -177.08 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.173 0.987 . . . . 73.14 112.312 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' GLU . 3.2 mp -107.49 138.53 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.376 0.88 . . . . 73.44 113.376 -162.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.06 126.64 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.148 -0.933 . . . . 72.45 109.593 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -103.7 136.53 43.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.1 0.778 . . . . 74.4 113.1 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.823 ' HB3' ' CZ2' ' A' ' 37' ' ' TRP . 10.9 p30 -88.39 -179.44 6.1 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 64.31 110.758 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.52 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -71.16 -9.72 58.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 71.45 111.774 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.18 6.82 46.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 71.1 110.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 52.5 mmtt 68.82 23.79 6.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.347 -0.842 . . . . 73.04 111.684 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' A' ' 114' ' ' TRP . 40.4 ttpt -90.67 114.49 26.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.453 -0.943 . . . . 61.43 108.453 171.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HB2' HG23 ' A' ' 28' ' ' ILE . 6.0 pt-20 -92.51 102.0 14.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.734 -0.666 . . . . 70.35 110.791 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.823 ' CZ2' ' HB3' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -80.27 147.08 31.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 64.42 109.689 -177.173 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 56' ' ' MET . 28.1 ttpp -106.06 119.45 39.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.753 -0.462 . . . . 74.22 109.753 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.99 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.665 . . . . 42.15 111.27 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -109.2 -129.43 5.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.49 -0.644 . . . . 35.24 111.49 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 mm? -76.08 141.85 71.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.686 0.279 . . . . 74.34 111.134 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_endo -86.97 120.43 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.245 2.63 . . . . 72.31 111.775 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 53' ' ' LEU . 3.8 mp -96.57 -54.82 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.407 . . . . 61.01 110.622 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 97.74 162.99 31.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.828 -0.701 . . . . 71.02 111.491 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.75 ' HB2' HG12 ' A' ' 51' ' ' ILE . 27.6 tp60 -133.56 128.59 35.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.987 0.394 . . . . 73.31 110.175 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.58 108.6 2.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.617 -0.802 . . . . 25.21 112.418 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -16.14 46.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.906 -0.664 . . . . 63.04 112.291 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.679 ' CE2' ' HA ' ' A' ' 198' ' ' TYR . 21.2 m-85 -113.38 -59.39 2.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.736 0.303 . . . . 72.35 110.318 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.72 -105.59 0.22 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.8 -0.714 . . . . 64.32 112.562 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.667 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 49.8 t -142.05 142.0 32.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 75.11 110.596 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.75 HG12 ' HB2' ' A' ' 45' ' ' GLN . 27.4 mm -121.74 136.88 57.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.25 144.66 35.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.755 0.312 . . . . 55.44 110.643 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 69' ' ' VAL . 57.9 tp -84.37 152.04 24.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.364 -0.606 . . . . 61.03 109.364 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.38 104.4 12.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.827 0.346 . . . . 64.23 111.056 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.1 -35.18 42.73 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.11 -0.7 . . . . 71.25 109.11 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.822 ' SD ' ' HA ' ' A' ' 37' ' ' TRP . 13.8 tpt 69.54 -70.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.482 -1.235 . . . . 73.2 113.194 171.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -139.32 104.9 5.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.176 0.512 . . . . 64.15 111.159 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -83.61 40.01 0.71 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 64.51 111.52 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 75.43 110.799 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.131 0 N-CA-C 109.243 -0.651 . . . . 74.23 109.243 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 68.0 Cg_endo -78.37 55.84 5.58 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 121.594 1.529 . . . . 52.35 110.95 169.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 8.6 p -145.51 157.93 43.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.999 -0.546 . . . . 75.21 110.699 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 53' ' ' LEU . 7.2 m -135.34 161.43 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 63.22 110.369 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.583 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 4.9 p -119.75 119.98 61.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.651 0.739 . . . . 72.32 111.934 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 4.8 tptp -79.98 115.97 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.776 -1.102 . . . . 74.43 108.768 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 128' ' ' PHE . 6.9 p -125.7 128.32 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.065 0.46 . . . . 63.43 111.577 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -138.06 152.24 71.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 75.13 109.833 177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.92 165.8 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.346 2.03 . . . . 60.11 112.302 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.1 m -78.08 69.94 4.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.332 0.587 . . . . 72.15 110.453 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -122.66 7.12 9.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 70.34 110.453 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 67.62 93.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.267 -0.878 . . . . 64.03 110.762 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.63 -154.11 6.14 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.576 -0.738 . . . . 62.55 111.646 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 31.4 Cg_exo -59.15 -35.52 97.62 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.21 2.607 . . . . 73.12 112.553 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.54 -36.37 44.72 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.926 0.766 . . . . 72.4 111.433 -176.598 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -66.57 -49.28 66.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.788 0.328 . . . . 75.42 110.805 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 m -62.71 -48.35 79.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 62.32 111.107 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 8.3 pt-20 -69.35 -33.54 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.166 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.614 HD22 ' HD3' ' A' ' 127' ' ' ARG . 43.7 tp -58.48 -47.48 83.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.003 0.43 . . . . 75.53 110.575 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.39 -36.8 82.03 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.117 -0.492 . . . . 75.41 110.511 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.45 -52.59 64.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.941 -0.572 . . . . 73.13 110.237 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 4.9 m-85 -57.27 -46.89 82.65 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.697 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.95 64.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 74.42 111.337 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -90.52 -26.81 19.57 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.848 0.314 . . . . 73.02 111.848 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.76 17.99 22.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.768 0.318 . . . . 73.4 111.649 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -85.54 164.74 17.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.555 0.576 . . . . 51.14 112.555 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 96' ' ' ILE . 2.8 tppt? 77.88 99.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.847 -1.07 . . . . 75.31 111.09 170.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 11.6 Cg_endo -55.12 -29.16 64.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.441 2.761 . . . . 64.43 113.443 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 4.3 tp10 -55.42 -59.43 4.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 73.3 110.596 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 6.4 tp60 -68.11 -35.6 78.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.966 -0.561 . . . . 74.33 110.449 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' LYS . 73.5 mt -55.45 -49.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 44.02 110.277 177.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -59.52 -42.78 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.456 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.7 mmtt -55.65 -59.59 4.64 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.723 -0.671 . . . . 75.23 112.113 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.91 -34.97 69.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.024 -0.67 . . . . 73.22 111.228 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.647 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.5 mt -59.15 -49.14 84.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 121.095 -0.242 . . . . 74.24 111.199 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -74.63 -35.74 62.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 74.14 111.267 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.7 m -72.63 -39.78 66.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.799 0.333 . . . . 54.13 111.226 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -87.89 7.08 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.462 -0.335 . . . . 72.13 111.848 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 71.07 29.49 2.91 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.423 0.452 . . . . 71.34 112.138 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.05 -169.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.799 -0.445 . . . . 72.31 109.799 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 26.5 mmtm -115.36 -62.76 1.55 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.845 -0.428 . . . . 75.25 109.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 100' ' ' ILE . 37.6 p90 -174.85 138.56 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.442 0.464 . . . . 61.41 110.503 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' A' ' 100' ' ' ILE . 72.8 mt -79.24 118.57 21.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.178 -0.464 . . . . 72.03 109.844 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.503 ' HA3' ' CZ ' ' A' ' 160' ' ' ARG . . . -79.03 54.87 4.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.383 -0.913 . . . . 75.1 111.817 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.59 149.96 39.02 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.905 -0.406 . . . . 71.35 109.905 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.74 ' HB3' ' HE2' ' A' ' 134' ' ' PHE . 21.0 Cg_exo -66.08 144.72 76.78 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.26 1.973 . . . . 64.41 111.923 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 16.0 tttp -70.74 118.26 13.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 65.53 110.56 -176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.498 ' CD1' ' HD2' ' A' ' 87' ' ' TYR . 66.4 t80 -95.23 120.68 35.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 75.45 110.926 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.479 ' NE1' ' HD3' ' A' ' 112' ' ' LYS . 80.0 m95 -98.92 -51.31 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 75.13 110.769 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -169.0 172.61 43.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.864 -0.607 . . . . 73.11 112.134 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.622 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 34.2 p -160.3 157.37 27.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.196 -0.298 . . . . 74.02 110.196 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.25 -177.92 46.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.572 -0.823 . . . . 42.31 112.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.5 tt -126.15 134.37 51.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.858 0.361 . . . . 75.01 110.206 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.573 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . 56.3 t60 -140.88 118.23 11.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.465 -0.568 . . . . 74.33 109.465 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.3 t70 -67.45 129.77 40.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.89 -0.595 . . . . 63.51 110.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 84.7 tttt -134.85 122.67 22.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.234 -0.439 . . . . 75.45 110.022 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 22.1 m120 66.73 15.95 10.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.063 -0.517 . . . . 72.44 111.522 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 -2.01 61.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.559 -0.829 . . . . 65.3 112.052 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 61.12 109.667 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.9 m -76.37 104.88 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 72.44 110.658 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -93.95 136.54 34.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.565 -0.743 . . . . 73.21 110.492 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.614 ' HD3' HD22 ' A' ' 84' ' ' LEU . 36.2 ttm180 -112.28 124.29 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.7 p90 -126.9 160.23 31.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 72.55 111.943 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.622 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 30.3 ttp -145.19 135.87 24.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.373 -0.83 . . . . 75.22 110.28 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.577 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 3.6 mm -96.99 128.34 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 62.34 111.539 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.6 ptp -122.59 167.78 12.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.996 -1.002 . . . . 74.1 108.976 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 11.0 t70 -72.53 152.03 42.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.96 -0.756 . . . . 71.03 108.96 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HD3' HG13 ' A' ' 69' ' ' VAL . 27.7 tpt180 -76.59 102.07 5.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.817 0.818 . . . . 75.1 112.05 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.74 ' HE2' ' HB3' ' A' ' 111' ' ' PRO . 8.9 m-85 -102.69 141.85 34.81 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.253 -1.388 . . . . 62.34 107.253 168.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.66 10.5 0.81 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.4 -1.381 . . . . 43.54 113.41 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.926 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 16.2 m -113.73 123.39 49.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.803 -0.814 . . . . 71.41 108.803 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.937 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 2.3 m-20 -105.03 129.51 53.45 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 121.151 -0.22 . . . . 62.23 110.412 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.35 -24.02 67.5 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.431 -0.508 . . . . 74.2 109.677 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.937 ' HG2' ' HB3' ' A' ' 137' ' ' ASP . 28.0 pt20 -70.68 -37.12 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 51.45 110.413 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 63.1 mttp -70.94 -35.05 72.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.9 0.381 . . . . 73.42 110.202 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.52 -31.03 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.278 -0.419 . . . . 63.33 110.512 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 147' ' ' LYS . 40.0 t80 -52.74 -53.72 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.686 -0.688 . . . . 70.35 111.886 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -99.57 -1.75 37.45 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 63.05 111.245 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.94 -32.87 15.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.37 . . . . 71.43 110.542 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -0.65 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.45 -0.574 . . . . 73.22 109.45 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 147' ' ' LYS . . . 55.29 36.69 27.59 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.659 -0.701 . . . . 65.32 111.226 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 142' ' ' TYR . 29.8 mtmt 72.57 93.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.551 -0.749 . . . . 72.15 112.46 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.3 tpp85 -143.69 97.64 3.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.865 -1.061 . . . . 70.42 109.244 173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -119.64 153.81 34.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 75.42 110.234 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 m -101.28 175.44 5.58 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.634 -0.506 . . . . 40.34 109.634 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 328' ' ' LEU . 21.8 ttm180 -67.32 -37.13 82.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.347 -0.141 . . . . 74.34 111.084 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 335' ' ' ASP . 2.1 tmtp? -55.98 -46.99 78.5 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.319 -0.252 . . . . 73.24 110.319 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.492 ' O ' HD13 ' A' ' 157' ' ' LEU . 0.0 OUTLIER -58.26 -48.1 81.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.846 0.355 . . . . 54.22 111.195 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.25 -42.07 90.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.312 -0.404 . . . . 44.24 110.771 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.32 -52.64 21.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 52.34 111.182 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -63.72 -44.04 94.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.539 0.209 . . . . 71.04 110.838 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 161' ' ' ILE . 10.9 mp -64.64 -41.87 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 62.43 110.755 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -59.35 -49.54 77.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.6 0.238 . . . . 75.11 110.531 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 325' ' ' LEU . 8.8 mp -58.47 -50.72 72.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.403 -0.362 . . . . 62.3 111.752 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -66.08 -21.9 66.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 72.4 111.222 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 157' ' ' LEU . 23.6 mm -69.66 -40.91 79.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 109.72 -0.474 . . . . 75.22 109.72 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.76 -47.5 86.03 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.984 0.178 . . . . 72.45 110.784 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.41 -56.37 13.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.9 0.381 . . . . 75.51 111.419 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.485 HG21 HH21 ' A' ' 160' ' ' ARG . 11.3 tt -68.72 -35.86 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.418 -0.355 . . . . 74.14 111.05 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.576 HD13 ' CD2' ' A' ' 175' ' ' HIS . 68.5 tp -67.28 -38.5 85.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.547 -0.297 . . . . 61.32 111.488 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 27.8 mm-40 -76.63 -28.83 56.22 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.592 -0.443 . . . . 64.31 110.204 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -60.32 -48.71 80.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.357 . . . . 73.21 110.391 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 173' ' ' TYR . 18.5 pt -72.49 -31.97 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 73.11 110.957 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 23.6 m170 -64.84 -38.05 89.67 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.982 0.176 . . . . 73.4 111.06 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.1 -6.17 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.012 0.434 . . . . 71.13 111.137 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -100.65 -85.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.217 -0.66 . . . . 53.11 109.217 170.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 15.0 pt-20 -169.44 1.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 71.35 111.746 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' A' ' 168' ' ' ILE . 39.2 m-85 -106.19 158.09 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.178 0.513 . . . . 72.52 111.719 -165.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.72 168.55 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.876 -1.056 . . . . 75.33 108.561 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.576 ' CD2' HD13 ' A' ' 165' ' ' LEU . 8.4 p80 -102.94 121.37 42.38 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.447 -0.501 . . . . 72.12 110.645 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 -39.14 95.24 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.768 -0.73 . . . . 74.13 112.731 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.4 t70 -135.06 127.85 31.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 70.14 111.976 -175.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.713 ' HB ' HG22 ' A' ' 246' ' ' ILE . 32.2 mm -111.88 124.72 68.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.311 -0.996 . . . . 64.22 108.311 167.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -166.08 167.64 16.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.645 -0.502 . . . . 71.21 109.645 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.54 -19.16 63.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 41.34 110.946 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.684 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 3.1 p -75.1 -21.07 59.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 54.43 111.963 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.517 ' HA ' HG12 ' A' ' 196' ' ' VAL . 2.0 p30 -110.79 12.51 22.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 72.44 111.733 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.2 mt -113.47 114.4 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.293 -0.412 . . . . 70.42 110.586 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.31 138.74 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 72.24 110.86 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.926 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 39.3 mt -95.18 154.02 17.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.105 -0.702 . . . . 72.33 109.105 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.444 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 27.5 t-20 -59.44 147.56 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.477 -0.564 . . . . 73.2 109.477 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.421 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 10.7 p90 -60.91 -25.59 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -120.41 -26.3 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.007 0.373 . . . . 65.41 112.007 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.517 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 4.9 t30 -112.1 115.01 50.79 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.573 -0.451 . . . . 45.03 111.106 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 7.6 Cg_exo -72.99 -29.83 11.56 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.299 2.666 . . . . 43.2 114.413 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.27 13.7 10.99 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.514 -0.474 . . . . 65.21 111.53 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.519 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 18.9 mm-40 -112.92 94.98 5.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 71.42 109.992 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 157' ' ' LEU . 6.4 p -104.99 126.54 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 74.21 111.2 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 45.1 m-85 -128.75 158.98 37.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.631 . . . . 75.2 110.238 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' A' ' 160' ' ' ARG . 8.3 mp -83.34 147.21 28.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.244 -0.28 . . . . 74.11 110.244 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 182' ' ' ASN . 14.7 p -83.79 148.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.309 -0.405 . . . . 61.22 110.618 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.0 88.0 0.15 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.721 0.772 . . . . 72.14 110.422 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.679 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -105.72 -9.38 17.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.803 -1.09 . . . . 75.34 111.303 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 57.55 16.96 24.57 Favored Glycine 0 C--O 1.223 -0.555 0 CA-C-N 115.904 -0.589 . . . . 41.14 112.726 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 353' ' ' THR . 0.5 OUTLIER -91.9 49.1 1.5 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.674 0.749 . . . . 55.02 110.238 -174.077 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -119.87 110.4 16.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.41 -0.814 . . . . 42.43 110.169 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -98.27 -174.54 2.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.833 -1.173 . . . . 63.34 107.833 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.475 ' HD2' ' OE1' ' A' ' 172' ' ' GLU . 36.8 ptt180 -131.29 133.52 45.47 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.683 -0.636 . . . . 62.34 111.675 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -93.59 -17.51 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.309 -0.86 . . . . 71.43 110.169 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 40.4 m -128.6 76.0 79.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.254 -0.43 . . . . 71.42 110.884 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 203' ' ' ARG . 91.5 Cg_exo -45.35 103.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.182 2.588 . . . . 74.44 113.263 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 61.81 28.73 17.64 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.325 -0.852 . . . . 63.21 111.301 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.42 -15.68 45.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 51.24 113.078 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.28 110.53 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 O-C-N 122.409 -0.465 . . . . 75.2 109.938 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 14.9 p-80 -63.8 127.45 31.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 75.11 110.399 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 214' ' ' LYS . 37.6 tptt -103.14 142.99 33.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.798 -0.637 . . . . 63.34 110.114 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -81.68 -169.3 2.26 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.166 -0.309 . . . . 62.33 110.166 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.738 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 69.1 t80 -64.1 91.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.431 -0.581 . . . . 61.44 109.431 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.547 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 22.2 tptm -156.0 16.09 0.35 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.163 -0.472 . . . . 70.24 110.517 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 237' ' ' ALA . 35.0 tt0 -72.51 -66.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.924 0.392 . . . . 65.34 110.486 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -140.52 140.35 22.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.787 -0.449 . . . . 73.14 109.787 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 123.206 2.604 . . . . 74.43 113.451 179.521 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.53 0.205 . . . . 70.45 110.985 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -99.8 -166.85 29.45 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.862 -0.685 . . . . 44.14 112.087 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.9 p -70.38 143.9 51.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 75.51 111.062 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 271' ' ' VAL . 0.3 OUTLIER -64.8 -20.66 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.644 0.735 . . . . 65.42 109.546 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.414 ' HG2' HD21 ' A' ' 265' ' ' LEU . 19.4 mt-10 -61.58 -48.43 80.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.02 -0.991 . . . . 71.3 111.475 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.1 m-85 -111.77 -15.83 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -169.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 232' ' ' ALA . 1.1 p -54.39 -27.07 34.1 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.652 0.982 . . . . 70.4 113.652 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.553 ' HB2' ' HE2' ' A' ' 249' ' ' TYR . 15.3 t 64.43 -159.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.337 0.398 . . . . 72.43 110.418 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 3.3 mp -67.33 -45.65 85.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.613 -0.267 . . . . 73.13 110.981 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -74.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.722 0.638 . . . . 74.55 112.722 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 228' ' ' THR . . . -67.88 -27.59 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.01 112.163 -172.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.624 -0.262 . . . . 75.54 110.976 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 2.7 t30 -82.56 -36.64 26.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.641 -0.254 . . . . 45.03 110.882 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 144.5 9.3 0.37 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 119.794 -1.194 . . . . 61.42 114.121 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.738 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 12.1 p -122.41 139.58 48.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 117.374 0.587 . . . . 43.11 110.547 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 215' ' ' GLU . . . -55.14 148.93 27.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 64.1 110.575 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.33 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.833 2.356 . . . . 64.03 111.489 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.6 p -79.16 -72.36 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.768 0.794 . . . . 70.34 110.767 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -42.51 0.09 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.832 -1.544 . . . . 74.33 106.832 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 48.8 ttt-85 -58.23 -70.2 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.51 -1.677 . . . . 72.01 111.174 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.716 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -62.99 -36.38 93.38 Favored Glycine 0 C--O 1.223 -0.543 0 CA-C-N 115.821 -0.627 . . . . 72.3 112.886 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.0 -50.54 66.38 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.261 0.553 . . . . 71.43 110.475 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.62 -30.7 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.531 -0.758 . . . . 43.35 111.02 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 279' ' ' ARG . 39.2 mt-10 -66.1 -39.22 89.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.049 -0.26 . . . . 73.11 110.716 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.6 mt -58.2 -47.33 87.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.124 0.488 . . . . 74.14 109.814 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.13 -43.62 98.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.729 -0.669 . . . . 73.11 110.26 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.18 96.44 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.979 -0.555 . . . . 54.11 112.769 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.553 ' HE2' ' HB2' ' A' ' 229' ' ' SER . 19.3 m-85 -59.04 -41.33 87.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 73.45 110.518 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.5 m -62.73 -45.09 94.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.573 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 90.4 mtp -59.66 -50.26 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 63.0 111.47 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -66.07 -36.62 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 121.01 -0.276 . . . . 72.32 110.392 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -62.57 -42.88 99.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 74.05 110.983 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -64.04 -38.9 92.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 72.05 111.145 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.5 tp -81.11 -30.33 34.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.446 0.536 . . . . 64.3 112.446 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 290' ' ' PHE . 76.6 p -103.45 -28.82 11.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.388 -0.525 . . . . 65.43 111.828 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 147' ' ' LYS . . . 76.3 14.27 82.51 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.101 -0.571 . . . . 61.14 113.019 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -150.68 149.93 30.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.349 0.575 . . . . 74.54 112.05 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 95.6 mt -129.82 139.44 35.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 55.11 108.87 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.646 ' HG2' ' HE1' ' A' ' 278' ' ' TYR . 25.0 Cg_exo -65.25 -9.92 23.88 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.678 2.252 . . . . 54.12 113.044 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.596 ' HB2' HG12 ' A' ' 271' ' ' VAL . 38.6 p90 -118.98 28.16 8.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.122 0.416 . . . . 61.15 112.122 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 55.0 mt-10 -66.78 -51.22 58.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.191 0.52 . . . . 62.15 110.825 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.74 -27.69 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.701 -0.681 . . . . 73.14 110.687 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 270' ' ' TYR . 79.5 m-20 -98.58 12.99 33.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.739 -0.664 . . . . 74.22 111.01 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.425 HD23 ' HD1' ' A' ' 261' ' ' TRP . 3.0 tm? -58.94 -39.18 80.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.016 0.436 . . . . 60.51 111.183 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -78.84 11.34 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.048 -0.524 . . . . 64.24 111.737 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -125.99 106.01 25.64 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.282 -0.636 . . . . 53.42 109.282 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 271' ' ' VAL . 20.8 Cg_endo -60.54 -23.09 74.49 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.027 2.485 . . . . 70.32 113.385 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -74.03 -46.89 40.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.946 -0.39 . . . . 70.42 109.946 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 16.2 m-30 -67.21 -41.78 85.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.836 -0.62 . . . . 71.11 110.822 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 261' ' ' TRP . 17.1 m -64.69 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.765 0.317 . . . . 71.15 110.216 177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 276' ' ' ILE . 53.0 ttt-85 -66.55 -48.5 69.48 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.241 -0.436 . . . . 53.03 110.495 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.0 -40.77 90.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.354 -0.385 . . . . 72.32 110.694 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 35.2 m -61.82 -41.85 98.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.951 -0.568 . . . . 70.0 110.97 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 229' ' ' SER . 68.2 mttm -63.92 -37.63 88.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 72.43 110.288 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.1 mt -65.54 -38.76 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 73.01 110.581 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.489 ' HA ' ' OE2' ' A' ' 280' ' ' GLU . 0.3 OUTLIER -62.27 -40.49 96.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.904 0.383 . . . . 74.24 110.453 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.646 ' HE1' ' HG2' ' A' ' 260' ' ' PRO . 28.0 m-85 -66.76 -29.89 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 73.34 110.751 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.45 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -81.54 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 64.52 111.211 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.489 ' OE2' ' HA ' ' A' ' 277' ' ' ARG . 49.4 mt-10 -79.88 -71.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.1 0.476 . . . . 70.34 110.222 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.91 94.45 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.913 -0.585 . . . . 63.32 109.626 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 282' ' ' ILE . 3.9 mp -67.07 -51.99 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.432 -0.349 . . . . 74.13 110.468 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.94 84.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 74.21 111.399 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.2 m -61.65 -45.94 91.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.339 -0.391 . . . . 73.52 111.183 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 289' ' ' CYS . 3.9 mm? -65.88 -44.47 85.25 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.307 -0.406 . . . . 64.14 111.184 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.5 mmt -67.13 -43.46 82.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 71.53 111.243 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.66 -45.37 77.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 73.44 110.939 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.65 5.2 51.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.013 -0.54 . . . . 53.42 111.603 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 48.8 t -85.19 -43.79 13.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.014 -0.736 . . . . 54.01 109.014 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.672 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 53.4 t80 -129.44 78.94 74.87 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.672 -0.695 . . . . 62.23 109.895 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -94.48 36.74 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.354 2.703 . . . . 64.2 111.903 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.44 -166.81 1.69 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.543 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.96 66.93 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.581 0.705 . . . . 75.35 111.079 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.672 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 46.6 t30 -167.7 151.5 6.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.56 -1.2 . . . . 71.12 107.761 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -107.26 112.29 62.88 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.288 -0.565 . . . . 72.41 110.718 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.08 109.21 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.473 2.115 . . . . 74.41 110.978 172.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -136.96 -40.72 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.512 -0.852 . . . . 64.34 111.631 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.569 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 0.7 OUTLIER -63.87 -61.3 2.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 72.33 109.952 -178.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.508 HG21 ' HB ' ' A' ' 252' ' ' ILE . 3.5 mp -62.21 -40.12 86.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.486 -0.779 . . . . 63.42 110.56 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.11 -54.21 49.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.635 . . . . 72.1 111.479 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -69.1 -39.88 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.127 -0.229 . . . . 74.52 111.16 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 306' ' ' VAL . 44.8 t80 -56.33 -53.39 57.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 74.14 110.546 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 306' ' ' VAL . 62.0 mtp -72.77 -30.58 64.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.88 -0.6 . . . . 64.24 111.635 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.476 ' HA ' HG12 ' A' ' 282' ' ' ILE . 40.9 tt0 -66.63 -45.29 79.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.316 0.579 . . . . 71.42 109.657 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 19.1 m -59.68 -47.32 86.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.225 -0.898 . . . . 73.34 111.67 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 303' ' ' MET . 20.0 m -68.74 -27.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 74.12 111.128 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 7.7 tmtm? -67.29 -33.97 76.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.168 0.509 . . . . 73.42 110.056 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 308' ' ' LEU . 6.0 tt -75.14 -31.26 61.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.598 -0.728 . . . . 72.22 109.976 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 92.9 mt -63.89 -33.86 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 64.52 111.897 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 8.3 t70 60.51 -165.75 0.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.818 -0.438 . . . . 71.42 109.818 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -63.6 -37.61 87.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.579 0.585 . . . . 73.4 112.579 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 m -149.3 74.95 1.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.201 -0.6 . . . . 61.31 112.519 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -118.67 -175.47 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.704 -0.48 . . . . 55.34 109.704 165.851 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 39.5 mttp -86.19 109.38 22.62 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.448 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 4.0 Cg_endo -85.64 119.14 1.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.932 2.421 . . . . 74.23 112.526 -176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.25 85.98 6.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 61.3 110.128 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -65.51 -34.1 77.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.886 -0.597 . . . . 60.34 111.686 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.71 -29.44 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.892 -0.323 . . . . 72.33 110.688 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.73 -45.08 60.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 93.7 mt -56.53 -46.02 80.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.783 -0.644 . . . . 62.43 110.02 174.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -54.34 -50.14 68.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.682 -0.69 . . . . 75.54 110.998 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -37.83 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 44.45 111.847 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.8 pp -72.3 -28.72 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 120.571 -0.452 . . . . 74.13 111.035 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.87 -49.35 62.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.272 0.558 . . . . 62.34 109.629 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 159' ' ' LEU . 4.3 mm? -64.65 -31.15 72.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.584 -0.735 . . . . 74.54 110.618 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -59.74 -47.04 87.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 74.53 109.939 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -61.31 -46.14 95.02 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.756 -0.735 . . . . 72.14 112.072 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 26.8 tp -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.433 0.635 . . . . 65.23 110.558 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 329' ' ' LYS . 34.8 ttpt -65.75 -46.48 78.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.011 -0.995 . . . . 74.21 112.123 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.67 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.623 0.601 . . . . 71.12 112.623 -172.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.69 -7.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.021 0.438 . . . . 75.21 111.363 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 90.18 24.65 28.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.226 -0.988 . . . . 71.35 113.082 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 12.4 p -100.78 138.98 37.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.881 0.372 . . . . 64.22 110.436 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -151.67 80.61 1.28 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.983 -0.553 . . . . 62.54 109.761 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.861 ' HA ' ' HG2' ' A' ' 152' ' ' LYS . 26.2 t0 68.46 111.29 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.053 -0.976 . . . . 61.1 109.782 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -76.8 -7.04 54.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 61.24 111.058 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.93 58.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.268 -0.968 . . . . 61.12 113.152 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 111.841 0.312 . . . . 71.31 111.841 173.466 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 353' ' ' THR . 9.8 tmtt? . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.635 -0.135 . . . . 74.35 110.635 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.651 ' HA ' ' HG ' ' A' ' 200' ' ' LEU . 0.6 OUTLIER 69.23 179.19 0.24 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.402 1.081 . . . . 61.01 111.655 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -65.45 144.13 15.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.728 0.775 . . . . 65.51 112.847 -172.131 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.9 t -71.96 154.7 41.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.642 -1.163 . . . . 64.05 111.06 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 74.53 109.727 178.014 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 109.46 -0.571 . . . . 73.12 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 39' ' ' VAL . . . 99.1 2.1 56.98 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.598 -0.811 . . . . 75.41 111.821 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 13.5 pt-20 -74.63 155.43 37.82 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.116 0.484 . . . . 74.03 110.756 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 38' ' ' LYS . 33.3 mm -87.11 118.74 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 72.33 110.191 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.1 137.9 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.889 0.376 . . . . 73.34 110.212 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 10.0 m -86.42 111.54 20.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 65.4 109.954 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HA ' ' A' ' 35' ' ' LYS . 12.0 t70 -111.38 159.57 17.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 71.45 110.272 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.473 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -62.03 -22.56 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.047 0.451 . . . . 71.31 110.134 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.57 23.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 70.24 111.151 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 2.8 tmmt? 74.0 44.88 0.24 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 54.43 110.466 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.617 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 60.0 pttt 45.28 -149.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.858 0.863 . . . . 74.41 112.681 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 53.9 mt-10 69.59 39.37 1.56 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.299 0.64 . . . . 61.32 111.095 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -126.77 121.38 31.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.79 -0.818 . . . . 72.24 108.79 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 23.1 pttp -105.22 131.65 52.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.791 -0.764 . . . . 72.24 110.96 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 26' ' ' GLY . 2.7 p -70.75 129.68 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.488 -0.778 . . . . 70.12 110.499 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.753 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -116.69 -106.28 2.45 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.624 -0.798 . . . . 63.1 113.185 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.0 tm? -62.89 118.3 40.87 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-O 121.15 0.5 . . . . 75.35 110.899 -174.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.904 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.7 Cg_exo -73.78 93.38 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.755 2.303 . . . . 63.21 111.733 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.07 -53.15 27.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.292 0.568 . . . . 73.42 109.618 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.17 -56.38 0.51 Allowed Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.456 -0.793 . . . . 51.31 112.035 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.6 ' HG2' ' HA2' ' A' ' 49' ' ' GLY . 56.4 mt-30 -151.77 130.05 12.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.837 0.351 . . . . 73.12 110.527 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' H ' HD12 ' A' ' 51' ' ' ILE . . . -99.55 26.71 23.33 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.331 -1.108 . . . . 75.23 110.331 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.62 -50.65 0.76 Allowed Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.608 -0.597 . . . . 72.11 111.608 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 79' ' ' PRO . 49.4 t80 -77.22 -76.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.588 0.232 . . . . 61.24 110.405 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 45' ' ' GLN . . . 172.86 150.43 7.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.131 -1.033 . . . . 61.1 113.084 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.9 t 45.66 67.01 0.8 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.989 0.915 . . . . 63.34 112.398 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 46' ' ' GLY . 17.0 mt -123.46 136.46 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 71.15 111.705 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.904 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 73.4 m-85 -129.42 165.9 20.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.393 . . . . 74.3 111.059 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 54' ' ' ALA . 1.3 tm? -90.81 143.12 27.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.067 -0.716 . . . . 74.35 109.067 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.589 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -92.55 75.27 5.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.236 0.541 . . . . 65.53 110.738 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.753 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 8.9 m-20 -79.29 67.47 5.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.652 . . . . 72.01 110.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.606 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 16.0 tpt -82.0 -52.25 7.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.645 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.39 115.37 7.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.484 . . . . 73.04 110.009 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.8 m -126.2 38.88 4.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 62.04 110.504 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 112.49 0.552 . . . . 75.15 112.49 -174.099 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 113.839 1.052 . . . . 73.33 113.839 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 58.0 Cg_endo -71.03 33.12 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.136 1.89 . . . . 74.04 113.757 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.5 138.32 54.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.972 0.415 . . . . 74.23 110.22 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 133' ' ' ARG . 15.9 m -114.92 143.22 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.09 -0.505 . . . . 70.33 109.862 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.0 p -117.13 116.09 50.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.88 0.847 . . . . 61.12 110.137 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HD3' ' SD ' ' A' ' 129' ' ' MET . 16.3 ptmt -92.7 128.43 38.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.591 -1.186 . . . . 74.2 109.208 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 6.9 p -135.47 124.26 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 119.542 -0.863 . . . . 61.11 112.816 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 5.6 mm-40 -124.71 171.43 7.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.111 -0.95 . . . . 72.53 108.809 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.61 152.99 51.83 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.905 1.737 . . . . 34.41 111.43 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 127' ' ' ARG . 28.9 t -53.71 -35.99 61.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.082 0.468 . . . . 73.15 110.408 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.39 116.02 30.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.771 . . . . 75.05 109.612 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -151.7 -68.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 44.33 110.745 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 -86.9 0.38 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.719 -0.753 . . . . 71.32 112.111 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . 51.1 Cg_exo -53.71 -43.73 55.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.123 2.549 . . . . 72.01 113.05 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 3.4 tm? -55.77 -45.84 78.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.962 0.41 . . . . 72.24 110.418 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.93 -35.96 77.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.15 0.5 . . . . 74.43 110.635 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -67.72 -48.48 66.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.93 -0.577 . . . . 64.22 110.921 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.792 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . 8.1 pt-20 -69.63 -27.89 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.141 -0.318 . . . . 73.12 110.141 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 129' ' ' MET . 59.7 tp -62.99 -44.2 96.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.414 -0.357 . . . . 72.4 110.63 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 42.0 tptt -64.1 -46.14 85.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.261 -0.427 . . . . 43.34 109.876 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 60.8 t80 -59.57 -47.93 83.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 73.44 110.128 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.43 -46.83 80.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.221 -0.9 . . . . 72.33 110.474 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 18.5 tm0? -61.47 -35.39 77.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.218 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 79.0 mtp180 -81.44 -18.74 44.27 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.084 0.401 . . . . 75.41 112.084 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.97 -34.9 6.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.66 0.615 . . . . 43.34 112.66 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.51 11.29 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.262 0.553 . . . . 75.15 111.998 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG2' ' HD2' ' A' ' 93' ' ' PRO . 30.0 tttm -76.86 139.79 66.49 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 115.384 -0.825 . . . . 62.31 110.269 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 80.8 Cg_exo -47.37 -53.48 6.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.343 2.696 . . . . 63.32 113.697 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -40.72 93.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 51.34 110.683 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 167' ' ' TYR . 13.2 mm100 -61.59 -48.9 78.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.609 -0.723 . . . . 65.44 111.148 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' NZ ' ' A' ' 112' ' ' LYS . 62.3 mt -66.0 -48.62 81.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.892 -0.594 . . . . 74.14 111.283 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -61.66 -37.91 85.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 73.51 111.026 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -61.24 -48.58 80.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 72.12 110.262 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -66.79 -46.0 76.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 64.02 111.096 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -54.95 -50.66 60.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.273 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -69.25 -32.43 71.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.457 . . . . 74.41 111.194 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 m -76.24 -40.36 52.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.593 -0.276 . . . . 72.34 111.743 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 10.8 ttt180 -93.64 9.05 38.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.973 -0.291 . . . . 61.34 111.167 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.866 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.1 mmpt? 64.81 28.9 12.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.234 -0.439 . . . . 73.2 111.542 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 88.5 mt -90.86 -173.61 3.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.041 -0.527 . . . . 75.24 111.022 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -26.54 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.21 109.833 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -154.13 165.2 36.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 73.41 110.213 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.4 tp -124.98 137.17 54.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 70.51 109.461 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.7 52.96 2.83 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.299 -0.477 . . . . 72.34 113.253 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.64 133.22 23.22 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.071 -0.714 . . . . 63.12 109.071 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG3' ' HZ ' ' A' ' 134' ' ' PHE . 24.2 Cg_exo -60.77 136.78 68.61 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.406 2.071 . . . . 64.33 111.401 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.734 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -65.29 125.77 26.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.09 0.472 . . . . 73.42 110.815 -178.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.36 113.96 19.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 64.41 110.114 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CD1' HG22 ' A' ' 130' ' ' ILE . 24.5 m95 -92.48 -49.94 5.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.287 -0.635 . . . . 72.52 109.287 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.41 ' HA3' ' OD1' ' A' ' 31' ' ' ASP . . . -176.63 -168.76 37.12 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.591 -0.814 . . . . 74.5 112.684 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 82.4 p -179.96 177.21 0.68 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.934 -1.136 . . . . 73.34 107.934 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.82 -175.83 43.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.09 -1.529 . . . . 43.0 113.929 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 125' ' ' SER . 2.0 tm? -120.33 127.3 52.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.03 -1.1 . . . . 73.24 108.03 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 51.7 t60 -130.89 117.14 18.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.02 0.438 . . . . 72.15 111.083 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -67.1 149.89 49.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 53.21 109.994 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -128.12 -89.33 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.865 0.364 . . . . 64.35 110.177 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -142.3 87.4 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.989 -0.745 . . . . 62.33 108.989 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -36.42 3.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.066 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -109.34 163.71 13.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.904 -0.406 . . . . 73.42 109.904 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 118' ' ' LEU . 50.0 m -123.98 138.54 54.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.174 -0.466 . . . . 60.05 109.815 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 66.1 m-85 -103.65 145.63 29.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.515 . . . . 73.45 110.998 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.0 ttt180 -118.31 116.84 27.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.96 -0.756 . . . . 75.05 108.96 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 44.7 p90 -123.48 163.14 21.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.176 0.512 . . . . 73.15 112.244 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.481 ' SD ' ' HD3' ' A' ' 71' ' ' LYS . 14.2 ttm -143.46 133.12 23.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.937 -1.029 . . . . 71.15 109.785 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.452 HG22 ' CD1' ' A' ' 114' ' ' TRP . 37.5 mt -97.77 127.03 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.686 0.279 . . . . 64.23 110.25 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.522 ' HE1' HG23 ' A' ' 196' ' ' VAL . 18.7 ptm -138.78 177.97 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 72.11 111.273 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.63 142.03 58.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.731 -0.668 . . . . 63.54 111.351 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.504 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 9.0 tpt180 -79.33 112.89 17.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.267 0.556 . . . . 72.11 111.152 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.593 ' HZ ' ' HG3' ' A' ' 111' ' ' PRO . 16.0 m-85 -102.02 149.29 24.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.915 -0.584 . . . . 62.33 109.597 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.54 -6.54 2.96 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.651 -0.785 . . . . 43.13 111.883 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.957 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 44.9 m -120.8 124.21 44.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.952 0.406 . . . . 72.24 111.551 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 184' ' ' LEU . 13.3 m-20 -98.07 125.73 43.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 74.04 109.56 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 17.2 tp -67.38 -18.67 65.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.184 0.516 . . . . 63.14 109.615 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 46.3 tp60 -60.09 -50.4 73.86 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.541 -0.754 . . . . 72.32 111.192 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -31.05 67.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.73 0.3 . . . . 61.15 110.283 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 138' ' ' LEU . 71.7 mt -64.25 -51.95 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 61.42 110.733 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.938 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -68.91 -31.83 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.889 -0.412 . . . . 70.35 109.889 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.34 -53.45 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 73.43 111.178 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.15 -22.09 53.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.809 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 9.7 t-20 -96.38 -1.48 47.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.936 0.398 . . . . 72.03 111.359 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 58.57 33.68 23.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.166 -0.47 . . . . 63.51 111.034 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.938 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 56.4 pttt 43.15 42.86 3.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.763 1.225 . . . . 63.24 113.226 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -115.68 90.09 3.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.077 -0.712 . . . . 73.01 109.077 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.44 157.36 17.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.542 . . . . 75.24 111.364 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -71.21 158.37 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.683 -0.689 . . . . 54.31 111.452 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 298' ' ' GLU . 6.1 tpt180 -53.73 -39.03 64.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.162 -0.926 . . . . 62.41 111.084 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -61.71 -61.96 2.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.527 -0.761 . . . . 53.12 111.564 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t -64.86 -36.37 84.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.31 112.088 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.25 -43.04 98.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.727 0.299 . . . . 75.51 110.913 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 328' ' ' LEU . 0.4 OUTLIER -64.87 -47.4 78.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.457 -0.338 . . . . 70.1 110.168 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 335' ' ' ASP . 5.8 tp-100 -59.15 -45.24 91.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.835 0.35 . . . . 74.42 110.723 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.485 ' O ' HD13 ' A' ' 161' ' ' ILE . 35.2 tp -59.98 -46.81 88.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.367 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.2 t -61.3 -39.27 89.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 64.44 110.459 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.51 -49.72 74.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.509 . . . . 73.33 110.202 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.719 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -60.62 -40.55 92.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.892 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 157' ' ' LEU . 1.7 mp -61.79 -40.64 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 71.41 109.864 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.98 -37.87 86.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 73.03 110.781 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.6 m-20 -56.12 -58.19 8.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.363 0.601 . . . . 73.42 110.593 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 195' ' ' LEU . 18.7 tt -71.14 -35.89 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.573 -0.739 . . . . 74.13 111.231 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.8 -38.54 91.34 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.825 -0.171 . . . . 53.22 110.91 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.342 -0.614 . . . . 63.03 109.342 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 95' ' ' GLN . 61.4 t80 -56.18 -45.19 79.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.142 -0.936 . . . . 70.34 111.962 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.401 HG21 ' HZ ' ' A' ' 86' ' ' PHE . 35.1 pt -84.89 -32.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.856 -0.337 . . . . 63.4 111.874 -176.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.644 ' HE1' ' HA ' ' A' ' 240' ' ' ARG . 5.1 t60 -66.2 -41.13 90.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.301 -0.259 . . . . 65.01 110.301 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.905 0.383 . . . . 61.42 110.452 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -88.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 73.33 110.467 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 11.2 pt-20 -166.11 11.69 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.856 0.687 . . . . 71.21 112.856 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.78 141.81 51.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.778 -0.369 . . . . 73.13 110.895 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 238' ' ' PRO . 12.9 m -123.65 126.06 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 75.54 110.392 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 201' ' ' ALA . 41.7 t-80 -89.09 69.84 8.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.983 -0.747 . . . . 61.11 108.983 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.89 46.68 3.39 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.689 -0.687 . . . . 64.15 113.806 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 224' ' ' THR . 11.1 t70 -175.7 96.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 73.21 109.255 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.719 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -90.01 70.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.392 0.615 . . . . 60.34 110.393 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.674 ' HD2' ' OG1' ' A' ' 224' ' ' THR . 56.6 tttm -83.76 134.87 34.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.143 -0.688 . . . . 73.12 109.143 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -54.87 -26.34 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 73.11 112.051 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 0.9 OUTLIER -66.5 -25.56 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.409 -0.359 . . . . 70.23 111.261 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 200' ' ' LEU . 6.9 t-20 -84.11 -7.42 59.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 73.03 109.882 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 161' ' ' ILE . 21.1 mt -105.75 115.57 30.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.071 -0.968 . . . . 63.13 110.503 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.1 mm? -118.08 140.35 49.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 74.03 110.535 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 9.0 mp -100.72 145.27 28.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.655 -0.498 . . . . 73.31 109.655 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.671 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 25.5 t-20 -59.99 147.64 38.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.17 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -57.69 -26.83 62.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.395 0.517 . . . . 72.45 112.395 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -115.48 -15.83 11.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 70.31 111.878 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.26 107.11 30.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 112.018 0.377 . . . . 73.43 112.018 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.548 ' HA ' HD23 ' A' ' 185' ' ' LEU . 17.9 Cg_exo -67.62 -21.84 45.06 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.069 2.513 . . . . 73.0 111.586 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.683 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 7.3 p-10 -91.39 6.51 45.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.556 . . . . 71.45 111.047 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -119.35 99.78 6.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 61.35 109.646 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.24 133.67 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.885 -0.598 . . . . 73.53 110.496 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.671 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 18.0 m-85 -128.17 158.05 39.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 71.32 110.018 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 164' ' ' ILE . 82.9 mt -95.63 150.2 20.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.671 0.272 . . . . 73.43 110.608 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.2 p -138.23 175.87 7.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.736 -0.839 . . . . 70.05 108.736 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 196' ' ' VAL . 0.6 OUTLIER 75.64 -58.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.461 0.476 . . . . 64.53 110.769 174.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.792 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 25.8 m-85 63.77 12.21 6.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.428 -0.805 . . . . 74.43 112.343 173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.35 -15.64 81.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.601 -1.0 . . . . 62.13 110.601 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 352' ' ' LYS . 89.9 mt -92.92 17.09 11.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.01 -0.595 . . . . 64.14 110.283 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 175' ' ' HIS . . . -127.76 99.42 5.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.104 -0.702 . . . . 45.21 109.104 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -99.54 149.64 23.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.302 0.572 . . . . 72.44 111.106 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 203' ' ' ARG . 32.7 ptt180 -60.1 115.52 3.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.852 -1.067 . . . . 74.34 111.131 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -101.83 -29.76 11.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.384 0.611 . . . . 70.45 109.745 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 45.7 m -133.88 64.42 66.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 71.04 109.643 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.25 113.86 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.93 2.42 . . . . 63.43 113.167 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 70.21 14.3 7.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.723 -0.671 . . . . 51.42 110.457 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.04 -7.25 52.24 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.874 -0.679 . . . . 62.1 112.307 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.84 111.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 74.15 110.535 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -102.69 128.58 49.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.285 -0.416 . . . . 74.01 110.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -115.46 162.22 17.48 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.371 -0.603 . . . . 74.05 109.371 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -83.75 -172.16 4.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.484 0.659 . . . . 70.45 111.915 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -76.41 151.86 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 75.33 111.861 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -134.33 0.65 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 74.45 110.473 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 69.49 -63.13 0.39 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.501 -0.772 . . . . 72.42 112.522 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 4.4 t0 -157.2 105.5 1.88 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.76 0.314 . . . . 72.12 111.778 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.452 -0.916 0 C-N-CA 123.49 2.793 . . . . 61.01 113.3 172.713 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 120.917 0.389 . . . . 70.51 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.57 -170.4 46.32 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.959 -0.564 . . . . 73.0 112.833 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.674 ' OG1' ' HD2' ' A' ' 179' ' ' LYS . 1.1 m -91.1 114.25 26.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.689 -0.486 . . . . 61.55 109.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 271' ' ' VAL . 18.3 tt -52.77 -17.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 113.377 0.88 . . . . 74.24 113.377 -167.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -65.42 -43.88 89.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 73.41 109.846 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.61 ' HD2' ' HB ' ' A' ' 224' ' ' THR . 36.6 m-85 -96.07 -41.41 8.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.58 -0.736 . . . . 74.33 111.381 -174.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 0.2 OUTLIER -57.45 -5.56 0.35 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.499 1.296 . . . . 51.33 114.499 -166.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.6 t 62.99 -158.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.932 0.396 . . . . 60.43 110.162 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.5 mt -71.87 -47.53 55.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.417 -0.356 . . . . 72.25 110.795 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -35.99 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.276 1.213 . . . . 60.42 114.276 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.624 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -70.0 -30.14 67.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.477 0.547 . . . . 50.22 112.477 -167.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -21.76 61.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 74.3 110.119 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.24 -34.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.785 -0.45 . . . . 64.33 109.785 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 216' ' ' ASP . . . 142.17 -33.93 1.88 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.242 -0.98 . . . . 62.23 113.231 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.52 140.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.827 0.314 . . . . 74.44 110.637 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -56.86 135.34 79.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 60.42 110.348 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 75.8 Cg_exo -49.89 115.72 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 2.458 . . . . 74.54 112.279 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 84.6 p -83.59 -178.06 6.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.04 -0.527 . . . . 73.52 110.534 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.644 ' HA ' ' HE1' ' A' ' 169' ' ' HIS . 9.3 ptp85 -64.55 -31.29 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.612 0.72 . . . . 71.23 109.537 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -64.26 -40.26 95.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.226 -0.897 . . . . 71.41 109.538 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -58.93 -69.29 1.32 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.068 -0.969 . . . . 53.54 112.391 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -61.45 -33.82 74.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.128 0.464 . . . . 61.42 112.078 -170.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.59 -46.92 57.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.566 -0.454 . . . . 73.11 111.734 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.18 -27.71 60.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.003 0.43 . . . . 71.42 110.305 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.5 mt -63.92 -45.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 74.01 110.507 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 161' ' ' ILE . 37.6 tp -60.38 -36.51 78.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.834 -0.432 . . . . 74.33 109.834 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.19 -47.61 88.3 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.754 -0.736 . . . . 63.23 112.142 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -59.65 -43.75 93.79 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.777 0.322 . . . . 73.54 110.79 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 35.4 m -65.49 -37.44 86.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.908 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.38 -50.71 70.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.866 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.8 tt -69.79 -28.62 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.649 -0.42 . . . . 63.23 110.443 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.79 -50.84 71.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.934 0.397 . . . . 63.33 110.322 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.9 m0 -70.3 -24.97 63.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.531 -0.759 . . . . 53.22 111.012 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 294' ' ' ASN . 30.1 tp -76.39 -32.6 58.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.03 111.719 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -103.37 -27.24 12.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.531 0.567 . . . . 44.13 112.531 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.426 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 86.83 -20.49 24.09 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.447 -0.882 . . . . 44.35 112.588 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -147.36 144.35 28.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.616 -0.512 . . . . 75.34 109.616 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.74 149.03 36.39 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 72.33 110.29 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.17 -34.94 98.57 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.323 2.015 . . . . 61.34 112.18 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -96.57 13.64 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 75.51 110.862 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.18 -31.15 69.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 75.13 110.669 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -84.13 -6.86 59.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.794 0.807 . . . . 70.04 109.556 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.876 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 2.9 m-20 -106.86 5.12 28.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.927 -1.033 . . . . 61.21 109.51 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 265' ' ' LEU . 1.9 tm? -65.16 -33.7 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.553 -0.749 . . . . 75.42 111.537 -170.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.42 -23.22 65.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.207 0.447 . . . . 71.33 112.207 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 14.7 t70 -109.7 127.5 27.04 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.929 0.395 . . . . 65.03 111.69 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.94 -39.85 67.47 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.391 2.728 . . . . 52.54 113.649 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 9.8 ptmm? -79.11 -37.88 37.56 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.359 -0.536 . . . . 42.13 110.008 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 9.1 m-85 -58.11 -42.84 86.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.56 0.219 . . . . 75.32 110.818 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 225' ' ' ILE . 65.3 t -63.16 -50.6 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.563 -0.29 . . . . 62.55 110.519 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 276' ' ' ILE . 31.0 ttp180 -60.13 -48.86 79.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.602 -0.272 . . . . 73.41 111.273 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.68 -45.72 85.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.466 0.479 . . . . 73.54 111.514 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 21.4 m -66.79 -43.26 84.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.102 -0.499 . . . . 52.34 111.174 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 7.8 mmmm -61.6 -32.64 72.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.758 0.313 . . . . 74.53 110.636 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 272' ' ' ARG . 75.7 mt -72.91 -44.44 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.385 -0.37 . . . . 74.23 111.013 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.45 -32.61 74.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.973 0.416 . . . . 71.14 110.563 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -74.24 -32.25 62.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.38 -0.373 . . . . 62.25 110.817 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 276' ' ' ILE . 23.7 mtp180 -59.11 -33.42 70.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.39 -0.368 . . . . 71.42 110.854 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.45 -39.9 70.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.569 -0.742 . . . . 74.21 111.417 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.449 ' O ' HD23 ' A' ' 285' ' ' LEU . 2.1 t-20 -153.99 84.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.193 0.52 . . . . 62.52 110.438 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.675 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -78.72 -35.96 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 73.52 111.968 -176.161 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.73 80.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.797 0.332 . . . . 75.35 111.241 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -75.3 -45.71 38.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 44.43 110.454 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -61.67 -42.41 98.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.925 0.343 . . . . 72.42 111.925 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.0 mmt -74.99 -43.58 53.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.93 -0.308 . . . . 72.11 111.301 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.69 -38.98 84.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.102 0.477 . . . . 71.22 111.023 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -84.54 -2.0 56.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.84 -0.618 . . . . 75.33 110.575 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.46 -21.4 38.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 74.31 109.393 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -137.48 76.92 41.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.029 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.49 44.7 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.557 2.838 . . . . 72.42 112.691 -173.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.11 -179.44 3.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.975 -0.38 . . . . 71.21 109.975 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -81.05 20.54 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.372 0.508 . . . . 74.01 112.372 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.784 HD21 HD11 ' A' ' 255' ' ' LEU . 41.5 t30 -77.47 -48.14 17.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.47 -0.567 . . . . 54.34 109.47 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 23.9 tptm 77.85 95.09 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 115.222 -0.899 . . . . 65.35 111.147 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.84 48.04 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.889 2.392 . . . . 55.51 112.196 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.14 54.93 Favored Glycine 0 C--O 1.238 0.356 0 CA-C-N 115.942 -0.572 . . . . 65.02 112.76 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 323' ' ' ILE . 1.7 mp0 -55.37 -45.14 76.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 74.44 110.497 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.7 mp -63.0 -45.3 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 73.34 110.827 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.13 50.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 75.51 111.428 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 304' ' ' GLU . 22.3 mtpp -77.17 -27.94 53.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 71.14 111.897 -176.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -55.99 -52.78 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.518 . . . . 54.1 109.97 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.555 ' HA ' HG22 ' A' ' 306' ' ' VAL . 55.6 mtp -72.68 -36.28 67.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.464 -0.789 . . . . 72.54 110.869 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 301' ' ' LYS . 38.7 tt0 -57.39 -46.42 83.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.362 0.601 . . . . 74.42 109.795 173.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 47.9 m -63.17 -52.5 62.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.037 -0.983 . . . . 73.44 112.078 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.6 m -64.24 -27.35 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.712 0.291 . . . . 72.41 111.551 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -80.65 -30.48 36.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.711 0.291 . . . . 71.2 111.042 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.86 -17.73 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 74.44 110.326 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 67.8 mt -71.16 -13.84 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 61.31 110.889 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 35.7 t70 59.23 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 73.34 111.736 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.53 ' O ' ' HD2' ' A' ' 240' ' ' ARG . 49.5 t80 -152.4 -48.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.442 0.163 . . . . 71.21 110.685 174.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 5.4 m -125.67 36.14 4.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.243 0.544 . . . . 50.14 111.668 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 14.8 tp10 -90.49 23.06 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.937 -0.477 . . . . 54.14 110.04 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 72.36 130.64 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 115.466 -0.788 . . . . 54.44 111.811 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.54 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 1.4 Cg_endo -82.37 118.31 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.415 2.076 . . . . 75.31 110.881 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 320' ' ' LEU . 16.9 tp -104.09 92.6 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 74.41 110.138 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.72 -40.44 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 75.52 111.556 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.6 pm0 -67.22 -29.3 68.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.21 111.617 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.06 -48.87 69.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.791 -0.448 . . . . 71.33 109.791 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 9.4 mp -60.47 -43.15 97.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.602 -0.726 . . . . 45.32 110.619 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 325' ' ' LEU . 1.2 tmt_? -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.63 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.21 -40.5 71.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 72.31 111.274 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -63.72 -37.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.618 0.247 . . . . 75.44 110.373 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.531 HD23 ' HB3' ' A' ' 298' ' ' GLU . 87.1 mt -67.86 -46.73 70.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.954 0.407 . . . . 73.04 110.667 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 321' ' ' ARG . 4.3 mm? -66.93 -29.26 69.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.43 111.171 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -66.34 -42.38 88.23 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.406 -0.59 . . . . 72.13 109.406 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.99 98.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.802 -0.713 . . . . 44.11 111.925 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 155' ' ' LEU . 14.1 mt -69.18 -36.37 77.26 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.854 -0.204 . . . . 75.01 111.488 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -60.3 -34.03 73.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.747 0.308 . . . . 71.24 110.426 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.82 -29.79 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 54.53 111.816 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.7 pt -107.68 1.01 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 74.04 111.094 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 77.07 24.99 65.1 Favored Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.949 -0.643 . . . . 64.03 113.052 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 62.6 m -107.45 156.7 18.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.077 0.465 . . . . 63.41 111.254 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -152.96 16.8 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.394 -0.965 . . . . 64.23 108.394 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 338' ' ' LYS . 24.7 t70 67.27 125.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.529 -1.214 . . . . 73.34 109.298 -162.016 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.26 0.91 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.282 -0.872 . . . . 45.4 110.763 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -70.56 -10.16 66.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.842 -0.694 . . . . 50.21 111.824 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.683 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 12.3 mmmm . . . . . 0 CA--C 1.519 -0.221 0 C-N-CA 123.622 0.769 . . . . 72.01 111.431 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 200' ' ' LEU . 4.5 mptp? . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.246 0.546 . . . . 70.44 110.556 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.8 t -161.45 157.67 25.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 71.4 108.691 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.1 OUTLIER -99.63 126.83 52.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.323 0.582 . . . . 63.32 111.785 -173.395 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 18.5 m -75.95 74.12 2.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.608 -0.724 . . . . 51.43 109.908 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.68 . . . . 75.03 110.432 -179.453 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG13 ' HA2' ' A' ' 40' ' ' GLY . 90.1 t . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 108.389 -0.967 . . . . 64.33 108.389 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.81 -5.66 59.97 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.492 -0.861 . . . . 62.02 112.271 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.52 140.82 31.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.697 -0.483 . . . . 70.35 109.697 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -98.53 131.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.247 0.546 . . . . 72.13 110.779 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.3 137.0 47.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.745 -0.661 . . . . 44.03 110.039 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 23.6 m -106.76 121.01 43.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.29 -0.414 . . . . 73.55 110.627 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.603 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 3.2 p-10 -83.35 -175.44 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 71.11 110.812 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.481 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 25.3 mmt -65.95 -28.09 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.372 0.508 . . . . 73.24 112.372 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.752 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . . . -90.71 9.69 28.89 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.99 0.424 . . . . 75.24 110.822 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 63.4 69.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.412 -0.813 . . . . 65.42 112.862 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.752 ' HE2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -127.33 141.91 51.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.162 -0.681 . . . . 74.12 109.162 168.325 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.59 101.55 14.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.983 0.42 . . . . 71.4 110.233 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.579 ' HZ2' ' HZ2' ' A' ' 35' ' ' LYS . 70.5 m95 -98.97 108.61 21.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 75.01 110.515 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.73 123.41 27.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.212 -0.662 . . . . 73.23 109.212 175.875 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.86 132.32 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.531 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -116.12 -131.75 4.88 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 121.09 -0.576 . . . . 65.3 112.992 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.8 tt -63.75 128.31 92.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.053 0.454 . . . . 64.14 111.381 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.9 Cg_exo -74.95 100.65 1.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.15 2.567 . . . . 63.0 111.991 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 53' ' ' LEU . 69.3 mt -62.33 -55.93 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.162 0.506 . . . . 73.44 110.925 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.94 148.05 18.49 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.649 -0.786 . . . . 62.54 111.899 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' HG12 ' A' ' 51' ' ' ILE . 25.3 tm0? -112.73 165.88 11.87 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.262 -1.014 . . . . 73.55 108.262 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' ' NZ ' ' A' ' 140' ' ' LYS . . . -40.57 -51.45 3.85 Favored Glycine 0 C--N 1.335 0.475 0 O-C-N 123.47 0.482 . . . . 64.04 113.884 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 26.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.959 -1.115 . . . . 72.21 113.47 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.572 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 75.5 t80 -129.84 -77.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.094 0.447 . . . . 75.04 111.287 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.66 -40.63 76.79 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.179 -0.534 . . . . 54.43 113.954 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' GLN . 59.3 m 64.2 96.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.31 0.576 . . . . 74.14 110.81 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 45' ' ' GLN . 4.1 mm -101.31 139.71 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 51.43 111.618 -172.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.81 158.73 16.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 73.23 109.728 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 43' ' ' ILE . 9.5 tt -97.1 144.57 26.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.582 -0.525 . . . . 73.43 109.582 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -118.5 114.78 23.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.759 0.314 . . . . 31.43 110.283 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.43 8.42 33.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.395 -0.366 . . . . 73.11 111.049 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 1.4 tmt? 69.49 -60.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.376 0.67 . . . . 60.32 109.805 -174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 56' ' ' MET . 62.9 t30 174.16 149.05 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.931 0.769 . . . . 74.22 109.273 171.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p -82.39 73.22 9.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.344 0.592 . . . . 63.11 110.348 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.337 -0.847 . . . . 61.44 109.728 -179.237 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.699 0.761 . . . . 74.2 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HG2' ' CH2' ' A' ' 114' ' ' TRP . 82.5 Cg_endo -90.92 37.96 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.427 2.751 . . . . 75.23 113.76 -169.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.89 139.05 53.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.153 0.501 . . . . 70.13 111.606 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 53' ' ' LEU . 34.2 m -130.29 162.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.235 -0.654 . . . . 72.23 109.235 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.56 ' HB ' HG12 ' A' ' 130' ' ' ILE . 7.4 p -132.73 130.13 58.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.611 0.72 . . . . 71.21 111.688 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' HD12 ' A' ' 51' ' ' ILE . 76.2 tttt -94.79 137.47 33.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.023 -0.989 . . . . 74.41 109.42 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.83 140.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 72.34 111.743 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 16.2 mt-10 -157.35 161.1 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 75.15 109.576 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.01 148.54 92.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.321 2.014 . . . . 51.22 111.353 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.0 t -47.47 -50.02 24.1 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.553 0.533 . . . . 65.14 112.208 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.48 45.28 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.749 0.309 . . . . 65.1 111.456 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -69.34 -37.5 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.353 0.597 . . . . 73.41 110.264 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.03 -80.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.584 -0.817 . . . . 74.33 112.422 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.572 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.4 Cg_exo -60.91 -40.99 48.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.075 2.517 . . . . 51.35 112.768 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 1.6 tm? -52.63 -48.6 66.27 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 123.518 0.511 . . . . 74.43 111.172 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.29 -45.9 89.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.706 0.289 . . . . 74.24 111.185 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 201' ' ' ALA . 3.2 m -63.61 -42.5 98.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.336 0.589 . . . . 61.35 110.424 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.21 -30.27 64.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 73.22 110.484 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.63 -41.97 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 53.23 110.729 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HD2' ' HE2' ' A' ' 173' ' ' TYR . 41.6 ttmt -63.71 -40.11 95.95 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.714 -0.395 . . . . 75.03 109.961 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.24 -45.44 93.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.317 0.58 . . . . 73.45 109.648 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.5 ' OH ' ' HA ' ' A' ' 113' ' ' TYR . 81.1 t80 -58.28 -37.24 74.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 75.33 110.926 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.52 -32.77 72.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 71.32 111.057 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 12.4 mmt180 -72.08 -37.9 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.52 111.075 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 96' ' ' ILE . . . -96.27 17.16 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 73.34 111.118 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' LYS . . . -87.63 146.9 25.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.909 -0.587 . . . . 63.44 111.594 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 91' ' ' ALA . 41.2 ttmt 77.92 117.25 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.256 -0.884 . . . . 72.34 111.533 174.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -56.52 -29.33 78.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.337 2.691 . . . . 61.33 113.087 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.43 -53.26 60.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.684 0.278 . . . . 71.2 111.395 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.89 -47.75 81.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.152 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 90' ' ' ALA . 59.0 mt -56.21 -51.25 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.674 . . . . 74.44 111.022 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -53.83 -42.17 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 72.31 110.621 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -60.32 -60.23 4.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.576 -0.738 . . . . 65.41 111.449 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -73.26 -34.44 65.83 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 119.964 -0.694 . . . . 72.0 111.353 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.3 mm -59.72 -38.04 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.668 -0.413 . . . . 63.13 110.475 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -78.77 -48.13 15.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.307 -0.406 . . . . 63.43 111.24 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.0 m -73.66 -43.92 58.17 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.891 0.33 . . . . 74.34 111.891 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.555 ' O ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -73.92 -27.33 60.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.782 -0.822 . . . . 65.3 108.782 178.899 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.575 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 9.9 mtmp? 71.66 83.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.663 -1.153 . . . . 71.22 111.474 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.1 mt -121.69 173.74 7.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.986 -1.006 . . . . 42.41 109.318 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -89.35 -62.57 1.45 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.906 -0.318 . . . . 54.55 110.469 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 160' ' ' ARG . 27.4 p90 -164.78 146.26 7.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.916 0.389 . . . . 74.14 110.546 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 100' ' ' ILE . 42.3 mt -91.85 118.08 30.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 63.23 111.019 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.52 59.69 4.94 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 109.977 -1.249 . . . . 74.42 109.977 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.776 HG22 ' HD2' ' A' ' 111' ' ' PRO . 2.2 p -121.12 151.56 55.64 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.261 -0.47 . . . . 71.31 110.285 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.776 ' HD2' HG22 ' A' ' 110' ' ' VAL . 89.2 Cg_exo -42.84 134.77 5.3 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.96 2.44 . . . . 63.41 113.618 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 131' ' ' MET . 23.5 tptm -91.46 130.5 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 74.53 110.142 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.5 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 46.1 t80 -91.09 128.62 36.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.131 0.491 . . . . 73.31 112.135 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.565 ' CD1' HG22 ' A' ' 130' ' ' ILE . 47.6 m95 -129.71 -43.66 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.369 -0.832 . . . . 74.24 108.794 170.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.89 162.93 32.24 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.7 -1.136 . . . . 44.54 111.448 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 p -164.16 145.5 8.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.746 -0.464 . . . . 60.52 109.746 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.481 ' HA2' ' HG2' ' A' ' 32' ' ' MET . . . -170.17 -171.55 35.75 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.141 -1.028 . . . . 62.22 112.817 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.84 130.84 44.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.035 -0.728 . . . . 74.4 109.035 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.457 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 30.7 t-80 -125.5 133.32 52.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.487 -0.324 . . . . 70.51 110.137 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' SER . 25.7 m-20 69.54 145.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.919 0.762 . . . . 73.52 112.0 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -151.52 -24.49 0.2 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 60.44 111.243 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.02 -67.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.336 -0.393 . . . . 73.55 111.827 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.92 -28.27 3.46 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.12 -0.792 . . . . 52.31 111.12 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.0 130.68 46.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.19 -0.671 . . . . 62.04 109.19 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 4.0 p -113.92 117.43 31.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.827 0.346 . . . . 74.42 110.46 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' ' 120' ' ' ASP . 96.1 m-85 -110.82 132.62 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.226 0.536 . . . . 73.55 111.672 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -111.95 127.46 55.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.581 -0.736 . . . . 71.13 109.099 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 49.0 p90 -123.3 142.1 51.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.222 0.534 . . . . 73.44 110.86 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.8 ptm -136.13 130.18 32.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.379 -0.828 . . . . 73.52 109.879 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.565 HG22 ' CD1' ' A' ' 114' ' ' TRP . 15.9 mt -97.51 135.31 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.986 -0.552 . . . . 74.44 111.543 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 53.8 mtm -130.73 -179.88 5.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.038 -0.528 . . . . 73.11 109.788 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.05 165.44 24.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.697 -0.483 . . . . 32.43 109.697 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -69.39 133.19 47.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.397 0.618 . . . . 75.41 111.519 -172.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 20.5 m-85 -122.3 172.21 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.669 . . . . 74.34 110.202 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.775 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -173.72 -51.54 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 41.12 111.916 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.1 m -100.86 144.15 30.16 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.753 -0.462 . . . . 75.11 109.753 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 p30 -139.01 163.04 33.44 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.018 -0.364 . . . . 62.32 110.018 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.0 mp -73.14 -24.4 60.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.189 0.44 . . . . 70.22 112.189 -173.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 10.0 pt20 -71.24 -31.8 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.623 -0.431 . . . . 70.12 110.424 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.498 ' NZ ' ' HA2' ' A' ' 46' ' ' GLY . 55.9 mttp -71.75 -37.24 70.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.99 0.424 . . . . 74.2 110.757 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 137' ' ' ASP . 62.0 mt -74.66 -51.54 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.915 -0.584 . . . . 71.52 112.281 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HD1' ' HB2' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -65.96 -32.61 74.19 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.337 0.495 . . . . 71.15 112.337 -166.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.83 -6.82 59.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.181 -0.607 . . . . 72.44 110.823 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -104.05 -30.28 10.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.36 0.6 . . . . 64.2 110.45 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -97.92 -0.61 44.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.546 -0.752 . . . . 75.42 110.876 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.11 16.23 9.44 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.462 -0.79 . . . . 52.3 111.926 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HE3' ' HB3' ' A' ' 253' ' ' GLN . 2.6 ttpt 64.19 53.67 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.732 -0.667 . . . . 73.33 110.939 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 148' ' ' ARG . 6.4 tmm_? -133.43 95.15 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.366 -0.975 . . . . 75.33 108.366 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 44.6 m-85 -103.68 157.23 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.871 -0.604 . . . . 74.54 111.368 -172.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.2 p -60.9 147.88 41.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.773 -0.648 . . . . 54.12 110.778 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HD3' ' OE2' ' A' ' 298' ' ' GLU . 26.7 ttm-85 -61.88 -33.19 73.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 71.43 110.608 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.32 -46.17 90.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.268 177.288 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 32.6 m -72.03 -45.74 59.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.772 -0.649 . . . . 71.44 111.155 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.2 -40.92 76.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.401 -0.363 . . . . 73.35 110.681 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 324' ' ' LEU . 19.2 tp -63.48 -47.89 79.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 74.15 110.668 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.7 -45.48 81.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.691 0.281 . . . . 70.31 111.051 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 161' ' ' ILE . 93.2 mt -58.52 -51.62 69.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 70.35 110.146 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 247' ' ' LEU . 15.5 m -57.9 -43.2 86.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.776 -0.647 . . . . 73.2 110.921 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 92.8 mt -61.19 -56.12 24.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.206 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -65.59 -23.5 66.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.614 0.245 . . . . 72.23 111.3 -176.05 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 157' ' ' LEU . 27.1 mm -65.62 -46.46 89.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.649 -0.501 . . . . 75.33 109.649 174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.09 -38.72 92.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.618 0.229 . . . . 73.42 111.618 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.82 -55.51 33.92 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.161 0.505 . . . . 75.23 110.656 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.584 HG21 HH21 ' A' ' 160' ' ' ARG . 16.9 tt -70.44 -36.22 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.001 -0.545 . . . . 71.32 110.59 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 58.8 tp -62.65 -37.32 85.89 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.456 -0.202 . . . . 60.5 110.456 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -50.83 66.28 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.194 0.521 . . . . 75.14 109.874 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 44.1 t80 -51.68 -44.64 63.18 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 114.825 -1.08 . . . . 73.43 111.805 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.74 -31.36 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.768 0.318 . . . . 73.14 111.189 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.666 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 30.3 t-80 -50.77 -54.96 19.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.511 -0.768 . . . . 75.23 111.098 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.47 40.2 1.59 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.403 0.62 . . . . 63.42 110.66 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.623 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 3.0 t-80 -110.21 -72.72 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 73.45 109.083 174.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.68 -38.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.461 -0.336 . . . . 73.45 111.293 173.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 46.8 m-85 -107.33 138.79 42.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 72.52 111.639 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.26 172.51 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.122 -0.49 . . . . 72.05 110.396 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 44.2 t60 -141.16 111.76 6.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.356 -0.384 . . . . 72.44 110.111 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.78 -44.26 6.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 72.53 113.568 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.788 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 35.7 t70 -81.37 87.09 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.267 -0.549 . . . . 74.22 112.269 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.69 63.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.703 . . . . 53.22 109.534 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -97.31 156.99 16.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.328 -0.619 . . . . 70.24 109.328 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -64.01 -10.84 24.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.943 0.349 . . . . 63.31 111.943 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.532 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 46.6 t -71.56 -22.55 61.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.457 -0.338 . . . . 71.22 111.134 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -95.42 -2.25 49.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 70.12 110.794 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.46 126.62 55.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 74.31 111.512 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 1.0 OUTLIER -137.71 158.74 43.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 65.14 110.996 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 193' ' ' VAL . 43.6 mt -102.67 152.17 21.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.936 -0.575 . . . . 72.45 111.25 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.748 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 42.1 t-20 -69.38 128.1 35.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.507 -0.923 . . . . 75.1 108.507 169.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.775 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 39.7 t80 -60.21 -35.36 75.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 71.22 111.905 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.493 ' HD3' ' NH1' ' A' ' 133' ' ' ARG . 76.0 tttt -97.78 -25.49 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.386 -0.37 . . . . 63.24 111.218 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 82.7 m-20 -115.99 98.17 50.66 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.42 -0.355 . . . . 55.33 110.14 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 189' ' ' ASN . 33.7 Cg_endo -63.98 -21.67 68.44 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 123.089 2.526 . . . . 71.13 113.241 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 31.2 p-10 -95.77 6.91 47.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 74.23 111.296 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -106.16 91.86 3.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.026 -0.534 . . . . 75.21 109.834 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.436 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.1 p -102.42 122.95 55.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.695 -0.684 . . . . 74.42 110.109 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.748 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 79.3 m-85 -106.91 157.76 17.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.647 -0.706 . . . . 74.11 110.897 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.446 ' HB2' HH22 ' A' ' 160' ' ' ARG . 43.1 tp -109.16 101.66 10.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 72.0 109.444 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 111' ' ' PRO . 24.2 m -146.13 171.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.6 0.238 . . . . 73.51 110.831 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.54 51.6 4.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.497 -0.774 . . . . 65.03 110.775 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.677 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 22.5 p90 -126.67 -44.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.423 -0.808 . . . . 73.23 111.124 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 79' ' ' PRO . . . 67.02 5.67 34.28 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.899 -0.667 . . . . 63.12 112.873 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.93 HD11 ' HD2' ' A' ' 352' ' ' LYS . 30.3 mt -92.33 97.31 10.79 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.768 0.318 . . . . 55.42 110.873 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 82' ' ' THR . . . -149.47 100.14 2.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 75.2 109.663 173.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -105.18 143.01 33.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.389 -0.368 . . . . 74.31 110.463 -176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 203' ' ' ARG . 8.8 ptm180 -71.3 115.98 11.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.118 -0.492 . . . . 75.1 111.55 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 239' ' ' SER . 68.9 t80 -83.76 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.72 -0.673 . . . . 60.14 109.746 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 8.1 p -99.33 119.51 60.23 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 54.24 109.42 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.639 ' HG2' HG23 ' A' ' 209' ' ' VAL . 11.7 Cg_endo -56.64 88.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.233 2.622 . . . . 73.51 113.559 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 62.62 24.58 14.64 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.448 -0.796 . . . . 65.25 112.626 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.11 -42.6 1.37 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.364 -0.922 . . . . 42.43 113.232 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.639 HG23 ' HG2' ' A' ' 206' ' ' PRO . 24.4 m -79.19 132.42 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 64.24 111.068 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -70.0 153.61 43.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 65.13 110.727 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.771 ' HE2' ' HA ' ' A' ' 211' ' ' LYS . 0.1 OUTLIER -130.86 134.6 46.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 74.21 109.444 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.86 145.91 55.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.458 -0.571 . . . . 74.34 109.458 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.58 136.81 56.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.477 0.656 . . . . 63.21 111.187 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.43 -148.88 0.36 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.118 -0.946 . . . . 74.25 108.962 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -139.75 -49.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.767 -0.373 . . . . 64.44 110.086 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -138.84 104.26 7.49 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.088 0.403 . . . . 60.42 112.088 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 54.9 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 122.029 1.819 . . . . 74.51 109.989 162.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.081 0.467 . . . . 73.1 110.554 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.788 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 88.4 -153.38 24.19 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.455 -0.793 . . . . 42.35 112.303 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.73 145.42 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 73.04 110.181 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.489 ' HA ' HG22 ' A' ' 228' ' ' THR . 15.3 tt -61.39 -23.44 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.709 0.633 . . . . 74.14 112.709 -171.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.46 -34.47 76.0 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.32 -0.237 . . . . 72.42 111.222 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 246' ' ' ILE . 13.3 m-85 -104.07 -17.65 14.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.418 0.525 . . . . 75.31 112.418 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 1.8 t -72.94 7.97 1.78 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.091 0.472 . . . . 53.05 111.451 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 26.2 t 63.34 -179.77 0.15 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.264 0.554 . . . . 72.01 110.932 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.5 -41.13 64.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 72.32 109.559 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.09 -62.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.847 -1.069 . . . . 64.42 111.589 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -66.4 -29.41 69.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.254 . . . . 54.21 111.228 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -64.7 -29.69 70.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.232 -0.187 . . . . 54.14 110.543 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -76.13 -27.17 56.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 53.33 110.002 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 133.59 -20.81 4.09 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.027 -0.606 . . . . 62.13 113.251 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.1 130.75 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 42.22 112.309 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -62.71 123.7 80.41 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 75.14 108.652 170.113 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 239' ' ' SER . 73.2 Cg_exo -46.14 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.682 2.922 . . . . 72.31 114.887 -168.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.527 ' HA ' ' OH ' ' A' ' 204' ' ' TYR . 3.6 m 161.37 -83.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.751 1.221 . . . . 64.32 108.173 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.607 ' HG2' ' HG3' ' A' ' 315' ' ' PRO . 9.5 mpt_? -136.09 -31.87 0.89 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.36 -0.978 . . . . 72.42 108.36 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.759 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.32 -67.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.188 -1.369 . . . . 70.51 112.216 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.71 -40.51 96.65 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-N 116.03 -0.532 . . . . 72.0 112.864 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.31 -53.85 39.1 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.802 0.81 . . . . 73.31 110.284 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 306' ' ' VAL . 10.5 mp -64.96 -33.11 75.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.055 -0.975 . . . . 74.3 110.952 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.57 -40.45 97.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.524 0.202 . . . . 74.42 110.532 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.662 HG13 ' O ' ' A' ' 242' ' ' GLY . 73.0 mt -56.63 -46.17 82.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.117 -0.492 . . . . 45.31 110.737 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.7 tp -61.91 -40.25 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.223 -0.591 . . . . 74.53 110.532 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.34 91.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.554 -0.831 . . . . 23.44 112.044 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 275' ' ' LYS . 20.7 m-85 -64.67 -45.02 88.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.505 0.193 . . . . 70.03 111.464 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 5.0 p -72.58 -35.96 68.07 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.408 -0.517 . . . . 73.54 111.219 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 85.5 mtp -58.21 -52.12 66.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.341 . . . . 63.21 110.651 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.5 tt -67.62 -32.11 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 71.2 110.775 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.689 ' HB3' ' HE3' ' A' ' 147' ' ' LYS . 19.0 mt-30 -62.34 -50.95 69.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.676 0.274 . . . . 63.51 111.211 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 147' ' ' LYS . 29.7 m0 -68.18 -24.42 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.131 -0.486 . . . . 65.01 111.496 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -84.99 -31.47 23.49 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.34 0.496 . . . . 71.13 112.34 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.535 HG22 ' HD1' ' A' ' 290' ' ' PHE . 51.7 p -103.92 -28.67 11.44 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.999 0.74 . . . . 43.24 112.999 -171.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 112.55 -49.49 0.84 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.184 -1.007 . . . . 71.53 112.956 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -151.62 145.41 25.08 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.609 -0.347 . . . . 74.12 110.348 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.505 ' CD1' ' HG3' ' A' ' 253' ' ' GLN . 31.2 mt -104.97 147.48 34.55 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.642 -0.254 . . . . 72.43 110.4 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.5 -35.93 86.93 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.875 2.383 . . . . 60.1 112.907 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.568 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 18.6 p90 -95.35 8.34 43.48 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 120.686 -0.405 . . . . 73.34 111.117 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 265' ' ' LEU . 66.2 tt0 -85.14 -24.8 27.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.343 0.592 . . . . 63.51 109.689 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -96.92 -23.4 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.653 -0.703 . . . . 72.43 109.671 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 261' ' ' TRP . 94.7 m-20 -102.51 14.34 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.731 -0.668 . . . . 72.01 111.354 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -70.08 -12.73 61.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.02 0.438 . . . . 75.12 110.783 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -64.64 -16.65 63.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 74.32 111.356 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 5.9 t70 -129.72 117.96 18.63 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-O 120.933 0.397 . . . . 63.04 110.626 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.69 -27.84 27.64 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.722 2.948 . . . . 72.24 113.946 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.9 mttp -60.26 -52.45 65.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.902 0.382 . . . . 73.42 110.279 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.539 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 95.4 m-85 -72.37 -34.67 68.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 75.53 110.994 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 265' ' ' LEU . 92.5 t -55.57 -50.5 66.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.35 -0.386 . . . . 65.23 110.602 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -70.33 -44.07 68.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 73.12 110.368 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.29 -55.42 31.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.784 -0.644 . . . . 63.41 111.174 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.5 p -61.11 -44.37 97.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.027 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.47 ' HE3' ' CZ ' ' A' ' 249' ' ' TYR . 50.4 mttp -55.95 -48.11 76.36 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 116.651 -0.249 . . . . 74.51 111.174 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.6 -41.91 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.732 -0.213 . . . . 62.54 111.066 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -63.03 -40.23 97.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.545 -0.298 . . . . 75.32 111.384 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.945 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 23.0 m-85 -73.88 -33.36 64.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.684 0.278 . . . . 72.34 111.219 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 279' ' ' ARG . 13.8 mtp180 -71.43 -23.76 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 73.41 111.173 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -57.49 -59.07 5.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 75.12 110.378 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.5 88.52 2.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 61.31 110.023 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.2 mm -55.44 -51.37 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 54.22 111.33 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.27 83.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 62.23 111.28 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 31.4 m -68.09 -44.06 77.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 75.24 111.697 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.1 mm? -64.39 -46.67 82.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.598 -0.274 . . . . 64.22 111.336 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -32.69 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.255 . . . . 45.13 111.013 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.48 -37.91 79.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.144 -0.48 . . . . 61.13 111.014 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -94.54 -13.26 26.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.462 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 46.3 t -78.18 -25.28 47.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.842 0.353 . . . . 73.43 111.157 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.535 ' HD1' HG22 ' A' ' 256' ' ' THR . 19.9 t80 -109.82 93.07 13.7 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.15 109.594 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 88.8 Cg_exo -47.45 -48.35 15.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.678 2.918 . . . . 75.0 114.329 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.92 -25.08 67.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 74.33 110.773 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 58.97 41.91 20.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 72.13 110.17 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -63.75 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.794 . . . . 75.12 110.021 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 331' ' ' ILE . 50.9 mttp -152.88 99.07 2.77 Favored Pre-proline 0 C--O 1.227 -0.127 0 CA-C-O 120.489 0.185 . . . . 73.44 110.513 172.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -99.4 38.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.887 2.391 . . . . 72.15 111.419 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.24 -50.9 5.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.068 -0.587 . . . . 34.34 113.268 -170.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.936 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.6 mp0 -54.88 -52.91 61.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.965 0.412 . . . . 63.03 110.213 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.1 mp -60.65 -47.32 93.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.425 -0.807 . . . . 72.4 111.12 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.29 86.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.774 0.321 . . . . 53.44 111.543 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -66.48 -38.57 87.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.157 0.503 . . . . 71.24 110.046 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 320' ' ' LEU . 76.2 t80 -60.0 -52.51 65.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.468 -0.787 . . . . 75.24 110.76 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 306' ' ' VAL . 79.9 mtp -71.93 -32.19 67.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.339 -0.391 . . . . 63.13 111.616 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.51 -42.24 91.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.715 0.769 . . . . 71.44 109.333 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 m -65.39 -44.03 88.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.756 -1.111 . . . . 74.23 111.548 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 302' ' ' TYR . 4.2 m -70.04 -27.24 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 72.13 110.654 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.5 -44.09 92.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.199 0.523 . . . . 73.41 110.009 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.8 tp -76.93 1.71 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 61.34 110.943 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -9.03 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.328 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 21.0 t70 64.36 -81.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.258 0.623 . . . . 74.41 111.083 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -149.6 -44.77 0.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.604 -0.517 . . . . 71.14 109.604 174.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.5 t -154.98 37.86 0.41 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.691 -0.686 . . . . 70.0 110.622 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -51.75 -69.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.051 0.453 . . . . 54.52 111.143 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -175.63 110.34 0.26 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.596 -0.729 . . . . 74.11 109.545 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.607 ' HG3' ' HG2' ' A' ' 240' ' ' ARG . 51.8 Cg_endo -69.81 117.64 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.841 1.694 . . . . 64.32 111.121 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 319' ' ' ASN . 16.5 tp -108.56 82.15 1.57 Allowed 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.355 -0.609 . . . . 62.33 109.355 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -58.3 -36.43 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.333 -0.849 . . . . 70.11 110.977 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.15 -52.34 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 65.34 110.527 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.482 ' HB2' HD23 ' A' ' 316' ' ' LEU . 8.2 t30 -59.22 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 50.23 111.325 -176.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 3.3 mm? -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.498 -0.319 . . . . 62.21 111.426 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -69.53 -34.03 73.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.65 0.262 . . . . 63.22 110.869 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.5 -42.94 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 72.42 111.254 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -67.92 -27.33 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 120.887 -0.325 . . . . 65.12 111.039 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 73.1 mt -65.13 -47.46 77.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.077 -0.342 . . . . 72.33 110.077 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.12 -33.13 75.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.246 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -39.42 89.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 75.03 110.261 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.936 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.11 -45.02 94.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.004 -0.617 . . . . 34.34 112.088 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 331' ' ' ILE . 31.1 tp -65.2 -35.25 80.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.336 0.588 . . . . 74.1 110.041 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.29 -34.3 77.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.792 -0.64 . . . . 71.34 110.12 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.43 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 71.04 111.547 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . 13.1 tt -86.79 -2.76 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.413 0.625 . . . . 72.43 109.901 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 78.19 24.38 63.85 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.722 -0.672 . . . . 71.23 112.867 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 11.1 t -120.65 159.55 25.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.952 -0.388 . . . . 72.0 109.952 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -174.0 4.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.576 -0.527 . . . . 74.31 109.576 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 28.1 t70 -65.39 120.04 12.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.145 0.497 . . . . 71.05 111.076 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.26 100.79 7.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.68 . . . . 65.23 109.371 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' GLY . . . . . 0.53 ' C ' ' HD2' ' A' ' 338' ' ' LYS . . . 82.34 -81.05 1.73 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.821 -0.704 . . . . 75.21 111.493 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.692 ' HB2' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 111.875 0.324 . . . . 70.11 111.875 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.93 ' HD2' HD11 ' A' ' 200' ' ' LEU . 11.1 tppt? . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.811 0.339 . . . . 74.14 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 52.4 m -156.83 150.9 24.97 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.42 -0.355 . . . . 72.43 110.114 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.747 HG23 ' HA ' ' A' ' 200' ' ' LEU . 12.9 pt -74.93 143.22 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.917 0.389 . . . . 71.11 111.984 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 97.9 3.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.593 -0.73 . . . . 62.23 110.428 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 58.9 pttt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 71.11 111.661 179.764 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' HA2' ' A' ' 40' ' ' GLY . 40.2 t . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.999 -0.371 . . . . 71.2 109.999 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.8 -0.14 57.74 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.961 -0.563 . . . . 52.22 113.192 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 39.4 tt0 -71.17 129.86 40.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.316 0.558 . . . . 74.34 110.097 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -77.44 130.46 36.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.435 0.636 . . . . 73.2 110.766 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -134.12 128.45 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.072 -0.967 . . . . 75.41 109.584 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 49.6 m -108.39 119.08 38.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.922 0.392 . . . . 64.12 110.35 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 116' ' ' SER . 5.7 p-10 -92.93 169.15 10.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 54.5 109.953 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 116' ' ' SER . 24.7 ptt? -71.96 -10.22 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.278 0.473 . . . . 71.14 112.278 -170.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.96 8.85 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.673 0.273 . . . . 55.2 110.601 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? 69.45 81.45 0.17 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.541 -0.754 . . . . 74.32 111.534 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' THR . 35.6 mtmm -152.99 135.95 15.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.009 -0.541 . . . . 72.3 109.966 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -105.55 89.23 3.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.985 -0.376 . . . . 71.53 109.985 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' ASN . 27.4 p-90 -116.19 160.15 20.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.872 0.368 . . . . 73.52 110.918 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.524 ' HB3' HD12 ' A' ' 28' ' ' ILE . 1.1 ptpm? -110.64 127.22 55.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.277 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.89 144.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.375 -0.602 . . . . 60.34 109.375 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -111.73 -121.12 4.0 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.481 -0.866 . . . . 43.2 113.198 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 92.2 mt -81.39 138.01 48.39 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 75.1 111.425 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.4 Cg_exo -74.39 108.07 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.056 2.504 . . . . 54.32 112.057 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 53' ' ' LEU . 45.2 mt -76.75 -47.57 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 62.5 109.842 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.53 -32.53 6.42 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.754 -0.657 . . . . 64.24 112.953 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.56 141.74 28.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.873 0.368 . . . . 75.22 110.516 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.08 62.33 0.14 Allowed Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.148 -0.781 . . . . 70.35 111.148 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.98 8.1 87.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.014 -0.612 . . . . 72.52 112.642 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 53.2 t80 -164.87 -73.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.919 -0.4 . . . . 64.13 109.919 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.58 157.7 7.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.952 -0.642 . . . . 71.44 112.064 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.4 m 63.19 38.13 10.78 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.04 0.448 . . . . 70.13 111.057 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' LYS . 2.1 mm -98.2 137.79 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 62.55 110.722 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -117.06 147.88 41.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.241 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' HD11 ' A' ' 43' ' ' ILE . 60.3 tp -85.95 152.94 22.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.086 -0.709 . . . . 63.43 109.086 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.56 31.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.735 -0.468 . . . . 33.42 109.735 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 23.2 t70 -83.81 -49.43 9.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.21 0.528 . . . . 75.04 110.233 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 54.6 ttp -162.13 135.3 6.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.914 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -97.63 -44.44 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.36 . . . . 72.52 110.11 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.5 t -100.89 120.11 39.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.365 -0.606 . . . . 74.3 109.365 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 113.397 0.888 . . . . 53.45 113.397 -169.352 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.963 0.411 . . . . 73.4 109.961 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.78 44.79 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.154 2.569 . . . . 63.34 112.34 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 p -148.4 148.96 30.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.134 0.492 . . . . 71.05 111.697 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 132' ' ' ASP . 21.6 m -125.85 157.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.034 -0.728 . . . . 61.42 109.034 172.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.7 p -128.71 124.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.18 0.514 . . . . 75.12 111.169 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -87.44 132.82 33.87 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 72.31 108.968 173.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.7 129.29 74.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.425 -0.51 . . . . 60.53 112.023 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 80' ' ' LEU . 43.8 mt-10 -125.87 159.01 63.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 63.33 109.363 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.96 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.392 2.061 . . . . 55.43 112.608 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -66.68 -36.48 82.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.443 0.64 . . . . 61.54 109.525 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -88.87 73.92 8.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.103 -0.953 . . . . 75.01 109.227 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -81.25 177.38 9.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.729 -0.669 . . . . 64.03 110.399 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -130.05 -100.59 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.522 -0.847 . . . . 73.42 112.553 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.9 Cg_exo -61.91 -21.73 72.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.556 2.837 . . . . 74.12 113.307 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 46.0 tp -51.17 -34.94 33.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.678 0.621 . . . . 61.41 112.678 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 86.1 t80 -66.76 -44.65 80.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.531 -0.468 . . . . 74.51 110.553 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -68.24 -50.03 56.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.842 -0.617 . . . . 74.32 110.708 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 198' ' ' TYR . 9.1 pt-20 -64.58 -52.98 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.247 -0.888 . . . . 72.12 110.875 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 63.4 tp -59.93 -40.93 90.59 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 111.572 0.212 . . . . 55.41 111.572 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 3.3 tmtm? -60.95 -51.12 70.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.783 0.325 . . . . 64.04 110.612 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.8 -32.26 67.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.222 -0.591 . . . . 73.11 109.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 31.2 t80 -57.67 -45.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 51.52 109.795 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 28.3 mt-30 -61.33 -38.54 87.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.927 -0.579 . . . . 65.41 110.697 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HA ' ' HZ2' ' A' ' 92' ' ' LYS . 17.4 mtm180 -68.9 -28.08 66.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.832 -0.347 . . . . 71.44 111.902 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.89 -35.58 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.856 0.687 . . . . 34.41 112.856 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.2 80.13 7.67 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.415 0.894 . . . . 63.32 113.415 -169.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HZ2' ' HA ' ' A' ' 89' ' ' ARG . 5.4 mptt -139.61 129.57 14.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 108.983 -0.747 . . . . 70.22 108.983 168.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.99 -38.36 69.31 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.618 2.212 . . . . 64.54 111.849 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 98' ' ' LYS . 16.5 tt0 -64.69 -61.03 2.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 71.32 110.847 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.64 -34.22 77.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 73.44 111.511 -172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 100' ' ' ILE . 66.9 mt -64.71 -52.61 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.673 -0.24 . . . . 73.42 110.445 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.57 ' HA ' HD11 ' A' ' 100' ' ' ILE . 6.6 tp-100 -58.13 -36.69 73.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.323 0.582 . . . . 73.22 110.27 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 48.2 mtpt -67.98 -28.86 67.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 62.2 111.126 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.755 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 57.4 t90 -66.3 -56.26 12.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.611 -0.268 . . . . 74.42 110.792 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.07 -26.02 37.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 C-N-CA 120.685 -0.406 . . . . 74.34 111.422 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -66.22 -39.32 89.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.95 -0.3 . . . . 73.41 110.437 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.3 m -76.02 -48.98 18.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.353 -0.385 . . . . 62.3 111.738 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.31 57.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 72.23 109.651 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 1.028 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER 58.35 77.28 0.3 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.103 -0.953 . . . . 73.01 111.087 -174.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 100' ' ' ILE . 95.7 mt -136.7 -176.69 4.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.888 -1.051 . . . . 73.12 108.892 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -79.57 -70.22 0.53 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.643 0.258 . . . . 64.31 110.805 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.428 ' HA ' HG21 ' A' ' 100' ' ' ILE . 30.8 p90 -159.94 163.17 34.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 71.11 109.94 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HG ' ' CE3' ' A' ' 99' ' ' TRP . 0.9 OUTLIER -79.42 137.19 37.17 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.566 0.541 . . . . 65.42 111.356 -176.021 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.33 17.82 16.98 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 121.256 -0.497 . . . . 63.33 112.655 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 HD22 ' A' ' 108' ' ' LEU . 76.0 t -101.71 135.25 19.8 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.743 0.417 . . . . 75.04 110.372 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 28.3 Cg_endo -63.78 159.62 40.75 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.366 2.71 . . . . 50.35 114.269 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -81.38 154.67 26.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.101 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -99.97 116.51 32.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.515 -0.311 . . . . 75.41 110.355 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.598 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 41.1 m95 -100.88 -29.14 12.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.953 0.406 . . . . 75.13 110.546 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 158.32 -179.53 33.94 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.577 -0.821 . . . . 71.52 112.645 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.666 ' O ' ' HG2' ' A' ' 32' ' ' MET . 36.9 p -169.99 175.33 5.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.529 -0.915 . . . . 61.24 108.529 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.14 -150.93 19.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.477 -1.344 . . . . 60.55 113.293 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.1 tt -133.27 134.13 43.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.883 0.373 . . . . 73.24 110.522 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -126.54 108.63 11.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 29.4 t70 -79.09 150.58 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.299 0.571 . . . . 54.21 111.718 -172.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -133.05 52.44 2.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.725 -0.843 . . . . 64.25 108.725 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 67.17 75.84 0.3 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.895 -1.048 . . . . 44.14 111.168 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.25 -42.88 3.18 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.9 -0.591 . . . . 65.21 112.008 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -89.06 82.74 6.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.879 -0.786 . . . . 71.42 108.879 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.8 m -78.46 135.95 37.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.776 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -94.69 137.98 33.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.035 0.445 . . . . 73.13 110.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -112.77 120.36 41.23 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.64 -0.874 . . . . 72.45 108.64 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 42.1 p90 -133.94 162.71 31.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.421 0.526 . . . . 72.43 112.421 -170.078 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.3 ttm -129.87 131.49 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.719 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -102.68 122.93 55.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.273 0.558 . . . . 74.13 109.746 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ptm -133.83 -169.97 2.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.531 -0.759 . . . . 62.42 110.445 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.9 m-20 -64.24 169.71 4.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.864 0.364 . . . . 73.33 111.962 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.734 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -82.5 106.0 14.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.51 0.671 . . . . 74.14 111.978 -174.962 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -124.39 172.25 9.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 74.31 110.26 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.23 -38.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.841 . . . . 34.13 112.344 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 m -95.87 128.19 42.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.368 -0.234 . . . . 73.14 110.368 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -122.66 160.9 24.85 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.646 -0.501 . . . . 74.23 109.646 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 10.6 mp -75.8 -8.43 56.86 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.227 0.454 . . . . 75.02 112.227 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -73.67 -49.75 24.32 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.148 -0.686 . . . . 75.15 109.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -76.86 -21.64 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.606 -0.438 . . . . 73.31 110.914 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 54.6 mt -74.12 -51.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.562 -0.29 . . . . 64.44 110.947 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.446 ' HE1' ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.76 -32.47 73.78 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.126 -0.23 . . . . 74.42 110.944 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.18 -43.31 82.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 63.22 110.137 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.71 -31.53 61.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 34.34 110.986 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.25 -2.59 58.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 75.52 110.912 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.97 38.04 22.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.472 -0.785 . . . . 72.14 112.511 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.652 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 74.1 mttt 62.17 73.12 0.48 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.433 0.531 . . . . 75.13 112.433 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -156.29 82.2 0.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.307 0.575 . . . . 73.04 109.729 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.49 141.34 29.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.604 -0.726 . . . . 51.32 111.141 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 144.09 57.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.77 -0.65 . . . . 75.12 109.852 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.525 ' HD2' HD13 ' A' ' 331' ' ' ILE . 13.1 ttm180 -63.24 -29.55 70.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.347 0.129 . . . . 71.05 111.347 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 333' ' ' SER . 57.3 mttp -57.6 -44.59 85.53 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.21 0.528 . . . . 72.44 110.071 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.53 ' O ' HD13 ' A' ' 157' ' ' LEU . 6.8 m -66.98 -41.32 87.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.38 -0.827 . . . . 74.15 110.577 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.52 -45.51 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 75.52 111.403 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.563 ' HG ' HD22 ' A' ' 328' ' ' LEU . 3.9 mm? -68.55 -37.69 80.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.506 -0.316 . . . . 74.24 111.356 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -65.84 -39.62 90.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.181 0.515 . . . . 50.34 109.98 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.56 HD12 HG11 ' A' ' 193' ' ' VAL . 5.2 mp -63.19 -51.98 64.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.53 -0.759 . . . . 63.42 111.295 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.2 p -63.19 -34.98 78.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 73.33 111.178 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.25 -40.54 97.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 74.14 110.801 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.831 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -68.94 -43.22 75.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 65.42 111.204 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 42.5 mt -64.59 -29.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.149 -0.478 . . . . 74.51 109.845 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 317' ' ' TYR . 29.0 tp -63.1 -55.68 23.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.523 -0.762 . . . . 73.44 111.148 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.755 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 4.8 p-10 -67.93 -31.51 71.32 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.573 -0.451 . . . . 73.44 110.703 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 168' ' ' ILE . 70.5 mt -66.82 -46.82 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.41 -0.359 . . . . 65.32 111.041 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.3 pp -68.71 -33.81 74.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 64.31 110.086 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 165' ' ' LEU . 5.4 mm-40 -55.58 -56.31 21.82 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.323 -0.399 . . . . 61.23 110.362 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.39 -49.09 79.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 60.11 112.192 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.8 pt -75.01 -38.26 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.107 0.41 . . . . 62.45 112.107 -173.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -72.78 -21.0 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.11 0.481 . . . . 71.43 109.831 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 207' ' ' GLU . 31.8 tt0 -75.27 -6.0 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.478 -0.783 . . . . 70.33 110.302 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -124.44 -69.69 0.79 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.663 -0.415 . . . . 64.22 111.645 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 203' ' ' ARG . 35.6 mt-10 -155.48 -59.02 0.1 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.469 0.544 . . . . 74.42 112.469 -170.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.847 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 48.1 m-85 -83.71 147.78 27.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.12 0.785 . . . . 70.34 113.12 -166.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.486 HG22 ' HD2' ' A' ' 204' ' ' TYR . 16.9 m -132.26 164.03 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.981 -1.008 . . . . 70.41 108.924 171.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -105.35 131.2 53.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.738 -0.467 . . . . 73.13 109.738 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.31 -10.41 64.0 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.05 -1.22 . . . . 62.54 110.05 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 1.071 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 15.6 t70 -123.88 110.73 15.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.675 -0.763 . . . . 75.1 110.638 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.2 mm -111.86 66.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.416 -0.957 . . . . 74.24 108.416 166.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 79.9 tttt -90.54 161.77 15.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.886 -0.597 . . . . 75.44 109.882 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -57.6 -19.31 25.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 71.33 111.786 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 p -75.91 -12.07 60.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.522 -0.308 . . . . 35.2 111.488 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 195' ' ' LEU . 3.0 m-20 -82.5 -30.05 30.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.713 0.292 . . . . 51.34 110.646 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 6.4 mp -94.05 131.54 39.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 62.41 110.581 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 194' ' ' TYR . 1.1 pp -138.42 157.43 46.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 73.31 111.048 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.59 156.69 20.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 70.34 109.5 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.65 HD21 ' HE1' ' A' ' 194' ' ' TYR . 51.1 m-80 -63.51 152.15 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.709 -0.478 . . . . 74.51 109.709 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -56.5 -32.7 65.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.101 -0.499 . . . . 70.21 111.133 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.47 3.43 5.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.209 0.448 . . . . 74.35 112.209 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 186' ' ' ASN . 12.7 m120 -128.53 92.89 39.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.823 -0.351 . . . . 73.41 111.242 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -9.26 16.46 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.829 2.353 . . . . 72.4 111.258 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.13 -6.89 50.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 74.13 111.193 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.68 122.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.094 0.474 . . . . 71.0 110.573 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 157' ' ' LEU . 7.1 p -103.62 137.45 32.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.451 -0.795 . . . . 75.31 109.712 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.65 ' HE1' HD21 ' A' ' 186' ' ' ASN . 4.7 m-85 -114.09 158.17 21.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 182' ' ' ASN . 10.1 tt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.42 -0.956 . . . . 53.01 108.42 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 195' ' ' LEU . 7.2 p -50.79 130.49 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.528 0.68 . . . . 72.11 111.285 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.639 ' HB2' ' CD2' ' A' ' 198' ' ' TYR . 1.2 p-10 -58.25 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.627 -1.17 . . . . 75.41 112.684 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 197' ' ' ASP . 24.1 m-85 -135.21 26.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.953 -0.467 . . . . 71.31 111.796 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -64.13 -39.38 97.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.504 -0.855 . . . . 70.02 111.167 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.38 89.35 2.77 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.188 -0.671 . . . . 74.35 109.188 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -166.23 149.66 7.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 61.3 110.842 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -142.45 144.65 33.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.63 -0.507 . . . . 65.42 109.63 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.847 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 23.1 ptt180 -84.44 141.08 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 75.34 110.327 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.486 ' HD2' HG22 ' A' ' 174' ' ' VAL . 6.9 m-85 -139.23 -59.35 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 73.03 112.257 -171.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.95 121.75 41.0 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.548 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 103.38 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 62.14 111.791 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 170' ' ' GLU . 29.1 tt0 71.65 -11.38 0.74 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.754 0.821 . . . . 75.51 111.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.63 -30.79 1.94 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.359 -0.924 . . . . 70.22 113.165 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.72 122.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.24 0.543 . . . . 65.31 110.903 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -89.6 154.76 19.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.06 -0.518 . . . . 71.03 110.472 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 8.8 mtpm? -93.72 -175.11 3.65 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.021 -0.536 . . . . 51.14 110.159 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.4 mp0 -52.68 130.09 31.43 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.53 0.519 . . . . 73.31 110.664 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 49.2 p90 -65.37 129.13 38.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 74.32 110.609 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.404 ' NZ ' ' HB2' ' A' ' 212' ' ' GLU . 42.0 mmtm -98.08 -45.18 6.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.627 -0.715 . . . . 62.33 110.575 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 234' ' ' ASN . 50.4 mt-10 67.2 -5.13 0.75 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.134 0.79 . . . . 73.54 113.134 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 215' ' ' GLU . 6.0 t70 169.2 86.25 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 O-C-N 123.515 0.51 . . . . 73.44 110.033 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 61.3 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 122.22 1.947 . . . . 73.25 111.973 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG22 ' A' ' 355' ' ' THR . 20.5 p-10 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.508 0.194 . . . . 62.31 111.393 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 1.071 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -93.79 -149.49 25.38 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 74.41 113.775 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.504 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 69.3 p -81.26 150.14 28.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.661 0.267 . . . . 75.0 110.988 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.23 -31.33 47.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.708 -175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.594 ' HA ' HD21 ' A' ' 265' ' ' LEU . 2.4 mp0 -49.14 -50.93 35.2 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.456 -0.793 . . . . 63.22 111.184 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 179' ' ' LYS . 97.3 m-85 -101.92 -13.58 17.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 72.34 112.031 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 35.9 m -46.95 -49.58 20.42 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.385 0.428 . . . . 63.41 111.086 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.3 m 59.33 -156.02 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.853 -0.612 . . . . 74.32 110.888 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 230' ' ' ILE . 3.4 mp -71.75 -53.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.367 -0.378 . . . . 74.41 110.282 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 238' ' ' PRO . 1.6 m-20 -49.46 -60.56 2.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.514 -0.766 . . . . 61.32 112.991 -173.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.2 67.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.928 0.394 . . . . 50.33 111.795 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -67.82 -42.82 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.391 0.615 . . . . 74.22 109.863 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.856 ' HB3' ' HA ' ' A' ' 215' ' ' GLU . 6.4 m-20 -77.25 -4.53 45.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.17 . . . . 70.34 111.195 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.11 53.74 Favored Glycine 0 C--N 1.335 0.515 0 O-C-N 123.497 0.498 . . . . 53.42 112.56 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 7.4 p -120.25 140.98 42.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.584 0.23 . . . . 75.13 110.839 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.07 106.94 2.12 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.871 -0.789 . . . . 72.12 108.871 169.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.462 ' HB3' ' OD2' ' A' ' 231' ' ' ASP . 19.9 Cg_endo -61.07 -87.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.503 2.136 . . . . 71.24 112.826 -171.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 240' ' ' ARG . 20.7 m 171.13 -49.37 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.798 1.239 . . . . 70.31 107.736 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 239' ' ' SER . 0.0 OUTLIER 176.38 -16.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.818 -1.537 . . . . 70.3 107.76 -173.031 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.574 ' NH2' ' HD2' ' A' ' 279' ' ' ARG . 9.5 mmm180 -52.4 -68.0 0.21 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.334 -1.303 . . . . 73.42 110.984 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -45.55 -42.02 9.8 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 123.706 0.629 . . . . 75.2 113.711 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.02 -64.99 0.64 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.769 0.795 . . . . 74.14 110.207 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.442 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 36.2 mt -74.06 -30.46 62.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.78 -1.1 . . . . 74.11 111.198 -174.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 279' ' ' ARG . 7.8 tp10 -62.21 -57.91 9.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.42 110.274 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.74 -41.29 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 75.24 110.341 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.89 -41.63 82.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.051 0.453 . . . . 71.24 110.816 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -43.76 98.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.07 -0.586 . . . . 24.41 112.203 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -63.07 -34.53 77.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.668 0.27 . . . . 72.32 110.896 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 57.9 m -62.0 -51.79 66.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.014 0.435 . . . . 71.54 110.525 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 76.3 mtm -61.45 -42.02 98.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.862 -0.608 . . . . 64.01 111.866 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.59 -34.33 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.392 -0.523 . . . . 74.32 110.974 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.27 -40.33 71.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 71.4 110.231 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.07 -28.46 67.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.246 -0.434 . . . . 74.53 111.247 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.8 tp -92.34 -40.04 11.14 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.174 0.435 . . . . 73.23 112.174 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 m -100.14 -17.63 17.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.509 . . . . 71.13 111.25 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.652 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 85.69 -59.74 4.74 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.759 -0.734 . . . . 62.32 112.545 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -113.8 141.76 46.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.336 -0.508 . . . . 71.21 109.924 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 85.6 mt -103.16 142.08 23.83 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.69 . . . . 71.22 110.098 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 278' ' ' TYR . 15.2 Cg_exo -68.84 -2.3 9.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.807 2.338 . . . . 74.22 112.967 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 36.4 p90 -124.3 5.6 8.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 73.01 110.21 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 34.1 tt0 -72.31 -21.63 61.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 71.55 111.048 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.92 -20.18 33.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.451 . . . . 54.22 109.976 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 89.2 m-20 -96.15 7.12 47.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.78 -0.646 . . . . 64.32 110.465 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.9 tm? -64.39 -20.84 66.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.472 -0.785 . . . . 74.55 110.519 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -73.35 -1.6 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 74.25 112.337 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 271' ' ' VAL . 20.8 t70 -137.28 120.87 11.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 121.073 -0.251 . . . . 73.34 110.958 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 34.8 Cg_exo -58.12 -29.73 88.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.307 2.671 . . . . 50.23 113.505 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.42 -41.71 38.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.805 0.336 . . . . 75.22 110.245 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 24.3 m-85 -64.63 -40.92 96.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.715 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 267' ' ' ASP . 89.8 t -54.16 -49.33 62.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 123.125 0.265 . . . . 71.25 110.975 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 276' ' ' ILE . 45.3 mtm180 -62.4 -59.05 5.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.631 -0.259 . . . . 63.34 111.115 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.0 -47.96 79.59 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.486 0.491 . . . . 73.35 111.629 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.8 m -58.53 -50.54 73.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.479 -0.328 . . . . 75.24 110.53 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.39 -32.92 73.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.654 -0.248 . . . . 73.25 111.229 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 272' ' ' ARG . 82.8 mt -64.15 -42.41 95.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 55.1 110.216 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 280' ' ' GLU . 11.0 mmp_? -62.0 -41.64 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 71.24 111.053 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 260' ' ' PRO . 73.3 m-85 -74.08 -43.27 58.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 73.02 110.904 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.574 ' HD2' ' NH2' ' A' ' 241' ' ' ARG . 34.3 ttp180 -65.38 -20.02 66.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.355 0.597 . . . . 62.13 110.708 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 277' ' ' ARG . 36.6 tt0 -60.53 -47.91 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.164 -0.925 . . . . 75.13 110.761 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -159.2 94.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.299 0.571 . . . . 74.32 110.41 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 303' ' ' MET . 0.2 OUTLIER -80.67 -29.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.598 -0.728 . . . . 73.3 111.921 -177.038 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.41 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -52.53 -48.36 66.11 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.522 0.564 . . . . 74.44 112.522 -168.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.9 m -69.53 -38.11 77.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.96 0.409 . . . . 75.24 111.666 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.417 HD13 ' HD1' ' A' ' 278' ' ' TYR . 76.5 mt -72.7 -48.2 40.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.067 -0.515 . . . . 74.4 111.321 -172.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.455 ' SD ' ' HB ' ' A' ' 282' ' ' ILE . 1.3 mpt? -61.24 -40.56 94.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.348 . . . . 71.43 110.765 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.21 -28.16 69.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.896 -0.593 . . . . 74.1 111.224 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -75.36 -43.64 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 72.22 110.774 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.11 -41.89 99.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.89 -0.595 . . . . 74.33 111.472 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.428 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 47.2 m-85 -123.15 82.2 51.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.56 -0.291 . . . . 74.11 110.953 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.62 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.288 1.992 . . . . 64.33 112.045 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.05 -9.0 28.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.338 0.59 . . . . 71.02 109.993 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -74.82 -36.13 62.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.006 -174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -173.66 -165.98 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 65.43 108.632 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.4 ptmm? -120.88 114.27 32.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 65.54 111.51 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 290' ' ' PHE . 42.2 Cg_endo -105.23 37.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.675 2.917 . . . . 75.54 112.163 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -79.5 -50.87 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.847 -0.692 . . . . 72.42 113.068 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.463 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.1 pm0 -64.17 -36.94 85.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.911 0.386 . . . . 74.41 110.864 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.64 -48.37 72.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 74.15 110.773 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.9 -35.73 79.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 75.44 110.375 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 49.7 tptt -70.95 -42.11 70.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 74.24 110.076 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.515 ' O ' HG13 ' A' ' 306' ' ' VAL . 82.7 t80 -56.19 -49.22 74.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.528 -0.76 . . . . 73.12 110.536 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.751 ' HB2' HG13 ' A' ' 282' ' ' ILE . 79.1 mtp -72.69 -31.38 64.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 74.25 111.235 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 37.1 tt0 -62.06 -42.23 98.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.774 0.797 . . . . 64.4 109.056 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 86.8 m -60.56 -45.98 91.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.634 -1.166 . . . . 71.3 111.211 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 9.8 m -73.03 -33.79 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 121.028 -0.269 . . . . 75.24 111.712 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -72.75 -24.63 60.99 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.816 -0.439 . . . . 74.13 109.816 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.16 -12.04 60.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.882 -0.599 . . . . 73.32 110.816 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 96.6 mt -81.12 8.25 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 73.35 111.401 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.47 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.357 0.663 . . . . 74.32 112.209 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.89 -50.72 0.71 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.514 -0.921 . . . . 64.42 108.514 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 17.3 m -136.64 67.66 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.514 -0.766 . . . . 72.33 110.349 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 13.0 tp10 -104.46 161.28 14.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 62.42 109.608 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.25 110.14 5.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 74.42 111.205 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.29 121.6 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.863 2.375 . . . . 70.42 113.034 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.3 mt -93.79 92.86 7.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.523 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' A' ' 320' ' ' LEU . 12.7 m-85 -63.76 -32.14 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 74.13 111.013 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 321' ' ' ARG . 21.7 mp0 -57.11 -46.45 82.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 74.34 110.14 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -68.13 -37.01 80.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 64.02 110.472 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 317' ' ' TYR . 96.2 mt -60.27 -52.29 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 73.35 110.919 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 318' ' ' GLU . 6.6 ptp180 -66.85 -28.39 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 75.01 109.739 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.39 -51.78 58.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 53.42 111.122 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -69.46 -30.04 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 121.063 -0.255 . . . . 74.54 111.24 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.47 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.1 mt -67.83 -48.54 65.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 73.14 110.344 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.61 -29.73 69.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 72.3 110.755 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -48.02 82.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.188 -0.671 . . . . 62.14 109.188 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.463 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.85 -38.51 94.38 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.893 -0.67 . . . . 62.24 112.749 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 333' ' ' SER . 41.7 tp -66.5 -41.96 88.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.172 0.511 . . . . 73.13 110.561 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.54 -25.88 60.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.98 -0.554 . . . . 62.24 110.544 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.07 83.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 75.42 110.587 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.525 HD13 ' HD2' ' A' ' 151' ' ' ARG . 47.0 pt -89.35 7.29 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 73.43 110.647 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 73.34 25.33 73.19 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.005 -0.543 . . . . 55.54 113.424 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.581 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 59.4 m -112.29 139.36 47.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.875 0.369 . . . . 73.53 111.494 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -136.61 -66.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 74.42 110.084 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.22 147.36 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.943 0.402 . . . . 75.42 110.299 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.46 -39.89 5.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.932 -0.576 . . . . 74.14 109.789 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.61 -31.16 1.67 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.008 -0.615 . . . . 55.52 112.626 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.653 ' NZ ' ' HB3' ' A' ' 338' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.573 0.582 . . . . 62.35 112.573 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 353' ' ' THR . 37.4 mmtm . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.881 -0.415 . . . . 71.12 109.881 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 352' ' ' LYS . 8.7 t -157.03 172.52 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -67.24 142.88 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.791 0.329 . . . . 73.03 110.404 177.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 222' ' ' ASP . 14.5 t -98.02 135.03 40.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.671 -0.863 . . . . 74.21 108.671 176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 71.11 109.986 -174.676 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.488 HG13 ' HA2' ' A' ' 40' ' ' GLY . 92.0 t . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.775 0.321 . . . . 65.34 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.47 -15.61 57.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.203 -0.522 . . . . 63.11 114.363 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.1 mm-40 -63.47 129.06 38.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.799 0.799 . . . . 70.22 109.737 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.707 HG22 ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -95.2 131.43 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.626 . . . . 55.33 111.993 -174.235 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 38.9 pt -96.91 150.13 4.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.437 -0.801 . . . . 61.12 109.213 171.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HZ ' ' A' ' 128' ' ' PHE . 6.8 m -105.63 113.24 26.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.534 -0.303 . . . . 54.24 111.225 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.6 t70 -65.13 152.1 44.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 55.23 109.658 175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.4 tpt -67.35 -18.85 65.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.476 . . . . 73.15 111.454 -174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.31 17.45 20.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.099 -0.5 . . . . 74.23 110.639 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 68.81 84.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.406 0.682 . . . . 74.41 111.373 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 41.1 mtmt -152.57 131.94 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 51.15 109.371 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 56' ' ' MET . 3.4 mp0 -89.06 127.74 35.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.737 0.303 . . . . 74.43 110.738 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 74.5 m95 -125.25 117.73 24.45 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.555 -0.535 . . . . 70.22 109.555 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.707 ' HG2' HG22 ' A' ' 28' ' ' ILE . 22.0 mtmm -78.75 130.75 36.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.572 -0.451 . . . . 75.42 109.88 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.62 HG23 ' CD2' ' A' ' 52' ' ' TYR . 3.2 p -67.38 117.5 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.166 -0.47 . . . . 63.02 110.431 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -90.51 -128.93 3.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.845 -0.693 . . . . 50.32 111.841 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.4 mt -86.81 137.62 33.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.721 -0.282 . . . . 70.23 111.049 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.71 102.69 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.824 2.349 . . . . 51.31 110.331 171.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mt -86.98 -70.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.903 -0.589 . . . . 74.11 110.697 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 112.25 165.7 17.3 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.667 -0.778 . . . . 72.54 111.78 -176.063 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.893 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 2.2 tt0 -131.91 166.17 22.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.41 -0.589 . . . . 54.14 109.41 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' OD2' ' A' ' 137' ' ' ASP . . . -82.82 42.61 2.98 Favored Glycine 0 C--O 1.232 -0.026 0 C-N-CA 121.511 -0.376 . . . . 62.31 112.959 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 352' ' ' LYS . . . 179.11 -75.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 109.999 -1.241 . . . . 61.42 109.999 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.512 ' HZ ' ' HA ' ' A' ' 353' ' ' THR . 24.1 m-85 -96.64 83.45 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 62.53 109.586 168.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.893 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -68.95 -158.38 1.5 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.901 -0.59 . . . . 74.35 113.608 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 72.2 m 70.77 30.99 2.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.296 0.569 . . . . 70.4 110.806 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 45' ' ' GLN . 4.2 mm -93.88 122.0 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.307 -0.627 . . . . 74.53 109.307 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.764 ' HE1' ' HB ' ' A' ' 72' ' ' VAL . 28.3 p90 -108.2 150.43 27.26 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.154 -0.618 . . . . 72.51 110.879 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.9 tt -68.97 134.17 49.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.363 -0.835 . . . . 75.23 110.512 -176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 70' ' ' VAL . . . -95.68 102.92 14.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.083 -0.508 . . . . 64.03 109.959 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.37 -35.9 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 71.51 111.251 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.823 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 13.9 tmm? 66.17 -73.92 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.236 -0.654 . . . . 62.12 109.236 -172.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.14 140.71 13.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.931 -0.766 . . . . 63.15 108.931 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -81.72 49.6 1.37 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.359 0.6 . . . . 44.34 110.624 -173.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 75.43 109.951 -179.87 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.263 -0.643 . . . . 72.52 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.29 32.18 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.293 2.662 . . . . 74.33 113.593 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.2 p -127.52 136.69 52.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.529 0.681 . . . . 63.44 111.226 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 m -141.99 162.38 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.343 -0.844 . . . . 71.31 109.282 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -132.78 126.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.676 0.75 . . . . 51.12 111.421 -179.057 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 48' ' ' PHE . 60.8 tttm -87.5 127.22 35.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.702 -1.136 . . . . 75.43 109.171 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.764 ' HB ' ' HE1' ' A' ' 52' ' ' TYR . 11.9 p -116.42 135.6 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.014 0.435 . . . . 55.4 111.573 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 49.2 mm-40 -142.36 143.4 26.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.524 -0.762 . . . . 74.31 109.072 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 77' ' ' ASN . 37.6 Cg_exo -60.49 133.01 46.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.52 1.48 . . . . 75.32 109.978 170.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -60.09 -30.39 69.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.788 0.328 . . . . 75.32 110.896 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.74 24.22 10.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 63.54 111.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 74' ' ' PRO . 63.3 t30 -85.98 -50.19 7.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.913 0.387 . . . . 73.0 110.223 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.85 -77.67 0.24 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.378 -0.915 . . . . 52.15 113.65 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.95 -43.31 59.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.268 2.645 . . . . 34.34 114.295 -169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.01 -29.93 67.62 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 111.957 0.354 . . . . 73.44 111.957 -171.882 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -66.02 -50.76 63.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.429 -0.508 . . . . 73.41 110.504 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 m -69.06 -40.18 78.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.489 0.662 . . . . 71.45 110.005 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.73 -53.71 54.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.803 -1.089 . . . . 72.13 111.074 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 80' ' ' LEU . 51.7 tp -66.24 -33.03 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 72.52 111.074 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.474 ' HE3' ' OH ' ' A' ' 173' ' ' TYR . 64.8 tttp -60.01 -47.34 86.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.011 0.434 . . . . 75.14 110.096 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 173' ' ' TYR . 59.0 t80 -71.19 -41.62 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.361 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -57.32 -50.23 73.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 63.43 110.838 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -24.41 63.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.109 0.48 . . . . 74.1 110.533 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -69.7 -39.16 77.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 71.24 111.597 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.44 -34.09 7.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.228 0.825 . . . . 75.22 113.228 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 113' ' ' TYR . . . -85.77 100.39 12.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.548 0.689 . . . . 73.14 111.819 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -166.75 100.41 0.66 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.388 -0.968 . . . . 71.24 108.388 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -43.07 -45.33 9.43 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.78 2.987 . . . . 74.35 114.042 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.74 -49.68 74.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.36 -0.382 . . . . 74.32 110.959 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.47 -38.74 87.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.621 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 100' ' ' ILE . 81.0 mt -58.13 -53.29 47.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.727 -0.669 . . . . 74.34 110.879 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -62.1 -40.78 97.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.515 -0.311 . . . . 74.52 111.248 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -57.06 -48.98 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.341 -0.39 . . . . 64.24 110.877 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.565 ' CE2' ' HG3' ' A' ' 103' ' ' ARG . 66.0 t-105 -65.24 -49.01 71.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 74.33 110.711 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 96' ' ' ILE . 94.4 mt -53.52 -51.29 43.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.137 0.494 . . . . 75.4 111.519 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -73.72 -31.21 63.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.51 -0.768 . . . . 73.42 111.226 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.3 m -76.17 -40.09 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.02 0.438 . . . . 54.14 111.238 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 11.1 mmm180 -91.8 10.0 30.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 72.55 111.915 -173.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.7 mmpt? 63.58 27.25 14.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 74.3 111.617 173.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 163' ' ' ASP . 97.7 mt -89.11 178.36 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.977 0.418 . . . . 65.23 111.438 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -83.32 -66.95 0.83 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.964 -0.754 . . . . 73.13 108.964 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HA ' ' CD1' ' A' ' 100' ' ' ILE . 18.7 p90 179.87 133.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.728 -1.124 . . . . 74.32 109.541 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -78.74 116.14 18.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.54 -0.541 . . . . 74.3 109.54 177.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.93 72.19 1.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.749 -0.659 . . . . 74.42 112.904 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 111' ' ' PRO . 67.4 t -101.99 140.33 21.09 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.755 -0.831 . . . . 64.54 108.755 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 110' ' ' VAL . 1.3 Cg_endo -44.88 134.33 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.199 2.599 . . . . 73.11 112.443 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 21.4 tptm -65.4 106.23 1.34 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 73.11 110.693 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 35.1 t80 -79.85 113.8 18.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.726 -1.125 . . . . 74.4 111.184 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 130' ' ' ILE . 15.0 m95 -97.94 -36.23 10.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.467 -0.938 . . . . 75.33 108.467 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.49 178.25 48.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.724 -1.125 . . . . 64.43 111.115 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 32' ' ' MET . 14.9 p -172.68 165.42 5.42 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.481 -0.563 . . . . 71.4 109.481 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.09 -173.81 46.09 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.92 -1.134 . . . . 53.34 113.103 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.8 tt -134.93 128.68 32.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.44 -0.948 . . . . 75.31 108.44 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -140.89 125.62 18.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 73.55 110.566 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.24 123.92 26.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 64.34 110.098 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -87.93 -56.97 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.222 -0.444 . . . . 70.32 110.277 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.05 79.93 0.77 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.288 -0.634 . . . . 73.35 109.288 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.19 33.52 85.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.169 -0.773 . . . . 73.4 111.169 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.449 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 13.6 tppt? -158.91 105.0 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.498 -0.556 . . . . 74.53 109.498 -174.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.491 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.3 m -78.85 108.73 12.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.038 0.447 . . . . 64.15 111.07 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -92.05 131.75 37.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.053 -0.521 . . . . 73.43 110.555 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.466 ' HE ' HD23 ' A' ' 84' ' ' LEU . 10.0 ttt180 -113.24 117.15 31.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.507 -0.923 . . . . 72.54 108.507 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HZ ' ' O ' ' A' ' 30' ' ' THR . 49.0 p90 -133.44 161.62 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.068 0.461 . . . . 73.22 112.057 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.4 ptp -139.46 141.65 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 53.43 110.55 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.779 HD13 ' HB ' ' A' ' 70' ' ' VAL . 11.2 mm -98.31 118.56 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.142 0.496 . . . . 63.32 110.312 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 21.6 ptm -127.72 163.68 23.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.674 -0.694 . . . . 71.25 110.509 -175.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.89 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.9 t70 -70.35 156.85 38.75 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.718 -0.475 . . . . 71.52 109.718 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 133' ' ' ARG . 22.3 tpt180 -82.81 108.52 16.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.388 0.614 . . . . 74.44 111.31 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 17.0 m-85 -103.26 142.27 34.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.062 -1.088 . . . . 75.41 108.062 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.29 -4.38 3.23 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 119.583 -1.294 . . . . 65.54 113.453 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.928 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.4 m -120.59 124.49 45.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.844 0.354 . . . . 75.34 110.295 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.828 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 3.9 m-20 -90.53 134.99 33.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.022 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 36.9 tp -61.83 -36.61 81.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.951 -0.759 . . . . 64.24 108.951 172.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.828 ' HG3' ' HB3' ' A' ' 137' ' ' ASP . 1.4 pp0? -64.64 -28.15 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 72.34 111.547 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 58.2 mttp -72.52 -39.82 67.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.837 -0.345 . . . . 71.04 110.629 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.28 -36.9 44.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.515 0.674 . . . . 74.54 109.337 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 139' ' ' GLN . 28.6 t80 -55.19 -54.27 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.738 -1.119 . . . . 74.4 111.202 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.97 -33.87 61.94 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.755 -0.378 . . . . 61.31 111.235 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.79 -32.76 72.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.945 0.35 . . . . 60.54 111.945 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -105.1 8.68 34.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 75.42 110.614 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.11 48.52 17.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.805 -0.634 . . . . 75.1 111.319 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.699 ' HG3' HE22 ' A' ' 253' ' ' GLN . 0.0 OUTLIER 43.67 77.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.818 1.247 . . . . 71.14 113.749 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.63 102.97 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.751 -0.659 . . . . 74.23 109.269 168.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.691 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 65.9 m-85 -108.76 156.1 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.996 -0.547 . . . . 70.13 109.884 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -70.59 156.88 38.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.319 -0.4 . . . . 74.01 110.585 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.6 ' HG2' HD13 ' A' ' 331' ' ' ILE . 25.0 tpt180 -45.99 -57.28 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.547 -0.752 . . . . 73.35 112.144 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -67.27 -28.1 67.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 75.0 111.514 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 m -70.94 -45.19 64.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.442 -0.345 . . . . 61.02 110.571 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.84 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 53.43 110.585 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 324' ' ' LEU . 0.2 OUTLIER -65.02 -42.87 93.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 72.52 110.325 -178.986 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -55.21 -52.57 62.93 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.773 -0.454 . . . . 72.43 109.773 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.24 -50.65 73.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.936 -0.575 . . . . 65.24 111.125 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.452 ' HA ' HD12 ' A' ' 161' ' ' ILE . 32.1 t -57.93 -38.05 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 55.35 111.241 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.81 -40.86 75.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.856 -0.424 . . . . 64.21 109.856 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.593 ' HA ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -67.42 -31.4 71.58 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.787 0.803 . . . . 63.22 110.307 -178.916 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 158' ' ' SER . 58.4 mt -67.92 -35.14 71.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.591 -0.731 . . . . 71.15 109.695 174.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 43.4 tp -63.84 -40.48 96.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 55.22 110.088 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.593 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.4 m-20 -53.34 -59.52 4.47 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.491 0.663 . . . . 65.13 110.895 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -67.11 -37.35 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.856 -0.611 . . . . 65.01 111.101 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.66 -37.94 89.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.72 0.295 . . . . 74.2 110.296 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -56.09 -58.81 6.34 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.87 -0.605 . . . . 74.12 109.46 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.5 -48.98 73.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.859 -1.064 . . . . 74.22 112.572 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 164' ' ' ILE . 39.7 pt -84.19 -36.52 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.605 0.594 . . . . 63.23 112.605 -170.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -82.34 -26.17 33.21 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 71.35 112.144 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.37 -18.46 64.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.75 -0.78 . . . . 65.21 110.048 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.9 -74.75 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 70.22 112.346 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -135.86 -68.71 0.5 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.145 0.794 . . . . 74.52 113.145 -167.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 79.6 m-85 -84.99 167.26 16.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.488 0.922 . . . . 72.32 113.488 -161.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 238' ' ' PRO . 27.4 m -142.21 172.18 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.065 -1.425 . . . . 71.13 109.48 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -158.64 96.21 1.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.612 -0.514 . . . . 72.43 109.612 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -67.49 -33.61 82.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.116 -0.564 . . . . 74.52 112.389 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.544 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 20.6 t70 -74.57 91.56 2.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.141 0.496 . . . . 74.34 111.315 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.04 67.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.038 0.923 . . . . 70.5 108.955 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.432 ' HZ2' ' HB2' ' A' ' 179' ' ' LYS . 3.7 ttmp? -88.27 139.14 30.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.99 -1.005 . . . . 60.42 109.222 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -56.17 -16.68 5.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.314 0.487 . . . . 75.13 112.314 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' A' ' 139' ' ' GLN . 29.8 t -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.331 -0.395 . . . . 72.11 111.431 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' O ' HD12 ' A' ' 195' ' ' LEU . 84.5 m-20 -92.21 -11.74 34.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.724 0.297 . . . . 75.42 111.584 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 184' ' ' LEU . 6.4 mp -100.49 119.47 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 74.5 110.493 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.4 mm? -119.03 140.59 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.682 -0.69 . . . . 73.43 110.61 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 69.2 mt -97.87 142.82 29.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.989 -0.55 . . . . 74.11 110.339 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.642 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -61.48 136.75 58.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.981 -0.554 . . . . 75.53 110.042 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -56.17 -31.27 63.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.832 0.348 . . . . 62.22 111.627 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.7 ' HA ' ' HE3' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -90.97 -22.58 20.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.959 0.355 . . . . 64.32 111.959 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -138.42 110.21 8.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 111.888 0.329 . . . . 64.41 111.888 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.57 -12.94 32.14 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.73 2.286 . . . . 73.32 111.252 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -90.49 7.39 39.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.369 -0.832 . . . . 44.1 111.153 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 16.7 mm-40 -121.84 106.78 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.431 . . . . 62.13 110.76 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.2 122.11 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 75.33 110.813 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -114.75 157.44 23.2 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.866 -0.606 . . . . 75.24 109.922 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 182' ' ' ASN . 34.1 tp -107.53 103.3 12.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.222 -0.658 . . . . 73.05 109.222 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 184' ' ' LEU . 32.7 m -120.77 -167.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.497 -0.319 . . . . 62.14 110.487 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.2 m-20 70.66 -62.13 0.45 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.816 0.698 . . . . 63.53 110.674 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 60.98 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 74.02 111.654 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 354' ' ' ILE . . . 68.46 -68.34 0.39 Allowed Glycine 0 N--CA 1.447 -0.63 0 O-C-N 123.415 0.447 . . . . 74.54 112.088 -174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 353' ' ' THR . 2.4 mp -88.26 81.07 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.856 0.36 . . . . 73.42 110.145 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.73 98.02 5.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.144 0.497 . . . . 73.34 110.01 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -164.11 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.365 -0.976 . . . . 73.54 108.365 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 9.3 ptp180 -137.75 150.62 47.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.559 -0.456 . . . . 62.34 111.426 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -83.1 -36.74 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.583 -0.735 . . . . 75.41 110.412 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 6.6 p -134.82 129.64 19.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.198 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 9.9 Cg_exo -71.49 100.71 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.943 2.429 . . . . 65.03 111.094 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 71.06 -62.57 0.45 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.456 0.702 . . . . 73.21 112.053 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.7 -36.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.791 . . . . 74.22 112.963 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 26.6 m -60.87 132.4 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.443 . . . . 71.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.32 138.16 37.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.136 -0.483 . . . . 73.23 109.857 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 211' ' ' LYS . 12.6 tptm -108.33 172.63 6.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.131 0.491 . . . . 75.15 112.311 -167.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -90.96 174.19 7.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.505 -0.771 . . . . 70.21 111.019 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -73.19 6.27 2.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.972 0.731 . . . . 73.4 112.972 -168.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -166.5 96.78 0.57 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.71 -0.619 . . . . 71.3 110.633 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.455 ' OE1' ' HG2' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -136.24 -4.14 2.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.377 -0.829 . . . . 64.43 110.859 178.238 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 217' ' ' PRO . 10.6 t70 -79.05 148.01 70.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.823 -0.626 . . . . 65.13 110.774 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 216' ' ' ASP . 69.6 Cg_exo . . . . . 0 N--CA 1.481 0.758 0 C-N-CA 124.32 3.347 . . . . 60.13 114.928 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 121.595 0.712 . . . . 72.55 111.785 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . 110.52 174.82 20.49 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.723 -0.751 . . . . 61.34 112.459 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.39 141.63 43.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.669 0.271 . . . . 70.01 110.622 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 271' ' ' VAL . 15.4 tt -58.36 -17.06 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.355 0.598 . . . . 73.35 111.323 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -50.49 -55.52 15.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.921 -1.036 . . . . 74.31 111.603 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.577 ' O ' HG12 ' A' ' 246' ' ' ILE . 38.9 m-85 -111.24 -28.11 8.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.071 0.767 . . . . 70.15 113.071 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.8 t -64.98 -6.4 8.44 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.758 0.651 . . . . 71.54 112.758 -169.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.781 ' HA ' ' HE2' ' A' ' 275' ' ' LYS . 23.0 t 65.0 -169.85 0.2 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.138 0.494 . . . . 73.35 111.393 176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 234' ' ' ASN . 15.3 pt -73.34 -34.35 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.795 -0.639 . . . . 73.31 111.684 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' O ' HG12 ' A' ' 236' ' ' VAL . 11.7 t70 -53.82 -74.88 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.827 -170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.78 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 70.44 111.616 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -62.7 -27.53 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.603 -0.271 . . . . 70.15 111.62 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 0.0 OUTLIER -78.41 -28.81 46.93 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.859 0.318 . . . . 54.4 111.859 -175.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 216' ' ' ASP . . . 112.37 45.65 0.78 Allowed Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.346 -0.931 . . . . 63.55 112.848 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 231' ' ' ASP . 15.0 p -123.44 143.27 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.0 -0.741 . . . . 72.32 109.0 171.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -53.25 110.72 2.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.676 -0.861 . . . . 73.34 108.676 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.507 ' HG2' HG21 ' A' ' 174' ' ' VAL . 69.6 Cg_exo -41.97 115.18 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.772 2.981 . . . . 75.54 113.561 -169.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 93.9 p -90.83 -175.54 4.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.248 -0.887 . . . . 71.35 111.163 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.878 ' HG2' ' HB3' ' A' ' 315' ' ' PRO . 9.8 mtm-85 -53.94 -36.69 63.06 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.534 -0.757 . . . . 71.25 111.248 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.481 HH22 ' HD2' ' A' ' 279' ' ' ARG . 12.3 mtp180 -66.27 -33.56 76.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.797 -0.638 . . . . 75.4 110.498 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.41 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -57.43 -65.1 3.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.881 -0.676 . . . . 70.3 111.84 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.16 -48.1 71.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.34 0.59 . . . . 70.2 110.758 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.678 ' HG ' HD21 ' A' ' 320' ' ' LEU . 9.2 mp -67.95 -46.02 72.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.169 -0.923 . . . . 75.22 112.045 -173.496 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -64.43 -47.08 80.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.611 -0.435 . . . . 70.44 110.789 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 227' ' ' PHE . 76.0 mt -61.45 -40.11 85.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.347 -0.388 . . . . 65.53 111.425 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 251' ' ' MET . 37.9 tp -64.23 -45.12 89.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 75.53 110.217 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.64 95.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.906 -0.664 . . . . 74.23 112.081 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 14.8 m-30 -56.26 -45.84 79.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.782 0.325 . . . . 73.04 110.812 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.82 -35.22 78.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 73.14 110.892 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 83.8 mtp -59.47 -54.54 45.47 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.737 0.303 . . . . 75.25 110.988 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.6 tt -67.8 -32.06 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 74.53 110.45 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.699 HE22 ' HG3' ' A' ' 147' ' ' LYS . 9.5 tm0? -61.58 -53.59 54.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 74.22 110.364 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.691 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.8 m0 -69.45 -26.42 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 75.3 111.662 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.547 HD11 HD21 ' A' ' 294' ' ' ASN . 33.4 tp -83.87 -36.22 23.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.203 0.446 . . . . 74.13 112.203 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.5 p -103.49 -27.4 12.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.688 -0.405 . . . . 61.21 112.058 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 98.79 -1.35 58.09 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.429 -0.891 . . . . 63.0 113.272 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -148.12 163.16 37.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.178 0.513 . . . . 74.04 111.691 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.664 ' HG ' ' HG2' ' A' ' 253' ' ' GLN . 60.2 mt -111.87 142.48 26.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.649 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.47 -25.68 59.38 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.615 2.21 . . . . 64.52 112.601 177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.446 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 48.0 p90 -111.65 18.94 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.353 -0.385 . . . . 73.43 110.771 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 35.3 tt0 -66.03 -44.5 84.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.551 . . . . 72.21 110.467 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.96 -6.72 55.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.97 0.891 . . . . 70.23 109.552 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 5.9 m-20 -104.62 0.8 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.097 -0.956 . . . . 74.22 111.227 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 261' ' ' TRP . 80.5 mt -71.33 -6.9 43.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.12 0.486 . . . . 55.23 110.885 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -60.91 -33.4 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.483 -0.781 . . . . 44.24 111.332 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.734 ' HB2' ' CD1' ' A' ' 270' ' ' TYR . 7.8 m-20 -145.33 145.82 27.89 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-O 120.541 0.21 . . . . 34.14 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 25.3 Cg_endo -62.92 -28.09 75.09 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.61 2.207 . . . . 53.31 112.002 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -42.49 96.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.202 0.525 . . . . 73.13 109.719 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.734 ' CD1' ' HB2' ' A' ' 267' ' ' ASP . 9.5 m-85 -66.67 -45.33 79.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.554 -0.748 . . . . 74.31 111.31 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 225' ' ' ILE . 20.3 m -65.03 -29.16 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.535 -0.302 . . . . 60.25 111.225 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 33.7 mtm180 -60.62 -58.61 7.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.096 -0.705 . . . . 75.32 109.096 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -52.26 -50.55 61.87 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.859 -1.064 . . . . 63.42 111.018 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 50.3 m -59.6 -50.33 74.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 72.13 111.463 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 59.7 mttp -66.36 -44.49 83.06 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.879 -0.329 . . . . 74.42 111.376 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.5 -48.34 85.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 120.812 0.339 . . . . 74.53 110.935 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -54.71 -50.09 69.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 74.21 110.776 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -74.21 -39.07 63.38 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.481 ' HD2' HH22 ' A' ' 241' ' ' ARG . 52.2 ttp180 -50.44 -40.34 50.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.542 0.337 . . . . 72.24 111.792 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -70.28 -36.15 74.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.297 0.48 . . . . 75.51 112.297 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -129.19 38.57 3.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.795 0.331 . . . . 74.12 111.663 -170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.91 -50.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 113.115 0.783 . . . . 45.32 113.115 -176.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.538 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.07 -47.77 82.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 73.02 112.149 -172.387 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -68.25 -44.4 75.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.011 0.434 . . . . 73.22 111.204 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 285' ' ' LEU . 4.3 mm? -67.25 -50.98 58.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 72.35 111.431 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -60.87 -40.54 93.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 71.3 111.193 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.64 -42.31 98.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 74.14 111.23 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -81.8 -15.72 53.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.614 -0.266 . . . . 74.4 111.674 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.6 m -72.89 -28.08 62.27 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.29 -0.256 . . . . 64.51 111.217 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 294' ' ' ASN . 3.9 t80 -128.69 86.63 57.06 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 71.21 110.518 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -94.91 24.93 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.389 2.726 . . . . 62.41 113.011 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 293' ' ' LYS . 8.1 tt0 -100.38 -166.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.376 -0.602 . . . . 71.51 109.376 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 31.0 mmtp -81.29 62.44 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.457 0.646 . . . . 64.32 111.583 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 255' ' ' LEU . 38.7 t-20 -157.11 128.91 7.1 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.368 -1.345 . . . . 73.51 107.368 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -100.87 106.08 41.94 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.176 -0.209 . . . . 75.01 111.305 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 93.6 Cg_endo -93.6 38.17 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.899 2.399 . . . . 74.55 111.967 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -73.39 -42.34 42.06 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.077 -0.582 . . . . 72.44 111.972 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.3 pm0 -66.44 -35.84 81.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.19 . . . . 64.54 110.527 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.451 HG13 ' OE2' ' A' ' 298' ' ' GLU . 44.3 mt -67.79 -46.96 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 62.12 110.509 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.67 -39.91 90.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 63.2 110.537 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.525 ' HD3' HD11 ' A' ' 323' ' ' ILE . 85.3 tttt -80.58 -28.79 37.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 74.5 110.785 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 33.2 t80 -55.71 -50.2 70.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.207 0.527 . . . . 73.55 109.897 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 306' ' ' VAL . 95.2 mmm -70.54 -34.57 72.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.598 -0.728 . . . . 72.21 110.711 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HA ' HD11 ' A' ' 282' ' ' ILE . 0.3 OUTLIER -61.67 -42.2 98.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.808 0.813 . . . . 65.33 109.384 175.477 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 59.9 m -61.81 -51.38 68.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.927 -1.033 . . . . 33.44 111.488 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 16.3 m -67.75 -27.85 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.494 -0.321 . . . . 73.45 111.582 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -25.54 33.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.871 0.367 . . . . 65.02 110.212 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 27.5 tp -86.96 -16.01 37.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 75.23 111.036 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 305' ' ' THR . 80.0 mt -68.97 -101.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.499 -0.319 . . . . 75.32 111.06 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 313' ' ' GLU . 24.3 t70 166.82 164.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.994 -0.743 . . . . 73.54 108.994 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.5 -37.04 85.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.976 0.417 . . . . 75.31 110.576 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.473 ' HA ' ' NH2' ' A' ' 240' ' ' ARG . 0.2 OUTLIER -105.99 -26.27 11.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.015 -0.539 . . . . 54.3 112.336 -171.765 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 310' ' ' ASP . 5.3 tp10 -92.83 112.51 24.5 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.277 0.843 . . . . 72.2 113.277 -168.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.525 ' HG2' ' OE1' ' A' ' 313' ' ' GLU . 39.8 mmtm 68.42 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 115.529 1.677 . . . . 73.35 115.529 162.013 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.878 ' HB3' ' HG2' ' A' ' 240' ' ' ARG . 94.7 Cg_endo -93.6 116.78 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.101 1.867 . . . . 71.32 109.02 156.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.579 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.1 tp -126.04 98.48 5.52 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.125 -0.63 . . . . 61.02 111.111 -171.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.418 ' HD1' HD11 ' A' ' 162' ' ' LEU . 74.6 m-85 -64.63 -35.45 81.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.75 . . . . 70.32 110.735 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.36 -42.96 82.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.684 0.624 . . . . 75.23 112.684 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.579 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 26.5 t-20 -60.64 -43.72 97.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.109 0.48 . . . . 61.11 109.795 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.678 HD21 ' HG ' ' A' ' 244' ' ' LEU . 6.7 mp -69.11 -42.2 76.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.393 -0.821 . . . . 63.23 110.189 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -58.62 -49.48 77.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 73.34 110.347 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.25 -29.19 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 70.3 110.285 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.525 HD11 ' HD3' ' A' ' 301' ' ' LYS . 0.3 OUTLIER -63.91 -43.16 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 72.11 110.186 176.364 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 87.9 mt -70.11 -45.93 65.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 62.54 111.095 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 328' ' ' LEU . 4.5 mm? -64.28 -32.75 74.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.666 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -61.82 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.241 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -63.38 -33.26 86.75 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.888 -0.597 . . . . 75.01 112.217 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 325' ' ' LEU . 96.6 mt -69.82 -44.15 70.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.087 0.47 . . . . 73.24 110.263 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.56 -27.3 69.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 74.54 111.187 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.0 73.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.11 111.615 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.6 HD13 ' HG2' ' A' ' 151' ' ' ARG . 48.4 pt -97.04 -2.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 70.03 111.181 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.613 -0.803 . . . . 55.1 113.587 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.8 m -138.37 170.53 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.151 0.476 . . . . 64.01 110.553 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.491 ' O ' HD13 ' A' ' 328' ' ' LEU . 96.2 mttt -124.99 -85.64 0.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.024 -0.362 . . . . 71.35 110.024 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -127.12 150.73 49.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.59 -0.522 . . . . 73.52 109.59 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.01 -20.56 28.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.932 0.396 . . . . 52.24 110.672 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 92.4 -6.33 77.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.93 -0.652 . . . . 73.13 112.235 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 109.81 -0.441 . . . . 70.42 109.81 -178.322 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.4 ' HE3' ' HA3' ' A' ' 47' ' ' GLY . 17.8 ptpt . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 109.979 -0.378 . . . . 63.41 109.979 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 13.5 t -176.01 164.18 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.056 -0.35 . . . . 53.5 110.056 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -67.14 142.02 17.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.885 0.374 . . . . 63.52 111.069 -176.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 6.2 t -94.78 76.0 3.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.85 0.833 . . . . 71.42 110.587 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 15.5 ptmt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 74.04 110.248 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.621 0.248 . . . . 72.43 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.6 1.56 57.65 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.983 -0.627 . . . . 42.13 112.47 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 39' ' ' VAL . 14.6 pt-20 -71.79 139.02 48.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.974 0.416 . . . . 74.31 109.982 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 38' ' ' LYS . 46.8 mm -88.34 116.18 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.434 -0.803 . . . . 63.31 110.342 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 33.5 pt -106.39 147.21 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.923 -0.581 . . . . 60.22 110.851 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.5 m -109.53 127.04 54.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.4 -0.818 . . . . 73.33 109.129 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 1.8 p-10 -131.26 -163.18 1.29 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.777 -0.369 . . . . 72.04 111.396 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.8 mmt -63.23 -24.05 67.7 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.392 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . . . -81.02 21.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 53.44 109.947 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 38.9 mmtm 89.81 -38.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.763 1.225 . . . . 75.24 113.427 166.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.658 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 52.9 pttt 160.36 166.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.974 0.731 . . . . 71.2 112.974 -172.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.658 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 40.2 mt-10 73.85 50.57 0.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.967 1.469 . . . . 75.05 114.967 159.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.584 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 75.7 m95 -106.18 141.31 37.75 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 163.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 23.1 pttp -114.27 120.06 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.913 -0.773 . . . . 60.22 108.913 172.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 27' ' ' GLU . 15.0 p -75.53 145.54 10.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.26 -0.427 . . . . 70.31 111.293 -172.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.48 -148.63 23.81 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.948 -0.569 . . . . 60.02 112.444 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.4 153.3 81.67 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.578 0.227 . . . . 71.0 111.176 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.61 135.6 24.29 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.11 2.54 . . . . 75.13 111.748 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 53' ' ' LEU . 60.3 mt -108.48 -58.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.016 0.436 . . . . 74.15 110.33 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 161.58 37.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.868 -0.682 . . . . 73.31 112.38 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.72 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 33.2 tt0 -139.51 159.95 40.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.587 -0.524 . . . . 71.12 109.587 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 45' ' ' GLN . . . -76.05 -34.06 48.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.001 -0.618 . . . . 70.34 112.033 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.28 -85.04 0.79 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.983 -0.847 . . . . 73.21 110.983 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 197' ' ' ASP . 31.6 m-85 -98.55 94.17 6.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.329 -0.619 . . . . 64.24 109.329 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.72 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -73.26 -162.04 6.95 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.05 -0.523 . . . . 65.42 113.56 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.92 31.82 13.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.371 0.605 . . . . 72.12 111.15 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LYS . 37.9 mm -88.82 134.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.818 -0.628 . . . . 74.25 109.829 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -107.8 159.16 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.774 0.321 . . . . 53.53 110.625 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 69' ' ' VAL . 37.3 tp -81.65 133.38 35.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.463 -0.569 . . . . 73.44 109.463 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 69' ' ' VAL . . . -98.01 103.13 15.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.984 0.421 . . . . 24.45 110.503 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 6.8 t70 -96.32 -175.57 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.541 -0.911 . . . . 72.14 108.541 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 37' ' ' TRP . 71.7 mtm -136.74 152.55 50.47 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.175 -0.328 . . . . 63.13 110.875 -171.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -125.69 -60.5 1.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.556 -0.293 . . . . 74.12 110.42 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -120.16 38.67 3.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.115 0.483 . . . . 73.42 110.498 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.305 -0.628 . . . . 55.32 109.305 176.288 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 133' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.366 -0.975 . . . . 51.13 108.366 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.61 9.54 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.259 1.973 . . . . 61.43 112.462 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.1 p -162.01 151.38 15.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.554 0.692 . . . . 72.34 112.668 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 53' ' ' LEU . 35.8 m -127.09 165.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.207 -1.034 . . . . 54.23 108.207 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.27 120.45 51.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.409 0.623 . . . . 65.02 111.574 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 51' ' ' ILE . 1.9 ttmp? -79.71 119.0 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 72.21 108.877 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.37 120.14 61.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.763 0.316 . . . . 75.34 110.515 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -136.52 156.9 76.13 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.336 -0.616 . . . . 65.43 109.336 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.12 147.01 92.47 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.921 1.748 . . . . 75.21 110.978 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 66.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.095 0.474 . . . . 74.52 110.097 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -151.99 -40.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 63.41 110.708 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.542 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 65.7 t30 -63.91 123.49 19.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.008 -0.542 . . . . 74.21 111.878 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.26 -54.07 36.61 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.643 -0.708 . . . . 63.42 113.829 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.542 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 91.3 Cg_exo -46.95 -37.93 22.88 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.082 2.521 . . . . 74.13 113.344 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.35 -50.97 71.93 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -60.31 -40.26 89.92 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.571 0.701 . . . . 70.54 110.701 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.1 m -71.34 -47.09 58.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 71.24 111.579 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.53 -36.18 78.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.797 -0.446 . . . . 65.14 109.797 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.86 -38.43 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 54.41 110.58 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HA ' ' HG3' ' A' ' 88' ' ' GLN . 6.1 ttpp -70.54 -31.54 68.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.864 0.364 . . . . 64.41 110.425 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.43 -32.55 71.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.869 -0.332 . . . . 73.53 110.584 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -65.88 -50.1 65.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 65.02 110.403 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -68.31 -16.05 63.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.677 0.275 . . . . 72.14 111.098 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.54 -68.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.947 0.351 . . . . 72.24 111.947 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.47 -34.41 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.011 0.745 . . . . 72.25 113.011 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.92 88.66 4.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.667 0.746 . . . . 45.03 110.583 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 4.7 ttmp? -168.96 129.82 1.05 Allowed Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.04 -0.982 . . . . 65.24 109.452 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.44 -51.47 7.9 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.331 2.687 . . . . 64.55 113.397 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 34.4 mt-10 -63.74 -45.06 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 111.901 0.334 . . . . 74.11 111.901 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' HG2' ' HD2' ' A' ' 92' ' ' LYS . 33.1 mm-40 -62.94 -47.91 81.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.682 0.277 . . . . 72.32 110.908 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 100' ' ' ILE . 69.8 mt -59.27 -47.47 90.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 73.43 110.0 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -54.81 -47.7 73.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.194 -0.912 . . . . 64.4 111.115 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 58.3 mtpt -61.81 -46.2 90.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.56 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 108' ' ' LEU . 44.7 t90 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.822 -0.351 . . . . 63.03 110.82 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 96' ' ' ILE . 30.5 mm -60.5 -37.94 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 64.13 111.357 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -75.96 -34.3 59.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.42 -0.355 . . . . 72.34 111.459 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.9 m -76.85 -48.68 17.71 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.898 0.38 . . . . 71.22 111.516 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 103' ' ' ARG . 5.6 tpm_? -76.64 -18.87 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.286 -0.416 . . . . 75.33 110.609 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? 64.74 78.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.822 0.82 . . . . 74.1 109.971 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.0 mt -138.64 -167.96 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.117 -0.947 . . . . 64.32 109.845 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -106.38 -50.86 3.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.777 -0.369 . . . . 75.41 110.964 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -153.4 146.76 24.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.681 0.277 . . . . 63.42 110.416 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 99' ' ' TRP . 46.4 tp -97.95 133.59 42.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 64.11 110.428 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.7 58.54 4.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 30.33 112.492 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -111.33 137.55 21.09 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.251 -0.648 . . . . 74.02 109.251 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' ' CD2' ' A' ' 194' ' ' TYR . 7.9 Cg_endo -50.5 134.5 39.42 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.564 2.176 . . . . 40.04 112.782 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.996 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.8 tptm -73.66 126.97 31.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 73.21 110.331 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.46 134.18 55.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.697 -0.683 . . . . 73.42 110.245 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CD1' HG22 ' A' ' 130' ' ' ILE . 40.0 m95 -107.27 -75.16 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.418 0.627 . . . . 73.13 110.055 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.48 -168.18 12.02 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.281 -0.872 . . . . 41.34 111.458 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' MET . 66.6 p -175.32 173.01 2.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.184 -0.302 . . . . 71.5 110.184 -175.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.07 -170.54 42.55 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.81 -0.71 . . . . 72.0 112.226 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.449 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -122.0 132.17 54.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.181 -0.674 . . . . 63.14 109.181 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -148.65 123.19 9.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.636 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.82 145.36 52.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.708 -0.849 . . . . 71.23 108.708 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -143.82 18.42 1.81 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.126 -0.629 . . . . 74.13 112.151 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -179.67 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.179 0.514 . . . . 71.43 111.616 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.44 14.91 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.91 -1.676 . . . . 60.32 108.91 -166.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 1.4 tpmt? -146.09 124.97 12.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.807 -1.197 . . . . 74.32 108.279 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 118' ' ' LEU . 18.4 m -75.63 105.1 6.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.91 0.386 . . . . 70.4 110.372 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.38 144.75 25.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.075 -0.511 . . . . 73.42 109.671 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -113.34 125.7 54.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.106 -1.072 . . . . 73.33 108.106 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -121.12 148.41 44.24 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.159 0.504 . . . . 70.33 111.064 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.26 134.83 40.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.226 -0.897 . . . . 71.23 109.304 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.505 HG22 ' CD1' ' A' ' 114' ' ' TRP . 19.1 mt -96.73 123.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.32 0.581 . . . . 74.41 110.137 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 11.8 ptm -128.67 -179.16 4.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.84 -1.073 . . . . 72.34 110.417 -172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.996 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 31.6 t70 -68.92 156.19 38.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.36 . . . . 53.14 111.346 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.595 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 2.4 tmt_? -89.32 106.94 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 71.04 110.732 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 132' ' ' ASP . 19.2 m-85 -102.21 172.24 7.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.689 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.45 -37.5 0.02 OUTLIER Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.693 -0.765 . . . . 62.0 112.706 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.7 m -121.55 142.07 50.44 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.809 -0.23 . . . . 74.43 111.036 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -124.65 176.69 6.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.642 0.258 . . . . 52.32 110.807 176.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 183' ' ' LEU . 5.3 mp -77.63 -27.9 51.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.346 0.499 . . . . 73.22 112.346 -177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 181' ' ' SER . 23.5 tt0 -75.39 -34.41 61.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.57 -0.452 . . . . 74.25 111.274 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.6 tptt -68.7 -38.43 80.29 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 73.5 110.117 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 137' ' ' ASP . 1.8 mp -68.18 -38.84 80.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 74.4 109.763 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.18 -43.09 74.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.493 -0.776 . . . . 65.22 110.425 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.46 -50.37 18.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.804 -0.634 . . . . 73.51 110.904 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.77 73.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.383 0.512 . . . . 71.41 112.383 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -100.61 0.79 39.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 75.23 110.647 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.52 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 56.53 75.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.896 -0.593 . . . . 54.35 111.923 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.52 ' HD3' ' C ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER 29.71 77.13 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.043 1.337 . . . . 74.24 114.132 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -160.28 105.7 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.64 -0.709 . . . . 71.13 109.092 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 49.9 m-85 -110.1 155.73 21.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.101 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -78.49 155.52 29.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.92 -0.582 . . . . 73.24 110.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -57.8 -38.85 76.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 74.24 110.642 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.56 -45.87 88.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 62.5 110.494 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.682 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.8 m -66.54 -52.37 46.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.827 -0.624 . . . . 62.52 110.948 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.7 t -60.24 -47.26 92.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.138 -0.483 . . . . 71.53 111.648 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.55 -37.87 80.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 71.52 110.762 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.873 HE21 ' HB2' ' A' ' 335' ' ' ASP . 30.2 mm-40 -60.22 -47.53 85.57 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.695 0.283 . . . . 64.5 110.61 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 153' ' ' THR . 81.9 mt -58.11 -50.51 73.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 70.44 110.131 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 247' ' ' LEU . 25.2 t -58.18 -47.44 83.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.891 -0.595 . . . . 65.0 110.94 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 325' ' ' LEU . 0.7 OUTLIER -64.74 -52.64 55.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 72.12 111.083 -176.315 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.438 ' NH1' HD22 ' A' ' 159' ' ' LEU . 13.6 mmt180 -72.51 -30.11 64.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 70.32 111.348 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -71.09 -30.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.818 -0.438 . . . . 74.53 109.818 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.45 -43.84 76.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.943 -0.391 . . . . 75.31 109.943 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.571 ' HB3' ' HH2' ' A' ' 99' ' ' TRP . 72.7 m-20 -58.53 -55.22 37.89 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.683 0.754 . . . . 72.14 110.432 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.598 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -63.19 -34.79 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 60.1 110.378 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.731 ' O ' ' HB3' ' A' ' 169' ' ' HIS . 6.3 tt -56.44 -37.93 70.92 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.577 -0.283 . . . . 72.14 110.318 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -57.29 -59.56 4.94 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.112 -0.699 . . . . 73.53 109.112 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.46 -28.19 66.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.967 -1.469 . . . . 74.54 113.501 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.0 pt -108.9 -48.18 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.908 0.707 . . . . 43.25 112.908 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.731 ' HB3' ' O ' ' A' ' 165' ' ' LEU . 7.0 t60 -59.87 -47.66 84.84 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.998 0.186 . . . . 75.11 110.85 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.688 ' HG3' ' HD2' ' A' ' 169' ' ' HIS . 21.1 mt-10 -106.47 80.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.978 0.894 . . . . 75.31 109.404 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -175.35 -44.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.481 -1.69 . . . . 74.1 109.128 -170.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -162.61 -72.62 0.05 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.938 -0.573 . . . . 74.42 111.403 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.643 ' CD1' ' HA ' ' A' ' 203' ' ' ARG . 21.9 m-85 -122.79 155.21 37.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.187 0.518 . . . . 64.31 111.388 -174.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 204' ' ' TYR . 31.0 m -97.37 167.29 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 51.51 109.431 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . 2.9 m-70 -114.3 -85.77 0.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.862 -0.335 . . . . 71.23 111.558 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.96 6.45 85.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.683 -0.77 . . . . 52.0 111.38 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 200' ' ' LEU . 17.8 p-10 -89.66 28.39 1.32 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 73.34 111.077 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.481 ' HB ' HG22 ' A' ' 246' ' ' ILE . 46.2 mm -75.6 97.45 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.314 0.578 . . . . 63.2 110.527 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.789 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -157.3 165.04 36.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.461 -0.791 . . . . 75.43 109.502 172.651 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.44 -23.56 64.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.967 0.729 . . . . 74.41 112.967 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.409 ' HB3' ' OE1' ' A' ' 139' ' ' GLN . 67.7 p -75.51 -18.59 59.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.837 0.31 . . . . 71.55 111.837 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 177' ' ' ASP . 2.6 m-20 -97.44 -26.94 14.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 111.891 0.33 . . . . 73.35 111.891 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.505 ' HB2' HD22 ' A' ' 138' ' ' LEU . 6.3 mp -95.69 118.38 32.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.11 0.481 . . . . 71.25 110.407 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -133.81 158.67 42.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.565 -0.743 . . . . 75.41 110.88 177.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 11.7 mt -103.55 157.59 16.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.906 -0.588 . . . . 72.15 109.601 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 23.8 t-20 -65.62 142.31 58.1 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 2.5 p90 -60.58 -22.24 63.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.964 0.357 . . . . 72.22 111.964 -173.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -124.25 6.23 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.293 0.568 . . . . 73.43 110.261 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 47.6 t-20 -139.87 101.92 7.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.892 -0.595 . . . . 72.35 109.835 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.48 -20.47 5.8 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.832 2.355 . . . . 75.02 113.716 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.47 1.62 57.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.953 0.406 . . . . 52.11 111.257 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.54 107.55 15.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.994 0.426 . . . . 73.51 110.437 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.33 142.12 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 73.12 109.937 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 111' ' ' PRO . 44.1 m-85 -127.04 157.49 39.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.302 . . . . 73.24 110.732 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.7 mt -96.49 129.91 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.258 -0.428 . . . . 75.33 110.479 174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 184' ' ' LEU . 34.2 m -135.79 177.49 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 54.12 110.225 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 53.5 t0 59.8 66.73 0.95 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.6 0.714 . . . . 75.23 109.287 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -75.38 67.52 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.16 -0.927 . . . . 74.42 111.078 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.71 ' HA3' ' HB2' ' A' ' 352' ' ' LYS . . . -93.52 1.87 69.74 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.464 -0.789 . . . . 71.54 111.651 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 77.8 mt -138.19 94.35 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.56 0.695 . . . . 70.44 110.587 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -155.0 115.8 3.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.725 -1.125 . . . . 74.3 108.921 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -132.38 160.61 35.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.635 -0.257 . . . . 75.05 110.699 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.643 ' HA ' ' CD1' ' A' ' 173' ' ' TYR . 5.4 ptp180 -62.52 149.36 43.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.144 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.472 ' HB2' HG13 ' A' ' 174' ' ' VAL . 42.1 t80 -149.86 -56.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 73.13 110.534 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 209' ' ' VAL . 5.8 p -148.34 72.08 10.93 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 73.43 111.534 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.76 142.67 4.89 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.989 2.459 . . . . 73.03 111.853 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 66.25 9.48 6.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 72.31 111.726 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.86 67.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.04 -0.6 . . . . 52.32 112.299 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 61.9 t -96.42 117.44 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.537 0.208 . . . . 70.24 110.49 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -100.23 145.86 27.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.853 -0.425 . . . . 71.0 109.853 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -114.97 152.58 32.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.303 -0.408 . . . . 64.33 110.413 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.39 173.98 11.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.483 -0.562 . . . . 64.34 109.483 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 236' ' ' VAL . 19.4 p90 -79.19 74.03 5.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.665 1.222 . . . . 74.11 110.223 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -154.91 92.97 1.5 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.055 -1.43 . . . . 71.32 108.49 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 2.7 mm-40 -122.61 -98.5 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.251 0.834 . . . . 71.25 113.251 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.49 119.26 61.92 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.411 -0.359 . . . . 73.25 111.664 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 N--CA 1.462 -0.358 0 C-N-CA 122.769 2.313 . . . . 62.34 112.379 177.793 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 355' ' ' THR . 19.0 p-10 . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.108 0.48 . . . . 74.04 110.849 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -77.04 177.34 52.45 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.687 -0.768 . . . . 71.31 111.361 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -73.26 129.69 38.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.248 0.547 . . . . 75.43 111.667 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.452 HG23 HG21 ' A' ' 271' ' ' VAL . 47.7 mm -54.17 -31.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.342 -0.845 . . . . 72.34 112.336 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -56.92 -69.46 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.277 -0.42 . . . . 72.25 111.566 -179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.6 m-85 -112.48 49.34 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.107 0.41 . . . . 72.42 112.107 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -18.18 35.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.629 0.252 . . . . 73.2 111.519 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.4 m 52.48 -162.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.891 -0.595 . . . . 53.43 111.159 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.2 mp -72.83 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.711 0.291 . . . . 74.11 110.507 177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 238' ' ' PRO . 1.3 m-20 -51.44 -70.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.159 -0.928 . . . . 74.34 112.468 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.22 70.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 42.12 111.383 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.32 -28.79 68.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.034 -0.53 . . . . 53.21 110.767 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -91.15 -30.62 16.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.859 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.57 6.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.668 -0.777 . . . . 70.54 111.625 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 9.1 p -120.49 141.55 40.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.236 -0.283 . . . . 71.13 110.236 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.71 124.69 58.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 42.41 110.778 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.621 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 91.0 Cg_exo -46.63 106.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 64.12 112.418 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 312' ' ' THR . 36.4 m -92.04 42.26 1.1 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.148 -0.933 . . . . 63.22 110.928 -172.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 239' ' ' SER . 66.0 mtt180 85.29 -28.69 0.08 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.075 0.95 . . . . 65.24 111.159 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 311' ' ' TYR . 9.4 mmm180 -59.13 -61.39 2.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.542 0.21 . . . . 64.55 110.921 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -49.18 -55.36 12.45 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 115.724 -0.671 . . . . 44.22 113.219 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.487 ' HB3' HD11 ' A' ' 165' ' ' LEU . 3.3 m-20 -52.72 -54.56 32.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.98 0.419 . . . . 72.34 111.176 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 240' ' ' ARG . 11.2 mp -64.92 -45.93 83.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 74.04 111.391 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.46 -38.57 84.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.075 -0.25 . . . . 63.34 111.593 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 178' ' ' ILE . 84.2 mt -59.13 -44.0 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 74.13 110.482 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 158' ' ' SER . 33.2 tp -61.57 -42.63 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 72.41 110.293 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.63 95.86 Favored Glycine 0 C--O 1.236 0.271 0 C-N-CA 120.907 -0.663 . . . . 73.14 112.227 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -58.79 -49.16 78.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.649 0.261 . . . . 64.34 111.279 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 28.5 p -66.43 -36.79 83.68 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 73.31 111.453 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 72.5 mtm -60.65 -51.75 68.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.881 0.372 . . . . 74.43 111.023 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.4 tt -67.38 -30.23 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.582 -0.447 . . . . 75.41 110.694 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.53 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 35.0 tt0 -67.91 -44.95 75.74 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.532 0.206 . . . . 64.33 110.584 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 22.7 m0 -65.4 -29.15 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 73.11 110.902 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -81.04 -35.71 31.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 71.34 112.003 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 62.5 p -103.37 -27.93 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.858 -0.337 . . . . 73.43 111.74 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.36 17.09 65.18 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.865 -0.683 . . . . 44.52 112.982 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -155.6 144.17 20.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.128 0.464 . . . . 65.02 111.145 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 29.3 mt -108.95 138.84 20.46 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.11 109.825 171.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 48.3 Cg_exo -58.03 -28.33 82.88 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.867 2.378 . . . . 74.03 112.57 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 274' ' ' SER . 46.7 p90 -108.22 11.72 27.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.375 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 38.4 tt0 -75.56 -39.37 58.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 71.51 110.36 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.45 -29.15 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.69 0.757 . . . . 62.32 109.864 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 7.3 m-20 -108.04 19.75 19.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.138 -0.937 . . . . 73.52 110.689 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 262' ' ' GLU . 1.8 tt -75.93 73.29 2.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.825 0.821 . . . . 73.24 110.362 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -147.52 -63.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.544 -1.207 . . . . 72.02 109.817 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.747 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 12.1 t70 -91.33 135.27 28.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.245 -0.888 . . . . 73.25 111.431 -173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -58.23 -27.11 79.43 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.498 2.799 . . . . 75.55 114.331 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 269' ' ' LYS . 1.8 mppt? -82.72 -40.07 21.09 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.605 -0.438 . . . . 73.04 110.542 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.747 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 37.0 m-85 -60.93 -49.19 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 73.32 110.704 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.452 HG21 HG23 ' A' ' 225' ' ' ILE . 33.8 m -66.6 -31.71 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.816 -0.354 . . . . 52.13 110.663 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -58.58 -56.67 19.17 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.087 0.47 . . . . 75.03 110.352 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.85 -43.47 79.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.474 -0.785 . . . . 72.14 111.038 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 41.7 m -60.34 -41.2 93.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 74.02 111.501 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.36 -48.29 70.66 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.114 -0.235 . . . . 73.41 110.615 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.46 -40.68 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 72.35 111.03 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -56.13 -51.02 69.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.647 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 33.4 m-85 -74.45 -36.05 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 74.23 111.12 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.531 ' HD2' HH22 ' A' ' 241' ' ' ARG . 26.2 ttp180 -57.23 -31.95 66.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.538 . . . . 64.34 111.28 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.5 -23.22 50.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.108 -0.496 . . . . 62.23 111.063 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -127.98 30.43 5.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.581 -0.281 . . . . 71.21 110.779 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -47.95 -42.28 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.04 1.126 . . . . 63.3 114.04 -171.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.16 -50.51 73.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.423 0.527 . . . . 71.43 112.423 -169.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 t -78.08 -36.21 48.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.834 0.35 . . . . 73.52 110.313 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 278' ' ' TYR . 89.9 mt -71.95 -44.8 62.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 65.44 111.372 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.445 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -72.02 -40.6 68.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.639 -0.255 . . . . 63.34 110.946 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.79 -35.41 80.51 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.145 0.497 . . . . 63.53 111.046 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 288' ' ' LYS . 28.5 ttmt -99.76 7.63 44.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.774 -0.648 . . . . 72.22 110.658 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 47.0 t -75.95 -22.95 55.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.203 0.525 . . . . 74.24 110.048 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 33.6 t80 -127.35 77.39 75.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.546 -0.909 . . . . 74.22 108.546 173.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.85 12.07 2.76 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.895 2.397 . . . . 75.52 113.364 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 4.0 mp0 -71.11 -99.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.661 -0.496 . . . . 63.21 109.661 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -161.52 79.13 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.334 0.588 . . . . 73.32 110.771 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.5 t-20 -150.3 162.92 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.035 -1.098 . . . . 75.01 108.035 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.85 103.87 43.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 111.905 0.335 . . . . 75.41 111.905 -175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 85.1 Cg_endo -98.26 37.81 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.011 2.474 . . . . 45.13 111.207 173.246 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -74.02 -43.71 32.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.628 -0.714 . . . . 63.41 111.942 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.4 mp0 -53.39 -51.15 63.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.212 0.53 . . . . 72.02 109.849 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 252' ' ' ILE . 20.7 mt -62.09 -50.93 78.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.281 -0.872 . . . . 73.35 111.4 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 63.43 111.149 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.77 -28.54 40.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.489 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.405 ' HE1' ' O ' ' A' ' 244' ' ' LEU . 52.1 t80 -60.74 -42.64 97.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.287 -0.634 . . . . 64.21 109.287 172.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 306' ' ' VAL . 66.3 mtp -72.71 -36.16 67.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.541 -0.754 . . . . 74.45 110.809 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -55.93 -46.42 78.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 63.22 109.342 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 91.3 m -57.33 -52.28 65.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.713 -1.131 . . . . 50.31 111.611 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 303' ' ' MET . 22.9 m -67.45 -31.63 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 111.78 0.289 . . . . 61.04 111.78 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -70.32 -48.81 54.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.095 0.474 . . . . 73.41 110.808 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 17.5 tp -82.73 -3.03 55.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 62.43 110.481 -175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 6.9 tt -67.65 -76.7 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.314 -0.857 . . . . 75.23 110.315 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 8.1 t70 162.19 -152.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.134 -1.432 . . . . 71.21 107.134 -176.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 241' ' ' ARG . 20.4 t80 -105.03 -39.97 6.06 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.938 -0.393 . . . . 74.44 109.938 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 239' ' ' SER . 1.6 m -138.4 5.51 2.48 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.683 0.623 . . . . 52.24 112.683 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.22 -89.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.556 1.317 . . . . 73.44 114.556 -167.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 314' ' ' LYS . 13.2 tppt? -109.09 107.42 59.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 113.165 0.802 . . . . 74.13 113.165 -161.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 68.7 Cg_endo -88.73 119.82 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.618 2.212 . . . . 64.21 112.034 169.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.2 mt -118.84 85.55 2.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.268 0.556 . . . . 65.23 109.786 176.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 315' ' ' PRO . 80.7 m-85 -67.98 -34.97 77.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.704 -0.68 . . . . 72.31 111.964 -172.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -29.53 46.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.902 -0.319 . . . . 72.25 110.904 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.62 -48.71 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.889 -0.411 . . . . 73.44 109.889 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 85.9 mt -58.4 -43.61 88.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.617 -0.72 . . . . 63.23 110.485 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.419 ' O ' HD23 ' A' ' 325' ' ' LEU . 7.4 mtp180 -64.21 -33.36 75.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 72.12 111.12 177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.44 -46.16 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 320' ' ' LEU . 0.3 OUTLIER -72.45 -27.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 119.474 -0.89 . . . . 55.54 110.414 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.13 -49.04 75.96 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.492 -0.559 . . . . 73.02 109.492 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 329' ' ' LYS . 4.0 mm? -67.59 -26.91 66.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 73.45 111.002 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' GLN . . . . . 0.673 ' HA ' ' HE2' ' A' ' 329' ' ' LYS . 20.2 tp60 -59.52 -49.01 79.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 61.42 110.427 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.91 -38.55 94.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.248 -0.977 . . . . 62.23 111.298 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.937 HD11 ' HA ' ' A' ' 334' ' ' LYS . 3.0 tm? -57.21 -50.35 73.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.181 -0.51 . . . . 65.43 111.043 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 326' ' ' GLN . 54.8 pttt -81.15 -17.48 49.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.759 0.281 . . . . 75.4 111.759 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.76 63.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 73.12 110.894 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -77.46 -6.95 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.206 0.527 . . . . 70.55 110.626 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 89.67 12.27 62.76 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.856 -0.688 . . . . 61.5 112.887 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 170.37 8.69 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.043 -0.354 . . . . 61.21 110.043 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.937 ' HA ' HD11 ' A' ' 328' ' ' LEU . 77.6 tttt -146.28 156.56 43.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.541 . . . . 75.25 109.538 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.873 ' HB2' HE21 ' A' ' 156' ' ' GLN . 6.9 p-10 -87.65 126.64 35.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.166 0.508 . . . . 64.52 110.142 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -104.3 -24.18 13.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 62.51 110.862 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 85.39 -1.96 88.25 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.172 -0.537 . . . . 64.22 112.42 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.613 0.207 . . . . 71.51 110.803 -175.294 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.71 ' HB2' ' HA3' ' A' ' 199' ' ' GLY . 3.9 mppt? . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.756 0.312 . . . . 74.35 110.549 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.7 t -134.3 132.47 39.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.29 -0.413 . . . . 70.32 110.562 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.724 HG13 ' HD3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -84.69 142.7 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 71.32 110.782 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.421 ' HB ' ' OD2' ' A' ' 222' ' ' ASP . 4.9 t -79.54 81.77 5.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.038 0.923 . . . . 71.21 110.045 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.724 ' HD3' HG13 ' A' ' 354' ' ' ILE . 10.5 mtpm? . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.439 -0.8 . . . . 54.05 110.509 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.232 0.164 0 N-CA-C 110.298 -0.26 . . . . 74.55 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.87 57.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.88 -0.676 . . . . 74.3 112.73 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.03 167.56 12.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.315 0.578 . . . . 73.45 111.527 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.92 131.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.144 -0.935 . . . . 64.23 111.249 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 37' ' ' TRP . 12.7 tt -105.77 136.81 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 72.55 109.427 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.5 m -93.83 113.95 26.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.134 0.42 . . . . 74.14 112.134 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 14.4 t70 -72.65 154.77 40.58 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.06 174.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.684 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 52.3 tpp -70.63 -30.36 66.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.879 0.371 . . . . 74.31 110.971 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.82 18.48 3.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.052 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 61.29 77.71 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.062 -0.972 . . . . 74.44 110.032 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 45.4 mmtm -140.52 115.48 9.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.972 -1.013 . . . . 53.04 109.139 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.74 111.55 17.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.245 -0.434 . . . . 40.42 110.228 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 29' ' ' ILE . 83.9 m95 -108.89 163.15 13.54 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.95 -0.759 . . . . 73.32 108.95 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 56' ' ' MET . 21.7 ttpt -114.6 129.49 56.68 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.654 -0.418 . . . . 64.33 110.25 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -75.89 104.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.071 0.462 . . . . 63.31 109.9 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.22 -104.54 2.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.442 -0.885 . . . . 73.31 113.246 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 mm? -86.29 127.71 60.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.043 0.449 . . . . 63.12 111.471 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.3 Cg_exo -78.74 106.25 2.08 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.106 2.537 . . . . 70.0 111.77 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -81.28 -37.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 71.03 110.17 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 87.53 -45.44 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.829 -0.7 . . . . 60.51 112.696 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.23 165.63 10.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.596 -0.52 . . . . 52.21 109.596 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 71' ' ' LYS . . . 98.77 13.36 40.73 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.445 -1.462 . . . . 74.15 109.445 -168.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.849 ' HA3' HD11 ' A' ' 51' ' ' ILE . . . -168.24 -164.4 23.87 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 114.325 -0.938 . . . . 61.22 111.169 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -102.92 8.72 39.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.764 0.316 . . . . 74.42 111.625 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.03 -76.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.329 -0.939 . . . . 63.24 113.182 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' CYS . . . . . 0.628 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 84.6 m -150.18 110.43 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 73.1 109.964 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.849 HD11 ' HA3' ' A' ' 47' ' ' GLY . 30.3 mm -100.31 137.83 26.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.073 -0.512 . . . . 74.35 110.62 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -110.07 145.15 37.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 74.3 110.616 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HA ' HG12 ' A' ' 69' ' ' VAL . 9.7 tt -91.16 138.27 31.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.421 -0.585 . . . . 75.22 109.421 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.18 96.23 5.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 71.55 110.945 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.13 -32.4 19.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 63.12 110.444 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.622 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 9.2 tpt 62.27 34.85 15.65 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.658 -0.701 . . . . 61.23 111.465 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.5 t30 74.07 121.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.573 0.701 . . . . 52.3 111.831 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 m -71.11 108.95 4.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.572 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.848 -0.615 . . . . 35.21 111.051 -177.871 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.196 0.522 . . . . 61.12 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 4.0 Cg_exo -79.87 40.72 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.294 2.663 . . . . 74.45 112.341 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 131' ' ' MET . 2.2 p -140.71 137.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.398 0.618 . . . . 70.21 111.931 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 53' ' ' LEU . 30.9 m -137.87 161.85 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.312 -0.858 . . . . 62.43 108.971 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -123.59 122.29 64.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.482 0.658 . . . . 62.45 112.371 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.847 ' HA ' HD12 ' A' ' 51' ' ' ILE . 36.9 ttmt -89.6 122.19 32.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.741 -1.118 . . . . 65.33 109.297 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 128' ' ' PHE . 35.7 m -115.91 139.16 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.03 0.382 . . . . 72.41 112.03 -175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 6.6 mm-40 -148.91 139.44 13.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 74.44 109.823 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 25.2 Cg_exo -63.1 150.94 87.18 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.942 2.428 . . . . 40.22 112.324 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 m -73.06 66.83 0.85 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.301 0.572 . . . . 54.42 112.068 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -113.61 -6.44 13.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.52 -1.289 . . . . 72.41 107.52 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 90.69 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 113.987 -1.46 . . . . 42.45 111.391 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.43 -139.66 5.72 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.441 -0.8 . . . . 51.1 111.5 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG3' HG23 ' A' ' 353' ' ' THR . 28.0 Cg_exo -61.59 -22.93 75.66 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.057 2.505 . . . . 74.42 112.175 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -56.81 -34.74 67.99 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.743 -0.662 . . . . 62.31 110.294 178.55 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.19 -41.43 85.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 73.32 110.43 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.2 m -65.59 -41.76 92.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.235 -0.439 . . . . 71.45 110.348 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -58.31 -45.99 86.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.694 . . . . 73.43 110.425 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -67.48 -33.69 75.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 73.34 111.128 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HE3' ' HE1' ' A' ' 173' ' ' TYR . 6.2 tmtm? -64.19 -45.18 89.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.351 -0.611 . . . . 74.34 109.351 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' A' ' 168' ' ' ILE . 87.8 t80 -65.26 -41.5 94.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 73.41 110.275 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' ' HD1' ' A' ' 113' ' ' TYR . 42.8 t80 -59.28 -49.03 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.076 -0.965 . . . . 75.52 110.512 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -64.04 -34.17 77.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 64.13 111.226 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -75.52 -53.56 8.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.493 0.553 . . . . 64.22 112.493 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.75 -33.7 7.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.832 0.679 . . . . 60.13 112.832 -169.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.06 84.84 7.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.322 0.582 . . . . 64.23 110.738 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -157.48 128.43 3.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.772 -0.649 . . . . 74.44 109.466 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.0 -52.38 8.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.354 2.703 . . . . 63.15 113.23 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.75 -45.37 92.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -69.22 -45.58 69.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.004 -0.543 . . . . 75.41 110.716 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.11 -50.42 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 73.02 110.998 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -61.46 -37.3 83.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.809 0.338 . . . . 75.43 110.391 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 34.0 ttmt -59.63 -51.5 69.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 73.43 110.832 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.823 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 23.6 t90 -68.59 -51.1 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 73.22 110.684 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.93 -40.05 81.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.713 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 101' ' ' ARG . 45.7 ttt-85 -63.77 -56.54 14.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 75.31 110.856 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.3 m -65.04 -40.84 95.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.754 -0.657 . . . . 40.21 111.239 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -75.53 -13.83 60.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.988 -0.551 . . . . 74.1 110.929 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 62.58 57.74 1.77 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.336 0.588 . . . . 74.15 110.392 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -117.62 -174.52 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 75.04 110.806 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.47 -59.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.878 -0.601 . . . . 63.34 111.284 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -144.81 157.26 44.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 72.31 110.764 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -105.8 137.35 43.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 60.24 109.199 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.27 33.05 1.78 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.941 -0.647 . . . . 62.24 113.287 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 108' ' ' LEU . 11.0 p -109.25 137.16 20.14 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.405 -0.591 . . . . 74.54 109.405 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD2' HG23 ' A' ' 110' ' ' VAL . 5.9 Cg_endo -47.28 135.21 19.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.51 2.807 . . . . 72.43 113.343 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 44.3 tptt -65.01 121.15 14.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 71.04 110.839 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.534 ' HD1' ' CE2' ' A' ' 87' ' ' TYR . 27.2 t80 -80.44 132.27 35.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.272 -0.876 . . . . 74.34 111.357 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.535 ' HB2' HG22 ' A' ' 130' ' ' ILE . 69.9 m95 -122.42 -54.03 1.89 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.875 -0.787 . . . . 51.43 108.875 170.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.38 176.71 46.72 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.393 -0.822 . . . . 71.25 111.96 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -157.29 153.62 27.75 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.996 -0.742 . . . . 72.33 108.996 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 32' ' ' MET . . . -161.43 176.07 37.98 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.357 -1.401 . . . . 70.2 114.147 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 126' ' ' TYR . 19.1 tp -137.08 129.08 29.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.01 108.785 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -144.49 131.79 20.75 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.701 -0.4 . . . . 73.2 110.648 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 8.2 t70 -69.74 136.75 51.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 61.31 110.824 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -90.72 -60.01 2.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 54.11 109.258 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -170.18 85.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.633 -0.712 . . . . 54.35 109.603 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.38 -34.86 5.43 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.604 -0.598 . . . . 40.24 111.604 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -132.02 140.8 49.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 75.0 109.919 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 11.5 p -89.65 156.14 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 63.03 110.897 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 118' ' ' LEU . 15.8 m-85 -111.5 130.69 55.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.737 -0.665 . . . . 72.41 110.391 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -96.44 118.03 32.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.709 -0.849 . . . . 74.41 108.709 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.566 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.6 p90 -129.16 156.57 43.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.967 0.413 . . . . 75.43 111.5 -173.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 18.5 ptp -137.27 139.59 41.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.671 -0.695 . . . . 55.54 110.335 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.547 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.7 mm -97.86 117.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.1 -0.5 . . . . 53.32 109.711 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER -121.84 -175.96 3.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 75.34 111.088 -175.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 20.8 t70 -64.5 157.01 27.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 70.12 110.633 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 1.2 tmt_? -93.71 109.36 21.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.268 0.556 . . . . 72.45 110.045 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 63.7 m-85 -101.84 171.39 7.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.589 . . . . 73.22 109.9 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.7 -36.78 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.472 -0.871 . . . . 42.24 112.42 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.5 m -103.06 124.94 49.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.962 0.411 . . . . 62.11 111.141 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 1.3 m-20 -87.42 132.9 33.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.06 -0.518 . . . . 65.03 109.905 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 14.8 tp -68.94 -38.29 79.37 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.065 -1.087 . . . . 63.21 108.065 171.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.979 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 4.9 pt20 -59.51 -49.0 79.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.339 -0.846 . . . . 75.14 112.418 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 25.2 mtmm -71.57 -36.91 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.768 -0.373 . . . . 55.54 111.371 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.03 -48.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 71.02 110.568 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.05 -44.95 95.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 71.14 111.922 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.3 -34.39 59.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.876 0.369 . . . . 62.24 110.727 -172.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.4 -28.85 62.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 73.12 110.557 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.64 0.11 56.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.37 0.605 . . . . 63.22 110.185 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 58.81 45.12 15.93 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.296 -0.865 . . . . 72.11 112.27 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 254' ' ' TRP . 0.0 OUTLIER 39.89 79.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.932 0.872 . . . . 74.12 112.998 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 148' ' ' ARG . 14.4 ttt180 -146.5 88.48 1.78 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.68 -1.145 . . . . 74.43 108.367 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.727 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 52.4 m-85 -120.09 156.16 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.084 -0.507 . . . . 74.32 112.025 -172.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.4 m -67.61 155.66 38.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.854 . . . . 72.42 110.257 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.607 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 7.7 tpp85 -59.71 -39.7 85.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.824 0.345 . . . . 73.42 110.797 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HD2' ' HB2' ' A' ' 335' ' ' ASP . 26.2 pttm -66.3 -30.36 70.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.337 -0.392 . . . . 63.04 111.201 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.431 ' O ' HD13 ' A' ' 157' ' ' LEU . 6.9 m -70.2 -41.52 73.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 60.4 110.175 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.72 -43.62 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.617 -0.72 . . . . 65.24 110.945 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.652 HD22 HD22 ' A' ' 328' ' ' LEU . 3.3 mp -69.06 -40.16 78.69 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.483 0.549 . . . . 75.21 112.483 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -56.29 -45.06 80.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 72.31 110.301 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 153' ' ' THR . 8.6 mp -64.18 -52.03 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 73.22 111.313 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.3 p -65.27 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.286 . . . . 45.22 111.671 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 325' ' ' LEU . 7.0 mp -56.3 -48.99 75.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.539 0.2 . . . . 52.42 111.539 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 2.3 mmp_? -61.15 -42.68 98.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 73.02 110.907 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 183' ' ' LEU . 31.4 mm -63.62 -38.19 81.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 72.04 110.581 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 317' ' ' TYR . 67.3 mt -58.01 -53.04 62.73 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.891 0.33 . . . . 75.34 111.891 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.823 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -70.08 -39.44 75.59 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.454 -0.498 . . . . 34.23 112.119 -175.611 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.54 -36.57 75.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.871 -0.731 . . . . 72.52 110.953 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.91 -38.86 83.47 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.797 -0.183 . . . . 73.14 111.212 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 167' ' ' TYR . 4.1 pt-20 -68.93 -40.96 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.233 -0.587 . . . . 54.31 110.009 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.484 ' N ' ' HG3' ' A' ' 166' ' ' GLU . 66.3 t80 -55.84 -45.81 78.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.693 -0.685 . . . . 75.32 111.735 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.404 HG21 ' HE1' ' A' ' 86' ' ' PHE . 26.9 pt -82.55 -31.46 9.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.486 -0.324 . . . . 72.33 111.797 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -66.8 -27.06 67.27 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.436 -0.347 . . . . 74.12 110.689 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 37.0 tt0 -77.65 28.56 0.16 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.107 0.479 . . . . 61.23 111.491 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -151.18 -65.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.525 -0.734 . . . . 74.42 111.597 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 35.3 mt-10 -147.25 -31.44 0.32 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.696 0.628 . . . . 63.33 112.696 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.449 ' HE1' ' HE3' ' A' ' 85' ' ' LYS . 5.4 m-85 -99.18 128.85 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.784 1.031 . . . . 75.41 113.784 -155.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.4 m -123.01 139.5 49.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.707 -1.133 . . . . 62.32 108.015 163.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -93.77 -32.88 13.81 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.827 -0.349 . . . . 73.03 110.203 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.65 -76.87 0.28 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.078 -0.582 . . . . 71.22 111.852 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.9 101.93 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.037 0.446 . . . . 64.35 110.343 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 178' ' ' ILE . 9.4 tp -99.73 20.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.876 0.846 . . . . 71.15 110.051 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -57.56 144.3 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.93 . . . . 64.35 110.256 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 183' ' ' LEU . . . -62.3 -0.36 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.906 -0.588 . . . . 72.44 112.553 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.979 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 14.2 p -70.48 -17.28 62.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 54.31 111.514 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 198' ' ' TYR . 14.6 m120 -112.53 6.67 18.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 60.14 111.3 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 180' ' ' ALA . 7.1 mp -105.06 115.66 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.706 -0.479 . . . . 63.34 109.706 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.63 140.3 49.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.433 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 53.3 mt -94.71 138.41 32.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.707 -0.679 . . . . 74.51 109.874 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.61 140.47 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.096 -0.705 . . . . 63.3 109.096 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 5.6 p90 -62.42 -22.4 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.128 0.418 . . . . 73.54 112.128 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -104.3 -51.18 3.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.761 0.315 . . . . 65.32 111.039 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -112.11 106.82 56.12 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 74.14 110.979 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.13 -11.71 25.32 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.096 2.531 . . . . 55.5 112.49 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 26.8 t70 -70.87 -19.99 62.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.57 . . . . 71.24 110.703 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -111.09 103.05 11.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.45 0.643 . . . . 72.53 110.18 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.94 137.99 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 64.12 109.74 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.517 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 96.3 m-85 -120.3 141.98 49.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.044 0.449 . . . . 64.24 111.054 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 182' ' ' ASN . 37.6 tp -90.76 99.97 12.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.728 -0.669 . . . . 54.41 109.392 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.5 m -139.99 160.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.457 -0.338 . . . . 74.45 111.636 -174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.44 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 16.6 t70 60.67 78.16 0.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.968 -1.015 . . . . 63.21 111.575 174.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.62 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 19.4 p90 -151.41 -40.76 0.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.548 -0.751 . . . . 63.42 112.015 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.658 ' O ' ' HB ' ' A' ' 354' ' ' ILE . . . 66.72 2.16 15.03 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.751 -0.737 . . . . 70.41 112.661 -175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.62 ' H ' ' HD2' ' A' ' 198' ' ' TYR . 6.2 mp -91.94 35.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 73.24 111.474 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -84.49 97.78 9.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.363 -0.977 . . . . 72.52 108.363 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -99.97 127.48 46.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.265 0.555 . . . . 72.05 110.697 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 2.0 ttp180 -72.86 112.45 8.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.483 -0.78 . . . . 61.44 110.229 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.573 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 13.7 p90 -92.57 -26.22 17.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.84 -0.43 . . . . 75.42 109.84 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 18.0 p -133.31 127.42 19.84 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 74.22 111.145 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.65 131.39 13.51 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.505 2.137 . . . . 70.44 111.752 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 65.96 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.79 0.681 . . . . 74.32 111.291 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.27 15.75 0.14 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.155 -0.545 . . . . 41.51 111.927 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 45.0 t -94.95 110.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.931 -0.396 . . . . 74.51 109.931 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.98 145.82 55.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 70.01 110.998 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 214' ' ' LYS . 74.8 tttt -111.02 145.09 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.828 -0.624 . . . . 74.05 110.755 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.2 -163.39 1.02 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.872 -0.604 . . . . 71.52 110.172 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.565 ' HA ' HG23 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -76.27 67.79 2.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.809 0.67 . . . . 71.4 112.809 -175.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.427 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 75.6 tttt -158.43 83.28 0.83 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.855 -0.611 . . . . 72.23 109.725 169.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 235' ' ' GLY . 9.8 tp10 -105.9 -72.93 0.7 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.939 -0.573 . . . . 75.44 110.464 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -138.34 109.39 8.14 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.61 -0.268 . . . . 61.03 110.418 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 123.23 2.62 . . . . 71.11 112.481 -178.372 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.323 . . . . 75.43 111.491 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -96.88 -170.46 33.95 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 71.21 112.789 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.3 m -69.58 142.24 53.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.443 0.164 . . . . 44.32 110.77 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -56.96 -23.83 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.471 0.653 . . . . 73.41 110.542 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.23 -53.47 54.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.465 -0.788 . . . . 65.42 111.937 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.27 7.0 19.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.085 0.772 . . . . 74.53 113.085 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -21.1 66.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 60.55 111.288 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.677 ' HA ' ' CD ' ' A' ' 275' ' ' LYS . 50.8 m 59.77 -162.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.709 -0.678 . . . . 64.44 110.247 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.2 OUTLIER -71.0 -34.16 54.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.421 -0.512 . . . . 74.11 110.281 176.436 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.424 ' HA ' HG13 ' A' ' 236' ' ' VAL . 5.2 m-20 -59.76 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.631 -0.713 . . . . 63.34 112.316 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.59 72.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 63.33 111.714 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -68.97 -31.35 70.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.496 -0.32 . . . . 73.24 111.164 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.69 0.52 55.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 64.23 110.711 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 215' ' ' GLU . . . 87.12 33.89 11.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.459 -0.877 . . . . 71.44 113.829 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 213' ' ' TYR . 1.4 p -120.79 129.22 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.226 0.513 . . . . 42.44 110.803 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -77.29 111.6 18.03 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 51.24 109.578 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 123.82 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.577 2.185 . . . . 73.32 113.295 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.1 m -95.37 104.59 16.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.886 -0.597 . . . . 55.31 110.041 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.645 HH21 ' HB2' ' A' ' 244' ' ' LEU . 0.0 OUTLIER 79.8 -56.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.64 0.776 . . . . 72.02 110.866 175.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.658 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.61 -54.89 38.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.32 -0.4 . . . . 74.11 111.457 -173.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.13 -44.95 97.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 55.23 112.592 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.43 -53.74 33.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.113 0.482 . . . . 72.52 111.12 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.645 ' HB2' HH21 ' A' ' 240' ' ' ARG . 3.7 mm? -72.22 -40.34 67.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.662 . . . . 64.51 111.537 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -46.43 89.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.69 0.281 . . . . 61.45 111.049 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 242' ' ' GLY . 75.1 mt -66.6 -33.92 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 65.3 110.714 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.1 86.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.517 -0.549 . . . . 65.3 109.517 174.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.47 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -58.76 -39.1 93.25 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.737 -0.744 . . . . 75.02 112.18 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.07 -42.18 94.4 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.965 0.358 . . . . 75.42 111.965 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 31.2 p -69.64 -35.8 75.53 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.243 -0.583 . . . . 74.15 110.955 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 70.6 mtm -65.69 -46.81 77.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.056 -0.258 . . . . 62.35 111.073 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.8 -28.78 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.738 -0.385 . . . . 54.45 110.586 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -46.55 87.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.97 -0.382 . . . . 71.31 109.97 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 16.8 m0 -67.32 -28.64 68.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.915 -0.584 . . . . 75.11 110.906 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -83.9 -35.78 23.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 74.33 112.628 -173.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 42.9 p -102.64 -14.69 16.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.416 0.524 . . . . 73.34 112.416 -171.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.28 -33.54 4.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.235 -0.983 . . . . 61.15 113.006 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 143.93 18.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.371 -0.488 . . . . 73.14 110.868 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.496 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.3 mt -103.9 149.5 37.25 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 73.23 110.315 176.455 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.01 -40.25 86.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.751 2.301 . . . . 73.3 112.681 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 25.0 p90 -87.13 -0.38 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.531 -0.304 . . . . 71.32 111.35 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 265' ' ' LEU . 84.7 tt0 -79.63 -28.27 40.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.093 0.473 . . . . 73.34 109.945 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.19 -27.95 32.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 64.5 110.26 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -108.4 17.42 22.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.529 -0.76 . . . . 54.13 112.098 -173.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 262' ' ' GLU . 4.2 pp -73.56 -7.85 53.55 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.091 0.472 . . . . 64.1 111.085 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -64.21 -14.12 53.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 73.23 111.058 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.706 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 10.9 t70 -134.69 127.89 18.71 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 63.23 110.223 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.0 Cg_exo -61.59 -33.06 87.71 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.351 2.701 . . . . 71.52 114.794 -171.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.706 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 22.9 pttm -74.29 -24.04 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.515 -0.474 . . . . 75.13 111.471 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 267' ' ' ASP . 74.6 m-85 -71.22 -49.55 42.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 73.3 110.157 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.671 HG13 ' HZ2' ' A' ' 275' ' ' LYS . 96.1 t -58.5 -37.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.784 -0.644 . . . . 74.03 110.954 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.427 ' O ' HG13 ' A' ' 276' ' ' ILE . 48.5 ttt-85 -59.85 -61.9 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 73.14 110.876 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -45.58 91.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.974 -0.557 . . . . 73.54 111.82 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 15.1 p -61.46 -49.92 74.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.883 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.677 ' CD ' ' HA ' ' A' ' 229' ' ' SER . 56.2 mttp -66.69 -37.35 84.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 61.15 111.75 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 280' ' ' GLU . 83.0 mt -60.85 -49.58 84.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.42 . . . . 55.44 110.557 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -69.01 -33.63 73.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 74.42 111.003 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.81 -36.4 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 64.1 110.644 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 282' ' ' ILE . 58.2 ttp180 -71.06 -38.22 72.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 74.31 110.805 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 72.7 mt-10 -67.58 -42.32 82.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 74.24 110.986 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.488 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.0 m-80 -117.78 46.97 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 73.52 110.649 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.63 -51.35 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.865 0.691 . . . . 73.33 112.865 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.51 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.11 -43.54 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.913 0.387 . . . . 61.25 111.339 -175.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.4 m -65.96 -45.39 81.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.839 -0.619 . . . . 75.02 110.853 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.0 mm? -69.39 -43.12 74.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 72.21 111.603 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 282' ' ' ILE . 30.5 mmt -64.57 -40.34 95.38 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.965 -0.294 . . . . 74.21 111.051 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 16.1 t70 -66.26 -48.64 69.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 74.31 111.2 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -98.94 14.54 28.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.847 -0.615 . . . . 64.23 111.875 -169.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 47.4 t -85.44 -27.25 25.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 60.02 109.777 173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 290' ' ' PHE . 0.1 OUTLIER -138.1 68.5 48.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 64.3 111.298 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.19 31.89 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.035 2.49 . . . . 71.34 111.919 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.76 -85.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.666 -0.697 . . . . 70.2 111.808 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -145.4 16.27 1.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.964 0.887 . . . . 71.42 109.492 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -104.73 -142.92 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.338 -0.847 . . . . 61.01 109.958 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 47.9 tptt -156.06 114.98 2.16 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.657 -0.247 . . . . 63.21 110.613 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.511 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 47.3 Cg_endo -95.42 77.99 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.342 2.695 . . . . 65.42 111.697 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -119.95 -59.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.201 -0.999 . . . . 63.22 112.535 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.607 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 1.1 mp0 -60.02 -61.43 2.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.675 0.274 . . . . 74.11 110.399 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.554 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.7 mp -60.6 -37.17 74.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.62 . . . . 60.34 110.63 -177.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.61 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 70.33 111.335 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 40.4 tptt -72.03 -33.58 68.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.34 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -55.41 -49.39 72.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.669 -0.696 . . . . 74.1 110.708 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.47 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 94.3 mmm -72.02 -39.67 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 74.05 111.057 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.534 ' HA ' HG13 ' A' ' 282' ' ' ILE . 23.1 tt0 -57.46 -45.68 84.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.634 0.73 . . . . 63.23 109.71 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.6 m -60.07 -51.08 71.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.54 -1.209 . . . . 63.25 112.0 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 303' ' ' MET . 31.0 m -73.37 -27.91 24.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.331 0.493 . . . . 42.51 112.331 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -75.62 -43.82 45.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.889 0.376 . . . . 71.32 110.703 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.95 76.74 10.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.344 0.498 . . . . 75.0 112.344 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.634 HD11 HH11 ' A' ' 240' ' ' ARG . 0.5 OUTLIER -163.28 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.864 171.061 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.999 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 32.4 t70 -178.35 164.22 1.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.993 -0.373 . . . . 64.13 109.993 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.658 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 2.2 t80 -58.58 -64.6 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.861 0.465 . . . . 75.25 111.069 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 t -114.77 36.42 3.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.409 0.623 . . . . 74.42 110.731 -173.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 9.9 tp10 -67.57 -86.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 65.41 111.481 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 179.98 137.53 0.29 Allowed Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 109.502 -0.555 . . . . 72.53 109.502 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -91.96 128.64 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.622 2.215 . . . . 73.12 112.995 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.498 ' O ' HD13 ' A' ' 320' ' ' LEU . 90.4 mt -79.96 75.78 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.518 -0.549 . . . . 74.03 109.518 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.6 ' CE1' ' HB3' ' A' ' 162' ' ' LEU . 67.1 t80 -57.67 -39.29 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.778 -0.646 . . . . 74.31 111.401 -174.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.08 -43.7 98.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.517 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -76.7 -29.87 56.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.52 -0.309 . . . . 72.5 111.225 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 323' ' ' ILE . 7.1 mp -69.34 -48.13 62.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 74.32 110.9 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.442 HH22 ' NH2' ' A' ' 160' ' ' ARG . 20.9 ttt180 -70.57 -28.13 64.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 75.34 109.758 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.41 -41.03 66.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.882 -0.599 . . . . 71.41 111.464 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -67.72 -36.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.956 -0.387 . . . . 75.14 109.956 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 155' ' ' LEU . 92.1 mt -60.46 -49.43 77.59 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.936 0.398 . . . . 61.21 110.079 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 159' ' ' LEU . 3.8 mm? -62.61 -37.92 88.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.554 . . . . 51.12 111.408 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -55.56 -47.36 76.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.586 -0.279 . . . . 75.2 110.827 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.586 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.83 -42.64 96.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 75.15 112.184 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 333' ' ' SER . 27.4 tp -65.86 -42.97 89.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 71.13 111.114 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -66.69 -32.59 73.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 73.22 110.363 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.19 64.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 54.24 111.089 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 328' ' ' LEU . 12.7 tt -85.68 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 120.948 0.404 . . . . 72.11 110.495 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.83 36.45 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.562 -0.827 . . . . 43.25 113.508 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.682 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 52.3 m -129.42 162.57 27.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.034 0.417 . . . . 73.12 111.16 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.785 ' HD2' ' HB2' ' A' ' 336' ' ' ASP . 5.6 tmtt? -179.5 -51.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.931 -0.766 . . . . 74.42 108.931 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.759 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 8.1 t70 70.04 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.154 -0.93 . . . . 71.3 110.473 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ASP . . . . . 0.785 ' HB2' ' HD2' ' A' ' 334' ' ' LYS . 10.9 t70 58.56 94.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.669 0.606 . . . . 72.11 111.21 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 150.14 -36.07 0.97 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.958 -0.857 . . . . 61.14 110.958 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 N-CA-C 109.547 -0.538 . . . . 62.43 109.547 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 mttt . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.153 0.501 . . . . 74.32 112.133 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 79' ' ' PRO . 95.8 m -150.44 137.35 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.641 -0.708 . . . . 73.22 109.946 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -66.91 134.03 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.271 0.558 . . . . 62.13 110.27 -176.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.454 ' N ' HD13 ' A' ' 354' ' ' ILE . 50.9 m -64.96 94.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 35.11 112.054 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 115.761 -0.654 . . . . 74.22 111.305 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HA ' HG13 ' A' ' 39' ' ' VAL . 61.3 t . . . . . 0 C--O 1.235 0.295 0 CA-C-O 120.896 0.379 . . . . 74.4 110.928 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.37 0.03 56.96 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.694 -0.765 . . . . 32.13 113.425 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 9.4 pt-20 -82.48 150.74 26.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.029 -0.73 . . . . 73.01 109.029 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 1.2 tp -91.42 131.54 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 63.24 110.057 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.34 132.14 71.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.498 -0.773 . . . . 72.23 109.222 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 m -118.08 114.08 22.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.935 -0.395 . . . . 75.21 109.935 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' OD2' ' HA3' ' A' ' 115' ' ' GLY . 4.7 p-10 -95.23 -172.02 2.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 70.21 110.41 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.1 mmt -70.58 -11.27 60.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.475 0.546 . . . . 74.23 112.475 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.06 2.45 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.226 -0.296 . . . . 53.34 110.372 174.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.28 24.93 8.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.517 -0.765 . . . . 74.21 110.687 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' THR . 29.1 mtpp -93.63 124.75 37.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.85 -0.614 . . . . 71.24 110.163 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.79 92.21 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.354 -0.61 . . . . 71.12 109.354 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 1.004 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 25.1 p-90 -116.83 140.02 49.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.792 -0.64 . . . . 74.33 111.141 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 56' ' ' MET . 23.6 pttm -85.6 139.26 31.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.101 -0.703 . . . . 44.22 109.101 174.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 25' ' ' VAL . 3.6 p -66.95 117.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 74.23 109.061 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.98 -121.59 4.89 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.418 -0.896 . . . . 40.51 112.731 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.685 HD22 ' HD2' ' A' ' 42' ' ' PRO . 2.4 tm? -73.31 118.02 65.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.916 0.388 . . . . 73.33 110.397 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.685 ' HD2' HD22 ' A' ' 41' ' ' LEU . 65.1 Cg_endo -75.91 96.7 1.07 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.492 2.128 . . . . 72.43 111.797 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 53' ' ' LEU . 56.7 mt -62.77 -45.56 98.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.242 0.544 . . . . 65.33 110.337 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.25 83.67 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.399 -0.819 . . . . 62.11 112.226 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -139.04 159.85 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.902 -0.407 . . . . 65.32 109.902 -174.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.73 49.88 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.634 -0.793 . . . . 74.32 111.497 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.03 112.06 2.71 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.686 -0.768 . . . . 60.04 112.218 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.583 ' HD2' ' HE2' ' A' ' 71' ' ' LYS . 21.5 m-85 68.25 -72.38 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.465 0.706 . . . . 71.2 111.447 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.8 174.91 13.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.034 -0.603 . . . . 72.51 111.625 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.39 31.1 17.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.379 . . . . 62.12 111.483 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 71' ' ' LYS . 18.1 mm -88.82 136.59 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.92 -0.4 . . . . 74.24 109.92 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -108.19 153.65 22.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.52 0.2 . . . . 73.32 110.975 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 43' ' ' ILE . 8.1 tt -100.91 137.39 39.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.372 -0.603 . . . . 52.25 109.372 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . . . -94.98 93.73 7.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 53.41 110.494 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.13 -15.87 57.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 72.13 110.837 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' MET . . . . . 1.004 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 47.8 mtp 59.94 -163.47 0.24 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.75 -0.659 . . . . 73.43 110.39 -176.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.38 141.22 48.45 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.545 -0.909 . . . . 62.23 108.545 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -77.35 38.12 0.22 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.337 0.495 . . . . 63.32 112.337 -171.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.324 -0.501 0 N-CA-C 109.592 -0.521 . . . . 74.22 109.592 173.744 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.516 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.221 0.452 . . . . 51.21 112.221 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.629 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 56.1 Cg_endo -71.21 62.39 2.62 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.697 1.598 . . . . 54.04 112.611 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 54' ' ' ALA . 9.3 p -120.79 152.47 38.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.7 -0.482 . . . . 74.34 109.7 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -122.94 155.8 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.656 0.265 . . . . 64.2 110.784 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -121.48 120.71 62.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.314 0.578 . . . . 54.23 111.415 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HG3' HD12 ' A' ' 51' ' ' ILE . 77.6 tttt -95.64 131.84 41.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 64.21 109.116 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 128' ' ' PHE . 34.7 m -118.68 151.76 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.207 0.447 . . . . 52.23 112.207 -173.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 127' ' ' ARG . 4.1 pt-20 -132.9 155.93 80.62 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.322 -0.399 . . . . 72.3 110.211 172.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.29 114.87 2.53 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.632 2.221 . . . . 74.25 112.24 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t 81.47 -96.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.032 0.933 . . . . 61.11 112.467 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -171.02 12.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.299 1.222 . . . . 62.0 114.299 -167.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.37 103.95 3.74 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.779 -0.768 . . . . 74.23 112.394 -171.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.96 -161.24 32.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.921 -0.657 . . . . 53.31 111.781 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.896 ' HB3' ' HA2' ' A' ' 199' ' ' GLY . 31.2 Cg_exo -60.02 -26.64 82.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.017 2.478 . . . . 72.33 112.465 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.8 tm? -64.52 -37.07 86.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.457 -0.572 . . . . 70.45 109.457 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.88 -38.28 86.02 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.214 0.53 . . . . 74.43 109.808 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.3 m -62.87 -45.05 94.37 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.68 -0.691 . . . . 72.33 110.162 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.68 -29.72 69.06 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.934 -0.576 . . . . 74.51 110.752 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -59.08 -50.24 74.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.418 -0.215 . . . . 74.42 110.418 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -58.57 -47.27 84.83 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.769 0.319 . . . . 63.54 110.627 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.405 ' HD2' ' CD1' ' A' ' 87' ' ' TYR . 83.8 t80 -57.58 -52.19 66.41 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.895 -0.593 . . . . 75.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CD1' ' HD2' ' A' ' 86' ' ' PHE . 6.1 m-30 -62.35 -43.73 98.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.594 -0.275 . . . . 75.44 111.232 -175.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.18 -33.46 76.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.81 0.3 . . . . 72.22 111.81 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -95.48 -23.04 17.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.663 0.616 . . . . 72.01 112.663 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HB2' ' HE2' ' A' ' 167' ' ' TYR . . . -104.11 -34.54 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.78 0.659 . . . . 73.4 112.78 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.81 78.36 9.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.31 0.576 . . . . 72.21 111.594 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 19.2 tptp -155.51 101.79 2.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.894 -0.78 . . . . 73.53 108.894 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -43.72 -46.46 10.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.878 3.052 . . . . 75.3 114.138 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.26 -51.73 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 75.2 111.156 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -64.95 -40.89 95.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 74.43 110.488 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 72.8 mt -57.94 -53.6 43.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 50.23 110.857 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -62.04 -31.05 71.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.829 -0.623 . . . . 72.23 110.637 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 98' ' ' LYS . 10.5 tppt? -70.54 -50.9 32.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.099 -0.501 . . . . 75.21 111.525 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -73.53 -35.66 65.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 119.749 -0.78 . . . . 65.43 110.57 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.84 -34.95 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.439 0.638 . . . . 71.42 110.089 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -65.46 -49.34 69.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.243 -0.89 . . . . 74.41 111.229 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -75.75 -41.8 52.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.287 0.477 . . . . 73.31 112.287 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 105' ' ' LEU . 18.4 mmt180 -78.1 -17.38 57.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.477 -0.329 . . . . 72.35 111.189 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 64.95 59.97 0.84 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.949 0.88 . . . . 54.42 110.177 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 103' ' ' ARG . 7.3 mp -97.09 -166.3 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.557 -1.201 . . . . 75.12 108.542 173.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -128.64 -54.42 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.9 -0.72 . . . . 52.32 112.388 -174.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -164.73 107.88 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.713 -0.395 . . . . 71.55 110.981 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.544 HD22 ' CZ2' ' A' ' 99' ' ' TRP . 18.2 tp -80.21 132.0 35.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.01 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.72 70.91 2.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.997 -0.62 . . . . 63.1 111.904 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 96' ' ' ILE . 11.3 p -115.89 142.44 29.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.515 -0.18 . . . . 62.5 110.515 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.478 ' HG3' HG11 ' A' ' 196' ' ' VAL . 6.8 Cg_exo -72.82 140.4 32.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.468 2.112 . . . . 72.43 112.084 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -72.57 106.49 4.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.696 -0.483 . . . . 74.32 109.696 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -81.7 119.91 24.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.985 -0.552 . . . . 74.15 110.743 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CD1' HG22 ' A' ' 130' ' ' ILE . 41.9 m95 -95.73 -65.63 0.96 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.205 0.526 . . . . 72.11 109.802 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.537 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -151.07 -170.76 18.43 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.622 -0.717 . . . . 75.23 112.317 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 129' ' ' MET . 51.2 p -167.8 -177.36 3.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.864 -0.421 . . . . 71.23 109.864 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.43 -175.08 38.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.22 -0.99 . . . . 43.43 112.629 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -133.39 127.88 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.915 -0.772 . . . . 54.03 108.915 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -138.62 120.87 15.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 63.2 110.772 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 11.7 t70 -81.36 131.26 35.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 63.42 110.612 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -96.26 -53.21 3.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 62.32 110.588 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -169.22 91.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 70.05 109.869 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.27 11.5 67.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.194 -0.527 . . . . 64.15 112.162 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -144.16 108.35 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.078 -0.342 . . . . 63.12 110.078 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.523 ' HB3' HD21 ' A' ' 118' ' ' LEU . 24.3 m -85.09 111.33 19.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.04 -0.527 . . . . 73.12 109.901 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -91.53 128.33 37.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 72.0 110.987 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 32.3 ttm180 -91.21 128.27 36.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.333 -0.988 . . . . 74.45 108.333 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.586 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.8 p90 -134.1 152.68 51.94 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.955 -0.298 . . . . 72.13 111.147 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 70.9 mtm -136.97 140.46 42.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.078 -0.51 . . . . 71.52 110.285 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 8.1 mm -99.05 119.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.212 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.35 -174.14 3.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 63.14 110.315 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.92 158.04 26.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 63.32 110.625 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -67.15 115.46 6.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 65.33 112.186 -174.673 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 29.7 m-85 -119.52 171.68 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.512 -0.767 . . . . 50.3 109.283 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 -54.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.385 -0.912 . . . . 52.22 112.105 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -81.1 124.31 29.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 74.42 110.702 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.624 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -92.95 145.35 24.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.094 -1.076 . . . . 64.2 108.094 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 33.1 tp -60.92 -38.08 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.668 -0.413 . . . . 73.22 110.065 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.878 ' HA ' ' HD2' ' A' ' 142' ' ' TYR . 50.7 tt0 -59.97 -37.24 79.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.2 111.531 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -55.24 -59.59 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 75.55 110.43 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.23 -39.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.264 -0.88 . . . . 73.22 111.12 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.878 ' HD2' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.48 -38.74 91.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.353 -0.385 . . . . 74.24 111.234 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' CE2' ' A' ' 142' ' ' TYR . 32.6 mt-10 -83.48 -18.49 38.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.722 -0.391 . . . . 71.22 111.439 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -79.03 -23.98 43.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.323 0.582 . . . . 71.42 110.06 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -97.72 1.09 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.544 -0.753 . . . . 71.44 109.27 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.76 39.92 30.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.105 -0.952 . . . . 62.25 111.98 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 41.5 pttt 42.52 38.29 1.21 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.074 0.95 . . . . 74.14 113.22 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -98.76 81.33 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.075 -0.713 . . . . 73.15 109.075 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.93 156.97 26.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.965 0.412 . . . . 71.14 111.291 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.8 t -99.34 -172.55 2.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 54.43 110.224 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.446 ' HD3' ' CD ' ' A' ' 298' ' ' GLU . 3.9 ttm180 -65.39 -24.03 67.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 71.53 111.294 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -58.09 -68.73 0.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.927 -0.579 . . . . 74.23 111.897 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.7 p -59.11 -47.34 85.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 63.33 111.905 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.33 -41.67 71.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.689 -0.687 . . . . 53.31 111.332 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -71.41 -50.03 35.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.363 -0.38 . . . . 73.44 110.412 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.92 -44.95 87.16 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.863 0.363 . . . . 75.12 111.204 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 161' ' ' ILE . 8.3 mp -61.29 -52.73 63.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.125 -0.489 . . . . 73.12 111.137 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.0 p -63.74 -34.13 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.24 . . . . 72.01 111.526 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.33 -53.44 57.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.412 -0.358 . . . . 71.21 110.356 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -70.16 -29.27 66.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.07 0.462 . . . . 73.31 110.78 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 157' ' ' LEU . 30.1 mm -67.5 -37.99 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.15 110.523 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.55 -39.92 95.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.971 -0.381 . . . . 62.54 109.971 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.17 -63.23 1.22 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.685 0.755 . . . . 71.43 110.462 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 195' ' ' LEU . 18.4 tt -64.45 -34.85 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.375 -0.829 . . . . 73.12 111.264 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 175' ' ' HIS . 50.3 tp -60.95 -40.05 91.82 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.825 -0.17 . . . . 63.31 111.274 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -65.74 -39.11 90.77 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.535 -0.466 . . . . 64.11 110.904 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 49.1 t80 -59.06 -49.44 77.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.371 -0.532 . . . . 73.11 111.594 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.0 pt -74.03 -32.2 32.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.813 -0.355 . . . . 64.14 110.969 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.95 -45.75 92.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 73.03 110.915 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.33 8.08 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.94 0.4 . . . . 73.43 110.928 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -104.86 -67.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.083 -0.247 . . . . 75.01 111.016 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -152.46 -58.94 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.518 0.562 . . . . 53.24 112.518 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HA ' ' A' ' 203' ' ' ARG . 10.5 p90 -121.36 164.75 16.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.331 0.863 . . . . 63.42 113.331 -164.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.9 173.27 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.756 -1.111 . . . . 71.32 108.931 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CE1' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -129.44 103.7 7.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.585 0.707 . . . . 74.52 112.038 -175.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.01 -39.4 89.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.362 -0.836 . . . . 53.1 111.524 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 1.018 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 28.5 t70 -89.84 91.07 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.256 0.55 . . . . 75.5 110.041 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 178' ' ' ILE . 8.4 tt -110.01 25.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.087 0.946 . . . . 75.23 109.242 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.6 162.16 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.138 -0.937 . . . . 74.14 109.96 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.14 -5.37 1.04 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.033 0.753 . . . . 75.24 113.033 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 352' ' ' LYS . 1.0 OUTLIER -76.87 -20.65 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 50.51 110.413 176.102 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -88.37 -15.12 36.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 71.25 110.292 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 138' ' ' LEU . 6.4 mp -97.52 120.57 38.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 70.33 110.297 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.5 mm? -116.22 141.82 47.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.957 -0.565 . . . . 74.12 110.449 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 190' ' ' PRO . 9.8 mp -99.29 160.36 14.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.772 0.32 . . . . 74.23 110.559 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.42 151.22 47.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.179 -0.675 . . . . 52.25 109.179 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.06 -26.23 62.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.303 0.483 . . . . 75.23 112.303 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 188' ' ' LYS . 32.5 tptt -112.36 -58.09 2.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.8 0.667 . . . . 74.05 112.8 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -104.57 131.13 22.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.414 0.626 . . . . 73.44 112.201 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 185' ' ' LEU . 96.5 Cg_endo -77.21 -7.5 17.15 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.326 2.684 . . . . 73.05 113.544 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.88 -6.9 57.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.313 0.578 . . . . 73.45 110.182 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.455 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 88.1 mm-40 -105.29 92.75 4.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 72.41 110.342 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.16 120.45 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.441 0.639 . . . . 63.44 109.849 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 61.9 m-85 -113.08 154.86 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.351 -0.84 . . . . 74.42 109.515 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 164' ' ' ILE . 14.0 tp -110.12 107.48 17.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.882 -0.414 . . . . 74.3 109.882 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.478 HG11 ' HG3' ' A' ' 111' ' ' PRO . 19.8 m -138.41 -166.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 54.53 109.972 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.05 56.17 1.06 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.854 0.835 . . . . 71.21 109.922 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -82.85 67.12 8.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.61 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.896 ' HA2' ' HB3' ' A' ' 79' ' ' PRO . . . -64.34 -57.84 12.11 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.436 -0.802 . . . . 51.54 111.498 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 222' ' ' ASP . 3.7 mp -106.47 88.06 2.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.341 0.591 . . . . 70.43 110.289 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -114.8 110.65 20.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.542 -0.754 . . . . 54.02 109.761 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.47 115.58 29.63 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.066 -0.516 . . . . 74.12 109.63 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 173' ' ' TYR . 35.8 ptt180 -69.76 137.36 51.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 71.0 111.543 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.625 ' CE1' ' HA ' ' A' ' 239' ' ' SER . 56.0 t80 -93.68 -55.64 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.561 -0.745 . . . . 75.21 110.546 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.5 p -110.81 96.73 30.3 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 72.43 110.651 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 28.8 Cg_exo -60.94 114.44 2.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.671 2.248 . . . . 63.35 112.077 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 64.45 20.19 12.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.609 -0.723 . . . . 70.04 111.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.05 60.23 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.872 -0.68 . . . . 61.34 113.121 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 55.6 t -88.88 118.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.806 0.336 . . . . 73.1 110.624 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.486 ' HB2' ' OE2' ' A' ' 212' ' ' GLU . 17.9 p80 -71.09 128.11 34.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 70.23 111.001 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -114.13 -31.02 6.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 60.23 111.164 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' A' ' 210' ' ' HIS . 2.8 mp0 59.1 -100.04 0.1 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.273 -174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.566 ' HA ' HG23 ' A' ' 236' ' ' VAL . 18.1 p90 -80.71 103.41 10.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.593 0.711 . . . . 75.43 110.953 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -98.14 -51.38 4.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.033 -0.729 . . . . 65.42 109.033 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 217' ' ' PRO . 37.0 tt0 62.65 90.48 0.08 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.197 -0.91 . . . . 75.11 112.525 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.47 82.55 62.88 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.531 -0.759 . . . . 75.35 109.872 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.419 ' HD3' ' HG2' ' A' ' 215' ' ' GLU . 56.7 Cg_endo . . . . . 0 CA--C 1.528 0.202 0 C-N-CA 123.068 2.512 . . . . 60.44 112.619 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 200' ' ' LEU . 2.6 m-20 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.467 0.651 . . . . 71.53 112.337 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 1.018 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . 147.24 164.16 11.0 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.919 -1.037 . . . . 63.54 111.017 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 226' ' ' GLU . 22.8 m -69.02 139.62 54.95 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.785 -0.45 . . . . 73.24 109.785 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.554 ' HA ' ' OG1' ' A' ' 228' ' ' THR . 49.4 mt -56.31 -22.33 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.569 0.699 . . . . 52.22 110.997 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 224' ' ' THR . 34.9 tt0 -51.68 -42.51 62.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.311 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 246' ' ' ILE . 59.1 m-85 -104.32 -90.72 0.38 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.766 -0.652 . . . . 74.43 109.635 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 225' ' ' ILE . 28.0 m 67.02 -63.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.822 0.701 . . . . 71.41 112.566 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 275' ' ' LYS . 49.7 m 67.75 172.09 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.284 0.634 . . . . 73.53 111.094 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.7 mp -71.75 -40.53 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.159 0.504 . . . . 71.5 109.866 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . 1.6 m-20 -54.3 -61.13 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.682 -1.145 . . . . 74.52 111.758 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.02 82.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 70.51 111.538 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -67.9 -26.54 66.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.499 -0.319 . . . . 74.12 111.503 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.463 ' HB3' HG12 ' A' ' 236' ' ' VAL . 65.6 t30 -80.36 -4.7 54.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.539 0.685 . . . . 55.11 109.66 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.66 76.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.55 -0.75 . . . . 60.34 112.326 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 213' ' ' TYR . 7.2 p -111.81 127.7 68.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.954 0.407 . . . . 64.11 110.441 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.94 112.24 39.05 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.004 -0.543 . . . . 74.32 109.704 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.686 ' HG2' ' HA3' ' A' ' 242' ' ' GLY . 24.6 Cg_exo -63.15 152.78 77.89 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.325 2.017 . . . . 52.43 111.398 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 16.0 p -77.09 -18.37 58.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.444 . . . . 71.3 111.08 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.801 ' HD3' ' HG3' ' A' ' 315' ' ' PRO . 7.1 ptp180 178.11 -40.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 71.52 110.449 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 241' ' ' ARG . 9.9 ttt180 -55.17 -53.91 49.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 74.44 111.771 -175.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.686 ' HA3' ' HG2' ' A' ' 238' ' ' PRO . . . -59.78 -44.98 96.52 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 116.005 -0.543 . . . . 63.42 114.232 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.51 -42.07 92.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 61.43 109.452 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.87 -36.12 82.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.734 -0.667 . . . . 74.02 110.828 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -51.03 71.26 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.997 -0.547 . . . . 64.02 110.339 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 227' ' ' PHE . 66.9 mt -63.23 -39.73 86.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.425 -0.807 . . . . 73.15 110.831 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.3 tp -57.82 -43.45 85.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.344 -0.389 . . . . 63.2 110.392 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.68 97.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.037 -0.602 . . . . 63.42 112.555 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 252' ' ' ILE . 35.5 m-85 -67.11 -31.22 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 74.31 111.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 178' ' ' ILE . 59.6 m -65.93 -44.13 86.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 72.44 109.655 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.1 mtp -61.62 -49.9 74.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.131 -0.94 . . . . 62.14 111.199 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.667 HD12 ' SD ' ' A' ' 286' ' ' MET . 4.6 tt -61.85 -36.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.993 -0.283 . . . . 64.24 110.875 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.441 ' HB2' HD21 ' A' ' 259' ' ' LEU . 8.7 tt0 -59.77 -50.48 73.68 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.101 -0.24 . . . . 72.31 111.323 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.13 -31.04 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.744 0.307 . . . . 71.23 111.186 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.0 tp -84.56 -19.13 33.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.336 0.495 . . . . 64.13 112.336 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.3 p -106.48 -27.83 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.109 -0.369 . . . . 64.5 111.979 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 113.35 -35.8 4.37 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.575 -0.821 . . . . 40.52 112.708 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -156.98 165.5 35.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.941 0.371 . . . . 70.21 110.081 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 253' ' ' GLN . 72.0 mt -94.27 139.61 22.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.201 -0.296 . . . . 65.24 110.201 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 32.8 Cg_exo -60.59 -27.31 84.62 Favored 'Trans proline' 0 CA--C 1.526 0.122 0 C-N-CA 122.726 2.284 . . . . 64.14 112.36 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -100.07 10.95 40.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.126 -0.488 . . . . 64.12 111.057 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 50.6 tt0 -69.28 -29.59 67.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.237 0.541 . . . . 72.31 110.906 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.3 -21.56 49.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.025 0.441 . . . . 74.3 110.733 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.84 5.25 24.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 72.43 112.012 -173.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 2.7 pp -79.88 8.25 7.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.915 0.388 . . . . 72.53 111.369 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -67.54 -17.85 64.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 70.42 110.093 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 16.0 t70 -141.64 134.21 13.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.63 -0.714 . . . . 71.44 109.522 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 46.9 Cg_exo -56.91 -19.16 30.72 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 123.308 2.672 . . . . 61.11 114.151 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.59 -53.92 51.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.032 0.444 . . . . 71.34 111.134 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -67.44 -33.88 76.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.051 -0.522 . . . . 70.4 110.439 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 225' ' ' ILE . 61.7 t -61.09 -43.08 95.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 54.25 110.372 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -55.13 -57.1 13.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 73.35 110.421 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -64.76 -40.87 96.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.94 -0.573 . . . . 62.22 111.472 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -59.76 -40.47 88.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.496 -0.32 . . . . 43.44 111.106 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 229' ' ' SER . 44.4 mmtm -66.96 -39.82 87.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.012 -0.275 . . . . 64.15 110.918 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 58.8 mt -63.95 -49.13 83.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.777 0.322 . . . . 72.42 110.824 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -57.78 -47.24 83.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 74.3 110.974 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.15 -36.26 64.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.312 0.486 . . . . 74.41 112.312 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -68.48 -29.02 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 75.41 110.252 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -65.24 0.75 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.975 -0.557 . . . . 75.55 110.021 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.439 ' O ' HD23 ' A' ' 285' ' ' LEU . 47.2 t30 -107.58 77.54 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 63.22 110.387 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 282' ' ' ILE . 0.2 OUTLIER -79.11 -48.83 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.283 -0.871 . . . . 72.14 111.193 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 65.41 112.205 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 39.3 t -66.23 -48.08 71.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.56 -0.291 . . . . 63.54 111.041 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -67.13 -34.17 77.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.652 0.241 . . . . 65.5 111.652 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.667 ' SD ' HD12 ' A' ' 252' ' ' ILE . 26.2 mmt -71.06 -37.94 72.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.961 0.41 . . . . 73.13 111.092 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.4 -38.91 12.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.145 0.424 . . . . 75.21 112.145 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -78.03 -15.09 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.135 0.421 . . . . 73.52 112.135 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 88.9 m -76.94 -21.58 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 75.13 110.516 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.623 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 6.4 m-85 -133.98 86.7 36.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 64.45 110.64 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.38 -69.03 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.73 2.287 . . . . 52.4 111.955 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.06 95.51 3.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.104 0.478 . . . . 72.23 110.271 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 178.61 -52.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.272 -1.01 . . . . 74.23 108.272 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.623 ' O ' ' HB3' ' A' ' 290' ' ' PHE . 27.7 t-20 -148.58 163.18 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.547 -1.206 . . . . 64.21 107.946 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 1.7 tpmt? -136.94 106.22 8.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.504 -0.478 . . . . 71.01 111.016 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.01 45.14 1.92 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.375 2.716 . . . . 65.54 111.537 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.58 99.76 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.784 -0.644 . . . . 73.22 112.319 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 298' ' ' GLU . 28.8 mp0 -62.78 -41.32 99.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.694 -0.484 . . . . 73.24 109.694 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.44 HG21 ' HB ' ' A' ' 252' ' ' ILE . 15.0 mm -63.93 -46.86 92.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.644 -0.707 . . . . 72.1 110.28 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.1 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.685 -0.689 . . . . 71.44 110.971 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.75 -44.52 95.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.776 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -56.62 -50.86 70.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.586 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.546 ' HA ' HG22 ' A' ' 306' ' ' VAL . 12.3 mtp -70.89 -38.62 73.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.633 -0.258 . . . . 61.23 111.612 -175.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.3 -35.74 81.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.504 0.668 . . . . 73.5 109.407 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 54.7 m -65.57 -52.85 49.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 71.03 111.22 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 303' ' ' MET . 35.3 m -67.26 -30.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.05 0.452 . . . . 45.41 110.802 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -57.44 -43.45 83.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 74.33 110.461 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.91 11.23 21.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.886 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 315' ' ' PRO . 42.9 mt -90.7 -23.29 20.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.874 -0.417 . . . . 72.53 109.874 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.577 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 28.6 t70 56.48 -156.72 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.447 -0.797 . . . . 32.11 110.748 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.577 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.1 m-85 -86.16 -33.01 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.916 0.389 . . . . 75.14 110.112 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.9 t -144.99 26.5 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.01 111.42 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 7.8 tt0 -92.88 23.19 4.33 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.512 0.672 . . . . 74.44 109.627 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.14 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 114.34 -1.3 . . . . 73.31 112.222 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.801 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 93.5 Cg_endo -78.88 119.6 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.823 2.348 . . . . 70.53 111.799 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.7 tp -93.41 84.36 4.72 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.0 0.429 . . . . 53.1 110.12 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 320' ' ' LEU . 74.2 m-85 -60.47 -32.77 71.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.623 -0.717 . . . . 75.51 110.086 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.78 -46.15 74.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.512 -0.767 . . . . 71.22 110.541 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 28.9 t-20 -72.33 -35.28 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.581 -0.282 . . . . 74.21 110.703 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 97.0 mt -58.39 -52.85 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 51.23 110.34 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.53 -21.54 61.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 75.45 110.323 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.04 -50.92 44.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.198 -0.455 . . . . 54.33 110.933 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -70.91 -29.59 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.795 -0.362 . . . . 63.11 110.996 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 85.5 mt -64.8 -49.4 70.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.082 0.468 . . . . 63.2 110.096 175.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.94 -26.76 64.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 75.32 110.945 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -58.48 -47.81 82.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 74.41 109.853 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.432 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -74.97 -39.88 36.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.819 -0.705 . . . . 61.54 112.368 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 2.6 tm? -57.67 -49.44 76.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.19 0.519 . . . . 72.4 110.204 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -24.61 58.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.431 -0.349 . . . . 73.34 111.477 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.63 91.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 75.04 111.184 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -88.21 -9.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.246 0.546 . . . . 52.54 110.602 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 69.49 20.86 75.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.928 -0.653 . . . . 63.34 112.952 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -131.73 138.64 48.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.803 0.302 . . . . 63.32 110.993 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 334' ' ' LYS . 26.6 mtmt -113.35 -73.07 0.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.859 0.838 . . . . 53.3 109.047 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -167.53 -39.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.069 -1.423 . . . . 71.33 107.718 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.6 t0 69.72 32.7 3.17 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 114.461 -1.245 . . . . 65.21 110.973 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.64 14.22 41.4 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.965 -0.636 . . . . 63.04 112.696 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 110.272 -0.27 . . . . 73.43 110.272 -176.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.48 ' CB ' ' HA3' ' A' ' 199' ' ' GLY . 65.8 mttm . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.097 -0.705 . . . . 72.21 109.097 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 12.0 t -169.63 140.14 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.109 -0.33 . . . . 73.32 110.109 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 138.37 22.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.799 -0.445 . . . . 73.21 109.799 178.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 32.8 m -68.55 80.92 0.27 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.352 0.596 . . . . 53.41 112.174 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 74.22 110.243 171.587 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.5 HG13 ' HA2' ' A' ' 40' ' ' GLY . 84.7 t . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.642 . . . . 64.41 109.265 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.99 2.13 56.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.147 -1.025 . . . . 43.34 113.422 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 31.3 mt-10 -78.72 140.79 38.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.282 0.541 . . . . 73.32 110.414 174.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -82.18 131.75 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 64.12 111.153 -175.353 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.59 135.04 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.08 -0.964 . . . . 72.34 108.943 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -115.64 133.73 55.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 63.44 110.28 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -97.58 -172.5 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.844 -0.428 . . . . 72.22 109.844 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 18.5 mmt -72.49 -20.02 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 71.14 110.99 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 12.93 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.538 -0.301 . . . . 24.14 110.983 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 11.6 mptt 65.86 33.14 8.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.911 -0.586 . . . . 70.24 112.404 172.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmpp? -83.58 115.16 21.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.34 84.28 3.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.347 0.594 . . . . 72.31 109.953 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 46.0 p-90 -114.84 149.73 36.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.724 -0.671 . . . . 64.43 110.933 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.836 ' HG2' ' HB2' ' A' ' 57' ' ' ASN . 18.2 pttp -98.57 134.46 41.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 71.24 109.377 173.365 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.06 132.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.694 -0.484 . . . . 64.22 109.694 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -107.56 -133.41 7.15 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.722 -0.751 . . . . 65.23 112.564 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 42' ' ' PRO . 38.8 tp -66.55 125.23 90.17 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.97 0.414 . . . . 52.12 111.667 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 41' ' ' LEU . 21.7 Cg_exo -65.67 108.99 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.394 2.063 . . . . 63.44 110.946 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 45' ' ' GLN . 47.5 mt -76.35 -52.32 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 62.32 109.709 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.88 -18.17 17.56 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.867 -0.682 . . . . 73.31 112.641 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.536 ' HB2' ' OD2' ' A' ' 137' ' ' ASP . 20.0 pt20 -124.45 165.14 18.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.676 -0.49 . . . . 72.23 109.676 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.97 66.26 0.15 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.794 -0.717 . . . . 61.42 111.916 -172.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 181' ' ' SER . . . 80.5 -88.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.998 -0.62 . . . . 52.35 112.83 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -89.59 -13.66 36.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 74.23 111.253 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.32 167.46 42.79 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.838 -0.696 . . . . 34.33 113.143 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.2 m 62.77 35.11 14.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.172 0.511 . . . . 62.01 111.56 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.825 HG23 ' HB3' ' A' ' 71' ' ' LYS . 5.3 mm -89.27 138.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 71.23 109.668 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.13 138.67 49.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.95 0.405 . . . . 73.24 111.088 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.435 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 tm? -73.02 127.21 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.706 -0.85 . . . . 73.32 108.706 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.02 91.37 7.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.279 0.562 . . . . 44.41 109.698 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.4 t70 -79.74 61.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.82 . . . . 61.33 109.03 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.591 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -35.8 127.96 0.66 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.65 -1.159 . . . . 75.34 112.302 -175.127 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.836 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 65.5 t30 -93.63 79.67 4.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.614 -0.721 . . . . 75.43 110.718 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 p -126.31 145.87 50.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.89 0.376 . . . . 72.14 110.964 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.81 -0.632 . . . . 75.31 109.785 173.264 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.273 0.559 . . . . 65.15 109.585 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 133' ' ' ARG . 4.5 Cg_endo -84.08 25.57 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.457 2.771 . . . . 71.43 112.424 -170.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB2' HG23 ' A' ' 130' ' ' ILE . 9.6 p -162.05 142.26 10.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.483 0.658 . . . . 54.34 112.566 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 133' ' ' ARG . 35.8 m -127.98 149.1 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.163 -0.926 . . . . 72.32 108.684 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.4 p -121.12 126.06 74.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.066 0.46 . . . . 74.43 109.954 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.825 ' HB3' HG23 ' A' ' 51' ' ' ILE . 25.1 pttm -111.13 139.87 46.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.291 -0.964 . . . . 63.0 109.944 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 128' ' ' PHE . 32.7 m -110.53 151.28 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.98 -1.009 . . . . 70.02 111.881 -168.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.723 ' OE1' ' HA ' ' A' ' 77' ' ' ASN . 43.1 tt0 -127.31 130.23 23.76 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.854 -1.066 . . . . 64.52 108.246 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -174.27 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.301 2.001 . . . . 73.44 112.272 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -66.34 71.86 0.07 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.28 0.562 . . . . 52.23 110.723 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -141.06 -59.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.772 -0.649 . . . . 62.44 109.309 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.723 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 69.97 87.91 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.305 1.003 . . . . 63.04 111.213 175.484 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.79 -80.07 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 51.32 112.547 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.57 -45.04 19.17 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.554 2.169 . . . . 73.44 112.668 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 71' ' ' LYS . 62.4 tp -73.18 -38.61 66.09 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.52 -0.548 . . . . 72.54 109.52 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 90.8 t80 -55.96 -44.0 78.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.036 -0.529 . . . . 73.5 110.579 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . 0.43 HG21 ' HA2' ' A' ' 199' ' ' GLY . 36.8 m -67.17 -49.64 64.0 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 115.879 -0.6 . . . . 73.55 111.4 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 197' ' ' ASP . 5.6 pt-20 -73.16 -24.14 60.53 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.057 -0.657 . . . . 54.51 110.923 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -64.13 -43.19 96.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.441 -0.577 . . . . 45.43 109.441 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 81' ' ' PHE . 32.4 mmmt -59.76 -48.33 82.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.051 -0.522 . . . . 74.35 110.483 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.69 -45.38 83.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.091 -0.504 . . . . 74.54 110.797 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 113' ' ' TYR . 47.5 t80 -61.58 -46.29 90.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.795 . . . . 73.13 110.975 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.0 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.284 . . . . 63.14 110.941 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.35 -39.82 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 72.52 110.685 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.61 15.64 27.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.056 0.455 . . . . 33.01 111.586 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 113' ' ' TYR . . . -80.45 40.22 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.114 -0.494 . . . . 64.2 112.195 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.778 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -138.59 114.98 8.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.523 -0.308 . . . . 73.5 110.617 -177.345 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.81 -31.08 91.45 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.545 2.163 . . . . 71.55 111.488 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.778 ' HG2' ' HB3' ' A' ' 92' ' ' LYS . 10.6 pt-20 -54.86 -53.0 61.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.601 -0.727 . . . . 74.04 111.132 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt-30 -72.17 -43.89 63.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.968 -0.56 . . . . 74.12 110.177 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.6 mt -53.87 -54.49 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.711 -0.677 . . . . 73.44 111.006 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.4 -32.72 71.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 70.04 110.718 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -58.39 -59.19 5.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.957 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.623 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.1 -31.81 70.79 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 120.162 -0.615 . . . . 75.14 110.774 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' ILE . 20.4 mt -54.49 -47.28 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 121.191 -0.203 . . . . 51.5 111.252 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -72.61 -35.24 67.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.041 -0.664 . . . . 71.43 110.954 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.6 m -70.52 -40.47 73.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.128 0.489 . . . . 65.34 111.979 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.63 ' HG2' HD13 ' A' ' 105' ' ' LEU . 5.3 tpt180 -87.12 -9.57 54.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.359 . . . . 71.4 110.982 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 67.93 37.99 2.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.966 0.889 . . . . 64.25 109.541 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.709 ' HG ' ' HB2' ' A' ' 163' ' ' ASP . 1.5 tp -79.81 170.69 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.974 -1.012 . . . . 74.3 109.301 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.489 ' HB3' HH22 ' A' ' 160' ' ' ARG . 9.3 tmtm? -113.33 -56.98 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.277 -0.569 . . . . 74.12 110.711 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -151.86 120.72 6.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.737 0.303 . . . . 74.23 110.235 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.623 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 33.5 tp -79.26 130.87 35.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.041 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.61 49.0 2.68 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.906 -0.664 . . . . 72.25 113.068 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.58 118.79 15.9 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 110.118 -0.327 . . . . 73.21 110.118 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 134' ' ' PHE . 92.5 Cg_endo -80.08 161.17 23.6 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.265 2.643 . . . . 64.31 113.468 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.36 137.25 58.24 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.742 -0.663 . . . . 71.4 111.436 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.463 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 40.5 t80 -94.33 133.49 37.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.351 -0.84 . . . . 75.33 110.33 177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.462 ' HB2' HG22 ' A' ' 130' ' ' ILE . 39.2 m95 -112.66 -36.39 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.047 -0.261 . . . . 74.14 111.699 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.87 48.3 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.484 -0.865 . . . . 63.23 112.601 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 80.3 p -169.71 166.71 9.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 61.14 109.939 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.53 174.12 33.02 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.205 -0.998 . . . . 61.33 112.644 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 125' ' ' SER . 10.1 tt -118.53 127.24 53.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.085 -0.709 . . . . 75.14 109.085 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -131.29 119.72 22.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.989 0.423 . . . . 71.32 110.192 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.723 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 37.9 t70 -74.29 120.8 20.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 72.15 109.572 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.68 -60.47 2.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.199 0.523 . . . . 64.21 110.312 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -178.41 96.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.883 -1.053 . . . . 74.3 108.3 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 -37.18 2.33 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.71 -0.757 . . . . 33.03 111.787 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -110.44 131.69 54.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.185 -0.302 . . . . 53.0 110.185 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 19.4 m -103.04 118.46 36.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.125 -0.489 . . . . 73.22 109.809 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.38 124.75 43.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.114 0.483 . . . . 72.31 111.017 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -98.41 120.29 38.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.183 -1.043 . . . . 71.24 108.183 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 72' ' ' VAL . 35.0 p90 -139.1 163.99 30.97 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.741 -0.384 . . . . 61.24 111.554 -171.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 26.0 ptt? -146.58 146.42 30.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.309 0.576 . . . . 62.33 111.635 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -96.68 124.37 49.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.439 -1.255 . . . . 71.04 110.631 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 16.6 ptm -130.66 176.46 8.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.147 -0.933 . . . . 74.52 109.014 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 69' ' ' VAL . 12.6 t70 -65.81 170.37 5.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.645 -0.422 . . . . 53.13 110.079 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.999 ' HD2' ' HB2' ' A' ' 188' ' ' LYS . 4.1 ptp180 -67.93 113.59 5.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.873 0.844 . . . . 73.31 112.639 -167.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -115.26 171.3 7.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.107 -0.951 . . . . 73.4 109.433 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.65 -43.4 0.18 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.624 -1.274 . . . . 72.52 113.389 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.763 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.3 m -80.63 122.41 27.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.945 0.402 . . . . 72.03 111.479 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 45' ' ' GLN . 5.1 m-20 -88.55 129.11 35.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.613 -0.721 . . . . 61.12 110.065 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 141' ' ' ILE . 14.8 tp -66.82 -29.96 70.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.389 0.614 . . . . 74.44 109.379 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.502 ' CG ' ' HB3' ' A' ' 137' ' ' ASP . 20.3 pt20 -62.56 -44.28 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.291 -0.868 . . . . 71.0 111.403 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HG3' ' HG3' ' A' ' 139' ' ' GLN . 63.2 mttp -78.8 -11.43 59.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.942 0.401 . . . . 63.35 110.715 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 138' ' ' LEU . 94.3 mt -74.9 -51.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.481 . . . . 73.53 110.145 172.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.833 ' HB2' ' HA ' ' A' ' 147' ' ' LYS . 1.1 p90 -72.08 -32.32 66.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.533 -0.467 . . . . 75.33 110.155 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.06 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.323 . . . . 75.51 110.845 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.88 -32.35 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.385 . . . . 63.54 111.378 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 50.0 t30 -104.41 19.78 19.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.75 -0.38 . . . . 75.31 111.773 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 54.57 32.42 16.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.869 0.468 . . . . 43.43 112.19 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.833 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 31.1 ttmt 65.43 22.32 11.91 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.586 -0.734 . . . . 73.21 112.0 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' ASN . 30.0 mmt180 -83.35 107.56 15.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.462 -0.57 . . . . 70.41 109.462 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -112.75 152.19 29.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 72.33 110.772 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 p -89.22 172.78 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 50.23 110.614 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 37.5 mmm-85 -68.23 -35.92 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 72.15 111.275 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -73.26 -39.74 65.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.799 -175.031 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.0 p -64.86 -56.17 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 61.15 111.237 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.45 ' CG1' ' HG3' ' A' ' 251' ' ' MET . 40.5 t -59.8 -37.43 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.085 -0.507 . . . . 75.43 110.919 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.821 HD22 ' HG ' ' A' ' 328' ' ' LEU . 15.0 tp -56.62 -51.22 69.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.646 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -68.0 -33.57 74.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.032 -0.531 . . . . 62.45 110.719 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 95.4 mt -61.7 -50.8 70.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 73.04 110.202 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -55.0 -37.9 67.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 72.22 110.942 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.92 -45.96 91.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.662 -0.244 . . . . 61.44 111.472 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.649 ' NE ' ' HA ' ' A' ' 160' ' ' ARG . 9.7 mmp_? -63.31 -38.61 91.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.134 0.493 . . . . 72.24 111.51 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.8 mp -71.81 -32.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.585 -0.446 . . . . 71.11 109.987 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -59.22 -56.0 27.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.497 -0.319 . . . . 62.22 111.321 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.709 ' HB2' ' HG ' ' A' ' 105' ' ' LEU . 43.4 p-10 -78.1 -24.64 47.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.049 -0.66 . . . . 75.0 112.018 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' A' ' 161' ' ' ILE . 12.1 tt -72.89 -36.49 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.268 -0.573 . . . . 71.03 110.41 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.517 HD23 HD11 ' A' ' 168' ' ' ILE . 42.6 mt -65.26 -38.1 89.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.288 . . . . 73.34 110.456 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -56.5 -51.69 67.54 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.4 0.619 . . . . 74.22 110.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -61.21 -49.98 74.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.132 -0.94 . . . . 64.12 112.29 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.517 HD11 HD23 ' A' ' 165' ' ' LEU . 35.1 pt -71.35 -37.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.277 -0.569 . . . . 73.34 111.518 -175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.723 ' HA ' HG12 ' A' ' 174' ' ' VAL . 62.9 t-80 -68.54 -40.86 80.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.372 -0.531 . . . . 74.34 111.554 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 209' ' ' VAL . 0.5 OUTLIER -85.54 13.86 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.379 -0.529 . . . . 63.04 111.294 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.2 78.76 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.503 0.668 . . . . 74.14 111.352 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 2.7 mp0 72.78 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.266 -1.334 . . . . 64.41 113.289 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.425 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 91.7 m-85 -80.79 118.13 22.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.023 0.749 . . . . 75.34 113.023 -162.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 169' ' ' HIS . 3.2 m -125.72 138.92 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.831 -0.622 . . . . 63.22 110.283 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 1.043 ' HB2' ' HA ' ' A' ' 201' ' ' ALA . 4.6 t-80 -175.68 -50.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.0 0.428 . . . . 64.52 110.94 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.35 -75.93 0.29 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.077 -0.809 . . . . 70.45 111.077 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.92 34.54 13.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.051 0.453 . . . . 74.23 111.764 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 161' ' ' ILE . 21.4 mm -79.39 65.26 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.026 0.917 . . . . 63.3 110.018 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.887 ' HE3' HG21 ' A' ' 224' ' ' THR . 12.8 mmtt -103.4 141.65 35.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 73.01 109.157 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.53 47.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.197 0.522 . . . . 72.34 110.807 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 11.7 p -77.09 -19.28 57.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 74.55 111.552 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.499 ' OD1' ' HE3' ' A' ' 352' ' ' LYS . 17.2 m120 -114.4 2.58 14.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.668 0.27 . . . . 63.34 111.231 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.543 HD21 HD11 ' A' ' 161' ' ' ILE . 10.7 mp -104.13 111.21 23.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.095 -0.705 . . . . 53.15 109.095 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 47' ' ' GLY . 3.7 mm? -113.57 130.81 56.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.056 0.455 . . . . 53.22 111.688 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.763 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 94.1 mt -75.06 145.62 42.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.385 -0.825 . . . . 75.14 110.432 173.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.822 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 24.2 t-20 -73.7 137.48 44.08 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.523 -0.917 . . . . 70.33 108.523 172.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.753 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 33.2 t80 -62.77 -31.14 72.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.095 0.474 . . . . 62.12 111.11 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.999 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 6.2 tmtm? -91.57 -45.55 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.973 -0.558 . . . . 74.03 110.151 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 48.6 m-80 -104.88 100.05 22.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.431 -0.349 . . . . 73.42 110.852 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.06 -6.15 13.04 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.975 2.45 . . . . 75.34 113.237 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.437 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 8.9 p-10 -92.86 -1.01 57.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.719 0.266 . . . . 74.21 111.719 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.481 ' OE1' ' HD2' ' A' ' 160' ' ' ARG . 84.4 mm-40 -129.09 129.73 45.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.383 . . . . 73.44 111.06 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 185' ' ' LEU . 28.6 m -106.03 143.31 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.269 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.822 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 36.8 m-85 -118.56 155.11 31.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.177 -0.465 . . . . 74.34 109.824 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 164' ' ' ILE . 11.3 mt -95.93 146.41 24.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.686 0.279 . . . . 73.03 110.964 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -120.84 -171.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.399 -0.593 . . . . 54.2 109.399 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 8.2 t70 76.25 -71.77 0.11 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.634 0.584 . . . . 74.42 110.638 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 23.1 m-85 58.03 9.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.545 0.943 . . . . 72.04 113.545 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.664 ' HA3' ' CG2' ' A' ' 354' ' ' ILE . . . -100.1 -33.98 5.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.937 -1.125 . . . . 61.44 114.444 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 8.5 mp -68.41 -23.03 64.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.369 0.584 . . . . 74.41 110.018 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 1.043 ' HA ' ' HB2' ' A' ' 175' ' ' HIS . . . -58.48 112.35 1.55 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.518 -0.764 . . . . 73.25 110.054 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' TYR . . . . . 0.654 ' HE2' ' HA ' ' A' ' 356' ' ' LYS . 6.4 t80 -98.47 132.37 43.97 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.56 -0.904 . . . . 75.33 108.56 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 7.1 ppt_? -86.54 141.56 28.96 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.405 0.521 . . . . 74.2 112.405 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.789 ' HB2' HG12 ' A' ' 209' ' ' VAL . 32.1 m-85 -69.67 -92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.309 -0.859 . . . . 72.14 109.947 170.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 40.1 m -142.48 141.23 20.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.889 -1.051 . . . . 72.25 108.793 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 50.1 Cg_exo -53.71 104.65 0.11 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.945 2.43 . . . . 73.1 112.454 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 62.1 22.15 12.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.448 -0.797 . . . . 73.14 111.564 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.58 42.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.04 -0.824 . . . . 73.22 111.04 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.789 HG12 ' HB2' ' A' ' 204' ' ' TYR . 15.8 m -59.29 109.89 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.483 0.659 . . . . 75.23 112.611 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 t60 179.85 124.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.266 -0.879 . . . . 65.44 109.156 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -152.67 163.38 39.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.554 -0.906 . . . . 70.14 108.554 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -112.25 174.95 5.64 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.516 -0.55 . . . . 53.45 109.516 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -61.82 101.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.348 0.594 . . . . 75.45 112.245 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -105.0 -3.41 23.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 74.12 110.057 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.433 ' HG3' HD21 ' A' ' 234' ' ' ASN . 43.0 tt0 66.03 -76.27 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 114.851 -1.068 . . . . 54.24 111.689 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -118.43 100.64 51.43 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.953 0.406 . . . . 75.35 111.917 -171.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 C-N-CA 122.71 2.273 . . . . 65.34 112.066 171.999 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.429 ' O ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.109 0.481 . . . . 71.24 110.316 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 162.74 177.9 36.13 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.177 -0.919 . . . . 54.42 110.924 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.887 HG21 ' HE3' ' A' ' 179' ' ' LYS . 23.6 p -78.63 117.12 19.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 71.42 110.574 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.614 ' HB ' HD12 ' A' ' 265' ' ' LEU . 57.9 mt -63.0 -21.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 63.33 112.124 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 265' ' ' LEU . 1.6 mp0 -58.26 -42.89 87.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.013 0.435 . . . . 75.41 110.273 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.59 ' HE1' ' HA ' ' A' ' 250' ' ' CYS . 97.8 m-85 -102.25 -18.44 15.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.604 -0.726 . . . . 74.32 110.69 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 225' ' ' ILE . 90.7 m -66.78 108.6 2.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.525 . . . . 74.34 110.982 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.9 p -73.29 -173.52 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.315 -0.857 . . . . 73.21 110.791 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.16 -38.05 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 72.42 110.317 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.62 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.447 -0.797 . . . . 71.55 111.353 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.06 -44.83 87.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 35.1 111.718 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -61.35 -37.33 82.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.834 0.349 . . . . 52.42 110.86 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 215' ' ' GLU . 29.0 t-20 -74.25 -36.88 63.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 63.34 110.535 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.87 -19.77 12.04 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.748 -0.739 . . . . 71.51 112.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.63 134.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 52.15 110.699 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.47 114.33 55.85 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.093 -0.503 . . . . 64.34 110.444 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.64 ' HB2' ' H ' ' A' ' 242' ' ' GLY . 87.1 Cg_endo -80.83 147.74 17.19 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.819 2.346 . . . . 71.12 112.428 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.42 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 49.0 m -88.55 69.77 8.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.934 0.397 . . . . 72.3 110.543 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.568 ' O ' HD23 ' A' ' 244' ' ' LEU . 20.2 mtp180 73.29 -4.76 2.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.39 -0.823 . . . . 75.45 111.461 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -56.74 7.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.457 . . . . 71.2 109.838 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 238' ' ' PRO . . . -71.22 -36.31 63.74 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.837 -0.697 . . . . 44.43 112.034 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.41 -49.53 69.73 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.375 0.607 . . . . 75.31 110.003 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 240' ' ' ARG . 4.4 mm? -72.04 -32.68 67.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 74.14 111.656 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.65 -38.03 80.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.384 -0.526 . . . . 74.44 110.553 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 242' ' ' GLY . 60.4 mt -59.81 -44.22 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.318 -0.253 . . . . 55.35 110.318 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 161' ' ' ILE . 53.6 tp -60.57 -36.35 78.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.879 0.371 . . . . 44.12 110.429 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.64 95.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.907 -0.663 . . . . 72.34 111.684 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -62.14 -44.59 96.29 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.053 -0.351 . . . . 75.02 110.053 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.59 ' HA ' ' HE1' ' A' ' 227' ' ' PHE . 39.3 m -59.31 -50.19 74.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 75.33 110.709 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.45 ' HG3' ' CG1' ' A' ' 154' ' ' VAL . 26.7 ttt -60.15 -48.53 81.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.536 -0.756 . . . . 72.34 111.583 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.423 HG23 HD21 ' A' ' 259' ' ' LEU . 12.9 tt -68.1 -33.35 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.752 -0.379 . . . . 75.45 110.872 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.712 ' HG2' ' HD3' ' A' ' 147' ' ' LYS . 8.5 tt0 -66.82 -46.95 73.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.633 -0.258 . . . . 73.11 110.738 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -66.85 -27.98 67.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.048 0.452 . . . . 72.11 110.747 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 294' ' ' ASN . 24.0 tp -77.65 -28.64 51.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.52 . . . . 72.42 111.457 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' THR . . . . . 0.437 HG22 ' CE2' ' A' ' 290' ' ' PHE . 27.8 p -101.47 -27.31 13.2 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.232 0.456 . . . . 43.12 112.232 -173.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.477 ' HA3' ' NH1' ' A' ' 148' ' ' ARG . . . 96.79 -37.27 3.5 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.573 -0.822 . . . . 74.45 111.579 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.14 142.21 19.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.75 -0.463 . . . . 75.12 109.75 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.562 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 89.4 mt -97.5 145.05 29.03 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.137 -0.483 . . . . 74.44 110.406 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.07 -20.53 61.43 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.702 2.268 . . . . 74.33 112.875 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.587 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 12.6 p90 -106.58 -2.79 21.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.424 -0.511 . . . . 75.42 111.969 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.591 ' O ' HD22 ' A' ' 265' ' ' LEU . 8.2 pt-20 -86.36 -25.92 25.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.901 -0.719 . . . . 72.5 109.662 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.94 -37.34 55.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.607 0.718 . . . . 72.01 109.668 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -108.86 27.58 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.02 . . . . 71.11 111.588 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.614 HD12 ' HB ' ' A' ' 225' ' ' ILE . 1.4 pt? -86.05 -2.0 57.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.951 0.405 . . . . 72.12 111.062 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.6 -8.64 43.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.917 -0.583 . . . . 74.24 111.44 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 269' ' ' LYS . 10.4 t0 -128.25 122.99 22.27 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.874 -0.417 . . . . 61.02 109.874 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.05 -26.34 25.27 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.57 2.847 . . . . 74.12 114.041 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.7 mttp -55.03 -50.09 69.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.865 0.364 . . . . 73.1 110.882 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -73.97 -36.35 64.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 72.24 111.844 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.92 -50.53 75.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.891 0.377 . . . . 44.31 110.39 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -67.32 -42.85 82.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.872 -0.603 . . . . 71.25 110.59 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 277' ' ' ARG . 18.4 t70 -55.26 -61.74 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.631 -0.713 . . . . 75.14 110.65 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.2 p -57.01 -47.86 79.86 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.647 0.592 . . . . 63.33 112.253 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -58.73 -49.78 76.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.209 0.448 . . . . 73.14 112.209 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.94 -37.95 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.972 0.415 . . . . 72.12 110.369 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 273' ' ' ASP . 27.6 ttt180 -58.16 -44.02 87.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.474 -0.784 . . . . 55.12 110.761 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.9 m-85 -73.22 -31.25 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 70.34 110.976 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.59 ' HA ' ' HD3' ' A' ' 307' ' ' LYS . 2.0 ttp180 -67.18 -23.46 65.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.628 -0.26 . . . . 65.14 111.207 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.03 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.986 0.422 . . . . 55.11 110.829 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 285' ' ' LEU . 2.8 t-20 -110.18 94.36 4.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.251 -0.648 . . . . 71.14 109.251 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.632 ' HB ' ' HG2' ' A' ' 304' ' ' GLU . 12.9 mt -80.4 -47.74 20.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.319 -0.855 . . . . 71.45 111.599 -170.498 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' HB2' ' OE2' ' A' ' 304' ' ' GLU . . . -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 71.42 112.341 -171.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.5 t -61.1 -41.37 96.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.651 0.241 . . . . 75.31 111.651 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.4 mm? -72.16 -42.99 65.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.705 0.288 . . . . 74.1 110.998 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -74.33 -34.46 63.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.847 0.356 . . . . 62.21 110.987 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 14.2 t70 -70.43 -33.65 71.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 75.04 110.174 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -76.87 -11.48 59.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 71.53 111.369 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.3 m -63.74 -55.29 24.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.752 0.311 . . . . 75.42 110.975 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 293' ' ' LYS . 50.5 m-85 -136.76 73.0 54.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 74.35 111.299 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.23 -53.62 3.39 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.394 2.063 . . . . 74.42 112.28 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -120.58 -25.13 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.45 0.537 . . . . 72.31 112.45 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 293' ' ' LYS . 9.7 tmtm? -71.56 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.5 110.683 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 25.2 t-20 -158.89 -90.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.984 -0.286 . . . . 73.21 110.791 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.585 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 28.8 tptp 172.75 115.64 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-O 120.825 0.345 . . . . 75.11 110.348 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.793 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 95.8 Cg_endo -89.88 59.94 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.99 2.46 . . . . 65.14 111.612 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.94 -83.02 1.56 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.391 -0.909 . . . . 64.22 113.06 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.501 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -53.63 -54.98 29.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.795 0.438 . . . . 60.14 111.14 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.657 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.0 mp -58.26 -42.56 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 73.13 111.278 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.24 -54.1 48.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 73.35 111.019 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -65.48 -37.83 87.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.137 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 17.7 t80 -58.53 -42.81 88.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.224 0.535 . . . . 73.42 110.278 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.411 ' HA ' ' CE ' ' A' ' 303' ' ' MET . 1.0 OUTLIER -65.34 -47.05 77.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.449 -0.796 . . . . 72.25 111.051 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 282' ' ' ILE . 46.8 mt-10 -59.12 -47.04 86.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 74.23 109.837 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 88.1 m -57.67 -52.19 66.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.259 -0.882 . . . . 62.24 112.154 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.537 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 33.4 m -67.92 -27.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 73.53 111.485 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 279' ' ' ARG . 44.0 mttp -80.81 -16.26 54.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 74.21 110.891 176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 82.6 mt -89.62 0.74 56.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 52.13 110.664 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 314' ' ' LYS . 27.6 mt -79.81 0.19 31.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.3 0.571 . . . . 52.43 109.718 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 31.3 t70 64.55 -88.44 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.611 -1.177 . . . . 64.23 111.939 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -153.73 -48.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.204 0.526 . . . . 74.22 110.415 -173.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.9 m -140.06 33.53 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.553 . . . . 73.15 110.841 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 49.7 mm-40 -82.99 -88.65 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.102 -0.374 . . . . 73.53 111.482 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.656 ' O ' HD22 ' A' ' 309' ' ' LEU . 10.3 ptpp? -175.98 154.25 1.42 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.12 -0.696 . . . . 74.41 109.12 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 240' ' ' ARG . 96.3 Cg_endo -90.66 125.75 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.213 1.942 . . . . 63.21 110.807 167.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 316' ' ' LEU . 7.5 tp -79.48 79.66 5.92 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.23 -0.656 . . . . 74.14 109.23 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.443 ' CE1' HD12 ' A' ' 162' ' ' LEU . 73.7 t80 -55.51 -49.37 72.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.973 -1.012 . . . . 75.43 112.524 -171.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -34.36 70.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.611 -0.268 . . . . 61.11 111.179 -175.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.25 -45.71 69.08 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.336 -0.246 . . . . 72.21 110.336 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.86 -45.22 86.64 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.318 -0.401 . . . . 63.52 110.795 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.25 -42.26 93.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 54.23 110.275 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.97 -55.51 32.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 64.54 111.202 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.49 -28.14 42.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.677 0.275 . . . . 74.54 111.401 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 155' ' ' LEU . 27.0 tp -66.71 -50.92 61.25 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.474 0.654 . . . . 74.32 110.125 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.4 mm? -73.35 -32.81 64.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 73.14 110.441 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -63.85 -47.54 80.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 61.31 110.773 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.2 -40.77 96.97 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 44.02 112.061 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.821 ' HG ' HD22 ' A' ' 155' ' ' LEU . 2.3 tm? -68.96 -41.6 77.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.098 0.475 . . . . 73.53 110.153 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.98 -25.3 67.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 72.44 110.681 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.57 -22.57 63.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 72.43 112.34 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.5 tt -92.25 -1.07 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.338 0.589 . . . . 71.31 110.694 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.82 24.11 33.66 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.451 -0.88 . . . . 52.02 112.622 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.411 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 50.2 m -128.86 169.37 14.67 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 122.748 -0.266 . . . . 72.01 110.407 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -159.22 -154.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.296 -0.631 . . . . 70.32 109.296 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.97 116.96 4.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.609 0.242 . . . . 65.15 111.014 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.71 89.66 3.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.094 -0.503 . . . . 61.53 111.493 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 68.4 13.36 65.12 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.004 -0.544 . . . . 64.4 114.165 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 338' ' ' LYS . 29.8 mmtm . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.684 0.624 . . . . 75.01 112.684 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 110.301 -0.259 . . . . 75.24 110.301 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 41.7 m -107.65 139.72 41.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.507 -0.315 . . . . 64.41 110.848 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.664 ' CG2' ' HA3' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -68.83 134.18 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.833 0.349 . . . . 73.13 110.73 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 222' ' ' ASP . 12.3 t -93.41 142.55 27.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 60.24 111.885 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 202' ' ' TYR . 23.5 pttm . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 115.096 -0.956 . . . . 65.13 108.978 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 40' ' ' GLY . 66.4 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.114 -0.328 . . . . 71.42 110.114 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 38' ' ' LYS . . . 100.38 2.86 55.61 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.96 -0.638 . . . . 63.52 112.856 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.04 130.95 44.8 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.81 -0.811 . . . . 75.31 108.81 173.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.53 128.86 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 62.0 111.505 -172.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -125.87 129.81 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.915 . . . . 62.2 109.939 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.7 m -104.29 123.13 46.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.075 -0.511 . . . . 71.51 110.035 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.707 ' HA ' ' HZ ' ' A' ' 128' ' ' PHE . 4.8 p-10 -82.26 175.65 10.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.544 -0.539 . . . . 71.02 109.544 175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.5 ptm -71.86 -11.2 60.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.233 0.457 . . . . 75.14 112.233 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.75 2.59 53.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 71.04 110.25 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 65.91 77.91 0.28 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.091 -0.959 . . . . 73.2 112.586 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.88 138.67 9.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.26 -0.882 . . . . 50.51 109.079 167.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -89.1 130.48 35.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 73.43 111.77 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 20.8 p-90 -136.07 147.21 47.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.503 -0.772 . . . . 73.42 109.27 172.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 17.0 pttp -94.59 136.78 34.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.416 -0.514 . . . . 70.05 111.003 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.2 144.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.684 -0.689 . . . . 52.43 109.794 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -108.39 -110.61 3.41 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.58 -0.819 . . . . 62.2 112.763 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.5 mp -95.35 137.1 22.13 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 63.22 111.235 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.0 Cg_exo -75.14 120.08 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.967 2.444 . . . . 74.14 111.449 174.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 53' ' ' LEU . 42.3 mt -90.88 -33.6 5.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.34 0.591 . . . . 74.44 110.097 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.8 -47.17 2.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.803 -0.713 . . . . 72.32 111.775 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -122.95 165.35 16.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.013 -0.366 . . . . 74.32 110.013 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.53 55.07 0.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.026 -1.229 . . . . 72.3 110.026 -170.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 154.0 -93.39 0.14 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 111.141 -0.784 . . . . 61.33 111.141 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.624 ' H ' HD11 ' A' ' 51' ' ' ILE . 90.1 m-85 -146.41 -55.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.239 -0.652 . . . . 75.25 109.239 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.03 157.55 29.86 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.695 -0.562 . . . . 65.23 111.695 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.0 t 57.34 46.27 18.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.185 0.517 . . . . 63.12 110.762 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 71' ' ' LYS . 42.5 mm -88.45 138.48 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 71.12 111.817 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.3 152.4 37.86 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.12 -0.491 . . . . 73.44 111.067 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 43' ' ' ILE . 9.5 tt -101.32 143.92 30.78 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.196 -0.668 . . . . 72.11 109.196 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.93 108.43 17.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.071 0.462 . . . . 53.34 110.912 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.33 42.37 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 71.2 109.592 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.901 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 13.0 tpt -49.5 -30.88 9.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.275 -0.875 . . . . 65.43 112.553 -176.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' MET . 8.9 m-80 68.99 -166.36 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.311 0.382 . . . . 63.42 110.332 -177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 m -124.93 148.46 48.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.255 -0.276 . . . . 61.13 110.255 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 61.21 111.119 -179.039 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.424 0.63 . . . . 43.31 110.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.808 ' HA ' ' HG2' ' A' ' 133' ' ' ARG . 4.8 Cg_exo -76.62 85.54 1.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.98 2.454 . . . . 74.23 112.303 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 131' ' ' MET . 6.1 p -153.66 138.68 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.222 0.534 . . . . 43.21 111.441 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.16 160.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.48 -0.782 . . . . 73.35 109.115 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 4.1 p -128.1 119.41 50.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.653 0.739 . . . . 72.22 111.958 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.9 ptmt -99.96 123.3 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.083 -0.962 . . . . 65.45 109.677 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG12 ' CB ' ' A' ' 128' ' ' PHE . 13.9 m -114.29 151.85 16.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.054 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' VAL . 18.1 mm-40 -165.34 145.27 5.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 O-C-N 123.821 0.701 . . . . 73.24 110.025 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' TYR . 27.4 Cg_endo -63.47 141.25 79.97 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.291 1.994 . . . . 74.14 111.532 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -64.84 -21.38 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.103 0.478 . . . . 51.13 110.448 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.26 11.12 15.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.919 -0.582 . . . . 62.23 111.931 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 54.4 t30 -95.26 -53.91 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.392 -0.523 . . . . 74.31 110.312 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.66 -76.04 0.41 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.901 -1.142 . . . . 51.12 114.248 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.45 -35.36 21.49 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.195 3.263 . . . . 70.52 114.684 -170.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -56.84 -45.42 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 71.15 110.395 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.46 -31.47 70.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.697 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.8 m -65.64 -49.02 70.2 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.205 -0.452 . . . . 75.15 110.64 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.65 -31.83 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.14 109.862 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD13 ' HG2' ' A' ' 129' ' ' MET . 59.8 tp -61.34 -41.33 96.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.929 -0.578 . . . . 64.51 110.739 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.736 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -62.23 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.56 -0.291 . . . . 74.42 110.608 177.078 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.91 -51.91 68.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.211 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE1' ' HG2' ' A' ' 131' ' ' MET . 73.0 t80 -60.43 -34.55 74.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.493 -0.776 . . . . 72.14 111.826 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.93 -42.41 69.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.311 . . . . 72.42 111.442 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -80.51 -28.27 37.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.421 -0.354 . . . . 53.01 110.776 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -93.64 16.23 14.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.857 0.36 . . . . 53.42 111.325 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -95.2 164.88 12.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.377 -0.374 . . . . 61.13 111.619 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 37.9 ttmt 72.29 110.5 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 74.23 111.389 176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.01 -36.98 78.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.404 2.736 . . . . 70.34 113.34 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.25 -42.1 98.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.925 0.393 . . . . 71.55 110.941 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -66.65 -48.64 68.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 64.54 109.889 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.5 mt -56.57 -51.31 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.303 -0.862 . . . . 53.25 110.598 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.4 -36.74 69.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 45.42 110.683 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -61.95 -56.52 18.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 75.23 111.236 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.594 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 2.1 p90 -72.55 -35.04 67.91 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 119.683 -0.807 . . . . 74.55 111.154 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' ILE . 33.4 mm -58.3 -42.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.47 0.653 . . . . 71.42 109.984 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.83 -57.77 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.021 -0.991 . . . . 74.25 111.222 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -71.6 -29.88 65.19 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.181 0.437 . . . . 61.42 112.181 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -83.55 -6.25 59.4 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.453 0.538 . . . . 72.43 112.453 -177.901 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.6 mptt 63.34 31.0 15.51 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.511 0.507 . . . . 74.32 111.237 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 94.4 mt -83.59 169.08 15.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.661 . . . . 72.31 109.558 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -101.94 -72.74 0.68 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.16 0.43 . . . . 61.12 112.16 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -150.8 110.46 4.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.509 . . . . 75.22 111.614 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -79.77 127.92 32.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 43.35 110.692 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.95 67.87 3.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.025 -0.607 . . . . 74.14 112.398 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 ' HB1' ' A' ' 90' ' ' ALA . 6.2 p -110.65 135.3 20.73 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 122.284 0.234 . . . . 73.45 110.694 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 194' ' ' TYR . 34.8 Cg_exo -61.0 152.87 68.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.996 2.464 . . . . 74.31 113.136 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -70.34 136.54 49.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.761 -0.654 . . . . 62.42 111.124 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.459 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 48.7 t80 -84.53 129.79 34.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.679 -0.691 . . . . 63.44 111.461 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.623 ' HB2' HG22 ' A' ' 130' ' ' ILE . 81.7 m95 -120.78 -50.78 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.327 0.584 . . . . 75.42 109.974 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.17 178.3 43.05 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.747 -0.661 . . . . 52.13 112.321 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' MET . 22.8 t -164.69 -178.87 5.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.429 -0.582 . . . . 42.02 109.429 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.91 -151.52 23.23 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.969 -0.634 . . . . 70.11 111.921 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.6 pt? -137.13 145.67 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.904 -0.406 . . . . 62.05 109.904 175.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -149.19 108.1 3.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.452 -0.34 . . . . 73.11 110.199 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 17.0 t70 -174.34 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.504 0.503 . . . . 75.12 110.286 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 54.1 29.68 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.406 0.622 . . . . 65.2 111.419 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.03 -30.95 6.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.582 -0.895 . . . . 74.32 108.582 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.75 -42.08 0.35 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.919 -1.037 . . . . 64.54 111.316 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 125' ' ' SER . 14.9 tptm -173.58 -177.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.525 -0.546 . . . . 64.35 109.525 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 1.2 p -76.32 104.99 7.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.501 0.667 . . . . 73.44 111.212 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 7.3 m-85 -98.36 120.48 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.505 -0.77 . . . . 71.31 110.002 176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -92.03 142.49 27.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.978 -0.379 . . . . 72.15 109.978 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' ' 31' ' ' ASP . 52.9 p90 -127.82 143.68 51.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.512 -0.313 . . . . 75.15 110.737 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 77.2 mtp -123.1 122.14 37.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 74.52 110.496 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.623 HG22 ' HB2' ' A' ' 114' ' ' TRP . 4.7 mm -98.42 117.04 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 64.5 110.173 175.872 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 67.2 mtm -127.84 179.89 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.187 -0.671 . . . . 62.23 109.187 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.1 t70 -63.54 154.3 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.315 -0.624 . . . . 75.21 109.315 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.808 ' HG2' ' HA ' ' A' ' 67' ' ' PRO . 11.6 ptp180 -82.31 125.37 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.494 0.664 . . . . 61.44 110.992 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -104.34 171.7 7.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.529 -0.76 . . . . 65.52 109.781 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.75 -38.7 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.855 -1.164 . . . . 51.1 113.264 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.799 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 69.8 m -94.37 124.71 38.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 71.33 111.485 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.559 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 1.1 m-20 -90.21 134.54 34.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.868 -0.606 . . . . 72.52 110.038 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.8 tp -69.66 -29.22 66.62 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 174.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 29.0 pt20 -69.86 -33.12 71.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.745 -0.661 . . . . 75.34 110.987 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -69.56 -39.8 77.17 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.376 -0.601 . . . . 74.33 109.376 178.121 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.57 -40.97 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.7 -0.682 . . . . 74.31 110.115 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.754 ' CE1' ' HD3' ' A' ' 147' ' ' LYS . 22.5 t80 -52.75 -48.83 66.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.58 . . . . 74.54 110.655 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.8 -44.92 79.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 74.12 111.371 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.57 51.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.039 0.385 . . . . 70.23 112.039 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -96.74 2.59 52.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.935 0.397 . . . . 64.31 110.887 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.16 38.55 29.97 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.074 -0.512 . . . . 72.43 111.644 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.754 ' HD3' ' CE1' ' A' ' 142' ' ' TYR . 37.3 pttt 46.33 29.46 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 75.0 113.726 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -99.92 84.08 2.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.366 -0.605 . . . . 63.33 109.366 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 5.0 m-30 -94.52 156.38 16.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.782 -0.644 . . . . 71.35 110.68 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 p -73.51 138.06 44.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.239 -0.652 . . . . 75.21 109.239 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.79 71.53 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.326 0.491 . . . . 73.51 112.326 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -60.15 -39.25 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 72.35 110.929 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.461 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 30.4 m -71.57 -40.43 69.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.102 -0.499 . . . . 65.33 110.057 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.14 -47.18 84.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.778 -0.646 . . . . 70.14 111.28 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.758 ' HB3' HD22 ' A' ' 328' ' ' LEU . 0.2 OUTLIER -70.71 -44.11 67.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.687 -176.99 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -55.73 -46.2 77.81 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.03 0.443 . . . . 74.13 110.736 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 161' ' ' ILE . 87.7 mt -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.903 -0.59 . . . . 72.04 110.931 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 p -64.24 -32.25 73.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 72.35 111.808 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.54 HD11 HD23 ' A' ' 325' ' ' LEU . 76.3 mt -61.25 -53.41 57.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.658 0.266 . . . . 73.42 110.851 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -66.81 -29.47 69.42 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.106 0.479 . . . . 61.4 110.538 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 28.2 mm -68.97 -35.04 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 71.04 110.359 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.44 -46.62 89.31 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.729 -0.471 . . . . 63.13 109.729 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -57.2 -48.38 78.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.479 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 161' ' ' ILE . 15.9 tt -72.32 -36.85 56.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.443 -0.344 . . . . 73.14 111.607 -175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.43 HD21 HD11 ' A' ' 178' ' ' ILE . 37.1 mt -64.63 -38.7 91.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.99 -0.284 . . . . 72.4 110.84 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -71.32 -37.9 71.75 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.942 -0.303 . . . . 62.42 110.532 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -50.91 -42.21 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 61.23 110.979 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 169' ' ' HIS . 38.8 pt -91.91 -43.82 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.411 0.523 . . . . 75.15 112.411 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.415 ' N ' HG13 ' A' ' 168' ' ' ILE . 3.0 t-160 -72.86 -30.94 64.38 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.623 0.249 . . . . 63.02 111.567 -171.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.489 ' HG2' HH22 ' A' ' 240' ' ' ARG . 3.5 tm-20 -59.18 -28.77 66.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 70.41 110.084 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -101.41 -66.47 0.91 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.745 0.646 . . . . 61.2 112.745 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 173' ' ' TYR . 11.3 pt-20 -145.97 -60.56 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.219 1.192 . . . . 73.34 114.219 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.606 ' HB3' ' HD2' ' A' ' 203' ' ' ARG . 55.2 p90 -104.42 160.36 14.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.343 0.592 . . . . 74.34 112.47 -168.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 14.2 m -129.54 172.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.096 -0.956 . . . . 74.32 109.741 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 13.4 t-80 -98.98 -41.32 7.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.834 -0.432 . . . . 72.15 109.834 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 228' ' ' THR . . . 62.66 38.45 96.46 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.766 -0.73 . . . . 44.44 112.754 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.553 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 19.3 t70 179.71 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.765 0.426 . . . . 65.34 109.889 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.43 HD11 HD21 ' A' ' 165' ' ' LEU . 49.5 mm -111.16 79.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.508 0.67 . . . . 61.43 110.1 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.79 ' HZ2' ' HD2' ' A' ' 227' ' ' PHE . 46.4 mttp -103.79 153.05 21.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.46 -0.791 . . . . 64.44 110.647 174.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -63.36 -16.27 59.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 72.31 110.918 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 12.7 m -71.84 -14.16 61.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.961 -0.563 . . . . 63.44 111.472 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -97.43 -12.4 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 74.14 110.913 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 8.0 mp -105.67 120.26 41.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.363 0.601 . . . . 73.32 110.622 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 196' ' ' VAL . 3.6 mm? -118.03 131.35 56.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.298 -0.865 . . . . 51.24 110.131 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 86.2 mt -86.84 154.9 20.52 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.485 -0.561 . . . . 71.25 109.485 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.13 153.46 18.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.344 -0.984 . . . . 73.21 108.344 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -47.56 -33.29 6.3 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.419 0.525 . . . . 62.25 112.419 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -154.84 51.75 0.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.519 . . . . 75.34 110.441 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 2.7 t-20 -135.43 107.4 10.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.379 -0.601 . . . . 72.01 109.379 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 23.2 Cg_exo -66.49 -29.49 44.7 Favored 'Trans proline' 0 N--CA 1.474 0.36 0 C-N-CA 123.437 2.758 . . . . 41.23 115.305 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.492 ' HB3' ' HG3' ' A' ' 338' ' ' LYS . 0.7 OUTLIER -94.29 -21.91 18.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.079 -0.649 . . . . 64.12 111.483 -173.334 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 194' ' ' TYR . 19.4 tp60 -91.38 93.62 9.12 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.569 0.7 . . . . 73.32 110.373 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.49 142.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.838 -1.074 . . . . 73.52 110.247 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CZ ' ' HG3' ' A' ' 192' ' ' GLN . 37.1 m-85 -124.04 157.34 34.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.045 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.9 tp -94.49 99.36 11.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.613 -0.884 . . . . 54.32 108.613 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.561 ' HB ' HD23 ' A' ' 184' ' ' LEU . 46.7 t -130.26 157.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 53.0 110.465 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 51.16 64.96 1.63 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.818 0.818 . . . . 60.33 111.297 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -123.17 -64.85 1.14 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.078 -0.965 . . . . 73.35 110.65 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . 77.02 -13.7 8.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.552 . . . . 35.11 112.059 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -84.63 89.75 7.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.127 0.489 . . . . 72.44 110.073 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -141.92 99.25 3.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 74.02 109.912 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.67 138.52 42.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 43.41 109.675 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.606 ' HD2' ' HB3' ' A' ' 173' ' ' TYR . 4.8 mpt_? -71.36 129.06 37.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.944 0.402 . . . . 72.2 111.496 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.627 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 11.6 t80 -95.49 -54.41 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.763 -0.653 . . . . 73.52 110.064 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 172' ' ' GLU . 6.7 p -134.1 105.39 11.39 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.697 -0.683 . . . . 71.34 110.105 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 210' ' ' HIS . 52.2 Cg_exo -54.16 107.37 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.586 2.19 . . . . 62.02 111.568 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 65.9 11.68 7.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.103 -0.953 . . . . 74.12 111.418 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.54 -5.51 40.84 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.024 -0.607 . . . . 51.12 113.223 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.26 111.54 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.03 0.415 . . . . 74.24 111.536 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.578 ' HB2' ' HD2' ' A' ' 206' ' ' PRO . 12.6 t-160 -178.19 -101.13 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.96 -0.563 . . . . 62.12 110.888 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.474 ' HE3' HG23 ' A' ' 312' ' ' THR . 60.3 tttm 51.49 89.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 63.01 111.947 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -166.22 136.71 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 54.33 111.139 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.753 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 20.3 t80 -94.75 80.45 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 75.03 111.495 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -178.9 70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.547 -0.751 . . . . 72.12 109.517 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -106.49 -71.29 0.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.082 -0.508 . . . . 64.13 110.777 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -119.12 118.2 32.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.915 0.388 . . . . 75.13 110.395 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.233 0.266 0 C-N-CA 123.295 2.663 . . . . 72.0 112.899 -177.006 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.963 0.411 . . . . 44.23 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -88.04 -155.36 28.96 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.898 -0.667 . . . . 70.4 112.36 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.9 p -88.7 151.59 22.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.941 0.4 . . . . 60.04 111.062 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -53.27 -33.08 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 113.739 1.014 . . . . 54.44 113.739 -167.738 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -60.15 2.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.272 0.842 . . . . 73.2 113.272 -170.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.79 ' HD2' ' HZ2' ' A' ' 179' ' ' LYS . 28.9 m-85 -87.89 -0.23 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.28 0.474 . . . . 61.55 112.28 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 39.4 m -85.61 -10.3 56.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.346 0.593 . . . . 72.12 109.815 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.0 t 67.44 -175.7 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.1 -0.955 . . . . 72.23 111.259 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 82.6 mt -70.5 -34.59 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.393 -0.822 . . . . 51.3 109.731 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.621 ' HB3' ' HA ' ' A' ' 238' ' ' PRO . 1.8 m-20 -47.38 -84.23 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.801 -1.091 . . . . 74.52 112.547 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.643 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -66.31 -28.32 68.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.154 -0.476 . . . . 65.5 111.993 -172.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.05 -26.6 62.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.662 -0.415 . . . . 75.21 110.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -95.75 -4.85 43.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.369 . . . . 63.15 110.981 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.59 21.07 17.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.352 -0.927 . . . . 73.1 113.391 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.753 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 7.1 p -117.63 141.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 60.32 109.67 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -56.71 125.06 66.77 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.084 -0.507 . . . . 64.4 110.966 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.643 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 33.3 Cg_exo -60.27 115.18 2.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.156 2.571 . . . . 71.03 112.701 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 69.9 m -83.79 169.31 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 51.2 110.774 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.489 HH22 ' HG2' ' A' ' 170' ' ' GLU . 20.4 mtt180 -59.51 -20.53 56.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.528 0.68 . . . . 72.32 110.251 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.577 HH11 ' HG ' ' A' ' 309' ' ' LEU . 10.7 mmt180 -64.99 -41.82 95.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.094 -0.957 . . . . 74.22 109.645 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -69.59 -41.41 75.87 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 74.14 112.275 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.07 -45.18 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.581 0.229 . . . . 73.53 111.083 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.529 HD23 HG12 ' A' ' 306' ' ' VAL . 9.5 mp -60.9 -41.99 97.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.403 -0.362 . . . . 72.24 110.916 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.92 -51.09 71.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.788 -0.642 . . . . 74.1 110.771 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.4 mt -62.35 -42.1 94.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.009 -0.541 . . . . 75.21 111.09 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 251' ' ' MET . 46.8 tp -61.96 -39.52 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.169 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.53 -39.65 98.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.339 -0.934 . . . . 74.03 111.645 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -66.55 -39.47 88.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.907 0.336 . . . . 73.34 111.907 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' A' ' 247' ' ' LEU . 20.0 p -68.12 -34.17 75.88 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.294 -0.563 . . . . 71.51 110.133 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 81.6 mtp -62.9 -53.59 51.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.443 -0.344 . . . . 70.32 110.983 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.542 HD12 ' SD ' ' A' ' 286' ' ' MET . 5.5 tt -65.98 -31.7 54.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.679 0.276 . . . . 53.34 110.303 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -56.26 -53.95 51.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 72.33 110.898 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 19.1 m0 -76.39 -25.16 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 71.43 111.222 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.5 tp -76.35 -46.3 28.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 60.23 111.617 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 76.5 p -103.71 -17.73 14.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.914 -0.315 . . . . 72.23 111.674 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 72.14 18.48 77.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 54.11 111.914 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -144.48 147.35 33.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.675 0.274 . . . . 75.25 110.957 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.871 ' HB2' ' HG3' ' A' ' 262' ' ' GLU . 96.1 mt -118.28 138.93 26.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.652 -0.87 . . . . 74.32 108.652 168.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 23.0 Cg_exo -65.45 -17.35 57.36 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.978 2.452 . . . . 61.21 114.243 -171.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 16.3 p90 -132.93 34.64 3.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.414 0.524 . . . . 74.42 112.414 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 259' ' ' LEU . 43.4 mt-10 -68.03 -42.72 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.41 0.624 . . . . 63.41 109.692 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.13 -21.21 64.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 73.2 109.939 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 3.2 m-20 -89.81 -2.55 58.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.252 -0.886 . . . . 44.41 111.157 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.525 HD23 HG11 ' A' ' 271' ' ' VAL . 89.7 mt -66.63 -2.83 5.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.796 0.331 . . . . 64.42 111.521 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -62.59 -40.02 95.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.919 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.573 ' OD1' ' HE3' ' A' ' 269' ' ' LYS . 10.7 t70 -135.13 135.41 22.78 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 42.31 110.982 -171.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.6 Cg_exo -60.72 -28.86 87.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.242 2.628 . . . . 72.33 113.476 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.573 ' HE3' ' OD1' ' A' ' 267' ' ' ASP . 0.0 OUTLIER -78.11 -34.93 49.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.729 -0.471 . . . . 71.43 109.729 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.616 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 6.4 m-85 -56.63 -50.54 71.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.811 -0.631 . . . . 74.41 111.058 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.525 HG11 HD23 ' A' ' 265' ' ' LEU . 7.8 m -70.47 -35.3 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 71.34 111.479 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 276' ' ' ILE . 82.3 mtt180 -56.96 -56.34 22.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.512 0.196 . . . . 74.14 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 0.1 OUTLIER -66.39 -42.67 87.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 72.14 111.439 -176.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 16.2 m -61.01 -41.97 97.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.217 0.532 . . . . 73.42 110.256 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.21 -43.91 92.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.277 -0.874 . . . . 75.51 110.471 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 272' ' ' ARG . 79.7 mt -66.14 -44.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 72.34 111.274 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 26.4 mmt180 -68.96 -36.15 77.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.589 0.233 . . . . 73.53 111.606 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 21.2 m-85 -73.12 -33.92 65.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.061 -0.255 . . . . 74.11 110.868 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -72.13 -22.93 61.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.267 0.556 . . . . 73.44 109.971 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -74.82 -53.44 9.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.537 -0.756 . . . . 65.54 110.51 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.536 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.4 m-80 -111.72 55.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.635 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -52.13 -51.04 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 73.01 112.077 -178.701 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.526 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.23 -46.94 84.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 63.23 111.42 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.4 m -61.19 -49.14 78.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.811 -0.631 . . . . 74.5 111.143 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.3 mm? -71.58 -44.23 64.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.31 111.874 -175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.542 ' SD ' HD12 ' A' ' 252' ' ' ILE . 21.8 mmt -64.69 -38.66 91.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.0 -0.28 . . . . 55.22 111.726 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.17 -39.01 65.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 74.12 110.413 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.05 -39.1 63.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 72.21 111.731 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.8 m -77.37 -11.36 59.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.607 0.225 . . . . 54.31 111.607 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 10.5 t80 -129.7 69.53 81.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.181 0.515 . . . . 64.12 110.449 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -90.67 12.35 2.43 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.041 2.494 . . . . 72.44 112.534 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -75.03 -9.38 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 74.22 110.375 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 71.27 84.56 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.893 -1.049 . . . . 71.31 112.221 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.716 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 27.3 t-20 -128.3 -80.27 0.58 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.802 -1.184 . . . . 62.41 107.802 169.399 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 60.0 tttp 175.13 96.85 0.08 OUTLIER Pre-proline 0 N--CA 1.461 0.092 0 O-C-N 123.743 0.652 . . . . 74.15 110.526 169.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -99.84 38.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.986 2.457 . . . . 73.0 111.47 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.3 -51.46 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 71.15 112.924 -172.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 0.9 OUTLIER -72.61 -30.85 64.7 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.235 -0.283 . . . . 74.32 110.235 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.3 mp -63.08 -44.3 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 71.24 109.57 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.33 88.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.933 -0.576 . . . . 63.13 111.138 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.71 -41.07 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.635 -0.257 . . . . 63.01 110.648 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.447 ' O ' ' HB ' ' A' ' 305' ' ' THR . 56.9 t80 -55.14 -45.35 75.64 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.502 -0.317 . . . . 61.25 110.986 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 306' ' ' VAL . 74.8 mtp -72.72 -31.35 64.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.598 -0.274 . . . . 64.52 111.62 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.29 -30.37 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.475 0.655 . . . . 72.24 109.236 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 86.7 m -66.32 -40.3 89.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.346 -0.843 . . . . 71.42 110.869 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 5.7 m -73.49 -27.03 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.819 -0.352 . . . . 61.31 110.492 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -62.3 -42.85 99.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 63.25 110.498 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 32.1 tp -97.11 16.22 20.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 55.44 110.05 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 27.4 tp -71.92 -32.53 67.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 74.12 110.666 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 27.1 t70 67.5 161.7 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.322 -0.854 . . . . 60.53 110.848 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -77.75 -22.72 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.699 0.285 . . . . 74.31 111.187 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.474 HG23 ' HE3' ' A' ' 211' ' ' LYS . 24.3 m -124.01 -20.28 5.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.592 0.59 . . . . 71.23 112.592 -173.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 14.5 tp10 -57.02 -101.16 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.344 0.868 . . . . 73.11 113.344 -166.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -147.04 120.17 4.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 121.641 -0.662 . . . . 74.21 111.508 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 309' ' ' LEU . 57.3 Cg_endo -91.03 118.57 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.542 2.162 . . . . 54.12 111.121 170.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 96.1 mt -116.04 82.43 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.79 0.328 . . . . 74.54 111.318 -176.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.517 ' HA ' HD12 ' A' ' 320' ' ' LEU . 35.9 m-85 -62.28 -33.46 74.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.022 -0.535 . . . . 72.54 111.428 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.28 -40.45 90.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 75.43 110.95 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -73.21 -37.51 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.687 -0.486 . . . . 72.42 109.687 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 50.6 mt -59.32 -47.71 84.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.113 -0.494 . . . . 73.13 110.154 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -57.96 -41.59 83.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 70.45 110.408 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.49 -52.28 61.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.706 -0.679 . . . . 73.51 111.686 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.5 tt -63.58 -47.52 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 111.91 0.337 . . . . 72.04 111.91 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.5 mt -66.19 -39.14 89.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.247 0.546 . . . . 63.23 110.435 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 159' ' ' LEU . 2.8 tm? -69.28 -35.28 75.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.152 -0.684 . . . . 73.23 109.152 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -62.91 -37.71 88.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 73.04 109.962 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.17 -41.0 95.13 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.903 -0.665 . . . . 61.14 112.215 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 155' ' ' LEU . 41.6 tp -71.65 -37.94 70.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.19 0.519 . . . . 42.34 110.746 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -72.08 -22.98 61.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.162 -0.472 . . . . 55.22 110.511 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.496 . . . . 73.34 110.957 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 328' ' ' LEU . 33.5 pt -95.44 1.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.982 0.42 . . . . 73.23 110.583 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.08 75.38 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.774 -0.648 . . . . 43.15 113.224 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 5.4 t -117.32 170.13 8.94 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.474 -0.427 . . . . 53.41 110.751 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 328' ' ' LEU . 27.3 ttpp -160.11 -56.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 74.43 108.889 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 178.6 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.914 -1.039 . . . . 75.24 108.452 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.8 t70 72.45 -71.55 0.13 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.681 -1.145 . . . . 74.22 111.786 172.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -117.94 57.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.805 -0.712 . . . . 65.2 112.303 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.046 0.451 . . . . 71.34 110.91 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.665 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 28.4 ttpt . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 109.173 -0.677 . . . . 54.13 109.173 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.658 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 10.4 t -106.67 162.39 13.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.168 -0.308 . . . . 72.34 110.168 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.44 143.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.398 0.618 . . . . 70.11 111.738 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.5 m -101.4 97.35 7.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.329 -0.851 . . . . 75.1 111.125 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 74.11 110.749 179.69 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.802 -0.444 . . . . 64.4 109.802 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.99 -7.87 60.82 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.725 -0.75 . . . . 51.43 112.404 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.56 128.64 36.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.824 0.345 . . . . 64.13 110.914 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.8 mt -86.62 129.0 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 74.31 110.174 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 37' ' ' TRP . 29.4 pt -116.26 147.12 19.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 61.31 110.81 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 35' ' ' LYS . 55.0 m -118.15 125.77 50.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.512 -0.767 . . . . 74.52 109.6 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 2.2 p-10 -121.27 -164.53 1.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.881 0.372 . . . . 72.44 111.057 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.516 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 13.8 mmt -68.63 -14.43 63.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.336 -0.393 . . . . 71.24 111.697 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.508 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -81.7 11.37 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 70.21 109.78 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 24.4 tptp 92.36 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.034 1.334 . . . . 65.23 113.285 167.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.978 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 21.2 ptmt 159.59 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.563 0.54 . . . . 72.05 111.608 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.978 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 38.8 mt-10 82.62 59.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.186 1.18 . . . . 73.4 114.186 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' ILE . 40.4 m95 -138.95 151.13 46.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.189 -1.411 . . . . 73.24 107.189 165.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.722 ' HE3' ' HB3' ' A' ' 56' ' ' MET . 61.0 pttt -154.47 144.47 21.83 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.857 -0.737 . . . . 63.31 111.24 172.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.81 126.44 25.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.293 -0.867 . . . . 74.03 110.619 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.68 -60.66 0.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.449 -0.882 . . . . 70.14 112.355 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 6.6 tt -103.82 120.62 50.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.998 -0.371 . . . . 65.3 109.998 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 4.8 Cg_exo -79.0 112.74 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.351 2.701 . . . . 75.13 111.776 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.773 HG22 ' HG2' ' A' ' 45' ' ' GLN . 49.2 mt -95.48 -57.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.37 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -20.1 22.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.205 -0.522 . . . . 62.34 113.254 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.773 ' HG2' HG22 ' A' ' 43' ' ' ILE . 12.0 pt20 -111.44 165.01 12.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.006 -0.368 . . . . 75.41 110.006 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.85 -170.15 26.45 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.693 -0.963 . . . . 72.24 110.693 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.605 ' HA3' ' CG2' ' A' ' 196' ' ' VAL . . . -81.85 50.38 4.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.752 -0.737 . . . . 45.1 113.098 -175.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 4.2 t80 166.5 -37.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.395 0.678 . . . . 74.22 109.299 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.24 157.2 17.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.031 -0.604 . . . . 65.42 112.25 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.9 m 65.16 41.37 4.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.131 0.491 . . . . 72.1 111.349 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 71' ' ' LYS . 5.2 mm -97.33 138.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.494 -0.558 . . . . 70.1 109.494 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.67 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 97.7 m-85 -122.32 167.36 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 61.43 111.752 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 55' ' ' ASP . 3.8 tt -115.16 139.53 49.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.069 -0.514 . . . . 73.43 109.999 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -93.1 68.22 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 72.41 109.763 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HD22 ' A' ' 53' ' ' LEU . 31.7 t70 -89.47 -14.93 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.162 -0.926 . . . . 72.11 112.041 -169.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.722 ' HB3' ' HE3' ' A' ' 38' ' ' LYS . 5.2 mmt -95.05 -0.71 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.446 0.536 . . . . 73.03 112.446 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' OD1' ' HB1' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -105.35 80.2 1.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.481 0.658 . . . . 75.42 110.503 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -124.9 104.23 8.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.706 -0.679 . . . . 71.35 110.707 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.261 -0.427 . . . . 71.43 110.067 177.535 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 111.839 0.311 . . . . 75.31 111.839 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 10.7 Cg_exo -73.58 43.94 0.84 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.573 2.182 . . . . 74.21 112.814 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.0 m -117.31 142.35 47.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.754 0.311 . . . . 71.14 110.326 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 53' ' ' LEU . 31.7 m -117.15 158.74 17.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 73.21 109.831 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.64 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.1 p -137.72 126.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.326 0.584 . . . . 75.3 111.664 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.651 ' HB3' HD12 ' A' ' 51' ' ' ILE . 46.7 pttt -98.81 136.26 39.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.398 -0.819 . . . . 73.44 109.132 174.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 8.4 p -137.21 138.2 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.568 0.581 . . . . 64.3 112.568 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 27.0 mt-10 -123.1 163.76 31.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.598 -0.728 . . . . 73.4 109.05 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.75 -177.07 1.11 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.328 2.019 . . . . 73.13 111.918 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.1 t -76.83 11.72 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.772 0.32 . . . . 71.35 111.696 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.81 -40.51 92.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 73.4 109.739 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 81' ' ' PHE . 64.0 t30 60.7 83.02 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.06 -0.973 . . . . 63.35 111.468 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.51 -83.05 0.18 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.647 -0.787 . . . . 73.13 111.719 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.86 -44.38 16.63 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.683 2.255 . . . . 74.44 111.624 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.93 -34.9 73.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.454 -0.339 . . . . 54.4 110.405 177.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.503 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 74.7 t80 -63.57 -47.76 80.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.043 0.449 . . . . 72.01 110.257 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.0 m -65.54 -42.63 91.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.66 -0.7 . . . . 65.05 110.074 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.85 -43.7 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.23 -0.895 . . . . 70.03 110.54 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.547 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 46.4 tp -55.83 -47.35 77.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.736 -0.666 . . . . 71.41 110.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 11.1 mmpt? -60.47 -41.76 94.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.46 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.98 -44.44 94.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.799 -0.637 . . . . 73.35 110.814 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.611 ' HD2' ' HB2' ' A' ' 113' ' ' TYR . 18.9 m-85 -70.55 -39.61 73.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.824 0.305 . . . . 73.4 111.824 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 81.5 mm-40 -68.02 -18.31 64.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.038 0.447 . . . . 61.55 110.5 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -96.72 -70.49 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 74.44 111.634 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.673 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -83.89 -34.48 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.274 0.842 . . . . 70.13 113.274 -170.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.34 79.36 3.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.377 0.608 . . . . 73.34 112.16 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -154.24 116.33 2.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.845 -0.798 . . . . 74.21 108.845 176.361 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' HD2' ' HD3' ' A' ' 92' ' ' LYS . 9.7 Cg_endo -52.05 -54.02 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.333 2.688 . . . . 75.14 114.067 -170.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 1.2 pp20? -72.95 -28.34 62.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.845 0.355 . . . . 72.25 110.624 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.457 ' CB ' ' HB3' ' A' ' 92' ' ' LYS . 3.6 tp-100 -67.81 -48.99 64.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.458 -0.571 . . . . 72.53 109.458 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG23 HD12 ' A' ' 108' ' ' LEU . 81.5 mt -57.19 -53.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.603 -0.726 . . . . 75.43 110.434 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.02 -40.05 66.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.429 -0.805 . . . . 75.33 110.611 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 18.5 ttpt -67.24 -59.47 3.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.25 -0.886 . . . . 72.11 111.482 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 1.3 p90 -68.44 -34.03 75.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 120.474 -0.49 . . . . 70.42 110.833 -176.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 105' ' ' LEU . 2.9 tp -72.1 -29.09 31.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.885 0.374 . . . . 74.44 110.032 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -65.52 -47.34 76.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.736 -0.665 . . . . 65.0 109.778 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -74.66 -19.01 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 71.14 111.447 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 166' ' ' GLU . 17.9 tpt180 -79.44 -18.45 52.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.538 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 103' ' ' ARG . 63.5 mttm 71.44 28.32 2.92 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.777 0.673 . . . . 75.03 111.197 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 100' ' ' ILE . 46.7 mt -100.0 -170.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.432 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HG3' ' HB2' ' A' ' 107' ' ' TYR . 24.7 pttm -119.58 -34.91 3.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.514 0.561 . . . . 75.31 112.514 -172.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -150.03 179.27 8.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.926 0.393 . . . . 75.14 110.758 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -162.16 127.96 3.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.799 -0.815 . . . . 54.41 108.799 170.3 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.53 59.67 4.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.822 -0.704 . . . . 33.53 112.625 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.51 HG23 HD22 ' A' ' 108' ' ' LEU . 88.5 t -116.83 122.51 31.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.977 -0.379 . . . . 72.23 109.977 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 18.0 Cg_exo -66.19 149.32 85.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.884 2.389 . . . . 74.22 113.07 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.6 tptm -65.07 117.59 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 74.42 110.561 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.611 ' HB2' ' HD2' ' A' ' 87' ' ' TYR . 61.2 t80 -89.03 123.03 32.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.342 -0.845 . . . . 75.33 110.121 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -96.4 -67.01 0.87 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.286 -0.635 . . . . 64.4 109.286 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLY . . . . . 0.416 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -155.36 -178.13 29.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.423 -0.808 . . . . 75.34 112.144 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 32' ' ' MET . 58.6 p -164.73 163.7 21.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 55.24 109.046 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.26 -168.74 36.84 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.738 -1.22 . . . . 74.22 113.118 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.17 127.28 31.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.534 -0.543 . . . . 61.41 109.534 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -123.46 109.94 14.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.945 -0.571 . . . . 75.23 110.637 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 13.8 t70 -75.7 118.79 18.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.426 -0.583 . . . . 71.23 109.426 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.66 94.67 5.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.391 -0.368 . . . . 75.23 111.03 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.1 m120 71.51 -41.78 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.548 0.739 . . . . 72.13 112.846 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.89 -38.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.637 -0.792 . . . . 75.04 112.708 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.31 143.54 45.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.896 0.379 . . . . 63.42 110.114 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.87 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.0 p -94.62 149.16 21.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.15 112.134 -174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.453 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 67.4 m-85 -115.57 145.28 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 73.51 109.968 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -112.45 120.46 41.72 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.01 -0.737 . . . . 72.32 109.01 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.52 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -124.87 162.93 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 72.43 112.042 -170.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.8 ttm -144.88 136.95 25.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 71.11 110.695 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.64 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.2 mm -97.45 127.78 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 74.32 111.021 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 71.1 mtp -121.28 164.2 17.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.526 -0.761 . . . . 74.45 110.426 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.656 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 25.5 t70 -81.26 98.35 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.219 -0.446 . . . . 70.23 111.306 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HG2' ' C ' ' A' ' 132' ' ' ASP . 3.7 ptt180 29.71 95.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.411 1.634 . . . . 65.51 115.411 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.32 151.88 26.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.776 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -165.73 -15.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.38 -1.391 . . . . 71.1 114.967 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.737 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.7 m -120.65 124.7 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.274 1.037 . . . . 64.44 111.682 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.496 ' HB2' ' HG2' ' A' ' 140' ' ' LYS . 1.3 m-20 -101.29 131.05 47.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.855 -0.794 . . . . 73.32 108.855 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.617 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 4.9 mp -61.48 -36.91 81.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 55.32 110.856 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 27.2 pt20 -58.79 -47.92 83.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 137' ' ' ASP . 20.3 ptmt -70.29 -34.85 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 71.54 110.783 -175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 137' ' ' ASP . 17.1 mt -75.05 -39.77 44.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.515 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -62.44 -43.44 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 73.12 111.957 -175.286 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.86 -40.6 83.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.185 -0.606 . . . . 72.04 110.601 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.89 -31.75 70.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 74.51 111.136 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -88.78 5.66 42.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 54.42 110.392 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.4 41.28 13.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.466 -0.788 . . . . 64.22 112.216 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER 41.75 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.935 0.894 . . . . 72.44 112.668 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 11.6 ttp180 -153.78 93.5 1.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.038 -0.983 . . . . 74.21 109.975 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.669 ' HD2' HG21 ' A' ' 153' ' ' THR . 85.0 m-85 -112.6 137.74 50.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.001 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.6 p -73.31 168.85 18.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.375 -0.375 . . . . 52.34 110.978 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.546 ' HB3' HD11 ' A' ' 328' ' ' LEU . 81.8 mtt180 -55.03 -37.06 66.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.913 -0.585 . . . . 74.14 110.725 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -60.65 -42.94 97.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.352 -0.84 . . . . 73.32 110.572 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.669 HG21 ' HD2' ' A' ' 149' ' ' PHE . 10.2 m -71.76 -52.23 18.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.5 -0.773 . . . . 61.42 111.303 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.82 -42.82 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.41 110.966 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 328' ' ' LEU . 16.9 tp -65.61 -49.47 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.575 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 20.8 mm-40 -58.97 -47.74 84.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.923 0.342 . . . . 71.04 111.923 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.87 -43.92 97.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.472 -0.331 . . . . 73.21 110.892 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t -62.33 -43.04 99.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.15 110.355 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 82.3 mt -61.45 -39.9 92.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.242 -0.436 . . . . 71.31 111.262 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 81.6 mmt-85 -62.73 -49.15 76.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.017 0.437 . . . . 73.31 110.378 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.56 -30.31 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 65.45 110.681 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -47.42 86.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 70.11 110.569 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.46 -42.23 99.32 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.59 0.71 . . . . 65.12 110.097 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.586 ' O ' HG12 ' A' ' 168' ' ' ILE . 61.3 mt -61.44 -46.44 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.225 -0.898 . . . . 63.44 110.74 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.438 ' HG ' ' HE1' ' A' ' 317' ' ' TYR . 64.4 tp -57.69 -39.03 76.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 74.32 110.803 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 103' ' ' ARG . 2.0 mm-40 -56.13 -65.81 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.767 -0.652 . . . . 54.34 110.476 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.453 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 82.2 t80 -63.27 -49.47 73.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.626 -0.715 . . . . 73.3 112.861 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 164' ' ' ILE . 30.7 pt -79.46 -32.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.293 -0.563 . . . . 73.51 112.249 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.777 ' HE1' HG12 ' A' ' 174' ' ' VAL . 2.8 t60 -88.21 -18.19 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.038 -0.665 . . . . 74.31 111.117 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -86.88 21.96 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.907 0.861 . . . . 70.31 109.018 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -131.03 -79.37 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.475 -0.784 . . . . 74.54 111.137 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.755 ' HG2' ' H ' ' A' ' 207' ' ' GLU . 32.3 mt-10 -147.46 -46.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 74.2 111.977 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.96 137.63 35.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.709 . . . . 54.41 112.821 -161.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.777 HG12 ' HE1' ' A' ' 169' ' ' HIS . 33.2 m -106.69 170.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.942 -1.026 . . . . 61.01 109.729 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.741 ' HB3' ' HD2' ' A' ' 198' ' ' TYR . 1.8 p-80 -147.62 103.23 3.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.205 0.526 . . . . 70.03 111.188 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 -28.36 15.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.628 -0.796 . . . . 34.35 111.989 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 199' ' ' GLY . 5.7 t0 -112.94 93.78 4.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.913 0.387 . . . . 74.01 110.059 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 64.8 mt -92.28 -73.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.22 -0.659 . . . . 73.11 109.22 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 180' ' ' ALA . 6.3 tptm 50.76 -139.25 0.94 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.572 -0.529 . . . . 74.22 109.572 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -120.84 -3.58 9.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.408 0.623 . . . . 74.42 109.408 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 39.7 m -77.88 -27.68 49.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.419 -0.81 . . . . 72.44 112.044 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 76.7 m-20 -104.51 6.31 34.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.444 -0.503 . . . . 74.02 111.558 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.72 120.17 40.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.651 . . . . 73.34 109.721 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.582 HD11 ' N ' ' A' ' 47' ' ' GLY . 66.0 mt -120.59 143.67 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.004 -0.544 . . . . 72.41 110.834 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.8 mt -92.5 141.4 28.55 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.334 -0.617 . . . . 63.22 109.334 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.502 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 25.4 t-20 -60.55 139.19 57.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.446 -0.946 . . . . 73.1 108.446 171.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.776 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 71.7 t80 -57.36 -30.52 64.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.718 0.266 . . . . 75.14 111.718 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 83.1 tttt -116.15 -30.52 5.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.48 -0.488 . . . . 73.41 111.799 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 85.2 m-20 -99.46 101.87 14.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.793 0.33 . . . . 63.14 110.888 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 10.2 Cg_exo -71.78 -25.81 19.88 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.995 2.463 . . . . 61.34 113.387 -174.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -4.94 59.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.024 0.44 . . . . 72.43 111.18 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -108.62 97.1 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.386 0.612 . . . . 73.45 110.449 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 160' ' ' ARG . 7.9 p -103.38 130.87 53.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.255 -0.884 . . . . 73.2 109.23 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.502 ' HE2' ' HB2' ' A' ' 186' ' ' ASN . 41.9 m-85 -115.72 155.45 27.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.004 -0.544 . . . . 72.51 110.189 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 2.9 tt -120.52 122.7 41.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.407 -0.59 . . . . 63.43 109.407 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.605 ' CG2' ' HA3' ' A' ' 47' ' ' GLY . 16.5 m -129.17 166.95 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 61.22 110.58 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.0 t70 68.97 -57.9 0.51 Allowed 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.984 0.803 . . . . 74.2 111.842 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.785 ' HB2' ' HB2' ' A' ' 201' ' ' ALA . 93.7 m-85 75.79 5.37 3.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.606 0.762 . . . . 73.23 112.052 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 177' ' ' ASP . . . 82.48 -38.77 2.63 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.37 -0.443 . . . . 65.22 112.946 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.789 ' HA ' ' HA ' ' A' ' 354' ' ' ILE . 1.1 pp -164.38 40.05 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.3 0.24 . . . . 72.32 110.882 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 198' ' ' TYR . . . -53.21 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.549 0.69 . . . . 74.4 111.761 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -123.4 133.58 54.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 172' ' ' GLU . 10.9 ptp180 -77.71 109.74 11.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.324 0.583 . . . . 74.21 109.918 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 2.9 t80 -66.83 -46.18 75.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.305 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 54.6 m -142.42 140.06 18.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.843 -0.799 . . . . 72.23 108.843 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 14.4 Cg_exo -68.1 98.04 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.381 2.054 . . . . 73.24 112.151 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.755 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 33.6 tt0 73.91 -54.7 0.68 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.961 -1.018 . . . . 54.52 111.761 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.11 65.8 2.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.948 -0.644 . . . . 42.44 112.534 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 1.001 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 7.6 p -58.54 112.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.639 0.733 . . . . 71.23 112.411 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -169.45 72.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.374 -0.83 . . . . 74.1 110.575 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -126.15 150.59 48.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 71.44 110.095 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.39 171.64 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.5 -0.318 . . . . 74.54 110.82 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.916 ' HB2' HG21 ' A' ' 236' ' ' VAL . 16.2 p90 -74.54 92.1 2.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.372 0.606 . . . . 74.41 112.517 -168.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 67.5 mmtt -152.64 104.96 2.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.939 -0.573 . . . . 74.14 110.315 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 68.6 mm-40 -136.42 -155.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 64.41 109.855 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 10.7 t70 -85.58 115.31 61.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.913 -0.403 . . . . 72.51 109.913 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PRO . . . . . 0.881 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 28.0 Cg_exo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 123.688 2.926 . . . . 62.15 114.272 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 N-CA-C 113.065 0.765 . . . . 75.15 113.065 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -97.68 164.31 21.86 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.986 -1.246 . . . . 52.34 109.986 169.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 226' ' ' GLU . 14.9 t -68.74 113.15 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.1 0.95 . . . . 73.52 110.069 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.588 HG12 HG11 ' A' ' 271' ' ' VAL . 15.5 tt -57.24 -21.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.043 -0.981 . . . . 54.33 111.831 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.514 ' HG2' ' OG1' ' A' ' 224' ' ' THR . 17.1 pt-20 -60.12 -44.69 94.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 75.21 110.489 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.623 ' HB3' HG23 ' A' ' 246' ' ' ILE . 9.3 m-30 -109.53 -34.67 6.44 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.635 0.606 . . . . 72.11 112.635 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 232' ' ' ALA . 7.4 t -70.9 14.15 0.16 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.543 0.572 . . . . 74.04 112.543 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 227' ' ' PHE . 33.3 t 66.52 -177.23 0.2 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.659 0.743 . . . . 73.41 111.863 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 233' ' ' HIS . 42.3 mt -72.35 -35.15 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.067 -0.97 . . . . 72.13 110.081 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' HB3' HG13 ' A' ' 236' ' ' VAL . 4.1 m-20 -49.9 -56.35 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.64 -1.164 . . . . 72.4 112.334 -174.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.26 -49.69 76.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.473 0.546 . . . . 73.01 112.473 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.443 ' CD2' ' HA ' ' A' ' 230' ' ' ILE . 12.0 p80 -70.82 -16.39 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.546 -0.461 . . . . 73.45 110.61 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.51 -21.22 45.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 73.41 109.909 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . 0.881 ' HA3' ' HA ' ' A' ' 217' ' ' PRO . . . 111.17 20.07 7.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.776 -0.726 . . . . 44.35 113.617 175.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 213' ' ' TYR . 7.3 p -122.17 136.41 59.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.333 -0.51 . . . . 73.23 110.966 175.103 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.582 ' HB3' ' CE1' ' A' ' 204' ' ' TYR . . . -64.46 125.83 89.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 73.35 110.977 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 33.0 Cg_exo -60.6 130.57 34.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.922 2.415 . . . . 51.4 112.065 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 240' ' ' ARG . 21.9 p -153.21 154.22 34.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.165 -0.47 . . . . 62.32 110.837 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 239' ' ' SER . 4.1 mpt_? 57.09 -100.5 0.11 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.508 0.723 . . . . 74.24 111.23 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 241' ' ' ARG . 6.7 ttp-105 -64.19 -32.09 73.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.031 -0.531 . . . . 71.24 110.282 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.609 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.5 -57.17 21.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.927 -0.654 . . . . 73.31 112.026 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 239' ' ' SER . 4.5 m-20 -57.15 -42.48 81.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 72.24 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.531 HD23 HG12 ' A' ' 306' ' ' VAL . 9.7 mp -61.28 -42.78 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.947 -0.57 . . . . 43.31 111.106 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 279' ' ' ARG . 54.0 tt0 -69.22 -37.68 78.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 34.41 110.795 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 227' ' ' PHE . 69.9 mt -62.47 -41.93 93.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.919 0.39 . . . . 71.24 110.473 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 250' ' ' CYS . 52.8 tp -60.06 -40.41 89.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.97 -0.559 . . . . 61.22 110.436 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.466 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.03 -40.68 97.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.5 -0.857 . . . . 63.35 111.903 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 227' ' ' PHE . 22.1 m-30 -65.6 -41.14 93.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.89 0.329 . . . . 72.03 111.89 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 247' ' ' LEU . 26.4 p -69.06 -34.37 75.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.007 -0.677 . . . . 73.5 110.543 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -66.89 -39.82 87.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.59 -0.277 . . . . 74.42 111.401 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 tt -69.62 -34.32 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.459 -0.497 . . . . 72.31 110.67 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.521 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 3.3 mm100 -68.1 -32.6 73.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.637 0.256 . . . . 54.33 111.402 176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -75.98 -38.1 57.8 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 74.44 111.184 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.3 tp -80.54 -48.04 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.17 0.433 . . . . 72.13 112.17 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 58.9 p -109.66 -27.67 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.16 0.505 . . . . 72.24 111.143 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.485 ' HA3' ' HG3' ' A' ' 147' ' ' LYS . . . 68.32 34.95 81.34 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.45 112.906 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.09 142.84 34.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 72.24 110.903 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 262' ' ' GLU . 88.6 mt -117.71 142.62 30.93 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.841 -0.618 . . . . 61.12 109.694 170.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 25.4 Cg_exo -63.94 -49.43 3.98 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 122.379 2.053 . . . . 71.22 111.138 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.435 ' HD1' HD23 ' A' ' 265' ' ' LEU . 30.7 p90 -82.94 25.58 0.67 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 64.35 111.142 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 259' ' ' LEU . 23.0 tt0 -68.37 -48.47 64.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 73.54 111.413 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.7 -32.74 71.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.19 0.519 . . . . 72.3 110.884 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -107.23 22.25 16.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.868 -0.605 . . . . 73.53 111.06 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 265' ' ' LEU . 3.0 tm? -61.33 -24.02 66.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.764 0.792 . . . . 75.33 109.706 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -68.13 -15.82 63.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.7 -1.137 . . . . 65.5 112.064 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.717 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 9.0 t0 -125.78 122.66 24.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.887 0.375 . . . . 64.05 110.638 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.71 -24.04 77.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.295 2.663 . . . . 61.12 113.82 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.5 -48.32 72.97 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.165 0.507 . . . . 74.51 109.952 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 97.4 m-85 -67.33 -38.69 85.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.361 -0.836 . . . . 72.22 110.595 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.588 HG11 HG12 ' A' ' 225' ' ' ILE . 59.1 t -57.28 -49.77 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.204 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 276' ' ' ILE . 16.7 ttp180 -57.66 -54.42 47.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 65.4 110.428 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.95 -48.59 78.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.037 -0.983 . . . . 74.53 111.935 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.7 t -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.398 -0.365 . . . . 55.42 111.237 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 261' ' ' TRP . 96.4 mttt -70.35 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.746 -0.381 . . . . 75.24 110.629 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.6 mt -64.76 -38.5 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.037 0.446 . . . . 71.15 110.007 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.07 -45.71 79.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.623 -0.717 . . . . 74.3 110.963 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -76.09 -32.42 59.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.957 -0.297 . . . . 65.31 111.706 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 275' ' ' LYS . 99.6 mtt180 -60.18 -23.41 63.95 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.581 0.229 . . . . 71.13 110.771 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -50.32 -53.58 27.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.793 -0.64 . . . . 72.51 110.412 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -170.11 99.41 0.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 63.44 109.615 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.21 -34.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 70.03 110.743 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.626 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -60.08 -46.75 88.54 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.6 0.593 . . . . 73.01 112.6 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 15.8 m -60.26 -48.75 80.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.228 0.537 . . . . 73.23 110.993 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.21 -50.21 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 73.02 111.204 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.22 -45.08 94.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 74.54 111.486 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.17 -31.94 73.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 75.01 111.425 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -82.62 -13.21 56.89 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.717 0.294 . . . . 72.44 111.444 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 92.0 m -78.64 -69.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.796 0.295 . . . . 33.33 111.796 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 294' ' ' ASN . 39.2 m-85 -125.29 90.78 50.24 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 112.112 0.412 . . . . 74.01 112.112 -173.296 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -92.49 1.1 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.665 2.243 . . . . 70.43 112.105 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.89 -69.46 0.45 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.307 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 293' ' ' LYS . 3.1 mmmp? -49.56 -61.97 1.81 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.773 -0.649 . . . . 73.54 111.655 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.489 ' H ' ' HB3' ' A' ' 290' ' ' PHE . 15.8 m120 -113.54 -155.72 0.58 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.997 -0.742 . . . . 70.22 108.997 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.687 ' HE3' HG21 ' A' ' 331' ' ' ILE . 26.7 tptp -164.97 87.24 1.04 Allowed Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.774 0.321 . . . . 73.12 110.154 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -100.64 37.29 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.11 2.54 . . . . 73.53 112.171 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.02 -37.74 7.1 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.495 -0.859 . . . . 73.42 111.072 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.667 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 20.9 mp0 -66.95 -47.12 72.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.762 -0.829 . . . . 75.31 108.762 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.8 mp -59.09 -38.96 77.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 114.863 -1.062 . . . . 74.11 110.363 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -59.57 -50.25 74.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.532 -0.304 . . . . 71.34 111.208 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.1 -43.18 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.15 110.107 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.449 ' CE1' HD22 ' A' ' 320' ' ' LEU . 87.7 t80 -56.92 -47.08 81.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.412 -0.813 . . . . 73.04 111.203 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.525 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.2 -41.85 80.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 54.33 111.568 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -60.21 -40.55 90.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 64.14 109.77 175.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 98.4 m -60.28 -50.15 74.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.322 -0.854 . . . . 74.15 111.296 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 19.8 m -70.67 -33.99 55.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.842 0.312 . . . . 73.55 111.842 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -21.12 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.454 -0.498 . . . . 72.21 110.312 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.9 tp -81.49 -5.3 57.82 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.158 -0.474 . . . . 63.25 110.968 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 305' ' ' THR . 90.1 mt -91.17 6.61 44.39 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.776 0.287 . . . . 71.31 111.776 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.595 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 24.3 t70 61.45 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.705 0.628 . . . . 71.41 111.961 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 -52.12 0.31 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.179 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.2 t -149.12 29.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.761 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 42.6 mm-40 -51.89 -62.87 1.36 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.45 -0.341 . . . . 75.41 111.028 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -171.12 102.27 0.4 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.502 -0.317 . . . . 73.34 110.398 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.4 118.85 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.538 2.159 . . . . 71.54 111.576 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.3 mt -114.33 92.83 4.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.453 -0.34 . . . . 63.53 111.354 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' A' ' 165' ' ' LEU . 97.5 m-85 -57.66 -34.07 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.164 0.507 . . . . 71.23 110.084 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.37 -55.33 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.055 -0.975 . . . . 61.43 111.027 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.97 -41.55 95.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.969 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 67.3 mt -56.96 -53.3 59.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.32 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 322' ' ' ASP . 11.0 ptt180 -65.26 -36.53 84.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.928 0.394 . . . . 60.13 110.207 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ASP . . . . . 0.508 ' N ' ' HG3' ' A' ' 321' ' ' ARG . 30.0 t70 -68.23 -51.21 47.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.819 -0.628 . . . . 74.43 111.63 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.88 -31.23 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.924 -0.311 . . . . 73.51 111.14 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.41 -48.87 59.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.372 -0.376 . . . . 73.22 110.571 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -39.88 83.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.11 110.046 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.23 -48.43 81.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 61.43 111.197 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.667 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.36 -46.15 91.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 33.3 112.085 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -60.96 -45.21 95.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 62.21 110.841 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -70.25 -26.91 64.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.016 0.436 . . . . 70.01 110.583 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.24 -29.28 63.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.537 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.687 HG21 ' HE3' ' A' ' 295' ' ' LYS . 32.6 pt -90.19 -5.51 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 63.11 111.063 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 91.58 23.91 27.34 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.782 -0.723 . . . . 62.12 113.405 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -127.22 138.53 53.13 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.438 -0.448 . . . . 73.12 110.373 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 334' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 334' ' ' LYS . 9.9 mtpm? -138.66 -113.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.329 . . . . 73.34 111.647 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -159.73 113.93 2.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.507 0.67 . . . . 74.1 111.578 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.6 156.04 4.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.851 -1.068 . . . . 65.03 109.263 172.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.33 50.74 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.288 -0.725 . . . . 63.24 111.288 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 61.8 mttp . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.173 -0.514 . . . . 60.23 110.701 -178.959 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 353' ' ' THR . 12.8 tptp . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.821 -0.437 . . . . 61.41 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 14.8 t -173.48 156.27 2.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.376 -0.602 . . . . 72.42 109.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.789 ' HA ' ' HA ' ' A' ' 200' ' ' LEU . 0.2 OUTLIER -67.43 131.81 32.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.097 0.475 . . . . 62.12 111.204 -176.322 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 355' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 355' ' ' THR . 7.6 t -78.61 85.29 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.182 0.992 . . . . 61.1 110.752 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.534 -0.757 . . . . 74.42 110.499 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' HD3' ' A' ' 42' ' ' PRO . 61.5 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.001 -0.74 . . . . 71.3 109.001 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.599 -0.81 . . . . 74.03 112.687 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.1 147.07 43.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 117.202 0.501 . . . . 74.23 110.097 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -106.72 115.88 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.933 -0.576 . . . . 74.14 109.629 176.124 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 37' ' ' TRP . 14.9 pt -97.49 141.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.923 -0.581 . . . . 54.42 110.538 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 112.08 23.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.012 -0.54 . . . . 73.33 111.117 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.691 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 11.7 t70 -93.62 -179.2 4.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.64 -0.874 . . . . 62.31 108.64 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' MET . . . . . 0.59 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 17.1 mmt -73.35 -13.76 61.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.416 0.524 . . . . 30.41 112.416 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HH2' ' A' ' 37' ' ' TRP . . . -84.73 2.58 41.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.869 0.366 . . . . 63.04 110.727 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 32.2 ttmt 48.26 73.44 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.907 0.883 . . . . 73.04 112.561 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.873 ' H ' ' HZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -143.61 -154.96 0.56 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.321 -1.363 . . . . 72.42 107.321 173.648 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 3.1 mp0 -123.27 102.12 7.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.16 0.505 . . . . 72.24 111.029 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.873 ' HZ3' ' H ' ' A' ' 35' ' ' LYS . 3.8 m-90 -85.04 104.85 15.33 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.925 -0.769 . . . . 75.25 108.925 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -79.5 122.26 26.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.505 . . . . 73.11 110.832 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 52' ' ' TYR . 60.6 t -74.79 107.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.733 -0.469 . . . . 73.14 109.733 174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -61.13 4.56 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.779 -0.724 . . . . 23.24 112.116 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 pt? -159.64 152.06 17.55 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.066 -0.346 . . . . 64.15 110.066 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.4 Cg_exo -73.91 101.83 1.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.742 2.295 . . . . 74.01 111.562 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 53' ' ' LEU . 65.0 mt -66.74 -42.78 89.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 73.03 109.72 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.96 -31.38 8.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.64 -0.79 . . . . 75.14 111.873 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -140.81 129.86 23.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.581 0.705 . . . . 64.11 110.925 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 39.43 0.12 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 108.239 -1.944 . . . . 61.52 108.239 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.34 122.76 4.96 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.456 -1.058 . . . . 72.2 110.456 -166.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.703 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 6.3 t80 66.91 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.129 0.572 . . . . 64.21 111.262 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.5 165.22 16.89 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.208 -0.52 . . . . 72.13 111.938 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.88 35.13 21.8 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.231 0.538 . . . . 71.2 110.892 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 71' ' ' LYS . 43.0 mm -88.44 138.53 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 65.11 111.051 -175.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 30.0 m-85 -108.28 157.23 18.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.813 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 43' ' ' ILE . 59.6 tp -94.35 136.61 34.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 71.23 109.776 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.1 103.31 15.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.602 0.239 . . . . 70.23 110.443 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 56' ' ' MET . 27.8 t70 -79.37 -25.6 42.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 63.34 110.327 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.508 ' HE3' ' HA ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER 67.26 163.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.375 -0.83 . . . . 71.14 110.804 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -87.44 65.92 8.85 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.048 -0.723 . . . . 72.12 109.048 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.9 m -77.36 70.12 3.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 63.22 110.709 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.592 -0.731 . . . . 71.54 111.06 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.294 0.569 . . . . 71.35 111.1 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 133' ' ' ARG . 4.1 Cg_exo -80.14 38.86 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.014 2.476 . . . . 73.44 111.504 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . 0.439 ' HB2' HG23 ' A' ' 130' ' ' ILE . 6.9 p -145.3 138.18 26.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.549 0.69 . . . . 60.04 112.771 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.75 165.76 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.061 -0.972 . . . . 70.22 108.409 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.676 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -119.83 120.15 62.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.841 0.829 . . . . 71.02 112.68 -178.106 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HA ' HD12 ' A' ' 51' ' ' ILE . 22.1 tptm -84.21 125.8 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 113.198 -1.819 . . . . 70.3 108.662 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.01 150.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.566 0.58 . . . . 50.01 112.566 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -152.2 135.25 9.25 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.388 -0.824 . . . . 72.42 109.11 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 -166.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.322 2.015 . . . . 73.2 111.715 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.4 m -74.68 60.29 0.91 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.215 0.531 . . . . 60.35 110.869 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -105.56 -38.99 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.347 -0.612 . . . . 71.34 109.347 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.65 76.01 0.33 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.135 -0.938 . . . . 62.12 110.523 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -152.24 -99.09 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.246 -0.978 . . . . 23.31 112.733 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 49.0 Cg_exo -56.9 -45.59 35.23 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.127 2.552 . . . . 71.41 113.614 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -68.98 -41.02 78.44 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.999 -0.28 . . . . 62.3 110.815 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 85.1 t80 -61.37 -47.55 85.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.928 0.394 . . . . 74.02 110.289 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 m -66.1 -42.59 89.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.596 . . . . 74.11 110.587 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 87' ' ' TYR . 36.4 tt0 -64.88 -40.62 95.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.655 -0.702 . . . . 63.14 110.419 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.95 -39.28 85.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 72.3 110.535 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 10.9 mmpt? -59.02 -44.66 91.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.304 -0.407 . . . . 63.31 110.202 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.69 -49.55 77.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.764 -0.653 . . . . 75.31 110.836 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.547 ' HE2' ' HG2' ' A' ' 83' ' ' GLU . 56.3 m-85 -64.01 -38.32 90.65 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.651 -0.249 . . . . 73.12 111.426 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -61.42 -37.41 83.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.813 0.34 . . . . 53.52 110.78 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -88.26 -27.19 21.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.928 0.344 . . . . 74.51 111.928 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.58 16.05 25.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 60.25 111.893 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -76.05 163.87 26.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.039 0.385 . . . . 63.12 112.039 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.1 mmtt 75.89 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.161 -0.927 . . . . 75.31 112.425 175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 -35.69 98.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.492 2.795 . . . . 75.51 113.184 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.44 -41.89 90.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 72.02 110.863 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.57 -42.32 78.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 70.3 109.797 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 92' ' ' LYS . 59.2 mt -57.8 -53.48 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 64.1 110.572 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -60.29 -31.83 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 74.33 111.332 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -58.76 -56.36 23.25 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.238 0.336 . . . . 70.05 110.686 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.757 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.81 -34.19 73.35 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.303 -0.559 . . . . 72.51 110.735 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 107' ' ' TYR . 56.7 mt -58.13 -50.5 78.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.786 -0.188 . . . . 74.22 111.055 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -66.51 -38.44 87.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 73.2 110.621 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -67.57 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 60.51 111.402 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -78.03 -15.34 59.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.464 . . . . 71.14 110.965 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 68.77 33.21 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.64 -0.709 . . . . 71.23 110.697 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 106' ' ' LYS . 21.1 tp -81.95 177.13 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.985 -1.117 . . . . 74.41 107.985 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' H ' ' HG ' ' A' ' 105' ' ' LEU . 20.2 mmtm -103.15 -49.89 3.63 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.949 -0.7 . . . . 75.02 111.816 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . 0.703 ' HE2' ' HD3' ' A' ' 160' ' ' ARG . 34.4 p90 -162.0 -176.98 5.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 73.43 111.428 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 52.8 tp -133.22 131.76 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.569 -0.53 . . . . 62.54 109.569 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.4 57.64 4.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.868 -0.682 . . . . 72.35 112.66 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.19 131.47 22.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.303 . . . . 60.24 110.47 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.48 145.76 72.0 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 73.1 111.923 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -58.83 129.11 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.805 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -100.48 128.94 46.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 70.53 109.919 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CG ' HG22 ' A' ' 130' ' ' ILE . 43.6 m95 -100.69 -62.96 1.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.492 . . . . 74.21 109.945 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.83 -157.79 15.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.637 -0.71 . . . . 42.12 112.223 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 32' ' ' MET . 14.0 p -169.07 152.4 5.11 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.551 -0.537 . . . . 74.53 109.551 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -158.7 -164.92 14.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.028 -1.082 . . . . 70.22 113.315 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.3 137.06 42.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.741 0.305 . . . . 74.32 110.477 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' HIS . . . . . 0.454 ' CG ' HG22 ' A' ' 29' ' ' ILE . 72.8 t60 -140.75 113.18 8.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.841 0.353 . . . . 71.33 110.241 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 32.8 t70 -72.43 126.39 29.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.059 -0.519 . . . . 64.1 110.422 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 122' ' ' ASN . 46.1 tptt -89.42 25.13 2.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.247 0.546 . . . . 64.0 109.539 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 4.5 m-20 74.25 63.99 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.305 -0.861 . . . . 72.31 110.158 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.4 -54.04 0.72 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.794 -1.094 . . . . 62.54 111.33 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -112.91 121.98 46.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.972 -0.381 . . . . 60.43 109.972 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 47.3 m -86.68 117.57 25.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.596 -0.52 . . . . 74.52 109.596 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -91.18 140.45 29.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.066 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -99.22 133.99 42.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.589 -0.523 . . . . 72.0 109.589 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.606 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 43.9 p90 -128.78 161.12 30.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.557 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 48.2 ttp -139.52 133.26 30.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.977 -0.556 . . . . 74.43 110.099 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.676 HD13 ' HB ' ' A' ' 70' ' ' VAL . 13.1 mm -96.43 123.99 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.183 0.515 . . . . 74.12 110.296 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.4 ptm -137.13 -178.09 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 75.22 110.671 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.49 154.8 34.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.085 0.469 . . . . 75.53 110.833 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 67' ' ' PRO . 28.9 ptt180 -89.88 124.17 34.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.723 -0.671 . . . . 72.24 112.199 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 26.0 m-85 -103.05 160.31 14.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 65.51 109.832 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLY . . . . . 0.727 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -145.44 -25.81 0.1 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.089 -1.053 . . . . 64.3 113.252 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.752 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 58.8 m -121.48 126.42 49.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.876 0.338 . . . . 73.34 111.694 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -98.04 134.94 40.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 72.53 109.929 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 61.52 111.211 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.451 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 22.9 tp60 -58.33 -49.31 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.452 . . . . 74.45 112.104 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 137' ' ' ASP . 20.5 pttm -85.61 -20.92 28.78 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.981 -0.687 . . . . 75.33 111.009 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.96 -46.35 79.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.277 0.56 . . . . 71.34 109.647 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.731 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -67.32 -32.76 73.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.792 . . . . 70.25 110.514 176.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.69 -54.92 8.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.948 -0.569 . . . . 75.13 111.405 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.51 72.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 54.33 111.76 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -87.4 0.53 55.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 73.32 110.167 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 53.86 52.35 13.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.454 -0.794 . . . . 75.41 112.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.1 OUTLIER 40.08 75.96 0.07 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.53 0.732 . . . . 62.42 112.257 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 18.2 ttp180 -149.79 79.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.582 -0.736 . . . . 73.34 109.235 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.731 ' HZ ' ' HA ' ' A' ' 142' ' ' TYR . 38.3 m-85 -111.02 156.47 21.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.121 0.486 . . . . 73.32 111.702 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 154' ' ' VAL . 42.0 p -68.02 152.1 46.03 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.373 -0.83 . . . . 61.14 110.197 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.584 ' HG2' HD23 ' A' ' 328' ' ' LEU . 41.0 ttm105 -66.56 -26.38 67.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.963 0.411 . . . . 71.35 110.186 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.22 -43.89 69.73 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.171 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.465 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 21.2 p -68.27 -44.64 75.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 72.2 110.943 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 150' ' ' SER . 92.6 t -57.61 -42.84 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 65.35 111.152 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 324' ' ' LEU . 2.5 mm? -64.9 -42.37 94.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.52 -0.309 . . . . 75.43 111.001 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 17.8 mm-40 -59.97 -46.01 90.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.49 0.186 . . . . 61.01 110.858 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 153' ' ' THR . 98.7 mt -59.62 -41.15 89.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.888 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.7 t -59.57 -47.11 86.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 63.35 111.006 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 325' ' ' LEU . 10.1 mp -63.8 -37.92 89.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 45.32 111.388 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.703 ' HD3' ' HE2' ' A' ' 107' ' ' TYR . 15.3 mmt180 -57.88 -52.59 64.84 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.465 -0.568 . . . . 72.51 109.465 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.0 -49.75 82.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.093 -0.958 . . . . 73.3 110.784 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.63 -54.54 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.948 0.351 . . . . 63.1 111.948 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.55 -48.6 76.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.579 0.228 . . . . 64.11 111.362 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 167' ' ' TYR . 16.7 tt -72.34 -36.63 55.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 120.428 -0.509 . . . . 61.51 111.21 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.4 -38.27 81.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 73.25 110.924 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 34.1 mm-40 -76.78 -23.95 52.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.842 -0.343 . . . . 54.23 110.517 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 164' ' ' ILE . 69.6 t80 -58.39 -48.65 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.31 110.076 172.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.6 pt -80.27 -32.29 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.54 -0.3 . . . . 72.04 111.372 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.756 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 4.9 m170 -56.55 -44.18 80.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.935 0.346 . . . . 75.22 111.935 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.15 12.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 65.43 111.41 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -120.97 -72.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.268 -0.424 . . . . 71.21 109.905 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 203' ' ' ARG . 9.2 pt-20 -177.3 -35.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.541 0.571 . . . . 73.04 112.541 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.56 135.85 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 74.31 111.005 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 28.7 m -129.8 142.9 42.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.593 -0.731 . . . . 54.03 109.536 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.563 ' CE1' ' HB3' ' A' ' 200' ' ' LEU . 3.6 t60 -100.96 -47.07 4.9 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.788 -0.365 . . . . 63.42 110.1 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.971 ' HA2' ' HB3' ' A' ' 243' ' ' ASP . . . 73.23 -62.14 1.79 Allowed Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.918 -0.658 . . . . 72.23 111.979 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 4.9 t70 -55.08 111.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.199 0.6 . . . . 61.01 112.457 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.62 43.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.45 0.643 . . . . 62.22 109.585 170.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -81.6 145.44 30.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.608 -0.516 . . . . 64.15 109.608 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.08 -2.14 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.835 0.68 . . . . 71.03 112.835 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 4.7 p -76.91 -26.44 54.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.709 0.263 . . . . 74.34 111.709 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.61 -0.61 31.7 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 111.787 0.291 . . . . 75.41 111.787 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.77 111.19 23.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 75.04 109.973 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.3 mm? -114.26 136.07 53.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.087 -0.506 . . . . 64.35 110.598 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.5 mt -93.58 141.71 28.16 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.82 -0.627 . . . . 71.53 110.141 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.98 138.74 58.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.528 -0.545 . . . . 74.21 109.528 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' TYR . . . . . 0.727 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 64.0 t80 -57.99 -30.91 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.37 0.508 . . . . 74.24 112.37 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 26.5 tptp -101.58 -44.25 5.64 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.808 -0.357 . . . . 72.51 111.125 -176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.594 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 4.4 m120 -102.01 104.85 38.78 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 63.1 111.505 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 17.4 Cg_exo -68.42 -14.21 39.44 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.208 2.605 . . . . 45.15 112.247 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.48 -3.8 58.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.889 -0.596 . . . . 73.01 110.799 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' A' ' 189' ' ' ASN . 72.3 mt-30 -109.64 96.99 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 73.42 110.524 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.1 p -103.55 134.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 70.44 109.969 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 64.2 m-85 -125.2 157.28 36.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.016 -0.538 . . . . 75.24 110.202 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 72.7 mt -103.1 127.5 50.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.199 -0.455 . . . . 64.35 110.066 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 184' ' ' LEU . 7.6 p -139.37 170.78 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.624 -0.51 . . . . 71.04 109.624 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 196' ' ' VAL . 69.1 m-20 65.12 56.81 0.99 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.002 0.906 . . . . 75.03 109.617 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.456 ' HD2' ' HB2' ' A' ' 201' ' ' ALA . 4.5 m-85 -73.91 39.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.365 -1.289 . . . . 74.03 112.809 -176.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -81.15 47.39 3.57 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.262 -0.735 . . . . 53.15 111.262 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 tt -170.98 44.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 70.45 108.096 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . . . -133.04 106.07 7.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 72.34 110.268 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -115.72 -177.45 3.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.096 -0.502 . . . . 74.13 110.44 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' A' ' 172' ' ' GLU . 58.8 mtt-85 -104.54 117.81 35.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.274 -0.421 . . . . 74.44 111.388 -170.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -87.99 -45.3 10.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.181 0.515 . . . . 74.33 110.239 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 172' ' ' GLU . 11.0 p -128.81 66.33 75.15 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.889 -0.596 . . . . 60.54 110.838 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.55 143.9 76.55 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.645 2.23 . . . . 63.53 112.349 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 74.07 6.74 4.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.436 -0.802 . . . . 75.42 111.144 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.03 10.92 74.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.097 -0.573 . . . . 42.13 112.471 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 40.4 t -116.71 128.14 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.646 -0.501 . . . . 75.11 109.646 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -64.66 141.63 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.855 -0.424 . . . . 65.13 109.855 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -114.34 166.47 11.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 72.41 111.332 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -72.89 144.67 47.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 64.04 110.152 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.452 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 53.6 p90 -68.2 147.46 52.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.42 -0.585 . . . . 72.0 109.42 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 2.3 mptp? -90.58 -69.26 0.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.346 0.869 . . . . 60.23 113.346 -167.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 9.3 mm-40 63.35 71.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.627 -0.879 . . . . 73.31 108.627 -165.448 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.6 146.22 68.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.901 -1.045 . . . . 64.15 111.004 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 C--N 1.347 0.471 0 C-N-CA 122.78 2.32 . . . . 74.31 113.379 177.672 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.287 0.477 . . . . 75.01 112.287 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 200' ' ' LEU . . . -77.27 153.14 40.87 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.671 -0.776 . . . . 72.42 112.866 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -70.2 122.39 19.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.09 0.471 . . . . 65.23 110.551 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.87 -12.91 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.959 -0.564 . . . . 55.33 111.709 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' GLU . . . . . 0.493 ' HA ' HD21 ' A' ' 265' ' ' LEU . 38.5 tt0 -55.34 -59.54 4.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.555 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.82 -33.05 7.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.11 -0.496 . . . . 72.11 110.103 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 98.5 m -58.0 121.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.701 0.763 . . . . 74.15 110.84 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.625 ' H ' HD11 ' A' ' 246' ' ' ILE . 47.7 t -56.61 166.38 0.94 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.105 -1.407 . . . . 73.2 111.758 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 230' ' ' ILE . 37.5 mt -55.15 -51.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.436 -0.802 . . . . 54.34 110.608 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -56.16 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 51.22 111.504 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.45 97.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 73.44 111.817 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 39.0 t60 -76.24 -17.53 59.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 61.42 110.467 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.66 -8.41 59.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.597 -0.729 . . . . 72.43 111.683 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 86.7 24.14 39.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.055 -1.069 . . . . 65.34 112.843 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 213' ' ' TYR . 10.0 p -120.51 140.98 42.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.303 -0.629 . . . . 71.53 109.303 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.46 113.56 7.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.662 0.268 . . . . 54.12 110.771 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.48 134.93 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.587 2.191 . . . . 55.1 112.117 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 34.9 p -79.36 -164.52 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.969 -0.56 . . . . 64.34 109.66 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -62.93 -19.28 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.453 -0.499 . . . . 74.44 109.965 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -63.32 -30.55 71.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.909 -0.587 . . . . 64.3 111.116 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.25 -66.65 2.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.05 -0.595 . . . . 73.54 112.502 -175.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.971 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -76.8 -29.77 56.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.252 0.464 . . . . 74.5 112.252 -174.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.99 -34.2 77.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 70.13 110.981 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.99 -34.31 61.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.503 -0.554 . . . . 44.51 109.503 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.625 HD11 ' H ' ' A' ' 229' ' ' SER . 93.7 mt -64.41 -37.77 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 71.41 110.393 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 47.9 tp -61.5 -40.2 93.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 174.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.15 99.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.601 -0.809 . . . . 61.21 111.743 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -54.37 -57.14 12.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.844 0.354 . . . . 73.24 111.218 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.2 p -67.21 -40.94 86.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 73.1 111.993 -174.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.12 -47.57 85.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.672 0.272 . . . . 72.3 111.42 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.34 -29.24 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.414 -0.514 . . . . 71.02 110.253 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -67.55 -46.8 71.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.595 -0.275 . . . . 73.1 110.543 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -61.96 -31.28 71.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.352 -0.385 . . . . 62.55 110.588 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.59 -41.2 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.015 -0.539 . . . . 71.01 112.089 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 67.1 p -101.92 -27.89 12.71 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.186 0.439 . . . . 71.11 112.186 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 96.96 -5.07 63.39 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.488 -0.863 . . . . 71.5 113.694 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -150.83 144.07 24.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.799 0.8 . . . . 53.51 112.458 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.447 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 60.3 mt -122.5 138.9 29.94 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.198 -0.91 . . . . 71.21 108.871 166.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 46.2 Cg_exo -58.19 -34.79 98.91 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.728 2.285 . . . . 51.12 113.309 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.516 ' HB2' HG12 ' A' ' 271' ' ' VAL . 36.7 p90 -95.3 2.92 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.646 -0.252 . . . . 72.14 111.438 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.86 -33.84 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.889 0.376 . . . . 74.31 110.492 -177.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.42 -28.64 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.723 0.773 . . . . 74.55 109.309 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 270' ' ' TYR . 57.3 m-20 -86.23 7.14 26.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.069 -0.968 . . . . 43.01 110.497 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.7 tm? -54.94 -35.32 64.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 63.43 111.243 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.57 14.88 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.817 0.673 . . . . 72.04 112.817 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.7 t70 -139.89 113.98 7.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.733 0.301 . . . . 73.11 110.325 174.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.87 -30.81 92.72 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.41 2.74 . . . . 73.15 113.777 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -69.2 -44.54 71.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.694 0.283 . . . . 71.25 110.647 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 264' ' ' ASN . 43.8 m-85 -66.71 -49.97 64.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 61.14 111.669 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 261' ' ' TRP . 19.4 m -62.5 -35.81 71.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.131 -0.227 . . . . 74.23 111.585 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 276' ' ' ILE . 30.1 ttm180 -63.06 -53.27 56.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.6 -0.273 . . . . 72.33 110.334 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.66 -40.0 88.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 52.52 111.14 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.7 m -61.66 -44.69 96.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.451 -0.341 . . . . 45.33 111.34 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.71 -33.6 71.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.709 0.29 . . . . 75.12 110.868 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 272' ' ' ARG . 77.4 mt -67.21 -43.88 88.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.948 0.404 . . . . 71.32 109.981 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -63.0 -36.15 82.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.851 -0.613 . . . . 73.03 110.293 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.29 -46.3 89.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 74.12 111.026 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -64.5 -26.35 68.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.924 0.392 . . . . 71.34 110.866 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.13 -32.17 50.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 63.14 111.32 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' ASN . . . . . 0.635 ' HB3' HD23 ' A' ' 285' ' ' LEU . 8.5 t-20 -136.05 53.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.947 0.403 . . . . 74.25 110.389 -172.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -57.0 -44.45 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 113.577 0.954 . . . . 74.32 113.577 -171.946 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.445 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -69.8 -47.32 63.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.866 0.321 . . . . 64.23 111.866 -170.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.4 t -68.36 -45.15 73.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.511 -0.313 . . . . 73.01 110.74 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.0 mm? -61.21 -53.44 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 64.3 111.575 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 286' ' ' MET . . . . . 0.487 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.1 OUTLIER -59.7 -42.79 93.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.743 0.275 . . . . 75.51 111.743 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.07 -37.33 85.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.131 0.491 . . . . 73.34 111.088 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -89.85 1.72 55.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 73.25 111.624 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 90.4 m -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 63.13 110.707 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 14.8 t80 -132.81 86.97 42.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 71.43 109.223 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.9 34.35 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.431 2.754 . . . . 75.52 112.847 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 51.5 mt-10 -120.59 -165.67 1.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 73.31 110.293 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -92.04 85.55 5.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.084 0.469 . . . . 74.13 110.661 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.27 -165.64 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.99 -0.744 . . . . 64.31 108.99 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.791 ' HD3' HD12 ' A' ' 331' ' ' ILE . 21.7 mtpp -120.48 90.14 45.14 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.483 0.183 . . . . 72.1 111.489 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -99.53 36.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.94 2.427 . . . . 73.21 111.395 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.56 -42.9 3.53 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.795 -0.717 . . . . 70.44 112.031 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -56.84 -46.08 81.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.968 0.413 . . . . 75.11 110.128 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.16 -41.24 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.895 -0.593 . . . . 71.21 110.586 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.91 -50.14 74.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 73.42 111.171 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.469 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 320' ' ' LEU . 73.1 t80 -56.19 -46.54 79.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 72.4 110.843 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.533 ' HA ' HG22 ' A' ' 306' ' ' VAL . 94.8 mmm -71.46 -39.37 70.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.814 -0.63 . . . . 63.25 111.209 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 25.2 tt0 -58.66 -50.03 75.37 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.771 0.796 . . . . 72.1 109.369 174.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 88.9 m -57.65 -50.97 71.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.702 -1.136 . . . . 73.03 111.733 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 303' ' ' MET . 33.7 m -67.21 -27.22 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 112.21 0.448 . . . . 45.43 112.21 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -80.33 -19.86 45.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.363 -0.535 . . . . 72.13 110.339 -179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 30.4 tp -94.41 17.84 12.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.116 -0.493 . . . . 63.21 111.143 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 315' ' ' PRO . 92.2 mt -93.77 -12.78 28.38 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.282 0.475 . . . . 51.25 112.282 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 313' ' ' GLU . 13.2 t70 58.48 -164.37 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.591 0.356 . . . . 74.23 110.123 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.455 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.3 m-85 -64.93 -52.07 58.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 63.53 110.416 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 19.8 m -155.16 69.05 0.7 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.222 0.534 . . . . 75.14 111.023 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 310' ' ' ASP . 25.2 mt-10 -104.99 33.43 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 64.12 109.493 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 25.4 mttt 64.53 103.53 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.219 0 CA-C-N 114.512 -1.222 . . . . 75.1 112.239 -176.436 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.557 ' HA ' HD22 ' A' ' 309' ' ' LEU . 19.6 Cg_endo -63.22 136.49 56.04 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.284 1.989 . . . . 63.22 110.49 170.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 92.9 mt -79.19 79.82 5.59 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.857 -0.337 . . . . 61.41 110.699 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 315' ' ' PRO . 17.2 m-85 -53.41 -48.5 68.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.495 -0.775 . . . . 72.15 109.948 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -63.04 -53.24 56.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.848 -1.069 . . . . 61.3 111.785 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 27.0 t-20 -59.77 -51.37 70.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.747 -0.206 . . . . 62.42 111.333 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 302' ' ' TYR . 95.5 mt -59.16 -48.75 80.46 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.948 0.404 . . . . 75.41 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -62.3 -40.56 96.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 73.02 110.203 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.72 -49.38 47.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 63.41 111.51 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.79 -33.61 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.872 -0.331 . . . . 74.13 111.323 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 155' ' ' LEU . 88.7 mt -69.9 -49.37 52.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 74.43 110.591 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 159' ' ' LEU . 82.5 mt -67.04 -34.07 76.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 72.52 111.031 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -64.12 -47.67 79.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.48 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.77 79.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.69 -0.767 . . . . 73.22 111.975 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.584 HD23 ' HG2' ' A' ' 151' ' ' ARG . 3.1 tm? -68.23 -49.54 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.094 0.473 . . . . 73.52 110.336 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 333' ' ' SER . 85.6 tttt -71.87 -34.34 69.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 72.21 111.065 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -27.32 67.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.173 0.434 . . . . 71.41 112.173 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.791 HD12 ' HD3' ' A' ' 295' ' ' LYS . 15.6 tt -86.25 -6.3 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.416 -0.514 . . . . 73.2 110.87 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 110.64 24.45 5.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.278 -0.963 . . . . 54.41 113.875 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 13.3 t -119.47 149.57 41.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.332 0.566 . . . . 44.43 110.082 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -162.7 27.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.551 -0.907 . . . . 72.43 108.551 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.49 105.87 17.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.311 -1.313 . . . . 73.04 110.804 -170.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.2 -21.16 5.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 74.31 111.641 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.76 -23.47 64.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.632 -0.794 . . . . 53.33 113.126 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.674 0.274 . . . . 63.21 110.772 -178.474 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.41 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.72 -0.474 . . . . 72.44 109.72 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.9 t -104.38 153.87 20.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.609 0.243 . . . . 73.41 110.366 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.22 128.44 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.282 0.563 . . . . 55.44 110.981 -173.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 33.3 m -77.82 97.96 5.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 63.24 111.822 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 109.519 -0.549 . . . . 72.34 109.519 170.689 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG13 ' HA2' ' A' ' 40' ' ' GLY . 61.9 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 108.712 -0.847 . . . . 70.33 108.712 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.37 2.95 56.63 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.307 -0.949 . . . . 51.42 112.911 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 133.0 51.2 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.197 -0.668 . . . . 73.13 109.197 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -81.04 131.11 34.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.678 0.751 . . . . 63.53 111.338 -173.159 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.63 129.85 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.726 -1.124 . . . . 65.14 109.641 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 21.1 m -118.45 123.83 46.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.559 -0.291 . . . . 74.23 110.594 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 3.2 p-10 -111.2 -173.09 2.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.398 -0.365 . . . . 74.24 110.71 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.06 -14.31 61.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.356 0.502 . . . . 64.24 112.356 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.29 8.54 8.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.836 0.35 . . . . 34.2 110.434 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.6 tptt 55.81 63.21 2.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.334 -0.848 . . . . 74.45 110.686 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' THR . 48.6 mmtm -134.92 120.84 19.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.059 -0.973 . . . . 75.45 109.723 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.93 77.29 4.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 73.2 109.428 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.594 ' HB2' ' O ' ' A' ' 56' ' ' MET . 37.4 p-90 -96.81 -176.55 3.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.686 -0.688 . . . . 71.23 110.375 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HG2' ' HB3' ' A' ' 56' ' ' MET . 18.8 pttp -133.69 137.14 45.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.3 111.562 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.01 151.68 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.952 -1.022 . . . . 74.3 110.797 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -96.6 -124.44 4.67 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.452 -0.659 . . . . 50.44 111.452 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.2 mp -92.13 128.88 43.55 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.838 0.351 . . . . 72.34 110.48 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 15.5 Cg_exo -68.91 119.1 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.91 2.406 . . . . 75.13 111.463 176.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.83 -59.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.147 0.499 . . . . 73.43 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.67 -8.3 76.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.899 -0.667 . . . . 61.33 112.316 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -127.4 161.38 28.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.487 0.184 . . . . 72.44 110.561 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.67 -130.92 2.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.402 -1.079 . . . . 64.34 110.402 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.57 -2.69 86.94 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.473 -0.87 . . . . 70.34 111.527 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.78 -68.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.728 -0.471 . . . . 50.22 109.728 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.93 174.23 24.63 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.865 -0.683 . . . . 64.53 111.888 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.7 m 62.68 32.72 16.07 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.108 0.48 . . . . 73.55 111.583 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.13 137.37 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 73.01 110.603 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.42 ' HB2' HG13 ' A' ' 70' ' ' VAL . 11.0 m-85 -111.89 148.97 32.53 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.849 -0.426 . . . . 74.4 109.849 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 54' ' ' ALA . 4.5 tt -90.63 139.87 30.3 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.828 -0.804 . . . . 33.03 108.828 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.796 -0.362 . . . . 62.43 110.751 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.77 -53.37 6.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 74.54 110.495 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 22.7 ttt -118.75 122.8 43.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.463 -0.789 . . . . 74.22 110.038 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -144.3 142.64 30.55 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.392 -0.966 . . . . 71.35 108.392 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.2 m -72.37 76.17 1.02 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.428 0.633 . . . . 71.2 110.457 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.443 -0.821 0 CA-C-N 115.623 -0.717 . . . . 64.15 110.035 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.122 0.487 . . . . 71.23 110.018 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' C ' ' HB2' ' A' ' 133' ' ' ARG . 3.6 Cg_exo -79.67 40.36 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.149 2.566 . . . . 75.44 111.273 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 p -144.26 146.95 32.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.623 0.725 . . . . 73.14 112.826 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 132' ' ' ASP . 34.6 m -128.08 167.05 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.021 -0.99 . . . . 74.32 109.389 172.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.1 p -130.42 123.83 56.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.256 0.551 . . . . 73.11 111.488 -176.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -82.43 122.3 27.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.443 -0.577 . . . . 72.41 109.443 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.9 122.48 65.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.4 -0.364 . . . . 62.44 110.577 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 80' ' ' LEU . 6.0 tp10 -136.07 137.54 25.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 74.21 109.053 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.62 133.25 50.34 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.17 1.913 . . . . 74.12 112.061 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 t -81.18 15.01 2.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.099 0.476 . . . . 40.03 110.655 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 124' ' ' LYS . 10.0 t70 -67.65 -69.1 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 63.44 110.105 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -170.32 118.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.705 -0.68 . . . . 52.11 109.477 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.71 -161.95 28.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.465 -0.874 . . . . 72.31 112.478 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.01 -21.54 49.37 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.18 2.587 . . . . 72.43 112.913 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 80' ' ' LEU . 1.2 tm? -52.31 -37.64 56.31 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.602 0.564 . . . . 74.11 111.16 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.15 -41.81 85.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 73.01 110.574 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -69.15 -46.3 67.96 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.708 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 80' ' ' LEU . 11.4 pt-20 -67.99 -31.1 70.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.189 -0.46 . . . . 72.4 110.838 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.51 -39.71 88.82 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.366 -0.235 . . . . 74.22 110.366 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -57.26 -49.01 77.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 53.0 110.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.11 -49.51 69.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 74.44 111.131 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' ' HD1' ' A' ' 113' ' ' TYR . 55.8 t80 -59.91 -38.13 81.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.731 -0.668 . . . . 75.44 111.563 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -74.14 -39.63 63.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 64.52 110.867 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -27.83 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 71.33 110.955 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HA ' ' CH2' ' A' ' 99' ' ' TRP . . . -106.74 16.52 24.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.963 0.411 . . . . 64.21 111.352 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' LYS . . . -82.58 158.19 23.17 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.109 -0.496 . . . . 72.25 111.478 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' ILE . 49.9 mtmt 75.17 107.01 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.293 -0.867 . . . . 64.1 111.394 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.531 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 49.7 Cg_exo -55.69 -35.33 92.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.362 2.708 . . . . 75.52 113.197 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.739 ' HG2' ' HE2' ' A' ' 98' ' ' LYS . 38.6 tt0 -66.46 -45.8 78.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 61.01 110.946 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.702 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 48.8 tt0 -62.64 -36.87 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.405 -0.591 . . . . 74.13 109.405 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 93' ' ' PRO . 67.4 mt -55.96 -45.88 80.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.537 -0.756 . . . . 72.03 110.284 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 96.3 mt-30 -53.78 -47.06 71.11 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.856 -0.611 . . . . 73.23 110.586 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.739 ' HE2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -63.85 -57.75 8.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.48 0.548 . . . . 74.12 112.48 -177.532 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.606 ' CH2' ' HA ' ' A' ' 90' ' ' ALA . 1.1 p90 -69.52 -34.71 74.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 119.968 -0.693 . . . . 61.41 111.501 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 108' ' ' LEU . 26.1 mm -63.45 -47.07 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.41 . . . . 74.45 110.122 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.94 -35.67 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 74.31 110.886 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.1 m -76.25 -34.63 59.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.555 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -84.61 1.91 43.93 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 122.299 -0.251 . . . . 54.24 111.546 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 65.94 25.9 11.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.582 0.551 . . . . 74.15 111.104 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.58 -178.32 5.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 74.3 109.362 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.9 -45.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.73 0.641 . . . . 74.2 112.73 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -154.08 117.48 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.522 -0.871 . . . . 75.43 112.342 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.6 pt? -103.96 136.24 43.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 74.44 109.294 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.85 66.65 3.53 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.852 -0.689 . . . . 73.24 112.926 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 11.7 p -104.11 136.76 19.15 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 110.262 -0.273 . . . . 72.43 110.262 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 38.8 Cg_exo -61.73 146.23 96.81 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.685 2.256 . . . . 64.23 112.719 176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -67.77 122.91 19.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.623 -0.717 . . . . 75.2 111.157 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HD1' ' CZ ' ' A' ' 87' ' ' TYR . 40.4 t80 -84.33 116.08 22.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.976 -0.557 . . . . 72.4 110.866 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.485 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 73.3 m95 -104.71 -63.01 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 74.21 109.065 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.08 172.13 31.39 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.148 -0.933 . . . . 62.14 111.305 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 p -169.83 159.82 8.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.577 0.227 . . . . 73.3 110.628 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.41 -165.03 37.62 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.855 -0.688 . . . . 61.15 111.662 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -137.47 147.22 45.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.914 0.387 . . . . 74.32 110.452 178.275 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -124.55 112.08 16.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.561 -0.533 . . . . 73.11 109.561 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 15.1 t0 -71.74 148.08 46.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.005 -0.543 . . . . 53.15 111.031 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.473 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 26.5 tptp -117.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.545 -0.752 . . . . 72.52 110.179 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 121' ' ' LYS . 15.8 m120 -135.26 30.72 3.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.287 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.26 -31.64 6.35 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.008 -0.837 . . . . 53.41 111.008 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 76' ' ' ASP . 44.3 mttp -100.18 96.4 7.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.19 -0.67 . . . . 74.43 109.19 173.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 4.9 p -76.26 142.56 41.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.436 -0.802 . . . . 62.43 111.254 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -96.18 121.57 38.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.86 -0.609 . . . . 72.21 109.716 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 118' ' ' LEU . 16.0 ttt180 -102.57 132.77 48.43 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.269 -0.641 . . . . 74.52 109.269 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.568 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 39.9 p90 -133.41 160.06 38.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.038 0.447 . . . . 74.34 111.797 -170.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.2 ptp -142.31 141.04 32.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.613 -0.721 . . . . 71.25 109.888 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -97.3 122.76 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.036 0.446 . . . . 74.23 110.384 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.5 mtm -127.15 -175.98 3.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 72.21 110.282 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 5.7 m-20 -58.3 152.52 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 65.11 110.502 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.464 ' HB2' ' C ' ' A' ' 67' ' ' PRO . 35.3 ttt180 -72.79 105.62 4.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.711 -0.478 . . . . 65.21 109.711 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 132' ' ' ASP . 28.3 m-85 -101.76 171.02 7.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.274 -0.421 . . . . 75.24 110.533 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.29 -43.97 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.674 -0.774 . . . . 71.42 111.844 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 5.6 t -120.87 159.8 24.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.069 0.462 . . . . 70.15 110.531 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.825 ' HB3' HD13 ' A' ' 184' ' ' LEU . 1.1 p30 -143.57 -172.54 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 72.33 109.78 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 6.8 mp -77.08 -24.51 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.164 -0.471 . . . . 75.15 112.075 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.78 ' HA ' ' HD1' ' A' ' 142' ' ' TYR . 3.2 pt20 -75.46 -36.29 60.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.695 -0.802 . . . . 63.22 109.968 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 43.1 mttp -57.83 -34.25 69.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 73.41 110.182 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.0 -51.29 20.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.489 -0.778 . . . . 63.41 111.227 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.78 ' HD1' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -72.18 -33.85 67.99 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.752 0.649 . . . . 74.14 112.752 -170.264 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.471 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 31.2 mt-10 -72.07 -31.25 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.349 . . . . 75.54 110.913 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.54 -32.1 15.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.979 0.362 . . . . 74.53 111.979 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -98.95 0.31 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 64.23 110.742 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.81 64.85 1.44 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.51 -0.768 . . . . 54.42 111.984 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 142' ' ' TYR . 17.5 ptpt 34.09 74.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.199 1.185 . . . . 60.13 114.199 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.42 103.84 5.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 70.14 110.415 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 89.6 m-85 -121.03 155.8 33.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.975 -0.557 . . . . 75.01 110.474 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 154' ' ' VAL . 67.0 p -80.62 148.35 30.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.46 -0.336 . . . . 55.24 110.208 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -26.63 66.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.002 0.43 . . . . 74.24 110.549 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 335' ' ' ASP . 63.0 tttm -62.08 -51.79 66.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.655 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 33.3 m -64.26 -46.84 81.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.274 -0.876 . . . . 53.11 110.497 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 150' ' ' SER . 69.6 t -54.64 -46.01 72.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 75.13 111.462 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 328' ' ' LEU . 1.7 tp -63.82 -49.15 73.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.615 -0.266 . . . . 72.12 110.734 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -60.44 -39.91 89.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 63.01 110.801 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 153' ' ' THR . 94.0 mt -62.41 -49.69 74.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.416 -0.356 . . . . 61.1 110.425 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 m -58.1 -40.56 81.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 72.14 111.179 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 321' ' ' ARG . 3.5 mm? -61.98 -54.31 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 64.52 111.471 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.404 ' O ' HG22 ' A' ' 164' ' ' ILE . 86.6 mtt180 -64.16 -39.27 93.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.957 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 195' ' ' LEU . 1.6 mp -65.89 -40.39 87.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.606 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.92 -44.13 96.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.616 0.246 . . . . 72.13 110.898 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.42 -55.37 35.95 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.026 -0.534 . . . . 51.23 110.846 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 160' ' ' ARG . 13.8 tt -69.16 -35.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.087 -0.506 . . . . 75.23 111.519 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 45.2 tp -63.81 -39.4 94.16 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.276 -0.17 . . . . 62.34 111.331 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 169' ' ' HIS . 22.8 tp10 -80.85 -25.61 37.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.968 0.413 . . . . 65.23 110.365 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.42 -45.81 92.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.442 . . . . 71.03 110.487 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.85 -29.67 11.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 71.11 110.521 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 3.5 t-160 -61.95 -21.85 65.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.663 -0.699 . . . . 74.34 110.468 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -96.42 10.21 38.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.773 -0.648 . . . . 75.1 109.918 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' HIS . . . . . 0.519 ' CD2' ' HG2' ' A' ' 172' ' ' GLU . 73.9 t60 -116.68 -77.3 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.435 -0.348 . . . . 73.33 111.767 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 206' ' ' PRO . 8.3 pt-20 -161.22 -10.11 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.339 1.237 . . . . 73.35 114.339 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.568 ' CD2' ' HB1' ' A' ' 201' ' ' ALA . 16.7 p90 -155.97 161.85 40.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.714 0.688 . . . . 74.14 111.229 -170.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.716 HG13 ' HE2' ' A' ' 204' ' ' TYR . 35.6 m -131.6 160.44 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.637 -0.71 . . . . 60.11 110.209 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.64 96.55 10.75 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.005 -1.109 . . . . 73.11 108.005 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.47 73.57 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.948 -0.644 . . . . 14.24 112.389 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 179' ' ' LYS . 25.1 t70 -121.26 98.49 6.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.039 0.447 . . . . 54.14 110.305 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 178' ' ' ILE . 30.5 mm -87.8 38.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.388 1.09 . . . . 73.34 109.274 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . 0.469 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 7.9 ttpm? -75.95 164.83 25.79 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.586 -0.894 . . . . 73.32 108.586 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -56.58 -15.87 5.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.562 0.579 . . . . 61.11 112.562 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 179' ' ' LYS . 11.9 p -76.82 -15.43 59.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.731 0.301 . . . . 63.31 111.595 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 183' ' ' LEU . 5.6 t-20 -83.2 -30.75 27.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.626 0.727 . . . . 71.3 110.346 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.553 ' HG ' HD21 ' A' ' 195' ' ' LEU . 6.0 mp -96.11 110.9 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.999 -1.0 . . . . 75.33 110.695 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.825 HD13 ' HB3' ' A' ' 137' ' ' ASP . 2.2 mm? -98.33 156.6 16.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.704 -0.68 . . . . 73.04 110.228 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 79.5 mt -119.27 159.13 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.512 -0.551 . . . . 63.22 109.512 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 11.9 t30 -60.86 151.06 31.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.825 -1.176 . . . . 72.31 107.825 170.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -48.72 -27.83 3.18 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.085 0.772 . . . . 73.35 113.085 -166.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -156.58 34.93 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.244 0.545 . . . . 72.31 110.557 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 5.0 t30 -126.08 103.5 26.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.558 -0.534 . . . . 73.42 109.558 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.61 -28.67 13.97 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.087 2.525 . . . . 61.11 114.337 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.75 -6.84 55.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.759 -0.376 . . . . 75.35 111.156 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.566 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 11.4 mm-40 -111.81 97.04 6.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 55.14 110.837 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.76 130.07 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.989 -1.005 . . . . 70.24 110.322 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.487 ' CD2' ' HE1' ' A' ' 134' ' ' PHE . 35.0 m-85 -124.43 147.38 48.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.063 -0.717 . . . . 70.42 109.063 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.553 HD21 ' HG ' ' A' ' 183' ' ' LEU . 49.4 mt -96.56 116.3 28.86 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.593 -0.443 . . . . 52.41 110.814 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.579 HG23 ' CE2' ' A' ' 198' ' ' TYR . 2.7 p -148.43 87.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.817 0.818 . . . . 53.24 110.963 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.75 -50.91 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 60.43 109.493 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 196' ' ' VAL . 18.5 m-85 51.51 35.02 13.39 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.494 -0.775 . . . . 72.05 110.705 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -154.27 -31.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.853 -1.067 . . . . 42.2 112.117 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 25.7 mt -97.01 9.77 41.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.78 0.8 . . . . 54.23 108.855 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 173' ' ' TYR . . . -97.46 111.67 23.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.831 -1.077 . . . . 73.23 110.528 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -98.49 115.26 28.17 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.204 -0.453 . . . . 71.31 109.907 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.434 ' NH2' ' HB3' ' A' ' 206' ' ' PRO . 0.6 OUTLIER -87.74 114.54 24.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.54 0.686 . . . . 61.35 110.101 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.716 ' HE2' HG13 ' A' ' 174' ' ' VAL . 9.5 p90 -89.65 -41.57 11.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.142 -0.935 . . . . 71.32 111.527 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 78.0 m -153.04 108.18 2.65 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.599 -0.519 . . . . 64.43 109.599 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 172' ' ' GLU . 28.0 Cg_endo -63.32 84.05 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.899 2.399 . . . . 70.42 113.628 -174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 76.48 -11.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.263 1.025 . . . . 74.44 110.574 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 51.65 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.418 -1.073 . . . . 65.25 110.418 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' VAL . . . . . 0.694 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 3.4 p -48.88 111.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.742 0.782 . . . . 54.03 113.075 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -164.13 70.9 0.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 54.12 109.003 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 205' ' ' CYS . 47.2 tptt -139.54 111.06 7.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.473 -0.785 . . . . 73.14 109.402 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -101.53 176.42 5.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 75.4 111.278 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 9.6 p90 -74.17 84.04 1.84 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.634 -0.712 . . . . 71.24 110.527 177.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -166.17 28.07 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.456 0.646 . . . . 71.31 109.771 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.64 144.5 51.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 63.33 111.594 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -173.82 91.76 0.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.048 -0.978 . . . . 73.43 108.567 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.462 -0.356 0 C-N-CA 122.14 1.894 . . . . 74.24 110.948 176.838 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 222' ' ' ASP . . . . . 0.612 ' OD1' HG21 ' A' ' 228' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 114.149 1.166 . . . . 62.43 114.149 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.405 ' O ' ' HE1' ' A' ' 233' ' ' HIS . . . -127.0 -116.35 2.01 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.449 -0.881 . . . . 41.11 114.229 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.9 m -92.1 110.67 22.05 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.369 0.267 . . . . 63.22 111.438 -173.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.1 tt -58.36 -19.09 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 111.88 0.326 . . . . 73.13 111.88 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.94 -61.83 2.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.44 -0.345 . . . . 74.33 110.642 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.446 ' HD2' ' SG ' ' A' ' 250' ' ' CYS . 84.4 m-85 -86.15 -42.95 13.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.634 -0.257 . . . . 74.22 110.817 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.612 HG21 ' OD1' ' A' ' 222' ' ' ASP . 26.0 m -57.91 -27.67 63.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.158 -0.474 . . . . 72.34 111.364 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 71.5 m 65.99 -170.01 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.592 -0.731 . . . . 73.12 111.463 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.1 OUTLIER -72.65 -33.89 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 73.53 112.218 -175.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 236' ' ' VAL . 1.2 p-10 -58.09 -75.25 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.999 0.74 . . . . 63.54 112.999 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.435 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.04 -30.47 71.0 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.185 0.517 . . . . 54.51 111.346 -176.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 229' ' ' SER . 1.5 t60 -71.74 -23.92 61.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.855 -0.612 . . . . 73.31 111.043 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -97.54 -15.19 20.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 62.33 111.035 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.2 -9.95 59.72 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.294 -0.955 . . . . 54.45 112.689 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 231' ' ' ASP . 8.1 p -71.64 129.72 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 74.14 109.639 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -61.51 116.95 22.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.009 -0.541 . . . . 72.14 112.112 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.77 106.11 0.31 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.779 2.319 . . . . 74.02 110.835 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.0 p -130.51 109.49 10.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.954 -0.566 . . . . 72.34 111.505 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 312' ' ' THR . 2.2 mpt_? 76.66 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.005 -0.998 . . . . 71.31 110.994 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 310' ' ' ASP . 21.6 ttp180 -69.58 -30.94 68.83 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.297 -0.561 . . . . 73.21 110.172 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -52.94 46.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 74.14 111.782 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 165' ' ' LEU . 4.5 m-20 -53.84 -46.04 71.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.463 0.649 . . . . 63.03 110.327 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' LEU . . . . . 0.495 HD13 HD21 ' A' ' 320' ' ' LEU . 75.0 mt -71.75 -35.99 70.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.478 -0.783 . . . . 73.24 111.699 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.64 -39.95 95.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 71.32 110.329 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 227' ' ' PHE . 80.3 mt -64.85 -49.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.62 . . . . 65.44 110.307 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 251' ' ' MET . 51.1 tp -58.81 -47.13 85.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.286 -0.415 . . . . 63.41 111.251 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -34.7 90.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.958 -0.639 . . . . 51.15 112.243 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.429 ' CD2' ' HE3' ' A' ' 275' ' ' LYS . 24.0 t80 -62.72 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.231 0.539 . . . . 74.03 109.811 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 227' ' ' PHE . 60.5 m -61.67 -45.36 94.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.625 -0.716 . . . . 72.52 110.433 176.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -55.23 -52.97 61.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.943 -0.571 . . . . 65.11 111.612 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.9 tt -65.49 -37.16 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 63.45 111.124 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.444 HE21 ' CD1' ' A' ' 259' ' ' LEU . 15.4 mt-30 -69.14 -42.21 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 65.03 111.771 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 41.0 m0 -62.34 -31.84 72.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 71.4 110.674 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.16 -41.26 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.189 -0.459 . . . . 72.24 112.208 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 65.2 p -104.06 -29.11 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.767 0.654 . . . . 73.52 112.767 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.0 24.09 64.51 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 121.056 -0.592 . . . . 31.15 112.985 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -155.67 142.86 19.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.114 0.457 . . . . 75.35 109.937 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.444 ' CD1' HE21 ' A' ' 253' ' ' GLN . 20.4 mt -130.57 149.75 74.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 74.44 111.272 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.2 6.45 3.47 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.97 2.447 . . . . 74.34 112.926 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -143.45 24.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 73.42 110.914 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.552 ' HA ' HD23 ' A' ' 265' ' ' LEU . 12.9 pt-20 -63.83 -30.38 71.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.362 0.504 . . . . 55.3 112.362 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 266' ' ' LYS . 34.5 t70 -83.02 -25.61 32.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.379 -0.529 . . . . 73.24 109.796 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ASN . . . . . 0.83 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 95.2 m-20 -77.34 -3.78 41.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.782 -0.644 . . . . 73.55 110.469 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 262' ' ' GLU . 2.1 mm? -61.57 -18.56 59.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.802 -0.636 . . . . 65.4 110.592 172.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 263' ' ' ASP . 6.0 ptmt -70.57 -19.27 62.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 71.01 111.604 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.592 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 16.1 t70 -135.5 132.56 19.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.955 0.407 . . . . 63.32 111.38 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 271' ' ' VAL . 26.0 Cg_endo -62.24 -30.68 81.85 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.247 2.631 . . . . 52.4 114.494 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' LYS . . . . . 0.592 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 7.3 ptpp? -73.57 -29.56 62.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.879 -0.728 . . . . 63.3 109.832 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.83 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 54.3 m-85 -76.97 -44.35 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.729 -0.669 . . . . 74.22 111.451 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 29.9 m -63.89 -35.8 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.839 -0.345 . . . . 64.01 110.796 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -61.83 -57.49 11.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 74.13 110.287 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.76 -49.74 73.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.335 -0.848 . . . . 75.13 111.127 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 20.1 m -63.11 -44.58 95.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 73.4 111.595 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LYS . . . . . 0.429 ' HE3' ' CD2' ' A' ' 249' ' ' TYR . 68.5 tttt -66.04 -37.33 85.59 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.684 -0.406 . . . . 74.03 110.457 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 78.5 mt -69.01 -47.9 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.606 -0.27 . . . . 61.2 111.146 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -60.96 -40.71 94.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.332 . . . . 73.04 110.908 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -73.4 -31.45 63.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 63.43 110.985 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.45 -20.2 65.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 63.4 111.133 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -80.39 -35.59 35.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.457 -0.338 . . . . 65.03 110.79 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -123.23 47.51 1.98 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.814 0.34 . . . . 73.03 110.651 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.0 mt -51.84 -52.84 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.33 0.863 . . . . 54.14 113.33 -171.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -62.83 -48.66 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.244 0.461 . . . . 70.22 112.244 -169.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.0 m -64.88 -48.41 74.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.219 0.533 . . . . 72.1 110.558 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.64 -54.4 16.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.523 -0.762 . . . . 65.22 111.674 -174.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -65.04 -43.34 92.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.57 0.211 . . . . 70.01 111.57 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.42 -39.94 81.4 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.804 -0.359 . . . . 74.13 111.278 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -76.42 -20.73 56.8 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.99 -0.284 . . . . 71.41 111.377 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 97.9 m -76.86 -16.35 59.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 74.51 110.476 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.493 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 59.4 t80 -115.24 81.06 7.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.576 -0.527 . . . . 71.52 109.576 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 91.1 Cg_endo -95.26 34.92 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.458 2.772 . . . . 63.03 112.13 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -82.18 -174.9 5.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.594 -0.73 . . . . 74.33 110.258 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.7 mmtt -89.28 13.17 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.106 0.479 . . . . 73.12 110.848 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.493 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 3.1 t-20 -105.88 -163.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.292 -1.003 . . . . 74.51 108.292 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.457 ' HE3' ' HB ' ' A' ' 331' ' ' ILE . 19.6 pttp -149.66 124.9 4.87 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.79 0.328 . . . . 75.43 111.208 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 290' ' ' PHE . 65.3 Cg_endo -95.43 37.22 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 54.02 111.88 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.67 86.64 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.95 -0.643 . . . . 51.41 111.838 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.721 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.4 mp0 -52.43 -46.49 66.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.029 0.442 . . . . 72.3 110.7 176.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.8 mp -71.97 -42.69 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.78 -0.645 . . . . 61.52 110.789 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.83 68.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.809 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 301' ' ' LYS . 23.3 mtpp -75.07 -30.16 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 74.35 111.506 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.45 -45.96 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.083 0.468 . . . . 61.42 110.134 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.579 ' HA ' HG22 ' A' ' 306' ' ' VAL . 72.1 mtp -72.28 -35.42 68.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 72.32 110.64 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -57.42 -44.33 84.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.577 0.703 . . . . 64.33 109.583 173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.8 m -61.13 -49.98 75.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.891 -1.05 . . . . 64.32 111.893 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 303' ' ' MET . 16.8 m -66.77 -27.53 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.911 0.386 . . . . 75.12 110.758 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -65.25 -42.26 93.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 75.2 110.042 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 50.0 tp -71.37 -21.61 62.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.428 -0.805 . . . . 54.4 110.906 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 309' ' ' LEU . 6.3 tt -71.1 -14.75 62.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.043 -0.526 . . . . 63.44 110.291 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 34.8 t70 67.56 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.628 -0.715 . . . . 50.41 111.852 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -136.43 -51.93 0.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.24 -0.652 . . . . 70.23 109.24 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 240' ' ' ARG . 55.3 m -148.37 75.88 1.34 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.786 -0.643 . . . . 74.11 111.358 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.419 ' HB2' ' HG ' ' A' ' 309' ' ' LEU . 51.1 mm-40 -83.3 -165.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.106 -1.072 . . . . 74.22 108.106 162.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 314' ' ' LYS . 11.0 tmtt? -76.13 113.53 28.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.516 -0.92 . . . . 70.22 108.516 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 240' ' ' ARG . 12.3 Cg_exo -68.43 117.46 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.038 1.826 . . . . 72.24 110.966 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 95.6 mt -94.11 68.68 3.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.072 -0.513 . . . . 72.42 110.521 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -57.92 -32.86 68.18 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.211 -0.663 . . . . 64.35 109.211 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.4 mp0 -58.01 -56.7 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.756 -1.111 . . . . 73.53 110.302 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 26.2 t-20 -71.96 -33.17 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 75.44 111.734 -175.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 7.9 mp -61.28 -48.19 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.367 . . . . 72.24 111.058 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.534 ' HB2' HD11 ' A' ' 159' ' ' LEU . 15.4 ptp180 -72.01 -24.67 61.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.325 -0.55 . . . . 65.0 109.951 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.08 -49.02 55.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 73.05 110.989 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -62.68 -39.0 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 110.066 -0.346 . . . . 75.04 110.066 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.5 mt -62.33 -49.74 74.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 62.0 110.527 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 325' ' ' LEU . . . . . 0.645 ' O ' ' HG3' ' A' ' 329' ' ' LYS . 4.1 mm? -70.15 -26.9 64.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 64.33 111.366 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.01 -43.54 64.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.918 0.389 . . . . 71.52 110.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.721 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.03 -36.04 92.57 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 61.34 111.798 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 155' ' ' LEU . 17.4 tp -69.21 -29.93 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 74.13 110.057 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 325' ' ' LEU . 62.3 mttp -65.28 -38.78 91.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 45.34 110.55 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.28 73.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.755 -0.657 . . . . 74.05 111.655 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.457 ' HB ' ' HE3' ' A' ' 295' ' ' LYS . 15.2 tt -92.64 2.49 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 63.51 110.375 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.09 25.77 73.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.897 -0.668 . . . . 61.11 113.576 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 333' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 25.6 m -121.83 158.93 27.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.435 0.617 . . . . 62.34 111.272 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -150.74 172.76 15.07 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.042 -0.725 . . . . 73.4 109.042 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 30.6 t70 -120.63 127.74 52.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.763 -0.458 . . . . 74.44 109.763 172.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.74 21.11 3.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 64.3 110.832 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.23 45.37 15.24 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.491 -1.043 . . . . 64.44 110.491 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.559 -0.32 . . . . 71.42 111.716 -172.598 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.659 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 57.7 tptt . . . . . 0 C--O 1.224 -0.265 0 N-CA-C 108.51 -0.922 . . . . 75.3 108.51 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.4 t -73.18 164.62 26.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.522 0.146 . . . . 74.43 110.656 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -66.3 142.36 16.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 71.54 111.683 -174.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.0 t -75.36 134.84 40.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.766 -0.457 . . . . 71.1 109.766 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 356' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.646 0.736 . . . . 63.25 109.105 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.202 0.525 . . . . 73.1 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.52 -9.1 62.44 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.776 -0.647 . . . . 63.23 112.547 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.61 138.37 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 73.12 111.091 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -95.4 129.17 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.654 -0.703 . . . . 73.44 111.909 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 37' ' ' TRP . 31.3 pt -121.78 137.63 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.665 -0.698 . . . . 64.1 109.195 167.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 18.6 m -118.36 124.26 47.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.107 -0.237 . . . . 41.01 111.238 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.52 -177.93 4.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.459 -0.337 . . . . 71.11 110.482 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -16.78 62.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 71.52 112.744 -173.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.65 30.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.776 0.322 . . . . 65.2 110.525 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt 58.44 77.94 0.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.286 -0.87 . . . . 75.42 111.354 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 30' ' ' THR . 47.0 mmtm -136.09 125.18 24.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 71.11 108.73 173.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.18 85.45 6.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.008 0.432 . . . . 75.32 110.236 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 45.1 m95 -79.34 117.04 19.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.887 -0.597 . . . . 72.11 109.479 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 23.0 pttm -97.38 131.18 44.3 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.882 -0.727 . . . . 72.33 109.181 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 52' ' ' TYR . 59.0 t -67.8 130.32 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.931 -0.577 . . . . 71.45 110.947 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.15 -101.49 1.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.752 -0.737 . . . . 63.35 111.78 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -84.41 121.96 75.18 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.049 0.452 . . . . 72.13 110.11 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 7.4 Cg_exo -73.72 99.72 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.034 2.49 . . . . 73.23 111.376 175.06 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.94 -56.34 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 72.44 110.585 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.84 -24.76 28.27 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.82 -0.705 . . . . 64.21 112.246 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -134.9 165.72 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.951 0.405 . . . . 74.54 111.266 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.62 52.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.596 -0.729 . . . . 43.33 111.743 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.4 16.79 77.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.923 -0.656 . . . . 53.24 112.892 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -168.22 -84.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.117 -0.327 . . . . 74.21 110.117 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.28 144.92 4.2 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.283 -0.96 . . . . 14.14 112.67 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.8 m 62.67 61.15 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.323 0.582 . . . . 75.12 111.016 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.66 HD12 ' HB3' ' A' ' 71' ' ' LYS . 1.1 mm -118.31 138.29 49.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.805 -0.634 . . . . 74.24 109.836 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 39' ' ' VAL . 97.7 m-85 -122.28 154.13 37.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.53 0.205 . . . . 71.52 110.623 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.95 132.37 34.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.914 -0.773 . . . . 62.34 108.914 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.29 98.9 8.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 74.02 112.126 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.69 59.87 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.913 -0.585 . . . . 74.53 109.876 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.3 ttm -36.52 -72.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.162 0.914 . . . . 73.35 112.825 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -178.57 -176.27 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.3 m -70.76 123.67 22.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.574 -0.528 . . . . 70.04 109.574 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.238 -179.052 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 108.821 -0.807 . . . . 60.3 108.821 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 84.9 Cg_endo -82.59 39.05 0.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.3 . . . . 70.23 112.836 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 70.9 m -136.81 137.57 39.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.577 0.704 . . . . 55.54 112.15 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.66 154.0 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.203 -0.908 . . . . 71.22 109.323 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.598 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.8 p -125.22 123.99 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.455 0.645 . . . . 74.43 111.746 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.66 ' HB3' HD12 ' A' ' 51' ' ' ILE . 10.5 ptmm? -103.23 133.81 47.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.228 -0.896 . . . . 53.25 109.487 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.57 148.72 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.082 0.401 . . . . 73.44 112.082 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 31.9 tt0 -142.43 139.49 17.63 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 171.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.39 176.19 2.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.312 2.008 . . . . 51.34 111.697 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.2 m -79.53 41.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.112 0.482 . . . . 65.32 111.537 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -84.06 -24.66 30.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.33 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 t30 70.01 75.76 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.429 0.633 . . . . 72.1 110.371 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -124.52 -128.21 3.25 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.48 -0.782 . . . . 63.44 112.271 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 19.3 Cg_endo -59.95 -35.0 94.85 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.874 2.383 . . . . 64.35 112.759 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.2 tm? -56.03 -50.01 72.12 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.122 0.264 . . . . 74.35 111.12 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -67.21 -38.14 84.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.745 0.307 . . . . 73.44 111.063 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.5 m -64.96 -46.84 79.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 65.24 109.811 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.697 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 39.7 tt0 -60.77 -43.34 98.16 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.694 -1.139 . . . . 45.15 110.209 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.22 -48.64 73.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.796 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -56.79 -58.5 7.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 74.54 110.276 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 79.6 t80 -59.67 -51.32 70.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.27 -0.877 . . . . 74.42 111.388 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.58 -47.16 85.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.343 -0.844 . . . . 70.12 111.648 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -68.32 -30.08 68.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 74.45 111.103 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.33 -30.36 62.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 73.41 111.521 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -34.37 11.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.468 0.544 . . . . 54.4 112.468 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.47 88.98 7.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.389 0.515 . . . . 50.22 112.389 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 95' ' ' GLN . 1.3 ttpp -146.12 105.86 4.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.989 -0.745 . . . . 53.4 108.989 171.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 -54.11 5.46 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.899 3.066 . . . . 72.14 115.041 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -33.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.381 . . . . 73.54 110.497 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 26.0 tp60 -65.03 -47.94 75.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 55.22 110.016 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 92' ' ' LYS . 74.2 mt -58.98 -53.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 115.676 -0.693 . . . . 65.42 110.685 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.0 -41.67 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 72.53 110.961 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -65.24 -53.18 48.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.145 -0.48 . . . . 73.34 111.502 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -72.91 -34.65 66.76 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.931 -0.708 . . . . 72.41 110.965 -175.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.4 mm -63.16 -45.17 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.666 0.27 . . . . 62.42 111.031 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -73.03 -27.9 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.807 0.337 . . . . 65.03 110.544 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.8 m -75.75 -40.87 54.68 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.12 0.486 . . . . 75.33 110.574 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.73 ' HG3' HD13 ' A' ' 105' ' ' LEU . 31.1 tpt180 -72.55 -18.41 61.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 73.2 110.365 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 39.8 tptt 67.57 54.05 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.963 -1.017 . . . . 51.12 110.217 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . 0.73 HD13 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mp -108.56 -167.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.824 -1.08 . . . . 75.04 109.449 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.11 -61.91 1.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.098 -0.334 . . . . 72.04 110.098 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -173.78 144.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 73.55 110.339 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HG ' HG23 ' A' ' 110' ' ' VAL . 44.3 tp -79.43 115.0 18.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.968 -0.753 . . . . 63.22 108.968 175.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' NH2' ' A' ' 160' ' ' ARG . . . -77.42 60.24 3.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.019 -0.61 . . . . 71.04 113.098 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 108' ' ' LEU . 92.1 t -123.47 132.87 24.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.384 -0.598 . . . . 55.14 109.384 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.69 152.83 12.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.103 2.535 . . . . 74.14 112.996 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -76.94 122.33 24.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 74.23 110.674 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -80.74 111.77 17.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.257 -0.883 . . . . 72.14 110.276 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 130' ' ' ILE . 40.4 m95 -90.2 -59.28 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.49 -0.559 . . . . 74.32 109.49 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.32 37.9 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.321 -0.854 . . . . 43.11 111.35 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.2 p -163.34 172.97 13.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.805 -0.443 . . . . 72.33 109.805 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.94 -173.01 40.78 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.124 -1.036 . . . . 75.24 112.271 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 125' ' ' SER . 8.6 tt -121.44 132.93 55.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.395 -0.595 . . . . 71.54 109.395 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -139.22 126.65 21.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.863 0.363 . . . . 72.11 110.422 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 21.6 t70 -75.68 126.75 31.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.803 -0.635 . . . . 71.4 110.487 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.861 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -83.45 -54.7 4.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.982 -0.377 . . . . 74.22 109.982 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.09 71.47 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.591 -0.522 . . . . 64.31 109.591 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.35 -19.08 49.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.831 -0.699 . . . . 73.31 111.632 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -113.76 120.0 39.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.124 -0.695 . . . . 64.45 109.124 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.6 p -92.87 134.52 35.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 71.44 110.813 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.09 140.24 50.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.974 -0.557 . . . . 73.31 110.312 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -105.61 124.56 49.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.083 -0.71 . . . . 70.43 109.083 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.598 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 48.7 p90 -122.29 154.42 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.075 -0.511 . . . . 62.15 110.869 -173.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 80.3 mtp -129.61 124.77 34.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 65.4 110.777 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ILE . . . . . 0.571 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 mm -98.13 121.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 63.34 110.461 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -133.25 178.09 7.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 74.01 109.321 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.3 p-10 -68.13 154.96 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 34.15 110.202 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -83.26 122.99 29.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.385 0.612 . . . . 71.11 112.118 -171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 90.2 m-85 -102.8 171.55 7.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.195 -0.911 . . . . 73.13 109.121 173.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.25 -30.43 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.886 -1.15 . . . . 65.01 113.24 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 49.9 m -105.27 125.67 51.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.048 0.424 . . . . 60.01 112.057 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 184' ' ' LEU . 3.9 m-20 -88.91 124.14 33.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.805 -0.634 . . . . 75.1 109.543 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 13.4 tp -64.35 -26.26 68.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.221 0.534 . . . . 73.4 109.768 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 28.2 tt0 -62.9 -48.7 77.84 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.787 -0.642 . . . . 71.21 110.977 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.74 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 9.0 mmpt? -70.07 -29.79 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.225 -0.443 . . . . 54.13 110.233 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -65.09 -48.98 81.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.653 -0.703 . . . . 73.41 110.993 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.77 -32.12 73.21 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 119.866 -0.734 . . . . 74.34 109.68 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.05 -38.9 89.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 73.32 110.69 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.6 67.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.917 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' A' ' 148' ' ' ARG . 55.4 t30 -104.55 6.09 34.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.432 . . . . 64.14 110.906 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.57 54.9 6.02 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.706 -0.679 . . . . 71.53 112.257 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.484 ' O ' ' HA2' ' A' ' 257' ' ' GLY . 46.3 mtmt 55.59 53.44 9.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 75.24 112.569 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.464 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . 35.8 mmt180 -123.46 96.41 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 74.42 109.87 173.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.653 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 21.7 m-85 -102.14 132.21 48.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.202 -0.454 . . . . 62.34 111.016 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 m -58.2 144.96 38.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.504 -0.771 . . . . 74.14 109.628 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 294' ' ' ASN . 45.9 ttt85 -59.92 -37.9 80.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.686 -0.234 . . . . 62.12 111.51 -172.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 153' ' ' THR . 11.9 ptpt -61.67 -38.19 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 62.25 110.253 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.545 ' N ' ' HG3' ' A' ' 152' ' ' LYS . 9.0 m -68.0 -45.37 74.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.106 -0.497 . . . . 61.4 110.436 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.6 t -61.89 -47.34 93.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.385 -0.37 . . . . 72.32 110.585 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.784 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -62.84 -52.4 63.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 74.44 110.545 -176.333 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -63.48 -33.52 75.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.587 0.232 . . . . 74.2 110.812 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 161' ' ' ILE . 2.7 mp -65.94 -51.21 60.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 70.01 110.681 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 247' ' ' LEU . 36.3 p -58.18 -37.16 74.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.075 -0.25 . . . . 43.42 110.902 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 74.5 mt -60.33 -54.39 46.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 75.21 111.219 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.497 HH11 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -66.57 -15.76 63.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.118 0.485 . . . . 70.44 111.0 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 157' ' ' LEU . 37.4 mm -72.35 -42.41 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.452 -0.573 . . . . 63.11 109.452 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.524 ' HB3' ' HE1' ' A' ' 317' ' ' TYR . 2.2 mm? -62.04 -42.21 98.93 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.62 -0.263 . . . . 73.42 110.459 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -63.03 1.22 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.6 0.714 . . . . 64.22 110.703 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 168' ' ' ILE . 18.1 tt -68.16 -41.4 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.234 -0.894 . . . . 64.15 111.565 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 243' ' ' ASP . 30.9 mt -63.66 -39.02 93.29 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.516 -0.474 . . . . 72.0 110.885 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 7.5 tp10 -57.28 -56.68 18.63 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.819 -0.438 . . . . 71.53 109.819 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.8 -42.94 80.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.473 -0.785 . . . . 74.24 112.078 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 174' ' ' VAL . 28.1 pt -80.7 -40.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.943 0.719 . . . . 54.01 112.943 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' HA ' ' A' ' 166' ' ' GLU . 1.3 p-80 -75.89 -17.83 59.64 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.696 -0.802 . . . . 73.22 111.253 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.3 16.33 17.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 71.3 109.966 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -136.95 -89.01 0.28 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.106 -0.497 . . . . 65.33 110.88 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -147.56 114.96 6.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.615 0.245 . . . . 73.24 110.711 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 64.8 m-85 76.26 157.43 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.237 0.961 . . . . 74.43 112.35 169.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 22.2 m -142.33 172.41 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.394 -0.821 . . . . 72.2 109.594 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 14.2 t60 -119.9 103.12 9.06 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.984 -0.286 . . . . 54.11 110.414 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.503 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . -73.71 -46.93 22.33 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.847 -0.692 . . . . 51.4 112.114 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . 0.954 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 24.9 t70 -65.58 94.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.146 0.498 . . . . 72.33 110.281 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.466 HD11 HD12 ' A' ' 161' ' ' ILE . 8.3 tp -97.45 14.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.759 -0.655 . . . . 61.44 110.605 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -53.6 146.28 13.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.2 -0.455 . . . . 71.52 110.072 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.98 -10.65 6.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.807 0.669 . . . . 75.01 112.807 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.9 p -73.79 -15.93 61.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.983 0.42 . . . . 71.41 110.826 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASN . . . . . 0.466 ' O ' HD12 ' A' ' 195' ' ' LEU . 41.3 m-80 -85.77 -16.67 38.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 75.41 110.751 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.73 115.0 29.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.972 -0.558 . . . . 35.44 110.253 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.0 mm? -110.69 135.21 51.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 63.54 110.229 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.9 mt -85.54 137.59 32.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.954 -0.567 . . . . 63.31 109.853 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -62.58 135.13 57.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.941 -0.572 . . . . 63.54 109.893 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -56.0 -33.54 64.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.847 -0.615 . . . . 73.11 112.126 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -81.86 -54.21 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 71.0 110.812 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.1 112.83 49.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.446 -0.343 . . . . 62.4 111.531 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.36 -10.56 28.35 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.845 2.363 . . . . 64.22 111.138 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ASP . . . . . 0.581 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 5.0 p-10 -88.67 0.67 56.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.433 -0.803 . . . . 65.43 110.592 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 77.4 mt-30 -114.07 102.64 10.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.526 . . . . 62.22 110.081 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.3 p -106.79 120.59 58.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.319 0.58 . . . . 73.25 110.703 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 93.3 m-85 -117.12 157.81 25.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.114 -0.494 . . . . 74.41 110.312 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 182' ' ' ASN . 31.6 tp -96.91 150.55 20.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.272 -0.422 . . . . 44.22 110.454 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 197' ' ' ASP . 3.0 p -136.39 -155.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.04 -0.726 . . . . 62.13 109.04 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.553 ' N ' HG13 ' A' ' 196' ' ' VAL . 9.2 t70 72.24 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.318 0.647 . . . . 72.32 109.706 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' TYR . . . . . 0.697 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 36.1 m-85 55.92 -7.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.246 1.202 . . . . 74.34 114.246 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 197' ' ' ASP . . . -72.72 -31.43 62.59 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.949 -0.861 . . . . 53.33 110.949 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . 0.687 ' HB2' ' CE1' ' A' ' 175' ' ' HIS . 92.0 mt -89.06 53.53 2.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.069 0.462 . . . . 71.44 110.307 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 173' ' ' TYR . . . -98.75 99.0 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 62.42 110.163 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -122.35 104.57 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 75.51 111.888 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ARG . . . . . 0.572 ' HB2' HG22 ' A' ' 174' ' ' VAL . 31.9 ttm180 -178.73 -73.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.077 -0.51 . . . . 72.12 110.44 172.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' TYR . . . . . 0.507 ' H ' ' HA ' ' A' ' 173' ' ' TYR . 81.9 t80 70.61 112.4 0.05 Allowed 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 124.036 0.835 . . . . 72.23 111.044 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 56.6 m -116.07 100.89 53.89 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.056 -0.72 . . . . 73.31 109.056 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 11.5 Cg_endo -55.41 107.4 0.24 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.471 2.114 . . . . 63.14 111.818 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 206' ' ' PRO . 11.2 mm-40 72.29 16.05 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.84 -0.618 . . . . 70.24 110.746 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.55 74.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.891 -0.671 . . . . 50.12 111.878 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.3 111.61 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 73.41 110.015 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' HIS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 238' ' ' PRO . 24.7 p80 -87.55 147.16 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.448 . . . . 73.1 110.947 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' LYS . . . . . 0.43 ' HB2' ' HG2' ' A' ' 238' ' ' PRO . 53.6 mtpt -71.35 166.63 21.24 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 73.42 110.168 173.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 212' ' ' GLU . 8.6 pt-20 -82.7 174.34 11.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.852 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -74.96 88.54 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.953 0.882 . . . . 74.11 110.66 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -138.85 12.69 2.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.266 -0.879 . . . . 44.01 110.494 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' GLU . . . . . 1.082 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 4.1 mm-40 -102.52 118.04 36.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 72.44 111.472 -171.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -150.41 82.75 6.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.84 -0.8 . . . . 75.41 108.84 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 C-N-CA 122.297 1.998 . . . . 74.31 111.474 179.147 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 111.768 0.284 . . . . 63.44 111.768 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLY . . . . . 0.954 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -109.51 -104.17 2.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.75 -0.738 . . . . 74.34 112.81 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 228' ' ' THR . 2.2 p -89.82 146.99 24.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.671 0.272 . . . . 63.1 110.525 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -68.22 -27.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 74.22 110.548 -175.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -55.74 5.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.487 -0.324 . . . . 52.05 110.14 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' PHE . . . . . 0.415 ' HB3' HG22 ' A' ' 178' ' ' ILE . 90.8 m-85 -86.15 3.16 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.017 0.377 . . . . 74.33 112.017 -169.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 228' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 6.8 t -77.71 -6.02 52.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 72.24 110.517 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.571 ' HA ' ' HE2' ' A' ' 249' ' ' TYR . 41.9 t 65.96 173.36 0.23 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.147 0.499 . . . . 75.15 111.168 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.7 -34.84 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.222 0.534 . . . . 73.41 109.57 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.79 -62.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.281 -0.872 . . . . 73.32 112.294 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -65.43 -28.38 69.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 54.53 110.939 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' HIS . . . . . 0.531 ' HB2' HG23 ' A' ' 228' ' ' THR . 14.3 t-80 -74.82 -17.82 60.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.381 -0.372 . . . . 61.51 110.719 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -82.94 -30.06 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.693 -0.855 . . . . 63.1 108.693 170.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 109.75 -9.1 32.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.237 -0.892 . . . . 55.32 112.392 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' VAL . . . . . 1.082 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 5.3 p -62.04 109.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.619 0.723 . . . . 75.43 110.172 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -67.46 -61.43 4.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 54.31 112.433 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 31.5 Cg_endo -93.79 73.08 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.673 2.248 . . . . 55.01 113.573 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.9 t -132.46 110.42 10.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.795 0.331 . . . . 42.5 110.701 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' ARG . . . . . 0.453 ' HA ' ' OD1' ' A' ' 243' ' ' ASP . 29.8 ttt180 -66.73 -16.91 64.57 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.552 0.692 . . . . 65.33 110.492 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . 0.962 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.53 -43.36 75.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.904 -1.043 . . . . 75.33 109.61 175.334 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 242' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -63.74 -46.32 92.22 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.128 -0.942 . . . . 64.21 112.423 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ASP . . . . . 0.532 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -47.28 -51.57 18.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.645 0.736 . . . . 65.54 110.358 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.4 -31.95 64.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.858 -1.065 . . . . 72.34 111.956 -173.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.96 -38.66 64.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.7 -0.4 . . . . 65.52 110.547 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ILE . . . . . 0.503 HD13 ' HA2' ' A' ' 176' ' ' GLY . 90.9 mt -58.69 -48.38 86.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.375 0.607 . . . . 64.22 110.59 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -59.73 -41.03 89.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.645 -0.707 . . . . 74.32 110.06 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 252' ' ' ILE . . . -54.84 -41.98 77.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.01 -0.614 . . . . 75.4 112.111 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' TYR . . . . . 0.571 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 19.4 m-30 -55.94 -59.49 4.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.808 0.337 . . . . 71.32 111.026 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 247' ' ' LEU . 25.6 p -62.35 -36.15 81.32 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.552 -0.459 . . . . 51.44 111.32 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.2 mtp -60.99 -54.39 45.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.667 0.27 . . . . 54.55 111.278 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 248' ' ' GLY . 8.9 tt -68.36 -36.49 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 64.22 110.677 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.573 0.225 . . . . 53.44 111.348 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 39.0 m0 -75.77 -27.39 58.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 74.12 110.991 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 tp -84.24 -31.52 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.347 -0.388 . . . . 74.41 111.72 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.3 p -101.73 -20.95 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.06 -0.4 . . . . 73.13 111.52 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 85.11 -19.58 21.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.9 -0.667 . . . . 75.44 112.851 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.9 143.65 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.785 -0.45 . . . . 61.55 109.785 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 262' ' ' GLU . 86.6 mt -119.58 141.76 31.55 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.132 -0.321 . . . . 63.41 110.132 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 48.1 Cg_exo -57.08 -45.68 34.08 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.031 2.487 . . . . 63.02 112.504 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 36.8 p90 -80.29 -17.87 50.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.904 -0.589 . . . . 72.13 110.755 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' GLU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 259' ' ' LEU . 1.8 tm-20 -77.7 -35.31 52.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.294 0.569 . . . . 70.43 109.763 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.52 -34.53 76.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.317 0.58 . . . . 54.11 110.041 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -108.45 24.76 12.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 73.52 111.992 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.439 ' HA ' HG13 ' A' ' 271' ' ' VAL . 3.4 pp -71.81 -1.33 13.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.756 0.312 . . . . 74.34 111.666 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.54 -6.25 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.469 -0.332 . . . . 74.52 110.747 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 33.0 t70 -139.06 125.56 12.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.108 -0.33 . . . . 64.0 110.108 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 36.4 Cg_exo -60.4 -21.71 68.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.306 2.671 . . . . 72.43 113.981 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.87 -39.39 79.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.726 -0.39 . . . . 44.53 110.17 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' TYR . . . . . 0.61 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 44.8 m-85 -65.88 -50.45 64.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 73.12 111.456 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' VAL . . . . . 0.617 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 30.0 m -63.3 -35.18 71.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.992 -0.283 . . . . 74.01 111.201 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 276' ' ' ILE . 38.8 ttp180 -63.17 -62.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.987 0.422 . . . . 71.11 110.408 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 11.2 t70 -62.99 -44.41 96.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.515 -0.766 . . . . 71.04 111.352 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' SER . . . . . 0.478 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 25.1 m -61.18 -47.41 86.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.406 . . . . 60.32 111.225 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.8 -36.63 84.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.79 -0.364 . . . . 72.23 111.132 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.5 mt -60.38 -42.65 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.601 0.238 . . . . 74.1 110.585 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 273' ' ' ASP . 57.2 mtt180 -61.14 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.404 -0.362 . . . . 64.1 110.755 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 278' ' ' TYR . . . . . 0.478 ' HD1' ' O ' ' A' ' 274' ' ' SER . 35.7 m-85 -69.86 -43.67 71.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.057 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' ARG . . . . . 0.493 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 2.3 ptm180 -67.99 -25.21 65.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.908 -0.317 . . . . 65.44 111.347 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -85.5 -42.79 14.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.872 0.368 . . . . 74.34 110.803 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.51 87.45 2.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.138 0.494 . . . . 73.31 110.351 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -81.64 -40.67 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.428 0.899 . . . . 61.42 113.428 -172.0 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -65.89 -51.35 59.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.345 0.868 . . . . 55.24 113.345 -163.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.7 p -77.04 -28.89 55.0 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.574 -0.45 . . . . 74.11 110.944 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.95 -54.97 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 73.44 110.458 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -63.47 -39.67 95.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.602 -0.272 . . . . 75.33 111.316 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.84 -38.29 90.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 74.2 111.486 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -91.75 -20.31 21.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.728 0.64 . . . . 74.24 112.728 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.25 -44.9 86.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.748 0.309 . . . . 75.02 111.199 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 296' ' ' PRO . 17.5 p90 -136.82 89.74 17.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 122.002 0.906 . . . . 65.21 110.77 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.11 49.43 3.03 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.856 2.371 . . . . 71.11 111.986 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -100.39 -145.59 0.34 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.332 -0.395 . . . . 64.15 110.807 -178.332 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 293' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 70.1 mmtt -120.03 17.29 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.646 0.98 . . . . 62.13 113.646 -166.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.501 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 14.6 m-80 -93.13 -15.99 25.41 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.184 -0.323 . . . . 65.55 110.345 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 11.4 mptt 75.1 112.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 123.847 0.717 . . . . 61.34 111.05 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 290' ' ' PHE . 96.7 Cg_endo -83.04 37.71 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.551 2.167 . . . . 45.4 112.255 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -81.72 -68.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.9 -0.667 . . . . 64.13 112.5 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLU . . . . . 0.414 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.9 mp0 -55.98 -36.63 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 122.045 0.138 . . . . 60.0 111.266 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 2.9 mp -61.71 -49.53 83.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.827 0.346 . . . . 74.35 110.609 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.36 85.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 63.2 110.807 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 301' ' ' LYS . 69.1 mmtt -68.3 -31.59 71.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.275 -0.42 . . . . 71.51 111.808 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 82.5 t80 -62.24 -47.68 83.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.079 0.466 . . . . 75.4 110.257 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG22 ' A' ' 306' ' ' VAL . 68.6 mtp -73.25 -31.13 63.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.323 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 33.2 tt0 -59.76 -44.16 93.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.745 -0.835 . . . . 70.34 108.745 171.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 58.6 m -58.47 -46.44 86.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.91 -1.041 . . . . 64.21 111.695 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 303' ' ' MET . 14.1 m -68.17 -26.21 33.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.97 -0.292 . . . . 71.52 111.25 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 18.5 ttmt -74.68 -34.08 62.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 72.41 110.14 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 91.7 mt -81.99 5.16 20.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 72.44 112.126 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 315' ' ' PRO . 4.2 pp -107.19 9.28 30.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.417 0.627 . . . . 71.42 109.452 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 12.2 t70 67.41 -81.82 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.335 -1.302 . . . . 65.41 111.887 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' TYR . . . . . 0.962 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.8 OUTLIER -161.91 -48.81 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.954 0.883 . . . . 63.04 109.364 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 m -145.4 35.94 1.08 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.052 -1.092 . . . . 75.51 108.052 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' GLU . . . . . 0.564 ' O ' ' HD3' ' A' ' 314' ' ' LYS . 3.4 tm-20 -77.54 -82.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.898 -1.047 . . . . 73.52 108.793 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 313' ' ' GLU . 0.6 OUTLIER -150.96 99.73 3.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.051 -0.722 . . . . 64.35 109.051 171.348 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.534 ' HA ' HD22 ' A' ' 309' ' ' LEU . 24.4 Cg_exo -63.28 118.28 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.017 1.812 . . . . 72.34 111.124 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.9 84.02 4.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.384 0.612 . . . . 63.41 110.55 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' TYR . . . . . 0.524 ' HE1' ' HB3' ' A' ' 162' ' ' LEU . 61.5 t80 -64.41 -38.89 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.333 -0.848 . . . . 72.34 110.807 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 39.8 tt0 -56.73 -55.09 38.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.342 -0.845 . . . . 60.41 111.327 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -57.05 -50.3 73.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.127 -0.488 . . . . 52.33 111.776 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 4.2 pp -65.05 -40.26 94.51 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.903 -0.319 . . . . 62.11 111.641 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 321' ' ' ARG . . . . . 0.433 ' N ' HD12 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.47 -25.51 59.44 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.332 -0.547 . . . . 72.22 109.886 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 318' ' ' GLU . 0.4 OUTLIER -73.5 -45.39 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 74.42 110.413 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.13 -31.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.931 -0.307 . . . . 74.33 111.14 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.7 mt -63.79 -48.62 76.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.911 0.386 . . . . 73.12 110.175 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.9 -38.67 89.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.161 -0.472 . . . . 50.01 110.688 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -60.74 -44.79 96.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 54.12 110.891 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.414 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.76 -46.37 83.49 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.772 . . . . 70.12 112.556 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' LEU . . . . . 0.784 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 1.8 tm? -63.49 -38.87 92.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 64.34 110.038 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 72.35 110.652 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.31 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 51.52 111.812 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 328' ' ' LEU . 40.5 pt -76.8 -6.34 8.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.844 0.354 . . . . 72.11 111.362 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.06 25.44 14.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.483 -0.865 . . . . 73.23 113.149 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 41.1 m -129.02 147.71 50.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.921 0.36 . . . . 44.54 110.985 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -172.1 75.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.648 0.737 . . . . 74.13 110.324 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -94.41 -8.32 39.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 55.23 110.613 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.0 t70 82.03 -19.73 0.4 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.669 0.788 . . . . 62.4 112.352 171.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . 155.5 50.34 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.554 -1.308 . . . . 73.45 113.842 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 338' ' ' LYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 21.2 ttmm . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 108.997 -0.742 . . . . 73.42 108.997 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' LYS . . . . . 0.528 ' HB3' HD21 ' A' ' 200' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.13 0.491 . . . . 64.4 110.894 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.0 t -129.39 168.89 15.62 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.069 -1.086 . . . . 73.02 108.069 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 200' ' ' LEU . 3.4 pt -66.01 142.67 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.417 0.627 . . . . 54.13 111.836 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 m -73.07 72.46 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.857 -1.065 . . . . 51.42 110.583 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.726 -0.67 . . . . 72.03 111.282 -177.419 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.019 -0.363 . . . . 63.12 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.3 143.34 24.99 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.785 2.323 . . . . 73.14 113.085 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -135.02 148.19 49.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 73.43 109.56 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.68 134.33 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 71.1 111.104 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -152.7 135.5 15.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.979 -0.555 . . . . 73.43 110.3 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 179.67 108.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.48 0.487 . . . . 74.04 110.703 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.12 90.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.717 0.294 . . . . 62.11 111.045 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -178.71 109.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.782 -0.644 . . . . 72.15 110.019 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.59 151.34 11.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.6 -0.273 . . . . 71.03 111.06 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 105.48 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.193 -0.527 . . . . 62.45 113.411 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -157.64 79.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 75.22 110.723 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -146.09 126.94 14.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 75.41 110.129 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.8 m -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.131 -0.486 . . . . 71.01 110.488 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -133.3 119.35 19.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.822 -0.436 . . . . 71.3 109.822 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.98 80.09 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 64.55 111.932 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.72 145.15 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.294 -0.412 . . . . 70.15 110.012 171.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -149.82 149.53 30.64 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.03 -0.73 . . . . 72.54 109.03 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.62 75.56 1.49 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 75.43 112.404 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.4 pp -124.86 120.46 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 74.2 109.489 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.02 -51.3 4.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.006 -0.543 . . . . 73.12 110.658 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 69.16 -63.0 0.39 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.227 0.954 . . . . 64.43 112.686 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.21 -71.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.896 0.332 . . . . 71.11 111.896 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.76 113.09 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.38 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.01 0.819 . . . . 73.13 109.461 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.3 121.64 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.458 -0.792 . . . . 71.35 110.358 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.75 1.29 56.34 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.778 -0.725 . . . . 64.2 113.24 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.8 mt-10 -70.05 110.08 4.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.275 0.537 . . . . 75.41 109.642 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.905 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -89.74 133.47 31.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.157 0.503 . . . . 75.22 110.499 178.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.59 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.79 -0.641 . . . . 74.4 110.888 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 24.0 m -84.65 125.67 32.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.736 0.303 . . . . 64.41 110.534 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -170.5 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 63.32 110.462 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 75.1 mtm -71.67 -20.55 61.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.778 0.288 . . . . 71.42 111.778 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.71 1.95 32.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.999 0.428 . . . . 54.11 110.343 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 71.22 24.37 3.83 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.141 -0.936 . . . . 71.23 112.595 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 30' ' ' THR . 90.1 mttt -103.05 136.72 42.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 52.14 109.532 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.905 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 19.2 tt0 -96.66 97.38 9.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.564 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 63.3 m95 -80.85 128.09 33.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.341 -0.845 . . . . 73.31 111.217 -172.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.727 ' HB3' ' HA ' ' A' ' 56' ' ' MET . 68.1 tttt -92.01 108.02 19.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.294 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' GLU . 10.0 p -68.74 136.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.949 0.404 . . . . 62.22 110.124 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -109.15 -86.13 1.75 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.694 -0.765 . . . . 40.22 112.588 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 95.2 mt -106.78 136.45 19.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.859 0.361 . . . . 72.35 111.527 -174.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.2 Cg_exo -78.07 106.69 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.163 2.575 . . . . 73.12 111.431 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 45' ' ' GLN . 60.0 mt -73.9 -49.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 75.02 110.063 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.59 -23.56 12.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.907 -0.663 . . . . 52.24 112.371 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.3 mp0 -110.35 164.79 12.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.115 -0.328 . . . . 64.45 110.115 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.83 -166.57 28.33 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.644 -0.983 . . . . 74.0 110.644 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.835 ' HA3' HG11 ' A' ' 196' ' ' VAL . . . -82.54 46.65 3.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.402 -0.904 . . . . 74.43 112.463 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.783 ' HD1' ' HB3' ' A' ' 351' ' ' ALA . 65.8 t80 177.93 -59.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.999 0.428 . . . . 74.12 110.013 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.32 154.78 8.97 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.532 -0.758 . . . . 73.04 111.215 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.4 m 59.27 38.4 23.3 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.23 0.538 . . . . 71.5 111.322 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 48' ' ' PHE . 16.6 mm -88.43 138.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.94 -0.573 . . . . 71.12 110.062 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' A' ' 39' ' ' VAL . 87.4 m-85 -108.13 152.59 24.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 72.13 110.999 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.71 143.62 30.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.257 -0.646 . . . . 75.31 109.257 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.57 114.67 27.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.19 0.519 . . . . 72.12 111.137 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 28.3 t70 -84.98 -40.81 16.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.802 -0.635 . . . . 54.14 109.649 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.727 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 96.7 mmm 63.21 173.99 0.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.079 -0.964 . . . . 74.43 112.345 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -89.57 108.71 19.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.796 -0.638 . . . . 73.14 109.913 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -83.31 83.43 7.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.117 0.484 . . . . 53.24 110.363 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -70.76 -66.07 0.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.778 -0.647 . . . . 70.13 110.731 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -144.82 -55.56 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.974 -0.557 . . . . 75.33 109.722 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 p -142.81 93.31 2.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.929 -0.578 . . . . 72.34 110.631 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.61 143.17 16.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.538 . . . . 64.33 110.147 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.81 -100.43 0.13 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.793 -0.717 . . . . 53.32 112.449 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -120.22 14.49 12.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.258 0.552 . . . . 65.42 109.817 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.39 -27.13 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.411 -0.813 . . . . 70.11 111.668 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -76.12 -50.41 3.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.915 0.709 . . . . 51.23 112.915 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 7.8 Cg_exo -74.16 51.44 2.46 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.575 2.184 . . . . 71.42 113.912 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 31.2 p -138.93 162.44 34.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.075 0.464 . . . . 72.32 111.286 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.48 166.37 27.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 64.01 109.369 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.6 p -136.33 128.99 45.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.536 -0.466 . . . . 64.23 112.138 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' SD ' ' A' ' 129' ' ' MET . 32.6 ttpt -85.35 142.55 29.24 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.826 -0.624 . . . . 63.35 109.582 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.83 132.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.952 -0.388 . . . . 71.05 109.952 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 5.1 tp10 -140.1 135.64 16.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.299 -0.409 . . . . 62.42 109.99 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.13 143.55 94.78 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.499 2.133 . . . . 73.23 112.151 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t -71.61 -2.64 17.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.388 -0.369 . . . . 71.12 111.66 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.2 -22.23 64.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.292 -0.633 . . . . 72.41 109.292 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.63 105.49 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.843 -1.071 . . . . 72.11 113.128 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -108.38 -89.63 2.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.298 -0.865 . . . . 72.13 111.13 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -84.83 -20.75 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.386 2.724 . . . . 74.23 111.831 176.143 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 55.2 tp -52.26 -49.53 63.87 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.405 0.891 . . . . 72.42 113.405 -169.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.2 -45.2 95.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.395 -0.522 . . . . 74.12 111.008 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.0 m -64.95 -46.51 81.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.022 0.439 . . . . 54.42 110.68 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 36.1 tt0 -65.29 -52.45 54.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.403 -0.817 . . . . 73.24 111.276 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.93 -39.36 90.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.41 110.918 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.05 -49.72 76.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.805 -0.443 . . . . 63.22 109.805 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.466 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 76.2 t80 -65.93 -44.42 85.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.714 -0.676 . . . . 74.22 110.316 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.95 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 68.2 t80 -54.96 -53.9 49.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.804 -0.634 . . . . 54.32 111.005 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.54 -31.76 72.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.921 -0.581 . . . . 72.02 110.705 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -78.83 -29.52 44.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 71.12 111.877 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.66 -35.35 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.912 0.338 . . . . 75.53 111.912 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -83.64 71.52 10.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.748 0.785 . . . . 64.12 110.567 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 96' ' ' ILE . 4.6 tmtt? -125.02 103.79 30.17 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.839 -1.073 . . . . 64.24 109.428 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -42.98 -47.94 7.99 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.083 3.189 . . . . 53.42 113.368 -174.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 11.1 tp10 -57.99 -60.19 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 74.12 110.721 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -61.7 -41.46 97.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.566 -0.743 . . . . 72.31 111.504 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 69.6 mt -58.03 -52.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 O-C-N 123.073 0.233 . . . . 65.13 110.82 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -58.45 -42.61 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.532 -0.304 . . . . 64.34 110.959 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.7 mmtp -61.86 -62.67 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.907 -0.588 . . . . 62.53 111.943 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.643 ' CH2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.9 -35.23 72.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.584 -0.447 . . . . 71.02 111.643 -171.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.938 -0.305 . . . . 70.51 110.393 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -69.17 -41.33 77.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 53.12 111.129 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 p -76.4 -31.79 58.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.843 0.682 . . . . 73.3 112.843 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 36.1 ttm180 -89.7 5.54 45.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.065 0.459 . . . . 61.03 110.557 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 61.71 30.39 18.43 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.631 -0.713 . . . . 64.34 110.648 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HG ' ' OD1' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -78.95 161.3 26.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.571 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HB2' HH22 ' A' ' 321' ' ' ARG . 5.5 tmtm? -85.61 -66.29 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -163.07 135.51 5.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 72.42 110.817 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.643 HD22 ' CH2' ' A' ' 99' ' ' TRP . 26.7 tp -79.6 121.12 24.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 72.5 110.32 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.96 56.36 4.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.876 -0.678 . . . . 60.22 112.717 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 93.1 t -128.15 125.56 23.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.922 -0.399 . . . . 70.44 109.922 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.95 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -56.1 143.78 82.58 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.897 2.398 . . . . 75.11 112.593 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 113' ' ' TYR . 20.8 tptm -67.79 131.56 45.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 73.55 111.003 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.453 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 77.7 t80 -80.69 124.47 29.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 61.5 110.341 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.624 ' CD1' HG22 ' A' ' 130' ' ' ILE . 14.2 m95 -106.11 -58.67 1.88 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.476 -0.564 . . . . 72.15 109.476 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.39 174.51 35.56 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.048 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.9 p -171.27 147.82 2.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.554 -0.535 . . . . 74.22 109.554 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.32 -167.9 33.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.116 -1.04 . . . . 50.02 112.611 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.5 tt -126.95 133.46 50.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.723 -0.473 . . . . 75.04 109.723 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -134.84 109.48 8.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.473 -0.331 . . . . 70.34 110.29 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.834 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 18.0 t70 -73.68 122.88 23.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.115 -0.493 . . . . 71.3 109.69 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 66.0 tttp -129.46 121.56 27.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.071 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 20.1 m120 63.74 16.5 9.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.915 -0.584 . . . . 62.04 111.658 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.57 -0.25 56.76 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.685 -0.769 . . . . 74.45 112.405 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -117.22 115.35 25.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.095 -0.705 . . . . 70.13 109.095 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.834 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.7 p -76.31 119.61 20.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 72.44 111.157 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 129.81 55.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 75.31 109.656 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.42 134.37 40.77 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.796 -0.816 . . . . 71.52 108.796 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.54 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 44.6 p90 -122.48 142.88 50.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.233 -0.44 . . . . 63.12 111.021 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.642 ' SD ' ' HE2' ' A' ' 71' ' ' LYS . 15.4 ptm -129.87 131.22 46.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 73.1 109.993 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 70' ' ' VAL . 3.3 mm -97.5 123.04 49.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 72.21 110.624 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 38.4 mtm -126.5 178.38 5.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 71.13 110.415 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -65.58 151.39 46.56 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.625 -0.509 . . . . 73.1 109.625 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -72.23 116.12 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.254 0.549 . . . . 72.23 111.113 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 17.0 m-85 -104.97 143.35 33.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.214 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.527 ' HA3' ' CD1' ' A' ' 187' ' ' TYR . . . -140.16 -15.36 0.52 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.475 -0.869 . . . . 61.14 112.721 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.887 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 13.6 m -122.2 132.29 54.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.682 -0.305 . . . . 73.11 110.503 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 139' ' ' GLN . 3.6 p30 -125.74 148.88 48.93 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.843 -0.428 . . . . 74.33 109.843 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.44 HD21 HD21 ' A' ' 157' ' ' LEU . 9.8 mp -74.71 -8.1 55.34 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.989 0.366 . . . . 53.15 111.989 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.679 ' HG2' ' HG ' ' A' ' 349' ' ' LEU . 55.7 tp60 -76.91 -48.6 17.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 64.44 110.647 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.58 -37.22 62.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.949 0.404 . . . . 61.21 110.049 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 341' ' ' LEU . 69.5 mt -62.44 -33.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.503 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.5 ' CE1' ' HD2' ' A' ' 147' ' ' LYS . 13.9 t80 -53.23 -46.59 69.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.009 -0.541 . . . . 75.2 109.581 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -71.22 -52.91 16.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.476 -0.784 . . . . 72.23 110.796 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.07 73.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.912 0.708 . . . . 74.24 112.912 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -104.23 10.03 35.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.92 0.39 . . . . 71.35 110.368 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.404 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 53.28 40.27 31.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.742 -0.663 . . . . 50.31 111.628 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER 42.73 30.78 0.26 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.583 1.153 . . . . 61.2 113.669 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -86.27 95.01 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.515 -0.474 . . . . 74.52 110.042 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 66.5 m-85 -109.15 119.8 40.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.078 -0.51 . . . . 74.24 109.828 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.7 m -74.7 168.18 20.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.266 -0.424 . . . . 72.52 110.72 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 53.2 mtm-85 -51.67 -47.0 64.0 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.315 -0.402 . . . . 63.51 111.648 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.778 ' HE2' ' HB2' ' A' ' 340' ' ' ASP . 0.0 OUTLIER -63.99 -30.05 71.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.853 0.358 . . . . 64.1 111.29 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.567 ' N ' ' HD3' ' A' ' 152' ' ' LYS . 1.3 m -72.49 -52.12 17.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.895 0.378 . . . . 72.21 110.383 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -41.06 91.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.71 -0.677 . . . . 75.5 110.913 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.04 -50.11 75.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 74.34 110.764 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.619 ' NE2' ' HA ' ' A' ' 335' ' ' ASP . 1.5 mp0 -64.06 -38.31 90.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.557 -0.292 . . . . 62.52 111.264 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 161' ' ' ILE . 4.8 mp -60.94 -52.83 63.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 62.21 110.558 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.6 p -68.03 -31.85 71.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 64.33 111.095 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.0 tp -57.03 -53.11 61.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 71.42 111.043 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 156' ' ' GLN . 2.1 mpt_? -67.91 -29.41 68.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.938 0.399 . . . . 73.31 110.638 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 157' ' ' LEU . 40.3 mm -65.73 -36.96 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 51.22 110.241 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 158' ' ' SER . 94.2 mt -62.16 -43.53 98.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 60.22 110.441 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.644 ' OD1' ' HG ' ' A' ' 105' ' ' LEU . 51.3 m-20 -55.71 -54.37 45.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.352 0.596 . . . . 73.2 110.484 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.98 -37.77 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 75.24 111.948 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.63 -38.58 90.79 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.829 -0.349 . . . . 72.22 111.169 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.39 -47.82 75.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.229 -0.588 . . . . 72.11 110.075 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.538 ' HA ' ' OE2' ' A' ' 170' ' ' GLU . 63.5 t80 -58.49 -41.67 85.83 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.437 0.532 . . . . 75.25 112.437 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.466 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 pt -88.29 -33.3 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.601 -0.439 . . . . 60.45 112.069 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.769 ' HD2' ' HD3' ' A' ' 240' ' ' ARG . 37.0 t60 -91.57 -5.92 53.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.665 0.269 . . . . 71.33 111.064 -172.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 167' ' ' TYR . 13.2 pt-20 -78.81 -19.79 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.482 . . . . 72.11 109.734 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 1.9 t60 -97.49 -65.07 0.99 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.91 -0.587 . . . . 73.32 111.447 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 203' ' ' ARG . 35.7 tt0 -162.05 -44.31 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.24 0.829 . . . . 61.42 113.24 -168.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -80.49 158.06 25.97 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.246 0.832 . . . . 73.41 113.246 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.727 HG12 ' CE1' ' A' ' 169' ' ' HIS . 3.6 m -129.7 172.26 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.58 -1.191 . . . . 74.22 108.48 171.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 19.7 t-80 -144.64 92.49 2.3 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.115 -0.698 . . . . 75.24 109.115 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -63.71 -47.33 87.54 Favored Glycine 0 C--O 1.226 -0.4 0 O-C-N 123.522 0.514 . . . . 73.25 113.67 -170.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.568 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.1 t0 -99.02 105.44 17.57 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.387 -0.478 . . . . 72.14 110.525 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.407 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 29.0 mm -89.97 91.3 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 74.02 109.575 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -93.98 149.82 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.372 -0.831 . . . . 72.31 109.798 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 138' ' ' LEU . . . -54.85 -26.83 37.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 45.11 111.733 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.5 p -77.39 -5.58 50.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.945 0.35 . . . . 72.23 111.945 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 197' ' ' ASP . 12.2 m120 -83.18 -22.96 33.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 71.13 110.809 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.75 115.97 31.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.426 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.5 HD21 HG12 ' A' ' 196' ' ' VAL . 2.6 mm? -113.83 131.8 56.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.817 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.887 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.8 mt -89.45 140.92 29.04 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.178 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 189' ' ' ASN . 43.7 t-20 -59.71 125.61 24.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.97 -0.752 . . . . 71.31 108.97 175.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.527 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 36.2 t80 -52.6 -31.27 35.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.507 0.558 . . . . 74.42 112.507 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -126.91 24.55 6.44 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.381 -0.527 . . . . 71.41 111.914 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 14.7 t-20 -159.57 80.78 2.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.456 -0.572 . . . . 72.14 109.456 174.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.67 -24.26 55.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 123.33 2.686 . . . . 63.05 113.993 -170.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 338' ' ' LYS . 4.4 p30 -71.0 -14.38 62.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.926 -0.309 . . . . 73.05 111.592 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.404 ' HG3' ' OD1' ' A' ' 191' ' ' ASP . 77.1 mt-30 -114.04 114.75 26.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 50.11 110.294 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.68 142.86 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.831 . . . . 72.1 110.787 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.785 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 59.1 m-85 -115.92 157.97 23.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 65.44 109.945 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 8.9 tt -115.97 141.21 48.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 70.25 109.792 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.835 HG11 ' HA3' ' A' ' 47' ' ' GLY . 1.4 p -141.27 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.568 -0.901 . . . . 72.21 108.568 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 196' ' ' VAL . 17.8 t70 68.74 65.49 0.31 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 53.23 108.449 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 83' ' ' GLU . 85.6 m-85 -88.49 16.52 6.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.099 -1.409 . . . . 71.14 110.656 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -70.33 -26.52 74.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.702 -0.761 . . . . 72.43 111.296 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 177' ' ' ASP . 35.7 mt -88.78 36.38 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 72.4 110.494 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -106.07 98.88 8.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.161 0.505 . . . . 73.44 110.354 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -100.27 145.84 27.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.964 -0.754 . . . . 71.21 108.964 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.608 ' HB2' ' HG2' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -88.86 130.54 35.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.164 0.506 . . . . 70.43 111.028 -177.537 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -103.23 -54.0 2.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 74.22 110.088 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.18 94.43 30.57 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.792 -0.64 . . . . 72.54 110.427 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 207' ' ' GLU . 18.5 Cg_endo -60.0 123.17 12.65 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.486 2.124 . . . . 61.02 111.523 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 206' ' ' PRO . 32.4 tt0 70.31 -63.96 0.38 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.865 0.728 . . . . 75.21 111.076 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.68 28.51 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.413 -0.675 . . . . 73.32 111.413 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.94 110.7 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.211 -0.292 . . . . 75.11 110.211 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -75.94 104.41 6.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.914 . . . . 64.31 108.531 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -88.44 0.08 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.906 -0.588 . . . . 71.03 111.631 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 173.05 139.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.442 -0.947 . . . . 74.4 108.442 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -84.3 87.92 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.075 0.941 . . . . 71.02 110.241 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 3.0 mmtt -155.24 33.15 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.031 -0.986 . . . . 64.21 109.947 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.3 -5.55 54.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.316 -0.856 . . . . 71.05 109.645 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.7 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.1 p-10 -79.33 113.8 39.63 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.144 -0.935 . . . . 72.15 111.499 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.95 -52.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.515 2.144 . . . . 72.11 111.876 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -156.03 -56.21 0.09 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 71.44 109.327 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -163.66 138.82 6.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 72.24 110.087 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.638 ' HB2' ' HA2' ' A' ' 235' ' ' GLY . 84.3 m -134.32 -60.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.013 -0.365 . . . . 63.35 110.013 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 41.1 p-80 52.98 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.49 1.116 . . . . 62.2 113.733 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -86.2 105.88 16.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.521 0.677 . . . . 74.31 109.613 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 102.23 -166.28 17.42 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.691 -0.766 . . . . 74.4 112.293 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 70.4 p -80.29 151.35 29.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.961 0.41 . . . . 62.2 110.994 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 228' ' ' THR . 17.9 tt -63.02 -9.02 3.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.67 0.747 . . . . 63.34 110.885 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.05 -68.13 0.32 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.783 -1.098 . . . . 75.41 111.521 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.422 ' HB3' HG23 ' A' ' 246' ' ' ILE . 77.7 m-85 -103.24 -11.19 18.16 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.243 0.46 . . . . 61.1 112.243 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.6 t -62.34 -8.94 6.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.01 0.374 . . . . 74.53 112.01 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.9 t 62.49 -174.04 0.15 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.771 0.429 . . . . 60.23 110.9 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.7 mp -73.33 -40.19 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.382 -0.599 . . . . 72.2 109.382 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 236' ' ' VAL . 2.1 m-20 -49.69 -72.65 0.05 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.603 -1.18 . . . . 73.4 111.934 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.42 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 72.44 111.53 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 67.6 t60 -62.46 -39.8 94.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.537 0.208 . . . . 74.41 110.579 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -73.24 -26.19 61.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.659 . . . . 74.23 109.219 179.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.638 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 110.75 7.25 25.87 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.775 -0.648 . . . . 73.45 112.817 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 9.5 p -89.94 136.98 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.973 0.416 . . . . 60.51 110.413 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.92 115.07 43.08 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 74.13 109.891 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.677 ' HB2' ' HA3' ' A' ' 242' ' ' GLY . 81.7 Cg_endo -79.28 148.97 21.59 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.647 2.231 . . . . 73.34 112.857 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.5 t -85.47 -159.95 0.48 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.797 -0.816 . . . . 55.52 108.797 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.769 ' HD3' ' HD2' ' A' ' 169' ' ' HIS . 14.9 mmt-85 -54.18 -35.55 62.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.75 0.309 . . . . 71.53 111.237 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 8.2 mmm180 -56.65 -32.89 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 72.41 112.125 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 238' ' ' PRO . . . -67.37 -54.73 18.51 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.593 -0.813 . . . . 75.34 111.72 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.88 -41.75 83.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.043 0.449 . . . . 74.14 110.538 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 91.8 mt -64.36 -38.46 91.12 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.863 -0.608 . . . . 74.12 110.891 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.81 -50.27 69.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.491 0.662 . . . . 74.32 110.189 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 35.6 mt -59.04 -47.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.018 -0.992 . . . . 74.04 110.89 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 161' ' ' ILE . 56.7 tp -57.9 -42.63 85.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 64.1 110.608 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.64 94.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.965 -0.636 . . . . 64.23 112.051 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -64.26 -42.0 96.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 64.42 110.906 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 27.0 m -69.65 -36.87 76.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.582 -0.281 . . . . 71.3 110.691 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.8 mtp -62.11 -49.8 74.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 73.4 111.015 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.08 -32.01 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 70.15 110.708 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -56.48 -53.93 51.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.011 0.434 . . . . 71.51 110.503 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.0 m0 -69.27 -28.44 66.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 71.43 111.252 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.24 -32.77 38.36 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.188 0.44 . . . . 72.33 112.188 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 290' ' ' PHE . 61.7 p -103.8 -28.58 11.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.421 -0.512 . . . . 74.14 111.75 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 114.8 -36.74 3.8 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.338 -0.934 . . . . 74.13 113.062 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.53 147.48 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.265 0.533 . . . . 74.22 111.102 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.1 mt -94.17 139.22 22.45 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.44 -0.345 . . . . 71.21 110.449 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 -36.95 98.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.981 2.454 . . . . 73.32 112.53 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.541 ' HB2' HG12 ' A' ' 271' ' ' VAL . 41.7 p90 -87.55 -2.35 58.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 75.33 110.852 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 64.2 tt0 -86.92 -37.79 17.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.141 -0.689 . . . . 73.4 109.141 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.99 -20.37 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.133 -0.691 . . . . 71.31 109.133 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -107.9 26.18 10.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.924 . . . . 74.25 110.795 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -74.36 64.41 1.12 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.685 0.755 . . . . 72.43 109.873 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -157.22 14.07 0.25 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.149 -0.932 . . . . 61.21 109.442 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 13.9 t70 -157.31 120.31 2.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.917 -0.583 . . . . 74.51 110.556 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 15.6 Cg_exo -68.85 -27.23 31.26 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.0 2.467 . . . . 62.42 112.602 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -73.32 -48.37 34.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.556 -0.535 . . . . 71.42 109.556 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.563 . . . . 53.31 112.184 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 261' ' ' TRP . 35.3 m -65.49 -41.86 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.55 -0.46 . . . . 72.44 110.906 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -66.7 -48.79 68.13 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.19 -0.3 . . . . 74.51 110.19 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.91 -53.36 56.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.225 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 27.2 m -59.06 -41.77 88.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.353 0.408 . . . . 74.34 111.463 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 279' ' ' ARG . 97.6 mttt -63.86 -48.25 77.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.009 -0.276 . . . . 63.31 110.942 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.668 HG12 HH21 ' A' ' 279' ' ' ARG . 66.0 mt -63.12 -43.37 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.304 0.573 . . . . 45.34 110.281 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.71 -46.62 77.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.801 -1.091 . . . . 74.3 111.538 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.743 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 32.4 m-85 -74.26 -32.2 62.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 73.2 111.814 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.668 HH21 HG12 ' A' ' 276' ' ' ILE . 88.0 mtm180 -74.71 -16.23 60.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.256 0.465 . . . . 74.22 112.256 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 41.3 mt-10 -60.9 -48.99 79.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.77 0.319 . . . . 74.1 110.742 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.504 ' HB2' HD23 ' A' ' 285' ' ' LEU . 15.1 m120 -127.93 70.93 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 71.4 109.725 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -54.02 -44.28 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.764 -0.653 . . . . 54.04 112.615 -173.657 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.457 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.6 -47.51 78.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 73.21 110.847 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 27.8 t -67.22 -49.25 65.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.715 -0.675 . . . . 74.31 110.605 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.743 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.0 mm? -64.16 -50.37 68.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 74.13 111.561 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 282' ' ' ILE . 0.1 OUTLIER -58.38 -44.66 89.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.543 0.211 . . . . 73.13 111.56 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.713 ' HA ' ' HG2' ' A' ' 296' ' ' PRO . 18.8 t70 -68.16 -27.46 66.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 74.34 110.812 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -96.58 6.46 48.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.941 -0.572 . . . . 70.12 111.533 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.6 -38.41 59.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.027 0.441 . . . . 71.21 110.795 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 256' ' ' THR . 29.3 t80 -137.56 75.29 44.8 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 73.41 109.575 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -93.93 110.94 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.382 2.721 . . . . 74.52 112.54 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -159.59 -82.66 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.257 -0.646 . . . . 71.11 109.257 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -144.13 29.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -94.8 162.46 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.632 -1.167 . . . . 64.11 109.855 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -122.68 90.81 49.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.576 -0.527 . . . . 52.13 109.576 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.713 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 89.1 Cg_endo -98.85 37.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.055 2.503 . . . . 51.44 112.207 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.87 -39.91 12.8 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.629 -0.796 . . . . 65.43 111.654 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.5 mp0 -55.03 -44.21 74.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.269 -0.466 . . . . 64.13 110.123 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.6 mp -69.74 -42.58 80.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 62.24 110.528 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.74 -48.6 81.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 75.11 111.18 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 301' ' ' LYS . 8.5 mmpt? -66.08 -41.94 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 73.21 110.836 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -55.59 -48.56 74.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.108 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.515 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.67 -37.84 79.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.2 -0.454 . . . . 64.42 111.366 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.5 -39.86 94.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.28 0.562 . . . . 75.12 109.619 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.8 m -65.19 -44.51 88.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.191 -0.913 . . . . 74.31 111.388 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 29.4 m -69.01 -31.61 51.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 120.622 -0.431 . . . . 73.23 111.349 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -74.03 -28.28 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.249 0.547 . . . . 64.23 109.907 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.04 -16.89 61.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 71.34 111.782 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 306' ' ' VAL . 4.2 pp -95.64 16.45 17.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.673 0.273 . . . . 60.14 111.601 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 16.1 t70 68.48 -96.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.786 -0.643 . . . . 71.04 111.478 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.2 OUTLIER -136.89 -38.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.943 0.402 . . . . 74.3 110.035 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.7 t -158.38 29.17 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 72.33 110.045 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -71.46 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.235 -0.654 . . . . 74.43 109.235 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 58.8 mmtt -130.25 79.59 72.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 70.41 111.227 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' HD22 ' A' ' 309' ' ' LEU . 18.3 Cg_endo -91.78 118.05 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.598 2.199 . . . . 72.32 111.531 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 319' ' ' ASN . 30.3 tp -133.7 103.99 6.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.057 -0.519 . . . . 71.13 109.721 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.406 ' OH ' ' HD2' ' A' ' 240' ' ' ARG . 4.5 m-85 -64.66 -33.72 76.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.641 -0.709 . . . . 74.2 111.472 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.28 -27.39 66.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.632 -0.427 . . . . 72.53 110.709 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.519 ' HB2' HD23 ' A' ' 316' ' ' LEU . 5.9 t30 -72.25 -38.51 68.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.328 0.585 . . . . 61.41 109.457 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' A' ' 323' ' ' ILE . 68.7 mt -69.96 -37.08 75.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.45 -0.796 . . . . 75.31 109.381 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.585 HH22 ' HB2' ' A' ' 106' ' ' LYS . 23.8 ttt180 -59.65 -41.06 89.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.785 -1.098 . . . . 74.45 109.973 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.73 -52.39 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 74.32 111.985 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.437 0.161 . . . . 54.13 110.956 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 155' ' ' LEU . 94.1 mt -64.38 -46.92 81.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.713 0.292 . . . . 64.5 110.992 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.49 -34.92 78.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 73.34 111.03 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -42.77 95.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 72.34 110.402 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.47 -46.34 85.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 40.02 111.711 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.508 HD22 ' HG ' ' A' ' 155' ' ' LEU . 35.1 tp -59.78 -42.66 93.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.172 0.51 . . . . 65.42 110.698 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -70.88 -25.83 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.674 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.9 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 41.2 111.01 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.5 tt -89.17 2.9 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.384 0.612 . . . . 73.31 110.611 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.39 15.31 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.952 -0.642 . . . . 71.33 113.847 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.1 t -121.97 138.57 54.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.407 0.604 . . . . 63.15 110.856 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -154.67 99.5 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.067 -0.515 . . . . 73.14 109.806 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.619 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 13.8 t70 55.26 54.12 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.047 0.927 . . . . 72.13 108.675 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.449 ' HB3' ' HE3' ' A' ' 152' ' ' LYS . 29.4 t70 -66.49 103.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.346 -1.297 . . . . 75.23 112.486 -167.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.01 71.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.56 -0.745 . . . . 52.34 113.565 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 191' ' ' ASP . 96.2 mttt 58.3 78.1 0.26 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.967 0.413 . . . . 71.2 110.884 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.809 ' HG ' ' H ' ' A' ' 340' ' ' ASP . 13.1 tp 65.36 -169.66 0.2 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.566 -0.743 . . . . 75.34 110.571 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.809 ' H ' ' HG ' ' A' ' 339' ' ' LEU . 14.7 t70 -144.04 2.72 1.18 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.323 0.582 . . . . 71.21 110.5 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 185' ' ' LEU . 8.3 tp -104.38 82.98 2.0 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.008 0.433 . . . . 71.02 110.727 -171.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 16.2 m -111.23 22.53 15.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.045 -0.525 . . . . 73.34 110.121 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.9 t -63.83 -25.02 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.527 -0.76 . . . . 71.41 111.593 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.657 ' HA ' ' OG ' ' A' ' 136' ' ' SER . 31.5 m 41.63 54.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 61.32 113.222 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 136' ' ' SER . 2.4 mm-40 -102.42 144.78 30.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.566 -0.743 . . . . 55.3 110.791 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -126.37 116.32 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 73.51 110.02 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 162.65 58.52 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.649 -0.58 . . . . 74.03 111.649 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 139' ' ' GLN . . . -93.1 -143.9 13.87 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.024 -0.608 . . . . 75.04 113.604 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.679 ' HG ' ' HG2' ' A' ' 139' ' ' GLN . 97.5 mt -114.1 -162.73 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.446 -0.377 . . . . 54.35 110.657 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -116.96 162.41 17.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 74.25 110.454 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.783 ' HB3' ' HD1' ' A' ' 48' ' ' PHE . . . -82.04 164.94 21.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.433 -0.349 . . . . 55.2 110.108 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.638 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 23.5 mtmm -129.56 159.33 36.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.966 0.412 . . . . 63.43 111.363 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.01 159.22 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 73.51 111.911 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -74.87 141.22 16.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.155 0.502 . . . . 73.21 111.254 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.9 t -86.18 73.66 10.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.539 0.685 . . . . 61.22 110.092 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -72.96 -38.05 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.786 -0.643 . . . . 63.0 111.443 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.539 ' HG3' ' N ' ' A' ' 358' ' ' ARG . 16.5 ptpt -168.0 -50.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 74.33 111.231 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.539 ' N ' ' HG3' ' A' ' 357' ' ' LYS . 7.1 tpt180 -151.37 134.16 15.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 62.11 110.325 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -119.39 109.87 16.28 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.403 -0.591 . . . . 74.33 109.403 172.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.609 ' NZ ' ' HB2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.078 -0.963 . . . . 63.34 110.493 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.661 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 64.4 mtt . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 119.756 -0.164 . . . . 64.53 111.041 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 95.5 Cg_endo -83.27 139.19 9.17 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.814 1.676 . . . . 72.32 111.706 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -130.29 118.51 21.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.118 -0.492 . . . . 54.32 110.743 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.37 106.47 9.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.64 -0.709 . . . . 64.43 110.157 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -114.9 123.76 49.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.924 -0.58 . . . . 72.43 110.193 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.72 124.9 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 70.44 110.16 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.03 88.99 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 71.14 110.49 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.42 99.57 8.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 64.33 110.222 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.38 95.57 6.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.41 -0.359 . . . . 74.44 110.416 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 104.66 3.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.62 -0.8 . . . . 72.14 111.948 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.406 ' HD2' HH11 ' A' ' 11' ' ' ARG . 2.6 ptm180 -130.54 135.69 48.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.695 -0.483 . . . . 71.4 109.695 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -131.56 109.38 10.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.587 -0.523 . . . . 71.13 109.587 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 p -118.64 121.55 40.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.74 -0.664 . . . . 72.33 109.958 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -154.74 29.99 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.295 -0.411 . . . . 72.41 110.5 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.88 109.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 61.14 110.132 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -120.66 116.23 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.522 . . . . 72.12 111.441 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -108.43 166.19 10.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.966 -0.753 . . . . 73.21 108.966 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -73.68 86.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.918 0.39 . . . . 71.02 110.982 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp -170.1 161.91 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 71.43 111.042 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.04 -82.75 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.077 -1.083 . . . . 53.44 108.077 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -145.98 -179.34 6.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.267 -1.012 . . . . 65.55 108.267 169.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.405 ' HG2' ' H ' ' A' ' 22' ' ' GLN . 10.6 pt20 -76.11 75.36 2.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.573 0.701 . . . . 74.42 111.11 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -169.37 84.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.135 -0.938 . . . . 73.34 109.402 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.22 -162.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.684 -0.689 . . . . 73.35 109.918 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.57 ' HA ' HG23 ' A' ' 39' ' ' VAL . 99.3 t -60.48 134.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.309 -0.405 . . . . 74.34 110.031 173.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . 99.6 -3.59 57.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 72.41 112.655 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -96.67 159.43 14.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.944 0.402 . . . . 72.51 110.714 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -79.1 146.06 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 72.34 112.159 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tp -133.79 122.51 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.236 -0.893 . . . . 72.34 109.568 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -96.77 134.21 40.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.712 -0.222 . . . . 64.11 111.505 -175.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.57 -176.32 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.565 -0.532 . . . . 73.34 109.565 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.406 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 50.4 tpp -72.59 -22.54 60.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.552 0.215 . . . . 65.22 111.162 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.7 21.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.108 0.48 . . . . 73.15 110.226 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 71.07 36.12 1.48 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.991 -1.004 . . . . 70.02 111.409 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.05 121.96 45.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 51.13 110.199 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mp0 -87.03 97.2 10.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.187 -0.46 . . . . 70.03 110.226 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 44.1 m95 -84.93 -171.74 3.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.63 -0.878 . . . . 65.14 108.63 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -134.68 137.05 43.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.426 . . . . 72.54 110.402 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 25' ' ' VAL . 2.4 m -69.23 118.64 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 73.04 110.693 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 56' ' ' MET . . . -107.28 -116.43 4.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.834 -0.698 . . . . 74.45 112.214 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 mm? -91.08 122.69 66.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.81 0.338 . . . . 74.03 110.977 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_exo -78.51 104.77 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.914 2.409 . . . . 71.15 111.052 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 45' ' ' GLN . 58.9 mt -79.14 -46.86 23.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 75.53 110.227 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.37 -27.67 8.3 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.433 -0.667 . . . . 73.13 111.433 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.743 ' HG3' HD11 ' A' ' 349' ' ' LEU . 2.2 mp0 -107.79 165.27 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.29 -0.455 . . . . 72.12 109.878 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 184' ' ' LEU . . . 156.69 -88.37 0.12 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.498 -0.641 . . . . 52.25 111.498 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . -158.22 50.13 0.42 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.609 -0.805 . . . . 63.3 112.353 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 63.7 t80 171.71 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.119 0.568 . . . . 74.02 109.684 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 161.18 134.77 1.7 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.99 -0.844 . . . . 75.41 110.99 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.5 t 65.52 76.48 0.33 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.622 0.725 . . . . 54.45 110.176 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.413 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.1 mm -121.65 135.47 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 73.52 109.73 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.548 ' CE1' HG12 ' A' ' 39' ' ' VAL . 51.9 p90 -131.15 154.78 47.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.181 -0.608 . . . . 64.11 111.311 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.0 tt -71.52 133.18 45.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 65.32 109.418 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 37' ' ' TRP . . . -93.39 36.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.224 0.453 . . . . 73.23 112.224 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' O ' HD22 ' A' ' 53' ' ' LEU . 17.0 t0 -178.73 152.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.112 -0.699 . . . . 72.33 109.112 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 26' ' ' GLY . 4.6 ppp? -144.58 6.66 1.26 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 73.51 110.38 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -139.33 -179.34 5.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 75.02 109.792 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -90.21 72.69 7.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.764 -0.458 . . . . 72.33 109.764 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 m -59.23 -37.1 76.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.493 0.663 . . . . 43.14 109.789 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 61' ' ' SER . 17.5 tt0 -144.96 -163.33 1.68 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.572 -1.64 . . . . 73.41 106.572 170.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.515 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 50.6 m -66.77 86.85 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.682 0.673 . . . . 74.15 111.489 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.51 124.42 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 74.44 111.312 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.4 -1.01 5.3 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.295 -0.866 . . . . 70.13 111.206 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 m -120.31 23.58 10.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 111.562 0.208 . . . . 52.14 111.562 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' HB2' HH12 ' A' ' 133' ' ' ARG . 22.2 m-20 60.66 25.46 15.22 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.38 0.425 . . . . 72.2 111.231 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.76 91.8 0.07 OUTLIER Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 121.562 0.696 . . . . 64.33 110.12 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.72 23.34 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.891 2.394 . . . . 73.22 113.084 -172.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.2 p -124.18 139.02 54.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.367 0.603 . . . . 74.41 111.944 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 53' ' ' LEU . 20.5 m -130.85 170.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.393 -0.821 . . . . 63.21 109.544 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.847 ' HB ' HD13 ' A' ' 130' ' ' ILE . 1.5 p -132.48 127.2 56.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.059 0.457 . . . . 62.03 111.431 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -85.34 130.1 34.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.241 -0.891 . . . . 73.02 109.101 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.6 127.74 66.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.983 0.42 . . . . 74.11 111.397 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 25.9 tt0 -115.25 141.01 26.47 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.393 -0.965 . . . . 64.23 108.393 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.38 -171.45 0.12 Allowed 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.218 1.945 . . . . 65.41 111.639 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 t -76.79 78.97 3.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.256 0.551 . . . . 64.52 109.559 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -122.08 -52.49 1.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 73.43 110.541 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.38 46.34 1.98 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.884 0.849 . . . . 44.24 109.651 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.98 -80.81 0.86 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.127 -0.942 . . . . 44.31 111.658 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.8 Cg_exo -59.77 -43.96 34.35 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.712 2.275 . . . . 35.0 112.033 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.28 -33.27 75.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.298 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.57 -50.53 69.11 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.909 0.385 . . . . 53.34 111.033 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.0 m -65.15 -43.74 90.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 74.11 110.674 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -66.83 -35.48 80.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 70.13 110.388 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.07 -49.28 78.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 74.22 109.944 178.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -60.23 -39.69 87.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.007 0.432 . . . . 75.31 110.708 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.01 -52.62 65.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.413 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.84 -33.19 73.71 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.25 111.382 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -63.61 -28.46 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.642 0.238 . . . . 74.32 111.642 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmp_? -93.65 -16.09 24.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.054 0.39 . . . . 73.32 112.054 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.81 17.71 22.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.597 0.713 . . . . 22.21 110.511 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.21 136.27 38.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.067 -0.97 . . . . 75.12 112.807 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 34.4 ttmt 73.45 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.83 -1.077 . . . . 74.43 111.948 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 62.0 Cg_exo -53.03 -28.71 41.46 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.711 2.94 . . . . 73.35 113.373 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.83 -50.87 62.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 72.11 111.163 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 35.1 mt-30 -73.19 -34.72 66.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.117 -0.492 . . . . 62.22 110.132 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' PRO . 65.8 mt -58.9 -53.96 40.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.488 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -62.48 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 75.52 110.574 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 22.2 ttmm -55.04 -65.3 0.61 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.94 -0.573 . . . . 74.31 111.37 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.59 ' HZ2' HD11 ' A' ' 108' ' ' LEU . 3.7 p90 -69.5 -32.9 72.05 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.496 -0.482 . . . . 73.31 110.884 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 107' ' ' TYR . 48.7 mt -59.05 -39.5 78.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 120.67 0.271 . . . . 73.41 110.594 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -76.51 -27.62 56.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.87 0.366 . . . . 73.43 110.312 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -70.43 -44.21 68.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.748 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 103' ' ' ARG . 42.2 mtt-85 -83.2 -13.81 54.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.474 -0.33 . . . . 71.13 110.759 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 57.51 69.57 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.745 0.783 . . . . 75.1 109.733 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.599 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 10.2 tp -108.81 -167.91 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.76 -1.109 . . . . 71.22 109.04 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 107' ' ' TYR . 20.7 tptm -100.16 -68.15 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.571 -0.452 . . . . 73.12 110.033 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.609 ' CD1' ' HG3' ' A' ' 106' ' ' LYS . 55.2 p90 -179.96 152.06 0.45 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.985 0.422 . . . . 61.12 110.587 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 HD11 ' HZ2' ' A' ' 99' ' ' TRP . 83.5 mt -78.41 136.55 37.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 74.1 111.007 -176.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.84 51.5 4.45 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.126 -0.789 . . . . 74.41 111.126 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 108' ' ' LEU . 60.5 t -119.73 129.75 25.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.876 -0.416 . . . . 62.11 109.876 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 35.1 Cg_exo -61.07 148.86 91.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.763 2.308 . . . . 53.44 112.454 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.575 ' HD2' ' CE2' ' A' ' 114' ' ' TRP . 4.1 ttmp? -62.91 128.57 36.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.779 -0.646 . . . . 74.21 110.804 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -90.9 85.14 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.929 -0.578 . . . . 72.34 110.656 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.575 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 10.4 m95 -67.33 -55.5 13.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 72.41 109.858 173.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.09 -171.32 36.94 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.414 -0.812 . . . . 70.52 111.622 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.502 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 43.1 p 176.94 175.14 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.475 -0.565 . . . . 61.44 109.475 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 32' ' ' MET . . . 154.15 -159.32 28.74 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.069 -1.062 . . . . 72.42 112.884 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.8 tt -131.52 138.64 49.02 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.495 -0.557 . . . . 73.32 109.495 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -143.24 134.86 26.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.683 -0.488 . . . . 74.44 109.683 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.881 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.9 t70 -74.89 140.07 43.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.801 -0.444 . . . . 73.53 109.801 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -103.46 40.68 1.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.714 -0.476 . . . . 44.23 109.714 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.42 67.53 0.83 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.651 -0.704 . . . . 73.42 110.412 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.03 -58.24 0.56 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.261 -0.881 . . . . 52.11 111.492 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 42.4 tptt -134.29 142.74 47.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.431 -0.581 . . . . 62.23 109.431 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.881 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.9 m -88.29 148.73 24.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.325 -0.398 . . . . 72.31 111.437 -176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.8 151.64 37.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.81 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -113.39 120.0 39.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.925 -0.769 . . . . 75.14 108.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -134.95 162.4 32.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 73.44 112.081 -171.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 45.7 ttm -140.2 139.81 35.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.672 -0.695 . . . . 74.22 110.613 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.847 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.7 mm -98.17 126.0 51.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.322 -0.399 . . . . 60.41 110.421 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 8.2 ptp -138.54 -179.22 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 71.35 110.38 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -73.21 156.15 38.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.66 -0.866 . . . . 74.14 108.66 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.594 HH12 ' HB2' ' A' ' 65' ' ' ASP . 25.1 ptt180 -85.41 135.2 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.027 0.441 . . . . 65.15 111.781 -174.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 43.3 m-85 -124.02 153.44 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.3 109.841 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.504 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -159.13 8.67 0.17 Allowed Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.946 -1.121 . . . . 72.52 113.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.069 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.0 m -122.98 125.5 45.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.021 -0.694 . . . . 72.33 110.791 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 181' ' ' SER . 3.3 t70 -116.48 140.14 49.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 74.31 111.422 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.2 mp -67.94 -33.06 73.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.71 -0.677 . . . . 73.21 111.797 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 55.2 tp60 -72.63 -35.83 67.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.46 . . . . 61.23 110.088 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 46.4 tptt -70.83 -48.13 55.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.026 -0.534 . . . . 73.24 110.528 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.448 HG21 ' HB2' ' A' ' 341' ' ' LEU . 80.7 mt -62.43 -30.04 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.97 -0.559 . . . . 74.31 110.176 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 1.1 t80 -51.27 -46.08 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.534 -0.757 . . . . 72.41 110.593 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.54 -36.01 33.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.205 -0.452 . . . . 70.23 110.138 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.349 0.5 . . . . 72.54 112.349 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -101.95 3.66 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 65.55 110.475 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' C ' ' HG2' ' A' ' 147' ' ' LYS . . . 59.02 55.8 4.28 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.318 -0.856 . . . . 55.02 111.935 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 257' ' ' GLY . 21.9 pttm 45.53 38.78 4.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.067 0.947 . . . . 75.22 113.113 172.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -115.79 88.75 2.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 71.31 109.933 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -101.75 123.8 46.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.397 -0.365 . . . . 72.12 111.009 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.9 m -72.37 147.32 46.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.906 -0.588 . . . . 72.14 110.861 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.638 ' NH2' ' HB3' ' A' ' 295' ' ' LYS . 42.0 ttm105 -56.11 -36.5 68.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.126 -0.488 . . . . 73.21 111.912 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 340' ' ' ASP . 12.7 ptpt -51.78 -44.3 63.35 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.354 0.597 . . . . 74.43 110.75 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.543 ' HA ' HD22 ' A' ' 339' ' ' LEU . 74.9 m -71.93 -49.98 32.96 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.678 -0.692 . . . . 42.03 110.791 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.12 -35.24 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 42.24 110.646 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.715 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -65.78 -52.74 48.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 74.52 110.851 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.608 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 25.5 tt0 -60.6 -46.77 88.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.33 -0.548 . . . . 65.35 109.883 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 153' ' ' THR . 6.4 mp -54.92 -51.72 65.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.905 -0.589 . . . . 75.21 111.226 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -57.68 -44.71 85.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 54.22 110.445 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 89.6 mt -63.75 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 71.4 111.116 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.63 -38.04 86.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.115 0.483 . . . . 75.41 110.734 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.596 HD11 HD21 ' A' ' 183' ' ' LEU . 59.1 mt -71.04 -37.27 66.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.061 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.82 -50.7 71.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.252 -0.431 . . . . 61.43 110.382 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.599 ' OD2' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-20 -52.34 -57.55 9.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.771 -0.65 . . . . 71.42 111.323 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.14 -35.9 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.793 -0.639 . . . . 70.43 111.012 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 16.7 tp -60.59 -38.7 85.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.779 0.323 . . . . 73.42 110.85 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.66 -48.09 64.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.595 -0.52 . . . . 74.53 109.595 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.64 -48.6 77.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.901 -0.59 . . . . 71.24 111.834 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 165' ' ' LEU . 32.2 pt -67.04 -36.97 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.88 -0.328 . . . . 64.41 111.716 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 49.2 m80 -69.99 -26.89 64.3 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.586 -0.445 . . . . 54.03 110.863 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.9 -27.55 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.182 0.515 . . . . 61.12 109.928 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.99 66.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 73.22 111.466 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 77.8 -51.39 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.814 1.042 . . . . 71.31 113.814 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -85.91 142.06 29.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.497 1.295 . . . . 71.2 114.497 -161.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 169' ' ' HIS . 25.6 m -115.88 164.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.404 -1.271 . . . . 75.03 107.949 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -126.16 92.47 3.59 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 64.43 110.358 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -65.29 -42.08 96.37 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.715 -0.675 . . . . 51.32 113.249 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 32.7 t70 -89.18 107.72 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 73.41 111.577 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.581 ' HB ' HG22 ' A' ' 246' ' ' ILE . 38.0 mm -110.89 112.27 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.918 -0.771 . . . . 75.04 108.918 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -138.49 159.03 43.12 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.923 -0.769 . . . . 74.41 108.923 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -55.9 -36.44 67.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 72.21 111.204 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.579 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 4.6 m -68.98 -5.34 21.0 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 70.42 112.44 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -93.2 -13.37 28.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.009 0.433 . . . . 62.23 110.72 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 161' ' ' ILE . 7.3 mp -105.89 111.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.723 -0.671 . . . . 73.42 109.755 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 196' ' ' VAL . 3.7 mm? -114.48 130.94 56.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.798 -0.637 . . . . 73.44 110.326 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.069 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 41.4 mt -84.62 142.88 29.62 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.638 -0.71 . . . . 73.2 109.674 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.443 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 40.5 t-20 -59.93 135.43 57.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.533 -0.543 . . . . 73.53 109.533 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 82.7 t80 -61.82 -30.38 70.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.981 0.419 . . . . 73.35 111.221 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -93.95 -36.02 12.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.303 -0.408 . . . . 72.04 110.074 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 4.6 m-20 -114.96 87.97 16.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 61.14 110.215 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 342' ' ' SER . 57.1 Cg_endo -73.2 -11.21 24.93 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.349 2.033 . . . . 61.21 112.157 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -96.16 15.21 21.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 74.21 109.924 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.18 107.65 8.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.196 -0.911 . . . . 74.44 109.063 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 157' ' ' LEU . 10.7 p -102.21 142.21 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.37 0.605 . . . . 72.33 112.035 -172.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.44 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 95.7 m-85 -125.75 144.42 50.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.462 -0.79 . . . . 71.13 110.181 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.45 99.94 11.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.902 -1.147 . . . . 74.12 107.902 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.65 HG22 HD23 ' A' ' 184' ' ' LEU . 29.2 m -101.34 0.77 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.203 0.446 . . . . 62.24 112.203 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.48 95.88 5.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.043 0.449 . . . . 73.24 109.812 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.47 6.5 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.809 -0.632 . . . . 74.42 109.715 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.55 -33.73 67.53 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.516 -0.765 . . . . 74.12 111.457 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.47 30.33 2.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.437 . . . . 72.44 110.743 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -92.83 99.69 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.163 0.506 . . . . 71.42 109.661 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -107.5 138.77 43.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.952 -0.567 . . . . 75.3 110.349 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.33 133.46 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 62.04 110.871 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 206' ' ' PRO . 5.9 t80 -137.31 -54.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 63.13 111.295 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.2 p -108.37 103.15 49.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 112.07 0.396 . . . . 63.44 112.07 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 24.6 Cg_exo -63.28 118.31 5.22 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.697 2.265 . . . . 72.45 110.8 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 64.77 10.11 5.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.943 -0.571 . . . . 75.22 111.059 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 169' ' ' HIS . . . 96.07 0.88 61.53 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.741 -0.742 . . . . 64.41 113.063 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.82 110.79 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 117.128 0.464 . . . . 72.52 112.189 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -177.63 144.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.963 -0.754 . . . . 64.1 108.963 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.68 115.22 8.1 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.611 -0.515 . . . . 72.3 109.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -159.14 102.81 1.62 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.029 -0.268 . . . . 64.41 110.915 -175.014 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.463 ' HA ' HG23 ' A' ' 236' ' ' VAL . 44.8 p90 -124.89 130.99 53.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 64.11 111.334 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 71.9 mmtt -129.18 -86.74 0.54 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.078 -0.964 . . . . 72.44 108.933 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 29.6 tt0 177.39 -63.81 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.946 -0.57 . . . . 54.31 110.161 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -148.76 104.74 3.43 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.039 -0.528 . . . . 75.2 111.307 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.461 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 1.4 Cg_endo -83.8 -50.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.965 2.443 . . . . 62.33 112.003 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -151.87 21.34 0.69 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.399 -0.364 . . . . 73.45 111.228 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 219' ' ' ARG . 1.4 mpt_? 51.63 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.103 0.561 . . . . 72.33 111.288 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.668 ' SG ' ' HA2' ' A' ' 235' ' ' GLY . 97.7 m -56.84 -41.17 77.41 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.813 0.301 . . . . 75.11 111.813 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 45.28 43.39 8.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.917 0.887 . . . . 64.15 112.269 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -80.66 -53.91 6.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.005 -0.543 . . . . 71.3 110.003 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -90.43 171.2 36.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.891 -0.671 . . . . 61.25 112.534 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 228' ' ' THR . 25.0 p -69.6 130.82 43.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 73.14 110.716 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.549 HG12 HG11 ' A' ' 271' ' ' VAL . 16.6 tt -63.46 -18.05 21.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.443 0.639 . . . . 73.33 110.324 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.596 ' HG2' HD13 ' A' ' 265' ' ' LEU . 24.8 mt-10 -55.59 -63.03 1.3 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.974 -1.012 . . . . 63.03 111.06 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.85 -40.56 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.893 -0.594 . . . . 74.31 111.15 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 93.2 m -56.63 -29.16 61.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.098 -0.501 . . . . 63.21 110.908 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 35.8 m 64.11 -147.48 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.72 -0.673 . . . . 52.44 111.372 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 60.0 mt -72.65 -34.72 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.846 0.355 . . . . 73.25 110.962 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' A' ' 236' ' ' VAL . 1.5 m-20 -51.76 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.03 -0.987 . . . . 64.12 113.599 -169.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.91 -29.43 67.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 42.33 111.404 -173.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 229' ' ' SER . 58.3 t-80 -66.77 -33.6 75.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.943 -0.571 . . . . 72.24 111.492 -175.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 5.9 m-20 -92.89 -27.77 16.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 72.52 111.029 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.668 ' HA2' ' SG ' ' A' ' 220' ' ' CYS . . . 127.01 -4.99 7.37 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.717 -1.23 . . . . 71.03 114.182 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 231' ' ' ASP . 3.2 p -75.24 127.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.743 0.771 . . . . 64.14 109.626 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 212' ' ' GLU . . . -59.08 121.36 54.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 60.31 112.075 -172.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 16.5 Cg_exo -66.95 101.18 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.949 2.433 . . . . 73.43 111.841 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 51.0 m -84.89 -168.42 2.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.171 -0.677 . . . . 74.04 109.171 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 20.1 mmt180 -52.24 -46.62 65.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.873 0.324 . . . . 74.21 111.873 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 307' ' ' LYS . 20.2 ttt180 -68.97 -30.08 68.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.969 -0.292 . . . . 54.14 110.789 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.5 23.97 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.786 -0.721 . . . . 62.21 111.99 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -60.1 -42.0 93.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.926 0.393 . . . . 62.33 110.42 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 89.8 mt -62.42 -38.74 90.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.18 -0.464 . . . . 74.44 111.592 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.43 -48.92 75.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.311 0.577 . . . . 75.15 109.877 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.581 HG22 ' HB ' ' A' ' 178' ' ' ILE . 68.6 mt -57.03 -44.48 82.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.13 -0.941 . . . . 74.5 110.718 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.5 -41.47 94.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.68 -46.2 93.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.301 -0.476 . . . . 53.53 112.62 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -61.96 -38.25 87.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 73.33 110.878 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.5 m -66.89 -47.16 72.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.416 . . . . 60.25 110.631 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 86.7 mtp -60.89 -43.32 98.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 63.42 111.301 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 286' ' ' MET . 12.7 tt -67.35 -34.95 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.458 -0.497 . . . . 74.51 110.917 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -62.96 -43.65 98.2 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.83 -0.348 . . . . 65.25 110.452 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -66.01 -35.29 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 73.44 110.631 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.0 -32.84 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 74.11 111.818 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.5 p -102.71 -27.98 12.39 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.623 -0.431 . . . . 73.43 111.825 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 147' ' ' LYS . . . 119.75 -45.87 1.19 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 65.13 113.719 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.01 159.33 39.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.596 0.698 . . . . 73.23 111.098 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 90.7 mt -95.19 137.64 22.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 61.42 110.582 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.8 Cg_exo -67.33 -28.79 39.24 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.004 2.469 . . . . 51.51 112.907 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -101.66 9.91 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.757 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 16.5 tt0 -59.44 -45.78 90.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.595 . . . . 63.21 112.315 -170.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.77 -16.3 61.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 74.41 111.049 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -107.54 16.87 23.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.39 . . . . 73.33 111.096 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' A' ' 226' ' ' GLU . 37.4 mt -70.07 -14.03 62.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.551 0.691 . . . . 75.15 110.007 172.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.23 -19.42 58.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.119 -0.946 . . . . 60.43 110.018 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 271' ' ' VAL . 9.6 m-20 -94.83 113.29 60.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.455 -0.793 . . . . 73.12 110.071 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.72 -38.47 93.0 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.706 2.271 . . . . 73.24 112.89 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 269' ' ' LYS . 7.7 mtpm? -69.47 -42.98 74.14 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.894 -0.323 . . . . 64.45 111.467 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.71 -38.46 91.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.003 -0.279 . . . . 73.21 111.19 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.549 HG11 HG12 ' A' ' 225' ' ' ILE . 38.2 t -65.75 -39.88 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.948 0.404 . . . . 53.15 110.224 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -64.07 -56.31 15.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 72.13 110.335 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.41 -44.68 96.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.781 -0.645 . . . . 65.2 112.023 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 55.3 p -63.57 -50.49 69.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 121.083 -0.247 . . . . 74.14 111.321 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 33.3 mmtp -64.08 -34.04 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.18 -0.208 . . . . 74.13 111.31 -175.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.43 -53.76 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.925 0.393 . . . . 72.44 111.014 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -71.1 -30.82 67.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 65.14 111.475 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -73.47 -35.44 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.725 -0.216 . . . . 73.44 110.91 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.87 -31.22 72.21 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.253 0.549 . . . . 71.01 110.238 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.36 -59.37 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.256 -0.883 . . . . 73.41 110.483 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.472 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.6 OUTLIER -108.57 59.42 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.312 -0.404 . . . . 65.12 111.195 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -62.81 -43.95 99.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.55 112.196 -177.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.47 -47.8 77.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.795 0.295 . . . . 61.13 111.795 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.6 t -66.44 -46.71 75.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.76 0.314 . . . . 75.35 110.927 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.4 mm? -68.16 -49.86 58.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 73.44 111.821 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.559 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -62.09 -39.99 94.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.627 0.251 . . . . 64.4 111.55 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.64 -31.33 66.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 72.32 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -69.91 -33.2 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 64.22 109.975 178.682 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.23 -19.66 62.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 75.45 111.264 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.933 ' HB3' ' HB3' ' A' ' 296' ' ' PRO . 6.7 t80 -128.52 87.81 54.03 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 121.101 0.476 . . . . 71.33 110.323 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.5 2.98 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.365 2.71 . . . . 73.5 111.939 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.9 149.69 24.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.684 -0.858 . . . . 73.24 108.684 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.3 mmtt -91.98 29.67 1.56 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.037 0.384 . . . . 55.44 112.037 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.601 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 42.3 t-20 -64.11 -69.88 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.943 -1.502 . . . . 72.21 106.943 167.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.638 ' HB3' ' NH2' ' A' ' 151' ' ' ARG . 49.9 tptt 169.15 114.76 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.257 0.973 . . . . 74.33 109.59 160.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.933 ' HB3' ' HB3' ' A' ' 290' ' ' PHE . 89.3 Cg_endo -96.22 46.26 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.673 2.249 . . . . 75.43 111.544 169.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.25 -43.02 1.02 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.384 -0.912 . . . . 33.33 113.048 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.485 ' HB2' HD12 ' A' ' 299' ' ' ILE . 0.9 OUTLIER -57.53 -64.11 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 74.11 110.408 -175.612 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 298' ' ' GLU . 2.8 mp -60.25 -39.69 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 72.52 111.049 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.63 68.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.374 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 12.8 tptt -79.93 -23.27 41.87 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.354 . . . . 75.03 110.926 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 320' ' ' LEU . 65.7 t80 -59.99 -48.22 82.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 75.01 109.911 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.623 ' HA ' HG22 ' A' ' 306' ' ' VAL . 82.6 mtp -72.5 -32.9 66.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.983 -0.553 . . . . 73.32 110.548 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 4.4 tp10 -54.96 -45.74 74.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.788 0.804 . . . . 74.54 109.109 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 63.2 m -63.57 -47.33 81.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.315 -1.311 . . . . 64.32 111.965 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 303' ' ' MET . 21.6 m -66.2 -34.26 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.862 -0.335 . . . . 71.33 111.741 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -76.45 -27.67 56.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.406 -0.518 . . . . 74.13 109.755 177.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 24.6 tp -77.4 -26.96 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.784 -0.643 . . . . 74.04 110.925 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 310' ' ' ASP . 4.4 pp -86.3 18.46 3.18 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.765 0.317 . . . . 65.34 110.745 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 24.0 t70 73.47 -79.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.497 -0.774 . . . . 73.22 111.938 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -162.11 -31.43 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.537 0.684 . . . . 74.22 109.755 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.6 t -170.57 29.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.486 -0.779 . . . . 74.01 108.978 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 3.3 tm-20 -70.85 -71.11 0.27 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.177 -0.92 . . . . 64.23 110.274 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -132.31 87.36 43.17 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.386 -0.37 . . . . 74.05 110.275 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.51 118.0 3.15 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.414 2.076 . . . . 63.54 111.689 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.2 mt -112.31 94.58 5.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.226 0.536 . . . . 74.23 110.183 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -68.41 -33.33 74.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.513 -0.767 . . . . 73.43 110.807 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.93 -38.94 90.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 61.13 110.567 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.85 -44.84 88.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 64.44 110.437 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 86.8 mt -60.19 -47.88 84.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 73.3 110.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 325' ' ' LEU . 8.1 ppt_? -73.78 -19.09 60.87 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.741 -0.384 . . . . 62.33 111.214 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.17 -32.57 29.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 60.12 111.449 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -75.81 -32.57 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 120.005 -0.678 . . . . 52.23 110.042 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 298' ' ' GLU . 95.2 mt -66.08 -41.92 90.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.944 -0.761 . . . . 52.04 108.944 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -65.12 -32.02 73.51 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.512 -0.767 . . . . 70.24 110.121 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -49.19 78.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.263 -0.643 . . . . 75.41 109.263 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.1 -40.31 95.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.753 -0.737 . . . . 64.22 112.689 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.715 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 28.8 tp -69.12 -43.36 74.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.377 0.608 . . . . 63.04 110.848 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.94 -38.11 82.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.242 -0.89 . . . . 72.14 110.892 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.07 75.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 60.14 111.291 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -89.8 -7.28 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.974 0.416 . . . . 53.51 110.759 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 83.77 26.34 42.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 45.54 113.563 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 9.4 t -117.87 171.35 8.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.257 0.528 . . . . 63.41 110.925 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' A' ' 328' ' ' LEU . 0.0 OUTLIER -153.44 161.14 42.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 62.51 110.425 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 156' ' ' GLN . 7.2 p-10 -89.81 -12.09 40.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.73 0.3 . . . . 74.14 111.499 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.3 102.01 14.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 72.33 111.077 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 147.08 -68.79 0.38 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.155 -1.021 . . . . 64.22 113.014 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 156.98 30.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.214 -0.291 . . . . 72.45 110.214 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 153' ' ' THR . 49.6 mt -100.24 -115.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.8 -0.182 . . . . 73.14 110.989 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.746 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 9.6 t70 -174.07 -33.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.041 0.448 . . . . 64.32 111.067 -174.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.448 ' HB2' HG21 ' A' ' 141' ' ' ILE . 1.5 pt? -93.25 17.25 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.547 . . . . 72.05 110.302 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 190' ' ' PRO . 4.6 m -73.58 81.04 1.49 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.582 -0.735 . . . . 73.1 110.97 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.1 t -127.57 0.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.807 -0.633 . . . . 45.11 110.471 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.609 ' HA ' ' OG ' ' A' ' 136' ' ' SER . 13.0 p 47.02 103.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.572 1.149 . . . . 62.31 113.745 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -129.05 99.35 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.478 -0.783 . . . . 72.42 112.044 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 53.09 -94.75 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.204 1.001 . . . . 73.2 113.518 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 155.94 169.38 20.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.0 -0.619 . . . . 64.41 111.843 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -101.44 130.5 10.25 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.824 -0.703 . . . . 70.1 112.428 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.743 HD11 ' HG3' ' A' ' 45' ' ' GLN . 6.3 mp -120.19 126.66 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.617 0.246 . . . . 71.52 110.492 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -148.92 141.89 24.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.842 -0.429 . . . . 53.35 109.842 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -123.09 80.29 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.118 0.485 . . . . 70.54 110.833 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -141.85 116.17 9.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.117 -0.492 . . . . 72.13 110.237 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.5 t -100.97 -171.03 1.93 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 73.24 110.085 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.69 144.3 14.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.128 0.489 . . . . 75.25 111.084 -176.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 220' ' ' CYS . 15.2 t -73.04 166.97 22.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.628 . . . . 74.11 110.874 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.17 131.54 22.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.293 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -70.03 106.88 3.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.809 -0.441 . . . . 74.44 109.809 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -78.14 113.1 15.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.704 -0.48 . . . . 75.0 109.704 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -86.6 175.03 8.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 73.51 110.071 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.436 -0.792 . . . . 72.22 109.484 177.351 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.895 0.378 . . . . 71.21 110.048 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.4 Cg_endo -83.17 138.47 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.855 2.37 . . . . 70.43 112.456 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -143.22 97.63 3.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.615 -0.721 . . . . 75.41 109.571 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 p -123.54 134.19 67.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.317 -0.856 . . . . 62.53 109.753 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 137.14 47.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.459 -0.337 . . . . 73.54 110.64 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.98 104.53 3.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.897 -0.592 . . . . 64.31 110.279 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.39 -58.41 2.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.736 -0.665 . . . . 74.14 109.871 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 65.84 147.01 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.255 0.972 . . . . 70.15 112.201 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.46 134.88 37.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 71.24 109.948 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.87 -179.53 40.55 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.777 -0.725 . . . . 50.2 111.967 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 63.0 82.46 0.18 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.398 0.618 . . . . 72.35 111.232 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.18 176.23 5.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 74.14 109.996 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.9 p -120.67 124.75 45.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.828 0.347 . . . . 62.31 111.264 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 t -79.06 102.4 8.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.214 -0.448 . . . . 52.21 109.989 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.23 104.97 9.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.967 -0.56 . . . . 63.32 110.135 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -139.09 152.35 47.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.332 -0.618 . . . . 75.42 109.332 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 17' ' ' ARG . 15.8 ptt180 -146.29 153.47 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 64.14 110.604 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -148.51 172.3 14.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.694 -0.685 . . . . 72.44 109.965 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -80.51 95.81 6.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.302 -0.629 . . . . 71.24 109.302 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.64 -71.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 73.53 111.189 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -138.38 143.85 39.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.932 -1.136 . . . . 60.13 107.932 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 53.1 tt0 -168.26 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.699 -0.482 . . . . 72.34 109.699 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 31.2 t80 168.7 115.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 53.34 110.737 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -173.03 127.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 34.43 110.795 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.8 129.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.743 0.306 . . . . 61.53 110.548 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.83 0.01 56.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.056 -0.592 . . . . 74.35 112.198 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.44 160.43 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 71.01 110.932 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.44 115.59 45.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.961 -0.563 . . . . 72.03 109.673 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 37' ' ' TRP . 19.2 pt -96.68 122.73 48.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.859 -0.609 . . . . 63.23 109.965 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 17.6 m -101.11 119.17 38.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.099 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.6 p-10 -90.03 -170.3 2.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.427 -0.351 . . . . 72.24 110.355 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.68 -21.1 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 73.11 111.222 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.81 2.41 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 44.23 109.96 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 60.13 34.64 21.2 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.164 -0.925 . . . . 75.44 111.353 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' THR . 30.3 mmmt -92.83 150.43 20.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.019 -0.537 . . . . 71.21 109.932 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.87 96.2 7.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.875 -0.602 . . . . 74.44 110.66 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HB2' HG13 ' A' ' 29' ' ' ILE . 25.6 m95 -98.92 138.72 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 63.31 109.637 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 56' ' ' MET . 31.6 ttmt -106.46 119.28 38.85 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.831 -0.347 . . . . 64.22 110.629 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.29 127.61 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 61.21 110.727 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . -113.96 -115.19 3.17 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.515 -0.85 . . . . 60.1 113.01 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 49.5 tp -77.93 125.47 85.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.572 0.225 . . . . 71.3 111.504 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 10.0 Cg_exo -72.47 120.03 6.48 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.854 2.37 . . . . 73.22 111.254 172.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 45' ' ' GLN . 63.1 mt -97.04 -53.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.117 0.484 . . . . 74.04 110.749 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' HA2' ' A' ' 49' ' ' GLY . . . 94.73 -25.19 24.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.822 -0.704 . . . . 74.21 112.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.468 ' H ' HG22 ' A' ' 43' ' ' ILE . 7.2 tp-100 -117.0 162.94 16.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.651 -0.5 . . . . 70.11 109.651 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.23 -3.34 16.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.623 -1.391 . . . . 74.14 109.623 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -176.49 -142.66 4.42 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 114.296 -0.952 . . . . 72.11 110.976 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.84 ' HZ ' ' HA3' ' A' ' 199' ' ' GLY . 92.4 m-85 -60.86 -46.95 88.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.62 0.247 . . . . 74.23 111.066 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . 156.36 164.72 13.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.765 -0.731 . . . . 55.54 111.691 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.0 m 61.83 39.17 14.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.014 0.435 . . . . 41.31 111.042 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 6.2 mm -88.68 132.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 72.23 109.809 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -109.63 164.52 12.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 75.34 111.06 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 HH21 ' A' ' 133' ' ' ARG . 7.0 tt -83.09 128.89 34.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.957 -0.757 . . . . 51.22 108.957 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -106.3 37.1 2.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.716 1.006 . . . . 73.23 113.716 -166.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.6 t0 172.39 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.977 0.511 . . . . 63.45 109.965 169.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.447 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 21.5 ptm -107.39 19.94 19.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.107 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 58' ' ' SER . 8.2 t-20 -124.63 -165.16 1.34 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 63.13 109.72 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 22.8 t -107.99 89.99 3.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.985 0.422 . . . . 74.22 110.146 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 p -62.6 -29.21 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.402 0.62 . . . . 72.44 110.151 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -169.04 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.839 -1.073 . . . . 73.31 108.387 171.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -137.9 108.16 6.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.021 -0.99 . . . . 70.22 109.206 172.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.97 133.8 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.75 -0.463 . . . . 52.54 109.75 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.76 32.7 2.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 72.44 112.648 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.3 m 55.48 35.55 25.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.017 0.437 . . . . 75.44 110.846 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -153.45 -47.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.188 -0.46 . . . . 71.42 112.03 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . 67.31 83.17 0.19 Allowed Pre-proline 0 N--CA 1.463 0.182 0 O-C-N 124.158 0.911 . . . . 43.11 109.39 -170.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 133' ' ' ARG . 89.7 Cg_endo -80.67 29.74 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.187 2.591 . . . . 53.14 113.003 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 p -130.82 137.06 49.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.301 0.572 . . . . 74.22 111.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 143.85 37.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.626 -0.879 . . . . 71.43 108.626 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 6.2 p -118.64 121.06 66.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.482 0.658 . . . . 71.3 111.947 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HD3' ' HD2' ' A' ' 48' ' ' PHE . 39.0 ttmt -89.36 126.11 35.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.216 -0.902 . . . . 72.5 109.09 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.24 133.04 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.159 0.504 . . . . 73.02 111.97 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 15.8 mt-10 -140.1 170.53 9.53 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.862 -0.792 . . . . 72.32 108.862 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 14.3 Cg_endo -57.13 156.43 24.78 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.402 2.068 . . . . 72.13 112.799 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.552 ' HA ' ' HG3' ' A' ' 127' ' ' ARG . 15.5 t -84.37 34.04 0.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 44.54 110.834 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 360' ' ' LYS . 0.3 OUTLIER -108.82 -83.67 0.55 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.179 -0.464 . . . . 62.45 111.165 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.22 -89.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.89 -0.324 . . . . 73.41 111.19 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.51 -176.63 1.46 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.101 -0.5 . . . . 74.22 113.552 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.518 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 6.4 Cg_exo -74.82 -22.04 15.65 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.059 2.506 . . . . 73.24 111.249 169.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.523 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.7 tm? -51.94 -40.54 60.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.513 -0.767 . . . . 70.31 110.823 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.95 -38.87 83.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 53.5 111.021 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.9 m -67.04 -41.62 86.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.07 0.462 . . . . 65.41 110.25 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 198' ' ' TYR . 31.3 mt-10 -67.08 -38.07 85.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.832 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.85 -41.7 71.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.008 0.432 . . . . 64.55 109.913 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -57.04 -54.08 50.78 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 55.12 110.897 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -64.49 -48.69 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.729 0.64 . . . . 62.53 112.729 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.506 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 3.8 m-85 -65.97 -34.26 77.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.611 0.244 . . . . 71.22 111.403 -175.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.55 -33.74 58.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.813 -0.355 . . . . 73.24 111.901 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 13.6 tpt180 -97.44 -45.81 6.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.911 0.708 . . . . 75.3 112.911 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -0.97 56.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.855 0.687 . . . . 63.14 112.855 -169.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -104.36 -151.59 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.084 -0.246 . . . . 73.22 111.156 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG2' ' OE2' ' A' ' 94' ' ' GLU . 56.9 tttm 74.56 102.94 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 123.689 0.796 . . . . 72.01 110.05 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 Cg_endo -50.26 -52.77 8.29 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.387 3.392 . . . . 60.43 115.567 -165.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.568 ' OE2' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -72.01 -32.55 67.28 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 74.41 112.901 -169.16 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -74.55 -30.11 61.62 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.029 -0.669 . . . . 71.23 110.333 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 91' ' ' ALA . 72.6 mt -61.15 -53.03 54.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.344 -0.613 . . . . 64.12 109.344 172.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.1 -34.73 60.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 72.14 110.497 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -56.54 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.783 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.473 ' HE1' HD12 ' A' ' 108' ' ' LEU . 1.8 p90 -70.11 -34.17 72.77 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.949 -0.701 . . . . 74.32 111.249 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 108' ' ' LEU . 60.7 mt -64.45 -33.34 62.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.201 0.524 . . . . 41.22 109.694 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -71.03 -40.84 71.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.551 -0.75 . . . . 74.24 110.275 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 m -67.85 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 43.21 111.532 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -75.91 -23.5 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 75.14 111.173 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 68.92 64.52 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.941 0.776 . . . . 65.11 110.039 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' OD2' ' A' ' 163' ' ' ASP . 3.4 mm? -106.97 -163.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.163 -0.926 . . . . 64.2 109.625 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG2' HD21 ' A' ' 159' ' ' LEU . 50.8 tptt -121.74 -59.62 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.472 0.545 . . . . 72.21 112.472 -174.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -159.07 98.38 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.514 -0.475 . . . . 74.41 111.447 -168.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.511 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tt -78.9 115.19 18.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.739 -0.837 . . . . 73.14 108.739 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.54 64.79 3.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.956 -0.64 . . . . 34.11 112.722 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.511 ' HB ' HD22 ' A' ' 108' ' ' LEU . 7.7 p -111.24 135.9 20.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.087 -0.338 . . . . 70.33 110.087 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG12 ' A' ' 196' ' ' VAL . 19.1 Cg_endo -60.12 140.07 90.58 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.854 2.369 . . . . 65.41 112.802 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.872 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 84.2 tttt -65.62 128.73 37.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.08 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -109.52 117.71 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.57 -0.741 . . . . 64.35 110.698 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 130' ' ' ILE . 38.5 m95 -89.86 -49.45 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.425 0.631 . . . . 75.44 109.554 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 178.32 -174.49 46.76 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.901 -1.045 . . . . 71.41 111.881 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.472 ' C ' ' HB2' ' A' ' 31' ' ' ASP . 93.1 p -168.37 150.51 5.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.847 -0.798 . . . . 54.14 108.847 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -166.41 -162.41 17.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.086 -1.054 . . . . 72.43 113.067 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.3 tt -128.48 129.3 45.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.862 -0.422 . . . . 74.35 109.862 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -129.59 123.86 32.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.153 -0.684 . . . . 64.24 109.153 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 7.3 t70 -89.11 138.07 31.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.27 -0.423 . . . . 73.01 110.177 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 121' ' ' LYS . 13.2 tmtt? -90.94 28.9 1.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.7 0.762 . . . . 62.32 109.581 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.0 t30 62.27 70.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.944 -1.025 . . . . 72.01 110.058 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.66 10.68 12.45 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.245 -0.889 . . . . 75.2 111.78 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.79 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -164.49 104.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.813 -0.44 . . . . 73.54 109.813 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB3' HD21 ' A' ' 118' ' ' LEU . 12.4 m -76.14 130.59 38.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.278 -0.419 . . . . 44.24 111.176 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.89 149.02 41.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 75.13 110.478 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 75' ' ' SER . 94.1 mtt180 -113.11 133.17 55.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.475 -0.565 . . . . 51.2 109.475 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 54.4 p90 -126.7 143.39 51.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.272 -0.422 . . . . 64.23 110.895 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 17.1 ptp -128.84 137.2 51.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.406 -0.361 . . . . 75.44 110.259 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CD1' ' A' ' 114' ' ' TRP . 49.8 mt -103.97 121.4 55.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 73.2 111.794 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ptm -122.72 178.25 5.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.502 -0.772 . . . . 74.41 109.89 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.872 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.2 t70 -80.95 -178.15 6.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.72 0.295 . . . . 72.52 111.126 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.628 HH21 HD12 ' A' ' 53' ' ' LEU . 5.8 mmt85 -83.79 83.83 7.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.412 0.625 . . . . 73.51 112.352 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -103.69 170.56 7.86 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.907 -0.775 . . . . 71.54 108.907 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.63 -41.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.347 -1.406 . . . . 65.22 113.544 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.796 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 18.4 m -71.23 122.85 20.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.011 0.406 . . . . 75.32 111.21 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.61 ' HB2' ' HA2' ' A' ' 347' ' ' GLY . 0.3 OUTLIER -84.54 118.13 24.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.433 -0.803 . . . . 75.11 110.106 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.24 -22.67 67.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.642 -0.873 . . . . 63.43 108.642 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.515 ' CG ' ' HD3' ' A' ' 350' ' ' LYS . 5.8 tp-100 -56.07 -48.6 75.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.752 -1.113 . . . . 74.44 110.977 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.59 ' CB ' ' HB2' ' A' ' 346' ' ' ASN . 59.6 mmtt -75.46 -27.97 59.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 73.33 111.531 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.846 HD11 ' HA ' ' A' ' 345' ' ' GLU . 1.7 mp -61.5 -46.69 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.023 -0.271 . . . . 74.54 110.279 176.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -74.02 -32.99 63.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.385 -0.526 . . . . 74.2 110.301 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.92 -33.67 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.833 0.349 . . . . 44.1 110.924 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -83.94 -31.37 25.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.142 0.423 . . . . 53.02 112.142 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -104.24 13.82 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 71.03 111.018 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 55.2 46.61 23.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.95 -0.568 . . . . 74.22 111.373 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.617 ' HB3' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER 42.09 38.79 1.17 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.0 113.17 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -94.71 96.85 9.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.964 0.411 . . . . 73.21 110.133 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 85.0 m-85 -113.5 147.74 37.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.44 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 154' ' ' VAL . 7.3 p -83.55 167.82 16.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.017 -0.538 . . . . 34.43 110.898 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.649 ' NH1' ' HB ' ' A' ' 331' ' ' ILE . 35.4 ttt180 -55.18 -46.18 75.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 73.12 111.23 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 333' ' ' SER . 86.2 mttt -58.2 -51.79 68.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.223 -0.444 . . . . 63.44 111.478 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -56.28 -43.67 79.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.938 -0.574 . . . . 75.14 112.025 -178.52 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 150' ' ' SER . 53.0 t -64.11 -48.43 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 71.2 110.735 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.606 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 2.7 mm? -58.43 -45.15 89.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.394 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 57.4 mm-40 -61.27 -44.84 96.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 61.33 111.494 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 88.4 mt -61.1 -49.11 78.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 72.52 110.622 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.1 p -62.52 -31.99 72.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 74.23 111.297 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 106' ' ' LYS . 59.4 tp -63.12 -46.77 85.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 74.43 110.629 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 12.4 mmt85 -63.03 -44.73 95.12 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.893 0.854 . . . . 60.3 110.02 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.96 -33.88 66.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.578 -1.192 . . . . 62.52 110.815 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.7 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.871 -0.418 . . . . 73.05 109.871 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -55.32 -56.94 14.33 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.516 0.674 . . . . 72.31 110.459 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.3 tt -67.88 -37.13 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.566 -0.743 . . . . 75.44 111.572 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.543 ' HG ' ' HE2' ' A' ' 175' ' ' HIS . 8.8 tt -61.03 -39.4 89.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.293 -0.262 . . . . 71.51 110.293 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -67.33 -54.02 24.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 71.15 109.363 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -56.05 -46.68 78.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.574 -0.739 . . . . 75.23 112.293 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 164' ' ' ILE . 29.1 pt -80.77 -32.41 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.208 0.447 . . . . 74.32 112.208 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 240' ' ' ARG . 3.7 t60 -69.48 -34.76 74.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.373 -0.603 . . . . 64.23 109.373 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -27.04 67.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.453 -0.794 . . . . 65.35 110.503 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.81 19.46 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 72.35 112.098 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 204' ' ' TYR . 44.5 mt-10 72.1 16.65 5.26 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.711 0.634 . . . . 75.41 112.711 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -121.4 144.65 48.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.253 0.549 . . . . 72.43 110.856 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 202' ' ' TYR . 23.6 t -104.31 163.44 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.51 -0.768 . . . . 74.12 109.352 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HE2' ' HG ' ' A' ' 165' ' ' LEU . 5.7 p80 -132.33 105.3 7.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.076 -0.713 . . . . 73.32 109.076 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.438 ' HA3' ' OD2' ' A' ' 222' ' ' ASP . . . -63.76 -54.88 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.638 -0.71 . . . . 65.33 114.148 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 200' ' ' LEU . 24.4 t70 -80.6 90.13 5.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.605 0.717 . . . . 64.4 111.626 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.54 HG22 ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -94.3 102.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.916 -1.512 . . . . 55.14 106.916 159.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.697 ' HG3' ' HE2' ' A' ' 227' ' ' PHE . 29.4 tttp -173.99 -137.04 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.171 -1.418 . . . . 74.51 107.171 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 179' ' ' LYS . . . -120.9 1.24 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.479 -0.328 . . . . 23.21 110.636 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.468 ' O ' HD22 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -77.69 -28.02 50.93 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 111.959 0.355 . . . . 73.4 111.959 -171.543 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 182' ' ' ASN . 5.6 m120 -108.55 11.06 26.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.722 0.296 . . . . 64.14 111.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 179' ' ' LYS . 8.3 mp -102.61 109.46 21.08 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.369 -0.532 . . . . 72.23 109.986 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.633 HD21 HD21 ' A' ' 349' ' ' LEU . 3.8 mm? -117.79 128.57 54.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.839 . . . . 71.02 109.821 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 80.6 mt -81.43 146.85 30.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.771 -0.649 . . . . 74.23 110.269 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.27 121.01 13.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.476 -1.676 . . . . 73.4 106.476 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -14.34 54.6 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.761 -0.376 . . . . 53.24 111.728 -167.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -87.22 -53.71 4.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.842 0.353 . . . . 74.41 110.814 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.1 m-20 -108.48 114.45 59.09 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.918 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 6.8 Cg_exo -73.11 -12.45 25.72 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 123.241 2.627 . . . . 74.3 112.398 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.956 ' HA ' ' HB2' ' A' ' 339' ' ' LEU . 8.2 p-10 -86.55 4.56 39.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 63.31 110.837 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 194' ' ' TYR . 80.0 mt-30 -123.45 96.77 5.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.925 -0.58 . . . . 73.51 110.995 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.2 130.69 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.666 -0.697 . . . . 71.52 109.676 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 192' ' ' GLN . 89.0 m-85 -120.17 142.23 49.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.084 -0.507 . . . . 61.12 110.709 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 164' ' ' ILE . 34.2 tp -88.15 99.27 12.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.245 -1.02 . . . . 74.23 108.245 175.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.467 HG22 HD23 ' A' ' 184' ' ' LEU . 15.3 m -120.61 -178.2 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.345 -0.389 . . . . 73.02 110.212 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . 2.6 t70 60.16 71.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.787 0.804 . . . . 75.12 108.979 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.548 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 70.5 m-85 -81.47 34.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.083 -0.962 . . . . 73.33 111.556 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.84 ' HA3' ' HZ ' ' A' ' 48' ' ' PHE . . . -77.25 -3.4 81.91 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.556 -0.831 . . . . 72.44 112.348 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 352' ' ' LYS . 5.4 mp -114.75 34.37 4.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.701 0.286 . . . . 73.15 111.376 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.08 125.86 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.866 0.365 . . . . 51.13 110.438 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.708 ' HD1' HD11 ' A' ' 354' ' ' ILE . 36.2 t80 -108.35 174.77 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.077 -0.51 . . . . 73.14 109.913 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -89.07 135.61 33.47 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.59 0.356 . . . . 72.34 111.173 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 172' ' ' GLU . 8.5 t80 -96.98 -60.34 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 72.15 110.416 173.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 8.4 p -138.04 142.56 36.24 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.647 -0.251 . . . . 74.35 110.881 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 3.1 Cg_exo -75.53 74.83 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.197 2.598 . . . . 54.44 112.203 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.94 86.66 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.573 -0.739 . . . . 53.44 111.921 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.07 -53.89 4.91 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 72.41 113.775 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 14.5 m -73.02 111.07 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.304 0.573 . . . . 64.13 110.936 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 205' ' ' CYS . 20.0 m80 -74.59 110.23 8.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.84 -0.618 . . . . 71.11 109.964 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 212' ' ' GLU . 8.1 tmtm? -97.92 130.89 44.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 75.11 108.872 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -84.19 -98.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.387 -0.37 . . . . 71.43 111.57 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 20.4 p90 -91.97 91.61 7.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.808 0.813 . . . . 75.24 112.121 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -39.74 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.239 -0.892 . . . . 72.43 108.938 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.07 179.34 0.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.975 -1.012 . . . . 72.12 111.905 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 12.0 t70 -147.94 127.86 6.62 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 64.14 110.134 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 21.9 Cg_exo -66.3 -22.7 52.7 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.172 2.581 . . . . 75.15 113.384 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 219' ' ' ARG . 22.1 pttm -124.98 17.83 8.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.877 0.325 . . . . 75.13 111.877 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.431 ' HD2' ' C ' ' A' ' 218' ' ' LYS . 1.0 OUTLIER 66.5 124.33 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.769 0.828 . . . . 73.34 111.847 177.076 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.542 ' CB ' ' HA2' ' A' ' 235' ' ' GLY . 36.6 t -72.5 -58.7 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.4 . . . . 74.22 110.255 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 27.2 p80 44.66 40.98 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.053 0.941 . . . . 75.14 112.592 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.438 ' OD2' ' HA3' ' A' ' 176' ' ' GLY . 5.1 p-10 -67.27 -31.17 71.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.966 -0.561 . . . . 73.1 111.083 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.51 170.32 40.4 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.782 -0.723 . . . . 52.23 111.725 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 228' ' ' THR . 53.1 p -70.49 141.96 51.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.093 0.446 . . . . 71.33 111.5 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 265' ' ' LEU . 73.3 mt -55.49 -34.11 33.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 115.769 -0.65 . . . . 63.25 112.406 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.798 ' HG3' ' HG ' ' A' ' 265' ' ' LEU . 3.0 mp0 -52.69 -39.43 61.97 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.002 0.43 . . . . 72.45 110.366 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.828 ' HB3' HG23 ' A' ' 246' ' ' ILE . 70.9 m-85 -105.06 -93.0 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.404 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' THR . 7.5 p 58.03 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.049 1.5 . . . . 63.44 115.049 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 47.6 t 64.44 -175.84 0.17 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.851 -0.796 . . . . 44.12 108.851 -172.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 230' ' ' ILE . 2.9 mp -71.2 -37.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.2 -0.667 . . . . 71.13 109.2 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.75 -73.2 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.691 -1.141 . . . . 63.34 112.104 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.61 -29.65 70.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.372 -0.376 . . . . 75.24 111.783 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.458 ' HE1' HG23 ' A' ' 225' ' ' ILE . 8.1 t60 -66.21 -37.46 85.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 75.55 110.297 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -77.92 -38.33 45.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 74.45 110.513 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 220' ' ' CYS . . . 114.55 9.26 14.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.761 -0.733 . . . . 71.43 112.109 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 6.2 p -89.35 137.71 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.737 -0.468 . . . . 61.54 109.737 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -57.64 117.92 22.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 74.41 111.203 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 23.5 Cg_exo -65.24 101.91 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.681 2.254 . . . . 62.53 111.42 176.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 204' ' ' TYR . 3.1 p -77.68 -20.58 53.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 72.32 110.657 -176.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.781 ' HD2' ' HG3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER 178.3 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.18 -0.918 . . . . 51.54 108.823 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HD3' ' HD1' ' A' ' 311' ' ' TYR . 5.7 mtp85 -59.5 -60.96 3.01 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.183 -0.917 . . . . 72.42 111.404 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 238' ' ' PRO . . . -43.36 -65.97 1.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 O-C-N 124.065 0.853 . . . . 54.33 114.203 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.11 -30.54 65.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.339 0.57 . . . . 63.32 111.624 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.49 ' HB3' HH21 ' A' ' 240' ' ' ARG . 17.6 tp -75.29 -35.78 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.887 0.375 . . . . 61.41 110.921 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.09 -37.55 46.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.492 -0.322 . . . . 62.1 110.401 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 227' ' ' PHE . 87.4 mt -60.93 -38.29 78.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.743 -0.465 . . . . 73.55 109.743 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 178' ' ' ILE . 51.8 tp -59.4 -47.35 85.8 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.365 175.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.39 -44.94 93.39 Favored Glycine 0 C--O 1.237 0.283 0 C-N-CA 120.978 -0.629 . . . . 44.01 112.233 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 12.7 m-85 -57.09 -44.08 82.83 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 120.572 0.225 . . . . 72.13 111.142 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.54 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.6 m -67.19 -38.1 84.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.622 -0.263 . . . . 73.23 111.36 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 84.3 mtp -60.4 -49.64 76.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.57 -0.286 . . . . 63.54 110.924 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.636 ' HB ' HG21 ' A' ' 299' ' ' ILE . 12.3 tt -70.32 -31.43 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 74.24 110.305 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.543 ' OE1' ' HG3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -61.02 -46.16 91.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.576 . . . . 63.03 110.181 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.3 m0 -71.7 -35.3 70.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.14 111.369 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.4 tp -76.42 -30.87 57.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.984 0.364 . . . . 74.33 111.984 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.534 HG21 ' HB3' ' A' ' 289' ' ' CYS . 73.6 p -103.36 -27.59 12.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 71.01 111.378 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 83.66 0.25 89.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.769 -0.729 . . . . 70.01 113.238 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -157.07 144.04 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.369 0.584 . . . . 71.23 111.425 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 92.2 mt -129.74 139.55 35.99 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 75.24 109.567 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 38.8 Cg_exo -58.22 -24.27 66.3 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.115 2.543 . . . . 70.21 113.752 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.771 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 25.1 p90 -98.91 -17.73 18.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.406 0.521 . . . . 75.41 112.406 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 1.5 pp20? -86.16 -14.66 43.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.336 -0.546 . . . . 71.53 110.68 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.86 -45.85 90.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 61.34 109.571 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.39 29.05 7.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.367 -0.833 . . . . 75.5 109.737 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.798 ' HG ' ' HG3' ' A' ' 226' ' ' GLU . 2.5 tm? -47.7 -34.24 7.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.855 0.862 . . . . 53.31 112.525 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -66.44 -12.25 56.22 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.013 0.375 . . . . 50.52 112.013 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.6 110.5 49.82 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 73.14 109.665 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.509 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 32.0 Cg_endo -63.04 -24.44 73.7 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.194 2.596 . . . . 72.25 113.999 -171.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -63.13 -49.98 72.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.791 0.329 . . . . 75.51 110.792 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -63.18 -36.82 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 73.33 110.285 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 69.7 t -62.35 -45.21 99.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 73.44 111.136 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 79.9 mtp180 -64.78 -54.87 24.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 73.12 111.394 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.31 -41.44 97.01 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.709 0.29 . . . . 71.21 111.692 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 27.7 m -62.91 -40.28 97.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.477 -0.329 . . . . 72.02 110.796 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -65.17 -42.78 93.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 74.34 111.129 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.7 mt -61.43 -46.21 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 71.23 110.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -64.12 -34.82 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.379 -0.373 . . . . 75.23 111.514 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 282' ' ' ILE . 5.1 m-85 -72.16 -32.31 66.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.707 -0.224 . . . . 74.51 111.597 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -77.92 -34.07 51.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 74.03 110.538 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.51 -42.63 12.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.969 -0.56 . . . . 74.31 112.032 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.447 ' O ' HD23 ' A' ' 285' ' ' LEU . 10.9 t-20 -124.86 81.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.589 . . . . 74.13 110.481 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -74.38 -34.09 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 75.31 112.54 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.85 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.2 m -70.27 -48.84 54.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 53.44 110.972 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.1 mm? -63.12 -50.59 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.078 -0.51 . . . . 74.12 111.364 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.635 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.3 OUTLIER -60.79 -40.76 93.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.897 0.332 . . . . 73.42 111.897 -177.547 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.73 -42.39 95.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.908 0.385 . . . . 74.54 111.115 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 288' ' ' LYS . 43.3 mmtm -81.21 4.31 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.354 0.502 . . . . 74.24 112.354 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 256' ' ' THR . 80.2 m -83.32 -17.43 42.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 51.31 109.904 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 0.9 OUTLIER -123.7 89.41 51.4 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 73.43 109.81 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.88 3.03 7.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.323 2.682 . . . . 73.2 112.481 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 6.1 mm-40 -99.71 174.21 6.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.893 -0.78 . . . . 65.53 108.893 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -86.86 79.59 8.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.434 0.635 . . . . 71.03 111.304 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -159.92 157.02 28.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.004 -0.998 . . . . 73.54 108.601 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -105.07 117.49 58.45 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 112.227 0.455 . . . . 71.43 112.227 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -95.51 38.57 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.297 2.664 . . . . 60.33 110.957 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -69.91 -36.92 74.3 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.547 -0.751 . . . . 61.23 113.209 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.535 ' HB3' HD23 ' A' ' 324' ' ' LEU . 1.5 mp0 -50.99 -52.72 39.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.965 0.412 . . . . 74.13 110.69 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.636 HG21 ' HB ' ' A' ' 252' ' ' ILE . 4.0 mp -70.76 -36.64 65.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.616 . . . . 73.25 110.415 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.73 68.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.454 -0.339 . . . . 72.21 110.784 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.011 -0.541 . . . . 64.5 110.156 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.568 ' CD1' HD22 ' A' ' 320' ' ' LEU . 68.0 t80 -56.66 -42.79 79.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 110.2 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.635 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 95.7 mmm -70.44 -40.86 73.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.57 -0.741 . . . . 63.33 110.603 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.671 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 46.6 mt-10 -53.06 -50.42 64.38 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.204 -0.665 . . . . 64.01 109.204 172.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 79.3 m -56.83 -50.49 72.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.659 -1.155 . . . . 73.2 112.087 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 303' ' ' MET . 28.8 m -69.41 -26.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.391 0.515 . . . . 54.51 112.391 -174.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -90.92 -16.15 28.6 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.786 -0.366 . . . . 75.12 111.692 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 53.0 mt -68.37 -37.59 80.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 74.34 110.592 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.3 pp -87.13 12.92 10.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.381 0.61 . . . . 42.12 110.19 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.85 -93.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.643 -1.162 . . . . 73.43 112.961 171.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HD1' ' HD3' ' A' ' 241' ' ' ARG . 40.2 t80 -115.72 -58.56 2.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.86 0.319 . . . . 73.23 111.86 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.1 p -133.73 10.07 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.1 0.407 . . . . 74.13 112.1 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.0 60.9 6.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.387 0.514 . . . . 73.32 112.387 -169.026 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? 64.97 103.86 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.389 -0.823 . . . . 74.42 113.189 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.781 ' HG3' ' HD2' ' A' ' 240' ' ' ARG . 4.4 Cg_exo -78.92 119.5 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.734 2.289 . . . . 63.21 111.303 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 94.1 mt -84.32 81.38 8.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.758 0.313 . . . . 65.13 110.987 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.49 -36.42 75.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 64.3 111.366 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -61.45 -45.99 91.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.415 . . . . 63.35 110.498 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.05 -40.32 90.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.277 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 87.8 mt -58.19 -52.55 65.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 74.13 110.1 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -40.33 77.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 73.15 110.805 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.65 -50.31 69.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 63.14 111.635 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.69 -31.97 27.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 111.679 0.252 . . . . 74.53 111.679 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 298' ' ' GLU . 93.0 mt -66.35 -48.63 69.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 72.24 110.621 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.6 -27.11 63.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 72.32 110.919 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.38 -49.06 78.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.437 -0.579 . . . . 71.42 109.437 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.72 -40.18 93.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.656 -0.783 . . . . 62.4 112.108 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.606 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 tm? -59.08 -43.96 91.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 62.43 110.517 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 333' ' ' SER . 30.1 ttpt -72.82 -30.01 63.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 70.01 110.855 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.03 69.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 73.45 112.071 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.649 ' HB ' ' NH1' ' A' ' 151' ' ' ARG . 13.7 tt -83.34 -7.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 62.32 111.013 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.19 -6.15 26.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.588 -0.815 . . . . 60.13 113.188 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.707 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 20.1 p -100.19 158.48 15.83 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.659 -0.318 . . . . 64.31 110.704 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -148.87 -68.36 0.22 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.294 -0.632 . . . . 72.31 109.294 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 336' ' ' ASP . 9.2 t70 56.43 -155.9 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.722 -0.672 . . . . 65.4 111.402 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 335' ' ' ASP . 27.2 t70 -153.03 -36.7 0.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.22 -0.446 . . . . 65.33 110.855 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.499 ' HA2' ' OE1' ' A' ' 156' ' ' GLN . . . 177.97 49.73 0.07 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.969 -1.11 . . . . 45.3 114.082 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.59 130.33 51.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.278 0.539 . . . . 74.13 111.556 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.956 ' HB2' ' HA ' ' A' ' 191' ' ' ASP . 3.9 mm? -121.34 147.15 46.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 53.11 110.185 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.29 -75.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.176 -0.675 . . . . 74.42 109.176 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.591 HD12 HD11 ' A' ' 185' ' ' LEU . 3.7 mm? 44.5 28.23 0.3 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.918 -1.037 . . . . 74.32 113.613 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.1 p -104.22 15.84 27.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.508 0.67 . . . . 72.54 109.892 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.505 HG13 HG12 ' A' ' 344' ' ' VAL . 7.5 p -61.74 -42.21 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.137 -0.938 . . . . 72.02 111.7 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 343' ' ' VAL . 7.5 p -162.72 -54.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.874 0.694 . . . . 53.44 112.874 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.846 ' HA ' HD11 ' A' ' 141' ' ' ILE . 45.8 mt-10 65.8 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.568 0.581 . . . . 62.22 112.568 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 140' ' ' LYS . 20.5 m120 -131.75 -165.05 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.38 -0.97 . . . . 60.42 108.38 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.61 ' HA2' ' HB2' ' A' ' 137' ' ' ASP . . . -156.07 164.22 32.23 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.28 -0.962 . . . . 73.52 112.47 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 164.83 -40.28 0.3 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.652 -0.785 . . . . 61.22 113.565 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.633 HD21 HD21 ' A' ' 184' ' ' LEU . 52.2 mt 63.12 95.56 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.294 0.568 . . . . 70.21 111.08 -172.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.515 ' HD3' ' CG ' ' A' ' 139' ' ' GLN . 50.7 mtpt -83.0 -0.28 48.09 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.908 -0.587 . . . . 74.53 111.905 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -158.27 121.45 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.902 -0.407 . . . . 70.24 109.902 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.905 ' HA ' HD11 ' A' ' 200' ' ' LEU . 33.1 pttt -161.85 87.9 0.68 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.829 0.347 . . . . 75.25 111.919 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 10.8 t 166.85 135.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.291 -0.868 . . . . 73.33 109.602 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.882 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -94.4 142.08 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.546 -0.538 . . . . 73.44 109.546 175.548 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.514 ' N ' HD13 ' A' ' 354' ' ' ILE . 24.5 m -64.48 97.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.045 -0.525 . . . . 63.34 111.97 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.467 ' HE3' ' CG2' ' A' ' 354' ' ' ILE . 94.9 mttt -114.37 -85.15 0.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.638 . . . . 73.43 109.992 174.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 64.1 tttm 175.77 122.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.316 -1.365 . . . . 63.13 107.316 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 358' ' ' ARG . 19.8 ptt-85 -66.49 146.87 54.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.194 0.521 . . . . 73.2 111.869 -171.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -160.15 -90.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.27 -1.011 . . . . 63.43 108.27 178.43 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 359' ' ' LYS . 34.1 ttmt . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.195 -1.409 . . . . 75.22 107.195 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.604 -0.147 . . . . 73.11 110.604 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.47 154.43 59.28 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.795 2.33 . . . . 73.14 111.766 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -153.25 125.61 8.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.01 -0.367 . . . . 72.11 110.01 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 p -159.11 135.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.876 0.369 . . . . 41.4 111.052 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 58.0 pttt -137.33 94.3 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.622 0.725 . . . . 63.42 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.95 85.23 2.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.962 -0.563 . . . . 71.42 109.958 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.631 -0.713 . . . . 71.41 110.125 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.54 149.81 29.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.98 0.419 . . . . 62.23 110.105 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.89 33.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.837 -0.62 . . . . 54.13 109.853 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.23 105.49 2.72 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.665 -0.779 . . . . 32.53 112.42 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -117.73 86.99 2.62 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.847 -0.797 . . . . 73.54 108.847 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -96.2 94.11 7.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 72.23 110.67 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -108.94 122.94 48.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.491 -0.559 . . . . 72.44 109.491 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 p -88.12 124.48 33.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.431 -0.35 . . . . 73.13 111.178 -177.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.3 108.32 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.407 -0.59 . . . . 72.01 109.407 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -125.71 20.83 7.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.056 -0.52 . . . . 74.25 111.517 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -68.98 88.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.323 0.582 . . . . 63.04 110.73 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -124.79 -1.44 7.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.555 -0.748 . . . . 75.23 109.288 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.1 pt? -87.5 113.93 23.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.132 -0.94 . . . . 74.21 111.198 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . -161.56 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.131 -0.94 . . . . 64.32 109.608 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 42.8 tt0 173.04 -74.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.657 0.598 . . . . 71.04 109.657 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -123.02 56.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.578 0.704 . . . . 74.24 109.519 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -79.63 -23.65 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.484 -0.78 . . . . 73.14 110.553 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.04 -53.11 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 61.43 109.687 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.36 142.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.358 -0.837 . . . . 71.4 110.242 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.24 -21.91 43.32 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.798 -0.715 . . . . 73.33 113.533 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.67 160.76 29.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.704 0.752 . . . . 73.01 110.306 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 6.4 pt -116.76 129.67 72.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.468 0.651 . . . . 65.44 110.949 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 33.1 pt -91.8 154.48 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.511 -0.768 . . . . 75.22 111.091 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 35' ' ' LYS . 4.8 m -112.5 114.13 26.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 72.21 111.273 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.678 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.7 p-10 -112.05 -166.54 1.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 55.3 109.834 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.624 ' HG2' ' O ' ' A' ' 116' ' ' SER . 20.9 mmt -63.65 -22.55 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.337 -0.392 . . . . 74.52 111.46 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.52 4.8 19.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.776 0.322 . . . . 53.23 111.013 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 71.26 44.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.771 -0.649 . . . . 75.22 111.61 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HB2' HG23 ' A' ' 30' ' ' THR . 37.7 ttmt 72.97 113.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.324 -0.853 . . . . 74.22 113.262 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.76 37.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 75.41 110.61 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 11.3 m95 -134.01 126.12 29.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 70.41 110.117 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.58 124.9 50.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.682 0.277 . . . . 74.22 110.304 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.97 126.14 25.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 44.22 110.928 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.02 -107.88 3.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.766 -0.73 . . . . 55.15 112.306 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.852 ' HB3' HD12 ' A' ' 53' ' ' LEU . 49.1 tp -86.67 123.94 70.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.727 0.299 . . . . 72.24 110.71 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 41' ' ' LEU . 58.2 Cg_endo -74.81 109.04 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.45 2.1 . . . . 71.13 111.837 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 36.9 mt -74.0 -53.46 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.34 0.59 . . . . 72.31 110.048 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.92 -29.51 5.88 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.65 -0.705 . . . . 73.32 112.575 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -119.01 165.1 14.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.163 -0.31 . . . . 73.44 110.163 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.13 51.82 1.43 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.548 -0.834 . . . . 73.31 111.749 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 350' ' ' LYS . . . 145.67 -126.71 2.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.503 -0.856 . . . . 60.52 112.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -92.77 -33.69 14.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.9 0.381 . . . . 61.42 110.919 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.443 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 141.13 160.68 8.39 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.369 -0.692 . . . . 71.14 111.369 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.8 t 53.53 53.81 11.01 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.273 0.558 . . . . 52.0 110.652 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.3 mm -89.07 137.81 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 64.33 110.273 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' HG13 ' A' ' 70' ' ' VAL . 84.5 m-85 -121.22 148.54 44.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 64.32 111.193 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.852 HD12 ' HB3' ' A' ' 41' ' ' LEU . 75.3 mt -87.4 140.72 29.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.049 -0.523 . . . . 75.34 109.837 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.29 37.84 4.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.374 0.607 . . . . 65.15 109.914 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 8.7 p-10 -98.22 9.12 43.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.489 -0.778 . . . . 73.45 111.249 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.62 2.61 50.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 74.32 111.736 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.38 87.78 7.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.158 -0.617 . . . . 73.31 110.029 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 t -104.1 79.77 1.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.727 -0.842 . . . . 72.01 108.727 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.9 m -66.02 -56.28 12.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 62.15 110.756 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -142.86 -64.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.892 -0.41 . . . . 73.11 109.892 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.1 p -140.81 90.95 2.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 53.25 111.263 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 66' ' ' ALA . 8.1 p -81.7 144.46 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.156 -0.475 . . . . 64.11 109.804 176.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.84 -104.27 0.12 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.981 -0.628 . . . . 73.31 113.378 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 p -81.17 62.69 5.22 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.815 0.672 . . . . 75.3 112.815 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 66.13 16.71 10.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.531 -0.304 . . . . 53.05 111.729 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . 63.58 88.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.234 0 O-C-N 123.697 0.623 . . . . 71.14 110.557 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 187' ' ' TYR . 93.3 Cg_endo -80.81 36.95 0.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.089 2.526 . . . . 72.13 113.14 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.6 m -117.86 136.15 53.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.62 0.724 . . . . 53.33 111.849 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 53' ' ' LEU . 35.4 m -136.2 148.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.996 -1.002 . . . . 75.12 108.746 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -123.73 120.66 60.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.291 0.567 . . . . 54.34 111.028 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CB ' HD12 ' A' ' 51' ' ' ILE . 25.3 pttm -105.58 134.44 48.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 126' ' ' TYR . 15.9 t -120.51 148.94 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 63.14 112.054 -165.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 80' ' ' LEU . 18.1 mm-40 -137.8 141.16 31.88 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 70.43 109.422 173.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.65 134.64 58.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.456 2.104 . . . . 72.34 111.633 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -73.41 88.46 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.185 0.517 . . . . 63.03 111.1 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -139.15 -68.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.585 -0.894 . . . . 72.15 108.585 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 5.3 p30 -128.5 -75.42 0.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.558 -0.746 . . . . 72.21 109.032 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . 72.35 110.5 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 114.058 0.383 . . . . 73.03 114.058 170.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA2' ' A' ' 78' ' ' GLY . 12.0 Cg_endo -55.77 -22.35 36.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.858 2.372 . . . . 60.52 111.398 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 57.9 tp -59.85 -30.1 68.74 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.454 -0.793 . . . . 64.43 110.559 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.35 -38.93 71.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.933 -0.395 . . . . 73.14 109.933 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.6 m -60.95 -46.96 88.6 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.426 0.632 . . . . 64.32 109.522 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 34.6 tt0 -63.14 -37.98 89.35 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.348 -0.842 . . . . 52.55 110.64 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.4 -45.3 88.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.486 -0.324 . . . . 60.34 110.681 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.82 -50.97 71.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.852 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 168' ' ' ILE . 92.7 t80 -62.63 -40.1 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 64.41 110.95 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 2.8 t80 -62.3 -45.14 94.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.309 -0.859 . . . . 72.33 111.052 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.02 -29.68 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.678 0.275 . . . . 72.11 111.323 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 7.6 tpm_? -69.2 -27.84 65.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 73.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.75 10.83 36.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 71.12 110.912 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.89 173.78 11.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.384 . . . . 71.01 111.74 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 36.7 ttmt 70.83 98.22 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.129 -0.941 . . . . 71.22 110.321 -177.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.92 -31.51 81.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.693 2.928 . . . . 72.32 113.741 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.747 ' HG2' ' HE3' ' A' ' 98' ' ' LYS . 43.6 tt0 -60.86 -46.8 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.219 -0.193 . . . . 74.34 110.787 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -58.77 -44.1 90.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.884 0.373 . . . . 72.04 110.055 179.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.1 mt -56.32 -52.72 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.484 -0.78 . . . . 72.21 110.224 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.16 -36.83 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.099 -0.501 . . . . 75.1 110.96 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.747 ' HE3' ' HG2' ' A' ' 94' ' ' GLU . 97.4 mttt -60.44 -58.44 8.48 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.044 -0.525 . . . . 72.23 111.177 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.683 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.2 p90 -72.44 -34.23 67.65 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.155 -0.618 . . . . 72.12 110.788 -174.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 96' ' ' ILE . 22.4 mm -55.28 -49.12 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.548 0.213 . . . . 61.3 110.731 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.83 -44.89 84.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.301 . . . . 73.44 111.135 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.5 m -71.13 -23.97 62.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 72.13 111.575 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.607 HH22 ' HB2' ' A' ' 170' ' ' GLU . 20.6 ttt180 -96.24 -1.84 47.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.457 -176.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.95 35.68 8.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.76 -0.654 . . . . 71.15 111.325 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.532 HD11 ' HD3' ' A' ' 103' ' ' ARG . 81.2 mt -94.97 -165.51 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.524 . . . . 73.02 109.956 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HG3' HD21 ' A' ' 159' ' ' LEU . 3.2 mmmp? -108.87 -61.79 1.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.751 -0.463 . . . . 71.21 109.751 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 32.4 p90 178.62 144.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 73.33 109.618 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 22.5 tp -79.34 125.49 29.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.673 -0.694 . . . . 63.32 110.805 -172.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 59.71 4.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.105 -0.569 . . . . 40.42 112.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.48 134.41 21.97 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.716 -0.475 . . . . 64.01 109.716 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.729 ' HB3' ' HZ ' ' A' ' 134' ' ' PHE . 17.1 Cg_endo -59.8 142.55 98.85 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.302 2.001 . . . . 72.41 112.057 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.72 147.83 50.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 74.21 111.303 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.05 128.98 55.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.913 -0.585 . . . . 72.24 110.742 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.59 ' HB2' HG22 ' A' ' 130' ' ' ILE . 70.3 m95 -103.33 -59.7 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.304 0.573 . . . . 73.34 109.665 174.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.17 175.52 42.3 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.507 -0.77 . . . . 74.32 112.564 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' MET . 18.7 p -150.49 155.93 40.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.442 -0.947 . . . . 75.31 108.442 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.678 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -172.56 -160.01 20.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.201 -1.476 . . . . 72.53 113.799 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 tp -136.92 136.21 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.058 -0.571 . . . . 74.15 110.02 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 3.7 t-160 -139.77 121.91 15.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.212 -0.662 . . . . 65.2 109.212 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 22.3 t70 -88.49 130.83 35.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 71.42 109.905 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -87.34 -72.02 0.54 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.919 0.39 . . . . 71.4 110.667 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -135.75 33.4 2.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 74.41 110.184 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.1 -23.1 21.89 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.477 -1.049 . . . . 52.11 110.477 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.7 mptt -87.45 104.44 16.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.77 -0.826 . . . . 64.15 108.77 172.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.1 m -77.52 129.07 35.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.468 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . 47.8 m-85 -107.89 124.1 49.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.084 -0.507 . . . . 65.22 111.106 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -100.29 131.28 46.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.037 -0.727 . . . . 74.42 109.037 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 17.5 p90 -144.52 164.7 30.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.39 -0.368 . . . . 72.3 111.467 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 16.7 ptp -135.63 143.43 45.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.958 -0.565 . . . . 64.31 110.972 174.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.59 HG22 ' HB2' ' A' ' 114' ' ' TRP . 6.0 mm -97.48 121.34 47.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.279 -0.873 . . . . 75.04 110.027 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.9 ptm -133.56 176.46 8.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.461 -0.791 . . . . 71.34 109.871 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -72.47 145.83 47.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.264 0.554 . . . . 74.3 111.757 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HD3' HG11 ' A' ' 69' ' ' VAL . 16.6 tpt180 -71.37 129.35 38.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.221 -0.9 . . . . 73.12 111.385 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 50.0 m-85 -103.76 142.53 34.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.246 -0.65 . . . . 75.42 109.246 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.37 -16.14 4.36 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.432 -0.89 . . . . 64.31 111.754 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.861 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 61.4 m -121.71 125.88 47.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.609 0.243 . . . . 73.25 110.421 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.01 138.11 44.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 71.44 109.454 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.736 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.4 tp -71.85 -17.38 62.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.232 -0.284 . . . . 75.31 110.232 -176.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.886 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 52.4 tt0 -68.85 -51.15 43.54 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.152 0.427 . . . . 64.14 112.152 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.5 tptt -79.56 -35.31 40.02 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.255 -0.578 . . . . 74.21 110.436 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -43.2 92.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.167 -0.47 . . . . 73.21 111.265 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -65.38 -31.52 72.67 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.315 -0.554 . . . . 75.41 110.232 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -67.01 -38.17 85.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.825 0.345 . . . . 62.15 110.424 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.04 -32.21 68.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 74.11 111.529 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.403 ' OD1' HG21 ' A' ' 343' ' ' VAL . 14.6 m120 -99.06 4.6 47.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 75.52 111.136 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.3 33.98 21.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.055 -0.521 . . . . 70.35 110.967 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 16.9 pttp 43.32 33.09 0.55 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.485 1.114 . . . . 71.21 113.15 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -110.58 95.92 5.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.53 -0.915 . . . . 73.22 108.53 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 147' ' ' LYS . 24.7 m-85 -112.32 157.12 21.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.612 -0.722 . . . . 74.2 110.949 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 m -62.69 156.31 23.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.009 -0.541 . . . . 73.22 109.751 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -55.72 -26.04 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.822 0.305 . . . . 72.45 111.822 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG2' ' OD2' ' A' ' 335' ' ' ASP . 57.1 mttm -52.65 -54.32 35.01 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.231 0.539 . . . . 70.33 111.004 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 339' ' ' LEU . 1.9 m -65.16 -36.17 83.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.638 -0.71 . . . . 73.45 111.222 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 -49.38 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.107 -0.497 . . . . 63.13 110.788 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.615 ' HG ' HD22 ' A' ' 328' ' ' LEU . 0.5 OUTLIER -68.5 -50.39 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 52.13 110.53 -176.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.564 ' HG3' ' H ' ' A' ' 337' ' ' GLY . 2.3 mp0 -61.61 -40.43 94.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.128 0.418 . . . . 73.12 112.128 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.9 mp -63.96 -46.83 82.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.03 -0.268 . . . . 65.11 110.36 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.454 ' HA ' HD11 ' A' ' 247' ' ' LEU . 37.6 t -60.27 -46.65 89.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.865 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 106' ' ' LYS . 58.7 tp -55.62 -46.36 77.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 64.42 111.277 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.584 HH11 HG12 ' A' ' 193' ' ' VAL . 89.9 mtt180 -66.68 -34.03 76.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 74.31 111.294 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 157' ' ' LEU . 48.1 mm -68.89 -34.71 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 63.3 110.291 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.477 HD11 HD12 ' A' ' 324' ' ' LEU . 95.7 mt -61.11 -47.41 86.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.486 -0.324 . . . . 61.32 110.6 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.74 -48.02 78.73 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.124 -0.489 . . . . 72.04 111.155 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' ILE . 14.7 tt -71.83 -36.47 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.774 -0.37 . . . . 50.25 111.677 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 168' ' ' ILE . 42.5 tp -65.41 -32.62 74.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.44 110.985 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 317' ' ' TYR . 28.6 tp10 -68.12 -45.96 72.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.826 -0.435 . . . . 53.13 109.826 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -59.04 -44.05 91.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 72.05 111.893 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 165' ' ' LEU . 40.6 pt -76.57 -34.28 23.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.715 -0.394 . . . . 65.12 111.683 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -75.79 -19.1 59.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.67 -0.412 . . . . 75.2 110.443 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.607 ' HB2' HH22 ' A' ' 103' ' ' ARG . 13.6 tt0 -53.34 -31.8 46.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.016 -0.735 . . . . 75.45 109.016 170.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.545 ' C ' ' HG3' ' A' ' 172' ' ' GLU . 48.1 m80 -98.45 -101.94 0.21 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.981 -1.008 . . . . 63.44 110.596 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' HG3' ' C ' ' A' ' 171' ' ' HIS . 12.1 mt-10 -153.87 14.0 0.47 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.645 0.239 . . . . 75.54 111.645 -171.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -122.46 148.04 45.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 72.41 112.601 -164.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.01 173.21 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.034 -0.984 . . . . 70.21 109.401 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.14 -65.11 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 63.42 110.897 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.28 50.97 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.435 -0.888 . . . . 33.21 113.056 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 34.0 t70 -141.37 108.37 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.983 0.392 . . . . 54.03 111.169 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 178' ' ' ILE . 25.2 mm -111.27 35.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.81 0.814 . . . . 73.13 109.4 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 56.4 tptt -59.71 134.87 57.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 72.41 110.169 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -48.06 -33.64 8.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.83 0.678 . . . . 75.32 112.83 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.886 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 28.6 p -59.41 -25.58 64.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.848 0.356 . . . . 64.44 111.671 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -88.51 1.02 55.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 74.41 111.87 -171.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.21 127.01 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 63.45 110.579 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.42 134.9 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 62.02 111.007 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.861 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 8.6 mp -95.64 145.86 24.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.149 -0.478 . . . . 54.52 109.815 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.438 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 26.2 t-20 -62.73 144.39 56.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.378 -0.373 . . . . 63.15 110.417 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.654 ' CE2' ' HE2' ' A' ' 188' ' ' LYS . 1.3 p90 -60.56 -32.37 71.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.219 0.451 . . . . 72.34 112.219 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.654 ' HE2' ' CE2' ' A' ' 187' ' ' TYR . 75.8 mmtt -93.71 -43.91 8.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 72.53 110.237 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -101.94 105.3 41.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 71.22 111.961 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 4.3 Cg_exo -77.15 -7.04 17.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.957 2.438 . . . . 75.02 111.466 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 192' ' ' GLN . 5.0 p-10 -87.96 -16.86 32.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.839 -0.619 . . . . 71.13 110.7 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HG3' ' OD2' ' A' ' 191' ' ' ASP . 42.8 mt-30 -111.08 110.98 21.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.405 0.621 . . . . 71.1 111.11 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.584 HG12 HH11 ' A' ' 160' ' ' ARG . 13.0 p -108.09 138.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.882 -1.053 . . . . 75.13 109.913 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 47.0 m-85 -125.33 153.74 42.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.442 -0.577 . . . . 63.51 109.442 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 32.5 tp -96.48 142.3 28.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.059 -0.349 . . . . 62.35 110.059 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.701 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.0 p -124.04 -173.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.293 -0.632 . . . . 73.32 109.293 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 196' ' ' VAL . 52.5 t0 60.63 62.32 1.53 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.894 0.854 . . . . 75.33 109.116 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.773 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 21.7 m-85 -81.11 7.59 10.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.147 -0.933 . . . . 71.24 109.788 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.45 76.5 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.579 -0.737 . . . . 63.33 111.622 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.885 ' HA ' ' HB ' ' A' ' 354' ' ' ILE . 2.4 pp -89.91 4.07 51.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.753 0.311 . . . . 74.43 111.355 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -68.89 102.1 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.194 0.521 . . . . 64.25 109.974 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.605 ' HB2' HG13 ' A' ' 354' ' ' ILE . 84.8 t80 -98.39 125.54 43.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 71.52 110.117 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 34.8 ttt180 -74.4 97.16 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 54.25 109.147 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.66 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 2.7 p90 -87.07 -14.93 40.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 73.52 111.625 -170.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 24.8 p -137.4 104.47 8.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.82 0.343 . . . . 72.55 110.871 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 34.1 Cg_endo -66.16 119.97 7.06 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.413 2.075 . . . . 74.32 111.708 176.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.411 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 3.4 mp0 64.98 -80.79 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.769 -0.65 . . . . 73.24 111.046 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.84 0.64 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 74.25 112.098 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 51.0 t -105.63 111.74 36.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.077 -0.342 . . . . 71.12 110.077 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -83.94 146.07 28.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.859 0.361 . . . . 74.34 110.295 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 212' ' ' GLU . 10.1 mmtt -84.02 156.37 22.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.449 . . . . 73.3 109.989 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -102.25 153.62 19.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.315 -0.624 . . . . 73.45 109.315 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.874 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -74.13 55.82 0.59 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.563 0.579 . . . . 72.01 112.563 -174.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -117.28 -15.49 10.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.11 -0.496 . . . . 74.13 110.498 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 236' ' ' VAL . 3.0 tp10 -80.94 141.14 34.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.669 -170.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -148.98 83.15 6.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.534 -0.913 . . . . 70.43 108.534 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.75 -51.17 2.55 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.414 2.076 . . . . 72.15 112.205 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -175.79 29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 75.0 110.012 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 62.84 95.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.759 0.662 . . . . 74.44 111.349 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.483 ' HB3' ' OD2' ' A' ' 222' ' ' ASP . 99.3 m -67.06 -48.45 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 75.24 111.665 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 21.4 p80 47.21 35.08 3.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.677 0.791 . . . . 63.43 112.815 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 220' ' ' CYS . 28.6 m-20 -66.46 -36.83 83.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.449 . . . . 64.2 110.906 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -76.44 159.36 49.97 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.707 -0.758 . . . . 74.42 111.674 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 228' ' ' THR . 6.6 p -68.58 150.3 48.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.472 0.177 . . . . 61.44 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 265' ' ' LEU . 43.8 mm -52.97 -34.36 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.903 0.383 . . . . 71.52 111.479 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.18 -47.06 84.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.964 -0.562 . . . . 74.41 111.293 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.984 ' HB3' HG23 ' A' ' 246' ' ' ILE . 41.0 m-85 -112.1 15.75 20.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 75.31 111.968 -170.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 224' ' ' THR . 1.3 p -57.87 -36.83 72.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.441 0.534 . . . . 63.1 112.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.6 t 57.23 -173.97 0.08 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.378 -0.601 . . . . 73.31 109.378 -170.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.5 -39.15 54.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.262 0.553 . . . . 65.51 109.849 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.82 -66.45 0.4 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.888 -1.051 . . . . 65.02 111.967 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.57 69.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 75.12 111.914 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -63.02 -43.67 98.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.629 -0.26 . . . . 65.11 111.099 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.39 -32.88 58.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.212 0.53 . . . . 75.42 110.819 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.25 1.45 55.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.625 -0.798 . . . . 62.54 111.49 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 213' ' ' TYR . 8.8 p -72.42 141.88 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 110.0 -0.37 . . . . 64.01 110.0 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -47.76 109.89 1.23 Allowed Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 61.41 111.728 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.57 121.21 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 73.21 111.864 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 m -79.8 170.59 16.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.033 -0.53 . . . . 75.42 109.82 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -62.7 -29.98 71.06 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.415 -0.514 . . . . 74.24 110.434 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 0.2 OUTLIER -55.12 -38.8 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.42 109.858 174.348 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -67.26 -50.95 41.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.536 -0.756 . . . . 65.31 111.971 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -39.67 94.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.992 0.425 . . . . 74.44 110.174 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.35 -44.28 97.44 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.086 -0.506 . . . . 54.12 110.775 174.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.62 -36.99 81.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.76 -0.655 . . . . 74.11 110.181 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.984 HG23 ' HB3' ' A' ' 227' ' ' PHE . 96.5 mt -62.77 -43.01 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.648 -0.706 . . . . 72.42 110.151 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 251' ' ' MET . 61.7 tp -60.34 -39.6 87.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.321 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.805 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.62 -42.06 99.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.035 -0.602 . . . . 73.13 112.254 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 246' ' ' ILE . 22.2 m-85 -56.93 -41.35 78.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.248 0.547 . . . . 60.42 110.046 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 46.4 m -65.57 -45.44 83.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.553 -0.749 . . . . 74.52 110.656 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.2 mtp -58.39 -48.53 80.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 74.13 111.228 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.473 ' HB ' ' HE1' ' A' ' 286' ' ' MET . 8.9 tt -66.53 -34.29 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.713 -0.395 . . . . 75.41 110.742 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.505 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 41.6 tt0 -66.75 -46.4 75.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.141 -0.224 . . . . 71.24 110.772 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.0 m0 -68.37 -28.21 66.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 71.01 111.363 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.5 tp -81.49 -31.05 33.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 74.3 111.706 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.7 p -101.8 -28.2 12.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.801 -0.359 . . . . 74.04 111.683 -173.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 87.01 -13.79 58.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.858 -0.687 . . . . 73.3 112.745 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -156.26 141.04 17.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.919 -0.4 . . . . 75.54 109.919 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 93.9 mt -101.79 148.93 36.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 52.14 110.758 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.448 ' HG2' ' CE3' ' A' ' 261' ' ' TRP . 18.2 Cg_endo -60.07 -29.11 88.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.708 2.272 . . . . 63.53 112.766 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.515 ' HB3' ' CB ' ' A' ' 274' ' ' SER . 33.5 p90 -105.13 7.58 33.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.72 0.295 . . . . 70.34 111.222 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 39.8 tt0 -67.22 -37.48 83.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.026 0.441 . . . . 44.2 111.332 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.56 -22.14 62.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.348 0.594 . . . . 73.41 110.091 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -109.56 21.73 16.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.526 -0.761 . . . . 75.11 110.731 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 225' ' ' ILE . 1.6 tm? -63.33 -24.0 67.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 73.03 111.03 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -88.56 12.69 13.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 62.54 111.698 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.54 118.46 17.98 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-O 120.766 0.317 . . . . 73.52 110.636 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 271' ' ' VAL . 24.4 Cg_exo -63.17 -30.62 74.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 73.03 113.267 -177.021 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -73.23 -41.67 63.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.751 0.31 . . . . 74.32 110.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -68.89 -46.54 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 74.22 111.204 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 268' ' ' PRO . 34.1 m -62.88 -31.21 51.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.928 -0.309 . . . . 70.03 111.143 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 276' ' ' ILE . 10.7 ttt85 -61.16 -62.72 1.64 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 110.139 -0.319 . . . . 74.45 110.139 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.39 -44.65 84.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.77 -0.65 . . . . 74.52 111.563 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 261' ' ' TRP . 19.7 m -65.15 -40.94 95.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.962 -0.563 . . . . 52.2 111.668 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -78.52 -23.01 46.5 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.537 -0.465 . . . . 53.5 110.921 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 272' ' ' ARG . 62.4 mt -71.32 -46.5 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.838 -0.431 . . . . 73.13 109.838 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -62.64 -40.01 95.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.346 -0.388 . . . . 75.01 110.545 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -60.14 -46.86 88.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 74.11 110.842 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -76.98 -13.91 59.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 73.43 110.624 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.83 -36.19 79.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.099 -0.501 . . . . 54.11 110.052 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 281' ' ' ASN . 2.6 t-20 -161.9 96.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.416 -0.587 . . . . 64.02 109.416 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 303' ' ' MET . 3.7 mp -80.16 -51.48 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.186 0.439 . . . . 54.42 112.186 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.409 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.12 -46.94 84.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.597 0.221 . . . . 71.21 111.597 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -64.99 -37.14 86.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 62.54 110.559 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.27 -34.44 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 65.01 110.69 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.473 ' HE1' ' HB ' ' A' ' 252' ' ' ILE . 49.5 mtt -74.38 -34.22 63.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.687 -0.233 . . . . 75.21 111.44 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -59.92 -36.52 77.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.288 -0.634 . . . . 71.53 109.288 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -75.35 -24.48 57.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.976 -1.011 . . . . 74.02 110.965 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.0 m -72.85 -23.46 60.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.619 -0.264 . . . . 72.14 111.229 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.82 81.24 11.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.85 0.315 . . . . 53.42 111.85 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.37 -18.34 49.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.533 2.156 . . . . 74.42 111.228 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -76.78 -5.91 50.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.75 -0.659 . . . . 54.32 109.85 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 64.95 90.14 0.09 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.057 -0.974 . . . . 72.24 112.315 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.44 -177.14 3.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.816 -1.549 . . . . 75.41 106.816 170.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -122.29 87.26 48.21 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 118.808 0.731 . . . . 73.03 110.332 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.46 39.65 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.323 2.682 . . . . 75.1 111.348 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -65.61 -37.32 93.47 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.837 -0.619 . . . . 72.14 112.861 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.567 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -60.35 -46.61 89.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.31 0.576 . . . . 72.31 109.899 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -76.29 -38.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.473 -0.785 . . . . 72.24 110.442 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.39 -53.24 59.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 75.43 111.488 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.593 ' HB3' HD11 ' A' ' 323' ' ' ILE . 27.8 tptp -69.4 -36.32 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.397 -0.365 . . . . 72.02 110.412 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.536 ' CD1' HD12 ' A' ' 320' ' ' LEU . 62.9 t80 -55.76 -50.92 69.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.908 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.805 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 82.9 mmm -70.61 -40.86 72.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.918 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.15 -34.15 77.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.547 -0.538 . . . . 74.41 109.547 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -73.25 -45.23 57.14 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.508 0.558 . . . . 74.2 112.508 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.1 m -63.54 -25.3 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.348 0.594 . . . . 74.41 110.342 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -74.6 -44.18 51.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 71.33 111.455 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 85.1 mt -84.38 71.23 10.7 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.139 0.792 . . . . 64.23 113.139 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 310' ' ' ASP . 1.3 pt? -159.61 -71.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.369 -0.974 . . . . 53.14 108.369 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.948 ' H ' ' HG ' ' A' ' 309' ' ' LEU . 2.8 t70 174.52 -73.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 124.002 0.814 . . . . 71.12 109.093 168.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 0.4 OUTLIER -162.35 -51.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.245 0.832 . . . . 71.12 113.245 173.085 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 7.0 m -139.36 32.0 2.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.598 0.713 . . . . 72.22 110.943 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 310' ' ' ASP . 7.8 mp0 -62.5 -76.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 64.13 109.962 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -156.75 93.51 2.36 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 73.43 109.459 173.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 117.39 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.949 1.766 . . . . 62.31 110.747 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.07 85.43 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 75.3 109.923 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.471 ' CZ ' ' HD2' ' A' ' 321' ' ' ARG . 60.5 t80 -57.2 -36.91 71.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.43 -0.805 . . . . 73.31 110.987 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.52 -39.26 90.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 72.13 110.417 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -68.06 -42.97 79.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 64.14 111.274 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.536 HD12 ' CD1' ' A' ' 302' ' ' TYR . 2.0 mm? -63.07 -43.38 98.73 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.939 -0.304 . . . . 75.5 110.749 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.558 ' NH2' ' HG2' ' A' ' 106' ' ' LYS . 65.0 mtp85 -67.7 -38.5 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.911 -0.316 . . . . 73.42 110.351 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -48.4 76.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 64.32 111.203 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -64.67 -41.42 92.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.815 -0.175 . . . . 64.03 111.232 -176.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 162' ' ' LEU . 80.5 mt -63.24 -46.06 88.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.822 0.344 . . . . 71.45 110.869 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -35.26 75.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.449 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -55.68 -47.84 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.862 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.567 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -68.07 -45.89 69.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.901 -0.666 . . . . 71.15 112.166 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.615 HD22 ' HG ' ' A' ' 155' ' ' LEU . 40.6 tp -59.17 -45.7 90.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.127 0.489 . . . . 74.21 110.812 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -73.96 -24.63 59.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 61.42 111.164 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.43 -43.14 77.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.682 0.277 . . . . 65.44 110.991 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.29 -6.73 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.364 0.602 . . . . 74.43 110.651 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.99 24.31 38.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.893 -0.67 . . . . 71.51 112.943 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.0 t -108.21 153.53 23.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.903 -0.406 . . . . 61.43 109.903 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.0 132.86 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.152 -0.476 . . . . 65.21 109.831 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 16.7 m-20 -138.6 -58.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.382 -0.372 . . . . 63.22 110.482 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 48.9 t0 59.29 90.15 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.169 0.918 . . . . 55.44 111.064 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.564 ' H ' ' HG3' ' A' ' 156' ' ' GLN . . . 96.85 -31.85 7.18 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.825 -0.703 . . . . 70.34 112.398 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 335' ' ' ASP . 53.4 mttp -71.78 131.33 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 54.11 110.984 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 153' ' ' THR . 27.5 mt -114.76 -172.15 2.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.138 -0.483 . . . . 75.21 110.527 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -148.39 37.63 0.84 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.291 1.043 . . . . 71.04 108.388 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 17.4 tp -132.64 39.31 3.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.002 -0.999 . . . . 73.52 111.05 -171.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.9 m -80.58 34.85 0.34 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.265 -0.425 . . . . 72.32 110.835 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.403 HG21 ' OD1' ' A' ' 145' ' ' ASN . 59.6 t -71.24 -52.13 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 74.33 110.683 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.8 t 64.49 95.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.71 -0.677 . . . . 64.11 111.794 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -100.75 -52.47 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 64.14 110.424 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 49.7 t30 74.13 93.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.96 0.788 . . . . 73.34 112.07 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -137.71 -57.75 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.38 -1.088 . . . . 53.24 110.38 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 102.69 171.03 26.61 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.835 -0.698 . . . . 43.3 112.812 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 349' ' ' LEU . 2.3 pt? -131.17 178.24 6.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.126 0.489 . . . . 62.24 111.132 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 9.7 mtmp? -120.96 141.22 50.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.434 -0.803 . . . . 63.31 109.418 169.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.26 154.94 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.53 . . . . 75.24 112.389 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.58 ' O ' ' HB ' ' A' ' 353' ' ' THR . 0.1 OUTLIER -93.95 -45.71 7.49 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.781 -0.645 . . . . 64.12 112.087 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 93.8 m 74.83 139.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.871 0.732 . . . . 71.33 110.666 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.885 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.4 OUTLIER -90.8 140.57 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 72.43 110.844 -177.614 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.505 ' N ' HD13 ' A' ' 354' ' ' ILE . 88.0 m -68.64 102.48 1.5 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.009 -0.541 . . . . 73.51 110.833 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 360' ' ' LYS . 4.9 tmtt? -141.06 112.5 7.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.281 -0.637 . . . . 65.43 109.281 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -156.34 131.53 9.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 73.31 111.101 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -175.95 -67.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.883 -1.154 . . . . 73.2 107.883 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 359' ' ' LYS . 1.6 tpmt? -146.96 -47.04 0.18 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.426 -1.694 . . . . 61.43 106.426 170.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 356' ' ' LYS . 53.4 mttp . . . . . 0 C--O 1.241 0.613 0 CA-C-N 114.017 -1.447 . . . . 71.33 107.948 161.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 66.0 mtt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.135 -0.32 . . . . 75.11 110.135 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 87.2 Cg_exo -45.88 149.55 2.11 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.659 2.906 . . . . 51.53 114.02 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -142.31 137.8 30.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 74.13 110.785 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.38 109.62 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.391 -0.596 . . . . 64.52 109.391 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.496 ' HE3' ' CE1' ' A' ' 171' ' ' HIS . 18.6 ptmt -125.24 122.07 35.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.967 0.413 . . . . 75.44 111.11 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 171.99 15.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 61.1 110.066 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.82 163.9 31.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.464 -0.335 . . . . 61.52 110.586 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -119.47 152.92 36.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 74.13 110.266 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.18 151.8 33.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.093 -0.503 . . . . 70.12 110.808 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.69 136.22 12.76 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.857 -0.687 . . . . 52.25 112.037 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' A' ' 11' ' ' ARG . 18.8 ttt85 -113.32 115.98 29.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.163 -0.68 . . . . 73.22 109.163 176.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.61 148.01 24.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.918 -0.583 . . . . 53.24 111.075 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 75' ' ' SER . 16.5 m -126.6 141.07 51.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.51 -0.768 . . . . 54.21 109.536 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -143.81 104.32 4.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 64.43 110.132 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 76' ' ' ASP . . . -164.46 83.73 0.42 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 54.54 110.199 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.672 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -92.81 172.15 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 72.12 110.18 -179.031 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.732 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -172.13 116.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.77 -0.826 . . . . 74.41 108.77 -176.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -79.72 27.73 0.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.321 0.489 . . . . 74.43 112.321 -171.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 55.2 tp -137.43 160.08 40.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.298 -0.63 . . . . 75.24 109.298 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.74 125.53 8.39 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.701 0.286 . . . . 52.32 110.426 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.1 pm0 -76.88 -30.14 56.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.568 -0.53 . . . . 63.14 109.568 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 70.77 -12.08 0.58 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.203 -0.908 . . . . 74.43 112.359 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -81.65 93.34 6.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.076 0.465 . . . . 71.0 110.088 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -126.27 -2.3 6.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.824 -0.625 . . . . 73.33 110.864 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.43 121.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 52.23 110.473 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.65 1.22 83.33 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.883 -0.675 . . . . 71.41 112.537 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 154.02 20.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.088 -0.338 . . . . 74.52 110.088 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 14.6 mt -106.42 136.94 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 71.44 111.639 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.41 136.1 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.44 -0.8 . . . . 75.11 109.466 175.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -106.12 121.86 45.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.268 -0.271 . . . . 73.43 110.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.25 179.6 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.772 -0.371 . . . . 74.52 110.01 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.6 mmt -63.41 -22.1 66.68 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.387 0.514 . . . . 73.33 112.387 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.74 6.08 16.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.739 0.305 . . . . 60.13 111.218 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 74.71 11.37 3.85 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.613 -0.721 . . . . 75.53 111.337 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 133.48 33.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.788 -0.449 . . . . 51.24 109.788 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 42.6 mt-10 -104.61 92.47 4.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.379 0.609 . . . . 73.22 110.501 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 56' ' ' MET . 10.9 m95 -83.64 159.02 21.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 71.52 109.089 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.06 146.68 44.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.098 -0.641 . . . . 75.21 110.618 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 ' CE1' ' A' ' 52' ' ' TYR . 58.5 t -72.65 116.88 15.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.393 -0.821 . . . . 41.04 110.409 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 -94.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.518 -0.848 . . . . 62.44 112.095 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.9 mm? -111.74 129.95 23.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.759 0.314 . . . . 62.41 110.869 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.8 Cg_exo -75.07 103.77 1.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.193 2.595 . . . . 73.12 111.544 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.3 mt -86.82 -47.89 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.016 -175.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.65 -30.8 8.99 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.137 -0.554 . . . . 73.34 112.05 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -118.07 163.25 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.181 -0.303 . . . . 73.14 110.181 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.69 -33.27 1.3 Allowed Glycine 0 C--O 1.227 -0.325 0 N-CA-C 111.146 -0.782 . . . . 40.12 111.146 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.54 -71.55 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.38 -0.688 . . . . 42.42 111.38 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HD1' ' HB1' ' A' ' 351' ' ' ALA . 80.8 m-85 -122.58 -71.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.82 0.343 . . . . 74.4 110.382 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.34 157.68 30.09 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.451 -0.66 . . . . 44.14 111.451 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.9 t 60.46 50.48 5.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.278 0.561 . . . . 74.4 110.843 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -105.85 137.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 72.15 109.877 177.294 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.537 ' CE1' HG22 ' A' ' 39' ' ' VAL . 52.6 p90 -128.78 158.78 37.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 72.21 111.228 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.85 132.15 39.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.553 -0.749 . . . . 70.24 109.943 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.89 105.56 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.588 -0.278 . . . . 65.43 110.279 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 1.1 p-10 -95.51 -27.53 15.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.474 -0.33 . . . . 53.44 111.009 -176.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.632 ' HB2' ' CE3' ' A' ' 37' ' ' TRP . 1.8 tmt? 66.5 -84.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.709 0.63 . . . . 64.03 110.466 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 178.61 133.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.691 -0.855 . . . . 55.12 108.691 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -79.49 54.49 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.024 0.44 . . . . 73.34 110.725 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m -92.79 -60.51 1.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.035 -0.529 . . . . 64.52 111.635 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -144.88 -58.51 0.35 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.607 0.241 . . . . 75.14 111.611 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 t -58.1 -75.67 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.885 -0.598 . . . . 25.03 111.108 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.608 HG21 ' HA ' ' A' ' 66' ' ' ALA . 5.9 p -83.75 143.66 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.657 0.265 . . . . 62.45 110.441 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.2 178.1 47.54 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.591 -1.004 . . . . 74.53 110.591 171.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 t -77.73 61.67 2.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.429 0.633 . . . . 62.12 110.521 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.43 -43.93 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.685 -0.689 . . . . 72.14 110.227 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.608 ' HA ' HG21 ' A' ' 62' ' ' VAL . . . 61.36 73.48 0.58 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.045 -0.98 . . . . 74.14 111.692 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.52 36.36 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.535 2.157 . . . . 61.14 111.571 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -133.75 137.92 45.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.697 0.76 . . . . 53.11 112.385 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG13 ' HG3' ' A' ' 133' ' ' ARG . 31.5 m -132.42 152.25 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.881 -1.054 . . . . 75.23 108.67 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.63 ' HB ' HG12 ' A' ' 130' ' ' ILE . 1.2 p -131.97 131.19 61.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.058 0.456 . . . . 43.34 112.139 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -92.15 139.52 30.54 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.401 -0.818 . . . . 63.44 109.841 176.347 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.57 134.74 49.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.502 -0.479 . . . . 70.42 112.123 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.751 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 3.0 mt-10 -144.57 177.89 1.64 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.612 -0.722 . . . . 55.31 109.069 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.751 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 37.3 Cg_endo -66.96 164.4 29.98 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.673 1.582 . . . . 64.4 112.14 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 7.4 m -59.04 -40.29 84.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.75 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 15' ' ' ALA . 11.4 t70 -85.42 88.04 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.232 0.539 . . . . 73.3 109.595 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 12.4 t-20 -121.09 -166.07 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.35 -0.841 . . . . 72.55 109.329 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . -125.9 -75.82 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.75 -0.54 . . . . 33.32 111.75 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 17.8 Cg_endo -58.43 -24.59 69.62 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.098 2.532 . . . . 72.35 113.036 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.697 HD12 ' HE ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -57.21 -30.46 64.58 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.767 0.317 . . . . 73.21 111.379 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -72.79 -45.55 57.93 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.094 0.473 . . . . 73.42 110.116 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -48.43 77.18 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.218 -0.901 . . . . 73.05 110.814 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 10.9 pt-20 -65.81 -36.65 84.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.233 -0.439 . . . . 75.31 110.883 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.75 -50.57 73.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.881 0.372 . . . . 62.41 110.163 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -45.75 84.09 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.021 -0.536 . . . . 72.41 110.595 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -67.67 -50.48 57.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 60.51 111.128 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 1.7 t80 -59.93 -42.37 93.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 74.42 110.837 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 6.7 tp60 -72.65 -34.26 67.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.198 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -75.7 -21.27 57.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.702 0.287 . . . . 74.15 111.361 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.01 15.72 24.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.084 0.469 . . . . 51.54 111.165 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.62 -175.75 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.621 . . . . 70.02 111.897 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.93 92.13 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.021 -0.99 . . . . 74.44 110.755 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.19 -29.14 55.13 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.844 2.363 . . . . 23.33 111.884 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -62.33 -54.75 35.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.706 -0.679 . . . . 71.22 110.285 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.26 -43.83 95.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.627 -0.715 . . . . 64.32 110.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG23 HD21 ' A' ' 108' ' ' LEU . 81.4 mt -56.96 -54.34 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.691 -0.686 . . . . 73.52 110.66 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -58.23 -38.64 77.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 74.5 110.504 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -60.08 -58.92 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.503 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -34.9 67.54 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.077 -0.649 . . . . 72.53 111.005 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 108' ' ' LEU . 33.5 mm -59.63 -43.64 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 71.22 110.783 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -78.11 -41.06 36.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.503 -0.317 . . . . 73.31 111.51 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 m -75.83 -35.78 59.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.106 0.41 . . . . 71.4 112.106 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -94.92 -5.79 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.763 -0.199 . . . . 74.12 111.04 -174.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 73.06 84.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.905 0.753 . . . . 74.33 111.853 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 163' ' ' ASP . 5.6 mp -137.18 -176.58 4.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.436 -0.802 . . . . 61.34 109.173 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.649 ' HD2' ' HD1' ' A' ' 107' ' ' TYR . 1.3 tmtm? -96.57 -72.03 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.189 -0.671 . . . . 53.14 109.189 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.649 ' HD1' ' HD2' ' A' ' 106' ' ' LYS . 35.1 p90 175.53 123.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.389 -0.597 . . . . 72.41 109.389 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.6 pt? -78.22 135.96 37.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.69 -0.404 . . . . 70.21 110.128 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.52 67.94 2.78 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.989 -0.55 . . . . 74.51 113.098 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.37 128.83 25.81 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.766 0.317 . . . . 72.22 110.163 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.2 Cg_endo -55.71 144.89 74.08 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.906 2.404 . . . . 65.13 113.229 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.882 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 23.5 tptm -62.52 132.33 52.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.388 -0.824 . . . . 55.0 111.39 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.609 . . . . 74.42 110.646 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 132' ' ' ASP . 71.4 m95 -116.63 -71.95 0.71 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 62.42 109.581 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.63 -178.07 25.15 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.252 -0.885 . . . . 72.02 111.733 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 32' ' ' MET . 48.5 p -166.64 167.91 14.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.213 -0.662 . . . . 74.41 109.213 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.51 -147.44 16.29 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.847 -1.168 . . . . 64.32 112.88 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.455 ' H ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.09 147.87 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.042 0.449 . . . . 72.4 110.759 -176.306 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 29' ' ' ILE . 44.0 t-80 -123.7 115.76 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 60.25 109.112 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.826 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 9.3 t70 -83.98 136.81 33.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.189 -0.46 . . . . 74.55 109.931 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 6.1 ptmm? -87.96 20.0 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.598 0.237 . . . . 74.31 110.376 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 66.99 75.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.881 -0.785 . . . . 72.15 108.881 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.42 -24.21 3.08 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.157 -0.929 . . . . 54.32 112.079 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.732 ' HE2' ' HB2' ' A' ' 17' ' ' ARG . 18.6 ttpp -168.17 136.99 2.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.928 -0.397 . . . . 72.22 109.928 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 9.2 m -84.09 155.44 22.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.257 0.551 . . . . 73.33 112.002 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.54 155.34 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.339 -0.846 . . . . 75.34 108.745 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.697 ' HE ' HD12 ' A' ' 80' ' ' LEU . 32.7 ttt180 -114.83 128.0 56.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.426 0.155 . . . . 72.32 110.803 -171.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -137.9 163.12 32.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.231 0.539 . . . . 45.45 112.005 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.779 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 37.0 ttm -145.11 141.29 28.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.501 -0.772 . . . . 65.44 110.03 176.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.63 HG12 ' HB ' ' A' ' 70' ' ' VAL . 47.4 mt -100.79 134.62 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 54.15 111.42 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 12.3 ptm -129.68 175.65 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 62.14 109.535 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.882 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 5.0 t70 -72.44 174.54 7.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.807 -0.442 . . . . 75.14 109.807 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.592 ' HE ' ' HE1' ' A' ' 187' ' ' TYR . 9.7 ttp180 -86.77 93.11 9.18 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.17 0.986 . . . . 54.24 110.99 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.599 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 47.0 m-85 -103.06 170.55 7.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.822 -1.081 . . . . 72.53 109.322 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.11 -46.1 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.5 -0.857 . . . . 42.24 111.946 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 19.6 m -95.33 125.72 40.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.927 -0.397 . . . . 73.31 109.927 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 p30 -116.8 174.41 6.1 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.031 -0.359 . . . . 72.22 110.031 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.421 HD21 HD21 ' A' ' 157' ' ' LEU . 11.2 mp -74.5 -20.14 60.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 73.22 111.397 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 56.4 tp60 -74.35 -37.27 63.57 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.908 -0.404 . . . . 72.05 109.908 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 55.7 mttp -57.7 -51.44 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.816 -0.629 . . . . 71.23 110.654 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 341' ' ' LEU . 2.0 mp -68.14 -34.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.327 -0.397 . . . . 52.52 110.263 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.639 ' HE2' HE22 ' A' ' 253' ' ' GLN . 48.1 t80 -52.7 -52.94 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 74.51 110.841 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -80.64 -41.57 23.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.903 -0.59 . . . . 73.02 111.83 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.32 70.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.272 0.471 . . . . 73.33 112.272 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.86 ' HB2' HG11 ' A' ' 344' ' ' VAL . 2.1 t-20 -105.51 0.08 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 71.03 110.536 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.74 46.46 25.82 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.322 -0.854 . . . . 63.24 112.018 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 33.2 mttt 71.56 100.07 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.604 -0.726 . . . . 63.44 112.577 175.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.573 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . 7.2 mmt180 -150.33 72.78 1.12 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 63.41 109.882 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.89 118.88 37.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.874 -0.603 . . . . 73.33 109.862 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -70.85 149.93 46.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.374 -0.375 . . . . 72.33 110.08 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.576 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 11.3 ttp180 -61.16 -31.44 71.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.329 -0.396 . . . . 74.5 111.348 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -59.86 -48.37 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.184 0.516 . . . . 74.23 109.922 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.523 HG23 HD22 ' A' ' 339' ' ' LEU . 90.2 m -61.93 -48.67 79.39 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.336 -0.847 . . . . 74.41 110.521 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.2 t -55.87 -47.71 79.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.085 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 324' ' ' LEU . 0.3 OUTLIER -62.69 -48.63 78.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.581 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 22.6 mm-40 -62.46 -41.32 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.119 -0.232 . . . . 74.5 111.212 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.6 mp -59.98 -47.48 85.63 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.101 0.25 . . . . 72.23 110.619 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.5 t -59.65 -43.97 93.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 54.34 110.561 176.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 162' ' ' LEU . 24.5 tp -63.98 -35.63 81.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.05 -0.523 . . . . 73.3 110.879 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.686 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -61.14 -45.03 96.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.332 0.586 . . . . 73.31 109.761 175.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 164' ' ' ILE . 49.5 mm -66.22 -35.11 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.225 -0.898 . . . . 73.41 110.126 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 159' ' ' LEU . 50.5 mt -56.92 -54.78 42.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.219 0.451 . . . . 72.05 112.219 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.462 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.9 p30 -76.25 -35.05 59.15 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.522 -0.871 . . . . 63.12 112.201 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 161' ' ' ILE . 13.4 tt -67.02 -37.02 78.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.034 -0.666 . . . . 64.31 110.32 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 47.5 tp -69.59 -36.86 76.63 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 116.317 -0.401 . . . . 73.44 110.356 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -57.06 -52.52 64.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.602 -0.518 . . . . 74.24 109.602 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -58.47 -40.41 82.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.361 -0.836 . . . . 75.12 112.43 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 29.3 pt -92.47 -32.64 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.006 0.743 . . . . 73.0 113.006 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 2.4 t-160 -73.87 -29.71 62.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.04 -0.356 . . . . 75.52 110.04 -175.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -27.46 69.24 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.945 -0.571 . . . . 72.14 110.084 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.496 ' CE1' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -102.24 -67.61 0.86 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.49 -0.777 . . . . 73.41 112.649 -169.632 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -148.35 -68.39 0.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.291 0.849 . . . . 75.34 113.291 -166.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.11 146.64 25.32 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.321 0.86 . . . . 73.53 113.321 -166.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 202' ' ' TYR . 15.0 m -120.86 149.65 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.716 -1.216 . . . . 52.53 107.716 164.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 178' ' ' ILE . 23.6 p80 -74.67 -29.42 61.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.618 -0.433 . . . . 72.33 111.669 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.575 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 75.45 -59.77 2.84 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.932 -0.652 . . . . 63.25 113.168 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.799 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 9.8 t70 -104.9 131.61 52.17 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 72.11 109.911 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 246' ' ' ILE . 7.8 tp -114.69 14.43 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.942 0.349 . . . . 71.2 111.942 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.53 ' HD2' ' HE2' ' A' ' 227' ' ' PHE . 50.5 tptt -57.34 152.27 14.54 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.23 -0.294 . . . . 62.15 110.586 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.19 -14.8 11.87 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.081 0.4 . . . . 44.24 112.081 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 p -76.99 -15.11 59.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.942 0.401 . . . . 25.14 110.705 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.599 HD21 HD22 ' A' ' 200' ' ' LEU . 3.0 m-20 -90.35 -12.08 38.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.048 -0.524 . . . . 52.42 111.104 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.74 131.5 56.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.099 0.476 . . . . 72.53 110.235 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -127.53 157.16 40.88 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.571 -0.74 . . . . 73.12 110.378 179.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.579 HD11 HD23 ' A' ' 341' ' ' LEU . 48.9 mt -106.16 149.07 27.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.864 -0.607 . . . . 62.11 109.72 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.599 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 24.0 t-20 -64.07 121.4 14.07 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.131 -1.433 . . . . 72.54 107.131 168.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.592 ' HE1' ' HE ' ' A' ' 133' ' ' ARG . 1.7 p90 -70.27 -15.78 62.94 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.3 -0.96 . . . . 72.14 110.582 -167.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -88.16 -28.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.962 -0.563 . . . . 74.35 110.448 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.546 ' HB3' ' OD1' ' A' ' 191' ' ' ASP . 45.2 m-80 -136.2 109.59 9.76 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-O 120.809 0.337 . . . . 72.13 111.211 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 13.6 Cg_exo -69.63 -7.73 21.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.263 2.642 . . . . 75.44 112.95 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 338' ' ' LYS . 9.9 p-10 -85.95 -7.65 58.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 73.34 110.268 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.657 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 80.6 mt-30 -101.23 91.95 4.74 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.586 -0.734 . . . . 74.52 110.029 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.96 122.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.832 -0.622 . . . . 61.45 110.024 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 64.8 m-85 -128.39 151.77 48.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.935 -0.575 . . . . 64.42 110.292 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 196' ' ' VAL . 3.3 tt -84.87 150.51 24.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.218 -1.401 . . . . 73.14 107.218 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.541 ' N ' HD23 ' A' ' 195' ' ' LEU . 31.6 m -56.78 178.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.772 0.32 . . . . 61.11 111.618 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 3.4 m-20 -63.7 11.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.121 0.786 . . . . 75.14 113.121 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 196' ' ' VAL . 6.1 m-85 61.5 43.7 10.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.774 0.797 . . . . 72.21 110.981 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' ILE . . . -68.96 -10.73 62.12 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.685 -1.366 . . . . 61.12 109.685 166.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.599 HD22 HD21 ' A' ' 182' ' ' ASN . 5.7 mp -113.56 104.89 12.71 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.072 -1.084 . . . . 73.24 108.072 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.871 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -163.24 107.55 1.06 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.795 -0.638 . . . . 42.33 110.745 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.518 ' O ' HG22 ' A' ' 174' ' ' VAL . 55.1 t80 -99.4 126.0 45.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.841 -0.8 . . . . 75.51 108.841 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.585 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 14.8 ptm180 -81.97 123.84 29.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 65.54 110.79 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' ' HB1' ' A' ' 237' ' ' ALA . 18.4 t80 -84.36 -18.4 36.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.671 . . . . 72.01 109.952 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 55.5 m -118.24 85.77 25.57 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.934 -0.575 . . . . 71.13 110.91 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 209' ' ' VAL . 13.1 Cg_exo -70.5 103.69 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.607 2.204 . . . . 74.15 111.124 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.585 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 28.8 tt0 70.11 -1.28 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.991 -0.549 . . . . 74.24 111.031 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.32 -12.25 10.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.238 -0.506 . . . . 41.44 111.864 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 49.6 t -69.46 132.63 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 75.41 111.241 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -105.97 110.13 22.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.173 -0.677 . . . . 71.43 109.173 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 17.2 mmmt -103.76 152.75 21.48 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.155 0.798 . . . . 70.14 113.155 -170.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.33 -166.36 1.57 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.496 -1.229 . . . . 72.21 109.514 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.6 p90 -76.48 152.15 36.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 74.33 111.603 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 215' ' ' GLU . 21.6 ttmm -140.92 -53.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 75.24 110.994 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 214' ' ' LYS . 41.9 tt0 72.54 111.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.861 0.726 . . . . 72.32 110.491 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -91.12 134.65 29.61 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 51.15 110.505 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.28 -23.43 74.26 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.149 2.566 . . . . 50.23 113.173 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -101.32 3.05 40.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.68 0.276 . . . . 75.4 110.862 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 53.23 81.63 0.09 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.53 -0.759 . . . . 74.32 111.998 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.426 ' O ' HG21 ' A' ' 355' ' ' THR . 80.1 m -80.24 67.51 6.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.406 0.622 . . . . 70.12 111.292 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 17.8 p80 -79.33 140.89 37.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.409 -0.814 . . . . 71.12 109.744 171.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.94 -53.04 5.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.117 0.484 . . . . 71.23 110.068 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.799 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -103.61 -158.2 24.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.68 -0.772 . . . . 73.44 112.431 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 38.7 p -79.07 144.21 34.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.775 -0.25 . . . . 54.21 110.486 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 271' ' ' VAL . 15.7 tt -55.1 -24.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.324 0.583 . . . . 74.41 111.177 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.42 -61.96 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.17 -0.923 . . . . 64.41 111.489 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.768 ' HZ ' ' HG3' ' A' ' 253' ' ' GLN . 10.7 m-85 -103.95 -22.37 13.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.902 0.705 . . . . 73.22 112.902 -173.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.0 OUTLIER -70.05 -7.34 40.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.997 0.427 . . . . 74.34 110.462 -178.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 25.7 t 68.58 175.91 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.347 -0.842 . . . . 74.34 111.082 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.493 HD11 ' NH1' ' A' ' 279' ' ' ARG . 4.9 pt -71.42 -32.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 72.24 110.229 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 238' ' ' PRO . 2.2 m-20 -46.43 -69.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.269 -0.878 . . . . 72.44 111.188 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 221' ' ' HIS . . . -68.83 -29.04 67.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 73.22 111.2 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 26.6 t-80 -55.17 -41.91 72.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.831 0.348 . . . . 75.51 110.915 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -79.56 0.94 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 75.11 111.486 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 220' ' ' CYS . . . 72.33 32.8 62.14 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 120.965 -0.636 . . . . 71.41 112.687 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 213' ' ' TYR . 3.4 p -120.95 140.94 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.281 -0.266 . . . . 74.02 110.281 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB1' ' HD1' ' A' ' 204' ' ' TYR . . . -54.76 110.64 2.28 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 109.008 -0.738 . . . . 51.32 109.008 170.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.591 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . 23.6 Cg_exo -62.82 -91.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.862 2.375 . . . . 40.43 113.866 -167.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 238' ' ' PRO . 55.7 p 173.11 -158.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.645 -0.502 . . . . 72.51 109.645 -172.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.436 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 4.0 mpt_? -85.52 -45.76 11.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.878 -1.156 . . . . 70.51 107.878 168.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 19.1 ttt-85 -62.33 -39.55 93.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.032 -1.44 . . . . 74.41 111.686 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.9 -57.32 12.97 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.976 -0.556 . . . . 64.42 112.765 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HA ' HD12 ' A' ' 246' ' ' ILE . 11.6 t70 -67.05 -32.52 73.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 65.5 110.482 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 315' ' ' PRO . 77.9 mt -63.57 -39.71 95.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.48 -0.327 . . . . 71.14 111.27 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.09 -34.98 78.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.256 0.55 . . . . 73.2 109.805 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.587 HG22 ' HB ' ' A' ' 178' ' ' ILE . 70.0 mt -60.64 -42.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 74.23 110.447 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.548 HD12 ' SG ' ' A' ' 250' ' ' CYS . 39.0 tp -66.58 -38.06 86.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.045 -0.525 . . . . 71.53 109.966 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.41 96.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 72.52 111.38 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 246' ' ' ILE . 14.1 m-30 -51.19 -58.84 5.09 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 122.603 0.361 . . . . 74.51 111.403 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.548 ' SG ' HD12 ' A' ' 247' ' ' LEU . 30.1 p -61.45 -37.35 83.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.821 -0.351 . . . . 71.44 111.662 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 64.9 mtm -60.86 -50.93 71.46 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.779 -0.368 . . . . 62.41 111.416 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.472 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.5 tt -70.06 -31.58 48.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.682 -0.407 . . . . 73.21 110.424 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 24.0 tm0? -64.98 -51.79 59.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.56 -0.291 . . . . 64.32 110.573 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -63.3 -40.45 97.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.318 . . . . 74.55 111.565 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 290' ' ' PHE . 33.9 tp -77.86 -30.95 51.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.629 0.603 . . . . 74.35 112.629 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 60.6 p -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.412 -0.515 . . . . 60.54 110.867 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.541 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 83.96 7.41 85.58 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.843 -0.694 . . . . 64.51 113.109 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.07 143.82 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.973 0.887 . . . . 74.32 112.49 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 89.5 mt -129.48 139.39 35.54 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.332 -0.849 . . . . 32.24 108.798 168.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.54 -37.23 97.84 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.339 2.026 . . . . 72.12 112.162 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.6 ' HB2' HG12 ' A' ' 271' ' ' VAL . 34.4 p90 -92.5 11.32 26.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.957 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 36.8 tt0 -86.46 -39.41 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 44.23 110.504 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -84.15 -24.52 30.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.459 0.647 . . . . 73.42 109.339 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.68 22.63 15.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.111 -0.95 . . . . 71.24 111.189 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.694 ' HA ' ' CG1' ' A' ' 271' ' ' VAL . 3.4 pp -70.78 -13.99 62.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.541 0.686 . . . . 54.2 110.302 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 265' ' ' LEU . 19.9 ptmt -79.01 2.97 18.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.786 -1.097 . . . . 75.25 110.796 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 15.0 t70 -135.01 127.6 18.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 55.1 110.441 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 22.4 Cg_exo -65.71 -29.58 51.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.025 2.483 . . . . 73.4 113.558 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -79.07 -38.08 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.667 -0.413 . . . . 73.44 110.609 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.425 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 28.8 m-85 -69.29 -49.74 53.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.438 -0.346 . . . . 71.2 111.209 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.694 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 22.3 m -54.7 -40.4 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 120.491 -0.484 . . . . 53.52 111.12 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 276' ' ' ILE . 42.0 ttt85 -62.07 -55.79 25.44 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.58 0.229 . . . . 72.1 111.12 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 24.2 t70 -61.23 -46.33 90.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.31 111.353 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 261' ' ' TRP . 69.3 m -60.64 -39.4 88.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 53.34 111.175 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 67.6 mttm -64.71 -40.2 94.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 74.11 110.362 176.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 272' ' ' ARG . 81.5 mt -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.05 110.027 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 277' ' ' ARG . 14.7 mmp_? -56.83 -48.53 77.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 73.45 110.985 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -67.21 -44.47 79.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 70.13 111.845 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.493 ' NH1' HD11 ' A' ' 230' ' ' ILE . 89.2 mtt180 -65.11 -42.1 94.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.906 0.384 . . . . 75.22 110.922 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.23 -57.72 8.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 72.54 111.19 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 61.6 t30 -115.36 59.03 0.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 73.11 110.904 -171.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.563 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -51.7 -51.45 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.671 0.619 . . . . 74.44 112.671 -176.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.563 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.93 -47.88 83.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.106 0.41 . . . . 72.31 112.106 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' SER . . . . . 0.621 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 5.1 m -77.69 -28.46 51.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.38 -0.373 . . . . 70.02 111.02 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 281' ' ' ASN . 2.7 mm? -68.76 -54.74 14.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.998 -0.281 . . . . 65.01 110.529 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.412 ' HG2' HG22 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -60.07 -41.26 92.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 73.32 110.976 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.28 -51.61 68.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.841 -0.618 . . . . 62.03 111.423 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -91.19 3.54 54.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.244 0.461 . . . . 75.02 112.244 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.56 -23.64 42.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.604 -0.517 . . . . 73.22 109.604 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.498 ' HE2' ' HG ' ' A' ' 255' ' ' LEU . 0.4 OUTLIER -133.64 73.85 71.58 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.295 -0.412 . . . . 72.31 110.98 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.48 32.49 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.724 2.283 . . . . 75.43 111.106 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 171.2 8.14 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.214 -0.903 . . . . 70.44 109.259 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -73.24 86.27 1.43 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.561 0.696 . . . . 74.24 111.82 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 26.9 t-20 -152.48 -89.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.537 -0.756 . . . . 75.22 110.047 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.723 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 0.9 OUTLIER 169.73 102.77 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 109.578 -0.527 . . . . 74.51 109.578 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -99.02 50.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.241 2.627 . . . . 63.11 112.228 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -117.14 -46.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.208 -0.996 . . . . 43.25 113.529 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 2.6 mp0 -58.2 -56.56 20.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 73.32 111.03 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 299' ' ' ILE . 3.7 mp -63.1 -33.94 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.866 -0.607 . . . . 70.32 110.407 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.42 -53.93 50.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 72.15 110.922 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.5 -27.83 63.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.096 -0.502 . . . . 65.13 111.158 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.478 ' CD2' HD22 ' A' ' 320' ' ' LEU . 33.6 t80 -62.1 -53.11 60.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.942 0.401 . . . . 71.54 110.282 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.593 ' HA ' HG22 ' A' ' 306' ' ' VAL . 70.1 mtp -72.61 -31.89 65.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 60.33 110.914 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.506 ' HA ' HG13 ' A' ' 282' ' ' ILE . 36.9 tt0 -60.85 -46.84 88.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.57 . . . . 63.01 109.572 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.652 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 29.0 m -57.09 -52.97 63.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.118 -0.946 . . . . 74.41 111.212 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 24.9 m -63.34 -32.33 56.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 121.068 -0.253 . . . . 45.14 111.336 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.515 ' HA ' ' HE ' ' A' ' 241' ' ' ARG . 86.7 tttt -60.49 -48.09 83.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 64.41 110.187 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 47.4 tp -70.78 -19.69 62.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.684 . . . . 63.51 111.297 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 53.1 mt -72.81 -19.26 61.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.265 0.469 . . . . 71.04 112.265 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 21.6 t70 62.09 -179.86 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.918 0.389 . . . . 75.45 110.304 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -84.39 -23.39 30.11 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.782 -0.574 . . . . 63.44 110.065 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.5 m -95.88 -24.43 16.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.043 0.757 . . . . 54.15 113.043 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.759 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 5.2 mm-40 -87.28 -172.99 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.136 -0.626 . . . . 74.12 112.03 -169.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.654 ' H ' ' HD2' ' A' ' 314' ' ' LYS . 7.4 mptt -85.44 132.2 45.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 71.42 110.782 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.593 ' HA ' HD13 ' A' ' 309' ' ' LEU . 57.7 Cg_endo -74.08 118.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.097 1.864 . . . . 64.55 111.226 174.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.3 mt -87.54 77.32 8.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.319 -0.4 . . . . 62.21 111.36 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.21 -34.02 76.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.539 . . . . 74.13 110.423 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.21 -51.09 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.911 -0.586 . . . . 72.25 110.323 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -65.28 -42.29 93.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.497 -0.774 . . . . 73.1 110.664 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 90.5 mt -63.45 -43.14 98.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 72.21 110.67 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -56.44 -52.56 64.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 74.31 110.703 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.05 -44.72 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 73.44 111.769 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.0 -32.95 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.762 -0.375 . . . . 64.23 111.777 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 155' ' ' LEU . 88.8 mt -69.47 -49.59 53.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.242 0.544 . . . . 74.3 110.406 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.3 mm? -67.88 -26.83 66.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 64.05 110.697 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.22 -47.57 79.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.908 0.385 . . . . 51.24 110.264 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.7 96.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 63.41 112.0 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 333' ' ' SER . 3.9 mm? -73.4 -32.46 64.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 72.03 111.135 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.26 -24.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.916 0.388 . . . . 73.15 110.508 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.8 -24.46 65.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.019 -0.537 . . . . 72.43 111.267 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 49.1 pt -111.95 13.19 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.421 . . . . 61.31 110.588 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.22 25.08 75.35 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.867 -0.606 . . . . 71.41 113.033 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 37.5 m -120.51 145.49 47.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.313 0.578 . . . . 75.14 111.761 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -140.27 -72.71 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.383 -0.826 . . . . 75.12 109.168 174.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.2 115.49 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.796 -1.093 . . . . 74.12 109.557 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -164.06 -69.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.399 -0.819 . . . . 74.52 109.146 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.16 87.34 1.19 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.918 -0.873 . . . . 53.55 110.918 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HD3' ' HB2' ' A' ' 191' ' ' ASP . 89.2 mttt -43.25 102.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.569 0.951 . . . . 73.41 113.569 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 153' ' ' THR . 35.6 mt 62.44 -174.32 0.15 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.181 -0.918 . . . . 72.23 112.837 171.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.31 7.51 1.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.433 -0.803 . . . . 65.42 110.324 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.583 HD11 HG21 ' A' ' 141' ' ' ILE . 9.5 tp -78.44 -52.82 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 74.2 110.989 -170.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 50.1 m 58.86 23.7 11.63 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 74.55 112.725 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.5 m 38.77 83.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.874 0.87 . . . . 71.02 112.789 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 145' ' ' ASN . 7.3 p -63.5 -55.86 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.63 -0.714 . . . . 61.12 111.465 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.449 ' N ' HG13 ' A' ' 344' ' ' VAL . 2.6 mp0 -149.56 -176.23 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.235 -0.283 . . . . 73.25 110.235 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.96 176.46 5.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.564 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -168.21 -169.51 31.78 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.827 -0.909 . . . . 53.1 110.827 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -119.53 112.79 2.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.638 -0.792 . . . . 63.4 112.338 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.6 pt? -93.77 168.07 11.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.885 0.374 . . . . 71.3 110.801 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -125.36 130.97 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 65.31 109.867 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.496 ' HB1' ' HD1' ' A' ' 48' ' ' PHE . . . -88.71 163.02 15.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 74.31 111.022 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.587 ' HB2' HD21 ' A' ' 200' ' ' LEU . 40.8 mtmt -138.95 176.56 8.59 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.661 -0.496 . . . . 74.25 109.661 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.0 t -144.79 162.43 36.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.525 0.202 . . . . 64.31 111.092 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -66.39 143.64 15.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.966 -0.561 . . . . 64.01 111.638 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 220' ' ' CYS . 13.2 t -79.75 132.79 36.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.509 -0.768 . . . . 73.43 109.267 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -150.75 7.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 72.52 111.374 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 64.09 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.073 -0.512 . . . . 72.22 109.909 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -147.7 170.11 18.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.984 -0.376 . . . . 74.43 109.984 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -90.63 -177.15 4.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.006 0.431 . . . . 64.13 111.315 -175.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.474 ' HB2' ' HE2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.064 -0.969 . . . . 75.45 110.766 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.871 -0.418 . . . . 65.14 109.871 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.97 136.67 23.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.302 2.002 . . . . 62.54 112.474 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.571 ' O ' ' HD2' ' A' ' 3' ' ' ARG . 6.2 ppt_? -177.51 104.65 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 74.22 109.586 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.6 t -120.35 120.22 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 44.43 110.547 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -126.15 100.32 6.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.164 0.507 . . . . 73.12 110.997 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 90.03 0.32 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.414 -0.812 . . . . 64.42 109.637 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.57 90.39 3.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 64.24 111.122 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -88.78 135.92 33.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 74.04 110.092 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.37 118.58 37.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.347 -0.388 . . . . 74.05 110.442 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.87 132.62 11.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.807 -0.711 . . . . 35.41 111.981 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 11' ' ' ARG . 38.0 ttt180 -156.19 105.93 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.043 -0.355 . . . . 73.34 110.043 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -130.79 128.93 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.089 0.471 . . . . 74.25 110.444 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -106.41 121.58 44.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 75.11 110.55 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -157.38 133.85 9.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 61.02 110.174 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.34 146.75 18.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 54.3 110.998 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -129.92 156.38 44.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 72.3 109.979 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -134.88 115.29 13.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.343 -0.614 . . . . 62.41 109.343 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -119.06 118.06 30.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.023 0.44 . . . . 74.53 111.283 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.5 tp -175.19 112.84 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 72.1 109.906 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.75 98.8 1.81 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.231 -0.44 . . . . 53.35 110.053 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -111.48 131.87 54.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.052 0.453 . . . . 73.34 110.64 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -84.42 49.03 1.6 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 73.31 112.064 -173.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.31 -49.83 6.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.144 -0.687 . . . . 63.54 109.144 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.89 -72.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.799 -1.091 . . . . 70.21 108.446 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.85 126.32 26.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 74.14 109.802 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.72 1.72 56.34 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.601 -0.809 . . . . 70.03 113.482 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.96 153.46 30.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.585 0.692 . . . . 74.54 109.464 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.9 131.57 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.355 0.597 . . . . 65.45 111.01 -175.447 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.53 137.45 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.132 -0.94 . . . . 74.04 109.536 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.6 m -117.49 120.4 37.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.569 -0.287 . . . . 74.42 110.405 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.9 p-10 -91.04 -169.53 2.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.267 -0.424 . . . . 74.21 110.336 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 11.2 mmt -72.2 -17.81 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.797 0.295 . . . . 72.32 111.797 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.95 9.49 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 72.11 110.979 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 69.4 17.73 8.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.71 -0.677 . . . . 74.13 111.497 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 10.3 mmpt? -83.7 127.17 33.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.62 -0.511 . . . . 75.04 109.62 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.01 92.38 4.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 73.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -116.05 172.18 7.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.389 -0.823 . . . . 72.13 111.164 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -98.47 145.93 26.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 73.04 110.322 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -95.41 103.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.94 -129.97 6.73 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.652 -0.785 . . . . 64.21 113.687 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.9 mp -69.84 131.11 89.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.94 0.4 . . . . 61.33 111.827 -172.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 17.0 Cg_exo -67.76 124.0 11.4 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.883 2.388 . . . . 43.34 111.425 174.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 53' ' ' LEU . 59.3 mt -104.86 -66.33 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.047 0.451 . . . . 71.24 110.699 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 94.97 102.47 1.82 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.785 -0.721 . . . . 53.54 111.732 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' H ' HG12 ' A' ' 51' ' ' ILE . 45.7 tp60 -86.55 165.71 16.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.344 -0.243 . . . . 75.02 110.344 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.11 -29.46 68.76 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.12 -0.562 . . . . 63.05 113.776 -170.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 351' ' ' ALA . . . -71.16 -63.3 3.17 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 73.51 112.85 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.95 -34.71 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.647 0.261 . . . . 64.31 111.583 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 -179.79 45.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.796 -0.716 . . . . 50.4 112.695 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 91.0 m 63.32 30.37 15.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.5 0.667 . . . . 75.42 111.136 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 71' ' ' LYS . 34.6 mm -89.33 136.79 22.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.55 -0.75 . . . . 73.52 109.675 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -107.48 145.92 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.197 0.523 . . . . 74.03 111.113 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' HB2' HD11 ' A' ' 43' ' ' ILE . 64.1 tp -79.29 145.66 33.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.326 -0.852 . . . . 72.04 109.711 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.91 116.61 26.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.397 -0.594 . . . . 73.32 109.397 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 25.6 m-20 -76.76 -50.88 12.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.183 -0.673 . . . . 64.22 109.183 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt 48.37 43.72 19.63 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.25 -0.886 . . . . 71.41 109.931 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -72.23 77.11 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.821 . . . . 74.22 110.447 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.4 m -126.78 -162.61 1.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.136 -0.938 . . . . 62.0 110.275 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.6 m -98.01 7.8 45.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.623 0.249 . . . . 63.41 111.617 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.02 49.3 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 74.34 110.899 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m 62.12 86.21 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.619 -0.719 . . . . 74.24 111.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.48 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.739 -0.664 . . . . 74.42 110.366 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.12 -123.91 3.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.53 -1.028 . . . . 75.02 110.53 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 16.9 m -84.28 61.94 6.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.744 -0.835 . . . . 63.41 108.744 170.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.666 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 5.5 m-20 72.65 -83.32 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.783 -1.098 . . . . 71.23 110.946 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . . . -96.54 102.44 11.39 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.366 -0.834 . . . . 52.13 110.339 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 65' ' ' ASP . 86.2 Cg_endo -95.94 11.07 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.855 2.37 . . . . 75.44 110.994 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.441 ' HB2' HG23 ' A' ' 130' ' ' ILE . 7.0 p -145.91 153.92 41.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.602 0.715 . . . . 72.44 112.905 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 133' ' ' ARG . 15.3 m -136.89 153.82 30.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.035 -0.984 . . . . 64.01 109.098 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.9 p -122.42 122.64 66.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.3 0.571 . . . . 62.2 111.646 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 22.6 ttpt -87.24 126.63 34.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.71 -0.677 . . . . 64.41 109.781 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.63 123.15 70.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 123.745 0.653 . . . . 74.44 110.009 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 41.7 mt-10 -140.69 152.51 66.13 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.356 -0.383 . . . . 75.32 110.344 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.51 126.0 20.05 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.591 2.194 . . . . 64.41 111.964 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -85.74 -15.97 40.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.128 0.49 . . . . 61.41 110.36 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.63 -20.08 43.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.863 -0.608 . . . . 73.11 110.78 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -172.07 96.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.216 -0.661 . . . . 73.41 109.216 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 79' ' ' PRO . . . -163.78 145.62 10.65 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.032 -1.08 . . . . 53.31 113.224 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.0 Cg_exo -60.88 -19.59 62.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.98 3.12 . . . . 50.1 112.285 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.2 tm? -50.72 -30.05 12.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.855 -0.611 . . . . 54.32 110.741 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.72 -48.38 75.29 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.76 0.314 . . . . 71.53 110.828 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.6 m -67.63 -41.99 83.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 73.53 110.481 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -58.45 -42.52 87.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.744 . . . . 65.01 110.513 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.68 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 54.42 110.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 66.7 mmtt -63.55 -46.85 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.922 -0.311 . . . . 64.32 110.451 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.06 -39.95 95.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.04 110.048 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t80 -63.29 -34.4 77.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.407 -0.815 . . . . 73.43 110.662 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -77.51 -32.67 54.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.82 0.343 . . . . 74.31 111.345 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' A' ' 173' ' ' TYR . 39.5 mmt180 -78.73 -49.21 13.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.091 0.404 . . . . 74.11 112.091 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.83 -31.47 10.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.859 0.688 . . . . 73.42 112.859 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -84.42 89.0 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.42 0.628 . . . . 72.34 111.324 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 95' ' ' GLN . 8.9 tmtt? -154.04 91.98 3.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.525 -0.917 . . . . 71.12 108.525 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 113' ' ' TYR . 95.6 Cg_exo -44.25 -52.56 5.62 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.952 3.101 . . . . 73.21 114.53 -170.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.7 -45.16 92.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 74.24 110.625 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 6.9 tp60 -66.27 -44.39 83.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.707 -0.678 . . . . 73.43 110.565 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 92' ' ' LYS . 68.4 mt -58.94 -53.75 43.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.977 -0.556 . . . . 64.44 110.574 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.54 -38.88 69.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.236 -0.438 . . . . 54.2 110.593 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -61.07 -62.3 1.95 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.773 -0.648 . . . . 74.35 111.371 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.802 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -71.3 -34.36 70.56 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.253 -0.579 . . . . 71.41 111.105 -173.476 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 100' ' ' ILE . 17.0 mm -58.75 -50.68 78.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.312 0.101 . . . . 72.04 111.027 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -69.4 -36.85 77.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.657 -0.417 . . . . 62.33 110.806 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 54.21 110.782 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 7.8 ttt180 -83.38 0.97 43.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 72.04 110.374 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 26.0 mtpp 66.54 29.62 8.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.358 -0.837 . . . . 72.33 111.532 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 89.1 mt -92.34 176.7 6.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.72 -0.673 . . . . 53.45 109.942 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 10.8 mmpt? -103.37 -55.01 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.595 -0.275 . . . . 74.45 111.051 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -157.51 171.18 20.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 72.23 110.109 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 39.3 tp -129.32 137.57 51.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.995 -0.372 . . . . 73.21 109.995 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.86 64.21 3.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.155 -0.545 . . . . 25.41 113.253 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 135.8 27.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 110.065 -0.346 . . . . 70.25 110.065 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.07 135.07 30.11 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.039 2.492 . . . . 42.41 112.509 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.861 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 24.2 tptm -66.75 124.06 21.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 73.43 111.001 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.613 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 14.0 t80 -81.27 112.56 18.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.67 -0.695 . . . . 71.32 111.022 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' ILE . 68.9 m95 -105.42 -52.51 2.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.624 -0.88 . . . . 73.13 108.624 169.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.44 46.91 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.008 -0.996 . . . . 45.04 111.759 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 p -168.74 162.84 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.625 -0.509 . . . . 73.02 109.625 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.67 -179.44 46.18 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.754 -1.212 . . . . 70.31 113.207 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 119' ' ' HIS . 5.9 tt -123.88 137.74 54.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.688 -0.856 . . . . 75.35 108.688 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -134.84 147.7 49.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 73.44 110.822 178.76 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.97 140.96 37.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.389 -0.823 . . . . 71.01 110.175 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 126' ' ' TYR . 43.4 tttm -108.66 17.64 21.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.638 -0.255 . . . . 65.11 110.501 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 56.8 m-80 71.27 97.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.309 0.644 . . . . 71.53 110.207 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.05 -44.81 1.4 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.807 -0.711 . . . . 65.34 112.012 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -129.69 138.25 51.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.831 -0.433 . . . . 74.3 109.831 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.0 m -101.53 140.57 35.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 75.41 110.349 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 121' ' ' LYS . 35.5 p90 -128.3 149.94 50.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.182 0.515 . . . . 60.35 110.155 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -117.57 142.42 47.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.027 -0.731 . . . . 74.1 109.027 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.6 p90 -137.93 153.07 49.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.989 0.423 . . . . 53.12 111.291 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 20.0 ptp -139.75 139.42 36.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.982 -0.554 . . . . 74.45 110.576 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 114' ' ' TRP . 5.0 mm -98.17 118.69 45.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.859 -0.61 . . . . 62.5 110.065 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 196' ' ' VAL . 25.1 ptt? -123.2 171.1 9.6 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.13 -0.693 . . . . 71.24 109.13 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t70 -65.2 162.15 17.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 72.23 110.442 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.7 tpt180 -76.57 112.79 13.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.44 0.638 . . . . 61.31 110.862 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.11 143.08 33.06 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.942 -0.762 . . . . 75.12 108.942 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -136.92 -2.15 2.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.291 -0.957 . . . . 55.42 112.233 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' SER . . . . . 1.093 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.8 m -121.83 125.27 46.1 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.845 -0.209 . . . . 70.53 110.512 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.482 ' HA ' HD13 ' A' ' 184' ' ' LEU . 6.4 p-10 -116.35 139.67 50.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.434 -0.58 . . . . 72.02 109.434 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 5.6 tp -68.95 -15.34 63.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.718 -0.219 . . . . 60.13 110.928 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.645 ' HB3' HD13 ' A' ' 349' ' ' LEU . 41.6 mm-40 -62.3 -50.19 72.66 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.012 0.434 . . . . 51.41 110.963 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.865 ' HB2' ' HA3' ' A' ' 347' ' ' GLY . 4.4 tppp? -80.6 -23.24 39.96 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.497 -0.481 . . . . 75.13 109.841 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.863 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 27.6 mt -60.19 -51.26 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 75.31 111.794 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.686 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 5.5 p90 -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.386 -0.525 . . . . 72.33 110.228 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -80.99 -25.98 36.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.527 . . . . 73.51 110.705 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.0 0.428 . . . . 60.02 110.592 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 145' ' ' ASN . 12.0 m120 -101.38 2.38 39.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 63.31 110.157 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 44.16 72.74 0.18 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.046 -0.979 . . . . 73.33 112.672 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.7 pttp 45.23 34.11 1.35 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.058 0.943 . . . . 74.53 112.951 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -138.87 92.68 2.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.061 0.458 . . . . 74.41 109.82 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.686 ' CZ ' ' HA ' ' A' ' 142' ' ' TYR . 55.6 m-85 -104.14 150.95 23.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.968 -0.56 . . . . 72.51 111.666 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -86.7 147.98 25.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.689 -0.687 . . . . 41.54 109.162 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -57.55 -29.08 64.09 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 112.736 0.643 . . . . 74.31 112.736 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.23 -53.64 55.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.861 0.362 . . . . 73.34 111.402 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 157' ' ' LEU . 3.9 m -64.32 -44.95 89.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 60.1 111.038 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.96 -40.05 85.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.94 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.734 ' HG ' HD22 ' A' ' 328' ' ' LEU . 1.7 mm? -63.29 -50.94 68.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 72.11 111.623 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.49 ' HB3' HD21 ' A' ' 339' ' ' LEU . 16.8 tt0 -61.88 -38.36 88.01 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.009 -0.676 . . . . 71.33 110.267 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 153' ' ' THR . 7.7 mp -59.96 -48.6 81.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 71.42 110.447 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -56.26 -47.52 78.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 54.22 110.491 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.805 ' HG ' ' HD2' ' A' ' 321' ' ' ARG . 9.1 mp -57.3 -52.42 65.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.882 -0.599 . . . . 65.42 111.266 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 164' ' ' ILE . 2.1 mpt_? -67.75 -33.68 75.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 70.52 111.379 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -63.62 -43.53 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.7 -0.481 . . . . 72.23 109.7 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 321' ' ' ARG . 83.0 mt -63.01 -42.45 99.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.73 -0.214 . . . . 61.0 110.805 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.24 -60.53 3.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.362 0.601 . . . . 73.45 110.775 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 tt -71.83 -39.74 68.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 72.43 111.968 -174.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.8 mp -65.71 -36.89 84.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 117.759 0.254 . . . . 65.11 111.302 -177.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.26 -48.72 74.68 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.182 -0.673 . . . . 70.4 109.182 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 79.5 t80 -57.48 -46.26 83.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.157 -0.929 . . . . 75.0 111.816 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 164' ' ' ILE . 34.1 pt -82.41 -32.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.466 0.543 . . . . 75.25 112.466 -174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -64.54 -43.62 93.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 110.011 -0.366 . . . . 73.34 110.011 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -82.95 14.66 3.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.714 0.769 . . . . 72.35 109.472 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 1.4 t-80 -136.69 40.95 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.467 -0.788 . . . . 64.4 109.842 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 205' ' ' CYS . 41.7 mt-10 85.4 -61.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.395 1.059 . . . . 53.31 113.557 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 89' ' ' ARG . 13.0 m-85 -84.27 116.13 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.406 0.521 . . . . 73.44 112.406 -164.636 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 238' ' ' PRO . 16.4 t -109.63 151.21 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.357 -0.609 . . . . 70.32 109.357 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -115.46 106.95 14.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 72.05 109.739 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.42 -25.86 55.95 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.551 -0.833 . . . . 71.14 111.828 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.552 ' HB3' HD13 ' A' ' 200' ' ' LEU . 7.1 t70 -98.38 101.73 13.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 75.33 110.24 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.71 31.95 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.961 0.886 . . . . 72.13 110.078 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 179' ' ' LYS . 3.4 ttmp? -62.96 149.62 44.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.166 -0.925 . . . . 63.33 110.699 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.62 -14.61 8.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.786 0.662 . . . . 63.51 112.786 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 m -73.48 -20.81 60.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.48 . . . . 75.51 110.847 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.521 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 3.5 t-20 -82.32 -21.49 36.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.488 -0.778 . . . . 42.14 111.592 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.467 HD23 HG21 ' A' ' 193' ' ' VAL . 5.9 mp -101.85 119.67 39.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.985 0.422 . . . . 63.02 111.533 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 137' ' ' ASP . 3.9 mm? -121.47 145.68 47.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 60.1 110.159 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 1.093 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 52.6 mt -109.67 152.2 25.91 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 110.054 -0.35 . . . . 71.22 110.054 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.61 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 21.1 t-20 -72.64 147.91 45.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 72.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 -20.91 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 72.22 111.527 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -113.85 -9.84 13.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.972 0.415 . . . . 72.34 110.25 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -135.35 96.72 13.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 62.51 110.512 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.68 -18.75 15.01 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.968 2.445 . . . . 72.03 112.897 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 338' ' ' LYS . 5.5 p-10 -86.88 5.33 37.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.08 0.466 . . . . 74.02 111.583 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -118.65 109.53 16.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.728 -0.471 . . . . 72.54 109.728 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.467 HG21 HD23 ' A' ' 183' ' ' LEU . 6.5 p -103.57 126.47 58.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.101 -0.499 . . . . 75.35 110.528 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.61 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 9.7 m-85 -114.03 156.34 24.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.711 -0.677 . . . . 74.12 109.462 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.521 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 21.3 mt -107.8 116.89 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.838 -0.431 . . . . 75.35 109.838 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 131' ' ' MET . 9.2 p -159.96 159.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.79 -0.186 . . . . 74.32 111.027 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.4 t70 64.98 29.75 12.13 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.533 0.682 . . . . 70.02 110.74 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.735 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 18.9 p90 -100.06 -41.62 7.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 75.55 111.108 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.8 32.9 75.83 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.619 -0.801 . . . . 53.4 111.993 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 352' ' ' LYS . 30.5 mt -131.2 90.31 2.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.249 0.547 . . . . 63.24 110.589 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.28 121.85 9.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 65.11 110.981 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 61.4 t80 -114.34 131.18 56.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.143 -0.688 . . . . 74.54 109.143 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.858 0.361 . . . . 74.32 111.524 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 31.8 t80 -80.81 -40.09 25.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 54.43 109.96 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 10.7 p -125.81 87.8 55.33 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 43.31 110.79 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 18.7 Cg_endo -59.42 113.84 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.624 2.216 . . . . 70.12 111.733 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 63.9 26.63 14.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.828 -0.624 . . . . 75.44 111.373 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.35 -19.8 52.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.749 -0.739 . . . . 64.12 113.123 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.52 114.15 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.091 -0.337 . . . . 62.51 110.091 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -100.38 157.07 16.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.825 -0.35 . . . . 72.14 110.272 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -115.44 -172.91 2.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.516 -0.55 . . . . 74.24 109.516 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -97.83 -164.27 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.198 0.311 . . . . 61.45 110.42 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -60.29 97.88 0.05 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.575 0.702 . . . . 73.14 111.088 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 236' ' ' VAL . 55.2 mtpt -67.42 -53.73 26.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.36 -0.836 . . . . 72.53 112.256 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 37.8 77.94 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.126 0.965 . . . . 72.43 110.359 -164.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.8 135.77 59.25 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.194 -1.366 . . . . 64.55 111.492 -168.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.36 -18.85 66.57 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 123.268 2.646 . . . . 61.43 113.656 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.722 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 1.1 tpmt? -86.16 -8.84 57.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.234 -0.654 . . . . 63.22 109.234 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? 57.46 62.02 2.29 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.442 -0.799 . . . . 64.32 110.22 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.01 55.22 0.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.465 -0.788 . . . . 63.31 112.39 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 51.9 p-80 -67.27 134.37 51.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.481 -0.781 . . . . 65.5 110.047 171.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 202' ' ' TYR . 16.2 p-10 -89.84 -39.63 12.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.087 -0.338 . . . . 71.41 110.087 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . -108.24 -169.41 21.32 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.822 -0.704 . . . . 61.41 113.743 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.574 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 0.7 OUTLIER -90.53 148.77 22.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.963 0.411 . . . . 54.31 110.902 -176.054 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.47 HG12 HG11 ' A' ' 271' ' ' VAL . 13.3 tt -63.64 -24.28 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 113.761 1.022 . . . . 62.45 113.761 -168.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.574 ' OE1' ' HB ' ' A' ' 224' ' ' THR . 0.0 OUTLIER -70.1 -41.43 74.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.288 -0.565 . . . . 65.03 110.878 -172.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.496 ' O ' HG12 ' A' ' 246' ' ' ILE . 29.4 m-85 -101.02 -39.94 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.268 -0.173 . . . . 72.01 111.454 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.6 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 94.0 m -60.29 -14.87 20.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.358 0.503 . . . . 65.54 112.358 -175.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 14.1 m 72.28 -167.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 52.32 111.053 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.5 mp -71.54 -34.42 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.764 -0.458 . . . . 71.54 109.764 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.633 ' O ' HG12 ' A' ' 236' ' ' VAL . 25.2 t70 -44.64 -91.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.479 -1.237 . . . . 70.32 113.279 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.6 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.75 -27.79 69.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.122 -0.361 . . . . 73.24 111.686 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 42.8 t-80 -56.84 -37.27 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 72.3 111.246 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.68 0.5 52.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 71.3 111.49 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.77 8.16 62.3 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.462 -0.875 . . . . 52.04 113.352 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 231' ' ' ASP . 11.9 p -86.96 140.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.979 -0.749 . . . . 44.22 108.979 175.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -68.0 117.19 46.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.471 -0.331 . . . . 72.14 110.131 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.497 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 6.6 Cg_endo -49.25 124.12 11.25 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.635 2.89 . . . . 74.45 112.983 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 t -143.09 93.38 2.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.25 -0.432 . . . . 53.21 111.297 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 59.6 mtt180 75.96 -57.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.604 -0.726 . . . . 73.22 112.052 170.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.752 ' HG3' ' HD1' ' A' ' 311' ' ' TYR . 11.4 mmm-85 -57.38 -54.69 43.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.422 0.153 . . . . 70.43 110.592 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.02 -58.55 9.32 Favored Glycine 0 N--CA 1.448 -0.56 0 O-C-N 123.794 0.684 . . . . 61.41 112.426 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.42 -47.99 47.57 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.11 0.481 . . . . 73.43 111.412 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 64.3 mt -71.78 -45.29 62.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.803 -0.635 . . . . 65.42 111.529 -175.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.96 -39.11 79.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.559 0.219 . . . . 71.34 111.061 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 227' ' ' PHE . 99.0 mt -59.63 -45.85 93.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.066 0.46 . . . . 73.24 110.288 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -65.06 -43.08 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 61.42 110.591 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.36 -42.84 95.85 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.923 -0.656 . . . . 73.2 112.504 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.53 ' CZ ' ' HD2' ' A' ' 275' ' ' LYS . 22.9 m-30 -66.33 -48.43 70.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.491 0.182 . . . . 75.34 111.491 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.4 p -66.8 -40.91 88.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.574 -0.451 . . . . 72.11 111.088 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.47 -45.6 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 63.34 110.896 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.346 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.465 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 48.9 tt0 -71.51 -41.61 69.04 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 121.097 -0.241 . . . . 75.43 110.458 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -66.73 -26.32 66.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 74.24 110.672 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.1 tp -81.18 -41.19 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.776 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.5 p -103.62 -27.26 12.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.391 0.515 . . . . 54.32 112.391 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.7 -59.52 0.36 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.724 -0.75 . . . . 75.22 113.048 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -121.76 144.02 49.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.848 0.356 . . . . 72.23 110.963 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 94.8 mt -105.7 145.12 30.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 75.52 110.715 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 31.2 Cg_exo -60.62 -31.92 92.73 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.803 2.335 . . . . 40.05 112.291 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 48.0 p90 -96.84 11.09 36.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.41 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 30.5 tt0 -83.18 -42.06 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.162 0.506 . . . . 44.24 110.201 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -88.54 -12.11 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.051 -0.522 . . . . 63.53 109.829 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.17 10.1 25.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.748 -0.66 . . . . 75.44 111.907 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 3.7 pp -70.86 -7.31 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.178 0.513 . . . . 74.11 110.916 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.45 -13.07 60.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.794 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.9 t70 -124.61 122.03 25.78 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 62.2 109.841 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 32.7 Cg_exo -62.69 -30.59 78.74 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.987 2.458 . . . . 74.52 113.375 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.571 ' HZ2' ' HB2' ' A' ' 269' ' ' LYS . 0.0 OUTLIER -76.45 -38.06 56.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.061 -0.348 . . . . 73.44 110.061 -176.848 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.51 -49.13 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.899 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.724 ' O ' ' HG2' ' A' ' 275' ' ' LYS . 38.0 t -55.88 -50.99 65.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.599 0.238 . . . . 73.13 110.997 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -61.14 -50.41 73.31 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.262 -0.426 . . . . 64.51 111.182 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 32.1 t70 -61.37 -45.6 93.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 74.33 111.082 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.9 m -61.31 -32.76 72.62 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.719 -0.219 . . . . 50.53 111.49 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 35.2 mmtp -60.27 -49.46 77.53 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.189 -0.671 . . . . 65.31 109.189 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.64 -33.1 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.213 -0.903 . . . . 72.4 110.968 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 16.5 mmm180 -62.66 -40.27 96.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.672 -0.24 . . . . 43.04 111.041 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 278' ' ' TYR . 2.9 m-85 -74.06 -33.99 63.87 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.513 -0.475 . . . . 72.41 110.942 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -66.74 -20.96 66.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.467 -0.333 . . . . 73.2 110.957 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -49.64 -56.9 8.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.866 -0.607 . . . . 74.12 110.759 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -150.31 75.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.82 -0.807 . . . . 63.01 108.82 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -53.47 -37.19 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.793 -1.094 . . . . 65.55 113.232 -171.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.585 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -61.41 -49.0 78.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.013 -0.275 . . . . 64.41 111.676 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 m -78.07 -39.09 42.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.733 0.302 . . . . 74.11 111.114 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.76 -46.26 90.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 74.31 111.192 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.26 -29.03 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 60.41 110.805 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 17.1 t70 -62.32 -31.38 72.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 71.43 110.169 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 288' ' ' LYS . 9.2 mtpm? -83.61 -21.63 32.5 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.891 -0.595 . . . . 62.13 111.735 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.01 -38.63 86.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.657 0.265 . . . . 62.5 111.264 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 5.4 t80 -135.81 79.49 45.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.765 -0.374 . . . . 64.35 110.486 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.59 19.71 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.113 2.542 . . . . 73.53 111.918 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 33.8 mt-10 -87.48 35.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.877 -0.601 . . . . 74.55 111.42 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 68.82 10.06 7.7 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.548 0.944 . . . . 72.33 113.548 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 27.0 t-20 -82.09 -81.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.875 -0.417 . . . . 73.21 109.875 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 2.0 tpmt? 168.22 107.72 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.141 0 O-C-N 123.59 0.557 . . . . 74.32 109.757 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -102.34 39.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.667 2.911 . . . . 74.23 111.881 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.16 -38.27 2.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.527 -0.844 . . . . 54.21 113.334 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.463 ' HB3' HD23 ' A' ' 324' ' ' LEU . 2.8 mp0 -59.14 -53.64 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.43 . . . . 51.13 110.51 -176.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.67 -37.77 80.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.604 -0.725 . . . . 75.44 110.323 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.36 -52.5 64.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 71.31 111.31 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 301' ' ' LYS . 21.8 ttmt -70.69 -31.98 69.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.916 0.389 . . . . 74.52 110.538 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.416 ' O ' HG13 ' A' ' 306' ' ' VAL . 64.6 t80 -57.95 -48.97 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 73.4 110.217 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.551 ' HA ' HG22 ' A' ' 306' ' ' VAL . 87.4 mtp -72.48 -32.61 66.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 62.03 111.274 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.47 -37.67 78.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.841 0.829 . . . . 74.34 108.878 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.489 HG21 HD21 ' A' ' 320' ' ' LEU . 60.7 m -69.06 -42.59 76.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.632 -1.167 . . . . 54.45 111.455 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 303' ' ' MET . 5.5 m -70.55 -26.94 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.882 0.372 . . . . 75.04 110.578 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.44 -48.72 76.59 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.53 . . . . 74.31 110.215 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 308' ' ' LEU . 3.3 tt -68.5 -25.54 65.01 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.471 -0.786 . . . . 74.33 110.046 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -62.52 -18.84 62.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.519 -0.764 . . . . 73.34 111.878 -176.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.6 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.391 0.432 . . . . 74.22 110.294 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.752 ' HD1' ' HG3' ' A' ' 241' ' ' ARG . 3.9 m-30 -136.75 -43.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 71.02 110.402 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.4 t -136.92 20.61 3.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 73.12 112.205 -168.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -88.83 50.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.638 -0.664 . . . . 74.43 112.277 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER 58.97 94.22 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.196 -0.911 . . . . 70.24 113.456 170.205 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.4 121.4 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.786 2.324 . . . . 64.44 111.802 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.2 mt -84.96 99.08 10.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.824 0.345 . . . . 73.52 110.366 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -61.64 -45.03 95.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.942 -0.572 . . . . 73.23 111.765 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.0 -0.37 . . . . 54.15 110.0 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.29 -36.5 84.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 73.32 110.336 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 323' ' ' ILE . 77.2 mt -60.68 -48.7 80.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 65.2 110.982 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.805 ' HD2' ' HG ' ' A' ' 159' ' ' LEU . 32.8 ptt180 -74.2 -20.88 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.841 -0.744 . . . . 73.2 110.772 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.94 -39.88 79.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.716 -0.22 . . . . 54.35 110.818 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.2 pp -72.18 -30.23 35.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.791 -0.448 . . . . 54.12 109.791 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.63 -49.31 63.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 64.32 110.279 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.763 HD11 HD21 ' A' ' 159' ' ' LEU . 88.8 mt -64.86 -29.24 70.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.055 -0.521 . . . . 51.33 110.66 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -63.96 -47.48 80.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.607 . . . . 74.51 110.497 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.65 -30.65 76.68 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 72.43 111.942 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.734 HD22 ' HG ' ' A' ' 155' ' ' LEU . 56.4 tp -72.8 -50.59 23.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 72.3 110.835 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -73.83 -14.02 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.311 -0.404 . . . . 74.34 110.696 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.98 -23.61 67.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.499 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.2 tt -97.17 -6.8 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 60.44 110.113 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.71 24.02 34.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.856 -0.688 . . . . 72.21 113.208 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.8 m -123.36 158.62 30.67 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.455 -0.438 . . . . 42.51 110.595 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -156.45 176.73 12.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.439 -0.346 . . . . 75.31 110.135 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.23 -36.07 18.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.721 -0.474 . . . . 71.55 109.721 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.8 t70 75.14 16.92 2.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.091 -0.959 . . . . 62.22 110.88 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.51 39.08 50.97 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.934 -0.866 . . . . 41.11 110.934 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 191' ' ' ASP . 39.0 ttmt -156.5 109.17 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.397 -0.402 . . . . 75.44 110.343 -175.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 156' ' ' GLN . 45.3 mt -78.97 92.93 5.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.689 0.757 . . . . 63.53 110.11 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.88 63.93 6.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.637 -1.246 . . . . 74.04 107.637 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 141' ' ' ILE . 8.9 tp -72.5 -80.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.912 -1.494 . . . . 62.04 111.066 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.6 m 170.26 -162.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.373 -1.285 . . . . 74.53 108.268 -168.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.89 115.12 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.08 0.467 . . . . 51.34 110.163 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.679 HG23 ' HB3' ' A' ' 140' ' ' LYS . 2.6 p -80.14 -49.58 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.819 -0.628 . . . . 71.45 110.827 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 345' ' ' GLU . 3.8 tp10 50.52 45.82 26.15 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.61 -0.723 . . . . 74.41 112.068 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 73.31 130.63 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.803 0.811 . . . . 52.2 113.015 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 140' ' ' LYS . . . -137.47 -70.03 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.311 -0.859 . . . . 61.42 111.325 170.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 84.34 -71.48 2.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.521 -0.371 . . . . 74.1 112.894 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 139' ' ' GLN . 8.8 mp 63.72 -92.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.23 0.612 . . . . 64.21 111.834 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -165.82 164.26 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 70.21 111.227 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . 0.544 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . . . -137.43 -156.64 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 45.25 110.365 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.822 ' HB3' HD21 ' A' ' 200' ' ' LEU . 35.2 tptt -138.13 -158.91 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 10.3 t -155.87 169.73 23.72 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.513 0.197 . . . . 72.42 110.71 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.517 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -69.22 144.06 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.698 0.629 . . . . 65.13 112.698 -172.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 11.4 t -92.07 132.83 36.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.188 -0.914 . . . . 62.55 110.001 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -170.41 -88.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.492 0.187 . . . . 73.43 110.613 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 57.5 tttp 177.71 95.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.442 -0.577 . . . . 71.33 109.442 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 358' ' ' ARG . 40.0 mtt180 -84.78 87.9 7.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.306 0.574 . . . . 73.14 109.974 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 360' ' ' LYS . 1.0 OUTLIER -112.68 -20.44 11.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.372 -0.831 . . . . 74.1 110.768 -173.998 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 359' ' ' LYS . 39.2 mttm . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.604 -0.712 . . . . 74.42 109.654 -168.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.6 mpp? . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.0 -0.37 . . . . 64.31 110.0 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 20.2 Cg_exo -65.26 139.05 58.46 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.682 2.255 . . . . 64.12 112.484 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -102.42 116.69 33.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.0 -0.741 . . . . 75.22 109.0 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.58 130.45 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.54 0.57 . . . . 64.43 112.54 -170.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -123.71 90.36 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.702 -0.681 . . . . 65.41 109.681 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.01 105.37 2.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.588 0.233 . . . . 65.52 110.924 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.5 113.59 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 53.1 110.571 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -132.05 140.76 48.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.819 0.342 . . . . 72.44 110.276 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.83 36.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.155 -0.475 . . . . 50.2 110.977 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.01 64.25 0.27 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.025 -0.607 . . . . 72.44 112.841 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -134.44 149.87 50.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 73.34 110.363 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.14 137.3 39.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 74.41 110.337 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -83.54 136.81 34.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.925 -0.579 . . . . 50.43 110.368 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 m -153.12 148.15 26.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.648 -0.251 . . . . 73.03 110.439 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.67 ' H ' ' HG3' ' A' ' 36' ' ' GLU . . . -72.99 140.23 47.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 71.24 110.926 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.23 -49.3 7.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 60.14 111.472 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -152.81 178.53 9.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.011 0.434 . . . . 72.53 111.343 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.613 ' CD2' ' HB3' ' A' ' 27' ' ' GLU . 19.7 t-80 -90.4 123.37 34.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.578 -0.737 . . . . 73.03 109.909 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.713 HD13 ' HD2' ' A' ' 38' ' ' LYS . 11.3 mp -85.43 164.48 17.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 65.12 109.942 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.11 129.26 39.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.84 0.352 . . . . 54.34 111.057 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.684 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 9.8 tp10 -150.09 -88.77 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 71.2 109.707 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 49.2 tt0 163.63 -39.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.814 0.696 . . . . 74.42 110.506 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -95.93 -50.8 4.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.956 0.725 . . . . 74.44 112.956 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . 173.35 -17.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.076 0.465 . . . . 74.52 110.434 -167.274 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.684 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 46.6 t -60.78 127.22 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.259 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . 99.04 -1.79 57.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.765 -0.731 . . . . 62.24 114.125 175.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -110.82 -177.08 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.173 0.987 . . . . 73.14 112.312 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' GLU . 3.2 mp -107.49 138.53 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.376 0.88 . . . . 73.44 113.376 -162.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.06 126.64 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.148 -0.933 . . . . 72.45 109.593 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -103.7 136.53 43.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.1 0.778 . . . . 74.4 113.1 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.823 ' HB3' ' CZ2' ' A' ' 37' ' ' TRP . 10.9 p30 -88.39 -179.44 6.1 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 64.31 110.758 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.52 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -71.16 -9.72 58.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 71.45 111.774 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.18 6.82 46.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 71.1 110.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 52.5 mmtt 68.82 23.79 6.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.347 -0.842 . . . . 73.04 111.684 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.679 ' HZ1' ' HB3' ' A' ' 114' ' ' TRP . 40.4 ttpt -90.67 114.49 26.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.453 -0.943 . . . . 61.43 108.453 171.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.67 ' HG3' ' H ' ' A' ' 15' ' ' ALA . 6.0 pt-20 -92.51 102.0 14.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.734 -0.666 . . . . 70.35 110.791 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.823 ' CZ2' ' HB3' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -80.27 147.08 31.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 64.42 109.689 -177.173 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.713 ' HD2' HD13 ' A' ' 19' ' ' LEU . 28.1 ttpp -106.06 119.45 39.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.753 -0.462 . . . . 74.22 109.753 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.99 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.665 . . . . 42.15 111.27 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -109.2 -129.43 5.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.49 -0.644 . . . . 35.24 111.49 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 mm? -76.08 141.85 71.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.686 0.279 . . . . 74.34 111.134 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_endo -86.97 120.43 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.245 2.63 . . . . 72.31 111.775 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 53' ' ' LEU . 3.8 mp -96.57 -54.82 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.407 . . . . 61.01 110.622 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 97.74 162.99 31.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.828 -0.701 . . . . 71.02 111.491 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.75 ' HB2' HG12 ' A' ' 51' ' ' ILE . 27.6 tp60 -133.56 128.59 35.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.987 0.394 . . . . 73.31 110.175 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.58 108.6 2.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.617 -0.802 . . . . 25.21 112.418 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -16.14 46.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.906 -0.664 . . . . 63.04 112.291 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.679 ' CE2' ' HA ' ' A' ' 198' ' ' TYR . 21.2 m-85 -113.38 -59.39 2.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.736 0.303 . . . . 72.35 110.318 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.72 -105.59 0.22 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.8 -0.714 . . . . 64.32 112.562 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.667 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 49.8 t -142.05 142.0 32.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 75.11 110.596 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.75 HG12 ' HB2' ' A' ' 45' ' ' GLN . 27.4 mm -121.74 136.88 57.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.25 144.66 35.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.755 0.312 . . . . 55.44 110.643 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 69' ' ' VAL . 57.9 tp -84.37 152.04 24.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.364 -0.606 . . . . 61.03 109.364 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.38 104.4 12.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.827 0.346 . . . . 64.23 111.056 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.1 -35.18 42.73 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.11 -0.7 . . . . 71.25 109.11 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.822 ' SD ' ' HA ' ' A' ' 37' ' ' TRP . 13.8 tpt 69.54 -70.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.482 -1.235 . . . . 73.2 113.194 171.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -139.32 104.9 5.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.176 0.512 . . . . 64.15 111.159 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -83.61 40.01 0.71 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 64.51 111.52 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 m -104.45 -75.73 0.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 75.43 110.799 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.36 -1.88 22.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 61.13 110.049 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 t 62.85 77.87 0.31 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.547 -0.751 . . . . 65.3 109.198 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 64' ' ' SER . 4.4 p -60.4 129.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.058 -0.973 . . . . 64.12 111.365 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.03 23.49 5.19 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 116.057 -0.52 . . . . 65.34 113.276 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.488 ' H ' HG22 ' A' ' 62' ' ' VAL . 22.2 m -121.02 -77.76 0.59 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.935 -0.394 . . . . 73.5 109.935 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -90.08 92.07 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.43 -0.35 . . . . 65.11 110.064 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -172.39 -50.36 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.421 -0.809 . . . . 74.23 109.243 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 68.0 Cg_endo -78.37 55.84 5.58 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 121.594 1.529 . . . . 52.35 110.95 169.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 8.6 p -145.51 157.93 43.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.999 -0.546 . . . . 75.21 110.699 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 53' ' ' LEU . 7.2 m -135.34 161.43 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 63.22 110.369 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.583 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 4.9 p -119.75 119.98 61.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.651 0.739 . . . . 72.32 111.934 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 4.8 tptp -79.98 115.97 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.776 -1.102 . . . . 74.43 108.768 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 128' ' ' PHE . 6.9 p -125.7 128.32 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.065 0.46 . . . . 63.43 111.577 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -138.06 152.24 71.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 75.13 109.833 177.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.92 165.8 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.346 2.03 . . . . 60.11 112.302 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.1 m -78.08 69.94 4.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.332 0.587 . . . . 72.15 110.453 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -122.66 7.12 9.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 70.34 110.453 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 67.62 93.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.267 -0.878 . . . . 64.03 110.762 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.63 -154.11 6.14 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.576 -0.738 . . . . 62.55 111.646 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 31.4 Cg_exo -59.15 -35.52 97.62 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.21 2.607 . . . . 73.12 112.553 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.54 -36.37 44.72 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.926 0.766 . . . . 72.4 111.433 -176.598 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -66.57 -49.28 66.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.788 0.328 . . . . 75.42 110.805 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 m -62.71 -48.35 79.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 62.32 111.107 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 8.3 pt-20 -69.35 -33.54 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.166 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.614 HD22 ' HD3' ' A' ' 127' ' ' ARG . 43.7 tp -58.48 -47.48 83.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.003 0.43 . . . . 75.53 110.575 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.39 -36.8 82.03 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.117 -0.492 . . . . 75.41 110.511 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.45 -52.59 64.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.941 -0.572 . . . . 73.13 110.237 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 4.9 m-85 -57.27 -46.89 82.65 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.697 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.95 64.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 74.42 111.337 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -90.52 -26.81 19.57 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.848 0.314 . . . . 73.02 111.848 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.76 17.99 22.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.768 0.318 . . . . 73.4 111.649 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -85.54 164.74 17.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.555 0.576 . . . . 51.14 112.555 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 96' ' ' ILE . 2.8 tppt? 77.88 99.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.847 -1.07 . . . . 75.31 111.09 170.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 11.6 Cg_endo -55.12 -29.16 64.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.441 2.761 . . . . 64.43 113.443 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 4.3 tp10 -55.42 -59.43 4.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 73.3 110.596 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 6.4 tp60 -68.11 -35.6 78.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.966 -0.561 . . . . 74.33 110.449 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' LYS . 73.5 mt -55.45 -49.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 44.02 110.277 177.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -59.52 -42.78 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.456 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.7 mmtt -55.65 -59.59 4.64 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.723 -0.671 . . . . 75.23 112.113 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.91 -34.97 69.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.024 -0.67 . . . . 73.22 111.228 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.647 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.5 mt -59.15 -49.14 84.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 121.095 -0.242 . . . . 74.24 111.199 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -74.63 -35.74 62.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 74.14 111.267 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.7 m -72.63 -39.78 66.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.799 0.333 . . . . 54.13 111.226 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -87.89 7.08 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.462 -0.335 . . . . 72.13 111.848 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 71.07 29.49 2.91 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.423 0.452 . . . . 71.34 112.138 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.05 -169.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.799 -0.445 . . . . 72.31 109.799 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 26.5 mmtm -115.36 -62.76 1.55 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.845 -0.428 . . . . 75.25 109.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 100' ' ' ILE . 37.6 p90 -174.85 138.56 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.442 0.464 . . . . 61.41 110.503 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' A' ' 100' ' ' ILE . 72.8 mt -79.24 118.57 21.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.178 -0.464 . . . . 72.03 109.844 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.503 ' HA3' ' CZ ' ' A' ' 160' ' ' ARG . . . -79.03 54.87 4.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.383 -0.913 . . . . 75.1 111.817 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.59 149.96 39.02 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.905 -0.406 . . . . 71.35 109.905 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.74 ' HB3' ' HE2' ' A' ' 134' ' ' PHE . 21.0 Cg_exo -66.08 144.72 76.78 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.26 1.973 . . . . 64.41 111.923 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 16.0 tttp -70.74 118.26 13.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 65.53 110.56 -176.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.498 ' CD1' ' HD2' ' A' ' 87' ' ' TYR . 66.4 t80 -95.23 120.68 35.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 75.45 110.926 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.679 ' HB3' ' HZ1' ' A' ' 35' ' ' LYS . 80.0 m95 -98.92 -51.31 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 75.13 110.769 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -169.0 172.61 43.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.864 -0.607 . . . . 73.11 112.134 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.622 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 34.2 p -160.3 157.37 27.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.196 -0.298 . . . . 74.02 110.196 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.25 -177.92 46.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.572 -0.823 . . . . 42.31 112.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.5 tt -126.15 134.37 51.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.858 0.361 . . . . 75.01 110.206 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.573 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . 56.3 t60 -140.88 118.23 11.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.465 -0.568 . . . . 74.33 109.465 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.3 t70 -67.45 129.77 40.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.89 -0.595 . . . . 63.51 110.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 84.7 tttt -134.85 122.67 22.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.234 -0.439 . . . . 75.45 110.022 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 22.1 m120 66.73 15.95 10.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.063 -0.517 . . . . 72.44 111.522 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 -2.01 61.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.559 -0.829 . . . . 65.3 112.052 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 61.12 109.667 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.9 m -76.37 104.88 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 72.44 110.658 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -93.95 136.54 34.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.565 -0.743 . . . . 73.21 110.492 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.614 ' HD3' HD22 ' A' ' 84' ' ' LEU . 36.2 ttm180 -112.28 124.29 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.7 p90 -126.9 160.23 31.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 72.55 111.943 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.622 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 30.3 ttp -145.19 135.87 24.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.373 -0.83 . . . . 75.22 110.28 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.577 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 3.6 mm -96.99 128.34 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 62.34 111.539 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.6 ptp -122.59 167.78 12.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.996 -1.002 . . . . 74.1 108.976 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 11.0 t70 -72.53 152.03 42.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.96 -0.756 . . . . 71.03 108.96 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HD3' HG13 ' A' ' 69' ' ' VAL . 27.7 tpt180 -76.59 102.07 5.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.817 0.818 . . . . 75.1 112.05 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.74 ' HE2' ' HB3' ' A' ' 111' ' ' PRO . 8.9 m-85 -102.69 141.85 34.81 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.253 -1.388 . . . . 62.34 107.253 168.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.66 10.5 0.81 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.4 -1.381 . . . . 43.54 113.41 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.926 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 16.2 m -113.73 123.39 49.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.803 -0.814 . . . . 71.41 108.803 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.937 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 2.3 m-20 -105.03 129.51 53.45 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 121.151 -0.22 . . . . 62.23 110.412 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.35 -24.02 67.5 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.431 -0.508 . . . . 74.2 109.677 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.937 ' HG2' ' HB3' ' A' ' 137' ' ' ASP . 28.0 pt20 -70.68 -37.12 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 51.45 110.413 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 63.1 mttp -70.94 -35.05 72.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.9 0.381 . . . . 73.42 110.202 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 341' ' ' LEU . 1.8 mp -74.52 -31.03 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.278 -0.419 . . . . 63.33 110.512 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 147' ' ' LYS . 40.0 t80 -52.74 -53.72 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.686 -0.688 . . . . 70.35 111.886 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -99.57 -1.75 37.45 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 63.05 111.245 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.94 -32.87 15.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.37 . . . . 71.43 110.542 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -0.65 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.45 -0.574 . . . . 73.22 109.45 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 147' ' ' LYS . . . 55.29 36.69 27.59 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.659 -0.701 . . . . 65.32 111.226 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 142' ' ' TYR . 29.8 mtmt 72.57 93.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.551 -0.749 . . . . 72.15 112.46 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.3 tpp85 -143.69 97.64 3.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.865 -1.061 . . . . 70.42 109.244 173.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -119.64 153.81 34.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 75.42 110.234 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 m -101.28 175.44 5.58 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.634 -0.506 . . . . 40.34 109.634 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 328' ' ' LEU . 21.8 ttm180 -67.32 -37.13 82.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.347 -0.141 . . . . 74.34 111.084 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 335' ' ' ASP . 2.1 tmtp? -55.98 -46.99 78.5 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.319 -0.252 . . . . 73.24 110.319 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.501 ' HA ' HD22 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -58.26 -48.1 81.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.846 0.355 . . . . 54.22 111.195 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.25 -42.07 90.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.312 -0.404 . . . . 44.24 110.771 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.32 -52.64 21.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 52.34 111.182 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -63.72 -44.04 94.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.539 0.209 . . . . 71.04 110.838 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 161' ' ' ILE . 10.9 mp -64.64 -41.87 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 62.43 110.755 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -59.35 -49.54 77.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.6 0.238 . . . . 75.11 110.531 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 325' ' ' LEU . 8.8 mp -58.47 -50.72 72.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.403 -0.362 . . . . 62.3 111.752 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -66.08 -21.9 66.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 72.4 111.222 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 157' ' ' LEU . 23.6 mm -69.66 -40.91 79.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 109.72 -0.474 . . . . 75.22 109.72 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.76 -47.5 86.03 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.984 0.178 . . . . 72.45 110.784 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.41 -56.37 13.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.9 0.381 . . . . 75.51 111.419 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.485 HG21 HH21 ' A' ' 160' ' ' ARG . 11.3 tt -68.72 -35.86 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.418 -0.355 . . . . 74.14 111.05 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.576 HD13 ' CD2' ' A' ' 175' ' ' HIS . 68.5 tp -67.28 -38.5 85.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.547 -0.297 . . . . 61.32 111.488 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 27.8 mm-40 -76.63 -28.83 56.22 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.592 -0.443 . . . . 64.31 110.204 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -60.32 -48.71 80.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.357 . . . . 73.21 110.391 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 173' ' ' TYR . 18.5 pt -72.49 -31.97 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 73.11 110.957 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 23.6 m170 -64.84 -38.05 89.67 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.982 0.176 . . . . 73.4 111.06 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.1 -6.17 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.012 0.434 . . . . 71.13 111.137 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -100.65 -85.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.217 -0.66 . . . . 53.11 109.217 170.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 15.0 pt-20 -169.44 1.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 71.35 111.746 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' A' ' 168' ' ' ILE . 39.2 m-85 -106.19 158.09 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.178 0.513 . . . . 72.52 111.719 -165.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.72 168.55 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.876 -1.056 . . . . 75.33 108.561 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.576 ' CD2' HD13 ' A' ' 165' ' ' LEU . 8.4 p80 -102.94 121.37 42.38 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.447 -0.501 . . . . 72.12 110.645 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 -39.14 95.24 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.768 -0.73 . . . . 74.13 112.731 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.4 t70 -135.06 127.85 31.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 70.14 111.976 -175.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.713 ' HB ' HG22 ' A' ' 246' ' ' ILE . 32.2 mm -111.88 124.72 68.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.311 -0.996 . . . . 64.22 108.311 167.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -166.08 167.64 16.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.645 -0.502 . . . . 71.21 109.645 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.54 -19.16 63.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 41.34 110.946 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.684 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 3.1 p -75.1 -21.07 59.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 54.43 111.963 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.517 ' HA ' HG12 ' A' ' 196' ' ' VAL . 2.0 p30 -110.79 12.51 22.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 72.44 111.733 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.2 mt -113.47 114.4 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.293 -0.412 . . . . 70.42 110.586 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.31 138.74 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 72.24 110.86 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.926 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 39.3 mt -95.18 154.02 17.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.105 -0.702 . . . . 72.33 109.105 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.444 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 27.5 t-20 -59.44 147.56 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.477 -0.564 . . . . 73.2 109.477 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.421 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 10.7 p90 -60.91 -25.59 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -120.41 -26.3 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.007 0.373 . . . . 65.41 112.007 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.517 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 4.9 t30 -112.1 115.01 50.79 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.573 -0.451 . . . . 45.03 111.106 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 7.6 Cg_exo -72.99 -29.83 11.56 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.299 2.666 . . . . 43.2 114.413 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.664 ' HA ' HD12 ' A' ' 339' ' ' LEU . 8.3 p-10 -88.27 13.7 10.99 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.514 -0.474 . . . . 65.21 111.53 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.519 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 18.9 mm-40 -112.92 94.98 5.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 71.42 109.992 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 157' ' ' LEU . 6.4 p -104.99 126.54 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 74.21 111.2 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 45.1 m-85 -128.75 158.98 37.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.631 . . . . 75.2 110.238 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' A' ' 160' ' ' ARG . 8.3 mp -83.34 147.21 28.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.244 -0.28 . . . . 74.11 110.244 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 182' ' ' ASN . 14.7 p -83.79 148.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.309 -0.405 . . . . 61.22 110.618 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.0 88.0 0.15 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.721 0.772 . . . . 72.14 110.422 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.679 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -105.72 -9.38 17.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.803 -1.09 . . . . 75.34 111.303 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 57.55 16.96 24.57 Favored Glycine 0 C--O 1.223 -0.555 0 CA-C-N 115.904 -0.589 . . . . 41.14 112.726 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 353' ' ' THR . 0.5 OUTLIER -91.9 49.1 1.5 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.674 0.749 . . . . 55.02 110.238 -174.077 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -119.87 110.4 16.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.41 -0.814 . . . . 42.43 110.169 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -98.27 -174.54 2.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.833 -1.173 . . . . 63.34 107.833 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.475 ' HD2' ' OE1' ' A' ' 172' ' ' GLU . 36.8 ptt180 -131.29 133.52 45.47 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.683 -0.636 . . . . 62.34 111.675 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -93.59 -17.51 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.309 -0.86 . . . . 71.43 110.169 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 40.4 m -128.6 76.0 79.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.254 -0.43 . . . . 71.42 110.884 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 203' ' ' ARG . 91.5 Cg_exo -45.35 103.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.182 2.588 . . . . 74.44 113.263 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 61.81 28.73 17.64 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.325 -0.852 . . . . 63.21 111.301 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.42 -15.68 45.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 51.24 113.078 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.28 110.53 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 O-C-N 122.409 -0.465 . . . . 75.2 109.938 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 14.9 p-80 -63.8 127.45 31.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 75.11 110.399 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 214' ' ' LYS . 37.6 tptt -103.14 142.99 33.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.798 -0.637 . . . . 63.34 110.114 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -81.68 -169.3 2.26 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.166 -0.309 . . . . 62.33 110.166 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.738 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 69.1 t80 -64.1 91.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.431 -0.581 . . . . 61.44 109.431 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.547 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 22.2 tptm -156.0 16.09 0.35 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.163 -0.472 . . . . 70.24 110.517 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 237' ' ' ALA . 35.0 tt0 -72.51 -66.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.924 0.392 . . . . 65.34 110.486 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -140.52 140.35 22.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.787 -0.449 . . . . 73.14 109.787 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 3.3 Cg_endo -47.35 -51.06 10.14 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.206 2.604 . . . . 74.43 113.451 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 217' ' ' PRO . 32.1 mmtm -160.12 5.67 0.08 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.291 0.478 . . . . 74.01 112.291 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.45 ' NH2' ' HB2' ' A' ' 357' ' ' LYS . 7.3 ttp85 -113.36 37.56 3.16 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.508 0.671 . . . . 72.32 110.567 -171.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.492 ' HB2' ' HA2' ' A' ' 235' ' ' GLY . 41.0 t -71.13 -86.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.855 -0.528 . . . . 71.03 110.117 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.402 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 21.3 m-70 53.82 40.79 31.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 75.43 110.881 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.24 -48.47 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.204 0.315 . . . . 70.45 110.985 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -99.8 -166.85 29.45 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.862 -0.685 . . . . 44.14 112.087 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.9 p -70.38 143.9 51.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 75.51 111.062 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 271' ' ' VAL . 0.3 OUTLIER -64.8 -20.66 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.644 0.735 . . . . 65.42 109.546 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.414 ' HG2' HD21 ' A' ' 265' ' ' LEU . 19.4 mt-10 -61.58 -48.43 80.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.02 -0.991 . . . . 71.3 111.475 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.1 m-85 -111.77 -15.83 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -169.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 232' ' ' ALA . 1.1 p -54.39 -27.07 34.1 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.652 0.982 . . . . 70.4 113.652 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.553 ' HB2' ' HE2' ' A' ' 249' ' ' TYR . 15.3 t 64.43 -159.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.337 0.398 . . . . 72.43 110.418 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 3.3 mp -67.33 -45.65 85.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.613 -0.267 . . . . 73.13 110.981 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -74.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.722 0.638 . . . . 74.55 112.722 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 228' ' ' THR . . . -67.88 -27.59 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.01 112.163 -172.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.624 -0.262 . . . . 75.54 110.976 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 2.7 t30 -82.56 -36.64 26.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.641 -0.254 . . . . 45.03 110.882 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 144.5 9.3 0.37 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 119.794 -1.194 . . . . 61.42 114.121 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.738 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 12.1 p -122.41 139.58 48.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 117.374 0.587 . . . . 43.11 110.547 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 215' ' ' GLU . . . -55.14 148.93 27.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 64.1 110.575 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.33 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.833 2.356 . . . . 64.03 111.489 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.6 p -79.16 -72.36 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.768 0.794 . . . . 70.34 110.767 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -42.51 0.09 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.832 -1.544 . . . . 74.33 106.832 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 48.8 ttt-85 -58.23 -70.2 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.51 -1.677 . . . . 72.01 111.174 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.716 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -62.99 -36.38 93.38 Favored Glycine 0 C--O 1.223 -0.543 0 CA-C-N 115.821 -0.627 . . . . 72.3 112.886 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.0 -50.54 66.38 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.261 0.553 . . . . 71.43 110.475 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.62 -30.7 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.531 -0.758 . . . . 43.35 111.02 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 279' ' ' ARG . 39.2 mt-10 -66.1 -39.22 89.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.049 -0.26 . . . . 73.11 110.716 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.6 mt -58.2 -47.33 87.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.124 0.488 . . . . 74.14 109.814 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.13 -43.62 98.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.729 -0.669 . . . . 73.11 110.26 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.18 96.44 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.979 -0.555 . . . . 54.11 112.769 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.553 ' HE2' ' HB2' ' A' ' 229' ' ' SER . 19.3 m-85 -59.04 -41.33 87.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 73.45 110.518 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.5 m -62.73 -45.09 94.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.573 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 90.4 mtp -59.66 -50.26 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 63.0 111.47 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -66.07 -36.62 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 121.01 -0.276 . . . . 72.32 110.392 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -62.57 -42.88 99.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 74.05 110.983 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -64.04 -38.9 92.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 72.05 111.145 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.5 tp -81.11 -30.33 34.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.446 0.536 . . . . 64.3 112.446 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 290' ' ' PHE . 76.6 p -103.45 -28.82 11.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.388 -0.525 . . . . 65.43 111.828 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 147' ' ' LYS . . . 76.3 14.27 82.51 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.101 -0.571 . . . . 61.14 113.019 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -150.68 149.93 30.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.349 0.575 . . . . 74.54 112.05 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 95.6 mt -129.82 139.44 35.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 55.11 108.87 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.646 ' HG2' ' HE1' ' A' ' 278' ' ' TYR . 25.0 Cg_exo -65.25 -9.92 23.88 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.678 2.252 . . . . 54.12 113.044 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.596 ' HB2' HG12 ' A' ' 271' ' ' VAL . 38.6 p90 -118.98 28.16 8.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.122 0.416 . . . . 61.15 112.122 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 55.0 mt-10 -66.78 -51.22 58.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.191 0.52 . . . . 62.15 110.825 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.74 -27.69 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.701 -0.681 . . . . 73.14 110.687 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 270' ' ' TYR . 79.5 m-20 -98.58 12.99 33.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.739 -0.664 . . . . 74.22 111.01 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.425 HD23 ' HD1' ' A' ' 261' ' ' TRP . 3.0 tm? -58.94 -39.18 80.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.016 0.436 . . . . 60.51 111.183 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -78.84 11.34 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.048 -0.524 . . . . 64.24 111.737 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -125.99 106.01 25.64 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.282 -0.636 . . . . 53.42 109.282 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 271' ' ' VAL . 20.8 Cg_endo -60.54 -23.09 74.49 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.027 2.485 . . . . 70.32 113.385 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -74.03 -46.89 40.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.946 -0.39 . . . . 70.42 109.946 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 16.2 m-30 -67.21 -41.78 85.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.836 -0.62 . . . . 71.11 110.822 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 261' ' ' TRP . 17.1 m -64.69 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.765 0.317 . . . . 71.15 110.216 177.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 276' ' ' ILE . 53.0 ttt-85 -66.55 -48.5 69.48 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.241 -0.436 . . . . 53.03 110.495 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.0 -40.77 90.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.354 -0.385 . . . . 72.32 110.694 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 35.2 m -61.82 -41.85 98.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.951 -0.568 . . . . 70.0 110.97 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 229' ' ' SER . 68.2 mttm -63.92 -37.63 88.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 72.43 110.288 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.1 mt -65.54 -38.76 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 73.01 110.581 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.489 ' HA ' ' OE2' ' A' ' 280' ' ' GLU . 0.3 OUTLIER -62.27 -40.49 96.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.904 0.383 . . . . 74.24 110.453 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.646 ' HE1' ' HG2' ' A' ' 260' ' ' PRO . 28.0 m-85 -66.76 -29.89 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 73.34 110.751 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.45 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -81.54 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 64.52 111.211 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.489 ' OE2' ' HA ' ' A' ' 277' ' ' ARG . 49.4 mt-10 -79.88 -71.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.1 0.476 . . . . 70.34 110.222 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.91 94.45 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.913 -0.585 . . . . 63.32 109.626 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 282' ' ' ILE . 3.9 mp -67.07 -51.99 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.432 -0.349 . . . . 74.13 110.468 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.94 84.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 74.21 111.399 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.2 m -61.65 -45.94 91.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.339 -0.391 . . . . 73.52 111.183 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 289' ' ' CYS . 3.9 mm? -65.88 -44.47 85.25 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.307 -0.406 . . . . 64.14 111.184 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.5 mmt -67.13 -43.46 82.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 71.53 111.243 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.66 -45.37 77.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 73.44 110.939 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.65 5.2 51.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.013 -0.54 . . . . 53.42 111.603 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 48.8 t -85.19 -43.79 13.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.014 -0.736 . . . . 54.01 109.014 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.672 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 53.4 t80 -129.44 78.94 74.87 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.672 -0.695 . . . . 62.23 109.895 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -94.48 36.74 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.354 2.703 . . . . 64.2 111.903 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.44 -166.81 1.69 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.543 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.96 66.93 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.581 0.705 . . . . 75.35 111.079 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.672 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 46.6 t30 -167.7 151.5 6.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.56 -1.2 . . . . 71.12 107.761 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -107.26 112.29 62.88 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.288 -0.565 . . . . 72.41 110.718 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.08 109.21 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.473 2.115 . . . . 74.41 110.978 172.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -136.96 -40.72 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.512 -0.852 . . . . 64.34 111.631 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.569 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 0.7 OUTLIER -63.87 -61.3 2.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 72.33 109.952 -178.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.508 HG21 ' HB ' ' A' ' 252' ' ' ILE . 3.5 mp -62.21 -40.12 86.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.486 -0.779 . . . . 63.42 110.56 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.11 -54.21 49.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.635 . . . . 72.1 111.479 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -69.1 -39.88 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.127 -0.229 . . . . 74.52 111.16 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 306' ' ' VAL . 44.8 t80 -56.33 -53.39 57.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 74.14 110.546 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 306' ' ' VAL . 62.0 mtp -72.77 -30.58 64.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.88 -0.6 . . . . 64.24 111.635 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.476 ' HA ' HG12 ' A' ' 282' ' ' ILE . 40.9 tt0 -66.63 -45.29 79.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.316 0.579 . . . . 71.42 109.657 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 19.1 m -59.68 -47.32 86.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.225 -0.898 . . . . 73.34 111.67 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 303' ' ' MET . 20.0 m -68.74 -27.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 74.12 111.128 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 7.7 tmtm? -67.29 -33.97 76.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.168 0.509 . . . . 73.42 110.056 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 308' ' ' LEU . 6.0 tt -75.14 -31.26 61.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.598 -0.728 . . . . 72.22 109.976 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 92.9 mt -63.89 -33.86 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 64.52 111.897 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 8.3 t70 60.51 -165.75 0.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.818 -0.438 . . . . 71.42 109.818 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -63.6 -37.61 87.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.579 0.585 . . . . 73.4 112.579 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 m -149.3 74.95 1.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.201 -0.6 . . . . 61.31 112.519 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -118.67 -175.47 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.704 -0.48 . . . . 55.34 109.704 165.851 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 39.5 mttp -86.19 109.38 22.62 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.448 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 4.0 Cg_endo -85.64 119.14 1.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.932 2.421 . . . . 74.23 112.526 -176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.25 85.98 6.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 61.3 110.128 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -65.51 -34.1 77.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.886 -0.597 . . . . 60.34 111.686 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.71 -29.44 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.892 -0.323 . . . . 72.33 110.688 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.73 -45.08 60.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 93.7 mt -56.53 -46.02 80.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.783 -0.644 . . . . 62.43 110.02 174.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -54.34 -50.14 68.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.682 -0.69 . . . . 75.54 110.998 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -37.83 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 44.45 111.847 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.8 pp -72.3 -28.72 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 120.571 -0.452 . . . . 74.13 111.035 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.87 -49.35 62.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.272 0.558 . . . . 62.34 109.629 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 159' ' ' LEU . 4.3 mm? -64.65 -31.15 72.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.584 -0.735 . . . . 74.54 110.618 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -59.74 -47.04 87.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 74.53 109.939 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -61.31 -46.14 95.02 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.756 -0.735 . . . . 72.14 112.072 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 26.8 tp -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.433 0.635 . . . . 65.23 110.558 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 329' ' ' LYS . 34.8 ttpt -65.75 -46.48 78.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.011 -0.995 . . . . 74.21 112.123 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.67 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.623 0.601 . . . . 71.12 112.623 -172.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.69 -7.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.021 0.438 . . . . 75.21 111.363 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 90.18 24.65 28.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.226 -0.988 . . . . 71.35 113.082 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 12.4 p -100.78 138.98 37.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.881 0.372 . . . . 64.22 110.436 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -151.67 80.61 1.28 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.983 -0.553 . . . . 62.54 109.761 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.861 ' HA ' ' HG2' ' A' ' 152' ' ' LYS . 26.2 t0 68.46 111.29 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.053 -0.976 . . . . 61.1 109.782 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -76.8 -7.04 54.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 61.24 111.058 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.93 58.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.268 -0.968 . . . . 61.12 113.152 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt 60.77 36.14 19.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.841 0.312 . . . . 71.31 111.841 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 191' ' ' ASP . 29.1 mt 72.33 110.12 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.467 -0.788 . . . . 74.33 111.464 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.75 96.86 10.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 74.32 109.508 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 141' ' ' ILE . 12.7 tp -160.78 24.96 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.029 -0.532 . . . . 64.24 110.529 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 41.3 m -82.15 87.02 6.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.357 0.598 . . . . 73.21 110.864 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.14 -46.58 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.282 -0.872 . . . . 65.22 108.692 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.406 ' HA ' HD11 ' A' ' 141' ' ' ILE . 23.4 t 31.09 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.936 -1.484 . . . . 72.34 114.016 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.402 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 29.4 tt0 -127.86 -96.21 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.597 -0.441 . . . . 73.04 110.995 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 140' ' ' LYS . 65.6 t30 -166.19 161.9 17.2 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.808 0.277 . . . . 72.41 110.725 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 120.59 174.13 15.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.216 -0.516 . . . . 34.43 112.302 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 139' ' ' GLN . . . 84.02 -1.03 89.25 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.287 -0.482 . . . . 61.52 113.97 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 349' ' ' LEU . 4.3 mm? -64.8 120.39 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.212 0.506 . . . . 64.43 112.007 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -163.1 118.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 65.42 109.814 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.51 174.74 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.551 -0.295 . . . . 64.23 110.79 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 353' ' ' THR . 9.8 tmtt? -164.08 -57.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.736 -0.211 . . . . 74.35 110.635 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.651 ' HA ' ' HG ' ' A' ' 200' ' ' LEU . 0.6 OUTLIER 69.23 179.19 0.24 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.402 1.081 . . . . 61.01 111.655 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -65.45 144.13 15.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.728 0.775 . . . . 65.51 112.847 -172.131 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.9 t -71.96 154.7 41.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.642 -1.163 . . . . 64.05 111.06 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -149.97 146.77 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 74.53 109.727 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.45 ' HB2' ' NH2' ' A' ' 219' ' ' ARG . 29.6 ttpt -138.93 69.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.69 0.281 . . . . 74.42 110.44 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.57 155.64 1.8 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.984 -0.553 . . . . 53.33 110.058 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 359' ' ' LYS . 0.0 OUTLIER -78.46 142.31 37.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.092 0.473 . . . . 41.12 111.489 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 360' ' ' LYS . 29.9 ttpt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.321 -0.847 . . . . 63.52 109.044 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.693 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 87.9 mtp . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 119.475 -0.298 . . . . 53.42 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 87.7 Cg_endo -80.77 142.24 14.04 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.512 1.474 . . . . 61.2 111.622 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -119.59 120.42 36.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.353 -0.385 . . . . 64.44 110.801 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -86.04 147.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.02 -0.537 . . . . 74.32 110.088 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -159.69 134.9 8.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.319 -0.4 . . . . 74.31 110.582 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -173.35 112.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.526 -0.761 . . . . 73.13 109.827 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 76.62 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.199 0.523 . . . . 72.3 110.921 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.38 86.99 2.39 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.315 -0.624 . . . . 71.41 109.315 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.37 119.33 2.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 72.14 110.564 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.21 127.13 1.74 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.421 -0.895 . . . . 45.31 112.596 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 11' ' ' ARG . 3.9 mpt_? -124.22 151.47 44.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.789 0.328 . . . . 75.32 110.597 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -94.98 133.71 38.45 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.629 -0.508 . . . . 74.11 109.629 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -79.79 128.22 33.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.16 -0.473 . . . . 63.03 111.119 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -65.79 113.18 4.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.363 -0.606 . . . . 73.22 109.363 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.71 172.94 11.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.025 0.441 . . . . 44.22 111.536 -173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -68.91 162.17 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 60.42 111.105 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -134.18 139.76 46.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.54 . . . . 70.01 109.982 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 21' ' ' GLU . 3.6 p80 -153.73 133.29 12.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.458 -0.337 . . . . 73.34 110.484 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 19' ' ' LEU . 3.0 pp -77.05 -17.38 58.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 72.43 111.027 -177.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -82.11 63.51 6.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.473 . . . . 74.31 109.901 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 27.5 tt0 -145.11 89.96 2.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.583 -0.735 . . . . 72.4 109.469 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.94 3.78 54.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.559 -0.746 . . . . 75.32 111.439 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 7.46 32.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.353 -0.385 . . . . 74.14 110.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.91 -163.21 1.01 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.233 -0.439 . . . . 73.41 110.121 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.31 143.74 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.46 -0.571 . . . . 73.12 109.46 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 39' ' ' VAL . . . 99.1 2.1 56.98 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.598 -0.811 . . . . 75.41 111.821 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 13.5 pt-20 -74.63 155.43 37.82 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.116 0.484 . . . . 74.03 110.756 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 38' ' ' LYS . 33.3 mm -87.11 118.74 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 72.33 110.191 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.1 137.9 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.889 0.376 . . . . 73.34 110.212 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 10.0 m -86.42 111.54 20.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 65.4 109.954 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HA ' ' A' ' 35' ' ' LYS . 12.0 t70 -111.38 159.57 17.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 71.45 110.272 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.473 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -62.03 -22.56 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.047 0.451 . . . . 71.31 110.134 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.57 23.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 70.24 111.151 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 2.8 tmmt? 74.0 44.88 0.24 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 54.43 110.466 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.617 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 60.0 pttt 45.28 -149.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.858 0.863 . . . . 74.41 112.681 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 53.9 mt-10 69.59 39.37 1.56 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.299 0.64 . . . . 61.32 111.095 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -126.77 121.38 31.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.79 -0.818 . . . . 72.24 108.79 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 23.1 pttp -105.22 131.65 52.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.791 -0.764 . . . . 72.24 110.96 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 26' ' ' GLY . 2.7 p -70.75 129.68 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.488 -0.778 . . . . 70.12 110.499 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.753 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -116.69 -106.28 2.45 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.624 -0.798 . . . . 63.1 113.185 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.0 tm? -62.89 118.3 40.87 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-O 121.15 0.5 . . . . 75.35 110.899 -174.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.904 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.7 Cg_exo -73.78 93.38 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.755 2.303 . . . . 63.21 111.733 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.07 -53.15 27.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.292 0.568 . . . . 73.42 109.618 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.17 -56.38 0.51 Allowed Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.456 -0.793 . . . . 51.31 112.035 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.6 ' HG2' ' HA2' ' A' ' 49' ' ' GLY . 56.4 mt-30 -151.77 130.05 12.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.837 0.351 . . . . 73.12 110.527 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' H ' HD12 ' A' ' 51' ' ' ILE . . . -99.55 26.71 23.33 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.331 -1.108 . . . . 75.23 110.331 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 348' ' ' GLY . . . 113.62 -50.65 0.76 Allowed Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.608 -0.597 . . . . 72.11 111.608 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 79' ' ' PRO . 49.4 t80 -77.22 -76.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.588 0.232 . . . . 61.24 110.405 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 45' ' ' GLN . . . 172.86 150.43 7.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.131 -1.033 . . . . 61.1 113.084 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.9 t 45.66 67.01 0.8 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.989 0.915 . . . . 63.34 112.398 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 46' ' ' GLY . 17.0 mt -123.46 136.46 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 71.15 111.705 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.904 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 73.4 m-85 -129.42 165.9 20.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.393 . . . . 74.3 111.059 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 54' ' ' ALA . 1.3 tm? -90.81 143.12 27.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.067 -0.716 . . . . 74.35 109.067 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.589 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -92.55 75.27 5.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.236 0.541 . . . . 65.53 110.738 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.753 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 8.9 m-20 -79.29 67.47 5.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.652 . . . . 72.01 110.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.606 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 16.0 tpt -82.0 -52.25 7.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.645 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 62' ' ' VAL . 50.7 t-20 -144.39 115.37 7.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.484 . . . . 73.04 110.009 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.8 m -126.2 38.88 4.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 62.04 110.504 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m -71.03 -53.27 15.35 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.49 0.552 . . . . 75.15 112.49 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.26 24.31 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 72.04 112.085 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m 57.96 64.9 1.41 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.767 0.794 . . . . 63.44 108.998 -170.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 65' ' ' ASP . 7.9 m -63.0 141.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.598 -1.183 . . . . 72.51 112.678 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.79 0.9 52.18 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.444 -0.798 . . . . 62.42 112.258 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.5 m -120.49 -49.11 2.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.186 0.439 . . . . 70.33 112.186 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' HB2' HG21 ' A' ' 62' ' ' VAL . 6.1 m-20 -67.13 -63.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.736 0.643 . . . . 72.41 112.736 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -63.24 -43.18 79.62 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 113.839 1.052 . . . . 73.33 113.839 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 58.0 Cg_endo -71.03 33.12 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.136 1.89 . . . . 74.04 113.757 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.5 138.32 54.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.972 0.415 . . . . 74.23 110.22 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 133' ' ' ARG . 15.9 m -114.92 143.22 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.09 -0.505 . . . . 70.33 109.862 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.0 p -117.13 116.09 50.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.88 0.847 . . . . 61.12 110.137 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HD3' ' SD ' ' A' ' 129' ' ' MET . 16.3 ptmt -92.7 128.43 38.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.591 -1.186 . . . . 74.2 109.208 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 6.9 p -135.47 124.26 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 119.542 -0.863 . . . . 61.11 112.816 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 5.6 mm-40 -124.71 171.43 7.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.111 -0.95 . . . . 72.53 108.809 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.61 152.99 51.83 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.905 1.737 . . . . 34.41 111.43 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 127' ' ' ARG . 28.9 t -53.71 -35.99 61.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.082 0.468 . . . . 73.15 110.408 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.552 ' CG ' ' HZ1' ' A' ' 359' ' ' LYS . 6.8 t70 -99.39 116.02 30.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.771 . . . . 75.05 109.612 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -151.7 -68.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 44.33 110.745 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 -86.9 0.38 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.719 -0.753 . . . . 71.32 112.111 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . 51.1 Cg_exo -53.71 -43.73 55.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.123 2.549 . . . . 72.01 113.05 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 3.4 tm? -55.77 -45.84 78.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.962 0.41 . . . . 72.24 110.418 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.93 -35.96 77.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.15 0.5 . . . . 74.43 110.635 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -67.72 -48.48 66.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.93 -0.577 . . . . 64.22 110.921 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.792 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . 8.1 pt-20 -69.63 -27.89 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.141 -0.318 . . . . 73.12 110.141 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 129' ' ' MET . 59.7 tp -62.99 -44.2 96.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.414 -0.357 . . . . 72.4 110.63 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 42.0 tptt -64.1 -46.14 85.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.261 -0.427 . . . . 43.34 109.876 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 60.8 t80 -59.57 -47.93 83.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 73.44 110.128 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.43 -46.83 80.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.221 -0.9 . . . . 72.33 110.474 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 18.5 tm0? -61.47 -35.39 77.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.218 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 79.0 mtp180 -81.44 -18.74 44.27 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.084 0.401 . . . . 75.41 112.084 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.97 -34.9 6.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.66 0.615 . . . . 43.34 112.66 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.51 11.29 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.262 0.553 . . . . 75.15 111.998 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG2' ' HD2' ' A' ' 93' ' ' PRO . 30.0 tttm -76.86 139.79 66.49 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 115.384 -0.825 . . . . 62.31 110.269 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 80.8 Cg_exo -47.37 -53.48 6.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.343 2.696 . . . . 63.32 113.697 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -40.72 93.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 51.34 110.683 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 167' ' ' TYR . 13.2 mm100 -61.59 -48.9 78.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.609 -0.723 . . . . 65.44 111.148 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' NZ ' ' A' ' 112' ' ' LYS . 62.3 mt -66.0 -48.62 81.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.892 -0.594 . . . . 74.14 111.283 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -61.66 -37.91 85.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 73.51 111.026 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -61.24 -48.58 80.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 72.12 110.262 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -66.79 -46.0 76.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 64.02 111.096 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -54.95 -50.66 60.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.273 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -69.25 -32.43 71.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.457 . . . . 74.41 111.194 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 m -76.24 -40.36 52.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.593 -0.276 . . . . 72.34 111.743 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 10.8 ttt180 -93.64 9.05 38.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.973 -0.291 . . . . 61.34 111.167 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.866 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.1 mmpt? 64.81 28.9 12.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.234 -0.439 . . . . 73.2 111.542 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 88.5 mt -90.86 -173.61 3.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.041 -0.527 . . . . 75.24 111.022 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -26.54 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.21 109.833 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -154.13 165.2 36.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 73.41 110.213 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.4 tp -124.98 137.17 54.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 70.51 109.461 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.7 52.96 2.83 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.299 -0.477 . . . . 72.34 113.253 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.64 133.22 23.22 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.071 -0.714 . . . . 63.12 109.071 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG3' ' HZ ' ' A' ' 134' ' ' PHE . 24.2 Cg_exo -60.77 136.78 68.61 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.406 2.071 . . . . 64.33 111.401 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.734 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -65.29 125.77 26.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.09 0.472 . . . . 73.42 110.815 -178.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.36 113.96 19.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 64.41 110.114 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CD1' HG22 ' A' ' 130' ' ' ILE . 24.5 m95 -92.48 -49.94 5.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.287 -0.635 . . . . 72.52 109.287 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' HA3' ' OD1' ' A' ' 31' ' ' ASP . . . -176.63 -168.76 37.12 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.591 -0.814 . . . . 74.5 112.684 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 82.4 p -179.96 177.21 0.68 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.934 -1.136 . . . . 73.34 107.934 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.82 -175.83 43.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.09 -1.529 . . . . 43.0 113.929 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 125' ' ' SER . 2.0 tm? -120.33 127.3 52.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.03 -1.1 . . . . 73.24 108.03 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 51.7 t60 -130.89 117.14 18.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.02 0.438 . . . . 72.15 111.083 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -67.1 149.89 49.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 53.21 109.994 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -128.12 -89.33 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.865 0.364 . . . . 64.35 110.177 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -142.3 87.4 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.989 -0.745 . . . . 62.33 108.989 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -36.42 3.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.066 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -109.34 163.71 13.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.904 -0.406 . . . . 73.42 109.904 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 118' ' ' LEU . 50.0 m -123.98 138.54 54.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.174 -0.466 . . . . 60.05 109.815 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 66.1 m-85 -103.65 145.63 29.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.515 . . . . 73.45 110.998 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.0 ttt180 -118.31 116.84 27.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.96 -0.756 . . . . 75.05 108.96 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 44.7 p90 -123.48 163.14 21.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.176 0.512 . . . . 73.15 112.244 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.481 ' SD ' ' HD3' ' A' ' 71' ' ' LYS . 14.2 ttm -143.46 133.12 23.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.937 -1.029 . . . . 71.15 109.785 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.452 HG22 ' CD1' ' A' ' 114' ' ' TRP . 37.5 mt -97.77 127.03 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.686 0.279 . . . . 64.23 110.25 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.522 ' HE1' HG23 ' A' ' 196' ' ' VAL . 18.7 ptm -138.78 177.97 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 72.11 111.273 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.63 142.03 58.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.731 -0.668 . . . . 63.54 111.351 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.504 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 9.0 tpt180 -79.33 112.89 17.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.267 0.556 . . . . 72.11 111.152 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.593 ' HZ ' ' HG3' ' A' ' 111' ' ' PRO . 16.0 m-85 -102.02 149.29 24.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.915 -0.584 . . . . 62.33 109.597 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.54 -6.54 2.96 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.651 -0.785 . . . . 43.13 111.883 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.957 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 44.9 m -120.8 124.21 44.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.952 0.406 . . . . 72.24 111.551 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 184' ' ' LEU . 13.3 m-20 -98.07 125.73 43.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 74.04 109.56 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 17.2 tp -67.38 -18.67 65.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.184 0.516 . . . . 63.14 109.615 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 46.3 tp60 -60.09 -50.4 73.86 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.541 -0.754 . . . . 72.32 111.192 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -31.05 67.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.73 0.3 . . . . 61.15 110.283 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.565 HG21 ' HG ' ' A' ' 341' ' ' LEU . 71.7 mt -64.25 -51.95 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 61.42 110.733 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.938 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -68.91 -31.83 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.889 -0.412 . . . . 70.35 109.889 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.34 -53.45 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 73.43 111.178 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.15 -22.09 53.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.809 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 9.7 t-20 -96.38 -1.48 47.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.936 0.398 . . . . 72.03 111.359 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 58.57 33.68 23.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.166 -0.47 . . . . 63.51 111.034 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.938 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 56.4 pttt 43.15 42.86 3.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.763 1.225 . . . . 63.24 113.226 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -115.68 90.09 3.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.077 -0.712 . . . . 73.01 109.077 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.44 157.36 17.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.542 . . . . 75.24 111.364 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -71.21 158.37 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.683 -0.689 . . . . 54.31 111.452 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 298' ' ' GLU . 6.1 tpt180 -53.73 -39.03 64.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.162 -0.926 . . . . 62.41 111.084 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -61.71 -61.96 2.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.527 -0.761 . . . . 53.12 111.564 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t -64.86 -36.37 84.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.31 112.088 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.25 -43.04 98.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.727 0.299 . . . . 75.51 110.913 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 328' ' ' LEU . 0.4 OUTLIER -64.87 -47.4 78.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.457 -0.338 . . . . 70.1 110.168 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 335' ' ' ASP . 5.8 tp-100 -59.15 -45.24 91.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.835 0.35 . . . . 74.42 110.723 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.485 ' O ' HD13 ' A' ' 161' ' ' ILE . 35.2 tp -59.98 -46.81 88.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.367 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.2 t -61.3 -39.27 89.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 64.44 110.459 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.51 -49.72 74.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.509 . . . . 73.33 110.202 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.719 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -60.62 -40.55 92.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.892 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 157' ' ' LEU . 1.7 mp -61.79 -40.64 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 71.41 109.864 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.98 -37.87 86.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 73.03 110.781 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.6 m-20 -56.12 -58.19 8.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.363 0.601 . . . . 73.42 110.593 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 195' ' ' LEU . 18.7 tt -71.14 -35.89 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.573 -0.739 . . . . 74.13 111.231 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.8 -38.54 91.34 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.825 -0.171 . . . . 53.22 110.91 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.342 -0.614 . . . . 63.03 109.342 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 95' ' ' GLN . 61.4 t80 -56.18 -45.19 79.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.142 -0.936 . . . . 70.34 111.962 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.401 HG21 ' HZ ' ' A' ' 86' ' ' PHE . 35.1 pt -84.89 -32.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.856 -0.337 . . . . 63.4 111.874 -176.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.644 ' HE1' ' HA ' ' A' ' 240' ' ' ARG . 5.1 t60 -66.2 -41.13 90.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.301 -0.259 . . . . 65.01 110.301 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.905 0.383 . . . . 61.42 110.452 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -88.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 73.33 110.467 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 11.2 pt-20 -166.11 11.69 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.856 0.687 . . . . 71.21 112.856 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.78 141.81 51.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.778 -0.369 . . . . 73.13 110.895 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 238' ' ' PRO . 12.9 m -123.65 126.06 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 75.54 110.392 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 201' ' ' ALA . 41.7 t-80 -89.09 69.84 8.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.983 -0.747 . . . . 61.11 108.983 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.89 46.68 3.39 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.689 -0.687 . . . . 64.15 113.806 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 224' ' ' THR . 11.1 t70 -175.7 96.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 73.21 109.255 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.719 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -90.01 70.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.392 0.615 . . . . 60.34 110.393 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.674 ' HD2' ' OG1' ' A' ' 224' ' ' THR . 56.6 tttm -83.76 134.87 34.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.143 -0.688 . . . . 73.12 109.143 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -54.87 -26.34 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 73.11 112.051 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 0.9 OUTLIER -66.5 -25.56 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.409 -0.359 . . . . 70.23 111.261 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 200' ' ' LEU . 6.9 t-20 -84.11 -7.42 59.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 73.03 109.882 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 161' ' ' ILE . 21.1 mt -105.75 115.57 30.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.071 -0.968 . . . . 63.13 110.503 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.867 HD21 ' HE3' ' A' ' 350' ' ' LYS . 4.1 mm? -118.08 140.35 49.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 74.03 110.535 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 9.0 mp -100.72 145.27 28.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.655 -0.498 . . . . 73.31 109.655 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.671 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 25.5 t-20 -59.99 147.64 38.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.17 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -57.69 -26.83 62.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.395 0.517 . . . . 72.45 112.395 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -115.48 -15.83 11.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 70.31 111.878 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.26 107.11 30.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 112.018 0.377 . . . . 73.43 112.018 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.548 ' HA ' HD23 ' A' ' 185' ' ' LEU . 17.9 Cg_exo -67.62 -21.84 45.06 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.069 2.513 . . . . 73.0 111.586 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.683 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 7.3 p-10 -91.39 6.51 45.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.556 . . . . 71.45 111.047 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -119.35 99.78 6.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 61.35 109.646 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.24 133.67 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.885 -0.598 . . . . 73.53 110.496 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.671 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 18.0 m-85 -128.17 158.05 39.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 71.32 110.018 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 164' ' ' ILE . 82.9 mt -95.63 150.2 20.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.671 0.272 . . . . 73.43 110.608 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.2 p -138.23 175.87 7.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.736 -0.839 . . . . 70.05 108.736 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 196' ' ' VAL . 0.6 OUTLIER 75.64 -58.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.461 0.476 . . . . 64.53 110.769 174.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.792 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 25.8 m-85 63.77 12.21 6.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.428 -0.805 . . . . 74.43 112.343 173.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.35 -15.64 81.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.601 -1.0 . . . . 62.13 110.601 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 352' ' ' LYS . 89.9 mt -92.92 17.09 11.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.01 -0.595 . . . . 64.14 110.283 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 175' ' ' HIS . . . -127.76 99.42 5.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.104 -0.702 . . . . 45.21 109.104 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -99.54 149.64 23.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.302 0.572 . . . . 72.44 111.106 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 203' ' ' ARG . 32.7 ptt180 -60.1 115.52 3.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.852 -1.067 . . . . 74.34 111.131 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -101.83 -29.76 11.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.384 0.611 . . . . 70.45 109.745 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 45.7 m -133.88 64.42 66.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 71.04 109.643 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.25 113.86 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.93 2.42 . . . . 63.43 113.167 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 70.21 14.3 7.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.723 -0.671 . . . . 51.42 110.457 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.04 -7.25 52.24 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.874 -0.679 . . . . 62.1 112.307 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.84 111.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 74.15 110.535 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -102.69 128.58 49.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.285 -0.416 . . . . 74.01 110.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -115.46 162.22 17.48 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.371 -0.603 . . . . 74.05 109.371 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -83.75 -172.16 4.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.484 0.659 . . . . 70.45 111.915 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -76.41 151.86 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 75.33 111.861 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -134.33 0.65 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 74.45 110.473 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 69.49 -63.13 0.39 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.501 -0.772 . . . . 72.42 112.522 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 4.4 t0 -157.2 105.5 1.88 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.76 0.314 . . . . 72.12 111.778 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -101.2 0.75 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.49 2.793 . . . . 61.01 113.3 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 4.7 tmtt? 176.23 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.243 0.09 . . . . 75.24 111.243 -170.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 218' ' ' LYS . 99.3 mtt180 71.09 103.25 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.334 -0.617 . . . . 65.23 109.334 -168.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.448 ' H ' ' HA2' ' A' ' 235' ' ' GLY . 49.5 t -79.5 -54.69 5.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.557 -0.747 . . . . 63.33 111.134 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.4 p80 44.19 41.31 4.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.765 . . . . 73.12 111.888 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -67.72 -38.36 83.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.707 -0.678 . . . . 70.51 110.776 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.57 -170.4 46.32 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.959 -0.564 . . . . 73.0 112.833 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.674 ' OG1' ' HD2' ' A' ' 179' ' ' LYS . 1.1 m -91.1 114.25 26.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.689 -0.486 . . . . 61.55 109.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 271' ' ' VAL . 18.3 tt -52.77 -17.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 113.377 0.88 . . . . 74.24 113.377 -167.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -65.42 -43.88 89.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 73.41 109.846 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.61 ' HD2' ' HB ' ' A' ' 224' ' ' THR . 36.6 m-85 -96.07 -41.41 8.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.58 -0.736 . . . . 74.33 111.381 -174.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 0.2 OUTLIER -57.45 -5.56 0.35 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.499 1.296 . . . . 51.33 114.499 -166.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.6 t 62.99 -158.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.932 0.396 . . . . 60.43 110.162 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.5 mt -71.87 -47.53 55.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.417 -0.356 . . . . 72.25 110.795 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -35.99 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.276 1.213 . . . . 60.42 114.276 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.624 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -70.0 -30.14 67.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.477 0.547 . . . . 50.22 112.477 -167.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -21.76 61.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 74.3 110.119 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 219' ' ' ARG . 4.1 t30 -87.24 -34.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.785 -0.45 . . . . 64.33 109.785 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.448 ' HA2' ' H ' ' A' ' 220' ' ' CYS . . . 142.17 -33.93 1.88 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.242 -0.98 . . . . 62.23 113.231 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.52 140.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.827 0.314 . . . . 74.44 110.637 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -56.86 135.34 79.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 60.42 110.348 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 75.8 Cg_exo -49.89 115.72 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 2.458 . . . . 74.54 112.279 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 84.6 p -83.59 -178.06 6.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.04 -0.527 . . . . 73.52 110.534 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.644 ' HA ' ' HE1' ' A' ' 169' ' ' HIS . 9.3 ptp85 -64.55 -31.29 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.612 0.72 . . . . 71.23 109.537 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -64.26 -40.26 95.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.226 -0.897 . . . . 71.41 109.538 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -58.93 -69.29 1.32 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.068 -0.969 . . . . 53.54 112.391 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -61.45 -33.82 74.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.128 0.464 . . . . 61.42 112.078 -170.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.59 -46.92 57.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.566 -0.454 . . . . 73.11 111.734 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.18 -27.71 60.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.003 0.43 . . . . 71.42 110.305 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.5 mt -63.92 -45.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 74.01 110.507 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 161' ' ' ILE . 37.6 tp -60.38 -36.51 78.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.834 -0.432 . . . . 74.33 109.834 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.19 -47.61 88.3 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.754 -0.736 . . . . 63.23 112.142 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -59.65 -43.75 93.79 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.777 0.322 . . . . 73.54 110.79 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 35.4 m -65.49 -37.44 86.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.908 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.38 -50.71 70.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.866 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.8 tt -69.79 -28.62 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.649 -0.42 . . . . 63.23 110.443 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.79 -50.84 71.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.934 0.397 . . . . 63.33 110.322 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.9 m0 -70.3 -24.97 63.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.531 -0.759 . . . . 53.22 111.012 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 294' ' ' ASN . 30.1 tp -76.39 -32.6 58.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.03 111.719 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -103.37 -27.24 12.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.531 0.567 . . . . 44.13 112.531 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.426 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 86.83 -20.49 24.09 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.447 -0.882 . . . . 44.35 112.588 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -147.36 144.35 28.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.616 -0.512 . . . . 75.34 109.616 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.74 149.03 36.39 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 72.33 110.29 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.17 -34.94 98.57 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.323 2.015 . . . . 61.34 112.18 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -96.57 13.64 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 75.51 110.862 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.18 -31.15 69.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 75.13 110.669 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -84.13 -6.86 59.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.794 0.807 . . . . 70.04 109.556 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.876 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 2.9 m-20 -106.86 5.12 28.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.927 -1.033 . . . . 61.21 109.51 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 265' ' ' LEU . 1.9 tm? -65.16 -33.7 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.553 -0.749 . . . . 75.42 111.537 -170.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.42 -23.22 65.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.207 0.447 . . . . 71.33 112.207 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 14.7 t70 -109.7 127.5 27.04 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.929 0.395 . . . . 65.03 111.69 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.94 -39.85 67.47 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.391 2.728 . . . . 52.54 113.649 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 9.8 ptmm? -79.11 -37.88 37.56 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.359 -0.536 . . . . 42.13 110.008 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 9.1 m-85 -58.11 -42.84 86.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.56 0.219 . . . . 75.32 110.818 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 225' ' ' ILE . 65.3 t -63.16 -50.6 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.563 -0.29 . . . . 62.55 110.519 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 276' ' ' ILE . 31.0 ttp180 -60.13 -48.86 79.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.602 -0.272 . . . . 73.41 111.273 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.68 -45.72 85.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.466 0.479 . . . . 73.54 111.514 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 21.4 m -66.79 -43.26 84.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.102 -0.499 . . . . 52.34 111.174 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 7.8 mmmm -61.6 -32.64 72.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.758 0.313 . . . . 74.53 110.636 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 272' ' ' ARG . 75.7 mt -72.91 -44.44 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.385 -0.37 . . . . 74.23 111.013 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.45 -32.61 74.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.973 0.416 . . . . 71.14 110.563 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -74.24 -32.25 62.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.38 -0.373 . . . . 62.25 110.817 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 276' ' ' ILE . 23.7 mtp180 -59.11 -33.42 70.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.39 -0.368 . . . . 71.42 110.854 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.45 -39.9 70.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.569 -0.742 . . . . 74.21 111.417 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.449 ' O ' HD23 ' A' ' 285' ' ' LEU . 2.1 t-20 -153.99 84.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.193 0.52 . . . . 62.52 110.438 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.675 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -78.72 -35.96 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 73.52 111.968 -176.161 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.73 80.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.797 0.332 . . . . 75.35 111.241 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -75.3 -45.71 38.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 44.43 110.454 -178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -61.67 -42.41 98.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.925 0.343 . . . . 72.42 111.925 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.0 mmt -74.99 -43.58 53.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.93 -0.308 . . . . 72.11 111.301 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.69 -38.98 84.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.102 0.477 . . . . 71.22 111.023 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -84.54 -2.0 56.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.84 -0.618 . . . . 75.33 110.575 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.46 -21.4 38.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 74.31 109.393 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -137.48 76.92 41.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.029 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.49 44.7 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.557 2.838 . . . . 72.42 112.691 -173.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.11 -179.44 3.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.975 -0.38 . . . . 71.21 109.975 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -81.05 20.54 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.372 0.508 . . . . 74.01 112.372 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.784 HD21 HD11 ' A' ' 255' ' ' LEU . 41.5 t30 -77.47 -48.14 17.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.47 -0.567 . . . . 54.34 109.47 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 23.9 tptm 77.85 95.09 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 115.222 -0.899 . . . . 65.35 111.147 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.84 48.04 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.889 2.392 . . . . 55.51 112.196 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.14 54.93 Favored Glycine 0 C--O 1.238 0.356 0 CA-C-N 115.942 -0.572 . . . . 65.02 112.76 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 323' ' ' ILE . 1.7 mp0 -55.37 -45.14 76.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 74.44 110.497 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.7 mp -63.0 -45.3 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 73.34 110.827 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.13 50.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 75.51 111.428 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 304' ' ' GLU . 22.3 mtpp -77.17 -27.94 53.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 71.14 111.897 -176.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -55.99 -52.78 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.518 . . . . 54.1 109.97 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.555 ' HA ' HG22 ' A' ' 306' ' ' VAL . 55.6 mtp -72.68 -36.28 67.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.464 -0.789 . . . . 72.54 110.869 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 301' ' ' LYS . 38.7 tt0 -57.39 -46.42 83.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.362 0.601 . . . . 74.42 109.795 173.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 47.9 m -63.17 -52.5 62.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.037 -0.983 . . . . 73.44 112.078 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.6 m -64.24 -27.35 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.712 0.291 . . . . 72.41 111.551 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -80.65 -30.48 36.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.711 0.291 . . . . 71.2 111.042 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.86 -17.73 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 74.44 110.326 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 67.8 mt -71.16 -13.84 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 61.31 110.889 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 35.7 t70 59.23 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 73.34 111.736 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.53 ' O ' ' HD2' ' A' ' 240' ' ' ARG . 49.5 t80 -152.4 -48.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.442 0.163 . . . . 71.21 110.685 174.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 5.4 m -125.67 36.14 4.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.243 0.544 . . . . 50.14 111.668 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 14.8 tp10 -90.49 23.06 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.937 -0.477 . . . . 54.14 110.04 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 72.36 130.64 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 115.466 -0.788 . . . . 54.44 111.811 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.54 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 1.4 Cg_endo -82.37 118.31 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.415 2.076 . . . . 75.31 110.881 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 320' ' ' LEU . 16.9 tp -104.09 92.6 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 74.41 110.138 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.72 -40.44 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 75.52 111.556 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.6 pm0 -67.22 -29.3 68.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.21 111.617 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.06 -48.87 69.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.791 -0.448 . . . . 71.33 109.791 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 9.4 mp -60.47 -43.15 97.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.602 -0.726 . . . . 45.32 110.619 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 325' ' ' LEU . 1.2 tmt_? -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.63 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.21 -40.5 71.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 72.31 111.274 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -63.72 -37.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.618 0.247 . . . . 75.44 110.373 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.531 HD23 ' HB3' ' A' ' 298' ' ' GLU . 87.1 mt -67.86 -46.73 70.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.954 0.407 . . . . 73.04 110.667 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 321' ' ' ARG . 4.3 mm? -66.93 -29.26 69.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.43 111.171 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.8 tm0? -66.34 -42.38 88.23 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.406 -0.59 . . . . 72.13 109.406 178.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.99 98.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.802 -0.713 . . . . 44.11 111.925 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 155' ' ' LEU . 14.1 mt -69.18 -36.37 77.26 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.854 -0.204 . . . . 75.01 111.488 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -60.3 -34.03 73.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.747 0.308 . . . . 71.24 110.426 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.82 -29.79 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 54.53 111.816 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.7 pt -107.68 1.01 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 74.04 111.094 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 77.07 24.99 65.1 Favored Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.949 -0.643 . . . . 64.03 113.052 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 62.6 m -107.45 156.7 18.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.077 0.465 . . . . 63.41 111.254 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -152.96 16.8 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.394 -0.965 . . . . 64.23 108.394 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 338' ' ' LYS . 24.7 t70 67.27 125.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.529 -1.214 . . . . 73.34 109.298 -162.016 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.26 0.91 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.282 -0.872 . . . . 45.4 110.763 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -70.56 -10.16 66.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.842 -0.694 . . . . 50.21 111.824 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.683 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 12.3 mmmm 67.41 82.9 0.17 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.622 0.769 . . . . 72.01 111.431 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 191' ' ' ASP . 50.9 mt 59.8 71.63 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.902 -1.044 . . . . 74.3 112.793 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.56 95.97 0.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.911 -1.144 . . . . 75.31 107.911 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.565 ' HG ' HG21 ' A' ' 141' ' ' ILE . 2.5 tp -149.26 -44.37 0.14 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.734 0.642 . . . . 72.33 112.734 -166.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.6 m -50.9 120.19 4.61 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.787 0.662 . . . . 74.33 112.787 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 344' ' ' VAL . 18.3 m -131.06 20.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 73.02 110.144 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 69.0 t 90.77 109.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 124.317 1.011 . . . . 63.44 109.735 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.585 ' HG2' ' HB3' ' A' ' 136' ' ' SER . 6.1 mp0 -110.65 135.63 50.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.51 -0.768 . . . . 74.42 111.638 -169.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -178.07 106.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 70.22 110.019 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 175.81 66.71 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.554 -0.831 . . . . 73.52 111.905 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.467 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . -78.79 58.51 4.23 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.137 -0.554 . . . . 70.11 113.197 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.69 83.44 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 53.43 110.315 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.867 ' HE3' HD21 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -156.8 106.73 2.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.503 0.668 . . . . 54.31 110.663 177.052 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -148.83 106.66 3.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 73.51 109.845 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 200' ' ' LEU . 4.5 mptp? -99.81 -167.7 1.5 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.246 0.546 . . . . 70.44 110.556 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.8 t -161.45 157.67 25.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 71.4 108.691 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.1 OUTLIER -99.63 126.83 52.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.323 0.582 . . . . 63.32 111.785 -173.395 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 18.5 m -75.95 74.12 2.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.608 -0.724 . . . . 51.43 109.908 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -94.94 -32.05 13.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.68 . . . . 75.03 110.432 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 179.65 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.14 -0.689 . . . . 70.31 109.14 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -179.55 149.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.914 -0.773 . . . . 74.12 108.914 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.552 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 8.2 tmtm? -106.35 119.18 38.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.749 0.309 . . . . 43.4 110.568 -177.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 45.2 tttm . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.491 -0.766 . . . . 75.33 109.332 174.071 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtp . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.646 0.26 . . . . 61.24 110.599 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -93.02 137.06 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.413 2.075 . . . . 63.11 111.398 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -161.84 78.37 0.53 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.96 -0.755 . . . . 55.04 108.96 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.87 161.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.363 0.601 . . . . 73.33 111.567 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -117.89 95.47 4.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.627 -1.249 . . . . 73.11 107.627 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.47 -77.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.531 0.567 . . . . 73.23 112.531 -167.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.29 176.68 3.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.381 -0.372 . . . . 64.14 110.936 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -142.63 129.58 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.111 -0.495 . . . . 73.21 109.742 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.92 97.58 6.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.015 0.436 . . . . 64.31 110.469 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.75 94.6 1.47 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.784 -0.722 . . . . 63.3 112.917 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -146.08 149.22 33.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.201 -0.666 . . . . 72.31 109.201 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.03 144.76 50.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.487 . . . . 74.32 110.942 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -130.91 128.63 40.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.983 -0.553 . . . . 73.32 111.328 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -151.15 120.17 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.446 -0.343 . . . . 54.13 110.285 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.48 109.09 3.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 44.45 110.578 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -137.13 119.34 15.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 61.04 110.251 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 17' ' ' ARG . 20.2 ttt180 -160.03 97.35 1.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.53 -0.759 . . . . 62.54 110.353 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -111.83 123.16 49.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 72.35 109.655 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 19' ' ' LEU . 2.5 pt? -147.93 8.12 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.103 -0.499 . . . . 74.11 111.238 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB1' HG21 ' A' ' 25' ' ' VAL . . . -120.6 73.29 1.0 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.5 . . . . 24.11 111.52 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -132.09 108.21 9.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.219 -0.659 . . . . 61.04 109.219 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -171.24 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.873 -0.331 . . . . 45.41 111.856 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -158.07 74.15 0.7 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.459 0.647 . . . . 55.04 110.068 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 175.5 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.266 -1.383 . . . . 74.04 107.266 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.466 HG13 ' HA2' ' A' ' 40' ' ' GLY . 90.1 t -67.05 140.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.944 -1.026 . . . . 64.33 108.389 164.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.81 -5.66 59.97 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.492 -0.861 . . . . 62.02 112.271 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.52 140.82 31.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.697 -0.483 . . . . 70.35 109.697 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -98.53 131.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.247 0.546 . . . . 72.13 110.779 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.3 137.0 47.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.745 -0.661 . . . . 44.03 110.039 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 23.6 m -106.76 121.01 43.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.29 -0.414 . . . . 73.55 110.627 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.603 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 3.2 p-10 -83.35 -175.44 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 71.11 110.812 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.481 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 25.3 mmt -65.95 -28.09 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.372 0.508 . . . . 73.24 112.372 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.752 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . . . -90.71 9.69 28.89 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.99 0.424 . . . . 75.24 110.822 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 63.4 69.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.412 -0.813 . . . . 65.42 112.862 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.752 ' HE2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -127.33 141.91 51.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.162 -0.681 . . . . 74.12 109.162 168.325 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.59 101.55 14.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.983 0.42 . . . . 71.4 110.233 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.579 ' HZ2' ' HZ2' ' A' ' 35' ' ' LYS . 70.5 m95 -98.97 108.61 21.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 75.01 110.515 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.73 123.41 27.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.212 -0.662 . . . . 73.23 109.212 175.875 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.86 132.32 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.531 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -116.12 -131.75 4.88 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 121.09 -0.576 . . . . 65.3 112.992 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.8 tt -63.75 128.31 92.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.053 0.454 . . . . 64.14 111.381 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.9 Cg_exo -74.95 100.65 1.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.15 2.567 . . . . 63.0 111.991 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 53' ' ' LEU . 69.3 mt -62.33 -55.93 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.162 0.506 . . . . 73.44 110.925 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.94 148.05 18.49 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.649 -0.786 . . . . 62.54 111.899 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' HG12 ' A' ' 51' ' ' ILE . 25.3 tm0? -112.73 165.88 11.87 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.262 -1.014 . . . . 73.55 108.262 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' ' NZ ' ' A' ' 140' ' ' LYS . . . -40.57 -51.45 3.85 Favored Glycine 0 C--N 1.335 0.475 0 O-C-N 123.47 0.482 . . . . 64.04 113.884 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 26.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.959 -1.115 . . . . 72.21 113.47 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.572 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 75.5 t80 -129.84 -77.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.094 0.447 . . . . 75.04 111.287 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.66 -40.63 76.79 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.179 -0.534 . . . . 54.43 113.954 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' GLN . 59.3 m 64.2 96.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.31 0.576 . . . . 74.14 110.81 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 45' ' ' GLN . 4.1 mm -101.31 139.71 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 51.43 111.618 -172.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.81 158.73 16.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 73.23 109.728 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 43' ' ' ILE . 9.5 tt -97.1 144.57 26.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.582 -0.525 . . . . 73.43 109.582 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -118.5 114.78 23.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.759 0.314 . . . . 31.43 110.283 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.43 8.42 33.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.395 -0.366 . . . . 73.11 111.049 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 1.4 tmt? 69.49 -60.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.376 0.67 . . . . 60.32 109.805 -174.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 56' ' ' MET . 62.9 t30 174.16 149.05 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.931 0.769 . . . . 74.22 109.273 171.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p -82.39 73.22 9.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.344 0.592 . . . . 63.11 110.348 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.8 m -139.57 -173.92 3.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.337 -0.847 . . . . 61.44 109.728 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.93 56.79 2.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.668 . . . . 54.01 109.635 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 p -120.22 -52.93 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.743 . . . . 62.23 109.986 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.21 136.87 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 45.1 110.045 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.3 -10.92 4.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.472 -0.871 . . . . 73.13 112.529 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.4 m -116.88 -77.76 0.57 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.701 -0.293 . . . . 62.44 111.236 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 4.9 p30 -146.34 -35.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.725 0.639 . . . . 74.31 112.725 -173.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 65' ' ' ASP . . . 75.41 80.61 0.14 Allowed Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 124.098 0.874 . . . . 74.2 109.25 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HG2' ' CH2' ' A' ' 114' ' ' TRP . 82.5 Cg_endo -90.92 37.96 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.427 2.751 . . . . 75.23 113.76 -169.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.89 139.05 53.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.153 0.501 . . . . 70.13 111.606 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 53' ' ' LEU . 34.2 m -130.29 162.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.235 -0.654 . . . . 72.23 109.235 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.56 ' HB ' HG12 ' A' ' 130' ' ' ILE . 7.4 p -132.73 130.13 58.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.611 0.72 . . . . 71.21 111.688 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' HD12 ' A' ' 51' ' ' ILE . 76.2 tttt -94.79 137.47 33.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.023 -0.989 . . . . 74.41 109.42 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.83 140.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 72.34 111.743 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 16.2 mt-10 -157.35 161.1 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 75.15 109.576 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.01 148.54 92.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.321 2.014 . . . . 51.22 111.353 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.0 t -47.47 -50.02 24.1 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.553 0.533 . . . . 65.14 112.208 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.48 45.28 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.749 0.309 . . . . 65.1 111.456 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -69.34 -37.5 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.353 0.597 . . . . 73.41 110.264 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.03 -80.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.584 -0.817 . . . . 74.33 112.422 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.572 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.4 Cg_exo -60.91 -40.99 48.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.075 2.517 . . . . 51.35 112.768 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 1.6 tm? -52.63 -48.6 66.27 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 123.518 0.511 . . . . 74.43 111.172 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.29 -45.9 89.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.706 0.289 . . . . 74.24 111.185 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 201' ' ' ALA . 3.2 m -63.61 -42.5 98.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.336 0.589 . . . . 61.35 110.424 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.21 -30.27 64.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 73.22 110.484 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.63 -41.97 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 53.23 110.729 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HD2' ' HE2' ' A' ' 173' ' ' TYR . 41.6 ttmt -63.71 -40.11 95.95 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.714 -0.395 . . . . 75.03 109.961 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.24 -45.44 93.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.317 0.58 . . . . 73.45 109.648 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.5 ' OH ' ' HA ' ' A' ' 113' ' ' TYR . 81.1 t80 -58.28 -37.24 74.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 75.33 110.926 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.52 -32.77 72.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 71.32 111.057 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 12.4 mmt180 -72.08 -37.9 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.52 111.075 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 96' ' ' ILE . . . -96.27 17.16 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 73.34 111.118 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' LYS . . . -87.63 146.9 25.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.909 -0.587 . . . . 63.44 111.594 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 91' ' ' ALA . 41.2 ttmt 77.92 117.25 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.256 -0.884 . . . . 72.34 111.533 174.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -56.52 -29.33 78.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.337 2.691 . . . . 61.33 113.087 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.43 -53.26 60.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.684 0.278 . . . . 71.2 111.395 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.89 -47.75 81.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.152 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 90' ' ' ALA . 59.0 mt -56.21 -51.25 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.674 . . . . 74.44 111.022 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -53.83 -42.17 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 72.31 110.621 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -60.32 -60.23 4.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.576 -0.738 . . . . 65.41 111.449 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -73.26 -34.44 65.83 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 119.964 -0.694 . . . . 72.0 111.353 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.3 mm -59.72 -38.04 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.668 -0.413 . . . . 63.13 110.475 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -78.77 -48.13 15.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.307 -0.406 . . . . 63.43 111.24 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.0 m -73.66 -43.92 58.17 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.891 0.33 . . . . 74.34 111.891 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.555 ' O ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -73.92 -27.33 60.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.782 -0.822 . . . . 65.3 108.782 178.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.575 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 9.9 mtmp? 71.66 83.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.663 -1.153 . . . . 71.22 111.474 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.1 mt -121.69 173.74 7.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.986 -1.006 . . . . 42.41 109.318 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -89.35 -62.57 1.45 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.906 -0.318 . . . . 54.55 110.469 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 160' ' ' ARG . 27.4 p90 -164.78 146.26 7.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.916 0.389 . . . . 74.14 110.546 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 100' ' ' ILE . 42.3 mt -91.85 118.08 30.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 63.23 111.019 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.52 59.69 4.94 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 109.977 -1.249 . . . . 74.42 109.977 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.776 HG22 ' HD2' ' A' ' 111' ' ' PRO . 2.2 p -121.12 151.56 55.64 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.261 -0.47 . . . . 71.31 110.285 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.776 ' HD2' HG22 ' A' ' 110' ' ' VAL . 89.2 Cg_exo -42.84 134.77 5.3 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.96 2.44 . . . . 63.41 113.618 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 131' ' ' MET . 23.5 tptm -91.46 130.5 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 74.53 110.142 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.5 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 46.1 t80 -91.09 128.62 36.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.131 0.491 . . . . 73.31 112.135 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.565 ' CD1' HG22 ' A' ' 130' ' ' ILE . 47.6 m95 -129.71 -43.66 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.369 -0.832 . . . . 74.24 108.794 170.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.89 162.93 32.24 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.7 -1.136 . . . . 44.54 111.448 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 p -164.16 145.5 8.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.746 -0.464 . . . . 60.52 109.746 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' HA2' ' HG2' ' A' ' 32' ' ' MET . . . -170.17 -171.55 35.75 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.141 -1.028 . . . . 62.22 112.817 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.84 130.84 44.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.035 -0.728 . . . . 74.4 109.035 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.457 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 30.7 t-80 -125.5 133.32 52.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.487 -0.324 . . . . 70.51 110.137 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' SER . 25.7 m-20 69.54 145.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.919 0.762 . . . . 73.52 112.0 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -151.52 -24.49 0.2 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 60.44 111.243 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -61.02 -67.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.336 -0.393 . . . . 73.55 111.827 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.92 -28.27 3.46 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.12 -0.792 . . . . 52.31 111.12 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.0 130.68 46.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.19 -0.671 . . . . 62.04 109.19 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 4.0 p -113.92 117.43 31.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.827 0.346 . . . . 74.42 110.46 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' ' 120' ' ' ASP . 96.1 m-85 -110.82 132.62 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.226 0.536 . . . . 73.55 111.672 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -111.95 127.46 55.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.581 -0.736 . . . . 71.13 109.099 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 49.0 p90 -123.3 142.1 51.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.222 0.534 . . . . 73.44 110.86 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.8 ptm -136.13 130.18 32.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.379 -0.828 . . . . 73.52 109.879 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.565 HG22 ' CD1' ' A' ' 114' ' ' TRP . 15.9 mt -97.51 135.31 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.986 -0.552 . . . . 74.44 111.543 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 53.8 mtm -130.73 -179.88 5.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.038 -0.528 . . . . 73.11 109.788 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.05 165.44 24.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.697 -0.483 . . . . 32.43 109.697 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -69.39 133.19 47.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.397 0.618 . . . . 75.41 111.519 -172.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 20.5 m-85 -122.3 172.21 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.669 . . . . 74.34 110.202 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.775 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -173.72 -51.54 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 41.12 111.916 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.518 ' HB3' HG21 ' A' ' 344' ' ' VAL . 21.1 m -100.86 144.15 30.16 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.753 -0.462 . . . . 75.11 109.753 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 p30 -139.01 163.04 33.44 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.018 -0.364 . . . . 62.32 110.018 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.0 mp -73.14 -24.4 60.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.189 0.44 . . . . 70.22 112.189 -173.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 10.0 pt20 -71.24 -31.8 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.623 -0.431 . . . . 70.12 110.424 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.666 ' HG2' ' H ' ' A' ' 347' ' ' GLY . 55.9 mttp -71.75 -37.24 70.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.99 0.424 . . . . 74.2 110.757 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.854 HG12 HG22 ' A' ' 344' ' ' VAL . 62.0 mt -74.66 -51.54 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.915 -0.584 . . . . 71.52 112.281 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HD1' ' HB2' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -65.96 -32.61 74.19 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.337 0.495 . . . . 71.15 112.337 -166.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.83 -6.82 59.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.181 -0.607 . . . . 72.44 110.823 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -104.05 -30.28 10.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.36 0.6 . . . . 64.2 110.45 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -97.92 -0.61 44.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.546 -0.752 . . . . 75.42 110.876 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.11 16.23 9.44 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.462 -0.79 . . . . 52.3 111.926 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HE3' ' HB3' ' A' ' 253' ' ' GLN . 2.6 ttpt 64.19 53.67 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.732 -0.667 . . . . 73.33 110.939 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 148' ' ' ARG . 6.4 tmm_? -133.43 95.15 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.366 -0.975 . . . . 75.33 108.366 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 44.6 m-85 -103.68 157.23 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.871 -0.604 . . . . 74.54 111.368 -172.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.2 p -60.9 147.88 41.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.773 -0.648 . . . . 54.12 110.778 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HD3' ' OE2' ' A' ' 298' ' ' GLU . 26.7 ttm-85 -61.88 -33.19 73.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 71.43 110.608 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.32 -46.17 90.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.268 177.288 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.532 HG23 HD22 ' A' ' 339' ' ' LEU . 32.6 m -72.03 -45.74 59.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.772 -0.649 . . . . 71.44 111.155 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.2 -40.92 76.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.401 -0.363 . . . . 73.35 110.681 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 324' ' ' LEU . 19.2 tp -63.48 -47.89 79.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 74.15 110.668 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.7 -45.48 81.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.691 0.281 . . . . 70.31 111.051 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 161' ' ' ILE . 93.2 mt -58.52 -51.62 69.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 70.35 110.146 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 247' ' ' LEU . 15.5 m -57.9 -43.2 86.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.776 -0.647 . . . . 73.2 110.921 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 92.8 mt -61.19 -56.12 24.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.206 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -65.59 -23.5 66.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.614 0.245 . . . . 72.23 111.3 -176.05 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 157' ' ' LEU . 27.1 mm -65.62 -46.46 89.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.649 -0.501 . . . . 75.33 109.649 174.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.09 -38.72 92.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.618 0.229 . . . . 73.42 111.618 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.82 -55.51 33.92 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.161 0.505 . . . . 75.23 110.656 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.584 HG21 HH21 ' A' ' 160' ' ' ARG . 16.9 tt -70.44 -36.22 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.001 -0.545 . . . . 71.32 110.59 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 58.8 tp -62.65 -37.32 85.89 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.456 -0.202 . . . . 60.5 110.456 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -50.83 66.28 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.194 0.521 . . . . 75.14 109.874 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 44.1 t80 -51.68 -44.64 63.18 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 114.825 -1.08 . . . . 73.43 111.805 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.74 -31.36 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.768 0.318 . . . . 73.14 111.189 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.666 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 30.3 t-80 -50.77 -54.96 19.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.511 -0.768 . . . . 75.23 111.098 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.47 40.2 1.59 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.403 0.62 . . . . 63.42 110.66 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.623 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 3.0 t-80 -110.21 -72.72 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 73.45 109.083 174.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.68 -38.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.461 -0.336 . . . . 73.45 111.293 173.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 46.8 m-85 -107.33 138.79 42.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 72.52 111.639 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.26 172.51 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.122 -0.49 . . . . 72.05 110.396 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 44.2 t60 -141.16 111.76 6.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.356 -0.384 . . . . 72.44 110.111 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.78 -44.26 6.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 72.53 113.568 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.788 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 35.7 t70 -81.37 87.09 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.267 -0.549 . . . . 74.22 112.269 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.69 63.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.703 . . . . 53.22 109.534 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -97.31 156.99 16.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.328 -0.619 . . . . 70.24 109.328 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -64.01 -10.84 24.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.943 0.349 . . . . 63.31 111.943 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.532 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 46.6 t -71.56 -22.55 61.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.457 -0.338 . . . . 71.22 111.134 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -95.42 -2.25 49.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 70.12 110.794 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.46 126.62 55.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 74.31 111.512 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 1.0 OUTLIER -137.71 158.74 43.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 65.14 110.996 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 193' ' ' VAL . 43.6 mt -102.67 152.17 21.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.936 -0.575 . . . . 72.45 111.25 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.748 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 42.1 t-20 -69.38 128.1 35.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.507 -0.923 . . . . 75.1 108.507 169.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.775 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 39.7 t80 -60.21 -35.36 75.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 71.22 111.905 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.493 ' HD3' ' NH1' ' A' ' 133' ' ' ARG . 76.0 tttt -97.78 -25.49 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.386 -0.37 . . . . 63.24 111.218 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 82.7 m-20 -115.99 98.17 50.66 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.42 -0.355 . . . . 55.33 110.14 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 189' ' ' ASN . 33.7 Cg_endo -63.98 -21.67 68.44 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 123.089 2.526 . . . . 71.13 113.241 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 31.2 p-10 -95.77 6.91 47.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 74.23 111.296 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -106.16 91.86 3.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.026 -0.534 . . . . 75.21 109.834 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.436 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.1 p -102.42 122.95 55.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.695 -0.684 . . . . 74.42 110.109 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.748 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 79.3 m-85 -106.91 157.76 17.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.647 -0.706 . . . . 74.11 110.897 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.446 ' HB2' HH22 ' A' ' 160' ' ' ARG . 43.1 tp -109.16 101.66 10.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 72.0 109.444 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 111' ' ' PRO . 24.2 m -146.13 171.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.6 0.238 . . . . 73.51 110.831 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.54 51.6 4.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.497 -0.774 . . . . 65.03 110.775 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.677 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 22.5 p90 -126.67 -44.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.423 -0.808 . . . . 73.23 111.124 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 79' ' ' PRO . . . 67.02 5.67 34.28 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.899 -0.667 . . . . 63.12 112.873 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.93 HD11 ' HD2' ' A' ' 352' ' ' LYS . 30.3 mt -92.33 97.31 10.79 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.768 0.318 . . . . 55.42 110.873 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 82' ' ' THR . . . -149.47 100.14 2.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 75.2 109.663 173.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -105.18 143.01 33.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.389 -0.368 . . . . 74.31 110.463 -176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 203' ' ' ARG . 8.8 ptm180 -71.3 115.98 11.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.118 -0.492 . . . . 75.1 111.55 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 239' ' ' SER . 68.9 t80 -83.76 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.72 -0.673 . . . . 60.14 109.746 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 8.1 p -99.33 119.51 60.23 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 54.24 109.42 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.639 ' HG2' HG23 ' A' ' 209' ' ' VAL . 11.7 Cg_endo -56.64 88.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.233 2.622 . . . . 73.51 113.559 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 62.62 24.58 14.64 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.448 -0.796 . . . . 65.25 112.626 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.11 -42.6 1.37 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.364 -0.922 . . . . 42.43 113.232 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.639 HG23 ' HG2' ' A' ' 206' ' ' PRO . 24.4 m -79.19 132.42 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 64.24 111.068 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -70.0 153.61 43.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 65.13 110.727 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.771 ' HE2' ' HA ' ' A' ' 211' ' ' LYS . 0.1 OUTLIER -130.86 134.6 46.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 74.21 109.444 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.86 145.91 55.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.458 -0.571 . . . . 74.34 109.458 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.58 136.81 56.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.477 0.656 . . . . 63.21 111.187 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.43 -148.88 0.36 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.118 -0.946 . . . . 74.25 108.962 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -139.75 -49.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.767 -0.373 . . . . 64.44 110.086 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -138.84 104.26 7.49 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.088 0.403 . . . . 60.42 112.088 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 54.9 Cg_endo -76.72 -42.63 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.029 1.819 . . . . 74.51 109.989 162.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.579 ' CE ' ' HA ' ' A' ' 218' ' ' LYS . 0.1 OUTLIER 175.81 58.34 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.578 -0.737 . . . . 52.04 110.467 173.3 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 50.95 38.87 21.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.607 0.763 . . . . 73.43 112.197 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.502 ' N ' ' HA2' ' A' ' 235' ' ' GLY . 48.8 t -83.9 91.97 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 75.35 111.731 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 20.1 p-80 -101.14 131.96 46.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.542 -0.753 . . . . 72.24 110.3 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -92.9 124.25 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.081 0.467 . . . . 73.1 110.554 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.788 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 88.4 -153.38 24.19 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.455 -0.793 . . . . 42.35 112.303 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.73 145.42 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 73.04 110.181 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.489 ' HA ' HG22 ' A' ' 228' ' ' THR . 15.3 tt -61.39 -23.44 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.709 0.633 . . . . 74.14 112.709 -171.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.46 -34.47 76.0 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.32 -0.237 . . . . 72.42 111.222 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 246' ' ' ILE . 13.3 m-85 -104.07 -17.65 14.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.418 0.525 . . . . 75.31 112.418 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 1.8 t -72.94 7.97 1.78 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.091 0.472 . . . . 53.05 111.451 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 26.2 t 63.34 -179.77 0.15 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.264 0.554 . . . . 72.01 110.932 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.5 -41.13 64.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 72.32 109.559 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.09 -62.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.847 -1.069 . . . . 64.42 111.589 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -66.4 -29.41 69.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.254 . . . . 54.21 111.228 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.613 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -64.7 -29.69 70.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.232 -0.187 . . . . 54.14 110.543 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -76.13 -27.17 56.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 53.33 110.002 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.502 ' HA2' ' N ' ' A' ' 220' ' ' CYS . . . 133.59 -20.81 4.09 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.027 -0.606 . . . . 62.13 113.251 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.1 130.75 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 42.22 112.309 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -62.71 123.7 80.41 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 75.14 108.652 170.113 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 239' ' ' SER . 73.2 Cg_exo -46.14 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.682 2.922 . . . . 72.31 114.887 -168.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.527 ' HA ' ' OH ' ' A' ' 204' ' ' TYR . 3.6 m 161.37 -83.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.751 1.221 . . . . 64.32 108.173 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.607 ' HG2' ' HG3' ' A' ' 315' ' ' PRO . 9.5 mpt_? -136.09 -31.87 0.89 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.36 -0.978 . . . . 72.42 108.36 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.759 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.32 -67.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.188 -1.369 . . . . 70.51 112.216 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.71 -40.51 96.65 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-N 116.03 -0.532 . . . . 72.0 112.864 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.31 -53.85 39.1 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.802 0.81 . . . . 73.31 110.284 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 306' ' ' VAL . 10.5 mp -64.96 -33.11 75.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.055 -0.975 . . . . 74.3 110.952 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.57 -40.45 97.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.524 0.202 . . . . 74.42 110.532 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.662 HG13 ' O ' ' A' ' 242' ' ' GLY . 73.0 mt -56.63 -46.17 82.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.117 -0.492 . . . . 45.31 110.737 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.7 tp -61.91 -40.25 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.223 -0.591 . . . . 74.53 110.532 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.34 91.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.554 -0.831 . . . . 23.44 112.044 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 275' ' ' LYS . 20.7 m-85 -64.67 -45.02 88.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.505 0.193 . . . . 70.03 111.464 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 5.0 p -72.58 -35.96 68.07 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.408 -0.517 . . . . 73.54 111.219 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 85.5 mtp -58.21 -52.12 66.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.341 . . . . 63.21 110.651 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.5 tt -67.62 -32.11 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 71.2 110.775 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.689 ' HB3' ' HE3' ' A' ' 147' ' ' LYS . 19.0 mt-30 -62.34 -50.95 69.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.676 0.274 . . . . 63.51 111.211 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 147' ' ' LYS . 29.7 m0 -68.18 -24.42 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.131 -0.486 . . . . 65.01 111.496 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -84.99 -31.47 23.49 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.34 0.496 . . . . 71.13 112.34 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.535 HG22 ' HD1' ' A' ' 290' ' ' PHE . 51.7 p -103.92 -28.67 11.44 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.999 0.74 . . . . 43.24 112.999 -171.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 112.55 -49.49 0.84 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.184 -1.007 . . . . 71.53 112.956 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -151.62 145.41 25.08 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.609 -0.347 . . . . 74.12 110.348 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.505 ' CD1' ' HG3' ' A' ' 253' ' ' GLN . 31.2 mt -104.97 147.48 34.55 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.642 -0.254 . . . . 72.43 110.4 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.5 -35.93 86.93 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.875 2.383 . . . . 60.1 112.907 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.568 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 18.6 p90 -95.35 8.34 43.48 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 120.686 -0.405 . . . . 73.34 111.117 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 265' ' ' LEU . 66.2 tt0 -85.14 -24.8 27.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.343 0.592 . . . . 63.51 109.689 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -96.92 -23.4 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.653 -0.703 . . . . 72.43 109.671 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 261' ' ' TRP . 94.7 m-20 -102.51 14.34 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.731 -0.668 . . . . 72.01 111.354 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -70.08 -12.73 61.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.02 0.438 . . . . 75.12 110.783 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -64.64 -16.65 63.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 74.32 111.356 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 5.9 t70 -129.72 117.96 18.63 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-O 120.933 0.397 . . . . 63.04 110.626 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -51.69 -27.84 27.64 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.722 2.948 . . . . 72.24 113.946 -179.302 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.9 mttp -60.26 -52.45 65.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.902 0.382 . . . . 73.42 110.279 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.539 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 95.4 m-85 -72.37 -34.67 68.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 75.53 110.994 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 265' ' ' LEU . 92.5 t -55.57 -50.5 66.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.35 -0.386 . . . . 65.23 110.602 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -70.33 -44.07 68.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 73.12 110.368 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.29 -55.42 31.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.784 -0.644 . . . . 63.41 111.174 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.5 p -61.11 -44.37 97.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.027 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.47 ' HE3' ' CZ ' ' A' ' 249' ' ' TYR . 50.4 mttp -55.95 -48.11 76.36 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 116.651 -0.249 . . . . 74.51 111.174 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.6 -41.91 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.732 -0.213 . . . . 62.54 111.066 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -63.03 -40.23 97.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.545 -0.298 . . . . 75.32 111.384 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.945 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 23.0 m-85 -73.88 -33.36 64.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.684 0.278 . . . . 72.34 111.219 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 279' ' ' ARG . 13.8 mtp180 -71.43 -23.76 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 73.41 111.173 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -57.49 -59.07 5.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 75.12 110.378 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.5 88.52 2.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 61.31 110.023 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.2 mm -55.44 -51.37 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 54.22 111.33 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.27 83.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 62.23 111.28 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 31.4 m -68.09 -44.06 77.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 75.24 111.697 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.1 mm? -64.39 -46.67 82.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.598 -0.274 . . . . 64.22 111.336 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -32.69 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.255 . . . . 45.13 111.013 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.48 -37.91 79.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.144 -0.48 . . . . 61.13 111.014 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -94.54 -13.26 26.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.462 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 46.3 t -78.18 -25.28 47.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.842 0.353 . . . . 73.43 111.157 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.535 ' HD1' HG22 ' A' ' 256' ' ' THR . 19.9 t80 -109.82 93.07 13.7 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.15 109.594 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 88.8 Cg_exo -47.45 -48.35 15.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.678 2.918 . . . . 75.0 114.329 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.92 -25.08 67.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 74.33 110.773 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 58.97 41.91 20.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 72.13 110.17 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -63.75 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.794 . . . . 75.12 110.021 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 331' ' ' ILE . 50.9 mttp -152.88 99.07 2.77 Favored Pre-proline 0 C--O 1.227 -0.127 0 CA-C-O 120.489 0.185 . . . . 73.44 110.513 172.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -99.4 38.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.887 2.391 . . . . 72.15 111.419 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.24 -50.9 5.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.068 -0.587 . . . . 34.34 113.268 -170.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.936 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.6 mp0 -54.88 -52.91 61.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.965 0.412 . . . . 63.03 110.213 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.1 mp -60.65 -47.32 93.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.425 -0.807 . . . . 72.4 111.12 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.29 86.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.774 0.321 . . . . 53.44 111.543 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -66.48 -38.57 87.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.157 0.503 . . . . 71.24 110.046 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 320' ' ' LEU . 76.2 t80 -60.0 -52.51 65.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.468 -0.787 . . . . 75.24 110.76 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 306' ' ' VAL . 79.9 mtp -71.93 -32.19 67.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.339 -0.391 . . . . 63.13 111.616 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.51 -42.24 91.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.715 0.769 . . . . 71.44 109.333 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 m -65.39 -44.03 88.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.756 -1.111 . . . . 74.23 111.548 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 302' ' ' TYR . 4.2 m -70.04 -27.24 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 72.13 110.654 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.5 -44.09 92.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.199 0.523 . . . . 73.41 110.009 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.8 tp -76.93 1.71 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 61.34 110.943 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -9.03 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.328 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 21.0 t70 64.36 -81.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.258 0.623 . . . . 74.41 111.083 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -149.6 -44.77 0.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.604 -0.517 . . . . 71.14 109.604 174.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.5 t -154.98 37.86 0.41 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.691 -0.686 . . . . 70.0 110.622 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -51.75 -69.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.051 0.453 . . . . 54.52 111.143 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -175.63 110.34 0.26 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.596 -0.729 . . . . 74.11 109.545 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.607 ' HG3' ' HG2' ' A' ' 240' ' ' ARG . 51.8 Cg_endo -69.81 117.64 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.841 1.694 . . . . 64.32 111.121 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 319' ' ' ASN . 16.5 tp -108.56 82.15 1.57 Allowed 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.355 -0.609 . . . . 62.33 109.355 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -58.3 -36.43 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.333 -0.849 . . . . 70.11 110.977 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.15 -52.34 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 65.34 110.527 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.482 ' HB2' HD23 ' A' ' 316' ' ' LEU . 8.2 t30 -59.22 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 50.23 111.325 -176.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 3.3 mm? -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.498 -0.319 . . . . 62.21 111.426 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -69.53 -34.03 73.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.65 0.262 . . . . 63.22 110.869 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.5 -42.94 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 72.42 111.254 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -67.92 -27.33 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 120.887 -0.325 . . . . 65.12 111.039 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 73.1 mt -65.13 -47.46 77.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.077 -0.342 . . . . 72.33 110.077 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.12 -33.13 75.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.246 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -39.42 89.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 75.03 110.261 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.936 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.11 -45.02 94.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.004 -0.617 . . . . 34.34 112.088 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 331' ' ' ILE . 31.1 tp -65.2 -35.25 80.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.336 0.588 . . . . 74.1 110.041 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.29 -34.3 77.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.792 -0.64 . . . . 71.34 110.12 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.43 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 71.04 111.547 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . 13.1 tt -86.79 -2.76 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.413 0.625 . . . . 72.43 109.901 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 78.19 24.38 63.85 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.722 -0.672 . . . . 71.23 112.867 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 11.1 t -120.65 159.55 25.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.952 -0.388 . . . . 72.0 109.952 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -174.0 4.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.576 -0.527 . . . . 74.31 109.576 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 28.1 t70 -65.39 120.04 12.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.145 0.497 . . . . 71.05 111.076 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.26 100.79 7.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.68 . . . . 65.23 109.371 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.53 ' C ' ' HD2' ' A' ' 338' ' ' LYS . . . 82.34 -81.05 1.73 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.821 -0.704 . . . . 75.21 111.493 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.692 ' HB2' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -170.25 -66.16 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.875 0.324 . . . . 70.11 111.875 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.532 HD22 HG23 ' A' ' 153' ' ' THR . 94.1 mt -144.91 -179.26 6.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.518 0.199 . . . . 75.11 110.678 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -173.3 98.3 0.12 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.71 -0.848 . . . . 75.3 108.71 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 141' ' ' ILE . 20.7 mt -96.79 -79.75 0.45 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.706 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 20.2 p -175.06 -86.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.399 0.518 . . . . 75.43 112.399 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 7.2 p -163.03 -30.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.372 0.508 . . . . 63.14 112.372 -172.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.854 HG22 HG12 ' A' ' 141' ' ' ILE . 39.2 t 69.73 100.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.99 0.424 . . . . 72.03 110.624 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -109.33 21.58 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 72.4 111.968 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 74.33 151.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.963 0.887 . . . . 74.24 113.139 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.666 ' H ' ' HG2' ' A' ' 140' ' ' LYS . . . -176.43 164.95 35.01 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 109.408 -1.477 . . . . 71.42 109.408 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -142.86 105.09 0.38 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.955 -1.117 . . . . 75.51 113.172 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.536 HD11 ' HE2' ' A' ' 142' ' ' TYR . 79.7 mt -111.48 150.47 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.315 . . . . 74.32 110.151 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -152.7 -165.64 2.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 75.33 110.713 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 66.85 90.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.916 0.76 . . . . 74.43 110.828 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.93 ' HD2' HD11 ' A' ' 200' ' ' LEU . 11.1 tppt? -158.66 104.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 74.14 110.696 -174.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 52.4 m -156.83 150.9 24.97 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.42 -0.355 . . . . 72.43 110.114 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.747 HG23 ' HA ' ' A' ' 200' ' ' LEU . 12.9 pt -74.93 143.22 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.917 0.389 . . . . 71.11 111.984 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 97.9 3.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.593 -0.73 . . . . 62.23 110.428 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -135.44 -19.2 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 71.11 111.661 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 357' ' ' LYS . 6.7 mmpt? -70.7 106.7 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 72.22 111.284 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.6 105.49 1.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 73.13 109.468 176.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 359' ' ' LYS . 14.1 tmtt? -64.4 127.86 33.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.94 -0.392 . . . . 72.2 109.94 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.47 ' NZ ' ' HB3' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.616 -0.707 . . . . 71.12 109.097 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.18 -0.304 . . . . 62.24 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.98 136.34 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.01 1.807 . . . . 62.52 112.339 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -143.82 27.42 1.49 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.842 -0.617 . . . . 74.54 109.857 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -93.89 144.86 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.611 -0.722 . . . . 65.13 111.759 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -130.39 102.42 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.713 -0.676 . . . . 55.35 109.238 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.85 108.61 9.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.895 0.379 . . . . 72.13 111.384 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.52 134.98 24.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 71.4 109.999 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.88 122.59 27.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.957 0.408 . . . . 72.4 111.141 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.92 142.75 30.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.988 -0.551 . . . . 74.43 109.901 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.03 -132.01 16.28 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.107 -0.797 . . . . 53.03 111.107 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -160.52 105.21 1.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.717 0.77 . . . . 75.13 110.243 173.804 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -98.3 75.77 2.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.456 -0.793 . . . . 74.21 108.934 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 p -86.44 122.93 31.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.259 -0.882 . . . . 52.44 111.519 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.8 m -131.2 99.72 4.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 65.42 109.497 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.46 43.59 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.429 -0.351 . . . . 62.12 111.193 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.01 49.64 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.437 0.637 . . . . 64.54 110.856 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -72.29 109.31 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 65.51 111.349 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -140.54 38.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.734 0.778 . . . . 72.12 108.935 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.2 tp -92.07 124.95 36.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.848 -1.069 . . . . 73.54 111.14 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.49 -78.35 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 41.41 109.51 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 68.08 -16.4 0.19 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.205 1.187 . . . . 75.53 114.205 168.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -83.39 -90.27 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.207 0.458 . . . . 70.11 111.182 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -134.06 93.49 3.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.501 0.667 . . . . 74.1 111.191 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 178.4 -59.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.196 -1.366 . . . . 54.21 107.978 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' HA2' ' A' ' 40' ' ' GLY . 40.2 t -66.19 123.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.851 -1.068 . . . . 71.2 109.999 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.8 -0.14 57.74 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.961 -0.563 . . . . 52.22 113.192 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 39.4 tt0 -71.17 129.86 40.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.316 0.558 . . . . 74.34 110.097 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -77.44 130.46 36.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.435 0.636 . . . . 73.2 110.766 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -134.12 128.45 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.072 -0.967 . . . . 75.41 109.584 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 49.6 m -108.39 119.08 38.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.922 0.392 . . . . 64.12 110.35 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 116' ' ' SER . 5.7 p-10 -92.93 169.15 10.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 54.5 109.953 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 116' ' ' SER . 24.7 ptt? -71.96 -10.22 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.278 0.473 . . . . 71.14 112.278 -170.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.96 8.85 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.673 0.273 . . . . 55.2 110.601 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? 69.45 81.45 0.17 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.541 -0.754 . . . . 74.32 111.534 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' THR . 35.6 mtmm -152.99 135.95 15.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.009 -0.541 . . . . 72.3 109.966 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -105.55 89.23 3.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.985 -0.376 . . . . 71.53 109.985 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' ASN . 27.4 p-90 -116.19 160.15 20.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.872 0.368 . . . . 73.52 110.918 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.524 ' HB3' HD12 ' A' ' 28' ' ' ILE . 1.1 ptpm? -110.64 127.22 55.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.277 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.89 144.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.375 -0.602 . . . . 60.34 109.375 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -111.73 -121.12 4.0 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.481 -0.866 . . . . 43.2 113.198 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 92.2 mt -81.39 138.01 48.39 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 75.1 111.425 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.4 Cg_exo -74.39 108.07 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.056 2.504 . . . . 54.32 112.057 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 53' ' ' LEU . 45.2 mt -76.75 -47.57 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 62.5 109.842 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.53 -32.53 6.42 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.754 -0.657 . . . . 64.24 112.953 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.56 141.74 28.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.873 0.368 . . . . 75.22 110.516 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.08 62.33 0.14 Allowed Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.148 -0.781 . . . . 70.35 111.148 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.98 8.1 87.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.014 -0.612 . . . . 72.52 112.642 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 53.2 t80 -164.87 -73.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.919 -0.4 . . . . 64.13 109.919 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.58 157.7 7.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.952 -0.642 . . . . 71.44 112.064 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.4 m 63.19 38.13 10.78 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.04 0.448 . . . . 70.13 111.057 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' LYS . 2.1 mm -98.2 137.79 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 62.55 110.722 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -117.06 147.88 41.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.241 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' HD11 ' A' ' 43' ' ' ILE . 60.3 tp -85.95 152.94 22.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.086 -0.709 . . . . 63.43 109.086 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.56 31.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.735 -0.468 . . . . 33.42 109.735 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 23.2 t70 -83.81 -49.43 9.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.21 0.528 . . . . 75.04 110.233 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 54.6 ttp -162.13 135.3 6.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.914 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -97.63 -44.44 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.36 . . . . 72.52 110.11 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.5 t -100.89 120.11 39.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.365 -0.606 . . . . 74.3 109.365 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.5 p -61.21 -57.66 11.53 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.397 0.888 . . . . 53.45 113.397 -169.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.04 -58.54 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.56 -0.456 . . . . 73.24 111.045 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -85.15 77.38 10.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.06 0.457 . . . . 70.23 110.509 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.88 143.26 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.916 -0.583 . . . . 71.3 110.345 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.57 -89.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.688 -0.767 . . . . 71.3 111.949 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 m -111.35 50.31 0.83 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.916 -0.402 . . . . 74.43 109.916 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 65.13 -88.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.326 -0.852 . . . . 45.14 109.91 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -166.29 94.79 0.76 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.117 -0.492 . . . . 73.4 109.961 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.78 44.79 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.154 2.569 . . . . 63.34 112.34 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 p -148.4 148.96 30.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.134 0.492 . . . . 71.05 111.697 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 132' ' ' ASP . 21.6 m -125.85 157.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.034 -0.728 . . . . 61.42 109.034 172.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.7 p -128.71 124.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.18 0.514 . . . . 75.12 111.169 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -87.44 132.82 33.87 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 72.31 108.968 173.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.7 129.29 74.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.425 -0.51 . . . . 60.53 112.023 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 80' ' ' LEU . 43.8 mt-10 -125.87 159.01 63.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 63.33 109.363 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.96 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.392 2.061 . . . . 55.43 112.608 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -66.68 -36.48 82.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.443 0.64 . . . . 61.54 109.525 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -88.87 73.92 8.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.103 -0.953 . . . . 75.01 109.227 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -81.25 177.38 9.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.729 -0.669 . . . . 64.03 110.399 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -130.05 -100.59 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.522 -0.847 . . . . 73.42 112.553 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.9 Cg_exo -61.91 -21.73 72.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.556 2.837 . . . . 74.12 113.307 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 46.0 tp -51.17 -34.94 33.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.678 0.621 . . . . 61.41 112.678 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 86.1 t80 -66.76 -44.65 80.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.531 -0.468 . . . . 74.51 110.553 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -68.24 -50.03 56.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.842 -0.617 . . . . 74.32 110.708 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 198' ' ' TYR . 9.1 pt-20 -64.58 -52.98 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.247 -0.888 . . . . 72.12 110.875 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 63.4 tp -59.93 -40.93 90.59 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 111.572 0.212 . . . . 55.41 111.572 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 3.3 tmtm? -60.95 -51.12 70.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.783 0.325 . . . . 64.04 110.612 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.8 -32.26 67.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.222 -0.591 . . . . 73.11 109.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 31.2 t80 -57.67 -45.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 51.52 109.795 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 28.3 mt-30 -61.33 -38.54 87.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.927 -0.579 . . . . 65.41 110.697 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HA ' ' HZ2' ' A' ' 92' ' ' LYS . 17.4 mtm180 -68.9 -28.08 66.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.832 -0.347 . . . . 71.44 111.902 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.89 -35.58 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.856 0.687 . . . . 34.41 112.856 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.2 80.13 7.67 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.415 0.894 . . . . 63.32 113.415 -169.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HZ2' ' HA ' ' A' ' 89' ' ' ARG . 5.4 mptt -139.61 129.57 14.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 108.983 -0.747 . . . . 70.22 108.983 168.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.99 -38.36 69.31 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.618 2.212 . . . . 64.54 111.849 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 98' ' ' LYS . 16.5 tt0 -64.69 -61.03 2.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 71.32 110.847 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.64 -34.22 77.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 73.44 111.511 -172.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 100' ' ' ILE . 66.9 mt -64.71 -52.61 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.673 -0.24 . . . . 73.42 110.445 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.57 ' HA ' HD11 ' A' ' 100' ' ' ILE . 6.6 tp-100 -58.13 -36.69 73.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.323 0.582 . . . . 73.22 110.27 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 48.2 mtpt -67.98 -28.86 67.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 62.2 111.126 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.755 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 57.4 t90 -66.3 -56.26 12.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.611 -0.268 . . . . 74.42 110.792 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.07 -26.02 37.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 C-N-CA 120.685 -0.406 . . . . 74.34 111.422 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -66.22 -39.32 89.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.95 -0.3 . . . . 73.41 110.437 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.3 m -76.02 -48.98 18.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.353 -0.385 . . . . 62.3 111.738 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.31 57.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 72.23 109.651 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 1.028 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER 58.35 77.28 0.3 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.103 -0.953 . . . . 73.01 111.087 -174.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 100' ' ' ILE . 95.7 mt -136.7 -176.69 4.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.888 -1.051 . . . . 73.12 108.892 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -79.57 -70.22 0.53 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.643 0.258 . . . . 64.31 110.805 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.428 ' HA ' HG21 ' A' ' 100' ' ' ILE . 30.8 p90 -159.94 163.17 34.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 71.11 109.94 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HG ' ' CE3' ' A' ' 99' ' ' TRP . 0.9 OUTLIER -79.42 137.19 37.17 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.566 0.541 . . . . 65.42 111.356 -176.021 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.33 17.82 16.98 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 121.256 -0.497 . . . . 63.33 112.655 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 HD22 ' A' ' 108' ' ' LEU . 76.0 t -101.71 135.25 19.8 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.743 0.417 . . . . 75.04 110.372 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 28.3 Cg_endo -63.78 159.62 40.75 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.366 2.71 . . . . 50.35 114.269 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -81.38 154.67 26.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.101 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -99.97 116.51 32.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.515 -0.311 . . . . 75.41 110.355 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.598 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 41.1 m95 -100.88 -29.14 12.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.953 0.406 . . . . 75.13 110.546 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 158.32 -179.53 33.94 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.577 -0.821 . . . . 71.52 112.645 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.666 ' O ' ' HG2' ' A' ' 32' ' ' MET . 36.9 p -169.99 175.33 5.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.529 -0.915 . . . . 61.24 108.529 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.14 -150.93 19.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.477 -1.344 . . . . 60.55 113.293 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.1 tt -133.27 134.13 43.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.883 0.373 . . . . 73.24 110.522 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -126.54 108.63 11.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 29.4 t70 -79.09 150.58 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.299 0.571 . . . . 54.21 111.718 -172.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -133.05 52.44 2.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.725 -0.843 . . . . 64.25 108.725 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 67.17 75.84 0.3 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.895 -1.048 . . . . 44.14 111.168 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.25 -42.88 3.18 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.9 -0.591 . . . . 65.21 112.008 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -89.06 82.74 6.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.879 -0.786 . . . . 71.42 108.879 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.8 m -78.46 135.95 37.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.776 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -94.69 137.98 33.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.035 0.445 . . . . 73.13 110.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -112.77 120.36 41.23 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.64 -0.874 . . . . 72.45 108.64 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 42.1 p90 -133.94 162.71 31.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.421 0.526 . . . . 72.43 112.421 -170.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.3 ttm -129.87 131.49 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.719 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -102.68 122.93 55.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.273 0.558 . . . . 74.13 109.746 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ptm -133.83 -169.97 2.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.531 -0.759 . . . . 62.42 110.445 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.9 m-20 -64.24 169.71 4.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.864 0.364 . . . . 73.33 111.962 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.734 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -82.5 106.0 14.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.51 0.671 . . . . 74.14 111.978 -174.962 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -124.39 172.25 9.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 74.31 110.26 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.23 -38.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.841 . . . . 34.13 112.344 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 m -95.87 128.19 42.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.368 -0.234 . . . . 73.14 110.368 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -122.66 160.9 24.85 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.646 -0.501 . . . . 74.23 109.646 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 10.6 mp -75.8 -8.43 56.86 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.227 0.454 . . . . 75.02 112.227 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' HB3' ' HA2' ' A' ' 348' ' ' GLY . 10.3 tm0? -73.67 -49.75 24.32 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.148 -0.686 . . . . 75.15 109.148 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 345' ' ' GLU . 13.5 pttm -76.86 -21.64 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.606 -0.438 . . . . 73.31 110.914 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 54.6 mt -74.12 -51.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.562 -0.29 . . . . 64.44 110.947 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.446 ' HE1' ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.76 -32.47 73.78 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.126 -0.23 . . . . 74.42 110.944 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.18 -43.31 82.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 63.22 110.137 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.71 -31.53 61.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 34.34 110.986 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.25 -2.59 58.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 75.52 110.912 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.97 38.04 22.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.472 -0.785 . . . . 72.14 112.511 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.652 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 74.1 mttt 62.17 73.12 0.48 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.433 0.531 . . . . 75.13 112.433 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -156.29 82.2 0.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.307 0.575 . . . . 73.04 109.729 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.49 141.34 29.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.604 -0.726 . . . . 51.32 111.141 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 144.09 57.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.77 -0.65 . . . . 75.12 109.852 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.525 ' HD2' HD13 ' A' ' 331' ' ' ILE . 13.1 ttm180 -63.24 -29.55 70.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.347 0.129 . . . . 71.05 111.347 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 333' ' ' SER . 57.3 mttp -57.6 -44.59 85.53 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.21 0.528 . . . . 72.44 110.071 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.545 ' HA ' HD22 ' A' ' 339' ' ' LEU . 6.8 m -66.98 -41.32 87.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.38 -0.827 . . . . 74.15 110.577 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.52 -45.51 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 75.52 111.403 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.563 ' HG ' HD22 ' A' ' 328' ' ' LEU . 3.9 mm? -68.55 -37.69 80.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.506 -0.316 . . . . 74.24 111.356 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.42 ' HG2' HD21 ' A' ' 339' ' ' LEU . 52.3 tp60 -65.84 -39.62 90.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.181 0.515 . . . . 50.34 109.98 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.56 HD12 HG11 ' A' ' 193' ' ' VAL . 5.2 mp -63.19 -51.98 64.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.53 -0.759 . . . . 63.42 111.295 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.2 p -63.19 -34.98 78.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 73.33 111.178 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.25 -40.54 97.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 74.14 110.801 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.831 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -68.94 -43.22 75.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 65.42 111.204 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 42.5 mt -64.59 -29.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.149 -0.478 . . . . 74.51 109.845 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 317' ' ' TYR . 29.0 tp -63.1 -55.68 23.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.523 -0.762 . . . . 73.44 111.148 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.755 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 4.8 p-10 -67.93 -31.51 71.32 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.573 -0.451 . . . . 73.44 110.703 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 168' ' ' ILE . 70.5 mt -66.82 -46.82 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.41 -0.359 . . . . 65.32 111.041 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.3 pp -68.71 -33.81 74.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 64.31 110.086 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 165' ' ' LEU . 5.4 mm-40 -55.58 -56.31 21.82 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.323 -0.399 . . . . 61.23 110.362 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.39 -49.09 79.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 60.11 112.192 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.8 pt -75.01 -38.26 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.107 0.41 . . . . 62.45 112.107 -173.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -72.78 -21.0 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.11 0.481 . . . . 71.43 109.831 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 207' ' ' GLU . 31.8 tt0 -75.27 -6.0 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.478 -0.783 . . . . 70.33 110.302 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -124.44 -69.69 0.79 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.663 -0.415 . . . . 64.22 111.645 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 203' ' ' ARG . 35.6 mt-10 -155.48 -59.02 0.1 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.469 0.544 . . . . 74.42 112.469 -170.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.847 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 48.1 m-85 -83.71 147.78 27.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.12 0.785 . . . . 70.34 113.12 -166.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.486 HG22 ' HD2' ' A' ' 204' ' ' TYR . 16.9 m -132.26 164.03 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.981 -1.008 . . . . 70.41 108.924 171.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -105.35 131.2 53.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.738 -0.467 . . . . 73.13 109.738 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.31 -10.41 64.0 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.05 -1.22 . . . . 62.54 110.05 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 1.071 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 15.6 t70 -123.88 110.73 15.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.675 -0.763 . . . . 75.1 110.638 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.2 mm -111.86 66.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.416 -0.957 . . . . 74.24 108.416 166.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 79.9 tttt -90.54 161.77 15.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.886 -0.597 . . . . 75.44 109.882 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -57.6 -19.31 25.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 71.33 111.786 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 p -75.91 -12.07 60.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.522 -0.308 . . . . 35.2 111.488 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 195' ' ' LEU . 3.0 m-20 -82.5 -30.05 30.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.713 0.292 . . . . 51.34 110.646 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 6.4 mp -94.05 131.54 39.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 62.41 110.581 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 194' ' ' TYR . 1.1 pp -138.42 157.43 46.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 73.31 111.048 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.59 156.69 20.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 70.34 109.5 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.65 HD21 ' HE1' ' A' ' 194' ' ' TYR . 51.1 m-80 -63.51 152.15 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.709 -0.478 . . . . 74.51 109.709 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -56.5 -32.7 65.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.101 -0.499 . . . . 70.21 111.133 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.47 3.43 5.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.209 0.448 . . . . 74.35 112.209 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 186' ' ' ASN . 12.7 m120 -128.53 92.89 39.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.823 -0.351 . . . . 73.41 111.242 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -9.26 16.46 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.829 2.353 . . . . 72.4 111.258 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.13 -6.89 50.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 74.13 111.193 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.68 122.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.094 0.474 . . . . 71.0 110.573 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 157' ' ' LEU . 7.1 p -103.62 137.45 32.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.451 -0.795 . . . . 75.31 109.712 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.65 ' HE1' HD21 ' A' ' 186' ' ' ASN . 4.7 m-85 -114.09 158.17 21.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 182' ' ' ASN . 10.1 tt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.42 -0.956 . . . . 53.01 108.42 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 195' ' ' LEU . 7.2 p -50.79 130.49 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.528 0.68 . . . . 72.11 111.285 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.639 ' HB2' ' CD2' ' A' ' 198' ' ' TYR . 1.2 p-10 -58.25 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.627 -1.17 . . . . 75.41 112.684 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 197' ' ' ASP . 24.1 m-85 -135.21 26.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.953 -0.467 . . . . 71.31 111.796 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -64.13 -39.38 97.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.504 -0.855 . . . . 70.02 111.167 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.38 89.35 2.77 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.188 -0.671 . . . . 74.35 109.188 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -166.23 149.66 7.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 61.3 110.842 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -142.45 144.65 33.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.63 -0.507 . . . . 65.42 109.63 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.847 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 23.1 ptt180 -84.44 141.08 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 75.34 110.327 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.486 ' HD2' HG22 ' A' ' 174' ' ' VAL . 6.9 m-85 -139.23 -59.35 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 73.03 112.257 -171.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.95 121.75 41.0 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.548 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 103.38 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 62.14 111.791 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 170' ' ' GLU . 29.1 tt0 71.65 -11.38 0.74 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.754 0.821 . . . . 75.51 111.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.63 -30.79 1.94 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.359 -0.924 . . . . 70.22 113.165 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.72 122.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.24 0.543 . . . . 65.31 110.903 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -89.6 154.76 19.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.06 -0.518 . . . . 71.03 110.472 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 8.8 mtpm? -93.72 -175.11 3.65 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.021 -0.536 . . . . 51.14 110.159 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.4 mp0 -52.68 130.09 31.43 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.53 0.519 . . . . 73.31 110.664 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 49.2 p90 -65.37 129.13 38.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 74.32 110.609 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.404 ' NZ ' ' HB2' ' A' ' 212' ' ' GLU . 42.0 mmtm -98.08 -45.18 6.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.627 -0.715 . . . . 62.33 110.575 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 234' ' ' ASN . 50.4 mt-10 67.2 -5.13 0.75 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.134 0.79 . . . . 73.54 113.134 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 215' ' ' GLU . 6.0 t70 169.2 86.25 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 O-C-N 123.515 0.51 . . . . 73.44 110.033 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 61.3 Cg_endo -87.72 -40.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.22 1.947 . . . . 73.25 111.973 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 28.6 ttpt -168.47 11.92 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.713 -0.676 . . . . 70.24 110.241 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.52 98.72 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.061 0.458 . . . . 71.42 111.216 -167.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.413 ' HB3' HG21 ' A' ' 355' ' ' THR . 74.7 m -71.23 -68.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.315 -0.402 . . . . 72.5 110.371 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.437 ' HD2' HG21 ' A' ' 228' ' ' THR . 57.6 t-80 55.57 92.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.711 0.632 . . . . 72.41 112.024 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG22 ' A' ' 355' ' ' THR . 20.5 p-10 -91.23 -59.53 2.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.61 -0.268 . . . . 62.31 111.393 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 1.071 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -93.79 -149.49 25.38 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 74.41 113.775 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.504 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 69.3 p -81.26 150.14 28.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.661 0.267 . . . . 75.0 110.988 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.23 -31.33 47.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.708 -175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.594 ' HA ' HD21 ' A' ' 265' ' ' LEU . 2.4 mp0 -49.14 -50.93 35.2 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.456 -0.793 . . . . 63.22 111.184 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 179' ' ' LYS . 97.3 m-85 -101.92 -13.58 17.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 72.34 112.031 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.437 HG21 ' HD2' ' A' ' 221' ' ' HIS . 35.9 m -46.95 -49.58 20.42 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.385 0.428 . . . . 63.41 111.086 176.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.3 m 59.33 -156.02 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.853 -0.612 . . . . 74.32 110.888 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 230' ' ' ILE . 3.4 mp -71.75 -53.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.367 -0.378 . . . . 74.41 110.282 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 238' ' ' PRO . 1.6 m-20 -49.46 -60.56 2.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.514 -0.766 . . . . 61.32 112.991 -173.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.2 67.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.928 0.394 . . . . 50.33 111.795 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -67.82 -42.82 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.391 0.615 . . . . 74.22 109.863 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.856 ' HB3' ' HA ' ' A' ' 215' ' ' GLU . 6.4 m-20 -77.25 -4.53 45.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.17 . . . . 70.34 111.195 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.11 53.74 Favored Glycine 0 C--N 1.335 0.515 0 O-C-N 123.497 0.498 . . . . 53.42 112.56 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 7.4 p -120.25 140.98 42.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.584 0.23 . . . . 75.13 110.839 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.07 106.94 2.12 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.871 -0.789 . . . . 72.12 108.871 169.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.462 ' HB3' ' OD2' ' A' ' 231' ' ' ASP . 19.9 Cg_endo -61.07 -87.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.503 2.136 . . . . 71.24 112.826 -171.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 240' ' ' ARG . 20.7 m 171.13 -49.37 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.798 1.239 . . . . 70.31 107.736 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 239' ' ' SER . 0.0 OUTLIER 176.38 -16.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.818 -1.537 . . . . 70.3 107.76 -173.031 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.574 ' NH2' ' HD2' ' A' ' 279' ' ' ARG . 9.5 mmm180 -52.4 -68.0 0.21 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.334 -1.303 . . . . 73.42 110.984 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -45.55 -42.02 9.8 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 123.706 0.629 . . . . 75.2 113.711 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.02 -64.99 0.64 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.769 0.795 . . . . 74.14 110.207 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.442 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 36.2 mt -74.06 -30.46 62.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.78 -1.1 . . . . 74.11 111.198 -174.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 279' ' ' ARG . 7.8 tp10 -62.21 -57.91 9.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.42 110.274 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.74 -41.29 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 75.24 110.341 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.89 -41.63 82.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.051 0.453 . . . . 71.24 110.816 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -43.76 98.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.07 -0.586 . . . . 24.41 112.203 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -63.07 -34.53 77.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.668 0.27 . . . . 72.32 110.896 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 57.9 m -62.0 -51.79 66.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.014 0.435 . . . . 71.54 110.525 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 76.3 mtm -61.45 -42.02 98.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.862 -0.608 . . . . 64.01 111.866 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.59 -34.33 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.392 -0.523 . . . . 74.32 110.974 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.27 -40.33 71.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 71.4 110.231 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.07 -28.46 67.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.246 -0.434 . . . . 74.53 111.247 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.8 tp -92.34 -40.04 11.14 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.174 0.435 . . . . 73.23 112.174 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 m -100.14 -17.63 17.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.509 . . . . 71.13 111.25 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.652 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 85.69 -59.74 4.74 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.759 -0.734 . . . . 62.32 112.545 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -113.8 141.76 46.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.336 -0.508 . . . . 71.21 109.924 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 85.6 mt -103.16 142.08 23.83 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.69 . . . . 71.22 110.098 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 278' ' ' TYR . 15.2 Cg_exo -68.84 -2.3 9.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.807 2.338 . . . . 74.22 112.967 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 36.4 p90 -124.3 5.6 8.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 73.01 110.21 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 34.1 tt0 -72.31 -21.63 61.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 71.55 111.048 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.92 -20.18 33.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.451 . . . . 54.22 109.976 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 89.2 m-20 -96.15 7.12 47.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.78 -0.646 . . . . 64.32 110.465 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.9 tm? -64.39 -20.84 66.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.472 -0.785 . . . . 74.55 110.519 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -73.35 -1.6 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 74.25 112.337 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 271' ' ' VAL . 20.8 t70 -137.28 120.87 11.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 121.073 -0.251 . . . . 73.34 110.958 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 34.8 Cg_exo -58.12 -29.73 88.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.307 2.671 . . . . 50.23 113.505 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.42 -41.71 38.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.805 0.336 . . . . 75.22 110.245 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 24.3 m-85 -64.63 -40.92 96.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.715 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 267' ' ' ASP . 89.8 t -54.16 -49.33 62.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 123.125 0.265 . . . . 71.25 110.975 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 276' ' ' ILE . 45.3 mtm180 -62.4 -59.05 5.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.631 -0.259 . . . . 63.34 111.115 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.0 -47.96 79.59 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.486 0.491 . . . . 73.35 111.629 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.8 m -58.53 -50.54 73.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.479 -0.328 . . . . 75.24 110.53 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.39 -32.92 73.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.654 -0.248 . . . . 73.25 111.229 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 272' ' ' ARG . 82.8 mt -64.15 -42.41 95.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 55.1 110.216 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 280' ' ' GLU . 11.0 mmp_? -62.0 -41.64 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 71.24 111.053 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 260' ' ' PRO . 73.3 m-85 -74.08 -43.27 58.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 73.02 110.904 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.574 ' HD2' ' NH2' ' A' ' 241' ' ' ARG . 34.3 ttp180 -65.38 -20.02 66.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.355 0.597 . . . . 62.13 110.708 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 277' ' ' ARG . 36.6 tt0 -60.53 -47.91 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.164 -0.925 . . . . 75.13 110.761 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -159.2 94.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.299 0.571 . . . . 74.32 110.41 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 303' ' ' MET . 0.2 OUTLIER -80.67 -29.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.598 -0.728 . . . . 73.3 111.921 -177.038 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.41 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -52.53 -48.36 66.11 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.522 0.564 . . . . 74.44 112.522 -168.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.9 m -69.53 -38.11 77.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.96 0.409 . . . . 75.24 111.666 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.417 HD13 ' HD1' ' A' ' 278' ' ' TYR . 76.5 mt -72.7 -48.2 40.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.067 -0.515 . . . . 74.4 111.321 -172.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.455 ' SD ' ' HB ' ' A' ' 282' ' ' ILE . 1.3 mpt? -61.24 -40.56 94.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.348 . . . . 71.43 110.765 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.21 -28.16 69.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.896 -0.593 . . . . 74.1 111.224 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -75.36 -43.64 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 72.22 110.774 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.11 -41.89 99.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.89 -0.595 . . . . 74.33 111.472 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.428 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 47.2 m-85 -123.15 82.2 51.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.56 -0.291 . . . . 74.11 110.953 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.62 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.288 1.992 . . . . 64.33 112.045 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.05 -9.0 28.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.338 0.59 . . . . 71.02 109.993 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -74.82 -36.13 62.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.006 -174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -173.66 -165.98 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 65.43 108.632 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.4 ptmm? -120.88 114.27 32.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 65.54 111.51 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 290' ' ' PHE . 42.2 Cg_endo -105.23 37.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.675 2.917 . . . . 75.54 112.163 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -79.5 -50.87 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.847 -0.692 . . . . 72.42 113.068 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.463 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.1 pm0 -64.17 -36.94 85.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.911 0.386 . . . . 74.41 110.864 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.64 -48.37 72.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 74.15 110.773 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.9 -35.73 79.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 75.44 110.375 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 49.7 tptt -70.95 -42.11 70.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 74.24 110.076 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.515 ' O ' HG13 ' A' ' 306' ' ' VAL . 82.7 t80 -56.19 -49.22 74.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.528 -0.76 . . . . 73.12 110.536 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.751 ' HB2' HG13 ' A' ' 282' ' ' ILE . 79.1 mtp -72.69 -31.38 64.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 74.25 111.235 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 37.1 tt0 -62.06 -42.23 98.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.774 0.797 . . . . 64.4 109.056 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 86.8 m -60.56 -45.98 91.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.634 -1.166 . . . . 71.3 111.211 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 9.8 m -73.03 -33.79 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 121.028 -0.269 . . . . 75.24 111.712 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -72.75 -24.63 60.99 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.816 -0.439 . . . . 74.13 109.816 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.16 -12.04 60.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.882 -0.599 . . . . 73.32 110.816 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 96.6 mt -81.12 8.25 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 73.35 111.401 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.47 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.357 0.663 . . . . 74.32 112.209 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.89 -50.72 0.71 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.514 -0.921 . . . . 64.42 108.514 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 17.3 m -136.64 67.66 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.514 -0.766 . . . . 72.33 110.349 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 13.0 tp10 -104.46 161.28 14.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 62.42 109.608 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.25 110.14 5.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 74.42 111.205 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.29 121.6 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.863 2.375 . . . . 70.42 113.034 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.3 mt -93.79 92.86 7.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.523 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' A' ' 320' ' ' LEU . 12.7 m-85 -63.76 -32.14 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 74.13 111.013 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 321' ' ' ARG . 21.7 mp0 -57.11 -46.45 82.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 74.34 110.14 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -68.13 -37.01 80.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 64.02 110.472 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 317' ' ' TYR . 96.2 mt -60.27 -52.29 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 73.35 110.919 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 318' ' ' GLU . 6.6 ptp180 -66.85 -28.39 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 75.01 109.739 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.39 -51.78 58.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 53.42 111.122 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -69.46 -30.04 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 121.063 -0.255 . . . . 74.54 111.24 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.47 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.1 mt -67.83 -48.54 65.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 73.14 110.344 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.61 -29.73 69.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 72.3 110.755 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -48.02 82.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.188 -0.671 . . . . 62.14 109.188 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.463 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.85 -38.51 94.38 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.893 -0.67 . . . . 62.24 112.749 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 333' ' ' SER . 41.7 tp -66.5 -41.96 88.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.172 0.511 . . . . 73.13 110.561 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.54 -25.88 60.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.98 -0.554 . . . . 62.24 110.544 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.07 83.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 75.42 110.587 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.525 HD13 ' HD2' ' A' ' 151' ' ' ARG . 47.0 pt -89.35 7.29 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 73.43 110.647 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 73.34 25.33 73.19 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.005 -0.543 . . . . 55.54 113.424 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.581 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 59.4 m -112.29 139.36 47.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.875 0.369 . . . . 73.53 111.494 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -136.61 -66.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 74.42 110.084 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.22 147.36 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.943 0.402 . . . . 75.42 110.299 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.46 -39.89 5.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.932 -0.576 . . . . 74.14 109.789 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.61 -31.16 1.67 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.008 -0.615 . . . . 55.52 112.626 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.653 ' NZ ' ' HB3' ' A' ' 338' ' ' LYS . 0.1 OUTLIER -172.88 29.8 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.573 0.582 . . . . 62.35 112.573 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 153' ' ' THR . 49.3 mt 71.57 150.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.09 0.947 . . . . 54.13 112.756 173.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 341' ' ' LEU . 34.0 t70 -122.01 104.85 9.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.024 -0.989 . . . . 71.33 110.081 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 340' ' ' ASP . 1.7 pt? 174.2 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.278 -0.874 . . . . 53.53 110.049 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.0 m -66.96 81.12 0.11 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.941 -0.572 . . . . 75.24 112.242 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.12 -30.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.113 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 46.6 t 59.62 95.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.494 -0.776 . . . . 74.12 112.429 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 35.3 mt-10 -134.79 -165.41 1.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.6 . . . . 70.53 109.625 173.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.18 153.63 20.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.602 0.239 . . . . 62.22 111.058 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 146.74 -147.67 18.73 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.304 -0.718 . . . . 54.32 111.304 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 139' ' ' GLN . . . 82.83 49.36 5.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.704 -0.76 . . . . 22.01 112.241 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.3 mt -125.74 169.72 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.811 0.339 . . . . 75.34 111.412 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 63.61 87.44 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.355 -0.839 . . . . 74.55 112.395 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -127.38 -169.14 1.99 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 41.53 109.396 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 353' ' ' THR . 37.4 mmtm -144.13 -145.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.881 -0.415 . . . . 71.12 109.881 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 352' ' ' LYS . 8.7 t -157.03 172.52 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -67.24 142.88 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.791 0.329 . . . . 73.03 110.404 177.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 222' ' ' ASP . 14.5 t -98.02 135.03 40.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.671 -0.863 . . . . 74.21 108.671 176.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -173.21 -52.15 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 71.11 109.986 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 358' ' ' ARG . 19.1 pttp -163.71 -175.33 4.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.815 -0.809 . . . . 53.05 108.815 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 357' ' ' LYS . 57.4 mtm180 -78.79 164.07 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.694 -0.484 . . . . 65.23 109.694 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -72.13 -40.41 68.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.864 0.364 . . . . 62.43 110.201 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.697 -0.668 . . . . 71.44 109.88 177.003 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.014 0.435 . . . . 75.43 110.708 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.404 ' HB2' HG23 ' A' ' 4' ' ' VAL . 72.6 Cg_endo -79.7 152.52 22.62 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.433 2.089 . . . . 71.21 111.413 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 3' ' ' ARG . 19.9 mmm180 -110.03 61.32 0.6 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.777 -0.453 . . . . 53.0 109.777 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 2' ' ' PRO . 61.0 t -97.2 108.8 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.877 -0.601 . . . . 75.1 110.752 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -109.49 141.94 41.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.067 -0.515 . . . . 74.1 109.829 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.89 108.9 3.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.375 . . . . 71.23 110.926 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.29 107.18 3.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 61.35 109.712 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -96.82 116.3 28.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.293 0.568 . . . . 71.22 111.163 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.58 129.79 16.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.559 -0.746 . . . . 71.11 109.443 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.93 89.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.481 -0.866 . . . . 62.33 112.613 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -116.52 110.83 19.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.161 0.505 . . . . 74.25 110.026 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 48.2 tt0 -99.02 119.89 38.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.099 0.476 . . . . 63.15 111.417 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -130.57 120.39 23.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.23 -0.656 . . . . 74.24 109.23 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -169.05 101.99 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 75.42 110.799 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.91 113.97 14.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 74.2 109.616 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -135.43 159.89 40.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.214 0.531 . . . . 73.13 111.342 -176.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -130.29 103.33 6.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 73.3 109.323 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -97.76 44.05 1.05 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.099 0.476 . . . . 64.41 109.944 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.0 111.1 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 64.11 111.33 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 132.39 16.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.495 -0.775 . . . . 74.21 110.064 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 12.0 tp10 -156.06 150.81 26.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.792 -0.818 . . . . 74.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.54 -21.02 3.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.102 0.408 . . . . 74.43 112.102 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -119.35 29.3 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.338 0.59 . . . . 53.11 110.833 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . . . -158.97 -65.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 72.1 110.131 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 21' ' ' GLU . 92.0 t -67.18 147.55 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.462 -0.79 . . . . 65.34 110.7 175.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.47 -15.61 57.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.203 -0.522 . . . . 63.11 114.363 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.1 mm-40 -63.47 129.06 38.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.799 0.799 . . . . 70.22 109.737 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.707 HG22 ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -95.2 131.43 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.626 . . . . 55.33 111.993 -174.235 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 38.9 pt -96.91 150.13 4.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.437 -0.801 . . . . 61.12 109.213 171.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HZ ' ' A' ' 128' ' ' PHE . 6.8 m -105.63 113.24 26.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.534 -0.303 . . . . 54.24 111.225 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.6 t70 -65.13 152.1 44.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 55.23 109.658 175.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.4 tpt -67.35 -18.85 65.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.476 . . . . 73.15 111.454 -174.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.31 17.45 20.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.099 -0.5 . . . . 74.23 110.639 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 68.81 84.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.406 0.682 . . . . 74.41 111.373 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 41.1 mtmt -152.57 131.94 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 51.15 109.371 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 56' ' ' MET . 3.4 mp0 -89.06 127.74 35.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.737 0.303 . . . . 74.43 110.738 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 74.5 m95 -125.25 117.73 24.45 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.555 -0.535 . . . . 70.22 109.555 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.707 ' HG2' HG22 ' A' ' 28' ' ' ILE . 22.0 mtmm -78.75 130.75 36.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.572 -0.451 . . . . 75.42 109.88 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.62 HG23 ' CD2' ' A' ' 52' ' ' TYR . 3.2 p -67.38 117.5 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.166 -0.47 . . . . 63.02 110.431 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -90.51 -128.93 3.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.845 -0.693 . . . . 50.32 111.841 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.4 mt -86.81 137.62 33.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.721 -0.282 . . . . 70.23 111.049 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.71 102.69 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.824 2.349 . . . . 51.31 110.331 171.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mt -86.98 -70.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.903 -0.589 . . . . 74.11 110.697 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 112.25 165.7 17.3 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.667 -0.778 . . . . 72.54 111.78 -176.063 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.893 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 2.2 tt0 -131.91 166.17 22.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.41 -0.589 . . . . 54.14 109.41 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' OD2' ' A' ' 137' ' ' ASP . . . -82.82 42.61 2.98 Favored Glycine 0 C--O 1.232 -0.026 0 C-N-CA 121.511 -0.376 . . . . 62.31 112.959 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 352' ' ' LYS . . . 179.11 -75.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 109.999 -1.241 . . . . 61.42 109.999 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.512 ' HZ ' ' HA ' ' A' ' 353' ' ' THR . 24.1 m-85 -96.64 83.45 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 62.53 109.586 168.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.893 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -68.95 -158.38 1.5 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.901 -0.59 . . . . 74.35 113.608 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 72.2 m 70.77 30.99 2.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.296 0.569 . . . . 70.4 110.806 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 45' ' ' GLN . 4.2 mm -93.88 122.0 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.307 -0.627 . . . . 74.53 109.307 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.764 ' HE1' ' HB ' ' A' ' 72' ' ' VAL . 28.3 p90 -108.2 150.43 27.26 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.154 -0.618 . . . . 72.51 110.879 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.9 tt -68.97 134.17 49.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.363 -0.835 . . . . 75.23 110.512 -176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 70' ' ' VAL . . . -95.68 102.92 14.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.083 -0.508 . . . . 64.03 109.959 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.37 -35.9 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 71.51 111.251 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.823 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 13.9 tmm? 66.17 -73.92 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.236 -0.654 . . . . 62.12 109.236 -172.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.14 140.71 13.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.931 -0.766 . . . . 63.15 108.931 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -81.72 49.6 1.37 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.359 0.6 . . . . 44.34 110.624 -173.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -152.82 26.83 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 75.43 109.951 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 61' ' ' SER . 0.6 OUTLIER -81.87 170.34 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 72.34 109.275 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.539 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 21.3 t -67.93 -29.1 68.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.382 -0.372 . . . . 73.13 110.064 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG21 ' HD3' ' A' ' 67' ' ' PRO . 5.1 p -82.42 143.65 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.708 -0.479 . . . . 74.2 109.708 173.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.96 -46.07 0.11 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.13 -1.033 . . . . 72.14 113.137 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -78.16 -56.9 4.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.083 0.401 . . . . 64.42 112.083 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.46 -63.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.477 0.547 . . . . 72.14 112.477 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.34 77.33 0.36 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 109.263 -0.643 . . . . 72.52 109.263 -167.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 62' ' ' VAL . 85.7 Cg_endo -80.29 32.18 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.293 2.662 . . . . 74.33 113.593 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.2 p -127.52 136.69 52.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.529 0.681 . . . . 63.44 111.226 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 m -141.99 162.38 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.343 -0.844 . . . . 71.31 109.282 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -132.78 126.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.676 0.75 . . . . 51.12 111.421 -179.057 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 48' ' ' PHE . 60.8 tttm -87.5 127.22 35.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.702 -1.136 . . . . 75.43 109.171 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.764 ' HB ' ' HE1' ' A' ' 52' ' ' TYR . 11.9 p -116.42 135.6 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.014 0.435 . . . . 55.4 111.573 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 49.2 mm-40 -142.36 143.4 26.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.524 -0.762 . . . . 74.31 109.072 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 77' ' ' ASN . 37.6 Cg_exo -60.49 133.01 46.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.52 1.48 . . . . 75.32 109.978 170.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -60.09 -30.39 69.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.788 0.328 . . . . 75.32 110.896 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.74 24.22 10.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 63.54 111.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 74' ' ' PRO . 63.3 t30 -85.98 -50.19 7.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.913 0.387 . . . . 73.0 110.223 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.85 -77.67 0.24 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.378 -0.915 . . . . 52.15 113.65 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.95 -43.31 59.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.268 2.645 . . . . 34.34 114.295 -169.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.01 -29.93 67.62 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 111.957 0.354 . . . . 73.44 111.957 -171.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -66.02 -50.76 63.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.429 -0.508 . . . . 73.41 110.504 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 m -69.06 -40.18 78.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.489 0.662 . . . . 71.45 110.005 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.73 -53.71 54.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.803 -1.089 . . . . 72.13 111.074 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 80' ' ' LEU . 51.7 tp -66.24 -33.03 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 72.52 111.074 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.474 ' HE3' ' OH ' ' A' ' 173' ' ' TYR . 64.8 tttp -60.01 -47.34 86.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.011 0.434 . . . . 75.14 110.096 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 173' ' ' TYR . 59.0 t80 -71.19 -41.62 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.361 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -57.32 -50.23 73.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 63.43 110.838 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -24.41 63.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.109 0.48 . . . . 74.1 110.533 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -69.7 -39.16 77.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 71.24 111.597 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.44 -34.09 7.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.228 0.825 . . . . 75.22 113.228 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 113' ' ' TYR . . . -85.77 100.39 12.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.548 0.689 . . . . 73.14 111.819 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -166.75 100.41 0.66 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.388 -0.968 . . . . 71.24 108.388 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -43.07 -45.33 9.43 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.78 2.987 . . . . 74.35 114.042 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.74 -49.68 74.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.36 -0.382 . . . . 74.32 110.959 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -66.47 -38.74 87.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.621 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 100' ' ' ILE . 81.0 mt -58.13 -53.29 47.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.727 -0.669 . . . . 74.34 110.879 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -62.1 -40.78 97.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.515 -0.311 . . . . 74.52 111.248 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -57.06 -48.98 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.341 -0.39 . . . . 64.24 110.877 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.565 ' CE2' ' HG3' ' A' ' 103' ' ' ARG . 66.0 t-105 -65.24 -49.01 71.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 74.33 110.711 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 96' ' ' ILE . 94.4 mt -53.52 -51.29 43.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.137 0.494 . . . . 75.4 111.519 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -73.72 -31.21 63.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.51 -0.768 . . . . 73.42 111.226 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.3 m -76.17 -40.09 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.02 0.438 . . . . 54.14 111.238 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 11.1 mmm180 -91.8 10.0 30.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 72.55 111.915 -173.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.7 mmpt? 63.58 27.25 14.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 74.3 111.617 173.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 163' ' ' ASP . 97.7 mt -89.11 178.36 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.977 0.418 . . . . 65.23 111.438 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -83.32 -66.95 0.83 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.964 -0.754 . . . . 73.13 108.964 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HA ' ' CD1' ' A' ' 100' ' ' ILE . 18.7 p90 179.87 133.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.728 -1.124 . . . . 74.32 109.541 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -78.74 116.14 18.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.54 -0.541 . . . . 74.3 109.54 177.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.93 72.19 1.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.749 -0.659 . . . . 74.42 112.904 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 111' ' ' PRO . 67.4 t -101.99 140.33 21.09 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.755 -0.831 . . . . 64.54 108.755 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 110' ' ' VAL . 1.3 Cg_endo -44.88 134.33 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.199 2.599 . . . . 73.11 112.443 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 21.4 tptm -65.4 106.23 1.34 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 73.11 110.693 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 35.1 t80 -79.85 113.8 18.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.726 -1.125 . . . . 74.4 111.184 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 130' ' ' ILE . 15.0 m95 -97.94 -36.23 10.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.467 -0.938 . . . . 75.33 108.467 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.49 178.25 48.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.724 -1.125 . . . . 64.43 111.115 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 32' ' ' MET . 14.9 p -172.68 165.42 5.42 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.481 -0.563 . . . . 71.4 109.481 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.09 -173.81 46.09 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.92 -1.134 . . . . 53.34 113.103 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.8 tt -134.93 128.68 32.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.44 -0.948 . . . . 75.31 108.44 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -140.89 125.62 18.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 73.55 110.566 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.24 123.92 26.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 64.34 110.098 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -87.93 -56.97 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.222 -0.444 . . . . 70.32 110.277 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.05 79.93 0.77 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.288 -0.634 . . . . 73.35 109.288 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.19 33.52 85.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.169 -0.773 . . . . 73.4 111.169 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.449 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 13.6 tppt? -158.91 105.0 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.498 -0.556 . . . . 74.53 109.498 -174.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.491 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.3 m -78.85 108.73 12.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.038 0.447 . . . . 64.15 111.07 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -92.05 131.75 37.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.053 -0.521 . . . . 73.43 110.555 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.466 ' HE ' HD23 ' A' ' 84' ' ' LEU . 10.0 ttt180 -113.24 117.15 31.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.507 -0.923 . . . . 72.54 108.507 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HZ ' ' O ' ' A' ' 30' ' ' THR . 49.0 p90 -133.44 161.62 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.068 0.461 . . . . 73.22 112.057 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.4 ptp -139.46 141.65 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 53.43 110.55 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.779 HD13 ' HB ' ' A' ' 70' ' ' VAL . 11.2 mm -98.31 118.56 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.142 0.496 . . . . 63.32 110.312 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 21.6 ptm -127.72 163.68 23.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.674 -0.694 . . . . 71.25 110.509 -175.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.89 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.9 t70 -70.35 156.85 38.75 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.718 -0.475 . . . . 71.52 109.718 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 133' ' ' ARG . 22.3 tpt180 -82.81 108.52 16.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.388 0.614 . . . . 74.44 111.31 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 17.0 m-85 -103.26 142.27 34.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.062 -1.088 . . . . 75.41 108.062 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.29 -4.38 3.23 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 119.583 -1.294 . . . . 65.54 113.453 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.928 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.4 m -120.59 124.49 45.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.844 0.354 . . . . 75.34 110.295 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.828 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 3.9 m-20 -90.53 134.99 33.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.022 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 36.9 tp -61.83 -36.61 81.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.951 -0.759 . . . . 64.24 108.951 172.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.828 ' HG3' ' HB3' ' A' ' 137' ' ' ASP . 1.4 pp0? -64.64 -28.15 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 72.34 111.547 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 58.2 mttp -72.52 -39.82 67.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.837 -0.345 . . . . 71.04 110.629 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.28 -36.9 44.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.515 0.674 . . . . 74.54 109.337 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 139' ' ' GLN . 28.6 t80 -55.19 -54.27 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.738 -1.119 . . . . 74.4 111.202 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.97 -33.87 61.94 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.755 -0.378 . . . . 61.31 111.235 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.79 -32.76 72.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.945 0.35 . . . . 60.54 111.945 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -105.1 8.68 34.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 75.42 110.614 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.11 48.52 17.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.805 -0.634 . . . . 75.1 111.319 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.699 ' HG3' HE22 ' A' ' 253' ' ' GLN . 0.0 OUTLIER 43.67 77.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.818 1.247 . . . . 71.14 113.749 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.63 102.97 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.751 -0.659 . . . . 74.23 109.269 168.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.691 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 65.9 m-85 -108.76 156.1 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.996 -0.547 . . . . 70.13 109.884 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -70.59 156.88 38.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.319 -0.4 . . . . 74.01 110.585 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.6 ' HG2' HD13 ' A' ' 331' ' ' ILE . 25.0 tpt180 -45.99 -57.28 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.547 -0.752 . . . . 73.35 112.144 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -67.27 -28.1 67.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 75.0 111.514 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 m -70.94 -45.19 64.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.442 -0.345 . . . . 61.02 110.571 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.84 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 53.43 110.585 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 324' ' ' LEU . 0.2 OUTLIER -65.02 -42.87 93.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 72.52 110.325 -178.986 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -55.21 -52.57 62.93 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.773 -0.454 . . . . 72.43 109.773 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.24 -50.65 73.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.936 -0.575 . . . . 65.24 111.125 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.452 ' HA ' HD12 ' A' ' 161' ' ' ILE . 32.1 t -57.93 -38.05 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 55.35 111.241 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.81 -40.86 75.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.856 -0.424 . . . . 64.21 109.856 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.593 ' HA ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -67.42 -31.4 71.58 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.787 0.803 . . . . 63.22 110.307 -178.916 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 158' ' ' SER . 58.4 mt -67.92 -35.14 71.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.591 -0.731 . . . . 71.15 109.695 174.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 43.4 tp -63.84 -40.48 96.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 55.22 110.088 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.593 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.4 m-20 -53.34 -59.52 4.47 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.491 0.663 . . . . 65.13 110.895 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -67.11 -37.35 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.856 -0.611 . . . . 65.01 111.101 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.66 -37.94 89.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.72 0.295 . . . . 74.2 110.296 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -56.09 -58.81 6.34 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.87 -0.605 . . . . 74.12 109.46 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.5 -48.98 73.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.859 -1.064 . . . . 74.22 112.572 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 164' ' ' ILE . 39.7 pt -84.19 -36.52 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.605 0.594 . . . . 63.23 112.605 -170.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -82.34 -26.17 33.21 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 71.35 112.144 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.37 -18.46 64.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.75 -0.78 . . . . 65.21 110.048 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.9 -74.75 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 70.22 112.346 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -135.86 -68.71 0.5 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.145 0.794 . . . . 74.52 113.145 -167.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 79.6 m-85 -84.99 167.26 16.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.488 0.922 . . . . 72.32 113.488 -161.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 238' ' ' PRO . 27.4 m -142.21 172.18 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.065 -1.425 . . . . 71.13 109.48 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -158.64 96.21 1.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.612 -0.514 . . . . 72.43 109.612 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -67.49 -33.61 82.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.116 -0.564 . . . . 74.52 112.389 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.544 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 20.6 t70 -74.57 91.56 2.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.141 0.496 . . . . 74.34 111.315 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.04 67.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.038 0.923 . . . . 70.5 108.955 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.432 ' HZ2' ' HB2' ' A' ' 179' ' ' LYS . 3.7 ttmp? -88.27 139.14 30.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.99 -1.005 . . . . 60.42 109.222 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -56.17 -16.68 5.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.314 0.487 . . . . 75.13 112.314 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' A' ' 139' ' ' GLN . 29.8 t -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.331 -0.395 . . . . 72.11 111.431 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' O ' HD12 ' A' ' 195' ' ' LEU . 84.5 m-20 -92.21 -11.74 34.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.724 0.297 . . . . 75.42 111.584 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 184' ' ' LEU . 6.4 mp -100.49 119.47 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 74.5 110.493 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.4 mm? -119.03 140.59 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.682 -0.69 . . . . 73.43 110.61 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 69.2 mt -97.87 142.82 29.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.989 -0.55 . . . . 74.11 110.339 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.642 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -61.48 136.75 58.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.981 -0.554 . . . . 75.53 110.042 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -56.17 -31.27 63.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.832 0.348 . . . . 62.22 111.627 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.7 ' HA ' ' HE3' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -90.97 -22.58 20.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.959 0.355 . . . . 64.32 111.959 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -138.42 110.21 8.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 111.888 0.329 . . . . 64.41 111.888 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.57 -12.94 32.14 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.73 2.286 . . . . 73.32 111.252 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.992 ' HA ' ' HB2' ' A' ' 339' ' ' LEU . 7.4 p-10 -90.49 7.39 39.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.369 -0.832 . . . . 44.1 111.153 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 16.7 mm-40 -121.84 106.78 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.431 . . . . 62.13 110.76 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.2 122.11 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 75.33 110.813 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -114.75 157.44 23.2 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.866 -0.606 . . . . 75.24 109.922 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 182' ' ' ASN . 34.1 tp -107.53 103.3 12.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.222 -0.658 . . . . 73.05 109.222 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 184' ' ' LEU . 32.7 m -120.77 -167.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.497 -0.319 . . . . 62.14 110.487 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.2 m-20 70.66 -62.13 0.45 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.816 0.698 . . . . 63.53 110.674 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 60.98 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 74.02 111.654 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 354' ' ' ILE . . . 68.46 -68.34 0.39 Allowed Glycine 0 N--CA 1.447 -0.63 0 O-C-N 123.415 0.447 . . . . 74.54 112.088 -174.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 353' ' ' THR . 2.4 mp -88.26 81.07 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.856 0.36 . . . . 73.42 110.145 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.73 98.02 5.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.144 0.497 . . . . 73.34 110.01 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -164.11 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.365 -0.976 . . . . 73.54 108.365 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 9.3 ptp180 -137.75 150.62 47.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.559 -0.456 . . . . 62.34 111.426 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -83.1 -36.74 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.583 -0.735 . . . . 75.41 110.412 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 6.6 p -134.82 129.64 19.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.198 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 9.9 Cg_exo -71.49 100.71 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.943 2.429 . . . . 65.03 111.094 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 71.06 -62.57 0.45 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.456 0.702 . . . . 73.21 112.053 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.7 -36.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.791 . . . . 74.22 112.963 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 26.6 m -60.87 132.4 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.443 . . . . 71.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -100.32 138.16 37.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.136 -0.483 . . . . 73.23 109.857 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 211' ' ' LYS . 12.6 tptm -108.33 172.63 6.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.131 0.491 . . . . 75.15 112.311 -167.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -90.96 174.19 7.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.505 -0.771 . . . . 70.21 111.019 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -73.19 6.27 2.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.972 0.731 . . . . 73.4 112.972 -168.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -166.5 96.78 0.57 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.71 -0.619 . . . . 71.3 110.633 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.455 ' OE1' ' HG2' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -136.24 -4.14 2.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.377 -0.829 . . . . 64.43 110.859 178.238 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 217' ' ' PRO . 10.6 t70 -79.05 148.01 70.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.823 -0.626 . . . . 65.13 110.774 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.761 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 69.6 Cg_exo -54.79 1.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.32 3.347 . . . . 60.13 114.928 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' A' ' 217' ' ' PRO . 0.0 OUTLIER 112.83 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.748 1.619 . . . . 72.12 110.941 172.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 69.71 92.21 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.227 -0.897 . . . . 74.11 111.505 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.488 ' H ' ' HA2' ' A' ' 235' ' ' GLY . 7.7 p -86.85 -30.45 21.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.946 -0.39 . . . . 55.33 109.946 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 29.1 m80 73.89 -58.08 0.6 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.086 0.954 . . . . 74.32 111.704 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 30.4 t70 37.57 74.58 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.912 0.885 . . . . 72.55 111.785 -171.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . 110.52 174.82 20.49 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.723 -0.751 . . . . 61.34 112.459 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.39 141.63 43.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.669 0.271 . . . . 70.01 110.622 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 271' ' ' VAL . 15.4 tt -58.36 -17.06 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.355 0.598 . . . . 73.35 111.323 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -50.49 -55.52 15.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.921 -1.036 . . . . 74.31 111.603 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.577 ' O ' HG12 ' A' ' 246' ' ' ILE . 38.9 m-85 -111.24 -28.11 8.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.071 0.767 . . . . 70.15 113.071 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.8 t -64.98 -6.4 8.44 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.758 0.651 . . . . 71.54 112.758 -169.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.781 ' HA ' ' HE2' ' A' ' 275' ' ' LYS . 23.0 t 65.0 -169.85 0.2 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.138 0.494 . . . . 73.35 111.393 176.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 234' ' ' ASN . 15.3 pt -73.34 -34.35 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.795 -0.639 . . . . 73.31 111.684 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' O ' HG12 ' A' ' 236' ' ' VAL . 11.7 t70 -53.82 -74.88 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.827 -170.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.78 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 70.44 111.616 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 57.6 t-80 -62.7 -27.53 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.603 -0.271 . . . . 70.15 111.62 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 0.0 OUTLIER -78.41 -28.81 46.93 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.859 0.318 . . . . 54.4 111.859 -175.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.488 ' HA2' ' H ' ' A' ' 220' ' ' CYS . . . 112.37 45.65 0.78 Allowed Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.346 -0.931 . . . . 63.55 112.848 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 231' ' ' ASP . 15.0 p -123.44 143.27 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.0 -0.741 . . . . 72.32 109.0 171.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -53.25 110.72 2.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.676 -0.861 . . . . 73.34 108.676 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.507 ' HG2' HG21 ' A' ' 174' ' ' VAL . 69.6 Cg_exo -41.97 115.18 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.772 2.981 . . . . 75.54 113.561 -169.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 93.9 p -90.83 -175.54 4.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.248 -0.887 . . . . 71.35 111.163 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.878 ' HG2' ' HB3' ' A' ' 315' ' ' PRO . 9.8 mtm-85 -53.94 -36.69 63.06 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.534 -0.757 . . . . 71.25 111.248 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.481 HH22 ' HD2' ' A' ' 279' ' ' ARG . 12.3 mtp180 -66.27 -33.56 76.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.797 -0.638 . . . . 75.4 110.498 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.41 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -57.43 -65.1 3.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.881 -0.676 . . . . 70.3 111.84 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.16 -48.1 71.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.34 0.59 . . . . 70.2 110.758 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.678 ' HG ' HD21 ' A' ' 320' ' ' LEU . 9.2 mp -67.95 -46.02 72.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.169 -0.923 . . . . 75.22 112.045 -173.496 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -64.43 -47.08 80.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.611 -0.435 . . . . 70.44 110.789 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 227' ' ' PHE . 76.0 mt -61.45 -40.11 85.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.347 -0.388 . . . . 65.53 111.425 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 251' ' ' MET . 37.9 tp -64.23 -45.12 89.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 75.53 110.217 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.64 95.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.906 -0.664 . . . . 74.23 112.081 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 14.8 m-30 -56.26 -45.84 79.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.782 0.325 . . . . 73.04 110.812 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.82 -35.22 78.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 73.14 110.892 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 83.8 mtp -59.47 -54.54 45.47 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.737 0.303 . . . . 75.25 110.988 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.6 tt -67.8 -32.06 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 74.53 110.45 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.699 HE22 ' HG3' ' A' ' 147' ' ' LYS . 9.5 tm0? -61.58 -53.59 54.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 74.22 110.364 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.691 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.8 m0 -69.45 -26.42 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 75.3 111.662 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.547 HD11 HD21 ' A' ' 294' ' ' ASN . 33.4 tp -83.87 -36.22 23.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.203 0.446 . . . . 74.13 112.203 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.5 p -103.49 -27.4 12.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.688 -0.405 . . . . 61.21 112.058 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 98.79 -1.35 58.09 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.429 -0.891 . . . . 63.0 113.272 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -148.12 163.16 37.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.178 0.513 . . . . 74.04 111.691 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.664 ' HG ' ' HG2' ' A' ' 253' ' ' GLN . 60.2 mt -111.87 142.48 26.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.649 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.47 -25.68 59.38 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.615 2.21 . . . . 64.52 112.601 177.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.446 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 48.0 p90 -111.65 18.94 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.353 -0.385 . . . . 73.43 110.771 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 35.3 tt0 -66.03 -44.5 84.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.551 . . . . 72.21 110.467 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.96 -6.72 55.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.97 0.891 . . . . 70.23 109.552 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 5.9 m-20 -104.62 0.8 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.097 -0.956 . . . . 74.22 111.227 -177.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 261' ' ' TRP . 80.5 mt -71.33 -6.9 43.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.12 0.486 . . . . 55.23 110.885 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -60.91 -33.4 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.483 -0.781 . . . . 44.24 111.332 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.734 ' HB2' ' CD1' ' A' ' 270' ' ' TYR . 7.8 m-20 -145.33 145.82 27.89 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-O 120.541 0.21 . . . . 34.14 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 25.3 Cg_endo -62.92 -28.09 75.09 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.61 2.207 . . . . 53.31 112.002 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -42.49 96.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.202 0.525 . . . . 73.13 109.719 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.734 ' CD1' ' HB2' ' A' ' 267' ' ' ASP . 9.5 m-85 -66.67 -45.33 79.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.554 -0.748 . . . . 74.31 111.31 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 225' ' ' ILE . 20.3 m -65.03 -29.16 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.535 -0.302 . . . . 60.25 111.225 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 33.7 mtm180 -60.62 -58.61 7.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.096 -0.705 . . . . 75.32 109.096 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -52.26 -50.55 61.87 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.859 -1.064 . . . . 63.42 111.018 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 50.3 m -59.6 -50.33 74.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 72.13 111.463 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 59.7 mttp -66.36 -44.49 83.06 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.879 -0.329 . . . . 74.42 111.376 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.5 -48.34 85.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 120.812 0.339 . . . . 74.53 110.935 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -54.71 -50.09 69.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 74.21 110.776 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -74.21 -39.07 63.38 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.481 ' HD2' HH22 ' A' ' 241' ' ' ARG . 52.2 ttp180 -50.44 -40.34 50.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.542 0.337 . . . . 72.24 111.792 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -70.28 -36.15 74.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.297 0.48 . . . . 75.51 112.297 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -129.19 38.57 3.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.795 0.331 . . . . 74.12 111.663 -170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.91 -50.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 113.115 0.783 . . . . 45.32 113.115 -176.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.538 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.07 -47.77 82.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 73.02 112.149 -172.387 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -68.25 -44.4 75.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.011 0.434 . . . . 73.22 111.204 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 285' ' ' LEU . 4.3 mm? -67.25 -50.98 58.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 72.35 111.431 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -60.87 -40.54 93.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 71.3 111.193 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.64 -42.31 98.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 74.14 111.23 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -81.8 -15.72 53.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.614 -0.266 . . . . 74.4 111.674 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.6 m -72.89 -28.08 62.27 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.29 -0.256 . . . . 64.51 111.217 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 294' ' ' ASN . 3.9 t80 -128.69 86.63 57.06 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 71.21 110.518 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -94.91 24.93 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.389 2.726 . . . . 62.41 113.011 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 293' ' ' LYS . 8.1 tt0 -100.38 -166.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.376 -0.602 . . . . 71.51 109.376 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 31.0 mmtp -81.29 62.44 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.457 0.646 . . . . 64.32 111.583 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 255' ' ' LEU . 38.7 t-20 -157.11 128.91 7.1 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.368 -1.345 . . . . 73.51 107.368 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -100.87 106.08 41.94 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.176 -0.209 . . . . 75.01 111.305 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 93.6 Cg_endo -93.6 38.17 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.899 2.399 . . . . 74.55 111.967 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -73.39 -42.34 42.06 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.077 -0.582 . . . . 72.44 111.972 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.3 pm0 -66.44 -35.84 81.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.19 . . . . 64.54 110.527 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.451 HG13 ' OE2' ' A' ' 298' ' ' GLU . 44.3 mt -67.79 -46.96 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 62.12 110.509 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.67 -39.91 90.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 63.2 110.537 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.525 ' HD3' HD11 ' A' ' 323' ' ' ILE . 85.3 tttt -80.58 -28.79 37.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 74.5 110.785 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 33.2 t80 -55.71 -50.2 70.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.207 0.527 . . . . 73.55 109.897 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 306' ' ' VAL . 95.2 mmm -70.54 -34.57 72.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.598 -0.728 . . . . 72.21 110.711 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HA ' HD11 ' A' ' 282' ' ' ILE . 0.3 OUTLIER -61.67 -42.2 98.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.808 0.813 . . . . 65.33 109.384 175.477 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 59.9 m -61.81 -51.38 68.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.927 -1.033 . . . . 33.44 111.488 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 16.3 m -67.75 -27.85 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.494 -0.321 . . . . 73.45 111.582 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -25.54 33.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.871 0.367 . . . . 65.02 110.212 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 27.5 tp -86.96 -16.01 37.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 75.23 111.036 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 305' ' ' THR . 80.0 mt -68.97 -101.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.499 -0.319 . . . . 75.32 111.06 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 313' ' ' GLU . 24.3 t70 166.82 164.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.994 -0.743 . . . . 73.54 108.994 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.5 -37.04 85.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.976 0.417 . . . . 75.31 110.576 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.473 ' HA ' ' NH2' ' A' ' 240' ' ' ARG . 0.2 OUTLIER -105.99 -26.27 11.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.015 -0.539 . . . . 54.3 112.336 -171.765 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 310' ' ' ASP . 5.3 tp10 -92.83 112.51 24.5 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.277 0.843 . . . . 72.2 113.277 -168.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.525 ' HG2' ' OE1' ' A' ' 313' ' ' GLU . 39.8 mmtm 68.42 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 115.529 1.677 . . . . 73.35 115.529 162.013 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.878 ' HB3' ' HG2' ' A' ' 240' ' ' ARG . 94.7 Cg_endo -93.6 116.78 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.101 1.867 . . . . 71.32 109.02 156.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.579 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.1 tp -126.04 98.48 5.52 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.125 -0.63 . . . . 61.02 111.111 -171.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.418 ' HD1' HD11 ' A' ' 162' ' ' LEU . 74.6 m-85 -64.63 -35.45 81.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.75 . . . . 70.32 110.735 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.36 -42.96 82.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.684 0.624 . . . . 75.23 112.684 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.579 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 26.5 t-20 -60.64 -43.72 97.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.109 0.48 . . . . 61.11 109.795 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.678 HD21 ' HG ' ' A' ' 244' ' ' LEU . 6.7 mp -69.11 -42.2 76.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.393 -0.821 . . . . 63.23 110.189 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -58.62 -49.48 77.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 73.34 110.347 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.25 -29.19 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 70.3 110.285 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.525 HD11 ' HD3' ' A' ' 301' ' ' LYS . 0.3 OUTLIER -63.91 -43.16 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 72.11 110.186 176.364 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 87.9 mt -70.11 -45.93 65.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 62.54 111.095 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 328' ' ' LEU . 4.5 mm? -64.28 -32.75 74.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.666 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -61.82 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.241 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -63.38 -33.26 86.75 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.888 -0.597 . . . . 75.01 112.217 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 325' ' ' LEU . 96.6 mt -69.82 -44.15 70.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.087 0.47 . . . . 73.24 110.263 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.56 -27.3 69.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 74.54 111.187 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.0 73.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.11 111.615 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.6 HD13 ' HG2' ' A' ' 151' ' ' ARG . 48.4 pt -97.04 -2.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 70.03 111.181 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.613 -0.803 . . . . 55.1 113.587 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.8 m -138.37 170.53 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.151 0.476 . . . . 64.01 110.553 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.491 ' O ' HD13 ' A' ' 328' ' ' LEU . 96.2 mttt -124.99 -85.64 0.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.024 -0.362 . . . . 71.35 110.024 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -127.12 150.73 49.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.59 -0.522 . . . . 73.52 109.59 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.01 -20.56 28.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.932 0.396 . . . . 52.24 110.672 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 92.4 -6.33 77.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.93 -0.652 . . . . 73.13 112.235 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -155.04 175.0 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.81 -0.441 . . . . 70.42 109.81 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.992 ' HB2' ' HA ' ' A' ' 191' ' ' ASP . 43.7 mt -88.4 135.13 33.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.222 -0.658 . . . . 74.32 109.222 166.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.93 19.08 12.04 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.74 0.781 . . . . 73.52 109.534 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.1 97.96 4.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.999 -1.0 . . . . 73.2 111.086 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.9 m -86.69 109.46 19.22 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.67 -0.863 . . . . 51.31 108.67 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.76 84.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.562 0.696 . . . . 75.12 111.738 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 345' ' ' GLU . 96.4 t -66.11 -53.7 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.275 -0.875 . . . . 73.34 110.244 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.62 ' HG3' HG12 ' A' ' 344' ' ' VAL . 42.8 mt-10 -150.64 -170.11 3.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.363 -0.835 . . . . 65.12 110.298 -176.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 3.2 p-10 -129.25 158.52 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 71.45 111.078 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 140' ' ' LYS . . . -139.5 -165.36 10.24 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.009 -0.837 . . . . 43.41 111.009 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -149.14 72.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.031 -1.081 . . . . 72.23 113.605 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.2 tt -114.87 107.19 15.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.237 -0.653 . . . . 54.54 109.237 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -128.9 -127.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.3 -0.409 . . . . 71.54 111.378 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 74.95 104.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.683 0.793 . . . . 73.33 111.754 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.4 ' HE3' ' HA3' ' A' ' 47' ' ' GLY . 17.8 ptpt -164.86 147.36 8.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.477 -0.783 . . . . 63.41 109.979 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 13.5 t -176.01 164.18 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.056 -0.35 . . . . 53.5 110.056 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -67.14 142.02 17.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.885 0.374 . . . . 63.52 111.069 -176.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 6.2 t -94.78 76.0 3.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.85 0.833 . . . . 71.42 110.587 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 15.5 ptmt -98.9 129.07 45.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 74.04 110.248 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -143.31 -38.03 0.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.265 -0.425 . . . . 51.33 111.637 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.455 ' O ' ' HD2' ' A' ' 358' ' ' ARG . 0.4 OUTLIER -96.56 51.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 71.52 110.546 -177.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -175.68 120.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.545 -0.752 . . . . 71.32 109.949 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.482 ' NZ ' ' HB3' ' A' ' 360' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.661 -0.685 . . . . 65.5 109.731 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.609 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 97.7 mmm . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.957 -0.386 . . . . 62.22 109.957 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 16.6 Cg_endo -57.9 146.13 87.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.719 2.279 . . . . 74.23 112.388 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -137.56 108.98 6.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.881 -0.6 . . . . 62.44 110.984 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.11 120.8 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 70.0 109.772 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -122.41 105.7 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 73.2 111.304 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -157.16 93.88 1.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.252 -0.885 . . . . 60.33 109.81 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.47 7.63 33.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.544 . . . . 64.34 111.595 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.71 121.28 27.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.46 -0.337 . . . . 75.12 110.483 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.12 109.29 1.97 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.076 -0.511 . . . . 73.1 110.673 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.92 125.36 1.83 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.968 -0.634 . . . . 75.01 111.818 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 11' ' ' ARG . 9.3 mmm180 -122.67 112.94 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.056 0.455 . . . . 73.04 111.471 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -116.43 116.65 28.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.441 -0.578 . . . . 71.4 109.441 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -115.33 122.94 47.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.94 0.4 . . . . 71.44 110.215 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -93.02 114.56 27.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.125 0.488 . . . . 73.21 110.513 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.11 139.91 43.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.723 -0.671 . . . . 54.21 111.169 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -109.57 115.99 30.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.194 0.521 . . . . 74.11 111.335 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HA ' ' HE ' ' A' ' 17' ' ' ARG . 1.8 mmp_? -104.1 103.78 13.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.962 -0.755 . . . . 73.11 108.962 172.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -65.99 150.59 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 74.32 110.661 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 mp -79.48 33.52 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 73.43 111.998 -173.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.68 -4.77 40.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.405 -0.961 . . . . 65.04 108.405 169.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.52 -41.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.297 -1.32 . . . . 75.51 109.275 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 48.97 -128.09 2.03 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.458 -0.792 . . . . 64.21 109.212 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 158.72 68.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.432 1.493 . . . . 75.41 109.219 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.1 -179.25 5.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.019 0.438 . . . . 74.03 112.071 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.67 136.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 72.43 110.99 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.6 1.56 57.65 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.983 -0.627 . . . . 42.13 112.47 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 39' ' ' VAL . 14.6 pt-20 -71.79 139.02 48.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.974 0.416 . . . . 74.31 109.982 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 38' ' ' LYS . 46.8 mm -88.34 116.18 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.434 -0.803 . . . . 63.31 110.342 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 33.5 pt -106.39 147.21 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.923 -0.581 . . . . 60.22 110.851 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.5 m -109.53 127.04 54.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.4 -0.818 . . . . 73.33 109.129 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 1.8 p-10 -131.26 -163.18 1.29 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.777 -0.369 . . . . 72.04 111.396 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.8 mmt -63.23 -24.05 67.7 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.392 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . . . -81.02 21.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 53.44 109.947 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 38.9 mmtm 89.81 -38.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.763 1.225 . . . . 75.24 113.427 166.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.658 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 52.9 pttt 160.36 166.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.974 0.731 . . . . 71.2 112.974 -172.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.658 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 40.2 mt-10 73.85 50.57 0.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.967 1.469 . . . . 75.05 114.967 159.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.584 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 75.7 m95 -106.18 141.31 37.75 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 163.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 23.1 pttp -114.27 120.06 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.913 -0.773 . . . . 60.22 108.913 172.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 27' ' ' GLU . 15.0 p -75.53 145.54 10.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.26 -0.427 . . . . 70.31 111.293 -172.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.48 -148.63 23.81 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.948 -0.569 . . . . 60.02 112.444 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.4 153.3 81.67 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.578 0.227 . . . . 71.0 111.176 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.61 135.6 24.29 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.11 2.54 . . . . 75.13 111.748 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 53' ' ' LEU . 60.3 mt -108.48 -58.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.016 0.436 . . . . 74.15 110.33 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 161.58 37.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.868 -0.682 . . . . 73.31 112.38 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.72 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 33.2 tt0 -139.51 159.95 40.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.587 -0.524 . . . . 71.12 109.587 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 45' ' ' GLN . . . -76.05 -34.06 48.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.001 -0.618 . . . . 70.34 112.033 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.28 -85.04 0.79 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.983 -0.847 . . . . 73.21 110.983 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 197' ' ' ASP . 31.6 m-85 -98.55 94.17 6.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.329 -0.619 . . . . 64.24 109.329 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.72 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -73.26 -162.04 6.95 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.05 -0.523 . . . . 65.42 113.56 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.92 31.82 13.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.371 0.605 . . . . 72.12 111.15 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LYS . 37.9 mm -88.82 134.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.818 -0.628 . . . . 74.25 109.829 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -107.8 159.16 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.774 0.321 . . . . 53.53 110.625 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 69' ' ' VAL . 37.3 tp -81.65 133.38 35.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.463 -0.569 . . . . 73.44 109.463 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 69' ' ' VAL . . . -98.01 103.13 15.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.984 0.421 . . . . 24.45 110.503 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 6.8 t70 -96.32 -175.57 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.541 -0.911 . . . . 72.14 108.541 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 37' ' ' TRP . 71.7 mtm -136.74 152.55 50.47 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.175 -0.328 . . . . 63.13 110.875 -171.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -125.69 -60.5 1.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.556 -0.293 . . . . 74.12 110.42 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -120.16 38.67 3.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.115 0.483 . . . . 73.42 110.498 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -107.06 -76.55 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.305 -0.628 . . . . 55.32 109.305 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -142.27 173.8 11.19 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.082 -0.71 . . . . 74.41 109.082 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.2 m -73.13 148.2 44.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.775 -0.454 . . . . 73.44 109.775 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 122.06 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.39 0.614 . . . . 64.13 111.006 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 69.72 3.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.905 -0.664 . . . . 31.01 112.493 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 m 71.24 -34.87 0.31 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.631 0.773 . . . . 42.53 112.864 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -145.66 -73.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.479 -0.563 . . . . 62.01 109.479 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 133' ' ' ARG . . . 179.62 125.56 0.22 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.569 -1.196 . . . . 51.13 108.366 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.61 9.54 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.259 1.973 . . . . 61.43 112.462 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.1 p -162.01 151.38 15.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.554 0.692 . . . . 72.34 112.668 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 53' ' ' LEU . 35.8 m -127.09 165.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.207 -1.034 . . . . 54.23 108.207 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.27 120.45 51.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.409 0.623 . . . . 65.02 111.574 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 51' ' ' ILE . 1.9 ttmp? -79.71 119.0 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 72.21 108.877 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.37 120.14 61.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.763 0.316 . . . . 75.34 110.515 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -136.52 156.9 76.13 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.336 -0.616 . . . . 65.43 109.336 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.12 147.01 92.47 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.921 1.748 . . . . 75.21 110.978 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 66.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.095 0.474 . . . . 74.52 110.097 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -151.99 -40.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 63.41 110.708 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.542 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 65.7 t30 -63.91 123.49 19.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.008 -0.542 . . . . 74.21 111.878 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.26 -54.07 36.61 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.643 -0.708 . . . . 63.42 113.829 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.542 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 91.3 Cg_exo -46.95 -37.93 22.88 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.082 2.521 . . . . 74.13 113.344 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.35 -50.97 71.93 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -60.31 -40.26 89.92 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.571 0.701 . . . . 70.54 110.701 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.1 m -71.34 -47.09 58.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 71.24 111.579 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.53 -36.18 78.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.797 -0.446 . . . . 65.14 109.797 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.86 -38.43 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 54.41 110.58 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HA ' ' HG3' ' A' ' 88' ' ' GLN . 6.1 ttpp -70.54 -31.54 68.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.864 0.364 . . . . 64.41 110.425 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.43 -32.55 71.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.869 -0.332 . . . . 73.53 110.584 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -65.88 -50.1 65.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 65.02 110.403 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -68.31 -16.05 63.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.677 0.275 . . . . 72.14 111.098 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.54 -68.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.947 0.351 . . . . 72.24 111.947 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.47 -34.41 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.011 0.745 . . . . 72.25 113.011 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.92 88.66 4.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.667 0.746 . . . . 45.03 110.583 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 4.7 ttmp? -168.96 129.82 1.05 Allowed Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.04 -0.982 . . . . 65.24 109.452 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.44 -51.47 7.9 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.331 2.687 . . . . 64.55 113.397 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 34.4 mt-10 -63.74 -45.06 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 111.901 0.334 . . . . 74.11 111.901 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' HG2' ' HD2' ' A' ' 92' ' ' LYS . 33.1 mm-40 -62.94 -47.91 81.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.682 0.277 . . . . 72.32 110.908 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 100' ' ' ILE . 69.8 mt -59.27 -47.47 90.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 73.43 110.0 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -54.81 -47.7 73.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.194 -0.912 . . . . 64.4 111.115 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 58.3 mtpt -61.81 -46.2 90.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.56 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 108' ' ' LEU . 44.7 t90 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.822 -0.351 . . . . 63.03 110.82 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 96' ' ' ILE . 30.5 mm -60.5 -37.94 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 64.13 111.357 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -75.96 -34.3 59.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.42 -0.355 . . . . 72.34 111.459 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.9 m -76.85 -48.68 17.71 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.898 0.38 . . . . 71.22 111.516 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 103' ' ' ARG . 5.6 tpm_? -76.64 -18.87 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.286 -0.416 . . . . 75.33 110.609 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? 64.74 78.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.822 0.82 . . . . 74.1 109.971 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.0 mt -138.64 -167.96 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.117 -0.947 . . . . 64.32 109.845 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -106.38 -50.86 3.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.777 -0.369 . . . . 75.41 110.964 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -153.4 146.76 24.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.681 0.277 . . . . 63.42 110.416 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 99' ' ' TRP . 46.4 tp -97.95 133.59 42.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 64.11 110.428 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.7 58.54 4.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 30.33 112.492 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -111.33 137.55 21.09 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.251 -0.648 . . . . 74.02 109.251 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' ' CD2' ' A' ' 194' ' ' TYR . 7.9 Cg_endo -50.5 134.5 39.42 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.564 2.176 . . . . 40.04 112.782 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.996 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.8 tptm -73.66 126.97 31.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 73.21 110.331 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.46 134.18 55.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.697 -0.683 . . . . 73.42 110.245 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CD1' HG22 ' A' ' 130' ' ' ILE . 40.0 m95 -107.27 -75.16 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.418 0.627 . . . . 73.13 110.055 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.48 -168.18 12.02 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.281 -0.872 . . . . 41.34 111.458 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' MET . 66.6 p -175.32 173.01 2.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.184 -0.302 . . . . 71.5 110.184 -175.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.07 -170.54 42.55 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.81 -0.71 . . . . 72.0 112.226 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.449 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -122.0 132.17 54.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.181 -0.674 . . . . 63.14 109.181 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -148.65 123.19 9.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.636 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.82 145.36 52.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.708 -0.849 . . . . 71.23 108.708 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -143.82 18.42 1.81 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.126 -0.629 . . . . 74.13 112.151 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -179.67 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.179 0.514 . . . . 71.43 111.616 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.44 14.91 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.91 -1.676 . . . . 60.32 108.91 -166.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 1.4 tpmt? -146.09 124.97 12.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.807 -1.197 . . . . 74.32 108.279 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 118' ' ' LEU . 18.4 m -75.63 105.1 6.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.91 0.386 . . . . 70.4 110.372 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.38 144.75 25.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.075 -0.511 . . . . 73.42 109.671 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -113.34 125.7 54.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.106 -1.072 . . . . 73.33 108.106 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -121.12 148.41 44.24 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.159 0.504 . . . . 70.33 111.064 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.26 134.83 40.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.226 -0.897 . . . . 71.23 109.304 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.505 HG22 ' CD1' ' A' ' 114' ' ' TRP . 19.1 mt -96.73 123.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.32 0.581 . . . . 74.41 110.137 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 11.8 ptm -128.67 -179.16 4.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.84 -1.073 . . . . 72.34 110.417 -172.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.996 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 31.6 t70 -68.92 156.19 38.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.36 . . . . 53.14 111.346 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.595 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 2.4 tmt_? -89.32 106.94 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 71.04 110.732 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 132' ' ' ASP . 19.2 m-85 -102.21 172.24 7.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.689 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.45 -37.5 0.02 OUTLIER Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.693 -0.765 . . . . 62.0 112.706 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.7 m -121.55 142.07 50.44 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.809 -0.23 . . . . 74.43 111.036 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -124.65 176.69 6.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.642 0.258 . . . . 52.32 110.807 176.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 183' ' ' LEU . 5.3 mp -77.63 -27.9 51.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.346 0.499 . . . . 73.22 112.346 -177.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 181' ' ' SER . 23.5 tt0 -75.39 -34.41 61.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.57 -0.452 . . . . 74.25 111.274 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.6 tptt -68.7 -38.43 80.29 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 73.5 110.117 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.587 HG12 ' HG ' ' A' ' 341' ' ' LEU . 1.8 mp -68.18 -38.84 80.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 74.4 109.763 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.18 -43.09 74.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.493 -0.776 . . . . 65.22 110.425 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.46 -50.37 18.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.804 -0.634 . . . . 73.51 110.904 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.77 73.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.383 0.512 . . . . 71.41 112.383 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -100.61 0.79 39.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 75.23 110.647 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.52 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 56.53 75.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.896 -0.593 . . . . 54.35 111.923 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.52 ' HD3' ' C ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER 29.71 77.13 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.043 1.337 . . . . 74.24 114.132 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -160.28 105.7 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.64 -0.709 . . . . 71.13 109.092 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 49.9 m-85 -110.1 155.73 21.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.101 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -78.49 155.52 29.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.92 -0.582 . . . . 73.24 110.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -57.8 -38.85 76.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 74.24 110.642 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.56 -45.87 88.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 62.5 110.494 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.682 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.8 m -66.54 -52.37 46.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.827 -0.624 . . . . 62.52 110.948 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.7 t -60.24 -47.26 92.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.138 -0.483 . . . . 71.53 111.648 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.55 -37.87 80.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 71.52 110.762 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.873 HE21 ' HB2' ' A' ' 335' ' ' ASP . 30.2 mm-40 -60.22 -47.53 85.57 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.695 0.283 . . . . 64.5 110.61 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 153' ' ' THR . 81.9 mt -58.11 -50.51 73.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 70.44 110.131 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 247' ' ' LEU . 25.2 t -58.18 -47.44 83.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.891 -0.595 . . . . 65.0 110.94 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 325' ' ' LEU . 0.7 OUTLIER -64.74 -52.64 55.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 72.12 111.083 -176.315 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.438 ' NH1' HD22 ' A' ' 159' ' ' LEU . 13.6 mmt180 -72.51 -30.11 64.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 70.32 111.348 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -71.09 -30.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.818 -0.438 . . . . 74.53 109.818 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.45 -43.84 76.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.943 -0.391 . . . . 75.31 109.943 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.571 ' HB3' ' HH2' ' A' ' 99' ' ' TRP . 72.7 m-20 -58.53 -55.22 37.89 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.683 0.754 . . . . 72.14 110.432 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.598 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -63.19 -34.79 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 60.1 110.378 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.731 ' O ' ' HB3' ' A' ' 169' ' ' HIS . 6.3 tt -56.44 -37.93 70.92 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.577 -0.283 . . . . 72.14 110.318 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -57.29 -59.56 4.94 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.112 -0.699 . . . . 73.53 109.112 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.46 -28.19 66.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.967 -1.469 . . . . 74.54 113.501 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.0 pt -108.9 -48.18 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.908 0.707 . . . . 43.25 112.908 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.731 ' HB3' ' O ' ' A' ' 165' ' ' LEU . 7.0 t60 -59.87 -47.66 84.84 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.998 0.186 . . . . 75.11 110.85 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.688 ' HG3' ' HD2' ' A' ' 169' ' ' HIS . 21.1 mt-10 -106.47 80.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.978 0.894 . . . . 75.31 109.404 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -175.35 -44.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.481 -1.69 . . . . 74.1 109.128 -170.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -162.61 -72.62 0.05 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.938 -0.573 . . . . 74.42 111.403 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.643 ' CD1' ' HA ' ' A' ' 203' ' ' ARG . 21.9 m-85 -122.79 155.21 37.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.187 0.518 . . . . 64.31 111.388 -174.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 204' ' ' TYR . 31.0 m -97.37 167.29 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 51.51 109.431 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . 2.9 m-70 -114.3 -85.77 0.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.862 -0.335 . . . . 71.23 111.558 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.96 6.45 85.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.683 -0.77 . . . . 52.0 111.38 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 200' ' ' LEU . 17.8 p-10 -89.66 28.39 1.32 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 73.34 111.077 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.481 ' HB ' HG22 ' A' ' 246' ' ' ILE . 46.2 mm -75.6 97.45 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.314 0.578 . . . . 63.2 110.527 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.789 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -157.3 165.04 36.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.461 -0.791 . . . . 75.43 109.502 172.651 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.44 -23.56 64.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.967 0.729 . . . . 74.41 112.967 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.409 ' HB3' ' OE1' ' A' ' 139' ' ' GLN . 67.7 p -75.51 -18.59 59.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.837 0.31 . . . . 71.55 111.837 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 177' ' ' ASP . 2.6 m-20 -97.44 -26.94 14.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 111.891 0.33 . . . . 73.35 111.891 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.505 ' HB2' HD22 ' A' ' 138' ' ' LEU . 6.3 mp -95.69 118.38 32.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.11 0.481 . . . . 71.25 110.407 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -133.81 158.67 42.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.565 -0.743 . . . . 75.41 110.88 177.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.435 HD11 HD23 ' A' ' 341' ' ' LEU . 11.7 mt -103.55 157.59 16.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.906 -0.588 . . . . 72.15 109.601 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 23.8 t-20 -65.62 142.31 58.1 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 2.5 p90 -60.58 -22.24 63.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.964 0.357 . . . . 72.22 111.964 -173.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -124.25 6.23 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.293 0.568 . . . . 73.43 110.261 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 47.6 t-20 -139.87 101.92 7.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.892 -0.595 . . . . 72.35 109.835 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.48 -20.47 5.8 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.832 2.355 . . . . 75.02 113.716 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.47 1.62 57.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.953 0.406 . . . . 52.11 111.257 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.54 107.55 15.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.994 0.426 . . . . 73.51 110.437 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.33 142.12 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 73.12 109.937 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 111' ' ' PRO . 44.1 m-85 -127.04 157.49 39.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.302 . . . . 73.24 110.732 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.7 mt -96.49 129.91 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.258 -0.428 . . . . 75.33 110.479 174.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 184' ' ' LEU . 34.2 m -135.79 177.49 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 54.12 110.225 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 53.5 t0 59.8 66.73 0.95 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.6 0.714 . . . . 75.23 109.287 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -75.38 67.52 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.16 -0.927 . . . . 74.42 111.078 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.71 ' HA3' ' HB2' ' A' ' 352' ' ' LYS . . . -93.52 1.87 69.74 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.464 -0.789 . . . . 71.54 111.651 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 77.8 mt -138.19 94.35 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.56 0.695 . . . . 70.44 110.587 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -155.0 115.8 3.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.725 -1.125 . . . . 74.3 108.921 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -132.38 160.61 35.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.635 -0.257 . . . . 75.05 110.699 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.643 ' HA ' ' CD1' ' A' ' 173' ' ' TYR . 5.4 ptp180 -62.52 149.36 43.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.144 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.472 ' HB2' HG13 ' A' ' 174' ' ' VAL . 42.1 t80 -149.86 -56.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 73.13 110.534 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 209' ' ' VAL . 5.8 p -148.34 72.08 10.93 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 73.43 111.534 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.76 142.67 4.89 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.989 2.459 . . . . 73.03 111.853 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 66.25 9.48 6.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 72.31 111.726 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.86 67.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.04 -0.6 . . . . 52.32 112.299 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 61.9 t -96.42 117.44 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.537 0.208 . . . . 70.24 110.49 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -100.23 145.86 27.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.853 -0.425 . . . . 71.0 109.853 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -114.97 152.58 32.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.303 -0.408 . . . . 64.33 110.413 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.39 173.98 11.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.483 -0.562 . . . . 64.34 109.483 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 236' ' ' VAL . 19.4 p90 -79.19 74.03 5.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.665 1.222 . . . . 74.11 110.223 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -154.91 92.97 1.5 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.055 -1.43 . . . . 71.32 108.49 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 2.7 mm-40 -122.61 -98.5 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.251 0.834 . . . . 71.25 113.251 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.49 119.26 61.92 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.411 -0.359 . . . . 73.25 111.664 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.29 -15.2 18.12 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.769 2.313 . . . . 62.34 112.379 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.34 -20.68 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.922 -0.399 . . . . 74.13 109.922 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 72.98 102.0 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.184 -0.916 . . . . 73.43 110.245 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.57 -73.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.555 -0.748 . . . . 73.54 111.633 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 46.15 26.84 0.47 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.838 0.855 . . . . 75.14 112.423 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 355' ' ' THR . 19.0 p-10 -94.51 -4.53 47.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.108 0.48 . . . . 74.04 110.849 -176.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -77.04 177.34 52.45 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.687 -0.768 . . . . 71.31 111.361 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -73.26 129.69 38.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.248 0.547 . . . . 75.43 111.667 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.452 HG23 HG21 ' A' ' 271' ' ' VAL . 47.7 mm -54.17 -31.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.342 -0.845 . . . . 72.34 112.336 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -56.92 -69.46 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.277 -0.42 . . . . 72.25 111.566 -179.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.6 m-85 -112.48 49.34 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.107 0.41 . . . . 72.42 112.107 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -18.18 35.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.629 0.252 . . . . 73.2 111.519 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.4 m 52.48 -162.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.891 -0.595 . . . . 53.43 111.159 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.2 mp -72.83 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.711 0.291 . . . . 74.11 110.507 177.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 238' ' ' PRO . 1.3 m-20 -51.44 -70.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.159 -0.928 . . . . 74.34 112.468 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.22 70.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 42.12 111.383 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.32 -28.79 68.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.034 -0.53 . . . . 53.21 110.767 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -91.15 -30.62 16.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.859 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.57 6.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.668 -0.777 . . . . 70.54 111.625 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 9.1 p -120.49 141.55 40.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.236 -0.283 . . . . 71.13 110.236 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.71 124.69 58.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 42.41 110.778 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.621 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 91.0 Cg_exo -46.63 106.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 64.12 112.418 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 312' ' ' THR . 36.4 m -92.04 42.26 1.1 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.148 -0.933 . . . . 63.22 110.928 -172.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 239' ' ' SER . 66.0 mtt180 85.29 -28.69 0.08 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.075 0.95 . . . . 65.24 111.159 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 311' ' ' TYR . 9.4 mmm180 -59.13 -61.39 2.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.542 0.21 . . . . 64.55 110.921 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -49.18 -55.36 12.45 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 115.724 -0.671 . . . . 44.22 113.219 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.487 ' HB3' HD11 ' A' ' 165' ' ' LEU . 3.3 m-20 -52.72 -54.56 32.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.98 0.419 . . . . 72.34 111.176 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 240' ' ' ARG . 11.2 mp -64.92 -45.93 83.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 74.04 111.391 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.46 -38.57 84.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.075 -0.25 . . . . 63.34 111.593 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 178' ' ' ILE . 84.2 mt -59.13 -44.0 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 74.13 110.482 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 158' ' ' SER . 33.2 tp -61.57 -42.63 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 72.41 110.293 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.63 95.86 Favored Glycine 0 C--O 1.236 0.271 0 C-N-CA 120.907 -0.663 . . . . 73.14 112.227 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -58.79 -49.16 78.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.649 0.261 . . . . 64.34 111.279 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 28.5 p -66.43 -36.79 83.68 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 73.31 111.453 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 72.5 mtm -60.65 -51.75 68.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.881 0.372 . . . . 74.43 111.023 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.4 tt -67.38 -30.23 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.582 -0.447 . . . . 75.41 110.694 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.53 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 35.0 tt0 -67.91 -44.95 75.74 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.532 0.206 . . . . 64.33 110.584 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 22.7 m0 -65.4 -29.15 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 73.11 110.902 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -81.04 -35.71 31.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 71.34 112.003 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 62.5 p -103.37 -27.93 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.858 -0.337 . . . . 73.43 111.74 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.36 17.09 65.18 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.865 -0.683 . . . . 44.52 112.982 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -155.6 144.17 20.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.128 0.464 . . . . 65.02 111.145 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 29.3 mt -108.95 138.84 20.46 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.11 109.825 171.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 48.3 Cg_exo -58.03 -28.33 82.88 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.867 2.378 . . . . 74.03 112.57 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 274' ' ' SER . 46.7 p90 -108.22 11.72 27.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.375 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 38.4 tt0 -75.56 -39.37 58.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 71.51 110.36 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.45 -29.15 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.69 0.757 . . . . 62.32 109.864 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 7.3 m-20 -108.04 19.75 19.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.138 -0.937 . . . . 73.52 110.689 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 262' ' ' GLU . 1.8 tt -75.93 73.29 2.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.825 0.821 . . . . 73.24 110.362 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -147.52 -63.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.544 -1.207 . . . . 72.02 109.817 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.747 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 12.1 t70 -91.33 135.27 28.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.245 -0.888 . . . . 73.25 111.431 -173.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -58.23 -27.11 79.43 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.498 2.799 . . . . 75.55 114.331 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 269' ' ' LYS . 1.8 mppt? -82.72 -40.07 21.09 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.605 -0.438 . . . . 73.04 110.542 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.747 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 37.0 m-85 -60.93 -49.19 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 73.32 110.704 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.452 HG21 HG23 ' A' ' 225' ' ' ILE . 33.8 m -66.6 -31.71 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.816 -0.354 . . . . 52.13 110.663 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -58.58 -56.67 19.17 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.087 0.47 . . . . 75.03 110.352 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.85 -43.47 79.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.474 -0.785 . . . . 72.14 111.038 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 41.7 m -60.34 -41.2 93.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 74.02 111.501 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.36 -48.29 70.66 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.114 -0.235 . . . . 73.41 110.615 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.46 -40.68 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 72.35 111.03 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -56.13 -51.02 69.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.647 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 33.4 m-85 -74.45 -36.05 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 74.23 111.12 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.531 ' HD2' HH22 ' A' ' 241' ' ' ARG . 26.2 ttp180 -57.23 -31.95 66.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.538 . . . . 64.34 111.28 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.5 -23.22 50.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.108 -0.496 . . . . 62.23 111.063 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -127.98 30.43 5.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.581 -0.281 . . . . 71.21 110.779 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -47.95 -42.28 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.04 1.126 . . . . 63.3 114.04 -171.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.16 -50.51 73.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.423 0.527 . . . . 71.43 112.423 -169.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 t -78.08 -36.21 48.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.834 0.35 . . . . 73.52 110.313 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 278' ' ' TYR . 89.9 mt -71.95 -44.8 62.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 65.44 111.372 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.445 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -72.02 -40.6 68.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.639 -0.255 . . . . 63.34 110.946 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.79 -35.41 80.51 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.145 0.497 . . . . 63.53 111.046 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 288' ' ' LYS . 28.5 ttmt -99.76 7.63 44.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.774 -0.648 . . . . 72.22 110.658 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 47.0 t -75.95 -22.95 55.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.203 0.525 . . . . 74.24 110.048 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 33.6 t80 -127.35 77.39 75.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.546 -0.909 . . . . 74.22 108.546 173.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.85 12.07 2.76 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.895 2.397 . . . . 75.52 113.364 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 4.0 mp0 -71.11 -99.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.661 -0.496 . . . . 63.21 109.661 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -161.52 79.13 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.334 0.588 . . . . 73.32 110.771 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.5 t-20 -150.3 162.92 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.035 -1.098 . . . . 75.01 108.035 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.85 103.87 43.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 111.905 0.335 . . . . 75.41 111.905 -175.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 85.1 Cg_endo -98.26 37.81 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.011 2.474 . . . . 45.13 111.207 173.246 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -74.02 -43.71 32.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.628 -0.714 . . . . 63.41 111.942 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.4 mp0 -53.39 -51.15 63.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.212 0.53 . . . . 72.02 109.849 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 252' ' ' ILE . 20.7 mt -62.09 -50.93 78.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.281 -0.872 . . . . 73.35 111.4 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 63.43 111.149 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.77 -28.54 40.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.489 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.405 ' HE1' ' O ' ' A' ' 244' ' ' LEU . 52.1 t80 -60.74 -42.64 97.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.287 -0.634 . . . . 64.21 109.287 172.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 306' ' ' VAL . 66.3 mtp -72.71 -36.16 67.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.541 -0.754 . . . . 74.45 110.809 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -55.93 -46.42 78.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 63.22 109.342 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 91.3 m -57.33 -52.28 65.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.713 -1.131 . . . . 50.31 111.611 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 303' ' ' MET . 22.9 m -67.45 -31.63 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 111.78 0.289 . . . . 61.04 111.78 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -70.32 -48.81 54.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.095 0.474 . . . . 73.41 110.808 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 17.5 tp -82.73 -3.03 55.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 62.43 110.481 -175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 6.9 tt -67.65 -76.7 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.314 -0.857 . . . . 75.23 110.315 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 8.1 t70 162.19 -152.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.134 -1.432 . . . . 71.21 107.134 -176.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 241' ' ' ARG . 20.4 t80 -105.03 -39.97 6.06 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.938 -0.393 . . . . 74.44 109.938 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 239' ' ' SER . 1.6 m -138.4 5.51 2.48 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.683 0.623 . . . . 52.24 112.683 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.22 -89.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.556 1.317 . . . . 73.44 114.556 -167.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 314' ' ' LYS . 13.2 tppt? -109.09 107.42 59.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 113.165 0.802 . . . . 74.13 113.165 -161.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 68.7 Cg_endo -88.73 119.82 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.618 2.212 . . . . 64.21 112.034 169.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.2 mt -118.84 85.55 2.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.268 0.556 . . . . 65.23 109.786 176.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 315' ' ' PRO . 80.7 m-85 -67.98 -34.97 77.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.704 -0.68 . . . . 72.31 111.964 -172.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -29.53 46.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.902 -0.319 . . . . 72.25 110.904 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.62 -48.71 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.889 -0.411 . . . . 73.44 109.889 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 85.9 mt -58.4 -43.61 88.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.617 -0.72 . . . . 63.23 110.485 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.419 ' O ' HD23 ' A' ' 325' ' ' LEU . 7.4 mtp180 -64.21 -33.36 75.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 72.12 111.12 177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.44 -46.16 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 320' ' ' LEU . 0.3 OUTLIER -72.45 -27.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 119.474 -0.89 . . . . 55.54 110.414 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.13 -49.04 75.96 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.492 -0.559 . . . . 73.02 109.492 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 329' ' ' LYS . 4.0 mm? -67.59 -26.91 66.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 73.45 111.002 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' GLN . . . . . 0.673 ' HA ' ' HE2' ' A' ' 329' ' ' LYS . 20.2 tp60 -59.52 -49.01 79.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 61.42 110.427 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.91 -38.55 94.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.248 -0.977 . . . . 62.23 111.298 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.937 HD11 ' HA ' ' A' ' 334' ' ' LYS . 3.0 tm? -57.21 -50.35 73.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.181 -0.51 . . . . 65.43 111.043 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 326' ' ' GLN . 54.8 pttt -81.15 -17.48 49.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.759 0.281 . . . . 75.4 111.759 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.76 63.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 73.12 110.894 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -77.46 -6.95 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.206 0.527 . . . . 70.55 110.626 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 89.67 12.27 62.76 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.856 -0.688 . . . . 61.5 112.887 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 170.37 8.69 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.043 -0.354 . . . . 61.21 110.043 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.937 ' HA ' HD11 ' A' ' 328' ' ' LEU . 77.6 tttt -146.28 156.56 43.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.541 . . . . 75.25 109.538 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.873 ' HB2' HE21 ' A' ' 156' ' ' GLN . 6.9 p-10 -87.65 126.64 35.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.166 0.508 . . . . 64.52 110.142 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -104.3 -24.18 13.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 62.51 110.862 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 85.39 -1.96 88.25 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.172 -0.537 . . . . 64.22 112.42 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.57 -27.82 62.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.613 0.207 . . . . 71.51 110.803 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 94.7 mt 60.76 88.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 123.823 0.702 . . . . 65.2 112.318 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.65 91.86 1.13 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 73.14 109.432 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.587 ' HG ' HG12 ' A' ' 141' ' ' ILE . 14.2 tp -127.64 9.27 6.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.312 -0.404 . . . . 73.55 110.717 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 44.7 m 73.03 -41.84 0.51 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.633 0.773 . . . . 73.11 112.276 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 34.1 t 63.33 71.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.618 0.723 . . . . 72.44 109.215 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.6 t -88.69 -67.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.887 . . . . 61.22 111.311 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 346' ' ' ASN . 29.3 tt0 -168.27 173.94 7.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.812 -0.81 . . . . 64.54 108.812 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 345' ' ' GLU . 22.5 p-10 -98.72 158.31 15.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.077 0.465 . . . . 65.53 110.309 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 140' ' ' LYS . . . -173.96 21.6 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.775 -0.648 . . . . 44.21 111.515 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -75.31 68.64 2.05 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.731 -0.271 . . . . 74.2 113.298 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 349' ' ' LEU . 2.7 pp -83.99 128.24 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.412 -0.588 . . . . 74.44 109.412 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -165.85 -65.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.92 -0.4 . . . . 62.31 109.92 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 62.49 103.74 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.824 0.702 . . . . 71.11 111.828 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.71 ' HB2' ' HA3' ' A' ' 199' ' ' GLY . 3.9 mppt? -110.42 169.77 8.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.549 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.7 t -134.3 132.47 39.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.29 -0.413 . . . . 70.32 110.562 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.724 HG13 ' HD3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -84.69 142.7 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 71.32 110.782 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.421 ' HB ' ' OD2' ' A' ' 222' ' ' ASP . 4.9 t -79.54 81.77 5.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.038 0.923 . . . . 71.21 110.045 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.724 ' HD3' HG13 ' A' ' 354' ' ' ILE . 10.5 mtpm? -140.46 168.53 19.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.439 -0.8 . . . . 54.05 110.509 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -110.82 150.22 29.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.097 -0.502 . . . . 74.32 110.649 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -96.7 146.36 24.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.662 -0.496 . . . . 72.53 109.662 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -109.65 -62.21 1.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.754 0.312 . . . . 72.02 110.401 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 42.7 mttp . . . . . 0 C--O 1.245 0.849 0 CA-C-O 118.585 -0.722 . . . . 74.32 110.231 175.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 65.9 mtt . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.038 -0.356 . . . . 63.11 110.038 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 Cg_endo -62.82 138.66 70.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.586 2.191 . . . . 50.34 111.797 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 2.1 mpt_? -94.92 137.65 33.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 71.15 110.338 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.08 145.79 12.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 70.32 111.235 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.08 139.97 47.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.983 -0.553 . . . . 75.43 110.319 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 153.35 28.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.419 . . . . 53.53 111.471 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.74 15.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 75.01 110.037 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -103.88 112.04 24.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.03 0.443 . . . . 65.23 111.442 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.77 112.27 12.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.936 -0.575 . . . . 71.01 109.62 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 118.75 4.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.651 -0.785 . . . . 74.23 113.171 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -87.07 127.09 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.82 0.343 . . . . 74.41 110.086 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -121.19 112.58 18.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.025 -0.534 . . . . 73.45 110.21 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.1 m -85.38 125.7 33.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.206 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -134.8 116.16 14.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 73.45 110.252 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.21 108.95 1.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 63.54 110.687 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -143.18 98.99 3.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.093 0.473 . . . . 72.21 110.299 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -150.85 88.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.453 -0.34 . . . . 75.2 111.06 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -173.34 149.67 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.836 -0.431 . . . . 53.11 109.836 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 37.2 tp -161.76 121.22 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.805 -0.443 . . . . 72.3 109.805 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.54 5.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 35.35 111.827 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' H ' ' HG ' ' A' ' 19' ' ' LEU . 24.6 mt-10 -123.58 172.43 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.551 0.215 . . . . 55.01 110.84 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.58 93.37 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.022 0.439 . . . . 61.31 111.307 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -134.07 67.21 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.279 -0.637 . . . . 71.3 109.279 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.33 -56.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.875 -1.057 . . . . 71.31 109.557 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.03 127.43 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.597 -0.729 . . . . 74.55 110.298 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.87 57.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.88 -0.676 . . . . 74.3 112.73 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.03 167.56 12.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.315 0.578 . . . . 73.45 111.527 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.92 131.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.144 -0.935 . . . . 64.23 111.249 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 37' ' ' TRP . 12.7 tt -105.77 136.81 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 72.55 109.427 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.5 m -93.83 113.95 26.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.134 0.42 . . . . 74.14 112.134 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 14.4 t70 -72.65 154.77 40.58 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.06 174.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.684 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 52.3 tpp -70.63 -30.36 66.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.879 0.371 . . . . 74.31 110.971 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.82 18.48 3.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.052 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 61.29 77.71 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.062 -0.972 . . . . 74.44 110.032 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 45.4 mmtm -140.52 115.48 9.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.972 -1.013 . . . . 53.04 109.139 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.74 111.55 17.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.245 -0.434 . . . . 40.42 110.228 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 29' ' ' ILE . 83.9 m95 -108.89 163.15 13.54 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.95 -0.759 . . . . 73.32 108.95 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 56' ' ' MET . 21.7 ttpt -114.6 129.49 56.68 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.654 -0.418 . . . . 64.33 110.25 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -75.89 104.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.071 0.462 . . . . 63.31 109.9 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.22 -104.54 2.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.442 -0.885 . . . . 73.31 113.246 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 mm? -86.29 127.71 60.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.043 0.449 . . . . 63.12 111.471 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.3 Cg_exo -78.74 106.25 2.08 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.106 2.537 . . . . 70.0 111.77 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -81.28 -37.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 71.03 110.17 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 87.53 -45.44 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.829 -0.7 . . . . 60.51 112.696 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.7 tp-100 -103.23 165.63 10.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.596 -0.52 . . . . 52.21 109.596 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 71' ' ' LYS . . . 98.77 13.36 40.73 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.445 -1.462 . . . . 74.15 109.445 -168.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.849 ' HA3' HD11 ' A' ' 51' ' ' ILE . . . -168.24 -164.4 23.87 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 114.325 -0.938 . . . . 61.22 111.169 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -102.92 8.72 39.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.764 0.316 . . . . 74.42 111.625 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.03 -76.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.329 -0.939 . . . . 63.24 113.182 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' CYS . . . . . 0.628 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 84.6 m -150.18 110.43 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 73.1 109.964 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.849 HD11 ' HA3' ' A' ' 47' ' ' GLY . 30.3 mm -100.31 137.83 26.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.073 -0.512 . . . . 74.35 110.62 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -110.07 145.15 37.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 74.3 110.616 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HA ' HG12 ' A' ' 69' ' ' VAL . 9.7 tt -91.16 138.27 31.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.421 -0.585 . . . . 75.22 109.421 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.18 96.23 5.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 71.55 110.945 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.13 -32.4 19.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 63.12 110.444 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.622 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 9.2 tpt 62.27 34.85 15.65 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.658 -0.701 . . . . 61.23 111.465 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.5 t30 74.07 121.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.573 0.701 . . . . 52.3 111.831 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.615 ' HA ' HG11 ' A' ' 62' ' ' VAL . 13.5 m -71.11 108.95 4.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.572 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 m -131.28 -67.31 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.848 -0.615 . . . . 35.21 111.051 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -157.97 -60.76 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 74.01 110.612 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 m -64.21 -21.36 66.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 64.2 112.465 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.615 HG11 ' HA ' ' A' ' 58' ' ' SER . 8.8 p -80.82 145.13 9.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.904 0.383 . . . . 64.04 110.776 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.79 -170.75 13.59 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.5 -0.857 . . . . 62.51 111.262 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.4 m -79.98 27.1 0.32 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.571 -0.37 . . . . 71.23 111.479 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 38.6 t70 175.56 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.567 -0.288 . . . . 75.12 110.63 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . 76.9 116.79 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 124.362 1.039 . . . . 61.12 110.878 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 4.0 Cg_exo -79.87 40.72 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.294 2.663 . . . . 74.45 112.341 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 131' ' ' MET . 2.2 p -140.71 137.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.398 0.618 . . . . 70.21 111.931 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 53' ' ' LEU . 30.9 m -137.87 161.85 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.312 -0.858 . . . . 62.43 108.971 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -123.59 122.29 64.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.482 0.658 . . . . 62.45 112.371 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.847 ' HA ' HD12 ' A' ' 51' ' ' ILE . 36.9 ttmt -89.6 122.19 32.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.741 -1.118 . . . . 65.33 109.297 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 128' ' ' PHE . 35.7 m -115.91 139.16 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.03 0.382 . . . . 72.41 112.03 -175.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 6.6 mm-40 -148.91 139.44 13.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 74.44 109.823 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 25.2 Cg_exo -63.1 150.94 87.18 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.942 2.428 . . . . 40.22 112.324 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 m -73.06 66.83 0.85 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.301 0.572 . . . . 54.42 112.068 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -113.61 -6.44 13.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.52 -1.289 . . . . 72.41 107.52 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 90.69 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 113.987 -1.46 . . . . 42.45 111.391 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.43 -139.66 5.72 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.441 -0.8 . . . . 51.1 111.5 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG3' HG23 ' A' ' 353' ' ' THR . 28.0 Cg_exo -61.59 -22.93 75.66 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.057 2.505 . . . . 74.42 112.175 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -56.81 -34.74 67.99 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.743 -0.662 . . . . 62.31 110.294 178.55 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.19 -41.43 85.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 73.32 110.43 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.2 m -65.59 -41.76 92.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.235 -0.439 . . . . 71.45 110.348 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -58.31 -45.99 86.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.694 . . . . 73.43 110.425 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -67.48 -33.69 75.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 73.34 111.128 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HE3' ' HE1' ' A' ' 173' ' ' TYR . 6.2 tmtm? -64.19 -45.18 89.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.351 -0.611 . . . . 74.34 109.351 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' A' ' 168' ' ' ILE . 87.8 t80 -65.26 -41.5 94.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 73.41 110.275 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' ' HD1' ' A' ' 113' ' ' TYR . 42.8 t80 -59.28 -49.03 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.076 -0.965 . . . . 75.52 110.512 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -64.04 -34.17 77.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 64.13 111.226 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -75.52 -53.56 8.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.493 0.553 . . . . 64.22 112.493 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.75 -33.7 7.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.832 0.679 . . . . 60.13 112.832 -169.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.06 84.84 7.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.322 0.582 . . . . 64.23 110.738 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -157.48 128.43 3.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.772 -0.649 . . . . 74.44 109.466 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.0 -52.38 8.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.354 2.703 . . . . 63.15 113.23 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.75 -45.37 92.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -69.22 -45.58 69.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.004 -0.543 . . . . 75.41 110.716 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.11 -50.42 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 73.02 110.998 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -61.46 -37.3 83.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.809 0.338 . . . . 75.43 110.391 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 34.0 ttmt -59.63 -51.5 69.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 73.43 110.832 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.823 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 23.6 t90 -68.59 -51.1 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 73.22 110.684 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.93 -40.05 81.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.713 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 101' ' ' ARG . 45.7 ttt-85 -63.77 -56.54 14.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 75.31 110.856 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.3 m -65.04 -40.84 95.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.754 -0.657 . . . . 40.21 111.239 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -75.53 -13.83 60.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.988 -0.551 . . . . 74.1 110.929 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 62.58 57.74 1.77 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.336 0.588 . . . . 74.15 110.392 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -117.62 -174.52 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 75.04 110.806 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.47 -59.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.878 -0.601 . . . . 63.34 111.284 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -144.81 157.26 44.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 72.31 110.764 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -105.8 137.35 43.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 60.24 109.199 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.27 33.05 1.78 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.941 -0.647 . . . . 62.24 113.287 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 108' ' ' LEU . 11.0 p -109.25 137.16 20.14 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.405 -0.591 . . . . 74.54 109.405 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD2' HG23 ' A' ' 110' ' ' VAL . 5.9 Cg_endo -47.28 135.21 19.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.51 2.807 . . . . 72.43 113.343 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 44.3 tptt -65.01 121.15 14.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 71.04 110.839 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.534 ' HD1' ' CE2' ' A' ' 87' ' ' TYR . 27.2 t80 -80.44 132.27 35.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.272 -0.876 . . . . 74.34 111.357 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.535 ' HB2' HG22 ' A' ' 130' ' ' ILE . 69.9 m95 -122.42 -54.03 1.89 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.875 -0.787 . . . . 51.43 108.875 170.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.38 176.71 46.72 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.393 -0.822 . . . . 71.25 111.96 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -157.29 153.62 27.75 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.996 -0.742 . . . . 72.33 108.996 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 32' ' ' MET . . . -161.43 176.07 37.98 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.357 -1.401 . . . . 70.2 114.147 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 126' ' ' TYR . 19.1 tp -137.08 129.08 29.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.01 108.785 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -144.49 131.79 20.75 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.701 -0.4 . . . . 73.2 110.648 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 8.2 t70 -69.74 136.75 51.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 61.31 110.824 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -90.72 -60.01 2.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 54.11 109.258 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -170.18 85.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.633 -0.712 . . . . 54.35 109.603 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.38 -34.86 5.43 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.604 -0.598 . . . . 40.24 111.604 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -132.02 140.8 49.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 75.0 109.919 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 11.5 p -89.65 156.14 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 63.03 110.897 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 118' ' ' LEU . 15.8 m-85 -111.5 130.69 55.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.737 -0.665 . . . . 72.41 110.391 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -96.44 118.03 32.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.709 -0.849 . . . . 74.41 108.709 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.566 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.6 p90 -129.16 156.57 43.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.967 0.413 . . . . 75.43 111.5 -173.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 18.5 ptp -137.27 139.59 41.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.671 -0.695 . . . . 55.54 110.335 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.547 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.7 mm -97.86 117.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.1 -0.5 . . . . 53.32 109.711 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER -121.84 -175.96 3.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 75.34 111.088 -175.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 20.8 t70 -64.5 157.01 27.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 70.12 110.633 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 1.2 tmt_? -93.71 109.36 21.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.268 0.556 . . . . 72.45 110.045 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 63.7 m-85 -101.84 171.39 7.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.589 . . . . 73.22 109.9 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.7 -36.78 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.472 -0.871 . . . . 42.24 112.42 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.5 m -103.06 124.94 49.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.962 0.411 . . . . 62.11 111.141 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 1.3 m-20 -87.42 132.9 33.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.06 -0.518 . . . . 65.03 109.905 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 14.8 tp -68.94 -38.29 79.37 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.065 -1.087 . . . . 63.21 108.065 171.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.979 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 4.9 pt20 -59.51 -49.0 79.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.339 -0.846 . . . . 75.14 112.418 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 25.2 mtmm -71.57 -36.91 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.768 -0.373 . . . . 55.54 111.371 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.03 -48.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 71.02 110.568 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.05 -44.95 95.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 71.14 111.922 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.3 -34.39 59.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.876 0.369 . . . . 62.24 110.727 -172.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.4 -28.85 62.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 73.12 110.557 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.64 0.11 56.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.37 0.605 . . . . 63.22 110.185 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 58.81 45.12 15.93 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.296 -0.865 . . . . 72.11 112.27 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 254' ' ' TRP . 0.0 OUTLIER 39.89 79.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.932 0.872 . . . . 74.12 112.998 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 148' ' ' ARG . 14.4 ttt180 -146.5 88.48 1.78 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.68 -1.145 . . . . 74.43 108.367 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.727 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 52.4 m-85 -120.09 156.16 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.084 -0.507 . . . . 74.32 112.025 -172.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.4 m -67.61 155.66 38.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.854 . . . . 72.42 110.257 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.607 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 7.7 tpp85 -59.71 -39.7 85.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.824 0.345 . . . . 73.42 110.797 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HD2' ' HB2' ' A' ' 335' ' ' ASP . 26.2 pttm -66.3 -30.36 70.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.337 -0.392 . . . . 63.04 111.201 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.431 ' O ' HD13 ' A' ' 157' ' ' LEU . 6.9 m -70.2 -41.52 73.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 60.4 110.175 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.72 -43.62 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.617 -0.72 . . . . 65.24 110.945 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.652 HD22 HD22 ' A' ' 328' ' ' LEU . 3.3 mp -69.06 -40.16 78.69 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.483 0.549 . . . . 75.21 112.483 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -56.29 -45.06 80.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 72.31 110.301 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 153' ' ' THR . 8.6 mp -64.18 -52.03 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 73.22 111.313 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.3 p -65.27 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.286 . . . . 45.22 111.671 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 325' ' ' LEU . 7.0 mp -56.3 -48.99 75.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.539 0.2 . . . . 52.42 111.539 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 2.3 mmp_? -61.15 -42.68 98.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 73.02 110.907 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 183' ' ' LEU . 31.4 mm -63.62 -38.19 81.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 72.04 110.581 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 317' ' ' TYR . 67.3 mt -58.01 -53.04 62.73 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.891 0.33 . . . . 75.34 111.891 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.823 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -70.08 -39.44 75.59 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.454 -0.498 . . . . 34.23 112.119 -175.611 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.54 -36.57 75.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.871 -0.731 . . . . 72.52 110.953 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.91 -38.86 83.47 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.797 -0.183 . . . . 73.14 111.212 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 167' ' ' TYR . 4.1 pt-20 -68.93 -40.96 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.233 -0.587 . . . . 54.31 110.009 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.484 ' N ' ' HG3' ' A' ' 166' ' ' GLU . 66.3 t80 -55.84 -45.81 78.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.693 -0.685 . . . . 75.32 111.735 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.404 HG21 ' HE1' ' A' ' 86' ' ' PHE . 26.9 pt -82.55 -31.46 9.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.486 -0.324 . . . . 72.33 111.797 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -66.8 -27.06 67.27 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.436 -0.347 . . . . 74.12 110.689 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 37.0 tt0 -77.65 28.56 0.16 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.107 0.479 . . . . 61.23 111.491 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -151.18 -65.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.525 -0.734 . . . . 74.42 111.597 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 35.3 mt-10 -147.25 -31.44 0.32 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.696 0.628 . . . . 63.33 112.696 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.449 ' HE1' ' HE3' ' A' ' 85' ' ' LYS . 5.4 m-85 -99.18 128.85 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.784 1.031 . . . . 75.41 113.784 -155.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.4 m -123.01 139.5 49.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.707 -1.133 . . . . 62.32 108.015 163.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -93.77 -32.88 13.81 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.827 -0.349 . . . . 73.03 110.203 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.65 -76.87 0.28 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.078 -0.582 . . . . 71.22 111.852 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.9 101.93 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.037 0.446 . . . . 64.35 110.343 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 178' ' ' ILE . 9.4 tp -99.73 20.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.876 0.846 . . . . 71.15 110.051 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -57.56 144.3 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.93 . . . . 64.35 110.256 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 183' ' ' LEU . . . -62.3 -0.36 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.906 -0.588 . . . . 72.44 112.553 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.979 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 14.2 p -70.48 -17.28 62.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 54.31 111.514 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 198' ' ' TYR . 14.6 m120 -112.53 6.67 18.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 60.14 111.3 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 180' ' ' ALA . 7.1 mp -105.06 115.66 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.706 -0.479 . . . . 63.34 109.706 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.63 140.3 49.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.433 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 53.3 mt -94.71 138.41 32.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.707 -0.679 . . . . 74.51 109.874 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.61 140.47 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.096 -0.705 . . . . 63.3 109.096 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 5.6 p90 -62.42 -22.4 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.128 0.418 . . . . 73.54 112.128 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -104.3 -51.18 3.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.761 0.315 . . . . 65.32 111.039 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -112.11 106.82 56.12 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 74.14 110.979 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.13 -11.71 25.32 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.096 2.531 . . . . 55.5 112.49 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 26.8 t70 -70.87 -19.99 62.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.57 . . . . 71.24 110.703 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -111.09 103.05 11.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.45 0.643 . . . . 72.53 110.18 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.94 137.99 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 64.12 109.74 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.517 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 96.3 m-85 -120.3 141.98 49.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.044 0.449 . . . . 64.24 111.054 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 182' ' ' ASN . 37.6 tp -90.76 99.97 12.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.728 -0.669 . . . . 54.41 109.392 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.5 m -139.99 160.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.457 -0.338 . . . . 74.45 111.636 -174.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.44 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 16.6 t70 60.67 78.16 0.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.968 -1.015 . . . . 63.21 111.575 174.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.62 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 19.4 p90 -151.41 -40.76 0.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.548 -0.751 . . . . 63.42 112.015 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.658 ' O ' ' HB ' ' A' ' 354' ' ' ILE . . . 66.72 2.16 15.03 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.751 -0.737 . . . . 70.41 112.661 -175.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.62 ' H ' ' HD2' ' A' ' 198' ' ' TYR . 6.2 mp -91.94 35.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 73.24 111.474 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -84.49 97.78 9.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.363 -0.977 . . . . 72.52 108.363 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -99.97 127.48 46.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.265 0.555 . . . . 72.05 110.697 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 2.0 ttp180 -72.86 112.45 8.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.483 -0.78 . . . . 61.44 110.229 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.573 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 13.7 p90 -92.57 -26.22 17.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.84 -0.43 . . . . 75.42 109.84 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 18.0 p -133.31 127.42 19.84 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 74.22 111.145 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.65 131.39 13.51 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.505 2.137 . . . . 70.44 111.752 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 65.96 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.79 0.681 . . . . 74.32 111.291 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.27 15.75 0.14 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.155 -0.545 . . . . 41.51 111.927 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 45.0 t -94.95 110.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.931 -0.396 . . . . 74.51 109.931 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.98 145.82 55.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 70.01 110.998 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 214' ' ' LYS . 74.8 tttt -111.02 145.09 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.828 -0.624 . . . . 74.05 110.755 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.2 -163.39 1.02 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.872 -0.604 . . . . 71.52 110.172 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.565 ' HA ' HG23 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -76.27 67.79 2.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.809 0.67 . . . . 71.4 112.809 -175.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.427 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 75.6 tttt -158.43 83.28 0.83 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.855 -0.611 . . . . 72.23 109.725 169.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 235' ' ' GLY . 9.8 tp10 -105.9 -72.93 0.7 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.939 -0.573 . . . . 75.44 110.464 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -138.34 109.39 8.14 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.61 -0.268 . . . . 61.03 110.418 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.2 -14.07 43.16 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.23 2.62 . . . . 71.11 112.481 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 218' ' ' LYS . 46.1 tptt -85.99 3.88 40.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.237 0.541 . . . . 74.12 110.05 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.448 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 69.7 mtt85 67.27 85.6 0.14 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.44 -0.8 . . . . 62.24 110.653 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.02 -42.81 77.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.43 -1.259 . . . . 64.42 112.915 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 44.64 75.64 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.869 0.842 . . . . 72.24 111.453 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.32 -43.06 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 75.43 111.491 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -96.88 -170.46 33.95 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 71.21 112.789 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.3 m -69.58 142.24 53.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.443 0.164 . . . . 44.32 110.77 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -56.96 -23.83 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.471 0.653 . . . . 73.41 110.542 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.23 -53.47 54.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.465 -0.788 . . . . 65.42 111.937 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.27 7.0 19.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.085 0.772 . . . . 74.53 113.085 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -21.1 66.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 60.55 111.288 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.677 ' HA ' ' CD ' ' A' ' 275' ' ' LYS . 50.8 m 59.77 -162.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.709 -0.678 . . . . 64.44 110.247 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.2 OUTLIER -71.0 -34.16 54.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.421 -0.512 . . . . 74.11 110.281 176.436 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.424 ' HA ' HG13 ' A' ' 236' ' ' VAL . 5.2 m-20 -59.76 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.631 -0.713 . . . . 63.34 112.316 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.59 72.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 63.33 111.714 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -68.97 -31.35 70.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.496 -0.32 . . . . 73.24 111.164 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.69 0.52 55.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 64.23 110.711 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 215' ' ' GLU . . . 87.12 33.89 11.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.459 -0.877 . . . . 71.44 113.829 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 213' ' ' TYR . 1.4 p -120.79 129.22 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.226 0.513 . . . . 42.44 110.803 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -77.29 111.6 18.03 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 51.24 109.578 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 123.82 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.577 2.185 . . . . 73.32 113.295 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.1 m -95.37 104.59 16.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.886 -0.597 . . . . 55.31 110.041 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.645 HH21 ' HB2' ' A' ' 244' ' ' LEU . 0.0 OUTLIER 79.8 -56.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.64 0.776 . . . . 72.02 110.866 175.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.658 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.61 -54.89 38.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.32 -0.4 . . . . 74.11 111.457 -173.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.13 -44.95 97.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 55.23 112.592 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.43 -53.74 33.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.113 0.482 . . . . 72.52 111.12 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.645 ' HB2' HH21 ' A' ' 240' ' ' ARG . 3.7 mm? -72.22 -40.34 67.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.662 . . . . 64.51 111.537 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -46.43 89.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.69 0.281 . . . . 61.45 111.049 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 242' ' ' GLY . 75.1 mt -66.6 -33.92 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 65.3 110.714 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.1 86.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.517 -0.549 . . . . 65.3 109.517 174.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.47 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -58.76 -39.1 93.25 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.737 -0.744 . . . . 75.02 112.18 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.07 -42.18 94.4 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.965 0.358 . . . . 75.42 111.965 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 31.2 p -69.64 -35.8 75.53 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.243 -0.583 . . . . 74.15 110.955 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 70.6 mtm -65.69 -46.81 77.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.056 -0.258 . . . . 62.35 111.073 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.8 -28.78 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.738 -0.385 . . . . 54.45 110.586 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -46.55 87.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.97 -0.382 . . . . 71.31 109.97 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 16.8 m0 -67.32 -28.64 68.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.915 -0.584 . . . . 75.11 110.906 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -83.9 -35.78 23.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 74.33 112.628 -173.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 42.9 p -102.64 -14.69 16.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.416 0.524 . . . . 73.34 112.416 -171.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.28 -33.54 4.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.235 -0.983 . . . . 61.15 113.006 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 143.93 18.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.371 -0.488 . . . . 73.14 110.868 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.496 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.3 mt -103.9 149.5 37.25 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 73.23 110.315 176.455 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.01 -40.25 86.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.751 2.301 . . . . 73.3 112.681 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 25.0 p90 -87.13 -0.38 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.531 -0.304 . . . . 71.32 111.35 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 265' ' ' LEU . 84.7 tt0 -79.63 -28.27 40.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.093 0.473 . . . . 73.34 109.945 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.19 -27.95 32.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 64.5 110.26 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -108.4 17.42 22.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.529 -0.76 . . . . 54.13 112.098 -173.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 262' ' ' GLU . 4.2 pp -73.56 -7.85 53.55 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.091 0.472 . . . . 64.1 111.085 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -64.21 -14.12 53.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 73.23 111.058 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.706 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 10.9 t70 -134.69 127.89 18.71 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 63.23 110.223 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.0 Cg_exo -61.59 -33.06 87.71 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.351 2.701 . . . . 71.52 114.794 -171.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.706 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 22.9 pttm -74.29 -24.04 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.515 -0.474 . . . . 75.13 111.471 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 267' ' ' ASP . 74.6 m-85 -71.22 -49.55 42.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 73.3 110.157 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.671 HG13 ' HZ2' ' A' ' 275' ' ' LYS . 96.1 t -58.5 -37.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.784 -0.644 . . . . 74.03 110.954 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.427 ' O ' HG13 ' A' ' 276' ' ' ILE . 48.5 ttt-85 -59.85 -61.9 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 73.14 110.876 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -45.58 91.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.974 -0.557 . . . . 73.54 111.82 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 15.1 p -61.46 -49.92 74.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.883 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.677 ' CD ' ' HA ' ' A' ' 229' ' ' SER . 56.2 mttp -66.69 -37.35 84.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 61.15 111.75 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 280' ' ' GLU . 83.0 mt -60.85 -49.58 84.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.42 . . . . 55.44 110.557 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -69.01 -33.63 73.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 74.42 111.003 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.81 -36.4 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 64.1 110.644 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 282' ' ' ILE . 58.2 ttp180 -71.06 -38.22 72.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 74.31 110.805 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 72.7 mt-10 -67.58 -42.32 82.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 74.24 110.986 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.488 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.0 m-80 -117.78 46.97 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 73.52 110.649 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.63 -51.35 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.865 0.691 . . . . 73.33 112.865 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.51 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.11 -43.54 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.913 0.387 . . . . 61.25 111.339 -175.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.4 m -65.96 -45.39 81.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.839 -0.619 . . . . 75.02 110.853 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.0 mm? -69.39 -43.12 74.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 72.21 111.603 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 282' ' ' ILE . 30.5 mmt -64.57 -40.34 95.38 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.965 -0.294 . . . . 74.21 111.051 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 16.1 t70 -66.26 -48.64 69.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 74.31 111.2 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -98.94 14.54 28.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.847 -0.615 . . . . 64.23 111.875 -169.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 47.4 t -85.44 -27.25 25.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 60.02 109.777 173.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 290' ' ' PHE . 0.1 OUTLIER -138.1 68.5 48.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 64.3 111.298 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.19 31.89 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.035 2.49 . . . . 71.34 111.919 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.76 -85.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.666 -0.697 . . . . 70.2 111.808 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -145.4 16.27 1.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.964 0.887 . . . . 71.42 109.492 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -104.73 -142.92 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.338 -0.847 . . . . 61.01 109.958 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 47.9 tptt -156.06 114.98 2.16 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.657 -0.247 . . . . 63.21 110.613 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.511 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 47.3 Cg_endo -95.42 77.99 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.342 2.695 . . . . 65.42 111.697 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -119.95 -59.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.201 -0.999 . . . . 63.22 112.535 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.607 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 1.1 mp0 -60.02 -61.43 2.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.675 0.274 . . . . 74.11 110.399 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.554 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.7 mp -60.6 -37.17 74.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.62 . . . . 60.34 110.63 -177.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.61 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 70.33 111.335 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 40.4 tptt -72.03 -33.58 68.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.34 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -55.41 -49.39 72.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.669 -0.696 . . . . 74.1 110.708 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.47 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 94.3 mmm -72.02 -39.67 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 74.05 111.057 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.534 ' HA ' HG13 ' A' ' 282' ' ' ILE . 23.1 tt0 -57.46 -45.68 84.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.634 0.73 . . . . 63.23 109.71 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.6 m -60.07 -51.08 71.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.54 -1.209 . . . . 63.25 112.0 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 303' ' ' MET . 31.0 m -73.37 -27.91 24.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.331 0.493 . . . . 42.51 112.331 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -75.62 -43.82 45.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.889 0.376 . . . . 71.32 110.703 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.95 76.74 10.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.344 0.498 . . . . 75.0 112.344 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.634 HD11 HH11 ' A' ' 240' ' ' ARG . 0.5 OUTLIER -163.28 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.864 171.061 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.999 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 32.4 t70 -178.35 164.22 1.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.993 -0.373 . . . . 64.13 109.993 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.658 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 2.2 t80 -58.58 -64.6 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.861 0.465 . . . . 75.25 111.069 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 t -114.77 36.42 3.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.409 0.623 . . . . 74.42 110.731 -173.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 9.9 tp10 -67.57 -86.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 65.41 111.481 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 179.98 137.53 0.29 Allowed Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 109.502 -0.555 . . . . 72.53 109.502 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -91.96 128.64 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.622 2.215 . . . . 73.12 112.995 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.498 ' O ' HD13 ' A' ' 320' ' ' LEU . 90.4 mt -79.96 75.78 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.518 -0.549 . . . . 74.03 109.518 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.6 ' CE1' ' HB3' ' A' ' 162' ' ' LEU . 67.1 t80 -57.67 -39.29 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.778 -0.646 . . . . 74.31 111.401 -174.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.08 -43.7 98.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.517 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -76.7 -29.87 56.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.52 -0.309 . . . . 72.5 111.225 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 323' ' ' ILE . 7.1 mp -69.34 -48.13 62.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 74.32 110.9 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.442 HH22 ' NH2' ' A' ' 160' ' ' ARG . 20.9 ttt180 -70.57 -28.13 64.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 75.34 109.758 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.41 -41.03 66.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.882 -0.599 . . . . 71.41 111.464 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -67.72 -36.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.956 -0.387 . . . . 75.14 109.956 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 155' ' ' LEU . 92.1 mt -60.46 -49.43 77.59 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.936 0.398 . . . . 61.21 110.079 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 159' ' ' LEU . 3.8 mm? -62.61 -37.92 88.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.554 . . . . 51.12 111.408 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -55.56 -47.36 76.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.586 -0.279 . . . . 75.2 110.827 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.586 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.83 -42.64 96.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 75.15 112.184 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 333' ' ' SER . 27.4 tp -65.86 -42.97 89.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 71.13 111.114 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -66.69 -32.59 73.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 73.22 110.363 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.19 64.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 54.24 111.089 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 328' ' ' LEU . 12.7 tt -85.68 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 120.948 0.404 . . . . 72.11 110.495 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.83 36.45 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.562 -0.827 . . . . 43.25 113.508 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.682 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 52.3 m -129.42 162.57 27.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.034 0.417 . . . . 73.12 111.16 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.785 ' HD2' ' HB2' ' A' ' 336' ' ' ASP . 5.6 tmtt? -179.5 -51.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.931 -0.766 . . . . 74.42 108.931 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.759 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 8.1 t70 70.04 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.154 -0.93 . . . . 71.3 110.473 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ASP . . . . . 0.785 ' HB2' ' HD2' ' A' ' 334' ' ' LYS . 10.9 t70 58.56 94.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.669 0.606 . . . . 72.11 111.21 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 150.14 -36.07 0.97 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.958 -0.857 . . . . 61.14 110.958 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -150.82 157.49 43.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.547 -0.538 . . . . 62.43 109.547 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 28.1 tp -90.38 130.85 36.42 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.999 -0.371 . . . . 70.3 109.999 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.687 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 27.9 t0 -78.97 85.16 4.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.926 -0.579 . . . . 72.14 111.004 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 342' ' ' SER . 61.9 mt -138.93 -41.03 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.082 -0.963 . . . . 71.15 109.91 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.541 ' O ' ' HB ' ' A' ' 343' ' ' VAL . 44.4 t 74.18 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.978 -1.01 . . . . 72.41 108.734 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 342' ' ' SER . 10.2 p 167.32 81.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 122.137 0.97 . . . . 74.42 109.196 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.84 -77.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.437 -0.801 . . . . 61.55 111.274 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -138.67 165.78 26.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 75.03 111.12 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.97 146.84 50.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.862 -0.608 . . . . 75.25 109.856 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -120.27 -141.86 6.43 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.97 -0.634 . . . . 43.04 112.101 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -137.36 106.2 0.53 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.47 -0.872 . . . . 75.24 112.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.46 156.25 42.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.762 -0.459 . . . . 63.24 109.762 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -115.34 163.5 15.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.929 0.395 . . . . 74.23 111.245 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.14 -168.41 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.743 . . . . 72.14 109.675 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -140.37 -179.69 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.153 0.501 . . . . 74.32 112.133 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 79' ' ' PRO . 95.8 m -150.44 137.35 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.641 -0.708 . . . . 73.22 109.946 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -66.91 134.03 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.271 0.558 . . . . 62.13 110.27 -176.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.454 ' N ' HD13 ' A' ' 354' ' ' ILE . 50.9 m -64.96 94.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 35.11 112.054 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.37 -25.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.761 -0.654 . . . . 74.22 111.305 174.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 356' ' ' LYS . 77.3 tttt -122.51 145.85 47.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.131 -0.228 . . . . 71.02 110.412 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 358' ' ' ARG . 22.5 ttt180 -73.96 -54.05 8.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -176.18 -177.3 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.963 -1.125 . . . . 70.12 107.963 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.655 -0.688 . . . . 44.45 109.869 176.71 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.954 -0.387 . . . . 70.43 109.954 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.35 138.78 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.879 2.386 . . . . 71.3 112.328 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.72 118.35 18.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.273 0.558 . . . . 75.14 109.856 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.81 102.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.234 0.54 . . . . 62.22 110.509 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -104.81 123.45 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.986 -0.552 . . . . 72.32 109.784 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.75 122.62 4.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 72.24 110.505 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.85 -5.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 51.14 111.308 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 93.21 7.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.265 0.555 . . . . 53.51 111.292 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.99 78.69 1.3 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.632 -0.713 . . . . 32.25 110.144 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.91 -132.64 52.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.771 -0.649 . . . . 72.24 112.55 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.777 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 1.2 mmp_? 57.39 78.47 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.3 0.64 . . . . 73.4 112.355 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.21 -176.75 3.62 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.855 -0.424 . . . . 72.31 109.855 173.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -79.62 122.61 26.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.984 0.421 . . . . 72.34 111.736 -171.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.0 m -92.45 142.43 27.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.571 -0.74 . . . . 74.55 109.336 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.62 176.85 8.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.111 0.482 . . . . 75.42 112.042 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -145.31 -165.46 2.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.08 -0.963 . . . . 63.33 109.289 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 7.7 tpm_? -57.72 -26.99 62.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.482 0.489 . . . . 64.33 111.46 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 17' ' ' ARG . 35.2 m170 77.19 61.04 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.485 0.714 . . . . 73.41 112.36 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 19' ' ' LEU . 2.3 pt? -145.0 88.03 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.668 0.747 . . . . 73.25 109.747 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.33 113.7 14.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.961 -0.563 . . . . 70.25 110.672 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -24.06 12.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 71.41 109.937 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 53.5 tp60 55.62 -101.58 0.13 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.58 -0.736 . . . . 72.12 109.575 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 16.3 t80 178.37 77.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.319 0.58 . . . . 65.44 109.478 173.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.53 ' HB1' ' OE2' ' A' ' 27' ' ' GLU . . . -130.13 2.09 4.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.478 -0.783 . . . . 43.24 109.879 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HA ' HG13 ' A' ' 39' ' ' VAL . 61.3 t -56.24 128.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.22 -0.9 . . . . 74.4 110.928 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.37 0.03 56.96 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.694 -0.765 . . . . 32.13 113.425 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 9.4 pt-20 -82.48 150.74 26.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.029 -0.73 . . . . 73.01 109.029 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 1.2 tp -91.42 131.54 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 63.24 110.057 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.34 132.14 71.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.498 -0.773 . . . . 72.23 109.222 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 m -118.08 114.08 22.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.935 -0.395 . . . . 75.21 109.935 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' OD2' ' HA3' ' A' ' 115' ' ' GLY . 4.7 p-10 -95.23 -172.02 2.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 70.21 110.41 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.1 mmt -70.58 -11.27 60.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.475 0.546 . . . . 74.23 112.475 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.06 2.45 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.226 -0.296 . . . . 53.34 110.372 174.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.28 24.93 8.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.517 -0.765 . . . . 74.21 110.687 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' THR . 29.1 mtpp -93.63 124.75 37.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.85 -0.614 . . . . 71.24 110.163 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.79 92.21 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.354 -0.61 . . . . 71.12 109.354 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 1.004 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 25.1 p-90 -116.83 140.02 49.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.792 -0.64 . . . . 74.33 111.141 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 56' ' ' MET . 23.6 pttm -85.6 139.26 31.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.101 -0.703 . . . . 44.22 109.101 174.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 25' ' ' VAL . 3.6 p -66.95 117.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 74.23 109.061 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.98 -121.59 4.89 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.418 -0.896 . . . . 40.51 112.731 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.685 HD22 ' HD2' ' A' ' 42' ' ' PRO . 2.4 tm? -73.31 118.02 65.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.916 0.388 . . . . 73.33 110.397 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.685 ' HD2' HD22 ' A' ' 41' ' ' LEU . 65.1 Cg_endo -75.91 96.7 1.07 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.492 2.128 . . . . 72.43 111.797 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 53' ' ' LEU . 56.7 mt -62.77 -45.56 98.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.242 0.544 . . . . 65.33 110.337 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.25 83.67 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.399 -0.819 . . . . 62.11 112.226 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.796 ' HG2' HD11 ' A' ' 349' ' ' LEU . 61.1 mt-30 -139.04 159.85 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.902 -0.407 . . . . 65.32 109.902 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.73 49.88 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.634 -0.793 . . . . 74.32 111.497 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.03 112.06 2.71 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.686 -0.768 . . . . 60.04 112.218 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.583 ' HD2' ' HE2' ' A' ' 71' ' ' LYS . 21.5 m-85 68.25 -72.38 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.465 0.706 . . . . 71.2 111.447 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 18' ' ' HIS . . . 138.8 174.91 13.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.034 -0.603 . . . . 72.51 111.625 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.39 31.1 17.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.379 . . . . 62.12 111.483 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 71' ' ' LYS . 18.1 mm -88.82 136.59 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.92 -0.4 . . . . 74.24 109.92 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -108.19 153.65 22.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.52 0.2 . . . . 73.32 110.975 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 43' ' ' ILE . 8.1 tt -100.91 137.39 39.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.372 -0.603 . . . . 52.25 109.372 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . . . -94.98 93.73 7.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 53.41 110.494 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.13 -15.87 57.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 72.13 110.837 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' MET . . . . . 1.004 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 47.8 mtp 59.94 -163.47 0.24 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.75 -0.659 . . . . 73.43 110.39 -176.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.38 141.22 48.45 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.545 -0.909 . . . . 62.23 108.545 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -77.35 38.12 0.22 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.337 0.495 . . . . 63.32 112.337 -171.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 -38.42 10.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.592 -0.521 . . . . 74.22 109.592 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.46 102.3 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 74.01 109.964 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -169.05 124.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.496 HG12 ' OD1' ' A' ' 65' ' ' ASP . 8.5 p -82.6 144.06 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.486 -0.561 . . . . 55.11 109.486 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.51 4.05 1.11 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.152 -0.547 . . . . 21.14 113.723 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -104.44 -18.21 14.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.868 0.334 . . . . 51.12 111.378 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -108.61 -22.45 12.26 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.638 -0.425 . . . . 63.43 110.928 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.516 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -60.36 -42.56 89.65 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.221 0.452 . . . . 51.21 112.221 174.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.629 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 56.1 Cg_endo -71.21 62.39 2.62 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.697 1.598 . . . . 54.04 112.611 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 54' ' ' ALA . 9.3 p -120.79 152.47 38.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.7 -0.482 . . . . 74.34 109.7 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -122.94 155.8 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.656 0.265 . . . . 64.2 110.784 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -121.48 120.71 62.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.314 0.578 . . . . 54.23 111.415 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HG3' HD12 ' A' ' 51' ' ' ILE . 77.6 tttt -95.64 131.84 41.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 64.21 109.116 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 128' ' ' PHE . 34.7 m -118.68 151.76 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.207 0.447 . . . . 52.23 112.207 -173.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 127' ' ' ARG . 4.1 pt-20 -132.9 155.93 80.62 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.322 -0.399 . . . . 72.3 110.211 172.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HB2' HH12 ' A' ' 358' ' ' ARG . 2.0 Cg_endo -82.29 114.87 2.53 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.632 2.221 . . . . 74.25 112.24 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t 81.47 -96.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.032 0.933 . . . . 61.11 112.467 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -171.02 12.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.299 1.222 . . . . 62.0 114.299 -167.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.573 ' CB ' ' HB3' ' A' ' 359' ' ' LYS . 0.5 OUTLIER -146.37 103.95 3.74 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.779 -0.768 . . . . 74.23 112.394 -171.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.96 -161.24 32.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.921 -0.657 . . . . 53.31 111.781 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.896 ' HB3' ' HA2' ' A' ' 199' ' ' GLY . 31.2 Cg_exo -60.02 -26.64 82.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.017 2.478 . . . . 72.33 112.465 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.8 tm? -64.52 -37.07 86.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.457 -0.572 . . . . 70.45 109.457 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.88 -38.28 86.02 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.214 0.53 . . . . 74.43 109.808 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.3 m -62.87 -45.05 94.37 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.68 -0.691 . . . . 72.33 110.162 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.68 -29.72 69.06 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.934 -0.576 . . . . 74.51 110.752 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -59.08 -50.24 74.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.418 -0.215 . . . . 74.42 110.418 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -58.57 -47.27 84.83 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.769 0.319 . . . . 63.54 110.627 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.405 ' HD2' ' CD1' ' A' ' 87' ' ' TYR . 83.8 t80 -57.58 -52.19 66.41 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.895 -0.593 . . . . 75.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CD1' ' HD2' ' A' ' 86' ' ' PHE . 6.1 m-30 -62.35 -43.73 98.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.594 -0.275 . . . . 75.44 111.232 -175.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.18 -33.46 76.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.81 0.3 . . . . 72.22 111.81 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -95.48 -23.04 17.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.663 0.616 . . . . 72.01 112.663 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HB2' ' HE2' ' A' ' 167' ' ' TYR . . . -104.11 -34.54 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.78 0.659 . . . . 73.4 112.78 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.81 78.36 9.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.31 0.576 . . . . 72.21 111.594 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 19.2 tptp -155.51 101.79 2.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.894 -0.78 . . . . 73.53 108.894 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -43.72 -46.46 10.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.878 3.052 . . . . 75.3 114.138 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.26 -51.73 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 75.2 111.156 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -64.95 -40.89 95.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 74.43 110.488 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 72.8 mt -57.94 -53.6 43.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 50.23 110.857 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -62.04 -31.05 71.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.829 -0.623 . . . . 72.23 110.637 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 98' ' ' LYS . 10.5 tppt? -70.54 -50.9 32.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.099 -0.501 . . . . 75.21 111.525 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -73.53 -35.66 65.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 119.749 -0.78 . . . . 65.43 110.57 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.84 -34.95 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.439 0.638 . . . . 71.42 110.089 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -65.46 -49.34 69.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.243 -0.89 . . . . 74.41 111.229 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -75.75 -41.8 52.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.287 0.477 . . . . 73.31 112.287 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 105' ' ' LEU . 18.4 mmt180 -78.1 -17.38 57.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.477 -0.329 . . . . 72.35 111.189 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 64.95 59.97 0.84 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.949 0.88 . . . . 54.42 110.177 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 103' ' ' ARG . 7.3 mp -97.09 -166.3 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.557 -1.201 . . . . 75.12 108.542 173.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -128.64 -54.42 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.9 -0.72 . . . . 52.32 112.388 -174.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -164.73 107.88 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.713 -0.395 . . . . 71.55 110.981 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.544 HD22 ' CZ2' ' A' ' 99' ' ' TRP . 18.2 tp -80.21 132.0 35.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.01 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.72 70.91 2.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.997 -0.62 . . . . 63.1 111.904 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 96' ' ' ILE . 11.3 p -115.89 142.44 29.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.515 -0.18 . . . . 62.5 110.515 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.478 ' HG3' HG11 ' A' ' 196' ' ' VAL . 6.8 Cg_exo -72.82 140.4 32.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.468 2.112 . . . . 72.43 112.084 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -72.57 106.49 4.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.696 -0.483 . . . . 74.32 109.696 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -81.7 119.91 24.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.985 -0.552 . . . . 74.15 110.743 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CD1' HG22 ' A' ' 130' ' ' ILE . 41.9 m95 -95.73 -65.63 0.96 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.205 0.526 . . . . 72.11 109.802 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.537 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -151.07 -170.76 18.43 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.622 -0.717 . . . . 75.23 112.317 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 129' ' ' MET . 51.2 p -167.8 -177.36 3.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.864 -0.421 . . . . 71.23 109.864 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.43 -175.08 38.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.22 -0.99 . . . . 43.43 112.629 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -133.39 127.88 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.915 -0.772 . . . . 54.03 108.915 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -138.62 120.87 15.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 63.2 110.772 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 11.7 t70 -81.36 131.26 35.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 63.42 110.612 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -96.26 -53.21 3.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 62.32 110.588 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -169.22 91.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 70.05 109.869 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.27 11.5 67.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.194 -0.527 . . . . 64.15 112.162 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -144.16 108.35 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.078 -0.342 . . . . 63.12 110.078 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.523 ' HB3' HD21 ' A' ' 118' ' ' LEU . 24.3 m -85.09 111.33 19.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.04 -0.527 . . . . 73.12 109.901 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -91.53 128.33 37.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 72.0 110.987 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 32.3 ttm180 -91.21 128.27 36.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.333 -0.988 . . . . 74.45 108.333 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.586 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.8 p90 -134.1 152.68 51.94 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.955 -0.298 . . . . 72.13 111.147 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 70.9 mtm -136.97 140.46 42.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.078 -0.51 . . . . 71.52 110.285 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 8.1 mm -99.05 119.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.212 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.35 -174.14 3.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 63.14 110.315 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.92 158.04 26.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 63.32 110.625 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -67.15 115.46 6.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 65.33 112.186 -174.673 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 29.7 m-85 -119.52 171.68 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.512 -0.767 . . . . 50.3 109.283 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 -54.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.385 -0.912 . . . . 52.22 112.105 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -81.1 124.31 29.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 74.42 110.702 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.624 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -92.95 145.35 24.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.094 -1.076 . . . . 64.2 108.094 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 33.1 tp -60.92 -38.08 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.668 -0.413 . . . . 73.22 110.065 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.878 ' HA ' ' HD2' ' A' ' 142' ' ' TYR . 50.7 tt0 -59.97 -37.24 79.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.2 111.531 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.888 ' HB3' ' HB2' ' A' ' 345' ' ' GLU . 8.8 mttp -55.24 -59.59 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 75.55 110.43 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.23 -39.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.264 -0.88 . . . . 73.22 111.12 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.878 ' HD2' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.48 -38.74 91.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.353 -0.385 . . . . 74.24 111.234 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' CE2' ' A' ' 142' ' ' TYR . 32.6 mt-10 -83.48 -18.49 38.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.722 -0.391 . . . . 71.22 111.439 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -79.03 -23.98 43.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.323 0.582 . . . . 71.42 110.06 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -97.72 1.09 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.544 -0.753 . . . . 71.44 109.27 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.76 39.92 30.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.105 -0.952 . . . . 62.25 111.98 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 41.5 pttt 42.52 38.29 1.21 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.074 0.95 . . . . 74.14 113.22 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -98.76 81.33 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.075 -0.713 . . . . 73.15 109.075 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.93 156.97 26.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.965 0.412 . . . . 71.14 111.291 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.8 t -99.34 -172.55 2.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 54.43 110.224 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.446 ' HD3' ' CD ' ' A' ' 298' ' ' GLU . 3.9 ttm180 -65.39 -24.03 67.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 71.53 111.294 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -58.09 -68.73 0.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.927 -0.579 . . . . 74.23 111.897 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.7 p -59.11 -47.34 85.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 63.33 111.905 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.33 -41.67 71.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.689 -0.687 . . . . 53.31 111.332 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -71.41 -50.03 35.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.363 -0.38 . . . . 73.44 110.412 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.92 -44.95 87.16 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.863 0.363 . . . . 75.12 111.204 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 161' ' ' ILE . 8.3 mp -61.29 -52.73 63.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.125 -0.489 . . . . 73.12 111.137 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.0 p -63.74 -34.13 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.24 . . . . 72.01 111.526 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.33 -53.44 57.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.412 -0.358 . . . . 71.21 110.356 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -70.16 -29.27 66.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.07 0.462 . . . . 73.31 110.78 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 157' ' ' LEU . 30.1 mm -67.5 -37.99 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.15 110.523 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.55 -39.92 95.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.971 -0.381 . . . . 62.54 109.971 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.17 -63.23 1.22 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.685 0.755 . . . . 71.43 110.462 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 195' ' ' LEU . 18.4 tt -64.45 -34.85 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.375 -0.829 . . . . 73.12 111.264 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 175' ' ' HIS . 50.3 tp -60.95 -40.05 91.82 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.825 -0.17 . . . . 63.31 111.274 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -65.74 -39.11 90.77 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.535 -0.466 . . . . 64.11 110.904 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 49.1 t80 -59.06 -49.44 77.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.371 -0.532 . . . . 73.11 111.594 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.0 pt -74.03 -32.2 32.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.813 -0.355 . . . . 64.14 110.969 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.95 -45.75 92.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 73.03 110.915 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.33 8.08 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.94 0.4 . . . . 73.43 110.928 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -104.86 -67.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.083 -0.247 . . . . 75.01 111.016 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -152.46 -58.94 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.518 0.562 . . . . 53.24 112.518 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HA ' ' A' ' 203' ' ' ARG . 10.5 p90 -121.36 164.75 16.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.331 0.863 . . . . 63.42 113.331 -164.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.9 173.27 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.756 -1.111 . . . . 71.32 108.931 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CE1' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -129.44 103.7 7.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.585 0.707 . . . . 74.52 112.038 -175.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.01 -39.4 89.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.362 -0.836 . . . . 53.1 111.524 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 1.018 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 28.5 t70 -89.84 91.07 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.256 0.55 . . . . 75.5 110.041 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 178' ' ' ILE . 8.4 tt -110.01 25.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.087 0.946 . . . . 75.23 109.242 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.6 162.16 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.138 -0.937 . . . . 74.14 109.96 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.14 -5.37 1.04 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.033 0.753 . . . . 75.24 113.033 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 352' ' ' LYS . 1.0 OUTLIER -76.87 -20.65 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 50.51 110.413 176.102 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -88.37 -15.12 36.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 71.25 110.292 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 138' ' ' LEU . 6.4 mp -97.52 120.57 38.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 70.33 110.297 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.5 mm? -116.22 141.82 47.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.957 -0.565 . . . . 74.12 110.449 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 190' ' ' PRO . 9.8 mp -99.29 160.36 14.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.772 0.32 . . . . 74.23 110.559 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.42 151.22 47.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.179 -0.675 . . . . 52.25 109.179 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.06 -26.23 62.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.303 0.483 . . . . 75.23 112.303 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 188' ' ' LYS . 32.5 tptt -112.36 -58.09 2.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.8 0.667 . . . . 74.05 112.8 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -104.57 131.13 22.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.414 0.626 . . . . 73.44 112.201 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 185' ' ' LEU . 96.5 Cg_endo -77.21 -7.5 17.15 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.326 2.684 . . . . 73.05 113.544 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.88 -6.9 57.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.313 0.578 . . . . 73.45 110.182 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.455 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 88.1 mm-40 -105.29 92.75 4.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 72.41 110.342 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.16 120.45 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.441 0.639 . . . . 63.44 109.849 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 61.9 m-85 -113.08 154.86 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.351 -0.84 . . . . 74.42 109.515 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 164' ' ' ILE . 14.0 tp -110.12 107.48 17.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.882 -0.414 . . . . 74.3 109.882 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.478 HG11 ' HG3' ' A' ' 111' ' ' PRO . 19.8 m -138.41 -166.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 54.53 109.972 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.05 56.17 1.06 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.854 0.835 . . . . 71.21 109.922 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -82.85 67.12 8.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.61 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.896 ' HA2' ' HB3' ' A' ' 79' ' ' PRO . . . -64.34 -57.84 12.11 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.436 -0.802 . . . . 51.54 111.498 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 222' ' ' ASP . 3.7 mp -106.47 88.06 2.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.341 0.591 . . . . 70.43 110.289 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -114.8 110.65 20.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.542 -0.754 . . . . 54.02 109.761 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.47 115.58 29.63 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.066 -0.516 . . . . 74.12 109.63 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 173' ' ' TYR . 35.8 ptt180 -69.76 137.36 51.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 71.0 111.543 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.625 ' CE1' ' HA ' ' A' ' 239' ' ' SER . 56.0 t80 -93.68 -55.64 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.561 -0.745 . . . . 75.21 110.546 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.5 p -110.81 96.73 30.3 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 72.43 110.651 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 28.8 Cg_exo -60.94 114.44 2.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.671 2.248 . . . . 63.35 112.077 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 64.45 20.19 12.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.609 -0.723 . . . . 70.04 111.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.05 60.23 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.872 -0.68 . . . . 61.34 113.121 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 55.6 t -88.88 118.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.806 0.336 . . . . 73.1 110.624 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.486 ' HB2' ' OE2' ' A' ' 212' ' ' GLU . 17.9 p80 -71.09 128.11 34.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 70.23 111.001 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -114.13 -31.02 6.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 60.23 111.164 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' A' ' 210' ' ' HIS . 2.8 mp0 59.1 -100.04 0.1 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.273 -174.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.566 ' HA ' HG23 ' A' ' 236' ' ' VAL . 18.1 p90 -80.71 103.41 10.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.593 0.711 . . . . 75.43 110.953 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -98.14 -51.38 4.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.033 -0.729 . . . . 65.42 109.033 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 217' ' ' PRO . 37.0 tt0 62.65 90.48 0.08 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.197 -0.91 . . . . 75.11 112.525 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.47 82.55 62.88 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.531 -0.759 . . . . 75.35 109.872 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.419 ' HD3' ' HG2' ' A' ' 215' ' ' GLU . 56.7 Cg_endo -71.85 1.97 5.25 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.068 2.512 . . . . 60.44 112.619 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -48.88 -58.42 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.765 -0.652 . . . . 74.22 111.068 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -163.25 36.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 74.45 110.852 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 99.3 m -98.27 136.17 38.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.31 -0.405 . . . . 75.33 110.666 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.6 p80 178.87 32.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.586 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 200' ' ' LEU . 2.6 m-20 -45.91 105.29 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.784 -1.098 . . . . 71.53 112.337 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 1.018 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . 147.24 164.16 11.0 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.919 -1.037 . . . . 63.54 111.017 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 226' ' ' GLU . 22.8 m -69.02 139.62 54.95 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.785 -0.45 . . . . 73.24 109.785 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.554 ' HA ' ' OG1' ' A' ' 228' ' ' THR . 49.4 mt -56.31 -22.33 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.569 0.699 . . . . 52.22 110.997 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 224' ' ' THR . 34.9 tt0 -51.68 -42.51 62.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.311 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 246' ' ' ILE . 59.1 m-85 -104.32 -90.72 0.38 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.766 -0.652 . . . . 74.43 109.635 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 225' ' ' ILE . 28.0 m 67.02 -63.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.822 0.701 . . . . 71.41 112.566 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 275' ' ' LYS . 49.7 m 67.75 172.09 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.284 0.634 . . . . 73.53 111.094 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.7 mp -71.75 -40.53 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.159 0.504 . . . . 71.5 109.866 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . 1.6 m-20 -54.3 -61.13 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.682 -1.145 . . . . 74.52 111.758 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.02 82.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 70.51 111.538 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -67.9 -26.54 66.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.499 -0.319 . . . . 74.12 111.503 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.463 ' HB3' HG12 ' A' ' 236' ' ' VAL . 65.6 t30 -80.36 -4.7 54.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.539 0.685 . . . . 55.11 109.66 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.66 76.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.55 -0.75 . . . . 60.34 112.326 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 213' ' ' TYR . 7.2 p -111.81 127.7 68.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.954 0.407 . . . . 64.11 110.441 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.94 112.24 39.05 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.004 -0.543 . . . . 74.32 109.704 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.686 ' HG2' ' HA3' ' A' ' 242' ' ' GLY . 24.6 Cg_exo -63.15 152.78 77.89 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.325 2.017 . . . . 52.43 111.398 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 16.0 p -77.09 -18.37 58.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.444 . . . . 71.3 111.08 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.801 ' HD3' ' HG3' ' A' ' 315' ' ' PRO . 7.1 ptp180 178.11 -40.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 71.52 110.449 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 241' ' ' ARG . 9.9 ttt180 -55.17 -53.91 49.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 74.44 111.771 -175.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.686 ' HA3' ' HG2' ' A' ' 238' ' ' PRO . . . -59.78 -44.98 96.52 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 116.005 -0.543 . . . . 63.42 114.232 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.51 -42.07 92.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 61.43 109.452 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.87 -36.12 82.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.734 -0.667 . . . . 74.02 110.828 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -51.03 71.26 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.997 -0.547 . . . . 64.02 110.339 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 227' ' ' PHE . 66.9 mt -63.23 -39.73 86.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.425 -0.807 . . . . 73.15 110.831 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.3 tp -57.82 -43.45 85.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.344 -0.389 . . . . 63.2 110.392 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.68 97.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.037 -0.602 . . . . 63.42 112.555 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 252' ' ' ILE . 35.5 m-85 -67.11 -31.22 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 74.31 111.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 178' ' ' ILE . 59.6 m -65.93 -44.13 86.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 72.44 109.655 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.1 mtp -61.62 -49.9 74.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.131 -0.94 . . . . 62.14 111.199 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.667 HD12 ' SD ' ' A' ' 286' ' ' MET . 4.6 tt -61.85 -36.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.993 -0.283 . . . . 64.24 110.875 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.441 ' HB2' HD21 ' A' ' 259' ' ' LEU . 8.7 tt0 -59.77 -50.48 73.68 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.101 -0.24 . . . . 72.31 111.323 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.13 -31.04 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.744 0.307 . . . . 71.23 111.186 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.0 tp -84.56 -19.13 33.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.336 0.495 . . . . 64.13 112.336 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.3 p -106.48 -27.83 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.109 -0.369 . . . . 64.5 111.979 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 113.35 -35.8 4.37 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.575 -0.821 . . . . 40.52 112.708 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -156.98 165.5 35.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.941 0.371 . . . . 70.21 110.081 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 253' ' ' GLN . 72.0 mt -94.27 139.61 22.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.201 -0.296 . . . . 65.24 110.201 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 32.8 Cg_exo -60.59 -27.31 84.62 Favored 'Trans proline' 0 CA--C 1.526 0.122 0 C-N-CA 122.726 2.284 . . . . 64.14 112.36 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -100.07 10.95 40.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.126 -0.488 . . . . 64.12 111.057 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 50.6 tt0 -69.28 -29.59 67.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.237 0.541 . . . . 72.31 110.906 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.3 -21.56 49.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.025 0.441 . . . . 74.3 110.733 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.84 5.25 24.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 72.43 112.012 -173.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 2.7 pp -79.88 8.25 7.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.915 0.388 . . . . 72.53 111.369 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -67.54 -17.85 64.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 70.42 110.093 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 16.0 t70 -141.64 134.21 13.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.63 -0.714 . . . . 71.44 109.522 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 46.9 Cg_exo -56.91 -19.16 30.72 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 123.308 2.672 . . . . 61.11 114.151 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.59 -53.92 51.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.032 0.444 . . . . 71.34 111.134 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -67.44 -33.88 76.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.051 -0.522 . . . . 70.4 110.439 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 225' ' ' ILE . 61.7 t -61.09 -43.08 95.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 54.25 110.372 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -55.13 -57.1 13.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 73.35 110.421 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -64.76 -40.87 96.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.94 -0.573 . . . . 62.22 111.472 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -59.76 -40.47 88.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.496 -0.32 . . . . 43.44 111.106 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 229' ' ' SER . 44.4 mmtm -66.96 -39.82 87.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.012 -0.275 . . . . 64.15 110.918 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 58.8 mt -63.95 -49.13 83.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.777 0.322 . . . . 72.42 110.824 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -57.78 -47.24 83.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 74.3 110.974 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.15 -36.26 64.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.312 0.486 . . . . 74.41 112.312 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -68.48 -29.02 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 75.41 110.252 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -65.24 0.75 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.975 -0.557 . . . . 75.55 110.021 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.439 ' O ' HD23 ' A' ' 285' ' ' LEU . 47.2 t30 -107.58 77.54 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 63.22 110.387 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 282' ' ' ILE . 0.2 OUTLIER -79.11 -48.83 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.283 -0.871 . . . . 72.14 111.193 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 65.41 112.205 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 39.3 t -66.23 -48.08 71.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.56 -0.291 . . . . 63.54 111.041 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -67.13 -34.17 77.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.652 0.241 . . . . 65.5 111.652 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.667 ' SD ' HD12 ' A' ' 252' ' ' ILE . 26.2 mmt -71.06 -37.94 72.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.961 0.41 . . . . 73.13 111.092 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.4 -38.91 12.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.145 0.424 . . . . 75.21 112.145 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -78.03 -15.09 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.135 0.421 . . . . 73.52 112.135 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 88.9 m -76.94 -21.58 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 75.13 110.516 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.623 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 6.4 m-85 -133.98 86.7 36.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 64.45 110.64 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.38 -69.03 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.73 2.287 . . . . 52.4 111.955 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.06 95.51 3.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.104 0.478 . . . . 72.23 110.271 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 178.61 -52.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.272 -1.01 . . . . 74.23 108.272 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.623 ' O ' ' HB3' ' A' ' 290' ' ' PHE . 27.7 t-20 -148.58 163.18 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.547 -1.206 . . . . 64.21 107.946 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 1.7 tpmt? -136.94 106.22 8.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.504 -0.478 . . . . 71.01 111.016 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.01 45.14 1.92 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.375 2.716 . . . . 65.54 111.537 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.58 99.76 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.784 -0.644 . . . . 73.22 112.319 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 298' ' ' GLU . 28.8 mp0 -62.78 -41.32 99.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.694 -0.484 . . . . 73.24 109.694 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.44 HG21 ' HB ' ' A' ' 252' ' ' ILE . 15.0 mm -63.93 -46.86 92.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.644 -0.707 . . . . 72.1 110.28 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.1 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.685 -0.689 . . . . 71.44 110.971 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.75 -44.52 95.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.776 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -56.62 -50.86 70.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.586 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.546 ' HA ' HG22 ' A' ' 306' ' ' VAL . 12.3 mtp -70.89 -38.62 73.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.633 -0.258 . . . . 61.23 111.612 -175.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.3 -35.74 81.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.504 0.668 . . . . 73.5 109.407 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 54.7 m -65.57 -52.85 49.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 71.03 111.22 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 303' ' ' MET . 35.3 m -67.26 -30.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.05 0.452 . . . . 45.41 110.802 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -57.44 -43.45 83.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 74.33 110.461 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.91 11.23 21.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.886 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 315' ' ' PRO . 42.9 mt -90.7 -23.29 20.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.874 -0.417 . . . . 72.53 109.874 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.577 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 28.6 t70 56.48 -156.72 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.447 -0.797 . . . . 32.11 110.748 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.577 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.1 m-85 -86.16 -33.01 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.916 0.389 . . . . 75.14 110.112 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.9 t -144.99 26.5 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.01 111.42 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 7.8 tt0 -92.88 23.19 4.33 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.512 0.672 . . . . 74.44 109.627 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.14 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 114.34 -1.3 . . . . 73.31 112.222 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.801 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 93.5 Cg_endo -78.88 119.6 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.823 2.348 . . . . 70.53 111.799 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.7 tp -93.41 84.36 4.72 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.0 0.429 . . . . 53.1 110.12 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 320' ' ' LEU . 74.2 m-85 -60.47 -32.77 71.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.623 -0.717 . . . . 75.51 110.086 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.78 -46.15 74.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.512 -0.767 . . . . 71.22 110.541 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 28.9 t-20 -72.33 -35.28 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.581 -0.282 . . . . 74.21 110.703 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 97.0 mt -58.39 -52.85 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 51.23 110.34 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.53 -21.54 61.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 75.45 110.323 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.04 -50.92 44.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.198 -0.455 . . . . 54.33 110.933 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -70.91 -29.59 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.795 -0.362 . . . . 63.11 110.996 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 85.5 mt -64.8 -49.4 70.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.082 0.468 . . . . 63.2 110.096 175.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.94 -26.76 64.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 75.32 110.945 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -58.48 -47.81 82.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 74.41 109.853 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.432 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -74.97 -39.88 36.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.819 -0.705 . . . . 61.54 112.368 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 2.6 tm? -57.67 -49.44 76.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.19 0.519 . . . . 72.4 110.204 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -24.61 58.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.431 -0.349 . . . . 73.34 111.477 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.63 91.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 75.04 111.184 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -88.21 -9.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.246 0.546 . . . . 52.54 110.602 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 69.49 20.86 75.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.928 -0.653 . . . . 63.34 112.952 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -131.73 138.64 48.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.803 0.302 . . . . 63.32 110.993 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 334' ' ' LYS . 26.6 mtmt -113.35 -73.07 0.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.859 0.838 . . . . 53.3 109.047 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -167.53 -39.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.069 -1.423 . . . . 71.33 107.718 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.6 t0 69.72 32.7 3.17 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 114.461 -1.245 . . . . 65.21 110.973 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.64 14.22 41.4 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.965 -0.636 . . . . 63.04 112.696 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' A' ' 339' ' ' LEU . 5.8 tmmm? -179.71 110.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.272 -0.27 . . . . 73.43 110.272 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 338' ' ' LYS . 8.6 mp -69.16 178.27 2.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.788 0.328 . . . . 74.41 110.613 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.31 12.8 2.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.39 0.614 . . . . 71.53 110.597 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.44 96.12 6.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.471 -0.786 . . . . 60.24 108.992 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 343' ' ' VAL . 5.8 m -69.58 15.63 0.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.888 -1.051 . . . . 74.42 113.405 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 342' ' ' SER . 0.4 OUTLIER 69.12 -7.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.818 0.847 . . . . 60.55 112.331 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.37 98.79 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.211 -0.663 . . . . 65.11 109.211 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 140' ' ' LYS . 14.6 pt-20 -108.92 -55.93 2.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 60.22 111.853 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' A' ' 345' ' ' GLU . 18.8 m120 66.02 -77.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.37 0.668 . . . . 73.42 112.747 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 140' ' ' LYS . . . -144.01 166.71 27.01 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.531 -0.843 . . . . 75.22 112.561 -174.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 152.49 -7.53 0.52 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.876 -0.678 . . . . 51.0 113.038 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 45' ' ' GLN . 85.3 mt -54.47 128.36 31.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.65 0.38 . . . . 74.32 111.853 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -141.75 -177.51 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.034 -0.358 . . . . 73.23 110.034 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -126.88 159.01 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 44.24 111.517 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.484 ' H ' ' HE1' ' A' ' 48' ' ' PHE . 65.8 mttm -141.12 169.8 16.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.374 -0.83 . . . . 72.21 109.097 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 12.0 t -169.63 140.14 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.109 -0.33 . . . . 73.32 110.109 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 138.37 22.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.799 -0.445 . . . . 73.21 109.799 178.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 32.8 m -68.55 80.92 0.27 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.352 0.596 . . . . 53.41 112.174 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -153.09 -82.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 74.22 110.243 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.556 ' HG2' ' N ' ' A' ' 358' ' ' ARG . 75.7 tttt -160.77 156.61 25.53 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.197 0.522 . . . . 74.33 111.586 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.556 ' N ' ' HG2' ' A' ' 357' ' ' LYS . 3.3 tpm_? -97.64 110.14 22.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.306 -0.861 . . . . 52.01 109.15 171.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 77' ' ' ASN . 42.5 tttm -103.7 132.97 49.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.009 0.433 . . . . 75.35 111.5 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 360' ' ' LYS . 5.5 ptmm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.892 -0.781 . . . . 75.21 108.892 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 110.25 -0.278 . . . . 62.55 110.25 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.94 138.39 44.12 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.307 2.672 . . . . 74.42 113.374 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 292' ' ' GLU . 5.9 mmm180 -138.1 99.03 3.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.386 -0.824 . . . . 74.33 109.045 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.6 m -73.08 94.17 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.196 0.522 . . . . 71.11 111.952 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -136.3 -56.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 75.42 111.496 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 293' ' ' LYS . . . -107.64 -178.95 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.804 0.335 . . . . 43.22 111.531 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . . . -158.16 -173.26 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 63.53 110.127 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' OE1' ' HA ' ' A' ' 8' ' ' GLN . 13.1 mm-40 -95.64 150.65 20.11 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.224 -0.287 . . . . 74.52 110.224 175.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.07 153.16 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 65.14 111.234 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.56 176.65 16.19 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.426 -0.67 . . . . 62.44 111.426 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -143.13 120.68 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 51.02 110.864 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.81 94.8 8.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 51.3 110.825 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 t -80.59 167.22 20.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 52.14 108.967 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.476 ' HA ' HG11 ' A' ' 343' ' ' VAL . 56.7 m -135.55 120.94 19.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 73.31 112.014 -176.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.606 ' H ' HG11 ' A' ' 343' ' ' VAL . . . -140.87 148.49 40.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.098 -0.955 . . . . 61.15 109.009 175.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -153.4 139.45 18.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.262 -0.175 . . . . 71.44 110.676 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HG3' HD21 ' A' ' 41' ' ' LEU . 6.8 ptt180 -166.09 132.15 2.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.212 0.53 . . . . 74.22 111.112 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.663 ' HA ' HD22 ' A' ' 41' ' ' LEU . 19.5 t60 -149.74 14.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.374 -0.972 . . . . 65.32 108.374 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.55 148.25 23.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 75.22 111.199 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.41 -82.03 0.15 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.708 -0.678 . . . . 71.31 109.492 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 74.86 9.29 4.08 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.794 0.807 . . . . 74.32 109.746 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -93.69 141.6 28.3 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.622 -1.172 . . . . 65.2 108.226 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.23 94.61 3.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.783 0.801 . . . . 74.53 110.697 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -179.68 -45.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.657 -1.608 . . . . 73.33 106.657 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.5 HG13 ' HA2' ' A' ' 40' ' ' GLY . 84.7 t -66.86 140.35 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 113.829 -1.532 . . . . 64.41 109.265 166.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.99 2.13 56.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.147 -1.025 . . . . 43.34 113.422 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 31.3 mt-10 -78.72 140.79 38.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.282 0.541 . . . . 73.32 110.414 174.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -82.18 131.75 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 64.12 111.153 -175.353 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.59 135.04 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.08 -0.964 . . . . 72.34 108.943 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -115.64 133.73 55.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 63.44 110.28 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -97.58 -172.5 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.844 -0.428 . . . . 72.22 109.844 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 18.5 mmt -72.49 -20.02 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 71.14 110.99 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 12.93 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.538 -0.301 . . . . 24.14 110.983 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 11.6 mptt 65.86 33.14 8.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.911 -0.586 . . . . 70.24 112.404 172.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmpp? -83.58 115.16 21.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.34 84.28 3.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.347 0.594 . . . . 72.31 109.953 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 46.0 p-90 -114.84 149.73 36.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.724 -0.671 . . . . 64.43 110.933 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' HG2' ' HB2' ' A' ' 57' ' ' ASN . 18.2 pttp -98.57 134.46 41.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 71.24 109.377 173.365 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.06 132.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.694 -0.484 . . . . 64.22 109.694 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -107.56 -133.41 7.15 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.722 -0.751 . . . . 65.23 112.564 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD21 ' HG3' ' A' ' 17' ' ' ARG . 38.8 tp -66.55 125.23 90.17 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.97 0.414 . . . . 52.12 111.667 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 41' ' ' LEU . 21.7 Cg_exo -65.67 108.99 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.394 2.063 . . . . 63.44 110.946 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 45' ' ' GLN . 47.5 mt -76.35 -52.32 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 62.32 109.709 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.88 -18.17 17.56 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.867 -0.682 . . . . 73.31 112.641 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.536 ' HB2' ' OD2' ' A' ' 137' ' ' ASP . 20.0 pt20 -124.45 165.14 18.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.676 -0.49 . . . . 72.23 109.676 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.97 66.26 0.15 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.794 -0.717 . . . . 61.42 111.916 -172.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 181' ' ' SER . . . 80.5 -88.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.998 -0.62 . . . . 52.35 112.83 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -89.59 -13.66 36.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 74.23 111.253 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.32 167.46 42.79 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.838 -0.696 . . . . 34.33 113.143 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.2 m 62.77 35.11 14.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.172 0.511 . . . . 62.01 111.56 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.825 HG23 ' HB3' ' A' ' 71' ' ' LYS . 5.3 mm -89.27 138.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 71.23 109.668 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.13 138.67 49.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.95 0.405 . . . . 73.24 111.088 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.435 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 tm? -73.02 127.21 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.706 -0.85 . . . . 73.32 108.706 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.02 91.37 7.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.279 0.562 . . . . 44.41 109.698 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.4 t70 -79.74 61.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.82 . . . . 61.33 109.03 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.591 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -35.8 127.96 0.66 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.65 -1.159 . . . . 75.34 112.302 -175.127 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.836 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 65.5 t30 -93.63 79.67 4.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.614 -0.721 . . . . 75.43 110.718 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 p -126.31 145.87 50.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.89 0.376 . . . . 72.14 110.964 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -83.1 -32.18 26.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.81 -0.632 . . . . 75.31 109.785 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -138.8 86.78 2.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.777 -0.647 . . . . 74.4 110.654 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -178.47 -48.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.907 -0.588 . . . . 62.14 109.464 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.898 HG23 ' HD3' ' A' ' 67' ' ' PRO . 8.8 p -81.94 143.33 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.548 -0.538 . . . . 51.43 109.548 173.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.71 34.87 5.43 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.405 -1.078 . . . . 62.2 110.405 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.9 t 64.58 18.42 11.38 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.934 -0.633 . . . . 55.14 109.645 -173.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -99.9 -23.19 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 63.25 112.001 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.2 81.17 0.25 Allowed Pre-proline 0 C--N 1.331 -0.205 0 O-C-N 123.693 0.621 . . . . 65.15 109.585 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.898 ' HD3' HG23 ' A' ' 62' ' ' VAL . 4.5 Cg_endo -84.08 25.57 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.457 2.771 . . . . 71.43 112.424 -170.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB2' HG23 ' A' ' 130' ' ' ILE . 9.6 p -162.05 142.26 10.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.483 0.658 . . . . 54.34 112.566 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 133' ' ' ARG . 35.8 m -127.98 149.1 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.163 -0.926 . . . . 72.32 108.684 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.4 p -121.12 126.06 74.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.066 0.46 . . . . 74.43 109.954 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.825 ' HB3' HG23 ' A' ' 51' ' ' ILE . 25.1 pttm -111.13 139.87 46.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.291 -0.964 . . . . 63.0 109.944 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 128' ' ' PHE . 32.7 m -110.53 151.28 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.98 -1.009 . . . . 70.02 111.881 -168.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.723 ' OE1' ' HA ' ' A' ' 77' ' ' ASN . 43.1 tt0 -127.31 130.23 23.76 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.854 -1.066 . . . . 64.52 108.246 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -174.27 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.301 2.001 . . . . 73.44 112.272 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -66.34 71.86 0.07 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.28 0.562 . . . . 52.23 110.723 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -141.06 -59.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.772 -0.649 . . . . 62.44 109.309 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.723 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 69.97 87.91 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.305 1.003 . . . . 63.04 111.213 175.484 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.79 -80.07 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 51.32 112.547 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.57 -45.04 19.17 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.554 2.169 . . . . 73.44 112.668 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 71' ' ' LYS . 62.4 tp -73.18 -38.61 66.09 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.52 -0.548 . . . . 72.54 109.52 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 90.8 t80 -55.96 -44.0 78.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.036 -0.529 . . . . 73.5 110.579 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . 0.43 HG21 ' HA2' ' A' ' 199' ' ' GLY . 36.8 m -67.17 -49.64 64.0 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 115.879 -0.6 . . . . 73.55 111.4 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 197' ' ' ASP . 5.6 pt-20 -73.16 -24.14 60.53 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.057 -0.657 . . . . 54.51 110.923 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -64.13 -43.19 96.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.441 -0.577 . . . . 45.43 109.441 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 81' ' ' PHE . 32.4 mmmt -59.76 -48.33 82.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.051 -0.522 . . . . 74.35 110.483 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.69 -45.38 83.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.091 -0.504 . . . . 74.54 110.797 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 113' ' ' TYR . 47.5 t80 -61.58 -46.29 90.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.795 . . . . 73.13 110.975 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -68.0 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.284 . . . . 63.14 110.941 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.35 -39.82 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 72.52 110.685 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.61 15.64 27.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.056 0.455 . . . . 33.01 111.586 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 113' ' ' TYR . . . -80.45 40.22 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.114 -0.494 . . . . 64.2 112.195 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.778 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -138.59 114.98 8.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.523 -0.308 . . . . 73.5 110.617 -177.345 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.81 -31.08 91.45 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.545 2.163 . . . . 71.55 111.488 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.778 ' HG2' ' HB3' ' A' ' 92' ' ' LYS . 10.6 pt-20 -54.86 -53.0 61.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.601 -0.727 . . . . 74.04 111.132 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt-30 -72.17 -43.89 63.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.968 -0.56 . . . . 74.12 110.177 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.6 mt -53.87 -54.49 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.711 -0.677 . . . . 73.44 111.006 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.4 -32.72 71.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 70.04 110.718 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -58.39 -59.19 5.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.957 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.623 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.1 -31.81 70.79 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 120.162 -0.615 . . . . 75.14 110.774 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' ILE . 20.4 mt -54.49 -47.28 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 121.191 -0.203 . . . . 51.5 111.252 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -72.61 -35.24 67.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.041 -0.664 . . . . 71.43 110.954 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.6 m -70.52 -40.47 73.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.128 0.489 . . . . 65.34 111.979 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.63 ' HG2' HD13 ' A' ' 105' ' ' LEU . 5.3 tpt180 -87.12 -9.57 54.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.359 . . . . 71.4 110.982 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 67.93 37.99 2.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.966 0.889 . . . . 64.25 109.541 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.709 ' HG ' ' HB2' ' A' ' 163' ' ' ASP . 1.5 tp -79.81 170.69 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.974 -1.012 . . . . 74.3 109.301 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.489 ' HB3' HH22 ' A' ' 160' ' ' ARG . 9.3 tmtm? -113.33 -56.98 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.277 -0.569 . . . . 74.12 110.711 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -151.86 120.72 6.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.737 0.303 . . . . 74.23 110.235 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.623 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 33.5 tp -79.26 130.87 35.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.041 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.61 49.0 2.68 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.906 -0.664 . . . . 72.25 113.068 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.58 118.79 15.9 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 110.118 -0.327 . . . . 73.21 110.118 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 134' ' ' PHE . 92.5 Cg_endo -80.08 161.17 23.6 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.265 2.643 . . . . 64.31 113.468 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.36 137.25 58.24 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.742 -0.663 . . . . 71.4 111.436 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.463 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 40.5 t80 -94.33 133.49 37.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.351 -0.84 . . . . 75.33 110.33 177.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.462 ' HB2' HG22 ' A' ' 130' ' ' ILE . 39.2 m95 -112.66 -36.39 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.047 -0.261 . . . . 74.14 111.699 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.87 48.3 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.484 -0.865 . . . . 63.23 112.601 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 80.3 p -169.71 166.71 9.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 61.14 109.939 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.53 174.12 33.02 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.205 -0.998 . . . . 61.33 112.644 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 125' ' ' SER . 10.1 tt -118.53 127.24 53.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.085 -0.709 . . . . 75.14 109.085 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -131.29 119.72 22.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.989 0.423 . . . . 71.32 110.192 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.723 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 37.9 t70 -74.29 120.8 20.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 72.15 109.572 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.68 -60.47 2.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.199 0.523 . . . . 64.21 110.312 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -178.41 96.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.883 -1.053 . . . . 74.3 108.3 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 -37.18 2.33 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.71 -0.757 . . . . 33.03 111.787 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -110.44 131.69 54.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.185 -0.302 . . . . 53.0 110.185 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 19.4 m -103.04 118.46 36.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.125 -0.489 . . . . 73.22 109.809 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.38 124.75 43.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.114 0.483 . . . . 72.31 111.017 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -98.41 120.29 38.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.183 -1.043 . . . . 71.24 108.183 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 72' ' ' VAL . 35.0 p90 -139.1 163.99 30.97 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.741 -0.384 . . . . 61.24 111.554 -171.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 26.0 ptt? -146.58 146.42 30.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.309 0.576 . . . . 62.33 111.635 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -96.68 124.37 49.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.439 -1.255 . . . . 71.04 110.631 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 16.6 ptm -130.66 176.46 8.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.147 -0.933 . . . . 74.52 109.014 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 69' ' ' VAL . 12.6 t70 -65.81 170.37 5.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.645 -0.422 . . . . 53.13 110.079 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.999 ' HD2' ' HB2' ' A' ' 188' ' ' LYS . 4.1 ptp180 -67.93 113.59 5.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.873 0.844 . . . . 73.31 112.639 -167.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -115.26 171.3 7.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.107 -0.951 . . . . 73.4 109.433 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.65 -43.4 0.18 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.624 -1.274 . . . . 72.52 113.389 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.763 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.3 m -80.63 122.41 27.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.945 0.402 . . . . 72.03 111.479 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 45' ' ' GLN . 5.1 m-20 -88.55 129.11 35.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.613 -0.721 . . . . 61.12 110.065 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 141' ' ' ILE . 14.8 tp -66.82 -29.96 70.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.389 0.614 . . . . 74.44 109.379 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.502 ' CG ' ' HB3' ' A' ' 137' ' ' ASP . 20.3 pt20 -62.56 -44.28 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.291 -0.868 . . . . 71.0 111.403 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.696 ' HD3' ' HA ' ' A' ' 346' ' ' ASN . 63.2 mttp -78.8 -11.43 59.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.942 0.401 . . . . 63.35 110.715 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.818 HD13 ' HG ' ' A' ' 341' ' ' LEU . 94.3 mt -74.9 -51.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.481 . . . . 73.53 110.145 172.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.833 ' HB2' ' HA ' ' A' ' 147' ' ' LYS . 1.1 p90 -72.08 -32.32 66.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.533 -0.467 . . . . 75.33 110.155 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.06 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.323 . . . . 75.51 110.845 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.88 -32.35 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.385 . . . . 63.54 111.378 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 50.0 t30 -104.41 19.78 19.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.75 -0.38 . . . . 75.31 111.773 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 54.57 32.42 16.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.869 0.468 . . . . 43.43 112.19 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.833 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 31.1 ttmt 65.43 22.32 11.91 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.586 -0.734 . . . . 73.21 112.0 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' ASN . 30.0 mmt180 -83.35 107.56 15.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.462 -0.57 . . . . 70.41 109.462 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -112.75 152.19 29.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 72.33 110.772 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 p -89.22 172.78 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 50.23 110.614 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 37.5 mmm-85 -68.23 -35.92 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 72.15 111.275 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -73.26 -39.74 65.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.799 -175.031 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.0 p -64.86 -56.17 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 61.15 111.237 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.45 ' CG1' ' HG3' ' A' ' 251' ' ' MET . 40.5 t -59.8 -37.43 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.085 -0.507 . . . . 75.43 110.919 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.821 HD22 ' HG ' ' A' ' 328' ' ' LEU . 15.0 tp -56.62 -51.22 69.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.646 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -68.0 -33.57 74.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.032 -0.531 . . . . 62.45 110.719 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 95.4 mt -61.7 -50.8 70.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 73.04 110.202 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -55.0 -37.9 67.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 72.22 110.942 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.92 -45.96 91.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.662 -0.244 . . . . 61.44 111.472 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.649 ' HA ' ' NE ' ' A' ' 160' ' ' ARG . 9.7 mmp_? -63.31 -38.61 91.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.134 0.493 . . . . 72.24 111.51 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.8 mp -71.81 -32.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.585 -0.446 . . . . 71.11 109.987 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -59.22 -56.0 27.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.497 -0.319 . . . . 62.22 111.321 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.709 ' HB2' ' HG ' ' A' ' 105' ' ' LEU . 43.4 p-10 -78.1 -24.64 47.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.049 -0.66 . . . . 75.0 112.018 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' A' ' 161' ' ' ILE . 12.1 tt -72.89 -36.49 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.268 -0.573 . . . . 71.03 110.41 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.517 HD23 HD11 ' A' ' 168' ' ' ILE . 42.6 mt -65.26 -38.1 89.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.288 . . . . 73.34 110.456 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -56.5 -51.69 67.54 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.4 0.619 . . . . 74.22 110.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -61.21 -49.98 74.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.132 -0.94 . . . . 64.12 112.29 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.517 HD11 HD23 ' A' ' 165' ' ' LEU . 35.1 pt -71.35 -37.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.277 -0.569 . . . . 73.34 111.518 -175.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.723 ' HA ' HG12 ' A' ' 174' ' ' VAL . 62.9 t-80 -68.54 -40.86 80.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.372 -0.531 . . . . 74.34 111.554 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 209' ' ' VAL . 0.5 OUTLIER -85.54 13.86 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.379 -0.529 . . . . 63.04 111.294 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.2 78.76 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.503 0.668 . . . . 74.14 111.352 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 2.7 mp0 72.78 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.266 -1.334 . . . . 64.41 113.289 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.425 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 91.7 m-85 -80.79 118.13 22.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.023 0.749 . . . . 75.34 113.023 -162.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 169' ' ' HIS . 3.2 m -125.72 138.92 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.831 -0.622 . . . . 63.22 110.283 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 1.043 ' HB2' ' HA ' ' A' ' 201' ' ' ALA . 4.6 t-80 -175.68 -50.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.0 0.428 . . . . 64.52 110.94 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.35 -75.93 0.29 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.077 -0.809 . . . . 70.45 111.077 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.92 34.54 13.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.051 0.453 . . . . 74.23 111.764 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 161' ' ' ILE . 21.4 mm -79.39 65.26 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.026 0.917 . . . . 63.3 110.018 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.887 ' HE3' HG21 ' A' ' 224' ' ' THR . 12.8 mmtt -103.4 141.65 35.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 73.01 109.157 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.53 47.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.197 0.522 . . . . 72.34 110.807 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 11.7 p -77.09 -19.28 57.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 74.55 111.552 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.499 ' OD1' ' HE3' ' A' ' 352' ' ' LYS . 17.2 m120 -114.4 2.58 14.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.668 0.27 . . . . 63.34 111.231 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.543 HD21 HD11 ' A' ' 161' ' ' ILE . 10.7 mp -104.13 111.21 23.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.095 -0.705 . . . . 53.15 109.095 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 47' ' ' GLY . 3.7 mm? -113.57 130.81 56.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.056 0.455 . . . . 53.22 111.688 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.763 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 94.1 mt -75.06 145.62 42.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.385 -0.825 . . . . 75.14 110.432 173.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.822 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 24.2 t-20 -73.7 137.48 44.08 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.523 -0.917 . . . . 70.33 108.523 172.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.753 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 33.2 t80 -62.77 -31.14 72.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.095 0.474 . . . . 62.12 111.11 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.999 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 6.2 tmtm? -91.57 -45.55 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.973 -0.558 . . . . 74.03 110.151 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 48.6 m-80 -104.88 100.05 22.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.431 -0.349 . . . . 73.42 110.852 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.06 -6.15 13.04 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.975 2.45 . . . . 75.34 113.237 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.557 ' HA ' HD12 ' A' ' 339' ' ' LEU . 8.9 p-10 -92.86 -1.01 57.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.719 0.266 . . . . 74.21 111.719 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.481 ' OE1' ' HD2' ' A' ' 160' ' ' ARG . 84.4 mm-40 -129.09 129.73 45.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.383 . . . . 73.44 111.06 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 185' ' ' LEU . 28.6 m -106.03 143.31 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.269 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.822 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 36.8 m-85 -118.56 155.11 31.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.177 -0.465 . . . . 74.34 109.824 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 164' ' ' ILE . 11.3 mt -95.93 146.41 24.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.686 0.279 . . . . 73.03 110.964 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -120.84 -171.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.399 -0.593 . . . . 54.2 109.399 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 8.2 t70 76.25 -71.77 0.11 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.634 0.584 . . . . 74.42 110.638 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 23.1 m-85 58.03 9.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.545 0.943 . . . . 72.04 113.545 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.664 ' HA3' ' CG2' ' A' ' 354' ' ' ILE . . . -100.1 -33.98 5.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.937 -1.125 . . . . 61.44 114.444 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 8.5 mp -68.41 -23.03 64.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.369 0.584 . . . . 74.41 110.018 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 1.043 ' HA ' ' HB2' ' A' ' 175' ' ' HIS . . . -58.48 112.35 1.55 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.518 -0.764 . . . . 73.25 110.054 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' TYR . . . . . 0.654 ' HE2' ' HA ' ' A' ' 356' ' ' LYS . 6.4 t80 -98.47 132.37 43.97 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.56 -0.904 . . . . 75.33 108.56 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 7.1 ppt_? -86.54 141.56 28.96 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.405 0.521 . . . . 74.2 112.405 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.789 ' HB2' HG12 ' A' ' 209' ' ' VAL . 32.1 m-85 -69.67 -92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.309 -0.859 . . . . 72.14 109.947 170.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 40.1 m -142.48 141.23 20.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.889 -1.051 . . . . 72.25 108.793 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 50.1 Cg_exo -53.71 104.65 0.11 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.945 2.43 . . . . 73.1 112.454 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 62.1 22.15 12.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.448 -0.797 . . . . 73.14 111.564 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.58 42.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.04 -0.824 . . . . 73.22 111.04 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.789 HG12 ' HB2' ' A' ' 204' ' ' TYR . 15.8 m -59.29 109.89 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.483 0.659 . . . . 75.23 112.611 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 t60 179.85 124.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.266 -0.879 . . . . 65.44 109.156 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -152.67 163.38 39.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.554 -0.906 . . . . 70.14 108.554 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -112.25 174.95 5.64 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.516 -0.55 . . . . 53.45 109.516 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -61.82 101.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.348 0.594 . . . . 75.45 112.245 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -105.0 -3.41 23.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 74.12 110.057 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.433 ' HG3' HD21 ' A' ' 234' ' ' ASN . 43.0 tt0 66.03 -76.27 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 114.851 -1.068 . . . . 54.24 111.689 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -118.43 100.64 51.43 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.953 0.406 . . . . 75.35 111.917 -171.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -86.36 -47.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.71 2.273 . . . . 65.34 112.066 171.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -150.18 21.47 0.86 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.137 0.575 . . . . 64.32 110.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 56.39 82.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.896 -0.593 . . . . 73.1 110.865 -171.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.777 ' HB3' ' HA2' ' A' ' 235' ' ' GLY . 25.4 t -85.23 16.24 3.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 34.21 111.218 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 9.8 p-80 -67.22 9.61 0.21 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.619 0.6 . . . . 72.13 112.619 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.429 ' O ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -82.85 110.95 18.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.109 0.481 . . . . 71.24 110.316 -174.287 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 162.74 177.9 36.13 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.177 -0.919 . . . . 54.42 110.924 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.887 HG21 ' HE3' ' A' ' 179' ' ' LYS . 23.6 p -78.63 117.12 19.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 71.42 110.574 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.614 ' HB ' HD12 ' A' ' 265' ' ' LEU . 57.9 mt -63.0 -21.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 63.33 112.124 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 265' ' ' LEU . 1.6 mp0 -58.26 -42.89 87.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.013 0.435 . . . . 75.41 110.273 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.59 ' HE1' ' HA ' ' A' ' 250' ' ' CYS . 97.8 m-85 -102.25 -18.44 15.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.604 -0.726 . . . . 74.32 110.69 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 225' ' ' ILE . 90.7 m -66.78 108.6 2.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.525 . . . . 74.34 110.982 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.9 p -73.29 -173.52 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.315 -0.857 . . . . 73.21 110.791 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.16 -38.05 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 72.42 110.317 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.62 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.447 -0.797 . . . . 71.55 111.353 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.06 -44.83 87.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 35.1 111.718 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 68.4 t60 -61.35 -37.33 82.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.834 0.349 . . . . 52.42 110.86 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 215' ' ' GLU . 29.0 t-20 -74.25 -36.88 63.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 63.34 110.535 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.777 ' HA2' ' HB3' ' A' ' 220' ' ' CYS . . . 116.87 -19.77 12.04 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.748 -0.739 . . . . 71.51 112.411 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.63 134.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 52.15 110.699 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.47 114.33 55.85 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.093 -0.503 . . . . 64.34 110.444 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.64 ' HB2' ' H ' ' A' ' 242' ' ' GLY . 87.1 Cg_endo -80.83 147.74 17.19 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.819 2.346 . . . . 71.12 112.428 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.42 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 49.0 m -88.55 69.77 8.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.934 0.397 . . . . 72.3 110.543 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.568 ' O ' HD23 ' A' ' 244' ' ' LEU . 20.2 mtp180 73.29 -4.76 2.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.39 -0.823 . . . . 75.45 111.461 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -56.74 7.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.457 . . . . 71.2 109.838 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 238' ' ' PRO . . . -71.22 -36.31 63.74 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.837 -0.697 . . . . 44.43 112.034 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.41 -49.53 69.73 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.375 0.607 . . . . 75.31 110.003 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 240' ' ' ARG . 4.4 mm? -72.04 -32.68 67.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 74.14 111.656 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.65 -38.03 80.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.384 -0.526 . . . . 74.44 110.553 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 242' ' ' GLY . 60.4 mt -59.81 -44.22 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.318 -0.253 . . . . 55.35 110.318 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 161' ' ' ILE . 53.6 tp -60.57 -36.35 78.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.879 0.371 . . . . 44.12 110.429 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.64 95.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.907 -0.663 . . . . 72.34 111.684 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -62.14 -44.59 96.29 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.053 -0.351 . . . . 75.02 110.053 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.59 ' HA ' ' HE1' ' A' ' 227' ' ' PHE . 39.3 m -59.31 -50.19 74.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 75.33 110.709 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.45 ' HG3' ' CG1' ' A' ' 154' ' ' VAL . 26.7 ttt -60.15 -48.53 81.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.536 -0.756 . . . . 72.34 111.583 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.423 HG23 HD21 ' A' ' 259' ' ' LEU . 12.9 tt -68.1 -33.35 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.752 -0.379 . . . . 75.45 110.872 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.712 ' HG2' ' HD3' ' A' ' 147' ' ' LYS . 8.5 tt0 -66.82 -46.95 73.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.633 -0.258 . . . . 73.11 110.738 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -66.85 -27.98 67.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.048 0.452 . . . . 72.11 110.747 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 294' ' ' ASN . 24.0 tp -77.65 -28.64 51.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.52 . . . . 72.42 111.457 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' THR . . . . . 0.437 HG22 ' CE2' ' A' ' 290' ' ' PHE . 27.8 p -101.47 -27.31 13.2 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.232 0.456 . . . . 43.12 112.232 -173.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.477 ' HA3' ' NH1' ' A' ' 148' ' ' ARG . . . 96.79 -37.27 3.5 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.573 -0.822 . . . . 74.45 111.579 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.14 142.21 19.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.75 -0.463 . . . . 75.12 109.75 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.562 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 89.4 mt -97.5 145.05 29.03 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.137 -0.483 . . . . 74.44 110.406 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.07 -20.53 61.43 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.702 2.268 . . . . 74.33 112.875 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.587 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 12.6 p90 -106.58 -2.79 21.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.424 -0.511 . . . . 75.42 111.969 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.591 ' O ' HD22 ' A' ' 265' ' ' LEU . 8.2 pt-20 -86.36 -25.92 25.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.901 -0.719 . . . . 72.5 109.662 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.94 -37.34 55.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.607 0.718 . . . . 72.01 109.668 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -108.86 27.58 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.02 . . . . 71.11 111.588 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.614 HD12 ' HB ' ' A' ' 225' ' ' ILE . 1.4 pt? -86.05 -2.0 57.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.951 0.405 . . . . 72.12 111.062 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.6 -8.64 43.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.917 -0.583 . . . . 74.24 111.44 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 269' ' ' LYS . 10.4 t0 -128.25 122.99 22.27 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.874 -0.417 . . . . 61.02 109.874 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.05 -26.34 25.27 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.57 2.847 . . . . 74.12 114.041 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.7 mttp -55.03 -50.09 69.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.865 0.364 . . . . 73.1 110.882 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -73.97 -36.35 64.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 72.24 111.844 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.92 -50.53 75.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.891 0.377 . . . . 44.31 110.39 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -67.32 -42.85 82.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.872 -0.603 . . . . 71.25 110.59 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 277' ' ' ARG . 18.4 t70 -55.26 -61.74 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.631 -0.713 . . . . 75.14 110.65 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.2 p -57.01 -47.86 79.86 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.647 0.592 . . . . 63.33 112.253 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -58.73 -49.78 76.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.209 0.448 . . . . 73.14 112.209 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.94 -37.95 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.972 0.415 . . . . 72.12 110.369 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 273' ' ' ASP . 27.6 ttt180 -58.16 -44.02 87.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.474 -0.784 . . . . 55.12 110.761 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.9 m-85 -73.22 -31.25 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 70.34 110.976 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.59 ' HA ' ' HD3' ' A' ' 307' ' ' LYS . 2.0 ttp180 -67.18 -23.46 65.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.628 -0.26 . . . . 65.14 111.207 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.03 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.986 0.422 . . . . 55.11 110.829 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 285' ' ' LEU . 2.8 t-20 -110.18 94.36 4.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.251 -0.648 . . . . 71.14 109.251 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.632 ' HB ' ' HG2' ' A' ' 304' ' ' GLU . 12.9 mt -80.4 -47.74 20.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.319 -0.855 . . . . 71.45 111.599 -170.498 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' HB2' ' OE2' ' A' ' 304' ' ' GLU . . . -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 71.42 112.341 -171.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.5 t -61.1 -41.37 96.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.651 0.241 . . . . 75.31 111.651 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.4 mm? -72.16 -42.99 65.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.705 0.288 . . . . 74.1 110.998 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -74.33 -34.46 63.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.847 0.356 . . . . 62.21 110.987 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 14.2 t70 -70.43 -33.65 71.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 75.04 110.174 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -76.87 -11.48 59.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 71.53 111.369 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.3 m -63.74 -55.29 24.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.752 0.311 . . . . 75.42 110.975 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 293' ' ' LYS . 50.5 m-85 -136.76 73.0 54.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 74.35 111.299 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.23 -53.62 3.39 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.394 2.063 . . . . 74.42 112.28 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 3' ' ' ARG . 41.8 tt0 -120.58 -25.13 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.45 0.537 . . . . 72.31 112.45 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.7 tmtm? -71.56 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.5 110.683 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 25.2 t-20 -158.89 -90.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.984 -0.286 . . . . 73.21 110.791 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.585 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 28.8 tptp 172.75 115.64 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-O 120.825 0.345 . . . . 75.11 110.348 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.793 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 95.8 Cg_endo -89.88 59.94 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.99 2.46 . . . . 65.14 111.612 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.94 -83.02 1.56 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.391 -0.909 . . . . 64.22 113.06 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.501 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -53.63 -54.98 29.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.795 0.438 . . . . 60.14 111.14 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 299' ' ' ILE . 4.0 mp -58.26 -42.56 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 73.13 111.278 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.24 -54.1 48.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 73.35 111.019 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -65.48 -37.83 87.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.137 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 17.7 t80 -58.53 -42.81 88.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.224 0.535 . . . . 73.42 110.278 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.411 ' CE ' ' HA ' ' A' ' 303' ' ' MET . 1.0 OUTLIER -65.34 -47.05 77.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.449 -0.796 . . . . 72.25 111.051 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 282' ' ' ILE . 46.8 mt-10 -59.12 -47.04 86.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 74.23 109.837 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 88.1 m -57.67 -52.19 66.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.259 -0.882 . . . . 62.24 112.154 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.537 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 33.4 m -67.92 -27.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 73.53 111.485 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 279' ' ' ARG . 44.0 mttp -80.81 -16.26 54.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 74.21 110.891 176.598 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 82.6 mt -89.62 0.74 56.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 52.13 110.664 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 314' ' ' LYS . 27.6 mt -79.81 0.19 31.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.3 0.571 . . . . 52.43 109.718 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 31.3 t70 64.55 -88.44 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.611 -1.177 . . . . 64.23 111.939 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -153.73 -48.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.204 0.526 . . . . 74.22 110.415 -173.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.9 m -140.06 33.53 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.553 . . . . 73.15 110.841 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 49.7 mm-40 -82.99 -88.65 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.102 -0.374 . . . . 73.53 111.482 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.656 ' O ' HD22 ' A' ' 309' ' ' LEU . 10.3 ptpp? -175.98 154.25 1.42 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.12 -0.696 . . . . 74.41 109.12 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 240' ' ' ARG . 96.3 Cg_endo -90.66 125.75 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.213 1.942 . . . . 63.21 110.807 167.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 316' ' ' LEU . 7.5 tp -79.48 79.66 5.92 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.23 -0.656 . . . . 74.14 109.23 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.443 ' CE1' HD12 ' A' ' 162' ' ' LEU . 73.7 t80 -55.51 -49.37 72.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.973 -1.012 . . . . 75.43 112.524 -171.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -34.36 70.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.611 -0.268 . . . . 61.11 111.179 -175.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.25 -45.71 69.08 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.336 -0.246 . . . . 72.21 110.336 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.86 -45.22 86.64 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.318 -0.401 . . . . 63.52 110.795 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.25 -42.26 93.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 54.23 110.275 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.97 -55.51 32.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 64.54 111.202 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.49 -28.14 42.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.677 0.275 . . . . 74.54 111.401 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 155' ' ' LEU . 27.0 tp -66.71 -50.92 61.25 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.474 0.654 . . . . 74.32 110.125 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.4 mm? -73.35 -32.81 64.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 73.14 110.441 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -63.85 -47.54 80.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 61.31 110.773 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.2 -40.77 96.97 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 44.02 112.061 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.821 ' HG ' HD22 ' A' ' 155' ' ' LEU . 2.3 tm? -68.96 -41.6 77.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.098 0.475 . . . . 73.53 110.153 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.98 -25.3 67.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 72.44 110.681 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.57 -22.57 63.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 72.43 112.34 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.5 tt -92.25 -1.07 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.338 0.589 . . . . 71.31 110.694 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.82 24.11 33.66 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.451 -0.88 . . . . 52.02 112.622 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.411 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 50.2 m -128.86 169.37 14.67 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 122.748 -0.266 . . . . 72.01 110.407 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -159.22 -154.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.296 -0.631 . . . . 70.32 109.296 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.97 116.96 4.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.609 0.242 . . . . 65.15 111.014 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.71 89.66 3.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.094 -0.503 . . . . 61.53 111.493 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 68.4 13.36 65.12 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.004 -0.544 . . . . 64.4 114.165 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 338' ' ' LYS . 29.8 mmtm 59.13 88.38 0.07 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.684 0.624 . . . . 75.01 112.684 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 191' ' ' ASP . 59.2 mt 68.32 174.97 0.27 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.149 -0.932 . . . . 71.11 112.501 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -178.14 102.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.785 -1.098 . . . . 65.12 109.201 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.818 ' HG ' HD13 ' A' ' 141' ' ' ILE . 2.7 mm? -116.02 -80.25 0.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.151 0.501 . . . . 54.23 110.307 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 25.5 p 168.93 -100.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.511 -1.222 . . . . 72.22 109.312 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.606 HG11 ' H ' ' A' ' 15' ' ' ALA . 4.1 m -159.09 1.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.804 -0.635 . . . . 54.03 112.012 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 140' ' ' LYS . 66.2 t 63.81 101.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.955 0.407 . . . . 65.43 111.484 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -107.99 30.32 6.47 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.255 -0.278 . . . . 72.23 111.137 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.696 ' HA ' ' HD3' ' A' ' 140' ' ' LYS . 16.9 m120 62.39 -169.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.023 -0.535 . . . . 73.2 111.08 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.49 0.97 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.603 -0.808 . . . . 50.01 111.977 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -171.16 168.52 41.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.542 -0.837 . . . . 41.32 112.263 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.7 tt -161.36 122.75 2.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.868 -0.79 . . . . 75.34 108.868 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -143.99 116.05 8.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.808 0.337 . . . . 74.44 110.342 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -100.76 179.07 4.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.74 -0.664 . . . . 70.53 110.582 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -148.59 178.32 8.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 75.24 110.301 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 359' ' ' LYS . 41.7 m -107.65 139.72 41.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.507 -0.315 . . . . 64.41 110.848 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.664 ' CG2' ' HA3' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -68.83 134.18 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.833 0.349 . . . . 73.13 110.73 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 222' ' ' ASP . 12.3 t -93.41 142.55 27.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 60.24 111.885 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 202' ' ' TYR . 23.5 pttm 177.84 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.096 -0.956 . . . . 65.13 108.978 174.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 356' ' ' LYS . 87.8 tttt 169.95 -49.8 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 114.732 -1.122 . . . . 75.25 108.338 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -149.0 164.11 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.658 -1.155 . . . . 74.32 108.63 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.597 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -68.84 -29.99 68.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.848 0.314 . . . . 73.4 111.848 -177.332 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 359' ' ' LYS . 8.4 tmtt? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.391 -0.814 . . . . 74.22 108.878 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.653 -0.499 . . . . 53.42 109.653 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.87 137.9 39.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.275 1.983 . . . . 72.01 111.303 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -146.48 24.3 1.25 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.339 0.59 . . . . 61.44 110.113 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -86.28 119.59 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.625 -0.716 . . . . 70.05 110.593 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -162.95 101.41 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.584 0.706 . . . . 54.25 111.402 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.01 100.1 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 70.14 109.435 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.72 93.7 4.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.453 . . . . 24.21 111.744 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -125.07 135.7 52.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.042 -0.526 . . . . 50.01 109.824 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.9 95.09 1.6 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.317 -0.401 . . . . 65.21 110.244 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.13 0.41 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.503 -0.855 . . . . 75.45 112.461 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 6.3 ptt180 -174.21 147.02 1.17 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.416 -0.216 . . . . 63.22 110.416 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 63.0 tt0 169.97 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.011 0.924 . . . . 54.45 109.068 168.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.8 m -82.06 123.0 28.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.108 -0.497 . . . . 74.22 110.703 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -144.02 96.76 2.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.921 -0.581 . . . . 74.33 109.852 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.88 -4.27 56.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.887 -0.597 . . . . 52.33 111.317 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -112.59 119.08 36.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.174 -0.467 . . . . 74.01 110.168 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -76.66 166.26 23.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.828 -0.623 . . . . 75.11 111.625 -174.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -175.26 168.41 3.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.268 -1.012 . . . . 75.23 108.268 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.3 pt? -106.54 136.1 46.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.857 -0.337 . . . . 72.1 110.424 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.47 13.26 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 44.44 111.546 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.89 138.41 30.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.416 -0.356 . . . . 64.44 110.111 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -125.32 -30.77 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.471 -0.332 . . . . 75.14 111.226 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -89.99 56.04 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.522 0.677 . . . . 53.12 110.473 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -178.65 -54.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.756 -1.111 . . . . 65.22 108.325 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 40' ' ' GLY . 66.4 t -65.35 128.53 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.628 -1.169 . . . . 71.42 110.114 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 38' ' ' LYS . . . 100.38 2.86 55.61 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.96 -0.638 . . . . 63.52 112.856 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.04 130.95 44.8 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.81 -0.811 . . . . 75.31 108.81 173.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.53 128.86 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 62.0 111.505 -172.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -125.87 129.81 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.915 . . . . 62.2 109.939 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.7 m -104.29 123.13 46.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.075 -0.511 . . . . 71.51 110.035 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.707 ' HA ' ' HZ ' ' A' ' 128' ' ' PHE . 4.8 p-10 -82.26 175.65 10.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.544 -0.539 . . . . 71.02 109.544 175.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.5 ptm -71.86 -11.2 60.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.233 0.457 . . . . 75.14 112.233 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.75 2.59 53.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 71.04 110.25 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 65.91 77.91 0.28 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.091 -0.959 . . . . 73.2 112.586 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.88 138.67 9.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.26 -0.882 . . . . 50.51 109.079 167.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -89.1 130.48 35.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 73.43 111.77 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 20.8 p-90 -136.07 147.21 47.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.503 -0.772 . . . . 73.42 109.27 172.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 17.0 pttp -94.59 136.78 34.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.416 -0.514 . . . . 70.05 111.003 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.2 144.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.684 -0.689 . . . . 52.43 109.794 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -108.39 -110.61 3.41 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.58 -0.819 . . . . 62.2 112.763 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.5 mp -95.35 137.1 22.13 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 63.22 111.235 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.0 Cg_exo -75.14 120.08 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.967 2.444 . . . . 74.14 111.449 174.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 53' ' ' LEU . 42.3 mt -90.88 -33.6 5.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.34 0.591 . . . . 74.44 110.097 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.8 -47.17 2.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.803 -0.713 . . . . 72.32 111.775 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -122.95 165.35 16.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.013 -0.366 . . . . 74.32 110.013 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.567 ' HA2' HD22 ' A' ' 349' ' ' LEU . . . 115.53 55.07 0.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.026 -1.229 . . . . 72.3 110.026 -170.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 154.0 -93.39 0.14 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 111.141 -0.784 . . . . 61.33 111.141 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.624 ' H ' HD11 ' A' ' 51' ' ' ILE . 90.1 m-85 -146.41 -55.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.239 -0.652 . . . . 75.25 109.239 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.03 157.55 29.86 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.695 -0.562 . . . . 65.23 111.695 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.0 t 57.34 46.27 18.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.185 0.517 . . . . 63.12 110.762 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 71' ' ' LYS . 42.5 mm -88.45 138.48 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 71.12 111.817 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.3 152.4 37.86 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.12 -0.491 . . . . 73.44 111.067 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 43' ' ' ILE . 9.5 tt -101.32 143.92 30.78 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.196 -0.668 . . . . 72.11 109.196 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.93 108.43 17.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.071 0.462 . . . . 53.34 110.912 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.33 42.37 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 71.2 109.592 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.901 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 13.0 tpt -49.5 -30.88 9.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.275 -0.875 . . . . 65.43 112.553 -176.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' MET . 8.9 m-80 68.99 -166.36 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.311 0.382 . . . . 63.42 110.332 -177.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 61' ' ' SER . 13.5 m -124.93 148.46 48.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.255 -0.276 . . . . 61.13 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 p -76.39 -42.22 45.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 61.21 111.119 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -106.33 97.45 7.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.25 110.34 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.4 t 68.13 158.2 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.395 -0.82 . . . . 72.25 110.588 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.17 131.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.114 0.483 . . . . 63.31 110.523 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.12 -148.39 8.9 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.474 -0.87 . . . . 60.43 111.109 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -88.75 57.89 4.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.991 0.424 . . . . 54.12 109.915 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 67.68 7.96 6.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.211 -0.904 . . . . 63.41 110.36 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.88 90.98 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 115.701 -0.681 . . . . 43.31 110.454 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.808 ' HA ' ' HG2' ' A' ' 133' ' ' ARG . 4.8 Cg_exo -76.62 85.54 1.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.98 2.454 . . . . 74.23 112.303 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 131' ' ' MET . 6.1 p -153.66 138.68 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.222 0.534 . . . . 43.21 111.441 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.16 160.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.48 -0.782 . . . . 73.35 109.115 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 4.1 p -128.1 119.41 50.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.653 0.739 . . . . 72.22 111.958 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.9 ptmt -99.96 123.3 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.083 -0.962 . . . . 65.45 109.677 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG12 ' CB ' ' A' ' 128' ' ' PHE . 13.9 m -114.29 151.85 16.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.054 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' VAL . 18.1 mm-40 -165.34 145.27 5.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 O-C-N 123.821 0.701 . . . . 73.24 110.025 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' TYR . 27.4 Cg_endo -63.47 141.25 79.97 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.291 1.994 . . . . 74.14 111.532 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -64.84 -21.38 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.103 0.478 . . . . 51.13 110.448 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.26 11.12 15.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.919 -0.582 . . . . 62.23 111.931 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 54.4 t30 -95.26 -53.91 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.392 -0.523 . . . . 74.31 110.312 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.66 -76.04 0.41 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.901 -1.142 . . . . 51.12 114.248 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.45 -35.36 21.49 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.195 3.263 . . . . 70.52 114.684 -170.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -56.84 -45.42 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 71.15 110.395 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.46 -31.47 70.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.697 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.8 m -65.64 -49.02 70.2 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.205 -0.452 . . . . 75.15 110.64 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.65 -31.83 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.14 109.862 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD13 ' HG2' ' A' ' 129' ' ' MET . 59.8 tp -61.34 -41.33 96.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.929 -0.578 . . . . 64.51 110.739 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.736 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -62.23 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.56 -0.291 . . . . 74.42 110.608 177.078 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.91 -51.91 68.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.211 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE1' ' HG2' ' A' ' 131' ' ' MET . 73.0 t80 -60.43 -34.55 74.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.493 -0.776 . . . . 72.14 111.826 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.93 -42.41 69.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.311 . . . . 72.42 111.442 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -80.51 -28.27 37.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.421 -0.354 . . . . 53.01 110.776 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -93.64 16.23 14.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.857 0.36 . . . . 53.42 111.325 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -95.2 164.88 12.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.377 -0.374 . . . . 61.13 111.619 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 37.9 ttmt 72.29 110.5 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 74.23 111.389 176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.01 -36.98 78.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.404 2.736 . . . . 70.34 113.34 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.25 -42.1 98.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.925 0.393 . . . . 71.55 110.941 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -66.65 -48.64 68.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 64.54 109.889 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.5 mt -56.57 -51.31 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.303 -0.862 . . . . 53.25 110.598 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.4 -36.74 69.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 45.42 110.683 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -61.95 -56.52 18.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 75.23 111.236 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.594 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 2.1 p90 -72.55 -35.04 67.91 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 119.683 -0.807 . . . . 74.55 111.154 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' ILE . 33.4 mm -58.3 -42.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.47 0.653 . . . . 71.42 109.984 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.83 -57.77 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.021 -0.991 . . . . 74.25 111.222 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -71.6 -29.88 65.19 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.181 0.437 . . . . 61.42 112.181 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -83.55 -6.25 59.4 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.453 0.538 . . . . 72.43 112.453 -177.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.6 mptt 63.34 31.0 15.51 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.511 0.507 . . . . 74.32 111.237 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 94.4 mt -83.59 169.08 15.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.661 . . . . 72.31 109.558 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -101.94 -72.74 0.68 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.16 0.43 . . . . 61.12 112.16 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -150.8 110.46 4.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.509 . . . . 75.22 111.614 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -79.77 127.92 32.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 43.35 110.692 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.95 67.87 3.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.025 -0.607 . . . . 74.14 112.398 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 ' HB1' ' A' ' 90' ' ' ALA . 6.2 p -110.65 135.3 20.73 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 122.284 0.234 . . . . 73.45 110.694 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 194' ' ' TYR . 34.8 Cg_exo -61.0 152.87 68.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.996 2.464 . . . . 74.31 113.136 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -70.34 136.54 49.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.761 -0.654 . . . . 62.42 111.124 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.459 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 48.7 t80 -84.53 129.79 34.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.679 -0.691 . . . . 63.44 111.461 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.623 ' HB2' HG22 ' A' ' 130' ' ' ILE . 81.7 m95 -120.78 -50.78 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.327 0.584 . . . . 75.42 109.974 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.17 178.3 43.05 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.747 -0.661 . . . . 52.13 112.321 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' MET . 22.8 t -164.69 -178.87 5.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.429 -0.582 . . . . 42.02 109.429 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.91 -151.52 23.23 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.969 -0.634 . . . . 70.11 111.921 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.6 pt? -137.13 145.67 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.904 -0.406 . . . . 62.05 109.904 175.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -149.19 108.1 3.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.452 -0.34 . . . . 73.11 110.199 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 17.0 t70 -174.34 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.504 0.503 . . . . 75.12 110.286 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 54.1 29.68 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.406 0.622 . . . . 65.2 111.419 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.03 -30.95 6.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.582 -0.895 . . . . 74.32 108.582 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.75 -42.08 0.35 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.919 -1.037 . . . . 64.54 111.316 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 125' ' ' SER . 14.9 tptm -173.58 -177.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.525 -0.546 . . . . 64.35 109.525 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 1.2 p -76.32 104.99 7.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.501 0.667 . . . . 73.44 111.212 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 7.3 m-85 -98.36 120.48 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.505 -0.77 . . . . 71.31 110.002 176.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -92.03 142.49 27.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.978 -0.379 . . . . 72.15 109.978 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' ' 31' ' ' ASP . 52.9 p90 -127.82 143.68 51.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.512 -0.313 . . . . 75.15 110.737 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 77.2 mtp -123.1 122.14 37.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 74.52 110.496 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.623 HG22 ' HB2' ' A' ' 114' ' ' TRP . 4.7 mm -98.42 117.04 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 64.5 110.173 175.872 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 67.2 mtm -127.84 179.89 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.187 -0.671 . . . . 62.23 109.187 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.1 t70 -63.54 154.3 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.315 -0.624 . . . . 75.21 109.315 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.808 ' HG2' ' HA ' ' A' ' 67' ' ' PRO . 11.6 ptp180 -82.31 125.37 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.494 0.664 . . . . 61.44 110.992 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -104.34 171.7 7.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.529 -0.76 . . . . 65.52 109.781 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.75 -38.7 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.855 -1.164 . . . . 51.1 113.264 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.799 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 69.8 m -94.37 124.71 38.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 71.33 111.485 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.559 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 1.1 m-20 -90.21 134.54 34.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.868 -0.606 . . . . 72.52 110.038 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.8 tp -69.66 -29.22 66.62 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 174.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 29.0 pt20 -69.86 -33.12 71.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.745 -0.661 . . . . 75.34 110.987 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -69.56 -39.8 77.17 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.376 -0.601 . . . . 74.33 109.376 178.121 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.77 HG21 ' HG ' ' A' ' 341' ' ' LEU . 66.8 mt -68.57 -40.97 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.7 -0.682 . . . . 74.31 110.115 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.754 ' CE1' ' HD3' ' A' ' 147' ' ' LYS . 22.5 t80 -52.75 -48.83 66.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.58 . . . . 74.54 110.655 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.8 -44.92 79.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 74.12 111.371 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.57 51.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.039 0.385 . . . . 70.23 112.039 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -96.74 2.59 52.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.935 0.397 . . . . 64.31 110.887 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.16 38.55 29.97 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.074 -0.512 . . . . 72.43 111.644 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.754 ' HD3' ' CE1' ' A' ' 142' ' ' TYR . 37.3 pttt 46.33 29.46 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 75.0 113.726 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -99.92 84.08 2.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.366 -0.605 . . . . 63.33 109.366 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 5.0 m-30 -94.52 156.38 16.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.782 -0.644 . . . . 71.35 110.68 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 p -73.51 138.06 44.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.239 -0.652 . . . . 75.21 109.239 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.79 71.53 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.326 0.491 . . . . 73.51 112.326 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' A' ' 340' ' ' ASP . 11.0 pttp -60.15 -39.25 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 72.35 110.929 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.506 HG23 HD23 ' A' ' 339' ' ' LEU . 30.4 m -71.57 -40.43 69.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.102 -0.499 . . . . 65.33 110.057 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.14 -47.18 84.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.778 -0.646 . . . . 70.14 111.28 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.758 ' HB3' HD22 ' A' ' 328' ' ' LEU . 0.2 OUTLIER -70.71 -44.11 67.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.687 -176.99 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.765 ' HG2' HD11 ' A' ' 339' ' ' LEU . 6.8 tp-100 -55.73 -46.2 77.81 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.03 0.443 . . . . 74.13 110.736 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 161' ' ' ILE . 87.7 mt -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.903 -0.59 . . . . 72.04 110.931 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 p -64.24 -32.25 73.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 72.35 111.808 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.54 HD11 HD23 ' A' ' 325' ' ' LEU . 76.3 mt -61.25 -53.41 57.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.658 0.266 . . . . 73.42 110.851 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -66.81 -29.47 69.42 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.106 0.479 . . . . 61.4 110.538 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 28.2 mm -68.97 -35.04 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 71.04 110.359 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.44 -46.62 89.31 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.729 -0.471 . . . . 63.13 109.729 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -57.2 -48.38 78.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.479 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 161' ' ' ILE . 15.9 tt -72.32 -36.85 56.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.443 -0.344 . . . . 73.14 111.607 -175.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.43 HD21 HD11 ' A' ' 178' ' ' ILE . 37.1 mt -64.63 -38.7 91.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.99 -0.284 . . . . 72.4 110.84 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -71.32 -37.9 71.75 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.942 -0.303 . . . . 62.42 110.532 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -50.91 -42.21 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 61.23 110.979 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 169' ' ' HIS . 38.8 pt -91.91 -43.82 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.411 0.523 . . . . 75.15 112.411 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.415 ' N ' HG13 ' A' ' 168' ' ' ILE . 3.0 t-160 -72.86 -30.94 64.38 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.623 0.249 . . . . 63.02 111.567 -171.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.489 ' HG2' HH22 ' A' ' 240' ' ' ARG . 3.5 tm-20 -59.18 -28.77 66.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 70.41 110.084 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -101.41 -66.47 0.91 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.745 0.646 . . . . 61.2 112.745 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 173' ' ' TYR . 11.3 pt-20 -145.97 -60.56 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.219 1.192 . . . . 73.34 114.219 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.606 ' HB3' ' HD2' ' A' ' 203' ' ' ARG . 55.2 p90 -104.42 160.36 14.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.343 0.592 . . . . 74.34 112.47 -168.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 14.2 m -129.54 172.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.096 -0.956 . . . . 74.32 109.741 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 13.4 t-80 -98.98 -41.32 7.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.834 -0.432 . . . . 72.15 109.834 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 228' ' ' THR . . . 62.66 38.45 96.46 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.766 -0.73 . . . . 44.44 112.754 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.553 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 19.3 t70 179.71 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.765 0.426 . . . . 65.34 109.889 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.43 HD11 HD21 ' A' ' 165' ' ' LEU . 49.5 mm -111.16 79.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.508 0.67 . . . . 61.43 110.1 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.79 ' HZ2' ' HD2' ' A' ' 227' ' ' PHE . 46.4 mttp -103.79 153.05 21.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.46 -0.791 . . . . 64.44 110.647 174.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -63.36 -16.27 59.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 72.31 110.918 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 12.7 m -71.84 -14.16 61.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.961 -0.563 . . . . 63.44 111.472 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -97.43 -12.4 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 74.14 110.913 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 8.0 mp -105.67 120.26 41.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.363 0.601 . . . . 73.32 110.622 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 196' ' ' VAL . 3.6 mm? -118.03 131.35 56.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.298 -0.865 . . . . 51.24 110.131 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 86.2 mt -86.84 154.9 20.52 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.485 -0.561 . . . . 71.25 109.485 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.13 153.46 18.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.344 -0.984 . . . . 73.21 108.344 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -47.56 -33.29 6.3 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.419 0.525 . . . . 62.25 112.419 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -154.84 51.75 0.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.519 . . . . 75.34 110.441 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 2.7 t-20 -135.43 107.4 10.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.379 -0.601 . . . . 72.01 109.379 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 23.2 Cg_exo -66.49 -29.49 44.7 Favored 'Trans proline' 0 N--CA 1.474 0.36 0 C-N-CA 123.437 2.758 . . . . 41.23 115.305 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.557 ' HA ' HD13 ' A' ' 339' ' ' LEU . 0.7 OUTLIER -94.29 -21.91 18.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.079 -0.649 . . . . 64.12 111.483 -173.334 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 194' ' ' TYR . 19.4 tp60 -91.38 93.62 9.12 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.569 0.7 . . . . 73.32 110.373 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.49 142.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.838 -1.074 . . . . 73.52 110.247 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CZ ' ' HG3' ' A' ' 192' ' ' GLN . 37.1 m-85 -124.04 157.34 34.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.045 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.9 tp -94.49 99.36 11.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.613 -0.884 . . . . 54.32 108.613 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.561 ' HB ' HD23 ' A' ' 184' ' ' LEU . 46.7 t -130.26 157.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 53.0 110.465 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 51.16 64.96 1.63 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.818 0.818 . . . . 60.33 111.297 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -123.17 -64.85 1.14 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.078 -0.965 . . . . 73.35 110.65 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . 77.02 -13.7 8.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.552 . . . . 35.11 112.059 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -84.63 89.75 7.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.127 0.489 . . . . 72.44 110.073 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -141.92 99.25 3.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 74.02 109.912 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.67 138.52 42.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 43.41 109.675 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.606 ' HD2' ' HB3' ' A' ' 173' ' ' TYR . 4.8 mpt_? -71.36 129.06 37.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.944 0.402 . . . . 72.2 111.496 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.627 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 11.6 t80 -95.49 -54.41 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.763 -0.653 . . . . 73.52 110.064 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 172' ' ' GLU . 6.7 p -134.1 105.39 11.39 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.697 -0.683 . . . . 71.34 110.105 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 210' ' ' HIS . 52.2 Cg_exo -54.16 107.37 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.586 2.19 . . . . 62.02 111.568 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 65.9 11.68 7.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.103 -0.953 . . . . 74.12 111.418 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.54 -5.51 40.84 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.024 -0.607 . . . . 51.12 113.223 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.26 111.54 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.03 0.415 . . . . 74.24 111.536 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.578 ' HB2' ' HD2' ' A' ' 206' ' ' PRO . 12.6 t-160 -178.19 -101.13 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.96 -0.563 . . . . 62.12 110.888 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.474 ' HE3' HG23 ' A' ' 312' ' ' THR . 60.3 tttm 51.49 89.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 63.01 111.947 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -166.22 136.71 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 54.33 111.139 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.753 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 20.3 t80 -94.75 80.45 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 75.03 111.495 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -178.9 70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.547 -0.751 . . . . 72.12 109.517 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -106.49 -71.29 0.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.082 -0.508 . . . . 64.13 110.777 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -119.12 118.2 32.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.915 0.388 . . . . 75.13 110.395 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.63 0.46 10.0 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.295 2.663 . . . . 72.0 112.899 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 16.6 ttmm -100.04 -8.6 23.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.546 -0.539 . . . . 73.03 109.546 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 218' ' ' LYS . 29.1 mtm105 73.19 114.36 0.06 Allowed 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.163 -0.926 . . . . 73.25 110.697 -177.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 37.1 m -61.01 -53.06 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.963 -0.562 . . . . 74.03 111.847 -175.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 26.0 p80 44.51 43.62 6.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.515 0.726 . . . . 64.5 111.911 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.71 -59.48 4.43 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.486 . . . . 44.23 111.207 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -88.04 -155.36 28.96 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.898 -0.667 . . . . 70.4 112.36 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.9 p -88.7 151.59 22.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.941 0.4 . . . . 60.04 111.062 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -53.27 -33.08 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 113.739 1.014 . . . . 54.44 113.739 -167.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -60.15 2.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.272 0.842 . . . . 73.2 113.272 -170.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.79 ' HD2' ' HZ2' ' A' ' 179' ' ' LYS . 28.9 m-85 -87.89 -0.23 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.28 0.474 . . . . 61.55 112.28 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 39.4 m -85.61 -10.3 56.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.346 0.593 . . . . 72.12 109.815 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.0 t 67.44 -175.7 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.1 -0.955 . . . . 72.23 111.259 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 82.6 mt -70.5 -34.59 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.393 -0.822 . . . . 51.3 109.731 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.621 ' HB3' ' HA ' ' A' ' 238' ' ' PRO . 1.8 m-20 -47.38 -84.23 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.801 -1.091 . . . . 74.52 112.547 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.643 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -66.31 -28.32 68.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.154 -0.476 . . . . 65.5 111.993 -172.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.05 -26.6 62.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.662 -0.415 . . . . 75.21 110.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.412 ' C ' ' HG2' ' A' ' 219' ' ' ARG . 2.7 t-20 -95.75 -4.85 43.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.369 . . . . 63.15 110.981 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.59 21.07 17.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.352 -0.927 . . . . 73.1 113.391 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.753 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 7.1 p -117.63 141.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 60.32 109.67 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -56.71 125.06 66.77 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.084 -0.507 . . . . 64.4 110.966 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.643 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 33.3 Cg_exo -60.27 115.18 2.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.156 2.571 . . . . 71.03 112.701 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 69.9 m -83.79 169.31 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 51.2 110.774 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.489 HH22 ' HG2' ' A' ' 170' ' ' GLU . 20.4 mtt180 -59.51 -20.53 56.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.528 0.68 . . . . 72.32 110.251 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.577 HH11 ' HG ' ' A' ' 309' ' ' LEU . 10.7 mmt180 -64.99 -41.82 95.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.094 -0.957 . . . . 74.22 109.645 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -69.59 -41.41 75.87 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 74.14 112.275 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.07 -45.18 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.581 0.229 . . . . 73.53 111.083 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.529 HD23 HG12 ' A' ' 306' ' ' VAL . 9.5 mp -60.9 -41.99 97.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.403 -0.362 . . . . 72.24 110.916 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.92 -51.09 71.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.788 -0.642 . . . . 74.1 110.771 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.4 mt -62.35 -42.1 94.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.009 -0.541 . . . . 75.21 111.09 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 251' ' ' MET . 46.8 tp -61.96 -39.52 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.169 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.53 -39.65 98.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.339 -0.934 . . . . 74.03 111.645 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -66.55 -39.47 88.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.907 0.336 . . . . 73.34 111.907 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' A' ' 247' ' ' LEU . 20.0 p -68.12 -34.17 75.88 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.294 -0.563 . . . . 71.51 110.133 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 81.6 mtp -62.9 -53.59 51.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.443 -0.344 . . . . 70.32 110.983 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.542 HD12 ' SD ' ' A' ' 286' ' ' MET . 5.5 tt -65.98 -31.7 54.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.679 0.276 . . . . 53.34 110.303 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -56.26 -53.95 51.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 72.33 110.898 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 19.1 m0 -76.39 -25.16 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 71.43 111.222 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.5 tp -76.35 -46.3 28.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 60.23 111.617 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 76.5 p -103.71 -17.73 14.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.914 -0.315 . . . . 72.23 111.674 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 72.14 18.48 77.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 54.11 111.914 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -144.48 147.35 33.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.675 0.274 . . . . 75.25 110.957 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.871 ' HB2' ' HG3' ' A' ' 262' ' ' GLU . 96.1 mt -118.28 138.93 26.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.652 -0.87 . . . . 74.32 108.652 168.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 23.0 Cg_exo -65.45 -17.35 57.36 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.978 2.452 . . . . 61.21 114.243 -171.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 16.3 p90 -132.93 34.64 3.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.414 0.524 . . . . 74.42 112.414 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 259' ' ' LEU . 43.4 mt-10 -68.03 -42.72 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.41 0.624 . . . . 63.41 109.692 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.13 -21.21 64.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 73.2 109.939 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 3.2 m-20 -89.81 -2.55 58.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.252 -0.886 . . . . 44.41 111.157 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.525 HD23 HG11 ' A' ' 271' ' ' VAL . 89.7 mt -66.63 -2.83 5.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.796 0.331 . . . . 64.42 111.521 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -62.59 -40.02 95.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.919 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.573 ' OD1' ' HE3' ' A' ' 269' ' ' LYS . 10.7 t70 -135.13 135.41 22.78 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 42.31 110.982 -171.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.6 Cg_exo -60.72 -28.86 87.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.242 2.628 . . . . 72.33 113.476 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.573 ' HE3' ' OD1' ' A' ' 267' ' ' ASP . 0.0 OUTLIER -78.11 -34.93 49.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.729 -0.471 . . . . 71.43 109.729 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.616 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 6.4 m-85 -56.63 -50.54 71.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.811 -0.631 . . . . 74.41 111.058 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.525 HG11 HD23 ' A' ' 265' ' ' LEU . 7.8 m -70.47 -35.3 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 71.34 111.479 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 276' ' ' ILE . 82.3 mtt180 -56.96 -56.34 22.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.512 0.196 . . . . 74.14 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 0.1 OUTLIER -66.39 -42.67 87.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 72.14 111.439 -176.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 16.2 m -61.01 -41.97 97.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.217 0.532 . . . . 73.42 110.256 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.21 -43.91 92.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.277 -0.874 . . . . 75.51 110.471 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 272' ' ' ARG . 79.7 mt -66.14 -44.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 72.34 111.274 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 26.4 mmt180 -68.96 -36.15 77.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.589 0.233 . . . . 73.53 111.606 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 21.2 m-85 -73.12 -33.92 65.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.061 -0.255 . . . . 74.11 110.868 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -72.13 -22.93 61.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.267 0.556 . . . . 73.44 109.971 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -74.82 -53.44 9.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.537 -0.756 . . . . 65.54 110.51 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.536 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.4 m-80 -111.72 55.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.635 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -52.13 -51.04 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 73.01 112.077 -178.701 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.526 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.23 -46.94 84.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 63.23 111.42 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.4 m -61.19 -49.14 78.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.811 -0.631 . . . . 74.5 111.143 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.3 mm? -71.58 -44.23 64.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.31 111.874 -175.173 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.542 ' SD ' HD12 ' A' ' 252' ' ' ILE . 21.8 mmt -64.69 -38.66 91.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.0 -0.28 . . . . 55.22 111.726 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.17 -39.01 65.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 74.12 110.413 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.05 -39.1 63.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 72.21 111.731 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.8 m -77.37 -11.36 59.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.607 0.225 . . . . 54.31 111.607 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 10.5 t80 -129.7 69.53 81.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.181 0.515 . . . . 64.12 110.449 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -90.67 12.35 2.43 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.041 2.494 . . . . 72.44 112.534 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -75.03 -9.38 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 74.22 110.375 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 71.27 84.56 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.893 -1.049 . . . . 71.31 112.221 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.716 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 27.3 t-20 -128.3 -80.27 0.58 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.802 -1.184 . . . . 62.41 107.802 169.399 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 60.0 tttp 175.13 96.85 0.08 OUTLIER Pre-proline 0 N--CA 1.461 0.092 0 O-C-N 123.743 0.652 . . . . 74.15 110.526 169.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -99.84 38.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.986 2.457 . . . . 73.0 111.47 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.3 -51.46 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 71.15 112.924 -172.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 0.9 OUTLIER -72.61 -30.85 64.7 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.235 -0.283 . . . . 74.32 110.235 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.3 mp -63.08 -44.3 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 71.24 109.57 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.33 88.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.933 -0.576 . . . . 63.13 111.138 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.71 -41.07 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.635 -0.257 . . . . 63.01 110.648 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.447 ' O ' ' HB ' ' A' ' 305' ' ' THR . 56.9 t80 -55.14 -45.35 75.64 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.502 -0.317 . . . . 61.25 110.986 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 306' ' ' VAL . 74.8 mtp -72.72 -31.35 64.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.598 -0.274 . . . . 64.52 111.62 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.29 -30.37 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.475 0.655 . . . . 72.24 109.236 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 86.7 m -66.32 -40.3 89.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.346 -0.843 . . . . 71.42 110.869 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 5.7 m -73.49 -27.03 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.819 -0.352 . . . . 61.31 110.492 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -62.3 -42.85 99.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 63.25 110.498 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 32.1 tp -97.11 16.22 20.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 55.44 110.05 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 27.4 tp -71.92 -32.53 67.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 74.12 110.666 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 27.1 t70 67.5 161.7 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.322 -0.854 . . . . 60.53 110.848 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -77.75 -22.72 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.699 0.285 . . . . 74.31 111.187 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.474 HG23 ' HE3' ' A' ' 211' ' ' LYS . 24.3 m -124.01 -20.28 5.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.592 0.59 . . . . 71.23 112.592 -173.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 14.5 tp10 -57.02 -101.16 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.344 0.868 . . . . 73.11 113.344 -166.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -147.04 120.17 4.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 121.641 -0.662 . . . . 74.21 111.508 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 309' ' ' LEU . 57.3 Cg_endo -91.03 118.57 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.542 2.162 . . . . 54.12 111.121 170.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 96.1 mt -116.04 82.43 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.79 0.328 . . . . 74.54 111.318 -176.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.517 ' HA ' HD12 ' A' ' 320' ' ' LEU . 35.9 m-85 -62.28 -33.46 74.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.022 -0.535 . . . . 72.54 111.428 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.28 -40.45 90.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 75.43 110.95 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -73.21 -37.51 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.687 -0.486 . . . . 72.42 109.687 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 50.6 mt -59.32 -47.71 84.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.113 -0.494 . . . . 73.13 110.154 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -57.96 -41.59 83.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 70.45 110.408 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.49 -52.28 61.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.706 -0.679 . . . . 73.51 111.686 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.5 tt -63.58 -47.52 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 111.91 0.337 . . . . 72.04 111.91 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.5 mt -66.19 -39.14 89.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.247 0.546 . . . . 63.23 110.435 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 159' ' ' LEU . 2.8 tm? -69.28 -35.28 75.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.152 -0.684 . . . . 73.23 109.152 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -62.91 -37.71 88.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 73.04 109.962 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.17 -41.0 95.13 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.903 -0.665 . . . . 61.14 112.215 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 155' ' ' LEU . 41.6 tp -71.65 -37.94 70.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.19 0.519 . . . . 42.34 110.746 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -72.08 -22.98 61.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.162 -0.472 . . . . 55.22 110.511 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.496 . . . . 73.34 110.957 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 328' ' ' LEU . 33.5 pt -95.44 1.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.982 0.42 . . . . 73.23 110.583 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.08 75.38 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.774 -0.648 . . . . 43.15 113.224 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 5.4 t -117.32 170.13 8.94 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.474 -0.427 . . . . 53.41 110.751 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 328' ' ' LEU . 27.3 ttpp -160.11 -56.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 74.43 108.889 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.629 ' HB2' ' H ' ' A' ' 339' ' ' LEU . 7.1 p-10 178.6 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.914 -1.039 . . . . 75.24 108.452 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.8 t70 72.45 -71.55 0.13 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.681 -1.145 . . . . 74.22 111.786 172.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -117.94 57.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.805 -0.712 . . . . 65.2 112.303 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER 62.76 64.93 0.85 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.046 0.451 . . . . 71.34 110.91 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 156' ' ' GLN . 10.9 mp 63.04 -171.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.075 -0.966 . . . . 61.32 111.487 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' ASP . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 152' ' ' LYS . 32.4 t70 -159.43 82.37 0.76 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.264 -0.88 . . . . 73.31 108.732 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.77 ' HG ' HG21 ' A' ' 141' ' ' ILE . 28.8 tp -125.76 -74.97 0.59 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.316 -0.856 . . . . 61.41 110.727 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 58.1 m -173.78 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.269 -0.423 . . . . 60.0 111.237 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 84.5 t 67.81 96.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.65 -0.704 . . . . 55.12 110.124 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 345' ' ' GLU . 19.4 t -88.95 -15.73 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.528 -0.76 . . . . 54.35 110.811 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 344' ' ' VAL . 7.2 tt0 73.59 -37.3 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.185 0.594 . . . . 71.23 111.643 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -125.46 130.39 51.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.698 -0.482 . . . . 73.12 109.698 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -136.87 -121.7 2.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.621 -0.8 . . . . 22.32 112.829 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -179.88 73.4 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.35 -0.452 . . . . 53.02 112.266 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.567 HD22 ' HA2' ' A' ' 46' ' ' GLY . 6.8 mp -59.07 145.14 43.22 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.392 0.277 . . . . 75.13 111.09 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -164.99 116.87 1.18 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.752 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.74 -178.34 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.301 -0.408 . . . . 64.23 112.1 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.665 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 28.4 ttpt -142.72 170.61 15.38 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.173 -0.677 . . . . 54.13 109.173 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.658 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 10.4 t -106.67 162.39 13.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.168 -0.308 . . . . 72.34 110.168 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.44 143.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.398 0.618 . . . . 70.11 111.738 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.5 m -101.4 97.35 7.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.329 -0.851 . . . . 75.1 111.125 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -145.98 -48.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 74.11 110.749 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.05 131.45 44.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.441 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -65.94 113.74 4.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 63.15 109.574 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -123.51 148.39 46.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 63.54 111.5 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.517 -0.754 . . . . 73.51 109.18 173.448 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.914 -0.402 . . . . 73.22 109.914 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.48 146.9 40.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.534 2.156 . . . . 64.35 111.993 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -98.09 113.91 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.14 -0.482 . . . . 71.32 109.824 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -81.06 131.41 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.417 -0.356 . . . . 65.55 110.47 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 122.24 13.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 73.05 110.656 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.85 -6.37 0.45 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.596 -0.729 . . . . 73.32 110.936 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.53 40.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 60.23 110.997 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -110.76 142.43 42.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.795 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 260' ' ' PRO . . . -84.56 145.74 27.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 75.44 110.372 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.33 -165.31 14.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.564 -0.826 . . . . 73.04 112.728 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -129.16 130.26 46.16 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.46 0.304 . . . . 72.15 110.7 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -171.3 37.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 63.15 110.851 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -82.36 120.0 24.87 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.181 -0.608 . . . . 74.23 110.605 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.6 m -162.49 124.61 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 75.05 109.733 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.64 149.75 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.9 0.381 . . . . 51.23 110.388 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.19 -175.22 4.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.409 . . . . 72.53 110.401 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -147.95 110.76 4.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.182 0.515 . . . . 65.23 111.83 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -145.35 124.58 12.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.948 -0.569 . . . . 72.13 110.21 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 349' ' ' LEU . 4.4 pp -152.11 147.14 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.153 -0.476 . . . . 64.21 110.064 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.44 152.51 46.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.405 -0.361 . . . . 73.23 110.306 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -145.25 -166.87 2.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 74.31 111.434 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 76.11 52.64 0.06 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.981 -1.008 . . . . 74.21 113.051 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -81.19 174.1 11.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.752 -1.203 . . . . 65.3 107.752 164.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.67 95.59 5.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.253 0.549 . . . . 73.03 111.31 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 132.56 31.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.664 -0.698 . . . . 64.4 109.802 174.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.99 -7.87 60.82 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.725 -0.75 . . . . 51.43 112.404 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.56 128.64 36.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.824 0.345 . . . . 64.13 110.914 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.8 mt -86.62 129.0 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 74.31 110.174 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 37' ' ' TRP . 29.4 pt -116.26 147.12 19.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 61.31 110.81 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 35' ' ' LYS . 55.0 m -118.15 125.77 50.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.512 -0.767 . . . . 74.52 109.6 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 2.2 p-10 -121.27 -164.53 1.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.881 0.372 . . . . 72.44 111.057 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.516 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 13.8 mmt -68.63 -14.43 63.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.336 -0.393 . . . . 71.24 111.697 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.508 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -81.7 11.37 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 70.21 109.78 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 24.4 tptp 92.36 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.034 1.334 . . . . 65.23 113.285 167.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.978 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 21.2 ptmt 159.59 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.563 0.54 . . . . 72.05 111.608 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.978 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 38.8 mt-10 82.62 59.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.186 1.18 . . . . 73.4 114.186 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' ILE . 40.4 m95 -138.95 151.13 46.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.189 -1.411 . . . . 73.24 107.189 165.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.722 ' HE3' ' HB3' ' A' ' 56' ' ' MET . 61.0 pttt -154.47 144.47 21.83 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.857 -0.737 . . . . 63.31 111.24 172.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.81 126.44 25.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.293 -0.867 . . . . 74.03 110.619 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.68 -60.66 0.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.449 -0.882 . . . . 70.14 112.355 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 6.6 tt -103.82 120.62 50.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.998 -0.371 . . . . 65.3 109.998 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 4.8 Cg_exo -79.0 112.74 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.351 2.701 . . . . 75.13 111.776 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.773 HG22 ' HG2' ' A' ' 45' ' ' GLN . 49.2 mt -95.48 -57.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.37 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -20.1 22.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.205 -0.522 . . . . 62.34 113.254 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.773 ' HG2' HG22 ' A' ' 43' ' ' ILE . 12.0 pt20 -111.44 165.01 12.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.006 -0.368 . . . . 75.41 110.006 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.85 -170.15 26.45 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.693 -0.963 . . . . 72.24 110.693 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.605 ' HA3' ' CG2' ' A' ' 196' ' ' VAL . . . -81.85 50.38 4.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.752 -0.737 . . . . 45.1 113.098 -175.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 4.2 t80 166.5 -37.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.395 0.678 . . . . 74.22 109.299 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.24 157.2 17.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.031 -0.604 . . . . 65.42 112.25 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.9 m 65.16 41.37 4.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.131 0.491 . . . . 72.1 111.349 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 71' ' ' LYS . 5.2 mm -97.33 138.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.494 -0.558 . . . . 70.1 109.494 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.67 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 97.7 m-85 -122.32 167.36 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 61.43 111.752 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 55' ' ' ASP . 3.8 tt -115.16 139.53 49.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.069 -0.514 . . . . 73.43 109.999 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -93.1 68.22 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 72.41 109.763 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HD22 ' A' ' 53' ' ' LEU . 31.7 t70 -89.47 -14.93 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.162 -0.926 . . . . 72.11 112.041 -169.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.722 ' HB3' ' HE3' ' A' ' 38' ' ' LYS . 5.2 mmt -95.05 -0.71 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.446 0.536 . . . . 73.03 112.446 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' OD1' ' HB1' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -105.35 80.2 1.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.481 0.658 . . . . 75.42 110.503 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -124.9 104.23 8.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.706 -0.679 . . . . 71.35 110.707 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.8 m -107.31 125.34 51.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.261 -0.427 . . . . 71.43 110.067 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 62.83 35.22 13.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.264 0.554 . . . . 75.02 110.476 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.3 m 59.15 27.89 17.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.643 -0.708 . . . . 75.03 111.267 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.73 129.19 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.191 0.52 . . . . 72.14 111.412 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.94 24.67 30.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.066 -0.588 . . . . 55.13 113.012 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.446 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 p -117.46 -54.43 2.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.796 0.298 . . . . 74.42 111.212 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.7 -28.0 63.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 65.14 112.148 -173.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -72.95 -50.12 7.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 111.839 0.311 . . . . 75.31 111.839 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 10.7 Cg_exo -73.58 43.94 0.84 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.573 2.182 . . . . 74.21 112.814 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.0 m -117.31 142.35 47.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.754 0.311 . . . . 71.14 110.326 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 53' ' ' LEU . 31.7 m -117.15 158.74 17.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 73.21 109.831 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.64 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.1 p -137.72 126.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.326 0.584 . . . . 75.3 111.664 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.651 ' HB3' HD12 ' A' ' 51' ' ' ILE . 46.7 pttt -98.81 136.26 39.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.398 -0.819 . . . . 73.44 109.132 174.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 8.4 p -137.21 138.2 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.568 0.581 . . . . 64.3 112.568 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 27.0 mt-10 -123.1 163.76 31.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.598 -0.728 . . . . 73.4 109.05 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.75 -177.07 1.11 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.328 2.019 . . . . 73.13 111.918 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.1 t -76.83 11.72 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.772 0.32 . . . . 71.35 111.696 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.81 -40.51 92.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 73.4 109.739 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 81' ' ' PHE . 64.0 t30 60.7 83.02 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.06 -0.973 . . . . 63.35 111.468 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.51 -83.05 0.18 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.647 -0.787 . . . . 73.13 111.719 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.86 -44.38 16.63 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.683 2.255 . . . . 74.44 111.624 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.93 -34.9 73.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.454 -0.339 . . . . 54.4 110.405 177.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.503 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 74.7 t80 -63.57 -47.76 80.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.043 0.449 . . . . 72.01 110.257 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.0 m -65.54 -42.63 91.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.66 -0.7 . . . . 65.05 110.074 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.85 -43.7 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.23 -0.895 . . . . 70.03 110.54 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.547 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 46.4 tp -55.83 -47.35 77.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.736 -0.666 . . . . 71.41 110.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 11.1 mmpt? -60.47 -41.76 94.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.46 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.98 -44.44 94.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.799 -0.637 . . . . 73.35 110.814 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.611 ' HD2' ' HB2' ' A' ' 113' ' ' TYR . 18.9 m-85 -70.55 -39.61 73.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.824 0.305 . . . . 73.4 111.824 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 81.5 mm-40 -68.02 -18.31 64.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.038 0.447 . . . . 61.55 110.5 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -96.72 -70.49 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 74.44 111.634 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.673 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -83.89 -34.48 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.274 0.842 . . . . 70.13 113.274 -170.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.34 79.36 3.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.377 0.608 . . . . 73.34 112.16 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -154.24 116.33 2.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.845 -0.798 . . . . 74.21 108.845 176.361 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' HD2' ' HD3' ' A' ' 92' ' ' LYS . 9.7 Cg_endo -52.05 -54.02 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.333 2.688 . . . . 75.14 114.067 -170.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 1.2 pp20? -72.95 -28.34 62.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.845 0.355 . . . . 72.25 110.624 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.457 ' CB ' ' HB3' ' A' ' 92' ' ' LYS . 3.6 tp-100 -67.81 -48.99 64.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.458 -0.571 . . . . 72.53 109.458 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG23 HD12 ' A' ' 108' ' ' LEU . 81.5 mt -57.19 -53.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.603 -0.726 . . . . 75.43 110.434 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.02 -40.05 66.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.429 -0.805 . . . . 75.33 110.611 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 18.5 ttpt -67.24 -59.47 3.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.25 -0.886 . . . . 72.11 111.482 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 1.3 p90 -68.44 -34.03 75.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 120.474 -0.49 . . . . 70.42 110.833 -176.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 105' ' ' LEU . 2.9 tp -72.1 -29.09 31.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.885 0.374 . . . . 74.44 110.032 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -65.52 -47.34 76.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.736 -0.665 . . . . 65.0 109.778 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -74.66 -19.01 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 71.14 111.447 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 166' ' ' GLU . 17.9 tpt180 -79.44 -18.45 52.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.538 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 103' ' ' ARG . 63.5 mttm 71.44 28.32 2.92 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.777 0.673 . . . . 75.03 111.197 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 100' ' ' ILE . 46.7 mt -100.0 -170.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.432 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HG3' ' HB2' ' A' ' 107' ' ' TYR . 24.7 pttm -119.58 -34.91 3.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.514 0.561 . . . . 75.31 112.514 -172.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -150.03 179.27 8.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.926 0.393 . . . . 75.14 110.758 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -162.16 127.96 3.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.799 -0.815 . . . . 54.41 108.799 170.3 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.53 59.67 4.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.822 -0.704 . . . . 33.53 112.625 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.51 HG23 HD22 ' A' ' 108' ' ' LEU . 88.5 t -116.83 122.51 31.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.977 -0.379 . . . . 72.23 109.977 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 18.0 Cg_exo -66.19 149.32 85.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.884 2.389 . . . . 74.22 113.07 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.6 tptm -65.07 117.59 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 74.42 110.561 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.611 ' HB2' ' HD2' ' A' ' 87' ' ' TYR . 61.2 t80 -89.03 123.03 32.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.342 -0.845 . . . . 75.33 110.121 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -96.4 -67.01 0.87 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.286 -0.635 . . . . 64.4 109.286 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -155.36 -178.13 29.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.423 -0.808 . . . . 75.34 112.144 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 32' ' ' MET . 58.6 p -164.73 163.7 21.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 55.24 109.046 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.26 -168.74 36.84 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.738 -1.22 . . . . 74.22 113.118 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.17 127.28 31.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.534 -0.543 . . . . 61.41 109.534 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -123.46 109.94 14.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.945 -0.571 . . . . 75.23 110.637 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 13.8 t70 -75.7 118.79 18.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.426 -0.583 . . . . 71.23 109.426 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -105.66 94.67 5.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.391 -0.368 . . . . 75.23 111.03 -174.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.1 m120 71.51 -41.78 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.548 0.739 . . . . 72.13 112.846 173.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.89 -38.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.637 -0.792 . . . . 75.04 112.708 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.31 143.54 45.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.896 0.379 . . . . 63.42 110.114 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.87 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.0 p -94.62 149.16 21.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.15 112.134 -174.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.453 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 67.4 m-85 -115.57 145.28 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 73.51 109.968 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -112.45 120.46 41.72 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.01 -0.737 . . . . 72.32 109.01 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.52 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -124.87 162.93 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 72.43 112.042 -170.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.8 ttm -144.88 136.95 25.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 71.11 110.695 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.64 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.2 mm -97.45 127.78 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 74.32 111.021 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 71.1 mtp -121.28 164.2 17.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.526 -0.761 . . . . 74.45 110.426 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.656 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 25.5 t70 -81.26 98.35 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.219 -0.446 . . . . 70.23 111.306 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HG2' ' C ' ' A' ' 132' ' ' ASP . 3.7 ptt180 29.71 95.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.411 1.634 . . . . 65.51 115.411 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.32 151.88 26.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.776 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -165.73 -15.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.38 -1.391 . . . . 71.1 114.967 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.737 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.7 m -120.65 124.7 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.274 1.037 . . . . 64.44 111.682 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.496 ' HB2' ' HG2' ' A' ' 140' ' ' LYS . 1.3 m-20 -101.29 131.05 47.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.855 -0.794 . . . . 73.32 108.855 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.617 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 4.9 mp -61.48 -36.91 81.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 55.32 110.856 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 27.2 pt20 -58.79 -47.92 83.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 137' ' ' ASP . 20.3 ptmt -70.29 -34.85 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 71.54 110.783 -175.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 341' ' ' LEU . 17.1 mt -75.05 -39.77 44.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.515 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -62.44 -43.44 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 73.12 111.957 -175.286 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.86 -40.6 83.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.185 -0.606 . . . . 72.04 110.601 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.89 -31.75 70.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 74.51 111.136 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -88.78 5.66 42.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 54.42 110.392 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.4 41.28 13.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.466 -0.788 . . . . 64.22 112.216 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER 41.75 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.935 0.894 . . . . 72.44 112.668 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 11.6 ttp180 -153.78 93.5 1.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.038 -0.983 . . . . 74.21 109.975 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.669 ' HD2' HG21 ' A' ' 153' ' ' THR . 85.0 m-85 -112.6 137.74 50.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.001 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.6 p -73.31 168.85 18.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.375 -0.375 . . . . 52.34 110.978 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.546 ' HB3' HD11 ' A' ' 328' ' ' LEU . 81.8 mtt180 -55.03 -37.06 66.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.913 -0.585 . . . . 74.14 110.725 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -60.65 -42.94 97.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.352 -0.84 . . . . 73.32 110.572 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.669 HG21 ' HD2' ' A' ' 149' ' ' PHE . 10.2 m -71.76 -52.23 18.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.5 -0.773 . . . . 61.42 111.303 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.82 -42.82 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.41 110.966 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 328' ' ' LEU . 16.9 tp -65.61 -49.47 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.575 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 20.8 mm-40 -58.97 -47.74 84.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.923 0.342 . . . . 71.04 111.923 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.87 -43.92 97.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.472 -0.331 . . . . 73.21 110.892 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t -62.33 -43.04 99.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.15 110.355 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 82.3 mt -61.45 -39.9 92.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.242 -0.436 . . . . 71.31 111.262 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 81.6 mmt-85 -62.73 -49.15 76.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.017 0.437 . . . . 73.31 110.378 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.56 -30.31 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 65.45 110.681 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -47.42 86.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 70.11 110.569 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.46 -42.23 99.32 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.59 0.71 . . . . 65.12 110.097 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.586 ' O ' HG12 ' A' ' 168' ' ' ILE . 61.3 mt -61.44 -46.44 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.225 -0.898 . . . . 63.44 110.74 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.438 ' HG ' ' HE1' ' A' ' 317' ' ' TYR . 64.4 tp -57.69 -39.03 76.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 74.32 110.803 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 103' ' ' ARG . 2.0 mm-40 -56.13 -65.81 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.767 -0.652 . . . . 54.34 110.476 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.453 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 82.2 t80 -63.27 -49.47 73.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.626 -0.715 . . . . 73.3 112.861 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 164' ' ' ILE . 30.7 pt -79.46 -32.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.293 -0.563 . . . . 73.51 112.249 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.777 ' HE1' HG12 ' A' ' 174' ' ' VAL . 2.8 t60 -88.21 -18.19 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.038 -0.665 . . . . 74.31 111.117 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -86.88 21.96 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.907 0.861 . . . . 70.31 109.018 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -131.03 -79.37 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.475 -0.784 . . . . 74.54 111.137 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.755 ' HG2' ' H ' ' A' ' 207' ' ' GLU . 32.3 mt-10 -147.46 -46.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 74.2 111.977 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.96 137.63 35.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.709 . . . . 54.41 112.821 -161.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.777 HG12 ' HE1' ' A' ' 169' ' ' HIS . 33.2 m -106.69 170.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.942 -1.026 . . . . 61.01 109.729 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.741 ' HB3' ' HD2' ' A' ' 198' ' ' TYR . 1.8 p-80 -147.62 103.23 3.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.205 0.526 . . . . 70.03 111.188 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 -28.36 15.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.628 -0.796 . . . . 34.35 111.989 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 199' ' ' GLY . 5.7 t0 -112.94 93.78 4.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.913 0.387 . . . . 74.01 110.059 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 64.8 mt -92.28 -73.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.22 -0.659 . . . . 73.11 109.22 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 180' ' ' ALA . 6.3 tptm 50.76 -139.25 0.94 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.572 -0.529 . . . . 74.22 109.572 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -120.84 -3.58 9.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.408 0.623 . . . . 74.42 109.408 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 39.7 m -77.88 -27.68 49.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.419 -0.81 . . . . 72.44 112.044 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 76.7 m-20 -104.51 6.31 34.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.444 -0.503 . . . . 74.02 111.558 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.72 120.17 40.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.651 . . . . 73.34 109.721 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.582 HD11 ' N ' ' A' ' 47' ' ' GLY . 66.0 mt -120.59 143.67 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.004 -0.544 . . . . 72.41 110.834 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.8 mt -92.5 141.4 28.55 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.334 -0.617 . . . . 63.22 109.334 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.502 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 25.4 t-20 -60.55 139.19 57.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.446 -0.946 . . . . 73.1 108.446 171.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.776 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 71.7 t80 -57.36 -30.52 64.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.718 0.266 . . . . 75.14 111.718 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 83.1 tttt -116.15 -30.52 5.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.48 -0.488 . . . . 73.41 111.799 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 85.2 m-20 -99.46 101.87 14.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.793 0.33 . . . . 63.14 110.888 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 10.2 Cg_exo -71.78 -25.81 19.88 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.995 2.463 . . . . 61.34 113.387 -174.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' HA ' HD23 ' A' ' 339' ' ' LEU . 1.0 OUTLIER -83.69 -4.94 59.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.024 0.44 . . . . 72.43 111.18 -174.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -108.62 97.1 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.386 0.612 . . . . 73.45 110.449 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 160' ' ' ARG . 7.9 p -103.38 130.87 53.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.255 -0.884 . . . . 73.2 109.23 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.502 ' HE2' ' HB2' ' A' ' 186' ' ' ASN . 41.9 m-85 -115.72 155.45 27.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.004 -0.544 . . . . 72.51 110.189 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 2.9 tt -120.52 122.7 41.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.407 -0.59 . . . . 63.43 109.407 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.605 ' CG2' ' HA3' ' A' ' 47' ' ' GLY . 16.5 m -129.17 166.95 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 61.22 110.58 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.0 t70 68.97 -57.9 0.51 Allowed 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.984 0.803 . . . . 74.2 111.842 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.785 ' HB2' ' HB2' ' A' ' 201' ' ' ALA . 93.7 m-85 75.79 5.37 3.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.606 0.762 . . . . 73.23 112.052 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 177' ' ' ASP . . . 82.48 -38.77 2.63 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.37 -0.443 . . . . 65.22 112.946 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.789 ' HA ' ' HA ' ' A' ' 354' ' ' ILE . 1.1 pp -164.38 40.05 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.3 0.24 . . . . 72.32 110.882 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 198' ' ' TYR . . . -53.21 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.549 0.69 . . . . 74.4 111.761 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -123.4 133.58 54.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 172' ' ' GLU . 10.9 ptp180 -77.71 109.74 11.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.324 0.583 . . . . 74.21 109.918 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 2.9 t80 -66.83 -46.18 75.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.305 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 54.6 m -142.42 140.06 18.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.843 -0.799 . . . . 72.23 108.843 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 14.4 Cg_exo -68.1 98.04 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.381 2.054 . . . . 73.24 112.151 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.755 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 33.6 tt0 73.91 -54.7 0.68 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.961 -1.018 . . . . 54.52 111.761 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.11 65.8 2.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.948 -0.644 . . . . 42.44 112.534 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 1.001 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 7.6 p -58.54 112.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.639 0.733 . . . . 71.23 112.411 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -169.45 72.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.374 -0.83 . . . . 74.1 110.575 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -126.15 150.59 48.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 71.44 110.095 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.39 171.64 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.5 -0.318 . . . . 74.54 110.82 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.916 ' HB2' HG21 ' A' ' 236' ' ' VAL . 16.2 p90 -74.54 92.1 2.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.372 0.606 . . . . 74.41 112.517 -168.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 67.5 mmtt -152.64 104.96 2.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.939 -0.573 . . . . 74.14 110.315 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 68.6 mm-40 -136.42 -155.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 64.41 109.855 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 10.7 t70 -85.58 115.31 61.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.913 -0.403 . . . . 72.51 109.913 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PRO . . . . . 0.881 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 28.0 Cg_exo -62.84 0.28 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.688 2.926 . . . . 62.15 114.272 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.22 -48.3 0.78 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.058 -0.401 . . . . 74.34 110.98 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -84.28 43.41 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 71.21 111.732 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.565 ' HB3' ' HA2' ' A' ' 235' ' ' GLY . 41.8 t -131.63 3.08 4.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 53.35 108.864 170.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.7 8.35 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 72.03 110.739 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.14 9.34 17.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 75.15 113.065 -167.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -97.68 164.31 21.86 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.986 -1.246 . . . . 52.34 109.986 169.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 226' ' ' GLU . 14.9 t -68.74 113.15 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.1 0.95 . . . . 73.52 110.069 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.588 HG12 HG11 ' A' ' 271' ' ' VAL . 15.5 tt -57.24 -21.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.043 -0.981 . . . . 54.33 111.831 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.514 ' HG2' ' OG1' ' A' ' 224' ' ' THR . 17.1 pt-20 -60.12 -44.69 94.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 75.21 110.489 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.623 ' HB3' HG23 ' A' ' 246' ' ' ILE . 9.3 m-30 -109.53 -34.67 6.44 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.635 0.606 . . . . 72.11 112.635 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 232' ' ' ALA . 7.4 t -70.9 14.15 0.16 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.543 0.572 . . . . 74.04 112.543 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 227' ' ' PHE . 33.3 t 66.52 -177.23 0.2 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.659 0.743 . . . . 73.41 111.863 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 233' ' ' HIS . 42.3 mt -72.35 -35.15 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.067 -0.97 . . . . 72.13 110.081 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' HB3' HG13 ' A' ' 236' ' ' VAL . 4.1 m-20 -49.9 -56.35 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.64 -1.164 . . . . 72.4 112.334 -174.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.26 -49.69 76.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.473 0.546 . . . . 73.01 112.473 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.443 ' CD2' ' HA ' ' A' ' 230' ' ' ILE . 12.0 p80 -70.82 -16.39 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.546 -0.461 . . . . 73.45 110.61 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.51 -21.22 45.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 73.41 109.909 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.881 ' HA3' ' HA ' ' A' ' 217' ' ' PRO . . . 111.17 20.07 7.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.776 -0.726 . . . . 44.35 113.617 175.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 213' ' ' TYR . 7.3 p -122.17 136.41 59.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.333 -0.51 . . . . 73.23 110.966 175.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.582 ' HB3' ' CE1' ' A' ' 204' ' ' TYR . . . -64.46 125.83 89.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 73.35 110.977 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 33.0 Cg_exo -60.6 130.57 34.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.922 2.415 . . . . 51.4 112.065 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 240' ' ' ARG . 21.9 p -153.21 154.22 34.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.165 -0.47 . . . . 62.32 110.837 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 239' ' ' SER . 4.1 mpt_? 57.09 -100.5 0.11 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.508 0.723 . . . . 74.24 111.23 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 241' ' ' ARG . 6.7 ttp-105 -64.19 -32.09 73.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.031 -0.531 . . . . 71.24 110.282 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.609 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.5 -57.17 21.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.927 -0.654 . . . . 73.31 112.026 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 239' ' ' SER . 4.5 m-20 -57.15 -42.48 81.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 72.24 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.531 HD23 HG12 ' A' ' 306' ' ' VAL . 9.7 mp -61.28 -42.78 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.947 -0.57 . . . . 43.31 111.106 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 279' ' ' ARG . 54.0 tt0 -69.22 -37.68 78.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 34.41 110.795 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 227' ' ' PHE . 69.9 mt -62.47 -41.93 93.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.919 0.39 . . . . 71.24 110.473 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 250' ' ' CYS . 52.8 tp -60.06 -40.41 89.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.97 -0.559 . . . . 61.22 110.436 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.466 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.03 -40.68 97.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.5 -0.857 . . . . 63.35 111.903 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 227' ' ' PHE . 22.1 m-30 -65.6 -41.14 93.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.89 0.329 . . . . 72.03 111.89 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 247' ' ' LEU . 26.4 p -69.06 -34.37 75.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.007 -0.677 . . . . 73.5 110.543 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -66.89 -39.82 87.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.59 -0.277 . . . . 74.42 111.401 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 tt -69.62 -34.32 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.459 -0.497 . . . . 72.31 110.67 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.521 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 3.3 mm100 -68.1 -32.6 73.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.637 0.256 . . . . 54.33 111.402 176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -75.98 -38.1 57.8 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 74.44 111.184 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.3 tp -80.54 -48.04 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.17 0.433 . . . . 72.13 112.17 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 58.9 p -109.66 -27.67 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.16 0.505 . . . . 72.24 111.143 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.485 ' HA3' ' HG3' ' A' ' 147' ' ' LYS . . . 68.32 34.95 81.34 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.45 112.906 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.09 142.84 34.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 72.24 110.903 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.567 ' O ' ' HB2' ' A' ' 262' ' ' GLU . 88.6 mt -117.71 142.62 30.93 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.841 -0.618 . . . . 61.12 109.694 170.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 25.4 Cg_exo -63.94 -49.43 3.98 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 122.379 2.053 . . . . 71.22 111.138 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.435 ' HD1' HD23 ' A' ' 265' ' ' LEU . 30.7 p90 -82.94 25.58 0.67 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 64.35 111.142 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 259' ' ' LEU . 23.0 tt0 -68.37 -48.47 64.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 73.54 111.413 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.7 -32.74 71.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.19 0.519 . . . . 72.3 110.884 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -107.23 22.25 16.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.868 -0.605 . . . . 73.53 111.06 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 265' ' ' LEU . 3.0 tm? -61.33 -24.02 66.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.764 0.792 . . . . 75.33 109.706 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -68.13 -15.82 63.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.7 -1.137 . . . . 65.5 112.064 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.717 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 9.0 t0 -125.78 122.66 24.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.887 0.375 . . . . 64.05 110.638 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.71 -24.04 77.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.295 2.663 . . . . 61.12 113.82 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.5 -48.32 72.97 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.165 0.507 . . . . 74.51 109.952 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 97.4 m-85 -67.33 -38.69 85.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.361 -0.836 . . . . 72.22 110.595 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.588 HG11 HG12 ' A' ' 225' ' ' ILE . 59.1 t -57.28 -49.77 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.204 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 276' ' ' ILE . 16.7 ttp180 -57.66 -54.42 47.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 65.4 110.428 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.95 -48.59 78.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.037 -0.983 . . . . 74.53 111.935 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.7 t -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.398 -0.365 . . . . 55.42 111.237 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 261' ' ' TRP . 96.4 mttt -70.35 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.746 -0.381 . . . . 75.24 110.629 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.6 mt -64.76 -38.5 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.037 0.446 . . . . 71.15 110.007 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.07 -45.71 79.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.623 -0.717 . . . . 74.3 110.963 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -76.09 -32.42 59.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.957 -0.297 . . . . 65.31 111.706 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 275' ' ' LYS . 99.6 mtt180 -60.18 -23.41 63.95 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.581 0.229 . . . . 71.13 110.771 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -50.32 -53.58 27.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.793 -0.64 . . . . 72.51 110.412 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -170.11 99.41 0.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 63.44 109.615 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.21 -34.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 70.03 110.743 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.626 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -60.08 -46.75 88.54 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.6 0.593 . . . . 73.01 112.6 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 15.8 m -60.26 -48.75 80.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.228 0.537 . . . . 73.23 110.993 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.21 -50.21 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 73.02 111.204 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.22 -45.08 94.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 74.54 111.486 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.17 -31.94 73.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 75.01 111.425 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -82.62 -13.21 56.89 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.717 0.294 . . . . 72.44 111.444 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 92.0 m -78.64 -69.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.796 0.295 . . . . 33.33 111.796 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 294' ' ' ASN . 39.2 m-85 -125.29 90.78 50.24 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 112.112 0.412 . . . . 74.01 112.112 -173.296 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -92.49 1.1 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.665 2.243 . . . . 70.43 112.105 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.89 -69.46 0.45 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.307 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 293' ' ' LYS . 3.1 mmmp? -49.56 -61.97 1.81 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.773 -0.649 . . . . 73.54 111.655 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.489 ' H ' ' HB3' ' A' ' 290' ' ' PHE . 15.8 m120 -113.54 -155.72 0.58 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.997 -0.742 . . . . 70.22 108.997 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.687 ' HE3' HG21 ' A' ' 331' ' ' ILE . 26.7 tptp -164.97 87.24 1.04 Allowed Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.774 0.321 . . . . 73.12 110.154 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -100.64 37.29 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.11 2.54 . . . . 73.53 112.171 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.02 -37.74 7.1 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.495 -0.859 . . . . 73.42 111.072 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.667 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 20.9 mp0 -66.95 -47.12 72.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.762 -0.829 . . . . 75.31 108.762 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.8 mp -59.09 -38.96 77.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 114.863 -1.062 . . . . 74.11 110.363 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -59.57 -50.25 74.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.532 -0.304 . . . . 71.34 111.208 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.1 -43.18 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.15 110.107 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.449 ' CE1' HD22 ' A' ' 320' ' ' LEU . 87.7 t80 -56.92 -47.08 81.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.412 -0.813 . . . . 73.04 111.203 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.525 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.2 -41.85 80.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 54.33 111.568 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -60.21 -40.55 90.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 64.14 109.77 175.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 98.4 m -60.28 -50.15 74.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.322 -0.854 . . . . 74.15 111.296 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 19.8 m -70.67 -33.99 55.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.842 0.312 . . . . 73.55 111.842 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -21.12 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.454 -0.498 . . . . 72.21 110.312 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.9 tp -81.49 -5.3 57.82 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.158 -0.474 . . . . 63.25 110.968 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 305' ' ' THR . 90.1 mt -91.17 6.61 44.39 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.776 0.287 . . . . 71.31 111.776 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.595 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 24.3 t70 61.45 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.705 0.628 . . . . 71.41 111.961 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 -52.12 0.31 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.179 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.2 t -149.12 29.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.761 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 42.6 mm-40 -51.89 -62.87 1.36 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.45 -0.341 . . . . 75.41 111.028 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -171.12 102.27 0.4 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.502 -0.317 . . . . 73.34 110.398 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.4 118.85 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.538 2.159 . . . . 71.54 111.576 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.3 mt -114.33 92.83 4.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.453 -0.34 . . . . 63.53 111.354 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' A' ' 165' ' ' LEU . 97.5 m-85 -57.66 -34.07 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.164 0.507 . . . . 71.23 110.084 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.37 -55.33 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.055 -0.975 . . . . 61.43 111.027 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.97 -41.55 95.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.969 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 67.3 mt -56.96 -53.3 59.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.32 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 322' ' ' ASP . 11.0 ptt180 -65.26 -36.53 84.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.928 0.394 . . . . 60.13 110.207 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.508 ' N ' ' HG3' ' A' ' 321' ' ' ARG . 30.0 t70 -68.23 -51.21 47.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.819 -0.628 . . . . 74.43 111.63 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.88 -31.23 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.924 -0.311 . . . . 73.51 111.14 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.41 -48.87 59.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.372 -0.376 . . . . 73.22 110.571 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -39.88 83.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.11 110.046 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.23 -48.43 81.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 61.43 111.197 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.667 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.36 -46.15 91.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 33.3 112.085 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -60.96 -45.21 95.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 62.21 110.841 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -70.25 -26.91 64.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.016 0.436 . . . . 70.01 110.583 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.24 -29.28 63.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.537 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.687 HG21 ' HE3' ' A' ' 295' ' ' LYS . 32.6 pt -90.19 -5.51 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 63.11 111.063 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 91.58 23.91 27.34 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.782 -0.723 . . . . 62.12 113.405 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -127.22 138.53 53.13 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.438 -0.448 . . . . 73.12 110.373 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 334' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 334' ' ' LYS . 9.9 mtpm? -138.66 -113.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.329 . . . . 73.34 111.647 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -159.73 113.93 2.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.507 0.67 . . . . 74.1 111.578 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.6 156.04 4.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.851 -1.068 . . . . 65.03 109.263 172.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.33 50.74 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.288 -0.725 . . . . 63.24 111.288 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 59.09 66.31 1.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.173 -0.514 . . . . 60.23 110.701 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.562 HD12 HG23 ' A' ' 153' ' ' THR . 4.2 mm? 68.1 -171.54 0.19 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.059 -0.973 . . . . 75.52 111.352 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -122.78 17.7 10.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.736 0.779 . . . . 70.31 108.904 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 141' ' ' ILE . 6.1 tt -125.68 108.37 11.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.384 -0.825 . . . . 73.52 110.839 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.1 m -143.45 16.74 1.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.812 -0.631 . . . . 74.44 109.775 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.08 -34.93 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 73.13 112.323 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.5 t 54.89 91.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.122 0.487 . . . . 73.44 111.411 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.32 168.85 12.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.456 -0.338 . . . . 51.43 110.969 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.403 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 59.3 t30 -136.98 143.49 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 74.22 110.531 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -161.26 -77.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.101 -0.571 . . . . 54.01 111.717 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -130.83 166.31 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.034 -0.603 . . . . 74.22 111.63 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 19' ' ' LEU . 2.6 pt? -165.25 141.59 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.912 0.387 . . . . 63.34 110.486 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -125.06 165.42 18.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 74.02 110.258 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.75 46.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.124 -0.695 . . . . 54.04 109.124 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 353' ' ' THR . 12.8 tptp -143.44 -157.14 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.821 -0.437 . . . . 61.41 109.821 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 353' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 14.8 t -173.48 156.27 2.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.376 -0.602 . . . . 72.42 109.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.789 ' HA ' ' HA ' ' A' ' 200' ' ' LEU . 0.2 OUTLIER -67.43 131.81 32.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.097 0.475 . . . . 62.12 111.204 -176.322 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 355' ' ' THR . 7.6 t -78.61 85.29 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.182 0.992 . . . . 61.1 110.752 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -109.25 -29.4 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.534 -0.757 . . . . 74.42 110.499 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 356' ' ' LYS . 61.3 tttm 172.23 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 108.529 -0.915 . . . . 74.14 108.529 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.4 ' HG2' ' HG2' ' A' ' 359' ' ' LYS . 54.8 ttm-85 173.1 -64.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.477 -1.238 . . . . 72.32 108.413 176.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 359' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 360' ' ' LYS . 49.1 pttt -178.09 -38.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.578 -1.192 . . . . 72.54 108.084 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.535 ' HG2' ' HG3' ' A' ' 359' ' ' LYS . 29.9 mmmt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.746 -1.121 . . . . 73.24 108.489 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.252 -0.277 . . . . 72.21 110.252 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.93 138.55 44.66 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.393 2.062 . . . . 63.3 111.981 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -134.5 140.35 46.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 74.12 110.259 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.5 t -85.6 98.69 6.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.24 0.543 . . . . 73.12 110.496 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -114.66 130.18 56.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.504 -0.771 . . . . 62.5 109.753 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.7 149.03 31.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 64.01 110.949 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.4 84.56 2.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.908 -0.587 . . . . 61.35 110.29 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -77.41 133.58 38.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.105 -0.498 . . . . 70.42 109.911 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.15 136.31 47.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.332 -0.395 . . . . 74.34 110.855 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.69 119.49 4.94 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.115 -0.794 . . . . 54.03 111.115 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -97.56 -171.38 2.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 64.54 110.933 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -124.22 145.22 49.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.0 -0.546 . . . . 71.1 110.028 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -97.59 122.74 41.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.41 -0.359 . . . . 74.14 110.616 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -123.28 31.37 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.084 0.468 . . . . 72.22 111.097 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.56 89.36 3.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.162 0.506 . . . . 61.22 110.275 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 35.7 ttpt -97.41 94.3 6.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.89 -0.596 . . . . 74.52 110.741 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -177.24 140.89 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 74.13 110.82 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -121.09 28.32 7.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.851 -0.796 . . . . 74.02 108.851 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.0 143.33 25.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.666 -0.697 . . . . 73.34 110.092 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.48 -75.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.798 0.686 . . . . 64.55 109.776 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -137.85 74.95 1.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.607 -0.724 . . . . 71.52 110.328 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 60.65 87.48 0.09 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.931 -1.032 . . . . 74.32 111.665 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -81.64 81.49 7.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.605 0.716 . . . . 75.43 109.789 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.24 -55.03 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.192 -1.367 . . . . 75.42 107.834 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' HD3' ' A' ' 42' ' ' PRO . 61.5 t -66.37 108.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.933 -1.031 . . . . 71.3 109.001 169.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.599 -0.81 . . . . 74.03 112.687 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.1 147.07 43.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 117.202 0.501 . . . . 74.23 110.097 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -106.72 115.88 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.933 -0.576 . . . . 74.14 109.629 176.124 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 37' ' ' TRP . 14.9 pt -97.49 141.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.923 -0.581 . . . . 54.42 110.538 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 112.08 23.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.012 -0.54 . . . . 73.33 111.117 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.691 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 11.7 t70 -93.62 -179.2 4.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.64 -0.874 . . . . 62.31 108.64 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' MET . . . . . 0.59 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 17.1 mmt -73.35 -13.76 61.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.416 0.524 . . . . 30.41 112.416 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HH2' ' A' ' 37' ' ' TRP . . . -84.73 2.58 41.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.869 0.366 . . . . 63.04 110.727 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 32.2 ttmt 48.26 73.44 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.907 0.883 . . . . 73.04 112.561 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.873 ' H ' ' HZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -143.61 -154.96 0.56 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.321 -1.363 . . . . 72.42 107.321 173.648 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 3.1 mp0 -123.27 102.12 7.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.16 0.505 . . . . 72.24 111.029 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.873 ' HZ3' ' H ' ' A' ' 35' ' ' LYS . 3.8 m-90 -85.04 104.85 15.33 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.925 -0.769 . . . . 75.25 108.925 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -79.5 122.26 26.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.505 . . . . 73.11 110.832 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 52' ' ' TYR . 60.6 t -74.79 107.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.733 -0.469 . . . . 73.14 109.733 174.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -61.13 4.56 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.779 -0.724 . . . . 23.24 112.116 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 pt? -159.64 152.06 17.55 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.066 -0.346 . . . . 64.15 110.066 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.4 Cg_exo -73.91 101.83 1.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.742 2.295 . . . . 74.01 111.562 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 53' ' ' LEU . 65.0 mt -66.74 -42.78 89.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 73.03 109.72 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.96 -31.38 8.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.64 -0.79 . . . . 75.14 111.873 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 349' ' ' LEU . 2.0 tm0? -140.81 129.86 23.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.581 0.705 . . . . 64.11 110.925 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 39.43 0.12 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 108.239 -1.944 . . . . 61.52 108.239 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.34 122.76 4.96 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.456 -1.058 . . . . 72.2 110.456 -166.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.703 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 6.3 t80 66.91 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.129 0.572 . . . . 64.21 111.262 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.5 165.22 16.89 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.208 -0.52 . . . . 72.13 111.938 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.88 35.13 21.8 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.231 0.538 . . . . 71.2 110.892 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 71' ' ' LYS . 43.0 mm -88.44 138.53 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 65.11 111.051 -175.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 30.0 m-85 -108.28 157.23 18.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.813 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 43' ' ' ILE . 59.6 tp -94.35 136.61 34.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 71.23 109.776 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.1 103.31 15.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.602 0.239 . . . . 70.23 110.443 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 56' ' ' MET . 27.8 t70 -79.37 -25.6 42.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 63.34 110.327 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.508 ' HE3' ' HA ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER 67.26 163.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.375 -0.83 . . . . 71.14 110.804 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -87.44 65.92 8.85 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.048 -0.723 . . . . 72.12 109.048 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.9 m -77.36 70.12 3.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 63.22 110.709 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 p -66.89 -56.73 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.592 -0.731 . . . . 71.54 111.06 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -137.33 7.62 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 71.12 110.45 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -137.25 82.24 1.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.918 -0.583 . . . . 71.53 110.476 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.9 p -82.28 142.52 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 72.12 110.885 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.18 -165.87 36.92 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 52.35 111.594 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.1 t -75.16 62.63 1.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.937 0.399 . . . . 64.34 110.79 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HB3' HH12 ' A' ' 133' ' ' ARG . 0.1 OUTLIER 67.44 26.83 8.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.492 -0.776 . . . . 71.54 111.346 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.73 83.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 123.851 0.719 . . . . 71.35 111.1 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 133' ' ' ARG . 4.1 Cg_exo -80.14 38.86 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.014 2.476 . . . . 73.44 111.504 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . 0.439 ' HB2' HG23 ' A' ' 130' ' ' ILE . 6.9 p -145.3 138.18 26.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.549 0.69 . . . . 60.04 112.771 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.75 165.76 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.061 -0.972 . . . . 70.22 108.409 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.676 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -119.83 120.15 62.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.841 0.829 . . . . 71.02 112.68 -178.106 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HA ' HD12 ' A' ' 51' ' ' ILE . 22.1 tptm -84.21 125.8 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 113.198 -1.819 . . . . 70.3 108.662 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.01 150.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.566 0.58 . . . . 50.01 112.566 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -152.2 135.25 9.25 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.388 -0.824 . . . . 72.42 109.11 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 -166.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.322 2.015 . . . . 73.2 111.715 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.4 m -74.68 60.29 0.91 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.215 0.531 . . . . 60.35 110.869 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -105.56 -38.99 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.347 -0.612 . . . . 71.34 109.347 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.65 76.01 0.33 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.135 -0.938 . . . . 62.12 110.523 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -152.24 -99.09 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.246 -0.978 . . . . 23.31 112.733 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 49.0 Cg_exo -56.9 -45.59 35.23 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.127 2.552 . . . . 71.41 113.614 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -68.98 -41.02 78.44 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.999 -0.28 . . . . 62.3 110.815 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 85.1 t80 -61.37 -47.55 85.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.928 0.394 . . . . 74.02 110.289 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 m -66.1 -42.59 89.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.596 . . . . 74.11 110.587 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 87' ' ' TYR . 36.4 tt0 -64.88 -40.62 95.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.655 -0.702 . . . . 63.14 110.419 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.95 -39.28 85.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 72.3 110.535 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 10.9 mmpt? -59.02 -44.66 91.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.304 -0.407 . . . . 63.31 110.202 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.69 -49.55 77.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.764 -0.653 . . . . 75.31 110.836 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.547 ' HE2' ' HG2' ' A' ' 83' ' ' GLU . 56.3 m-85 -64.01 -38.32 90.65 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.651 -0.249 . . . . 73.12 111.426 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -61.42 -37.41 83.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.813 0.34 . . . . 53.52 110.78 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -88.26 -27.19 21.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.928 0.344 . . . . 74.51 111.928 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.58 16.05 25.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 60.25 111.893 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -76.05 163.87 26.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.039 0.385 . . . . 63.12 112.039 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.1 mmtt 75.89 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.161 -0.927 . . . . 75.31 112.425 175.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 -35.69 98.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.492 2.795 . . . . 75.51 113.184 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.44 -41.89 90.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 72.02 110.863 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.57 -42.32 78.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 70.3 109.797 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 92' ' ' LYS . 59.2 mt -57.8 -53.48 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 64.1 110.572 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.9 mm-40 -60.29 -31.83 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 74.33 111.332 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -58.76 -56.36 23.25 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.238 0.336 . . . . 70.05 110.686 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.757 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.81 -34.19 73.35 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.303 -0.559 . . . . 72.51 110.735 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 107' ' ' TYR . 56.7 mt -58.13 -50.5 78.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.786 -0.188 . . . . 74.22 111.055 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -66.51 -38.44 87.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 73.2 110.621 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -67.57 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 60.51 111.402 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -78.03 -15.34 59.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.464 . . . . 71.14 110.965 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 68.77 33.21 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.64 -0.709 . . . . 71.23 110.697 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 106' ' ' LYS . 21.1 tp -81.95 177.13 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.985 -1.117 . . . . 74.41 107.985 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' H ' ' HG ' ' A' ' 105' ' ' LEU . 20.2 mmtm -103.15 -49.89 3.63 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.949 -0.7 . . . . 75.02 111.816 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . 0.703 ' HE2' ' HD3' ' A' ' 160' ' ' ARG . 34.4 p90 -162.0 -176.98 5.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 73.43 111.428 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 52.8 tp -133.22 131.76 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.569 -0.53 . . . . 62.54 109.569 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.4 57.64 4.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.868 -0.682 . . . . 72.35 112.66 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.19 131.47 22.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.303 . . . . 60.24 110.47 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.48 145.76 72.0 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 73.1 111.923 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -58.83 129.11 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.805 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -100.48 128.94 46.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 70.53 109.919 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CG ' HG22 ' A' ' 130' ' ' ILE . 43.6 m95 -100.69 -62.96 1.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.492 . . . . 74.21 109.945 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.83 -157.79 15.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.637 -0.71 . . . . 42.12 112.223 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 32' ' ' MET . 14.0 p -169.07 152.4 5.11 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.551 -0.537 . . . . 74.53 109.551 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -158.7 -164.92 14.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.028 -1.082 . . . . 70.22 113.315 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.3 137.06 42.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.741 0.305 . . . . 74.32 110.477 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' HIS . . . . . 0.454 ' CG ' HG22 ' A' ' 29' ' ' ILE . 72.8 t60 -140.75 113.18 8.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.841 0.353 . . . . 71.33 110.241 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 32.8 t70 -72.43 126.39 29.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.059 -0.519 . . . . 64.1 110.422 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 122' ' ' ASN . 46.1 tptt -89.42 25.13 2.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.247 0.546 . . . . 64.0 109.539 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 4.5 m-20 74.25 63.99 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.305 -0.861 . . . . 72.31 110.158 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.4 -54.04 0.72 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.794 -1.094 . . . . 62.54 111.33 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -112.91 121.98 46.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.972 -0.381 . . . . 60.43 109.972 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 47.3 m -86.68 117.57 25.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.596 -0.52 . . . . 74.52 109.596 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -91.18 140.45 29.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.066 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -99.22 133.99 42.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.589 -0.523 . . . . 72.0 109.589 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.606 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 43.9 p90 -128.78 161.12 30.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.557 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 48.2 ttp -139.52 133.26 30.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.977 -0.556 . . . . 74.43 110.099 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.676 HD13 ' HB ' ' A' ' 70' ' ' VAL . 13.1 mm -96.43 123.99 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.183 0.515 . . . . 74.12 110.296 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.4 ptm -137.13 -178.09 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 75.22 110.671 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.49 154.8 34.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.085 0.469 . . . . 75.53 110.833 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 67' ' ' PRO . 28.9 ptt180 -89.88 124.17 34.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.723 -0.671 . . . . 72.24 112.199 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 26.0 m-85 -103.05 160.31 14.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 65.51 109.832 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.727 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -145.44 -25.81 0.1 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.089 -1.053 . . . . 64.3 113.252 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.752 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 58.8 m -121.48 126.42 49.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.876 0.338 . . . . 73.34 111.694 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -98.04 134.94 40.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 72.53 109.929 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 61.52 111.211 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.451 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 22.9 tp60 -58.33 -49.31 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.452 . . . . 74.45 112.104 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 137' ' ' ASP . 20.5 pttm -85.61 -20.92 28.78 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.981 -0.687 . . . . 75.33 111.009 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.96 -46.35 79.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.277 0.56 . . . . 71.34 109.647 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.731 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -67.32 -32.76 73.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.792 . . . . 70.25 110.514 176.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.69 -54.92 8.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.948 -0.569 . . . . 75.13 111.405 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.51 72.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 54.33 111.76 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -87.4 0.53 55.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 73.32 110.167 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 53.86 52.35 13.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.454 -0.794 . . . . 75.41 112.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.1 OUTLIER 40.08 75.96 0.07 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.53 0.732 . . . . 62.42 112.257 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 18.2 ttp180 -149.79 79.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.582 -0.736 . . . . 73.34 109.235 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.731 ' HZ ' ' HA ' ' A' ' 142' ' ' TYR . 38.3 m-85 -111.02 156.47 21.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.121 0.486 . . . . 73.32 111.702 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 154' ' ' VAL . 42.0 p -68.02 152.1 46.03 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.373 -0.83 . . . . 61.14 110.197 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.584 ' HG2' HD23 ' A' ' 328' ' ' LEU . 41.0 ttm105 -66.56 -26.38 67.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.963 0.411 . . . . 71.35 110.186 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.22 -43.89 69.73 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.171 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.465 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 21.2 p -68.27 -44.64 75.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 72.2 110.943 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 150' ' ' SER . 92.6 t -57.61 -42.84 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 65.35 111.152 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 324' ' ' LEU . 2.5 mm? -64.9 -42.37 94.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.52 -0.309 . . . . 75.43 111.001 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 17.8 mm-40 -59.97 -46.01 90.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.49 0.186 . . . . 61.01 110.858 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 153' ' ' THR . 98.7 mt -59.62 -41.15 89.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.888 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.7 t -59.57 -47.11 86.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 63.35 111.006 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 325' ' ' LEU . 10.1 mp -63.8 -37.92 89.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 45.32 111.388 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.703 ' HD3' ' HE2' ' A' ' 107' ' ' TYR . 15.3 mmt180 -57.88 -52.59 64.84 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.465 -0.568 . . . . 72.51 109.465 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.0 -49.75 82.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.093 -0.958 . . . . 73.3 110.784 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.63 -54.54 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.948 0.351 . . . . 63.1 111.948 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.55 -48.6 76.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.579 0.228 . . . . 64.11 111.362 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 167' ' ' TYR . 16.7 tt -72.34 -36.63 55.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 120.428 -0.509 . . . . 61.51 111.21 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.4 -38.27 81.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 73.25 110.924 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 34.1 mm-40 -76.78 -23.95 52.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.842 -0.343 . . . . 54.23 110.517 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 164' ' ' ILE . 69.6 t80 -58.39 -48.65 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.31 110.076 172.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.6 pt -80.27 -32.29 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.54 -0.3 . . . . 72.04 111.372 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.756 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 4.9 m170 -56.55 -44.18 80.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.935 0.346 . . . . 75.22 111.935 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.15 12.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 65.43 111.41 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -120.97 -72.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.268 -0.424 . . . . 71.21 109.905 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 203' ' ' ARG . 9.2 pt-20 -177.3 -35.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.541 0.571 . . . . 73.04 112.541 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.56 135.85 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 74.31 111.005 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 28.7 m -129.8 142.9 42.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.593 -0.731 . . . . 54.03 109.536 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.563 ' CE1' ' HB3' ' A' ' 200' ' ' LEU . 3.6 t60 -100.96 -47.07 4.9 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.788 -0.365 . . . . 63.42 110.1 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.971 ' HA2' ' HB3' ' A' ' 243' ' ' ASP . . . 73.23 -62.14 1.79 Allowed Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.918 -0.658 . . . . 72.23 111.979 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 4.9 t70 -55.08 111.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.199 0.6 . . . . 61.01 112.457 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.62 43.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.45 0.643 . . . . 62.22 109.585 170.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -81.6 145.44 30.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.608 -0.516 . . . . 64.15 109.608 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.08 -2.14 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.835 0.68 . . . . 71.03 112.835 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 4.7 p -76.91 -26.44 54.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.709 0.263 . . . . 74.34 111.709 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.61 -0.61 31.7 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 111.787 0.291 . . . . 75.41 111.787 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.77 111.19 23.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 75.04 109.973 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.3 mm? -114.26 136.07 53.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.087 -0.506 . . . . 64.35 110.598 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.5 mt -93.58 141.71 28.16 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.82 -0.627 . . . . 71.53 110.141 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.98 138.74 58.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.528 -0.545 . . . . 74.21 109.528 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' TYR . . . . . 0.727 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 64.0 t80 -57.99 -30.91 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.37 0.508 . . . . 74.24 112.37 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 26.5 tptp -101.58 -44.25 5.64 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.808 -0.357 . . . . 72.51 111.125 -176.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.594 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 4.4 m120 -102.01 104.85 38.78 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 63.1 111.505 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.66 ' HB3' HG21 ' A' ' 343' ' ' VAL . 17.4 Cg_exo -68.42 -14.21 39.44 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.208 2.605 . . . . 45.15 112.247 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.544 ' HA ' ' HG ' ' A' ' 339' ' ' LEU . 6.7 p-10 -88.48 -3.8 58.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.889 -0.596 . . . . 73.01 110.799 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' A' ' 189' ' ' ASN . 72.3 mt-30 -109.64 96.99 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 73.42 110.524 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.1 p -103.55 134.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 70.44 109.969 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 64.2 m-85 -125.2 157.28 36.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.016 -0.538 . . . . 75.24 110.202 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 72.7 mt -103.1 127.5 50.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.199 -0.455 . . . . 64.35 110.066 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 184' ' ' LEU . 7.6 p -139.37 170.78 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.624 -0.51 . . . . 71.04 109.624 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 196' ' ' VAL . 69.1 m-20 65.12 56.81 0.99 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.002 0.906 . . . . 75.03 109.617 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.456 ' HD2' ' HB2' ' A' ' 201' ' ' ALA . 4.5 m-85 -73.91 39.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.365 -1.289 . . . . 74.03 112.809 -176.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -81.15 47.39 3.57 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.262 -0.735 . . . . 53.15 111.262 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 tt -170.98 44.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 70.45 108.096 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . . . -133.04 106.07 7.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 72.34 110.268 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -115.72 -177.45 3.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.096 -0.502 . . . . 74.13 110.44 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' A' ' 172' ' ' GLU . 58.8 mtt-85 -104.54 117.81 35.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.274 -0.421 . . . . 74.44 111.388 -170.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -87.99 -45.3 10.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.181 0.515 . . . . 74.33 110.239 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 172' ' ' GLU . 11.0 p -128.81 66.33 75.15 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.889 -0.596 . . . . 60.54 110.838 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.55 143.9 76.55 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.645 2.23 . . . . 63.53 112.349 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 74.07 6.74 4.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.436 -0.802 . . . . 75.42 111.144 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.03 10.92 74.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.097 -0.573 . . . . 42.13 112.471 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 40.4 t -116.71 128.14 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.646 -0.501 . . . . 75.11 109.646 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -64.66 141.63 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.855 -0.424 . . . . 65.13 109.855 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -114.34 166.47 11.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 72.41 111.332 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -72.89 144.67 47.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 64.04 110.152 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.452 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 53.6 p90 -68.2 147.46 52.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.42 -0.585 . . . . 72.0 109.42 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 2.3 mptp? -90.58 -69.26 0.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.346 0.869 . . . . 60.23 113.346 -167.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 9.3 mm-40 63.35 71.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.627 -0.879 . . . . 73.31 108.627 -165.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.6 146.22 68.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.901 -1.045 . . . . 64.15 111.004 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.41 -24.59 71.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.78 2.32 . . . . 74.31 113.379 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -103.0 -39.58 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.962 -0.384 . . . . 63.53 109.962 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 93.0 mtt-85 74.03 117.62 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.317 -0.856 . . . . 43.04 110.974 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.634 ' SG ' ' HA2' ' A' ' 235' ' ' GLY . 9.1 p -57.57 -48.97 77.89 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 113.448 0.907 . . . . 70.44 113.448 -170.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 12.8 p-80 46.81 32.69 1.86 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.271 0.629 . . . . 72.12 111.998 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.18 -41.61 76.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.287 0.477 . . . . 75.01 112.287 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 200' ' ' LEU . . . -77.27 153.14 40.87 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.671 -0.776 . . . . 72.42 112.866 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -70.2 122.39 19.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.09 0.471 . . . . 65.23 110.551 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.87 -12.91 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.959 -0.564 . . . . 55.33 111.709 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' GLU . . . . . 0.493 ' HA ' HD21 ' A' ' 265' ' ' LEU . 38.5 tt0 -55.34 -59.54 4.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.555 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.82 -33.05 7.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.11 -0.496 . . . . 72.11 110.103 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 98.5 m -58.0 121.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.701 0.763 . . . . 74.15 110.84 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.625 ' H ' HD11 ' A' ' 246' ' ' ILE . 47.7 t -56.61 166.38 0.94 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.105 -1.407 . . . . 73.2 111.758 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 230' ' ' ILE . 37.5 mt -55.15 -51.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.436 -0.802 . . . . 54.34 110.608 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -56.16 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 51.22 111.504 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.45 97.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 73.44 111.817 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 39.0 t60 -76.24 -17.53 59.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 61.42 110.467 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 219' ' ' ARG . 6.0 t30 -80.66 -8.41 59.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.597 -0.729 . . . . 72.43 111.683 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.634 ' HA2' ' SG ' ' A' ' 220' ' ' CYS . . . 86.7 24.14 39.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.055 -1.069 . . . . 65.34 112.843 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 213' ' ' TYR . 10.0 p -120.51 140.98 42.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.303 -0.629 . . . . 71.53 109.303 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.46 113.56 7.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.662 0.268 . . . . 54.12 110.771 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.48 134.93 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.587 2.191 . . . . 55.1 112.117 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 34.9 p -79.36 -164.52 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.969 -0.56 . . . . 64.34 109.66 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -62.93 -19.28 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.453 -0.499 . . . . 74.44 109.965 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -63.32 -30.55 71.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.909 -0.587 . . . . 64.3 111.116 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.25 -66.65 2.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.05 -0.595 . . . . 73.54 112.502 -175.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.971 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -76.8 -29.77 56.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.252 0.464 . . . . 74.5 112.252 -174.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.99 -34.2 77.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 70.13 110.981 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.99 -34.31 61.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.503 -0.554 . . . . 44.51 109.503 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.625 HD11 ' H ' ' A' ' 229' ' ' SER . 93.7 mt -64.41 -37.77 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 71.41 110.393 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 47.9 tp -61.5 -40.2 93.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 174.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.15 99.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.601 -0.809 . . . . 61.21 111.743 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -54.37 -57.14 12.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.844 0.354 . . . . 73.24 111.218 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.2 p -67.21 -40.94 86.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 73.1 111.993 -174.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.12 -47.57 85.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.672 0.272 . . . . 72.3 111.42 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.34 -29.24 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.414 -0.514 . . . . 71.02 110.253 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -67.55 -46.8 71.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.595 -0.275 . . . . 73.1 110.543 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -61.96 -31.28 71.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.352 -0.385 . . . . 62.55 110.588 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.59 -41.2 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.015 -0.539 . . . . 71.01 112.089 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 67.1 p -101.92 -27.89 12.71 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.186 0.439 . . . . 71.11 112.186 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 96.96 -5.07 63.39 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.488 -0.863 . . . . 71.5 113.694 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -150.83 144.07 24.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.799 0.8 . . . . 53.51 112.458 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.447 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 60.3 mt -122.5 138.9 29.94 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.198 -0.91 . . . . 71.21 108.871 166.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 46.2 Cg_exo -58.19 -34.79 98.91 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.728 2.285 . . . . 51.12 113.309 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.516 ' HB2' HG12 ' A' ' 271' ' ' VAL . 36.7 p90 -95.3 2.92 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.646 -0.252 . . . . 72.14 111.438 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.86 -33.84 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.889 0.376 . . . . 74.31 110.492 -177.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.42 -28.64 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.723 0.773 . . . . 74.55 109.309 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 270' ' ' TYR . 57.3 m-20 -86.23 7.14 26.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.069 -0.968 . . . . 43.01 110.497 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.7 tm? -54.94 -35.32 64.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 63.43 111.243 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.57 14.88 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.817 0.673 . . . . 72.04 112.817 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.7 t70 -139.89 113.98 7.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.733 0.301 . . . . 73.11 110.325 174.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.87 -30.81 92.72 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.41 2.74 . . . . 73.15 113.777 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -69.2 -44.54 71.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.694 0.283 . . . . 71.25 110.647 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 264' ' ' ASN . 43.8 m-85 -66.71 -49.97 64.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 61.14 111.669 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 261' ' ' TRP . 19.4 m -62.5 -35.81 71.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.131 -0.227 . . . . 74.23 111.585 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 276' ' ' ILE . 30.1 ttm180 -63.06 -53.27 56.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.6 -0.273 . . . . 72.33 110.334 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.66 -40.0 88.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 52.52 111.14 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.7 m -61.66 -44.69 96.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.451 -0.341 . . . . 45.33 111.34 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.71 -33.6 71.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.709 0.29 . . . . 75.12 110.868 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 272' ' ' ARG . 77.4 mt -67.21 -43.88 88.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.948 0.404 . . . . 71.32 109.981 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -63.0 -36.15 82.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.851 -0.613 . . . . 73.03 110.293 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.29 -46.3 89.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 74.12 111.026 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -64.5 -26.35 68.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.924 0.392 . . . . 71.34 110.866 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.13 -32.17 50.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 63.14 111.32 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' ASN . . . . . 0.635 ' HB3' HD23 ' A' ' 285' ' ' LEU . 8.5 t-20 -136.05 53.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.947 0.403 . . . . 74.25 110.389 -172.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -57.0 -44.45 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 113.577 0.954 . . . . 74.32 113.577 -171.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.445 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -69.8 -47.32 63.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.866 0.321 . . . . 64.23 111.866 -170.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.4 t -68.36 -45.15 73.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.511 -0.313 . . . . 73.01 110.74 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.0 mm? -61.21 -53.44 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 64.3 111.575 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 286' ' ' MET . . . . . 0.487 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.1 OUTLIER -59.7 -42.79 93.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.743 0.275 . . . . 75.51 111.743 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.07 -37.33 85.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.131 0.491 . . . . 73.34 111.088 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -89.85 1.72 55.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 73.25 111.624 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 90.4 m -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 63.13 110.707 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 14.8 t80 -132.81 86.97 42.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 71.43 109.223 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.9 34.35 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.431 2.754 . . . . 75.52 112.847 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 51.5 mt-10 -120.59 -165.67 1.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 73.31 110.293 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -92.04 85.55 5.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.084 0.469 . . . . 74.13 110.661 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.27 -165.64 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.99 -0.744 . . . . 64.31 108.99 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.791 ' HD3' HD12 ' A' ' 331' ' ' ILE . 21.7 mtpp -120.48 90.14 45.14 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.483 0.183 . . . . 72.1 111.489 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -99.53 36.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.94 2.427 . . . . 73.21 111.395 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.56 -42.9 3.53 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.795 -0.717 . . . . 70.44 112.031 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -56.84 -46.08 81.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.968 0.413 . . . . 75.11 110.128 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.16 -41.24 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.895 -0.593 . . . . 71.21 110.586 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.91 -50.14 74.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 73.42 111.171 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.469 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 320' ' ' LEU . 73.1 t80 -56.19 -46.54 79.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 72.4 110.843 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.533 ' HA ' HG22 ' A' ' 306' ' ' VAL . 94.8 mmm -71.46 -39.37 70.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.814 -0.63 . . . . 63.25 111.209 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 25.2 tt0 -58.66 -50.03 75.37 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.771 0.796 . . . . 72.1 109.369 174.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 88.9 m -57.65 -50.97 71.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.702 -1.136 . . . . 73.03 111.733 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 303' ' ' MET . 33.7 m -67.21 -27.22 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 112.21 0.448 . . . . 45.43 112.21 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -80.33 -19.86 45.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.363 -0.535 . . . . 72.13 110.339 -179.539 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 30.4 tp -94.41 17.84 12.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.116 -0.493 . . . . 63.21 111.143 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 315' ' ' PRO . 92.2 mt -93.77 -12.78 28.38 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.282 0.475 . . . . 51.25 112.282 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 313' ' ' GLU . 13.2 t70 58.48 -164.37 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.591 0.356 . . . . 74.23 110.123 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.455 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.3 m-85 -64.93 -52.07 58.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 63.53 110.416 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 19.8 m -155.16 69.05 0.7 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.222 0.534 . . . . 75.14 111.023 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 310' ' ' ASP . 25.2 mt-10 -104.99 33.43 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 64.12 109.493 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 25.4 mttt 64.53 103.53 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.219 0 CA-C-N 114.512 -1.222 . . . . 75.1 112.239 -176.436 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.557 ' HA ' HD22 ' A' ' 309' ' ' LEU . 19.6 Cg_endo -63.22 136.49 56.04 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.284 1.989 . . . . 63.22 110.49 170.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 92.9 mt -79.19 79.82 5.59 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.857 -0.337 . . . . 61.41 110.699 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 315' ' ' PRO . 17.2 m-85 -53.41 -48.5 68.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.495 -0.775 . . . . 72.15 109.948 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -63.04 -53.24 56.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.848 -1.069 . . . . 61.3 111.785 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 27.0 t-20 -59.77 -51.37 70.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.747 -0.206 . . . . 62.42 111.333 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 302' ' ' TYR . 95.5 mt -59.16 -48.75 80.46 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.948 0.404 . . . . 75.41 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -62.3 -40.56 96.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 73.02 110.203 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.72 -49.38 47.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 63.41 111.51 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.79 -33.61 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.872 -0.331 . . . . 74.13 111.323 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 155' ' ' LEU . 88.7 mt -69.9 -49.37 52.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 74.43 110.591 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 159' ' ' LEU . 82.5 mt -67.04 -34.07 76.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 72.52 111.031 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 57.3 tt0 -64.12 -47.67 79.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.48 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.77 79.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.69 -0.767 . . . . 73.22 111.975 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.584 HD23 ' HG2' ' A' ' 151' ' ' ARG . 3.1 tm? -68.23 -49.54 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.094 0.473 . . . . 73.52 110.336 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 333' ' ' SER . 85.6 tttt -71.87 -34.34 69.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 72.21 111.065 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -27.32 67.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.173 0.434 . . . . 71.41 112.173 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.791 HD12 ' HD3' ' A' ' 295' ' ' LYS . 15.6 tt -86.25 -6.3 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.416 -0.514 . . . . 73.2 110.87 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 110.64 24.45 5.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.278 -0.963 . . . . 54.41 113.875 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 13.3 t -119.47 149.57 41.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.332 0.566 . . . . 44.43 110.082 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -162.7 27.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.551 -0.907 . . . . 72.43 108.551 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.49 105.87 17.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.311 -1.313 . . . . 73.04 110.804 -170.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.2 -21.16 5.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 74.31 111.641 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.76 -23.47 64.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.632 -0.794 . . . . 53.33 113.126 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -139.69 119.27 13.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.674 0.274 . . . . 63.21 110.772 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 191' ' ' ASP . 58.0 mt -87.47 117.83 26.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.756 -0.461 . . . . 64.31 109.756 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -83.49 25.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.342 -0.39 . . . . 74.35 110.847 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 342' ' ' SER . 25.6 tp -51.65 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.758 . . . . 45.43 111.372 -176.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 341' ' ' LEU . 7.6 t 176.62 -65.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.128 -0.487 . . . . 64.34 110.154 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.66 HG21 ' HB3' ' A' ' 190' ' ' PRO . 61.8 t 66.09 97.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 O-C-N 123.811 0.695 . . . . 75.41 110.824 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.664 HG13 ' H ' ' A' ' 345' ' ' GLU . 2.2 p -111.56 -74.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.79 -0.641 . . . . 51.51 111.65 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.664 ' H ' HG13 ' A' ' 344' ' ' VAL . 42.1 mt-10 -157.4 -175.69 5.54 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.829 0.347 . . . . 75.13 110.219 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 17.3 p30 -112.32 160.35 17.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.07 -0.514 . . . . 75.25 110.104 176.445 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 132.62 15.3 1.42 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.114 -1.041 . . . . 62.25 113.539 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.29 80.12 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.348 -0.93 . . . . 62.34 111.453 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.45 ' HA ' HE21 ' A' ' 45' ' ' GLN . 2.7 tt 54.52 89.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.717 0.807 . . . . 72.2 112.302 171.552 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 350' ' ' LYS . 37.9 mmtm -138.52 131.43 29.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.656 -0.702 . . . . 53.21 109.283 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -132.8 138.53 47.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.277 -0.42 . . . . 72.03 110.992 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.41 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -145.15 134.26 22.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.72 -0.474 . . . . 72.44 109.72 -178.174 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.9 t -104.38 153.87 20.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.609 0.243 . . . . 73.41 110.366 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.22 128.44 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.282 0.563 . . . . 55.44 110.981 -173.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 355' ' ' THR . . . . . 0.704 HG23 ' HB2' ' A' ' 358' ' ' ARG . 33.3 m -77.82 97.96 5.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 63.24 111.822 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -82.84 -48.34 10.87 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.519 -0.549 . . . . 72.34 109.519 170.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -151.53 86.33 1.33 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.675 . . . . 64.53 110.255 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.704 ' HB2' HG23 ' A' ' 355' ' ' THR . 15.2 mmt180 -134.58 113.11 11.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.525 -0.761 . . . . 65.51 109.037 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.36 -51.54 3.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.726 -0.472 . . . . 63.54 109.726 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.911 -1.144 . . . . 52.11 107.911 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.576 0.227 . . . . 72.14 111.014 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.08 138.09 15.99 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.495 2.13 . . . . 61.25 110.685 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -121.44 -75.92 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 74.45 111.544 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.73 113.05 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.556 0.694 . . . . 75.31 111.274 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -126.68 -93.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.401 -0.818 . . . . 73.04 109.391 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.47 138.63 1.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.798 -0.637 . . . . 71.1 109.909 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.67 90.79 1.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.141 0.496 . . . . 73.41 110.445 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 16.2 pt20 -88.73 60.26 5.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.324 0.583 . . . . 73.03 110.88 -177.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.4 102.62 6.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.647 -0.706 . . . . 72.42 110.861 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.85 111.52 4.26 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.904 -0.665 . . . . 72.24 111.496 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -144.98 114.72 7.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.598 0.237 . . . . 64.24 111.375 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' 143' ' ' GLU . 11.6 pt20 -150.19 131.48 14.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.119 -0.697 . . . . 65.01 109.119 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -130.74 122.68 27.68 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.055 -0.258 . . . . 44.44 111.19 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -174.49 131.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 73.43 110.765 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.45 35.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 52.41 109.902 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -116.35 99.79 7.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.74 0.274 . . . . 64.41 111.74 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -169.48 106.65 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 63.34 111.244 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.597 ' HE1' ' HB2' ' A' ' 42' ' ' PRO . 55.0 t-80 -169.16 89.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.093 -0.958 . . . . 74.04 108.946 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 19' ' ' LEU . 3.2 pp -98.28 157.46 16.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.34 -0.391 . . . . 73.45 111.295 -175.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.78 140.3 20.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 75.0 109.617 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.37 172.56 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.034 -0.358 . . . . 75.43 110.034 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 66.82 -88.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.343 0.657 . . . . 72.4 111.659 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -124.26 91.08 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.417 0.627 . . . . 60.22 110.894 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -172.58 -58.7 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.62 -1.252 . . . . 41.33 107.62 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG13 ' HA2' ' A' ' 40' ' ' GLY . 61.9 t -65.59 130.96 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.515 -1.22 . . . . 70.33 108.712 167.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.37 2.95 56.63 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.307 -0.949 . . . . 51.42 112.911 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 133.0 51.2 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.197 -0.668 . . . . 73.13 109.197 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -81.04 131.11 34.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.678 0.751 . . . . 63.53 111.338 -173.159 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.63 129.85 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.726 -1.124 . . . . 65.14 109.641 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 21.1 m -118.45 123.83 46.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.559 -0.291 . . . . 74.23 110.594 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 3.2 p-10 -111.2 -173.09 2.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.398 -0.365 . . . . 74.24 110.71 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.06 -14.31 61.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.356 0.502 . . . . 64.24 112.356 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.29 8.54 8.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.836 0.35 . . . . 34.2 110.434 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.6 tptt 55.81 63.21 2.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.334 -0.848 . . . . 74.45 110.686 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' THR . 48.6 mmtm -134.92 120.84 19.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.059 -0.973 . . . . 75.45 109.723 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.93 77.29 4.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 73.2 109.428 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.594 ' HB2' ' O ' ' A' ' 56' ' ' MET . 37.4 p-90 -96.81 -176.55 3.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.686 -0.688 . . . . 71.23 110.375 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HG2' ' HB3' ' A' ' 56' ' ' MET . 18.8 pttp -133.69 137.14 45.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.3 111.562 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.01 151.68 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.952 -1.022 . . . . 74.3 110.797 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -96.6 -124.44 4.67 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.452 -0.659 . . . . 50.44 111.452 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.2 mp -92.13 128.88 43.55 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.838 0.351 . . . . 72.34 110.48 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.597 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 15.5 Cg_exo -68.91 119.1 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.91 2.406 . . . . 75.13 111.463 176.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.83 -59.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.147 0.499 . . . . 73.43 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.67 -8.3 76.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.899 -0.667 . . . . 61.33 112.316 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -127.4 161.38 28.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.487 0.184 . . . . 72.44 110.561 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.67 -130.92 2.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.402 -1.079 . . . . 64.34 110.402 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.57 -2.69 86.94 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.473 -0.87 . . . . 70.34 111.527 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.78 -68.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.728 -0.471 . . . . 50.22 109.728 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.93 174.23 24.63 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.865 -0.683 . . . . 64.53 111.888 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.7 m 62.68 32.72 16.07 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.108 0.48 . . . . 73.55 111.583 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.13 137.37 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 73.01 110.603 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.42 ' HB2' HG13 ' A' ' 70' ' ' VAL . 11.0 m-85 -111.89 148.97 32.53 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.849 -0.426 . . . . 74.4 109.849 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 54' ' ' ALA . 4.5 tt -90.63 139.87 30.3 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.828 -0.804 . . . . 33.03 108.828 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.796 -0.362 . . . . 62.43 110.751 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.77 -53.37 6.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 74.54 110.495 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 22.7 ttt -118.75 122.8 43.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.463 -0.789 . . . . 74.22 110.038 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -144.3 142.64 30.55 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.392 -0.966 . . . . 71.35 108.392 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.2 m -72.37 76.17 1.02 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.428 0.633 . . . . 71.2 110.457 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.675 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.5 m -81.37 141.84 33.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.623 -0.717 . . . . 64.15 110.035 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.93 -33.61 70.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 72.12 110.474 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -147.02 82.71 1.56 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.963 -0.562 . . . . 64.41 109.917 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 11.1 p -82.42 125.58 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 73.44 110.337 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 53.04 1.14 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.796 . . . . 55.44 111.702 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m 68.69 3.27 3.81 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.355 0.598 . . . . 62.51 110.499 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.05 122.12 13.75 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.31 -0.859 . . . . 62.13 109.232 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -73.73 110.68 9.59 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-O 121.122 0.487 . . . . 71.23 110.018 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' C ' ' HB2' ' A' ' 133' ' ' ARG . 3.6 Cg_exo -79.67 40.36 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.149 2.566 . . . . 75.44 111.273 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 p -144.26 146.95 32.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.623 0.725 . . . . 73.14 112.826 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 132' ' ' ASP . 34.6 m -128.08 167.05 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.021 -0.99 . . . . 74.32 109.389 172.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.1 p -130.42 123.83 56.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.256 0.551 . . . . 73.11 111.488 -176.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -82.43 122.3 27.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.443 -0.577 . . . . 72.41 109.443 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.9 122.48 65.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.4 -0.364 . . . . 62.44 110.577 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 80' ' ' LEU . 6.0 tp10 -136.07 137.54 25.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 74.21 109.053 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.62 133.25 50.34 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.17 1.913 . . . . 74.12 112.061 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 t -81.18 15.01 2.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.099 0.476 . . . . 40.03 110.655 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 124' ' ' LYS . 10.0 t70 -67.65 -69.1 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 63.44 110.105 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -170.32 118.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.705 -0.68 . . . . 52.11 109.477 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.71 -161.95 28.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.465 -0.874 . . . . 72.31 112.478 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.01 -21.54 49.37 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.18 2.587 . . . . 72.43 112.913 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 80' ' ' LEU . 1.2 tm? -52.31 -37.64 56.31 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.602 0.564 . . . . 74.11 111.16 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.15 -41.81 85.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 73.01 110.574 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -69.15 -46.3 67.96 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.708 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 80' ' ' LEU . 11.4 pt-20 -67.99 -31.1 70.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.189 -0.46 . . . . 72.4 110.838 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.51 -39.71 88.82 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.366 -0.235 . . . . 74.22 110.366 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -57.26 -49.01 77.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 53.0 110.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.11 -49.51 69.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 74.44 111.131 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' ' HD1' ' A' ' 113' ' ' TYR . 55.8 t80 -59.91 -38.13 81.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.731 -0.668 . . . . 75.44 111.563 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.8 tp60 -74.14 -39.63 63.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 64.52 110.867 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -27.83 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 71.33 110.955 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HA ' ' CH2' ' A' ' 99' ' ' TRP . . . -106.74 16.52 24.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.963 0.411 . . . . 64.21 111.352 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' LYS . . . -82.58 158.19 23.17 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.109 -0.496 . . . . 72.25 111.478 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' ILE . 49.9 mtmt 75.17 107.01 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.293 -0.867 . . . . 64.1 111.394 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.531 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 49.7 Cg_exo -55.69 -35.33 92.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.362 2.708 . . . . 75.52 113.197 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.739 ' HG2' ' HE2' ' A' ' 98' ' ' LYS . 38.6 tt0 -66.46 -45.8 78.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 61.01 110.946 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.702 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 48.8 tt0 -62.64 -36.87 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.405 -0.591 . . . . 74.13 109.405 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 93' ' ' PRO . 67.4 mt -55.96 -45.88 80.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.537 -0.756 . . . . 72.03 110.284 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 96.3 mt-30 -53.78 -47.06 71.11 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.856 -0.611 . . . . 73.23 110.586 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.739 ' HE2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -63.85 -57.75 8.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.48 0.548 . . . . 74.12 112.48 -177.532 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.606 ' CH2' ' HA ' ' A' ' 90' ' ' ALA . 1.1 p90 -69.52 -34.71 74.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 119.968 -0.693 . . . . 61.41 111.501 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 108' ' ' LEU . 26.1 mm -63.45 -47.07 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.41 . . . . 74.45 110.122 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.94 -35.67 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 74.31 110.886 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.1 m -76.25 -34.63 59.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.555 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -84.61 1.91 43.93 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 122.299 -0.251 . . . . 54.24 111.546 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 65.94 25.9 11.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.582 0.551 . . . . 74.15 111.104 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.58 -178.32 5.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 74.3 109.362 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.9 -45.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.73 0.641 . . . . 74.2 112.73 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -154.08 117.48 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.522 -0.871 . . . . 75.43 112.342 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.6 pt? -103.96 136.24 43.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 74.44 109.294 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.85 66.65 3.53 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.852 -0.689 . . . . 73.24 112.926 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 11.7 p -104.11 136.76 19.15 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 110.262 -0.273 . . . . 72.43 110.262 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 38.8 Cg_exo -61.73 146.23 96.81 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.685 2.256 . . . . 64.23 112.719 176.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -67.77 122.91 19.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.623 -0.717 . . . . 75.2 111.157 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HD1' ' CZ ' ' A' ' 87' ' ' TYR . 40.4 t80 -84.33 116.08 22.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.976 -0.557 . . . . 72.4 110.866 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.485 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 73.3 m95 -104.71 -63.01 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 74.21 109.065 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.08 172.13 31.39 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.148 -0.933 . . . . 62.14 111.305 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 p -169.83 159.82 8.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.577 0.227 . . . . 73.3 110.628 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.41 -165.03 37.62 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.855 -0.688 . . . . 61.15 111.662 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -137.47 147.22 45.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.914 0.387 . . . . 74.32 110.452 178.275 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -124.55 112.08 16.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.561 -0.533 . . . . 73.11 109.561 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 15.1 t0 -71.74 148.08 46.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.005 -0.543 . . . . 53.15 111.031 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.473 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 26.5 tptp -117.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.545 -0.752 . . . . 72.52 110.179 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 121' ' ' LYS . 15.8 m120 -135.26 30.72 3.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.287 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.26 -31.64 6.35 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.008 -0.837 . . . . 53.41 111.008 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 76' ' ' ASP . 44.3 mttp -100.18 96.4 7.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.19 -0.67 . . . . 74.43 109.19 173.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 4.9 p -76.26 142.56 41.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.436 -0.802 . . . . 62.43 111.254 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -96.18 121.57 38.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.86 -0.609 . . . . 72.21 109.716 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 118' ' ' LEU . 16.0 ttt180 -102.57 132.77 48.43 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.269 -0.641 . . . . 74.52 109.269 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.568 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 39.9 p90 -133.41 160.06 38.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.038 0.447 . . . . 74.34 111.797 -170.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.2 ptp -142.31 141.04 32.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.613 -0.721 . . . . 71.25 109.888 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -97.3 122.76 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.036 0.446 . . . . 74.23 110.384 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.5 mtm -127.15 -175.98 3.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 72.21 110.282 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 5.7 m-20 -58.3 152.52 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 65.11 110.502 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.464 ' HB2' ' C ' ' A' ' 67' ' ' PRO . 35.3 ttt180 -72.79 105.62 4.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.711 -0.478 . . . . 65.21 109.711 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 132' ' ' ASP . 28.3 m-85 -101.76 171.02 7.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.274 -0.421 . . . . 75.24 110.533 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.29 -43.97 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.674 -0.774 . . . . 71.42 111.844 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 5.6 t -120.87 159.8 24.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.069 0.462 . . . . 70.15 110.531 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.825 ' HB3' HD13 ' A' ' 184' ' ' LEU . 1.1 p30 -143.57 -172.54 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 72.33 109.78 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 6.8 mp -77.08 -24.51 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.164 -0.471 . . . . 75.15 112.075 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.78 ' HA ' ' HD1' ' A' ' 142' ' ' TYR . 3.2 pt20 -75.46 -36.29 60.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.695 -0.802 . . . . 63.22 109.968 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.862 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 43.1 mttp -57.83 -34.25 69.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 73.41 110.182 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.504 HG23 ' HG2' ' A' ' 345' ' ' GLU . 72.7 mt -76.0 -51.29 20.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.489 -0.778 . . . . 63.41 111.227 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.78 ' HD1' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -72.18 -33.85 67.99 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.752 0.649 . . . . 74.14 112.752 -170.264 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.522 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 31.2 mt-10 -72.07 -31.25 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.349 . . . . 75.54 110.913 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.54 -32.1 15.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.979 0.362 . . . . 74.53 111.979 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.625 ' HB2' ' HG3' ' A' ' 345' ' ' GLU . 6.7 t-20 -98.95 0.31 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 64.23 110.742 -176.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.81 64.85 1.44 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.51 -0.768 . . . . 54.42 111.984 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 142' ' ' TYR . 17.5 ptpt 34.09 74.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.199 1.185 . . . . 60.13 114.199 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.42 103.84 5.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 70.14 110.415 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 89.6 m-85 -121.03 155.8 33.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.975 -0.557 . . . . 75.01 110.474 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 154' ' ' VAL . 67.0 p -80.62 148.35 30.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.46 -0.336 . . . . 55.24 110.208 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -26.63 66.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.002 0.43 . . . . 74.24 110.549 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 335' ' ' ASP . 63.0 tttm -62.08 -51.79 66.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.655 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 33.3 m -64.26 -46.84 81.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.274 -0.876 . . . . 53.11 110.497 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 150' ' ' SER . 69.6 t -54.64 -46.01 72.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 75.13 111.462 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 328' ' ' LEU . 1.7 tp -63.82 -49.15 73.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.615 -0.266 . . . . 72.12 110.734 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -60.44 -39.91 89.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 63.01 110.801 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 153' ' ' THR . 94.0 mt -62.41 -49.69 74.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.416 -0.356 . . . . 61.1 110.425 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 m -58.1 -40.56 81.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 72.14 111.179 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 321' ' ' ARG . 3.5 mm? -61.98 -54.31 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 64.52 111.471 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.404 ' O ' HG22 ' A' ' 164' ' ' ILE . 86.6 mtt180 -64.16 -39.27 93.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.957 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 195' ' ' LEU . 1.6 mp -65.89 -40.39 87.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.606 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.92 -44.13 96.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.616 0.246 . . . . 72.13 110.898 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.42 -55.37 35.95 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.026 -0.534 . . . . 51.23 110.846 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 160' ' ' ARG . 13.8 tt -69.16 -35.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.087 -0.506 . . . . 75.23 111.519 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 45.2 tp -63.81 -39.4 94.16 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.276 -0.17 . . . . 62.34 111.331 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 169' ' ' HIS . 22.8 tp10 -80.85 -25.61 37.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.968 0.413 . . . . 65.23 110.365 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.42 -45.81 92.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.442 . . . . 71.03 110.487 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.85 -29.67 11.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 71.11 110.521 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 3.5 t-160 -61.95 -21.85 65.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.663 -0.699 . . . . 74.34 110.468 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -96.42 10.21 38.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.773 -0.648 . . . . 75.1 109.918 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' HIS . . . . . 0.519 ' CD2' ' HG2' ' A' ' 172' ' ' GLU . 73.9 t60 -116.68 -77.3 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.435 -0.348 . . . . 73.33 111.767 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 206' ' ' PRO . 8.3 pt-20 -161.22 -10.11 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.339 1.237 . . . . 73.35 114.339 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.568 ' CD2' ' HB1' ' A' ' 201' ' ' ALA . 16.7 p90 -155.97 161.85 40.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.714 0.688 . . . . 74.14 111.229 -170.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.716 HG13 ' HE2' ' A' ' 204' ' ' TYR . 35.6 m -131.6 160.44 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.637 -0.71 . . . . 60.11 110.209 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.64 96.55 10.75 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.005 -1.109 . . . . 73.11 108.005 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.47 73.57 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.948 -0.644 . . . . 14.24 112.389 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 179' ' ' LYS . 25.1 t70 -121.26 98.49 6.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.039 0.447 . . . . 54.14 110.305 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 178' ' ' ILE . 30.5 mm -87.8 38.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.388 1.09 . . . . 73.34 109.274 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . 0.469 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 7.9 ttpm? -75.95 164.83 25.79 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.586 -0.894 . . . . 73.32 108.586 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -56.58 -15.87 5.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.562 0.579 . . . . 61.11 112.562 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 179' ' ' LYS . 11.9 p -76.82 -15.43 59.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.731 0.301 . . . . 63.31 111.595 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 183' ' ' LEU . 5.6 t-20 -83.2 -30.75 27.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.626 0.727 . . . . 71.3 110.346 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.553 ' HG ' HD21 ' A' ' 195' ' ' LEU . 6.0 mp -96.11 110.9 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.999 -1.0 . . . . 75.33 110.695 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.825 HD13 ' HB3' ' A' ' 137' ' ' ASP . 2.2 mm? -98.33 156.6 16.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.704 -0.68 . . . . 73.04 110.228 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 79.5 mt -119.27 159.13 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.512 -0.551 . . . . 63.22 109.512 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 11.9 t30 -60.86 151.06 31.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.825 -1.176 . . . . 72.31 107.825 170.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -48.72 -27.83 3.18 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.085 0.772 . . . . 73.35 113.085 -166.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -156.58 34.93 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.244 0.545 . . . . 72.31 110.557 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 5.0 t30 -126.08 103.5 26.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.558 -0.534 . . . . 73.42 109.558 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.4 ' O ' HD12 ' A' ' 339' ' ' LEU . 66.8 Cg_endo -72.61 -28.67 13.97 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.087 2.525 . . . . 61.11 114.337 -169.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.75 -6.84 55.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.759 -0.376 . . . . 75.35 111.156 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.566 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 11.4 mm-40 -111.81 97.04 6.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 55.14 110.837 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.76 130.07 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.989 -1.005 . . . . 70.24 110.322 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.487 ' CD2' ' HE1' ' A' ' 134' ' ' PHE . 35.0 m-85 -124.43 147.38 48.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.063 -0.717 . . . . 70.42 109.063 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.553 HD21 ' HG ' ' A' ' 183' ' ' LEU . 49.4 mt -96.56 116.3 28.86 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.593 -0.443 . . . . 52.41 110.814 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.579 HG23 ' CE2' ' A' ' 198' ' ' TYR . 2.7 p -148.43 87.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.817 0.818 . . . . 53.24 110.963 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.75 -50.91 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 60.43 109.493 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 196' ' ' VAL . 18.5 m-85 51.51 35.02 13.39 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.494 -0.775 . . . . 72.05 110.705 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -154.27 -31.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.853 -1.067 . . . . 42.2 112.117 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 25.7 mt -97.01 9.77 41.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.78 0.8 . . . . 54.23 108.855 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 173' ' ' TYR . . . -97.46 111.67 23.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.831 -1.077 . . . . 73.23 110.528 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -98.49 115.26 28.17 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.204 -0.453 . . . . 71.31 109.907 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.434 ' NH2' ' HB3' ' A' ' 206' ' ' PRO . 0.6 OUTLIER -87.74 114.54 24.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.54 0.686 . . . . 61.35 110.101 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.716 ' HE2' HG13 ' A' ' 174' ' ' VAL . 9.5 p90 -89.65 -41.57 11.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.142 -0.935 . . . . 71.32 111.527 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 78.0 m -153.04 108.18 2.65 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.599 -0.519 . . . . 64.43 109.599 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 172' ' ' GLU . 28.0 Cg_endo -63.32 84.05 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.899 2.399 . . . . 70.42 113.628 -174.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 76.48 -11.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.263 1.025 . . . . 74.44 110.574 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 51.65 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.418 -1.073 . . . . 65.25 110.418 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' VAL . . . . . 0.694 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 3.4 p -48.88 111.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.742 0.782 . . . . 54.03 113.075 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -164.13 70.9 0.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 54.12 109.003 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 205' ' ' CYS . 47.2 tptt -139.54 111.06 7.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.473 -0.785 . . . . 73.14 109.402 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -101.53 176.42 5.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 75.4 111.278 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 9.6 p90 -74.17 84.04 1.84 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.634 -0.712 . . . . 71.24 110.527 177.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -166.17 28.07 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.456 0.646 . . . . 71.31 109.771 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.64 144.5 51.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 63.33 111.594 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -173.82 91.76 0.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.048 -0.978 . . . . 73.43 108.567 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.29 -51.69 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.14 1.894 . . . . 74.24 110.948 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.803 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.1 OUTLIER -168.57 26.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.772 -0.825 . . . . 73.4 108.772 176.979 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 234' ' ' ASN . 99.0 mtt180 61.56 101.99 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.971 -1.013 . . . . 64.44 111.652 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.86 -36.12 64.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.821 -1.081 . . . . 72.44 112.416 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 48.84 44.07 21.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.521 0.728 . . . . 71.12 111.945 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' ASP . . . . . 0.612 ' OD1' HG21 ' A' ' 228' ' ' THR . 1.0 OUTLIER -40.65 -77.33 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.149 1.166 . . . . 62.43 114.149 176.675 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.405 ' O ' ' HE1' ' A' ' 233' ' ' HIS . . . -127.0 -116.35 2.01 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.449 -0.881 . . . . 41.11 114.229 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.9 m -92.1 110.67 22.05 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.369 0.267 . . . . 63.22 111.438 -173.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.1 tt -58.36 -19.09 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 111.88 0.326 . . . . 73.13 111.88 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.94 -61.83 2.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.44 -0.345 . . . . 74.33 110.642 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.446 ' HD2' ' SG ' ' A' ' 250' ' ' CYS . 84.4 m-85 -86.15 -42.95 13.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.634 -0.257 . . . . 74.22 110.817 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.612 HG21 ' OD1' ' A' ' 222' ' ' ASP . 26.0 m -57.91 -27.67 63.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.158 -0.474 . . . . 72.34 111.364 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 71.5 m 65.99 -170.01 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.592 -0.731 . . . . 73.12 111.463 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.1 OUTLIER -72.65 -33.89 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 73.53 112.218 -175.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 236' ' ' VAL . 1.2 p-10 -58.09 -75.25 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.999 0.74 . . . . 63.54 112.999 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.435 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.04 -30.47 71.0 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.185 0.517 . . . . 54.51 111.346 -176.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 229' ' ' SER . 1.5 t60 -71.74 -23.92 61.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.855 -0.612 . . . . 73.31 111.043 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 219' ' ' ARG . 6.3 m-20 -97.54 -15.19 20.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 62.33 111.035 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.2 -9.95 59.72 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.294 -0.955 . . . . 54.45 112.689 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 231' ' ' ASP . 8.1 p -71.64 129.72 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 74.14 109.639 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -61.51 116.95 22.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.009 -0.541 . . . . 72.14 112.112 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.77 106.11 0.31 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.779 2.319 . . . . 74.02 110.835 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.0 p -130.51 109.49 10.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.954 -0.566 . . . . 72.34 111.505 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 312' ' ' THR . 2.2 mpt_? 76.66 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.005 -0.998 . . . . 71.31 110.994 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 310' ' ' ASP . 21.6 ttp180 -69.58 -30.94 68.83 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.297 -0.561 . . . . 73.21 110.172 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -52.94 46.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 74.14 111.782 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 165' ' ' LEU . 4.5 m-20 -53.84 -46.04 71.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.463 0.649 . . . . 63.03 110.327 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' LEU . . . . . 0.495 HD13 HD21 ' A' ' 320' ' ' LEU . 75.0 mt -71.75 -35.99 70.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.478 -0.783 . . . . 73.24 111.699 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.64 -39.95 95.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 71.32 110.329 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 227' ' ' PHE . 80.3 mt -64.85 -49.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.62 . . . . 65.44 110.307 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 251' ' ' MET . 51.1 tp -58.81 -47.13 85.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.286 -0.415 . . . . 63.41 111.251 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -34.7 90.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.958 -0.639 . . . . 51.15 112.243 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.429 ' CD2' ' HE3' ' A' ' 275' ' ' LYS . 24.0 t80 -62.72 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.231 0.539 . . . . 74.03 109.811 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 227' ' ' PHE . 60.5 m -61.67 -45.36 94.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.625 -0.716 . . . . 72.52 110.433 176.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -55.23 -52.97 61.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.943 -0.571 . . . . 65.11 111.612 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.9 tt -65.49 -37.16 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 63.45 111.124 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.444 HE21 ' CD1' ' A' ' 259' ' ' LEU . 15.4 mt-30 -69.14 -42.21 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 65.03 111.771 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 41.0 m0 -62.34 -31.84 72.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 71.4 110.674 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.16 -41.26 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.189 -0.459 . . . . 72.24 112.208 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 65.2 p -104.06 -29.11 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.767 0.654 . . . . 73.52 112.767 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.0 24.09 64.51 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 121.056 -0.592 . . . . 31.15 112.985 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -155.67 142.86 19.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.114 0.457 . . . . 75.35 109.937 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.444 ' CD1' HE21 ' A' ' 253' ' ' GLN . 20.4 mt -130.57 149.75 74.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 74.44 111.272 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.2 6.45 3.47 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.97 2.447 . . . . 74.34 112.926 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -143.45 24.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 73.42 110.914 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.552 ' HA ' HD23 ' A' ' 265' ' ' LEU . 12.9 pt-20 -63.83 -30.38 71.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.362 0.504 . . . . 55.3 112.362 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 266' ' ' LYS . 34.5 t70 -83.02 -25.61 32.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.379 -0.529 . . . . 73.24 109.796 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.83 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 95.2 m-20 -77.34 -3.78 41.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.782 -0.644 . . . . 73.55 110.469 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 262' ' ' GLU . 2.1 mm? -61.57 -18.56 59.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.802 -0.636 . . . . 65.4 110.592 172.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 263' ' ' ASP . 6.0 ptmt -70.57 -19.27 62.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 71.01 111.604 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.592 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 16.1 t70 -135.5 132.56 19.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.955 0.407 . . . . 63.32 111.38 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 271' ' ' VAL . 26.0 Cg_endo -62.24 -30.68 81.85 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.247 2.631 . . . . 52.4 114.494 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' LYS . . . . . 0.592 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 7.3 ptpp? -73.57 -29.56 62.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.879 -0.728 . . . . 63.3 109.832 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.83 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 54.3 m-85 -76.97 -44.35 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.729 -0.669 . . . . 74.22 111.451 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 29.9 m -63.89 -35.8 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.839 -0.345 . . . . 64.01 110.796 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -61.83 -57.49 11.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 74.13 110.287 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.76 -49.74 73.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.335 -0.848 . . . . 75.13 111.127 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 20.1 m -63.11 -44.58 95.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 73.4 111.595 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LYS . . . . . 0.429 ' HE3' ' CD2' ' A' ' 249' ' ' TYR . 68.5 tttt -66.04 -37.33 85.59 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.684 -0.406 . . . . 74.03 110.457 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 78.5 mt -69.01 -47.9 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.606 -0.27 . . . . 61.2 111.146 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -60.96 -40.71 94.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.332 . . . . 73.04 110.908 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -73.4 -31.45 63.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 63.43 110.985 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.45 -20.2 65.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 63.4 111.133 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -80.39 -35.59 35.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.457 -0.338 . . . . 65.03 110.79 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -123.23 47.51 1.98 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.814 0.34 . . . . 73.03 110.651 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.0 mt -51.84 -52.84 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.33 0.863 . . . . 54.14 113.33 -171.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -62.83 -48.66 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.244 0.461 . . . . 70.22 112.244 -169.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.0 m -64.88 -48.41 74.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.219 0.533 . . . . 72.1 110.558 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.64 -54.4 16.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.523 -0.762 . . . . 65.22 111.674 -174.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -65.04 -43.34 92.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.57 0.211 . . . . 70.01 111.57 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.42 -39.94 81.4 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.804 -0.359 . . . . 74.13 111.278 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -76.42 -20.73 56.8 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.99 -0.284 . . . . 71.41 111.377 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 97.9 m -76.86 -16.35 59.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 74.51 110.476 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.493 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 59.4 t80 -115.24 81.06 7.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.576 -0.527 . . . . 71.52 109.576 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 91.1 Cg_endo -95.26 34.92 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.458 2.772 . . . . 63.03 112.13 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -82.18 -174.9 5.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.594 -0.73 . . . . 74.33 110.258 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.7 mmtt -89.28 13.17 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.106 0.479 . . . . 73.12 110.848 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.493 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 3.1 t-20 -105.88 -163.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.292 -1.003 . . . . 74.51 108.292 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.457 ' HE3' ' HB ' ' A' ' 331' ' ' ILE . 19.6 pttp -149.66 124.9 4.87 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.79 0.328 . . . . 75.43 111.208 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 290' ' ' PHE . 65.3 Cg_endo -95.43 37.22 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 54.02 111.88 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.67 86.64 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.95 -0.643 . . . . 51.41 111.838 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.721 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.4 mp0 -52.43 -46.49 66.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.029 0.442 . . . . 72.3 110.7 176.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.8 mp -71.97 -42.69 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.78 -0.645 . . . . 61.52 110.789 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.83 68.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.809 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 301' ' ' LYS . 23.3 mtpp -75.07 -30.16 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 74.35 111.506 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.45 -45.96 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.083 0.468 . . . . 61.42 110.134 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.579 ' HA ' HG22 ' A' ' 306' ' ' VAL . 72.1 mtp -72.28 -35.42 68.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 72.32 110.64 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -57.42 -44.33 84.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.577 0.703 . . . . 64.33 109.583 173.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.8 m -61.13 -49.98 75.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.891 -1.05 . . . . 64.32 111.893 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 303' ' ' MET . 16.8 m -66.77 -27.53 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.911 0.386 . . . . 75.12 110.758 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -65.25 -42.26 93.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 75.2 110.042 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 50.0 tp -71.37 -21.61 62.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.428 -0.805 . . . . 54.4 110.906 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 309' ' ' LEU . 6.3 tt -71.1 -14.75 62.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.043 -0.526 . . . . 63.44 110.291 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 34.8 t70 67.56 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.628 -0.715 . . . . 50.41 111.852 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -136.43 -51.93 0.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.24 -0.652 . . . . 70.23 109.24 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 240' ' ' ARG . 55.3 m -148.37 75.88 1.34 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.786 -0.643 . . . . 74.11 111.358 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.419 ' HB2' ' HG ' ' A' ' 309' ' ' LEU . 51.1 mm-40 -83.3 -165.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.106 -1.072 . . . . 74.22 108.106 162.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 314' ' ' LYS . 11.0 tmtt? -76.13 113.53 28.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.516 -0.92 . . . . 70.22 108.516 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 240' ' ' ARG . 12.3 Cg_exo -68.43 117.46 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.038 1.826 . . . . 72.24 110.966 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 95.6 mt -94.11 68.68 3.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.072 -0.513 . . . . 72.42 110.521 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -57.92 -32.86 68.18 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.211 -0.663 . . . . 64.35 109.211 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.4 mp0 -58.01 -56.7 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.756 -1.111 . . . . 73.53 110.302 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 26.2 t-20 -71.96 -33.17 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 75.44 111.734 -175.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 7.9 mp -61.28 -48.19 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.367 . . . . 72.24 111.058 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.534 ' HB2' HD11 ' A' ' 159' ' ' LEU . 15.4 ptp180 -72.01 -24.67 61.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.325 -0.55 . . . . 65.0 109.951 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.08 -49.02 55.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 73.05 110.989 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -62.68 -39.0 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 110.066 -0.346 . . . . 75.04 110.066 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.5 mt -62.33 -49.74 74.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 62.0 110.527 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 325' ' ' LEU . . . . . 0.645 ' O ' ' HG3' ' A' ' 329' ' ' LYS . 4.1 mm? -70.15 -26.9 64.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 64.33 111.366 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.01 -43.54 64.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.918 0.389 . . . . 71.52 110.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.721 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.03 -36.04 92.57 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 61.34 111.798 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 155' ' ' LEU . 17.4 tp -69.21 -29.93 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 74.13 110.057 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 325' ' ' LEU . 62.3 mttp -65.28 -38.78 91.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 45.34 110.55 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.28 73.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.755 -0.657 . . . . 74.05 111.655 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.457 ' HB ' ' HE3' ' A' ' 295' ' ' LYS . 15.2 tt -92.64 2.49 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 63.51 110.375 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.09 25.77 73.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.897 -0.668 . . . . 61.11 113.576 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 333' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 25.6 m -121.83 158.93 27.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.435 0.617 . . . . 62.34 111.272 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -150.74 172.76 15.07 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.042 -0.725 . . . . 73.4 109.042 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 30.6 t70 -120.63 127.74 52.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.763 -0.458 . . . . 74.44 109.763 172.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.74 21.11 3.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 64.3 110.832 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.23 45.37 15.24 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.491 -1.043 . . . . 64.44 110.491 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -131.94 -32.96 1.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.559 -0.32 . . . . 71.42 111.716 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.558 HD22 HG23 ' A' ' 153' ' ' THR . 78.2 mt 65.65 179.56 0.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.496 0.497 . . . . 73.13 110.313 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -179.48 82.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.154 0.502 . . . . 74.43 109.83 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 153' ' ' THR . 1.4 pp -106.98 -36.61 6.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.99 -0.55 . . . . 64.23 110.857 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 342' ' ' SER . . . . . 0.477 ' N ' HD12 ' A' ' 341' ' ' LEU . 77.3 p 178.33 -119.93 0.0 OUTLIER 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.819 -0.628 . . . . 74.05 109.584 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.437 ' O ' ' HB ' ' A' ' 344' ' ' VAL . 7.4 p -131.29 9.82 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.526 0.679 . . . . 74.14 109.287 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 57.9 t 74.63 105.95 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 114.927 -1.033 . . . . 73.03 109.747 -175.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' GLU . . . . . 0.625 ' HG3' ' HB2' ' A' ' 145' ' ' ASN . 8.6 mm-40 -72.56 -54.5 9.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.64 -0.709 . . . . 75.23 112.724 -168.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ASN . . . . . 0.862 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 4.8 m-20 74.06 115.26 0.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.71 0.631 . . . . 74.31 110.699 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 151.78 64.9 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.136 -0.786 . . . . 52.31 111.136 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 348' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . 170.99 132.1 1.43 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.057 -0.592 . . . . 62.41 112.008 -176.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.6 tt -175.56 103.92 0.08 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.904 -0.406 . . . . 55.22 109.904 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.829 ' HE2' ' HA ' ' A' ' 350' ' ' LYS . 7.4 mmpt? -146.42 115.03 6.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.304 -0.628 . . . . 72.0 109.304 176.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -130.87 171.63 12.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 73.34 111.779 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.659 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 57.7 tptt -163.67 152.9 14.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.51 -0.922 . . . . 75.3 108.51 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.4 t -73.18 164.62 26.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.522 0.146 . . . . 74.43 110.656 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -66.3 142.36 16.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 71.54 111.683 -174.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.0 t -75.36 134.84 40.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.766 -0.457 . . . . 71.1 109.766 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 356' ' ' LYS . 0.0 OUTLIER -128.06 -61.07 1.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.646 0.736 . . . . 63.25 109.105 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -131.1 -166.32 1.68 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.799 -1.091 . . . . 71.2 108.222 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -77.49 86.18 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 63.12 109.539 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 48.6 tttm 76.44 -55.49 0.58 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.065 -0.971 . . . . 73.4 111.03 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.562 -0.733 . . . . 72.13 110.301 176.788 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.436 -0.209 . . . . 74.04 110.436 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.58 138.99 39.33 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.685 2.257 . . . . 43.54 111.607 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -86.08 -46.49 10.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.157 -0.474 . . . . 74.5 111.396 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.31 133.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.741 0.305 . . . . 54.03 111.418 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -103.2 118.75 37.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.636 -0.875 . . . . 71.1 108.636 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.18 122.33 40.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.108 0.48 . . . . 73.33 112.123 -171.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.72 128.73 9.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.378 -0.828 . . . . 51.21 108.979 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -134.17 131.63 38.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 73.51 111.466 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.68 37.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.509 -0.769 . . . . 73.13 109.264 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.23 152.9 19.89 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.578 -0.82 . . . . 60.31 111.987 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -83.58 134.08 34.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.98 0.419 . . . . 55.53 110.721 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -139.48 114.72 9.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 71.52 109.425 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -90.1 122.81 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.083 0.468 . . . . 63.32 111.218 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 m -81.73 80.28 8.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.182 -0.673 . . . . 73.03 109.182 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.83 133.1 47.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 71.34 112.199 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.562 -0.745 . . . . 65.22 109.774 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.99 122.45 47.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.092 -0.706 . . . . 74.04 109.092 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -89.61 85.72 6.55 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.407 -0.517 . . . . 71.34 110.533 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 tt -109.43 92.6 4.12 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.338 -0.986 . . . . 65.12 108.338 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -71.66 0.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.965 -0.562 . . . . 62.04 111.295 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -120.81 152.05 38.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.125 0.488 . . . . 54.41 111.14 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -80.05 72.12 6.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 74.41 109.948 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -131.59 18.7 4.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.945 0.879 . . . . 75.31 109.32 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.7 -48.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.768 -1.105 . . . . 32.03 109.252 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.06 116.72 5.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.39 -0.823 . . . . 73.1 110.374 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.52 -9.1 62.44 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.776 -0.647 . . . . 63.23 112.547 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.61 138.37 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 73.12 111.091 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -95.4 129.17 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.654 -0.703 . . . . 73.44 111.909 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 37' ' ' TRP . 31.3 pt -121.78 137.63 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.665 -0.698 . . . . 64.1 109.195 167.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 18.6 m -118.36 124.26 47.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.107 -0.237 . . . . 41.01 111.238 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.52 -177.93 4.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.459 -0.337 . . . . 71.11 110.482 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -16.78 62.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 71.52 112.744 -173.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.65 30.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.776 0.322 . . . . 65.2 110.525 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt 58.44 77.94 0.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.286 -0.87 . . . . 75.42 111.354 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 30' ' ' THR . 47.0 mmtm -136.09 125.18 24.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 71.11 108.73 173.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.18 85.45 6.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.008 0.432 . . . . 75.32 110.236 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 45.1 m95 -79.34 117.04 19.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.887 -0.597 . . . . 72.11 109.479 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 23.0 pttm -97.38 131.18 44.3 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.882 -0.727 . . . . 72.33 109.181 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 52' ' ' TYR . 59.0 t -67.8 130.32 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.931 -0.577 . . . . 71.45 110.947 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.15 -101.49 1.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.752 -0.737 . . . . 63.35 111.78 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -84.41 121.96 75.18 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.049 0.452 . . . . 72.13 110.11 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 7.4 Cg_exo -73.72 99.72 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.034 2.49 . . . . 73.23 111.376 175.06 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.94 -56.34 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 72.44 110.585 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.84 -24.76 28.27 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.82 -0.705 . . . . 64.21 112.246 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -134.9 165.72 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.951 0.405 . . . . 74.54 111.266 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.62 52.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.596 -0.729 . . . . 43.33 111.743 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.4 16.79 77.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.923 -0.656 . . . . 53.24 112.892 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -168.22 -84.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.117 -0.327 . . . . 74.21 110.117 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.28 144.92 4.2 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.283 -0.96 . . . . 14.14 112.67 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.8 m 62.67 61.15 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.323 0.582 . . . . 75.12 111.016 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.66 HD12 ' HB3' ' A' ' 71' ' ' LYS . 1.1 mm -118.31 138.29 49.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.805 -0.634 . . . . 74.24 109.836 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 39' ' ' VAL . 97.7 m-85 -122.28 154.13 37.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.53 0.205 . . . . 71.52 110.623 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.95 132.37 34.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.914 -0.773 . . . . 62.34 108.914 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.29 98.9 8.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 74.02 112.126 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.69 59.87 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.913 -0.585 . . . . 74.53 109.876 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.3 ttm -36.52 -72.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.162 0.914 . . . . 73.35 112.825 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -178.57 -176.27 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.3 m -70.76 123.67 22.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.574 -0.528 . . . . 70.04 109.574 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.58 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 16.0 t -105.63 176.95 5.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.238 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.32 -73.23 0.17 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 63.55 110.581 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -112.25 66.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.411 0.624 . . . . 72.44 109.703 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 59' ' ' SER . 12.6 p -81.62 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.675 -0.693 . . . . 55.42 110.16 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.61 165.48 40.6 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 109.728 -1.349 . . . . 54.24 109.728 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -79.95 60.42 3.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.424 0.63 . . . . 74.34 110.045 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -178.27 -120.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.636 -1.166 . . . . 72.42 108.664 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -179.2 93.45 0.21 Allowed Pre-proline 0 C--N 1.32 -0.679 0 C-N-CA 123.811 0.844 . . . . 60.3 108.821 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 84.9 Cg_endo -82.59 39.05 0.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.3 . . . . 70.23 112.836 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 70.9 m -136.81 137.57 39.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.577 0.704 . . . . 55.54 112.15 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.66 154.0 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.203 -0.908 . . . . 71.22 109.323 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.598 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.8 p -125.22 123.99 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.455 0.645 . . . . 74.43 111.746 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.66 ' HB3' HD12 ' A' ' 51' ' ' ILE . 10.5 ptmm? -103.23 133.81 47.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.228 -0.896 . . . . 53.25 109.487 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.57 148.72 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.082 0.401 . . . . 73.44 112.082 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 31.9 tt0 -142.43 139.49 17.63 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 171.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.39 176.19 2.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.312 2.008 . . . . 51.34 111.697 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.2 m -79.53 41.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.112 0.482 . . . . 65.32 111.537 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -84.06 -24.66 30.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.33 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 38.8 t30 70.01 75.76 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.429 0.633 . . . . 72.1 110.371 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -124.52 -128.21 3.25 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.48 -0.782 . . . . 63.44 112.271 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 19.3 Cg_endo -59.95 -35.0 94.85 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.874 2.383 . . . . 64.35 112.759 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.2 tm? -56.03 -50.01 72.12 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.122 0.264 . . . . 74.35 111.12 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -67.21 -38.14 84.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.745 0.307 . . . . 73.44 111.063 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.5 m -64.96 -46.84 79.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 65.24 109.811 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.697 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 39.7 tt0 -60.77 -43.34 98.16 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.694 -1.139 . . . . 45.15 110.209 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.22 -48.64 73.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.796 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -56.79 -58.5 7.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 74.54 110.276 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 79.6 t80 -59.67 -51.32 70.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.27 -0.877 . . . . 74.42 111.388 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.58 -47.16 85.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.343 -0.844 . . . . 70.12 111.648 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -68.32 -30.08 68.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 74.45 111.103 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.33 -30.36 62.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 73.41 111.521 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -34.37 11.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.468 0.544 . . . . 54.4 112.468 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.47 88.98 7.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.389 0.515 . . . . 50.22 112.389 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 95' ' ' GLN . 1.3 ttpp -146.12 105.86 4.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.989 -0.745 . . . . 53.4 108.989 171.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 -54.11 5.46 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.899 3.066 . . . . 72.14 115.041 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -33.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.381 . . . . 73.54 110.497 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 26.0 tp60 -65.03 -47.94 75.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 55.22 110.016 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 92' ' ' LYS . 74.2 mt -58.98 -53.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 115.676 -0.693 . . . . 65.42 110.685 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.0 -41.67 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 72.53 110.961 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -65.24 -53.18 48.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.145 -0.48 . . . . 73.34 111.502 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -72.91 -34.65 66.76 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.931 -0.708 . . . . 72.41 110.965 -175.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.4 mm -63.16 -45.17 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.666 0.27 . . . . 62.42 111.031 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -73.03 -27.9 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.807 0.337 . . . . 65.03 110.544 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.8 m -75.75 -40.87 54.68 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.12 0.486 . . . . 75.33 110.574 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.73 ' HG3' HD13 ' A' ' 105' ' ' LEU . 31.1 tpt180 -72.55 -18.41 61.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 73.2 110.365 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 39.8 tptt 67.57 54.05 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.963 -1.017 . . . . 51.12 110.217 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . 0.73 HD13 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mp -108.56 -167.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.824 -1.08 . . . . 75.04 109.449 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.11 -61.91 1.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.098 -0.334 . . . . 72.04 110.098 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -173.78 144.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 73.55 110.339 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HG ' HG23 ' A' ' 110' ' ' VAL . 44.3 tp -79.43 115.0 18.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.968 -0.753 . . . . 63.22 108.968 175.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' NH2' ' A' ' 160' ' ' ARG . . . -77.42 60.24 3.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.019 -0.61 . . . . 71.04 113.098 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 108' ' ' LEU . 92.1 t -123.47 132.87 24.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.384 -0.598 . . . . 55.14 109.384 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.69 152.83 12.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.103 2.535 . . . . 74.14 112.996 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -76.94 122.33 24.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 74.23 110.674 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -80.74 111.77 17.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.257 -0.883 . . . . 72.14 110.276 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 130' ' ' ILE . 40.4 m95 -90.2 -59.28 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.49 -0.559 . . . . 74.32 109.49 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.32 37.9 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.321 -0.854 . . . . 43.11 111.35 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.2 p -163.34 172.97 13.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.805 -0.443 . . . . 72.33 109.805 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.94 -173.01 40.78 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.124 -1.036 . . . . 75.24 112.271 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 125' ' ' SER . 8.6 tt -121.44 132.93 55.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.395 -0.595 . . . . 71.54 109.395 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -139.22 126.65 21.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.863 0.363 . . . . 72.11 110.422 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 21.6 t70 -75.68 126.75 31.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.803 -0.635 . . . . 71.4 110.487 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.861 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -83.45 -54.7 4.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.982 -0.377 . . . . 74.22 109.982 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.09 71.47 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.591 -0.522 . . . . 64.31 109.591 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.35 -19.08 49.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.831 -0.699 . . . . 73.31 111.632 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -113.76 120.0 39.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.124 -0.695 . . . . 64.45 109.124 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.6 p -92.87 134.52 35.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 71.44 110.813 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.09 140.24 50.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.974 -0.557 . . . . 73.31 110.312 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -105.61 124.56 49.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.083 -0.71 . . . . 70.43 109.083 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.598 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 48.7 p90 -122.29 154.42 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.075 -0.511 . . . . 62.15 110.869 -173.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 80.3 mtp -129.61 124.77 34.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 65.4 110.777 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ILE . . . . . 0.571 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 mm -98.13 121.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 63.34 110.461 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -133.25 178.09 7.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 74.01 109.321 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.3 p-10 -68.13 154.96 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 34.15 110.202 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -83.26 122.99 29.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.385 0.612 . . . . 71.11 112.118 -171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 90.2 m-85 -102.8 171.55 7.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.195 -0.911 . . . . 73.13 109.121 173.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.25 -30.43 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.886 -1.15 . . . . 65.01 113.24 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 49.9 m -105.27 125.67 51.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.048 0.424 . . . . 60.01 112.057 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 184' ' ' LEU . 3.9 m-20 -88.91 124.14 33.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.805 -0.634 . . . . 75.1 109.543 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 13.4 tp -64.35 -26.26 68.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.221 0.534 . . . . 73.4 109.768 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 28.2 tt0 -62.9 -48.7 77.84 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.787 -0.642 . . . . 71.21 110.977 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.74 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 9.0 mmpt? -70.07 -29.79 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.225 -0.443 . . . . 54.13 110.233 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.525 HG21 HD12 ' A' ' 341' ' ' LEU . 82.3 mt -65.09 -48.98 81.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.653 -0.703 . . . . 73.41 110.993 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.77 -32.12 73.21 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 119.866 -0.734 . . . . 74.34 109.68 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.05 -38.9 89.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 73.32 110.69 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.6 67.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.917 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASN . . . . . 0.464 ' ND2' ' HB2' ' A' ' 148' ' ' ARG . 55.4 t30 -104.55 6.09 34.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.432 . . . . 64.14 110.906 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.57 54.9 6.02 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.706 -0.679 . . . . 71.53 112.257 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.484 ' O ' ' HA2' ' A' ' 257' ' ' GLY . 46.3 mtmt 55.59 53.44 9.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 75.24 112.569 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.464 ' HB2' ' ND2' ' A' ' 145' ' ' ASN . 35.8 mmt180 -123.46 96.41 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 74.42 109.87 173.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.653 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 21.7 m-85 -102.14 132.21 48.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.202 -0.454 . . . . 62.34 111.016 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 m -58.2 144.96 38.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.504 -0.771 . . . . 74.14 109.628 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 294' ' ' ASN . 45.9 ttt85 -59.92 -37.9 80.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.686 -0.234 . . . . 62.12 111.51 -172.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 153' ' ' THR . 11.9 ptpt -61.67 -38.19 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 62.25 110.253 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.545 ' N ' ' HG3' ' A' ' 152' ' ' LYS . 9.0 m -68.0 -45.37 74.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.106 -0.497 . . . . 61.4 110.436 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.6 t -61.89 -47.34 93.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.385 -0.37 . . . . 72.32 110.585 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.784 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -62.84 -52.4 63.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 74.44 110.545 -176.333 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -63.48 -33.52 75.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.587 0.232 . . . . 74.2 110.812 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 161' ' ' ILE . 2.7 mp -65.94 -51.21 60.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 70.01 110.681 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 247' ' ' LEU . 36.3 p -58.18 -37.16 74.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.075 -0.25 . . . . 43.42 110.902 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 74.5 mt -60.33 -54.39 46.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 75.21 111.219 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.497 HH11 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -66.57 -15.76 63.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.118 0.485 . . . . 70.44 111.0 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 157' ' ' LEU . 37.4 mm -72.35 -42.41 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.452 -0.573 . . . . 63.11 109.452 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.524 ' HB3' ' HE1' ' A' ' 317' ' ' TYR . 2.2 mm? -62.04 -42.21 98.93 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.62 -0.263 . . . . 73.42 110.459 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -63.03 1.22 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.6 0.714 . . . . 64.22 110.703 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 168' ' ' ILE . 18.1 tt -68.16 -41.4 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.234 -0.894 . . . . 64.15 111.565 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 243' ' ' ASP . 30.9 mt -63.66 -39.02 93.29 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.516 -0.474 . . . . 72.0 110.885 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 7.5 tp10 -57.28 -56.68 18.63 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.819 -0.438 . . . . 71.53 109.819 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.8 -42.94 80.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.473 -0.785 . . . . 74.24 112.078 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 174' ' ' VAL . 28.1 pt -80.7 -40.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.943 0.719 . . . . 54.01 112.943 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' HA ' ' A' ' 166' ' ' GLU . 1.3 p-80 -75.89 -17.83 59.64 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.696 -0.802 . . . . 73.22 111.253 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.3 16.33 17.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 71.3 109.966 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -136.95 -89.01 0.28 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.106 -0.497 . . . . 65.33 110.88 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -147.56 114.96 6.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.615 0.245 . . . . 73.24 110.711 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 64.8 m-85 76.26 157.43 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.237 0.961 . . . . 74.43 112.35 169.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 22.2 m -142.33 172.41 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.394 -0.821 . . . . 72.2 109.594 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 14.2 t60 -119.9 103.12 9.06 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.984 -0.286 . . . . 54.11 110.414 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.503 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . -73.71 -46.93 22.33 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.847 -0.692 . . . . 51.4 112.114 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . 0.954 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 24.9 t70 -65.58 94.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.146 0.498 . . . . 72.33 110.281 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.466 HD11 HD12 ' A' ' 161' ' ' ILE . 8.3 tp -97.45 14.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.759 -0.655 . . . . 61.44 110.605 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -53.6 146.28 13.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.2 -0.455 . . . . 71.52 110.072 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.98 -10.65 6.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.807 0.669 . . . . 75.01 112.807 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.9 p -73.79 -15.93 61.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.983 0.42 . . . . 71.41 110.826 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.466 ' O ' HD12 ' A' ' 195' ' ' LEU . 41.3 m-80 -85.77 -16.67 38.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 75.41 110.751 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.73 115.0 29.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.972 -0.558 . . . . 35.44 110.253 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.0 mm? -110.69 135.21 51.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 63.54 110.229 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.9 mt -85.54 137.59 32.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.954 -0.567 . . . . 63.31 109.853 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -62.58 135.13 57.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.941 -0.572 . . . . 63.54 109.893 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -56.0 -33.54 64.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.847 -0.615 . . . . 73.11 112.126 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -81.86 -54.21 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 71.0 110.812 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.1 112.83 49.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.446 -0.343 . . . . 62.4 111.531 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.36 -10.56 28.35 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.845 2.363 . . . . 64.22 111.138 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ASP . . . . . 0.581 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 5.0 p-10 -88.67 0.67 56.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.433 -0.803 . . . . 65.43 110.592 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 77.4 mt-30 -114.07 102.64 10.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.526 . . . . 62.22 110.081 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.3 p -106.79 120.59 58.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.319 0.58 . . . . 73.25 110.703 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 93.3 m-85 -117.12 157.81 25.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.114 -0.494 . . . . 74.41 110.312 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 182' ' ' ASN . 31.6 tp -96.91 150.55 20.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.272 -0.422 . . . . 44.22 110.454 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 197' ' ' ASP . 3.0 p -136.39 -155.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.04 -0.726 . . . . 62.13 109.04 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.553 ' N ' HG13 ' A' ' 196' ' ' VAL . 9.2 t70 72.24 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.318 0.647 . . . . 72.32 109.706 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . 0.697 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 36.1 m-85 55.92 -7.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.246 1.202 . . . . 74.34 114.246 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 197' ' ' ASP . . . -72.72 -31.43 62.59 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.949 -0.861 . . . . 53.33 110.949 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.687 ' HB2' ' CE1' ' A' ' 175' ' ' HIS . 92.0 mt -89.06 53.53 2.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.069 0.462 . . . . 71.44 110.307 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 173' ' ' TYR . . . -98.75 99.0 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 62.42 110.163 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -122.35 104.57 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 75.51 111.888 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ARG . . . . . 0.572 ' HB2' HG22 ' A' ' 174' ' ' VAL . 31.9 ttm180 -178.73 -73.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.077 -0.51 . . . . 72.12 110.44 172.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' TYR . . . . . 0.507 ' H ' ' HA ' ' A' ' 173' ' ' TYR . 81.9 t80 70.61 112.4 0.05 Allowed 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 124.036 0.835 . . . . 72.23 111.044 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 56.6 m -116.07 100.89 53.89 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.056 -0.72 . . . . 73.31 109.056 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 11.5 Cg_endo -55.41 107.4 0.24 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.471 2.114 . . . . 63.14 111.818 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 206' ' ' PRO . 11.2 mm-40 72.29 16.05 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.84 -0.618 . . . . 70.24 110.746 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.55 74.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.891 -0.671 . . . . 50.12 111.878 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.3 111.61 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 73.41 110.015 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' HIS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 238' ' ' PRO . 24.7 p80 -87.55 147.16 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.448 . . . . 73.1 110.947 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' LYS . . . . . 0.43 ' HB2' ' HG2' ' A' ' 238' ' ' PRO . 53.6 mtpt -71.35 166.63 21.24 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 73.42 110.168 173.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 212' ' ' GLU . 8.6 pt-20 -82.7 174.34 11.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.852 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -74.96 88.54 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.953 0.882 . . . . 74.11 110.66 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -138.85 12.69 2.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.266 -0.879 . . . . 44.01 110.494 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' GLU . . . . . 1.082 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 4.1 mm-40 -102.52 118.04 36.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 72.44 111.472 -171.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -150.41 82.75 6.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.84 -0.8 . . . . 75.41 108.84 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.14 -51.82 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.297 1.998 . . . . 74.31 111.474 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 75.0 mmtt -146.78 6.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 74.54 110.161 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 234' ' ' ASN . 8.3 mtm-85 63.75 94.42 0.05 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.976 0.893 . . . . 55.31 108.64 -162.098 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 233' ' ' HIS . 66.0 m -79.19 -168.53 1.52 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.076 -1.42 . . . . 72.22 113.069 -165.327 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 -178.48 93.81 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.712 -1.586 . . . . 71.04 108.246 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -76.69 -64.74 1.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 63.44 111.768 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLY . . . . . 0.954 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -109.51 -104.17 2.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.75 -0.738 . . . . 74.34 112.81 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 228' ' ' THR . 2.2 p -89.82 146.99 24.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.671 0.272 . . . . 63.1 110.525 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -68.22 -27.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 74.22 110.548 -175.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -55.74 5.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.487 -0.324 . . . . 52.05 110.14 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' PHE . . . . . 0.415 ' HB3' HG22 ' A' ' 178' ' ' ILE . 90.8 m-85 -86.15 3.16 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.017 0.377 . . . . 74.33 112.017 -169.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 6.8 t -77.71 -6.02 52.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 72.24 110.517 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.571 ' HA ' ' HE2' ' A' ' 249' ' ' TYR . 41.9 t 65.96 173.36 0.23 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.147 0.499 . . . . 75.15 111.168 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.7 -34.84 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.222 0.534 . . . . 73.41 109.57 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.79 -62.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.281 -0.872 . . . . 73.32 112.294 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -65.43 -28.38 69.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 54.53 110.939 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' HIS . . . . . 0.531 ' HB2' HG23 ' A' ' 228' ' ' THR . 14.3 t-80 -74.82 -17.82 60.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.381 -0.372 . . . . 61.51 110.719 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 219' ' ' ARG . 47.7 t30 -82.94 -30.06 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.693 -0.855 . . . . 63.1 108.693 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 109.75 -9.1 32.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.237 -0.892 . . . . 55.32 112.392 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' VAL . . . . . 1.082 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 5.3 p -62.04 109.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.619 0.723 . . . . 75.43 110.172 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -67.46 -61.43 4.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 54.31 112.433 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 31.5 Cg_endo -93.79 73.08 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.673 2.248 . . . . 55.01 113.573 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.9 t -132.46 110.42 10.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.795 0.331 . . . . 42.5 110.701 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' ARG . . . . . 0.453 ' HA ' ' OD1' ' A' ' 243' ' ' ASP . 29.8 ttt180 -66.73 -16.91 64.57 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.552 0.692 . . . . 65.33 110.492 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . 0.962 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.53 -43.36 75.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.904 -1.043 . . . . 75.33 109.61 175.334 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -63.74 -46.32 92.22 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.128 -0.942 . . . . 64.21 112.423 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ASP . . . . . 0.532 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -47.28 -51.57 18.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.645 0.736 . . . . 65.54 110.358 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.4 -31.95 64.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.858 -1.065 . . . . 72.34 111.956 -173.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.96 -38.66 64.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.7 -0.4 . . . . 65.52 110.547 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ILE . . . . . 0.503 HD13 ' HA2' ' A' ' 176' ' ' GLY . 90.9 mt -58.69 -48.38 86.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.375 0.607 . . . . 64.22 110.59 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -59.73 -41.03 89.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.645 -0.707 . . . . 74.32 110.06 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 252' ' ' ILE . . . -54.84 -41.98 77.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.01 -0.614 . . . . 75.4 112.111 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' TYR . . . . . 0.571 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 19.4 m-30 -55.94 -59.49 4.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.808 0.337 . . . . 71.32 111.026 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 247' ' ' LEU . 25.6 p -62.35 -36.15 81.32 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.552 -0.459 . . . . 51.44 111.32 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.2 mtp -60.99 -54.39 45.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.667 0.27 . . . . 54.55 111.278 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 248' ' ' GLY . 8.9 tt -68.36 -36.49 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 64.22 110.677 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.573 0.225 . . . . 53.44 111.348 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 39.0 m0 -75.77 -27.39 58.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 74.12 110.991 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 tp -84.24 -31.52 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.347 -0.388 . . . . 74.41 111.72 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.3 p -101.73 -20.95 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.06 -0.4 . . . . 73.13 111.52 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 85.11 -19.58 21.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.9 -0.667 . . . . 75.44 112.851 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.9 143.65 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.785 -0.45 . . . . 61.55 109.785 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 262' ' ' GLU . 86.6 mt -119.58 141.76 31.55 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.132 -0.321 . . . . 63.41 110.132 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 48.1 Cg_exo -57.08 -45.68 34.08 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.031 2.487 . . . . 63.02 112.504 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 36.8 p90 -80.29 -17.87 50.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.904 -0.589 . . . . 72.13 110.755 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' GLU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 259' ' ' LEU . 1.8 tm-20 -77.7 -35.31 52.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.294 0.569 . . . . 70.43 109.763 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.52 -34.53 76.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.317 0.58 . . . . 54.11 110.041 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -108.45 24.76 12.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 73.52 111.992 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.439 ' HA ' HG13 ' A' ' 271' ' ' VAL . 3.4 pp -71.81 -1.33 13.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.756 0.312 . . . . 74.34 111.666 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.54 -6.25 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.469 -0.332 . . . . 74.52 110.747 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 33.0 t70 -139.06 125.56 12.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.108 -0.33 . . . . 64.0 110.108 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 36.4 Cg_exo -60.4 -21.71 68.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.306 2.671 . . . . 72.43 113.981 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.87 -39.39 79.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.726 -0.39 . . . . 44.53 110.17 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' TYR . . . . . 0.61 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 44.8 m-85 -65.88 -50.45 64.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 73.12 111.456 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' VAL . . . . . 0.617 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 30.0 m -63.3 -35.18 71.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.992 -0.283 . . . . 74.01 111.201 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 276' ' ' ILE . 38.8 ttp180 -63.17 -62.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.987 0.422 . . . . 71.11 110.408 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 11.2 t70 -62.99 -44.41 96.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.515 -0.766 . . . . 71.04 111.352 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' SER . . . . . 0.478 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 25.1 m -61.18 -47.41 86.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.406 . . . . 60.32 111.225 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.8 -36.63 84.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.79 -0.364 . . . . 72.23 111.132 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.5 mt -60.38 -42.65 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.601 0.238 . . . . 74.1 110.585 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 273' ' ' ASP . 57.2 mtt180 -61.14 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.404 -0.362 . . . . 64.1 110.755 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 278' ' ' TYR . . . . . 0.478 ' HD1' ' O ' ' A' ' 274' ' ' SER . 35.7 m-85 -69.86 -43.67 71.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.057 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' ARG . . . . . 0.493 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 2.3 ptm180 -67.99 -25.21 65.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.908 -0.317 . . . . 65.44 111.347 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -85.5 -42.79 14.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.872 0.368 . . . . 74.34 110.803 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -130.51 87.45 2.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.138 0.494 . . . . 73.31 110.351 -177.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -81.64 -40.67 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.428 0.899 . . . . 61.42 113.428 -172.0 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -65.89 -51.35 59.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.345 0.868 . . . . 55.24 113.345 -163.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.7 p -77.04 -28.89 55.0 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.574 -0.45 . . . . 74.11 110.944 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -64.95 -54.97 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 73.44 110.458 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -63.47 -39.67 95.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.602 -0.272 . . . . 75.33 111.316 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.84 -38.29 90.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 74.2 111.486 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -91.75 -20.31 21.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.728 0.64 . . . . 74.24 112.728 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.25 -44.9 86.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.748 0.309 . . . . 75.02 111.199 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 296' ' ' PRO . 17.5 p90 -136.82 89.74 17.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 122.002 0.906 . . . . 65.21 110.77 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.11 49.43 3.03 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.856 2.371 . . . . 71.11 111.986 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -100.39 -145.59 0.34 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.332 -0.395 . . . . 64.15 110.807 -178.332 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 293' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 70.1 mmtt -120.03 17.29 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.646 0.98 . . . . 62.13 113.646 -166.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.501 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 14.6 m-80 -93.13 -15.99 25.41 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.184 -0.323 . . . . 65.55 110.345 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 11.4 mptt 75.1 112.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 123.847 0.717 . . . . 61.34 111.05 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 290' ' ' PHE . 96.7 Cg_endo -83.04 37.71 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.551 2.167 . . . . 45.4 112.255 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -81.72 -68.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.9 -0.667 . . . . 64.13 112.5 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLU . . . . . 0.414 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.9 mp0 -55.98 -36.63 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 122.045 0.138 . . . . 60.0 111.266 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 2.9 mp -61.71 -49.53 83.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.827 0.346 . . . . 74.35 110.609 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.36 85.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 63.2 110.807 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 301' ' ' LYS . 69.1 mmtt -68.3 -31.59 71.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.275 -0.42 . . . . 71.51 111.808 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 82.5 t80 -62.24 -47.68 83.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.079 0.466 . . . . 75.4 110.257 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG22 ' A' ' 306' ' ' VAL . 68.6 mtp -73.25 -31.13 63.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.323 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 33.2 tt0 -59.76 -44.16 93.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.745 -0.835 . . . . 70.34 108.745 171.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 58.6 m -58.47 -46.44 86.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.91 -1.041 . . . . 64.21 111.695 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 303' ' ' MET . 14.1 m -68.17 -26.21 33.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.97 -0.292 . . . . 71.52 111.25 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 18.5 ttmt -74.68 -34.08 62.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 72.41 110.14 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 91.7 mt -81.99 5.16 20.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 72.44 112.126 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 315' ' ' PRO . 4.2 pp -107.19 9.28 30.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.417 0.627 . . . . 71.42 109.452 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 12.2 t70 67.41 -81.82 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.335 -1.302 . . . . 65.41 111.887 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' TYR . . . . . 0.962 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.8 OUTLIER -161.91 -48.81 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.954 0.883 . . . . 63.04 109.364 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 m -145.4 35.94 1.08 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.052 -1.092 . . . . 75.51 108.052 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' GLU . . . . . 0.564 ' O ' ' HD3' ' A' ' 314' ' ' LYS . 3.4 tm-20 -77.54 -82.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.898 -1.047 . . . . 73.52 108.793 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 313' ' ' GLU . 0.6 OUTLIER -150.96 99.73 3.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.051 -0.722 . . . . 64.35 109.051 171.348 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.534 ' HA ' HD22 ' A' ' 309' ' ' LEU . 24.4 Cg_exo -63.28 118.28 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.017 1.812 . . . . 72.34 111.124 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.9 84.02 4.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.384 0.612 . . . . 63.41 110.55 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' TYR . . . . . 0.524 ' HE1' ' HB3' ' A' ' 162' ' ' LEU . 61.5 t80 -64.41 -38.89 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.333 -0.848 . . . . 72.34 110.807 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 39.8 tt0 -56.73 -55.09 38.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.342 -0.845 . . . . 60.41 111.327 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -57.05 -50.3 73.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.127 -0.488 . . . . 52.33 111.776 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 4.2 pp -65.05 -40.26 94.51 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.903 -0.319 . . . . 62.11 111.641 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 321' ' ' ARG . . . . . 0.433 ' N ' HD12 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.47 -25.51 59.44 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.332 -0.547 . . . . 72.22 109.886 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 318' ' ' GLU . 0.4 OUTLIER -73.5 -45.39 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 74.42 110.413 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.13 -31.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.931 -0.307 . . . . 74.33 111.14 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.7 mt -63.79 -48.62 76.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.911 0.386 . . . . 73.12 110.175 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.9 -38.67 89.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.161 -0.472 . . . . 50.01 110.688 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -60.74 -44.79 96.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 54.12 110.891 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.414 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.76 -46.37 83.49 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.772 . . . . 70.12 112.556 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' LEU . . . . . 0.784 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 1.8 tm? -63.49 -38.87 92.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 64.34 110.038 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 72.35 110.652 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.31 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 51.52 111.812 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 328' ' ' LEU . 40.5 pt -76.8 -6.34 8.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.844 0.354 . . . . 72.11 111.362 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.06 25.44 14.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.483 -0.865 . . . . 73.23 113.149 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 41.1 m -129.02 147.71 50.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.921 0.36 . . . . 44.54 110.985 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -172.1 75.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.648 0.737 . . . . 74.13 110.324 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -94.41 -8.32 39.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 55.23 110.613 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.0 t70 82.03 -19.73 0.4 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.669 0.788 . . . . 62.4 112.352 171.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . 155.5 50.34 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.554 -1.308 . . . . 73.45 113.842 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 338' ' ' LYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 21.2 ttmm -119.55 99.82 6.9 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.997 -0.742 . . . . 73.42 108.997 170.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 339' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 153' ' ' THR . 37.8 mt -86.8 151.67 23.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.157 -0.929 . . . . 74.2 112.036 -169.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -114.72 91.1 3.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.594 -0.73 . . . . 70.55 110.221 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 141' ' ' ILE . 3.2 mm? -99.04 -46.95 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.129 -0.487 . . . . 75.45 109.746 175.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 45.3 m 70.55 -44.77 0.58 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 73.12 113.324 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.79 -34.39 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.109 0.411 . . . . 74.13 112.109 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 344' ' ' VAL . . . . . 0.478 ' HB ' ' OG ' ' A' ' 136' ' ' SER . 34.6 m 40.97 43.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.007 0.923 . . . . 75.25 113.366 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -68.2 147.36 52.35 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.81 -0.632 . . . . 63.35 111.511 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -115.42 148.04 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 54.42 110.778 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 347' ' ' GLY . . . . . 0.561 ' HA3' ' HD2' ' A' ' 140' ' ' LYS . . . -152.41 -56.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 63.23 113.135 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 73.99 91.37 0.15 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.147 -0.549 . . . . 72.4 113.034 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 350' ' ' LYS . 4.7 tt -152.39 92.38 1.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.642 -0.328 . . . . 63.3 110.423 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 350' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 349' ' ' LEU . 0.6 OUTLIER -159.56 104.51 1.61 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.67 178.45 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -142.66 91.35 2.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.796 0.332 . . . . 63.41 111.347 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' LYS . . . . . 0.528 ' HB3' HD21 ' A' ' 200' ' ' LEU . 0.4 OUTLIER -159.5 155.3 26.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.13 0.491 . . . . 64.4 110.894 176.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.0 t -129.39 168.89 15.62 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.069 -1.086 . . . . 73.02 108.069 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 200' ' ' LEU . 3.4 pt -66.01 142.67 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.417 0.627 . . . . 54.13 111.836 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 m -73.07 72.46 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.857 -1.065 . . . . 51.42 110.583 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -115.35 -48.26 2.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.726 -0.67 . . . . 72.03 111.282 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' LYS . . . . . 0.666 ' HG2' ' H ' ' A' ' 358' ' ' ARG . 31.7 ttmt -171.63 -166.35 0.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.947 -1.131 . . . . 63.32 107.947 -173.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ARG . . . . . 0.666 ' H ' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -86.72 -62.24 1.55 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 72.21 109.865 172.141 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 66.1 mttp -138.4 149.24 45.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.454 -0.339 . . . . 63.5 110.509 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 360' ' ' LYS . 1.8 tmtp? . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.116 -0.945 . . . . 74.12 110.373 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.35 110.358 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.75 1.29 56.34 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.778 -0.725 . . . . 64.2 113.24 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.8 mt-10 -70.05 110.08 4.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.275 0.537 . . . . 75.41 109.642 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.905 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -89.74 133.47 31.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.157 0.503 . . . . 75.22 110.499 178.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.59 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.79 -0.641 . . . . 74.4 110.888 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 24.0 m -84.65 125.67 32.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.736 0.303 . . . . 64.41 110.534 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -170.5 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 63.32 110.462 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 75.1 mtm -71.67 -20.55 61.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.778 0.288 . . . . 71.42 111.778 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.71 1.95 32.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.999 0.428 . . . . 54.11 110.343 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 71.22 24.37 3.83 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.141 -0.936 . . . . 71.23 112.595 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 30' ' ' THR . 90.1 mttt -103.05 136.72 42.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 52.14 109.532 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.905 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 19.2 tt0 -96.66 97.38 9.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.564 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 63.3 m95 -80.85 128.09 33.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.341 -0.845 . . . . 73.31 111.217 -172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.727 ' HB3' ' HA ' ' A' ' 56' ' ' MET . 68.1 tttt -92.01 108.02 19.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.294 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' GLU . 10.0 p -68.74 136.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.949 0.404 . . . . 62.22 110.124 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -109.15 -86.13 1.75 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.694 -0.765 . . . . 40.22 112.588 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 95.2 mt -106.78 136.45 19.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.859 0.361 . . . . 72.35 111.527 -174.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.2 Cg_exo -78.07 106.69 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.163 2.575 . . . . 73.12 111.431 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 45' ' ' GLN . 60.0 mt -73.9 -49.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 75.02 110.063 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.59 -23.56 12.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.907 -0.663 . . . . 52.24 112.371 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.3 mp0 -110.35 164.79 12.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.115 -0.328 . . . . 64.45 110.115 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.83 -166.57 28.33 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.644 -0.983 . . . . 74.0 110.644 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.835 ' HA3' HG11 ' A' ' 196' ' ' VAL . . . -82.54 46.65 3.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.402 -0.904 . . . . 74.43 112.463 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.448 ' HB3' HD11 ' A' ' 51' ' ' ILE . 65.8 t80 177.93 -59.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.999 0.428 . . . . 74.12 110.013 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.32 154.78 8.97 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.532 -0.758 . . . . 73.04 111.215 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.4 m 59.27 38.4 23.3 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.23 0.538 . . . . 71.5 111.322 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 48' ' ' PHE . 16.6 mm -88.43 138.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.94 -0.573 . . . . 71.12 110.062 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' A' ' 39' ' ' VAL . 87.4 m-85 -108.13 152.59 24.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 72.13 110.999 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.71 143.62 30.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.257 -0.646 . . . . 75.31 109.257 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.57 114.67 27.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.19 0.519 . . . . 72.12 111.137 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 28.3 t70 -84.98 -40.81 16.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.802 -0.635 . . . . 54.14 109.649 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.727 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 96.7 mmm 63.21 173.99 0.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.079 -0.964 . . . . 74.43 112.345 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -89.57 108.71 19.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.796 -0.638 . . . . 73.14 109.913 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -83.31 83.43 7.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.117 0.484 . . . . 53.24 110.363 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m . . . . . 0 C--N 1.326 -0.423 0 CA-C-N 115.778 -0.647 . . . . 70.13 110.731 179.449 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.516 0 N-CA-C 112.915 0.709 . . . . 51.23 112.915 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 7.8 Cg_exo -74.16 51.44 2.46 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.575 2.184 . . . . 71.42 113.912 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 31.2 p -138.93 162.44 34.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.075 0.464 . . . . 72.32 111.286 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.48 166.37 27.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 64.01 109.369 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.6 p -136.33 128.99 45.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.536 -0.466 . . . . 64.23 112.138 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' SD ' ' A' ' 129' ' ' MET . 32.6 ttpt -85.35 142.55 29.24 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.826 -0.624 . . . . 63.35 109.582 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.83 132.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.952 -0.388 . . . . 71.05 109.952 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 5.1 tp10 -140.1 135.64 16.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.299 -0.409 . . . . 62.42 109.99 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.13 143.55 94.78 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.499 2.133 . . . . 73.23 112.151 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t -71.61 -2.64 17.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.388 -0.369 . . . . 71.12 111.66 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.2 -22.23 64.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.292 -0.633 . . . . 72.41 109.292 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.63 105.49 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.843 -1.071 . . . . 72.11 113.128 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -108.38 -89.63 2.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.298 -0.865 . . . . 72.13 111.13 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -84.83 -20.75 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.386 2.724 . . . . 74.23 111.831 176.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 55.2 tp -52.26 -49.53 63.87 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.405 0.891 . . . . 72.42 113.405 -169.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.2 -45.2 95.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.395 -0.522 . . . . 74.12 111.008 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.0 m -64.95 -46.51 81.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.022 0.439 . . . . 54.42 110.68 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 36.1 tt0 -65.29 -52.45 54.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.403 -0.817 . . . . 73.24 111.276 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.93 -39.36 90.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.41 110.918 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.05 -49.72 76.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.805 -0.443 . . . . 63.22 109.805 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.466 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 76.2 t80 -65.93 -44.42 85.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.714 -0.676 . . . . 74.22 110.316 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.95 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 68.2 t80 -54.96 -53.9 49.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.804 -0.634 . . . . 54.32 111.005 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.54 -31.76 72.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.921 -0.581 . . . . 72.02 110.705 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -78.83 -29.52 44.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 71.12 111.877 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.66 -35.35 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.912 0.338 . . . . 75.53 111.912 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -83.64 71.52 10.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.748 0.785 . . . . 64.12 110.567 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 96' ' ' ILE . 4.6 tmtt? -125.02 103.79 30.17 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.839 -1.073 . . . . 64.24 109.428 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -42.98 -47.94 7.99 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.083 3.189 . . . . 53.42 113.368 -174.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 11.1 tp10 -57.99 -60.19 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 74.12 110.721 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -61.7 -41.46 97.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.566 -0.743 . . . . 72.31 111.504 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 69.6 mt -58.03 -52.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 O-C-N 123.073 0.233 . . . . 65.13 110.82 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -58.45 -42.61 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.532 -0.304 . . . . 64.34 110.959 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.7 mmtp -61.86 -62.67 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.907 -0.588 . . . . 62.53 111.943 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.643 ' CH2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.9 -35.23 72.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.584 -0.447 . . . . 71.02 111.643 -171.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.938 -0.305 . . . . 70.51 110.393 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -69.17 -41.33 77.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 53.12 111.129 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 p -76.4 -31.79 58.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.843 0.682 . . . . 73.3 112.843 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 36.1 ttm180 -89.7 5.54 45.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.065 0.459 . . . . 61.03 110.557 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 61.71 30.39 18.43 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.631 -0.713 . . . . 64.34 110.648 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HG ' ' OD1' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -78.95 161.3 26.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.571 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HB2' HH22 ' A' ' 321' ' ' ARG . 5.5 tmtm? -85.61 -66.29 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -163.07 135.51 5.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 72.42 110.817 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.643 HD22 ' CH2' ' A' ' 99' ' ' TRP . 26.7 tp -79.6 121.12 24.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 72.5 110.32 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.96 56.36 4.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.876 -0.678 . . . . 60.22 112.717 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 93.1 t -128.15 125.56 23.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.922 -0.399 . . . . 70.44 109.922 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.95 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -56.1 143.78 82.58 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.897 2.398 . . . . 75.11 112.593 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 113' ' ' TYR . 20.8 tptm -67.79 131.56 45.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 73.55 111.003 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.453 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 77.7 t80 -80.69 124.47 29.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 61.5 110.341 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.624 ' CD1' HG22 ' A' ' 130' ' ' ILE . 14.2 m95 -106.11 -58.67 1.88 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.476 -0.564 . . . . 72.15 109.476 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.39 174.51 35.56 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.048 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.9 p -171.27 147.82 2.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.554 -0.535 . . . . 74.22 109.554 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.32 -167.9 33.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.116 -1.04 . . . . 50.02 112.611 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.5 tt -126.95 133.46 50.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.723 -0.473 . . . . 75.04 109.723 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -134.84 109.48 8.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.473 -0.331 . . . . 70.34 110.29 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.834 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 18.0 t70 -73.68 122.88 23.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.115 -0.493 . . . . 71.3 109.69 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 66.0 tttp -129.46 121.56 27.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.071 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 20.1 m120 63.74 16.5 9.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.915 -0.584 . . . . 62.04 111.658 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.57 -0.25 56.76 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.685 -0.769 . . . . 74.45 112.405 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -117.22 115.35 25.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.095 -0.705 . . . . 70.13 109.095 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.834 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.7 p -76.31 119.61 20.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 72.44 111.157 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 129.81 55.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 75.31 109.656 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.42 134.37 40.77 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.796 -0.816 . . . . 71.52 108.796 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.54 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 44.6 p90 -122.48 142.88 50.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.233 -0.44 . . . . 63.12 111.021 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.642 ' SD ' ' HE2' ' A' ' 71' ' ' LYS . 15.4 ptm -129.87 131.22 46.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 73.1 109.993 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 70' ' ' VAL . 3.3 mm -97.5 123.04 49.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 72.21 110.624 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 38.4 mtm -126.5 178.38 5.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 71.13 110.415 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -65.58 151.39 46.56 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.625 -0.509 . . . . 73.1 109.625 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -72.23 116.12 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.254 0.549 . . . . 72.23 111.113 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 17.0 m-85 -104.97 143.35 33.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.214 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.527 ' HA3' ' CD1' ' A' ' 187' ' ' TYR . . . -140.16 -15.36 0.52 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.475 -0.869 . . . . 61.14 112.721 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.887 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 13.6 m -122.2 132.29 54.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.682 -0.305 . . . . 73.11 110.503 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 139' ' ' GLN . 3.6 p30 -125.74 148.88 48.93 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.843 -0.428 . . . . 74.33 109.843 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.44 HD21 HD21 ' A' ' 157' ' ' LEU . 9.8 mp -74.71 -8.1 55.34 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.989 0.366 . . . . 53.15 111.989 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.413 ' HB3' ' OD1' ' A' ' 137' ' ' ASP . 7.5 tp-100 -76.91 -48.6 17.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 64.44 110.647 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.58 -37.22 62.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.949 0.404 . . . . 61.21 110.049 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.44 -33.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.503 176.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.5 ' CE1' ' HD2' ' A' ' 147' ' ' LYS . 13.9 t80 -53.23 -46.59 69.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.009 -0.541 . . . . 75.2 109.581 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -71.22 -52.91 16.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.476 -0.784 . . . . 72.23 110.796 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.07 73.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.912 0.708 . . . . 74.24 112.912 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -104.23 10.03 35.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.92 0.39 . . . . 71.35 110.368 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.404 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 53.28 40.27 31.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.742 -0.663 . . . . 50.31 111.628 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER 42.73 30.78 0.26 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.583 1.153 . . . . 61.2 113.669 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -86.27 95.01 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.515 -0.474 . . . . 74.52 110.042 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 66.5 m-85 -109.15 119.8 40.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.078 -0.51 . . . . 74.24 109.828 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.7 m -74.7 168.18 20.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.266 -0.424 . . . . 72.52 110.72 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 53.2 mtm-85 -51.67 -47.0 64.0 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.315 -0.402 . . . . 63.51 111.648 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 153' ' ' THR . 0.0 OUTLIER -63.99 -30.05 71.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.853 0.358 . . . . 64.1 111.29 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.567 ' N ' ' HD3' ' A' ' 152' ' ' LYS . 1.3 m -72.49 -52.12 17.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.895 0.378 . . . . 72.21 110.383 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -41.06 91.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.71 -0.677 . . . . 75.5 110.913 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.04 -50.11 75.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 74.34 110.764 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.619 ' NE2' ' HA ' ' A' ' 335' ' ' ASP . 1.5 mp0 -64.06 -38.31 90.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.557 -0.292 . . . . 62.52 111.264 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 161' ' ' ILE . 4.8 mp -60.94 -52.83 63.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 62.21 110.558 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.6 p -68.03 -31.85 71.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 64.33 111.095 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.0 tp -57.03 -53.11 61.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 71.42 111.043 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 156' ' ' GLN . 2.1 mpt_? -67.91 -29.41 68.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.938 0.399 . . . . 73.31 110.638 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 157' ' ' LEU . 40.3 mm -65.73 -36.96 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 51.22 110.241 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 158' ' ' SER . 94.2 mt -62.16 -43.53 98.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 60.22 110.441 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.644 ' OD1' ' HG ' ' A' ' 105' ' ' LEU . 51.3 m-20 -55.71 -54.37 45.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.352 0.596 . . . . 73.2 110.484 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.98 -37.77 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 75.24 111.948 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.63 -38.58 90.79 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.829 -0.349 . . . . 72.22 111.169 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.39 -47.82 75.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.229 -0.588 . . . . 72.11 110.075 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.538 ' HA ' ' OE2' ' A' ' 170' ' ' GLU . 63.5 t80 -58.49 -41.67 85.83 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.437 0.532 . . . . 75.25 112.437 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.466 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 pt -88.29 -33.3 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.601 -0.439 . . . . 60.45 112.069 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.769 ' HD2' ' HD3' ' A' ' 240' ' ' ARG . 37.0 t60 -91.57 -5.92 53.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.665 0.269 . . . . 71.33 111.064 -172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 167' ' ' TYR . 13.2 pt-20 -78.81 -19.79 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.482 . . . . 72.11 109.734 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -97.49 -65.07 0.99 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.91 -0.587 . . . . 73.32 111.447 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 203' ' ' ARG . 35.7 tt0 -162.05 -44.31 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.24 0.829 . . . . 61.42 113.24 -168.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -80.49 158.06 25.97 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.246 0.832 . . . . 73.41 113.246 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.727 HG12 ' CE1' ' A' ' 169' ' ' HIS . 3.6 m -129.7 172.26 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.58 -1.191 . . . . 74.22 108.48 171.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 19.7 t-80 -144.64 92.49 2.3 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.115 -0.698 . . . . 75.24 109.115 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -63.71 -47.33 87.54 Favored Glycine 0 C--O 1.226 -0.4 0 O-C-N 123.522 0.514 . . . . 73.25 113.67 -170.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.568 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.1 t0 -99.02 105.44 17.57 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.387 -0.478 . . . . 72.14 110.525 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.407 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 29.0 mm -89.97 91.3 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 74.02 109.575 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -93.98 149.82 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.372 -0.831 . . . . 72.31 109.798 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 138' ' ' LEU . . . -54.85 -26.83 37.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 45.11 111.733 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.5 p -77.39 -5.58 50.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.945 0.35 . . . . 72.23 111.945 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 197' ' ' ASP . 12.2 m120 -83.18 -22.96 33.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 71.13 110.809 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.75 115.97 31.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.426 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.5 HD21 HG12 ' A' ' 196' ' ' VAL . 2.6 mm? -113.83 131.8 56.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.817 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.887 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.8 mt -89.45 140.92 29.04 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.178 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 189' ' ' ASN . 43.7 t-20 -59.71 125.61 24.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.97 -0.752 . . . . 71.31 108.97 175.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.527 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 36.2 t80 -52.6 -31.27 35.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.507 0.558 . . . . 74.42 112.507 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -126.91 24.55 6.44 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.381 -0.527 . . . . 71.41 111.914 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 6.1 t30 -159.57 80.78 2.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.456 -0.572 . . . . 72.14 109.456 174.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.67 -24.26 55.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 123.33 2.686 . . . . 63.05 113.993 -170.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 338' ' ' LYS . 4.4 p30 -71.0 -14.38 62.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.926 -0.309 . . . . 73.05 111.592 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.404 ' HG3' ' OD1' ' A' ' 191' ' ' ASP . 77.1 mt-30 -114.04 114.75 26.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 50.11 110.294 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.68 142.86 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.831 . . . . 72.1 110.787 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.785 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 59.1 m-85 -115.92 157.97 23.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 65.44 109.945 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 8.9 tt -115.97 141.21 48.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 70.25 109.792 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.835 HG11 ' HA3' ' A' ' 47' ' ' GLY . 1.4 p -141.27 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.568 -0.901 . . . . 72.21 108.568 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 196' ' ' VAL . 17.8 t70 68.74 65.49 0.31 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 53.23 108.449 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 83' ' ' GLU . 85.6 m-85 -88.49 16.52 6.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.099 -1.409 . . . . 71.14 110.656 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -70.33 -26.52 74.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.702 -0.761 . . . . 72.43 111.296 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 177' ' ' ASP . 35.7 mt -88.78 36.38 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 72.4 110.494 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -106.07 98.88 8.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.161 0.505 . . . . 73.44 110.354 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -100.27 145.84 27.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.964 -0.754 . . . . 71.21 108.964 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.608 ' HB2' ' HG2' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -88.86 130.54 35.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.164 0.506 . . . . 70.43 111.028 -177.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -103.23 -54.0 2.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 74.22 110.088 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.18 94.43 30.57 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.792 -0.64 . . . . 72.54 110.427 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 207' ' ' GLU . 18.5 Cg_endo -60.0 123.17 12.65 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.486 2.124 . . . . 61.02 111.523 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 206' ' ' PRO . 32.4 tt0 70.31 -63.96 0.38 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.865 0.728 . . . . 75.21 111.076 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.68 28.51 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.413 -0.675 . . . . 73.32 111.413 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.94 110.7 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.211 -0.292 . . . . 75.11 110.211 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -75.94 104.41 6.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.914 . . . . 64.31 108.531 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -88.44 0.08 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.906 -0.588 . . . . 71.03 111.631 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 173.05 139.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.442 -0.947 . . . . 74.4 108.442 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -84.3 87.92 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.075 0.941 . . . . 71.02 110.241 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 3.0 mmtt -155.24 33.15 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.031 -0.986 . . . . 64.21 109.947 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.3 -5.55 54.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.316 -0.856 . . . . 71.05 109.645 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.7 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.1 p-10 -79.33 113.8 39.63 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.144 -0.935 . . . . 72.15 111.499 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo . . . . . 0 N--CA 1.45 -1.04 0 C-N-CA 122.515 2.144 . . . . 72.11 111.876 175.644 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.521 0.677 . . . . 74.31 109.613 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 102.23 -166.28 17.42 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.691 -0.766 . . . . 74.4 112.293 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 70.4 p -80.29 151.35 29.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.961 0.41 . . . . 62.2 110.994 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 228' ' ' THR . 17.9 tt -63.02 -9.02 3.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.67 0.747 . . . . 63.34 110.885 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.05 -68.13 0.32 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.783 -1.098 . . . . 75.41 111.521 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.422 ' HB3' HG23 ' A' ' 246' ' ' ILE . 77.7 m-85 -103.24 -11.19 18.16 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.243 0.46 . . . . 61.1 112.243 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.6 t -62.34 -8.94 6.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.01 0.374 . . . . 74.53 112.01 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.9 t 62.49 -174.04 0.15 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.771 0.429 . . . . 60.23 110.9 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.7 mp -73.33 -40.19 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.382 -0.599 . . . . 72.2 109.382 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 236' ' ' VAL . 2.1 m-20 -49.69 -72.65 0.05 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.603 -1.18 . . . . 73.4 111.934 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.42 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 72.44 111.53 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 67.6 t60 -62.46 -39.8 94.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.537 0.208 . . . . 74.41 110.579 178.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.24 -26.19 61.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.659 . . . . 74.23 109.219 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 110.75 7.25 25.87 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.775 -0.648 . . . . 73.45 112.817 177.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 9.5 p -89.94 136.98 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.973 0.416 . . . . 60.51 110.413 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.92 115.07 43.08 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 74.13 109.891 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.677 ' HB2' ' HA3' ' A' ' 242' ' ' GLY . 81.7 Cg_endo -79.28 148.97 21.59 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.647 2.231 . . . . 73.34 112.857 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.5 t -85.47 -159.95 0.48 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.797 -0.816 . . . . 55.52 108.797 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.769 ' HD3' ' HD2' ' A' ' 169' ' ' HIS . 14.9 mmt-85 -54.18 -35.55 62.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.75 0.309 . . . . 71.53 111.237 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 8.2 mmm180 -56.65 -32.89 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 72.41 112.125 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 238' ' ' PRO . . . -67.37 -54.73 18.51 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.593 -0.813 . . . . 75.34 111.72 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.88 -41.75 83.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.043 0.449 . . . . 74.14 110.538 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 91.8 mt -64.36 -38.46 91.12 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.863 -0.608 . . . . 74.12 110.891 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.81 -50.27 69.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.491 0.662 . . . . 74.32 110.189 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 35.6 mt -59.04 -47.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.018 -0.992 . . . . 74.04 110.89 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 161' ' ' ILE . 56.7 tp -57.9 -42.63 85.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 64.1 110.608 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.64 94.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.965 -0.636 . . . . 64.23 112.051 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -64.26 -42.0 96.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 64.42 110.906 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 27.0 m -69.65 -36.87 76.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.582 -0.281 . . . . 71.3 110.691 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.8 mtp -62.11 -49.8 74.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 73.4 111.015 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.08 -32.01 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 70.15 110.708 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -56.48 -53.93 51.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.011 0.434 . . . . 71.51 110.503 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.0 m0 -69.27 -28.44 66.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 71.43 111.252 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.24 -32.77 38.36 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.188 0.44 . . . . 72.33 112.188 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 290' ' ' PHE . 61.7 p -103.8 -28.58 11.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.421 -0.512 . . . . 74.14 111.75 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 114.8 -36.74 3.8 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.338 -0.934 . . . . 74.13 113.062 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.53 147.48 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.265 0.533 . . . . 74.22 111.102 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.1 mt -94.17 139.22 22.45 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.44 -0.345 . . . . 71.21 110.449 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 -36.95 98.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.981 2.454 . . . . 73.32 112.53 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.541 ' HB2' HG12 ' A' ' 271' ' ' VAL . 41.7 p90 -87.55 -2.35 58.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 75.33 110.852 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 64.2 tt0 -86.92 -37.79 17.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.141 -0.689 . . . . 73.4 109.141 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.99 -20.37 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.133 -0.691 . . . . 71.31 109.133 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -107.9 26.18 10.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.924 . . . . 74.25 110.795 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -74.36 64.41 1.12 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.685 0.755 . . . . 72.43 109.873 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -157.22 14.07 0.25 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.149 -0.932 . . . . 61.21 109.442 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 13.9 t70 -157.31 120.31 2.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.917 -0.583 . . . . 74.51 110.556 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 15.6 Cg_exo -68.85 -27.23 31.26 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.0 2.467 . . . . 62.42 112.602 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -73.32 -48.37 34.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.556 -0.535 . . . . 71.42 109.556 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.563 . . . . 53.31 112.184 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 261' ' ' TRP . 35.3 m -65.49 -41.86 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.55 -0.46 . . . . 72.44 110.906 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -66.7 -48.79 68.13 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.19 -0.3 . . . . 74.51 110.19 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.91 -53.36 56.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.225 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 27.2 m -59.06 -41.77 88.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.353 0.408 . . . . 74.34 111.463 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 279' ' ' ARG . 97.6 mttt -63.86 -48.25 77.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.009 -0.276 . . . . 63.31 110.942 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.668 HG12 HH21 ' A' ' 279' ' ' ARG . 66.0 mt -63.12 -43.37 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.304 0.573 . . . . 45.34 110.281 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.71 -46.62 77.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.801 -1.091 . . . . 74.3 111.538 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.743 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 32.4 m-85 -74.26 -32.2 62.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 73.2 111.814 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.668 HH21 HG12 ' A' ' 276' ' ' ILE . 88.0 mtm180 -74.71 -16.23 60.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.256 0.465 . . . . 74.22 112.256 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 41.3 mt-10 -60.9 -48.99 79.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.77 0.319 . . . . 74.1 110.742 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.504 ' HB2' HD23 ' A' ' 285' ' ' LEU . 15.1 m120 -127.93 70.93 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 71.4 109.725 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -54.02 -44.28 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.764 -0.653 . . . . 54.04 112.615 -173.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.457 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.6 -47.51 78.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 73.21 110.847 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 27.8 t -67.22 -49.25 65.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.715 -0.675 . . . . 74.31 110.605 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.743 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.0 mm? -64.16 -50.37 68.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 74.13 111.561 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 282' ' ' ILE . 0.1 OUTLIER -58.38 -44.66 89.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.543 0.211 . . . . 73.13 111.56 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.713 ' HA ' ' HG2' ' A' ' 296' ' ' PRO . 18.8 t70 -68.16 -27.46 66.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 74.34 110.812 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -96.58 6.46 48.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.941 -0.572 . . . . 70.12 111.533 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.6 -38.41 59.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.027 0.441 . . . . 71.21 110.795 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 256' ' ' THR . 29.3 t80 -137.56 75.29 44.8 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 73.41 109.575 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -93.93 110.94 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.382 2.721 . . . . 74.52 112.54 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -159.59 -82.66 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.257 -0.646 . . . . 71.11 109.257 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -144.13 29.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -94.8 162.46 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.632 -1.167 . . . . 64.11 109.855 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -122.68 90.81 49.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.576 -0.527 . . . . 52.13 109.576 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.713 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 89.1 Cg_endo -98.85 37.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.055 2.503 . . . . 51.44 112.207 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.87 -39.91 12.8 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.629 -0.796 . . . . 65.43 111.654 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.5 mp0 -55.03 -44.21 74.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.269 -0.466 . . . . 64.13 110.123 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.6 mp -69.74 -42.58 80.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 62.24 110.528 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.74 -48.6 81.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 75.11 111.18 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 301' ' ' LYS . 8.5 mmpt? -66.08 -41.94 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 73.21 110.836 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -55.59 -48.56 74.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.108 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.515 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.67 -37.84 79.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.2 -0.454 . . . . 64.42 111.366 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.5 -39.86 94.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.28 0.562 . . . . 75.12 109.619 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.8 m -65.19 -44.51 88.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.191 -0.913 . . . . 74.31 111.388 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 29.4 m -69.01 -31.61 51.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 120.622 -0.431 . . . . 73.23 111.349 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -74.03 -28.28 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.249 0.547 . . . . 64.23 109.907 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.04 -16.89 61.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 71.34 111.782 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 306' ' ' VAL . 4.2 pp -95.64 16.45 17.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.673 0.273 . . . . 60.14 111.601 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 16.1 t70 68.48 -96.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.786 -0.643 . . . . 71.04 111.478 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.2 OUTLIER -136.89 -38.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.943 0.402 . . . . 74.3 110.035 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.7 t -158.38 29.17 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 72.33 110.045 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -71.46 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.235 -0.654 . . . . 74.43 109.235 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 58.8 mmtt -130.25 79.59 72.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 70.41 111.227 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' HD22 ' A' ' 309' ' ' LEU . 18.3 Cg_endo -91.78 118.05 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.598 2.199 . . . . 72.32 111.531 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 319' ' ' ASN . 30.3 tp -133.7 103.99 6.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.057 -0.519 . . . . 71.13 109.721 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.406 ' OH ' ' HD2' ' A' ' 240' ' ' ARG . 4.5 m-85 -64.66 -33.72 76.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.641 -0.709 . . . . 74.2 111.472 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.28 -27.39 66.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.632 -0.427 . . . . 72.53 110.709 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.519 ' HB2' HD23 ' A' ' 316' ' ' LEU . 5.9 t30 -72.25 -38.51 68.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.328 0.585 . . . . 61.41 109.457 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' A' ' 323' ' ' ILE . 68.7 mt -69.96 -37.08 75.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.45 -0.796 . . . . 75.31 109.381 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.585 HH22 ' HB2' ' A' ' 106' ' ' LYS . 23.8 ttt180 -59.65 -41.06 89.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.785 -1.098 . . . . 74.45 109.973 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.73 -52.39 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 74.32 111.985 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.437 0.161 . . . . 54.13 110.956 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 155' ' ' LEU . 94.1 mt -64.38 -46.92 81.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.713 0.292 . . . . 64.5 110.992 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.49 -34.92 78.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 73.34 111.03 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -42.77 95.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 72.34 110.402 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.47 -46.34 85.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 40.02 111.711 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.508 HD22 ' HG ' ' A' ' 155' ' ' LEU . 35.1 tp -59.78 -42.66 93.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.172 0.51 . . . . 65.42 110.698 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -70.88 -25.83 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.674 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.9 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 41.2 111.01 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.5 tt -89.17 2.9 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.384 0.612 . . . . 73.31 110.611 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.39 15.31 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.952 -0.642 . . . . 71.33 113.847 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.1 t -121.97 138.57 54.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.407 0.604 . . . . 63.15 110.856 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -154.67 99.5 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.067 -0.515 . . . . 73.14 109.806 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.619 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 13.8 t70 55.26 54.12 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.047 0.927 . . . . 72.13 108.675 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.449 ' HB3' ' HE3' ' A' ' 152' ' ' LYS . 29.4 t70 -66.49 103.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.346 -1.297 . . . . 75.23 112.486 -167.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.01 71.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.56 -0.745 . . . . 52.34 113.565 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 191' ' ' ASP . 96.2 mttt . . . . . 0 C--O 1.234 0.261 0 CA-C-O 120.967 0.413 . . . . 71.2 110.884 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.638 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 23.5 mtmm . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.966 0.412 . . . . 63.43 111.363 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.01 159.22 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 73.51 111.911 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -74.87 141.22 16.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.155 0.502 . . . . 73.21 111.254 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.9 t -86.18 73.66 10.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.539 0.685 . . . . 61.22 110.092 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 53.9 pttt . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 115.786 -0.643 . . . . 63.0 111.443 -176.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.57 ' HA ' HG23 ' A' ' 39' ' ' VAL . 99.3 t . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 110.031 -0.359 . . . . 74.34 110.031 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . 99.6 -3.59 57.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 72.41 112.655 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -96.67 159.43 14.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.944 0.402 . . . . 72.51 110.714 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -79.1 146.06 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 72.34 112.159 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tp -133.79 122.51 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.236 -0.893 . . . . 72.34 109.568 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -96.77 134.21 40.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.712 -0.222 . . . . 64.11 111.505 -175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.57 -176.32 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.565 -0.532 . . . . 73.34 109.565 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.406 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 50.4 tpp -72.59 -22.54 60.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.552 0.215 . . . . 65.22 111.162 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.7 21.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.108 0.48 . . . . 73.15 110.226 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 71.07 36.12 1.48 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.991 -1.004 . . . . 70.02 111.409 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.05 121.96 45.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 51.13 110.199 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mp0 -87.03 97.2 10.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.187 -0.46 . . . . 70.03 110.226 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 44.1 m95 -84.93 -171.74 3.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.63 -0.878 . . . . 65.14 108.63 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -134.68 137.05 43.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.426 . . . . 72.54 110.402 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 25' ' ' VAL . 2.4 m -69.23 118.64 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 73.04 110.693 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 56' ' ' MET . . . -107.28 -116.43 4.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.834 -0.698 . . . . 74.45 112.214 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 mm? -91.08 122.69 66.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.81 0.338 . . . . 74.03 110.977 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_exo -78.51 104.77 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.914 2.409 . . . . 71.15 111.052 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 45' ' ' GLN . 58.9 mt -79.14 -46.86 23.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 75.53 110.227 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.37 -27.67 8.3 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.433 -0.667 . . . . 73.13 111.433 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.424 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.0 mp0 -107.79 165.27 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.29 -0.455 . . . . 72.12 109.878 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 184' ' ' LEU . . . 156.69 -88.37 0.12 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.498 -0.641 . . . . 52.25 111.498 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . -158.22 50.13 0.42 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.609 -0.805 . . . . 63.3 112.353 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 63.7 t80 171.71 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.119 0.568 . . . . 74.02 109.684 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.413 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 161.18 134.77 1.7 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.99 -0.844 . . . . 75.41 110.99 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.5 t 65.52 76.48 0.33 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.622 0.725 . . . . 54.45 110.176 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.413 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.1 mm -121.65 135.47 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 73.52 109.73 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.548 ' CE1' HG12 ' A' ' 39' ' ' VAL . 51.9 p90 -131.15 154.78 47.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.181 -0.608 . . . . 64.11 111.311 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.0 tt -71.52 133.18 45.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 65.32 109.418 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 37' ' ' TRP . . . -93.39 36.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.224 0.453 . . . . 73.23 112.224 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.44 ' O ' HD22 ' A' ' 53' ' ' LEU . 17.0 t0 -178.73 152.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.112 -0.699 . . . . 72.33 109.112 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 26' ' ' GLY . 4.6 ppp? -144.58 6.66 1.26 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 73.51 110.38 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -139.33 -179.34 5.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 75.02 109.792 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -90.21 72.69 7.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.764 -0.458 . . . . 72.33 109.764 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 121.493 0.663 . . . . 43.14 109.789 176.226 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.173 0 CA-C-O 121.562 0.696 . . . . 64.33 110.12 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.72 23.34 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.891 2.394 . . . . 73.22 113.084 -172.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.2 p -124.18 139.02 54.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.367 0.603 . . . . 74.41 111.944 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 53' ' ' LEU . 20.5 m -130.85 170.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.393 -0.821 . . . . 63.21 109.544 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.847 ' HB ' HD13 ' A' ' 130' ' ' ILE . 1.5 p -132.48 127.2 56.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.059 0.457 . . . . 62.03 111.431 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -85.34 130.1 34.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.241 -0.891 . . . . 73.02 109.101 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.6 127.74 66.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.983 0.42 . . . . 74.11 111.397 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 25.9 tt0 -115.25 141.01 26.47 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.393 -0.965 . . . . 64.23 108.393 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.38 -171.45 0.12 Allowed 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.218 1.945 . . . . 65.41 111.639 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 t -76.79 78.97 3.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.256 0.551 . . . . 64.52 109.559 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -122.08 -52.49 1.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 73.43 110.541 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.38 46.34 1.98 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.884 0.849 . . . . 44.24 109.651 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.98 -80.81 0.86 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.127 -0.942 . . . . 44.31 111.658 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.8 Cg_exo -59.77 -43.96 34.35 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.712 2.275 . . . . 35.0 112.033 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.28 -33.27 75.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.298 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.57 -50.53 69.11 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.909 0.385 . . . . 53.34 111.033 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.0 m -65.15 -43.74 90.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 74.11 110.674 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -66.83 -35.48 80.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 70.13 110.388 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.07 -49.28 78.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 74.22 109.944 178.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -60.23 -39.69 87.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.007 0.432 . . . . 75.31 110.708 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.01 -52.62 65.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.413 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.84 -33.19 73.71 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.25 111.382 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -63.61 -28.46 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.642 0.238 . . . . 74.32 111.642 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.624 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmp_? -93.65 -16.09 24.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.054 0.39 . . . . 73.32 112.054 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.81 17.71 22.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.597 0.713 . . . . 22.21 110.511 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.21 136.27 38.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.067 -0.97 . . . . 75.12 112.807 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 34.4 ttmt 73.45 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.83 -1.077 . . . . 74.43 111.948 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 62.0 Cg_exo -53.03 -28.71 41.46 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.711 2.94 . . . . 73.35 113.373 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.83 -50.87 62.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 72.11 111.163 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 35.1 mt-30 -73.19 -34.72 66.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.117 -0.492 . . . . 62.22 110.132 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' PRO . 65.8 mt -58.9 -53.96 40.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.488 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -62.48 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 75.52 110.574 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 22.2 ttmm -55.04 -65.3 0.61 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.94 -0.573 . . . . 74.31 111.37 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.59 ' HZ2' HD11 ' A' ' 108' ' ' LEU . 3.7 p90 -69.5 -32.9 72.05 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.496 -0.482 . . . . 73.31 110.884 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 107' ' ' TYR . 48.7 mt -59.05 -39.5 78.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 120.67 0.271 . . . . 73.41 110.594 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -76.51 -27.62 56.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.87 0.366 . . . . 73.43 110.312 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -70.43 -44.21 68.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.748 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 103' ' ' ARG . 42.2 mtt-85 -83.2 -13.81 54.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.474 -0.33 . . . . 71.13 110.759 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 57.51 69.57 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.745 0.783 . . . . 75.1 109.733 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.599 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 10.2 tp -108.81 -167.91 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.76 -1.109 . . . . 71.22 109.04 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 107' ' ' TYR . 20.7 tptm -100.16 -68.15 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.571 -0.452 . . . . 73.12 110.033 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.609 ' CD1' ' HG3' ' A' ' 106' ' ' LYS . 55.2 p90 -179.96 152.06 0.45 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.985 0.422 . . . . 61.12 110.587 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 HD11 ' HZ2' ' A' ' 99' ' ' TRP . 83.5 mt -78.41 136.55 37.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 74.1 111.007 -176.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.84 51.5 4.45 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.126 -0.789 . . . . 74.41 111.126 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 108' ' ' LEU . 60.5 t -119.73 129.75 25.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.876 -0.416 . . . . 62.11 109.876 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 35.1 Cg_exo -61.07 148.86 91.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.763 2.308 . . . . 53.44 112.454 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.575 ' HD2' ' CE2' ' A' ' 114' ' ' TRP . 4.1 ttmp? -62.91 128.57 36.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.779 -0.646 . . . . 74.21 110.804 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -90.9 85.14 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.929 -0.578 . . . . 72.34 110.656 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.575 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 10.4 m95 -67.33 -55.5 13.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 72.41 109.858 173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.09 -171.32 36.94 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.414 -0.812 . . . . 70.52 111.622 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.502 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 43.1 p 176.94 175.14 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.475 -0.565 . . . . 61.44 109.475 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 32' ' ' MET . . . 154.15 -159.32 28.74 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.069 -1.062 . . . . 72.42 112.884 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.8 tt -131.52 138.64 49.02 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.495 -0.557 . . . . 73.32 109.495 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -143.24 134.86 26.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.683 -0.488 . . . . 74.44 109.683 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.881 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.9 t70 -74.89 140.07 43.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.801 -0.444 . . . . 73.53 109.801 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -103.46 40.68 1.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.714 -0.476 . . . . 44.23 109.714 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.42 67.53 0.83 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.651 -0.704 . . . . 73.42 110.412 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.03 -58.24 0.56 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.261 -0.881 . . . . 52.11 111.492 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 42.4 tptt -134.29 142.74 47.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.431 -0.581 . . . . 62.23 109.431 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.881 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.9 m -88.29 148.73 24.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.325 -0.398 . . . . 72.31 111.437 -176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.8 151.64 37.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.81 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -113.39 120.0 39.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.925 -0.769 . . . . 75.14 108.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -134.95 162.4 32.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 73.44 112.081 -171.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 45.7 ttm -140.2 139.81 35.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.672 -0.695 . . . . 74.22 110.613 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.847 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.7 mm -98.17 126.0 51.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.322 -0.399 . . . . 60.41 110.421 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 8.2 ptp -138.54 -179.22 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 71.35 110.38 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -73.21 156.15 38.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.66 -0.866 . . . . 74.14 108.66 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.554 ' HB3' HG13 ' A' ' 69' ' ' VAL . 25.1 ptt180 -85.41 135.2 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.027 0.441 . . . . 65.15 111.781 -174.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 43.3 m-85 -124.02 153.44 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.3 109.841 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.504 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -159.13 8.67 0.17 Allowed Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.946 -1.121 . . . . 72.52 113.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.069 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.0 m -122.98 125.5 45.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.021 -0.694 . . . . 72.33 110.791 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 181' ' ' SER . 3.3 t70 -116.48 140.14 49.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 74.31 111.422 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.2 mp -67.94 -33.06 73.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.71 -0.677 . . . . 73.21 111.797 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 55.2 tp60 -72.63 -35.83 67.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.46 . . . . 61.23 110.088 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 46.4 tptt -70.83 -48.13 55.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.026 -0.534 . . . . 73.24 110.528 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 80.7 mt -62.43 -30.04 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.97 -0.559 . . . . 74.31 110.176 177.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 1.1 t80 -51.27 -46.08 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.534 -0.757 . . . . 72.41 110.593 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.54 -36.01 33.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.205 -0.452 . . . . 70.23 110.138 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.349 0.5 . . . . 72.54 112.349 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -101.95 3.66 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 65.55 110.475 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' C ' ' HG2' ' A' ' 147' ' ' LYS . . . 59.02 55.8 4.28 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.318 -0.856 . . . . 55.02 111.935 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 257' ' ' GLY . 21.9 pttm 45.53 38.78 4.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.067 0.947 . . . . 75.22 113.113 172.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -115.79 88.75 2.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 71.31 109.933 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -101.75 123.8 46.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.397 -0.365 . . . . 72.12 111.009 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.9 m -72.37 147.32 46.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.906 -0.588 . . . . 72.14 110.861 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.638 ' NH2' ' HB3' ' A' ' 295' ' ' LYS . 42.0 ttm105 -56.11 -36.5 68.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.126 -0.488 . . . . 73.21 111.912 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 12.7 ptpt -51.78 -44.3 63.35 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.354 0.597 . . . . 74.43 110.75 179.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.458 ' O ' HD13 ' A' ' 157' ' ' LEU . 74.9 m -71.93 -49.98 32.96 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.678 -0.692 . . . . 42.03 110.791 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.12 -35.24 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 42.24 110.646 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.715 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -65.78 -52.74 48.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 74.52 110.851 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.608 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 25.5 tt0 -60.6 -46.77 88.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.33 -0.548 . . . . 65.35 109.883 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 153' ' ' THR . 6.4 mp -54.92 -51.72 65.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.905 -0.589 . . . . 75.21 111.226 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -57.68 -44.71 85.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 54.22 110.445 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 89.6 mt -63.75 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 71.4 111.116 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.63 -38.04 86.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.115 0.483 . . . . 75.41 110.734 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.596 HD11 HD21 ' A' ' 183' ' ' LEU . 59.1 mt -71.04 -37.27 66.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.061 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.82 -50.7 71.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.252 -0.431 . . . . 61.43 110.382 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.599 ' OD2' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-20 -52.34 -57.55 9.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.771 -0.65 . . . . 71.42 111.323 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.14 -35.9 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.793 -0.639 . . . . 70.43 111.012 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 16.7 tp -60.59 -38.7 85.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.779 0.323 . . . . 73.42 110.85 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.66 -48.09 64.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.595 -0.52 . . . . 74.53 109.595 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.64 -48.6 77.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.901 -0.59 . . . . 71.24 111.834 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 165' ' ' LEU . 32.2 pt -67.04 -36.97 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.88 -0.328 . . . . 64.41 111.716 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 49.2 m80 -69.99 -26.89 64.3 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.586 -0.445 . . . . 54.03 110.863 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.9 -27.55 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.182 0.515 . . . . 61.12 109.928 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.99 66.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 73.22 111.466 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 77.8 -51.39 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.814 1.042 . . . . 71.31 113.814 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -85.91 142.06 29.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.497 1.295 . . . . 71.2 114.497 -161.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 169' ' ' HIS . 25.6 m -115.88 164.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.404 -1.271 . . . . 75.03 107.949 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -126.16 92.47 3.59 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 64.43 110.358 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -65.29 -42.08 96.37 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.715 -0.675 . . . . 51.32 113.249 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 32.7 t70 -89.18 107.72 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 73.41 111.577 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.581 ' HB ' HG22 ' A' ' 246' ' ' ILE . 38.0 mm -110.89 112.27 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.918 -0.771 . . . . 75.04 108.918 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -138.49 159.03 43.12 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.923 -0.769 . . . . 74.41 108.923 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -55.9 -36.44 67.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 72.21 111.204 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.579 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 4.6 m -68.98 -5.34 21.0 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 70.42 112.44 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -93.2 -13.37 28.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.009 0.433 . . . . 62.23 110.72 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 161' ' ' ILE . 7.3 mp -105.89 111.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.723 -0.671 . . . . 73.42 109.755 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 196' ' ' VAL . 3.7 mm? -114.48 130.94 56.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.798 -0.637 . . . . 73.44 110.326 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 1.069 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 41.4 mt -84.62 142.88 29.62 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.638 -0.71 . . . . 73.2 109.674 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.443 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 40.5 t-20 -59.93 135.43 57.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.533 -0.543 . . . . 73.53 109.533 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 82.7 t80 -61.82 -30.38 70.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.981 0.419 . . . . 73.35 111.221 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -93.95 -36.02 12.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.303 -0.408 . . . . 72.04 110.074 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 4.6 m-20 -114.96 87.97 16.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 61.14 110.215 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -73.2 -11.21 24.93 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.349 2.033 . . . . 61.21 112.157 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -96.16 15.21 21.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 74.21 109.924 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.18 107.65 8.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.196 -0.911 . . . . 74.44 109.063 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 157' ' ' LEU . 10.7 p -102.21 142.21 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.37 0.605 . . . . 72.33 112.035 -172.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.44 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 95.7 m-85 -125.75 144.42 50.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.462 -0.79 . . . . 71.13 110.181 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.45 99.94 11.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.902 -1.147 . . . . 74.12 107.902 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.65 HG22 HD23 ' A' ' 184' ' ' LEU . 29.2 m -101.34 0.77 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.203 0.446 . . . . 62.24 112.203 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.48 95.88 5.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.043 0.449 . . . . 73.24 109.812 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.47 6.5 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.809 -0.632 . . . . 74.42 109.715 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.55 -33.73 67.53 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.516 -0.765 . . . . 74.12 111.457 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.47 30.33 2.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.437 . . . . 72.44 110.743 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -92.83 99.69 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.163 0.506 . . . . 71.42 109.661 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -107.5 138.77 43.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.952 -0.567 . . . . 75.3 110.349 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.33 133.46 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 62.04 110.871 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 206' ' ' PRO . 5.9 t80 -137.31 -54.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 63.13 111.295 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.2 p -108.37 103.15 49.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 112.07 0.396 . . . . 63.44 112.07 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 24.6 Cg_exo -63.28 118.31 5.22 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.697 2.265 . . . . 72.45 110.8 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 64.77 10.11 5.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.943 -0.571 . . . . 75.22 111.059 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 169' ' ' HIS . . . 96.07 0.88 61.53 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.741 -0.742 . . . . 64.41 113.063 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.82 110.79 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 117.128 0.464 . . . . 72.52 112.189 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -177.63 144.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.963 -0.754 . . . . 64.1 108.963 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.68 115.22 8.1 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.611 -0.515 . . . . 72.3 109.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -159.14 102.81 1.62 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.029 -0.268 . . . . 64.41 110.915 -175.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.463 ' HA ' HG23 ' A' ' 236' ' ' VAL . 44.8 p90 -124.89 130.99 53.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 64.11 111.334 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 71.9 mmtt -129.18 -86.74 0.54 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.078 -0.964 . . . . 72.44 108.933 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 29.6 tt0 177.39 -63.81 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.946 -0.57 . . . . 54.31 110.161 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -148.76 104.74 3.43 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.039 -0.528 . . . . 75.2 111.307 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.461 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 1.4 Cg_endo . . . . . 0 N--CA 1.453 -0.87 0 C-N-CA 122.965 2.443 . . . . 62.33 112.003 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 . . . . . 0 C--O 1.233 0.232 0 N-CA-C 110.003 -0.369 . . . . 71.3 110.003 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -90.43 171.2 36.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.891 -0.671 . . . . 61.25 112.534 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 228' ' ' THR . 25.0 p -69.6 130.82 43.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 73.14 110.716 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.549 HG12 HG11 ' A' ' 271' ' ' VAL . 16.6 tt -63.46 -18.05 21.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.443 0.639 . . . . 73.33 110.324 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.596 ' HG2' HD13 ' A' ' 265' ' ' LEU . 24.8 mt-10 -55.59 -63.03 1.3 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.974 -1.012 . . . . 63.03 111.06 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.85 -40.56 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.893 -0.594 . . . . 74.31 111.15 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 93.2 m -56.63 -29.16 61.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.098 -0.501 . . . . 63.21 110.908 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 35.8 m 64.11 -147.48 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.72 -0.673 . . . . 52.44 111.372 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 60.0 mt -72.65 -34.72 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.846 0.355 . . . . 73.25 110.962 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' A' ' 236' ' ' VAL . 1.5 m-20 -51.76 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.03 -0.987 . . . . 64.12 113.599 -169.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.91 -29.43 67.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 42.33 111.404 -173.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 229' ' ' SER . 58.3 t-80 -66.77 -33.6 75.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.943 -0.571 . . . . 72.24 111.492 -175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 5.9 m-20 -92.89 -27.77 16.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 72.52 111.029 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.461 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 127.01 -4.99 7.37 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.717 -1.23 . . . . 71.03 114.182 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 231' ' ' ASP . 3.2 p -75.24 127.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.743 0.771 . . . . 64.14 109.626 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 212' ' ' GLU . . . -59.08 121.36 54.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 60.31 112.075 -172.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 16.5 Cg_exo -66.95 101.18 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.949 2.433 . . . . 73.43 111.841 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 51.0 m -84.89 -168.42 2.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.171 -0.677 . . . . 74.04 109.171 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 20.1 mmt180 -52.24 -46.62 65.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.873 0.324 . . . . 74.21 111.873 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 307' ' ' LYS . 20.2 ttt180 -68.97 -30.08 68.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.969 -0.292 . . . . 54.14 110.789 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.5 23.97 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.786 -0.721 . . . . 62.21 111.99 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -60.1 -42.0 93.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.926 0.393 . . . . 62.33 110.42 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 89.8 mt -62.42 -38.74 90.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.18 -0.464 . . . . 74.44 111.592 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.43 -48.92 75.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.311 0.577 . . . . 75.15 109.877 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.581 HG22 ' HB ' ' A' ' 178' ' ' ILE . 68.6 mt -57.03 -44.48 82.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.13 -0.941 . . . . 74.5 110.718 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.5 -41.47 94.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.68 -46.2 93.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.301 -0.476 . . . . 53.53 112.62 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -61.96 -38.25 87.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 73.33 110.878 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.5 m -66.89 -47.16 72.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.416 . . . . 60.25 110.631 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 86.7 mtp -60.89 -43.32 98.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 63.42 111.301 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 286' ' ' MET . 12.7 tt -67.35 -34.95 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.458 -0.497 . . . . 74.51 110.917 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -62.96 -43.65 98.2 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.83 -0.348 . . . . 65.25 110.452 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -66.01 -35.29 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 73.44 110.631 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.0 -32.84 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 74.11 111.818 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.5 p -102.71 -27.98 12.39 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.623 -0.431 . . . . 73.43 111.825 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 147' ' ' LYS . . . 119.75 -45.87 1.19 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 65.13 113.719 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.01 159.33 39.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.596 0.698 . . . . 73.23 111.098 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 90.7 mt -95.19 137.64 22.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 61.42 110.582 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.8 Cg_exo -67.33 -28.79 39.24 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.004 2.469 . . . . 51.51 112.907 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -101.66 9.91 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.757 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 16.5 tt0 -59.44 -45.78 90.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.595 . . . . 63.21 112.315 -170.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.77 -16.3 61.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 74.41 111.049 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -107.54 16.87 23.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.39 . . . . 73.33 111.096 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' A' ' 226' ' ' GLU . 37.4 mt -70.07 -14.03 62.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.551 0.691 . . . . 75.15 110.007 172.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.23 -19.42 58.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.119 -0.946 . . . . 60.43 110.018 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 271' ' ' VAL . 9.6 m-20 -94.83 113.29 60.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.455 -0.793 . . . . 73.12 110.071 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.72 -38.47 93.0 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.706 2.271 . . . . 73.24 112.89 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 269' ' ' LYS . 7.7 mtpm? -69.47 -42.98 74.14 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.894 -0.323 . . . . 64.45 111.467 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.71 -38.46 91.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.003 -0.279 . . . . 73.21 111.19 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.549 HG11 HG12 ' A' ' 225' ' ' ILE . 38.2 t -65.75 -39.88 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.948 0.404 . . . . 53.15 110.224 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -64.07 -56.31 15.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 72.13 110.335 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.41 -44.68 96.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.781 -0.645 . . . . 65.2 112.023 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 55.3 p -63.57 -50.49 69.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 121.083 -0.247 . . . . 74.14 111.321 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 33.3 mmtp -64.08 -34.04 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.18 -0.208 . . . . 74.13 111.31 -175.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.43 -53.76 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.925 0.393 . . . . 72.44 111.014 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -71.1 -30.82 67.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 65.14 111.475 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -73.47 -35.44 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.725 -0.216 . . . . 73.44 110.91 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.87 -31.22 72.21 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.253 0.549 . . . . 71.01 110.238 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.36 -59.37 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.256 -0.883 . . . . 73.41 110.483 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.472 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.6 OUTLIER -108.57 59.42 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.312 -0.404 . . . . 65.12 111.195 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -62.81 -43.95 99.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.55 112.196 -177.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.47 -47.8 77.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.795 0.295 . . . . 61.13 111.795 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.6 t -66.44 -46.71 75.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.76 0.314 . . . . 75.35 110.927 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.4 mm? -68.16 -49.86 58.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 73.44 111.821 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.559 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -62.09 -39.99 94.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.627 0.251 . . . . 64.4 111.55 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.64 -31.33 66.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 72.32 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -69.91 -33.2 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 64.22 109.975 178.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.23 -19.66 62.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 75.45 111.264 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.933 ' HB3' ' HB3' ' A' ' 296' ' ' PRO . 6.7 t80 -128.52 87.81 54.03 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 121.101 0.476 . . . . 71.33 110.323 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.5 2.98 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.365 2.71 . . . . 73.5 111.939 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.9 149.69 24.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.684 -0.858 . . . . 73.24 108.684 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.3 mmtt -91.98 29.67 1.56 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.037 0.384 . . . . 55.44 112.037 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.601 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 42.3 t-20 -64.11 -69.88 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.943 -1.502 . . . . 72.21 106.943 167.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.638 ' HB3' ' NH2' ' A' ' 151' ' ' ARG . 49.9 tptt 169.15 114.76 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.257 0.973 . . . . 74.33 109.59 160.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.933 ' HB3' ' HB3' ' A' ' 290' ' ' PHE . 89.3 Cg_endo -96.22 46.26 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.673 2.249 . . . . 75.43 111.544 169.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.25 -43.02 1.02 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.384 -0.912 . . . . 33.33 113.048 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.485 ' HB2' HD12 ' A' ' 299' ' ' ILE . 0.9 OUTLIER -57.53 -64.11 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 74.11 110.408 -175.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 298' ' ' GLU . 2.8 mp -60.25 -39.69 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 72.52 111.049 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.63 68.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.374 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 12.8 tptt -79.93 -23.27 41.87 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.354 . . . . 75.03 110.926 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 320' ' ' LEU . 65.7 t80 -59.99 -48.22 82.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 75.01 109.911 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.623 ' HA ' HG22 ' A' ' 306' ' ' VAL . 82.6 mtp -72.5 -32.9 66.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.983 -0.553 . . . . 73.32 110.548 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 4.4 tp10 -54.96 -45.74 74.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.788 0.804 . . . . 74.54 109.109 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 63.2 m -63.57 -47.33 81.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.315 -1.311 . . . . 64.32 111.965 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 303' ' ' MET . 21.6 m -66.2 -34.26 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.862 -0.335 . . . . 71.33 111.741 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -76.45 -27.67 56.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.406 -0.518 . . . . 74.13 109.755 177.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 24.6 tp -77.4 -26.96 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.784 -0.643 . . . . 74.04 110.925 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 310' ' ' ASP . 4.4 pp -86.3 18.46 3.18 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.765 0.317 . . . . 65.34 110.745 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 24.0 t70 73.47 -79.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.497 -0.774 . . . . 73.22 111.938 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -162.11 -31.43 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.537 0.684 . . . . 74.22 109.755 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.6 t -170.57 29.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.486 -0.779 . . . . 74.01 108.978 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 3.3 tm-20 -70.85 -71.11 0.27 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.177 -0.92 . . . . 64.23 110.274 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -132.31 87.36 43.17 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.386 -0.37 . . . . 74.05 110.275 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.51 118.0 3.15 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.414 2.076 . . . . 63.54 111.689 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.2 mt -112.31 94.58 5.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.226 0.536 . . . . 74.23 110.183 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -68.41 -33.33 74.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.513 -0.767 . . . . 73.43 110.807 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.93 -38.94 90.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 61.13 110.567 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.85 -44.84 88.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 64.44 110.437 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 86.8 mt -60.19 -47.88 84.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 73.3 110.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 325' ' ' LEU . 8.1 ppt_? -73.78 -19.09 60.87 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.741 -0.384 . . . . 62.33 111.214 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.17 -32.57 29.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 60.12 111.449 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -75.81 -32.57 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 120.005 -0.678 . . . . 52.23 110.042 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 298' ' ' GLU . 95.2 mt -66.08 -41.92 90.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.944 -0.761 . . . . 52.04 108.944 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -65.12 -32.02 73.51 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.512 -0.767 . . . . 70.24 110.121 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -49.19 78.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.263 -0.643 . . . . 75.41 109.263 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.1 -40.31 95.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.753 -0.737 . . . . 64.22 112.689 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.715 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 28.8 tp -69.12 -43.36 74.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.377 0.608 . . . . 63.04 110.848 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.94 -38.11 82.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.242 -0.89 . . . . 72.14 110.892 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.07 75.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 60.14 111.291 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -89.8 -7.28 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.974 0.416 . . . . 53.51 110.759 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 83.77 26.34 42.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 45.54 113.563 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 9.4 t -117.87 171.35 8.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.257 0.528 . . . . 63.41 110.925 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' A' ' 328' ' ' LEU . 0.0 OUTLIER -153.44 161.14 42.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 62.51 110.425 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 156' ' ' GLN . 7.2 p-10 -89.81 -12.09 40.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.73 0.3 . . . . 74.14 111.499 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.3 102.01 14.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 72.33 111.077 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 147.08 -68.79 0.38 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.155 -1.021 . . . . 64.22 113.014 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 86.0 tttt . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 110.214 -0.291 . . . . 72.45 110.214 -173.56 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 23.2 tptm . . . . . 0 N--CA 1.455 -0.181 0 CA-C-O 120.985 0.422 . . . . 72.13 110.237 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.5 t -100.97 -171.03 1.93 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 73.24 110.085 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.69 144.3 14.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.128 0.489 . . . . 75.25 111.084 -176.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 15.2 t -73.04 166.97 22.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.628 . . . . 74.11 110.874 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 83.2 tttt . . . . . 0 C--N 1.323 -0.561 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.293 -176.15 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t . . . . . 0 N--CA 1.464 0.249 0 CA-C-O 120.743 0.306 . . . . 61.53 110.548 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.83 0.01 56.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.056 -0.592 . . . . 74.35 112.198 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.44 160.43 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 71.01 110.932 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.44 115.59 45.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.961 -0.563 . . . . 72.03 109.673 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 37' ' ' TRP . 19.2 pt -96.68 122.73 48.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.859 -0.609 . . . . 63.23 109.965 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 17.6 m -101.11 119.17 38.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.099 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.6 p-10 -90.03 -170.3 2.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.427 -0.351 . . . . 72.24 110.355 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.68 -21.1 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 73.11 111.222 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.81 2.41 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 44.23 109.96 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 60.13 34.64 21.2 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.164 -0.925 . . . . 75.44 111.353 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' THR . 30.3 mmmt -92.83 150.43 20.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.019 -0.537 . . . . 71.21 109.932 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.87 96.2 7.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.875 -0.602 . . . . 74.44 110.66 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HB2' HG13 ' A' ' 29' ' ' ILE . 25.6 m95 -98.92 138.72 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 63.31 109.637 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 56' ' ' MET . 31.6 ttmt -106.46 119.28 38.85 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.831 -0.347 . . . . 64.22 110.629 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.29 127.61 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 61.21 110.727 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . -113.96 -115.19 3.17 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.515 -0.85 . . . . 60.1 113.01 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 49.5 tp -77.93 125.47 85.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.572 0.225 . . . . 71.3 111.504 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 10.0 Cg_exo -72.47 120.03 6.48 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.854 2.37 . . . . 73.22 111.254 172.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 45' ' ' GLN . 63.1 mt -97.04 -53.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.117 0.484 . . . . 74.04 110.749 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' HA2' ' A' ' 49' ' ' GLY . . . 94.73 -25.19 24.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.822 -0.704 . . . . 74.21 112.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.468 ' H ' HG22 ' A' ' 43' ' ' ILE . 49.5 tp60 -117.0 162.94 16.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.651 -0.5 . . . . 70.11 109.651 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.23 -3.34 16.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.623 -1.391 . . . . 74.14 109.623 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -176.49 -142.66 4.42 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 114.296 -0.952 . . . . 72.11 110.976 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.84 ' HZ ' ' HA3' ' A' ' 199' ' ' GLY . 92.4 m-85 -60.86 -46.95 88.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.62 0.247 . . . . 74.23 111.066 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . 156.36 164.72 13.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.765 -0.731 . . . . 55.54 111.691 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.0 m 61.83 39.17 14.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.014 0.435 . . . . 41.31 111.042 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 6.2 mm -88.68 132.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 72.23 109.809 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -109.63 164.52 12.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 75.34 111.06 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 HH21 ' A' ' 133' ' ' ARG . 7.0 tt -83.09 128.89 34.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.957 -0.757 . . . . 51.22 108.957 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -106.3 37.1 2.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.716 1.006 . . . . 73.23 113.716 -166.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.47 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.6 t0 172.39 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.977 0.511 . . . . 63.45 109.965 169.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.447 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 21.5 ptm -107.39 19.94 19.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.107 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 58' ' ' SER . 8.2 t-20 -124.63 -165.16 1.34 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 63.13 109.72 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 22.8 t -107.99 89.99 3.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.985 0.422 . . . . 74.22 110.146 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.402 0.62 . . . . 72.44 110.151 174.771 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . . . . . . 0 N--CA 1.463 0.182 0 N-CA-C 109.39 -0.596 . . . . 43.11 109.39 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 133' ' ' ARG . 89.7 Cg_endo -80.67 29.74 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.187 2.591 . . . . 53.14 113.003 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 p -130.82 137.06 49.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.301 0.572 . . . . 74.22 111.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 143.85 37.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.626 -0.879 . . . . 71.43 108.626 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 6.2 p -118.64 121.06 66.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.482 0.658 . . . . 71.3 111.947 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HD3' ' HD2' ' A' ' 48' ' ' PHE . 39.0 ttmt -89.36 126.11 35.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.216 -0.902 . . . . 72.5 109.09 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.24 133.04 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.159 0.504 . . . . 73.02 111.97 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 15.8 mt-10 -140.1 170.53 9.53 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.862 -0.792 . . . . 72.32 108.862 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 14.3 Cg_endo -57.13 156.43 24.78 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.402 2.068 . . . . 72.13 112.799 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.552 ' HA ' ' HG3' ' A' ' 127' ' ' ARG . 15.5 t -84.37 34.04 0.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 44.54 110.834 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -108.82 -83.67 0.55 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.179 -0.464 . . . . 62.45 111.165 -177.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.22 -89.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.89 -0.324 . . . . 73.41 111.19 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.51 -176.63 1.46 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.101 -0.5 . . . . 74.22 113.552 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.518 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 6.4 Cg_exo -74.82 -22.04 15.65 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.059 2.506 . . . . 73.24 111.249 169.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.523 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.7 tm? -51.94 -40.54 60.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.513 -0.767 . . . . 70.31 110.823 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.95 -38.87 83.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 53.5 111.021 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.9 m -67.04 -41.62 86.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.07 0.462 . . . . 65.41 110.25 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 198' ' ' TYR . 31.3 mt-10 -67.08 -38.07 85.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.832 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.85 -41.7 71.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.008 0.432 . . . . 64.55 109.913 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -57.04 -54.08 50.78 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 55.12 110.897 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -64.49 -48.69 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.729 0.64 . . . . 62.53 112.729 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.506 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 3.8 m-85 -65.97 -34.26 77.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.611 0.244 . . . . 71.22 111.403 -175.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.55 -33.74 58.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.813 -0.355 . . . . 73.24 111.901 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 13.6 tpt180 -97.44 -45.81 6.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.911 0.708 . . . . 75.3 112.911 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -0.97 56.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.855 0.687 . . . . 63.14 112.855 -169.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -104.36 -151.59 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.084 -0.246 . . . . 73.22 111.156 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG2' ' OE2' ' A' ' 94' ' ' GLU . 56.9 tttm 74.56 102.94 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 123.689 0.796 . . . . 72.01 110.05 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 Cg_endo -50.26 -52.77 8.29 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.387 3.392 . . . . 60.43 115.567 -165.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.568 ' OE2' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -72.01 -32.55 67.28 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 74.41 112.901 -169.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -74.55 -30.11 61.62 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.029 -0.669 . . . . 71.23 110.333 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 91' ' ' ALA . 72.6 mt -61.15 -53.03 54.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.344 -0.613 . . . . 64.12 109.344 172.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.1 -34.73 60.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 72.14 110.497 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -56.54 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.783 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.473 ' HE1' HD12 ' A' ' 108' ' ' LEU . 1.8 p90 -70.11 -34.17 72.77 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.949 -0.701 . . . . 74.32 111.249 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 108' ' ' LEU . 60.7 mt -64.45 -33.34 62.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.201 0.524 . . . . 41.22 109.694 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -71.03 -40.84 71.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.551 -0.75 . . . . 74.24 110.275 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 m -67.85 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 43.21 111.532 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -75.91 -23.5 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 75.14 111.173 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 68.92 64.52 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.941 0.776 . . . . 65.11 110.039 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' OD2' ' A' ' 163' ' ' ASP . 3.4 mm? -106.97 -163.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.163 -0.926 . . . . 64.2 109.625 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG2' HD21 ' A' ' 159' ' ' LEU . 50.8 tptt -121.74 -59.62 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.472 0.545 . . . . 72.21 112.472 -174.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -159.07 98.38 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.514 -0.475 . . . . 74.41 111.447 -168.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.511 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tt -78.9 115.19 18.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.739 -0.837 . . . . 73.14 108.739 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.54 64.79 3.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.956 -0.64 . . . . 34.11 112.722 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.511 ' HB ' HD22 ' A' ' 108' ' ' LEU . 7.7 p -111.24 135.9 20.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.087 -0.338 . . . . 70.33 110.087 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG12 ' A' ' 196' ' ' VAL . 19.1 Cg_endo -60.12 140.07 90.58 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.854 2.369 . . . . 65.41 112.802 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.872 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 84.2 tttt -65.62 128.73 37.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.08 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -109.52 117.71 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.57 -0.741 . . . . 64.35 110.698 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 130' ' ' ILE . 38.5 m95 -89.86 -49.45 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.425 0.631 . . . . 75.44 109.554 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 178.32 -174.49 46.76 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.901 -1.045 . . . . 71.41 111.881 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.472 ' C ' ' HB2' ' A' ' 31' ' ' ASP . 93.1 p -168.37 150.51 5.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.847 -0.798 . . . . 54.14 108.847 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -166.41 -162.41 17.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.086 -1.054 . . . . 72.43 113.067 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.3 tt -128.48 129.3 45.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.862 -0.422 . . . . 74.35 109.862 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -129.59 123.86 32.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.153 -0.684 . . . . 64.24 109.153 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 7.3 t70 -89.11 138.07 31.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.27 -0.423 . . . . 73.01 110.177 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 121' ' ' LYS . 13.2 tmtt? -90.94 28.9 1.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.7 0.762 . . . . 62.32 109.581 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.0 t30 62.27 70.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.944 -1.025 . . . . 72.01 110.058 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.66 10.68 12.45 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.245 -0.889 . . . . 75.2 111.78 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.79 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -164.49 104.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.813 -0.44 . . . . 73.54 109.813 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB3' HD21 ' A' ' 118' ' ' LEU . 12.4 m -76.14 130.59 38.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.278 -0.419 . . . . 44.24 111.176 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.89 149.02 41.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 75.13 110.478 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 75' ' ' SER . 94.1 mtt180 -113.11 133.17 55.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.475 -0.565 . . . . 51.2 109.475 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.596 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 54.4 p90 -126.7 143.39 51.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.272 -0.422 . . . . 64.23 110.895 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 17.1 ptp -128.84 137.2 51.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.406 -0.361 . . . . 75.44 110.259 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CD1' ' A' ' 114' ' ' TRP . 49.8 mt -103.97 121.4 55.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 73.2 111.794 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ptm -122.72 178.25 5.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.502 -0.772 . . . . 74.41 109.89 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.872 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.2 t70 -80.95 -178.15 6.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.72 0.295 . . . . 72.52 111.126 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.628 HH21 HD12 ' A' ' 53' ' ' LEU . 5.8 mmt85 -83.79 83.83 7.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.412 0.625 . . . . 73.51 112.352 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -103.69 170.56 7.86 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.907 -0.775 . . . . 71.54 108.907 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.63 -41.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.347 -1.406 . . . . 65.22 113.544 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.796 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 18.4 m -71.23 122.85 20.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.011 0.406 . . . . 75.32 111.21 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.54 118.13 24.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.433 -0.803 . . . . 75.11 110.106 177.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.24 -22.67 67.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.642 -0.873 . . . . 63.43 108.642 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.432 ' HB2' HE21 ' A' ' 139' ' ' GLN . 5.8 tp-100 -56.07 -48.6 75.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.752 -1.113 . . . . 74.44 110.977 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 59.6 mmtt -75.46 -27.97 59.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 73.33 111.531 -176.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.7 mp -61.5 -46.69 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.023 -0.271 . . . . 74.54 110.279 176.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -74.02 -32.99 63.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.385 -0.526 . . . . 74.2 110.301 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.92 -33.67 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.833 0.349 . . . . 44.1 110.924 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -83.94 -31.37 25.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.142 0.423 . . . . 53.02 112.142 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -104.24 13.82 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 71.03 111.018 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.403 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 55.2 46.61 23.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.95 -0.568 . . . . 74.22 111.373 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.617 ' HB3' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER 42.09 38.79 1.17 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.0 113.17 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -94.71 96.85 9.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.964 0.411 . . . . 73.21 110.133 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 85.0 m-85 -113.5 147.74 37.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.44 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 154' ' ' VAL . 7.3 p -83.55 167.82 16.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.017 -0.538 . . . . 34.43 110.898 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.649 ' NH1' ' HB ' ' A' ' 331' ' ' ILE . 35.4 ttt180 -55.18 -46.18 75.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 73.12 111.23 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 333' ' ' SER . 86.2 mttt -58.2 -51.79 68.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.223 -0.444 . . . . 63.44 111.478 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -56.28 -43.67 79.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.938 -0.574 . . . . 75.14 112.025 -178.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 150' ' ' SER . 53.0 t -64.11 -48.43 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 71.2 110.735 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.606 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 2.7 mm? -58.43 -45.15 89.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.394 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 57.4 mm-40 -61.27 -44.84 96.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 61.33 111.494 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 88.4 mt -61.1 -49.11 78.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 72.52 110.622 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.1 p -62.52 -31.99 72.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 74.23 111.297 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 106' ' ' LYS . 59.4 tp -63.12 -46.77 85.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 74.43 110.629 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 12.4 mmt85 -63.03 -44.73 95.12 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.893 0.854 . . . . 60.3 110.02 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.96 -33.88 66.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.578 -1.192 . . . . 62.52 110.815 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.7 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.871 -0.418 . . . . 73.05 109.871 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -55.32 -56.94 14.33 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.516 0.674 . . . . 72.31 110.459 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.3 tt -67.88 -37.13 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.566 -0.743 . . . . 75.44 111.572 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.543 ' HG ' ' HE2' ' A' ' 175' ' ' HIS . 8.8 tt -61.03 -39.4 89.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.293 -0.262 . . . . 71.51 110.293 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -67.33 -54.02 24.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 71.15 109.363 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -56.05 -46.68 78.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.574 -0.739 . . . . 75.23 112.293 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 164' ' ' ILE . 29.1 pt -80.77 -32.41 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.208 0.447 . . . . 74.32 112.208 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 240' ' ' ARG . 3.7 t60 -69.48 -34.76 74.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.373 -0.603 . . . . 64.23 109.373 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -27.04 67.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.453 -0.794 . . . . 65.35 110.503 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.81 19.46 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 72.35 112.098 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 204' ' ' TYR . 44.5 mt-10 72.1 16.65 5.26 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.711 0.634 . . . . 75.41 112.711 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -121.4 144.65 48.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.253 0.549 . . . . 72.43 110.856 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 202' ' ' TYR . 23.6 t -104.31 163.44 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.51 -0.768 . . . . 74.12 109.352 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HE2' ' HG ' ' A' ' 165' ' ' LEU . 5.7 p80 -132.33 105.3 7.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.076 -0.713 . . . . 73.32 109.076 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.438 ' HA3' ' OD2' ' A' ' 222' ' ' ASP . . . -63.76 -54.88 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.638 -0.71 . . . . 65.33 114.148 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 200' ' ' LEU . 24.4 t70 -80.6 90.13 5.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.605 0.717 . . . . 64.4 111.626 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.54 HG22 ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -94.3 102.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.916 -1.512 . . . . 55.14 106.916 159.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.697 ' HG3' ' HE2' ' A' ' 227' ' ' PHE . 29.4 tttp -173.99 -137.04 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.171 -1.418 . . . . 74.51 107.171 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 179' ' ' LYS . . . -120.9 1.24 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.479 -0.328 . . . . 23.21 110.636 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.69 -28.02 50.93 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 111.959 0.355 . . . . 73.4 111.959 -171.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 182' ' ' ASN . 5.6 m120 -108.55 11.06 26.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.722 0.296 . . . . 64.14 111.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 179' ' ' LYS . 8.3 mp -102.61 109.46 21.08 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.369 -0.532 . . . . 72.23 109.986 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.467 HD23 HG22 ' A' ' 196' ' ' VAL . 3.8 mm? -117.79 128.57 54.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.839 . . . . 71.02 109.821 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 80.6 mt -81.43 146.85 30.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.771 -0.649 . . . . 74.23 110.269 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.27 121.01 13.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.476 -1.676 . . . . 73.4 106.476 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -14.34 54.6 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.761 -0.376 . . . . 53.24 111.728 -167.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -87.22 -53.71 4.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.842 0.353 . . . . 74.41 110.814 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.1 m-20 -108.48 114.45 59.09 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.918 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 6.8 Cg_exo -73.11 -12.45 25.72 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 123.241 2.627 . . . . 74.3 112.398 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -86.55 4.56 39.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 63.31 110.837 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 194' ' ' TYR . 80.0 mt-30 -123.45 96.77 5.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.925 -0.58 . . . . 73.51 110.995 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.2 130.69 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.666 -0.697 . . . . 71.52 109.676 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 192' ' ' GLN . 89.0 m-85 -120.17 142.23 49.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.084 -0.507 . . . . 61.12 110.709 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 164' ' ' ILE . 34.2 tp -88.15 99.27 12.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.245 -1.02 . . . . 74.23 108.245 175.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.467 HG22 HD23 ' A' ' 184' ' ' LEU . 15.3 m -120.61 -178.2 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.345 -0.389 . . . . 73.02 110.212 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . 2.6 t70 60.16 71.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.787 0.804 . . . . 75.12 108.979 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.548 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 70.5 m-85 -81.47 34.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.083 -0.962 . . . . 73.33 111.556 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.84 ' HA3' ' HZ ' ' A' ' 48' ' ' PHE . . . -77.25 -3.4 81.91 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.556 -0.831 . . . . 72.44 112.348 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 352' ' ' LYS . 5.4 mp -114.75 34.37 4.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.701 0.286 . . . . 73.15 111.376 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.08 125.86 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.866 0.365 . . . . 51.13 110.438 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.708 ' HD1' HD11 ' A' ' 354' ' ' ILE . 36.2 t80 -108.35 174.77 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.077 -0.51 . . . . 73.14 109.913 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -89.07 135.61 33.47 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.59 0.356 . . . . 72.34 111.173 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 172' ' ' GLU . 8.5 t80 -96.98 -60.34 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 72.15 110.416 173.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 8.4 p -138.04 142.56 36.24 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.647 -0.251 . . . . 74.35 110.881 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 3.1 Cg_exo -75.53 74.83 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.197 2.598 . . . . 54.44 112.203 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.94 86.66 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.573 -0.739 . . . . 53.44 111.921 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.07 -53.89 4.91 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 72.41 113.775 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 14.5 m -73.02 111.07 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.304 0.573 . . . . 64.13 110.936 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 205' ' ' CYS . 20.0 m80 -74.59 110.23 8.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.84 -0.618 . . . . 71.11 109.964 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 212' ' ' GLU . 8.1 tmtm? -97.92 130.89 44.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 75.11 108.872 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -84.19 -98.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.387 -0.37 . . . . 71.43 111.57 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 20.4 p90 -91.97 91.61 7.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.808 0.813 . . . . 75.24 112.121 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -39.74 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.239 -0.892 . . . . 72.43 108.938 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.07 179.34 0.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.975 -1.012 . . . . 72.12 111.905 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 12.0 t70 -147.94 127.86 6.62 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 64.14 110.134 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 21.9 Cg_exo . . . . . 0 CA--C 1.532 0.378 0 C-N-CA 123.172 2.581 . . . . 75.15 113.384 -176.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.438 ' OD2' ' HA3' ' A' ' 176' ' ' GLY . 5.1 p-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.81 0.338 . . . . 73.1 111.083 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.51 170.32 40.4 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.782 -0.723 . . . . 52.23 111.725 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 228' ' ' THR . 53.1 p -70.49 141.96 51.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.093 0.446 . . . . 71.33 111.5 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 265' ' ' LEU . 73.3 mt -55.49 -34.11 33.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 115.769 -0.65 . . . . 63.25 112.406 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.798 ' HG3' ' HG ' ' A' ' 265' ' ' LEU . 3.0 mp0 -52.69 -39.43 61.97 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.002 0.43 . . . . 72.45 110.366 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.828 ' HB3' HG23 ' A' ' 246' ' ' ILE . 70.9 m-85 -105.06 -93.0 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.404 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' THR . 7.5 p 58.03 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.049 1.5 . . . . 63.44 115.049 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 47.6 t 64.44 -175.84 0.17 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.851 -0.796 . . . . 44.12 108.851 -172.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 230' ' ' ILE . 2.9 mp -71.2 -37.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.2 -0.667 . . . . 71.13 109.2 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.75 -73.2 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.691 -1.141 . . . . 63.34 112.104 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.61 -29.65 70.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.372 -0.376 . . . . 75.24 111.783 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.458 ' HE1' HG23 ' A' ' 225' ' ' ILE . 8.1 t60 -66.21 -37.46 85.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 75.55 110.297 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -77.92 -38.33 45.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 74.45 110.513 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 216' ' ' ASP . . . 114.55 9.26 14.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.761 -0.733 . . . . 71.43 112.109 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 6.2 p -89.35 137.71 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.737 -0.468 . . . . 61.54 109.737 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -57.64 117.92 22.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 74.41 111.203 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 23.5 Cg_exo -65.24 101.91 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.681 2.254 . . . . 62.53 111.42 176.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 204' ' ' TYR . 3.1 p -77.68 -20.58 53.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 72.32 110.657 -176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.781 ' HD2' ' HG3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER 178.3 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.18 -0.918 . . . . 51.54 108.823 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HD3' ' HD1' ' A' ' 311' ' ' TYR . 5.7 mtp85 -59.5 -60.96 3.01 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.183 -0.917 . . . . 72.42 111.404 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 238' ' ' PRO . . . -43.36 -65.97 1.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 O-C-N 124.065 0.853 . . . . 54.33 114.203 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.11 -30.54 65.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.339 0.57 . . . . 63.32 111.624 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.49 ' HB3' HH21 ' A' ' 240' ' ' ARG . 17.6 tp -75.29 -35.78 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.887 0.375 . . . . 61.41 110.921 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.09 -37.55 46.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.492 -0.322 . . . . 62.1 110.401 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 227' ' ' PHE . 87.4 mt -60.93 -38.29 78.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.743 -0.465 . . . . 73.55 109.743 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 178' ' ' ILE . 51.8 tp -59.4 -47.35 85.8 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.365 175.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.39 -44.94 93.39 Favored Glycine 0 C--O 1.237 0.283 0 C-N-CA 120.978 -0.629 . . . . 44.01 112.233 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 12.7 m-85 -57.09 -44.08 82.83 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 120.572 0.225 . . . . 72.13 111.142 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.54 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.6 m -67.19 -38.1 84.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.622 -0.263 . . . . 73.23 111.36 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 84.3 mtp -60.4 -49.64 76.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.57 -0.286 . . . . 63.54 110.924 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.636 ' HB ' HG21 ' A' ' 299' ' ' ILE . 12.3 tt -70.32 -31.43 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 74.24 110.305 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.543 ' OE1' ' HG3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -61.02 -46.16 91.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.576 . . . . 63.03 110.181 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.3 m0 -71.7 -35.3 70.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.14 111.369 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.4 tp -76.42 -30.87 57.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.984 0.364 . . . . 74.33 111.984 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.534 HG21 ' HB3' ' A' ' 289' ' ' CYS . 73.6 p -103.36 -27.59 12.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 71.01 111.378 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 83.66 0.25 89.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.769 -0.729 . . . . 70.01 113.238 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -157.07 144.04 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.369 0.584 . . . . 71.23 111.425 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 92.2 mt -129.74 139.55 35.99 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 75.24 109.567 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 38.8 Cg_exo -58.22 -24.27 66.3 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.115 2.543 . . . . 70.21 113.752 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.771 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 25.1 p90 -98.91 -17.73 18.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.406 0.521 . . . . 75.41 112.406 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 1.5 pp20? -86.16 -14.66 43.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.336 -0.546 . . . . 71.53 110.68 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.86 -45.85 90.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 61.34 109.571 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.39 29.05 7.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.367 -0.833 . . . . 75.5 109.737 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.798 ' HG ' ' HG3' ' A' ' 226' ' ' GLU . 2.5 tm? -47.7 -34.24 7.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.855 0.862 . . . . 53.31 112.525 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -66.44 -12.25 56.22 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.013 0.375 . . . . 50.52 112.013 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.6 110.5 49.82 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 73.14 109.665 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.509 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 32.0 Cg_endo -63.04 -24.44 73.7 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.194 2.596 . . . . 72.25 113.999 -171.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -63.13 -49.98 72.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.791 0.329 . . . . 75.51 110.792 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -63.18 -36.82 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 73.33 110.285 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 69.7 t -62.35 -45.21 99.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 73.44 111.136 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 79.9 mtp180 -64.78 -54.87 24.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 73.12 111.394 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.31 -41.44 97.01 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.709 0.29 . . . . 71.21 111.692 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 27.7 m -62.91 -40.28 97.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.477 -0.329 . . . . 72.02 110.796 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -65.17 -42.78 93.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 74.34 111.129 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.7 mt -61.43 -46.21 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 71.23 110.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -64.12 -34.82 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.379 -0.373 . . . . 75.23 111.514 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 282' ' ' ILE . 5.1 m-85 -72.16 -32.31 66.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.707 -0.224 . . . . 74.51 111.597 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -77.92 -34.07 51.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 74.03 110.538 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.51 -42.63 12.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.969 -0.56 . . . . 74.31 112.032 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.447 ' O ' HD23 ' A' ' 285' ' ' LEU . 10.9 t-20 -124.86 81.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.589 . . . . 74.13 110.481 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -74.38 -34.09 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 75.31 112.54 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.85 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.2 m -70.27 -48.84 54.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 53.44 110.972 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.1 mm? -63.12 -50.59 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.078 -0.51 . . . . 74.12 111.364 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.635 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.3 OUTLIER -60.79 -40.76 93.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.897 0.332 . . . . 73.42 111.897 -177.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.73 -42.39 95.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.908 0.385 . . . . 74.54 111.115 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 288' ' ' LYS . 43.3 mmtm -81.21 4.31 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.354 0.502 . . . . 74.24 112.354 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 256' ' ' THR . 80.2 m -83.32 -17.43 42.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 51.31 109.904 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 0.9 OUTLIER -123.7 89.41 51.4 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 73.43 109.81 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.88 3.03 7.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.323 2.682 . . . . 73.2 112.481 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 6.1 mm-40 -99.71 174.21 6.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.893 -0.78 . . . . 65.53 108.893 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -86.86 79.59 8.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.434 0.635 . . . . 71.03 111.304 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.92 157.02 28.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.004 -0.998 . . . . 73.54 108.601 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -105.07 117.49 58.45 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 112.227 0.455 . . . . 71.43 112.227 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -95.51 38.57 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.297 2.664 . . . . 60.33 110.957 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -69.91 -36.92 74.3 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.547 -0.751 . . . . 61.23 113.209 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.535 ' HB3' HD23 ' A' ' 324' ' ' LEU . 1.5 mp0 -50.99 -52.72 39.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.965 0.412 . . . . 74.13 110.69 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.636 HG21 ' HB ' ' A' ' 252' ' ' ILE . 4.0 mp -70.76 -36.64 65.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.616 . . . . 73.25 110.415 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.73 68.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.454 -0.339 . . . . 72.21 110.784 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.011 -0.541 . . . . 64.5 110.156 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.568 ' CD1' HD22 ' A' ' 320' ' ' LEU . 68.0 t80 -56.66 -42.79 79.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 110.2 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.635 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 95.7 mmm -70.44 -40.86 73.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.57 -0.741 . . . . 63.33 110.603 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.671 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 46.6 mt-10 -53.06 -50.42 64.38 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.204 -0.665 . . . . 64.01 109.204 172.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 79.3 m -56.83 -50.49 72.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.659 -1.155 . . . . 73.2 112.087 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 303' ' ' MET . 28.8 m -69.41 -26.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.391 0.515 . . . . 54.51 112.391 -174.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -90.92 -16.15 28.6 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.786 -0.366 . . . . 75.12 111.692 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 53.0 mt -68.37 -37.59 80.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 74.34 110.592 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.3 pp -87.13 12.92 10.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.381 0.61 . . . . 42.12 110.19 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.85 -93.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.643 -1.162 . . . . 73.43 112.961 171.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HD1' ' HD3' ' A' ' 241' ' ' ARG . 40.2 t80 -115.72 -58.56 2.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.86 0.319 . . . . 73.23 111.86 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.1 p -133.73 10.07 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.1 0.407 . . . . 74.13 112.1 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.0 60.9 6.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.387 0.514 . . . . 73.32 112.387 -169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? 64.97 103.86 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.389 -0.823 . . . . 74.42 113.189 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.781 ' HG3' ' HD2' ' A' ' 240' ' ' ARG . 4.4 Cg_exo -78.92 119.5 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.734 2.289 . . . . 63.21 111.303 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 94.1 mt -84.32 81.38 8.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.758 0.313 . . . . 65.13 110.987 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.49 -36.42 75.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 64.3 111.366 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -61.45 -45.99 91.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.415 . . . . 63.35 110.498 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.05 -40.32 90.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.277 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 87.8 mt -58.19 -52.55 65.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 74.13 110.1 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -40.33 77.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 73.15 110.805 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.65 -50.31 69.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 63.14 111.635 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.69 -31.97 27.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 111.679 0.252 . . . . 74.53 111.679 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 298' ' ' GLU . 93.0 mt -66.35 -48.63 69.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 72.24 110.621 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.6 -27.11 63.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 72.32 110.919 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.38 -49.06 78.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.437 -0.579 . . . . 71.42 109.437 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.72 -40.18 93.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.656 -0.783 . . . . 62.4 112.108 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.606 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 tm? -59.08 -43.96 91.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 62.43 110.517 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 333' ' ' SER . 30.1 ttpt -72.82 -30.01 63.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 70.01 110.855 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.03 69.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 73.45 112.071 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.649 ' HB ' ' NH1' ' A' ' 151' ' ' ARG . 13.7 tt -83.34 -7.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 62.32 111.013 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.19 -6.15 26.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.588 -0.815 . . . . 60.13 113.188 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.707 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 20.1 p -100.19 158.48 15.83 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.659 -0.318 . . . . 64.31 110.704 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -148.87 -68.36 0.22 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.294 -0.632 . . . . 72.31 109.294 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 336' ' ' ASP . 9.2 t70 56.43 -155.9 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.722 -0.672 . . . . 65.4 111.402 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 335' ' ' ASP . 27.2 t70 -153.03 -36.7 0.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.22 -0.446 . . . . 65.33 110.855 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . 0.499 ' HA2' ' OE1' ' A' ' 156' ' ' GLN . . . 177.97 49.73 0.07 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.969 -1.11 . . . . 45.3 114.082 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 117.278 0.539 . . . . 74.13 111.556 177.803 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.905 ' HA ' HD11 ' A' ' 200' ' ' LEU . 33.1 pttt . . . . . 0 CA--C 1.53 0.207 0 CA-C-O 120.829 0.347 . . . . 75.25 111.919 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 10.8 t 166.85 135.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.291 -0.868 . . . . 73.33 109.602 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.882 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -94.4 142.08 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.546 -0.538 . . . . 73.44 109.546 175.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.514 ' N ' HD13 ' A' ' 354' ' ' ILE . 24.5 m -64.48 97.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.045 -0.525 . . . . 63.34 111.97 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.467 ' HE3' ' CG2' ' A' ' 354' ' ' ILE . 94.9 mttt . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.638 . . . . 73.43 109.992 174.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.242 -0.281 . . . . 71.4 110.242 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.24 -21.91 43.32 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.798 -0.715 . . . . 73.33 113.533 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.67 160.76 29.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.704 0.752 . . . . 73.01 110.306 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 6.4 pt -116.76 129.67 72.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.468 0.651 . . . . 65.44 110.949 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.553 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 33.1 pt -91.8 154.48 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.511 -0.768 . . . . 75.22 111.091 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 35' ' ' LYS . 4.8 m -112.5 114.13 26.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 72.21 111.273 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.678 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.7 p-10 -112.05 -166.54 1.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 55.3 109.834 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.624 ' HG2' ' O ' ' A' ' 116' ' ' SER . 20.9 mmt -63.65 -22.55 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.337 -0.392 . . . . 74.52 111.46 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.52 4.8 19.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.776 0.322 . . . . 53.23 111.013 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 71.26 44.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.771 -0.649 . . . . 75.22 111.61 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HB2' HG23 ' A' ' 30' ' ' THR . 37.7 ttmt 72.97 113.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.324 -0.853 . . . . 74.22 113.262 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.76 37.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 75.41 110.61 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 11.3 m95 -134.01 126.12 29.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 70.41 110.117 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.58 124.9 50.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.682 0.277 . . . . 74.22 110.304 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.97 126.14 25.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 44.22 110.928 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.02 -107.88 3.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.766 -0.73 . . . . 55.15 112.306 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.852 ' HB3' HD12 ' A' ' 53' ' ' LEU . 49.1 tp -86.67 123.94 70.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.727 0.299 . . . . 72.24 110.71 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 41' ' ' LEU . 58.2 Cg_endo -74.81 109.04 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.45 2.1 . . . . 71.13 111.837 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 36.9 mt -74.0 -53.46 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.34 0.59 . . . . 72.31 110.048 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.92 -29.51 5.88 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.65 -0.705 . . . . 73.32 112.575 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -119.01 165.1 14.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.163 -0.31 . . . . 73.44 110.163 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.13 51.82 1.43 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.548 -0.834 . . . . 73.31 111.749 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 145.67 -126.71 2.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.503 -0.856 . . . . 60.52 112.008 -178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -92.77 -33.69 14.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.9 0.381 . . . . 61.42 110.919 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.443 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 141.13 160.68 8.39 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.369 -0.692 . . . . 71.14 111.369 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.8 t 53.53 53.81 11.01 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.273 0.558 . . . . 52.0 110.652 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.3 mm -89.07 137.81 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 64.33 110.273 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' HG13 ' A' ' 70' ' ' VAL . 84.5 m-85 -121.22 148.54 44.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 64.32 111.193 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.852 HD12 ' HB3' ' A' ' 41' ' ' LEU . 75.3 mt -87.4 140.72 29.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.049 -0.523 . . . . 75.34 109.837 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.29 37.84 4.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.374 0.607 . . . . 65.15 109.914 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 8.7 p-10 -98.22 9.12 43.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.489 -0.778 . . . . 73.45 111.249 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.62 2.61 50.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 74.32 111.736 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.38 87.78 7.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.158 -0.617 . . . . 73.31 110.029 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 t -104.1 79.77 1.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.727 -0.842 . . . . 72.01 108.727 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.9 m . . . . . 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 62.15 110.756 -176.604 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.464 0.234 0 CA-C-O 121.31 0.576 . . . . 71.14 110.557 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 187' ' ' TYR . 93.3 Cg_endo -80.81 36.95 0.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.089 2.526 . . . . 72.13 113.14 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.6 m -117.86 136.15 53.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.62 0.724 . . . . 53.33 111.849 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 53' ' ' LEU . 35.4 m -136.2 148.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.996 -1.002 . . . . 75.12 108.746 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -123.73 120.66 60.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.291 0.567 . . . . 54.34 111.028 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CB ' HD12 ' A' ' 51' ' ' ILE . 25.3 pttm -105.58 134.44 48.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 126' ' ' TYR . 15.9 t -120.51 148.94 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 63.14 112.054 -165.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 80' ' ' LEU . 18.1 mm-40 -137.8 141.16 31.88 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 70.43 109.422 173.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.65 134.64 58.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.456 2.104 . . . . 72.34 111.633 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -73.41 88.46 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.185 0.517 . . . . 63.03 111.1 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -139.15 -68.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.585 -0.894 . . . . 72.15 108.585 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.465 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 5.3 p30 -128.5 -75.42 0.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.558 -0.746 . . . . 72.21 109.032 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . 72.35 110.5 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 114.058 0.383 . . . . 73.03 114.058 170.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA2' ' A' ' 78' ' ' GLY . 12.0 Cg_endo -55.77 -22.35 36.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.858 2.372 . . . . 60.52 111.398 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 57.9 tp -59.85 -30.1 68.74 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.454 -0.793 . . . . 64.43 110.559 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.35 -38.93 71.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.933 -0.395 . . . . 73.14 109.933 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.6 m -60.95 -46.96 88.6 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.426 0.632 . . . . 64.32 109.522 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 34.6 tt0 -63.14 -37.98 89.35 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.348 -0.842 . . . . 52.55 110.64 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.4 -45.3 88.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.486 -0.324 . . . . 60.34 110.681 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.82 -50.97 71.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.852 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 168' ' ' ILE . 92.7 t80 -62.63 -40.1 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 64.41 110.95 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 2.8 t80 -62.3 -45.14 94.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.309 -0.859 . . . . 72.33 111.052 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.02 -29.68 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.678 0.275 . . . . 72.11 111.323 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 7.6 tpm_? -69.2 -27.84 65.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 73.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.75 10.83 36.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 71.12 110.912 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.89 173.78 11.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.384 . . . . 71.01 111.74 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.799 ' HB3' HE21 ' A' ' 95' ' ' GLN . 36.7 ttmt 70.83 98.22 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.129 -0.941 . . . . 71.22 110.321 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.92 -31.51 81.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.693 2.928 . . . . 72.32 113.741 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.747 ' HG2' ' HE3' ' A' ' 98' ' ' LYS . 43.6 tt0 -60.86 -46.8 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.219 -0.193 . . . . 74.34 110.787 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.799 HE21 ' HB3' ' A' ' 92' ' ' LYS . 45.2 mt-30 -58.77 -44.1 90.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.884 0.373 . . . . 72.04 110.055 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.1 mt -56.32 -52.72 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.484 -0.78 . . . . 72.21 110.224 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.16 -36.83 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.099 -0.501 . . . . 75.1 110.96 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.747 ' HE3' ' HG2' ' A' ' 94' ' ' GLU . 97.4 mttt -60.44 -58.44 8.48 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.044 -0.525 . . . . 72.23 111.177 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.683 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.2 p90 -72.44 -34.23 67.65 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.155 -0.618 . . . . 72.12 110.788 -174.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 96' ' ' ILE . 22.4 mm -55.28 -49.12 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.548 0.213 . . . . 61.3 110.731 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.83 -44.89 84.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.301 . . . . 73.44 111.135 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.5 m -71.13 -23.97 62.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 72.13 111.575 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.607 HH22 ' HB2' ' A' ' 170' ' ' GLU . 20.6 ttt180 -96.24 -1.84 47.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.457 -176.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.95 35.68 8.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.76 -0.654 . . . . 71.15 111.325 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.532 HD11 ' HD3' ' A' ' 103' ' ' ARG . 81.2 mt -94.97 -165.51 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.524 . . . . 73.02 109.956 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HG3' HD21 ' A' ' 159' ' ' LEU . 3.2 mmmp? -108.87 -61.79 1.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.751 -0.463 . . . . 71.21 109.751 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 32.4 p90 178.62 144.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 73.33 109.618 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 22.5 tp -79.34 125.49 29.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.673 -0.694 . . . . 63.32 110.805 -172.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 59.71 4.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.105 -0.569 . . . . 40.42 112.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.48 134.41 21.97 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.716 -0.475 . . . . 64.01 109.716 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.729 ' HB3' ' HZ ' ' A' ' 134' ' ' PHE . 17.1 Cg_endo -59.8 142.55 98.85 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.302 2.001 . . . . 72.41 112.057 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.72 147.83 50.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 74.21 111.303 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.05 128.98 55.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.913 -0.585 . . . . 72.24 110.742 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.59 ' HB2' HG22 ' A' ' 130' ' ' ILE . 70.3 m95 -103.33 -59.7 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.304 0.573 . . . . 73.34 109.665 174.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.17 175.52 42.3 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.507 -0.77 . . . . 74.32 112.564 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' MET . 18.7 p -150.49 155.93 40.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.442 -0.947 . . . . 75.31 108.442 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.678 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -172.56 -160.01 20.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.201 -1.476 . . . . 72.53 113.799 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 tp -136.92 136.21 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.058 -0.571 . . . . 74.15 110.02 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 3.7 t-160 -139.77 121.91 15.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.212 -0.662 . . . . 65.2 109.212 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 22.3 t70 -88.49 130.83 35.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 71.42 109.905 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -87.34 -72.02 0.54 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.919 0.39 . . . . 71.4 110.667 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -135.75 33.4 2.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 74.41 110.184 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.1 -23.1 21.89 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.477 -1.049 . . . . 52.11 110.477 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.7 mptt -87.45 104.44 16.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.77 -0.826 . . . . 64.15 108.77 172.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.1 m -77.52 129.07 35.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.468 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . 47.8 m-85 -107.89 124.1 49.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.084 -0.507 . . . . 65.22 111.106 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -100.29 131.28 46.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.037 -0.727 . . . . 74.42 109.037 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 17.5 p90 -144.52 164.7 30.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.39 -0.368 . . . . 72.3 111.467 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 16.7 ptp -135.63 143.43 45.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.958 -0.565 . . . . 64.31 110.972 174.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.59 HG22 ' HB2' ' A' ' 114' ' ' TRP . 6.0 mm -97.48 121.34 47.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.279 -0.873 . . . . 75.04 110.027 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.9 ptm -133.56 176.46 8.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.461 -0.791 . . . . 71.34 109.871 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -72.47 145.83 47.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.264 0.554 . . . . 74.3 111.757 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HD3' HG11 ' A' ' 69' ' ' VAL . 16.6 tpt180 -71.37 129.35 38.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.221 -0.9 . . . . 73.12 111.385 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 50.0 m-85 -103.76 142.53 34.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.246 -0.65 . . . . 75.42 109.246 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.37 -16.14 4.36 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.432 -0.89 . . . . 64.31 111.754 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.861 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 61.4 m -121.71 125.88 47.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.609 0.243 . . . . 73.25 110.421 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.01 138.11 44.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 71.44 109.454 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.736 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.4 tp -71.85 -17.38 62.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.232 -0.284 . . . . 75.31 110.232 -176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.886 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 52.4 tt0 -68.85 -51.15 43.54 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.152 0.427 . . . . 64.14 112.152 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.5 tptt -79.56 -35.31 40.02 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.255 -0.578 . . . . 74.21 110.436 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -43.2 92.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.167 -0.47 . . . . 73.21 111.265 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -65.38 -31.52 72.67 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.315 -0.554 . . . . 75.41 110.232 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -67.01 -38.17 85.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.825 0.345 . . . . 62.15 110.424 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.04 -32.21 68.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 74.11 111.529 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -99.06 4.6 47.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 75.52 111.136 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.3 33.98 21.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.055 -0.521 . . . . 70.35 110.967 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 16.9 pttp 43.32 33.09 0.55 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.485 1.114 . . . . 71.21 113.15 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -110.58 95.92 5.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.53 -0.915 . . . . 73.22 108.53 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 147' ' ' LYS . 24.7 m-85 -112.32 157.12 21.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.612 -0.722 . . . . 74.2 110.949 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 m -62.69 156.31 23.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.009 -0.541 . . . . 73.22 109.751 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -55.72 -26.04 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.822 0.305 . . . . 72.45 111.822 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG2' ' OD2' ' A' ' 335' ' ' ASP . 57.1 mttm -52.65 -54.32 35.01 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.231 0.539 . . . . 70.33 111.004 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 1.9 m -65.16 -36.17 83.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.638 -0.71 . . . . 73.45 111.222 -174.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 -49.38 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.107 -0.497 . . . . 63.13 110.788 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.615 ' HG ' HD22 ' A' ' 328' ' ' LEU . 0.5 OUTLIER -68.5 -50.39 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 52.13 110.53 -176.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.564 ' HG3' ' H ' ' A' ' 337' ' ' GLY . 2.3 mp0 -61.61 -40.43 94.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.128 0.418 . . . . 73.12 112.128 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.9 mp -63.96 -46.83 82.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.03 -0.268 . . . . 65.11 110.36 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.454 ' HA ' HD11 ' A' ' 247' ' ' LEU . 37.6 t -60.27 -46.65 89.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.865 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 106' ' ' LYS . 58.7 tp -55.62 -46.36 77.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 64.42 111.277 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.584 HH11 HG12 ' A' ' 193' ' ' VAL . 89.9 mtt180 -66.68 -34.03 76.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 74.31 111.294 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 157' ' ' LEU . 48.1 mm -68.89 -34.71 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 63.3 110.291 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.477 HD11 HD12 ' A' ' 324' ' ' LEU . 95.7 mt -61.11 -47.41 86.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.486 -0.324 . . . . 61.32 110.6 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.74 -48.02 78.73 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.124 -0.489 . . . . 72.04 111.155 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' ILE . 14.7 tt -71.83 -36.47 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.774 -0.37 . . . . 50.25 111.677 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 168' ' ' ILE . 42.5 tp -65.41 -32.62 74.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.44 110.985 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 317' ' ' TYR . 28.6 tp10 -68.12 -45.96 72.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.826 -0.435 . . . . 53.13 109.826 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -59.04 -44.05 91.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 72.05 111.893 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 165' ' ' LEU . 40.6 pt -76.57 -34.28 23.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.715 -0.394 . . . . 65.12 111.683 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -75.79 -19.1 59.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.67 -0.412 . . . . 75.2 110.443 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.607 ' HB2' HH22 ' A' ' 103' ' ' ARG . 13.6 tt0 -53.34 -31.8 46.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.016 -0.735 . . . . 75.45 109.016 170.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.545 ' C ' ' HG3' ' A' ' 172' ' ' GLU . 48.1 m80 -98.45 -101.94 0.21 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.981 -1.008 . . . . 63.44 110.596 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.545 ' HG3' ' C ' ' A' ' 171' ' ' HIS . 12.1 mt-10 -153.87 14.0 0.47 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.645 0.239 . . . . 75.54 111.645 -171.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -122.46 148.04 45.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 72.41 112.601 -164.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.01 173.21 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.034 -0.984 . . . . 70.21 109.401 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.14 -65.11 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 63.42 110.897 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.28 50.97 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.435 -0.888 . . . . 33.21 113.056 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 34.0 t70 -141.37 108.37 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.983 0.392 . . . . 54.03 111.169 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 178' ' ' ILE . 25.2 mm -111.27 35.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.81 0.814 . . . . 73.13 109.4 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 56.4 tptt -59.71 134.87 57.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 72.41 110.169 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -48.06 -33.64 8.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.83 0.678 . . . . 75.32 112.83 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.886 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 28.6 p -59.41 -25.58 64.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.848 0.356 . . . . 64.44 111.671 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -88.51 1.02 55.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 74.41 111.87 -171.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.21 127.01 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 63.45 110.579 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.42 134.9 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 62.02 111.007 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.861 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 8.6 mp -95.64 145.86 24.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.149 -0.478 . . . . 54.52 109.815 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.438 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 26.2 t-20 -62.73 144.39 56.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.378 -0.373 . . . . 63.15 110.417 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.654 ' CE2' ' HE2' ' A' ' 188' ' ' LYS . 1.3 p90 -60.56 -32.37 71.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.219 0.451 . . . . 72.34 112.219 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.654 ' HE2' ' CE2' ' A' ' 187' ' ' TYR . 75.8 mmtt -93.71 -43.91 8.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 72.53 110.237 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -101.94 105.3 41.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 71.22 111.961 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 4.3 Cg_exo -77.15 -7.04 17.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.957 2.438 . . . . 75.02 111.466 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 192' ' ' GLN . 5.0 p-10 -87.96 -16.86 32.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.839 -0.619 . . . . 71.13 110.7 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HG3' ' OD2' ' A' ' 191' ' ' ASP . 42.8 mt-30 -111.08 110.98 21.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.405 0.621 . . . . 71.1 111.11 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.584 HG12 HH11 ' A' ' 160' ' ' ARG . 13.0 p -108.09 138.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.882 -1.053 . . . . 75.13 109.913 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 47.0 m-85 -125.33 153.74 42.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.442 -0.577 . . . . 63.51 109.442 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 32.5 tp -96.48 142.3 28.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.059 -0.349 . . . . 62.35 110.059 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.701 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.0 p -124.04 -173.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.293 -0.632 . . . . 73.32 109.293 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 196' ' ' VAL . 52.5 t0 60.63 62.32 1.53 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.894 0.854 . . . . 75.33 109.116 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.773 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 21.7 m-85 -81.11 7.59 10.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.147 -0.933 . . . . 71.24 109.788 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.45 76.5 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.579 -0.737 . . . . 63.33 111.622 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.885 ' HA ' ' HB ' ' A' ' 354' ' ' ILE . 2.4 pp -89.91 4.07 51.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.753 0.311 . . . . 74.43 111.355 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -68.89 102.1 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.194 0.521 . . . . 64.25 109.974 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.605 ' HB2' HG13 ' A' ' 354' ' ' ILE . 84.8 t80 -98.39 125.54 43.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 71.52 110.117 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 34.8 ttt180 -74.4 97.16 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 54.25 109.147 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.66 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 2.7 p90 -87.07 -14.93 40.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 73.52 111.625 -170.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 24.8 p -137.4 104.47 8.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.82 0.343 . . . . 72.55 110.871 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 34.1 Cg_endo -66.16 119.97 7.06 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.413 2.075 . . . . 74.32 111.708 176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.411 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 3.4 mp0 64.98 -80.79 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.769 -0.65 . . . . 73.24 111.046 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.84 0.64 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 74.25 112.098 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 51.0 t -105.63 111.74 36.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.077 -0.342 . . . . 71.12 110.077 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -83.94 146.07 28.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.859 0.361 . . . . 74.34 110.295 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 212' ' ' GLU . 10.1 mmtt -84.02 156.37 22.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.449 . . . . 73.3 109.989 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -102.25 153.62 19.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.315 -0.624 . . . . 73.45 109.315 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.874 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -74.13 55.82 0.59 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.563 0.579 . . . . 72.01 112.563 -174.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -117.28 -15.49 10.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.11 -0.496 . . . . 74.13 110.498 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 236' ' ' VAL . 3.0 tp10 -80.94 141.14 34.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.669 -170.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -148.98 83.15 6.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.534 -0.913 . . . . 70.43 108.534 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 C--O 1.233 0.243 0 C-N-CA 122.414 2.076 . . . . 72.15 112.205 -176.077 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 . . . . . 0 N--CA 1.463 0.215 0 CA-C-O 121.044 0.449 . . . . 64.2 110.906 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -76.44 159.36 49.97 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.707 -0.758 . . . . 74.42 111.674 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 228' ' ' THR . 6.6 p -68.58 150.3 48.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.472 0.177 . . . . 61.44 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 265' ' ' LEU . 43.8 mm -52.97 -34.36 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.903 0.383 . . . . 71.52 111.479 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.18 -47.06 84.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.964 -0.562 . . . . 74.41 111.293 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.984 ' HB3' HG23 ' A' ' 246' ' ' ILE . 41.0 m-85 -112.1 15.75 20.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 75.31 111.968 -170.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 224' ' ' THR . 1.3 p -57.87 -36.83 72.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.441 0.534 . . . . 63.1 112.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.6 t 57.23 -173.97 0.08 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.378 -0.601 . . . . 73.31 109.378 -170.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.5 -39.15 54.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.262 0.553 . . . . 65.51 109.849 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.82 -66.45 0.4 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.888 -1.051 . . . . 65.02 111.967 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.57 69.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 75.12 111.914 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -63.02 -43.67 98.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.629 -0.26 . . . . 65.11 111.099 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.39 -32.88 58.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.212 0.53 . . . . 75.42 110.819 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.25 1.45 55.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.625 -0.798 . . . . 62.54 111.49 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 213' ' ' TYR . 8.8 p -72.42 141.88 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 110.0 -0.37 . . . . 64.01 110.0 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -47.76 109.89 1.23 Allowed Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 61.41 111.728 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.57 121.21 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 73.21 111.864 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 m -79.8 170.59 16.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.033 -0.53 . . . . 75.42 109.82 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -62.7 -29.98 71.06 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.415 -0.514 . . . . 74.24 110.434 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 0.2 OUTLIER -55.12 -38.8 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.42 109.858 174.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -67.26 -50.95 41.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.536 -0.756 . . . . 65.31 111.971 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -39.67 94.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.992 0.425 . . . . 74.44 110.174 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.35 -44.28 97.44 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.086 -0.506 . . . . 54.12 110.775 174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.62 -36.99 81.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.76 -0.655 . . . . 74.11 110.181 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.984 HG23 ' HB3' ' A' ' 227' ' ' PHE . 96.5 mt -62.77 -43.01 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.648 -0.706 . . . . 72.42 110.151 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 251' ' ' MET . 61.7 tp -60.34 -39.6 87.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.321 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.805 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.62 -42.06 99.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.035 -0.602 . . . . 73.13 112.254 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 246' ' ' ILE . 22.2 m-85 -56.93 -41.35 78.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.248 0.547 . . . . 60.42 110.046 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 46.4 m -65.57 -45.44 83.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.553 -0.749 . . . . 74.52 110.656 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.2 mtp -58.39 -48.53 80.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 74.13 111.228 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.473 ' HB ' ' HE1' ' A' ' 286' ' ' MET . 8.9 tt -66.53 -34.29 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.713 -0.395 . . . . 75.41 110.742 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.505 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 41.6 tt0 -66.75 -46.4 75.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.141 -0.224 . . . . 71.24 110.772 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.0 m0 -68.37 -28.21 66.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 71.01 111.363 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.5 tp -81.49 -31.05 33.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 74.3 111.706 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.7 p -101.8 -28.2 12.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.801 -0.359 . . . . 74.04 111.683 -173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 87.01 -13.79 58.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.858 -0.687 . . . . 73.3 112.745 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -156.26 141.04 17.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.919 -0.4 . . . . 75.54 109.919 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 93.9 mt -101.79 148.93 36.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 52.14 110.758 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.448 ' HG2' ' CE3' ' A' ' 261' ' ' TRP . 18.2 Cg_endo -60.07 -29.11 88.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.708 2.272 . . . . 63.53 112.766 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.515 ' HB3' ' CB ' ' A' ' 274' ' ' SER . 33.5 p90 -105.13 7.58 33.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.72 0.295 . . . . 70.34 111.222 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 39.8 tt0 -67.22 -37.48 83.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.026 0.441 . . . . 44.2 111.332 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.56 -22.14 62.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.348 0.594 . . . . 73.41 110.091 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -109.56 21.73 16.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.526 -0.761 . . . . 75.11 110.731 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 225' ' ' ILE . 1.6 tm? -63.33 -24.0 67.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 73.03 111.03 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -88.56 12.69 13.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 62.54 111.698 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.54 118.46 17.98 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-O 120.766 0.317 . . . . 73.52 110.636 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 271' ' ' VAL . 24.4 Cg_exo -63.17 -30.62 74.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 73.03 113.267 -177.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -73.23 -41.67 63.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.751 0.31 . . . . 74.32 110.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -68.89 -46.54 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 74.22 111.204 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 268' ' ' PRO . 34.1 m -62.88 -31.21 51.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.928 -0.309 . . . . 70.03 111.143 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 276' ' ' ILE . 10.7 ttt85 -61.16 -62.72 1.64 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 110.139 -0.319 . . . . 74.45 110.139 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.39 -44.65 84.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.77 -0.65 . . . . 74.52 111.563 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 261' ' ' TRP . 19.7 m -65.15 -40.94 95.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.962 -0.563 . . . . 52.2 111.668 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -78.52 -23.01 46.5 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.537 -0.465 . . . . 53.5 110.921 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 272' ' ' ARG . 62.4 mt -71.32 -46.5 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.838 -0.431 . . . . 73.13 109.838 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -62.64 -40.01 95.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.346 -0.388 . . . . 75.01 110.545 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -60.14 -46.86 88.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 74.11 110.842 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -76.98 -13.91 59.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 73.43 110.624 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.83 -36.19 79.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.099 -0.501 . . . . 54.11 110.052 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 281' ' ' ASN . 2.6 t-20 -161.9 96.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.416 -0.587 . . . . 64.02 109.416 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 303' ' ' MET . 3.7 mp -80.16 -51.48 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.186 0.439 . . . . 54.42 112.186 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.409 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.12 -46.94 84.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.597 0.221 . . . . 71.21 111.597 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -64.99 -37.14 86.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 62.54 110.559 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.27 -34.44 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 65.01 110.69 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.473 ' HE1' ' HB ' ' A' ' 252' ' ' ILE . 49.5 mtt -74.38 -34.22 63.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.687 -0.233 . . . . 75.21 111.44 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -59.92 -36.52 77.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.288 -0.634 . . . . 71.53 109.288 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -75.35 -24.48 57.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.976 -1.011 . . . . 74.02 110.965 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.0 m -72.85 -23.46 60.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.619 -0.264 . . . . 72.14 111.229 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.82 81.24 11.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.85 0.315 . . . . 53.42 111.85 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.37 -18.34 49.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.533 2.156 . . . . 74.42 111.228 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -76.78 -5.91 50.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.75 -0.659 . . . . 54.32 109.85 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 64.95 90.14 0.09 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.057 -0.974 . . . . 72.24 112.315 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.44 -177.14 3.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.816 -1.549 . . . . 75.41 106.816 170.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -122.29 87.26 48.21 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 118.808 0.731 . . . . 73.03 110.332 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.46 39.65 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.323 2.682 . . . . 75.1 111.348 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -65.61 -37.32 93.47 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.837 -0.619 . . . . 72.14 112.861 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.567 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -60.35 -46.61 89.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.31 0.576 . . . . 72.31 109.899 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -76.29 -38.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.473 -0.785 . . . . 72.24 110.442 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.39 -53.24 59.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 75.43 111.488 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.593 ' HB3' HD11 ' A' ' 323' ' ' ILE . 27.8 tptp -69.4 -36.32 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.397 -0.365 . . . . 72.02 110.412 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.536 ' CD1' HD12 ' A' ' 320' ' ' LEU . 62.9 t80 -55.76 -50.92 69.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.908 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.805 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 82.9 mmm -70.61 -40.86 72.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.918 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.15 -34.15 77.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.547 -0.538 . . . . 74.41 109.547 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -73.25 -45.23 57.14 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.508 0.558 . . . . 74.2 112.508 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.1 m -63.54 -25.3 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.348 0.594 . . . . 74.41 110.342 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -74.6 -44.18 51.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 71.33 111.455 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 85.1 mt -84.38 71.23 10.7 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.139 0.792 . . . . 64.23 113.139 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 310' ' ' ASP . 1.3 pt? -159.61 -71.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.369 -0.974 . . . . 53.14 108.369 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.948 ' H ' ' HG ' ' A' ' 309' ' ' LEU . 2.8 t70 174.52 -73.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 124.002 0.814 . . . . 71.12 109.093 168.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 0.4 OUTLIER -162.35 -51.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.245 0.832 . . . . 71.12 113.245 173.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 7.0 m -139.36 32.0 2.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.598 0.713 . . . . 72.22 110.943 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 310' ' ' ASP . 7.8 mp0 -62.5 -76.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 64.13 109.962 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -156.75 93.51 2.36 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 73.43 109.459 173.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 117.39 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.949 1.766 . . . . 62.31 110.747 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.07 85.43 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 75.3 109.923 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.471 ' CZ ' ' HD2' ' A' ' 321' ' ' ARG . 60.5 t80 -57.2 -36.91 71.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.43 -0.805 . . . . 73.31 110.987 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.52 -39.26 90.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 72.13 110.417 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -68.06 -42.97 79.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 64.14 111.274 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.536 HD12 ' CD1' ' A' ' 302' ' ' TYR . 2.0 mm? -63.07 -43.38 98.73 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.939 -0.304 . . . . 75.5 110.749 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.558 ' NH2' ' HG2' ' A' ' 106' ' ' LYS . 65.0 mtp85 -67.7 -38.5 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.911 -0.316 . . . . 73.42 110.351 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -48.4 76.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 64.32 111.203 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -64.67 -41.42 92.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.815 -0.175 . . . . 64.03 111.232 -176.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 162' ' ' LEU . 80.5 mt -63.24 -46.06 88.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.822 0.344 . . . . 71.45 110.869 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -35.26 75.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.449 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -55.68 -47.84 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.862 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.567 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -68.07 -45.89 69.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.901 -0.666 . . . . 71.15 112.166 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.615 HD22 ' HG ' ' A' ' 155' ' ' LEU . 40.6 tp -59.17 -45.7 90.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.127 0.489 . . . . 74.21 110.812 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -73.96 -24.63 59.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 61.42 111.164 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.43 -43.14 77.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.682 0.277 . . . . 65.44 110.991 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.29 -6.73 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.364 0.602 . . . . 74.43 110.651 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.99 24.31 38.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.893 -0.67 . . . . 71.51 112.943 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.0 t -108.21 153.53 23.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.903 -0.406 . . . . 61.43 109.903 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.0 132.86 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.152 -0.476 . . . . 65.21 109.831 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 16.7 m-20 -138.6 -58.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.382 -0.372 . . . . 63.22 110.482 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 48.9 t0 59.29 90.15 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.169 0.918 . . . . 55.44 111.064 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . 0.564 ' H ' ' HG3' ' A' ' 156' ' ' GLN . . . 96.85 -31.85 7.18 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.825 -0.703 . . . . 70.34 112.398 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 335' ' ' ASP . 53.4 mttp . . . . . 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 54.11 110.984 -177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.58 ' O ' ' HB ' ' A' ' 353' ' ' THR . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.47 0 N-CA-C 112.087 0.402 . . . . 64.12 112.087 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 93.8 m 74.83 139.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.871 0.732 . . . . 71.33 110.666 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.885 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.4 OUTLIER -90.8 140.57 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 72.43 110.844 -177.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.505 ' N ' HD13 ' A' ' 354' ' ' ILE . 88.0 m -68.64 102.48 1.5 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.009 -0.541 . . . . 73.51 110.833 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 4.9 tmtt? . . . . . 0 C--N 1.317 -0.819 0 N-CA-C 109.281 -0.637 . . . . 65.43 109.281 178.035 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.806 0.336 . . . . 52.23 110.473 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.65 1.22 83.33 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.883 -0.675 . . . . 71.41 112.537 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 154.02 20.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.088 -0.338 . . . . 74.52 110.088 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 14.6 mt -106.42 136.94 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 71.44 111.639 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.41 136.1 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.44 -0.8 . . . . 75.11 109.466 175.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -106.12 121.86 45.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.268 -0.271 . . . . 73.43 110.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.25 179.6 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.772 -0.371 . . . . 74.52 110.01 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.6 mmt -63.41 -22.1 66.68 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.387 0.514 . . . . 73.33 112.387 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.74 6.08 16.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.739 0.305 . . . . 60.13 111.218 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 74.71 11.37 3.85 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.613 -0.721 . . . . 75.53 111.337 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 133.48 33.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.788 -0.449 . . . . 51.24 109.788 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 42.6 mt-10 -104.61 92.47 4.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.379 0.609 . . . . 73.22 110.501 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 56' ' ' MET . 10.9 m95 -83.64 159.02 21.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 71.52 109.089 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.06 146.68 44.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.098 -0.641 . . . . 75.21 110.618 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 ' CE1' ' A' ' 52' ' ' TYR . 58.5 t -72.65 116.88 15.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.393 -0.821 . . . . 41.04 110.409 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 -94.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.518 -0.848 . . . . 62.44 112.095 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.9 mm? -111.74 129.95 23.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.759 0.314 . . . . 62.41 110.869 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.8 Cg_exo -75.07 103.77 1.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.193 2.595 . . . . 73.12 111.544 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.3 mt -86.82 -47.89 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.016 -175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.65 -30.8 8.99 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.137 -0.554 . . . . 73.34 112.05 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -118.07 163.25 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.181 -0.303 . . . . 73.14 110.181 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.69 -33.27 1.3 Allowed Glycine 0 C--O 1.227 -0.325 0 N-CA-C 111.146 -0.782 . . . . 40.12 111.146 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.54 -71.55 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.38 -0.688 . . . . 42.42 111.38 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.444 ' HZ ' ' H ' ' A' ' 199' ' ' GLY . 80.8 m-85 -122.58 -71.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.82 0.343 . . . . 74.4 110.382 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.34 157.68 30.09 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.451 -0.66 . . . . 44.14 111.451 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.9 t 60.46 50.48 5.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.278 0.561 . . . . 74.4 110.843 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -105.85 137.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 72.15 109.877 177.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.537 ' CE1' HG22 ' A' ' 39' ' ' VAL . 52.6 p90 -128.78 158.78 37.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 72.21 111.228 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.85 132.15 39.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.553 -0.749 . . . . 70.24 109.943 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.89 105.56 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.588 -0.278 . . . . 65.43 110.279 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 1.1 p-10 -95.51 -27.53 15.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.474 -0.33 . . . . 53.44 111.009 -176.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.632 ' HB2' ' CE3' ' A' ' 37' ' ' TRP . 1.8 tmt? 66.5 -84.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.709 0.63 . . . . 64.03 110.466 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 178.61 133.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.691 -0.855 . . . . 55.12 108.691 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -79.49 54.49 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.024 0.44 . . . . 73.34 110.725 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m . . . . . 0 C--N 1.324 -0.502 0 CA-C-N 116.035 -0.529 . . . . 64.52 111.635 -178.458 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.447 ' CB ' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.888 0.375 . . . . 74.14 111.692 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.52 36.36 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.535 2.157 . . . . 61.14 111.571 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -133.75 137.92 45.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.697 0.76 . . . . 53.11 112.385 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.464 HG13 ' HG3' ' A' ' 133' ' ' ARG . 31.5 m -132.42 152.25 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.881 -1.054 . . . . 75.23 108.67 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.63 ' HB ' HG12 ' A' ' 130' ' ' ILE . 1.2 p -131.97 131.19 61.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.058 0.456 . . . . 43.34 112.139 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -92.15 139.52 30.54 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.401 -0.818 . . . . 63.44 109.841 176.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.57 134.74 49.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.502 -0.479 . . . . 70.42 112.123 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.751 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 3.0 mt-10 -144.57 177.89 1.64 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.612 -0.722 . . . . 55.31 109.069 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.751 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 37.3 Cg_endo -66.96 164.4 29.98 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.673 1.582 . . . . 64.4 112.14 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -59.04 -40.29 84.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.75 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -85.42 88.04 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.232 0.539 . . . . 73.3 109.595 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 12.4 t-20 -121.09 -166.07 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.35 -0.841 . . . . 72.55 109.329 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . -125.9 -75.82 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.75 -0.54 . . . . 33.32 111.75 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 17.8 Cg_endo -58.43 -24.59 69.62 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.098 2.532 . . . . 72.35 113.036 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.697 HD12 ' HE ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -57.21 -30.46 64.58 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.767 0.317 . . . . 73.21 111.379 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -72.79 -45.55 57.93 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.094 0.473 . . . . 73.42 110.116 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -48.43 77.18 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.218 -0.901 . . . . 73.05 110.814 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 10.9 pt-20 -65.81 -36.65 84.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.233 -0.439 . . . . 75.31 110.883 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.75 -50.57 73.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.881 0.372 . . . . 62.41 110.163 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -45.75 84.09 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.021 -0.536 . . . . 72.41 110.595 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -67.67 -50.48 57.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 60.51 111.128 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 1.7 t80 -59.93 -42.37 93.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 74.42 110.837 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 6.7 tp60 -72.65 -34.26 67.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.198 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.455 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -75.7 -21.27 57.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.702 0.287 . . . . 74.15 111.361 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.01 15.72 24.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.084 0.469 . . . . 51.54 111.165 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.62 -175.75 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.621 . . . . 70.02 111.897 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.93 92.13 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.021 -0.99 . . . . 74.44 110.755 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.19 -29.14 55.13 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.844 2.363 . . . . 23.33 111.884 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -62.33 -54.75 35.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.706 -0.679 . . . . 71.22 110.285 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.26 -43.83 95.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.627 -0.715 . . . . 64.32 110.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.441 HG23 HD21 ' A' ' 108' ' ' LEU . 81.4 mt -56.96 -54.34 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.691 -0.686 . . . . 73.52 110.66 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -58.23 -38.64 77.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 74.5 110.504 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -60.08 -58.92 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.503 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -34.9 67.54 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.077 -0.649 . . . . 72.53 111.005 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 108' ' ' LEU . 33.5 mm -59.63 -43.64 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 71.22 110.783 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -78.11 -41.06 36.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.503 -0.317 . . . . 73.31 111.51 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 m -75.83 -35.78 59.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.106 0.41 . . . . 71.4 112.106 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -94.92 -5.79 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.763 -0.199 . . . . 74.12 111.04 -174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 73.06 84.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.905 0.753 . . . . 74.33 111.853 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 163' ' ' ASP . 5.6 mp -137.18 -176.58 4.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.436 -0.802 . . . . 61.34 109.173 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.649 ' HD2' ' HD1' ' A' ' 107' ' ' TYR . 1.3 tmtm? -96.57 -72.03 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.189 -0.671 . . . . 53.14 109.189 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.649 ' HD1' ' HD2' ' A' ' 106' ' ' LYS . 35.1 p90 175.53 123.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.389 -0.597 . . . . 72.41 109.389 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.672 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.6 pt? -78.22 135.96 37.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.69 -0.404 . . . . 70.21 110.128 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.52 67.94 2.78 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.989 -0.55 . . . . 74.51 113.098 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.37 128.83 25.81 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.766 0.317 . . . . 72.22 110.163 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.2 Cg_endo -55.71 144.89 74.08 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.906 2.404 . . . . 65.13 113.229 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.882 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 23.5 tptm -62.52 132.33 52.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.388 -0.824 . . . . 55.0 111.39 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.609 . . . . 74.42 110.646 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 132' ' ' ASP . 71.4 m95 -116.63 -71.95 0.71 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 62.42 109.581 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.63 -178.07 25.15 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.252 -0.885 . . . . 72.02 111.733 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 32' ' ' MET . 48.5 p -166.64 167.91 14.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.213 -0.662 . . . . 74.41 109.213 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.51 -147.44 16.29 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.847 -1.168 . . . . 64.32 112.88 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.455 ' H ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.09 147.87 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.042 0.449 . . . . 72.4 110.759 -176.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 29' ' ' ILE . 44.0 t-80 -123.7 115.76 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 60.25 109.112 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.826 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 9.3 t70 -83.98 136.81 33.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.189 -0.46 . . . . 74.55 109.931 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 6.1 ptmm? -87.96 20.0 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.598 0.237 . . . . 74.31 110.376 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 66.99 75.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.881 -0.785 . . . . 72.15 108.881 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.42 -24.21 3.08 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.157 -0.929 . . . . 54.32 112.079 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.436 ' O ' ' HG2' ' A' ' 121' ' ' LYS . 18.6 ttpp -168.17 136.99 2.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.928 -0.397 . . . . 72.22 109.928 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 9.2 m -84.09 155.44 22.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.257 0.551 . . . . 73.33 112.002 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.54 155.34 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.339 -0.846 . . . . 75.34 108.745 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.697 ' HE ' HD12 ' A' ' 80' ' ' LEU . 32.7 ttt180 -114.83 128.0 56.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.426 0.155 . . . . 72.32 110.803 -171.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -137.9 163.12 32.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.231 0.539 . . . . 45.45 112.005 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.779 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 37.0 ttm -145.11 141.29 28.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.501 -0.772 . . . . 65.44 110.03 176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.63 HG12 ' HB ' ' A' ' 70' ' ' VAL . 47.4 mt -100.79 134.62 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 54.15 111.42 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 12.3 ptm -129.68 175.65 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 62.14 109.535 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.882 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 5.0 t70 -72.44 174.54 7.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.807 -0.442 . . . . 75.14 109.807 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.592 ' HE ' ' HE1' ' A' ' 187' ' ' TYR . 9.7 ttp180 -86.77 93.11 9.18 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.17 0.986 . . . . 54.24 110.99 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.599 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 47.0 m-85 -103.06 170.55 7.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.822 -1.081 . . . . 72.53 109.322 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.11 -46.1 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.5 -0.857 . . . . 42.24 111.946 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 19.6 m -95.33 125.72 40.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.927 -0.397 . . . . 73.31 109.927 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 p30 -116.8 174.41 6.1 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.031 -0.359 . . . . 72.22 110.031 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.421 HD21 HD21 ' A' ' 157' ' ' LEU . 11.2 mp -74.5 -20.14 60.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 73.22 111.397 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -74.35 -37.27 63.57 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.908 -0.404 . . . . 72.05 109.908 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 55.7 mttp -57.7 -51.44 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.816 -0.629 . . . . 71.23 110.654 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.0 mp -68.14 -34.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.327 -0.397 . . . . 52.52 110.263 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.639 ' HE2' HE22 ' A' ' 253' ' ' GLN . 48.1 t80 -52.7 -52.94 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 74.51 110.841 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -80.64 -41.57 23.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.903 -0.59 . . . . 73.02 111.83 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.32 70.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.272 0.471 . . . . 73.33 112.272 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.573 ' OD1' ' HB2' ' A' ' 148' ' ' ARG . 2.1 t-20 -105.51 0.08 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 71.03 110.536 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.74 46.46 25.82 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.322 -0.854 . . . . 63.24 112.018 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 33.2 mttt 71.56 100.07 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.604 -0.726 . . . . 63.44 112.577 175.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.573 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . 7.2 mmt180 -150.33 72.78 1.12 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 63.41 109.882 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.89 118.88 37.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.874 -0.603 . . . . 73.33 109.862 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -70.85 149.93 46.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.374 -0.375 . . . . 72.33 110.08 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.636 ' HD3' HD21 ' A' ' 294' ' ' ASN . 11.3 ttp180 -61.16 -31.44 71.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.329 -0.396 . . . . 74.5 111.348 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -59.86 -48.37 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.184 0.516 . . . . 74.23 109.922 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 90.2 m -61.93 -48.67 79.39 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.336 -0.847 . . . . 74.41 110.521 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.2 t -55.87 -47.71 79.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.085 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 324' ' ' LEU . 0.3 OUTLIER -62.69 -48.63 78.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.581 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 22.6 mm-40 -62.46 -41.32 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.119 -0.232 . . . . 74.5 111.212 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.6 mp -59.98 -47.48 85.63 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.101 0.25 . . . . 72.23 110.619 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.5 t -59.65 -43.97 93.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 54.34 110.561 176.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 162' ' ' LEU . 24.5 tp -63.98 -35.63 81.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.05 -0.523 . . . . 73.3 110.879 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.686 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -61.14 -45.03 96.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.332 0.586 . . . . 73.31 109.761 175.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 164' ' ' ILE . 49.5 mm -66.22 -35.11 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.225 -0.898 . . . . 73.41 110.126 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 159' ' ' LEU . 50.5 mt -56.92 -54.78 42.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.219 0.451 . . . . 72.05 112.219 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.462 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.9 p30 -76.25 -35.05 59.15 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.522 -0.871 . . . . 63.12 112.201 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 161' ' ' ILE . 13.4 tt -67.02 -37.02 78.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.034 -0.666 . . . . 64.31 110.32 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 47.5 tp -69.59 -36.86 76.63 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 116.317 -0.401 . . . . 73.44 110.356 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -57.06 -52.52 64.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.602 -0.518 . . . . 74.24 109.602 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -58.47 -40.41 82.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.361 -0.836 . . . . 75.12 112.43 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 29.3 pt -92.47 -32.64 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.006 0.743 . . . . 73.0 113.006 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 2.4 t-160 -73.87 -29.71 62.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.04 -0.356 . . . . 75.52 110.04 -175.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -27.46 69.24 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.945 -0.571 . . . . 72.14 110.084 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -102.24 -67.61 0.86 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.49 -0.777 . . . . 73.41 112.649 -169.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -148.35 -68.39 0.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.291 0.849 . . . . 75.34 113.291 -166.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.11 146.64 25.32 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.321 0.86 . . . . 73.53 113.321 -166.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 202' ' ' TYR . 15.0 m -120.86 149.65 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.716 -1.216 . . . . 52.53 107.716 164.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 178' ' ' ILE . 23.6 p80 -74.67 -29.42 61.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.618 -0.433 . . . . 72.33 111.669 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.575 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 75.45 -59.77 2.84 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.932 -0.652 . . . . 63.25 113.168 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.799 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 9.8 t70 -104.9 131.61 52.17 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 72.11 109.911 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 246' ' ' ILE . 7.8 tp -114.69 14.43 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.942 0.349 . . . . 71.2 111.942 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.53 ' HD2' ' HE2' ' A' ' 227' ' ' PHE . 50.5 tptt -57.34 152.27 14.54 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.23 -0.294 . . . . 62.15 110.586 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.19 -14.8 11.87 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.081 0.4 . . . . 44.24 112.081 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 p -76.99 -15.11 59.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.942 0.401 . . . . 25.14 110.705 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.599 HD21 HD22 ' A' ' 200' ' ' LEU . 3.0 m-20 -90.35 -12.08 38.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.048 -0.524 . . . . 52.42 111.104 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.74 131.5 56.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.099 0.476 . . . . 72.53 110.235 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -127.53 157.16 40.88 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.571 -0.74 . . . . 73.12 110.378 179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 48.9 mt -106.16 149.07 27.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.864 -0.607 . . . . 62.11 109.72 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.599 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 24.0 t-20 -64.07 121.4 14.07 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.131 -1.433 . . . . 72.54 107.131 168.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.592 ' HE1' ' HE ' ' A' ' 133' ' ' ARG . 1.7 p90 -70.27 -15.78 62.94 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.3 -0.96 . . . . 72.14 110.582 -167.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -88.16 -28.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.962 -0.563 . . . . 74.35 110.448 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.546 ' HB3' ' OD1' ' A' ' 191' ' ' ASP . 45.2 m-80 -136.2 109.59 9.76 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-O 120.809 0.337 . . . . 72.13 111.211 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 13.6 Cg_exo -69.63 -7.73 21.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.263 2.642 . . . . 75.44 112.95 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 338' ' ' LYS . 9.9 p-10 -85.95 -7.65 58.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 73.34 110.268 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.657 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 80.6 mt-30 -101.23 91.95 4.74 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.586 -0.734 . . . . 74.52 110.029 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.96 122.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.832 -0.622 . . . . 61.45 110.024 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 64.8 m-85 -128.39 151.77 48.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.935 -0.575 . . . . 64.42 110.292 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 196' ' ' VAL . 3.3 tt -84.87 150.51 24.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.218 -1.401 . . . . 73.14 107.218 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.541 ' N ' HD23 ' A' ' 195' ' ' LEU . 31.6 m -56.78 178.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.772 0.32 . . . . 61.11 111.618 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 3.4 m-20 -63.7 11.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.121 0.786 . . . . 75.14 113.121 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 196' ' ' VAL . 6.1 m-85 61.5 43.7 10.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.774 0.797 . . . . 72.21 110.981 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' ILE . . . -68.96 -10.73 62.12 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.685 -1.366 . . . . 61.12 109.685 166.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.599 HD22 HD21 ' A' ' 182' ' ' ASN . 5.7 mp -113.56 104.89 12.71 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.072 -1.084 . . . . 73.24 108.072 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.871 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -163.24 107.55 1.06 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.795 -0.638 . . . . 42.33 110.745 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.518 ' O ' HG22 ' A' ' 174' ' ' VAL . 55.1 t80 -99.4 126.0 45.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.841 -0.8 . . . . 75.51 108.841 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.585 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 14.8 ptm180 -81.97 123.84 29.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 65.54 110.79 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' ' HB1' ' A' ' 237' ' ' ALA . 18.4 t80 -84.36 -18.4 36.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.671 . . . . 72.01 109.952 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 55.5 m -118.24 85.77 25.57 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.934 -0.575 . . . . 71.13 110.91 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 209' ' ' VAL . 13.1 Cg_exo -70.5 103.69 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.607 2.204 . . . . 74.15 111.124 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.585 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 28.8 tt0 70.11 -1.28 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.991 -0.549 . . . . 74.24 111.031 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.32 -12.25 10.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.238 -0.506 . . . . 41.44 111.864 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 49.6 t -69.46 132.63 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 75.41 111.241 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -105.97 110.13 22.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.173 -0.677 . . . . 71.43 109.173 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 17.2 mmmt -103.76 152.75 21.48 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.155 0.798 . . . . 70.14 113.155 -170.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.33 -166.36 1.57 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.496 -1.229 . . . . 72.21 109.514 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.6 p90 -76.48 152.15 36.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 74.33 111.603 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 215' ' ' GLU . 21.6 ttmm -140.92 -53.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 75.24 110.994 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 214' ' ' LYS . 41.9 tt0 72.54 111.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.861 0.726 . . . . 72.32 110.491 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -91.12 134.65 29.61 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 51.15 110.505 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 123.149 2.566 . . . . 50.23 113.173 -178.717 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 t70 . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 121.117 0.484 . . . . 71.23 110.068 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.799 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -103.61 -158.2 24.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.68 -0.772 . . . . 73.44 112.431 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 38.7 p -79.07 144.21 34.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.775 -0.25 . . . . 54.21 110.486 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 271' ' ' VAL . 15.7 tt -55.1 -24.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.324 0.583 . . . . 74.41 111.177 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.42 -61.96 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.17 -0.923 . . . . 64.41 111.489 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.768 ' HZ ' ' HG3' ' A' ' 253' ' ' GLN . 10.7 m-85 -103.95 -22.37 13.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.902 0.705 . . . . 73.22 112.902 -173.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.0 OUTLIER -70.05 -7.34 40.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.997 0.427 . . . . 74.34 110.462 -178.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 25.7 t 68.58 175.91 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.347 -0.842 . . . . 74.34 111.082 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.493 HD11 ' NH1' ' A' ' 279' ' ' ARG . 4.9 pt -71.42 -32.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 72.24 110.229 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 238' ' ' PRO . 2.2 m-20 -46.43 -69.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.269 -0.878 . . . . 72.44 111.188 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -68.83 -29.04 67.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 73.22 111.2 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.407 ' HB3' ' HA ' ' A' ' 230' ' ' ILE . 26.6 t-80 -55.17 -41.91 72.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.831 0.348 . . . . 75.51 110.915 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -79.56 0.94 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 75.11 111.486 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 72.33 32.8 62.14 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 120.965 -0.636 . . . . 71.41 112.687 176.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 213' ' ' TYR . 3.4 p -120.95 140.94 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.281 -0.266 . . . . 74.02 110.281 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB1' ' HD1' ' A' ' 204' ' ' TYR . . . -54.76 110.64 2.28 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 109.008 -0.738 . . . . 51.32 109.008 170.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.591 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . 23.6 Cg_exo -62.82 -91.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.862 2.375 . . . . 40.43 113.866 -167.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 238' ' ' PRO . 55.7 p 173.11 -158.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.645 -0.502 . . . . 72.51 109.645 -172.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.436 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 4.0 mpt_? -85.52 -45.76 11.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.878 -1.156 . . . . 70.51 107.878 168.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 19.1 ttt-85 -62.33 -39.55 93.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.032 -1.44 . . . . 74.41 111.686 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.9 -57.32 12.97 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.976 -0.556 . . . . 64.42 112.765 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HA ' HD12 ' A' ' 246' ' ' ILE . 11.6 t70 -67.05 -32.52 73.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 65.5 110.482 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 315' ' ' PRO . 77.9 mt -63.57 -39.71 95.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.48 -0.327 . . . . 71.14 111.27 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.09 -34.98 78.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.256 0.55 . . . . 73.2 109.805 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.587 HG22 ' HB ' ' A' ' 178' ' ' ILE . 70.0 mt -60.64 -42.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 74.23 110.447 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.548 HD12 ' SG ' ' A' ' 250' ' ' CYS . 39.0 tp -66.58 -38.06 86.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.045 -0.525 . . . . 71.53 109.966 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.41 96.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 72.52 111.38 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 246' ' ' ILE . 14.1 m-30 -51.19 -58.84 5.09 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 122.603 0.361 . . . . 74.51 111.403 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.548 ' SG ' HD12 ' A' ' 247' ' ' LEU . 30.1 p -61.45 -37.35 83.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.821 -0.351 . . . . 71.44 111.662 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 64.9 mtm -60.86 -50.93 71.46 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.779 -0.368 . . . . 62.41 111.416 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.472 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.5 tt -70.06 -31.58 48.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.682 -0.407 . . . . 73.21 110.424 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 24.0 tm0? -64.98 -51.79 59.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.56 -0.291 . . . . 64.32 110.573 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -63.3 -40.45 97.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.318 . . . . 74.55 111.565 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 290' ' ' PHE . 33.9 tp -77.86 -30.95 51.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.629 0.603 . . . . 74.35 112.629 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 60.6 p -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.412 -0.515 . . . . 60.54 110.867 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.541 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 83.96 7.41 85.58 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.843 -0.694 . . . . 64.51 113.109 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.07 143.82 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.973 0.887 . . . . 74.32 112.49 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 89.5 mt -129.48 139.39 35.54 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.332 -0.849 . . . . 32.24 108.798 168.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.54 -37.23 97.84 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.339 2.026 . . . . 72.12 112.162 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.6 ' HB2' HG12 ' A' ' 271' ' ' VAL . 34.4 p90 -92.5 11.32 26.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.957 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 36.8 tt0 -86.46 -39.41 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 44.23 110.504 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -84.15 -24.52 30.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.459 0.647 . . . . 73.42 109.339 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.68 22.63 15.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.111 -0.95 . . . . 71.24 111.189 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.694 ' HA ' ' CG1' ' A' ' 271' ' ' VAL . 3.4 pp -70.78 -13.99 62.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.541 0.686 . . . . 54.2 110.302 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 265' ' ' LEU . 19.9 ptmt -79.01 2.97 18.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.786 -1.097 . . . . 75.25 110.796 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 15.0 t70 -135.01 127.6 18.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 55.1 110.441 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 22.4 Cg_exo -65.71 -29.58 51.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.025 2.483 . . . . 73.4 113.558 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -79.07 -38.08 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.667 -0.413 . . . . 73.44 110.609 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.425 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 28.8 m-85 -69.29 -49.74 53.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.438 -0.346 . . . . 71.2 111.209 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.694 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 22.3 m -54.7 -40.4 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 120.491 -0.484 . . . . 53.52 111.12 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 276' ' ' ILE . 42.0 ttt85 -62.07 -55.79 25.44 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.58 0.229 . . . . 72.1 111.12 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 24.2 t70 -61.23 -46.33 90.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.31 111.353 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 261' ' ' TRP . 69.3 m -60.64 -39.4 88.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 53.34 111.175 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 67.6 mttm -64.71 -40.2 94.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 74.11 110.362 176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 272' ' ' ARG . 81.5 mt -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.05 110.027 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 14.7 mmp_? -56.83 -48.53 77.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 73.45 110.985 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -67.21 -44.47 79.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 70.13 111.845 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.493 ' NH1' HD11 ' A' ' 230' ' ' ILE . 89.2 mtt180 -65.11 -42.1 94.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.906 0.384 . . . . 75.22 110.922 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.23 -57.72 8.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 72.54 111.19 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 61.6 t30 -115.36 59.03 0.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 73.11 110.904 -171.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.563 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -51.7 -51.45 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.671 0.619 . . . . 74.44 112.671 -176.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.563 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.93 -47.88 83.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.106 0.41 . . . . 72.31 112.106 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.621 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 5.1 m -77.69 -28.46 51.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.38 -0.373 . . . . 70.02 111.02 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 281' ' ' ASN . 2.7 mm? -68.76 -54.74 14.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.998 -0.281 . . . . 65.01 110.529 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.412 ' HG2' HG22 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -60.07 -41.26 92.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 73.32 110.976 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.28 -51.61 68.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.841 -0.618 . . . . 62.03 111.423 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -91.19 3.54 54.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.244 0.461 . . . . 75.02 112.244 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.56 -23.64 42.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.604 -0.517 . . . . 73.22 109.604 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.498 ' HE2' ' HG ' ' A' ' 255' ' ' LEU . 0.4 OUTLIER -133.64 73.85 71.58 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.295 -0.412 . . . . 72.31 110.98 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.48 32.49 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.724 2.283 . . . . 75.43 111.106 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 171.2 8.14 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.214 -0.903 . . . . 70.44 109.259 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -73.24 86.27 1.43 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.561 0.696 . . . . 74.24 111.82 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.636 HD21 ' HD3' ' A' ' 151' ' ' ARG . 12.6 t30 -152.48 -89.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.537 -0.756 . . . . 75.22 110.047 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.723 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 0.9 OUTLIER 169.73 102.77 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 109.578 -0.527 . . . . 74.51 109.578 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -99.02 50.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.241 2.627 . . . . 63.11 112.228 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -117.14 -46.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.208 -0.996 . . . . 43.25 113.529 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 2.6 mp0 -58.2 -56.56 20.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 73.32 111.03 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.7 mp -63.1 -33.94 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.866 -0.607 . . . . 70.32 110.407 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.42 -53.93 50.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 72.15 110.922 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.5 -27.83 63.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.096 -0.502 . . . . 65.13 111.158 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.478 ' CD2' HD22 ' A' ' 320' ' ' LEU . 33.6 t80 -62.1 -53.11 60.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.942 0.401 . . . . 71.54 110.282 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.593 ' HA ' HG22 ' A' ' 306' ' ' VAL . 70.1 mtp -72.61 -31.89 65.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 60.33 110.914 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.506 ' HA ' HG13 ' A' ' 282' ' ' ILE . 36.9 tt0 -60.85 -46.84 88.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.57 . . . . 63.01 109.572 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.652 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 29.0 m -57.09 -52.97 63.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.118 -0.946 . . . . 74.41 111.212 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 24.9 m -63.34 -32.33 56.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 121.068 -0.253 . . . . 45.14 111.336 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.515 ' HA ' ' HE ' ' A' ' 241' ' ' ARG . 86.7 tttt -60.49 -48.09 83.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 64.41 110.187 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 47.4 tp -70.78 -19.69 62.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.684 . . . . 63.51 111.297 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 53.1 mt -72.81 -19.26 61.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.265 0.469 . . . . 71.04 112.265 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 21.6 t70 62.09 -179.86 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.918 0.389 . . . . 75.45 110.304 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -84.39 -23.39 30.11 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.782 -0.574 . . . . 63.44 110.065 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.5 m -95.88 -24.43 16.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.043 0.757 . . . . 54.15 113.043 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.759 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 5.2 mm-40 -87.28 -172.99 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.136 -0.626 . . . . 74.12 112.03 -169.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.654 ' HD2' ' H ' ' A' ' 314' ' ' LYS . 7.4 mptt -85.44 132.2 45.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 71.42 110.782 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.593 ' HA ' HD13 ' A' ' 309' ' ' LEU . 57.7 Cg_endo -74.08 118.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.097 1.864 . . . . 64.55 111.226 174.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.3 mt -87.54 77.32 8.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.319 -0.4 . . . . 62.21 111.36 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.21 -34.02 76.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.539 . . . . 74.13 110.423 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.21 -51.09 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.911 -0.586 . . . . 72.25 110.323 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -65.28 -42.29 93.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.497 -0.774 . . . . 73.1 110.664 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 90.5 mt -63.45 -43.14 98.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 72.21 110.67 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -56.44 -52.56 64.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 74.31 110.703 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.05 -44.72 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 73.44 111.769 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.0 -32.95 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.762 -0.375 . . . . 64.23 111.777 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 155' ' ' LEU . 88.8 mt -69.47 -49.59 53.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.242 0.544 . . . . 74.3 110.406 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.3 mm? -67.88 -26.83 66.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 64.05 110.697 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.22 -47.57 79.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.908 0.385 . . . . 51.24 110.264 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.7 96.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 63.41 112.0 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 333' ' ' SER . 3.9 mm? -73.4 -32.46 64.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 72.03 111.135 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.26 -24.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.916 0.388 . . . . 73.15 110.508 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.8 -24.46 65.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.019 -0.537 . . . . 72.43 111.267 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 49.1 pt -111.95 13.19 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.421 . . . . 61.31 110.588 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.22 25.08 75.35 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.867 -0.606 . . . . 71.41 113.033 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 37.5 m -120.51 145.49 47.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.313 0.578 . . . . 75.14 111.761 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -140.27 -72.71 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.383 -0.826 . . . . 75.12 109.168 174.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.2 115.49 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.796 -1.093 . . . . 74.12 109.557 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -164.06 -69.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.399 -0.819 . . . . 74.52 109.146 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.16 87.34 1.19 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.918 -0.873 . . . . 53.55 110.918 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HD3' ' HB2' ' A' ' 191' ' ' ASP . 89.2 mttt . . . . . 0 C--N 1.328 -0.346 0 N-CA-C 113.569 0.951 . . . . 73.41 113.569 -177.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.587 ' HB2' HD21 ' A' ' 200' ' ' LEU . 40.8 mtmt . . . . . 0 C--O 1.232 0.142 0 N-CA-C 109.661 -0.496 . . . . 74.25 109.661 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.0 t -144.79 162.43 36.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.525 0.202 . . . . 64.31 111.092 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -66.39 143.64 15.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.966 -0.561 . . . . 64.01 111.638 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 13.2 t -79.75 132.79 36.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.509 -0.768 . . . . 73.43 109.267 173.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.1 tttp . . . . . 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 72.52 111.374 -176.625 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t . . . . . 0 N--CA 1.452 -0.364 0 N-CA-C 109.802 -0.444 . . . . 74.14 109.802 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.72 1.72 56.34 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.601 -0.809 . . . . 70.03 113.482 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.96 153.46 30.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.585 0.692 . . . . 74.54 109.464 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.9 131.57 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.355 0.597 . . . . 65.45 111.01 -175.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.53 137.45 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.132 -0.94 . . . . 74.04 109.536 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.6 m -117.49 120.4 37.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.569 -0.287 . . . . 74.42 110.405 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.9 p-10 -91.04 -169.53 2.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.267 -0.424 . . . . 74.21 110.336 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 11.2 mmt -72.2 -17.81 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.797 0.295 . . . . 72.32 111.797 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.95 9.49 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 72.11 110.979 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 69.4 17.73 8.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.71 -0.677 . . . . 74.13 111.497 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 10.3 mmpt? -83.7 127.17 33.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.62 -0.511 . . . . 75.04 109.62 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.01 92.38 4.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 73.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -116.05 172.18 7.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.389 -0.823 . . . . 72.13 111.164 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -98.47 145.93 26.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 73.04 110.322 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -95.41 103.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.94 -129.97 6.73 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.652 -0.785 . . . . 64.21 113.687 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.9 mp -69.84 131.11 89.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.94 0.4 . . . . 61.33 111.827 -172.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 17.0 Cg_exo -67.76 124.0 11.4 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.883 2.388 . . . . 43.34 111.425 174.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 53' ' ' LEU . 59.3 mt -104.86 -66.33 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.047 0.451 . . . . 71.24 110.699 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 94.97 102.47 1.82 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.785 -0.721 . . . . 53.54 111.732 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.438 ' H ' HG12 ' A' ' 51' ' ' ILE . 45.7 tp60 -86.55 165.71 16.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.344 -0.243 . . . . 75.02 110.344 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.11 -29.46 68.76 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.12 -0.562 . . . . 63.05 113.776 -170.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.16 -63.3 3.17 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 73.51 112.85 -176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.95 -34.71 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.647 0.261 . . . . 64.31 111.583 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 -179.79 45.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.796 -0.716 . . . . 50.4 112.695 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 91.0 m 63.32 30.37 15.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.5 0.667 . . . . 75.42 111.136 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 71' ' ' LYS . 34.6 mm -89.33 136.79 22.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.55 -0.75 . . . . 73.52 109.675 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -107.48 145.92 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.197 0.523 . . . . 74.03 111.113 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.519 ' HB2' HD11 ' A' ' 43' ' ' ILE . 64.1 tp -79.29 145.66 33.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.326 -0.852 . . . . 72.04 109.711 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.91 116.61 26.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.397 -0.594 . . . . 73.32 109.397 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 25.6 m-20 -76.76 -50.88 12.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.183 -0.673 . . . . 64.22 109.183 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt 48.37 43.72 19.63 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.25 -0.886 . . . . 71.41 109.931 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -72.23 77.11 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.821 . . . . 74.22 110.447 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.4 m -126.78 -162.61 1.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.136 -0.938 . . . . 62.0 110.275 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.6 m . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.623 0.249 . . . . 63.41 111.617 -177.742 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . . . . . . . . 0 N--CA 1.444 -0.772 0 CA-C-O 120.879 0.371 . . . . 52.13 110.339 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -95.94 11.07 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.855 2.37 . . . . 75.44 110.994 176.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.441 ' HB2' HG23 ' A' ' 130' ' ' ILE . 7.0 p -145.91 153.92 41.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.602 0.715 . . . . 72.44 112.905 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 133' ' ' ARG . 15.3 m -136.89 153.82 30.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.035 -0.984 . . . . 64.01 109.098 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.9 p -122.42 122.64 66.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.3 0.571 . . . . 62.2 111.646 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 22.6 ttpt -87.24 126.63 34.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.71 -0.677 . . . . 64.41 109.781 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.63 123.15 70.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 123.745 0.653 . . . . 74.44 110.009 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 41.7 mt-10 -140.69 152.51 66.13 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.356 -0.383 . . . . 75.32 110.344 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.51 126.0 20.05 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.591 2.194 . . . . 64.41 111.964 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -85.74 -15.97 40.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.128 0.49 . . . . 61.41 110.36 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.63 -20.08 43.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.863 -0.608 . . . . 73.11 110.78 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -172.07 96.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.216 -0.661 . . . . 73.41 109.216 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 79' ' ' PRO . . . -163.78 145.62 10.65 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.032 -1.08 . . . . 53.31 113.224 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.0 Cg_exo -60.88 -19.59 62.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.98 3.12 . . . . 50.1 112.285 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.2 tm? -50.72 -30.05 12.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.855 -0.611 . . . . 54.32 110.741 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.72 -48.38 75.29 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.76 0.314 . . . . 71.53 110.828 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.6 m -67.63 -41.99 83.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 73.53 110.481 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -58.45 -42.52 87.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.744 . . . . 65.01 110.513 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.68 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 54.42 110.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 66.7 mmtt -63.55 -46.85 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.922 -0.311 . . . . 64.32 110.451 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.06 -39.95 95.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.04 110.048 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t80 -63.29 -34.4 77.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.407 -0.815 . . . . 73.43 110.662 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -77.51 -32.67 54.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.82 0.343 . . . . 74.31 111.345 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' A' ' 173' ' ' TYR . 39.5 mmt180 -78.73 -49.21 13.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.091 0.404 . . . . 74.11 112.091 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.83 -31.47 10.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.859 0.688 . . . . 73.42 112.859 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -84.42 89.0 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.42 0.628 . . . . 72.34 111.324 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 95' ' ' GLN . 8.9 tmtt? -154.04 91.98 3.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.525 -0.917 . . . . 71.12 108.525 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 113' ' ' TYR . 95.6 Cg_exo -44.25 -52.56 5.62 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.952 3.101 . . . . 73.21 114.53 -170.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.7 -45.16 92.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 74.24 110.625 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 6.9 tp60 -66.27 -44.39 83.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.707 -0.678 . . . . 73.43 110.565 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 92' ' ' LYS . 68.4 mt -58.94 -53.75 43.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.977 -0.556 . . . . 64.44 110.574 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.54 -38.88 69.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.236 -0.438 . . . . 54.2 110.593 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -61.07 -62.3 1.95 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.773 -0.648 . . . . 74.35 111.371 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.802 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -71.3 -34.36 70.56 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.253 -0.579 . . . . 71.41 111.105 -173.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 100' ' ' ILE . 17.0 mm -58.75 -50.68 78.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.312 0.101 . . . . 72.04 111.027 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -69.4 -36.85 77.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.657 -0.417 . . . . 62.33 110.806 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 54.21 110.782 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.483 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 7.8 ttt180 -83.38 0.97 43.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 72.04 110.374 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 26.0 mtpp 66.54 29.62 8.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.358 -0.837 . . . . 72.33 111.532 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 89.1 mt -92.34 176.7 6.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.72 -0.673 . . . . 53.45 109.942 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 10.8 mmpt? -103.37 -55.01 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.595 -0.275 . . . . 74.45 111.051 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -157.51 171.18 20.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 72.23 110.109 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 39.3 tp -129.32 137.57 51.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.995 -0.372 . . . . 73.21 109.995 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.86 64.21 3.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.155 -0.545 . . . . 25.41 113.253 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 135.8 27.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 110.065 -0.346 . . . . 70.25 110.065 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.07 135.07 30.11 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.039 2.492 . . . . 42.41 112.509 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.861 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 24.2 tptm -66.75 124.06 21.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 73.43 111.001 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.613 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 14.0 t80 -81.27 112.56 18.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.67 -0.695 . . . . 71.32 111.022 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' ILE . 68.9 m95 -105.42 -52.51 2.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.624 -0.88 . . . . 73.13 108.624 169.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.44 46.91 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.008 -0.996 . . . . 45.04 111.759 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 p -168.74 162.84 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.625 -0.509 . . . . 73.02 109.625 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.67 -179.44 46.18 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.754 -1.212 . . . . 70.31 113.207 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 119' ' ' HIS . 5.9 tt -123.88 137.74 54.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.688 -0.856 . . . . 75.35 108.688 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -134.84 147.7 49.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 73.44 110.822 178.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.97 140.96 37.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.389 -0.823 . . . . 71.01 110.175 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 126' ' ' TYR . 43.4 tttm -108.66 17.64 21.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.638 -0.255 . . . . 65.11 110.501 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 56.8 m-80 71.27 97.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.309 0.644 . . . . 71.53 110.207 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.05 -44.81 1.4 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.807 -0.711 . . . . 65.34 112.012 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -129.69 138.25 51.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.831 -0.433 . . . . 74.3 109.831 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.0 m -101.53 140.57 35.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 75.41 110.349 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 121' ' ' LYS . 35.5 p90 -128.3 149.94 50.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.182 0.515 . . . . 60.35 110.155 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -117.57 142.42 47.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.027 -0.731 . . . . 74.1 109.027 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.6 p90 -137.93 153.07 49.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.989 0.423 . . . . 53.12 111.291 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 20.0 ptp -139.75 139.42 36.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.982 -0.554 . . . . 74.45 110.576 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 114' ' ' TRP . 5.0 mm -98.17 118.69 45.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.859 -0.61 . . . . 62.5 110.065 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 196' ' ' VAL . 25.1 ptt? -123.2 171.1 9.6 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.13 -0.693 . . . . 71.24 109.13 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t70 -65.2 162.15 17.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 72.23 110.442 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.7 tpt180 -76.57 112.79 13.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.44 0.638 . . . . 61.31 110.862 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.11 143.08 33.06 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.942 -0.762 . . . . 75.12 108.942 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -136.92 -2.15 2.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.291 -0.957 . . . . 55.42 112.233 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 1.093 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.8 m -121.83 125.27 46.1 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.845 -0.209 . . . . 70.53 110.512 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.482 ' HA ' HD13 ' A' ' 184' ' ' LEU . 6.4 p-10 -116.35 139.67 50.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.434 -0.58 . . . . 72.02 109.434 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 5.6 tp -68.95 -15.34 63.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.718 -0.219 . . . . 60.13 110.928 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -62.3 -50.19 72.66 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.012 0.434 . . . . 51.41 110.963 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 4.4 tppp? -80.6 -23.24 39.96 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.497 -0.481 . . . . 75.13 109.841 176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.863 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 27.6 mt -60.19 -51.26 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 75.31 111.794 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.686 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 5.5 p90 -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.386 -0.525 . . . . 72.33 110.228 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -80.99 -25.98 36.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.527 . . . . 73.51 110.705 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.0 0.428 . . . . 60.02 110.592 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 145' ' ' ASN . 12.0 m120 -101.38 2.38 39.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 63.31 110.157 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 44.16 72.74 0.18 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.046 -0.979 . . . . 73.33 112.672 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.7 pttp 45.23 34.11 1.35 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.058 0.943 . . . . 74.53 112.951 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -138.87 92.68 2.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.061 0.458 . . . . 74.41 109.82 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.686 ' CZ ' ' HA ' ' A' ' 142' ' ' TYR . 55.6 m-85 -104.14 150.95 23.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.968 -0.56 . . . . 72.51 111.666 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -86.7 147.98 25.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.689 -0.687 . . . . 41.54 109.162 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -57.55 -29.08 64.09 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 112.736 0.643 . . . . 74.31 112.736 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.23 -53.64 55.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.861 0.362 . . . . 73.34 111.402 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 157' ' ' LEU . 3.9 m -64.32 -44.95 89.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 60.1 111.038 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.96 -40.05 85.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.94 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.734 ' HG ' HD22 ' A' ' 328' ' ' LEU . 1.7 mm? -63.29 -50.94 68.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 72.11 111.623 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.408 ' O ' ' HD3' ' A' ' 160' ' ' ARG . 16.8 tt0 -61.88 -38.36 88.01 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.009 -0.676 . . . . 71.33 110.267 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 153' ' ' THR . 7.7 mp -59.96 -48.6 81.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 71.42 110.447 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -56.26 -47.52 78.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 54.22 110.491 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.805 ' HG ' ' HD2' ' A' ' 321' ' ' ARG . 9.1 mp -57.3 -52.42 65.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.882 -0.599 . . . . 65.42 111.266 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 164' ' ' ILE . 2.1 mpt_? -67.75 -33.68 75.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 70.52 111.379 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -63.62 -43.53 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.7 -0.481 . . . . 72.23 109.7 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 321' ' ' ARG . 83.0 mt -63.01 -42.45 99.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.73 -0.214 . . . . 61.0 110.805 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.24 -60.53 3.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.362 0.601 . . . . 73.45 110.775 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 tt -71.83 -39.74 68.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 72.43 111.968 -174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.8 mp -65.71 -36.89 84.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 117.759 0.254 . . . . 65.11 111.302 -177.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.26 -48.72 74.68 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.182 -0.673 . . . . 70.4 109.182 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 79.5 t80 -57.48 -46.26 83.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.157 -0.929 . . . . 75.0 111.816 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 164' ' ' ILE . 34.1 pt -82.41 -32.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.466 0.543 . . . . 75.25 112.466 -174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -64.54 -43.62 93.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 110.011 -0.366 . . . . 73.34 110.011 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -82.95 14.66 3.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.714 0.769 . . . . 72.35 109.472 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 1.4 t-80 -136.69 40.95 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.467 -0.788 . . . . 64.4 109.842 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 205' ' ' CYS . 41.7 mt-10 85.4 -61.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.395 1.059 . . . . 53.31 113.557 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 89' ' ' ARG . 13.0 m-85 -84.27 116.13 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.406 0.521 . . . . 73.44 112.406 -164.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 238' ' ' PRO . 16.4 t -109.63 151.21 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.357 -0.609 . . . . 70.32 109.357 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -115.46 106.95 14.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 72.05 109.739 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.42 -25.86 55.95 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.551 -0.833 . . . . 71.14 111.828 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.552 ' HB3' HD13 ' A' ' 200' ' ' LEU . 7.1 t70 -98.38 101.73 13.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 75.33 110.24 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.71 31.95 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.961 0.886 . . . . 72.13 110.078 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 179' ' ' LYS . 3.4 ttmp? -62.96 149.62 44.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.166 -0.925 . . . . 63.33 110.699 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.62 -14.61 8.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.786 0.662 . . . . 63.51 112.786 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 m -73.48 -20.81 60.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.48 . . . . 75.51 110.847 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.633 ' ND2' HD22 ' A' ' 195' ' ' LEU . 2.1 t30 -82.32 -21.49 36.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.488 -0.778 . . . . 42.14 111.592 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.467 HD23 HG21 ' A' ' 193' ' ' VAL . 5.9 mp -101.85 119.67 39.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.985 0.422 . . . . 63.02 111.533 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 137' ' ' ASP . 3.9 mm? -121.47 145.68 47.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 60.1 110.159 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 1.093 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 52.6 mt -109.67 152.2 25.91 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 110.054 -0.35 . . . . 71.22 110.054 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.61 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 21.1 t-20 -72.64 147.91 45.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 72.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 -20.91 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 72.22 111.527 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -113.85 -9.84 13.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.972 0.415 . . . . 72.34 110.25 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -135.35 96.72 13.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 62.51 110.512 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.68 -18.75 15.01 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.968 2.445 . . . . 72.03 112.897 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 338' ' ' LYS . 5.5 p-10 -86.88 5.33 37.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.08 0.466 . . . . 74.02 111.583 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -118.65 109.53 16.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.728 -0.471 . . . . 72.54 109.728 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.467 HG21 HD23 ' A' ' 183' ' ' LEU . 6.5 p -103.57 126.47 58.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.101 -0.499 . . . . 75.35 110.528 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.61 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 9.7 m-85 -114.03 156.34 24.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.711 -0.677 . . . . 74.12 109.462 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.633 HD22 ' ND2' ' A' ' 182' ' ' ASN . 21.3 mt -107.8 116.89 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.838 -0.431 . . . . 75.35 109.838 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 131' ' ' MET . 9.2 p -159.96 159.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.79 -0.186 . . . . 74.32 111.027 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.4 t70 64.98 29.75 12.13 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.533 0.682 . . . . 70.02 110.74 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.735 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 18.9 p90 -100.06 -41.62 7.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 75.55 111.108 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.8 32.9 75.83 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.619 -0.801 . . . . 53.4 111.993 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 352' ' ' LYS . 30.5 mt -131.2 90.31 2.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.249 0.547 . . . . 63.24 110.589 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.28 121.85 9.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 65.11 110.981 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 61.4 t80 -114.34 131.18 56.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.143 -0.688 . . . . 74.54 109.143 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.858 0.361 . . . . 74.32 111.524 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 31.8 t80 -80.81 -40.09 25.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 54.43 109.96 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 10.7 p -125.81 87.8 55.33 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 43.31 110.79 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 18.7 Cg_endo -59.42 113.84 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.624 2.216 . . . . 70.12 111.733 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 63.9 26.63 14.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.828 -0.624 . . . . 75.44 111.373 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.35 -19.8 52.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.749 -0.739 . . . . 64.12 113.123 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.52 114.15 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.091 -0.337 . . . . 62.51 110.091 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -100.38 157.07 16.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.825 -0.35 . . . . 72.14 110.272 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -115.44 -172.91 2.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.516 -0.55 . . . . 74.24 109.516 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -97.83 -164.27 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.198 0.311 . . . . 61.45 110.42 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -60.29 97.88 0.05 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.575 0.702 . . . . 73.14 111.088 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 236' ' ' VAL . 55.2 mtpt -67.42 -53.73 26.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.36 -0.836 . . . . 72.53 112.256 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 37.8 77.94 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.126 0.965 . . . . 72.43 110.359 -164.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.8 135.77 59.25 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.194 -1.366 . . . . 64.55 111.492 -168.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo . . . . . 0 CA--C 1.53 0.301 0 C-N-CA 123.268 2.646 . . . . 61.43 113.656 -177.501 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 202' ' ' TYR . 16.2 p-10 . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 110.087 -0.338 . . . . 71.41 110.087 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . -108.24 -169.41 21.32 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.822 -0.704 . . . . 61.41 113.743 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.574 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 0.7 OUTLIER -90.53 148.77 22.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.963 0.411 . . . . 54.31 110.902 -176.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.47 HG12 HG11 ' A' ' 271' ' ' VAL . 13.3 tt -63.64 -24.28 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 113.761 1.022 . . . . 62.45 113.761 -168.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.574 ' OE1' ' HB ' ' A' ' 224' ' ' THR . 0.0 OUTLIER -70.1 -41.43 74.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.288 -0.565 . . . . 65.03 110.878 -172.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.496 ' O ' HG12 ' A' ' 246' ' ' ILE . 29.4 m-85 -101.02 -39.94 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.268 -0.173 . . . . 72.01 111.454 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.6 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 94.0 m -60.29 -14.87 20.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.358 0.503 . . . . 65.54 112.358 -175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 14.1 m 72.28 -167.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 52.32 111.053 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.5 mp -71.54 -34.42 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.764 -0.458 . . . . 71.54 109.764 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.633 ' O ' HG12 ' A' ' 236' ' ' VAL . 25.2 t70 -44.64 -91.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.479 -1.237 . . . . 70.32 113.279 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.6 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.75 -27.79 69.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.122 -0.361 . . . . 73.24 111.686 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.42 ' CE1' HD12 ' A' ' 225' ' ' ILE . 81.1 t60 -56.84 -37.27 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 72.3 111.246 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.68 0.5 52.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 71.3 111.49 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.77 8.16 62.3 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.462 -0.875 . . . . 52.04 113.352 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 231' ' ' ASP . 11.9 p -86.96 140.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.979 -0.749 . . . . 44.22 108.979 175.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -68.0 117.19 46.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.471 -0.331 . . . . 72.14 110.131 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.497 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 6.6 Cg_endo -49.25 124.12 11.25 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.635 2.89 . . . . 74.45 112.983 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 t -143.09 93.38 2.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.25 -0.432 . . . . 53.21 111.297 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 59.6 mtt180 75.96 -57.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.604 -0.726 . . . . 73.22 112.052 170.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.752 ' HG3' ' HD1' ' A' ' 311' ' ' TYR . 11.4 mmm-85 -57.38 -54.69 43.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.422 0.153 . . . . 70.43 110.592 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.02 -58.55 9.32 Favored Glycine 0 N--CA 1.448 -0.56 0 O-C-N 123.794 0.684 . . . . 61.41 112.426 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.42 -47.99 47.57 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.11 0.481 . . . . 73.43 111.412 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 64.3 mt -71.78 -45.29 62.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.803 -0.635 . . . . 65.42 111.529 -175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.96 -39.11 79.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.559 0.219 . . . . 71.34 111.061 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 227' ' ' PHE . 99.0 mt -59.63 -45.85 93.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.066 0.46 . . . . 73.24 110.288 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -65.06 -43.08 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 61.42 110.591 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.36 -42.84 95.85 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.923 -0.656 . . . . 73.2 112.504 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.53 ' CZ ' ' HD2' ' A' ' 275' ' ' LYS . 22.9 m-30 -66.33 -48.43 70.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.491 0.182 . . . . 75.34 111.491 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.4 p -66.8 -40.91 88.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.574 -0.451 . . . . 72.11 111.088 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.47 -45.6 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 63.34 110.896 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.346 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.465 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 48.9 tt0 -71.51 -41.61 69.04 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 121.097 -0.241 . . . . 75.43 110.458 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -66.73 -26.32 66.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 74.24 110.672 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.1 tp -81.18 -41.19 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.776 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.5 p -103.62 -27.26 12.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.391 0.515 . . . . 54.32 112.391 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.7 -59.52 0.36 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.724 -0.75 . . . . 75.22 113.048 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -121.76 144.02 49.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.848 0.356 . . . . 72.23 110.963 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 94.8 mt -105.7 145.12 30.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 75.52 110.715 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 31.2 Cg_exo -60.62 -31.92 92.73 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.803 2.335 . . . . 40.05 112.291 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 48.0 p90 -96.84 11.09 36.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.41 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 30.5 tt0 -83.18 -42.06 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.162 0.506 . . . . 44.24 110.201 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -88.54 -12.11 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.051 -0.522 . . . . 63.53 109.829 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.17 10.1 25.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.748 -0.66 . . . . 75.44 111.907 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 3.7 pp -70.86 -7.31 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.178 0.513 . . . . 74.11 110.916 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.45 -13.07 60.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.794 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.9 t70 -124.61 122.03 25.78 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 62.2 109.841 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 32.7 Cg_exo -62.69 -30.59 78.74 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.987 2.458 . . . . 74.52 113.375 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.571 ' HZ2' ' HB2' ' A' ' 269' ' ' LYS . 0.0 OUTLIER -76.45 -38.06 56.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.061 -0.348 . . . . 73.44 110.061 -176.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.51 -49.13 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.899 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.724 ' O ' ' HG2' ' A' ' 275' ' ' LYS . 38.0 t -55.88 -50.99 65.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.599 0.238 . . . . 73.13 110.997 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -61.14 -50.41 73.31 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.262 -0.426 . . . . 64.51 111.182 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 32.1 t70 -61.37 -45.6 93.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 74.33 111.082 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.9 m -61.31 -32.76 72.62 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.719 -0.219 . . . . 50.53 111.49 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 35.2 mmtp -60.27 -49.46 77.53 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.189 -0.671 . . . . 65.31 109.189 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.64 -33.1 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.213 -0.903 . . . . 72.4 110.968 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 16.5 mmm180 -62.66 -40.27 96.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.672 -0.24 . . . . 43.04 111.041 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 278' ' ' TYR . 2.9 m-85 -74.06 -33.99 63.87 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.513 -0.475 . . . . 72.41 110.942 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -66.74 -20.96 66.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.467 -0.333 . . . . 73.2 110.957 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -49.64 -56.9 8.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.866 -0.607 . . . . 74.12 110.759 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -150.31 75.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.82 -0.807 . . . . 63.01 108.82 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -53.47 -37.19 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.793 -1.094 . . . . 65.55 113.232 -171.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.585 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -61.41 -49.0 78.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.013 -0.275 . . . . 64.41 111.676 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 m -78.07 -39.09 42.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.733 0.302 . . . . 74.11 111.114 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.76 -46.26 90.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 74.31 111.192 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.26 -29.03 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 60.41 110.805 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 17.1 t70 -62.32 -31.38 72.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 71.43 110.169 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 288' ' ' LYS . 9.2 mtpm? -83.61 -21.63 32.5 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.891 -0.595 . . . . 62.13 111.735 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.01 -38.63 86.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.657 0.265 . . . . 62.5 111.264 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 5.4 t80 -135.81 79.49 45.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.765 -0.374 . . . . 64.35 110.486 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.59 19.71 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.113 2.542 . . . . 73.53 111.918 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 33.8 mt-10 -87.48 35.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.877 -0.601 . . . . 74.55 111.42 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 68.82 10.06 7.7 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.548 0.944 . . . . 72.33 113.548 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 11.6 t30 -82.09 -81.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.875 -0.417 . . . . 73.21 109.875 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 2.0 tpmt? 168.22 107.72 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.141 0 O-C-N 123.59 0.557 . . . . 74.32 109.757 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -102.34 39.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.667 2.911 . . . . 74.23 111.881 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.16 -38.27 2.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.527 -0.844 . . . . 54.21 113.334 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.463 ' HB3' HD23 ' A' ' 324' ' ' LEU . 2.8 mp0 -59.14 -53.64 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.43 . . . . 51.13 110.51 -176.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.67 -37.77 80.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.604 -0.725 . . . . 75.44 110.323 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.36 -52.5 64.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 71.31 111.31 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 301' ' ' LYS . 21.8 ttmt -70.69 -31.98 69.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.916 0.389 . . . . 74.52 110.538 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.416 ' O ' HG13 ' A' ' 306' ' ' VAL . 64.6 t80 -57.95 -48.97 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 73.4 110.217 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.551 ' HA ' HG22 ' A' ' 306' ' ' VAL . 87.4 mtp -72.48 -32.61 66.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 62.03 111.274 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.47 -37.67 78.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.841 0.829 . . . . 74.34 108.878 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.489 HG21 HD21 ' A' ' 320' ' ' LEU . 60.7 m -69.06 -42.59 76.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.632 -1.167 . . . . 54.45 111.455 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 303' ' ' MET . 5.5 m -70.55 -26.94 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.882 0.372 . . . . 75.04 110.578 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.44 -48.72 76.59 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.53 . . . . 74.31 110.215 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 308' ' ' LEU . 3.3 tt -68.5 -25.54 65.01 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.471 -0.786 . . . . 74.33 110.046 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -62.52 -18.84 62.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.519 -0.764 . . . . 73.34 111.878 -176.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.6 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.391 0.432 . . . . 74.22 110.294 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.752 ' HD1' ' HG3' ' A' ' 241' ' ' ARG . 3.9 m-30 -136.75 -43.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 71.02 110.402 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.4 t -136.92 20.61 3.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 73.12 112.205 -168.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -88.83 50.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.638 -0.664 . . . . 74.43 112.277 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER 58.97 94.22 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.196 -0.911 . . . . 70.24 113.456 170.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.4 121.4 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.786 2.324 . . . . 64.44 111.802 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.2 mt -84.96 99.08 10.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.824 0.345 . . . . 73.52 110.366 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -61.64 -45.03 95.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.942 -0.572 . . . . 73.23 111.765 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.0 -0.37 . . . . 54.15 110.0 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.29 -36.5 84.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 73.32 110.336 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 323' ' ' ILE . 77.2 mt -60.68 -48.7 80.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 65.2 110.982 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.805 ' HD2' ' HG ' ' A' ' 159' ' ' LEU . 32.8 ptt180 -74.2 -20.88 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.841 -0.744 . . . . 73.2 110.772 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.94 -39.88 79.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.716 -0.22 . . . . 54.35 110.818 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.2 pp -72.18 -30.23 35.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.791 -0.448 . . . . 54.12 109.791 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.63 -49.31 63.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 64.32 110.279 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.763 HD11 HD21 ' A' ' 159' ' ' LEU . 88.8 mt -64.86 -29.24 70.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.055 -0.521 . . . . 51.33 110.66 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -63.96 -47.48 80.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.607 . . . . 74.51 110.497 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.65 -30.65 76.68 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 72.43 111.942 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.734 HD22 ' HG ' ' A' ' 155' ' ' LEU . 56.4 tp -72.8 -50.59 23.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 72.3 110.835 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -73.83 -14.02 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.311 -0.404 . . . . 74.34 110.696 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.98 -23.61 67.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.499 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.2 tt -97.17 -6.8 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 60.44 110.113 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.71 24.02 34.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.856 -0.688 . . . . 72.21 113.208 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.8 m -123.36 158.62 30.67 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.455 -0.438 . . . . 42.51 110.595 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -156.45 176.73 12.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.439 -0.346 . . . . 75.31 110.135 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.23 -36.07 18.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.721 -0.474 . . . . 71.55 109.721 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.8 t70 75.14 16.92 2.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.091 -0.959 . . . . 62.22 110.88 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.51 39.08 50.97 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.934 -0.866 . . . . 41.11 110.934 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 191' ' ' ASP . 39.0 ttmt . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.397 -0.402 . . . . 75.44 110.343 -175.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.822 ' HB3' HD21 ' A' ' 200' ' ' LEU . 35.2 tptt . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 10.3 t -155.87 169.73 23.72 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.513 0.197 . . . . 72.42 110.71 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.517 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -69.22 144.06 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.698 0.629 . . . . 65.13 112.698 -172.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 11.4 t -92.07 132.83 36.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.188 -0.914 . . . . 62.55 110.001 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 61.6 tttp . . . . . 0 C--N 1.328 -0.337 0 CA-C-O 120.492 0.187 . . . . 73.43 110.613 174.728 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 40' ' ' GLY . 46.6 t . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.689 0.28 . . . . 71.34 110.259 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.04 -1.79 57.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.765 -0.731 . . . . 62.24 114.125 175.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -110.82 -177.08 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.173 0.987 . . . . 73.14 112.312 177.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' GLU . 3.2 mp -107.49 138.53 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.376 0.88 . . . . 73.44 113.376 -162.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.06 126.64 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.148 -0.933 . . . . 72.45 109.593 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -103.7 136.53 43.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.1 0.778 . . . . 74.4 113.1 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.823 ' HB3' ' CZ2' ' A' ' 37' ' ' TRP . 10.9 p30 -88.39 -179.44 6.1 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 64.31 110.758 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.52 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -71.16 -9.72 58.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 71.45 111.774 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.18 6.82 46.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 71.1 110.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 52.5 mmtt 68.82 23.79 6.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.347 -0.842 . . . . 73.04 111.684 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' NZ ' ' HB3' ' A' ' 114' ' ' TRP . 40.4 ttpt -90.67 114.49 26.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.453 -0.943 . . . . 61.43 108.453 171.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.481 ' HB2' HG23 ' A' ' 28' ' ' ILE . 6.0 pt-20 -92.51 102.0 14.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.734 -0.666 . . . . 70.35 110.791 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.823 ' CZ2' ' HB3' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -80.27 147.08 31.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 64.42 109.689 -177.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.487 ' HE3' ' O ' ' A' ' 56' ' ' MET . 28.1 ttpp -106.06 119.45 39.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.753 -0.462 . . . . 74.22 109.753 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.99 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.665 . . . . 42.15 111.27 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -109.2 -129.43 5.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.49 -0.644 . . . . 35.24 111.49 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 mm? -76.08 141.85 71.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.686 0.279 . . . . 74.34 111.134 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_endo -86.97 120.43 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.245 2.63 . . . . 72.31 111.775 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 53' ' ' LEU . 3.8 mp -96.57 -54.82 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.407 . . . . 61.01 110.622 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 97.74 162.99 31.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.828 -0.701 . . . . 71.02 111.491 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.75 ' HB2' HG12 ' A' ' 51' ' ' ILE . 27.6 tp60 -133.56 128.59 35.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.987 0.394 . . . . 73.31 110.175 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.58 108.6 2.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.617 -0.802 . . . . 25.21 112.418 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -16.14 46.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.906 -0.664 . . . . 63.04 112.291 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.679 ' CE2' ' HA ' ' A' ' 198' ' ' TYR . 21.2 m-85 -113.38 -59.39 2.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.736 0.303 . . . . 72.35 110.318 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.72 -105.59 0.22 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.8 -0.714 . . . . 64.32 112.562 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.667 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 49.8 t -142.05 142.0 32.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 75.11 110.596 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.75 HG12 ' HB2' ' A' ' 45' ' ' GLN . 27.4 mm -121.74 136.88 57.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.25 144.66 35.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.755 0.312 . . . . 55.44 110.643 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 69' ' ' VAL . 57.9 tp -84.37 152.04 24.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.364 -0.606 . . . . 61.03 109.364 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.38 104.4 12.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.827 0.346 . . . . 64.23 111.056 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.1 -35.18 42.73 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.11 -0.7 . . . . 71.25 109.11 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.822 ' SD ' ' HA ' ' A' ' 37' ' ' TRP . 13.8 tpt 69.54 -70.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.482 -1.235 . . . . 73.2 113.194 171.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -139.32 104.9 5.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.176 0.512 . . . . 64.15 111.159 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -83.61 40.01 0.71 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 64.51 111.52 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 m . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 75.43 110.799 -179.908 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.528 0.131 0 N-CA-C 109.243 -0.651 . . . . 74.23 109.243 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 68.0 Cg_endo -78.37 55.84 5.58 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 121.594 1.529 . . . . 52.35 110.95 169.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 8.6 p -145.51 157.93 43.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.999 -0.546 . . . . 75.21 110.699 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 53' ' ' LEU . 7.2 m -135.34 161.43 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 63.22 110.369 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.583 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 4.9 p -119.75 119.98 61.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.651 0.739 . . . . 72.32 111.934 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 4.8 tptp -79.98 115.97 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.776 -1.102 . . . . 74.43 108.768 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 128' ' ' PHE . 6.9 p -125.7 128.32 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.065 0.46 . . . . 63.43 111.577 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -138.06 152.24 71.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 75.13 109.833 177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.92 165.8 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.346 2.03 . . . . 60.11 112.302 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.1 m -78.08 69.94 4.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.332 0.587 . . . . 72.15 110.453 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -122.66 7.12 9.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 70.34 110.453 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 67.62 93.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.267 -0.878 . . . . 64.03 110.762 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.63 -154.11 6.14 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.576 -0.738 . . . . 62.55 111.646 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 31.4 Cg_exo -59.15 -35.52 97.62 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.21 2.607 . . . . 73.12 112.553 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.54 -36.37 44.72 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.926 0.766 . . . . 72.4 111.433 -176.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -66.57 -49.28 66.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.788 0.328 . . . . 75.42 110.805 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 m -62.71 -48.35 79.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 62.32 111.107 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 8.3 pt-20 -69.35 -33.54 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.166 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.614 HD22 ' HD3' ' A' ' 127' ' ' ARG . 43.7 tp -58.48 -47.48 83.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.003 0.43 . . . . 75.53 110.575 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.39 -36.8 82.03 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.117 -0.492 . . . . 75.41 110.511 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.45 -52.59 64.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.941 -0.572 . . . . 73.13 110.237 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 4.9 m-85 -57.27 -46.89 82.65 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.697 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.95 64.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 74.42 111.337 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -90.52 -26.81 19.57 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.848 0.314 . . . . 73.02 111.848 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.76 17.99 22.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.768 0.318 . . . . 73.4 111.649 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -85.54 164.74 17.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.555 0.576 . . . . 51.14 112.555 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 96' ' ' ILE . 2.8 tppt? 77.88 99.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.847 -1.07 . . . . 75.31 111.09 170.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 11.6 Cg_endo -55.12 -29.16 64.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.441 2.761 . . . . 64.43 113.443 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 4.3 tp10 -55.42 -59.43 4.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 73.3 110.596 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 6.4 tp60 -68.11 -35.6 78.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.966 -0.561 . . . . 74.33 110.449 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' LYS . 73.5 mt -55.45 -49.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 44.02 110.277 177.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -59.52 -42.78 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.456 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.7 mmtt -55.65 -59.59 4.64 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.723 -0.671 . . . . 75.23 112.113 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.91 -34.97 69.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.024 -0.67 . . . . 73.22 111.228 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.647 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.5 mt -59.15 -49.14 84.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 121.095 -0.242 . . . . 74.24 111.199 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -74.63 -35.74 62.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 74.14 111.267 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.7 m -72.63 -39.78 66.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.799 0.333 . . . . 54.13 111.226 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -87.89 7.08 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.462 -0.335 . . . . 72.13 111.848 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 71.07 29.49 2.91 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.423 0.452 . . . . 71.34 112.138 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.05 -169.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.799 -0.445 . . . . 72.31 109.799 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 26.5 mmtm -115.36 -62.76 1.55 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.845 -0.428 . . . . 75.25 109.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 100' ' ' ILE . 37.6 p90 -174.85 138.56 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.442 0.464 . . . . 61.41 110.503 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' A' ' 100' ' ' ILE . 72.8 mt -79.24 118.57 21.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.178 -0.464 . . . . 72.03 109.844 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.503 ' HA3' ' CZ ' ' A' ' 160' ' ' ARG . . . -79.03 54.87 4.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.383 -0.913 . . . . 75.1 111.817 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.59 149.96 39.02 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.905 -0.406 . . . . 71.35 109.905 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.74 ' HB3' ' HE2' ' A' ' 134' ' ' PHE . 21.0 Cg_exo -66.08 144.72 76.78 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.26 1.973 . . . . 64.41 111.923 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 16.0 tttp -70.74 118.26 13.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 65.53 110.56 -176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.498 ' CD1' ' HD2' ' A' ' 87' ' ' TYR . 66.4 t80 -95.23 120.68 35.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 75.45 110.926 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.479 ' NE1' ' HD3' ' A' ' 112' ' ' LYS . 80.0 m95 -98.92 -51.31 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 75.13 110.769 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -169.0 172.61 43.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.864 -0.607 . . . . 73.11 112.134 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.622 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 34.2 p -160.3 157.37 27.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.196 -0.298 . . . . 74.02 110.196 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.25 -177.92 46.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.572 -0.823 . . . . 42.31 112.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.5 tt -126.15 134.37 51.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.858 0.361 . . . . 75.01 110.206 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.573 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . 56.3 t60 -140.88 118.23 11.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.465 -0.568 . . . . 74.33 109.465 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.3 t70 -67.45 129.77 40.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.89 -0.595 . . . . 63.51 110.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 84.7 tttt -134.85 122.67 22.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.234 -0.439 . . . . 75.45 110.022 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 22.1 m120 66.73 15.95 10.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.063 -0.517 . . . . 72.44 111.522 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 -2.01 61.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.559 -0.829 . . . . 65.3 112.052 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 61.12 109.667 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.9 m -76.37 104.88 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 72.44 110.658 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -93.95 136.54 34.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.565 -0.743 . . . . 73.21 110.492 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.614 ' HD3' HD22 ' A' ' 84' ' ' LEU . 36.2 ttm180 -112.28 124.29 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.7 p90 -126.9 160.23 31.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 72.55 111.943 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.622 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 30.3 ttp -145.19 135.87 24.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.373 -0.83 . . . . 75.22 110.28 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.577 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 3.6 mm -96.99 128.34 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 62.34 111.539 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.6 ptp -122.59 167.78 12.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.996 -1.002 . . . . 74.1 108.976 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 11.0 t70 -72.53 152.03 42.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.96 -0.756 . . . . 71.03 108.96 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HD3' HG13 ' A' ' 69' ' ' VAL . 27.7 tpt180 -76.59 102.07 5.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.817 0.818 . . . . 75.1 112.05 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.74 ' HE2' ' HB3' ' A' ' 111' ' ' PRO . 8.9 m-85 -102.69 141.85 34.81 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.253 -1.388 . . . . 62.34 107.253 168.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.66 10.5 0.81 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.4 -1.381 . . . . 43.54 113.41 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.926 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 16.2 m -113.73 123.39 49.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.803 -0.814 . . . . 71.41 108.803 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.937 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 2.3 m-20 -105.03 129.51 53.45 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 121.151 -0.22 . . . . 62.23 110.412 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.35 -24.02 67.5 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.431 -0.508 . . . . 74.2 109.677 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.937 ' HG2' ' HB3' ' A' ' 137' ' ' ASP . 28.0 pt20 -70.68 -37.12 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 51.45 110.413 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 63.1 mttp -70.94 -35.05 72.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.9 0.381 . . . . 73.42 110.202 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 1.8 mp -74.52 -31.03 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.278 -0.419 . . . . 63.33 110.512 175.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 147' ' ' LYS . 40.0 t80 -52.74 -53.72 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.686 -0.688 . . . . 70.35 111.886 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -99.57 -1.75 37.45 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 63.05 111.245 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.94 -32.87 15.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.37 . . . . 71.43 110.542 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -0.65 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.45 -0.574 . . . . 73.22 109.45 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 147' ' ' LYS . . . 55.29 36.69 27.59 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.659 -0.701 . . . . 65.32 111.226 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 142' ' ' TYR . 29.8 mtmt 72.57 93.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.551 -0.749 . . . . 72.15 112.46 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.3 tpp85 -143.69 97.64 3.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.865 -1.061 . . . . 70.42 109.244 173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -119.64 153.81 34.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 75.42 110.234 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 m -101.28 175.44 5.58 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.634 -0.506 . . . . 40.34 109.634 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 328' ' ' LEU . 21.8 ttm180 -67.32 -37.13 82.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.347 -0.141 . . . . 74.34 111.084 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 335' ' ' ASP . 2.1 tmtp? -55.98 -46.99 78.5 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.319 -0.252 . . . . 73.24 110.319 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.492 ' O ' HD13 ' A' ' 157' ' ' LEU . 0.0 OUTLIER -58.26 -48.1 81.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.846 0.355 . . . . 54.22 111.195 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.25 -42.07 90.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.312 -0.404 . . . . 44.24 110.771 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.32 -52.64 21.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 52.34 111.182 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -63.72 -44.04 94.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.539 0.209 . . . . 71.04 110.838 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 161' ' ' ILE . 10.9 mp -64.64 -41.87 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 62.43 110.755 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -59.35 -49.54 77.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.6 0.238 . . . . 75.11 110.531 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 325' ' ' LEU . 8.8 mp -58.47 -50.72 72.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.403 -0.362 . . . . 62.3 111.752 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -66.08 -21.9 66.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 72.4 111.222 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 157' ' ' LEU . 23.6 mm -69.66 -40.91 79.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 109.72 -0.474 . . . . 75.22 109.72 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.76 -47.5 86.03 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.984 0.178 . . . . 72.45 110.784 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.41 -56.37 13.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.9 0.381 . . . . 75.51 111.419 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.485 HG21 HH21 ' A' ' 160' ' ' ARG . 11.3 tt -68.72 -35.86 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.418 -0.355 . . . . 74.14 111.05 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.576 HD13 ' CD2' ' A' ' 175' ' ' HIS . 68.5 tp -67.28 -38.5 85.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.547 -0.297 . . . . 61.32 111.488 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 27.8 mm-40 -76.63 -28.83 56.22 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.592 -0.443 . . . . 64.31 110.204 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -60.32 -48.71 80.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.357 . . . . 73.21 110.391 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 173' ' ' TYR . 18.5 pt -72.49 -31.97 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 73.11 110.957 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 23.6 m170 -64.84 -38.05 89.67 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.982 0.176 . . . . 73.4 111.06 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.1 -6.17 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.012 0.434 . . . . 71.13 111.137 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -100.65 -85.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.217 -0.66 . . . . 53.11 109.217 170.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 15.0 pt-20 -169.44 1.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 71.35 111.746 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' A' ' 168' ' ' ILE . 39.2 m-85 -106.19 158.09 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.178 0.513 . . . . 72.52 111.719 -165.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.72 168.55 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.876 -1.056 . . . . 75.33 108.561 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.576 ' CD2' HD13 ' A' ' 165' ' ' LEU . 8.4 p80 -102.94 121.37 42.38 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.447 -0.501 . . . . 72.12 110.645 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 -39.14 95.24 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.768 -0.73 . . . . 74.13 112.731 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.4 t70 -135.06 127.85 31.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 70.14 111.976 -175.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.713 ' HB ' HG22 ' A' ' 246' ' ' ILE . 32.2 mm -111.88 124.72 68.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.311 -0.996 . . . . 64.22 108.311 167.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -166.08 167.64 16.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.645 -0.502 . . . . 71.21 109.645 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.54 -19.16 63.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 41.34 110.946 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.684 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 3.1 p -75.1 -21.07 59.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 54.43 111.963 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.517 ' HA ' HG12 ' A' ' 196' ' ' VAL . 2.0 p30 -110.79 12.51 22.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 72.44 111.733 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.2 mt -113.47 114.4 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.293 -0.412 . . . . 70.42 110.586 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.31 138.74 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 72.24 110.86 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.926 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 39.3 mt -95.18 154.02 17.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.105 -0.702 . . . . 72.33 109.105 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.444 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 27.5 t-20 -59.44 147.56 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.477 -0.564 . . . . 73.2 109.477 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.421 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 10.7 p90 -60.91 -25.59 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -120.41 -26.3 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.007 0.373 . . . . 65.41 112.007 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.517 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 4.9 t30 -112.1 115.01 50.79 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.573 -0.451 . . . . 45.03 111.106 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 7.6 Cg_exo -72.99 -29.83 11.56 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.299 2.666 . . . . 43.2 114.413 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -88.27 13.7 10.99 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.514 -0.474 . . . . 65.21 111.53 -175.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.519 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 18.9 mm-40 -112.92 94.98 5.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 71.42 109.992 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 157' ' ' LEU . 6.4 p -104.99 126.54 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 74.21 111.2 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 45.1 m-85 -128.75 158.98 37.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.631 . . . . 75.2 110.238 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' A' ' 160' ' ' ARG . 8.3 mp -83.34 147.21 28.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.244 -0.28 . . . . 74.11 110.244 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 182' ' ' ASN . 14.7 p -83.79 148.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.309 -0.405 . . . . 61.22 110.618 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.0 88.0 0.15 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.721 0.772 . . . . 72.14 110.422 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.679 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -105.72 -9.38 17.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.803 -1.09 . . . . 75.34 111.303 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 57.55 16.96 24.57 Favored Glycine 0 C--O 1.223 -0.555 0 CA-C-N 115.904 -0.589 . . . . 41.14 112.726 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 353' ' ' THR . 0.5 OUTLIER -91.9 49.1 1.5 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.674 0.749 . . . . 55.02 110.238 -174.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -119.87 110.4 16.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.41 -0.814 . . . . 42.43 110.169 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -98.27 -174.54 2.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.833 -1.173 . . . . 63.34 107.833 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.475 ' HD2' ' OE1' ' A' ' 172' ' ' GLU . 36.8 ptt180 -131.29 133.52 45.47 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.683 -0.636 . . . . 62.34 111.675 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -93.59 -17.51 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.309 -0.86 . . . . 71.43 110.169 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 40.4 m -128.6 76.0 79.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.254 -0.43 . . . . 71.42 110.884 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 203' ' ' ARG . 91.5 Cg_exo -45.35 103.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.182 2.588 . . . . 74.44 113.263 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 61.81 28.73 17.64 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.325 -0.852 . . . . 63.21 111.301 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.42 -15.68 45.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 51.24 113.078 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.28 110.53 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 O-C-N 122.409 -0.465 . . . . 75.2 109.938 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 14.9 p-80 -63.8 127.45 31.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 75.11 110.399 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 214' ' ' LYS . 37.6 tptt -103.14 142.99 33.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.798 -0.637 . . . . 63.34 110.114 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -81.68 -169.3 2.26 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.166 -0.309 . . . . 62.33 110.166 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.738 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 69.1 t80 -64.1 91.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.431 -0.581 . . . . 61.44 109.431 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.547 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 22.2 tptm -156.0 16.09 0.35 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.163 -0.472 . . . . 70.24 110.517 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 237' ' ' ALA . 35.0 tt0 -72.51 -66.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.924 0.392 . . . . 65.34 110.486 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -140.52 140.35 22.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.787 -0.449 . . . . 73.14 109.787 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 C--N 1.347 0.451 0 C-N-CA 123.206 2.604 . . . . 74.43 113.451 179.521 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 31.9 t70 . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.53 0.205 . . . . 70.45 110.985 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -99.8 -166.85 29.45 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.862 -0.685 . . . . 44.14 112.087 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.9 p -70.38 143.9 51.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 75.51 111.062 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 271' ' ' VAL . 0.3 OUTLIER -64.8 -20.66 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.644 0.735 . . . . 65.42 109.546 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.414 ' HG2' HD21 ' A' ' 265' ' ' LEU . 19.4 mt-10 -61.58 -48.43 80.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.02 -0.991 . . . . 71.3 111.475 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.1 m-85 -111.77 -15.83 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -169.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 232' ' ' ALA . 1.1 p -54.39 -27.07 34.1 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.652 0.982 . . . . 70.4 113.652 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.553 ' HB2' ' HE2' ' A' ' 249' ' ' TYR . 15.3 t 64.43 -159.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.337 0.398 . . . . 72.43 110.418 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 3.3 mp -67.33 -45.65 85.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.613 -0.267 . . . . 73.13 110.981 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -74.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.722 0.638 . . . . 74.55 112.722 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 228' ' ' THR . . . -67.88 -27.59 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.01 112.163 -172.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.624 -0.262 . . . . 75.54 110.976 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 2.7 t30 -82.56 -36.64 26.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.641 -0.254 . . . . 45.03 110.882 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 144.5 9.3 0.37 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 119.794 -1.194 . . . . 61.42 114.121 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.738 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 12.1 p -122.41 139.58 48.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 117.374 0.587 . . . . 43.11 110.547 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 215' ' ' GLU . . . -55.14 148.93 27.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 64.1 110.575 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.33 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.833 2.356 . . . . 64.03 111.489 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.6 p -79.16 -72.36 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.768 0.794 . . . . 70.34 110.767 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -42.51 0.09 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.832 -1.544 . . . . 74.33 106.832 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 48.8 ttt-85 -58.23 -70.2 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.51 -1.677 . . . . 72.01 111.174 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.716 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -62.99 -36.38 93.38 Favored Glycine 0 C--O 1.223 -0.543 0 CA-C-N 115.821 -0.627 . . . . 72.3 112.886 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.0 -50.54 66.38 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.261 0.553 . . . . 71.43 110.475 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.62 -30.7 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.531 -0.758 . . . . 43.35 111.02 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 279' ' ' ARG . 39.2 mt-10 -66.1 -39.22 89.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.049 -0.26 . . . . 73.11 110.716 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.6 mt -58.2 -47.33 87.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.124 0.488 . . . . 74.14 109.814 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.13 -43.62 98.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.729 -0.669 . . . . 73.11 110.26 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.18 96.44 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.979 -0.555 . . . . 54.11 112.769 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.553 ' HE2' ' HB2' ' A' ' 229' ' ' SER . 19.3 m-85 -59.04 -41.33 87.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 73.45 110.518 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.5 m -62.73 -45.09 94.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.573 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 90.4 mtp -59.66 -50.26 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 63.0 111.47 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -66.07 -36.62 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 121.01 -0.276 . . . . 72.32 110.392 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -62.57 -42.88 99.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 74.05 110.983 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -64.04 -38.9 92.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 72.05 111.145 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.5 tp -81.11 -30.33 34.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.446 0.536 . . . . 64.3 112.446 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 290' ' ' PHE . 76.6 p -103.45 -28.82 11.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.388 -0.525 . . . . 65.43 111.828 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 147' ' ' LYS . . . 76.3 14.27 82.51 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.101 -0.571 . . . . 61.14 113.019 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -150.68 149.93 30.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.349 0.575 . . . . 74.54 112.05 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 95.6 mt -129.82 139.44 35.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 55.11 108.87 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.646 ' HG2' ' HE1' ' A' ' 278' ' ' TYR . 25.0 Cg_exo -65.25 -9.92 23.88 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.678 2.252 . . . . 54.12 113.044 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.596 ' HB2' HG12 ' A' ' 271' ' ' VAL . 38.6 p90 -118.98 28.16 8.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.122 0.416 . . . . 61.15 112.122 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 55.0 mt-10 -66.78 -51.22 58.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.191 0.52 . . . . 62.15 110.825 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.74 -27.69 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.701 -0.681 . . . . 73.14 110.687 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 270' ' ' TYR . 13.6 m120 -98.58 12.99 33.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.739 -0.664 . . . . 74.22 111.01 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.425 HD23 ' HD1' ' A' ' 261' ' ' TRP . 3.0 tm? -58.94 -39.18 80.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.016 0.436 . . . . 60.51 111.183 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -78.84 11.34 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.048 -0.524 . . . . 64.24 111.737 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -125.99 106.01 25.64 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.282 -0.636 . . . . 53.42 109.282 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 271' ' ' VAL . 20.8 Cg_endo -60.54 -23.09 74.49 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.027 2.485 . . . . 70.32 113.385 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -74.03 -46.89 40.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.946 -0.39 . . . . 70.42 109.946 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 16.2 m-30 -67.21 -41.78 85.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.836 -0.62 . . . . 71.11 110.822 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 261' ' ' TRP . 17.1 m -64.69 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.765 0.317 . . . . 71.15 110.216 177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 276' ' ' ILE . 53.0 ttt-85 -66.55 -48.5 69.48 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.241 -0.436 . . . . 53.03 110.495 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.0 -40.77 90.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.354 -0.385 . . . . 72.32 110.694 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 35.2 m -61.82 -41.85 98.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.951 -0.568 . . . . 70.0 110.97 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 229' ' ' SER . 68.2 mttm -63.92 -37.63 88.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 72.43 110.288 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.1 mt -65.54 -38.76 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 73.01 110.581 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.489 ' HA ' ' OE2' ' A' ' 280' ' ' GLU . 0.3 OUTLIER -62.27 -40.49 96.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.904 0.383 . . . . 74.24 110.453 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.646 ' HE1' ' HG2' ' A' ' 260' ' ' PRO . 28.0 m-85 -66.76 -29.89 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 73.34 110.751 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.45 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -81.54 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 64.52 111.211 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.489 ' OE2' ' HA ' ' A' ' 277' ' ' ARG . 49.4 mt-10 -79.88 -71.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.1 0.476 . . . . 70.34 110.222 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.91 94.45 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.913 -0.585 . . . . 63.32 109.626 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 282' ' ' ILE . 3.9 mp -67.07 -51.99 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.432 -0.349 . . . . 74.13 110.468 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.94 84.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 74.21 111.399 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.2 m -61.65 -45.94 91.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.339 -0.391 . . . . 73.52 111.183 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 289' ' ' CYS . 3.9 mm? -65.88 -44.47 85.25 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.307 -0.406 . . . . 64.14 111.184 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.5 mmt -67.13 -43.46 82.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 71.53 111.243 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.66 -45.37 77.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 73.44 110.939 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.65 5.2 51.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.013 -0.54 . . . . 53.42 111.603 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 48.8 t -85.19 -43.79 13.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.014 -0.736 . . . . 54.01 109.014 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.672 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 53.4 t80 -129.44 78.94 74.87 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.672 -0.695 . . . . 62.23 109.895 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -94.48 36.74 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.354 2.703 . . . . 64.2 111.903 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.44 -166.81 1.69 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.543 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.96 66.93 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.581 0.705 . . . . 75.35 111.079 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.672 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 46.6 t30 -167.7 151.5 6.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.56 -1.2 . . . . 71.12 107.761 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -107.26 112.29 62.88 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.288 -0.565 . . . . 72.41 110.718 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.08 109.21 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.473 2.115 . . . . 74.41 110.978 172.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -136.96 -40.72 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.512 -0.852 . . . . 64.34 111.631 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.569 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 0.7 OUTLIER -63.87 -61.3 2.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 72.33 109.952 -178.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.508 HG21 ' HB ' ' A' ' 252' ' ' ILE . 3.5 mp -62.21 -40.12 86.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.486 -0.779 . . . . 63.42 110.56 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.11 -54.21 49.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.635 . . . . 72.1 111.479 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -69.1 -39.88 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.127 -0.229 . . . . 74.52 111.16 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 306' ' ' VAL . 44.8 t80 -56.33 -53.39 57.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 74.14 110.546 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 306' ' ' VAL . 62.0 mtp -72.77 -30.58 64.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.88 -0.6 . . . . 64.24 111.635 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.476 ' HA ' HG12 ' A' ' 282' ' ' ILE . 40.9 tt0 -66.63 -45.29 79.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.316 0.579 . . . . 71.42 109.657 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 19.1 m -59.68 -47.32 86.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.225 -0.898 . . . . 73.34 111.67 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 303' ' ' MET . 20.0 m -68.74 -27.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 74.12 111.128 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 7.7 tmtm? -67.29 -33.97 76.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.168 0.509 . . . . 73.42 110.056 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 308' ' ' LEU . 6.0 tt -75.14 -31.26 61.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.598 -0.728 . . . . 72.22 109.976 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 92.9 mt -63.89 -33.86 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 64.52 111.897 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 8.3 t70 60.51 -165.75 0.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.818 -0.438 . . . . 71.42 109.818 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -63.6 -37.61 87.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.579 0.585 . . . . 73.4 112.579 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 m -149.3 74.95 1.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.201 -0.6 . . . . 61.31 112.519 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -118.67 -175.47 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.704 -0.48 . . . . 55.34 109.704 165.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 39.5 mttp -86.19 109.38 22.62 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.448 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 4.0 Cg_endo -85.64 119.14 1.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.932 2.421 . . . . 74.23 112.526 -176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.25 85.98 6.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 61.3 110.128 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -65.51 -34.1 77.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.886 -0.597 . . . . 60.34 111.686 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.71 -29.44 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.892 -0.323 . . . . 72.33 110.688 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.73 -45.08 60.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 93.7 mt -56.53 -46.02 80.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.783 -0.644 . . . . 62.43 110.02 174.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -54.34 -50.14 68.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.682 -0.69 . . . . 75.54 110.998 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -37.83 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 44.45 111.847 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.8 pp -72.3 -28.72 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 120.571 -0.452 . . . . 74.13 111.035 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.87 -49.35 62.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.272 0.558 . . . . 62.34 109.629 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 159' ' ' LEU . 4.3 mm? -64.65 -31.15 72.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.584 -0.735 . . . . 74.54 110.618 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -47.04 87.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 74.53 109.939 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -61.31 -46.14 95.02 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.756 -0.735 . . . . 72.14 112.072 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 26.8 tp -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.433 0.635 . . . . 65.23 110.558 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 329' ' ' LYS . 34.8 ttpt -65.75 -46.48 78.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.011 -0.995 . . . . 74.21 112.123 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.67 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.623 0.601 . . . . 71.12 112.623 -172.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.69 -7.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.021 0.438 . . . . 75.21 111.363 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 90.18 24.65 28.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.226 -0.988 . . . . 71.35 113.082 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 12.4 p -100.78 138.98 37.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.881 0.372 . . . . 64.22 110.436 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -151.67 80.61 1.28 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.983 -0.553 . . . . 62.54 109.761 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.861 ' HA ' ' HG2' ' A' ' 152' ' ' LYS . 26.2 t0 68.46 111.29 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.053 -0.976 . . . . 61.1 109.782 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -76.8 -7.04 54.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 61.24 111.058 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.93 58.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.268 -0.968 . . . . 61.12 113.152 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 111.841 0.312 . . . . 71.31 111.841 173.466 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 353' ' ' THR . 9.8 tmtt? . . . . . 0 CA--C 1.533 0.321 0 N-CA-C 110.635 -0.135 . . . . 74.35 110.635 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.651 ' HA ' ' HG ' ' A' ' 200' ' ' LEU . 0.6 OUTLIER 69.23 179.19 0.24 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.402 1.081 . . . . 61.01 111.655 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -65.45 144.13 15.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.728 0.775 . . . . 65.51 112.847 -172.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.9 t -71.96 154.7 41.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.642 -1.163 . . . . 64.05 111.06 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt . . . . . 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 74.53 109.727 178.014 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t . . . . . 0 N--CA 1.457 -0.125 0 N-CA-C 109.46 -0.571 . . . . 73.12 109.46 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 39' ' ' VAL . . . 99.1 2.1 56.98 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.598 -0.811 . . . . 75.41 111.821 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 13.5 pt-20 -74.63 155.43 37.82 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.116 0.484 . . . . 74.03 110.756 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 38' ' ' LYS . 33.3 mm -87.11 118.74 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 72.33 110.191 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.1 137.9 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.889 0.376 . . . . 73.34 110.212 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 10.0 m -86.42 111.54 20.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 65.4 109.954 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HA ' ' A' ' 35' ' ' LYS . 12.0 t70 -111.38 159.57 17.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 71.45 110.272 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.473 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -62.03 -22.56 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.047 0.451 . . . . 71.31 110.134 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.57 23.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 70.24 111.151 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 2.8 tmmt? 74.0 44.88 0.24 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 54.43 110.466 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.617 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 60.0 pttt 45.28 -149.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.858 0.863 . . . . 74.41 112.681 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 53.9 mt-10 69.59 39.37 1.56 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.299 0.64 . . . . 61.32 111.095 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -126.77 121.38 31.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.79 -0.818 . . . . 72.24 108.79 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 23.1 pttp -105.22 131.65 52.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.791 -0.764 . . . . 72.24 110.96 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 26' ' ' GLY . 2.7 p -70.75 129.68 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.488 -0.778 . . . . 70.12 110.499 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.753 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -116.69 -106.28 2.45 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.624 -0.798 . . . . 63.1 113.185 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.0 tm? -62.89 118.3 40.87 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-O 121.15 0.5 . . . . 75.35 110.899 -174.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.904 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.7 Cg_exo -73.78 93.38 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.755 2.303 . . . . 63.21 111.733 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.07 -53.15 27.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.292 0.568 . . . . 73.42 109.618 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.17 -56.38 0.51 Allowed Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.456 -0.793 . . . . 51.31 112.035 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.6 ' HG2' ' HA2' ' A' ' 49' ' ' GLY . 56.4 mt-30 -151.77 130.05 12.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.837 0.351 . . . . 73.12 110.527 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.522 ' H ' HD12 ' A' ' 51' ' ' ILE . . . -99.55 26.71 23.33 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.331 -1.108 . . . . 75.23 110.331 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 113.62 -50.65 0.76 Allowed Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.608 -0.597 . . . . 72.11 111.608 -175.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 79' ' ' PRO . 49.4 t80 -77.22 -76.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.588 0.232 . . . . 61.24 110.405 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 45' ' ' GLN . . . 172.86 150.43 7.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.131 -1.033 . . . . 61.1 113.084 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.9 t 45.66 67.01 0.8 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.989 0.915 . . . . 63.34 112.398 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 46' ' ' GLY . 17.0 mt -123.46 136.46 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 71.15 111.705 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.904 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 73.4 m-85 -129.42 165.9 20.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.393 . . . . 74.3 111.059 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 54' ' ' ALA . 1.3 tm? -90.81 143.12 27.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.067 -0.716 . . . . 74.35 109.067 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.589 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -92.55 75.27 5.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.236 0.541 . . . . 65.53 110.738 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.753 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 8.9 m-20 -79.29 67.47 5.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.652 . . . . 72.01 110.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.606 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 16.0 tpt -82.0 -52.25 7.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.645 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.7 t-20 -144.39 115.37 7.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.484 . . . . 73.04 110.009 -175.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.8 m -126.2 38.88 4.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 62.04 110.504 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 112.49 0.552 . . . . 75.15 112.49 -174.099 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.506 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 113.839 1.052 . . . . 73.33 113.839 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 58.0 Cg_endo -71.03 33.12 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.136 1.89 . . . . 74.04 113.757 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.5 138.32 54.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.972 0.415 . . . . 74.23 110.22 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 133' ' ' ARG . 15.9 m -114.92 143.22 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.09 -0.505 . . . . 70.33 109.862 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.0 p -117.13 116.09 50.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.88 0.847 . . . . 61.12 110.137 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HD3' ' SD ' ' A' ' 129' ' ' MET . 16.3 ptmt -92.7 128.43 38.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.591 -1.186 . . . . 74.2 109.208 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 6.9 p -135.47 124.26 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 119.542 -0.863 . . . . 61.11 112.816 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 5.6 mm-40 -124.71 171.43 7.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.111 -0.95 . . . . 72.53 108.809 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.61 152.99 51.83 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.905 1.737 . . . . 34.41 111.43 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 127' ' ' ARG . 28.9 t -53.71 -35.99 61.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.082 0.468 . . . . 73.15 110.408 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.39 116.02 30.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.771 . . . . 75.05 109.612 174.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -151.7 -68.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 44.33 110.745 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 -86.9 0.38 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.719 -0.753 . . . . 71.32 112.111 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . 51.1 Cg_exo -53.71 -43.73 55.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.123 2.549 . . . . 72.01 113.05 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 3.4 tm? -55.77 -45.84 78.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.962 0.41 . . . . 72.24 110.418 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.93 -35.96 77.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.15 0.5 . . . . 74.43 110.635 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -67.72 -48.48 66.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.93 -0.577 . . . . 64.22 110.921 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.792 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . 8.1 pt-20 -69.63 -27.89 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.141 -0.318 . . . . 73.12 110.141 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 129' ' ' MET . 59.7 tp -62.99 -44.2 96.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.414 -0.357 . . . . 72.4 110.63 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 42.0 tptt -64.1 -46.14 85.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.261 -0.427 . . . . 43.34 109.876 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 60.8 t80 -59.57 -47.93 83.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 73.44 110.128 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.43 -46.83 80.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.221 -0.9 . . . . 72.33 110.474 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -61.47 -35.39 77.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.218 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 79.0 mtp180 -81.44 -18.74 44.27 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.084 0.401 . . . . 75.41 112.084 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.97 -34.9 6.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.66 0.615 . . . . 43.34 112.66 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.51 11.29 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.262 0.553 . . . . 75.15 111.998 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG2' ' HD2' ' A' ' 93' ' ' PRO . 30.0 tttm -76.86 139.79 66.49 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 115.384 -0.825 . . . . 62.31 110.269 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 80.8 Cg_exo -47.37 -53.48 6.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.343 2.696 . . . . 63.32 113.697 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -40.72 93.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 51.34 110.683 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 167' ' ' TYR . 13.2 mm100 -61.59 -48.9 78.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.609 -0.723 . . . . 65.44 111.148 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' NZ ' ' A' ' 112' ' ' LYS . 62.3 mt -66.0 -48.62 81.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.892 -0.594 . . . . 74.14 111.283 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -61.66 -37.91 85.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 73.51 111.026 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -61.24 -48.58 80.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 72.12 110.262 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -66.79 -46.0 76.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 64.02 111.096 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -54.95 -50.66 60.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.273 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -69.25 -32.43 71.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.457 . . . . 74.41 111.194 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 m -76.24 -40.36 52.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.593 -0.276 . . . . 72.34 111.743 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 10.8 ttt180 -93.64 9.05 38.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.973 -0.291 . . . . 61.34 111.167 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.866 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.1 mmpt? 64.81 28.9 12.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.234 -0.439 . . . . 73.2 111.542 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 88.5 mt -90.86 -173.61 3.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.041 -0.527 . . . . 75.24 111.022 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -26.54 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.21 109.833 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -154.13 165.2 36.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 73.41 110.213 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.4 tp -124.98 137.17 54.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 70.51 109.461 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.7 52.96 2.83 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.299 -0.477 . . . . 72.34 113.253 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.64 133.22 23.22 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.071 -0.714 . . . . 63.12 109.071 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG3' ' HZ ' ' A' ' 134' ' ' PHE . 24.2 Cg_exo -60.77 136.78 68.61 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.406 2.071 . . . . 64.33 111.401 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.734 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -65.29 125.77 26.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.09 0.472 . . . . 73.42 110.815 -178.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.36 113.96 19.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 64.41 110.114 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CD1' HG22 ' A' ' 130' ' ' ILE . 24.5 m95 -92.48 -49.94 5.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.287 -0.635 . . . . 72.52 109.287 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.41 ' HA3' ' OD1' ' A' ' 31' ' ' ASP . . . -176.63 -168.76 37.12 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.591 -0.814 . . . . 74.5 112.684 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 82.4 p -179.96 177.21 0.68 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.934 -1.136 . . . . 73.34 107.934 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.82 -175.83 43.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.09 -1.529 . . . . 43.0 113.929 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 125' ' ' SER . 2.0 tm? -120.33 127.3 52.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.03 -1.1 . . . . 73.24 108.03 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 51.7 t60 -130.89 117.14 18.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.02 0.438 . . . . 72.15 111.083 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -67.1 149.89 49.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 53.21 109.994 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -128.12 -89.33 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.865 0.364 . . . . 64.35 110.177 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -142.3 87.4 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.989 -0.745 . . . . 62.33 108.989 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -36.42 3.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.066 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -109.34 163.71 13.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.904 -0.406 . . . . 73.42 109.904 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 118' ' ' LEU . 50.0 m -123.98 138.54 54.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.174 -0.466 . . . . 60.05 109.815 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 66.1 m-85 -103.65 145.63 29.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.515 . . . . 73.45 110.998 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.0 ttt180 -118.31 116.84 27.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.96 -0.756 . . . . 75.05 108.96 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 44.7 p90 -123.48 163.14 21.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.176 0.512 . . . . 73.15 112.244 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.481 ' SD ' ' HD3' ' A' ' 71' ' ' LYS . 14.2 ttm -143.46 133.12 23.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.937 -1.029 . . . . 71.15 109.785 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.452 HG22 ' CD1' ' A' ' 114' ' ' TRP . 37.5 mt -97.77 127.03 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.686 0.279 . . . . 64.23 110.25 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.522 ' HE1' HG23 ' A' ' 196' ' ' VAL . 18.7 ptm -138.78 177.97 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 72.11 111.273 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.63 142.03 58.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.731 -0.668 . . . . 63.54 111.351 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.504 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 9.0 tpt180 -79.33 112.89 17.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.267 0.556 . . . . 72.11 111.152 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.593 ' HZ ' ' HG3' ' A' ' 111' ' ' PRO . 16.0 m-85 -102.02 149.29 24.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.915 -0.584 . . . . 62.33 109.597 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.54 -6.54 2.96 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.651 -0.785 . . . . 43.13 111.883 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.957 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 44.9 m -120.8 124.21 44.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.952 0.406 . . . . 72.24 111.551 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 184' ' ' LEU . 13.3 m-20 -98.07 125.73 43.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 74.04 109.56 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 17.2 tp -67.38 -18.67 65.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.184 0.516 . . . . 63.14 109.615 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 46.3 tp60 -60.09 -50.4 73.86 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.541 -0.754 . . . . 72.32 111.192 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -31.05 67.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.73 0.3 . . . . 61.15 110.283 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 138' ' ' LEU . 71.7 mt -64.25 -51.95 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 61.42 110.733 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.938 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -68.91 -31.83 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.889 -0.412 . . . . 70.35 109.889 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.34 -53.45 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 73.43 111.178 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.15 -22.09 53.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.809 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 9.7 t-20 -96.38 -1.48 47.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.936 0.398 . . . . 72.03 111.359 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 58.57 33.68 23.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.166 -0.47 . . . . 63.51 111.034 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.938 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 56.4 pttt 43.15 42.86 3.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.763 1.225 . . . . 63.24 113.226 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -115.68 90.09 3.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.077 -0.712 . . . . 73.01 109.077 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.44 157.36 17.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.542 . . . . 75.24 111.364 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -71.21 158.37 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.683 -0.689 . . . . 54.31 111.452 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 298' ' ' GLU . 6.1 tpt180 -53.73 -39.03 64.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.162 -0.926 . . . . 62.41 111.084 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -61.71 -61.96 2.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.527 -0.761 . . . . 53.12 111.564 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t -64.86 -36.37 84.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.31 112.088 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.25 -43.04 98.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.727 0.299 . . . . 75.51 110.913 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 328' ' ' LEU . 0.4 OUTLIER -64.87 -47.4 78.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.457 -0.338 . . . . 70.1 110.168 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 335' ' ' ASP . 5.8 tp-100 -59.15 -45.24 91.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.835 0.35 . . . . 74.42 110.723 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.485 ' O ' HD13 ' A' ' 161' ' ' ILE . 35.2 tp -59.98 -46.81 88.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.367 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.2 t -61.3 -39.27 89.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 64.44 110.459 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.51 -49.72 74.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.509 . . . . 73.33 110.202 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.719 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -60.62 -40.55 92.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.892 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 157' ' ' LEU . 1.7 mp -61.79 -40.64 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 71.41 109.864 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.98 -37.87 86.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 73.03 110.781 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.6 m-20 -56.12 -58.19 8.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.363 0.601 . . . . 73.42 110.593 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 195' ' ' LEU . 18.7 tt -71.14 -35.89 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.573 -0.739 . . . . 74.13 111.231 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.8 -38.54 91.34 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.825 -0.171 . . . . 53.22 110.91 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.342 -0.614 . . . . 63.03 109.342 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 95' ' ' GLN . 61.4 t80 -56.18 -45.19 79.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.142 -0.936 . . . . 70.34 111.962 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.401 HG21 ' HZ ' ' A' ' 86' ' ' PHE . 35.1 pt -84.89 -32.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.856 -0.337 . . . . 63.4 111.874 -176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.644 ' HE1' ' HA ' ' A' ' 240' ' ' ARG . 5.1 t60 -66.2 -41.13 90.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.301 -0.259 . . . . 65.01 110.301 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.905 0.383 . . . . 61.42 110.452 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -88.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 73.33 110.467 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 11.2 pt-20 -166.11 11.69 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.856 0.687 . . . . 71.21 112.856 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.78 141.81 51.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.778 -0.369 . . . . 73.13 110.895 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 238' ' ' PRO . 12.9 m -123.65 126.06 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 75.54 110.392 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 201' ' ' ALA . 41.7 t-80 -89.09 69.84 8.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.983 -0.747 . . . . 61.11 108.983 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.89 46.68 3.39 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.689 -0.687 . . . . 64.15 113.806 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 224' ' ' THR . 11.1 t70 -175.7 96.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 73.21 109.255 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.719 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -90.01 70.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.392 0.615 . . . . 60.34 110.393 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.674 ' HD2' ' OG1' ' A' ' 224' ' ' THR . 56.6 tttm -83.76 134.87 34.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.143 -0.688 . . . . 73.12 109.143 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -54.87 -26.34 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 73.11 112.051 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 0.9 OUTLIER -66.5 -25.56 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.409 -0.359 . . . . 70.23 111.261 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 200' ' ' LEU . 6.9 t-20 -84.11 -7.42 59.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 73.03 109.882 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 161' ' ' ILE . 21.1 mt -105.75 115.57 30.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.071 -0.968 . . . . 63.13 110.503 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.529 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.1 mm? -118.08 140.35 49.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 74.03 110.535 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 9.0 mp -100.72 145.27 28.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.655 -0.498 . . . . 73.31 109.655 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.671 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 25.5 t-20 -59.99 147.64 38.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.17 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -57.69 -26.83 62.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.395 0.517 . . . . 72.45 112.395 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -115.48 -15.83 11.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 70.31 111.878 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.26 107.11 30.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 112.018 0.377 . . . . 73.43 112.018 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.548 ' HA ' HD23 ' A' ' 185' ' ' LEU . 17.9 Cg_exo -67.62 -21.84 45.06 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.069 2.513 . . . . 73.0 111.586 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.683 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 7.3 p-10 -91.39 6.51 45.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.556 . . . . 71.45 111.047 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -119.35 99.78 6.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 61.35 109.646 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.24 133.67 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.885 -0.598 . . . . 73.53 110.496 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.671 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 18.0 m-85 -128.17 158.05 39.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 71.32 110.018 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 164' ' ' ILE . 82.9 mt -95.63 150.2 20.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.671 0.272 . . . . 73.43 110.608 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.2 p -138.23 175.87 7.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.736 -0.839 . . . . 70.05 108.736 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 196' ' ' VAL . 0.6 OUTLIER 75.64 -58.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.461 0.476 . . . . 64.53 110.769 174.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.792 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 25.8 m-85 63.77 12.21 6.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.428 -0.805 . . . . 74.43 112.343 173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.35 -15.64 81.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.601 -1.0 . . . . 62.13 110.601 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 352' ' ' LYS . 89.9 mt -92.92 17.09 11.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.01 -0.595 . . . . 64.14 110.283 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 175' ' ' HIS . . . -127.76 99.42 5.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.104 -0.702 . . . . 45.21 109.104 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -99.54 149.64 23.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.302 0.572 . . . . 72.44 111.106 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 203' ' ' ARG . 32.7 ptt180 -60.1 115.52 3.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.852 -1.067 . . . . 74.34 111.131 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -101.83 -29.76 11.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.384 0.611 . . . . 70.45 109.745 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 45.7 m -133.88 64.42 66.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 71.04 109.643 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.25 113.86 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.93 2.42 . . . . 63.43 113.167 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 70.21 14.3 7.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.723 -0.671 . . . . 51.42 110.457 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.04 -7.25 52.24 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.874 -0.679 . . . . 62.1 112.307 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.84 111.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 74.15 110.535 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -102.69 128.58 49.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.285 -0.416 . . . . 74.01 110.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -115.46 162.22 17.48 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.371 -0.603 . . . . 74.05 109.371 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -83.75 -172.16 4.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.484 0.659 . . . . 70.45 111.915 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -76.41 151.86 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 75.33 111.861 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -134.33 0.65 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 74.45 110.473 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 69.49 -63.13 0.39 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.501 -0.772 . . . . 72.42 112.522 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 4.4 t0 -157.2 105.5 1.88 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.76 0.314 . . . . 72.12 111.778 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo . . . . . 0 N--CA 1.452 -0.916 0 C-N-CA 123.49 2.793 . . . . 61.01 113.3 172.713 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 . . . . . 0 C--O 1.237 0.422 0 CA-C-O 120.917 0.389 . . . . 70.51 110.776 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.57 -170.4 46.32 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.959 -0.564 . . . . 73.0 112.833 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.674 ' OG1' ' HD2' ' A' ' 179' ' ' LYS . 1.1 m -91.1 114.25 26.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.689 -0.486 . . . . 61.55 109.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 271' ' ' VAL . 18.3 tt -52.77 -17.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 113.377 0.88 . . . . 74.24 113.377 -167.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -65.42 -43.88 89.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 73.41 109.846 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.61 ' HD2' ' HB ' ' A' ' 224' ' ' THR . 36.6 m-85 -96.07 -41.41 8.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.58 -0.736 . . . . 74.33 111.381 -174.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 0.2 OUTLIER -57.45 -5.56 0.35 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.499 1.296 . . . . 51.33 114.499 -166.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.6 t 62.99 -158.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.932 0.396 . . . . 60.43 110.162 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.5 mt -71.87 -47.53 55.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.417 -0.356 . . . . 72.25 110.795 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -35.99 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.276 1.213 . . . . 60.42 114.276 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.624 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -70.0 -30.14 67.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.477 0.547 . . . . 50.22 112.477 -167.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -21.76 61.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 74.3 110.119 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -87.24 -34.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.785 -0.45 . . . . 64.33 109.785 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.401 ' HA3' ' HA ' ' A' ' 216' ' ' ASP . . . 142.17 -33.93 1.88 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.242 -0.98 . . . . 62.23 113.231 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.52 140.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.827 0.314 . . . . 74.44 110.637 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -56.86 135.34 79.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 60.42 110.348 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 75.8 Cg_exo -49.89 115.72 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 2.458 . . . . 74.54 112.279 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 84.6 p -83.59 -178.06 6.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.04 -0.527 . . . . 73.52 110.534 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.644 ' HA ' ' HE1' ' A' ' 169' ' ' HIS . 9.3 ptp85 -64.55 -31.29 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.612 0.72 . . . . 71.23 109.537 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -64.26 -40.26 95.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.226 -0.897 . . . . 71.41 109.538 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -58.93 -69.29 1.32 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.068 -0.969 . . . . 53.54 112.391 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -61.45 -33.82 74.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.128 0.464 . . . . 61.42 112.078 -170.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.59 -46.92 57.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.566 -0.454 . . . . 73.11 111.734 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.18 -27.71 60.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.003 0.43 . . . . 71.42 110.305 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.5 mt -63.92 -45.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 74.01 110.507 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 161' ' ' ILE . 37.6 tp -60.38 -36.51 78.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.834 -0.432 . . . . 74.33 109.834 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.19 -47.61 88.3 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.754 -0.736 . . . . 63.23 112.142 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -59.65 -43.75 93.79 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.777 0.322 . . . . 73.54 110.79 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 35.4 m -65.49 -37.44 86.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.908 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.38 -50.71 70.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.866 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.8 tt -69.79 -28.62 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.649 -0.42 . . . . 63.23 110.443 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.79 -50.84 71.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.934 0.397 . . . . 63.33 110.322 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.9 m0 -70.3 -24.97 63.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.531 -0.759 . . . . 53.22 111.012 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 294' ' ' ASN . 30.1 tp -76.39 -32.6 58.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.03 111.719 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -103.37 -27.24 12.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.531 0.567 . . . . 44.13 112.531 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.426 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 86.83 -20.49 24.09 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.447 -0.882 . . . . 44.35 112.588 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -147.36 144.35 28.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.616 -0.512 . . . . 75.34 109.616 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.74 149.03 36.39 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 72.33 110.29 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.17 -34.94 98.57 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.323 2.015 . . . . 61.34 112.18 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -96.57 13.64 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 75.51 110.862 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.18 -31.15 69.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 75.13 110.669 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -84.13 -6.86 59.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.794 0.807 . . . . 70.04 109.556 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.876 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 2.9 m-20 -106.86 5.12 28.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.927 -1.033 . . . . 61.21 109.51 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 265' ' ' LEU . 1.9 tm? -65.16 -33.7 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.553 -0.749 . . . . 75.42 111.537 -170.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.42 -23.22 65.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.207 0.447 . . . . 71.33 112.207 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 14.7 t70 -109.7 127.5 27.04 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.929 0.395 . . . . 65.03 111.69 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.94 -39.85 67.47 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.391 2.728 . . . . 52.54 113.649 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 9.8 ptmm? -79.11 -37.88 37.56 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.359 -0.536 . . . . 42.13 110.008 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 9.1 m-85 -58.11 -42.84 86.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.56 0.219 . . . . 75.32 110.818 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 225' ' ' ILE . 65.3 t -63.16 -50.6 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.563 -0.29 . . . . 62.55 110.519 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 276' ' ' ILE . 31.0 ttp180 -60.13 -48.86 79.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.602 -0.272 . . . . 73.41 111.273 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.68 -45.72 85.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.466 0.479 . . . . 73.54 111.514 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 21.4 m -66.79 -43.26 84.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.102 -0.499 . . . . 52.34 111.174 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 7.8 mmmm -61.6 -32.64 72.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.758 0.313 . . . . 74.53 110.636 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 272' ' ' ARG . 75.7 mt -72.91 -44.44 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.385 -0.37 . . . . 74.23 111.013 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.45 -32.61 74.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.973 0.416 . . . . 71.14 110.563 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -74.24 -32.25 62.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.38 -0.373 . . . . 62.25 110.817 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 276' ' ' ILE . 23.7 mtp180 -59.11 -33.42 70.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.39 -0.368 . . . . 71.42 110.854 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.45 -39.9 70.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.569 -0.742 . . . . 74.21 111.417 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 284' ' ' SER . 36.5 t30 -153.99 84.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.193 0.52 . . . . 62.52 110.438 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.675 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -78.72 -35.96 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 73.52 111.968 -176.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.73 80.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.797 0.332 . . . . 75.35 111.241 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . 0.514 ' HB3' ' ND2' ' A' ' 281' ' ' ASN . 22.7 t -75.3 -45.71 38.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 44.43 110.454 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -61.67 -42.41 98.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.925 0.343 . . . . 72.42 111.925 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.0 mmt -74.99 -43.58 53.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.93 -0.308 . . . . 72.11 111.301 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.69 -38.98 84.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.102 0.477 . . . . 71.22 111.023 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -84.54 -2.0 56.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.84 -0.618 . . . . 75.33 110.575 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.46 -21.4 38.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 74.31 109.393 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -137.48 76.92 41.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.029 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.49 44.7 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.557 2.838 . . . . 72.42 112.691 -173.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.11 -179.44 3.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.975 -0.38 . . . . 71.21 109.975 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -81.05 20.54 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.372 0.508 . . . . 74.01 112.372 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.784 HD21 HD11 ' A' ' 255' ' ' LEU . 41.5 t30 -77.47 -48.14 17.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.47 -0.567 . . . . 54.34 109.47 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 23.9 tptm 77.85 95.09 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 115.222 -0.899 . . . . 65.35 111.147 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.84 48.04 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.889 2.392 . . . . 55.51 112.196 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.14 54.93 Favored Glycine 0 C--O 1.238 0.356 0 CA-C-N 115.942 -0.572 . . . . 65.02 112.76 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 323' ' ' ILE . 1.7 mp0 -55.37 -45.14 76.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 74.44 110.497 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.7 mp -63.0 -45.3 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 73.34 110.827 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.13 50.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 75.51 111.428 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 304' ' ' GLU . 22.3 mtpp -77.17 -27.94 53.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 71.14 111.897 -176.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -55.99 -52.78 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.518 . . . . 54.1 109.97 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.555 ' HA ' HG22 ' A' ' 306' ' ' VAL . 55.6 mtp -72.68 -36.28 67.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.464 -0.789 . . . . 72.54 110.869 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 301' ' ' LYS . 38.7 tt0 -57.39 -46.42 83.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.362 0.601 . . . . 74.42 109.795 173.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 47.9 m -63.17 -52.5 62.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.037 -0.983 . . . . 73.44 112.078 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.6 m -64.24 -27.35 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.712 0.291 . . . . 72.41 111.551 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -80.65 -30.48 36.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.711 0.291 . . . . 71.2 111.042 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.86 -17.73 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 74.44 110.326 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 67.8 mt -71.16 -13.84 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 61.31 110.889 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 35.7 t70 59.23 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 73.34 111.736 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.53 ' O ' ' HD2' ' A' ' 240' ' ' ARG . 49.5 t80 -152.4 -48.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.442 0.163 . . . . 71.21 110.685 174.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 5.4 m -125.67 36.14 4.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.243 0.544 . . . . 50.14 111.668 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 14.8 tp10 -90.49 23.06 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.937 -0.477 . . . . 54.14 110.04 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 72.36 130.64 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 115.466 -0.788 . . . . 54.44 111.811 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.54 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 1.4 Cg_endo -82.37 118.31 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.415 2.076 . . . . 75.31 110.881 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 320' ' ' LEU . 16.9 tp -104.09 92.6 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 74.41 110.138 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.72 -40.44 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 75.52 111.556 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.6 pm0 -67.22 -29.3 68.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.21 111.617 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.06 -48.87 69.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.791 -0.448 . . . . 71.33 109.791 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 9.4 mp -60.47 -43.15 97.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.602 -0.726 . . . . 45.32 110.619 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 325' ' ' LEU . 1.2 tmt_? -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.63 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.21 -40.5 71.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 72.31 111.274 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -63.72 -37.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.618 0.247 . . . . 75.44 110.373 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.531 HD23 ' HB3' ' A' ' 298' ' ' GLU . 87.1 mt -67.86 -46.73 70.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.954 0.407 . . . . 73.04 110.667 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 321' ' ' ARG . 4.3 mm? -66.93 -29.26 69.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.43 111.171 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 326' ' ' GLN . 1.0 OUTLIER -66.34 -42.38 88.23 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.406 -0.59 . . . . 72.13 109.406 178.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.99 98.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.802 -0.713 . . . . 44.11 111.925 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 155' ' ' LEU . 14.1 mt -69.18 -36.37 77.26 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.854 -0.204 . . . . 75.01 111.488 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -60.3 -34.03 73.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.747 0.308 . . . . 71.24 110.426 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.82 -29.79 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 54.53 111.816 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.7 pt -107.68 1.01 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 74.04 111.094 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 77.07 24.99 65.1 Favored Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.949 -0.643 . . . . 64.03 113.052 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 62.6 m -107.45 156.7 18.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.077 0.465 . . . . 63.41 111.254 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -152.96 16.8 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.394 -0.965 . . . . 64.23 108.394 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 338' ' ' LYS . 24.7 t70 67.27 125.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.529 -1.214 . . . . 73.34 109.298 -162.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.26 0.91 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.282 -0.872 . . . . 45.4 110.763 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -70.56 -10.16 66.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.842 -0.694 . . . . 50.21 111.824 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.683 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 12.3 mmmm . . . . . 0 CA--C 1.519 -0.221 0 C-N-CA 123.622 0.769 . . . . 72.01 111.431 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 200' ' ' LEU . 4.5 mptp? . . . . . 0 N--CA 1.45 -0.428 0 CA-C-O 121.246 0.546 . . . . 70.44 110.556 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.8 t -161.45 157.67 25.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 71.4 108.691 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.1 OUTLIER -99.63 126.83 52.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.323 0.582 . . . . 63.32 111.785 -173.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 18.5 m -75.95 74.12 2.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.608 -0.724 . . . . 51.43 109.908 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.68 . . . . 75.03 110.432 -179.453 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.466 HG13 ' HA2' ' A' ' 40' ' ' GLY . 90.1 t . . . . . 0 N--CA 1.445 -0.711 0 N-CA-C 108.389 -0.967 . . . . 64.33 108.389 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.81 -5.66 59.97 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.492 -0.861 . . . . 62.02 112.271 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.52 140.82 31.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.697 -0.483 . . . . 70.35 109.697 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -98.53 131.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.247 0.546 . . . . 72.13 110.779 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.3 137.0 47.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.745 -0.661 . . . . 44.03 110.039 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 23.6 m -106.76 121.01 43.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.29 -0.414 . . . . 73.55 110.627 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.603 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 3.2 p-10 -83.35 -175.44 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 71.11 110.812 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.481 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 25.3 mmt -65.95 -28.09 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.372 0.508 . . . . 73.24 112.372 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.752 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . . . -90.71 9.69 28.89 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.99 0.424 . . . . 75.24 110.822 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 63.4 69.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.412 -0.813 . . . . 65.42 112.862 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.752 ' HE2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -127.33 141.91 51.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.162 -0.681 . . . . 74.12 109.162 168.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.59 101.55 14.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.983 0.42 . . . . 71.4 110.233 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.579 ' HZ2' ' HZ2' ' A' ' 35' ' ' LYS . 70.5 m95 -98.97 108.61 21.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 75.01 110.515 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.73 123.41 27.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.212 -0.662 . . . . 73.23 109.212 175.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.86 132.32 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.531 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -116.12 -131.75 4.88 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 121.09 -0.576 . . . . 65.3 112.992 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.8 tt -63.75 128.31 92.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.053 0.454 . . . . 64.14 111.381 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.9 Cg_exo -74.95 100.65 1.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.15 2.567 . . . . 63.0 111.991 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 53' ' ' LEU . 69.3 mt -62.33 -55.93 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.162 0.506 . . . . 73.44 110.925 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.94 148.05 18.49 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.649 -0.786 . . . . 62.54 111.899 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' HG12 ' A' ' 51' ' ' ILE . 25.3 tm0? -112.73 165.88 11.87 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.262 -1.014 . . . . 73.55 108.262 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' ' NZ ' ' A' ' 140' ' ' LYS . . . -40.57 -51.45 3.85 Favored Glycine 0 C--N 1.335 0.475 0 O-C-N 123.47 0.482 . . . . 64.04 113.884 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 26.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.959 -1.115 . . . . 72.21 113.47 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.572 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 75.5 t80 -129.84 -77.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.094 0.447 . . . . 75.04 111.287 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.66 -40.63 76.79 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.179 -0.534 . . . . 54.43 113.954 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' GLN . 59.3 m 64.2 96.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.31 0.576 . . . . 74.14 110.81 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 45' ' ' GLN . 4.1 mm -101.31 139.71 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 51.43 111.618 -172.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.81 158.73 16.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 73.23 109.728 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 43' ' ' ILE . 9.5 tt -97.1 144.57 26.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.582 -0.525 . . . . 73.43 109.582 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -118.5 114.78 23.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.759 0.314 . . . . 31.43 110.283 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.43 8.42 33.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.395 -0.366 . . . . 73.11 111.049 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 1.4 tmt? 69.49 -60.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.376 0.67 . . . . 60.32 109.805 -174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 56' ' ' MET . 62.9 t30 174.16 149.05 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.931 0.769 . . . . 74.22 109.273 171.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p -82.39 73.22 9.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.344 0.592 . . . . 63.11 110.348 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.8 m . . . . . 0 C--N 1.323 -0.571 0 CA-C-N 115.337 -0.847 . . . . 61.44 109.728 -179.237 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.483 0 CA-C-O 121.699 0.761 . . . . 74.2 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HG2' ' CH2' ' A' ' 114' ' ' TRP . 82.5 Cg_endo -90.92 37.96 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.427 2.751 . . . . 75.23 113.76 -169.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.89 139.05 53.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.153 0.501 . . . . 70.13 111.606 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 53' ' ' LEU . 34.2 m -130.29 162.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.235 -0.654 . . . . 72.23 109.235 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.56 ' HB ' HG12 ' A' ' 130' ' ' ILE . 7.4 p -132.73 130.13 58.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.611 0.72 . . . . 71.21 111.688 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' HD12 ' A' ' 51' ' ' ILE . 76.2 tttt -94.79 137.47 33.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.023 -0.989 . . . . 74.41 109.42 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.83 140.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 72.34 111.743 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 16.2 mt-10 -157.35 161.1 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 75.15 109.576 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.01 148.54 92.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.321 2.014 . . . . 51.22 111.353 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.0 t -47.47 -50.02 24.1 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.553 0.533 . . . . 65.14 112.208 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.48 45.28 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.749 0.309 . . . . 65.1 111.456 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -69.34 -37.5 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.353 0.597 . . . . 73.41 110.264 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.03 -80.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.584 -0.817 . . . . 74.33 112.422 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.572 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.4 Cg_exo -60.91 -40.99 48.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.075 2.517 . . . . 51.35 112.768 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 1.6 tm? -52.63 -48.6 66.27 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 123.518 0.511 . . . . 74.43 111.172 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.29 -45.9 89.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.706 0.289 . . . . 74.24 111.185 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 201' ' ' ALA . 3.2 m -63.61 -42.5 98.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.336 0.589 . . . . 61.35 110.424 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.21 -30.27 64.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 73.22 110.484 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.63 -41.97 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 53.23 110.729 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HD2' ' HE2' ' A' ' 173' ' ' TYR . 41.6 ttmt -63.71 -40.11 95.95 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.714 -0.395 . . . . 75.03 109.961 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.24 -45.44 93.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.317 0.58 . . . . 73.45 109.648 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.5 ' OH ' ' HA ' ' A' ' 113' ' ' TYR . 81.1 t80 -58.28 -37.24 74.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 75.33 110.926 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.52 -32.77 72.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 71.32 111.057 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 12.4 mmt180 -72.08 -37.9 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.52 111.075 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 96' ' ' ILE . . . -96.27 17.16 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 73.34 111.118 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' LYS . . . -87.63 146.9 25.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.909 -0.587 . . . . 63.44 111.594 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 91' ' ' ALA . 41.2 ttmt 77.92 117.25 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.256 -0.884 . . . . 72.34 111.533 174.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -56.52 -29.33 78.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.337 2.691 . . . . 61.33 113.087 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.43 -53.26 60.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.684 0.278 . . . . 71.2 111.395 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.89 -47.75 81.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.152 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 90' ' ' ALA . 59.0 mt -56.21 -51.25 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.674 . . . . 74.44 111.022 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -53.83 -42.17 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 72.31 110.621 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -60.32 -60.23 4.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.576 -0.738 . . . . 65.41 111.449 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -73.26 -34.44 65.83 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 119.964 -0.694 . . . . 72.0 111.353 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.3 mm -59.72 -38.04 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.668 -0.413 . . . . 63.13 110.475 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -78.77 -48.13 15.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.307 -0.406 . . . . 63.43 111.24 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.0 m -73.66 -43.92 58.17 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.891 0.33 . . . . 74.34 111.891 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.555 ' O ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -73.92 -27.33 60.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.782 -0.822 . . . . 65.3 108.782 178.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.575 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 9.9 mtmp? 71.66 83.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.663 -1.153 . . . . 71.22 111.474 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.1 mt -121.69 173.74 7.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.986 -1.006 . . . . 42.41 109.318 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -89.35 -62.57 1.45 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.906 -0.318 . . . . 54.55 110.469 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 160' ' ' ARG . 27.4 p90 -164.78 146.26 7.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.916 0.389 . . . . 74.14 110.546 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 100' ' ' ILE . 42.3 mt -91.85 118.08 30.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 63.23 111.019 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.52 59.69 4.94 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 109.977 -1.249 . . . . 74.42 109.977 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.776 HG22 ' HD2' ' A' ' 111' ' ' PRO . 2.2 p -121.12 151.56 55.64 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.261 -0.47 . . . . 71.31 110.285 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.776 ' HD2' HG22 ' A' ' 110' ' ' VAL . 89.2 Cg_exo -42.84 134.77 5.3 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.96 2.44 . . . . 63.41 113.618 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 131' ' ' MET . 23.5 tptm -91.46 130.5 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 74.53 110.142 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.5 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 46.1 t80 -91.09 128.62 36.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.131 0.491 . . . . 73.31 112.135 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.565 ' CD1' HG22 ' A' ' 130' ' ' ILE . 47.6 m95 -129.71 -43.66 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.369 -0.832 . . . . 74.24 108.794 170.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.89 162.93 32.24 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.7 -1.136 . . . . 44.54 111.448 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 p -164.16 145.5 8.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.746 -0.464 . . . . 60.52 109.746 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.481 ' HA2' ' HG2' ' A' ' 32' ' ' MET . . . -170.17 -171.55 35.75 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.141 -1.028 . . . . 62.22 112.817 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.84 130.84 44.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.035 -0.728 . . . . 74.4 109.035 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.457 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 30.7 t-80 -125.5 133.32 52.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.487 -0.324 . . . . 70.51 110.137 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' SER . 25.7 m-20 69.54 145.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.919 0.762 . . . . 73.52 112.0 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -151.52 -24.49 0.2 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 60.44 111.243 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -67.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.336 -0.393 . . . . 73.55 111.827 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.92 -28.27 3.46 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.12 -0.792 . . . . 52.31 111.12 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.0 130.68 46.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.19 -0.671 . . . . 62.04 109.19 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 4.0 p -113.92 117.43 31.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.827 0.346 . . . . 74.42 110.46 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' ' 120' ' ' ASP . 96.1 m-85 -110.82 132.62 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.226 0.536 . . . . 73.55 111.672 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -111.95 127.46 55.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.581 -0.736 . . . . 71.13 109.099 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 49.0 p90 -123.3 142.1 51.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.222 0.534 . . . . 73.44 110.86 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.8 ptm -136.13 130.18 32.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.379 -0.828 . . . . 73.52 109.879 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.565 HG22 ' CD1' ' A' ' 114' ' ' TRP . 15.9 mt -97.51 135.31 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.986 -0.552 . . . . 74.44 111.543 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 53.8 mtm -130.73 -179.88 5.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.038 -0.528 . . . . 73.11 109.788 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.05 165.44 24.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.697 -0.483 . . . . 32.43 109.697 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -69.39 133.19 47.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.397 0.618 . . . . 75.41 111.519 -172.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 20.5 m-85 -122.3 172.21 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.669 . . . . 74.34 110.202 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.775 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -173.72 -51.54 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 41.12 111.916 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 21.1 m -100.86 144.15 30.16 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.753 -0.462 . . . . 75.11 109.753 178.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 p30 -139.01 163.04 33.44 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.018 -0.364 . . . . 62.32 110.018 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.0 mp -73.14 -24.4 60.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.189 0.44 . . . . 70.22 112.189 -173.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 10.0 pt20 -71.24 -31.8 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.623 -0.431 . . . . 70.12 110.424 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.498 ' NZ ' ' HA2' ' A' ' 46' ' ' GLY . 55.9 mttp -71.75 -37.24 70.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.99 0.424 . . . . 74.2 110.757 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.573 HG13 ' O ' ' A' ' 137' ' ' ASP . 62.0 mt -74.66 -51.54 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.915 -0.584 . . . . 71.52 112.281 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HD1' ' HB2' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -65.96 -32.61 74.19 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.337 0.495 . . . . 71.15 112.337 -166.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.83 -6.82 59.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.181 -0.607 . . . . 72.44 110.823 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -104.05 -30.28 10.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.36 0.6 . . . . 64.2 110.45 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -97.92 -0.61 44.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.546 -0.752 . . . . 75.42 110.876 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.11 16.23 9.44 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.462 -0.79 . . . . 52.3 111.926 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HE3' ' HB3' ' A' ' 253' ' ' GLN . 2.6 ttpt 64.19 53.67 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.732 -0.667 . . . . 73.33 110.939 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 148' ' ' ARG . 6.4 tmm_? -133.43 95.15 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.366 -0.975 . . . . 75.33 108.366 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 44.6 m-85 -103.68 157.23 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.871 -0.604 . . . . 74.54 111.368 -172.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.2 p -60.9 147.88 41.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.773 -0.648 . . . . 54.12 110.778 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HD3' ' OE2' ' A' ' 298' ' ' GLU . 26.7 ttm-85 -61.88 -33.19 73.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 71.43 110.608 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.32 -46.17 90.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.268 177.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.428 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 32.6 m -72.03 -45.74 59.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.772 -0.649 . . . . 71.44 111.155 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.2 -40.92 76.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.401 -0.363 . . . . 73.35 110.681 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 324' ' ' LEU . 19.2 tp -63.48 -47.89 79.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 74.15 110.668 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.7 -45.48 81.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.691 0.281 . . . . 70.31 111.051 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 161' ' ' ILE . 93.2 mt -58.52 -51.62 69.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 70.35 110.146 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 247' ' ' LEU . 15.5 m -57.9 -43.2 86.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.776 -0.647 . . . . 73.2 110.921 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 92.8 mt -61.19 -56.12 24.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.206 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -65.59 -23.5 66.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.614 0.245 . . . . 72.23 111.3 -176.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 157' ' ' LEU . 27.1 mm -65.62 -46.46 89.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.649 -0.501 . . . . 75.33 109.649 174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.09 -38.72 92.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.618 0.229 . . . . 73.42 111.618 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.82 -55.51 33.92 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.161 0.505 . . . . 75.23 110.656 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.584 HG21 HH21 ' A' ' 160' ' ' ARG . 16.9 tt -70.44 -36.22 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.001 -0.545 . . . . 71.32 110.59 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 58.8 tp -62.65 -37.32 85.89 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.456 -0.202 . . . . 60.5 110.456 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -50.83 66.28 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.194 0.521 . . . . 75.14 109.874 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 44.1 t80 -51.68 -44.64 63.18 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 114.825 -1.08 . . . . 73.43 111.805 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.74 -31.36 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.768 0.318 . . . . 73.14 111.189 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.666 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 30.3 t-80 -50.77 -54.96 19.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.511 -0.768 . . . . 75.23 111.098 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.47 40.2 1.59 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.403 0.62 . . . . 63.42 110.66 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.623 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 3.0 t-80 -110.21 -72.72 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 73.45 109.083 174.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.68 -38.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.461 -0.336 . . . . 73.45 111.293 173.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 46.8 m-85 -107.33 138.79 42.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 72.52 111.639 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.26 172.51 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.122 -0.49 . . . . 72.05 110.396 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 44.2 t60 -141.16 111.76 6.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.356 -0.384 . . . . 72.44 110.111 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.78 -44.26 6.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 72.53 113.568 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.788 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 35.7 t70 -81.37 87.09 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.267 -0.549 . . . . 74.22 112.269 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.69 63.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.703 . . . . 53.22 109.534 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -97.31 156.99 16.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.328 -0.619 . . . . 70.24 109.328 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -64.01 -10.84 24.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.943 0.349 . . . . 63.31 111.943 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.532 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 46.6 t -71.56 -22.55 61.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.457 -0.338 . . . . 71.22 111.134 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -95.42 -2.25 49.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 70.12 110.794 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.46 126.62 55.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 74.31 111.512 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 1.0 OUTLIER -137.71 158.74 43.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 65.14 110.996 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 193' ' ' VAL . 43.6 mt -102.67 152.17 21.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.936 -0.575 . . . . 72.45 111.25 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.748 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 42.1 t-20 -69.38 128.1 35.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.507 -0.923 . . . . 75.1 108.507 169.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.775 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 39.7 t80 -60.21 -35.36 75.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 71.22 111.905 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.493 ' HD3' ' NH1' ' A' ' 133' ' ' ARG . 76.0 tttt -97.78 -25.49 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.386 -0.37 . . . . 63.24 111.218 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 82.7 m-20 -115.99 98.17 50.66 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.42 -0.355 . . . . 55.33 110.14 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 189' ' ' ASN . 33.7 Cg_endo -63.98 -21.67 68.44 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 123.089 2.526 . . . . 71.13 113.241 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 31.2 p-10 -95.77 6.91 47.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 74.23 111.296 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -106.16 91.86 3.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.026 -0.534 . . . . 75.21 109.834 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.436 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.1 p -102.42 122.95 55.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.695 -0.684 . . . . 74.42 110.109 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.748 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 79.3 m-85 -106.91 157.76 17.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.647 -0.706 . . . . 74.11 110.897 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.446 ' HB2' HH22 ' A' ' 160' ' ' ARG . 43.1 tp -109.16 101.66 10.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 72.0 109.444 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 111' ' ' PRO . 24.2 m -146.13 171.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.6 0.238 . . . . 73.51 110.831 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.54 51.6 4.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.497 -0.774 . . . . 65.03 110.775 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.677 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 22.5 p90 -126.67 -44.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.423 -0.808 . . . . 73.23 111.124 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 79' ' ' PRO . . . 67.02 5.67 34.28 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.899 -0.667 . . . . 63.12 112.873 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.93 HD11 ' HD2' ' A' ' 352' ' ' LYS . 30.3 mt -92.33 97.31 10.79 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.768 0.318 . . . . 55.42 110.873 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 82' ' ' THR . . . -149.47 100.14 2.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 75.2 109.663 173.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -105.18 143.01 33.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.389 -0.368 . . . . 74.31 110.463 -176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 203' ' ' ARG . 8.8 ptm180 -71.3 115.98 11.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.118 -0.492 . . . . 75.1 111.55 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 239' ' ' SER . 68.9 t80 -83.76 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.72 -0.673 . . . . 60.14 109.746 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 8.1 p -99.33 119.51 60.23 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 54.24 109.42 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.639 ' HG2' HG23 ' A' ' 209' ' ' VAL . 11.7 Cg_endo -56.64 88.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.233 2.622 . . . . 73.51 113.559 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 62.62 24.58 14.64 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.448 -0.796 . . . . 65.25 112.626 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.11 -42.6 1.37 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.364 -0.922 . . . . 42.43 113.232 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.639 HG23 ' HG2' ' A' ' 206' ' ' PRO . 24.4 m -79.19 132.42 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 64.24 111.068 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -70.0 153.61 43.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 65.13 110.727 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.771 ' HE2' ' HA ' ' A' ' 211' ' ' LYS . 0.1 OUTLIER -130.86 134.6 46.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 74.21 109.444 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.86 145.91 55.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.458 -0.571 . . . . 74.34 109.458 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.58 136.81 56.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.477 0.656 . . . . 63.21 111.187 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.43 -148.88 0.36 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.118 -0.946 . . . . 74.25 108.962 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -139.75 -49.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.767 -0.373 . . . . 64.44 110.086 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -138.84 104.26 7.49 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.088 0.403 . . . . 60.42 112.088 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 54.9 Cg_endo . . . . . 0 N--CA 1.455 -0.78 0 C-N-CA 122.029 1.819 . . . . 74.51 109.989 162.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.1 t70 . . . . . 0 CA--C 1.517 -0.289 0 CA-C-O 121.081 0.467 . . . . 73.1 110.554 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.788 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 88.4 -153.38 24.19 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.455 -0.793 . . . . 42.35 112.303 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.73 145.42 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 73.04 110.181 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.489 ' HA ' HG22 ' A' ' 228' ' ' THR . 15.3 tt -61.39 -23.44 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.709 0.633 . . . . 74.14 112.709 -171.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.46 -34.47 76.0 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.32 -0.237 . . . . 72.42 111.222 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 246' ' ' ILE . 13.3 m-85 -104.07 -17.65 14.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.418 0.525 . . . . 75.31 112.418 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 1.8 t -72.94 7.97 1.78 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.091 0.472 . . . . 53.05 111.451 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 26.2 t 63.34 -179.77 0.15 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.264 0.554 . . . . 72.01 110.932 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.5 -41.13 64.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 72.32 109.559 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.09 -62.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.847 -1.069 . . . . 64.42 111.589 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -66.4 -29.41 69.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.254 . . . . 54.21 111.228 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -64.7 -29.69 70.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.232 -0.187 . . . . 54.14 110.543 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -76.13 -27.17 56.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 53.33 110.002 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 217' ' ' PRO . . . 133.59 -20.81 4.09 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.027 -0.606 . . . . 62.13 113.251 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.1 130.75 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 42.22 112.309 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -62.71 123.7 80.41 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 75.14 108.652 170.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 239' ' ' SER . 73.2 Cg_exo -46.14 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.682 2.922 . . . . 72.31 114.887 -168.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.527 ' HA ' ' OH ' ' A' ' 204' ' ' TYR . 3.6 m 161.37 -83.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.751 1.221 . . . . 64.32 108.173 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.607 ' HG2' ' HG3' ' A' ' 315' ' ' PRO . 9.5 mpt_? -136.09 -31.87 0.89 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.36 -0.978 . . . . 72.42 108.36 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.759 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.32 -67.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.188 -1.369 . . . . 70.51 112.216 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.71 -40.51 96.65 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-N 116.03 -0.532 . . . . 72.0 112.864 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.31 -53.85 39.1 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.802 0.81 . . . . 73.31 110.284 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 306' ' ' VAL . 10.5 mp -64.96 -33.11 75.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.055 -0.975 . . . . 74.3 110.952 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.57 -40.45 97.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.524 0.202 . . . . 74.42 110.532 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.662 HG13 ' O ' ' A' ' 242' ' ' GLY . 73.0 mt -56.63 -46.17 82.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.117 -0.492 . . . . 45.31 110.737 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.7 tp -61.91 -40.25 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.223 -0.591 . . . . 74.53 110.532 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.34 91.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.554 -0.831 . . . . 23.44 112.044 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 275' ' ' LYS . 20.7 m-85 -64.67 -45.02 88.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.505 0.193 . . . . 70.03 111.464 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 5.0 p -72.58 -35.96 68.07 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.408 -0.517 . . . . 73.54 111.219 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 85.5 mtp -58.21 -52.12 66.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.341 . . . . 63.21 110.651 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.5 tt -67.62 -32.11 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 71.2 110.775 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.689 ' HB3' ' HE3' ' A' ' 147' ' ' LYS . 19.0 mt-30 -62.34 -50.95 69.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.676 0.274 . . . . 63.51 111.211 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 147' ' ' LYS . 29.7 m0 -68.18 -24.42 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.131 -0.486 . . . . 65.01 111.496 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -84.99 -31.47 23.49 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.34 0.496 . . . . 71.13 112.34 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.535 HG22 ' HD1' ' A' ' 290' ' ' PHE . 51.7 p -103.92 -28.67 11.44 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.999 0.74 . . . . 43.24 112.999 -171.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 112.55 -49.49 0.84 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.184 -1.007 . . . . 71.53 112.956 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -151.62 145.41 25.08 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.609 -0.347 . . . . 74.12 110.348 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.505 ' CD1' ' HG3' ' A' ' 253' ' ' GLN . 31.2 mt -104.97 147.48 34.55 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.642 -0.254 . . . . 72.43 110.4 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.5 -35.93 86.93 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.875 2.383 . . . . 60.1 112.907 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.568 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 18.6 p90 -95.35 8.34 43.48 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 120.686 -0.405 . . . . 73.34 111.117 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 265' ' ' LEU . 66.2 tt0 -85.14 -24.8 27.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.343 0.592 . . . . 63.51 109.689 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -96.92 -23.4 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.653 -0.703 . . . . 72.43 109.671 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 261' ' ' TRP . 94.7 m-20 -102.51 14.34 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.731 -0.668 . . . . 72.01 111.354 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -70.08 -12.73 61.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.02 0.438 . . . . 75.12 110.783 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -64.64 -16.65 63.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 74.32 111.356 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 5.9 t70 -129.72 117.96 18.63 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-O 120.933 0.397 . . . . 63.04 110.626 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 233' ' ' HIS . 77.4 Cg_exo -51.69 -27.84 27.64 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.722 2.948 . . . . 72.24 113.946 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.9 mttp -60.26 -52.45 65.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.902 0.382 . . . . 73.42 110.279 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.539 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 95.4 m-85 -72.37 -34.67 68.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 75.53 110.994 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 265' ' ' LEU . 92.5 t -55.57 -50.5 66.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.35 -0.386 . . . . 65.23 110.602 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -70.33 -44.07 68.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 73.12 110.368 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.29 -55.42 31.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.784 -0.644 . . . . 63.41 111.174 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.5 p -61.11 -44.37 97.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.027 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.47 ' HE3' ' CZ ' ' A' ' 249' ' ' TYR . 50.4 mttp -55.95 -48.11 76.36 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 116.651 -0.249 . . . . 74.51 111.174 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.6 -41.91 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.732 -0.213 . . . . 62.54 111.066 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -63.03 -40.23 97.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.545 -0.298 . . . . 75.32 111.384 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.945 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 23.0 m-85 -73.88 -33.36 64.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.684 0.278 . . . . 72.34 111.219 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 279' ' ' ARG . 13.8 mtp180 -71.43 -23.76 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 73.41 111.173 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -57.49 -59.07 5.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 75.12 110.378 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.5 88.52 2.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 61.31 110.023 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.2 mm -55.44 -51.37 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 54.22 111.33 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.27 83.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 62.23 111.28 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 31.4 m -68.09 -44.06 77.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 75.24 111.697 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.1 mm? -64.39 -46.67 82.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.598 -0.274 . . . . 64.22 111.336 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -32.69 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.255 . . . . 45.13 111.013 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.48 -37.91 79.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.144 -0.48 . . . . 61.13 111.014 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -94.54 -13.26 26.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.462 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 46.3 t -78.18 -25.28 47.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.842 0.353 . . . . 73.43 111.157 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.535 ' HD1' HG22 ' A' ' 256' ' ' THR . 19.9 t80 -109.82 93.07 13.7 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.15 109.594 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 88.8 Cg_exo -47.45 -48.35 15.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.678 2.918 . . . . 75.0 114.329 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.92 -25.08 67.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 74.33 110.773 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 58.97 41.91 20.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 72.13 110.17 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -63.75 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.794 . . . . 75.12 110.021 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 331' ' ' ILE . 50.9 mttp -152.88 99.07 2.77 Favored Pre-proline 0 C--O 1.227 -0.127 0 CA-C-O 120.489 0.185 . . . . 73.44 110.513 172.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -99.4 38.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.887 2.391 . . . . 72.15 111.419 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.24 -50.9 5.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.068 -0.587 . . . . 34.34 113.268 -170.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.936 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.6 mp0 -54.88 -52.91 61.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.965 0.412 . . . . 63.03 110.213 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.1 mp -60.65 -47.32 93.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.425 -0.807 . . . . 72.4 111.12 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.29 86.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.774 0.321 . . . . 53.44 111.543 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -66.48 -38.57 87.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.157 0.503 . . . . 71.24 110.046 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 320' ' ' LEU . 76.2 t80 -60.0 -52.51 65.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.468 -0.787 . . . . 75.24 110.76 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 306' ' ' VAL . 79.9 mtp -71.93 -32.19 67.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.339 -0.391 . . . . 63.13 111.616 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.51 -42.24 91.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.715 0.769 . . . . 71.44 109.333 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 m -65.39 -44.03 88.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.756 -1.111 . . . . 74.23 111.548 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 302' ' ' TYR . 4.2 m -70.04 -27.24 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 72.13 110.654 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.5 -44.09 92.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.199 0.523 . . . . 73.41 110.009 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.8 tp -76.93 1.71 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 61.34 110.943 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -9.03 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.328 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 21.0 t70 64.36 -81.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.258 0.623 . . . . 74.41 111.083 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -149.6 -44.77 0.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.604 -0.517 . . . . 71.14 109.604 174.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.5 t -154.98 37.86 0.41 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.691 -0.686 . . . . 70.0 110.622 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -51.75 -69.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.051 0.453 . . . . 54.52 111.143 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -175.63 110.34 0.26 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.596 -0.729 . . . . 74.11 109.545 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.607 ' HG3' ' HG2' ' A' ' 240' ' ' ARG . 51.8 Cg_endo -69.81 117.64 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.841 1.694 . . . . 64.32 111.121 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 319' ' ' ASN . 16.5 tp -108.56 82.15 1.57 Allowed 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.355 -0.609 . . . . 62.33 109.355 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -58.3 -36.43 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.333 -0.849 . . . . 70.11 110.977 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.15 -52.34 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 65.34 110.527 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.482 ' HB2' HD23 ' A' ' 316' ' ' LEU . 8.2 t30 -59.22 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 50.23 111.325 -176.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 3.3 mm? -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.498 -0.319 . . . . 62.21 111.426 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -69.53 -34.03 73.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.65 0.262 . . . . 63.22 110.869 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.5 -42.94 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 72.42 111.254 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -67.92 -27.33 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 120.887 -0.325 . . . . 65.12 111.039 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 73.1 mt -65.13 -47.46 77.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.077 -0.342 . . . . 72.33 110.077 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.12 -33.13 75.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.246 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -39.42 89.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 75.03 110.261 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.936 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.11 -45.02 94.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.004 -0.617 . . . . 34.34 112.088 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 331' ' ' ILE . 31.1 tp -65.2 -35.25 80.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.336 0.588 . . . . 74.1 110.041 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.29 -34.3 77.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.792 -0.64 . . . . 71.34 110.12 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.43 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 71.04 111.547 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . 13.1 tt -86.79 -2.76 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.413 0.625 . . . . 72.43 109.901 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 78.19 24.38 63.85 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.722 -0.672 . . . . 71.23 112.867 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 11.1 t -120.65 159.55 25.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.952 -0.388 . . . . 72.0 109.952 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -174.0 4.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.576 -0.527 . . . . 74.31 109.576 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 28.1 t70 -65.39 120.04 12.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.145 0.497 . . . . 71.05 111.076 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.26 100.79 7.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.68 . . . . 65.23 109.371 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . 0.53 ' C ' ' HD2' ' A' ' 338' ' ' LYS . . . 82.34 -81.05 1.73 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.821 -0.704 . . . . 75.21 111.493 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.692 ' HB2' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.534 0.344 0 N-CA-C 111.875 0.324 . . . . 70.11 111.875 177.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.93 ' HD2' HD11 ' A' ' 200' ' ' LEU . 11.1 tppt? . . . . . 0 N--CA 1.453 -0.285 0 CA-C-O 120.811 0.339 . . . . 74.14 110.696 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 52.4 m -156.83 150.9 24.97 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.42 -0.355 . . . . 72.43 110.114 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.747 HG23 ' HA ' ' A' ' 200' ' ' LEU . 12.9 pt -74.93 143.22 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.917 0.389 . . . . 71.11 111.984 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 97.9 3.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.593 -0.73 . . . . 62.23 110.428 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 58.9 pttt . . . . . 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 71.11 111.661 179.764 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' HA2' ' A' ' 40' ' ' GLY . 40.2 t . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.999 -0.371 . . . . 71.2 109.999 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.8 -0.14 57.74 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.961 -0.563 . . . . 52.22 113.192 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 39.4 tt0 -71.17 129.86 40.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.316 0.558 . . . . 74.34 110.097 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -77.44 130.46 36.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.435 0.636 . . . . 73.2 110.766 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -134.12 128.45 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.072 -0.967 . . . . 75.41 109.584 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 49.6 m -108.39 119.08 38.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.922 0.392 . . . . 64.12 110.35 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 116' ' ' SER . 5.7 p-10 -92.93 169.15 10.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 54.5 109.953 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 116' ' ' SER . 24.7 ptt? -71.96 -10.22 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.278 0.473 . . . . 71.14 112.278 -170.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.96 8.85 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.673 0.273 . . . . 55.2 110.601 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? 69.45 81.45 0.17 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.541 -0.754 . . . . 74.32 111.534 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' THR . 35.6 mtmm -152.99 135.95 15.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.009 -0.541 . . . . 72.3 109.966 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -105.55 89.23 3.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.985 -0.376 . . . . 71.53 109.985 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' ASN . 27.4 p-90 -116.19 160.15 20.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.872 0.368 . . . . 73.52 110.918 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.524 ' HB3' HD12 ' A' ' 28' ' ' ILE . 1.1 ptpm? -110.64 127.22 55.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.277 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.89 144.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.375 -0.602 . . . . 60.34 109.375 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -111.73 -121.12 4.0 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.481 -0.866 . . . . 43.2 113.198 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 92.2 mt -81.39 138.01 48.39 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 75.1 111.425 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.4 Cg_exo -74.39 108.07 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.056 2.504 . . . . 54.32 112.057 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 53' ' ' LEU . 45.2 mt -76.75 -47.57 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 62.5 109.842 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.53 -32.53 6.42 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.754 -0.657 . . . . 64.24 112.953 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.56 141.74 28.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.873 0.368 . . . . 75.22 110.516 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.08 62.33 0.14 Allowed Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.148 -0.781 . . . . 70.35 111.148 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.98 8.1 87.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.014 -0.612 . . . . 72.52 112.642 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 53.2 t80 -164.87 -73.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.919 -0.4 . . . . 64.13 109.919 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.58 157.7 7.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.952 -0.642 . . . . 71.44 112.064 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.4 m 63.19 38.13 10.78 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.04 0.448 . . . . 70.13 111.057 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' LYS . 2.1 mm -98.2 137.79 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 62.55 110.722 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -117.06 147.88 41.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.241 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' HD11 ' A' ' 43' ' ' ILE . 60.3 tp -85.95 152.94 22.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.086 -0.709 . . . . 63.43 109.086 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.56 31.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.735 -0.468 . . . . 33.42 109.735 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 23.2 t70 -83.81 -49.43 9.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.21 0.528 . . . . 75.04 110.233 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 54.6 ttp -162.13 135.3 6.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.914 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -97.63 -44.44 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.36 . . . . 72.52 110.11 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.5 t -100.89 120.11 39.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.365 -0.606 . . . . 74.3 109.365 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 C--O 1.234 0.253 0 N-CA-C 113.397 0.888 . . . . 53.45 113.397 -169.352 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.963 0.411 . . . . 73.4 109.961 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.78 44.79 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.154 2.569 . . . . 63.34 112.34 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 p -148.4 148.96 30.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.134 0.492 . . . . 71.05 111.697 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 132' ' ' ASP . 21.6 m -125.85 157.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.034 -0.728 . . . . 61.42 109.034 172.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.7 p -128.71 124.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.18 0.514 . . . . 75.12 111.169 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -87.44 132.82 33.87 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 72.31 108.968 173.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.7 129.29 74.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.425 -0.51 . . . . 60.53 112.023 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 80' ' ' LEU . 43.8 mt-10 -125.87 159.01 63.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 63.33 109.363 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.96 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.392 2.061 . . . . 55.43 112.608 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -66.68 -36.48 82.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.443 0.64 . . . . 61.54 109.525 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -88.87 73.92 8.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.103 -0.953 . . . . 75.01 109.227 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -81.25 177.38 9.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.729 -0.669 . . . . 64.03 110.399 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -130.05 -100.59 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.522 -0.847 . . . . 73.42 112.553 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.9 Cg_exo -61.91 -21.73 72.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.556 2.837 . . . . 74.12 113.307 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 46.0 tp -51.17 -34.94 33.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.678 0.621 . . . . 61.41 112.678 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 86.1 t80 -66.76 -44.65 80.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.531 -0.468 . . . . 74.51 110.553 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -68.24 -50.03 56.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.842 -0.617 . . . . 74.32 110.708 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 198' ' ' TYR . 9.1 pt-20 -64.58 -52.98 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.247 -0.888 . . . . 72.12 110.875 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 63.4 tp -59.93 -40.93 90.59 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 111.572 0.212 . . . . 55.41 111.572 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 3.3 tmtm? -60.95 -51.12 70.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.783 0.325 . . . . 64.04 110.612 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.8 -32.26 67.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.222 -0.591 . . . . 73.11 109.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 31.2 t80 -57.67 -45.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 51.52 109.795 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 28.3 mt-30 -61.33 -38.54 87.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.927 -0.579 . . . . 65.41 110.697 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HA ' ' HZ2' ' A' ' 92' ' ' LYS . 17.4 mtm180 -68.9 -28.08 66.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.832 -0.347 . . . . 71.44 111.902 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.89 -35.58 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.856 0.687 . . . . 34.41 112.856 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.2 80.13 7.67 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.415 0.894 . . . . 63.32 113.415 -169.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HZ2' ' HA ' ' A' ' 89' ' ' ARG . 5.4 mptt -139.61 129.57 14.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 108.983 -0.747 . . . . 70.22 108.983 168.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.99 -38.36 69.31 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.618 2.212 . . . . 64.54 111.849 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 98' ' ' LYS . 16.5 tt0 -64.69 -61.03 2.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 71.32 110.847 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.64 -34.22 77.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 73.44 111.511 -172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 100' ' ' ILE . 66.9 mt -64.71 -52.61 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.673 -0.24 . . . . 73.42 110.445 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.57 ' HA ' HD11 ' A' ' 100' ' ' ILE . 6.6 tp-100 -58.13 -36.69 73.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.323 0.582 . . . . 73.22 110.27 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 48.2 mtpt -67.98 -28.86 67.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 62.2 111.126 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.755 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 57.4 t90 -66.3 -56.26 12.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.611 -0.268 . . . . 74.42 110.792 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.07 -26.02 37.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 C-N-CA 120.685 -0.406 . . . . 74.34 111.422 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -66.22 -39.32 89.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.95 -0.3 . . . . 73.41 110.437 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.3 m -76.02 -48.98 18.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.353 -0.385 . . . . 62.3 111.738 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.31 57.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 72.23 109.651 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 1.028 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER 58.35 77.28 0.3 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.103 -0.953 . . . . 73.01 111.087 -174.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 100' ' ' ILE . 95.7 mt -136.7 -176.69 4.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.888 -1.051 . . . . 73.12 108.892 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -79.57 -70.22 0.53 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.643 0.258 . . . . 64.31 110.805 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.428 ' HA ' HG21 ' A' ' 100' ' ' ILE . 30.8 p90 -159.94 163.17 34.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 71.11 109.94 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HG ' ' CE3' ' A' ' 99' ' ' TRP . 0.9 OUTLIER -79.42 137.19 37.17 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.566 0.541 . . . . 65.42 111.356 -176.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.33 17.82 16.98 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 121.256 -0.497 . . . . 63.33 112.655 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 HD22 ' A' ' 108' ' ' LEU . 76.0 t -101.71 135.25 19.8 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.743 0.417 . . . . 75.04 110.372 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 28.3 Cg_endo -63.78 159.62 40.75 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.366 2.71 . . . . 50.35 114.269 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -81.38 154.67 26.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.101 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -99.97 116.51 32.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.515 -0.311 . . . . 75.41 110.355 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.598 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 41.1 m95 -100.88 -29.14 12.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.953 0.406 . . . . 75.13 110.546 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 158.32 -179.53 33.94 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.577 -0.821 . . . . 71.52 112.645 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.666 ' O ' ' HG2' ' A' ' 32' ' ' MET . 36.9 p -169.99 175.33 5.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.529 -0.915 . . . . 61.24 108.529 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.14 -150.93 19.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.477 -1.344 . . . . 60.55 113.293 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.1 tt -133.27 134.13 43.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.883 0.373 . . . . 73.24 110.522 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -126.54 108.63 11.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 29.4 t70 -79.09 150.58 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.299 0.571 . . . . 54.21 111.718 -172.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -133.05 52.44 2.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.725 -0.843 . . . . 64.25 108.725 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 67.17 75.84 0.3 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.895 -1.048 . . . . 44.14 111.168 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.25 -42.88 3.18 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.9 -0.591 . . . . 65.21 112.008 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -89.06 82.74 6.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.879 -0.786 . . . . 71.42 108.879 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.8 m -78.46 135.95 37.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.776 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -94.69 137.98 33.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.035 0.445 . . . . 73.13 110.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -112.77 120.36 41.23 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.64 -0.874 . . . . 72.45 108.64 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 42.1 p90 -133.94 162.71 31.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.421 0.526 . . . . 72.43 112.421 -170.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.3 ttm -129.87 131.49 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.719 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -102.68 122.93 55.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.273 0.558 . . . . 74.13 109.746 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ptm -133.83 -169.97 2.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.531 -0.759 . . . . 62.42 110.445 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.9 m-20 -64.24 169.71 4.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.864 0.364 . . . . 73.33 111.962 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.734 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -82.5 106.0 14.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.51 0.671 . . . . 74.14 111.978 -174.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -124.39 172.25 9.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 74.31 110.26 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.23 -38.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.841 . . . . 34.13 112.344 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 m -95.87 128.19 42.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.368 -0.234 . . . . 73.14 110.368 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -122.66 160.9 24.85 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.646 -0.501 . . . . 74.23 109.646 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 10.6 mp -75.8 -8.43 56.86 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.227 0.454 . . . . 75.02 112.227 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -73.67 -49.75 24.32 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.148 -0.686 . . . . 75.15 109.148 -179.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 13.5 pttm -76.86 -21.64 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.606 -0.438 . . . . 73.31 110.914 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 54.6 mt -74.12 -51.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.562 -0.29 . . . . 64.44 110.947 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.446 ' HE1' ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.76 -32.47 73.78 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.126 -0.23 . . . . 74.42 110.944 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.18 -43.31 82.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 63.22 110.137 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.71 -31.53 61.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 34.34 110.986 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.25 -2.59 58.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 75.52 110.912 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.97 38.04 22.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.472 -0.785 . . . . 72.14 112.511 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.652 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 74.1 mttt 62.17 73.12 0.48 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.433 0.531 . . . . 75.13 112.433 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -156.29 82.2 0.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.307 0.575 . . . . 73.04 109.729 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.49 141.34 29.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.604 -0.726 . . . . 51.32 111.141 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 144.09 57.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.77 -0.65 . . . . 75.12 109.852 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.525 ' HD2' HD13 ' A' ' 331' ' ' ILE . 13.1 ttm180 -63.24 -29.55 70.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.347 0.129 . . . . 71.05 111.347 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 333' ' ' SER . 57.3 mttp -57.6 -44.59 85.53 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.21 0.528 . . . . 72.44 110.071 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.53 ' O ' HD13 ' A' ' 157' ' ' LEU . 6.8 m -66.98 -41.32 87.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.38 -0.827 . . . . 74.15 110.577 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.52 -45.51 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 75.52 111.403 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.563 ' HG ' HD22 ' A' ' 328' ' ' LEU . 3.9 mm? -68.55 -37.69 80.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.506 -0.316 . . . . 74.24 111.356 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 52.3 tp60 -65.84 -39.62 90.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.181 0.515 . . . . 50.34 109.98 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.56 HD12 HG11 ' A' ' 193' ' ' VAL . 5.2 mp -63.19 -51.98 64.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.53 -0.759 . . . . 63.42 111.295 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.2 p -63.19 -34.98 78.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 73.33 111.178 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.25 -40.54 97.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 74.14 110.801 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.831 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -68.94 -43.22 75.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 65.42 111.204 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 42.5 mt -64.59 -29.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.149 -0.478 . . . . 74.51 109.845 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 317' ' ' TYR . 29.0 tp -63.1 -55.68 23.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.523 -0.762 . . . . 73.44 111.148 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.755 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 4.8 p-10 -67.93 -31.51 71.32 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.573 -0.451 . . . . 73.44 110.703 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 168' ' ' ILE . 70.5 mt -66.82 -46.82 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.41 -0.359 . . . . 65.32 111.041 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.3 pp -68.71 -33.81 74.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 64.31 110.086 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 165' ' ' LEU . 5.4 mm-40 -55.58 -56.31 21.82 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.323 -0.399 . . . . 61.23 110.362 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.39 -49.09 79.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 60.11 112.192 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.8 pt -75.01 -38.26 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.107 0.41 . . . . 62.45 112.107 -173.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.78 -21.0 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.11 0.481 . . . . 71.43 109.831 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 207' ' ' GLU . 31.8 tt0 -75.27 -6.0 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.478 -0.783 . . . . 70.33 110.302 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -124.44 -69.69 0.79 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.663 -0.415 . . . . 64.22 111.645 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 203' ' ' ARG . 35.6 mt-10 -155.48 -59.02 0.1 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.469 0.544 . . . . 74.42 112.469 -170.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.847 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 48.1 m-85 -83.71 147.78 27.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.12 0.785 . . . . 70.34 113.12 -166.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.486 HG22 ' HD2' ' A' ' 204' ' ' TYR . 16.9 m -132.26 164.03 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.981 -1.008 . . . . 70.41 108.924 171.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -105.35 131.2 53.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.738 -0.467 . . . . 73.13 109.738 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.31 -10.41 64.0 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.05 -1.22 . . . . 62.54 110.05 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 1.071 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 15.6 t70 -123.88 110.73 15.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.675 -0.763 . . . . 75.1 110.638 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.2 mm -111.86 66.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.416 -0.957 . . . . 74.24 108.416 166.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 79.9 tttt -90.54 161.77 15.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.886 -0.597 . . . . 75.44 109.882 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -57.6 -19.31 25.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 71.33 111.786 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 p -75.91 -12.07 60.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.522 -0.308 . . . . 35.2 111.488 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -82.5 -30.05 30.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.713 0.292 . . . . 51.34 110.646 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 6.4 mp -94.05 131.54 39.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 62.41 110.581 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 194' ' ' TYR . 1.1 pp -138.42 157.43 46.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 73.31 111.048 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.59 156.69 20.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 70.34 109.5 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.65 HD21 ' HE1' ' A' ' 194' ' ' TYR . 51.1 m-80 -63.51 152.15 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.709 -0.478 . . . . 74.51 109.709 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -56.5 -32.7 65.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.101 -0.499 . . . . 70.21 111.133 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.47 3.43 5.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.209 0.448 . . . . 74.35 112.209 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 186' ' ' ASN . 12.7 m120 -128.53 92.89 39.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.823 -0.351 . . . . 73.41 111.242 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -9.26 16.46 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.829 2.353 . . . . 72.4 111.258 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.13 -6.89 50.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 74.13 111.193 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.68 122.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.094 0.474 . . . . 71.0 110.573 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 157' ' ' LEU . 7.1 p -103.62 137.45 32.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.451 -0.795 . . . . 75.31 109.712 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.65 ' HE1' HD21 ' A' ' 186' ' ' ASN . 4.7 m-85 -114.09 158.17 21.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 182' ' ' ASN . 10.1 tt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.42 -0.956 . . . . 53.01 108.42 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 195' ' ' LEU . 7.2 p -50.79 130.49 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.528 0.68 . . . . 72.11 111.285 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.639 ' HB2' ' CD2' ' A' ' 198' ' ' TYR . 1.2 p-10 -58.25 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.627 -1.17 . . . . 75.41 112.684 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 197' ' ' ASP . 24.1 m-85 -135.21 26.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.953 -0.467 . . . . 71.31 111.796 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -64.13 -39.38 97.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.504 -0.855 . . . . 70.02 111.167 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.38 89.35 2.77 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.188 -0.671 . . . . 74.35 109.188 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -166.23 149.66 7.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 61.3 110.842 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -142.45 144.65 33.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.63 -0.507 . . . . 65.42 109.63 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.847 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 23.1 ptt180 -84.44 141.08 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 75.34 110.327 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.486 ' HD2' HG22 ' A' ' 174' ' ' VAL . 6.9 m-85 -139.23 -59.35 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 73.03 112.257 -171.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.95 121.75 41.0 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.548 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 103.38 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 62.14 111.791 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 170' ' ' GLU . 29.1 tt0 71.65 -11.38 0.74 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.754 0.821 . . . . 75.51 111.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.63 -30.79 1.94 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.359 -0.924 . . . . 70.22 113.165 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.72 122.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.24 0.543 . . . . 65.31 110.903 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -89.6 154.76 19.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.06 -0.518 . . . . 71.03 110.472 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 8.8 mtpm? -93.72 -175.11 3.65 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.021 -0.536 . . . . 51.14 110.159 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.4 mp0 -52.68 130.09 31.43 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.53 0.519 . . . . 73.31 110.664 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 49.2 p90 -65.37 129.13 38.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 74.32 110.609 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.404 ' NZ ' ' HB2' ' A' ' 212' ' ' GLU . 42.0 mmtm -98.08 -45.18 6.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.627 -0.715 . . . . 62.33 110.575 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 234' ' ' ASN . 50.4 mt-10 67.2 -5.13 0.75 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.134 0.79 . . . . 73.54 113.134 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 215' ' ' GLU . 6.0 t70 169.2 86.25 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 O-C-N 123.515 0.51 . . . . 73.44 110.033 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 61.3 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 C-N-CA 122.22 1.947 . . . . 73.25 111.973 174.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG22 ' A' ' 355' ' ' THR . 20.5 p-10 . . . . . 0 C--O 1.234 0.272 0 CA-C-O 120.508 0.194 . . . . 62.31 111.393 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 1.071 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -93.79 -149.49 25.38 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 74.41 113.775 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.504 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 69.3 p -81.26 150.14 28.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.661 0.267 . . . . 75.0 110.988 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.23 -31.33 47.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.708 -175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.594 ' HA ' HD21 ' A' ' 265' ' ' LEU . 2.4 mp0 -49.14 -50.93 35.2 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.456 -0.793 . . . . 63.22 111.184 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 179' ' ' LYS . 97.3 m-85 -101.92 -13.58 17.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 72.34 112.031 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 35.9 m -46.95 -49.58 20.42 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.385 0.428 . . . . 63.41 111.086 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.3 m 59.33 -156.02 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.853 -0.612 . . . . 74.32 110.888 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 230' ' ' ILE . 3.4 mp -71.75 -53.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.367 -0.378 . . . . 74.41 110.282 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 238' ' ' PRO . 1.6 m-20 -49.46 -60.56 2.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.514 -0.766 . . . . 61.32 112.991 -173.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.2 67.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.928 0.394 . . . . 50.33 111.795 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -67.82 -42.82 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.391 0.615 . . . . 74.22 109.863 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.856 ' HB3' ' HA ' ' A' ' 215' ' ' GLU . 6.4 m-20 -77.25 -4.53 45.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.17 . . . . 70.34 111.195 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.11 53.74 Favored Glycine 0 C--N 1.335 0.515 0 O-C-N 123.497 0.498 . . . . 53.42 112.56 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 7.4 p -120.25 140.98 42.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.584 0.23 . . . . 75.13 110.839 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.07 106.94 2.12 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.871 -0.789 . . . . 72.12 108.871 169.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.462 ' HB3' ' OD2' ' A' ' 231' ' ' ASP . 19.9 Cg_endo -61.07 -87.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.503 2.136 . . . . 71.24 112.826 -171.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 240' ' ' ARG . 20.7 m 171.13 -49.37 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.798 1.239 . . . . 70.31 107.736 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 239' ' ' SER . 0.0 OUTLIER 176.38 -16.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.818 -1.537 . . . . 70.3 107.76 -173.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.574 ' NH2' ' HD2' ' A' ' 279' ' ' ARG . 9.5 mmm180 -52.4 -68.0 0.21 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.334 -1.303 . . . . 73.42 110.984 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -45.55 -42.02 9.8 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 123.706 0.629 . . . . 75.2 113.711 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.02 -64.99 0.64 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.769 0.795 . . . . 74.14 110.207 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.442 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 36.2 mt -74.06 -30.46 62.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.78 -1.1 . . . . 74.11 111.198 -174.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 279' ' ' ARG . 7.8 tp10 -62.21 -57.91 9.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.42 110.274 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.74 -41.29 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 75.24 110.341 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.89 -41.63 82.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.051 0.453 . . . . 71.24 110.816 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -43.76 98.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.07 -0.586 . . . . 24.41 112.203 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -63.07 -34.53 77.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.668 0.27 . . . . 72.32 110.896 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 57.9 m -62.0 -51.79 66.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.014 0.435 . . . . 71.54 110.525 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 76.3 mtm -61.45 -42.02 98.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.862 -0.608 . . . . 64.01 111.866 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.59 -34.33 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.392 -0.523 . . . . 74.32 110.974 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.27 -40.33 71.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 71.4 110.231 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.07 -28.46 67.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.246 -0.434 . . . . 74.53 111.247 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.8 tp -92.34 -40.04 11.14 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.174 0.435 . . . . 73.23 112.174 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 m -100.14 -17.63 17.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.509 . . . . 71.13 111.25 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.652 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 85.69 -59.74 4.74 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.759 -0.734 . . . . 62.32 112.545 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -113.8 141.76 46.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.336 -0.508 . . . . 71.21 109.924 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 85.6 mt -103.16 142.08 23.83 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.69 . . . . 71.22 110.098 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 278' ' ' TYR . 15.2 Cg_exo -68.84 -2.3 9.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.807 2.338 . . . . 74.22 112.967 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 36.4 p90 -124.3 5.6 8.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 73.01 110.21 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 34.1 tt0 -72.31 -21.63 61.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 71.55 111.048 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.92 -20.18 33.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.451 . . . . 54.22 109.976 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 89.2 m-20 -96.15 7.12 47.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.78 -0.646 . . . . 64.32 110.465 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.9 tm? -64.39 -20.84 66.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.472 -0.785 . . . . 74.55 110.519 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -73.35 -1.6 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 74.25 112.337 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 271' ' ' VAL . 20.8 t70 -137.28 120.87 11.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 121.073 -0.251 . . . . 73.34 110.958 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 34.8 Cg_exo -58.12 -29.73 88.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.307 2.671 . . . . 50.23 113.505 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.42 -41.71 38.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.805 0.336 . . . . 75.22 110.245 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 24.3 m-85 -64.63 -40.92 96.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.715 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 267' ' ' ASP . 89.8 t -54.16 -49.33 62.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 123.125 0.265 . . . . 71.25 110.975 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 276' ' ' ILE . 45.3 mtm180 -62.4 -59.05 5.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.631 -0.259 . . . . 63.34 111.115 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.0 -47.96 79.59 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.486 0.491 . . . . 73.35 111.629 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.8 m -58.53 -50.54 73.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.479 -0.328 . . . . 75.24 110.53 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.39 -32.92 73.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.654 -0.248 . . . . 73.25 111.229 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 272' ' ' ARG . 82.8 mt -64.15 -42.41 95.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 55.1 110.216 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 280' ' ' GLU . 11.0 mmp_? -62.0 -41.64 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 71.24 111.053 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 260' ' ' PRO . 73.3 m-85 -74.08 -43.27 58.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 73.02 110.904 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.574 ' HD2' ' NH2' ' A' ' 241' ' ' ARG . 34.3 ttp180 -65.38 -20.02 66.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.355 0.597 . . . . 62.13 110.708 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 277' ' ' ARG . 36.6 tt0 -60.53 -47.91 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.164 -0.925 . . . . 75.13 110.761 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -159.2 94.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.299 0.571 . . . . 74.32 110.41 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 303' ' ' MET . 0.2 OUTLIER -80.67 -29.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.598 -0.728 . . . . 73.3 111.921 -177.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.41 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -52.53 -48.36 66.11 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.522 0.564 . . . . 74.44 112.522 -168.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.9 m -69.53 -38.11 77.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.96 0.409 . . . . 75.24 111.666 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.417 HD13 ' HD1' ' A' ' 278' ' ' TYR . 76.5 mt -72.7 -48.2 40.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.067 -0.515 . . . . 74.4 111.321 -172.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.455 ' SD ' ' HB ' ' A' ' 282' ' ' ILE . 1.3 mpt? -61.24 -40.56 94.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.348 . . . . 71.43 110.765 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.21 -28.16 69.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.896 -0.593 . . . . 74.1 111.224 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -75.36 -43.64 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 72.22 110.774 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.11 -41.89 99.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.89 -0.595 . . . . 74.33 111.472 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.428 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 47.2 m-85 -123.15 82.2 51.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.56 -0.291 . . . . 74.11 110.953 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.62 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.288 1.992 . . . . 64.33 112.045 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.05 -9.0 28.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.338 0.59 . . . . 71.02 109.993 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -74.82 -36.13 62.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.006 -174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -173.66 -165.98 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 65.43 108.632 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.4 ptmm? -120.88 114.27 32.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 65.54 111.51 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 290' ' ' PHE . 42.2 Cg_endo -105.23 37.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.675 2.917 . . . . 75.54 112.163 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -79.5 -50.87 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.847 -0.692 . . . . 72.42 113.068 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.463 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.1 pm0 -64.17 -36.94 85.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.911 0.386 . . . . 74.41 110.864 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.64 -48.37 72.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 74.15 110.773 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.9 -35.73 79.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 75.44 110.375 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 49.7 tptt -70.95 -42.11 70.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 74.24 110.076 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.515 ' O ' HG13 ' A' ' 306' ' ' VAL . 82.7 t80 -56.19 -49.22 74.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.528 -0.76 . . . . 73.12 110.536 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.751 ' HB2' HG13 ' A' ' 282' ' ' ILE . 79.1 mtp -72.69 -31.38 64.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 74.25 111.235 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 37.1 tt0 -62.06 -42.23 98.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.774 0.797 . . . . 64.4 109.056 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 86.8 m -60.56 -45.98 91.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.634 -1.166 . . . . 71.3 111.211 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 9.8 m -73.03 -33.79 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 121.028 -0.269 . . . . 75.24 111.712 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -72.75 -24.63 60.99 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.816 -0.439 . . . . 74.13 109.816 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.16 -12.04 60.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.882 -0.599 . . . . 73.32 110.816 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 96.6 mt -81.12 8.25 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 73.35 111.401 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.47 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.357 0.663 . . . . 74.32 112.209 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.89 -50.72 0.71 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.514 -0.921 . . . . 64.42 108.514 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 17.3 m -136.64 67.66 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.514 -0.766 . . . . 72.33 110.349 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 13.0 tp10 -104.46 161.28 14.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 62.42 109.608 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.25 110.14 5.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 74.42 111.205 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.29 121.6 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.863 2.375 . . . . 70.42 113.034 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.3 mt -93.79 92.86 7.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.523 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' A' ' 320' ' ' LEU . 12.7 m-85 -63.76 -32.14 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 74.13 111.013 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 321' ' ' ARG . 21.7 mp0 -57.11 -46.45 82.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 74.34 110.14 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -68.13 -37.01 80.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 64.02 110.472 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 317' ' ' TYR . 96.2 mt -60.27 -52.29 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 73.35 110.919 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 318' ' ' GLU . 6.6 ptp180 -66.85 -28.39 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 75.01 109.739 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.39 -51.78 58.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 53.42 111.122 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -69.46 -30.04 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 121.063 -0.255 . . . . 74.54 111.24 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.47 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.1 mt -67.83 -48.54 65.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 73.14 110.344 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.61 -29.73 69.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 72.3 110.755 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -48.02 82.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.188 -0.671 . . . . 62.14 109.188 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.463 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.85 -38.51 94.38 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.893 -0.67 . . . . 62.24 112.749 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 333' ' ' SER . 41.7 tp -66.5 -41.96 88.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.172 0.511 . . . . 73.13 110.561 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.54 -25.88 60.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.98 -0.554 . . . . 62.24 110.544 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.07 83.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 75.42 110.587 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.525 HD13 ' HD2' ' A' ' 151' ' ' ARG . 47.0 pt -89.35 7.29 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 73.43 110.647 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 73.34 25.33 73.19 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.005 -0.543 . . . . 55.54 113.424 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.581 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 59.4 m -112.29 139.36 47.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.875 0.369 . . . . 73.53 111.494 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -136.61 -66.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 74.42 110.084 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.22 147.36 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.943 0.402 . . . . 75.42 110.299 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.46 -39.89 5.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.932 -0.576 . . . . 74.14 109.789 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.61 -31.16 1.67 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.008 -0.615 . . . . 55.52 112.626 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.653 ' NZ ' ' HB3' ' A' ' 338' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.467 0.419 0 N-CA-C 112.573 0.582 . . . . 62.35 112.573 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 353' ' ' THR . 37.4 mmtm . . . . . 0 CA--C 1.533 0.326 0 N-CA-C 109.881 -0.415 . . . . 71.12 109.881 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 352' ' ' LYS . 8.7 t -157.03 172.52 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -67.24 142.88 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.791 0.329 . . . . 73.03 110.404 177.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 222' ' ' ASP . 14.5 t -98.02 135.03 40.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.671 -0.863 . . . . 74.21 108.671 176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt . . . . . 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 71.11 109.986 -174.676 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.488 HG13 ' HA2' ' A' ' 40' ' ' GLY . 92.0 t . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 120.775 0.321 . . . . 65.34 110.7 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.47 -15.61 57.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.203 -0.522 . . . . 63.11 114.363 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.1 mm-40 -63.47 129.06 38.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.799 0.799 . . . . 70.22 109.737 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.707 HG22 ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -95.2 131.43 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.626 . . . . 55.33 111.993 -174.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 38.9 pt -96.91 150.13 4.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.437 -0.801 . . . . 61.12 109.213 171.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HZ ' ' A' ' 128' ' ' PHE . 6.8 m -105.63 113.24 26.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.534 -0.303 . . . . 54.24 111.225 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.6 t70 -65.13 152.1 44.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 55.23 109.658 175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.4 tpt -67.35 -18.85 65.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.476 . . . . 73.15 111.454 -174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.31 17.45 20.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.099 -0.5 . . . . 74.23 110.639 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 68.81 84.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.406 0.682 . . . . 74.41 111.373 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 41.1 mtmt -152.57 131.94 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 51.15 109.371 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 56' ' ' MET . 3.4 mp0 -89.06 127.74 35.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.737 0.303 . . . . 74.43 110.738 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 74.5 m95 -125.25 117.73 24.45 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.555 -0.535 . . . . 70.22 109.555 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.707 ' HG2' HG22 ' A' ' 28' ' ' ILE . 22.0 mtmm -78.75 130.75 36.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.572 -0.451 . . . . 75.42 109.88 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.62 HG23 ' CD2' ' A' ' 52' ' ' TYR . 3.2 p -67.38 117.5 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.166 -0.47 . . . . 63.02 110.431 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -90.51 -128.93 3.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.845 -0.693 . . . . 50.32 111.841 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.4 mt -86.81 137.62 33.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.721 -0.282 . . . . 70.23 111.049 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.71 102.69 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.824 2.349 . . . . 51.31 110.331 171.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mt -86.98 -70.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.903 -0.589 . . . . 74.11 110.697 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 112.25 165.7 17.3 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.667 -0.778 . . . . 72.54 111.78 -176.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.893 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 2.2 tt0 -131.91 166.17 22.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.41 -0.589 . . . . 54.14 109.41 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' OD2' ' A' ' 137' ' ' ASP . . . -82.82 42.61 2.98 Favored Glycine 0 C--O 1.232 -0.026 0 C-N-CA 121.511 -0.376 . . . . 62.31 112.959 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 352' ' ' LYS . . . 179.11 -75.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 109.999 -1.241 . . . . 61.42 109.999 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.512 ' HZ ' ' HA ' ' A' ' 353' ' ' THR . 24.1 m-85 -96.64 83.45 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 62.53 109.586 168.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.893 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -68.95 -158.38 1.5 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.901 -0.59 . . . . 74.35 113.608 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 72.2 m 70.77 30.99 2.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.296 0.569 . . . . 70.4 110.806 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 45' ' ' GLN . 4.2 mm -93.88 122.0 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.307 -0.627 . . . . 74.53 109.307 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.764 ' HE1' ' HB ' ' A' ' 72' ' ' VAL . 28.3 p90 -108.2 150.43 27.26 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.154 -0.618 . . . . 72.51 110.879 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.9 tt -68.97 134.17 49.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.363 -0.835 . . . . 75.23 110.512 -176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 70' ' ' VAL . . . -95.68 102.92 14.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.083 -0.508 . . . . 64.03 109.959 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.37 -35.9 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 71.51 111.251 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.823 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 13.9 tmm? 66.17 -73.92 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.236 -0.654 . . . . 62.12 109.236 -172.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.14 140.71 13.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.931 -0.766 . . . . 63.15 108.931 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -81.72 49.6 1.37 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.359 0.6 . . . . 44.34 110.624 -173.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m . . . . . 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 75.43 109.951 -179.87 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.231 0 N-CA-C 109.263 -0.643 . . . . 72.52 109.263 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -80.29 32.18 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.293 2.662 . . . . 74.33 113.593 -169.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.2 p -127.52 136.69 52.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.529 0.681 . . . . 63.44 111.226 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 m -141.99 162.38 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.343 -0.844 . . . . 71.31 109.282 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -132.78 126.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.676 0.75 . . . . 51.12 111.421 -179.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 48' ' ' PHE . 60.8 tttm -87.5 127.22 35.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.702 -1.136 . . . . 75.43 109.171 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.764 ' HB ' ' HE1' ' A' ' 52' ' ' TYR . 11.9 p -116.42 135.6 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.014 0.435 . . . . 55.4 111.573 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 49.2 mm-40 -142.36 143.4 26.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.524 -0.762 . . . . 74.31 109.072 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 77' ' ' ASN . 37.6 Cg_exo -60.49 133.01 46.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.52 1.48 . . . . 75.32 109.978 170.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -60.09 -30.39 69.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.788 0.328 . . . . 75.32 110.896 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.74 24.22 10.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 63.54 111.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 74' ' ' PRO . 63.3 t30 -85.98 -50.19 7.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.913 0.387 . . . . 73.0 110.223 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.85 -77.67 0.24 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.378 -0.915 . . . . 52.15 113.65 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.95 -43.31 59.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.268 2.645 . . . . 34.34 114.295 -169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.01 -29.93 67.62 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 111.957 0.354 . . . . 73.44 111.957 -171.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -66.02 -50.76 63.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.429 -0.508 . . . . 73.41 110.504 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 m -69.06 -40.18 78.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.489 0.662 . . . . 71.45 110.005 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.73 -53.71 54.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.803 -1.089 . . . . 72.13 111.074 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 80' ' ' LEU . 51.7 tp -66.24 -33.03 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 72.52 111.074 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.474 ' HE3' ' OH ' ' A' ' 173' ' ' TYR . 64.8 tttp -60.01 -47.34 86.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.011 0.434 . . . . 75.14 110.096 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 173' ' ' TYR . 59.0 t80 -71.19 -41.62 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.361 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -57.32 -50.23 73.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 63.43 110.838 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -24.41 63.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.109 0.48 . . . . 74.1 110.533 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -69.7 -39.16 77.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 71.24 111.597 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.44 -34.09 7.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.228 0.825 . . . . 75.22 113.228 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 113' ' ' TYR . . . -85.77 100.39 12.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.548 0.689 . . . . 73.14 111.819 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -166.75 100.41 0.66 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.388 -0.968 . . . . 71.24 108.388 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -43.07 -45.33 9.43 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.78 2.987 . . . . 74.35 114.042 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.74 -49.68 74.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.36 -0.382 . . . . 74.32 110.959 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.47 -38.74 87.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.621 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 100' ' ' ILE . 81.0 mt -58.13 -53.29 47.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.727 -0.669 . . . . 74.34 110.879 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -62.1 -40.78 97.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.515 -0.311 . . . . 74.52 111.248 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -57.06 -48.98 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.341 -0.39 . . . . 64.24 110.877 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.565 ' CE2' ' HG3' ' A' ' 103' ' ' ARG . 66.0 t-105 -65.24 -49.01 71.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 74.33 110.711 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 96' ' ' ILE . 94.4 mt -53.52 -51.29 43.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.137 0.494 . . . . 75.4 111.519 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -73.72 -31.21 63.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.51 -0.768 . . . . 73.42 111.226 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.3 m -76.17 -40.09 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.02 0.438 . . . . 54.14 111.238 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 11.1 mmm180 -91.8 10.0 30.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 72.55 111.915 -173.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.7 mmpt? 63.58 27.25 14.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 74.3 111.617 173.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 163' ' ' ASP . 97.7 mt -89.11 178.36 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.977 0.418 . . . . 65.23 111.438 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -83.32 -66.95 0.83 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.964 -0.754 . . . . 73.13 108.964 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HA ' ' CD1' ' A' ' 100' ' ' ILE . 18.7 p90 179.87 133.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.728 -1.124 . . . . 74.32 109.541 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -78.74 116.14 18.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.54 -0.541 . . . . 74.3 109.54 177.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.93 72.19 1.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.749 -0.659 . . . . 74.42 112.904 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 111' ' ' PRO . 67.4 t -101.99 140.33 21.09 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.755 -0.831 . . . . 64.54 108.755 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 110' ' ' VAL . 1.3 Cg_endo -44.88 134.33 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.199 2.599 . . . . 73.11 112.443 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 21.4 tptm -65.4 106.23 1.34 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 73.11 110.693 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 35.1 t80 -79.85 113.8 18.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.726 -1.125 . . . . 74.4 111.184 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 130' ' ' ILE . 15.0 m95 -97.94 -36.23 10.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.467 -0.938 . . . . 75.33 108.467 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.49 178.25 48.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.724 -1.125 . . . . 64.43 111.115 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 32' ' ' MET . 14.9 p -172.68 165.42 5.42 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.481 -0.563 . . . . 71.4 109.481 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.09 -173.81 46.09 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.92 -1.134 . . . . 53.34 113.103 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.8 tt -134.93 128.68 32.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.44 -0.948 . . . . 75.31 108.44 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -140.89 125.62 18.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 73.55 110.566 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.24 123.92 26.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 64.34 110.098 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -87.93 -56.97 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.222 -0.444 . . . . 70.32 110.277 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.05 79.93 0.77 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.288 -0.634 . . . . 73.35 109.288 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.19 33.52 85.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.169 -0.773 . . . . 73.4 111.169 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.449 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 13.6 tppt? -158.91 105.0 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.498 -0.556 . . . . 74.53 109.498 -174.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.491 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.3 m -78.85 108.73 12.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.038 0.447 . . . . 64.15 111.07 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -92.05 131.75 37.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.053 -0.521 . . . . 73.43 110.555 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.466 ' HE ' HD23 ' A' ' 84' ' ' LEU . 10.0 ttt180 -113.24 117.15 31.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.507 -0.923 . . . . 72.54 108.507 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HZ ' ' O ' ' A' ' 30' ' ' THR . 49.0 p90 -133.44 161.62 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.068 0.461 . . . . 73.22 112.057 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.4 ptp -139.46 141.65 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 53.43 110.55 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.779 HD13 ' HB ' ' A' ' 70' ' ' VAL . 11.2 mm -98.31 118.56 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.142 0.496 . . . . 63.32 110.312 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 21.6 ptm -127.72 163.68 23.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.674 -0.694 . . . . 71.25 110.509 -175.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.89 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.9 t70 -70.35 156.85 38.75 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.718 -0.475 . . . . 71.52 109.718 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 133' ' ' ARG . 22.3 tpt180 -82.81 108.52 16.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.388 0.614 . . . . 74.44 111.31 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 17.0 m-85 -103.26 142.27 34.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.062 -1.088 . . . . 75.41 108.062 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.29 -4.38 3.23 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 119.583 -1.294 . . . . 65.54 113.453 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.928 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.4 m -120.59 124.49 45.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.844 0.354 . . . . 75.34 110.295 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.828 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 3.9 m-20 -90.53 134.99 33.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.022 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 36.9 tp -61.83 -36.61 81.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.951 -0.759 . . . . 64.24 108.951 172.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.828 ' HG3' ' HB3' ' A' ' 137' ' ' ASP . 1.4 pp0? -64.64 -28.15 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 72.34 111.547 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 58.2 mttp -72.52 -39.82 67.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.837 -0.345 . . . . 71.04 110.629 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.28 -36.9 44.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.515 0.674 . . . . 74.54 109.337 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 139' ' ' GLN . 28.6 t80 -55.19 -54.27 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.738 -1.119 . . . . 74.4 111.202 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.97 -33.87 61.94 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.755 -0.378 . . . . 61.31 111.235 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.79 -32.76 72.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.945 0.35 . . . . 60.54 111.945 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -105.1 8.68 34.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 75.42 110.614 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.11 48.52 17.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.805 -0.634 . . . . 75.1 111.319 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.699 ' HG3' HE22 ' A' ' 253' ' ' GLN . 0.0 OUTLIER 43.67 77.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.818 1.247 . . . . 71.14 113.749 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.63 102.97 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.751 -0.659 . . . . 74.23 109.269 168.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.691 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 65.9 m-85 -108.76 156.1 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.996 -0.547 . . . . 70.13 109.884 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -70.59 156.88 38.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.319 -0.4 . . . . 74.01 110.585 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.6 ' HG2' HD13 ' A' ' 331' ' ' ILE . 25.0 tpt180 -45.99 -57.28 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.547 -0.752 . . . . 73.35 112.144 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -67.27 -28.1 67.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 75.0 111.514 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 m -70.94 -45.19 64.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.442 -0.345 . . . . 61.02 110.571 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.84 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 53.43 110.585 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 324' ' ' LEU . 0.2 OUTLIER -65.02 -42.87 93.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 72.52 110.325 -178.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -55.21 -52.57 62.93 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.773 -0.454 . . . . 72.43 109.773 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.24 -50.65 73.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.936 -0.575 . . . . 65.24 111.125 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.452 ' HA ' HD12 ' A' ' 161' ' ' ILE . 32.1 t -57.93 -38.05 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 55.35 111.241 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.81 -40.86 75.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.856 -0.424 . . . . 64.21 109.856 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.593 ' HA ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -67.42 -31.4 71.58 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.787 0.803 . . . . 63.22 110.307 -178.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 158' ' ' SER . 58.4 mt -67.92 -35.14 71.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.591 -0.731 . . . . 71.15 109.695 174.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 43.4 tp -63.84 -40.48 96.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 55.22 110.088 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.593 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.4 m-20 -53.34 -59.52 4.47 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.491 0.663 . . . . 65.13 110.895 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -67.11 -37.35 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.856 -0.611 . . . . 65.01 111.101 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.66 -37.94 89.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.72 0.295 . . . . 74.2 110.296 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -56.09 -58.81 6.34 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.87 -0.605 . . . . 74.12 109.46 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.5 -48.98 73.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.859 -1.064 . . . . 74.22 112.572 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 164' ' ' ILE . 39.7 pt -84.19 -36.52 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.605 0.594 . . . . 63.23 112.605 -170.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -82.34 -26.17 33.21 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 71.35 112.144 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.37 -18.46 64.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.75 -0.78 . . . . 65.21 110.048 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.9 -74.75 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 70.22 112.346 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -135.86 -68.71 0.5 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.145 0.794 . . . . 74.52 113.145 -167.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 79.6 m-85 -84.99 167.26 16.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.488 0.922 . . . . 72.32 113.488 -161.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 238' ' ' PRO . 27.4 m -142.21 172.18 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.065 -1.425 . . . . 71.13 109.48 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -158.64 96.21 1.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.612 -0.514 . . . . 72.43 109.612 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -67.49 -33.61 82.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.116 -0.564 . . . . 74.52 112.389 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.544 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 20.6 t70 -74.57 91.56 2.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.141 0.496 . . . . 74.34 111.315 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.04 67.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.038 0.923 . . . . 70.5 108.955 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.432 ' HZ2' ' HB2' ' A' ' 179' ' ' LYS . 3.7 ttmp? -88.27 139.14 30.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.99 -1.005 . . . . 60.42 109.222 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -56.17 -16.68 5.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.314 0.487 . . . . 75.13 112.314 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' A' ' 139' ' ' GLN . 29.8 t -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.331 -0.395 . . . . 72.11 111.431 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.436 ' O ' HD12 ' A' ' 195' ' ' LEU . 84.5 m-20 -92.21 -11.74 34.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.724 0.297 . . . . 75.42 111.584 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 184' ' ' LEU . 6.4 mp -100.49 119.47 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 74.5 110.493 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.4 mm? -119.03 140.59 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.682 -0.69 . . . . 73.43 110.61 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 69.2 mt -97.87 142.82 29.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.989 -0.55 . . . . 74.11 110.339 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.642 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -61.48 136.75 58.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.981 -0.554 . . . . 75.53 110.042 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -56.17 -31.27 63.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.832 0.348 . . . . 62.22 111.627 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.7 ' HA ' ' HE3' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -90.97 -22.58 20.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.959 0.355 . . . . 64.32 111.959 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -138.42 110.21 8.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 111.888 0.329 . . . . 64.41 111.888 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.57 -12.94 32.14 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.73 2.286 . . . . 73.32 111.252 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -90.49 7.39 39.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.369 -0.832 . . . . 44.1 111.153 -177.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 16.7 mm-40 -121.84 106.78 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.431 . . . . 62.13 110.76 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.2 122.11 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 75.33 110.813 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -114.75 157.44 23.2 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.866 -0.606 . . . . 75.24 109.922 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 182' ' ' ASN . 34.1 tp -107.53 103.3 12.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.222 -0.658 . . . . 73.05 109.222 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 184' ' ' LEU . 32.7 m -120.77 -167.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.497 -0.319 . . . . 62.14 110.487 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.2 m-20 70.66 -62.13 0.45 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.816 0.698 . . . . 63.53 110.674 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 60.98 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 74.02 111.654 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 354' ' ' ILE . . . 68.46 -68.34 0.39 Allowed Glycine 0 N--CA 1.447 -0.63 0 O-C-N 123.415 0.447 . . . . 74.54 112.088 -174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 353' ' ' THR . 2.4 mp -88.26 81.07 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.856 0.36 . . . . 73.42 110.145 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.73 98.02 5.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.144 0.497 . . . . 73.34 110.01 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -164.11 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.365 -0.976 . . . . 73.54 108.365 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 9.3 ptp180 -137.75 150.62 47.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.559 -0.456 . . . . 62.34 111.426 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -83.1 -36.74 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.583 -0.735 . . . . 75.41 110.412 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 6.6 p -134.82 129.64 19.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.198 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 9.9 Cg_exo -71.49 100.71 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.943 2.429 . . . . 65.03 111.094 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 71.06 -62.57 0.45 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.456 0.702 . . . . 73.21 112.053 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.7 -36.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.791 . . . . 74.22 112.963 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 26.6 m -60.87 132.4 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.443 . . . . 71.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.32 138.16 37.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.136 -0.483 . . . . 73.23 109.857 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 211' ' ' LYS . 12.6 tptm -108.33 172.63 6.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.131 0.491 . . . . 75.15 112.311 -167.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -90.96 174.19 7.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.505 -0.771 . . . . 70.21 111.019 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -73.19 6.27 2.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.972 0.731 . . . . 73.4 112.972 -168.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -166.5 96.78 0.57 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.71 -0.619 . . . . 71.3 110.633 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.455 ' OE1' ' HG2' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -136.24 -4.14 2.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.377 -0.829 . . . . 64.43 110.859 178.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 217' ' ' PRO . 10.6 t70 -79.05 148.01 70.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.823 -0.626 . . . . 65.13 110.774 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.489 ' HD2' ' OD1' ' A' ' 216' ' ' ASP . 69.6 Cg_exo . . . . . 0 N--CA 1.481 0.758 0 C-N-CA 124.32 3.347 . . . . 60.13 114.928 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 30.4 t70 . . . . . 0 N--CA 1.47 0.561 0 CA-C-O 121.595 0.712 . . . . 72.55 111.785 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . 110.52 174.82 20.49 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.723 -0.751 . . . . 61.34 112.459 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.39 141.63 43.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.669 0.271 . . . . 70.01 110.622 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 271' ' ' VAL . 15.4 tt -58.36 -17.06 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.355 0.598 . . . . 73.35 111.323 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -50.49 -55.52 15.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.921 -1.036 . . . . 74.31 111.603 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.577 ' O ' HG12 ' A' ' 246' ' ' ILE . 38.9 m-85 -111.24 -28.11 8.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.071 0.767 . . . . 70.15 113.071 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.8 t -64.98 -6.4 8.44 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.758 0.651 . . . . 71.54 112.758 -169.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.781 ' HA ' ' HE2' ' A' ' 275' ' ' LYS . 23.0 t 65.0 -169.85 0.2 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.138 0.494 . . . . 73.35 111.393 176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 234' ' ' ASN . 15.3 pt -73.34 -34.35 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.795 -0.639 . . . . 73.31 111.684 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' O ' HG12 ' A' ' 236' ' ' VAL . 11.7 t70 -53.82 -74.88 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.827 -170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.78 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 70.44 111.616 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -62.7 -27.53 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.603 -0.271 . . . . 70.15 111.62 -177.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 0.0 OUTLIER -78.41 -28.81 46.93 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.859 0.318 . . . . 54.4 111.859 -175.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 216' ' ' ASP . . . 112.37 45.65 0.78 Allowed Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.346 -0.931 . . . . 63.55 112.848 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 231' ' ' ASP . 15.0 p -123.44 143.27 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.0 -0.741 . . . . 72.32 109.0 171.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -53.25 110.72 2.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.676 -0.861 . . . . 73.34 108.676 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.507 ' HG2' HG21 ' A' ' 174' ' ' VAL . 69.6 Cg_exo -41.97 115.18 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.772 2.981 . . . . 75.54 113.561 -169.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 93.9 p -90.83 -175.54 4.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.248 -0.887 . . . . 71.35 111.163 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.878 ' HG2' ' HB3' ' A' ' 315' ' ' PRO . 9.8 mtm-85 -53.94 -36.69 63.06 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.534 -0.757 . . . . 71.25 111.248 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.481 HH22 ' HD2' ' A' ' 279' ' ' ARG . 12.3 mtp180 -66.27 -33.56 76.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.797 -0.638 . . . . 75.4 110.498 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.41 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -57.43 -65.1 3.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.881 -0.676 . . . . 70.3 111.84 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.16 -48.1 71.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.34 0.59 . . . . 70.2 110.758 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.678 ' HG ' HD21 ' A' ' 320' ' ' LEU . 9.2 mp -67.95 -46.02 72.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.169 -0.923 . . . . 75.22 112.045 -173.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -64.43 -47.08 80.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.611 -0.435 . . . . 70.44 110.789 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 227' ' ' PHE . 76.0 mt -61.45 -40.11 85.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.347 -0.388 . . . . 65.53 111.425 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 251' ' ' MET . 37.9 tp -64.23 -45.12 89.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 75.53 110.217 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.64 95.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.906 -0.664 . . . . 74.23 112.081 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 14.8 m-30 -56.26 -45.84 79.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.782 0.325 . . . . 73.04 110.812 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.82 -35.22 78.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 73.14 110.892 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 83.8 mtp -59.47 -54.54 45.47 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.737 0.303 . . . . 75.25 110.988 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.6 tt -67.8 -32.06 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 74.53 110.45 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.699 HE22 ' HG3' ' A' ' 147' ' ' LYS . 9.5 tm0? -61.58 -53.59 54.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 74.22 110.364 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.691 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.8 m0 -69.45 -26.42 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 75.3 111.662 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.547 HD11 HD21 ' A' ' 294' ' ' ASN . 33.4 tp -83.87 -36.22 23.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.203 0.446 . . . . 74.13 112.203 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.5 p -103.49 -27.4 12.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.688 -0.405 . . . . 61.21 112.058 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 98.79 -1.35 58.09 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.429 -0.891 . . . . 63.0 113.272 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -148.12 163.16 37.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.178 0.513 . . . . 74.04 111.691 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.664 ' HG ' ' HG2' ' A' ' 253' ' ' GLN . 60.2 mt -111.87 142.48 26.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.649 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.47 -25.68 59.38 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.615 2.21 . . . . 64.52 112.601 177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.446 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 48.0 p90 -111.65 18.94 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.353 -0.385 . . . . 73.43 110.771 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 35.3 tt0 -66.03 -44.5 84.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.551 . . . . 72.21 110.467 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.96 -6.72 55.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.97 0.891 . . . . 70.23 109.552 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -104.62 0.8 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.097 -0.956 . . . . 74.22 111.227 -177.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 261' ' ' TRP . 80.5 mt -71.33 -6.9 43.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.12 0.486 . . . . 55.23 110.885 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -60.91 -33.4 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.483 -0.781 . . . . 44.24 111.332 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.734 ' HB2' ' CD1' ' A' ' 270' ' ' TYR . 7.8 m-20 -145.33 145.82 27.89 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-O 120.541 0.21 . . . . 34.14 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 25.3 Cg_endo -62.92 -28.09 75.09 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.61 2.207 . . . . 53.31 112.002 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -42.49 96.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.202 0.525 . . . . 73.13 109.719 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.734 ' CD1' ' HB2' ' A' ' 267' ' ' ASP . 9.5 m-85 -66.67 -45.33 79.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.554 -0.748 . . . . 74.31 111.31 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 225' ' ' ILE . 20.3 m -65.03 -29.16 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.535 -0.302 . . . . 60.25 111.225 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 33.7 mtm180 -60.62 -58.61 7.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.096 -0.705 . . . . 75.32 109.096 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -52.26 -50.55 61.87 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.859 -1.064 . . . . 63.42 111.018 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 50.3 m -59.6 -50.33 74.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 72.13 111.463 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 59.7 mttp -66.36 -44.49 83.06 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.879 -0.329 . . . . 74.42 111.376 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.5 -48.34 85.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 120.812 0.339 . . . . 74.53 110.935 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -54.71 -50.09 69.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 74.21 110.776 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -74.21 -39.07 63.38 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.481 ' HD2' HH22 ' A' ' 241' ' ' ARG . 52.2 ttp180 -50.44 -40.34 50.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.542 0.337 . . . . 72.24 111.792 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -70.28 -36.15 74.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.297 0.48 . . . . 75.51 112.297 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -129.19 38.57 3.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.795 0.331 . . . . 74.12 111.663 -170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.91 -50.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 113.115 0.783 . . . . 45.32 113.115 -176.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.538 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.07 -47.77 82.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 73.02 112.149 -172.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -68.25 -44.4 75.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.011 0.434 . . . . 73.22 111.204 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 285' ' ' LEU . 4.3 mm? -67.25 -50.98 58.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 72.35 111.431 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -60.87 -40.54 93.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 71.3 111.193 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.64 -42.31 98.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 74.14 111.23 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -81.8 -15.72 53.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.614 -0.266 . . . . 74.4 111.674 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.6 m -72.89 -28.08 62.27 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.29 -0.256 . . . . 64.51 111.217 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 294' ' ' ASN . 3.9 t80 -128.69 86.63 57.06 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 71.21 110.518 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -94.91 24.93 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.389 2.726 . . . . 62.41 113.011 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 293' ' ' LYS . 8.1 tt0 -100.38 -166.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.376 -0.602 . . . . 71.51 109.376 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 31.0 mmtp -81.29 62.44 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.457 0.646 . . . . 64.32 111.583 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 255' ' ' LEU . 38.7 t-20 -157.11 128.91 7.1 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.368 -1.345 . . . . 73.51 107.368 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -100.87 106.08 41.94 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.176 -0.209 . . . . 75.01 111.305 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 93.6 Cg_endo -93.6 38.17 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.899 2.399 . . . . 74.55 111.967 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -73.39 -42.34 42.06 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.077 -0.582 . . . . 72.44 111.972 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.3 pm0 -66.44 -35.84 81.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.19 . . . . 64.54 110.527 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.451 HG13 ' OE2' ' A' ' 298' ' ' GLU . 44.3 mt -67.79 -46.96 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 62.12 110.509 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.67 -39.91 90.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 63.2 110.537 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.525 ' HD3' HD11 ' A' ' 323' ' ' ILE . 85.3 tttt -80.58 -28.79 37.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 74.5 110.785 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 33.2 t80 -55.71 -50.2 70.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.207 0.527 . . . . 73.55 109.897 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 306' ' ' VAL . 95.2 mmm -70.54 -34.57 72.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.598 -0.728 . . . . 72.21 110.711 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HA ' HD11 ' A' ' 282' ' ' ILE . 0.3 OUTLIER -61.67 -42.2 98.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.808 0.813 . . . . 65.33 109.384 175.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 59.9 m -61.81 -51.38 68.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.927 -1.033 . . . . 33.44 111.488 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 16.3 m -67.75 -27.85 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.494 -0.321 . . . . 73.45 111.582 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -25.54 33.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.871 0.367 . . . . 65.02 110.212 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 27.5 tp -86.96 -16.01 37.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 75.23 111.036 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 305' ' ' THR . 80.0 mt -68.97 -101.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.499 -0.319 . . . . 75.32 111.06 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 313' ' ' GLU . 24.3 t70 166.82 164.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.994 -0.743 . . . . 73.54 108.994 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.5 -37.04 85.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.976 0.417 . . . . 75.31 110.576 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.473 ' HA ' ' NH2' ' A' ' 240' ' ' ARG . 0.2 OUTLIER -105.99 -26.27 11.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.015 -0.539 . . . . 54.3 112.336 -171.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 310' ' ' ASP . 5.3 tp10 -92.83 112.51 24.5 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.277 0.843 . . . . 72.2 113.277 -168.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.525 ' HG2' ' OE1' ' A' ' 313' ' ' GLU . 39.8 mmtm 68.42 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 115.529 1.677 . . . . 73.35 115.529 162.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.878 ' HB3' ' HG2' ' A' ' 240' ' ' ARG . 94.7 Cg_endo -93.6 116.78 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.101 1.867 . . . . 71.32 109.02 156.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.579 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.1 tp -126.04 98.48 5.52 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.125 -0.63 . . . . 61.02 111.111 -171.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.418 ' HD1' HD11 ' A' ' 162' ' ' LEU . 74.6 m-85 -64.63 -35.45 81.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.75 . . . . 70.32 110.735 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.36 -42.96 82.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.684 0.624 . . . . 75.23 112.684 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.579 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 26.5 t-20 -60.64 -43.72 97.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.109 0.48 . . . . 61.11 109.795 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.678 HD21 ' HG ' ' A' ' 244' ' ' LEU . 6.7 mp -69.11 -42.2 76.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.393 -0.821 . . . . 63.23 110.189 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -58.62 -49.48 77.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 73.34 110.347 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.25 -29.19 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 70.3 110.285 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.525 HD11 ' HD3' ' A' ' 301' ' ' LYS . 0.3 OUTLIER -63.91 -43.16 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 72.11 110.186 176.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 87.9 mt -70.11 -45.93 65.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 62.54 111.095 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 328' ' ' LEU . 4.5 mm? -64.28 -32.75 74.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.666 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.82 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.241 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -63.38 -33.26 86.75 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.888 -0.597 . . . . 75.01 112.217 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 325' ' ' LEU . 96.6 mt -69.82 -44.15 70.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.087 0.47 . . . . 73.24 110.263 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.56 -27.3 69.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 74.54 111.187 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.0 73.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.11 111.615 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.6 HD13 ' HG2' ' A' ' 151' ' ' ARG . 48.4 pt -97.04 -2.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 70.03 111.181 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.613 -0.803 . . . . 55.1 113.587 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.8 m -138.37 170.53 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.151 0.476 . . . . 64.01 110.553 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.491 ' O ' HD13 ' A' ' 328' ' ' LEU . 96.2 mttt -124.99 -85.64 0.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.024 -0.362 . . . . 71.35 110.024 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -127.12 150.73 49.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.59 -0.522 . . . . 73.52 109.59 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.01 -20.56 28.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.932 0.396 . . . . 52.24 110.672 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 92.4 -6.33 77.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.93 -0.652 . . . . 73.13 112.235 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.0 pttm . . . . . 0 C--N 1.324 -0.542 0 N-CA-C 109.81 -0.441 . . . . 70.42 109.81 -178.322 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.4 ' HE3' ' HA3' ' A' ' 47' ' ' GLY . 17.8 ptpt . . . . . 0 CA--C 1.529 0.153 0 N-CA-C 109.979 -0.378 . . . . 63.41 109.979 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 13.5 t -176.01 164.18 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.056 -0.35 . . . . 53.5 110.056 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -67.14 142.02 17.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.885 0.374 . . . . 63.52 111.069 -176.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 6.2 t -94.78 76.0 3.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.85 0.833 . . . . 71.42 110.587 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 15.5 ptmt . . . . . 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 74.04 110.248 177.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.621 0.248 . . . . 72.43 110.99 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.6 1.56 57.65 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.983 -0.627 . . . . 42.13 112.47 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 39' ' ' VAL . 14.6 pt-20 -71.79 139.02 48.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.974 0.416 . . . . 74.31 109.982 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 38' ' ' LYS . 46.8 mm -88.34 116.18 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.434 -0.803 . . . . 63.31 110.342 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 33.5 pt -106.39 147.21 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.923 -0.581 . . . . 60.22 110.851 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.5 m -109.53 127.04 54.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.4 -0.818 . . . . 73.33 109.129 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 1.8 p-10 -131.26 -163.18 1.29 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.777 -0.369 . . . . 72.04 111.396 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.8 mmt -63.23 -24.05 67.7 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.392 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . . . -81.02 21.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 53.44 109.947 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 38.9 mmtm 89.81 -38.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.763 1.225 . . . . 75.24 113.427 166.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.658 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 52.9 pttt 160.36 166.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.974 0.731 . . . . 71.2 112.974 -172.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.658 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 40.2 mt-10 73.85 50.57 0.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.967 1.469 . . . . 75.05 114.967 159.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.584 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 75.7 m95 -106.18 141.31 37.75 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 163.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 23.1 pttp -114.27 120.06 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.913 -0.773 . . . . 60.22 108.913 172.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 27' ' ' GLU . 15.0 p -75.53 145.54 10.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.26 -0.427 . . . . 70.31 111.293 -172.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.48 -148.63 23.81 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.948 -0.569 . . . . 60.02 112.444 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.4 153.3 81.67 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.578 0.227 . . . . 71.0 111.176 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.61 135.6 24.29 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.11 2.54 . . . . 75.13 111.748 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 53' ' ' LEU . 60.3 mt -108.48 -58.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.016 0.436 . . . . 74.15 110.33 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 161.58 37.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.868 -0.682 . . . . 73.31 112.38 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.72 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 33.2 tt0 -139.51 159.95 40.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.587 -0.524 . . . . 71.12 109.587 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 45' ' ' GLN . . . -76.05 -34.06 48.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.001 -0.618 . . . . 70.34 112.033 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.28 -85.04 0.79 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.983 -0.847 . . . . 73.21 110.983 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 197' ' ' ASP . 31.6 m-85 -98.55 94.17 6.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.329 -0.619 . . . . 64.24 109.329 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.72 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -73.26 -162.04 6.95 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.05 -0.523 . . . . 65.42 113.56 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.92 31.82 13.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.371 0.605 . . . . 72.12 111.15 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LYS . 37.9 mm -88.82 134.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.818 -0.628 . . . . 74.25 109.829 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -107.8 159.16 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.774 0.321 . . . . 53.53 110.625 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 69' ' ' VAL . 37.3 tp -81.65 133.38 35.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.463 -0.569 . . . . 73.44 109.463 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 69' ' ' VAL . . . -98.01 103.13 15.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.984 0.421 . . . . 24.45 110.503 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 6.8 t70 -96.32 -175.57 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.541 -0.911 . . . . 72.14 108.541 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 37' ' ' TRP . 71.7 mtm -136.74 152.55 50.47 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.175 -0.328 . . . . 63.13 110.875 -171.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -125.69 -60.5 1.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.556 -0.293 . . . . 74.12 110.42 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -120.16 38.67 3.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.115 0.483 . . . . 73.42 110.498 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.305 -0.628 . . . . 55.32 109.305 176.288 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 133' ' ' ARG . . . . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 108.366 -0.975 . . . . 51.13 108.366 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.61 9.54 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.259 1.973 . . . . 61.43 112.462 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.1 p -162.01 151.38 15.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.554 0.692 . . . . 72.34 112.668 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 53' ' ' LEU . 35.8 m -127.09 165.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.207 -1.034 . . . . 54.23 108.207 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.27 120.45 51.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.409 0.623 . . . . 65.02 111.574 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 51' ' ' ILE . 1.9 ttmp? -79.71 119.0 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 72.21 108.877 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.37 120.14 61.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.763 0.316 . . . . 75.34 110.515 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -136.52 156.9 76.13 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.336 -0.616 . . . . 65.43 109.336 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.12 147.01 92.47 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.921 1.748 . . . . 75.21 110.978 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 66.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.095 0.474 . . . . 74.52 110.097 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -151.99 -40.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 63.41 110.708 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.542 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 65.7 t30 -63.91 123.49 19.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.008 -0.542 . . . . 74.21 111.878 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.26 -54.07 36.61 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.643 -0.708 . . . . 63.42 113.829 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.542 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 91.3 Cg_exo -46.95 -37.93 22.88 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.082 2.521 . . . . 74.13 113.344 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.35 -50.97 71.93 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -60.31 -40.26 89.92 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.571 0.701 . . . . 70.54 110.701 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.1 m -71.34 -47.09 58.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 71.24 111.579 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.53 -36.18 78.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.797 -0.446 . . . . 65.14 109.797 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.86 -38.43 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 54.41 110.58 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HA ' ' HG3' ' A' ' 88' ' ' GLN . 6.1 ttpp -70.54 -31.54 68.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.864 0.364 . . . . 64.41 110.425 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.43 -32.55 71.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.869 -0.332 . . . . 73.53 110.584 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -65.88 -50.1 65.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 65.02 110.403 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -68.31 -16.05 63.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.677 0.275 . . . . 72.14 111.098 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.54 -68.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.947 0.351 . . . . 72.24 111.947 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.47 -34.41 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.011 0.745 . . . . 72.25 113.011 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.92 88.66 4.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.667 0.746 . . . . 45.03 110.583 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 4.7 ttmp? -168.96 129.82 1.05 Allowed Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.04 -0.982 . . . . 65.24 109.452 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.44 -51.47 7.9 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.331 2.687 . . . . 64.55 113.397 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 34.4 mt-10 -63.74 -45.06 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 111.901 0.334 . . . . 74.11 111.901 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.4 ' HG2' ' HD2' ' A' ' 92' ' ' LYS . 33.1 mm-40 -62.94 -47.91 81.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.682 0.277 . . . . 72.32 110.908 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 100' ' ' ILE . 69.8 mt -59.27 -47.47 90.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 73.43 110.0 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -54.81 -47.7 73.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.194 -0.912 . . . . 64.4 111.115 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 58.3 mtpt -61.81 -46.2 90.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.56 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 108' ' ' LEU . 44.7 t90 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.822 -0.351 . . . . 63.03 110.82 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 96' ' ' ILE . 30.5 mm -60.5 -37.94 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 64.13 111.357 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -75.96 -34.3 59.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.42 -0.355 . . . . 72.34 111.459 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.9 m -76.85 -48.68 17.71 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.898 0.38 . . . . 71.22 111.516 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 103' ' ' ARG . 5.6 tpm_? -76.64 -18.87 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.286 -0.416 . . . . 75.33 110.609 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? 64.74 78.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.822 0.82 . . . . 74.1 109.971 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.0 mt -138.64 -167.96 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.117 -0.947 . . . . 64.32 109.845 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -106.38 -50.86 3.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.777 -0.369 . . . . 75.41 110.964 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -153.4 146.76 24.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.681 0.277 . . . . 63.42 110.416 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 99' ' ' TRP . 46.4 tp -97.95 133.59 42.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 64.11 110.428 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.7 58.54 4.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 30.33 112.492 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -111.33 137.55 21.09 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.251 -0.648 . . . . 74.02 109.251 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' ' CD2' ' A' ' 194' ' ' TYR . 7.9 Cg_endo -50.5 134.5 39.42 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.564 2.176 . . . . 40.04 112.782 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.996 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.8 tptm -73.66 126.97 31.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 73.21 110.331 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.46 134.18 55.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.697 -0.683 . . . . 73.42 110.245 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CD1' HG22 ' A' ' 130' ' ' ILE . 40.0 m95 -107.27 -75.16 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.418 0.627 . . . . 73.13 110.055 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.48 -168.18 12.02 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.281 -0.872 . . . . 41.34 111.458 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' MET . 66.6 p -175.32 173.01 2.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.184 -0.302 . . . . 71.5 110.184 -175.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.07 -170.54 42.55 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.81 -0.71 . . . . 72.0 112.226 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.449 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -122.0 132.17 54.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.181 -0.674 . . . . 63.14 109.181 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -148.65 123.19 9.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.636 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.82 145.36 52.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.708 -0.849 . . . . 71.23 108.708 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -143.82 18.42 1.81 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.126 -0.629 . . . . 74.13 112.151 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -179.67 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.179 0.514 . . . . 71.43 111.616 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.44 14.91 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.91 -1.676 . . . . 60.32 108.91 -166.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 1.4 tpmt? -146.09 124.97 12.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.807 -1.197 . . . . 74.32 108.279 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 118' ' ' LEU . 18.4 m -75.63 105.1 6.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.91 0.386 . . . . 70.4 110.372 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.38 144.75 25.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.075 -0.511 . . . . 73.42 109.671 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -113.34 125.7 54.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.106 -1.072 . . . . 73.33 108.106 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -121.12 148.41 44.24 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.159 0.504 . . . . 70.33 111.064 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.26 134.83 40.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.226 -0.897 . . . . 71.23 109.304 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.505 HG22 ' CD1' ' A' ' 114' ' ' TRP . 19.1 mt -96.73 123.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.32 0.581 . . . . 74.41 110.137 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 11.8 ptm -128.67 -179.16 4.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.84 -1.073 . . . . 72.34 110.417 -172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.996 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 31.6 t70 -68.92 156.19 38.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.36 . . . . 53.14 111.346 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.595 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 2.4 tmt_? -89.32 106.94 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 71.04 110.732 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 132' ' ' ASP . 19.2 m-85 -102.21 172.24 7.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.689 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.45 -37.5 0.02 OUTLIER Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.693 -0.765 . . . . 62.0 112.706 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.7 m -121.55 142.07 50.44 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.809 -0.23 . . . . 74.43 111.036 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -124.65 176.69 6.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.642 0.258 . . . . 52.32 110.807 176.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 183' ' ' LEU . 5.3 mp -77.63 -27.9 51.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.346 0.499 . . . . 73.22 112.346 -177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 181' ' ' SER . 23.5 tt0 -75.39 -34.41 61.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.57 -0.452 . . . . 74.25 111.274 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.6 tptt -68.7 -38.43 80.29 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 73.5 110.117 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.495 HD13 ' O ' ' A' ' 137' ' ' ASP . 1.8 mp -68.18 -38.84 80.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 74.4 109.763 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.18 -43.09 74.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.493 -0.776 . . . . 65.22 110.425 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.46 -50.37 18.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.804 -0.634 . . . . 73.51 110.904 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.77 73.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.383 0.512 . . . . 71.41 112.383 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.61 0.79 39.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 75.23 110.647 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.52 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 56.53 75.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.896 -0.593 . . . . 54.35 111.923 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.52 ' HD3' ' C ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER 29.71 77.13 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.043 1.337 . . . . 74.24 114.132 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -160.28 105.7 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.64 -0.709 . . . . 71.13 109.092 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 49.9 m-85 -110.1 155.73 21.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.101 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -78.49 155.52 29.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.92 -0.582 . . . . 73.24 110.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -57.8 -38.85 76.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 74.24 110.642 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.56 -45.87 88.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 62.5 110.494 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.682 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.8 m -66.54 -52.37 46.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.827 -0.624 . . . . 62.52 110.948 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.7 t -60.24 -47.26 92.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.138 -0.483 . . . . 71.53 111.648 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.55 -37.87 80.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 71.52 110.762 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.873 HE21 ' HB2' ' A' ' 335' ' ' ASP . 30.2 mm-40 -60.22 -47.53 85.57 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.695 0.283 . . . . 64.5 110.61 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 153' ' ' THR . 81.9 mt -58.11 -50.51 73.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 70.44 110.131 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 247' ' ' LEU . 25.2 t -58.18 -47.44 83.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.891 -0.595 . . . . 65.0 110.94 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 325' ' ' LEU . 0.7 OUTLIER -64.74 -52.64 55.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 72.12 111.083 -176.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.438 ' NH1' HD22 ' A' ' 159' ' ' LEU . 13.6 mmt180 -72.51 -30.11 64.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 70.32 111.348 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -71.09 -30.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.818 -0.438 . . . . 74.53 109.818 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.45 -43.84 76.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.943 -0.391 . . . . 75.31 109.943 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.571 ' HB3' ' HH2' ' A' ' 99' ' ' TRP . 72.7 m-20 -58.53 -55.22 37.89 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.683 0.754 . . . . 72.14 110.432 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.598 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -63.19 -34.79 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 60.1 110.378 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.731 ' O ' ' HB3' ' A' ' 169' ' ' HIS . 6.3 tt -56.44 -37.93 70.92 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.577 -0.283 . . . . 72.14 110.318 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -57.29 -59.56 4.94 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.112 -0.699 . . . . 73.53 109.112 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.46 -28.19 66.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.967 -1.469 . . . . 74.54 113.501 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.0 pt -108.9 -48.18 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.908 0.707 . . . . 43.25 112.908 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.731 ' HB3' ' O ' ' A' ' 165' ' ' LEU . 7.0 t60 -59.87 -47.66 84.84 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.998 0.186 . . . . 75.11 110.85 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.688 ' HG3' ' HD2' ' A' ' 169' ' ' HIS . 21.1 mt-10 -106.47 80.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.978 0.894 . . . . 75.31 109.404 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -175.35 -44.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.481 -1.69 . . . . 74.1 109.128 -170.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -162.61 -72.62 0.05 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.938 -0.573 . . . . 74.42 111.403 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.643 ' CD1' ' HA ' ' A' ' 203' ' ' ARG . 21.9 m-85 -122.79 155.21 37.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.187 0.518 . . . . 64.31 111.388 -174.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 204' ' ' TYR . 31.0 m -97.37 167.29 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 51.51 109.431 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . 2.9 m-70 -114.3 -85.77 0.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.862 -0.335 . . . . 71.23 111.558 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.96 6.45 85.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.683 -0.77 . . . . 52.0 111.38 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 200' ' ' LEU . 17.8 p-10 -89.66 28.39 1.32 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 73.34 111.077 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.481 ' HB ' HG22 ' A' ' 246' ' ' ILE . 46.2 mm -75.6 97.45 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.314 0.578 . . . . 63.2 110.527 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.789 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -157.3 165.04 36.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.461 -0.791 . . . . 75.43 109.502 172.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.44 -23.56 64.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.967 0.729 . . . . 74.41 112.967 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.409 ' HB3' ' OE1' ' A' ' 139' ' ' GLN . 67.7 p -75.51 -18.59 59.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.837 0.31 . . . . 71.55 111.837 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 177' ' ' ASP . 2.6 m-20 -97.44 -26.94 14.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 111.891 0.33 . . . . 73.35 111.891 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.505 ' HB2' HD22 ' A' ' 138' ' ' LEU . 6.3 mp -95.69 118.38 32.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.11 0.481 . . . . 71.25 110.407 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -133.81 158.67 42.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.565 -0.743 . . . . 75.41 110.88 177.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 11.7 mt -103.55 157.59 16.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.906 -0.588 . . . . 72.15 109.601 -179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 23.8 t-20 -65.62 142.31 58.1 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 2.5 p90 -60.58 -22.24 63.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.964 0.357 . . . . 72.22 111.964 -173.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -124.25 6.23 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.293 0.568 . . . . 73.43 110.261 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 47.6 t-20 -139.87 101.92 7.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.892 -0.595 . . . . 72.35 109.835 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.48 -20.47 5.8 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.832 2.355 . . . . 75.02 113.716 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.47 1.62 57.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.953 0.406 . . . . 52.11 111.257 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.54 107.55 15.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.994 0.426 . . . . 73.51 110.437 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.33 142.12 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 73.12 109.937 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 111' ' ' PRO . 44.1 m-85 -127.04 157.49 39.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.302 . . . . 73.24 110.732 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.7 mt -96.49 129.91 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.258 -0.428 . . . . 75.33 110.479 174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 184' ' ' LEU . 34.2 m -135.79 177.49 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 54.12 110.225 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 53.5 t0 59.8 66.73 0.95 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.6 0.714 . . . . 75.23 109.287 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -75.38 67.52 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.16 -0.927 . . . . 74.42 111.078 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.71 ' HA3' ' HB2' ' A' ' 352' ' ' LYS . . . -93.52 1.87 69.74 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.464 -0.789 . . . . 71.54 111.651 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 77.8 mt -138.19 94.35 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.56 0.695 . . . . 70.44 110.587 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -155.0 115.8 3.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.725 -1.125 . . . . 74.3 108.921 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -132.38 160.61 35.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.635 -0.257 . . . . 75.05 110.699 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.643 ' HA ' ' CD1' ' A' ' 173' ' ' TYR . 5.4 ptp180 -62.52 149.36 43.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.144 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.472 ' HB2' HG13 ' A' ' 174' ' ' VAL . 42.1 t80 -149.86 -56.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 73.13 110.534 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 209' ' ' VAL . 5.8 p -148.34 72.08 10.93 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 73.43 111.534 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.76 142.67 4.89 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.989 2.459 . . . . 73.03 111.853 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 66.25 9.48 6.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 72.31 111.726 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.86 67.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.04 -0.6 . . . . 52.32 112.299 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 61.9 t -96.42 117.44 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.537 0.208 . . . . 70.24 110.49 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -100.23 145.86 27.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.853 -0.425 . . . . 71.0 109.853 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -114.97 152.58 32.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.303 -0.408 . . . . 64.33 110.413 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.39 173.98 11.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.483 -0.562 . . . . 64.34 109.483 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 236' ' ' VAL . 19.4 p90 -79.19 74.03 5.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.665 1.222 . . . . 74.11 110.223 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -154.91 92.97 1.5 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.055 -1.43 . . . . 71.32 108.49 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 2.7 mm-40 -122.61 -98.5 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.251 0.834 . . . . 71.25 113.251 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.49 119.26 61.92 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.411 -0.359 . . . . 73.25 111.664 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 N--CA 1.462 -0.358 0 C-N-CA 122.769 2.313 . . . . 62.34 112.379 177.793 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 355' ' ' THR . 19.0 p-10 . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.108 0.48 . . . . 74.04 110.849 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -77.04 177.34 52.45 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.687 -0.768 . . . . 71.31 111.361 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -73.26 129.69 38.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.248 0.547 . . . . 75.43 111.667 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.452 HG23 HG21 ' A' ' 271' ' ' VAL . 47.7 mm -54.17 -31.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.342 -0.845 . . . . 72.34 112.336 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -56.92 -69.46 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.277 -0.42 . . . . 72.25 111.566 -179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.6 m-85 -112.48 49.34 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.107 0.41 . . . . 72.42 112.107 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -18.18 35.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.629 0.252 . . . . 73.2 111.519 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.4 m 52.48 -162.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.891 -0.595 . . . . 53.43 111.159 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.2 mp -72.83 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.711 0.291 . . . . 74.11 110.507 177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 238' ' ' PRO . 1.3 m-20 -51.44 -70.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.159 -0.928 . . . . 74.34 112.468 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.22 70.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 42.12 111.383 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.32 -28.79 68.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.034 -0.53 . . . . 53.21 110.767 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.15 -30.62 16.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.859 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.57 6.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.668 -0.777 . . . . 70.54 111.625 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 9.1 p -120.49 141.55 40.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.236 -0.283 . . . . 71.13 110.236 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.71 124.69 58.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 42.41 110.778 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.621 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 91.0 Cg_exo -46.63 106.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 64.12 112.418 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 312' ' ' THR . 36.4 m -92.04 42.26 1.1 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.148 -0.933 . . . . 63.22 110.928 -172.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 239' ' ' SER . 66.0 mtt180 85.29 -28.69 0.08 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.075 0.95 . . . . 65.24 111.159 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 311' ' ' TYR . 9.4 mmm180 -59.13 -61.39 2.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.542 0.21 . . . . 64.55 110.921 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -49.18 -55.36 12.45 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 115.724 -0.671 . . . . 44.22 113.219 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.487 ' HB3' HD11 ' A' ' 165' ' ' LEU . 3.3 m-20 -52.72 -54.56 32.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.98 0.419 . . . . 72.34 111.176 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 240' ' ' ARG . 11.2 mp -64.92 -45.93 83.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 74.04 111.391 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.46 -38.57 84.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.075 -0.25 . . . . 63.34 111.593 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 178' ' ' ILE . 84.2 mt -59.13 -44.0 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 74.13 110.482 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 158' ' ' SER . 33.2 tp -61.57 -42.63 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 72.41 110.293 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.63 95.86 Favored Glycine 0 C--O 1.236 0.271 0 C-N-CA 120.907 -0.663 . . . . 73.14 112.227 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -58.79 -49.16 78.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.649 0.261 . . . . 64.34 111.279 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 28.5 p -66.43 -36.79 83.68 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 73.31 111.453 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 72.5 mtm -60.65 -51.75 68.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.881 0.372 . . . . 74.43 111.023 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.4 tt -67.38 -30.23 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.582 -0.447 . . . . 75.41 110.694 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.53 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 35.0 tt0 -67.91 -44.95 75.74 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.532 0.206 . . . . 64.33 110.584 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 22.7 m0 -65.4 -29.15 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 73.11 110.902 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -81.04 -35.71 31.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 71.34 112.003 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 62.5 p -103.37 -27.93 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.858 -0.337 . . . . 73.43 111.74 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.36 17.09 65.18 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.865 -0.683 . . . . 44.52 112.982 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -155.6 144.17 20.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.128 0.464 . . . . 65.02 111.145 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 29.3 mt -108.95 138.84 20.46 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.11 109.825 171.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 48.3 Cg_exo -58.03 -28.33 82.88 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.867 2.378 . . . . 74.03 112.57 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 274' ' ' SER . 46.7 p90 -108.22 11.72 27.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.375 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 38.4 tt0 -75.56 -39.37 58.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 71.51 110.36 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.45 -29.15 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.69 0.757 . . . . 62.32 109.864 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -108.04 19.75 19.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.138 -0.937 . . . . 73.52 110.689 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 262' ' ' GLU . 1.8 tt -75.93 73.29 2.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.825 0.821 . . . . 73.24 110.362 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -147.52 -63.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.544 -1.207 . . . . 72.02 109.817 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.747 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 12.1 t70 -91.33 135.27 28.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.245 -0.888 . . . . 73.25 111.431 -173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -58.23 -27.11 79.43 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.498 2.799 . . . . 75.55 114.331 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 269' ' ' LYS . 1.8 mppt? -82.72 -40.07 21.09 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.605 -0.438 . . . . 73.04 110.542 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.747 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 37.0 m-85 -60.93 -49.19 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 73.32 110.704 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.452 HG21 HG23 ' A' ' 225' ' ' ILE . 33.8 m -66.6 -31.71 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.816 -0.354 . . . . 52.13 110.663 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -58.58 -56.67 19.17 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.087 0.47 . . . . 75.03 110.352 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.85 -43.47 79.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.474 -0.785 . . . . 72.14 111.038 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 41.7 m -60.34 -41.2 93.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 74.02 111.501 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.36 -48.29 70.66 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.114 -0.235 . . . . 73.41 110.615 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.46 -40.68 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 72.35 111.03 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -56.13 -51.02 69.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.647 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 33.4 m-85 -74.45 -36.05 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 74.23 111.12 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.531 ' HD2' HH22 ' A' ' 241' ' ' ARG . 26.2 ttp180 -57.23 -31.95 66.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.538 . . . . 64.34 111.28 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.5 -23.22 50.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.108 -0.496 . . . . 62.23 111.063 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -127.98 30.43 5.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.581 -0.281 . . . . 71.21 110.779 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -47.95 -42.28 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.04 1.126 . . . . 63.3 114.04 -171.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.16 -50.51 73.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.423 0.527 . . . . 71.43 112.423 -169.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 t -78.08 -36.21 48.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.834 0.35 . . . . 73.52 110.313 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 278' ' ' TYR . 89.9 mt -71.95 -44.8 62.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 65.44 111.372 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.445 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -72.02 -40.6 68.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.639 -0.255 . . . . 63.34 110.946 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.79 -35.41 80.51 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.145 0.497 . . . . 63.53 111.046 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 288' ' ' LYS . 28.5 ttmt -99.76 7.63 44.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.774 -0.648 . . . . 72.22 110.658 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 47.0 t -75.95 -22.95 55.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.203 0.525 . . . . 74.24 110.048 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 33.6 t80 -127.35 77.39 75.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.546 -0.909 . . . . 74.22 108.546 173.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.85 12.07 2.76 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.895 2.397 . . . . 75.52 113.364 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 4.0 mp0 -71.11 -99.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.661 -0.496 . . . . 63.21 109.661 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -161.52 79.13 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.334 0.588 . . . . 73.32 110.771 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.5 t-20 -150.3 162.92 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.035 -1.098 . . . . 75.01 108.035 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.85 103.87 43.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 111.905 0.335 . . . . 75.41 111.905 -175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 85.1 Cg_endo -98.26 37.81 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.011 2.474 . . . . 45.13 111.207 173.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -74.02 -43.71 32.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.628 -0.714 . . . . 63.41 111.942 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.4 mp0 -53.39 -51.15 63.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.212 0.53 . . . . 72.02 109.849 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 252' ' ' ILE . 20.7 mt -62.09 -50.93 78.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.281 -0.872 . . . . 73.35 111.4 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 63.43 111.149 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.77 -28.54 40.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.489 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.405 ' HE1' ' O ' ' A' ' 244' ' ' LEU . 52.1 t80 -60.74 -42.64 97.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.287 -0.634 . . . . 64.21 109.287 172.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 306' ' ' VAL . 66.3 mtp -72.71 -36.16 67.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.541 -0.754 . . . . 74.45 110.809 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -55.93 -46.42 78.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 63.22 109.342 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 91.3 m -57.33 -52.28 65.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.713 -1.131 . . . . 50.31 111.611 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 303' ' ' MET . 22.9 m -67.45 -31.63 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 111.78 0.289 . . . . 61.04 111.78 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -70.32 -48.81 54.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.095 0.474 . . . . 73.41 110.808 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 17.5 tp -82.73 -3.03 55.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 62.43 110.481 -175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 6.9 tt -67.65 -76.7 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.314 -0.857 . . . . 75.23 110.315 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 8.1 t70 162.19 -152.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.134 -1.432 . . . . 71.21 107.134 -176.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 241' ' ' ARG . 20.4 t80 -105.03 -39.97 6.06 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.938 -0.393 . . . . 74.44 109.938 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 239' ' ' SER . 1.6 m -138.4 5.51 2.48 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.683 0.623 . . . . 52.24 112.683 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.22 -89.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.556 1.317 . . . . 73.44 114.556 -167.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 314' ' ' LYS . 13.2 tppt? -109.09 107.42 59.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 113.165 0.802 . . . . 74.13 113.165 -161.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 68.7 Cg_endo -88.73 119.82 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.618 2.212 . . . . 64.21 112.034 169.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.2 mt -118.84 85.55 2.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.268 0.556 . . . . 65.23 109.786 176.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 315' ' ' PRO . 80.7 m-85 -67.98 -34.97 77.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.704 -0.68 . . . . 72.31 111.964 -172.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -29.53 46.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.902 -0.319 . . . . 72.25 110.904 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.62 -48.71 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.889 -0.411 . . . . 73.44 109.889 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 85.9 mt -58.4 -43.61 88.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.617 -0.72 . . . . 63.23 110.485 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.419 ' O ' HD23 ' A' ' 325' ' ' LEU . 7.4 mtp180 -64.21 -33.36 75.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 72.12 111.12 177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.44 -46.16 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 320' ' ' LEU . 0.3 OUTLIER -72.45 -27.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 119.474 -0.89 . . . . 55.54 110.414 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.13 -49.04 75.96 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.492 -0.559 . . . . 73.02 109.492 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 329' ' ' LYS . 4.0 mm? -67.59 -26.91 66.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 73.45 111.002 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . 0.673 ' HA ' ' HE2' ' A' ' 329' ' ' LYS . 20.2 tp60 -59.52 -49.01 79.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 61.42 110.427 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.91 -38.55 94.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.248 -0.977 . . . . 62.23 111.298 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.937 HD11 ' HA ' ' A' ' 334' ' ' LYS . 3.0 tm? -57.21 -50.35 73.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.181 -0.51 . . . . 65.43 111.043 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 326' ' ' GLN . 54.8 pttt -81.15 -17.48 49.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.759 0.281 . . . . 75.4 111.759 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.76 63.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 73.12 110.894 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -77.46 -6.95 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.206 0.527 . . . . 70.55 110.626 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 89.67 12.27 62.76 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.856 -0.688 . . . . 61.5 112.887 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 170.37 8.69 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.043 -0.354 . . . . 61.21 110.043 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.937 ' HA ' HD11 ' A' ' 328' ' ' LEU . 77.6 tttt -146.28 156.56 43.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.541 . . . . 75.25 109.538 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.873 ' HB2' HE21 ' A' ' 156' ' ' GLN . 6.9 p-10 -87.65 126.64 35.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.166 0.508 . . . . 64.52 110.142 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -104.3 -24.18 13.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 62.51 110.862 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 85.39 -1.96 88.25 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.172 -0.537 . . . . 64.22 112.42 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.613 0.207 . . . . 71.51 110.803 -175.294 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.71 ' HB2' ' HA3' ' A' ' 199' ' ' GLY . 3.9 mppt? . . . . . 0 N--CA 1.456 -0.154 0 CA-C-O 120.756 0.312 . . . . 74.35 110.549 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.7 t -134.3 132.47 39.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.29 -0.413 . . . . 70.32 110.562 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.724 HG13 ' HD3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -84.69 142.7 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 71.32 110.782 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.421 ' HB ' ' OD2' ' A' ' 222' ' ' ASP . 4.9 t -79.54 81.77 5.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.038 0.923 . . . . 71.21 110.045 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.724 ' HD3' HG13 ' A' ' 354' ' ' ILE . 10.5 mtpm? . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 115.439 -0.8 . . . . 54.05 110.509 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t . . . . . 0 C--O 1.232 0.164 0 N-CA-C 110.298 -0.26 . . . . 74.55 110.298 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.87 57.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.88 -0.676 . . . . 74.3 112.73 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.03 167.56 12.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.315 0.578 . . . . 73.45 111.527 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.92 131.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.144 -0.935 . . . . 64.23 111.249 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 37' ' ' TRP . 12.7 tt -105.77 136.81 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 72.55 109.427 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.5 m -93.83 113.95 26.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.134 0.42 . . . . 74.14 112.134 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 14.4 t70 -72.65 154.77 40.58 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.06 174.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.684 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 52.3 tpp -70.63 -30.36 66.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.879 0.371 . . . . 74.31 110.971 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.82 18.48 3.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.052 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 61.29 77.71 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.062 -0.972 . . . . 74.44 110.032 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 45.4 mmtm -140.52 115.48 9.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.972 -1.013 . . . . 53.04 109.139 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.74 111.55 17.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.245 -0.434 . . . . 40.42 110.228 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 29' ' ' ILE . 83.9 m95 -108.89 163.15 13.54 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.95 -0.759 . . . . 73.32 108.95 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 56' ' ' MET . 21.7 ttpt -114.6 129.49 56.68 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.654 -0.418 . . . . 64.33 110.25 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -75.89 104.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.071 0.462 . . . . 63.31 109.9 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.22 -104.54 2.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.442 -0.885 . . . . 73.31 113.246 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 mm? -86.29 127.71 60.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.043 0.449 . . . . 63.12 111.471 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.3 Cg_exo -78.74 106.25 2.08 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.106 2.537 . . . . 70.0 111.77 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -81.28 -37.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 71.03 110.17 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 87.53 -45.44 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.829 -0.7 . . . . 60.51 112.696 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -103.23 165.63 10.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.596 -0.52 . . . . 52.21 109.596 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 71' ' ' LYS . . . 98.77 13.36 40.73 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.445 -1.462 . . . . 74.15 109.445 -168.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.849 ' HA3' HD11 ' A' ' 51' ' ' ILE . . . -168.24 -164.4 23.87 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 114.325 -0.938 . . . . 61.22 111.169 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -102.92 8.72 39.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.764 0.316 . . . . 74.42 111.625 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.03 -76.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.329 -0.939 . . . . 63.24 113.182 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . 0.628 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 84.6 m -150.18 110.43 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 73.1 109.964 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.849 HD11 ' HA3' ' A' ' 47' ' ' GLY . 30.3 mm -100.31 137.83 26.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.073 -0.512 . . . . 74.35 110.62 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -110.07 145.15 37.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 74.3 110.616 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HA ' HG12 ' A' ' 69' ' ' VAL . 9.7 tt -91.16 138.27 31.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.421 -0.585 . . . . 75.22 109.421 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.18 96.23 5.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 71.55 110.945 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.13 -32.4 19.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 63.12 110.444 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.622 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 9.2 tpt 62.27 34.85 15.65 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.658 -0.701 . . . . 61.23 111.465 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.5 t30 74.07 121.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.573 0.701 . . . . 52.3 111.831 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 m -71.11 108.95 4.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.572 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 C--N 1.326 -0.413 0 CA-C-N 115.848 -0.615 . . . . 35.21 111.051 -177.871 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 N--CA 1.468 0.47 0 CA-C-O 121.196 0.522 . . . . 61.12 110.878 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 4.0 Cg_exo -79.87 40.72 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.294 2.663 . . . . 74.45 112.341 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 131' ' ' MET . 2.2 p -140.71 137.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.398 0.618 . . . . 70.21 111.931 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 53' ' ' LEU . 30.9 m -137.87 161.85 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.312 -0.858 . . . . 62.43 108.971 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -123.59 122.29 64.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.482 0.658 . . . . 62.45 112.371 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.847 ' HA ' HD12 ' A' ' 51' ' ' ILE . 36.9 ttmt -89.6 122.19 32.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.741 -1.118 . . . . 65.33 109.297 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 128' ' ' PHE . 35.7 m -115.91 139.16 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.03 0.382 . . . . 72.41 112.03 -175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 6.6 mm-40 -148.91 139.44 13.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 74.44 109.823 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 25.2 Cg_exo -63.1 150.94 87.18 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.942 2.428 . . . . 40.22 112.324 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 m -73.06 66.83 0.85 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.301 0.572 . . . . 54.42 112.068 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -113.61 -6.44 13.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.52 -1.289 . . . . 72.41 107.52 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 90.69 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 113.987 -1.46 . . . . 42.45 111.391 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.43 -139.66 5.72 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.441 -0.8 . . . . 51.1 111.5 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG3' HG23 ' A' ' 353' ' ' THR . 28.0 Cg_exo -61.59 -22.93 75.66 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.057 2.505 . . . . 74.42 112.175 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -56.81 -34.74 67.99 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.743 -0.662 . . . . 62.31 110.294 178.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.19 -41.43 85.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 73.32 110.43 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.2 m -65.59 -41.76 92.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.235 -0.439 . . . . 71.45 110.348 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -58.31 -45.99 86.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.694 . . . . 73.43 110.425 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -67.48 -33.69 75.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 73.34 111.128 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HE3' ' HE1' ' A' ' 173' ' ' TYR . 6.2 tmtm? -64.19 -45.18 89.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.351 -0.611 . . . . 74.34 109.351 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' A' ' 168' ' ' ILE . 87.8 t80 -65.26 -41.5 94.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 73.41 110.275 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' ' HD1' ' A' ' 113' ' ' TYR . 42.8 t80 -59.28 -49.03 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.076 -0.965 . . . . 75.52 110.512 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -64.04 -34.17 77.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 64.13 111.226 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -75.52 -53.56 8.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.493 0.553 . . . . 64.22 112.493 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.75 -33.7 7.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.832 0.679 . . . . 60.13 112.832 -169.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.06 84.84 7.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.322 0.582 . . . . 64.23 110.738 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -157.48 128.43 3.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.772 -0.649 . . . . 74.44 109.466 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.0 -52.38 8.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.354 2.703 . . . . 63.15 113.23 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.75 -45.37 92.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -69.22 -45.58 69.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.004 -0.543 . . . . 75.41 110.716 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.11 -50.42 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 73.02 110.998 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -61.46 -37.3 83.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.809 0.338 . . . . 75.43 110.391 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 34.0 ttmt -59.63 -51.5 69.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 73.43 110.832 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.823 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 23.6 t90 -68.59 -51.1 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 73.22 110.684 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.93 -40.05 81.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.713 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 101' ' ' ARG . 45.7 ttt-85 -63.77 -56.54 14.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 75.31 110.856 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.3 m -65.04 -40.84 95.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.754 -0.657 . . . . 40.21 111.239 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -75.53 -13.83 60.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.988 -0.551 . . . . 74.1 110.929 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 62.58 57.74 1.77 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.336 0.588 . . . . 74.15 110.392 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -117.62 -174.52 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 75.04 110.806 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.47 -59.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.878 -0.601 . . . . 63.34 111.284 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -144.81 157.26 44.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 72.31 110.764 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -105.8 137.35 43.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 60.24 109.199 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.27 33.05 1.78 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.941 -0.647 . . . . 62.24 113.287 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 108' ' ' LEU . 11.0 p -109.25 137.16 20.14 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.405 -0.591 . . . . 74.54 109.405 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD2' HG23 ' A' ' 110' ' ' VAL . 5.9 Cg_endo -47.28 135.21 19.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.51 2.807 . . . . 72.43 113.343 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 44.3 tptt -65.01 121.15 14.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 71.04 110.839 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.534 ' HD1' ' CE2' ' A' ' 87' ' ' TYR . 27.2 t80 -80.44 132.27 35.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.272 -0.876 . . . . 74.34 111.357 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.535 ' HB2' HG22 ' A' ' 130' ' ' ILE . 69.9 m95 -122.42 -54.03 1.89 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.875 -0.787 . . . . 51.43 108.875 170.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.38 176.71 46.72 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.393 -0.822 . . . . 71.25 111.96 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -157.29 153.62 27.75 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.996 -0.742 . . . . 72.33 108.996 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 32' ' ' MET . . . -161.43 176.07 37.98 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.357 -1.401 . . . . 70.2 114.147 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 126' ' ' TYR . 19.1 tp -137.08 129.08 29.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.01 108.785 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -144.49 131.79 20.75 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.701 -0.4 . . . . 73.2 110.648 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 8.2 t70 -69.74 136.75 51.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 61.31 110.824 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -90.72 -60.01 2.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 54.11 109.258 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -170.18 85.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.633 -0.712 . . . . 54.35 109.603 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.38 -34.86 5.43 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.604 -0.598 . . . . 40.24 111.604 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -132.02 140.8 49.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 75.0 109.919 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 11.5 p -89.65 156.14 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 63.03 110.897 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 118' ' ' LEU . 15.8 m-85 -111.5 130.69 55.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.737 -0.665 . . . . 72.41 110.391 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -96.44 118.03 32.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.709 -0.849 . . . . 74.41 108.709 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.566 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.6 p90 -129.16 156.57 43.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.967 0.413 . . . . 75.43 111.5 -173.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 18.5 ptp -137.27 139.59 41.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.671 -0.695 . . . . 55.54 110.335 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.547 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.7 mm -97.86 117.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.1 -0.5 . . . . 53.32 109.711 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER -121.84 -175.96 3.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 75.34 111.088 -175.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 20.8 t70 -64.5 157.01 27.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 70.12 110.633 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 1.2 tmt_? -93.71 109.36 21.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.268 0.556 . . . . 72.45 110.045 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 63.7 m-85 -101.84 171.39 7.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.589 . . . . 73.22 109.9 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.7 -36.78 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.472 -0.871 . . . . 42.24 112.42 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.5 m -103.06 124.94 49.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.962 0.411 . . . . 62.11 111.141 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 1.3 m-20 -87.42 132.9 33.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.06 -0.518 . . . . 65.03 109.905 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 14.8 tp -68.94 -38.29 79.37 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.065 -1.087 . . . . 63.21 108.065 171.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.979 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 4.9 pt20 -59.51 -49.0 79.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.339 -0.846 . . . . 75.14 112.418 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 25.2 mtmm -71.57 -36.91 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.768 -0.373 . . . . 55.54 111.371 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.03 -48.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 71.02 110.568 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.05 -44.95 95.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 71.14 111.922 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.3 -34.39 59.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.876 0.369 . . . . 62.24 110.727 -172.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.4 -28.85 62.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 73.12 110.557 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.64 0.11 56.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.37 0.605 . . . . 63.22 110.185 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 58.81 45.12 15.93 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.296 -0.865 . . . . 72.11 112.27 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 254' ' ' TRP . 0.0 OUTLIER 39.89 79.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.932 0.872 . . . . 74.12 112.998 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 148' ' ' ARG . 14.4 ttt180 -146.5 88.48 1.78 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.68 -1.145 . . . . 74.43 108.367 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.727 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 52.4 m-85 -120.09 156.16 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.084 -0.507 . . . . 74.32 112.025 -172.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.4 m -67.61 155.66 38.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.854 . . . . 72.42 110.257 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.607 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 7.7 tpp85 -59.71 -39.7 85.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.824 0.345 . . . . 73.42 110.797 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HD2' ' HB2' ' A' ' 335' ' ' ASP . 26.2 pttm -66.3 -30.36 70.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.337 -0.392 . . . . 63.04 111.201 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.431 ' O ' HD13 ' A' ' 157' ' ' LEU . 6.9 m -70.2 -41.52 73.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 60.4 110.175 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.72 -43.62 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.617 -0.72 . . . . 65.24 110.945 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.652 HD22 HD22 ' A' ' 328' ' ' LEU . 3.3 mp -69.06 -40.16 78.69 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.483 0.549 . . . . 75.21 112.483 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -56.29 -45.06 80.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 72.31 110.301 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 153' ' ' THR . 8.6 mp -64.18 -52.03 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 73.22 111.313 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.3 p -65.27 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.286 . . . . 45.22 111.671 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 325' ' ' LEU . 7.0 mp -56.3 -48.99 75.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.539 0.2 . . . . 52.42 111.539 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 2.3 mmp_? -61.15 -42.68 98.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 73.02 110.907 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 183' ' ' LEU . 31.4 mm -63.62 -38.19 81.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 72.04 110.581 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 317' ' ' TYR . 67.3 mt -58.01 -53.04 62.73 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.891 0.33 . . . . 75.34 111.891 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.823 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -70.08 -39.44 75.59 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.454 -0.498 . . . . 34.23 112.119 -175.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.54 -36.57 75.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.871 -0.731 . . . . 72.52 110.953 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.91 -38.86 83.47 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.797 -0.183 . . . . 73.14 111.212 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 167' ' ' TYR . 4.1 pt-20 -68.93 -40.96 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.233 -0.587 . . . . 54.31 110.009 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.484 ' N ' ' HG3' ' A' ' 166' ' ' GLU . 66.3 t80 -55.84 -45.81 78.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.693 -0.685 . . . . 75.32 111.735 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.404 HG21 ' HE1' ' A' ' 86' ' ' PHE . 26.9 pt -82.55 -31.46 9.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.486 -0.324 . . . . 72.33 111.797 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -66.8 -27.06 67.27 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.436 -0.347 . . . . 74.12 110.689 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 37.0 tt0 -77.65 28.56 0.16 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.107 0.479 . . . . 61.23 111.491 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -151.18 -65.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.525 -0.734 . . . . 74.42 111.597 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 35.3 mt-10 -147.25 -31.44 0.32 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.696 0.628 . . . . 63.33 112.696 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.449 ' HE1' ' HE3' ' A' ' 85' ' ' LYS . 5.4 m-85 -99.18 128.85 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.784 1.031 . . . . 75.41 113.784 -155.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.4 m -123.01 139.5 49.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.707 -1.133 . . . . 62.32 108.015 163.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -93.77 -32.88 13.81 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.827 -0.349 . . . . 73.03 110.203 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.65 -76.87 0.28 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.078 -0.582 . . . . 71.22 111.852 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.9 101.93 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.037 0.446 . . . . 64.35 110.343 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 178' ' ' ILE . 9.4 tp -99.73 20.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.876 0.846 . . . . 71.15 110.051 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -57.56 144.3 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.93 . . . . 64.35 110.256 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 183' ' ' LEU . . . -62.3 -0.36 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.906 -0.588 . . . . 72.44 112.553 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.979 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 14.2 p -70.48 -17.28 62.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 54.31 111.514 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 198' ' ' TYR . 14.6 m120 -112.53 6.67 18.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 60.14 111.3 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 180' ' ' ALA . 7.1 mp -105.06 115.66 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.706 -0.479 . . . . 63.34 109.706 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.63 140.3 49.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.433 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 53.3 mt -94.71 138.41 32.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.707 -0.679 . . . . 74.51 109.874 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.61 140.47 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.096 -0.705 . . . . 63.3 109.096 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 5.6 p90 -62.42 -22.4 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.128 0.418 . . . . 73.54 112.128 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -104.3 -51.18 3.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.761 0.315 . . . . 65.32 111.039 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -112.11 106.82 56.12 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 74.14 110.979 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.13 -11.71 25.32 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.096 2.531 . . . . 55.5 112.49 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 26.8 t70 -70.87 -19.99 62.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.57 . . . . 71.24 110.703 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -111.09 103.05 11.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.45 0.643 . . . . 72.53 110.18 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.94 137.99 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 64.12 109.74 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.517 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 96.3 m-85 -120.3 141.98 49.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.044 0.449 . . . . 64.24 111.054 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 182' ' ' ASN . 37.6 tp -90.76 99.97 12.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.728 -0.669 . . . . 54.41 109.392 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.5 m -139.99 160.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.457 -0.338 . . . . 74.45 111.636 -174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.44 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 16.6 t70 60.67 78.16 0.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.968 -1.015 . . . . 63.21 111.575 174.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.62 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 19.4 p90 -151.41 -40.76 0.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.548 -0.751 . . . . 63.42 112.015 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.658 ' O ' ' HB ' ' A' ' 354' ' ' ILE . . . 66.72 2.16 15.03 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.751 -0.737 . . . . 70.41 112.661 -175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.62 ' H ' ' HD2' ' A' ' 198' ' ' TYR . 6.2 mp -91.94 35.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 73.24 111.474 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -84.49 97.78 9.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.363 -0.977 . . . . 72.52 108.363 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -99.97 127.48 46.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.265 0.555 . . . . 72.05 110.697 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 2.0 ttp180 -72.86 112.45 8.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.483 -0.78 . . . . 61.44 110.229 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.573 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 13.7 p90 -92.57 -26.22 17.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.84 -0.43 . . . . 75.42 109.84 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 18.0 p -133.31 127.42 19.84 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 74.22 111.145 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.65 131.39 13.51 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.505 2.137 . . . . 70.44 111.752 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 65.96 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.79 0.681 . . . . 74.32 111.291 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.27 15.75 0.14 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.155 -0.545 . . . . 41.51 111.927 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 45.0 t -94.95 110.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.931 -0.396 . . . . 74.51 109.931 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.98 145.82 55.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 70.01 110.998 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 214' ' ' LYS . 74.8 tttt -111.02 145.09 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.828 -0.624 . . . . 74.05 110.755 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.2 -163.39 1.02 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.872 -0.604 . . . . 71.52 110.172 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.565 ' HA ' HG23 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -76.27 67.79 2.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.809 0.67 . . . . 71.4 112.809 -175.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.427 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 75.6 tttt -158.43 83.28 0.83 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.855 -0.611 . . . . 72.23 109.725 169.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 235' ' ' GLY . 9.8 tp10 -105.9 -72.93 0.7 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.939 -0.573 . . . . 75.44 110.464 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -138.34 109.39 8.14 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.61 -0.268 . . . . 61.03 110.418 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo . . . . . 0 C--N 1.344 0.327 0 C-N-CA 123.23 2.62 . . . . 71.11 112.481 -178.372 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.777 0.323 . . . . 75.43 111.491 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -96.88 -170.46 33.95 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 71.21 112.789 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.3 m -69.58 142.24 53.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.443 0.164 . . . . 44.32 110.77 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -56.96 -23.83 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.471 0.653 . . . . 73.41 110.542 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.23 -53.47 54.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.465 -0.788 . . . . 65.42 111.937 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.27 7.0 19.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.085 0.772 . . . . 74.53 113.085 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -21.1 66.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 60.55 111.288 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.677 ' HA ' ' CD ' ' A' ' 275' ' ' LYS . 50.8 m 59.77 -162.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.709 -0.678 . . . . 64.44 110.247 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.2 OUTLIER -71.0 -34.16 54.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.421 -0.512 . . . . 74.11 110.281 176.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.424 ' HA ' HG13 ' A' ' 236' ' ' VAL . 5.2 m-20 -59.76 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.631 -0.713 . . . . 63.34 112.316 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.59 72.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 63.33 111.714 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -68.97 -31.35 70.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.496 -0.32 . . . . 73.24 111.164 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.69 0.52 55.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 64.23 110.711 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 215' ' ' GLU . . . 87.12 33.89 11.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.459 -0.877 . . . . 71.44 113.829 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 213' ' ' TYR . 1.4 p -120.79 129.22 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.226 0.513 . . . . 42.44 110.803 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -77.29 111.6 18.03 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 51.24 109.578 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 123.82 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.577 2.185 . . . . 73.32 113.295 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.1 m -95.37 104.59 16.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.886 -0.597 . . . . 55.31 110.041 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.645 HH21 ' HB2' ' A' ' 244' ' ' LEU . 0.0 OUTLIER 79.8 -56.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.64 0.776 . . . . 72.02 110.866 175.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.658 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.61 -54.89 38.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.32 -0.4 . . . . 74.11 111.457 -173.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.13 -44.95 97.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 55.23 112.592 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.43 -53.74 33.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.113 0.482 . . . . 72.52 111.12 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.645 ' HB2' HH21 ' A' ' 240' ' ' ARG . 3.7 mm? -72.22 -40.34 67.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.662 . . . . 64.51 111.537 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -46.43 89.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.69 0.281 . . . . 61.45 111.049 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 242' ' ' GLY . 75.1 mt -66.6 -33.92 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 65.3 110.714 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.1 86.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.517 -0.549 . . . . 65.3 109.517 174.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.47 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -58.76 -39.1 93.25 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.737 -0.744 . . . . 75.02 112.18 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.07 -42.18 94.4 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.965 0.358 . . . . 75.42 111.965 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 31.2 p -69.64 -35.8 75.53 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.243 -0.583 . . . . 74.15 110.955 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 70.6 mtm -65.69 -46.81 77.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.056 -0.258 . . . . 62.35 111.073 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.8 -28.78 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.738 -0.385 . . . . 54.45 110.586 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -46.55 87.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.97 -0.382 . . . . 71.31 109.97 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 16.8 m0 -67.32 -28.64 68.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.915 -0.584 . . . . 75.11 110.906 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -83.9 -35.78 23.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 74.33 112.628 -173.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 42.9 p -102.64 -14.69 16.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.416 0.524 . . . . 73.34 112.416 -171.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.28 -33.54 4.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.235 -0.983 . . . . 61.15 113.006 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 143.93 18.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.371 -0.488 . . . . 73.14 110.868 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.496 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.3 mt -103.9 149.5 37.25 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 73.23 110.315 176.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.01 -40.25 86.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.751 2.301 . . . . 73.3 112.681 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 25.0 p90 -87.13 -0.38 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.531 -0.304 . . . . 71.32 111.35 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 265' ' ' LEU . 84.7 tt0 -79.63 -28.27 40.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.093 0.473 . . . . 73.34 109.945 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.19 -27.95 32.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 64.5 110.26 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -108.4 17.42 22.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.529 -0.76 . . . . 54.13 112.098 -173.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 262' ' ' GLU . 4.2 pp -73.56 -7.85 53.55 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.091 0.472 . . . . 64.1 111.085 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -64.21 -14.12 53.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 73.23 111.058 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.706 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 10.9 t70 -134.69 127.89 18.71 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 63.23 110.223 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.0 Cg_exo -61.59 -33.06 87.71 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.351 2.701 . . . . 71.52 114.794 -171.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.706 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 22.9 pttm -74.29 -24.04 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.515 -0.474 . . . . 75.13 111.471 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 267' ' ' ASP . 74.6 m-85 -71.22 -49.55 42.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 73.3 110.157 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.671 HG13 ' HZ2' ' A' ' 275' ' ' LYS . 96.1 t -58.5 -37.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.784 -0.644 . . . . 74.03 110.954 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.427 ' O ' HG13 ' A' ' 276' ' ' ILE . 48.5 ttt-85 -59.85 -61.9 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 73.14 110.876 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -45.58 91.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.974 -0.557 . . . . 73.54 111.82 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 15.1 p -61.46 -49.92 74.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.883 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.677 ' CD ' ' HA ' ' A' ' 229' ' ' SER . 56.2 mttp -66.69 -37.35 84.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 61.15 111.75 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 280' ' ' GLU . 83.0 mt -60.85 -49.58 84.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.42 . . . . 55.44 110.557 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -69.01 -33.63 73.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 74.42 111.003 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.81 -36.4 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 64.1 110.644 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 282' ' ' ILE . 58.2 ttp180 -71.06 -38.22 72.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 74.31 110.805 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 72.7 mt-10 -67.58 -42.32 82.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 74.24 110.986 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.488 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.0 m-80 -117.78 46.97 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 73.52 110.649 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.63 -51.35 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.865 0.691 . . . . 73.33 112.865 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.51 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.11 -43.54 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.913 0.387 . . . . 61.25 111.339 -175.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.4 m -65.96 -45.39 81.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.839 -0.619 . . . . 75.02 110.853 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.0 mm? -69.39 -43.12 74.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 72.21 111.603 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 282' ' ' ILE . 30.5 mmt -64.57 -40.34 95.38 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.965 -0.294 . . . . 74.21 111.051 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 16.1 t70 -66.26 -48.64 69.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 74.31 111.2 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -98.94 14.54 28.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.847 -0.615 . . . . 64.23 111.875 -169.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 47.4 t -85.44 -27.25 25.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 60.02 109.777 173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 290' ' ' PHE . 0.1 OUTLIER -138.1 68.5 48.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 64.3 111.298 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.19 31.89 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.035 2.49 . . . . 71.34 111.919 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.76 -85.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.666 -0.697 . . . . 70.2 111.808 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -145.4 16.27 1.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.964 0.887 . . . . 71.42 109.492 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -104.73 -142.92 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.338 -0.847 . . . . 61.01 109.958 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 47.9 tptt -156.06 114.98 2.16 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.657 -0.247 . . . . 63.21 110.613 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.511 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 47.3 Cg_endo -95.42 77.99 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.342 2.695 . . . . 65.42 111.697 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -119.95 -59.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.201 -0.999 . . . . 63.22 112.535 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.607 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 1.1 mp0 -60.02 -61.43 2.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.675 0.274 . . . . 74.11 110.399 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.554 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.7 mp -60.6 -37.17 74.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.62 . . . . 60.34 110.63 -177.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.61 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 70.33 111.335 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 40.4 tptt -72.03 -33.58 68.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.34 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -55.41 -49.39 72.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.669 -0.696 . . . . 74.1 110.708 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.47 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 94.3 mmm -72.02 -39.67 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 74.05 111.057 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.534 ' HA ' HG13 ' A' ' 282' ' ' ILE . 23.1 tt0 -57.46 -45.68 84.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.634 0.73 . . . . 63.23 109.71 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.6 m -60.07 -51.08 71.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.54 -1.209 . . . . 63.25 112.0 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 303' ' ' MET . 31.0 m -73.37 -27.91 24.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.331 0.493 . . . . 42.51 112.331 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -75.62 -43.82 45.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.889 0.376 . . . . 71.32 110.703 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.95 76.74 10.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.344 0.498 . . . . 75.0 112.344 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.634 HD11 HH11 ' A' ' 240' ' ' ARG . 0.5 OUTLIER -163.28 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.864 171.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.999 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 32.4 t70 -178.35 164.22 1.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.993 -0.373 . . . . 64.13 109.993 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.658 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 2.2 t80 -58.58 -64.6 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.861 0.465 . . . . 75.25 111.069 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 t -114.77 36.42 3.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.409 0.623 . . . . 74.42 110.731 -173.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 9.9 tp10 -67.57 -86.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 65.41 111.481 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 179.98 137.53 0.29 Allowed Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 109.502 -0.555 . . . . 72.53 109.502 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -91.96 128.64 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.622 2.215 . . . . 73.12 112.995 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.498 ' O ' HD13 ' A' ' 320' ' ' LEU . 90.4 mt -79.96 75.78 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.518 -0.549 . . . . 74.03 109.518 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.6 ' CE1' ' HB3' ' A' ' 162' ' ' LEU . 67.1 t80 -57.67 -39.29 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.778 -0.646 . . . . 74.31 111.401 -174.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.08 -43.7 98.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.517 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -76.7 -29.87 56.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.52 -0.309 . . . . 72.5 111.225 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 323' ' ' ILE . 7.1 mp -69.34 -48.13 62.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 74.32 110.9 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.442 HH22 ' NH2' ' A' ' 160' ' ' ARG . 20.9 ttt180 -70.57 -28.13 64.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 75.34 109.758 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.41 -41.03 66.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.882 -0.599 . . . . 71.41 111.464 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -67.72 -36.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.956 -0.387 . . . . 75.14 109.956 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 155' ' ' LEU . 92.1 mt -60.46 -49.43 77.59 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.936 0.398 . . . . 61.21 110.079 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 159' ' ' LEU . 3.8 mm? -62.61 -37.92 88.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.554 . . . . 51.12 111.408 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -55.56 -47.36 76.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.586 -0.279 . . . . 75.2 110.827 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.586 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.83 -42.64 96.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 75.15 112.184 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 333' ' ' SER . 27.4 tp -65.86 -42.97 89.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 71.13 111.114 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -66.69 -32.59 73.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 73.22 110.363 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.19 64.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 54.24 111.089 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 328' ' ' LEU . 12.7 tt -85.68 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 120.948 0.404 . . . . 72.11 110.495 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.83 36.45 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.562 -0.827 . . . . 43.25 113.508 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.682 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 52.3 m -129.42 162.57 27.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.034 0.417 . . . . 73.12 111.16 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.785 ' HD2' ' HB2' ' A' ' 336' ' ' ASP . 5.6 tmtt? -179.5 -51.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.931 -0.766 . . . . 74.42 108.931 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.759 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 8.1 t70 70.04 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.154 -0.93 . . . . 71.3 110.473 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . 0.785 ' HB2' ' HD2' ' A' ' 334' ' ' LYS . 10.9 t70 58.56 94.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.669 0.606 . . . . 72.11 111.21 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 150.14 -36.07 0.97 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.958 -0.857 . . . . 61.14 110.958 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.527 0 N-CA-C 109.547 -0.538 . . . . 62.43 109.547 172.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 mttt . . . . . 0 CA--C 1.522 -0.123 0 CA-C-O 121.153 0.501 . . . . 74.32 112.133 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 79' ' ' PRO . 95.8 m -150.44 137.35 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.641 -0.708 . . . . 73.22 109.946 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -66.91 134.03 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.271 0.558 . . . . 62.13 110.27 -176.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.454 ' N ' HD13 ' A' ' 354' ' ' ILE . 50.9 m -64.96 94.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 35.11 112.054 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.41 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 115.761 -0.654 . . . . 74.22 111.305 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HA ' HG13 ' A' ' 39' ' ' VAL . 61.3 t . . . . . 0 C--O 1.235 0.295 0 CA-C-O 120.896 0.379 . . . . 74.4 110.928 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.37 0.03 56.96 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.694 -0.765 . . . . 32.13 113.425 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 9.4 pt-20 -82.48 150.74 26.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.029 -0.73 . . . . 73.01 109.029 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 1.2 tp -91.42 131.54 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 63.24 110.057 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.34 132.14 71.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.498 -0.773 . . . . 72.23 109.222 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 m -118.08 114.08 22.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.935 -0.395 . . . . 75.21 109.935 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.537 ' OD2' ' HA3' ' A' ' 115' ' ' GLY . 4.7 p-10 -95.23 -172.02 2.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 70.21 110.41 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.1 mmt -70.58 -11.27 60.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.475 0.546 . . . . 74.23 112.475 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.06 2.45 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.226 -0.296 . . . . 53.34 110.372 174.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.28 24.93 8.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.517 -0.765 . . . . 74.21 110.687 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' THR . 29.1 mtpp -93.63 124.75 37.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.85 -0.614 . . . . 71.24 110.163 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.79 92.21 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.354 -0.61 . . . . 71.12 109.354 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 1.004 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 25.1 p-90 -116.83 140.02 49.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.792 -0.64 . . . . 74.33 111.141 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 56' ' ' MET . 23.6 pttm -85.6 139.26 31.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.101 -0.703 . . . . 44.22 109.101 174.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 25' ' ' VAL . 3.6 p -66.95 117.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 74.23 109.061 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.98 -121.59 4.89 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.418 -0.896 . . . . 40.51 112.731 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.685 HD22 ' HD2' ' A' ' 42' ' ' PRO . 2.4 tm? -73.31 118.02 65.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.916 0.388 . . . . 73.33 110.397 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.685 ' HD2' HD22 ' A' ' 41' ' ' LEU . 65.1 Cg_endo -75.91 96.7 1.07 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.492 2.128 . . . . 72.43 111.797 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 53' ' ' LEU . 56.7 mt -62.77 -45.56 98.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.242 0.544 . . . . 65.33 110.337 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.25 83.67 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.399 -0.819 . . . . 62.11 112.226 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 61.1 mt-30 -139.04 159.85 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.902 -0.407 . . . . 65.32 109.902 -174.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.73 49.88 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.634 -0.793 . . . . 74.32 111.497 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.03 112.06 2.71 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.686 -0.768 . . . . 60.04 112.218 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.583 ' HD2' ' HE2' ' A' ' 71' ' ' LYS . 21.5 m-85 68.25 -72.38 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.465 0.706 . . . . 71.2 111.447 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 138.8 174.91 13.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.034 -0.603 . . . . 72.51 111.625 -177.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.39 31.1 17.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.379 . . . . 62.12 111.483 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 71' ' ' LYS . 18.1 mm -88.82 136.59 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.92 -0.4 . . . . 74.24 109.92 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -108.19 153.65 22.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.52 0.2 . . . . 73.32 110.975 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 43' ' ' ILE . 8.1 tt -100.91 137.39 39.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.372 -0.603 . . . . 52.25 109.372 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . . . -94.98 93.73 7.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 53.41 110.494 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.13 -15.87 57.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 72.13 110.837 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 1.004 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 47.8 mtp 59.94 -163.47 0.24 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.75 -0.659 . . . . 73.43 110.39 -176.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.38 141.22 48.45 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.545 -0.909 . . . . 62.23 108.545 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -77.35 38.12 0.22 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.337 0.495 . . . . 63.32 112.337 -171.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.0 m . . . . . 0 C--N 1.324 -0.501 0 N-CA-C 109.592 -0.521 . . . . 74.22 109.592 173.744 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.516 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.538 0.515 0 N-CA-C 112.221 0.452 . . . . 51.21 112.221 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.629 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 56.1 Cg_endo -71.21 62.39 2.62 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.697 1.598 . . . . 54.04 112.611 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 54' ' ' ALA . 9.3 p -120.79 152.47 38.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.7 -0.482 . . . . 74.34 109.7 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -122.94 155.8 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.656 0.265 . . . . 64.2 110.784 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -121.48 120.71 62.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.314 0.578 . . . . 54.23 111.415 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HG3' HD12 ' A' ' 51' ' ' ILE . 77.6 tttt -95.64 131.84 41.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 64.21 109.116 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 128' ' ' PHE . 34.7 m -118.68 151.76 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.207 0.447 . . . . 52.23 112.207 -173.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 127' ' ' ARG . 4.1 pt-20 -132.9 155.93 80.62 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.322 -0.399 . . . . 72.3 110.211 172.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -82.29 114.87 2.53 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.632 2.221 . . . . 74.25 112.24 176.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t 81.47 -96.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.032 0.933 . . . . 61.11 112.467 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -171.02 12.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.299 1.222 . . . . 62.0 114.299 -167.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -146.37 103.95 3.74 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.779 -0.768 . . . . 74.23 112.394 -171.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.96 -161.24 32.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.921 -0.657 . . . . 53.31 111.781 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.896 ' HB3' ' HA2' ' A' ' 199' ' ' GLY . 31.2 Cg_exo -60.02 -26.64 82.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.017 2.478 . . . . 72.33 112.465 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.8 tm? -64.52 -37.07 86.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.457 -0.572 . . . . 70.45 109.457 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.88 -38.28 86.02 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.214 0.53 . . . . 74.43 109.808 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.3 m -62.87 -45.05 94.37 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.68 -0.691 . . . . 72.33 110.162 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.68 -29.72 69.06 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.934 -0.576 . . . . 74.51 110.752 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -59.08 -50.24 74.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.418 -0.215 . . . . 74.42 110.418 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -58.57 -47.27 84.83 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.769 0.319 . . . . 63.54 110.627 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.405 ' HD2' ' CD1' ' A' ' 87' ' ' TYR . 83.8 t80 -57.58 -52.19 66.41 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.895 -0.593 . . . . 75.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CD1' ' HD2' ' A' ' 86' ' ' PHE . 6.1 m-30 -62.35 -43.73 98.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.594 -0.275 . . . . 75.44 111.232 -175.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.18 -33.46 76.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.81 0.3 . . . . 72.22 111.81 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -95.48 -23.04 17.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.663 0.616 . . . . 72.01 112.663 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HB2' ' HE2' ' A' ' 167' ' ' TYR . . . -104.11 -34.54 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.78 0.659 . . . . 73.4 112.78 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.81 78.36 9.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.31 0.576 . . . . 72.21 111.594 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 19.2 tptp -155.51 101.79 2.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.894 -0.78 . . . . 73.53 108.894 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -43.72 -46.46 10.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.878 3.052 . . . . 75.3 114.138 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.26 -51.73 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 75.2 111.156 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -64.95 -40.89 95.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 74.43 110.488 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 72.8 mt -57.94 -53.6 43.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 50.23 110.857 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -62.04 -31.05 71.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.829 -0.623 . . . . 72.23 110.637 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 98' ' ' LYS . 10.5 tppt? -70.54 -50.9 32.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.099 -0.501 . . . . 75.21 111.525 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -73.53 -35.66 65.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 119.749 -0.78 . . . . 65.43 110.57 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.84 -34.95 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.439 0.638 . . . . 71.42 110.089 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -65.46 -49.34 69.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.243 -0.89 . . . . 74.41 111.229 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -75.75 -41.8 52.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.287 0.477 . . . . 73.31 112.287 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 105' ' ' LEU . 18.4 mmt180 -78.1 -17.38 57.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.477 -0.329 . . . . 72.35 111.189 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 64.95 59.97 0.84 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.949 0.88 . . . . 54.42 110.177 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 103' ' ' ARG . 7.3 mp -97.09 -166.3 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.557 -1.201 . . . . 75.12 108.542 173.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -128.64 -54.42 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.9 -0.72 . . . . 52.32 112.388 -174.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -164.73 107.88 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.713 -0.395 . . . . 71.55 110.981 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.544 HD22 ' CZ2' ' A' ' 99' ' ' TRP . 18.2 tp -80.21 132.0 35.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.01 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.72 70.91 2.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.997 -0.62 . . . . 63.1 111.904 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 96' ' ' ILE . 11.3 p -115.89 142.44 29.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.515 -0.18 . . . . 62.5 110.515 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.478 ' HG3' HG11 ' A' ' 196' ' ' VAL . 6.8 Cg_exo -72.82 140.4 32.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.468 2.112 . . . . 72.43 112.084 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -72.57 106.49 4.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.696 -0.483 . . . . 74.32 109.696 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -81.7 119.91 24.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.985 -0.552 . . . . 74.15 110.743 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CD1' HG22 ' A' ' 130' ' ' ILE . 41.9 m95 -95.73 -65.63 0.96 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.205 0.526 . . . . 72.11 109.802 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.537 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -151.07 -170.76 18.43 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.622 -0.717 . . . . 75.23 112.317 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 129' ' ' MET . 51.2 p -167.8 -177.36 3.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.864 -0.421 . . . . 71.23 109.864 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.43 -175.08 38.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.22 -0.99 . . . . 43.43 112.629 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -133.39 127.88 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.915 -0.772 . . . . 54.03 108.915 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -138.62 120.87 15.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 63.2 110.772 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 11.7 t70 -81.36 131.26 35.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 63.42 110.612 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -96.26 -53.21 3.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 62.32 110.588 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -169.22 91.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 70.05 109.869 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.27 11.5 67.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.194 -0.527 . . . . 64.15 112.162 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -144.16 108.35 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.078 -0.342 . . . . 63.12 110.078 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.523 ' HB3' HD21 ' A' ' 118' ' ' LEU . 24.3 m -85.09 111.33 19.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.04 -0.527 . . . . 73.12 109.901 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -91.53 128.33 37.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 72.0 110.987 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 32.3 ttm180 -91.21 128.27 36.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.333 -0.988 . . . . 74.45 108.333 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.586 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.8 p90 -134.1 152.68 51.94 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.955 -0.298 . . . . 72.13 111.147 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 70.9 mtm -136.97 140.46 42.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.078 -0.51 . . . . 71.52 110.285 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 8.1 mm -99.05 119.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.212 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.35 -174.14 3.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 63.14 110.315 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.92 158.04 26.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 63.32 110.625 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -67.15 115.46 6.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 65.33 112.186 -174.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 29.7 m-85 -119.52 171.68 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.512 -0.767 . . . . 50.3 109.283 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 -54.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.385 -0.912 . . . . 52.22 112.105 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -81.1 124.31 29.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 74.42 110.702 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.624 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -92.95 145.35 24.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.094 -1.076 . . . . 64.2 108.094 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 33.1 tp -60.92 -38.08 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.668 -0.413 . . . . 73.22 110.065 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.878 ' HA ' ' HD2' ' A' ' 142' ' ' TYR . 50.7 tt0 -59.97 -37.24 79.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.2 111.531 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 8.8 mttp -55.24 -59.59 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 75.55 110.43 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.23 -39.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.264 -0.88 . . . . 73.22 111.12 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.878 ' HD2' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.48 -38.74 91.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.353 -0.385 . . . . 74.24 111.234 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' CE2' ' A' ' 142' ' ' TYR . 32.6 mt-10 -83.48 -18.49 38.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.722 -0.391 . . . . 71.22 111.439 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -79.03 -23.98 43.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.323 0.582 . . . . 71.42 110.06 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -97.72 1.09 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.544 -0.753 . . . . 71.44 109.27 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.76 39.92 30.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.105 -0.952 . . . . 62.25 111.98 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 41.5 pttt 42.52 38.29 1.21 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.074 0.95 . . . . 74.14 113.22 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -98.76 81.33 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.075 -0.713 . . . . 73.15 109.075 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.93 156.97 26.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.965 0.412 . . . . 71.14 111.291 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.8 t -99.34 -172.55 2.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 54.43 110.224 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.446 ' HD3' ' CD ' ' A' ' 298' ' ' GLU . 3.9 ttm180 -65.39 -24.03 67.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 71.53 111.294 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -58.09 -68.73 0.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.927 -0.579 . . . . 74.23 111.897 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.7 p -59.11 -47.34 85.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 63.33 111.905 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.33 -41.67 71.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.689 -0.687 . . . . 53.31 111.332 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -71.41 -50.03 35.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.363 -0.38 . . . . 73.44 110.412 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.92 -44.95 87.16 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.863 0.363 . . . . 75.12 111.204 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 161' ' ' ILE . 8.3 mp -61.29 -52.73 63.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.125 -0.489 . . . . 73.12 111.137 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.0 p -63.74 -34.13 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.24 . . . . 72.01 111.526 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.33 -53.44 57.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.412 -0.358 . . . . 71.21 110.356 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -70.16 -29.27 66.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.07 0.462 . . . . 73.31 110.78 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 157' ' ' LEU . 30.1 mm -67.5 -37.99 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.15 110.523 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.55 -39.92 95.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.971 -0.381 . . . . 62.54 109.971 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.17 -63.23 1.22 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.685 0.755 . . . . 71.43 110.462 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 195' ' ' LEU . 18.4 tt -64.45 -34.85 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.375 -0.829 . . . . 73.12 111.264 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 175' ' ' HIS . 50.3 tp -60.95 -40.05 91.82 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.825 -0.17 . . . . 63.31 111.274 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -65.74 -39.11 90.77 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.535 -0.466 . . . . 64.11 110.904 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 49.1 t80 -59.06 -49.44 77.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.371 -0.532 . . . . 73.11 111.594 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.0 pt -74.03 -32.2 32.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.813 -0.355 . . . . 64.14 110.969 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.95 -45.75 92.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 73.03 110.915 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.33 8.08 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.94 0.4 . . . . 73.43 110.928 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -104.86 -67.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.083 -0.247 . . . . 75.01 111.016 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -152.46 -58.94 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.518 0.562 . . . . 53.24 112.518 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HA ' ' A' ' 203' ' ' ARG . 10.5 p90 -121.36 164.75 16.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.331 0.863 . . . . 63.42 113.331 -164.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.9 173.27 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.756 -1.111 . . . . 71.32 108.931 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CE1' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -129.44 103.7 7.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.585 0.707 . . . . 74.52 112.038 -175.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.01 -39.4 89.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.362 -0.836 . . . . 53.1 111.524 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 1.018 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 28.5 t70 -89.84 91.07 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.256 0.55 . . . . 75.5 110.041 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 178' ' ' ILE . 8.4 tt -110.01 25.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.087 0.946 . . . . 75.23 109.242 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.6 162.16 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.138 -0.937 . . . . 74.14 109.96 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.14 -5.37 1.04 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.033 0.753 . . . . 75.24 113.033 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 352' ' ' LYS . 1.0 OUTLIER -76.87 -20.65 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 50.51 110.413 176.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -88.37 -15.12 36.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 71.25 110.292 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 138' ' ' LEU . 6.4 mp -97.52 120.57 38.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 70.33 110.297 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.5 mm? -116.22 141.82 47.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.957 -0.565 . . . . 74.12 110.449 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 190' ' ' PRO . 9.8 mp -99.29 160.36 14.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.772 0.32 . . . . 74.23 110.559 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.42 151.22 47.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.179 -0.675 . . . . 52.25 109.179 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.06 -26.23 62.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.303 0.483 . . . . 75.23 112.303 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 188' ' ' LYS . 32.5 tptt -112.36 -58.09 2.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.8 0.667 . . . . 74.05 112.8 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -104.57 131.13 22.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.414 0.626 . . . . 73.44 112.201 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 185' ' ' LEU . 96.5 Cg_endo -77.21 -7.5 17.15 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.326 2.684 . . . . 73.05 113.544 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.88 -6.9 57.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.313 0.578 . . . . 73.45 110.182 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.455 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 88.1 mm-40 -105.29 92.75 4.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 72.41 110.342 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.16 120.45 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.441 0.639 . . . . 63.44 109.849 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 61.9 m-85 -113.08 154.86 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.351 -0.84 . . . . 74.42 109.515 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 164' ' ' ILE . 14.0 tp -110.12 107.48 17.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.882 -0.414 . . . . 74.3 109.882 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.478 HG11 ' HG3' ' A' ' 111' ' ' PRO . 19.8 m -138.41 -166.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 54.53 109.972 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.05 56.17 1.06 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.854 0.835 . . . . 71.21 109.922 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -82.85 67.12 8.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.61 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.896 ' HA2' ' HB3' ' A' ' 79' ' ' PRO . . . -64.34 -57.84 12.11 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.436 -0.802 . . . . 51.54 111.498 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 222' ' ' ASP . 3.7 mp -106.47 88.06 2.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.341 0.591 . . . . 70.43 110.289 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -114.8 110.65 20.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.542 -0.754 . . . . 54.02 109.761 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.47 115.58 29.63 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.066 -0.516 . . . . 74.12 109.63 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 173' ' ' TYR . 35.8 ptt180 -69.76 137.36 51.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 71.0 111.543 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.625 ' CE1' ' HA ' ' A' ' 239' ' ' SER . 56.0 t80 -93.68 -55.64 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.561 -0.745 . . . . 75.21 110.546 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.5 p -110.81 96.73 30.3 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 72.43 110.651 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 28.8 Cg_exo -60.94 114.44 2.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.671 2.248 . . . . 63.35 112.077 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 64.45 20.19 12.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.609 -0.723 . . . . 70.04 111.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.05 60.23 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.872 -0.68 . . . . 61.34 113.121 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 55.6 t -88.88 118.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.806 0.336 . . . . 73.1 110.624 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.486 ' HB2' ' OE2' ' A' ' 212' ' ' GLU . 17.9 p80 -71.09 128.11 34.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 70.23 111.001 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -114.13 -31.02 6.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 60.23 111.164 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' A' ' 210' ' ' HIS . 2.8 mp0 59.1 -100.04 0.1 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.273 -174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.566 ' HA ' HG23 ' A' ' 236' ' ' VAL . 18.1 p90 -80.71 103.41 10.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.593 0.711 . . . . 75.43 110.953 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -98.14 -51.38 4.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.033 -0.729 . . . . 65.42 109.033 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 217' ' ' PRO . 37.0 tt0 62.65 90.48 0.08 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.197 -0.91 . . . . 75.11 112.525 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.47 82.55 62.88 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.531 -0.759 . . . . 75.35 109.872 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.419 ' HD3' ' HG2' ' A' ' 215' ' ' GLU . 56.7 Cg_endo . . . . . 0 CA--C 1.528 0.202 0 C-N-CA 123.068 2.512 . . . . 60.44 112.619 -178.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 200' ' ' LEU . 2.6 m-20 . . . . . 0 C--O 1.233 0.218 0 CA-C-O 121.467 0.651 . . . . 71.53 112.337 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 1.018 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . 147.24 164.16 11.0 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.919 -1.037 . . . . 63.54 111.017 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 226' ' ' GLU . 22.8 m -69.02 139.62 54.95 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.785 -0.45 . . . . 73.24 109.785 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.554 ' HA ' ' OG1' ' A' ' 228' ' ' THR . 49.4 mt -56.31 -22.33 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.569 0.699 . . . . 52.22 110.997 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 224' ' ' THR . 34.9 tt0 -51.68 -42.51 62.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.311 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 246' ' ' ILE . 59.1 m-85 -104.32 -90.72 0.38 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.766 -0.652 . . . . 74.43 109.635 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 225' ' ' ILE . 28.0 m 67.02 -63.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.822 0.701 . . . . 71.41 112.566 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 275' ' ' LYS . 49.7 m 67.75 172.09 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.284 0.634 . . . . 73.53 111.094 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.7 mp -71.75 -40.53 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.159 0.504 . . . . 71.5 109.866 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . 1.6 m-20 -54.3 -61.13 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.682 -1.145 . . . . 74.52 111.758 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.02 82.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 70.51 111.538 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -67.9 -26.54 66.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.499 -0.319 . . . . 74.12 111.503 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.463 ' HB3' HG12 ' A' ' 236' ' ' VAL . 65.6 t30 -80.36 -4.7 54.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.539 0.685 . . . . 55.11 109.66 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.66 76.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.55 -0.75 . . . . 60.34 112.326 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 213' ' ' TYR . 7.2 p -111.81 127.7 68.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.954 0.407 . . . . 64.11 110.441 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.94 112.24 39.05 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.004 -0.543 . . . . 74.32 109.704 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.686 ' HG2' ' HA3' ' A' ' 242' ' ' GLY . 24.6 Cg_exo -63.15 152.78 77.89 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.325 2.017 . . . . 52.43 111.398 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 16.0 p -77.09 -18.37 58.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.444 . . . . 71.3 111.08 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.801 ' HD3' ' HG3' ' A' ' 315' ' ' PRO . 7.1 ptp180 178.11 -40.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 71.52 110.449 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 241' ' ' ARG . 9.9 ttt180 -55.17 -53.91 49.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 74.44 111.771 -175.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.686 ' HA3' ' HG2' ' A' ' 238' ' ' PRO . . . -59.78 -44.98 96.52 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 116.005 -0.543 . . . . 63.42 114.232 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.51 -42.07 92.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 61.43 109.452 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.87 -36.12 82.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.734 -0.667 . . . . 74.02 110.828 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -51.03 71.26 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.997 -0.547 . . . . 64.02 110.339 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 227' ' ' PHE . 66.9 mt -63.23 -39.73 86.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.425 -0.807 . . . . 73.15 110.831 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.3 tp -57.82 -43.45 85.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.344 -0.389 . . . . 63.2 110.392 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.68 97.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.037 -0.602 . . . . 63.42 112.555 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 252' ' ' ILE . 35.5 m-85 -67.11 -31.22 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 74.31 111.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 178' ' ' ILE . 59.6 m -65.93 -44.13 86.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 72.44 109.655 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.1 mtp -61.62 -49.9 74.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.131 -0.94 . . . . 62.14 111.199 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.667 HD12 ' SD ' ' A' ' 286' ' ' MET . 4.6 tt -61.85 -36.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.993 -0.283 . . . . 64.24 110.875 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.441 ' HB2' HD21 ' A' ' 259' ' ' LEU . 8.7 tt0 -59.77 -50.48 73.68 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.101 -0.24 . . . . 72.31 111.323 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.13 -31.04 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.744 0.307 . . . . 71.23 111.186 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.0 tp -84.56 -19.13 33.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.336 0.495 . . . . 64.13 112.336 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.3 p -106.48 -27.83 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.109 -0.369 . . . . 64.5 111.979 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 113.35 -35.8 4.37 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.575 -0.821 . . . . 40.52 112.708 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -156.98 165.5 35.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.941 0.371 . . . . 70.21 110.081 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 253' ' ' GLN . 72.0 mt -94.27 139.61 22.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.201 -0.296 . . . . 65.24 110.201 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 32.8 Cg_exo -60.59 -27.31 84.62 Favored 'Trans proline' 0 CA--C 1.526 0.122 0 C-N-CA 122.726 2.284 . . . . 64.14 112.36 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -100.07 10.95 40.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.126 -0.488 . . . . 64.12 111.057 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 50.6 tt0 -69.28 -29.59 67.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.237 0.541 . . . . 72.31 110.906 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.3 -21.56 49.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.025 0.441 . . . . 74.3 110.733 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.84 5.25 24.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 72.43 112.012 -173.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 2.7 pp -79.88 8.25 7.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.915 0.388 . . . . 72.53 111.369 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -67.54 -17.85 64.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 70.42 110.093 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 16.0 t70 -141.64 134.21 13.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.63 -0.714 . . . . 71.44 109.522 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 46.9 Cg_exo -56.91 -19.16 30.72 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 123.308 2.672 . . . . 61.11 114.151 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.59 -53.92 51.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.032 0.444 . . . . 71.34 111.134 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -67.44 -33.88 76.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.051 -0.522 . . . . 70.4 110.439 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 225' ' ' ILE . 61.7 t -61.09 -43.08 95.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 54.25 110.372 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -55.13 -57.1 13.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 73.35 110.421 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -64.76 -40.87 96.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.94 -0.573 . . . . 62.22 111.472 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -59.76 -40.47 88.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.496 -0.32 . . . . 43.44 111.106 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 229' ' ' SER . 44.4 mmtm -66.96 -39.82 87.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.012 -0.275 . . . . 64.15 110.918 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 58.8 mt -63.95 -49.13 83.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.777 0.322 . . . . 72.42 110.824 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -57.78 -47.24 83.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 74.3 110.974 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.15 -36.26 64.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.312 0.486 . . . . 74.41 112.312 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -68.48 -29.02 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 75.41 110.252 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -65.24 0.75 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.975 -0.557 . . . . 75.55 110.021 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.439 ' O ' HD23 ' A' ' 285' ' ' LEU . 47.2 t30 -107.58 77.54 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 63.22 110.387 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 282' ' ' ILE . 0.2 OUTLIER -79.11 -48.83 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.283 -0.871 . . . . 72.14 111.193 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 65.41 112.205 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 39.3 t -66.23 -48.08 71.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.56 -0.291 . . . . 63.54 111.041 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -67.13 -34.17 77.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.652 0.241 . . . . 65.5 111.652 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.667 ' SD ' HD12 ' A' ' 252' ' ' ILE . 26.2 mmt -71.06 -37.94 72.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.961 0.41 . . . . 73.13 111.092 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.4 -38.91 12.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.145 0.424 . . . . 75.21 112.145 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -78.03 -15.09 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.135 0.421 . . . . 73.52 112.135 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 88.9 m -76.94 -21.58 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 75.13 110.516 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.623 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 6.4 m-85 -133.98 86.7 36.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 64.45 110.64 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.38 -69.03 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.73 2.287 . . . . 52.4 111.955 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.06 95.51 3.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.104 0.478 . . . . 72.23 110.271 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 178.61 -52.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.272 -1.01 . . . . 74.23 108.272 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.623 ' O ' ' HB3' ' A' ' 290' ' ' PHE . 15.1 t30 -148.58 163.18 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.547 -1.206 . . . . 64.21 107.946 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 1.7 tpmt? -136.94 106.22 8.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.504 -0.478 . . . . 71.01 111.016 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.01 45.14 1.92 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.375 2.716 . . . . 65.54 111.537 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.58 99.76 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.784 -0.644 . . . . 73.22 112.319 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 298' ' ' GLU . 28.8 mp0 -62.78 -41.32 99.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.694 -0.484 . . . . 73.24 109.694 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.44 HG21 ' HB ' ' A' ' 252' ' ' ILE . 15.0 mm -63.93 -46.86 92.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.644 -0.707 . . . . 72.1 110.28 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.1 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.685 -0.689 . . . . 71.44 110.971 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.75 -44.52 95.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.776 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -56.62 -50.86 70.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.586 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.546 ' HA ' HG22 ' A' ' 306' ' ' VAL . 12.3 mtp -70.89 -38.62 73.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.633 -0.258 . . . . 61.23 111.612 -175.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.3 -35.74 81.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.504 0.668 . . . . 73.5 109.407 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 54.7 m -65.57 -52.85 49.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 71.03 111.22 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 303' ' ' MET . 35.3 m -67.26 -30.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.05 0.452 . . . . 45.41 110.802 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -57.44 -43.45 83.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 74.33 110.461 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.91 11.23 21.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.886 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 315' ' ' PRO . 42.9 mt -90.7 -23.29 20.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.874 -0.417 . . . . 72.53 109.874 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.577 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 28.6 t70 56.48 -156.72 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.447 -0.797 . . . . 32.11 110.748 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.577 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.1 m-85 -86.16 -33.01 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.916 0.389 . . . . 75.14 110.112 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.9 t -144.99 26.5 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.01 111.42 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 7.8 tt0 -92.88 23.19 4.33 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.512 0.672 . . . . 74.44 109.627 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.14 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 114.34 -1.3 . . . . 73.31 112.222 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.801 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 93.5 Cg_endo -78.88 119.6 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.823 2.348 . . . . 70.53 111.799 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.7 tp -93.41 84.36 4.72 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.0 0.429 . . . . 53.1 110.12 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 320' ' ' LEU . 74.2 m-85 -60.47 -32.77 71.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.623 -0.717 . . . . 75.51 110.086 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.78 -46.15 74.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.512 -0.767 . . . . 71.22 110.541 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 28.9 t-20 -72.33 -35.28 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.581 -0.282 . . . . 74.21 110.703 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 97.0 mt -58.39 -52.85 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 51.23 110.34 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.53 -21.54 61.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 75.45 110.323 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.04 -50.92 44.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.198 -0.455 . . . . 54.33 110.933 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -70.91 -29.59 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.795 -0.362 . . . . 63.11 110.996 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 85.5 mt -64.8 -49.4 70.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.082 0.468 . . . . 63.2 110.096 175.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.94 -26.76 64.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 75.32 110.945 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -58.48 -47.81 82.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 74.41 109.853 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.432 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -74.97 -39.88 36.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.819 -0.705 . . . . 61.54 112.368 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 2.6 tm? -57.67 -49.44 76.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.19 0.519 . . . . 72.4 110.204 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -24.61 58.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.431 -0.349 . . . . 73.34 111.477 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.63 91.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 75.04 111.184 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -88.21 -9.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.246 0.546 . . . . 52.54 110.602 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 69.49 20.86 75.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.928 -0.653 . . . . 63.34 112.952 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -131.73 138.64 48.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.803 0.302 . . . . 63.32 110.993 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 334' ' ' LYS . 26.6 mtmt -113.35 -73.07 0.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.859 0.838 . . . . 53.3 109.047 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -167.53 -39.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.069 -1.423 . . . . 71.33 107.718 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.6 t0 69.72 32.7 3.17 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 114.461 -1.245 . . . . 65.21 110.973 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.64 14.22 41.4 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.965 -0.636 . . . . 63.04 112.696 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 5.8 tmmm? . . . . . 0 C--N 1.33 -0.25 0 N-CA-C 110.272 -0.27 . . . . 73.43 110.272 -176.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.48 ' CB ' ' HA3' ' A' ' 199' ' ' GLY . 65.8 mttm . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 109.097 -0.705 . . . . 72.21 109.097 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 12.0 t -169.63 140.14 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.109 -0.33 . . . . 73.32 110.109 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 138.37 22.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.799 -0.445 . . . . 73.21 109.799 178.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 32.8 m -68.55 80.92 0.27 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.352 0.596 . . . . 53.41 112.174 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? . . . . . 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 74.22 110.243 171.587 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.5 HG13 ' HA2' ' A' ' 40' ' ' GLY . 84.7 t . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 109.265 -0.642 . . . . 64.41 109.265 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.99 2.13 56.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.147 -1.025 . . . . 43.34 113.422 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 31.3 mt-10 -78.72 140.79 38.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.282 0.541 . . . . 73.32 110.414 174.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -82.18 131.75 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 64.12 111.153 -175.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.59 135.04 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.08 -0.964 . . . . 72.34 108.943 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -115.64 133.73 55.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 63.44 110.28 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -97.58 -172.5 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.844 -0.428 . . . . 72.22 109.844 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 18.5 mmt -72.49 -20.02 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 71.14 110.99 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 12.93 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.538 -0.301 . . . . 24.14 110.983 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 11.6 mptt 65.86 33.14 8.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.911 -0.586 . . . . 70.24 112.404 172.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmpp? -83.58 115.16 21.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.34 84.28 3.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.347 0.594 . . . . 72.31 109.953 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 46.0 p-90 -114.84 149.73 36.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.724 -0.671 . . . . 64.43 110.933 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.836 ' HG2' ' HB2' ' A' ' 57' ' ' ASN . 18.2 pttp -98.57 134.46 41.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 71.24 109.377 173.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.06 132.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.694 -0.484 . . . . 64.22 109.694 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -107.56 -133.41 7.15 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.722 -0.751 . . . . 65.23 112.564 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.423 HD12 ' HD2' ' A' ' 42' ' ' PRO . 38.8 tp -66.55 125.23 90.17 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.97 0.414 . . . . 52.12 111.667 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 41' ' ' LEU . 21.7 Cg_exo -65.67 108.99 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.394 2.063 . . . . 63.44 110.946 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 45' ' ' GLN . 47.5 mt -76.35 -52.32 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 62.32 109.709 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.88 -18.17 17.56 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.867 -0.682 . . . . 73.31 112.641 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.536 ' HB2' ' OD2' ' A' ' 137' ' ' ASP . 20.0 pt20 -124.45 165.14 18.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.676 -0.49 . . . . 72.23 109.676 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.97 66.26 0.15 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.794 -0.717 . . . . 61.42 111.916 -172.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 181' ' ' SER . . . 80.5 -88.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.998 -0.62 . . . . 52.35 112.83 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -89.59 -13.66 36.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 74.23 111.253 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.32 167.46 42.79 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.838 -0.696 . . . . 34.33 113.143 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.2 m 62.77 35.11 14.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.172 0.511 . . . . 62.01 111.56 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.825 HG23 ' HB3' ' A' ' 71' ' ' LYS . 5.3 mm -89.27 138.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 71.23 109.668 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.13 138.67 49.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.95 0.405 . . . . 73.24 111.088 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.435 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 tm? -73.02 127.21 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.706 -0.85 . . . . 73.32 108.706 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.02 91.37 7.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.279 0.562 . . . . 44.41 109.698 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.4 t70 -79.74 61.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.82 . . . . 61.33 109.03 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.591 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -35.8 127.96 0.66 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.65 -1.159 . . . . 75.34 112.302 -175.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.836 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 65.5 t30 -93.63 79.67 4.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.614 -0.721 . . . . 75.43 110.718 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 p -126.31 145.87 50.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.89 0.376 . . . . 72.14 110.964 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p . . . . . 0 C--N 1.319 -0.721 0 CA-C-N 115.81 -0.632 . . . . 75.31 109.785 173.264 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.108 0 CA-C-O 121.273 0.559 . . . . 65.15 109.585 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.528 ' HA ' ' CZ ' ' A' ' 133' ' ' ARG . 4.5 Cg_endo -84.08 25.57 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.457 2.771 . . . . 71.43 112.424 -170.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB2' HG23 ' A' ' 130' ' ' ILE . 9.6 p -162.05 142.26 10.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.483 0.658 . . . . 54.34 112.566 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 133' ' ' ARG . 35.8 m -127.98 149.1 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.163 -0.926 . . . . 72.32 108.684 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.4 p -121.12 126.06 74.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.066 0.46 . . . . 74.43 109.954 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.825 ' HB3' HG23 ' A' ' 51' ' ' ILE . 25.1 pttm -111.13 139.87 46.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.291 -0.964 . . . . 63.0 109.944 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 128' ' ' PHE . 32.7 m -110.53 151.28 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.98 -1.009 . . . . 70.02 111.881 -168.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.723 ' OE1' ' HA ' ' A' ' 77' ' ' ASN . 43.1 tt0 -127.31 130.23 23.76 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.854 -1.066 . . . . 64.52 108.246 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -174.27 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.301 2.001 . . . . 73.44 112.272 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -66.34 71.86 0.07 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.28 0.562 . . . . 52.23 110.723 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -141.06 -59.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.772 -0.649 . . . . 62.44 109.309 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.723 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 69.97 87.91 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.305 1.003 . . . . 63.04 111.213 175.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.79 -80.07 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 51.32 112.547 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.57 -45.04 19.17 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.554 2.169 . . . . 73.44 112.668 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 71' ' ' LYS . 62.4 tp -73.18 -38.61 66.09 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.52 -0.548 . . . . 72.54 109.52 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.442 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 90.8 t80 -55.96 -44.0 78.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.036 -0.529 . . . . 73.5 110.579 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . 0.43 HG21 ' HA2' ' A' ' 199' ' ' GLY . 36.8 m -67.17 -49.64 64.0 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 115.879 -0.6 . . . . 73.55 111.4 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 197' ' ' ASP . 5.6 pt-20 -73.16 -24.14 60.53 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.057 -0.657 . . . . 54.51 110.923 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -64.13 -43.19 96.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.441 -0.577 . . . . 45.43 109.441 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 81' ' ' PHE . 32.4 mmmt -59.76 -48.33 82.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.051 -0.522 . . . . 74.35 110.483 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.69 -45.38 83.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.091 -0.504 . . . . 74.54 110.797 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 113' ' ' TYR . 47.5 t80 -61.58 -46.29 90.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.795 . . . . 73.13 110.975 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.0 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.284 . . . . 63.14 110.941 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.35 -39.82 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 72.52 110.685 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.61 15.64 27.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.056 0.455 . . . . 33.01 111.586 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 113' ' ' TYR . . . -80.45 40.22 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.114 -0.494 . . . . 64.2 112.195 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.778 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -138.59 114.98 8.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.523 -0.308 . . . . 73.5 110.617 -177.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.81 -31.08 91.45 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.545 2.163 . . . . 71.55 111.488 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.778 ' HG2' ' HB3' ' A' ' 92' ' ' LYS . 10.6 pt-20 -54.86 -53.0 61.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.601 -0.727 . . . . 74.04 111.132 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt-30 -72.17 -43.89 63.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.968 -0.56 . . . . 74.12 110.177 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.6 mt -53.87 -54.49 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.711 -0.677 . . . . 73.44 111.006 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.4 -32.72 71.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 70.04 110.718 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -58.39 -59.19 5.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.957 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.623 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.1 -31.81 70.79 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 120.162 -0.615 . . . . 75.14 110.774 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' ILE . 20.4 mt -54.49 -47.28 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 121.191 -0.203 . . . . 51.5 111.252 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -72.61 -35.24 67.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.041 -0.664 . . . . 71.43 110.954 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.6 m -70.52 -40.47 73.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.128 0.489 . . . . 65.34 111.979 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.63 ' HG2' HD13 ' A' ' 105' ' ' LEU . 5.3 tpt180 -87.12 -9.57 54.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.359 . . . . 71.4 110.982 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 67.93 37.99 2.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.966 0.889 . . . . 64.25 109.541 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.709 ' HG ' ' HB2' ' A' ' 163' ' ' ASP . 1.5 tp -79.81 170.69 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.974 -1.012 . . . . 74.3 109.301 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.489 ' HB3' HH22 ' A' ' 160' ' ' ARG . 9.3 tmtm? -113.33 -56.98 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.277 -0.569 . . . . 74.12 110.711 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -151.86 120.72 6.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.737 0.303 . . . . 74.23 110.235 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.623 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 33.5 tp -79.26 130.87 35.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.041 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.61 49.0 2.68 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.906 -0.664 . . . . 72.25 113.068 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.58 118.79 15.9 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 110.118 -0.327 . . . . 73.21 110.118 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 134' ' ' PHE . 92.5 Cg_endo -80.08 161.17 23.6 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.265 2.643 . . . . 64.31 113.468 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.36 137.25 58.24 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.742 -0.663 . . . . 71.4 111.436 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.463 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 40.5 t80 -94.33 133.49 37.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.351 -0.84 . . . . 75.33 110.33 177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.462 ' HB2' HG22 ' A' ' 130' ' ' ILE . 39.2 m95 -112.66 -36.39 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.047 -0.261 . . . . 74.14 111.699 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.87 48.3 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.484 -0.865 . . . . 63.23 112.601 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 80.3 p -169.71 166.71 9.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 61.14 109.939 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.53 174.12 33.02 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.205 -0.998 . . . . 61.33 112.644 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 125' ' ' SER . 10.1 tt -118.53 127.24 53.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.085 -0.709 . . . . 75.14 109.085 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -131.29 119.72 22.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.989 0.423 . . . . 71.32 110.192 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.723 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 37.9 t70 -74.29 120.8 20.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 72.15 109.572 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.68 -60.47 2.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.199 0.523 . . . . 64.21 110.312 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -178.41 96.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.883 -1.053 . . . . 74.3 108.3 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 -37.18 2.33 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.71 -0.757 . . . . 33.03 111.787 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -110.44 131.69 54.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.185 -0.302 . . . . 53.0 110.185 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 19.4 m -103.04 118.46 36.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.125 -0.489 . . . . 73.22 109.809 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.38 124.75 43.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.114 0.483 . . . . 72.31 111.017 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -98.41 120.29 38.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.183 -1.043 . . . . 71.24 108.183 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 72' ' ' VAL . 35.0 p90 -139.1 163.99 30.97 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.741 -0.384 . . . . 61.24 111.554 -171.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 26.0 ptt? -146.58 146.42 30.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.309 0.576 . . . . 62.33 111.635 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -96.68 124.37 49.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.439 -1.255 . . . . 71.04 110.631 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 16.6 ptm -130.66 176.46 8.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.147 -0.933 . . . . 74.52 109.014 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 69' ' ' VAL . 12.6 t70 -65.81 170.37 5.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.645 -0.422 . . . . 53.13 110.079 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.999 ' HD2' ' HB2' ' A' ' 188' ' ' LYS . 4.1 ptp180 -67.93 113.59 5.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.873 0.844 . . . . 73.31 112.639 -167.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -115.26 171.3 7.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.107 -0.951 . . . . 73.4 109.433 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.65 -43.4 0.18 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.624 -1.274 . . . . 72.52 113.389 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.763 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.3 m -80.63 122.41 27.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.945 0.402 . . . . 72.03 111.479 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 45' ' ' GLN . 5.1 m-20 -88.55 129.11 35.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.613 -0.721 . . . . 61.12 110.065 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 141' ' ' ILE . 14.8 tp -66.82 -29.96 70.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.389 0.614 . . . . 74.44 109.379 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.502 ' CG ' ' HB3' ' A' ' 137' ' ' ASP . 20.3 pt20 -62.56 -44.28 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.291 -0.868 . . . . 71.0 111.403 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.443 ' HG3' ' HG3' ' A' ' 139' ' ' GLN . 63.2 mttp -78.8 -11.43 59.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.942 0.401 . . . . 63.35 110.715 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.475 HD12 ' HA ' ' A' ' 138' ' ' LEU . 94.3 mt -74.9 -51.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.481 . . . . 73.53 110.145 172.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.833 ' HB2' ' HA ' ' A' ' 147' ' ' LYS . 1.1 p90 -72.08 -32.32 66.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.533 -0.467 . . . . 75.33 110.155 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.06 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.323 . . . . 75.51 110.845 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.88 -32.35 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.385 . . . . 63.54 111.378 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 50.0 t30 -104.41 19.78 19.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.75 -0.38 . . . . 75.31 111.773 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 54.57 32.42 16.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.869 0.468 . . . . 43.43 112.19 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.833 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 31.1 ttmt 65.43 22.32 11.91 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.586 -0.734 . . . . 73.21 112.0 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' ASN . 30.0 mmt180 -83.35 107.56 15.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.462 -0.57 . . . . 70.41 109.462 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -112.75 152.19 29.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 72.33 110.772 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 p -89.22 172.78 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 50.23 110.614 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 37.5 mmm-85 -68.23 -35.92 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 72.15 111.275 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -73.26 -39.74 65.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.799 -175.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.0 p -64.86 -56.17 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 61.15 111.237 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.45 ' CG1' ' HG3' ' A' ' 251' ' ' MET . 40.5 t -59.8 -37.43 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.085 -0.507 . . . . 75.43 110.919 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.821 HD22 ' HG ' ' A' ' 328' ' ' LEU . 15.0 tp -56.62 -51.22 69.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.646 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -68.0 -33.57 74.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.032 -0.531 . . . . 62.45 110.719 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 95.4 mt -61.7 -50.8 70.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 73.04 110.202 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -55.0 -37.9 67.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 72.22 110.942 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.92 -45.96 91.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.662 -0.244 . . . . 61.44 111.472 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.649 ' NE ' ' HA ' ' A' ' 160' ' ' ARG . 9.7 mmp_? -63.31 -38.61 91.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.134 0.493 . . . . 72.24 111.51 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.8 mp -71.81 -32.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.585 -0.446 . . . . 71.11 109.987 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -59.22 -56.0 27.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.497 -0.319 . . . . 62.22 111.321 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.709 ' HB2' ' HG ' ' A' ' 105' ' ' LEU . 43.4 p-10 -78.1 -24.64 47.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.049 -0.66 . . . . 75.0 112.018 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' A' ' 161' ' ' ILE . 12.1 tt -72.89 -36.49 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.268 -0.573 . . . . 71.03 110.41 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.517 HD23 HD11 ' A' ' 168' ' ' ILE . 42.6 mt -65.26 -38.1 89.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.288 . . . . 73.34 110.456 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -56.5 -51.69 67.54 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.4 0.619 . . . . 74.22 110.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -61.21 -49.98 74.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.132 -0.94 . . . . 64.12 112.29 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.517 HD11 HD23 ' A' ' 165' ' ' LEU . 35.1 pt -71.35 -37.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.277 -0.569 . . . . 73.34 111.518 -175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.723 ' HA ' HG12 ' A' ' 174' ' ' VAL . 62.9 t-80 -68.54 -40.86 80.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.372 -0.531 . . . . 74.34 111.554 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 209' ' ' VAL . 0.5 OUTLIER -85.54 13.86 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.379 -0.529 . . . . 63.04 111.294 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.2 78.76 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.503 0.668 . . . . 74.14 111.352 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 2.7 mp0 72.78 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.266 -1.334 . . . . 64.41 113.289 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.425 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 91.7 m-85 -80.79 118.13 22.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.023 0.749 . . . . 75.34 113.023 -162.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 169' ' ' HIS . 3.2 m -125.72 138.92 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.831 -0.622 . . . . 63.22 110.283 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 1.043 ' HB2' ' HA ' ' A' ' 201' ' ' ALA . 4.6 t-80 -175.68 -50.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.0 0.428 . . . . 64.52 110.94 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.35 -75.93 0.29 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.077 -0.809 . . . . 70.45 111.077 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.92 34.54 13.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.051 0.453 . . . . 74.23 111.764 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 161' ' ' ILE . 21.4 mm -79.39 65.26 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.026 0.917 . . . . 63.3 110.018 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.887 ' HE3' HG21 ' A' ' 224' ' ' THR . 12.8 mmtt -103.4 141.65 35.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 73.01 109.157 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.53 47.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.197 0.522 . . . . 72.34 110.807 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 11.7 p -77.09 -19.28 57.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 74.55 111.552 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.499 ' OD1' ' HE3' ' A' ' 352' ' ' LYS . 17.2 m120 -114.4 2.58 14.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.668 0.27 . . . . 63.34 111.231 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.543 HD21 HD11 ' A' ' 161' ' ' ILE . 10.7 mp -104.13 111.21 23.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.095 -0.705 . . . . 53.15 109.095 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 47' ' ' GLY . 3.7 mm? -113.57 130.81 56.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.056 0.455 . . . . 53.22 111.688 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.763 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 94.1 mt -75.06 145.62 42.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.385 -0.825 . . . . 75.14 110.432 173.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.822 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 24.2 t-20 -73.7 137.48 44.08 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.523 -0.917 . . . . 70.33 108.523 172.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.753 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 33.2 t80 -62.77 -31.14 72.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.095 0.474 . . . . 62.12 111.11 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.999 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 6.2 tmtm? -91.57 -45.55 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.973 -0.558 . . . . 74.03 110.151 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 48.6 m-80 -104.88 100.05 22.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.431 -0.349 . . . . 73.42 110.852 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.06 -6.15 13.04 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.975 2.45 . . . . 75.34 113.237 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.437 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 8.9 p-10 -92.86 -1.01 57.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.719 0.266 . . . . 74.21 111.719 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.481 ' OE1' ' HD2' ' A' ' 160' ' ' ARG . 84.4 mm-40 -129.09 129.73 45.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.383 . . . . 73.44 111.06 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 185' ' ' LEU . 28.6 m -106.03 143.31 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.269 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.822 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 36.8 m-85 -118.56 155.11 31.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.177 -0.465 . . . . 74.34 109.824 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 164' ' ' ILE . 11.3 mt -95.93 146.41 24.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.686 0.279 . . . . 73.03 110.964 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -120.84 -171.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.399 -0.593 . . . . 54.2 109.399 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 8.2 t70 76.25 -71.77 0.11 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.634 0.584 . . . . 74.42 110.638 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 23.1 m-85 58.03 9.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.545 0.943 . . . . 72.04 113.545 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.664 ' HA3' ' CG2' ' A' ' 354' ' ' ILE . . . -100.1 -33.98 5.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.937 -1.125 . . . . 61.44 114.444 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 8.5 mp -68.41 -23.03 64.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.369 0.584 . . . . 74.41 110.018 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 1.043 ' HA ' ' HB2' ' A' ' 175' ' ' HIS . . . -58.48 112.35 1.55 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.518 -0.764 . . . . 73.25 110.054 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . 0.654 ' HE2' ' HA ' ' A' ' 356' ' ' LYS . 6.4 t80 -98.47 132.37 43.97 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.56 -0.904 . . . . 75.33 108.56 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 7.1 ppt_? -86.54 141.56 28.96 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.405 0.521 . . . . 74.2 112.405 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.789 ' HB2' HG12 ' A' ' 209' ' ' VAL . 32.1 m-85 -69.67 -92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.309 -0.859 . . . . 72.14 109.947 170.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 40.1 m -142.48 141.23 20.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.889 -1.051 . . . . 72.25 108.793 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 50.1 Cg_exo -53.71 104.65 0.11 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.945 2.43 . . . . 73.1 112.454 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 62.1 22.15 12.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.448 -0.797 . . . . 73.14 111.564 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.58 42.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.04 -0.824 . . . . 73.22 111.04 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.789 HG12 ' HB2' ' A' ' 204' ' ' TYR . 15.8 m -59.29 109.89 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.483 0.659 . . . . 75.23 112.611 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 t60 179.85 124.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.266 -0.879 . . . . 65.44 109.156 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -152.67 163.38 39.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.554 -0.906 . . . . 70.14 108.554 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -112.25 174.95 5.64 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.516 -0.55 . . . . 53.45 109.516 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -61.82 101.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.348 0.594 . . . . 75.45 112.245 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -105.0 -3.41 23.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 74.12 110.057 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.433 ' HG3' HD21 ' A' ' 234' ' ' ASN . 43.0 tt0 66.03 -76.27 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 114.851 -1.068 . . . . 54.24 111.689 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -118.43 100.64 51.43 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.953 0.406 . . . . 75.35 111.917 -171.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.456 -0.707 0 C-N-CA 122.71 2.273 . . . . 65.34 112.066 171.999 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.429 ' O ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.109 0.481 . . . . 71.24 110.316 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 162.74 177.9 36.13 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.177 -0.919 . . . . 54.42 110.924 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.887 HG21 ' HE3' ' A' ' 179' ' ' LYS . 23.6 p -78.63 117.12 19.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 71.42 110.574 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.614 ' HB ' HD12 ' A' ' 265' ' ' LEU . 57.9 mt -63.0 -21.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 63.33 112.124 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 265' ' ' LEU . 1.6 mp0 -58.26 -42.89 87.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.013 0.435 . . . . 75.41 110.273 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.59 ' HE1' ' HA ' ' A' ' 250' ' ' CYS . 97.8 m-85 -102.25 -18.44 15.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.604 -0.726 . . . . 74.32 110.69 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 225' ' ' ILE . 90.7 m -66.78 108.6 2.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.525 . . . . 74.34 110.982 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.9 p -73.29 -173.52 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.315 -0.857 . . . . 73.21 110.791 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.16 -38.05 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 72.42 110.317 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.62 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.447 -0.797 . . . . 71.55 111.353 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.06 -44.83 87.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 35.1 111.718 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 68.4 t60 -61.35 -37.33 82.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.834 0.349 . . . . 52.42 110.86 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 215' ' ' GLU . 29.0 t-20 -74.25 -36.88 63.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 63.34 110.535 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.87 -19.77 12.04 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.748 -0.739 . . . . 71.51 112.411 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.63 134.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 52.15 110.699 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.47 114.33 55.85 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.093 -0.503 . . . . 64.34 110.444 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.64 ' HB2' ' H ' ' A' ' 242' ' ' GLY . 87.1 Cg_endo -80.83 147.74 17.19 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.819 2.346 . . . . 71.12 112.428 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.42 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 49.0 m -88.55 69.77 8.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.934 0.397 . . . . 72.3 110.543 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.568 ' O ' HD23 ' A' ' 244' ' ' LEU . 20.2 mtp180 73.29 -4.76 2.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.39 -0.823 . . . . 75.45 111.461 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -56.74 7.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.457 . . . . 71.2 109.838 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 238' ' ' PRO . . . -71.22 -36.31 63.74 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.837 -0.697 . . . . 44.43 112.034 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.41 -49.53 69.73 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.375 0.607 . . . . 75.31 110.003 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 240' ' ' ARG . 4.4 mm? -72.04 -32.68 67.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 74.14 111.656 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.65 -38.03 80.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.384 -0.526 . . . . 74.44 110.553 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 242' ' ' GLY . 60.4 mt -59.81 -44.22 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.318 -0.253 . . . . 55.35 110.318 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 161' ' ' ILE . 53.6 tp -60.57 -36.35 78.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.879 0.371 . . . . 44.12 110.429 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.64 95.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.907 -0.663 . . . . 72.34 111.684 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -62.14 -44.59 96.29 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.053 -0.351 . . . . 75.02 110.053 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.59 ' HA ' ' HE1' ' A' ' 227' ' ' PHE . 39.3 m -59.31 -50.19 74.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 75.33 110.709 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.45 ' HG3' ' CG1' ' A' ' 154' ' ' VAL . 26.7 ttt -60.15 -48.53 81.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.536 -0.756 . . . . 72.34 111.583 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.423 HG23 HD21 ' A' ' 259' ' ' LEU . 12.9 tt -68.1 -33.35 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.752 -0.379 . . . . 75.45 110.872 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.712 ' HG2' ' HD3' ' A' ' 147' ' ' LYS . 8.5 tt0 -66.82 -46.95 73.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.633 -0.258 . . . . 73.11 110.738 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -66.85 -27.98 67.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.048 0.452 . . . . 72.11 110.747 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 294' ' ' ASN . 24.0 tp -77.65 -28.64 51.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.52 . . . . 72.42 111.457 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . 0.437 HG22 ' CE2' ' A' ' 290' ' ' PHE . 27.8 p -101.47 -27.31 13.2 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.232 0.456 . . . . 43.12 112.232 -173.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.477 ' HA3' ' NH1' ' A' ' 148' ' ' ARG . . . 96.79 -37.27 3.5 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.573 -0.822 . . . . 74.45 111.579 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.14 142.21 19.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.75 -0.463 . . . . 75.12 109.75 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.562 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 89.4 mt -97.5 145.05 29.03 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.137 -0.483 . . . . 74.44 110.406 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.07 -20.53 61.43 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.702 2.268 . . . . 74.33 112.875 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.587 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 12.6 p90 -106.58 -2.79 21.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.424 -0.511 . . . . 75.42 111.969 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.591 ' O ' HD22 ' A' ' 265' ' ' LEU . 8.2 pt-20 -86.36 -25.92 25.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.901 -0.719 . . . . 72.5 109.662 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.94 -37.34 55.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.607 0.718 . . . . 72.01 109.668 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -108.86 27.58 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.02 . . . . 71.11 111.588 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.614 HD12 ' HB ' ' A' ' 225' ' ' ILE . 1.4 pt? -86.05 -2.0 57.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.951 0.405 . . . . 72.12 111.062 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.6 -8.64 43.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.917 -0.583 . . . . 74.24 111.44 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 269' ' ' LYS . 10.4 t0 -128.25 122.99 22.27 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.874 -0.417 . . . . 61.02 109.874 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.05 -26.34 25.27 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.57 2.847 . . . . 74.12 114.041 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.7 mttp -55.03 -50.09 69.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.865 0.364 . . . . 73.1 110.882 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -73.97 -36.35 64.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 72.24 111.844 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.92 -50.53 75.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.891 0.377 . . . . 44.31 110.39 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -67.32 -42.85 82.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.872 -0.603 . . . . 71.25 110.59 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 277' ' ' ARG . 18.4 t70 -55.26 -61.74 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.631 -0.713 . . . . 75.14 110.65 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.2 p -57.01 -47.86 79.86 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.647 0.592 . . . . 63.33 112.253 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -58.73 -49.78 76.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.209 0.448 . . . . 73.14 112.209 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.94 -37.95 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.972 0.415 . . . . 72.12 110.369 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 273' ' ' ASP . 27.6 ttt180 -58.16 -44.02 87.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.474 -0.784 . . . . 55.12 110.761 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.9 m-85 -73.22 -31.25 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 70.34 110.976 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.59 ' HA ' ' HD3' ' A' ' 307' ' ' LYS . 2.0 ttp180 -67.18 -23.46 65.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.628 -0.26 . . . . 65.14 111.207 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.03 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.986 0.422 . . . . 55.11 110.829 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 285' ' ' LEU . 2.8 t-20 -110.18 94.36 4.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.251 -0.648 . . . . 71.14 109.251 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.632 ' HB ' ' HG2' ' A' ' 304' ' ' GLU . 12.9 mt -80.4 -47.74 20.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.319 -0.855 . . . . 71.45 111.599 -170.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' HB2' ' OE2' ' A' ' 304' ' ' GLU . . . -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 71.42 112.341 -171.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.5 t -61.1 -41.37 96.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.651 0.241 . . . . 75.31 111.651 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.4 mm? -72.16 -42.99 65.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.705 0.288 . . . . 74.1 110.998 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -74.33 -34.46 63.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.847 0.356 . . . . 62.21 110.987 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 14.2 t70 -70.43 -33.65 71.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 75.04 110.174 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -76.87 -11.48 59.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 71.53 111.369 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.3 m -63.74 -55.29 24.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.752 0.311 . . . . 75.42 110.975 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 293' ' ' LYS . 50.5 m-85 -136.76 73.0 54.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 74.35 111.299 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.23 -53.62 3.39 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.394 2.063 . . . . 74.42 112.28 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -120.58 -25.13 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.45 0.537 . . . . 72.31 112.45 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 293' ' ' LYS . 9.7 tmtm? -71.56 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.5 110.683 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 25.2 t-20 -158.89 -90.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.984 -0.286 . . . . 73.21 110.791 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.585 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 28.8 tptp 172.75 115.64 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-O 120.825 0.345 . . . . 75.11 110.348 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.793 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 95.8 Cg_endo -89.88 59.94 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.99 2.46 . . . . 65.14 111.612 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.94 -83.02 1.56 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.391 -0.909 . . . . 64.22 113.06 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.501 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -53.63 -54.98 29.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.795 0.438 . . . . 60.14 111.14 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.657 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.0 mp -58.26 -42.56 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 73.13 111.278 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.24 -54.1 48.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 73.35 111.019 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -65.48 -37.83 87.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.137 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 17.7 t80 -58.53 -42.81 88.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.224 0.535 . . . . 73.42 110.278 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.411 ' HA ' ' CE ' ' A' ' 303' ' ' MET . 1.0 OUTLIER -65.34 -47.05 77.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.449 -0.796 . . . . 72.25 111.051 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 282' ' ' ILE . 46.8 mt-10 -59.12 -47.04 86.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 74.23 109.837 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 88.1 m -57.67 -52.19 66.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.259 -0.882 . . . . 62.24 112.154 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.537 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 33.4 m -67.92 -27.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 73.53 111.485 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 279' ' ' ARG . 44.0 mttp -80.81 -16.26 54.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 74.21 110.891 176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 82.6 mt -89.62 0.74 56.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 52.13 110.664 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 314' ' ' LYS . 27.6 mt -79.81 0.19 31.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.3 0.571 . . . . 52.43 109.718 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 31.3 t70 64.55 -88.44 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.611 -1.177 . . . . 64.23 111.939 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -153.73 -48.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.204 0.526 . . . . 74.22 110.415 -173.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.9 m -140.06 33.53 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.553 . . . . 73.15 110.841 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 49.7 mm-40 -82.99 -88.65 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.102 -0.374 . . . . 73.53 111.482 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.656 ' O ' HD22 ' A' ' 309' ' ' LEU . 10.3 ptpp? -175.98 154.25 1.42 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.12 -0.696 . . . . 74.41 109.12 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 240' ' ' ARG . 96.3 Cg_endo -90.66 125.75 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.213 1.942 . . . . 63.21 110.807 167.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 316' ' ' LEU . 7.5 tp -79.48 79.66 5.92 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.23 -0.656 . . . . 74.14 109.23 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.443 ' CE1' HD12 ' A' ' 162' ' ' LEU . 73.7 t80 -55.51 -49.37 72.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.973 -1.012 . . . . 75.43 112.524 -171.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -34.36 70.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.611 -0.268 . . . . 61.11 111.179 -175.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.25 -45.71 69.08 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.336 -0.246 . . . . 72.21 110.336 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.86 -45.22 86.64 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.318 -0.401 . . . . 63.52 110.795 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.25 -42.26 93.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 54.23 110.275 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.97 -55.51 32.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 64.54 111.202 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.49 -28.14 42.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.677 0.275 . . . . 74.54 111.401 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 155' ' ' LEU . 27.0 tp -66.71 -50.92 61.25 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.474 0.654 . . . . 74.32 110.125 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.4 mm? -73.35 -32.81 64.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 73.14 110.441 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.85 -47.54 80.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 61.31 110.773 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.2 -40.77 96.97 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 44.02 112.061 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.821 ' HG ' HD22 ' A' ' 155' ' ' LEU . 2.3 tm? -68.96 -41.6 77.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.098 0.475 . . . . 73.53 110.153 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.98 -25.3 67.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 72.44 110.681 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.57 -22.57 63.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 72.43 112.34 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.5 tt -92.25 -1.07 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.338 0.589 . . . . 71.31 110.694 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.82 24.11 33.66 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.451 -0.88 . . . . 52.02 112.622 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.411 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 50.2 m -128.86 169.37 14.67 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 122.748 -0.266 . . . . 72.01 110.407 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -159.22 -154.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.296 -0.631 . . . . 70.32 109.296 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.97 116.96 4.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.609 0.242 . . . . 65.15 111.014 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.71 89.66 3.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.094 -0.503 . . . . 61.53 111.493 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 68.4 13.36 65.12 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.004 -0.544 . . . . 64.4 114.165 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 338' ' ' LYS . 29.8 mmtm . . . . . 0 C--O 1.234 0.258 0 N-CA-C 112.684 0.624 . . . . 75.01 112.684 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.184 0 N-CA-C 110.301 -0.259 . . . . 75.24 110.301 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 41.7 m -107.65 139.72 41.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.507 -0.315 . . . . 64.41 110.848 -175.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.664 ' CG2' ' HA3' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -68.83 134.18 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.833 0.349 . . . . 73.13 110.73 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 222' ' ' ASP . 12.3 t -93.41 142.55 27.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 60.24 111.885 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 202' ' ' TYR . 23.5 pttm . . . . . 0 N--CA 1.465 0.277 0 CA-C-N 115.096 -0.956 . . . . 65.13 108.978 174.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 40' ' ' GLY . 66.4 t . . . . . 0 N--CA 1.451 -0.411 0 N-CA-C 110.114 -0.328 . . . . 71.42 110.114 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 38' ' ' LYS . . . 100.38 2.86 55.61 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.96 -0.638 . . . . 63.52 112.856 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.04 130.95 44.8 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.81 -0.811 . . . . 75.31 108.81 173.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.53 128.86 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 62.0 111.505 -172.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -125.87 129.81 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.915 . . . . 62.2 109.939 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.7 m -104.29 123.13 46.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.075 -0.511 . . . . 71.51 110.035 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.707 ' HA ' ' HZ ' ' A' ' 128' ' ' PHE . 4.8 p-10 -82.26 175.65 10.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.544 -0.539 . . . . 71.02 109.544 175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.5 ptm -71.86 -11.2 60.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.233 0.457 . . . . 75.14 112.233 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.75 2.59 53.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 71.04 110.25 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 65.91 77.91 0.28 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.091 -0.959 . . . . 73.2 112.586 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.88 138.67 9.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.26 -0.882 . . . . 50.51 109.079 167.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -89.1 130.48 35.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 73.43 111.77 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 20.8 p-90 -136.07 147.21 47.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.503 -0.772 . . . . 73.42 109.27 172.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 17.0 pttp -94.59 136.78 34.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.416 -0.514 . . . . 70.05 111.003 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.2 144.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.684 -0.689 . . . . 52.43 109.794 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -108.39 -110.61 3.41 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.58 -0.819 . . . . 62.2 112.763 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.5 mp -95.35 137.1 22.13 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 63.22 111.235 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.0 Cg_exo -75.14 120.08 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.967 2.444 . . . . 74.14 111.449 174.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 53' ' ' LEU . 42.3 mt -90.88 -33.6 5.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.34 0.591 . . . . 74.44 110.097 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.8 -47.17 2.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.803 -0.713 . . . . 72.32 111.775 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -122.95 165.35 16.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.013 -0.366 . . . . 74.32 110.013 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 115.53 55.07 0.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.026 -1.229 . . . . 72.3 110.026 -170.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 154.0 -93.39 0.14 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 111.141 -0.784 . . . . 61.33 111.141 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.624 ' H ' HD11 ' A' ' 51' ' ' ILE . 90.1 m-85 -146.41 -55.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.239 -0.652 . . . . 75.25 109.239 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.03 157.55 29.86 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.695 -0.562 . . . . 65.23 111.695 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.0 t 57.34 46.27 18.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.185 0.517 . . . . 63.12 110.762 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 71' ' ' LYS . 42.5 mm -88.45 138.48 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 71.12 111.817 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.3 152.4 37.86 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.12 -0.491 . . . . 73.44 111.067 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 43' ' ' ILE . 9.5 tt -101.32 143.92 30.78 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.196 -0.668 . . . . 72.11 109.196 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.93 108.43 17.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.071 0.462 . . . . 53.34 110.912 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.33 42.37 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 71.2 109.592 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.901 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 13.0 tpt -49.5 -30.88 9.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.275 -0.875 . . . . 65.43 112.553 -176.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' MET . 8.9 m-80 68.99 -166.36 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.311 0.382 . . . . 63.42 110.332 -177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.5 m -124.93 148.46 48.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.255 -0.276 . . . . 61.13 110.255 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 p . . . . . 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 61.21 111.119 -179.039 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.314 0 CA-C-O 121.424 0.63 . . . . 43.31 110.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.808 ' HA ' ' HG2' ' A' ' 133' ' ' ARG . 4.8 Cg_exo -76.62 85.54 1.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.98 2.454 . . . . 74.23 112.303 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 131' ' ' MET . 6.1 p -153.66 138.68 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.222 0.534 . . . . 43.21 111.441 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.16 160.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.48 -0.782 . . . . 73.35 109.115 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.587 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 4.1 p -128.1 119.41 50.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.653 0.739 . . . . 72.22 111.958 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.9 ptmt -99.96 123.3 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.083 -0.962 . . . . 65.45 109.677 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.503 HG12 ' CB ' ' A' ' 128' ' ' PHE . 13.9 m -114.29 151.85 16.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.054 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' VAL . 18.1 mm-40 -165.34 145.27 5.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 O-C-N 123.821 0.701 . . . . 73.24 110.025 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' TYR . 27.4 Cg_endo -63.47 141.25 79.97 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.291 1.994 . . . . 74.14 111.532 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -64.84 -21.38 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.103 0.478 . . . . 51.13 110.448 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.26 11.12 15.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.919 -0.582 . . . . 62.23 111.931 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 54.4 t30 -95.26 -53.91 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.392 -0.523 . . . . 74.31 110.312 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.66 -76.04 0.41 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.901 -1.142 . . . . 51.12 114.248 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.45 -35.36 21.49 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.195 3.263 . . . . 70.52 114.684 -170.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -56.84 -45.42 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 71.15 110.395 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.46 -31.47 70.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.697 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.8 m -65.64 -49.02 70.2 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.205 -0.452 . . . . 75.15 110.64 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.65 -31.83 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.14 109.862 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.401 HD13 ' HG2' ' A' ' 129' ' ' MET . 59.8 tp -61.34 -41.33 96.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.929 -0.578 . . . . 64.51 110.739 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.736 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -62.23 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.56 -0.291 . . . . 74.42 110.608 177.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.91 -51.91 68.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.211 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE1' ' HG2' ' A' ' 131' ' ' MET . 73.0 t80 -60.43 -34.55 74.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.493 -0.776 . . . . 72.14 111.826 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.93 -42.41 69.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.311 . . . . 72.42 111.442 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -80.51 -28.27 37.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.421 -0.354 . . . . 53.01 110.776 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -93.64 16.23 14.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.857 0.36 . . . . 53.42 111.325 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -95.2 164.88 12.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.377 -0.374 . . . . 61.13 111.619 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 37.9 ttmt 72.29 110.5 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 74.23 111.389 176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.01 -36.98 78.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.404 2.736 . . . . 70.34 113.34 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.25 -42.1 98.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.925 0.393 . . . . 71.55 110.941 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -66.65 -48.64 68.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 64.54 109.889 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.5 mt -56.57 -51.31 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.303 -0.862 . . . . 53.25 110.598 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.4 -36.74 69.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 45.42 110.683 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -61.95 -56.52 18.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 75.23 111.236 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.594 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 2.1 p90 -72.55 -35.04 67.91 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 119.683 -0.807 . . . . 74.55 111.154 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' ILE . 33.4 mm -58.3 -42.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.47 0.653 . . . . 71.42 109.984 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.83 -57.77 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.021 -0.991 . . . . 74.25 111.222 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -71.6 -29.88 65.19 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.181 0.437 . . . . 61.42 112.181 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -83.55 -6.25 59.4 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.453 0.538 . . . . 72.43 112.453 -177.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.6 mptt 63.34 31.0 15.51 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.511 0.507 . . . . 74.32 111.237 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 94.4 mt -83.59 169.08 15.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.661 . . . . 72.31 109.558 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -101.94 -72.74 0.68 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.16 0.43 . . . . 61.12 112.16 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -150.8 110.46 4.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.509 . . . . 75.22 111.614 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -79.77 127.92 32.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 43.35 110.692 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.95 67.87 3.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.025 -0.607 . . . . 74.14 112.398 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 ' HB1' ' A' ' 90' ' ' ALA . 6.2 p -110.65 135.3 20.73 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 122.284 0.234 . . . . 73.45 110.694 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 194' ' ' TYR . 34.8 Cg_exo -61.0 152.87 68.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.996 2.464 . . . . 74.31 113.136 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -70.34 136.54 49.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.761 -0.654 . . . . 62.42 111.124 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.459 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 48.7 t80 -84.53 129.79 34.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.679 -0.691 . . . . 63.44 111.461 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.623 ' HB2' HG22 ' A' ' 130' ' ' ILE . 81.7 m95 -120.78 -50.78 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.327 0.584 . . . . 75.42 109.974 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.17 178.3 43.05 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.747 -0.661 . . . . 52.13 112.321 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' MET . 22.8 t -164.69 -178.87 5.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.429 -0.582 . . . . 42.02 109.429 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.91 -151.52 23.23 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.969 -0.634 . . . . 70.11 111.921 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.6 pt? -137.13 145.67 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.904 -0.406 . . . . 62.05 109.904 175.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -149.19 108.1 3.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.452 -0.34 . . . . 73.11 110.199 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 17.0 t70 -174.34 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.504 0.503 . . . . 75.12 110.286 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 54.1 29.68 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.406 0.622 . . . . 65.2 111.419 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.03 -30.95 6.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.582 -0.895 . . . . 74.32 108.582 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.75 -42.08 0.35 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.919 -1.037 . . . . 64.54 111.316 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 125' ' ' SER . 14.9 tptm -173.58 -177.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.525 -0.546 . . . . 64.35 109.525 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 1.2 p -76.32 104.99 7.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.501 0.667 . . . . 73.44 111.212 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 7.3 m-85 -98.36 120.48 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.505 -0.77 . . . . 71.31 110.002 176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -92.03 142.49 27.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.978 -0.379 . . . . 72.15 109.978 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' ' 31' ' ' ASP . 52.9 p90 -127.82 143.68 51.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.512 -0.313 . . . . 75.15 110.737 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 77.2 mtp -123.1 122.14 37.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 74.52 110.496 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.623 HG22 ' HB2' ' A' ' 114' ' ' TRP . 4.7 mm -98.42 117.04 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 64.5 110.173 175.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 67.2 mtm -127.84 179.89 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.187 -0.671 . . . . 62.23 109.187 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.1 t70 -63.54 154.3 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.315 -0.624 . . . . 75.21 109.315 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.808 ' HG2' ' HA ' ' A' ' 67' ' ' PRO . 11.6 ptp180 -82.31 125.37 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.494 0.664 . . . . 61.44 110.992 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -104.34 171.7 7.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.529 -0.76 . . . . 65.52 109.781 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.75 -38.7 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.855 -1.164 . . . . 51.1 113.264 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.799 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 69.8 m -94.37 124.71 38.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 71.33 111.485 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.559 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 1.1 m-20 -90.21 134.54 34.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.868 -0.606 . . . . 72.52 110.038 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.8 tp -69.66 -29.22 66.62 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 174.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 29.0 pt20 -69.86 -33.12 71.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.745 -0.661 . . . . 75.34 110.987 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -69.56 -39.8 77.17 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.376 -0.601 . . . . 74.33 109.376 178.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.8 mt -68.57 -40.97 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.7 -0.682 . . . . 74.31 110.115 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.754 ' CE1' ' HD3' ' A' ' 147' ' ' LYS . 22.5 t80 -52.75 -48.83 66.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.58 . . . . 74.54 110.655 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.8 -44.92 79.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 74.12 111.371 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.57 51.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.039 0.385 . . . . 70.23 112.039 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -96.74 2.59 52.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.935 0.397 . . . . 64.31 110.887 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.16 38.55 29.97 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.074 -0.512 . . . . 72.43 111.644 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.754 ' HD3' ' CE1' ' A' ' 142' ' ' TYR . 37.3 pttt 46.33 29.46 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 75.0 113.726 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -99.92 84.08 2.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.366 -0.605 . . . . 63.33 109.366 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 5.0 m-30 -94.52 156.38 16.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.782 -0.644 . . . . 71.35 110.68 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 p -73.51 138.06 44.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.239 -0.652 . . . . 75.21 109.239 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.79 71.53 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.326 0.491 . . . . 73.51 112.326 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 11.0 pttp -60.15 -39.25 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 72.35 110.929 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.461 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 30.4 m -71.57 -40.43 69.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.102 -0.499 . . . . 65.33 110.057 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.14 -47.18 84.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.778 -0.646 . . . . 70.14 111.28 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.758 ' HB3' HD22 ' A' ' 328' ' ' LEU . 0.2 OUTLIER -70.71 -44.11 67.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.687 -176.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -55.73 -46.2 77.81 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.03 0.443 . . . . 74.13 110.736 178.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 161' ' ' ILE . 87.7 mt -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.903 -0.59 . . . . 72.04 110.931 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 p -64.24 -32.25 73.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 72.35 111.808 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.54 HD11 HD23 ' A' ' 325' ' ' LEU . 76.3 mt -61.25 -53.41 57.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.658 0.266 . . . . 73.42 110.851 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -66.81 -29.47 69.42 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.106 0.479 . . . . 61.4 110.538 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 28.2 mm -68.97 -35.04 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 71.04 110.359 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.44 -46.62 89.31 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.729 -0.471 . . . . 63.13 109.729 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -57.2 -48.38 78.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.479 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 161' ' ' ILE . 15.9 tt -72.32 -36.85 56.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.443 -0.344 . . . . 73.14 111.607 -175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.43 HD21 HD11 ' A' ' 178' ' ' ILE . 37.1 mt -64.63 -38.7 91.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.99 -0.284 . . . . 72.4 110.84 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -71.32 -37.9 71.75 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.942 -0.303 . . . . 62.42 110.532 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -50.91 -42.21 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 61.23 110.979 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 169' ' ' HIS . 38.8 pt -91.91 -43.82 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.411 0.523 . . . . 75.15 112.411 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.415 ' N ' HG13 ' A' ' 168' ' ' ILE . 3.0 t-160 -72.86 -30.94 64.38 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.623 0.249 . . . . 63.02 111.567 -171.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.489 ' HG2' HH22 ' A' ' 240' ' ' ARG . 3.5 tm-20 -59.18 -28.77 66.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 70.41 110.084 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -101.41 -66.47 0.91 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.745 0.646 . . . . 61.2 112.745 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 173' ' ' TYR . 11.3 pt-20 -145.97 -60.56 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.219 1.192 . . . . 73.34 114.219 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.606 ' HB3' ' HD2' ' A' ' 203' ' ' ARG . 55.2 p90 -104.42 160.36 14.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.343 0.592 . . . . 74.34 112.47 -168.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 14.2 m -129.54 172.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.096 -0.956 . . . . 74.32 109.741 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 13.4 t-80 -98.98 -41.32 7.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.834 -0.432 . . . . 72.15 109.834 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 228' ' ' THR . . . 62.66 38.45 96.46 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.766 -0.73 . . . . 44.44 112.754 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.553 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 19.3 t70 179.71 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.765 0.426 . . . . 65.34 109.889 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.43 HD11 HD21 ' A' ' 165' ' ' LEU . 49.5 mm -111.16 79.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.508 0.67 . . . . 61.43 110.1 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.79 ' HZ2' ' HD2' ' A' ' 227' ' ' PHE . 46.4 mttp -103.79 153.05 21.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.46 -0.791 . . . . 64.44 110.647 174.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -63.36 -16.27 59.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 72.31 110.918 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 12.7 m -71.84 -14.16 61.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.961 -0.563 . . . . 63.44 111.472 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -97.43 -12.4 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 74.14 110.913 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 8.0 mp -105.67 120.26 41.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.363 0.601 . . . . 73.32 110.622 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 196' ' ' VAL . 3.6 mm? -118.03 131.35 56.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.298 -0.865 . . . . 51.24 110.131 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 86.2 mt -86.84 154.9 20.52 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.485 -0.561 . . . . 71.25 109.485 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.13 153.46 18.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.344 -0.984 . . . . 73.21 108.344 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -47.56 -33.29 6.3 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.419 0.525 . . . . 62.25 112.419 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -154.84 51.75 0.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.519 . . . . 75.34 110.441 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 2.7 t-20 -135.43 107.4 10.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.379 -0.601 . . . . 72.01 109.379 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 23.2 Cg_exo -66.49 -29.49 44.7 Favored 'Trans proline' 0 N--CA 1.474 0.36 0 C-N-CA 123.437 2.758 . . . . 41.23 115.305 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.492 ' HB3' ' HG3' ' A' ' 338' ' ' LYS . 0.7 OUTLIER -94.29 -21.91 18.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.079 -0.649 . . . . 64.12 111.483 -173.334 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 194' ' ' TYR . 19.4 tp60 -91.38 93.62 9.12 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.569 0.7 . . . . 73.32 110.373 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.49 142.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.838 -1.074 . . . . 73.52 110.247 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CZ ' ' HG3' ' A' ' 192' ' ' GLN . 37.1 m-85 -124.04 157.34 34.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.045 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.9 tp -94.49 99.36 11.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.613 -0.884 . . . . 54.32 108.613 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.561 ' HB ' HD23 ' A' ' 184' ' ' LEU . 46.7 t -130.26 157.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 53.0 110.465 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 51.16 64.96 1.63 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.818 0.818 . . . . 60.33 111.297 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -123.17 -64.85 1.14 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.078 -0.965 . . . . 73.35 110.65 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . 77.02 -13.7 8.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.552 . . . . 35.11 112.059 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -84.63 89.75 7.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.127 0.489 . . . . 72.44 110.073 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -141.92 99.25 3.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 74.02 109.912 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.67 138.52 42.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 43.41 109.675 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.606 ' HD2' ' HB3' ' A' ' 173' ' ' TYR . 4.8 mpt_? -71.36 129.06 37.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.944 0.402 . . . . 72.2 111.496 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.627 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 11.6 t80 -95.49 -54.41 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.763 -0.653 . . . . 73.52 110.064 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 172' ' ' GLU . 6.7 p -134.1 105.39 11.39 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.697 -0.683 . . . . 71.34 110.105 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 210' ' ' HIS . 52.2 Cg_exo -54.16 107.37 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.586 2.19 . . . . 62.02 111.568 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 65.9 11.68 7.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.103 -0.953 . . . . 74.12 111.418 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.54 -5.51 40.84 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.024 -0.607 . . . . 51.12 113.223 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.26 111.54 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.03 0.415 . . . . 74.24 111.536 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.578 ' HB2' ' HD2' ' A' ' 206' ' ' PRO . 12.6 t-160 -178.19 -101.13 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.96 -0.563 . . . . 62.12 110.888 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.474 ' HE3' HG23 ' A' ' 312' ' ' THR . 60.3 tttm 51.49 89.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 63.01 111.947 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -166.22 136.71 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 54.33 111.139 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.753 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 20.3 t80 -94.75 80.45 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 75.03 111.495 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -178.9 70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.547 -0.751 . . . . 72.12 109.517 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -106.49 -71.29 0.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.082 -0.508 . . . . 64.13 110.777 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -119.12 118.2 32.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.915 0.388 . . . . 75.13 110.395 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo . . . . . 0 C--O 1.233 0.266 0 C-N-CA 123.295 2.663 . . . . 72.0 112.899 -177.006 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.1 t70 . . . . . 0 N--CA 1.466 0.345 0 CA-C-O 120.963 0.411 . . . . 44.23 111.207 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -88.04 -155.36 28.96 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.898 -0.667 . . . . 70.4 112.36 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.9 p -88.7 151.59 22.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.941 0.4 . . . . 60.04 111.062 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -53.27 -33.08 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 113.739 1.014 . . . . 54.44 113.739 -167.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -60.15 2.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.272 0.842 . . . . 73.2 113.272 -170.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.79 ' HD2' ' HZ2' ' A' ' 179' ' ' LYS . 28.9 m-85 -87.89 -0.23 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.28 0.474 . . . . 61.55 112.28 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 39.4 m -85.61 -10.3 56.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.346 0.593 . . . . 72.12 109.815 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.0 t 67.44 -175.7 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.1 -0.955 . . . . 72.23 111.259 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 82.6 mt -70.5 -34.59 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.393 -0.822 . . . . 51.3 109.731 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.621 ' HB3' ' HA ' ' A' ' 238' ' ' PRO . 1.8 m-20 -47.38 -84.23 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.801 -1.091 . . . . 74.52 112.547 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.643 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -66.31 -28.32 68.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.154 -0.476 . . . . 65.5 111.993 -172.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.05 -26.6 62.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.662 -0.415 . . . . 75.21 110.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -95.75 -4.85 43.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.369 . . . . 63.15 110.981 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.59 21.07 17.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.352 -0.927 . . . . 73.1 113.391 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.753 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 7.1 p -117.63 141.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 60.32 109.67 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -56.71 125.06 66.77 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.084 -0.507 . . . . 64.4 110.966 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.643 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 33.3 Cg_exo -60.27 115.18 2.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.156 2.571 . . . . 71.03 112.701 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 69.9 m -83.79 169.31 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 51.2 110.774 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.489 HH22 ' HG2' ' A' ' 170' ' ' GLU . 20.4 mtt180 -59.51 -20.53 56.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.528 0.68 . . . . 72.32 110.251 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.577 HH11 ' HG ' ' A' ' 309' ' ' LEU . 10.7 mmt180 -64.99 -41.82 95.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.094 -0.957 . . . . 74.22 109.645 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -69.59 -41.41 75.87 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 74.14 112.275 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.07 -45.18 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.581 0.229 . . . . 73.53 111.083 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.529 HD23 HG12 ' A' ' 306' ' ' VAL . 9.5 mp -60.9 -41.99 97.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.403 -0.362 . . . . 72.24 110.916 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.92 -51.09 71.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.788 -0.642 . . . . 74.1 110.771 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.4 mt -62.35 -42.1 94.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.009 -0.541 . . . . 75.21 111.09 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 251' ' ' MET . 46.8 tp -61.96 -39.52 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.169 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.53 -39.65 98.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.339 -0.934 . . . . 74.03 111.645 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -66.55 -39.47 88.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.907 0.336 . . . . 73.34 111.907 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' A' ' 247' ' ' LEU . 20.0 p -68.12 -34.17 75.88 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.294 -0.563 . . . . 71.51 110.133 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 81.6 mtp -62.9 -53.59 51.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.443 -0.344 . . . . 70.32 110.983 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.542 HD12 ' SD ' ' A' ' 286' ' ' MET . 5.5 tt -65.98 -31.7 54.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.679 0.276 . . . . 53.34 110.303 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.26 -53.95 51.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 72.33 110.898 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 19.1 m0 -76.39 -25.16 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 71.43 111.222 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.5 tp -76.35 -46.3 28.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 60.23 111.617 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 76.5 p -103.71 -17.73 14.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.914 -0.315 . . . . 72.23 111.674 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 72.14 18.48 77.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 54.11 111.914 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -144.48 147.35 33.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.675 0.274 . . . . 75.25 110.957 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.871 ' HB2' ' HG3' ' A' ' 262' ' ' GLU . 96.1 mt -118.28 138.93 26.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.652 -0.87 . . . . 74.32 108.652 168.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 23.0 Cg_exo -65.45 -17.35 57.36 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.978 2.452 . . . . 61.21 114.243 -171.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 16.3 p90 -132.93 34.64 3.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.414 0.524 . . . . 74.42 112.414 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 259' ' ' LEU . 43.4 mt-10 -68.03 -42.72 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.41 0.624 . . . . 63.41 109.692 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.13 -21.21 64.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 73.2 109.939 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 3.2 m-20 -89.81 -2.55 58.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.252 -0.886 . . . . 44.41 111.157 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.525 HD23 HG11 ' A' ' 271' ' ' VAL . 89.7 mt -66.63 -2.83 5.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.796 0.331 . . . . 64.42 111.521 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -62.59 -40.02 95.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.919 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.573 ' OD1' ' HE3' ' A' ' 269' ' ' LYS . 10.7 t70 -135.13 135.41 22.78 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 42.31 110.982 -171.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.6 Cg_exo -60.72 -28.86 87.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.242 2.628 . . . . 72.33 113.476 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.573 ' HE3' ' OD1' ' A' ' 267' ' ' ASP . 0.0 OUTLIER -78.11 -34.93 49.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.729 -0.471 . . . . 71.43 109.729 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.616 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 6.4 m-85 -56.63 -50.54 71.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.811 -0.631 . . . . 74.41 111.058 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.525 HG11 HD23 ' A' ' 265' ' ' LEU . 7.8 m -70.47 -35.3 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 71.34 111.479 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 276' ' ' ILE . 82.3 mtt180 -56.96 -56.34 22.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.512 0.196 . . . . 74.14 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 0.1 OUTLIER -66.39 -42.67 87.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 72.14 111.439 -176.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 16.2 m -61.01 -41.97 97.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.217 0.532 . . . . 73.42 110.256 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.21 -43.91 92.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.277 -0.874 . . . . 75.51 110.471 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 272' ' ' ARG . 79.7 mt -66.14 -44.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 72.34 111.274 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 26.4 mmt180 -68.96 -36.15 77.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.589 0.233 . . . . 73.53 111.606 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 21.2 m-85 -73.12 -33.92 65.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.061 -0.255 . . . . 74.11 110.868 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -72.13 -22.93 61.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.267 0.556 . . . . 73.44 109.971 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -74.82 -53.44 9.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.537 -0.756 . . . . 65.54 110.51 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.536 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.4 m-80 -111.72 55.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.635 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -52.13 -51.04 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 73.01 112.077 -178.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.526 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.23 -46.94 84.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 63.23 111.42 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.4 m -61.19 -49.14 78.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.811 -0.631 . . . . 74.5 111.143 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.3 mm? -71.58 -44.23 64.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.31 111.874 -175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.542 ' SD ' HD12 ' A' ' 252' ' ' ILE . 21.8 mmt -64.69 -38.66 91.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.0 -0.28 . . . . 55.22 111.726 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.17 -39.01 65.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 74.12 110.413 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.05 -39.1 63.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 72.21 111.731 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.8 m -77.37 -11.36 59.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.607 0.225 . . . . 54.31 111.607 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 10.5 t80 -129.7 69.53 81.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.181 0.515 . . . . 64.12 110.449 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -90.67 12.35 2.43 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.041 2.494 . . . . 72.44 112.534 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -75.03 -9.38 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 74.22 110.375 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 71.27 84.56 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.893 -1.049 . . . . 71.31 112.221 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.716 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 27.3 t-20 -128.3 -80.27 0.58 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.802 -1.184 . . . . 62.41 107.802 169.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 60.0 tttp 175.13 96.85 0.08 OUTLIER Pre-proline 0 N--CA 1.461 0.092 0 O-C-N 123.743 0.652 . . . . 74.15 110.526 169.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -99.84 38.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.986 2.457 . . . . 73.0 111.47 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.3 -51.46 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 71.15 112.924 -172.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 0.9 OUTLIER -72.61 -30.85 64.7 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.235 -0.283 . . . . 74.32 110.235 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.3 mp -63.08 -44.3 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 71.24 109.57 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.33 88.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.933 -0.576 . . . . 63.13 111.138 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.71 -41.07 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.635 -0.257 . . . . 63.01 110.648 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.447 ' O ' ' HB ' ' A' ' 305' ' ' THR . 56.9 t80 -55.14 -45.35 75.64 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.502 -0.317 . . . . 61.25 110.986 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 306' ' ' VAL . 74.8 mtp -72.72 -31.35 64.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.598 -0.274 . . . . 64.52 111.62 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.29 -30.37 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.475 0.655 . . . . 72.24 109.236 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 86.7 m -66.32 -40.3 89.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.346 -0.843 . . . . 71.42 110.869 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 5.7 m -73.49 -27.03 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.819 -0.352 . . . . 61.31 110.492 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -62.3 -42.85 99.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 63.25 110.498 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 32.1 tp -97.11 16.22 20.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 55.44 110.05 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 27.4 tp -71.92 -32.53 67.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 74.12 110.666 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 27.1 t70 67.5 161.7 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.322 -0.854 . . . . 60.53 110.848 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -77.75 -22.72 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.699 0.285 . . . . 74.31 111.187 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.474 HG23 ' HE3' ' A' ' 211' ' ' LYS . 24.3 m -124.01 -20.28 5.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.592 0.59 . . . . 71.23 112.592 -173.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 14.5 tp10 -57.02 -101.16 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.344 0.868 . . . . 73.11 113.344 -166.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -147.04 120.17 4.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 121.641 -0.662 . . . . 74.21 111.508 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 309' ' ' LEU . 57.3 Cg_endo -91.03 118.57 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.542 2.162 . . . . 54.12 111.121 170.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 96.1 mt -116.04 82.43 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.79 0.328 . . . . 74.54 111.318 -176.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.517 ' HA ' HD12 ' A' ' 320' ' ' LEU . 35.9 m-85 -62.28 -33.46 74.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.022 -0.535 . . . . 72.54 111.428 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.28 -40.45 90.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 75.43 110.95 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -73.21 -37.51 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.687 -0.486 . . . . 72.42 109.687 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 50.6 mt -59.32 -47.71 84.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.113 -0.494 . . . . 73.13 110.154 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -57.96 -41.59 83.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 70.45 110.408 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.49 -52.28 61.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.706 -0.679 . . . . 73.51 111.686 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.5 tt -63.58 -47.52 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 111.91 0.337 . . . . 72.04 111.91 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.5 mt -66.19 -39.14 89.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.247 0.546 . . . . 63.23 110.435 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 159' ' ' LEU . 2.8 tm? -69.28 -35.28 75.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.152 -0.684 . . . . 73.23 109.152 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -62.91 -37.71 88.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 73.04 109.962 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.17 -41.0 95.13 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.903 -0.665 . . . . 61.14 112.215 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 155' ' ' LEU . 41.6 tp -71.65 -37.94 70.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.19 0.519 . . . . 42.34 110.746 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -72.08 -22.98 61.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.162 -0.472 . . . . 55.22 110.511 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.496 . . . . 73.34 110.957 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 328' ' ' LEU . 33.5 pt -95.44 1.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.982 0.42 . . . . 73.23 110.583 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.08 75.38 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.774 -0.648 . . . . 43.15 113.224 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 5.4 t -117.32 170.13 8.94 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.474 -0.427 . . . . 53.41 110.751 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 328' ' ' LEU . 27.3 ttpp -160.11 -56.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 74.43 108.889 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 178.6 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.914 -1.039 . . . . 75.24 108.452 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.8 t70 72.45 -71.55 0.13 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.681 -1.145 . . . . 74.22 111.786 172.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -117.94 57.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.805 -0.712 . . . . 65.2 112.303 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER . . . . . 0 C--O 1.234 0.28 0 CA-C-O 121.046 0.451 . . . . 71.34 110.91 -178.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.665 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 28.4 ttpt . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 109.173 -0.677 . . . . 54.13 109.173 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.658 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 10.4 t -106.67 162.39 13.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.168 -0.308 . . . . 72.34 110.168 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.44 143.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.398 0.618 . . . . 70.11 111.738 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.5 m -101.4 97.35 7.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.329 -0.851 . . . . 75.1 111.125 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm . . . . . 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 74.11 110.749 179.69 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t . . . . . 0 N--CA 1.451 -0.399 0 N-CA-C 109.802 -0.444 . . . . 64.4 109.802 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.99 -7.87 60.82 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.725 -0.75 . . . . 51.43 112.404 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.56 128.64 36.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.824 0.345 . . . . 64.13 110.914 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.8 mt -86.62 129.0 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 74.31 110.174 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 37' ' ' TRP . 29.4 pt -116.26 147.12 19.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 61.31 110.81 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 35' ' ' LYS . 55.0 m -118.15 125.77 50.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.512 -0.767 . . . . 74.52 109.6 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 2.2 p-10 -121.27 -164.53 1.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.881 0.372 . . . . 72.44 111.057 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.516 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 13.8 mmt -68.63 -14.43 63.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.336 -0.393 . . . . 71.24 111.697 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.508 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -81.7 11.37 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 70.21 109.78 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 24.4 tptp 92.36 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.034 1.334 . . . . 65.23 113.285 167.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.978 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 21.2 ptmt 159.59 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.563 0.54 . . . . 72.05 111.608 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.978 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 38.8 mt-10 82.62 59.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.186 1.18 . . . . 73.4 114.186 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' ILE . 40.4 m95 -138.95 151.13 46.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.189 -1.411 . . . . 73.24 107.189 165.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.722 ' HE3' ' HB3' ' A' ' 56' ' ' MET . 61.0 pttt -154.47 144.47 21.83 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.857 -0.737 . . . . 63.31 111.24 172.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.81 126.44 25.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.293 -0.867 . . . . 74.03 110.619 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.68 -60.66 0.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.449 -0.882 . . . . 70.14 112.355 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 6.6 tt -103.82 120.62 50.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.998 -0.371 . . . . 65.3 109.998 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 4.8 Cg_exo -79.0 112.74 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.351 2.701 . . . . 75.13 111.776 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.773 HG22 ' HG2' ' A' ' 45' ' ' GLN . 49.2 mt -95.48 -57.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.37 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -20.1 22.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.205 -0.522 . . . . 62.34 113.254 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.773 ' HG2' HG22 ' A' ' 43' ' ' ILE . 12.0 pt20 -111.44 165.01 12.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.006 -0.368 . . . . 75.41 110.006 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.85 -170.15 26.45 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.693 -0.963 . . . . 72.24 110.693 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.605 ' HA3' ' CG2' ' A' ' 196' ' ' VAL . . . -81.85 50.38 4.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.752 -0.737 . . . . 45.1 113.098 -175.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 4.2 t80 166.5 -37.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.395 0.678 . . . . 74.22 109.299 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.24 157.2 17.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.031 -0.604 . . . . 65.42 112.25 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.9 m 65.16 41.37 4.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.131 0.491 . . . . 72.1 111.349 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 71' ' ' LYS . 5.2 mm -97.33 138.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.494 -0.558 . . . . 70.1 109.494 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.67 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 97.7 m-85 -122.32 167.36 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 61.43 111.752 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 55' ' ' ASP . 3.8 tt -115.16 139.53 49.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.069 -0.514 . . . . 73.43 109.999 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -93.1 68.22 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 72.41 109.763 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HD22 ' A' ' 53' ' ' LEU . 31.7 t70 -89.47 -14.93 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.162 -0.926 . . . . 72.11 112.041 -169.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.722 ' HB3' ' HE3' ' A' ' 38' ' ' LYS . 5.2 mmt -95.05 -0.71 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.446 0.536 . . . . 73.03 112.446 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.41 ' OD1' ' HB1' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -105.35 80.2 1.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.481 0.658 . . . . 75.42 110.503 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -124.9 104.23 8.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.706 -0.679 . . . . 71.35 110.707 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.8 m . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 116.261 -0.427 . . . . 71.43 110.067 177.535 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 111.839 0.311 . . . . 75.31 111.839 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 10.7 Cg_exo -73.58 43.94 0.84 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.573 2.182 . . . . 74.21 112.814 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.0 m -117.31 142.35 47.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.754 0.311 . . . . 71.14 110.326 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 53' ' ' LEU . 31.7 m -117.15 158.74 17.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 73.21 109.831 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.64 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.1 p -137.72 126.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.326 0.584 . . . . 75.3 111.664 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.651 ' HB3' HD12 ' A' ' 51' ' ' ILE . 46.7 pttt -98.81 136.26 39.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.398 -0.819 . . . . 73.44 109.132 174.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 8.4 p -137.21 138.2 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.568 0.581 . . . . 64.3 112.568 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 27.0 mt-10 -123.1 163.76 31.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.598 -0.728 . . . . 73.4 109.05 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.75 -177.07 1.11 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.328 2.019 . . . . 73.13 111.918 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.1 t -76.83 11.72 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.772 0.32 . . . . 71.35 111.696 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.81 -40.51 92.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 73.4 109.739 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 81' ' ' PHE . 64.0 t30 60.7 83.02 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.06 -0.973 . . . . 63.35 111.468 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.51 -83.05 0.18 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.647 -0.787 . . . . 73.13 111.719 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.86 -44.38 16.63 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.683 2.255 . . . . 74.44 111.624 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.93 -34.9 73.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.454 -0.339 . . . . 54.4 110.405 177.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.503 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 74.7 t80 -63.57 -47.76 80.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.043 0.449 . . . . 72.01 110.257 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.0 m -65.54 -42.63 91.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.66 -0.7 . . . . 65.05 110.074 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.85 -43.7 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.23 -0.895 . . . . 70.03 110.54 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.547 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 46.4 tp -55.83 -47.35 77.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.736 -0.666 . . . . 71.41 110.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 11.1 mmpt? -60.47 -41.76 94.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.46 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.98 -44.44 94.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.799 -0.637 . . . . 73.35 110.814 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.611 ' HD2' ' HB2' ' A' ' 113' ' ' TYR . 18.9 m-85 -70.55 -39.61 73.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.824 0.305 . . . . 73.4 111.824 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 81.5 mm-40 -68.02 -18.31 64.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.038 0.447 . . . . 61.55 110.5 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -96.72 -70.49 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 74.44 111.634 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.673 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -83.89 -34.48 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.274 0.842 . . . . 70.13 113.274 -170.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.34 79.36 3.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.377 0.608 . . . . 73.34 112.16 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -154.24 116.33 2.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.845 -0.798 . . . . 74.21 108.845 176.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.431 ' HD2' ' HD3' ' A' ' 92' ' ' LYS . 9.7 Cg_endo -52.05 -54.02 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.333 2.688 . . . . 75.14 114.067 -170.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 1.2 pp20? -72.95 -28.34 62.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.845 0.355 . . . . 72.25 110.624 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.457 ' CB ' ' HB3' ' A' ' 92' ' ' LYS . 3.6 tp-100 -67.81 -48.99 64.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.458 -0.571 . . . . 72.53 109.458 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.484 HG23 HD12 ' A' ' 108' ' ' LEU . 81.5 mt -57.19 -53.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.603 -0.726 . . . . 75.43 110.434 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.02 -40.05 66.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.429 -0.805 . . . . 75.33 110.611 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 18.5 ttpt -67.24 -59.47 3.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.25 -0.886 . . . . 72.11 111.482 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 1.3 p90 -68.44 -34.03 75.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 120.474 -0.49 . . . . 70.42 110.833 -176.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 105' ' ' LEU . 2.9 tp -72.1 -29.09 31.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.885 0.374 . . . . 74.44 110.032 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -65.52 -47.34 76.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.736 -0.665 . . . . 65.0 109.778 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -74.66 -19.01 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 71.14 111.447 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 166' ' ' GLU . 17.9 tpt180 -79.44 -18.45 52.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.538 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 103' ' ' ARG . 63.5 mttm 71.44 28.32 2.92 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.777 0.673 . . . . 75.03 111.197 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 100' ' ' ILE . 46.7 mt -100.0 -170.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.432 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HG3' ' HB2' ' A' ' 107' ' ' TYR . 24.7 pttm -119.58 -34.91 3.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.514 0.561 . . . . 75.31 112.514 -172.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -150.03 179.27 8.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.926 0.393 . . . . 75.14 110.758 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -162.16 127.96 3.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.799 -0.815 . . . . 54.41 108.799 170.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.53 59.67 4.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.822 -0.704 . . . . 33.53 112.625 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.51 HG23 HD22 ' A' ' 108' ' ' LEU . 88.5 t -116.83 122.51 31.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.977 -0.379 . . . . 72.23 109.977 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 18.0 Cg_exo -66.19 149.32 85.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.884 2.389 . . . . 74.22 113.07 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.6 tptm -65.07 117.59 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 74.42 110.561 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.611 ' HB2' ' HD2' ' A' ' 87' ' ' TYR . 61.2 t80 -89.03 123.03 32.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.342 -0.845 . . . . 75.33 110.121 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -96.4 -67.01 0.87 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.286 -0.635 . . . . 64.4 109.286 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . 0.416 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -155.36 -178.13 29.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.423 -0.808 . . . . 75.34 112.144 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 32' ' ' MET . 58.6 p -164.73 163.7 21.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 55.24 109.046 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.26 -168.74 36.84 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.738 -1.22 . . . . 74.22 113.118 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.17 127.28 31.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.534 -0.543 . . . . 61.41 109.534 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -123.46 109.94 14.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.945 -0.571 . . . . 75.23 110.637 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 13.8 t70 -75.7 118.79 18.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.426 -0.583 . . . . 71.23 109.426 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.765 ' HG2' HD22 ' A' ' 122' ' ' ASN . 87.2 tttt -105.66 94.67 5.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.391 -0.368 . . . . 75.23 111.03 -174.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.765 HD22 ' HG2' ' A' ' 121' ' ' LYS . 44.6 m-80 71.51 -41.78 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.548 0.739 . . . . 72.13 112.846 173.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.89 -38.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.637 -0.792 . . . . 75.04 112.708 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.31 143.54 45.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.896 0.379 . . . . 63.42 110.114 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.87 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.0 p -94.62 149.16 21.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.15 112.134 -174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.453 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 67.4 m-85 -115.57 145.28 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 73.51 109.968 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -112.45 120.46 41.72 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.01 -0.737 . . . . 72.32 109.01 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.52 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -124.87 162.93 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 72.43 112.042 -170.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.8 ttm -144.88 136.95 25.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 71.11 110.695 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.64 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.2 mm -97.45 127.78 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 74.32 111.021 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 71.1 mtp -121.28 164.2 17.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.526 -0.761 . . . . 74.45 110.426 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.656 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 25.5 t70 -81.26 98.35 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.219 -0.446 . . . . 70.23 111.306 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HG2' ' C ' ' A' ' 132' ' ' ASP . 3.7 ptt180 29.71 95.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.411 1.634 . . . . 65.51 115.411 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.32 151.88 26.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.776 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -165.73 -15.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.38 -1.391 . . . . 71.1 114.967 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.737 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.7 m -120.65 124.7 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.274 1.037 . . . . 64.44 111.682 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.496 ' HB2' ' HG2' ' A' ' 140' ' ' LYS . 1.3 m-20 -101.29 131.05 47.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.855 -0.794 . . . . 73.32 108.855 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.617 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 4.9 mp -61.48 -36.91 81.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 55.32 110.856 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 27.2 pt20 -58.79 -47.92 83.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 137' ' ' ASP . 20.3 ptmt -70.29 -34.85 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 71.54 110.783 -175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.461 HG13 ' O ' ' A' ' 137' ' ' ASP . 17.1 mt -75.05 -39.77 44.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.515 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -62.44 -43.44 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 73.12 111.957 -175.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.86 -40.6 83.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.185 -0.606 . . . . 72.04 110.601 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.89 -31.75 70.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 74.51 111.136 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -88.78 5.66 42.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 54.42 110.392 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.4 41.28 13.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.466 -0.788 . . . . 64.22 112.216 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER 41.75 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.935 0.894 . . . . 72.44 112.668 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 11.6 ttp180 -153.78 93.5 1.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.038 -0.983 . . . . 74.21 109.975 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.669 ' HD2' HG21 ' A' ' 153' ' ' THR . 85.0 m-85 -112.6 137.74 50.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.001 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.6 p -73.31 168.85 18.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.375 -0.375 . . . . 52.34 110.978 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.546 ' HB3' HD11 ' A' ' 328' ' ' LEU . 81.8 mtt180 -55.03 -37.06 66.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.913 -0.585 . . . . 74.14 110.725 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -60.65 -42.94 97.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.352 -0.84 . . . . 73.32 110.572 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.669 HG21 ' HD2' ' A' ' 149' ' ' PHE . 10.2 m -71.76 -52.23 18.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.5 -0.773 . . . . 61.42 111.303 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.82 -42.82 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.41 110.966 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 328' ' ' LEU . 16.9 tp -65.61 -49.47 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.575 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 20.8 mm-40 -58.97 -47.74 84.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.923 0.342 . . . . 71.04 111.923 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.87 -43.92 97.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.472 -0.331 . . . . 73.21 110.892 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t -62.33 -43.04 99.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.15 110.355 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 82.3 mt -61.45 -39.9 92.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.242 -0.436 . . . . 71.31 111.262 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 81.6 mmt-85 -62.73 -49.15 76.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.017 0.437 . . . . 73.31 110.378 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.56 -30.31 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 65.45 110.681 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -47.42 86.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 70.11 110.569 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.46 -42.23 99.32 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.59 0.71 . . . . 65.12 110.097 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.586 ' O ' HG12 ' A' ' 168' ' ' ILE . 61.3 mt -61.44 -46.44 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.225 -0.898 . . . . 63.44 110.74 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.438 ' HG ' ' HE1' ' A' ' 317' ' ' TYR . 64.4 tp -57.69 -39.03 76.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 74.32 110.803 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 103' ' ' ARG . 2.0 mm-40 -56.13 -65.81 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.767 -0.652 . . . . 54.34 110.476 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.453 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 82.2 t80 -63.27 -49.47 73.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.626 -0.715 . . . . 73.3 112.861 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 164' ' ' ILE . 30.7 pt -79.46 -32.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.293 -0.563 . . . . 73.51 112.249 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.777 ' HE1' HG12 ' A' ' 174' ' ' VAL . 2.8 t60 -88.21 -18.19 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.038 -0.665 . . . . 74.31 111.117 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -86.88 21.96 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.907 0.861 . . . . 70.31 109.018 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -131.03 -79.37 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.475 -0.784 . . . . 74.54 111.137 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.755 ' HG2' ' H ' ' A' ' 207' ' ' GLU . 32.3 mt-10 -147.46 -46.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 74.2 111.977 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.96 137.63 35.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.709 . . . . 54.41 112.821 -161.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.777 HG12 ' HE1' ' A' ' 169' ' ' HIS . 33.2 m -106.69 170.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.942 -1.026 . . . . 61.01 109.729 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.741 ' HB3' ' HD2' ' A' ' 198' ' ' TYR . 1.8 p-80 -147.62 103.23 3.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.205 0.526 . . . . 70.03 111.188 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 -28.36 15.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.628 -0.796 . . . . 34.35 111.989 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 199' ' ' GLY . 5.7 t0 -112.94 93.78 4.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.913 0.387 . . . . 74.01 110.059 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 64.8 mt -92.28 -73.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.22 -0.659 . . . . 73.11 109.22 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 180' ' ' ALA . 6.3 tptm 50.76 -139.25 0.94 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.572 -0.529 . . . . 74.22 109.572 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -120.84 -3.58 9.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.408 0.623 . . . . 74.42 109.408 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 39.7 m -77.88 -27.68 49.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.419 -0.81 . . . . 72.44 112.044 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 76.7 m-20 -104.51 6.31 34.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.444 -0.503 . . . . 74.02 111.558 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.72 120.17 40.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.651 . . . . 73.34 109.721 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.582 HD11 ' N ' ' A' ' 47' ' ' GLY . 66.0 mt -120.59 143.67 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.004 -0.544 . . . . 72.41 110.834 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.8 mt -92.5 141.4 28.55 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.334 -0.617 . . . . 63.22 109.334 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.502 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 25.4 t-20 -60.55 139.19 57.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.446 -0.946 . . . . 73.1 108.446 171.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.776 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 71.7 t80 -57.36 -30.52 64.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.718 0.266 . . . . 75.14 111.718 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 83.1 tttt -116.15 -30.52 5.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.48 -0.488 . . . . 73.41 111.799 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 85.2 m-20 -99.46 101.87 14.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.793 0.33 . . . . 63.14 110.888 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 10.2 Cg_exo -71.78 -25.81 19.88 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.995 2.463 . . . . 61.34 113.387 -174.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -83.69 -4.94 59.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.024 0.44 . . . . 72.43 111.18 -174.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -108.62 97.1 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.386 0.612 . . . . 73.45 110.449 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 160' ' ' ARG . 7.9 p -103.38 130.87 53.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.255 -0.884 . . . . 73.2 109.23 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.502 ' HE2' ' HB2' ' A' ' 186' ' ' ASN . 41.9 m-85 -115.72 155.45 27.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.004 -0.544 . . . . 72.51 110.189 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 2.9 tt -120.52 122.7 41.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.407 -0.59 . . . . 63.43 109.407 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.605 ' CG2' ' HA3' ' A' ' 47' ' ' GLY . 16.5 m -129.17 166.95 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 61.22 110.58 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.0 t70 68.97 -57.9 0.51 Allowed 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.984 0.803 . . . . 74.2 111.842 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.785 ' HB2' ' HB2' ' A' ' 201' ' ' ALA . 93.7 m-85 75.79 5.37 3.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.606 0.762 . . . . 73.23 112.052 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 177' ' ' ASP . . . 82.48 -38.77 2.63 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.37 -0.443 . . . . 65.22 112.946 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.789 ' HA ' ' HA ' ' A' ' 354' ' ' ILE . 1.1 pp -164.38 40.05 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.3 0.24 . . . . 72.32 110.882 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 198' ' ' TYR . . . -53.21 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.549 0.69 . . . . 74.4 111.761 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -123.4 133.58 54.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 172' ' ' GLU . 10.9 ptp180 -77.71 109.74 11.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.324 0.583 . . . . 74.21 109.918 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 2.9 t80 -66.83 -46.18 75.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.305 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 54.6 m -142.42 140.06 18.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.843 -0.799 . . . . 72.23 108.843 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 14.4 Cg_exo -68.1 98.04 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.381 2.054 . . . . 73.24 112.151 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.755 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 33.6 tt0 73.91 -54.7 0.68 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.961 -1.018 . . . . 54.52 111.761 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.11 65.8 2.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.948 -0.644 . . . . 42.44 112.534 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 1.001 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 7.6 p -58.54 112.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.639 0.733 . . . . 71.23 112.411 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -169.45 72.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.374 -0.83 . . . . 74.1 110.575 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -126.15 150.59 48.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 71.44 110.095 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.39 171.64 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.5 -0.318 . . . . 74.54 110.82 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.916 ' HB2' HG21 ' A' ' 236' ' ' VAL . 16.2 p90 -74.54 92.1 2.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.372 0.606 . . . . 74.41 112.517 -168.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 67.5 mmtt -152.64 104.96 2.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.939 -0.573 . . . . 74.14 110.315 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 68.6 mm-40 -136.42 -155.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 64.41 109.855 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 10.7 t70 -85.58 115.31 61.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.913 -0.403 . . . . 72.51 109.913 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . 0.881 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 28.0 Cg_exo . . . . . 0 C--N 1.346 0.398 0 C-N-CA 123.688 2.926 . . . . 62.15 114.272 -172.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.182 0 N-CA-C 113.065 0.765 . . . . 75.15 113.065 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -97.68 164.31 21.86 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.986 -1.246 . . . . 52.34 109.986 169.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 226' ' ' GLU . 14.9 t -68.74 113.15 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.1 0.95 . . . . 73.52 110.069 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.588 HG12 HG11 ' A' ' 271' ' ' VAL . 15.5 tt -57.24 -21.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.043 -0.981 . . . . 54.33 111.831 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.514 ' HG2' ' OG1' ' A' ' 224' ' ' THR . 17.1 pt-20 -60.12 -44.69 94.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 75.21 110.489 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.623 ' HB3' HG23 ' A' ' 246' ' ' ILE . 9.3 m-30 -109.53 -34.67 6.44 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.635 0.606 . . . . 72.11 112.635 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 232' ' ' ALA . 7.4 t -70.9 14.15 0.16 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.543 0.572 . . . . 74.04 112.543 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 227' ' ' PHE . 33.3 t 66.52 -177.23 0.2 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.659 0.743 . . . . 73.41 111.863 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 233' ' ' HIS . 42.3 mt -72.35 -35.15 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.067 -0.97 . . . . 72.13 110.081 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.504 ' HB3' HG13 ' A' ' 236' ' ' VAL . 4.1 m-20 -49.9 -56.35 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.64 -1.164 . . . . 72.4 112.334 -174.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.26 -49.69 76.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.473 0.546 . . . . 73.01 112.473 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.443 ' CD2' ' HA ' ' A' ' 230' ' ' ILE . 12.0 p80 -70.82 -16.39 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.546 -0.461 . . . . 73.45 110.61 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.51 -21.22 45.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 73.41 109.909 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . 0.881 ' HA3' ' HA ' ' A' ' 217' ' ' PRO . . . 111.17 20.07 7.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.776 -0.726 . . . . 44.35 113.617 175.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 213' ' ' TYR . 7.3 p -122.17 136.41 59.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.333 -0.51 . . . . 73.23 110.966 175.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.582 ' HB3' ' CE1' ' A' ' 204' ' ' TYR . . . -64.46 125.83 89.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 73.35 110.977 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 33.0 Cg_exo -60.6 130.57 34.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.922 2.415 . . . . 51.4 112.065 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 240' ' ' ARG . 21.9 p -153.21 154.22 34.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.165 -0.47 . . . . 62.32 110.837 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 239' ' ' SER . 4.1 mpt_? 57.09 -100.5 0.11 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.508 0.723 . . . . 74.24 111.23 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 241' ' ' ARG . 6.7 ttp-105 -64.19 -32.09 73.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.031 -0.531 . . . . 71.24 110.282 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.609 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.5 -57.17 21.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.927 -0.654 . . . . 73.31 112.026 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 239' ' ' SER . 4.5 m-20 -57.15 -42.48 81.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 72.24 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.531 HD23 HG12 ' A' ' 306' ' ' VAL . 9.7 mp -61.28 -42.78 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.947 -0.57 . . . . 43.31 111.106 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 279' ' ' ARG . 54.0 tt0 -69.22 -37.68 78.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 34.41 110.795 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 227' ' ' PHE . 69.9 mt -62.47 -41.93 93.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.919 0.39 . . . . 71.24 110.473 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 250' ' ' CYS . 52.8 tp -60.06 -40.41 89.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.97 -0.559 . . . . 61.22 110.436 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.466 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.03 -40.68 97.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.5 -0.857 . . . . 63.35 111.903 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 227' ' ' PHE . 22.1 m-30 -65.6 -41.14 93.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.89 0.329 . . . . 72.03 111.89 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 247' ' ' LEU . 26.4 p -69.06 -34.37 75.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.007 -0.677 . . . . 73.5 110.543 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -66.89 -39.82 87.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.59 -0.277 . . . . 74.42 111.401 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 tt -69.62 -34.32 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.459 -0.497 . . . . 72.31 110.67 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.957 HE21 ' HG ' ' A' ' 259' ' ' LEU . 16.1 mm-40 -68.1 -32.6 73.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.637 0.256 . . . . 54.33 111.402 176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -75.98 -38.1 57.8 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 74.44 111.184 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.3 tp -80.54 -48.04 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.17 0.433 . . . . 72.13 112.17 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 58.9 p -109.66 -27.67 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.16 0.505 . . . . 72.24 111.143 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.485 ' HA3' ' HG3' ' A' ' 147' ' ' LYS . . . 68.32 34.95 81.34 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.45 112.906 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.09 142.84 34.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 72.24 110.903 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.957 ' HG ' HE21 ' A' ' 253' ' ' GLN . 88.6 mt -117.71 142.62 30.93 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.841 -0.618 . . . . 61.12 109.694 170.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 25.4 Cg_exo -63.94 -49.43 3.98 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 122.379 2.053 . . . . 71.22 111.138 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.435 ' HD1' HD23 ' A' ' 265' ' ' LEU . 30.7 p90 -82.94 25.58 0.67 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 64.35 111.142 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 259' ' ' LEU . 23.0 tt0 -68.37 -48.47 64.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 73.54 111.413 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.7 -32.74 71.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.19 0.519 . . . . 72.3 110.884 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -107.23 22.25 16.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.868 -0.605 . . . . 73.53 111.06 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 265' ' ' LEU . 3.0 tm? -61.33 -24.02 66.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.764 0.792 . . . . 75.33 109.706 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -68.13 -15.82 63.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.7 -1.137 . . . . 65.5 112.064 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.717 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 9.0 t0 -125.78 122.66 24.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.887 0.375 . . . . 64.05 110.638 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.71 -24.04 77.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.295 2.663 . . . . 61.12 113.82 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.5 -48.32 72.97 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.165 0.507 . . . . 74.51 109.952 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 97.4 m-85 -67.33 -38.69 85.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.361 -0.836 . . . . 72.22 110.595 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.588 HG11 HG12 ' A' ' 225' ' ' ILE . 59.1 t -57.28 -49.77 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.204 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 276' ' ' ILE . 16.7 ttp180 -57.66 -54.42 47.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 65.4 110.428 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.95 -48.59 78.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.037 -0.983 . . . . 74.53 111.935 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.7 t -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.398 -0.365 . . . . 55.42 111.237 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 261' ' ' TRP . 96.4 mttt -70.35 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.746 -0.381 . . . . 75.24 110.629 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.6 mt -64.76 -38.5 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.037 0.446 . . . . 71.15 110.007 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.07 -45.71 79.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.623 -0.717 . . . . 74.3 110.963 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -76.09 -32.42 59.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.957 -0.297 . . . . 65.31 111.706 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 275' ' ' LYS . 99.6 mtt180 -60.18 -23.41 63.95 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.581 0.229 . . . . 71.13 110.771 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -50.32 -53.58 27.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.793 -0.64 . . . . 72.51 110.412 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -170.11 99.41 0.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 63.44 109.615 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.21 -34.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 70.03 110.743 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.626 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -60.08 -46.75 88.54 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.6 0.593 . . . . 73.01 112.6 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 15.8 m -60.26 -48.75 80.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.228 0.537 . . . . 73.23 110.993 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.21 -50.21 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 73.02 111.204 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.22 -45.08 94.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 74.54 111.486 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.17 -31.94 73.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 75.01 111.425 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -82.62 -13.21 56.89 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.717 0.294 . . . . 72.44 111.444 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 92.0 m -78.64 -69.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.796 0.295 . . . . 33.33 111.796 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 294' ' ' ASN . 39.2 m-85 -125.29 90.78 50.24 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 112.112 0.412 . . . . 74.01 112.112 -173.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -92.49 1.1 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.665 2.243 . . . . 70.43 112.105 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.89 -69.46 0.45 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.307 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 293' ' ' LYS . 3.1 mmmp? -49.56 -61.97 1.81 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.773 -0.649 . . . . 73.54 111.655 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.489 ' H ' ' HB3' ' A' ' 290' ' ' PHE . 15.8 m120 -113.54 -155.72 0.58 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.997 -0.742 . . . . 70.22 108.997 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.687 ' HE3' HG21 ' A' ' 331' ' ' ILE . 26.7 tptp -164.97 87.24 1.04 Allowed Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.774 0.321 . . . . 73.12 110.154 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -100.64 37.29 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.11 2.54 . . . . 73.53 112.171 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.02 -37.74 7.1 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.495 -0.859 . . . . 73.42 111.072 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.667 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 20.9 mp0 -66.95 -47.12 72.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.762 -0.829 . . . . 75.31 108.762 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.8 mp -59.09 -38.96 77.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 114.863 -1.062 . . . . 74.11 110.363 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -59.57 -50.25 74.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.532 -0.304 . . . . 71.34 111.208 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.1 -43.18 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.15 110.107 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.449 ' CE1' HD22 ' A' ' 320' ' ' LEU . 87.7 t80 -56.92 -47.08 81.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.412 -0.813 . . . . 73.04 111.203 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.525 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.2 -41.85 80.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 54.33 111.568 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -60.21 -40.55 90.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 64.14 109.77 175.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 98.4 m -60.28 -50.15 74.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.322 -0.854 . . . . 74.15 111.296 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 19.8 m -70.67 -33.99 55.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.842 0.312 . . . . 73.55 111.842 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -21.12 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.454 -0.498 . . . . 72.21 110.312 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.9 tp -81.49 -5.3 57.82 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.158 -0.474 . . . . 63.25 110.968 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 305' ' ' THR . 90.1 mt -91.17 6.61 44.39 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.776 0.287 . . . . 71.31 111.776 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.595 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 24.3 t70 61.45 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.705 0.628 . . . . 71.41 111.961 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 -52.12 0.31 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.179 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.2 t -149.12 29.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.761 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 42.6 mm-40 -51.89 -62.87 1.36 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.45 -0.341 . . . . 75.41 111.028 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -171.12 102.27 0.4 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.502 -0.317 . . . . 73.34 110.398 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.4 118.85 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.538 2.159 . . . . 71.54 111.576 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.3 mt -114.33 92.83 4.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.453 -0.34 . . . . 63.53 111.354 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' A' ' 165' ' ' LEU . 97.5 m-85 -57.66 -34.07 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.164 0.507 . . . . 71.23 110.084 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.37 -55.33 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.055 -0.975 . . . . 61.43 111.027 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.97 -41.55 95.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.969 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 67.3 mt -56.96 -53.3 59.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.32 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 322' ' ' ASP . 11.0 ptt180 -65.26 -36.53 84.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.928 0.394 . . . . 60.13 110.207 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . 0.508 ' N ' ' HG3' ' A' ' 321' ' ' ARG . 30.0 t70 -68.23 -51.21 47.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.819 -0.628 . . . . 74.43 111.63 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.88 -31.23 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.924 -0.311 . . . . 73.51 111.14 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.41 -48.87 59.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.372 -0.376 . . . . 73.22 110.571 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -39.88 83.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.11 110.046 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.23 -48.43 81.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 61.43 111.197 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.667 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.36 -46.15 91.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 33.3 112.085 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -60.96 -45.21 95.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 62.21 110.841 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -70.25 -26.91 64.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.016 0.436 . . . . 70.01 110.583 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.24 -29.28 63.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.537 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.687 HG21 ' HE3' ' A' ' 295' ' ' LYS . 32.6 pt -90.19 -5.51 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 63.11 111.063 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 91.58 23.91 27.34 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.782 -0.723 . . . . 62.12 113.405 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -127.22 138.53 53.13 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.438 -0.448 . . . . 73.12 110.373 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 334' ' ' LYS . 9.9 mtpm? -138.66 -113.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.329 . . . . 73.34 111.647 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -159.73 113.93 2.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.507 0.67 . . . . 74.1 111.578 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.6 156.04 4.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.851 -1.068 . . . . 65.03 109.263 172.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.33 50.74 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.288 -0.725 . . . . 63.24 111.288 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 61.8 mttp . . . . . 0 C--N 1.333 -0.147 0 CA-C-N 115.173 -0.514 . . . . 60.23 110.701 -178.959 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 353' ' ' THR . 12.8 tptp . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 109.821 -0.437 . . . . 61.41 109.821 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 14.8 t -173.48 156.27 2.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.376 -0.602 . . . . 72.42 109.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.789 ' HA ' ' HA ' ' A' ' 200' ' ' LEU . 0.2 OUTLIER -67.43 131.81 32.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.097 0.475 . . . . 62.12 111.204 -176.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 355' ' ' THR . 7.6 t -78.61 85.29 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.182 0.992 . . . . 61.1 110.752 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.534 -0.757 . . . . 74.42 110.499 178.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' HD3' ' A' ' 42' ' ' PRO . 61.5 t . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.001 -0.74 . . . . 71.3 109.001 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.599 -0.81 . . . . 74.03 112.687 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.1 147.07 43.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 117.202 0.501 . . . . 74.23 110.097 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -106.72 115.88 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.933 -0.576 . . . . 74.14 109.629 176.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 37' ' ' TRP . 14.9 pt -97.49 141.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.923 -0.581 . . . . 54.42 110.538 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 112.08 23.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.012 -0.54 . . . . 73.33 111.117 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.691 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 11.7 t70 -93.62 -179.2 4.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.64 -0.874 . . . . 62.31 108.64 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . 0.59 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 17.1 mmt -73.35 -13.76 61.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.416 0.524 . . . . 30.41 112.416 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HH2' ' A' ' 37' ' ' TRP . . . -84.73 2.58 41.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.869 0.366 . . . . 63.04 110.727 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.604 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 32.2 ttmt 48.26 73.44 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.907 0.883 . . . . 73.04 112.561 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.873 ' H ' ' HZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -143.61 -154.96 0.56 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.321 -1.363 . . . . 72.42 107.321 173.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 3.1 mp0 -123.27 102.12 7.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.16 0.505 . . . . 72.24 111.029 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.873 ' HZ3' ' H ' ' A' ' 35' ' ' LYS . 3.8 m-90 -85.04 104.85 15.33 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.925 -0.769 . . . . 75.25 108.925 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -79.5 122.26 26.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.505 . . . . 73.11 110.832 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 52' ' ' TYR . 60.6 t -74.79 107.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.733 -0.469 . . . . 73.14 109.733 174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -61.13 4.56 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.779 -0.724 . . . . 23.24 112.116 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 pt? -159.64 152.06 17.55 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.066 -0.346 . . . . 64.15 110.066 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.4 Cg_exo -73.91 101.83 1.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.742 2.295 . . . . 74.01 111.562 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 53' ' ' LEU . 65.0 mt -66.74 -42.78 89.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 73.03 109.72 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.96 -31.38 8.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.64 -0.79 . . . . 75.14 111.873 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 2.0 tm0? -140.81 129.86 23.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.581 0.705 . . . . 64.11 110.925 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 39.43 0.12 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 108.239 -1.944 . . . . 61.52 108.239 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.34 122.76 4.96 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.456 -1.058 . . . . 72.2 110.456 -166.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.703 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 6.3 t80 66.91 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.129 0.572 . . . . 64.21 111.262 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.5 165.22 16.89 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.208 -0.52 . . . . 72.13 111.938 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.88 35.13 21.8 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.231 0.538 . . . . 71.2 110.892 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 71' ' ' LYS . 43.0 mm -88.44 138.53 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 65.11 111.051 -175.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 30.0 m-85 -108.28 157.23 18.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.813 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 43' ' ' ILE . 59.6 tp -94.35 136.61 34.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 71.23 109.776 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.1 103.31 15.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.602 0.239 . . . . 70.23 110.443 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 56' ' ' MET . 27.8 t70 -79.37 -25.6 42.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 63.34 110.327 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.508 ' HE3' ' HA ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER 67.26 163.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.375 -0.83 . . . . 71.14 110.804 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -87.44 65.92 8.85 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.048 -0.723 . . . . 72.12 109.048 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.9 m -77.36 70.12 3.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 63.22 110.709 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 p . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.592 -0.731 . . . . 71.54 111.06 -179.547 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.294 0.569 . . . . 71.35 111.1 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 133' ' ' ARG . 4.1 Cg_exo -80.14 38.86 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.014 2.476 . . . . 73.44 111.504 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . 0.439 ' HB2' HG23 ' A' ' 130' ' ' ILE . 6.9 p -145.3 138.18 26.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.549 0.69 . . . . 60.04 112.771 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.75 165.76 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.061 -0.972 . . . . 70.22 108.409 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.676 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -119.83 120.15 62.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.841 0.829 . . . . 71.02 112.68 -178.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HA ' HD12 ' A' ' 51' ' ' ILE . 22.1 tptm -84.21 125.8 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 113.198 -1.819 . . . . 70.3 108.662 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.01 150.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.566 0.58 . . . . 50.01 112.566 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -152.2 135.25 9.25 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.388 -0.824 . . . . 72.42 109.11 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 -166.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.322 2.015 . . . . 73.2 111.715 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.4 m -74.68 60.29 0.91 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.215 0.531 . . . . 60.35 110.869 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -105.56 -38.99 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.347 -0.612 . . . . 71.34 109.347 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.65 76.01 0.33 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.135 -0.938 . . . . 62.12 110.523 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -152.24 -99.09 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.246 -0.978 . . . . 23.31 112.733 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 49.0 Cg_exo -56.9 -45.59 35.23 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.127 2.552 . . . . 71.41 113.614 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -68.98 -41.02 78.44 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.999 -0.28 . . . . 62.3 110.815 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 85.1 t80 -61.37 -47.55 85.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.928 0.394 . . . . 74.02 110.289 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 m -66.1 -42.59 89.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.596 . . . . 74.11 110.587 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 87' ' ' TYR . 36.4 tt0 -64.88 -40.62 95.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.655 -0.702 . . . . 63.14 110.419 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.95 -39.28 85.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 72.3 110.535 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 10.9 mmpt? -59.02 -44.66 91.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.304 -0.407 . . . . 63.31 110.202 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.69 -49.55 77.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.764 -0.653 . . . . 75.31 110.836 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.547 ' HE2' ' HG2' ' A' ' 83' ' ' GLU . 56.3 m-85 -64.01 -38.32 90.65 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.651 -0.249 . . . . 73.12 111.426 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -61.42 -37.41 83.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.813 0.34 . . . . 53.52 110.78 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -88.26 -27.19 21.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.928 0.344 . . . . 74.51 111.928 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.58 16.05 25.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 60.25 111.893 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -76.05 163.87 26.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.039 0.385 . . . . 63.12 112.039 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.1 mmtt 75.89 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.161 -0.927 . . . . 75.31 112.425 175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 -35.69 98.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.492 2.795 . . . . 75.51 113.184 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.44 -41.89 90.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 72.02 110.863 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.57 -42.32 78.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 70.3 109.797 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 92' ' ' LYS . 59.2 mt -57.8 -53.48 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 64.1 110.572 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.692 ' HA ' HE21 ' A' ' 97' ' ' GLN . 0.0 OUTLIER -60.29 -31.83 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 74.33 111.332 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -58.76 -56.36 23.25 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.238 0.336 . . . . 70.05 110.686 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.757 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.81 -34.19 73.35 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.303 -0.559 . . . . 72.51 110.735 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 107' ' ' TYR . 56.7 mt -58.13 -50.5 78.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.786 -0.188 . . . . 74.22 111.055 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -66.51 -38.44 87.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 73.2 110.621 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -67.57 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 60.51 111.402 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -78.03 -15.34 59.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.464 . . . . 71.14 110.965 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 68.77 33.21 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.64 -0.709 . . . . 71.23 110.697 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 106' ' ' LYS . 21.1 tp -81.95 177.13 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.985 -1.117 . . . . 74.41 107.985 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.502 ' H ' ' HG ' ' A' ' 105' ' ' LEU . 20.2 mmtm -103.15 -49.89 3.63 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.949 -0.7 . . . . 75.02 111.816 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . 0.703 ' HE2' ' HD3' ' A' ' 160' ' ' ARG . 34.4 p90 -162.0 -176.98 5.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 73.43 111.428 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 52.8 tp -133.22 131.76 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.569 -0.53 . . . . 62.54 109.569 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.4 57.64 4.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.868 -0.682 . . . . 72.35 112.66 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.19 131.47 22.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.303 . . . . 60.24 110.47 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.48 145.76 72.0 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 73.1 111.923 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -58.83 129.11 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.805 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -100.48 128.94 46.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 70.53 109.919 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CG ' HG22 ' A' ' 130' ' ' ILE . 43.6 m95 -100.69 -62.96 1.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.492 . . . . 74.21 109.945 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.83 -157.79 15.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.637 -0.71 . . . . 42.12 112.223 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 32' ' ' MET . 14.0 p -169.07 152.4 5.11 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.551 -0.537 . . . . 74.53 109.551 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -158.7 -164.92 14.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.028 -1.082 . . . . 70.22 113.315 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.3 137.06 42.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.741 0.305 . . . . 74.32 110.477 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . 0.454 ' CG ' HG22 ' A' ' 29' ' ' ILE . 72.8 t60 -140.75 113.18 8.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.841 0.353 . . . . 71.33 110.241 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 32.8 t70 -72.43 126.39 29.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.059 -0.519 . . . . 64.1 110.422 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 122' ' ' ASN . 46.1 tptt -89.42 25.13 2.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.247 0.546 . . . . 64.0 109.539 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.8 OUTLIER 74.25 63.99 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.305 -0.861 . . . . 72.31 110.158 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.4 -54.04 0.72 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.794 -1.094 . . . . 62.54 111.33 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -112.91 121.98 46.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.972 -0.381 . . . . 60.43 109.972 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 47.3 m -86.68 117.57 25.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.596 -0.52 . . . . 74.52 109.596 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -91.18 140.45 29.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.066 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -99.22 133.99 42.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.589 -0.523 . . . . 72.0 109.589 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.606 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 43.9 p90 -128.78 161.12 30.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.557 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 48.2 ttp -139.52 133.26 30.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.977 -0.556 . . . . 74.43 110.099 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.676 HD13 ' HB ' ' A' ' 70' ' ' VAL . 13.1 mm -96.43 123.99 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.183 0.515 . . . . 74.12 110.296 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.4 ptm -137.13 -178.09 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 75.22 110.671 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.49 154.8 34.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.085 0.469 . . . . 75.53 110.833 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 67' ' ' PRO . 28.9 ptt180 -89.88 124.17 34.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.723 -0.671 . . . . 72.24 112.199 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 26.0 m-85 -103.05 160.31 14.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 65.51 109.832 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . 0.727 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -145.44 -25.81 0.1 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.089 -1.053 . . . . 64.3 113.252 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.752 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 58.8 m -121.48 126.42 49.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.876 0.338 . . . . 73.34 111.694 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -98.04 134.94 40.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 72.53 109.929 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 61.52 111.211 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.451 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 22.9 tp60 -58.33 -49.31 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.452 . . . . 74.45 112.104 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 137' ' ' ASP . 20.5 pttm -85.61 -20.92 28.78 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.981 -0.687 . . . . 75.33 111.009 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.96 -46.35 79.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.277 0.56 . . . . 71.34 109.647 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.731 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -67.32 -32.76 73.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.792 . . . . 70.25 110.514 176.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.69 -54.92 8.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.948 -0.569 . . . . 75.13 111.405 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.51 72.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 54.33 111.76 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -87.4 0.53 55.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 73.32 110.167 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 53.86 52.35 13.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.454 -0.794 . . . . 75.41 112.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.1 OUTLIER 40.08 75.96 0.07 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.53 0.732 . . . . 62.42 112.257 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 18.2 ttp180 -149.79 79.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.582 -0.736 . . . . 73.34 109.235 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.731 ' HZ ' ' HA ' ' A' ' 142' ' ' TYR . 38.3 m-85 -111.02 156.47 21.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.121 0.486 . . . . 73.32 111.702 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 154' ' ' VAL . 42.0 p -68.02 152.1 46.03 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.373 -0.83 . . . . 61.14 110.197 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.584 ' HG2' HD23 ' A' ' 328' ' ' LEU . 41.0 ttm105 -66.56 -26.38 67.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.963 0.411 . . . . 71.35 110.186 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.22 -43.89 69.73 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.171 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.465 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 21.2 p -68.27 -44.64 75.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 72.2 110.943 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 150' ' ' SER . 92.6 t -57.61 -42.84 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 65.35 111.152 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 324' ' ' LEU . 2.5 mm? -64.9 -42.37 94.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.52 -0.309 . . . . 75.43 111.001 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 17.8 mm-40 -59.97 -46.01 90.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.49 0.186 . . . . 61.01 110.858 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 153' ' ' THR . 98.7 mt -59.62 -41.15 89.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.888 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.7 t -59.57 -47.11 86.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 63.35 111.006 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 325' ' ' LEU . 10.1 mp -63.8 -37.92 89.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 45.32 111.388 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.703 ' HD3' ' HE2' ' A' ' 107' ' ' TYR . 15.3 mmt180 -57.88 -52.59 64.84 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.465 -0.568 . . . . 72.51 109.465 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.0 -49.75 82.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.093 -0.958 . . . . 73.3 110.784 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.63 -54.54 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.948 0.351 . . . . 63.1 111.948 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.55 -48.6 76.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.579 0.228 . . . . 64.11 111.362 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 167' ' ' TYR . 16.7 tt -72.34 -36.63 55.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 120.428 -0.509 . . . . 61.51 111.21 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.4 -38.27 81.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 73.25 110.924 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 34.1 mm-40 -76.78 -23.95 52.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.842 -0.343 . . . . 54.23 110.517 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 164' ' ' ILE . 69.6 t80 -58.39 -48.65 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.31 110.076 172.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.6 pt -80.27 -32.29 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.54 -0.3 . . . . 72.04 111.372 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.756 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 4.9 m170 -56.55 -44.18 80.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.935 0.346 . . . . 75.22 111.935 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.15 12.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 65.43 111.41 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -120.97 -72.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.268 -0.424 . . . . 71.21 109.905 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 203' ' ' ARG . 9.2 pt-20 -177.3 -35.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.541 0.571 . . . . 73.04 112.541 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.56 135.85 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 74.31 111.005 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 28.7 m -129.8 142.9 42.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.593 -0.731 . . . . 54.03 109.536 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.563 ' CE1' ' HB3' ' A' ' 200' ' ' LEU . 3.6 t60 -100.96 -47.07 4.9 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.788 -0.365 . . . . 63.42 110.1 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.971 ' HA2' ' HB3' ' A' ' 243' ' ' ASP . . . 73.23 -62.14 1.79 Allowed Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.918 -0.658 . . . . 72.23 111.979 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 4.9 t70 -55.08 111.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.199 0.6 . . . . 61.01 112.457 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.62 43.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.45 0.643 . . . . 62.22 109.585 170.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -81.6 145.44 30.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.608 -0.516 . . . . 64.15 109.608 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.08 -2.14 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.835 0.68 . . . . 71.03 112.835 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 4.7 p -76.91 -26.44 54.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.709 0.263 . . . . 74.34 111.709 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.61 -0.61 31.7 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 111.787 0.291 . . . . 75.41 111.787 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.77 111.19 23.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 75.04 109.973 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.3 mm? -114.26 136.07 53.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.087 -0.506 . . . . 64.35 110.598 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.5 mt -93.58 141.71 28.16 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.82 -0.627 . . . . 71.53 110.141 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.98 138.74 58.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.528 -0.545 . . . . 74.21 109.528 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . 0.727 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 64.0 t80 -57.99 -30.91 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.37 0.508 . . . . 74.24 112.37 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 26.5 tptp -101.58 -44.25 5.64 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.808 -0.357 . . . . 72.51 111.125 -176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.594 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 4.4 m120 -102.01 104.85 38.78 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 63.1 111.505 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 17.4 Cg_exo -68.42 -14.21 39.44 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.208 2.605 . . . . 45.15 112.247 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -88.48 -3.8 58.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.889 -0.596 . . . . 73.01 110.799 -178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' A' ' 189' ' ' ASN . 72.3 mt-30 -109.64 96.99 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 73.42 110.524 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.1 p -103.55 134.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 70.44 109.969 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 64.2 m-85 -125.2 157.28 36.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.016 -0.538 . . . . 75.24 110.202 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 72.7 mt -103.1 127.5 50.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.199 -0.455 . . . . 64.35 110.066 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 184' ' ' LEU . 7.6 p -139.37 170.78 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.624 -0.51 . . . . 71.04 109.624 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 196' ' ' VAL . 69.1 m-20 65.12 56.81 0.99 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.002 0.906 . . . . 75.03 109.617 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.456 ' HD2' ' HB2' ' A' ' 201' ' ' ALA . 4.5 m-85 -73.91 39.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.365 -1.289 . . . . 74.03 112.809 -176.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -81.15 47.39 3.57 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.262 -0.735 . . . . 53.15 111.262 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 tt -170.98 44.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 70.45 108.096 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . . . -133.04 106.07 7.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 72.34 110.268 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -115.72 -177.45 3.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.096 -0.502 . . . . 74.13 110.44 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' A' ' 172' ' ' GLU . 58.8 mtt-85 -104.54 117.81 35.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.274 -0.421 . . . . 74.44 111.388 -170.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -87.99 -45.3 10.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.181 0.515 . . . . 74.33 110.239 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 172' ' ' GLU . 11.0 p -128.81 66.33 75.15 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.889 -0.596 . . . . 60.54 110.838 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.55 143.9 76.55 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.645 2.23 . . . . 63.53 112.349 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 74.07 6.74 4.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.436 -0.802 . . . . 75.42 111.144 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.03 10.92 74.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.097 -0.573 . . . . 42.13 112.471 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 40.4 t -116.71 128.14 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.646 -0.501 . . . . 75.11 109.646 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -64.66 141.63 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.855 -0.424 . . . . 65.13 109.855 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -114.34 166.47 11.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 72.41 111.332 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -72.89 144.67 47.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 64.04 110.152 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.452 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 53.6 p90 -68.2 147.46 52.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.42 -0.585 . . . . 72.0 109.42 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 2.3 mptp? -90.58 -69.26 0.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.346 0.869 . . . . 60.23 113.346 -167.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 9.3 mm-40 63.35 71.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.627 -0.879 . . . . 73.31 108.627 -165.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.6 146.22 68.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.901 -1.045 . . . . 64.15 111.004 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo . . . . . 0 C--N 1.347 0.471 0 C-N-CA 122.78 2.32 . . . . 74.31 113.379 177.672 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.8 t70 . . . . . 0 C--O 1.235 0.329 0 N-CA-C 112.287 0.477 . . . . 75.01 112.287 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 200' ' ' LEU . . . -77.27 153.14 40.87 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.671 -0.776 . . . . 72.42 112.866 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -70.2 122.39 19.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.09 0.471 . . . . 65.23 110.551 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.87 -12.91 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.959 -0.564 . . . . 55.33 111.709 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . 0.493 ' HA ' HD21 ' A' ' 265' ' ' LEU . 38.5 tt0 -55.34 -59.54 4.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.555 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.82 -33.05 7.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.11 -0.496 . . . . 72.11 110.103 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 98.5 m -58.0 121.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.701 0.763 . . . . 74.15 110.84 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.625 ' H ' HD11 ' A' ' 246' ' ' ILE . 47.7 t -56.61 166.38 0.94 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.105 -1.407 . . . . 73.2 111.758 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 230' ' ' ILE . 37.5 mt -55.15 -51.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.436 -0.802 . . . . 54.34 110.608 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -56.16 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 51.22 111.504 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.45 97.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 73.44 111.817 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 42.2 t-80 -76.24 -17.53 59.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 61.42 110.467 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.66 -8.41 59.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.597 -0.729 . . . . 72.43 111.683 -176.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 86.7 24.14 39.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.055 -1.069 . . . . 65.34 112.843 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 213' ' ' TYR . 10.0 p -120.51 140.98 42.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.303 -0.629 . . . . 71.53 109.303 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.46 113.56 7.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.662 0.268 . . . . 54.12 110.771 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.48 134.93 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.587 2.191 . . . . 55.1 112.117 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 34.9 p -79.36 -164.52 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.969 -0.56 . . . . 64.34 109.66 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -62.93 -19.28 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.453 -0.499 . . . . 74.44 109.965 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -63.32 -30.55 71.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.909 -0.587 . . . . 64.3 111.116 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.25 -66.65 2.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.05 -0.595 . . . . 73.54 112.502 -175.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.971 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -76.8 -29.77 56.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.252 0.464 . . . . 74.5 112.252 -174.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.99 -34.2 77.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 70.13 110.981 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.99 -34.31 61.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.503 -0.554 . . . . 44.51 109.503 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.625 HD11 ' H ' ' A' ' 229' ' ' SER . 93.7 mt -64.41 -37.77 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 71.41 110.393 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 47.9 tp -61.5 -40.2 93.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 174.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.15 99.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.601 -0.809 . . . . 61.21 111.743 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -54.37 -57.14 12.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.844 0.354 . . . . 73.24 111.218 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.2 p -67.21 -40.94 86.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 73.1 111.993 -174.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.12 -47.57 85.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.672 0.272 . . . . 72.3 111.42 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.34 -29.24 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.414 -0.514 . . . . 71.02 110.253 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -67.55 -46.8 71.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.595 -0.275 . . . . 73.1 110.543 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -61.96 -31.28 71.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.352 -0.385 . . . . 62.55 110.588 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.59 -41.2 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.015 -0.539 . . . . 71.01 112.089 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 67.1 p -101.92 -27.89 12.71 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.186 0.439 . . . . 71.11 112.186 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 96.96 -5.07 63.39 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.488 -0.863 . . . . 71.5 113.694 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -150.83 144.07 24.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.799 0.8 . . . . 53.51 112.458 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.447 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 60.3 mt -122.5 138.9 29.94 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.198 -0.91 . . . . 71.21 108.871 166.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 46.2 Cg_exo -58.19 -34.79 98.91 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.728 2.285 . . . . 51.12 113.309 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.516 ' HB2' HG12 ' A' ' 271' ' ' VAL . 36.7 p90 -95.3 2.92 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.646 -0.252 . . . . 72.14 111.438 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.86 -33.84 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.889 0.376 . . . . 74.31 110.492 -177.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.42 -28.64 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.723 0.773 . . . . 74.55 109.309 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 270' ' ' TYR . 9.9 m120 -86.23 7.14 26.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.069 -0.968 . . . . 43.01 110.497 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.7 tm? -54.94 -35.32 64.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 63.43 111.243 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.57 14.88 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.817 0.673 . . . . 72.04 112.817 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.7 t70 -139.89 113.98 7.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.733 0.301 . . . . 73.11 110.325 174.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.87 -30.81 92.72 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.41 2.74 . . . . 73.15 113.777 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -69.2 -44.54 71.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.694 0.283 . . . . 71.25 110.647 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 264' ' ' ASN . 43.8 m-85 -66.71 -49.97 64.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 61.14 111.669 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 261' ' ' TRP . 19.4 m -62.5 -35.81 71.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.131 -0.227 . . . . 74.23 111.585 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 276' ' ' ILE . 30.1 ttm180 -63.06 -53.27 56.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.6 -0.273 . . . . 72.33 110.334 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.66 -40.0 88.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 52.52 111.14 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.7 m -61.66 -44.69 96.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.451 -0.341 . . . . 45.33 111.34 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.71 -33.6 71.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.709 0.29 . . . . 75.12 110.868 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 272' ' ' ARG . 77.4 mt -67.21 -43.88 88.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.948 0.404 . . . . 71.32 109.981 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -63.0 -36.15 82.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.851 -0.613 . . . . 73.03 110.293 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.29 -46.3 89.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 74.12 111.026 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -64.5 -26.35 68.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.924 0.392 . . . . 71.34 110.866 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.13 -32.17 50.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 63.14 111.32 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.635 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -136.05 53.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.947 0.403 . . . . 74.25 110.389 -172.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -57.0 -44.45 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 113.577 0.954 . . . . 74.32 113.577 -171.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.445 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -69.8 -47.32 63.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.866 0.321 . . . . 64.23 111.866 -170.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.4 t -68.36 -45.15 73.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.511 -0.313 . . . . 73.01 110.74 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.0 mm? -61.21 -53.44 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 64.3 111.575 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . 0.487 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.1 OUTLIER -59.7 -42.79 93.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.743 0.275 . . . . 75.51 111.743 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.07 -37.33 85.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.131 0.491 . . . . 73.34 111.088 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -89.85 1.72 55.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 73.25 111.624 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 90.4 m -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 63.13 110.707 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 14.8 t80 -132.81 86.97 42.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 71.43 109.223 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.9 34.35 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.431 2.754 . . . . 75.52 112.847 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 51.5 mt-10 -120.59 -165.67 1.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 73.31 110.293 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -92.04 85.55 5.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.084 0.469 . . . . 74.13 110.661 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.27 -165.64 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.99 -0.744 . . . . 64.31 108.99 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.791 ' HD3' HD12 ' A' ' 331' ' ' ILE . 21.7 mtpp -120.48 90.14 45.14 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.483 0.183 . . . . 72.1 111.489 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -99.53 36.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.94 2.427 . . . . 73.21 111.395 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.56 -42.9 3.53 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.795 -0.717 . . . . 70.44 112.031 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -56.84 -46.08 81.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.968 0.413 . . . . 75.11 110.128 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.16 -41.24 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.895 -0.593 . . . . 71.21 110.586 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.91 -50.14 74.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 73.42 111.171 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.469 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 320' ' ' LEU . 73.1 t80 -56.19 -46.54 79.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 72.4 110.843 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.533 ' HA ' HG22 ' A' ' 306' ' ' VAL . 94.8 mmm -71.46 -39.37 70.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.814 -0.63 . . . . 63.25 111.209 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 25.2 tt0 -58.66 -50.03 75.37 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.771 0.796 . . . . 72.1 109.369 174.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 88.9 m -57.65 -50.97 71.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.702 -1.136 . . . . 73.03 111.733 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 303' ' ' MET . 33.7 m -67.21 -27.22 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 112.21 0.448 . . . . 45.43 112.21 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -80.33 -19.86 45.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.363 -0.535 . . . . 72.13 110.339 -179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 30.4 tp -94.41 17.84 12.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.116 -0.493 . . . . 63.21 111.143 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 315' ' ' PRO . 92.2 mt -93.77 -12.78 28.38 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.282 0.475 . . . . 51.25 112.282 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 313' ' ' GLU . 13.2 t70 58.48 -164.37 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.591 0.356 . . . . 74.23 110.123 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.455 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.3 m-85 -64.93 -52.07 58.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 63.53 110.416 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 19.8 m -155.16 69.05 0.7 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.222 0.534 . . . . 75.14 111.023 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 310' ' ' ASP . 25.2 mt-10 -104.99 33.43 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 64.12 109.493 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 25.4 mttt 64.53 103.53 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.219 0 CA-C-N 114.512 -1.222 . . . . 75.1 112.239 -176.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.557 ' HA ' HD22 ' A' ' 309' ' ' LEU . 19.6 Cg_endo -63.22 136.49 56.04 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.284 1.989 . . . . 63.22 110.49 170.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 92.9 mt -79.19 79.82 5.59 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.857 -0.337 . . . . 61.41 110.699 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 315' ' ' PRO . 17.2 m-85 -53.41 -48.5 68.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.495 -0.775 . . . . 72.15 109.948 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -63.04 -53.24 56.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.848 -1.069 . . . . 61.3 111.785 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 27.0 t-20 -59.77 -51.37 70.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.747 -0.206 . . . . 62.42 111.333 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 302' ' ' TYR . 95.5 mt -59.16 -48.75 80.46 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.948 0.404 . . . . 75.41 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -62.3 -40.56 96.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 73.02 110.203 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.72 -49.38 47.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 63.41 111.51 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.79 -33.61 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.872 -0.331 . . . . 74.13 111.323 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 155' ' ' LEU . 88.7 mt -69.9 -49.37 52.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 74.43 110.591 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 159' ' ' LEU . 82.5 mt -67.04 -34.07 76.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 72.52 111.031 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.12 -47.67 79.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.48 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.77 79.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.69 -0.767 . . . . 73.22 111.975 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.584 HD23 ' HG2' ' A' ' 151' ' ' ARG . 3.1 tm? -68.23 -49.54 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.094 0.473 . . . . 73.52 110.336 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 333' ' ' SER . 85.6 tttt -71.87 -34.34 69.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 72.21 111.065 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -27.32 67.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.173 0.434 . . . . 71.41 112.173 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.791 HD12 ' HD3' ' A' ' 295' ' ' LYS . 15.6 tt -86.25 -6.3 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.416 -0.514 . . . . 73.2 110.87 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 110.64 24.45 5.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.278 -0.963 . . . . 54.41 113.875 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 13.3 t -119.47 149.57 41.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.332 0.566 . . . . 44.43 110.082 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -162.7 27.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.551 -0.907 . . . . 72.43 108.551 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.49 105.87 17.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.311 -1.313 . . . . 73.04 110.804 -170.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.2 -21.16 5.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 74.31 111.641 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.76 -23.47 64.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.632 -0.794 . . . . 53.33 113.126 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.674 0.274 . . . . 63.21 110.772 -178.474 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.41 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.155 0 N-CA-C 109.72 -0.474 . . . . 72.44 109.72 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.9 t -104.38 153.87 20.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.609 0.243 . . . . 73.41 110.366 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.22 128.44 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.282 0.563 . . . . 55.44 110.981 -173.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 33.3 m -77.82 97.96 5.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 63.24 111.822 -178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 90.3 mttt . . . . . 0 C--N 1.327 -0.397 0 N-CA-C 109.519 -0.549 . . . . 72.34 109.519 170.689 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.574 HG13 ' HA2' ' A' ' 40' ' ' GLY . 61.9 t . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 108.712 -0.847 . . . . 70.33 108.712 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.37 2.95 56.63 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.307 -0.949 . . . . 51.42 112.911 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 133.0 51.2 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.197 -0.668 . . . . 73.13 109.197 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -81.04 131.11 34.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.678 0.751 . . . . 63.53 111.338 -173.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.63 129.85 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.726 -1.124 . . . . 65.14 109.641 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 21.1 m -118.45 123.83 46.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.559 -0.291 . . . . 74.23 110.594 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 3.2 p-10 -111.2 -173.09 2.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.398 -0.365 . . . . 74.24 110.71 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.06 -14.31 61.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.356 0.502 . . . . 64.24 112.356 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.29 8.54 8.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.836 0.35 . . . . 34.2 110.434 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.6 tptt 55.81 63.21 2.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.334 -0.848 . . . . 74.45 110.686 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' THR . 48.6 mmtm -134.92 120.84 19.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.059 -0.973 . . . . 75.45 109.723 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.93 77.29 4.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 73.2 109.428 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.594 ' HB2' ' O ' ' A' ' 56' ' ' MET . 37.4 p-90 -96.81 -176.55 3.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.686 -0.688 . . . . 71.23 110.375 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HG2' ' HB3' ' A' ' 56' ' ' MET . 18.8 pttp -133.69 137.14 45.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.3 111.562 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.01 151.68 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.952 -1.022 . . . . 74.3 110.797 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -96.6 -124.44 4.67 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.452 -0.659 . . . . 50.44 111.452 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.2 mp -92.13 128.88 43.55 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.838 0.351 . . . . 72.34 110.48 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 15.5 Cg_exo -68.91 119.1 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.91 2.406 . . . . 75.13 111.463 176.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.83 -59.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.147 0.499 . . . . 73.43 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.67 -8.3 76.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.899 -0.667 . . . . 61.33 112.316 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -127.4 161.38 28.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.487 0.184 . . . . 72.44 110.561 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.67 -130.92 2.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.402 -1.079 . . . . 64.34 110.402 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.57 -2.69 86.94 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.473 -0.87 . . . . 70.34 111.527 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.78 -68.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.728 -0.471 . . . . 50.22 109.728 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.93 174.23 24.63 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.865 -0.683 . . . . 64.53 111.888 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.7 m 62.68 32.72 16.07 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.108 0.48 . . . . 73.55 111.583 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.13 137.37 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 73.01 110.603 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.42 ' HB2' HG13 ' A' ' 70' ' ' VAL . 11.0 m-85 -111.89 148.97 32.53 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.849 -0.426 . . . . 74.4 109.849 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 54' ' ' ALA . 4.5 tt -90.63 139.87 30.3 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.828 -0.804 . . . . 33.03 108.828 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.512 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.796 -0.362 . . . . 62.43 110.751 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.77 -53.37 6.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 74.54 110.495 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 22.7 ttt -118.75 122.8 43.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.463 -0.789 . . . . 74.22 110.038 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -144.3 142.64 30.55 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.392 -0.966 . . . . 71.35 108.392 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.2 m -72.37 76.17 1.02 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.428 0.633 . . . . 71.2 110.457 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.5 m . . . . . 0 N--CA 1.443 -0.821 0 CA-C-N 115.623 -0.717 . . . . 64.15 110.035 179.403 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.122 0.487 . . . . 71.23 110.018 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.464 ' C ' ' HB2' ' A' ' 133' ' ' ARG . 3.6 Cg_exo -79.67 40.36 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.149 2.566 . . . . 75.44 111.273 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 p -144.26 146.95 32.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.623 0.725 . . . . 73.14 112.826 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 132' ' ' ASP . 34.6 m -128.08 167.05 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.021 -0.99 . . . . 74.32 109.389 172.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.1 p -130.42 123.83 56.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.256 0.551 . . . . 73.11 111.488 -176.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -82.43 122.3 27.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.443 -0.577 . . . . 72.41 109.443 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.9 122.48 65.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.4 -0.364 . . . . 62.44 110.577 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 80' ' ' LEU . 6.0 tp10 -136.07 137.54 25.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 74.21 109.053 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.62 133.25 50.34 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.17 1.913 . . . . 74.12 112.061 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 t -81.18 15.01 2.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.099 0.476 . . . . 40.03 110.655 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 124' ' ' LYS . 10.0 t70 -67.65 -69.1 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 63.44 110.105 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -170.32 118.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.705 -0.68 . . . . 52.11 109.477 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.71 -161.95 28.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.465 -0.874 . . . . 72.31 112.478 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.01 -21.54 49.37 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.18 2.587 . . . . 72.43 112.913 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 80' ' ' LEU . 1.2 tm? -52.31 -37.64 56.31 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.602 0.564 . . . . 74.11 111.16 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.15 -41.81 85.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 73.01 110.574 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -69.15 -46.3 67.96 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.708 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 80' ' ' LEU . 11.4 pt-20 -67.99 -31.1 70.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.189 -0.46 . . . . 72.4 110.838 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.51 -39.71 88.82 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.366 -0.235 . . . . 74.22 110.366 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -57.26 -49.01 77.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 53.0 110.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.11 -49.51 69.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 74.44 111.131 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' ' HD1' ' A' ' 113' ' ' TYR . 55.8 t80 -59.91 -38.13 81.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.731 -0.668 . . . . 75.44 111.563 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.14 -39.63 63.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 64.52 110.867 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -27.83 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 71.33 110.955 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HA ' ' CH2' ' A' ' 99' ' ' TRP . . . -106.74 16.52 24.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.963 0.411 . . . . 64.21 111.352 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' LYS . . . -82.58 158.19 23.17 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.109 -0.496 . . . . 72.25 111.478 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' ILE . 49.9 mtmt 75.17 107.01 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.293 -0.867 . . . . 64.1 111.394 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.531 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 49.7 Cg_exo -55.69 -35.33 92.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.362 2.708 . . . . 75.52 113.197 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.739 ' HG2' ' HE2' ' A' ' 98' ' ' LYS . 38.6 tt0 -66.46 -45.8 78.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 61.01 110.946 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.702 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 48.8 tt0 -62.64 -36.87 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.405 -0.591 . . . . 74.13 109.405 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 93' ' ' PRO . 67.4 mt -55.96 -45.88 80.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.537 -0.756 . . . . 72.03 110.284 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 96.3 mt-30 -53.78 -47.06 71.11 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.856 -0.611 . . . . 73.23 110.586 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.739 ' HE2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -63.85 -57.75 8.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.48 0.548 . . . . 74.12 112.48 -177.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.606 ' CH2' ' HA ' ' A' ' 90' ' ' ALA . 1.1 p90 -69.52 -34.71 74.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 119.968 -0.693 . . . . 61.41 111.501 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 108' ' ' LEU . 26.1 mm -63.45 -47.07 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.41 . . . . 74.45 110.122 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.94 -35.67 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 74.31 110.886 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.1 m -76.25 -34.63 59.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.555 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -84.61 1.91 43.93 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 122.299 -0.251 . . . . 54.24 111.546 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 65.94 25.9 11.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.582 0.551 . . . . 74.15 111.104 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.58 -178.32 5.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 74.3 109.362 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.9 -45.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.73 0.641 . . . . 74.2 112.73 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -154.08 117.48 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.522 -0.871 . . . . 75.43 112.342 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.6 pt? -103.96 136.24 43.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 74.44 109.294 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.85 66.65 3.53 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.852 -0.689 . . . . 73.24 112.926 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 11.7 p -104.11 136.76 19.15 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 110.262 -0.273 . . . . 72.43 110.262 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 38.8 Cg_exo -61.73 146.23 96.81 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.685 2.256 . . . . 64.23 112.719 176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -67.77 122.91 19.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.623 -0.717 . . . . 75.2 111.157 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HD1' ' CZ ' ' A' ' 87' ' ' TYR . 40.4 t80 -84.33 116.08 22.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.976 -0.557 . . . . 72.4 110.866 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.485 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 73.3 m95 -104.71 -63.01 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 74.21 109.065 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.08 172.13 31.39 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.148 -0.933 . . . . 62.14 111.305 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 p -169.83 159.82 8.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.577 0.227 . . . . 73.3 110.628 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.41 -165.03 37.62 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.855 -0.688 . . . . 61.15 111.662 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -137.47 147.22 45.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.914 0.387 . . . . 74.32 110.452 178.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -124.55 112.08 16.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.561 -0.533 . . . . 73.11 109.561 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 15.1 t0 -71.74 148.08 46.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.005 -0.543 . . . . 53.15 111.031 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.473 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 26.5 tptp -117.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.545 -0.752 . . . . 72.52 110.179 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 121' ' ' LYS . 15.8 m120 -135.26 30.72 3.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.287 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.26 -31.64 6.35 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.008 -0.837 . . . . 53.41 111.008 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 76' ' ' ASP . 44.3 mttp -100.18 96.4 7.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.19 -0.67 . . . . 74.43 109.19 173.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 4.9 p -76.26 142.56 41.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.436 -0.802 . . . . 62.43 111.254 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -96.18 121.57 38.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.86 -0.609 . . . . 72.21 109.716 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 118' ' ' LEU . 16.0 ttt180 -102.57 132.77 48.43 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.269 -0.641 . . . . 74.52 109.269 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.568 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 39.9 p90 -133.41 160.06 38.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.038 0.447 . . . . 74.34 111.797 -170.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.2 ptp -142.31 141.04 32.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.613 -0.721 . . . . 71.25 109.888 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -97.3 122.76 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.036 0.446 . . . . 74.23 110.384 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.5 mtm -127.15 -175.98 3.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 72.21 110.282 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 5.7 m-20 -58.3 152.52 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 65.11 110.502 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.464 ' HB2' ' C ' ' A' ' 67' ' ' PRO . 35.3 ttt180 -72.79 105.62 4.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.711 -0.478 . . . . 65.21 109.711 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 132' ' ' ASP . 28.3 m-85 -101.76 171.02 7.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.274 -0.421 . . . . 75.24 110.533 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.29 -43.97 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.674 -0.774 . . . . 71.42 111.844 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 5.6 t -120.87 159.8 24.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.069 0.462 . . . . 70.15 110.531 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.825 ' HB3' HD13 ' A' ' 184' ' ' LEU . 1.1 p30 -143.57 -172.54 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 72.33 109.78 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 6.8 mp -77.08 -24.51 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.164 -0.471 . . . . 75.15 112.075 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.78 ' HA ' ' HD1' ' A' ' 142' ' ' TYR . 3.2 pt20 -75.46 -36.29 60.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.695 -0.802 . . . . 63.22 109.968 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 43.1 mttp -57.83 -34.25 69.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 73.41 110.182 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.7 mt -76.0 -51.29 20.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.489 -0.778 . . . . 63.41 111.227 175.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.78 ' HD1' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -72.18 -33.85 67.99 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.752 0.649 . . . . 74.14 112.752 -170.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.471 ' HG3' ' CE1' ' A' ' 142' ' ' TYR . 31.2 mt-10 -72.07 -31.25 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.349 . . . . 75.54 110.913 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.54 -32.1 15.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.979 0.362 . . . . 74.53 111.979 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -98.95 0.31 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 64.23 110.742 -176.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.81 64.85 1.44 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.51 -0.768 . . . . 54.42 111.984 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 142' ' ' TYR . 17.5 ptpt 34.09 74.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.199 1.185 . . . . 60.13 114.199 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.42 103.84 5.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 70.14 110.415 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 89.6 m-85 -121.03 155.8 33.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.975 -0.557 . . . . 75.01 110.474 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 154' ' ' VAL . 67.0 p -80.62 148.35 30.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.46 -0.336 . . . . 55.24 110.208 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -26.63 66.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.002 0.43 . . . . 74.24 110.549 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 335' ' ' ASP . 63.0 tttm -62.08 -51.79 66.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.655 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 33.3 m -64.26 -46.84 81.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.274 -0.876 . . . . 53.11 110.497 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 150' ' ' SER . 69.6 t -54.64 -46.01 72.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 75.13 111.462 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 328' ' ' LEU . 1.7 tp -63.82 -49.15 73.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.615 -0.266 . . . . 72.12 110.734 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -60.44 -39.91 89.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 63.01 110.801 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 153' ' ' THR . 94.0 mt -62.41 -49.69 74.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.416 -0.356 . . . . 61.1 110.425 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 m -58.1 -40.56 81.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 72.14 111.179 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 321' ' ' ARG . 3.5 mm? -61.98 -54.31 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 64.52 111.471 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.404 ' O ' HG22 ' A' ' 164' ' ' ILE . 86.6 mtt180 -64.16 -39.27 93.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.957 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 195' ' ' LEU . 1.6 mp -65.89 -40.39 87.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.606 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.92 -44.13 96.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.616 0.246 . . . . 72.13 110.898 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.42 -55.37 35.95 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.026 -0.534 . . . . 51.23 110.846 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 160' ' ' ARG . 13.8 tt -69.16 -35.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.087 -0.506 . . . . 75.23 111.519 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 45.2 tp -63.81 -39.4 94.16 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.276 -0.17 . . . . 62.34 111.331 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 169' ' ' HIS . 22.8 tp10 -80.85 -25.61 37.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.968 0.413 . . . . 65.23 110.365 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.42 -45.81 92.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.442 . . . . 71.03 110.487 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.85 -29.67 11.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 71.11 110.521 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 3.5 t-160 -61.95 -21.85 65.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.663 -0.699 . . . . 74.34 110.468 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -96.42 10.21 38.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.773 -0.648 . . . . 75.1 109.918 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . 0.519 ' CD2' ' HG2' ' A' ' 172' ' ' GLU . 73.9 t60 -116.68 -77.3 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.435 -0.348 . . . . 73.33 111.767 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 206' ' ' PRO . 8.3 pt-20 -161.22 -10.11 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.339 1.237 . . . . 73.35 114.339 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.568 ' CD2' ' HB1' ' A' ' 201' ' ' ALA . 16.7 p90 -155.97 161.85 40.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.714 0.688 . . . . 74.14 111.229 -170.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.716 HG13 ' HE2' ' A' ' 204' ' ' TYR . 35.6 m -131.6 160.44 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.637 -0.71 . . . . 60.11 110.209 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.64 96.55 10.75 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.005 -1.109 . . . . 73.11 108.005 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.47 73.57 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.948 -0.644 . . . . 14.24 112.389 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 179' ' ' LYS . 25.1 t70 -121.26 98.49 6.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.039 0.447 . . . . 54.14 110.305 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 178' ' ' ILE . 30.5 mm -87.8 38.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.388 1.09 . . . . 73.34 109.274 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . 0.469 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 7.9 ttpm? -75.95 164.83 25.79 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.586 -0.894 . . . . 73.32 108.586 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -56.58 -15.87 5.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.562 0.579 . . . . 61.11 112.562 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 179' ' ' LYS . 11.9 p -76.82 -15.43 59.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.731 0.301 . . . . 63.31 111.595 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 183' ' ' LEU . 5.6 t-20 -83.2 -30.75 27.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.626 0.727 . . . . 71.3 110.346 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.553 ' HG ' HD21 ' A' ' 195' ' ' LEU . 6.0 mp -96.11 110.9 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.999 -1.0 . . . . 75.33 110.695 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.825 HD13 ' HB3' ' A' ' 137' ' ' ASP . 2.2 mm? -98.33 156.6 16.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.704 -0.68 . . . . 73.04 110.228 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 79.5 mt -119.27 159.13 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.512 -0.551 . . . . 63.22 109.512 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 11.9 t30 -60.86 151.06 31.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.825 -1.176 . . . . 72.31 107.825 170.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -48.72 -27.83 3.18 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.085 0.772 . . . . 73.35 113.085 -166.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -156.58 34.93 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.244 0.545 . . . . 72.31 110.557 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 5.0 t30 -126.08 103.5 26.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.558 -0.534 . . . . 73.42 109.558 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -72.61 -28.67 13.97 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.087 2.525 . . . . 61.11 114.337 -169.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.75 -6.84 55.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.759 -0.376 . . . . 75.35 111.156 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.566 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 11.4 mm-40 -111.81 97.04 6.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 55.14 110.837 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.76 130.07 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.989 -1.005 . . . . 70.24 110.322 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.487 ' CD2' ' HE1' ' A' ' 134' ' ' PHE . 35.0 m-85 -124.43 147.38 48.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.063 -0.717 . . . . 70.42 109.063 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.553 HD21 ' HG ' ' A' ' 183' ' ' LEU . 49.4 mt -96.56 116.3 28.86 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.593 -0.443 . . . . 52.41 110.814 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.579 HG23 ' CE2' ' A' ' 198' ' ' TYR . 2.7 p -148.43 87.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.817 0.818 . . . . 53.24 110.963 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.75 -50.91 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 60.43 109.493 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 196' ' ' VAL . 18.5 m-85 51.51 35.02 13.39 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.494 -0.775 . . . . 72.05 110.705 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -154.27 -31.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.853 -1.067 . . . . 42.2 112.117 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 25.7 mt -97.01 9.77 41.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.78 0.8 . . . . 54.23 108.855 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 173' ' ' TYR . . . -97.46 111.67 23.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.831 -1.077 . . . . 73.23 110.528 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -98.49 115.26 28.17 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.204 -0.453 . . . . 71.31 109.907 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.434 ' NH2' ' HB3' ' A' ' 206' ' ' PRO . 0.6 OUTLIER -87.74 114.54 24.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.54 0.686 . . . . 61.35 110.101 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.716 ' HE2' HG13 ' A' ' 174' ' ' VAL . 9.5 p90 -89.65 -41.57 11.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.142 -0.935 . . . . 71.32 111.527 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 78.0 m -153.04 108.18 2.65 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.599 -0.519 . . . . 64.43 109.599 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 172' ' ' GLU . 28.0 Cg_endo -63.32 84.05 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.899 2.399 . . . . 70.42 113.628 -174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 76.48 -11.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.263 1.025 . . . . 74.44 110.574 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 51.65 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.418 -1.073 . . . . 65.25 110.418 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . 0.694 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 3.4 p -48.88 111.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.742 0.782 . . . . 54.03 113.075 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -164.13 70.9 0.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 54.12 109.003 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 205' ' ' CYS . 47.2 tptt -139.54 111.06 7.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.473 -0.785 . . . . 73.14 109.402 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -101.53 176.42 5.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 75.4 111.278 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 9.6 p90 -74.17 84.04 1.84 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.634 -0.712 . . . . 71.24 110.527 177.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -166.17 28.07 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.456 0.646 . . . . 71.31 109.771 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.64 144.5 51.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 63.33 111.594 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -173.82 91.76 0.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.048 -0.978 . . . . 73.43 108.567 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo . . . . . 0 N--CA 1.462 -0.356 0 C-N-CA 122.14 1.894 . . . . 74.24 110.948 176.838 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . 0.612 ' OD1' HG21 ' A' ' 228' ' ' THR . 1.0 OUTLIER . . . . . 0 CA--C 1.538 0.483 0 N-CA-C 114.149 1.166 . . . . 62.43 114.149 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.405 ' O ' ' HE1' ' A' ' 233' ' ' HIS . . . -127.0 -116.35 2.01 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.449 -0.881 . . . . 41.11 114.229 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.9 m -92.1 110.67 22.05 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.369 0.267 . . . . 63.22 111.438 -173.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.1 tt -58.36 -19.09 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 111.88 0.326 . . . . 73.13 111.88 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.94 -61.83 2.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.44 -0.345 . . . . 74.33 110.642 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.446 ' HD2' ' SG ' ' A' ' 250' ' ' CYS . 84.4 m-85 -86.15 -42.95 13.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.634 -0.257 . . . . 74.22 110.817 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.612 HG21 ' OD1' ' A' ' 222' ' ' ASP . 26.0 m -57.91 -27.67 63.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.158 -0.474 . . . . 72.34 111.364 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 71.5 m 65.99 -170.01 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.592 -0.731 . . . . 73.12 111.463 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.1 OUTLIER -72.65 -33.89 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 73.53 112.218 -175.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 236' ' ' VAL . 1.2 p-10 -58.09 -75.25 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.999 0.74 . . . . 63.54 112.999 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.435 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.04 -30.47 71.0 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.185 0.517 . . . . 54.51 111.346 -176.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 229' ' ' SER . 1.5 t60 -71.74 -23.92 61.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.855 -0.612 . . . . 73.31 111.043 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -97.54 -15.19 20.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 62.33 111.035 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.2 -9.95 59.72 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.294 -0.955 . . . . 54.45 112.689 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 231' ' ' ASP . 8.1 p -71.64 129.72 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 74.14 109.639 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -61.51 116.95 22.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.009 -0.541 . . . . 72.14 112.112 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.77 106.11 0.31 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.779 2.319 . . . . 74.02 110.835 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.0 p -130.51 109.49 10.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.954 -0.566 . . . . 72.34 111.505 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 312' ' ' THR . 2.2 mpt_? 76.66 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.005 -0.998 . . . . 71.31 110.994 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 310' ' ' ASP . 21.6 ttp180 -69.58 -30.94 68.83 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.297 -0.561 . . . . 73.21 110.172 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -52.94 46.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 74.14 111.782 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 165' ' ' LEU . 4.5 m-20 -53.84 -46.04 71.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.463 0.649 . . . . 63.03 110.327 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . 0.495 HD13 HD21 ' A' ' 320' ' ' LEU . 75.0 mt -71.75 -35.99 70.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.478 -0.783 . . . . 73.24 111.699 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.64 -39.95 95.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 71.32 110.329 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 227' ' ' PHE . 80.3 mt -64.85 -49.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.62 . . . . 65.44 110.307 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 251' ' ' MET . 51.1 tp -58.81 -47.13 85.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.286 -0.415 . . . . 63.41 111.251 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -34.7 90.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.958 -0.639 . . . . 51.15 112.243 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.429 ' CD2' ' HE3' ' A' ' 275' ' ' LYS . 24.0 t80 -62.72 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.231 0.539 . . . . 74.03 109.811 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 227' ' ' PHE . 60.5 m -61.67 -45.36 94.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.625 -0.716 . . . . 72.52 110.433 176.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -55.23 -52.97 61.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.943 -0.571 . . . . 65.11 111.612 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.9 tt -65.49 -37.16 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 63.45 111.124 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.444 HE21 ' CD1' ' A' ' 259' ' ' LEU . 15.4 mt-30 -69.14 -42.21 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 65.03 111.771 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 41.0 m0 -62.34 -31.84 72.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 71.4 110.674 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.16 -41.26 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.189 -0.459 . . . . 72.24 112.208 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 65.2 p -104.06 -29.11 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.767 0.654 . . . . 73.52 112.767 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.0 24.09 64.51 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 121.056 -0.592 . . . . 31.15 112.985 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -155.67 142.86 19.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.114 0.457 . . . . 75.35 109.937 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.444 ' CD1' HE21 ' A' ' 253' ' ' GLN . 20.4 mt -130.57 149.75 74.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 74.44 111.272 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.2 6.45 3.47 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.97 2.447 . . . . 74.34 112.926 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -143.45 24.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 73.42 110.914 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.552 ' HA ' HD23 ' A' ' 265' ' ' LEU . 12.9 pt-20 -63.83 -30.38 71.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.362 0.504 . . . . 55.3 112.362 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 266' ' ' LYS . 34.5 t70 -83.02 -25.61 32.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.379 -0.529 . . . . 73.24 109.796 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . 0.83 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 95.2 m-20 -77.34 -3.78 41.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.782 -0.644 . . . . 73.55 110.469 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 262' ' ' GLU . 2.1 mm? -61.57 -18.56 59.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.802 -0.636 . . . . 65.4 110.592 172.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 263' ' ' ASP . 6.0 ptmt -70.57 -19.27 62.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 71.01 111.604 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.592 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 16.1 t70 -135.5 132.56 19.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.955 0.407 . . . . 63.32 111.38 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 271' ' ' VAL . 26.0 Cg_endo -62.24 -30.68 81.85 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.247 2.631 . . . . 52.4 114.494 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . 0.592 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 7.3 ptpp? -73.57 -29.56 62.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.879 -0.728 . . . . 63.3 109.832 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.83 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 54.3 m-85 -76.97 -44.35 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.729 -0.669 . . . . 74.22 111.451 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 29.9 m -63.89 -35.8 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.839 -0.345 . . . . 64.01 110.796 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -61.83 -57.49 11.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 74.13 110.287 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.76 -49.74 73.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.335 -0.848 . . . . 75.13 111.127 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 20.1 m -63.11 -44.58 95.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 73.4 111.595 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . 0.429 ' HE3' ' CD2' ' A' ' 249' ' ' TYR . 68.5 tttt -66.04 -37.33 85.59 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.684 -0.406 . . . . 74.03 110.457 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 78.5 mt -69.01 -47.9 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.606 -0.27 . . . . 61.2 111.146 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -60.96 -40.71 94.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.332 . . . . 73.04 110.908 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -73.4 -31.45 63.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 63.43 110.985 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.45 -20.2 65.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 63.4 111.133 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -80.39 -35.59 35.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.457 -0.338 . . . . 65.03 110.79 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -123.23 47.51 1.98 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.814 0.34 . . . . 73.03 110.651 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.0 mt -51.84 -52.84 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.33 0.863 . . . . 54.14 113.33 -171.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -62.83 -48.66 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.244 0.461 . . . . 70.22 112.244 -169.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.0 m -64.88 -48.41 74.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.219 0.533 . . . . 72.1 110.558 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.64 -54.4 16.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.523 -0.762 . . . . 65.22 111.674 -174.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -65.04 -43.34 92.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.57 0.211 . . . . 70.01 111.57 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.42 -39.94 81.4 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.804 -0.359 . . . . 74.13 111.278 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -76.42 -20.73 56.8 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.99 -0.284 . . . . 71.41 111.377 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 97.9 m -76.86 -16.35 59.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 74.51 110.476 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.493 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 59.4 t80 -115.24 81.06 7.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.576 -0.527 . . . . 71.52 109.576 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 91.1 Cg_endo -95.26 34.92 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.458 2.772 . . . . 63.03 112.13 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -82.18 -174.9 5.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.594 -0.73 . . . . 74.33 110.258 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.7 mmtt -89.28 13.17 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.106 0.479 . . . . 73.12 110.848 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.493 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 3.1 t-20 -105.88 -163.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.292 -1.003 . . . . 74.51 108.292 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.457 ' HE3' ' HB ' ' A' ' 331' ' ' ILE . 19.6 pttp -149.66 124.9 4.87 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.79 0.328 . . . . 75.43 111.208 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 290' ' ' PHE . 65.3 Cg_endo -95.43 37.22 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 54.02 111.88 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.67 86.64 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.95 -0.643 . . . . 51.41 111.838 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.721 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.4 mp0 -52.43 -46.49 66.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.029 0.442 . . . . 72.3 110.7 176.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.8 mp -71.97 -42.69 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.78 -0.645 . . . . 61.52 110.789 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.83 68.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.809 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 301' ' ' LYS . 23.3 mtpp -75.07 -30.16 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 74.35 111.506 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.45 -45.96 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.083 0.468 . . . . 61.42 110.134 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.579 ' HA ' HG22 ' A' ' 306' ' ' VAL . 72.1 mtp -72.28 -35.42 68.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 72.32 110.64 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -57.42 -44.33 84.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.577 0.703 . . . . 64.33 109.583 173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.8 m -61.13 -49.98 75.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.891 -1.05 . . . . 64.32 111.893 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 303' ' ' MET . 16.8 m -66.77 -27.53 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.911 0.386 . . . . 75.12 110.758 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -65.25 -42.26 93.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 75.2 110.042 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 50.0 tp -71.37 -21.61 62.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.428 -0.805 . . . . 54.4 110.906 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 309' ' ' LEU . 6.3 tt -71.1 -14.75 62.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.043 -0.526 . . . . 63.44 110.291 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 34.8 t70 67.56 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.628 -0.715 . . . . 50.41 111.852 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -136.43 -51.93 0.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.24 -0.652 . . . . 70.23 109.24 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 240' ' ' ARG . 55.3 m -148.37 75.88 1.34 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.786 -0.643 . . . . 74.11 111.358 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.419 ' HB2' ' HG ' ' A' ' 309' ' ' LEU . 51.1 mm-40 -83.3 -165.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.106 -1.072 . . . . 74.22 108.106 162.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 314' ' ' LYS . 11.0 tmtt? -76.13 113.53 28.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.516 -0.92 . . . . 70.22 108.516 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 240' ' ' ARG . 12.3 Cg_exo -68.43 117.46 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.038 1.826 . . . . 72.24 110.966 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 95.6 mt -94.11 68.68 3.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.072 -0.513 . . . . 72.42 110.521 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -57.92 -32.86 68.18 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.211 -0.663 . . . . 64.35 109.211 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.4 mp0 -58.01 -56.7 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.756 -1.111 . . . . 73.53 110.302 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 26.2 t-20 -71.96 -33.17 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 75.44 111.734 -175.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 7.9 mp -61.28 -48.19 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.367 . . . . 72.24 111.058 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.534 ' HB2' HD11 ' A' ' 159' ' ' LEU . 15.4 ptp180 -72.01 -24.67 61.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.325 -0.55 . . . . 65.0 109.951 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.08 -49.02 55.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 73.05 110.989 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -62.68 -39.0 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 110.066 -0.346 . . . . 75.04 110.066 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.5 mt -62.33 -49.74 74.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 62.0 110.527 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . 0.645 ' O ' ' HG3' ' A' ' 329' ' ' LYS . 4.1 mm? -70.15 -26.9 64.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 64.33 111.366 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.01 -43.54 64.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.918 0.389 . . . . 71.52 110.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.721 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.03 -36.04 92.57 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 61.34 111.798 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 155' ' ' LEU . 17.4 tp -69.21 -29.93 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 74.13 110.057 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 325' ' ' LEU . 62.3 mttp -65.28 -38.78 91.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 45.34 110.55 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.28 73.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.755 -0.657 . . . . 74.05 111.655 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.457 ' HB ' ' HE3' ' A' ' 295' ' ' LYS . 15.2 tt -92.64 2.49 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 63.51 110.375 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.09 25.77 73.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.897 -0.668 . . . . 61.11 113.576 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 25.6 m -121.83 158.93 27.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.435 0.617 . . . . 62.34 111.272 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -150.74 172.76 15.07 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.042 -0.725 . . . . 73.4 109.042 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 30.6 t70 -120.63 127.74 52.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.763 -0.458 . . . . 74.44 109.763 172.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.74 21.11 3.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 64.3 110.832 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.23 45.37 15.24 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.491 -1.043 . . . . 64.44 110.491 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 115.559 -0.32 . . . . 71.42 111.716 -172.598 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.659 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 57.7 tptt . . . . . 0 C--O 1.224 -0.265 0 N-CA-C 108.51 -0.922 . . . . 75.3 108.51 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.4 t -73.18 164.62 26.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.522 0.146 . . . . 74.43 110.656 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -66.3 142.36 16.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 71.54 111.683 -174.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.0 t -75.36 134.84 40.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.766 -0.457 . . . . 71.1 109.766 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 356' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 121.646 0.736 . . . . 63.25 109.105 178.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.451 -0.389 0 CA-C-O 121.202 0.525 . . . . 73.1 110.374 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.52 -9.1 62.44 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.776 -0.647 . . . . 63.23 112.547 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.61 138.37 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 73.12 111.091 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -95.4 129.17 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.654 -0.703 . . . . 73.44 111.909 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 37' ' ' TRP . 31.3 pt -121.78 137.63 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.665 -0.698 . . . . 64.1 109.195 167.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 18.6 m -118.36 124.26 47.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.107 -0.237 . . . . 41.01 111.238 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.52 -177.93 4.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.459 -0.337 . . . . 71.11 110.482 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -16.78 62.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 71.52 112.744 -173.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.65 30.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.776 0.322 . . . . 65.2 110.525 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt 58.44 77.94 0.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.286 -0.87 . . . . 75.42 111.354 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 30' ' ' THR . 47.0 mmtm -136.09 125.18 24.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 71.11 108.73 173.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.18 85.45 6.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.008 0.432 . . . . 75.32 110.236 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 45.1 m95 -79.34 117.04 19.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.887 -0.597 . . . . 72.11 109.479 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 23.0 pttm -97.38 131.18 44.3 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.882 -0.727 . . . . 72.33 109.181 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 52' ' ' TYR . 59.0 t -67.8 130.32 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.931 -0.577 . . . . 71.45 110.947 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.15 -101.49 1.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.752 -0.737 . . . . 63.35 111.78 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -84.41 121.96 75.18 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.049 0.452 . . . . 72.13 110.11 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 7.4 Cg_exo -73.72 99.72 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.034 2.49 . . . . 73.23 111.376 175.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.94 -56.34 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 72.44 110.585 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.84 -24.76 28.27 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.82 -0.705 . . . . 64.21 112.246 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -134.9 165.72 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.951 0.405 . . . . 74.54 111.266 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.62 52.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.596 -0.729 . . . . 43.33 111.743 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.4 16.79 77.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.923 -0.656 . . . . 53.24 112.892 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -168.22 -84.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.117 -0.327 . . . . 74.21 110.117 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.28 144.92 4.2 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.283 -0.96 . . . . 14.14 112.67 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.8 m 62.67 61.15 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.323 0.582 . . . . 75.12 111.016 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.66 HD12 ' HB3' ' A' ' 71' ' ' LYS . 1.1 mm -118.31 138.29 49.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.805 -0.634 . . . . 74.24 109.836 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 39' ' ' VAL . 97.7 m-85 -122.28 154.13 37.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.53 0.205 . . . . 71.52 110.623 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.95 132.37 34.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.914 -0.773 . . . . 62.34 108.914 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.29 98.9 8.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 74.02 112.126 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.69 59.87 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.913 -0.585 . . . . 74.53 109.876 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.3 ttm -36.52 -72.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.162 0.914 . . . . 73.35 112.825 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -178.57 -176.27 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.3 m -70.76 123.67 22.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.574 -0.528 . . . . 70.04 109.574 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 C--N 1.324 -0.538 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.238 -179.052 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.222 0 N-CA-C 108.821 -0.807 . . . . 60.3 108.821 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 84.9 Cg_endo -82.59 39.05 0.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.3 . . . . 70.23 112.836 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 70.9 m -136.81 137.57 39.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.577 0.704 . . . . 55.54 112.15 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.66 154.0 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.203 -0.908 . . . . 71.22 109.323 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.598 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.8 p -125.22 123.99 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.455 0.645 . . . . 74.43 111.746 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.66 ' HB3' HD12 ' A' ' 51' ' ' ILE . 10.5 ptmm? -103.23 133.81 47.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.228 -0.896 . . . . 53.25 109.487 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.57 148.72 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.082 0.401 . . . . 73.44 112.082 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 31.9 tt0 -142.43 139.49 17.63 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 171.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.39 176.19 2.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.312 2.008 . . . . 51.34 111.697 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.2 m -79.53 41.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.112 0.482 . . . . 65.32 111.537 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -84.06 -24.66 30.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.33 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 70.01 75.76 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.429 0.633 . . . . 72.1 110.371 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -124.52 -128.21 3.25 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.48 -0.782 . . . . 63.44 112.271 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 19.3 Cg_endo -59.95 -35.0 94.85 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.874 2.383 . . . . 64.35 112.759 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.2 tm? -56.03 -50.01 72.12 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.122 0.264 . . . . 74.35 111.12 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -67.21 -38.14 84.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.745 0.307 . . . . 73.44 111.063 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.5 m -64.96 -46.84 79.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 65.24 109.811 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.697 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 39.7 tt0 -60.77 -43.34 98.16 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.694 -1.139 . . . . 45.15 110.209 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.22 -48.64 73.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.796 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -56.79 -58.5 7.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 74.54 110.276 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 79.6 t80 -59.67 -51.32 70.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.27 -0.877 . . . . 74.42 111.388 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.58 -47.16 85.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.343 -0.844 . . . . 70.12 111.648 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -68.32 -30.08 68.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 74.45 111.103 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.33 -30.36 62.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 73.41 111.521 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -34.37 11.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.468 0.544 . . . . 54.4 112.468 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.47 88.98 7.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.389 0.515 . . . . 50.22 112.389 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 95' ' ' GLN . 1.3 ttpp -146.12 105.86 4.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.989 -0.745 . . . . 53.4 108.989 171.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 -54.11 5.46 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.899 3.066 . . . . 72.14 115.041 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -33.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.381 . . . . 73.54 110.497 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 26.0 tp60 -65.03 -47.94 75.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 55.22 110.016 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 92' ' ' LYS . 74.2 mt -58.98 -53.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 115.676 -0.693 . . . . 65.42 110.685 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.0 -41.67 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 72.53 110.961 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -65.24 -53.18 48.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.145 -0.48 . . . . 73.34 111.502 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -72.91 -34.65 66.76 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.931 -0.708 . . . . 72.41 110.965 -175.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.4 mm -63.16 -45.17 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.666 0.27 . . . . 62.42 111.031 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -73.03 -27.9 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.807 0.337 . . . . 65.03 110.544 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.8 m -75.75 -40.87 54.68 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.12 0.486 . . . . 75.33 110.574 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.73 ' HG3' HD13 ' A' ' 105' ' ' LEU . 31.1 tpt180 -72.55 -18.41 61.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 73.2 110.365 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 39.8 tptt 67.57 54.05 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.963 -1.017 . . . . 51.12 110.217 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . 0.73 HD13 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mp -108.56 -167.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.824 -1.08 . . . . 75.04 109.449 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.11 -61.91 1.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.098 -0.334 . . . . 72.04 110.098 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -173.78 144.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 73.55 110.339 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HG ' HG23 ' A' ' 110' ' ' VAL . 44.3 tp -79.43 115.0 18.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.968 -0.753 . . . . 63.22 108.968 175.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' NH2' ' A' ' 160' ' ' ARG . . . -77.42 60.24 3.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.019 -0.61 . . . . 71.04 113.098 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 108' ' ' LEU . 92.1 t -123.47 132.87 24.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.384 -0.598 . . . . 55.14 109.384 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.69 152.83 12.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.103 2.535 . . . . 74.14 112.996 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -76.94 122.33 24.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 74.23 110.674 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -80.74 111.77 17.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.257 -0.883 . . . . 72.14 110.276 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 130' ' ' ILE . 40.4 m95 -90.2 -59.28 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.49 -0.559 . . . . 74.32 109.49 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.32 37.9 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.321 -0.854 . . . . 43.11 111.35 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.2 p -163.34 172.97 13.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.805 -0.443 . . . . 72.33 109.805 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.94 -173.01 40.78 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.124 -1.036 . . . . 75.24 112.271 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 125' ' ' SER . 8.6 tt -121.44 132.93 55.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.395 -0.595 . . . . 71.54 109.395 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -139.22 126.65 21.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.863 0.363 . . . . 72.11 110.422 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 21.6 t70 -75.68 126.75 31.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.803 -0.635 . . . . 71.4 110.487 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.861 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -83.45 -54.7 4.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.982 -0.377 . . . . 74.22 109.982 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.09 71.47 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.591 -0.522 . . . . 64.31 109.591 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.35 -19.08 49.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.831 -0.699 . . . . 73.31 111.632 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -113.76 120.0 39.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.124 -0.695 . . . . 64.45 109.124 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.6 p -92.87 134.52 35.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 71.44 110.813 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.09 140.24 50.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.974 -0.557 . . . . 73.31 110.312 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -105.61 124.56 49.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.083 -0.71 . . . . 70.43 109.083 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.598 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 48.7 p90 -122.29 154.42 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.075 -0.511 . . . . 62.15 110.869 -173.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 80.3 mtp -129.61 124.77 34.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 65.4 110.777 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ILE . . . . . 0.571 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 mm -98.13 121.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 63.34 110.461 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -133.25 178.09 7.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 74.01 109.321 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.3 p-10 -68.13 154.96 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 34.15 110.202 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -83.26 122.99 29.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.385 0.612 . . . . 71.11 112.118 -171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 90.2 m-85 -102.8 171.55 7.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.195 -0.911 . . . . 73.13 109.121 173.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.25 -30.43 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.886 -1.15 . . . . 65.01 113.24 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 49.9 m -105.27 125.67 51.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.048 0.424 . . . . 60.01 112.057 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 184' ' ' LEU . 3.9 m-20 -88.91 124.14 33.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.805 -0.634 . . . . 75.1 109.543 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 13.4 tp -64.35 -26.26 68.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.221 0.534 . . . . 73.4 109.768 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 28.2 tt0 -62.9 -48.7 77.84 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.787 -0.642 . . . . 71.21 110.977 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.74 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 9.0 mmpt? -70.07 -29.79 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.225 -0.443 . . . . 54.13 110.233 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 82.3 mt -65.09 -48.98 81.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.653 -0.703 . . . . 73.41 110.993 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.77 -32.12 73.21 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 119.866 -0.734 . . . . 74.34 109.68 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.05 -38.9 89.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 73.32 110.69 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.6 67.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.917 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -104.55 6.09 34.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.432 . . . . 64.14 110.906 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.57 54.9 6.02 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.706 -0.679 . . . . 71.53 112.257 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.484 ' O ' ' HA2' ' A' ' 257' ' ' GLY . 46.3 mtmt 55.59 53.44 9.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 75.24 112.569 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -123.46 96.41 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 74.42 109.87 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.653 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 21.7 m-85 -102.14 132.21 48.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.202 -0.454 . . . . 62.34 111.016 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 m -58.2 144.96 38.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.504 -0.771 . . . . 74.14 109.628 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 294' ' ' ASN . 45.9 ttt85 -59.92 -37.9 80.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.686 -0.234 . . . . 62.12 111.51 -172.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 153' ' ' THR . 11.9 ptpt -61.67 -38.19 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 62.25 110.253 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.545 ' N ' ' HG3' ' A' ' 152' ' ' LYS . 9.0 m -68.0 -45.37 74.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.106 -0.497 . . . . 61.4 110.436 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.6 t -61.89 -47.34 93.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.385 -0.37 . . . . 72.32 110.585 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.784 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -62.84 -52.4 63.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 74.44 110.545 -176.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -63.48 -33.52 75.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.587 0.232 . . . . 74.2 110.812 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 161' ' ' ILE . 2.7 mp -65.94 -51.21 60.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 70.01 110.681 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 247' ' ' LEU . 36.3 p -58.18 -37.16 74.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.075 -0.25 . . . . 43.42 110.902 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 74.5 mt -60.33 -54.39 46.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 75.21 111.219 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.497 HH11 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -66.57 -15.76 63.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.118 0.485 . . . . 70.44 111.0 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 157' ' ' LEU . 37.4 mm -72.35 -42.41 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.452 -0.573 . . . . 63.11 109.452 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.524 ' HB3' ' HE1' ' A' ' 317' ' ' TYR . 2.2 mm? -62.04 -42.21 98.93 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.62 -0.263 . . . . 73.42 110.459 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -63.03 1.22 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.6 0.714 . . . . 64.22 110.703 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 168' ' ' ILE . 18.1 tt -68.16 -41.4 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.234 -0.894 . . . . 64.15 111.565 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 243' ' ' ASP . 30.9 mt -63.66 -39.02 93.29 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.516 -0.474 . . . . 72.0 110.885 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 7.5 tp10 -57.28 -56.68 18.63 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.819 -0.438 . . . . 71.53 109.819 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.8 -42.94 80.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.473 -0.785 . . . . 74.24 112.078 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 174' ' ' VAL . 28.1 pt -80.7 -40.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.943 0.719 . . . . 54.01 112.943 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' HA ' ' A' ' 166' ' ' GLU . 1.3 p-80 -75.89 -17.83 59.64 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.696 -0.802 . . . . 73.22 111.253 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.3 16.33 17.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 71.3 109.966 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -136.95 -89.01 0.28 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.106 -0.497 . . . . 65.33 110.88 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -147.56 114.96 6.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.615 0.245 . . . . 73.24 110.711 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 64.8 m-85 76.26 157.43 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.237 0.961 . . . . 74.43 112.35 169.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 22.2 m -142.33 172.41 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.394 -0.821 . . . . 72.2 109.594 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 14.2 t60 -119.9 103.12 9.06 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.984 -0.286 . . . . 54.11 110.414 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.503 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . -73.71 -46.93 22.33 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.847 -0.692 . . . . 51.4 112.114 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . 0.954 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 24.9 t70 -65.58 94.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.146 0.498 . . . . 72.33 110.281 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.466 HD11 HD12 ' A' ' 161' ' ' ILE . 8.3 tp -97.45 14.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.759 -0.655 . . . . 61.44 110.605 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -53.6 146.28 13.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.2 -0.455 . . . . 71.52 110.072 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.98 -10.65 6.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.807 0.669 . . . . 75.01 112.807 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.9 p -73.79 -15.93 61.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.983 0.42 . . . . 71.41 110.826 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASN . . . . . 0.466 ' O ' HD12 ' A' ' 195' ' ' LEU . 41.3 m-80 -85.77 -16.67 38.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 75.41 110.751 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.73 115.0 29.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.972 -0.558 . . . . 35.44 110.253 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.0 mm? -110.69 135.21 51.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 63.54 110.229 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.9 mt -85.54 137.59 32.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.954 -0.567 . . . . 63.31 109.853 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -62.58 135.13 57.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.941 -0.572 . . . . 63.54 109.893 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -56.0 -33.54 64.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.847 -0.615 . . . . 73.11 112.126 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -81.86 -54.21 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 71.0 110.812 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.1 112.83 49.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.446 -0.343 . . . . 62.4 111.531 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.36 -10.56 28.35 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.845 2.363 . . . . 64.22 111.138 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ASP . . . . . 0.581 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 5.0 p-10 -88.67 0.67 56.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.433 -0.803 . . . . 65.43 110.592 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 77.4 mt-30 -114.07 102.64 10.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.526 . . . . 62.22 110.081 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.3 p -106.79 120.59 58.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.319 0.58 . . . . 73.25 110.703 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 93.3 m-85 -117.12 157.81 25.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.114 -0.494 . . . . 74.41 110.312 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 182' ' ' ASN . 31.6 tp -96.91 150.55 20.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.272 -0.422 . . . . 44.22 110.454 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 197' ' ' ASP . 3.0 p -136.39 -155.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.04 -0.726 . . . . 62.13 109.04 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.553 ' N ' HG13 ' A' ' 196' ' ' VAL . 9.2 t70 72.24 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.318 0.647 . . . . 72.32 109.706 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . 0.697 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 36.1 m-85 55.92 -7.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.246 1.202 . . . . 74.34 114.246 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 197' ' ' ASP . . . -72.72 -31.43 62.59 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.949 -0.861 . . . . 53.33 110.949 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . 0.687 ' HB2' ' CE1' ' A' ' 175' ' ' HIS . 92.0 mt -89.06 53.53 2.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.069 0.462 . . . . 71.44 110.307 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 173' ' ' TYR . . . -98.75 99.0 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 62.42 110.163 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -122.35 104.57 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 75.51 111.888 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ARG . . . . . 0.572 ' HB2' HG22 ' A' ' 174' ' ' VAL . 31.9 ttm180 -178.73 -73.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.077 -0.51 . . . . 72.12 110.44 172.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' TYR . . . . . 0.507 ' H ' ' HA ' ' A' ' 173' ' ' TYR . 81.9 t80 70.61 112.4 0.05 Allowed 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 124.036 0.835 . . . . 72.23 111.044 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 56.6 m -116.07 100.89 53.89 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.056 -0.72 . . . . 73.31 109.056 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 11.5 Cg_endo -55.41 107.4 0.24 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.471 2.114 . . . . 63.14 111.818 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 206' ' ' PRO . 11.2 mm-40 72.29 16.05 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.84 -0.618 . . . . 70.24 110.746 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.55 74.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.891 -0.671 . . . . 50.12 111.878 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.3 111.61 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 73.41 110.015 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' HIS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 238' ' ' PRO . 24.7 p80 -87.55 147.16 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.448 . . . . 73.1 110.947 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' LYS . . . . . 0.43 ' HB2' ' HG2' ' A' ' 238' ' ' PRO . 53.6 mtpt -71.35 166.63 21.24 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 73.42 110.168 173.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 212' ' ' GLU . 8.6 pt-20 -82.7 174.34 11.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.852 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -74.96 88.54 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.953 0.882 . . . . 74.11 110.66 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -138.85 12.69 2.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.266 -0.879 . . . . 44.01 110.494 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' GLU . . . . . 1.082 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 4.1 mm-40 -102.52 118.04 36.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 72.44 111.472 -171.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -150.41 82.75 6.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.84 -0.8 . . . . 75.41 108.84 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 N--CA 1.459 -0.543 0 C-N-CA 122.297 1.998 . . . . 74.31 111.474 179.147 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 . . . . . 0 CA--C 1.534 0.331 0 N-CA-C 111.768 0.284 . . . . 63.44 111.768 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLY . . . . . 0.954 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -109.51 -104.17 2.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.75 -0.738 . . . . 74.34 112.81 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 228' ' ' THR . 2.2 p -89.82 146.99 24.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.671 0.272 . . . . 63.1 110.525 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -68.22 -27.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 74.22 110.548 -175.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -55.74 5.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.487 -0.324 . . . . 52.05 110.14 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' PHE . . . . . 0.415 ' HB3' HG22 ' A' ' 178' ' ' ILE . 90.8 m-85 -86.15 3.16 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.017 0.377 . . . . 74.33 112.017 -169.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 6.8 t -77.71 -6.02 52.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 72.24 110.517 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.571 ' HA ' ' HE2' ' A' ' 249' ' ' TYR . 41.9 t 65.96 173.36 0.23 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.147 0.499 . . . . 75.15 111.168 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.7 -34.84 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.222 0.534 . . . . 73.41 109.57 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.79 -62.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.281 -0.872 . . . . 73.32 112.294 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -65.43 -28.38 69.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 54.53 110.939 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' HIS . . . . . 0.531 ' HB2' HG23 ' A' ' 228' ' ' THR . 14.3 t-80 -74.82 -17.82 60.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.381 -0.372 . . . . 61.51 110.719 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -82.94 -30.06 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.693 -0.855 . . . . 63.1 108.693 170.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 109.75 -9.1 32.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.237 -0.892 . . . . 55.32 112.392 176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' VAL . . . . . 1.082 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 5.3 p -62.04 109.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.619 0.723 . . . . 75.43 110.172 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -67.46 -61.43 4.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 54.31 112.433 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 31.5 Cg_endo -93.79 73.08 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.673 2.248 . . . . 55.01 113.573 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.9 t -132.46 110.42 10.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.795 0.331 . . . . 42.5 110.701 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' ARG . . . . . 0.453 ' HA ' ' OD1' ' A' ' 243' ' ' ASP . 29.8 ttt180 -66.73 -16.91 64.57 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.552 0.692 . . . . 65.33 110.492 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . 0.962 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.53 -43.36 75.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.904 -1.043 . . . . 75.33 109.61 175.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -63.74 -46.32 92.22 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.128 -0.942 . . . . 64.21 112.423 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ASP . . . . . 0.532 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -47.28 -51.57 18.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.645 0.736 . . . . 65.54 110.358 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.4 -31.95 64.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.858 -1.065 . . . . 72.34 111.956 -173.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.96 -38.66 64.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.7 -0.4 . . . . 65.52 110.547 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ILE . . . . . 0.503 HD13 ' HA2' ' A' ' 176' ' ' GLY . 90.9 mt -58.69 -48.38 86.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.375 0.607 . . . . 64.22 110.59 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -59.73 -41.03 89.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.645 -0.707 . . . . 74.32 110.06 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 252' ' ' ILE . . . -54.84 -41.98 77.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.01 -0.614 . . . . 75.4 112.111 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' TYR . . . . . 0.571 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 19.4 m-30 -55.94 -59.49 4.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.808 0.337 . . . . 71.32 111.026 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 247' ' ' LEU . 25.6 p -62.35 -36.15 81.32 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.552 -0.459 . . . . 51.44 111.32 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.2 mtp -60.99 -54.39 45.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.667 0.27 . . . . 54.55 111.278 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 248' ' ' GLY . 8.9 tt -68.36 -36.49 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 64.22 110.677 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.573 0.225 . . . . 53.44 111.348 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 39.0 m0 -75.77 -27.39 58.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 74.12 110.991 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 tp -84.24 -31.52 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.347 -0.388 . . . . 74.41 111.72 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.3 p -101.73 -20.95 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.06 -0.4 . . . . 73.13 111.52 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 85.11 -19.58 21.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.9 -0.667 . . . . 75.44 112.851 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.9 143.65 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.785 -0.45 . . . . 61.55 109.785 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 262' ' ' GLU . 86.6 mt -119.58 141.76 31.55 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.132 -0.321 . . . . 63.41 110.132 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 48.1 Cg_exo -57.08 -45.68 34.08 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.031 2.487 . . . . 63.02 112.504 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 36.8 p90 -80.29 -17.87 50.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.904 -0.589 . . . . 72.13 110.755 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' GLU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 259' ' ' LEU . 1.8 tm-20 -77.7 -35.31 52.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.294 0.569 . . . . 70.43 109.763 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.52 -34.53 76.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.317 0.58 . . . . 54.11 110.041 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -108.45 24.76 12.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 73.52 111.992 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.439 ' HA ' HG13 ' A' ' 271' ' ' VAL . 3.4 pp -71.81 -1.33 13.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.756 0.312 . . . . 74.34 111.666 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.54 -6.25 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.469 -0.332 . . . . 74.52 110.747 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 33.0 t70 -139.06 125.56 12.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.108 -0.33 . . . . 64.0 110.108 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 36.4 Cg_exo -60.4 -21.71 68.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.306 2.671 . . . . 72.43 113.981 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.87 -39.39 79.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.726 -0.39 . . . . 44.53 110.17 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' TYR . . . . . 0.61 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 44.8 m-85 -65.88 -50.45 64.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 73.12 111.456 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' VAL . . . . . 0.617 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 30.0 m -63.3 -35.18 71.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.992 -0.283 . . . . 74.01 111.201 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 276' ' ' ILE . 38.8 ttp180 -63.17 -62.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.987 0.422 . . . . 71.11 110.408 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 11.2 t70 -62.99 -44.41 96.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.515 -0.766 . . . . 71.04 111.352 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' SER . . . . . 0.478 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 25.1 m -61.18 -47.41 86.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.406 . . . . 60.32 111.225 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.8 -36.63 84.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.79 -0.364 . . . . 72.23 111.132 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.5 mt -60.38 -42.65 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.601 0.238 . . . . 74.1 110.585 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 273' ' ' ASP . 57.2 mtt180 -61.14 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.404 -0.362 . . . . 64.1 110.755 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' TYR . . . . . 0.478 ' HD1' ' O ' ' A' ' 274' ' ' SER . 35.7 m-85 -69.86 -43.67 71.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.057 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' ARG . . . . . 0.493 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 2.3 ptm180 -67.99 -25.21 65.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.908 -0.317 . . . . 65.44 111.347 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -85.5 -42.79 14.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.872 0.368 . . . . 74.34 110.803 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' ASN . . . . . 0.81 HD22 HD23 ' A' ' 285' ' ' LEU . 9.5 t30 -130.51 87.45 2.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.138 0.494 . . . . 73.31 110.351 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -81.64 -40.67 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.428 0.899 . . . . 61.42 113.428 -172.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -65.89 -51.35 59.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.345 0.868 . . . . 55.24 113.345 -163.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.7 p -77.04 -28.89 55.0 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.574 -0.45 . . . . 74.11 110.944 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.81 HD23 HD22 ' A' ' 281' ' ' ASN . 1.9 mm? -64.95 -54.97 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 73.44 110.458 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -63.47 -39.67 95.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.602 -0.272 . . . . 75.33 111.316 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.84 -38.29 90.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 74.2 111.486 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -91.75 -20.31 21.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.728 0.64 . . . . 74.24 112.728 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.25 -44.9 86.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.748 0.309 . . . . 75.02 111.199 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 296' ' ' PRO . 17.5 p90 -136.82 89.74 17.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 122.002 0.906 . . . . 65.21 110.77 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.11 49.43 3.03 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.856 2.371 . . . . 71.11 111.986 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -100.39 -145.59 0.34 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.332 -0.395 . . . . 64.15 110.807 -178.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 70.1 mmtt -120.03 17.29 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.646 0.98 . . . . 62.13 113.646 -166.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.501 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 14.6 m-80 -93.13 -15.99 25.41 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.184 -0.323 . . . . 65.55 110.345 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 11.4 mptt 75.1 112.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 123.847 0.717 . . . . 61.34 111.05 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 290' ' ' PHE . 96.7 Cg_endo -83.04 37.71 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.551 2.167 . . . . 45.4 112.255 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -81.72 -68.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.9 -0.667 . . . . 64.13 112.5 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLU . . . . . 0.414 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.9 mp0 -55.98 -36.63 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 122.045 0.138 . . . . 60.0 111.266 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 2.9 mp -61.71 -49.53 83.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.827 0.346 . . . . 74.35 110.609 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.36 85.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 63.2 110.807 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 301' ' ' LYS . 69.1 mmtt -68.3 -31.59 71.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.275 -0.42 . . . . 71.51 111.808 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 82.5 t80 -62.24 -47.68 83.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.079 0.466 . . . . 75.4 110.257 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG22 ' A' ' 306' ' ' VAL . 68.6 mtp -73.25 -31.13 63.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.323 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 33.2 tt0 -59.76 -44.16 93.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.745 -0.835 . . . . 70.34 108.745 171.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 58.6 m -58.47 -46.44 86.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.91 -1.041 . . . . 64.21 111.695 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 303' ' ' MET . 14.1 m -68.17 -26.21 33.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.97 -0.292 . . . . 71.52 111.25 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 18.5 ttmt -74.68 -34.08 62.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 72.41 110.14 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 91.7 mt -81.99 5.16 20.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 72.44 112.126 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 315' ' ' PRO . 4.2 pp -107.19 9.28 30.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.417 0.627 . . . . 71.42 109.452 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 12.2 t70 67.41 -81.82 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.335 -1.302 . . . . 65.41 111.887 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' TYR . . . . . 0.962 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.8 OUTLIER -161.91 -48.81 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.954 0.883 . . . . 63.04 109.364 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 m -145.4 35.94 1.08 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.052 -1.092 . . . . 75.51 108.052 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' GLU . . . . . 0.564 ' O ' ' HD3' ' A' ' 314' ' ' LYS . 3.4 tm-20 -77.54 -82.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.898 -1.047 . . . . 73.52 108.793 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 313' ' ' GLU . 0.6 OUTLIER -150.96 99.73 3.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.051 -0.722 . . . . 64.35 109.051 171.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.534 ' HA ' HD22 ' A' ' 309' ' ' LEU . 24.4 Cg_exo -63.28 118.28 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.017 1.812 . . . . 72.34 111.124 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.9 84.02 4.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.384 0.612 . . . . 63.41 110.55 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' TYR . . . . . 0.524 ' HE1' ' HB3' ' A' ' 162' ' ' LEU . 61.5 t80 -64.41 -38.89 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.333 -0.848 . . . . 72.34 110.807 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 39.8 tt0 -56.73 -55.09 38.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.342 -0.845 . . . . 60.41 111.327 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -57.05 -50.3 73.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.127 -0.488 . . . . 52.33 111.776 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 4.2 pp -65.05 -40.26 94.51 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.903 -0.319 . . . . 62.11 111.641 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' ARG . . . . . 0.433 ' N ' HD12 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.47 -25.51 59.44 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.332 -0.547 . . . . 72.22 109.886 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 318' ' ' GLU . 0.4 OUTLIER -73.5 -45.39 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 74.42 110.413 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.13 -31.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.931 -0.307 . . . . 74.33 111.14 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.7 mt -63.79 -48.62 76.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.911 0.386 . . . . 73.12 110.175 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.9 -38.67 89.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.161 -0.472 . . . . 50.01 110.688 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -60.74 -44.79 96.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 54.12 110.891 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.414 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.76 -46.37 83.49 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.772 . . . . 70.12 112.556 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' LEU . . . . . 0.784 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 1.8 tm? -63.49 -38.87 92.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 64.34 110.038 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 72.35 110.652 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.31 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 51.52 111.812 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 328' ' ' LEU . 40.5 pt -76.8 -6.34 8.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.844 0.354 . . . . 72.11 111.362 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.06 25.44 14.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.483 -0.865 . . . . 73.23 113.149 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 41.1 m -129.02 147.71 50.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.921 0.36 . . . . 44.54 110.985 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -172.1 75.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.648 0.737 . . . . 74.13 110.324 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -94.41 -8.32 39.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 55.23 110.613 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.0 t70 82.03 -19.73 0.4 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.669 0.788 . . . . 62.4 112.352 171.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . 155.5 50.34 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.554 -1.308 . . . . 73.45 113.842 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' LYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 21.2 ttmm . . . . . 0 C--N 1.325 -0.481 0 N-CA-C 108.997 -0.742 . . . . 73.42 108.997 170.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' LYS . . . . . 0.528 ' HB3' HD21 ' A' ' 200' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.52 -0.2 0 CA-C-O 121.13 0.491 . . . . 64.4 110.894 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.0 t -129.39 168.89 15.62 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.069 -1.086 . . . . 73.02 108.069 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 200' ' ' LEU . 3.4 pt -66.01 142.67 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.417 0.627 . . . . 54.13 111.836 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 m -73.07 72.46 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.857 -1.065 . . . . 51.42 110.583 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 115.726 -0.67 . . . . 72.03 111.282 -177.419 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.4 mpt? . . . . . 0 N--CA 1.48 1.063 0 N-CA-C 110.019 -0.363 . . . . 63.12 110.019 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.3 143.34 24.99 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.785 2.323 . . . . 73.14 113.085 -175.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 55.2 mtt180 -135.02 148.19 49.87 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.805 -0.634 . . . . 73.43 109.56 175.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.4 m -106.68 134.33 48.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.044 0.449 . . . . 71.1 111.104 179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -152.7 135.5 15.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.979 -0.555 . . . . 73.43 110.3 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . 179.67 108.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.37 0 O-C-N 123.48 0.487 . . . . 74.04 110.703 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -158.12 90.38 1.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.717 0.294 . . . . 62.11 111.045 177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -178.71 109.69 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.782 -0.644 . . . . 72.15 110.019 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -164.59 151.34 11.05 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.6 -0.273 . . . . 71.03 111.06 -179.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.16 105.48 0.5 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.193 -0.527 . . . . 62.45 113.411 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 17.3 tpt180 -157.64 79.46 0.87 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.076 0.465 . . . . 75.22 110.723 175.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 9.6 mt-30 -146.09 126.94 14.43 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.997 -0.547 . . . . 75.41 110.129 174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.8 m -127.23 126.82 43.4 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.131 -0.486 . . . . 71.01 110.488 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.3 m -133.3 119.35 19.65 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.822 -0.436 . . . . 71.3 109.822 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -157.98 80.09 0.85 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.865 0.364 . . . . 64.55 111.932 -177.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -124.72 145.15 49.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.294 -0.412 . . . . 70.15 110.012 171.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.6 ttm180 -149.82 149.53 30.64 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.03 -0.73 . . . . 72.54 109.03 -176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -142.62 75.56 1.49 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.463 0.649 . . . . 75.43 112.404 178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.545 ' O ' HD12 ' A' ' 19' ' ' LEU . 1.4 pp -124.86 120.46 31.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.816 -0.629 . . . . 74.2 109.489 170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -98.02 -51.3 4.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.006 -0.543 . . . . 73.12 110.658 -175.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 69.16 -63.0 0.39 Allowed 'General case' 0 CA--C 1.531 0.238 0 O-C-N 124.227 0.954 . . . . 64.43 112.686 176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 21.5 tp60 -66.21 -71.98 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 111.896 0.332 . . . . 71.11 111.896 -173.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 22.9 m-85 -144.76 113.09 6.54 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 111.453 0.168 . . . . 73.24 111.453 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.38 -63.73 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 O-C-N 124.01 0.819 . . . . 73.13 109.461 175.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 42.6 t -65.3 121.64 14.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.458 -0.792 . . . . 71.35 110.358 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.75 1.29 56.34 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.778 -0.725 . . . . 64.2 113.24 178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.51 ' O ' HG12 ' A' ' 39' ' ' VAL . 31.8 mt-10 -70.05 110.08 4.91 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 117.275 0.537 . . . . 75.41 109.642 173.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.905 ' HB ' ' HG2' ' A' ' 36' ' ' GLU . 0.2 OUTLIER -89.74 133.47 31.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-O 121.157 0.503 . . . . 75.22 110.499 178.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 14.5 pt -129.59 122.38 55.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.79 -0.641 . . . . 74.4 110.888 -178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.553 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 24.0 m -84.65 125.67 32.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.736 0.303 . . . . 64.41 110.534 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.21 -170.5 2.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 63.32 110.462 -179.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 75.1 mtm -71.67 -20.55 61.92 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.778 0.288 . . . . 71.42 111.778 -177.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.71 1.95 32.0 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.999 0.428 . . . . 54.11 110.343 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt 71.22 24.37 3.83 Favored 'General case' 0 N--CA 1.461 0.116 0 CA-C-N 115.141 -0.936 . . . . 71.23 112.595 174.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 30' ' ' THR . 90.1 mttt -103.05 136.72 42.34 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.532 -0.544 . . . . 52.14 109.532 172.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.905 ' HG2' ' HB ' ' A' ' 28' ' ' ILE . 19.2 tt0 -96.66 97.38 9.32 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 109.259 -0.645 . . . . 74.02 109.259 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.564 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 63.3 m95 -80.85 128.09 33.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.341 -0.845 . . . . 73.31 111.217 -172.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.727 ' HB3' ' HA ' ' A' ' 56' ' ' MET . 68.1 tttt -92.01 108.02 19.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.164 -0.471 . . . . 71.51 110.294 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.51 HG12 ' O ' ' A' ' 27' ' ' GLU . 10.0 p -68.74 136.08 27.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.949 0.404 . . . . 62.22 110.124 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -109.15 -86.13 1.75 Allowed Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.694 -0.765 . . . . 40.22 112.588 -178.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 95.2 mt -106.78 136.45 19.42 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-O 120.859 0.361 . . . . 72.35 111.527 -174.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.511 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.2 Cg_exo -78.07 106.69 2.2 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.163 2.575 . . . . 73.12 111.431 174.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG22 ' H ' ' A' ' 45' ' ' GLN . 60.0 mt -73.9 -49.49 34.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.186 0.517 . . . . 75.02 110.063 179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 87.59 -23.56 12.51 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.907 -0.663 . . . . 52.24 112.371 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.458 ' H ' HG22 ' A' ' 43' ' ' ILE . 2.3 mp0 -110.35 164.79 12.33 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 110.115 -0.328 . . . . 64.45 110.115 -177.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.83 -166.57 28.33 Favored Glycine 0 N--CA 1.441 -1.009 0 N-CA-C 110.644 -0.983 . . . . 74.0 110.644 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.835 ' HA3' HG11 ' A' ' 196' ' ' VAL . . . -82.54 46.65 3.61 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.402 -0.904 . . . . 74.43 112.463 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.783 ' HD1' ' HB3' ' A' ' 351' ' ' ALA . 65.8 t80 177.93 -59.02 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.999 0.428 . . . . 74.12 110.013 -179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 124.32 154.78 8.97 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-N 115.532 -0.758 . . . . 73.04 111.215 -176.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 78.4 m 59.27 38.4 23.3 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.23 0.538 . . . . 71.5 111.322 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 48' ' ' PHE . 16.6 mm -88.43 138.44 19.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.94 -0.573 . . . . 71.12 110.062 -178.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.462 ' HB3' HG23 ' A' ' 39' ' ' VAL . 87.4 m-85 -108.13 152.59 24.34 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.422 -0.354 . . . . 72.13 110.999 -178.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.9 tt -100.71 143.62 30.65 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.257 -0.646 . . . . 75.31 109.257 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -92.57 114.67 27.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.19 0.519 . . . . 72.12 111.137 -177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.528 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 28.3 t70 -84.98 -40.81 16.48 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.802 -0.635 . . . . 54.14 109.649 179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.727 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 96.7 mmm 63.21 173.99 0.16 Allowed 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 115.079 -0.964 . . . . 74.43 112.345 178.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -89.57 108.71 19.82 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.796 -0.638 . . . . 73.14 109.913 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.6 p -83.31 83.43 7.87 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.117 0.484 . . . . 53.24 110.363 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 4.5 m -70.76 -66.07 0.65 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.778 -0.647 . . . . 70.13 110.731 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.3 tt0 -144.82 -55.56 0.33 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.974 -0.557 . . . . 75.33 109.722 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.0 p -142.81 93.31 2.5 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.929 -0.578 . . . . 72.34 110.631 176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.6 p -64.61 143.17 16.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.015 -0.538 . . . . 64.33 110.147 178.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.81 -100.43 0.13 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.793 -0.717 . . . . 53.32 112.449 -177.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.3 m -120.22 14.49 12.17 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.258 0.552 . . . . 65.42 109.817 179.273 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -78.39 -27.13 46.71 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.411 -0.813 . . . . 70.11 111.668 -172.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -76.12 -50.41 3.0 Favored Pre-proline 0 C--N 1.323 -0.554 0 N-CA-C 112.915 0.709 . . . . 51.23 112.915 -176.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 7.8 Cg_exo -74.16 51.44 2.46 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 122.575 2.184 . . . . 71.42 113.912 -176.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 31.2 p -138.93 162.44 34.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.075 0.464 . . . . 72.32 111.286 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -129.48 166.37 27.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.821 -0.627 . . . . 64.01 109.369 176.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.86 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.6 p -136.33 128.99 45.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 C-N-CA 120.536 -0.466 . . . . 64.23 112.138 -177.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.642 ' HE2' ' SD ' ' A' ' 129' ' ' MET . 32.6 ttpt -85.35 142.55 29.24 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-N 115.826 -0.624 . . . . 63.35 109.582 175.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 62.1 t -108.83 132.01 57.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.952 -0.388 . . . . 71.05 109.952 177.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.979 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 5.1 tp10 -140.1 135.64 16.47 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.299 -0.409 . . . . 62.42 109.99 -175.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.13 143.55 94.78 Favored 'Trans proline' 0 CA--C 1.53 0.288 0 C-N-CA 122.499 2.133 . . . . 73.23 112.151 177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.4 t -71.61 -2.64 17.8 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.388 -0.369 . . . . 71.12 111.66 -176.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -68.2 -22.23 64.82 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.292 -0.633 . . . . 72.41 109.292 175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 36.9 t30 68.63 105.49 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 CA-C-N 114.843 -1.071 . . . . 72.11 113.128 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.411 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -108.38 -89.63 2.06 Favored Glycine 0 N--CA 1.443 -0.849 0 CA-C-N 115.298 -0.865 . . . . 72.13 111.13 171.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.411 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -84.83 -20.75 3.53 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 123.386 2.724 . . . . 74.23 111.831 176.143 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.979 ' HB2' ' HG2' ' A' ' 73' ' ' GLU . 55.2 tp -52.26 -49.53 63.87 Favored 'General case' 0 C--O 1.219 -0.546 0 N-CA-C 113.405 0.891 . . . . 72.42 113.405 -169.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -61.2 -45.2 95.56 Favored 'General case' 0 C--N 1.324 -0.502 0 C-N-CA 120.395 -0.522 . . . . 74.12 111.008 -175.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.0 m -64.95 -46.51 81.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.022 0.439 . . . . 54.42 110.68 179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.44 ' HG3' ' CD2' ' A' ' 198' ' ' TYR . 36.1 tt0 -65.29 -52.45 54.12 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.403 -0.817 . . . . 73.24 111.276 -177.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -65.93 -39.36 90.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.239 -0.437 . . . . 72.41 110.918 -176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -59.05 -49.72 76.82 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.805 -0.443 . . . . 63.22 109.805 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.466 ' CZ ' HG22 ' A' ' 168' ' ' ILE . 76.2 t80 -65.93 -44.42 85.19 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.714 -0.676 . . . . 74.22 110.316 177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.95 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 68.2 t80 -54.96 -53.9 49.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.804 -0.634 . . . . 54.32 111.005 -178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -66.54 -31.76 72.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.921 -0.581 . . . . 72.02 110.705 -178.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 48.0 tpt85 -78.83 -29.52 44.72 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 71.12 111.877 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.66 -35.35 11.63 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 111.912 0.338 . . . . 75.53 111.912 -176.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.51 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -83.64 71.52 10.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.748 0.785 . . . . 64.12 110.567 -178.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.467 ' O ' HG13 ' A' ' 96' ' ' ILE . 4.6 tmtt? -125.02 103.79 30.17 Favored Pre-proline 0 C--N 1.319 -0.724 0 CA-C-N 114.839 -1.073 . . . . 64.24 109.428 -178.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 1.0 OUTLIER -42.98 -47.94 7.99 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 124.083 3.189 . . . . 53.42 113.368 -174.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 11.1 tp10 -57.99 -60.19 4.11 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.907 -0.588 . . . . 74.12 110.721 178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 47.8 tp60 -61.7 -41.46 97.63 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.566 -0.743 . . . . 72.31 111.504 -175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.618 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 69.6 mt -58.03 -52.31 59.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 O-C-N 123.073 0.233 . . . . 65.13 110.82 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -58.45 -42.61 87.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.532 -0.304 . . . . 64.34 110.959 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 34.7 mmtp -61.86 -62.67 1.63 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.907 -0.588 . . . . 62.53 111.943 -177.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.643 ' CH2' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -70.9 -35.23 72.21 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.584 -0.447 . . . . 71.02 111.643 -171.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 26.6 mm -61.89 -45.61 98.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 C-N-CA 120.938 -0.305 . . . . 70.51 110.393 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -69.17 -41.33 77.36 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.258 -0.428 . . . . 53.12 111.129 -178.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.4 p -76.4 -31.79 58.17 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 112.843 0.682 . . . . 73.3 112.843 -175.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 103' ' ' ARG . 36.1 ttm180 -89.7 5.54 45.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.065 0.459 . . . . 61.03 110.557 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 55.7 mmtt 61.71 30.39 18.43 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.631 -0.713 . . . . 64.34 110.648 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.644 ' HG ' ' OD1' ' A' ' 163' ' ' ASP . 1.0 OUTLIER -78.95 161.3 26.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 74.34 110.571 -175.352 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.585 ' HB2' HH22 ' A' ' 321' ' ' ARG . 5.5 tmtm? -85.61 -66.29 0.92 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.982 -0.377 . . . . 75.42 109.982 -175.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -163.07 135.51 5.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.948 0.404 . . . . 72.42 110.817 176.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.643 HD22 ' CH2' ' A' ' 99' ' ' TRP . 26.7 tp -79.6 121.12 24.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.823 -0.626 . . . . 72.5 110.32 177.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.96 56.36 4.94 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.876 -0.678 . . . . 60.22 112.717 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.409 ' HA ' ' HD2' ' A' ' 111' ' ' PRO . 93.1 t -128.15 125.56 23.45 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 109.922 -0.399 . . . . 70.44 109.922 178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.95 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 9.3 Cg_endo -56.1 143.78 82.58 Favored 'Trans proline' 0 CA--C 1.53 0.29 0 C-N-CA 122.897 2.398 . . . . 75.11 112.593 178.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.453 ' HE2' ' O ' ' A' ' 113' ' ' TYR . 20.8 tptm -67.79 131.56 45.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.856 -0.611 . . . . 73.55 111.003 179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.453 ' O ' ' HE2' ' A' ' 112' ' ' LYS . 77.7 t80 -80.69 124.47 29.05 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.191 -0.459 . . . . 61.5 110.341 176.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.624 ' CD1' HG22 ' A' ' 130' ' ' ILE . 14.2 m95 -106.11 -58.67 1.88 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.476 -0.564 . . . . 72.15 109.476 176.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -158.39 174.51 35.56 Favored Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.599 -0.728 . . . . 63.41 112.048 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 53.9 p -171.27 147.82 2.55 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.554 -0.535 . . . . 74.22 109.554 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -172.32 -167.9 33.0 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.116 -1.04 . . . . 50.02 112.611 -178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 9.5 tt -126.95 133.46 50.6 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.723 -0.473 . . . . 75.04 109.723 -178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.9 t60 -134.84 109.48 8.55 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.473 -0.331 . . . . 70.34 110.29 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.834 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 18.0 t70 -73.68 122.88 23.04 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.115 -0.493 . . . . 71.3 109.69 175.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.402 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 66.0 tttp -129.46 121.56 27.55 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.143 -0.48 . . . . 74.44 110.071 -177.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.402 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 20.1 m120 63.74 16.5 9.8 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.915 -0.584 . . . . 62.04 111.658 179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 99.57 -0.25 56.76 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.685 -0.769 . . . . 74.45 112.405 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 51.5 tptt -117.22 115.35 25.14 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.095 -0.705 . . . . 70.13 109.095 177.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.834 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 2.7 p -76.31 119.61 20.43 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.428 0.632 . . . . 72.44 111.157 -178.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -109.63 129.81 55.56 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.655 -0.702 . . . . 75.31 109.656 176.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -97.42 134.37 40.77 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 108.796 -0.816 . . . . 71.52 108.796 177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.54 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 44.6 p90 -122.48 142.88 50.1 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.233 -0.44 . . . . 63.12 111.021 -174.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.642 ' SD ' ' HE2' ' A' ' 71' ' ' LYS . 15.4 ptm -129.87 131.22 46.01 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 73.1 109.993 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.86 HD13 ' HB ' ' A' ' 70' ' ' VAL . 3.3 mm -97.5 123.04 49.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.129 -0.487 . . . . 72.21 110.624 -174.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 38.4 mtm -126.5 178.38 5.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.938 -0.574 . . . . 71.13 110.415 -177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -65.58 151.39 46.56 Favored 'General case' 0 N--CA 1.463 0.205 0 N-CA-C 109.625 -0.509 . . . . 73.1 109.625 178.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 33.9 ptt180 -72.23 116.12 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.254 0.549 . . . . 72.23 111.113 -177.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.568 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 17.0 m-85 -104.97 143.35 33.29 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.181 -0.463 . . . . 75.14 110.214 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.527 ' HA3' ' CD1' ' A' ' 187' ' ' TYR . . . -140.16 -15.36 0.52 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.475 -0.869 . . . . 61.14 112.721 178.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.887 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 13.6 m -122.2 132.29 54.37 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.682 -0.305 . . . . 73.11 110.503 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 139' ' ' GLN . 3.6 p30 -125.74 148.88 48.93 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.843 -0.428 . . . . 74.33 109.843 175.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.44 HD21 HD21 ' A' ' 157' ' ' LEU . 9.8 mp -74.71 -8.1 55.34 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.989 0.366 . . . . 53.15 111.989 -176.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.679 ' HG2' ' HG ' ' A' ' 349' ' ' LEU . 7.5 tp-100 -76.91 -48.6 17.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.742 0.306 . . . . 64.44 110.647 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 49.8 tptt -74.58 -37.22 62.99 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.949 0.404 . . . . 61.21 110.049 177.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.449 HG21 HD11 ' A' ' 341' ' ' LEU . 69.5 mt -62.44 -33.29 58.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.153 -0.476 . . . . 73.34 110.503 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.5 ' CE1' ' HD2' ' A' ' 147' ' ' LYS . 13.9 t80 -53.23 -46.59 69.19 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.009 -0.541 . . . . 75.2 109.581 174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -71.22 -52.91 16.4 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.476 -0.784 . . . . 72.23 110.796 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -65.99 -32.07 73.34 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.912 0.708 . . . . 74.24 112.912 -171.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -104.23 10.03 35.83 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.92 0.39 . . . . 71.35 110.368 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.404 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 53.28 40.27 31.03 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.742 -0.663 . . . . 50.31 111.628 178.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.528 ' HG3' ' O ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER 42.73 30.78 0.26 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.583 1.153 . . . . 61.2 113.669 -179.971 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 -86.27 95.01 9.48 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.515 -0.474 . . . . 74.52 110.042 175.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 66.5 m-85 -109.15 119.8 40.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.078 -0.51 . . . . 74.24 109.828 178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 57.7 m -74.7 168.18 20.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.266 -0.424 . . . . 72.52 110.72 178.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.569 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 53.2 mtm-85 -51.67 -47.0 64.0 Favored 'General case' 0 C--O 1.221 -0.412 0 CA-C-N 116.315 -0.402 . . . . 63.51 111.648 179.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.778 ' HE2' ' HB2' ' A' ' 340' ' ' ASP . 0.0 OUTLIER -63.99 -30.05 71.16 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.853 0.358 . . . . 64.1 111.29 -179.044 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.567 ' N ' ' HD3' ' A' ' 152' ' ' LYS . 1.3 m -72.49 -52.12 17.13 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.895 0.378 . . . . 72.21 110.383 178.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.4 t -64.51 -41.06 91.19 Favored 'Isoleucine or valine' 0 C--O 1.233 0.233 0 CA-C-N 115.71 -0.677 . . . . 75.5 110.913 -179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.569 ' HB2' ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -60.04 -50.11 75.02 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.898 -0.592 . . . . 74.34 110.764 -179.241 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.619 ' NE2' ' HA ' ' A' ' 335' ' ' ASP . 1.5 mp0 -64.06 -38.31 90.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.557 -0.292 . . . . 62.52 111.264 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.573 ' O ' HG12 ' A' ' 161' ' ' ILE . 4.8 mp -60.94 -52.83 63.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.813 0.34 . . . . 62.21 110.558 176.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.6 p -68.03 -31.85 71.81 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.154 -0.476 . . . . 64.33 111.095 -177.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 48.0 tp -57.03 -53.11 61.76 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.337 -0.392 . . . . 71.42 111.043 178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.493 ' HD3' ' O ' ' A' ' 156' ' ' GLN . 2.1 mpt_? -67.91 -29.41 68.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.938 0.399 . . . . 73.31 110.638 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.573 HG12 ' O ' ' A' ' 157' ' ' LEU . 40.3 mm -65.73 -36.96 78.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.276 -0.42 . . . . 51.22 110.241 175.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.498 ' HG ' ' O ' ' A' ' 158' ' ' SER . 94.2 mt -62.16 -43.53 98.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 60.22 110.441 176.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.644 ' OD1' ' HG ' ' A' ' 105' ' ' LEU . 51.3 m-20 -55.71 -54.37 45.15 Favored 'General case' 0 C--O 1.239 0.549 0 CA-C-O 121.352 0.596 . . . . 73.2 110.484 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.0 tt -71.98 -37.77 61.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.631 -0.713 . . . . 75.24 111.948 -174.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 23.3 mt -62.63 -38.58 90.79 Favored 'General case' 0 CA--C 1.52 -0.205 0 C-N-CA 120.829 -0.349 . . . . 72.22 111.169 -178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -65.39 -47.82 75.01 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.229 -0.588 . . . . 72.11 110.075 176.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.538 ' HA ' ' OE2' ' A' ' 170' ' ' GLU . 63.5 t80 -58.49 -41.67 85.83 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 112.437 0.532 . . . . 75.25 112.437 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.466 HG22 ' CZ ' ' A' ' 86' ' ' PHE . 26.2 pt -88.29 -33.3 6.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 120.601 -0.439 . . . . 60.45 112.069 -173.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.769 ' HD2' ' HD3' ' A' ' 240' ' ' ARG . 37.0 t60 -91.57 -5.92 53.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.665 0.269 . . . . 71.33 111.064 -172.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.538 ' OE2' ' HA ' ' A' ' 167' ' ' TYR . 13.2 pt-20 -78.81 -19.79 51.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.113 0.482 . . . . 72.11 109.734 173.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 -97.49 -65.07 0.99 Allowed 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.91 -0.587 . . . . 73.32 111.447 -177.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.608 ' HG2' ' HB2' ' A' ' 203' ' ' ARG . 35.7 tt0 -162.05 -44.31 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.24 0.829 . . . . 61.42 113.24 -168.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -80.49 158.06 25.97 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 113.246 0.832 . . . . 73.41 113.246 -167.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.727 HG12 ' CE1' ' A' ' 169' ' ' HIS . 3.6 m -129.7 172.26 15.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 114.58 -1.191 . . . . 74.22 108.48 171.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 200' ' ' LEU . 19.7 t-80 -144.64 92.49 2.3 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.115 -0.698 . . . . 75.24 109.115 171.055 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -63.71 -47.33 87.54 Favored Glycine 0 C--O 1.226 -0.4 0 O-C-N 123.522 0.514 . . . . 73.25 113.67 -170.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.568 ' HB3' HD13 ' A' ' 200' ' ' LEU . 26.1 t0 -99.02 105.44 17.57 Favored 'General case' 0 C--N 1.317 -0.834 0 O-C-N 122.387 -0.478 . . . . 72.14 110.525 -178.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.407 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 29.0 mm -89.97 91.3 3.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.52 0.676 . . . . 74.02 109.575 174.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -93.98 149.82 20.9 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.372 -0.831 . . . . 72.31 109.798 -176.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 138' ' ' LEU . . . -54.85 -26.83 37.99 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.785 0.326 . . . . 45.11 111.733 175.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.5 p -77.39 -5.58 50.24 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.945 0.35 . . . . 72.23 111.945 -179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.473 ' ND2' ' HB3' ' A' ' 197' ' ' ASP . 12.2 m120 -83.18 -22.96 33.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.793 0.33 . . . . 71.13 110.809 179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.6 mp -100.75 115.97 31.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.142 -0.481 . . . . 74.42 110.426 -177.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.5 HD21 HG12 ' A' ' 196' ' ' VAL . 2.6 mm? -113.83 131.8 56.12 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.886 -0.597 . . . . 60.32 109.817 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.887 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.8 mt -89.45 140.92 29.04 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.198 -0.456 . . . . 74.35 110.178 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 189' ' ' ASN . 43.7 t-20 -59.71 125.61 24.31 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.97 -0.752 . . . . 71.31 108.97 175.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.527 ' CD1' ' HA3' ' A' ' 135' ' ' GLY . 36.2 t80 -52.6 -31.27 35.51 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.507 0.558 . . . . 74.42 112.507 -172.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 50.7 mttm -126.91 24.55 6.44 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.381 -0.527 . . . . 71.41 111.914 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.516 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 6.1 t30 -159.57 80.78 2.56 Favored Pre-proline 0 C--N 1.325 -0.49 0 N-CA-C 109.456 -0.572 . . . . 72.14 109.456 174.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -65.67 -24.26 55.48 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 123.33 2.686 . . . . 63.05 113.993 -170.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 338' ' ' LYS . 4.4 p30 -71.0 -14.38 62.33 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.926 -0.309 . . . . 73.05 111.592 -175.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.404 ' HG3' ' OD1' ' A' ' 191' ' ' ASP . 77.1 mt-30 -114.04 114.75 26.55 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.228 0.537 . . . . 50.11 110.294 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.3 p -105.68 142.86 17.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.373 -0.831 . . . . 72.1 110.787 -175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.785 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 59.1 m-85 -115.92 157.97 23.73 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.144 -0.48 . . . . 65.44 109.945 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.442 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 8.9 tt -115.97 141.21 48.42 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.792 -0.447 . . . . 70.25 109.792 177.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.835 HG11 ' HA3' ' A' ' 47' ' ' GLY . 1.4 p -141.27 -172.11 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.568 -0.901 . . . . 72.21 108.568 176.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.528 ' H ' HG22 ' A' ' 196' ' ' VAL . 17.8 t70 68.74 65.49 0.31 Allowed 'General case' 0 C--O 1.239 0.521 0 CA-C-O 122.506 1.146 . . . . 53.23 108.449 -174.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.44 ' CD2' ' HG3' ' A' ' 83' ' ' GLU . 85.6 m-85 -88.49 16.52 6.4 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 114.099 -1.409 . . . . 71.14 110.656 -179.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.638 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -70.33 -26.52 74.07 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.702 -0.761 . . . . 72.43 111.296 173.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.568 HD13 ' HB3' ' A' ' 177' ' ' ASP . 35.7 mt -88.78 36.38 0.8 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.953 0.406 . . . . 72.4 110.494 176.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -106.07 98.88 8.51 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.161 0.505 . . . . 73.44 110.354 176.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 70.4 t80 -100.27 145.84 27.62 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.964 -0.754 . . . . 71.21 108.964 177.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.608 ' HB2' ' HG2' ' A' ' 172' ' ' GLU . 0.0 OUTLIER -88.86 130.54 35.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.164 0.506 . . . . 70.43 111.028 -177.537 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 28.9 t80 -103.23 -54.0 2.7 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.773 -0.649 . . . . 74.22 110.088 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 6.5 p -113.18 94.43 30.57 Favored Pre-proline 0 N--CA 1.447 -0.592 0 CA-C-N 115.792 -0.64 . . . . 72.54 110.427 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 207' ' ' GLU . 18.5 Cg_endo -60.0 123.17 12.65 Favored 'Trans proline' 0 C--O 1.237 0.427 0 C-N-CA 122.486 2.124 . . . . 61.02 111.523 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 206' ' ' PRO . 32.4 tt0 70.31 -63.96 0.38 Allowed 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.865 0.728 . . . . 75.21 111.076 -178.025 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 178.68 28.51 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.84 0 N-CA-C 111.413 -0.675 . . . . 73.32 111.413 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 45.0 t -103.94 110.7 30.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.211 -0.292 . . . . 75.11 110.211 -178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 -75.94 104.41 6.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.531 -0.914 . . . . 64.31 108.531 176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -88.44 0.08 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.906 -0.588 . . . . 71.03 111.631 -170.259 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 173.05 139.45 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.442 -0.947 . . . . 74.4 108.442 -167.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 22.4 p90 -84.3 87.92 7.22 Favored 'General case' 0 N--CA 1.449 -0.49 0 CA-C-O 122.075 0.941 . . . . 71.02 110.241 -178.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 3.0 mmtt -155.24 33.15 0.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.031 -0.986 . . . . 64.21 109.947 173.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -79.3 -5.55 54.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.316 -0.856 . . . . 71.05 109.645 178.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.7 ' HB3' ' HB ' ' A' ' 236' ' ' VAL . 10.1 p-10 -79.33 113.8 39.63 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 115.144 -0.935 . . . . 72.15 111.499 -174.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -89.95 -52.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.04 0 C-N-CA 122.515 2.144 . . . . 72.11 111.876 175.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -156.03 -56.21 0.09 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.704 -0.68 . . . . 71.44 109.327 -178.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -163.66 138.82 6.27 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 72.24 110.087 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.638 ' HB2' ' HA2' ' A' ' 235' ' ' GLY . 84.3 m -134.32 -60.08 0.81 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.013 -0.365 . . . . 63.35 110.013 176.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.614 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 41.1 p-80 52.98 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.49 1.116 . . . . 62.2 113.733 173.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -86.2 105.88 16.91 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.521 0.677 . . . . 74.31 109.613 168.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 102.23 -166.28 17.42 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.691 -0.766 . . . . 74.4 112.293 179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 70.4 p -80.29 151.35 29.59 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.961 0.41 . . . . 62.2 110.994 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.465 ' HA ' HG22 ' A' ' 228' ' ' THR . 17.9 tt -63.02 -9.02 3.92 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-O 121.67 0.747 . . . . 63.34 110.885 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 15.7 tt0 -60.05 -68.13 0.32 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.783 -1.098 . . . . 75.41 111.521 -178.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.422 ' HB3' HG23 ' A' ' 246' ' ' ILE . 77.7 m-85 -103.24 -11.19 18.16 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.243 0.46 . . . . 61.1 112.243 -174.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.465 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.6 t -62.34 -8.94 6.73 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.01 0.374 . . . . 74.53 112.01 -176.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 22.9 t 62.49 -174.04 0.15 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 122.771 0.429 . . . . 60.23 110.9 -179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.409 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.7 mp -73.33 -40.19 56.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.382 -0.599 . . . . 72.2 109.382 174.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.438 ' O ' HG12 ' A' ' 236' ' ' VAL . 2.1 m-20 -49.69 -72.65 0.05 OUTLIER 'General case' 0 C--O 1.235 0.341 0 CA-C-N 114.603 -1.18 . . . . 73.4 111.934 -174.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -64.33 -31.42 72.62 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.961 -0.563 . . . . 72.44 111.53 -174.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.614 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 67.6 t60 -62.46 -39.8 94.57 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.537 0.208 . . . . 74.41 110.579 178.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -73.24 -26.19 61.02 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.219 -0.659 . . . . 74.23 109.219 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.638 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 110.75 7.25 25.87 Favored Glycine 0 N--CA 1.445 -0.763 0 CA-C-N 115.775 -0.648 . . . . 73.45 112.817 177.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.7 ' HB ' ' HB3' ' A' ' 216' ' ' ASP . 9.5 p -89.94 136.98 22.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.973 0.416 . . . . 60.51 110.413 -178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -75.92 115.07 43.08 Favored Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.099 -0.5 . . . . 74.13 109.891 177.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.677 ' HB2' ' HA3' ' A' ' 242' ' ' GLY . 81.7 Cg_endo -79.28 148.97 21.59 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 122.647 2.231 . . . . 73.34 112.857 -176.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 17.5 t -85.47 -159.95 0.48 Allowed 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 108.797 -0.816 . . . . 55.52 108.797 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.769 ' HD3' ' HD2' ' A' ' 169' ' ' HIS . 14.9 mmt-85 -54.18 -35.55 62.44 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.75 0.309 . . . . 71.53 111.237 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 8.2 mmm180 -56.65 -32.89 65.8 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.271 -0.422 . . . . 72.41 112.125 178.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.677 ' HA3' ' HB2' ' A' ' 238' ' ' PRO . . . -67.37 -54.73 18.51 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.593 -0.813 . . . . 75.34 111.72 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -57.88 -41.75 83.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.043 0.449 . . . . 74.14 110.538 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 91.8 mt -64.36 -38.46 91.12 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.863 -0.608 . . . . 74.12 110.891 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -63.81 -50.27 69.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.491 0.662 . . . . 74.32 110.189 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 35.6 mt -59.04 -47.41 90.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.018 -0.992 . . . . 74.04 110.89 -178.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.485 HD13 HG21 ' A' ' 161' ' ' ILE . 56.7 tp -57.9 -42.63 85.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.071 -0.513 . . . . 64.1 110.608 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.64 94.48 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.965 -0.636 . . . . 64.23 112.051 178.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.1 m-30 -64.26 -42.0 96.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.74 0.305 . . . . 64.42 110.906 179.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.407 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 27.0 m -69.65 -36.87 76.45 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.582 -0.281 . . . . 71.3 110.691 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.464 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.8 mtp -62.11 -49.8 74.45 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.446 -0.343 . . . . 73.4 111.015 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.9 tt -68.08 -32.01 54.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 70.15 110.708 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 3.8 tp-100 -56.48 -53.93 51.69 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.011 0.434 . . . . 71.51 110.503 175.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 21.0 m0 -69.27 -28.44 66.31 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.932 -0.576 . . . . 71.43 111.252 -176.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.7 tp -80.24 -32.77 38.36 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.188 0.44 . . . . 72.33 112.188 -176.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.682 HG22 ' HB2' ' A' ' 290' ' ' PHE . 61.7 p -103.8 -28.58 11.55 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.421 -0.512 . . . . 74.14 111.75 -173.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 114.8 -36.74 3.8 Favored Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.338 -0.934 . . . . 74.13 113.062 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.53 147.48 20.5 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 117.265 0.533 . . . . 74.22 111.102 -179.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.446 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.1 mt -94.17 139.22 22.45 Favored Pre-proline 0 C--N 1.326 -0.452 0 CA-C-N 116.44 -0.345 . . . . 71.21 110.449 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -56.51 -36.95 98.17 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 122.981 2.454 . . . . 73.32 112.53 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.541 ' HB2' HG12 ' A' ' 271' ' ' VAL . 41.7 p90 -87.55 -2.35 58.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.464 -0.335 . . . . 75.33 110.852 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.429 ' O ' ' HB2' ' A' ' 265' ' ' LEU . 64.2 tt0 -86.92 -37.79 17.29 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.141 -0.689 . . . . 73.4 109.141 175.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -67.99 -20.37 65.02 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.133 -0.691 . . . . 71.31 109.133 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -107.9 26.18 10.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.166 -0.924 . . . . 74.25 110.795 175.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 262' ' ' GLU . 0.3 OUTLIER -74.36 64.41 1.12 Allowed 'General case' 0 N--CA 1.462 0.152 0 CA-C-O 121.685 0.755 . . . . 72.43 109.873 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 10.3 ptmm? -157.22 14.07 0.25 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.149 -0.932 . . . . 61.21 109.442 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.463 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 13.9 t70 -157.31 120.31 2.17 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 115.917 -0.583 . . . . 74.51 110.556 -171.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 15.6 Cg_exo -68.85 -27.23 31.26 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 123.0 2.467 . . . . 62.42 112.602 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 30.0 mtmt -73.32 -48.37 34.97 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.556 -0.535 . . . . 71.42 109.556 -177.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 14.5 m-85 -62.81 -42.99 99.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.96 -0.563 . . . . 53.31 112.184 -178.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.541 HG12 ' HB2' ' A' ' 261' ' ' TRP . 35.3 m -65.49 -41.86 91.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 120.55 -0.46 . . . . 72.44 110.906 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -66.7 -48.79 68.13 Favored 'General case' 0 C--O 1.232 0.158 0 N-CA-C 110.19 -0.3 . . . . 74.51 110.19 178.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -54.91 -53.36 56.56 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-N 115.657 -0.701 . . . . 75.25 111.225 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.402 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 27.2 m -59.06 -41.77 88.73 Favored 'General case' 0 C--N 1.328 -0.338 0 O-C-N 123.353 0.408 . . . . 74.34 111.463 -176.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 279' ' ' ARG . 97.6 mttt -63.86 -48.25 77.46 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 121.009 -0.276 . . . . 63.31 110.942 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.668 HG12 HH21 ' A' ' 279' ' ' ARG . 66.0 mt -63.12 -43.37 98.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.304 0.573 . . . . 45.34 110.281 177.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 62.2 ttt180 -55.71 -46.62 77.67 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.801 -1.091 . . . . 74.3 111.538 -176.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.743 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 32.4 m-85 -74.26 -32.2 62.85 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.065 -0.516 . . . . 73.2 111.814 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.668 HH21 HG12 ' A' ' 276' ' ' ILE . 88.0 mtm180 -74.71 -16.23 60.76 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.256 0.465 . . . . 74.22 112.256 -177.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 41.3 mt-10 -60.9 -48.99 79.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.77 0.319 . . . . 74.1 110.742 176.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.504 ' HB2' HD23 ' A' ' 285' ' ' LEU . 15.1 m120 -127.93 70.93 1.35 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.116 -0.493 . . . . 71.4 109.725 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.563 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -54.02 -44.28 61.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.764 -0.653 . . . . 54.04 112.615 -173.657 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.457 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.6 -47.51 78.36 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.006 0.431 . . . . 73.21 110.847 -176.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 27.8 t -67.22 -49.25 65.21 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.715 -0.675 . . . . 74.31 110.605 -179.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.743 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.0 mm? -64.16 -50.37 68.44 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.248 -0.433 . . . . 74.13 111.561 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 282' ' ' ILE . 0.1 OUTLIER -58.38 -44.66 89.01 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 120.543 0.211 . . . . 73.13 111.56 -178.034 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.713 ' HA ' ' HG2' ' A' ' 296' ' ' PRO . 18.8 t70 -68.16 -27.46 66.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.188 0.518 . . . . 74.34 110.812 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.0 tttm -96.58 6.46 48.68 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.941 -0.572 . . . . 70.12 111.533 -177.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 84.0 m -75.6 -38.41 59.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.027 0.441 . . . . 71.21 110.795 176.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.682 ' HB2' HG22 ' A' ' 256' ' ' THR . 29.3 t80 -137.56 75.29 44.8 Favored Pre-proline 0 C--N 1.323 -0.562 0 CA-C-N 115.941 -0.572 . . . . 73.41 109.575 -179.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -93.93 110.94 0.19 Allowed 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 123.382 2.721 . . . . 74.52 112.54 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -159.59 -82.66 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.257 -0.646 . . . . 71.11 109.257 179.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 52.3 mttm -144.13 29.67 1.31 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 108.535 -0.913 . . . . 73.44 108.535 169.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 50.8 t30 -94.8 162.46 13.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.632 -1.167 . . . . 64.11 109.855 -178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -122.68 90.81 49.78 Favored Pre-proline 0 C--N 1.319 -0.747 0 N-CA-C 109.576 -0.527 . . . . 52.13 109.576 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.713 ' HG2' ' HA ' ' A' ' 287' ' ' ASP . 89.1 Cg_endo -98.85 37.9 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 123.055 2.503 . . . . 51.44 112.207 177.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.87 -39.91 12.8 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.629 -0.796 . . . . 65.43 111.654 -176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.534 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.5 mp0 -55.03 -44.21 74.44 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.269 -0.466 . . . . 64.13 110.123 177.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.416 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.6 mp -69.74 -42.58 80.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.961 -0.563 . . . . 62.24 110.528 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.74 -48.6 81.02 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.344 -0.389 . . . . 75.11 111.18 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.783 ' HE2' ' HA ' ' A' ' 301' ' ' LYS . 8.5 mmpt? -66.08 -41.94 90.05 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.414 . . . . 73.21 110.836 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -55.59 -48.56 74.64 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.108 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.515 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.67 -37.84 79.94 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.2 -0.454 . . . . 64.42 111.366 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -64.5 -39.86 94.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.28 0.562 . . . . 75.12 109.619 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 93.8 m -65.19 -44.51 88.18 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.191 -0.913 . . . . 74.31 111.388 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.561 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 29.4 m -69.01 -31.61 51.08 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.151 0 C-N-CA 120.622 -0.431 . . . . 73.23 111.349 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -74.03 -28.28 61.35 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.249 0.547 . . . . 64.23 109.907 177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 35.7 tp -74.04 -16.89 61.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.523 -0.762 . . . . 71.34 111.782 -176.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 306' ' ' VAL . 4.2 pp -95.64 16.45 17.25 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-O 120.673 0.273 . . . . 60.14 111.601 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 16.1 t70 68.48 -96.96 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.786 -0.643 . . . . 71.04 111.478 172.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.2 OUTLIER -136.89 -38.1 0.65 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.943 0.402 . . . . 74.3 110.035 175.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.7 t -158.38 29.17 0.24 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.975 -0.557 . . . . 72.33 110.045 176.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -68.21 -71.46 0.21 Allowed 'General case' 0 C--N 1.333 -0.136 0 N-CA-C 109.235 -0.654 . . . . 74.43 109.235 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 58.8 mmtt -130.25 79.59 72.34 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 70.41 111.227 175.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.506 ' HA ' HD22 ' A' ' 309' ' ' LEU . 18.3 Cg_endo -91.78 118.05 0.48 Allowed 'Trans proline' 0 N--CA 1.445 -1.359 0 C-N-CA 122.598 2.199 . . . . 72.32 111.531 176.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.519 HD23 ' HB2' ' A' ' 319' ' ' ASN . 30.3 tp -133.7 103.99 6.13 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.057 -0.519 . . . . 71.13 109.721 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.406 ' OH ' ' HD2' ' A' ' 240' ' ' ARG . 4.5 m-85 -64.66 -33.72 76.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.641 -0.709 . . . . 74.2 111.472 -176.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -68.28 -27.39 66.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.632 -0.427 . . . . 72.53 110.709 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.519 ' HB2' HD23 ' A' ' 316' ' ' LEU . 5.9 t30 -72.25 -38.51 68.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.328 0.585 . . . . 61.41 109.457 178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.423 ' HA ' HG22 ' A' ' 323' ' ' ILE . 68.7 mt -69.96 -37.08 75.69 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.45 -0.796 . . . . 75.31 109.381 175.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.585 HH22 ' HB2' ' A' ' 106' ' ' LYS . 23.8 ttt180 -59.65 -41.06 89.71 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.785 -1.098 . . . . 74.45 109.973 175.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -63.73 -52.39 60.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.815 -0.63 . . . . 74.32 111.985 179.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.481 HD11 ' HB2' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -61.12 -42.23 92.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.244 0 CA-C-O 120.437 0.161 . . . . 54.13 110.956 -176.433 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.523 ' HB3' HD11 ' A' ' 155' ' ' LEU . 94.1 mt -64.38 -46.92 81.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.713 0.292 . . . . 64.5 110.992 -179.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.49 -34.92 78.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.489 -0.323 . . . . 73.34 111.03 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -64.48 -42.77 95.69 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.279 -0.419 . . . . 72.34 110.402 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.532 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.47 -46.34 85.94 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.931 -0.652 . . . . 40.02 111.711 176.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.508 HD22 ' HG ' ' A' ' 155' ' ' LEU . 35.1 tp -59.78 -42.66 93.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.172 0.51 . . . . 65.42 110.698 178.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -70.88 -25.83 62.97 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 73.52 110.674 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -64.61 -36.9 85.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.416 -0.356 . . . . 41.2 111.01 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 17.5 tt -89.17 2.9 6.24 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-O 121.384 0.612 . . . . 73.31 110.611 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.94 24.39 15.31 Favored Glycine 0 C--N 1.329 0.189 0 C-N-CA 120.952 -0.642 . . . . 71.33 113.847 172.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 17.1 t -121.97 138.57 54.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 117.407 0.604 . . . . 63.15 110.856 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -154.67 99.5 2.16 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.067 -0.515 . . . . 73.14 109.806 177.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.619 ' HA ' ' NE2' ' A' ' 156' ' ' GLN . 13.8 t70 55.26 54.12 9.13 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.047 0.927 . . . . 72.13 108.675 -176.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.449 ' HB3' ' HE3' ' A' ' 152' ' ' LYS . 29.4 t70 -66.49 103.27 1.02 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.346 -1.297 . . . . 75.23 112.486 -167.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 65.17 26.01 71.33 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.56 -0.745 . . . . 52.34 113.565 172.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 191' ' ' ASP . 96.2 mttt 58.3 78.1 0.26 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.967 0.413 . . . . 71.2 110.884 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.809 ' HG ' ' H ' ' A' ' 340' ' ' ASP . 13.1 tp 65.36 -169.66 0.2 Allowed 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.566 -0.743 . . . . 75.34 110.571 -179.443 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.809 ' H ' ' HG ' ' A' ' 339' ' ' LEU . 14.7 t70 -144.04 2.72 1.18 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.323 0.582 . . . . 71.21 110.5 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.558 HD23 HD11 ' A' ' 185' ' ' LEU . 8.3 tp -104.38 82.98 2.0 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.008 0.433 . . . . 71.02 110.727 -171.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 16.2 m -111.23 22.53 15.1 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.045 -0.525 . . . . 73.34 110.121 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 22.9 t -63.83 -25.02 37.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.527 -0.76 . . . . 71.41 111.593 -176.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.657 ' HA ' ' OG ' ' A' ' 136' ' ' SER . 31.5 m 41.63 54.0 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 123.843 0.857 . . . . 61.32 113.222 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.453 ' O ' ' HA ' ' A' ' 136' ' ' SER . 2.4 mm-40 -102.42 144.78 30.45 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.566 -0.743 . . . . 55.3 110.791 176.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 49.0 t-20 -126.37 116.32 21.0 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.84 -0.618 . . . . 73.51 110.02 -177.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 162.65 58.52 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.649 -0.58 . . . . 74.03 111.649 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.457 ' HA2' ' HB3' ' A' ' 139' ' ' GLN . . . -93.1 -143.9 13.87 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 121.024 -0.608 . . . . 75.04 113.604 -175.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.679 ' HG ' ' HG2' ' A' ' 139' ' ' GLN . 97.5 mt -114.1 -162.73 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.446 -0.377 . . . . 54.35 110.657 -175.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -116.96 162.41 17.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.288 -0.414 . . . . 74.25 110.454 -175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.783 ' HB3' ' HD1' ' A' ' 48' ' ' PHE . . . -82.04 164.94 21.06 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.433 -0.349 . . . . 55.2 110.108 177.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.638 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 23.5 mtmm -129.56 159.33 36.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.966 0.412 . . . . 63.43 111.363 -174.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.01 159.22 22.24 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.955 -0.566 . . . . 73.51 111.911 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -74.87 141.22 16.26 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 CA-C-O 121.155 0.502 . . . . 73.21 111.254 -179.493 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 2.9 t -86.18 73.66 10.18 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.539 0.685 . . . . 61.22 110.092 174.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 53.9 pttt -72.96 -38.05 66.86 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.786 -0.643 . . . . 63.0 111.443 -176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.539 ' HG3' ' N ' ' A' ' 358' ' ' ARG . 16.5 ptpt -168.0 -50.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.865 0.364 . . . . 74.33 111.231 176.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.539 ' N ' ' HG3' ' A' ' 357' ' ' LYS . 7.1 tpt180 -151.37 134.16 15.69 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.55 -0.295 . . . . 62.11 110.325 -177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -119.39 109.87 16.28 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.403 -0.591 . . . . 74.33 109.403 172.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.609 ' NZ ' ' HB2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.979 0 CA-C-O 118.078 -0.963 . . . . 63.34 110.493 -177.001 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.661 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 64.4 mtt . . . . . 0 N--CA 1.482 1.135 0 CA-C-O 119.756 -0.164 . . . . 64.53 111.041 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.661 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 95.5 Cg_endo -83.27 139.19 9.17 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.814 1.676 . . . . 72.32 111.706 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -130.29 118.51 21.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.118 -0.492 . . . . 54.32 110.743 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.7 p -133.37 106.47 9.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.64 -0.709 . . . . 64.43 110.157 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -114.9 123.76 49.97 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.924 -0.58 . . . . 72.43 110.193 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -140.72 124.9 17.46 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.853 -0.612 . . . . 70.44 110.16 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.03 88.99 2.4 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.982 0.42 . . . . 71.14 110.49 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.3 mt-30 -80.42 99.57 8.04 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.787 -0.642 . . . . 64.33 110.222 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -80.38 95.57 6.43 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.41 -0.359 . . . . 74.44 110.416 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 104.66 3.0 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.62 -0.8 . . . . 72.14 111.948 -178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.406 ' HD2' HH11 ' A' ' 11' ' ' ARG . 2.6 ptm180 -130.54 135.69 48.18 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.695 -0.483 . . . . 71.4 109.695 179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -131.56 109.38 10.2 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.587 -0.523 . . . . 71.13 109.587 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.9 p -118.64 121.55 40.44 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.74 -0.664 . . . . 72.33 109.958 178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 68.8 m -154.74 29.99 0.42 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.295 -0.411 . . . . 72.41 110.5 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -61.88 109.99 1.41 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.128 -0.487 . . . . 61.14 110.132 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.5 tttp -120.66 116.23 24.89 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.195 0.522 . . . . 72.12 111.441 -174.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -108.43 166.19 10.95 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.966 -0.753 . . . . 73.21 108.966 173.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -73.68 86.66 1.66 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.918 0.39 . . . . 71.02 110.982 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 3.1 pp -170.1 161.91 8.73 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.594 -0.73 . . . . 71.43 111.042 179.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -171.04 -82.75 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.077 -1.083 . . . . 53.44 108.077 175.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -145.98 -179.34 6.64 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.267 -1.012 . . . . 65.55 108.267 169.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.405 ' HG2' ' H ' ' A' ' 22' ' ' GLN . 2.9 pt20 -76.11 75.36 2.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.573 0.701 . . . . 74.42 111.11 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -169.37 84.15 0.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.135 -0.938 . . . . 73.34 109.402 177.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -176.22 -162.49 0.09 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.684 -0.689 . . . . 73.35 109.918 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.57 ' HA ' HG23 ' A' ' 39' ' ' VAL . 99.3 t -60.48 134.94 25.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.309 -0.405 . . . . 74.34 110.031 173.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.596 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . 99.6 -3.59 57.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.625 -0.798 . . . . 72.41 112.655 -177.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.3 mm-40 -96.67 159.43 14.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.944 0.402 . . . . 72.51 110.714 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -79.1 146.06 8.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.792 -0.64 . . . . 72.34 112.159 -172.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 tp -133.79 122.51 42.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.236 -0.893 . . . . 72.34 109.568 175.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 3.6 m -96.77 134.21 40.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.712 -0.222 . . . . 64.11 111.505 -175.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -98.57 -176.32 3.34 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.565 -0.532 . . . . 73.34 109.565 175.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.406 ' HB2' ' HA3' ' A' ' 117' ' ' GLY . 50.4 tpp -72.59 -22.54 60.96 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.552 0.215 . . . . 65.22 111.162 -176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -80.83 3.7 21.67 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.108 0.48 . . . . 73.15 110.226 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 47.1 mmtm 71.07 36.12 1.48 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 114.991 -1.004 . . . . 70.02 111.409 173.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -107.05 121.96 45.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.105 -0.498 . . . . 51.13 110.199 174.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 4.1 mp0 -87.03 97.2 10.59 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.187 -0.46 . . . . 70.03 110.226 176.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 44.1 m95 -84.93 -171.74 3.8 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.63 -0.878 . . . . 65.14 108.63 175.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 66.0 mttt -134.68 137.05 43.23 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.634 -0.426 . . . . 72.54 110.402 174.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.57 HG23 ' HA ' ' A' ' 25' ' ' VAL . 2.4 m -69.23 118.64 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 C-N-CA 120.678 -0.409 . . . . 73.04 110.693 178.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.443 ' HA2' ' HB3' ' A' ' 56' ' ' MET . . . -107.28 -116.43 4.09 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.834 -0.698 . . . . 74.45 112.214 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.3 mm? -91.08 122.69 66.17 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.81 0.338 . . . . 74.03 110.977 -177.004 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_exo -78.51 104.77 1.87 Allowed 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.914 2.409 . . . . 71.15 111.052 174.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 45' ' ' GLN . 58.9 mt -79.14 -46.86 23.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.09 -0.505 . . . . 75.53 110.227 -177.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.37 -27.67 8.3 Favored Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 111.433 -0.667 . . . . 73.13 111.433 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.743 ' HG3' HD11 ' A' ' 349' ' ' LEU . 2.0 mp0 -107.79 165.27 11.57 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.29 -0.455 . . . . 72.12 109.878 -177.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 184' ' ' LEU . . . 156.69 -88.37 0.12 Allowed Glycine 0 N--CA 1.447 -0.62 0 N-CA-C 111.498 -0.641 . . . . 52.25 111.498 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 48' ' ' PHE . . . -158.22 50.13 0.42 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.609 -0.805 . . . . 63.3 112.353 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 63.7 t80 171.71 -79.08 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 123.119 0.568 . . . . 74.02 109.684 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.413 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 161.18 134.77 1.7 Allowed Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 110.99 -0.844 . . . . 75.41 110.99 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 50.5 t 65.52 76.48 0.33 Allowed 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.622 0.725 . . . . 54.45 110.176 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.413 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.1 mm -121.65 135.47 61.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.479 -0.782 . . . . 73.52 109.73 -178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.548 ' CE1' HG12 ' A' ' 39' ' ' VAL . 51.9 p90 -131.15 154.78 47.98 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.181 -0.608 . . . . 64.11 111.311 176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' HA ' HG12 ' A' ' 69' ' ' VAL . 2.0 tt -71.52 133.18 45.64 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.693 -0.685 . . . . 65.32 109.418 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 37' ' ' TRP . . . -93.39 36.93 1.05 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.224 0.453 . . . . 73.23 112.224 -171.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.44 ' O ' HD22 ' A' ' 53' ' ' LEU . 17.0 t0 -178.73 152.51 0.62 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.112 -0.699 . . . . 72.33 109.112 171.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.596 ' SD ' ' HA2' ' A' ' 26' ' ' GLY . 4.6 ppp? -144.58 6.66 1.26 Allowed 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.994 -0.548 . . . . 73.51 110.38 178.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -139.33 -179.34 5.82 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 75.02 109.792 -174.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.7 t -90.21 72.69 7.19 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 109.764 -0.458 . . . . 72.33 109.764 175.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 20.7 m -59.23 -37.1 76.68 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.493 0.663 . . . . 43.14 109.789 176.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.515 ' HG2' ' H ' ' A' ' 61' ' ' SER . 17.5 tt0 -144.96 -163.33 1.68 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.572 -1.64 . . . . 73.41 106.572 170.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.515 ' H ' ' HG2' ' A' ' 60' ' ' GLU . 50.6 m -66.77 86.85 0.13 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 118.682 0.673 . . . . 74.15 111.489 178.134 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.1 t -82.51 124.42 39.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.23 0.538 . . . . 74.44 111.312 175.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -130.4 -1.01 5.3 Favored Glycine 0 N--CA 1.444 -0.775 0 CA-C-N 115.295 -0.866 . . . . 70.13 111.206 174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 m -120.31 23.58 10.83 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 111.562 0.208 . . . . 52.14 111.562 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' HB2' HH12 ' A' ' 133' ' ' ARG . 22.2 m-20 60.66 25.46 15.22 Favored 'General case' 0 N--CA 1.472 0.654 0 O-C-N 123.38 0.425 . . . . 72.2 111.231 179.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 60.76 91.8 0.07 OUTLIER Pre-proline 0 C--O 1.232 0.173 0 CA-C-O 121.562 0.696 . . . . 64.33 110.12 -172.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.72 23.34 0.77 Allowed 'Trans proline' 0 N--CA 1.463 -0.323 0 C-N-CA 122.891 2.394 . . . . 73.22 113.084 -172.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 6.2 p -124.18 139.02 54.33 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.367 0.603 . . . . 74.41 111.944 -173.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.564 HG12 ' HA ' ' A' ' 53' ' ' LEU . 20.5 m -130.85 170.38 19.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.393 -0.821 . . . . 63.21 109.544 176.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.847 ' HB ' HD13 ' A' ' 130' ' ' ILE . 1.5 p -132.48 127.2 56.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-O 121.059 0.457 . . . . 62.03 111.431 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -85.34 130.1 34.67 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.241 -0.891 . . . . 73.02 109.101 174.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 45.1 t -109.6 127.74 66.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.983 0.42 . . . . 74.11 111.397 -175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.435 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 25.9 tt0 -115.25 141.01 26.47 Favored Pre-proline 0 C--N 1.322 -0.622 0 N-CA-C 108.393 -0.965 . . . . 64.23 108.393 175.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_exo -63.38 -171.45 0.12 Allowed 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.218 1.945 . . . . 65.41 111.639 173.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 19.5 t -76.79 78.97 3.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.256 0.551 . . . . 64.52 109.559 177.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -122.08 -52.49 1.97 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.845 -0.616 . . . . 73.43 110.541 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 65.6 t30 66.38 46.34 1.98 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 121.884 0.849 . . . . 44.24 109.651 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -115.98 -80.81 0.86 Allowed Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.127 -0.942 . . . . 44.31 111.658 177.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.43 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.8 Cg_exo -59.77 -43.96 34.35 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.712 2.275 . . . . 35.0 112.033 177.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.524 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 0.2 OUTLIER -63.28 -33.27 75.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 72.0 110.298 179.102 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -63.57 -50.53 69.11 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-O 120.909 0.385 . . . . 53.34 111.033 -178.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 19.0 m -65.15 -43.74 90.87 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.959 -0.564 . . . . 74.11 110.674 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -66.83 -35.48 80.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.741 -0.663 . . . . 70.13 110.388 -178.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -59.07 -49.28 78.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.246 -0.434 . . . . 74.22 109.944 178.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 55.8 tttm -60.23 -39.69 87.58 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 121.007 0.432 . . . . 75.31 110.708 178.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.2 t80 -59.01 -52.62 65.0 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.204 -0.453 . . . . 72.54 110.413 177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 17.8 m-85 -61.84 -33.19 73.71 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 116.187 -0.46 . . . . 72.25 111.382 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -63.61 -28.46 69.93 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.642 0.238 . . . . 74.32 111.642 176.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.624 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 2.9 mmp_? -93.65 -16.09 24.66 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.054 0.39 . . . . 73.32 112.054 177.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.81 17.71 22.81 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.597 0.713 . . . . 22.21 110.511 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.21 136.27 38.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.067 -0.97 . . . . 75.12 112.807 -170.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.429 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 34.4 ttmt 73.45 115.52 0.03 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-N 114.83 -1.077 . . . . 74.43 111.948 173.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 62.0 Cg_exo -53.03 -28.71 41.46 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.711 2.94 . . . . 73.35 113.373 -177.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 56.1 tt0 -52.83 -50.87 62.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.144 0.497 . . . . 72.11 111.163 177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.53 ' O ' ' HB3' ' A' ' 98' ' ' LYS . 35.1 mt-30 -73.19 -34.72 66.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.117 -0.492 . . . . 62.22 110.132 -178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.403 HD12 ' HA ' ' A' ' 93' ' ' PRO . 65.8 mt -58.9 -53.96 40.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.819 -0.628 . . . . 74.42 110.488 177.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.8 mm100 -62.48 -31.15 71.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.065 -0.516 . . . . 75.52 110.574 179.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 95' ' ' GLN . 22.2 ttmm -55.04 -65.3 0.61 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.94 -0.573 . . . . 74.31 111.37 177.659 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.59 ' HZ2' HD11 ' A' ' 108' ' ' LEU . 3.7 p90 -69.5 -32.9 72.05 Favored 'General case' 0 CA--C 1.528 0.104 0 C-N-CA 120.496 -0.482 . . . . 73.31 110.884 -175.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.604 HD13 ' HA ' ' A' ' 107' ' ' TYR . 48.7 mt -59.05 -39.5 78.55 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.178 0 CA-C-O 120.67 0.271 . . . . 73.41 110.594 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -76.51 -27.62 56.09 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.87 0.366 . . . . 73.43 110.312 177.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 31.0 m -70.43 -44.21 68.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.103 -0.499 . . . . 74.41 110.748 178.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 103' ' ' ARG . 42.2 mtt-85 -83.2 -13.81 54.64 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.474 -0.33 . . . . 71.13 110.759 177.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 37.1 ttpt 57.51 69.57 0.73 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.745 0.783 . . . . 75.1 109.733 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.599 ' HG ' ' OD2' ' A' ' 163' ' ' ASP . 10.2 tp -108.81 -167.91 1.28 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.76 -1.109 . . . . 71.22 109.04 -176.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HG3' ' CD1' ' A' ' 107' ' ' TYR . 20.7 tptm -100.16 -68.15 0.82 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 120.571 -0.452 . . . . 73.12 110.033 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.609 ' CD1' ' HG3' ' A' ' 106' ' ' LYS . 55.2 p90 -179.96 152.06 0.45 Allowed 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.985 0.422 . . . . 61.12 110.587 175.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 HD11 ' HZ2' ' A' ' 99' ' ' TRP . 83.5 mt -78.41 136.55 37.67 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.882 -0.599 . . . . 74.1 111.007 -176.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.84 51.5 4.45 Favored Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 111.126 -0.789 . . . . 74.41 111.126 171.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.482 HG23 ' HB3' ' A' ' 108' ' ' LEU . 60.5 t -119.73 129.75 25.2 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.876 -0.416 . . . . 62.11 109.876 -176.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 35.1 Cg_exo -61.07 148.86 91.63 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.763 2.308 . . . . 53.44 112.454 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.575 ' HD2' ' CE2' ' A' ' 114' ' ' TRP . 4.1 ttmp? -62.91 128.57 36.51 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.779 -0.646 . . . . 74.21 110.804 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 21.0 t80 -90.9 85.14 5.9 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.929 -0.578 . . . . 72.34 110.656 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.575 ' CE2' ' HD2' ' A' ' 112' ' ' LYS . 10.4 m95 -67.33 -55.5 13.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.944 -0.571 . . . . 72.41 109.858 173.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.09 -171.32 36.94 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.414 -0.812 . . . . 70.52 111.622 -177.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.502 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 43.1 p 176.94 175.14 0.38 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.475 -0.565 . . . . 61.44 109.475 -176.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 32' ' ' MET . . . 154.15 -159.32 28.74 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.069 -1.062 . . . . 72.42 112.884 175.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.486 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.8 tt -131.52 138.64 49.02 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.495 -0.557 . . . . 73.32 109.495 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -143.24 134.86 26.43 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.683 -0.488 . . . . 74.44 109.683 -179.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.881 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.9 t70 -74.89 140.07 43.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.801 -0.444 . . . . 73.53 109.801 178.216 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 2.0 ttpm? -103.46 40.68 1.37 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.714 -0.476 . . . . 44.23 109.714 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 60.42 67.53 0.83 Allowed 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.651 -0.704 . . . . 73.42 110.412 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 142.03 -58.24 0.56 Allowed Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.261 -0.881 . . . . 52.11 111.492 -179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.458 ' HD2' ' HA ' ' A' ' 124' ' ' LYS . 42.4 tptt -134.29 142.74 47.4 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.431 -0.581 . . . . 62.23 109.431 176.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.881 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.9 m -88.29 148.73 24.16 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.325 -0.398 . . . . 72.31 111.437 -176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -118.8 151.64 37.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.884 -0.598 . . . . 72.24 110.81 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.6 ttt85 -113.39 120.0 39.56 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 108.925 -0.769 . . . . 75.14 108.925 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.579 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -134.95 162.4 32.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.049 0.452 . . . . 73.44 112.081 -171.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.502 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 45.7 ttm -140.2 139.81 35.74 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.672 -0.695 . . . . 74.22 110.613 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.847 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.7 mm -98.17 126.0 51.31 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.322 -0.399 . . . . 60.41 110.421 -178.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 8.2 ptp -138.54 -179.22 5.68 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.75 -0.659 . . . . 71.35 110.38 -176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -73.21 156.15 38.85 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.66 -0.866 . . . . 74.14 108.66 172.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.594 HH12 ' HB2' ' A' ' 65' ' ' ASP . 25.1 ptt180 -85.41 135.2 33.97 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.027 0.441 . . . . 65.15 111.781 -174.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.443 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 43.3 m-85 -124.02 153.44 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.227 -0.442 . . . . 63.3 109.841 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.504 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -159.13 8.67 0.17 Allowed Glycine 0 C--O 1.226 -0.39 0 C-N-CA 119.946 -1.121 . . . . 72.52 113.662 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.069 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.0 m -122.98 125.5 45.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.021 -0.694 . . . . 72.33 110.791 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.579 ' OD1' ' HA ' ' A' ' 181' ' ' SER . 3.3 t70 -116.48 140.14 49.7 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.945 0.402 . . . . 74.31 111.422 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.512 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.2 mp -67.94 -33.06 73.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.71 -0.677 . . . . 73.21 111.797 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.481 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 55.2 tp60 -72.63 -35.83 67.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.065 0.46 . . . . 61.23 110.088 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 46.4 tptt -70.83 -48.13 55.72 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.026 -0.534 . . . . 73.24 110.528 176.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.448 HG21 ' HB2' ' A' ' 341' ' ' LEU . 80.7 mt -62.43 -30.04 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.188 0 CA-C-N 115.97 -0.559 . . . . 74.31 110.176 177.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 1.1 t80 -51.27 -46.08 62.28 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 115.534 -0.757 . . . . 72.41 110.593 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -80.54 -36.01 33.69 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.205 -0.452 . . . . 70.23 110.138 -178.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -70.42 -32.23 69.74 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 112.349 0.5 . . . . 72.54 112.349 -175.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -101.95 3.66 39.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.865 0.364 . . . . 65.55 110.475 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' C ' ' HG2' ' A' ' 147' ' ' LYS . . . 59.02 55.8 4.28 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.318 -0.856 . . . . 55.02 111.935 178.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.421 ' HD2' ' O ' ' A' ' 257' ' ' GLY . 21.9 pttm 45.53 38.78 4.13 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.067 0.947 . . . . 75.22 113.113 172.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.3 ttm180 -115.79 88.75 2.95 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.285 -0.416 . . . . 71.31 109.933 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -101.75 123.8 46.33 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.397 -0.365 . . . . 72.12 111.009 -177.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 26.9 m -72.37 147.32 46.35 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.906 -0.588 . . . . 72.14 110.861 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.638 ' NH2' ' HB3' ' A' ' 295' ' ' LYS . 42.0 ttm105 -56.11 -36.5 68.26 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.126 -0.488 . . . . 73.21 111.912 -177.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.746 ' HD2' ' HB2' ' A' ' 340' ' ' ASP . 12.7 ptpt -51.78 -44.3 63.35 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 121.354 0.597 . . . . 74.43 110.75 179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.543 ' HA ' HD22 ' A' ' 339' ' ' LEU . 74.9 m -71.93 -49.98 32.96 Favored 'General case' 0 N--CA 1.443 -0.805 0 CA-C-N 115.678 -0.692 . . . . 42.03 110.791 -179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -57.12 -35.24 47.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.059 -0.519 . . . . 42.24 110.646 -179.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.715 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -65.78 -52.74 48.35 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.992 -0.549 . . . . 74.52 110.851 -179.743 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.608 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 25.5 tt0 -60.6 -46.77 88.99 Favored 'General case' 0 N--CA 1.462 0.134 0 C-N-CA 120.33 -0.548 . . . . 65.35 109.883 178.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 153' ' ' THR . 6.4 mp -54.92 -51.72 65.19 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.905 -0.589 . . . . 75.21 111.226 179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 35.7 t -57.68 -44.71 85.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 54.22 110.445 179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.404 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 89.6 mt -63.75 -42.12 97.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.297 -0.41 . . . . 71.4 111.116 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.63 -38.04 86.21 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-O 121.115 0.483 . . . . 75.41 110.734 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.596 HD11 HD21 ' A' ' 183' ' ' LEU . 59.1 mt -71.04 -37.27 66.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.536 -0.756 . . . . 74.41 110.061 176.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 13.2 tp -61.82 -50.7 71.25 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.252 -0.431 . . . . 61.43 110.382 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.599 ' OD2' ' HG ' ' A' ' 105' ' ' LEU . 1.1 m-20 -52.34 -57.55 9.43 Favored 'General case' 0 C--O 1.24 0.58 0 CA-C-N 115.771 -0.65 . . . . 71.42 111.323 177.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 14.1 tt -66.14 -35.9 76.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 115.793 -0.639 . . . . 70.43 111.012 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 16.7 tp -60.59 -38.7 85.5 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.779 0.323 . . . . 73.42 110.85 -178.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -68.66 -48.09 64.89 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.595 -0.52 . . . . 74.53 109.595 179.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -56.64 -48.6 77.18 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.901 -0.59 . . . . 71.24 111.834 179.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.507 HD11 HD12 ' A' ' 165' ' ' LEU . 32.2 pt -67.04 -36.97 78.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.88 -0.328 . . . . 64.41 111.716 -174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.463 ' O ' ' HA2' ' A' ' 208' ' ' GLY . 49.2 m80 -69.99 -26.89 64.3 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.586 -0.445 . . . . 54.03 110.863 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -68.9 -27.55 65.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.182 0.515 . . . . 61.12 109.928 174.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 56.8 m-70 -121.99 66.21 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.137 -0.483 . . . . 73.22 111.466 -175.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 77.8 -51.39 0.52 Allowed 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.814 1.042 . . . . 71.31 113.814 168.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -85.91 142.06 29.12 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.497 1.295 . . . . 71.2 114.497 -161.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.459 HG12 ' CD2' ' A' ' 169' ' ' HIS . 25.6 m -115.88 164.3 12.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 114.404 -1.271 . . . . 75.03 107.949 167.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.7 t-160 -126.16 92.47 3.59 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.104 -0.639 . . . . 64.43 110.358 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.457 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -65.29 -42.08 96.37 Favored Glycine 0 N--CA 1.451 -0.339 0 CA-C-N 115.715 -0.675 . . . . 51.32 113.249 -175.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 32.7 t70 -89.18 107.72 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.04 0.448 . . . . 73.41 111.577 -178.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.581 ' HB ' HG22 ' A' ' 246' ' ' ILE . 38.0 mm -110.89 112.27 39.85 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 108.918 -0.771 . . . . 75.04 108.918 169.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 49.1 tttp -138.49 159.03 43.12 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 108.923 -0.769 . . . . 74.41 108.923 -179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -55.9 -36.44 67.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.82 0.343 . . . . 72.21 111.204 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.579 ' HA ' ' OD1' ' A' ' 137' ' ' ASP . 4.6 m -68.98 -5.34 21.0 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.847 -0.615 . . . . 70.42 112.44 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -93.2 -13.37 28.44 Favored 'General case' 0 C--O 1.239 0.508 0 CA-C-O 121.009 0.433 . . . . 62.23 110.72 -177.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 161' ' ' ILE . 7.3 mp -105.89 111.77 24.55 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.723 -0.671 . . . . 73.42 109.755 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.65 HD23 HG22 ' A' ' 196' ' ' VAL . 3.7 mm? -114.48 130.94 56.77 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.798 -0.637 . . . . 73.44 110.326 -177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.069 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 41.4 mt -84.62 142.88 29.62 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-N 115.638 -0.71 . . . . 73.2 109.674 178.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.443 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 40.5 t-20 -59.93 135.43 57.7 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.533 -0.543 . . . . 73.53 109.533 178.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 82.7 t80 -61.82 -30.38 70.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.981 0.419 . . . . 73.35 111.221 -176.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -93.95 -36.02 12.37 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.303 -0.408 . . . . 72.04 110.074 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 4.6 m-20 -114.96 87.97 16.16 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 61.14 110.215 -179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.426 ' HB2' ' HB3' ' A' ' 342' ' ' SER . 57.1 Cg_endo -73.2 -11.21 24.93 Favored 'Trans proline' 0 N--CA 1.466 -0.138 0 C-N-CA 122.349 2.033 . . . . 61.21 112.157 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -96.16 15.21 21.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.697 -0.683 . . . . 74.21 109.924 179.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 38.3 tt0 -133.18 107.65 8.32 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.196 -0.911 . . . . 74.44 109.063 -178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 157' ' ' LEU . 10.7 p -102.21 142.21 16.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.37 0.605 . . . . 72.33 112.035 -172.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.44 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 95.7 m-85 -125.75 144.42 50.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.462 -0.79 . . . . 71.13 110.181 177.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 1.3 tt -98.45 99.94 11.16 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.902 -1.147 . . . . 74.12 107.902 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.65 HG22 HD23 ' A' ' 184' ' ' LEU . 29.2 m -101.34 0.77 10.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 112.203 0.446 . . . . 62.24 112.203 -169.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -79.48 95.88 5.93 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.043 0.449 . . . . 73.24 109.812 176.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -109.47 6.5 24.21 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.809 -0.632 . . . . 74.42 109.715 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -70.55 -33.73 67.53 Favored Glycine 0 N--CA 1.447 -0.631 0 CA-C-N 115.516 -0.765 . . . . 74.12 111.457 177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -97.47 30.33 2.92 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.017 0.437 . . . . 72.44 110.743 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -92.83 99.69 12.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.163 0.506 . . . . 71.42 109.661 175.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 73.4 t80 -107.5 138.77 43.11 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.952 -0.567 . . . . 75.3 110.349 -176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 26.8 ptt180 -78.33 133.46 37.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.003 0.43 . . . . 62.04 110.871 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.452 ' O ' ' HD3' ' A' ' 206' ' ' PRO . 5.9 t80 -137.31 -54.56 0.69 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.154 -0.476 . . . . 63.13 111.295 -178.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 4.2 p -108.37 103.15 49.84 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 112.07 0.396 . . . . 63.44 112.07 -173.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 24.6 Cg_exo -63.28 118.31 5.22 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.697 2.265 . . . . 72.45 110.8 175.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 64.77 10.11 5.79 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-N 115.943 -0.571 . . . . 75.22 111.059 -176.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.463 ' HA2' ' O ' ' A' ' 169' ' ' HIS . . . 96.07 0.88 61.53 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.741 -0.742 . . . . 64.41 113.063 178.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 49.5 t -113.82 110.79 33.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 117.128 0.464 . . . . 72.52 112.189 -176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.9 t60 -177.63 144.55 0.38 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 108.963 -0.754 . . . . 64.1 108.963 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt -143.68 115.22 8.1 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.611 -0.515 . . . . 72.3 109.611 -176.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.456 ' O ' ' HB3' ' A' ' 237' ' ' ALA . 0.9 OUTLIER -159.14 102.81 1.62 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 121.029 -0.268 . . . . 64.41 110.915 -175.014 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.463 ' HA ' HG23 ' A' ' 236' ' ' VAL . 44.8 p90 -124.89 130.99 53.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.531 0.681 . . . . 64.11 111.334 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.442 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 71.9 mmtt -129.18 -86.74 0.54 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.078 -0.964 . . . . 72.44 108.933 175.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 29.6 tt0 177.39 -63.81 0.01 OUTLIER 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.946 -0.57 . . . . 54.31 110.161 172.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -148.76 104.74 3.43 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.039 -0.528 . . . . 75.2 111.307 -174.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.461 ' HD2' ' HA3' ' A' ' 235' ' ' GLY . 1.4 Cg_endo -83.8 -50.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 122.965 2.443 . . . . 62.33 112.003 172.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -151.87 21.34 0.69 Allowed 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 116.399 -0.364 . . . . 73.45 111.228 -176.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 219' ' ' ARG . 1.4 mpt_? 51.63 85.9 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 123.103 0.561 . . . . 72.33 111.288 -176.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.668 ' SG ' ' HA2' ' A' ' 235' ' ' GLY . 97.7 m -56.84 -41.17 77.41 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 111.813 0.301 . . . . 75.11 111.813 -177.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 45.28 43.39 8.12 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.917 0.887 . . . . 64.15 112.269 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 19.6 p-10 -80.66 -53.91 6.11 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.005 -0.543 . . . . 71.3 110.003 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -90.43 171.2 36.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.891 -0.671 . . . . 61.25 112.534 179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.424 ' O ' ' HB ' ' A' ' 228' ' ' THR . 25.0 p -69.6 130.82 43.48 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.926 0.393 . . . . 73.14 110.716 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.549 HG12 HG11 ' A' ' 271' ' ' VAL . 16.6 tt -63.46 -18.05 21.18 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-O 121.443 0.639 . . . . 73.33 110.324 -176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.596 ' HG2' HD13 ' A' ' 265' ' ' LEU . 24.8 mt-10 -55.59 -63.03 1.3 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.974 -1.012 . . . . 63.03 111.06 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -101.85 -40.56 6.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.893 -0.594 . . . . 74.31 111.15 -174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.458 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 93.2 m -56.63 -29.16 61.9 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.098 -0.501 . . . . 63.21 110.908 179.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.41 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 35.8 m 64.11 -147.48 0.29 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.72 -0.673 . . . . 52.44 111.372 171.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 60.0 mt -72.65 -34.72 48.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 120.846 0.355 . . . . 73.25 110.962 -174.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.498 ' HA ' HG13 ' A' ' 236' ' ' VAL . 1.5 m-20 -51.76 -92.1 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.03 -0.987 . . . . 64.12 113.599 -169.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.518 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -68.91 -29.43 67.7 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.995 0.426 . . . . 42.33 111.404 -173.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' A' ' 229' ' ' SER . 58.3 t-80 -66.77 -33.6 75.98 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.943 -0.571 . . . . 72.24 111.492 -175.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 5.9 m-20 -92.89 -27.77 16.9 Favored 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.769 -0.372 . . . . 72.52 111.029 -178.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.668 ' HA2' ' SG ' ' A' ' 220' ' ' CYS . . . 127.01 -4.99 7.37 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 119.717 -1.23 . . . . 71.03 114.182 175.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.498 HG13 ' HA ' ' A' ' 231' ' ' ASP . 3.2 p -75.24 127.55 36.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 117.743 0.771 . . . . 64.14 109.626 175.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 212' ' ' GLU . . . -59.08 121.36 54.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.753 -0.658 . . . . 60.31 112.075 -172.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.518 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 16.5 Cg_exo -66.95 101.18 0.56 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.949 2.433 . . . . 73.43 111.841 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 51.0 m -84.89 -168.42 2.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.171 -0.677 . . . . 74.04 109.171 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.534 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 20.1 mmt180 -52.24 -46.62 65.83 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.873 0.324 . . . . 74.21 111.873 -177.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.472 ' CZ ' ' HA ' ' A' ' 307' ' ' LYS . 20.2 ttt180 -68.97 -30.08 68.43 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 120.969 -0.292 . . . . 54.14 110.789 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -60.62 -56.5 23.97 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.786 -0.721 . . . . 62.21 111.99 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -60.1 -42.0 93.74 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.926 0.393 . . . . 62.33 110.42 177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.534 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 89.8 mt -62.42 -38.74 90.87 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 116.18 -0.464 . . . . 74.44 111.592 -179.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.43 -48.92 75.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 121.311 0.577 . . . . 75.15 109.877 -179.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.581 HG22 ' HB ' ' A' ' 178' ' ' ILE . 68.6 mt -57.03 -44.48 82.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.13 -0.941 . . . . 74.5 110.718 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 58.9 tp -60.5 -41.47 94.35 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.773 -0.649 . . . . 73.11 110.824 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.68 -46.2 93.69 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.301 -0.476 . . . . 53.53 112.62 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -61.96 -38.25 87.8 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.973 0.416 . . . . 73.33 110.878 179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 56.5 m -66.89 -47.16 72.66 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.286 -0.416 . . . . 60.25 110.631 178.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 86.7 mtp -60.89 -43.32 98.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.984 -0.553 . . . . 63.42 111.301 -177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.559 HD12 ' HG3' ' A' ' 286' ' ' MET . 12.7 tt -67.35 -34.95 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 C-N-CA 120.458 -0.497 . . . . 74.51 110.917 -178.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 37.3 tt0 -62.96 -43.65 98.2 Favored 'General case' 0 C--O 1.228 -0.071 0 C-N-CA 120.83 -0.348 . . . . 65.25 110.452 178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 23.9 m0 -66.01 -35.29 80.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.107 0.479 . . . . 73.44 110.631 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 45.3 tp -79.0 -32.84 45.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.877 -0.601 . . . . 74.11 111.818 -175.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 46.5 p -102.71 -27.98 12.39 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.623 -0.431 . . . . 73.43 111.825 -175.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.421 ' O ' ' HD2' ' A' ' 147' ' ' LYS . . . 119.75 -45.87 1.19 Allowed Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.355 -0.926 . . . . 65.13 113.719 176.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.01 159.33 39.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.596 0.698 . . . . 73.23 111.098 -173.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 90.7 mt -95.19 137.64 22.12 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-N 116.515 -0.311 . . . . 61.42 110.582 178.374 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 23.8 Cg_exo -67.33 -28.79 39.24 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 123.004 2.469 . . . . 51.51 112.907 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 42.4 p90 -101.66 9.91 40.62 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.212 -0.449 . . . . 75.11 110.757 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.522 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 16.5 tt0 -59.44 -45.78 90.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.892 -0.595 . . . . 63.21 112.315 -170.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -72.77 -16.3 61.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.036 0.446 . . . . 74.41 111.049 -176.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -107.54 16.87 23.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.341 -0.39 . . . . 73.33 111.096 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.596 HD13 ' HG2' ' A' ' 226' ' ' GLU . 37.4 mt -70.07 -14.03 62.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.551 0.691 . . . . 75.15 110.007 172.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 22.7 pttm -76.23 -19.42 58.38 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.119 -0.946 . . . . 60.43 110.018 174.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 271' ' ' VAL . 9.6 m-20 -94.83 113.29 60.89 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 115.455 -0.793 . . . . 73.12 110.071 -178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -57.72 -38.47 93.0 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.706 2.271 . . . . 73.24 112.89 -175.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.535 ' NZ ' ' HB3' ' A' ' 269' ' ' LYS . 7.7 mtpm? -69.47 -42.98 74.14 Favored 'General case' 0 C--O 1.223 -0.333 0 C-N-CA 120.894 -0.323 . . . . 64.45 111.467 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -63.71 -38.46 91.18 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 121.003 -0.279 . . . . 73.21 111.19 -177.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.549 HG11 HG12 ' A' ' 225' ' ' ILE . 38.2 t -65.75 -39.88 86.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.948 0.404 . . . . 53.15 110.224 175.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.4 ttt180 -64.07 -56.31 15.88 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.89 -0.595 . . . . 72.13 110.335 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -61.41 -44.68 96.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.781 -0.645 . . . . 65.2 112.023 -177.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 55.3 p -63.57 -50.49 69.24 Favored 'General case' 0 C--N 1.333 -0.112 0 C-N-CA 121.083 -0.247 . . . . 74.14 111.321 -176.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 33.3 mmtp -64.08 -34.04 77.12 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 121.18 -0.208 . . . . 74.13 111.31 -175.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.43 -53.76 26.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.925 0.393 . . . . 72.44 111.014 177.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 79.6 mtp180 -71.1 -30.82 67.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.476 -0.329 . . . . 65.14 111.475 -174.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -73.47 -35.44 65.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.725 -0.216 . . . . 73.44 110.91 176.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 30.1 mtt180 -62.87 -31.22 72.21 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.253 0.549 . . . . 71.01 110.238 173.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -71.36 -59.37 2.8 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.256 -0.883 . . . . 73.41 110.483 179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.472 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.6 OUTLIER -108.57 59.42 0.61 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.312 -0.404 . . . . 65.12 111.195 -171.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.531 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -62.81 -43.95 99.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.078 -0.51 . . . . 74.55 112.196 -177.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.451 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -64.47 -47.8 77.65 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 111.795 0.295 . . . . 61.13 111.795 -171.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 26.6 t -66.44 -46.71 75.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.76 0.314 . . . . 75.35 110.927 -177.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.4 mm? -68.16 -49.86 58.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.402 -0.363 . . . . 73.44 111.821 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.559 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -62.09 -39.99 94.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.627 0.251 . . . . 64.4 111.55 -177.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -71.64 -31.33 66.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.914 0.388 . . . . 72.32 111.103 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.474 ' O ' ' HD2' ' A' ' 288' ' ' LYS . 0.1 OUTLIER -69.91 -33.2 71.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.059 0.457 . . . . 64.22 109.975 178.682 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 72.8 m -71.23 -19.66 62.34 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.956 -0.565 . . . . 75.45 111.264 -174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.933 ' HB3' ' HB3' ' A' ' 296' ' ' PRO . 6.7 t80 -128.52 87.81 54.03 Favored Pre-proline 0 N--CA 1.448 -0.565 0 CA-C-O 121.101 0.476 . . . . 71.33 110.323 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -83.5 2.98 8.03 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 123.365 2.71 . . . . 73.5 111.939 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -86.9 149.69 24.63 Favored 'General case' 0 N--CA 1.443 -0.795 0 N-CA-C 108.684 -0.858 . . . . 73.24 108.684 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.501 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.3 mmtt -91.98 29.67 1.56 Allowed 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 112.037 0.384 . . . . 55.44 112.037 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.601 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 42.3 t-20 -64.11 -69.88 0.25 Allowed 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 106.943 -1.502 . . . . 72.21 106.943 167.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.638 ' HB3' ' NH2' ' A' ' 151' ' ' ARG . 49.9 tptt 169.15 114.76 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.514 0 O-C-N 124.257 0.973 . . . . 74.33 109.59 160.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.933 ' HB3' ' HB3' ' A' ' 290' ' ' PHE . 89.3 Cg_endo -96.22 46.26 0.14 Allowed 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.673 2.249 . . . . 75.43 111.544 169.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -111.25 -43.02 1.02 Allowed Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.384 -0.912 . . . . 33.33 113.048 -172.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.485 ' HB2' HD12 ' A' ' 299' ' ' ILE . 0.9 OUTLIER -57.53 -64.11 1.0 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.723 0.297 . . . . 74.11 110.408 -175.612 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.485 HD12 ' HB2' ' A' ' 298' ' ' GLU . 2.8 mp -60.25 -39.69 81.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.908 -0.587 . . . . 72.52 111.049 -178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.66 -51.63 68.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.272 -0.422 . . . . 44.21 111.374 -177.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 12.8 tptt -79.93 -23.27 41.87 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.816 -0.354 . . . . 75.03 110.926 -177.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.455 ' CD1' HD22 ' A' ' 320' ' ' LEU . 65.7 t80 -59.99 -48.22 82.62 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.005 0.431 . . . . 75.01 109.911 171.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.623 ' HA ' HG22 ' A' ' 306' ' ' VAL . 82.6 mtp -72.5 -32.9 66.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.983 -0.553 . . . . 73.32 110.548 178.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 4.4 tp10 -54.96 -45.74 74.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.788 0.804 . . . . 74.54 109.109 171.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 63.2 m -63.57 -47.33 81.94 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 114.315 -1.311 . . . . 64.32 111.965 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.623 HG22 ' HA ' ' A' ' 303' ' ' MET . 21.6 m -66.2 -34.26 69.01 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 C-N-CA 120.862 -0.335 . . . . 71.33 111.741 -174.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.472 ' HA ' ' CZ ' ' A' ' 241' ' ' ARG . 0.0 OUTLIER -76.45 -27.67 56.26 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 120.406 -0.518 . . . . 74.13 109.755 177.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 24.6 tp -77.4 -26.96 52.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.784 -0.643 . . . . 74.04 110.925 -178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.4 ' O ' ' HB3' ' A' ' 310' ' ' ASP . 4.4 pp -86.3 18.46 3.18 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-O 120.765 0.317 . . . . 65.34 110.745 177.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 24.0 t70 73.47 -79.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.497 -0.774 . . . . 73.22 111.938 171.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -162.11 -31.43 0.05 OUTLIER 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.537 0.684 . . . . 74.22 109.755 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 11.6 t -170.57 29.92 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.486 -0.779 . . . . 74.01 108.978 173.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.517 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 3.3 tm-20 -70.85 -71.11 0.27 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.177 -0.92 . . . . 64.23 110.274 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -132.31 87.36 43.17 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.386 -0.37 . . . . 74.05 110.275 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -81.51 118.0 3.15 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 122.414 2.076 . . . . 63.54 111.689 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.2 mt -112.31 94.58 5.0 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.226 0.536 . . . . 74.23 110.183 178.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -68.41 -33.33 74.04 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.513 -0.767 . . . . 73.43 110.807 -177.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.93 -38.94 90.35 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.417 -0.356 . . . . 61.13 110.567 176.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -64.85 -44.84 88.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 64.44 110.437 176.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 86.8 mt -60.19 -47.88 84.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.538 -0.756 . . . . 73.3 110.79 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.563 ' O ' ' HB2' ' A' ' 325' ' ' LEU . 8.1 ppt_? -73.78 -19.09 60.87 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 120.741 -0.384 . . . . 62.33 111.214 -177.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -82.17 -32.57 29.91 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.753 -0.379 . . . . 60.12 111.449 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -75.81 -32.57 24.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 120.005 -0.678 . . . . 52.23 110.042 176.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.469 HD23 ' HB3' ' A' ' 298' ' ' GLU . 95.2 mt -66.08 -41.92 90.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.944 -0.761 . . . . 52.04 108.944 171.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.563 ' HB2' ' O ' ' A' ' 321' ' ' ARG . 0.2 OUTLIER -65.12 -32.02 73.51 Favored 'General case' 0 C--O 1.217 -0.648 0 CA-C-N 115.512 -0.767 . . . . 70.24 110.121 177.147 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -49.19 78.79 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.263 -0.643 . . . . 75.41 109.263 177.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.1 -40.31 95.01 Favored Glycine 0 CA--C 1.522 0.487 0 C-N-CA 120.753 -0.737 . . . . 64.22 112.689 178.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.715 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 28.8 tp -69.12 -43.36 74.56 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.377 0.608 . . . . 63.04 110.848 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 31.3 ttpt -67.94 -38.11 82.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.242 -0.89 . . . . 72.14 110.892 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -65.53 -33.07 75.05 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.34 -0.391 . . . . 60.14 111.291 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -89.8 -7.28 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 CA-C-O 120.974 0.416 . . . . 53.51 110.759 -179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 83.77 26.34 42.34 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.503 -0.856 . . . . 45.54 113.563 172.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.485 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 9.4 t -117.87 171.35 8.12 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 117.257 0.528 . . . . 63.41 110.925 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.507 ' HA ' HD21 ' A' ' 328' ' ' LEU . 0.0 OUTLIER -153.44 161.14 42.57 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.989 -0.55 . . . . 62.51 110.425 -178.466 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.512 ' HB2' ' HG3' ' A' ' 156' ' ' GLN . 7.2 p-10 -89.81 -12.09 40.17 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.73 0.3 . . . . 74.14 111.499 -175.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -92.3 102.01 14.5 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.492 -0.322 . . . . 72.33 111.077 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 147.08 -68.79 0.38 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.155 -1.021 . . . . 64.22 113.014 176.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -158.74 156.98 30.84 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.214 -0.291 . . . . 72.45 110.214 -173.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 153' ' ' THR . 49.6 mt -100.24 -115.06 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.8 -0.182 . . . . 73.14 110.989 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.746 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 9.6 t70 -174.07 -33.03 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.041 0.448 . . . . 64.32 111.067 -174.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.448 ' HB2' HG21 ' A' ' 141' ' ' ILE . 1.5 pt? -93.25 17.25 11.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.25 0.547 . . . . 72.05 110.302 -178.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.426 ' HB3' ' HB2' ' A' ' 190' ' ' PRO . 4.6 m -73.58 81.04 1.49 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.582 -0.735 . . . . 73.1 110.97 -175.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.1 t -127.57 0.39 3.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-N 115.807 -0.633 . . . . 45.11 110.471 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.609 ' HA ' ' OG ' ' A' ' 136' ' ' SER . 13.0 p 47.02 103.71 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.074 0 C-N-CA 124.572 1.149 . . . . 62.31 113.745 -178.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -129.05 99.35 5.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.478 -0.783 . . . . 72.42 112.044 -177.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 53.09 -94.75 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 124.204 1.001 . . . . 73.2 113.518 169.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 155.94 169.38 20.12 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 121.0 -0.619 . . . . 64.41 111.843 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -101.44 130.5 10.25 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.824 -0.703 . . . . 70.1 112.428 -178.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.743 HD11 ' HG3' ' A' ' 45' ' ' GLN . 6.3 mp -120.19 126.66 51.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.617 0.246 . . . . 71.52 110.492 176.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 25.1 ttmt -148.92 141.89 24.79 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.842 -0.429 . . . . 53.35 109.842 176.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -123.09 80.29 1.75 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.118 0.485 . . . . 70.54 110.833 176.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -141.85 116.17 9.51 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.117 -0.492 . . . . 72.13 110.237 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 13.5 t -100.97 -171.03 1.93 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.798 -0.637 . . . . 73.24 110.085 178.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.433 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.69 144.3 14.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 CA-C-O 121.128 0.489 . . . . 75.25 111.084 -176.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.436 HG21 ' HB3' ' A' ' 220' ' ' CYS . 15.2 t -73.04 166.97 22.06 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.817 -0.628 . . . . 74.11 110.874 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -143.17 131.54 22.16 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.096 -0.502 . . . . 71.01 110.293 -176.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -70.03 106.88 3.39 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.809 -0.441 . . . . 74.44 109.809 175.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 41.5 ttt180 -78.14 113.1 15.76 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.704 -0.48 . . . . 75.0 109.704 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 21.7 pttp -86.6 175.03 8.52 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.115 -0.493 . . . . 73.51 110.071 -179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 87.9 tttt . . . . . 0 C--O 1.247 0.959 0 CA-C-O 118.436 -0.792 . . . . 72.22 109.484 177.351 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.496 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.009 0 CA-C-O 120.895 0.378 . . . . 71.21 110.048 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 2.4 Cg_endo -83.17 138.47 8.92 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 122.855 2.37 . . . . 70.43 112.456 -178.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.7 ptt180 -143.22 97.63 3.12 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.615 -0.721 . . . . 75.41 109.571 174.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 p -123.54 134.19 67.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.317 -0.856 . . . . 62.53 109.753 -177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -132.07 137.14 47.65 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.459 -0.337 . . . . 73.54 110.64 -177.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.98 104.53 3.7 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 115.897 -0.592 . . . . 64.31 110.279 178.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -116.39 -58.41 2.09 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.736 -0.665 . . . . 74.14 109.871 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 65.84 147.01 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.255 0.972 . . . . 70.15 112.201 177.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.46 134.88 37.78 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.833 -0.621 . . . . 71.24 109.948 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -167.87 -179.53 40.55 Favored Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.777 -0.725 . . . . 50.2 111.967 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 38.7 mtt180 63.0 82.46 0.18 Allowed 'General case' 0 C--O 1.235 0.318 0 CA-C-O 121.398 0.618 . . . . 72.35 111.232 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -112.18 176.23 5.1 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.7 -0.682 . . . . 74.14 109.996 177.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 18.9 p -120.67 124.75 45.96 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.828 0.347 . . . . 62.31 111.264 -177.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 27.8 t -79.06 102.4 8.38 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.214 -0.448 . . . . 52.21 109.989 177.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.23 104.97 9.15 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.967 -0.56 . . . . 63.32 110.135 177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -139.09 152.35 47.44 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.332 -0.618 . . . . 75.42 109.332 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 17' ' ' ARG . 15.8 ptt180 -146.29 153.47 40.6 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.997 0.427 . . . . 64.14 110.604 174.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.0 m-70 -148.51 172.3 14.72 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.694 -0.685 . . . . 72.44 109.965 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -80.51 95.81 6.59 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.302 -0.629 . . . . 71.24 109.302 179.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -162.64 -71.75 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.295 -0.411 . . . . 73.53 111.189 -179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -138.38 143.85 39.99 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.932 -1.136 . . . . 60.13 107.932 -172.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 53.1 tt0 -168.26 -79.98 0.02 OUTLIER 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.699 -0.482 . . . . 72.34 109.699 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.518 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 31.2 t80 168.7 115.07 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 O-C-N 124.064 0.852 . . . . 53.34 110.737 -177.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -173.03 127.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.098 -0.501 . . . . 34.43 110.795 176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 79.5 t -49.8 129.19 7.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.249 0 CA-C-O 120.743 0.306 . . . . 61.53 110.548 176.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.83 0.01 56.41 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.056 -0.592 . . . . 74.35 112.198 -174.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -70.44 160.43 32.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.974 0.416 . . . . 71.01 110.932 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 2.8 mp -103.44 115.59 45.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.961 -0.563 . . . . 72.03 109.673 174.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.526 HG13 ' HB2' ' A' ' 37' ' ' TRP . 19.2 pt -96.68 122.73 48.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 CA-C-N 115.859 -0.609 . . . . 63.23 109.965 176.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 17.6 m -101.11 119.17 38.35 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.205 -0.452 . . . . 74.44 110.099 179.329 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.519 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.6 p-10 -90.03 -170.3 2.73 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.427 -0.351 . . . . 72.24 110.355 -177.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.4 mmt -69.68 -21.1 63.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.805 0.336 . . . . 73.11 111.222 -177.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.81 2.41 42.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.136 0.493 . . . . 44.23 109.96 174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 60.13 34.64 21.2 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.164 -0.925 . . . . 75.44 111.353 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' THR . 30.3 mmmt -92.83 150.43 20.62 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 116.019 -0.537 . . . . 71.21 109.932 175.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -100.87 96.2 7.12 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.875 -0.602 . . . . 74.44 110.66 -176.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HB2' HG13 ' A' ' 29' ' ' ILE . 25.6 m95 -98.92 138.72 35.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.723 -0.671 . . . . 63.31 109.637 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' HG2' ' HG2' ' A' ' 56' ' ' MET . 31.6 ttmt -106.46 119.28 38.85 Favored 'General case' 0 C--N 1.322 -0.607 0 C-N-CA 120.831 -0.347 . . . . 64.22 110.629 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.3 t -66.29 127.61 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.819 -0.628 . . . . 61.21 110.727 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.446 ' HA2' ' SD ' ' A' ' 56' ' ' MET . . . -113.96 -115.19 3.17 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.515 -0.85 . . . . 60.1 113.01 -178.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 49.5 tp -77.93 125.47 85.41 Favored Pre-proline 0 C--N 1.326 -0.436 0 CA-C-O 120.572 0.225 . . . . 71.3 111.504 -175.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 10.0 Cg_exo -72.47 120.03 6.48 Favored 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 122.854 2.37 . . . . 73.22 111.254 172.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.468 HG22 ' H ' ' A' ' 45' ' ' GLN . 63.1 mt -97.04 -53.46 8.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.117 0.484 . . . . 74.04 110.749 -177.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.502 ' O ' ' HA2' ' A' ' 49' ' ' GLY . . . 94.73 -25.19 24.55 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.822 -0.704 . . . . 74.21 112.617 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.634 HE22 ' HG ' ' A' ' 349' ' ' LEU . 49.5 tp60 -117.0 162.94 16.98 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.651 -0.5 . . . . 70.11 109.651 -177.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 118.23 -3.34 16.23 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 109.623 -1.391 . . . . 74.14 109.623 -172.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' HA3' ' HE2' ' A' ' 71' ' ' LYS . . . -176.49 -142.66 4.42 Favored Glycine 0 N--CA 1.438 -1.198 0 CA-C-N 114.296 -0.952 . . . . 72.11 110.976 178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.84 ' HZ ' ' HA3' ' A' ' 199' ' ' GLY . 92.4 m-85 -60.86 -46.95 88.56 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.62 0.247 . . . . 74.23 111.066 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.502 ' HA2' ' O ' ' A' ' 44' ' ' GLY . . . 156.36 164.72 13.7 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.765 -0.731 . . . . 55.54 111.691 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.0 m 61.83 39.17 14.13 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.014 0.435 . . . . 41.31 111.042 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 ' CD1' ' HG3' ' A' ' 71' ' ' LYS . 6.2 mm -88.68 132.01 34.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 109.809 -0.441 . . . . 72.23 109.809 -178.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -109.63 164.52 12.46 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.806 0.336 . . . . 75.34 111.06 -177.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.628 HD12 HH21 ' A' ' 133' ' ' ARG . 7.0 tt -83.09 128.89 34.89 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.957 -0.757 . . . . 51.22 108.957 172.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 55' ' ' ASP . . . -106.3 37.1 2.38 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 113.716 1.006 . . . . 73.23 113.716 -166.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.47 ' H ' HD23 ' A' ' 53' ' ' LEU . 50.6 t0 172.39 100.81 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 122.977 0.511 . . . . 63.45 109.965 169.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.447 ' HG2' ' HG2' ' A' ' 38' ' ' LYS . 21.5 ptm -107.39 19.94 19.6 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.146 -0.479 . . . . 74.34 110.107 177.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' CG ' ' H ' ' A' ' 58' ' ' SER . 8.2 t-20 -124.63 -165.16 1.34 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.72 -0.474 . . . . 63.13 109.72 -178.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 57' ' ' ASN . 22.8 t -107.99 89.99 3.16 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 120.985 0.422 . . . . 74.22 110.146 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 1.2 p -62.6 -29.21 70.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.402 0.62 . . . . 72.44 110.151 174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -169.04 -68.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.839 -1.073 . . . . 73.31 108.387 171.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.8 m -137.9 108.16 6.45 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.021 -0.99 . . . . 70.22 109.206 172.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.7 p -75.97 133.8 30.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.75 -0.463 . . . . 52.54 109.75 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -79.76 32.7 2.15 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.686 -0.768 . . . . 72.44 112.648 -178.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.3 m 55.48 35.55 25.32 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.017 0.437 . . . . 75.44 110.846 -179.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -153.45 -47.97 0.09 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.188 -0.46 . . . . 71.42 112.03 -169.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB3' HD11 ' A' ' 53' ' ' LEU . . . 67.31 83.17 0.19 Allowed Pre-proline 0 N--CA 1.463 0.182 0 O-C-N 124.158 0.911 . . . . 43.11 109.39 -170.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.417 ' HA ' ' CG ' ' A' ' 133' ' ' ARG . 89.7 Cg_endo -80.67 29.74 0.52 Allowed 'Trans proline' 0 N--CA 1.463 -0.305 0 C-N-CA 123.187 2.591 . . . . 53.14 113.003 -171.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.4 p -130.82 137.06 49.24 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.301 0.572 . . . . 74.22 111.081 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 31.1 m -133.39 143.85 37.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 N-CA-C 108.626 -0.879 . . . . 71.43 108.626 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 6.2 p -118.64 121.06 66.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 121.482 0.658 . . . . 71.3 111.947 -173.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.582 ' HD3' ' HD2' ' A' ' 48' ' ' PHE . 39.0 ttmt -89.36 126.11 35.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.216 -0.902 . . . . 72.5 109.09 176.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -126.24 133.04 69.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.159 0.504 . . . . 73.02 111.97 -175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.746 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 15.8 mt-10 -140.1 170.53 9.53 Favored Pre-proline 0 CA--C 1.533 0.317 0 N-CA-C 108.862 -0.792 . . . . 72.32 108.862 175.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.746 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 14.3 Cg_endo -57.13 156.43 24.78 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.402 2.068 . . . . 72.13 112.799 179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.552 ' HA ' ' HG3' ' A' ' 127' ' ' ARG . 15.5 t -84.37 34.04 0.51 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.091 0.472 . . . . 44.54 110.834 -178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 360' ' ' LYS . 0.3 OUTLIER -108.82 -83.67 0.55 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.179 -0.464 . . . . 62.45 111.165 -177.518 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -134.22 -89.96 0.36 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.89 -0.324 . . . . 73.41 111.19 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 57.51 -176.63 1.46 Allowed Glycine 0 CA--C 1.525 0.71 0 CA-C-N 116.101 -0.5 . . . . 74.22 113.552 -177.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.518 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 6.4 Cg_exo -74.82 -22.04 15.65 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 123.059 2.506 . . . . 73.24 111.249 169.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.523 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 1.7 tm? -51.94 -40.54 60.97 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 115.513 -0.767 . . . . 70.31 110.823 179.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -59.95 -38.87 83.71 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.787 0.327 . . . . 53.5 111.021 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 97.9 m -67.04 -41.62 86.24 Favored 'General case' 0 C--O 1.238 0.451 0 CA-C-O 121.07 0.462 . . . . 65.41 110.25 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' HG2' ' HB2' ' A' ' 198' ' ' TYR . 31.3 mt-10 -67.08 -38.07 85.08 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.217 -0.447 . . . . 74.24 110.832 176.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.7 tp -54.85 -41.7 71.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.008 0.432 . . . . 64.55 109.913 178.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -57.04 -54.08 50.78 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-N 115.556 -0.747 . . . . 55.12 110.897 173.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -64.49 -48.69 74.24 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.729 0.64 . . . . 62.53 112.729 -175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.506 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 3.8 m-85 -65.97 -34.26 77.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.611 0.244 . . . . 71.22 111.403 -175.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -76.55 -33.74 58.53 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.813 -0.355 . . . . 73.24 111.901 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HA ' ' HD2' ' A' ' 89' ' ' ARG . 13.6 tpt180 -97.44 -45.81 6.31 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.911 0.708 . . . . 75.3 112.911 -174.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -93.41 -0.97 56.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.855 0.687 . . . . 63.14 112.855 -169.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.554 ' HA ' HD11 ' A' ' 96' ' ' ILE . . . -104.36 -151.59 0.44 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 121.084 -0.246 . . . . 73.22 111.156 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.568 ' HG2' ' OE2' ' A' ' 94' ' ' GLU . 56.9 tttm 74.56 102.94 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.362 0 C-N-CA 123.689 0.796 . . . . 72.01 110.05 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 9.6 Cg_endo -50.26 -52.77 8.29 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 124.387 3.392 . . . . 60.43 115.567 -165.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.568 ' OE2' ' HG2' ' A' ' 92' ' ' LYS . 0.0 OUTLIER -72.01 -32.55 67.28 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.901 0.704 . . . . 74.41 112.901 -169.16 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -74.55 -30.11 61.62 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.029 -0.669 . . . . 71.23 110.333 175.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.554 HD11 ' HA ' ' A' ' 91' ' ' ALA . 72.6 mt -61.15 -53.03 54.59 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 109.344 -0.613 . . . . 64.12 109.344 172.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 -54.1 -34.73 60.98 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.486 -0.779 . . . . 72.14 110.497 176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -56.54 12.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.058 -0.519 . . . . 74.4 110.783 -178.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.473 ' HE1' HD12 ' A' ' 108' ' ' LEU . 1.8 p90 -70.11 -34.17 72.77 Favored 'General case' 0 N--CA 1.462 0.148 0 C-N-CA 119.949 -0.701 . . . . 74.32 111.249 -174.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.411 HD11 ' HB2' ' A' ' 108' ' ' LEU . 60.7 mt -64.45 -33.34 62.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.201 0.524 . . . . 41.22 109.694 176.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 42.7 ttt180 -71.03 -40.84 71.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.551 -0.75 . . . . 74.24 110.275 176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.7 m -67.85 -48.37 66.34 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 43.21 111.532 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -75.91 -23.5 55.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 75.14 111.173 -177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 50.8 tptt 68.92 64.52 0.3 Allowed 'General case' 0 CA--C 1.53 0.203 0 O-C-N 123.941 0.776 . . . . 65.11 110.039 -174.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.411 ' HB3' ' OD2' ' A' ' 163' ' ' ASP . 3.4 mm? -106.97 -163.09 0.88 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.163 -0.926 . . . . 64.2 109.625 176.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.505 ' HG2' HD21 ' A' ' 159' ' ' LEU . 50.8 tptt -121.74 -59.62 1.66 Allowed 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.472 0.545 . . . . 72.21 112.472 -174.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 14.5 t80 -159.07 98.38 1.45 Allowed 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 120.514 -0.475 . . . . 74.41 111.447 -168.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.511 HD22 ' HB ' ' A' ' 110' ' ' VAL . 1.5 tt -78.9 115.19 18.42 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.739 -0.837 . . . . 73.14 108.739 176.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.54 64.79 3.77 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.956 -0.64 . . . . 34.11 112.722 -179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.511 ' HB ' HD22 ' A' ' 108' ' ' LEU . 7.7 p -111.24 135.9 20.92 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.087 -0.338 . . . . 70.33 110.087 179.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.439 ' HD3' HG12 ' A' ' 196' ' ' VAL . 19.1 Cg_endo -60.12 140.07 90.58 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.854 2.369 . . . . 65.41 112.802 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.872 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 84.2 tttt -65.62 128.73 37.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.2 -0.455 . . . . 74.13 110.08 176.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.3 t80 -109.52 117.71 34.69 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.57 -0.741 . . . . 64.35 110.698 -174.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.504 ' CD1' HG22 ' A' ' 130' ' ' ILE . 38.5 m95 -89.86 -49.45 6.61 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.425 0.631 . . . . 75.44 109.554 176.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 178.32 -174.49 46.76 Favored Glycine 0 N--CA 1.439 -1.139 0 CA-C-N 114.901 -1.045 . . . . 71.41 111.881 -177.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.472 ' C ' ' HB2' ' A' ' 31' ' ' ASP . 93.1 p -168.37 150.51 5.2 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.847 -0.798 . . . . 54.14 108.847 -178.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.519 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -166.41 -162.41 17.83 Favored Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 120.086 -1.054 . . . . 72.43 113.067 -177.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.473 HD21 ' HB3' ' A' ' 125' ' ' SER . 7.3 tt -128.48 129.3 45.88 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.862 -0.422 . . . . 74.35 109.862 -176.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -129.59 123.86 32.36 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.153 -0.684 . . . . 64.24 109.153 176.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 7.3 t70 -89.11 138.07 31.75 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.27 -0.423 . . . . 73.01 110.177 -177.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.557 ' HD3' ' O ' ' A' ' 121' ' ' LYS . 13.2 tmtt? -90.94 28.9 1.46 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.7 0.762 . . . . 62.32 109.581 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 4.0 t30 62.27 70.43 0.57 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.944 -1.025 . . . . 72.01 110.058 -177.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.66 10.68 12.45 Favored Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.245 -0.889 . . . . 75.2 111.78 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.79 ' HA ' ' HE2' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -164.49 104.97 0.84 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.813 -0.44 . . . . 73.54 109.813 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.473 ' HB3' HD21 ' A' ' 118' ' ' LEU . 12.4 m -76.14 130.59 38.51 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.278 -0.419 . . . . 44.24 111.176 -178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -117.89 149.02 41.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 75.13 110.478 174.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.552 ' HG3' ' HA ' ' A' ' 75' ' ' SER . 94.1 mtt180 -113.11 133.17 55.14 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.475 -0.565 . . . . 51.2 109.475 176.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.596 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 54.4 p90 -126.7 143.39 51.25 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.272 -0.422 . . . . 64.23 110.895 -176.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.406 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 17.1 ptp -128.84 137.2 51.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.406 -0.361 . . . . 75.44 110.259 177.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.504 HG22 ' CD1' ' A' ' 114' ' ' TRP . 49.8 mt -103.97 121.4 55.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.013 -0.539 . . . . 73.2 111.794 -175.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 15.9 ptm -122.72 178.25 5.1 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.502 -0.772 . . . . 74.41 109.89 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.872 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.2 t70 -80.95 -178.15 6.74 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 120.72 0.295 . . . . 72.52 111.126 -174.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.628 HH21 HD12 ' A' ' 53' ' ' LEU . 5.8 mmt85 -83.79 83.83 7.78 Favored 'General case' 0 C--O 1.238 0.485 0 CA-C-O 121.412 0.625 . . . . 73.51 112.352 -173.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -103.69 170.56 7.86 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.907 -0.775 . . . . 71.54 108.907 174.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -179.63 -41.7 0.07 OUTLIER Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 119.347 -1.406 . . . . 65.22 113.544 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.796 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 18.4 m -71.23 122.85 20.95 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 117.011 0.406 . . . . 75.32 111.21 -175.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.61 ' HB2' ' HA2' ' A' ' 347' ' ' GLY . 0.3 OUTLIER -84.54 118.13 24.14 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-N 115.433 -0.803 . . . . 75.11 110.106 177.112 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 5.1 tt -64.24 -22.67 67.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.642 -0.873 . . . . 63.43 108.642 174.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.515 ' CG ' ' HD3' ' A' ' 350' ' ' LYS . 5.8 tp-100 -56.07 -48.6 75.76 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 114.752 -1.113 . . . . 74.44 110.977 175.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.59 ' CB ' ' HB2' ' A' ' 346' ' ' ASN . 59.6 mmtt -75.46 -27.97 59.08 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.184 -0.462 . . . . 73.33 111.531 -176.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.846 HD11 ' HA ' ' A' ' 345' ' ' GLU . 1.7 mp -61.5 -46.69 96.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 121.023 -0.271 . . . . 74.54 110.279 176.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.617 ' CD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -74.02 -32.99 63.6 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 120.385 -0.526 . . . . 74.2 110.301 -179.197 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -67.92 -33.67 75.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.833 0.349 . . . . 44.1 110.924 -178.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -83.94 -31.37 25.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.142 0.423 . . . . 53.02 112.142 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 66.9 t30 -104.24 13.82 31.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.953 0.406 . . . . 71.03 111.018 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.403 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 55.2 46.61 23.45 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.95 -0.568 . . . . 74.22 111.373 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.617 ' HB3' ' CD1' ' A' ' 142' ' ' TYR . 0.6 OUTLIER 42.09 38.79 1.17 Allowed 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.588 1.155 . . . . 73.0 113.17 177.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 52.4 ttt180 -94.71 96.85 9.67 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.964 0.411 . . . . 73.21 110.133 177.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 85.0 m-85 -113.5 147.74 37.34 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.147 -0.479 . . . . 72.33 110.44 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 154' ' ' VAL . 7.3 p -83.55 167.82 16.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.017 -0.538 . . . . 34.43 110.898 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.649 ' NH1' ' HB ' ' A' ' 331' ' ' ILE . 35.4 ttt180 -55.18 -46.18 75.81 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.922 -0.581 . . . . 73.12 111.23 -176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 333' ' ' SER . 86.2 mttt -58.2 -51.79 68.26 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.223 -0.444 . . . . 63.44 111.478 -179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 0.1 OUTLIER -56.28 -43.67 79.04 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.938 -0.574 . . . . 75.14 112.025 -178.52 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 150' ' ' SER . 53.0 t -64.11 -48.43 85.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.518 -0.31 . . . . 71.2 110.735 -177.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.606 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 2.7 mm? -58.43 -45.15 89.04 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.15 -0.477 . . . . 75.01 111.394 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.557 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 57.4 mm-40 -61.27 -44.84 96.57 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.349 -0.387 . . . . 61.33 111.494 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 88.4 mt -61.1 -49.11 78.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.381 -0.372 . . . . 72.52 110.622 178.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.1 p -62.52 -31.99 72.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 74.23 111.297 -179.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.505 HD21 ' HG2' ' A' ' 106' ' ' LYS . 59.4 tp -63.12 -46.77 85.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.823 0.344 . . . . 74.43 110.629 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.557 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 12.4 mmt85 -63.03 -44.73 95.12 Favored 'General case' 0 C--O 1.24 0.554 0 CA-C-O 121.893 0.854 . . . . 60.3 110.02 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.96 -33.88 66.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 114.578 -1.192 . . . . 62.52 110.815 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -60.7 -48.58 81.14 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.871 -0.418 . . . . 73.05 109.871 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.411 ' OD2' ' HB3' ' A' ' 105' ' ' LEU . 1.0 OUTLIER -55.32 -56.94 14.33 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.516 0.674 . . . . 72.31 110.459 179.718 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.595 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.3 tt -67.88 -37.13 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 CA-C-N 115.566 -0.743 . . . . 75.44 111.572 -176.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.543 ' HG ' ' HE2' ' A' ' 175' ' ' HIS . 8.8 tt -61.03 -39.4 89.62 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 110.293 -0.262 . . . . 71.51 110.293 -177.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -67.33 -54.02 24.43 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.363 -0.606 . . . . 71.15 109.363 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -56.05 -46.68 78.83 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 115.574 -0.739 . . . . 75.23 112.293 -176.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.595 HG12 ' O ' ' A' ' 164' ' ' ILE . 29.1 pt -80.77 -32.41 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.208 0.447 . . . . 74.32 112.208 -174.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.454 ' CE1' ' HA ' ' A' ' 240' ' ' ARG . 3.7 t60 -69.48 -34.76 74.81 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.373 -0.603 . . . . 64.23 109.373 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.02 -27.04 67.81 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.453 -0.794 . . . . 65.35 110.503 175.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -85.81 19.46 2.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.977 -0.556 . . . . 72.35 112.098 -178.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.492 ' HA ' ' HD2' ' A' ' 204' ' ' TYR . 44.5 mt-10 72.1 16.65 5.26 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 112.711 0.634 . . . . 75.41 112.711 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -121.4 144.65 48.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.253 0.549 . . . . 72.43 110.856 178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 202' ' ' TYR . 23.6 t -104.31 163.44 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.51 -0.768 . . . . 74.12 109.352 179.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.543 ' HE2' ' HG ' ' A' ' 165' ' ' LEU . 5.7 p80 -132.33 105.3 7.21 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 109.076 -0.713 . . . . 73.32 109.076 -178.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.438 ' HA3' ' OD2' ' A' ' 222' ' ' ASP . . . -63.76 -54.88 28.18 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.638 -0.71 . . . . 65.33 114.148 -171.25 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.418 ' HB2' HD22 ' A' ' 200' ' ' LEU . 24.4 t70 -80.6 90.13 5.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.605 0.717 . . . . 64.4 111.626 -174.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.54 HG22 ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -94.3 102.62 13.81 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.916 -1.512 . . . . 55.14 106.916 159.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.697 ' HG3' ' HE2' ' A' ' 227' ' ' PHE . 29.4 tttp -173.99 -137.04 0.01 OUTLIER 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.171 -1.418 . . . . 74.51 107.171 -170.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.417 ' H ' ' CG ' ' A' ' 179' ' ' LYS . . . -120.9 1.24 10.42 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 116.479 -0.328 . . . . 23.21 110.636 177.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.468 ' O ' HD22 ' A' ' 349' ' ' LEU . 0.7 OUTLIER -77.69 -28.02 50.93 Favored 'General case' 0 C--O 1.226 -0.142 0 N-CA-C 111.959 0.355 . . . . 73.4 111.959 -171.543 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 182' ' ' ASN . 5.6 m120 -108.55 11.06 26.99 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.722 0.296 . . . . 64.14 111.172 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 179' ' ' LYS . 8.3 mp -102.61 109.46 21.08 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.369 -0.532 . . . . 72.23 109.986 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.633 HD21 HD21 ' A' ' 349' ' ' LEU . 3.8 mm? -117.79 128.57 54.99 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.353 -0.839 . . . . 71.02 109.821 -178.395 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.796 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 80.6 mt -81.43 146.85 30.06 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.771 -0.649 . . . . 74.23 110.269 178.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -65.27 121.01 13.81 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.476 -1.676 . . . . 73.4 106.476 165.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -64.18 -14.34 54.6 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.761 -0.376 . . . . 53.24 111.728 -167.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 81.9 mttt -87.22 -53.71 4.7 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.842 0.353 . . . . 74.41 110.814 179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.472 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 3.1 m-20 -108.48 114.45 59.09 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 116.215 -0.448 . . . . 72.41 110.918 -176.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 6.8 Cg_exo -73.11 -12.45 25.72 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 123.241 2.627 . . . . 74.3 112.398 -177.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.956 ' HA ' ' HB2' ' A' ' 339' ' ' LEU . 8.2 p-10 -86.55 4.56 39.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.098 -0.501 . . . . 63.31 110.837 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HB3' ' CE1' ' A' ' 194' ' ' TYR . 80.0 mt-30 -123.45 96.77 5.11 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.925 -0.58 . . . . 73.51 110.995 -179.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.7 p -103.2 130.69 53.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.666 -0.697 . . . . 71.52 109.676 176.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.408 ' CE1' ' HB3' ' A' ' 192' ' ' GLN . 89.0 m-85 -120.17 142.23 49.16 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.084 -0.507 . . . . 61.12 110.709 -177.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.445 HD23 HD13 ' A' ' 164' ' ' ILE . 34.2 tp -88.15 99.27 12.07 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.245 -1.02 . . . . 74.23 108.245 175.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.467 HG22 HD23 ' A' ' 184' ' ' LEU . 15.3 m -120.61 -178.2 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 116.345 -0.389 . . . . 73.02 110.212 -174.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.419 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . 2.6 t70 60.16 71.16 0.58 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.787 0.804 . . . . 75.12 108.979 -176.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.548 ' HB2' ' HG2' ' A' ' 83' ' ' GLU . 70.5 m-85 -81.47 34.04 0.37 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.083 -0.962 . . . . 73.33 111.556 -172.138 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.84 ' HA3' ' HZ ' ' A' ' 48' ' ' PHE . . . -77.25 -3.4 81.91 Favored Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.556 -0.831 . . . . 72.44 112.348 -179.144 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.905 HD11 ' HA ' ' A' ' 352' ' ' LYS . 5.4 mp -114.75 34.37 4.83 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.701 0.286 . . . . 73.15 111.376 -176.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -88.08 125.86 34.79 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.866 0.365 . . . . 51.13 110.438 176.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.708 ' HD1' HD11 ' A' ' 354' ' ' ILE . 36.2 t80 -108.35 174.77 5.73 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.077 -0.51 . . . . 73.14 109.913 -178.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 34.1 ptt180 -89.07 135.61 33.47 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 122.59 0.356 . . . . 72.34 111.173 -177.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.492 ' HD2' ' HA ' ' A' ' 172' ' ' GLU . 8.5 t80 -96.98 -60.34 1.61 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.75 0.309 . . . . 72.15 110.416 173.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.55 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 8.4 p -138.04 142.56 36.24 Favored Pre-proline 0 C--N 1.323 -0.544 0 CA-C-N 116.647 -0.251 . . . . 74.35 110.881 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 3.1 Cg_exo -75.53 74.83 4.13 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 123.197 2.598 . . . . 54.44 112.203 178.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 63.94 86.66 0.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.573 -0.739 . . . . 53.44 111.921 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 83.07 -53.89 4.91 Favored Glycine 0 N--CA 1.451 -0.323 0 CA-C-N 115.891 -0.595 . . . . 72.41 113.775 173.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.55 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 14.5 m -73.02 111.07 6.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.304 0.573 . . . . 64.13 110.936 -175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.511 ' HA ' ' HB3' ' A' ' 205' ' ' CYS . 20.0 m80 -74.59 110.23 8.71 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.84 -0.618 . . . . 71.11 109.964 -178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.48 ' HD3' ' N ' ' A' ' 212' ' ' GLU . 8.1 tmtm? -97.92 130.89 44.77 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.872 -0.788 . . . . 75.11 108.872 178.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.48 ' N ' ' HD3' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -84.19 -98.26 0.06 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.387 -0.37 . . . . 71.43 111.57 -176.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.524 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 20.4 p90 -91.97 91.61 7.93 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.808 0.813 . . . . 75.24 112.121 -175.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.85 -39.74 21.22 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.239 -0.892 . . . . 72.43 108.938 173.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 68.07 179.34 0.23 Allowed 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 114.975 -1.012 . . . . 72.12 111.905 176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.513 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 12.0 t70 -147.94 127.86 6.62 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.1 -0.5 . . . . 64.14 110.134 -176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.513 ' HD3' ' HA ' ' A' ' 216' ' ' ASP . 21.9 Cg_exo -66.3 -22.7 52.7 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 123.172 2.581 . . . . 75.15 113.384 -176.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.431 ' C ' ' HD2' ' A' ' 219' ' ' ARG . 22.1 pttm -124.98 17.83 8.5 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.877 0.325 . . . . 75.13 111.877 -175.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.431 ' HD2' ' C ' ' A' ' 218' ' ' LYS . 1.0 OUTLIER 66.5 124.33 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 123.769 0.828 . . . . 73.34 111.847 177.076 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.542 ' CB ' ' HA2' ' A' ' 235' ' ' GLY . 36.6 t -72.5 -58.7 3.17 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.321 -0.4 . . . . 74.22 110.255 178.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 27.2 p80 44.66 40.98 4.51 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.053 0.941 . . . . 75.14 112.592 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.438 ' OD2' ' HA3' ' A' ' 176' ' ' GLY . 5.1 p-10 -67.27 -31.17 71.32 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.966 -0.561 . . . . 73.1 111.083 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.51 170.32 40.4 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.782 -0.723 . . . . 52.23 111.725 175.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.476 ' O ' HG23 ' A' ' 228' ' ' THR . 53.1 p -70.49 141.96 51.93 Favored 'General case' 0 C--O 1.236 0.38 0 CA-C-N 117.093 0.446 . . . . 71.33 111.5 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.529 ' HB ' HD11 ' A' ' 265' ' ' LEU . 73.3 mt -55.49 -34.11 33.98 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 CA-C-N 115.769 -0.65 . . . . 63.25 112.406 -174.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.798 ' HG3' ' HG ' ' A' ' 265' ' ' LEU . 3.0 mp0 -52.69 -39.43 61.97 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.002 0.43 . . . . 72.45 110.366 179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.828 ' HB3' HG23 ' A' ' 246' ' ' ILE . 70.9 m-85 -105.06 -93.0 0.36 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.206 -0.452 . . . . 64.31 110.404 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.476 HG23 ' O ' ' A' ' 224' ' ' THR . 7.5 p 58.03 -33.29 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.049 1.5 . . . . 63.44 115.049 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.445 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 47.6 t 64.44 -175.84 0.17 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.851 -0.796 . . . . 44.12 108.851 -172.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.417 ' N ' HD12 ' A' ' 230' ' ' ILE . 2.9 mp -71.2 -37.94 68.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.2 -0.667 . . . . 71.13 109.2 175.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.75 -73.2 0.08 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.691 -1.141 . . . . 63.34 112.104 -175.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.61 -29.65 70.26 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.372 -0.376 . . . . 75.24 111.783 -173.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.458 ' HE1' HG23 ' A' ' 225' ' ' ILE . 8.1 t60 -66.21 -37.46 85.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.571 -0.286 . . . . 75.55 110.297 -178.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -77.92 -38.33 45.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.003 -0.544 . . . . 74.45 110.513 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 220' ' ' CYS . . . 114.55 9.26 14.94 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.761 -0.733 . . . . 71.43 112.109 -176.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 6.2 p -89.35 137.71 20.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 N-CA-C 109.737 -0.468 . . . . 61.54 109.737 178.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -57.64 117.92 22.15 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.986 -0.552 . . . . 74.41 111.203 -179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HB3' ' HA3' ' A' ' 242' ' ' GLY . 23.5 Cg_exo -65.24 101.91 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.681 2.254 . . . . 62.53 111.42 176.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.418 ' HA ' ' CD1' ' A' ' 204' ' ' TYR . 3.1 p -77.68 -20.58 53.45 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.88 -0.6 . . . . 72.32 110.657 -176.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.781 ' HD2' ' HG3' ' A' ' 315' ' ' PRO . 0.0 OUTLIER 178.3 -32.58 0.01 OUTLIER 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 115.18 -0.918 . . . . 51.54 108.823 173.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.974 ' HD3' ' HD1' ' A' ' 311' ' ' TYR . 5.7 mtp85 -59.5 -60.96 3.01 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.183 -0.917 . . . . 72.42 111.404 -177.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.606 ' HA3' ' HB3' ' A' ' 238' ' ' PRO . . . -43.36 -65.97 1.34 Allowed Glycine 0 N--CA 1.451 -0.304 0 O-C-N 124.065 0.853 . . . . 54.33 114.203 -177.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 20.2 p-10 -72.11 -30.54 65.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.339 0.57 . . . . 63.32 111.624 -169.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.49 ' HB3' HH21 ' A' ' 240' ' ' ARG . 17.6 tp -75.29 -35.78 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.887 0.375 . . . . 61.41 110.921 178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -78.09 -37.55 46.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.492 -0.322 . . . . 62.1 110.401 -179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.828 HG23 ' HB3' ' A' ' 227' ' ' PHE . 87.4 mt -60.93 -38.29 78.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 109.743 -0.465 . . . . 73.55 109.743 174.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.526 ' HA ' HG21 ' A' ' 178' ' ' ILE . 51.8 tp -59.4 -47.35 85.8 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.201 -0.454 . . . . 74.32 110.365 175.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -57.39 -44.94 93.39 Favored Glycine 0 C--O 1.237 0.283 0 C-N-CA 120.978 -0.629 . . . . 44.01 112.233 176.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.537 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 12.7 m-85 -57.09 -44.08 82.83 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-O 120.572 0.225 . . . . 72.13 111.142 177.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.54 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.6 m -67.19 -38.1 84.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.622 -0.263 . . . . 73.23 111.36 -177.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.463 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 84.3 mtp -60.4 -49.64 76.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.57 -0.286 . . . . 63.54 110.924 -178.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.636 ' HB ' HG21 ' A' ' 299' ' ' ILE . 12.3 tt -70.32 -31.43 46.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.946 0.403 . . . . 74.24 110.305 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.543 ' OE1' ' HG3' ' A' ' 147' ' ' LYS . 0.5 OUTLIER -61.02 -46.16 91.87 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.934 -0.576 . . . . 63.03 110.181 179.189 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 15.3 m0 -71.7 -35.3 70.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.214 -0.448 . . . . 74.14 111.369 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.4 tp -76.42 -30.87 57.61 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 111.984 0.364 . . . . 74.33 111.984 -173.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.534 HG21 ' HB3' ' A' ' 289' ' ' CYS . 73.6 p -103.36 -27.59 12.35 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.83 0.348 . . . . 71.01 111.378 -176.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HE3' ' A' ' 147' ' ' LYS . . . 83.66 0.25 89.82 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.769 -0.729 . . . . 70.01 113.238 176.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 31.6 p-80 -157.07 144.04 18.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.369 0.584 . . . . 71.23 111.425 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.564 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 92.2 mt -129.74 139.55 35.99 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.568 . . . . 75.24 109.567 172.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 38.8 Cg_exo -58.22 -24.27 66.3 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 123.115 2.543 . . . . 70.21 113.752 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.771 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 25.1 p90 -98.91 -17.73 18.22 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.406 0.521 . . . . 75.41 112.406 -174.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.564 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 1.5 pp20? -86.16 -14.66 43.41 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.336 -0.546 . . . . 71.53 110.68 -177.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -62.86 -45.85 90.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.881 -0.599 . . . . 61.34 109.571 171.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -108.39 29.05 7.72 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.367 -0.833 . . . . 75.5 109.737 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.798 ' HG ' ' HG3' ' A' ' 226' ' ' GLU . 2.5 tm? -47.7 -34.24 7.96 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 123.855 0.862 . . . . 53.31 112.525 -174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.3 ptmt -66.44 -12.25 56.22 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.013 0.375 . . . . 50.52 112.013 -177.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -113.6 110.5 49.82 Favored Pre-proline 0 C--N 1.327 -0.397 0 N-CA-C 109.665 -0.494 . . . . 73.14 109.665 177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.509 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 32.0 Cg_endo -63.04 -24.44 73.7 Favored 'Trans proline' 0 CA--C 1.529 0.237 0 C-N-CA 123.194 2.596 . . . . 72.25 113.999 -171.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 10.6 mptt -63.13 -49.98 72.24 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.791 0.329 . . . . 75.51 110.792 -176.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -63.18 -36.82 84.91 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.03 -0.532 . . . . 73.33 110.285 178.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.771 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 69.7 t -62.35 -45.21 99.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.626 -0.715 . . . . 73.44 111.136 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.509 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 79.9 mtp180 -64.78 -54.87 24.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 73.12 111.394 -176.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -61.31 -41.44 97.01 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.709 0.29 . . . . 71.21 111.692 -175.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.531 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 27.7 m -62.91 -40.28 97.12 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.477 -0.329 . . . . 72.02 110.796 179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 46.2 mttp -65.17 -42.78 93.36 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.575 -0.284 . . . . 74.34 111.129 178.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.7 mt -61.43 -46.21 97.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.327 -0.397 . . . . 71.23 110.393 178.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.3 mtm180 -64.12 -34.82 78.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.379 -0.373 . . . . 75.23 111.514 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.462 ' O ' HG22 ' A' ' 282' ' ' ILE . 5.1 m-85 -72.16 -32.31 66.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.707 -0.224 . . . . 74.51 111.597 179.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 25.6 ttp180 -77.92 -34.07 51.47 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.116 0.484 . . . . 74.03 110.538 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -87.51 -42.63 12.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.969 -0.56 . . . . 74.31 112.032 -175.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.447 ' O ' HD23 ' A' ' 285' ' ' LEU . 10.9 t-20 -124.86 81.34 1.95 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.336 0.589 . . . . 74.13 110.481 -177.071 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.615 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -74.38 -34.09 35.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 75.31 112.54 -174.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -65.44 -48.85 71.29 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.391 0.515 . . . . 54.43 112.391 -170.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 7.2 m -70.27 -48.84 54.97 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.863 0.363 . . . . 53.44 110.972 -175.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.447 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.1 mm? -63.12 -50.59 69.86 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.078 -0.51 . . . . 74.12 111.364 -176.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.635 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.3 OUTLIER -60.79 -40.76 93.84 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 111.897 0.332 . . . . 73.42 111.897 -177.547 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -64.73 -42.39 95.26 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.908 0.385 . . . . 74.54 111.115 178.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' A' ' 288' ' ' LYS . 43.3 mmtm -81.21 4.31 20.73 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.354 0.502 . . . . 74.24 112.354 -174.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.534 ' HB3' HG21 ' A' ' 256' ' ' THR . 80.2 m -83.32 -17.43 42.49 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.157 0.503 . . . . 51.31 109.904 173.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.4 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 0.9 OUTLIER -123.7 89.41 51.4 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 73.43 109.81 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_exo -79.88 3.03 7.93 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.323 2.682 . . . . 73.2 112.481 -177.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.4 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 6.1 mm-40 -99.71 174.21 6.33 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 108.893 -0.78 . . . . 65.53 108.893 -179.118 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -86.86 79.59 8.74 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-O 121.434 0.635 . . . . 71.03 111.304 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -159.92 157.02 28.21 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.004 -0.998 . . . . 73.54 108.601 176.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -105.07 117.49 58.45 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 112.227 0.455 . . . . 71.43 112.227 -173.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -95.51 38.57 0.14 Allowed 'Trans proline' 0 N--CA 1.455 -0.792 0 C-N-CA 123.297 2.664 . . . . 60.33 110.957 169.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -69.91 -36.92 74.3 Favored Glycine 0 N--CA 1.453 -0.226 0 CA-C-N 115.547 -0.751 . . . . 61.23 113.209 -171.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.535 ' HB3' HD23 ' A' ' 324' ' ' LEU . 1.5 mp0 -50.99 -52.72 39.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.965 0.412 . . . . 74.13 110.69 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.636 HG21 ' HB ' ' A' ' 252' ' ' ILE . 4.0 mp -70.76 -36.64 65.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.846 -0.616 . . . . 73.25 110.415 -176.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.95 -51.73 68.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.454 -0.339 . . . . 72.21 110.784 178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -71.05 -32.84 69.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.011 -0.541 . . . . 64.5 110.156 -178.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.568 ' CD1' HD22 ' A' ' 320' ' ' LEU . 68.0 t80 -56.66 -42.79 79.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.18 0.514 . . . . 75.31 110.2 174.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.635 ' HG3' ' HE2' ' A' ' 286' ' ' MET . 95.7 mmm -70.44 -40.86 73.5 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.57 -0.741 . . . . 63.33 110.603 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.671 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 46.6 mt-10 -53.06 -50.42 64.38 Favored 'General case' 0 CA--C 1.518 -0.26 0 N-CA-C 109.204 -0.665 . . . . 64.01 109.204 172.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 79.3 m -56.83 -50.49 72.24 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 114.659 -1.155 . . . . 73.2 112.087 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.497 HG22 ' HA ' ' A' ' 303' ' ' MET . 28.8 m -69.41 -26.55 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 112.391 0.515 . . . . 54.51 112.391 -174.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -90.92 -16.15 28.6 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.786 -0.366 . . . . 75.12 111.692 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.671 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 53.0 mt -68.37 -37.59 80.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.641 0.257 . . . . 74.34 110.592 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 1.3 pp -87.13 12.92 10.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.381 0.61 . . . . 42.12 110.19 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 26.5 t70 59.85 -93.82 0.04 OUTLIER 'General case' 0 C--O 1.235 0.296 0 CA-C-N 114.643 -1.162 . . . . 73.43 112.961 171.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.974 ' HD1' ' HD3' ' A' ' 241' ' ' ARG . 40.2 t80 -115.72 -58.56 2.1 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.86 0.319 . . . . 73.23 111.86 -170.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.1 p -133.73 10.07 3.96 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.1 0.407 . . . . 74.13 112.1 -171.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -84.0 60.9 6.13 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.387 0.514 . . . . 73.32 112.387 -169.026 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? 64.97 103.86 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.503 0 CA-C-N 115.389 -0.823 . . . . 74.42 113.189 172.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.781 ' HG3' ' HD2' ' A' ' 240' ' ' ARG . 4.4 Cg_exo -78.92 119.5 4.36 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.734 2.289 . . . . 63.21 111.303 174.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.59 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 94.1 mt -84.32 81.38 8.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.758 0.313 . . . . 65.13 110.987 -177.123 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -59.49 -36.42 75.98 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.07 -0.514 . . . . 64.3 111.366 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -61.45 -45.99 91.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.973 0.415 . . . . 63.35 110.498 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -66.05 -40.32 90.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 71.1 110.277 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 87.8 mt -58.19 -52.55 65.1 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.048 -0.524 . . . . 74.13 110.1 177.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.17 -40.33 77.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.798 -0.637 . . . . 73.15 110.805 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -63.65 -50.31 69.8 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 63.14 111.635 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -74.69 -31.97 27.92 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 111.679 0.252 . . . . 74.53 111.679 -174.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.535 HD23 ' HB3' ' A' ' 298' ' ' GLU . 93.0 mt -66.35 -48.63 69.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.896 0.379 . . . . 72.24 110.621 178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 94.1 mt -70.6 -27.11 63.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.297 -0.41 . . . . 72.32 110.919 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -61.38 -49.06 78.43 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.437 -0.579 . . . . 71.42 109.437 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.72 -40.18 93.83 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.656 -0.783 . . . . 62.4 112.108 178.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.606 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 3.1 tm? -59.08 -43.96 91.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.754 0.312 . . . . 62.43 110.517 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.707 ' HA ' ' O ' ' A' ' 333' ' ' SER . 30.1 ttpt -72.82 -30.01 63.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.906 0.384 . . . . 70.01 110.855 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.02 -29.03 69.47 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.075 -0.511 . . . . 73.45 112.071 -175.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.649 ' HB ' ' NH1' ' A' ' 151' ' ' ARG . 13.7 tt -83.34 -7.94 11.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.949 0.404 . . . . 62.32 111.013 -178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 112.19 -6.15 26.94 Favored Glycine 0 CA--C 1.518 0.259 0 C-N-CA 120.588 -0.815 . . . . 60.13 113.188 177.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.707 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 20.1 p -100.19 158.48 15.83 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 122.659 -0.318 . . . . 64.31 110.704 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -148.87 -68.36 0.22 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.294 -0.632 . . . . 72.31 109.294 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.534 ' CG ' ' H ' ' A' ' 336' ' ' ASP . 9.2 t70 56.43 -155.9 0.29 Allowed 'General case' 0 C--O 1.237 0.405 0 CA-C-N 115.722 -0.672 . . . . 65.4 111.402 172.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.534 ' H ' ' CG ' ' A' ' 335' ' ' ASP . 27.2 t70 -153.03 -36.7 0.11 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.22 -0.446 . . . . 65.33 110.855 -175.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.499 ' HA2' ' OE1' ' A' ' 156' ' ' GLN . . . 177.97 49.73 0.07 OUTLIER Glycine 0 CA--C 1.521 0.41 0 C-N-CA 119.969 -1.11 . . . . 45.3 114.082 -178.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -103.59 130.33 51.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 117.278 0.539 . . . . 74.13 111.556 177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.956 ' HB2' ' HA ' ' A' ' 191' ' ' ASP . 3.9 mm? -121.34 147.15 46.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 53.11 110.185 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -81.29 -75.6 0.28 Allowed 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.176 -0.675 . . . . 74.42 109.176 172.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.591 HD12 HD11 ' A' ' 185' ' ' LEU . 3.7 mm? 44.5 28.23 0.3 Allowed 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 114.918 -1.037 . . . . 74.32 113.613 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.1 p -104.22 15.84 27.49 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.508 0.67 . . . . 72.54 109.892 177.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.505 HG13 HG12 ' A' ' 344' ' ' VAL . 7.5 p -61.74 -42.21 93.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 CA-C-N 115.137 -0.938 . . . . 72.02 111.7 -178.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.505 HG12 HG13 ' A' ' 343' ' ' VAL . 7.5 p -162.72 -54.92 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 N-CA-C 112.874 0.694 . . . . 53.44 112.874 -179.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.846 ' HA ' HD11 ' A' ' 141' ' ' ILE . 45.8 mt-10 65.8 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.568 0.581 . . . . 62.22 112.568 -179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.59 ' HB2' ' CB ' ' A' ' 140' ' ' LYS . 20.5 m120 -131.75 -165.05 1.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.38 -0.97 . . . . 60.42 108.38 172.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.61 ' HA2' ' HB2' ' A' ' 137' ' ' ASP . . . -156.07 164.22 32.23 Favored Glycine 0 N--CA 1.453 -0.167 0 C-N-CA 120.28 -0.962 . . . . 73.52 112.47 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 164.83 -40.28 0.3 Allowed Glycine 0 CA--C 1.521 0.447 0 C-N-CA 120.652 -0.785 . . . . 61.22 113.565 175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.634 ' HG ' HE22 ' A' ' 45' ' ' GLN . 52.2 mt 63.12 95.56 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.449 0 CA-C-O 121.294 0.568 . . . . 70.21 111.08 -172.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.515 ' HD3' ' CG ' ' A' ' 139' ' ' GLN . 50.7 mtpt -83.0 -0.28 48.09 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.908 -0.587 . . . . 74.53 111.905 -176.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -158.27 121.45 3.87 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.902 -0.407 . . . . 70.24 109.902 178.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.905 ' HA ' HD11 ' A' ' 200' ' ' LEU . 33.1 pttt -161.85 87.9 0.68 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.829 0.347 . . . . 75.25 111.919 -178.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.508 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 10.8 t 166.85 135.16 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 115.291 -0.868 . . . . 73.33 109.602 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.882 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.0 OUTLIER -94.4 142.08 13.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 N-CA-C 109.546 -0.538 . . . . 73.44 109.546 175.548 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.514 ' N ' HD13 ' A' ' 354' ' ' ILE . 24.5 m -64.48 97.19 0.19 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.045 -0.525 . . . . 63.34 111.97 -177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.467 ' HE3' ' CG2' ' A' ' 354' ' ' ILE . 94.9 mttt -114.37 -85.15 0.6 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.441 0.638 . . . . 73.43 109.992 174.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 64.1 tttm 175.77 122.65 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.316 -1.365 . . . . 63.13 107.316 -175.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.428 HH11 ' HD3' ' A' ' 358' ' ' ARG . 19.8 ptt-85 -66.49 146.87 54.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.194 0.521 . . . . 73.2 111.869 -171.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.562 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -160.15 -90.63 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 108.27 -1.011 . . . . 63.43 108.27 178.43 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 359' ' ' LYS . 34.1 ttmt . . . . . 0 C--O 1.246 0.903 0 N-CA-C 107.195 -1.409 . . . . 75.22 107.195 -177.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpt? . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 110.604 -0.147 . . . . 73.11 110.604 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.47 154.43 59.28 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.795 2.33 . . . . 73.14 111.766 176.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 16.6 ttm180 -153.25 125.61 8.09 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.01 -0.367 . . . . 72.11 110.01 -176.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.1 p -159.11 135.49 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 120.876 0.369 . . . . 41.4 111.052 -175.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 5' ' ' LYS . 58.0 pttt -137.33 94.3 2.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.622 0.725 . . . . 63.42 110.138 175.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -123.95 85.23 2.38 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.962 -0.563 . . . . 71.42 109.958 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.93 140.46 39.71 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.631 -0.713 . . . . 71.41 110.125 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -109.54 149.81 29.09 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.98 0.419 . . . . 62.23 110.105 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.89 33.07 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.837 -0.62 . . . . 54.13 109.853 -179.522 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 100.23 105.49 2.72 Favored Glycine 0 N--CA 1.442 -0.945 0 C-N-CA 120.665 -0.779 . . . . 32.53 112.42 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.7 ttp180 -117.73 86.99 2.62 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.847 -0.797 . . . . 73.54 108.847 173.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -96.2 94.11 7.31 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.984 -0.553 . . . . 72.23 110.67 -173.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -108.94 122.94 48.29 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.491 -0.559 . . . . 72.44 109.491 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.1 p -88.12 124.48 33.84 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.431 -0.35 . . . . 73.13 111.178 -177.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.3 108.32 2.28 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.407 -0.59 . . . . 72.01 109.407 174.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 9.4 ptpp? -125.71 20.83 7.78 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.056 -0.52 . . . . 74.25 111.517 -170.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 70.2 ttt180 -68.98 88.7 0.4 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.323 0.582 . . . . 63.04 110.73 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.4 p-80 -124.79 -1.44 7.9 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.555 -0.748 . . . . 75.23 109.288 175.2 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.835 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.1 pt? -87.5 113.93 23.66 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.132 -0.94 . . . . 74.21 111.198 -174.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 21' ' ' GLU . . . -161.56 -84.65 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.131 -0.94 . . . . 64.32 109.608 175.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' ALA . 42.8 tt0 173.04 -74.48 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.254 0 O-C-N 123.657 0.598 . . . . 71.04 109.657 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -123.02 56.23 1.17 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.578 0.704 . . . . 74.24 109.519 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -79.63 -23.65 42.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.484 -0.78 . . . . 73.14 110.553 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -160.04 -53.11 0.05 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.635 -0.712 . . . . 61.43 109.687 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 7.7 p -65.36 142.81 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.358 -0.837 . . . . 71.4 110.242 174.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.24 -21.91 43.32 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.798 -0.715 . . . . 73.33 113.533 176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -68.67 160.76 29.59 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 117.704 0.752 . . . . 73.01 110.306 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 6.4 pt -116.76 129.67 72.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.468 0.651 . . . . 65.44 110.949 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.553 ' HB ' ' CZ ' ' A' ' 128' ' ' PHE . 33.1 pt -91.8 154.48 3.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.511 -0.768 . . . . 75.22 111.091 -176.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 35' ' ' LYS . 4.8 m -112.5 114.13 26.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.064 -0.516 . . . . 72.21 111.273 -176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.678 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 2.7 p-10 -112.05 -166.54 1.09 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.063 -0.517 . . . . 55.3 109.834 177.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.624 ' HG2' ' O ' ' A' ' 116' ' ' SER . 20.9 mmt -63.65 -22.55 66.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.337 -0.392 . . . . 74.52 111.46 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.52 4.8 19.95 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.776 0.322 . . . . 53.23 111.013 178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp 71.26 44.9 0.52 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.771 -0.649 . . . . 75.22 111.61 173.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HB2' HG23 ' A' ' 30' ' ' THR . 37.7 ttmt 72.97 113.72 0.06 Allowed 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 115.324 -0.853 . . . . 74.22 113.262 167.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -169.76 37.97 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.076 -0.511 . . . . 75.41 110.61 172.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.48 ' O ' ' HA ' ' A' ' 28' ' ' ILE . 11.3 m95 -134.01 126.12 29.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 110.117 -0.327 . . . . 70.41 110.117 -177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -105.58 124.9 50.32 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.682 0.277 . . . . 74.22 110.304 -178.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 94.1 t -66.97 126.14 25.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.893 -0.594 . . . . 44.22 110.928 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -108.02 -107.88 3.2 Favored Glycine 0 N--CA 1.442 -0.908 0 C-N-CA 120.766 -0.73 . . . . 55.15 112.306 177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.852 ' HB3' HD12 ' A' ' 53' ' ' LEU . 49.1 tp -86.67 123.94 70.09 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-O 120.727 0.299 . . . . 72.24 110.71 -177.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.632 ' HD2' HD12 ' A' ' 41' ' ' LEU . 58.2 Cg_endo -74.81 109.04 2.84 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 122.45 2.1 . . . . 71.13 111.837 174.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.4 ' HB ' ' HB ' ' A' ' 51' ' ' ILE . 36.9 mt -74.0 -53.46 17.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.34 0.59 . . . . 72.31 110.048 -179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 88.92 -29.51 5.88 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.65 -0.705 . . . . 73.32 112.575 -179.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 70.9 mt-30 -119.01 165.1 14.52 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.163 -0.31 . . . . 73.44 110.163 -175.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.13 51.82 1.43 Allowed Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.548 -0.834 . . . . 73.31 111.749 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 350' ' ' LYS . . . 145.67 -126.71 2.62 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.503 -0.856 . . . . 60.52 112.008 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -92.77 -33.69 14.19 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 120.9 0.381 . . . . 61.42 110.919 -173.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.443 ' H ' HD11 ' A' ' 51' ' ' ILE . . . 141.13 160.68 8.39 Favored Glycine 0 N--CA 1.449 -0.442 0 N-CA-C 111.369 -0.692 . . . . 71.14 111.369 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 19.8 t 53.53 53.81 11.01 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 121.273 0.558 . . . . 52.0 110.652 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.443 HD11 ' H ' ' A' ' 49' ' ' GLY . 5.3 mm -89.07 137.81 20.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.984 -0.553 . . . . 64.33 110.273 -177.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.492 ' HB2' HG13 ' A' ' 70' ' ' VAL . 84.5 m-85 -121.22 148.54 44.13 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 64.32 111.193 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.852 HD12 ' HB3' ' A' ' 41' ' ' LEU . 75.3 mt -87.4 140.72 29.24 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.049 -0.523 . . . . 75.34 109.837 171.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.29 37.84 4.03 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.374 0.607 . . . . 65.15 109.914 178.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.418 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 8.7 p-10 -98.22 9.12 43.7 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.489 -0.778 . . . . 73.45 111.249 -175.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 26.0 mmt -97.62 2.61 50.09 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.26 -0.427 . . . . 74.32 111.736 -175.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -89.38 87.78 7.23 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.158 -0.617 . . . . 73.31 110.029 177.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 5.6 t -104.1 79.77 1.65 Allowed 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.727 -0.842 . . . . 72.01 108.727 176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 13.9 m -66.02 -56.28 12.39 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.613 -0.721 . . . . 62.15 110.756 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -142.86 -64.16 0.41 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.892 -0.41 . . . . 73.11 109.892 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.1 p -140.81 90.95 2.37 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.219 0.533 . . . . 53.25 111.263 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.574 HG21 ' HB2' ' A' ' 66' ' ' ALA . 8.1 p -81.7 144.46 10.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.156 -0.475 . . . . 64.11 109.804 176.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.84 -104.27 0.12 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.981 -0.628 . . . . 73.31 113.378 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.1 p -81.17 62.69 5.22 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 112.815 0.672 . . . . 75.3 112.815 -171.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 66.13 16.71 10.55 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 116.531 -0.304 . . . . 53.05 111.729 173.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.574 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . 63.58 88.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.234 0 O-C-N 123.697 0.623 . . . . 71.14 110.557 -173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.574 ' HB3' ' OH ' ' A' ' 187' ' ' TYR . 93.3 Cg_endo -80.81 36.95 0.65 Allowed 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 123.089 2.526 . . . . 72.13 113.14 -174.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 61.6 m -117.86 136.15 53.63 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.62 0.724 . . . . 53.33 111.849 -175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG12 HD23 ' A' ' 53' ' ' LEU . 35.4 m -136.2 148.91 27.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 114.996 -1.002 . . . . 75.12 108.746 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.57 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.4 p -123.73 120.66 60.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.291 0.567 . . . . 54.34 111.028 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.405 ' CB ' HD12 ' A' ' 51' ' ' ILE . 25.3 pttm -105.58 134.44 48.7 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.234 -0.654 . . . . 74.42 109.234 176.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.51 ' CG1' ' HB3' ' A' ' 126' ' ' TYR . 15.9 t -120.51 148.94 23.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.711 -0.677 . . . . 63.14 112.054 -165.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.431 ' HG3' ' HB2' ' A' ' 80' ' ' LEU . 18.1 mm-40 -137.8 141.16 31.88 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.623 -0.717 . . . . 70.43 109.422 173.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.65 134.64 58.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.456 2.104 . . . . 72.34 111.633 177.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.9 t -73.41 88.46 1.59 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.185 0.517 . . . . 63.03 111.1 -176.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -139.15 -68.34 0.44 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.585 -0.894 . . . . 72.15 108.585 173.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.465 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 5.3 p30 -128.5 -75.42 0.56 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.558 -0.746 . . . . 72.21 109.032 172.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . 72.35 110.5 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.562 0 N-CA-C 114.058 0.383 . . . . 73.03 114.058 170.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA2' ' A' ' 78' ' ' GLY . 12.0 Cg_endo -55.77 -22.35 36.57 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 122.858 2.372 . . . . 60.52 111.398 170.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.431 ' HB2' ' HG3' ' A' ' 73' ' ' GLU . 57.9 tp -59.85 -30.1 68.74 Favored 'General case' 0 C--O 1.225 -0.208 0 CA-C-N 115.454 -0.793 . . . . 64.43 110.559 175.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -71.35 -38.93 71.59 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.933 -0.395 . . . . 73.14 109.933 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 12.6 m -60.95 -46.96 88.6 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.426 0.632 . . . . 64.32 109.522 174.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.773 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 34.6 tt0 -63.14 -37.98 89.35 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.348 -0.842 . . . . 52.55 110.64 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.4 -45.3 88.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.486 -0.324 . . . . 60.34 110.681 -179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 68.8 mmtt -59.82 -50.97 71.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.211 -0.449 . . . . 75.43 110.852 178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.461 ' CE1' HG22 ' A' ' 168' ' ' ILE . 92.7 t80 -62.63 -40.1 95.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.002 -0.545 . . . . 64.41 110.95 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 2.8 t80 -62.3 -45.14 94.58 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.309 -0.859 . . . . 72.33 111.052 -175.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.02 -29.68 63.2 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.678 0.275 . . . . 72.11 111.323 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.405 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 7.6 tpm_? -69.2 -27.84 65.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.829 0.347 . . . . 73.0 110.813 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -103.75 10.83 36.47 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.115 -0.493 . . . . 71.12 110.912 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.89 173.78 11.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.354 -0.384 . . . . 71.01 111.74 -176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.799 ' HB3' HE21 ' A' ' 95' ' ' GLN . 36.7 ttmt 70.83 98.22 0.04 OUTLIER Pre-proline 0 N--CA 1.465 0.284 0 CA-C-N 115.129 -0.941 . . . . 71.22 110.321 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -55.92 -31.51 81.9 Favored 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.693 2.928 . . . . 72.32 113.741 -173.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.747 ' HG2' ' HE3' ' A' ' 98' ' ' LYS . 43.6 tt0 -60.86 -46.8 89.15 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 121.219 -0.193 . . . . 74.34 110.787 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.799 HE21 ' HB3' ' A' ' 92' ' ' LYS . 45.2 mt-30 -58.77 -44.1 90.54 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.884 0.373 . . . . 72.04 110.055 179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.481 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.1 mt -56.32 -52.72 48.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.484 -0.78 . . . . 72.21 110.224 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 23.9 tp60 -58.16 -36.83 73.58 Favored 'General case' 0 C--O 1.239 0.505 0 CA-C-N 116.099 -0.501 . . . . 75.1 110.96 -179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.747 ' HE3' ' HG2' ' A' ' 94' ' ' GLU . 97.4 mttt -60.44 -58.44 8.48 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 116.044 -0.525 . . . . 72.23 111.177 178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.683 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.2 p90 -72.44 -34.23 67.65 Favored 'General case' 0 C--O 1.22 -0.484 0 C-N-CA 120.155 -0.618 . . . . 72.12 110.788 -174.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 96' ' ' ILE . 22.4 mm -55.28 -49.12 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 CA-C-O 120.548 0.213 . . . . 61.3 110.731 178.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 33.4 ttm180 -65.83 -44.89 84.23 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.731 0.301 . . . . 73.44 111.135 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 11.5 m -71.13 -23.97 62.19 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.128 0.49 . . . . 72.13 111.575 -176.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.607 HH22 ' HB2' ' A' ' 170' ' ' GLU . 20.6 ttt180 -96.24 -1.84 47.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.196 -0.456 . . . . 73.41 110.457 -176.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.95 35.68 8.09 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 115.76 -0.654 . . . . 71.15 111.325 177.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.532 HD11 ' HD3' ' A' ' 103' ' ' ARG . 81.2 mt -94.97 -165.51 1.31 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.048 -0.524 . . . . 73.02 109.956 178.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.596 ' HG3' HD21 ' A' ' 159' ' ' LEU . 3.2 mmmp? -108.87 -61.79 1.56 Allowed 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.751 -0.463 . . . . 71.21 109.751 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 32.4 p90 178.62 144.26 0.13 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.603 -0.726 . . . . 73.33 109.618 175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.683 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 22.5 tp -79.34 125.49 29.58 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.673 -0.694 . . . . 63.32 110.805 -172.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.45 59.71 4.9 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.105 -0.569 . . . . 40.42 112.2 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 11.8 p -113.48 134.41 21.97 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 109.716 -0.475 . . . . 64.01 109.716 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.729 ' HB3' ' HZ ' ' A' ' 134' ' ' PHE . 17.1 Cg_endo -59.8 142.55 98.85 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.302 2.001 . . . . 72.41 112.057 177.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -63.72 147.83 50.68 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.662 -0.699 . . . . 74.21 111.303 -176.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -117.05 128.98 55.7 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.913 -0.585 . . . . 72.24 110.742 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.59 ' HB2' HG22 ' A' ' 130' ' ' ILE . 70.3 m95 -103.33 -59.7 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.304 0.573 . . . . 73.34 109.665 174.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -167.17 175.52 42.3 Favored Glycine 0 N--CA 1.441 -1.032 0 CA-C-N 115.507 -0.77 . . . . 74.32 112.564 -178.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.624 ' O ' ' HG2' ' A' ' 32' ' ' MET . 18.7 p -150.49 155.93 40.45 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.442 -0.947 . . . . 75.31 108.442 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.678 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -172.56 -160.01 20.25 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 119.201 -1.476 . . . . 72.53 113.799 -177.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 27.8 tp -136.92 136.21 38.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.058 -0.571 . . . . 74.15 110.02 -175.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.583 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 3.7 t-160 -139.77 121.91 15.81 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.212 -0.662 . . . . 65.2 109.212 175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 22.3 t70 -88.49 130.83 35.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.233 -0.44 . . . . 71.42 109.905 -177.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 34.7 tptt -87.34 -72.02 0.54 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.919 0.39 . . . . 71.4 110.667 -176.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -135.75 33.4 2.95 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.817 -0.629 . . . . 74.41 110.184 -179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 110.1 -23.1 21.89 Favored Glycine 0 N--CA 1.449 -0.471 0 N-CA-C 110.477 -1.049 . . . . 52.11 110.477 -171.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.412 ' HD2' ' N ' ' A' ' 124' ' ' LYS . 12.7 mptt -87.45 104.44 16.46 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.77 -0.826 . . . . 64.15 108.77 172.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.499 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.1 m -77.52 129.07 35.2 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.829 -0.623 . . . . 62.11 110.468 -178.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.51 ' HB3' ' CG1' ' A' ' 72' ' ' VAL . 47.8 m-85 -107.89 124.1 49.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.084 -0.507 . . . . 65.22 111.106 -179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.2 ttm180 -100.29 131.28 46.31 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.037 -0.727 . . . . 74.42 109.037 176.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 17.5 p90 -144.52 164.7 30.11 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.39 -0.368 . . . . 72.3 111.467 -169.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.418 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 16.7 ptp -135.63 143.43 45.53 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.958 -0.565 . . . . 64.31 110.972 174.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.59 HG22 ' HB2' ' A' ' 114' ' ' TRP . 6.0 mm -97.48 121.34 47.9 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 CA-C-N 115.279 -0.873 . . . . 75.04 110.027 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 18.9 ptm -133.56 176.46 8.52 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.461 -0.791 . . . . 71.34 109.871 -178.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.533 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 0.3 OUTLIER -72.47 145.83 47.29 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.264 0.554 . . . . 74.3 111.757 -178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.449 ' HD3' HG11 ' A' ' 69' ' ' VAL . 16.6 tpt180 -71.37 129.35 38.6 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.221 -0.9 . . . . 73.12 111.385 -179.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.729 ' HZ ' ' HB3' ' A' ' 111' ' ' PRO . 50.0 m-85 -103.76 142.53 34.2 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.246 -0.65 . . . . 75.42 109.246 173.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -121.37 -16.14 4.36 Favored Glycine 0 CA--C 1.509 -0.334 0 C-N-CA 120.432 -0.89 . . . . 64.31 111.754 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.861 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 61.4 m -121.71 125.88 47.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.609 0.243 . . . . 73.25 110.421 178.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -108.01 138.11 44.84 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.454 -0.573 . . . . 71.44 109.454 175.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.736 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.4 tp -71.85 -17.38 62.14 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 110.232 -0.284 . . . . 75.31 110.232 -176.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.886 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 52.4 tt0 -68.85 -51.15 43.54 Favored 'General case' 0 C--O 1.234 0.239 0 N-CA-C 112.152 0.427 . . . . 64.14 112.152 -177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.429 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.5 tptt -79.56 -35.31 40.02 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.255 -0.578 . . . . 74.21 110.436 -178.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 70.1 mt -66.16 -43.2 92.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.167 -0.47 . . . . 73.21 111.265 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.3 OUTLIER -65.38 -31.52 72.67 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 120.315 -0.554 . . . . 75.41 110.232 -178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 59.0 tt0 -67.01 -38.17 85.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.825 0.345 . . . . 62.15 110.424 175.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.04 -32.21 68.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.243 -0.435 . . . . 74.11 111.529 -178.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.403 ' OD1' HG21 ' A' ' 343' ' ' VAL . 14.6 m120 -99.06 4.6 47.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.424 -0.353 . . . . 75.52 111.136 -179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.3 33.98 21.85 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 116.055 -0.521 . . . . 70.35 110.967 -178.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.508 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 16.9 pttp 43.32 33.09 0.55 Allowed 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.485 1.114 . . . . 71.21 113.15 -178.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -110.58 95.92 5.86 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.53 -0.915 . . . . 73.22 108.53 173.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.508 ' CZ ' ' HA ' ' A' ' 147' ' ' LYS . 24.7 m-85 -112.32 157.12 21.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.612 -0.722 . . . . 74.2 110.949 -172.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.9 m -62.69 156.31 23.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.009 -0.541 . . . . 73.22 109.751 172.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 25.5 ttm-85 -55.72 -26.04 43.37 Favored 'General case' 0 N--CA 1.468 0.464 0 N-CA-C 111.822 0.305 . . . . 72.45 111.822 -174.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.463 ' HG2' ' OD2' ' A' ' 335' ' ' ASP . 57.1 mttm -52.65 -54.32 35.01 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.231 0.539 . . . . 70.33 111.004 178.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.555 ' HA ' HD22 ' A' ' 339' ' ' LEU . 1.9 m -65.16 -36.17 83.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.638 -0.71 . . . . 73.45 111.222 -174.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.29 -49.38 76.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.107 -0.497 . . . . 63.13 110.788 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.615 ' HG ' HD22 ' A' ' 328' ' ' LEU . 0.5 OUTLIER -68.5 -50.39 52.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.058 -0.519 . . . . 52.13 110.53 -176.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.564 ' HG3' ' H ' ' A' ' 337' ' ' GLY . 2.3 mp0 -61.61 -40.43 94.79 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 112.128 0.418 . . . . 73.12 112.128 -176.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.499 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.9 mp -63.96 -46.83 82.93 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 121.03 -0.268 . . . . 65.11 110.36 178.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.454 ' HA ' HD11 ' A' ' 247' ' ' LEU . 37.6 t -60.27 -46.65 89.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.167 -0.47 . . . . 75.12 110.865 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 106' ' ' LYS . 58.7 tp -55.62 -46.36 77.38 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.982 -0.554 . . . . 64.42 111.277 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.584 HH11 HG12 ' A' ' 193' ' ' VAL . 89.9 mtt180 -66.68 -34.03 76.96 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.313 -0.403 . . . . 74.31 111.294 -178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.499 HG12 ' O ' ' A' ' 157' ' ' LEU . 48.1 mm -68.89 -34.71 65.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.405 -0.361 . . . . 63.3 110.291 177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.477 HD11 HD12 ' A' ' 324' ' ' LEU . 95.7 mt -61.11 -47.41 86.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.486 -0.324 . . . . 61.32 110.6 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.74 -48.02 78.73 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.124 -0.489 . . . . 72.04 111.155 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.45 HG22 ' HA ' ' A' ' 161' ' ' ILE . 14.7 tt -71.83 -36.47 58.5 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 120.774 -0.37 . . . . 50.25 111.677 -178.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.472 ' HA ' HG12 ' A' ' 168' ' ' ILE . 42.5 tp -65.41 -32.62 74.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.859 0.361 . . . . 72.44 110.985 -179.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.405 ' HB2' ' CZ ' ' A' ' 317' ' ' TYR . 28.6 tp10 -68.12 -45.96 72.21 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.826 -0.435 . . . . 53.13 109.826 174.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -59.04 -44.05 91.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.847 -0.615 . . . . 72.05 111.893 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.472 HG12 ' HA ' ' A' ' 165' ' ' LEU . 40.6 pt -76.57 -34.28 23.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 120.715 -0.394 . . . . 65.12 111.683 -176.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 50.1 t-80 -75.79 -19.1 59.23 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 120.67 -0.412 . . . . 75.2 110.443 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.607 ' HB2' HH22 ' A' ' 103' ' ' ARG . 13.6 tt0 -53.34 -31.8 46.05 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.016 -0.735 . . . . 75.45 109.016 170.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.545 ' C ' ' HG3' ' A' ' 172' ' ' GLU . 48.1 m80 -98.45 -101.94 0.21 Allowed 'General case' 0 N--CA 1.446 -0.656 0 CA-C-N 114.981 -1.008 . . . . 63.44 110.596 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.545 ' HG3' ' C ' ' A' ' 171' ' ' HIS . 12.1 mt-10 -153.87 14.0 0.47 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 111.645 0.239 . . . . 75.54 111.645 -171.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -122.46 148.04 45.61 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.601 0.593 . . . . 72.41 112.601 -164.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 20.7 m -134.01 173.21 15.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.034 -0.984 . . . . 70.21 109.401 175.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -99.14 -65.11 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.823 0.344 . . . . 63.42 110.897 -179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 92.3 -19.28 50.97 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.435 -0.888 . . . . 33.21 113.056 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.625 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 34.0 t70 -141.37 108.37 5.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.983 0.392 . . . . 54.03 111.169 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 178' ' ' ILE . 25.2 mm -111.27 35.97 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.81 0.814 . . . . 73.13 109.4 176.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.499 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 56.4 tptt -59.71 134.87 57.43 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.873 -0.603 . . . . 72.41 110.169 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.736 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -48.06 -33.64 8.38 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.83 0.678 . . . . 75.32 112.83 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.886 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 28.6 p -59.41 -25.58 64.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.848 0.356 . . . . 64.44 111.671 -178.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -88.51 1.02 55.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.071 -0.513 . . . . 74.41 111.87 -171.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mp -105.21 127.01 52.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.949 0.404 . . . . 63.45 110.579 179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.42 134.9 54.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 62.02 111.007 -177.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.861 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 8.6 mp -95.64 145.86 24.93 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.149 -0.478 . . . . 54.52 109.815 177.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.438 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 26.2 t-20 -62.73 144.39 56.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.378 -0.373 . . . . 63.15 110.417 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.654 ' CE2' ' HE2' ' A' ' 188' ' ' LYS . 1.3 p90 -60.56 -32.37 71.45 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.219 0.451 . . . . 72.34 112.219 -176.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.654 ' HE2' ' CE2' ' A' ' 187' ' ' TYR . 75.8 mmtt -93.71 -43.91 8.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.841 0.353 . . . . 72.53 110.237 178.379 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -101.94 105.3 41.11 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.944 -0.571 . . . . 71.22 111.961 -175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 4.3 Cg_exo -77.15 -7.04 17.03 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.957 2.438 . . . . 75.02 111.466 175.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.408 ' OD2' ' HG3' ' A' ' 192' ' ' GLN . 5.0 p-10 -87.96 -16.86 32.64 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.839 -0.619 . . . . 71.13 110.7 -178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.408 ' HG3' ' OD2' ' A' ' 191' ' ' ASP . 42.8 mt-30 -111.08 110.98 21.76 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.405 0.621 . . . . 71.1 111.11 -175.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.584 HG12 HH11 ' A' ' 160' ' ' ARG . 13.0 p -108.09 138.61 33.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 114.882 -1.053 . . . . 75.13 109.913 -179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.555 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 47.0 m-85 -125.33 153.74 42.86 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.442 -0.577 . . . . 63.51 109.442 -178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 32.5 tp -96.48 142.3 28.73 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 110.059 -0.349 . . . . 62.35 110.059 179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.701 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.0 p -124.04 -173.52 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.293 -0.632 . . . . 73.32 109.293 178.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.701 ' H ' HG22 ' A' ' 196' ' ' VAL . 52.5 t0 60.63 62.32 1.53 Allowed 'General case' 0 CA--C 1.514 -0.432 0 CA-C-O 121.894 0.854 . . . . 75.33 109.116 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.773 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 21.7 m-85 -81.11 7.59 10.67 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.147 -0.933 . . . . 71.24 109.788 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -71.93 -16.45 76.5 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.579 -0.737 . . . . 63.33 111.622 175.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.885 ' HA ' ' HB ' ' A' ' 354' ' ' ILE . 2.4 pp -89.91 4.07 51.12 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-O 120.753 0.311 . . . . 74.43 111.355 176.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -68.89 102.1 1.5 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.194 0.521 . . . . 64.25 109.974 175.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.605 ' HB2' HG13 ' A' ' 354' ' ' ILE . 84.8 t80 -98.39 125.54 43.58 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.824 -0.625 . . . . 71.52 110.117 -176.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.411 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 34.8 ttt180 -74.4 97.16 3.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.668 -0.696 . . . . 54.25 109.147 176.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.66 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 2.7 p90 -87.07 -14.93 40.07 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.195 -0.457 . . . . 73.52 111.625 -170.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.404 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 24.8 p -137.4 104.47 8.55 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.82 0.343 . . . . 72.55 110.871 177.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 34.1 Cg_endo -66.16 119.97 7.06 Favored 'Trans proline' 0 C--O 1.237 0.455 0 C-N-CA 122.413 2.075 . . . . 74.32 111.708 176.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.411 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 3.4 mp0 64.98 -80.79 0.03 OUTLIER 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.769 -0.65 . . . . 73.24 111.046 -178.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -153.87 17.84 0.64 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.963 -0.637 . . . . 74.25 112.098 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 51.0 t -105.63 111.74 36.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 N-CA-C 110.077 -0.342 . . . . 71.12 110.077 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -83.94 146.07 28.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.859 0.361 . . . . 74.34 110.295 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.449 ' HD3' ' OE2' ' A' ' 212' ' ' GLU . 10.1 mmtt -84.02 156.37 22.28 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.211 -0.449 . . . . 73.3 109.989 173.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.449 ' OE2' ' HD3' ' A' ' 211' ' ' LYS . 0.9 OUTLIER -102.25 153.62 19.8 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.315 -0.624 . . . . 73.45 109.315 176.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.874 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.1 OUTLIER -74.13 55.82 0.59 Allowed 'General case' 0 N--CA 1.467 0.379 0 N-CA-C 112.563 0.579 . . . . 72.01 112.563 -174.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -117.28 -15.49 10.4 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.11 -0.496 . . . . 74.13 110.498 178.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 236' ' ' VAL . 3.0 tp10 -80.94 141.14 34.8 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.85 -0.614 . . . . 74.13 111.669 -170.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -148.98 83.15 6.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 N-CA-C 108.534 -0.913 . . . . 70.43 108.534 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.75 -51.17 2.55 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.414 2.076 . . . . 72.15 112.205 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 4.8 mttm -175.79 29.67 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.817 -0.629 . . . . 75.0 110.012 177.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 69.5 mtt180 62.84 95.35 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.759 0.662 . . . . 74.44 111.349 179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.483 ' HB3' ' OD2' ' A' ' 222' ' ' ASP . 99.3 m -67.06 -48.45 68.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 75.24 111.665 -177.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 21.4 p80 47.21 35.08 3.41 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.677 0.791 . . . . 63.43 112.815 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.483 ' OD2' ' HB3' ' A' ' 220' ' ' CYS . 28.6 m-20 -66.46 -36.83 83.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.044 0.449 . . . . 64.2 110.906 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.625 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . -76.44 159.36 49.97 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.707 -0.758 . . . . 74.42 111.674 177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.459 ' O ' HG23 ' A' ' 228' ' ' THR . 6.6 p -68.58 150.3 48.17 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 120.472 0.177 . . . . 61.44 110.785 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.522 ' HB ' HD11 ' A' ' 265' ' ' LEU . 43.8 mm -52.97 -34.36 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-O 120.903 0.383 . . . . 71.52 111.479 -174.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -58.18 -47.06 84.59 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.964 -0.562 . . . . 74.41 111.293 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.984 ' HB3' HG23 ' A' ' 246' ' ' ILE . 41.0 m-85 -112.1 15.75 20.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.308 -0.405 . . . . 75.31 111.968 -170.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.459 HG23 ' O ' ' A' ' 224' ' ' THR . 1.3 p -57.87 -36.83 72.9 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.441 0.534 . . . . 63.1 112.441 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 32.6 t 57.23 -173.97 0.08 Allowed 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.378 -0.601 . . . . 73.31 109.378 -170.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 2.1 mp -73.5 -39.15 54.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.262 0.553 . . . . 65.51 109.849 174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -54.82 -66.45 0.4 Allowed 'General case' 0 C--O 1.235 0.29 0 CA-C-N 114.888 -1.051 . . . . 65.02 111.967 -173.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -65.63 -28.57 69.21 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.239 -0.437 . . . . 75.12 111.914 -174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -63.02 -43.67 98.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.629 -0.26 . . . . 65.11 111.099 179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -76.39 -32.88 58.81 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.212 0.53 . . . . 75.42 110.819 -178.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.25 1.45 55.78 Favored Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.625 -0.798 . . . . 62.54 111.49 -175.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.874 HG21 ' HA ' ' A' ' 213' ' ' TYR . 8.8 p -72.42 141.88 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 110.0 -0.37 . . . . 64.01 110.0 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.66 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -47.76 109.89 1.23 Allowed Pre-proline 0 C--O 1.233 0.208 0 CA-C-N 115.813 -0.63 . . . . 61.41 111.728 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.57 121.21 8.27 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.804 2.336 . . . . 73.21 111.864 -178.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 13.9 m -79.8 170.59 16.3 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.033 -0.53 . . . . 75.42 109.82 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 8.9 ttp180 -62.7 -29.98 71.06 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 120.415 -0.514 . . . . 74.24 110.434 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 0.2 OUTLIER -55.12 -38.8 68.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 65.42 109.858 174.348 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.475 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -67.26 -50.95 41.32 Favored Glycine 0 N--CA 1.444 -0.799 0 CA-C-N 115.536 -0.756 . . . . 65.31 111.971 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -39.67 94.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.992 0.425 . . . . 74.44 110.174 -178.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 61.4 mt -61.35 -44.28 97.44 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.086 -0.506 . . . . 54.12 110.775 174.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.62 -36.99 81.85 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.76 -0.655 . . . . 74.11 110.181 -178.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.984 HG23 ' HB3' ' A' ' 227' ' ' PHE . 96.5 mt -62.77 -43.01 98.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.648 -0.706 . . . . 72.42 110.151 175.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.501 ' O ' ' HG3' ' A' ' 251' ' ' MET . 61.7 tp -60.34 -39.6 87.69 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.236 -0.438 . . . . 71.21 110.321 175.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.805 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.62 -42.06 99.1 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.035 -0.602 . . . . 73.13 112.254 176.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.468 ' CD2' ' HA ' ' A' ' 246' ' ' ILE . 22.2 m-85 -56.93 -41.35 78.04 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.248 0.547 . . . . 60.42 110.046 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.452 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 46.4 m -65.57 -45.44 83.3 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.553 -0.749 . . . . 74.52 110.656 -179.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.501 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.2 mtp -58.39 -48.53 80.32 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.029 -0.532 . . . . 74.13 111.228 -177.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.473 ' HB ' ' HE1' ' A' ' 286' ' ' MET . 8.9 tt -66.53 -34.29 69.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.713 -0.395 . . . . 75.41 110.742 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.505 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 41.6 tt0 -66.75 -46.4 75.54 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 121.141 -0.224 . . . . 71.24 110.772 -179.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.462 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.0 m0 -68.37 -28.21 66.92 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.938 0.399 . . . . 71.01 111.363 -178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.5 tp -81.49 -31.05 33.06 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.194 -0.457 . . . . 74.3 111.706 -177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 44.7 p -101.8 -28.2 12.58 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.801 -0.359 . . . . 74.04 111.683 -173.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 87.01 -13.79 58.65 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.858 -0.687 . . . . 73.3 112.745 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 32.9 t-80 -156.26 141.04 17.07 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.919 -0.4 . . . . 75.54 109.919 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 93.9 mt -101.79 148.93 36.0 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.628 -0.26 . . . . 52.14 110.758 178.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.448 ' HG2' ' CE3' ' A' ' 261' ' ' TRP . 18.2 Cg_endo -60.07 -29.11 88.48 Favored 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.708 2.272 . . . . 63.53 112.766 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.515 ' HB3' ' CB ' ' A' ' 274' ' ' SER . 33.5 p90 -105.13 7.58 33.84 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.72 0.295 . . . . 70.34 111.222 -179.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 39.8 tt0 -67.22 -37.48 83.68 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.026 0.441 . . . . 44.2 111.332 -173.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.56 -22.14 62.62 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.348 0.594 . . . . 73.41 110.091 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -109.56 21.73 16.63 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.526 -0.761 . . . . 75.11 110.731 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.522 HD11 ' HB ' ' A' ' 225' ' ' ILE . 1.6 tm? -63.33 -24.0 67.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.635 -0.711 . . . . 73.03 111.03 -177.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -88.56 12.69 13.89 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.404 -0.362 . . . . 62.54 111.698 -177.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -130.54 118.46 17.98 Favored Pre-proline 0 C--O 1.233 0.193 0 CA-C-O 120.766 0.317 . . . . 73.52 110.636 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.423 ' HA ' HG22 ' A' ' 271' ' ' VAL . 24.4 Cg_exo -63.17 -30.62 74.97 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 123.231 2.62 . . . . 73.03 113.267 -177.021 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -73.23 -41.67 63.46 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.751 0.31 . . . . 74.32 110.293 -177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -68.89 -46.54 68.13 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.046 -0.525 . . . . 74.22 111.204 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.423 HG22 ' HA ' ' A' ' 268' ' ' PRO . 34.1 m -62.88 -31.21 51.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.205 0 C-N-CA 120.928 -0.309 . . . . 70.03 111.143 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 276' ' ' ILE . 10.7 ttt85 -61.16 -62.72 1.64 Allowed 'General case' 0 N--CA 1.457 -0.112 0 N-CA-C 110.139 -0.319 . . . . 74.45 110.139 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -57.39 -44.65 84.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.77 -0.65 . . . . 74.52 111.563 -175.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.515 ' CB ' ' HB3' ' A' ' 261' ' ' TRP . 19.7 m -65.15 -40.94 95.09 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.962 -0.563 . . . . 52.2 111.668 -175.361 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -78.52 -23.01 46.5 Favored 'General case' 0 C--N 1.332 -0.172 0 C-N-CA 120.537 -0.465 . . . . 53.5 110.921 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 272' ' ' ARG . 62.4 mt -71.32 -46.5 64.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.838 -0.431 . . . . 73.13 109.838 173.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 17.7 mmt180 -62.64 -40.01 95.64 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-N 116.346 -0.388 . . . . 75.01 110.545 176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -60.14 -46.86 88.23 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.948 -0.569 . . . . 74.11 110.842 177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -76.98 -13.91 59.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.191 -0.459 . . . . 73.43 110.624 -177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -67.83 -36.19 79.93 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.099 -0.501 . . . . 54.11 110.052 178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.405 HD22 ' HA ' ' A' ' 281' ' ' ASN . 2.6 t-20 -161.9 96.87 1.03 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.416 -0.587 . . . . 64.02 109.416 -177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 303' ' ' MET . 3.7 mp -80.16 -51.48 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.186 0.439 . . . . 54.42 112.186 -168.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.409 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.12 -46.94 84.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.597 0.221 . . . . 71.21 111.597 -173.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 22.7 t -64.99 -37.14 86.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.973 0.416 . . . . 62.54 110.559 -179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -66.27 -34.44 78.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.381 -0.372 . . . . 65.01 110.69 179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.473 ' HE1' ' HB ' ' A' ' 252' ' ' ILE . 49.5 mtt -74.38 -34.22 63.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.687 -0.233 . . . . 75.21 111.44 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -59.92 -36.52 77.19 Favored 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 109.288 -0.634 . . . . 71.53 109.288 172.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -75.35 -24.48 57.33 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.976 -1.011 . . . . 74.02 110.965 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.0 m -72.85 -23.46 60.75 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.619 -0.264 . . . . 72.14 111.229 -179.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -116.82 81.24 11.74 Favored Pre-proline 0 C--N 1.327 -0.387 0 N-CA-C 111.85 0.315 . . . . 53.42 111.85 176.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.37 -18.34 49.74 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.533 2.156 . . . . 74.42 111.228 174.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -76.78 -5.91 50.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.75 -0.659 . . . . 54.32 109.85 176.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 64.95 90.14 0.09 Allowed 'General case' 0 C--O 1.235 0.302 0 CA-C-N 115.057 -0.974 . . . . 72.24 112.315 178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 18.9 t-20 -120.44 -177.14 3.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 106.816 -1.549 . . . . 75.41 106.816 170.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -122.29 87.26 48.21 Favored Pre-proline 0 C--N 1.319 -0.736 0 CA-C-N 118.808 0.731 . . . . 73.03 110.332 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -86.46 39.65 0.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.323 2.682 . . . . 75.1 111.348 177.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -65.61 -37.32 93.47 Favored Glycine 0 N--CA 1.451 -0.336 0 CA-C-N 115.837 -0.619 . . . . 72.14 112.861 -172.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.567 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -60.35 -46.61 89.33 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.31 0.576 . . . . 72.31 109.899 -179.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.586 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.2 mp -76.29 -38.67 33.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.473 -0.785 . . . . 72.24 110.442 -174.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.409 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.39 -53.24 59.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.097 -0.501 . . . . 75.43 111.488 -178.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.593 ' HB3' HD11 ' A' ' 323' ' ' ILE . 27.8 tptp -69.4 -36.32 76.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.397 -0.365 . . . . 72.02 110.412 -178.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.536 ' CD1' HD12 ' A' ' 320' ' ' LEU . 62.9 t80 -55.76 -50.92 69.12 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.223 -0.444 . . . . 73.11 110.908 176.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.805 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 82.9 mmm -70.61 -40.86 72.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.105 -0.498 . . . . 73.14 111.918 -177.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -64.15 -34.15 77.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.547 -0.538 . . . . 74.41 109.547 178.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 5.6 m -73.25 -45.23 57.14 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.508 0.558 . . . . 74.2 112.508 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.494 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.1 m -63.54 -25.3 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 121.348 0.594 . . . . 74.41 110.342 178.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -74.6 -44.18 51.99 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.554 -0.748 . . . . 71.33 111.455 173.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 85.1 mt -84.38 71.23 10.7 Favored 'General case' 0 C--O 1.234 0.288 0 N-CA-C 113.139 0.792 . . . . 64.23 113.139 -170.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.948 ' HG ' ' H ' ' A' ' 310' ' ' ASP . 1.3 pt? -159.61 -71.71 0.08 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.369 -0.974 . . . . 53.14 108.369 165.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.948 ' H ' ' HG ' ' A' ' 309' ' ' LEU . 2.8 t70 174.52 -73.81 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.196 0 O-C-N 124.002 0.814 . . . . 71.12 109.093 168.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 0.4 OUTLIER -162.35 -51.22 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.464 0 N-CA-C 113.245 0.832 . . . . 71.12 113.245 173.085 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 7.0 m -139.36 32.0 2.11 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.598 0.713 . . . . 72.22 110.943 -175.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.575 ' OE1' ' HB3' ' A' ' 310' ' ' ASP . 7.8 mp0 -62.5 -76.48 0.06 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.776 -0.647 . . . . 64.13 109.962 173.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 4.6 ttmp? -156.75 93.51 2.36 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.759 -0.655 . . . . 73.43 109.459 173.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.54 117.39 4.7 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 121.949 1.766 . . . . 62.31 110.747 176.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 93.8 mt -83.07 85.43 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.196 -0.456 . . . . 75.3 109.923 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.471 ' CZ ' ' HD2' ' A' ' 321' ' ' ARG . 60.5 t80 -57.2 -36.91 71.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.43 -0.805 . . . . 73.31 110.987 -175.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -61.52 -39.26 90.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.961 -0.563 . . . . 72.13 110.417 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -68.06 -42.97 79.68 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.938 -0.574 . . . . 64.14 111.274 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.536 HD12 ' CD1' ' A' ' 302' ' ' TYR . 2.0 mm? -63.07 -43.38 98.73 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.939 -0.304 . . . . 75.5 110.749 -179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.558 ' NH2' ' HG2' ' A' ' 106' ' ' LYS . 65.0 mtp85 -67.7 -38.5 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.911 -0.316 . . . . 73.42 110.351 177.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.88 -48.4 76.83 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.077 -0.511 . . . . 64.32 111.203 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.593 HD11 ' HB3' ' A' ' 301' ' ' LYS . 0.0 OUTLIER -64.67 -41.42 92.19 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.815 -0.175 . . . . 64.03 111.232 -176.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 162' ' ' LEU . 80.5 mt -63.24 -46.06 88.67 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.822 0.344 . . . . 71.45 110.869 -178.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -69.27 -35.26 75.88 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.381 -0.372 . . . . 74.42 110.449 177.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.3 tp60 -55.68 -47.84 76.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 70.55 110.862 179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.567 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -68.07 -45.89 69.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.901 -0.666 . . . . 71.15 112.166 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.615 HD22 ' HG ' ' A' ' 155' ' ' LEU . 40.6 tp -59.17 -45.7 90.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.127 0.489 . . . . 74.21 110.812 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 61.4 mtpt -73.96 -24.63 59.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.115 -0.493 . . . . 61.42 111.164 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.43 -43.14 77.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.682 0.277 . . . . 65.44 110.991 179.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -78.29 -6.73 9.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.364 0.602 . . . . 74.43 110.651 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 86.99 24.31 38.22 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.893 -0.67 . . . . 71.51 112.943 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 5.0 t -108.21 153.53 23.06 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.903 -0.406 . . . . 61.43 109.903 -179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -172.0 132.86 0.69 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.152 -0.476 . . . . 65.21 109.831 -178.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.779 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 16.7 m-20 -138.6 -58.63 0.62 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.382 -0.372 . . . . 63.22 110.482 179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 48.9 t0 59.29 90.15 0.06 Allowed 'General case' 0 N--CA 1.468 0.447 0 O-C-N 124.169 0.918 . . . . 55.44 111.064 178.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.564 ' H ' ' HG3' ' A' ' 156' ' ' GLN . . . 96.85 -31.85 7.18 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.825 -0.703 . . . . 70.34 112.398 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 335' ' ' ASP . 53.4 mttp -71.78 131.33 42.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 54.11 110.984 -177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.555 HD22 ' HA ' ' A' ' 153' ' ' THR . 27.5 mt -114.76 -172.15 2.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.138 -0.483 . . . . 75.21 110.527 176.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -148.39 37.63 0.84 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 122.291 1.043 . . . . 71.04 108.388 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 17.4 tp -132.64 39.31 3.36 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.002 -0.999 . . . . 73.52 111.05 -171.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 12.9 m -80.58 34.85 0.34 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.265 -0.425 . . . . 72.32 110.835 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.403 HG21 ' OD1' ' A' ' 145' ' ' ASN . 59.6 t -71.24 -52.13 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.12 -0.491 . . . . 74.33 110.683 -177.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.8 t 64.49 95.43 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 CA-C-N 115.71 -0.677 . . . . 64.11 111.794 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -100.75 -52.47 3.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.026 -0.534 . . . . 64.14 110.424 175.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 49.7 t30 74.13 93.96 0.07 Allowed 'General case' 0 N--CA 1.47 0.534 0 O-C-N 123.96 0.788 . . . . 73.34 112.07 174.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -137.71 -57.75 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.38 -1.088 . . . . 53.24 110.38 175.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 102.69 171.03 26.61 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.835 -0.698 . . . . 43.3 112.812 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.427 ' H ' HD23 ' A' ' 349' ' ' LEU . 2.3 pt? -131.17 178.24 6.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.126 0.489 . . . . 62.24 111.132 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 9.7 mtmp? -120.96 141.22 50.89 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.434 -0.803 . . . . 63.31 109.418 169.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -62.26 154.94 26.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.53 . . . . 75.24 112.389 -174.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.58 ' O ' ' HB ' ' A' ' 353' ' ' THR . 0.1 OUTLIER -93.95 -45.71 7.49 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-N 115.781 -0.645 . . . . 64.12 112.087 -178.233 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.58 ' HB ' ' O ' ' A' ' 352' ' ' LYS . 93.8 m 74.83 139.01 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 O-C-N 123.871 0.732 . . . . 71.33 110.666 -173.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.885 ' HB ' ' HA ' ' A' ' 200' ' ' LEU . 0.4 OUTLIER -90.8 140.57 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.994 0.426 . . . . 72.43 110.844 -177.614 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.505 ' N ' HD13 ' A' ' 354' ' ' ILE . 88.0 m -68.64 102.48 1.5 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 116.009 -0.541 . . . . 73.51 110.833 175.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.481 ' HD2' ' O ' ' A' ' 360' ' ' LYS . 4.9 tmtt? -141.06 112.5 7.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.281 -0.637 . . . . 65.43 109.281 178.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -156.34 131.53 9.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.908 0.385 . . . . 73.31 111.101 -177.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -175.95 -67.88 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.883 -1.154 . . . . 73.2 107.883 177.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.769 ' HA ' ' HE3' ' A' ' 359' ' ' LYS . 1.6 tpmt? -146.96 -47.04 0.18 Allowed 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 106.426 -1.694 . . . . 61.43 106.426 170.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.481 ' O ' ' HD2' ' A' ' 356' ' ' LYS . 53.4 mttp . . . . . 0 C--O 1.241 0.613 0 CA-C-N 114.017 -1.447 . . . . 71.33 107.948 161.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 66.0 mtt . . . . . 0 N--CA 1.482 1.141 0 N-CA-C 110.135 -0.32 . . . . 75.11 110.135 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.51 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 87.2 Cg_exo -45.88 149.55 2.11 Favored 'Trans proline' 0 C--N 1.352 0.742 0 C-N-CA 123.659 2.906 . . . . 51.53 114.02 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 21.1 ptt180 -142.31 137.8 30.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.383 -0.826 . . . . 74.13 110.785 -176.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 60.2 t -108.38 109.62 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.391 -0.596 . . . . 64.52 109.391 176.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.496 ' HE3' ' CE1' ' A' ' 171' ' ' HIS . 18.6 ptmt -125.24 122.07 35.9 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.967 0.413 . . . . 75.44 111.11 -176.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -148.59 171.99 15.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.644 -0.707 . . . . 61.1 110.066 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.82 163.9 31.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.464 -0.335 . . . . 61.52 110.586 178.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -119.47 152.92 36.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.351 -0.386 . . . . 74.13 110.266 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -78.18 151.8 33.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.093 -0.503 . . . . 70.12 110.808 -178.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -95.69 136.22 12.76 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.857 -0.687 . . . . 52.25 112.037 -178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.46 HH11 ' HD2' ' A' ' 11' ' ' ARG . 18.8 ttt85 -113.32 115.98 29.0 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.163 -0.68 . . . . 73.22 109.163 176.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -88.61 148.01 24.28 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.918 -0.583 . . . . 53.24 111.075 -172.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 75' ' ' SER . 16.5 m -126.6 141.07 51.98 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.51 -0.768 . . . . 54.21 109.536 177.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.8 t -143.81 104.32 4.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.064 0.459 . . . . 64.43 110.132 179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.445 ' H ' ' HB2' ' A' ' 76' ' ' ASP . . . -164.46 83.73 0.42 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.429 -0.805 . . . . 54.54 110.199 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.672 ' H ' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -92.81 172.15 8.52 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.737 -0.665 . . . . 72.12 110.18 -179.031 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.732 ' HB2' ' HE2' ' A' ' 124' ' ' LYS . 0.6 OUTLIER -172.13 116.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.77 -0.826 . . . . 74.41 108.77 -176.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 47.7 p-80 -79.72 27.73 0.28 Allowed 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.321 0.489 . . . . 74.43 112.321 -171.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 17' ' ' ARG . 55.2 tp -137.43 160.08 40.11 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.298 -0.63 . . . . 75.24 109.298 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -152.74 125.53 8.39 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.701 0.286 . . . . 52.32 110.426 176.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 21' ' ' GLU . 1.1 pm0 -76.88 -30.14 56.09 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.568 -0.53 . . . . 63.14 109.568 175.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 70.77 -12.08 0.58 Allowed 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.203 -0.908 . . . . 74.43 112.359 173.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 81.3 t80 -81.65 93.34 6.73 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.076 0.465 . . . . 71.0 110.088 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 39' ' ' VAL . . . -126.27 -2.3 6.94 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.824 -0.625 . . . . 73.33 110.864 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 47.8 t -64.43 121.27 13.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 52.23 110.473 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 87.65 1.22 83.33 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.883 -0.675 . . . . 71.41 112.537 -179.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -88.63 154.02 20.65 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 110.088 -0.338 . . . . 74.52 110.088 179.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.437 ' CG2' ' HB3' ' A' ' 36' ' ' GLU . 14.6 mt -106.42 136.94 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.355 0.598 . . . . 71.44 111.639 -175.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.485 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -121.41 136.1 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.44 -0.8 . . . . 75.11 109.466 175.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.0 m -106.12 121.86 45.02 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 110.268 -0.271 . . . . 73.43 110.268 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.25 179.6 5.86 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.772 -0.371 . . . . 74.52 110.01 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.466 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.6 mmt -63.41 -22.1 66.68 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 112.387 0.514 . . . . 73.33 112.387 -175.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.74 6.08 16.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.739 0.305 . . . . 60.13 111.218 178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 74.71 11.37 3.85 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.613 -0.721 . . . . 75.53 111.337 175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.47 133.48 33.75 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.788 -0.449 . . . . 51.24 109.788 -179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.437 ' HB3' ' CG2' ' A' ' 28' ' ' ILE . 42.6 mt-10 -104.61 92.47 4.31 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 121.379 0.609 . . . . 73.22 110.501 -177.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.632 ' CE3' ' HB2' ' A' ' 56' ' ' MET . 10.9 m95 -83.64 159.02 21.66 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 71.52 109.089 -178.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -119.06 146.68 44.87 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.098 -0.641 . . . . 75.21 110.618 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.537 HG22 ' CE1' ' A' ' 52' ' ' TYR . 58.5 t -72.65 116.88 15.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.393 -0.821 . . . . 41.04 110.409 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -93.26 -94.17 1.5 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.518 -0.848 . . . . 62.44 112.095 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.9 mm? -111.74 129.95 23.66 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-O 120.759 0.314 . . . . 62.41 110.869 -177.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 4.8 Cg_exo -75.07 103.77 1.79 Allowed 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.193 2.595 . . . . 73.12 111.544 175.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 56.3 mt -86.82 -47.89 15.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.229 -0.441 . . . . 74.34 111.016 -175.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.65 -30.8 8.99 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 121.137 -0.554 . . . . 73.34 112.05 -178.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -118.07 163.25 16.9 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.181 -0.303 . . . . 73.14 110.181 -177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.69 -33.27 1.3 Allowed Glycine 0 C--O 1.227 -0.325 0 N-CA-C 111.146 -0.782 . . . . 40.12 111.146 -178.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -145.54 -71.55 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 111.38 -0.688 . . . . 42.42 111.38 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.496 ' HD1' ' HB1' ' A' ' 351' ' ' ALA . 80.8 m-85 -122.58 -71.04 0.74 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.82 0.343 . . . . 74.4 110.382 176.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.34 157.68 30.09 Favored Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.451 -0.66 . . . . 44.14 111.451 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 34.9 t 60.46 50.48 5.91 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.278 0.561 . . . . 74.4 110.843 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.546 ' CD1' ' HB3' ' A' ' 71' ' ' LYS . 0.2 OUTLIER -105.85 137.07 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.214 -0.448 . . . . 72.15 109.877 177.294 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.537 ' CE1' HG22 ' A' ' 39' ' ' VAL . 52.6 p90 -128.78 158.78 37.71 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.892 0.377 . . . . 72.21 111.228 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -76.85 132.15 39.01 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.553 -0.749 . . . . 70.24 109.943 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -121.89 105.56 10.46 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.588 -0.278 . . . . 65.43 110.279 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.447 ' HA ' ' CB ' ' A' ' 66' ' ' ALA . 1.1 p-10 -95.51 -27.53 15.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.474 -0.33 . . . . 53.44 111.009 -176.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.632 ' HB2' ' CE3' ' A' ' 37' ' ' TRP . 1.8 tmt? 66.5 -84.06 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 O-C-N 123.709 0.63 . . . . 64.03 110.466 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 178.61 133.87 0.08 Allowed 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.691 -0.855 . . . . 55.12 108.691 -178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 19.4 m -79.49 54.49 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.024 0.44 . . . . 73.34 110.725 -178.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.0 m -92.79 -60.51 1.8 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.035 -0.529 . . . . 64.52 111.635 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -144.88 -58.51 0.35 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.607 0.241 . . . . 75.14 111.611 -172.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 16.2 t -58.1 -75.67 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.885 -0.598 . . . . 25.03 111.108 -175.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.608 HG21 ' HA ' ' A' ' 66' ' ' ALA . 5.9 p -83.75 143.66 11.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.657 0.265 . . . . 62.45 110.441 177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -75.2 178.1 47.54 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 110.591 -1.004 . . . . 74.53 110.591 171.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.6 t -77.73 61.67 2.46 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.429 0.633 . . . . 62.12 110.521 -177.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -148.43 -43.93 0.15 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.685 -0.689 . . . . 72.14 110.227 -179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.608 ' HA ' HG21 ' A' ' 62' ' ' VAL . . . 61.36 73.48 0.58 Allowed Pre-proline 0 C--N 1.332 -0.182 0 CA-C-N 115.045 -0.98 . . . . 74.14 111.692 -179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.52 36.36 0.62 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.535 2.157 . . . . 61.14 111.571 177.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 1.8 p -133.75 137.92 45.46 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.697 0.76 . . . . 53.11 112.385 -176.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.464 HG13 ' HG3' ' A' ' 133' ' ' ARG . 31.5 m -132.42 152.25 36.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.881 -1.054 . . . . 75.23 108.67 174.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.63 ' HB ' HG12 ' A' ' 130' ' ' ILE . 1.2 p -131.97 131.19 61.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.058 0.456 . . . . 43.34 112.139 -174.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.779 ' HE3' ' HB3' ' A' ' 129' ' ' MET . 0.5 OUTLIER -92.15 139.52 30.54 Favored 'General case' 0 CA--C 1.518 -0.25 0 CA-C-N 115.401 -0.818 . . . . 63.44 109.841 176.347 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 p -136.57 134.74 49.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.502 -0.479 . . . . 70.42 112.123 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.751 ' HB3' ' HD2' ' A' ' 74' ' ' PRO . 3.0 mt-10 -144.57 177.89 1.64 Allowed Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 115.612 -0.722 . . . . 55.31 109.069 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.751 ' HD2' ' HB3' ' A' ' 73' ' ' GLU . 37.3 Cg_endo -66.96 164.4 29.98 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 121.673 1.582 . . . . 64.4 112.14 178.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.506 ' HB3' ' HB3' ' A' ' 13' ' ' SER . 7.4 m -59.04 -40.29 84.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 71.43 110.75 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.445 ' HB2' ' H ' ' A' ' 15' ' ' ALA . 11.4 t70 -85.42 88.04 7.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.232 0.539 . . . . 73.3 109.595 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.416 ' CG ' ' H ' ' A' ' 78' ' ' GLY . 12.4 t-20 -121.09 -166.07 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.35 -0.841 . . . . 72.55 109.329 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.416 ' H ' ' CG ' ' A' ' 77' ' ' ASN . . . -125.9 -75.82 0.24 Allowed Glycine 0 N--CA 1.446 -0.677 0 N-CA-C 111.75 -0.54 . . . . 33.32 111.75 178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 17.8 Cg_endo -58.43 -24.59 69.62 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.098 2.532 . . . . 72.35 113.036 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.697 HD12 ' HE ' ' A' ' 127' ' ' ARG . 0.2 OUTLIER -57.21 -30.46 64.58 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 120.767 0.317 . . . . 73.21 111.379 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -72.79 -45.55 57.93 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.094 0.473 . . . . 73.42 110.116 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -63.68 -48.43 77.18 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 115.218 -0.901 . . . . 73.05 110.814 -178.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.583 ' O ' ' HB2' ' A' ' 87' ' ' TYR . 10.9 pt-20 -65.81 -36.65 84.09 Favored 'General case' 0 C--O 1.221 -0.422 0 CA-C-N 116.233 -0.439 . . . . 75.31 110.883 -179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -58.75 -50.57 73.43 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.881 0.372 . . . . 62.41 110.163 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.05 -45.75 84.09 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-N 116.021 -0.536 . . . . 72.41 110.595 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -67.67 -50.48 57.52 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.982 -0.554 . . . . 60.51 111.128 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.583 ' HB2' ' O ' ' A' ' 83' ' ' GLU . 1.7 t80 -59.93 -42.37 93.82 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.928 -0.578 . . . . 74.42 110.837 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.411 ' OE1' ' HA ' ' A' ' 88' ' ' GLN . 6.7 tp60 -72.65 -34.26 67.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.291 -0.413 . . . . 74.52 111.198 -178.061 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.455 ' HA ' ' NE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -75.7 -21.27 57.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.702 0.287 . . . . 74.15 111.361 179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -108.01 15.72 24.07 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.084 0.469 . . . . 51.54 111.165 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -91.62 -175.75 4.28 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.833 -0.621 . . . . 70.02 111.897 -176.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 67.93 92.13 0.07 OUTLIER Pre-proline 0 N--CA 1.463 0.204 0 CA-C-N 115.021 -0.99 . . . . 74.44 110.755 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -54.19 -29.14 55.13 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.844 2.363 . . . . 23.33 111.884 177.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -62.33 -54.75 35.95 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 115.706 -0.679 . . . . 71.22 110.285 175.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 23.4 tp60 -60.26 -43.83 95.81 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 115.627 -0.715 . . . . 64.32 110.162 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.441 HG23 HD21 ' A' ' 108' ' ' LEU . 81.4 mt -56.96 -54.34 31.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.691 -0.686 . . . . 73.52 110.66 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -58.23 -38.64 77.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.941 -0.572 . . . . 74.5 110.504 -178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -60.08 -58.92 6.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.86 -0.609 . . . . 72.31 111.503 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -34.9 67.54 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.077 -0.649 . . . . 72.53 111.005 -172.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 108' ' ' LEU . 33.5 mm -59.63 -43.64 91.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.893 0.378 . . . . 71.22 110.783 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 24.4 ttt180 -78.11 -41.06 36.35 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.503 -0.317 . . . . 73.31 111.51 -178.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 m -75.83 -35.78 59.86 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.106 0.41 . . . . 71.4 112.106 -174.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 44.5 ttt-85 -94.92 -5.79 44.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.763 -0.199 . . . . 74.12 111.04 -174.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 86.8 tttt 73.06 84.25 0.12 Allowed 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.905 0.753 . . . . 74.33 111.853 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.462 HD23 ' HB2' ' A' ' 163' ' ' ASP . 5.6 mp -137.18 -176.58 4.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.436 -0.802 . . . . 61.34 109.173 172.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.649 ' HD2' ' HD1' ' A' ' 107' ' ' TYR . 1.3 tmtm? -96.57 -72.03 0.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.189 -0.671 . . . . 53.14 109.189 177.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.649 ' HD1' ' HD2' ' A' ' 106' ' ' LYS . 35.1 p90 175.53 123.31 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 109.389 -0.597 . . . . 72.41 109.389 171.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.6 pt? -78.22 135.96 37.69 Favored 'General case' 0 C--N 1.322 -0.592 0 C-N-CA 120.69 -0.404 . . . . 70.21 110.128 -175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -77.52 67.94 2.78 Favored Glycine 0 N--CA 1.452 -0.238 0 CA-C-N 115.989 -0.55 . . . . 74.51 113.098 -175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.4 p -105.37 128.83 25.81 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.766 0.317 . . . . 72.22 110.163 177.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.574 ' HG2' ' CE1' ' A' ' 87' ' ' TYR . 9.2 Cg_endo -55.71 144.89 74.08 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.906 2.404 . . . . 65.13 113.229 179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.882 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 23.5 tptm -62.52 132.33 52.11 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.388 -0.824 . . . . 55.0 111.39 -178.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 69.0 t80 -104.49 140.0 38.59 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.861 -0.609 . . . . 74.42 110.646 178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 132' ' ' ASP . 71.4 m95 -116.63 -71.95 0.71 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.001 -0.545 . . . . 62.42 109.581 174.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -150.63 -178.07 25.15 Favored Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.252 -0.885 . . . . 72.02 111.733 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 32' ' ' MET . 48.5 p -166.64 167.91 14.92 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.213 -0.662 . . . . 74.41 109.213 -177.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 155.51 -147.44 16.29 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 119.847 -1.168 . . . . 64.32 112.88 178.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.455 ' H ' HD13 ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.09 147.87 46.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.042 0.449 . . . . 72.4 110.759 -176.306 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.439 ' CG ' HG22 ' A' ' 29' ' ' ILE . 44.0 t-80 -123.7 115.76 21.95 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.112 -0.699 . . . . 60.25 109.112 174.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.826 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 9.3 t70 -83.98 136.81 33.91 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.189 -0.46 . . . . 74.55 109.931 -177.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.436 ' HG2' ' O ' ' A' ' 124' ' ' LYS . 6.1 ptmm? -87.96 20.0 3.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.598 0.237 . . . . 74.31 110.376 -179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 66.99 75.47 0.31 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 108.881 -0.785 . . . . 72.15 108.881 -173.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.42 -24.21 3.08 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.157 -0.929 . . . . 54.32 112.079 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.732 ' HE2' ' HB2' ' A' ' 17' ' ' ARG . 18.6 ttpp -168.17 136.99 2.38 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.928 -0.397 . . . . 72.22 109.928 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.826 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 9.2 m -84.09 155.44 22.66 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-O 121.257 0.551 . . . . 73.33 112.002 -174.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -117.54 155.34 29.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.339 -0.846 . . . . 75.34 108.745 167.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.697 ' HE ' HD12 ' A' ' 80' ' ' LEU . 32.7 ttt180 -114.83 128.0 56.04 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.426 0.155 . . . . 72.32 110.803 -171.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -137.9 163.12 32.27 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-O 121.231 0.539 . . . . 45.45 112.005 -175.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.779 ' HB3' ' HE3' ' A' ' 71' ' ' LYS . 37.0 ttm -145.11 141.29 28.67 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.501 -0.772 . . . . 65.44 110.03 176.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.63 HG12 ' HB ' ' A' ' 70' ' ' VAL . 47.4 mt -100.79 134.62 40.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.757 0.313 . . . . 54.15 111.42 -177.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 12.3 ptm -129.68 175.65 8.65 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 62.14 109.535 179.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.882 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 5.0 t70 -72.44 174.54 7.25 Favored 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.807 -0.442 . . . . 75.14 109.807 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.592 ' HE ' ' HE1' ' A' ' 187' ' ' TYR . 9.7 ttp180 -86.77 93.11 9.18 Favored 'General case' 0 C--O 1.243 0.711 0 CA-C-O 122.17 0.986 . . . . 54.24 110.99 -174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.599 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 47.0 m-85 -103.06 170.55 7.89 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 114.822 -1.081 . . . . 72.53 109.322 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -173.11 -46.1 0.05 OUTLIER Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.5 -0.857 . . . . 42.24 111.946 -179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.442 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 19.6 m -95.33 125.72 40.15 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.927 -0.397 . . . . 73.31 109.927 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.572 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.5 p30 -116.8 174.41 6.1 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 110.031 -0.359 . . . . 72.22 110.031 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.421 HD21 HD21 ' A' ' 157' ' ' LEU . 11.2 mp -74.5 -20.14 60.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.595 -0.275 . . . . 73.22 111.397 -176.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -74.35 -37.27 63.57 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.908 -0.404 . . . . 72.05 109.908 178.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.442 ' HD2' ' HA ' ' A' ' 136' ' ' SER . 55.7 mttp -57.7 -51.44 69.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.816 -0.629 . . . . 71.23 110.654 174.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.583 HG21 HD11 ' A' ' 341' ' ' LEU . 2.0 mp -68.14 -34.97 69.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.327 -0.397 . . . . 52.52 110.263 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.639 ' HE2' HE22 ' A' ' 253' ' ' GLN . 48.1 t80 -52.7 -52.94 53.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 74.51 110.841 178.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -80.64 -41.57 23.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.903 -0.59 . . . . 73.02 111.83 -175.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.13 -33.32 70.0 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.272 0.471 . . . . 73.33 112.272 -173.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.86 ' HB2' HG11 ' A' ' 344' ' ' VAL . 2.1 t-20 -105.51 0.08 26.34 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.138 0.494 . . . . 71.03 110.536 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 53.74 46.46 25.82 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-N 115.322 -0.854 . . . . 63.24 112.018 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.541 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 33.2 mttt 71.56 100.07 0.07 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.604 -0.726 . . . . 63.44 112.577 175.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.573 ' HB2' ' OD1' ' A' ' 145' ' ' ASN . 7.2 mmt180 -150.33 72.78 1.12 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.652 -0.704 . . . . 63.41 109.882 172.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -104.89 118.88 37.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.874 -0.603 . . . . 73.33 109.862 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 15.3 m -70.85 149.93 46.3 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.374 -0.375 . . . . 72.33 110.08 178.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.636 ' HD3' HD21 ' A' ' 294' ' ' ASN . 11.3 ttp180 -61.16 -31.44 71.17 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.329 -0.396 . . . . 74.5 111.348 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 15.0 ttmt -59.86 -48.37 81.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.184 0.516 . . . . 74.23 109.922 175.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.523 HG23 HD22 ' A' ' 339' ' ' LEU . 90.2 m -61.93 -48.67 79.39 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.336 -0.847 . . . . 74.41 110.521 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 95.2 t -55.87 -47.71 79.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.133 -0.485 . . . . 73.31 111.085 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 324' ' ' LEU . 0.3 OUTLIER -62.69 -48.63 78.46 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.581 -177.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.581 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 22.6 mm-40 -62.46 -41.32 98.68 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 121.119 -0.232 . . . . 74.5 111.212 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.426 ' O ' HG12 ' A' ' 161' ' ' ILE . 6.6 mp -59.98 -47.48 85.63 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.101 0.25 . . . . 72.23 110.619 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.432 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 33.5 t -59.65 -43.97 93.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.217 -0.447 . . . . 54.34 110.561 176.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' HA ' HD12 ' A' ' 162' ' ' LEU . 24.5 tp -63.98 -35.63 81.32 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 116.05 -0.523 . . . . 73.3 110.879 -179.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.686 ' HA ' ' NH1' ' A' ' 160' ' ' ARG . 0.5 OUTLIER -61.14 -45.03 96.31 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.332 0.586 . . . . 73.31 109.761 175.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.479 ' HA ' HG22 ' A' ' 164' ' ' ILE . 49.5 mm -66.22 -35.11 74.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.225 -0.898 . . . . 73.41 110.126 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 159' ' ' LEU . 50.5 mt -56.92 -54.78 42.71 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.219 0.451 . . . . 72.05 112.219 -178.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.462 ' HB2' HD23 ' A' ' 105' ' ' LEU . 11.9 p30 -76.25 -35.05 59.15 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 119.522 -0.871 . . . . 63.12 112.201 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.479 HG22 ' HA ' ' A' ' 161' ' ' ILE . 13.4 tt -67.02 -37.02 78.53 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 120.034 -0.666 . . . . 64.31 110.32 176.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.411 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 47.5 tp -69.59 -36.86 76.63 Favored 'General case' 0 C--O 1.216 -0.705 0 CA-C-N 116.317 -0.401 . . . . 73.44 110.356 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -57.06 -52.52 64.96 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.602 -0.518 . . . . 74.24 109.602 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.9 t80 -58.47 -40.41 82.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.361 -0.836 . . . . 75.12 112.43 -178.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 29.3 pt -92.47 -32.64 5.11 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 113.006 0.743 . . . . 73.0 113.006 -173.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 2.4 t-160 -73.87 -29.71 62.25 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.04 -0.356 . . . . 75.52 110.04 -175.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.65 -27.46 69.24 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.945 -0.571 . . . . 72.14 110.084 174.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.496 ' CE1' ' HE3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -102.24 -67.61 0.86 Allowed 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 115.49 -0.777 . . . . 73.41 112.649 -169.632 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -148.35 -68.39 0.23 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.291 0.849 . . . . 75.34 113.291 -166.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -88.11 146.64 25.32 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 113.321 0.86 . . . . 73.53 113.321 -166.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 202' ' ' TYR . 15.0 m -120.86 149.65 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 107.716 -1.216 . . . . 52.53 107.716 164.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.514 ' CE1' HD13 ' A' ' 178' ' ' ILE . 23.6 p80 -74.67 -29.42 61.23 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.618 -0.433 . . . . 72.33 111.669 -173.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.575 ' O ' HD13 ' A' ' 246' ' ' ILE . . . 75.45 -59.77 2.84 Favored Glycine 0 C--O 1.226 -0.384 0 C-N-CA 120.932 -0.652 . . . . 63.25 113.168 176.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.799 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 9.8 t70 -104.9 131.61 52.17 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 109.911 -0.403 . . . . 72.11 109.911 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.587 ' HB ' HG22 ' A' ' 246' ' ' ILE . 7.8 tp -114.69 14.43 8.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 N-CA-C 111.942 0.349 . . . . 71.2 111.942 -178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.53 ' HD2' ' HE2' ' A' ' 227' ' ' PHE . 50.5 tptt -57.34 152.27 14.54 Favored 'General case' 0 N--CA 1.466 0.374 0 O-C-N 122.23 -0.294 . . . . 62.15 110.586 -175.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -59.19 -14.8 11.87 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.081 0.4 . . . . 44.24 112.081 -178.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 22.7 p -76.99 -15.11 59.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.942 0.401 . . . . 25.14 110.705 178.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.599 HD21 HD22 ' A' ' 200' ' ' LEU . 3.0 m-20 -90.35 -12.08 38.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.048 -0.524 . . . . 52.42 111.104 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -114.74 131.5 56.75 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.099 0.476 . . . . 72.53 110.235 177.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.9 OUTLIER -127.53 157.16 40.88 Favored 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 115.571 -0.74 . . . . 73.12 110.378 179.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.579 HD11 HD23 ' A' ' 341' ' ' LEU . 48.9 mt -106.16 149.07 27.15 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.864 -0.607 . . . . 62.11 109.72 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.599 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 24.0 t-20 -64.07 121.4 14.07 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.131 -1.433 . . . . 72.54 107.131 168.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.592 ' HE1' ' HE ' ' A' ' 133' ' ' ARG . 1.7 p90 -70.27 -15.78 62.94 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 119.3 -0.96 . . . . 72.14 110.582 -167.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -88.16 -28.62 21.11 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.962 -0.563 . . . . 74.35 110.448 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.546 ' HB3' ' OD1' ' A' ' 191' ' ' ASP . 45.2 m-80 -136.2 109.59 9.76 Favored Pre-proline 0 C--O 1.233 0.207 0 CA-C-O 120.809 0.337 . . . . 72.13 111.211 177.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 13.6 Cg_exo -69.63 -7.73 21.77 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.263 2.642 . . . . 75.44 112.95 -177.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HD3' ' A' ' 338' ' ' LYS . 9.9 p-10 -85.95 -7.65 58.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.329 0.585 . . . . 73.34 110.268 178.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.657 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 80.6 mt-30 -101.23 91.95 4.74 Favored 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 115.586 -0.734 . . . . 74.52 110.029 -179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.5 p -102.96 122.81 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.832 -0.622 . . . . 61.45 110.024 -179.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.657 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 64.8 m-85 -128.39 151.77 48.97 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.935 -0.575 . . . . 64.42 110.292 -177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 196' ' ' VAL . 3.3 tt -84.87 150.51 24.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 107.218 -1.401 . . . . 73.14 107.218 171.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.541 ' N ' HD23 ' A' ' 195' ' ' LEU . 31.6 m -56.78 178.96 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 CA-C-O 120.772 0.32 . . . . 61.11 111.618 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 83' ' ' GLU . 3.4 m-20 -63.7 11.43 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.121 0.786 . . . . 75.14 113.121 -174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.472 ' H ' ' C ' ' A' ' 196' ' ' VAL . 6.1 m-85 61.5 43.7 10.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.774 0.797 . . . . 72.21 110.981 -175.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.513 ' O ' HG23 ' A' ' 354' ' ' ILE . . . -68.96 -10.73 62.12 Favored Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 109.685 -1.366 . . . . 61.12 109.685 166.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.599 HD22 HD21 ' A' ' 182' ' ' ASN . 5.7 mp -113.56 104.89 12.71 Favored 'General case' 0 C--O 1.238 0.471 0 N-CA-C 108.072 -1.084 . . . . 73.24 108.072 166.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.871 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -163.24 107.55 1.06 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.795 -0.638 . . . . 42.33 110.745 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.518 ' O ' HG22 ' A' ' 174' ' ' VAL . 55.1 t80 -99.4 126.0 45.2 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.841 -0.8 . . . . 75.51 108.841 177.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.585 ' NH2' ' H ' ' A' ' 207' ' ' GLU . 14.8 ptm180 -81.97 123.84 29.24 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.123 0.487 . . . . 65.54 110.79 -177.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.506 ' HD1' ' HB1' ' A' ' 237' ' ' ALA . 18.4 t80 -84.36 -18.4 36.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.725 -0.671 . . . . 72.01 109.952 -179.173 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 55.5 m -118.24 85.77 25.57 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 115.934 -0.575 . . . . 71.13 110.91 177.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 209' ' ' VAL . 13.1 Cg_exo -70.5 103.69 1.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 122.607 2.204 . . . . 74.15 111.124 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.585 ' H ' ' NH2' ' A' ' 203' ' ' ARG . 28.8 tt0 70.11 -1.28 2.47 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.991 -0.549 . . . . 74.24 111.031 178.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 120.32 -12.25 10.45 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 121.238 -0.506 . . . . 41.44 111.864 -177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 206' ' ' PRO . 49.6 t -69.46 132.63 32.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.976 0.417 . . . . 75.41 111.241 -178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 74.0 m80 -105.97 110.13 22.3 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.173 -0.677 . . . . 71.43 109.173 174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.425 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 17.2 mmmt -103.76 152.75 21.48 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.155 0.798 . . . . 70.14 113.155 -170.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.7 mp0 -89.33 -166.36 1.57 Allowed 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 114.496 -1.229 . . . . 72.21 109.514 174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.695 ' HA ' HG21 ' A' ' 236' ' ' VAL . 21.6 p90 -76.48 152.15 36.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.186 0.517 . . . . 74.33 111.603 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' A' ' 215' ' ' GLU . 21.6 ttmm -140.92 -53.33 0.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.669 -0.696 . . . . 75.24 110.994 -179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.423 ' HB3' ' O ' ' A' ' 214' ' ' LYS . 41.9 tt0 72.54 111.0 0.06 Allowed 'General case' 0 N--CA 1.466 0.357 0 O-C-N 123.861 0.726 . . . . 72.32 110.491 -176.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -91.12 134.65 29.61 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.264 -0.88 . . . . 51.15 110.505 -176.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.28 -23.43 74.26 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 123.149 2.566 . . . . 50.23 113.173 -178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -101.32 3.05 40.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.68 0.276 . . . . 75.4 110.862 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 72.0 mtt180 53.23 81.63 0.09 Allowed 'General case' 0 C--O 1.233 0.214 0 CA-C-N 115.53 -0.759 . . . . 74.32 111.998 176.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.426 ' O ' HG21 ' A' ' 355' ' ' THR . 80.1 m -80.24 67.51 6.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.406 0.622 . . . . 70.12 111.292 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 17.8 p80 -79.33 140.89 37.4 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.409 -0.814 . . . . 71.12 109.744 171.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -86.94 -53.04 5.11 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.117 0.484 . . . . 71.23 110.068 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.799 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -103.61 -158.2 24.69 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.68 -0.772 . . . . 73.44 112.431 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 38.7 p -79.07 144.21 34.83 Favored 'General case' 0 C--N 1.328 -0.335 0 O-C-N 122.775 -0.25 . . . . 54.21 110.486 -179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.491 HD13 HG21 ' A' ' 271' ' ' VAL . 15.7 tt -55.1 -24.67 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 121.324 0.583 . . . . 74.41 111.177 -178.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -55.42 -61.96 1.99 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.17 -0.923 . . . . 64.41 111.489 175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.768 ' HZ ' ' HG3' ' A' ' 253' ' ' GLN . 10.7 m-85 -103.95 -22.37 13.49 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.902 0.705 . . . . 73.22 112.902 -173.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 1.0 OUTLIER -70.05 -7.34 40.32 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.997 0.427 . . . . 74.34 110.462 -178.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 25.7 t 68.58 175.91 0.27 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.347 -0.842 . . . . 74.34 111.082 177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.493 HD11 ' NH1' ' A' ' 279' ' ' ARG . 4.9 pt -71.42 -32.77 47.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.7 -0.682 . . . . 72.24 110.229 177.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.591 ' HB3' ' HB3' ' A' ' 238' ' ' PRO . 2.2 m-20 -46.43 -69.21 0.14 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 115.269 -0.878 . . . . 72.44 111.188 177.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 221' ' ' HIS . . . -68.83 -29.04 67.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.397 -0.365 . . . . 73.22 111.2 -179.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.673 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 26.6 t-80 -55.17 -41.91 72.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.831 0.348 . . . . 75.51 110.915 178.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 -79.56 0.94 27.8 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.978 -0.556 . . . . 75.11 111.486 -175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.416 ' HA3' ' H ' ' A' ' 220' ' ' CYS . . . 72.33 32.8 62.14 Favored Glycine 0 CA--C 1.508 -0.359 0 C-N-CA 120.965 -0.636 . . . . 71.41 112.687 176.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.695 HG21 ' HA ' ' A' ' 213' ' ' TYR . 3.4 p -120.95 140.94 43.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 N-CA-C 110.281 -0.266 . . . . 74.02 110.281 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.506 ' HB1' ' HD1' ' A' ' 204' ' ' TYR . . . -54.76 110.64 2.28 Favored Pre-proline 0 N--CA 1.454 -0.228 0 N-CA-C 109.008 -0.738 . . . . 51.32 109.008 170.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.591 ' HB3' ' HB3' ' A' ' 231' ' ' ASP . 23.6 Cg_exo -62.82 -91.79 0.0 OUTLIER 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.862 2.375 . . . . 40.43 113.866 -167.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.46 ' H ' ' HB2' ' A' ' 238' ' ' PRO . 55.7 p 173.11 -158.25 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.645 -0.502 . . . . 72.51 109.645 -172.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.436 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 4.0 mpt_? -85.52 -45.76 11.48 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 107.878 -1.156 . . . . 70.51 107.878 168.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 19.1 ttt-85 -62.33 -39.55 93.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.032 -1.44 . . . . 74.41 111.686 -174.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.543 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.9 -57.32 12.97 Favored Glycine 0 N--CA 1.452 -0.257 0 CA-C-N 115.976 -0.556 . . . . 64.42 112.765 -178.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.583 ' HA ' HD12 ' A' ' 246' ' ' ILE . 11.6 t70 -67.05 -32.52 73.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.659 0.266 . . . . 65.5 110.482 -177.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 315' ' ' PRO . 77.9 mt -63.57 -39.71 95.08 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.48 -0.327 . . . . 71.14 111.27 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -67.09 -34.98 78.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 121.256 0.55 . . . . 73.2 109.805 177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.587 HG22 ' HB ' ' A' ' 178' ' ' ILE . 70.0 mt -60.64 -42.48 91.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.579 -0.737 . . . . 74.23 110.447 177.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.548 HD12 ' SG ' ' A' ' 250' ' ' CYS . 39.0 tp -66.58 -38.06 86.25 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 116.045 -0.525 . . . . 71.53 109.966 176.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.0 -41.41 96.4 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.779 -0.724 . . . . 72.52 111.38 174.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 246' ' ' ILE . 14.1 m-30 -51.19 -58.84 5.09 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 122.603 0.361 . . . . 74.51 111.403 176.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.548 ' SG ' HD12 ' A' ' 247' ' ' LEU . 30.1 p -61.45 -37.35 83.25 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.821 -0.351 . . . . 71.44 111.662 -173.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 64.9 mtm -60.86 -50.93 71.46 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 120.779 -0.368 . . . . 62.41 111.416 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.472 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.5 tt -70.06 -31.58 48.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.682 -0.407 . . . . 73.21 110.424 -179.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.768 ' HG3' ' HZ ' ' A' ' 227' ' ' PHE . 24.0 tm0? -64.98 -51.79 59.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.56 -0.291 . . . . 64.32 110.573 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.0 m0 -63.3 -40.45 97.38 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.767 0.318 . . . . 74.55 111.565 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.498 ' HG ' ' HE2' ' A' ' 290' ' ' PHE . 33.9 tp -77.86 -30.95 51.2 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.629 0.603 . . . . 74.35 112.629 -172.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 60.6 p -102.11 -26.52 13.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.412 -0.515 . . . . 60.54 110.867 -176.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.541 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 83.96 7.41 85.58 Favored Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.843 -0.694 . . . . 64.51 113.109 176.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -158.07 143.82 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 117.973 0.887 . . . . 74.32 112.49 176.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 89.5 mt -129.48 139.39 35.54 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.332 -0.849 . . . . 32.24 108.798 168.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -56.54 -37.23 97.84 Favored 'Trans proline' 0 C--O 1.234 0.279 0 C-N-CA 122.339 2.026 . . . . 72.12 112.162 -179.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.6 ' HB2' HG12 ' A' ' 271' ' ' VAL . 34.4 p90 -92.5 11.32 26.73 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.957 -178.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 36.8 tt0 -86.46 -39.41 16.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.031 0.443 . . . . 44.23 110.504 178.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 73.5 m-20 -84.15 -24.52 30.18 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.459 0.647 . . . . 73.42 109.339 174.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -107.68 22.63 15.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.111 -0.95 . . . . 71.24 111.189 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.694 ' HA ' ' CG1' ' A' ' 271' ' ' VAL . 3.4 pp -70.78 -13.99 62.26 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.541 0.686 . . . . 54.2 110.302 177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 265' ' ' LEU . 19.9 ptmt -79.01 2.97 18.6 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.786 -1.097 . . . . 75.25 110.796 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.458 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 15.0 t70 -135.01 127.6 18.27 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 55.1 110.441 179.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 22.4 Cg_exo -65.71 -29.58 51.23 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 123.025 2.483 . . . . 73.4 113.558 -176.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? -79.07 -38.08 37.28 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.667 -0.413 . . . . 73.44 110.609 -175.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.425 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 28.8 m-85 -69.29 -49.74 53.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.438 -0.346 . . . . 71.2 111.209 -179.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.694 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 22.3 m -54.7 -40.4 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.109 0 C-N-CA 120.491 -0.484 . . . . 53.52 111.12 173.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.472 ' O ' HG13 ' A' ' 276' ' ' ILE . 42.0 ttt85 -62.07 -55.79 25.44 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.58 0.229 . . . . 72.1 111.12 179.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 24.2 t70 -61.23 -46.33 90.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.25 -0.432 . . . . 73.31 111.353 -174.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.45 ' HB3' ' HE3' ' A' ' 261' ' ' TRP . 69.3 m -60.64 -39.4 88.15 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.518 -0.31 . . . . 53.34 111.175 -179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 271' ' ' VAL . 67.6 mttm -64.71 -40.2 94.94 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.883 -0.327 . . . . 74.11 110.362 176.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 272' ' ' ARG . 81.5 mt -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.24 -0.436 . . . . 73.05 110.027 177.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.45 ' HA ' ' NE ' ' A' ' 277' ' ' ARG . 14.7 mmp_? -56.83 -48.53 77.82 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.12 -0.491 . . . . 73.45 110.985 179.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 20.7 m-85 -67.21 -44.47 79.49 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.836 -0.62 . . . . 70.13 111.845 -177.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.493 ' NH1' HD11 ' A' ' 230' ' ' ILE . 89.2 mtt180 -65.11 -42.1 94.3 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.906 0.384 . . . . 75.22 110.922 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.23 -57.72 8.66 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.847 -0.615 . . . . 72.54 111.19 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.621 ' ND2' ' HB2' ' A' ' 284' ' ' SER . 61.6 t30 -115.36 59.03 0.71 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.051 0.453 . . . . 73.11 110.904 -171.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.563 HG12 ' N ' ' A' ' 283' ' ' ALA . 0.2 OUTLIER -51.7 -51.45 26.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.671 0.619 . . . . 74.44 112.671 -176.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.563 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.93 -47.88 83.49 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.106 0.41 . . . . 72.31 112.106 -172.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.621 ' HB2' ' ND2' ' A' ' 281' ' ' ASN . 5.1 m -77.69 -28.46 51.07 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.38 -0.373 . . . . 70.02 111.02 -175.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.431 HD23 ' HB3' ' A' ' 281' ' ' ASN . 2.7 mm? -68.76 -54.74 14.2 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 120.998 -0.281 . . . . 65.01 110.529 178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.412 ' HG2' HG22 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -60.07 -41.26 92.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.702 0.287 . . . . 73.32 110.976 179.323 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -57.28 -51.61 68.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.841 -0.618 . . . . 62.03 111.423 -177.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -91.19 3.54 54.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.244 0.461 . . . . 75.02 112.244 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 59.8 m -79.56 -23.64 42.65 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.604 -0.517 . . . . 73.22 109.604 171.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.498 ' HE2' ' HG ' ' A' ' 255' ' ' LEU . 0.4 OUTLIER -133.64 73.85 71.58 Favored Pre-proline 0 N--CA 1.451 -0.417 0 CA-C-N 116.295 -0.412 . . . . 72.31 110.98 178.208 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -86.48 32.49 0.45 Allowed 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.724 2.283 . . . . 75.43 111.106 175.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.39 171.2 8.14 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 115.214 -0.903 . . . . 70.44 109.259 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 20.8 pttp -73.24 86.27 1.43 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.561 0.696 . . . . 74.24 111.82 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.636 HD21 ' HD3' ' A' ' 151' ' ' ARG . 12.6 t30 -152.48 -89.12 0.06 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.537 -0.756 . . . . 75.22 110.047 173.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.723 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 0.9 OUTLIER 169.73 102.77 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.151 0 N-CA-C 109.578 -0.527 . . . . 74.51 109.578 -177.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -99.02 50.33 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 123.241 2.627 . . . . 63.11 112.228 175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -117.14 -46.18 0.51 Allowed Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.208 -0.996 . . . . 43.25 113.529 -175.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.576 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 2.6 mp0 -58.2 -56.56 20.47 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.951 0.405 . . . . 73.32 111.03 -175.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.494 HD12 ' H ' ' A' ' 299' ' ' ILE . 3.7 mp -63.1 -33.94 63.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.866 -0.607 . . . . 70.32 110.407 -177.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.42 -53.93 50.11 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.042 -0.527 . . . . 72.15 110.922 -179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 4.1 mptp? -71.5 -27.83 63.49 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.096 -0.502 . . . . 65.13 111.158 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.478 ' CD2' HD22 ' A' ' 320' ' ' LEU . 33.6 t80 -62.1 -53.11 60.13 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.942 0.401 . . . . 71.54 110.282 177.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.593 ' HA ' HG22 ' A' ' 306' ' ' VAL . 70.1 mtp -72.61 -31.89 65.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.95 -0.568 . . . . 60.33 110.914 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.506 ' HA ' HG13 ' A' ' 282' ' ' ILE . 36.9 tt0 -60.85 -46.84 88.98 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.296 0.57 . . . . 63.01 109.572 172.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.652 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 29.0 m -57.09 -52.97 63.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.118 -0.946 . . . . 74.41 111.212 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 24.9 m -63.34 -32.33 56.13 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.136 0 C-N-CA 121.068 -0.253 . . . . 45.14 111.336 -177.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.515 ' HA ' ' HE ' ' A' ' 241' ' ' ARG . 86.7 tttt -60.49 -48.09 83.3 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.996 0.427 . . . . 64.41 110.187 176.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 47.4 tp -70.78 -19.69 62.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.696 -0.684 . . . . 63.51 111.297 -178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.759 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 53.1 mt -72.81 -19.26 61.37 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 112.265 0.469 . . . . 71.04 112.265 -177.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.591 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 21.6 t70 62.09 -179.86 0.13 Allowed 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.918 0.389 . . . . 75.45 110.304 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 11.0 m-30 -84.39 -23.39 30.11 Favored 'General case' 0 C--N 1.322 -0.592 0 O-C-N 121.782 -0.574 . . . . 63.44 110.065 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 6.5 m -95.88 -24.43 16.44 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.043 0.757 . . . . 54.15 113.043 -170.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.759 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 5.2 mm-40 -87.28 -172.99 4.19 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.136 -0.626 . . . . 74.12 112.03 -169.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.654 ' H ' ' HD2' ' A' ' 314' ' ' LYS . 7.4 mptt -85.44 132.2 45.58 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 115.32 -0.855 . . . . 71.42 110.782 -172.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.593 ' HA ' HD13 ' A' ' 309' ' ' LEU . 57.7 Cg_endo -74.08 118.41 5.39 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.097 1.864 . . . . 64.55 111.226 174.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.587 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 91.3 mt -87.54 77.32 8.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.319 -0.4 . . . . 62.21 111.36 -175.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -63.21 -34.02 76.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.013 -0.539 . . . . 74.13 110.423 178.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -58.21 -51.09 71.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.911 -0.586 . . . . 72.25 110.323 177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 9.4 t30 -65.28 -42.29 93.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.497 -0.774 . . . . 73.1 110.664 -178.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.587 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 90.5 mt -63.45 -43.14 98.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.057 -0.52 . . . . 72.21 110.67 -179.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 50.0 ttp85 -56.44 -52.56 64.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 74.31 110.703 177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -62.05 -44.72 96.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.657 -0.701 . . . . 73.44 111.769 -173.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -71.0 -32.95 50.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 120.762 -0.375 . . . . 64.23 111.777 -175.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 155' ' ' LEU . 88.8 mt -69.47 -49.59 53.4 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.242 0.544 . . . . 74.3 110.406 178.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.438 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.3 mm? -67.88 -26.83 66.21 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.939 -0.573 . . . . 64.05 110.697 179.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -64.22 -47.57 79.2 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.908 0.385 . . . . 51.24 110.264 177.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -61.58 -38.7 96.28 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.923 -0.656 . . . . 63.41 112.0 179.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.474 ' HB3' ' O ' ' A' ' 333' ' ' SER . 3.9 mm? -73.4 -32.46 64.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.88 0.371 . . . . 72.03 111.135 176.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -65.26 -24.21 67.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.916 0.388 . . . . 73.15 110.508 178.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.8 -24.46 65.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.019 -0.537 . . . . 72.43 111.267 176.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 49.1 pt -111.95 13.19 8.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.985 0.421 . . . . 61.31 110.588 176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.22 25.08 75.35 Favored Glycine 0 C--N 1.333 0.401 0 CA-C-N 115.867 -0.606 . . . . 71.41 113.033 176.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.474 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 37.5 m -120.51 145.49 47.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.313 0.578 . . . . 75.14 111.761 -176.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 10.3 mtpm? -140.27 -72.71 0.36 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.383 -0.826 . . . . 75.12 109.168 174.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.2 115.49 2.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 114.796 -1.093 . . . . 74.12 109.557 179.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -164.06 -69.35 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.399 -0.819 . . . . 74.52 109.146 -176.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -79.16 87.34 1.19 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.918 -0.873 . . . . 53.55 110.918 171.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HD3' ' HB2' ' A' ' 191' ' ' ASP . 89.2 mttt -43.25 102.28 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 113.569 0.951 . . . . 73.41 113.569 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 153' ' ' THR . 35.6 mt 62.44 -174.32 0.15 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.181 -0.918 . . . . 72.23 112.837 171.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -145.31 7.51 1.16 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.433 -0.803 . . . . 65.42 110.324 -177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.583 HD11 HG21 ' A' ' 141' ' ' ILE . 9.5 tp -78.44 -52.82 7.99 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.455 -0.339 . . . . 74.2 110.989 -170.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 50.1 m 58.86 23.7 11.63 Favored 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 112.725 0.639 . . . . 74.55 112.725 174.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 27.5 m 38.77 83.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 C-N-CA 123.874 0.87 . . . . 71.02 112.789 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.86 HG11 ' HB2' ' A' ' 145' ' ' ASN . 7.3 p -63.5 -55.86 20.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 115.63 -0.714 . . . . 61.12 111.465 -177.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.449 ' N ' HG13 ' A' ' 344' ' ' VAL . 2.6 mp0 -149.56 -176.23 5.32 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 110.235 -0.283 . . . . 73.25 110.235 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -105.96 176.46 5.16 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.221 -0.445 . . . . 73.34 110.564 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -168.21 -169.51 31.78 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 110.827 -0.909 . . . . 53.1 110.827 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -119.53 112.79 2.34 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.638 -0.792 . . . . 63.4 112.338 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.559 HD23 ' H ' ' A' ' 349' ' ' LEU . 2.6 pt? -93.77 168.07 11.23 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.885 0.374 . . . . 71.3 110.801 -179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 92.8 mttt -125.36 130.97 53.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.984 -0.553 . . . . 65.31 109.867 174.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.496 ' HB1' ' HD1' ' A' ' 48' ' ' PHE . . . -88.71 163.02 15.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.265 -0.425 . . . . 74.31 111.022 -177.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.587 ' HB2' HD21 ' A' ' 200' ' ' LEU . 40.8 mtmt -138.95 176.56 8.59 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.661 -0.496 . . . . 74.25 109.661 -178.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 8.0 t -144.79 162.43 36.79 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.525 0.202 . . . . 64.31 111.092 -174.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.871 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -66.39 143.64 15.43 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-N 115.966 -0.561 . . . . 64.01 111.638 -179.311 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.426 HG21 ' O ' ' A' ' 220' ' ' CYS . 13.2 t -79.75 132.79 36.25 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.509 -0.768 . . . . 73.43 109.267 173.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 43.1 tttp -150.75 7.73 0.56 Allowed 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.57 -0.452 . . . . 72.52 111.374 -176.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 68.3 mttm 64.09 -90.88 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.073 -0.512 . . . . 72.22 109.909 -173.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 64.1 mtt-85 -147.7 170.11 18.25 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.984 -0.376 . . . . 74.43 109.984 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -90.63 -177.15 4.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.006 0.431 . . . . 64.13 111.315 -175.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.474 ' HB2' ' HE2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.064 -0.969 . . . . 75.45 110.766 -179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mpt? . . . . . 0 N--CA 1.479 1.014 0 N-CA-C 109.871 -0.418 . . . . 65.14 109.871 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -73.97 136.67 23.06 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.302 2.002 . . . . 62.54 112.474 -176.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.571 ' O ' ' HD2' ' A' ' 3' ' ' ARG . 6.2 ppt_? -177.51 104.65 0.05 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.383 -0.826 . . . . 74.22 109.586 177.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 67.6 t -120.35 120.22 62.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.12 -0.491 . . . . 44.43 110.547 -177.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -126.15 100.32 6.27 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.164 0.507 . . . . 73.12 110.997 178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -167.66 90.03 0.32 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.414 -0.812 . . . . 64.42 109.637 178.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.57 90.39 3.27 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 120.855 0.36 . . . . 64.24 111.122 -177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 20.0 pm0 -88.78 135.92 33.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.111 -0.495 . . . . 74.04 110.092 178.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -108.37 118.58 37.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.347 -0.388 . . . . 74.05 110.442 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.87 132.62 11.0 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.807 -0.711 . . . . 35.41 111.981 179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 11' ' ' ARG . 38.0 ttt180 -156.19 105.93 2.35 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.043 -0.355 . . . . 73.34 110.043 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -130.79 128.93 41.72 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.089 0.471 . . . . 74.25 110.444 178.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -106.41 121.58 44.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.948 -0.569 . . . . 75.11 110.55 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 55.5 m -157.38 133.85 9.81 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.155 -0.475 . . . . 61.02 110.174 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -158.34 146.75 18.7 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.362 -0.381 . . . . 54.3 110.998 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.1 mppt? -129.92 156.38 44.52 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.076 -0.511 . . . . 72.3 109.979 177.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 35.4 ttm-85 -134.88 115.29 13.45 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.343 -0.614 . . . . 62.41 109.343 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 22.2 p80 -119.06 118.06 30.41 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.023 0.44 . . . . 74.53 111.283 -176.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.5 tp -175.19 112.84 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.59 -0.732 . . . . 72.1 109.906 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -156.75 98.8 1.81 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.231 -0.44 . . . . 53.35 110.053 178.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 56.5 mm-40 -111.48 131.87 54.9 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.052 0.453 . . . . 73.34 110.64 -176.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -84.42 49.03 1.6 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.975 -0.557 . . . . 73.31 112.064 -173.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -89.31 -49.83 6.48 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.144 -0.687 . . . . 63.54 109.144 173.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -168.89 -72.88 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.799 -1.091 . . . . 70.21 108.446 176.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 95.4 t -66.85 126.32 26.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 115.688 -0.687 . . . . 74.14 109.802 170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.72 1.72 56.34 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.601 -0.809 . . . . 70.03 113.482 176.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -78.96 153.46 30.35 Favored 'General case' 0 C--O 1.237 0.439 0 CA-C-N 117.585 0.692 . . . . 74.54 109.464 175.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.417 ' HA ' HD12 ' A' ' 28' ' ' ILE . 0.9 OUTLIER -89.9 131.57 36.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 121.355 0.597 . . . . 65.45 111.01 -175.447 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 63.5 mt -124.53 137.45 57.27 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.763 0 CA-C-N 115.132 -0.94 . . . . 74.04 109.536 178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.53 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.6 m -117.49 120.4 37.98 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.569 -0.287 . . . . 74.42 110.405 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.405 ' OD1' ' HB2' ' A' ' 35' ' ' LYS . 4.9 p-10 -91.04 -169.53 2.38 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.267 -0.424 . . . . 74.21 110.336 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 11.2 mmt -72.2 -17.81 61.9 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.797 0.295 . . . . 72.32 111.797 -173.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -87.95 9.49 22.04 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.673 0.273 . . . . 72.11 110.979 179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 59.8 mttm 69.4 17.73 8.06 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 115.71 -0.677 . . . . 74.13 111.497 175.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.787 ' HE2' ' HA ' ' A' ' 35' ' ' LYS . 10.3 mmpt? -83.7 127.17 33.58 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.62 -0.511 . . . . 75.04 109.62 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -107.01 92.38 4.06 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.257 0.551 . . . . 73.0 109.738 -179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 7.6 p-90 -116.05 172.18 7.33 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.389 -0.823 . . . . 72.13 111.164 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -98.47 145.93 26.27 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.917 -0.583 . . . . 73.04 110.322 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 p -95.41 103.69 14.98 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 N-CA-C 108.617 -0.882 . . . . 71.31 108.617 166.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.94 -129.97 6.73 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.652 -0.785 . . . . 64.21 113.687 -170.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.9 mp -69.84 131.11 89.54 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.94 0.4 . . . . 61.33 111.827 -172.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 17.0 Cg_exo -67.76 124.0 11.4 Favored 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 122.883 2.388 . . . . 43.34 111.425 174.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.519 HD11 ' HB2' ' A' ' 53' ' ' LEU . 59.3 mt -104.86 -66.33 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.047 0.451 . . . . 71.24 110.699 -178.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.426 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 94.97 102.47 1.82 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.785 -0.721 . . . . 53.54 111.732 -175.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.438 ' H ' HG12 ' A' ' 51' ' ' ILE . 45.7 tp60 -86.55 165.71 16.01 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.344 -0.243 . . . . 75.02 110.344 -178.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -71.11 -29.46 68.76 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 121.12 -0.562 . . . . 63.05 113.776 -170.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' ' CB ' ' A' ' 351' ' ' ALA . . . -71.16 -63.3 3.17 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.796 -0.716 . . . . 73.51 112.85 -176.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -116.95 -34.71 4.33 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.647 0.261 . . . . 64.31 111.583 -175.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.01 -179.79 45.53 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.796 -0.716 . . . . 50.4 112.695 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 91.0 m 63.32 30.37 15.64 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.5 0.667 . . . . 75.42 111.136 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 71' ' ' LYS . 34.6 mm -89.33 136.79 22.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.55 -0.75 . . . . 73.52 109.675 -179.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -107.48 145.92 32.44 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.197 0.523 . . . . 74.03 111.113 -174.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.519 ' HB2' HD11 ' A' ' 43' ' ' ILE . 64.1 tp -79.29 145.66 33.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.326 -0.852 . . . . 72.04 109.711 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -119.91 116.61 26.16 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 109.397 -0.594 . . . . 73.32 109.397 175.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.458 ' HA ' ' HB2' ' A' ' 66' ' ' ALA . 25.6 m-20 -76.76 -50.88 12.49 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.183 -0.673 . . . . 64.22 109.183 -178.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 22.0 ttt 48.37 43.72 19.63 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 115.25 -0.886 . . . . 71.41 109.931 -176.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -72.23 77.11 0.98 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.395 -0.821 . . . . 74.22 110.447 -177.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.4 m -126.78 -162.61 1.16 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.136 -0.938 . . . . 62.0 110.275 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 65.6 m -98.01 7.8 45.75 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.623 0.249 . . . . 63.41 111.617 -177.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -80.02 49.3 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.783 0.325 . . . . 74.34 110.899 177.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 25.0 m 62.12 86.21 0.11 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.619 -0.719 . . . . 74.24 111.888 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.7 p -81.48 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 115.739 -0.664 . . . . 74.42 110.366 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -94.12 -123.91 3.85 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 110.53 -1.028 . . . . 75.02 110.53 174.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.444 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 16.9 m -84.28 61.94 6.86 Favored 'General case' 0 C--N 1.318 -0.791 0 N-CA-C 108.744 -0.835 . . . . 63.41 108.744 170.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.666 ' O ' ' HD3' ' A' ' 67' ' ' PRO . 5.5 m-20 72.65 -83.32 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.725 0 CA-C-N 114.783 -1.098 . . . . 71.23 110.946 -174.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 55' ' ' ASP . . . -96.54 102.44 11.39 Favored Pre-proline 0 C--N 1.318 -0.774 0 CA-C-N 115.366 -0.834 . . . . 52.13 110.339 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.666 ' HD3' ' O ' ' A' ' 65' ' ' ASP . 86.2 Cg_endo -95.94 11.07 1.41 Allowed 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.855 2.37 . . . . 75.44 110.994 176.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.441 ' HB2' HG23 ' A' ' 130' ' ' ILE . 7.0 p -145.91 153.92 41.37 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.602 0.715 . . . . 72.44 112.905 -174.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.471 HG13 ' HD2' ' A' ' 133' ' ' ARG . 15.3 m -136.89 153.82 30.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.035 -0.984 . . . . 64.01 109.098 173.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.565 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 3.9 p -122.42 122.64 66.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.3 0.571 . . . . 62.2 111.646 -178.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 128' ' ' PHE . 22.6 ttpt -87.24 126.63 34.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.71 -0.677 . . . . 64.41 109.781 174.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.63 123.15 70.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 123.745 0.653 . . . . 74.44 110.009 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.458 ' OE1' ' HD2' ' A' ' 79' ' ' PRO . 41.7 mt-10 -140.69 152.51 66.13 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.356 -0.383 . . . . 75.32 110.344 -177.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -58.51 126.0 20.05 Favored 'Trans proline' 0 CA--C 1.529 0.238 0 C-N-CA 122.591 2.194 . . . . 64.41 111.964 176.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.4 t -85.74 -15.97 40.43 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.128 0.49 . . . . 61.41 110.36 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -80.63 -20.08 43.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.863 -0.608 . . . . 73.11 110.78 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -172.07 96.95 0.16 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.216 -0.661 . . . . 73.41 109.216 179.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.402 ' HA2' ' HD3' ' A' ' 79' ' ' PRO . . . -163.78 145.62 10.65 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.032 -1.08 . . . . 53.31 113.224 -177.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 73' ' ' GLU . 34.0 Cg_exo -60.88 -19.59 62.85 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 123.98 3.12 . . . . 50.1 112.285 176.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 80' ' ' LEU . 2.2 tm? -50.72 -30.05 12.89 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.855 -0.611 . . . . 54.32 110.741 178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -55.72 -48.38 75.29 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-O 120.76 0.314 . . . . 71.53 110.828 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.6 m -67.63 -41.99 83.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.11 0.481 . . . . 73.53 110.481 179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 15.8 mm-40 -58.45 -42.52 87.59 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.562 -0.744 . . . . 65.01 110.513 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.68 -32.5 73.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.741 -0.663 . . . . 54.42 110.999 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 89' ' ' ARG . 66.7 mmtt -63.55 -46.85 84.07 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.922 -0.311 . . . . 64.32 110.451 177.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 93.3 t80 -64.06 -39.95 95.2 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.165 0.507 . . . . 73.04 110.048 176.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.573 ' O ' ' HB3' ' A' ' 91' ' ' ALA . 48.0 t80 -63.29 -34.4 77.59 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.407 -0.815 . . . . 73.43 110.662 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -77.51 -32.67 54.3 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.82 0.343 . . . . 74.31 111.345 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.633 ' HG3' ' CE2' ' A' ' 173' ' ' TYR . 39.5 mmt180 -78.73 -49.21 13.46 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 112.091 0.404 . . . . 74.11 112.091 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -102.83 -31.47 10.27 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.859 0.688 . . . . 73.42 112.859 -170.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.573 ' HB3' ' O ' ' A' ' 87' ' ' TYR . . . -84.42 89.0 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.42 0.628 . . . . 72.34 111.324 -176.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.543 ' HB3' ' HB3' ' A' ' 95' ' ' GLN . 8.9 tmtt? -154.04 91.98 3.11 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.525 -0.917 . . . . 71.12 108.525 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.613 ' HD3' ' HB3' ' A' ' 113' ' ' TYR . 95.6 Cg_exo -44.25 -52.56 5.62 Favored 'Trans proline' 0 N--CA 1.477 0.552 0 C-N-CA 123.952 3.101 . . . . 73.21 114.53 -170.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -59.7 -45.16 92.96 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.122 0.487 . . . . 74.24 110.625 -178.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.543 ' HB3' ' HB3' ' A' ' 92' ' ' LYS . 6.9 tp60 -66.27 -44.39 83.77 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.707 -0.678 . . . . 73.43 110.565 -178.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.483 HG13 ' O ' ' A' ' 92' ' ' LYS . 68.4 mt -58.94 -53.75 43.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 115.977 -0.556 . . . . 64.44 110.574 -179.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -55.54 -38.88 69.86 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.236 -0.438 . . . . 54.2 110.593 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -61.07 -62.3 1.95 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.773 -0.648 . . . . 74.35 111.371 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.802 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 0.3 OUTLIER -71.3 -34.36 70.56 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.253 -0.579 . . . . 71.41 111.105 -173.476 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.407 HD13 ' HA ' ' A' ' 100' ' ' ILE . 17.0 mm -58.75 -50.68 78.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.131 0 CA-C-O 120.312 0.101 . . . . 72.04 111.027 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 68.4 ttt180 -69.4 -36.85 77.14 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.657 -0.417 . . . . 62.33 110.806 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 41.5 m -64.43 -40.48 95.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.409 . . . . 54.21 110.782 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.483 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 7.8 ttt180 -83.38 0.97 43.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.055 -0.52 . . . . 72.04 110.374 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.403 ' HE3' ' HB3' ' A' ' 104' ' ' LYS . 26.0 mtpp 66.54 29.62 8.91 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.358 -0.837 . . . . 72.33 111.532 176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.483 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 89.1 mt -92.34 176.7 6.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.72 -0.673 . . . . 53.45 109.942 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.777 ' HE2' ' HA ' ' A' ' 106' ' ' LYS . 10.8 mmpt? -103.37 -55.01 2.48 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.595 -0.275 . . . . 74.45 111.051 -178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 41.6 p90 -157.51 171.18 20.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.472 -0.331 . . . . 72.23 110.109 -178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.802 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 39.3 tp -129.32 137.57 51.08 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.995 -0.372 . . . . 73.21 109.995 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.86 64.21 3.06 Favored Glycine 0 CA--C 1.518 0.279 0 C-N-CA 121.155 -0.545 . . . . 25.41 113.253 -178.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 p -126.39 135.8 27.71 Favored Pre-proline 0 C--N 1.322 -0.603 0 N-CA-C 110.065 -0.346 . . . . 70.25 110.065 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.07 135.07 30.11 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 123.039 2.492 . . . . 42.41 112.509 178.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.861 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 24.2 tptm -66.75 124.06 21.86 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.88 -0.6 . . . . 73.43 111.001 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.613 ' HB3' ' HD3' ' A' ' 93' ' ' PRO . 14.0 t80 -81.27 112.56 18.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.67 -0.695 . . . . 71.32 111.022 179.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.603 ' HB2' HG22 ' A' ' 130' ' ' ILE . 68.9 m95 -105.42 -52.51 2.82 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.624 -0.88 . . . . 73.13 108.624 169.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.44 46.91 Favored Glycine 0 N--CA 1.444 -0.769 0 CA-C-N 115.008 -0.996 . . . . 45.04 111.759 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 13.5 p -168.74 162.84 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.625 -0.509 . . . . 73.02 109.625 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -175.67 -179.44 46.18 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 119.754 -1.212 . . . . 70.31 113.207 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.51 HD23 ' N ' ' A' ' 119' ' ' HIS . 5.9 tt -123.88 137.74 54.59 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.688 -0.856 . . . . 75.35 108.688 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.51 ' N ' HD23 ' A' ' 118' ' ' LEU . 0.1 OUTLIER -134.84 147.7 49.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.323 0.582 . . . . 73.44 110.822 178.76 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -103.97 140.96 37.0 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.389 -0.823 . . . . 71.01 110.175 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.461 ' HB2' ' CE1' ' A' ' 126' ' ' TYR . 43.4 tttm -108.66 17.64 21.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.638 -0.255 . . . . 65.11 110.501 -178.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 121' ' ' LYS . 56.8 m-80 71.27 97.68 0.07 Allowed 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 123.309 0.644 . . . . 71.53 110.207 -174.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 105.05 -44.81 1.4 Allowed Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.807 -0.711 . . . . 65.34 112.012 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -129.69 138.25 51.06 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.831 -0.433 . . . . 74.3 109.831 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 8.0 m -101.53 140.57 35.64 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.305 -0.407 . . . . 75.41 110.349 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.461 ' CE1' ' HB2' ' A' ' 121' ' ' LYS . 35.5 p90 -128.3 149.94 50.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 121.182 0.515 . . . . 60.35 110.155 176.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -117.57 142.42 47.22 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.027 -0.731 . . . . 74.1 109.027 -176.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.503 ' HA ' ' O ' ' A' ' 71' ' ' LYS . 50.6 p90 -137.93 153.07 49.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.989 0.423 . . . . 53.12 111.291 -175.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.473 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 20.0 ptp -139.75 139.42 36.48 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.982 -0.554 . . . . 74.45 110.576 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.603 HG22 ' HB2' ' A' ' 114' ' ' TRP . 5.0 mm -98.17 118.69 45.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.859 -0.61 . . . . 62.5 110.065 176.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.416 ' SD ' HG21 ' A' ' 196' ' ' VAL . 25.1 ptt? -123.2 171.1 9.6 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.13 -0.693 . . . . 71.24 109.13 177.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.861 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 2.8 t70 -65.2 162.15 17.77 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.787 0.327 . . . . 72.23 110.442 -177.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.471 ' HD2' HG13 ' A' ' 69' ' ' VAL . 1.7 tpt180 -76.57 112.79 13.48 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.44 0.638 . . . . 61.31 110.862 -176.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 20.9 m-85 -103.11 143.08 33.06 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.942 -0.762 . . . . 75.12 108.942 175.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -136.92 -2.15 2.5 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.291 -0.957 . . . . 55.42 112.233 -178.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 1.093 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.8 m -121.83 125.27 46.1 Favored 'General case' 0 C--N 1.318 -0.762 0 O-C-N 122.845 -0.209 . . . . 70.53 110.512 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.482 ' HA ' HD13 ' A' ' 184' ' ' LEU . 6.4 p-10 -116.35 139.67 50.16 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.434 -0.58 . . . . 72.02 109.434 176.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.863 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 5.6 tp -68.95 -15.34 63.46 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.718 -0.219 . . . . 60.13 110.928 -174.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.645 ' HB3' HD13 ' A' ' 349' ' ' LEU . 41.6 mm-40 -62.3 -50.19 72.66 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.012 0.434 . . . . 51.41 110.963 177.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.865 ' HB2' ' HA3' ' A' ' 347' ' ' GLY . 4.4 tppp? -80.6 -23.24 39.96 Favored 'General case' 0 C--N 1.321 -0.651 0 C-N-CA 120.497 -0.481 . . . . 75.13 109.841 176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.863 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 27.6 mt -60.19 -51.26 75.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 75.31 111.794 178.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.686 ' HA ' ' CZ ' ' A' ' 149' ' ' PHE . 5.5 p90 -65.71 -30.37 71.04 Favored 'General case' 0 C--N 1.333 -0.137 0 C-N-CA 120.386 -0.525 . . . . 72.33 110.228 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -80.99 -25.98 36.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.042 -0.527 . . . . 73.51 110.705 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.75 -31.87 71.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.0 0.428 . . . . 60.02 110.592 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 145' ' ' ASN . 12.0 m120 -101.38 2.38 39.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 63.31 110.157 174.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 44.16 72.74 0.18 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.046 -0.979 . . . . 73.33 112.672 179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . . 15.7 pttp 45.23 34.11 1.35 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.058 0.943 . . . . 74.53 112.951 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 38.7 ttp180 -138.87 92.68 2.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.061 0.458 . . . . 74.41 109.82 177.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.686 ' CZ ' ' HA ' ' A' ' 142' ' ' TYR . 55.6 m-85 -104.14 150.95 23.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.968 -0.56 . . . . 72.51 111.666 -175.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.3 m -86.7 147.98 25.64 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.689 -0.687 . . . . 41.54 109.162 173.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 68.7 mtm180 -57.55 -29.08 64.09 Favored 'General case' 0 C--O 1.222 -0.358 0 N-CA-C 112.736 0.643 . . . . 74.31 112.736 -174.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -57.23 -53.64 55.86 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.861 0.362 . . . . 73.34 111.402 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 157' ' ' LEU . 3.9 m -64.32 -44.95 89.97 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.284 -0.416 . . . . 60.1 111.038 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 57.8 t -61.96 -40.05 85.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 72.11 110.94 -178.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.734 ' HG ' HD22 ' A' ' 328' ' ' LEU . 1.7 mm? -63.29 -50.94 68.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.129 -0.487 . . . . 72.11 111.623 -177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.49 ' HB3' HD21 ' A' ' 339' ' ' LEU . 16.8 tt0 -61.88 -38.36 88.01 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 120.009 -0.676 . . . . 71.33 110.267 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 153' ' ' THR . 7.7 mp -59.96 -48.6 81.02 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 71.42 110.447 175.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.4 t -56.26 -47.52 78.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.324 -0.398 . . . . 54.22 110.491 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.805 ' HG ' ' HD2' ' A' ' 321' ' ' ARG . 9.1 mp -57.3 -52.42 65.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.882 -0.599 . . . . 65.42 111.266 178.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.446 ' O ' HG22 ' A' ' 164' ' ' ILE . 2.1 mpt_? -67.75 -33.68 75.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.356 -0.384 . . . . 70.52 111.379 -174.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.576 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -63.62 -43.53 98.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.7 -0.481 . . . . 72.23 109.7 173.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.475 HD12 ' HB3' ' A' ' 321' ' ' ARG . 83.0 mt -63.01 -42.45 99.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.73 -0.214 . . . . 61.0 110.805 176.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -54.24 -60.53 3.22 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.362 0.601 . . . . 73.45 110.775 177.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.54 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 tt -71.83 -39.74 68.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.761 -0.654 . . . . 72.43 111.968 -174.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.576 ' HB2' ' O ' ' A' ' 161' ' ' ILE . 5.8 mp -65.71 -36.89 84.91 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 117.759 0.254 . . . . 65.11 111.302 -177.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -64.26 -48.72 74.68 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.182 -0.673 . . . . 70.4 109.182 176.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.496 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 79.5 t80 -57.48 -46.26 83.92 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 115.157 -0.929 . . . . 75.0 111.816 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 164' ' ' ILE . 34.1 pt -82.41 -32.74 10.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 112.466 0.543 . . . . 75.25 112.466 -174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -64.54 -43.62 93.39 Favored 'General case' 0 CA--C 1.518 -0.265 0 N-CA-C 110.011 -0.366 . . . . 73.34 110.011 -178.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -82.95 14.66 3.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.714 0.769 . . . . 72.35 109.472 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.496 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 1.4 t-80 -136.69 40.95 2.56 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.467 -0.788 . . . . 64.4 109.842 178.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HG2' ' O ' ' A' ' 205' ' ' CYS . 41.7 mt-10 85.4 -61.92 0.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.395 1.059 . . . . 53.31 113.557 174.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.633 ' CE2' ' HG3' ' A' ' 89' ' ' ARG . 13.0 m-85 -84.27 116.13 22.82 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.406 0.521 . . . . 73.44 112.406 -164.636 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.474 HG11 ' HB2' ' A' ' 238' ' ' PRO . 16.4 t -109.63 151.21 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 109.357 -0.609 . . . . 70.32 109.357 175.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 49.8 m170 -115.46 106.95 14.56 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.739 -0.467 . . . . 72.05 109.739 177.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.42 -25.86 55.95 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.551 -0.833 . . . . 71.14 111.828 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.552 ' HB3' HD13 ' A' ' 200' ' ' LEU . 7.1 t70 -98.38 101.73 13.26 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.118 0.485 . . . . 75.33 110.24 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 10.7 tp -91.71 31.95 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 CA-C-O 121.961 0.886 . . . . 72.13 110.078 -178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.425 ' NZ ' ' HB2' ' A' ' 179' ' ' LYS . 3.4 ttmp? -62.96 149.62 44.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.166 -0.925 . . . . 63.33 110.699 -174.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -58.62 -14.61 8.7 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.786 0.662 . . . . 63.51 112.786 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 3.3 m -73.48 -20.81 60.59 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.107 0.48 . . . . 75.51 110.847 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.633 ' ND2' HD22 ' A' ' 195' ' ' LEU . 2.1 t30 -82.32 -21.49 36.04 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.488 -0.778 . . . . 42.14 111.592 -175.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.467 HD23 HG21 ' A' ' 193' ' ' VAL . 5.9 mp -101.85 119.67 39.15 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-O 120.985 0.422 . . . . 63.02 111.533 -177.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.482 HD13 ' HA ' ' A' ' 137' ' ' ASP . 3.9 mm? -121.47 145.68 47.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.811 -0.631 . . . . 60.1 110.159 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 1.093 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 52.6 mt -109.67 152.2 25.91 Favored 'General case' 0 C--O 1.237 0.445 0 N-CA-C 110.054 -0.35 . . . . 71.22 110.054 176.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.61 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 21.1 t-20 -72.64 147.91 45.32 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.181 -0.463 . . . . 72.0 109.917 178.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 -20.91 60.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.795 0.331 . . . . 72.22 111.527 -174.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.4 tptt -113.85 -9.84 13.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.972 0.415 . . . . 72.34 110.25 -178.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 49.4 m-80 -135.35 96.72 13.7 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.178 -0.464 . . . . 62.51 110.512 -178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.68 -18.75 15.01 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 122.968 2.445 . . . . 72.03 112.897 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.499 ' HB3' ' HA ' ' A' ' 338' ' ' LYS . 5.5 p-10 -86.88 5.33 37.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.08 0.466 . . . . 74.02 111.583 -177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -118.65 109.53 16.24 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.728 -0.471 . . . . 72.54 109.728 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.467 HG21 HD23 ' A' ' 183' ' ' LEU . 6.5 p -103.57 126.47 58.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 116.101 -0.499 . . . . 75.35 110.528 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.61 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 9.7 m-85 -114.03 156.34 24.28 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.711 -0.677 . . . . 74.12 109.462 -178.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.633 HD22 ' ND2' ' A' ' 182' ' ' ASN . 21.3 mt -107.8 116.89 32.76 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.838 -0.431 . . . . 75.35 109.838 175.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.416 HG21 ' SD ' ' A' ' 131' ' ' MET . 9.2 p -159.96 159.02 2.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.79 -0.186 . . . . 74.32 111.027 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 9.4 t70 64.98 29.75 12.13 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.533 0.682 . . . . 70.02 110.74 173.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.735 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 18.9 p90 -100.06 -41.62 7.08 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.494 -0.775 . . . . 75.55 111.108 -178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . 59.8 32.9 75.83 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.619 -0.801 . . . . 53.4 111.993 -176.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 352' ' ' LYS . 30.5 mt -131.2 90.31 2.86 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.249 0.547 . . . . 63.24 110.589 -176.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -147.28 121.85 9.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.523 -0.762 . . . . 65.11 110.981 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.609 ' HB2' ' HB3' ' A' ' 222' ' ' ASP . 61.4 t80 -114.34 131.18 56.63 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.143 -0.688 . . . . 74.54 109.143 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -85.57 126.23 33.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.858 0.361 . . . . 74.32 111.524 -176.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.525 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 31.8 t80 -80.81 -40.09 25.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.937 -0.574 . . . . 54.43 109.96 174.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.502 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 10.7 p -125.81 87.8 55.33 Favored Pre-proline 0 C--N 1.321 -0.632 0 CA-C-N 115.638 -0.71 . . . . 43.31 110.79 -179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 18.7 Cg_endo -59.42 113.84 1.78 Allowed 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.624 2.216 . . . . 70.12 111.733 177.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 63.9 26.63 14.29 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.828 -0.624 . . . . 75.44 111.373 179.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 95.35 -19.8 52.51 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.749 -0.739 . . . . 64.12 113.123 175.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -87.52 114.15 25.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 110.091 -0.337 . . . . 62.51 110.091 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -100.38 157.07 16.89 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 120.825 -0.35 . . . . 72.14 110.272 -177.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -115.44 -172.91 2.23 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.516 -0.55 . . . . 74.24 109.516 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.485 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER -97.83 -164.27 1.12 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 123.198 0.311 . . . . 61.45 110.42 -179.167 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -60.29 97.88 0.05 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-O 121.575 0.702 . . . . 73.14 111.088 176.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.493 ' H ' HG23 ' A' ' 236' ' ' VAL . 55.2 mtpt -67.42 -53.73 26.56 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.36 -0.836 . . . . 72.53 112.256 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 37.8 77.94 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.572 0 CA-C-O 122.126 0.965 . . . . 72.43 110.359 -164.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -78.8 135.77 59.25 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 114.194 -1.366 . . . . 64.55 111.492 -168.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.36 -18.85 66.57 Favored 'Trans proline' 0 CA--C 1.53 0.301 0 C-N-CA 123.268 2.646 . . . . 61.43 113.656 -177.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.722 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 1.1 tpmt? -86.16 -8.84 57.54 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.234 -0.654 . . . . 63.22 109.234 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? 57.46 62.02 2.29 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.442 -0.799 . . . . 64.32 110.22 -176.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 76.8 m -75.01 55.22 0.7 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 115.465 -0.788 . . . . 63.31 112.39 -175.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 51.9 p-80 -67.27 134.37 51.47 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.481 -0.781 . . . . 65.5 110.047 171.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.609 ' HB3' ' HB2' ' A' ' 202' ' ' TYR . 16.2 p-10 -89.84 -39.63 12.95 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 110.087 -0.338 . . . . 71.41 110.087 176.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.513 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . -108.24 -169.41 21.32 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.822 -0.704 . . . . 61.41 113.743 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.574 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 0.7 OUTLIER -90.53 148.77 22.5 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.963 0.411 . . . . 54.31 110.902 -176.054 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.47 HG12 HG11 ' A' ' 271' ' ' VAL . 13.3 tt -63.64 -24.28 35.45 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 113.761 1.022 . . . . 62.45 113.761 -168.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.574 ' OE1' ' HB ' ' A' ' 224' ' ' THR . 0.0 OUTLIER -70.1 -41.43 74.03 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.288 -0.565 . . . . 65.03 110.878 -172.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.496 ' O ' HG12 ' A' ' 246' ' ' ILE . 29.4 m-85 -101.02 -39.94 7.48 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 121.268 -0.173 . . . . 72.01 111.454 179.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.6 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 94.0 m -60.29 -14.87 20.48 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.358 0.503 . . . . 65.54 112.358 -175.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 14.1 m 72.28 -167.92 0.13 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.174 -0.466 . . . . 52.32 111.053 173.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.479 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.5 mp -71.54 -34.42 52.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 N-CA-C 109.764 -0.458 . . . . 71.54 109.764 178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.633 ' O ' HG12 ' A' ' 236' ' ' VAL . 25.2 t70 -44.64 -91.31 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 114.479 -1.237 . . . . 70.32 113.279 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.6 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.75 -27.79 69.53 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.122 -0.361 . . . . 73.24 111.686 -174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.58 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 81.1 t60 -56.84 -37.27 71.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 72.3 111.246 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -85.68 0.5 52.54 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.774 0.321 . . . . 71.3 111.49 -177.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 92.77 8.16 62.3 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.462 -0.875 . . . . 52.04 113.352 175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.633 HG12 ' O ' ' A' ' 231' ' ' ASP . 11.9 p -86.96 140.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 108.979 -0.749 . . . . 44.22 108.979 175.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.525 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -68.0 117.19 46.28 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 116.471 -0.331 . . . . 72.14 110.131 178.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.497 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 6.6 Cg_endo -49.25 124.12 11.25 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.635 2.89 . . . . 74.45 112.983 -176.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 16.1 t -143.09 93.38 2.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.25 -0.432 . . . . 53.21 111.297 178.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.547 ' O ' ' HG ' ' A' ' 244' ' ' LEU . 59.6 mtt180 75.96 -57.28 0.57 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.604 -0.726 . . . . 73.22 112.052 170.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.752 ' HG3' ' HD1' ' A' ' 311' ' ' TYR . 11.4 mmm-85 -57.38 -54.69 43.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.422 0.153 . . . . 70.43 110.592 177.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.486 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -51.02 -58.55 9.32 Favored Glycine 0 N--CA 1.448 -0.56 0 O-C-N 123.794 0.684 . . . . 61.41 112.426 178.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.42 -47.99 47.57 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.11 0.481 . . . . 73.43 111.412 -176.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 240' ' ' ARG . 64.3 mt -71.78 -45.29 62.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.803 -0.635 . . . . 65.42 111.529 -175.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.96 -39.11 79.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.559 0.219 . . . . 71.34 111.061 -178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.496 HG12 ' O ' ' A' ' 227' ' ' PHE . 99.0 mt -59.63 -45.85 93.81 Favored 'Isoleucine or valine' 0 C--O 1.238 0.469 0 CA-C-O 121.066 0.46 . . . . 73.24 110.288 177.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.562 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -65.06 -43.08 93.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.919 -0.582 . . . . 61.42 110.591 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.36 -42.84 95.85 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.923 -0.656 . . . . 73.2 112.504 179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.53 ' CZ ' ' HD2' ' A' ' 275' ' ' LYS . 22.9 m-30 -66.33 -48.43 70.32 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.491 0.182 . . . . 75.34 111.491 -177.494 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.463 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.4 p -66.8 -40.91 88.27 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 120.574 -0.451 . . . . 72.11 111.088 -177.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 85.0 mtp -60.47 -45.6 93.11 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.829 0.347 . . . . 63.34 110.896 177.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -65.71 -29.97 48.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.105 -0.498 . . . . 70.3 110.346 -177.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.465 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 48.9 tt0 -71.51 -41.61 69.04 Favored 'General case' 0 C--O 1.222 -0.358 0 C-N-CA 121.097 -0.241 . . . . 75.43 110.458 178.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 24.3 m0 -66.73 -26.32 66.94 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.81 0.338 . . . . 74.24 110.672 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.1 tp -81.18 -41.19 22.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.854 -0.612 . . . . 74.2 111.776 -179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 32.5 p -103.62 -27.26 12.43 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.391 0.515 . . . . 54.32 112.391 -173.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 108.7 -59.52 0.36 Allowed Glycine 0 N--CA 1.445 -0.76 0 C-N-CA 120.724 -0.75 . . . . 75.22 113.048 177.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -121.76 144.02 49.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.848 0.356 . . . . 72.23 110.963 -173.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 94.8 mt -105.7 145.12 30.23 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.034 -0.53 . . . . 75.52 110.715 177.664 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 31.2 Cg_exo -60.62 -31.92 92.73 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.803 2.335 . . . . 40.05 112.291 178.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.489 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 48.0 p90 -96.84 11.09 36.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.024 -0.535 . . . . 74.42 110.41 -179.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.746 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 30.5 tt0 -83.18 -42.06 17.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.162 0.506 . . . . 44.24 110.201 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -88.54 -12.11 43.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.051 -0.522 . . . . 63.53 109.829 177.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -109.17 10.1 25.94 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.748 -0.66 . . . . 75.44 111.907 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.581 ' HA ' ' CG2' ' A' ' 271' ' ' VAL . 3.7 pp -70.86 -7.31 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-O 121.178 0.513 . . . . 74.11 110.916 -178.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 42.8 pttt -66.45 -13.07 60.27 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.429 -0.805 . . . . 75.12 110.794 173.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.9 t70 -124.61 122.03 25.78 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.133 -0.485 . . . . 62.2 109.841 174.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 32.7 Cg_exo -62.69 -30.59 78.74 Favored 'Trans proline' 0 C--O 1.235 0.358 0 C-N-CA 122.987 2.458 . . . . 74.52 113.375 -176.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.571 ' HZ2' ' HB2' ' A' ' 269' ' ' LYS . 0.0 OUTLIER -76.45 -38.06 56.03 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 110.061 -0.348 . . . . 73.44 110.061 -176.848 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -58.51 -49.13 78.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.161 -0.472 . . . . 63.41 110.899 176.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.724 ' O ' ' HG2' ' A' ' 275' ' ' LYS . 38.0 t -55.88 -50.99 65.4 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.127 0 CA-C-O 120.599 0.238 . . . . 73.13 110.997 176.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -61.14 -50.41 73.31 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.262 -0.426 . . . . 64.51 111.182 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.592 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 32.1 t70 -61.37 -45.6 93.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.874 -0.603 . . . . 74.33 111.082 -178.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 45.9 m -61.31 -32.76 72.62 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.719 -0.219 . . . . 50.53 111.49 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.724 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 35.2 mmtp -60.27 -49.46 77.53 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 109.189 -0.671 . . . . 65.31 109.189 174.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 51.8 mt -65.64 -33.1 61.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.213 -0.903 . . . . 72.4 110.968 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 16.5 mmm180 -62.66 -40.27 96.52 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.672 -0.24 . . . . 43.04 111.041 -179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.437 ' HD1' ' HA ' ' A' ' 278' ' ' TYR . 2.9 m-85 -74.06 -33.99 63.87 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.513 -0.475 . . . . 72.41 110.942 175.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 12.6 ttp180 -66.74 -20.96 66.07 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.467 -0.333 . . . . 73.2 110.957 179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -49.64 -56.9 8.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.866 -0.607 . . . . 74.12 110.759 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 40.4 t30 -150.31 75.85 1.25 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.82 -0.807 . . . . 63.01 108.82 178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -53.47 -37.19 29.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 114.793 -1.094 . . . . 65.55 113.232 -171.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.585 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -61.41 -49.0 78.65 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 121.013 -0.275 . . . . 64.41 111.676 -175.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 m -78.07 -39.09 42.78 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.733 0.302 . . . . 74.11 111.114 -177.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -61.76 -46.26 90.34 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.378 -0.374 . . . . 74.31 111.192 -179.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -74.26 -29.03 61.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 60.41 110.805 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 283' ' ' ALA . 17.1 t70 -62.32 -31.38 72.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.242 0.544 . . . . 71.43 110.169 177.039 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.541 ' NZ ' ' HB3' ' A' ' 288' ' ' LYS . 9.2 mtpm? -83.61 -21.63 32.5 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.891 -0.595 . . . . 62.13 111.735 177.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 94.1 m -67.01 -38.63 86.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.657 0.265 . . . . 62.5 111.264 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' A' ' 292' ' ' GLU . 5.4 t80 -135.81 79.49 45.8 Favored Pre-proline 0 C--N 1.327 -0.41 0 C-N-CA 120.765 -0.374 . . . . 64.35 110.486 178.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -92.59 19.71 0.88 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 123.113 2.542 . . . . 73.53 111.918 178.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.459 ' HB2' ' CE1' ' A' ' 290' ' ' PHE . 33.8 mt-10 -87.48 35.8 0.73 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.877 -0.601 . . . . 74.55 111.42 -174.22 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 68.82 10.06 7.7 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.548 0.944 . . . . 72.33 113.548 168.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.525 ' O ' ' HB2' ' A' ' 295' ' ' LYS . 11.6 t30 -82.09 -81.88 0.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.875 -0.417 . . . . 73.21 109.875 175.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 2.0 tpmt? 168.22 107.72 0.04 OUTLIER Pre-proline 0 N--CA 1.462 0.141 0 O-C-N 123.59 0.557 . . . . 74.32 109.757 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -102.34 39.77 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 123.667 2.911 . . . . 74.23 111.881 173.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.16 -38.27 2.34 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.527 -0.844 . . . . 54.21 113.334 -171.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.463 ' HB3' HD23 ' A' ' 324' ' ' LEU . 2.8 mp0 -59.14 -53.64 56.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.002 0.43 . . . . 51.13 110.51 -176.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.2 mp -64.67 -37.77 80.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.604 -0.725 . . . . 75.44 110.323 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.585 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.36 -52.5 64.38 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.04 -0.527 . . . . 71.31 111.31 -179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.433 ' HE3' ' HB2' ' A' ' 301' ' ' LYS . 21.8 ttmt -70.69 -31.98 69.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.916 0.389 . . . . 74.52 110.538 -177.32 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.416 ' O ' HG13 ' A' ' 306' ' ' VAL . 64.6 t80 -57.95 -48.97 78.37 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.76 -0.654 . . . . 73.4 110.217 172.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.551 ' HA ' HG22 ' A' ' 306' ' ' VAL . 87.4 mtp -72.48 -32.61 66.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 62.03 111.274 -178.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -59.47 -37.67 78.8 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.841 0.829 . . . . 74.34 108.878 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.489 HG21 HD21 ' A' ' 320' ' ' LEU . 60.7 m -69.06 -42.59 76.05 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 114.632 -1.167 . . . . 54.45 111.455 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.551 HG22 ' HA ' ' A' ' 303' ' ' MET . 5.5 m -70.55 -26.94 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-O 120.882 0.372 . . . . 75.04 110.578 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 71.5 tttt -63.44 -48.72 76.59 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.035 -0.53 . . . . 74.31 110.215 174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.484 ' O ' HD23 ' A' ' 308' ' ' LEU . 3.3 tt -68.5 -25.54 65.01 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.471 -0.786 . . . . 74.33 110.046 -179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.429 HD22 ' HA ' ' A' ' 309' ' ' LEU . 0.2 OUTLIER -62.52 -18.84 62.83 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.519 -0.764 . . . . 73.34 111.878 -176.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 27.8 t70 62.6 -93.93 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.373 0 O-C-N 123.391 0.432 . . . . 74.22 110.294 -177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.752 ' HD1' ' HG3' ' A' ' 241' ' ' ARG . 3.9 m-30 -136.75 -43.89 0.59 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.023 0.439 . . . . 71.02 110.402 174.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.4 t -136.92 20.61 3.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.096 -0.502 . . . . 73.12 112.205 -168.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 33.5 mm-40 -88.83 50.57 1.98 Allowed 'General case' 0 C--N 1.327 -0.41 0 O-C-N 121.638 -0.664 . . . . 74.43 112.277 -175.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.482 ' HD2' ' N ' ' A' ' 314' ' ' LYS . 0.1 OUTLIER 58.97 94.22 0.05 OUTLIER Pre-proline 0 N--CA 1.471 0.602 0 CA-C-N 115.196 -0.911 . . . . 70.24 113.456 170.205 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -90.4 121.4 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.786 2.324 . . . . 64.44 111.802 173.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.2 mt -84.96 99.08 10.74 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.824 0.345 . . . . 73.52 110.366 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -61.64 -45.03 95.81 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 115.942 -0.572 . . . . 73.23 111.765 -174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.0 -0.37 . . . . 54.15 110.0 -177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -64.29 -36.5 84.31 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.932 0.396 . . . . 73.32 110.336 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.694 ' O ' HG13 ' A' ' 323' ' ' ILE . 77.2 mt -60.68 -48.7 80.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.881 -0.6 . . . . 65.2 110.982 177.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.805 ' HD2' ' HG ' ' A' ' 159' ' ' LEU . 32.8 ptt180 -74.2 -20.88 60.04 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.841 -0.744 . . . . 73.2 110.772 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 -68.94 -39.88 79.32 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.716 -0.22 . . . . 54.35 110.818 176.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.2 pp -72.18 -30.23 35.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 N-CA-C 109.791 -0.448 . . . . 54.12 109.791 177.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.63 -49.31 63.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.003 -0.544 . . . . 64.32 110.279 176.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.763 HD11 HD21 ' A' ' 159' ' ' LEU . 88.8 mt -64.86 -29.24 70.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.055 -0.521 . . . . 51.33 110.66 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 24.7 tt0 -63.96 -47.48 80.28 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.866 -0.607 . . . . 74.51 110.497 177.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.65 -30.65 76.68 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 72.43 111.942 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.734 HD22 ' HG ' ' A' ' 155' ' ' LEU . 56.4 tp -72.8 -50.59 23.3 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.931 0.396 . . . . 72.3 110.835 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -73.83 -14.02 61.02 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.311 -0.404 . . . . 74.34 110.696 -176.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -63.98 -23.61 67.4 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.499 176.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.2 tt -97.17 -6.8 9.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.292 0.567 . . . . 60.44 110.113 178.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.71 24.02 34.25 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.856 -0.688 . . . . 72.21 113.208 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 45.8 m -123.36 158.62 30.67 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.455 -0.438 . . . . 42.51 110.595 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -156.45 176.73 12.32 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 116.439 -0.346 . . . . 75.31 110.135 178.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -87.23 -36.07 18.16 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.721 -0.474 . . . . 71.55 109.721 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.8 t70 75.14 16.92 2.72 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 115.091 -0.959 . . . . 62.22 110.88 173.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 73.51 39.08 50.97 Favored Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 110.934 -0.866 . . . . 41.11 110.934 -176.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.499 ' HA ' ' HB3' ' A' ' 191' ' ' ASP . 39.0 ttmt -156.5 109.17 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.397 -0.402 . . . . 75.44 110.343 -175.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.49 HD21 ' HB3' ' A' ' 156' ' ' GLN . 45.3 mt -78.97 92.93 5.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.689 0.757 . . . . 63.53 110.11 176.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -89.88 63.93 6.19 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 107.637 -1.246 . . . . 74.04 107.637 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.538 HD21 HG23 ' A' ' 141' ' ' ILE . 8.9 tp -72.5 -80.31 0.07 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 113.912 -1.494 . . . . 62.04 111.066 -175.054 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 11.6 m 170.26 -162.37 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.373 -1.285 . . . . 74.53 108.268 -168.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 44.4 t -111.89 115.12 48.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.08 0.467 . . . . 51.34 110.163 178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.679 HG23 ' HB3' ' A' ' 140' ' ' LYS . 2.6 p -80.14 -49.58 18.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.819 -0.628 . . . . 71.45 110.827 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.408 ' HA ' ' OE1' ' A' ' 345' ' ' GLU . 3.8 tp10 50.52 45.82 26.15 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 115.61 -0.723 . . . . 74.41 112.068 -177.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 73.31 130.63 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.815 0 CA-C-O 121.803 0.811 . . . . 52.2 113.015 171.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.865 ' HA3' ' HB2' ' A' ' 140' ' ' LYS . . . -137.47 -70.03 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.311 -0.859 . . . . 61.42 111.325 170.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 84.34 -71.48 2.97 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.521 -0.371 . . . . 74.1 112.894 175.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.645 HD13 ' HB3' ' A' ' 139' ' ' GLN . 8.8 mp 63.72 -92.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.23 0.612 . . . . 64.21 111.834 -179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -165.82 164.26 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.753 0.311 . . . . 70.21 111.227 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . 0.544 ' CB ' ' HA2' ' A' ' 47' ' ' GLY . . . -137.43 -156.64 0.71 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.022 -0.535 . . . . 45.25 110.365 177.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.822 ' HB3' HD21 ' A' ' 200' ' ' LEU . 35.2 tptt -138.13 -158.91 0.9 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.218 -0.66 . . . . 64.53 109.218 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.6 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 10.3 t -155.87 169.73 23.72 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-O 120.513 0.197 . . . . 72.42 110.71 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.517 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -69.22 144.06 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 N-CA-C 112.698 0.629 . . . . 65.13 112.698 -172.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 11.4 t -92.07 132.83 36.28 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.188 -0.914 . . . . 62.55 110.001 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -170.41 -88.49 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.492 0.187 . . . . 73.43 110.613 174.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 57.5 tttp 177.71 95.88 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.442 -0.577 . . . . 71.33 109.442 -174.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 358' ' ' ARG . 40.0 mtt180 -84.78 87.9 7.35 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.306 0.574 . . . . 73.14 109.974 -179.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.575 ' O ' ' HB2' ' A' ' 360' ' ' LYS . 1.0 OUTLIER -112.68 -20.44 11.67 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.372 -0.831 . . . . 74.1 110.768 -173.998 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 359' ' ' LYS . 39.2 mttm . . . . . 0 C--O 1.248 0.987 0 CA-C-O 118.604 -0.712 . . . . 74.42 109.654 -168.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.42 ' HA ' ' HD3' ' A' ' 2' ' ' PRO . 3.6 mpp? . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.0 -0.37 . . . . 64.31 110.0 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 1' ' ' MET . 20.2 Cg_exo -65.26 139.05 58.46 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.682 2.255 . . . . 64.12 112.484 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 86.7 mtt180 -102.42 116.69 33.15 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.0 -0.741 . . . . 75.22 109.0 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 42.2 t -106.58 130.45 58.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 112.54 0.57 . . . . 64.43 112.54 -170.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -123.71 90.36 3.26 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.702 -0.681 . . . . 65.41 109.681 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -154.01 105.37 2.73 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.588 0.233 . . . . 65.52 110.924 -179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -168.5 113.59 0.62 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.201 -0.454 . . . . 53.1 110.571 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -132.05 140.76 48.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.819 0.342 . . . . 72.44 110.276 178.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -79.28 132.83 36.59 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.155 -0.475 . . . . 50.2 110.977 -177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.01 64.25 0.27 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 121.025 -0.607 . . . . 72.44 112.841 -177.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.3 mmt180 -134.44 149.87 50.79 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.743 0.306 . . . . 73.34 110.363 176.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -137.14 137.3 39.07 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.099 -0.5 . . . . 74.41 110.337 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.1 p -83.54 136.81 34.12 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.925 -0.579 . . . . 50.43 110.368 178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 54.9 m -153.12 148.15 26.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.648 -0.251 . . . . 73.03 110.439 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.67 ' H ' ' HG3' ' A' ' 36' ' ' GLU . . . -72.99 140.23 47.21 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.961 0.41 . . . . 71.24 110.926 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -87.23 -49.3 7.36 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.225 -0.443 . . . . 60.14 111.472 -175.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 11.3 ptp180 -152.81 178.53 9.55 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.011 0.434 . . . . 72.53 111.343 -176.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.613 ' CD2' ' HB3' ' A' ' 27' ' ' GLU . 19.7 t-80 -90.4 123.37 34.07 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.578 -0.737 . . . . 73.03 109.909 175.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.713 HD13 ' HD2' ' A' ' 38' ' ' LYS . 11.3 mp -85.43 164.48 17.86 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.135 -0.484 . . . . 65.12 109.942 176.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.11 129.26 39.15 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.84 0.352 . . . . 54.34 111.057 -177.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.684 ' HG2' ' HB ' ' A' ' 25' ' ' VAL . 9.8 tp10 -150.09 -88.77 0.07 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.793 -0.64 . . . . 71.2 109.707 175.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.578 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 49.2 tt0 163.63 -39.82 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 123.814 0.696 . . . . 74.42 110.506 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -95.93 -50.8 4.72 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.956 0.725 . . . . 74.44 112.956 -170.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.564 ' O ' ' HG2' ' A' ' 27' ' ' GLU . . . 173.35 -17.75 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 121.076 0.465 . . . . 74.52 110.434 -167.274 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.684 ' HB ' ' HG2' ' A' ' 21' ' ' GLU . 46.6 t -60.78 127.22 19.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.15 -0.477 . . . . 71.34 110.259 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . 99.04 -1.79 57.84 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.765 -0.731 . . . . 62.24 114.125 175.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.613 ' HB3' ' CD2' ' A' ' 18' ' ' HIS . 0.9 OUTLIER -110.82 -177.08 3.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 118.173 0.987 . . . . 73.14 112.312 177.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.481 HG23 ' HB2' ' A' ' 36' ' ' GLU . 3.2 mp -107.49 138.53 33.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 N-CA-C 113.376 0.88 . . . . 73.44 113.376 -162.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 3.5 pt -132.06 126.64 56.75 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.148 -0.933 . . . . 72.45 109.593 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.5 p -103.7 136.53 43.22 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.1 0.778 . . . . 74.4 113.1 -172.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.823 ' HB3' ' CZ2' ' A' ' 37' ' ' TRP . 10.9 p30 -88.39 -179.44 6.1 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 115.913 -0.585 . . . . 64.31 110.758 172.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.52 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -71.16 -9.72 58.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.727 -0.67 . . . . 71.45 111.774 -178.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.18 6.82 46.25 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 71.1 110.109 -177.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.435 ' HD3' ' HA ' ' A' ' 34' ' ' LYS . 52.5 mmtt 68.82 23.79 6.77 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.347 -0.842 . . . . 73.04 111.684 178.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.679 ' HZ1' ' HB3' ' A' ' 114' ' ' TRP . 40.4 ttpt -90.67 114.49 26.8 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.453 -0.943 . . . . 61.43 108.453 171.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.67 ' HG3' ' H ' ' A' ' 15' ' ' ALA . 6.0 pt-20 -92.51 102.0 14.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.734 -0.666 . . . . 70.35 110.791 -176.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.823 ' CZ2' ' HB3' ' A' ' 31' ' ' ASP . 0.4 OUTLIER -80.27 147.08 31.32 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.924 -0.58 . . . . 64.42 109.689 -177.173 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.713 ' HD2' HD13 ' A' ' 19' ' ' LEU . 28.1 ttpp -106.06 119.45 39.24 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.753 -0.462 . . . . 74.22 109.753 176.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 43.4 t -64.99 136.52 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.738 -0.665 . . . . 42.15 111.27 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -109.2 -129.43 5.84 Favored Glycine 0 N--CA 1.442 -0.924 0 N-CA-C 111.49 -0.644 . . . . 35.24 111.49 176.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.493 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.2 mm? -76.08 141.85 71.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.686 0.279 . . . . 74.34 111.134 -176.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.7 Cg_endo -86.97 120.43 1.63 Allowed 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 123.245 2.63 . . . . 72.31 111.775 175.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.437 HD11 ' HB2' ' A' ' 53' ' ' LEU . 3.8 mp -96.57 -54.82 6.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.956 0.407 . . . . 61.01 110.622 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.667 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 97.74 162.99 31.31 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.828 -0.701 . . . . 71.02 111.491 -175.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.75 ' HB2' HG12 ' A' ' 51' ' ' ILE . 27.6 tp60 -133.56 128.59 35.57 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.987 0.394 . . . . 73.31 110.175 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -82.58 108.6 2.98 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.617 -0.802 . . . . 25.21 112.418 -178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.18 -16.14 46.19 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.906 -0.664 . . . . 63.04 112.291 177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.679 ' CE2' ' HA ' ' A' ' 198' ' ' TYR . 21.2 m-85 -113.38 -59.39 2.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.736 0.303 . . . . 72.35 110.318 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 170.72 -105.59 0.22 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.8 -0.714 . . . . 64.32 112.562 -178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.667 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 49.8 t -142.05 142.0 32.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.85 0.357 . . . . 75.11 110.596 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.75 HG12 ' HB2' ' A' ' 45' ' ' GLN . 27.4 mm -121.74 136.88 57.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.5 -0.556 . . . . 73.33 109.5 177.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -108.25 144.66 35.43 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 120.755 0.312 . . . . 55.44 110.643 179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.582 ' HA ' HG12 ' A' ' 69' ' ' VAL . 57.9 tp -84.37 152.04 24.32 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.364 -0.606 . . . . 61.03 109.364 172.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.38 104.4 12.55 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.827 0.346 . . . . 64.23 111.056 178.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -79.1 -35.18 42.73 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.11 -0.7 . . . . 71.25 109.11 175.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.822 ' SD ' ' HA ' ' A' ' 37' ' ' TRP . 13.8 tpt 69.54 -70.53 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.482 -1.235 . . . . 73.2 113.194 171.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -139.32 104.9 5.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.176 0.512 . . . . 64.15 111.159 -173.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.5 m -83.61 40.01 0.71 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.311 -0.859 . . . . 64.51 111.52 -175.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 33.0 m -104.45 -75.73 0.61 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.963 0.411 . . . . 75.43 110.799 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -106.36 -1.88 22.82 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.111 -0.495 . . . . 61.13 110.049 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 24.6 t 62.85 77.87 0.31 Allowed 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.547 -0.751 . . . . 65.3 109.198 -172.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.488 HG22 ' H ' ' A' ' 64' ' ' SER . 4.4 p -60.4 129.7 23.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.058 -0.973 . . . . 64.12 111.365 -175.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.03 23.49 5.19 Favored Glycine 0 C--N 1.332 0.316 0 CA-C-N 116.057 -0.52 . . . . 65.34 113.276 -175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.488 ' H ' HG22 ' A' ' 62' ' ' VAL . 22.2 m -121.02 -77.76 0.59 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.935 -0.394 . . . . 73.5 109.935 178.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -90.08 92.07 8.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.43 -0.35 . . . . 65.11 110.064 176.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.499 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -172.39 -50.36 0.0 OUTLIER Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.421 -0.809 . . . . 74.23 109.243 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 68.0 Cg_endo -78.37 55.84 5.58 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 121.594 1.529 . . . . 52.35 110.95 169.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 8.6 p -145.51 157.93 43.92 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.999 -0.546 . . . . 75.21 110.699 -179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 53' ' ' LEU . 7.2 m -135.34 161.43 39.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.348 -0.387 . . . . 63.22 110.369 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.583 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 4.9 p -119.75 119.98 61.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.651 0.739 . . . . 72.32 111.934 -177.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 51' ' ' ILE . 4.8 tptp -79.98 115.97 19.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.776 -1.102 . . . . 74.43 108.768 173.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 128' ' ' PHE . 6.9 p -125.7 128.32 72.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.065 0.46 . . . . 63.43 111.577 -177.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -138.06 152.24 71.55 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 115.886 -0.597 . . . . 75.13 109.833 177.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -77.92 165.8 25.92 Favored 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 122.346 2.03 . . . . 60.11 112.302 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.1 m -78.08 69.94 4.37 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.332 0.587 . . . . 72.15 110.453 178.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -122.66 7.12 9.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.612 -0.722 . . . . 70.34 110.453 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 67.62 93.27 0.08 Allowed 'General case' 0 N--CA 1.467 0.409 0 CA-C-N 115.267 -0.878 . . . . 64.03 110.762 -177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -147.63 -154.11 6.14 Favored Glycine 0 N--CA 1.444 -0.824 0 CA-C-N 115.576 -0.738 . . . . 62.55 111.646 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.457 ' O ' ' HG2' ' A' ' 83' ' ' GLU . 31.4 Cg_exo -59.15 -35.52 97.62 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 123.21 2.607 . . . . 73.12 112.553 -178.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.405 HD13 ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.54 -36.37 44.72 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 123.926 0.766 . . . . 72.4 111.433 -176.598 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -66.57 -49.28 66.9 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.788 0.328 . . . . 75.42 110.805 -176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 13.9 m -62.71 -48.35 79.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.923 -0.58 . . . . 62.32 111.107 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 79' ' ' PRO . 8.3 pt-20 -69.35 -33.54 73.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.968 -0.56 . . . . 71.31 111.166 -177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.614 HD22 ' HD3' ' A' ' 127' ' ' ARG . 43.7 tp -58.48 -47.48 83.91 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.003 0.43 . . . . 75.53 110.575 177.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -67.39 -36.8 82.03 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 116.117 -0.492 . . . . 75.41 110.511 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -60.45 -52.59 64.56 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.941 -0.572 . . . . 73.13 110.237 177.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HD2' ' CD1' ' A' ' 113' ' ' TYR . 4.9 m-85 -57.27 -46.89 82.65 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 116.139 -0.482 . . . . 74.2 110.697 176.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.43 -33.95 64.02 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 74.42 111.337 -176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.466 ' NE ' ' HA ' ' A' ' 89' ' ' ARG . 0.9 OUTLIER -90.52 -26.81 19.57 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 111.848 0.314 . . . . 73.02 111.848 -177.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.76 17.99 22.46 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.768 0.318 . . . . 73.4 111.649 -175.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -85.54 164.74 17.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 112.555 0.576 . . . . 51.14 112.555 -173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.428 ' O ' HG13 ' A' ' 96' ' ' ILE . 2.8 tppt? 77.88 99.07 0.04 OUTLIER Pre-proline 0 N--CA 1.466 0.337 0 CA-C-N 114.847 -1.07 . . . . 75.31 111.09 170.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 92' ' ' LYS . 11.6 Cg_endo -55.12 -29.16 64.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.441 2.761 . . . . 64.43 113.443 -175.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 4.3 tp10 -55.42 -59.43 4.83 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.949 0.404 . . . . 73.3 110.596 178.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.481 ' HA ' ' OE1' ' A' ' 95' ' ' GLN . 6.4 tp60 -68.11 -35.6 78.4 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.966 -0.561 . . . . 74.33 110.449 -176.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' LYS . 73.5 mt -55.45 -49.28 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.021 -0.536 . . . . 44.02 110.277 177.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 32.0 tt0 -59.52 -42.78 93.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.175 -0.466 . . . . 74.41 110.456 178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 94' ' ' GLU . 74.7 mmtt -55.65 -59.59 4.64 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 115.723 -0.671 . . . . 75.23 112.113 -176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -71.91 -34.97 69.54 Favored 'General case' 0 C--N 1.331 -0.208 0 C-N-CA 120.024 -0.67 . . . . 73.22 111.228 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.647 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.5 mt -59.15 -49.14 84.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 C-N-CA 121.095 -0.242 . . . . 74.24 111.199 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 14.3 mmm180 -74.63 -35.74 62.9 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.64 -0.424 . . . . 74.14 111.267 -175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.7 m -72.63 -39.78 66.95 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.799 0.333 . . . . 54.13 111.226 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 8.5 mtp180 -87.89 7.08 32.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.462 -0.335 . . . . 72.13 111.848 -176.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 71.07 29.49 2.91 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 123.423 0.452 . . . . 71.34 112.138 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 10.9 mp -79.05 -169.1 1.69 Allowed 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.799 -0.445 . . . . 72.31 109.799 175.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' LYS . 26.5 mmtm -115.36 -62.76 1.55 Allowed 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.845 -0.428 . . . . 75.25 109.845 176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HA ' HD13 ' A' ' 100' ' ' ILE . 37.6 p90 -174.85 138.56 0.48 Allowed 'General case' 0 C--N 1.327 -0.392 0 O-C-N 123.442 0.464 . . . . 61.41 110.503 176.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.647 ' HG ' HD11 ' A' ' 100' ' ' ILE . 72.8 mt -79.24 118.57 21.3 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.178 -0.464 . . . . 72.03 109.844 177.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.503 ' HA3' ' CZ ' ' A' ' 160' ' ' ARG . . . -79.03 54.87 4.27 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.383 -0.913 . . . . 75.1 111.817 176.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 35.9 m -106.59 149.96 39.02 Favored Pre-proline 0 C--N 1.321 -0.641 0 N-CA-C 109.905 -0.406 . . . . 71.35 109.905 -178.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.74 ' HB3' ' HE2' ' A' ' 134' ' ' PHE . 21.0 Cg_exo -66.08 144.72 76.78 Favored 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.26 1.973 . . . . 64.41 111.923 178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.854 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 16.0 tttp -70.74 118.26 13.3 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.895 -0.593 . . . . 65.53 110.56 -176.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.498 ' CD1' ' HD2' ' A' ' 87' ' ' TYR . 66.4 t80 -95.23 120.68 35.88 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.89 -0.595 . . . . 75.45 110.926 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.679 ' HB3' ' HZ1' ' A' ' 35' ' ' LYS . 80.0 m95 -98.92 -51.31 3.91 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.063 -0.517 . . . . 75.13 110.769 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -169.0 172.61 43.35 Favored Glycine 0 N--CA 1.45 -0.425 0 CA-C-N 115.864 -0.607 . . . . 73.11 112.134 -177.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.622 ' HB3' ' HG3' ' A' ' 129' ' ' MET . 34.2 p -160.3 157.37 27.91 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.196 -0.298 . . . . 74.02 110.196 -178.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -177.25 -177.92 46.52 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.572 -0.823 . . . . 42.31 112.617 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.5 tt -126.15 134.37 51.32 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.858 0.361 . . . . 75.01 110.206 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.573 ' HB3' ' HE2' ' A' ' 128' ' ' PHE . 56.3 t60 -140.88 118.23 11.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.465 -0.568 . . . . 74.33 109.465 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.68 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 17.3 t70 -67.45 129.77 40.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.89 -0.595 . . . . 63.51 110.195 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.493 ' HG2' ' OD1' ' A' ' 122' ' ' ASN . 84.7 tttt -134.85 122.67 22.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.234 -0.439 . . . . 75.45 110.022 -178.082 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.493 ' OD1' ' HG2' ' A' ' 121' ' ' LYS . 22.1 m120 66.73 15.95 10.26 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 116.063 -0.517 . . . . 72.44 111.522 178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 97.12 -2.01 61.19 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.559 -0.829 . . . . 65.3 112.052 -179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -112.58 121.93 46.22 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.667 -0.494 . . . . 61.12 109.667 177.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.68 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 14.9 m -76.37 104.88 7.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.081 0.467 . . . . 72.44 110.658 -179.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -93.95 136.54 34.13 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.565 -0.743 . . . . 73.21 110.492 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.614 ' HD3' HD22 ' A' ' 84' ' ' LEU . 36.2 ttm180 -112.28 124.29 52.14 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.075 -0.713 . . . . 75.54 109.075 176.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.583 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 4.7 p90 -126.9 160.23 31.6 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.208 0.528 . . . . 72.55 111.943 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.622 ' HG3' ' HB3' ' A' ' 116' ' ' SER . 30.3 ttp -145.19 135.87 24.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.373 -0.83 . . . . 75.22 110.28 -175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.577 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 3.6 mm -96.99 128.34 48.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 121.133 0.492 . . . . 62.34 111.539 -175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.6 ptp -122.59 167.78 12.97 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 114.996 -1.002 . . . . 74.1 108.976 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.854 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 11.0 t70 -72.53 152.03 42.1 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.96 -0.756 . . . . 71.03 108.96 174.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.434 ' HD3' HG13 ' A' ' 69' ' ' VAL . 27.7 tpt180 -76.59 102.07 5.96 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.817 0.818 . . . . 75.1 112.05 -174.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.74 ' HE2' ' HB3' ' A' ' 111' ' ' PRO . 8.9 m-85 -102.69 141.85 34.81 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 107.253 -1.388 . . . . 62.34 107.253 168.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -150.66 10.5 0.81 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 119.4 -1.381 . . . . 43.54 113.41 -171.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.926 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 16.2 m -113.73 123.39 49.77 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.803 -0.814 . . . . 71.41 108.803 175.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.937 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 2.3 m-20 -105.03 129.51 53.45 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 121.151 -0.22 . . . . 62.23 110.412 -175.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.9 mp -64.35 -24.02 67.5 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.431 -0.508 . . . . 74.2 109.677 172.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.937 ' HG2' ' HB3' ' A' ' 137' ' ' ASP . 28.0 pt20 -70.68 -37.12 73.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.001 -0.545 . . . . 51.45 110.413 175.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.552 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 63.1 mttp -70.94 -35.05 72.06 Favored 'General case' 0 C--O 1.224 -0.25 0 CA-C-O 120.9 0.381 . . . . 73.42 110.202 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.447 HG21 HD11 ' A' ' 341' ' ' LEU . 1.8 mp -74.52 -31.03 26.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.278 -0.419 . . . . 63.33 110.512 175.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.471 ' CZ ' ' HD3' ' A' ' 147' ' ' LYS . 40.0 t80 -52.74 -53.72 43.88 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.686 -0.688 . . . . 70.35 111.886 -175.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 19.6 tt0 -99.57 -1.75 37.45 Favored 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.728 -0.389 . . . . 63.05 111.245 -173.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.94 -32.87 15.1 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.876 0.37 . . . . 71.43 110.542 176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.87 -0.65 26.9 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.45 -0.574 . . . . 73.22 109.45 177.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 147' ' ' LYS . . . 55.29 36.69 27.59 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 115.659 -0.701 . . . . 65.32 111.226 -177.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.471 ' HD3' ' CZ ' ' A' ' 142' ' ' TYR . 29.8 mtmt 72.57 93.98 0.08 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.551 -0.749 . . . . 72.15 112.46 177.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 148' ' ' ARG . 2.3 tpp85 -143.69 97.64 3.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.865 -1.061 . . . . 70.42 109.244 173.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -119.64 153.81 34.95 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.8 -0.636 . . . . 75.42 110.234 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.1 m -101.28 175.44 5.58 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.634 -0.506 . . . . 40.34 109.634 176.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 328' ' ' LEU . 21.8 ttm180 -67.32 -37.13 82.82 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.347 -0.141 . . . . 74.34 111.084 -177.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.861 ' HG2' ' HA ' ' A' ' 335' ' ' ASP . 2.1 tmtp? -55.98 -46.99 78.5 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 110.319 -0.252 . . . . 73.24 110.319 177.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.501 ' HA ' HD22 ' A' ' 339' ' ' LEU . 0.0 OUTLIER -58.26 -48.1 81.51 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.846 0.355 . . . . 54.22 111.195 -179.735 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 46.2 t -66.25 -42.07 90.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.312 -0.404 . . . . 44.24 110.771 -179.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -70.32 -52.64 21.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.465 . . . . 52.34 111.182 -176.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -63.72 -44.04 94.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.539 0.209 . . . . 71.04 110.838 -175.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.608 ' O ' HG12 ' A' ' 161' ' ' ILE . 10.9 mp -64.64 -41.87 95.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.265 -0.425 . . . . 62.43 110.755 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.3 t -59.35 -49.54 77.44 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.6 0.238 . . . . 75.11 110.531 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 325' ' ' LEU . 8.8 mp -58.47 -50.72 72.72 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.403 -0.362 . . . . 62.3 111.752 -178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.558 ' HG3' ' O ' ' A' ' 157' ' ' LEU . 0.0 OUTLIER -66.08 -21.9 66.39 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 120.988 0.423 . . . . 72.4 111.222 -178.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.608 HG12 ' O ' ' A' ' 157' ' ' LEU . 23.6 mm -69.66 -40.91 79.93 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.374 0 N-CA-C 109.72 -0.474 . . . . 75.22 109.72 173.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 9.5 mp -60.76 -47.5 86.03 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.984 0.178 . . . . 72.45 110.784 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.41 -56.37 13.56 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.9 0.381 . . . . 75.51 111.419 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.485 HG21 HH21 ' A' ' 160' ' ' ARG . 11.3 tt -68.72 -35.86 71.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.418 -0.355 . . . . 74.14 111.05 -177.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.576 HD13 ' CD2' ' A' ' 175' ' ' HIS . 68.5 tp -67.28 -38.5 85.16 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.547 -0.297 . . . . 61.32 111.488 -176.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.452 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 27.8 mm-40 -76.63 -28.83 56.22 Favored 'General case' 0 C--N 1.319 -0.727 0 C-N-CA 120.592 -0.443 . . . . 64.31 110.204 177.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -60.32 -48.71 80.56 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.849 0.357 . . . . 73.21 110.391 174.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 173' ' ' TYR . 18.5 pt -72.49 -31.97 39.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 C-N-CA 120.857 -0.337 . . . . 73.11 110.957 178.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 23.6 m170 -64.84 -38.05 89.67 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 122.982 0.176 . . . . 73.4 111.06 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -71.1 -6.17 37.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.012 0.434 . . . . 71.13 111.137 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -100.65 -85.56 0.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.217 -0.66 . . . . 53.11 109.217 170.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.626 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 15.0 pt-20 -169.44 1.63 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.114 -0.494 . . . . 71.35 111.746 177.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' A' ' 168' ' ' ILE . 39.2 m-85 -106.19 158.09 17.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.178 0.513 . . . . 72.52 111.719 -165.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 29.9 m -137.72 168.55 20.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 114.876 -1.056 . . . . 75.33 108.561 174.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.576 ' CD2' HD13 ' A' ' 165' ' ' LEU . 8.4 p80 -102.94 121.37 42.38 Favored 'General case' 0 C--N 1.321 -0.637 0 C-N-CA 120.447 -0.501 . . . . 72.12 110.645 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -65.65 -39.14 95.24 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.768 -0.73 . . . . 74.13 112.731 -176.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.493 ' HB3' HD13 ' A' ' 200' ' ' LEU . 29.4 t70 -135.06 127.85 31.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.992 0.425 . . . . 70.14 111.976 -175.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.713 ' HB ' HG22 ' A' ' 246' ' ' ILE . 32.2 mm -111.88 124.72 68.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 108.311 -0.996 . . . . 64.22 108.311 167.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -166.08 167.64 16.21 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.645 -0.502 . . . . 71.21 109.645 -179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -62.54 -19.16 63.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.21 -0.45 . . . . 41.34 110.946 178.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.684 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 3.1 p -75.1 -21.07 59.15 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.065 -0.516 . . . . 54.43 111.963 -177.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.517 ' HA ' HG12 ' A' ' 196' ' ' VAL . 2.0 p30 -110.79 12.51 22.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.781 0.324 . . . . 72.44 111.733 -179.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 65.2 mt -113.47 114.4 26.51 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.293 -0.412 . . . . 70.42 110.586 177.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 49.5 mt -118.31 138.74 52.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.061 -0.518 . . . . 72.24 110.86 -178.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.926 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 39.3 mt -95.18 154.02 17.38 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.105 -0.702 . . . . 72.33 109.105 175.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.444 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 27.5 t-20 -59.44 147.56 36.05 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.477 -0.564 . . . . 73.2 109.477 175.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.421 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 10.7 p90 -60.91 -25.59 66.86 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 112.008 0.373 . . . . 73.31 112.008 -172.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -120.41 -26.3 5.43 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.007 0.373 . . . . 65.41 112.007 -176.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.517 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 4.9 t30 -112.1 115.01 50.79 Favored Pre-proline 0 C--N 1.328 -0.337 0 C-N-CA 120.573 -0.451 . . . . 45.03 111.106 -175.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 7.6 Cg_exo -72.99 -29.83 11.56 Favored 'Trans proline' 0 C--N 1.35 0.611 0 C-N-CA 123.299 2.666 . . . . 43.2 114.413 -171.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.664 ' HA ' HD12 ' A' ' 339' ' ' LEU . 8.3 p-10 -88.27 13.7 10.99 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 120.514 -0.474 . . . . 65.21 111.53 -175.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.519 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 18.9 mm-40 -112.92 94.98 5.16 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.091 -0.504 . . . . 71.42 109.992 175.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.472 HG11 ' HG ' ' A' ' 157' ' ' LEU . 6.4 p -104.99 126.54 59.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.937 -0.574 . . . . 74.21 111.2 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.519 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 45.1 m-85 -128.75 158.98 37.11 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.813 -0.631 . . . . 75.2 110.238 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.454 HD13 ' NH2' ' A' ' 160' ' ' ARG . 8.3 mp -83.34 147.21 28.06 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 110.244 -0.28 . . . . 74.11 110.244 176.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.517 HG12 ' HA ' ' A' ' 182' ' ' ASN . 14.7 p -83.79 148.98 4.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.309 -0.405 . . . . 61.22 110.618 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -67.0 88.0 0.15 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.721 0.772 . . . . 72.14 110.422 173.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.679 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 0.0 OUTLIER -105.72 -9.38 17.32 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.803 -1.09 . . . . 75.34 111.303 179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.543 ' O ' HG23 ' A' ' 354' ' ' ILE . . . 57.55 16.96 24.57 Favored Glycine 0 C--O 1.223 -0.555 0 CA-C-N 115.904 -0.589 . . . . 41.14 112.726 -175.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.651 ' HG ' ' HA ' ' A' ' 353' ' ' THR . 0.5 OUTLIER -91.9 49.1 1.5 Allowed 'General case' 0 C--O 1.234 0.282 0 CA-C-O 121.674 0.749 . . . . 55.02 110.238 -174.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -119.87 110.4 16.7 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.41 -0.814 . . . . 42.43 110.169 177.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.2 t80 -98.27 -174.54 2.86 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.833 -1.173 . . . . 63.34 107.833 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.475 ' HD2' ' OE1' ' A' ' 172' ' ' GLU . 36.8 ptt180 -131.29 133.52 45.47 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.683 -0.636 . . . . 62.34 111.675 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -93.59 -17.51 23.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.309 -0.86 . . . . 71.43 110.169 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.626 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 40.4 m -128.6 76.0 79.04 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.254 -0.43 . . . . 71.42 110.884 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 203' ' ' ARG . 91.5 Cg_exo -45.35 103.17 0.05 OUTLIER 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 123.182 2.588 . . . . 74.44 113.263 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 61.81 28.73 17.64 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 115.325 -0.852 . . . . 63.21 111.301 176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.42 -15.68 45.91 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.658 -0.782 . . . . 51.24 113.078 175.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.0 t -94.28 110.53 23.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 O-C-N 122.409 -0.465 . . . . 75.2 109.938 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 205' ' ' CYS . 14.9 p-80 -63.8 127.45 31.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.962 0.411 . . . . 75.11 110.399 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.547 ' HE3' ' HB3' ' A' ' 214' ' ' LYS . 37.6 tptt -103.14 142.99 33.19 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.798 -0.637 . . . . 63.34 110.114 -176.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 9.0 pm0 -81.68 -169.3 2.26 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.166 -0.309 . . . . 62.33 110.166 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.738 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 69.1 t80 -64.1 91.11 0.07 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.431 -0.581 . . . . 61.44 109.431 173.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.547 ' HB3' ' HE3' ' A' ' 211' ' ' LYS . 22.2 tptm -156.0 16.09 0.35 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.163 -0.472 . . . . 70.24 110.517 -175.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.434 ' OE1' ' HB2' ' A' ' 237' ' ' ALA . 35.0 tt0 -72.51 -66.75 0.62 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.924 0.392 . . . . 65.34 110.486 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -140.52 140.35 22.43 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 109.787 -0.449 . . . . 73.14 109.787 -179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.453 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 3.3 Cg_endo -47.35 -51.06 10.14 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 123.206 2.604 . . . . 74.43 113.451 179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.453 ' HG2' ' O ' ' A' ' 217' ' ' PRO . 32.1 mmtm -160.12 5.67 0.08 Allowed 'General case' 0 N--CA 1.473 0.722 0 N-CA-C 112.291 0.478 . . . . 74.01 112.291 -179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.45 ' NH2' ' HB2' ' A' ' 357' ' ' LYS . 7.3 ttp85 -113.36 37.56 3.16 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.508 0.671 . . . . 72.32 110.567 -171.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.492 ' HB2' ' HA2' ' A' ' 235' ' ' GLY . 41.0 t -71.13 -86.85 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 O-C-N 121.855 -0.528 . . . . 71.03 110.117 177.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.402 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 21.3 m-70 53.82 40.79 31.94 Favored 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.268 -0.424 . . . . 75.43 110.881 176.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -60.24 -48.47 81.61 Favored 'General case' 0 C--N 1.329 -0.322 0 O-C-N 123.204 0.315 . . . . 70.45 110.985 -176.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -99.8 -166.85 29.45 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.862 -0.685 . . . . 44.14 112.087 176.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 54.9 p -70.38 143.9 51.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.969 0.414 . . . . 75.51 111.062 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.442 HD12 HG21 ' A' ' 271' ' ' VAL . 0.3 OUTLIER -64.8 -20.66 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 121.644 0.735 . . . . 65.42 109.546 -178.441 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.414 ' HG2' HD21 ' A' ' 265' ' ' LEU . 19.4 mt-10 -61.58 -48.43 80.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.02 -0.991 . . . . 71.3 111.475 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.678 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.1 m-85 -111.77 -15.83 13.32 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 113.344 0.868 . . . . 75.41 113.344 -169.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.511 ' HB ' ' HB3' ' A' ' 232' ' ' ALA . 1.1 p -54.39 -27.07 34.1 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 113.652 0.982 . . . . 70.4 113.652 -174.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.553 ' HB2' ' HE2' ' A' ' 249' ' ' TYR . 15.3 t 64.43 -159.53 0.3 Allowed 'General case' 0 C--N 1.331 -0.205 0 O-C-N 123.337 0.398 . . . . 72.43 110.418 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 234' ' ' ASN . 3.3 mp -67.33 -45.65 85.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.613 -0.267 . . . . 73.13 110.981 -177.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.27 -74.79 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.722 0.638 . . . . 74.55 112.722 -175.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.511 ' HB3' ' HB ' ' A' ' 228' ' ' THR . . . -67.88 -27.59 66.79 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.95 -0.568 . . . . 71.01 112.163 -172.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.83 -27.03 60.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 116.624 -0.262 . . . . 75.54 110.976 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 230' ' ' ILE . 2.7 t30 -82.56 -36.64 26.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.641 -0.254 . . . . 45.03 110.882 -175.052 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 144.5 9.3 0.37 Allowed Glycine 0 CA--C 1.519 0.302 0 C-N-CA 119.794 -1.194 . . . . 61.42 114.121 177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.738 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 12.1 p -122.41 139.58 48.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 117.374 0.587 . . . . 43.11 110.547 177.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.434 ' HB2' ' OE1' ' A' ' 215' ' ' GLU . . . -55.14 148.93 27.58 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 64.1 110.575 172.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -49.33 108.25 0.19 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.833 2.356 . . . . 64.03 111.489 177.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 32.6 p -79.16 -72.36 0.39 Allowed 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.768 0.794 . . . . 70.34 110.767 -174.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -154.57 -42.51 0.09 Allowed 'General case' 0 C--N 1.311 -1.083 0 N-CA-C 106.832 -1.544 . . . . 74.33 106.832 176.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 310' ' ' ASP . 48.8 ttt-85 -58.23 -70.2 0.15 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 113.51 -1.677 . . . . 72.01 111.174 177.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.716 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -62.99 -36.38 93.38 Favored Glycine 0 C--O 1.223 -0.543 0 CA-C-N 115.821 -0.627 . . . . 72.3 112.886 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -54.0 -50.54 66.38 Favored 'General case' 0 C--O 1.241 0.617 0 CA-C-O 121.261 0.553 . . . . 71.43 110.475 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 87.7 mt -70.62 -30.7 67.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.531 -0.758 . . . . 43.35 111.02 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.427 ' OE2' ' HD3' ' A' ' 279' ' ' ARG . 39.2 mt-10 -66.1 -39.22 89.81 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 121.049 -0.26 . . . . 73.11 110.716 175.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.716 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.6 mt -58.2 -47.33 87.61 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.124 0.488 . . . . 74.14 109.814 177.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 64.5 tp -62.13 -43.62 98.43 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.729 -0.669 . . . . 73.11 110.26 176.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.03 -44.18 96.44 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 115.979 -0.555 . . . . 54.11 112.769 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.553 ' HE2' ' HB2' ' A' ' 229' ' ' SER . 19.3 m-85 -59.04 -41.33 87.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.877 0.37 . . . . 73.45 110.518 178.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.411 ' SG ' HG22 ' A' ' 178' ' ' ILE . 78.5 m -62.73 -45.09 94.33 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.206 -0.452 . . . . 74.53 110.573 177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 90.4 mtp -59.66 -50.26 74.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.051 -0.522 . . . . 63.0 111.47 -178.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.508 ' HB ' HG21 ' A' ' 299' ' ' ILE . 0.0 OUTLIER -66.07 -36.62 77.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 121.01 -0.276 . . . . 72.32 110.392 -179.714 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -62.57 -42.88 99.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.518 -0.31 . . . . 74.05 110.983 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 44.4 m0 -64.04 -38.9 92.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.759 0.314 . . . . 72.05 111.145 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.5 tp -81.11 -30.33 34.63 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.446 0.536 . . . . 64.3 112.446 -174.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.537 HG22 ' HB2' ' A' ' 290' ' ' PHE . 76.6 p -103.45 -28.82 11.56 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 120.388 -0.525 . . . . 65.43 111.828 -176.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 147' ' ' LYS . . . 76.3 14.27 82.51 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 121.101 -0.571 . . . . 61.14 113.019 -179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 14.4 m80 -150.68 149.93 30.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 117.349 0.575 . . . . 74.54 112.05 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.593 ' O ' ' HG3' ' A' ' 262' ' ' GLU . 95.6 mt -129.82 139.44 35.65 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.353 -0.84 . . . . 55.11 108.87 171.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.646 ' HG2' ' HE1' ' A' ' 278' ' ' TYR . 25.0 Cg_exo -65.25 -9.92 23.88 Favored 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 122.678 2.252 . . . . 54.12 113.044 -178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.596 ' HB2' HG12 ' A' ' 271' ' ' VAL . 38.6 p90 -118.98 28.16 8.44 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.122 0.416 . . . . 61.15 112.122 -175.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.593 ' HG3' ' O ' ' A' ' 259' ' ' LEU . 55.0 mt-10 -66.78 -51.22 58.28 Favored 'General case' 0 N--CA 1.468 0.427 0 CA-C-O 121.191 0.52 . . . . 62.15 110.825 177.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.74 -27.69 60.47 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.701 -0.681 . . . . 73.14 110.687 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.433 ' HB3' ' HB2' ' A' ' 270' ' ' TYR . 13.6 m120 -98.58 12.99 33.53 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.739 -0.664 . . . . 74.22 111.01 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.425 HD23 ' HD1' ' A' ' 261' ' ' TRP . 3.0 tm? -58.94 -39.18 80.84 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 121.016 0.436 . . . . 60.51 111.183 -175.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.1 ptmt -78.84 11.34 2.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.048 -0.524 . . . . 64.24 111.737 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -125.99 106.01 25.64 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 109.282 -0.636 . . . . 53.42 109.282 173.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.416 ' HA ' HG22 ' A' ' 271' ' ' VAL . 20.8 Cg_endo -60.54 -23.09 74.49 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.027 2.485 . . . . 70.32 113.385 -173.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -74.03 -46.89 40.57 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.946 -0.39 . . . . 70.42 109.946 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.433 ' HB2' ' HB3' ' A' ' 264' ' ' ASN . 16.2 m-30 -67.21 -41.78 85.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.836 -0.62 . . . . 71.11 110.822 -176.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.596 HG12 ' HB2' ' A' ' 261' ' ' TRP . 17.1 m -64.69 -34.1 67.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 120.765 0.317 . . . . 71.15 110.216 177.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.464 ' O ' HG13 ' A' ' 276' ' ' ILE . 53.0 ttt-85 -66.55 -48.5 69.48 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 116.241 -0.436 . . . . 53.03 110.495 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 -60.0 -40.77 90.36 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.354 -0.385 . . . . 72.32 110.694 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 35.2 m -61.82 -41.85 98.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.951 -0.568 . . . . 70.0 110.97 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.507 ' HD3' ' HA ' ' A' ' 229' ' ' SER . 68.2 mttm -63.92 -37.63 88.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.296 -0.411 . . . . 72.43 110.288 177.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.1 mt -65.54 -38.76 83.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.973 -0.558 . . . . 73.01 110.581 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.489 ' HA ' ' OE2' ' A' ' 280' ' ' GLU . 0.3 OUTLIER -62.27 -40.49 96.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.904 0.383 . . . . 74.24 110.453 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.646 ' HE1' ' HG2' ' A' ' 260' ' ' PRO . 28.0 m-85 -66.76 -29.89 69.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.107 -0.497 . . . . 73.34 110.751 174.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.45 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 0.0 OUTLIER -81.54 -7.95 59.65 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.808 -0.633 . . . . 64.52 111.211 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.489 ' OE2' ' HA ' ' A' ' 277' ' ' ARG . 49.4 mt-10 -79.88 -71.19 0.47 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.1 0.476 . . . . 70.34 110.222 173.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 82.6 m-20 -119.91 94.45 4.4 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.913 -0.585 . . . . 63.32 109.626 -179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 282' ' ' ILE . 3.9 mp -67.07 -51.99 48.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.432 -0.349 . . . . 74.13 110.468 -173.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.4 -46.94 84.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.92 -0.582 . . . . 74.21 111.399 -177.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.2 m -61.65 -45.94 91.91 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 116.339 -0.391 . . . . 73.52 111.183 -177.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 289' ' ' CYS . 3.9 mm? -65.88 -44.47 85.25 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 116.307 -0.406 . . . . 64.14 111.184 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.5 mmt -67.13 -43.46 82.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.702 0.287 . . . . 71.53 111.243 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -55.66 -45.37 77.7 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.849 -0.614 . . . . 73.44 110.939 -178.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 54.5 mtmt -96.65 5.2 51.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.013 -0.54 . . . . 53.42 111.603 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 48.8 t -85.19 -43.79 13.5 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.014 -0.736 . . . . 54.01 109.014 173.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.672 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 53.4 t80 -129.44 78.94 74.87 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 115.672 -0.695 . . . . 62.23 109.895 177.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -94.48 36.74 0.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 123.354 2.703 . . . . 64.2 111.903 -178.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -89.44 -166.81 1.69 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.943 -0.571 . . . . 72.03 109.543 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 28.5 mmtp -79.96 66.93 5.6 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.581 0.705 . . . . 75.35 111.079 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.672 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 46.6 t30 -167.7 151.5 6.31 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.56 -1.2 . . . . 71.12 107.761 177.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -107.26 112.29 62.88 Favored Pre-proline 0 C--N 1.32 -0.698 0 C-N-CA 120.288 -0.565 . . . . 72.41 110.718 -176.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -70.08 109.21 2.32 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.473 2.115 . . . . 74.41 110.978 172.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -136.96 -40.72 0.11 Allowed Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.512 -0.852 . . . . 64.34 111.631 177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.569 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 0.7 OUTLIER -63.87 -61.3 2.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.128 0.489 . . . . 72.33 109.952 -178.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.508 HG21 ' HB ' ' A' ' 252' ' ' ILE . 3.5 mp -62.21 -40.12 86.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.486 -0.779 . . . . 63.42 110.56 -179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.11 -54.21 49.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.802 -0.635 . . . . 72.1 111.479 -177.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -69.1 -39.88 78.72 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 121.127 -0.229 . . . . 74.52 111.16 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.401 ' O ' HG13 ' A' ' 306' ' ' VAL . 44.8 t80 -56.33 -53.39 57.83 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.138 0.494 . . . . 74.14 110.546 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.559 ' HA ' HG22 ' A' ' 306' ' ' VAL . 62.0 mtp -72.77 -30.58 64.24 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.88 -0.6 . . . . 64.24 111.635 -175.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.476 ' HA ' HG12 ' A' ' 282' ' ' ILE . 40.9 tt0 -66.63 -45.29 79.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.316 0.579 . . . . 71.42 109.657 174.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.546 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 19.1 m -59.68 -47.32 86.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.225 -0.898 . . . . 73.34 111.67 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.559 HG22 ' HA ' ' A' ' 303' ' ' MET . 20.0 m -68.74 -27.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 120.959 -0.296 . . . . 74.12 111.128 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.45 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 7.7 tmtm? -67.29 -33.97 76.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 121.168 0.509 . . . . 73.42 110.056 174.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.493 ' O ' HD23 ' A' ' 308' ' ' LEU . 6.0 tt -75.14 -31.26 61.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.598 -0.728 . . . . 72.22 109.976 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.746 ' O ' ' HB2' ' A' ' 313' ' ' GLU . 92.9 mt -63.89 -33.86 76.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 64.52 111.897 -177.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.543 ' O ' ' HB2' ' A' ' 241' ' ' ARG . 8.3 t70 60.51 -165.75 0.21 Allowed 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 109.818 -0.438 . . . . 71.42 109.818 -178.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -63.6 -37.61 87.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 112.579 0.585 . . . . 73.4 112.579 -173.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.0 m -149.3 74.95 1.26 Allowed 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.201 -0.6 . . . . 61.31 112.519 -176.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.746 ' HB2' ' O ' ' A' ' 309' ' ' LEU . 0.0 OUTLIER -118.67 -175.47 2.89 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.704 -0.48 . . . . 55.34 109.704 165.851 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.472 ' HA ' ' HD3' ' A' ' 315' ' ' PRO . 39.5 mttp -86.19 109.38 22.62 Favored Pre-proline 0 C--N 1.32 -0.681 0 CA-C-N 116.12 -0.491 . . . . 63.23 110.448 -175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 314' ' ' LYS . 4.0 Cg_endo -85.64 119.14 1.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.932 2.421 . . . . 74.23 112.526 -176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 84.5 mt -91.25 85.98 6.01 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.054 -0.521 . . . . 61.3 110.128 178.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -65.51 -34.1 77.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.886 -0.597 . . . . 60.34 111.686 -177.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -69.71 -29.44 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 120.892 -0.323 . . . . 72.33 110.688 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -72.73 -45.08 60.53 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.605 -0.517 . . . . 75.21 109.605 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.599 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 93.7 mt -56.53 -46.02 80.84 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.783 -0.644 . . . . 62.43 110.02 174.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -54.34 -50.14 68.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.682 -0.69 . . . . 75.54 110.998 175.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -67.36 -37.83 83.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.276 -0.42 . . . . 44.45 111.847 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.8 pp -72.3 -28.72 29.58 Favored 'Isoleucine or valine' 0 C--O 1.234 0.26 0 C-N-CA 120.571 -0.452 . . . . 74.13 111.035 -179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 96.2 mt -67.87 -49.35 62.57 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-O 121.272 0.558 . . . . 62.34 109.629 174.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.707 HD21 HD21 ' A' ' 159' ' ' LEU . 4.3 mm? -64.65 -31.15 72.25 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.584 -0.735 . . . . 74.54 110.618 177.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -59.74 -47.04 87.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 74.53 109.939 177.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.569 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -61.31 -46.14 95.02 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.756 -0.735 . . . . 72.14 112.072 178.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 151' ' ' ARG . 26.8 tp -58.59 -48.56 80.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.433 0.635 . . . . 65.23 110.558 177.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.473 ' HE2' ' HB3' ' A' ' 329' ' ' LYS . 34.8 ttpt -65.75 -46.48 78.67 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.011 -0.995 . . . . 74.21 112.123 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.68 -45.28 94.67 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.623 0.601 . . . . 71.12 112.623 -172.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 15.1 tt -79.69 -7.13 10.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.021 0.438 . . . . 75.21 111.363 -174.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 90.18 24.65 28.68 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.226 -0.988 . . . . 71.35 113.082 176.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 12.4 p -100.78 138.98 37.11 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.881 0.372 . . . . 64.22 110.436 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 42.1 pttt -151.67 80.61 1.28 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.983 -0.553 . . . . 62.54 109.761 -179.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.861 ' HA ' ' HG2' ' A' ' 152' ' ' LYS . 26.2 t0 68.46 111.29 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.053 -0.976 . . . . 61.1 109.782 -172.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -76.8 -7.04 54.68 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.783 -0.644 . . . . 61.24 111.058 -177.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 129.93 58.28 0.1 OUTLIER Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.268 -0.968 . . . . 61.12 113.152 177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 39.5 mmtt 60.77 36.14 19.36 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 111.841 0.312 . . . . 71.31 111.841 173.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.664 HD12 ' HA ' ' A' ' 191' ' ' ASP . 29.1 mt 72.33 110.12 0.06 Allowed 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.467 -0.788 . . . . 74.33 111.464 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -89.75 96.86 10.88 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.423 -0.808 . . . . 74.32 109.508 176.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.447 HD11 HG21 ' A' ' 141' ' ' ILE . 12.7 tp -160.78 24.96 0.14 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.029 -0.532 . . . . 64.24 110.529 -175.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 41.3 m -82.15 87.02 6.53 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.357 0.598 . . . . 73.21 110.864 -175.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.14 -46.58 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.282 -0.872 . . . . 65.22 108.692 175.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.406 ' HA ' HD11 ' A' ' 141' ' ' ILE . 23.4 t 31.09 92.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.936 -1.484 . . . . 72.34 114.016 178.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.402 ' O ' ' HD3' ' A' ' 140' ' ' LYS . 29.4 tt0 -127.86 -96.21 0.41 Allowed 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 120.597 -0.441 . . . . 73.04 110.995 175.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.477 ' HA ' ' HG2' ' A' ' 140' ' ' LYS . 65.6 t30 -166.19 161.9 17.2 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 117.808 0.277 . . . . 72.41 110.725 -179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 120.59 174.13 15.07 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.216 -0.516 . . . . 34.43 112.302 178.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 139' ' ' GLN . . . 84.02 -1.03 89.25 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 121.287 -0.482 . . . . 61.52 113.97 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.409 HD13 ' HA ' ' A' ' 349' ' ' LEU . 4.3 mm? -64.8 120.39 12.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.212 0.506 . . . . 64.43 112.007 -174.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 55.1 tptt -163.1 118.05 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 65.42 109.814 176.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.51 174.74 5.73 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.551 -0.295 . . . . 64.23 110.79 -178.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.598 ' O ' HG22 ' A' ' 353' ' ' THR . 9.8 tmtt? -164.08 -57.77 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 116.736 -0.211 . . . . 74.35 110.635 -179.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.651 ' HA ' ' HG ' ' A' ' 200' ' ' LEU . 0.6 OUTLIER 69.23 179.19 0.24 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.402 1.081 . . . . 61.01 111.655 -179.641 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.647 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -65.45 144.13 15.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.584 0 CA-C-O 121.728 0.775 . . . . 65.51 112.847 -172.131 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.9 t -71.96 154.7 41.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 114.642 -1.163 . . . . 64.05 111.06 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -149.97 146.77 27.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.998 -0.546 . . . . 74.53 109.727 178.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.45 ' HB2' ' NH2' ' A' ' 219' ' ' ARG . 29.6 ttpt -138.93 69.75 1.37 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.69 0.281 . . . . 74.42 110.44 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.57 155.64 1.8 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.984 -0.553 . . . . 53.33 110.058 178.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.593 ' O ' ' HD3' ' A' ' 359' ' ' LYS . 0.0 OUTLIER -78.46 142.31 37.6 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.092 0.473 . . . . 41.12 111.489 -177.59 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.455 ' HE2' ' HB3' ' A' ' 360' ' ' LYS . 29.9 ttpt . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.321 -0.847 . . . . 63.52 109.044 175.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.693 ' HB2' ' HD3' ' A' ' 2' ' ' PRO . 87.9 mtp . . . . . 0 N--CA 1.483 1.204 0 CA-C-O 119.475 -0.298 . . . . 53.42 110.785 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.693 ' HD3' ' HB2' ' A' ' 1' ' ' MET . 87.7 Cg_endo -80.77 142.24 14.04 Favored 'Trans proline' 0 C--N 1.356 0.932 0 C-N-CA 121.512 1.474 . . . . 61.2 111.622 177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 28.6 mtp180 -119.59 120.42 36.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.353 -0.385 . . . . 64.44 110.801 -179.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 26.6 m -86.04 147.81 5.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.02 -0.537 . . . . 74.32 110.088 177.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' N ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -159.69 134.9 8.16 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.319 -0.4 . . . . 74.31 110.582 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -173.35 112.47 0.21 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.526 -0.761 . . . . 73.13 109.827 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -89.61 76.62 7.31 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.199 0.523 . . . . 72.3 110.921 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -109.38 86.99 2.39 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.315 -0.624 . . . . 71.41 109.315 177.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.37 119.33 2.34 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.942 -0.572 . . . . 72.14 110.564 -178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 147.21 127.13 1.74 Allowed Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.421 -0.895 . . . . 45.31 112.596 178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.427 HH11 ' HD3' ' A' ' 11' ' ' ARG . 3.9 mpt_? -124.22 151.47 44.08 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.789 0.328 . . . . 75.32 110.597 176.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -94.98 133.71 38.45 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 109.629 -0.508 . . . . 74.11 109.629 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.0 m -79.79 128.22 33.17 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.16 -0.473 . . . . 63.03 111.119 -175.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.3 m -65.79 113.18 4.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.363 -0.606 . . . . 73.22 109.363 173.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.71 172.94 11.76 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.025 0.441 . . . . 44.22 111.536 -173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -68.91 162.17 27.18 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.574 -0.739 . . . . 60.42 111.105 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.6 ptm180 -134.18 139.76 46.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.013 -0.54 . . . . 70.01 109.982 178.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.425 ' CE1' ' HB2' ' A' ' 21' ' ' GLU . 3.6 p80 -153.73 133.29 12.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.458 -0.337 . . . . 73.34 110.484 178.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.429 ' H ' ' HG ' ' A' ' 19' ' ' LEU . 3.0 pp -77.05 -17.38 58.8 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.935 -0.575 . . . . 72.43 111.027 -177.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.405 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -82.11 63.51 6.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.473 . . . . 74.31 109.901 175.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.425 ' HB2' ' CE1' ' A' ' 18' ' ' HIS . 27.5 tt0 -145.11 89.96 2.0 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.583 -0.735 . . . . 72.4 109.469 -179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -94.94 3.78 54.56 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.559 -0.746 . . . . 75.32 111.439 -173.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -105.7 7.46 32.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.353 -0.385 . . . . 74.14 110.993 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -120.91 -163.21 1.01 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.233 -0.439 . . . . 73.41 110.121 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -63.31 143.74 15.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 109.46 -0.571 . . . . 73.12 109.46 175.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.494 ' H ' HG13 ' A' ' 39' ' ' VAL . . . 99.1 2.1 56.98 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.598 -0.811 . . . . 75.41 111.821 -172.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 13.5 pt-20 -74.63 155.43 37.82 Favored 'General case' 0 C--O 1.241 0.61 0 CA-C-O 121.116 0.484 . . . . 74.03 110.756 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.581 HD13 ' HB3' ' A' ' 38' ' ' LYS . 33.3 mm -87.11 118.74 33.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.537 -0.756 . . . . 72.33 110.191 177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.5 pt -90.1 137.9 20.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 120.889 0.376 . . . . 73.34 110.212 176.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.405 ' HA ' ' HB3' ' A' ' 35' ' ' LYS . 10.0 m -86.42 111.54 20.62 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.028 0.442 . . . . 65.4 109.954 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.541 ' H ' ' HA ' ' A' ' 35' ' ' LYS . 12.0 t70 -111.38 159.57 17.89 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.532 -0.758 . . . . 71.45 110.272 -173.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.473 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 8.9 mmt -62.03 -22.56 65.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.047 0.451 . . . . 71.31 110.134 175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.57 23.36 0.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.708 -0.678 . . . . 70.24 111.151 176.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.462 ' HE3' ' HB3' ' A' ' 34' ' ' LYS . 2.8 tmmt? 74.0 44.88 0.24 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.922 -0.581 . . . . 54.43 110.466 174.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.617 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 60.0 pttt 45.28 -149.52 0.08 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.858 0.863 . . . . 74.41 112.681 174.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.617 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 53.9 mt-10 69.59 39.37 1.56 Allowed 'General case' 0 N--CA 1.462 0.154 0 C-N-CA 123.299 0.64 . . . . 61.32 111.095 177.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 71.3 m95 -126.77 121.38 31.8 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.79 -0.818 . . . . 72.24 108.79 171.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.606 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 23.1 pttp -105.22 131.65 52.43 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.791 -0.764 . . . . 72.24 110.96 175.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.494 HG13 ' H ' ' A' ' 26' ' ' GLY . 2.7 p -70.75 129.68 34.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.488 -0.778 . . . . 70.12 110.499 -179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.753 ' HA3' ' HB2' ' A' ' 55' ' ' ASP . . . -116.69 -106.28 2.45 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.624 -0.798 . . . . 63.1 113.185 -174.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.0 tm? -62.89 118.3 40.87 Favored Pre-proline 0 C--O 1.235 0.339 0 CA-C-O 121.15 0.5 . . . . 75.35 110.899 -174.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.904 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.7 Cg_exo -73.78 93.38 0.86 Allowed 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 122.755 2.303 . . . . 63.21 111.733 176.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 62.0 mt -69.07 -53.15 27.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.292 0.568 . . . . 73.42 109.618 176.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 115.17 -56.38 0.51 Allowed Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.456 -0.793 . . . . 51.31 112.035 176.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.6 ' HG2' ' HA2' ' A' ' 49' ' ' GLY . 56.4 mt-30 -151.77 130.05 12.02 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.837 0.351 . . . . 73.12 110.527 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.522 ' H ' HD12 ' A' ' 51' ' ' ILE . . . -99.55 26.71 23.33 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 110.331 -1.108 . . . . 75.23 110.331 171.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 348' ' ' GLY . . . 113.62 -50.65 0.76 Allowed Glycine 0 N--CA 1.443 -0.889 0 N-CA-C 111.608 -0.597 . . . . 72.11 111.608 -175.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.716 ' HZ ' ' HB2' ' A' ' 79' ' ' PRO . 49.4 t80 -77.22 -76.9 0.16 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.588 0.232 . . . . 61.24 110.405 -178.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.6 ' HA2' ' HG2' ' A' ' 45' ' ' GLN . . . 172.86 150.43 7.37 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.131 -1.033 . . . . 61.1 113.084 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 24.9 t 45.66 67.01 0.8 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 123.989 0.915 . . . . 63.34 112.398 176.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.522 HD12 ' H ' ' A' ' 46' ' ' GLY . 17.0 mt -123.46 136.46 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.299 -0.409 . . . . 71.15 111.705 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.904 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 73.4 m-85 -129.42 165.9 20.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.924 0.393 . . . . 74.3 111.059 -175.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.589 HD13 ' N ' ' A' ' 54' ' ' ALA . 1.3 tm? -90.81 143.12 27.05 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.067 -0.716 . . . . 74.35 109.067 -179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.589 ' N ' HD13 ' A' ' 53' ' ' LEU . . . -92.55 75.27 5.11 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.236 0.541 . . . . 65.53 110.738 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.753 ' HB2' ' HA3' ' A' ' 40' ' ' GLY . 8.9 m-20 -79.29 67.47 5.02 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.767 -0.652 . . . . 72.01 110.19 179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.606 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 16.0 tpt -82.0 -52.25 7.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 73.32 110.645 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.43 ' O ' HG21 ' A' ' 62' ' ' VAL . 50.7 t-20 -144.39 115.37 7.85 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.136 -0.484 . . . . 73.04 110.009 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 45.8 m -126.2 38.88 4.05 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.976 0.417 . . . . 62.04 110.504 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 14.8 m -71.03 -53.27 15.35 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.49 0.552 . . . . 75.15 112.49 -174.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -105.26 24.31 12.29 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 112.085 0.402 . . . . 72.04 112.085 -171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 52.9 m 57.96 64.9 1.41 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.767 0.794 . . . . 63.44 108.998 -170.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.521 HG21 ' HB2' ' A' ' 65' ' ' ASP . 7.9 m -63.0 141.17 18.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 114.598 -1.183 . . . . 72.51 112.678 -174.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.79 0.9 52.18 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.444 -0.798 . . . . 62.42 112.258 176.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.5 m -120.49 -49.11 2.27 Favored 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.186 0.439 . . . . 70.33 112.186 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' HB2' HG21 ' A' ' 62' ' ' VAL . 6.1 m-20 -67.13 -63.34 1.08 Allowed 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 112.736 0.643 . . . . 72.41 112.736 -174.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.506 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -63.24 -43.18 79.62 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 113.839 1.052 . . . . 73.33 113.839 -173.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 66' ' ' ALA . 58.0 Cg_endo -71.03 33.12 0.23 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 122.136 1.89 . . . . 74.04 113.757 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 83.8 m -121.5 138.32 54.35 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.972 0.415 . . . . 74.23 110.22 175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.504 ' CG1' ' HD3' ' A' ' 133' ' ' ARG . 15.9 m -114.92 143.22 25.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.09 -0.505 . . . . 70.33 109.862 177.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.443 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.0 p -117.13 116.09 50.94 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 CA-C-O 121.88 0.847 . . . . 61.12 110.137 178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.481 ' HD3' ' SD ' ' A' ' 129' ' ' MET . 16.3 ptmt -92.7 128.43 38.56 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 114.591 -1.186 . . . . 74.2 109.208 179.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.421 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 6.9 p -135.47 124.26 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.809 0 C-N-CA 119.542 -0.863 . . . . 61.11 112.816 -173.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.555 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 5.6 mm-40 -124.71 171.43 7.35 Favored Pre-proline 0 C--N 1.319 -0.737 0 CA-C-N 115.111 -0.95 . . . . 72.53 108.809 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -58.61 152.99 51.83 Favored 'Trans proline' 0 N--CA 1.462 -0.343 0 C-N-CA 121.905 1.737 . . . . 34.41 111.43 174.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.418 ' HA ' ' HB2' ' A' ' 127' ' ' ARG . 28.9 t -53.71 -35.99 61.75 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.082 0.468 . . . . 73.15 110.408 177.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.552 ' CG ' ' HZ1' ' A' ' 359' ' ' LYS . 6.8 t70 -99.39 116.02 30.58 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.505 -0.771 . . . . 75.05 109.612 174.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -151.7 -68.3 0.17 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.157 -0.474 . . . . 44.33 110.745 -176.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 123.18 -86.9 0.38 Allowed Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.719 -0.753 . . . . 71.32 112.111 -178.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.716 ' HB2' ' HZ ' ' A' ' 48' ' ' PHE . 51.1 Cg_exo -53.71 -43.73 55.33 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.123 2.549 . . . . 72.01 113.05 -179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 3.4 tm? -55.77 -45.84 78.04 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 120.962 0.41 . . . . 72.24 110.418 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -68.93 -35.96 77.4 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.15 0.5 . . . . 74.43 110.635 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 25.3 m -67.72 -48.48 66.37 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.93 -0.577 . . . . 64.22 110.921 -177.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.792 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . 8.1 pt-20 -69.63 -27.89 65.45 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 110.141 -0.318 . . . . 73.12 110.141 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.445 HD13 ' HE2' ' A' ' 129' ' ' MET . 59.7 tp -62.99 -44.2 96.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.414 -0.357 . . . . 72.4 110.63 176.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.504 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 42.0 tptt -64.1 -46.14 85.52 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.261 -0.427 . . . . 43.34 109.876 179.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.401 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 60.8 t80 -59.57 -47.93 83.62 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.696 -0.684 . . . . 73.44 110.128 177.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 48.0 t80 -56.43 -46.83 80.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.221 -0.9 . . . . 72.33 110.474 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' O ' ' HB2' ' A' ' 92' ' ' LYS . 0.9 OUTLIER -61.47 -35.39 77.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.194 -0.457 . . . . 74.13 111.218 179.828 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.504 ' HG3' ' O ' ' A' ' 85' ' ' LYS . 79.0 mtp180 -81.44 -18.74 44.27 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.084 0.401 . . . . 75.41 112.084 -176.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.97 -34.9 6.77 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.66 0.615 . . . . 43.34 112.66 -178.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -95.51 11.29 33.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.262 0.553 . . . . 75.15 111.998 -172.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.432 ' HG2' ' HD2' ' A' ' 93' ' ' PRO . 30.0 tttm -76.86 139.79 66.49 Favored Pre-proline 0 C--N 1.31 -1.127 0 CA-C-N 115.384 -0.825 . . . . 62.31 110.269 -175.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.432 ' HD2' ' HG2' ' A' ' 92' ' ' LYS . 80.8 Cg_exo -47.37 -53.48 6.37 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 123.343 2.696 . . . . 63.32 113.697 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -65.36 -40.72 93.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 51.34 110.683 -176.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 167' ' ' TYR . 13.2 mm100 -61.59 -48.9 78.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.609 -0.723 . . . . 65.44 111.148 -176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.526 HD12 ' NZ ' ' A' ' 112' ' ' LYS . 62.3 mt -66.0 -48.62 81.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.892 -0.594 . . . . 74.14 111.283 -177.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 87.0 mm-40 -61.66 -37.91 85.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.898 0.38 . . . . 73.51 111.026 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.4 ttpp -61.24 -48.58 80.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.012 -0.54 . . . . 72.12 110.262 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 33.1 t-105 -66.79 -46.0 76.66 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.7 -0.682 . . . . 64.02 111.096 -176.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 66.3 mt -54.95 -50.66 60.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.239 -0.437 . . . . 73.14 111.273 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 29.4 ttm-85 -69.25 -32.43 71.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.196 -0.457 . . . . 74.41 111.194 -175.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 36.5 m -76.24 -40.36 52.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.593 -0.276 . . . . 72.34 111.743 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.547 ' HB3' ' HG ' ' A' ' 105' ' ' LEU . 10.8 ttt180 -93.64 9.05 38.52 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 120.973 -0.291 . . . . 61.34 111.167 -176.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.866 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.1 mmpt? 64.81 28.9 12.8 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.234 -0.439 . . . . 73.2 111.542 175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 88.5 mt -90.86 -173.61 3.76 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.041 -0.527 . . . . 75.24 111.022 -176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.97 -26.54 4.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.909 -0.587 . . . . 74.21 109.833 173.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.6 p90 -154.13 165.2 36.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.055 -0.52 . . . . 73.41 110.213 -178.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 58.4 tp -124.98 137.17 54.25 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.461 -0.57 . . . . 70.51 109.461 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -75.7 52.96 2.83 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.299 -0.477 . . . . 72.34 113.253 -177.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.8 p -132.64 133.22 23.22 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 109.071 -0.714 . . . . 63.12 109.071 176.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.593 ' HG3' ' HZ ' ' A' ' 134' ' ' PHE . 24.2 Cg_exo -60.77 136.78 68.61 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.406 2.071 . . . . 64.33 111.401 -178.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.734 ' HA ' ' HE3' ' A' ' 112' ' ' LYS . 0.3 OUTLIER -65.29 125.77 26.09 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.09 0.472 . . . . 73.42 110.815 -178.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.36 113.96 19.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.78 -0.645 . . . . 64.41 110.114 176.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.452 ' CD1' HG22 ' A' ' 130' ' ' ILE . 24.5 m95 -92.48 -49.94 5.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.287 -0.635 . . . . 72.52 109.287 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.41 ' HA3' ' OD1' ' A' ' 31' ' ' ASP . . . -176.63 -168.76 37.12 Favored Glycine 0 N--CA 1.438 -1.188 0 C-N-CA 120.591 -0.814 . . . . 74.5 112.684 -179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 82.4 p -179.96 177.21 0.68 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.934 -1.136 . . . . 73.34 107.934 -176.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 168.82 -175.83 43.2 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 119.09 -1.529 . . . . 43.0 113.929 176.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.512 HD11 ' HB3' ' A' ' 125' ' ' SER . 2.0 tm? -120.33 127.3 52.21 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.03 -1.1 . . . . 73.24 108.03 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.443 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 51.7 t60 -130.89 117.14 18.84 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.02 0.438 . . . . 72.15 111.083 -176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -67.1 149.89 49.94 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.629 -0.714 . . . . 53.21 109.994 174.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -128.12 -89.33 0.53 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.865 0.364 . . . . 64.35 110.177 -177.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 19.7 m120 -142.3 87.4 2.02 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.989 -0.745 . . . . 62.33 108.989 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 87.59 -36.42 3.35 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.727 -0.749 . . . . 73.04 112.066 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 9.8 mptt -109.34 163.71 13.15 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.904 -0.406 . . . . 73.42 109.904 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.512 ' HB3' HD11 ' A' ' 118' ' ' LEU . 50.0 m -123.98 138.54 54.45 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.174 -0.466 . . . . 60.05 109.815 176.006 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.421 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 66.1 m-85 -103.65 145.63 29.77 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.066 -0.515 . . . . 73.45 110.998 -177.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.418 ' HB2' ' HA ' ' A' ' 75' ' ' SER . 22.0 ttt180 -118.31 116.84 27.58 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.96 -0.756 . . . . 75.05 108.96 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.443 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 44.7 p90 -123.48 163.14 21.47 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.176 0.512 . . . . 73.15 112.244 -171.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.481 ' SD ' ' HD3' ' A' ' 71' ' ' LYS . 14.2 ttm -143.46 133.12 23.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.937 -1.029 . . . . 71.15 109.785 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.452 HG22 ' CD1' ' A' ' 114' ' ' TRP . 37.5 mt -97.77 127.03 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.686 0.279 . . . . 64.23 110.25 175.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.522 ' HE1' HG23 ' A' ' 196' ' ' VAL . 18.7 ptm -138.78 177.97 7.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.257 -0.429 . . . . 72.11 111.273 -178.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -65.63 142.03 58.2 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.731 -0.668 . . . . 63.54 111.351 -176.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.504 ' HD3' ' CG1' ' A' ' 69' ' ' VAL . 9.0 tpt180 -79.33 112.89 17.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.267 0.556 . . . . 72.11 111.152 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.593 ' HZ ' ' HG3' ' A' ' 111' ' ' PRO . 16.0 m-85 -102.02 149.29 24.39 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.915 -0.584 . . . . 62.33 109.597 177.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -132.54 -6.54 2.96 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.651 -0.785 . . . . 43.13 111.883 177.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.957 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 44.9 m -120.8 124.21 44.51 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 120.952 0.406 . . . . 72.24 111.551 -176.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.529 ' HA ' HD13 ' A' ' 184' ' ' LEU . 13.3 m-20 -98.07 125.73 43.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.891 -0.595 . . . . 74.04 109.56 173.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.639 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 17.2 tp -67.38 -18.67 65.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.184 0.516 . . . . 63.14 109.615 175.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.407 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 46.3 tp60 -60.09 -50.4 73.86 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.541 -0.754 . . . . 72.32 111.192 177.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.08 -31.05 67.34 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.73 0.3 . . . . 61.15 110.283 -179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.565 HG21 ' HG ' ' A' ' 341' ' ' LEU . 71.7 mt -64.25 -51.95 62.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.28 -0.418 . . . . 61.42 110.733 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.938 ' HD1' ' HB3' ' A' ' 147' ' ' LYS . 0.1 OUTLIER -68.91 -31.83 71.02 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.889 -0.412 . . . . 70.35 109.889 179.7 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -62.34 -53.45 54.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.996 -0.547 . . . . 73.43 111.178 179.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.15 -22.09 53.1 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.192 -0.458 . . . . 64.11 111.809 -176.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.402 ' HB3' ' O ' ' A' ' 141' ' ' ILE . 9.7 t-20 -96.38 -1.48 47.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.936 0.398 . . . . 72.03 111.359 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 58.57 33.68 23.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.166 -0.47 . . . . 63.51 111.034 -178.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.938 ' HB3' ' HD1' ' A' ' 142' ' ' TYR . 56.4 pttt 43.15 42.86 3.6 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.763 1.225 . . . . 63.24 113.226 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.5 ttm180 -115.68 90.09 3.25 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.077 -0.712 . . . . 73.01 109.077 172.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -106.44 157.36 17.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.237 0.542 . . . . 75.24 111.364 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.9 t -71.21 158.37 36.52 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.683 -0.689 . . . . 54.31 111.452 -178.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.464 HH21 ' CD ' ' A' ' 298' ' ' GLU . 6.1 tpt180 -53.73 -39.03 64.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.162 -0.926 . . . . 62.41 111.084 -179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -61.71 -61.96 2.14 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.527 -0.761 . . . . 53.12 111.564 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 9.7 t -64.86 -36.37 84.12 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 73.31 112.088 -175.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 80.3 t -63.25 -43.04 98.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.246 0 CA-C-O 120.727 0.299 . . . . 75.51 110.913 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 328' ' ' LEU . 0.4 OUTLIER -64.87 -47.4 78.0 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.457 -0.338 . . . . 70.1 110.168 -178.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.42 ' HB2' ' HB2' ' A' ' 335' ' ' ASP . 5.8 tp-100 -59.15 -45.24 91.48 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 120.835 0.35 . . . . 74.42 110.723 178.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.485 ' O ' HD13 ' A' ' 161' ' ' ILE . 35.2 tp -59.98 -46.81 88.25 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 71.51 110.367 179.574 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.2 t -61.3 -39.27 89.84 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.347 -0.388 . . . . 64.44 110.459 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.6 tt -62.51 -49.72 74.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.081 -0.509 . . . . 73.33 110.202 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.719 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.8 OUTLIER -60.62 -40.55 92.29 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.892 -178.414 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 157' ' ' LEU . 1.7 mp -61.79 -40.64 87.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 71.41 109.864 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 59.3 tp -61.98 -37.87 86.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.39 -0.368 . . . . 73.03 110.781 178.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.442 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.6 m-20 -56.12 -58.19 8.98 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 121.363 0.601 . . . . 73.42 110.593 177.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.539 HD13 HD12 ' A' ' 195' ' ' LEU . 18.7 tt -71.14 -35.89 60.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.573 -0.739 . . . . 74.13 111.231 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 52.2 tp -64.8 -38.54 91.34 Favored 'General case' 0 C--O 1.224 -0.281 0 CA-C-N 116.825 -0.171 . . . . 53.22 110.91 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -65.06 -45.05 86.92 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.342 -0.614 . . . . 63.03 109.342 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.493 ' OH ' ' HB3' ' A' ' 95' ' ' GLN . 61.4 t80 -56.18 -45.19 79.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.142 -0.936 . . . . 70.34 111.962 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.401 HG21 ' HZ ' ' A' ' 86' ' ' PHE . 35.1 pt -84.89 -32.29 7.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 C-N-CA 120.856 -0.337 . . . . 63.4 111.874 -176.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.644 ' HE1' ' HA ' ' A' ' 240' ' ' ARG . 5.1 t60 -66.2 -41.13 90.59 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.301 -0.259 . . . . 65.01 110.301 -178.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.15 -20.2 64.02 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.905 0.383 . . . . 61.42 110.452 179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -81.5 -88.16 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.491 . . . . 73.33 110.467 176.279 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.435 ' HB2' ' O ' ' A' ' 205' ' ' CYS . 11.2 pt-20 -166.11 11.69 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.856 0.687 . . . . 71.21 112.856 -176.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 85.6 m-85 -125.78 141.81 51.82 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.778 -0.369 . . . . 73.13 110.895 -177.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.42 HG21 ' O ' ' A' ' 238' ' ' PRO . 12.9 m -123.65 126.06 72.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.062 0.458 . . . . 75.54 110.392 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 201' ' ' ALA . 41.7 t-80 -89.09 69.84 8.4 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.983 -0.747 . . . . 61.11 108.983 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -80.89 46.68 3.39 Favored Glycine 0 N--CA 1.452 -0.25 0 CA-C-N 115.689 -0.687 . . . . 64.15 113.806 -171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.499 ' CG ' ' H ' ' A' ' 224' ' ' THR . 11.1 t70 -175.7 96.05 0.07 Allowed 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.255 -0.646 . . . . 73.21 109.255 175.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.719 ' HB ' ' SG ' ' A' ' 250' ' ' CYS . 21.5 mm -90.01 70.93 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-O 121.392 0.615 . . . . 60.34 110.393 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.674 ' HD2' ' OG1' ' A' ' 224' ' ' THR . 56.6 tttm -83.76 134.87 34.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.143 -0.688 . . . . 73.12 109.143 175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -54.87 -26.34 34.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 73.11 112.051 -177.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.407 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 0.9 OUTLIER -66.5 -25.56 66.75 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.409 -0.359 . . . . 70.23 111.261 -178.535 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.429 ' HB2' HD12 ' A' ' 200' ' ' LEU . 6.9 t-20 -84.11 -7.42 59.38 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.171 0.51 . . . . 73.03 109.882 -175.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.455 HD21 HD11 ' A' ' 161' ' ' ILE . 21.1 mt -105.75 115.57 30.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.071 -0.968 . . . . 63.13 110.503 -177.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.867 HD21 ' HE3' ' A' ' 350' ' ' LYS . 4.1 mm? -118.08 140.35 49.89 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.918 -0.583 . . . . 74.03 110.535 -177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.957 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 9.0 mp -100.72 145.27 28.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 109.655 -0.498 . . . . 73.31 109.655 178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.671 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 25.5 t-20 -59.99 147.64 38.24 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.234 -0.439 . . . . 71.5 110.17 178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 18.9 p90 -57.69 -26.83 62.27 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 112.395 0.517 . . . . 72.45 112.395 -174.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -115.48 -15.83 11.44 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.813 -0.355 . . . . 70.31 111.878 -175.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -124.26 107.11 30.24 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 112.018 0.377 . . . . 73.43 112.018 -175.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.548 ' HA ' HD23 ' A' ' 185' ' ' LEU . 17.9 Cg_exo -67.62 -21.84 45.06 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.069 2.513 . . . . 73.0 111.586 175.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.683 ' CB ' ' HB3' ' A' ' 338' ' ' LYS . 7.3 p-10 -91.39 6.51 45.1 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.556 . . . . 71.45 111.047 -175.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -119.35 99.78 6.9 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.927 -0.579 . . . . 61.35 109.646 177.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 11.7 p -107.24 133.67 51.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.885 -0.598 . . . . 73.53 110.496 -177.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.671 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 18.0 m-85 -128.17 158.05 39.12 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.733 -0.667 . . . . 71.32 110.018 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.539 HD12 HD13 ' A' ' 164' ' ' ILE . 82.9 mt -95.63 150.2 20.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.671 0.272 . . . . 73.43 110.608 174.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.526 HG22 ' H ' ' A' ' 197' ' ' ASP . 4.2 p -138.23 175.87 7.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 N-CA-C 108.736 -0.839 . . . . 70.05 108.736 176.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.526 ' H ' HG22 ' A' ' 196' ' ' VAL . 0.6 OUTLIER 75.64 -58.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.71 0 O-C-N 123.461 0.476 . . . . 64.53 110.769 174.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.792 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 25.8 m-85 63.77 12.21 6.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.428 -0.805 . . . . 74.43 112.343 173.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -77.35 -15.64 81.27 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 110.601 -1.0 . . . . 62.13 110.601 174.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.821 HD21 ' HE3' ' A' ' 352' ' ' LYS . 89.9 mt -92.92 17.09 11.18 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.01 -0.595 . . . . 64.14 110.283 175.098 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 175' ' ' HIS . . . -127.76 99.42 5.54 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.104 -0.702 . . . . 45.21 109.104 174.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 43.6 t80 -99.54 149.64 23.03 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.302 0.572 . . . . 72.44 111.106 -171.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 203' ' ' ARG . 32.7 ptt180 -60.1 115.52 3.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.852 -1.067 . . . . 74.34 111.131 176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 25.7 t80 -101.83 -29.76 11.67 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.384 0.611 . . . . 70.45 109.745 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.435 ' O ' ' HB2' ' A' ' 172' ' ' GLU . 45.7 m -133.88 64.42 66.83 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 71.04 109.643 174.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -54.25 113.86 1.54 Allowed 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 122.93 2.42 . . . . 63.43 113.167 -172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 70.21 14.3 7.63 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.723 -0.671 . . . . 51.42 110.457 176.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 103.04 -7.25 52.24 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.874 -0.679 . . . . 62.1 112.307 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 46.8 t -91.84 111.22 23.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.849 0.357 . . . . 74.15 110.535 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 24.8 t-80 -102.69 128.58 49.34 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.285 -0.416 . . . . 74.01 110.432 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 47.3 tptt -115.46 162.22 17.48 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.371 -0.603 . . . . 74.05 109.371 174.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -83.75 -172.16 4.0 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.484 0.659 . . . . 70.45 111.915 -177.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -76.41 151.86 36.41 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.048 -0.978 . . . . 75.33 111.861 -177.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -134.33 0.65 3.1 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.069 -0.514 . . . . 74.45 110.473 174.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 69.49 -63.13 0.39 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 115.501 -0.772 . . . . 72.42 112.522 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.401 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 4.4 t0 -157.2 105.5 1.88 Allowed Pre-proline 0 C--N 1.327 -0.406 0 CA-C-O 120.76 0.314 . . . . 72.12 111.778 -178.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_endo -101.2 0.75 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 123.49 2.793 . . . . 61.01 113.3 172.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.421 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 4.7 tmtt? 176.23 -25.07 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 111.243 0.09 . . . . 75.24 111.243 -170.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 218' ' ' LYS . 99.3 mtt180 71.09 103.25 0.06 Allowed 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 109.334 -0.617 . . . . 65.23 109.334 -168.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.448 ' H ' ' HA2' ' A' ' 235' ' ' GLY . 49.5 t -79.5 -54.69 5.66 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.557 -0.747 . . . . 63.33 111.134 -169.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.4 p80 44.19 41.31 4.17 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.614 0.765 . . . . 73.12 111.888 -178.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -67.72 -38.36 83.48 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.707 -0.678 . . . . 70.51 110.776 177.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -87.57 -170.4 46.32 Favored Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.959 -0.564 . . . . 73.0 112.833 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.674 ' OG1' ' HD2' ' A' ' 179' ' ' LYS . 1.1 m -91.1 114.25 26.73 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 109.689 -0.486 . . . . 61.55 109.689 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 271' ' ' VAL . 18.3 tt -52.77 -17.32 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 N-CA-C 113.377 0.88 . . . . 74.24 113.377 -167.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -65.42 -43.88 89.11 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.846 -0.427 . . . . 73.41 109.846 176.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.61 ' HD2' ' HB ' ' A' ' 224' ' ' THR . 36.6 m-85 -96.07 -41.41 8.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.58 -0.736 . . . . 74.33 111.381 -174.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.509 ' CG2' ' HB3' ' A' ' 232' ' ' ALA . 0.2 OUTLIER -57.45 -5.56 0.35 Allowed 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 114.499 1.296 . . . . 51.33 114.499 -166.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 17.6 t 62.99 -158.34 0.32 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.932 0.396 . . . . 60.43 110.162 178.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 63.5 mt -71.87 -47.53 55.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 116.417 -0.356 . . . . 72.25 110.795 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -35.99 -85.53 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 114.276 1.213 . . . . 60.42 114.276 -170.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.624 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -70.0 -30.14 67.38 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.477 0.547 . . . . 50.22 112.477 -167.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -21.76 61.33 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.685 -0.406 . . . . 74.3 110.119 -178.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.408 ' O ' ' HG2' ' A' ' 219' ' ' ARG . 4.1 t30 -87.24 -34.32 18.99 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.785 -0.45 . . . . 64.33 109.785 178.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.448 ' HA2' ' H ' ' A' ' 220' ' ' CYS . . . 142.17 -33.93 1.88 Allowed Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.242 -0.98 . . . . 62.23 113.231 177.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 11.6 p -72.52 140.98 17.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.827 0.314 . . . . 74.44 110.637 -179.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -56.86 135.34 79.28 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 60.42 110.348 177.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.624 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 75.8 Cg_exo -49.89 115.72 2.0 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.987 2.458 . . . . 74.54 112.279 -178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 84.6 p -83.59 -178.06 6.91 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.04 -0.527 . . . . 73.52 110.534 -178.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.644 ' HA ' ' HE1' ' A' ' 169' ' ' HIS . 9.3 ptp85 -64.55 -31.29 72.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.612 0.72 . . . . 71.23 109.537 174.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.8 mmm-85 -64.26 -40.26 95.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 115.226 -0.897 . . . . 71.41 109.538 173.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.443 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -58.93 -69.29 1.32 Allowed Glycine 0 N--CA 1.439 -1.108 0 CA-C-N 115.068 -0.969 . . . . 53.54 112.391 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 15.4 p-10 -61.45 -33.82 74.38 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 117.128 0.464 . . . . 61.42 112.078 -170.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 80.7 mt -71.59 -46.92 57.87 Favored 'General case' 0 C--O 1.237 0.424 0 C-N-CA 120.566 -0.454 . . . . 73.11 111.734 177.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -74.18 -27.71 60.94 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-O 121.003 0.43 . . . . 71.42 110.305 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 242' ' ' GLY . 69.5 mt -63.92 -45.46 96.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.046 -0.525 . . . . 74.01 110.507 175.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.404 HD13 HG21 ' A' ' 161' ' ' ILE . 37.6 tp -60.38 -36.51 78.22 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.834 -0.432 . . . . 74.33 109.834 176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.19 -47.61 88.3 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 120.754 -0.736 . . . . 63.23 112.142 173.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -59.65 -43.75 93.79 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 120.777 0.322 . . . . 73.54 110.79 178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.719 ' SG ' ' HB ' ' A' ' 178' ' ' ILE . 35.4 m -65.49 -37.44 86.81 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.209 -0.451 . . . . 75.11 110.908 -178.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 26.9 ttt -62.38 -50.71 70.48 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.18 -0.464 . . . . 74.4 110.866 -179.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.8 tt -69.79 -28.62 37.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 C-N-CA 120.649 -0.42 . . . . 63.23 110.443 179.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.79 -50.84 71.11 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.934 0.397 . . . . 63.33 110.322 177.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 13.9 m0 -70.3 -24.97 63.12 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.531 -0.759 . . . . 53.22 111.012 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 294' ' ' ASN . 30.1 tp -76.39 -32.6 58.64 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.226 -0.443 . . . . 74.03 111.719 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 51.9 p -103.37 -27.24 12.55 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.531 0.567 . . . . 44.13 112.531 -174.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.426 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 86.83 -20.49 24.09 Favored Glycine 0 CA--C 1.518 0.231 0 C-N-CA 120.447 -0.882 . . . . 44.35 112.588 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -147.36 144.35 28.67 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.616 -0.512 . . . . 75.34 109.616 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . . . . . . . . . 89.0 mt -102.74 149.03 36.39 Favored Pre-proline 0 C--N 1.318 -0.786 0 CA-C-N 116.3 -0.409 . . . . 72.33 110.29 176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_exo -59.17 -34.94 98.57 Favored 'Trans proline' 0 C--O 1.231 0.146 0 C-N-CA 122.323 2.015 . . . . 61.34 112.18 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 47.1 p90 -96.57 13.64 27.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.045 -0.525 . . . . 75.51 110.862 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -69.18 -31.15 69.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.24 0.543 . . . . 75.13 110.669 -177.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -84.13 -6.86 59.47 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.794 0.807 . . . . 70.04 109.556 177.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.876 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 2.9 m-20 -106.86 5.12 28.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 114.927 -1.033 . . . . 61.21 109.51 -179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 265' ' ' LEU . 1.9 tm? -65.16 -33.7 76.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.553 -0.749 . . . . 75.42 111.537 -170.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -61.42 -23.22 65.67 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.207 0.447 . . . . 71.33 112.207 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.61 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 14.7 t70 -109.7 127.5 27.04 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-O 120.929 0.395 . . . . 65.03 111.69 -174.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.94 -39.85 67.47 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 123.391 2.728 . . . . 52.54 113.649 -178.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.61 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 9.8 ptmm? -79.11 -37.88 37.56 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 120.359 -0.536 . . . . 42.13 110.008 -176.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.876 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 9.1 m-85 -58.11 -42.84 86.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.56 0.219 . . . . 75.32 110.818 178.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 225' ' ' ILE . 65.3 t -63.16 -50.6 78.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.563 -0.29 . . . . 62.55 110.519 175.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.439 ' O ' HG13 ' A' ' 276' ' ' ILE . 31.0 ttp180 -60.13 -48.86 79.96 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.602 -0.272 . . . . 73.41 111.273 -176.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -57.68 -45.72 85.26 Favored 'General case' 0 C--N 1.328 -0.334 0 O-C-N 123.466 0.479 . . . . 73.54 111.514 -179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 21.4 m -66.79 -43.26 84.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.102 -0.499 . . . . 52.34 111.174 -177.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 271' ' ' VAL . 7.8 mmmm -61.6 -32.64 72.77 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.758 0.313 . . . . 74.53 110.636 -179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 272' ' ' ARG . 75.7 mt -72.91 -44.44 57.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.259 0 CA-C-N 116.385 -0.37 . . . . 74.23 111.013 178.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -66.45 -32.61 74.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.973 0.416 . . . . 71.14 110.563 -177.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -74.24 -32.25 62.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.38 -0.373 . . . . 62.25 110.817 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 276' ' ' ILE . 23.7 mtp180 -59.11 -33.42 70.83 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.39 -0.368 . . . . 71.42 110.854 174.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -55.45 -39.9 70.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.569 -0.742 . . . . 74.21 111.417 178.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.514 ' ND2' ' HB3' ' A' ' 284' ' ' SER . 36.5 t30 -153.99 84.9 1.15 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.193 0.52 . . . . 62.52 110.438 -175.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.675 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -78.72 -35.96 18.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.209 -0.45 . . . . 73.52 111.968 -176.161 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -60.15 -48.73 80.52 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.797 0.332 . . . . 75.35 111.241 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . 0.514 ' HB3' ' ND2' ' A' ' 281' ' ' ASN . 22.7 t -75.3 -45.71 38.04 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.316 -0.402 . . . . 44.43 110.454 -178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -61.67 -42.41 98.87 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.925 0.343 . . . . 72.42 111.925 -176.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.0 mmt -74.99 -43.58 53.09 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.93 -0.308 . . . . 72.11 111.301 -177.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -67.69 -38.98 84.43 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 121.102 0.477 . . . . 71.22 111.023 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 29.4 ttpt -84.54 -2.0 56.68 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.84 -0.618 . . . . 75.33 110.575 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 42.0 t -81.46 -21.4 38.81 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.393 -0.595 . . . . 74.31 109.393 173.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . . . . . . . . . 19.6 t80 -137.48 76.92 41.71 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 115.506 -0.77 . . . . 72.32 109.029 175.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -83.49 44.7 1.67 Allowed 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 123.557 2.838 . . . . 72.42 112.691 -173.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -114.11 -179.44 3.63 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.975 -0.38 . . . . 71.21 109.975 -178.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -81.05 20.54 0.79 Allowed 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 112.372 0.508 . . . . 74.01 112.372 -173.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.784 HD21 HD11 ' A' ' 255' ' ' LEU . 41.5 t30 -77.47 -48.14 17.88 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.47 -0.567 . . . . 54.34 109.47 174.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 23.9 tptm 77.85 95.09 0.04 OUTLIER Pre-proline 0 N--CA 1.469 0.479 0 CA-C-N 115.222 -0.899 . . . . 65.35 111.147 176.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -82.84 48.04 2.63 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 122.889 2.392 . . . . 55.51 112.196 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -59.43 -52.14 54.93 Favored Glycine 0 C--O 1.238 0.356 0 CA-C-N 115.942 -0.572 . . . . 65.02 112.76 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.554 ' HA ' ' CD1' ' A' ' 323' ' ' ILE . 1.7 mp0 -55.37 -45.14 76.54 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.695 0.283 . . . . 74.44 110.497 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.528 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.7 mp -63.0 -45.3 99.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.97 -0.559 . . . . 73.34 110.827 -176.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.26 -54.13 50.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 75.51 111.428 -177.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.421 ' HA ' ' HB3' ' A' ' 304' ' ' GLU . 22.3 mtpp -77.17 -27.94 53.87 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.633 -0.427 . . . . 71.14 111.897 -176.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 45.1 t80 -55.99 -52.78 62.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.189 0.518 . . . . 54.1 109.97 173.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.555 ' HA ' HG22 ' A' ' 306' ' ' VAL . 55.6 mtp -72.68 -36.28 67.85 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.464 -0.789 . . . . 72.54 110.869 -177.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.421 ' HB3' ' HA ' ' A' ' 301' ' ' LYS . 38.7 tt0 -57.39 -46.42 83.47 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.362 0.601 . . . . 74.42 109.795 173.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 47.9 m -63.17 -52.5 62.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.037 -0.983 . . . . 73.44 112.078 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.555 HG22 ' HA ' ' A' ' 303' ' ' MET . 34.6 m -64.24 -27.35 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 CA-C-O 120.712 0.291 . . . . 72.41 111.551 -176.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -80.65 -30.48 36.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.711 0.291 . . . . 71.2 111.042 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 51.0 tp -67.86 -17.73 64.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.145 -0.479 . . . . 74.44 110.326 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.628 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 67.8 mt -71.16 -13.84 62.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.789 -0.641 . . . . 61.31 110.889 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 35.7 t70 59.23 -76.7 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 123.704 0.802 . . . . 73.34 111.736 178.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.53 ' O ' ' HD2' ' A' ' 240' ' ' ARG . 49.5 t80 -152.4 -48.74 0.1 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.442 0.163 . . . . 71.21 110.685 174.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 5.4 m -125.67 36.14 4.6 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.243 0.544 . . . . 50.14 111.668 -176.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 14.8 tp10 -90.49 23.06 3.14 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 121.937 -0.477 . . . . 54.14 110.04 176.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 60.5 mttp 72.36 130.64 0.04 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 CA-C-N 115.466 -0.788 . . . . 54.44 111.811 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.54 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 1.4 Cg_endo -82.37 118.31 2.89 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.415 2.076 . . . . 75.31 110.881 174.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.477 ' O ' HD13 ' A' ' 320' ' ' LEU . 16.9 tp -104.09 92.6 4.44 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.068 0.461 . . . . 74.41 110.138 -176.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -68.72 -40.44 79.94 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.852 -0.613 . . . . 75.52 111.556 -173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.466 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.6 pm0 -67.22 -29.3 68.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.187 -0.461 . . . . 65.21 111.617 -175.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -66.06 -48.87 69.6 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.791 -0.448 . . . . 71.33 109.791 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.507 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 9.4 mp -60.47 -43.15 97.21 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.602 -0.726 . . . . 45.32 110.619 178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.432 ' O ' HD23 ' A' ' 325' ' ' LEU . 1.2 tmt_? -62.51 -43.33 99.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.138 -0.483 . . . . 74.14 110.63 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -71.21 -40.5 71.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.341 -0.39 . . . . 72.31 111.274 -176.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.554 ' CD1' ' HA ' ' A' ' 298' ' ' GLU . 0.1 OUTLIER -63.72 -37.98 81.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 120.618 0.247 . . . . 75.44 110.373 -178.09 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.531 HD23 ' HB3' ' A' ' 298' ' ' GLU . 87.1 mt -67.86 -46.73 70.91 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.954 0.407 . . . . 73.04 110.667 178.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.432 HD23 ' O ' ' A' ' 321' ' ' ARG . 4.3 mm? -66.93 -29.26 69.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 72.43 111.171 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.405 HE21 ' HB3' ' A' ' 326' ' ' GLN . 1.0 OUTLIER -66.34 -42.38 88.23 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 109.406 -0.59 . . . . 72.13 109.406 178.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -59.96 -41.99 98.1 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.802 -0.713 . . . . 44.11 111.925 176.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.701 ' HG ' ' HG ' ' A' ' 155' ' ' LEU . 14.1 mt -69.18 -36.37 77.26 Favored 'General case' 0 C--N 1.327 -0.377 0 O-C-N 122.854 -0.204 . . . . 75.01 111.488 177.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 68.3 tttt -60.3 -34.03 73.2 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.747 0.308 . . . . 71.24 110.426 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -59.82 -29.79 68.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.997 -0.547 . . . . 54.53 111.816 179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 23.7 pt -107.68 1.01 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.945 0.402 . . . . 74.04 111.094 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 77.07 24.99 65.1 Favored Glycine 0 C--O 1.228 -0.253 0 C-N-CA 120.949 -0.643 . . . . 64.03 113.052 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.596 ' O ' ' HB3' ' A' ' 328' ' ' LEU . 62.6 m -107.45 156.7 18.67 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.077 0.465 . . . . 63.41 111.254 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -152.96 16.8 0.57 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.394 -0.965 . . . . 64.23 108.394 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.464 ' OD2' ' HA ' ' A' ' 338' ' ' LYS . 24.7 t70 67.27 125.71 0.02 OUTLIER 'General case' 0 C--O 1.233 0.216 0 CA-C-N 114.529 -1.214 . . . . 73.34 109.298 -162.016 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.49 -49.26 0.91 Allowed 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.282 -0.872 . . . . 45.4 110.763 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -70.56 -10.16 66.38 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.842 -0.694 . . . . 50.21 111.824 174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.683 ' HB3' ' CB ' ' A' ' 191' ' ' ASP . 12.3 mmmm 67.41 82.9 0.17 Allowed 'General case' 0 CA--C 1.519 -0.221 0 C-N-CA 123.622 0.769 . . . . 72.01 111.431 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.505 HD12 ' HA ' ' A' ' 191' ' ' ASP . 50.9 mt 59.8 71.63 0.57 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.902 -1.044 . . . . 74.3 112.793 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.56 95.97 0.5 Allowed 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.911 -1.144 . . . . 75.31 107.911 167.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.565 ' HG ' HG21 ' A' ' 141' ' ' ILE . 2.5 tp -149.26 -44.37 0.14 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.734 0.642 . . . . 72.33 112.734 -166.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 14.6 m -50.9 120.19 4.61 Favored 'General case' 0 N--CA 1.466 0.35 0 N-CA-C 112.787 0.662 . . . . 74.33 112.787 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 344' ' ' VAL . 18.3 m -131.06 20.38 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.697 -0.683 . . . . 73.02 110.144 178.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 69.0 t 90.77 109.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 124.317 1.011 . . . . 63.44 109.735 -177.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.585 ' HG2' ' HB3' ' A' ' 136' ' ' SER . 6.1 mp0 -110.65 135.63 50.97 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.51 -0.768 . . . . 74.42 111.638 -169.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -178.07 106.07 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.567 -0.742 . . . . 70.22 110.019 174.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 175.81 66.71 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.554 -0.831 . . . . 73.52 111.905 178.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.467 ' O ' ' HA2' ' A' ' 47' ' ' GLY . . . -78.79 58.51 4.23 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 121.137 -0.554 . . . . 70.11 113.197 -176.476 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -111.69 83.44 1.78 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.918 0.389 . . . . 53.43 110.315 177.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.867 ' HE3' HD21 ' A' ' 184' ' ' LEU . 0.0 OUTLIER -156.8 106.73 2.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.503 0.668 . . . . 54.31 110.663 177.052 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -148.83 106.66 3.69 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.374 -0.83 . . . . 73.51 109.845 178.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.821 ' HE3' HD21 ' A' ' 200' ' ' LEU . 4.5 mptp? -99.81 -167.7 1.5 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.246 0.546 . . . . 70.44 110.556 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 9.8 t -161.45 157.67 25.45 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.691 -0.855 . . . . 71.4 108.691 177.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.548 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.1 OUTLIER -99.63 126.83 52.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.323 0.582 . . . . 63.32 111.785 -173.395 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 18.5 m -75.95 74.12 2.85 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.608 -0.724 . . . . 51.43 109.908 173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -94.94 -32.05 13.37 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.705 -0.68 . . . . 75.03 110.432 -179.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 88.0 tttt 179.65 -86.75 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.14 -0.689 . . . . 70.31 109.14 -174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -179.55 149.45 0.38 Allowed 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.914 -0.773 . . . . 74.12 108.914 174.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.552 ' HZ1' ' CG ' ' A' ' 76' ' ' ASP . 8.2 tmtm? -106.35 119.18 38.57 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.749 0.309 . . . . 43.4 110.568 -177.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 45.2 tttm . . . . . 0 C--O 1.245 0.847 0 CA-C-O 118.491 -0.766 . . . . 75.33 109.332 174.071 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 78.7 mtp . . . . . 0 N--CA 1.478 0.93 0 CA-C-O 120.646 0.26 . . . . 61.24 110.599 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -93.02 137.06 1.4 Allowed 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.413 2.075 . . . . 63.11 111.398 170.523 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.1 ttp180 -161.84 78.37 0.53 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.96 -0.755 . . . . 55.04 108.96 178.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 22.2 m -139.87 161.38 26.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.363 0.601 . . . . 73.33 111.567 -173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.592 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -117.89 95.47 4.93 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 107.627 -1.249 . . . . 73.11 107.627 176.518 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -65.47 -77.72 0.06 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.531 0.567 . . . . 73.23 112.531 -167.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -171.29 176.68 3.81 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.381 -0.372 . . . . 64.14 110.936 -175.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 64.2 tt0 -142.63 129.58 20.66 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.111 -0.495 . . . . 73.21 109.742 177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -113.92 97.58 6.47 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.015 0.436 . . . . 64.31 110.469 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.75 94.6 1.47 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.784 -0.722 . . . . 63.3 112.917 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.3 ptt180 -146.08 149.22 33.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.201 -0.666 . . . . 72.31 109.201 174.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.03 144.76 50.99 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.124 0.487 . . . . 74.32 110.942 178.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 p -130.91 128.63 40.92 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.983 -0.553 . . . . 73.32 111.328 -178.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.3 m -151.15 120.17 6.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.446 -0.343 . . . . 54.13 110.285 176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -150.48 109.09 3.82 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.26 -0.427 . . . . 44.45 110.578 -179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.3 pttt -137.13 119.34 15.59 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.125 -0.489 . . . . 61.04 110.251 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.43 HH11 ' HD2' ' A' ' 17' ' ' ARG . 20.2 ttt180 -160.03 97.35 1.27 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.53 -0.759 . . . . 62.54 110.353 -177.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -111.83 123.16 49.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.861 -0.609 . . . . 72.35 109.655 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.408 ' N ' HD23 ' A' ' 19' ' ' LEU . 2.5 pt? -147.93 8.12 0.84 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.103 -0.499 . . . . 74.11 111.238 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.455 ' HB1' HG21 ' A' ' 25' ' ' VAL . . . -120.6 73.29 1.0 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.151 0.5 . . . . 24.11 111.52 -177.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -132.09 108.21 9.15 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.219 -0.659 . . . . 61.04 109.219 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -171.24 -93.89 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 120.873 -0.331 . . . . 45.41 111.856 -178.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -158.07 74.15 0.7 Allowed 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.459 0.647 . . . . 55.04 110.068 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 175.5 -72.96 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.266 -1.383 . . . . 74.04 107.266 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.466 HG13 ' HA2' ' A' ' 40' ' ' GLY . 90.1 t -67.05 140.64 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 CA-C-N 114.944 -1.026 . . . . 64.33 108.389 164.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.434 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.81 -5.66 59.97 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.492 -0.861 . . . . 62.02 112.271 -178.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -84.52 140.82 31.18 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.697 -0.483 . . . . 70.35 109.697 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.694 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.2 OUTLIER -98.53 131.97 44.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.247 0.546 . . . . 72.13 110.779 178.218 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 24.5 pt -113.3 137.0 47.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.745 -0.661 . . . . 44.03 110.039 176.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 23.6 m -106.76 121.01 43.53 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.29 -0.414 . . . . 73.55 110.627 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.603 ' OD1' ' HE3' ' A' ' 35' ' ' LYS . 3.2 p-10 -83.35 -175.44 5.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.27 -0.423 . . . . 71.11 110.812 -179.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.481 ' HG2' ' HA2' ' A' ' 117' ' ' GLY . 25.3 mmt -65.95 -28.09 68.65 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 112.372 0.508 . . . . 73.24 112.372 -173.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.752 ' HB3' ' HE2' ' A' ' 35' ' ' LYS . . . -90.71 9.69 28.89 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 120.99 0.424 . . . . 75.24 110.822 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.2 mptp? 63.4 69.51 0.56 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 115.412 -0.813 . . . . 65.42 112.862 175.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.752 ' HE2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -127.33 141.91 51.58 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.162 -0.681 . . . . 74.12 109.162 168.325 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -91.59 101.55 14.19 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.983 0.42 . . . . 71.4 110.233 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.579 ' HZ2' ' HZ2' ' A' ' 35' ' ' LYS . 70.5 m95 -98.97 108.61 21.34 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.002 -0.545 . . . . 75.01 110.515 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.434 ' HD3' ' HA2' ' A' ' 26' ' ' GLY . 0.0 OUTLIER -79.73 123.41 27.65 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.212 -0.662 . . . . 73.23 109.212 175.875 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.1 p -81.86 132.32 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.136 -0.484 . . . . 72.21 110.531 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.466 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -116.12 -131.75 4.88 Favored Glycine 0 N--CA 1.446 -0.633 0 C-N-CA 121.09 -0.576 . . . . 65.3 112.992 -176.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.488 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.8 tt -63.75 128.31 92.64 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.053 0.454 . . . . 64.14 111.381 -173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.9 Cg_exo -74.95 100.65 1.38 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 123.15 2.567 . . . . 63.0 111.991 177.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.664 HD11 HD12 ' A' ' 53' ' ' LEU . 69.3 mt -62.33 -55.93 20.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.162 0.506 . . . . 73.44 110.925 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.94 148.05 18.49 Favored Glycine 0 N--CA 1.444 -0.821 0 C-N-CA 120.649 -0.786 . . . . 62.54 111.899 -177.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.614 ' HB2' HG12 ' A' ' 51' ' ' ILE . 25.3 tm0? -112.73 165.88 11.87 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.262 -1.014 . . . . 73.55 108.262 177.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.498 ' HA2' ' NZ ' ' A' ' 140' ' ' LYS . . . -40.57 -51.45 3.85 Favored Glycine 0 C--N 1.335 0.475 0 O-C-N 123.47 0.482 . . . . 64.04 113.884 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 172.39 26.15 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 119.959 -1.115 . . . . 72.21 113.47 177.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.572 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 75.5 t80 -129.84 -77.92 0.54 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.094 0.447 . . . . 75.04 111.287 -179.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -69.66 -40.63 76.79 Favored Glycine 0 CA--C 1.52 0.398 0 C-N-CA 121.179 -0.534 . . . . 54.43 113.954 -173.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.529 ' H ' ' HB3' ' A' ' 45' ' ' GLN . 59.3 m 64.2 96.33 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 121.31 0.576 . . . . 74.14 110.81 -175.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.614 HG12 ' HB2' ' A' ' 45' ' ' GLN . 4.1 mm -101.31 139.71 21.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 51.43 111.618 -172.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -106.81 158.73 16.77 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.074 -0.512 . . . . 73.23 109.728 178.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.664 HD12 HD11 ' A' ' 43' ' ' ILE . 9.5 tt -97.1 144.57 26.84 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.582 -0.525 . . . . 73.43 109.582 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -118.5 114.78 23.36 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.759 0.314 . . . . 31.43 110.283 178.463 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -90.43 8.42 33.77 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.395 -0.366 . . . . 73.11 111.049 -177.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.454 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 1.4 tmt? 69.49 -60.62 0.46 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.376 0.67 . . . . 60.32 109.805 -174.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 56' ' ' MET . 62.9 t30 174.16 149.05 0.08 Allowed 'General case' 0 C--N 1.327 -0.371 0 O-C-N 123.931 0.769 . . . . 74.22 109.273 171.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.5 p -82.39 73.22 9.44 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.344 0.592 . . . . 63.11 110.348 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.8 m -139.57 -173.92 3.75 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.337 -0.847 . . . . 61.44 109.728 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.93 56.79 2.43 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.504 0.668 . . . . 54.01 109.635 177.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.9 p -120.22 -52.93 2.16 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.564 -0.743 . . . . 62.23 109.986 178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -74.21 136.87 24.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.943 -0.571 . . . . 45.1 110.045 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -125.3 -10.92 4.39 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.472 -0.871 . . . . 73.13 112.529 -178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.4 m -116.88 -77.76 0.57 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 122.701 -0.293 . . . . 62.44 111.236 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 4.9 p30 -146.34 -35.63 0.27 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.725 0.639 . . . . 74.31 112.725 -173.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.41 ' HB3' ' O ' ' A' ' 65' ' ' ASP . . . 75.41 80.61 0.14 Allowed Pre-proline 0 N--CA 1.469 0.483 0 O-C-N 124.098 0.874 . . . . 74.2 109.25 -171.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HG2' ' CH2' ' A' ' 114' ' ' TRP . 82.5 Cg_endo -90.92 37.96 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.427 2.751 . . . . 75.23 113.76 -169.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.6 p -119.89 139.05 53.01 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.153 0.501 . . . . 70.13 111.606 -178.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.477 HG12 ' HA ' ' A' ' 53' ' ' LEU . 34.2 m -130.29 162.48 38.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 109.235 -0.654 . . . . 72.23 109.235 176.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.56 ' HB ' HG12 ' A' ' 130' ' ' ILE . 7.4 p -132.73 130.13 58.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.611 0.72 . . . . 71.21 111.688 -176.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.508 ' HB2' HD12 ' A' ' 51' ' ' ILE . 76.2 tttt -94.79 137.47 33.84 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.023 -0.989 . . . . 74.41 109.42 175.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.8 p -126.83 140.27 49.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.03 0.443 . . . . 72.34 111.743 -176.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.56 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 16.2 mt-10 -157.35 161.1 29.93 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.79 -0.641 . . . . 75.15 109.576 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -62.01 148.54 92.96 Favored 'Trans proline' 0 C--O 1.234 0.312 0 C-N-CA 122.321 2.014 . . . . 51.22 111.353 171.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 39.0 t -47.47 -50.02 24.1 Favored 'General case' 0 C--O 1.234 0.24 0 O-C-N 123.553 0.533 . . . . 65.14 112.208 -176.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -118.48 45.28 2.06 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.749 0.309 . . . . 65.1 111.456 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -69.34 -37.5 77.69 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.353 0.597 . . . . 73.41 110.264 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 138.03 -80.43 0.29 Allowed Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.584 -0.817 . . . . 74.33 112.422 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.572 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.4 Cg_exo -60.91 -40.99 48.37 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.075 2.517 . . . . 51.35 112.768 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 1.6 tm? -52.63 -48.6 66.27 Favored 'General case' 0 C--O 1.224 -0.286 0 O-C-N 123.518 0.511 . . . . 74.43 111.172 -177.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -63.29 -45.9 89.28 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.706 0.289 . . . . 74.24 111.185 -175.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.505 HG22 ' HB3' ' A' ' 201' ' ' ALA . 3.2 m -63.61 -42.5 98.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.336 0.589 . . . . 61.35 110.424 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.4 tt0 -72.21 -30.27 64.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.171 -0.922 . . . . 73.22 110.484 -176.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.0 tp -66.63 -41.97 87.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.001 -0.545 . . . . 53.23 110.729 177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.591 ' HD2' ' HE2' ' A' ' 173' ' ' TYR . 41.6 ttmt -63.71 -40.11 95.95 Favored 'General case' 0 C--N 1.333 -0.146 0 C-N-CA 120.714 -0.395 . . . . 75.03 109.961 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -60.24 -45.44 93.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.317 0.58 . . . . 73.45 109.648 176.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.5 ' OH ' ' HA ' ' A' ' 113' ' ' TYR . 81.1 t80 -58.28 -37.24 74.62 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.062 -0.972 . . . . 75.33 110.926 176.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -68.52 -32.77 72.97 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.949 -0.568 . . . . 71.32 111.057 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 85' ' ' LYS . 12.4 mmt180 -72.08 -37.9 69.51 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 62.52 111.075 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.468 ' O ' HD11 ' A' ' 96' ' ' ILE . . . -96.27 17.16 16.42 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.925 -0.579 . . . . 73.34 111.118 -176.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.403 ' O ' ' HB3' ' A' ' 92' ' ' LYS . . . -87.63 146.9 25.52 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.909 -0.587 . . . . 63.44 111.594 -175.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 91' ' ' ALA . 41.2 ttmt 77.92 117.25 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.318 0 CA-C-N 115.256 -0.884 . . . . 72.34 111.533 174.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 92' ' ' LYS . 51.4 Cg_exo -56.52 -29.33 78.05 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 123.337 2.691 . . . . 61.33 113.087 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -57.43 -53.26 60.11 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.684 0.278 . . . . 71.2 111.395 -179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 75.9 mt-30 -62.89 -47.75 81.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.193 -0.458 . . . . 72.52 110.152 -179.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.468 HD11 ' O ' ' A' ' 90' ' ' ALA . 59.0 mt -56.21 -51.25 65.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 115.718 -0.674 . . . . 74.44 111.022 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -53.83 -42.17 68.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.058 0.456 . . . . 72.31 110.621 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -60.32 -60.23 4.15 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.576 -0.738 . . . . 65.41 111.449 -176.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -73.26 -34.44 65.83 Favored 'General case' 0 C--O 1.22 -0.482 0 C-N-CA 119.964 -0.694 . . . . 72.0 111.353 -174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.64 HD11 ' HG ' ' A' ' 108' ' ' LEU . 28.3 mm -59.72 -38.04 74.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.668 -0.413 . . . . 63.13 110.475 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 44.6 ttp180 -78.77 -48.13 15.42 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.307 -0.406 . . . . 63.43 111.24 -179.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.0 m -73.66 -43.92 58.17 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 111.891 0.33 . . . . 74.34 111.891 -175.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.555 ' O ' ' HD3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -73.92 -27.33 60.98 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.782 -0.822 . . . . 65.3 108.782 178.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.575 ' NZ ' ' HB2' ' A' ' 104' ' ' LYS . 9.9 mtmp? 71.66 83.37 0.14 Allowed 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 114.663 -1.153 . . . . 71.22 111.474 178.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 95.1 mt -121.69 173.74 7.26 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 114.986 -1.006 . . . . 42.41 109.318 175.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 32.3 mmmt -89.35 -62.57 1.45 Allowed 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 120.906 -0.318 . . . . 54.55 110.469 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.438 ' CZ ' ' HB3' ' A' ' 160' ' ' ARG . 27.4 p90 -164.78 146.26 7.98 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.916 0.389 . . . . 74.14 110.546 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' HG ' HD11 ' A' ' 100' ' ' ILE . 42.3 mt -91.85 118.08 30.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.163 -0.471 . . . . 63.23 111.019 -179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -83.52 59.69 4.94 Favored Glycine 0 N--CA 1.453 -0.211 0 N-CA-C 109.977 -1.249 . . . . 74.42 109.977 168.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.776 HG22 ' HD2' ' A' ' 111' ' ' PRO . 2.2 p -121.12 151.56 55.64 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.261 -0.47 . . . . 71.31 110.285 -168.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.776 ' HD2' HG22 ' A' ' 110' ' ' VAL . 89.2 Cg_exo -42.84 134.77 5.3 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 122.96 2.44 . . . . 63.41 113.618 175.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.438 ' O ' ' HA ' ' A' ' 131' ' ' MET . 23.5 tptm -91.46 130.5 37.28 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.344 -0.844 . . . . 74.53 110.142 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.5 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 46.1 t80 -91.09 128.62 36.99 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.131 0.491 . . . . 73.31 112.135 -176.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.565 ' CD1' HG22 ' A' ' 130' ' ' ILE . 47.6 m95 -129.71 -43.66 1.24 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.369 -0.832 . . . . 74.24 108.794 170.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -175.89 162.93 32.24 Favored Glycine 0 N--CA 1.443 -0.857 0 CA-C-N 114.7 -1.136 . . . . 44.54 111.448 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 23.2 p -164.16 145.5 8.6 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.746 -0.464 . . . . 60.52 109.746 -178.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.481 ' HA2' ' HG2' ' A' ' 32' ' ' MET . . . -170.17 -171.55 35.75 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.141 -1.028 . . . . 62.22 112.817 -178.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 7.2 tt -130.84 130.84 44.12 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.035 -0.728 . . . . 74.4 109.035 -178.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.457 ' HB2' ' HE2' ' A' ' 128' ' ' PHE . 30.7 t-80 -125.5 133.32 52.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.487 -0.324 . . . . 70.51 110.137 -178.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.449 ' O ' ' HA ' ' A' ' 125' ' ' SER . 25.7 m-20 69.54 145.87 0.06 Allowed 'General case' 0 C--N 1.328 -0.347 0 O-C-N 123.919 0.762 . . . . 73.52 112.0 179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.5 mttp -151.52 -24.49 0.2 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.473 -0.785 . . . . 60.44 111.243 -172.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.02 -67.14 0.43 Allowed 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.336 -0.393 . . . . 73.55 111.827 -169.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -112.92 -28.27 3.46 Favored Glycine 0 N--CA 1.449 -0.45 0 N-CA-C 111.12 -0.792 . . . . 52.31 111.12 179.274 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -129.0 130.68 46.96 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.19 -0.671 . . . . 62.04 109.19 176.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 120' ' ' ASP . 4.0 p -113.92 117.43 31.36 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 120.827 0.346 . . . . 74.42 110.46 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.418 ' HD2' ' HB2' ' A' ' 120' ' ' ASP . 96.1 m-85 -110.82 132.62 54.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.226 0.536 . . . . 73.55 111.672 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mtt180 -111.95 127.46 55.87 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.581 -0.736 . . . . 71.13 109.099 170.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.457 ' HE2' ' HB2' ' A' ' 119' ' ' HIS . 49.0 p90 -123.3 142.1 51.29 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.222 0.534 . . . . 73.44 110.86 -179.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 15.8 ptm -136.13 130.18 32.93 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.379 -0.828 . . . . 73.52 109.879 -178.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.565 HG22 ' CD1' ' A' ' 114' ' ' TRP . 15.9 mt -97.51 135.31 32.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.986 -0.552 . . . . 74.44 111.543 -175.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 53.8 mtm -130.73 -179.88 5.56 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.038 -0.528 . . . . 73.11 109.788 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -72.05 165.44 24.28 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.697 -0.483 . . . . 32.43 109.697 178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.541 ' O ' ' HG2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -69.39 133.19 47.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.397 0.618 . . . . 75.41 111.519 -172.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 20.5 m-85 -122.3 172.21 8.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.729 -0.669 . . . . 74.34 110.202 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.775 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -173.72 -51.54 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.897 -0.668 . . . . 41.12 111.916 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.518 ' HB3' HG21 ' A' ' 344' ' ' VAL . 21.1 m -100.86 144.15 30.16 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.753 -0.462 . . . . 75.11 109.753 178.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.627 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.4 p30 -139.01 163.04 33.44 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 110.018 -0.364 . . . . 62.32 110.018 178.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.534 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 10.0 mp -73.14 -24.4 60.59 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.189 0.44 . . . . 70.22 112.189 -173.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.532 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 10.0 pt20 -71.24 -31.8 67.98 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.623 -0.431 . . . . 70.12 110.424 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.666 ' HG2' ' H ' ' A' ' 347' ' ' GLY . 55.9 mttp -71.75 -37.24 70.57 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.99 0.424 . . . . 74.2 110.757 173.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.854 HG12 HG22 ' A' ' 344' ' ' VAL . 62.0 mt -74.66 -51.54 22.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.915 -0.584 . . . . 71.52 112.281 -174.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.678 ' HD1' ' HB2' ' A' ' 147' ' ' LYS . 0.3 OUTLIER -65.96 -32.61 74.19 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.337 0.495 . . . . 71.15 112.337 -166.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -80.83 -6.82 59.08 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.181 -0.607 . . . . 72.44 110.823 -177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -104.05 -30.28 10.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.36 0.6 . . . . 64.2 110.45 175.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -97.92 -0.61 44.58 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.546 -0.752 . . . . 75.42 110.876 -179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 68.11 16.23 9.44 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 115.462 -0.79 . . . . 52.3 111.926 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.689 ' HE3' ' HB3' ' A' ' 253' ' ' GLN . 2.6 ttpt 64.19 53.67 1.74 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.732 -0.667 . . . . 73.33 110.939 176.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 148' ' ' ARG . 6.4 tmm_? -133.43 95.15 3.44 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.366 -0.975 . . . . 75.33 108.366 175.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.475 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 44.6 m-85 -103.68 157.23 17.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.871 -0.604 . . . . 74.54 111.368 -172.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 41.2 p -60.9 147.88 41.54 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.773 -0.648 . . . . 54.12 110.778 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.418 ' HD3' ' OE2' ' A' ' 298' ' ' GLU . 26.7 ttm-85 -61.88 -33.19 73.75 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.036 -0.529 . . . . 71.43 110.608 -175.285 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.541 ' HE2' ' O ' ' A' ' 152' ' ' LYS . 0.0 OUTLIER -60.32 -46.17 90.83 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 115.669 -0.696 . . . . 63.44 110.268 177.288 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.532 HG23 HD22 ' A' ' 339' ' ' LEU . 32.6 m -72.03 -45.74 59.71 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.772 -0.649 . . . . 71.44 111.155 -178.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.9 t -57.2 -40.92 76.64 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-N 116.401 -0.363 . . . . 73.35 110.681 179.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 324' ' ' LEU . 19.2 tp -63.48 -47.89 79.88 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.124 -0.489 . . . . 74.15 110.668 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -56.7 -45.48 81.79 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.691 0.281 . . . . 70.31 111.051 178.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.597 ' O ' HG12 ' A' ' 161' ' ' ILE . 93.2 mt -58.52 -51.62 69.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.892 -0.595 . . . . 70.35 110.146 179.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.514 ' HA ' HD11 ' A' ' 247' ' ' LEU . 15.5 m -57.9 -43.2 86.01 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.776 -0.647 . . . . 73.2 110.921 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 92.8 mt -61.19 -56.12 24.32 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.199 -0.455 . . . . 63.44 111.206 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.584 HH21 HG21 ' A' ' 164' ' ' ILE . 0.0 OUTLIER -65.59 -23.5 66.85 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.614 0.245 . . . . 72.23 111.3 -176.05 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 157' ' ' LEU . 27.1 mm -65.62 -46.46 89.37 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.381 0 N-CA-C 109.649 -0.501 . . . . 75.33 109.649 174.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 mt -64.09 -38.72 92.09 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.618 0.229 . . . . 73.42 111.618 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -57.82 -55.51 33.92 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.161 0.505 . . . . 75.23 110.656 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.584 HG21 HH21 ' A' ' 160' ' ' ARG . 16.9 tt -70.44 -36.22 65.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 CA-C-N 116.001 -0.545 . . . . 71.32 110.59 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.666 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 58.8 tp -62.65 -37.32 85.89 Favored 'General case' 0 C--O 1.218 -0.591 0 N-CA-C 110.456 -0.202 . . . . 60.5 110.456 179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -50.83 66.28 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-O 121.194 0.521 . . . . 75.14 109.874 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.623 ' O ' ' HB2' ' A' ' 171' ' ' HIS . 44.1 t80 -51.68 -44.64 63.18 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 114.825 -1.08 . . . . 73.43 111.805 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 39.6 pt -83.74 -31.36 8.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.768 0.318 . . . . 73.14 111.189 -178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.666 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 30.3 t-80 -50.77 -54.96 19.12 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.511 -0.768 . . . . 75.23 111.098 -176.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -105.47 40.2 1.59 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.403 0.62 . . . . 63.42 110.66 178.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.623 ' HB2' ' O ' ' A' ' 167' ' ' TYR . 3.0 t-80 -110.21 -72.72 0.71 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.275 -0.875 . . . . 73.45 109.083 174.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -170.68 -38.49 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.461 -0.336 . . . . 73.45 111.293 173.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.591 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 46.8 m-85 -107.33 138.79 42.88 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.84 0.352 . . . . 72.52 111.639 -177.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 18.1 m -109.26 172.51 2.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 116.122 -0.49 . . . . 72.05 110.396 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 44.2 t60 -141.16 111.76 6.98 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.356 -0.384 . . . . 72.44 110.111 -177.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.78 -44.26 6.48 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.861 -0.685 . . . . 72.53 113.568 -175.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.788 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 35.7 t70 -81.37 87.09 6.18 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 122.267 -0.549 . . . . 74.22 112.269 -173.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 26.6 mm -86.69 63.95 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.575 0.703 . . . . 53.22 109.534 170.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 46.4 tptt -97.31 156.99 16.2 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.328 -0.619 . . . . 70.24 109.328 177.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.534 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -64.01 -10.84 24.1 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.943 0.349 . . . . 63.31 111.943 -177.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.532 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 46.6 t -71.56 -22.55 61.73 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.457 -0.338 . . . . 71.22 111.134 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -95.42 -2.25 49.28 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.469 . . . . 70.12 110.794 -174.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 90.5 mt -114.46 126.62 55.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.025 -0.534 . . . . 74.31 111.512 -172.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.627 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 1.0 OUTLIER -137.71 158.74 43.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.909 -0.587 . . . . 65.14 110.996 176.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.436 HD23 ' HB ' ' A' ' 193' ' ' VAL . 43.6 mt -102.67 152.17 21.52 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.936 -0.575 . . . . 72.45 111.25 -174.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.748 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 42.1 t-20 -69.38 128.1 35.38 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.507 -0.923 . . . . 75.1 108.507 169.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.775 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 39.7 t80 -60.21 -35.36 75.23 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.449 -0.342 . . . . 71.22 111.905 -174.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.493 ' HD3' ' NH1' ' A' ' 133' ' ' ARG . 76.0 tttt -97.78 -25.49 15.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.386 -0.37 . . . . 63.24 111.218 -176.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.52 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 82.7 m-20 -115.99 98.17 50.66 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.42 -0.355 . . . . 55.33 110.14 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 189' ' ' ASN . 33.7 Cg_endo -63.98 -21.67 68.44 Favored 'Trans proline' 0 C--N 1.341 0.143 0 C-N-CA 123.089 2.526 . . . . 71.13 113.241 -174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.692 ' HB3' ' HB2' ' A' ' 338' ' ' LYS . 31.2 p-10 -95.77 6.91 47.76 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.958 0.408 . . . . 74.23 111.296 -177.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 50.8 mm-40 -106.16 91.86 3.9 Favored 'General case' 0 N--CA 1.446 -0.657 0 CA-C-N 116.026 -0.534 . . . . 75.21 109.834 176.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.436 ' HB ' HD23 ' A' ' 185' ' ' LEU . 4.1 p -102.42 122.95 55.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-N 115.695 -0.684 . . . . 74.42 110.109 178.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.748 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 79.3 m-85 -106.91 157.76 17.53 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.647 -0.706 . . . . 74.11 110.897 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.446 ' HB2' HH22 ' A' ' 160' ' ' ARG . 43.1 tp -109.16 101.66 10.68 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.622 -0.717 . . . . 72.0 109.444 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.703 HG12 ' HG3' ' A' ' 111' ' ' PRO . 24.2 m -146.13 171.41 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 120.6 0.238 . . . . 73.51 110.831 -176.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.54 51.6 4.0 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.497 -0.774 . . . . 65.03 110.775 176.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.677 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 22.5 p90 -126.67 -44.63 1.66 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.423 -0.808 . . . . 73.23 111.124 -178.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 79' ' ' PRO . . . 67.02 5.67 34.28 Favored Glycine 0 CA--C 1.522 0.507 0 C-N-CA 120.899 -0.667 . . . . 63.12 112.873 -176.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.93 HD11 ' HD2' ' A' ' 352' ' ' LYS . 30.3 mt -92.33 97.31 10.79 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.768 0.318 . . . . 55.42 110.873 -178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.505 ' HB3' HG22 ' A' ' 82' ' ' THR . . . -149.47 100.14 2.97 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.848 -0.614 . . . . 75.2 109.663 173.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -105.18 143.01 33.95 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.389 -0.368 . . . . 74.31 110.463 -176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 203' ' ' ARG . 8.8 ptm180 -71.3 115.98 11.09 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.118 -0.492 . . . . 75.1 111.55 -176.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.527 ' OH ' ' HA ' ' A' ' 239' ' ' SER . 68.9 t80 -83.76 -61.69 1.77 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.72 -0.673 . . . . 60.14 109.746 177.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 8.1 p -99.33 119.51 60.23 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.57 -0.741 . . . . 54.24 109.42 176.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.639 ' HG2' HG23 ' A' ' 209' ' ' VAL . 11.7 Cg_endo -56.64 88.29 0.04 OUTLIER 'Trans proline' 0 CA--C 1.529 0.266 0 C-N-CA 123.233 2.622 . . . . 73.51 113.559 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 62.62 24.58 14.64 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.448 -0.796 . . . . 65.25 112.626 170.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 132.11 -42.6 1.37 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.364 -0.922 . . . . 42.43 113.232 174.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.639 HG23 ' HG2' ' A' ' 206' ' ' PRO . 24.4 m -79.19 132.42 32.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.962 0.41 . . . . 64.24 111.068 -177.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 32.8 p-80 -70.0 153.61 43.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 65.13 110.727 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.771 ' HE2' ' HA ' ' A' ' 211' ' ' LYS . 0.1 OUTLIER -130.86 134.6 46.95 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 74.21 109.444 179.671 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 33.0 mp0 -64.86 145.91 55.63 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.458 -0.571 . . . . 74.34 109.458 175.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 52.6 p90 -65.58 136.81 56.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.477 0.656 . . . . 63.21 111.187 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -100.43 -148.88 0.36 Allowed 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.118 -0.946 . . . . 74.25 108.962 176.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -139.75 -49.6 0.48 Allowed 'General case' 0 C--N 1.325 -0.492 0 C-N-CA 120.767 -0.373 . . . . 64.44 110.086 172.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -138.84 104.26 7.49 Favored Pre-proline 0 C--N 1.329 -0.325 0 N-CA-C 112.088 0.403 . . . . 60.42 112.088 176.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 54.9 Cg_endo -76.72 -42.63 0.32 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.029 1.819 . . . . 74.51 109.989 162.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.579 ' CE ' ' HA ' ' A' ' 218' ' ' LYS . 0.1 OUTLIER 175.81 58.34 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 115.578 -0.737 . . . . 52.04 110.467 173.3 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 50.95 38.87 21.43 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.607 0.763 . . . . 73.43 112.197 178.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.502 ' N ' ' HA2' ' A' ' 235' ' ' GLY . 48.8 t -83.9 91.97 7.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.32 0.581 . . . . 75.35 111.731 -175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.613 ' HB3' ' HA ' ' A' ' 233' ' ' HIS . 20.1 p-80 -101.14 131.96 46.83 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.542 -0.753 . . . . 72.24 110.3 174.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -92.9 124.25 36.76 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.081 0.467 . . . . 73.1 110.554 176.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.788 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . 88.4 -153.38 24.19 Favored Glycine 0 N--CA 1.442 -0.947 0 CA-C-N 115.455 -0.793 . . . . 42.35 112.303 177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.73 145.42 25.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.756 0.312 . . . . 73.04 110.181 -179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.489 ' HA ' HG22 ' A' ' 228' ' ' THR . 15.3 tt -61.39 -23.44 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 112.709 0.633 . . . . 74.14 112.709 -171.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -68.46 -34.47 76.0 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.32 -0.237 . . . . 72.42 111.222 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.497 ' O ' HG12 ' A' ' 246' ' ' ILE . 13.3 m-85 -104.07 -17.65 14.85 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 112.418 0.525 . . . . 75.31 112.418 -175.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 1.8 t -72.94 7.97 1.78 Allowed 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.091 0.472 . . . . 53.05 111.451 -174.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 233' ' ' HIS . 26.2 t 63.34 -179.77 0.15 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.264 0.554 . . . . 72.01 110.932 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 64.5 mt -72.5 -41.13 64.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 72.32 109.559 175.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -58.09 -62.27 1.95 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.847 -1.069 . . . . 64.42 111.589 -173.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.566 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -66.4 -29.41 69.57 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.64 -0.254 . . . . 54.21 111.228 -175.685 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.613 ' HA ' ' HB3' ' A' ' 221' ' ' HIS . 0.0 OUTLIER -64.7 -29.69 70.68 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.232 -0.187 . . . . 54.14 110.543 177.416 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -76.13 -27.17 56.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.283 -0.417 . . . . 53.33 110.002 173.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.502 ' HA2' ' N ' ' A' ' 220' ' ' CYS . . . 133.59 -20.81 4.09 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 121.027 -0.606 . . . . 62.13 113.251 178.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 4.6 p -93.1 130.75 41.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.196 0.522 . . . . 42.22 112.309 -173.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 238' ' ' PRO . . . -62.71 123.7 80.41 Favored Pre-proline 0 C--N 1.328 -0.368 0 N-CA-C 108.652 -0.87 . . . . 75.14 108.652 170.113 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.439 ' HB2' ' H ' ' A' ' 239' ' ' SER . 73.2 Cg_exo -46.14 -92.47 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 123.682 2.922 . . . . 72.31 114.887 -168.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.527 ' HA ' ' OH ' ' A' ' 204' ' ' TYR . 3.6 m 161.37 -83.5 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.751 1.221 . . . . 64.32 108.173 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.607 ' HG2' ' HG3' ' A' ' 315' ' ' PRO . 9.5 mpt_? -136.09 -31.87 0.89 Allowed 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.36 -0.978 . . . . 72.42 108.36 171.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.759 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.32 -67.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.188 -1.369 . . . . 70.51 112.216 179.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.662 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.71 -40.51 96.65 Favored Glycine 0 C--O 1.225 -0.411 0 CA-C-N 116.03 -0.532 . . . . 72.0 112.864 -175.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -52.31 -53.85 39.1 Favored 'General case' 0 C--O 1.244 0.797 0 CA-C-O 121.802 0.81 . . . . 73.31 110.284 179.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.483 ' HB3' ' CG1' ' A' ' 306' ' ' VAL . 10.5 mp -64.96 -33.11 75.25 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.055 -0.975 . . . . 74.3 110.952 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -63.57 -40.45 97.01 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 120.524 0.202 . . . . 74.42 110.532 175.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.662 HG13 ' O ' ' A' ' 242' ' ' GLY . 73.0 mt -56.63 -46.17 82.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 116.117 -0.492 . . . . 45.31 110.737 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.534 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.7 tp -61.91 -40.25 94.81 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.223 -0.591 . . . . 74.53 110.532 176.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.23 -37.34 91.68 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.554 -0.831 . . . . 23.44 112.044 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.47 ' CZ ' ' HE3' ' A' ' 275' ' ' LYS . 20.7 m-85 -64.67 -45.02 88.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.505 0.193 . . . . 70.03 111.464 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 5.0 p -72.58 -35.96 68.07 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.408 -0.517 . . . . 73.54 111.219 -178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.534 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 85.5 mtp -58.21 -52.12 66.9 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.815 0.341 . . . . 63.21 110.651 177.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 14.5 tt -67.62 -32.11 55.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.429 -0.351 . . . . 71.2 110.775 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.689 ' HB3' ' HE3' ' A' ' 147' ' ' LYS . 19.0 mt-30 -62.34 -50.95 69.57 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-O 120.676 0.274 . . . . 63.51 111.211 176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.525 ' HA ' ' HG2' ' A' ' 147' ' ' LYS . 29.7 m0 -68.18 -24.42 64.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.131 -0.486 . . . . 65.01 111.496 -176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -84.99 -31.47 23.49 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.34 0.496 . . . . 71.13 112.34 -179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.535 HG22 ' HD1' ' A' ' 290' ' ' PHE . 51.7 p -103.92 -28.67 11.44 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.999 0.74 . . . . 43.24 112.999 -171.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 112.55 -49.49 0.84 Allowed Glycine 0 CA--C 1.519 0.329 0 C-N-CA 120.184 -1.007 . . . . 71.53 112.956 -179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 4.7 m170 -151.62 145.41 25.08 Favored 'General case' 0 C--N 1.327 -0.406 0 O-C-N 122.609 -0.347 . . . . 74.12 110.348 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.505 ' CD1' ' HG3' ' A' ' 253' ' ' GLN . 31.2 mt -104.97 147.48 34.55 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.642 -0.254 . . . . 72.43 110.4 175.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.5 -35.93 86.93 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.875 2.383 . . . . 60.1 112.907 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.568 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 18.6 p90 -95.35 8.34 43.48 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 120.686 -0.405 . . . . 73.34 111.117 -178.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.436 ' O ' HD12 ' A' ' 265' ' ' LEU . 66.2 tt0 -85.14 -24.8 27.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.343 0.592 . . . . 63.51 109.689 177.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 30.1 m-20 -96.92 -23.4 16.34 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.653 -0.703 . . . . 72.43 109.671 171.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.423 ' HB2' ' HA ' ' A' ' 261' ' ' TRP . 94.7 m-20 -102.51 14.34 32.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.731 -0.668 . . . . 72.01 111.354 -177.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.568 ' HB3' ' O ' ' A' ' 261' ' ' TRP . 0.0 OUTLIER -70.08 -12.73 61.82 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.02 0.438 . . . . 75.12 110.783 -178.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 15.0 ptmm? -64.64 -16.65 63.11 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.504 -0.771 . . . . 74.32 111.356 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.539 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 5.9 t70 -129.72 117.96 18.63 Favored Pre-proline 0 N--CA 1.454 -0.275 0 CA-C-O 120.933 0.397 . . . . 63.04 110.626 179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.421 ' HB3' ' CE1' ' A' ' 233' ' ' HIS . 77.4 Cg_exo -51.69 -27.84 27.64 Favored 'Trans proline' 0 CA--C 1.53 0.316 0 C-N-CA 123.722 2.948 . . . . 72.24 113.946 -179.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.43 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.9 mttp -60.26 -52.45 65.22 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-O 120.902 0.382 . . . . 73.42 110.279 -179.348 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.539 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 95.4 m-85 -72.37 -34.67 68.14 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 75.53 110.994 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.53 HG22 ' HA ' ' A' ' 265' ' ' LEU . 92.5 t -55.57 -50.5 66.31 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 CA-C-N 116.35 -0.386 . . . . 65.23 110.602 175.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 9.3 ttp180 -70.33 -44.07 68.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.969 -0.559 . . . . 73.12 110.368 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -55.29 -55.42 31.68 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.784 -0.644 . . . . 63.41 111.174 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 25.5 p -61.11 -44.37 97.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.158 -0.474 . . . . 73.12 111.027 -179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.47 ' HE3' ' CZ ' ' A' ' 249' ' ' TYR . 50.4 mttp -55.95 -48.11 76.36 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-N 116.651 -0.249 . . . . 74.51 111.174 178.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 69.0 mt -66.6 -41.91 89.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.732 -0.213 . . . . 62.54 111.066 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -63.03 -40.23 97.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.545 -0.298 . . . . 75.32 111.384 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.945 ' HA ' ' HG ' ' A' ' 285' ' ' LEU . 23.0 m-85 -73.88 -33.36 64.01 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.684 0.278 . . . . 72.34 111.219 178.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 279' ' ' ARG . 13.8 mtp180 -71.43 -23.76 61.91 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.896 0.379 . . . . 73.41 111.173 177.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -57.49 -59.07 5.72 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.802 -0.635 . . . . 75.12 110.378 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 19.2 m120 -128.5 88.52 2.75 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.104 -0.498 . . . . 61.31 110.023 177.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 36.2 mm -55.44 -51.37 57.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.157 -0.474 . . . . 54.22 111.33 -175.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -63.27 -47.27 83.07 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.052 -0.522 . . . . 62.23 111.28 -176.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 31.4 m -68.09 -44.06 77.11 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.412 -0.358 . . . . 75.24 111.697 -175.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.945 ' HG ' ' HA ' ' A' ' 278' ' ' TYR . 4.1 mm? -64.39 -46.67 82.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.598 -0.274 . . . . 64.22 111.336 -177.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -70.1 -32.69 70.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.637 0.255 . . . . 45.13 111.013 179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -59.48 -37.91 79.47 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.144 -0.48 . . . . 61.13 111.014 177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 2.7 mmmp? -94.54 -13.26 26.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.97 -0.559 . . . . 63.35 111.462 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.426 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 46.3 t -78.18 -25.28 47.08 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.842 0.353 . . . . 73.43 111.157 -177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.535 ' HD1' HG22 ' A' ' 256' ' ' THR . 19.9 t80 -109.82 93.07 13.7 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.594 -0.521 . . . . 75.15 109.594 179.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.426 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 88.8 Cg_exo -47.45 -48.35 15.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 123.678 2.918 . . . . 75.0 114.329 -173.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.92 -25.08 67.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.75 0.309 . . . . 74.33 110.773 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 21.2 ttmm 58.97 41.91 20.25 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.739 -0.664 . . . . 72.13 110.17 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -63.75 -82.58 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.794 . . . . 75.12 110.021 -179.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.589 ' HE2' ' HA ' ' A' ' 331' ' ' ILE . 50.9 mttp -152.88 99.07 2.77 Favored Pre-proline 0 C--O 1.227 -0.127 0 CA-C-O 120.489 0.185 . . . . 73.44 110.513 172.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -99.4 38.24 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.887 2.391 . . . . 72.15 111.419 169.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -80.24 -50.9 5.22 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.068 -0.587 . . . . 34.34 113.268 -170.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.936 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.6 mp0 -54.88 -52.91 61.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.965 0.412 . . . . 63.03 110.213 -177.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.423 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.1 mp -60.65 -47.32 93.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.425 -0.807 . . . . 72.4 111.12 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.61 -47.29 86.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.774 0.321 . . . . 53.44 111.543 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -66.48 -38.57 87.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.157 0.503 . . . . 71.24 110.046 -178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.614 ' CD1' HD12 ' A' ' 320' ' ' LEU . 76.2 t80 -60.0 -52.51 65.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.468 -0.787 . . . . 75.24 110.76 176.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.506 ' HA ' HG22 ' A' ' 306' ' ' VAL . 79.9 mtp -71.93 -32.19 67.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.339 -0.391 . . . . 63.13 111.616 -175.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -59.51 -42.24 91.75 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.715 0.769 . . . . 71.44 109.333 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 82.3 m -65.39 -44.03 88.8 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 114.756 -1.111 . . . . 74.23 111.548 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 302' ' ' TYR . 4.2 m -70.04 -27.24 31.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.914 0.388 . . . . 72.13 110.654 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -64.5 -44.09 92.03 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.199 0.523 . . . . 73.41 110.009 174.327 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 32.8 tp -76.93 1.71 16.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.709 -0.678 . . . . 61.34 110.943 -178.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.14 -9.03 58.99 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.214 -0.448 . . . . 75.44 110.328 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 21.0 t70 64.36 -81.14 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 123.258 0.623 . . . . 74.41 111.083 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.759 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.3 OUTLIER -149.6 -44.77 0.14 Allowed 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.604 -0.517 . . . . 71.14 109.604 174.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.5 t -154.98 37.86 0.41 Allowed 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 115.691 -0.686 . . . . 70.0 110.622 -178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -51.75 -69.86 0.1 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.051 0.453 . . . . 54.52 111.143 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -175.63 110.34 0.26 Allowed Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 115.596 -0.729 . . . . 74.11 109.545 176.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.607 ' HG3' ' HG2' ' A' ' 240' ' ' ARG . 51.8 Cg_endo -69.81 117.64 5.2 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.841 1.694 . . . . 64.32 111.121 178.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' A' ' 319' ' ' ASN . 16.5 tp -108.56 82.15 1.57 Allowed 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 109.355 -0.609 . . . . 62.33 109.355 -179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -58.3 -36.43 73.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.333 -0.849 . . . . 70.11 110.977 -174.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -56.15 -52.34 64.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.047 -0.524 . . . . 65.34 110.527 177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.482 ' HB2' HD23 ' A' ' 316' ' ' LEU . 8.2 t30 -59.22 -50.52 73.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.953 -0.567 . . . . 50.23 111.325 -176.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 3.3 mm? -61.71 -45.42 94.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.498 -0.319 . . . . 62.21 111.426 -177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 62.6 mtp85 -69.53 -34.03 73.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.65 0.262 . . . . 63.22 110.869 -178.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -71.5 -42.94 67.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 72.42 111.254 179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.437 HG13 ' O ' ' A' ' 320' ' ' LEU . 2.7 pp -67.92 -27.33 37.27 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.092 0 C-N-CA 120.887 -0.325 . . . . 65.12 111.039 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 73.1 mt -65.13 -47.46 77.04 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 110.077 -0.342 . . . . 72.33 110.077 173.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -64.12 -33.13 75.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.222 -0.444 . . . . 73.43 110.246 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.04 -39.42 89.75 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.981 -0.554 . . . . 75.03 110.261 176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.936 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.11 -45.02 94.88 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.004 -0.617 . . . . 34.34 112.088 177.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.527 ' O ' HG22 ' A' ' 331' ' ' ILE . 31.1 tp -65.2 -35.25 80.47 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.336 0.588 . . . . 74.1 110.041 176.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.5 ttmt -66.29 -34.3 77.67 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-N 115.792 -0.64 . . . . 71.34 110.12 177.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -68.08 -30.43 69.61 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.902 -0.59 . . . . 71.04 111.547 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.589 ' HA ' ' HE2' ' A' ' 295' ' ' LYS . 13.1 tt -86.79 -2.76 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.413 0.625 . . . . 72.43 109.901 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 78.19 24.38 63.85 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.722 -0.672 . . . . 71.23 112.867 175.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.45 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 11.1 t -120.65 159.55 25.08 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.952 -0.388 . . . . 72.0 109.952 -177.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.86 -174.0 4.79 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.576 -0.527 . . . . 74.31 109.576 178.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.471 ' HA ' ' HD2' ' A' ' 152' ' ' LYS . 28.1 t70 -65.39 120.04 12.09 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.145 0.497 . . . . 71.05 111.076 -176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -122.26 100.79 7.14 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.705 -0.68 . . . . 65.23 109.371 174.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.53 ' C ' ' HD2' ' A' ' 338' ' ' LYS . . . 82.34 -81.05 1.73 Allowed Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.821 -0.704 . . . . 75.21 111.493 -176.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.692 ' HB2' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -170.25 -66.16 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 111.875 0.324 . . . . 70.11 111.875 177.53 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.532 HD22 HG23 ' A' ' 153' ' ' THR . 94.1 mt -144.91 -179.26 6.49 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.518 0.199 . . . . 75.11 110.678 -173.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -173.3 98.3 0.12 Allowed 'General case' 0 CA--C 1.518 -0.255 0 N-CA-C 108.71 -0.848 . . . . 75.3 108.71 177.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.503 HD13 HD13 ' A' ' 141' ' ' ILE . 20.7 mt -96.79 -79.75 0.45 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.234 -0.439 . . . . 72.24 111.706 -174.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 20.2 p -175.06 -86.47 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.399 0.518 . . . . 75.43 112.399 -175.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 7.2 p -163.03 -30.94 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 N-CA-C 112.372 0.508 . . . . 63.14 112.372 -172.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.854 HG22 HG12 ' A' ' 141' ' ' ILE . 39.2 t 69.73 100.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.543 0 CA-C-O 120.99 0.424 . . . . 72.03 110.624 -175.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 53.0 mm-40 -109.33 21.58 16.9 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 111.968 0.358 . . . . 72.4 111.968 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 55.1 m-80 74.33 151.13 0.12 Allowed 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.963 0.887 . . . . 74.24 113.139 174.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.666 ' H ' ' HG2' ' A' ' 140' ' ' LYS . . . -176.43 164.95 35.01 Favored Glycine 0 N--CA 1.444 -0.798 0 N-CA-C 109.408 -1.477 . . . . 71.42 109.408 -179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -142.86 105.09 0.38 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.955 -1.117 . . . . 75.51 113.172 -175.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.536 HD11 ' HE2' ' A' ' 142' ' ' TYR . 79.7 mt -111.48 150.47 29.86 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.151 -0.315 . . . . 74.32 110.151 175.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -152.7 -165.64 2.25 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.309 -0.405 . . . . 75.33 110.713 -178.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 66.85 90.26 0.09 Allowed 'General case' 0 N--CA 1.466 0.341 0 O-C-N 123.916 0.76 . . . . 74.43 110.828 -178.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.93 ' HD2' HD11 ' A' ' 200' ' ' LEU . 11.1 tppt? -158.66 104.81 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.036 -0.529 . . . . 74.14 110.696 -174.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 52.4 m -156.83 150.9 24.97 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 116.42 -0.355 . . . . 72.43 110.114 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.747 HG23 ' HA ' ' A' ' 200' ' ' LEU . 12.9 pt -74.93 143.22 13.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.917 0.389 . . . . 71.11 111.984 179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 23.9 m -75.33 97.9 3.71 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.593 -0.73 . . . . 62.23 110.428 175.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 58.9 pttt -135.44 -19.2 1.67 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.351 -0.386 . . . . 71.11 111.661 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.688 ' HE2' ' HA ' ' A' ' 357' ' ' LYS . 6.7 mmpt? -70.7 106.7 3.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.895 0.379 . . . . 72.22 111.284 -178.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -159.6 105.49 1.64 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.467 -0.788 . . . . 73.13 109.468 176.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.473 ' C ' ' HD3' ' A' ' 359' ' ' LYS . 14.1 tmtt? -64.4 127.86 33.3 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.94 -0.392 . . . . 72.2 109.94 178.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.47 ' NZ ' ' HB3' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.616 -0.707 . . . . 71.12 109.097 178.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.1 mtt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 110.18 -0.304 . . . . 62.24 110.18 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -78.98 136.34 13.04 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 122.01 1.807 . . . . 62.52 112.339 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -143.82 27.42 1.49 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.842 -0.617 . . . . 74.54 109.857 178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 28.2 m -93.89 144.86 8.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.611 -0.722 . . . . 65.13 111.759 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -130.39 102.42 6.17 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.713 -0.676 . . . . 55.35 109.238 173.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -130.85 108.61 9.97 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.895 0.379 . . . . 72.13 111.384 -176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -144.52 134.98 24.55 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.838 -0.619 . . . . 71.4 109.999 177.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -130.88 122.59 27.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.957 0.408 . . . . 72.4 111.141 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.92 142.75 30.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.988 -0.551 . . . . 74.43 109.901 175.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 73.03 -132.01 16.28 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.107 -0.797 . . . . 53.03 111.107 -175.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.45 ' HG2' ' O ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -160.52 105.21 1.44 Allowed 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.717 0.77 . . . . 75.13 110.243 173.804 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -98.3 75.77 2.28 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.456 -0.793 . . . . 74.21 108.934 177.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.6 p -86.44 122.93 31.08 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-N 115.259 -0.882 . . . . 52.44 111.519 -174.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 41.8 m -131.2 99.72 4.96 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.566 -0.743 . . . . 65.42 109.497 177.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -153.46 43.59 0.6 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.429 -0.351 . . . . 62.12 111.193 -174.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -81.01 49.64 1.27 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.437 0.637 . . . . 64.54 110.856 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 68.0 ttt180 -72.29 109.31 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.783 -0.644 . . . . 65.51 111.349 -178.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -140.54 38.33 1.86 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.734 0.778 . . . . 72.12 108.935 172.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 37.2 tp -92.07 124.95 36.55 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.848 -1.069 . . . . 73.54 111.14 -171.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -133.49 -78.35 0.48 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.51 -0.552 . . . . 41.41 109.51 175.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 68.08 -16.4 0.19 Allowed 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.205 1.187 . . . . 75.53 114.205 168.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -83.39 -90.27 0.09 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 118.207 0.458 . . . . 70.11 111.182 -176.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -134.06 93.49 3.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.501 0.667 . . . . 74.1 111.191 -178.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 178.4 -59.05 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.196 -1.366 . . . . 54.21 107.978 -179.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.461 HG13 ' HA2' ' A' ' 40' ' ' GLY . 40.2 t -66.19 123.79 19.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 114.851 -1.068 . . . . 71.2 109.999 175.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' 38' ' ' LYS . . . 98.8 -0.14 57.74 Favored Glycine 0 N--CA 1.442 -0.93 0 CA-C-N 115.961 -0.563 . . . . 52.22 113.192 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.409 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 39.4 tt0 -71.17 129.86 40.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 117.316 0.558 . . . . 74.34 110.097 179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -77.44 130.46 36.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 CA-C-O 121.435 0.636 . . . . 73.2 110.766 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.9 mt -134.12 128.45 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.844 0 CA-C-N 115.072 -0.967 . . . . 75.41 109.584 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.524 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 49.6 m -108.39 119.08 38.46 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.922 0.392 . . . . 64.12 110.35 176.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 116' ' ' SER . 5.7 p-10 -92.93 169.15 10.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.097 -0.501 . . . . 54.5 109.953 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.666 ' HG2' ' O ' ' A' ' 116' ' ' SER . 24.7 ptt? -71.96 -10.22 59.46 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.278 0.473 . . . . 71.14 112.278 -170.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.96 8.85 21.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.673 0.273 . . . . 55.2 110.601 176.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? 69.45 81.45 0.17 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.541 -0.754 . . . . 74.32 111.534 174.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.524 ' O ' ' HA ' ' A' ' 30' ' ' THR . 35.6 mtmm -152.99 135.95 15.5 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.009 -0.541 . . . . 72.3 109.966 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -105.55 89.23 3.04 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.985 -0.376 . . . . 71.53 109.985 174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.471 ' HB3' ' HA ' ' A' ' 57' ' ' ASN . 27.4 p-90 -116.19 160.15 20.81 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.872 0.368 . . . . 73.52 110.918 -177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.524 ' HB3' HD12 ' A' ' 28' ' ' ILE . 1.1 ptpm? -110.64 127.22 55.17 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.152 -0.476 . . . . 75.13 110.277 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -67.89 144.84 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.375 -0.602 . . . . 60.34 109.375 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.461 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -111.73 -121.12 4.0 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.481 -0.866 . . . . 43.2 113.198 -174.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.439 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 92.2 mt -81.39 138.01 48.39 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.978 0.418 . . . . 75.1 111.425 -172.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.4 Cg_exo -74.39 108.07 2.59 Favored 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 123.056 2.504 . . . . 54.32 112.057 177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 53' ' ' LEU . 45.2 mt -76.75 -47.57 28.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.152 0.501 . . . . 62.5 109.842 178.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 96.53 -32.53 6.42 Favored Glycine 0 N--CA 1.449 -0.461 0 CA-C-N 115.754 -0.657 . . . . 64.24 112.953 176.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -145.56 141.74 28.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.873 0.368 . . . . 75.22 110.516 -175.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -173.08 62.33 0.14 Allowed Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 111.148 -0.781 . . . . 70.35 111.148 -178.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 80.98 8.1 87.83 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.014 -0.612 . . . . 72.52 112.642 178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HZ ' ' HG2' ' A' ' 79' ' ' PRO . 53.2 t80 -164.87 -73.96 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.919 -0.4 . . . . 64.13 109.919 -178.329 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 146.58 157.7 7.45 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.952 -0.642 . . . . 71.44 112.064 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 81.4 m 63.19 38.13 10.78 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.04 0.448 . . . . 70.13 111.057 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.435 HD12 ' HB3' ' A' ' 71' ' ' LYS . 2.1 mm -98.2 137.79 24.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 62.55 110.722 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -117.06 147.88 41.98 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.144 -0.48 . . . . 71.03 110.241 177.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' HB2' HD11 ' A' ' 43' ' ' ILE . 60.3 tp -85.95 152.94 22.54 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.086 -0.709 . . . . 63.43 109.086 175.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.03 138.56 31.39 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.735 -0.468 . . . . 33.42 109.735 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.466 ' HB3' ' HG3' ' A' ' 38' ' ' LYS . 23.2 t70 -83.81 -49.43 9.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.21 0.528 . . . . 75.04 110.233 -178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . . . . . . . . . 54.6 ttp -162.13 135.3 6.12 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.334 -0.848 . . . . 73.41 109.914 -176.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.471 ' HA ' ' HB3' ' A' ' 37' ' ' TRP . 0.2 OUTLIER -97.63 -44.44 6.78 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.409 -0.36 . . . . 72.52 110.11 -179.156 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.5 t -100.89 120.11 39.67 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.365 -0.606 . . . . 74.3 109.365 178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 12.5 p -61.21 -57.66 11.53 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 113.397 0.888 . . . . 53.45 113.397 -169.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -96.04 -58.54 2.06 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 120.56 -0.456 . . . . 73.24 111.045 -176.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.8 m -85.15 77.38 10.06 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.06 0.457 . . . . 70.23 110.509 179.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -77.88 143.26 13.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.916 -0.583 . . . . 71.3 110.345 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -93.57 -89.93 1.6 Allowed Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.688 -0.767 . . . . 71.3 111.949 178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.4 m -111.35 50.31 0.83 Allowed 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.916 -0.402 . . . . 74.43 109.916 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 65.13 -88.47 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 115.326 -0.852 . . . . 45.14 109.91 -174.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -166.29 94.79 0.76 Allowed Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.117 -0.492 . . . . 73.4 109.961 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.78 44.79 1.73 Allowed 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 123.154 2.569 . . . . 63.34 112.34 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 5.5 p -148.4 148.96 30.92 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.134 0.492 . . . . 71.05 111.697 -176.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 132' ' ' ASP . 21.6 m -125.85 157.14 35.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 109.034 -0.728 . . . . 61.42 109.034 172.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 ' HB ' HG12 ' A' ' 130' ' ' ILE . 3.7 p -128.71 124.21 60.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.922 0 CA-C-O 121.18 0.514 . . . . 75.12 111.169 -177.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.435 ' HB3' HD12 ' A' ' 51' ' ' ILE . 0.3 OUTLIER -87.44 132.82 33.87 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.968 -0.753 . . . . 72.31 108.968 173.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.0 t -117.7 129.29 74.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 C-N-CA 120.425 -0.51 . . . . 60.53 112.023 -172.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.507 ' OE2' ' HB2' ' A' ' 80' ' ' LEU . 43.8 mt-10 -125.87 159.01 63.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.784 -0.644 . . . . 63.33 109.363 175.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -78.96 -165.64 0.35 Allowed 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.392 2.061 . . . . 55.43 112.608 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.4 m -66.68 -36.48 82.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.443 0.64 . . . . 61.54 109.525 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -88.87 73.92 8.31 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.103 -0.953 . . . . 75.01 109.227 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -81.25 177.38 9.04 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.729 -0.669 . . . . 64.03 110.399 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.436 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -130.05 -100.59 0.91 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.522 -0.847 . . . . 73.42 112.553 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.594 ' HG2' ' HZ ' ' A' ' 48' ' ' PHE . 33.9 Cg_exo -61.91 -21.73 72.89 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 123.556 2.837 . . . . 74.12 113.307 -175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.507 ' HB2' ' OE2' ' A' ' 73' ' ' GLU . 46.0 tp -51.17 -34.94 33.63 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.678 0.621 . . . . 61.41 112.678 -172.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.451 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 86.1 t80 -66.76 -44.65 80.86 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.531 -0.468 . . . . 74.51 110.553 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 24.6 m -68.24 -50.03 56.69 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-N 115.842 -0.617 . . . . 74.32 110.708 -176.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.619 ' HA ' ' HB2' ' A' ' 198' ' ' TYR . 9.1 pt-20 -64.58 -52.98 54.75 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.247 -0.888 . . . . 72.12 110.875 -177.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.502 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 63.4 tp -59.93 -40.93 90.59 Favored 'General case' 0 C--N 1.334 -0.101 0 N-CA-C 111.572 0.212 . . . . 55.41 111.572 -175.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 3.3 tmtm? -60.95 -51.12 70.62 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 120.783 0.325 . . . . 64.04 110.612 -178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -71.8 -32.26 67.44 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.222 -0.591 . . . . 73.11 109.897 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.523 ' HE1' ' HG2' ' A' ' 111' ' ' PRO . 31.2 t80 -57.67 -45.65 85.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.007 -0.542 . . . . 51.52 109.795 176.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 84' ' ' LEU . 28.3 mt-30 -61.33 -38.54 87.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.927 -0.579 . . . . 65.41 110.697 176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.503 ' HA ' ' HZ2' ' A' ' 92' ' ' LYS . 17.4 mtm180 -68.9 -28.08 66.36 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.832 -0.347 . . . . 71.44 111.902 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -92.89 -35.58 13.26 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.856 0.687 . . . . 34.41 112.856 -175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -88.2 80.13 7.67 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.415 0.894 . . . . 63.32 113.415 -169.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.503 ' HZ2' ' HA ' ' A' ' 89' ' ' ARG . 5.4 mptt -139.61 129.57 14.13 Favored Pre-proline 0 C--N 1.327 -0.37 0 N-CA-C 108.983 -0.747 . . . . 70.22 108.983 168.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -51.99 -38.36 69.31 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.618 2.212 . . . . 64.54 111.849 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.529 ' HG2' ' HD3' ' A' ' 98' ' ' LYS . 16.5 tt0 -64.69 -61.03 2.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.906 -0.588 . . . . 71.32 110.847 178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 70.1 mt-30 -65.64 -34.22 77.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.689 -0.687 . . . . 73.44 111.511 -172.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.55 ' O ' HD13 ' A' ' 100' ' ' ILE . 66.9 mt -64.71 -52.61 52.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.673 -0.24 . . . . 73.42 110.445 176.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.57 ' HA ' HD11 ' A' ' 100' ' ' ILE . 6.6 tp-100 -58.13 -36.69 73.32 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.323 0.582 . . . . 73.22 110.27 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.529 ' HD3' ' HG2' ' A' ' 94' ' ' GLU . 48.2 mtpt -67.98 -28.86 67.8 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.786 -0.643 . . . . 62.2 111.126 177.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.755 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 57.4 t90 -66.3 -56.26 12.02 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-N 116.611 -0.268 . . . . 74.42 110.792 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.632 HG22 ' HB2' ' A' ' 105' ' ' LEU . 0.0 OUTLIER -66.07 -26.02 37.29 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.241 0 C-N-CA 120.685 -0.406 . . . . 74.34 111.422 -179.825 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 72.4 ttt180 -66.22 -39.32 89.51 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.95 -0.3 . . . . 73.41 110.437 173.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.3 m -76.02 -48.98 18.9 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.353 -0.385 . . . . 62.3 111.738 -177.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -81.73 -13.31 57.96 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.239 0.542 . . . . 72.23 109.651 -178.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 1.028 ' HE3' ' HA ' ' A' ' 104' ' ' LYS . 0.2 OUTLIER 58.35 77.28 0.3 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.103 -0.953 . . . . 73.01 111.087 -174.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.632 ' HB2' HG22 ' A' ' 100' ' ' ILE . 95.7 mt -136.7 -176.69 4.44 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.888 -1.051 . . . . 73.12 108.892 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -79.57 -70.22 0.53 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.643 0.258 . . . . 64.31 110.805 -178.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.428 ' HA ' HG21 ' A' ' 100' ' ' ILE . 30.8 p90 -159.94 163.17 34.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.217 -0.447 . . . . 71.11 109.94 -179.516 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.532 ' HG ' ' CE3' ' A' ' 99' ' ' TRP . 0.9 OUTLIER -79.42 137.19 37.17 Favored 'General case' 0 C--O 1.235 0.307 0 O-C-N 123.566 0.541 . . . . 65.42 111.356 -176.021 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.33 17.82 16.98 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 121.256 -0.497 . . . . 63.33 112.655 176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 HD22 ' A' ' 108' ' ' LEU . 76.0 t -101.71 135.25 19.8 Favored Pre-proline 0 CA--C 1.534 0.341 0 C-N-CA 122.743 0.417 . . . . 75.04 110.372 179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.523 ' HG2' ' HE1' ' A' ' 87' ' ' TYR . 28.3 Cg_endo -63.78 159.62 40.75 Favored 'Trans proline' 0 CA--C 1.535 0.55 0 C-N-CA 123.366 2.71 . . . . 50.35 114.269 -179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -81.38 154.67 26.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.619 -1.173 . . . . 74.34 111.101 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -99.97 116.51 32.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.515 -0.311 . . . . 75.41 110.355 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.598 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 41.1 m95 -100.88 -29.14 12.39 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.953 0.406 . . . . 75.13 110.546 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 158.32 -179.53 33.94 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.577 -0.821 . . . . 71.52 112.645 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.666 ' O ' ' HG2' ' A' ' 32' ' ' MET . 36.9 p -169.99 175.33 5.14 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.529 -0.915 . . . . 61.24 108.529 178.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.14 -150.93 19.89 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 119.477 -1.344 . . . . 60.55 113.293 179.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.405 HD21 ' HB3' ' A' ' 125' ' ' SER . 9.1 tt -133.27 134.13 43.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.883 0.373 . . . . 73.24 110.522 -174.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -126.54 108.63 11.33 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 108.707 -0.849 . . . . 75.25 108.707 176.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.753 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 29.4 t70 -79.09 150.58 31.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.299 0.571 . . . . 54.21 111.718 -172.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -133.05 52.44 2.08 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.725 -0.843 . . . . 64.25 108.725 176.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 67.17 75.84 0.3 Allowed 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 114.895 -1.048 . . . . 44.14 111.168 -178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 86.25 -42.88 3.18 Favored Glycine 0 N--CA 1.449 -0.453 0 CA-C-N 115.9 -0.591 . . . . 65.21 112.008 176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.961 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 0.1 OUTLIER -89.06 82.74 6.59 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.879 -0.786 . . . . 71.42 108.879 177.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.753 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 13.8 m -78.46 135.95 37.5 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.224 -0.898 . . . . 74.13 110.776 -176.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -94.69 137.98 33.11 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.035 0.445 . . . . 73.13 110.776 178.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 45.0 ttt180 -112.77 120.36 41.23 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.64 -0.874 . . . . 72.45 108.64 -178.222 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 42.1 p90 -133.94 162.71 31.29 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.421 0.526 . . . . 72.43 112.421 -170.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 27.3 ttm -129.87 131.49 46.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.325 -0.852 . . . . 74.34 109.719 175.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.598 ' CG2' ' HB2' ' A' ' 114' ' ' TRP . 0.3 OUTLIER -102.68 122.93 55.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 CA-C-O 121.273 0.558 . . . . 74.13 109.746 178.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 19.6 ptm -133.83 -169.97 2.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.531 -0.759 . . . . 62.42 110.445 -172.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.629 ' O ' HG22 ' A' ' 69' ' ' VAL . 71.9 m-20 -64.24 169.71 4.34 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.864 0.364 . . . . 73.33 111.962 -178.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.734 ' HD3' ' H ' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -82.5 106.0 14.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.51 0.671 . . . . 74.14 111.978 -174.962 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -124.39 172.25 9.29 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.798 -0.637 . . . . 74.31 110.26 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 179.23 -38.14 0.08 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.535 -0.841 . . . . 34.13 112.344 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 20.0 m -95.87 128.19 42.54 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.368 -0.234 . . . . 73.14 110.368 179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.512 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -122.66 160.9 24.85 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.646 -0.501 . . . . 74.23 109.646 179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HA ' ' HB ' ' A' ' 141' ' ' ILE . 10.6 mp -75.8 -8.43 56.86 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.227 0.454 . . . . 75.02 112.227 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.446 ' HB3' ' HA2' ' A' ' 348' ' ' GLY . 10.3 tm0? -73.67 -49.75 24.32 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.148 -0.686 . . . . 75.15 109.148 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.521 ' HD2' ' O ' ' A' ' 345' ' ' GLU . 13.5 pttm -76.86 -21.64 54.68 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.606 -0.438 . . . . 73.31 110.914 177.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.556 ' HB ' ' HA ' ' A' ' 138' ' ' LEU . 54.6 mt -74.12 -51.5 23.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.562 -0.29 . . . . 64.44 110.947 176.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.446 ' HE1' ' HE3' ' A' ' 147' ' ' LYS . 0.2 OUTLIER -66.76 -32.47 73.78 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 121.126 -0.23 . . . . 74.42 110.944 -174.612 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -67.18 -43.31 82.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 63.22 110.137 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -74.71 -31.53 61.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.929 -0.578 . . . . 34.34 110.986 179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -87.25 -2.59 58.73 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.95 -0.568 . . . . 75.52 110.912 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 51.97 38.04 22.7 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 115.472 -0.785 . . . . 72.14 112.511 176.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.652 ' HD3' ' O ' ' A' ' 257' ' ' GLY . 74.1 mttt 62.17 73.12 0.48 Allowed 'General case' 0 C--O 1.235 0.326 0 N-CA-C 112.433 0.531 . . . . 75.13 112.433 175.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 26.3 ttm180 -156.29 82.2 0.98 Allowed 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.307 0.575 . . . . 73.04 109.729 174.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -96.49 141.34 29.89 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.604 -0.726 . . . . 51.32 111.141 -178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.2 m -65.45 144.09 57.27 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.77 -0.65 . . . . 75.12 109.852 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.525 ' HD2' HD13 ' A' ' 331' ' ' ILE . 13.1 ttm180 -63.24 -29.55 70.86 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 111.347 0.129 . . . . 71.05 111.347 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.41 ' HG2' ' HB3' ' A' ' 333' ' ' SER . 57.3 mttp -57.6 -44.59 85.53 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.21 0.528 . . . . 72.44 110.071 173.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.545 ' HA ' HD22 ' A' ' 339' ' ' LEU . 6.8 m -66.98 -41.32 87.0 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.38 -0.827 . . . . 74.15 110.577 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 64.5 t -58.52 -45.51 90.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.4 -0.363 . . . . 75.52 111.403 -178.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.563 ' HG ' HD22 ' A' ' 328' ' ' LEU . 3.9 mm? -68.55 -37.69 80.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.506 -0.316 . . . . 74.24 111.356 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.42 ' HG2' HD21 ' A' ' 339' ' ' LEU . 52.3 tp60 -65.84 -39.62 90.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.181 0.515 . . . . 50.34 109.98 178.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.56 HD12 HG11 ' A' ' 193' ' ' VAL . 5.2 mp -63.19 -51.98 64.15 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.53 -0.759 . . . . 63.42 111.295 178.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.2 p -63.19 -34.98 78.81 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.5 -0.318 . . . . 73.33 111.178 -178.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 61.7 tp -63.25 -40.54 97.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.764 0.316 . . . . 74.14 110.801 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.831 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 0.1 OUTLIER -68.94 -43.22 75.5 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.183 0.516 . . . . 65.42 111.204 -179.875 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 42.5 mt -64.59 -29.64 47.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 CA-C-N 116.149 -0.478 . . . . 74.51 109.845 176.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.527 HD11 ' HD2' ' A' ' 317' ' ' TYR . 29.0 tp -63.1 -55.68 23.3 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.523 -0.762 . . . . 73.44 111.148 -178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.755 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 4.8 p-10 -67.93 -31.51 71.32 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.573 -0.451 . . . . 73.44 110.703 -177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.449 ' O ' HG12 ' A' ' 168' ' ' ILE . 70.5 mt -66.82 -46.82 84.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.41 -0.359 . . . . 65.32 111.041 176.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 162' ' ' LEU . 4.3 pp -68.71 -33.81 74.57 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 120.624 -0.43 . . . . 64.31 110.086 178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.403 ' N ' HD12 ' A' ' 165' ' ' LEU . 5.4 mm-40 -55.58 -56.31 21.82 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 116.323 -0.399 . . . . 61.23 110.362 173.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -59.39 -49.09 79.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.531 -0.759 . . . . 60.11 112.192 -175.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.8 pt -75.01 -38.26 42.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 112.107 0.41 . . . . 62.45 112.107 -173.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -72.78 -21.0 61.06 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.11 0.481 . . . . 71.43 109.831 -179.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.535 ' O ' ' HA ' ' A' ' 207' ' ' GLU . 31.8 tt0 -75.27 -6.0 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.478 -0.783 . . . . 70.33 110.302 175.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 71.8 m80 -124.44 -69.69 0.79 Allowed 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.663 -0.415 . . . . 64.22 111.645 -177.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.793 ' HB3' ' HB2' ' A' ' 203' ' ' ARG . 35.6 mt-10 -155.48 -59.02 0.1 Allowed 'General case' 0 C--O 1.233 0.215 0 N-CA-C 112.469 0.544 . . . . 74.42 112.469 -170.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.847 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 48.1 m-85 -83.71 147.78 27.45 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 113.12 0.785 . . . . 70.34 113.12 -166.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.486 HG22 ' HD2' ' A' ' 204' ' ' TYR . 16.9 m -132.26 164.03 35.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 114.981 -1.008 . . . . 70.41 108.924 171.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 7.1 m-70 -105.35 131.2 53.09 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.738 -0.467 . . . . 73.13 109.738 174.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -90.31 -10.41 64.0 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.05 -1.22 . . . . 62.54 110.05 169.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 1.071 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 15.6 t70 -123.88 110.73 15.21 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.675 -0.763 . . . . 75.1 110.638 178.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 23.2 mm -111.86 66.49 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.416 -0.957 . . . . 74.24 108.416 166.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.442 ' HA ' ' CE2' ' A' ' 227' ' ' PHE . 79.9 tttt -90.54 161.77 15.32 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.886 -0.597 . . . . 75.44 109.882 -179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -57.6 -19.31 25.04 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.405 -0.361 . . . . 71.33 111.786 179.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 2.9 p -75.91 -12.07 60.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.522 -0.308 . . . . 35.2 111.488 178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.518 ' HB3' ' HG ' ' A' ' 195' ' ' LEU . 1.0 OUTLIER -82.5 -30.05 30.11 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.713 0.292 . . . . 51.34 110.646 178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 6.4 mp -94.05 131.54 39.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.993 0.425 . . . . 62.41 110.581 -174.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.59 ' CD1' ' HB2' ' A' ' 194' ' ' TYR . 1.1 pp -138.42 157.43 46.22 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.672 -0.695 . . . . 73.31 111.048 -178.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 69.3 mt -110.59 156.69 20.58 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.907 -0.588 . . . . 70.34 109.5 178.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.65 HD21 ' HE1' ' A' ' 194' ' ' TYR . 51.1 m-80 -63.51 152.15 39.34 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.709 -0.478 . . . . 74.51 109.709 175.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 62.3 t80 -56.5 -32.7 65.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.101 -0.499 . . . . 70.21 111.133 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -129.47 3.43 5.08 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.209 0.448 . . . . 74.35 112.209 -178.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.467 ' HB2' ' HB2' ' A' ' 186' ' ' ASN . 12.7 m120 -128.53 92.89 39.49 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 120.823 -0.351 . . . . 73.41 111.242 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -78.23 -9.26 16.46 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.829 2.353 . . . . 72.4 111.258 176.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -74.13 -6.89 50.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.611 -0.722 . . . . 74.13 111.193 -177.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -138.68 122.48 17.65 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-O 121.094 0.474 . . . . 71.0 110.573 177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.56 HG11 HD12 ' A' ' 157' ' ' LEU . 7.1 p -103.62 137.45 32.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.451 -0.795 . . . . 75.31 109.712 176.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.65 ' HE1' HD21 ' A' ' 186' ' ' ASN . 4.7 m-85 -114.09 158.17 21.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.932 -0.766 . . . . 73.32 108.932 178.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.518 ' HG ' ' HB3' ' A' ' 182' ' ' ASN . 10.1 tt -119.69 131.18 55.35 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 108.42 -0.956 . . . . 53.01 108.42 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HD23 ' A' ' 195' ' ' LEU . 7.2 p -50.79 130.49 10.55 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.222 0 CA-C-O 121.528 0.68 . . . . 72.11 111.285 -176.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.639 ' HB2' ' CD2' ' A' ' 198' ' ' TYR . 1.2 p-10 -58.25 -78.23 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 114.627 -1.17 . . . . 75.41 112.684 -174.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.639 ' CD2' ' HB2' ' A' ' 197' ' ' ASP . 24.1 m-85 -135.21 26.78 3.51 Favored 'General case' 0 CA--C 1.516 -0.327 0 O-C-N 121.953 -0.467 . . . . 71.31 111.796 -169.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . -64.13 -39.38 97.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.504 -0.855 . . . . 70.02 111.167 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 5.5 mp -130.38 89.35 2.77 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.188 -0.671 . . . . 74.35 109.188 173.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.574 ' H ' HG22 ' A' ' 354' ' ' ILE . . . -166.23 149.66 7.41 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.258 -0.428 . . . . 61.3 110.842 -175.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 35.0 t80 -142.45 144.65 33.15 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.63 -0.507 . . . . 65.42 109.63 177.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.847 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 23.1 ptt180 -84.44 141.08 31.07 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.025 0.44 . . . . 75.34 110.327 -178.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.486 ' HD2' HG22 ' A' ' 174' ' ' VAL . 6.9 m-85 -139.23 -59.35 0.58 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.649 -0.705 . . . . 73.03 112.257 -171.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 16.6 p -109.95 121.75 41.0 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.475 . . . . 75.15 111.548 -172.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.17 103.38 0.63 Allowed 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 122.834 2.356 . . . . 62.14 111.791 176.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.535 ' HA ' ' O ' ' A' ' 170' ' ' GLU . 29.1 tt0 71.65 -11.38 0.74 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.754 0.821 . . . . 75.51 111.974 177.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 143.63 -30.79 1.94 Allowed Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.359 -0.924 . . . . 70.22 113.165 178.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 29.2 m -69.72 122.99 22.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.24 0.543 . . . . 65.31 110.903 -178.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -89.6 154.76 19.73 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.06 -0.518 . . . . 71.03 110.472 -177.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.496 ' HB3' ' OE2' ' A' ' 212' ' ' GLU . 8.8 mtpm? -93.72 -175.11 3.65 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 116.021 -0.536 . . . . 51.14 110.159 177.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.627 ' CD ' ' H ' ' A' ' 212' ' ' GLU . 1.4 mp0 -52.68 130.09 31.43 Favored 'General case' 0 C--O 1.237 0.417 0 O-C-N 123.53 0.519 . . . . 73.31 110.664 -177.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.411 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 49.2 p90 -65.37 129.13 38.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.325 0.583 . . . . 74.32 110.609 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.404 ' NZ ' ' HB2' ' A' ' 212' ' ' GLU . 42.0 mmtm -98.08 -45.18 6.34 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.627 -0.715 . . . . 62.33 110.575 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 234' ' ' ASN . 50.4 mt-10 67.2 -5.13 0.75 Allowed 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 113.134 0.79 . . . . 73.54 113.134 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.575 ' HB2' ' O ' ' A' ' 215' ' ' GLU . 6.0 t70 169.2 86.25 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.352 0 O-C-N 123.515 0.51 . . . . 73.44 110.033 173.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 61.3 Cg_endo -87.72 -40.72 0.05 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.22 1.947 . . . . 73.25 111.973 174.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 218' ' ' LYS . 28.6 ttpt -168.47 11.92 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.713 -0.676 . . . . 70.24 110.241 -179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 58.52 98.72 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-O 121.061 0.458 . . . . 71.42 111.216 -167.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.413 ' HB3' HG21 ' A' ' 355' ' ' THR . 74.7 m -71.23 -68.91 0.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.315 -0.402 . . . . 72.5 110.371 177.07 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.437 ' HD2' HG21 ' A' ' 228' ' ' THR . 57.6 t-80 55.57 92.66 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.711 0.632 . . . . 72.41 112.024 175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.551 ' HB3' HG22 ' A' ' 355' ' ' THR . 20.5 p-10 -91.23 -59.53 2.13 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.61 -0.268 . . . . 62.31 111.393 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 1.071 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -93.79 -149.49 25.38 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.756 -0.735 . . . . 74.41 113.775 -174.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.504 ' HB ' ' OE1' ' A' ' 226' ' ' GLU . 69.3 p -81.26 150.14 28.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.661 0.267 . . . . 75.0 110.988 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 53.4 mt -60.23 -31.33 47.99 Favored 'Isoleucine or valine' 0 C--O 1.238 0.467 0 CA-C-N 116.196 -0.456 . . . . 74.5 110.708 -175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.594 ' HA ' HD21 ' A' ' 265' ' ' LEU . 2.4 mp0 -49.14 -50.93 35.2 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 115.456 -0.793 . . . . 63.22 111.184 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.442 ' CE2' ' HA ' ' A' ' 179' ' ' LYS . 97.3 m-85 -101.92 -13.58 17.56 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.189 -0.46 . . . . 72.34 112.031 -176.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.437 HG21 ' HD2' ' A' ' 221' ' ' HIS . 35.9 m -46.95 -49.58 20.42 Favored 'General case' 0 N--CA 1.466 0.369 0 O-C-N 123.385 0.428 . . . . 63.41 111.086 176.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 19.3 m 59.33 -156.02 0.35 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 115.853 -0.612 . . . . 74.32 110.888 175.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.401 HD12 ' N ' ' A' ' 230' ' ' ILE . 3.4 mp -71.75 -53.52 20.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.367 -0.378 . . . . 74.41 110.282 178.034 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.462 ' OD2' ' HB3' ' A' ' 238' ' ' PRO . 1.6 m-20 -49.46 -60.56 2.74 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 115.514 -0.766 . . . . 61.32 112.991 -173.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -69.94 -30.2 67.52 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 120.928 0.394 . . . . 50.33 111.795 -175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -67.82 -42.82 80.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.391 0.615 . . . . 74.22 109.863 176.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.856 ' HB3' ' HA ' ' A' ' 215' ' ' GLU . 6.4 m-20 -77.25 -4.53 45.31 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.627 -1.17 . . . . 70.34 111.195 -175.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 52.24 41.11 53.74 Favored Glycine 0 C--N 1.335 0.515 0 O-C-N 123.497 0.498 . . . . 53.42 112.56 177.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.411 ' CG2' ' HA ' ' A' ' 213' ' ' TYR . 7.4 p -120.25 140.98 42.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.584 0.23 . . . . 75.13 110.839 -177.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -71.07 106.94 2.12 Favored Pre-proline 0 N--CA 1.45 -0.472 0 N-CA-C 108.871 -0.789 . . . . 72.12 108.871 169.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.462 ' HB3' ' OD2' ' A' ' 231' ' ' ASP . 19.9 Cg_endo -61.07 -87.35 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.503 2.136 . . . . 71.24 112.826 -171.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.408 ' O ' ' HD3' ' A' ' 240' ' ' ARG . 20.7 m 171.13 -49.37 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.532 0 C-N-CA 124.798 1.239 . . . . 70.31 107.736 -178.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.408 ' HD3' ' O ' ' A' ' 239' ' ' SER . 0.0 OUTLIER 176.38 -16.86 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 113.818 -1.537 . . . . 70.3 107.76 -173.031 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.574 ' NH2' ' HD2' ' A' ' 279' ' ' ARG . 9.5 mmm180 -52.4 -68.0 0.21 Allowed 'General case' 0 C--O 1.216 -0.708 0 CA-C-N 114.334 -1.303 . . . . 73.42 110.984 174.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -45.55 -42.02 9.8 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 123.706 0.629 . . . . 75.2 113.711 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.02 -64.99 0.64 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.769 0.795 . . . . 74.14 110.207 177.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.442 HD21 ' CZ ' ' A' ' 317' ' ' TYR . 36.2 mt -74.06 -30.46 62.41 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.78 -1.1 . . . . 74.11 111.198 -174.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 279' ' ' ARG . 7.8 tp10 -62.21 -57.91 9.73 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.308 -0.86 . . . . 72.42 110.274 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . . . . . . . . . 67.0 mt -63.74 -41.29 92.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.581 -0.736 . . . . 75.24 110.341 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 55.4 tp -57.89 -41.63 82.93 Favored 'General case' 0 C--O 1.235 0.34 0 CA-C-O 121.051 0.453 . . . . 71.24 110.816 178.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -43.76 98.57 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 121.07 -0.586 . . . . 24.41 112.203 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -63.07 -34.53 77.78 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.668 0.27 . . . . 72.32 110.896 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 57.9 m -62.0 -51.79 66.6 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.014 0.435 . . . . 71.54 110.525 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 76.3 mtm -61.45 -42.02 98.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.862 -0.608 . . . . 64.01 111.866 -175.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.59 -34.33 64.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.392 -0.523 . . . . 74.32 110.974 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -71.27 -40.33 71.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 71.4 110.231 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 37.0 m0 -68.07 -28.46 67.39 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.246 -0.434 . . . . 74.53 111.247 179.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 46.8 tp -92.34 -40.04 11.14 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.174 0.435 . . . . 73.23 112.174 -176.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 3.5 m -100.14 -17.63 17.32 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.168 0.509 . . . . 71.13 111.25 -172.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.652 ' O ' ' HD3' ' A' ' 147' ' ' LYS . . . 85.69 -59.74 4.74 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.759 -0.734 . . . . 62.32 112.545 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 21.1 t-80 -113.8 141.76 46.9 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.336 -0.508 . . . . 71.21 109.924 -174.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 85.6 mt -103.16 142.08 23.83 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 115.683 -0.69 . . . . 71.22 110.098 -179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 278' ' ' TYR . 15.2 Cg_exo -68.84 -2.3 9.25 Favored 'Trans proline' 0 CA--C 1.532 0.413 0 C-N-CA 122.807 2.338 . . . . 74.22 112.967 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 36.4 p90 -124.3 5.6 8.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.997 0.427 . . . . 73.01 110.21 175.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.921 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 34.1 tt0 -72.31 -21.63 61.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.795 -0.639 . . . . 71.55 111.048 -171.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -83.92 -20.18 33.43 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.048 0.451 . . . . 54.22 109.976 177.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.699 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 89.2 m-20 -96.15 7.12 47.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.78 -0.646 . . . . 64.32 110.465 -179.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.594 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.9 tm? -64.39 -20.84 66.39 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 115.472 -0.785 . . . . 74.55 110.519 -178.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 20.8 ptmt -73.35 -1.6 18.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.927 -0.579 . . . . 74.25 112.337 -176.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.604 ' O ' HG23 ' A' ' 271' ' ' VAL . 20.8 t70 -137.28 120.87 11.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 C-N-CA 121.073 -0.251 . . . . 73.34 110.958 178.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 34.8 Cg_exo -58.12 -29.73 88.15 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 123.307 2.671 . . . . 50.23 113.505 -176.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -77.42 -41.71 38.88 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.805 0.336 . . . . 75.22 110.245 -178.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.699 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 24.3 m-85 -64.63 -40.92 96.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.089 -0.505 . . . . 74.32 110.715 175.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 267' ' ' ASP . 89.8 t -54.16 -49.33 62.88 Favored 'Isoleucine or valine' 0 C--O 1.232 0.146 0 O-C-N 123.125 0.265 . . . . 71.25 110.975 175.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 276' ' ' ILE . 45.3 mtm180 -62.4 -59.05 5.53 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.631 -0.259 . . . . 63.34 111.115 179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -57.0 -47.96 79.59 Favored 'General case' 0 C--O 1.232 0.157 0 O-C-N 123.486 0.491 . . . . 73.35 111.629 -174.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 31.8 m -58.53 -50.54 73.42 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 116.479 -0.328 . . . . 75.24 110.53 -178.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -62.39 -32.92 73.81 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.654 -0.248 . . . . 73.25 111.229 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.441 HG13 ' O ' ' A' ' 272' ' ' ARG . 82.8 mt -64.15 -42.41 95.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.868 0.366 . . . . 55.1 110.216 174.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 280' ' ' GLU . 11.0 mmp_? -62.0 -41.64 98.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.037 -0.529 . . . . 71.24 111.053 178.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 260' ' ' PRO . 73.3 m-85 -74.08 -43.27 58.33 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.383 -0.371 . . . . 73.02 110.904 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.574 ' HD2' ' NH2' ' A' ' 241' ' ' ARG . 34.3 ttp180 -65.38 -20.02 66.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.355 0.597 . . . . 62.13 110.708 -179.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.446 ' HB3' ' O ' ' A' ' 277' ' ' ARG . 36.6 tt0 -60.53 -47.91 84.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.164 -0.925 . . . . 75.13 110.761 176.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 12.1 t30 -159.2 94.89 1.22 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.299 0.571 . . . . 74.32 110.41 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.751 HG13 ' HB2' ' A' ' 303' ' ' MET . 0.2 OUTLIER -80.67 -29.83 11.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.598 -0.728 . . . . 73.3 111.921 -177.038 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.41 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -52.53 -48.36 66.11 Favored 'General case' 0 N--CA 1.464 0.231 0 N-CA-C 112.522 0.564 . . . . 74.44 112.522 -168.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.9 m -69.53 -38.11 77.38 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.96 0.409 . . . . 75.24 111.666 -176.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.417 HD13 ' HD1' ' A' ' 278' ' ' TYR . 76.5 mt -72.7 -48.2 40.92 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.067 -0.515 . . . . 74.4 111.321 -172.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.455 ' SD ' ' HB ' ' A' ' 282' ' ' ILE . 1.3 mpt? -61.24 -40.56 94.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.832 0.348 . . . . 71.43 110.765 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -64.21 -28.16 69.55 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 115.896 -0.593 . . . . 74.1 111.224 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -75.36 -43.64 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.251 -0.431 . . . . 72.22 110.774 176.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 76.7 m -63.11 -41.89 99.45 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.89 -0.595 . . . . 74.33 111.472 -175.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.428 ' HB2' ' HG3' ' A' ' 296' ' ' PRO . 47.2 m-85 -123.15 82.2 51.56 Favored Pre-proline 0 C--N 1.327 -0.401 0 CA-C-N 116.56 -0.291 . . . . 74.11 110.953 177.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -85.62 -76.03 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.288 1.992 . . . . 64.33 112.045 177.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -97.05 -9.0 28.98 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.338 0.59 . . . . 71.02 109.993 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -74.82 -36.13 62.42 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.167 -0.924 . . . . 74.23 111.006 -174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -173.66 -165.98 0.29 Allowed 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 108.632 -0.877 . . . . 65.43 108.632 179.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 296' ' ' PRO . 14.4 ptmm? -120.88 114.27 32.56 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.169 0.509 . . . . 65.54 111.51 -177.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.428 ' HG3' ' HB2' ' A' ' 290' ' ' PHE . 42.2 Cg_endo -105.23 37.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.903 0 C-N-CA 123.675 2.917 . . . . 75.54 112.163 175.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -79.5 -50.87 5.48 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.847 -0.692 . . . . 72.42 113.068 -172.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.463 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.1 pm0 -64.17 -36.94 85.69 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.911 0.386 . . . . 74.41 110.864 -176.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 45.7 mt -68.64 -48.37 72.08 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.975 -0.557 . . . . 74.15 110.773 -179.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.41 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -61.9 -35.73 79.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.038 -0.528 . . . . 75.44 110.375 179.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.407 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 49.7 tptt -70.95 -42.11 70.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.828 -0.624 . . . . 74.24 110.076 179.372 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.515 ' O ' HG13 ' A' ' 306' ' ' VAL . 82.7 t80 -56.19 -49.22 74.65 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.528 -0.76 . . . . 73.12 110.536 176.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.751 ' HB2' HG13 ' A' ' 282' ' ' ILE . 79.1 mtp -72.69 -31.38 64.98 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.971 -0.559 . . . . 74.25 111.235 -177.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.448 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 37.1 tt0 -62.06 -42.23 98.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.774 0.797 . . . . 64.4 109.056 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 86.8 m -60.56 -45.98 91.91 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.634 -1.166 . . . . 71.3 111.211 177.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.593 HG22 ' HA ' ' A' ' 303' ' ' MET . 9.8 m -73.03 -33.79 43.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 C-N-CA 121.028 -0.269 . . . . 75.24 111.712 -175.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -72.75 -24.63 60.99 Favored 'General case' 0 C--O 1.232 0.155 0 N-CA-C 109.816 -0.439 . . . . 74.13 109.816 179.293 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 40.9 tp -73.16 -12.04 60.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.882 -0.599 . . . . 73.32 110.816 177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.48 ' HA ' ' HB3' ' A' ' 313' ' ' GLU . 96.6 mt -81.12 8.25 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.058 -0.519 . . . . 73.35 111.401 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . . . . . . . . . 25.8 t70 53.47 -94.05 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.357 0.663 . . . . 74.32 112.209 175.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -135.89 -50.72 0.71 Allowed 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.514 -0.921 . . . . 64.42 108.514 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 17.3 m -136.64 67.66 1.45 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.514 -0.766 . . . . 72.33 110.349 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 309' ' ' LEU . 13.0 tp10 -104.46 161.28 14.22 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.608 -0.516 . . . . 62.42 109.608 175.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -68.25 110.14 5.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.075 -0.511 . . . . 74.42 111.205 -175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -90.29 121.6 0.9 Allowed 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 122.863 2.375 . . . . 70.42 113.034 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.452 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.3 mt -93.79 92.86 7.65 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.263 -0.426 . . . . 62.22 110.523 177.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.55 ' HA ' HD12 ' A' ' 320' ' ' LEU . 12.7 m-85 -63.76 -32.14 73.54 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.902 -0.59 . . . . 74.13 111.013 178.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.43 ' O ' ' HG2' ' A' ' 321' ' ' ARG . 21.7 mp0 -57.11 -46.45 82.59 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.478 -0.783 . . . . 74.34 110.14 174.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -68.13 -37.01 80.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 64.02 110.472 178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.55 HD12 ' HA ' ' A' ' 317' ' ' TYR . 96.2 mt -60.27 -52.29 65.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.008 -0.542 . . . . 73.35 110.919 179.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.43 ' HG2' ' O ' ' A' ' 318' ' ' GLU . 6.6 ptp180 -66.85 -28.39 68.3 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.151 -0.477 . . . . 75.01 109.739 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.39 -51.78 58.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.811 -0.631 . . . . 53.42 111.122 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.438 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -69.46 -30.04 44.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 121.063 -0.255 . . . . 74.54 111.24 -178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.47 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.1 mt -67.83 -48.54 65.92 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.963 0.411 . . . . 73.14 110.344 175.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 93.4 mt -67.61 -29.73 69.14 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.315 -0.402 . . . . 72.3 110.755 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -58.73 -48.02 82.62 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.188 -0.671 . . . . 62.14 109.188 176.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.463 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.85 -38.51 94.38 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.893 -0.67 . . . . 62.24 112.749 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 333' ' ' SER . 41.7 tp -66.5 -41.96 88.09 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.172 0.511 . . . . 73.13 110.561 178.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -73.54 -25.88 60.6 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.98 -0.554 . . . . 62.24 110.544 179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.46 -38.07 83.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.329 -0.396 . . . . 75.42 110.587 177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.525 HD13 ' HD2' ' A' ' 151' ' ' ARG . 47.0 pt -89.35 7.29 3.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.966 0.412 . . . . 73.43 110.647 177.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 73.34 25.33 73.19 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 116.005 -0.543 . . . . 55.54 113.424 174.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.581 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 59.4 m -112.29 139.36 47.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.875 0.369 . . . . 73.53 111.494 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 4.4 mppt? -136.61 -66.71 0.52 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.91 -0.586 . . . . 74.42 110.084 171.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -133.22 147.36 51.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.943 0.402 . . . . 75.42 110.299 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -106.46 -39.89 5.74 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.932 -0.576 . . . . 74.14 109.789 177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 145.61 -31.16 1.67 Allowed Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 121.008 -0.615 . . . . 55.52 112.626 178.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.653 ' NZ ' ' HB3' ' A' ' 338' ' ' LYS . 0.1 OUTLIER -172.88 29.8 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 112.573 0.582 . . . . 62.35 112.573 -179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 153' ' ' THR . 49.3 mt 71.57 150.74 0.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 122.09 0.947 . . . . 54.13 112.756 173.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 341' ' ' LEU . 34.0 t70 -122.01 104.85 9.8 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.024 -0.989 . . . . 71.33 110.081 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.433 ' HB3' ' O ' ' A' ' 340' ' ' ASP . 1.7 pt? 174.2 -23.23 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.427 0 CA-C-N 115.278 -0.874 . . . . 53.53 110.049 -178.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 5.0 m -66.96 81.12 0.11 Allowed 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 115.941 -0.572 . . . . 75.24 112.242 -176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 29.0 m -93.12 -30.08 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.245 -0.434 . . . . 74.32 110.113 173.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 46.6 t 59.62 95.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 CA-C-N 115.494 -0.776 . . . . 74.12 112.429 178.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.521 ' O ' ' HD2' ' A' ' 140' ' ' LYS . 35.3 mt-10 -134.79 -165.41 1.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.879 -0.6 . . . . 70.53 109.625 173.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -89.18 153.63 20.79 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.602 0.239 . . . . 62.22 111.058 -173.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 146.74 -147.67 18.73 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 111.304 -0.718 . . . . 54.32 111.304 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 139' ' ' GLN . . . 82.83 49.36 5.11 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.704 -0.76 . . . . 22.01 112.241 178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 97.3 mt -125.74 169.72 12.28 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.811 0.339 . . . . 75.34 111.412 -178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 93.5 mttt 63.61 87.44 0.11 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.355 -0.839 . . . . 74.55 112.395 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -127.38 -169.14 1.99 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.154 -0.93 . . . . 41.53 109.396 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.423 ' HB3' ' H ' ' A' ' 353' ' ' THR . 37.4 mmtm -144.13 -145.88 0.18 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.881 -0.415 . . . . 71.12 109.881 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.423 ' H ' ' HB3' ' A' ' 352' ' ' LYS . 8.7 t -157.03 172.52 18.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.666 -0.494 . . . . 73.42 109.666 -172.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.574 HG22 ' H ' ' A' ' 201' ' ' ALA . 0.2 OUTLIER -67.24 142.88 16.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.791 0.329 . . . . 73.03 110.404 177.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.551 HG22 ' HB3' ' A' ' 222' ' ' ASP . 14.5 t -98.02 135.03 40.3 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 108.671 -0.863 . . . . 74.21 108.671 176.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 32.1 ttpt -173.21 -52.15 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.012 0.434 . . . . 71.11 109.986 -174.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 358' ' ' ARG . 19.1 pttp -163.71 -175.33 4.08 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.815 -0.809 . . . . 53.05 108.815 177.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 357' ' ' LYS . 57.4 mtm180 -78.79 164.07 24.83 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 109.694 -0.484 . . . . 65.23 109.694 176.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -72.13 -40.41 68.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.864 0.364 . . . . 62.43 110.201 -178.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? . . . . . 0 C--O 1.247 0.967 0 CA-C-O 118.697 -0.668 . . . . 71.44 109.88 177.003 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.014 0.435 . . . . 75.43 110.708 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.404 ' HB2' HG23 ' A' ' 4' ' ' VAL . 72.6 Cg_endo -79.7 152.52 22.62 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.433 2.089 . . . . 71.21 111.413 175.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 3' ' ' ARG . 19.9 mmm180 -110.03 61.32 0.6 Allowed 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.777 -0.453 . . . . 53.0 109.777 178.248 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 2' ' ' PRO . 61.0 t -97.2 108.8 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.877 -0.601 . . . . 75.1 110.752 -177.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.6 ptmt -109.49 141.94 41.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.067 -0.515 . . . . 74.1 109.829 178.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -153.89 108.9 3.13 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.376 -0.375 . . . . 71.23 110.926 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -148.29 107.18 3.84 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.792 -0.64 . . . . 61.35 109.712 177.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 10.0 pt20 -96.82 116.3 28.92 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.293 0.568 . . . . 71.22 111.163 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -146.58 129.79 16.58 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.559 -0.746 . . . . 71.11 109.443 176.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.93 89.89 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.481 -0.866 . . . . 62.33 112.613 -178.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -116.52 110.83 19.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.161 0.505 . . . . 74.25 110.026 176.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -99.02 119.89 38.55 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.099 0.476 . . . . 63.15 111.417 -175.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.4 m -130.57 120.39 23.95 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.23 -0.656 . . . . 74.24 109.23 170.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 50.5 m -169.05 101.99 0.37 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.928 0.394 . . . . 75.42 110.799 -176.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -131.91 113.97 14.09 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.021 -0.536 . . . . 74.2 109.616 176.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.464 ' HD3' ' H ' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -135.43 159.89 40.17 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.214 0.531 . . . . 73.13 111.342 -176.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -130.29 103.33 6.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.366 -0.834 . . . . 73.3 109.323 174.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.4 t-80 -97.76 44.05 1.05 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.099 0.476 . . . . 64.41 109.944 -176.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 43.4 tp -62.0 111.1 1.78 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.482 -0.781 . . . . 64.11 111.33 -177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -149.29 132.39 16.3 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.495 -0.775 . . . . 74.21 110.064 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.686 ' HB3' ' HB ' ' A' ' 25' ' ' VAL . 12.0 tp10 -156.06 150.81 26.09 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.792 -0.818 . . . . 74.0 108.792 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -128.54 -21.02 3.53 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.102 0.408 . . . . 74.43 112.102 -172.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 18.2 t80 -119.35 29.3 7.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.338 0.59 . . . . 53.11 110.833 -177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.457 ' HB3' ' HG2' ' A' ' 21' ' ' GLU . . . -158.97 -65.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.944 -0.571 . . . . 72.1 110.131 176.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.686 ' HB ' ' HB3' ' A' ' 21' ' ' GLU . 92.0 t -67.18 147.55 12.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.462 -0.79 . . . . 65.34 110.7 175.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 101.47 -15.61 57.27 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 121.203 -0.522 . . . . 63.11 114.363 173.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.485 ' O ' HG12 ' A' ' 39' ' ' VAL . 48.1 mm-40 -63.47 129.06 38.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 117.799 0.799 . . . . 70.22 109.737 173.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.707 HG22 ' HG2' ' A' ' 38' ' ' LYS . 0.2 OUTLIER -95.2 131.43 42.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.414 0.626 . . . . 55.33 111.993 -174.235 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.475 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 38.9 pt -96.91 150.13 4.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.437 -0.801 . . . . 61.12 109.213 171.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.432 ' O ' ' HZ ' ' A' ' 128' ' ' PHE . 6.8 m -105.63 113.24 26.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.534 -0.303 . . . . 54.24 111.225 -176.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.574 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 9.6 t70 -65.13 152.1 44.41 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.891 -0.595 . . . . 55.23 109.658 175.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 116' ' ' SER . 2.4 tpt -67.35 -18.85 65.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.101 0.476 . . . . 73.15 111.454 -174.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -99.31 17.45 20.08 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.099 -0.5 . . . . 74.23 110.639 177.098 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt 68.81 84.34 0.15 Allowed 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 123.406 0.682 . . . . 74.41 111.373 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.574 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 41.1 mtmt -152.57 131.94 12.88 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.407 -0.815 . . . . 51.15 109.371 176.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 56' ' ' MET . 3.4 mp0 -89.06 127.74 35.71 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.737 0.303 . . . . 74.43 110.738 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 74.5 m95 -125.25 117.73 24.45 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.555 -0.535 . . . . 70.22 109.555 174.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.707 ' HG2' HG22 ' A' ' 28' ' ' ILE . 22.0 mtmm -78.75 130.75 36.12 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.572 -0.451 . . . . 75.42 109.88 177.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.62 HG23 ' CD2' ' A' ' 52' ' ' TYR . 3.2 p -67.38 117.5 8.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.166 -0.47 . . . . 63.02 110.431 175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.488 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -90.51 -128.93 3.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.845 -0.693 . . . . 50.32 111.841 175.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.4 mt -86.81 137.62 33.55 Favored Pre-proline 0 C--N 1.323 -0.558 0 O-C-N 122.721 -0.282 . . . . 70.23 111.049 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -72.71 102.69 1.45 Allowed 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.824 2.349 . . . . 51.31 110.331 171.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 43.6 mt -86.98 -70.54 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.903 -0.589 . . . . 74.11 110.697 -175.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.424 ' HA2' ' H ' ' A' ' 51' ' ' ILE . . . 112.25 165.7 17.3 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.667 -0.778 . . . . 72.54 111.78 -176.063 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.893 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 2.2 tt0 -131.91 166.17 22.25 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.41 -0.589 . . . . 54.14 109.41 178.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.509 ' HA3' ' OD2' ' A' ' 137' ' ' ASP . . . -82.82 42.61 2.98 Favored Glycine 0 C--O 1.232 -0.026 0 C-N-CA 121.511 -0.376 . . . . 62.31 112.959 -172.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.4 ' HA3' ' HE3' ' A' ' 352' ' ' LYS . . . 179.11 -75.06 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 109.999 -1.241 . . . . 61.42 109.999 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.512 ' HZ ' ' HA ' ' A' ' 353' ' ' THR . 24.1 m-85 -96.64 83.45 3.48 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 109.586 -0.524 . . . . 62.53 109.586 168.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.893 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -68.95 -158.38 1.5 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.901 -0.59 . . . . 74.35 113.608 177.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.405 ' HB2' ' O ' ' A' ' 49' ' ' GLY . 72.2 m 70.77 30.99 2.82 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.296 0.569 . . . . 70.4 110.806 -177.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.516 HG13 ' HB2' ' A' ' 45' ' ' GLN . 4.2 mm -93.88 122.0 44.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 109.307 -0.627 . . . . 74.53 109.307 176.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.764 ' HE1' ' HB ' ' A' ' 72' ' ' VAL . 28.3 p90 -108.2 150.43 27.26 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 120.154 -0.618 . . . . 72.51 110.879 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.589 ' HA ' HG12 ' A' ' 69' ' ' VAL . 7.9 tt -68.97 134.17 49.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.363 -0.835 . . . . 75.23 110.512 -176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.408 ' HB2' HG12 ' A' ' 70' ' ' VAL . . . -95.68 102.92 14.77 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.083 -0.508 . . . . 64.03 109.959 179.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.37 -35.9 40.1 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.882 -0.599 . . . . 71.51 111.251 -177.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.823 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 13.9 tmm? 66.17 -73.92 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 109.236 -0.654 . . . . 62.12 109.236 -172.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -159.14 140.71 13.25 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.931 -0.766 . . . . 63.15 108.931 171.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 m -81.72 49.6 1.37 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.359 0.6 . . . . 44.34 110.624 -173.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 49.3 m -152.82 26.83 0.55 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.513 -0.767 . . . . 75.43 109.951 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.539 ' CD ' ' H ' ' A' ' 61' ' ' SER . 0.6 OUTLIER -81.87 170.34 15.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.641 -0.709 . . . . 72.34 109.275 -178.605 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.539 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 21.3 t -67.93 -29.1 68.09 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.382 -0.372 . . . . 73.13 110.064 177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.479 HG21 ' HD3' ' A' ' 67' ' ' PRO . 5.1 p -82.42 143.65 11.69 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 N-CA-C 109.708 -0.479 . . . . 74.2 109.708 173.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -133.96 -46.07 0.11 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.13 -1.033 . . . . 72.14 113.137 -178.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.5 m -78.16 -56.9 4.1 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 112.083 0.401 . . . . 64.42 112.083 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.46 -63.5 1.39 Allowed 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.477 0.547 . . . . 72.14 112.477 -174.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.34 77.33 0.36 Allowed Pre-proline 0 N--CA 1.464 0.231 0 N-CA-C 109.263 -0.643 . . . . 72.52 109.263 -167.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.479 ' HD3' HG21 ' A' ' 62' ' ' VAL . 85.7 Cg_endo -80.29 32.18 0.5 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.293 2.662 . . . . 74.33 113.593 -169.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.2 p -127.52 136.69 52.09 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.529 0.681 . . . . 63.44 111.226 179.045 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.589 HG12 ' HA ' ' A' ' 53' ' ' LEU . 12.8 m -141.99 162.38 19.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.717 0 CA-C-N 115.343 -0.844 . . . . 71.31 109.282 176.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.779 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.7 OUTLIER -132.78 126.24 53.93 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-O 121.676 0.75 . . . . 51.12 111.421 -179.057 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.429 ' HE2' ' HB3' ' A' ' 48' ' ' PHE . 60.8 tttm -87.5 127.22 35.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.702 -1.136 . . . . 75.43 109.171 176.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.764 ' HB ' ' HE1' ' A' ' 52' ' ' TYR . 11.9 p -116.42 135.6 56.15 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 CA-C-O 121.014 0.435 . . . . 55.4 111.573 -176.57 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . 49.2 mm-40 -142.36 143.4 26.9 Favored Pre-proline 0 C--N 1.323 -0.586 0 CA-C-N 115.524 -0.762 . . . . 74.31 109.072 173.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HB2' ' HB2' ' A' ' 77' ' ' ASN . 37.6 Cg_exo -60.49 133.01 46.32 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 121.52 1.48 . . . . 75.32 109.978 170.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 10.0 t -60.09 -30.39 69.21 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.788 0.328 . . . . 75.32 110.896 -175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -101.74 24.22 10.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.317 -0.401 . . . . 63.54 111.097 -179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.535 ' HB2' ' HB2' ' A' ' 74' ' ' PRO . 63.3 t30 -85.98 -50.19 7.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.913 0.387 . . . . 73.0 110.223 177.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 147.85 -77.67 0.24 Allowed Glycine 0 CA--C 1.519 0.324 0 C-N-CA 120.378 -0.915 . . . . 52.15 113.65 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.95 -43.31 59.25 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.268 2.645 . . . . 34.34 114.295 -169.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.01 -29.93 67.62 Favored 'General case' 0 C--O 1.222 -0.365 0 N-CA-C 111.957 0.354 . . . . 73.44 111.957 -171.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -66.02 -50.76 63.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.429 -0.508 . . . . 73.41 110.504 -177.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.0 m -69.06 -40.18 78.67 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.489 0.662 . . . . 71.45 110.005 177.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -59.73 -53.71 54.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.803 -1.089 . . . . 72.13 111.074 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.472 ' HB2' HD13 ' A' ' 80' ' ' LEU . 51.7 tp -66.24 -33.03 74.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.029 -0.532 . . . . 72.52 111.074 -177.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.474 ' HE3' ' OH ' ' A' ' 173' ' ' TYR . 64.8 tttp -60.01 -47.34 86.22 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-O 121.011 0.434 . . . . 75.14 110.096 177.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.432 ' HE1' ' HB2' ' A' ' 173' ' ' TYR . 59.0 t80 -71.19 -41.62 70.08 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 73.05 110.361 178.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -57.32 -50.23 73.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.996 -0.547 . . . . 63.43 110.838 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.49 -24.41 63.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.109 0.48 . . . . 74.1 110.533 -178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -69.7 -39.16 77.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.025 -0.534 . . . . 71.24 111.597 176.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -107.44 -34.09 7.16 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 113.228 0.825 . . . . 75.22 113.228 -171.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.55 ' HB1' ' HB2' ' A' ' 113' ' ' TYR . . . -85.77 100.39 12.0 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.548 0.689 . . . . 73.14 111.819 -172.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 5.6 tmtm? -166.75 100.41 0.66 Allowed Pre-proline 0 C--N 1.32 -0.71 0 N-CA-C 108.388 -0.968 . . . . 71.24 108.388 177.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -43.07 -45.33 9.43 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.78 2.987 . . . . 74.35 114.042 -172.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -62.74 -49.68 74.07 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.36 -0.382 . . . . 74.32 110.959 -178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.47 -38.74 87.97 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 72.51 110.621 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.516 ' O ' HG13 ' A' ' 100' ' ' ILE . 81.0 mt -58.13 -53.29 47.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.727 -0.669 . . . . 74.34 110.879 179.367 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 79.0 mt-30 -62.1 -40.78 97.01 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.515 -0.311 . . . . 74.52 111.248 -178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -57.06 -48.98 77.24 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.341 -0.39 . . . . 64.24 110.877 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.565 ' CE2' ' HG3' ' A' ' 103' ' ' ARG . 66.0 t-105 -65.24 -49.01 71.3 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.918 -0.583 . . . . 74.33 110.711 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.516 HG13 ' O ' ' A' ' 96' ' ' ILE . 94.4 mt -53.52 -51.29 43.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 CA-C-O 121.137 0.494 . . . . 75.4 111.519 -177.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 23.0 ttm180 -73.72 -31.21 63.28 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.51 -0.768 . . . . 73.42 111.226 -172.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 56.3 m -76.17 -40.09 53.3 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.02 0.438 . . . . 54.14 111.238 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.565 ' HG3' ' CE2' ' A' ' 99' ' ' TRP . 11.1 mmm180 -91.8 10.0 30.34 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.326 -0.397 . . . . 72.55 111.915 -173.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.445 ' HA ' ' HE2' ' A' ' 104' ' ' LYS . 11.7 mmpt? 63.58 27.25 14.92 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.268 -0.423 . . . . 74.3 111.617 173.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.476 ' HB3' ' OD1' ' A' ' 163' ' ' ASP . 97.7 mt -89.11 178.36 6.4 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.977 0.418 . . . . 65.23 111.438 -174.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -83.32 -66.95 0.83 Allowed 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 108.964 -0.754 . . . . 73.13 108.964 172.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.411 ' HA ' ' CD1' ' A' ' 100' ' ' ILE . 18.7 p90 179.87 133.71 0.1 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.728 -1.124 . . . . 74.32 109.541 176.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.449 ' HG ' HG23 ' A' ' 96' ' ' ILE . 0.2 OUTLIER -78.74 116.14 18.9 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.54 -0.541 . . . . 74.3 109.54 177.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -74.93 72.19 1.61 Allowed Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.749 -0.659 . . . . 74.42 112.904 -176.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.417 HG13 ' HD2' ' A' ' 111' ' ' PRO . 67.4 t -101.99 140.33 21.09 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 108.755 -0.831 . . . . 64.54 108.755 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.417 ' HD2' HG13 ' A' ' 110' ' ' VAL . 1.3 Cg_endo -44.88 134.33 10.57 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.199 2.599 . . . . 73.11 112.443 179.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.89 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 21.4 tptm -65.4 106.23 1.34 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.726 -0.67 . . . . 73.11 110.693 -179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.55 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 35.1 t80 -79.85 113.8 18.28 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 114.726 -1.125 . . . . 74.4 111.184 177.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.465 ' CD1' HG22 ' A' ' 130' ' ' ILE . 15.0 m95 -97.94 -36.23 10.21 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.467 -0.938 . . . . 75.33 108.467 170.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.49 178.25 48.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.724 -1.125 . . . . 64.43 111.115 -177.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.407 ' O ' ' HB2' ' A' ' 32' ' ' MET . 14.9 p -172.68 165.42 5.42 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.481 -0.563 . . . . 71.4 109.481 -179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 174.09 -173.81 46.09 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 119.92 -1.134 . . . . 53.34 113.103 176.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.8 tt -134.93 128.68 32.99 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.44 -0.948 . . . . 75.31 108.44 179.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -140.89 125.62 18.0 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.881 0.372 . . . . 73.55 110.566 -178.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.24 123.92 26.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.87 -0.605 . . . . 64.34 110.098 175.273 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.8 tmtt? -87.93 -56.97 3.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.222 -0.444 . . . . 70.32 110.277 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -159.05 79.93 0.77 Allowed 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.288 -0.634 . . . . 73.35 109.288 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 66.19 33.52 85.45 Favored Glycine 0 N--CA 1.45 -0.382 0 N-CA-C 111.169 -0.773 . . . . 73.4 111.169 -177.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.449 ' HE2' ' HB2' ' A' ' 124' ' ' LYS . 13.6 tppt? -158.91 105.0 1.76 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.498 -0.556 . . . . 74.53 109.498 -174.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.491 ' HB3' HD21 ' A' ' 118' ' ' LEU . 25.3 m -78.85 108.73 12.52 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.038 0.447 . . . . 64.15 111.07 -177.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 63.9 m-85 -92.05 131.75 37.08 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.053 -0.521 . . . . 73.43 110.555 177.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.466 ' HE ' HD23 ' A' ' 84' ' ' LEU . 10.0 ttt180 -113.24 117.15 31.07 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.507 -0.923 . . . . 72.54 108.507 -178.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.432 ' HZ ' ' O ' ' A' ' 30' ' ' THR . 49.0 p90 -133.44 161.62 34.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.068 0.461 . . . . 73.22 112.057 -169.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 24.4 ptp -139.46 141.65 37.42 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.65 -0.704 . . . . 53.43 110.55 177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.779 HD13 ' HB ' ' A' ' 70' ' ' VAL . 11.2 mm -98.31 118.56 45.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.142 0.496 . . . . 63.32 110.312 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.482 ' HA ' ' O ' ' A' ' 112' ' ' LYS . 21.6 ptm -127.72 163.68 23.78 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.674 -0.694 . . . . 71.25 110.509 -175.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.89 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 7.9 t70 -70.35 156.85 38.75 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 109.718 -0.475 . . . . 71.52 109.718 178.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.442 ' HA ' ' HD2' ' A' ' 133' ' ' ARG . 22.3 tpt180 -82.81 108.52 16.22 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.388 0.614 . . . . 74.44 111.31 -176.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.642 ' HD1' ' HA ' ' A' ' 186' ' ' ASN . 17.0 m-85 -103.26 142.27 34.48 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.062 -1.088 . . . . 75.41 108.062 172.689 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -133.29 -4.38 3.23 Favored Glycine 0 CA--C 1.51 -0.278 0 C-N-CA 119.583 -1.294 . . . . 65.54 113.453 -172.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.928 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.4 m -120.59 124.49 45.41 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.844 0.354 . . . . 75.34 110.295 -179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.828 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 3.9 m-20 -90.53 134.99 33.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.157 -0.474 . . . . 53.34 110.022 177.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.429 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 36.9 tp -61.83 -36.61 81.68 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.951 -0.759 . . . . 64.24 108.951 172.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.828 ' HG3' ' HB3' ' A' ' 137' ' ' ASP . 1.4 pp0? -64.64 -28.15 69.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.435 -0.802 . . . . 72.34 111.547 179.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.614 ' HG3' ' HB2' ' A' ' 137' ' ' ASP . 58.2 mttp -72.52 -39.82 67.28 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.837 -0.345 . . . . 71.04 110.629 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.6 mt -74.28 -36.9 44.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.515 0.674 . . . . 74.54 109.337 173.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.624 ' HB3' ' HA ' ' A' ' 139' ' ' GLN . 28.6 t80 -55.19 -54.27 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.738 -1.119 . . . . 74.4 111.202 178.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -74.97 -33.87 61.94 Favored 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 120.755 -0.378 . . . . 61.31 111.235 -175.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.79 -32.76 72.72 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 111.945 0.35 . . . . 60.54 111.945 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -105.1 8.68 34.31 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.913 0.387 . . . . 75.42 110.614 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.11 48.52 17.38 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 115.805 -0.634 . . . . 75.1 111.319 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.699 ' HG3' HE22 ' A' ' 253' ' ' GLN . 0.0 OUTLIER 43.67 77.53 0.06 Allowed 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 124.818 1.247 . . . . 71.14 113.749 179.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.4 ttt180 -143.63 102.97 4.02 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.751 -0.659 . . . . 74.23 109.269 168.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.691 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 65.9 m-85 -108.76 156.1 20.0 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.996 -0.547 . . . . 70.13 109.884 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 8.2 t -70.59 156.88 38.86 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.319 -0.4 . . . . 74.01 110.585 -176.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.6 ' HG2' HD13 ' A' ' 331' ' ' ILE . 25.0 tpt180 -45.99 -57.28 4.55 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.547 -0.752 . . . . 73.35 112.144 -178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.1 mtpt -67.27 -28.1 67.75 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 75.0 111.514 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 6.9 m -70.94 -45.19 64.62 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.442 -0.345 . . . . 61.02 110.571 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.84 -43.66 97.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.244 -0.435 . . . . 53.43 110.585 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 324' ' ' LEU . 0.2 OUTLIER -65.02 -42.87 93.99 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 72.52 110.325 -178.986 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 6.8 tm0? -55.21 -52.57 62.93 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 109.773 -0.454 . . . . 72.43 109.773 179.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 10.8 mp -59.24 -50.65 73.18 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.936 -0.575 . . . . 65.24 111.125 179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.452 ' HA ' HD12 ' A' ' 161' ' ' ILE . 32.1 t -57.93 -38.05 75.21 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.279 -0.419 . . . . 55.35 111.241 -177.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 4.1 tt -69.81 -40.86 75.68 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.856 -0.424 . . . . 64.21 109.856 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.593 ' HA ' ' OD2' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -67.42 -31.4 71.58 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.787 0.803 . . . . 63.22 110.307 -178.916 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.452 HD12 ' HA ' ' A' ' 158' ' ' SER . 58.4 mt -67.92 -35.14 71.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.591 -0.731 . . . . 71.15 109.695 174.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.418 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 43.4 tp -63.84 -40.48 96.68 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.101 -0.499 . . . . 55.22 110.088 176.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.593 ' OD2' ' HA ' ' A' ' 160' ' ' ARG . 31.4 m-20 -53.34 -59.52 4.47 Favored 'General case' 0 C--O 1.239 0.539 0 CA-C-O 121.491 0.663 . . . . 65.13 110.895 176.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.49 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -67.11 -37.35 79.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 CA-C-N 115.856 -0.611 . . . . 65.01 111.101 -176.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 51.5 tp -63.66 -37.94 89.23 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.72 0.295 . . . . 74.2 110.296 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.418 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -56.09 -58.81 6.34 Favored 'General case' 0 C--O 1.242 0.702 0 CA-C-N 115.87 -0.605 . . . . 74.12 109.46 178.126 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.5 -48.98 73.75 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 114.859 -1.064 . . . . 74.22 112.572 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 164' ' ' ILE . 39.7 pt -84.19 -36.52 12.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 112.605 0.594 . . . . 63.23 112.605 -170.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -82.34 -26.17 33.21 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 71.35 112.144 -169.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -68.37 -18.46 64.47 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 119.75 -0.78 . . . . 65.21 110.048 175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 53.3 m80 -101.9 -74.75 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.884 -0.598 . . . . 70.22 112.346 -175.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -135.86 -68.71 0.5 Allowed 'General case' 0 C--O 1.235 0.329 0 N-CA-C 113.145 0.794 . . . . 74.52 113.145 -167.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 203' ' ' ARG . 79.6 m-85 -84.99 167.26 16.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.488 0.922 . . . . 72.32 113.488 -161.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.507 HG21 ' HG2' ' A' ' 238' ' ' PRO . 27.4 m -142.21 172.18 9.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 114.065 -1.425 . . . . 71.13 109.48 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -158.64 96.21 1.37 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.612 -0.514 . . . . 72.43 109.612 173.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.491 ' O ' HD13 ' A' ' 246' ' ' ILE . . . -67.49 -33.61 82.04 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.116 -0.564 . . . . 74.52 112.389 -178.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.544 ' HB2' ' CA ' ' A' ' 223' ' ' GLY . 20.6 t70 -74.57 91.56 2.32 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.141 0.496 . . . . 74.34 111.315 177.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 46.7 mm -97.04 67.25 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 122.038 0.923 . . . . 70.5 108.955 171.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.432 ' HZ2' ' HB2' ' A' ' 179' ' ' LYS . 3.7 ttmp? -88.27 139.14 30.8 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 114.99 -1.005 . . . . 60.42 109.222 177.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.429 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -56.17 -16.68 5.59 Favored 'General case' 0 N--CA 1.467 0.382 0 N-CA-C 112.314 0.487 . . . . 75.13 112.314 -179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.631 ' HA ' ' HG2' ' A' ' 139' ' ' GLN . 29.8 t -68.9 -15.73 63.57 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.331 -0.395 . . . . 72.11 111.431 178.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.436 ' O ' HD12 ' A' ' 195' ' ' LEU . 84.5 m-20 -92.21 -11.74 34.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.724 0.297 . . . . 75.42 111.584 -175.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.427 ' C ' HD22 ' A' ' 184' ' ' LEU . 6.4 mp -100.49 119.47 38.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.091 0.472 . . . . 74.5 110.493 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.4 mm? -119.03 140.59 49.78 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.682 -0.69 . . . . 73.43 110.61 -176.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.928 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 69.2 mt -97.87 142.82 29.16 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.989 -0.55 . . . . 74.11 110.339 179.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.642 ' HA ' ' HD1' ' A' ' 134' ' ' PHE . 0.1 OUTLIER -61.48 136.75 58.14 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.981 -0.554 . . . . 75.53 110.042 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 77.7 t80 -56.17 -31.27 63.26 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 120.832 0.348 . . . . 62.22 111.627 -178.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.7 ' HA ' ' HE3' ' A' ' 188' ' ' LYS . 0.0 OUTLIER -90.97 -22.58 20.76 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 111.959 0.355 . . . . 64.32 111.959 -179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -138.42 110.21 8.2 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 111.888 0.329 . . . . 64.41 111.888 -170.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_exo -70.57 -12.94 32.14 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.73 2.286 . . . . 73.32 111.252 173.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.992 ' HA ' ' HB2' ' A' ' 339' ' ' LEU . 7.4 p-10 -90.49 7.39 39.18 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.369 -0.832 . . . . 44.1 111.153 -177.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.442 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 16.7 mm-40 -121.84 106.78 11.59 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.251 -0.431 . . . . 62.13 110.76 179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -106.2 122.11 59.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.463 0.649 . . . . 75.33 110.813 -179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . . . . . . . . . 55.4 m-85 -114.75 157.44 23.2 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.866 -0.606 . . . . 75.24 109.922 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.436 HD12 ' O ' ' A' ' 182' ' ' ASN . 34.1 tp -107.53 103.3 12.59 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.222 -0.658 . . . . 73.05 109.222 176.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.471 HG22 HD23 ' A' ' 184' ' ' LEU . 32.7 m -120.77 -167.6 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.497 -0.319 . . . . 62.14 110.487 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 196' ' ' VAL . 4.2 m-20 70.66 -62.13 0.45 Allowed 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.816 0.698 . . . . 63.53 110.674 -176.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 60.98 -89.73 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.486 -0.779 . . . . 74.02 111.654 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.517 ' O ' HG22 ' A' ' 354' ' ' ILE . . . 68.46 -68.34 0.39 Allowed Glycine 0 N--CA 1.447 -0.63 0 O-C-N 123.415 0.447 . . . . 74.54 112.088 -174.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 353' ' ' THR . 2.4 mp -88.26 81.07 7.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.856 0.36 . . . . 73.42 110.145 -177.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -121.73 98.02 5.76 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.144 0.497 . . . . 73.34 110.01 173.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -101.32 -164.11 1.08 Allowed 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.365 -0.976 . . . . 73.54 108.365 176.406 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 173' ' ' TYR . 9.3 ptp180 -137.75 150.62 47.41 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.559 -0.456 . . . . 62.34 111.426 -179.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -83.1 -36.74 24.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.583 -0.735 . . . . 75.41 110.412 177.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 6.6 p -134.82 129.64 19.32 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.203 -0.453 . . . . 74.22 111.198 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 9.9 Cg_exo -71.49 100.71 1.06 Allowed 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.943 2.429 . . . . 65.03 111.094 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 42.5 mm-40 71.06 -62.57 0.45 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.456 0.702 . . . . 73.21 112.053 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -154.7 -36.0 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.64 -0.791 . . . . 74.22 112.963 -178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 26.6 m -60.87 132.4 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.029 0.443 . . . . 71.0 111.683 -177.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 37.1 m80 -100.32 138.16 37.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.136 -0.483 . . . . 73.23 109.857 -179.057 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.49 ' HD2' ' HA ' ' A' ' 211' ' ' LYS . 12.6 tptm -108.33 172.63 6.73 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 121.131 0.491 . . . . 75.15 112.311 -167.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -90.96 174.19 7.56 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 115.505 -0.771 . . . . 70.21 111.019 -175.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.409 ' HA ' HG21 ' A' ' 236' ' ' VAL . 0.3 OUTLIER -73.19 6.27 2.92 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.972 0.731 . . . . 73.4 112.972 -168.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 23.3 ttmm -166.5 96.78 0.57 Allowed 'General case' 0 C--N 1.321 -0.631 0 O-C-N 121.71 -0.619 . . . . 71.3 110.633 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.455 ' OE1' ' HG2' ' A' ' 211' ' ' LYS . 0.0 OUTLIER -136.24 -4.14 2.15 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.377 -0.829 . . . . 64.43 110.859 178.238 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.489 ' OD1' ' HD2' ' A' ' 217' ' ' PRO . 10.6 t70 -79.05 148.01 70.84 Favored Pre-proline 0 C--N 1.324 -0.514 0 CA-C-N 115.823 -0.626 . . . . 65.13 110.774 -174.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.761 ' O ' ' HB2' ' A' ' 218' ' ' LYS . 69.6 Cg_exo -54.79 1.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 124.32 3.347 . . . . 60.13 114.928 176.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' A' ' 217' ' ' PRO . 0.0 OUTLIER 112.83 100.37 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.748 1.619 . . . . 72.12 110.941 172.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.476 ' CZ ' ' HB3' ' A' ' 218' ' ' LYS . 0.0 OUTLIER 69.71 92.21 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.227 -0.897 . . . . 74.11 111.505 177.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.488 ' H ' ' HA2' ' A' ' 235' ' ' GLY . 7.7 p -86.85 -30.45 21.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.946 -0.39 . . . . 55.33 109.946 176.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 29.1 m80 73.89 -58.08 0.6 Allowed 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 124.086 0.954 . . . . 74.32 111.704 174.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 30.4 t70 37.57 74.58 0.08 Allowed 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.912 0.885 . . . . 72.55 111.785 -171.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.544 ' CA ' ' HB2' ' A' ' 177' ' ' ASP . . . 110.52 174.82 20.49 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.723 -0.751 . . . . 61.34 112.459 178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -75.39 141.63 43.22 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.669 0.271 . . . . 70.01 110.622 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.574 HD11 HG21 ' A' ' 271' ' ' VAL . 15.4 tt -58.36 -17.06 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 CA-C-O 121.355 0.598 . . . . 73.35 111.323 -178.299 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -50.49 -55.52 15.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.921 -1.036 . . . . 74.31 111.603 177.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.577 ' O ' HG12 ' A' ' 246' ' ' ILE . 38.9 m-85 -111.24 -28.11 8.39 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 113.071 0.767 . . . . 70.15 113.071 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.519 HG22 ' HA ' ' A' ' 225' ' ' ILE . 5.8 t -64.98 -6.4 8.44 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 112.758 0.651 . . . . 71.54 112.758 -169.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.781 ' HA ' ' HE2' ' A' ' 275' ' ' LYS . 23.0 t 65.0 -169.85 0.2 Allowed 'General case' 0 CA--C 1.531 0.227 0 CA-C-O 121.138 0.494 . . . . 73.35 111.393 176.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.465 ' O ' ' HB3' ' A' ' 234' ' ' ASN . 15.3 pt -73.34 -34.35 43.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.795 -0.639 . . . . 73.31 111.684 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' O ' HG12 ' A' ' 236' ' ' VAL . 11.7 t70 -53.82 -74.88 0.03 OUTLIER 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.658 -0.701 . . . . 74.25 111.827 -170.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -36.78 85.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.958 0.409 . . . . 70.44 111.616 -176.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.867 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 57.6 t-80 -62.7 -27.53 69.31 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.603 -0.271 . . . . 70.15 111.62 -177.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.465 ' HB3' ' O ' ' A' ' 230' ' ' ILE . 0.0 OUTLIER -78.41 -28.81 46.93 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 111.859 0.318 . . . . 54.4 111.859 -175.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.488 ' HA2' ' H ' ' A' ' 220' ' ' CYS . . . 112.37 45.65 0.78 Allowed Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.346 -0.931 . . . . 63.55 112.848 -177.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.504 HG12 ' O ' ' A' ' 231' ' ' ASP . 15.0 p -123.44 143.27 37.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.0 -0.741 . . . . 72.32 109.0 171.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -53.25 110.72 2.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 108.676 -0.861 . . . . 73.34 108.676 168.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.507 ' HG2' HG21 ' A' ' 174' ' ' VAL . 69.6 Cg_exo -41.97 115.18 0.43 Allowed 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 123.772 2.981 . . . . 75.54 113.561 -169.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 93.9 p -90.83 -175.54 4.4 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.248 -0.887 . . . . 71.35 111.163 -173.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.878 ' HG2' ' HB3' ' A' ' 315' ' ' PRO . 9.8 mtm-85 -53.94 -36.69 63.06 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 115.534 -0.757 . . . . 71.25 111.248 177.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.481 HH22 ' HD2' ' A' ' 279' ' ' ARG . 12.3 mtp180 -66.27 -33.56 76.01 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.797 -0.638 . . . . 75.4 110.498 -178.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.41 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -57.43 -65.1 3.8 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.881 -0.676 . . . . 70.3 111.84 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -54.16 -48.1 71.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.34 0.59 . . . . 70.2 110.758 -176.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.678 ' HG ' HD21 ' A' ' 320' ' ' LEU . 9.2 mp -67.95 -46.02 72.6 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.169 -0.923 . . . . 75.22 112.045 -173.496 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -64.43 -47.08 80.46 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.611 -0.435 . . . . 70.44 110.789 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 227' ' ' PHE . 76.0 mt -61.45 -40.11 85.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.347 -0.388 . . . . 65.53 111.425 -176.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.415 ' O ' ' HG3' ' A' ' 251' ' ' MET . 37.9 tp -64.23 -45.12 89.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.729 0.299 . . . . 75.53 110.217 178.05 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.15 -38.64 95.93 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.906 -0.664 . . . . 74.23 112.081 176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.458 ' O ' ' HB2' ' A' ' 253' ' ' GLN . 14.8 m-30 -56.26 -45.84 79.9 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.782 0.325 . . . . 73.04 110.812 176.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 36.5 m -67.82 -35.22 78.22 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.093 -0.503 . . . . 73.14 110.892 -177.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 83.8 mtp -59.47 -54.54 45.47 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-O 120.737 0.303 . . . . 75.25 110.988 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 10.6 tt -67.8 -32.06 54.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.495 -0.32 . . . . 74.53 110.45 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.699 HE22 ' HG3' ' A' ' 147' ' ' LYS . 9.5 tm0? -61.58 -53.59 54.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.025 -0.534 . . . . 74.22 110.364 -179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.691 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 27.8 m0 -69.45 -26.42 64.58 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.143 -0.481 . . . . 75.3 111.662 -177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.547 HD11 HD21 ' A' ' 294' ' ' ASN . 33.4 tp -83.87 -36.22 23.58 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.203 0.446 . . . . 74.13 112.203 -176.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.5 p -103.49 -27.4 12.4 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.688 -0.405 . . . . 61.21 112.058 -175.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.615 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 98.79 -1.35 58.09 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.429 -0.891 . . . . 63.0 113.272 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 86.8 m-70 -148.12 163.16 37.79 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.178 0.513 . . . . 74.04 111.691 -178.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.664 ' HG ' ' HG2' ' A' ' 253' ' ' GLN . 60.2 mt -111.87 142.48 26.78 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.202 -0.908 . . . . 74.44 109.649 169.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.47 -25.68 59.38 Favored 'Trans proline' 0 CA--C 1.53 0.282 0 C-N-CA 122.615 2.21 . . . . 64.52 112.601 177.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.446 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 48.0 p90 -111.65 18.94 18.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.353 -0.385 . . . . 73.43 110.771 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.412 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 35.3 tt0 -66.03 -44.5 84.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.258 0.551 . . . . 72.21 110.467 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -77.96 -6.72 55.34 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.97 0.891 . . . . 70.23 109.552 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.643 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -104.62 0.8 28.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.097 -0.956 . . . . 74.22 111.227 -177.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 261' ' ' TRP . 80.5 mt -71.33 -6.9 43.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.12 0.486 . . . . 55.23 110.885 179.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 14.7 ptmm? -60.91 -33.4 73.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.483 -0.781 . . . . 44.24 111.332 177.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.734 ' HB2' ' CD1' ' A' ' 270' ' ' TYR . 7.8 m-20 -145.33 145.82 27.89 Favored Pre-proline 0 CA--C 1.519 -0.23 0 CA-C-O 120.541 0.21 . . . . 34.14 110.534 -177.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.66 ' O ' ' HG3' ' A' ' 272' ' ' ARG . 25.3 Cg_endo -62.92 -28.09 75.09 Favored 'Trans proline' 0 N--CA 1.464 -0.251 0 C-N-CA 122.61 2.207 . . . . 53.31 112.002 177.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.48 -42.49 96.39 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.202 0.525 . . . . 73.13 109.719 179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.734 ' CD1' ' HB2' ' A' ' 267' ' ' ASP . 9.5 m-85 -66.67 -45.33 79.23 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.554 -0.748 . . . . 74.31 111.31 -176.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.574 HG21 HD11 ' A' ' 225' ' ' ILE . 20.3 m -65.03 -29.16 46.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.535 -0.302 . . . . 60.25 111.225 -178.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.66 ' HG3' ' O ' ' A' ' 268' ' ' PRO . 33.7 mtm180 -60.62 -58.61 7.75 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 109.096 -0.705 . . . . 75.32 109.096 172.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -52.26 -50.55 61.87 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-N 114.859 -1.064 . . . . 63.42 111.018 -178.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 50.3 m -59.6 -50.33 74.3 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.953 -0.567 . . . . 72.13 111.463 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.781 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 59.7 mttp -66.36 -44.49 83.06 Favored 'General case' 0 C--O 1.22 -0.458 0 C-N-CA 120.879 -0.329 . . . . 74.42 111.376 -175.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 76.7 mt -64.5 -48.34 85.42 Favored 'Isoleucine or valine' 0 C--O 1.24 0.586 0 CA-C-O 120.812 0.339 . . . . 74.53 110.935 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 37.4 ttp-105 -54.71 -50.09 69.15 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.592 -0.731 . . . . 74.21 110.776 -178.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -74.21 -39.07 63.38 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.184 -0.462 . . . . 74.53 111.581 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.481 ' HD2' HH22 ' A' ' 241' ' ' ARG . 52.2 ttp180 -50.44 -40.34 50.15 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 122.542 0.337 . . . . 72.24 111.792 -176.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -70.28 -36.15 74.2 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.297 0.48 . . . . 75.51 112.297 -178.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -129.19 38.57 3.89 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-O 120.795 0.331 . . . . 74.12 111.663 -170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.639 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.91 -50.87 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 113.115 0.783 . . . . 45.32 113.115 -176.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.538 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -58.07 -47.77 82.16 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.149 0.426 . . . . 73.02 112.149 -172.387 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -68.25 -44.4 75.71 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.011 0.434 . . . . 73.22 111.204 -176.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.429 HD13 ' HA ' ' A' ' 285' ' ' LEU . 4.3 mm? -67.25 -50.98 58.49 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.04 -0.527 . . . . 72.35 111.431 -178.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -60.87 -40.54 93.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.841 0.353 . . . . 71.3 111.193 -176.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -63.64 -42.31 98.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.106 -0.497 . . . . 74.14 111.23 -178.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -81.8 -15.72 53.29 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.614 -0.266 . . . . 74.4 111.674 -175.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.6 m -72.89 -28.08 62.27 Favored 'General case' 0 C--N 1.33 -0.281 0 O-C-N 122.29 -0.256 . . . . 64.51 111.217 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.458 ' CE1' ' HB3' ' A' ' 294' ' ' ASN . 3.9 t80 -128.69 86.63 57.06 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 71.21 110.518 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -94.91 24.93 0.35 Allowed 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 123.389 2.726 . . . . 62.41 113.011 -179.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.403 ' HG2' ' H ' ' A' ' 293' ' ' LYS . 8.1 tt0 -100.38 -166.69 1.35 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.376 -0.602 . . . . 71.51 109.376 -177.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.428 ' HD3' ' HA ' ' A' ' 293' ' ' LYS . 31.0 mmtp -81.29 62.44 5.21 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.457 0.646 . . . . 64.32 111.583 -178.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.547 HD21 HD11 ' A' ' 255' ' ' LEU . 38.7 t-20 -157.11 128.91 7.1 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.368 -1.345 . . . . 73.51 107.368 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 45.3 tptt -100.87 106.08 41.94 Favored Pre-proline 0 C--N 1.321 -0.655 0 C-N-CA 121.176 -0.209 . . . . 75.01 111.305 -170.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 93.6 Cg_endo -93.6 38.17 0.2 Allowed 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.899 2.399 . . . . 74.55 111.967 178.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -73.39 -42.34 42.06 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.077 -0.582 . . . . 72.44 111.972 -176.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.3 pm0 -66.44 -35.84 81.29 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.821 -0.19 . . . . 64.54 110.527 178.246 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.451 HG13 ' OE2' ' A' ' 298' ' ' GLU . 44.3 mt -67.79 -46.96 81.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.033 0.444 . . . . 62.12 110.509 177.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.538 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -60.67 -39.91 90.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.815 -0.629 . . . . 63.2 110.537 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.525 ' HD3' HD11 ' A' ' 323' ' ' ILE . 85.3 tttt -80.58 -28.79 37.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.337 -0.392 . . . . 74.5 110.785 -178.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 33.2 t80 -55.71 -50.2 70.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.207 0.527 . . . . 73.55 109.897 174.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.441 ' HA ' HG22 ' A' ' 306' ' ' VAL . 95.2 mmm -70.54 -34.57 72.41 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.598 -0.728 . . . . 72.21 110.711 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.408 ' HA ' HD11 ' A' ' 282' ' ' ILE . 0.3 OUTLIER -61.67 -42.2 98.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.808 0.813 . . . . 65.33 109.384 175.477 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.536 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 59.9 m -61.81 -51.38 68.5 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.927 -1.033 . . . . 33.44 111.488 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 16.3 m -67.75 -27.85 39.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.494 -0.321 . . . . 73.45 111.582 -174.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.56 -25.54 33.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.871 0.367 . . . . 65.02 110.212 -179.629 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 27.5 tp -86.96 -16.01 37.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.915 -0.584 . . . . 75.23 111.036 -178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 305' ' ' THR . 80.0 mt -68.97 -101.82 0.0 OUTLIER 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.499 -0.319 . . . . 75.32 111.06 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.612 ' HB3' ' HB3' ' A' ' 313' ' ' GLU . 24.3 t70 166.82 164.92 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 108.994 -0.743 . . . . 73.54 108.994 -178.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -63.5 -37.04 85.78 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.976 0.417 . . . . 75.31 110.576 173.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.473 ' HA ' ' NH2' ' A' ' 240' ' ' ARG . 0.2 OUTLIER -105.99 -26.27 11.74 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.015 -0.539 . . . . 54.3 112.336 -171.765 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.612 ' HB3' ' HB3' ' A' ' 310' ' ' ASP . 5.3 tp10 -92.83 112.51 24.5 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.277 0.843 . . . . 72.2 113.277 -168.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.525 ' HG2' ' OE1' ' A' ' 313' ' ' GLU . 39.8 mmtm 68.42 105.34 0.03 OUTLIER Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 115.529 1.677 . . . . 73.35 115.529 162.013 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.878 ' HB3' ' HG2' ' A' ' 240' ' ' ARG . 94.7 Cg_endo -93.6 116.78 0.29 Allowed 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 122.101 1.867 . . . . 71.32 109.02 156.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.579 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.1 tp -126.04 98.48 5.52 Favored 'General case' 0 C--N 1.317 -0.828 0 C-N-CA 120.125 -0.63 . . . . 61.02 111.111 -171.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.418 ' HD1' HD11 ' A' ' 162' ' ' LEU . 74.6 m-85 -64.63 -35.45 81.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.549 -0.75 . . . . 70.32 110.735 -178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.36 -42.96 82.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.684 0.624 . . . . 75.23 112.684 -175.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.579 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 26.5 t-20 -60.64 -43.72 97.22 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.109 0.48 . . . . 61.11 109.795 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.678 HD21 ' HG ' ' A' ' 244' ' ' LEU . 6.7 mp -69.11 -42.2 76.41 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.393 -0.821 . . . . 63.23 110.189 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 6.9 tmm_? -58.62 -49.48 77.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.658 -0.701 . . . . 73.34 110.347 178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -69.25 -29.19 67.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.164 -0.471 . . . . 70.3 110.285 -178.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.525 HD11 ' HD3' ' A' ' 301' ' ' LYS . 0.3 OUTLIER -63.91 -43.16 97.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.04 -0.527 . . . . 72.11 110.186 176.364 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 87.9 mt -70.11 -45.93 65.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 62.54 111.095 -176.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.499 HD13 HD12 ' A' ' 328' ' ' LEU . 4.5 mm? -64.28 -32.75 74.47 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.666 178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -61.82 -45.15 95.1 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.448 . . . . 73.13 110.241 176.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -63.38 -33.26 86.75 Favored Glycine 0 N--CA 1.451 -0.34 0 CA-C-N 115.888 -0.597 . . . . 75.01 112.217 179.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.499 HD12 HD13 ' A' ' 325' ' ' LEU . 96.6 mt -69.82 -44.15 70.56 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.087 0.47 . . . . 73.24 110.263 176.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.56 -27.3 69.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 74.54 111.187 178.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -62.28 -33.0 73.79 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.26 -0.427 . . . . 75.11 111.615 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.6 HD13 ' HG2' ' A' ' 151' ' ' ARG . 48.4 pt -97.04 -2.98 10.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.808 0.337 . . . . 70.03 111.181 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 87.78 25.43 32.37 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.613 -0.803 . . . . 55.1 113.587 175.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 59.8 m -138.37 170.53 15.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 117.151 0.476 . . . . 64.01 110.553 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.491 ' O ' HD13 ' A' ' 328' ' ' LEU . 96.2 mttt -124.99 -85.64 0.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 110.024 -0.362 . . . . 71.35 110.024 173.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -127.12 150.73 49.35 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.59 -0.522 . . . . 73.52 109.59 -177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -86.01 -20.56 28.66 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.932 0.396 . . . . 52.24 110.672 -178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 92.4 -6.33 77.98 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.93 -0.652 . . . . 73.13 112.235 -179.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 19.0 pttm -155.04 175.0 14.38 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.81 -0.441 . . . . 70.42 109.81 -178.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.992 ' HB2' ' HA ' ' A' ' 191' ' ' ASP . 43.7 mt -88.4 135.13 33.61 Favored 'General case' 0 N--CA 1.449 -0.477 0 N-CA-C 109.222 -0.658 . . . . 74.32 109.222 166.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -95.93 19.08 12.04 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.74 0.781 . . . . 73.52 109.534 -173.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 90.3 mt -76.1 97.96 4.22 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.999 -1.0 . . . . 73.2 111.086 -179.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 13.9 m -86.69 109.46 19.22 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 108.67 -0.863 . . . . 51.31 108.67 170.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 6.0 m -62.76 84.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 121.562 0.696 . . . . 75.12 111.738 178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.62 HG12 ' HG3' ' A' ' 345' ' ' GLU . 96.4 t -66.11 -53.7 34.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.275 -0.875 . . . . 73.34 110.244 177.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.62 ' HG3' HG12 ' A' ' 344' ' ' VAL . 42.8 mt-10 -150.64 -170.11 3.57 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.363 -0.835 . . . . 65.12 110.298 -176.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 3.2 p-10 -129.25 158.52 38.83 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.157 -0.474 . . . . 71.45 111.078 -177.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 140' ' ' LYS . . . -139.5 -165.36 10.24 Favored Glycine 0 N--CA 1.453 -0.228 0 N-CA-C 111.009 -0.837 . . . . 43.41 111.009 177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -149.14 72.45 0.3 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.031 -1.081 . . . . 72.23 113.605 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.2 tt -114.87 107.19 15.08 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.237 -0.653 . . . . 54.54 109.237 176.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 52.1 pttt -128.9 -127.35 0.22 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.3 -0.409 . . . . 71.54 111.378 -174.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 74.95 104.19 0.07 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.683 0.793 . . . . 73.33 111.754 179.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.4 ' HE3' ' HA3' ' A' ' 47' ' ' GLY . 17.8 ptpt -164.86 147.36 8.31 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.477 -0.783 . . . . 63.41 109.979 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.583 ' O ' ' HG ' ' A' ' 200' ' ' LEU . 13.5 t -176.01 164.18 2.79 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 110.056 -0.35 . . . . 53.5 110.056 176.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -67.14 142.02 17.15 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.885 0.374 . . . . 63.52 111.069 -176.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 6.2 t -94.78 76.0 3.66 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.85 0.833 . . . . 71.42 110.587 176.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 356' ' ' LYS . 15.5 ptmt -98.9 129.07 45.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.037 -0.529 . . . . 74.04 110.248 177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -143.31 -38.03 0.34 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.265 -0.425 . . . . 51.33 111.637 179.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.455 ' O ' ' HD2' ' A' ' 358' ' ' ARG . 0.4 OUTLIER -96.56 51.9 1.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.157 0.503 . . . . 71.52 110.546 -177.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -175.68 120.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.545 -0.752 . . . . 71.32 109.949 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.482 ' NZ ' ' HB3' ' A' ' 360' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.248 0.978 0 CA-C-O 118.661 -0.685 . . . . 65.5 109.731 174.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.609 ' HB3' ' HD2' ' A' ' 2' ' ' PRO . 97.7 mmm . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 109.957 -0.386 . . . . 62.22 109.957 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.609 ' HD2' ' HB3' ' A' ' 1' ' ' MET . 16.6 Cg_endo -57.9 146.13 87.93 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.719 2.279 . . . . 74.23 112.388 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 7.8 mmt85 -137.56 108.98 6.9 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.881 -0.6 . . . . 62.44 110.984 -179.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 50.7 t -72.11 120.8 21.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.883 -0.599 . . . . 70.0 109.772 177.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 20.0 pttt -122.41 105.7 10.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 73.2 111.304 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -157.16 93.88 1.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.252 -0.885 . . . . 60.33 109.81 178.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -105.47 7.63 33.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.004 -0.544 . . . . 64.34 111.595 -176.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -84.71 121.28 27.44 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.46 -0.337 . . . . 75.12 110.483 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -159.12 109.29 1.97 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.076 -0.511 . . . . 73.1 110.673 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -151.92 125.36 1.83 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.968 -0.634 . . . . 75.01 111.818 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 11' ' ' ARG . 9.3 mmm180 -122.67 112.94 18.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.056 0.455 . . . . 73.04 111.471 -177.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -116.43 116.65 28.07 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.441 -0.578 . . . . 71.4 109.441 174.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.6 t -115.33 122.94 47.42 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.94 0.4 . . . . 71.44 110.215 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 5.4 p -93.02 114.56 27.15 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.125 0.488 . . . . 73.21 110.513 179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.11 139.91 43.08 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.723 -0.671 . . . . 54.21 111.169 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.4 mmtt -109.57 115.99 30.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.194 0.521 . . . . 74.11 111.335 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.476 ' HA ' ' HE ' ' A' ' 17' ' ' ARG . 1.8 mmp_? -104.1 103.78 13.62 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.962 -0.755 . . . . 73.11 108.962 172.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 41.1 m80 -65.99 150.59 48.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.454 -0.339 . . . . 74.32 110.661 -176.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 8.9 mp -79.48 33.52 0.25 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.06 0.457 . . . . 73.43 111.998 -173.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -96.68 -4.77 40.27 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.405 -0.961 . . . . 65.04 108.405 169.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -164.52 -41.46 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.297 -1.32 . . . . 75.51 109.275 -179.146 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 48.97 -128.09 2.03 Favored 'General case' 0 C--O 1.22 -0.451 0 CA-C-N 115.458 -0.792 . . . . 64.21 109.212 -178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 158.72 68.84 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.432 1.493 . . . . 75.41 109.219 169.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -132.1 -179.25 5.3 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.019 0.438 . . . . 74.03 112.071 -173.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.67 136.09 21.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 115.339 -0.846 . . . . 72.43 110.99 179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.6 1.56 57.65 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.983 -0.627 . . . . 42.13 112.47 -179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.444 ' HG2' HG12 ' A' ' 39' ' ' VAL . 14.6 pt-20 -71.79 139.02 48.8 Favored 'General case' 0 C--O 1.24 0.587 0 CA-C-O 120.974 0.416 . . . . 74.31 109.982 178.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.511 HD13 ' HB3' ' A' ' 38' ' ' LYS . 46.8 mm -88.34 116.18 29.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.434 -0.803 . . . . 63.31 110.342 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.43 ' CG1' ' HB2' ' A' ' 37' ' ' TRP . 33.5 pt -106.39 147.21 12.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 115.923 -0.581 . . . . 60.22 110.851 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.622 ' HA ' ' HA ' ' A' ' 35' ' ' LYS . 28.5 m -109.53 127.04 54.18 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.4 -0.818 . . . . 73.33 109.129 175.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.526 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 1.8 p-10 -131.26 -163.18 1.29 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 120.777 -0.369 . . . . 72.04 111.396 -174.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.49 ' HG2' ' O ' ' A' ' 116' ' ' SER . 18.8 mmt -63.23 -24.05 67.7 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 116.238 -0.437 . . . . 74.43 111.392 177.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.584 ' HB3' ' HE1' ' A' ' 37' ' ' TRP . . . -81.02 21.42 0.71 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.32 0.581 . . . . 53.44 109.947 174.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 38.9 mmtm 89.81 -38.14 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.157 0 C-N-CA 124.763 1.225 . . . . 75.24 113.427 166.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.658 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 52.9 pttt 160.36 166.31 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 112.974 0.731 . . . . 71.2 112.974 -172.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.658 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 40.2 mt-10 73.85 50.57 0.12 Allowed 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 114.967 1.469 . . . . 75.05 114.967 159.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.584 ' HE1' ' HB3' ' A' ' 33' ' ' ALA . 75.7 m95 -106.18 141.31 37.75 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.334 -0.988 . . . . 74.32 108.334 163.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HB3' ' A' ' 55' ' ' ASP . 23.1 pttp -114.27 120.06 39.13 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.913 -0.773 . . . . 60.22 108.913 172.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG12 ' HG2' ' A' ' 27' ' ' GLU . 15.0 p -75.53 145.54 10.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 CA-C-N 116.26 -0.427 . . . . 70.31 111.293 -172.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.48 -148.63 23.81 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.948 -0.569 . . . . 60.02 112.444 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 7.1 mp -77.4 153.3 81.67 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 120.578 0.227 . . . . 71.0 111.176 -176.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.61 135.6 24.29 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.11 2.54 . . . . 75.13 111.748 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.404 HD11 HD13 ' A' ' 53' ' ' LEU . 60.3 mt -108.48 -58.12 3.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.016 0.436 . . . . 74.15 110.33 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 90.73 161.58 37.53 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.868 -0.682 . . . . 73.31 112.38 -179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.72 ' H ' ' HA2' ' A' ' 49' ' ' GLY . 33.2 tt0 -139.51 159.95 40.98 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.587 -0.524 . . . . 71.12 109.587 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.439 ' N ' ' HG2' ' A' ' 45' ' ' GLN . . . -76.05 -34.06 48.23 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 121.001 -0.618 . . . . 70.34 112.033 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.28 -85.04 0.79 Allowed Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.983 -0.847 . . . . 73.21 110.983 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.494 ' CE2' ' HA ' ' A' ' 197' ' ' ASP . 31.6 m-85 -98.55 94.17 6.54 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.329 -0.619 . . . . 64.24 109.329 176.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.72 ' HA2' ' H ' ' A' ' 45' ' ' GLN . . . -73.26 -162.04 6.95 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 116.05 -0.523 . . . . 65.42 113.56 -179.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.7 m 63.92 31.82 13.59 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-O 121.371 0.605 . . . . 72.12 111.15 -178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.404 HD12 ' HA ' ' A' ' 71' ' ' LYS . 37.9 mm -88.82 134.14 29.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.818 -0.628 . . . . 74.25 109.829 178.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -107.8 159.16 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.774 0.321 . . . . 53.53 110.625 -179.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.49 HD12 HG12 ' A' ' 69' ' ' VAL . 37.3 tp -81.65 133.38 35.36 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.463 -0.569 . . . . 73.44 109.463 175.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.421 ' H ' ' HA ' ' A' ' 69' ' ' VAL . . . -98.01 103.13 15.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.984 0.421 . . . . 24.45 110.503 -177.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.572 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 6.8 t70 -96.32 -175.57 3.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.541 -0.911 . . . . 72.14 108.541 177.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.529 ' HG2' ' CZ3' ' A' ' 37' ' ' TRP . 71.7 mtm -136.74 152.55 50.47 Favored 'General case' 0 C--N 1.318 -0.787 0 O-C-N 122.175 -0.328 . . . . 63.13 110.875 -171.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -125.69 -60.5 1.3 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.556 -0.293 . . . . 74.12 110.42 177.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 16.8 m -120.16 38.67 3.89 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.115 0.483 . . . . 73.42 110.498 178.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.0 m -107.06 -76.55 0.61 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.305 -0.628 . . . . 55.32 109.305 176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -142.27 173.8 11.19 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.082 -0.71 . . . . 74.41 109.082 173.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 29.2 m -73.13 148.2 44.14 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.775 -0.454 . . . . 73.44 109.775 176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.1 p -62.58 122.06 12.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.39 0.614 . . . . 64.13 111.006 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -80.86 69.72 3.18 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.905 -0.664 . . . . 31.01 112.493 -177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.9 m 71.24 -34.87 0.31 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.631 0.773 . . . . 42.53 112.864 175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -145.66 -73.3 0.24 Allowed 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.479 -0.563 . . . . 62.01 109.479 -176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.544 ' O ' ' HG3' ' A' ' 133' ' ' ARG . . . 179.62 125.56 0.22 Allowed Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 114.569 -1.196 . . . . 51.13 108.366 178.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -88.61 9.54 3.62 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.259 1.973 . . . . 61.43 112.462 -178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 3.1 p -162.01 151.38 15.98 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.554 0.692 . . . . 72.34 112.668 -173.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.49 HG12 HD12 ' A' ' 53' ' ' LEU . 35.8 m -127.09 165.33 25.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.207 -1.034 . . . . 54.23 108.207 171.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 p -129.27 120.45 51.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-O 121.409 0.623 . . . . 65.02 111.574 -177.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.404 ' HA ' HD12 ' A' ' 51' ' ' ILE . 1.9 ttmp? -79.71 119.0 22.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.268 -0.878 . . . . 72.21 108.877 175.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 47.6 t -120.37 120.14 61.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.763 0.316 . . . . 75.34 110.515 -179.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -136.52 156.9 76.13 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 109.336 -0.616 . . . . 65.43 109.336 175.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.12 147.01 92.47 Favored 'Trans proline' 0 N--CA 1.46 -0.463 0 C-N-CA 121.921 1.748 . . . . 75.21 110.978 173.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.2 t -72.07 66.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.095 0.474 . . . . 74.52 110.097 178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -151.99 -40.88 0.11 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.447 -0.797 . . . . 63.41 110.708 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.542 ' OD1' ' HD2' ' A' ' 79' ' ' PRO . 65.7 t30 -63.91 123.49 19.09 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.008 -0.542 . . . . 74.21 111.878 -172.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -55.26 -54.07 36.61 Favored Glycine 0 CA--C 1.524 0.63 0 CA-C-N 115.643 -0.708 . . . . 63.42 113.829 -179.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.542 ' HD2' ' OD1' ' A' ' 77' ' ' ASN . 91.3 Cg_exo -46.95 -37.93 22.88 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 123.082 2.521 . . . . 74.13 113.344 175.541 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -59.35 -50.97 71.93 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.928 -0.397 . . . . 74.4 109.928 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -60.31 -40.26 89.92 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.571 0.701 . . . . 70.54 110.701 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 11.1 m -71.34 -47.09 58.63 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.046 -0.979 . . . . 71.24 111.579 -172.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -68.53 -36.18 78.48 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.797 -0.446 . . . . 65.14 109.797 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 62.8 tp -60.86 -38.43 85.55 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.048 -0.524 . . . . 54.41 110.58 177.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HA ' ' HG3' ' A' ' 88' ' ' GLN . 6.1 ttpp -70.54 -31.54 68.63 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 120.864 0.364 . . . . 64.41 110.425 -179.101 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -69.43 -32.55 71.59 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.869 -0.332 . . . . 73.53 110.584 174.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 6.2 m-30 -65.88 -50.1 65.7 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.228 -0.442 . . . . 65.02 110.403 175.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -68.31 -16.05 63.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.677 0.275 . . . . 72.14 111.098 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 11.2 mmt180 -84.54 -68.79 0.69 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.947 0.351 . . . . 72.24 111.947 173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -96.47 -34.41 11.51 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.011 0.745 . . . . 72.25 113.011 -169.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -78.92 88.66 4.72 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.667 0.746 . . . . 45.03 110.583 -177.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.4 ' HD2' ' HG2' ' A' ' 95' ' ' GLN . 4.7 ttmp? -168.96 129.82 1.05 Allowed Pre-proline 0 C--N 1.32 -0.678 0 CA-C-N 115.04 -0.982 . . . . 65.24 109.452 -176.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -45.44 -51.47 7.9 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 123.331 2.687 . . . . 64.55 113.397 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 34.4 mt-10 -63.74 -45.06 91.58 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 111.901 0.334 . . . . 74.11 111.901 -177.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.4 ' HG2' ' HD2' ' A' ' 92' ' ' LYS . 33.1 mm-40 -62.94 -47.91 81.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.682 0.277 . . . . 72.32 110.908 -176.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.435 ' O ' HG12 ' A' ' 100' ' ' ILE . 69.8 mt -59.27 -47.47 90.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.995 -0.548 . . . . 73.43 110.0 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -54.81 -47.7 73.71 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.194 -0.912 . . . . 64.4 111.115 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLU . 58.3 mtpt -61.81 -46.2 90.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.226 -0.443 . . . . 73.24 111.56 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.618 ' CZ3' HD13 ' A' ' 108' ' ' LEU . 44.7 t90 -68.64 -43.83 75.46 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.822 -0.351 . . . . 63.03 110.82 -178.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.435 HG12 ' O ' ' A' ' 96' ' ' ILE . 30.5 mm -60.5 -37.94 76.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.779 0.323 . . . . 64.13 111.357 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 74.8 mtp85 -75.96 -34.3 59.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.42 -0.355 . . . . 72.34 111.459 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 29.9 m -76.85 -48.68 17.71 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 120.898 0.38 . . . . 71.22 111.516 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.477 ' NE ' ' HA ' ' A' ' 103' ' ' ARG . 5.6 tpm_? -76.64 -18.87 58.34 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.286 -0.416 . . . . 75.33 110.609 -177.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? 64.74 78.78 0.27 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.822 0.82 . . . . 74.1 109.971 -179.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 76.0 mt -138.64 -167.96 2.3 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.117 -0.947 . . . . 64.32 109.845 179.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 43.6 tttp -106.38 -50.86 3.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 120.777 -0.369 . . . . 75.41 110.964 -178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -153.4 146.76 24.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.681 0.277 . . . . 63.42 110.416 -177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.618 HD13 ' CZ3' ' A' ' 99' ' ' TRP . 46.4 tp -97.95 133.59 42.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.063 -0.517 . . . . 64.11 110.428 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -81.7 58.54 4.89 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.215 -0.517 . . . . 30.33 112.492 -179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.2 p -111.33 137.55 21.09 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 109.251 -0.648 . . . . 74.02 109.251 178.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.486 ' HA ' ' CD2' ' A' ' 194' ' ' TYR . 7.9 Cg_endo -50.5 134.5 39.42 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.564 2.176 . . . . 40.04 112.782 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.996 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.8 tptm -73.66 126.97 31.51 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.562 -0.745 . . . . 73.21 110.331 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -116.46 134.18 55.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.697 -0.683 . . . . 73.42 110.245 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.505 ' CD1' HG22 ' A' ' 130' ' ' ILE . 40.0 m95 -107.27 -75.16 0.64 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.418 0.627 . . . . 73.13 110.055 178.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -143.48 -168.18 12.02 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.281 -0.872 . . . . 41.34 111.458 -178.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.49 ' O ' ' HG2' ' A' ' 32' ' ' MET . 66.6 p -175.32 173.01 2.61 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 110.184 -0.302 . . . . 71.5 110.184 -175.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 169.07 -170.54 42.55 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.81 -0.71 . . . . 72.0 112.226 177.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.449 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -122.0 132.17 54.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.181 -0.674 . . . . 63.14 109.181 178.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 37.5 t60 -148.65 123.19 9.76 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.461 . . . . 73.21 110.636 -177.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -69.82 145.36 52.18 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.708 -0.849 . . . . 71.23 108.708 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -143.82 18.42 1.81 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.126 -0.629 . . . . 74.13 112.151 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 -179.67 8.96 0.0 OUTLIER 'General case' 0 N--CA 1.477 0.918 0 CA-C-O 121.179 0.514 . . . . 71.43 111.616 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.29 28.44 14.91 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 108.91 -1.676 . . . . 60.32 108.91 -166.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.694 ' HE3' ' HA ' ' A' ' 124' ' ' LYS . 1.4 tpmt? -146.09 124.97 12.68 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 113.807 -1.197 . . . . 74.32 108.279 -174.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.449 ' HB3' HD21 ' A' ' 118' ' ' LEU . 18.4 m -75.63 105.1 6.48 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.91 0.386 . . . . 70.4 110.372 -178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -92.38 144.75 25.06 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.075 -0.511 . . . . 73.42 109.671 175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.0 ttm180 -113.34 125.7 54.56 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.106 -1.072 . . . . 73.33 108.106 175.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 55.1 p90 -121.12 148.41 44.24 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 121.159 0.504 . . . . 70.33 111.064 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.5 ptp -135.26 134.83 40.38 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.226 -0.897 . . . . 71.23 109.304 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.505 HG22 ' CD1' ' A' ' 114' ' ' TRP . 19.1 mt -96.73 123.33 48.98 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.32 0.581 . . . . 74.41 110.137 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 11.8 ptm -128.67 -179.16 4.91 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.84 -1.073 . . . . 72.34 110.417 -172.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.996 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 31.6 t70 -68.92 156.19 38.96 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.857 0.36 . . . . 53.14 111.346 -175.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.595 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 2.4 tmt_? -89.32 106.94 18.77 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.189 0.519 . . . . 71.04 110.732 -174.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.436 ' CE1' ' HB3' ' A' ' 132' ' ' ASP . 19.2 m-85 -102.21 172.24 7.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.162 -0.472 . . . . 73.4 110.689 -175.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -157.45 -37.5 0.02 OUTLIER Glycine 0 C--O 1.226 -0.36 0 C-N-CA 120.693 -0.765 . . . . 62.0 112.706 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 66.7 m -121.55 142.07 50.44 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.809 -0.23 . . . . 74.43 111.036 179.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.542 ' HA ' ' HA ' ' A' ' 184' ' ' LEU . 2.9 p30 -124.65 176.69 6.39 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.642 0.258 . . . . 52.32 110.807 176.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.505 HD22 ' HB2' ' A' ' 183' ' ' LEU . 5.3 mp -77.63 -27.9 51.22 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.346 0.499 . . . . 73.22 112.346 -177.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.409 ' OE1' ' HB3' ' A' ' 181' ' ' SER . 23.5 tt0 -75.39 -34.41 61.08 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.57 -0.452 . . . . 74.25 111.274 -171.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HD2' ' HA ' ' A' ' 140' ' ' LYS . 45.6 tptt -68.7 -38.43 80.29 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.27 -0.572 . . . . 73.5 110.117 177.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.587 HG12 ' HG ' ' A' ' 341' ' ' LEU . 1.8 mp -68.18 -38.84 80.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.259 0.552 . . . . 74.4 109.763 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.9 t80 -55.18 -43.09 74.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.493 -0.776 . . . . 65.22 110.425 174.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -74.46 -50.37 18.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.804 -0.634 . . . . 73.51 110.904 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -64.94 -31.77 73.17 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.383 0.512 . . . . 71.41 112.383 -174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -100.61 0.79 39.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.85 0.357 . . . . 75.23 110.647 -178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.52 ' C ' ' HD3' ' A' ' 147' ' ' LYS . . . 56.53 75.84 0.33 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.896 -0.593 . . . . 54.35 111.923 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.52 ' HD3' ' C ' ' A' ' 146' ' ' ALA . 0.0 OUTLIER 29.71 77.13 0.03 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.043 1.337 . . . . 74.24 114.132 178.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 59.3 ttt-85 -160.28 105.7 1.51 Allowed 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.64 -0.709 . . . . 71.13 109.092 173.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 49.9 m-85 -110.1 155.73 21.51 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.113 -0.494 . . . . 75.13 111.101 -177.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 46.9 t -78.49 155.52 29.78 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.92 -0.582 . . . . 73.24 110.185 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 45.8 ttm-85 -57.8 -38.85 76.25 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.29 -0.414 . . . . 74.24 110.642 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -58.56 -45.87 88.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.0 -0.545 . . . . 62.5 110.494 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.682 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 4.8 m -66.54 -52.37 46.44 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.827 -0.624 . . . . 62.52 110.948 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 83.7 t -60.24 -47.26 92.93 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 116.138 -0.483 . . . . 71.53 111.648 -176.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.55 -37.87 80.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.424 -0.353 . . . . 71.52 110.762 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.873 HE21 ' HB2' ' A' ' 335' ' ' ASP . 30.2 mm-40 -60.22 -47.53 85.57 Favored 'General case' 0 CA--C 1.517 -0.305 0 CA-C-O 120.695 0.283 . . . . 64.5 110.61 175.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 153' ' ' THR . 81.9 mt -58.11 -50.51 73.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 70.44 110.131 178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.586 ' HA ' HD11 ' A' ' 247' ' ' LEU . 25.2 t -58.18 -47.44 83.42 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.891 -0.595 . . . . 65.0 110.94 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.504 HD11 HD21 ' A' ' 325' ' ' LEU . 0.7 OUTLIER -64.74 -52.64 55.97 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.04 -0.527 . . . . 72.12 111.083 -176.315 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.438 ' NH1' HD22 ' A' ' 159' ' ' LEU . 13.6 mmt180 -72.51 -30.11 64.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.42 -0.355 . . . . 70.32 111.348 -173.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.604 ' O ' ' HB2' ' A' ' 165' ' ' LEU . 1.5 mp -71.09 -30.72 42.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 109.818 -0.438 . . . . 74.53 109.818 175.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 7.6 tt -68.45 -43.84 76.19 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.943 -0.391 . . . . 75.31 109.943 177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.571 ' HB3' ' HH2' ' A' ' 99' ' ' TRP . 72.7 m-20 -58.53 -55.22 37.89 Favored 'General case' 0 C--O 1.245 0.84 0 CA-C-O 121.683 0.754 . . . . 72.14 110.432 178.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.598 ' O ' HG12 ' A' ' 168' ' ' ILE . 16.2 tt -63.19 -34.79 68.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.831 -0.622 . . . . 60.1 110.378 178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.731 ' O ' ' HB3' ' A' ' 169' ' ' HIS . 6.3 tt -56.44 -37.93 70.92 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.577 -0.283 . . . . 72.14 110.318 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -57.29 -59.56 4.94 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.112 -0.699 . . . . 73.53 109.112 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -59.46 -28.19 66.77 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-N 113.967 -1.469 . . . . 74.54 113.501 -171.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.598 HG12 ' O ' ' A' ' 164' ' ' ILE . 22.0 pt -108.9 -48.18 7.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 112.908 0.707 . . . . 43.25 112.908 -177.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.731 ' HB3' ' O ' ' A' ' 165' ' ' LEU . 7.0 t60 -59.87 -47.66 84.84 Favored 'General case' 0 N--CA 1.466 0.33 0 O-C-N 122.998 0.186 . . . . 75.11 110.85 -175.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.688 ' HG3' ' HD2' ' A' ' 169' ' ' HIS . 21.1 mt-10 -106.47 80.82 1.52 Allowed 'General case' 0 CA--C 1.512 -0.513 0 CA-C-O 121.978 0.894 . . . . 75.31 109.404 176.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 38.0 t-80 -175.35 -44.12 0.01 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 113.481 -1.69 . . . . 74.1 109.128 -170.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -162.61 -72.62 0.05 OUTLIER 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.938 -0.573 . . . . 74.42 111.403 -179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.643 ' CD1' ' HA ' ' A' ' 203' ' ' ARG . 21.9 m-85 -122.79 155.21 37.03 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.187 0.518 . . . . 64.31 111.388 -174.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.472 HG13 ' HB2' ' A' ' 204' ' ' TYR . 31.0 m -97.37 167.29 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.521 -0.763 . . . . 51.51 109.431 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.556 ' HB3' ' OD1' ' A' ' 177' ' ' ASP . 2.9 m-70 -114.3 -85.77 0.6 Allowed 'General case' 0 C--N 1.322 -0.625 0 C-N-CA 120.862 -0.335 . . . . 71.23 111.558 177.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 84.96 6.45 85.05 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.683 -0.77 . . . . 52.0 111.38 -173.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.798 ' HB3' ' HB2' ' A' ' 200' ' ' LEU . 17.8 p-10 -89.66 28.39 1.32 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.21 0.529 . . . . 73.34 111.077 -175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.481 ' HB ' HG22 ' A' ' 246' ' ' ILE . 46.2 mm -75.6 97.45 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.314 0.578 . . . . 63.2 110.527 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.789 ' HB3' ' HZ2' ' A' ' 179' ' ' LYS . 0.0 OUTLIER -157.3 165.04 36.93 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.461 -0.791 . . . . 75.43 109.502 172.651 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.44 -23.56 64.53 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.967 0.729 . . . . 74.41 112.967 -171.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.409 ' HB3' ' OE1' ' A' ' 139' ' ' GLN . 67.7 p -75.51 -18.59 59.77 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.837 0.31 . . . . 71.55 111.837 -176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.523 ' ND2' ' HB2' ' A' ' 177' ' ' ASP . 2.6 m-20 -97.44 -26.94 14.67 Favored 'General case' 0 CA--C 1.516 -0.359 0 N-CA-C 111.891 0.33 . . . . 73.35 111.891 -172.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.505 ' HB2' HD22 ' A' ' 138' ' ' LEU . 6.3 mp -95.69 118.38 32.27 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.11 0.481 . . . . 71.25 110.407 -178.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' ASP . 0.4 OUTLIER -133.81 158.67 42.78 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.565 -0.743 . . . . 75.41 110.88 177.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.435 HD11 HD23 ' A' ' 341' ' ' LEU . 11.7 mt -103.55 157.59 16.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.906 -0.588 . . . . 72.15 109.601 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 23.8 t-20 -65.62 142.31 58.1 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.618 -0.882 . . . . 73.21 108.618 171.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.595 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 2.5 p90 -60.58 -22.24 63.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.964 0.357 . . . . 72.22 111.964 -173.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -124.25 6.23 8.45 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.293 0.568 . . . . 73.43 110.261 -177.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.88 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 47.6 t-20 -139.87 101.92 7.06 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 115.892 -0.595 . . . . 72.35 109.835 -175.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -82.48 -20.47 5.8 Favored 'Trans proline' 0 N--CA 1.464 -0.209 0 C-N-CA 122.832 2.355 . . . . 75.02 113.716 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -91.47 1.62 57.0 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.953 0.406 . . . . 52.11 111.257 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -115.54 107.55 15.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.994 0.426 . . . . 73.51 110.437 174.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 13.6 p -104.33 142.12 18.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.002 -0.545 . . . . 73.12 109.937 178.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CD2' ' HA ' ' A' ' 111' ' ' PRO . 44.1 m-85 -127.04 157.49 39.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.537 -0.302 . . . . 73.24 110.732 -176.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 75.7 mt -96.49 129.91 43.76 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 116.258 -0.428 . . . . 75.33 110.479 174.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 184' ' ' LEU . 34.2 m -135.79 177.49 6.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.42 -0.355 . . . . 54.12 110.225 175.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.494 ' HA ' ' CE2' ' A' ' 48' ' ' PHE . 53.5 t0 59.8 66.73 0.95 Allowed 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 121.6 0.714 . . . . 75.23 109.287 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -75.38 67.52 1.96 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.16 -0.927 . . . . 74.42 111.078 -178.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.71 ' HA3' ' HB2' ' A' ' 352' ' ' LYS . . . -93.52 1.87 69.74 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.464 -0.789 . . . . 71.54 111.651 175.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.798 ' HB2' ' HB3' ' A' ' 177' ' ' ASP . 77.8 mt -138.19 94.35 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.56 0.695 . . . . 70.44 110.587 176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.452 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -155.0 115.8 3.93 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.725 -1.125 . . . . 74.3 108.921 176.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -132.38 160.61 35.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.635 -0.257 . . . . 75.05 110.699 -173.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.643 ' HA ' ' CD1' ' A' ' 173' ' ' TYR . 5.4 ptp180 -62.52 149.36 43.19 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.171 -0.468 . . . . 74.52 111.144 -178.023 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.472 ' HB2' HG13 ' A' ' 174' ' ' VAL . 42.1 t80 -149.86 -56.13 0.18 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.435 -0.348 . . . . 73.13 110.534 175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.483 ' HA ' ' O ' ' A' ' 209' ' ' VAL . 5.8 p -148.34 72.08 10.93 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-O 120.971 0.415 . . . . 73.43 111.534 179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -88.76 142.67 4.89 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.989 2.459 . . . . 73.03 111.853 177.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 66.25 9.48 6.39 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.181 -0.463 . . . . 72.31 111.726 178.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.86 67.78 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 121.04 -0.6 . . . . 52.32 112.299 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 205' ' ' CYS . 61.9 t -96.42 117.44 40.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.537 0.208 . . . . 70.24 110.49 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -100.23 145.86 27.57 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.853 -0.425 . . . . 71.0 109.853 178.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 22.9 ttmm -114.97 152.58 32.15 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.303 -0.408 . . . . 64.33 110.413 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -78.39 173.98 11.76 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.483 -0.562 . . . . 64.34 109.483 175.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.483 ' HB2' HG21 ' A' ' 236' ' ' VAL . 19.4 p90 -79.19 74.03 5.76 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 122.665 1.222 . . . . 74.11 110.223 178.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -154.91 92.97 1.5 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.055 -1.43 . . . . 71.32 108.49 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.611 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 2.7 mm-40 -122.61 -98.5 0.44 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 113.251 0.834 . . . . 71.25 113.251 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -98.49 119.26 61.92 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.411 -0.359 . . . . 73.25 111.664 -168.551 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.29 -15.2 18.12 Favored 'Trans proline' 0 N--CA 1.462 -0.358 0 C-N-CA 122.769 2.313 . . . . 62.34 112.379 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 63.3 tttp -78.34 -20.68 50.86 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.922 -0.399 . . . . 74.13 109.922 179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 93.0 mtt180 72.98 102.0 0.07 Allowed 'General case' 0 C--O 1.232 0.151 0 CA-C-N 115.184 -0.916 . . . . 73.43 110.245 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 57.1 m -59.57 -73.43 0.09 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.555 -0.748 . . . . 73.54 111.633 -176.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 26.4 p-80 46.15 26.84 0.47 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.838 0.855 . . . . 75.14 112.423 179.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.421 ' OD2' ' HB ' ' A' ' 355' ' ' THR . 19.0 p-10 -94.51 -4.53 47.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.108 0.48 . . . . 74.04 110.849 -176.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -77.04 177.34 52.45 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.687 -0.768 . . . . 71.31 111.361 173.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.8 p -73.26 129.69 38.59 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.248 0.547 . . . . 75.43 111.667 -177.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.452 HG23 HG21 ' A' ' 271' ' ' VAL . 47.7 mm -54.17 -31.26 21.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 CA-C-N 115.342 -0.845 . . . . 72.34 112.336 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.552 ' H ' ' HG3' ' A' ' 226' ' ' GLU . 0.0 OUTLIER -56.92 -69.46 0.15 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.277 -0.42 . . . . 72.25 111.566 -179.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.427 ' HB3' HG23 ' A' ' 246' ' ' ILE . 94.6 m-85 -112.48 49.34 0.93 Allowed 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.107 0.41 . . . . 72.42 112.107 -176.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.06 -18.18 35.12 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.629 0.252 . . . . 73.2 111.519 172.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 66.4 m 52.48 -162.96 0.09 Allowed 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 115.891 -0.595 . . . . 53.43 111.159 -173.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.407 ' N ' HD12 ' A' ' 230' ' ' ILE . 3.2 mp -72.83 -44.61 58.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-O 120.711 0.291 . . . . 74.11 110.507 177.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.621 ' OD2' ' HA ' ' A' ' 238' ' ' PRO . 1.3 m-20 -51.44 -70.92 0.07 Allowed 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 115.159 -0.928 . . . . 74.34 112.468 -172.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.84 -29.22 70.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.875 0.369 . . . . 42.12 111.383 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -66.32 -28.79 68.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.034 -0.53 . . . . 53.21 110.767 179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -91.15 -30.62 16.59 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.176 -0.465 . . . . 72.24 110.859 -178.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.71 27.57 6.66 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.668 -0.777 . . . . 70.54 111.625 -174.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.611 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 9.1 p -120.49 141.55 40.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 110.236 -0.283 . . . . 71.13 110.236 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -55.71 124.69 58.26 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.324 -0.398 . . . . 42.41 110.778 178.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.621 ' HA ' ' OD2' ' A' ' 231' ' ' ASP . 91.0 Cg_exo -46.63 106.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 123.199 2.599 . . . . 64.12 112.418 178.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 312' ' ' THR . 36.4 m -92.04 42.26 1.1 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.148 -0.933 . . . . 63.22 110.928 -172.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' A' ' 239' ' ' SER . 66.0 mtt180 85.29 -28.69 0.08 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.075 0.95 . . . . 65.24 111.159 -177.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.592 ' HG2' ' O ' ' A' ' 311' ' ' TYR . 9.4 mmm180 -59.13 -61.39 2.67 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-O 120.542 0.21 . . . . 64.55 110.921 177.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -49.18 -55.36 12.45 Favored Glycine 0 C--O 1.225 -0.443 0 CA-C-N 115.724 -0.671 . . . . 44.22 113.219 -179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.487 ' HB3' HD11 ' A' ' 165' ' ' LEU . 3.3 m-20 -52.72 -54.56 32.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.98 0.419 . . . . 72.34 111.176 -176.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.487 HD13 ' O ' ' A' ' 240' ' ' ARG . 11.2 mp -64.92 -45.93 83.77 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.711 -0.677 . . . . 74.04 111.391 -177.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -67.46 -38.57 84.68 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 121.075 -0.25 . . . . 63.34 111.593 -177.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.481 HG22 ' HB ' ' A' ' 178' ' ' ILE . 84.2 mt -59.13 -44.0 90.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.728 0.299 . . . . 74.13 110.482 177.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.586 HD11 ' HA ' ' A' ' 158' ' ' SER . 33.2 tp -61.57 -42.63 99.13 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.225 -0.443 . . . . 72.41 110.293 177.299 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.73 -45.63 95.86 Favored Glycine 0 C--O 1.236 0.271 0 C-N-CA 120.907 -0.663 . . . . 73.14 112.227 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 22.8 m-30 -58.79 -49.16 78.7 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.649 0.261 . . . . 64.34 111.279 -178.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 28.5 p -66.43 -36.79 83.68 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.888 -0.325 . . . . 73.31 111.453 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.426 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 72.5 mtm -60.65 -51.75 68.07 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.881 0.372 . . . . 74.43 111.023 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.528 ' HB ' HG21 ' A' ' 299' ' ' ILE . 15.4 tt -67.38 -30.23 48.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 120.582 -0.447 . . . . 75.41 110.694 -178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.53 ' HG3' ' HG ' ' A' ' 259' ' ' LEU . 35.0 tt0 -67.91 -44.95 75.74 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-O 120.532 0.206 . . . . 64.33 110.584 179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 22.7 m0 -65.4 -29.15 69.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.544 -0.298 . . . . 73.11 110.902 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 47.0 tp -81.04 -35.71 31.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.168 -0.469 . . . . 71.34 112.003 -179.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 62.5 p -103.37 -27.93 12.14 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.858 -0.337 . . . . 73.43 111.74 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 84.36 17.09 65.18 Favored Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.865 -0.683 . . . . 44.52 112.982 179.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -155.6 144.17 20.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.128 0.464 . . . . 65.02 111.145 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 262' ' ' GLU . 29.3 mt -108.95 138.84 20.46 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-N 116.211 -0.45 . . . . 73.11 109.825 171.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.459 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 48.3 Cg_exo -58.03 -28.33 82.88 Favored 'Trans proline' 0 CA--C 1.527 0.156 0 C-N-CA 122.867 2.378 . . . . 74.03 112.57 178.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.417 ' HB3' ' HB2' ' A' ' 274' ' ' SER . 46.7 p90 -108.22 11.72 27.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.215 -0.448 . . . . 73.34 111.375 -178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.912 ' HB2' ' HB2' ' A' ' 259' ' ' LEU . 38.4 tt0 -75.56 -39.37 58.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.037 0.446 . . . . 71.51 110.36 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -60.45 -29.15 68.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.69 0.757 . . . . 62.32 109.864 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.468 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 0.9 OUTLIER -108.04 19.75 19.59 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.138 -0.937 . . . . 73.52 110.689 -179.557 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 262' ' ' GLU . 1.8 tt -75.93 73.29 2.83 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.825 0.821 . . . . 73.24 110.362 -175.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -147.52 -63.11 0.27 Allowed 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 114.544 -1.207 . . . . 72.02 109.817 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.747 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 12.1 t70 -91.33 135.27 28.36 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 115.245 -0.888 . . . . 73.25 111.431 -173.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -58.23 -27.11 79.43 Favored 'Trans proline' 0 CA--C 1.534 0.496 0 C-N-CA 123.498 2.799 . . . . 75.55 114.331 -178.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.444 ' HE2' ' HB2' ' A' ' 269' ' ' LYS . 1.8 mppt? -82.72 -40.07 21.09 Favored 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 120.605 -0.438 . . . . 73.04 110.542 -177.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.747 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 37.0 m-85 -60.93 -49.19 78.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.401 -0.363 . . . . 73.32 110.704 178.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.452 HG21 HG23 ' A' ' 225' ' ' ILE . 33.8 m -66.6 -31.71 54.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 C-N-CA 120.816 -0.354 . . . . 52.13 110.663 177.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 19.9 ttp180 -58.58 -56.67 19.17 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-O 121.087 0.47 . . . . 75.03 110.352 175.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -67.85 -43.47 79.43 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.474 -0.785 . . . . 72.14 111.038 -173.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 261' ' ' TRP . 41.7 m -60.34 -41.2 93.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.401 -0.363 . . . . 74.02 111.501 -178.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -66.36 -48.29 70.66 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 121.114 -0.235 . . . . 73.41 110.615 179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.46 -40.68 89.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.937 0.399 . . . . 72.35 111.03 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 36.5 ttt180 -56.13 -51.02 69.46 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.67 -0.695 . . . . 74.25 110.647 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.459 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 33.4 m-85 -74.45 -36.05 63.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.893 -0.594 . . . . 74.23 111.12 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.531 ' HD2' HH22 ' A' ' 241' ' ' ARG . 26.2 ttp180 -57.23 -31.95 66.04 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 121.231 0.538 . . . . 64.34 111.28 178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -77.5 -23.22 50.31 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.108 -0.496 . . . . 62.23 111.063 -176.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -127.98 30.43 5.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.581 -0.281 . . . . 71.21 110.779 -173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.457 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -47.95 -42.28 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 114.04 1.126 . . . . 63.3 114.04 -171.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.41 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -58.16 -50.51 73.28 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 112.423 0.527 . . . . 71.43 112.423 -169.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 21.8 t -78.08 -36.21 48.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.834 0.35 . . . . 73.52 110.313 -177.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.436 HD13 ' CD2' ' A' ' 278' ' ' TYR . 89.9 mt -71.95 -44.8 62.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 65.44 111.372 -174.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.445 ' HG3' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -72.02 -40.6 68.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.639 -0.255 . . . . 63.34 110.946 -179.235 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -63.79 -35.41 80.51 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 121.145 0.497 . . . . 63.53 111.046 178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 288' ' ' LYS . 28.5 ttmt -99.76 7.63 44.9 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.774 -0.648 . . . . 72.22 110.658 -175.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 47.0 t -75.95 -22.95 55.43 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.203 0.525 . . . . 74.24 110.048 179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 33.6 t80 -127.35 77.39 75.77 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 108.546 -0.909 . . . . 74.22 108.546 173.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -80.85 12.07 2.76 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.895 2.397 . . . . 75.52 113.364 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.433 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 4.0 mp0 -71.11 -99.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.661 -0.496 . . . . 63.21 109.661 175.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 67.1 mttt -161.52 79.13 0.57 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.334 0.588 . . . . 73.32 110.771 173.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.515 ' O ' ' HD3' ' A' ' 296' ' ' PRO . 10.5 t-20 -150.3 162.92 39.58 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.035 -1.098 . . . . 75.01 108.035 170.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 12.8 mptt -104.85 103.87 43.24 Favored Pre-proline 0 C--N 1.324 -0.527 0 N-CA-C 111.905 0.335 . . . . 75.41 111.905 -175.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.515 ' HD3' ' O ' ' A' ' 294' ' ' ASN . 85.1 Cg_endo -98.26 37.81 0.1 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.121 0 C-N-CA 123.011 2.474 . . . . 45.13 111.207 173.246 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -74.02 -43.71 32.65 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.628 -0.714 . . . . 63.41 111.942 -174.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.552 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 1.4 mp0 -53.39 -51.15 63.45 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.212 0.53 . . . . 72.02 109.849 177.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.528 HG21 ' HB ' ' A' ' 252' ' ' ILE . 20.7 mt -62.09 -50.93 78.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.281 -0.872 . . . . 73.35 111.4 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.56 -40.31 86.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.214 -0.448 . . . . 63.43 111.149 -177.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 48.4 tttp -79.77 -28.54 40.34 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.24 -0.436 . . . . 74.42 110.489 -177.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.405 ' HE1' ' O ' ' A' ' 244' ' ' LEU . 52.1 t80 -60.74 -42.64 97.75 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.287 -0.634 . . . . 64.21 109.287 172.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.57 ' HA ' HG22 ' A' ' 306' ' ' VAL . 66.3 mtp -72.71 -36.16 67.76 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.541 -0.754 . . . . 74.45 110.809 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -55.93 -46.42 78.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.468 0.652 . . . . 63.22 109.342 171.339 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.519 ' O ' ' HB2' ' A' ' 309' ' ' LEU . 91.3 m -57.33 -52.28 65.99 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.713 -1.131 . . . . 50.31 111.611 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.57 HG22 ' HA ' ' A' ' 303' ' ' MET . 22.9 m -67.45 -31.63 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 N-CA-C 111.78 0.289 . . . . 61.04 111.78 -175.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 66.9 tttt -70.32 -48.81 54.87 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-O 121.095 0.474 . . . . 73.41 110.808 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 17.5 tp -82.73 -3.03 55.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.75 -0.659 . . . . 62.43 110.481 -175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 310' ' ' ASP . 6.9 tt -67.65 -76.7 0.08 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.314 -0.857 . . . . 75.23 110.315 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.569 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 8.1 t70 162.19 -152.01 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 107.134 -1.432 . . . . 71.21 107.134 -176.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.592 ' O ' ' HG2' ' A' ' 241' ' ' ARG . 20.4 t80 -105.03 -39.97 6.06 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 109.938 -0.393 . . . . 74.44 109.938 173.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 239' ' ' SER . 1.6 m -138.4 5.51 2.48 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.683 0.623 . . . . 52.24 112.683 -175.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -70.22 -89.29 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 114.556 1.317 . . . . 73.44 114.556 -167.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.418 ' HE2' ' HB2' ' A' ' 314' ' ' LYS . 13.2 tppt? -109.09 107.42 59.89 Favored Pre-proline 0 C--N 1.325 -0.489 0 N-CA-C 113.165 0.802 . . . . 74.13 113.165 -161.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.507 ' HB2' ' CE1' ' A' ' 317' ' ' TYR . 68.7 Cg_endo -88.73 119.82 1.1 Allowed 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 122.618 2.212 . . . . 64.21 112.034 169.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.638 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 93.2 mt -118.84 85.55 2.38 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.268 0.556 . . . . 65.23 109.786 176.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.507 ' CE1' ' HB2' ' A' ' 315' ' ' PRO . 80.7 m-85 -67.98 -34.97 77.54 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.704 -0.68 . . . . 72.31 111.964 -172.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.55 -29.53 46.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.902 -0.319 . . . . 72.25 110.904 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -65.62 -48.71 71.29 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.889 -0.411 . . . . 73.44 109.889 174.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.638 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 85.9 mt -58.4 -43.61 88.63 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.617 -0.72 . . . . 63.23 110.485 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.419 ' O ' HD23 ' A' ' 325' ' ' LEU . 7.4 mtp180 -64.21 -33.36 75.62 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.828 -0.623 . . . . 72.12 111.12 177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -73.44 -46.16 50.1 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.275 0.472 . . . . 75.11 112.275 -174.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 320' ' ' LEU . 0.3 OUTLIER -72.45 -27.8 26.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 C-N-CA 119.474 -0.89 . . . . 55.54 110.414 -179.392 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 46.1 tp -63.13 -49.04 75.96 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 109.492 -0.559 . . . . 73.02 109.492 172.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.52 ' O ' ' HG2' ' A' ' 329' ' ' LYS . 4.0 mm? -67.59 -26.91 66.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.777 -0.647 . . . . 73.45 111.002 176.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . 0.673 ' HA ' ' HE2' ' A' ' 329' ' ' LYS . 20.2 tp60 -59.52 -49.01 79.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.527 -0.306 . . . . 61.42 110.427 177.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -65.91 -38.55 94.34 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.248 -0.977 . . . . 62.23 111.298 176.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.937 HD11 ' HA ' ' A' ' 334' ' ' LYS . 3.0 tm? -57.21 -50.35 73.14 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.181 -0.51 . . . . 65.43 111.043 178.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.673 ' HE2' ' HA ' ' A' ' 326' ' ' GLN . 54.8 pttt -81.15 -17.48 49.65 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.759 0.281 . . . . 75.4 111.759 -176.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -73.47 -40.76 63.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.859 0.361 . . . . 73.12 110.894 179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 16.2 tt -77.46 -6.95 9.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 121.206 0.527 . . . . 70.55 110.626 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 89.67 12.27 62.76 Favored Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 120.856 -0.688 . . . . 61.5 112.887 175.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 20.3 m -99.36 170.37 8.69 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.043 -0.354 . . . . 61.21 110.043 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.937 ' HA ' HD11 ' A' ' 328' ' ' LEU . 77.6 tttt -146.28 156.56 43.45 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.538 -0.541 . . . . 75.25 109.538 172.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.873 ' HB2' HE21 ' A' ' 156' ' ' GLN . 6.9 p-10 -87.65 126.64 35.08 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.166 0.508 . . . . 64.52 110.142 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -104.3 -24.18 13.13 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.049 -0.523 . . . . 62.51 110.862 178.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 85.39 -1.96 88.25 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 121.172 -0.537 . . . . 64.22 112.42 178.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -72.57 -27.82 62.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.613 0.207 . . . . 71.51 110.803 -175.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 94.7 mt 60.76 88.67 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 O-C-N 123.823 0.702 . . . . 65.2 112.318 176.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -71.65 91.86 1.13 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 73.14 109.432 172.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.587 ' HG ' HG12 ' A' ' 141' ' ' ILE . 14.2 tp -127.64 9.27 6.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.312 -0.404 . . . . 73.55 110.717 -177.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 44.7 m 73.03 -41.84 0.51 Allowed 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.633 0.773 . . . . 73.11 112.276 176.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 34.1 t 63.33 71.61 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.618 0.723 . . . . 72.44 109.215 -175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 41.6 t -88.69 -67.39 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.25 -0.887 . . . . 61.22 111.311 -177.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.414 ' HG2' ' H ' ' A' ' 346' ' ' ASN . 29.3 tt0 -168.27 173.94 7.43 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.812 -0.81 . . . . 64.54 108.812 -175.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.414 ' H ' ' HG2' ' A' ' 345' ' ' GLU . 22.5 p-10 -98.72 158.31 15.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.077 0.465 . . . . 65.53 110.309 175.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.409 ' HA3' ' HD3' ' A' ' 140' ' ' LYS . . . -173.96 21.6 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.775 -0.648 . . . . 44.21 111.515 179.242 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -75.31 68.64 2.05 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.731 -0.271 . . . . 74.2 113.298 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.448 ' O ' HD12 ' A' ' 349' ' ' LEU . 2.7 pp -83.99 128.24 34.42 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.412 -0.588 . . . . 74.44 109.412 172.499 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 16.2 tptp -165.85 -65.51 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.92 -0.4 . . . . 62.31 109.92 -177.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . 62.49 103.74 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.824 0.702 . . . . 71.11 111.828 177.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.71 ' HB2' ' HA3' ' A' ' 199' ' ' GLY . 3.9 mppt? -110.42 169.77 8.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 74.35 110.549 179.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 4.7 t -134.3 132.47 39.61 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.29 -0.413 . . . . 70.32 110.562 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.724 HG13 ' HD3' ' A' ' 356' ' ' LYS . 0.2 OUTLIER -84.69 142.7 12.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 116.109 -0.496 . . . . 71.32 110.782 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.421 ' HB ' ' OD2' ' A' ' 222' ' ' ASP . 4.9 t -79.54 81.77 5.75 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 122.038 0.923 . . . . 71.21 110.045 172.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.724 ' HD3' HG13 ' A' ' 354' ' ' ILE . 10.5 mtpm? -140.46 168.53 19.58 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.439 -0.8 . . . . 54.05 110.509 -178.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -110.82 150.22 29.44 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.097 -0.502 . . . . 74.32 110.649 -177.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 79.0 ttt180 -96.7 146.36 24.95 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.662 -0.496 . . . . 72.53 109.662 176.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -109.65 -62.21 1.53 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.754 0.312 . . . . 72.02 110.401 179.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 42.7 mttp . . . . . 0 C--O 1.245 0.849 0 CA-C-O 118.585 -0.722 . . . . 74.32 110.231 175.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' HA ' ' HD2' ' A' ' 2' ' ' PRO . 65.9 mtt . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.038 -0.356 . . . . 63.11 110.038 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 1' ' ' MET . 24.4 Cg_endo -62.82 138.66 70.09 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.586 2.191 . . . . 50.34 111.797 179.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.471 ' N ' ' HD2' ' A' ' 3' ' ' ARG . 2.1 mpt_? -94.92 137.65 33.7 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.31 -0.404 . . . . 71.15 110.338 -177.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -71.08 145.79 12.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.085 -0.507 . . . . 70.32 111.235 -179.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.08 139.97 47.42 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.983 -0.553 . . . . 75.43 110.319 -178.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -113.38 153.35 28.71 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.981 0.419 . . . . 53.53 111.471 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -138.16 119.74 15.02 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.777 -0.647 . . . . 75.01 110.037 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -103.88 112.04 24.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.03 0.443 . . . . 65.23 111.442 -177.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -130.77 112.27 12.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.936 -0.575 . . . . 71.01 109.62 175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.89 118.75 4.92 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.651 -0.785 . . . . 74.23 113.171 -175.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 82.4 mtm180 -87.07 127.09 35.12 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.82 0.343 . . . . 74.41 110.086 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -121.19 112.58 18.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.025 -0.534 . . . . 73.45 110.21 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 25.1 m -85.38 125.7 33.18 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 116.204 -0.453 . . . . 64.42 110.206 176.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 33.9 p -134.8 116.16 14.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.282 -0.417 . . . . 73.45 110.252 -178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -159.21 108.95 1.92 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.174 -0.466 . . . . 63.54 110.687 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 47.9 pttt -143.18 98.99 3.36 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.093 0.473 . . . . 72.21 110.299 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.4 tpp180 -150.85 88.9 1.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.453 -0.34 . . . . 75.2 111.06 -178.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 1.6 p80 -173.34 149.67 1.77 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.836 -0.431 . . . . 53.11 109.836 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 37.2 tp -161.76 121.22 2.47 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.805 -0.443 . . . . 72.3 109.805 176.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -92.14 21.54 5.02 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.073 -0.512 . . . . 35.35 111.827 -176.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.4 ' H ' ' HG ' ' A' ' 19' ' ' LEU . 24.6 mt-10 -123.58 172.43 8.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.551 0.215 . . . . 55.01 110.84 177.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 50.7 tt0 -78.58 93.37 4.82 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.022 0.439 . . . . 61.31 111.307 -175.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -134.07 67.21 1.52 Allowed 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.279 -0.637 . . . . 71.3 109.279 174.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . 179.33 -56.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 114.875 -1.057 . . . . 71.31 109.557 -178.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 48.3 t -66.03 127.43 27.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.597 -0.729 . . . . 74.55 110.298 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.87 57.19 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.88 -0.676 . . . . 74.3 112.73 -179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.03 167.56 12.68 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-O 121.315 0.578 . . . . 73.45 111.527 178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 1.7 mp -88.92 131.1 37.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.144 -0.935 . . . . 64.23 111.249 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.403 ' CG2' ' HB2' ' A' ' 37' ' ' TRP . 12.7 tt -105.77 136.81 38.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.521 -0.763 . . . . 72.55 109.427 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.5 m -93.83 113.95 26.1 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 112.134 0.42 . . . . 74.14 112.134 -173.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.493 ' HB3' ' HB2' ' A' ' 35' ' ' LYS . 14.4 t70 -72.65 154.77 40.58 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.636 -0.711 . . . . 64.22 110.06 174.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.684 ' HB2' ' HA2' ' A' ' 117' ' ' GLY . 52.3 tpp -70.63 -30.36 66.98 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 120.879 0.371 . . . . 74.31 110.971 -175.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -86.82 18.48 3.44 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-N 116.203 -0.453 . . . . 61.3 110.052 178.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.506 ' O ' ' HD3' ' A' ' 34' ' ' LYS . 0.3 OUTLIER 61.29 77.71 0.32 Allowed 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 115.062 -0.972 . . . . 74.44 110.032 -178.21 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 31' ' ' ASP . 45.4 mmtm -140.52 115.48 9.72 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.972 -1.013 . . . . 53.04 109.139 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -80.74 111.55 17.29 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.245 -0.434 . . . . 40.42 110.228 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.403 ' HB2' ' CG2' ' A' ' 29' ' ' ILE . 83.9 m95 -108.89 163.15 13.54 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.95 -0.759 . . . . 73.32 108.95 174.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.622 ' HB2' ' HA ' ' A' ' 56' ' ' MET . 21.7 ttpt -114.6 129.49 56.68 Favored 'General case' 0 C--N 1.321 -0.659 0 C-N-CA 120.654 -0.418 . . . . 64.33 110.25 176.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.6 p -75.89 104.41 4.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.071 0.462 . . . . 63.31 109.9 175.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -106.22 -104.54 2.95 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.442 -0.885 . . . . 73.31 113.246 -175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 3.1 mm? -86.29 127.71 60.25 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-O 121.043 0.449 . . . . 63.12 111.471 -173.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 6.3 Cg_exo -78.74 106.25 2.08 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 123.106 2.537 . . . . 70.0 111.77 176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 61.6 mt -81.28 -37.09 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 71.03 110.17 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.628 ' HA2' ' HA ' ' A' ' 50' ' ' CYS . . . 87.53 -45.44 3.36 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.829 -0.7 . . . . 60.51 112.696 177.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -103.23 165.63 10.91 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.596 -0.52 . . . . 52.21 109.596 -175.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.63 ' O ' ' HE2' ' A' ' 71' ' ' LYS . . . 98.77 13.36 40.73 Favored Glycine 0 N--CA 1.444 -0.808 0 N-CA-C 109.445 -1.462 . . . . 74.15 109.445 -168.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.849 ' HA3' HD11 ' A' ' 51' ' ' ILE . . . -168.24 -164.4 23.87 Favored Glycine 0 N--CA 1.436 -1.364 0 CA-C-N 114.325 -0.938 . . . . 61.22 111.169 -178.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -102.92 8.72 39.06 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 120.764 0.316 . . . . 74.42 111.625 -171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -160.03 -76.98 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.329 -0.939 . . . . 63.24 113.182 -178.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . 0.628 ' HA ' ' HA2' ' A' ' 44' ' ' GLY . 84.6 m -150.18 110.43 4.17 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.964 -0.384 . . . . 73.1 109.964 -177.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.849 HD11 ' HA3' ' A' ' 47' ' ' GLY . 30.3 mm -100.31 137.83 26.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.073 -0.512 . . . . 74.35 110.62 -177.132 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 77.0 m-85 -110.07 145.15 37.58 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.828 0.347 . . . . 74.3 110.616 -176.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.458 ' HA ' HG12 ' A' ' 69' ' ' VAL . 9.7 tt -91.16 138.27 31.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.421 -0.585 . . . . 75.22 109.421 177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -114.18 96.23 5.69 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.797 0.332 . . . . 71.55 110.945 -178.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -87.13 -32.4 19.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.072 -0.513 . . . . 63.12 110.444 179.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.622 ' HA ' ' HB2' ' A' ' 38' ' ' LYS . 9.2 tpt 62.27 34.85 15.65 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 115.658 -0.701 . . . . 61.23 111.465 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.5 t30 74.07 121.66 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.573 0.701 . . . . 52.3 111.831 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.615 ' HA ' HG11 ' A' ' 62' ' ' VAL . 13.5 m -71.11 108.95 4.89 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.592 -0.731 . . . . 72.42 110.572 -177.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 26.2 m -131.28 -67.31 0.7 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.848 -0.615 . . . . 35.21 111.051 -177.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -157.97 -60.76 0.08 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.824 0.345 . . . . 74.01 110.612 -176.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 12.7 m -64.21 -21.36 66.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.988 -0.551 . . . . 64.2 112.465 -175.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.615 HG11 ' HA ' ' A' ' 58' ' ' SER . 8.8 p -80.82 145.13 9.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.904 0.383 . . . . 64.04 110.776 -178.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -71.79 -170.75 13.59 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.5 -0.857 . . . . 62.51 111.262 171.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 24.4 m -79.98 27.1 0.32 Allowed 'General case' 0 C--N 1.32 -0.706 0 O-C-N 122.571 -0.37 . . . . 71.23 111.479 -176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 66' ' ' ALA . 38.6 t70 175.56 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.454 0 CA-C-N 116.567 -0.288 . . . . 75.12 110.63 -174.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' HB2' ' CG2' ' A' ' 62' ' ' VAL . . . 76.9 116.79 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 124.362 1.039 . . . . 61.12 110.878 -177.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 66' ' ' ALA . 4.0 Cg_exo -79.87 40.72 1.0 Allowed 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.294 2.663 . . . . 74.45 112.341 -177.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' A' ' 131' ' ' MET . 2.2 p -140.71 137.26 33.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.398 0.618 . . . . 70.21 111.931 -178.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 53' ' ' LEU . 30.9 m -137.87 161.85 32.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.312 -0.858 . . . . 62.43 108.971 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.566 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -123.59 122.29 64.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.482 0.658 . . . . 62.45 112.371 -176.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.847 ' HA ' HD12 ' A' ' 51' ' ' ILE . 36.9 ttmt -89.6 122.19 32.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.741 -1.118 . . . . 65.33 109.297 175.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.472 HG12 ' HB3' ' A' ' 128' ' ' PHE . 35.7 m -115.91 139.16 43.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.03 0.382 . . . . 72.41 112.03 -175.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.525 ' HB2' ' HG ' ' A' ' 80' ' ' LEU . 6.6 mm-40 -148.91 139.44 13.47 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.665 -0.698 . . . . 74.44 109.823 174.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 73' ' ' GLU . 25.2 Cg_exo -63.1 150.94 87.18 Favored 'Trans proline' 0 C--O 1.235 0.353 0 C-N-CA 122.942 2.428 . . . . 40.22 112.324 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 56.0 m -73.06 66.83 0.85 Allowed 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.301 0.572 . . . . 54.42 112.068 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -113.61 -6.44 13.38 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 107.52 -1.289 . . . . 72.41 107.52 167.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 9.5 t30 65.57 90.69 0.09 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-N 113.987 -1.46 . . . . 42.45 111.391 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -121.43 -139.66 5.72 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.441 -0.8 . . . . 51.1 111.5 177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.595 ' HG3' HG23 ' A' ' 353' ' ' THR . 28.0 Cg_exo -61.59 -22.93 75.66 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 123.057 2.505 . . . . 74.42 112.175 -178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' HG ' ' HB2' ' A' ' 73' ' ' GLU . 0.9 OUTLIER -56.81 -34.74 67.99 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.743 -0.662 . . . . 62.31 110.294 178.55 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.2 t80 -67.19 -41.43 85.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.48 -0.327 . . . . 73.32 110.43 -178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 2.2 m -65.59 -41.76 92.46 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.235 -0.439 . . . . 71.45 110.348 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.8 mm-40 -58.31 -45.99 86.98 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.672 -0.694 . . . . 73.43 110.425 174.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.5 tp -67.48 -33.69 75.63 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.905 -0.589 . . . . 73.34 111.128 -178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HE3' ' HE1' ' A' ' 173' ' ' TYR . 6.2 tmtm? -64.19 -45.18 89.49 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.351 -0.611 . . . . 74.34 109.351 178.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.404 ' HE1' HG21 ' A' ' 168' ' ' ILE . 87.8 t80 -65.26 -41.5 94.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.852 -0.613 . . . . 73.41 110.275 176.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' CE2' ' HD1' ' A' ' 113' ' ' TYR . 42.8 t80 -59.28 -49.03 79.39 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.076 -0.965 . . . . 75.52 110.512 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -64.04 -34.17 77.42 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.064 0.459 . . . . 64.13 111.226 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 1.2 tpm_? -75.52 -53.56 8.45 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.493 0.553 . . . . 64.22 112.493 -176.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -105.75 -33.7 7.93 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.832 0.679 . . . . 60.13 112.832 -169.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.06 84.84 7.41 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.322 0.582 . . . . 64.23 110.738 -176.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . . . . . . . . . 31.1 tttt -157.48 128.43 3.65 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.772 -0.649 . . . . 74.44 109.466 -176.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_exo -48.0 -52.38 8.34 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.354 2.703 . . . . 63.15 113.23 -174.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -59.75 -45.37 92.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.154 -0.475 . . . . 74.41 110.999 -179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -69.22 -45.58 69.5 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.004 -0.543 . . . . 75.41 110.716 -173.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -63.11 -50.42 79.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.041 -0.527 . . . . 73.02 110.998 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -61.46 -37.3 83.07 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.809 0.338 . . . . 75.43 110.391 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.407 ' HE3' ' HB2' ' A' ' 98' ' ' LYS . 34.0 ttmt -59.63 -51.5 69.57 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.891 -0.595 . . . . 73.43 110.832 179.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.823 ' HH2' ' HB2' ' A' ' 163' ' ' ASP . 23.6 t90 -68.59 -51.1 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.711 -0.677 . . . . 73.22 110.684 -177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 35.1 mm -59.93 -40.05 81.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 74.51 111.713 -177.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 101' ' ' ARG . 45.7 ttt-85 -63.77 -56.54 14.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.395 -0.366 . . . . 75.31 110.856 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.3 m -65.04 -40.84 95.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.754 -0.657 . . . . 40.21 111.239 -174.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -75.53 -13.83 60.38 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.988 -0.551 . . . . 74.1 110.929 -178.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? 62.58 57.74 1.77 Allowed 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 121.336 0.588 . . . . 74.15 110.392 -179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 72.4 mt -117.62 -174.52 2.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.908 -0.587 . . . . 75.04 110.806 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 61.4 mmtt -100.47 -59.21 1.75 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.878 -0.601 . . . . 63.34 111.284 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -144.81 157.26 44.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.695 0.283 . . . . 72.31 110.764 -176.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.561 ' HB3' HG12 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -105.8 137.35 43.84 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.199 -0.667 . . . . 60.24 109.199 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -78.27 33.05 1.78 Allowed Glycine 0 CA--C 1.524 0.619 0 C-N-CA 120.941 -0.647 . . . . 62.24 113.287 -178.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.561 HG12 ' HB3' ' A' ' 108' ' ' LEU . 11.0 p -109.25 137.16 20.14 Favored Pre-proline 0 C--N 1.325 -0.472 0 N-CA-C 109.405 -0.591 . . . . 74.54 109.405 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.415 ' HD2' HG23 ' A' ' 110' ' ' VAL . 5.9 Cg_endo -47.28 135.21 19.8 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 123.51 2.807 . . . . 72.43 113.343 -177.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 44.3 tptt -65.01 121.15 14.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 71.04 110.839 177.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.534 ' HD1' ' CE2' ' A' ' 87' ' ' TYR . 27.2 t80 -80.44 132.27 35.7 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.272 -0.876 . . . . 74.34 111.357 178.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.535 ' HB2' HG22 ' A' ' 130' ' ' ILE . 69.9 m95 -122.42 -54.03 1.89 Allowed 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.875 -0.787 . . . . 51.43 108.875 170.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -174.38 176.71 46.72 Favored Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.393 -0.822 . . . . 71.25 111.96 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 68.0 m -157.29 153.62 27.75 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.996 -0.742 . . . . 72.33 108.996 178.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.684 ' HA2' ' HB2' ' A' ' 32' ' ' MET . . . -161.43 176.07 37.98 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 119.357 -1.401 . . . . 70.2 114.147 -177.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 126' ' ' TYR . 19.1 tp -137.08 129.08 29.27 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.785 -0.82 . . . . 72.01 108.785 176.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -144.49 131.79 20.75 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.701 -0.4 . . . . 73.2 110.648 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.963 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 8.2 t70 -69.74 136.75 51.32 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.085 -0.507 . . . . 61.31 110.824 177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -90.72 -60.01 2.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.258 -0.645 . . . . 54.11 109.258 174.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -170.18 85.06 0.12 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.633 -0.712 . . . . 54.35 109.603 177.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 103.38 -34.86 5.43 Favored Glycine 0 N--CA 1.447 -0.587 0 N-CA-C 111.604 -0.598 . . . . 40.24 111.604 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -132.02 140.8 49.04 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.948 0.404 . . . . 75.0 109.919 177.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.963 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 11.5 p -89.65 156.14 18.77 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.842 -0.617 . . . . 63.03 110.897 -178.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.41 ' O ' HD12 ' A' ' 118' ' ' LEU . 15.8 m-85 -111.5 130.69 55.64 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.737 -0.665 . . . . 72.41 110.391 175.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 43.7 ttm180 -96.44 118.03 32.12 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.709 -0.849 . . . . 74.41 108.709 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.566 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.6 p90 -129.16 156.57 43.69 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.967 0.413 . . . . 75.43 111.5 -173.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 18.5 ptp -137.27 139.59 41.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.671 -0.695 . . . . 55.54 110.335 177.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.547 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 8.7 mm -97.86 117.19 42.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.1 -0.5 . . . . 53.32 109.711 176.259 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.538 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 0.5 OUTLIER -121.84 -175.96 3.22 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.856 -0.611 . . . . 75.34 111.088 -175.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.709 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 20.8 t70 -64.5 157.01 27.85 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.709 -0.678 . . . . 70.12 110.633 177.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.432 ' HD2' ' CD1' ' A' ' 187' ' ' TYR . 1.2 tmt_? -93.71 109.36 21.02 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.268 0.556 . . . . 72.45 110.045 -175.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.517 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 63.7 m-85 -101.84 171.39 7.56 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.905 -0.589 . . . . 73.22 109.9 -179.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -156.7 -36.78 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.472 -0.871 . . . . 42.24 112.42 -179.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.696 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 29.5 m -103.06 124.94 49.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.962 0.411 . . . . 62.11 111.141 -178.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.591 ' HB3' ' HG3' ' A' ' 139' ' ' GLN . 1.3 m-20 -87.42 132.9 33.83 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.06 -0.518 . . . . 65.03 109.905 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.694 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 14.8 tp -68.94 -38.29 79.37 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.065 -1.087 . . . . 63.21 108.065 171.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.979 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 4.9 pt20 -59.51 -49.0 79.49 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.339 -0.846 . . . . 75.14 112.418 179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.563 ' HB2' ' HB2' ' A' ' 137' ' ' ASP . 25.2 mtmm -71.57 -36.91 71.08 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.768 -0.373 . . . . 55.54 111.371 -175.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 62.9 mt -72.03 -48.34 50.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.389 . . . . 71.02 110.568 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.694 ' HB3' ' O ' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -62.05 -44.95 95.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.99 -0.55 . . . . 71.14 111.922 -175.334 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -76.3 -34.39 59.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.876 0.369 . . . . 62.24 110.727 -172.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -73.4 -28.85 62.23 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.996 0.427 . . . . 73.12 110.557 178.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -87.64 0.11 56.11 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.37 0.605 . . . . 63.22 110.185 176.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.407 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 58.81 45.12 15.93 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 115.296 -0.865 . . . . 72.11 112.27 175.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 254' ' ' TRP . 0.0 OUTLIER 39.89 79.75 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 121.932 0.872 . . . . 74.12 112.998 -179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.419 HH11 ' HD2' ' A' ' 148' ' ' ARG . 14.4 ttt180 -146.5 88.48 1.78 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 114.68 -1.145 . . . . 74.43 108.367 177.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.727 ' HD2' ' HB3' ' A' ' 254' ' ' TRP . 52.4 m-85 -120.09 156.16 31.55 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.084 -0.507 . . . . 74.32 112.025 -172.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 16.4 m -67.61 155.66 38.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.32 -0.854 . . . . 72.42 110.257 175.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.607 ' HD2' ' OE2' ' A' ' 298' ' ' GLU . 7.7 tpp85 -59.71 -39.7 85.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.824 0.345 . . . . 73.42 110.797 -177.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.759 ' HD2' ' HB2' ' A' ' 335' ' ' ASP . 26.2 pttm -66.3 -30.36 70.76 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.337 -0.392 . . . . 63.04 111.201 -179.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.431 ' O ' HD13 ' A' ' 157' ' ' LEU . 6.9 m -70.2 -41.52 73.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.131 0.491 . . . . 60.4 110.175 178.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.8 t -59.72 -43.62 91.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.617 -0.72 . . . . 65.24 110.945 179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.652 HD22 HD22 ' A' ' 328' ' ' LEU . 3.3 mp -69.06 -40.16 78.69 Favored 'General case' 0 C--O 1.224 -0.239 0 N-CA-C 112.483 0.549 . . . . 75.21 112.483 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 16.3 mm100 -56.29 -45.06 80.34 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.041 0.448 . . . . 72.31 110.301 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 153' ' ' THR . 8.6 mp -64.18 -52.03 60.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.546 -0.752 . . . . 73.22 111.313 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' ' HG ' ' A' ' 162' ' ' LEU . 11.3 p -65.27 -44.01 89.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.572 -0.286 . . . . 45.22 111.671 -176.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 325' ' ' LEU . 7.0 mp -56.3 -48.99 75.55 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 111.539 0.2 . . . . 52.42 111.539 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.792 ' HA ' ' HE ' ' A' ' 160' ' ' ARG . 2.3 mmp_? -61.15 -42.68 98.98 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.825 0.345 . . . . 73.02 110.907 179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.434 HD11 HD21 ' A' ' 183' ' ' LEU . 31.4 mm -63.62 -38.19 81.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.106 -0.497 . . . . 72.04 110.581 177.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.6 ' HB3' ' CE1' ' A' ' 317' ' ' TYR . 67.3 mt -58.01 -53.04 62.73 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 111.891 0.33 . . . . 75.34 111.891 -178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.823 ' HB2' ' HH2' ' A' ' 99' ' ' TRP . 1.0 OUTLIER -70.08 -39.44 75.59 Favored 'General case' 0 C--O 1.237 0.41 0 C-N-CA 120.454 -0.498 . . . . 34.23 112.119 -175.611 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 11.1 tt -68.54 -36.57 75.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.871 -0.731 . . . . 72.52 110.953 177.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 10.2 tt -67.91 -38.86 83.47 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.797 -0.183 . . . . 73.14 111.212 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.484 ' HG3' ' N ' ' A' ' 167' ' ' TYR . 4.1 pt-20 -68.93 -40.96 78.71 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 120.233 -0.587 . . . . 54.31 110.009 179.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.484 ' N ' ' HG3' ' A' ' 166' ' ' GLU . 66.3 t80 -55.84 -45.81 78.31 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 115.693 -0.685 . . . . 75.32 111.735 179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.404 HG21 ' HE1' ' A' ' 86' ' ' PHE . 26.9 pt -82.55 -31.46 9.64 Favored 'Isoleucine or valine' 0 C--O 1.238 0.491 0 CA-C-N 116.486 -0.324 . . . . 72.33 111.797 -177.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 11.7 t60 -66.8 -27.06 67.27 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 116.436 -0.347 . . . . 74.12 110.689 -178.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 170' ' ' GLU . 37.0 tt0 -77.65 28.56 0.16 Allowed 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 121.107 0.479 . . . . 61.23 111.491 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 8.0 t-80 -151.18 -65.46 0.19 Allowed 'General case' 0 C--N 1.327 -0.408 0 O-C-N 121.525 -0.734 . . . . 74.42 111.597 175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 35.3 mt-10 -147.25 -31.44 0.32 Allowed 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.696 0.628 . . . . 63.33 112.696 -172.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.449 ' HE1' ' HE3' ' A' ' 85' ' ' LYS . 5.4 m-85 -99.18 128.85 45.38 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 113.784 1.031 . . . . 75.41 113.784 -155.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.53 HG13 ' CD1' ' A' ' 204' ' ' TYR . 15.4 m -123.01 139.5 49.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 114.707 -1.133 . . . . 62.32 108.015 163.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -93.77 -32.88 13.81 Favored 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.827 -0.349 . . . . 73.03 110.203 -177.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 68.65 -76.87 0.28 Allowed Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.078 -0.582 . . . . 71.22 111.852 -177.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.9 101.93 0.9 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.037 0.446 . . . . 64.35 110.343 176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.429 ' HA ' HD12 ' A' ' 178' ' ' ILE . 9.4 tp -99.73 20.54 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.876 0.846 . . . . 71.15 110.051 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 2.8 tmtm? -57.56 144.3 37.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.155 -0.93 . . . . 64.35 110.256 -179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 183' ' ' LEU . . . -62.3 -0.36 0.55 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 115.906 -0.588 . . . . 72.44 112.553 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.979 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 14.2 p -70.48 -17.28 62.97 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.872 0.368 . . . . 54.31 111.514 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.536 ' CG ' ' HB3' ' A' ' 198' ' ' TYR . 14.6 m120 -112.53 6.67 18.61 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.865 0.364 . . . . 60.14 111.3 -175.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 180' ' ' ALA . 7.1 mp -105.06 115.66 30.64 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.706 -0.479 . . . . 63.34 109.706 177.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.63 140.3 49.31 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.179 -0.464 . . . . 75.41 110.433 -177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.696 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 53.3 mt -94.71 138.41 32.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.707 -0.679 . . . . 74.51 109.874 -179.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -59.61 140.47 56.33 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.096 -0.705 . . . . 63.3 109.096 174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.432 ' CD1' ' HD2' ' A' ' 133' ' ' ARG . 5.6 p90 -62.42 -22.4 66.15 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.128 0.418 . . . . 73.54 112.128 -171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -104.3 -51.18 3.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.761 0.315 . . . . 65.32 111.039 -175.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -112.11 106.82 56.12 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.404 -0.362 . . . . 74.14 110.979 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -73.13 -11.71 25.32 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 123.096 2.531 . . . . 55.5 112.49 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.575 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 26.8 t70 -70.87 -19.99 62.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.296 0.57 . . . . 71.24 110.703 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 -111.09 103.05 11.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.45 0.643 . . . . 72.53 110.18 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.9 p -102.94 137.99 28.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 115.368 -0.833 . . . . 64.12 109.74 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.517 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 96.3 m-85 -120.3 141.98 49.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.044 0.449 . . . . 64.24 111.054 -175.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.41 HD12 ' O ' ' A' ' 182' ' ' ASN . 37.6 tp -90.76 99.97 12.9 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.728 -0.669 . . . . 54.41 109.392 177.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.4 HG12 ' HG3' ' A' ' 111' ' ' PRO . 27.5 m -139.99 160.84 26.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.457 -0.338 . . . . 74.45 111.636 -174.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.44 ' OD1' ' HA2' ' A' ' 47' ' ' GLY . 16.6 t70 60.67 78.16 0.29 Allowed 'General case' 0 CA--C 1.518 -0.272 0 CA-C-N 114.968 -1.015 . . . . 63.21 111.575 174.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.62 ' HD2' ' H ' ' A' ' 200' ' ' LEU . 19.4 p90 -151.41 -40.76 0.12 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.548 -0.751 . . . . 63.42 112.015 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.658 ' O ' ' HB ' ' A' ' 354' ' ' ILE . . . 66.72 2.16 15.03 Favored Glycine 0 CA--C 1.522 0.511 0 C-N-CA 120.751 -0.737 . . . . 70.41 112.661 -175.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.62 ' H ' ' HD2' ' A' ' 198' ' ' TYR . 6.2 mp -91.94 35.24 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.837 0.351 . . . . 73.24 111.474 -178.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -84.49 97.78 9.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.363 -0.977 . . . . 72.52 108.363 170.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 76.3 t80 -99.97 127.48 46.16 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.265 0.555 . . . . 72.05 110.697 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 2.0 ttp180 -72.86 112.45 8.91 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.483 -0.78 . . . . 61.44 110.229 176.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.573 ' HB2' ' HB1' ' A' ' 237' ' ' ALA . 13.7 p90 -92.57 -26.22 17.99 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.84 -0.43 . . . . 75.42 109.84 177.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 209' ' ' VAL . 18.0 p -133.31 127.42 19.84 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.296 -0.411 . . . . 74.22 111.145 -179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -75.65 131.39 13.51 Favored 'Trans proline' 0 N--CA 1.459 -0.513 0 C-N-CA 122.505 2.137 . . . . 70.44 111.752 175.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 65.96 -79.99 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 O-C-N 123.79 0.681 . . . . 74.32 111.291 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -162.27 15.75 0.14 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 121.155 -0.545 . . . . 41.51 111.927 177.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.415 ' O ' ' HB2' ' A' ' 205' ' ' CYS . 45.0 t -94.95 110.7 24.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.931 -0.396 . . . . 74.51 109.931 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 62.5 m170 -65.98 145.82 55.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.034 -0.53 . . . . 70.01 110.998 -174.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.427 ' HE2' ' O ' ' A' ' 214' ' ' LYS . 74.8 tttt -111.02 145.09 39.08 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.828 -0.624 . . . . 74.05 110.755 -172.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -100.2 -163.39 1.02 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.872 -0.604 . . . . 71.52 110.172 178.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.565 ' HA ' HG23 ' A' ' 236' ' ' VAL . 0.9 OUTLIER -76.27 67.79 2.57 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.809 0.67 . . . . 71.4 112.809 -175.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.427 ' O ' ' HE2' ' A' ' 211' ' ' LYS . 75.6 tttt -158.43 83.28 0.83 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.855 -0.611 . . . . 72.23 109.725 169.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 235' ' ' GLY . 9.8 tp10 -105.9 -72.93 0.7 Allowed 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.939 -0.573 . . . . 75.44 110.464 176.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -138.34 109.39 8.14 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.61 -0.268 . . . . 61.03 110.418 -178.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_exo -65.2 -14.07 43.16 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.23 2.62 . . . . 71.11 112.481 -178.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 218' ' ' LYS . 46.1 tptt -85.99 3.88 40.23 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.237 0.541 . . . . 74.12 110.05 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.448 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 69.7 mtt85 67.27 85.6 0.14 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.44 -0.8 . . . . 62.24 110.653 177.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 42.1 t -56.02 -42.81 77.05 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 114.43 -1.259 . . . . 64.42 112.915 -172.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 44.64 75.64 0.1 Allowed 'General case' 0 N--CA 1.472 0.67 0 CA-C-O 121.869 0.842 . . . . 72.24 111.453 -175.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -80.32 -43.06 21.85 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.071 -0.968 . . . . 75.43 111.491 -178.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -96.88 -170.46 33.95 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.697 -0.763 . . . . 71.21 112.789 -179.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.3 m -69.58 142.24 53.6 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.443 0.164 . . . . 44.32 110.77 -179.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.532 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -56.96 -23.83 18.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-O 121.471 0.653 . . . . 73.41 110.542 -179.455 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -62.23 -53.47 54.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.465 -0.788 . . . . 65.42 111.937 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -112.27 7.0 19.22 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 113.085 0.772 . . . . 74.53 113.085 -173.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -64.42 -21.1 66.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.755 0.312 . . . . 60.55 111.288 178.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.677 ' HA ' ' CD ' ' A' ' 275' ' ' LYS . 50.8 m 59.77 -162.93 0.24 Allowed 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 115.709 -0.678 . . . . 64.44 110.247 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.664 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.2 OUTLIER -71.0 -34.16 54.41 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 C-N-CA 120.421 -0.512 . . . . 74.11 110.281 176.436 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.424 ' HA ' HG13 ' A' ' 236' ' ' VAL . 5.2 m-20 -59.76 -77.96 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.631 -0.713 . . . . 63.34 112.316 -174.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.65 -31.59 72.81 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.362 -0.381 . . . . 63.33 111.714 -172.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -68.97 -31.35 70.15 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.496 -0.32 . . . . 73.24 111.164 -179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -94.69 0.52 55.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.142 0.496 . . . . 64.23 110.711 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.492 ' O ' ' HB3' ' A' ' 215' ' ' GLU . . . 87.12 33.89 11.47 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.459 -0.877 . . . . 71.44 113.829 174.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.565 HG23 ' HA ' ' A' ' 213' ' ' TYR . 1.4 p -120.79 129.22 75.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 117.226 0.513 . . . . 42.44 110.803 173.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.573 ' HB1' ' HB2' ' A' ' 204' ' ' TYR . . . -77.29 111.6 18.03 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.94 -0.573 . . . . 51.24 109.578 175.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -80.54 123.82 4.99 Favored 'Trans proline' 0 N--CA 1.458 -0.599 0 C-N-CA 122.577 2.185 . . . . 73.32 113.295 -173.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 66.1 m -95.37 104.59 16.5 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.886 -0.597 . . . . 55.31 110.041 173.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.645 HH21 ' HB2' ' A' ' 244' ' ' LEU . 0.0 OUTLIER 79.8 -56.56 0.38 Allowed 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.64 0.776 . . . . 72.02 110.866 175.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.658 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.61 -54.89 38.51 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.32 -0.4 . . . . 74.11 111.457 -173.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.427 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.13 -44.95 97.51 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.874 -0.679 . . . . 55.23 112.592 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -51.43 -53.74 33.84 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 121.113 0.482 . . . . 72.52 111.12 -177.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.645 ' HB2' HH21 ' A' ' 240' ' ' ARG . 3.7 mm? -72.22 -40.34 67.85 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.745 -0.662 . . . . 64.51 111.537 -175.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.08 -46.43 89.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.69 0.281 . . . . 61.45 111.049 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.427 HG13 ' O ' ' A' ' 242' ' ' GLY . 75.1 mt -66.6 -33.92 66.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.397 -0.365 . . . . 65.3 110.714 -178.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.07 -47.1 86.49 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.517 -0.549 . . . . 65.3 109.517 174.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.47 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -58.76 -39.1 93.25 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.737 -0.744 . . . . 75.02 112.18 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 20.3 m-85 -65.07 -42.18 94.4 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 111.965 0.358 . . . . 75.42 111.965 -178.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . . . . . . . . . 31.2 p -69.64 -35.8 75.53 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.243 -0.583 . . . . 74.15 110.955 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 70.6 mtm -65.69 -46.81 77.65 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.056 -0.258 . . . . 62.35 111.073 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.2 tt -66.8 -28.78 44.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 120.738 -0.385 . . . . 54.45 110.586 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.03 -46.55 87.04 Favored 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 109.97 -0.382 . . . . 71.31 109.97 177.454 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.727 ' HB3' ' HD2' ' A' ' 149' ' ' PHE . 16.8 m0 -67.32 -28.64 68.15 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-N 115.915 -0.584 . . . . 75.11 110.906 179.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 52.0 tp -83.9 -35.78 23.84 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.815 -0.63 . . . . 74.33 112.628 -173.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 42.9 p -102.64 -14.69 16.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.416 0.524 . . . . 73.34 112.416 -171.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 91.28 -33.54 4.69 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.235 -0.983 . . . . 61.15 113.006 176.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -157.16 143.93 18.32 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 122.371 -0.488 . . . . 73.14 110.868 176.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.496 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 96.3 mt -103.9 149.5 37.25 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.974 -0.557 . . . . 73.23 110.315 176.455 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -55.01 -40.25 86.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.751 2.301 . . . . 73.3 112.681 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.496 ' CZ2' HD13 ' A' ' 259' ' ' LEU . 25.0 p90 -87.13 -0.38 56.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.531 -0.304 . . . . 71.32 111.35 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.535 ' HA ' HD23 ' A' ' 265' ' ' LEU . 84.7 tt0 -79.63 -28.27 40.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.093 0.473 . . . . 73.34 109.945 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -82.19 -27.95 32.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.224 0.535 . . . . 64.5 110.26 175.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -108.4 17.42 22.13 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.529 -0.76 . . . . 54.13 112.098 -173.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.535 HD23 ' HA ' ' A' ' 262' ' ' GLU . 4.2 pp -73.56 -7.85 53.55 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 121.091 0.472 . . . . 64.1 111.085 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 54.2 pttt -64.21 -14.12 53.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.564 -0.744 . . . . 73.23 111.058 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.706 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 10.9 t70 -134.69 127.89 18.71 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 120.927 0.394 . . . . 63.23 110.223 -179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.0 Cg_exo -61.59 -33.06 87.71 Favored 'Trans proline' 0 CA--C 1.53 0.314 0 C-N-CA 123.351 2.701 . . . . 71.52 114.794 -171.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.706 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 22.9 pttm -74.29 -24.04 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.515 -0.474 . . . . 75.13 111.471 -173.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.506 ' CD1' ' HB3' ' A' ' 267' ' ' ASP . 74.6 m-85 -71.22 -49.55 42.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.881 0.372 . . . . 73.3 110.157 177.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.671 HG13 ' HZ2' ' A' ' 275' ' ' LYS . 96.1 t -58.5 -37.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.784 -0.644 . . . . 74.03 110.954 173.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.427 ' O ' HG13 ' A' ' 276' ' ' ILE . 48.5 ttt-85 -59.85 -61.9 2.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.605 -0.725 . . . . 73.14 110.876 -179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.58 -45.58 91.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.974 -0.557 . . . . 73.54 111.82 -174.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 15.1 p -61.46 -49.92 74.84 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 72.33 111.883 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.677 ' CD ' ' HA ' ' A' ' 229' ' ' SER . 56.2 mttp -66.69 -37.35 84.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.912 -0.315 . . . . 61.15 111.75 -176.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.536 ' O ' ' HG3' ' A' ' 280' ' ' GLU . 83.0 mt -60.85 -49.58 84.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.983 0.42 . . . . 55.44 110.557 178.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 70.9 mtp180 -69.01 -33.63 73.96 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.946 -0.57 . . . . 74.42 111.003 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -63.81 -36.4 83.79 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 64.1 110.644 175.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.414 ' O ' HG23 ' A' ' 282' ' ' ILE . 58.2 ttp180 -71.06 -38.22 72.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.353 -0.385 . . . . 74.31 110.805 179.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . 0.536 ' HG3' ' O ' ' A' ' 276' ' ' ILE . 72.7 mt-10 -67.58 -42.32 82.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.031 0.443 . . . . 74.24 110.986 -178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.488 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.0 m-80 -117.78 46.97 1.64 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.0 -0.545 . . . . 73.52 110.649 -173.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.585 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -49.63 -51.35 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 N-CA-C 112.865 0.691 . . . . 73.33 112.865 -176.768 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.51 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.11 -43.54 98.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.913 0.387 . . . . 61.25 111.339 -175.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.4 m -65.96 -45.39 81.9 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.839 -0.619 . . . . 75.02 110.853 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.488 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.0 mm? -69.39 -43.12 74.14 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.156 -0.474 . . . . 72.21 111.603 -177.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.473 ' HG2' ' O ' ' A' ' 282' ' ' ILE . 30.5 mmt -64.57 -40.34 95.38 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 120.965 -0.294 . . . . 74.21 111.051 -177.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.511 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 16.1 t70 -66.26 -48.64 69.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.326 0.584 . . . . 74.31 111.2 -178.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -98.94 14.54 28.69 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.847 -0.615 . . . . 64.23 111.875 -169.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 285' ' ' LEU . 47.4 t -85.44 -27.25 25.86 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.777 -0.453 . . . . 60.02 109.777 173.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 290' ' ' PHE . 0.1 OUTLIER -138.1 68.5 48.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 64.3 111.298 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.19 31.89 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 123.035 2.49 . . . . 71.34 111.919 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -84.76 -85.98 0.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.666 -0.697 . . . . 70.2 111.808 -173.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 15.5 tppt? -145.4 16.27 1.49 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.964 0.887 . . . . 71.42 109.492 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -104.73 -142.92 0.37 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.338 -0.847 . . . . 61.01 109.958 -176.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.411 ' HD2' ' HA ' ' A' ' 295' ' ' LYS . 47.9 tptt -156.06 114.98 2.16 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 116.657 -0.247 . . . . 63.21 110.613 -176.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.511 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 47.3 Cg_endo -95.42 77.99 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.054 0 C-N-CA 123.342 2.695 . . . . 65.42 111.697 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -119.95 -59.7 0.25 Allowed Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.201 -0.999 . . . . 63.22 112.535 -178.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.607 ' OE2' ' HD2' ' A' ' 151' ' ' ARG . 1.1 mp0 -60.02 -61.43 2.61 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.675 0.274 . . . . 74.11 110.399 -176.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.554 ' H ' HD12 ' A' ' 299' ' ' ILE . 4.7 mp -60.6 -37.17 74.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.835 -0.62 . . . . 60.34 110.63 -177.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.68 -53.61 51.9 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 70.33 111.335 -178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 301' ' ' LYS . 40.4 tptt -72.03 -33.58 68.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 73.12 110.34 -177.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 62.5 t80 -55.41 -49.39 72.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.669 -0.696 . . . . 74.1 110.708 176.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.47 ' SD ' ' HA3' ' A' ' 248' ' ' GLY . 94.3 mmm -72.02 -39.67 69.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.935 -0.575 . . . . 74.05 111.057 -177.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.534 ' HA ' HG13 ' A' ' 282' ' ' ILE . 23.1 tt0 -57.46 -45.68 84.49 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.634 0.73 . . . . 63.23 109.71 176.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.6 m -60.07 -51.08 71.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.54 -1.209 . . . . 63.25 112.0 -179.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 303' ' ' MET . 31.0 m -73.37 -27.91 24.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 112.331 0.493 . . . . 42.51 112.331 -174.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 13.1 tmtt? -75.62 -43.82 45.97 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.889 0.376 . . . . 71.32 110.703 -177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 95.2 mt -84.95 76.74 10.23 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 112.344 0.498 . . . . 75.0 112.344 -173.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.634 HD11 HH11 ' A' ' 240' ' ' ARG . 0.5 OUTLIER -163.28 -74.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.13 -0.486 . . . . 74.33 110.864 171.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.999 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 32.4 t70 -178.35 164.22 1.69 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.993 -0.373 . . . . 64.13 109.993 -178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.658 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 2.2 t80 -58.58 -64.6 0.87 Allowed 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 122.861 0.465 . . . . 75.25 111.069 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 t -114.77 36.42 3.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.409 0.623 . . . . 74.42 110.731 -173.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 9.9 tp10 -67.57 -86.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.587 -0.733 . . . . 65.41 111.481 -179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt 179.98 137.53 0.29 Allowed Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 109.502 -0.555 . . . . 72.53 109.502 -176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -91.96 128.64 1.02 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 122.622 2.215 . . . . 73.12 112.995 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.498 ' O ' HD13 ' A' ' 320' ' ' LEU . 90.4 mt -79.96 75.78 6.68 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.518 -0.549 . . . . 74.03 109.518 172.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.6 ' CE1' ' HB3' ' A' ' 162' ' ' LEU . 67.1 t80 -57.67 -39.29 76.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.778 -0.646 . . . . 74.31 111.401 -174.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -62.08 -43.7 98.28 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.294 -0.412 . . . . 61.42 110.517 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -76.7 -29.87 56.47 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.52 -0.309 . . . . 72.5 111.225 -178.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.558 ' O ' HG22 ' A' ' 323' ' ' ILE . 7.1 mp -69.34 -48.13 62.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.763 0.316 . . . . 74.32 110.9 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.442 HH22 ' NH2' ' A' ' 160' ' ' ARG . 20.9 ttt180 -70.57 -28.13 64.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.072 0.463 . . . . 75.34 109.758 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -72.41 -41.03 66.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.882 -0.599 . . . . 71.41 111.464 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.558 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -67.72 -36.88 77.46 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 N-CA-C 109.956 -0.387 . . . . 75.14 109.956 -179.444 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.439 ' O ' HD21 ' A' ' 155' ' ' LEU . 92.1 mt -60.46 -49.43 77.59 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.936 0.398 . . . . 61.21 110.079 175.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.673 HD21 HD21 ' A' ' 159' ' ' LEU . 3.8 mm? -62.61 -37.92 88.15 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.98 -0.554 . . . . 51.12 111.408 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -55.56 -47.36 76.5 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.586 -0.279 . . . . 75.2 110.827 178.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.586 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.83 -42.64 96.94 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.747 -0.74 . . . . 75.15 112.184 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.682 ' HG ' ' O ' ' A' ' 333' ' ' SER . 27.4 tp -65.86 -42.97 89.73 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.955 0.407 . . . . 71.13 111.114 -178.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -66.69 -32.59 73.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.879 0.371 . . . . 73.22 110.363 178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.87 -31.19 64.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.504 . . . . 54.24 111.089 -179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 328' ' ' LEU . 12.7 tt -85.68 -7.6 10.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.328 0 CA-C-O 120.948 0.404 . . . . 72.11 110.495 179.435 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 85.97 25.83 36.45 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.562 -0.827 . . . . 43.25 113.508 173.212 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.682 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 52.3 m -129.42 162.57 27.76 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 117.034 0.417 . . . . 73.12 111.16 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.785 ' HD2' ' HB2' ' A' ' 336' ' ' ASP . 5.6 tmtt? -179.5 -51.41 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 108.931 -0.766 . . . . 74.42 108.931 173.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.759 ' HB2' ' HD2' ' A' ' 152' ' ' LYS . 8.1 t70 70.04 -80.45 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.154 -0.93 . . . . 71.3 110.473 -177.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . 0.785 ' HB2' ' HD2' ' A' ' 334' ' ' LYS . 10.9 t70 58.56 94.67 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 O-C-N 123.669 0.606 . . . . 72.11 111.21 176.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 150.14 -36.07 0.97 Allowed Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.958 -0.857 . . . . 61.14 110.958 -176.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.575 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 0.0 OUTLIER -150.82 157.49 43.0 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.547 -0.538 . . . . 62.43 109.547 172.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . . . . . . . . . 28.1 tp -90.38 130.85 36.42 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.999 -0.371 . . . . 70.3 109.999 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.687 ' HB2' ' HE2' ' A' ' 152' ' ' LYS . 27.9 t0 -78.97 85.16 4.94 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.926 -0.579 . . . . 72.14 111.004 -178.244 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.41 ' O ' ' HB3' ' A' ' 342' ' ' SER . 61.9 mt -138.93 -41.03 0.48 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.082 -0.963 . . . . 71.15 109.91 175.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.541 ' O ' ' HB ' ' A' ' 343' ' ' VAL . 44.4 t 74.18 -92.34 0.02 OUTLIER 'General case' 0 CA--C 1.517 -0.294 0 CA-C-N 114.978 -1.01 . . . . 72.41 108.734 -178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.541 ' HB ' ' O ' ' A' ' 342' ' ' SER . 10.2 p 167.32 81.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 CA-C-O 122.137 0.97 . . . . 74.42 109.196 177.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.84 -77.43 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.437 -0.801 . . . . 61.55 111.274 -177.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -138.67 165.78 26.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.806 0.336 . . . . 75.03 111.12 -175.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -128.97 146.84 50.86 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.862 -0.608 . . . . 75.25 109.856 176.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -120.27 -141.86 6.43 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.97 -0.634 . . . . 43.04 112.101 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -137.36 106.2 0.53 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.47 -0.872 . . . . 75.24 112.251 179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -127.46 156.25 42.42 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.762 -0.459 . . . . 63.24 109.762 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -115.34 163.5 15.61 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.929 0.395 . . . . 74.23 111.245 -176.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -80.14 -168.41 1.64 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.564 -0.743 . . . . 72.14 109.675 172.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -140.37 -179.69 6.15 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.153 0.501 . . . . 74.32 112.133 -175.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.595 HG23 ' HG3' ' A' ' 79' ' ' PRO . 95.8 m -150.44 137.35 19.21 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.641 -0.708 . . . . 73.22 109.946 -178.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.658 ' HB ' ' O ' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -66.91 134.03 30.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 121.271 0.558 . . . . 62.13 110.27 -176.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.454 ' N ' HD13 ' A' ' 354' ' ' ILE . 50.9 m -64.96 94.18 0.13 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.507 -0.769 . . . . 35.11 112.054 -175.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.552 ' HD3' ' HB2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -172.37 -25.7 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.761 -0.654 . . . . 74.22 111.305 174.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.552 ' HB2' ' HD3' ' A' ' 356' ' ' LYS . 77.3 tttt -122.51 145.85 47.94 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.131 -0.228 . . . . 71.02 110.412 -179.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 358' ' ' ARG . 22.5 ttt180 -73.96 -54.05 8.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 64.21 110.408 -179.269 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 16.4 pttp -176.18 -177.3 0.87 Allowed 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 107.963 -1.125 . . . . 70.12 107.963 175.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 20.5 pttp . . . . . 0 C--O 1.245 0.821 0 CA-C-O 118.655 -0.688 . . . . 44.45 109.869 176.71 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 109.954 -0.387 . . . . 70.43 109.954 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -79.35 138.78 14.22 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 122.879 2.386 . . . . 71.3 112.328 -178.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.72 118.35 18.0 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.273 0.558 . . . . 75.14 109.856 177.107 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.3 t -92.81 102.12 13.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-O 121.234 0.54 . . . . 62.22 110.509 -178.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.784 ' HD3' ' H ' ' A' ' 5' ' ' LYS . 0.5 OUTLIER -104.81 123.45 47.7 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.986 -0.552 . . . . 72.32 109.784 178.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -156.75 122.62 4.84 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.935 -0.575 . . . . 72.24 110.505 -179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -152.85 -5.22 0.21 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.061 -0.518 . . . . 51.14 111.308 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -83.79 93.21 7.91 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.265 0.555 . . . . 53.51 111.292 -177.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -150.99 78.69 1.3 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.632 -0.713 . . . . 32.25 110.144 177.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 57.91 -132.64 52.66 Favored Glycine 0 N--CA 1.451 -0.346 0 CA-C-N 115.771 -0.649 . . . . 72.24 112.55 -177.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.777 ' HA ' ' HE ' ' A' ' 11' ' ' ARG . 1.2 mmp_? 57.39 78.47 0.23 Allowed 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 123.3 0.64 . . . . 73.4 112.355 177.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 43.8 mt-30 -97.21 -176.75 3.62 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.855 -0.424 . . . . 72.31 109.855 173.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 17.6 m -79.62 122.61 26.73 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.984 0.421 . . . . 72.34 111.736 -171.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 22.0 m -92.45 142.43 27.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.571 -0.74 . . . . 74.55 109.336 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.62 176.85 8.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.111 0.482 . . . . 75.42 112.042 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -145.31 -165.46 2.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.08 -0.963 . . . . 63.33 109.289 177.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 18' ' ' HIS . 7.7 tpm_? -57.72 -26.99 62.56 Favored 'General case' 0 CA--C 1.535 0.374 0 O-C-N 123.482 0.489 . . . . 64.33 111.46 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.458 ' HB2' ' O ' ' A' ' 17' ' ' ARG . 35.2 m170 77.19 61.04 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.485 0.714 . . . . 73.41 112.36 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 19' ' ' LEU . 2.3 pt? -145.0 88.03 1.87 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.668 0.747 . . . . 73.25 109.747 172.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -131.33 113.7 14.11 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.961 -0.563 . . . . 70.25 110.672 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.07 -24.06 12.84 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.083 -0.508 . . . . 71.41 109.937 177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 53.5 tp60 55.62 -101.58 0.13 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-N 115.58 -0.736 . . . . 72.12 109.575 -175.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' GLN . 16.3 t80 178.37 77.38 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.319 0.58 . . . . 65.44 109.478 173.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.53 ' HB1' ' OE2' ' A' ' 27' ' ' GLU . . . -130.13 2.09 4.73 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.478 -0.783 . . . . 43.24 109.879 177.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.53 ' HA ' HG13 ' A' ' 39' ' ' VAL . 61.3 t -56.24 128.17 16.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 115.22 -0.9 . . . . 74.4 110.928 -177.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.37 0.03 56.96 Favored Glycine 0 N--CA 1.444 -0.816 0 C-N-CA 120.694 -0.765 . . . . 32.13 113.425 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.578 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 9.4 pt-20 -82.48 150.74 26.85 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 109.029 -0.73 . . . . 73.01 109.029 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.431 HD12 ' HA ' ' A' ' 28' ' ' ILE . 1.2 tp -91.42 131.54 38.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.426 0.631 . . . . 63.24 110.057 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 59.0 mt -124.34 132.14 71.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.498 -0.773 . . . . 72.23 109.222 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.543 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 10.2 m -118.08 114.08 22.57 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.935 -0.395 . . . . 75.21 109.935 179.088 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.537 ' OD2' ' HA3' ' A' ' 115' ' ' GLY . 4.7 p-10 -95.23 -172.02 2.56 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.268 -0.424 . . . . 70.21 110.41 -177.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 25.1 mmt -70.58 -11.27 60.82 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.475 0.546 . . . . 74.23 112.475 -175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.06 2.45 39.17 Favored 'General case' 0 C--N 1.329 -0.316 0 O-C-N 122.226 -0.296 . . . . 53.34 110.372 174.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt 67.28 24.93 8.95 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.517 -0.765 . . . . 74.21 110.687 176.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.543 ' O ' ' HA ' ' A' ' 30' ' ' THR . 29.1 mtpp -93.63 124.75 37.84 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.85 -0.614 . . . . 71.24 110.163 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -95.79 92.21 6.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.354 -0.61 . . . . 71.12 109.354 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 1.004 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 25.1 p-90 -116.83 140.02 49.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.792 -0.64 . . . . 74.33 111.141 -175.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.621 ' HG2' ' O ' ' A' ' 56' ' ' MET . 23.6 pttm -85.6 139.26 31.57 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 109.101 -0.703 . . . . 44.22 109.101 174.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 25' ' ' VAL . 3.6 p -66.95 117.39 7.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.061 -0.718 . . . . 74.23 109.061 174.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -101.98 -121.59 4.89 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 120.418 -0.896 . . . . 40.51 112.731 -174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.685 HD22 ' HD2' ' A' ' 42' ' ' PRO . 2.4 tm? -73.31 118.02 65.2 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-O 120.916 0.388 . . . . 73.33 110.397 -176.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.685 ' HD2' HD22 ' A' ' 41' ' ' LEU . 65.1 Cg_endo -75.91 96.7 1.07 Allowed 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.492 2.128 . . . . 72.43 111.797 175.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 53' ' ' LEU . 56.7 mt -62.77 -45.56 98.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.242 0.544 . . . . 65.33 110.337 -179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.29 12.25 83.67 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 115.399 -0.819 . . . . 62.11 112.226 179.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.796 ' HG2' HD11 ' A' ' 349' ' ' LEU . 61.1 mt-30 -139.04 159.85 41.18 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.902 -0.407 . . . . 65.32 109.902 -174.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 106.73 49.88 0.88 Allowed Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.634 -0.793 . . . . 74.32 111.497 -176.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.03 112.06 2.71 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.686 -0.768 . . . . 60.04 112.218 -177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.583 ' HD2' ' HE2' ' A' ' 71' ' ' LYS . 21.5 m-85 68.25 -72.38 0.1 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.465 0.706 . . . . 71.2 111.447 -178.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.438 ' HA3' ' HB3' ' A' ' 18' ' ' HIS . . . 138.8 174.91 13.67 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 121.034 -0.603 . . . . 72.51 111.625 -177.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 75.2 m 62.39 31.1 17.39 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-O 120.895 0.379 . . . . 62.12 111.483 -178.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.623 HD12 ' HG3' ' A' ' 71' ' ' LYS . 18.1 mm -88.82 136.59 23.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.92 -0.4 . . . . 74.24 109.92 -179.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -108.19 153.65 22.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.52 0.2 . . . . 73.32 110.975 -175.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.546 HD12 HD11 ' A' ' 43' ' ' ILE . 8.1 tt -100.91 137.39 39.35 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.372 -0.603 . . . . 52.25 109.372 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.406 ' HB3' ' SG ' ' A' ' 68' ' ' CYS . . . -94.98 93.73 7.57 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.055 0.455 . . . . 53.41 110.494 -177.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -79.13 -15.87 57.5 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.038 -0.528 . . . . 72.13 110.837 -175.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 1.004 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 47.8 mtp 59.94 -163.47 0.24 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.75 -0.659 . . . . 73.43 110.39 -176.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 15.5 t-20 -116.38 141.22 48.45 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.545 -0.909 . . . . 62.23 108.545 174.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 22.6 m -77.35 38.12 0.22 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.337 0.495 . . . . 63.32 112.337 -171.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 50.0 m -96.05 -38.42 10.2 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.592 -0.521 . . . . 74.22 109.592 173.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -158.46 102.3 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 74.01 109.964 -179.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 5.5 p -169.05 124.42 0.88 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.187 -0.46 . . . . 74.04 110.504 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.496 HG12 ' OD1' ' A' ' 65' ' ' ASP . 8.5 p -82.6 144.06 10.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.486 -0.561 . . . . 55.11 109.486 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -63.51 4.05 1.11 Allowed Glycine 0 CA--C 1.523 0.565 0 C-N-CA 121.152 -0.547 . . . . 21.14 113.723 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 m -104.44 -18.21 14.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.868 0.334 . . . . 51.12 111.378 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' A' ' 62' ' ' VAL . 0.7 OUTLIER -108.61 -22.45 12.26 Favored 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 120.638 -0.425 . . . . 63.43 110.928 -179.409 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.516 ' N ' ' HD2' ' A' ' 67' ' ' PRO . . . -60.36 -42.56 89.65 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 112.221 0.452 . . . . 51.21 112.221 174.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.629 ' O ' ' HB3' ' A' ' 133' ' ' ARG . 56.1 Cg_endo -71.21 62.39 2.62 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 121.697 1.598 . . . . 54.04 112.611 175.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.406 ' SG ' ' HB3' ' A' ' 54' ' ' ALA . 9.3 p -120.79 152.47 38.31 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.7 -0.482 . . . . 74.34 109.7 172.029 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 34.1 m -122.94 155.8 28.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 120.656 0.265 . . . . 64.2 110.784 -178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.586 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.4 p -121.48 120.71 62.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.314 0.578 . . . . 54.23 111.415 -178.335 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.623 ' HG3' HD12 ' A' ' 51' ' ' ILE . 77.6 tttt -95.64 131.84 41.44 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.252 -0.885 . . . . 64.21 109.116 178.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.513 HG12 ' HB3' ' A' ' 128' ' ' PHE . 34.7 m -118.68 151.76 20.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.207 0.447 . . . . 52.23 112.207 -173.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.496 ' HG2' ' HB3' ' A' ' 127' ' ' ARG . 4.1 pt-20 -132.9 155.93 80.62 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 116.322 -0.399 . . . . 72.3 110.211 172.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.499 ' HB2' HH12 ' A' ' 358' ' ' ARG . 2.0 Cg_endo -82.29 114.87 2.53 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.632 2.221 . . . . 74.25 112.24 176.126 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.7 t 81.47 -96.66 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 124.032 0.933 . . . . 61.11 112.467 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -171.02 12.71 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 114.299 1.222 . . . . 62.0 114.299 -167.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.573 ' CB ' ' HB3' ' A' ' 359' ' ' LYS . 0.5 OUTLIER -146.37 103.95 3.74 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 119.779 -0.768 . . . . 74.23 112.394 -171.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 172.96 -161.24 32.38 Favored Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 120.921 -0.657 . . . . 53.31 111.781 177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.896 ' HB3' ' HA2' ' A' ' 199' ' ' GLY . 31.2 Cg_exo -60.02 -26.64 82.98 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 123.017 2.478 . . . . 72.33 112.465 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.8 tm? -64.52 -37.07 86.27 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.457 -0.572 . . . . 70.45 109.457 178.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -66.88 -38.28 86.02 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.214 0.53 . . . . 74.43 109.808 176.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.3 m -62.87 -45.05 94.37 Favored 'General case' 0 C--O 1.24 0.566 0 CA-C-N 115.68 -0.691 . . . . 72.33 110.162 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -67.68 -29.72 69.06 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 115.934 -0.576 . . . . 74.51 110.752 176.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 50.6 tp -59.08 -50.24 74.81 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.418 -0.215 . . . . 74.42 110.418 178.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -58.57 -47.27 84.83 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.769 0.319 . . . . 63.54 110.627 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.405 ' HD2' ' CD1' ' A' ' 87' ' ' TYR . 83.8 t80 -57.58 -52.19 66.41 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 115.895 -0.593 . . . . 75.0 111.127 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.405 ' CD1' ' HD2' ' A' ' 86' ' ' PHE . 6.1 m-30 -62.35 -43.73 98.13 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.594 -0.275 . . . . 75.44 111.232 -175.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -65.18 -33.46 76.07 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 111.81 0.3 . . . . 72.22 111.81 -177.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.1 mpt_? -95.48 -23.04 17.29 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.663 0.616 . . . . 72.01 112.663 -176.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.415 ' HB2' ' HE2' ' A' ' 167' ' ' TYR . . . -104.11 -34.54 8.37 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.78 0.659 . . . . 73.4 112.78 -174.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -85.81 78.36 9.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.31 0.576 . . . . 72.21 111.594 -173.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 19.2 tptp -155.51 101.79 2.21 Favored Pre-proline 0 C--N 1.323 -0.577 0 N-CA-C 108.894 -0.78 . . . . 73.53 108.894 176.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -43.72 -46.46 10.39 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 123.878 3.052 . . . . 75.3 114.138 -172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -58.26 -51.73 68.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.806 0.336 . . . . 75.2 111.156 -178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -64.95 -40.89 95.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.302 -0.408 . . . . 74.43 110.488 -178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.514 ' HA ' ' CZ3' ' A' ' 99' ' ' TRP . 72.8 mt -57.94 -53.6 43.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.047 -0.524 . . . . 50.23 110.857 -179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -62.04 -31.05 71.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.829 -0.623 . . . . 72.23 110.637 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HD3' ' HA ' ' A' ' 98' ' ' LYS . 10.5 tppt? -70.54 -50.9 32.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.099 -0.501 . . . . 75.21 111.525 -175.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.544 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -73.53 -35.66 65.6 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 119.749 -0.78 . . . . 65.43 110.57 -178.424 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 39.0 mt -60.84 -34.95 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 121.439 0.638 . . . . 71.42 110.089 176.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 54.4 ttt180 -65.46 -49.34 69.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.243 -0.89 . . . . 74.41 111.229 176.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.8 p -75.75 -41.8 52.25 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.287 0.477 . . . . 73.31 112.287 -175.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.533 ' HB2' HD13 ' A' ' 105' ' ' LEU . 18.4 mmt180 -78.1 -17.38 57.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.477 -0.329 . . . . 72.35 111.189 -177.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt 64.95 59.97 0.84 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-O 121.949 0.88 . . . . 54.42 110.177 -174.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.533 HD13 ' HB2' ' A' ' 103' ' ' ARG . 7.3 mp -97.09 -166.3 1.38 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.557 -1.201 . . . . 75.12 108.542 173.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 10.0 tptp -128.64 -54.42 1.24 Allowed 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.9 -0.72 . . . . 52.32 112.388 -174.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.0 t80 -164.73 107.88 0.88 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.713 -0.395 . . . . 71.55 110.981 -171.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.544 HD22 ' CZ2' ' A' ' 99' ' ' TRP . 18.2 tp -80.21 132.0 35.8 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.01 -178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -89.72 70.91 2.29 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.997 -0.62 . . . . 63.1 111.904 176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.41 HG11 HD13 ' A' ' 96' ' ' ILE . 11.3 p -115.89 142.44 29.11 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 110.515 -0.18 . . . . 62.5 110.515 -176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.478 ' HG3' HG11 ' A' ' 196' ' ' VAL . 6.8 Cg_exo -72.82 140.4 32.0 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.468 2.112 . . . . 72.43 112.084 175.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 65.5 tttp -72.57 106.49 4.64 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.696 -0.483 . . . . 74.32 109.696 174.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 55.6 t80 -81.7 119.91 24.44 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.985 -0.552 . . . . 74.15 110.743 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CD1' HG22 ' A' ' 130' ' ' ILE . 41.9 m95 -95.73 -65.63 0.96 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.205 0.526 . . . . 72.11 109.802 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.537 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -151.07 -170.76 18.43 Favored Glycine 0 N--CA 1.446 -0.664 0 CA-C-N 115.622 -0.717 . . . . 75.23 112.317 -177.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.444 ' HB3' ' HG2' ' A' ' 129' ' ' MET . 51.2 p -167.8 -177.36 3.42 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.864 -0.421 . . . . 71.23 109.864 -175.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 161.43 -175.08 38.05 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.22 -0.99 . . . . 43.43 112.629 176.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.523 HD21 ' HB3' ' A' ' 125' ' ' SER . 8.9 tt -133.39 127.88 34.39 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.915 -0.772 . . . . 54.03 108.915 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -138.62 120.87 15.85 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.852 0.358 . . . . 63.2 110.772 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 11.7 t70 -81.36 131.26 35.28 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.028 -0.533 . . . . 63.42 110.612 178.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 28.9 mmmt -96.26 -53.21 3.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.362 -0.381 . . . . 62.32 110.588 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -169.22 91.69 0.24 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.876 -0.602 . . . . 70.05 109.869 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 70.27 11.5 67.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.194 -0.527 . . . . 64.15 112.162 -177.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -144.16 108.35 4.78 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.078 -0.342 . . . . 63.12 110.078 -175.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.523 ' HB3' HD21 ' A' ' 118' ' ' LEU . 24.3 m -85.09 111.33 19.66 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.04 -0.527 . . . . 73.12 109.901 176.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -91.53 128.33 37.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.382 -0.372 . . . . 72.0 110.987 179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.496 ' HB3' ' HG2' ' A' ' 73' ' ' GLU . 32.3 ttm180 -91.21 128.27 36.97 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 108.333 -0.988 . . . . 74.45 108.333 170.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.586 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 53.8 p90 -134.1 152.68 51.94 Favored 'General case' 0 C--N 1.318 -0.772 0 C-N-CA 120.955 -0.298 . . . . 72.13 111.147 -174.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.571 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 70.9 mtm -136.97 140.46 42.21 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.078 -0.51 . . . . 71.52 110.285 176.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 8.1 mm -99.05 119.08 46.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.245 -0.434 . . . . 73.31 110.212 177.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.1 mpp? -126.35 -174.14 3.04 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.106 -0.497 . . . . 63.14 110.315 178.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -64.92 158.04 26.41 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.887 -0.597 . . . . 63.32 110.625 -179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.629 ' HB3' ' O ' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -67.15 115.46 6.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.578 0.704 . . . . 65.33 112.186 -174.673 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.45 ' CZ ' ' HB3' ' A' ' 111' ' ' PRO . 29.7 m-85 -119.52 171.68 8.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.512 -0.767 . . . . 50.3 109.283 175.745 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -177.03 -54.0 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.385 -0.912 . . . . 52.22 112.105 179.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . . . . . . . . . 16.1 m -81.1 124.31 29.11 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.167 0.508 . . . . 74.42 110.702 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.624 ' HA ' HD13 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -92.95 145.35 24.44 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.094 -1.076 . . . . 64.2 108.094 174.279 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.56 ' O ' ' HB3' ' A' ' 142' ' ' TYR . 33.1 tp -60.92 -38.08 84.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.668 -0.413 . . . . 73.22 110.065 -179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.878 ' HA ' ' HD2' ' A' ' 142' ' ' TYR . 50.7 tt0 -59.97 -37.24 79.03 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.215 -0.448 . . . . 71.2 111.531 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.888 ' HB3' ' HB2' ' A' ' 345' ' ' GLU . 8.8 mttp -55.24 -59.59 4.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.287 0.565 . . . . 75.55 110.43 177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 59.7 mt -69.23 -39.85 79.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.264 -0.88 . . . . 73.22 111.12 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.878 ' HD2' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -62.48 -38.74 91.01 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.353 -0.385 . . . . 74.24 111.234 -177.095 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.602 ' HG3' ' CE2' ' A' ' 142' ' ' TYR . 32.6 mt-10 -83.48 -18.49 38.36 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.722 -0.391 . . . . 71.22 111.439 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -79.03 -23.98 43.93 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.323 0.582 . . . . 71.42 110.06 174.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -97.72 1.09 48.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.544 -0.753 . . . . 71.44 109.27 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 55.76 39.92 30.77 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.105 -0.952 . . . . 62.25 111.98 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 41.5 pttt 42.52 38.29 1.21 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.074 0.95 . . . . 74.14 113.22 179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -98.76 81.33 2.64 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.075 -0.713 . . . . 73.15 109.075 171.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -116.93 156.97 26.5 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.965 0.412 . . . . 71.14 111.291 -174.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 19.8 t -99.34 -172.55 2.28 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.946 -0.57 . . . . 54.43 110.224 179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.446 ' HD3' ' CD ' ' A' ' 298' ' ' GLU . 3.9 ttm180 -65.39 -24.03 67.12 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.797 -0.638 . . . . 71.53 111.294 -174.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -58.09 -68.73 0.22 Allowed 'General case' 0 C--O 1.235 0.314 0 CA-C-N 115.927 -0.579 . . . . 74.23 111.897 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 3.7 p -59.11 -47.34 85.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.906 -0.588 . . . . 63.33 111.905 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.1 t -56.33 -41.67 71.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.689 -0.687 . . . . 53.31 111.332 -176.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.477 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -71.41 -50.03 35.94 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.363 -0.38 . . . . 73.44 110.412 -178.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 18.9 tp60 -57.92 -44.95 87.16 Favored 'General case' 0 C--O 1.241 0.629 0 CA-C-O 120.863 0.363 . . . . 75.12 111.204 -178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 161' ' ' ILE . 8.3 mp -61.29 -52.73 63.5 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.125 -0.489 . . . . 73.12 111.137 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 12.0 p -63.74 -34.13 77.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.24 . . . . 72.01 111.526 -176.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -60.33 -53.44 57.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.412 -0.358 . . . . 71.21 110.356 179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -70.16 -29.27 66.14 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-O 121.07 0.462 . . . . 73.31 110.78 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 157' ' ' LEU . 30.1 mm -67.5 -37.99 79.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 65.15 110.523 176.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.5 tt -63.55 -39.92 95.66 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.971 -0.381 . . . . 62.54 109.971 178.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -53.17 -63.23 1.22 Allowed 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.685 0.755 . . . . 71.43 110.462 176.376 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.588 HD13 ' HB3' ' A' ' 195' ' ' LEU . 18.4 tt -64.45 -34.85 72.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.375 -0.829 . . . . 73.12 111.264 -178.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.504 HD13 ' CE1' ' A' ' 175' ' ' HIS . 50.3 tp -60.95 -40.05 91.82 Favored 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 116.825 -0.17 . . . . 63.31 111.274 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -65.74 -39.11 90.77 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.535 -0.466 . . . . 64.11 110.904 175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.415 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 49.1 t80 -59.06 -49.44 77.88 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.371 -0.532 . . . . 73.11 111.594 177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 32.0 pt -74.03 -32.2 32.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 120.813 -0.355 . . . . 64.14 110.969 -178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -61.95 -45.75 92.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.682 -0.69 . . . . 73.03 110.915 178.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 17.4 mm-40 -82.33 8.08 12.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.94 0.4 . . . . 73.43 110.928 179.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -104.86 -67.63 0.9 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 121.083 -0.247 . . . . 75.01 111.016 -179.235 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -152.46 -58.94 0.15 Allowed 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.518 0.562 . . . . 53.24 112.518 -174.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HA ' ' A' ' 203' ' ' ARG . 10.5 p90 -121.36 164.75 16.57 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.331 0.863 . . . . 63.42 113.331 -164.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 27.8 m -116.9 173.27 4.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 114.756 -1.111 . . . . 71.32 108.931 173.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.504 ' CE1' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -129.44 103.7 7.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.585 0.707 . . . . 74.52 112.038 -175.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.01 -39.4 89.04 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.362 -0.836 . . . . 53.1 111.524 176.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 1.018 ' HB2' ' HA2' ' A' ' 223' ' ' GLY . 28.5 t70 -89.84 91.07 8.46 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.256 0.55 . . . . 75.5 110.041 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.546 HG12 ' O ' ' A' ' 178' ' ' ILE . 8.4 tt -110.01 25.25 3.21 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 122.087 0.946 . . . . 75.23 109.242 177.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 20.4 tptm -60.6 162.16 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.138 -0.937 . . . . 74.14 109.96 178.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.14 -5.37 1.04 Allowed 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 113.033 0.753 . . . . 75.24 113.033 -174.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.47 ' HB2' ' HZ1' ' A' ' 352' ' ' LYS . 1.0 OUTLIER -76.87 -20.65 56.03 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 50.51 110.413 176.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -88.37 -15.12 36.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.874 -0.603 . . . . 71.25 110.292 -175.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.425 HD22 HD22 ' A' ' 138' ' ' LEU . 6.4 mp -97.52 120.57 38.14 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.123 -0.49 . . . . 70.33 110.297 176.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.5 mm? -116.22 141.82 47.64 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.957 -0.565 . . . . 74.12 110.449 -178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 190' ' ' PRO . 9.8 mp -99.29 160.36 14.33 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.772 0.32 . . . . 74.23 110.559 178.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -66.42 151.22 47.62 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.179 -0.675 . . . . 52.25 109.179 173.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -58.06 -26.23 62.24 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.303 0.483 . . . . 75.23 112.303 -177.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.432 ' HA ' ' HD2' ' A' ' 188' ' ' LYS . 32.5 tptt -112.36 -58.09 2.19 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 112.8 0.667 . . . . 74.05 112.8 -174.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 12.6 p-10 -104.57 131.13 22.14 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.414 0.626 . . . . 73.44 112.201 -173.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.425 ' HA ' HD23 ' A' ' 185' ' ' LEU . 96.5 Cg_endo -77.21 -7.5 17.15 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.326 2.684 . . . . 73.05 113.544 -175.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -78.88 -6.9 57.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.313 0.578 . . . . 73.45 110.182 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.455 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 88.1 mm-40 -105.29 92.75 4.34 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 72.41 110.342 179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.16 120.45 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 121.441 0.639 . . . . 63.44 109.849 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.455 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 61.9 m-85 -113.08 154.86 25.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.351 -0.84 . . . . 74.42 109.515 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.588 ' HB3' HD13 ' A' ' 164' ' ' ILE . 14.0 tp -110.12 107.48 17.32 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.882 -0.414 . . . . 74.3 109.882 -178.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.478 HG11 ' HG3' ' A' ' 111' ' ' PRO . 19.8 m -138.41 -166.77 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.189 -0.459 . . . . 54.53 109.972 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 t70 65.05 56.17 1.06 Allowed 'General case' 0 CA--C 1.516 -0.333 0 CA-C-O 121.854 0.835 . . . . 71.21 109.922 176.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -82.85 67.12 8.79 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.086 -0.961 . . . . 73.43 110.61 -175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.896 ' HA2' ' HB3' ' A' ' 79' ' ' PRO . . . -64.34 -57.84 12.11 Favored Glycine 0 N--CA 1.439 -1.103 0 CA-C-N 115.436 -0.802 . . . . 51.54 111.498 175.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 222' ' ' ASP . 3.7 mp -106.47 88.06 2.68 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.341 0.591 . . . . 70.43 110.289 -177.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . . . . . . . . . . . -114.8 110.65 20.02 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.542 -0.754 . . . . 54.02 109.761 177.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -99.47 115.58 29.63 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.066 -0.516 . . . . 74.12 109.63 -174.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.612 ' HA ' ' HB3' ' A' ' 173' ' ' TYR . 35.8 ptt180 -69.76 137.36 51.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.16 -0.473 . . . . 71.0 111.543 -174.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.625 ' CE1' ' HA ' ' A' ' 239' ' ' SER . 56.0 t80 -93.68 -55.64 3.19 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.561 -0.745 . . . . 75.21 110.546 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . . . . . . . . . 3.5 p -110.81 96.73 30.3 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.953 -0.567 . . . . 72.43 110.651 179.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 204' ' ' TYR . 28.8 Cg_exo -60.94 114.44 2.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.671 2.248 . . . . 63.35 112.077 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 64.45 20.19 12.07 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.609 -0.723 . . . . 70.04 111.267 177.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 99.39 -8.05 60.23 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.872 -0.68 . . . . 61.34 113.121 177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 55.6 t -88.88 118.33 34.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.806 0.336 . . . . 73.1 110.624 -179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.486 ' HB2' ' OE2' ' A' ' 212' ' ' GLU . 17.9 p80 -71.09 128.11 34.85 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.132 0.491 . . . . 70.23 111.001 -177.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -114.13 -31.02 6.47 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.062 -0.517 . . . . 60.23 111.164 -178.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.486 ' OE2' ' HB2' ' A' ' 210' ' ' HIS . 2.8 mp0 59.1 -100.04 0.1 Allowed 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 115.992 -0.549 . . . . 63.42 110.273 -174.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.566 ' HA ' HG23 ' A' ' 236' ' ' VAL . 18.1 p90 -80.71 103.41 10.54 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-O 121.593 0.711 . . . . 75.43 110.953 -179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -98.14 -51.38 4.03 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.033 -0.729 . . . . 65.42 109.033 173.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 217' ' ' PRO . 37.0 tt0 62.65 90.48 0.08 Allowed 'General case' 0 C--O 1.236 0.379 0 CA-C-N 115.197 -0.91 . . . . 75.11 112.525 171.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.47 82.55 62.88 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-N 115.531 -0.759 . . . . 75.35 109.872 172.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.419 ' HD3' ' HG2' ' A' ' 215' ' ' GLU . 56.7 Cg_endo -71.85 1.97 5.25 Favored 'Trans proline' 0 CA--C 1.528 0.202 0 C-N-CA 123.068 2.512 . . . . 60.44 112.619 -178.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -48.88 -58.42 4.87 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.765 -0.652 . . . . 74.22 111.068 -179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 21.2 ptt180 -163.25 36.96 0.09 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.97 0.414 . . . . 74.45 110.852 175.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 99.3 m -98.27 136.17 38.85 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.31 -0.405 . . . . 75.33 110.666 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 29.6 p80 178.87 32.75 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.104 -0.953 . . . . 73.42 108.586 179.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.73 ' HB3' ' HB3' ' A' ' 200' ' ' LEU . 2.6 m-20 -45.91 105.29 0.06 Allowed 'General case' 0 C--O 1.233 0.218 0 CA-C-N 114.784 -1.098 . . . . 71.53 112.337 -173.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 1.018 ' HA2' ' HB2' ' A' ' 177' ' ' ASP . . . 147.24 164.16 11.0 Favored Glycine 0 N--CA 1.439 -1.107 0 CA-C-N 114.919 -1.037 . . . . 63.54 111.017 -177.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.467 HG22 ' H ' ' A' ' 226' ' ' GLU . 22.8 m -69.02 139.62 54.95 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.785 -0.45 . . . . 73.24 109.785 176.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.554 ' HA ' ' OG1' ' A' ' 228' ' ' THR . 49.4 mt -56.31 -22.33 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 121.569 0.699 . . . . 52.22 110.997 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.467 ' H ' HG22 ' A' ' 224' ' ' THR . 34.9 tt0 -51.68 -42.51 62.22 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.869 -1.06 . . . . 74.31 110.311 175.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.505 ' HB3' HG23 ' A' ' 246' ' ' ILE . 59.1 m-85 -104.32 -90.72 0.38 Allowed 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.766 -0.652 . . . . 74.43 109.635 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.554 ' OG1' ' HA ' ' A' ' 225' ' ' ILE . 28.0 m 67.02 -63.47 0.28 Allowed 'General case' 0 CA--C 1.536 0.441 0 O-C-N 123.822 0.701 . . . . 71.41 112.566 176.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.454 ' HA ' ' HG3' ' A' ' 275' ' ' LYS . 49.7 m 67.75 172.09 0.27 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.284 0.634 . . . . 73.53 111.094 -177.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.544 ' H ' HD12 ' A' ' 230' ' ' ILE . 4.7 mp -71.75 -40.53 69.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.159 0.504 . . . . 71.5 109.866 -177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.559 ' HB3' ' HG3' ' A' ' 238' ' ' PRO . 1.6 m-20 -54.3 -61.13 2.51 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 114.682 -1.145 . . . . 74.52 111.758 -175.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -63.25 -36.02 82.29 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.414 -0.357 . . . . 70.51 111.538 -177.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 13.6 t60 -67.9 -26.54 66.04 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.499 -0.319 . . . . 74.12 111.503 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.463 ' HB3' HG12 ' A' ' 236' ' ' VAL . 65.6 t30 -80.36 -4.7 54.55 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.539 0.685 . . . . 55.11 109.66 176.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 77.31 19.66 76.36 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.55 -0.75 . . . . 60.34 112.326 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.566 HG23 ' HA ' ' A' ' 213' ' ' TYR . 7.2 p -111.81 127.7 68.82 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.954 0.407 . . . . 64.11 110.441 179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -83.94 112.24 39.05 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 116.004 -0.543 . . . . 74.32 109.704 177.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.686 ' HG2' ' HA3' ' A' ' 242' ' ' GLY . 24.6 Cg_exo -63.15 152.78 77.89 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.325 2.017 . . . . 52.43 111.398 -179.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.625 ' HA ' ' CE1' ' A' ' 204' ' ' TYR . 16.0 p -77.09 -18.37 58.03 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.222 -0.444 . . . . 71.3 111.08 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.801 ' HD3' ' HG3' ' A' ' 315' ' ' PRO . 7.1 ptp180 178.11 -40.11 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.871 -0.604 . . . . 71.52 110.449 -179.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 241' ' ' ARG . 9.9 ttt180 -55.17 -53.91 49.94 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.368 -0.833 . . . . 74.44 111.771 -175.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.686 ' HA3' ' HG2' ' A' ' 238' ' ' PRO . . . -59.78 -44.98 96.52 Favored Glycine 0 CA--C 1.518 0.266 0 CA-C-N 116.005 -0.543 . . . . 63.42 114.232 -173.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -65.51 -42.07 92.47 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.452 -0.573 . . . . 61.43 109.452 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.87 -36.12 82.89 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.734 -0.667 . . . . 74.02 110.828 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.85 -51.03 71.26 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.997 -0.547 . . . . 64.02 110.339 176.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.505 HG23 ' HB3' ' A' ' 227' ' ' PHE . 66.9 mt -63.23 -39.73 86.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.425 -0.807 . . . . 73.15 110.831 -177.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.489 ' O ' ' HG3' ' A' ' 251' ' ' MET . 58.3 tp -57.82 -43.45 85.78 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.344 -0.389 . . . . 63.2 110.392 176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.94 -40.68 97.21 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 121.037 -0.602 . . . . 63.42 112.555 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.483 ' HA ' HG22 ' A' ' 252' ' ' ILE . 35.5 m-85 -67.11 -31.22 71.54 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.803 0.335 . . . . 74.31 111.332 179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.531 ' SG ' HG23 ' A' ' 178' ' ' ILE . 59.6 m -65.93 -44.13 86.0 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.324 0.583 . . . . 72.44 109.655 175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.489 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 90.1 mtp -61.62 -49.9 74.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.131 -0.94 . . . . 62.14 111.199 -177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.667 HD12 ' SD ' ' A' ' 286' ' ' MET . 4.6 tt -61.85 -36.61 74.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 120.993 -0.283 . . . . 64.24 110.875 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.441 ' HB2' HD21 ' A' ' 259' ' ' LEU . 8.7 tt0 -59.77 -50.48 73.68 Favored 'General case' 0 C--N 1.333 -0.127 0 C-N-CA 121.101 -0.24 . . . . 72.31 111.323 -178.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -66.13 -31.04 71.65 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.744 0.307 . . . . 71.23 111.186 -178.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 28.0 tp -84.56 -19.13 33.64 Favored 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.336 0.495 . . . . 64.13 112.336 -174.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 35.3 p -106.48 -27.83 10.68 Favored 'General case' 0 C--N 1.328 -0.33 0 O-C-N 122.109 -0.369 . . . . 64.5 111.979 -178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.529 ' O ' ' HG3' ' A' ' 147' ' ' LYS . . . 113.35 -35.8 4.37 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.575 -0.821 . . . . 40.52 112.708 179.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 16.3 p-80 -156.98 165.5 35.99 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.941 0.371 . . . . 70.21 110.081 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.441 HD21 ' HB2' ' A' ' 253' ' ' GLN . 72.0 mt -94.27 139.61 22.52 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 110.201 -0.296 . . . . 65.24 110.201 176.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 32.8 Cg_exo -60.59 -27.31 84.62 Favored 'Trans proline' 0 CA--C 1.526 0.122 0 C-N-CA 122.726 2.284 . . . . 64.14 112.36 -178.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 37.2 p90 -100.07 10.95 40.47 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.126 -0.488 . . . . 64.12 111.057 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.531 ' O ' ' HG ' ' A' ' 265' ' ' LEU . 50.6 tt0 -69.28 -29.59 67.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.237 0.541 . . . . 72.31 110.906 -175.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -78.3 -21.56 49.49 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.025 0.441 . . . . 74.3 110.733 177.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 49.6 m-80 -108.84 5.25 24.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.963 -0.562 . . . . 72.43 112.012 -173.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 262' ' ' GLU . 2.7 pp -79.88 8.25 7.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.915 0.388 . . . . 72.53 111.369 -178.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 34.7 tttp -67.54 -17.85 64.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.93 -0.577 . . . . 70.42 110.093 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 16.0 t70 -141.64 134.21 13.98 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.63 -0.714 . . . . 71.44 109.522 174.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 46.9 Cg_exo -56.91 -19.16 30.72 Favored 'Trans proline' 0 CA--C 1.532 0.418 0 C-N-CA 123.308 2.672 . . . . 61.11 114.151 -176.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt -60.59 -53.92 51.6 Favored 'General case' 0 N--CA 1.462 0.15 0 CA-C-O 121.032 0.444 . . . . 71.34 111.134 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -67.44 -33.88 76.05 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.051 -0.522 . . . . 70.4 110.439 -177.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.511 HG21 HG22 ' A' ' 225' ' ' ILE . 61.7 t -61.09 -43.08 95.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 54.25 110.372 174.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 1.4 tmm_? -55.13 -57.1 13.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.306 -0.861 . . . . 73.35 110.421 -179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -64.76 -40.87 96.01 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.94 -0.573 . . . . 62.22 111.472 -177.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 60.7 m -59.76 -40.47 88.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.496 -0.32 . . . . 43.44 111.106 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.454 ' HG3' ' HA ' ' A' ' 229' ' ' SER . 44.4 mmtm -66.96 -39.82 87.35 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 121.012 -0.275 . . . . 64.15 110.918 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 58.8 mt -63.95 -49.13 83.06 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-O 120.777 0.322 . . . . 72.42 110.824 178.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 3.3 tpm_? -57.78 -47.24 83.11 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.812 -0.631 . . . . 74.3 110.974 -178.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 16.7 m-85 -74.15 -36.26 64.12 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 112.312 0.486 . . . . 74.41 112.312 -175.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 24.5 ttp180 -68.48 -29.02 67.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.102 0.477 . . . . 75.41 110.252 178.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -70.1 -65.24 0.75 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.975 -0.557 . . . . 75.55 110.021 174.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.439 ' O ' HD23 ' A' ' 285' ' ' LEU . 47.2 t30 -107.58 77.54 1.14 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.559 0.695 . . . . 63.22 110.387 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.469 ' H ' HD12 ' A' ' 282' ' ' ILE . 0.2 OUTLIER -79.11 -48.83 20.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.283 -0.871 . . . . 72.14 111.193 -179.246 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -52.68 -47.79 66.95 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.934 -0.575 . . . . 65.41 112.205 -173.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 39.3 t -66.23 -48.08 71.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.56 -0.291 . . . . 63.54 111.041 -178.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.2 mm? -67.13 -34.17 77.02 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 111.652 0.241 . . . . 65.5 111.652 -177.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.667 ' SD ' HD12 ' A' ' 252' ' ' ILE . 26.2 mmt -71.06 -37.94 72.5 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.961 0.41 . . . . 73.13 111.092 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -90.4 -38.91 12.98 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 112.145 0.424 . . . . 75.21 112.145 -172.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -78.03 -15.09 59.23 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.135 0.421 . . . . 73.52 112.135 -172.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 88.9 m -76.94 -21.58 54.59 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.031 0.443 . . . . 75.13 110.516 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.623 ' HB3' ' O ' ' A' ' 294' ' ' ASN . 6.4 m-85 -133.98 86.7 36.9 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.037 -0.529 . . . . 64.45 110.64 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_exo -71.38 -69.03 0.02 OUTLIER 'Trans proline' 0 C--O 1.234 0.292 0 C-N-CA 122.73 2.287 . . . . 52.4 111.955 177.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -134.06 95.51 3.44 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.104 0.478 . . . . 72.23 110.271 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 24.0 tptm 178.61 -52.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.272 -1.01 . . . . 74.23 108.272 -177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.623 ' O ' ' HB3' ' A' ' 290' ' ' PHE . 15.1 t30 -148.58 163.18 38.02 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.547 -1.206 . . . . 64.21 107.946 176.167 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.605 ' HA ' ' HE3' ' A' ' 295' ' ' LYS . 1.7 tpmt? -136.94 106.22 8.85 Favored Pre-proline 0 C--N 1.32 -0.694 0 C-N-CA 120.504 -0.478 . . . . 71.01 111.016 -176.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -81.01 45.14 1.92 Allowed 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 123.375 2.716 . . . . 65.54 111.537 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -62.44 -41.58 99.76 Favored Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.784 -0.644 . . . . 73.22 112.319 -176.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.473 ' H ' ' CD ' ' A' ' 298' ' ' GLU . 28.8 mp0 -62.78 -41.32 99.2 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.694 -0.484 . . . . 73.24 109.694 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.44 HG21 ' HB ' ' A' ' 252' ' ' ILE . 15.0 mm -63.93 -46.86 92.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.272 0 CA-C-N 115.644 -0.707 . . . . 72.1 110.28 -178.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -58.89 -52.1 67.21 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.685 -0.689 . . . . 71.44 110.971 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -62.75 -44.52 95.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.226 -0.443 . . . . 73.5 110.776 -179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -56.62 -50.86 70.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.586 -179.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.546 ' HA ' HG22 ' A' ' 306' ' ' VAL . 12.3 mtp -70.89 -38.62 73.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.633 -0.258 . . . . 61.23 111.612 -175.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -63.3 -35.74 81.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.504 0.668 . . . . 73.5 109.407 175.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.623 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 54.7 m -65.57 -52.85 49.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 71.03 111.22 178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.546 HG22 ' HA ' ' A' ' 303' ' ' MET . 35.3 m -67.26 -30.2 48.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-O 121.05 0.452 . . . . 45.41 110.802 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -57.44 -43.45 83.93 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.617 -0.72 . . . . 74.33 110.461 174.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -89.91 11.23 21.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 72.03 111.886 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.626 HD22 ' HA ' ' A' ' 315' ' ' PRO . 42.9 mt -90.7 -23.29 20.77 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.874 -0.417 . . . . 72.53 109.874 173.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.577 ' CG ' ' H ' ' A' ' 311' ' ' TYR . 28.6 t70 56.48 -156.72 0.28 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.447 -0.797 . . . . 32.11 110.748 174.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.577 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.1 m-85 -86.16 -33.01 20.96 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.916 0.389 . . . . 75.14 110.112 178.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 8.9 t -144.99 26.5 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.039 -0.528 . . . . 74.01 111.42 -175.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.514 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 7.8 tt0 -92.88 23.19 4.33 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.512 0.672 . . . . 74.44 109.627 -178.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.14 104.9 0.03 OUTLIER Pre-proline 0 N--CA 1.462 0.155 0 CA-C-N 114.34 -1.3 . . . . 73.31 112.222 177.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.801 ' HG3' ' HD3' ' A' ' 240' ' ' ARG . 93.5 Cg_endo -78.88 119.6 4.41 Favored 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 122.823 2.348 . . . . 70.53 111.799 178.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.567 ' HG ' ' H ' ' A' ' 319' ' ' ASN . 22.7 tp -93.41 84.36 4.72 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.0 0.429 . . . . 53.1 110.12 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.473 ' HA ' HD12 ' A' ' 320' ' ' LEU . 74.2 m-85 -60.47 -32.77 71.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.623 -0.717 . . . . 75.51 110.086 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -54.78 -46.15 74.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.512 -0.767 . . . . 71.22 110.541 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.567 ' H ' ' HG ' ' A' ' 316' ' ' LEU . 28.9 t-20 -72.33 -35.28 68.56 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.581 -0.282 . . . . 74.21 110.703 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.571 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 97.0 mt -58.39 -52.85 63.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 51.23 110.34 177.356 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 38.7 ptt180 -72.53 -21.54 61.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 75.45 110.323 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -69.04 -50.92 44.28 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.198 -0.455 . . . . 54.33 110.933 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 324' ' ' LEU . 2.8 pp -70.91 -29.59 38.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.795 -0.362 . . . . 63.11 110.996 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 85.5 mt -64.8 -49.4 70.83 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.082 0.468 . . . . 63.2 110.096 175.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -69.94 -26.76 64.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.167 -0.47 . . . . 75.32 110.945 178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -58.48 -47.81 82.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.166 -0.47 . . . . 74.41 109.853 176.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.432 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -74.97 -39.88 36.9 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.819 -0.705 . . . . 61.54 112.368 178.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.477 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 2.6 tm? -57.67 -49.44 76.47 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.19 0.519 . . . . 72.4 110.204 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -74.88 -24.61 58.58 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.431 -0.349 . . . . 73.34 111.477 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -61.4 -39.63 91.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.756 0.312 . . . . 75.04 111.184 178.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 13.5 tt -88.21 -9.62 10.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 121.246 0.546 . . . . 52.54 110.602 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 69.49 20.86 75.84 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.928 -0.653 . . . . 63.34 112.952 172.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 19.9 m -131.73 138.64 48.72 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.803 0.302 . . . . 63.32 110.993 -175.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.481 ' HE3' ' HB2' ' A' ' 334' ' ' LYS . 26.6 mtmt -113.35 -73.07 0.68 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.859 0.838 . . . . 53.3 109.047 174.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -167.53 -39.36 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.069 -1.423 . . . . 71.33 107.718 -175.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 16.6 t0 69.72 32.7 3.17 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 114.461 -1.245 . . . . 65.21 110.973 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 97.64 14.22 41.4 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.965 -0.636 . . . . 63.04 112.696 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.52 ' HD2' ' O ' ' A' ' 339' ' ' LEU . 5.8 tmmm? -179.71 110.06 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.272 -0.27 . . . . 73.43 110.272 -176.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.52 ' O ' ' HD2' ' A' ' 338' ' ' LYS . 8.6 mp -69.16 178.27 2.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.788 0.328 . . . . 74.41 110.613 177.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -80.31 12.8 2.71 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.39 0.614 . . . . 71.53 110.597 -175.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . . . . . . . . . 81.0 mt -80.44 96.12 6.64 Favored 'General case' 0 N--CA 1.444 -0.736 0 CA-C-N 115.471 -0.786 . . . . 60.24 108.992 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 343' ' ' VAL . 5.8 m -69.58 15.63 0.07 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.888 -1.051 . . . . 74.42 113.405 -173.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 342' ' ' SER . 0.4 OUTLIER 69.12 -7.15 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 123.818 0.847 . . . . 60.55 112.331 175.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 60.7 t -76.37 98.79 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.211 -0.663 . . . . 65.11 109.211 175.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.888 ' HB2' ' HB3' ' A' ' 140' ' ' LYS . 14.6 pt-20 -108.92 -55.93 2.34 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.067 -0.515 . . . . 60.22 111.853 -176.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.41 ' H ' ' HG3' ' A' ' 345' ' ' GLU . 18.8 m120 66.02 -77.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.37 0.668 . . . . 73.42 112.747 178.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 140' ' ' LYS . . . -144.01 166.71 27.01 Favored Glycine 0 N--CA 1.453 -0.172 0 C-N-CA 120.531 -0.843 . . . . 75.22 112.561 -174.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 152.49 -7.53 0.52 Allowed Glycine 0 CA--C 1.522 0.51 0 C-N-CA 120.876 -0.678 . . . . 51.0 113.038 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 45' ' ' GLN . 85.3 mt -54.47 128.36 31.62 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 122.65 0.38 . . . . 74.32 111.853 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -141.75 -177.51 5.22 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.034 -0.358 . . . . 73.23 110.034 178.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -126.88 159.01 35.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.107 0.479 . . . . 44.24 111.517 -176.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.484 ' H ' ' HE1' ' A' ' 48' ' ' PHE . 65.8 mttm -141.12 169.8 16.93 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.374 -0.83 . . . . 72.21 109.097 179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.676 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 12.0 t -169.63 140.14 2.14 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.109 -0.33 . . . . 73.32 110.109 177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.62 138.37 22.84 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 109.799 -0.445 . . . . 73.21 109.799 178.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 32.8 m -68.55 80.92 0.27 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 121.352 0.596 . . . . 53.41 112.174 -176.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 8.0 ttpm? -153.09 -82.42 0.09 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.026 -0.534 . . . . 74.22 110.243 171.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.556 ' HG2' ' N ' ' A' ' 358' ' ' ARG . 75.7 tttt -160.77 156.61 25.53 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 121.197 0.522 . . . . 74.33 111.586 179.751 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.556 ' N ' ' HG2' ' A' ' 357' ' ' LYS . 3.3 tpm_? -97.64 110.14 22.76 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.306 -0.861 . . . . 52.01 109.15 171.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.573 ' HB3' ' CB ' ' A' ' 77' ' ' ASN . 42.5 tttm -103.7 132.97 49.46 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.009 0.433 . . . . 75.35 111.5 -179.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 360' ' ' LYS . 5.5 ptmm? . . . . . 0 C--O 1.249 1.06 0 N-CA-C 108.892 -0.781 . . . . 75.21 108.892 169.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 110.25 -0.278 . . . . 62.55 110.25 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.94 138.39 44.12 Favored 'Trans proline' 0 CA--C 1.531 0.354 0 C-N-CA 123.307 2.672 . . . . 74.42 113.374 -177.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.629 ' O ' ' HA ' ' A' ' 292' ' ' GLU . 5.9 mmm180 -138.1 99.03 3.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.386 -0.824 . . . . 74.33 109.045 176.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.6 m -73.08 94.17 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 121.196 0.522 . . . . 71.11 111.952 -176.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -136.3 -56.92 0.76 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.45 . . . . 75.42 111.496 179.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 293' ' ' LYS . . . -107.64 -178.95 3.77 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.804 0.335 . . . . 43.22 111.531 -175.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.507 ' HA ' ' HA ' ' A' ' 294' ' ' ASN . . . -158.16 -173.26 4.24 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.071 -0.513 . . . . 63.53 110.127 178.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.423 ' OE1' ' HA ' ' A' ' 8' ' ' GLN . 13.1 mm-40 -95.64 150.65 20.11 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.224 -0.287 . . . . 74.52 110.224 175.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -127.07 153.16 46.33 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.337 -0.392 . . . . 65.14 111.234 -177.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.56 176.65 16.19 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.426 -0.67 . . . . 62.44 111.426 177.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -143.13 120.68 11.74 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.971 0.415 . . . . 51.02 110.864 -178.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -83.81 94.8 8.27 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.098 -0.501 . . . . 51.3 110.825 -178.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 20.4 t -80.59 167.22 20.34 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 52.14 108.967 172.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.476 ' HA ' HG11 ' A' ' 343' ' ' VAL . 56.7 m -135.55 120.94 19.17 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.387 0.613 . . . . 73.31 112.014 -176.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.606 ' H ' HG11 ' A' ' 343' ' ' VAL . . . -140.87 148.49 40.58 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.098 -0.955 . . . . 61.15 109.009 175.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 tttp -153.4 139.45 18.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.262 -0.175 . . . . 71.44 110.676 -174.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.667 ' HG3' HD21 ' A' ' 41' ' ' LEU . 6.8 ptt180 -166.09 132.15 2.5 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 121.212 0.53 . . . . 74.22 111.112 174.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.663 ' HA ' HD22 ' A' ' 41' ' ' LEU . 19.5 t60 -149.74 14.91 0.85 Allowed 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.374 -0.972 . . . . 65.32 108.374 172.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.1 pp -98.55 148.25 23.96 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.282 -0.872 . . . . 75.22 111.199 -173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -145.41 -82.03 0.15 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.708 -0.678 . . . . 71.31 109.492 175.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 74.86 9.29 4.08 Favored 'General case' 0 CA--C 1.514 -0.416 0 CA-C-O 121.794 0.807 . . . . 74.32 109.746 167.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -93.69 141.6 28.3 Favored 'General case' 0 N--CA 1.443 -0.82 0 CA-C-N 114.622 -1.172 . . . . 65.2 108.226 168.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -76.23 94.61 3.57 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.783 0.801 . . . . 74.53 110.697 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -179.68 -45.26 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 106.657 -1.608 . . . . 73.33 106.657 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.5 HG13 ' HA2' ' A' ' 40' ' ' GLY . 84.7 t -66.86 140.35 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 CA-C-N 113.829 -1.532 . . . . 64.41 109.265 166.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.443 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.99 2.13 56.03 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.147 -1.025 . . . . 43.34 113.422 179.312 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 31.3 mt-10 -78.72 140.79 38.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 117.282 0.541 . . . . 73.32 110.414 174.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.51 HD12 ' HB3' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -82.18 131.75 33.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.337 0.589 . . . . 64.12 111.153 -175.353 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.59 135.04 63.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-N 115.08 -0.964 . . . . 72.34 108.943 175.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 18.3 m -115.64 133.73 55.74 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.603 -0.271 . . . . 63.44 110.28 -179.364 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -97.58 -172.5 2.41 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.844 -0.428 . . . . 72.22 109.844 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.431 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 18.5 mmt -72.49 -20.02 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 71.14 110.99 -177.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -94.8 12.93 26.29 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.538 -0.301 . . . . 24.14 110.983 179.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 34' ' ' LYS . 11.6 mptt 65.86 33.14 8.22 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.911 -0.586 . . . . 70.24 112.404 172.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.2 mmpp? -83.58 115.16 21.99 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.891 -0.781 . . . . 75.11 108.891 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -96.34 84.28 3.71 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.347 0.594 . . . . 72.31 109.953 -178.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.591 ' HB3' ' HG2' ' A' ' 56' ' ' MET . 46.0 p-90 -114.84 149.73 36.64 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.724 -0.671 . . . . 64.43 110.933 -174.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.836 ' HG2' ' HB2' ' A' ' 57' ' ' ASN . 18.2 pttp -98.57 134.46 41.48 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.377 -0.601 . . . . 71.24 109.377 173.365 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.9 p -66.06 132.17 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 109.694 -0.484 . . . . 64.22 109.694 179.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.5 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -107.56 -133.41 7.15 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.722 -0.751 . . . . 65.23 112.564 -175.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.667 HD21 ' HG3' ' A' ' 17' ' ' ARG . 38.8 tp -66.55 125.23 90.17 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-O 120.97 0.414 . . . . 52.12 111.667 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.423 ' HD2' HD12 ' A' ' 41' ' ' LEU . 21.7 Cg_exo -65.67 108.99 1.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 122.394 2.063 . . . . 63.44 110.946 171.111 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.531 HG22 ' HG2' ' A' ' 45' ' ' GLN . 47.5 mt -76.35 -52.32 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.709 -0.478 . . . . 62.32 109.709 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.88 -18.17 17.56 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.867 -0.682 . . . . 73.31 112.641 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.536 ' HB2' ' OD2' ' A' ' 137' ' ' ASP . 20.0 pt20 -124.45 165.14 18.3 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.676 -0.49 . . . . 72.23 109.676 -178.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.97 66.26 0.15 Allowed Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.794 -0.717 . . . . 61.42 111.916 -172.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.635 ' HA2' ' O ' ' A' ' 181' ' ' SER . . . 80.5 -88.64 1.31 Allowed Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.998 -0.62 . . . . 52.35 112.83 177.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -89.59 -13.66 36.72 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.82 0.343 . . . . 74.23 111.253 -174.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 89.32 167.46 42.79 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.838 -0.696 . . . . 34.33 113.143 175.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 71.2 m 62.77 35.11 14.07 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.172 0.511 . . . . 62.01 111.56 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.825 HG23 ' HB3' ' A' ' 71' ' ' LYS . 5.3 mm -89.27 138.53 19.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.034 -0.53 . . . . 71.23 109.668 178.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -113.13 138.67 49.6 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.95 0.405 . . . . 73.24 111.088 -178.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.435 HD22 HG12 ' A' ' 69' ' ' VAL . 3.5 tm? -73.02 127.21 31.9 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.706 -0.85 . . . . 73.32 108.706 176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.02 91.37 7.33 Favored 'General case' 0 N--CA 1.446 -0.663 0 CA-C-O 121.279 0.562 . . . . 44.41 109.698 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' A' ' 38' ' ' LYS . 2.4 t70 -79.74 61.01 3.57 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.395 -0.82 . . . . 61.33 109.03 -178.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.591 ' HG2' ' HB3' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -35.8 127.96 0.66 Allowed 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.65 -1.159 . . . . 75.34 112.302 -175.127 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.836 ' HB2' ' HG2' ' A' ' 38' ' ' LYS . 65.5 t30 -93.63 79.67 4.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.614 -0.721 . . . . 75.43 110.718 -173.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.0 p -126.31 145.87 50.26 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.89 0.376 . . . . 72.14 110.964 178.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 5.8 p -83.1 -32.18 26.88 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.81 -0.632 . . . . 75.31 109.785 173.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -138.8 86.78 2.17 Favored 'General case' 0 N--CA 1.449 -0.508 0 CA-C-N 115.777 -0.647 . . . . 74.4 110.654 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.9 t -178.47 -48.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.907 -0.588 . . . . 62.14 109.464 177.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.898 HG23 ' HD3' ' A' ' 67' ' ' PRO . 8.8 p -81.94 143.33 12.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.548 -0.538 . . . . 51.43 109.548 173.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -103.71 34.87 5.43 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 110.405 -1.078 . . . . 62.2 110.405 175.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.9 t 64.58 18.42 11.38 Favored 'General case' 0 C--O 1.232 0.132 0 CA-C-N 114.934 -0.633 . . . . 55.14 109.645 -173.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -99.9 -23.19 15.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.708 -0.678 . . . . 63.25 112.001 -175.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 59.2 81.17 0.25 Allowed Pre-proline 0 C--N 1.331 -0.205 0 O-C-N 123.693 0.621 . . . . 65.15 109.585 -170.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.898 ' HD3' HG23 ' A' ' 62' ' ' VAL . 4.5 Cg_endo -84.08 25.57 0.69 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.457 2.771 . . . . 71.43 112.424 -170.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.501 ' HB2' HG23 ' A' ' 130' ' ' ILE . 9.6 p -162.05 142.26 10.16 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.483 0.658 . . . . 54.34 112.566 -173.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.544 HG13 ' HA ' ' A' ' 133' ' ' ARG . 35.8 m -127.98 149.1 32.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.163 -0.926 . . . . 72.32 108.684 168.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.4 p -121.12 126.06 74.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 121.066 0.46 . . . . 74.43 109.954 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.825 ' HB3' HG23 ' A' ' 51' ' ' ILE . 25.1 pttm -111.13 139.87 46.15 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 119.291 -0.964 . . . . 63.0 109.944 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.555 HG12 ' HB3' ' A' ' 128' ' ' PHE . 32.7 m -110.53 151.28 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 CA-C-N 114.98 -1.009 . . . . 70.02 111.881 -168.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.723 ' OE1' ' HA ' ' A' ' 77' ' ' ASN . 43.1 tt0 -127.31 130.23 23.76 Favored Pre-proline 0 C--N 1.318 -0.767 0 CA-C-N 114.854 -1.066 . . . . 64.52 108.246 173.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -67.96 -174.27 0.6 Allowed 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.301 2.001 . . . . 73.44 112.272 -178.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.9 m -66.34 71.86 0.07 Allowed 'General case' 0 C--O 1.235 0.333 0 CA-C-O 121.28 0.562 . . . . 52.23 110.723 175.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -141.06 -59.51 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.772 -0.649 . . . . 62.44 109.309 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.723 ' HA ' ' OE1' ' A' ' 73' ' ' GLU . 0.9 OUTLIER 69.97 87.91 0.11 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 124.305 1.003 . . . . 63.04 111.213 175.484 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -154.79 -80.07 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.635 -0.793 . . . . 51.32 112.547 -178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -61.57 -45.04 19.17 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.554 2.169 . . . . 73.44 112.668 -178.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.465 HD13 ' HE2' ' A' ' 71' ' ' LYS . 62.4 tp -73.18 -38.61 66.09 Favored 'General case' 0 C--O 1.222 -0.386 0 N-CA-C 109.52 -0.548 . . . . 72.54 109.52 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.442 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 90.8 t80 -55.96 -44.0 78.05 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.036 -0.529 . . . . 73.5 110.579 177.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . 0.43 HG21 ' HA2' ' A' ' 199' ' ' GLY . 36.8 m -67.17 -49.64 64.0 Favored 'General case' 0 C--O 1.245 0.851 0 CA-C-N 115.879 -0.6 . . . . 73.55 111.4 -177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.594 ' HB3' ' O ' ' A' ' 197' ' ' ASP . 5.6 pt-20 -73.16 -24.14 60.53 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 120.057 -0.657 . . . . 54.51 110.923 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 9.3 tt -64.13 -43.19 96.03 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.441 -0.577 . . . . 45.43 109.441 176.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 81' ' ' PHE . 32.4 mmmt -59.76 -48.33 82.09 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.051 -0.522 . . . . 74.35 110.483 177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -65.69 -45.38 83.06 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-N 116.091 -0.504 . . . . 74.54 110.797 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.428 ' CE2' ' HB2' ' A' ' 113' ' ' TYR . 47.5 t80 -61.58 -46.29 90.51 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.45 -0.795 . . . . 73.13 110.975 -176.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -68.0 -32.58 73.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.695 0.284 . . . . 63.14 110.941 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 62.5 ttt180 -63.35 -39.82 95.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.336 -0.393 . . . . 72.52 110.685 179.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -100.61 15.64 27.44 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.056 0.455 . . . . 33.01 111.586 -178.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.463 ' HB1' ' HB3' ' A' ' 113' ' ' TYR . . . -80.45 40.22 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.114 -0.494 . . . . 64.2 112.195 -175.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.778 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -138.59 114.98 8.86 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 116.523 -0.308 . . . . 73.5 110.617 -177.345 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -57.81 -31.08 91.45 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.545 2.163 . . . . 71.55 111.488 176.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.778 ' HG2' ' HB3' ' A' ' 92' ' ' LYS . 10.6 pt-20 -54.86 -53.0 61.05 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.601 -0.727 . . . . 74.04 111.132 178.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.49 ' HG3' ' HG3' ' A' ' 94' ' ' GLU . 97.3 mt-30 -72.17 -43.89 63.88 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.968 -0.56 . . . . 74.12 110.177 -177.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.49 ' O ' HG13 ' A' ' 100' ' ' ILE . 72.6 mt -53.87 -54.49 19.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 115.711 -0.677 . . . . 73.44 111.006 -177.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 62.2 tt0 -69.4 -32.72 71.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.749 0.309 . . . . 70.04 110.718 -177.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.507 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -58.39 -59.19 5.74 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-N 116.156 -0.475 . . . . 74.41 110.957 179.791 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.623 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.1 -31.81 70.79 Favored 'General case' 0 C--O 1.223 -0.315 0 C-N-CA 120.162 -0.615 . . . . 75.14 110.774 -177.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 96' ' ' ILE . 20.4 mt -54.49 -47.28 71.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 121.191 -0.203 . . . . 51.5 111.252 177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 1.5 ptm180 -72.61 -35.24 67.82 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.041 -0.664 . . . . 71.43 110.954 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.6 m -70.52 -40.47 73.47 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.128 0.489 . . . . 65.34 111.979 -179.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.63 ' HG2' HD13 ' A' ' 105' ' ' LEU . 5.3 tpt180 -87.12 -9.57 54.99 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.409 -0.359 . . . . 71.4 110.982 -176.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 84.4 tttt 67.93 37.99 2.93 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 121.966 0.889 . . . . 64.25 109.541 -174.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.709 ' HG ' ' HB2' ' A' ' 163' ' ' ASP . 1.5 tp -79.81 170.69 16.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.974 -1.012 . . . . 74.3 109.301 177.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.489 ' HB3' HH22 ' A' ' 160' ' ' ARG . 9.3 tmtm? -113.33 -56.98 2.35 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.277 -0.569 . . . . 74.12 110.711 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -151.86 120.72 6.59 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.737 0.303 . . . . 74.23 110.235 -175.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.623 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 33.5 tp -79.26 130.87 35.9 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.21 -0.45 . . . . 72.32 110.041 -179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -76.61 49.0 2.68 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 120.906 -0.664 . . . . 72.25 113.068 178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 88.2 t -132.58 118.79 15.9 Favored Pre-proline 0 CA--C 1.531 0.233 0 N-CA-C 110.118 -0.327 . . . . 73.21 110.118 177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.485 ' HG3' ' CZ ' ' A' ' 134' ' ' PHE . 92.5 Cg_endo -80.08 161.17 23.6 Favored 'Trans proline' 0 CA--C 1.534 0.516 0 C-N-CA 123.265 2.643 . . . . 64.31 113.468 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.4 tptm -61.36 137.25 58.24 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 115.742 -0.663 . . . . 71.4 111.436 178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.463 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 40.5 t80 -94.33 133.49 37.84 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.351 -0.84 . . . . 75.33 110.33 177.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.462 ' HB2' HG22 ' A' ' 130' ' ' ILE . 39.2 m95 -112.66 -36.39 5.21 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.047 -0.261 . . . . 74.14 111.699 -178.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.87 48.3 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.484 -0.865 . . . . 63.23 112.601 -178.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.52 ' HA ' ' HA ' ' A' ' 129' ' ' MET . 80.3 p -169.71 166.71 9.73 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.939 -0.393 . . . . 61.14 109.939 -177.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 163.53 174.12 33.02 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.205 -0.998 . . . . 61.33 112.644 176.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.558 HD21 ' HB3' ' A' ' 125' ' ' SER . 10.1 tt -118.53 127.24 53.44 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.085 -0.709 . . . . 75.14 109.085 177.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -131.29 119.72 22.16 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.989 0.423 . . . . 71.32 110.192 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.723 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 37.9 t70 -74.29 120.8 20.36 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.861 -0.609 . . . . 72.15 109.572 177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -82.68 -60.47 2.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.199 0.523 . . . . 64.21 110.312 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 52.5 t-20 -178.41 96.95 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.883 -1.053 . . . . 74.3 108.3 -178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 80.93 -37.18 2.33 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.71 -0.757 . . . . 33.03 111.787 -175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -110.44 131.69 54.83 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 110.185 -0.302 . . . . 53.0 110.185 178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.723 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 19.4 m -103.04 118.46 36.85 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.125 -0.489 . . . . 73.22 109.809 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -98.38 124.75 43.23 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.114 0.483 . . . . 72.31 111.017 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 37.5 ttt180 -98.41 120.29 38.57 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.183 -1.043 . . . . 71.24 108.183 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.555 ' HB3' HG12 ' A' ' 72' ' ' VAL . 35.0 p90 -139.1 163.99 30.97 Favored 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 120.741 -0.384 . . . . 61.24 111.554 -171.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.52 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 26.0 ptt? -146.58 146.42 30.45 Favored 'General case' 0 C--O 1.242 0.695 0 CA-C-O 121.309 0.576 . . . . 62.33 111.635 175.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.582 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -96.68 124.37 49.43 Favored 'Isoleucine or valine' 0 C--O 1.237 0.404 0 CA-C-N 114.439 -1.255 . . . . 71.04 110.631 -177.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 16.6 ptm -130.66 176.46 8.17 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.147 -0.933 . . . . 74.52 109.014 179.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 69' ' ' VAL . 12.6 t70 -65.81 170.37 5.42 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.645 -0.422 . . . . 53.13 110.079 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.999 ' HD2' ' HB2' ' A' ' 188' ' ' LYS . 4.1 ptp180 -67.93 113.59 5.77 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.873 0.844 . . . . 73.31 112.639 -167.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.485 ' CZ ' ' HG3' ' A' ' 111' ' ' PRO . 3.2 m-85 -115.26 171.3 7.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.107 -0.951 . . . . 73.4 109.433 174.656 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 171.65 -43.4 0.18 Allowed Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 119.624 -1.274 . . . . 72.52 113.389 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.763 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 19.3 m -80.63 122.41 27.05 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.945 0.402 . . . . 72.03 111.479 -175.232 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.536 ' OD2' ' HB2' ' A' ' 45' ' ' GLN . 5.1 m-20 -88.55 129.11 35.55 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.613 -0.721 . . . . 61.12 110.065 174.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.475 ' HA ' HD12 ' A' ' 141' ' ' ILE . 14.8 tp -66.82 -29.96 70.03 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.389 0.614 . . . . 74.44 109.379 175.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.502 ' CG ' ' HB3' ' A' ' 137' ' ' ASP . 20.3 pt20 -62.56 -44.28 96.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.291 -0.868 . . . . 71.0 111.403 178.346 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.696 ' HD3' ' HA ' ' A' ' 346' ' ' ASN . 63.2 mttp -78.8 -11.43 59.99 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.942 0.401 . . . . 63.35 110.715 -176.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.818 HD13 ' HG ' ' A' ' 341' ' ' LEU . 94.3 mt -74.9 -51.27 22.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.143 -0.481 . . . . 73.53 110.145 172.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.833 ' HB2' ' HA ' ' A' ' 147' ' ' LYS . 1.1 p90 -72.08 -32.32 66.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 120.533 -0.467 . . . . 75.33 110.155 -177.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 13.9 mm-40 -59.06 -32.85 70.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.777 0.323 . . . . 75.51 110.845 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -84.88 -32.35 23.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.354 -0.385 . . . . 63.54 111.378 -179.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.515 ' O ' ' HG2' ' A' ' 148' ' ' ARG . 50.0 t30 -104.41 19.78 19.65 Favored 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 120.75 -0.38 . . . . 75.31 111.773 -178.27 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 54.57 32.42 16.94 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 122.869 0.468 . . . . 43.43 112.19 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.833 ' HA ' ' HB2' ' A' ' 142' ' ' TYR . 31.1 ttmt 65.43 22.32 11.91 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.586 -0.734 . . . . 73.21 112.0 175.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' A' ' 145' ' ' ASN . 30.0 mmt180 -83.35 107.56 15.95 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.462 -0.57 . . . . 70.41 109.462 175.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -112.75 152.19 29.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.058 0.456 . . . . 72.33 110.772 177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.3 p -89.22 172.78 8.81 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.936 -0.575 . . . . 50.23 110.614 -179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 37.5 mmm-85 -68.23 -35.92 78.69 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.409 -0.36 . . . . 72.15 111.275 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.532 ' N ' ' HD2' ' A' ' 152' ' ' LYS . 0.1 OUTLIER -73.26 -39.74 65.17 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.258 -0.428 . . . . 74.25 110.799 -175.031 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.519 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 3.0 p -64.86 -56.17 15.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 61.15 111.237 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.45 ' CG1' ' HG3' ' A' ' 251' ' ' MET . 40.5 t -59.8 -37.43 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.085 -0.507 . . . . 75.43 110.919 -179.172 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.821 HD22 ' HG ' ' A' ' 328' ' ' LEU . 15.0 tp -56.62 -51.22 69.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 63.02 110.646 179.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.4 mm-40 -68.0 -33.57 74.88 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.032 -0.531 . . . . 62.45 110.719 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 153' ' ' THR . 95.4 mt -61.7 -50.8 70.99 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.303 -0.408 . . . . 73.04 110.202 176.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 50.1 m -55.0 -37.9 67.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.211 -0.449 . . . . 72.22 110.942 179.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 87.7 mt -61.92 -45.96 91.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.662 -0.244 . . . . 61.44 111.472 178.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.649 ' HA ' ' NE ' ' A' ' 160' ' ' ARG . 9.7 mmp_? -63.31 -38.61 91.84 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 121.134 0.493 . . . . 72.24 111.51 179.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.552 ' HA ' HG22 ' A' ' 164' ' ' ILE . 1.8 mp -71.81 -32.04 43.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 C-N-CA 120.585 -0.446 . . . . 71.11 109.987 178.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.443 HD12 ' CE1' ' A' ' 317' ' ' TYR . 0.3 OUTLIER -59.22 -56.0 27.66 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.497 -0.319 . . . . 62.22 111.321 179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.709 ' HB2' ' HG ' ' A' ' 105' ' ' LEU . 43.4 p-10 -78.1 -24.64 47.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 120.049 -0.66 . . . . 75.0 112.018 -174.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.552 HG22 ' HA ' ' A' ' 161' ' ' ILE . 12.1 tt -72.89 -36.49 51.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 C-N-CA 120.268 -0.573 . . . . 71.03 110.41 174.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.517 HD23 HD11 ' A' ' 168' ' ' ILE . 42.6 mt -65.26 -38.1 89.28 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.706 0.288 . . . . 73.34 110.456 177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 22.4 mm-40 -56.5 -51.69 67.54 Favored 'General case' 0 C--O 1.24 0.605 0 CA-C-O 121.4 0.619 . . . . 74.22 110.129 175.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 26.2 t80 -61.21 -49.98 74.96 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.132 -0.94 . . . . 64.12 112.29 -177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.517 HD11 HD23 ' A' ' 165' ' ' LEU . 35.1 pt -71.35 -37.89 67.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 120.277 -0.569 . . . . 73.34 111.518 -175.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.723 ' HA ' HG12 ' A' ' 174' ' ' VAL . 62.9 t-80 -68.54 -40.86 80.52 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.372 -0.531 . . . . 74.34 111.554 -172.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' HA ' HG21 ' A' ' 209' ' ' VAL . 0.5 OUTLIER -85.54 13.86 6.36 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.379 -0.529 . . . . 63.04 111.294 -179.751 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -144.2 78.76 1.59 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.503 0.668 . . . . 74.14 111.352 174.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.622 ' O ' ' HA ' ' A' ' 203' ' ' ARG . 2.7 mp0 72.78 -82.32 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.266 -1.334 . . . . 64.41 113.289 172.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.425 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 91.7 m-85 -80.79 118.13 22.05 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 113.023 0.749 . . . . 75.34 113.023 -162.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.723 HG12 ' HA ' ' A' ' 169' ' ' HIS . 3.2 m -125.72 138.92 52.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 CA-C-N 115.831 -0.622 . . . . 63.22 110.283 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 1.043 ' HB2' ' HA ' ' A' ' 201' ' ' ALA . 4.6 t-80 -175.68 -50.68 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 121.0 0.428 . . . . 64.52 110.94 175.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 118.35 -75.93 0.29 Allowed Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 111.077 -0.809 . . . . 70.45 111.077 -178.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 51.92 34.54 13.8 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.051 0.453 . . . . 74.23 111.764 -177.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.465 HD12 HG13 ' A' ' 161' ' ' ILE . 21.4 mm -79.39 65.26 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 122.026 0.917 . . . . 63.3 110.018 -179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.887 ' HE3' HG21 ' A' ' 224' ' ' THR . 12.8 mmtt -103.4 141.65 35.58 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 114.694 -1.139 . . . . 73.01 109.157 176.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -60.04 -18.53 47.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.197 0.522 . . . . 72.34 110.807 177.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.635 ' O ' ' HA2' ' A' ' 47' ' ' GLY . 11.7 p -77.09 -19.28 57.24 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.797 -0.638 . . . . 74.55 111.552 178.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.499 ' OD1' ' HE3' ' A' ' 352' ' ' LYS . 17.2 m120 -114.4 2.58 14.73 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.668 0.27 . . . . 63.34 111.231 -176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.543 HD21 HD11 ' A' ' 161' ' ' ILE . 10.7 mp -104.13 111.21 23.7 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.095 -0.705 . . . . 53.15 109.095 174.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 47' ' ' GLY . 3.7 mm? -113.57 130.81 56.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.056 0.455 . . . . 53.22 111.688 -175.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.763 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 94.1 mt -75.06 145.62 42.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.385 -0.825 . . . . 75.14 110.432 173.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.822 ' HB2' ' HE1' ' A' ' 194' ' ' TYR . 24.2 t-20 -73.7 137.48 44.08 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.523 -0.917 . . . . 70.33 108.523 172.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.753 ' HB3' ' HG3' ' A' ' 133' ' ' ARG . 33.2 t80 -62.77 -31.14 72.05 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.095 0.474 . . . . 62.12 111.11 -175.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.999 ' HB2' ' HD2' ' A' ' 133' ' ' ARG . 6.2 tmtm? -91.57 -45.55 8.43 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.973 -0.558 . . . . 74.03 110.151 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.424 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 48.6 m-80 -104.88 100.05 22.07 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.431 -0.349 . . . . 73.42 110.852 -177.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.06 -6.15 13.04 Favored 'Trans proline' 0 N--CA 1.464 -0.234 0 C-N-CA 122.975 2.45 . . . . 75.34 113.237 -176.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.557 ' HA ' HD12 ' A' ' 339' ' ' LEU . 8.9 p-10 -92.86 -1.01 57.13 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 111.719 0.266 . . . . 74.21 111.719 -176.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.481 ' OE1' ' HD2' ' A' ' 160' ' ' ARG . 84.4 mm-40 -129.09 129.73 45.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.903 0.383 . . . . 73.44 111.06 -178.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.47 HG12 HD23 ' A' ' 185' ' ' LEU . 28.6 m -106.03 143.31 17.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.99 -0.55 . . . . 74.43 110.269 177.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.822 ' HE1' ' HB2' ' A' ' 186' ' ' ASN . 36.8 m-85 -118.56 155.11 31.48 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.177 -0.465 . . . . 74.34 109.824 178.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.45 HD12 HD13 ' A' ' 164' ' ' ILE . 11.3 mt -95.93 146.41 24.61 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.686 0.279 . . . . 73.03 110.964 177.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 197' ' ' ASP . 28.9 m -120.84 -171.8 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.399 -0.593 . . . . 54.2 109.399 170.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.594 ' O ' ' HB3' ' A' ' 83' ' ' GLU . 8.2 t70 76.25 -71.77 0.11 Allowed 'General case' 0 N--CA 1.475 0.819 0 O-C-N 123.634 0.584 . . . . 74.42 110.638 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.46 ' HD2' ' HB2' ' A' ' 83' ' ' GLU . 23.1 m-85 58.03 9.7 1.01 Allowed 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 113.545 0.943 . . . . 72.04 113.545 176.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.664 ' HA3' ' CG2' ' A' ' 354' ' ' ILE . . . -100.1 -33.98 5.01 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 119.937 -1.125 . . . . 61.44 114.444 -168.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.498 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 8.5 mp -68.41 -23.03 64.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 117.369 0.584 . . . . 74.41 110.018 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 1.043 ' HA ' ' HB2' ' A' ' 175' ' ' HIS . . . -58.48 112.35 1.55 Allowed 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.518 -0.764 . . . . 73.25 110.054 173.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . 0.654 ' HE2' ' HA ' ' A' ' 356' ' ' LYS . 6.4 t80 -98.47 132.37 43.97 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.56 -0.904 . . . . 75.33 108.56 -175.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.622 ' HA ' ' O ' ' A' ' 172' ' ' GLU . 7.1 ppt_? -86.54 141.56 28.96 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 112.405 0.521 . . . . 74.2 112.405 -171.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.789 ' HB2' HG12 ' A' ' 209' ' ' VAL . 32.1 m-85 -69.67 -92.31 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.309 -0.859 . . . . 72.14 109.947 170.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.407 ' HA ' ' HD3' ' A' ' 206' ' ' PRO . 40.1 m -142.48 141.23 20.22 Favored Pre-proline 0 N--CA 1.449 -0.518 0 CA-C-N 114.889 -1.051 . . . . 72.25 108.793 -179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 50.1 Cg_exo -53.71 104.65 0.11 Allowed 'Trans proline' 0 C--O 1.235 0.363 0 C-N-CA 122.945 2.43 . . . . 73.1 112.454 -178.303 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 62.1 22.15 12.9 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 115.448 -0.797 . . . . 73.14 111.564 178.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -145.58 42.88 0.95 Allowed Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.04 -0.824 . . . . 73.22 111.04 178.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.789 HG12 ' HB2' ' A' ' 204' ' ' TYR . 15.8 m -59.29 109.89 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.483 0.659 . . . . 75.23 112.611 -177.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 6.1 t60 179.85 124.44 0.07 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.266 -0.879 . . . . 65.44 109.156 173.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 39.7 tptt -152.67 163.38 39.77 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.554 -0.906 . . . . 70.14 108.554 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -112.25 174.95 5.64 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.516 -0.55 . . . . 53.45 109.516 -179.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -61.82 101.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.348 0.594 . . . . 75.45 112.245 -176.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 20.9 mmtt -105.0 -3.41 23.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.862 -0.608 . . . . 74.12 110.057 172.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.433 ' HG3' HD21 ' A' ' 234' ' ' ASN . 43.0 tt0 66.03 -76.27 0.05 OUTLIER 'General case' 0 C--O 1.225 -0.223 0 CA-C-N 114.851 -1.068 . . . . 54.24 111.689 -179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -118.43 100.64 51.43 Favored Pre-proline 0 C--N 1.321 -0.671 0 CA-C-O 120.953 0.406 . . . . 75.35 111.917 -171.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -86.36 -47.26 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.71 2.273 . . . . 65.34 112.066 171.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -150.18 21.47 0.86 Allowed 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.137 0.575 . . . . 64.32 110.112 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? 56.39 82.61 0.11 Allowed 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 115.896 -0.593 . . . . 73.1 110.865 -171.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.777 ' HB3' ' HA2' ' A' ' 235' ' ' GLY . 25.4 t -85.23 16.24 3.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 34.21 111.218 -174.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 9.8 p-80 -67.22 9.61 0.21 Allowed 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.619 0.6 . . . . 72.13 112.619 -179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.429 ' O ' HD23 ' A' ' 200' ' ' LEU . 0.2 OUTLIER -82.85 110.95 18.31 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.109 0.481 . . . . 71.24 110.316 -174.287 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . 162.74 177.9 36.13 Favored Glycine 0 N--CA 1.44 -1.062 0 CA-C-N 115.177 -0.919 . . . . 54.42 110.924 -179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.887 HG21 ' HE3' ' A' ' 179' ' ' LYS . 23.6 p -78.63 117.12 19.49 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.78 0.324 . . . . 71.42 110.574 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.614 ' HB ' HD12 ' A' ' 265' ' ' LEU . 57.9 mt -63.0 -21.63 28.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.522 -0.763 . . . . 63.33 112.124 -171.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.462 ' HG3' HD13 ' A' ' 265' ' ' LEU . 1.6 mp0 -58.26 -42.89 87.44 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.013 0.435 . . . . 75.41 110.273 178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.59 ' HE1' ' HA ' ' A' ' 250' ' ' CYS . 97.8 m-85 -102.25 -18.44 15.48 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.604 -0.726 . . . . 74.32 110.69 -176.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.582 ' HB ' ' HA ' ' A' ' 225' ' ' ILE . 90.7 m -66.78 108.6 2.57 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.044 -0.525 . . . . 74.34 110.982 -178.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 58.9 p -73.29 -173.52 1.37 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.315 -0.857 . . . . 73.21 110.791 177.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 54.8 mt -64.16 -38.05 81.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.326 -0.397 . . . . 72.42 110.317 -179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.62 -66.45 0.42 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.447 -0.797 . . . . 71.55 111.353 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.515 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.06 -44.83 87.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.818 -0.628 . . . . 35.1 111.718 -176.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 68.4 t60 -61.35 -37.33 82.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.834 0.349 . . . . 52.42 110.86 -177.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 215' ' ' GLU . 29.0 t-20 -74.25 -36.88 63.88 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.01 -0.541 . . . . 63.34 110.535 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.777 ' HA2' ' HB3' ' A' ' 220' ' ' CYS . . . 116.87 -19.77 12.04 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.748 -0.739 . . . . 71.51 112.411 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . . . . . . . . . 9.6 p -72.63 134.49 29.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.073 0.463 . . . . 52.15 110.699 -179.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -85.47 114.33 55.85 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.093 -0.503 . . . . 64.34 110.444 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.64 ' HB2' ' H ' ' A' ' 242' ' ' GLY . 87.1 Cg_endo -80.83 147.74 17.19 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 122.819 2.346 . . . . 71.12 112.428 -177.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.42 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 49.0 m -88.55 69.77 8.89 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.934 0.397 . . . . 72.3 110.543 177.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.568 ' O ' HD23 ' A' ' 244' ' ' LEU . 20.2 mtp180 73.29 -4.76 2.12 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.39 -0.823 . . . . 75.45 111.461 177.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.69 -56.74 7.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.061 0.457 . . . . 71.2 109.838 175.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.64 ' H ' ' HB2' ' A' ' 238' ' ' PRO . . . -71.22 -36.31 63.74 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.837 -0.697 . . . . 44.43 112.034 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -54.41 -49.53 69.73 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-O 121.375 0.607 . . . . 75.31 110.003 179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.568 HD23 ' O ' ' A' ' 240' ' ' ARG . 4.4 mm? -72.04 -32.68 67.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.551 -0.749 . . . . 74.14 111.656 -178.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -68.65 -38.03 80.12 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 120.384 -0.526 . . . . 74.44 110.553 177.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.46 HG13 ' O ' ' A' ' 242' ' ' GLY . 60.4 mt -59.81 -44.22 93.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 110.318 -0.253 . . . . 55.35 110.318 176.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.534 HD13 HG21 ' A' ' 161' ' ' ILE . 53.6 tp -60.57 -36.35 78.29 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.879 0.371 . . . . 44.12 110.429 175.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.57 -41.64 95.65 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.907 -0.663 . . . . 72.34 111.684 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -62.14 -44.59 96.29 Favored 'General case' 0 N--CA 1.462 0.158 0 N-CA-C 110.053 -0.351 . . . . 75.02 110.053 176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.59 ' HA ' ' HE1' ' A' ' 227' ' ' PHE . 39.3 m -59.31 -50.19 74.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.979 -0.555 . . . . 75.33 110.709 178.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.45 ' HG3' ' CG1' ' A' ' 154' ' ' VAL . 26.7 ttt -60.15 -48.53 81.34 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.536 -0.756 . . . . 72.34 111.583 -175.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.423 HG23 HD21 ' A' ' 259' ' ' LEU . 12.9 tt -68.1 -33.35 60.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.752 -0.379 . . . . 75.45 110.872 -179.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.712 ' HG2' ' HD3' ' A' ' 147' ' ' LYS . 8.5 tt0 -66.82 -46.95 73.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.633 -0.258 . . . . 73.11 110.738 -179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 28.9 m0 -66.85 -27.98 67.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.048 0.452 . . . . 72.11 110.747 179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . 0.403 HD11 ' ND2' ' A' ' 294' ' ' ASN . 24.0 tp -77.65 -28.64 51.3 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.057 -0.52 . . . . 72.42 111.457 -179.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . 0.437 HG22 ' CE2' ' A' ' 290' ' ' PHE . 27.8 p -101.47 -27.31 13.2 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.232 0.456 . . . . 43.12 112.232 -173.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.477 ' HA3' ' NH1' ' A' ' 148' ' ' ARG . . . 96.79 -37.27 3.5 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.573 -0.822 . . . . 74.45 111.579 -177.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -155.14 142.21 19.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.75 -0.463 . . . . 75.12 109.75 174.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.562 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 89.4 mt -97.5 145.05 29.03 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.137 -0.483 . . . . 74.44 110.406 178.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.07 -20.53 61.43 Favored 'Trans proline' 0 CA--C 1.529 0.226 0 C-N-CA 122.702 2.268 . . . . 74.33 112.875 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.587 ' O ' ' HB3' ' A' ' 265' ' ' LEU . 12.6 p90 -106.58 -2.79 21.46 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 120.424 -0.511 . . . . 75.42 111.969 -177.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.591 ' O ' HD22 ' A' ' 265' ' ' LEU . 8.2 pt-20 -86.36 -25.92 25.11 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 119.901 -0.719 . . . . 72.5 109.662 178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -76.94 -37.34 55.49 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.607 0.718 . . . . 72.01 109.668 172.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -108.86 27.58 9.33 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.955 -1.02 . . . . 71.11 111.588 -169.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.614 HD12 ' HB ' ' A' ' 225' ' ' ILE . 1.4 pt? -86.05 -2.0 57.9 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.951 0.405 . . . . 72.12 111.062 -177.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -68.6 -8.64 43.79 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.917 -0.583 . . . . 74.24 111.44 -176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.456 ' OD1' ' HG3' ' A' ' 269' ' ' LYS . 10.4 t0 -128.25 122.99 22.27 Favored Pre-proline 0 C--N 1.326 -0.435 0 N-CA-C 109.874 -0.417 . . . . 61.02 109.874 176.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.05 -26.34 25.27 Favored 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 123.57 2.847 . . . . 74.12 114.041 -178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.456 ' HG3' ' OD1' ' A' ' 267' ' ' ASP . 49.7 mttp -55.03 -50.09 69.93 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.865 0.364 . . . . 73.1 110.882 179.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -73.97 -36.35 64.57 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.594 -0.73 . . . . 72.24 111.844 -171.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . . . . . . . . . 60.2 t -56.92 -50.53 75.44 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 CA-C-O 120.891 0.377 . . . . 44.31 110.39 176.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -67.32 -42.85 82.95 Favored 'General case' 0 C--O 1.238 0.452 0 CA-C-N 115.872 -0.603 . . . . 71.25 110.59 178.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.608 ' O ' ' HB2' ' A' ' 277' ' ' ARG . 18.4 t70 -55.26 -61.74 2.13 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.631 -0.713 . . . . 75.14 110.65 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.2 p -57.01 -47.86 79.86 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.647 0.592 . . . . 63.33 112.253 -174.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -58.73 -49.78 76.34 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 112.209 0.448 . . . . 73.14 112.209 -176.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 64.7 mt -71.94 -37.95 62.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.972 0.415 . . . . 72.12 110.369 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.608 ' HB2' ' O ' ' A' ' 273' ' ' ASP . 27.6 ttt180 -58.16 -44.02 87.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.474 -0.784 . . . . 55.12 110.761 -179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.423 ' O ' HG12 ' A' ' 282' ' ' ILE . 19.9 m-85 -73.22 -31.25 64.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.189 -0.459 . . . . 70.34 110.976 178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.59 ' HA ' ' HD3' ' A' ' 307' ' ' LYS . 2.0 ttp180 -67.18 -23.46 65.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.628 -0.26 . . . . 65.14 111.207 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -68.03 -75.91 0.1 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.986 0.422 . . . . 55.11 110.829 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 285' ' ' LEU . 2.8 t-20 -110.18 94.36 4.98 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.251 -0.648 . . . . 71.14 109.251 177.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.632 ' HB ' ' HG2' ' A' ' 304' ' ' GLU . 12.9 mt -80.4 -47.74 20.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.319 -0.855 . . . . 71.45 111.599 -170.498 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' HB2' ' OE2' ' A' ' 304' ' ' GLU . . . -57.97 -48.79 78.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.94 -0.573 . . . . 71.42 112.341 -171.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 34.5 t -61.1 -41.37 96.55 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 111.651 0.241 . . . . 75.31 111.651 -174.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.452 HD23 ' O ' ' A' ' 281' ' ' ASN . 4.4 mm? -72.16 -42.99 65.29 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.705 0.288 . . . . 74.1 110.998 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -74.33 -34.46 63.45 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.847 0.356 . . . . 62.21 110.987 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.793 ' HA ' ' HB2' ' A' ' 296' ' ' PRO . 14.2 t70 -70.43 -33.65 71.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.259 0.552 . . . . 75.04 110.174 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 81.1 tttt -76.87 -11.48 59.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.976 -0.556 . . . . 71.53 111.369 -177.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 98.3 m -63.74 -55.29 24.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.752 0.311 . . . . 75.42 110.975 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.466 ' CE1' ' HD2' ' A' ' 293' ' ' LYS . 50.5 m-85 -136.76 73.0 54.91 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 74.35 111.299 178.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -59.23 -53.62 3.39 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 122.394 2.063 . . . . 74.42 112.28 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.629 ' HA ' ' O ' ' A' ' 3' ' ' ARG . 41.8 tt0 -120.58 -25.13 5.6 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.45 0.537 . . . . 72.31 112.45 -173.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.528 ' HA ' ' HB3' ' A' ' 6' ' ' ALA . 9.7 tmtm? -71.56 -10.04 59.16 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.5 110.683 -177.039 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.507 ' HA ' ' HA ' ' A' ' 7' ' ' ALA . 25.2 t-20 -158.89 -90.78 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 120.984 -0.286 . . . . 73.21 110.791 176.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.585 ' HD2' ' HD2' ' A' ' 296' ' ' PRO . 28.8 tptp 172.75 115.64 0.07 OUTLIER Pre-proline 0 N--CA 1.465 0.294 0 CA-C-O 120.825 0.345 . . . . 75.11 110.348 -177.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.793 ' HB2' ' HA ' ' A' ' 287' ' ' ASP . 95.8 Cg_endo -89.88 59.94 1.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.99 2.46 . . . . 65.14 111.612 177.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -106.94 -83.02 1.56 Allowed Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.391 -0.909 . . . . 64.22 113.06 -176.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.501 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.5 mp0 -53.63 -54.98 29.93 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 122.795 0.438 . . . . 60.14 111.14 -175.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.657 HD12 ' H ' ' A' ' 299' ' ' ILE . 4.0 mp -58.26 -42.56 83.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.808 -0.633 . . . . 73.13 111.278 -175.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -61.24 -54.1 48.41 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.934 0.397 . . . . 73.35 111.019 -177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 11.1 mmtp -65.48 -37.83 87.99 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.907 -0.588 . . . . 74.44 111.137 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.44 ' HB2' ' O ' ' A' ' 298' ' ' GLU . 17.7 t80 -58.53 -42.81 88.61 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.224 0.535 . . . . 73.42 110.278 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.411 ' CE ' ' HA ' ' A' ' 303' ' ' MET . 1.0 OUTLIER -65.34 -47.05 77.82 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.449 -0.796 . . . . 72.25 111.051 -179.645 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.632 ' HG2' ' HB ' ' A' ' 282' ' ' ILE . 46.8 mt-10 -59.12 -47.04 86.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.034 0.445 . . . . 74.23 109.837 177.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 88.1 m -57.67 -52.19 66.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.259 -0.882 . . . . 62.24 112.154 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.537 ' HA ' ' HG ' ' A' ' 309' ' ' LEU . 33.4 m -67.92 -27.65 38.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.858 0.361 . . . . 73.53 111.485 -176.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.59 ' HD3' ' HA ' ' A' ' 279' ' ' ARG . 44.0 mttp -80.81 -16.26 54.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 74.21 110.891 176.598 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.543 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 82.6 mt -89.62 0.74 56.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.288 -0.415 . . . . 52.13 110.664 176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.656 HD22 ' O ' ' A' ' 314' ' ' LYS . 27.6 mt -79.81 0.19 31.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.3 0.571 . . . . 52.43 109.718 176.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 31.3 t70 64.55 -88.44 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 114.611 -1.177 . . . . 64.23 111.939 174.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -153.73 -48.86 0.09 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.204 0.526 . . . . 74.22 110.415 -173.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 1.9 m -140.06 33.53 1.94 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.982 -0.553 . . . . 73.15 110.841 -175.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 49.7 mm-40 -82.99 -88.65 0.09 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.102 -0.374 . . . . 73.53 111.482 -178.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.656 ' O ' HD22 ' A' ' 309' ' ' LEU . 10.3 ptpp? -175.98 154.25 1.42 Allowed Pre-proline 0 C--N 1.325 -0.475 0 N-CA-C 109.12 -0.696 . . . . 74.41 109.12 -177.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.454 ' HG3' ' HB3' ' A' ' 240' ' ' ARG . 96.3 Cg_endo -90.66 125.75 1.14 Allowed 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.213 1.942 . . . . 63.21 110.807 167.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 316' ' ' LEU . 7.5 tp -79.48 79.66 5.92 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.23 -0.656 . . . . 74.14 109.23 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.443 ' CE1' HD12 ' A' ' 162' ' ' LEU . 73.7 t80 -55.51 -49.37 72.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 114.973 -1.012 . . . . 75.43 112.524 -171.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -34.36 70.74 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.611 -0.268 . . . . 61.11 111.179 -175.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 -69.25 -45.71 69.08 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.336 -0.246 . . . . 72.21 110.336 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . . . . . . . . . 81.0 mt -57.86 -45.22 86.64 Favored 'General case' 0 CA--C 1.522 -0.111 0 CA-C-N 116.318 -0.401 . . . . 63.52 110.795 178.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 79.7 ttt180 -65.25 -42.26 93.48 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.134 -0.485 . . . . 54.23 110.275 177.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -60.97 -55.51 32.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.816 -0.629 . . . . 64.54 111.202 -178.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -66.49 -28.14 42.48 Favored 'Isoleucine or valine' 0 C--O 1.232 0.158 0 CA-C-O 120.677 0.275 . . . . 74.54 111.401 -176.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.447 ' HG ' HD11 ' A' ' 155' ' ' LEU . 27.0 tp -66.71 -50.92 61.25 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-O 121.474 0.654 . . . . 74.32 110.125 179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 325' ' ' LEU . 4.4 mm? -73.35 -32.81 64.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.642 -0.708 . . . . 73.14 110.441 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -63.85 -47.54 80.34 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.233 -0.44 . . . . 61.31 110.773 179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.501 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.2 -40.77 96.97 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.891 -0.671 . . . . 44.02 112.061 -178.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.821 ' HG ' HD22 ' A' ' 155' ' ' LEU . 2.3 tm? -68.96 -41.6 77.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.098 0.475 . . . . 73.53 110.153 178.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -65.98 -25.3 67.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.957 -0.565 . . . . 72.44 110.681 178.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -69.57 -22.57 63.53 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.868 -0.605 . . . . 72.43 112.34 -177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.59 HG22 ' O ' ' A' ' 328' ' ' LEU . 13.5 tt -92.25 -1.07 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 CA-C-O 121.338 0.589 . . . . 71.31 110.694 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 88.82 24.11 33.66 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.451 -0.88 . . . . 52.02 112.622 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.411 ' HB3' ' HE2' ' A' ' 152' ' ' LYS . 50.2 m -128.86 169.37 14.67 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 122.748 -0.266 . . . . 72.01 110.407 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 56.9 pttt -159.22 -154.02 0.39 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.296 -0.631 . . . . 70.32 109.296 176.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -60.97 116.96 4.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.609 0.242 . . . . 65.15 111.014 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -115.71 89.66 3.15 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.094 -0.503 . . . . 61.53 111.493 -178.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 68.4 13.36 65.12 Favored Glycine 0 CA--C 1.519 0.313 0 CA-C-N 116.004 -0.544 . . . . 64.4 114.165 172.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.46 ' HA ' ' HD3' ' A' ' 338' ' ' LYS . 29.8 mmtm 59.13 88.38 0.07 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 112.684 0.624 . . . . 75.01 112.684 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.557 HD12 ' HA ' ' A' ' 191' ' ' ASP . 59.2 mt 68.32 174.97 0.27 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 115.149 -0.932 . . . . 71.11 112.501 175.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -178.14 102.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.785 -1.098 . . . . 65.12 109.201 -177.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.818 ' HG ' HD13 ' A' ' 141' ' ' ILE . 2.7 mm? -116.02 -80.25 0.6 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.151 0.501 . . . . 54.23 110.307 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 25.5 p 168.93 -100.9 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 114.511 -1.222 . . . . 72.22 109.312 -175.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.606 HG11 ' H ' ' A' ' 15' ' ' ALA . 4.1 m -159.09 1.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 CA-C-N 115.804 -0.635 . . . . 54.03 112.012 -176.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.572 HG13 ' HB2' ' A' ' 140' ' ' LYS . 66.2 t 63.81 101.39 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 CA-C-O 120.955 0.407 . . . . 65.43 111.484 -171.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -107.99 30.32 6.47 Favored 'General case' 0 C--N 1.329 -0.287 0 O-C-N 122.255 -0.278 . . . . 72.23 111.137 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.696 ' HA ' ' HD3' ' A' ' 140' ' ' LYS . 16.9 m120 62.39 -169.45 0.18 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.023 -0.535 . . . . 73.2 111.08 179.469 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 149.06 -38.49 0.97 Allowed Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.603 -0.808 . . . . 50.01 111.977 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -171.16 168.52 41.65 Favored Glycine 0 N--CA 1.445 -0.728 0 C-N-CA 120.542 -0.837 . . . . 41.32 112.263 179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 4.7 tt -161.36 122.75 2.87 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.868 -0.79 . . . . 75.34 108.868 177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 3.9 ttmp? -143.99 116.05 8.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.808 0.337 . . . . 74.44 110.342 178.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -100.76 179.07 4.52 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.74 -0.664 . . . . 70.53 110.582 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.499 ' HE3' ' OD1' ' A' ' 182' ' ' ASN . 0.0 OUTLIER -148.59 178.32 8.73 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.404 -0.362 . . . . 75.24 110.301 179.69 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.514 HG23 ' HB3' ' A' ' 359' ' ' LYS . 41.7 m -107.65 139.72 41.76 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.507 -0.315 . . . . 64.41 110.848 -175.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.664 ' CG2' ' HA3' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -68.83 134.18 30.62 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-O 120.833 0.349 . . . . 73.13 110.73 176.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.407 ' HB ' ' HB2' ' A' ' 222' ' ' ASP . 12.3 t -93.41 142.55 27.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.059 0.457 . . . . 60.24 111.885 -175.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.654 ' HA ' ' HE2' ' A' ' 202' ' ' TYR . 23.5 pttm 177.84 -32.01 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.096 -0.956 . . . . 65.13 108.978 174.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 356' ' ' LYS . 87.8 tttt 169.95 -49.8 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 114.732 -1.122 . . . . 75.25 108.338 177.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 12.5 ptp180 -149.0 164.11 35.55 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 114.658 -1.155 . . . . 74.32 108.63 174.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.597 ' HD2' ' N ' ' A' ' 360' ' ' LYS . 0.0 OUTLIER -68.84 -29.99 68.43 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.848 0.314 . . . . 73.4 111.848 -177.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.597 ' N ' ' HD2' ' A' ' 359' ' ' LYS . 8.4 tmtt? . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.391 -0.814 . . . . 74.22 108.878 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.9 mpp? . . . . . 0 N--CA 1.481 1.098 0 N-CA-C 109.653 -0.499 . . . . 53.42 109.653 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.87 137.9 39.3 Favored 'Trans proline' 0 N--CA 1.461 -0.387 0 C-N-CA 122.275 1.983 . . . . 72.01 111.303 176.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 30.2 ptt180 -146.48 24.3 1.25 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.339 0.59 . . . . 61.44 110.113 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.8 m -86.28 119.59 34.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.625 -0.716 . . . . 70.05 110.593 -179.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 53.4 pttt -162.95 101.41 0.99 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.584 0.706 . . . . 54.25 111.402 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -146.01 100.1 3.35 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.158 -0.928 . . . . 70.14 109.435 174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -122.72 93.7 4.05 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.05 0.453 . . . . 24.21 111.744 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -125.07 135.7 52.95 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.042 -0.526 . . . . 50.01 109.824 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.9 95.09 1.6 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.317 -0.401 . . . . 65.21 110.244 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -143.68 106.13 0.41 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.503 -0.855 . . . . 75.45 112.461 -178.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 12' ' ' GLN . 6.3 ptt180 -174.21 147.02 1.17 Allowed 'General case' 0 C--O 1.237 0.403 0 N-CA-C 110.416 -0.216 . . . . 63.22 110.416 177.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 11' ' ' ARG . 9.9 tt0 169.97 85.32 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.011 0.924 . . . . 54.45 109.068 168.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 24.8 m -82.06 123.0 28.54 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.108 -0.497 . . . . 74.22 110.703 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 49.5 m -144.02 96.76 2.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.921 -0.581 . . . . 74.33 109.852 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.88 -4.27 56.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.887 -0.597 . . . . 52.33 111.317 -176.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 56.9 tttm -112.59 119.08 36.9 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.174 -0.467 . . . . 74.01 110.168 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.3 ptt180 -76.66 166.26 23.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.828 -0.623 . . . . 75.11 111.625 -174.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -175.26 168.41 3.34 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.268 -1.012 . . . . 75.23 108.268 170.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.753 ' H ' HD23 ' A' ' 19' ' ' LEU . 2.3 pt? -106.54 136.1 46.9 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.857 -0.337 . . . . 72.1 110.424 -179.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -107.47 13.26 27.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.246 -0.434 . . . . 44.44 111.546 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -142.89 138.41 30.2 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.416 -0.356 . . . . 64.44 110.111 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -125.32 -30.77 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.471 -0.332 . . . . 75.14 111.226 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 13.2 t80 -89.99 56.04 3.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.522 0.677 . . . . 53.12 110.473 -177.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -178.65 -54.38 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 114.756 -1.111 . . . . 65.22 108.325 178.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.571 HG13 ' HA2' ' A' ' 40' ' ' GLY . 66.4 t -65.35 128.53 28.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 114.628 -1.169 . . . . 71.42 110.114 174.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.574 ' HA2' ' HD2' ' A' ' 38' ' ' LYS . . . 100.38 2.86 55.61 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.96 -0.638 . . . . 63.52 112.856 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.04 130.95 44.8 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.81 -0.811 . . . . 75.31 108.81 173.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -86.53 128.86 39.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-O 121.541 0.686 . . . . 62.0 111.505 -172.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 60.6 mt -125.87 129.81 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 CA-C-N 115.186 -0.915 . . . . 62.2 109.939 178.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 74.7 m -104.29 123.13 46.82 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.075 -0.511 . . . . 71.51 110.035 175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.707 ' HA ' ' HZ ' ' A' ' 128' ' ' PHE . 4.8 p-10 -82.26 175.65 10.11 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.544 -0.539 . . . . 71.02 109.544 175.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.424 ' HG2' ' O ' ' A' ' 116' ' ' SER . 12.5 ptm -71.86 -11.2 60.68 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.233 0.457 . . . . 75.14 112.233 -169.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -88.75 2.59 53.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.163 0.506 . . . . 71.04 110.25 176.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 65.91 77.91 0.28 Allowed 'General case' 0 C--O 1.235 0.305 0 CA-C-N 115.091 -0.959 . . . . 73.2 112.586 173.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.88 138.67 9.46 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.26 -0.882 . . . . 50.51 109.079 167.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -89.1 130.48 35.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.207 -0.451 . . . . 73.43 111.77 -173.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.544 ' HA ' ' SD ' ' A' ' 56' ' ' MET . 20.8 p-90 -136.07 147.21 47.76 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.503 -0.772 . . . . 73.42 109.27 172.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.901 ' HG2' ' HA ' ' A' ' 56' ' ' MET . 17.0 pttp -94.59 136.78 34.5 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.416 -0.514 . . . . 70.05 111.003 -176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.2 144.55 10.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.684 -0.689 . . . . 52.43 109.794 175.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.571 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -108.39 -110.61 3.41 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.58 -0.819 . . . . 62.2 112.763 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 6.5 mp -95.35 137.1 22.13 Favored Pre-proline 0 C--N 1.323 -0.57 0 CA-C-O 120.86 0.362 . . . . 63.22 111.235 -174.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 5.0 Cg_exo -75.14 120.08 5.88 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 122.967 2.444 . . . . 74.14 111.449 174.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.612 HD11 ' HB2' ' A' ' 53' ' ' LEU . 42.3 mt -90.88 -33.6 5.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.34 0.591 . . . . 74.44 110.097 -179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.8 -47.17 2.5 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.803 -0.713 . . . . 72.32 111.775 -178.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 17.1 pt20 -122.95 165.35 16.86 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 110.013 -0.366 . . . . 74.32 110.013 -178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.567 ' HA2' HD22 ' A' ' 349' ' ' LEU . . . 115.53 55.07 0.36 Allowed Glycine 0 N--CA 1.447 -0.593 0 N-CA-C 110.026 -1.229 . . . . 72.3 110.026 -170.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.587 ' HA2' ' HE3' ' A' ' 71' ' ' LYS . . . 154.0 -93.39 0.14 Allowed Glycine 0 N--CA 1.438 -1.195 0 N-CA-C 111.141 -0.784 . . . . 61.33 111.141 -170.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.624 ' H ' HD11 ' A' ' 51' ' ' ILE . 90.1 m-85 -146.41 -55.42 0.27 Allowed 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.239 -0.652 . . . . 75.25 109.239 174.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -164.03 157.55 29.86 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.695 -0.562 . . . . 65.23 111.695 175.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 11.0 t 57.34 46.27 18.68 Favored 'General case' 0 CA--C 1.535 0.377 0 CA-C-O 121.185 0.517 . . . . 63.12 110.762 177.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.68 HD12 ' HA ' ' A' ' 71' ' ' LYS . 42.5 mm -88.45 138.48 19.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.199 -0.455 . . . . 71.12 111.817 -173.092 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -120.3 152.4 37.86 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.12 -0.491 . . . . 73.44 111.067 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HB2' HD11 ' A' ' 43' ' ' ILE . 9.5 tt -101.32 143.92 30.78 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.196 -0.668 . . . . 72.11 109.196 174.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -112.93 108.43 17.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.071 0.462 . . . . 53.34 110.912 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -102.33 42.37 1.15 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.418 0.628 . . . . 71.2 109.592 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.901 ' HA ' ' HG2' ' A' ' 38' ' ' LYS . 13.0 tpt -49.5 -30.88 9.02 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.275 -0.875 . . . . 65.43 112.553 -176.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' A' ' 56' ' ' MET . 8.9 m-80 68.99 -166.36 0.18 Allowed 'General case' 0 C--N 1.33 -0.25 0 O-C-N 123.311 0.382 . . . . 63.42 110.332 -177.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 61' ' ' SER . 13.5 m -124.93 148.46 48.34 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.255 -0.276 . . . . 61.13 110.255 -179.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 9.7 p -76.39 -42.22 45.22 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.338 -0.392 . . . . 61.21 111.119 -179.039 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -106.33 97.45 7.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.25 110.34 179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.605 ' O ' ' HB2' ' A' ' 58' ' ' SER . 13.4 t 68.13 158.2 0.14 Allowed 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 115.395 -0.82 . . . . 72.25 110.588 -176.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.2 p -81.17 131.55 33.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.114 0.483 . . . . 63.31 110.523 -178.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -84.12 -148.39 8.9 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.474 -0.87 . . . . 60.43 111.109 174.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -88.75 57.89 4.38 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 120.991 0.424 . . . . 54.12 109.915 178.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.5 t70 67.68 7.96 6.04 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.211 -0.904 . . . . 63.41 110.36 -178.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 61.88 90.98 0.08 OUTLIER Pre-proline 0 C--O 1.235 0.314 0 CA-C-N 115.701 -0.681 . . . . 43.31 110.454 -172.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.808 ' HA ' ' HG2' ' A' ' 133' ' ' ARG . 4.8 Cg_exo -76.62 85.54 1.71 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.98 2.454 . . . . 74.23 112.303 -177.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.528 ' HA ' ' O ' ' A' ' 131' ' ' MET . 6.1 p -153.66 138.68 17.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.222 0.534 . . . . 43.21 111.441 178.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.1 m -139.16 160.33 29.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.48 -0.782 . . . . 73.35 109.115 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.587 ' HB ' ' CD1' ' A' ' 130' ' ' ILE . 4.1 p -128.1 119.41 50.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.653 0.739 . . . . 72.22 111.958 -176.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.68 ' HA ' HD12 ' A' ' 51' ' ' ILE . 17.9 ptmt -99.96 123.3 44.06 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.083 -0.962 . . . . 65.45 109.677 174.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.503 HG12 ' CB ' ' A' ' 128' ' ' PHE . 13.9 m -114.29 151.85 16.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.085 -0.507 . . . . 75.3 111.054 -174.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 72' ' ' VAL . 18.1 mm-40 -165.34 145.27 5.66 Favored Pre-proline 0 C--N 1.33 -0.275 0 O-C-N 123.821 0.701 . . . . 73.24 110.025 175.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 126' ' ' TYR . 27.4 Cg_endo -63.47 141.25 79.97 Favored 'Trans proline' 0 C--O 1.235 0.371 0 C-N-CA 122.291 1.994 . . . . 74.14 111.532 176.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 7.2 t -64.84 -21.38 66.78 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.103 0.478 . . . . 51.13 110.448 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -87.26 11.12 15.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.919 -0.582 . . . . 62.23 111.931 -179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.409 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 54.4 t30 -95.26 -53.91 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.392 -0.523 . . . . 74.31 110.312 174.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 131.66 -76.04 0.41 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.901 -1.142 . . . . 51.12 114.248 175.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -47.45 -35.36 21.49 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 124.195 3.263 . . . . 70.52 114.684 -170.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -56.84 -45.42 82.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.89 0.376 . . . . 71.15 110.395 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -68.46 -31.47 70.79 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.184 -0.462 . . . . 72.13 110.697 -175.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 22.8 m -65.64 -49.02 70.2 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 116.205 -0.452 . . . . 75.15 110.64 178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -70.65 -31.83 68.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.264 -0.425 . . . . 74.14 109.862 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.401 HD13 ' HG2' ' A' ' 129' ' ' MET . 59.8 tp -61.34 -41.33 96.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.929 -0.578 . . . . 64.51 110.739 176.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.736 ' HA ' ' HE3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -62.23 -43.46 98.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.56 -0.291 . . . . 74.42 110.608 177.078 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 86.2 t80 -58.91 -51.91 68.01 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.119 -0.491 . . . . 73.23 110.211 175.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CE1' ' HG2' ' A' ' 131' ' ' MET . 73.0 t80 -60.43 -34.55 74.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.493 -0.776 . . . . 72.14 111.826 -178.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -70.93 -42.41 69.9 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.311 . . . . 72.42 111.442 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 7.5 tpm_? -80.51 -28.27 37.49 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.421 -0.354 . . . . 53.01 110.776 -176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.594 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -93.64 16.23 14.33 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.857 0.36 . . . . 53.42 111.325 -179.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -95.2 164.88 12.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.377 -0.374 . . . . 61.13 111.619 -178.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.406 ' HE3' ' HB2' ' A' ' 92' ' ' LYS . 37.9 ttmt 72.29 110.5 0.03 OUTLIER Pre-proline 0 N--CA 1.465 0.316 0 CA-C-N 115.183 -0.917 . . . . 74.23 111.389 176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -53.01 -36.98 78.1 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 123.404 2.736 . . . . 70.34 113.34 -176.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -61.25 -42.1 98.05 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-O 120.925 0.393 . . . . 71.55 110.941 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 27.6 mm-40 -66.65 -48.64 68.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.161 -0.472 . . . . 64.54 109.889 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.411 ' O ' HG12 ' A' ' 100' ' ' ILE . 57.5 mt -56.57 -51.31 67.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.303 -0.862 . . . . 53.25 110.598 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -56.4 -36.74 69.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.613 -0.721 . . . . 45.42 110.683 -179.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 24.0 ttmm -61.95 -56.52 18.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.067 -0.515 . . . . 75.23 111.236 -179.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.594 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 2.1 p90 -72.55 -35.04 67.91 Favored 'General case' 0 C--O 1.224 -0.258 0 C-N-CA 119.683 -0.807 . . . . 74.55 111.154 -175.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.411 HG12 ' O ' ' A' ' 96' ' ' ILE . 33.4 mm -58.3 -42.98 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 CA-C-O 121.47 0.653 . . . . 71.42 109.984 176.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 77.1 ttt-85 -61.83 -57.77 10.54 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.021 -0.991 . . . . 74.25 111.222 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 52.3 m -71.6 -29.88 65.19 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.181 0.437 . . . . 61.42 112.181 -175.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.561 ' HB2' ' O ' ' A' ' 99' ' ' TRP . 0.0 OUTLIER -83.55 -6.25 59.4 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.453 0.538 . . . . 72.43 112.453 -177.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 104' ' ' LYS . 6.6 mptt 63.34 31.0 15.51 Favored 'General case' 0 N--CA 1.47 0.529 0 O-C-N 123.511 0.507 . . . . 74.32 111.237 -178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.459 ' HG ' ' HB3' ' A' ' 103' ' ' ARG . 94.4 mt -83.59 169.08 15.76 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.747 -0.661 . . . . 72.31 109.558 177.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 56.8 mmtt -101.94 -72.74 0.68 Allowed 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 112.16 0.43 . . . . 61.12 112.16 -177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 31.1 t80 -150.8 110.46 4.04 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.168 0.509 . . . . 75.22 111.614 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.1 tp -79.77 127.92 32.79 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.634 -0.712 . . . . 43.35 110.692 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -84.95 67.87 3.6 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.025 -0.607 . . . . 74.14 112.398 178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.455 HG21 ' HB1' ' A' ' 90' ' ' ALA . 6.2 p -110.65 135.3 20.73 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 122.284 0.234 . . . . 73.45 110.694 -179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.456 ' HA ' ' CE2' ' A' ' 194' ' ' TYR . 34.8 Cg_exo -61.0 152.87 68.07 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.996 2.464 . . . . 74.31 113.136 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -70.34 136.54 49.83 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.761 -0.654 . . . . 62.42 111.124 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.459 ' HA ' ' OH ' ' A' ' 87' ' ' TYR . 48.7 t80 -84.53 129.79 34.82 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.679 -0.691 . . . . 63.44 111.461 -179.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.623 ' HB2' HG22 ' A' ' 130' ' ' ILE . 81.7 m95 -120.78 -50.78 2.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.327 0.584 . . . . 75.42 109.974 173.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . 173.17 178.3 43.05 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.747 -0.661 . . . . 52.13 112.321 -178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.424 ' O ' ' HG2' ' A' ' 32' ' ' MET . 22.8 t -164.69 -178.87 5.55 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.429 -0.582 . . . . 42.02 109.429 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 153.91 -151.52 23.23 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.969 -0.634 . . . . 70.11 111.921 177.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 118' ' ' LEU . 2.6 pt? -137.13 145.67 44.12 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.904 -0.406 . . . . 62.05 109.904 175.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 35.1 t60 -149.19 108.1 3.87 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.452 -0.34 . . . . 73.11 110.199 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.405 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 17.0 t70 -174.34 -88.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 O-C-N 123.504 0.503 . . . . 75.12 110.286 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 20.0 mmtp 54.1 29.68 10.74 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.406 0.622 . . . . 65.2 111.419 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.8 t30 -115.03 -30.95 6.21 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.582 -0.895 . . . . 74.32 108.582 175.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -124.75 -42.08 0.35 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 114.919 -1.037 . . . . 64.54 111.316 172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.474 ' HG3' ' H ' ' A' ' 125' ' ' SER . 14.9 tptm -173.58 -177.38 1.43 Allowed 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.525 -0.546 . . . . 64.35 109.525 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.474 ' H ' ' HG3' ' A' ' 124' ' ' LYS . 1.2 p -76.32 104.99 7.11 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.501 0.667 . . . . 73.44 111.212 175.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 74' ' ' PRO . 7.3 m-85 -98.36 120.48 38.85 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.505 -0.77 . . . . 71.31 110.002 176.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -92.03 142.49 27.47 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.978 -0.379 . . . . 72.15 109.978 -177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.707 ' HZ ' ' HA ' ' A' ' 31' ' ' ASP . 52.9 p90 -127.82 143.68 51.11 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.512 -0.313 . . . . 75.15 110.737 -178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 77.2 mtp -123.1 122.14 37.74 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.785 -0.643 . . . . 74.52 110.496 -178.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.623 HG22 ' HB2' ' A' ' 114' ' ' TRP . 4.7 mm -98.42 117.04 42.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-O 121.058 0.456 . . . . 64.5 110.173 175.872 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 68' ' ' CYS . 67.2 mtm -127.84 179.89 5.31 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.187 -0.671 . . . . 62.23 109.187 176.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.419 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.1 t70 -63.54 154.3 32.96 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.315 -0.624 . . . . 75.21 109.315 177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.808 ' HG2' ' HA ' ' A' ' 67' ' ' PRO . 11.6 ptp180 -82.31 125.37 30.91 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.494 0.664 . . . . 61.44 110.992 -173.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 16.5 m-85 -104.34 171.7 7.19 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.529 -0.76 . . . . 65.52 109.781 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -164.75 -38.7 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 119.855 -1.164 . . . . 51.1 113.264 -177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.799 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 69.8 m -94.37 124.71 38.56 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.927 0.394 . . . . 71.33 111.485 -176.362 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.559 ' HB3' ' HG2' ' A' ' 139' ' ' GLN . 1.1 m-20 -90.21 134.54 34.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.868 -0.606 . . . . 72.52 110.038 174.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.43 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 12.8 tp -69.66 -29.22 66.62 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.807 -0.812 . . . . 74.54 108.807 174.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.603 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 29.0 pt20 -69.86 -33.12 71.85 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 115.745 -0.661 . . . . 75.34 110.987 179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.781 ' HA ' ' HE3' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -69.56 -39.8 77.17 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.376 -0.601 . . . . 74.33 109.376 178.121 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.77 HG21 ' HG ' ' A' ' 341' ' ' LEU . 66.8 mt -68.57 -40.97 82.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.7 -0.682 . . . . 74.31 110.115 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.754 ' CE1' ' HD3' ' A' ' 147' ' ' LYS . 22.5 t80 -52.75 -48.83 66.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.923 -0.58 . . . . 74.54 110.655 176.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -66.8 -44.92 79.96 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.19 -0.914 . . . . 74.12 111.371 -176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -77.79 -31.57 51.94 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.039 0.385 . . . . 70.23 112.039 -174.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -96.74 2.59 52.16 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.935 0.397 . . . . 64.31 110.887 -176.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 56.16 38.55 29.97 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.074 -0.512 . . . . 72.43 111.644 177.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.754 ' HD3' ' CE1' ' A' ' 142' ' ' TYR . 37.3 pttt 46.33 29.46 0.86 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.483 1.113 . . . . 75.0 113.726 -179.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 66.7 ttt180 -99.92 84.08 2.83 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.366 -0.605 . . . . 63.33 109.366 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.503 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 5.0 m-30 -94.52 156.38 16.48 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.782 -0.644 . . . . 71.35 110.68 -173.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 36.9 p -73.51 138.06 44.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.239 -0.652 . . . . 75.21 109.239 173.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -60.29 -32.79 71.53 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.326 0.491 . . . . 73.51 112.326 -171.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.426 ' HZ2' ' HB3' ' A' ' 340' ' ' ASP . 11.0 pttp -60.15 -39.25 85.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.887 0.375 . . . . 72.35 110.929 176.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.506 HG23 HD23 ' A' ' 339' ' ' LEU . 30.4 m -71.57 -40.43 69.96 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.102 -0.499 . . . . 65.33 110.057 177.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.0 t -57.14 -47.18 84.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.778 -0.646 . . . . 70.14 111.28 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.758 ' HB3' HD22 ' A' ' 328' ' ' LEU . 0.2 OUTLIER -70.71 -44.11 67.58 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.215 -0.448 . . . . 72.33 110.687 -176.99 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.765 ' HG2' HD11 ' A' ' 339' ' ' LEU . 6.8 tp-100 -55.73 -46.2 77.81 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.03 0.443 . . . . 74.13 110.736 178.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.487 ' O ' HG12 ' A' ' 161' ' ' ILE . 87.7 mt -61.92 -51.7 67.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.903 -0.59 . . . . 72.04 110.931 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 5.6 p -64.24 -32.25 73.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.487 -0.324 . . . . 72.35 111.808 -175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.54 HD11 HD23 ' A' ' 325' ' ' LEU . 76.3 mt -61.25 -53.41 57.12 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.658 0.266 . . . . 73.42 110.851 175.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -66.81 -29.47 69.42 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.106 0.479 . . . . 61.4 110.538 -178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.517 HD11 HD21 ' A' ' 183' ' ' LEU . 28.2 mm -68.97 -35.04 67.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.142 -0.481 . . . . 71.04 110.359 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 8.6 tt -61.44 -46.62 89.31 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.729 -0.471 . . . . 63.13 109.729 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -57.2 -48.38 78.91 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.226 -0.443 . . . . 70.53 111.479 178.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.484 HG22 ' HA ' ' A' ' 161' ' ' ILE . 15.9 tt -72.32 -36.85 56.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 CA-C-N 116.443 -0.344 . . . . 73.14 111.607 -175.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.43 HD21 HD11 ' A' ' 178' ' ' ILE . 37.1 mt -64.63 -38.7 91.89 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.99 -0.284 . . . . 72.4 110.84 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -71.32 -37.9 71.75 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.942 -0.303 . . . . 62.42 110.532 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -50.91 -42.21 59.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.317 -0.401 . . . . 61.23 110.979 177.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.415 HG13 ' N ' ' A' ' 169' ' ' HIS . 38.8 pt -91.91 -43.82 14.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 N-CA-C 112.411 0.523 . . . . 75.15 112.411 -178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.415 ' N ' HG13 ' A' ' 168' ' ' ILE . 3.0 t-160 -72.86 -30.94 64.38 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.623 0.249 . . . . 63.02 111.567 -171.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.489 ' HG2' HH22 ' A' ' 240' ' ' ARG . 3.5 tm-20 -59.18 -28.77 66.92 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.006 0.431 . . . . 70.41 110.084 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 78.7 m-70 -101.41 -66.47 0.91 Allowed 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 112.745 0.646 . . . . 61.2 112.745 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.533 ' HG3' ' HD1' ' A' ' 173' ' ' TYR . 11.3 pt-20 -145.97 -60.56 0.32 Allowed 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 114.219 1.192 . . . . 73.34 114.219 -172.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.606 ' HB3' ' HD2' ' A' ' 203' ' ' ARG . 55.2 p90 -104.42 160.36 14.97 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.343 0.592 . . . . 74.34 112.47 -168.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 14.2 m -129.54 172.32 15.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.096 -0.956 . . . . 74.32 109.741 -178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.553 ' CE1' ' HB3' ' A' ' 177' ' ' ASP . 13.4 t-80 -98.98 -41.32 7.63 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.834 -0.432 . . . . 72.15 109.834 175.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 228' ' ' THR . . . 62.66 38.45 96.46 Favored Glycine 0 CA--C 1.518 0.261 0 C-N-CA 120.766 -0.73 . . . . 44.44 112.754 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.553 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 19.3 t70 179.71 112.45 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 122.765 0.426 . . . . 65.34 109.889 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.43 HD11 HD21 ' A' ' 165' ' ' LEU . 49.5 mm -111.16 79.87 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.508 0.67 . . . . 61.43 110.1 175.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.79 ' HZ2' ' HD2' ' A' ' 227' ' ' PHE . 46.4 mttp -103.79 153.05 21.15 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.46 -0.791 . . . . 64.44 110.647 174.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.43 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -63.36 -16.27 59.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.686 -0.688 . . . . 72.31 110.918 176.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.603 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 12.7 m -71.84 -14.16 61.88 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.961 -0.563 . . . . 63.44 111.472 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -97.43 -12.4 22.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.968 0.413 . . . . 74.14 110.913 -178.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.517 HD21 HD11 ' A' ' 161' ' ' ILE . 8.0 mp -105.67 120.26 41.23 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.363 0.601 . . . . 73.32 110.622 -175.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.561 HD23 ' HB ' ' A' ' 196' ' ' VAL . 3.6 mm? -118.03 131.35 56.47 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.298 -0.865 . . . . 51.24 110.131 -178.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.799 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 86.2 mt -86.84 154.9 20.52 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.485 -0.561 . . . . 71.25 109.485 177.434 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -59.13 153.46 18.04 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 108.344 -0.984 . . . . 73.21 108.344 173.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -47.56 -33.29 6.3 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.419 0.525 . . . . 62.25 112.419 -169.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 3.6 ttmt -154.84 51.75 0.62 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.189 0.519 . . . . 75.34 110.441 175.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.481 ' HA ' ' HD3' ' A' ' 190' ' ' PRO . 2.7 t-20 -135.43 107.4 10.12 Favored Pre-proline 0 C--N 1.33 -0.282 0 N-CA-C 109.379 -0.601 . . . . 72.01 109.379 174.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 189' ' ' ASN . 23.2 Cg_exo -66.49 -29.49 44.7 Favored 'Trans proline' 0 N--CA 1.474 0.36 0 C-N-CA 123.437 2.758 . . . . 41.23 115.305 -168.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.557 ' HA ' HD13 ' A' ' 339' ' ' LEU . 0.7 OUTLIER -94.29 -21.91 18.71 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 120.079 -0.649 . . . . 64.12 111.483 -173.334 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.486 ' HG3' ' CZ ' ' A' ' 194' ' ' TYR . 19.4 tp60 -91.38 93.62 9.12 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-O 121.569 0.7 . . . . 73.32 110.373 -172.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 12.0 p -103.49 142.79 16.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 114.838 -1.074 . . . . 73.52 110.247 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.486 ' CZ ' ' HG3' ' A' ' 192' ' ' GLN . 37.1 m-85 -124.04 157.34 34.72 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.189 -0.459 . . . . 72.3 110.045 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 19.9 tp -94.49 99.36 11.54 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.613 -0.884 . . . . 54.32 108.613 171.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.561 ' HB ' HD23 ' A' ' 184' ' ' LEU . 46.7 t -130.26 157.02 42.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.986 -0.552 . . . . 53.0 110.465 -170.125 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 51.16 64.96 1.63 Allowed 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 121.818 0.818 . . . . 60.33 111.297 175.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.9 p90 -123.17 -64.85 1.14 Allowed 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.078 -0.965 . . . . 73.35 110.65 -178.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.665 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . 77.02 -13.7 8.75 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 121.142 -0.552 . . . . 35.11 112.059 -178.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.476 HD22 ' O ' ' A' ' 175' ' ' HIS . 0.3 OUTLIER -84.63 89.75 7.54 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-O 121.127 0.489 . . . . 72.44 110.073 -178.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.511 ' HA ' ' O ' ' A' ' 174' ' ' VAL . . . -141.92 99.25 3.49 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.481 -0.781 . . . . 74.02 109.912 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -106.67 138.52 42.7 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.84 -0.618 . . . . 43.41 109.675 -176.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.606 ' HD2' ' HB3' ' A' ' 173' ' ' TYR . 4.8 mpt_? -71.36 129.06 37.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.944 0.402 . . . . 72.2 111.496 -177.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.627 ' HA ' ' HB1' ' A' ' 237' ' ' ALA . 11.6 t80 -95.49 -54.41 3.39 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.763 -0.653 . . . . 73.52 110.064 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 172' ' ' GLU . 6.7 p -134.1 105.39 11.39 Favored Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.697 -0.683 . . . . 71.34 110.105 -178.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.578 ' HD2' ' HB2' ' A' ' 210' ' ' HIS . 52.2 Cg_exo -54.16 107.37 0.21 Allowed 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.586 2.19 . . . . 62.02 111.568 178.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 65.9 11.68 7.84 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.103 -0.953 . . . . 74.12 111.418 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 105.54 -5.51 40.84 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 121.024 -0.607 . . . . 51.12 113.223 178.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 47.1 t -111.26 111.54 36.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 117.03 0.415 . . . . 74.24 111.536 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.578 ' HB2' ' HD2' ' A' ' 206' ' ' PRO . 12.6 t-160 -178.19 -101.13 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 115.96 -0.563 . . . . 62.12 110.888 173.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.474 ' HE3' HG23 ' A' ' 312' ' ' THR . 60.3 tttm 51.49 89.72 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.118 0.567 . . . . 63.01 111.947 -173.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -166.22 136.71 3.44 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.822 0.344 . . . . 54.33 111.139 178.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.753 ' HD1' ' HB ' ' A' ' 236' ' ' VAL . 20.3 t80 -94.75 80.45 3.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.975 -0.557 . . . . 75.03 111.495 177.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -178.9 70.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.547 -0.751 . . . . 72.12 109.517 168.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -106.49 -71.29 0.76 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.082 -0.508 . . . . 64.13 110.777 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -119.12 118.2 32.92 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.915 0.388 . . . . 75.13 110.395 -178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -79.63 0.46 10.0 Favored 'Trans proline' 0 C--O 1.233 0.266 0 C-N-CA 123.295 2.663 . . . . 72.0 112.899 -177.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.481 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 16.6 ttmm -100.04 -8.6 23.63 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.546 -0.539 . . . . 73.03 109.546 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 218' ' ' LYS . 29.1 mtm105 73.19 114.36 0.06 Allowed 'General case' 0 C--O 1.225 -0.214 0 CA-C-N 115.163 -0.926 . . . . 73.25 110.697 -177.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 37.1 m -61.01 -53.06 61.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.963 -0.562 . . . . 74.03 111.847 -175.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 26.0 p80 44.51 43.62 6.5 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.515 0.726 . . . . 64.5 111.911 -178.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -52.71 -59.48 4.43 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 116.132 -0.486 . . . . 44.23 111.207 -178.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -88.04 -155.36 28.96 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.898 -0.667 . . . . 70.4 112.36 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 18.9 p -88.7 151.59 22.34 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.941 0.4 . . . . 60.04 111.062 -178.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.486 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -53.27 -33.08 20.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 N-CA-C 113.739 1.014 . . . . 54.44 113.739 -167.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.93 -60.15 2.33 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 113.272 0.842 . . . . 73.2 113.272 -170.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.79 ' HD2' ' HZ2' ' A' ' 179' ' ' LYS . 28.9 m-85 -87.89 -0.23 56.7 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.28 0.474 . . . . 61.55 112.28 -174.517 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 176' ' ' GLY . 39.4 m -85.61 -10.3 56.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.346 0.593 . . . . 72.12 109.815 171.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.0 t 67.44 -175.7 0.2 Allowed 'General case' 0 C--O 1.235 0.321 0 CA-C-N 115.1 -0.955 . . . . 72.23 111.259 174.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 82.6 mt -70.5 -34.59 58.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.393 -0.822 . . . . 51.3 109.731 178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.621 ' HB3' ' HA ' ' A' ' 238' ' ' PRO . 1.8 m-20 -47.38 -84.23 0.01 OUTLIER 'General case' 0 C--O 1.235 0.323 0 CA-C-N 114.801 -1.091 . . . . 74.52 112.547 -176.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.643 ' HB2' ' HG3' ' A' ' 238' ' ' PRO . . . -66.31 -28.32 68.59 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.154 -0.476 . . . . 65.5 111.993 -172.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . . . . . . . . . 36.7 t60 -72.05 -26.6 62.25 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 120.662 -0.415 . . . . 75.21 110.971 -178.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.412 ' C ' ' HG2' ' A' ' 219' ' ' ARG . 1.8 t30 -95.75 -4.85 43.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.369 . . . . 63.15 110.981 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 98.59 21.07 17.65 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.352 -0.927 . . . . 73.1 113.391 174.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.753 ' HB ' ' HD1' ' A' ' 213' ' ' TYR . 7.1 p -117.63 141.28 37.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 109.67 -0.493 . . . . 60.32 109.67 175.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.627 ' HB1' ' HA ' ' A' ' 204' ' ' TYR . . . -56.71 125.06 66.77 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 116.084 -0.507 . . . . 64.4 110.966 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.643 ' HG3' ' HB2' ' A' ' 232' ' ' ALA . 33.3 Cg_exo -60.27 115.18 2.48 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.156 2.571 . . . . 71.03 112.701 -175.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 69.9 m -83.79 169.31 15.33 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.814 -0.63 . . . . 51.2 110.774 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.489 HH22 ' HG2' ' A' ' 170' ' ' GLU . 20.4 mtt180 -59.51 -20.53 56.08 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.528 0.68 . . . . 72.32 110.251 177.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.577 HH11 ' HG ' ' A' ' 309' ' ' LEU . 10.7 mmt180 -64.99 -41.82 95.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.094 -0.957 . . . . 74.22 109.645 178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.499 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -69.59 -41.41 75.87 Favored Glycine 0 N--CA 1.449 -0.496 0 CA-C-N 115.426 -0.806 . . . . 74.14 112.275 -179.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -56.07 -45.18 79.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.581 0.229 . . . . 73.53 111.083 177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.529 HD23 HG12 ' A' ' 306' ' ' VAL . 9.5 mp -60.9 -41.99 97.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.403 -0.362 . . . . 72.24 110.916 176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -59.92 -51.09 71.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.788 -0.642 . . . . 74.1 110.771 177.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.499 HG13 ' O ' ' A' ' 242' ' ' GLY . 62.4 mt -62.35 -42.1 94.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 116.009 -0.541 . . . . 75.21 111.09 -178.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.484 ' O ' ' HG3' ' A' ' 251' ' ' MET . 46.8 tp -61.96 -39.52 92.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.221 -0.445 . . . . 75.42 110.169 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.53 -39.65 98.12 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.339 -0.934 . . . . 74.03 111.645 177.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 18.2 m-30 -66.55 -39.47 88.55 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.907 0.336 . . . . 73.34 111.907 -179.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.408 ' SG ' HD12 ' A' ' 247' ' ' LEU . 20.0 p -68.12 -34.17 75.88 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.294 -0.563 . . . . 71.51 110.133 179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 81.6 mtp -62.9 -53.59 51.8 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.443 -0.344 . . . . 70.32 110.983 178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.542 HD12 ' SD ' ' A' ' 286' ' ' MET . 5.5 tt -65.98 -31.7 54.86 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-O 120.679 0.276 . . . . 53.34 110.303 179.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -56.26 -53.95 51.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.001 -0.545 . . . . 72.33 110.898 177.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.503 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 19.1 m0 -76.39 -25.16 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.051 -0.522 . . . . 71.43 111.222 -177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 58.5 tp -76.35 -46.3 28.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.493 -0.321 . . . . 60.23 111.617 -178.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 76.5 p -103.71 -17.73 14.99 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.914 -0.315 . . . . 72.23 111.674 -174.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.735 ' HA2' ' HG3' ' A' ' 147' ' ' LYS . . . 72.14 18.48 77.97 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.923 -0.656 . . . . 54.11 111.914 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 80.2 m80 -144.48 147.35 33.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.675 0.274 . . . . 75.25 110.957 -176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.871 ' HB2' ' HG3' ' A' ' 262' ' ' GLU . 96.1 mt -118.28 138.93 26.14 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 108.652 -0.87 . . . . 74.32 108.652 168.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 278' ' ' TYR . 23.0 Cg_exo -65.45 -17.35 57.36 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 122.978 2.452 . . . . 61.21 114.243 -171.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.551 ' HB2' ' HB2' ' A' ' 264' ' ' ASN . 16.3 p90 -132.93 34.64 3.6 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.414 0.524 . . . . 74.42 112.414 -175.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.871 ' HG3' ' HB2' ' A' ' 259' ' ' LEU . 43.4 mt-10 -68.03 -42.72 80.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.41 0.624 . . . . 63.41 109.692 173.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -69.13 -21.21 64.03 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.55 -0.75 . . . . 73.2 109.939 176.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.616 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 3.2 m-20 -89.81 -2.55 58.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.252 -0.886 . . . . 44.41 111.157 -176.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.525 HD23 HG11 ' A' ' 271' ' ' VAL . 89.7 mt -66.63 -2.83 5.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.796 0.331 . . . . 64.42 111.521 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 51.1 mttp -62.59 -40.02 95.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.238 -0.437 . . . . 72.33 110.919 176.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.573 ' OD1' ' HE3' ' A' ' 269' ' ' LYS . 10.7 t70 -135.13 135.41 22.78 Favored Pre-proline 0 C--N 1.327 -0.397 0 CA-C-N 116.066 -0.515 . . . . 42.31 110.982 -171.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 35.6 Cg_exo -60.72 -28.86 87.21 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 123.242 2.628 . . . . 72.33 113.476 -178.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.573 ' HE3' ' OD1' ' A' ' 267' ' ' ASP . 0.0 OUTLIER -78.11 -34.93 49.79 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.729 -0.471 . . . . 71.43 109.729 -179.166 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.616 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 6.4 m-85 -56.63 -50.54 71.73 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 115.811 -0.631 . . . . 74.41 111.058 176.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.525 HG11 HD23 ' A' ' 265' ' ' LEU . 7.8 m -70.47 -35.3 61.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.403 -0.362 . . . . 71.34 111.479 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.43 ' O ' HG13 ' A' ' 276' ' ' ILE . 82.3 mtt180 -56.96 -56.34 22.95 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.512 0.196 . . . . 74.14 111.336 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 277' ' ' ARG . 0.1 OUTLIER -66.39 -42.67 87.57 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.578 -0.283 . . . . 72.14 111.439 -176.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 16.2 m -61.01 -41.97 97.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.217 0.532 . . . . 73.42 110.256 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -59.21 -43.91 92.27 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.277 -0.874 . . . . 75.51 110.471 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 272' ' ' ARG . 79.7 mt -66.14 -44.46 91.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.961 -0.563 . . . . 72.34 111.274 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 273' ' ' ASP . 26.4 mmt180 -68.96 -36.15 77.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.589 0.233 . . . . 73.53 111.606 -175.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.453 ' CZ ' ' HB3' ' A' ' 260' ' ' PRO . 21.2 m-85 -73.12 -33.92 65.84 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 121.061 -0.255 . . . . 74.11 110.868 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -72.13 -22.93 61.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.267 0.556 . . . . 73.44 109.971 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -74.82 -53.44 9.12 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.537 -0.756 . . . . 65.54 110.51 178.055 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.536 ' HB2' HD23 ' A' ' 285' ' ' LEU . 30.4 m-80 -111.72 55.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 72.41 110.635 -176.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.565 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -52.13 -51.04 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.732 -0.667 . . . . 73.01 112.077 -178.701 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.526 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -63.23 -46.94 84.61 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.754 0.311 . . . . 63.23 111.42 -176.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 2.4 m -61.19 -49.14 78.37 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.811 -0.631 . . . . 74.5 111.143 -176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.536 HD23 ' HB2' ' A' ' 281' ' ' ASN . 4.3 mm? -71.58 -44.23 64.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.297 -0.41 . . . . 74.31 111.874 -175.173 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.542 ' SD ' HD12 ' A' ' 252' ' ' ILE . 21.8 mmt -64.69 -38.66 91.74 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 121.0 -0.28 . . . . 55.22 111.726 -174.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.17 -39.01 65.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.065 0.46 . . . . 74.12 110.413 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -74.05 -39.1 63.74 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.981 -0.554 . . . . 72.21 111.731 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 73.8 m -77.37 -11.36 59.83 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.607 0.225 . . . . 54.31 111.607 -176.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.716 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 10.5 t80 -129.7 69.53 81.55 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.181 0.515 . . . . 64.12 110.449 178.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -90.67 12.35 2.43 Favored 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.041 2.494 . . . . 72.44 112.534 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -75.03 -9.38 58.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.97 -0.559 . . . . 74.22 110.375 179.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 88.6 tttt 71.27 84.56 0.13 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 114.893 -1.049 . . . . 71.31 112.221 175.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.716 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 27.3 t-20 -128.3 -80.27 0.58 Allowed 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.802 -1.184 . . . . 62.41 107.802 169.399 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.491 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 60.0 tttp 175.13 96.85 0.08 OUTLIER Pre-proline 0 N--CA 1.461 0.092 0 O-C-N 123.743 0.652 . . . . 74.15 110.526 169.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -99.84 38.02 0.08 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.986 2.457 . . . . 73.0 111.47 172.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -91.3 -51.46 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.709 -0.758 . . . . 71.15 112.924 -172.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 298' ' ' GLU . 0.9 OUTLIER -72.61 -30.85 64.7 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.235 -0.283 . . . . 74.32 110.235 -178.097 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 4.3 mp -63.08 -44.3 99.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 N-CA-C 109.57 -0.53 . . . . 71.24 109.57 174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -62.67 -46.33 88.66 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.933 -0.576 . . . . 63.13 111.138 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -66.71 -41.07 88.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.635 -0.257 . . . . 63.01 110.648 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.447 ' O ' ' HB ' ' A' ' 305' ' ' THR . 56.9 t80 -55.14 -45.35 75.64 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.502 -0.317 . . . . 61.25 110.986 173.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.54 ' O ' HG22 ' A' ' 306' ' ' VAL . 74.8 mtp -72.72 -31.35 64.9 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.598 -0.274 . . . . 64.52 111.62 -179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -68.29 -30.37 69.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.475 0.655 . . . . 72.24 109.236 173.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 86.7 m -66.32 -40.3 89.82 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.346 -0.843 . . . . 71.42 110.869 177.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.701 ' HA ' ' HB2' ' A' ' 309' ' ' LEU . 5.7 m -73.49 -27.03 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 120.819 -0.352 . . . . 61.31 110.492 177.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -62.3 -42.85 99.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.001 0.429 . . . . 63.25 110.498 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 32.1 tp -97.11 16.22 20.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.413 0.625 . . . . 55.44 110.05 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.701 ' HB2' ' HA ' ' A' ' 306' ' ' VAL . 27.4 tp -71.92 -32.53 67.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.768 -0.651 . . . . 74.12 110.666 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.558 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 27.1 t70 67.5 161.7 0.18 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.322 -0.854 . . . . 60.53 110.848 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 59.8 t80 -77.75 -22.72 49.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.699 0.285 . . . . 74.31 111.187 -177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.474 HG23 ' HE3' ' A' ' 211' ' ' LYS . 24.3 m -124.01 -20.28 5.4 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.592 0.59 . . . . 71.23 112.592 -173.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.558 ' HB2' ' HB3' ' A' ' 310' ' ' ASP . 14.5 tp10 -57.02 -101.16 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.344 0.868 . . . . 73.11 113.344 -166.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -147.04 120.17 4.91 Favored Pre-proline 0 C--N 1.329 -0.291 0 O-C-N 121.641 -0.662 . . . . 74.21 111.508 -175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 309' ' ' LEU . 57.3 Cg_endo -91.03 118.57 0.58 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.542 2.162 . . . . 54.12 111.121 170.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.637 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 96.1 mt -116.04 82.43 1.77 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.79 0.328 . . . . 74.54 111.318 -176.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.517 ' HA ' HD12 ' A' ' 320' ' ' LEU . 35.9 m-85 -62.28 -33.46 74.67 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.022 -0.535 . . . . 72.54 111.428 -179.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -60.28 -40.45 90.47 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.771 0.319 . . . . 75.43 110.95 178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 39.3 t-20 -73.21 -37.51 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.687 -0.486 . . . . 72.42 109.687 -179.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.637 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 50.6 mt -59.32 -47.71 84.37 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.113 -0.494 . . . . 73.13 110.154 176.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 41.3 ttp85 -57.96 -41.59 83.18 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 70.45 110.408 175.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -63.49 -52.28 61.96 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.706 -0.679 . . . . 73.51 111.686 -176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 3.5 tt -63.58 -47.52 91.04 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 111.91 0.337 . . . . 72.04 111.91 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.5 mt -66.19 -39.14 89.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.247 0.546 . . . . 63.23 110.435 -176.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.54 HD23 HD11 ' A' ' 159' ' ' LEU . 2.8 tm? -69.28 -35.28 75.89 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.152 -0.684 . . . . 73.23 109.152 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.1 tp60 -62.91 -37.71 88.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.058 -0.519 . . . . 73.04 109.962 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.17 -41.0 95.13 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.903 -0.665 . . . . 61.14 112.215 177.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.758 HD22 ' HB3' ' A' ' 155' ' ' LEU . 41.6 tp -71.65 -37.94 70.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.19 0.519 . . . . 42.34 110.746 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 50.4 tttp -72.08 -22.98 61.28 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.162 -0.472 . . . . 55.22 110.511 179.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.46 -31.44 72.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.108 -0.496 . . . . 73.34 110.957 178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.445 HD11 HD12 ' A' ' 328' ' ' LEU . 33.5 pt -95.44 1.86 10.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.982 0.42 . . . . 73.23 110.583 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.2 25.08 75.38 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-N 115.774 -0.648 . . . . 43.15 113.224 175.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.419 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 5.4 t -117.32 170.13 8.94 Favored 'General case' 0 C--N 1.323 -0.574 0 O-C-N 122.474 -0.427 . . . . 53.41 110.751 -176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.425 ' HA ' HD21 ' A' ' 328' ' ' LEU . 27.3 ttpp -160.11 -56.12 0.06 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.889 -0.782 . . . . 74.43 108.889 -179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.629 ' HB2' ' H ' ' A' ' 339' ' ' LEU . 7.1 p-10 178.6 -36.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.914 -1.039 . . . . 75.24 108.452 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 10.8 t70 72.45 -71.55 0.13 Allowed 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 114.681 -1.145 . . . . 74.22 111.786 172.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -117.94 57.51 0.53 Allowed Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.805 -0.712 . . . . 65.2 112.303 -177.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.492 ' HG3' ' HB3' ' A' ' 191' ' ' ASP . 0.0 OUTLIER 62.76 64.93 0.85 Allowed 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.046 0.451 . . . . 71.34 110.91 -178.776 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.765 HD11 ' HG2' ' A' ' 156' ' ' GLN . 10.9 mp 63.04 -171.06 0.17 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.075 -0.966 . . . . 61.32 111.487 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . 0.426 ' HB3' ' HZ2' ' A' ' 152' ' ' LYS . 32.4 t70 -159.43 82.37 0.76 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.264 -0.88 . . . . 73.31 108.732 177.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.77 ' HG ' HG21 ' A' ' 141' ' ' ILE . 28.8 tp -125.76 -74.97 0.59 Allowed 'General case' 0 C--N 1.313 -0.982 0 CA-C-N 115.316 -0.856 . . . . 61.41 110.727 -175.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 58.1 m -173.78 -69.87 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 116.269 -0.423 . . . . 60.0 111.237 -174.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 84.5 t 67.81 96.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 CA-C-N 115.65 -0.704 . . . . 55.12 110.124 -170.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.411 ' O ' ' HB3' ' A' ' 345' ' ' GLU . 19.4 t -88.95 -15.73 8.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.528 -0.76 . . . . 54.35 110.811 -174.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.411 ' HB3' ' O ' ' A' ' 344' ' ' VAL . 7.2 tt0 73.59 -37.3 0.37 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 123.185 0.594 . . . . 71.23 111.643 178.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -125.46 130.39 51.73 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.698 -0.482 . . . . 73.12 109.698 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -136.87 -121.7 2.07 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.621 -0.8 . . . . 22.32 112.829 -178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -179.88 73.4 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 121.35 -0.452 . . . . 53.02 112.266 -175.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.567 HD22 ' HA2' ' A' ' 46' ' ' GLY . 6.8 mp -59.07 145.14 43.22 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 122.392 0.277 . . . . 75.13 111.09 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -164.99 116.87 1.18 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.199 -0.455 . . . . 73.53 110.752 -175.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -109.74 -178.34 3.51 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 116.301 -0.408 . . . . 64.23 112.1 -175.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.665 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 28.4 ttpt -142.72 170.61 15.38 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.173 -0.677 . . . . 54.13 109.173 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.658 ' O ' ' HE3' ' A' ' 352' ' ' LYS . 10.4 t -106.67 162.39 13.81 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 110.168 -0.308 . . . . 72.34 110.168 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.628 ' H ' HD13 ' A' ' 354' ' ' ILE . 0.2 OUTLIER -66.44 143.22 15.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-O 121.398 0.618 . . . . 70.11 111.738 -178.733 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 19.5 m -101.4 97.35 7.83 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.329 -0.851 . . . . 75.1 111.125 -176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.6 ttmm -145.98 -48.25 0.21 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.966 -0.561 . . . . 74.11 110.749 179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -131.05 131.45 44.27 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.249 -0.432 . . . . 75.42 110.441 -178.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 26.3 ptt180 -65.94 113.74 4.63 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.574 -0.528 . . . . 63.15 109.574 172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -123.51 148.39 46.31 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.128 -0.487 . . . . 63.54 111.5 -172.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 13.0 ttpp . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.517 -0.754 . . . . 73.51 109.18 173.448 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.914 -0.402 . . . . 73.22 109.914 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -73.48 146.9 40.19 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.534 2.156 . . . . 64.35 111.993 -179.463 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.422 ' HD3' ' N ' ' A' ' 3' ' ' ARG . 0.6 OUTLIER -98.09 113.91 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.14 -0.482 . . . . 71.32 109.824 179.775 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 51.7 t -81.06 131.41 33.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.417 -0.356 . . . . 65.55 110.47 -178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.7 122.24 13.26 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.252 -0.431 . . . . 73.05 110.656 176.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -147.85 -6.37 0.45 Allowed 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.596 -0.729 . . . . 73.32 110.936 178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.67 155.53 40.37 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.477 -0.329 . . . . 60.23 110.997 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -110.76 142.43 42.73 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.205 -0.452 . . . . 73.14 110.795 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 260' ' ' PRO . . . -84.56 145.74 27.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.345 -0.389 . . . . 75.44 110.372 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -157.33 -165.31 14.9 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.564 -0.826 . . . . 73.04 112.728 -179.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.5 mmt180 -129.16 130.26 46.16 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 122.46 0.304 . . . . 72.15 110.7 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 5.4 tt0 -171.3 37.89 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.101 0.477 . . . . 63.15 110.851 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 p -82.36 120.0 24.87 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 120.181 -0.608 . . . . 74.23 110.605 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 51.6 m -162.49 124.61 2.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.665 -0.698 . . . . 75.05 109.733 179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -92.64 149.75 21.14 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.9 0.381 . . . . 51.23 110.388 179.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -88.19 -175.22 4.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.301 -0.409 . . . . 72.53 110.401 178.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 25.9 ptt180 -147.95 110.76 4.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.182 0.515 . . . . 65.23 111.83 -174.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -145.35 124.58 12.95 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.948 -0.569 . . . . 72.13 110.21 174.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.439 HD23 HD21 ' A' ' 349' ' ' LEU . 4.4 pp -152.11 147.14 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.153 -0.476 . . . . 64.21 110.064 177.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.44 152.51 46.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.405 -0.361 . . . . 73.23 110.306 -179.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -145.25 -166.87 2.53 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.331 -0.395 . . . . 74.31 111.434 -173.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 76.11 52.64 0.06 Allowed 'General case' 0 C--O 1.234 0.261 0 CA-C-N 114.981 -1.008 . . . . 74.21 113.051 173.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -81.19 174.1 11.88 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.752 -1.203 . . . . 65.3 107.752 164.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -79.67 95.59 5.98 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.253 0.549 . . . . 73.03 111.31 -176.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 97.0 t -66.23 132.56 31.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.664 -0.698 . . . . 64.4 109.802 174.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.99 -7.87 60.82 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.725 -0.75 . . . . 51.43 112.404 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -72.56 128.64 36.19 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-O 120.824 0.345 . . . . 64.13 110.914 177.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 75.8 mt -86.62 129.0 39.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.497 -0.774 . . . . 74.31 110.174 177.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.496 HG13 ' HB2' ' A' ' 37' ' ' TRP . 29.4 pt -116.26 147.12 19.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 116.064 -0.516 . . . . 61.31 110.81 -179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 35' ' ' LYS . 55.0 m -118.15 125.77 50.89 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.512 -0.767 . . . . 74.52 109.6 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.508 ' CG ' ' H ' ' A' ' 33' ' ' ALA . 2.2 p-10 -121.27 -164.53 1.13 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.881 0.372 . . . . 72.44 111.057 -174.783 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.516 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 13.8 mmt -68.63 -14.43 63.01 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.336 -0.393 . . . . 71.24 111.697 179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.508 ' H ' ' CG ' ' A' ' 31' ' ' ASP . . . -81.7 11.37 4.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.104 0.478 . . . . 70.21 109.78 172.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 35' ' ' LYS . 24.4 tptp 92.36 -28.66 0.03 OUTLIER 'General case' 0 N--CA 1.461 0.11 0 C-N-CA 125.034 1.334 . . . . 65.23 113.285 167.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.978 ' HG3' ' HG3' ' A' ' 36' ' ' GLU . 21.2 ptmt 159.59 176.49 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.86 0 O-C-N 123.563 0.54 . . . . 72.05 111.608 -177.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.978 ' HG3' ' HG3' ' A' ' 35' ' ' LYS . 38.8 mt-10 82.62 59.75 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 114.186 1.18 . . . . 73.4 114.186 165.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.496 ' HB2' HG13 ' A' ' 29' ' ' ILE . 40.4 m95 -138.95 151.13 46.64 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.189 -1.411 . . . . 73.24 107.189 165.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.722 ' HE3' ' HB3' ' A' ' 56' ' ' MET . 61.0 pttt -154.47 144.47 21.83 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 119.857 -0.737 . . . . 63.31 111.24 172.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.6 t -65.81 126.44 25.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.293 -0.867 . . . . 74.03 110.619 -175.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -121.68 -60.66 0.22 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.449 -0.882 . . . . 70.14 112.355 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.506 ' HB3' ' HB3' ' A' ' 53' ' ' LEU . 6.6 tt -103.82 120.62 50.77 Favored Pre-proline 0 C--N 1.323 -0.551 0 N-CA-C 109.998 -0.371 . . . . 65.3 109.998 -176.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.67 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 4.8 Cg_exo -79.0 112.74 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 123.351 2.701 . . . . 75.13 111.776 177.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.773 HG22 ' HG2' ' A' ' 45' ' ' GLN . 49.2 mt -95.48 -57.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.333 -0.394 . . . . 71.14 110.37 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 86.07 -20.1 22.71 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 121.205 -0.522 . . . . 62.34 113.254 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.773 ' HG2' HG22 ' A' ' 43' ' ' ILE . 12.0 pt20 -111.44 165.01 12.34 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 110.006 -0.368 . . . . 75.41 110.006 -176.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 144.85 -170.15 26.45 Favored Glycine 0 N--CA 1.438 -1.174 0 N-CA-C 110.693 -0.963 . . . . 72.24 110.693 -174.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.605 ' HA3' ' CG2' ' A' ' 196' ' ' VAL . . . -81.85 50.38 4.26 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.752 -0.737 . . . . 45.1 113.098 -175.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.594 ' HB2' ' O ' ' A' ' 47' ' ' GLY . 4.2 t80 166.5 -37.75 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.204 0 C-N-CA 123.395 0.678 . . . . 74.22 109.299 176.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 109.24 157.2 17.65 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 121.031 -0.604 . . . . 65.42 112.25 179.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 73.9 m 65.16 41.37 4.54 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-O 121.131 0.491 . . . . 72.1 111.349 179.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.651 HD12 ' HB3' ' A' ' 71' ' ' LYS . 5.2 mm -97.33 138.49 22.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 109.494 -0.558 . . . . 70.1 109.494 178.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.67 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 97.7 m-85 -122.32 167.36 13.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.834 0.35 . . . . 61.43 111.752 -175.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD22 ' HB2' ' A' ' 55' ' ' ASP . 3.8 tt -115.16 139.53 49.84 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.069 -0.514 . . . . 73.43 109.999 -177.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.523 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -93.1 68.22 4.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.59 0.71 . . . . 72.41 109.763 -178.381 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.585 ' HB2' HD22 ' A' ' 53' ' ' LEU . 31.7 t70 -89.47 -14.93 34.21 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.162 -0.926 . . . . 72.11 112.041 -169.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.722 ' HB3' ' HE3' ' A' ' 38' ' ' LYS . 5.2 mmt -95.05 -0.71 53.39 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.446 0.536 . . . . 73.03 112.446 -172.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.41 ' OD1' ' HB1' ' A' ' 54' ' ' ALA . 0.9 OUTLIER -105.35 80.2 1.56 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.481 0.658 . . . . 75.42 110.503 177.217 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 15.2 m -124.9 104.23 8.48 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.706 -0.679 . . . . 71.35 110.707 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.8 m -107.31 125.34 51.05 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.261 -0.427 . . . . 71.43 110.067 177.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 62.83 35.22 13.83 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 121.264 0.554 . . . . 75.02 110.476 177.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 10.3 m 59.15 27.89 17.02 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.643 -0.708 . . . . 75.03 111.267 178.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.73 129.19 15.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 CA-C-O 121.191 0.52 . . . . 72.14 111.412 -177.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -101.94 24.67 30.52 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 121.066 -0.588 . . . . 55.13 113.012 -175.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.446 ' O ' ' HD2' ' A' ' 67' ' ' PRO . 5.0 p -117.46 -54.43 2.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.796 0.298 . . . . 74.42 111.212 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -71.7 -28.0 63.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.083 -0.508 . . . . 65.14 112.148 -173.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB3' ' HD3' ' A' ' 67' ' ' PRO . . . -72.95 -50.12 7.09 Favored Pre-proline 0 CA--C 1.537 0.481 0 N-CA-C 111.839 0.311 . . . . 75.31 111.839 -179.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.624 ' HD3' ' HB3' ' A' ' 66' ' ' ALA . 10.7 Cg_exo -73.58 43.94 0.84 Allowed 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.573 2.182 . . . . 74.21 112.814 176.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 84.0 m -117.31 142.35 47.19 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.754 0.311 . . . . 71.14 110.326 178.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.441 HG12 ' HG ' ' A' ' 53' ' ' LEU . 31.7 m -117.15 158.74 17.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 109.831 -0.433 . . . . 73.21 109.831 178.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.64 ' HB ' HD13 ' A' ' 130' ' ' ILE . 2.1 p -137.72 126.34 33.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 121.326 0.584 . . . . 75.3 111.664 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.651 ' HB3' HD12 ' A' ' 51' ' ' ILE . 46.7 pttt -98.81 136.26 39.09 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.398 -0.819 . . . . 73.44 109.132 174.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 126' ' ' TYR . 8.4 p -137.21 138.2 45.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 112.568 0.581 . . . . 64.3 112.568 -172.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.515 ' OE1' ' HB2' ' A' ' 80' ' ' LEU . 27.0 mt-10 -123.1 163.76 31.68 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 115.598 -0.728 . . . . 73.4 109.05 172.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -67.75 -177.07 1.11 Allowed 'Trans proline' 0 CA--C 1.532 0.405 0 C-N-CA 122.328 2.019 . . . . 73.13 111.918 173.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 33.1 t -76.83 11.72 1.62 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.772 0.32 . . . . 71.35 111.696 -177.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -60.81 -40.51 92.95 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.739 -0.467 . . . . 73.4 109.739 175.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . 0.503 ' OD1' ' HB2' ' A' ' 81' ' ' PHE . 64.0 t30 60.7 83.02 0.15 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.06 -0.973 . . . . 63.35 111.468 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -134.51 -83.05 0.18 Allowed Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.647 -0.787 . . . . 73.13 111.719 177.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_exo -62.86 -44.38 16.63 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.683 2.255 . . . . 74.44 111.624 176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HB2' ' OE1' ' A' ' 73' ' ' GLU . 0.3 OUTLIER -59.93 -34.9 73.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.454 -0.339 . . . . 54.4 110.405 177.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.503 ' HB2' ' OD1' ' A' ' 77' ' ' ASN . 74.7 t80 -63.57 -47.76 80.22 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.043 0.449 . . . . 72.01 110.257 177.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 26.0 m -65.54 -42.63 91.71 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.66 -0.7 . . . . 65.05 110.074 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -60.85 -43.7 97.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.23 -0.895 . . . . 70.03 110.54 177.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.547 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 46.4 tp -55.83 -47.35 77.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.736 -0.666 . . . . 71.41 110.59 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.727 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 11.1 mmpt? -60.47 -41.76 94.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.212 -0.449 . . . . 72.34 110.46 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 92.7 t80 -59.98 -44.44 94.49 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.799 -0.637 . . . . 73.35 110.814 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.611 ' HD2' ' HB2' ' A' ' 113' ' ' TYR . 18.9 m-85 -70.55 -39.61 73.87 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 111.824 0.305 . . . . 73.4 111.824 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 84' ' ' LEU . 81.5 mm-40 -68.02 -18.31 64.67 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.038 0.447 . . . . 61.55 110.5 179.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.564 ' HA ' ' HE ' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -96.72 -70.49 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.088 -0.505 . . . . 74.44 111.634 176.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.673 ' HA ' ' HH2' ' A' ' 99' ' ' TRP . . . -83.89 -34.48 24.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 113.274 0.842 . . . . 70.13 113.274 -170.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -77.34 79.36 3.85 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.377 0.608 . . . . 73.34 112.16 -172.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.457 ' HB3' ' CB ' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -154.24 116.33 2.55 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 108.845 -0.798 . . . . 74.21 108.845 176.361 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.431 ' HD2' ' HD3' ' A' ' 92' ' ' LYS . 9.7 Cg_endo -52.05 -54.02 5.97 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 123.333 2.688 . . . . 75.14 114.067 -170.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' O ' ' HB2' ' A' ' 98' ' ' LYS . 1.2 pp20? -72.95 -28.34 62.36 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.845 0.355 . . . . 72.25 110.624 -177.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.457 ' CB ' ' HB3' ' A' ' 92' ' ' LYS . 3.6 tp-100 -67.81 -48.99 64.71 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.458 -0.571 . . . . 72.53 109.458 -179.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.484 HG23 HD12 ' A' ' 108' ' ' LEU . 81.5 mt -57.19 -53.05 48.58 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.189 0 CA-C-N 115.603 -0.726 . . . . 75.43 110.434 176.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 39.3 tt0 -54.02 -40.05 66.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.429 -0.805 . . . . 75.33 110.611 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 18.5 ttpt -67.24 -59.47 3.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.25 -0.886 . . . . 72.11 111.482 -175.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.673 ' HH2' ' HA ' ' A' ' 90' ' ' ALA . 1.3 p90 -68.44 -34.03 75.25 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 120.474 -0.49 . . . . 70.42 110.833 -176.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.649 HG13 ' HB2' ' A' ' 105' ' ' LEU . 2.9 tp -72.1 -29.09 31.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-O 120.885 0.374 . . . . 74.44 110.032 -177.338 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 48.3 ttt180 -65.52 -47.34 76.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.736 -0.665 . . . . 65.0 109.778 175.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.9 p -74.66 -19.01 60.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.977 -0.556 . . . . 71.14 111.447 177.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.462 HH21 ' CD ' ' A' ' 166' ' ' GLU . 17.9 tpt180 -79.44 -18.45 52.12 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-N 116.152 -0.476 . . . . 72.21 110.538 -179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.462 ' HB2' ' O ' ' A' ' 103' ' ' ARG . 63.5 mttm 71.44 28.32 2.92 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.777 0.673 . . . . 75.03 111.197 -178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.649 ' HB2' HG13 ' A' ' 100' ' ' ILE . 46.7 mt -100.0 -170.89 1.95 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.262 -0.426 . . . . 75.12 110.432 177.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.43 ' HG3' ' HB2' ' A' ' 107' ' ' TYR . 24.7 pttm -119.58 -34.91 3.66 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 112.514 0.561 . . . . 75.31 112.514 -172.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.43 ' HB2' ' HG3' ' A' ' 106' ' ' LYS . 0.3 OUTLIER -150.03 179.27 8.21 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.926 0.393 . . . . 75.14 110.758 -169.159 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 110' ' ' VAL . 0.5 OUTLIER -162.16 127.96 3.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.799 -0.815 . . . . 54.41 108.799 170.3 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.542 ' HA3' HD11 ' A' ' 164' ' ' ILE . . . -86.53 59.67 4.59 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.822 -0.704 . . . . 33.53 112.625 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.51 HG23 HD22 ' A' ' 108' ' ' LEU . 88.5 t -116.83 122.51 31.41 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.977 -0.379 . . . . 72.23 109.977 178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 18.0 Cg_exo -66.19 149.32 85.51 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.884 2.389 . . . . 74.22 113.07 -175.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.656 ' HB3' ' HB2' ' A' ' 132' ' ' ASP . 22.6 tptm -65.07 117.59 7.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.069 -0.514 . . . . 74.42 110.561 177.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.611 ' HB2' ' HD2' ' A' ' 87' ' ' TYR . 61.2 t80 -89.03 123.03 32.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.342 -0.845 . . . . 75.33 110.121 176.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -96.4 -67.01 0.87 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.286 -0.635 . . . . 64.4 109.286 176.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . 0.416 ' HA3' ' OD2' ' A' ' 31' ' ' ASP . . . -155.36 -178.13 29.3 Favored Glycine 0 N--CA 1.443 -0.846 0 CA-C-N 115.423 -0.808 . . . . 75.34 112.144 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.408 ' O ' ' HG2' ' A' ' 32' ' ' MET . 58.6 p -164.73 163.7 21.4 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.046 -0.724 . . . . 55.24 109.046 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -176.26 -168.74 36.84 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.738 -1.22 . . . . 74.22 113.118 -179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 10.5 tt -134.17 127.28 31.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.534 -0.543 . . . . 61.41 109.534 -178.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.6 t60 -123.46 109.94 14.47 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.945 -0.571 . . . . 75.23 110.637 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.87 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 13.8 t70 -75.7 118.79 18.9 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.426 -0.583 . . . . 71.23 109.426 175.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.765 ' HG2' HD22 ' A' ' 122' ' ' ASN . 87.2 tttt -105.66 94.67 5.32 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.391 -0.368 . . . . 75.23 111.03 -174.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.765 HD22 ' HG2' ' A' ' 121' ' ' LYS . 44.6 m-80 71.51 -41.78 0.51 Allowed 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.548 0.739 . . . . 72.13 112.846 173.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -155.89 -38.26 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.637 -0.792 . . . . 75.04 112.708 -178.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -116.31 143.54 45.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.896 0.379 . . . . 63.42 110.114 177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.87 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.0 p -94.62 149.16 21.52 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.965 -0.561 . . . . 74.15 112.134 -174.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.453 ' HB3' ' CG2' ' A' ' 72' ' ' VAL . 67.4 m-85 -115.57 145.28 42.81 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.371 -0.831 . . . . 73.51 109.968 175.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 22.4 ttm-85 -112.45 120.46 41.72 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.01 -0.737 . . . . 72.32 109.01 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.52 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 50.3 p90 -124.87 162.93 23.31 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.935 0.398 . . . . 72.43 112.042 -170.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.467 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 43.8 ttm -144.88 136.95 25.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.672 -0.695 . . . . 71.11 110.695 -179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.64 HD13 ' HB ' ' A' ' 70' ' ' VAL . 7.2 mm -97.45 127.78 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.132 0.491 . . . . 74.32 111.021 -178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 71.1 mtp -121.28 164.2 17.37 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.526 -0.761 . . . . 74.45 110.426 -178.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.656 ' HB2' ' HB3' ' A' ' 112' ' ' LYS . 25.5 t70 -81.26 98.35 8.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.219 -0.446 . . . . 70.23 111.306 178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HG2' ' C ' ' A' ' 132' ' ' ASP . 3.7 ptt180 29.71 95.53 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 115.411 1.634 . . . . 65.51 115.411 169.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -110.32 151.88 26.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.444 -0.576 . . . . 73.34 109.444 172.472 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.776 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -165.73 -15.53 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 119.38 -1.391 . . . . 71.1 114.967 -177.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.737 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 38.7 m -120.65 124.7 45.88 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 118.274 1.037 . . . . 64.44 111.682 -179.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.496 ' HB2' ' HG2' ' A' ' 140' ' ' LYS . 1.3 m-20 -101.29 131.05 47.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.855 -0.794 . . . . 73.32 108.855 175.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.617 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 4.9 mp -61.48 -36.91 81.77 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.492 -0.483 . . . . 55.32 110.856 178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.676 ' HB3' ' HA ' ' A' ' 181' ' ' SER . 27.2 pt20 -58.79 -47.92 83.07 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.455 0.539 . . . . 73.45 112.455 -175.12 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.496 ' HG2' ' HB2' ' A' ' 137' ' ' ASP . 20.3 ptmt -70.29 -34.85 73.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.828 0.347 . . . . 71.54 110.783 -175.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.55 HD13 HD21 ' A' ' 341' ' ' LEU . 17.1 mt -75.05 -39.77 44.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.186 -0.461 . . . . 75.34 110.515 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.694 ' CE1' ' HB3' ' A' ' 147' ' ' LYS . 0.0 OUTLIER -62.44 -43.44 98.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 73.12 111.957 -175.286 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -67.86 -40.6 83.59 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.185 -0.606 . . . . 72.04 110.601 -179.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -68.89 -31.75 70.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 74.51 111.136 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -88.78 5.66 42.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 54.42 110.392 178.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.4 41.28 13.06 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 115.466 -0.788 . . . . 64.22 112.216 176.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.694 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.0 OUTLIER 41.75 86.81 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.935 0.894 . . . . 72.44 112.668 -179.649 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.479 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 11.6 ttp180 -153.78 93.5 1.67 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.038 -0.983 . . . . 74.21 109.975 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.669 ' HD2' HG21 ' A' ' 153' ' ' THR . 85.0 m-85 -112.6 137.74 50.4 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.251 -0.431 . . . . 74.04 110.001 179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 74.6 p -73.31 168.85 18.35 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.375 -0.375 . . . . 52.34 110.978 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.546 ' HB3' HD11 ' A' ' 328' ' ' LEU . 81.8 mtt180 -55.03 -37.06 66.18 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 115.913 -0.585 . . . . 74.14 110.725 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 23.6 mtpt -60.65 -42.94 97.98 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.352 -0.84 . . . . 73.32 110.572 178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.669 HG21 ' HD2' ' A' ' 149' ' ' PHE . 10.2 m -71.76 -52.23 18.68 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.5 -0.773 . . . . 61.42 111.303 -176.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.3 t -57.82 -42.82 82.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.977 -0.556 . . . . 74.41 110.966 -177.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.56 HD22 ' HG ' ' A' ' 328' ' ' LEU . 16.9 tp -65.61 -49.47 68.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.195 -0.457 . . . . 71.41 110.575 -178.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.49 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 20.8 mm-40 -58.97 -47.74 84.04 Favored 'General case' 0 C--O 1.233 0.22 0 N-CA-C 111.923 0.342 . . . . 71.04 111.923 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 95.6 mt -61.87 -43.92 97.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.472 -0.331 . . . . 73.21 110.892 -178.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 33.7 t -62.33 -43.04 99.75 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 72.15 110.355 178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 82.3 mt -61.45 -39.9 92.51 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.242 -0.436 . . . . 71.31 111.262 -179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.49 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 81.6 mmt-85 -62.73 -49.15 76.2 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.017 0.437 . . . . 73.31 110.378 179.277 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.56 -30.31 49.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.774 -0.648 . . . . 65.45 110.681 179.325 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.14 -47.42 86.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.41 -0.359 . . . . 70.11 110.569 178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -62.46 -42.23 99.32 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-O 121.59 0.71 . . . . 65.12 110.097 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.586 ' O ' HG12 ' A' ' 168' ' ' ILE . 61.3 mt -61.44 -46.44 96.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.225 -0.898 . . . . 63.44 110.74 178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.438 ' HG ' ' HE1' ' A' ' 317' ' ' TYR . 64.4 tp -57.69 -39.03 76.23 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.919 -0.582 . . . . 74.32 110.803 -178.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.462 ' CD ' HH21 ' A' ' 103' ' ' ARG . 2.0 mm-40 -56.13 -65.81 0.54 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.767 -0.652 . . . . 54.34 110.476 175.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.453 ' HE2' ' HB2' ' A' ' 90' ' ' ALA . 82.2 t80 -63.27 -49.47 73.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.626 -0.715 . . . . 73.3 112.861 -172.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.586 HG12 ' O ' ' A' ' 164' ' ' ILE . 30.7 pt -79.46 -32.46 14.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 C-N-CA 120.293 -0.563 . . . . 73.51 112.249 -169.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.777 ' HE1' HG12 ' A' ' 174' ' ' VAL . 2.8 t60 -88.21 -18.19 29.21 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.038 -0.665 . . . . 74.31 111.117 -172.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -86.88 21.96 2.12 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.907 0.861 . . . . 70.31 109.018 169.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -131.03 -79.37 0.53 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.475 -0.784 . . . . 74.54 111.137 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.755 ' HG2' ' H ' ' A' ' 207' ' ' GLU . 32.3 mt-10 -147.46 -46.22 0.17 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.066 0.46 . . . . 74.2 111.977 -171.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -81.96 137.63 35.11 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.639 -0.709 . . . . 54.41 112.821 -161.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.777 HG12 ' HE1' ' A' ' 169' ' ' HIS . 33.2 m -106.69 170.75 2.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 114.942 -1.026 . . . . 61.01 109.729 173.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.741 ' HB3' ' HD2' ' A' ' 198' ' ' TYR . 1.8 p-80 -147.62 103.23 3.51 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.205 0.526 . . . . 70.03 111.188 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 -28.36 15.08 Favored Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.628 -0.796 . . . . 34.35 111.989 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.557 ' HB3' ' HA3' ' A' ' 199' ' ' GLY . 5.7 t0 -112.94 93.78 4.59 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.913 0.387 . . . . 74.01 110.059 -178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 64.8 mt -92.28 -73.45 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 109.22 -0.659 . . . . 73.11 109.22 174.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.532 ' HG3' ' H ' ' A' ' 180' ' ' ALA . 6.3 tptm 50.76 -139.25 0.94 Allowed 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 109.572 -0.529 . . . . 74.22 109.572 177.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.617 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -120.84 -3.58 9.7 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.408 0.623 . . . . 74.42 109.408 175.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.676 ' HA ' ' HB3' ' A' ' 139' ' ' GLN . 39.7 m -77.88 -27.68 49.73 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.419 -0.81 . . . . 72.44 112.044 -173.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.519 ' O ' ' HA ' ' A' ' 195' ' ' LEU . 76.7 m-20 -104.51 6.31 34.65 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.444 -0.503 . . . . 74.02 111.558 -176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.5 mp -104.72 120.17 40.72 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.767 -0.651 . . . . 73.34 109.721 174.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.582 HD11 ' N ' ' A' ' 47' ' ' GLY . 66.0 mt -120.59 143.67 48.51 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.004 -0.544 . . . . 72.41 110.834 -177.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.737 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.8 mt -92.5 141.4 28.55 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.334 -0.617 . . . . 63.22 109.334 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.502 ' HB2' ' HE2' ' A' ' 194' ' ' TYR . 25.4 t-20 -60.55 139.19 57.88 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.446 -0.946 . . . . 73.1 108.446 171.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.776 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 71.7 t80 -57.36 -30.52 64.92 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 111.718 0.266 . . . . 75.14 111.718 -173.036 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.443 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 83.1 tttt -116.15 -30.52 5.96 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 120.48 -0.488 . . . . 73.41 111.799 -178.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 186' ' ' ASN . 85.2 m-20 -99.46 101.87 14.6 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-O 120.793 0.33 . . . . 63.14 110.888 -177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 188' ' ' LYS . 10.2 Cg_exo -71.78 -25.81 19.88 Favored 'Trans proline' 0 CA--C 1.529 0.255 0 C-N-CA 122.995 2.463 . . . . 61.34 113.387 -174.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.543 ' HA ' HD23 ' A' ' 339' ' ' LEU . 1.0 OUTLIER -83.69 -4.94 59.03 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.024 0.44 . . . . 72.43 111.18 -174.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -108.62 97.1 6.81 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.386 0.612 . . . . 73.45 110.449 -178.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.423 HG12 ' HG3' ' A' ' 160' ' ' ARG . 7.9 p -103.38 130.87 53.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.255 -0.884 . . . . 73.2 109.23 176.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.502 ' HE2' ' HB2' ' A' ' 186' ' ' ASN . 41.9 m-85 -115.72 155.45 27.74 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.004 -0.544 . . . . 72.51 110.189 -174.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.519 ' HA ' ' O ' ' A' ' 182' ' ' ASN . 2.9 tt -120.52 122.7 41.2 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.407 -0.59 . . . . 63.43 109.407 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.605 ' CG2' ' HA3' ' A' ' 47' ' ' GLY . 16.5 m -129.17 166.95 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.431 -0.35 . . . . 61.22 110.58 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 22.0 t70 68.97 -57.9 0.51 Allowed 'General case' 0 N--CA 1.478 0.942 0 O-C-N 123.984 0.803 . . . . 74.2 111.842 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.785 ' HB2' ' HB2' ' A' ' 201' ' ' ALA . 93.7 m-85 75.79 5.37 3.91 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 123.606 0.762 . . . . 73.23 112.052 174.012 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.557 ' HA3' ' HB3' ' A' ' 177' ' ' ASP . . . 82.48 -38.77 2.63 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 121.37 -0.443 . . . . 65.22 112.946 177.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.789 ' HA ' ' HA ' ' A' ' 354' ' ' ILE . 1.1 pp -164.38 40.05 0.08 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 122.3 0.24 . . . . 72.32 110.882 -178.194 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.785 ' HB2' ' HB2' ' A' ' 198' ' ' TYR . . . -53.21 99.47 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 121.549 0.69 . . . . 74.4 111.761 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 17.0 t80 -123.4 133.58 54.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.649 -0.871 . . . . 74.23 108.649 -178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.514 ' HB2' ' HB3' ' A' ' 172' ' ' GLU . 10.9 ptp180 -77.71 109.74 11.96 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.324 0.583 . . . . 74.21 109.918 -179.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.582 ' CE1' ' HB3' ' A' ' 237' ' ' ALA . 2.9 t80 -66.83 -46.18 75.94 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.498 -0.774 . . . . 74.44 110.305 -176.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 1.001 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 54.6 m -142.42 140.06 18.42 Favored Pre-proline 0 C--N 1.324 -0.533 0 N-CA-C 108.843 -0.799 . . . . 72.23 108.843 174.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 205' ' ' CYS . 14.4 Cg_exo -68.1 98.04 0.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.381 2.054 . . . . 73.24 112.151 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.755 ' H ' ' HG2' ' A' ' 172' ' ' GLU . 33.6 tt0 73.91 -54.7 0.68 Allowed 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 114.961 -1.018 . . . . 54.52 111.761 178.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -91.11 65.8 2.52 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.948 -0.644 . . . . 42.44 112.534 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 1.001 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 7.6 p -58.54 112.08 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 CA-C-O 121.639 0.733 . . . . 71.23 112.411 178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -169.45 72.29 0.08 Allowed 'General case' 0 N--CA 1.462 0.144 0 CA-C-N 115.374 -0.83 . . . . 74.1 110.575 172.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -126.15 150.59 48.17 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.793 -0.64 . . . . 71.44 110.095 -179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.39 171.64 11.0 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.5 -0.318 . . . . 74.54 110.82 -179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.916 ' HB2' HG21 ' A' ' 236' ' ' VAL . 16.2 p90 -74.54 92.1 2.35 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.372 0.606 . . . . 74.41 112.517 -168.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 214' ' ' LYS . 67.5 mmtt -152.64 104.96 2.93 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 115.939 -0.573 . . . . 74.14 110.315 174.207 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 68.6 mm-40 -136.42 -155.7 0.64 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.208 -0.451 . . . . 64.41 109.855 177.6 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 217' ' ' PRO . 10.7 t70 -85.58 115.31 61.0 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.913 -0.403 . . . . 72.51 109.913 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . 0.881 ' HA ' ' HA3' ' A' ' 235' ' ' GLY . 28.0 Cg_exo -62.84 0.28 1.64 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.688 2.926 . . . . 62.15 114.272 -172.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -134.22 -48.3 0.78 Allowed 'General case' 0 C--N 1.323 -0.545 0 O-C-N 122.058 -0.401 . . . . 74.34 110.98 177.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . . . . . . . . . 15.1 mtm180 -84.28 43.41 0.95 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.379 0.609 . . . . 71.21 111.732 -176.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.565 ' HB3' ' HA2' ' A' ' 235' ' ' GLY . 41.8 t -131.63 3.08 4.15 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.864 -0.791 . . . . 53.35 108.864 170.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -81.7 8.35 10.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 114.998 -1.001 . . . . 72.03 110.739 -177.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.14 9.34 17.71 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 113.065 0.765 . . . . 75.15 113.065 -167.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . . . . . . . . . . . -97.68 164.31 21.86 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 109.986 -1.246 . . . . 52.34 109.986 169.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.514 ' OG1' ' HG2' ' A' ' 226' ' ' GLU . 14.9 t -68.74 113.15 5.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 118.1 0.95 . . . . 73.52 110.069 -179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.588 HG12 HG11 ' A' ' 271' ' ' VAL . 15.5 tt -57.24 -21.47 15.16 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 CA-C-N 115.043 -0.981 . . . . 54.33 111.831 -173.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.514 ' HG2' ' OG1' ' A' ' 224' ' ' THR . 17.1 pt-20 -60.12 -44.69 94.68 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.163 -0.472 . . . . 75.21 110.489 177.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.623 ' HB3' HG23 ' A' ' 246' ' ' ILE . 9.3 m-30 -109.53 -34.67 6.44 Favored 'General case' 0 C--O 1.224 -0.268 0 N-CA-C 112.635 0.606 . . . . 72.11 112.635 -171.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.41 HG23 ' HB3' ' A' ' 232' ' ' ALA . 7.4 t -70.9 14.15 0.16 Allowed 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.543 0.572 . . . . 74.04 112.543 -171.176 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.402 ' H ' ' C ' ' A' ' 227' ' ' PHE . 33.3 t 66.52 -177.23 0.2 Allowed 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 121.659 0.743 . . . . 73.41 111.863 175.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.443 ' HA ' ' CD2' ' A' ' 233' ' ' HIS . 42.3 mt -72.35 -35.15 51.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.067 -0.97 . . . . 72.13 110.081 177.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.504 ' HB3' HG13 ' A' ' 236' ' ' VAL . 4.1 m-20 -49.9 -56.35 10.87 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 114.64 -1.164 . . . . 72.4 112.334 -174.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.41 ' HB3' HG23 ' A' ' 228' ' ' THR . . . -58.26 -49.69 76.22 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.473 0.546 . . . . 73.01 112.473 -174.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.443 ' CD2' ' HA ' ' A' ' 230' ' ' ILE . 12.0 p80 -70.82 -16.39 62.72 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.546 -0.461 . . . . 73.45 110.61 -177.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -79.51 -21.22 45.56 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.012 0.434 . . . . 73.41 109.909 174.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.881 ' HA3' ' HA ' ' A' ' 217' ' ' PRO . . . 111.17 20.07 7.29 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.776 -0.726 . . . . 44.35 113.617 175.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 213' ' ' TYR . 7.3 p -122.17 136.41 59.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 O-C-N 122.333 -0.51 . . . . 73.23 110.966 175.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.582 ' HB3' ' CE1' ' A' ' 204' ' ' TYR . . . -64.46 125.83 89.34 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 73.35 110.977 179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 237' ' ' ALA . 33.0 Cg_exo -60.6 130.57 34.0 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.922 2.415 . . . . 51.4 112.065 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.492 ' HB2' ' HD2' ' A' ' 240' ' ' ARG . 21.9 p -153.21 154.22 34.27 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.165 -0.47 . . . . 62.32 110.837 178.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.492 ' HD2' ' HB2' ' A' ' 239' ' ' SER . 4.1 mpt_? 57.09 -100.5 0.11 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.508 0.723 . . . . 74.24 111.23 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 241' ' ' ARG . 6.7 ttp-105 -64.19 -32.09 73.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 116.031 -0.531 . . . . 71.24 110.282 -177.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.609 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -59.5 -57.17 21.0 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.927 -0.654 . . . . 73.31 112.026 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.407 ' OD1' ' HA ' ' A' ' 239' ' ' SER . 4.5 m-20 -57.15 -42.48 81.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.843 0.354 . . . . 72.24 110.869 -179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.531 HD23 HG12 ' A' ' 306' ' ' VAL . 9.7 mp -61.28 -42.78 99.22 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.947 -0.57 . . . . 43.31 111.106 178.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . 0.401 ' CD ' HH21 ' A' ' 279' ' ' ARG . 54.0 tt0 -69.22 -37.68 78.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.243 -0.435 . . . . 34.41 110.795 -179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.623 HG23 ' HB3' ' A' ' 227' ' ' PHE . 69.9 mt -62.47 -41.93 93.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 CA-C-O 120.919 0.39 . . . . 71.24 110.473 177.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 250' ' ' CYS . 52.8 tp -60.06 -40.41 89.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 115.97 -0.559 . . . . 61.22 110.436 177.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.466 ' HA3' ' SD ' ' A' ' 303' ' ' MET . . . -60.03 -40.68 97.35 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.5 -0.857 . . . . 63.35 111.903 176.591 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.481 ' HD2' ' HA ' ' A' ' 227' ' ' PHE . 22.1 m-30 -65.6 -41.14 93.1 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 111.89 0.329 . . . . 72.03 111.89 -179.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 247' ' ' LEU . 26.4 p -69.06 -34.37 75.06 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.007 -0.677 . . . . 73.5 110.543 -179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.424 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -66.89 -39.82 87.56 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.59 -0.277 . . . . 74.42 111.401 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 3.8 tt -69.62 -34.32 60.8 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 120.459 -0.497 . . . . 72.31 110.67 179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.957 HE21 ' HG ' ' A' ' 259' ' ' LEU . 16.1 mm-40 -68.1 -32.6 73.03 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.637 0.256 . . . . 54.33 111.402 176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 31.8 m0 -75.98 -38.1 57.8 Favored 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 120.768 -0.373 . . . . 74.44 111.184 176.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 50.3 tp -80.54 -48.04 13.33 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.17 0.433 . . . . 72.13 112.17 -174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 58.9 p -109.66 -27.67 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.16 0.505 . . . . 72.24 111.143 -176.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.485 ' HA3' ' HG3' ' A' ' 147' ' ' LYS . . . 68.32 34.95 81.34 Favored Glycine 0 N--CA 1.445 -0.723 0 CA-C-N 115.755 -0.657 . . . . 73.45 112.906 -178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -141.09 142.84 34.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.908 0.385 . . . . 72.24 110.903 179.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.957 ' HG ' HE21 ' A' ' 253' ' ' GLN . 88.6 mt -117.71 142.62 30.93 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 115.841 -0.618 . . . . 61.12 109.694 170.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.521 ' O ' ' HA ' ' A' ' 9' ' ' ALA . 25.4 Cg_exo -63.94 -49.43 3.98 Favored 'Trans proline' 0 C--N 1.332 -0.29 0 C-N-CA 122.379 2.053 . . . . 71.22 111.138 176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.435 ' HD1' HD23 ' A' ' 265' ' ' LEU . 30.7 p90 -82.94 25.58 0.67 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.141 -0.936 . . . . 64.35 111.142 -179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 259' ' ' LEU . 23.0 tt0 -68.37 -48.47 64.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.356 -0.384 . . . . 73.54 111.413 -174.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -69.7 -32.74 71.5 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.19 0.519 . . . . 72.3 110.884 -178.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 54.2 m-80 -107.23 22.25 16.27 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.868 -0.605 . . . . 73.53 111.06 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.477 HD13 ' O ' ' A' ' 265' ' ' LEU . 3.0 tm? -61.33 -24.02 66.15 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.764 0.792 . . . . 75.33 109.706 177.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -68.13 -15.82 63.75 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.7 -1.137 . . . . 65.5 112.064 -179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.717 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 9.0 t0 -125.78 122.66 24.63 Favored Pre-proline 0 C--N 1.332 -0.176 0 CA-C-O 120.887 0.375 . . . . 64.05 110.638 -178.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -61.71 -24.04 77.07 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 123.295 2.663 . . . . 61.12 113.82 -175.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -65.5 -48.32 72.97 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-O 121.165 0.507 . . . . 74.51 109.952 -178.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.717 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 97.4 m-85 -67.33 -38.69 85.28 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.361 -0.836 . . . . 72.22 110.595 -179.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.588 HG11 HG12 ' A' ' 225' ' ' ILE . 59.1 t -57.28 -49.77 78.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.227 -0.442 . . . . 73.01 110.204 176.133 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.429 ' O ' HG13 ' A' ' 276' ' ' ILE . 16.7 ttp180 -57.66 -54.42 47.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.933 -0.576 . . . . 65.4 110.428 177.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -62.95 -48.59 78.26 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.037 -0.983 . . . . 74.53 111.935 -173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 32.7 t -63.75 -34.88 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.398 -0.365 . . . . 55.42 111.237 -176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.415 ' HE2' ' CZ2' ' A' ' 261' ' ' TRP . 96.4 mttt -70.35 -39.29 74.73 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.746 -0.381 . . . . 75.24 110.629 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 272' ' ' ARG . 72.6 mt -64.76 -38.5 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 121.037 0.446 . . . . 71.15 110.007 175.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 68.9 ttt180 -56.07 -45.71 79.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.623 -0.717 . . . . 74.3 110.963 177.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -76.09 -32.42 59.21 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.957 -0.297 . . . . 65.31 111.706 178.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 275' ' ' LYS . 99.6 mtt180 -60.18 -23.41 63.95 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 120.581 0.229 . . . . 71.13 110.771 176.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 -50.32 -53.58 27.76 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 115.793 -0.64 . . . . 72.51 110.412 174.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -170.11 99.41 0.28 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.067 -0.515 . . . . 63.44 109.615 177.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 5.2 mp -72.21 -34.25 49.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.831 -0.622 . . . . 70.03 110.743 -178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.626 ' HA ' ' HB1' ' A' ' 300' ' ' ALA . . . -60.08 -46.75 88.54 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 112.6 0.593 . . . . 73.01 112.6 -172.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 15.8 m -60.26 -48.75 80.4 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.228 0.537 . . . . 73.23 110.993 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 85.2 mt -65.21 -50.21 66.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.728 -0.669 . . . . 73.02 111.204 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 23.6 mmt -60.22 -45.08 94.45 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.938 0.399 . . . . 74.54 111.486 -178.464 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.17 -31.94 73.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.801 -0.636 . . . . 75.01 111.425 -175.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -82.62 -13.21 56.89 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 120.717 0.294 . . . . 72.44 111.444 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 92.0 m -78.64 -69.94 0.53 Allowed 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 111.796 0.295 . . . . 33.33 111.796 -178.2 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.489 ' HB3' ' H ' ' A' ' 294' ' ' ASN . 39.2 m-85 -125.29 90.78 50.24 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 112.112 0.412 . . . . 74.01 112.112 -173.296 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -92.49 1.1 3.94 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.665 2.243 . . . . 70.43 112.105 173.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -137.89 -69.46 0.45 Allowed 'General case' 0 N--CA 1.462 0.138 0 CA-C-N 115.944 -0.571 . . . . 74.41 111.307 -176.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.499 ' NZ ' ' HB3' ' A' ' 293' ' ' LYS . 3.1 mmmp? -49.56 -61.97 1.81 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 115.773 -0.649 . . . . 73.54 111.655 -178.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.489 ' H ' ' HB3' ' A' ' 290' ' ' PHE . 15.8 m120 -113.54 -155.72 0.58 Allowed 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 108.997 -0.742 . . . . 70.22 108.997 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.687 ' HE3' HG21 ' A' ' 331' ' ' ILE . 26.7 tptp -164.97 87.24 1.04 Allowed Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.774 0.321 . . . . 73.12 110.154 -179.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_endo -100.64 37.29 0.07 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.205 0 C-N-CA 123.11 2.54 . . . . 73.53 112.171 177.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -89.02 -37.74 7.1 Favored Glycine 0 CA--C 1.508 -0.355 0 C-N-CA 120.495 -0.859 . . . . 73.42 111.072 -178.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.667 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 20.9 mp0 -66.95 -47.12 72.61 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.762 -0.829 . . . . 75.31 108.762 177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.525 ' H ' HD12 ' A' ' 299' ' ' ILE . 3.8 mp -59.09 -38.96 77.21 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-N 114.863 -1.062 . . . . 74.11 110.363 173.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . 0.626 ' HB1' ' HA ' ' A' ' 283' ' ' ALA . . . -59.57 -50.25 74.6 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.532 -0.304 . . . . 71.34 111.208 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.1 tptt -60.1 -43.18 95.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.252 -0.431 . . . . 75.15 110.107 177.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.449 ' CE1' HD22 ' A' ' 320' ' ' LEU . 87.7 t80 -56.92 -47.08 81.43 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.412 -0.813 . . . . 73.04 111.203 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.525 ' HA ' HG22 ' A' ' 306' ' ' VAL . 93.8 mmm -68.2 -41.85 80.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.336 -0.393 . . . . 54.33 111.568 -177.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -60.21 -40.55 90.49 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.264 0.554 . . . . 64.14 109.77 175.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 98.4 m -60.28 -50.15 74.8 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.322 -0.854 . . . . 74.15 111.296 177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.531 HG12 HD23 ' A' ' 244' ' ' LEU . 19.8 m -70.67 -33.99 55.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 111.842 0.312 . . . . 73.55 111.842 -175.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -21.12 59.74 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 120.454 -0.498 . . . . 72.21 110.312 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 44.9 tp -81.49 -5.3 57.82 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-N 116.158 -0.474 . . . . 63.25 110.968 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 305' ' ' THR . 90.1 mt -91.17 6.61 44.39 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 111.776 0.287 . . . . 71.31 111.776 -177.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.595 ' HB3' ' HG2' ' A' ' 313' ' ' GLU . 24.3 t70 61.45 -84.85 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 O-C-N 123.705 0.628 . . . . 71.41 111.961 176.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.24 -52.12 0.31 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.121 -0.491 . . . . 73.55 110.179 -179.034 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.2 t -149.12 29.73 0.79 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.765 -0.652 . . . . 73.41 110.761 -177.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.595 ' HG2' ' HB3' ' A' ' 310' ' ' ASP . 42.6 mm-40 -51.89 -62.87 1.36 Allowed 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 116.45 -0.341 . . . . 75.41 111.028 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -171.12 102.27 0.4 Allowed Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.502 -0.317 . . . . 73.34 110.398 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_exo -71.4 118.85 5.88 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.538 2.159 . . . . 71.54 111.576 177.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.616 ' O ' ' HG ' ' A' ' 320' ' ' LEU . 97.3 mt -114.33 92.83 4.09 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.453 -0.34 . . . . 63.53 111.354 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.438 ' HE1' ' HG ' ' A' ' 165' ' ' LEU . 97.5 m-85 -57.66 -34.07 68.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.164 0.507 . . . . 71.23 110.084 175.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -55.37 -55.33 32.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.055 -0.975 . . . . 61.43 111.027 -179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -64.97 -41.55 95.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.029 -0.532 . . . . 74.11 110.969 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.616 ' HG ' ' O ' ' A' ' 316' ' ' LEU . 67.3 mt -56.96 -53.3 59.54 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.208 -0.451 . . . . 71.33 111.32 -177.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.508 ' HG3' ' N ' ' A' ' 322' ' ' ASP . 11.0 ptt180 -65.26 -36.53 84.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.928 0.394 . . . . 60.13 110.207 -179.042 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.508 ' N ' ' HG3' ' A' ' 321' ' ' ARG . 30.0 t70 -68.23 -51.21 47.93 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.819 -0.628 . . . . 74.43 111.63 -173.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.8 pp -68.88 -31.23 49.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 120.924 -0.311 . . . . 73.51 111.14 -177.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . . . . . . . . . 44.2 tp -69.41 -48.87 59.72 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.372 -0.376 . . . . 73.22 110.571 178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.93 -39.88 83.43 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 71.11 110.046 -179.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 18.7 tt0 -60.23 -48.43 81.75 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.038 -0.528 . . . . 61.43 111.197 -178.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.667 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -64.36 -46.15 91.4 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.795 -0.717 . . . . 33.3 112.085 -178.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.56 ' HG ' HD22 ' A' ' 155' ' ' LEU . 0.6 OUTLIER -60.96 -45.21 95.64 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.048 0.452 . . . . 62.21 110.841 179.687 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -70.25 -26.91 64.05 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.016 0.436 . . . . 70.01 110.583 -178.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -72.24 -29.28 63.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.166 -0.47 . . . . 73.32 111.537 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.687 HG21 ' HE3' ' A' ' 295' ' ' LYS . 32.6 pt -90.19 -5.51 10.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.886 0.374 . . . . 63.11 111.063 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 91.58 23.91 27.34 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.782 -0.723 . . . . 62.12 113.405 174.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 23.1 m -127.22 138.53 53.13 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 122.438 -0.448 . . . . 73.12 110.373 178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . 0.463 ' NZ ' ' HB3' ' A' ' 334' ' ' LYS . 9.9 mtpm? -138.66 -113.86 0.16 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.329 . . . . 73.34 111.647 177.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -159.73 113.93 2.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.507 0.67 . . . . 74.1 111.578 -168.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -171.6 156.04 4.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.851 -1.068 . . . . 65.03 109.263 172.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 101.89 5.33 50.74 Favored Glycine 0 N--CA 1.447 -0.631 0 N-CA-C 111.288 -0.725 . . . . 63.24 111.288 -178.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 61.8 mttp 59.09 66.31 1.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.173 -0.514 . . . . 60.23 110.701 -178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.562 HD12 HG23 ' A' ' 153' ' ' THR . 4.2 mm? 68.1 -171.54 0.19 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.059 -0.973 . . . . 75.52 111.352 -179.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -122.78 17.7 10.25 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.736 0.779 . . . . 70.31 108.904 -179.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.55 HD21 HD13 ' A' ' 141' ' ' ILE . 6.1 tt -125.68 108.37 11.48 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.384 -0.825 . . . . 73.52 110.839 -171.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 49.1 m -143.45 16.74 1.85 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.812 -0.631 . . . . 74.44 109.775 171.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 18.0 m -77.08 -34.93 22.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.429 -0.805 . . . . 73.13 112.323 -175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . . . . . . . . . 45.5 t 54.89 91.24 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 CA-C-O 121.122 0.487 . . . . 73.44 111.411 -178.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -125.32 168.85 12.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.456 -0.338 . . . . 51.43 110.969 -177.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.403 ' OD1' ' HE3' ' A' ' 140' ' ' LYS . 59.3 t30 -136.98 143.49 42.84 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 74.22 110.531 -176.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . -161.26 -77.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.101 -0.571 . . . . 54.01 111.717 -179.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -130.83 166.31 22.62 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 121.034 -0.603 . . . . 74.22 111.63 178.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.439 HD21 HD23 ' A' ' 19' ' ' LEU . 2.6 pt? -165.25 141.59 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.912 0.387 . . . . 63.34 110.486 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . . . . . . . . . 55.1 pttt -125.06 165.42 18.22 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.974 -0.557 . . . . 74.02 110.258 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -140.19 156.75 46.39 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.124 -0.695 . . . . 54.04 109.124 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.457 ' HG3' ' H ' ' A' ' 353' ' ' THR . 12.8 tptp -143.44 -157.14 0.75 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.821 -0.437 . . . . 61.41 109.821 -178.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . 0.457 ' H ' ' HG3' ' A' ' 352' ' ' LYS . 14.8 t -173.48 156.27 2.98 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.376 -0.602 . . . . 72.42 109.376 178.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.789 ' HA ' ' HA ' ' A' ' 200' ' ' LEU . 0.2 OUTLIER -67.43 131.81 32.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.097 0.475 . . . . 62.12 111.204 -176.322 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 355' ' ' THR . 7.6 t -78.61 85.29 4.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.182 0.992 . . . . 61.1 110.752 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 357' ' ' LYS . 0.2 OUTLIER -109.25 -29.4 8.51 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.534 -0.757 . . . . 74.42 110.499 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 356' ' ' LYS . 61.3 tttm 172.23 -54.76 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 108.529 -0.915 . . . . 74.14 108.529 -175.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.4 ' HG2' ' HG2' ' A' ' 359' ' ' LYS . 54.8 ttm-85 173.1 -64.46 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 114.477 -1.238 . . . . 72.32 108.413 176.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . 0.535 ' HG3' ' HG2' ' A' ' 360' ' ' LYS . 49.1 pttt -178.09 -38.69 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.578 -1.192 . . . . 72.54 108.084 175.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.535 ' HG2' ' HG3' ' A' ' 359' ' ' LYS . 29.9 mmmt . . . . . 0 C--O 1.247 0.96 0 CA-C-O 117.746 -1.121 . . . . 73.24 108.489 175.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 110.252 -0.277 . . . . 72.21 110.252 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.93 138.55 44.66 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.393 2.062 . . . . 63.3 111.981 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 59.2 mtp180 -134.5 140.35 46.12 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.258 -0.428 . . . . 74.12 110.259 178.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.5 t -85.6 98.69 6.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.24 0.543 . . . . 73.12 110.496 179.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 16.0 pttp -114.66 130.18 56.77 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.504 -0.771 . . . . 62.5 109.753 175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -79.7 149.03 31.33 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.041 -0.527 . . . . 64.01 110.949 -176.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.4 84.56 2.06 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.908 -0.587 . . . . 61.35 110.29 178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -77.41 133.58 38.63 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.105 -0.498 . . . . 70.42 109.911 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -107.15 136.31 47.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.332 -0.395 . . . . 74.34 110.855 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -112.69 119.49 4.94 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 111.115 -0.794 . . . . 54.03 111.115 176.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -97.56 -171.38 2.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.912 0.387 . . . . 64.54 110.933 -176.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -124.22 145.22 49.48 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.0 -0.546 . . . . 71.1 110.028 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.2 p -97.59 122.74 41.01 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.41 -0.359 . . . . 74.14 110.616 178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.8 p -123.28 31.37 5.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.084 0.468 . . . . 72.22 111.097 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -124.56 89.36 3.06 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.162 0.506 . . . . 61.22 110.275 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.448 ' HE2' ' HB3' ' A' ' 16' ' ' LYS . 35.7 ttpt -97.41 94.3 6.97 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.89 -0.596 . . . . 74.52 110.741 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -177.24 140.89 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.286 -0.415 . . . . 74.13 110.82 179.296 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -121.09 28.32 7.93 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.851 -0.796 . . . . 74.02 108.851 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -150.0 143.33 25.12 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.666 -0.697 . . . . 73.34 110.092 177.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -177.48 -75.39 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 O-C-N 123.798 0.686 . . . . 64.55 109.776 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -137.85 74.95 1.5 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.607 -0.724 . . . . 71.52 110.328 -179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 60.65 87.48 0.09 Allowed 'General case' 0 C--O 1.234 0.241 0 CA-C-N 114.931 -1.032 . . . . 74.32 111.665 -177.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -81.64 81.49 7.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.605 0.716 . . . . 75.43 109.789 174.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -167.24 -55.03 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.192 -1.367 . . . . 75.42 107.834 178.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.438 HG22 ' HD3' ' A' ' 42' ' ' PRO . 61.5 t -66.37 108.33 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 114.933 -1.031 . . . . 71.3 109.001 169.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 99.18 0.28 57.15 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.599 -0.81 . . . . 74.03 112.687 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -74.1 147.07 43.07 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 117.202 0.501 . . . . 74.23 110.097 174.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.497 HD13 ' H ' ' A' ' 28' ' ' ILE . 0.1 OUTLIER -106.72 115.88 49.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.933 -0.576 . . . . 74.14 109.629 176.124 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.566 HG13 ' HB2' ' A' ' 37' ' ' TRP . 14.9 pt -97.49 141.61 15.59 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-N 115.923 -0.581 . . . . 54.42 110.538 -177.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.1 m -90.6 112.08 23.64 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.012 -0.54 . . . . 73.33 111.117 -176.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.691 ' HA ' ' HA3' ' A' ' 117' ' ' GLY . 11.7 t70 -93.62 -179.2 4.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.64 -0.874 . . . . 62.31 108.64 176.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . 0.59 ' CE ' ' HA ' ' A' ' 32' ' ' MET . 17.1 mmt -73.35 -13.76 61.16 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.416 0.524 . . . . 30.41 112.416 -172.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' ' HH2' ' A' ' 37' ' ' TRP . . . -84.73 2.58 41.34 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.869 0.366 . . . . 63.04 110.727 177.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.604 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 32.2 ttmt 48.26 73.44 0.21 Allowed 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 123.907 0.883 . . . . 73.04 112.561 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.873 ' H ' ' HZ3' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -143.61 -154.96 0.56 Allowed 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.321 -1.363 . . . . 72.42 107.321 173.648 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.471 ' HB3' ' HB ' ' A' ' 28' ' ' ILE . 3.1 mp0 -123.27 102.12 7.76 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.16 0.505 . . . . 72.24 111.029 178.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.873 ' HZ3' ' H ' ' A' ' 35' ' ' LYS . 3.8 m-90 -85.04 104.85 15.33 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 108.925 -0.769 . . . . 75.25 108.925 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 ttmt -79.5 122.26 26.23 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.088 -0.505 . . . . 73.11 110.832 -175.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.496 HG13 ' HB3' ' A' ' 52' ' ' TYR . 60.6 t -74.79 107.69 5.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.733 -0.469 . . . . 73.14 109.733 174.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -61.13 4.56 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.779 -0.724 . . . . 23.24 112.116 -177.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 2.5 pt? -159.64 152.06 17.55 Favored Pre-proline 0 C--N 1.326 -0.451 0 N-CA-C 110.066 -0.346 . . . . 64.15 110.066 179.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.549 ' HA ' ' HD1' ' A' ' 52' ' ' TYR . 6.4 Cg_exo -73.91 101.83 1.44 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.742 2.295 . . . . 74.01 111.562 175.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 53' ' ' LEU . 65.0 mt -66.74 -42.78 89.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.394 0.616 . . . . 73.03 109.72 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.96 -31.38 8.28 Favored Glycine 0 N--CA 1.444 -0.785 0 C-N-CA 120.64 -0.79 . . . . 75.14 111.873 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.45 HE21 ' HA ' ' A' ' 349' ' ' LEU . 2.0 tm0? -140.81 129.86 23.36 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.581 0.705 . . . . 64.11 110.925 179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -174.71 39.43 0.12 Allowed Glycine 0 N--CA 1.443 -0.883 0 N-CA-C 108.239 -1.944 . . . . 61.52 108.239 176.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.34 122.76 4.96 Favored Glycine 0 N--CA 1.442 -0.921 0 N-CA-C 110.456 -1.058 . . . . 72.2 110.456 -166.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.703 ' HB2' ' HE3' ' A' ' 71' ' ' LYS . 6.3 t80 66.91 -81.69 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.129 0.572 . . . . 64.21 111.262 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 160.5 165.22 16.89 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 121.208 -0.52 . . . . 72.13 111.938 -178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 8.1 t 59.88 35.13 21.8 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 121.231 0.538 . . . . 71.2 110.892 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.791 HD12 ' HA ' ' A' ' 71' ' ' LYS . 43.0 mm -88.44 138.53 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.034 -0.53 . . . . 65.11 111.051 -175.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.549 ' HD1' ' HA ' ' A' ' 42' ' ' PRO . 30.0 m-85 -108.28 157.23 18.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.255 -0.429 . . . . 74.43 110.813 -175.558 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.6 ' HB2' HD11 ' A' ' 43' ' ' ILE . 59.6 tp -94.35 136.61 34.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.127 -0.488 . . . . 71.23 109.776 175.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -93.1 103.31 15.61 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.602 0.239 . . . . 70.23 110.443 -179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 56' ' ' MET . 27.8 t70 -79.37 -25.6 42.19 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.074 -0.512 . . . . 63.34 110.327 -177.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.508 ' HE3' ' HA ' ' A' ' 37' ' ' TRP . 0.1 OUTLIER 67.26 163.99 0.2 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 115.375 -0.83 . . . . 71.14 110.804 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -87.44 65.92 8.85 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.048 -0.723 . . . . 72.12 109.048 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 17.9 m -77.36 70.12 3.71 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.291 -0.868 . . . . 63.22 110.709 -177.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 6.2 p -66.89 -56.73 9.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.592 -0.731 . . . . 71.54 111.06 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -137.33 7.62 2.86 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.264 0.554 . . . . 71.12 110.45 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.4 m -137.25 82.24 1.92 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.918 -0.583 . . . . 71.53 110.476 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.9 p -82.28 142.52 13.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.915 -0.584 . . . . 72.12 110.885 178.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -82.18 -165.87 36.92 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.765 -0.731 . . . . 52.35 111.594 175.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.1 t -75.16 62.63 1.23 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.937 0.399 . . . . 64.34 110.79 179.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HB3' HH12 ' A' ' 133' ' ' ARG . 0.1 OUTLIER 67.44 26.83 8.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 115.492 -0.776 . . . . 71.54 111.346 179.092 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 58.73 83.19 0.22 Allowed Pre-proline 0 C--N 1.33 -0.265 0 O-C-N 123.851 0.719 . . . . 71.35 111.1 -178.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.46 ' HA ' ' CD ' ' A' ' 133' ' ' ARG . 4.1 Cg_exo -80.14 38.86 0.78 Allowed 'Trans proline' 0 N--CA 1.46 -0.488 0 C-N-CA 123.014 2.476 . . . . 73.44 111.504 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . 0.439 ' HB2' HG23 ' A' ' 130' ' ' ILE . 6.9 p -145.3 138.18 26.2 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.549 0.69 . . . . 60.04 112.771 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.75 165.76 24.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.061 -0.972 . . . . 70.22 108.409 171.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.676 ' HB ' HD13 ' A' ' 130' ' ' ILE . 0.8 OUTLIER -119.83 120.15 62.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-O 121.841 0.829 . . . . 71.02 112.68 -178.106 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HA ' HD12 ' A' ' 51' ' ' ILE . 22.1 tptm -84.21 125.8 32.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 113.198 -1.819 . . . . 70.3 108.662 176.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -121.01 150.03 23.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 112.566 0.58 . . . . 50.01 112.566 -173.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -152.2 135.25 9.25 Favored Pre-proline 0 C--O 1.233 0.214 0 CA-C-N 115.388 -0.824 . . . . 72.42 109.11 171.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -73.08 -166.16 0.28 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.322 2.015 . . . . 73.2 111.715 175.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 17.4 m -74.68 60.29 0.91 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.215 0.531 . . . . 60.35 110.869 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -105.56 -38.99 6.25 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.347 -0.612 . . . . 71.34 109.347 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 8.0 t30 65.65 76.01 0.33 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.135 -0.938 . . . . 62.12 110.523 173.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 79' ' ' PRO . . . -152.24 -99.09 0.18 Allowed Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.246 -0.978 . . . . 23.31 112.733 178.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 78' ' ' GLY . 49.0 Cg_exo -56.9 -45.59 35.23 Favored 'Trans proline' 0 CA--C 1.529 0.242 0 C-N-CA 123.127 2.552 . . . . 71.41 113.614 -176.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -68.98 -41.02 78.44 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.999 -0.28 . . . . 62.3 110.815 -177.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.498 ' O ' ' HG2' ' A' ' 85' ' ' LYS . 85.1 t80 -61.37 -47.55 85.36 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.928 0.394 . . . . 74.02 110.289 179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 20.8 m -66.1 -42.59 89.08 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.888 -0.596 . . . . 74.11 110.587 -179.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG2' ' HE2' ' A' ' 87' ' ' TYR . 36.4 tt0 -64.88 -40.62 95.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.655 -0.702 . . . . 63.14 110.419 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 63.5 tp -59.95 -39.28 85.04 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.966 -0.561 . . . . 72.3 110.535 177.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.777 ' HA ' ' HE2' ' A' ' 85' ' ' LYS . 10.9 mmpt? -59.02 -44.66 91.75 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.304 -0.407 . . . . 63.31 110.202 176.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -59.69 -49.55 77.32 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.764 -0.653 . . . . 75.31 110.836 178.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.547 ' HE2' ' HG2' ' A' ' 83' ' ' GLU . 56.3 m-85 -64.01 -38.32 90.65 Favored 'General case' 0 C--O 1.223 -0.329 0 CA-C-N 116.651 -0.249 . . . . 73.12 111.426 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 25.6 tm0? -61.42 -37.41 83.39 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.813 0.34 . . . . 53.52 110.78 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 12.1 tpt180 -88.26 -27.19 21.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.928 0.344 . . . . 74.51 111.928 -175.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -106.58 16.05 25.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.893 0.331 . . . . 60.25 111.893 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 87' ' ' TYR . . . -76.05 163.87 26.71 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.039 0.385 . . . . 63.12 112.039 -177.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.475 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.1 mmtt 75.89 109.98 0.03 OUTLIER Pre-proline 0 N--CA 1.463 0.188 0 CA-C-N 115.161 -0.927 . . . . 75.31 112.425 175.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.62 -35.69 98.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.492 2.795 . . . . 75.51 113.184 -178.289 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -59.44 -41.89 90.65 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.898 0.38 . . . . 72.02 110.863 178.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -68.57 -42.32 78.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.06 -0.518 . . . . 70.3 109.797 178.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 92' ' ' LYS . 59.2 mt -57.8 -53.48 44.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 115.348 -0.842 . . . . 64.1 110.572 178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.692 ' HA ' HE21 ' A' ' 97' ' ' GLN . 0.0 OUTLIER -60.29 -31.83 70.61 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.412 -0.358 . . . . 74.33 111.332 179.245 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -58.76 -56.36 23.25 Favored 'General case' 0 C--O 1.237 0.438 0 O-C-N 123.238 0.336 . . . . 70.05 110.686 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.757 ' HZ2' HD22 ' A' ' 108' ' ' LEU . 1.9 p90 -69.81 -34.19 73.35 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 120.303 -0.559 . . . . 72.51 110.735 -178.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.541 HD13 ' HA ' ' A' ' 107' ' ' TYR . 56.7 mt -58.13 -50.5 78.02 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.114 0 CA-C-N 116.786 -0.188 . . . . 74.22 111.055 178.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 16.9 tpp180 -66.51 -38.44 87.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.803 0.335 . . . . 73.2 110.621 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.1 m -67.57 -44.64 77.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 60.51 111.402 -178.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 0.7 OUTLIER -78.03 -15.34 59.01 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.178 -0.464 . . . . 71.14 110.965 179.879 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 96.4 mttt 68.77 33.21 3.79 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.64 -0.709 . . . . 71.23 110.697 -176.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.502 ' HG ' ' H ' ' A' ' 106' ' ' LYS . 21.1 tp -81.95 177.13 9.02 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.985 -1.117 . . . . 74.41 107.985 173.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.502 ' H ' ' HG ' ' A' ' 105' ' ' LEU . 20.2 mmtm -103.15 -49.89 3.63 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 119.949 -0.7 . . . . 75.02 111.816 -179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . 0.703 ' HE2' ' HD3' ' A' ' 160' ' ' ARG . 34.4 p90 -162.0 -176.98 5.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.98 0.419 . . . . 73.43 111.428 179.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.757 HD22 ' HZ2' ' A' ' 99' ' ' TRP . 52.8 tp -133.22 131.76 40.71 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.569 -0.53 . . . . 62.54 109.569 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -85.4 57.64 4.92 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.868 -0.682 . . . . 72.35 112.66 -178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.0 p -113.19 131.47 22.85 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 120.735 0.303 . . . . 60.24 110.47 -178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_exo -67.48 145.76 72.0 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.738 2.292 . . . . 73.1 111.923 176.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -58.83 129.11 40.57 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.016 -0.538 . . . . 75.04 110.805 178.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -100.48 128.94 46.39 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.179 -0.464 . . . . 70.53 109.919 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.402 ' CG ' HG22 ' A' ' 130' ' ' ILE . 43.6 m95 -100.69 -62.96 1.18 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.134 0.492 . . . . 74.21 109.945 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -172.83 -157.79 15.51 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.637 -0.71 . . . . 42.12 112.223 -177.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.537 ' O ' ' HG2' ' A' ' 32' ' ' MET . 14.0 p -169.07 152.4 5.11 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 109.551 -0.537 . . . . 74.53 109.551 -176.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 31' ' ' ASP . . . -158.7 -164.92 14.93 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.028 -1.082 . . . . 70.22 113.315 -176.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 92.7 mt -135.3 137.06 42.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.741 0.305 . . . . 74.32 110.477 -176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . 0.454 ' CG ' HG22 ' A' ' 29' ' ' ILE . 72.8 t60 -140.75 113.18 8.0 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.841 0.353 . . . . 71.33 110.241 176.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.843 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 32.8 t70 -72.43 126.39 29.72 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.059 -0.519 . . . . 64.1 110.422 178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 122' ' ' ASN . 46.1 tptt -89.42 25.13 2.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.247 0.546 . . . . 64.0 109.539 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.51 HD22 ' N ' ' A' ' 122' ' ' ASN . 0.8 OUTLIER 74.25 63.99 0.08 Allowed 'General case' 0 C--O 1.234 0.267 0 CA-C-N 115.305 -0.861 . . . . 72.31 110.158 -179.193 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 137.4 -54.04 0.72 Allowed Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 114.794 -1.094 . . . . 62.54 111.33 -179.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -112.91 121.98 46.27 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.972 -0.381 . . . . 60.43 109.972 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.843 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 47.3 m -86.68 117.57 25.53 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.596 -0.52 . . . . 74.52 109.596 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -91.18 140.45 29.79 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.946 -0.57 . . . . 64.21 110.066 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 18.7 ttt180 -99.22 133.99 42.71 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.589 -0.523 . . . . 72.0 109.589 174.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.606 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 43.9 p90 -128.78 161.12 30.49 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.142 -0.481 . . . . 75.11 110.557 -177.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.442 ' HA ' ' HA ' ' A' ' 116' ' ' SER . 48.2 ttp -139.52 133.26 30.59 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.977 -0.556 . . . . 74.43 110.099 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.676 HD13 ' HB ' ' A' ' 70' ' ' VAL . 13.1 mm -96.43 123.99 48.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.183 0.515 . . . . 74.12 110.296 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 23.4 ptm -137.13 -178.09 5.05 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.561 -0.745 . . . . 75.22 110.671 -175.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.49 154.8 34.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.085 0.469 . . . . 75.53 110.833 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.46 ' CD ' ' HA ' ' A' ' 67' ' ' PRO . 28.9 ptt180 -89.88 124.17 34.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.723 -0.671 . . . . 72.24 112.199 -172.023 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.441 ' HE1' ' CD1' ' A' ' 194' ' ' TYR . 26.0 m-85 -103.05 160.31 14.74 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.901 -0.59 . . . . 65.51 109.832 175.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.727 ' HA3' ' HD1' ' A' ' 187' ' ' TYR . . . -145.44 -25.81 0.1 Allowed Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.089 -1.053 . . . . 64.3 113.252 -179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.752 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 58.8 m -121.48 126.42 49.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.876 0.338 . . . . 73.34 111.694 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.547 ' OD1' ' HG2' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -98.04 134.94 40.44 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.929 -0.397 . . . . 72.53 109.929 173.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 15.2 tp -71.69 -21.86 61.73 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.354 -0.385 . . . . 61.52 111.211 -174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.451 ' HB2' ' HA ' ' A' ' 181' ' ' SER . 22.9 tp60 -58.33 -49.31 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.207 -0.452 . . . . 74.45 112.104 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' HG2' ' OD1' ' A' ' 137' ' ' ASP . 20.5 pttm -85.61 -20.92 28.78 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 119.981 -0.687 . . . . 75.33 111.009 -177.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 68.6 mt -68.96 -46.35 79.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.277 0.56 . . . . 71.34 109.647 175.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.731 ' HA ' ' HZ ' ' A' ' 149' ' ' PHE . 0.0 OUTLIER -67.32 -32.76 73.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.459 -0.792 . . . . 70.25 110.514 176.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -71.69 -54.92 8.77 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.948 -0.569 . . . . 75.13 111.405 -179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -66.09 -31.51 72.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.438 -0.346 . . . . 54.33 111.76 -175.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -87.4 0.53 55.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.035 0.445 . . . . 73.32 110.167 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HG2' ' A' ' 147' ' ' LYS . . . 53.86 52.35 13.14 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 115.454 -0.794 . . . . 75.41 112.246 176.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.481 ' HB3' ' CE1' ' A' ' 142' ' ' TYR . 0.1 OUTLIER 40.08 75.96 0.07 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.53 0.732 . . . . 62.42 112.257 -178.635 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.401 ' HE ' ' HB3' ' A' ' 148' ' ' ARG . 18.2 ttp180 -149.79 79.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.582 -0.736 . . . . 73.34 109.235 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.731 ' HZ ' ' HA ' ' A' ' 142' ' ' TYR . 38.3 m-85 -111.02 156.47 21.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.121 0.486 . . . . 73.32 111.702 -173.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.461 ' O ' HG23 ' A' ' 154' ' ' VAL . 42.0 p -68.02 152.1 46.03 Favored 'General case' 0 N--CA 1.448 -0.57 0 CA-C-N 115.373 -0.83 . . . . 61.14 110.197 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.584 ' HG2' HD23 ' A' ' 328' ' ' LEU . 41.0 ttm105 -66.56 -26.38 67.1 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.963 0.411 . . . . 71.35 110.186 -177.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -70.22 -43.89 69.73 Favored 'General case' 0 CA--C 1.53 0.189 0 CA-C-N 116.016 -0.538 . . . . 74.31 111.171 179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.465 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 21.2 p -68.27 -44.64 75.12 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.724 0.297 . . . . 72.2 110.943 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 150' ' ' SER . 92.6 t -57.61 -42.84 82.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.064 -0.517 . . . . 65.35 111.152 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.536 HD11 ' HB3' ' A' ' 324' ' ' LEU . 2.5 mm? -64.9 -42.37 94.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.52 -0.309 . . . . 75.43 111.001 178.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.696 ' O ' ' HG2' ' A' ' 160' ' ' ARG . 17.8 mm-40 -59.97 -46.01 90.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.49 0.186 . . . . 61.01 110.858 176.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 153' ' ' THR . 98.7 mt -59.62 -41.15 89.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 71.11 110.888 178.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.7 t -59.57 -47.11 86.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.019 -0.537 . . . . 63.35 111.006 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.555 HD21 HD11 ' A' ' 325' ' ' LEU . 10.1 mp -63.8 -37.92 89.19 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.471 -0.332 . . . . 45.32 111.388 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.703 ' HD3' ' HE2' ' A' ' 107' ' ' TYR . 15.3 mmt180 -57.88 -52.59 64.84 Favored 'General case' 0 C--O 1.239 0.541 0 N-CA-C 109.465 -0.568 . . . . 72.51 109.465 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 48.6 mm -60.0 -49.75 82.8 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 CA-C-N 115.093 -0.958 . . . . 73.3 110.784 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 35.3 tp -57.63 -54.54 45.74 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 111.948 0.351 . . . . 63.1 111.948 -175.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.55 -48.6 76.96 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 120.579 0.228 . . . . 64.11 111.362 -177.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.463 ' O ' ' HB3' ' A' ' 167' ' ' TYR . 16.7 tt -72.34 -36.63 55.83 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 C-N-CA 120.428 -0.509 . . . . 61.51 111.21 -178.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 36.7 tp -68.4 -38.27 81.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.461 -0.336 . . . . 73.25 110.924 -176.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.756 ' HA ' ' HB2' ' A' ' 169' ' ' HIS . 34.1 mm-40 -76.78 -23.95 52.9 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.842 -0.343 . . . . 54.23 110.517 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 164' ' ' ILE . 69.6 t80 -58.39 -48.65 79.97 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.281 -0.418 . . . . 74.31 110.076 172.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 24.6 pt -80.27 -32.29 13.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.54 -0.3 . . . . 72.04 111.372 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.756 ' HB2' ' HA ' ' A' ' 166' ' ' GLU . 4.9 m170 -56.55 -44.18 80.66 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 111.935 0.346 . . . . 75.22 111.935 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -77.15 12.14 1.57 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.144 -0.48 . . . . 65.43 111.41 -177.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -120.97 -72.04 0.71 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.268 -0.424 . . . . 71.21 109.905 173.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.507 ' OE2' ' HD3' ' A' ' 203' ' ' ARG . 9.2 pt-20 -177.3 -35.07 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.541 0.571 . . . . 73.04 112.541 -177.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . . . . . . . . . 79.2 m-85 -71.56 135.85 47.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.005 0.431 . . . . 74.31 111.005 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 28.7 m -129.8 142.9 42.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 115.593 -0.731 . . . . 54.03 109.536 175.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.563 ' CE1' ' HB3' ' A' ' 200' ' ' LEU . 3.6 t60 -100.96 -47.07 4.9 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.788 -0.365 . . . . 63.42 110.1 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.971 ' HA2' ' HB3' ' A' ' 243' ' ' ASP . . . 73.23 -62.14 1.79 Allowed Glycine 0 C--O 1.226 -0.369 0 C-N-CA 120.918 -0.658 . . . . 72.23 111.979 -176.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.42 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 4.9 t70 -55.08 111.18 0.79 Allowed 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 123.199 0.6 . . . . 61.01 112.457 -179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 20.4 mm -111.62 43.7 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.45 0.643 . . . . 62.22 109.585 170.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -81.6 145.44 30.62 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.608 -0.516 . . . . 64.15 109.608 178.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . . . . . . . . . . . -66.08 -2.14 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.835 0.68 . . . . 71.03 112.835 -173.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.451 ' HA ' ' HB2' ' A' ' 139' ' ' GLN . 4.7 p -76.91 -26.44 54.1 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 111.709 0.263 . . . . 74.34 111.709 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -102.61 -0.61 31.7 Favored 'General case' 0 C--O 1.237 0.443 0 N-CA-C 111.787 0.291 . . . . 75.41 111.787 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.3 mp -96.77 111.19 23.47 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.254 -0.43 . . . . 75.04 109.973 174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.532 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.3 mm? -114.26 136.07 53.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.087 -0.506 . . . . 64.35 110.598 -178.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.752 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 61.5 mt -93.58 141.71 28.16 Favored 'General case' 0 C--O 1.24 0.597 0 CA-C-N 115.82 -0.627 . . . . 71.53 110.141 179.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -60.98 138.74 58.16 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.528 -0.545 . . . . 74.21 109.528 174.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . 0.727 ' HD1' ' HA3' ' A' ' 135' ' ' GLY . 64.0 t80 -57.99 -30.91 66.44 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 112.37 0.508 . . . . 74.24 112.37 -175.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . 0.47 ' O ' ' HD3' ' A' ' 190' ' ' PRO . 26.5 tptp -101.58 -44.25 5.64 Favored 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.808 -0.357 . . . . 72.51 111.125 -176.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.594 ' HB3' ' HG3' ' A' ' 192' ' ' GLN . 4.4 m120 -102.01 104.85 38.78 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.295 -0.411 . . . . 63.1 111.505 -177.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.66 ' HB3' HG21 ' A' ' 343' ' ' VAL . 17.4 Cg_exo -68.42 -14.21 39.44 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 123.208 2.605 . . . . 45.15 112.247 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.544 ' HA ' ' HG ' ' A' ' 339' ' ' LEU . 6.7 p-10 -88.48 -3.8 58.75 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.889 -0.596 . . . . 73.01 110.799 -178.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.594 ' HG3' ' HB3' ' A' ' 189' ' ' ASN . 72.3 mt-30 -109.64 96.99 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.068 0.461 . . . . 73.42 110.524 -178.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 10.1 p -103.55 134.67 44.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.957 -0.565 . . . . 70.44 109.969 176.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.441 ' CD1' ' HE1' ' A' ' 134' ' ' PHE . 64.2 m-85 -125.2 157.28 36.89 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.016 -0.538 . . . . 75.24 110.202 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . . . . . . . . . 72.7 mt -103.1 127.5 50.35 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.199 -0.455 . . . . 64.35 110.066 176.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.503 HG12 HD23 ' A' ' 184' ' ' LEU . 7.6 p -139.37 170.78 15.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.624 -0.51 . . . . 71.04 109.624 -177.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.468 ' H ' HG22 ' A' ' 196' ' ' VAL . 69.1 m-20 65.12 56.81 0.99 Allowed 'General case' 0 CA--C 1.512 -0.517 0 CA-C-O 122.002 0.906 . . . . 75.03 109.617 179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.456 ' HD2' ' HB2' ' A' ' 201' ' ' ALA . 4.5 m-85 -73.91 39.95 0.11 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.365 -1.289 . . . . 74.03 112.809 -176.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -81.15 47.39 3.57 Favored Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 111.262 -0.735 . . . . 53.15 111.262 174.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.563 ' HB3' ' CE1' ' A' ' 175' ' ' HIS . 1.2 tt -170.98 44.09 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.096 -1.076 . . . . 70.45 108.096 -178.661 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.456 ' HB2' ' HD2' ' A' ' 198' ' ' TYR . . . -133.04 106.07 7.43 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.682 -0.69 . . . . 72.34 110.268 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 14.1 p90 -115.72 -177.45 3.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.096 -0.502 . . . . 74.13 110.44 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.507 ' HD3' ' OE2' ' A' ' 172' ' ' GLU . 58.8 mtt-85 -104.54 117.81 35.04 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.274 -0.421 . . . . 74.44 111.388 -170.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . . . . . . . . . 15.6 t80 -87.99 -45.3 10.33 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.181 0.515 . . . . 74.33 110.239 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 172' ' ' GLU . 11.0 p -128.81 66.33 75.15 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.889 -0.596 . . . . 60.54 110.838 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -55.55 143.9 76.55 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.645 2.23 . . . . 63.53 112.349 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 74.07 6.74 4.79 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.436 -0.802 . . . . 75.42 111.144 176.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 86.03 10.92 74.23 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.097 -0.573 . . . . 42.13 112.471 178.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 40.4 t -116.71 128.14 74.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.646 -0.501 . . . . 75.11 109.646 -179.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 20.0 p-80 -64.66 141.63 58.71 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.855 -0.424 . . . . 65.13 109.855 -179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -114.34 166.47 11.63 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.077 0.465 . . . . 72.41 111.332 -175.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -72.89 144.67 47.3 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.591 -0.731 . . . . 64.04 110.152 179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.452 ' HB2' ' CG2' ' A' ' 236' ' ' VAL . 53.6 p90 -68.2 147.46 52.22 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.42 -0.585 . . . . 72.0 109.42 175.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 215' ' ' GLU . 2.3 mptp? -90.58 -69.26 0.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 113.346 0.869 . . . . 60.23 113.346 -167.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 214' ' ' LYS . 9.3 mm-40 63.35 71.89 0.49 Allowed 'General case' 0 N--CA 1.464 0.234 0 N-CA-C 108.627 -0.879 . . . . 73.31 108.627 -165.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -78.6 146.22 68.96 Favored Pre-proline 0 C--N 1.322 -0.609 0 CA-C-N 114.901 -1.045 . . . . 64.15 111.004 -171.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -63.41 -24.59 71.1 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.78 2.32 . . . . 74.31 113.379 177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -103.0 -39.58 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.962 -0.384 . . . . 63.53 109.962 178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.41 ' HD3' ' O ' ' A' ' 234' ' ' ASN . 93.0 mtt-85 74.03 117.62 0.05 Allowed 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.317 -0.856 . . . . 43.04 110.974 177.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.634 ' SG ' ' HA2' ' A' ' 235' ' ' GLY . 9.1 p -57.57 -48.97 77.89 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 113.448 0.907 . . . . 70.44 113.448 -170.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 233' ' ' HIS . 12.8 p-80 46.81 32.69 1.86 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 123.271 0.629 . . . . 72.12 111.998 -177.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -69.18 -41.61 76.95 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 112.287 0.477 . . . . 75.01 112.287 -172.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.484 ' HA2' HD11 ' A' ' 200' ' ' LEU . . . -77.27 153.14 40.87 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.671 -0.776 . . . . 72.42 112.866 -177.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 5.1 t -70.2 122.39 19.4 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.09 0.471 . . . . 65.23 110.551 179.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.8 tt -60.87 -12.91 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 CA-C-N 115.959 -0.564 . . . . 55.33 111.709 -173.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . 0.493 ' HA ' HD21 ' A' ' 265' ' ' LEU . 38.5 tt0 -55.34 -59.54 4.66 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.555 177.318 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -106.82 -33.05 7.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-N 116.11 -0.496 . . . . 72.11 110.103 -179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 98.5 m -58.0 121.7 11.24 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.701 0.763 . . . . 74.15 110.84 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.625 ' H ' HD11 ' A' ' 246' ' ' ILE . 47.7 t -56.61 166.38 0.94 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 114.105 -1.407 . . . . 73.2 111.758 179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.41 ' H ' HG13 ' A' ' 230' ' ' ILE . 37.5 mt -55.15 -51.63 52.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.436 -0.802 . . . . 54.34 110.608 -178.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -56.16 17.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.091 -0.959 . . . . 51.22 111.504 -172.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . . . . . . . . . . . -60.74 -42.45 97.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.989 -0.551 . . . . 73.44 111.817 -176.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 221' ' ' HIS . 42.2 t-80 -76.24 -17.53 59.45 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.062 0.458 . . . . 61.42 110.467 -178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 219' ' ' ARG . 6.0 t30 -80.66 -8.41 59.62 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.597 -0.729 . . . . 72.43 111.683 -176.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.634 ' HA2' ' SG ' ' A' ' 220' ' ' CYS . . . 86.7 24.14 39.89 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.055 -1.069 . . . . 65.34 112.843 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.452 ' CG2' ' HB2' ' A' ' 213' ' ' TYR . 10.0 p -120.51 140.98 42.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 109.303 -0.629 . . . . 71.53 109.303 174.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -59.46 113.56 7.33 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 120.662 0.268 . . . . 54.12 110.771 179.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -80.48 134.93 10.24 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.587 2.191 . . . . 55.1 112.117 -178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' A' ' 311' ' ' TYR . 34.9 p -79.36 -164.52 0.64 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.969 -0.56 . . . . 64.34 109.66 176.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -62.93 -19.28 64.09 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.453 -0.499 . . . . 74.44 109.965 175.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -63.32 -30.55 71.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.909 -0.587 . . . . 64.3 111.116 177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.577 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -61.25 -66.65 2.53 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.05 -0.595 . . . . 73.54 112.502 -175.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.971 ' HB3' ' HA2' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -76.8 -29.77 56.15 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 112.252 0.464 . . . . 74.5 112.252 -174.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 55.4 mt -65.99 -34.2 77.55 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.437 -0.505 . . . . 70.13 110.981 177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -74.99 -34.31 61.95 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.503 -0.554 . . . . 44.51 109.503 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.625 HD11 ' H ' ' A' ' 229' ' ' SER . 93.7 mt -64.41 -37.77 80.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.015 -0.539 . . . . 71.41 110.393 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.5 ' HA ' ' SG ' ' A' ' 250' ' ' CYS . 47.9 tp -61.5 -40.2 93.74 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.588 -0.523 . . . . 74.33 109.588 174.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -61.53 -43.15 99.69 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.601 -0.809 . . . . 61.21 111.743 174.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . . . . . . . . . 16.2 m-30 -54.37 -57.14 12.41 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.844 0.354 . . . . 73.24 111.218 177.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.5 ' SG ' ' HA ' ' A' ' 247' ' ' LEU . 7.2 p -67.21 -40.94 86.49 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.31 -0.405 . . . . 73.1 111.993 -174.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . . . . . . . . . 83.5 mtp -60.12 -47.57 85.36 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.672 0.272 . . . . 72.3 111.42 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 16.6 tt -70.34 -29.24 38.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 C-N-CA 120.414 -0.514 . . . . 71.02 110.253 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -67.55 -46.8 71.7 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.595 -0.275 . . . . 73.1 110.543 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . . . . . . . . . 25.9 m0 -61.96 -31.28 71.61 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 116.352 -0.385 . . . . 62.55 110.588 178.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 56.6 tp -78.59 -41.2 32.45 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.015 -0.539 . . . . 71.01 112.089 -177.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 67.1 p -101.92 -27.89 12.71 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.186 0.439 . . . . 71.11 112.186 -171.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 96.96 -5.07 63.39 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.488 -0.863 . . . . 71.5 113.694 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 19.4 m-70 -150.83 144.07 24.82 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 117.799 0.8 . . . . 53.51 112.458 -176.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.447 HD13 ' CZ2' ' A' ' 261' ' ' TRP . 60.3 mt -122.5 138.9 29.94 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-N 115.198 -0.91 . . . . 71.21 108.871 166.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 46.2 Cg_exo -58.19 -34.79 98.91 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.728 2.285 . . . . 51.12 113.309 -175.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.516 ' HB2' HG12 ' A' ' 271' ' ' VAL . 36.7 p90 -95.3 2.92 54.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.646 -0.252 . . . . 72.14 111.438 -175.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.86 -33.84 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.889 0.376 . . . . 74.31 110.492 -177.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.42 -28.64 37.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.723 0.773 . . . . 74.55 109.309 174.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 270' ' ' TYR . 9.9 m120 -86.23 7.14 26.4 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.069 -0.968 . . . . 43.01 110.497 -179.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.493 HD21 ' HA ' ' A' ' 226' ' ' GLU . 1.7 tm? -54.94 -35.32 64.11 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 115.941 -0.572 . . . . 63.43 111.243 -175.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.57 14.88 1.47 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.817 0.673 . . . . 72.04 112.817 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.408 ' HA ' ' HD3' ' A' ' 268' ' ' PRO . 12.7 t70 -139.89 113.98 7.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 120.733 0.301 . . . . 73.11 110.325 174.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 31.2 Cg_exo -59.87 -30.81 92.72 Favored 'Trans proline' 0 CA--C 1.53 0.307 0 C-N-CA 123.41 2.74 . . . . 73.15 113.777 -176.343 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -69.2 -44.54 71.94 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.694 0.283 . . . . 71.25 110.647 -177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.469 ' CB ' ' HB3' ' A' ' 264' ' ' ASN . 43.8 m-85 -66.71 -49.97 64.33 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.236 -0.438 . . . . 61.14 111.669 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.516 HG12 ' HB2' ' A' ' 261' ' ' TRP . 19.4 m -62.5 -35.81 71.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 121.131 -0.227 . . . . 74.23 111.585 -179.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.419 ' O ' HG13 ' A' ' 276' ' ' ILE . 30.1 ttm180 -63.06 -53.27 56.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.6 -0.273 . . . . 72.33 110.334 177.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -66.66 -40.0 88.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.228 -0.442 . . . . 52.52 111.14 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 46.7 m -61.66 -44.69 96.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.451 -0.341 . . . . 45.33 111.34 -178.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -70.71 -33.6 71.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.709 0.29 . . . . 75.12 110.868 -178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.419 HG13 ' O ' ' A' ' 272' ' ' ARG . 77.4 mt -67.21 -43.88 88.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.948 0.404 . . . . 71.32 109.981 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 23.6 ttm180 -63.0 -36.15 82.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.851 -0.613 . . . . 73.03 110.293 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -62.29 -46.3 89.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.119 -0.491 . . . . 74.12 111.026 176.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -64.5 -26.35 68.39 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 120.924 0.392 . . . . 71.34 110.866 178.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -78.13 -32.17 50.27 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.982 -0.554 . . . . 63.14 111.32 -178.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.635 ' HB3' HD23 ' A' ' 285' ' ' LEU . 0.2 OUTLIER -136.05 53.25 1.95 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.947 0.403 . . . . 74.25 110.389 -172.323 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.517 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -57.0 -44.45 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 113.577 0.954 . . . . 74.32 113.577 -171.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.445 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -69.8 -47.32 63.26 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.866 0.321 . . . . 64.23 111.866 -170.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 32.4 t -68.36 -45.15 73.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.511 -0.313 . . . . 73.01 110.74 -177.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.635 HD23 ' HB3' ' A' ' 281' ' ' ASN . 4.0 mm? -61.21 -53.44 56.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.44 -0.345 . . . . 64.3 111.575 -177.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . 0.487 ' HE2' ' HG3' ' A' ' 303' ' ' MET . 0.1 OUTLIER -59.7 -42.79 93.79 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 111.743 0.275 . . . . 75.51 111.743 -178.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -66.07 -37.33 85.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.131 0.491 . . . . 73.34 111.088 179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -89.85 1.72 55.85 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.059 -0.519 . . . . 73.25 111.624 -172.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 90.4 m -70.08 -23.77 63.12 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.905 0.383 . . . . 63.13 110.707 176.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.592 ' CE2' ' HB2' ' A' ' 292' ' ' GLU . 14.8 t80 -132.81 86.97 42.17 Favored Pre-proline 0 C--N 1.324 -0.511 0 N-CA-C 109.223 -0.658 . . . . 71.43 109.223 177.195 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -79.9 34.35 0.53 Allowed 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.431 2.754 . . . . 75.52 112.847 -174.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.592 ' HB2' ' CE2' ' A' ' 290' ' ' PHE . 51.5 mt-10 -120.59 -165.67 1.23 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.139 -0.482 . . . . 73.31 110.293 -179.025 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -92.04 85.55 5.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.084 0.469 . . . . 74.13 110.661 -179.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -146.27 -165.64 2.27 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.99 -0.744 . . . . 64.31 108.99 178.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.791 ' HD3' HD12 ' A' ' 331' ' ' ILE . 21.7 mtpp -120.48 90.14 45.14 Favored Pre-proline 0 C--N 1.326 -0.45 0 CA-C-O 120.483 0.183 . . . . 72.1 111.489 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -99.53 36.6 0.09 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 122.94 2.427 . . . . 73.21 111.395 172.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -95.56 -42.9 3.53 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.795 -0.717 . . . . 70.44 112.031 -176.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . . . . . . . . . 21.1 mp0 -56.84 -46.08 81.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.968 0.413 . . . . 75.11 110.128 177.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 3.5 mp -65.16 -41.24 91.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.895 -0.593 . . . . 71.21 110.586 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -60.91 -50.14 74.62 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.368 -0.378 . . . . 73.42 111.171 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . . . . . . . . . 52.2 tptt -65.19 -39.3 92.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.227 -0.442 . . . . 64.33 110.469 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 320' ' ' LEU . 73.1 t80 -56.19 -46.54 79.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.94 -0.573 . . . . 72.4 110.843 177.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.533 ' HA ' HG22 ' A' ' 306' ' ' VAL . 94.8 mmm -71.46 -39.37 70.98 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.814 -0.63 . . . . 63.25 111.209 -175.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.565 ' O ' ' HG3' ' A' ' 307' ' ' LYS . 25.2 tt0 -58.66 -50.03 75.37 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-O 121.771 0.796 . . . . 72.1 109.369 174.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.422 ' O ' ' HG ' ' A' ' 309' ' ' LEU . 88.9 m -57.65 -50.97 71.39 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.702 -1.136 . . . . 73.03 111.733 -179.47 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.533 HG22 ' HA ' ' A' ' 303' ' ' MET . 33.7 m -67.21 -27.22 38.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 N-CA-C 112.21 0.448 . . . . 45.43 112.21 -176.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.565 ' HG3' ' O ' ' A' ' 304' ' ' GLU . 0.0 OUTLIER -80.33 -19.86 45.55 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.363 -0.535 . . . . 72.13 110.339 -179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 308' ' ' LEU . 30.4 tp -94.41 17.84 12.27 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.116 -0.493 . . . . 63.21 111.143 178.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.557 HD22 ' HA ' ' A' ' 315' ' ' PRO . 92.2 mt -93.77 -12.78 28.38 Favored 'General case' 0 C--O 1.235 0.33 0 N-CA-C 112.282 0.475 . . . . 51.25 112.282 -177.342 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' A' ' 313' ' ' GLU . 13.2 t70 58.48 -164.37 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 122.591 0.356 . . . . 74.23 110.123 -177.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.455 ' H ' ' CG ' ' A' ' 310' ' ' ASP . 85.3 m-85 -64.93 -52.07 58.4 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 63.53 110.416 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 19.8 m -155.16 69.05 0.7 Allowed 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.222 0.534 . . . . 75.14 111.023 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.501 ' HG3' ' HB3' ' A' ' 310' ' ' ASP . 25.2 mt-10 -104.99 33.43 3.64 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.493 -0.558 . . . . 64.12 109.493 171.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.504 ' HA ' ' HD2' ' A' ' 315' ' ' PRO . 25.4 mttt 64.53 103.53 0.03 OUTLIER Pre-proline 0 CA--C 1.519 -0.219 0 CA-C-N 114.512 -1.222 . . . . 75.1 112.239 -176.436 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.557 ' HA ' HD22 ' A' ' 309' ' ' LEU . 19.6 Cg_endo -63.22 136.49 56.04 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 122.284 1.989 . . . . 63.22 110.49 170.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 92.9 mt -79.19 79.82 5.59 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.857 -0.337 . . . . 61.41 110.699 -176.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.426 ' CE1' ' HG2' ' A' ' 315' ' ' PRO . 17.2 m-85 -53.41 -48.5 68.65 Favored 'General case' 0 N--CA 1.461 0.123 0 CA-C-N 115.495 -0.775 . . . . 72.15 109.948 178.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . . . . . . . . . 6.5 pt-20 -63.04 -53.24 56.88 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 114.848 -1.069 . . . . 61.3 111.785 -178.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.467 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 27.0 t-20 -59.77 -51.37 70.04 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.747 -0.206 . . . . 62.42 111.333 -176.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 302' ' ' TYR . 95.5 mt -59.16 -48.75 80.46 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.948 0.404 . . . . 75.41 111.074 -177.385 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . . . . . . . . . 24.0 ttt-85 -62.3 -40.56 96.67 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.903 -0.589 . . . . 73.02 110.203 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -70.72 -49.38 47.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.757 -0.656 . . . . 63.41 111.51 -177.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.6 pp -64.79 -33.61 64.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 120.872 -0.331 . . . . 74.13 111.323 -174.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.536 ' HB3' HD11 ' A' ' 155' ' ' LEU . 88.7 mt -69.9 -49.37 52.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.829 0.347 . . . . 74.43 110.591 178.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.555 HD11 HD21 ' A' ' 159' ' ' LEU . 82.5 mt -67.04 -34.07 76.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.253 -0.43 . . . . 72.52 111.031 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -64.12 -47.67 79.08 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.197 -0.456 . . . . 65.43 110.48 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -66.41 -31.77 79.86 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.69 -0.767 . . . . 73.22 111.975 179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.584 HD23 ' HG2' ' A' ' 151' ' ' ARG . 3.1 tm? -68.23 -49.54 60.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.094 0.473 . . . . 73.52 110.336 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 333' ' ' SER . 85.6 tttt -71.87 -34.34 69.14 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.061 -0.518 . . . . 72.21 111.065 -176.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -66.98 -27.32 67.34 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.173 0.434 . . . . 71.41 112.173 -176.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.791 HD12 ' HD3' ' A' ' 295' ' ' LYS . 15.6 tt -86.25 -6.3 10.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 C-N-CA 120.416 -0.514 . . . . 73.2 110.87 -177.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 110.64 24.45 5.57 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.278 -0.963 . . . . 54.41 113.875 173.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.555 ' O ' ' HA ' ' A' ' 329' ' ' LYS . 13.3 t -119.47 149.57 41.66 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 117.332 0.566 . . . . 44.43 110.082 176.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -162.7 27.05 0.1 Allowed 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.551 -0.907 . . . . 72.43 108.551 -177.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.49 105.87 17.9 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 114.311 -1.313 . . . . 73.04 110.804 -170.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -122.2 -21.16 5.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.354 -0.385 . . . . 74.31 111.641 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . -78.76 -23.47 64.36 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.632 -0.794 . . . . 53.33 113.126 -175.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -139.69 119.27 13.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.674 0.274 . . . . 63.21 110.772 -178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.544 ' HG ' ' HA ' ' A' ' 191' ' ' ASP . 58.0 mt -87.47 117.83 26.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.756 -0.461 . . . . 64.31 109.756 173.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -83.49 25.15 0.77 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.342 -0.39 . . . . 74.35 110.847 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 342' ' ' SER . 25.6 tp -51.65 -74.5 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.533 -0.758 . . . . 45.43 111.372 -176.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 341' ' ' LEU . 7.6 t 176.62 -65.21 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.128 -0.487 . . . . 64.34 110.154 177.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.66 HG21 ' HB3' ' A' ' 190' ' ' PRO . 61.8 t 66.09 97.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 O-C-N 123.811 0.695 . . . . 75.41 110.824 -177.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.664 HG13 ' H ' ' A' ' 345' ' ' GLU . 2.2 p -111.56 -74.37 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.79 -0.641 . . . . 51.51 111.65 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.664 ' H ' HG13 ' A' ' 344' ' ' VAL . 42.1 mt-10 -157.4 -175.69 5.54 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.829 0.347 . . . . 75.13 110.219 -174.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.411 ' HB3' ' O ' ' A' ' 135' ' ' GLY . 17.3 p30 -112.32 160.35 17.76 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.07 -0.514 . . . . 75.25 110.104 176.445 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 132.62 15.3 1.42 Allowed Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.114 -1.041 . . . . 62.25 113.539 174.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . -61.03 -49.29 80.12 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.348 -0.93 . . . . 62.34 111.453 175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.45 ' HA ' HE21 ' A' ' 45' ' ' GLN . 2.7 tt 54.52 89.23 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 123.717 0.807 . . . . 72.2 112.302 171.552 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.415 ' HD3' ' HA ' ' A' ' 350' ' ' LYS . 37.9 mmtm -138.52 131.43 29.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.656 -0.702 . . . . 53.21 109.283 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -132.8 138.53 47.14 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.277 -0.42 . . . . 72.03 110.992 -175.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.41 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 0.0 OUTLIER -145.15 134.26 22.71 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.72 -0.474 . . . . 72.44 109.72 -178.174 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 14.9 t -104.38 153.87 20.54 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.609 0.243 . . . . 73.41 110.366 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.22 128.44 40.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.282 0.563 . . . . 55.44 110.981 -173.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . 0.704 HG23 ' HB2' ' A' ' 358' ' ' ARG . 33.3 m -77.82 97.96 5.41 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.81 -0.632 . . . . 63.24 111.822 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -82.84 -48.34 10.87 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.519 -0.549 . . . . 72.34 109.519 170.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -151.53 86.33 1.33 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.714 -0.675 . . . . 64.53 110.255 175.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.704 ' HB2' HG23 ' A' ' 355' ' ' THR . 15.2 mmt180 -134.58 113.11 11.42 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.525 -0.761 . . . . 65.51 109.037 176.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 56.7 mtpt -103.36 -51.54 3.2 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.726 -0.472 . . . . 63.54 109.726 -176.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.549 ' HA ' ' HE2' ' A' ' 360' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.909 0 N-CA-C 107.911 -1.144 . . . . 52.11 107.911 174.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.482 1.147 0 CA-C-O 120.576 0.227 . . . . 72.14 111.014 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -78.08 138.09 15.99 Favored 'Trans proline' 0 N--CA 1.458 -0.57 0 C-N-CA 122.495 2.13 . . . . 61.25 110.685 172.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 60.8 mtm180 -121.44 -75.92 0.59 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.742 0.306 . . . . 74.45 111.544 -175.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 5.5 p -85.73 113.05 23.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.556 0.694 . . . . 75.31 111.274 -173.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 81.3 mttt -126.68 -93.08 0.48 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.401 -0.818 . . . . 73.04 109.391 175.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -169.47 138.63 1.98 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.798 -0.637 . . . . 71.1 109.909 178.133 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -73.67 90.79 1.84 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.141 0.496 . . . . 73.41 110.445 176.49 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.42 ' H ' ' HG2' ' A' ' 8' ' ' GLN . 16.2 pt20 -88.73 60.26 5.47 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.324 0.583 . . . . 73.03 110.88 -177.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -128.4 102.62 6.73 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.647 -0.706 . . . . 72.42 110.861 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -97.85 111.52 4.26 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.904 -0.665 . . . . 72.24 111.496 177.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.0 tpm_? -144.98 114.72 7.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.598 0.237 . . . . 64.24 111.375 -175.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.522 ' HA ' ' OE1' ' A' ' 143' ' ' GLU . 11.6 pt20 -150.19 131.48 14.59 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.119 -0.697 . . . . 65.01 109.119 166.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.3 t -130.74 122.68 27.68 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 121.055 -0.258 . . . . 44.44 111.19 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 15.4 p -174.49 131.38 0.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.421 -0.354 . . . . 73.43 110.765 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -139.72 137.45 35.16 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.945 -0.57 . . . . 52.41 109.902 178.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -116.35 99.79 7.44 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 111.74 0.274 . . . . 64.41 111.74 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.0 ptt180 -169.48 106.65 0.39 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.411 0.624 . . . . 63.34 111.244 168.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.597 ' HE1' ' HB2' ' A' ' 42' ' ' PRO . 55.0 t-80 -169.16 89.93 0.21 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.093 -0.958 . . . . 74.04 108.946 175.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.409 ' H ' ' HG ' ' A' ' 19' ' ' LEU . 3.2 pp -98.28 157.46 16.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.34 -0.391 . . . . 73.45 111.295 -175.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -151.78 140.3 20.64 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.969 -0.56 . . . . 75.0 109.617 178.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -161.37 172.56 16.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 110.034 -0.358 . . . . 75.43 110.034 -176.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 66.82 -88.23 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.343 0.657 . . . . 72.4 111.659 179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -124.26 91.08 3.38 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.417 0.627 . . . . 60.22 110.894 -178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -172.58 -58.7 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 107.62 -1.252 . . . . 41.33 107.62 177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.574 HG13 ' HA2' ' A' ' 40' ' ' GLY . 61.9 t -65.59 130.96 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 CA-C-N 114.515 -1.22 . . . . 70.33 108.712 167.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 38' ' ' LYS . . . 99.37 2.95 56.63 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.307 -0.949 . . . . 51.42 112.911 -179.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.71 133.0 51.2 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.197 -0.668 . . . . 73.13 109.197 175.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -81.04 131.11 34.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.678 0.751 . . . . 63.53 111.338 -173.159 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 69.4 mt -130.63 129.85 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 CA-C-N 114.726 -1.124 . . . . 65.14 109.641 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 21.1 m -118.45 123.83 46.15 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.559 -0.291 . . . . 74.23 110.594 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.417 ' HB3' ' HE1' ' A' ' 128' ' ' PHE . 3.2 p-10 -111.2 -173.09 2.16 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.398 -0.365 . . . . 74.24 110.71 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 26.1 mmt -72.06 -14.31 61.83 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 112.356 0.502 . . . . 64.24 112.356 -173.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -81.29 8.54 8.84 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.836 0.35 . . . . 34.2 110.434 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 36.6 tptt 55.81 63.21 2.11 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.334 -0.848 . . . . 74.45 110.686 178.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 30' ' ' THR . 48.6 mmtm -134.92 120.84 19.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.059 -0.973 . . . . 75.45 109.723 178.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -92.93 77.29 4.74 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.428 -0.582 . . . . 73.2 109.428 173.135 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.594 ' HB2' ' O ' ' A' ' 56' ' ' MET . 37.4 p-90 -96.81 -176.55 3.61 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.686 -0.688 . . . . 71.23 110.375 -179.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' HG2' ' HB3' ' A' ' 56' ' ' MET . 18.8 pttp -133.69 137.14 45.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.32 0.581 . . . . 73.3 111.562 -176.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.6 p -71.01 151.68 8.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.952 -1.022 . . . . 74.3 110.797 -179.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.574 ' HA2' HG13 ' A' ' 25' ' ' VAL . . . -96.6 -124.44 4.67 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.452 -0.659 . . . . 50.44 111.452 177.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 7.2 mp -92.13 128.88 43.55 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-O 120.838 0.351 . . . . 72.34 110.48 -179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.597 ' HB2' ' HE1' ' A' ' 18' ' ' HIS . 15.5 Cg_exo -68.91 119.1 6.12 Favored 'Trans proline' 0 N--CA 1.461 -0.389 0 C-N-CA 122.91 2.406 . . . . 75.13 111.463 176.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.83 -59.11 2.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.147 0.499 . . . . 73.43 110.144 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.67 -8.3 76.82 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.899 -0.667 . . . . 61.33 112.316 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 72.2 mt-30 -127.4 161.38 28.81 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.487 0.184 . . . . 72.44 110.561 -176.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 171.67 -130.92 2.04 Favored Glycine 0 N--CA 1.445 -0.718 0 N-CA-C 110.402 -1.079 . . . . 64.34 110.402 178.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -85.57 -2.69 86.94 Favored Glycine 0 C--O 1.226 -0.405 0 C-N-CA 120.473 -0.87 . . . . 70.34 111.527 174.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -151.78 -68.56 0.17 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.728 -0.471 . . . . 50.22 109.728 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 154.93 174.23 24.63 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.865 -0.683 . . . . 64.53 111.888 178.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 61.7 m 62.68 32.72 16.07 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.108 0.48 . . . . 73.55 111.583 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.0 mm -96.13 137.37 24.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.429 -0.35 . . . . 73.01 110.603 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.42 ' HB2' HG13 ' A' ' 70' ' ' VAL . 11.0 m-85 -111.89 148.97 32.53 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.849 -0.426 . . . . 74.4 109.849 176.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.512 HD23 ' N ' ' A' ' 54' ' ' ALA . 4.5 tt -90.63 139.87 30.3 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.828 -0.804 . . . . 33.03 108.828 178.318 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.512 ' N ' HD23 ' A' ' 53' ' ' LEU . . . -92.51 119.41 31.97 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.796 -0.362 . . . . 62.43 110.751 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -79.77 -53.37 6.86 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 121.175 0.512 . . . . 74.54 110.495 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.594 ' O ' ' HB2' ' A' ' 37' ' ' TRP . 22.7 ttt -118.75 122.8 43.3 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.463 -0.789 . . . . 74.22 110.038 179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -144.3 142.64 30.55 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.392 -0.966 . . . . 71.35 108.392 176.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 71.2 m -72.37 76.17 1.02 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.428 0.633 . . . . 71.2 110.457 178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.675 ' HB2' ' HB ' ' A' ' 62' ' ' VAL . 16.5 m -81.37 141.84 33.6 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 115.623 -0.717 . . . . 64.15 110.035 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -58.93 -33.61 70.79 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.267 0.556 . . . . 72.12 110.474 179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 42.5 m -147.02 82.71 1.56 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.963 -0.562 . . . . 64.41 109.917 174.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.675 ' HB ' ' HB2' ' A' ' 59' ' ' SER . 11.1 p -82.42 125.58 39.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.058 -0.519 . . . . 73.44 110.337 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -98.62 53.04 1.14 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.796 . . . . 55.44 111.702 179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 m 68.69 3.27 3.81 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.355 0.598 . . . . 62.51 110.499 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -142.05 122.12 13.75 Favored 'General case' 0 CA--C 1.508 -0.651 0 CA-C-N 115.31 -0.859 . . . . 62.13 109.232 -179.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 67' ' ' PRO . . . -73.73 110.68 9.59 Favored Pre-proline 0 C--N 1.314 -0.948 0 CA-C-O 121.122 0.487 . . . . 71.23 110.018 173.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.464 ' C ' ' HB2' ' A' ' 133' ' ' ARG . 3.6 Cg_exo -79.67 40.36 0.95 Allowed 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.149 2.566 . . . . 75.44 111.273 -177.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 23.0 p -144.26 146.95 32.96 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.623 0.725 . . . . 73.14 112.826 -172.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 132' ' ' ASP . 34.6 m -128.08 167.05 23.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.021 -0.99 . . . . 74.32 109.389 172.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.591 ' HB ' HD13 ' A' ' 130' ' ' ILE . 3.1 p -130.42 123.83 56.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.256 0.551 . . . . 73.11 111.488 -176.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -82.43 122.3 27.84 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.443 -0.577 . . . . 72.41 109.443 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.5 t -110.9 122.48 65.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.4 -0.364 . . . . 62.44 110.577 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.447 ' HB3' HD23 ' A' ' 80' ' ' LEU . 6.0 tp10 -136.07 137.54 25.21 Favored Pre-proline 0 C--N 1.325 -0.491 0 N-CA-C 109.053 -0.721 . . . . 74.21 109.053 -177.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.62 133.25 50.34 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.17 1.913 . . . . 74.12 112.061 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 27.4 t -81.18 15.01 2.07 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.099 0.476 . . . . 40.03 110.655 -178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.468 ' OD2' ' HE3' ' A' ' 124' ' ' LYS . 10.0 t70 -67.65 -69.1 0.34 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.799 -0.637 . . . . 63.44 110.105 177.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -170.32 118.31 0.55 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.705 -0.68 . . . . 52.11 109.477 178.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 178.71 -161.95 28.75 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.465 -0.874 . . . . 72.31 112.478 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 39.8 Cg_endo -67.01 -21.54 49.37 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 123.18 2.587 . . . . 72.43 112.913 -176.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.495 HD13 ' O ' ' A' ' 80' ' ' LEU . 1.2 tm? -52.31 -37.64 56.31 Favored 'General case' 0 N--CA 1.465 0.283 0 O-C-N 123.602 0.564 . . . . 74.11 111.16 -175.018 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -67.15 -41.81 85.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.884 0.373 . . . . 73.01 110.574 -178.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 39.6 m -69.15 -46.3 67.96 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 116.201 -0.454 . . . . 75.14 110.708 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.474 ' HG2' ' HA ' ' A' ' 80' ' ' LEU . 11.4 pt-20 -67.99 -31.1 70.56 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.189 -0.46 . . . . 72.4 110.838 -179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.51 -39.71 88.82 Favored 'General case' 0 C--N 1.332 -0.175 0 N-CA-C 110.366 -0.235 . . . . 74.22 110.366 177.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 30.1 mmtm -57.26 -49.01 77.41 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.881 0.372 . . . . 53.0 110.708 176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 38.8 t80 -65.11 -49.51 69.67 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.98 -0.555 . . . . 74.44 111.131 177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CZ ' ' HD1' ' A' ' 113' ' ' TYR . 55.8 t80 -59.91 -38.13 81.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.731 -0.668 . . . . 75.44 111.563 -175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -74.14 -39.63 63.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.696 0.284 . . . . 64.52 110.867 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.39 -27.83 65.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.475 -0.33 . . . . 71.33 110.955 -177.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . 0.606 ' HA ' ' CH2' ' A' ' 99' ' ' TRP . . . -106.74 16.52 24.34 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.963 0.411 . . . . 64.21 111.352 -177.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 92' ' ' LYS . . . -82.58 158.19 23.17 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.109 -0.496 . . . . 72.25 111.478 -177.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.438 ' O ' HG13 ' A' ' 96' ' ' ILE . 49.9 mtmt 75.17 107.01 0.03 OUTLIER Pre-proline 0 N--CA 1.468 0.447 0 CA-C-N 115.293 -0.867 . . . . 64.1 111.394 177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.531 ' O ' ' HG3' ' A' ' 97' ' ' GLN . 49.7 Cg_exo -55.69 -35.33 92.97 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.362 2.708 . . . . 75.52 113.197 -176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.739 ' HG2' ' HE2' ' A' ' 98' ' ' LYS . 38.6 tt0 -66.46 -45.8 78.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.809 0.337 . . . . 61.01 110.946 -178.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.702 ' HA ' ' HE3' ' A' ' 98' ' ' LYS . 48.8 tt0 -62.64 -36.87 84.22 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.405 -0.591 . . . . 74.13 109.405 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.517 HD12 ' HA ' ' A' ' 93' ' ' PRO . 67.4 mt -55.96 -45.88 80.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 115.537 -0.756 . . . . 72.03 110.284 173.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 93' ' ' PRO . 96.3 mt-30 -53.78 -47.06 71.11 Favored 'General case' 0 N--CA 1.461 0.108 0 CA-C-N 115.856 -0.611 . . . . 73.23 110.586 179.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.739 ' HE2' ' HG2' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -63.85 -57.75 8.91 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 112.48 0.548 . . . . 74.12 112.48 -177.532 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.606 ' CH2' ' HA ' ' A' ' 90' ' ' ALA . 1.1 p90 -69.52 -34.71 74.65 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 119.968 -0.693 . . . . 61.41 111.501 -171.104 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . 0.485 HD11 HD22 ' A' ' 108' ' ' LEU . 26.1 mm -63.45 -47.07 93.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 120.96 0.41 . . . . 74.45 110.122 177.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 71.9 ttt180 -63.94 -35.67 81.44 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.62 -0.718 . . . . 74.31 110.886 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 26.1 m -76.25 -34.63 59.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-N 116.207 -0.451 . . . . 73.31 111.555 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 29.4 mtp180 -84.61 1.91 43.93 Favored 'General case' 0 C--N 1.331 -0.2 0 O-C-N 122.299 -0.251 . . . . 54.24 111.546 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 89.3 mttt 65.94 25.9 11.03 Favored 'General case' 0 N--CA 1.465 0.286 0 O-C-N 123.582 0.551 . . . . 74.15 111.104 177.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 86.6 mt -91.58 -178.32 5.05 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.779 -0.646 . . . . 74.3 109.362 178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -131.9 -45.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.73 0.641 . . . . 74.2 112.73 -179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -154.08 117.48 4.59 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 119.522 -0.871 . . . . 75.43 112.342 -175.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.694 ' H ' HD23 ' A' ' 108' ' ' LEU . 2.6 pt? -103.96 136.24 43.99 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.706 -0.679 . . . . 74.44 109.294 173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -79.85 66.65 3.53 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.852 -0.689 . . . . 73.24 112.926 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.426 ' HA ' ' HD3' ' A' ' 111' ' ' PRO . 11.7 p -104.11 136.76 19.15 Favored Pre-proline 0 C--N 1.326 -0.424 0 N-CA-C 110.262 -0.273 . . . . 72.43 110.262 -179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 110' ' ' VAL . 38.8 Cg_exo -61.73 146.23 96.81 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.685 2.256 . . . . 64.23 112.719 176.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -67.77 122.91 19.11 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.623 -0.717 . . . . 75.2 111.157 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.435 ' HD1' ' CZ ' ' A' ' 87' ' ' TYR . 40.4 t80 -84.33 116.08 22.83 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.976 -0.557 . . . . 72.4 110.866 177.2 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.485 ' HB2' ' CG2' ' A' ' 130' ' ' ILE . 73.3 m95 -104.71 -63.01 1.26 Allowed 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.065 -0.717 . . . . 74.21 109.065 170.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -152.08 172.13 31.39 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.148 -0.933 . . . . 62.14 111.305 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 28.8 p -169.83 159.82 8.18 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.577 0.227 . . . . 73.3 110.628 -176.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.41 -165.03 37.62 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.855 -0.688 . . . . 61.15 111.662 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.756 ' HB3' ' HG3' ' A' ' 127' ' ' ARG . 0.0 OUTLIER -137.47 147.22 45.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.914 0.387 . . . . 74.32 110.452 178.275 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -124.55 112.08 16.42 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.561 -0.533 . . . . 73.11 109.561 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.574 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 15.1 t0 -71.74 148.08 46.72 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.005 -0.543 . . . . 53.15 111.031 -178.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.473 ' HG3' ' OD1' ' A' ' 122' ' ' ASN . 26.5 tptp -117.32 -73.05 0.66 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.545 -0.752 . . . . 72.52 110.179 -177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.473 ' OD1' ' HG3' ' A' ' 121' ' ' LYS . 15.8 m120 -135.26 30.72 3.25 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.187 -0.46 . . . . 71.32 110.287 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 114.26 -31.64 6.35 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 111.008 -0.837 . . . . 53.41 111.008 -175.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.468 ' HE3' ' OD2' ' A' ' 76' ' ' ASP . 44.3 mttp -100.18 96.4 7.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.19 -0.67 . . . . 74.43 109.19 173.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 4.9 p -76.26 142.56 41.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.436 -0.802 . . . . 62.43 111.254 -176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -96.18 121.57 38.1 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.86 -0.609 . . . . 72.21 109.716 175.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.756 ' HG3' ' HB3' ' A' ' 118' ' ' LEU . 16.0 ttt180 -102.57 132.77 48.43 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.269 -0.641 . . . . 74.52 109.269 -175.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.568 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 39.9 p90 -133.41 160.06 38.5 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.038 0.447 . . . . 74.34 111.797 -170.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . . . . . . . . . 23.2 ptp -142.31 141.04 32.34 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.613 -0.721 . . . . 71.25 109.888 175.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.591 HD13 ' HB ' ' A' ' 70' ' ' VAL . 4.6 mm -97.3 122.76 49.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.036 0.446 . . . . 74.23 110.384 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 61.5 mtm -127.15 -175.98 3.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.812 -0.631 . . . . 72.21 110.282 -177.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.542 ' HB2' ' CE1' ' A' ' 134' ' ' PHE . 5.7 m-20 -58.3 152.52 17.25 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.089 -0.505 . . . . 65.11 110.502 175.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.464 ' HB2' ' C ' ' A' ' 67' ' ' PRO . 35.3 ttt180 -72.79 105.62 4.42 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.711 -0.478 . . . . 65.21 109.711 177.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.542 ' CE1' ' HB2' ' A' ' 132' ' ' ASP . 28.3 m-85 -101.76 171.02 7.79 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.274 -0.421 . . . . 75.24 110.533 -176.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.29 -43.97 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.674 -0.774 . . . . 71.42 111.844 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 140' ' ' LYS . 5.6 t -120.87 159.8 24.77 Favored 'General case' 0 N--CA 1.446 -0.653 0 CA-C-O 121.069 0.462 . . . . 70.15 110.531 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.825 ' HB3' HD13 ' A' ' 184' ' ' LEU . 1.1 p30 -143.57 -172.54 3.74 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.401 -0.818 . . . . 72.33 109.78 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.556 ' HB3' ' HB1' ' A' ' 180' ' ' ALA . 6.8 mp -77.08 -24.51 51.84 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.164 -0.471 . . . . 75.15 112.075 -179.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.78 ' HA ' ' HD1' ' A' ' 142' ' ' TYR . 3.2 pt20 -75.46 -36.29 60.7 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 119.695 -0.802 . . . . 63.22 109.968 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.862 ' HB3' ' HA ' ' A' ' 346' ' ' ASN . 43.1 mttp -57.83 -34.25 69.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.316 0.579 . . . . 73.41 110.182 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.504 HG23 ' HG2' ' A' ' 345' ' ' GLU . 72.7 mt -76.0 -51.29 20.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.489 -0.778 . . . . 63.41 111.227 175.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.78 ' HD1' ' HA ' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -72.18 -33.85 67.99 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 112.752 0.649 . . . . 74.14 112.752 -170.264 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.522 ' OE1' ' HA ' ' A' ' 12' ' ' GLN . 31.2 mt-10 -72.07 -31.25 65.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.834 0.349 . . . . 75.54 110.913 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -91.54 -32.1 15.68 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 111.979 0.362 . . . . 74.53 111.979 -177.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . 0.625 ' HB2' ' HG3' ' A' ' 345' ' ' GLU . 6.7 t-20 -98.95 0.31 43.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.084 0.469 . . . . 64.23 110.742 -176.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.81 64.85 1.44 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 115.51 -0.768 . . . . 54.42 111.984 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 142' ' ' TYR . 17.5 ptpt 34.09 74.81 0.06 Allowed 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.199 1.185 . . . . 60.13 114.199 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 82.5 mtt180 -136.42 103.84 5.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.929 -0.578 . . . . 70.14 110.415 172.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.512 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 89.6 m-85 -121.03 155.8 33.57 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.975 -0.557 . . . . 75.01 110.474 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 154' ' ' VAL . 67.0 p -80.62 148.35 30.32 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.46 -0.336 . . . . 55.24 110.208 177.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.23 -26.63 66.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.002 0.43 . . . . 74.24 110.549 179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.46 ' HE2' ' HA ' ' A' ' 335' ' ' ASP . 63.0 tttm -62.08 -51.79 66.5 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.654 -0.703 . . . . 74.35 109.655 175.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.574 ' O ' ' HG ' ' A' ' 157' ' ' LEU . 33.3 m -64.26 -46.84 81.96 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.274 -0.876 . . . . 53.11 110.497 177.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 150' ' ' SER . 69.6 t -54.64 -46.01 72.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 75.13 111.462 -179.03 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 328' ' ' LEU . 1.7 tp -63.82 -49.15 73.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.615 -0.266 . . . . 72.12 110.734 -177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -60.44 -39.91 89.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.326 -0.397 . . . . 63.01 110.801 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 153' ' ' THR . 94.0 mt -62.41 -49.69 74.51 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.416 -0.356 . . . . 61.1 110.425 176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 23.4 m -58.1 -40.56 81.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.088 -0.506 . . . . 72.14 111.179 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.534 HD11 ' HB2' ' A' ' 321' ' ' ARG . 3.5 mm? -61.98 -54.31 43.52 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.271 -0.422 . . . . 64.52 111.471 179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.404 ' O ' HG22 ' A' ' 164' ' ' ILE . 86.6 mtt180 -64.16 -39.27 93.64 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.172 -0.467 . . . . 73.45 110.957 -177.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.414 HG13 HD11 ' A' ' 195' ' ' LEU . 1.6 mp -65.89 -40.39 87.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.135 -0.484 . . . . 74.42 110.606 177.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 tp -62.92 -44.13 96.91 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.616 0.246 . . . . 72.13 110.898 -178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 22.8 m-20 -58.42 -55.37 35.95 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.026 -0.534 . . . . 51.23 110.846 178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 160' ' ' ARG . 13.8 tt -69.16 -35.5 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.087 -0.506 . . . . 75.23 111.519 -177.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.68 ' O ' ' HB2' ' A' ' 169' ' ' HIS . 45.2 tp -63.81 -39.4 94.16 Favored 'General case' 0 C--O 1.222 -0.343 0 C-N-CA 121.276 -0.17 . . . . 62.34 111.331 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' HA ' ' CB ' ' A' ' 169' ' ' HIS . 22.8 tp10 -80.85 -25.61 37.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.968 0.413 . . . . 65.23 110.365 177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.6 t80 -60.42 -45.81 92.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.029 0.442 . . . . 71.03 110.487 174.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 40.1 pt -80.85 -29.67 11.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.3 -0.409 . . . . 71.11 110.521 177.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.68 ' HB2' ' O ' ' A' ' 165' ' ' LEU . 3.5 t-160 -61.95 -21.85 65.15 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.663 -0.699 . . . . 74.34 110.468 176.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -96.42 10.21 38.9 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.773 -0.648 . . . . 75.1 109.918 176.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . 0.519 ' CD2' ' HG2' ' A' ' 172' ' ' GLU . 73.9 t60 -116.68 -77.3 0.57 Allowed 'General case' 0 CA--C 1.531 0.247 0 CA-C-N 116.435 -0.348 . . . . 73.33 111.767 -178.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.713 ' HB2' ' HA ' ' A' ' 206' ' ' PRO . 8.3 pt-20 -161.22 -10.11 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 114.339 1.237 . . . . 73.35 114.339 -173.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.568 ' CD2' ' HB1' ' A' ' 201' ' ' ALA . 16.7 p90 -155.97 161.85 40.44 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 118.714 0.688 . . . . 74.14 111.229 -170.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.716 HG13 ' HE2' ' A' ' 204' ' ' TYR . 35.6 m -131.6 160.44 42.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.637 -0.71 . . . . 60.11 110.209 177.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -89.64 96.55 10.75 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.005 -1.109 . . . . 73.11 108.005 171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -68.02 -21.47 73.57 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 120.948 -0.644 . . . . 14.24 112.389 -173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 179' ' ' LYS . 25.1 t70 -121.26 98.49 6.0 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.039 0.447 . . . . 54.14 110.305 179.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.501 HG22 ' O ' ' A' ' 178' ' ' ILE . 30.5 mm -87.8 38.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 122.388 1.09 . . . . 73.34 109.274 177.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . 0.469 ' HB3' ' OD2' ' A' ' 177' ' ' ASP . 7.9 ttpm? -75.95 164.83 25.79 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 108.586 -0.894 . . . . 73.32 108.586 175.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.556 ' HB1' ' HB3' ' A' ' 138' ' ' LEU . . . -56.58 -15.87 5.12 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.562 0.579 . . . . 61.11 112.562 -177.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 179' ' ' LYS . 11.9 p -76.82 -15.43 59.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.731 0.301 . . . . 63.31 111.595 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.426 ' HB3' HD12 ' A' ' 183' ' ' LEU . 5.6 t-20 -83.2 -30.75 27.5 Favored 'General case' 0 C--O 1.24 0.586 0 CA-C-O 121.626 0.727 . . . . 71.3 110.346 -177.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.553 ' HG ' HD21 ' A' ' 195' ' ' LEU . 6.0 mp -96.11 110.9 23.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.999 -1.0 . . . . 75.33 110.695 -174.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.825 HD13 ' HB3' ' A' ' 137' ' ' ASP . 2.2 mm? -98.33 156.6 16.65 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.704 -0.68 . . . . 73.04 110.228 177.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 79.5 mt -119.27 159.13 24.68 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 109.512 -0.551 . . . . 63.22 109.512 176.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 189' ' ' ASN . 11.9 t30 -60.86 151.06 31.01 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.825 -1.176 . . . . 72.31 107.825 170.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -48.72 -27.83 3.18 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 113.085 0.772 . . . . 73.35 113.085 -166.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 44.7 tptt -156.58 34.93 0.31 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.244 0.545 . . . . 72.31 110.557 174.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . 0.703 ' HB3' ' HB3' ' A' ' 186' ' ' ASN . 5.0 t30 -126.08 103.5 26.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 N-CA-C 109.558 -0.534 . . . . 73.42 109.558 176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.4 ' O ' HD12 ' A' ' 339' ' ' LEU . 66.8 Cg_endo -72.61 -28.67 13.97 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 123.087 2.525 . . . . 61.11 114.337 -169.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -77.75 -6.84 55.4 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.759 -0.376 . . . . 75.35 111.156 -174.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.566 ' HA ' ' OE1' ' A' ' 192' ' ' GLN . 11.4 mm-40 -111.81 97.04 6.42 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.308 0.575 . . . . 55.14 110.837 -178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 7.3 p -103.76 130.07 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 CA-C-N 114.989 -1.005 . . . . 70.24 110.322 177.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.487 ' CD2' ' HE1' ' A' ' 134' ' ' PHE . 35.0 m-85 -124.43 147.38 48.33 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.063 -0.717 . . . . 70.42 109.063 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.553 HD21 ' HG ' ' A' ' 183' ' ' LEU . 49.4 mt -96.56 116.3 28.86 Favored 'General case' 0 C--N 1.321 -0.641 0 C-N-CA 120.593 -0.443 . . . . 52.41 110.814 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.579 HG23 ' CE2' ' A' ' 198' ' ' TYR . 2.7 p -148.43 87.35 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.817 0.818 . . . . 53.24 110.963 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -108.75 -50.91 2.95 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.125 -0.943 . . . . 60.43 109.493 174.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.579 ' CE2' HG23 ' A' ' 196' ' ' VAL . 18.5 m-85 51.51 35.02 13.39 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.494 -0.775 . . . . 72.05 110.705 -177.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.659 ' HA3' ' O ' ' A' ' 352' ' ' LYS . . . -154.27 -31.66 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.853 -1.067 . . . . 42.2 112.117 -179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 177' ' ' ASP . 25.7 mt -97.01 9.77 41.11 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.78 0.8 . . . . 54.23 108.855 177.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.568 ' HB1' ' CD2' ' A' ' 173' ' ' TYR . . . -97.46 111.67 23.83 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.831 -1.077 . . . . 73.23 110.528 -178.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -98.49 115.26 28.17 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.204 -0.453 . . . . 71.31 109.907 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.434 ' NH2' ' HB3' ' A' ' 206' ' ' PRO . 0.6 OUTLIER -87.74 114.54 24.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.54 0.686 . . . . 61.35 110.101 179.057 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.716 ' HE2' HG13 ' A' ' 174' ' ' VAL . 9.5 p90 -89.65 -41.57 11.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.142 -0.935 . . . . 71.32 111.527 -173.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 209' ' ' VAL . 78.0 m -153.04 108.18 2.65 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.599 -0.519 . . . . 64.43 109.599 -178.125 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.713 ' HA ' ' HB2' ' A' ' 172' ' ' GLU . 28.0 Cg_endo -63.32 84.05 0.12 Allowed 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.899 2.399 . . . . 70.42 113.628 -174.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 76.48 -11.54 1.15 Allowed 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 124.263 1.025 . . . . 74.44 110.574 176.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -105.92 51.65 0.74 Allowed Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.418 -1.073 . . . . 65.25 110.418 175.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . 0.694 ' HA ' ' HB2' ' A' ' 205' ' ' CYS . 3.4 p -48.88 111.55 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.742 0.782 . . . . 54.03 113.075 -176.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -164.13 70.9 0.21 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.032 -0.985 . . . . 54.12 109.003 172.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.578 ' HB2' ' SG ' ' A' ' 205' ' ' CYS . 47.2 tptt -139.54 111.06 7.11 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.473 -0.785 . . . . 73.14 109.402 -178.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -101.53 176.42 5.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.011 -0.54 . . . . 75.4 111.278 -174.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . 0.401 ' HA ' ' CG2' ' A' ' 236' ' ' VAL . 9.6 p90 -74.17 84.04 1.84 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.634 -0.712 . . . . 71.24 110.527 177.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -166.17 28.07 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.456 0.646 . . . . 71.31 109.771 -176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -127.64 144.5 51.07 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.972 0.415 . . . . 63.33 111.594 -174.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -173.82 91.76 0.34 Allowed Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.048 -0.978 . . . . 73.43 108.567 176.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -69.29 -51.69 0.41 Allowed 'Trans proline' 0 N--CA 1.462 -0.356 0 C-N-CA 122.14 1.894 . . . . 74.24 110.948 176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.803 ' HA ' ' HE3' ' A' ' 218' ' ' LYS . 0.1 OUTLIER -168.57 26.07 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.772 -0.825 . . . . 73.4 108.772 176.979 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.599 ' HA ' ' O ' ' A' ' 234' ' ' ASN . 99.0 mtt180 61.56 101.99 0.03 OUTLIER 'General case' 0 C--O 1.232 0.137 0 CA-C-N 114.971 -1.013 . . . . 64.44 111.652 -178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . . . . . . . . . 60.3 m -54.86 -36.12 64.75 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.821 -1.081 . . . . 72.44 112.416 -173.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 42.3 p-80 48.84 44.07 21.74 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.521 0.728 . . . . 71.12 111.945 178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . 0.612 ' OD1' HG21 ' A' ' 228' ' ' THR . 1.0 OUTLIER -40.65 -77.33 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 114.149 1.166 . . . . 62.43 114.149 176.675 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.405 ' O ' ' HE1' ' A' ' 233' ' ' HIS . . . -127.0 -116.35 2.01 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.449 -0.881 . . . . 41.11 114.229 -170.036 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . . . . . . . . . 4.9 m -92.1 110.67 22.05 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.369 0.267 . . . . 63.22 111.438 -173.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . . . . . . . . . 16.1 tt -58.36 -19.09 12.98 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 N-CA-C 111.88 0.326 . . . . 73.13 111.88 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -61.94 -61.83 2.21 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.44 -0.345 . . . . 74.33 110.642 179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.446 ' HD2' ' SG ' ' A' ' 250' ' ' CYS . 84.4 m-85 -86.15 -42.95 13.43 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.634 -0.257 . . . . 74.22 110.817 -177.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.612 HG21 ' OD1' ' A' ' 222' ' ' ASP . 26.0 m -57.91 -27.67 63.55 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.158 -0.474 . . . . 72.34 111.364 -177.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 233' ' ' HIS . 71.5 m 65.99 -170.01 0.2 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.592 -0.731 . . . . 73.12 111.463 178.502 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . 0.541 HD13 ' H ' ' A' ' 230' ' ' ILE . 0.1 OUTLIER -72.65 -33.89 45.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.805 -0.634 . . . . 73.53 112.218 -175.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.413 ' HA ' ' CG1' ' A' ' 236' ' ' VAL . 1.2 p-10 -58.09 -75.25 0.05 OUTLIER 'General case' 0 CA--C 1.535 0.39 0 N-CA-C 112.999 0.74 . . . . 63.54 112.999 -172.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.435 ' HB3' ' CG2' ' A' ' 228' ' ' THR . . . -62.04 -30.47 71.0 Favored 'General case' 0 CA--C 1.517 -0.327 0 CA-C-O 121.185 0.517 . . . . 54.51 111.346 -176.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.489 ' HB2' ' O ' ' A' ' 229' ' ' SER . 1.5 t60 -71.74 -23.92 61.7 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.855 -0.612 . . . . 73.31 111.043 -177.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.599 ' O ' ' HA ' ' A' ' 219' ' ' ARG . 6.3 m-20 -97.54 -15.19 20.65 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.022 0.439 . . . . 62.33 111.035 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 100.2 -9.95 59.72 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.294 -0.955 . . . . 54.45 112.689 177.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 231' ' ' ASP . 8.1 p -71.64 129.72 35.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 N-CA-C 109.639 -0.504 . . . . 74.14 109.639 176.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . . . . . . . . . . . -61.51 116.95 22.98 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.009 -0.541 . . . . 72.14 112.112 -174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -59.77 106.11 0.31 Allowed 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.779 2.319 . . . . 74.02 110.835 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 4.0 p -130.51 109.49 10.72 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.954 -0.566 . . . . 72.34 111.505 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.728 ' HG2' HG23 ' A' ' 312' ' ' THR . 2.2 mpt_? 76.66 -86.12 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.005 -0.998 . . . . 71.31 110.994 172.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.653 ' HD3' ' O ' ' A' ' 310' ' ' ASP . 21.6 ttp180 -69.58 -30.94 68.83 Favored 'General case' 0 C--O 1.221 -0.409 0 C-N-CA 120.297 -0.561 . . . . 73.21 110.172 -177.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . . . . . . . . . . . -62.14 -52.94 46.28 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.749 -0.738 . . . . 74.14 111.782 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.465 ' HB3' HD21 ' A' ' 165' ' ' LEU . 4.5 m-20 -53.84 -46.04 71.08 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-O 121.463 0.649 . . . . 63.03 110.327 178.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . 0.495 HD13 HD21 ' A' ' 320' ' ' LEU . 75.0 mt -71.75 -35.99 70.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.478 -0.783 . . . . 73.24 111.699 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -63.64 -39.95 95.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.895 0.378 . . . . 71.32 110.329 -178.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.42 HG23 ' O ' ' A' ' 227' ' ' PHE . 80.3 mt -64.85 -49.22 81.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.837 -0.62 . . . . 65.44 110.307 176.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.499 ' O ' ' HG3' ' A' ' 251' ' ' MET . 51.1 tp -58.81 -47.13 85.87 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.286 -0.415 . . . . 63.41 111.251 -179.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -62.46 -34.7 90.18 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.958 -0.639 . . . . 51.15 112.243 179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.429 ' CD2' ' HE3' ' A' ' 275' ' ' LYS . 24.0 t80 -62.72 -43.75 97.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.231 0.539 . . . . 74.03 109.811 177.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.446 ' SG ' ' HD2' ' A' ' 227' ' ' PHE . 60.5 m -61.67 -45.36 94.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.625 -0.716 . . . . 72.52 110.433 176.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 86.2 mtp -55.23 -52.97 61.67 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 115.943 -0.571 . . . . 65.11 111.612 -177.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . . . . . . . . . 13.9 tt -65.49 -37.16 79.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.489 -0.323 . . . . 63.45 111.124 -176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.444 HE21 ' CD1' ' A' ' 259' ' ' LEU . 15.4 mt-30 -69.14 -42.21 76.28 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.894 -0.322 . . . . 65.03 111.771 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 41.0 m0 -62.34 -31.84 72.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.699 0.285 . . . . 71.4 110.674 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 55.7 tp -82.16 -41.26 20.64 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.189 -0.459 . . . . 72.24 112.208 -177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 65.2 p -104.06 -29.11 11.1 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 112.767 0.654 . . . . 73.52 112.767 -170.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . 62.0 24.09 64.51 Favored Glycine 0 CA--C 1.523 0.535 0 C-N-CA 121.056 -0.592 . . . . 31.15 112.985 -177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 3.8 t60 -155.67 142.86 19.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 117.114 0.457 . . . . 75.35 109.937 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.444 ' CD1' HE21 ' A' ' 253' ' ' GLN . 20.4 mt -130.57 149.75 74.4 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 120.91 0.386 . . . . 74.44 111.272 176.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo -75.2 6.45 3.47 Favored 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 122.97 2.447 . . . . 74.34 112.926 176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . . . . . . . . . 43.1 p90 -143.45 24.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.695 0.283 . . . . 73.42 110.914 177.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.552 ' HA ' HD23 ' A' ' 265' ' ' LEU . 12.9 pt-20 -63.83 -30.38 71.47 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.362 0.504 . . . . 55.3 112.362 -176.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 266' ' ' LYS . 34.5 t70 -83.02 -25.61 32.01 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.379 -0.529 . . . . 73.24 109.796 175.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.83 ' HB3' ' HB3' ' A' ' 270' ' ' TYR . 95.2 m-20 -77.34 -3.78 41.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.782 -0.644 . . . . 73.55 110.469 -178.593 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.552 HD23 ' HA ' ' A' ' 262' ' ' GLU . 2.1 mm? -61.57 -18.56 59.81 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.802 -0.636 . . . . 65.4 110.592 172.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . 0.566 ' HD2' ' O ' ' A' ' 263' ' ' ASP . 6.0 ptmt -70.57 -19.27 62.89 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.651 -0.704 . . . . 71.01 111.604 -177.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.592 ' OD1' ' HG2' ' A' ' 269' ' ' LYS . 16.1 t70 -135.5 132.56 19.86 Favored Pre-proline 0 CA--C 1.531 0.227 0 CA-C-O 120.955 0.407 . . . . 63.32 111.38 -176.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.406 ' HA ' HG22 ' A' ' 271' ' ' VAL . 26.0 Cg_endo -62.24 -30.68 81.85 Favored 'Trans proline' 0 CA--C 1.534 0.499 0 C-N-CA 123.247 2.631 . . . . 52.4 114.494 -175.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . 0.592 ' HG2' ' OD1' ' A' ' 267' ' ' ASP . 7.3 ptpp? -73.57 -29.56 62.49 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.879 -0.728 . . . . 63.3 109.832 -176.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.83 ' HB3' ' HB3' ' A' ' 264' ' ' ASN . 54.3 m-85 -76.97 -44.35 31.55 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.729 -0.669 . . . . 74.22 111.451 -178.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.494 ' CG1' ' HA ' ' A' ' 265' ' ' LEU . 29.9 m -63.89 -35.8 74.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 C-N-CA 120.839 -0.345 . . . . 64.01 110.796 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -61.83 -57.49 11.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.057 0.456 . . . . 74.13 110.287 175.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -62.76 -49.74 73.81 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.335 -0.848 . . . . 75.13 111.127 -174.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . . . . . . . . . 20.1 m -63.11 -44.58 95.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 73.4 111.595 -175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . 0.429 ' HE3' ' CD2' ' A' ' 249' ' ' TYR . 68.5 tttt -66.04 -37.33 85.59 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.684 -0.406 . . . . 74.03 110.457 -176.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . . . . . . . . . 78.5 mt -69.01 -47.9 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.606 -0.27 . . . . 61.2 111.146 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . . . . . . . . . 44.9 mmt-85 -60.96 -40.71 94.39 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.798 0.332 . . . . 73.04 110.908 -178.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -73.4 -31.45 63.89 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.422 -0.354 . . . . 63.43 110.985 178.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . . . . . . . . . 10.3 mtp180 -67.45 -20.2 65.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.315 -0.402 . . . . 63.4 111.133 175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 6.3 tp10 -80.39 -35.59 35.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.457 -0.338 . . . . 65.03 110.79 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -123.23 47.51 1.98 Allowed 'General case' 0 N--CA 1.466 0.352 0 CA-C-O 120.814 0.34 . . . . 73.03 110.651 -177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . . . . . . . . . 78.0 mt -51.84 -52.84 20.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 N-CA-C 113.33 0.863 . . . . 54.14 113.33 -171.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . . . . . . . . . . . -62.83 -48.66 78.09 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.244 0.461 . . . . 70.22 112.244 -169.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 14.0 m -64.88 -48.41 74.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.219 0.533 . . . . 72.1 110.558 -177.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 76.6 mt -68.64 -54.4 16.64 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.523 -0.762 . . . . 65.22 111.674 -174.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 22.2 mmt -65.04 -43.34 92.71 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.57 0.211 . . . . 70.01 111.57 -173.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -68.42 -39.94 81.4 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.804 -0.359 . . . . 74.13 111.278 -176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -76.42 -20.73 56.8 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 120.99 -0.284 . . . . 71.41 111.377 -175.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . 0.473 ' O ' ' HD3' ' A' ' 291' ' ' PRO . 97.9 m -76.86 -16.35 59.44 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.062 0.458 . . . . 74.51 110.476 176.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.493 ' HE2' ' HB3' ' A' ' 294' ' ' ASN . 59.4 t80 -115.24 81.06 7.83 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.576 -0.527 . . . . 71.52 109.576 176.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 289' ' ' CYS . 91.1 Cg_endo -95.26 34.92 0.16 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 123.458 2.772 . . . . 63.03 112.13 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -82.18 -174.9 5.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.594 -0.73 . . . . 74.33 110.258 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 56.7 mmtt -89.28 13.17 14.06 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.106 0.479 . . . . 73.12 110.848 177.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.493 ' HB3' ' HE2' ' A' ' 290' ' ' PHE . 3.1 t-20 -105.88 -163.34 0.93 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 108.292 -1.003 . . . . 74.51 108.292 173.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.457 ' HE3' ' HB ' ' A' ' 331' ' ' ILE . 19.6 pttp -149.66 124.9 4.87 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.79 0.328 . . . . 75.43 111.208 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.417 ' HG3' ' HB3' ' A' ' 290' ' ' PHE . 65.3 Cg_endo -95.43 37.22 0.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.834 2.356 . . . . 54.02 111.88 174.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -67.42 -43.67 86.64 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.95 -0.643 . . . . 51.41 111.838 -177.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.721 ' HG3' ' HA3' ' A' ' 327' ' ' GLY . 1.4 mp0 -52.43 -46.49 66.42 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.029 0.442 . . . . 72.3 110.7 176.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . 0.426 HD12 ' N ' ' A' ' 299' ' ' ILE . 3.8 mp -71.97 -42.69 68.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.78 -0.645 . . . . 61.52 110.789 -177.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -59.19 -51.83 68.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.17 -0.468 . . . . 70.25 111.809 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.474 ' HE3' ' HB3' ' A' ' 301' ' ' LYS . 23.3 mtpp -75.07 -30.16 60.88 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.697 -0.401 . . . . 74.35 111.506 -177.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -55.45 -45.96 76.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.083 0.468 . . . . 61.42 110.134 171.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.579 ' HA ' HG22 ' A' ' 306' ' ' VAL . 72.1 mtp -72.28 -35.42 68.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.945 -0.57 . . . . 72.32 110.64 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -57.42 -44.33 84.53 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.577 0.703 . . . . 64.33 109.583 173.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . . . . . . . . . 54.8 m -61.13 -49.98 75.06 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 114.891 -1.05 . . . . 64.32 111.893 178.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 303' ' ' MET . 16.8 m -66.77 -27.53 40.19 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.201 0 CA-C-O 120.911 0.386 . . . . 75.12 110.758 -178.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . . . . . . . . . 23.9 tptm -65.25 -42.26 93.47 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.204 0.526 . . . . 75.2 110.042 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . . . . . . . . . 50.0 tp -71.37 -21.61 62.0 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.428 -0.805 . . . . 54.4 110.906 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.43 ' O ' HD23 ' A' ' 309' ' ' LEU . 6.3 tt -71.1 -14.75 62.41 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.043 -0.526 . . . . 63.44 110.291 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.653 ' O ' ' HD3' ' A' ' 241' ' ' ARG . 34.8 t70 67.56 -85.41 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 115.628 -0.715 . . . . 50.41 111.852 174.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -136.43 -51.93 0.7 Allowed 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.24 -0.652 . . . . 70.23 109.24 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.728 HG23 ' HG2' ' A' ' 240' ' ' ARG . 55.3 m -148.37 75.88 1.34 Allowed 'General case' 0 N--CA 1.446 -0.627 0 CA-C-N 115.786 -0.643 . . . . 74.11 111.358 176.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.419 ' HB2' ' HG ' ' A' ' 309' ' ' LEU . 51.1 mm-40 -83.3 -165.92 1.22 Allowed 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 108.106 -1.072 . . . . 74.22 108.106 162.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.451 ' C ' ' HD3' ' A' ' 314' ' ' LYS . 11.0 tmtt? -76.13 113.53 28.83 Favored Pre-proline 0 C--N 1.328 -0.366 0 N-CA-C 108.516 -0.92 . . . . 70.22 108.516 173.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.587 ' HG3' ' HG3' ' A' ' 240' ' ' ARG . 12.3 Cg_exo -68.43 117.46 4.98 Favored 'Trans proline' 0 N--CA 1.454 -0.801 0 C-N-CA 122.038 1.826 . . . . 72.24 110.966 -179.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . 0.514 ' HB3' ' HB3' ' A' ' 319' ' ' ASN . 95.6 mt -94.11 68.68 3.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.072 -0.513 . . . . 72.42 110.521 -177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -57.92 -32.86 68.18 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.211 -0.663 . . . . 64.35 109.211 176.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.48 ' H ' ' CD ' ' A' ' 318' ' ' GLU . 1.4 mp0 -58.01 -56.7 18.56 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.756 -1.111 . . . . 73.53 110.302 174.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . 0.514 ' HB3' ' HB3' ' A' ' 316' ' ' LEU . 26.2 t-20 -71.96 -33.17 67.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.614 -0.721 . . . . 75.44 111.734 -175.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.538 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 7.9 mp -61.28 -48.19 82.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.87 0.367 . . . . 72.24 111.058 178.253 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.534 ' HB2' HD11 ' A' ' 159' ' ' LEU . 15.4 ptp180 -72.01 -24.67 61.6 Favored 'General case' 0 C--N 1.327 -0.413 0 C-N-CA 120.325 -0.55 . . . . 65.0 109.951 178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -70.08 -49.02 55.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.979 -0.555 . . . . 73.05 110.989 177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . 0.406 HG22 ' O ' ' A' ' 320' ' ' LEU . 0.0 OUTLIER -62.68 -39.0 83.08 Favored 'Isoleucine or valine' 0 C--O 1.233 0.235 0 N-CA-C 110.066 -0.346 . . . . 75.04 110.066 -178.591 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.578 ' HB3' HD11 ' A' ' 155' ' ' LEU . 79.5 mt -62.33 -49.74 74.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.881 0.372 . . . . 62.0 110.527 178.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . 0.645 ' O ' ' HG3' ' A' ' 329' ' ' LYS . 4.1 mm? -70.15 -26.9 64.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.258 -0.428 . . . . 64.33 111.366 179.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -72.01 -43.54 64.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.918 0.389 . . . . 71.52 110.32 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.721 ' HA3' ' HG3' ' A' ' 298' ' ' GLU . . . -65.03 -36.04 92.57 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.825 -0.702 . . . . 61.34 111.798 177.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.645 HD22 HD22 ' A' ' 155' ' ' LEU . 17.4 tp -69.21 -29.93 68.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.835 0.35 . . . . 74.13 110.057 177.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 325' ' ' LEU . 62.3 mttp -65.28 -38.78 91.32 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.402 -0.363 . . . . 45.34 110.55 175.187 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -60.54 -34.28 73.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.755 -0.657 . . . . 74.05 111.655 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.457 ' HB ' ' HE3' ' A' ' 295' ' ' LYS . 15.2 tt -92.64 2.49 8.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.327 0.584 . . . . 63.51 110.375 -178.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 72.09 25.77 73.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.897 -0.668 . . . . 61.11 113.576 173.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . 0.512 ' O ' ' HG ' ' A' ' 328' ' ' LEU . 25.6 m -121.83 158.93 27.83 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 117.435 0.617 . . . . 62.34 111.272 -177.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -150.74 172.76 15.07 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.042 -0.725 . . . . 73.4 109.042 174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . 0.46 ' HA ' ' HE2' ' A' ' 152' ' ' LYS . 30.6 t70 -120.63 127.74 52.36 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.763 -0.458 . . . . 74.44 109.763 172.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -88.74 21.11 3.15 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.896 -0.593 . . . . 64.3 110.832 -176.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . . . . . . . . . . . 76.23 45.37 15.24 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 110.491 -1.043 . . . . 64.44 110.491 -174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -131.94 -32.96 1.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.559 -0.32 . . . . 71.42 111.716 -172.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.558 HD22 HG23 ' A' ' 153' ' ' THR . 78.2 mt 65.65 179.56 0.2 Allowed 'General case' 0 N--CA 1.464 0.236 0 O-C-N 123.496 0.497 . . . . 73.13 110.313 -173.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -179.48 82.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.154 0.502 . . . . 74.43 109.83 176.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 153' ' ' THR . 1.4 pp -106.98 -36.61 6.56 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.99 -0.55 . . . . 64.23 110.857 -177.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . 0.477 ' N ' HD12 ' A' ' 341' ' ' LEU . 77.3 p 178.33 -119.93 0.0 OUTLIER 'General case' 0 C--O 1.236 0.353 0 CA-C-N 115.819 -0.628 . . . . 74.05 109.584 177.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.437 ' O ' ' HB ' ' A' ' 344' ' ' VAL . 7.4 p -131.29 9.82 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 121.526 0.679 . . . . 74.14 109.287 179.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.437 ' HB ' ' O ' ' A' ' 343' ' ' VAL . 57.9 t 74.63 105.95 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-N 114.927 -1.033 . . . . 73.03 109.747 -175.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . 0.625 ' HG3' ' HB2' ' A' ' 145' ' ' ASN . 8.6 mm-40 -72.56 -54.5 9.0 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.64 -0.709 . . . . 75.23 112.724 -168.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . 0.862 ' HA ' ' HB3' ' A' ' 140' ' ' LYS . 4.8 m-20 74.06 115.26 0.06 Allowed 'General case' 0 N--CA 1.475 0.816 0 O-C-N 123.71 0.631 . . . . 74.31 110.699 -173.31 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . . . . . . . . . . . 151.78 64.9 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 111.136 -0.786 . . . . 52.31 111.136 -178.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 140' ' ' LYS . . . 170.99 132.1 1.43 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 121.057 -0.592 . . . . 62.41 112.008 -176.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . . . . . . . . . 5.6 tt -175.56 103.92 0.08 Allowed 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 109.904 -0.406 . . . . 55.22 109.904 179.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.829 ' HE2' ' HA ' ' A' ' 350' ' ' LYS . 7.4 mmpt? -146.42 115.03 6.8 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.304 -0.628 . . . . 72.0 109.304 176.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -130.87 171.63 12.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.983 0.42 . . . . 73.34 111.779 -174.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.659 ' O ' ' HA3' ' A' ' 199' ' ' GLY . 57.7 tptt -163.67 152.9 14.35 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.51 -0.922 . . . . 75.3 108.51 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 11.4 t -73.18 164.62 26.42 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-N 117.522 0.146 . . . . 74.43 110.656 178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.566 ' HA ' ' O ' ' A' ' 199' ' ' GLY . 0.2 OUTLIER -66.3 142.36 16.85 Favored 'Isoleucine or valine' 0 C--O 1.237 0.422 0 CA-C-O 120.921 0.391 . . . . 71.54 111.683 -174.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 8.0 t -75.36 134.84 40.89 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 109.766 -0.457 . . . . 71.1 109.766 172.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . 0.408 ' HD2' ' H ' ' A' ' 356' ' ' LYS . 0.0 OUTLIER -128.06 -61.07 1.12 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.646 0.736 . . . . 63.25 109.105 178.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -131.1 -166.32 1.68 Allowed 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.799 -1.091 . . . . 71.2 108.222 176.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . . . . . . . . . 13.2 ttm180 -77.49 86.18 3.85 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.539 -0.541 . . . . 63.12 109.539 176.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 48.6 tttm 76.44 -55.49 0.58 Allowed 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.065 -0.971 . . . . 73.4 111.03 -178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.562 -0.733 . . . . 72.13 110.301 176.788 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.9 ttt . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.436 -0.209 . . . . 74.04 110.436 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.58 138.99 39.33 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 122.685 2.257 . . . . 43.54 111.607 174.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -86.08 -46.49 10.42 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.157 -0.474 . . . . 74.5 111.396 -172.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 59.9 t -131.31 133.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 120.741 0.305 . . . . 54.03 111.418 -174.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -103.2 118.75 37.5 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.636 -0.875 . . . . 71.1 108.636 170.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -97.18 122.33 40.08 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.108 0.48 . . . . 73.33 112.123 -171.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -153.72 128.73 9.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.378 -0.828 . . . . 51.21 108.979 173.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -134.17 131.63 38.84 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.096 0.474 . . . . 73.51 111.466 -175.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -143.55 161.68 37.85 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.509 -0.769 . . . . 73.13 109.264 176.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -130.23 152.9 19.89 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.578 -0.82 . . . . 60.31 111.987 -179.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 55.1 mtp85 -83.58 134.08 34.83 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.98 0.419 . . . . 55.53 110.721 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 25.6 tt0 -139.48 114.72 9.71 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.437 -0.801 . . . . 71.52 109.425 -179.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.9 t -90.1 122.81 33.42 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.083 0.468 . . . . 63.32 111.218 -173.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 12.1 m -81.73 80.28 8.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.182 -0.673 . . . . 73.03 109.182 173.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.83 133.1 47.02 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.48 -0.782 . . . . 71.34 112.199 -172.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -117.09 126.61 53.1 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.562 -0.745 . . . . 65.22 109.774 175.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.99 122.45 47.59 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.092 -0.706 . . . . 74.04 109.092 178.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -89.61 85.72 6.55 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 120.407 -0.517 . . . . 71.34 110.533 -178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 4.3 tt -109.43 92.6 4.12 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.338 -0.986 . . . . 65.12 108.338 175.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -93.24 -71.66 0.64 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.965 -0.562 . . . . 62.04 111.295 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -120.81 152.05 38.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.125 0.488 . . . . 54.41 111.14 -175.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -80.05 72.12 6.81 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.768 -0.651 . . . . 74.41 109.948 178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 29.9 t80 -131.59 18.7 4.74 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.945 0.879 . . . . 75.31 109.32 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -156.7 -48.75 0.07 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 114.768 -1.105 . . . . 32.03 109.252 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.3 p -66.06 116.72 5.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.39 -0.823 . . . . 73.1 110.374 174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 98.52 -9.1 62.44 Favored Glycine 0 N--CA 1.447 -0.622 0 CA-C-N 115.776 -0.647 . . . . 63.23 112.547 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.608 ' O ' ' HA ' ' A' ' 38' ' ' LYS . 0.1 OUTLIER -69.61 138.37 53.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 73.12 111.091 178.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 3.9 mp -95.4 129.17 45.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.654 -0.703 . . . . 73.44 111.909 -172.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.408 HG13 ' HB2' ' A' ' 37' ' ' TRP . 31.3 pt -121.78 137.63 54.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.665 -0.698 . . . . 64.1 109.195 167.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 18.6 m -118.36 124.26 47.31 Favored 'General case' 0 C--N 1.323 -0.551 0 C-N-CA 121.107 -0.237 . . . . 41.01 111.238 -176.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.52 -177.93 4.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.459 -0.337 . . . . 71.11 110.482 178.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.74 -16.78 62.22 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.744 0.646 . . . . 71.52 112.744 -173.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.54 8.65 30.09 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.776 0.322 . . . . 65.2 110.525 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt 58.44 77.94 0.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.286 -0.87 . . . . 75.42 111.354 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 30' ' ' THR . 47.0 mmtm -136.09 125.18 24.43 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.071 -0.968 . . . . 71.11 108.73 173.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -88.18 85.45 6.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.008 0.432 . . . . 75.32 110.236 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.476 ' HA ' ' HA ' ' A' ' 56' ' ' MET . 45.1 m95 -79.34 117.04 19.96 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.887 -0.597 . . . . 72.11 109.479 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.608 ' HA ' ' O ' ' A' ' 27' ' ' GLU . 23.0 pttm -97.38 131.18 44.3 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 119.882 -0.727 . . . . 72.33 109.181 172.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.526 HG13 ' HB3' ' A' ' 52' ' ' TYR . 59.0 t -67.8 130.32 32.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.931 -0.577 . . . . 71.45 110.947 -177.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -95.15 -101.49 1.81 Allowed Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.752 -0.737 . . . . 63.35 111.78 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 42' ' ' PRO . 1.0 OUTLIER -84.41 121.96 75.18 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 121.049 0.452 . . . . 72.13 110.11 179.632 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 41' ' ' LEU . 7.4 Cg_exo -73.72 99.72 1.18 Allowed 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 123.034 2.49 . . . . 73.23 111.376 175.06 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.6 mt -79.94 -56.34 7.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.056 -0.52 . . . . 72.44 110.585 -177.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 95.84 -24.76 28.27 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.82 -0.705 . . . . 64.21 112.246 178.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 9.4 mm-40 -134.9 165.72 24.65 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.951 0.405 . . . . 74.54 111.266 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 166.62 52.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.613 0 CA-C-N 115.596 -0.729 . . . . 43.33 111.743 -178.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 79.4 16.79 77.42 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.923 -0.656 . . . . 53.24 112.892 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 37.6 t80 -168.22 -84.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 110.117 -0.327 . . . . 74.21 110.117 179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 164.28 144.92 4.2 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.283 -0.96 . . . . 14.14 112.67 179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' CYS . . . . . . . . . . . . . 63.8 m 62.67 61.15 1.23 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.323 0.582 . . . . 75.12 111.016 178.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.66 HD12 ' HB3' ' A' ' 71' ' ' LYS . 1.1 mm -118.31 138.29 49.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 CA-C-N 115.805 -0.634 . . . . 74.24 109.836 178.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.526 ' HB3' HG13 ' A' ' 39' ' ' VAL . 97.7 m-85 -122.28 154.13 37.99 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.53 0.205 . . . . 71.52 110.623 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.8 tt -84.95 132.37 34.37 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.914 -0.773 . . . . 62.34 108.914 177.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -102.29 98.9 8.96 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.037 0.446 . . . . 74.02 112.126 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -98.69 59.87 1.27 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.913 -0.585 . . . . 74.53 109.876 175.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 37' ' ' TRP . 22.3 ttm -36.52 -72.07 0.06 Allowed 'General case' 0 N--CA 1.471 0.608 0 O-C-N 124.162 0.914 . . . . 73.35 112.825 -175.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -178.57 -176.27 0.47 Allowed 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.322 -0.992 . . . . 75.43 108.322 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 10.3 m -70.76 123.67 22.49 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 109.574 -0.528 . . . . 70.04 109.574 177.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.58 ' HB3' ' HB ' ' A' ' 62' ' ' VAL . 16.0 t -105.63 176.95 5.0 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.162 -0.472 . . . . 63.43 110.238 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -70.32 -73.23 0.17 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.232 -0.44 . . . . 63.55 110.581 -178.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.5 t -112.25 66.9 0.65 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.411 0.624 . . . . 72.44 109.703 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.58 ' HB ' ' HB3' ' A' ' 59' ' ' SER . 12.6 p -81.62 145.15 9.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.675 -0.693 . . . . 55.42 110.16 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -66.61 165.48 40.6 Favored Glycine 0 N--CA 1.438 -1.176 0 N-CA-C 109.728 -1.349 . . . . 54.24 109.728 172.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.3 m -79.95 60.42 3.52 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.424 0.63 . . . . 74.34 110.045 -177.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -178.27 -120.03 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.636 -1.166 . . . . 72.42 108.664 -174.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -179.2 93.45 0.21 Allowed Pre-proline 0 C--N 1.32 -0.679 0 C-N-CA 123.811 0.844 . . . . 60.3 108.821 177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' O ' ' HA ' ' A' ' 132' ' ' ASP . 84.9 Cg_endo -82.59 39.05 0.79 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.751 2.3 . . . . 70.23 112.836 -174.581 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 70.9 m -136.81 137.57 39.91 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.577 0.704 . . . . 55.54 112.15 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 16.2 m -137.66 154.0 28.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.203 -0.908 . . . . 71.22 109.323 173.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.598 ' CG2' ' HB2' ' A' ' 128' ' ' PHE . 2.8 p -125.22 123.99 66.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.455 0.645 . . . . 74.43 111.746 -178.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.66 ' HB3' HD12 ' A' ' 51' ' ' ILE . 10.5 ptmm? -103.23 133.81 47.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.228 -0.896 . . . . 53.25 109.487 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.2 t -123.57 148.72 27.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 N-CA-C 112.082 0.401 . . . . 73.44 112.082 -169.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.453 ' HB3' ' HG ' ' A' ' 80' ' ' LEU . 31.9 tt0 -142.43 139.49 17.63 Favored Pre-proline 0 C--O 1.236 0.35 0 N-CA-C 108.43 -0.952 . . . . 73.42 108.43 171.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -63.39 176.19 2.26 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.312 2.008 . . . . 51.34 111.697 174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 61.2 m -79.53 41.5 0.48 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.112 0.482 . . . . 65.32 111.537 -177.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -84.06 -24.66 30.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.255 -0.43 . . . . 74.42 110.33 178.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 70.01 75.76 0.21 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.429 0.633 . . . . 72.1 110.371 178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.418 ' HA3' ' HD2' ' A' ' 79' ' ' PRO . . . -124.52 -128.21 3.25 Favored Glycine 0 N--CA 1.445 -0.711 0 CA-C-N 115.48 -0.782 . . . . 63.44 112.271 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.418 ' HD2' ' HA3' ' A' ' 78' ' ' GLY . 19.3 Cg_endo -59.95 -35.0 94.85 Favored 'Trans proline' 0 N--CA 1.466 -0.125 0 C-N-CA 122.874 2.383 . . . . 64.35 112.759 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.453 ' HG ' ' HB3' ' A' ' 73' ' ' GLU . 1.2 tm? -56.03 -50.01 72.12 Favored 'General case' 0 N--CA 1.465 0.296 0 O-C-N 123.122 0.264 . . . . 74.35 111.12 -176.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -67.21 -38.14 84.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.745 0.307 . . . . 73.44 111.063 -175.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 9.5 m -64.96 -46.84 79.83 Favored 'General case' 0 C--O 1.243 0.739 0 CA-C-O 121.561 0.696 . . . . 65.24 109.811 177.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.697 ' HG3' ' HB2' ' A' ' 198' ' ' TYR . 39.7 tt0 -60.77 -43.34 98.16 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-N 114.694 -1.139 . . . . 45.15 110.209 177.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -55.22 -48.64 73.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 75.4 110.796 -178.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 39.9 tttt -56.79 -58.5 7.83 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.046 0.451 . . . . 74.54 110.276 179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.417 ' HZ ' HG21 ' A' ' 168' ' ' ILE . 79.6 t80 -59.67 -51.32 70.31 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.27 -0.877 . . . . 74.42 111.388 -176.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 91.8 t80 -58.58 -47.16 85.23 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.343 -0.844 . . . . 70.12 111.648 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -68.32 -30.08 68.98 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.857 0.361 . . . . 74.45 111.103 -177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -74.33 -30.36 62.0 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.427 -0.351 . . . . 73.41 111.521 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ALA . . . . . . . . . . . . . . . -95.87 -34.37 11.87 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 112.468 0.544 . . . . 54.4 112.468 -175.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -89.47 88.98 7.66 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.389 0.515 . . . . 50.22 112.389 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LYS . . . . . 0.511 ' HE3' ' HB2' ' A' ' 95' ' ' GLN . 1.3 ttpp -146.12 105.86 4.16 Favored Pre-proline 0 C--N 1.325 -0.462 0 N-CA-C 108.989 -0.745 . . . . 53.4 108.989 171.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 -54.11 5.46 Favored 'Trans proline' 0 N--CA 1.476 0.474 0 C-N-CA 123.899 3.066 . . . . 72.14 115.041 -167.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.77 -33.62 66.43 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.899 0.381 . . . . 73.54 110.497 -175.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB2' ' HE3' ' A' ' 92' ' ' LYS . 26.0 tp60 -65.03 -47.94 75.63 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.853 -0.612 . . . . 55.22 110.016 177.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.482 HG13 ' O ' ' A' ' 92' ' ' LYS . 74.2 mt -58.98 -53.5 46.98 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.194 0 CA-C-N 115.676 -0.693 . . . . 65.42 110.685 178.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -54.0 -41.67 68.19 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.831 -0.622 . . . . 72.53 110.961 -176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -65.24 -53.18 48.19 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.145 -0.48 . . . . 73.34 111.502 -177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TRP . . . . . 0.424 ' CZ2' HD22 ' A' ' 108' ' ' LEU . 0.2 OUTLIER -72.91 -34.65 66.76 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 119.931 -0.708 . . . . 72.41 110.965 -175.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ILE . . . . . . . . . . . . . 21.4 mm -63.16 -45.17 99.23 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-O 120.666 0.27 . . . . 62.42 111.031 179.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 37.0 ttm180 -73.03 -27.9 62.03 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.807 0.337 . . . . 65.03 110.544 -178.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 58.8 m -75.75 -40.87 54.68 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 121.12 0.486 . . . . 75.33 110.574 176.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.73 ' HG3' HD13 ' A' ' 105' ' ' LEU . 31.1 tpt180 -72.55 -18.41 61.63 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.812 -0.631 . . . . 73.2 110.365 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.461 ' HA ' ' HD2' ' A' ' 104' ' ' LYS . 39.8 tptt 67.57 54.05 0.69 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 114.963 -1.017 . . . . 51.12 110.217 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . 0.73 HD13 ' HG3' ' A' ' 103' ' ' ARG . 2.7 mp -108.56 -167.57 1.24 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.824 -1.08 . . . . 75.04 109.449 175.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 5.2 mtpm? -100.11 -61.91 1.31 Allowed 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.098 -0.334 . . . . 72.04 110.098 -177.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -173.78 144.2 1.05 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.045 -0.525 . . . . 73.55 110.339 178.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' HG ' HG23 ' A' ' 110' ' ' VAL . 44.3 tp -79.43 115.0 18.81 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.968 -0.753 . . . . 63.22 108.968 175.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.478 ' HA3' ' NH2' ' A' ' 160' ' ' ARG . . . -77.42 60.24 3.63 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.019 -0.61 . . . . 71.04 113.098 -175.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.556 HG23 ' HG ' ' A' ' 108' ' ' LEU . 92.1 t -123.47 132.87 24.28 Favored Pre-proline 0 C--N 1.322 -0.59 0 N-CA-C 109.384 -0.598 . . . . 55.14 109.384 178.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_exo -51.69 152.83 12.21 Favored 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 123.103 2.535 . . . . 74.14 112.996 -179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 48.5 tttp -76.94 122.33 24.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.232 0.539 . . . . 74.23 110.674 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -80.74 111.77 17.49 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.257 -0.883 . . . . 72.14 110.276 178.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 130' ' ' ILE . 40.4 m95 -90.2 -59.28 2.23 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.49 -0.559 . . . . 74.32 109.49 176.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLY . . . . . . . . . . . . . . . -164.64 166.32 37.9 Favored Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.321 -0.854 . . . . 43.11 111.35 179.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 89.2 p -163.34 172.97 13.85 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.805 -0.443 . . . . 72.33 109.805 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 164.94 -173.01 40.78 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.124 -1.036 . . . . 75.24 112.271 178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.507 HD21 ' HB2' ' A' ' 125' ' ' SER . 8.6 tt -121.44 132.93 55.02 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 109.395 -0.595 . . . . 71.54 109.395 179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' HIS . . . . . . . . . . . . . 29.0 t60 -139.22 126.65 21.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.863 0.363 . . . . 72.11 110.422 -178.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.647 ' HA ' ' HA ' ' A' ' 125' ' ' SER . 21.6 t70 -75.68 126.75 31.61 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.803 -0.635 . . . . 71.4 110.487 177.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.861 ' HA ' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -83.45 -54.7 4.78 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.982 -0.377 . . . . 74.22 109.982 177.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -166.09 71.47 0.14 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.591 -0.522 . . . . 64.31 109.591 178.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 91.35 -19.08 49.32 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.831 -0.699 . . . . 73.31 111.632 -179.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 2.7 mptp? -113.76 120.0 39.3 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.124 -0.695 . . . . 64.45 109.124 175.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . 0.647 ' HA ' ' HA ' ' A' ' 120' ' ' ASP . 3.6 p -92.87 134.52 35.0 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.029 0.442 . . . . 71.44 110.813 -178.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -119.09 140.24 50.44 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.974 -0.557 . . . . 73.31 110.312 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ttt180 -105.61 124.56 49.75 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 109.083 -0.71 . . . . 70.43 109.083 173.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.598 ' HB2' ' CG2' ' A' ' 70' ' ' VAL . 48.7 p90 -122.29 154.42 37.61 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.075 -0.511 . . . . 62.15 110.869 -173.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.524 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 80.3 mtp -129.61 124.77 34.56 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.72 -0.673 . . . . 65.4 110.777 -177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ILE . . . . . 0.571 ' CD1' ' HB ' ' A' ' 70' ' ' VAL . 7.4 mm -98.13 121.02 48.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.187 -0.46 . . . . 63.34 110.461 176.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -133.25 178.09 7.17 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.38 -0.827 . . . . 74.01 109.321 177.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.612 ' HA ' ' O ' ' A' ' 67' ' ' PRO . 6.3 p-10 -68.13 154.96 40.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.947 0.403 . . . . 34.15 110.202 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.7 ttp85 -83.26 122.99 29.15 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.385 0.612 . . . . 71.11 112.118 -171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PHE . . . . . 0.444 ' CE1' ' HB2' ' A' ' 194' ' ' TYR . 90.2 m-85 -102.8 171.55 7.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.195 -0.911 . . . . 73.13 109.121 173.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -155.25 -30.43 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 119.886 -1.15 . . . . 65.01 113.24 -179.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' SER . . . . . 0.789 ' HB2' ' HB2' ' A' ' 185' ' ' LEU . 49.9 m -105.27 125.67 51.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 117.048 0.424 . . . . 60.01 112.057 -174.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.457 ' HA ' HD13 ' A' ' 184' ' ' LEU . 3.9 m-20 -88.91 124.14 33.94 Favored 'General case' 0 CA--C 1.515 -0.385 0 CA-C-N 115.805 -0.634 . . . . 75.1 109.543 175.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.47 ' HB3' ' O ' ' A' ' 180' ' ' ALA . 13.4 tp -64.35 -26.26 68.4 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.221 0.534 . . . . 73.4 109.768 178.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.554 ' HA ' ' CD2' ' A' ' 142' ' ' TYR . 28.2 tt0 -62.9 -48.7 77.84 Favored 'General case' 0 C--N 1.334 -0.086 0 CA-C-N 115.787 -0.642 . . . . 71.21 110.977 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.74 ' HA ' ' HE2' ' A' ' 140' ' ' LYS . 9.0 mmpt? -70.07 -29.79 66.88 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.225 -0.443 . . . . 54.13 110.233 -177.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.525 HG21 HD12 ' A' ' 341' ' ' LEU . 82.3 mt -65.09 -48.98 81.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.653 -0.703 . . . . 73.41 110.993 176.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . 0.554 ' CD2' ' HA ' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -66.77 -32.12 73.21 Favored 'General case' 0 C--O 1.222 -0.379 0 C-N-CA 119.866 -0.734 . . . . 74.34 109.68 179.65 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -66.05 -38.9 89.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.81 0.338 . . . . 73.32 110.69 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ALA . . . . . . . . . . . . . . . -71.8 -32.6 67.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.175 -0.466 . . . . 61.24 111.917 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -104.55 6.09 34.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.008 0.432 . . . . 64.14 110.906 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 57.57 54.9 6.02 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.706 -0.679 . . . . 71.53 112.257 178.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.484 ' O ' ' HA2' ' A' ' 257' ' ' GLY . 46.3 mtmt 55.59 53.44 9.64 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.365 -0.834 . . . . 75.24 112.569 176.132 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -123.46 96.41 4.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.89 -0.596 . . . . 74.42 109.87 173.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.653 ' HB2' ' HB3' ' A' ' 254' ' ' TRP . 21.7 m-85 -102.14 132.21 48.17 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.202 -0.454 . . . . 62.34 111.016 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 20.3 m -58.2 144.96 38.91 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.504 -0.771 . . . . 74.14 109.628 174.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.501 ' NH1' ' HB3' ' A' ' 294' ' ' ASN . 45.9 ttt85 -59.92 -37.9 80.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.686 -0.234 . . . . 62.12 111.51 -172.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . 0.545 ' HG3' ' N ' ' A' ' 153' ' ' THR . 11.9 ptpt -61.67 -38.19 86.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.89 0.376 . . . . 62.25 110.253 178.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.545 ' N ' ' HG3' ' A' ' 152' ' ' LYS . 9.0 m -68.0 -45.37 74.27 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.106 -0.497 . . . . 61.4 110.436 -178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 50.6 t -61.89 -47.34 93.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.385 -0.37 . . . . 72.32 110.585 178.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.784 ' HG ' ' HB2' ' A' ' 328' ' ' LEU . 0.2 OUTLIER -62.84 -52.4 63.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.878 -0.601 . . . . 74.44 110.545 -176.333 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -63.48 -33.52 75.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.587 0.232 . . . . 74.2 110.812 -178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 161' ' ' ILE . 2.7 mp -65.94 -51.21 60.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.311 -0.404 . . . . 70.01 110.681 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 247' ' ' LEU . 36.3 p -58.18 -37.16 74.22 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 121.075 -0.25 . . . . 43.42 110.902 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.542 ' HG ' ' O ' ' A' ' 155' ' ' LEU . 74.5 mt -60.33 -54.39 46.21 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.516 -0.311 . . . . 75.21 111.219 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.497 HH11 HD13 ' A' ' 161' ' ' ILE . 0.1 OUTLIER -66.57 -15.76 63.66 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.118 0.485 . . . . 70.44 111.0 -178.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 157' ' ' LEU . 37.4 mm -72.35 -42.41 65.29 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.452 -0.573 . . . . 63.11 109.452 172.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.524 ' HB3' ' HE1' ' A' ' 317' ' ' TYR . 2.2 mm? -62.04 -42.21 98.93 Favored 'General case' 0 CA--C 1.52 -0.173 0 CA-C-N 116.62 -0.263 . . . . 73.42 110.459 175.18 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -48.97 -63.03 1.22 Allowed 'General case' 0 C--O 1.243 0.761 0 CA-C-O 121.6 0.714 . . . . 64.22 110.703 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . 0.429 ' O ' HG23 ' A' ' 168' ' ' ILE . 18.1 tt -68.16 -41.4 84.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.234 -0.894 . . . . 64.15 111.565 -174.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.532 HD13 ' HB3' ' A' ' 243' ' ' ASP . 30.9 mt -63.66 -39.02 93.29 Favored 'General case' 0 CA--C 1.518 -0.257 0 C-N-CA 120.516 -0.474 . . . . 72.0 110.885 -178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.469 ' HA ' ' NE2' ' A' ' 169' ' ' HIS . 7.5 tp10 -57.28 -56.68 18.63 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.819 -0.438 . . . . 71.53 109.819 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -56.8 -42.94 80.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.473 -0.785 . . . . 74.24 112.078 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.533 HD12 ' HA ' ' A' ' 174' ' ' VAL . 28.1 pt -80.7 -40.23 18.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 112.943 0.719 . . . . 54.01 112.943 -170.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' HIS . . . . . 0.469 ' NE2' ' HA ' ' A' ' 166' ' ' GLU . 1.3 p-80 -75.89 -17.83 59.64 Favored 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 119.696 -0.802 . . . . 73.22 111.253 -177.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -95.3 16.33 17.0 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.028 0.442 . . . . 71.3 109.966 173.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' HIS . . . . . . . . . . . . . 28.3 t60 -136.95 -89.01 0.28 Allowed 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 116.106 -0.497 . . . . 65.33 110.88 177.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -147.56 114.96 6.29 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.615 0.245 . . . . 73.24 110.711 -177.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' TYR . . . . . 0.612 ' HB3' ' HB1' ' A' ' 201' ' ' ALA . 64.8 m-85 76.26 157.43 0.19 Allowed 'General case' 0 N--CA 1.471 0.602 0 O-C-N 124.237 0.961 . . . . 74.43 112.35 169.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 201' ' ' ALA . 22.2 m -142.33 172.41 8.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.394 -0.821 . . . . 72.2 109.594 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' HIS . . . . . 0.687 ' CE1' ' HB2' ' A' ' 200' ' ' LEU . 14.2 t60 -119.9 103.12 9.06 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.984 -0.286 . . . . 54.11 110.414 -176.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.503 ' HA2' HD13 ' A' ' 246' ' ' ILE . . . -73.71 -46.93 22.33 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.847 -0.692 . . . . 51.4 112.114 -178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . 0.954 ' HB2' ' HA3' ' A' ' 223' ' ' GLY . 24.9 t70 -65.58 94.31 0.19 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.146 0.498 . . . . 72.33 110.281 176.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.466 HD11 HD12 ' A' ' 161' ' ' ILE . 8.3 tp -97.45 14.69 3.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.759 -0.655 . . . . 61.44 110.605 -176.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -53.6 146.28 13.45 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.2 -0.455 . . . . 71.52 110.072 -178.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' A' ' 138' ' ' LEU . . . -60.98 -10.65 6.13 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.807 0.669 . . . . 75.01 112.807 -173.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' SER . . . . . . . . . . . . . 6.9 p -73.79 -15.93 61.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.983 0.42 . . . . 71.41 110.826 176.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.466 ' O ' HD12 ' A' ' 195' ' ' LEU . 41.3 m-80 -85.77 -16.67 38.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.029 -0.532 . . . . 75.41 110.751 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 6.5 mp -105.73 115.0 29.5 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.972 -0.558 . . . . 35.44 110.253 -176.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 137' ' ' ASP . 4.0 mm? -110.69 135.21 51.64 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.914 -0.585 . . . . 63.54 110.229 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.789 ' HB2' ' HB2' ' A' ' 136' ' ' SER . 89.9 mt -85.54 137.59 32.78 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.954 -0.567 . . . . 63.31 109.853 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -62.58 135.13 57.24 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.941 -0.572 . . . . 63.54 109.893 177.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -56.0 -33.54 64.97 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.847 -0.615 . . . . 73.11 112.126 -177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -81.86 -54.21 5.54 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.879 0.371 . . . . 71.0 110.812 179.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -113.1 112.83 49.6 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.446 -0.343 . . . . 62.4 111.531 -177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_exo -70.36 -10.56 28.35 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.845 2.363 . . . . 64.22 111.138 175.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . 0.581 ' HB2' ' HA ' ' A' ' 338' ' ' LYS . 5.0 p-10 -88.67 0.67 56.19 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.433 -0.803 . . . . 65.43 110.592 177.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLN . . . . . 0.542 ' HB3' ' CE2' ' A' ' 194' ' ' TYR . 77.4 mt-30 -114.07 102.64 10.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.044 -0.526 . . . . 62.22 110.081 177.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 6.3 p -106.79 120.59 58.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.319 0.58 . . . . 73.25 110.703 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' TYR . . . . . 0.542 ' CE2' ' HB3' ' A' ' 192' ' ' GLN . 93.3 m-85 -117.12 157.81 25.29 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.114 -0.494 . . . . 74.41 110.312 -178.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.466 HD12 ' O ' ' A' ' 182' ' ' ASN . 31.6 tp -96.91 150.55 20.63 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.272 -0.422 . . . . 44.22 110.454 -175.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.553 HG13 ' N ' ' A' ' 197' ' ' ASP . 3.0 p -136.39 -155.46 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.04 -0.726 . . . . 62.13 109.04 178.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.553 ' N ' HG13 ' A' ' 196' ' ' VAL . 9.2 t70 72.24 -78.37 0.05 OUTLIER 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.318 0.647 . . . . 72.32 109.706 -176.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . 0.697 ' HB2' ' HG3' ' A' ' 83' ' ' GLU . 36.1 m-85 55.92 -7.95 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 114.246 1.202 . . . . 74.34 114.246 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.489 ' H ' ' C ' ' A' ' 197' ' ' ASP . . . -72.72 -31.43 62.59 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.949 -0.861 . . . . 53.33 110.949 177.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.687 ' HB2' ' CE1' ' A' ' 175' ' ' HIS . 92.0 mt -89.06 53.53 2.7 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.069 0.462 . . . . 71.44 110.307 176.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ALA . . . . . 0.612 ' HB1' ' HB3' ' A' ' 173' ' ' TYR . . . -98.75 99.0 10.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.999 -0.546 . . . . 62.42 110.163 175.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -122.35 104.57 9.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 75.51 111.888 -171.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ARG . . . . . 0.572 ' HB2' HG22 ' A' ' 174' ' ' VAL . 31.9 ttm180 -178.73 -73.99 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.077 -0.51 . . . . 72.12 110.44 172.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' TYR . . . . . 0.507 ' H ' ' HA ' ' A' ' 173' ' ' TYR . 81.9 t80 70.61 112.4 0.05 Allowed 'General case' 0 N--CA 1.458 -0.073 0 O-C-N 124.036 0.835 . . . . 72.23 111.044 -179.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' CYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 206' ' ' PRO . 56.6 m -116.07 100.89 53.89 Favored Pre-proline 0 C--N 1.318 -0.786 0 N-CA-C 109.056 -0.72 . . . . 73.31 109.056 176.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 205' ' ' CYS . 11.5 Cg_endo -55.41 107.4 0.24 Allowed 'Trans proline' 0 C--O 1.236 0.397 0 C-N-CA 122.471 2.114 . . . . 63.14 111.818 -177.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLU . . . . . 0.415 ' HB2' ' O ' ' A' ' 206' ' ' PRO . 11.2 mm-40 72.29 16.05 5.18 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.84 -0.618 . . . . 70.24 110.746 177.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 91.72 -10.55 74.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.891 -0.671 . . . . 50.12 111.878 -177.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' VAL . . . . . . . . . . . . . 43.3 t -91.3 111.61 24.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.886 0.374 . . . . 73.41 110.015 -179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' HIS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 238' ' ' PRO . 24.7 p80 -87.55 147.16 25.46 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.213 -0.448 . . . . 73.1 110.947 -176.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' LYS . . . . . 0.43 ' HB2' ' HG2' ' A' ' 238' ' ' PRO . 53.6 mtpt -71.35 166.63 21.24 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 73.42 110.168 173.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.437 ' H ' ' HG2' ' A' ' 212' ' ' GLU . 8.6 pt-20 -82.7 174.34 11.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.048 -0.524 . . . . 61.32 109.852 174.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' TYR . . . . . . . . . . . . . 7.1 p90 -74.96 88.54 2.36 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.953 0.882 . . . . 74.11 110.66 -177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LYS . . . . . . . . . . . . . 68.0 mmtt -138.85 12.69 2.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.266 -0.879 . . . . 44.01 110.494 -178.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' GLU . . . . . 1.082 ' HB2' ' HA ' ' A' ' 236' ' ' VAL . 4.1 mm-40 -102.52 118.04 36.01 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.996 0.427 . . . . 72.44 111.472 -171.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 44.9 t0 -150.41 82.75 6.18 Favored Pre-proline 0 C--N 1.321 -0.65 0 N-CA-C 108.84 -0.8 . . . . 75.41 108.84 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -74.14 -51.82 0.14 Allowed 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.297 1.998 . . . . 74.31 111.474 179.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LYS . . . . . 0.42 ' O ' ' HB2' ' A' ' 219' ' ' ARG . 75.0 mmtt -146.78 6.02 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.826 -0.625 . . . . 74.54 110.161 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ARG . . . . . 0.615 ' HA ' ' O ' ' A' ' 234' ' ' ASN . 8.3 mtm-85 63.75 94.42 0.05 Allowed 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.976 0.893 . . . . 55.31 108.64 -162.098 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' CYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 233' ' ' HIS . 66.0 m -79.19 -168.53 1.52 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.076 -1.42 . . . . 72.22 113.069 -165.327 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' HIS . . . . . . . . . . . . . 57.3 t60 -178.48 93.81 0.03 OUTLIER 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 113.712 -1.586 . . . . 71.04 108.246 -173.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' ASP . . . . . . . . . . . . . 12.4 p-10 -76.69 -64.74 1.05 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.197 -0.456 . . . . 63.44 111.768 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLY . . . . . 0.954 ' HA3' ' HB2' ' A' ' 177' ' ' ASP . . . -109.51 -104.17 2.86 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.75 -0.738 . . . . 74.34 112.81 -175.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' THR . . . . . 0.525 ' O ' ' HB ' ' A' ' 228' ' ' THR . 2.2 p -89.82 146.99 24.05 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.671 0.272 . . . . 63.1 110.525 178.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ILE . . . . . 0.514 HD13 ' O ' ' A' ' 225' ' ' ILE . 0.0 OUTLIER -68.22 -27.75 38.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 120.745 0.307 . . . . 74.22 110.548 -175.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -74.0 -55.74 5.78 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.487 -0.324 . . . . 52.05 110.14 179.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' PHE . . . . . 0.415 ' HB3' HG22 ' A' ' 178' ' ' ILE . 90.8 m-85 -86.15 3.16 44.01 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 112.017 0.377 . . . . 74.33 112.017 -169.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 232' ' ' ALA . 6.8 t -77.71 -6.02 52.52 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.94 0.4 . . . . 72.24 110.517 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.571 ' HA ' ' HE2' ' A' ' 249' ' ' TYR . 41.9 t 65.96 173.36 0.23 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.147 0.499 . . . . 75.15 111.168 177.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' ILE . . . . . . . . . . . . . 68.1 mt -70.7 -34.84 58.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.222 0.534 . . . . 73.41 109.57 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -64.79 -62.43 1.57 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.281 -0.872 . . . . 73.32 112.294 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 228' ' ' THR . . . -65.43 -28.38 69.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.789 0.328 . . . . 54.53 110.939 -177.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' HIS . . . . . 0.531 ' HB2' HG23 ' A' ' 228' ' ' THR . 14.3 t-80 -74.82 -17.82 60.55 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.381 -0.372 . . . . 61.51 110.719 176.456 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.615 ' O ' ' HA ' ' A' ' 219' ' ' ARG . 2.7 t-20 -82.94 -30.06 28.65 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 108.693 -0.855 . . . . 63.1 108.693 170.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . 0.429 ' HA2' ' HB2' ' A' ' 220' ' ' CYS . . . 109.75 -9.1 32.16 Favored Glycine 0 N--CA 1.442 -0.921 0 CA-C-N 115.237 -0.892 . . . . 55.32 112.392 176.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' VAL . . . . . 1.082 ' HA ' ' HB2' ' A' ' 215' ' ' GLU . 5.3 p -62.04 109.0 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-O 121.619 0.723 . . . . 75.43 110.172 177.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' ALA . . . . . 0.706 ' HB3' ' HD3' ' A' ' 238' ' ' PRO . . . -67.46 -61.43 4.54 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 54.31 112.433 -174.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.706 ' HD3' ' HB3' ' A' ' 237' ' ' ALA . 31.5 Cg_endo -93.79 73.08 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.673 2.248 . . . . 55.01 113.573 -172.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' SER . . . . . . . . . . . . . 35.9 t -132.46 110.42 10.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.795 0.331 . . . . 42.5 110.701 178.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' ARG . . . . . 0.453 ' HA ' ' OD1' ' A' ' 243' ' ' ASP . 29.8 ttt180 -66.73 -16.91 64.57 Favored 'General case' 0 C--O 1.239 0.502 0 CA-C-O 121.552 0.692 . . . . 65.33 110.492 -179.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . 0.962 ' HG3' ' HA ' ' A' ' 311' ' ' TYR . 0.0 OUTLIER -55.53 -43.36 75.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.904 -1.043 . . . . 75.33 109.61 175.334 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' GLY . . . . . 0.487 ' O ' HG13 ' A' ' 246' ' ' ILE . . . -63.74 -46.32 92.22 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 115.128 -0.942 . . . . 64.21 112.423 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ASP . . . . . 0.532 ' HB3' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -47.28 -51.57 18.65 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.645 0.736 . . . . 65.54 110.358 -179.666 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' LEU . . . . . . . . . . . . . 83.6 mt -73.4 -31.95 64.18 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.858 -1.065 . . . . 72.34 111.956 -173.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -73.96 -38.66 64.14 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 120.7 -0.4 . . . . 65.52 110.547 178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ILE . . . . . 0.503 HD13 ' HA2' ' A' ' 176' ' ' GLY . 90.9 mt -58.69 -48.38 86.07 Favored 'Isoleucine or valine' 0 C--O 1.24 0.567 0 CA-C-O 121.375 0.607 . . . . 64.22 110.59 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.538 HD13 HG21 ' A' ' 161' ' ' ILE . 57.7 tp -59.73 -41.03 89.99 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.645 -0.707 . . . . 74.32 110.06 176.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.427 ' O ' HG22 ' A' ' 252' ' ' ILE . . . -54.84 -41.98 77.71 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.01 -0.614 . . . . 75.4 112.111 177.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' TYR . . . . . 0.571 ' HE2' ' HA ' ' A' ' 229' ' ' SER . 19.4 m-30 -55.94 -59.49 4.81 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-O 120.808 0.337 . . . . 71.32 111.026 177.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' CYS . . . . . 0.525 ' SG ' HD12 ' A' ' 247' ' ' LEU . 25.6 p -62.35 -36.15 81.32 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 120.552 -0.459 . . . . 51.44 111.32 -175.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' MET . . . . . 0.4 ' HG3' ' O ' ' A' ' 247' ' ' LEU . 92.2 mtp -60.99 -54.39 45.51 Favored 'General case' 0 C--O 1.237 0.432 0 CA-C-O 120.667 0.27 . . . . 54.55 111.278 -179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 248' ' ' GLY . 8.9 tt -68.36 -36.49 75.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 C-N-CA 120.887 -0.325 . . . . 64.22 110.677 -177.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -66.17 -34.69 78.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.573 0.225 . . . . 53.44 111.348 -177.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' TRP . . . . . 0.653 ' HB3' ' HB2' ' A' ' 149' ' ' PHE . 39.0 m0 -75.77 -27.39 58.01 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.797 0.332 . . . . 74.12 110.991 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' LEU . . . . . . . . . . . . . 24.2 tp -84.24 -31.52 24.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.347 -0.388 . . . . 74.41 111.72 -178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' THR . . . . . . . . . . . . . 81.3 p -101.73 -20.95 14.75 Favored 'General case' 0 C--N 1.329 -0.308 0 O-C-N 122.06 -0.4 . . . . 73.13 111.52 -176.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.484 ' HA2' ' O ' ' A' ' 147' ' ' LYS . . . 85.11 -19.58 21.33 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.9 -0.667 . . . . 75.44 112.851 178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.9 143.65 18.46 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.785 -0.45 . . . . 61.55 109.785 -176.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' LEU . . . . . 0.682 ' HB2' ' HB3' ' A' ' 262' ' ' GLU . 86.6 mt -119.58 141.76 31.55 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 110.132 -0.321 . . . . 63.41 110.132 175.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 259' ' ' LEU . 48.1 Cg_exo -57.08 -45.68 34.08 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 123.031 2.487 . . . . 63.02 112.504 -178.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' TRP . . . . . 0.617 ' HB2' ' HA ' ' A' ' 271' ' ' VAL . 36.8 p90 -80.29 -17.87 50.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.904 -0.589 . . . . 72.13 110.755 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' GLU . . . . . 0.682 ' HB3' ' HB2' ' A' ' 259' ' ' LEU . 1.8 tm-20 -77.7 -35.31 52.26 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.294 0.569 . . . . 70.43 109.763 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -68.52 -34.53 76.04 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.317 0.58 . . . . 54.11 110.041 175.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -108.45 24.76 12.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.466 -0.788 . . . . 73.52 111.992 -175.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.439 ' HA ' HG13 ' A' ' 271' ' ' VAL . 3.4 pp -71.81 -1.33 13.74 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 120.756 0.312 . . . . 74.34 111.666 -177.343 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -73.54 -6.25 45.31 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.469 -0.332 . . . . 74.52 110.747 179.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASP . . . . . 0.61 ' HB3' ' HD2' ' A' ' 270' ' ' TYR . 33.0 t70 -139.06 125.56 12.59 Favored Pre-proline 0 C--N 1.327 -0.41 0 N-CA-C 110.108 -0.33 . . . . 64.0 110.108 176.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 267' ' ' ASP . 36.4 Cg_exo -60.4 -21.71 68.68 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 123.306 2.671 . . . . 72.43 113.981 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -68.87 -39.39 79.85 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 120.726 -0.39 . . . . 44.53 110.17 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' TYR . . . . . 0.61 ' HD2' ' HB3' ' A' ' 267' ' ' ASP . 44.8 m-85 -65.88 -50.45 64.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.942 -0.572 . . . . 73.12 111.456 -178.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' VAL . . . . . 0.617 ' HA ' ' HB2' ' A' ' 261' ' ' TRP . 30.0 m -63.3 -35.18 71.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 C-N-CA 120.992 -0.283 . . . . 74.01 111.201 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ARG . . . . . 0.456 ' O ' HG13 ' A' ' 276' ' ' ILE . 38.8 ttp180 -63.17 -62.65 1.56 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.987 0.422 . . . . 71.11 110.408 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ASP . . . . . 0.488 ' O ' ' HG3' ' A' ' 277' ' ' ARG . 11.2 t70 -62.99 -44.41 96.11 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.515 -0.766 . . . . 71.04 111.352 -172.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' SER . . . . . 0.478 ' O ' ' HD1' ' A' ' 278' ' ' TYR . 25.1 m -61.18 -47.41 86.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.308 -0.406 . . . . 60.32 111.225 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -65.8 -36.63 84.05 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.79 -0.364 . . . . 72.23 111.132 -178.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 272' ' ' ARG . 73.5 mt -60.38 -42.65 91.66 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.601 0.238 . . . . 74.1 110.585 177.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ARG . . . . . 0.488 ' HG3' ' O ' ' A' ' 273' ' ' ASP . 57.2 mtt180 -61.14 -44.5 97.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.404 -0.362 . . . . 64.1 110.755 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' TYR . . . . . 0.478 ' HD1' ' O ' ' A' ' 274' ' ' SER . 35.7 m-85 -69.86 -43.67 71.43 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.133 -0.485 . . . . 74.14 112.057 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' ARG . . . . . 0.493 ' O ' ' HE2' ' A' ' 307' ' ' LYS . 2.3 ptm180 -67.99 -25.21 65.31 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 120.908 -0.317 . . . . 65.44 111.347 -178.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -85.5 -42.79 14.12 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.872 0.368 . . . . 74.34 110.803 -177.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' ASN . . . . . 0.81 HD22 HD23 ' A' ' 285' ' ' LEU . 9.5 t30 -130.51 87.45 2.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.138 0.494 . . . . 73.31 110.351 -177.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ILE . . . . . 0.581 HD13 ' H ' ' A' ' 282' ' ' ILE . 0.2 OUTLIER -81.64 -40.67 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 113.428 0.899 . . . . 61.42 113.428 -172.0 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ALA . . . . . 0.42 ' N ' HG12 ' A' ' 282' ' ' ILE . . . -65.89 -51.35 59.51 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 113.345 0.868 . . . . 55.24 113.345 -163.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 4.7 p -77.04 -28.89 55.0 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.574 -0.45 . . . . 74.11 110.944 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.81 HD23 HD22 ' A' ' 281' ' ' ASN . 1.9 mm? -64.95 -54.97 22.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 73.44 110.458 178.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' MET . . . . . . . . . . . . . 24.6 mmt -63.47 -39.67 95.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.602 -0.272 . . . . 75.33 111.316 -177.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -62.84 -38.29 90.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.296 -0.411 . . . . 74.2 111.486 -179.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' LYS . . . . . . . . . . . . . 27.8 mtpp -91.75 -20.31 21.67 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.728 0.64 . . . . 74.24 112.728 -175.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' CYS . . . . . . . . . . . . . 81.5 m -65.25 -44.9 86.64 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.748 0.309 . . . . 75.02 111.199 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' PHE . . . . . 0.429 ' CZ ' ' HB3' ' A' ' 296' ' ' PRO . 17.5 p90 -136.82 89.74 17.16 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-O 122.002 0.906 . . . . 65.21 110.77 176.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -83.11 49.43 3.03 Favored 'Trans proline' 0 N--CA 1.461 -0.433 0 C-N-CA 122.856 2.371 . . . . 71.11 111.986 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' GLU . . . . . 0.439 ' CD ' ' H ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -100.39 -145.59 0.34 Allowed 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.332 -0.395 . . . . 64.15 110.807 -178.332 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' LYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 293' ' ' LYS . 70.1 mmtt -120.03 17.29 12.49 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.646 0.98 . . . . 62.13 113.646 -166.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.501 ' HB3' ' NH1' ' A' ' 151' ' ' ARG . 14.6 m-80 -93.13 -15.99 25.41 Favored 'General case' 0 C--N 1.323 -0.557 0 O-C-N 122.184 -0.323 . . . . 65.55 110.345 173.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 294' ' ' ASN . 11.4 mptt 75.1 112.66 0.03 OUTLIER Pre-proline 0 N--CA 1.469 0.505 0 O-C-N 123.847 0.717 . . . . 61.34 111.05 179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' PRO . . . . . 0.429 ' HB3' ' CZ ' ' A' ' 290' ' ' PHE . 96.7 Cg_endo -83.04 37.71 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.551 2.167 . . . . 45.4 112.255 177.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . . . . . . . . . . . -81.72 -68.58 1.44 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.9 -0.667 . . . . 64.13 112.5 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLU . . . . . 0.414 ' OE2' ' HA3' ' A' ' 327' ' ' GLY . 1.9 mp0 -55.98 -36.63 68.09 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 122.045 0.138 . . . . 60.0 111.266 -178.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ILE . . . . . . . . . . . . . 2.9 mp -61.71 -49.53 83.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 CA-C-O 120.827 0.346 . . . . 74.35 110.609 179.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' ALA . . . . . . . . . . . . . . . -65.12 -45.36 85.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.23 -0.441 . . . . 63.2 110.807 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 301' ' ' LYS . 69.1 mmtt -68.3 -31.59 71.13 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.275 -0.42 . . . . 71.51 111.808 -178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' TYR . . . . . 0.408 ' O ' ' HB ' ' A' ' 305' ' ' THR . 82.5 t80 -62.24 -47.68 83.32 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.079 0.466 . . . . 75.4 110.257 175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' MET . . . . . 0.517 ' HA ' HG22 ' A' ' 306' ' ' VAL . 68.6 mtp -73.25 -31.13 63.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 74.44 111.323 179.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' GLU . . . . . 0.512 ' O ' ' HG ' ' A' ' 308' ' ' LEU . 33.2 tt0 -59.76 -44.16 93.98 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.745 -0.835 . . . . 70.34 108.745 171.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.408 ' HB ' ' O ' ' A' ' 302' ' ' TYR . 58.6 m -58.47 -46.44 86.62 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.91 -1.041 . . . . 64.21 111.695 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.517 HG22 ' HA ' ' A' ' 303' ' ' MET . 14.1 m -68.17 -26.21 33.64 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 C-N-CA 120.97 -0.292 . . . . 71.52 111.25 -177.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LYS . . . . . 0.493 ' HE2' ' O ' ' A' ' 279' ' ' ARG . 18.5 ttmt -74.68 -34.08 62.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.049 0.452 . . . . 72.41 110.14 175.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 304' ' ' GLU . 91.7 mt -81.99 5.16 20.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.988 -0.551 . . . . 72.44 112.126 -174.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 315' ' ' PRO . 4.2 pp -107.19 9.28 30.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.417 0.627 . . . . 71.42 109.452 171.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ASP . . . . . 0.543 ' HB3' ' HB2' ' A' ' 313' ' ' GLU . 12.2 t70 67.41 -81.82 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 114.335 -1.302 . . . . 65.41 111.887 174.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' TYR . . . . . 0.962 ' HA ' ' HG3' ' A' ' 241' ' ' ARG . 0.8 OUTLIER -161.91 -48.81 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.954 0.883 . . . . 63.04 109.364 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . . . . . . . . . 9.6 m -145.4 35.94 1.08 Allowed 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 108.052 -1.092 . . . . 75.51 108.052 175.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' GLU . . . . . 0.564 ' O ' ' HD3' ' A' ' 314' ' ' LYS . 3.4 tm-20 -77.54 -82.01 0.09 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.898 -1.047 . . . . 73.52 108.793 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 313' ' ' GLU . 0.6 OUTLIER -150.96 99.73 3.08 Favored Pre-proline 0 C--N 1.328 -0.333 0 N-CA-C 109.051 -0.722 . . . . 64.35 109.051 171.348 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.534 ' HA ' HD22 ' A' ' 309' ' ' LEU . 24.4 Cg_exo -63.28 118.28 5.2 Favored 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.017 1.812 . . . . 72.34 111.124 179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' LEU . . . . . . . . . . . . . 14.7 tp -92.9 84.02 4.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.384 0.612 . . . . 63.41 110.55 -174.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' TYR . . . . . 0.524 ' HE1' ' HB3' ' A' ' 162' ' ' LEU . 61.5 t80 -64.41 -38.89 92.63 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.333 -0.848 . . . . 72.34 110.807 -177.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' GLU . . . . . 0.413 ' O ' ' HG3' ' A' ' 321' ' ' ARG . 39.8 tt0 -56.73 -55.09 38.65 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.342 -0.845 . . . . 60.41 111.327 -177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -57.05 -50.3 73.19 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.127 -0.488 . . . . 52.33 111.776 -177.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' LEU . . . . . 0.517 ' O ' ' HG ' ' A' ' 324' ' ' LEU . 4.2 pp -65.05 -40.26 94.51 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.903 -0.319 . . . . 62.11 111.641 -174.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' ARG . . . . . 0.433 ' N ' HD12 ' A' ' 320' ' ' LEU . 5.4 ppt_? -74.47 -25.51 59.44 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.332 -0.547 . . . . 72.22 109.886 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' A' ' 318' ' ' GLU . 0.4 OUTLIER -73.5 -45.39 54.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.279 -0.419 . . . . 74.42 110.413 -179.819 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ILE . . . . . . . . . . . . . 2.7 pp -69.13 -31.55 50.53 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 C-N-CA 120.931 -0.307 . . . . 74.33 111.14 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 320' ' ' LEU . 71.7 mt -63.79 -48.62 76.14 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 120.911 0.386 . . . . 73.12 110.175 175.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -61.9 -38.67 89.22 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.161 -0.472 . . . . 50.01 110.688 176.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' GLN . . . . . . . . . . . . . 22.2 tp60 -60.74 -44.79 96.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.411 . . . . 54.12 110.891 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.414 ' HA3' ' OE2' ' A' ' 298' ' ' GLU . . . -65.76 -46.37 83.49 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.678 -0.772 . . . . 70.12 112.556 179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' LEU . . . . . 0.784 ' HB2' ' HG ' ' A' ' 155' ' ' LEU . 1.8 tm? -63.49 -38.87 92.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.436 0.636 . . . . 64.34 110.038 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -72.16 -32.03 66.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.851 -0.613 . . . . 72.35 110.652 -179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.31 68.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.333 -0.394 . . . . 51.52 111.812 -176.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.469 HG12 ' O ' ' A' ' 328' ' ' LEU . 40.5 pt -76.8 -6.34 8.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.196 0 CA-C-O 120.844 0.354 . . . . 72.11 111.362 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . 95.06 25.44 14.44 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.483 -0.865 . . . . 73.23 113.149 175.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 41.1 m -129.02 147.71 50.91 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.921 0.36 . . . . 44.54 110.985 179.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' LYS . . . . . . . . . . . . . 21.5 pttp -172.1 75.06 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.648 0.737 . . . . 74.13 110.324 172.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -94.41 -8.32 39.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.807 -0.633 . . . . 55.23 110.613 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ASP . . . . . . . . . . . . . 35.0 t70 82.03 -19.73 0.4 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 123.669 0.788 . . . . 62.4 112.352 171.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 191' ' ' ASP . . . 155.5 50.34 0.01 OUTLIER Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 119.554 -1.308 . . . . 73.45 113.842 179.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' LYS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 191' ' ' ASP . 21.2 ttmm -119.55 99.82 6.9 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.997 -0.742 . . . . 73.42 108.997 170.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' LEU . . . . . 0.543 HD22 ' HA ' ' A' ' 153' ' ' THR . 37.8 mt -86.8 151.67 23.16 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.157 -0.929 . . . . 74.2 112.036 -169.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -114.72 91.1 3.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.594 -0.73 . . . . 70.55 110.221 178.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' LEU . . . . . 0.525 HD12 HG21 ' A' ' 141' ' ' ILE . 3.2 mm? -99.04 -46.95 5.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.129 -0.487 . . . . 75.45 109.746 175.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' SER . . . . . . . . . . . . . 45.3 m 70.55 -44.77 0.58 Allowed 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.324 0.861 . . . . 73.12 113.324 174.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 30.0 m -71.79 -34.39 51.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 112.109 0.411 . . . . 74.13 112.109 -177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' VAL . . . . . 0.478 ' HB ' ' OG ' ' A' ' 136' ' ' SER . 34.6 m 40.97 43.02 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 C-N-CA 124.007 0.923 . . . . 75.25 113.366 177.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -68.2 147.36 52.35 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 115.81 -0.632 . . . . 63.35 111.511 -175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -115.42 148.04 39.85 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.73 -0.668 . . . . 54.42 110.778 -177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' GLY . . . . . 0.561 ' HA3' ' HD2' ' A' ' 140' ' ' LYS . . . -152.41 -56.48 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.741 -0.743 . . . . 63.23 113.135 178.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' GLY . . . . . . . . . . . . . . . 73.99 91.37 0.15 Allowed Glycine 0 CA--C 1.52 0.383 0 C-N-CA 121.147 -0.549 . . . . 72.4 113.034 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' LEU . . . . . 0.446 ' O ' ' HG2' ' A' ' 350' ' ' LYS . 4.7 tt -152.39 92.38 1.68 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.642 -0.328 . . . . 63.3 110.423 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 349' ' ' LEU . 0.6 OUTLIER -159.56 104.51 1.61 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-N 116.133 -0.485 . . . . 73.4 110.67 178.45 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -142.66 91.35 2.3 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.796 0.332 . . . . 63.41 111.347 178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' LYS . . . . . 0.528 ' HB3' HD21 ' A' ' 200' ' ' LEU . 0.4 OUTLIER -159.5 155.3 26.22 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.13 0.491 . . . . 64.4 110.894 176.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' THR . . . . . . . . . . . . . 10.0 t -129.39 168.89 15.62 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.069 -1.086 . . . . 73.02 108.069 169.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ILE . . . . . 0.6 HG23 ' HA ' ' A' ' 200' ' ' LEU . 3.4 pt -66.01 142.67 16.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.417 0.627 . . . . 54.13 111.836 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' THR . . . . . . . . . . . . . 4.4 m -73.07 72.46 1.16 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 114.857 -1.065 . . . . 51.42 110.583 179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -115.35 -48.26 2.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.726 -0.67 . . . . 72.03 111.282 -177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' LYS . . . . . 0.666 ' HG2' ' H ' ' A' ' 358' ' ' ARG . 31.7 ttmt -171.63 -166.35 0.43 Allowed 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.947 -1.131 . . . . 63.32 107.947 -173.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ARG . . . . . 0.666 ' H ' ' HG2' ' A' ' 357' ' ' LYS . 0.0 OUTLIER -86.72 -62.24 1.55 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.865 -0.42 . . . . 72.21 109.865 172.141 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' LYS . . . . . . . . . . . . . 66.1 mttp -138.4 149.24 45.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.454 -0.339 . . . . 63.5 110.509 178.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' LYS . . . . . 0.449 ' C ' ' HD3' ' A' ' 360' ' ' LYS . 1.8 tmtp? . . . . . 0 C--O 1.246 0.881 0 CA-C-O 118.116 -0.945 . . . . 74.12 110.373 -177.502 . . . . . . . . 1 1 . 1 stop_ save_